PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Faklaris, O; Cottet, M; Falco, A; Villier, B; Laget, M; Zwier, JM; Trinquet, E; Mouillac, B; Pin, JP; Durroux, T				Faklaris, Orestis; Cottet, Martin; Falco, Amandine; Villier, Brice; Laget, Michel; Zwier, Jurriaan M.; Trinquet, Eric; Mouillac, Bernard; Pin, Jean-Philippe; Durroux, Thierry			Multicolor time-resolved Forster resonance energy transfer microscopy reveals the impact of GPCR oligomerization on internalization processes	FASEB JOURNAL			English	Article						oligomers; lanthanide; vasopressin; V1a/V2 receptor; quantum dot; multigate mode	PROTEIN-COUPLED RECEPTORS; MOLECULES IN-VIVO; BETA-ARRESTIN; LIVING CELLS; O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE; FUSION PROTEINS; QUANTUM DOTS; FRET; HETERODIMERIZATION; DIAGNOSTICS	Identifying the interacting partners and the dynamics of the molecular networks constitutes the key point in understanding cellular processes. Different methods often based on energy transfer strategies have been developed to examine the molecular dynamics of protein complexes. However, these methods suffer a couple of drawbacks: a single complex can be studied at a time, and its localization and tracking cannot generally be investigated. Here, we report a multicolor time-resolved Forster resonance energy transfer microscopy method that allows the identification of up to 3 different complexes simultaneously, their localization in cells, and their tracking after activation. Using this technique, we studied GPCR oligomerization and internalization in human embryonic kidney 293 cells. We definitively show that receptors can internalize as oligomers and that receptor coexpression deeply impacts oligomer internalization processes	[Faklaris, Orestis; Cottet, Martin; Falco, Amandine; Mouillac, Bernard; Pin, Jean-Philippe; Durroux, Thierry] CNRS, Unite Mixte Rech 5203, Inst Genom Fonct, Montpellier, France; [Faklaris, Orestis; Cottet, Martin; Falco, Amandine; Mouillac, Bernard; Pin, Jean-Philippe; Durroux, Thierry] INSERM, Montpellier, France; [Faklaris, Orestis; Cottet, Martin; Falco, Amandine; Mouillac, Bernard; Pin, Jean-Philippe; Durroux, Thierry] Univ Montpellier, F-34059 Montpellier, France; [Villier, Brice] Hamamastu Photon France, Massy, France; [Laget, Michel; Zwier, Jurriaan M.; Trinquet, Eric] Cisbio Bioassays, Codolet, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier	Durroux, T (corresponding author), INSERM U661, CNRS UMR 5203, Inst Genom Fonct, 141 Rue Cardonille, F-34094 Montpellier 5, France.	tdurroux@igf.cnrs.fr	MOUILLAC, Bernard/M-3896-2014; Pin, Jean-Philippe/Y-6668-2019; Faklaris, Orestis/GQY-4946-2022	MOUILLAC, Bernard/0000-0002-3906-8673; Pin, Jean-Philippe/0000-0002-1423-345X; Faklaris, Orestis/0000-0001-5965-5405; Durroux, Thierry/0000-0003-1091-6066; Zwier, Jurriaan/0000-0001-9017-5856	Centre National de la Recherche Scientifique, Institut National de la Sante et de la Recherche Medicale [ANR-06-BLAN-0087-03, ANR-09-BLAN-0272]; Fondation Recherche Medicale [DEQ20130326522]; Fondation Bettencourt Schuller; la Fondation pour la Recherche Medicale	Centre National de la Recherche Scientifique, Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)Centre National de la Recherche Scientifique (CNRS)); Fondation Recherche Medicale; Fondation Bettencourt Schuller; la Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by research grants from the Centre National de la Recherche Scientifique, Institut National de la Sante et de la Recherche Medicale (ANR-06-BLAN-0087-03 and ANR-09-BLAN-0272). The work was also supported by the Fondation Recherche Medicale (team DEQ20130326522) and the Fondation Bettencourt Schuller (to J.-P.P.). This work was also made possible by the Plateforme Arpege of Montpellier and the Region Languedoc-Roussillon. M.C. was supported by la Fondation pour la Recherche Medicale.	Albizu L, 2010, NAT CHEM BIOL, V6, P587, DOI [10.1038/nchembio.396, 10.1038/NCHEMBIO.396]; ALPHA B, 1990, PHOTOCHEM PHOTOBIOL, V52, P299, DOI 10.1111/j.1751-1097.1990.tb04185.x; Alvarez-Curto E, 2011, MOL PHARMACOL, V80, P1033, DOI 10.1124/mol.111.074674; Bazin H, 2002, J Biotechnol, V82, P233, DOI 10.1016/S1389-0352(01)00040-X; Breton B, 2010, BIOPHYS J, V99, P4037, DOI 10.1016/j.bpj.2010.10.025; Bunzli JCG, 2010, CHEM REV, V110, P2729, DOI 10.1021/cr900362e; Comps-Agrar L, 2012, FASEB J, V26, P3430, DOI 10.1096/fj.12-203646; Cottet M, 2013, BIOCHEM SOC T, V41, P148, DOI 10.1042/BST20120237; Cottet Martin, 2012, Front Endocrinol (Lausanne), V3, P92, DOI 10.3389/fendo.2012.00092; Coulon V, 2008, BIOPHYS J, V94, P1001, DOI 10.1529/biophysj.107.117275; Doumazane E, 2011, FASEB J, V25, P66, DOI 10.1096/fj.10-163147; Feinstein TN, 2013, J BIOL CHEM, V288, P27849, DOI 10.1074/jbc.M112.445098; Gautier A, 2008, CHEM BIOL, V15, P128, DOI 10.1016/j.chembiol.2008.01.007; Geissler D, 2014, INORG CHEM, V53, P1824, DOI 10.1021/ic4017883; Geissler D, 2010, ANGEW CHEM INT EDIT, V49, P1396, DOI 10.1002/anie.200906399; George SR, 2000, J BIOL CHEM, V275, P26128, DOI 10.1074/jbc.M000345200; Herrick-Davis K, 2006, J BIOL CHEM, V281, P27109, DOI 10.1074/jbc.M604390200; Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441; Juillerat A, 2005, CHEMBIOCHEM, V6, P1263, DOI 10.1002/cbic.200400431; Juillerat A, 2003, CHEM BIOL, V10, P313, DOI 10.1016/S1074-5521(03)00068-1; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Lin HL, 2013, J BIOL CHEM, V288, P11203, DOI 10.1074/jbc.M112.439950; MATHIS G, 1995, CLIN CHEM, V41, P1391; Maurel D, 2008, NAT METHODS, V5, P561, DOI [10.1038/nmeth.1213, 10.1038/NMETH.1213]; Milligan G, 2010, CURR OPIN PHARMACOL, V10, P23, DOI 10.1016/j.coph.2009.09.010; Morgner F, 2010, ANGEW CHEM INT EDIT, V49, P7570, DOI 10.1002/anie.201002943; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Rajapakse HE, 2010, P NATL ACAD SCI USA, V107, P13582, DOI 10.1073/pnas.1002025107; Rives ML, 2009, EMBO J, V28, P2195, DOI 10.1038/emboj.2009.177; Rocheville M, 2000, J BIOL CHEM, V275, P7862, DOI 10.1074/jbc.275.11.7862; Sartania N, 2007, CELL SIGNAL, V19, P1928, DOI 10.1016/j.cellsig.2007.05.002; Selvin PR, 2002, ANNU REV BIOPH BIOM, V31, P275, DOI 10.1146/annurev.biophys.31.101101.140927; Serradeil-Le Gal C, 1993, J CLIN INVEST, V92, P224; SerradeilLeGal C, 1996, J CLIN INVEST, V98, P2729, DOI 10.1172/JCI119098; Terrillon S, 2004, P NATL ACAD SCI USA, V101, P1548, DOI 10.1073/pnas.0305322101; Terrillon S, 2003, MOL ENDOCRINOL, V17, P677, DOI 10.1210/me.2002-0222; Zhang Y, 2006, ANGEW CHEM INT EDIT, V45, P4936, DOI 10.1002/anie.200601197	38	33	33	0	30	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2235	2246		10.1096/fj.14-260059	http://dx.doi.org/10.1096/fj.14-260059			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	25690655				2022-12-26	WOS:000355209500003
J	Gaspard, GJ; McMaster, CR				Gaspard, Gerard J.; McMaster, Christopher R.			The Mitochondrial Quality Control Protein Yme1 Is Necessary to Prevent Defective Mitophagy in a Yeast Model of Barth Syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BEEF-HEART MITOCHONDRIA; ADP/ATP CARRIER PROTEIN; TAZ GENE MUTATION; SACCHAROMYCES-CEREVISIAE; CARDIOLIPIN METABOLISM; INNER MEMBRANE; TAFAZZIN; DNA; PHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPIDS	The Saccharomyces cerevisiae TAZ1 gene is an orthologue of human TAZ; both encode the protein tafazzin. Tafazzin is a transacylase that transfers acyl chains with unsaturated fatty acids from phospholipids to monolysocardiolipin to generate cardiolipin with unsaturated fatty acids. Mutations in human TAZ cause Barth syndrome, a fatal childhood cardiomyopathy biochemically characterized by reduced cardiolipin mass and increased monolysocardiolipin levels. To uncover cellular processes that require tafazzin to maintain cell health, we performed a synthetic genetic array screen using taz1 Delta yeast cells to identify genes whose deletion aggravated its fitness. The synthetic genetic array screen uncovered several mitochondrial cellular processes that require tafazzin. Focusing on the i-AAA protease Yme1, a mitochondrial quality control protein that degrades misfolded proteins, we determined that in cells lacking both Yme1 and Taz1 function, there were substantive mitochondrial ultrastructural defects, ineffective superoxide scavenging, and a severe defect in mitophagy. We identify an important role for the mitochondrial protease Yme1 in the ability of cells that lack tafazzin function to maintain mitochondrial structural integrity and mitochondrial quality control and to undergo mitophagy.	[Gaspard, Gerard J.; McMaster, Christopher R.] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS B3H 4R2, Canada; [McMaster, Christopher R.] Dalhousie Univ, Dept Pharmacol, Halifax, NS B3H 4R2, Canada	Dalhousie University; Dalhousie University	McMaster, CR (corresponding author), Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS B3H 4R2, Canada.	Christopher.mcmaster@dal.ca		McMaster, Christopher/0000-0003-0822-5776	Genome Canada; Genome Atlantic; Barth Syndrome Foundation of Canada; Canadian Institutes of Health Research	Genome Canada(Genome Canada); Genome Atlantic; Barth Syndrome Foundation of Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Genome Canada, Genome Atlantic, and the Barth Syndrome Foundation of Canada. This study was also supported by a Canadian Institutes of Health Research grant (to C. R. M.).	Acehan D, 2007, LAB INVEST, V87, P40, DOI 10.1038/labinvest.3700480; Baile MG, 2014, J BIOL CHEM, V289, P1768, DOI 10.1074/jbc.M113.525733; BEYER K, 1985, BIOCHEMISTRY-US, V24, P3821, DOI 10.1021/bi00336a001; Beyer K, 1996, BIOCHEMISTRY-US, V35, P15784, DOI 10.1021/bi9610055; Brandner K, 2005, MOL BIOL CELL, V16, P5202, DOI 10.1091/mbc.E05-03-0256; CAMPBELL CL, 1994, MOL BIOL CELL, V5, P899, DOI 10.1091/mbc.5.8.899; Campbell CL, 1998, J CELL SCI, V111, P2455; Chen SL, 2008, MOL MICROBIOL, V68, P1061, DOI 10.1111/j.1365-2958.2008.06216.x; Clarke SLN, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-23; Claypool SM, 2008, J CELL BIOL, V182, P937, DOI 10.1083/jcb.200801152; Claypool SM, 2008, MOL BIOL CELL, V19, P5143, DOI 10.1091/mbc.E08-09-0896; Claypool SM, 2006, J CELL BIOL, V174, P379, DOI 10.1083/jcb.200605043; Connerth M, 2012, SCIENCE, V338, P815, DOI 10.1126/science.1225625; Diekert K, 2001, METHOD CELL BIOL, V65, P37, DOI 10.1016/S0091-679X(01)65003-9; Gebert N, 2009, CURR BIOL, V19, P2133, DOI 10.1016/j.cub.2009.10.074; Gonzalvez F, 2013, BBA-MOL BASIS DIS, V1832, P1194, DOI 10.1016/j.bbadis.2013.03.005; Gu ZM, 2004, MOL MICROBIOL, V51, P149, DOI 10.1046/j.1365-2958.2003.03802.x; Horvath SE, 2013, PROG LIPID RES, V52, P590, DOI 10.1016/j.plipres.2013.07.002; Houtkooper RH, 2008, CELL MOL LIFE SCI, V65, P2493, DOI 10.1007/s00018-008-8030-5; Jefferies JL, 2013, AM J MED GENET C, V163, P198, DOI 10.1002/ajmg.c.31372; Johnston J, 1997, AM J HUM GENET, V61, P1053, DOI 10.1086/301604; Joshi AS, 2012, J BIOL CHEM, V287, P17589, DOI 10.1074/jbc.M111.330167; Kanki T, 2009, AUTOPHAGY, V5, P1186, DOI 10.4161/auto.5.8.9854; Khuchua Z, 2006, CIRC RES, V99, P201, DOI 10.1161/01.RES.0000233378.95325.ce; Kurihara Y, 2012, J BIOL CHEM, V287, P3265, DOI 10.1074/jbc.M111.280156; Langer T, 2000, TRENDS BIOCHEM SCI, V25, P247, DOI 10.1016/S0968-0004(99)01541-8; LORENZ MC, 1995, GENE, V158, P113, DOI 10.1016/0378-1119(95)00144-U; McKenzie M, 2006, J MOL BIOL, V361, P462, DOI 10.1016/j.jmb.2006.06.057; Nebauer R, 2007, FEBS J, V274, P6180, DOI 10.1111/j.1742-4658.2007.06138.x; Neuwald AF, 1997, CURR BIOL, V7, pR465; Patil VA, 2013, J BIOL CHEM, V288, P1696, DOI 10.1074/jbc.M112.428938; Phoon CKL, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.111.000455; Potting C, 2010, EMBO J, V29, P2888, DOI 10.1038/emboj.2010.169; Ronvelia D, 2012, MOL GENET METAB, V107, P428, DOI 10.1016/j.ymgme.2012.09.013; Schagger H, 2001, METHOD CELL BIOL, V65, P231, DOI 10.1016/S0091-679X(01)65014-3; Schlame M, 2000, PROG LIPID RES, V39, P257, DOI 10.1016/S0163-7827(00)00005-9; Schlame M, 2002, ANN NEUROL, V51, P634, DOI 10.1002/ana.10176; Schneiter R, 1999, J CELL BIOL, V146, P741, DOI 10.1083/jcb.146.4.741; Swamy Mahima, 2006, Sci STKE, V2006, ppl4, DOI 10.1126/stke.3452006pl4; Tamura Y, 2009, J CELL BIOL, V185, P1029, DOI 10.1083/jcb.200812018; THORSNESS PE, 1993, MOL CELL BIOL, V13, P5418, DOI 10.1128/MCB.13.9.5418; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tsai CL, 2010, BIOCHEMISTRY-US, V49, P9132, DOI 10.1021/bi1013062; Vaden DL, 2005, ANAL BIOCHEM, V338, P162, DOI 10.1016/j.ab.2004.11.020; Whited K, 2013, HUM MOL GENET, V22, P483, DOI 10.1093/hmg/dds447; Xu Y, 2006, P NATL ACAD SCI USA, V103, P11584, DOI 10.1073/pnas.0603242103; Xu Y, 2006, J BIOL CHEM, V281, P39217, DOI 10.1074/jbc.M606100200	47	23	23	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					9284	9298		10.1074/jbc.M115.641878	http://dx.doi.org/10.1074/jbc.M115.641878			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25688091	hybrid, Green Published			2022-12-26	WOS:000352207100049
J	Rayavarapu, RR; Heiden, B; Pagani, N; Shaw, MM; Shuff, S; Zhang, SY; Schafer, ZT				Rayavarapu, Raju R.; Heiden, Brendan; Pagani, Nicholas; Shaw, Melissa M.; Shuff, Sydney; Zhang, Siyuan; Schafer, Zachary T.			The Role of Multicellular Aggregation in the Survival of ErbB2-positive Breast Cancer Cells during Extracellular Matrix Detachment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; E-CADHERIN EXPRESSION; ERBB2 REQUIRES; ANOIKIS; GROWTH; METASTASIS; ACTIVATION; SUPPRESSION; AUTOPHAGY; EGFR	The metastasis of cancer cells from the site of the primary tumor to distant sites in the body represents the most deadly manifestation of cancer. In order for metastasis to occur, cancer cells need to evade anoikis, which is defined as apoptosis caused by loss of attachment to extracellular matrix (ECM). Signaling from ErbB2 has previously been linked to the evasion of anoikis in breast cancer cells but the precise molecular mechanisms by which ErbB2 blocks anoikis have yet to be unveiled. In this study, we have identified a novel mechanism by which anoikis is inhibited in ErbB2-expressing cells: multicellular aggregation during ECM-detachment. Our data demonstrate that disruption of aggregation in ErbB2-positive cells is sufficient to induce anoikis and that this anoikis inhibition is a result of aggregation-induced stabilization of EGFR and consequent ERK/MAPK survival signaling. Furthermore, these data suggest that ECM-detached ErbB2-expressing cells may be uniquely susceptible to targeted therapy against EGFR and that this sensitivity could be exploited for specific elimination of ECM-detached cancer cells.	[Rayavarapu, Raju R.; Heiden, Brendan; Pagani, Nicholas; Shaw, Melissa M.; Shuff, Sydney; Zhang, Siyuan; Schafer, Zachary T.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA	University of Notre Dame	Schafer, ZT (corresponding author), Univ Notre Dame, Dept Biol Sci, Galvin Life Sci Ctr 222, Notre Dame, IN 46556 USA.	zschafe1@nd.edu	Zhang, Siyuan/A-1276-2014; Zhang, Siyuan/AAH-1157-2021	Zhang, Siyuan/0000-0003-0910-3666; Zhang, Siyuan/0000-0003-0910-3666; Shuff, Sydney/0000-0002-5026-3461; Heiden, Brendan/0000-0002-0116-7377	Glynn Family Honors Program; Notre Dame NSF-REU program in biology; NIH [5R00CA158066]; Lee National Denim Day Research Scholar Grant from the American Cancer Society [RSG-14-145-01-CSM]; Career Catalyst Grant from Susan G. Komen [CCR14302768]; NATIONAL CANCER INSTITUTE [R00CA158066] Funding Source: NIH RePORTER	Glynn Family Honors Program; Notre Dame NSF-REU program in biology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lee National Denim Day Research Scholar Grant from the American Cancer Society; Career Catalyst Grant from Susan G. Komen(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Glynn Family Honors Program and the Notre Dame NSF-REU program in biology (to N. P.).; Recipient of a Pathway to Independence Award (5R00CA158066) from the NIH.; Recipient of a Lee National Denim Day Research Scholar Grant (RSG-14-145-01-CSM) from the American Cancer Society and a Career Catalyst Grant (CCR14302768) from Susan G. Komen.	Adachi M, 2003, FEBS LETT, V551, P147, DOI 10.1016/S0014-5793(03)00915-3; Arteaga CL, 2014, CANCER CELL, V25, P282, DOI 10.1016/j.ccr.2014.02.025; Avivar-Valderas A, 2013, ONCOGENE, V32, P4932, DOI 10.1038/onc.2012.512; Avivar-Valderas A, 2011, MOL CELL BIOL, V31, P3616, DOI 10.1128/MCB.05164-11; Bossy-Wetzel E, 2000, METHOD ENZYMOL, V322, P235; Bremm A, 2008, CANCER RES, V68, P707, DOI 10.1158/0008-5472.CAN-07-1588; Buchheit C. L., 2014, CELL DEATH DIFFER, DOI [10.1038/cdd.2014.1209, DOI 10.1038/CDD.2014.1209]; Buchheit CL, 2014, NAT REV CANCER, V14, P632, DOI 10.1038/nrc3789; Buchheit CL, 2012, SEMIN CELL DEV BIOL, V23, P402, DOI 10.1016/j.semcdb.2012.04.007; Chao YL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-179; Davison CA, 2013, CANCER RES, V73, P3704, DOI 10.1158/0008-5472.CAN-12-2482; Douma S, 2004, NATURE, V430, P1034, DOI 10.1038/nature02765; Fernandez SV, 2013, BREAST CANCER RES TR, V140, P23, DOI 10.1007/s10549-013-2600-4; FIDLER IJ, 1973, EUR J CANCER, V9, P223, DOI 10.1016/S0014-2964(73)80022-2; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Fung C, 2008, MOL BIOL CELL, V19, P797, DOI 10.1091/mbc.E07-10-1092; Geiger TR, 2007, CANCER RES, V67, P6221, DOI 10.1158/0008-5472.CAN-07-0121; Goh LK, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a017459; Grassian AR, 2011, J BIOL CHEM, V286, P79, DOI 10.1074/jbc.M110.169821; Haenssen KK, 2010, J CELL SCI, V123, P1373, DOI 10.1242/jcs.050906; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Higgins MJ, 2011, J CLIN INVEST, V121, P3797, DOI 10.1172/JCI57152; Kowalski PJ, 2003, BREAST CANCER RES, V5, pR217, DOI 10.1186/bcr651; Kumar S, 2011, MOL CELL BIOL, V31, P4036, DOI 10.1128/MCB.01342-10; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Moss NM, 2009, CANCER RES, V69, P7121, DOI 10.1158/0008-5472.CAN-08-4151; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Ocana OH, 2012, CANCER CELL, V22, P709, DOI 10.1016/j.ccr.2012.10.012; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Pece S, 1999, J BIOL CHEM, V274, P19347, DOI 10.1074/jbc.274.27.19347; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; PIERCEALL WE, 1995, ONCOGENE, V11, P1319; Reginato MJ, 2005, MOL CELL BIOL, V25, P4591, DOI 10.1128/MCB.25.11.4591-4601.2005; Reginato MJ, 2003, NAT CELL BIOL, V5, P733, DOI 10.1038/ncb1026; Robertson FM, 2010, CA-CANCER J CLIN, V60, P351, DOI 10.3322/caac.20082; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Schmelzle T, 2007, P NATL ACAD SCI USA, V104, P3787, DOI 10.1073/pnas.0700115104; She QB, 2005, CANCER CELL, V8, P287, DOI 10.1016/j.ccr.2005.09.006; Shen XD, 2004, AM J PATHOL, V165, P1315, DOI 10.1016/S0002-9440(10)63390-1; Stott SL, 2010, P NATL ACAD SCI USA, V107, P18392, DOI 10.1073/pnas.1012539107; Tsai JH, 2012, CANCER CELL, V22, P725, DOI 10.1016/j.ccr.2012.09.022; van Roy F, 2014, NAT REV CANCER, V14, P121, DOI 10.1038/nrc3647; Wan LL, 2013, NAT MED, V19, P1450, DOI 10.1038/nm.3391; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; Wang SZE, 2006, CANCER CELL, V10, P25, DOI 10.1016/j.ccr.2006.05.023; WATANABE S, 1954, CANCER, V7, P215, DOI 10.1002/1097-0142(195403)7:2<215::AID-CNCR2820070203>3.0.CO;2-6; Weigel KJ, 2014, MOL CANCER RES, V12, P855, DOI 10.1158/1541-7786.MCR-14-0090; Whelan KA, 2013, J BIOL CHEM, V288, P15865, DOI 10.1074/jbc.M112.426999; Whelan KA, 2010, MOL BIOL CELL, V21, P3829, DOI 10.1091/mbc.E10-04-0353; Witta SE, 2006, CANCER RES, V66, P944, DOI 10.1158/0008-5472.CAN-05-1988; Yonesaka K, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002442; Yu M, 2011, J CELL BIOL, V192, P373, DOI 10.1083/jcb.201010021	54	29	30	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					8722	8733		10.1074/jbc.M114.612754	http://dx.doi.org/10.1074/jbc.M114.612754			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25681438	hybrid, Green Published			2022-12-26	WOS:000352207100004
J	Wang, HS; Luo, X; You, WW; Dong, YW; Ke, CH				Wang, Haishan; Luo, Xuan; You, Weiwei; Dong, Yunwei; Ke, Caihuan			Cytogenetic Analysis and Chromosomal Characteristics of the Polymorphic 18S rDNA of Haliotis discus hannai from Fujian, China	PLOS ONE			English	Article							PACIFIC ABALONE; RUFESCENS ARCHAEOGASTROPODA; TELOMERIC (TTAGGG)(N); (GATA)(N) REPEATS; ORGANIZER REGION; KARYOTYPE; NUCLEOLUS; PROTEINS; FISH; DNA	We report on novel chromosomal characteristics of Haliotis discus hannai from a breeding population at Fujian, China. The karyotypes of H. discus hannai we obtained from an abalone farm include a common type 2n = 36 = 10M + 8SM (82%) and two rare types 2n = 36 = 11M + 7SM (14%) and 2n = 36 = 10M + 7SM + 1ST (4%). The results of silver staining showed that the NORs of H. discus hannai were usually located terminally on the long arms of chromosome pairs 14 and 17, NORs were also sometimes located terminally on the short arms of other chromosomes, either metacentric or submetacentric pairs. The number of Ag-nucleoli ranged from 2 to 8, and the mean number was 3.61 +/- 0.93. Among the scored interphase cells, 41% had 3 detectable nucleoli and 37% had 4 nucleoli. The 18S rDNA FISH result is the first report of the location of 18S rDNA genes in H. discus hannai. The 18S rDNA locations were highly polymorphic in this species. Copies of the gene were observed in the terminal of long or/and short arms of submetacentric or/and metacentric chromosomes. Using FISH with probe for vertebrate-like telomeric sequences (CCCTAA)(3) displayed positive green FITC signals at telomere regions of all analyzed chromosome types. We found about 7% of chromosomes had breaks in prophase. A special form of nucleolus not previously described from H. discus hannai was observed in some interphase cells. It consists of many small silver-stained nucleoli gathered together to form a larger nucleolus and may correspond to prenucleolar bodies.	[Wang, Haishan; Luo, Xuan; You, Weiwei; Dong, Yunwei; Ke, Caihuan] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China; [Wang, Haishan; Luo, Xuan; You, Weiwei; Dong, Yunwei; Ke, Caihuan] Xiamen Univ, Coll Ocean, Xiamen, Peoples R China; [Wang, Haishan; Luo, Xuan; You, Weiwei; Dong, Yunwei; Ke, Caihuan] Xiamen Univ, Coll Earth Sci, Xiamen, Peoples R China	Xiamen University; Xiamen University; Xiamen University	Ke, CH (corresponding author), Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China.	chke@xmu.edu.cn	Dong, Yunwei/C-4617-2011	Dong, Yunwei/0000-0003-4550-2322	Hi-Tech Research and Development (863) Program of China [2012AA10A412]; National Natural Science Foundation of China [U1205121, 41106120, 31101896]; China Postdoctoral Science Foundation [20110490846]; Science & Technology Key Program of Fujian Province [2011N0033]; National Sparking Plan Project [2011GA720001]; Earmarked Fund for Modern Agro-industry Technology Research System [CARS-48]	Hi-Tech Research and Development (863) Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Science & Technology Key Program of Fujian Province; National Sparking Plan Project; Earmarked Fund for Modern Agro-industry Technology Research System	The work was supported by Hi-Tech Research and Development (863) Program of China (No. 2012AA10A412), the National Natural Science Foundation of China (U1205121), the National Natural Science Foundation of China (No. 41106120), China Postdoctoral Science Foundation (No. 20110490846), Science & Technology Key Program of Fujian Province (No. 2011N0033), National Sparking Plan Project (No. 2011GA720001) and National Natural Science Foundation of China (No. 31101896), the Earmarked Fund for Modern Agro-industry Technology Research System (CARS-48). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amar-Basulto G, 2011, AQUAC RES, V42, P1460, DOI 10.1111/j.1365-2109.2010.02738.x; An HS, 2011, INT J MOL SCI, V12, P4836, DOI 10.3390/ijms12084836; Angelier N, 2005, MOL BIOL CELL, V16, P2862, DOI 10.1091/mbc.e05-01-0041; ARAI K, 1986, AQUACULTURE, V58, P305, DOI 10.1016/0044-8486(86)90096-7; Arai K, 1982, B JPN SOC SCI FISHER, V48; BABU KA, 1985, INT REV CYTOL, V94, P151, DOI 10.1016/S0074-7696(08)60396-4; Bell P, 1997, J CELL SCI, V110, P43; Britton-Davidian J, 2012, HEREDITY, V108, P68, DOI 10.1038/hdy.2011.105; Cai MY, 2010, J SHELLFISH RES, V29, P735, DOI 10.2983/035.029.0327; COWELL JK, 1982, ANNU REV GENET, V16, P21, DOI 10.1146/annurev.ge.16.120182.000321; Cross I, 2003, GENETICA, V119, P65, DOI 10.1023/A:1024478407781; Fisheries CBo, 2008, CHIN FISH YB 2007; Gallardo-Escarate C, 2005, J SHELLFISH RES, V24, P1153; Gallardo-Escarate C, 2004, J SHELLFISH RES, V23, P205; Gallardo-Escarate C, 2007, J SHELLFISH RES, V26, P825, DOI 10.2983/0730-8000(2007)26[825:KCITCA]2.0.CO;2; Gallardo-Escarate C, 2005, HEREDITAS, V142, P73, DOI 10.1111/j.1601-5223.2005.01909.x; Guo XM, 1999, J SHELLFISH RES, V18, P19; Hernandez-Ibarra NK, 2007, AQUACULTURE, V272, pS268, DOI 10.1016/j.aquaculture.2007.07.086; Hernandez-Verdun D, 2006, HISTOCHEM CELL BIOL, V125, P127, DOI 10.1007/s00418-005-0046-4; Hernandez-Verdun D, 2002, J CELL SCI, V115, P2265; INSUA A, 1991, AQUACULTURE, V97, P317, DOI 10.1016/0044-8486(91)90324-Z; JORDAN G, 1987, NATURE, V329, P489, DOI 10.1038/329489a0; Kobayashi T, 2010, J SHELLFISH RES, V29, P643, DOI 10.2983/035.029.0313; KOMARU A, 1985, Venus the Japanese Journal of Malacology, V44, P249; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; Luo X, 2012, J SHELLFISH RES, V31, P316; Miyaki K, 1999, FISHERIES SCI, V65, P317, DOI 10.2331/fishsci.65.317; Nie HT, 2012, ANIM GENET, V43, P290, DOI 10.1111/j.1365-2052.2011.02254.x; Okumura SI, 1999, J SHELLFISH RES, V18, P605; Sakai M, 2005, J SHELLFISH RES, V24, P1149; Savino TM, 2001, J CELL BIOL, V153, P1097, DOI 10.1083/jcb.153.5.1097; Scheer Ulrich, 1993, Trends in Cell Biology, V3, P236, DOI 10.1016/0962-8924(93)90123-I; Seki Tetsuo, 1997, Bulletin of Tohoku National Fisheries Research Institute, V59, P1; Sekino M, 2007, GENETICS, V175, P945, DOI 10.1534/genetics.106.065839; THIRIOTQUIEVREUX C, 1992, J EXP MAR BIOL ECOL, V157, P33, DOI 10.1016/0022-0981(92)90072-I; VITTURI R, 1992, MAR BIOL, V112, P37, DOI 10.1007/BF00349725	36	23	24	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0113816	10.1371/journal.pone.0113816	http://dx.doi.org/10.1371/journal.pone.0113816			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25699679	Green Published, gold, Green Submitted			2022-12-26	WOS:000349789800001
J	Husaini, Y; Lockwood, GP; Nguyen, TV; Tsai, VWW; Mohammad, MG; Russell, PJ; Brown, DA; Breit, SN				Husaini, Yasmin; Lockwood, Glen P.; Nguyen, Trung V.; Tsai, Vicky Wang-Wei; Mohammad, Mohammad G.; Russell, Pamela J.; Brown, David A.; Breit, Samuel N.			Macrophage Inhibitory Cytokine-1 (MIC-1/GDF15) Gene Deletion Promotes Cancer Growth in TRAMP Prostate Cancer Prone Mice	PLOS ONE			English	Article							EXPRESSION; TUMORIGENESIS; CHEMOTHERAPY; GDF-15; IDENTIFICATION; MARKER; MEMBER; CELLS	The divergent TGF-beta superfamily member, macrophage inhibitory cytokine-1 (MIC-1/GDF15), is overexpressed by most cancers, including prostate cancer (PCa). Whilst its circulating levels are linked to cancer outcome, the role MIC-1/GDF15 plays in cancer development and progression is incompletely understood. To investigate its effect on PCa development and spread, we have used TRAMP prostate cancer prone mice bearing a germline deletion of MIC-1/GDF15 (TRAMP(MIC-/-)). On average TRAMP(MIC-/-) mice died about 5 weeks earlier and had larger prostatic tumors compared with TRAMP mice that were wild type for MIC-1/GDF15 (TRAMP(MIC+/+)). Additionally, at the time of death or ethical end point, even when adjusted for lifespan, there were no significant differences in the number of mice with metastases between the TRAMP(MIC+/+) and TRAMP(MIC-/-) groups. However, consistent with our previous data, more than twice as many TRAMP mice overexpressing MIC-1/GDF15 (TRAMP(fmsmic-1)) had metastases than TRAMP(MIC+/+) mice (p<0.0001). We conclude that germ line gene deletion of MIC-1/GDF15 leads to increased local tumor growth resulting in decreased survival consistent with an overall protective role for MIC-1/GDF15 in early primary tumor development. However, in advancing disease, as we have previously noted, MIC-1/GDF15 overexpression may promote local invasion and metastatic spread.	[Husaini, Yasmin; Lockwood, Glen P.; Nguyen, Trung V.; Tsai, Vicky Wang-Wei; Mohammad, Mohammad G.; Brown, David A.; Breit, Samuel N.] St Vincents Hosp, St Vincents Ctr Appl Med Res, Sydney, NSW 2010, Australia; [Husaini, Yasmin; Lockwood, Glen P.; Nguyen, Trung V.; Tsai, Vicky Wang-Wei; Mohammad, Mohammad G.; Brown, David A.; Breit, Samuel N.] Univ New S Wales, Sydney, NSW 2010, Australia; [Russell, Pamela J.] Queensland Univ Technol, Australian Prostate Canc Res Ctr Queensland, Inst Hlth & Biomed Innovat, Translat Res Inst, Brisbane, Qld 4102, Australia	St Vincents Hospital Sydney; University of New South Wales Sydney; Queensland University of Technology (QUT)	Brown, DA (corresponding author), St Vincents Hosp, St Vincents Ctr Appl Med Res, Sydney, NSW 2010, Australia.	D.Brown@amr.org.au; s.breit@amr.org.au	Russell, Pamela J/G-1685-2010; Russell, Pamela/O-8504-2019	Russell, Pamela J/0000-0002-3995-1239; Nguyen, Trung Viet/0000-0002-1749-8509; Mohammad, Mohammad/0000-0002-6775-1955; Brown, David/0000-0003-1382-9419	Cancer Council New South Wales; National Health and Medical Research Council of Australia (NHMRC)	Cancer Council New South Wales(Cancer Council New South Wales); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by grants from Cancer Council New South Wales (http://www.cancercouncil.com.au/) and The National Health and Medical Research Council of Australia (NHMRC) (https://www.nhmrc.gov.au/). DAB is a National Health and Medical Research Council Biomedical Career Development Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertoni M, 2002, ONCOGENE, V21, P4212, DOI 10.1038/sj.onc.1205610; American CS, 2014, CANC FACTS FIG; Baek KE, 2009, CLIN CHIM ACTA, V401, P128, DOI 10.1016/j.cca.2008.12.008; Baek SJ, 2006, GASTROENTEROLOGY, V131, P1553, DOI 10.1053/j.gastro.2006.09.015; Baek SJ, 2001, MOL PHARMACOL, V59, P901, DOI 10.1124/mol.59.4.901; Bauskin AR, 2005, CANCER RES, V65, P2330, DOI 10.1158/0008-5472.CAN-04-3827; Bauskin AR, 2006, CANCER RES, V66, P4983, DOI 10.1158/0008-5472.CAN-05-4067; Bauskin AR, 2010, J INTERF CYTOK RES, V30, P389, DOI 10.1089/jir.2009.0052; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Boyer J, 2006, CANCER RES, V66, P2765, DOI 10.1158/0008-5472.CAN-05-2693; Boyle GM, 2009, J INVEST DERMATOL, V129, P383, DOI 10.1038/jid.2008.270; Breit SN, 2011, GROWTH FACTORS, V29, P187, DOI 10.3109/08977194.2011.607137; Brown DA, 2006, CLIN CANCER RES, V12, P89, DOI 10.1158/1078-0432.CCR-05-1331; Brown DA, 2003, CLIN CANCER RES, V9, P2642; Brown DA, 2002, BIOTECHNIQUES, V33, P118, DOI 10.2144/02331rr03; Brown DA, 2012, CANCER EPIDEM BIOMAR, V21, P337, DOI 10.1158/1055-9965.EPI-11-0786; Brown DA, 2009, CLIN CANCER RES, V15, P6658, DOI 10.1158/1078-0432.CCR-08-3126; Cekanova M, 2009, CANCER PREV RES, V2, P450, DOI 10.1158/1940-6207.CAPR-09-0057; de Jager SCA, 2011, J EXP MED, V208, P217, DOI 10.1084/jem.20100370; Fluge O, 2006, THYROID, V16, P161; Gingrich JR, 1996, CANCER RES, V56, P4096; Huang CY, 2007, CLIN CANCER RES, V13, P5825, DOI 10.1158/1078-0432.CCR-07-1037; Husaini Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043833; Johnen H, 2007, NAT MED, V13, P1333, DOI 10.1038/nm1677; Joiner MC, 2011, RADIOTHER ONCOL, V101, P233, DOI 10.1016/j.radonc.2011.05.068; Koopmann J, 2006, CLIN CANCER RES, V12, P442, DOI 10.1158/1078-0432.CCR-05-0564; Koopmann J, 2004, CLIN CANCER RES, V10, P2386, DOI 10.1158/1078-0432.CCR-03-0165; Mehta RS, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju016; Modlich O, 2004, CLIN CANCER RES, V10, P6418, DOI 10.1158/1078-0432.CCR-04-1031; Roth P, 2010, CLIN CANCER RES, V16, P3851, DOI 10.1158/1078-0432.CCR-10-0705; Selander KS, 2007, CANCER EPIDEM BIOMAR, V16, P532, DOI 10.1158/1055-9965.EPI-06-0841; Senapati S, 2010, ONCOGENE, V29, P1293, DOI 10.1038/onc.2009.420; Staff AC, 2011, CLIN CANCER RES, V17, P4825, DOI 10.1158/1078-0432.CCR-11-0715; Staff AC, 2010, GYNECOL ONCOL, V118, P237, DOI 10.1016/j.ygyno.2010.05.032; Suesskind D, 2011, GRAEFES ARCH CLIN EX; Tsai VWW, 2012, J CACHEXIA SARCOPENI, V3, P239, DOI 10.1007/s13539-012-0082-6; Tsai VWW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055174; Tsui KH, 2012, J MOL ENDOCRINOL, V49, P153, DOI 10.1530/JME-11-0149; Wallin U, 2011, BRIT J CANCER, V104, P1619, DOI 10.1038/bjc.2011.112; Wang XY, 2012, PROSTATE, V72, P677, DOI 10.1002/pros.21471; Weber F, 2005, J CLIN ENDOCR METAB, V90, P2512, DOI 10.1210/jc.2004-2028; Welsh JB, 2003, P NATL ACAD SCI USA, V100, P3410, DOI 10.1073/pnas.0530278100; Zimmers TA, 2008, J CANCER RES CLIN, V134, P753, DOI 10.1007/s00432-007-0336-4; Zimmers TA, 2010, J CANCER RES CLIN, V136, P571, DOI 10.1007/s00432-009-0691-4	44	22	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0115189	10.1371/journal.pone.0115189	http://dx.doi.org/10.1371/journal.pone.0115189			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695521	Green Submitted, gold, Green Published			2022-12-26	WOS:000350062300004
J	Yang, M; Zhang, XD; Xu, YG; Mei, XY; Jiang, BB; Liao, JJ; Yin, ZB; Zheng, JF; Zhao, Z; Fan, LM; He, XH; Zhu, YY; Zhu, SS				Yang, Min; Zhang, Xiaodan; Xu, Yanguo; Mei, Xinyue; Jiang, Bingbing; Liao, Jingjing; Yin, Zhaobo; Zheng, Jianfen; Zhao, Zhi; Fan, Liming; He, Xiahong; Zhu, Youyong; Zhu, Shusheng			Autotoxic Ginsenosides in the Rhizosphere Contribute to the Replant Failure of Panax notoginseng	PLOS ONE			English	Article							AMERICAN GINSENG; PHENOLIC-COMPOUNDS; QUINQUEFOLIUM-L; FUSARIUM-WILT; CINNAMIC ACID; GROWTH; ROOTS; L.; IDENTIFICATION; PATHOGENS	Background and Aims Sanqi ginseng (Panax notoginseng) growth is often hampered by replant failure. In this study, we aimed to examine the role of autotoxicity in Sanqi replant failures and assess the role of ginsenosides in autotoxicity. Methods The autotoxicities were measured using seedling emergence bioassays and root cell vigor staining. The ginsenosides in the roots, soils, and root exudates were identified with HPLCMS. Results The seedling emergence and survival rate decreased significantly with the continuous number of planting years from one to three years. The root exudates, root extracts, and extracts from consecutively cultivated soils also showed significant autotoxicity against seedling emergence and growth. Ginsenosides, including R-1, Rg(1), Re, Rb-1, Rb-3, Rg(2), and Rd, were identified in the roots and consecutively cultivated soil. The ginsenosides, Rg(1), Re, Rg(2), and Rd, were identified in the root exudates. Furthermore, the ginsenosides, R-1, Rg(1), Re, Rg(2), and Rd, caused autotoxicity against seedling emergence and growth and root cell vigor at a concentration of 1.0 mu g/mL. Conclusion Our results demonstrated that autotoxicity results in replant failure of Sanqi ginseng. While Sanqi ginseng consecutively cultivated, some ginsenosides can accumulate in rhizosphere soils through root exudates or root decomposition, which impedes seedling emergence and growth.	[Yang, Min; Zhang, Xiaodan; Xu, Yanguo; Mei, Xinyue; Jiang, Bingbing; Liao, Jingjing; Yin, Zhaobo; Zheng, Jianfen; Zhao, Zhi; Fan, Liming; He, Xiahong; Zhu, Youyong; Zhu, Shusheng] Yunnan Agr Univ, Key Lab Agro Biodivers & Pest Management, Educ Minist China, Kunming, Peoples R China	Yunnan Agricultural University	Zhu, SS (corresponding author), Yunnan Agr Univ, Key Lab Agro Biodivers & Pest Management, Educ Minist China, Kunming, Peoples R China.	shushengzhu79@126.com			Yunnan Development and Reform Commission; Natural Science Foundation of China [30800731, 31260447]; Ministry of Science and Technology of China [2011CB100400]	Yunnan Development and Reform Commission; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This study was partially supported by Yunnan Development and Reform Commission, the Natural Science Foundation of China (30800731 and 31260447) and the "973" program from the Ministry of Science and Technology of China (2011CB100400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asaduzzaman M, 2012, SCI HORTIC-AMSTERDAM, V134, P26, DOI 10.1016/j.scienta.2011.11.035; Bi XB, 2010, ALLELOPATHY J, V25, P115; Chen ChangBao, 2006, Journal of Jilin Agricultural University, V28, P534; [陈超 Chen Chao], 2006, [制冷学报, Journal of Refrigeration], V27, P37; Chen ZJ, 2012, J WENSHAN U, V25, P1, DOI [10.1089/scd.2011.0471, DOI 10.1089/SCD.2011.0471, DOI 10.3969/J.ISSN.1674-9200.2012.06.002]; Chou CH, 1976, J CHEM ECOL, V2, P353, DOI 10.1007/BF00988282; Du Jia-fang, 2009, Shengtaixue Zazhi, V28, P445; Fan KW, 2002, MYCOLOGIA, V94, P569, DOI 10.2307/3761708; Fuzzati N, 1999, J CHROMATOGR A, V854, P69, DOI 10.1016/S0021-9673(99)00463-X; Gao Wei-Wei, 2006, Zhongguo Zhong Yao Za Zhi, V31, P1665; He CN, 2009, PLANT SOIL, V318, P63, DOI 10.1007/s11104-008-9817-8; Hoagland DR, 1950, WATER CULTURE METHOD, V347; Jiao XL, 2011, PLANT SOIL, V339, P317, DOI 10.1007/s11104-010-0580-2; Kong CH, 1999, J CHEM ECOL, V25, P2347, DOI 10.1023/A:1020882109682; Leite M, 1999, ANAL CELL PATHOL, V19, P139, DOI 10.1155/1999/176515; Li Y., 2012, OPEN J GENET, V2, P95, DOI [10.4236/ ojgen.2012.22014, DOI 10.4236/OJGEN.2012.22014]; [李勇 LI Yong], 2009, [生态学报, Acta Ecologica Sinica], V29, P161; [李勇 Li Yong], 2008, [生态环境, Ecology and Environment], V17, P1173; Li ZF, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0028806, 10.1371/journal.pone.0052388]; Luo PX, 1991, SW CHINA J AGR SCI, V4, P77; Luo WF, 1999, J YUNNAN AGR U, V14, P124; Miao ZuoQing, 2006, Scientia Agricultura Sinica, V39, P1371; Ng TB, 2006, J PHARM PHARMACOL, V58, P1007, DOI 10.1211/jpp.58.8.0001; Nicol RW, 2003, PHYTOCHEMISTRY, V64, P257, DOI 10.1016/S0031-9422(03)00271-1; Nicol RW, 2002, CAN J BOT, V80, P557, DOI [10.1139/b02-034, 10.1139/B02-034]; Ogweno JO, 2006, ALLELOPATHY J, V18, P93; Ou Xiaohong, 2012, Zhongguo Zhong Yao Za Zhi, V37, P1905; Rice EL, 1984, ALLELOPATHY; Tan GuoYin, 2012, Journal of Northwest A & F University - Natural Science Edition, V40, P197; WALLER GR, 1993, BOT BULL ACAD SINICA, V34, P1; WILLIAMS RD, 1982, WEED SCI, V30, P206, DOI 10.1017/S0043174500062342; Wu HW, 2007, PLANT SOIL, V296, P85, DOI 10.1007/s11104-007-9292-7; Wu L., 2008, SPECIAL WILD EC ANIM, V2, P68, DOI DOI 10.16720/J.CNKI.TCYJ.2008.02.005; Xiao H, 2010, CHINESE MED J RES PR, V24, P5; Yang JZ, 2010, SPECIAL WILD EC ANIM, V2, P37; [杨敏 Yang Min], 2014, [植物保护, Plant Protection], V40, P76; Ye SF, 2004, PLANT SOIL, V263, P143, DOI 10.1023/B:PLSO.0000047721.78555.dc; Ye SF, 2006, ENVIRON EXP BOT, V56, P255, DOI 10.1016/j.envexpbot.2005.02.010; Yousef LF, 2006, PHYTOCHEMISTRY, V67, P1740, DOI 10.1016/j.phytochem.2005.06.030; YU JQ, 1993, SOIL SCI PLANT NUTR, V39, P13, DOI 10.1080/00380768.1993.10416970; Zhang AH, 2011, J MED PLANTS RES, V5, P3217; Zhang YC, 2012, CHEM RES CHINESE U, V28, P31; Zhao YJ, 2005, ALLELOPATHY J, V15, P67; Zhou JM, 2009, SPECIAL WILD EC ANIM, V3, P37; 周家明, 2007, [中药材, Journal of Chinese Medicinal Materials], V30, P1615	45	85	102	5	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0118555	10.1371/journal.pone.0118555	http://dx.doi.org/10.1371/journal.pone.0118555			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695831	gold, Green Published, Green Submitted			2022-12-26	WOS:000350062300056
J	Bruno, EA; Guthrie, JW; Ellwood, SA; Mellanby, RJ; Clements, DN				Bruno, Elizabeth A.; Guthrie, James W.; Ellwood, Stephen A.; Mellanby, Richard J.; Clements, Dylan N.			Global Positioning System Derived Performance Measures Are Responsive Indicators of Physical Activity, Disease and the Success of Clinical Treatments in Domestic Dogs	PLOS ONE			English	Article							OSTEOARTHRITIS; ACCELEROMETER; PREVALENCE; CARPROFEN; LAMENESS; WEIGHT	Objective To assess the use of Global Positioning System receiver (GPS) derived performance measures for differentiating between: 1) different outdoor activities in healthy dogs; 2) healthy dogs and those with osteoarthritis; 3) osteoarthritic dogs before and after treatment with non-steroidal anti-inflammatory analgesia. Design Prospective study. Animals Ten healthy dogs and seven dogs with osteoarthritis of the elbow joint (OA dogs). Procedure Healthy dogs were walked on a standard route on-lead, off-lead and subjected to playing activity (chasing a ball) whilst wearing a GPS collar. Each dog was walked for five consecutive days. Dogs with OA were subjected to a single off-lead walk whilst wearing a GPS collar, and then administered oral Carprofen analgesia daily for two weeks. OA dogs were then subjected to the same walk, again wearing a GPS collar. Results GPS derived measures of physical performance could differentiate between on-lead activity, off-lead activity and playing activity in healthy dogs, and between healthy dogs and OA dogs. Variation in the performance measures analysed was greater between individual dogs than for individual dogs on different days. Performance measures could differentiate healthy dogs from OA dogs. OA Dogs treated with Carprofen analgesia showed improvements in their physical performance, which returned to values indistinguishable from those of healthy dogs on nearly all the measures assessed. Conclusions and Clinical Relevance GPS derived measures of physical performance in dogs are objective, easy to quantify, and can be used to gauge the effects of disease and success of clinical treatments. Specific stimuli can be used to modulate physical performance beyond the self-governed boundaries that dogs will naturally express when allowed to exercise freely without stimulation.	[Bruno, Elizabeth A.; Guthrie, James W.; Mellanby, Richard J.; Clements, Dylan N.] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin, Midlothian, Scotland; [Bruno, Elizabeth A.; Guthrie, James W.; Mellanby, Richard J.; Clements, Dylan N.] Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland; [Ellwood, Stephen A.] Wildlife Savvy Ltd, Abingdon, Oxon, England; [Mellanby, Richard J.] Univ Edinburgh, Ctr Inflammat Res, MRC, Edinburgh, Midlothian, Scotland	University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Clements, DN (corresponding author), Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin, Midlothian, Scotland.	Dylan.clements@ed.ac.uk		Guthrie, James/0000-0001-5648-8736; Clements, Dylan/0000-0002-0596-1885; Mellanby, Richard John/0000-0002-3467-7007	PetPlan Charitable Trust [08-29]; Wildlife Savvy Ltd.	PetPlan Charitable Trust; Wildlife Savvy Ltd.	This work was funded by the PetPlan Charitable Trust (Grant Number 08-29). Wildlife Savvy Ltd. provided support in the form of a salary for author SAE, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Ahlstrom O, 2011, BRIT J NUTR, V106, pS158, DOI 10.1017/S0007114511001838; Akos Z, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003446; Brown DD, 2013, ANIM BIOTELEM, V1, P20, DOI DOI 10.1186/2050-3385-1-20; Brown DC, 2010, JAVMA-J AM VET MED A, V237, P66, DOI 10.2460/javma.237.1.66; Buchanan JW., 1999, TXB CANINE FELINE CA, V2nd, P458; Burton NJ, 2008, VET COMP ORTHOPAED, V21, P110, DOI 10.3415/VCOT-07-04-0038; CASPERSEN CJ, 1985, PUBLIC HEALTH REP, V100, P126; Clarke SP, 2005, VET REC, V157, P793, DOI 10.1136/vr.157.25.793; Clements DN, 2005, VET REC, V156, P478, DOI 10.1136/vr.156.15.478; COWARD WA, 1988, P NUTR SOC, V47, P209, DOI 10.1079/PNS19880037; Hansen BD, 2007, AM J VET RES, V68, P468, DOI 10.2460/ajvr.68.5.468; Hay CW, 1997, AM J VET RES, V58, P1027; Hercock CA, 2009, J SMALL ANIM PRACT, V50, P266, DOI 10.1111/j.1748-5827.2009.00765.x; Innes JF, 2000, VET REC, V147, P325, DOI 10.1136/vr.147.12.325; Ireland JL, 2013, RES VET SCI, V95, P418, DOI 10.1016/j.rvsc.2013.05.007; Kim Y, 2013, PUBLIC HEALTH NUTR, V16, P440, DOI 10.1017/S1368980012002996; Mansa S, 2007, VET REC, V160, P427, DOI 10.1136/vr.160.13.427; Marshall WG, 2010, VET RES COMMUN, V34, P241, DOI 10.1007/s11259-010-9348-7; Melanson EL, 1996, CRIT REV FOOD SCI, V36, P385, DOI 10.1080/10408399609527732; Michel KE, 2011, AM J VET RES, V72, P866, DOI 10.2460/ajvr.72.7.866; Nuttall T, 2006, VET DERMATOL, V17, P348, DOI 10.1111/j.1365-3164.2006.00537.x; Sibley RJ, 2013, VET REC, V172, P92, DOI 10.1136/vr.f394; Stafford KJ, 2008, NEW ZEAL VET J, V56, P274, DOI 10.1080/00480169.2008.36847; Swimmer RA, 2011, J VET INTERN MED, V25, P405, DOI 10.1111/j.1939-1676.2011.0689.x; THORP BH, 1994, AVIAN PATHOL, V23, P203, DOI 10.1080/03079459408418991; Usherwood JR, 2005, NATURE, V438, P753, DOI 10.1038/438753a; VASSEUR PB, 1995, J AM VET MED ASSOC, V206, P807; Voss K, 2010, VET SURG, V39, P863, DOI 10.1111/j.1532-950X.2010.00729.x; Wernham BGJ, 2011, J VET INTERN MED, V25, P1298, DOI 10.1111/j.1939-1676.2011.00825.x; Wilson RP, 2006, J ANIM ECOL, V75, P1081, DOI 10.1111/j.1365-2656.2006.01127.x; Wrigglesworth DJ, 2011, AM J VET RES, V72, P1151, DOI 10.2460/ajvr.72.9.1151	31	7	7	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117094	10.1371/journal.pone.0117094	http://dx.doi.org/10.1371/journal.pone.0117094			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692761	Green Published, Green Submitted, gold			2022-12-26	WOS:000350061500038
J	Dufour, CMS; Meynard, C; Watson, J; Rioux, C; Benhamou, S; Perez, J; du Plessis, JJ; Avenant, N; Pillay, N; Ganem, G				Dufour, Claire M. S.; Meynard, Christine; Watson, Johan; Rioux, Camille; Benhamou, Simon; Perez, Julie; du Plessis, Jurie J.; Avenant, Nico; Pillay, Neville; Ganem, Guila			Space Use Variation in Co-Occurring Sister Species: Response to Environmental Variation or Competition?	PLOS ONE			English	Article							HOME-RANGE SIZE; ECOLOGICAL CHARACTER DISPLACEMENT; INTERSPECIFIC COMPETITION; RHABDOMYS-PUMILIO; SPATIAL NICHE; ORGANIZATION; SEPARATION	Coexistence often involves niche differentiation either as the result of environmental divergence, or in response to competition. Disentangling the causes of such divergence requires that environmental variation across space is taken into account, which is rarely done in empirical studies. We address the role of environmental variation versus competition in coexistence between two rodent species: Rhabdomys bechuanae (bechuanae) and Rhabdomys dilectus dilectus (dilectus) comparing their habitat preference and home range (HR) size in areas with similar climates, where their distributions abut (allopatry) or overlap (sympatry). Using Outlying Mean Index analyses, we test whether habitat characteristics of the species deviate significantly from a random sample of available habitats. In allopatry, results suggest habitat selection: dilectus preferring grasslands with little bare soil while bechuanae occurring in open shrublands. In sympatry, shrubland type habitats dominate and differences are less marked, yet dilectus selects habitats with more cover than bechuanae. Interestingly, bechuanae shows larger HRs than dilectus, and both species display larger HRs in sympatry. Further, HR overlaps between species are lower than expected. We discuss our results in light of data on the phylogeography of the genus and propose that evolution in allopatry resulted in adaptation leading to different habitat preferences, even at their distribution margins, a divergence expected to facilitate coexistence. However, since sympatry occurs in sites where environmental characteristics do not allow complete species separation, competition may explain reduced inter-species overlap and character displacement in HR size. This study reveals that both environmental variation and competition may shape species coexistence.	[Dufour, Claire M. S.; Rioux, Camille; Perez, Julie; Ganem, Guila] Univ Montpellier 2, EPHE, IRD, CNRS,UM2,Inst Sci Evolut Montpellier UMR5554, F-34095 Montpellier, France; [Dufour, Claire M. S.; Pillay, Neville; Ganem, Guila] Univ Witwatersrand, Sch Anim Plant & Environm Sci, ZA-2050 Johannesburg, South Africa; [Meynard, Christine] INRA IRD Cirad Montpellier SupAgro, INRA UMR CBGP, F-34988 Montferrier Sur Lez, France; [Watson, Johan] Biodivers Res, Dept Econ Dev Tourism & Environm Affairs, ZA-9300 Bloemfontein, South Africa; [Benhamou, Simon] CNRS, Ctr Ecol Fonct & Evolut, UMR 5175, UM2, F-34033 Montpellier, France; [du Plessis, Jurie J.; Avenant, Nico] Univ Orange Free State, Dept Mammal, Natl Museum, Bloemfontein, South Africa; [du Plessis, Jurie J.; Avenant, Nico] Univ Orange Free State, Ctr Environm Management, Bloemfontein, South Africa	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite de Montpellier; University of Witwatersrand; CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; University of the Free State; University of the Free State	Dufour, CMS (corresponding author), Univ Montpellier 2, EPHE, IRD, CNRS,UM2,Inst Sci Evolut Montpellier UMR5554, CC065, F-34095 Montpellier, France.	claire.dufour@univ-montp2.fr; guila.ganem@univ-montp2.fr	Ganem, Guila/AAC-1872-2022; Meynard, Christine N/B-2082-2010	Ganem, Guila/0000-0002-5244-4979; Meynard, Christine N/0000-0002-5983-6289; Avenant, Nico/0000-0002-5390-9010; Pillay, Neville/0000-0002-0778-726X	Free State DTEEA; SIBAGHE; French CNRS/SA NRF [4841, 81859, 191]	Free State DTEEA; SIBAGHE; French CNRS/SA NRF	This work was supported by Free State DTEEA, SIBAGHE, the French CNRS/SA NRF agreements through PICS (no 4841 and no 81859) and GDRI (no 191) programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 2006, ECOLOGY, V87, pS50, DOI 10.1890/0012-9658(2006)87[50:NEAART]2.0.CO;2; Arakaki S, 2011, J ANIM ECOL, V80, P137, DOI 10.1111/j.1365-2656.2010.01749.x; Benhamou S, 2014, ANIM BEHAV, V90, P171, DOI 10.1016/j.anbehav.2014.01.030; Borger L, 2006, J ANIM ECOL, V75, P1393, DOI 10.1111/j.1365-2656.2006.01164.x; BROWN WL, 1956, SYST ZOOL, V5, P49, DOI 10.2307/2411924; Case TJ, 2000, AM NAT, V155, P583, DOI 10.1086/303351; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; CLUTTONBROCK TH, 1989, PROC R SOC SER B-BIO, V236, P339, DOI 10.1098/rspb.1989.0027; Dayan T, 2005, ECOL LETT, V8, P875, DOI 10.1111/j.1461-0248.2005.00791.x; Doledec S, 2000, ECOLOGY, V81, P2914, DOI 10.1890/0012-9658(2000)081[2914:NSICAA]2.0.CO;2; du Toit N, 2012, MOL PHYLOGENET EVOL, V65, P75, DOI 10.1016/j.ympev.2012.05.036; Ganem G, 2012, ACTA OECOL, V42, P30, DOI 10.1016/j.actao.2012.01.003; Godsall B, 2014, J ANIM ECOL, V83, P126, DOI 10.1111/1365-2656.12116; Goldberg EE, 2006, EVOLUTION, V60, P1344, DOI 10.1111/j.0014-3820.2006.tb01214.x; GRANT P R, 1972, Biological Journal of the Linnean Society, V4, P39, DOI 10.1111/j.1095-8312.1972.tb00690.x; Grant PR, 2006, SCIENCE, V313, P224, DOI 10.1126/science.1128374; HAWES ML, 1977, J MAMMAL, V58, P354, DOI 10.2307/1379334; HOLMES WG, 1991, ANIM BEHAV, V42, P111, DOI 10.1016/S0003-3472(05)80611-6; Jonsson P, 2002, EVOL ECOL, V16, P455, DOI 10.1023/A:1020854525220; Lira AFA, 2013, ZOOLOGY, V116, P182, DOI 10.1016/j.zool.2013.01.002; Lopez-Darias M, 2012, ECOLOGY, V93, P2512, DOI 10.1890/12-0483.1; Losos JB, 2011, EVOLUTION, V65, P1827, DOI 10.1111/j.1558-5646.2011.01289.x; MACARTHUR R, 1966, AM NAT, V100, P319, DOI 10.1086/282425; McCormack JE, 2011, EVOLUTION, V65, P184, DOI 10.1111/j.1558-5646.2010.01097.x; Meynard CN, 2012, ECOL EVOL, V2, P1008, DOI 10.1002/ece3.219; Mikami OK, 2002, ECOGRAPHY, V25, P200, DOI 10.1034/j.1600-0587.2002.250208.x; Mucina L., 2006, VEGETATION S AFRICA; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Pfennig DW, 2012, EVOLUTIONS WEDGE COM, DOI [10.1016/S2214-109X(15)70024-0, DOI 10.1016/S2214-109X(15)70024-0]; Powell RA, 2012, J MAMMAL, V93, P948, DOI 10.1644/11-MAMM-S-177.1; Rambau RV, 2003, MOL PHYLOGENET EVOL, V28, P564, DOI 10.1016/S1055-7903(03)00058-7; SCHLUTER D, 1992, AM NAT, V140, P85, DOI 10.1086/285404; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; Schradin C, 2006, J ETHOL, V24, P37, DOI 10.1007/s10164-005-0158-2; Schradin C, 2005, J MAMMAL, V86, P99, DOI 10.1644/1545-1542(2005)086<0099:IVITSA>2.0.CO;2; Schradin C, 2004, BEHAV ECOL SOCIOBIOL, V55, P439, DOI 10.1007/s00265-003-0733-x; Schradin C, 2010, ANIM BEHAV, V79, P195, DOI 10.1016/j.anbehav.2009.10.027; Schradin C, 2009, AM NAT, V173, P376, DOI 10.1086/596535; Seidel K., 1992, STAT PROPERTIES APPL; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Stapp P, 1997, FUNCT ECOL, V11, P644, DOI 10.1046/j.1365-2435.1997.00133.x; Stradiotto A, 2009, J MAMMAL, V90, P704, DOI 10.1644/08-MAMM-A-120R1.1; Stuart YE, 2013, TRENDS ECOL EVOL, V28, P402, DOI 10.1016/j.tree.2013.02.014; TRFfS Computing, 2011, R LANG ENV STAT COMP, DOI [10.1016/j.neuroimage.2011.01.013, DOI 10.1016/J.NEUROIMAGE.2011.01.013]; TROMBULAK SC, 1985, J MAMMAL, V66, P329, DOI 10.2307/1381245; Tufto J, 1996, J ANIM ECOL, V65, P715, DOI 10.2307/5670; van Valen L., 1965, AM NAT, V99, P377, DOI DOI 10.1086/282379; Violle C, 2011, ECOL LETT, V14, P782, DOI 10.1111/j.1461-0248.2011.01644.x; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; Zar J.H., 2010, BIOSTAT ANAL	50	28	29	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117750	10.1371/journal.pone.0117750	http://dx.doi.org/10.1371/journal.pone.0117750			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693176	Green Published, gold			2022-12-26	WOS:000350061500072
J	Lee, CC; Wang, CN; Lee, YL; Tsai, YR; Liu, JJ				Lee, Chen-Chen; Wang, Chien-Neng; Lee, Yueh-Lun; Tsai, Yi-Ru; Liu, Jau-Jin			High Mobility Group Box 1 Induced Human Lung Myofibroblasts Differentiation and Enhanced Migration by Activation of MMP-9	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; GLYCATION END-PRODUCTS; MATRIX METALLOPROTEINASES; AIRWAY INFLAMMATION; ENDOTHELIAL-CELLS; MURINE MODEL; B1 HMGB1; ASTHMA; EXPRESSION; FIBROSIS	High mobility group box 1 (HMGB1) is a nuclear protein that involves the binding with DNA and influences chromatin regulation and transcription. HMGB1 is also a cytokine that can activate monocytes and neutrophils involved in inflammation. In this study, we investigated the role of HMGB1 on cellular activation using human fibroblast cell line WI-38. After treatment with 1, 10, and 100 ng/mL of HMGB1 for 24 h, we did not find obviously cytotoxicity and cellular proliferation of WI-38 cells by MTT and BrdU incorporation assay, respectively. However, we found that treatment with 10 and 100 ng/mL of HMGB1 induced the differentiation of lung fibroblasts into myofibroblasts and myofibroblasts showed higher migration ability through activation of matrix metalloproteinase (MMP)-9 activation. To delineate the mechanism underlying HMGB1-induced cellular migration, we examined HMGB1-induced mitogen activated protein kinases (MAPKs), including extracellular signal related kinase (ERK), c-Jun N-terminal kinase (JNK), and p38 mitogen activated protein kinase (p38) phosphorylation, as well as nuclear factor (NF)-kappa B nuclear translocation. Using specific inhibitors and shRNAs of protein kinases, we observed that repression of ERK, JNK, p38, and NF-kappa B all inhibited HMGB1-induced cellular differentiation, migration and MMP-9 activation in WI-38 cells. In addition, knocking down of RAGE but not TLR2 and TLR4 by shRNAs attenuated HMGB1-induced myofibroblast differentiation and migration. In conclusion, our study demonstrated that HMGB1 induced lung fibroblasts' differentiation into myofibroblasts and enhanced cell migration through induction of MMP-9 activation and the RAGE-MAPK and NF-kappa B interaction signaling pathways. Targeting HMGB1 might be a potential therapeutic approach for alleviation of airway remodeling seen in chronic airway inflammatory diseases.	[Lee, Chen-Chen; Liu, Jau-Jin] China Med Univ, Sch Med, Dept Microbiol & Immunol, Taichung, Taiwan; [Lee, Chen-Chen; Wang, Chien-Neng; Tsai, Yi-Ru] China Med Univ, Coll Med, Grad Inst Basic Med Sci, Taichung, Taiwan; [Lee, Yueh-Lun] Taipei Med Univ, Coll Med, Sch Med, Dept Microbiol & Immunol, Taipei, Taiwan	China Medical University Taiwan; China Medical University Taiwan; Taipei Medical University	Lee, CC (corresponding author), China Med Univ, Sch Med, Dept Microbiol & Immunol, Taichung, Taiwan.	leechenchen@mail.cmu.edu.tw	Lee, Chen-Chen/H-4267-2014		National Science Council in Taiwan [NSC 101-2320-B-039-047]; China medical University [CMU102-S-27, CMU102-BC-10]	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan); China medical University(China Medical University)	This study was supported by the National Science Council in Taiwan (NSC 101-2320-B-039-047) and China medical University (CMU102-S-27 and CMU102-BC-10).	Alam R, 2011, CLIN EXP ALLERGY, V41, P149, DOI 10.1111/j.1365-2222.2010.03658.x; Andersson U, 2000, J EXP MED, V192, P565, DOI 10.1084/jem.192.4.565; Aoshiba K, 2004, CLIN REV ALLERG IMMU, V27, P35, DOI 10.1385/CRIAI:27:1:035; BRAMLEY AM, 1994, EUR RESPIR J, V7, P337, DOI 10.1183/09031936.94.07020337; Ferhani N, 2010, AM J RESP CRIT CARE, V181, P917, DOI 10.1164/rccm.200903-0340OC; Fiuza C, 2003, BLOOD, V101, P2652, DOI 10.1182/blood-2002-05-1300; GOODWIN GH, 1973, EUR J BIOCHEM, V38, P14, DOI 10.1111/j.1432-1033.1973.tb03026.x; Greenlee KJ, 2007, PHYSIOL REV, V87, P69, DOI 10.1152/physrev.00022.2006; Hamada N, 2008, AM J RESP CELL MOL, V39, P440, DOI 10.1165/rcmb.2007-0330OC; Hou CC, 2011, MOL MED, V17, P807, DOI 10.2119/molmed.2010.00173; Ivanov S, 2007, BLOOD, V110, P1970, DOI 10.1182/blood-2006-09-044776; Jeffery Peter K, 2004, Proc Am Thorac Soc, V1, P176, DOI 10.1513/pats.200402-009MS; Kohan M, 2009, AM J RESP CELL MOL, V41, P290, DOI 10.1165/rcmb.2008-0307OC; Kokkola R, 2005, SCAND J IMMUNOL, V61, P1, DOI 10.1111/j.0300-9475.2005.01534.x; Kolodsick JE, 2003, AM J RESP CELL MOL, V29, P537, DOI 10.1165/rcmb.2002-0243OC; Lagente V, 2005, BRAZ J MED BIOL RES, V38, P1521, DOI 10.1590/S0100-879X2005001000009; Lee CC, 2013, BIOCHEM PHARMACOL, V86, P940, DOI 10.1016/j.bcp.2013.08.003; Lee CC, 2012, J AGR FOOD CHEM, V60, P9405, DOI 10.1021/jf2038778; Lee CC, 2012, TOXICOL IN VITRO, V26, P552, DOI 10.1016/j.tiv.2012.01.021; Lee CC, 2011, LIFE SCI, V89, P364, DOI 10.1016/j.lfs.2011.07.002; Lenga Y, 2008, CIRC RES, V102, P319, DOI 10.1161/CIRCRESAHA.107.160408; Lewis CC, 2005, J ALLERGY CLIN IMMUN, V115, P534, DOI 10.1016/j.jaci.2004.11.051; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lin CD, 2014, NANOMEDICINE LOND; Messmer D, 2004, J IMMUNOL, V173, P307, DOI 10.4049/jimmunol.173.1.307; Milara J, 2013, THORAX, V68, P410, DOI 10.1136/thoraxjnl-2012-201761; Nelson KK, 2004, FREE RADICAL BIO MED, V37, P768, DOI 10.1016/j.freeradbiomed.2004.06.008; Park JS, 2003, AM J PHYSIOL-CELL PH, V284, pC870, DOI 10.1152/ajpcell.00322.2002; Pascual RM, 2005, J ALLERGY CLIN IMMUN, V116, P477, DOI 10.1016/j.jaci.2005.07.011; Rao YK, 2013, INT IMMUNOPHARMACOL, V17, P617, DOI 10.1016/j.intimp.2013.08.002; Rowe SM, 2008, AM J RESP CRIT CARE, V178, P822, DOI 10.1164/rccm.200712-1894OC; Shim EJ, 2012, CLIN EXP ALLERGY, V42, P958, DOI 10.1111/j.1365-2222.2012.03998.x; Sivakumar P, 2012, CURR OPIN PULM MED, V18, P462, DOI 10.1097/MCP.0b013e328356800f; Stefanidakis M, 2006, BLOOD, V108, P1441, DOI 10.1182/blood-2006-02-005363; van Beijnum JR, 2008, ANGIOGENESIS, V11, P91, DOI 10.1007/s10456-008-9093-5; Wang HC, 2009, SHOCK, V32, P348, DOI 10.1097/SHK.0b013e3181a551bd; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Yang H, 2005, J LEUKOCYTE BIOL, V78, P1, DOI 10.1189/jlb.1104648; Yang J, 2012, MOL BIOL REP, V39, P3361, DOI 10.1007/s11033-011-1106-6; Yu M, 2006, SHOCK, V26, P174, DOI 10.1097/01.shk.0000225404.51320.82	40	23	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0116393	10.1371/journal.pone.0116393	http://dx.doi.org/10.1371/journal.pone.0116393			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692286	Green Published, gold, Green Submitted			2022-12-26	WOS:000350061500014
J	Relvas, LJM; Makhoul, M; Dewispelaere, R; Caspers, L; Communi, D; Boeynaems, JM; Robaye, B; Bruyns, C; Willermain, F				Relvas, Lia Judice M.; Makhoul, Maya; Dewispelaere, Remi; Caspers, Laure; Communi, Didier; Boeynaems, Jean-Marie; Robaye, Bernard; Bruyns, Catherine; Willermain, Francois			P2Y(2)R Deficiency Attenuates Experimental Autoimmune Uveitis Development	PLOS ONE			English	Article							DENDRITIC CELLS; T-CELLS; EXTRACELLULAR NUCLEOTIDES; RECEPTOR ACTIVATION; CYTOKINE PRODUCTION; LUNG INFLAMMATION; SYSTEM; ENCEPHALOMYELITIS; EXPRESSION; RESPONSES	We aimed to study the role of the nucleotide receptor P2Y(2)R in the development of experimental autoimmune uveitis (EAU). EAU was induced in P2Y(2)(+/+) and P2Y(2)(-/-) mice by immunization with IRBP peptide or by adoptive transfer of in vitro restimulated semi-purified IRBP-specific enriched T lymphocytes from spleens and lymph nodes isolated from native C57BI/6 or P2Y(2)(+/+) and P2Y(2)(-/-) immunized mice. Clinical and histological scores were used to grade disease severity. Splenocytes and lymph node cell phenotypes were analyzed using flow cytometry. Semi-purified lymphocytes and MACS-purified CD4(+) T lymphocytes from P2Y(2)(+/+) and P2Y(2)(-/-) immunized mice were tested for proliferation and cytokine secretion. Our data show that clinical and histological scores were significantly decreased in IRBP-immunized P2Y(2)(-/-) mice as in P2Y(2)(-/-) mice adoptively transfered with enriched T lymphocytes from C57BI/6 IRBP-immunized mice. In parallel, naive C57BI/6 mice adoptively transferred with T lymphocytes from P2Y(2)(-/-) IRBP-immunized mice also showed significantly less disease. No differences in term of spleen and lymph node cell recruitment or phenotype appeared between P2Y(2)(-/-) and P2Y(2)(+/+) immunized mice. However, once restimulated in vitro with IRBP, P2Y(2)(-/-) T cells proliferate less and secrete less cytokines than the P2Y(2)(+/+) one. We further found that antigen-presenting cells of P2Y(2)(-/-) immunized mice were responsible for this proliferation defect. Together our data show that P2Y(2)(-/-) mice are less susceptible to mount an autoimmune response against IRBP. Those results are in accordance with the danger model, which makes a link between autoreactive lymphocyte activation, cell migration and the release of danger signals such as extracellular nucleotides.	[Relvas, Lia Judice M.; Dewispelaere, Remi; Caspers, Laure; Willermain, Francois] CHU St Pierre & Brugmann, Dept Ophthalmol, Brussels, Belgium; [Relvas, Lia Judice M.; Makhoul, Maya; Dewispelaere, Remi; Communi, Didier; Boeynaems, Jean-Marie; Bruyns, Catherine; Willermain, Francois] IRIBHM, Inst Interdisciplinary Res, Brussels, Belgium; [Robaye, Bernard] IRIBHM, Inst Interdisciplinary Res, Gosselies, Belgium; [Boeynaems, Jean-Marie] Free Univ Brussels, Erasme Hosp, Dept Lab Med, B-1050 Brussels, Belgium; [Relvas, Lia Judice M.; Makhoul, Maya; Dewispelaere, Remi; Caspers, Laure; Communi, Didier; Boeynaems, Jean-Marie; Robaye, Bernard; Bruyns, Catherine; Willermain, Francois] Univ Libre Bruxelles, Brussels, Belgium	Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Libre de Bruxelles	Relvas, LJM (corresponding author), CHU St Pierre & Brugmann, Dept Ophthalmol, Brussels, Belgium.	ljudiced@ulb.ac.be			Fondation Vesale; Fondation Brugmann; Fond de recherche en ophtalmologie (FRO)	Fondation Vesale; Fondation Brugmann; Fond de recherche en ophtalmologie (FRO)	Funding provided by Fondation Vesale, LJR; Fondation Brugmann, LJR; Fond de recherche en ophtalmologie (FRO), LJR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker OJ, 2008, MOL IMMUNOL, V45, P65, DOI 10.1016/j.molimm.2007.05.009; Bours MJL, 2006, PHARMACOL THERAPEUT, V112, P358, DOI 10.1016/j.pharmthera.2005.04.013; CASPI RR, 1988, J IMMUNOL, V140, P1490; Chan CC, 1998, BRIT J OPHTHALMOL, V82, P91, DOI 10.1136/bjo.82.1.91; Chen LF, 2006, J IMMUNOL, V176, P3115, DOI 10.4049/jimmunol.176.5.3115; Dick AD, 2004, PROG RETIN EYE RES, V23, P617, DOI 10.1016/j.preteyeres.2004.06.005; Granstein RD, 2005, J IMMUNOL, V174, P7725, DOI 10.4049/jimmunol.174.12.7725; Holtkamp GM, 2001, PROG RETIN EYE RES, V20, P29, DOI 10.1016/S1350-9462(00)00017-3; Hou WQ, 2003, J IMMUNOL, V170, P1728, DOI 10.4049/jimmunol.170.4.1728; Idzko M, 2007, NAT MED, V13, P913, DOI 10.1038/nm1617; Junger WG, 2011, NAT REV IMMUNOL, V11, P201, DOI 10.1038/nri2938; Kukulski F, 2010, MOL IMMUNOL, V47, P991, DOI 10.1016/j.molimm.2009.11.020; Kunitomi A, 2000, J LEUKOCYTE BIOL, V68, P111; Liston A, 2009, J IMMUNOL, V182, P3121, DOI 10.4049/jimmunol.0713169; Matzinger P, 2002, ANN NY ACAD SCI, V961, P341, DOI 10.1111/j.1749-6632.2002.tb03118.x; Matzinger P, 2011, NAT REV IMMUNOL, V11, P221, DOI 10.1038/nri2940; Mizumoto N, 2002, NAT MED, V8, P358, DOI 10.1038/nm0402-358; Muller T, 2010, ALLERGY, V65, P1545, DOI 10.1111/j.1398-9995.2010.02426.x; Relvas LJM, 2009, INVEST OPHTH VIS SCI, V50, P1241, DOI 10.1167/iovs.08-1902; Shao H, 2006, EXP EYE RES, V82, P323, DOI 10.1016/j.exer.2005.07.008; Sharp AJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-33; Trabanelli S, 2012, J IMMUNOL, V189, P1303, DOI 10.4049/jimmunol.1103800; Vanderstocken G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050385; Vanderstocken G, 2010, J IMMUNOL, V185, P3702, DOI 10.4049/jimmunol.0903908; Vitiello L, 2012, BLOOD, V120, P511, DOI 10.1182/blood-2012-01-406496; Weber FC, 2010, J EXP MED, V207, P2609, DOI 10.1084/jem.20092489; Whiting D, 2004, J IMMUNOL, V172, P7417, DOI 10.4049/jimmunol.172.12.7417; Willermain F, 2000, INVEST OPHTH VIS SCI, V41, P3485; Willermain F, 2012, PROG RETIN EYE RES, V31, P182, DOI 10.1016/j.preteyeres.2011.11.004; Xu HP, 2008, EXP EYE RES, V87, P319, DOI 10.1016/j.exer.2008.06.012	30	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0116518	10.1371/journal.pone.0116518	http://dx.doi.org/10.1371/journal.pone.0116518			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692550	Green Submitted, Green Published, gold			2022-12-26	WOS:000350061500016
J	Smith, TM; Tafforeau, P; Le Cabec, A; Bonnin, A; Houssaye, A; Pouech, J; Moggi-Cecchi, J; Manthi, F; Ward, C; Makaremi, M; Menter, CG				Smith, Tanya M.; Tafforeau, Paul; Le Cabec, Adeline; Bonnin, Anne; Houssaye, Alexandra; Pouech, Joane; Moggi-Cecchi, Jacopo; Manthi, Fredrick; Ward, Carol; Makaremi, Masrour; Menter, Colin G.			Dental Ontogeny in Pliocene and Early Pleistocene Homininsl	PLOS ONE			English	Article							HUMAN LIFE-HISTORY; TOOTH DEVELOPMENT; MODERN HUMANS; HISTOLOGICAL RECONSTRUCTION; ENAMEL MICROSTRUCTURE; BRIEF COMMUNICATION; CROSS-STRIATIONS; PAN-TROGLODYTES; FOSSIL HOMINID; AGE	Until recently, our understanding of the evolution of human growth and development derived from studies of fossil juveniles that employed extant populations for both age determination and comparison. This circular approach has led to considerable debate about the humanlike and ape-like affinities of fossil hominins. Teeth are invaluable for understanding maturation as age at death can be directly assessed from dental microstructure, and dental development has been shown to correlate with life history across primates broadly. We employ non-destructive synchrotron imaging to characterize incremental development, molar emergence, and age at death in more than 20 Australopithecus anamensis, Australopithecus africanus, Paranthropus robustus and South African early Homo juveniles. Long-period line periodicities range from at least 6-12 days (possibly 5-13 days), and do not support the hypothesis that australopiths have lower mean values than extant or fossil Homo. Crown formation times of australopith and early Homo postcanine teeth fall below or at the low end of extant human values; Paranthropus robustus dentitions have the shortest formation times. Pliocene and early Pleistocene hominins show remarkable variation, and previous reports of age at death that employ a narrow range of estimated long-period line periodicities, cuspal enamel thicknesses, or initiation ages are likely to be in error. New chronological ages for SK 62 and StW 151 are several months younger than previous histological estimates, while Sts 24 is more than one year older. Extant human standards overestimate age at death in hominins predating Homo sapiens, and should not be applied to other fossil taxa. We urge caution when inferring life history as aspects of dental development in Pliocene and early Pleistocene fossils are distinct from modern humans and African apes, and recent work has challenged the predictive power of primate-wide associations between hominoid first molar emergence and certain life history variables.	[Smith, Tanya M.; Le Cabec, Adeline; Bonnin, Anne; Houssaye, Alexandra] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA; [Tafforeau, Paul; Le Cabec, Adeline; Bonnin, Anne; Houssaye, Alexandra; Pouech, Joane] ESRF European Synchrotron, Grenoble, France; [Le Cabec, Adeline] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany; [Bonnin, Anne] Swiss Light Source, Paul Scherrer Inst, Villigen, Switzerland; [Houssaye, Alexandra] Museum Natl Hist Nat, CNRS, Dept Ecol & Gest Biodiversit, UMR 7179, F-75231 Paris, France; [Pouech, Joane] Univ Lyon 1, CNRS, Lab Geol, UMR 5276, Villeurbanne, France; [Moggi-Cecchi, Jacopo] Univ Florence, Dipartimento Biol, Florence, Italy; [Manthi, Fredrick] Natl Museums Kenya, Dept Earth Sci, Nairobi, Kenya; [Ward, Carol] Univ Missouri, Dept Pathol & Anat Sci, Columbia, MO USA; [Makaremi, Masrour] Univ Bordeaux 2, Dept Orthodont, F-33076 Bordeaux, France; [Menter, Colin G.] Univ Johannesburg, Ctr Anthropol Res, Johannesburg, South Africa	Harvard University; European Synchrotron Radiation Facility (ESRF); Max Planck Society; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Florence; University of Missouri System; University of Missouri Columbia; UDICE-French Research Universities; Universite de Bordeaux; University of Johannesburg	Smith, TM (corresponding author), Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA.	tsmith@fas.harvard.edu; paul.tafforeau@esrf.fr	Houssaye, Alexandra/J-5631-2015; Smith, Tanya/T-2683-2017; BONNIN, Anne/J-3633-2014; LE CABEC, Adeline/I-1661-2019	BONNIN, Anne/0000-0001-5537-8682; LE CABEC, Adeline/0000-0001-6948-4726; Ward, Carol/0000-0001-6255-9668; Smith, Tanya M./0000-0001-8175-8208; MOGGI CECCHI, IACOPO/0000-0001-5055-8369; Tafforeau, Paul/0000-0002-5962-1683	National Science Foundation [BCS 1126470]; Radcliffe Institute for Advance Study; Wenner-Gren Hunt Fellowship; Harvard University; National Research Foundation of South Africa; Italian Ministry of Foreign Affairs (Direzione Generale per la Promozione e la Cooperazione Culturale, ufficio V, Archaeology); Italian Embassy and Italian Cultural Institute in Pretoria; European Synchrotron Radiation Facility [EC 275, 697]; Division Of Behavioral and Cognitive Sci [1126470] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Radcliffe Institute for Advance Study; Wenner-Gren Hunt Fellowship; Harvard University; National Research Foundation of South Africa(National Research Foundation - South Africa); Italian Ministry of Foreign Affairs (Direzione Generale per la Promozione e la Cooperazione Culturale, ufficio V, Archaeology); Italian Embassy and Italian Cultural Institute in Pretoria; European Synchrotron Radiation Facility; Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This work was supported by funding from the National Science Foundation, BCS 1126470, T.M.S., P.T.; Radcliffe Institute for Advance Study, T.M.S.; Wenner-Gren Hunt Fellowship, T.M.S.; Harvard University, T.M.S.; the National Research Foundation of South Africa, C.M.; the Italian Ministry of Foreign Affairs (Direzione Generale per la Promozione e la Cooperazione Culturale, ufficio V, Archaeology), J.M-C.; the Italian Embassy and Italian Cultural Institute in Pretoria, J.M-C.; and the European Synchrotron Radiation Facility, EC 275 & 697, T.M.S., C.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemseged Z, 2006, NATURE, V443, P296, DOI 10.1038/nature05047; AlQahtani SJ, 2010, AM J PHYS ANTHROPOL, V142, P481, DOI 10.1002/ajpa.21258; Anderson D L, 1976, J Forensic Sci, V21, P191; Anemone RL, 2002, HUMAN EVOLUTION THROUGH DEVELOPMENTAL CHANGE, P249; Antoine D, 2009, J ANAT, V214, P45, DOI 10.1111/j.1469-7580.2008.01010.x; Berger LR, 2010, SCIENCE, V328, P195, DOI 10.1126/science.1184944; Beynon A.D., 1992, P295; BEYNON AD, 1987, ARCH ORAL BIOL, V32, P773, DOI 10.1016/0003-9969(87)90002-1; BEYNON AD, 1991, AM J PHYS ANTHROPOL, V86, P189, DOI 10.1002/ajpa.1330860208; BEYNON AD, 1988, NATURE, V335, P509, DOI 10.1038/335509a0; BEYNON AD, 1987, NATURE, V326, P493, DOI 10.1038/326493a0; Breuer T, 2009, AM J PRIMATOL, V71, P106, DOI 10.1002/ajp.20628; BROMAGE TG, 1985, NATURE, V317, P525, DOI 10.1038/317525a0; BROMAGE TG, 1991, AM J PHYS ANTHROPOL, V86, P205, DOI 10.1002/ajpa.1330860209; Bromage TG, 2012, J THEOR BIOL, V305, P131, DOI 10.1016/j.jtbi.2012.04.007; Bromage TG, 2009, CALCIFIED TISSUE INT, V84, P388, DOI 10.1007/s00223-009-9221-2; Broom R, 1941, NATURE, V147, P607, DOI 10.1038/147607a0; Broom R, 1950, TRANSVAAL MUSEUM MEM, V4; CONROY GC, 1991, AM J PHYS ANTHROPOL, V86, P243, DOI 10.1002/ajpa.1330860212; CONROY GC, 1991, AM J PHYS ANTHROPOL, V86, P137, DOI 10.1002/ajpa.1330860205; Dart RA, 1948, AM J PHYS ANTHROP-NE, V6, P391, DOI 10.1002/ajpa.1330060410; Dean C, 2001, NATURE, V414, P628, DOI 10.1038/414628a; Dean M. C., 2009, 1 HUMANS ORIGIN EARL, P101; Dean MC, 2010, PHILOS T R SOC B, V365, P3397, DOI 10.1098/rstb.2010.0052; Dean MC, 2009, ANN HUM BIOL, V36, P545, DOI 10.1080/03014460902956725; DEAN MC, 1987, J HUM EVOL, V16, P197, DOI 10.1016/0047-2484(87)90076-5; Dean MC, 2001, AM J PHYS ANTHROPOL, V116, P209, DOI 10.1002/ajpa.1116; DEAN MC, 1993, AM J PHYS ANTHROPOL, V91, P401, DOI 10.1002/ajpa.1330910402; Dean MC, 1996, ARCH ORAL BIOL, V41, P233, DOI 10.1016/0003-9969(95)00137-9; Dean MC., 1995, STRUCTURE FUNCTION E, P239; Dean MC., 1993, INT J OSTEOARCHAEOL, V3, P249, DOI [10.1002/oa.1390030404, DOI 10.1002/OA.1390030404]; DEMIRJIAN A, 1973, HUM BIOL, V45, P211; FitzGerald CM, 1998, J HUM EVOL, V35, P371, DOI 10.1006/jhev.1998.0232; Green DR, 2011, AM J PHYS ANTHROPOL, V144, P148; GRINE F E, 1982, Annals of the Transvaal Museum, V33, P165; Grine F.E., 1988, P3; Guatelli-Steinberg D, 2009, EVOL ANTHROPOL, V18, P9, DOI 10.1002/evan.20190; Hawkes K, 2006, SCH AM RES, P95; Hochberg Z., 2012, EVODEVO CHILD GROWTH, V1st; Humphrey LT, 2010, SEMIN CELL DEV BIOL, V21, P453, DOI 10.1016/j.semcdb.2009.11.003; Kelley J, 2003, J HUM EVOL, V44, P307, DOI 10.1016/S0047-2484(03)00005-8; Kelley J, 2014, AM J PHYS ANTHROPOL, V153, P156; Kelley J, 2012, INT J PRIMATOL, V33, P1332, DOI 10.1007/s10764-012-9607-2; Kelley J, 2010, P NATL ACAD SCI USA, V107, P1035, DOI 10.1073/pnas.0906206107; Keyser AW, 2000, S AFR J SCI, V96, P193; Knott C, 2001, FOUND HUM B, P429; Konner M., 2010, EVOLUTION CHILDHOOD; Kuykendall K.L., 2003, Cambridge Studies in Biological and Evolutionary Anthropology, V37, P191; Kuykendall KL, 1996, AM J PHYS ANTHROPOL, V99, P135, DOI 10.1002/(SICI)1096-8644(199601)99:1<135::AID-AJPA8>3.0.CO;2-#; Lacruz RS, 2008, J ANAT, V213, P148, DOI 10.1111/j.1469-7580.2008.00938.x; Lacruz RS, 2007, AM J PHYS ANTHROPOL, V132, P175, DOI 10.1002/ajpa.20506; Lacruz RS, 2006, J HUM EVOL, V51, P580, DOI 10.1016/j.jhevol.2006.05.007; Lacruz RS, 2010, J HUM EVOL, V58, P201, DOI 10.1016/j.jhevol.2009.11.007; Lacruz RS, 2005, S AFR J SCI, V101, P567; Le Cabec A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123019; Liversidge HM, 2008, ANN HUM BIOL, V35, P294, DOI 10.1080/03014460801971445; Liversidge HM, 2006, ANN HUM BIOL, V33, P454, DOI 10.1080/03014460600802387; Liversidge HM, 2010, AM J PHYS ANTHROPOL, V143, P545, DOI 10.1002/ajpa.21349; Liversidge HM, 2004, AM J PHYS ANTHROPOL, V123, P172, DOI 10.1002/ajpa.10318; Macho Gabriele A., 1995, Evolutionary Anthropology, V4, P17, DOI 10.1002/evan.1360040105; MANN A, 1988, NATURE, V333, P123, DOI 10.1038/333123a0; McNulty KP, 2006, J HUM EVOL, V51, P274, DOI 10.1016/j.jhevol.2006.04.005; MIMURA F, 1939, KOBYO SHI, V13, P454; Moggi-Cecchi J, 1998, AM J PHYS ANTHROPOL, V106, P425, DOI 10.1002/(SICI)1096-8644(199808)106:4<425::AID-AJPA2>3.0.CO;2-I; Moggi-Cecchi J, 2010, J HUM EVOL, V58, P374, DOI 10.1016/j.jhevol.2010.01.006; MOORREES COENRAAD F.A., 1963, JOUR DENT RES, V42, P1490, DOI 10.1177/00220345630420062701; Okada M., 1943, SHANGHAI EVENING POS, P26; PUSEY AE, 1983, ANIM BEHAV, V31, P363, DOI 10.1016/S0003-3472(83)80055-4; RAMIREZROZZI FV, 1993, J HUM EVOL, V24, P429, DOI 10.1006/jhev.1993.1030; Reid DJ, 2006, J HUM EVOL, V50, P329, DOI 10.1016/j.jhevol.2005.09.003; Reid DJ, 1998, J HUM EVOL, V35, P427, DOI 10.1006/jhev.1998.0248; Reid DJ, 2000, AM J PHYS ANTHROPOL, V113, P135; Robinson J. T, 1956, TRANSVAAL MUSEUM MEM, V9; Robson SL, 2008, J ANAT, V212, P394, DOI 10.1111/j.1469-7580.2008.00867.x; Rozzi FR, 1998, J HUM EVOL, V35, P543, DOI 10.1006/jhev.1998.0250; Rozzi FVR, 1997, CR ACAD SCI II A, V325, P231; Schwartz G.T., 1997, THESIS WASHINGTON U; Schwartz GT, 2006, INT J PRIMATOL, V27, P1201, DOI 10.1007/s10764-006-9051-2; Schwartz GT, 2012, CURR ANTHROPOL, V53, pS395, DOI 10.1086/667591; Schwartz GT, 2001, AM J PHYS ANTHROPOL, V115, P269, DOI 10.1002/ajpa.1081; Schwartz JH, 2005, HUMAN FOSSIL RECORD, V4; Skinner MM, 2006, SCH AM RES, P331; SMITH BH, 1991, AM J PHYS ANTHROPOL, V86, P157, DOI 10.1002/ajpa.1330860206; SMITH BH, 1995, ANNU REV ANTHROPOL, V24, P257, DOI 10.1146/annurev.an.24.100195.001353; SMITH BH, 1989, EVOLUTION, V43, P683, DOI 10.1111/j.1558-5646.1989.tb04266.x; Smith BH, 1992, EVOL ANTHROPOL, V1, P134, DOI DOI 10.1002/EVAN.1360010406; Smith TM, 2007, VERTEBR PALEOBIOL PA, P177, DOI 10.1007/978-1-4020-5845-5_12; Smith TM, 2007, J HUM EVOL, V52, P201, DOI 10.1016/j.jhevol.2006.09.004; Smith TM, 2010, J HUM EVOL, V58, P363, DOI 10.1016/j.jhevol.2010.02.008; Smith T. M., 2014, SCLADINA I 4A JUVENI, P155; Smith TM, 2008, EVOL ANTHROPOL, V17, P213, DOI 10.1002/evan.20176; Smith TM, 2007, P NATL ACAD SCI USA, V104, P20220, DOI 10.1073/pnas.0707051104; Smith TM, 2008, J HUM EVOL, V54, P205, DOI 10.1016/j.jhevol.2007.09.020; Smith TM, 2013, ANNU REV ANTHROPOL, V42, P191, DOI 10.1146/annurev-anthro-092412-155550; Smith TM, 2013, P NATL ACAD SCI USA, V110, P2787, DOI 10.1073/pnas.1218746110; Smith TM, 2012, J HUM EVOL, V62, P395, DOI 10.1016/j.jhevol.2011.12.004; Smith TM, 2010, P NATL ACAD SCI USA, V107, P20923, DOI 10.1073/pnas.1010906107; Smith Tanya M., 2009, Paleoanthropology, V2009, P117; Smith TM, 2006, J ANAT, V208, P99, DOI 10.1111/j.1469-7580.2006.00499.x; Smith TM, 2006, J ANAT, V208, P125, DOI 10.1111/j.1469-7580.2006.00500.x; Smith TM, 2004, J HUM EVOL, V46, P551, DOI 10.1016/j.jhevol.2004.01.006; Stoinski TS, 2013, AM J PHYS ANTHROPOL, V152, P165, DOI 10.1002/ajpa.22301; Tafforeau P, 2008, J HUM EVOL, V54, P272, DOI 10.1016/j.jhevol.2007.09.018; Tafforeau P, 2007, PALAEOGEOGR PALAEOCL, V246, P206, DOI 10.1016/j.palaeo.2006.10.001; Thompson ME, 2013, AM J PRIMATOL, V75, P222, DOI 10.1002/ajp.22084; Ward CV, 2001, J HUM EVOL, V41, P255, DOI 10.1006/jhev.2001.0507	106	48	49	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118118	10.1371/journal.pone.0118118	http://dx.doi.org/10.1371/journal.pone.0118118			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692765	Green Published, Green Submitted, gold			2022-12-26	WOS:000350061500098
J	Vanevski, F; Xu, BJ				Vanevski, Filip; Xu, Baoji			HuD Interacts with Bdnf mRNA and Is Essential for Activity-Induced BDNF Synthesis in Dendrites	PLOS ONE			English	Article							LONG-TERM POTENTIATION; BINDING PROTEIN HUD; NEUROTROPHIC FACTOR BDNF; NEURONAL ELAV PROTEINS; KINASE-C ACTIVATION; SYNAPTIC PLASTICITY; HIPPOCAMPAL-NEURONS; POSTTRANSCRIPTIONAL REGULATION; DIFFERENTIAL EXPRESSION; DEPENDENT TRANSLATION	Highly specific activity-dependent neuronal responses are necessary for modulating synapses to facilitate learning and memory. We present evidence linking a number of important processes involved in regulating synaptic plasticity, suggesting a mechanistic pathway whereby activity-dependent signaling, likely through protein kinase C (PKC)-mediated phosphorylation of HuD, can relieve basal repression of Bdnf mRNA translation in dendrites, allowing for increased TrkB signaling and synaptic remodeling. We demonstrate that the neuronal ELAV family of RNA binding proteins associates in vivo with several Bdnf mRNA isoforms present in the adult brain in an activity-dependent manner, and that one member, HuD, interacts directly with sequences in the long Bdnf 3' untranslated region (3'UTR) and co-localizes with Bdnf mRNA in dendrites of hippocampal neurons. Activation of PKC leads to increased dendritic translation of mRNAs containing the long Bdnf 3'UTR, a process that is dependent on the presence of HuD and its phosphorylation at threonine residues 149 and/or 165. Thus, we found a direct effect of HuD on regulating translation of dendritic Bdnf mRNAs to mediate local and activity-dependent increases in dendritic BDNF synthesis.	[Vanevski, Filip; Xu, Baoji] Georgetown Univ, Med Ctr, Dept Physiol & Pharmacol, Washington, DC 20007 USA	Georgetown University	Xu, BJ (corresponding author), Georgetown Univ, Med Ctr, Dept Physiol & Pharmacol, Washington, DC 20007 USA.	bxu@scripps.edu			US National Institutes of Health [R21 NS066235, R01 NS073930, R01 NS050596, F31 NS060453]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS066235, R01NS050596, F31NS060453, R01NS073930] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the US National Institutes of Health to BX (R21 NS066235, R01 NS073930, and R01 NS050596) and FV (F31 NS060453). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu W, 2005, P NATL ACAD SCI USA, V102, P4625, DOI 10.1073/pnas.0407523102; Allen M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055718; An JJ, 2008, CELL, V134, P175, DOI 10.1016/j.cell.2008.05.045; Anderson KD, 2000, J NEUROCHEM, V75, P1103, DOI 10.1046/j.1471-4159.2000.0751103.x; Anderson KD, 2001, EXP NEUROL, V168, P250, DOI 10.1006/exnr.2000.7599; Antic D, 1998, J CELL SCI, V111, P183; Atlas R, 2007, J NEUROSCI RES, V85, P173, DOI 10.1002/jnr.21099; Bolognani F, 2007, NEUROBIOL LEARN MEM, V87, P635, DOI 10.1016/j.nlm.2006.11.004; Bolognani F, 2010, NUCLEIC ACIDS RES, V38, P117, DOI 10.1093/nar/gkp863; Chandrasekar V, 2009, MOL CELL NEUROSCI, V42, P350, DOI 10.1016/j.mcn.2009.08.009; Chiaruttini C, 2008, MOL CELL NEUROSCI, V37, P11, DOI 10.1016/j.mcn.2007.08.011; Chung SM, 1997, J BIOL CHEM, V272, P6593, DOI 10.1074/jbc.272.10.6593; Gomez-Palacio-Schjetnan A, 2008, NEUROSCI LETT, V445, P62, DOI 10.1016/j.neulet.2008.08.069; Gooney M, 2002, BEHAV NEUROSCI, V116, P455, DOI 10.1037//0735-7044.116.3.455; Hall J, 2000, NAT NEUROSCI, V3, P533, DOI 10.1038/75698; Huang YS, 2002, EMBO J, V21, P2139, DOI 10.1093/emboj/21.9.2139; Jacobsen A, 2010, GENOME RES, V20, P1010, DOI 10.1101/gr.103259.109; Kanhema T, 2006, J NEUROCHEM, V99, P1328, DOI 10.1111/j.1471-4159.2006.04158.x; Kelleher RJ, 2004, NEURON, V44, P59, DOI 10.1016/j.neuron.2004.09.013; KLANN E, 1993, P NATL ACAD SCI USA, V90, P8337, DOI 10.1073/pnas.90.18.8337; Kulkarni M, 2010, BIOCHEM SOC T, V38, P242, DOI 10.1042/BST0380242; Kullmann M, 2002, GENE DEV, V16, P3087, DOI 10.1101/gad.248902; Lau AG, 2010, P NATL ACAD SCI USA, V107, P15945, DOI 10.1073/pnas.1002929107; Lim CS, 2012, HIPPOCAMPUS, V22, P2303, DOI 10.1002/hipo.22048; Ling DSF, 2002, NAT NEUROSCI, V5, P295, DOI 10.1038/nn829; Lu Y, 2008, NEUROBIOL LEARN MEM, V89, P312, DOI 10.1016/j.nlm.2007.08.018; Malkovska I, 2006, J NEUROSCI RES, V83, P211, DOI 10.1002/jnr.20728; Mellios N, 2008, HUM MOL GENET, V17, P3030, DOI 10.1093/hmg/ddn201; Orefice LL, 2013, J NEUROSCI, V33, P11618, DOI 10.1523/JNEUROSCI.0012-13.2013; Pascale A, 2008, CELL MOL LIFE SCI, V65, P128, DOI 10.1007/s00018-007-7017-y; Pascale A, 2005, P NATL ACAD SCI USA, V102, P12065, DOI 10.1073/pnas.0504702102; Pascale A, 2004, P NATL ACAD SCI USA, V101, P1217, DOI 10.1073/pnas.0307674100; Perrone-Bizzozero N, 2002, J NEUROSCI RES, V68, P121, DOI 10.1002/jnr.10175; Poulsen FR, 2004, NEUROSCIENCE, V126, P665, DOI 10.1016/j.neuroscience.2004.04.008; Quattrone A, 2001, P NATL ACAD SCI USA, V98, P11668, DOI 10.1073/pnas.191388398; Ramakers GMJ, 2000, NEUROSCI LETT, V286, P53, DOI 10.1016/S0304-3940(00)01081-8; Ratti A, 2006, J CELL SCI, V119, P1442, DOI 10.1242/jcs.02852; Ratti A, 2008, J BIOL CHEM, V283, P7531, DOI 10.1074/jbc.M706082200; Scheetz AJ, 2000, NAT NEUROSCI, V3, P211, DOI 10.1038/72915; Schratt GM, 2004, J NEUROSCI, V24, P7366, DOI 10.1523/JNEUROSCI.1739-04.2004; Slipczuk L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006007; Son H, 1996, NEUROSCIENCE, V72, P1, DOI 10.1016/0306-4522(95)00532-3; Soule J, 2006, BIOCHEM SOC T, V34, P600, DOI 10.1042/BST0340600; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O; Tongiorgi E, 1997, J NEUROSCI, V17, P9492; Vaghi V, 2014, J BIOL CHEM, V289, P27702, DOI 10.1074/jbc.M114.586719; Verpelli C, 2010, J NEUROSCI, V30, P5830, DOI 10.1523/JNEUROSCI.0119-10.2010; Wang ZH, 2011, NEUROCHEM RES, V36, P1027, DOI 10.1007/s11064-011-0443-0; Waterhouse EG, 2009, MOL CELL NEUROSCI, V42, P81, DOI 10.1016/j.mcn.2009.06.009	50	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117264	10.1371/journal.pone.0117264	http://dx.doi.org/10.1371/journal.pone.0117264			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692578	gold, Green Submitted, Green Published			2022-12-26	WOS:000350061500046
J	Hayasaka, H; Kobayashi, D; Yoshimura, H; Nakayama, EE; Shioda, T; Miyasaka, M				Hayasaka, Haruko; Kobayashi, Daichi; Yoshimura, Hiromi; Nakayama, Emi E.; Shioda, Tatsuo; Miyasaka, Masayuki			The HIV-1 Gp120/CXCR4 Axis Promotes CCR7 Ligand-Dependent CD4 T Cell Migration: CCR7 Homo- and CCR7/CXCR4 Hetero-Oligomer Formation as a Possible Mechanism for Up-Regulation of Functional CCR7	PLOS ONE			English	Article							HIGH ENDOTHELIAL VENULES; VIRUS TYPE-1 GP120; LYMPH-NODES; CHEMOKINE; CXCR4; BINDING; DIMERIZATION; TRAFFICKING; LYMPHOCYTES; ACTIVATION	During human immunodeficiency virus (HIV) infection, enhanced migration of infected cells to lymph nodes leads to efficient propagation of HIV-1. The selective chemokine receptors, including CXCR4 and CCR7, may play a role in this process, yet the viral factors regulating chemokine-dependent T cell migration remain relatively unclear. The functional cooperation between the CXCR4 ligand chemokine CXCL12 and the CCR7 ligand chemokines CCL19 and CCL21 enhances CCR7-dependent T cell motility in vitro as well as cell trafficking into the lymph nodes in vivo. In this study, we report that a recombinant form of a viral CXCR4 ligand, X4-tropic HIV-1 gp120, enhanced the CD4 T cell response to CCR7 ligands in a manner dependent on CXCR4 and CD4, and that this effect was recapitulated by HIV-1 virions. HIV-1 gp120 significantly enhanced CCR7-dependent CD4 T cell migration from the footpad of mice to the draining lymph nodes in in vivo transfer experiments. We also demonstrated that CXCR4 expression is required for stable CCR7 expression on the CD4 T cell surface, whereas CXCR4 signaling facilitated CCR7 ligand binding to the cell surface and increased the level of CCR7 homo-as well as CXCR4/CCR7 hetero-oligomers without affecting CCR7 expression levels. Our findings indicate that HIV-evoked CXCR4 signaling promotes CCR7-dependent CD4 T cell migration by up-regulating CCR7 function, which is likely to be induced by increased formation of CCR7 homo-and CXCR4/CCR7 hetero-oligomers on the surface of CD4 T cells.	[Hayasaka, Haruko; Kobayashi, Daichi; Yoshimura, Hiromi] Osaka Univ, Dept Microbiol & Immunol, WPI Immunol Frontier Res Ctr, Lab Immune Regulat,Grad Sch Med, Suita, Osaka, Japan; [Nakayama, Emi E.; Shioda, Tatsuo] Osaka Univ, Microbial Dis Res Inst, Dept Viral Infect, Suita, Osaka 565, Japan; [Miyasaka, Masayuki] Osaka Univ, Inst Acad Initiat, Suita, Osaka, Japan; [Miyasaka, Masayuki] Univ Turku, MediCity Lab, FIN-20520 Turku, Finland	Osaka University; Osaka University; Osaka University; University of Turku	Hayasaka, H (corresponding author), Osaka Univ, Dept Microbiol & Immunol, WPI Immunol Frontier Res Ctr, Lab Immune Regulat,Grad Sch Med, Suita, Osaka, Japan.	hayasaka@orgctl.med.osaka-u.ac.jp	Miyasaka, Masayuki/AAM-6343-2020	Kobayashi, Daichi/0000-0003-0389-0240; ying mei, zhong shan/0000-0002-0477-0980	Ministry of Education, Culture, Sports, Science and Technology [21121007]; Grants-in-Aid for Scientific Research [25460268] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work is supported by the Ministry of Education, Culture, Sports, Science and Technology (Grant-in-Aid for Scientific Research on Innovative Areas, 21121007 to HH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai ZB, 2009, J IMMUNOL, V182, P1287, DOI 10.4049/jimmunol.182.3.1287; Balabanian K, 2004, J IMMUNOL, V173, P7150, DOI 10.4049/jimmunol.173.12.7150; BANDA NK, 1992, J EXP MED, V176, P1099, DOI 10.1084/jem.176.4.1099; Bandres JC, 1998, J VIROL, V72, P2500, DOI 10.1128/JVI.72.3.2500-2504.1998; Bozzini S, 1998, J MED VIROL, V54, P44, DOI 10.1002/(SICI)1096-9071(199801)54:1&lt;44::AID-JMV7&gt;3.0.CO;2-P; Bucy RP, 1999, J CLIN INVEST, V103, P1391, DOI 10.1172/JCI5863; Campbell JJ, 1998, J CELL BIOL, V141, P1053, DOI 10.1083/jcb.141.4.1053; Contento RL, 2008, P NATL ACAD SCI USA, V105, P10101, DOI 10.1073/pnas.0804286105; Debes GF, 2005, NAT IMMUNOL, V6, P889, DOI 10.1038/ni1238; Decaillot FM, 2011, J BIOL CHEM, V286, P32188, DOI 10.1074/jbc.M111.277038; Ebisuno Y, 2003, J IMMUNOL, V171, P1642, DOI 10.4049/jimmunol.171.4.1642; Freedman BD, 2003, IMMUNOL RES, V27, P261, DOI 10.1385/IR:27:2-3:261; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Green DS, 2009, J VIROL, V83, P5765, DOI 10.1128/JVI.00130-09; Hernanz-Falcon P, 2004, NAT IMMUNOL, V5, P216, DOI 10.1038/ni1027; Irhimeh MR, 2007, EXP HEMATOL, V35, P989, DOI 10.1016/j.exphem.2007.02.009; Iyengar S, 1999, J IMMUNOL, V162, P6263; Kanemitsu N, 2005, BLOOD, V106, P2613, DOI 10.1182/blood-2005-01-0133; Klasse PJ, 2004, VIROLOGY, V323, P1, DOI 10.1016/j.virol.2004.03.003; Lapham CK, 1996, SCIENCE, V274, P602, DOI 10.1126/science.274.5287.602; Lee C, 2003, J LEUKOCYTE BIOL, V74, P676, DOI 10.1189/jlb.0503206; Legler DF, 1998, J EXP MED, V187, P655, DOI 10.1084/jem.187.4.655; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Munoz LM, 2012, IMMUNOL LETT, V145, P23, DOI 10.1016/j.imlet.2012.04.012; Mellado M, 2001, EMBO J, V20, P2497, DOI 10.1093/emboj/20.10.2497; Misse D, 1998, J VIROL, V72, P7280; Misse D, 1999, BLOOD, V93, P2454, DOI 10.1182/blood.V93.8.2454.408k35_2454_2462; Miyasaka M, 2004, NAT REV IMMUNOL, V4, P360, DOI 10.1038/nri1354; Murooka TT, 2012, NATURE, V490, P283, DOI 10.1038/nature11398; Murphy JW, 2007, J BIOL CHEM, V282, P10018, DOI 10.1074/jbc.M608796200; Nagasawa T, 1998, SEMIN IMMUNOL, V10, P179, DOI 10.1006/smim.1998.0128; Nitta N, 2007, J IMMUNOL METHODS, V320, P155, DOI 10.1016/j.jim.2006.12.010; Ohishi M, 2007, VIROLOGY, V362, P131, DOI 10.1016/j.virol.2006.12.030; Paoletti S, 2005, BLOOD, V105, P3405, DOI 10.1182/blood-2004-04-1648; Rodriguez-Frade JM, 1999, P NATL ACAD SCI USA, V96, P3628, DOI 10.1073/pnas.96.7.3628; Shamri R, 2005, NAT IMMUNOL, V6, P497, DOI 10.1038/ni1194; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Su SB, 1999, J IMMUNOL, V162, P7128; TENNERRACZ K, 1988, AIDS, V2, P299, DOI 10.1097/00002030-198808000-00010; Umemoto E, 2012, J IMMUNOL, V189, P191, DOI 10.4049/jimmunol.1200802; Vanbervliet B, 2003, J EXP MED, V198, P823, DOI 10.1084/jem.20020437; Vila-Coro AJ, 1999, FASEB J, V13, P1699, DOI 10.1096/fasebj.13.13.1699; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Wang JH, 2006, MOL CANCER THER, V5, P2474, DOI 10.1158/1535-7163.MCT-05-0261; Wang JM, 1998, J IMMUNOL, V161, P4309; Yang BG, 2007, J IMMUNOL, V179, P4376, DOI 10.4049/jimmunol.179.7.4376; Yoshida R, 1998, INT IMMUNOL, V10, P901, DOI 10.1093/intimm/10.7.901; Yu D, 1997, GENES CELLS, V2, P457, DOI 10.1046/j.1365-2443.1997.1340332.x	48	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117454	10.1371/journal.pone.0117454	http://dx.doi.org/10.1371/journal.pone.0117454			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25688986	gold, Green Published, Green Submitted			2022-12-26	WOS:000350322700046
J	Tancharoen, S; Matsuyama, T; Kawahara, KI; Tanaka, K; Lee, LJ; Machigashira, M; Noguchi, K; Ito, T; Imamura, T; Potempa, J; Kikuchi, K; Maruyama, I				Tancharoen, Salunya; Matsuyama, Takashi; Kawahara, Ko-Ichi; Tanaka, Kenji; Lee, Lyang-Ja; Machigashira, Miho; Noguchi, Kazuyuki; Ito, Takashi; Imamura, Takahisa; Potempa, Jan; Kikuchi, Kiyoshi; Maruyama, Ikuro			Cleavage of Host Cytokeratin-6 by Lysine-Specific Gingipain Induces Gingival Inflammation in Periodontitis Patients	PLOS ONE			English	Article							PROTEIN-KINASE PATHWAYS; PORPHYROMONAS-GINGIVALIS; EPITHELIAL-CELLS; INTERMEDIATE-FILAMENTS; KGP-PROTEINASE; HAIR FOLLICLE; DISEASE; MOUSE; CYTOKINES; MIGRATION	Background/Purpose Lysine-specific gingipain (Kgp) is a virulence factor secreted from Porphyromonas gingivalis (P. gingivalis), a major etiological bacterium of periodontal disease. Keratin intermediate filaments maintain the structural integrity of gingival epithelial cells, but are targeted by Kgp to produce a novel cytokeratin 6 fragment (K6F). We investigated the release of K6F and its induction of cytokine secretion. Methods K6F present in the gingival crevicular fluid of periodontal disease patients and in gingipain-treated rat gingival epithelial cell culture supernatants was measured by matrix-assisted laser desorption/ionization time-of-flight mass spectrometer-based rapid quantitative peptide analysis using BLOTCHIP. K6F in gingival tissues was immunostained, and cytokeratin 6 protein was analyzed by immunofluorescence staining and flow cytometry. Activation of MAPK in gingival epithelial cells was evaluated by immunoblotting. ELISA was used to measure K6F and the cytokines release induced by K6F. Human gingival fibroblast migration was assessed using a Matrigel invasion chamber assay. Results We identified K6F, corresponding to the C-terminus region of human cytokeratin 6 (amino acids 359-378), in the gingival crevicular fluid of periodontal disease patients and in the supernatant from gingival epithelial cells cultured with Kgp. K6F antigen was distributed from the basal to the spinous epithelial layers in gingivae from periodontal disease patients. Cytokeratin 6 on gingival epithelial cells was degraded by Kgp, but not by Arg-gingipain, P. gingivalis lipopolysaccharide or Actinobacillus actinomycetemcomitans lipopolysaccharide. K6F, but not a scrambled K6F peptide, induced human gingival fibroblast migration and secretion of interleukin (IL)-6, IL-8 and monocyte chemoattractant protein-1. These effects of K6F were mediated by activation of p38 MAPK and Jun N-terminal kinase, but not p42/44 MAPK or p-Akt. Conclusion Kgp degrades gingival epithelial cell cytokeratin 6 to K6F that, on release, induces invasion and cytokine secretion by human gingival fibroblasts. Thus, Kgp may contribute to the development of periodontal disease.	[Tancharoen, Salunya] Mahidol Univ, Fac Dent, Dept Pharmacol, Bangkok 10700, Thailand; [Matsuyama, Takashi; Machigashira, Miho; Noguchi, Kazuyuki] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Periodontol, Kagoshima 890, Japan; [Kawahara, Ko-Ichi] Osaka Inst Technol, Lab Funct Foods, Dept Biomed Engn, Osaka 535, Japan; [Tanaka, Kenji; Lee, Lyang-Ja] Protosera Inc, Membrane Prot & Ligand Anal Ctr, Amagasaki, Hyogo, Japan; [Ito, Takashi; Maruyama, Ikuro] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Syst Biol Thromboregulat, Kagoshima 890, Japan; [Imamura, Takahisa] Kumamoto Univ, Dept Mol Pathol, Fac Life Sci, Kumamoto, Japan; [Potempa, Jan] Univ Louisville, Sch Dent, Dept Periodont Endodont & Dent Hyg, Louisville, KY 40292 USA; [Potempa, Jan] Jagiellonian Univ, Dept Microbiol, Fac Biochem Biophys & Biotechnol, Krakow, Poland; [Kikuchi, Kiyoshi] Kurume Univ, Sch Med, Dept Physiol, Fukuoka, Japan	Mahidol University; Kagoshima University; Osaka Institute of Technology; Kagoshima University; Kumamoto University; University of Louisville; Jagiellonian University; Kurume University	Maruyama, I (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Syst Biol Thromboregulat, Kagoshima 890, Japan.	rinken@m3.kufm.kagoshima-u.ac.jp	tancharoen, salunya/AAJ-4765-2020; Potempa, Jan/AAA-6850-2021	Potempa, Jan/0000-0002-3600-7461				Amano T, 2003, GENE DEV, V17, P2436, DOI 10.1101/gad.1096603; Andrian E, 2006, ORAL MICROBIOL IMMUN, V21, P123, DOI 10.1111/j.1399-302X.2006.00248.x; Andrian E, 2004, INFECT IMMUN, V72, P4689, DOI 10.1128/IAI.72.8.4689-4698.2004; Angelucci C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050804; [Anonymous], 2014, NM0055553 NRS; Ara T, 2009, J PERIODONTAL RES, V44, P21, DOI 10.1111/j.1600-0765.2007.01041.x; Araki Y, 2011, PROTEOMICS, V11, P2727, DOI 10.1002/pmic.201000753; Barth K, 2013, J CELL PHYSIOL, V228, P1413, DOI 10.1002/jcp.24299; BICKEL M, 1985, J PERIODONTAL RES, V20, P35, DOI 10.1111/j.1600-0765.1985.tb00408.x; Bragulla HH, 2009, J ANAT, V214, P516, DOI 10.1111/j.1469-7580.2009.01066.x; Chen AL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002842; Chen T, 2001, INFECT IMMUN, V69, P3048, DOI 10.1128/IAI.69.5.3048-3056.2001; COMOGLIO PM, 1973, J CELL SCI, V13, P415; Coulombe PA, 2002, CURR OPIN CELL BIOL, V14, P110, DOI 10.1016/S0955-0674(01)00301-5; Dey M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078751; Dong F, 2004, INFECT IMMUN, V72, P3863, DOI 10.1128/IAI.72.7.3863-3868.2004; Ekuni D, 2005, J PERIODONTOL, V76, P43, DOI 10.1902/jop.2005.76.1.43; Elisoa A, 2007, J CELLULAR PHYSL, V211, P56; Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514; Fujimura S, 1998, FEMS MICROBIOL LETT, V163, P173, DOI 10.1016/S0378-1097(98)00169-4; Gibson FC, 2005, J PERIODONTOL, V76, P1629, DOI 10.1902/jop.2005.76.10.1629; GRAVES DT, 1995, CRIT REV ORAL BIOL M, V6, P109, DOI 10.1177/10454411950060020101; Graves DT, 1999, CLIN INFECT DIS, V28, P482, DOI 10.1086/515178; Grenier D, 2001, INFECT IMMUN, V69, P5166, DOI 10.1128/IAI.69.8.5166-5172.2001; Habtezion A, 2005, J CELL SCI, V118, P1971, DOI 10.1242/jcs.02316; HANAZAWA S, 1993, INFECT IMMUN, V61, P5219, DOI 10.1128/IAI.61.12.5219-5224.1993; Hirose M, 2001, J PERIODONTOL, V72, P590, DOI 10.1902/jop.2001.72.5.590; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Imamura T, 2003, J PERIODONTOL, V74, P111, DOI 10.1902/jop.2003.74.1.111; Junemann S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041606; Kamath L, 2001, CANCER RES, V61, P5933; Kayal RA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/639368; Kenji T, 2009, BIOCH BIOPHYSICAL RE, V379, P110, DOI [10.1016/j.bbrc.2008.12.016, DOI 10.1016/J.BBRC.2008.12.016]; Kinane DF, 2008, FRONT BIOSCI-LANDMRK, V13, P966, DOI 10.2741/2736; Kinane JA, 2012, CELL MICROBIOL, V14, P1085, DOI 10.1111/j.1462-5822.2012.01780.x; Komine M, 2001, J INVEST DERMATOL, V116, P330, DOI 10.1046/j.1523-1747.2001.01249.x; Lewis JP, 1999, J BACTERIOL, V181, P4905, DOI 10.1128/JB.181.16.4905-4913.1999; Mezyk-Kopec R, 2005, INFECT IMMUN, V73, P1506, DOI 10.1128/IAI.73.3.1506-1514.2005; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Noursadeghi M, 2008, J IMMUNOL METHODS, V329, P194, DOI 10.1016/j.jim.2007.10.015; O'Brien-Simpson NM, 2009, INFECT IMMUN, V77, P1246, DOI 10.1128/IAI.01038-08; Park Hong-Gyu, 2013, International Journal of Oral Biology, V38, P73, DOI 10.11620/IJOB.2013.38.2.073; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Romanelli R, 1999, INFECT IMMUN, V67, P2319, DOI 10.1128/IAI.67.5.2319-2326.1999; Rothnagel JA, 1999, DIFFERENTIATION, V65, P119, DOI 10.1046/j.1432-0436.1999.6520119.x; Sanaie AR, 2002, J PERIODONTAL RES, V37, P66, DOI 10.1034/j.1600-0765.2002.t01-1-90770.x; Seipelt J, 2000, J BIOL CHEM, V275, P20084, DOI 10.1074/jbc.275.26.20084; Senga Y, 1996, UROLOGY, V48, P703, DOI 10.1016/S0090-4295(96)00253-1; Silva-Boghossian CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075898; SOMERMAN MJ, 1988, J DENT RES, V67, P66, DOI 10.1177/00220345880670011301; Sroka A, 2001, J BACTERIOL, V183, P5609, DOI 10.1128/JB.183.19.5609-5616.2001; Subrahmanyam M V, 2003, Indian J Clin Biochem, V18, P5, DOI 10.1007/BF02867658; Takahashi K, 1996, P NATL ACAD SCI USA, V93, P14776, DOI 10.1073/pnas.93.25.14776; Takahashi K, 1998, GENOMICS, V53, P170, DOI 10.1006/geno.1998.5476; Tancharoen S, 2008, J CELL PHYSIOL, V217, P338, DOI 10.1002/jcp.21506; Tancharoen S, 2005, J IMMUNOL, V174, P5796, DOI 10.4049/jimmunol.174.9.5796; Tang YQ, 2011, ADV EXP MED BIOL, V712, P15, DOI 10.1007/978-1-4419-8414-2_2; UITTO VJ, 1991, CRIT REV ORAL BIOL M, V2, P323, DOI 10.1177/10454411910020030301; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Veith PD, 2004, INFECT IMMUN, V72, P3655, DOI 10.1128/IAI.72.6.3655-3657.2004; Watanabe K, 2001, INFECT IMMUN, V69, P6731, DOI 10.1128/IAI.69.11.6731-6737.2001; Wojcik SM, 1999, DIFFERENTIATION, V65, P97, DOI 10.1046/j.1432-0436.1999.6520097.x; Wojcik SM, 2000, MOL CELL BIOL, V20, P5248, DOI 10.1128/MCB.20.14.5248-5255.2000; Wong P, 2000, J CELL BIOL, V150, P921, DOI 10.1083/jcb.150.4.921; Xu Y, 2009, BMB REP, V42, P344, DOI 10.5483/BMBRep.2009.42.6.344; Yasuhara R, 2011, J ORAL BIOSCI, V53, P197, DOI 10.2330/joralbiosci.53.197; Yasuhara R, 2009, BIOCHEM J, V419, P159, DOI 10.1042/BJ20081469	67	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117775	10.1371/journal.pone.0117775	http://dx.doi.org/10.1371/journal.pone.0117775			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25688865	Green Published, Green Submitted, gold			2022-12-26	WOS:000350322700071
J	Long, WH; Zou, XL; Zhang, XK				Long, Weihua; Zou, Xiling; Zhang, Xuekun			Transcriptome Analysis of Canola (Brassica napus) under Salt Stress at the Germination Stage	PLOS ONE			English	Article							L-ASCORBIC-ACID; SALINITY TOLERANCE; GENE-EXPRESSION; VITAMIN-C; ARABIDOPSIS; OXYGENASE; BIOSYNTHESIS; DROUGHT; ENCODES; PLANTS	Canola (Brassica napus) is one of the most important oil crops in the world. However, its yield has been constrained by salt stress. In this study, transcriptome profiles were explored using Digital Gene Expression (DGE) at 0, 3, 12 and 24 hours after H2O (control) and NaCl treatments on B. napus roots at the germination stage. Comparisons of gene-expression between the control and the treatment were conducted after tag-mapping to the sequenced Brassica rapa genome. The differentially expressed genes during the time course of salt stress were focused on, and 163 genes were identified to be differentially expressed at all the time points. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analyses revealed that some of the genes were involved in proline metabolism, inositol metabolism, carbohydrate metabolic processes and oxidation-reduction processes and may play vital roles in the salt-stress response at the germination stage. Thus, this study provides new candidate salt stress responding genes, which may function in novel putative nodes in the molecular pathways of salt stress resistance.	[Long, Weihua; Zou, Xiling; Zhang, Xuekun] Chinese Acad Agr Sci, Key Lab Biol & Genet Improvement Oil Crops, Minist Agr, Oil Crops Res Inst, Wuhan 430062, Peoples R China	Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Zhang, XK (corresponding author), Chinese Acad Agr Sci, Key Lab Biol & Genet Improvement Oil Crops, Minist Agr, Oil Crops Res Inst, Wuhan 430062, Peoples R China.	seedcq@263.net			Opening Fund of Key Lab of Biology and Genetic Improvement of Oil Crops of Ministry of Agriculture [2011-1]; Hi-Tech Research and Development Program of China [2011AA10A104]	Opening Fund of Key Lab of Biology and Genetic Improvement of Oil Crops of Ministry of Agriculture; Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China)	Funding provided by the Opening Fund of Key Lab of Biology and Genetic Improvement of Oil Crops of Ministry of Agriculture (2011-1), Hi-Tech Research and Development Program of China (2011AA10A104).	Agarwal PK, 2013, MOL BIOTECHNOL, V54, P102, DOI 10.1007/s12033-012-9538-3; Albrecht U, 2012, PLANT SCI, V185, P118, DOI 10.1016/j.plantsci.2011.09.008; Ali Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048819; Alos E, 2013, PLANT SCI, V207, P2, DOI 10.1016/j.plantsci.2013.02.007; An P, 2014, J AGRON CROP SCI, V200, P212, DOI 10.1111/jac.12060; Ashraf M, 2013, PLANT BREEDING, V132, P10, DOI 10.1111/pbr.12000; Atkinson RG, 2009, POSTHARVEST BIOL TEC, V51, P149, DOI 10.1016/j.postharvbio.2008.06.014; Bak S, 2012, ARABIDOPSIS BOOK, V9, pe0144; Bazakos C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042931; Chao DY, 2005, CELL RES, V15, P796, DOI 10.1038/sj.cr.7290349; Chen L, 2010, ACTA BIOCH BIOPH SIN, V42, P154, DOI 10.1093/abbs/gmp113; Chen S, 2012, GENE, V504, P203, DOI 10.1016/j.gene.2012.05.023; Cheung F, 2009, PLANT CELL, V21, P1912, DOI 10.1105/tpc.108.060376; Cho SK, 2006, FEBS LETT, V580, P3136, DOI 10.1016/j.febslet.2006.04.062; Cotsaftis O, 2011, MOL PLANT, V4, P25, DOI 10.1093/mp/ssq056; Cruz-Rus E, 2011, J EXP BOT, V62, P4191, DOI 10.1093/jxb/err122; Dang ZH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-29; Endres S, 2011, PLANTA, V234, P157, DOI 10.1007/s00425-011-1394-z; Endres S, 2009, PLANT PHYSIOL, V149, P1042, DOI 10.1104/pp.108.130948; Fang LK, 2012, PLANT BIOTECHNOL J, V10, P524, DOI 10.1111/j.1467-7652.2012.00679.x; Fujita M, 2006, CURR OPIN PLANT BIOL, V9, P436, DOI 10.1016/j.pbi.2006.05.014; Ge Y, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-153; Han YS, 2013, J EXP BOT, V64, P4225, DOI 10.1093/jxb/ert229; Harper AL, 2012, NAT BIOTECHNOL, V30, P798, DOI 10.1038/nbt.2302; Hong LZ, 2011, GENOME RES, V21, P1905, DOI 10.1101/gr.122135.111; Jamil A, 2011, CRIT REV PLANT SCI, V30, P435, DOI 10.1080/07352689.2011.605739; Jan A, 2001, PLANT PHYSIOL, V136, P3670; Jiang JJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-72; Jung JH, 2011, PLANT SIGNAL BEHAV, V6, P1198, DOI 10.4161/psb.6.8.15792; Kanter U, 2005, PLANTA, V221, P243, DOI 10.1007/s00425-004-1441-0; Khan Taqi Ahmed, 2011, Journal of Agrobiology, V28, P97, DOI 10.2478/v10146-011-0011-x; Korbes AP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050663; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; Langlois-Meurinne M, 2005, PLANT PHYSIOL, V139, P1890, DOI 10.1104/pp.105.067223; Lee SC, 2008, MOL CELLS, V26, P595; Li MJ, 2011, J AM SOC HORTIC SCI, V136, P231, DOI 10.21273/JASHS.136.4.231; [龙卫华 Long Weihua], 2013, [中国油料作物学报, Chinese Journal of Oil Crop Sciences], V35, P271; Lorence A, 2004, PLANT PHYSIOL, V134, P1200, DOI 10.1104/pp.103.033936; Ludwig AA, 2004, J EXP BOT, V55, P181, DOI 10.1093/jxb/erh008; Ma SS, 2006, J EXP BOT, V57, P1097, DOI 10.1093/jxb/erj098; Nakagami H, 2005, TRENDS PLANT SCI, V10, P339, DOI 10.1016/j.tplants.2005.05.009; Nishitani K, 1997, INT REV CYTOL, V173, P157; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Park J, 2011, PLANT PHYSIOL, V156, P537, DOI 10.1104/pp.111.177071; Rana D, 2004, PLANT J, V40, P725, DOI 10.1111/j.1365-313X.2004.02244.x; Ren ZH, 2005, NAT GENET, V37, P1141, DOI 10.1038/ng1643; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Rozema J, 2008, SCIENCE, V322, P1478, DOI 10.1126/science.1168572; Saadia M, 2012, MOLECULES, V17, P5803, DOI 10.3390/molecules17055803; Shalata A, 2001, J EXP BOT, V52, P2207, DOI 10.1093/jexbot/52.364.2207; Strickler SR, 2012, AM J BOT, V99, P257, DOI 10.3732/ajb.1100292; Sun W, 2010, PLANT CELL PHYSIOL, V51, P997, DOI 10.1093/pcp/pcq056; Sun YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053632; Suwabe K, 2008, GENOME, V51, P169, DOI 10.1139/G07-113; Tabuchi A, 1997, PLANT CELL PHYSIOL, V38, P653, DOI 10.1093/oxfordjournals.pcp.a029217; Tognetti VB, 2010, PLANT CELL, V22, P2660, DOI 10.1105/tpc.109.071316; Trick M, 2009, PLANT BIOTECHNOL J, V7, P334, DOI 10.1111/j.1467-7652.2008.00396.x; van Damme M, 2008, PLANT J, V54, P785, DOI 10.1111/j.1365-313X.2008.03427.x; Varshney RK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-523; Verslues Paul E, 2010, Arabidopsis Book, V8, pe0140, DOI 10.1199/tab.0140; Wang XJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-716; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wheeler GL, 1998, NATURE, V393, P365, DOI 10.1038/30728; Xiong L, 2002, PLANT CELL ENVIRON, V25, P131, DOI 10.1046/j.1365-3040.2002.00782.x; Xue XN, 2009, BMB REP, V42, P28, DOI 10.5483/BMBRep.2009.42.1.028; Yamaguchi T, 2005, TRENDS PLANT SCI, V10, P615, DOI 10.1016/j.tplants.2005.10.002; Yan XH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-26; Zang YX, 2009, BIOTECHNOL BIOPROC E, V14, P467, DOI 10.1007/s12257-008-0294-y; Zhao YD, 2002, GENE DEV, V16, P3100, DOI 10.1101/gad.1035402; Zhu JK, 2003, CURR OPIN PLANT BIOL, V6, P441, DOI 10.1016/S1369-5266(03)00085-2; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zhu JK, 1998, PLANT CELL, V10, P1181, DOI 10.1105/tpc.10.7.1181; Zou XL, 2013, INT J MOL SCI, V14, P2637, DOI 10.3390/ijms14022637	73	29	33	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0116217	10.1371/journal.pone.0116217	http://dx.doi.org/10.1371/journal.pone.0116217			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679513	Green Submitted, gold, Green Published			2022-12-26	WOS:000350682600016
J	Park, MW; Kim, KH; Kim, EY; Lee, SY; Ko, JJ; Lee, KA				Park, Min-Woo; Kim, Kyeoung-Hwa; Kim, Eun-Young; Lee, Su-Yeon; Ko, Jung-Jae; Lee, Kyung-Ah			Associations among Sebox and Other MEGs and Its Effects on Early Embryogenesis	PLOS ONE			English	Article							PREIMPLANTATION MOUSE EMBRYOGENESIS; EARLY EMBRYONIC-DEVELOPMENT; ZYGOTIC GENE ACTIVATION; MATERNAL-EFFECT GENE; MESSENGER-RNAS; EXPRESSION; OOCYTES; TRANSITION; DEGRADATION; STAGE	In a previous report, we identified Sebox as a new candidate maternal effect gene that is essential for embryonic development and primarily impacts the two-cell (2C) stage. The present study was conducted to determine the mechanism of action for Sebox in this capacity, as shown by changes in the expression levels of other known MEG mRNAs after Sebox RNA interference (RNAi) in oocytes. Sebox-knockdown metaphase II (Mll) oocytes displayed normal morphology, but among the 23 MEGs monitored, 8 genes were upregulated, and 15 genes were unchanged. We hypothesized that the perturbed gene expression of these MEGs may cause the arrest of embryo development at the 2C stage and examined the expression of several marker genes for the degradation of maternal factors and zygotic genome activation. We found that some maternal mRNAs, c-mos, Gbx2, and Gdf9, were not fully degraded in Sebox-knockdown 2C embryos, and that several zygotic genome activation markers, Mt1a, Rpl23, Ube2a and Wee1, were not fully expressed in conjunction with diminished embryonic transcriptional activity. In addition, Sebox may be involved in the formation of the subcortical maternal complex through its regulation of the upstream regulator, Figla. Therefore, we concluded that Sebox is important in preparing oocytes for embryonic development by orchestrating the expression of other important MEGs.	[Park, Min-Woo; Kim, Kyeoung-Hwa; Kim, Eun-Young; Lee, Su-Yeon; Ko, Jung-Jae; Lee, Kyung-Ah] CHA Univ, Coll Life Sci, Dept Biomed Sci, Songnam 463400, Gyeonggi Do, South Korea	Pochon Cha University	Ko, JJ (corresponding author), CHA Univ, Coll Life Sci, Dept Biomed Sci, Pangyo Ro 335, Songnam 463400, Gyeonggi Do, South Korea.	highko@cha.ac.kr; leeka@ovary.co.kr			Priority Research Centers Program, through the National Research Foundation of Korea (NRF), - Ministry of Education, Science, and Technology [2009-0093821]	Priority Research Centers Program, through the National Research Foundation of Korea (NRF), - Ministry of Education, Science, and Technology	This work was supported by the Priority Research Centers Program, through the National Research Foundation of Korea (NRF), and funded by the Ministry of Education, Science, and Technology (2009-0093821). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh Z, 2005, MOL REPROD DEV, V72, P281, DOI 10.1002/mrd.20340; Cinquanta M, 2000, P NATL ACAD SCI USA, V97, P8904, DOI 10.1073/pnas.97.16.8904; GOLBUS MS, 1973, J EXP ZOOL, V186, P207, DOI 10.1002/jez.1401860211; Hamatani T, 2004, HUM MOL GENET, V13, P2263, DOI 10.1093/hmg/ddh241; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; Joshi S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-67; Kigami D, 2003, BIOL REPROD, V68, P651, DOI 10.1095/biolreprod.102.007906; Kim Kyeoung-Hwa, 2014, Clin Exp Reprod Med, V41, P47, DOI 10.5653/cerm.2014.41.2.47; Kim KH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023304; Kim KH, 2008, BIOL REPROD, V79, P1192, DOI 10.1095/biolreprod.108.068478; Latham KE, 1999, INT REV CYTOL, V193, P71; Lee Hyun-Seo, 2011, Clin Exp Reprod Med, V38, P68, DOI 10.5653/cerm.2011.38.2.68; Li L, 2008, DEV CELL, V15, P416, DOI 10.1016/j.devcel.2008.07.010; Li L, 2010, DEVELOPMENT, V137, P859, DOI 10.1242/dev.039487; Lykke-Andersen K, 2008, MOL BIOL CELL, V19, P4383, DOI 10.1091/mbc.E08-02-0219; Ma J, 2006, DEVELOPMENT, V133, P2053, DOI 10.1242/dev.02371; Moreno DL, 2014, ZYGOTE, V22, P64, DOI 10.1017/S0967199412000342; NUSSLEINVOLHARD C, 1980, NATURE, V283, P474, DOI 10.1038/283474a0; Ohsugi M, 2008, DEVELOPMENT, V135, P259, DOI 10.1242/dev.011445; Park Geon Tae, 2013, Clin Exp Reprod Med, V40, P1, DOI 10.5653/cerm.2013.40.1.1; PAYNTON BV, 1988, DEV BIOL, V129, P304, DOI 10.1016/0012-1606(88)90377-6; Qiu JJ, 2003, CELL RES, V13, P179, DOI 10.1038/sj.cr.7290162; Rother F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018310; SCHULTZ RM, 1993, BIOESSAYS, V15, P531, DOI 10.1002/bies.950150806; Schultz RM, 2002, HUM REPROD UPDATE, V8, P323, DOI 10.1093/humupd/8.4.323; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; TELFORD NA, 1990, MOL REPROD DEV, V26, P90, DOI 10.1002/mrd.1080260113; Tong ZB, 2000, NAT GENET, V26, P267, DOI 10.1038/81547; Tsai TC, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-88; Waksmundzka M, 2001, MOL REPROD DEV, V58, P173, DOI 10.1002/1098-2795(200102)58:2&lt;173::AID-MRD6&gt;3.0.CO;2-2; Wan LB, 2008, DEVELOPMENT, V135, P2729, DOI 10.1242/dev.024539; Wang QT, 2004, DEV CELL, V6, P133, DOI 10.1016/S1534-5807(03)00404-0; Yoon SJ, 2005, FERTIL STERIL, V83, P1293, DOI 10.1016/j.fertnstert.2004.09.037; Yurttas P, 2008, DEVELOPMENT, V135, P2627, DOI 10.1242/dev.016329; Zeng FY, 2005, DEV BIOL, V283, P40, DOI 10.1016/j.ydbio.2005.03.038; Zeng FY, 2004, DEV BIOL, V272, P483, DOI 10.1016/j.ydbio.2004.05.018; ZERNICKAGOETZ M, 1994, MOL REPROD DEV, V38, P30, DOI 10.1002/mrd.1080380106	37	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0115050	10.1371/journal.pone.0115050	http://dx.doi.org/10.1371/journal.pone.0115050			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679966	Green Published, gold, Green Submitted			2022-12-26	WOS:000350682600004
J	Suzuki, K; Sato, M; Zheng, W; Shinohara, R; Yokomichi, H; Yamagata, Z				Suzuki, Kohta; Sato, Miri; Zheng, Wei; Shinohara, Ryoji; Yokomichi, Hiroshi; Yamagata, Zentaro			Childhood Growth Trajectories According to Combinations of Pregestational Weight Status and Maternal Smoking during Pregnancy: A Multilevel Analysis	PLOS ONE			English	Article							BODY-MASS INDEX; SOCIOECONOMIC-STATUS; OBESITY; ASSOCIATION; CHILDREN; RISK; OVERWEIGHT; EXPOSURE; BIRTH; WOMEN	Pregestational weight status and maternal smoking during pregnancy are significantly associated with fetal and childhood growth. However, few studies have examined associations between childhood growth and combinations of these factors using multilevel analysis. This study aimed to describe differences in childhood growth trajectories according to these combinations, using data from a prospective cohort study in Japan. The study participants were 1,973 women and their singletons, who were born between April 1, 1991 and March 31, 2003. Children were categorized according to whether they were born to normal-weight, nonsmoking mothers (NN); normal-weight, smoking mothers (NS); underweight, nonsmoking mothers (UN); underweight, smoking mothers (US); overweight, nonsmoking mothers (ON); or overweight, smoking mothers (OS). Birth weight and anthropometric data were collected from 1,965 children at birth (99.6%), 1,655 aged 3 (83.9%), 1,527 aged 5 (77.4%), 1,497 aged 7-8 (75.9%), and 1,501 aged 9-10 (76.1%). Multilevel analysis examining both individual and age as different level variables according to sex was used to describe the trajectories of body mass index z scores for statistical analyses. Although children of the OS group were the leanest at birth, their body mass indices had increased rapidly by 3 years of age. Moreover, body mass index was also likely to increase in boys in the NS and ON groups. A different trend was observed in girls. Body mass index decreased from 5 years of age in girls in the US group. There were no remarkable differences in body mass index trajectories between children in the other groups. In conclusion, childhood growth trajectories differed according to combinations of pregestational weight status and maternal smoking during pregnancy. Further, there were sex-related differences in the associations between childhood growth and factor combinations.	[Suzuki, Kohta; Zheng, Wei; Yokomichi, Hiroshi; Yamagata, Zentaro] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Hlth Sci, Chuo Ku, Yamanashi, Japan; [Sato, Miri; Shinohara, Ryoji; Yamagata, Zentaro] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Ctr Birth Cohort Studies, Chuo Ku, Yamanashi, Japan	University of Yamanashi; University of Yamanashi	Suzuki, K (corresponding author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Hlth Sci, Chuo Ku, Yamanashi, Japan.	kohtas@yamanashi.ac.jp	Yokomichi, Hiroshi/B-2816-2013	Yokomichi, Hiroshi/0000-0001-7369-155X	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [KAKENHI 23390173, KAKENHI 20590639, KAKENHI 23590785]; Grants-in-Aid for Scientific Research [24790614] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research (KAKENHI 23390173, KAKENHI 20590639, and KAKENHI 23590785) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM S, 1971, HSMHA HEALTH REP, V86, P273, DOI 10.2307/4594149; Balding DJ, 2004, APPL LONGITUDINAL AN; Barker DJP, 2005, NEW ENGL J MED, V353, P1802, DOI 10.1056/NEJMoa044160; Bhargava SK, 2004, NEW ENGL J MED, V350, P865, DOI 10.1056/NEJMoa035698; Burstyn I, 2009, NICOTINE TOB RES, V11, P670, DOI 10.1093/ntr/ntp048; CHARNEY E, 1976, NEW ENGL J MED, V295, P6, DOI 10.1056/NEJM197607012950102; Chihara I, 2011, ARCH GYNECOL OBSTET, V284, P1117, DOI 10.1007/s00404-010-1812-7; Dietz WH, 1998, J NUTR, V128, p411S, DOI 10.1093/jn/128.2.411S; Dubois L, 2006, INT J OBESITY, V30, P610, DOI 10.1038/sj.ijo.0803141; Durmus B, 2013, PEDIATR OBES, V8, P339, DOI 10.1111/j.2047-6310.2012.00114.x; Eriksson JG, 2003, DIABETOLOGIA, V46, P190, DOI 10.1007/s00125-002-1012-5; Heaman M, 2013, PAEDIATR PERINAT EP, V27, P54, DOI 10.1111/ppe.12016; Hernandez-Diaz S, 2006, AM J EPIDEMIOL, V164, P1115, DOI 10.1093/aje/kwj275; Jang SY, 2012, ASIAN PAC J CANCER P, V13, P1003, DOI 10.7314/APJCP.2012.13.3.1003; Jeric M, 2013, EARLY HUM DEV, V89, P277, DOI 10.1016/j.earlhumdev.2012.10.004; Legler J, 2013, OBESITY, V21, P1084, DOI 10.1002/oby.20478; Levine M D, 2004, Arch Womens Ment Health, V7, P155; Levine MD, 2010, AM J PREV MED, V39, P345, DOI 10.1016/j.amepre.2010.05.023; Lombardo C, 2012, EAT WEIGHT DISORD-ST, V17, pE116, DOI 10.1007/BF03325335; Mizutani T, 2007, OBESITY, V15, P3133, DOI 10.1038/oby.2007.373; Nguyen DM, 2010, GASTROENTEROL CLIN N, V39, P1, DOI 10.1016/j.gtc.2009.12.014; Phillips DIW, 1996, DIABETOLOGIA, V39, P1119; Power C, 2002, INT J EPIDEMIOL, V31, P413, DOI 10.1093/ije/31.2.413; Reid JL, 2010, CAN J PUBLIC HEALTH, V101, P73, DOI 10.1007/BF03405567; SOBAL J, 1989, PSYCHOL BULL, V105, P260, DOI 10.1037/0033-2909.105.2.260; Suzuki K, 2011, INT J OBESITY, V35, P53, DOI 10.1038/ijo.2010.198; Suzuki K, 2009, J EPIDEMIOL, V19, P136, DOI 10.2188/jea.JE20081012; Swanson JM, 2009, SEMIN REPROD MED, V27, P391, DOI 10.1055/s-0029-1237427; Toschke AM, 2003, AM J EPIDEMIOL, V158, P1068, DOI 10.1093/aje/kwg258; Toschke AM, 2002, EUR J PEDIATR, V161, P445, DOI 10.1007/s00431-002-0983-z; Twisk JWR., 2006, APPL MULTILEVEL ANAL, DOI [10.1017/CBO9780511610806, DOI 10.1017/CBO9780511610806]; Vik T, 1996, EARLY HUM DEV, V45, P245, DOI 10.1016/0378-3782(96)01735-5; Voigt M, 2011, Z GEBURTSH NEONATOL, V215, P23, DOI 10.1055/s-0030-1254142; von Kries R, 2002, AM J EPIDEMIOL, V156, P954, DOI 10.1093/aje/kwf128; WHO, 2006, WHO CHILD GROWTH STA; Wideroe M, 2003, PAEDIATR PERINAT EP, V17, P171, DOI 10.1046/j.1365-3016.2003.00481.x	36	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0118538	10.1371/journal.pone.0118538	http://dx.doi.org/10.1371/journal.pone.0118538			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680116	Green Published, Green Submitted, gold			2022-12-26	WOS:000350682600124
J	Yu, L; Wang, YJ; Wang, YQ; Sun, SQ; Liu, LZY				Yu, Lei; Wang, Yujie; Wang, Yunqi; Sun, Suqi; Liu, Liziyuan			Quantifying Components of Soil Respiration and Their Response to Abiotic Factors in Two Typical Subtropical Forest Stands, Southwest China	PLOS ONE			English	Article							TEMPERATE DECIDUOUS FOREST; LAND-USE CHANGE; ROOT RESPIRATION; CO2 EFFLUX; HETEROTROPHIC RESPIRATION; AUTOTROPHIC COMPONENTS; SEASONAL-VARIATIONS; TEMPORAL VARIATION; FINE ROOTS; CARBON	Separating the components of soil respiration and understanding the roles of abiotic factors at a temporal scale among different forest types are critical issues in forest ecosystem carbon cycling. This study quantified the proportions of autotrophic (R-A) and heterotrophic (R-H) in total soil (R-T) respiration using trenching and litter removal. Field studies were conducted in two typical subtropical forest stands (broadleaf and needle leaf mixed forest; bamboo forest) at Jinyun Mountain, near the Three Georges Reservoir in southwest China, during the growing season (Apr.-Sep.) from 2010 to 2012. The effects of air temperature (AT), soil temperature (ST) and soil moisture (SM) at 6cm depth, solar radiation (SR), pH on components of soil respiration were analyzed. Results show that: 1) SR, AT, and ST exhibited a similar temporal trend. The observed abiotic factors showed slight interannual variability for the two forest stands. 2) The contributions of R-H and R-A to R-T for broadleaf and needle leaf mixed forest were 73.25% and 26.75%, respectively, while those for bamboo forest were 89.02% and 10.98%, respectively; soil respiration peaked from June to July. In both stands, CO2 released from the decomposition of soil organic matter (SOM), the strongest contributor to R-T, accounted for over 63% of R-H. 3) AT and ST were significantly positively correlated with R-T and its components (p<0.05), and were major factors affecting soil respiration. 4) Components of soil respiration were significantly different between two forest stands (p<0.05), indicating that vegetation types played a role in soil respiration and its components.	[Yu, Lei; Wang, Yujie; Wang, Yunqi; Sun, Suqi; Liu, Liziyuan] Beijing Forestry Univ, Minist Educ, Key Lab Soil & Water Conservat & Desertificat Com, Beijing, Peoples R China	Beijing Forestry University	Wang, YJ (corresponding author), Beijing Forestry Univ, Minist Educ, Key Lab Soil & Water Conservat & Desertificat Com, Beijing, Peoples R China.	95833797@qq.com			Forest Ecosystem Carbon and Nand Water Coupled Observation, Simulation and Application of Technology in Southwest of China [201104009-03]; CFERN & GENE Award Funds	Forest Ecosystem Carbon and Nand Water Coupled Observation, Simulation and Application of Technology in Southwest of China; CFERN & GENE Award Funds	This study was supported by the funding of Forest Ecosystem Carbon and Nand Water Coupled Observation, Simulation and Application of Technology in Southwest of China(201104009-03), and was supported by CFERN & GENE Award Funds on Ecological Paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Atkin OK, 2003, TRENDS PLANT SCI, V8, P343, DOI 10.1016/S1360-1385(03)00136-5; Atkin OK, 2002, PLANT PHYSIOL, V128, P212, DOI 10.1104/pp.010326; Bond-Lamberty B, 2004, TREE PHYSIOL, V24, P1387, DOI 10.1093/treephys/24.12.1387; Bond-Lamberty B, 2004, GLOBAL CHANGE BIOL, V10, P1756, DOI 10.1111/j.1365-2486.2004.00816.x; Bond-Lamberty B, 2010, NATURE, V464, P579, DOI 10.1038/nature08930; Borken W, 2003, SOIL SCI SOC AM J, V67, P1888, DOI 10.2136/sssaj2003.1888; Buchmann N, 2000, SOIL BIOL BIOCHEM, V32, P1625, DOI 10.1016/S0038-0717(00)00077-8; Burton AJ, 2002, OECOLOGIA, V131, P559, DOI 10.1007/s00442-002-0931-7; Butler A, 2012, PLANT SOIL, V352, P129, DOI 10.1007/s11104-011-0984-7; [常建国 CHANG JianGuo], 2007, [生态学报, Acta Ecologica Sinica], V27, P1791; Chen BY, 2010, SOIL BIOL BIOCHEM, V42, P1735, DOI 10.1016/j.soilbio.2010.06.010; Chen MQ, 2010, J BAMBOO RES CHINESE, V29, P5, DOI [10.3969/j.issn.1000-6567.2010.03.002, DOI 10.3969/J.ISSN.1000-6567.2010.03.002]; Conant RT, 2004, SOIL BIOL BIOCHEM, V36, P945, DOI 10.1016/j.soilbio.2004.02.013; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Davidson EA, 2006, GLOBAL CHANGE BIOL, V12, P154, DOI 10.1111/j.1365-2486.2005.01065.x; [冯华敏 Feng Huamin], 2011, [水土保持通报, Bulletin of Soil and Water Conservation], V31, P38; Fenn KM, 2010, SOIL BIOL BIOCHEM, V42, P1685, DOI 10.1016/j.soilbio.2010.05.028; Fierer N, 2003, GLOBAL CHANGE BIOL, V9, P1322, DOI 10.1046/j.1365-2486.2003.00663.x; Franzluebbers AJ, 2001, SOIL BIOL BIOCHEM, V33, P1103, DOI 10.1016/S0038-0717(01)00016-5; Grant RF, 2001, SOIL SCI SOC AM J, V65, P205, DOI 10.2136/sssaj2001.651205x; Han GX, 2007, SOIL BIOL BIOCHEM, V39, P418, DOI 10.1016/j.soilbio.2006.08.009; Hanson PJ, 2000, BIOGEOCHEMISTRY, V48, P115, DOI 10.1023/A:1006244819642; Heinemeyer A, 2007, GLOBAL CHANGE BIOL, V13, P1786, DOI 10.1111/j.1365-2486.2007.01383.x; Hogberg P, 2006, TRENDS ECOL EVOL, V21, P548, DOI 10.1016/j.tree.2006.06.004; Ilstedt U, 2000, SOIL BIOL BIOCHEM, V32, P1591, DOI 10.1016/S0038-0717(00)00073-0; John B, 2002, BIOL FERT SOILS, V35, P238, DOI 10.1007/s00374-002-0470-8; Kang SY, 2003, GLOBAL CHANGE BIOL, V9, P1427, DOI 10.1046/j.1365-2486.2003.00668.x; Kara EE, 2004, BIOL FERT SOILS, V39, P474, DOI 10.1007/s00374-004-0729-3; KASPAR TC, 1992, SOIL SCI, V154, P290, DOI 10.1097/00010694-199210000-00005; Kelting DL, 1998, SOIL BIOL BIOCHEM, V30, P961, DOI 10.1016/S0038-0717(97)00186-7; Kominami Y, 2012, J FOREST RES-JPN, V17, P296, DOI 10.1007/s10310-011-0315-0; Kuzyakov Y, 2002, J PLANT NUTR SOIL SC, V165, P382, DOI 10.1002/1522-2624(200208)165:4<382::AID-JPLN382>3.0.CO;2-#; Landsberg J.J, 1997, APPL PHYSL ECOLOGY F; Lee MS, 2003, PLANT SOIL, V255, P311, DOI 10.1023/A:1026192607512; Li XD, 2010, SOIL BIOL BIOCHEM, V42, P337, DOI 10.1016/j.soilbio.2009.11.013; Liu CX, 2013, SOIL RESP IMPACT FAC, V44, P587; Liu J, 2011, FOREST ECOL MANAG, V262, P1131, DOI 10.1016/j.foreco.2011.06.015; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Luo Yand, 2006, SOIL RESP ENV; Melillo JM, 2002, SCIENCE, V298, P2173, DOI 10.1126/science.1074153; Mo J, 2008, GLOBAL CHANGE BIOL, V14, P403, DOI 10.1111/j.1365-2486.2007.01503.x; Moyano FE, 2008, AGR FOREST METEOROL, V148, P135, DOI 10.1016/j.agrformet.2007.09.006; Moyano FE, 2007, SOIL BIOL BIOCHEM, V39, P843, DOI 10.1016/j.soilbio.2006.10.001; Nobel P.S., 2005, PHYSIOCHEMICAL ENV P; Raich JW, 2000, BIOGEOCHEMISTRY, V48, P71, DOI 10.1023/A:1006112000616; Rodeghiero M, 2006, PLANT SOIL, V284, P7, DOI 10.1007/s11104-005-5109-8; Saiz G, 2006, GLOBAL CHANGE BIOL, V12, P1007, DOI 10.1111/j.1365-2486.2006.01145.x; Satomura T, 2006, ECOL RES, V21, P741, DOI 10.1007/s11284-006-0182-x; Schlesinger WH, 2000, BIOGEOCHEMISTRY, V48, P7, DOI 10.1023/A:1006247623877; Scott-Denton LE, 2006, GLOBAL CHANGE BIOL, V12, P205, DOI 10.1111/j.1365-2486.2005.01064.x; Shen Xiao-shuai, 2011, Huanjing Kexue, V32, P3181; SITAULA BK, 1995, SOIL BIOL BIOCHEM, V27, P1401, DOI 10.1016/0038-0717(95)00078-S; Subke JA, 2006, GLOBAL CHANGE BIOL, V12, P921, DOI 10.1111/j.1365-2486.2006.01117.x; Tang JW, 2005, BIOGEOCHEMISTRY, V73, P183, DOI 10.1007/s10533-004-5889-6; Vose JM, 2002, GLOBAL CHANGE BIOL, V8, P182, DOI 10.1046/j.1365-2486.2002.00464.x; Wang CK, 2006, GLOBAL CHANGE BIOL, V12, P2103, DOI 10.1111/j.1365-2486.2006.01234.x; Wang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080937; Wang YS, 2003, ADV ATMOS SCI, V20, P119, DOI 10.1007/BF03342056; Xu LK, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002281; Xu M, 2001, GLOBAL CHANGE BIOL, V7, P667, DOI 10.1046/j.1354-1013.2001.00435.x; Yi ZG, 2007, FOREST ECOL MANAG, V243, P178, DOI 10.1016/j.foreco.2007.02.022; Zhang Q, 2013, AGR FOREST METEOROL, V180, P34, DOI 10.1016/j.agrformet.2013.04.028; Zhang T, 2013, ATMOS ENVIRON, V77, P856, DOI 10.1016/j.atmosenv.2013.06.011; Zhang Wen-Li, 2010, Chinese Journal of Plant Ecology, V34, P1265, DOI 10.3773/j.issn.1005-264x.2010.11.003; Zheng ZM, 2009, SOIL BIOL BIOCHEM, V41, P1531, DOI 10.1016/j.soilbio.2009.04.013	65	18	21	5	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117490	10.1371/journal.pone.0117490	http://dx.doi.org/10.1371/journal.pone.0117490			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680112	gold, Green Published, Green Submitted			2022-12-26	WOS:000350682600068
J	Ghosh, AK; Sardar, AH; Mandal, A; Saini, S; Abhishek, K; Kumar, A; Purkait, B; Singh, R; Das, S; Mukhopadhyay, R; Roy, S; Das, P				Ghosh, Ayan K.; Sardar, Abul H.; Mandal, Abhishek; Saini, Savita; Abhishek, Kumar; Kumar, Ashish; Purkait, Bidyut; Singh, Ruby; Das, Sushmita; Mukhopadhyay, Rupkatha; Roy, Syamal; Das, Pradeep			Metabolic reconfiguration of the central glucose metabolism: a crucial strategy of Leishmania donovani for its survival during oxidative stress	FASEB JOURNAL			English	Article						metabolic flux; NADPH; PPP	PENTOSE-PHOSPHATE PATHWAY; AMPHOTERICIN-B RESISTANCE; TRYPANOSOMA-BRUCEI; GENE-EXPRESSION; TRIOSEPHOSPHATE ISOMERASE; PYRIDINE-NUCLEOTIDES; PARASITIC PROTOZOA; GLUTATHIONE LEVELS; CELL-DEATH; REDOX	Understanding the mechanism that allows the intracellular protozoan parasite Leishmania donovani (Ld) to respond to reactive oxygen species (ROS) is of increasing therapeutic importance because of the continuing resistance toward antileishmanial drugs and for determining the illusive survival strategy of these parasites. A shift in primary carbon metabolism is the fastest response to oxidative stress. A (CO2)-C-14 evolution study, expression of glucose transporters together with consumption assays, indicated a shift in metabolic flux of the parasites from glycolysis toward pentose phosphate pathway (PPP) when exposed to different oxidants in vitro/ex vivo. Changes in gene expression, protein levels, and enzyme activities all pointed to a metabolic reconfiguration of the central glucose metabolism in response to oxidants. Generation of glucose-6-phosphate dehydrogenase (G6PDH) (similar to 5-fold) and transaldolase (TAL) (similar to 4.2-fold) overexpressing Ld cells reaffirmed that lethal doses of ROS were counterbalanced by effective manipulation of NADPH:NADP(+) ratio and stringent maintenance of reduced thiol content. The extent of protein carbonylation and accumulation of lipid peroxidized products were also found to be less in overexpressed cell lines. Interestingly, the LD50 of sodium antimony gluconate (SAG), amphotericin-B (AmB), and miltefosine were significantly high toward overexpressing parasites. Consequently, this study illustrates that Ld strategizes a metabolic reconfiguration for replenishment of NADPH pool to encounter oxidative challenges.	[Ghosh, Ayan K.; Sardar, Abul H.; Mandal, Abhishek; Abhishek, Kumar; Kumar, Ashish; Purkait, Bidyut; Singh, Ruby; Das, Pradeep] Indian Council Med Res, Rajendra Mem Res Inst Med Sci, Div Mol Biol, Patna, Bihar, India; [Saini, Savita] Natl Inst Pharmaceut Educ & Res, Dept Biotechnol, Vaishali, Bihar, India; [Das, Sushmita] All India Inst Med Sci, Dept Microbiol, Patna, Bihar, India; [Mukhopadhyay, Rupkatha; Roy, Syamal] CSIR, Indian Inst Chem Biol, Div Infect Dis & Immunol, Kolkata, India	Indian Council of Medical Research (ICMR); ICMR - Rajendra Memorial Research Institute of Medical Sciences (RMRI); National Institute of Pharmaceutical Education & Research (NIPER); All India Institute of Medical Sciences (AIIMS) Patna; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Das, P (corresponding author), Rajendra Mem Res Inst Med Sci, Patna 800007, Bihar, India.	drpradeep.das@gmail.com	GHOSH, AYAN/GYV-5906-2022; Mandal, Abhishek/Y-5333-2019; Mukhopadhyay, Rupkatha/AAY-4304-2020	Mukhopadhyay, Rupkatha/0000-0002-4120-2966	Indian Council of Medical Research, Ministry of Health and Family Welfare, Government of India	Indian Council of Medical Research, Ministry of Health and Family Welfare, Government of India	The authors thank Prof. Siddhartha Roy (Director, CSIR-IICB) for allowing A.K.G. to perform the PPP flux measurement experiments in the laboratory of Dr. Syamal Roy. They also thank Prof. M. P. Barrett (University of Glasgow, United Kingdom), Prof. Paul A. M. Michaels (de Duve Institute, Brussels, Belgium), Dr. Scott M. Landfear (Oregon Health and Science University, Portland, USA), and Prof. Greg Matlashewski (McGill University, Montreal, QC, Canada) for their kind gift of Tb6PGDH and LmTKL antibodies, LmTPI antibody, LeGT2 (P1L) antibody and pLP-NEO2 vector, respectively. They also thank Dr. Vahab Ali (RMRIMS, Patna) for his kind gift of LdTryR antibody. The authors are extremely grateful to Mr. Amar Kant Singh and Mr. Subhas Kumar for providing technical assistance throughout this study. This work was funded by the Indian Council of Medical Research, Ministry of Health and Family Welfare, Government of India.	Akerman SE, 2005, J BIOL CHEM, V280, P564, DOI 10.1074/jbc.M406367200; Allmann S, 2013, J BIOL CHEM, V288, P18494, DOI 10.1074/jbc.M113.462978; Barrett MP, 1997, PARASITOL TODAY, V13, P11, DOI 10.1016/S0169-4758(96)10075-2; Berg M, 2013, MOL MICROBIOL, V90, P428, DOI 10.1111/mmi.12374; Bhandari V, 2014, ANTIMICROB AGENTS CH, V58, P2580, DOI 10.1128/AAC.01574-13; Birkholtz LM, 2011, BIOCHEM J, V438, P229, DOI 10.1042/BJ20110362; BOVERIS A, 1980, BIOCHEM J, V188, P643, DOI 10.1042/bj1880643; Chawla B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026660; Deschacht M, 2012, PARASITOLOGY, V139, P1429, DOI 10.1017/S003118201200073X; Diaz-Albiter H, 2012, J BIOL CHEM, V287, P23995, DOI 10.1074/jbc.M112.376095; Dolai S, 2009, EUKARYOT CELL, V8, P1721, DOI 10.1128/EC.00198-09; EGGLESTON LV, 1974, BIOCHEM J, V138, P425, DOI 10.1042/bj1380425; Garza-Ramos G, 1998, EUR J BIOCHEM, V253, P684, DOI 10.1046/j.1432-1327.1998.2530684.x; Gazanion E, 2011, PARASITOL INT, V60, P19, DOI 10.1016/j.parint.2010.09.005; GHOSH DK, 1971, EXP PARASITOL, V29, P103, DOI 10.1016/0014-4894(71)90017-8; Godon C, 1998, J BIOL CHEM, V273, P22480, DOI 10.1074/jbc.273.35.22480; Grant CM., 2008, J BIOL-LONDON, V7, P1, DOI DOI 10.1186/jbiol63; He SS, 2012, ANTIMICROB AGENTS CH, V56, P2428, DOI 10.1128/AAC.06386-11; Huynh TT, 2003, J BIOL CHEM, V278, P39794, DOI 10.1074/jbc.M306306200; Jeelani G, 2013, BIOCHIMIE, V95, P309, DOI 10.1016/j.biochi.2012.09.034; Kapoor P, 2000, TROP MED INT HEALTH, V5, P438, DOI 10.1046/j.1365-3156.2000.00565.x; KATZ J, 1960, J BIOL CHEM, V235, P2165; Kim DH, 2013, MOL MICROBIOL, V88, P841, DOI 10.1111/mmi.12243; Krauth-Siegel RL, 2008, BBA-GEN SUBJECTS, V1780, P1236, DOI 10.1016/j.bbagen.2008.03.006; Kruger A, 2011, ANTIOXID REDOX SIGN, V15, P311, DOI 10.1089/ars.2010.3797; Kumar A, 2014, ANTIMICROB AGENTS CH, V58, P6172, DOI 10.1128/AAC.02834-14; Maugeri DA, 2003, MOL BIOCHEM PARASIT, V130, P117, DOI 10.1016/S0166-6851(03)00173-7; Mishra J, 2013, EXP PARASITOL, V135, P397, DOI 10.1016/j.exppara.2013.08.004; Moreira W, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.83; Mukherjee A, 2013, MOL MICROBIOL, V88, P189, DOI 10.1111/mmi.12178; Muller S, 2004, MOL MICROBIOL, V53, P1291, DOI 10.1111/j.1365-2958.2004.04257.x; NYAME K, 1994, MOL BIOCHEM PARASIT, V67, P269, DOI 10.1016/0166-6851(94)00139-1; OGBUNUDE POJ, 1983, MOL BIOCHEM PARASIT, V9, P279, DOI 10.1016/0166-6851(83)90084-1; OstoaSaloma P, 1997, EUR J BIOCHEM, V244, P700, DOI 10.1111/j.1432-1033.1997.00700.x; PANDOLFI PP, 1995, EMBO J, V14, P5209, DOI 10.1002/j.1460-2075.1995.tb00205.x; Papadopoulou B, 2003, ASM NEWS, V69, P282; PASTAKIA KB, 1987, MOL BIOCHEM PARASIT, V26, P175, DOI 10.1016/0166-6851(87)90141-1; Perl A, 2011, TRENDS MOL MED, V17, P395, DOI 10.1016/j.molmed.2011.01.014; Pocsi I, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-182; Pollak N, 2007, J BIOL CHEM, V282, P33562, DOI 10.1074/jbc.M704442200; Pollak N, 2007, BIOCHEM J, V402, P205, DOI 10.1042/BJ20061638; Portal P, 2008, MOL BIOCHEM PARASIT, V160, P42, DOI 10.1016/j.molbiopara.2008.03.007; Purkait B, 2012, ANTIMICROB AGENTS CH, V56, P1031, DOI 10.1128/AAC.00030-11; Puskas F, 2000, FASEB J, V14, P1352, DOI 10.1096/fj.14.10.1352; Qian YM, 2008, BIOCHEM J, V415, P123, DOI 10.1042/BJ20080722; Ralser M., 2007, J BIOL, V6, P10, DOI [DOI 10.1186/jbiol61, 10.1186/jbiol61]; Ralser M, 2009, NAT BIOTECHNOL, V27, P604, DOI 10.1038/nbt0709-604; Rodriguez-Contreras D, 2007, MOL BIOCHEM PARASIT, V153, P9, DOI 10.1016/j.molbiopara.2007.01.010; Rosenzweig D, 2008, PROTEOMICS, V8, P1843, DOI 10.1002/pmic.200701043; Rosenzweig D, 2008, FASEB J, V22, P590, DOI 10.1096/fj.07-9254com; Salvemini F, 1999, J BIOL CHEM, V274, P2750, DOI 10.1074/jbc.274.5.2750; Sandoval JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025573; Sardar AH, 2013, EXP PARASITOL, V135, P715, DOI 10.1016/j.exppara.2013.10.011; Sardar AH, 2013, J PROTEOMICS, V81, P185, DOI 10.1016/j.jprot.2013.01.011; Shi WX, 1999, J BIOL CHEM, V274, P21114, DOI 10.1074/jbc.274.30.21114; Singh R, 2007, J BACTERIOL, V189, P6665, DOI 10.1128/JB.00555-07; Sudhandiran G, 2003, J BIOL CHEM, V278, P25120, DOI 10.1074/jbc.M301975200; Tian WN, 1998, J BIOL CHEM, V273, P10609, DOI 10.1074/jbc.273.17.10609; Tovar J, 1998, P NATL ACAD SCI USA, V95, P5311, DOI 10.1073/pnas.95.9.5311; Van Assche T, 2011, FREE RADICAL BIO MED, V51, P337, DOI 10.1016/j.freeradbiomed.2011.05.011; WILLIAMS JF, 1987, INT J BIOCHEM, V19, P749, DOI 10.1016/0020-711X(87)90239-4; WILSON ME, 1994, INFECT IMMUN, V62, P5133, DOI 10.1128/IAI.62.11.5133-5141.1994; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672; ZHANG WW, 1995, NUCLEIC ACIDS RES, V23, P4073, DOI 10.1093/nar/23.20.4073; Zhang ZQ, 2000, ANAL BIOCHEM, V285, P163, DOI 10.1006/abio.2000.4701	65	30	31	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2015	29	5					2081	2098		10.1096/fj.14-258624	http://dx.doi.org/10.1096/fj.14-258624			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZJ	25690656				2022-12-26	WOS:000354114600040
J	Liu, CX; Zhang, YQ; Li, J; Wang, YY; Ren, FL; Zhou, YF; Wu, YY; Feng, YR; Zhou, Y; Su, FQ; Jia, BQ; Wang, D; Chang, ZJ				Liu, Chunxiao; Zhang, Yanquan; Li, Jun; Wang, Yinyin; Ren, Fangli; Zhou, Yifan; Wu, Yinyuan; Feng, Yarui; Zhou, Yu; Su, Fuqin; Jia, Baoqing; Wang, Dong; Chang, Zhijie			p15RS/RPRD1A (p15INK4b-related Sequence/Regulation of Nuclear Pre-mRNA Domain-containing Protein 1A) Interacts with HDAC2 in Inhibition of the Wnt/beta-Catenin Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE 1; C-TERMINAL DOMAIN; BETA-CATENIN; POLYMERASE-II; TRANSCRIPTION TERMINATION; P15RS; DIFFERENTIATION; ACETYLATION; COMPLEX; BINDING	We previously reported that p15RS (p15INK4b-related sequence), a regulation of nuclear pre-mRNA domain containing protein, inhibited Wnt signaling by interrupting the formation of the beta-catenin.TCF4 complex. However, how p15RS functions as an intrinsic repressor to repress transcription remains unclear. In this study, we show that p15RS, through a specific interaction with HDAC2 (histone deacetylase 2), a deacetylase that regulates gene transcription, maintains histone H3 in a deacetylated state in the promoter region of Wnt-targeted genes where beta-catenin.TCF4 is bound. We observed that histone deacetylase inhibitors impair the ability of p15RS in inhibiting Wnt/beta-catenin signaling. Depletion of HDAC2 markedly disabled p15RS inhibition of Wnt/beta-catenin-mediated transcription. Interestingly, overexpression of p15RS decreases the level of acetylated histone H3 in the c-MYC promoter. Finally, we demonstrate that p15RS significantly enhances the association of HDAC2 and TCF4 and enhances the occupancy of HDAC2 to DNA, resulting in the deacetylation of histone H3 and the failure of p-catenin interaction. We propose that p15RS acts as an intrinsic transcriptional repressor for Wnt/beta-catenin-mediated gene transcription at least partially through recruiting HDAC2 to occupy the promoter and maintaining deacetylated histone H3.	[Liu, Chunxiao; Zhang, Yanquan; Wang, Yinyin; Ren, Fangli; Zhou, Yifan; Wu, Yinyuan; Feng, Yarui; Zhou, Yu; Su, Fuqin; Wang, Dong; Chang, Zhijie] Tsinghua Univ, Sch Med, State Key Lab Biomembrane & Membrane Biotechnol, Sch Life Sci,Natl Engn Lab Antitumor Therapeut, Beijing 100084, Peoples R China; [Liu, Chunxiao; Zhang, Yanquan; Wang, Yinyin; Ren, Fangli; Feng, Yarui; Wang, Dong; Chang, Zhijie] Sichuan Univ, West China Hosp, Collaborat Innovat Ctr Biotherapy, State Key Lab Biotherapy, Chengdu 610041, Sichuan, Peoples R China; [Li, Jun] Third Mil Med Sch, Dept Immunol, Chongqing 610041, Peoples R China; [Wu, Yinyuan] Harvard Univ, Sch Med, Boston Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Jia, Baoqing] Chinese Peoples Liberat Army Gen Hosp, Dept Surg Oncol, Beijing 100853, Peoples R China; [Jia, Baoqing] Chinese Peoples Liberat Army Gen Hosp, Dept Pathol, Beijing 100853, Peoples R China; [Wang, Dong] Tsinghua Univ, Bioinformat Div, Beijing 100084, Peoples R China; [Wang, Dong] Tsinghua Univ, Ctr Synthet & Syst Biol, Beijing 100084, Peoples R China	Tsinghua University; Sichuan University; Harvard University; Boston Children's Hospital; Harvard Medical School; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Tsinghua University; Tsinghua University	Chang, ZJ (corresponding author), Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China.	zhijiec@tsinghua.edu.cn	Wang, Dong/AAH-5611-2020; Chang, Zhijie/AAH-8109-2019; Zhang, Yanquan/D-5615-2017; Wang, Dong/C-8775-2013	Wang, Dong/0000-0001-7877-7440; Zhang, Yanquan/0000-0003-3527-9972; Wang, Dong/0000-0002-3656-329X; Chang, Zhijie/0000-0003-1567-3227	973 Project Grant [2011CB910502]; National Natural Science Foundation of China [30871286, 31071225, 31030040, 81372372]; Tsinghua Science Foundation [20121080018]; Major Program Grant [2013ZX08011-006]; 863 Project Grant in China [SS2014AA020802]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA020802] Funding Source: NIH RePORTER	973 Project Grant(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua Science Foundation; Major Program Grant; 863 Project Grant in China(National High Technology Research and Development Program of China); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by 973 Project Grant 2011CB910502, National Natural Science Foundation of China Grants 30871286, 31071225, 31030040, and 81372372, Tsinghua Science Foundation Grant 20121080018, Major Program Grant 2013ZX08011-006, and 863 Project Grant SS2014AA020802 in China.	Aghdassi A, 2012, GUT, V61, P439, DOI 10.1136/gutjnl-2011-300060; Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Baksh S, 2002, MOL CELL, V10, P1071, DOI 10.1016/S1097-2765(02)00701-3; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Beumer JH, 2010, CURR CLIN PHARMACOL, V5, P196, DOI 10.2174/157488410791498770; Bieliauskas AV, 2008, CHEM SOC REV, V37, P1402, DOI 10.1039/b703830p; Billin AN, 2000, MOL CELL BIOL, V20, P6882, DOI 10.1128/MCB.20.18.6882-6890.2000; Cadigan KM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007906; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Doetzlhofer A, 1999, MOL CELL BIOL, V19, P5504; Dovey OM, 2010, P NATL ACAD SCI USA, V107, P8242, DOI 10.1073/pnas.1000478107; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Harms KL, 2007, CANCER RES, V67, P3145, DOI 10.1158/0008-5472.CAN-06-4397; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Jennings BH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-205; Juan LJ, 2000, J BIOL CHEM, V275, P20436, DOI 10.1074/jbc.M000202200; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; Levy L, 2004, MOL CELL BIOL, V24, P3404, DOI 10.1128/MCB.24.8.3404-3414.2004; Li HL, 2009, NAT NEUROSCI, V12, P815, DOI 10.1038/nn0709-815; Liu J, 2002, BIOCHEM BIOPH RES CO, V299, P880, DOI 10.1016/S0006-291X(02)02684-0; Lu DD, 2012, CANCER CELL, V21, P92, DOI 10.1016/j.ccr.2011.12.016; Lunde BM, 2010, NAT STRUCT MOL BIOL, V17, P1195, DOI 10.1038/nsmb.1893; Mei KR, 2014, SCI CHINA LIFE SCI, V57, P97, DOI 10.1007/s11427-013-4589-7; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Ni ZY, 2014, NAT STRUCT MOL BIOL, V21, P686, DOI 10.1038/nsmb.2853; Ni ZY, 2011, TRANSCR-AUSTIN, V2, P237, DOI 10.4161/trns.2.5.17803; Reichert N, 2012, CELL MOL LIFE SCI, V69, P2173, DOI 10.1007/s00018-012-0921-9; Roose J, 1998, NATURE, V395, P608, DOI 10.1038/26989; Sakai H, 2002, J BIOL CHEM, V277, P48714, DOI 10.1074/jbc.M208461200; SIEGFRIED E, 1992, CELL, V71, P1167, DOI 10.1016/S0092-8674(05)80065-0; Toh Y, 2000, J EXP CLIN CANC RES, V19, P105; Winkler CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010166; Wolf D, 2002, J BIOL CHEM, V277, P25562, DOI 10.1074/jbc.M201196200; Wu YY, 2010, J BIOL CHEM, V285, P34621, DOI 10.1074/jbc.M110.148791; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Yarden RI, 1999, P NATL ACAD SCI USA, V96, P4983, DOI 10.1073/pnas.96.9.4983; Ye F, 2009, NAT NEUROSCI, V12, P829, DOI 10.1038/nn.2333; Zhang XC, 2012, CELL CYCLE, V11, P1988, DOI 10.4161/cc.20400; Zhang YQ, 2014, J BIOL CHEM, V289, P22589, DOI 10.1074/jbc.M114.560979	40	28	28	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9701	9713		10.1074/jbc.M114.620872	http://dx.doi.org/10.1074/jbc.M114.620872			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25697359	Green Published, hybrid			2022-12-26	WOS:000352729400032
J	Cheng, Z; Liu, F; Zhu, S; Tian, HM; Wang, L; Wang, YH				Cheng, Zhe; Liu, Fan; Zhu, Shan; Tian, Huimin; Wang, Liang; Wang, Yanhai			A Rapid and Convenient Method for Fluorescence Analysis of In Vitro Cultivated Metacestode Vesicles from Echinococcus multilocularis	PLOS ONE			English	Article							GROWTH; CELLS	We here describe a convenient method for preparation, fixation and fluorescence analysis of in vitro cultivated metacestode vesicles from E. multilocularis. Parasite materials could be prepared in one hour, did not need to be sectioned, and were subsequently utilized for further whole-mount staining assays directly. Using these preparations, in combination with conventional fluorescence staining techniques, we could detect the expression and subcellular localization of a specific protein and identify in situ proliferative or apoptotic cells in the germinal layer of metacestode vesicles. Based on this approach, future molecular and cellular analysis of Echinococcus metacestode vesicles in the in vitro system will be greatly facilitated.	[Cheng, Zhe; Zhu, Shan; Wang, Liang; Wang, Yanhai] Xiamen Univ, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen, Fujian, Peoples R China; [Liu, Fan; Tian, Huimin] Xiamen Univ, Coll Med, Xiamen, Fujian, Peoples R China	Xiamen University; Xiamen University	Wang, YH (corresponding author), Xiamen Univ, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen, Fujian, Peoples R China.	wangyh@xmu.edu.cn		Wang, Yanhai/0000-0002-0002-2467; Cheng, Zhe/0000-0003-4764-0163	Fundamental Research Funds for the Central Universities of People's Republic of China [2012121044]; National Natural Science Foundation of China [81000740, 81171596, 81201305, 81471970]	Fundamental Research Funds for the Central Universities of People's Republic of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Fundamental Research Funds for the Central Universities of People's Republic of China (No. 2012121044) and the National Natural Science Foundation of China (No. 81000740, 81171596, 81201305, 81471970) (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brehm K, 2010, PARASITOLOGY, V137, P537, DOI 10.1017/S0031182009991727; Brehm K, 2008, EXP PARASITOL, V119, P506, DOI 10.1016/j.exppara.2008.03.007; Diaz A, 2011, TRENDS PARASITOL, V27, P204, DOI 10.1016/j.pt.2010.12.012; Eckert J, 2004, CLIN MICROBIOL REV, V17, P107, DOI 10.1128/CMR.17.1.107-135.2004; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Koziol U, 2014, EVODEVO, V5, DOI 10.1186/2041-9139-5-10; Koziol U, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-24; Kummer L, 2013, CHEM BIOL, V20, P847, DOI 10.1016/j.chembiol.2013.04.016; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Spiliotis M, 2006, INT J PARASITOL, V36, P1097, DOI 10.1016/j.ijpara.2006.05.008; Spiliotis Markus, 2009, V470, P245, DOI 10.1007/978-1-59745-204-5_17; Zhao J, 2003, MOL CELL, V11, P405, DOI 10.1016/S1097-2765(03)00036-4	12	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118215	10.1371/journal.pone.0118215	http://dx.doi.org/10.1371/journal.pone.0118215			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25705880	Green Submitted, Green Published, gold			2022-12-26	WOS:000350662100155
J	Popa-Lisseanu, AG; Kramer-Schadt, S; Quetglas, J; Delgado-Huertas, A; Kelm, DH; Ibanez, C				Popa-Lisseanu, Ana G.; Kramer-Schadt, Stephanie; Quetglas, Juan; Delgado-Huertas, Antonio; Kelm, Detlev H.; Ibanez, Carlos			Seasonal Variation in Stable Carbon and Nitrogen Isotope Values of Bats Reflect Environmental Baselines	PLOS ONE			English	Article							SEALS CALLORHINUS-URSINUS; ECOSYSTEM RESPIRATION; FEEDING ECOLOGY; GLOBAL PATTERNS; MYOTIS-MYOTIS; DIET QUALITY; AMAZON BASIN; DELTA-N-15; DISCRIMINATION; DELTA-C-13	The stable carbon and nitrogen isotope composition of animal tissues is commonly used to trace wildlife diets and analyze food chains. Changes in an animal's isotopic values over time are generally assumed to indicate diet shifts or, less frequently, physiological changes. Although plant isotopic values are known to correlate with climatic seasonality, only a few studies restricted to aquatic environments have investigated whether temporal isotopic varia-tion in consumers may also reflect environmental baselines through trophic propagation. We modeled the monthly variation in carbon and nitrogen isotope values in whole blood of four insectivorous bat species occupying different foraging niches in southern Spain. We found a common pattern of isotopic variation independent of feeding habits, with an overall change as large as or larger than one trophic step. Physiological changes related to reproduction or to fat deposition prior to hibernation had no effect on isotopic variation, but juvenile bats had higher delta C-13 and delta N-15 values than adults. Aridity was the factor that best explained isotopic variation: bat blood became enriched in both C-13 and N-15 after hotter and/or drier periods. Our study is the first to show that consumers in terrestrial ecosystems reflect seasonal environmental dynamics in their isotope values. We highlight the danger of misinterpreting stable isotope data when not accounting for seasonal isotopic baselines in food web studies. Understanding how environmental seasonality is inte-grated in animals' isotope values will be crucial for developing reliable methods to use stable isotopes as dietary tracers.	[Popa-Lisseanu, Ana G.; Quetglas, Juan; Kelm, Detlev H.; Ibanez, Carlos] CSIC, Estn Biol Donana, E-41080 Seville, Spain; [Popa-Lisseanu, Ana G.; Delgado-Huertas, Antonio] CSIC, Estn Expt Zaidin, Granada, Spain; [Kramer-Schadt, Stephanie] Leibniz Inst Zoo & Wildlife Res IZW, Berlin, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ); Leibniz Institut fur Zoo und Wildtierforschung	Popa-Lisseanu, AG (corresponding author), Leibniz Inst Zoo & Wildlife Res IZW, Berlin, Germany.	anapopa@izw-berlin.de	Huertas, Antonio Delgado/F-6866-2011; Ibanez, Carlos/H-7577-2015; Kramer-Schadt, Stephanie/A-8778-2013; Vazquez-Dominguez, Guillermo GVD/L-7818-2014	Huertas, Antonio Delgado/0000-0002-7240-1570; Ibanez, Carlos/0000-0003-1181-7641; Kramer-Schadt, Stephanie/0000-0002-9269-4446; Quetglas Santos, Juan/0000-0003-1579-8636	Junta de Andalucia [P06-RNM-02362]; Spanish Ministry of Education and Science [AP-2002-3721]; Alexander von Humboldt Foundation	Junta de Andalucia(Junta de Andalucia); Spanish Ministry of Education and Science(Spanish Government); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	This project was funded by the Junta de Andalucia (project P06-RNM-02362). A.G.P.-L. was supported by the Spanish Ministry of Education and Science (pre-doctoral fellowship AP-2002-3721), by the Junta de Andalucia, and during the writing stage, by the Alexander von Humboldt Foundation with a post-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBROSE SH, 1987, NATURE, V325, P201, DOI 10.1038/325201a0; Amundson R, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001903; [Anonymous], 1985, OECOLOGIA; Anthony E.L.P., 1988, P47; Arlettaz R, 1997, J ANIM ECOL, V66, P897, DOI 10.2307/6005; Bedard-Haughn A, 2003, J HYDROL, V272, P175, DOI 10.1016/S0022-1694(02)00263-9; Blumenthal SA, 2012, P NATL ACAD SCI USA, V109, P21277, DOI 10.1073/pnas.1215782109; Bosch J, 1997, OECOLOGIA, V109, P583, DOI 10.1007/s004420050120; Bowling DR, 2002, OECOLOGIA, V131, P113, DOI 10.1007/s00442-001-0851-y; Cerling TE, 2004, AFR J ECOL, V42, P88, DOI 10.1111/j.1365-2028.2004.00500.x; Cherel Y, 2005, ECOLOGY, V86, P2881, DOI 10.1890/05-0562; Codron J, 2005, J ARCHAEOL SCI, V32, P1757, DOI 10.1016/j.jas.2005.06.006; Consejeria de Agricultura y Pesca, 2004, AN EST AGR PESQ AND; Craine JM, 2009, NEW PHYTOL, V183, P980, DOI 10.1111/j.1469-8137.2009.02917.x; Dalerum F, 2005, OECOLOGIA, V144, P647, DOI 10.1007/s00442-005-0118-0; Darimont CT, 2002, CAN J ZOOL, V80, P1638, DOI 10.1139/Z02-149; Della Coletta L, 2009, SCI AGR, V66, P467, DOI 10.1590/S0103-90162009000400006; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1977, SCIENCE, V197, P261, DOI 10.1126/science.327543; Dethier MN, 2013, MAR ECOL PROG SER, V478, P1, DOI 10.3354/meps10310; Dietz C., 2007, HDB FLEDERMAUSE EURO; Ehleringer J.R., 1991, CARBON ISOTOPE TECHN, P187; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; Fuller BT, 2005, RAPID COMMUN MASS SP, V19, P2497, DOI 10.1002/rcm.2090; Fuller BT, 2004, RAPID COMMUN MASS SP, V18, P2889, DOI 10.1002/rcm.1708; Gross J., 2012, NORTEST TESTS NORMAL; Gustine DD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103471; Habran S, 2010, MAR MAMMAL SCI, V26, P880, DOI 10.1111/j.1748-7692.2010.00372.x; Hache S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094437; Harding AMA, 2008, POLAR BIOL, V31, P725, DOI 10.1007/s00300-008-0413-4; Harding EK, 2001, OECOLOGIA, V129, P436, DOI 10.1007/s004420100729; Hartman G, 2011, FUNCT ECOL, V25, P122, DOI 10.1111/j.1365-2435.2010.01782.x; HERRERA J, 1986, VEGETATIO, V68, P91; Hobson KA, 2000, CAN J ZOOL, V78, P1332, DOI 10.1139/cjz-78-8-1332; Hobson KA, 1997, CAN J ZOOL, V75, P1720, DOI 10.1139/z97-799; HOBSON KA, 1993, CONDOR, V95, P388, DOI 10.2307/1369361; HoghJensen H, 1997, PLANT PHYSIOL BIOCH, V35, P55; Hopkins JB, 2012, J WILDLIFE MANAGE, V76, P703, DOI 10.1002/jwmg.318; Houlton BZ, 2006, P NATL ACAD SCI USA, V103, P8745, DOI 10.1073/pnas.0510185103; Ibanez C, 2001, P NATL ACAD SCI USA, V98, P9700, DOI 10.1073/pnas.171140598; Ibanez C, 1997, J ZOOL, V243, P836, DOI 10.1111/j.1469-7998.1997.tb01981.x; Ibanez C., 2004, HDB SAUGETIERE EUROP, VII, P695, DOI DOI 10.1080/0964704X.2013.774246; Jardine TD, 2008, FRESHWATER BIOL, V53, P2192, DOI 10.1111/j.1365-2427.2008.02044.x; Jenkins SG, 2001, OECOLOGIA, V129, P336, DOI 10.1007/s004420100755; Kunz T.H., 1988, P277; Kurle CM, 2002, CAN J ZOOL, V80, P902, DOI 10.1139/Z02-069; Kurle CM, 2001, OECOLOGIA, V126, P254, DOI 10.1007/s004420000518; Lee TN, 2012, J EXP BIOL, V215, P3354, DOI 10.1242/jeb.068528; McDowell NG, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002049; Miron MLL, 2006, J EXP BIOL, V209, P541, DOI 10.1242/jeb.02016; Murphy BP, 2006, FUNCT ECOL, V20, P1062, DOI 10.1111/j.1365-2435.2006.01186.x; Nelson DE, 1998, OECOLOGIA, V116, P177, DOI 10.1007/s004420050577; Ometto JPHB, 2006, BIOGEOCHEMISTRY, V79, P251, DOI 10.1007/s10533-006-9008-8; Ometto JPHB, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001462; Ostrom PH, 1997, OECOLOGIA, V109, P108, DOI 10.1007/s004420050064; Parker KL, 2005, J MAMMAL, V86, P610, DOI 10.1644/1545-1542(2005)86[610:PCIFCR]2.0.CO;2; Pearson SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062891; Perez-Jorda JL, 1994, THESIS U SEVILLE; Peri PL, 2012, GLOBAL CHANGE BIOL, V18, P311, DOI 10.1111/j.1365-2486.2011.02494.x; Phillips DL, 2012, J MAMMAL, V93, P342, DOI 10.1644/11-MAMM-S-158.1; Polischuk SC, 2001, CAN J ZOOL, V79, P499, DOI 10.1139/cjz-79-3-499; Popa-Lisseanu AG, 2009, J ZOOL, V278, P126, DOI 10.1111/j.1469-7998.2009.00556.x; Popa-Lisseanu AG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000205; Popa-Lisseanu AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030388; Porte A, 2001, TREE PHYSIOL, V21, P861, DOI 10.1093/treephys/21.12-13.861; Presetnik P, 2013, MAMMALIA, V77, P297, DOI 10.1515/mammalia-2012-0033; Quan C, 2013, PALAEOGEOGR PALAEOCL, V386, P86, DOI 10.1016/j.palaeo.2013.05.008; R Development Core Team, 2014, R LANG ENV STAT COMP; Rascher KG, 2010, TREE PHYSIOL, V30, P1499, DOI 10.1093/treephys/tpq092; Reserva Biologica de Donana, 2014, EQ SEG MED FIS MET P; Rolff C, 2000, MAR ECOL PROG SER, V203, P47, DOI 10.3354/meps203047; Roth JD, 2002, OECOLOGIA, V133, P70, DOI 10.1007/s00442-002-1004-7; Schulze ED, 2006, TREE PHYSIOL, V26, P479, DOI 10.1093/treephys/26.4.479; Sears J, 2009, OECOLOGIA, V159, P41, DOI 10.1007/s00442-008-1199-3; Shim JH, 2009, OECOLOGIA, V160, P321, DOI 10.1007/s00442-009-1302-4; Smirnov DG, 2012, IZVESTIIA AKAD NAUK, V2, P227; Speakman JR, 1999, P NUTR SOC, V58, P123, DOI 10.1079/PNS19990017; Srivastava RK, 2008, J EXP ZOOL PART A, V309A, P94, DOI 10.1002/jez.440; Uhrin Marcel, 2006, Vespertilio, V9-10, P183; Vizzini S, 2003, MAR BIOL, V142, P1009, DOI 10.1007/s00227-003-1027-6; Voigt CC, 2006, J MAMMAL, V87, P1, DOI 10.1644/05-MAMM-F-276R1.1; Voigt CC, 2006, CAN J ZOOL, V84, P397, DOI 10.1139/z06-007; Voigt CC, 2014, BIODIVERS CONSERV, V23, P617, DOI 10.1007/s10531-014-0620-y; Wang L, 2012, BIOGEOSCIENCES, V9, P1583, DOI 10.5194/bg-9-1583-2012; Wang LL, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031021; Warren CR, 2001, OECOLOGIA, V127, P476, DOI 10.1007/s004420000609; Werner C, 2006, NEW PHYTOL, V172, P330, DOI 10.1111/j.1469-8137.2006.01836.x; Whitaker JO, 2009, ACTA CHIROPTEROL, V11, P393, DOI 10.3161/150811009X485611; Williams DG, 1996, OECOLOGIA, V106, P455, DOI 10.1007/BF00329701; Wood S, 2014, MGCV MIXED GAM COMPU; Woodland RJ, 2012, OECOLOGIA, V169, P199, DOI 10.1007/s00442-011-2178-7; Woodland RJ, 2012, ECOLOGY, V93, P131, DOI 10.1890/11-0505.1; Zhoufeng Wang, 2011, 2011 International Symposium on Water Resource and Environmental Protection (ISWREP), P2418, DOI 10.1109/ISWREP.2011.5893756	93	9	9	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0117052	10.1371/journal.pone.0117052	http://dx.doi.org/10.1371/journal.pone.0117052			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25700080	Green Published, Green Submitted, gold			2022-12-26	WOS:000349789800015
J	Afulani, PA				Afulani, Patience A.			Rural/Urban and Socioeconomic Differentials in Quality of Antenatal Care in Ghana	PLOS ONE			English	Article							MATERNAL MORTALITY; OF-CARE; HEALTH; DELIVERY; SERVICES; STRATEGIES; LEVEL; MODEL; LABOR; TOO	Background Approximately 800 women die of pregnancy-related complications every day. Over half of these deaths occur in sub-Saharan Africa (SSA). Most maternal deaths can be prevented with high quality maternal health services. It is well established that use of maternal health services vary by place of residence and socioeconomic status (SES), but few studies have examined the determinants of quality of maternal health services in SSA. The purpose of this study is to examine the determinants of antenatal care (ANC) quality in Ghana-focusing on the role of place of residence and SES (education and wealth). The analysis also examines the interactions of these variables and the mediating role of ANC timing, frequency, facility type, and provider type. Methods The data are from the Ghana Maternal Health Survey (N = 4,868). Analytic techniques include multilevel linear regression with mediation and moderation analysis. Results Urban residence and higher SES are positively associated with higher ANC quality, but the urban effect is completely explained by sociodemographic factors. Specifically, about half of the urban effect is explained by education and wealth alone, with other variables accounting for the remainder. The effects of education are conditional on wealth and are strongest for poor women. Starting ANC visits early and attending the recommended four visits as well as receiving ANC from a higher level facility and from a skilled provider are associated with higher quality ANC. These factors partially explain the SES differentials.	[Afulani, Patience A.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Community Hlth Sci, Los Angeles, CA 90089 USA; [Afulani, Patience A.] Calif Ctr Populat Res, Los Angeles, CA USA	University of California System; University of California Los Angeles	Afulani, PA (corresponding author), Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Community Hlth Sci, Los Angeles, CA 90089 USA.	pafulani@ucla.edu		Afulani, Patience/0000-0002-6739-234X	Bixby Doctoral Fellowship in Population from the UCLA Bixby Center on Population and Reproductive Health; Celia and Joseph Blann Fellowship from the UCLA School of Public Health; UCLA Affiliates Scholarship from the UCLA Graduate Division	Bixby Doctoral Fellowship in Population from the UCLA Bixby Center on Population and Reproductive Health; Celia and Joseph Blann Fellowship from the UCLA School of Public Health; UCLA Affiliates Scholarship from the UCLA Graduate Division	The author received no funding for this work. She was supported by the following fellowships: the Bixby Doctoral Fellowship in Population from the UCLA Bixby Center on Population and Reproductive Health; the Celia and Joseph Blann Fellowship from the UCLA School of Public Health; and the UCLA Affiliates Scholarship from the UCLA Graduate Division. These fellowship funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjiwanou V, 2013, SOC SCI MED, V86, P26, DOI 10.1016/j.socscimed.2013.02.047; ADLER NE, 1994, AM PSYCHOL, V49, P15, DOI 10.1037/0003-066X.49.1.15; Andersen HM, 2004, SOC SCI MED, V59, P2003, DOI 10.1016/j.socscimed.2004.03.005; Aneshensel CS, 2013, THEOR BAS DAT AN SOC, DOI [10.1016/j.jfo.2013.06.003, DOI 10.1016/J.JFO.2013.06.003]; [Anonymous], 2008, DEMOGRAPHIC HLTH RES; Appiah-Denkyira E, 2013, INTERVENTIONS HUMAN, DOI [10.1016/j.jfo.2013.06.003, DOI 10.1016/J.JFO.2013.06.003]; Atinga RA, 2013, INT J SOC ECON, V40, P852, DOI 10.1108/IJSE-2011-0075; Basu S, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001244; Bbaale E, 2011, AUSTRALAS MED J, V4, P516, DOI 10.4066/AMJ.2011.849; Boller C, 2003, B WORLD HEALTH ORGAN, V81, P116; Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; Bullough C, 2005, BJOG-INT J OBSTET GY, V112, P1180, DOI 10.1111/j.1471-0528.2005.00718.x; Cai TJ, 2013, SOCIOL METHODOL, V43, P178, DOI 10.1177/0081175012460221; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Carroli G, 2001, PAEDIATR PERINAT EP, V15, P1; Crosby RA., 2006, RES METHODS HLTH PRO; D'Ambruoso L, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-140; Davis J., 1971, ELEMENTARY SURVEY AN; DONABEDIAN A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI 10.1001/jama.260.12.1743; DONABEDIAN A, 1966, MILBANK FUND Q, V44, P166, DOI 10.2307/3348969; Duong DV, 2004, SOC SCI MED, V59, P2585, DOI 10.1016/j.socscimed.2004.04.007; Fauveau V, 2006, INT J GYNECOL OBSTET, V94, P179, DOI 10.1016/j.ijgo.2006.05.020; Friberg IK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000295; Gabrysch S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-34; Ghana Health Service, 2012, GHAN HHLTH SERV 2011; [Ghana Health Service UNICEF UNFPA WHO AMDD Ghana Ministry of Health], 2011, NAT ASS EM OBST NEWB; Ghana Statistical Service, 2012, 2010 CENS REP; Ghana Statistical Service, 2011, MULT IND CLUST SURV; Ghana Statistical Service Ghana Health Service Macro International, 2009, GHAN MAT HLTH SURV 2; Graham WJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001368; Graham WJ, 2012, LANCET, V379, pE5, DOI 10.1016/S0140-6736(10)62267-2; GSS, 2008, MEAS DHS MACR INT GH; Hamilton LC, 2012, STAT STATA VERSION 1, DOI [10.1007/s12070-012-0514-9, DOI 10.1007/S12070-012-0514-9]; Harvey SA, 2007, B WORLD HEALTH ORGAN, V85, P783, DOI 10.2471/BLT.06.038455; Hox J. J., 2010, MULTILEVEL ANAL; Hulton L, 2000, FRAMEWORK EVALUATION; Hutchinson PL, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-203; Joshi C, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-94; Kolenikov S, 2009, REV INCOME WEALTH, V55, P128, DOI 10.1111/j.1475-4991.2008.00309.x; Krull JL, 2001, MULTIVAR BEHAV RES, V36, P249, DOI 10.1207/S15327906MBR3602_06; Kyei NNA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046475; MacKinnon D.P., 2012, INTRO STAT MEDIATION; Ministry of Health Ghana Ghana Health service UNDP, 2011, GHAN MDG ACC FRAM CO; Mood C, 2010, EUR SOCIOL REV, V26, P67, DOI 10.1093/esr/jcp006; Moyer CA, 2014, MIDWIFERY, V30, P262, DOI 10.1016/j.midw.2013.05.006; Moyer CA, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-40; Nikiema B, 2009, HEALTH POLICY PLANN, V24, P367, DOI 10.1093/heapol/czp017; Rabe-Hesketh S, 2012, MULTILEVEL LONGITUDI, VII, DOI [10.1007/ s12070- 012- 0514- 9, DOI 10.1007/S12070-012-0514-9]; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; Tran TK, 2012, BMC PLANT BIOL, V12, P0, DOI [10.1186/ 1472- 6963- 12- 40, DOI 10.1186/1471-2229-12-1]; Treiman D., 2009, QUANTITATIVE DATA AN; Tuncalp O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044536; United Nations Secretary General, 2010, GLOB STRAT WOM CHILD; van den Broek NR, 2009, BJOG-INT J OBSTET GY, V116, P18, DOI 10.1111/j.1471-0528.2009.02333.x; van Duong D, 2004, INT J QUAL HEALTH C, V16, P447, DOI 10.1093/intqhc/mzh073; Villar J, 2001, LANCET, V357, P1551, DOI 10.1016/S0140-6736(00)04722-X; Wall SN, 2010, SEMIN PERINATOL, V34, P395, DOI 10.1053/j.semperi.2010.09.009; *WHO, 2004, MAK PREG SAF CRIT RO; WHO Department of making pregnancy safer, 2006, STAND MAT NEON CAR M; WHO UNICEF UNFPA Bank W & UNDP, 2014, TRENDS MAT MORT 1990; Witter S, 2007, REPROD HEALTH MATTER, V15, P61; Witter S, 2009, GLOBAL HEALTH ACTION, V2, DOI 10.3402/gha.v2i0.1881; World Health Organization, 2005, WORLD HLTH REP 2005; World Health Organization U, 2003, ANT CA DEV COUNTR PR; World Health Organization (WHO), 2012, TRENDS MAT MORT 1990	65	51	51	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0117996	10.1371/journal.pone.0117996	http://dx.doi.org/10.1371/journal.pone.0117996			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC0XE	25695737	Green Published, Green Submitted, gold			2022-12-26	WOS:000350062300037
J	Serra, AJ; de Carvalho, PDC; Lanza, F; Flandes, CD; Silva, SC; Suzuki, FS; Bocalini, DS; Andrade, E; Casarin, C; Silva, JA				Serra, Andrey Jorge; Camillo de Carvalho, Paulo de Tarso; Lanza, Fernanda; Flandes, Camila de Amorim; Silva, Shirley Cardoso; Suzuki, Frank Shiguemitsu; Bocalini, Danilo Sales; Andrade, Erinaldo; Casarin, Cezar; Silva, Jose Antonio, Jr.			Correlation of Six-Minute Walking Performance with Quality of Life is Domain-and Gender-Specific in Healthy Older Adults	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; 10 COUNTRIES; SF-36; EXERCISE; WOMEN	We analyzed the relationship between performance on the 6-min walk test (6MWT) and health-related quality of life (HRQoL) in older subjects. Our secondary aim was to determine the distance to be completed on the 6MWT for the subject to achieve a score of 50 on the Short Form (36) Health Survey (SF-36). Associations were tested using linear correlation and multivariate linear regression. Participants were 130 healthy older individuals. The predictive performance of the 6MWT based on an SF-36 score of 50 was assessed using a receiver operating characteristic curve and its area under curve (AUC). Associations were observed between physical functioning, role-emotional, social functioning, vitality, general health score, and 6MWT performance in women, after adjusting for confounding variables (coefficients: 0.57, 0.38, 0.40, and 0.46, respectively; p < 0.05). No association was found for men. The distance for the 6MWT to predict an SF-36 score of 50 was 481 m for men in the physical functioning (AUC: 0.79) and role-physical (AUC: 0.84) domains, and 420 m for women in role-emotional (AUC: 0.75), role-physical (AUC: 0.80), and general health (AUC: 0.80) domains. Our results indicate that superior 6MWT performance may be associated with better HRQoL in several domains in only healthy older women. No association between 6MWT performance and role-emotional, mental health, or vitality domains was found. We suggest that a score of 50 is represented by a 6MWT distance of 481 m for men and 420 m for women, at least in the role-physical domain.	[Serra, Andrey Jorge; Camillo de Carvalho, Paulo de Tarso; Flandes, Camila de Amorim; Silva, Shirley Cardoso; Suzuki, Frank Shiguemitsu; Andrade, Erinaldo; Casarin, Cezar; Silva, Jose Antonio, Jr.] Nove Julho Univ UNINOVE, Sao Paulo, SP, Brazil; [Lanza, Fernanda] Nove Julho Univ UNINOVE, Postgrad Program Rehabil Sci, Sao Paulo, SP, Brazil; [Bocalini, Danilo Sales] Univ Sao Judas Tadeu, Sao Paulo, SP, Brazil	Universidade Nove de Julho; Universidade Nove de Julho; Universidade Sao Judas Tadeu	Serra, AJ (corresponding author), Nove Julho Univ UNINOVE, Sao Paulo, SP, Brazil.	andreyserra@gmail.com	Silva, Jose Antonio/AAA-8100-2019; ANDRADE, ERINALDO L/O-8090-2014; Serra, Andrey Jorge/E-7460-2015; de Tarso C de Carvalho, Paulo/G-5333-2011; Bocalini, Danilo/J-1997-2014; Lanza, Fernanda C/N-8414-2013	Silva, Jose Antonio/0000-0001-6904-9185; ANDRADE, ERINALDO L/0000-0002-2598-4558; Serra, Andrey Jorge/0000-0002-5407-8183; de Tarso C de Carvalho, Paulo/0000-0001-9624-4103; Lanza, Fernanda C/0000-0002-4748-6947				Andresen EM, 1999, AGE AGEING, V28, P562, DOI 10.1093/ageing/28.6.562; Brown CD, 2008, COPD, V5, P117, DOI 10.1080/15412550801941265; Chodzko-Zajko WJ, 2009, MED SCI SPORT EXER, V41, P1510, DOI 10.1249/MSS.0b013e3181a0c95c; Ciconelli RM, 1999, REV BRAS REUMATOL, V39, P143, DOI DOI 10.1590/S0482-50042010000300005; Cohen-Mansfield J, 2013, INT J AGING HUM DEV, V77, P37, DOI 10.2190/AG.77.1.c; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Daltroy LH, 1999, SOC SCI MED, V48, P1549, DOI 10.1016/S0277-9536(99)00048-9; Enright PL, 1998, AM J RESP CRIT CARE, V158, P1384, DOI 10.1164/ajrccm.158.5.9710086; Groepenhoff H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072013; Hsieh CB, 2010, TRANSPL P, V42, P3597, DOI 10.1016/j.transproceed.2010.06.033; KANTZ ME, 1992, MED CARE, V30, pMS240, DOI 10.1097/00005650-199205001-00024; Leinonen R, 2001, SOC SCI MED, V52, P1329, DOI 10.1016/S0277-9536(00)00249-5; Vieira DCL, 2013, CLIN INTERV AGING, V8, P1377, DOI 10.2147/CIA.S50333; Lorraine Phillips J, 2005, Prev Chronic Dis, V2, pA12; MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004; Olivares PR, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-117; Oudegeest-Sander MH, 2014, J AGING PHY IN PRESS; Rejeski WJ, 2001, J GERONTOL A-BIOL, V56, P23, DOI 10.1093/gerona/56.suppl_2.23; Serra AJ, 2009, CONSCIENTIAE SAUDE, V8, P19, DOI [10.1364/OE.22.031568, DOI 10.1364/OE.22.031568]; Smedt DD, 2013, EUR J PREV CARDIOL, V21, P796; Sozeri-Varma G, 2012, AGING DIS, V3, P465; Sun F, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-449; Wanderley FAC, 2011, QUAL LIFE RES, V20, P1371, DOI 10.1007/s11136-011-9875-x; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P1159, DOI 10.1016/S0895-4356(98)00107-3; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P1167, DOI 10.1016/S0895-4356(98)00108-5; Ware JE, 2004, SF 36 HLTH SURV UPDA; Williams JS, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-25; World Health Organization, 2013, AG LIF COURS CAR IND	28	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0117359	10.1371/journal.pone.0117359	http://dx.doi.org/10.1371/journal.pone.0117359			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC0XE	25695668	Green Published, gold, Green Submitted			2022-12-26	WOS:000350062300021
J	Gomez, E; Alvarez, B; Duchaud, E; Guijarro, JA				Gomez, Esther; Alvarez, Beatriz; Duchaud, Eric; Guijarro, Jose A.			Development of a Markerless Deletion System for the Fish-Pathogenic Bacterium Flavobacterium psychrophilum	PLOS ONE			English	Article							RAINBOW-TROUT; CYSTEINE PROTEASE; GENE REPLACEMENT; COLDWATER DISEASE; GLIDING MOTILITY; CYTOPHAGA; VIRULENCE; CONSTRUCTION; TRANSPOSON; CELLS	Flavobacterium psychrophilum is a Gram-negative fish pathogen that causes important economic losses in aquaculture worldwide. Although the genome of this bacterium has been determined, the function and relative importance of genes in relation to virulence remain to be established. To investigate their respective contribution to the bacterial pathogenesis, effective tools for gene inactivation are required. In the present study, a markerless gene deletion system has been successfully developed for the first time in this bacterium. Using this method, the F. psychrophilum fcpB gene, encoding a predicted cysteine protease homologous to Streptococcus pyogenes streptopain, was deleted. The developed system involved the construction of a conjugative plasmid that harbors the flanking sequences of the fcpB gene and an I-SceI meganuclease restriction site. Once this plasmid was integrated in the genome by homologous recombination, the merodiploid was resolved by the introduction of a plasmid expressing I-SceI under the control of the fpp2 F. psychrophilum inducible promoter. The resulting deleted fcpB mutant presented a decrease in extracellular proteolytic activity compared to the parental strain. However, there were not significant differences between their LD50 in an intramuscularly challenged rainbow trout infection model. The mutagenesis approach developed in this work represents an improvement over the gene inactivation tools existing hitherto for this "fastidious" bacterium. Unlike transposon mutagenesis and gene disruption, gene markerless deletion has less potential for polar effects and allows the mutation of virtually any non-essential gene or gene clusters.	[Gomez, Esther; Guijarro, Jose A.] Univ Oviedo, Fac Med, Dept Biol Func, Area Microbiol,IUBA, E-33006 Oviedo, Spain; [Alvarez, Beatriz] Univ Autonoma Chile, Fac Ciencias Salud, Santiago, Chile; [Duchaud, Eric] INRA, Virol & Immunol Mol UR892, F-78350 Jouy En Josas, France	University of Oviedo; Universidad Autonoma de Chile; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Guijarro, JA (corresponding author), Univ Oviedo, Fac Med, Dept Biol Func, Area Microbiol,IUBA, E-33006 Oviedo, Spain.	jaga@uniovi.es	Alvarez, Beatriz/AAL-5969-2020; Alvarez, Beatriz/L-1266-2014	Alvarez, Beatriz/0000-0002-9613-5473; Alvarez, Beatriz/0000-0002-9613-5473	Spanish Ministerio de Economia y Competitividad [AGL2009-07003]	Spanish Ministerio de Economia y Competitividad(Spanish Government)	Funding provided by grant AGL2009-07003 from the Spanish Ministerio de Economia y Competitividad. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 1997, P NATL ACAD SCI USA, V94, P12139, DOI 10.1073/pnas.94.22.12139; Alvarez B, 2007, LETT APPL MICROBIOL, V44, P569, DOI 10.1111/j.1472-765X.2007.02126.x; Alvarez B, 2006, APPL ENVIRON MICROB, V72, P4044, DOI 10.1128/AEM.00128-06; Alvarez B, 2004, APPL ENVIRON MICROB, V70, P581, DOI 10.1128/AEM.70.1.581-587.2004; Alvarez B, 2008, MICROBIOL-SGM, V154, P1144, DOI 10.1099/mic.0.2007/010900-0; Bertolini J. M., 1994, Journal of Aquatic Animal Health, V6, P224, DOI 10.1577/1548-8667(1994)006&lt;0224:EDOPFS&gt;2.3.CO;2; Borg AF, 1960, STUDIES MYXOBACTERIA, V8; Chakroun C, 1998, DIS AQUAT ORGAN, V33, P167, DOI 10.3354/dao033167; Cipriano R.C., 2005, FLAVOBACTERIUM PSYCH; Duchaud E, 2007, NAT BIOTECHNOL, V25, P763, DOI 10.1038/nbt1313; Gomez E, 2012, GENE, V497, P263, DOI 10.1016/j.gene.2012.01.069; Herring CD, 2003, GENE, V311, P153, DOI 10.1016/S0378-1119(03)00585-7; Holt, 1987, CYTOPHAGA PSYCHROPHI; Horzempa J, 2010, J MICROBIOL METH, V80, P106, DOI 10.1016/j.mimet.2009.10.013; Hung CH, 2012, MED MICROBIOL IMMUN, V201, P357, DOI 10.1007/s00430-012-0241-6; LI LY, 1995, J BACTERIOL, V177, P4992, DOI 10.1128/jb.177.17.4992-4999.1995; Lopez CM, 2009, APPL ENVIRON MICROB, V75, P6496, DOI 10.1128/AEM.01669-09; Lorenzen E, 1997, DIS AQUAT ORGAN, V31, P209, DOI 10.3354/dao031209; Lorenzen E, 1997, DIS AQUAT ORGAN, V31, P197, DOI 10.3354/dao031197; McBride MJ, 1996, J BACTERIOL, V178, P583, DOI 10.1128/jb.178.3.583-590.1996; McBride MJ, 1996, APPL ENVIRON MICROB, V62, P3017, DOI 10.1128/AEM.62.8.3017-3022.1996; Michel C, 1999, RES MICROBIOL, V150, P351, DOI 10.1016/S0923-2508(99)80061-8; Moller JD, 2003, APPL ENVIRON MICROB, V69, P5275, DOI 10.1128/AEM.69.9.5275-5280.2003; Nematollahi A, 2003, DIS AQUAT ORGAN, V55, P101, DOI 10.3354/dao055101; OHARANEMOTO Y, 1994, CAN J MICROBIOL, V40, P930, DOI 10.1139/m94-149; Ohkuni H, 2004, INDIAN J MED RES, V119, P33; Ostland VE, 2000, J FISH DIS, V23, P329, DOI 10.1046/j.1365-2761.2000.00251.x; Patrick S, 2009, MICROBIOL-SGM, V155, P1039, DOI 10.1099/mic.0.025361-0; Perez-Pascual D, 2011, MICROBIOL-SGM, V157, P1196, DOI 10.1099/mic.0.046938-0; Perez-Pascual D, 2009, INT MICROBIOL, V12, P207, DOI 10.2436/20.1501.01.100; Posfai G, 1999, NUCLEIC ACIDS RES, V27, P4409, DOI 10.1093/nar/27.22.4409; Sambrook J., 2001, MOL CLONING LAB MANU; Secades P, 2001, APPL ENVIRON MICROB, V67, P2436, DOI 10.1128/AEM.67.6.2436-2444.2001; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Stockbauer KE, 1999, P NATL ACAD SCI USA, V96, P242, DOI 10.1073/pnas.96.1.242; Sumitomo T, 2011, J BIOL CHEM, V286, P2750, DOI 10.1074/jbc.M110.171504; Tsai PJ, 1998, INFECT IMMUN, V66, P1460, DOI 10.1128/IAI.66.4.1460-1466.1998; Wang HY, 2012, APPL ENVIRON MICROB, V78, P1826, DOI 10.1128/AEM.07230-11	38	8	9	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117969	10.1371/journal.pone.0117969	http://dx.doi.org/10.1371/journal.pone.0117969			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692569	Green Published, gold, Green Submitted			2022-12-26	WOS:000350061500086
J	Griese, M; Kirmeier, HG; Liebisch, G; Rauch, D; Stuckler, F; Schmitz, G; Zarbock, R				Griese, Matthias; Kirmeier, Hannah G.; Liebisch, Gerhard; Rauch, Daniela; Stueckler, Ferdinand; Schmitz, Gerd; Zarbock, Ralf		ILD-BAL Working Grp Kids-Lung-Regi	Surfactant Lipidomics in Healthy Children and Childhood Interstitial Lung Disease	PLOS ONE			English	Article							HIGH-THROUGHPUT QUANTIFICATION; PULMONARY SURFACTANT; PHOSPHATIDYLCHOLINE COMPOSITION; PHOSPHOLIPID-COMPOSITION; YOUNG-CHILDREN; ABCA3; MUTATIONS; CLASSIFICATION; CHOLESTEROL; PROTEINS	Background Lipids account for the majority of pulmonary surfactant, which is essential for normal breathing. We asked if interstitial lung diseases (ILD) in children may disrupt alveolar surfactant and give clues for disease categorization. Methods Comprehensive lipidomics profiles of broncho-alveolar lavage fluid were generated in 115 children by electrospray ionization tandem mass spectrometry (ESI-MS/MS). Two reference populations were compared to a broad range of children with ILD. Results Class and species composition in healthy children did not differ from that in children with ILD related to diffuse developmental disorders, chronic tachypnoe of infancy, ILD related to lung vessels and the heart, and ILD related to reactive lymphoid lesions. As groups, ILDs related to the alveolar surfactant region, ILD related to unclear respiratory distress syndrome in the mature neonate, or in part ILD related to growth abnormalities reflecting deficient alveolarisation, had significant alterations of some surfactant specific phospholipids. Additionally, lipids derived from inflammatory processes were identified and differentiated. In children with ABCA3-deficiency from two ILD causing mutations saturated and monounsaturated phosphatidylcholine species with 30 and 32 carbons and almost all phosphatidylglycerol species were severely reduced. In other alveolar disorders lipidomic profiles may be of less diagnostic value, but nevertheless may substantiate lack of significant involvement of mechanisms related to surfactant lipid metabolism. Conclusions Lipidomic profiling may identify specific forms of ILD in children with surfactant alterations and characterized the molecular species pattern likely to be transported by ABCA3 in vivo.	[Griese, Matthias; Kirmeier, Hannah G.; Rauch, Daniela; Zarbock, Ralf] Ludwig Maximilians Univ Munchen, Hauner Childrens Hosp, Dept Pediat Pulmonol, Member German Ctr Lung Res DZL, D-80337 Munich, Germany; [Liebisch, Gerhard; Stueckler, Ferdinand] Helmholtz Ctr Munich, Inst Computat Biol, Neuherberg, Germany; [Schmitz, Gerd] Univ Regensburg, Inst Clin Chem, D-93053 Regensburg, Germany; [Schmitz, Gerd] Univ Regensburg, Lab Med, D-93053 Regensburg, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Regensburg; University of Regensburg	Griese, M (corresponding author), Ludwig Maximilians Univ Munchen, Hauner Childrens Hosp, Dept Pediat Pulmonol, Member German Ctr Lung Res DZL, Lindwurmstr 4a, D-80337 Munich, Germany.	Matthias.griese@med.uni-muenchen.de	Liebisch, Gerhard/G-6130-2010; Zarbock, Ralf/K-9031-2019	Liebisch, Gerhard/0000-0003-4886-0811; Schmitz, Gerd/0000-0002-1325-1007	kids-lung-register foundation; DFG [970/8-1]; BMBF-Goldnet; chILD-EU (FP7) [305653]	kids-lung-register foundation; DFG(German Research Foundation (DFG)); BMBF-Goldnet; chILD-EU (FP7)	This project was supported by the kids-lung-register foundation. The work of M.G. in this study was supported by DFG-970/8-1, BMBF-Goldnet, and chILD-EU (FP7, No. 305653). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHTON MR, 1992, ARCH DIS CHILD-FETAL, V67, P378, DOI 10.1136/adc.67.4_Spec_No.378; ASHTON MR, 1994, ARCH DIS CHILD-FETAL, V71, pF114, DOI 10.1136/fn.71.2.F114; Ban N, 2007, J BIOL CHEM, V282, P9628, DOI 10.1074/jbc.M611767200; Bernhard W, 2001, AM J RESP CELL MOL, V25, P725, DOI 10.1165/ajrcmb.25.6.4616; Brasch F, 2004, EUR RESPIR J, V24, P30, DOI 10.1183/09031936.04.00000104; Brasch F, 2006, AM J RESP CRIT CARE, V174, P571, DOI 10.1164/rccm.200509-1535OC; Bullard JE, 2005, AM J RESP CRIT CARE, V172, P1026, DOI 10.1164/rccm.200503-504OC; Deutsch GH, 2007, AM J RESP CRIT CARE, V176, P1120, DOI 10.1164/rccm.200703-393OC; Garmany TH, 2006, PEDIATR RES, V59, P801, DOI 10.1203/01.pdr.0000219311.14291.df; Griese M, 1999, EUR RESPIR J, V13, P1455, DOI 10.1034/j.1399-3003.1999.13f36.x; Griese M, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-121; Griese M, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-26; Gunther A, 1999, EUR RESPIR J, V14, P565, DOI 10.1034/j.1399-3003.1999.14c14.x; Hamvas A, 2013, CHEST, V144, P794, DOI 10.1378/chest.12-2502; HUGHES DA, 1990, EUR RESPIR J, V3, P1128; Kleinlein B, 2011, ARCH DIS CHILD-FETAL, V96, pF453, DOI 10.1136/adc.2009.180448; Kurland G, 2013, AM J RESP CRIT CARE, V188, P376, DOI 10.1164/rccm.201305-0923ST; Langston C, 2009, PEDIATR DEVEL PATHOL, V12, P421, DOI 10.2350/08-11-0559.1; Leidl K, 2008, BBA-MOL CELL BIOL L, V1781, P655, DOI 10.1016/j.bbalip.2008.07.008; Liebisch G, 2006, BBA-MOL CELL BIOL L, V1761, P121, DOI 10.1016/j.bbalip.2005.12.007; Liebisch G, 2004, BBA-MOL CELL BIOL L, V1686, P108, DOI 10.1016/j.bbalip.2004.09.003; Liebisch G, 2013, J LIPID RES, V54, P1523, DOI 10.1194/jlr.M033506; Mander A, 2002, AM J RESP CELL MOL, V27, P714, DOI 10.1165/rcmb.4746; Nogee LM, 1998, BBA-MOL BASIS DIS, V1408, P323, DOI 10.1016/S0925-4439(98)00078-7; Postle AD, 1999, AM J RESP CELL MOL, V20, P90, DOI 10.1165/ajrcmb.20.1.3253; Postle AD, 2006, J LIPID RES, V47, P1322, DOI 10.1194/jlr.M600054-JLR200; Pynn CJ, 2010, AM J PHYSIOL-REG I, V299, pR1306, DOI 10.1152/ajpregu.00380.2010; Rice A, 2013, HISTOPATHOLOGY, V63, P743, DOI 10.1111/his.12185; Ridsdale R, 2005, AM J RESP CRIT CARE, V172, P225, DOI 10.1164/rccm.200501-109OC; Rooney SA, 2001, COMP BIOCHEM PHYS A, V129, P233, DOI 10.1016/S1095-6433(01)00320-8; Schmidt R, 2006, CRIT CARE MED, V34, P2370, DOI 10.1097/01.CCM.0000234036.19145.52; Schuerman FABA, 2008, EUR J MED RES, V13, P281; Shulenin S, 2004, NEW ENGL J MED, V350, P1296, DOI 10.1056/NEJMoa032178; Soares JJ, 2013, PEDIATRICS, V132, P684, DOI 10.1542/peds.2013-1780; Stacklies W, 2007, BIOINFORMATICS, V23, P1164, DOI 10.1093/bioinformatics/btm069; Tafel Oliver, 2008, BMC Pulm Med, V8, P6, DOI 10.1186/1471-2466-8-6; Todd DA, 2010, PEDIATR CRIT CARE ME, V11, P82, DOI 10.1097/PCC.0b013e3181ae5a4c; Wambach JA, 2012, PEDIATRICS, V130, pE1575, DOI 10.1542/peds.2012-0918; Weichert N, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-4; Wiesner P, 2009, J LIPID RES, V50, P574, DOI 10.1194/jlr.D800028-JLR200; Wortmann SB, 2012, NAT GENET, V44, P797, DOI 10.1038/ng.2325; Wright JR, 2006, AM J PHYSIOL-LUNG C, V291, pL847, DOI 10.1152/ajplung.00261.2006; Wright SM, 2000, J APPL PHYSIOL, V89, P1283, DOI 10.1152/jappl.2000.89.4.1283	43	30	31	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117985	10.1371/journal.pone.0117985	http://dx.doi.org/10.1371/journal.pone.0117985			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692779	gold, Green Published, Green Submitted			2022-12-26	WOS:000350061500088
J	Kakumani, PK; Chinnappan, M; Singh, AK; Malhotra, P; Mukherjee, SK; Bhatnagar, RK				Kakumani, Pavan Kumar; Chinnappan, Mahendran; Singh, Ashok K.; Malhotra, Pawan; Mukherjee, Sunil K.; Bhatnagar, Raj K.			Identification and Characteristics of microRNAs from Army Worm, Spodoptera frugiperda Cell Line Sf21	PLOS ONE			English	Article							POSTTRANSCRIPTIONAL REGULATION; TARGET RECOGNITION; RNAS; BIOGENESIS; EVOLUTION; GENES	microRNAs play important regulatory role in all intrinsic cellular functions. Amongst lepidopteran insects, miRNAs from only Bombyx mori have been studied extensively with a little focus on Spodoptera sp. In the present study, we identified a total of 226 miRNAs from Spodoptera frugiperda cell line Sf21. Of the total, 116 miRNAs were well conserved within other insects, like B. mori, Drosophila melanogaster and Tribolium castenum while the remaining 110 miRNAs were identified as novel based on comparative analysis with the insect miRNA data set. Landscape distribution analysis based on Sf21 genome assembly revealed clustering of few novel miRNAs. A total of 5 miRNA clusters were identified and the largest one encodes 5 miRNA genes. In addition, 12 miRNAs were validated using northern blot analysis and putative functional role assignment for 6 Sf miRNAs was investigated by examining their relative abundance at different developmental stages of Spodoptera litura and body parts of 6th instar larvae. Further, we identified a total of 809 potential target genes with GO terms for selected miRNAs, involved in different metabolic and signalling pathways of the insect. The newly identified miRNAs greatly enrich the repertoire of insect miRNAs and analysis of expression profiles reveal their involvement at various steps of biochemical pathways of the army worm.	[Kakumani, Pavan Kumar; Chinnappan, Mahendran; Bhatnagar, Raj K.] Int Ctr Genet Engn & Biotechnol, Insect Resistance Grp, New Delhi 110067, India; [Singh, Ashok K.] Univ Delhi, Dept Zool, New Delhi 110007, India; [Malhotra, Pawan] Int Ctr Genet Engn & Biotechnol, Malaria Grp, New Delhi 110067, India; [Mukherjee, Sunil K.] Int Ctr Genet Engn & Biotechnol, Plant Mol Biol Grp, New Delhi 110067, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; University of Delhi; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Malhotra, P (corresponding author), Int Ctr Genet Engn & Biotechnol, Plant Mol Biol Grp, Aruna Asaf Ali Marg, New Delhi 110067, India.	pawanm@icgeb.res.in; sunilm@icgeb.res.in; raj@icgeb.res.in	Chinnappan, Mahendran/AAH-4930-2021; Singh, Ashok/HGF-2506-2022; Kakumani, Pavan Kumar/AFH-9007-2022	Kakumani, Pavan Kumar/0000-0002-8755-860X	Dept. of Biotechnology, Govt. of India [BT/PR10673/AGR/36/579/2008]	Dept. of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India)	This work was supported by a financial grant from the Dept. of Biotechnology, Govt. of India, (BT/PR10673/AGR/36/579/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Bartel DP, 2007, CELL, V131, P11, DOI 10.1016/S0092-8674(04)00045-5; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Cristino AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019350; Cullen BR, 2006, NAT GENET, V38, pS25, DOI 10.1038/ng1793; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Ge X, 2013, INT J BIOL SCI, V9, P1, DOI 10.7150/ijbs.5249; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Grun D, 2005, PLOS COMPUT BIOL, V1, P51, DOI 10.1371/journal.pcbi.0010013; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; He PA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-248; Hussain M, 2010, J VIROL, V84, P612, DOI 10.1128/JVI.01794-09; Joglekar MV, 2007, DEV BIOL, V311, P603, DOI 10.1016/j.ydbio.2007.09.008; Kakumani PK, 2014, GENOMICS, V104, P134, DOI 10.1016/j.ygeno.2014.06.005; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Mehrabadi M, 2013, J GEN VIROL, V94, P1385, DOI 10.1099/vir.0.051060-0; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Plasterk R, 2006, FEBS J, V273, P15; Rao ZC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037730; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rubio M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-386; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; Skalsky RL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-119; Stocks MB, 2012, BIOINFORMATICS, V28, P2059, DOI 10.1093/bioinformatics/bts311; Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Weaver DB, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r97; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Yu XM, 2009, GENOMICS, V94, P438, DOI 10.1016/j.ygeno.2009.08.007; Yu XM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002997; Zhang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004677	50	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0116988	10.1371/journal.pone.0116988	http://dx.doi.org/10.1371/journal.pone.0116988			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693181	Green Submitted, Green Published, gold			2022-12-26	WOS:000350061500032
J	Kanda, RK; Coulson, T				Kanda, Ravinder K.; Coulson, Tim			The Effect of Life History on Retroviral Genome Invasions	PLOS ONE			English	Article							MOUTH-DISEASE-VIRUS; ENDOGENOUS RETROVIRUSES; EVOLUTION; FAMILY; BETARETROVIRUSES; HERV-K(HML-2); TRANSMISSION; EXPRESSION; RESISTANCE; DIVERSITY	Endogenous retroviruses (ERV), or the remnants of past retroviral infections that are no longer active, are found in the genomes of most vertebrates, typically constituting approximately 10% of the genome. In some vertebrates, particularly in shorter-lived species like rodents, it is not unusual to find active endogenous retroviruses. In longer-lived species, including humans where substantial effort has been invested in searching for active ERVs, it is unusual to find them; to date none have been found in humans. Presumably the chance of detecting an active ERV infection is a function of the length of an ERV epidemic. Intuitively, given that ERVs or signatures of past ERV infections are passed from parents to offspring, we might expect to detect more active ERVs in species with longer generation times, as it should take more years for an infection to run its course in longer than in shorter lived species. This means the observation of more active ERV infections in shorter compared to longer-lived species is paradoxical. We explore this paradox using a modeling approach to investigate factors that influence ERV epidemic length. Our simple epidemiological model may explain why we find evidence of active ERV infections in shorter rather than longer-lived species.	[Kanda, Ravinder K.; Coulson, Tim] Univ Oxford, Dept Zool, Oxford, England	University of Oxford	Kanda, RK (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford, England.	ravinder.kanda@zoo.ox.ac.uk	Coulson, Tim/AAL-8148-2021	Coulson, Tim/0000-0001-9371-9003	ERC; Natural Environment Research Council [1221700, NE/I023783/2, 1136795, NE/G004390/2, NE/I023783/1, NE/E015921/1, NE/K014218/1, NE/I023791/2, NE/H007148/1, NE/G004390/1, NE/H007148/2, NE/I023791/1] Funding Source: researchfish; NERC [NE/I023791/2, NE/G004390/2, NE/H007148/2, NE/E015921/1, NE/K014218/1, NE/I023791/1, NE/I023783/1, NE/I023783/2, NE/G004390/1] Funding Source: UKRI	ERC(European Research Council (ERC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by an ERC grant awarded to Tim Coulson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anai Y, 2012, J VIROL, V86, P8634, DOI 10.1128/JVI.00280-12; ANDERSON R M, 1991; ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0; Arnaud F, 2008, CELL MOL LIFE SCI, V65, P3422, DOI 10.1007/s00018-008-8500-9; Arnaud F, 2007, PLOS PATHOG, V3, P1716, DOI 10.1371/journal.ppat.0030170; Aswad A, 2012, TRENDS ECOL EVOL, V27, P627, DOI 10.1016/j.tree.2012.07.007; Belshaw R, 2005, MOL BIOL EVOL, V22, P814, DOI 10.1093/molbev/msi088; Belshaw R, 2005, J VIROL, V79, P12507, DOI 10.1128/JVI.79.19.12507-12514.2005; Belshaw R, 2004, P NATL ACAD SCI USA, V101, P4894, DOI 10.1073/pnas.0307800101; Best S, 1997, TRENDS MICROBIOL, V5, P313, DOI 10.1016/S0966-842X(97)01086-X; Bielby J, 2007, AM NAT, V169, P748, DOI 10.1086/516847; Blikstad V, 2008, CELL MOL LIFE SCI, V65, P3348, DOI 10.1007/s00018-008-8495-2; Boeke JD, 1997, RETROVIRUSES; Burton J, 2012, MATH BIOSCI, V239, P91, DOI 10.1016/j.mbs.2012.05.003; Caswell, 2000, MATRIX POPULATION MO; Downey RF, 2014, INT J CANC; Eble P, 2006, VET RES, V37, P647, DOI 10.1051/vetres:2006026; Elleder D, 2012, J VIROL, V86, P2787, DOI 10.1128/JVI.06859-11; Feschotte C, 2012, NAT REV GENET, V13, P283, DOI 10.1038/nrg3199; Gifford R, 2003, VIRUS GENES, V26, P291, DOI 10.1023/A:1024455415443; Gold JGR, 2014, J NEUROL NEUROSURG P; Hanger JJ, 2000, J VIROL, V74, P4264, DOI 10.1128/JVI.74.9.4264-4272.2000; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Herniou E, 1998, J VIROL, V72, P5955, DOI 10.1128/JVI.72.7.5955-5966.1998; Hohn O, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00246; Holt MP, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00287; Hughes JF, 2004, P NATL ACAD SCI USA, V101, P1668, DOI 10.1073/pnas.0307885100; JENKINS NA, 1981, NATURE, V293, P370, DOI 10.1038/293370a0; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Kanda RK, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0505; Kassiotis G, 2014, J IMMUNOL, V192, P1343, DOI 10.4049/jimmunol.1302972; Katzourakis A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004214; Krylova O, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0098; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lawson AB, 2011, SPAT SPATIO-TEMPORAL, V2, P185, DOI 10.1016/j.sste.2011.07.004; Lee A, 2014, J VIROL, V88, P12907, DOI 10.1128/JVI.01825-14; Maksakova IA, 2006, PLOS GENET, V2, P1, DOI 10.1371/journal.pgen.0020002; Muller V, 2006, PLOS PATHOG, V2, P149, DOI 10.1371/journal.ppat.0020015; NELLAKER C, 2012, GENOME BIOL, V13, DOI DOI 10.1186/GB-; Nexo BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016652; Nissen KK, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-111; Orsel K, 2009, PREV VET MED, V88, P158, DOI 10.1016/j.prevetmed.2008.09.001; Palmarini M, 2004, J GEN VIROL, V85, P1, DOI 10.1099/vir.0.19547-0; Rebollo R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-159; Rhyu DW, 2014, INT J MOL SCI, V15, P9173, DOI 10.3390/ijms15069173; Ruprecht K, 2008, J VIROL, V82, P10008, DOI 10.1128/JVI.01016-08; Sharp PM, 2005, J VIROL, V79, P3891, DOI 10.1128/JVI.79.7.3891-3902.2005; STEARNS SC, 1977, ANNU REV ECOL SYST, V8, P145, DOI 10.1146/annurev.es.08.110177.001045; Stocking C, 2008, CELL MOL LIFE SCI, V65, P3383, DOI 10.1007/s00018-008-8497-0; Stoye JP, 2001, CURR BIOL, V11, pR914, DOI 10.1016/S0960-9822(01)00553-X; Tarlinton R, 2008, CELL MOL LIFE SCI, V65, P3413, DOI 10.1007/s00018-008-8499-y; Tarlinton RE, 2006, NATURE, V442, P79, DOI 10.1038/nature04841; Taylor GM, 2001, J VIROL, V75, P11244, DOI 10.1128/JVI.75.22.11244-11248.2001; Team RDC, 2011, R LANG ENV STAT COMP, DOI [10.1080/17437199.2011.587961, DOI 10.1080/17437199.2011.587961]; Tikhonenko A T, 1990, Virus Genes, V3, P251, DOI 10.1007/BF00393184; Uziel A, 2012, J THEOR BIOL, V305, P88, DOI 10.1016/j.jtbi.2012.02.031; Vynnycky E., 2010, INTRO INFECT DIS MOD, DOI DOI 10.1038/NRMICRO1845; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Weiss RA, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-67; Zhang Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000007	60	1	1	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117442	10.1371/journal.pone.0117442	http://dx.doi.org/10.1371/journal.pone.0117442			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692467	Green Published, gold, Green Submitted			2022-12-26	WOS:000350061500055
J	Salehi, F; Baronio, R; Idrogo-Lam, R; Vu, H; Hall, LV; Kaiser, P; Lathrop, RH				Salehi, Faezeh; Baronio, Roberta; Idrogo-Lam, Ryan; Huy Vu; Hall, Linda V.; Kaiser, Peter; Lathrop, Richard H.			CHOPER Filters Enable Rare Mutation Detection in Complex Mutagenesis Populations by Next-Generation Sequencing	PLOS ONE			English	Article							WILD-TYPE P53; ERROR-CORRECTION; CODON USAGE; SHORT READS; SUPPRESSOR; PROTEIN; GENOME; ONCOGENE; GENES; YEAST	Next-generation sequencing (NGS) has revolutionized genetics and enabled the accurate identification of many genetic variants across many genomes. However, detection of biologically important low-frequency variants within genetically heterogeneous populations remains challenging, because they are difficult to distinguish from intrinsic NGS sequencing error rates. Approaches to overcome these limitations are essential to detect rare mutations in large cohorts, virus or microbial populations, mitochondria heteroplasmy, and other heterogeneous mixtures such as tumors. Modifications in library preparation can overcome some of these limitations, but are experimentally challenging and restricted to skilled biologists. This paper describes a novel quality filtering and base pruning pipeline, called Complex Heterogeneous Overlapped Paired-End Reads (CHOPER), designed to detect sequence variants in a complex population with high sequence similarity derived from All-Codon-Scanning (ACS) mutagenesis. A novel fast alignment algorithm, designed for the specified application, has O(n) time complexity. CHOPER was applied to a p53 cancer mutant reactivation study derived from ACS mutagenesis. Relative to error filtering based on Phred quality scores, CHOPER improved accuracy by about 13% while discarding only half as many bases. These results are a step toward extending the power of NGS to the analysis of genetically heterogeneous populations.	[Salehi, Faezeh; Idrogo-Lam, Ryan; Huy Vu; Lathrop, Richard H.] Univ Calif Irvine, Dept Comp Sci, Irvine, CA 92697 USA; [Baronio, Roberta; Hall, Linda V.; Kaiser, Peter] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; [Salehi, Faezeh; Baronio, Roberta; Hall, Linda V.; Kaiser, Peter; Lathrop, Richard H.] Univ Calif Irvine, Inst Genom & Bioinformat, Irvine, CA 92697 USA; [Kaiser, Peter; Lathrop, Richard H.] Univ Calif Irvine, Chao Family Comprehens Canc Ctr, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Salehi, F (corresponding author), Univ Calif Irvine, Dept Comp Sci, Irvine, CA 92697 USA.	ssalehia@uci.edu; pkaiser@uci.edu			National Institutes of Health under National Cancer Institute [R01CA112560]; NATIONAL CANCER INSTITUTE [R01CA112560, P30CA062203] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001414] Funding Source: NIH RePORTER	National Institutes of Health under National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by the National Institutes of Health under National Cancer Institute grant number R01CA112560 to R.H.L. and P.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo A, 2014, NATURE, V505, P686, DOI 10.1038/nature12861; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; Baroni TE, 2004, P NATL ACAD SCI USA, V101, P4930, DOI 10.1073/pnas.0401162101; Baronio R, 2010, NUCLEIC ACIDS RES, V38, P7079, DOI 10.1093/nar/gkq571; Brachmann RK, 1998, EMBO J, V17, P1847, DOI 10.1093/emboj/17.7.1847; Demma M, 2010, J BIOL CHEM, V285, P10198, DOI 10.1074/jbc.M109.083469; ELIYAHU D, 1989, P NATL ACAD SCI USA, V86, P8763, DOI 10.1073/pnas.86.22.8763; Eren AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066643; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; FINLAY CA, 1989, CELL, V57, P1083, DOI 10.1016/0092-8674(89)90045-7; GOTOH O, 1982, J MOL BIOL, V162, P705, DOI 10.1016/0022-2836(82)90398-9; Homer N, 2009, PLOS ONE, V4, pA95, DOI 10.1371/journal.pone.0007767; Jiang H, 2008, BIOINFORMATICS, V24, P2395, DOI 10.1093/bioinformatics/btn429; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kelley DR, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r116; Kim I, 2013, MOL CELL PROTEOMICS, V12, P3370, DOI 10.1074/mcp.O113.031708; Li MK, 2010, AM J HUM GENET, V87, P237, DOI 10.1016/j.ajhg.2010.07.014; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Lin H, 2008, BIOINFORMATICS, V24, P2431, DOI 10.1093/bioinformatics/btn416; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Minoche AE, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r112; Ren HY, 2013, MOL BIOL CELL, V24, P3016, DOI 10.1091/mbc.E13-05-0240; Robison K, 2010, BRIEF BIOINFORM, V11, P524, DOI 10.1093/bib/bbq013; ROBZYK K, 1992, NUCLEIC ACIDS RES, V20, P3790, DOI 10.1093/nar/20.14.3790; Salmela L, 2011, BIOINFORMATICS, V27, P1455, DOI 10.1093/bioinformatics/btr170; Salmela L, 2010, BIOINFORMATICS, V26, P1284, DOI 10.1093/bioinformatics/btq151; Schmitt MW, 2012, P NATL ACAD SCI USA, V109, P14508, DOI 10.1073/pnas.1208715109; SHARP PM, 1986, NUCLEIC ACIDS RES, V14, P5125, DOI 10.1093/nar/14.13.5125; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Smith AD, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-128; Smith AD, 2009, BIOINFORMATICS, V25, P2841, DOI 10.1093/bioinformatics/btp533; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Yang X, 2013, BRIEF BIOINFORM, V14, P56, DOI 10.1093/bib/bbs015; Zagordi O, 2010, NUCLEIC ACIDS RES, V38, P7400, DOI 10.1093/nar/gkq655; Zagordi O, 2010, J COMPUT BIOL, V17, P417, DOI 10.1089/cmb.2009.0164	41	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0116877	10.1371/journal.pone.0116877	http://dx.doi.org/10.1371/journal.pone.0116877			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692681	Green Published, gold			2022-12-26	WOS:000350061500027
J	Bao, HD; Zhu, F; Wang, F; Liu, Z; Bao, MH; He, SY; Zhu, ZZ; Qiu, Y				Bao, Hongda; Zhu, Feng; Wang, Fei; Liu, Zhen; Bao, Mike H.; He, Shouyu; Zhu, Zezhang; Qiu, Yong			Scoliosis Related Information on the Internet in China: Can Patients Benefit from This Information?	PLOS ONE			English	Article							ADOLESCENT IDIOPATHIC SCOLIOSIS; MEDICAL INFORMATION; QUALITY	Background There has been an increasing popularity of searching health related information online in recent years. Despite that considerable amount of scoliosis patients have shown interest in obtaining scoliosis information through Internet, previous studies have demonstrated poor quality of online information. However, this conclusion may vary depending on region and culture. Since China has a restricted Internet access outside of its borders, the aim of this study is to evaluate the quality of scoliosis information available online using recognized scoring systems and to analyze the Internet as a source of health information in China. Methods A survey-based questionnaire was distributed to 280 respondents at outpatient clinics. Information on demographics and Internet use was collected. Binary logistic analysis was performed to identify possible predictors for the use of Internet. In addition, the top 60 scoliosis related websites assessed through 4 search engines were reviewed by a surgeon and the quality of online information was evaluated using DISCERN score and JAMA benchmark. Results Use of the Internet as a source for scoliosis related information was confirmed in 87.8% of the respondents. College education, Internet access at home and urban residence were identified as potential predictors for Internet use. However, the quality of online scoliosis related information was poor with an average DISCERN score of 27.9 +/- 11.7 and may be misleading for scoliosis patients. Conclusion The study outlines the profile of scoliosis patients who use the Internet as a source of health information. It was shown that 87.8% of the scoliosis patients in outpatient clinics have searched for scoliosis related information on Internet. Urban patients, higher education and Internet access at home were identified as potential predictors for Internet search. However, the overall quality of online scoliosis related information was poor and confusing. Physician based websites seemed to contain more reliable information.	[Bao, Hongda; Zhu, Feng; Wang, Fei; Liu, Zhen; He, Shouyu; Zhu, Zezhang; Qiu, Yong] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Spine Surg, Nanjing 210008, Jiangsu, Peoples R China; [Bao, Mike H.] Geisel Sch Med Dartmouth, Hanover, NH USA	Nanjing University; Dartmouth College	Qiu, Y (corresponding author), Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Spine Surg, Nanjing 210008, Jiangsu, Peoples R China.	scoliosis2002@sina.com		Bao, Mike/0000-0002-0909-052X				Andreassen HK, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-53; Avraham S, 2014, FERTIL STERIL, V101, P222, DOI 10.1016/j.fertnstert.2013.09.008; Baker JF, 2012, EUR SPINE J, V21, P1972, DOI 10.1007/s00586-012-2429-2; Callejas-Rubio JL, 2013, CLIN RHEUMATOL, DOI [10.1007/s10067-013-2464-3, DOI 10.1007/S10067-013-2464-3]; Cheung KMC, 2007, SPINE, V32, P1141, DOI 10.1097/01.brs.0000261562.48888.e3; China National Network Information Center, 2013, STAT REP INT DEV CHI; de Boer MJ, 2007, PATIENT EDUC COUNS, V68, P86, DOI 10.1016/j.pec.2007.05.012; Diaz JA, 2002, J GEN INTERN MED, V17, P180, DOI 10.1046/j.1525-1497.2002.10603.x; Gao LL, 2013, MIDWIFERY, V29, P730, DOI 10.1016/j.midw.2012.07.003; Harris Interactive, 2012, NUMB CYB AD GOING ON; Kummervold PE, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.1023; Liu JM, 2013, SEIZURE-EUR J EPILEP, V22, P787, DOI 10.1016/j.seizure.2013.06.007; MacCulloch R, 2010, SCOLIOSIS SPINAL DIS, V5, DOI 10.1186/1748-7161-5-13; Mathur S, 2005, SPINE, V30, P2695, DOI 10.1097/01.brs.0000188266.22041.c2; Morr S, 2010, SPINE J, V10, P350, DOI 10.1016/j.spinee.2010.02.009; Nason GJ, 2012, SPINE, V37, pE1364, DOI 10.1097/BRS.0b013e31826619b5; Ohlow MA, 2013, INT J CLIN PRACT, V67, P990, DOI 10.1111/ijcp.12162; Romano M, 2013, SPINE, V38, pE883, DOI 10.1097/BRS.0b013e31829459f8; Silberg WM, 1997, JAMA-J AM MED ASSOC, V277, P1244, DOI 10.1001/jama.277.15.1244; Valero-Aguilera B, 2013, SUPPORT CARE CANCER, DOI [10.1007/s00520-013-2020-3, DOI 10.1007/S00520-013-2020-3]; Valero-Aguilera B, 2012, SUPPORT CARE CANCER, V20, P3087, DOI 10.1007/s00520-012-1431-x; Wang C, 2010, SPINE PHILA PA 1976; Wellburn S, 2013, SPINE, V38, P1590, DOI 10.1097/BRS.0b013e31829965bc	23	10	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0118289	10.1371/journal.pone.0118289	http://dx.doi.org/10.1371/journal.pone.0118289			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689064	Green Submitted, Green Published, gold			2022-12-26	WOS:000350322700112
J	Irvin, R; Vallabhaneni, S; Scott, H; Williams, JK; Wilton, L; Li, X; Buchbinder, S				Irvin, Risha; Vallabhaneni, Snigdha; Scott, Hyman; Williams, John K.; Wilton, Leo; Li, Xin; Buchbinder, Susan		HPTN 061	Examining Levels of Risk Behaviors among Black Men Who Have Sex with Men (MSM) and the Association with HIV Acquisition	PLOS ONE			English	Article							WHITE MEN; INFECTION; DISPARITIES; REDUCTION	Seroadaptation is defined as the practice of modifying sexual behavior based on one's own HIV serostatus, the perceived HIV serostatus of sexual partners, and differences in risk of HIV transmission by sexual acts. Because this definition implies intent, we use the term "seroprotection" to describe HIV negative participants reporting condomless anal sex (CAS) either exclusively with seronegative partners, or only as the insertive partner with HIV positive or unknown serostatus partners. Little is known about seroprotection in Black men who have sex with men (MSM). We evaluated the independent association of seroprotection and HIV acquisition among the 1144 HIV-negative Black MSM enrolled in HPTN 061 using Cox models; we stratified by city of enrollment, and controlled for number of partners, age, and drug use. Behaviors reported at 0, 6, and 12 months were assigned to three mutually exclusive categories: (1) No CAS; (2) Seroprotection; and (3) CAS without seroprotection. In 2,861 six-month intervals; 28 HIV seroconversions occurred. No CAS was reported at 33.3% of visits, seroprotection at 46.6% of visits, and CAS without seroprotection at 20.1% of visits. The seroconversion rate per 100 person-years for no CAS was 0.98 (95% CI: 0.27, 2.51), compared with 2.39 (95% CI: 1.03, 4.71) and 13.33 (95% CI: 7.62, 21.66) for seroprotection and CAS without seroprotection, respectively. Compared to CAS without seroprotection, intervals without CAS were associated with an 87% reduction (aHR: 0.13, 95% CI: 0.03-0.46) in HIV acquisition and intervals with seroprotection with a 78% reduction (aHR: 0.22, 95% CI: 0.09-0.57). No CAS is the safest behavior to prevent HIV acquisition. Seroprotective behaviors significantly reduced risk, but HIV incidence was still >2/100 person-years, suggesting that additional strategies, such as pre-exposure prophylaxis, are warranted for this population.	[Irvin, Risha] Johns Hopkins Univ, Div Infect Dis, Baltimore, MD 21231 USA; [Irvin, Risha; Scott, Hyman; Buchbinder, Susan] San Francisco Dept Publ Hlth, Bridge HIV, San Francisco, CA USA; [Vallabhaneni, Snigdha] Univ Calif San Francisco, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA; [Williams, John K.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; [Wilton, Leo] SUNY Binghamton, Dept Human Dev, Binghamton, NY USA; [Wilton, Leo] Univ Johannesburg, Fac Humanities, Johannesburg, South Africa; [Li, Xin] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Buchbinder, Susan] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	Johns Hopkins University; San Francisco Department of Public Health; University of California System; University of California San Francisco; University of California System; University of California Los Angeles; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; University of Johannesburg; Fred Hutchinson Cancer Center; University of California System; University of California San Francisco	Irvin, R (corresponding author), Johns Hopkins Univ, Div Infect Dis, Baltimore, MD 21231 USA.	rirvin1@jhmi.edu			National Institute of Allergy and Infectious Disease (NIAID) [HPTN 061]; National Institute on Drug Abuse (NIDA); National Institute of Mental Health (NIMH); Fenway Institute CRS: Harvard University CFAR [P30 AI060354]; CTU for HIV Prevention and Microbicide Research [UM1 AI069480]; George Washington University CRS: District of Columbia Developmental CFAR [P30 AI087714]; Harlem Prevention Center CRS and NY Blood Center/Union Square CRS: Columbia University CTU [5U01 AI069466]; ARRA funding [3U01 AI069466-03S1]; Hope Clinic of the Emory Vaccine Center CRS; Ponce de Leon Center CRS: Emory University HIV/AIDS CTU [5U01 AI069418]; CFAR [P30 AI050409]; CTSA [UL1 RR025008]; San Francisco Vaccine and Prevention CRS: ARRA funding [3U01 AI069496-03S1, 3U01 AI069496-03S2]; UCLA Vine Street CRS: UCLA Department of Medicine, Division of Infectious Diseases CTU [U01 AI069424]; HPTN Scholars Program - NIAID and NIMH; San Francisco Department of Public Health; Johns Hopkins University Center for AIDS Research [1P30AI094189]; UCLA HIV/AIDS; Substance Abuse; Trauma Training Program [1R25DA035692-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R25HD045810] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI087714, U01AI069496, UM1AI068613, U01AI069418, UM1AI069496, U01AI069466, P30AI094189, UM1AI068619, UM1AI068617, U01AI069424, P30AI027763, P30AI060354, P30AI050409, UM1AI069480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH019105, P30MH062246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R25DA035692] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Fenway Institute CRS: Harvard University CFAR; CTU for HIV Prevention and Microbicide Research; George Washington University CRS: District of Columbia Developmental CFAR; Harlem Prevention Center CRS and NY Blood Center/Union Square CRS: Columbia University CTU; ARRA funding; Hope Clinic of the Emory Vaccine Center CRS; Ponce de Leon Center CRS: Emory University HIV/AIDS CTU; CFAR; CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); San Francisco Vaccine and Prevention CRS: ARRA funding; UCLA Vine Street CRS: UCLA Department of Medicine, Division of Infectious Diseases CTU; HPTN Scholars Program - NIAID and NIMH; San Francisco Department of Public Health; Johns Hopkins University Center for AIDS Research; UCLA HIV/AIDS; Substance Abuse; Trauma Training Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	HPTN 061 grant support provided by the National Institute of Allergy and Infectious Disease (NIAID), National Institute on Drug Abuse (NIDA) and National Institute of Mental Health (NIMH): Cooperative Agreements UM1 AI068619, UM1 AI068617, and UM1 AI068613. Additional site funding-Fenway Institute CRS: Harvard University CFAR (P30 AI060354) and CTU for HIV Prevention and Microbicide Research (UM1 AI069480); George Washington University CRS: District of Columbia Developmental CFAR (P30 AI087714); Harlem Prevention Center CRS and NY Blood Center/Union Square CRS: Columbia University CTU (5U01 AI069466) and ARRA funding (3U01 AI069466-03S1); Hope Clinic of the Emory Vaccine Center CRS and The Ponce de Leon Center CRS: Emory University HIV/AIDS CTU (5U01 AI069418), CFAR (P30 AI050409) and CTSA (UL1 RR025008); San Francisco Vaccine and Prevention CRS: ARRA funding (3U01 AI069496-03S1, 3U01 AI069496-03S2); UCLA Vine Street CRS: UCLA Department of Medicine, Division of Infectious Diseases CTU (U01 AI069424). The primary author's work on this manuscript was supported through the HPTN Scholars Program funded by NIAID and NIMH. Additional support was provided to the primary author by The San Francisco Department of Public Health, The Johns Hopkins University Center for AIDS Research (1P30AI094189) and the UCLA HIV/AIDS, Substance Abuse, and Trauma Training Program (1R25DA035692-01). The funder had a role in the design of the HPTN 061 study by providing input into the design. The funder did not have a role in the data collection and analysis, decision to publish, or preparation of the manuscript.	Eaton LA, 2010, AM J PUBLIC HEALTH, V100, P503, DOI 10.2105/AJPH.2008.155903; Golden MR, 2008, JAIDS-J ACQ IMM DEF, V49, P212, DOI 10.1097/QAI.0b013e31818455e8; Golden MR, 2012, SEX TRANSM DIS, V39, P659, DOI 10.1097/OLQ.0b013e31825727cb; Jablonski O, AIDS 2008 XVII INTER; Jin FY, 2009, AIDS, V23, P243, DOI 10.1097/QAD.0b013e32831fb51a; Koblin BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070413; Lieb S, 2011, PUBLIC HEALTH REP, V126, P60, DOI 10.1177/003335491112600110; Mao LM, 2006, AIDS, V20, P1204, DOI 10.1097/01.aids.0000226964.17966.75; Marks G, 2010, SEX TRANSM DIS, V37, P325, DOI 10.1097/OLQ.0b013e3181c95dac; Maulsby C, 2014, AIDS BEHAV, V18, P10, DOI 10.1007/s10461-013-0476-2; McFarland W, 2011, AIDS CARE, V23, P261, DOI 10.1080/09540121.2010.507748; Millett GA, 2007, AIDS, V21, P2083, DOI 10.1097/QAD.0b013e3282e9a64b; Millett GA, 2012, LANCET, V380, P341, DOI 10.1016/S0140-6736(12)60899-X; Philip SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012662; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Snowden JM, 2009, SEX TRANSM INFECT, V85, P469, DOI 10.1136/sti.2009.036269; Torian Lucia, 2011, Morbidity and Mortality Weekly Report, V60, P689; Vallabhaneni S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045718; Wejnert C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076878	19	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0118281	10.1371/journal.pone.0118281	http://dx.doi.org/10.1371/journal.pone.0118281			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC4KQ	25688980	Green Published, Green Submitted, gold			2022-12-26	WOS:000350322700111
J	Nemcova, E; Cernochova, M; Ruzicka, F; Malisova, B; Freiberger, T; Nemec, P				Nemcova, Eva; Cernochova, Michaela; Ruzicka, Filip; Malisova, Barbora; Freiberger, Tomas; Nemec, Petr			Rapid Identification of Medically Important Candida Isolates Using High Resolution Melting Analysis	PLOS ONE			English	Article							REAL-TIME PCR; MOLECULAR-IDENTIFICATION; SPECIES IDENTIFICATION; FUNGAL PATHOGENS; ANTIFUNGAL SUSCEPTIBILITY; ACCURATE IDENTIFICATION; INVASIVE CANDIDIASIS; MASS-SPECTROMETRY; CURVE ANALYSIS; EPIDEMIOLOGY	An increasing trend in non albicans infections and various susceptibility patterns to antifungal agents implies a requirement for the quick and reliable identification of a number of medically important Candida species. Real-time PCR followed by high resolution melting analysis (HRMA) was developed, tested on 25 reference Candida collection strains and validated on an additional 143 clinical isolates in this study. All reference strains and clinical isolates inconclusive when using phenotypic methods and/or HRMA were analysed using ITS2 sequencing. Considering reference and clinical strains together, 23 out of 27 Candida species could be clearly distinguished by HRMA, while the remaining 4 species were grouped in 2 pairs, when applying the mean Tm +/- 3 SD values, the shape of the derivative melting curve (dMelt curve) and, in some cases, the normalized and temperature-shifted difference plot against C. krusei. HRMA as a simple, rapid and inexpensive tool was shown to be useful in identifying a wide spectrum of clinically important Candida species. It may complement the current clinical diagnostic approach based on commercially available biochemical kits.	[Nemcova, Eva; Cernochova, Michaela; Malisova, Barbora; Nemec, Petr] Ctr Cardiovasc Surg & Transplantat Brno, Brno, Czech Republic; [Nemcova, Eva; Nemec, Petr] St Annes Univ Hosp Brno, Int Clin Res Ctr, Brno, Czech Republic; [Cernochova, Michaela; Malisova, Barbora; Freiberger, Tomas] Masaryk Univ, Cent European Inst Technol, Mol Immunol & Microbiol, Brno, Czech Republic; [Ruzicka, Filip] Masaryk Univ, Fac Med, Dept Microbiol, Brno, Czech Republic; [Ruzicka, Filip] St Annes Univ Hosp Brno, Brno, Czech Republic	St Anne's University Hospital Brno (FNUSA-ICRC); Masaryk University Brno; Masaryk University Brno; St Anne's University Hospital Brno (FNUSA-ICRC)	Freiberger, T (corresponding author), Masaryk Univ, Cent European Inst Technol, Mol Immunol & Microbiol, Brno, Czech Republic.	tfreiber@med.muni.cz; petr.nemec@cktch.cz	Freiberger, Tomas/D-8421-2011; Růžička, Filip/K-6360-2015	Freiberger, Tomas/0000-0001-6532-7053; Ruzicka, Filip/0000-0001-5679-0513	European Regional Development Fund-Project FNUSA-ICRC [CZ.1.05/1.1.00/02.0123]; grant CKTCH Brno [201211]	European Regional Development Fund-Project FNUSA-ICRC; grant CKTCH Brno	The study was supported by the European Regional Development Fund-Project FNUSA-ICRC (No. CZ.1.05/1.1.00/02.0123) and by the grant CKTCH Brno No. 201211. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2002, J CLIN MICROBIOL, V40, P2483, DOI 10.1128/JCM.40.7.2483-2489.2002; Alnuaimi AD, 2014, MOL ORAL MICROBIOL, V29, P117, DOI 10.1111/omi.12050; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arancia S, 2011, DIAGN MICR INFEC DIS, V69, P283, DOI 10.1016/j.diagmicrobio.2010.10.003; Bergman A, 2007, EUR J CLIN MICROBIOL, V26, P813, DOI 10.1007/s10096-007-0369-2; Borman AM, 2010, J CLIN MICROBIOL, V48, P3648, DOI 10.1128/JCM.01071-10; Canton E, 2011, ANTIMICROB AGENTS CH, V55, P5590, DOI 10.1128/AAC.00466-11; Cassagne C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028425; CBS-KNAW Fungal Biodiversity Centre, CBS FIL FUNG DAT; Cheng JC, 2006, CLIN CHEM, V52, P1997, DOI 10.1373/clinchem.2006.069286; Chryssanthou E, 2007, APMIS, V115, P1281, DOI 10.1111/j.1600-0643.2007.00801.x; Ciardo DE, 2006, J CLIN MICROBIOL, V44, P77, DOI 10.1128/JCM.44.1.77-84.2006; Cornet M, 2011, J MOL DIAGN, V13, P12, DOI 10.1016/j.jmoldx.2010.11.014; Cuenca-Estrella M, 2012, CLIN MICROBIOL INFEC, V18, P9, DOI 10.1111/1469-0691.12038; Decat E, 2013, RES MICROBIOL, V164, P110, DOI 10.1016/j.resmic.2012.10.017; Dendis M, 2003, CLIN MICROBIOL INFEC, V9, P1191, DOI 10.1111/j.1469-0691.2003.00719.x; Desnos-Ollivier M, 2008, J CLIN MICROBIOL, V46, P3237, DOI 10.1128/JCM.01451-08; Dunyach C, 2008, DIAGN MICR INFEC DIS, V60, P263, DOI 10.1016/j.diagmicrobio.2007.09.014; Dwight Z, 2011, BIOINFORMATICS, V27, P1019, DOI 10.1093/bioinformatics/btr065; Ellepola ANB, 2005, J MICROBIOL, V43, P65; Ellepola ANB, 2003, ORAL MICROBIOL IMMUN, V18, P379, DOI 10.1046/j.0902-0055.2003.00103.x; Fricke S, 2010, J APPL MICROBIOL, V109, P1150, DOI 10.1111/j.1365-2672.2010.04736.x; Gharizadeh B, 2004, MYCOSES, V47, P29, DOI 10.1046/j.1439-0507.2003.00949.x; Goldschmidt P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037660; Hachem R, 2008, CANCER, V112, P2493, DOI 10.1002/cncr.23466; Hamal P, 2008, MED MYCOL, V46, P601, DOI 10.1080/13693780802078180; Horn DL, 2009, CLIN INFECT DIS, V48, P1695, DOI 10.1086/599039; Hrncirova K, 2010, J CLIN MICROBIOL, V48, P3392, DOI 10.1128/JCM.01109-10; Hsu MC, 2003, J MED MICROBIOL, V52, P1071, DOI 10.1099/jmm.0.05302-0; Kaleta EJ, 2011, J CLIN MICROBIOL, V49, P345, DOI 10.1128/JCM.00936-10; Klingspor L, 2006, CLIN MICROBIOL INFEC, V12, P745, DOI 10.1111/j.1469-0691.2006.01498.x; Krcmery V, 2002, J HOSP INFECT, V50, P243, DOI 10.1053/jhin.2001.1151; Kurtzman CP, 1997, J CLIN MICROBIOL, V35, P1216, DOI 10.1128/JCM.35.5.1216-1223.1997; Lau A, 2008, J CLIN MICROBIOL, V46, P3021, DOI 10.1128/JCM.00689-08; Leaw SN, 2006, J CLIN MICROBIOL, V44, P693, DOI 10.1128/JCM.44.3.693-699.2006; Leroy O, 2009, CRIT CARE MED, V37, P1612, DOI 10.1097/CCM.0b013e31819efac0; Lockhart SR, 2008, J CLIN MICROBIOL, V46, P2659, DOI 10.1128/JCM.00803-08; Loeffler J, 2000, J CLIN MICROBIOL, V38, P586, DOI 10.1128/JCM.38.2.586-590.2000; Maaroufi Y, 2004, J CLIN MICROBIOL, V42, P3159, DOI 10.1128/JCM.42.7.3159-3163.2004; Mandviwala T, 2010, J MOL DIAGN, V12, P91, DOI 10.2353/jmoldx.2010.090085; Marchetti O, 2004, CLIN INFECT DIS, V38, P311, DOI 10.1086/380637; Marklein G, 2009, J CLIN MICROBIOL, V47, P2912, DOI 10.1128/JCM.00389-09; Martin D, 2005, EUR J CLIN MICROBIOL, V24, P329, DOI 10.1007/s10096-005-1321-y; Montero CI, 2008, EUR J CLIN MICROBIOL, V27, P821, DOI 10.1007/s10096-008-0510-x; Pappas PG, 2004, CLIN INFECT DIS, V38, P161, DOI 10.1086/380796; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Pfaller MA, 2002, J CLIN MICROBIOL, V40, P3551, DOI 10.1128/JCM.40.10.3551-3557.2002; Pincus DH, 1999, J CLIN MICROBIOL, V37, P3533, DOI 10.1128/JCM.37.11.3533-3539.1999; Plachy R, 2005, J MICROBIOL METH, V60, P107, DOI 10.1016/j.mimet.2004.09.003; Pryce TM, 2003, DIAGN MICR INFEC DIS, V47, P487, DOI 10.1016/S0732-8893(03)00139-1; Quiles-Melero I, 2012, EUR J CLIN MICROBIOL, V31, P67, DOI 10.1007/s10096-011-1277-z; Reed GH, 2007, PHARMACOGENOMICS, V8, P597, DOI 10.2217/14622416.8.6.597; Shepard JR, 2008, J CLIN MICROBIOL, V46, P50, DOI 10.1128/JCM.01385-07; Slany M, 2010, CAN J MICROBIOL, V56, P1040, DOI 10.1139/W10-091; Somogyvari F, 2012, IN VIVO, V26, P979; Staib P, 1999, MYCOSES, V42, P521, DOI 10.1046/j.1439-0507.1999.00516.x; Steer PA, 2009, J CLIN MICROBIOL, V47, P311, DOI 10.1128/JCM.01567-08; Stephens AJ, 2008, CLIN CHEM, V54, P432, DOI 10.1373/clinchem.2007.093658; Tajiri-Utagawa E, 2009, J CLIN MICROBIOL, V47, P435, DOI 10.1128/JCM.01247-08; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tortorano AM, 2004, EUR J CLIN MICROBIOL, V23, P317, DOI 10.1007/s10096-004-1103-y; Trtkova J, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-234; Valenza G, 2006, MYCOSES, V49, P331, DOI 10.1111/j.1439-0507.2006.01240.x; Wang QM, 2008, APPL ENVIRON MICROB, V74, P2604, DOI 10.1128/AEM.02223-07; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Won H, 2010, J CLIN MICROBIOL, V48, P3410, DOI 10.1128/JCM.00718-10; Zhao YA, 2009, J CLIN MICROBIOL, V47, P2067, DOI 10.1128/JCM.02230-08	67	27	29	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0116940	10.1371/journal.pone.0116940	http://dx.doi.org/10.1371/journal.pone.0116940			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689781	gold, Green Published, Green Submitted			2022-12-26	WOS:000350322700028
J	Wu, SY; Shao, FJ; Ji, J; Sun, RC; Dong, RZ; Zhou, YK; Xu, SJ; Sui, Y; Hu, JL				Wu, Shunyao; Shao, Fengjing; Ji, Jun; Sun, Rencheng; Dong, Rizhuang; Zhou, Yuanke; Xu, Shaojie; Sui, Yi; Hu, Jianlong			Network Propagation with Dual Flow for Gene Prioritization	PLOS ONE			English	Article							COMMON HOUSEKEEPING GENES; DISEASE-GENES; ASSOCIATIONS; WALKING	Based on the hypothesis that the neighbors of disease genes trend to cause similar diseases, network-based methods for disease prediction have received increasing attention. Taking full advantage of network structure, the performance of global distance measurements is generally superior to local distance measurements. However, some problems exist in the global distance measurements. For example, global distance measurements may mistake non-disease hub proteins that have dense interactions with known disease proteins for potential disease proteins. To find a new method to avoid the aforementioned problem, we analyzed the differences between disease proteins and other proteins by using essential proteins (proteins encoded by essential genes) as references. We find that disease proteins are not well connected with essential proteins in the protein interaction networks. Based on this new finding, we proposed a novel strategy for gene prioritization based on protein interaction networks. We allocated positive flow to disease genes and negative flow to essential genes, and adopted network propagation for gene prioritization. Experimental results on 110 diseases verified the effectiveness and potential of the proposed method.	[Wu, Shunyao; Shao, Fengjing] Qingdao Univ, Coll Automat Engn, Qingdao 266071, Peoples R China; [Wu, Shunyao; Shao, Fengjing; Ji, Jun; Sun, Rencheng; Zhou, Yuanke; Xu, Shaojie; Sui, Yi; Hu, Jianlong] Qingdao Univ, Coll Informat Engn, Qingdao 266071, Peoples R China; [Dong, Rizhuang] Qingdao Technol Univ, Sch Comp Engn, Qingdao, Peoples R China	Qingdao University; Qingdao University; Qingdao University of Technology	Shao, FJ (corresponding author), Qingdao Univ, Coll Automat Engn, Qingdao 266071, Peoples R China.	sfj@qdu.edu.cn		Wu, Shunyao/0000-0001-7774-9261	The State Key Program of National Natural Science of China [91130035]; National Natural Science Foundation of China; National Science Foundation of Shandong Province [ZR2012FZ003, ZR2012FQ017]; Shandong Provincial Natural Science Foundation, China	The State Key Program of National Natural Science of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Shandong Provincial Natural Science Foundation, China(Natural Science Foundation of Shandong Province)	1. The State Key Program of National Natural Science of China (No. 91130035), National Natural Science Foundation of China (http://www.nsfc.gov.cn/), FS; 2. The National Science Foundation of Shandong Province (No. ZR2012FZ003), Shandong Provincial Natural Science Foundation, China (http://www.sdnsf.gov.cn/portal/), FS; 3. The National Science Foundation of Shandong Province (No. ZR2012FQ017), Shandong Provincial Natural Science Foundation, China (http://www.sdnsf.gov.cn/portal/), RS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adie EA, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-55; Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Bromberg Y, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002902; CHANG C, 2011, FILM COMMENT, V47, P6, DOI DOI 10.1371/J0URNAL.P0NE.0022859; Congiu M, 2011, LIVER INT, V31, P386, DOI 10.1111/j.1478-3231.2010.02374.x; Dickerson JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027368; Franke L, 2006, AM J HUM GENET, V78, P1011, DOI 10.1086/504300; Furlong LI, 2013, TRENDS GENET, V29, P150, DOI 10.1016/j.tig.2012.11.004; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Guibinga GH, 2010, MOL THER, V18, P54, DOI 10.1038/mt.2009.178; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Itan Y, 2013, P NATL ACAD SCI USA, V110, P5558, DOI [10.1073/pnas.1218167110, 10.1073/PNAS.1218167110]; Jin WF, 2012, HUM MOL GENET, V21, P1611, DOI 10.1093/hmg/ddr599; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Li YJ, 2010, BIOINFORMATICS, V26, P1219, DOI 10.1093/bioinformatics/btq108; Linghu B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r91; Newman MEJ, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.108701; Oti M, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.041376; Radivojac P, 2008, PROTEINS, V72, P1030, DOI 10.1002/prot.21989; Smalter A, 2007, IEEE INT C BIOINFORM, P209, DOI 10.1109/BIBM.2007.47; Nguyen TP, 2012, ARTIF INTELL MED, V54, P63, DOI 10.1016/j.artmed.2011.09.003; Tu ZD, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-31; Vanunu O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000641; Wang XJ, 2011, BRIEF FUNCT GENOMICS, V10, P280, DOI 10.1093/bfgp/elr024; Waxman S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-243; Wu SY, 2014, PHYSICA A, V398, P217, DOI 10.1016/j.physa.2013.12.046; Xu JZ, 2006, BIOINFORMATICS, V22, P2800, DOI 10.1093/bioinformatics/btl467; Yang P, 2012, BIOINFORMATICS, V28, P2640, DOI 10.1093/bioinformatics/bts504; Yang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021502	30	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0116505	10.1371/journal.pone.0116505	http://dx.doi.org/10.1371/journal.pone.0116505			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689268	Green Submitted, Green Published, gold			2022-12-26	WOS:000350322700010
J	Hayyan, M; Looi, CY; Hayyan, A; Wong, WF; Hashim, MA				Hayyan, Maan; Looi, Chung Yeng; Hayyan, Adeeb; Wong, Won Fen; Hashim, Mohd Ali			In Vitro and In Vivo Toxicity Profiling of Ammonium-Based Deep Eutectic Solvents	PLOS ONE			English	Article							IMIDAZOLIUM IONIC LIQUIDS; CHOLINE CHLORIDE; CELLS; BIOTRANSFORMATIONS; CYTOTOXICITY; MEDIA; MODEL	The cytotoxic potential of ammonium-based deep eutectic solvents (DESs) with four hydrogen bond donors, namely glycerine (Gl), ethylene glycol (EG), triethylene glycol (TEG) and urea (U) were investigated. The toxicity of DESs was examined using In Vitro cell lines and In Vivo animal model. IC50 and selectivity index were determined for the DESs, their individual components and their combinations as aqueous solutions for comparison purposes. The cytotoxicity effect of DESs varied depending on cell lines. The IC50 for the Gl(DES), EG(DES), U-DES and TEG(DES) followed the sequence of TEG(DES)<Gl(DES)<EG(DES)<U-DES for OKF6, MCF-7, A375, HT29 and H413, respectively. Gl(DES) was selective against MCF-7 and A375, EG(DES) was selective against MCF-7, PC3, HepG2 and HT29, U-DES was selective against MCF-7, PC3, HepG2 and HT29, and TEG(DES) was selective against MCF-7 and A375. However, acute toxicity studies using ICR mice showed that these DESs were relatively toxic in comparison to their individual components. DES did not cause DNA damage, but it could enhance ROS production and induce apoptosis in treated cancer cells as evidenced by marked LDH release. Furthermore, the examined DESs showed less cytotoxicity compared with ionic liquids. To the best of our knowledge, this is the first time that combined In Vitro and In Vivo toxicity profiles of DESs were being demonstrated, raising the toxicity issue of these neoteric mixtures and their potential applicability to be used for therapeutic purposes.	[Hayyan, Maan] Univ Malaya, Dept Civil Engn, Kuala Lumpur, Malaysia; [Hayyan, Maan; Hayyan, Adeeb; Hashim, Mohd Ali] Univ Malaya, UMCiL, Kuala Lumpur, Malaysia; [Looi, Chung Yeng] Univ Malaya, Fac Med, Dept Pharmacol, Kuala Lumpur 50603, Malaysia; [Hayyan, Adeeb; Hashim, Mohd Ali] Univ Malaya, Dept Chem Engn, Kuala Lumpur, Malaysia; [Wong, Won Fen] Univ Malaya, Dept Med Microbiol, Fac Med, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya	Hayyan, M (corresponding author), Univ Malaya, Dept Civil Engn, Kuala Lumpur, Malaysia.	maan_hayyan@yahoo.com	HASHIM, MOHD ALI/B-9065-2010; Wong, Won Fen/D-3087-2012; Looi, Chung Yeng/A-2623-2013; Hayyan, Adeeb/G-6552-2014; Hayyan, Maan/A-1089-2011	HASHIM, MOHD ALI/0000-0002-0570-6788; Wong, Won Fen/0000-0003-1082-1956; Looi, Chung Yeng/0000-0002-4830-3495; Hayyan, Adeeb/0000-0002-3738-8198; Hayyan, Maan/0000-0002-2179-0801	University of Malaya HIR-MOHE [D000003-16001]; University of Malaya Centre for Ionic Liquids (UMCiL)	University of Malaya HIR-MOHE(Universiti Malaya); University of Malaya Centre for Ionic Liquids (UMCiL)	This work was supported by the University of Malaya HIR-MOHE (D000003-16001) and University of Malaya Centre for Ionic Liquids (UMCiL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott AP, 2004, J AM CHEM SOC, V126, P9142, DOI 10.1021/ja048266j; Abbott AR, 2006, CHEMPHYSCHEM, V7, P803, DOI 10.1002/cphc.200500489; Badisa RB, 2009, ANTICANCER RES, V29, P2993; Bubalo MC, 2014, ECOTOX ENVIRON SAFE, V99, P1, DOI 10.1016/j.ecoenv.2013.10.019; Choi YH, 2011, PLANT PHYSIOL, V156, P1701, DOI 10.1104/pp.111.178426; Cvjetko M, 2012, ARH HIG RADA TOKSIKO, V63, P15, DOI 10.2478/10004-1254-63-2012-2132; Dai YT, 2013, ANAL CHIM ACTA, V766, P61, DOI 10.1016/j.aca.2012.12.019; de Maria PD, 2011, CURR OPIN CHEM BIOL, V15, P220, DOI 10.1016/j.cbpa.2010.11.008; Desoubzdanne D, 2008, J NAT PROD, V71, P1189, DOI 10.1021/np8000909; Durand E, 2012, PROCESS BIOCHEM, V47, P2081, DOI 10.1016/j.procbio.2012.07.027; Goessel G, 2005, P NATL ACAD SCI USA, V102, P15599, DOI 10.1073/pnas.0409730102; Gorke J, 2010, BIOTECHNOL BIOPROC E, V15, P40, DOI 10.1007/s12257-009-3079-z; Gorke JT, 2008, CHEM COMMUN, P1235, DOI 10.1039/b716317g; Guo WJ, 2013, GREEN CHEM, V15, P226, DOI 10.1039/c2gc36602a; Gutierrez MC, 2010, ANGEW CHEM INT EDIT, V49, P2158, DOI 10.1002/anie.200905212; Hayyan A, 2012, THERMOCHIM ACTA, V541, P70, DOI 10.1016/j.tca.2012.04.030; Hayyan M, 2013, CHEMOSPHERE, V93, P455, DOI 10.1016/j.chemosphere.2013.05.013; Hayyan M, 2013, CHEMOSPHERE, V90, P2193, DOI 10.1016/j.chemosphere.2012.11.004; Hayyan M, 2010, FUEL PROCESS TECHNOL, V91, P116, DOI 10.1016/j.fuproc.2009.09.002; Jhong HR, 2009, ELECTROCHEM COMMUN, V11, P209, DOI 10.1016/j.elecom.2008.11.001; Jodynis-Liebert J, 2010, REGUL TOXICOL PHARM, V57, P266, DOI 10.1016/j.yrtph.2010.03.006; Leron RB, 2013, THERMOCHIM ACTA, V551, P14, DOI 10.1016/j.tca.2012.09.041; Leron RB, 2012, J CHEM THERMODYN, V54, P293, DOI 10.1016/j.jct.2012.05.008; Liew SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087286; Looi CY, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-166; Looi CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023640; Muhammad N, 2012, J CHEM ENG DATA, V57, P2191, DOI 10.1021/je300086w; Paydar M, 2013, INT J PHARMACEUT, V9, DOI [10.1186/1687-9856-2013-9, DOI 10.1186/1687-9856-2013-9]; Paydar M, 2014, DRUG DES DEV THER, V8, P719, DOI 10.2147/DDDT.S58178; Prior RL, 1999, FREE RADICAL BIO MED, V27, P1173, DOI 10.1016/S0891-5849(99)00203-8; Radosevic K, 2015, ECOTOX ENVIRON SAFE, V112, P46, DOI 10.1016/j.ecoenv.2014.09.034; Samori C, 2010, ECOTOX ENVIRON SAFE, V73, P1456, DOI 10.1016/j.ecoenv.2010.07.020; Singh BS, 2012, CATAL COMMUN, V24, P70, DOI 10.1016/j.catcom.2012.03.021; Smith EL, 2014, CHEM REV, V114, P11060, DOI 10.1021/cr300162p; Wong WF, 2012, J IMMUNOL, V188, P5408, DOI 10.4049/jimmunol.1102991; Wu SH, 2012, THERMOCHIM ACTA, V544, P1, DOI 10.1016/j.tca.2012.05.031; Zhang QH, 2012, CHEM SOC REV, V41, P7108, DOI 10.1039/c2cs35178a; Zhao H, 2011, J MOL CATAL B-ENZYM, V72, P163, DOI 10.1016/j.molcatb.2011.05.015	38	148	150	4	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117934	10.1371/journal.pone.0117934	http://dx.doi.org/10.1371/journal.pone.0117934			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679975	Green Published, gold, Green Submitted			2022-12-26	WOS:000350682600095
J	Li, XF; Zhong, BM; Han, WT; Zhao, N; Liu, W; Sui, Y; Wang, YW; Lu, YP; Wang, H; Li, JX; Jiang, M				Li, Xuefu; Zhong, Bomeng; Han, Weitian; Zhao, Ning; Liu, Wei; Sui, Yu; Wang, Yawen; Lu, Yongping; Wang, Hong; Li, Jianxin; Jiang, Miao			Two Novel Mutations in Myosin Binding Protein C Slow Causing Distal Arthrogryposis Type 2 in Two Large Han Chinese Families May Suggest Important Functional Role of Immunoglobulin Domain C2	PLOS ONE			English	Article							FREEMAN-SHELDON-SYNDROME; WHISTLING-FACE-SYNDROME; CARPO-TARSAL DYSPLASIA; HYPERTROPHIC CARDIOMYOPATHY; SKELETAL-MUSCLE; HALL-SYNDROME; CONTRACTURES; VARIANT; PIEZO2; ECEL1	Distal arthrogryposes (DAs) are a group of disorders that mainly involve the distal parts of the limbs and at least ten different DAs have been described to date. DAs are mostly described as autosomal dominant disorders with variable expressivity and incomplete penetrance, but recently autosomal recessive pattern was reported in distal arthrogryposis type 5D. Mutations in the contractile genes are found in about 50% of all DA patients. Of these genes, mutations in the gene encoding myosin binding protein C slow MYBPC1 were recently identified in two families with distal arthrogryposis type 1B. Here, we described two large Chinese families with autosomal dominant distal arthrogryposis type 2(DA2) with incomplete penetrance and variable expressivity. Some unique overextension contractures of the lower limbs and some distinctive facial features were present in our DA2 pedigrees. We performed follow-up DNA sequencing after linkage mapping and first identified two novel MYBPC1 mutations (c.1075G>A [p.E359K] and c.956C>T [p.P319L]) responsible for these Chinese DA2 families of which one introduced by germline mosacism. Each mutation was found to cosegregate with the DA2 phenotype in each family but not in population controls. Both substitutions occur within C2 immunoglobulin domain, which together with C1 and the M motif constitute the binding site for the S2 subfragment of myosin. Our results expand the phenotypic spectrum of MYBPC1-related arthrogryposis multiplex congenita (AMC). We also proposed the possible molecular mechanisms that may underlie the pathogenesis of DA2 myopathy associated with these two substitutions in MYBPC1.	[Li, Xuefu; Han, Weitian; Zhao, Ning; Liu, Wei; Sui, Yu; Wang, Yawen; Lu, Yongping; Wang, Hong; Li, Jianxin; Jiang, Miao] Key Lab Reprod Hlth Liaoning Prov, Shenyang, Peoples R China; [Zhong, Bomeng] Nanjing First Hosp, Emergency Dept, Nanjing, Jiangsu, Peoples R China		Jiang, M (corresponding author), Key Lab Reprod Hlth Liaoning Prov, Shenyang, Peoples R China.	jiangmiaocpt@aliyun.com			National Natural Science Foundation of China [81071442]; Research Fund of the Liaoning Provincial Department of Science and Technology [2010225031]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund of the Liaoning Provincial Department of Science and Technology	The National Natural Science Foundation of China to Miao Jiang (Grant No. 81071442) played an important role in study design, data analysis, preparation of the manuscript and decision to publish, the Research Fund of the Liaoning Provincial Department of Science and Technology to Miao Jiang (Grant No. 2010225031) played an important role in the sample collection and diagnosis of the distal arthrogryposis.	Ababou A, 2007, J BIOL CHEM, V282, P9204, DOI 10.1074/jbc.M610899200; Ackermann MA, 2013, FASEB J, DOI [10.1096/fj.13-240390, DOI 10.1096/FJ.13-240390]; Ackermann MA, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/636403; Ackermann MA, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/652065; Aren G, 2003, QUINTESSENCE INT, V34, P307; Bamshad M, 1996, AM J MED GENET, V65, P277, DOI 10.1002/(SICI)1096-8628(19961111)65:4<277::AID-AJMG6>3.0.CO;2-M; Bamshad M, 2009, J BONE JOINT SURG AM, V91A, P40, DOI 10.2106/JBJS.I.00281; Beck AE, 2013, AM J MED GENET A, V161A, P550, DOI 10.1002/ajmg.a.35809; CERVENKA J, 1970, ARCHIV OTOLARYNGOL, V91, P183; Chen Z, 2011, BIOCHEM J, V436, P437, DOI 10.1042/BJ20102007; Coste B, 2013, P NATL ACAD SCI USA, V110, P4667, DOI 10.1073/pnas.1221400110; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Dieterich K, 2013, HUM MOL GENET, V22, P1483, DOI 10.1093/hmg/dds514; FITZSIMMONS JS, 1984, J MED GENET, V21, P364, DOI 10.1136/jmg.21.5.364; FRASER FC, 1970, J AMER MED ASSOC, V211, P1374, DOI 10.1001/jama.211.8.1374; Gruen M, 1999, J MOL BIOL, V286, P933, DOI 10.1006/jmbi.1998.2522; Gurnett CA, 2010, HUM MOL GENET, V19, P1165, DOI 10.1093/hmg/ddp587; Ha K, 2013, HUM MOL GENET, DOI [10.1093/hmg/ddt644, DOI 10.1093/HMG/DDT644]; HALL JG, 1982, AM J MED GENET, V11, P185, DOI 10.1002/ajmg.1320110208; Hegde SS, 2010, INDIAN J PEDIATR, V77, P196, DOI 10.1007/s12098-009-0227-6; Jiang M, 2006, HUM GENET, V120, P238, DOI 10.1007/s00439-006-0183-4; Kimber E, 2012, ACTA PAEDIATR, V101, P877, DOI 10.1111/j.1651-2227.2012.02708.x; Kontrogianni-Konstantopoulos A, 2009, PHYSIOL REV, V89, P1217, DOI 10.1152/physrev.00017.2009; Krakowiak PA, 1997, AM J HUM GENET, V60, P426; Krakowiak PA, 1998, AM J MED GENET, V76, P93, DOI 10.1002/(SICI)1096-8628(19980226)76:1<93::AID-AJMG17>3.0.CO;2-K; LAI MMR, 1991, J MED GENET, V28, P701, DOI 10.1136/jmg.28.10.701; Li XF, 2013, GENE, V527, P630, DOI 10.1016/j.gene.2013.06.082; Markus B, 2012, HUM MUTAT, DOI [10.1002/humu.22247, DOI 10.1002/HUMU.22247]; Marston S, 2012, J MUSCLE RES CELL M, V33, P75, DOI 10.1007/s10974-011-9268-3; McMillin MJ, 2013, AM J HUM GENET, V92, P150, DOI 10.1016/j.ajhg.2012.11.014; McMillin MJ, 2014, AM J HUM GENET, DOI [10.1016/j.ajhg.2014.12.009, DOI 10.1016/J.AJHG.2014.12.009]; OTTO F M, 1953, Z Kinderheilkd, V73, P240, DOI 10.1007/BF00436029; PFEIFFER RA, 1972, Z KINDERHEILKD, V112, P43, DOI 10.1007/BF00491964; RINTALA AE, 1968, ACTA PAEDIATR SCAND, V57, P553, DOI 10.1111/j.1651-2227.1968.tb06979.x; Sadayappan S, 2009, CIRCULATION, V119, P1253, DOI 10.1161/CIRCULATIONAHA.108.798983; SH S S. S, 2009, IRAN J CHILD NEUROLO, P51; Shaaban S, 2013, CLIN GENET, DOI [10.1111/cge.12212, DOI 10.1111/CGE.12212]; Shaheen R, 2013, CLIN GENET, DOI [10.1111/cge.12212, DOI 10.1111/CGE.12212]; Stevenson DA, 2006, AM J MED GENET A, V140A, P2797, DOI 10.1002/ajmg.a.31528; Stevenson DA, 2006, PEDIATRICS, V117, P754, DOI 10.1542/peds.2005-1219; Sung SS, 2003, AM J HUM GENET, V73, P212, DOI 10.1086/376418; Sung SS, 2003, AM J HUM GENET, V72, P681, DOI 10.1086/368294; Tajsharghi H, 2007, NEUROLOGY, V68, P772, DOI 10.1212/01.wnl.0000256339.40667.fb; Toydemir RM, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-11; Toydemir RM, 2006, NAT GENET, V38, P561, DOI 10.1038/ng1775; VANEK J, 1986, J MED GENET, V23, P231, DOI 10.1136/jmg.23.3.231; Medrano RFV, 2014, MOL BIOTECHNOL, V56, P599, DOI 10.1007/s12033-014-9734-4; Vydyanath A, 2012, J MUSCLE RES CELL M, V33, P61, DOI 10.1007/s10974-012-9286-9; WEINSTEIN S, 1969, AM J DIS CHILD, V117, P427, DOI 10.1001/archpedi.1969.02100030429007; Weissbrod O, 2011, STAT APPL GENET MOL, V10, DOI [10.2202/1544-6115.1666, DOI 10.2202/1544-6115.1666]; WETTSTEIN A, 1980, HUM GENET, V55, P177, DOI 10.1007/BF00291765; Zlotogora J, 1998, HUM GENET, V102, P381, DOI 10.1007/s004390050708	52	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117158	10.1371/journal.pone.0117158	http://dx.doi.org/10.1371/journal.pone.0117158			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679999	Green Submitted, gold, Green Published			2022-12-26	WOS:000350682600053
J	Monti, L; Donati, D; Menci, E; Cioni, S; Bellini, M; Grazzini, I; Leonini, S; Galluzzi, P; Severi, S; Burroni, L; Casasco, A; Morbidelli, L; Santarnecchi, E; Piu, P				Monti, Lucia; Donati, Donatella; Menci, Elisabetta; Cioni, Samuele; Bellini, Matteo; Grazzini, Irene; Leonini, Sara; Galluzzi, Paolo; Severi, Sauro; Burroni, Luca; Casasco, Alfredo; Morbidelli, Lucia; Santarnecchi, Emiliano; Piu, Pietro			Cerebral Circulation Time is Prolonged and Not Correlated with EDSS in Multiple Sclerosis Patients: A Study Using Digital Subtracted Angiography	PLOS ONE			English	Article							WHITE-MATTER HYPERINTENSITIES; BLOOD-FLOW; ABSOLUTE QUANTIFICATION; COMPUTED-TOMOGRAPHY; VASCULAR-DISEASE; CT PERFUSION; SEGMENTATION; DIFFUSION; LESIONS	Literature has suggested that changes in brain flow circulation occur in patients with multiple sclerosis. In this study, digital subtraction angiography (DSA) was used to measure the absolute CCT value in MS patients and to correlate its value to age at disease onset and duration, and to expand disability status scale (EDSS). DSA assessment was performed on eighty MS patients and on a control group of forty-four age-matched patients. CCT in MS and control groups was calculated by analyzing the angiographic images. Lesion and brain volumes were calculated in a representative group of MS patients. Statistical correlations among CCT and disease duration, age at disease onset, lesion load, brain volumes and EDSS were considered. A significant difference between CCT in MS patients (mean = 4.9s; sd = 1.27s) and control group (mean = 2.8s; sd = 0.51s) was demonstrated. No significant statistical correlation was found between CCT and the other parameters in all MS patients. Significantly increased CCT value in MS patients suggests the presence of microvascular dysfunctions, which do not depend on clinical and MRI findings. Hemodynamic changes may not be exclusively the result of a late chronic inflammatory process.	[Monti, Lucia; Menci, Elisabetta; Cioni, Samuele; Bellini, Matteo; Grazzini, Irene; Leonini, Sara; Galluzzi, Paolo] Azienda Osped Univ Senese, Unit Neuroimaging & Neurointervent, Dept Neurol & Sensorial Sci, Santa Maria Scotte Gen Hosp, Siena, Italy; [Donati, Donatella; Santarnecchi, Emiliano; Piu, Pietro] Univ Siena, Dept Med Surg & Neurosci, I-53100 Siena, Italy; [Severi, Sauro] Gen Hosp S Donato Arezzo, Dept Neurol, Arezzo, Italy; [Burroni, Luca] Azienda Osped Univ Senese, Santa Maria Scotte Gen Hosp, Nucl Med Unit, Siena, Italy; [Casasco, Alfredo] Clin Nuestra Senora Rosario, Unit Endovasc & Percutaneous Therapy, Madrid, Spain; [Morbidelli, Lucia] Univ Siena, Dept Life Sci, I-53100 Siena, Italy; [Santarnecchi, Emiliano] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Berenson Allen Ctr Noninvas Brain Stimulat, Boston, MA 02215 USA	University of Siena; University Hospital of Siena; University of Siena; University of Siena; University Hospital of Siena; University of Siena; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Monti, L (corresponding author), Azienda Osped Univ Senese, Unit Neuroimaging & Neurointervent, Dept Neurol & Sensorial Sci, Santa Maria Scotte Gen Hosp, Siena, Italy.	l.monti@ao-siena.toscana.it	Grazzini, Irene/AAL-2260-2020; MONTI, LUCIA/ABF-7076-2021; Morbidelli, Lucia/AAC-7858-2020; Burroni, Luca/AAB-1958-2021; Morbidelli, Lucia/K-4053-2016; Santarnecchi, Emiliano/H-7528-2017	Burroni, Luca/0000-0001-5659-6091; Morbidelli, Lucia/0000-0001-8148-7049; Santarnecchi, Emiliano/0000-0002-6533-7427; Piu, Pietro/0000-0002-7504-1822; Galluzzi, Paolo/0000-0002-7553-5064; Bellini, Matteo/0000-0001-5280-0526				ADAMS CWM, 1988, J NEUROL NEUROSUR PS, V51, P260, DOI 10.1136/jnnp.51.2.260; ADAMS CWM, 1989, J NEUROL SCI, V92, P291, DOI 10.1016/0022-510X(89)90144-5; Aikawa H, 2010, NEUROL MED-CHIR, V50, P269, DOI 10.2176/nmc.50.269; BARTOLINI A, 1981, STROKE, V12, P241, DOI 10.1161/01.STR.12.2.241; Burroni L, 2011, NUCL MED COMMUN, V32, P457, DOI 10.1097/MNM.0b013e3283449330; Cerasa A, 2012, J NEUROSCI METH, V203, P193, DOI 10.1016/j.jneumeth.2011.08.047; Chiu FY, 2012, EUR J RADIOL, V81, P4087, DOI 10.1016/j.ejrad.2012.07.018; Confavreux C, 2006, BRAIN, V129, P595, DOI 10.1093/brain/awh714; D'haeseleer M, 2013, P NATL ACAD SCI USA, V110, P5654, DOI 10.1073/pnas.1222560110; Debernard L, 2014, J NEUROL NEUROSUR PS, V42, P154; Eisele P, 2012, AM J NEURORADIOL, V33, P1369, DOI 10.3174/ajnr.A2975; Gibson E, 2010, J MAGN RESON IMAGING, V31, P1311, DOI 10.1002/jmri.22004; GILROY J, 1963, AMER J ROENTGENOL RA, V90, P490; GOTHAM JE, 1962, J NEUROL NEUROSUR PS, V25, P292, DOI 10.1136/jnnp.25.4.292; GREITZ T, 1968, ACTA RADIOL DIAGN, V7, P331, DOI 10.1177/028418516800700406; HAMILTON WF, 1947, AM J PHYSIOL, V148, P35, DOI 10.1152/ajplegacy.1947.148.1.35; Ingrisch M, 2012, INVEST RADIOL, V47, P252, DOI 10.1097/RLI.0b013e31823bfc97; Iorio M, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00076; Jennett B, 1972, Prog Brain Res, V35, P365; Killeen RP, 2011, ACAD RADIOL, V18, P1094, DOI 10.1016/j.acra.2011.04.004; Knutsson L, 2015, J MAGN RESON IMAGING, V41, P903, DOI 10.1002/jmri.24621; Kudo K, 2013, RADIOLOGY, V267, P201, DOI 10.1148/radiol.12112618; Law M, 2004, RADIOLOGY, V231, P645, DOI 10.1148/radiol.2313030996; Lieber Baruch B., 2005, Critical Reviews in Biomedical Engineering, V33, P1, DOI 10.1615/CritRevBiomedEng.v33.i1.10; Lin CJ, 2012, AM J NEURORADIOL, V33, P1685, DOI 10.3174/ajnr.A3049; MACPHERS.P, 1973, J NEUROL NEUROSUR PS, V36, P1069, DOI 10.1136/jnnp.36.6.1069; Mancini M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092730; Mancini M, 2012, RADIOLOGY, V262, P947, DOI 10.1148/radiol.11111239; RANEY R. B., 1950, CALIFORNIA MED, V73, P342; Sato K, 2014, J CEREBR BLOOD F MET, V34, P136, DOI 10.1038/jcbfm.2013.176; Stanimirovic DB, 2012, J CEREBR BLOOD F MET, V32, P1207, DOI 10.1038/jcbfm.2012.25; Varga AW, 2009, J NEUROL SCI, V282, P28, DOI 10.1016/j.jns.2008.12.036; WAKEFIELD AJ, 1994, J CLIN PATHOL, V47, P129, DOI 10.1136/jcp.47.2.129; Wu MJ, 2006, PSYCHIAT RES-NEUROIM, V148, P133, DOI 10.1016/j.pscychresns.2006.09.003; Ziegelitz D, 2009, MAGN RESON MED, V62, P56, DOI 10.1002/mrm.21975; ZIERLER KL, 1965, CIRC RES, V16, P309, DOI 10.1161/01.RES.16.4.309; Zivadinov R, 2008, NEUROL RES, V30, P816, DOI 10.1179/174313208X341003	37	10	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0116681	10.1371/journal.pone.0116681	http://dx.doi.org/10.1371/journal.pone.0116681			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679526	gold, Green Published, Green Submitted			2022-12-26	WOS:000350682600030
J	Rotschafer, SE; Marshak, S; Cramer, KS				Rotschafer, Sarah E.; Marshak, Sonya; Cramer, Karina S.			Deletion of Fmr1 Alters Function and Synaptic Inputs in the Auditory Brainstem	PLOS ONE			English	Article							FRAGILE-X-SYNDROME; MENTAL-RETARDATION PROTEIN; MOUSE MODEL; SUPERIOR OLIVE; YOUNG MALES; ABNORMALITIES; AUTISM; HYPEREXCITABILITY; LOCALIZATION; MALFORMATION	Fragile X Syndrome (FXS), a neurodevelopmental disorder, is the most prevalent singlegene cause of autism spectrum disorder. Autism has been associated with impaired auditory processing, abnormalities in the auditory brainstem response (ABR), and reduced cell number and size in the auditory brainstem nuclei. FXS is characterized by elevated cortical responses to sound stimuli, with some evidence for aberrant ABRs. Here, we assessed ABRs and auditory brainstem anatomy in Fmr1(-/-) mice, an animal model of FXS. We found that Fmr1(-/-) mice showed elevated response thresholds to both click and tone stimuli. Amplitudes of ABR responses were reduced in Fmr1(-/-) mice for early peaks of the ABR. The growth of the peak I response with sound intensity was less steep in mutants that in wild type mice. In contrast, amplitudes and response growth in peaks IV and V did not differ between these groups. We did not observe differences in peak latencies or in interpeak latencies. Cell size was reduced in Fmr1(-/-) mice in the ventral cochlear nucleus (VCN) and in the medial nucleus of the trapezoid body (MNTB). We quantified levels of inhibitory and excitatory synaptic inputs in these nuclei using markers for presynaptic proteins. We measured VGAT and VGLUT immunolabeling in VCN, MNTB, and the lateral superior olive (LSO). VGAT expression in MNTB was significantly greater in the Fmr1(-/-) mouse than in wild type mice. Together, these observations demonstrate that FXS affects peripheral and central aspects of hearing and alters the balance of excitation and inhibition in the auditory brainstem.	[Rotschafer, Sarah E.; Marshak, Sonya; Cramer, Karina S.] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA	University of California System; University of California Irvine	Cramer, KS (corresponding author), Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA.	cramerk@uci.edu		Cramer, Karina/0000-0003-3793-4862	National Institutes of Health, National Institute for Deafness and Other Communication Disorders Institutional Training Grant [T32DC010775]; University of California Irvine Center for Autism Research and Translation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC008369, T32DC010775] Funding Source: NIH RePORTER	National Institutes of Health, National Institute for Deafness and Other Communication Disorders Institutional Training Grant; University of California Irvine Center for Autism Research and Translation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health, National Institute for Deafness and Other Communication Disorders Institutional Training Grant T32DC010775 to SER. The National Institutes of Health, National Institute for Deafness and Other Communication Disorders Core Center P30DC008369, assisted in providing equipment and analysis for SER, SM, and KSC. University of California Irvine Center for Autism Research and Translation provided a seed grant to KSC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARINAMI T, 1988, JPN J HUM GENET, V33, P224; Ascano M, 2012, NATURE, V492, P382, DOI 10.1038/nature11737; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Beebe K, 2014, NEUROSCIENCE, V273, P79, DOI 10.1016/j.neuroscience.2014.05.006; Berry-Kravis E, 2002, DEV MED CHILD NEUROL, V44, P724; Brown MR, 2011, HEARING RES, V279, P32, DOI 10.1016/j.heares.2011.03.004; Brown MR, 2010, NAT NEUROSCI, V13, P819, DOI 10.1038/nn.2563; Castren M, 2003, BRAIN TOPOGR, V15, P165, DOI 10.1023/A:1022606200636; Chen L, 2001, NEUROSCIENCE, V103, P1043, DOI 10.1016/S0306-4522(01)00036-7; El Idrissi A, 2005, NEUROSCI LETT, V377, P141, DOI 10.1016/j.neulet.2004.11.087; Farzin F, 2006, J DEV BEHAV PEDIATR, V27, pS137, DOI 10.1097/00004703-200604002-00012; FERRI R, 1987, INT J NEUROSCI, V34, P172; Frankland PW, 2004, MOL PSYCHIATR, V9, P417, DOI 10.1038/sj.mp.4001432; Galvez R, 2003, BRAIN RES, V971, P83, DOI 10.1016/S0006-8993(03)02363-1; Gibson JR, 2008, J NEUROPHYSIOL, V100, P2615, DOI 10.1152/jn.90752.2008; GILLBERG C, 1986, J MENT DEFIC RES, V30, P27; Gothelf D, 2008, ANN NEUROL, V63, P40, DOI 10.1002/ana.21243; Haas BW, 2009, DEV MED CHILD NEUROL, V51, P593, DOI 10.1111/j.1469-8749.2009.03295.x; Hagerman PJ, 2002, AM J HUM GENET, V71, P259; Hagerman R, 2002, AM J HUM GENET, V71, P287; Hallahan BP, 2011, NEUROIMAGE, V54, P16, DOI 10.1016/j.neuroimage.2010.08.015; Hazlett HC, 2012, J AM ACAD CHILD PSY, V51, P921, DOI 10.1016/j.jaac.2012.07.003; Heard TT, 2014, INT J DEV NEUROSCI; HINTON VJ, 1991, AM J MED GENET, V41, P289, DOI 10.1002/ajmg.1320410306; Hoeft F, 2011, ARCH GEN PSYCHIAT, V68, P295, DOI 10.1001/archgenpsychiatry.2010.153; Irwin SA, 2000, NEUROBIOL LEARN MEM, V73, P87, DOI 10.1006/nlme.1999.3914; Irwin SA, 2002, AM J MED GENET, V111, P140, DOI 10.1002/ajmg.10500; Kandler K, 2005, TRENDS NEUROSCI, V28, P290, DOI 10.1016/j.tins.2005.04.007; Kim H, 2013, J NEUROSCI, V33, P15686, DOI 10.1523/JNEUROSCI.3246-12.2013; Knipper L, 2013, PROG NEUROBIOL, V111, P17, DOI 10.1016/j.pneurobio.2013.08.002; Kulesza RJ, 2008, BRAIN RES, V1200, P132, DOI 10.1016/j.brainres.2008.01.009; Kulesza RJ, 2011, BRAIN RES, V1367, P360, DOI 10.1016/j.brainres.2010.10.015; Lozano R, 2014, NEUROPSYCH DIS TREAT, V10, P1769, DOI 10.2147/NDT.S42919; Lukose R, 2011, BRAIN RES, V1398, P102, DOI 10.1016/j.brainres.2011.05.013; Melcher JR, 1996, HEARING RES, V95, P144, DOI 10.1016/0378-5955(96)00032-9; Miezejeski CM, 1997, AM J MED GENET, V74, P167, DOI 10.1002/(SICI)1096-8628(19970418)74:2<167::AID-AJMG10>3.0.CO;2-G; Miller LJ, 1999, AM J MED GENET, V83, P268, DOI 10.1002/(SICI)1096-8628(19990402)83:4<268::AID-AJMG7>3.0.CO;2-K; Nielsen DM, 2002, BRAIN RES, V927, P8, DOI 10.1016/S0006-8993(01)03309-1; Olmos-Serrano JL, 2010, J NEUROSCI, V30, P9929, DOI 10.1523/JNEUROSCI.1714-10.2010; Osterweil EK, 2010, J NEUROSCI, V30, P15616, DOI 10.1523/JNEUROSCI.3888-10.2010; Paluszkiewicz SM, 2011, J NEUROPHYSIOL, V106, P2264, DOI 10.1152/jn.00421.2011; Pan LY, 2004, CURR BIOL, V14, P1863, DOI 10.1016/j.cub.2004.09.085; Parham K, 2001, HANDBOOK OF MOUSE AUDITORY RESEARCH: FROM BEHAVIOR TO MOLECULAR BIOLOGY, P37; Roberts J, 2005, J SPEECH LANG HEAR R, V48, P494, DOI 10.1044/1092-4388(2005/034); Rojas DC, 2001, NEUROREPORT, V12, P2573, DOI 10.1097/00001756-200108080-00056; Rotschafer S, 2013, BRAIN RES, V1506, P12, DOI 10.1016/j.brainres.2013.02.038; Rotschafer SE, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00019; Rotschafer SE, 2012, BRAIN RES, V1439, P7, DOI 10.1016/j.brainres.2011.12.041; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Spencer CM, 2005, GENES BRAIN BEHAV, V4, P420, DOI 10.1111/j.1601-183X.2005.00123.x; STCLAIR DM, 1987, BIOL PSYCHIAT, V22, P303, DOI 10.1016/0006-3223(87)90148-X; Strumbos JG, 2010, J NEUROSCI, V30, P10263, DOI 10.1523/JNEUROSCI.1125-10.2010; Suhl JA, 2014, HUM MOL GENET, V23, P5479, DOI 10.1093/hmg/ddu272; Tamminga CA, 2007, AM J PSYCHIAT, V164, P556, DOI 10.1176/appi.ajp.164.4.556; Van der Molen MJW, 2012, CLIN NEUROPHYSIOL, V123, P720, DOI 10.1016/j.clinph.2011.08.023; Van der Molen MJW, 2012, CLIN NEUROPHYSIOL, V123, P1309, DOI 10.1016/j.clinph.2011.11.039; Van der Molen MJW, 2012, BRAIN COGNITION, V78, P206, DOI 10.1016/j.bandc.2011.12.008; Wang Y, 2014, J COMP NEUROL, V522, P2107, DOI 10.1002/cne.23520; WISNIEWSKI KE, 1991, AM J MED GENET, V38, P476, DOI 10.1002/ajmg.1320380267; Zeng FG, 2013, HEARING RES, V295, P172, DOI 10.1016/j.heares.2012.05.009	61	44	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117266	10.1371/journal.pone.0117266	http://dx.doi.org/10.1371/journal.pone.0117266			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679778	gold, Green Published			2022-12-26	WOS:000350682600059
J	Sarma, T; Koutsouris, A; Yu, JZ; Krbanjevic, A; Hope, TJ; Rasenick, MM				Sarma, Tulika; Koutsouris, Athanasia; Yu, Jiang Zhu; Krbanjevic, Aleksandar; Hope, Thomas J.; Rasenick, Mark M.			Activation of Microtubule Dynamics Increases Neuronal Growth via the Nerve Growth Factor (NGF)- and G alpha(s)-mediated Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G Protein; Growth Factor; Microtubule; Neurite Outgrowth; Neurotrophin	HETEROTRIMERIC G-PROTEINS; FLUID SHEAR-STRESS; CELL-SHAPE CHANGE; MEMBRANE EXPANSION; ACTIN CYTOSKELETON; NEURITE OUTGROWTH; ENDOTHELIAL-CELLS; PLASMA-MEMBRANE; ALPHA-SUBUNITS; LIPID RAFTS	Signals that activate the G protein G(s) and promote neuronal differentiation evoke G(s) internalization in rat pheochromocytoma (PC12) cells. These agents also significantly increase G(s) association with microtubules, resulting in an increase in microtubule dynamics because of the activation of tubulin GTPase by G(s). To determine the function of G(s)/microtubule association in neuronal development, we used real-time trafficking of a GFP-G(s) fusion protein. GFP-G(s) concentrates at the distal end of the neurites in differentiated living PC12 cells as well as in cultured hippocampal neurons. G(s) translocates to specialized membrane compartments at tips of growing neurites. A dominant-negative G chimera that interferes with G(s) binding to tubulin and activation of tubulin GTPase attenuates neurite elongation and neurite number both in PC12 cells and primary hippocampal neurons. This effect is greatest on differentiation induced by activated G(s). Together, these data suggest that activated G(s) translocates from the plasma membrane and, through interaction with tubulin/microtubules in the cytosol, is important for neurite formation, development, and outgrowth. Characterization of neuronal G protein dynamics and their contribution to microtubule dynamics is important for understanding the molecular mechanisms by which G protein-coupled receptor signaling orchestrates neuronal growth and differentiation.	[Sarma, Tulika; Koutsouris, Athanasia; Yu, Jiang Zhu; Krbanjevic, Aleksandar; Rasenick, Mark M.] Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60612 USA; [Krbanjevic, Aleksandar; Rasenick, Mark M.] Univ Illinois, Coll Med, Psychiat, Chicago, IL 60612 USA; [Hope, Thomas J.] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Rasenick, Mark M.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Northwestern University; Feinberg School of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Rasenick, MM (corresponding author), Univ Illinois, Dept Physiol & Biophys, 835 S Wolcott M-C 901, Chicago, IL 60680 USA.	raz@uic.edu			Veterans Affairs merit award [BX11049]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER	Veterans Affairs merit award(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Veterans Affairs merit award BX11049.	ALETTA JM, 1988, J NEUROSCI, V8, P1425; Allen JA, 2005, MOL PHARMACOL, V67, P1493, DOI 10.1124/mol.104.008342; Chaineau M, 2009, FEBS LETT, V583, P3817, DOI 10.1016/j.febslet.2009.10.026; Chen NF, 2003, J BIOL CHEM, V278, P15285, DOI 10.1074/jbc.M300841200; Chieregatti E, 2005, NAT REV MOL CELL BIO, V6, P181, DOI 10.1038/nrm1572; Czysz A. H., 2014, NEUROPSYCHOPHARMACOL; Da Silva JS, 2002, NAT REV NEUROSCI, V3, P694, DOI 10.1038/nrn918; Dave RH, 2011, J BIOL CHEM, V286, P4319, DOI 10.1074/jbc.M110.196436; Denker SP, 1996, J CELL BIOL, V133, P1027, DOI 10.1083/jcb.133.5.1027; Dent EW, 1999, J NEUROSCI, V19, P8894, DOI 10.1523/JNEUROSCI.19-20-08894.1999; Efendiev R, 2013, J BIOL CHEM, V288, P3929, DOI 10.1074/jbc.M112.428144; Emery AC, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003993; Gordon-Weeks PR, 2004, J NEUROBIOL, V58, P70, DOI 10.1002/neu.10266; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HEIDEMANN SR, 1985, J CELL BIOL, V100, P916, DOI 10.1083/jcb.100.3.916; Hewavitharana T, 2012, CELL SIGNAL, V24, P25, DOI 10.1016/j.cellsig.2011.08.014; Hu XD, 2011, J NEUROSCI, V31, P15597, DOI 10.1523/JNEUROSCI.2445-11.2011; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Hynes TR, 2004, J BIOL CHEM, V279, P44101, DOI 10.1074/jbc.M405151200; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Ishida T, 1997, ANN NY ACAD SCI, V811, P12, DOI 10.1111/j.1749-6632.1997.tb51984.x; Jalali S, 1998, ARTERIOSCL THROM VAS, V18, P227, DOI 10.1161/01.ATV.18.2.227; Joiner MLA, 2010, EMBO J, V29, P482, DOI 10.1038/emboj.2009.344; Kheradmand F, 1998, SCIENCE, V280, P898, DOI 10.1126/science.280.5365.898; Malek AM, 1996, J CELL SCI, V109, P713; Marrari Y, 2007, BIOCHEMISTRY-US, V46, P7665, DOI 10.1021/bi700338m; Pfenninger KH, 2009, NAT REV NEUROSCI, V10, P251, DOI 10.1038/nrn2593; Pfenninger KH, 2003, J CELL SCI, V116, P1209, DOI 10.1242/jcs.00285; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Popova JS, 2003, J BIOL CHEM, V278, P34299, DOI 10.1074/jbc.M301748200; Pyne NJ, 2011, TRENDS PHARMACOL SCI, V32, P443, DOI 10.1016/j.tips.2011.04.002; ROSETTE C, 1995, J CELL BIOL, V128, P1111, DOI 10.1083/jcb.128.6.1111; Roychowdhury S, 1999, J BIOL CHEM, V274, P13485, DOI 10.1074/jbc.274.19.13485; Roychowdhury S, 1997, J BIOL CHEM, V272, P31576, DOI 10.1074/jbc.272.50.31576; Saini DK, 2009, TRENDS PHARMACOL SCI, V30, P278, DOI 10.1016/j.tips.2009.04.001; Sarma T, 2003, FASEB J, V17, P848, DOI 10.1096/fj.02-0730com; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Vilardaga JP, 2012, TRENDS PHARMACOL SCI, V33, P423, DOI 10.1016/j.tips.2012.05.004; WANG N, 1990, J BIOL CHEM, V265, P1239; Wedegaertner PB, 1996, MOL BIOL CELL, V7, P1225, DOI 10.1091/mbc.7.8.1225; Witte H, 2008, CURR OPIN NEUROBIOL, V18, P479, DOI 10.1016/j.conb.2008.09.019; Wolfgang WJ, 2004, DEV BIOL, V268, P295, DOI 10.1016/j.ydbio.2004.01.007; Yu JZ, 2009, J BIOL CHEM, V284, P10462, DOI 10.1074/jbc.M809166200; Yu JZ, 2002, MOL PHARMACOL, V61, P352, DOI 10.1124/mol.61.2.352	45	23	23	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10045	10056		10.1074/jbc.M114.630632	http://dx.doi.org/10.1074/jbc.M114.630632			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25691569	hybrid, Green Published			2022-12-26	WOS:000353241100012
J	Khanna, RS; Le, HT; Wang, J; Fung, TCH; Pallen, CJ				Khanna, Ranvikram S.; Le, Hoa T.; Wang, Jing; Fung, Thomas C. H.; Pallen, Catherine J.			The Interaction of Protein-tyrosine Phosphatase alpha (PTP alpha) and RACK1 Protein Enables Insulin-like Growth Factor 1 (IGF-1)-stimulated Abl-dependent and -independent Tyrosine Phosphorylation of PTP alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; IGF-I RECEPTOR; BREAST-CANCER CELLS; SCAFFOLDING PROTEIN; RPTP-ALPHA; FAMILY KINASES; BETA-SUBUNIT; C-ABL; MIGRATION; EXPRESSION	Protein tyrosine phosphatase alpha (PTP alpha) promotes integrinstimulated cell migration in part through the role of Src-phosphorylated PTP alpha-Tyr(P)-789 in recruiting and localizing p130Cas to focal adhesions. The growth factor IGF-1 also stimulatesPTP alpha-Tyr-789 phosphorylation to positively regulate cell movement. This is in contrast to integrin-induced PTP alpha phosphorylation, that induced by IGF-1 can occur in cells lacking Src family kinases (SFKs), indicating that an unknown kinase distinct from SFKs can target PTP alpha. We show that this IGF-1stimulated tyrosine kinase is Abl. We found that PTP alpha binds to the scaffold protein RACK1 and that RACK1 coordinates the IGF-1 receptor, PTP alpha, and Abl in a complex to enable IGF-1stimulated and Abl-dependent PTP alpha-Tyr-789 phosphorylation. In cells expressing SFKs, IGF-1-stimulated phosphorylation of PTP alpha is mediated by RACK1 but is Abl-independent. Furthermore, expressing the SFKs Src and Fyn in SFK-deficient cells switches IGF-1-induced PTP alpha phosphorylation to occur in an Abl-independent manner, suggesting that SFK activity dominantly regulates IGF-1/IGF-1 receptor signaling to PTP alpha. RACK1 is a molecular scaffold that integrates growth factor and integrin signaling, and our identification of PTP alpha as a RACK1 binding protein suggests that RACK1 may coordinate PTP alpha Tyr- 789 phosphorylation in these signaling networks to promote cell migration.	[Khanna, Ranvikram S.] Univ British Columbia, Dept Med, Vancouver, BC V5Z 4H4, Canada; [Le, Hoa T.; Wang, Jing; Pallen, Catherine J.] Univ British Columbia, Dept Pediat, Vancouver, BC V5Z 4H4, Canada; [Khanna, Ranvikram S.; Le, Hoa T.; Wang, Jing; Fung, Thomas C. H.; Pallen, Catherine J.] Univ British Columbia, Child & Family Res Inst, Vancouver, BC V5Z 4H4, Canada	University of British Columbia; University of British Columbia; Child & Family Research Institute; University of British Columbia	Pallen, CJ (corresponding author), Child & Family Res Inst, 3102-950 W 28th Ave, Vancouver, BC V5Z 4H4, Canada.	cpallen@mail.ubc.ca		Pallen, Catherine/0000-0002-3576-5295	Canadian Institutes of Health Research [MOP-49410]; Michael Cuccione Studentship; Michael Cuccione Fellowship; Child and Family Research Institute	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Cuccione Studentship; Michael Cuccione Fellowship; Child and Family Research Institute	This work was supported by Canadian Institutes of Health Research Grant MOP-49410 (to C. J. P.).r Recipient of a Michael Cuccione Studentship.r Recipient of a Michael Cuccione Fellowship.r Recipient of an investigator award from the Child and Family Research Institute.	Adams DR, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-22; Ardini E, 2000, ONCOGENE, V19, P4979, DOI 10.1038/sj.onc.1203869; Berndt A, 1999, HISTOCHEM CELL BIOL, V111, P399, DOI 10.1007/s004180050373; Bhandari V, 1998, J BIOL CHEM, V273, P8691, DOI 10.1074/jbc.273.15.8691; Boivin B, 2013, J BIOL CHEM, V288, P36926, DOI 10.1074/jbc.M113.527564; Brasher BB, 2000, J BIOL CHEM, V275, P35631, DOI 10.1074/jbc.M005401200; Chang BY, 1998, MOL CELL BIOL, V18, P3245, DOI 10.1128/MCB.18.6.3245; Chang BY, 2002, ONCOGENE, V21, P7619, DOI 10.1038/sj.onc.1206002; Chen M, 2006, J BIOL CHEM, V281, P11972, DOI 10.1074/jbc.M600561200; Chen SC, 2009, AM J PHYSIOL-CELL PH, V297, pC133, DOI 10.1152/ajpcell.00110.2009; Colicelli J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3139re6; Cox EA, 2003, MOL BIOL CELL, V14, P658, DOI 10.1091/mbc.E02-03-0142; FELLER SM, 1994, EMBO J, V13, P2341, DOI 10.1002/j.1460-2075.1994.tb06518.x; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; Gandin Valentina, 2013, Genes Cancer, V4, P369, DOI 10.1177/1947601913486348; Greuber EK, 2013, NAT REV CANCER, V13, P559, DOI 10.1038/nrc3563; Guvakova MA, 2007, INT J BIOCHEM CELL B, V39, P890, DOI 10.1016/j.biocel.2006.10.013; Hermanto U, 2002, MOL CELL BIOL, V22, P2345, DOI 10.1128/MCB.22.7.2345-2365.2002; JIA ZC, 1995, SCIENCE, V268, P1754, DOI 10.1126/science.7540771; Kiely PA, 2005, J BIOL CHEM, V280, P7624, DOI 10.1074/jbc.M412889200; Kiely PA, 2009, J BIOL CHEM, V284, P20263, DOI 10.1074/jbc.M109.017640; Krndija D, 2010, ONCOGENE, V29, P2724, DOI 10.1038/onc.2010.25; Lammers R, 2000, J BIOL CHEM, V275, P3391, DOI 10.1074/jbc.275.5.3391; LeRoith D, 2003, CANCER LETT, V195, P127, DOI 10.1016/S0304-3835(03)00159-9; Li JJ, 2015, ONCOGENE, V34, P1890, DOI 10.1038/onc.2014.127; Liliental J, 1998, J BIOL CHEM, V273, P2379, DOI 10.1074/jbc.273.4.2379; Liu L, 2008, ONCOGENE, V27, P4998, DOI 10.1038/onc.2008.137; McCahill A, 2002, MOL PHARMACOL, V62, P1261, DOI 10.1124/mol.62.6.1261; Mourton T, 2001, J BIOL CHEM, V276, P14896, DOI 10.1074/jbc.M010823200; Slack-Davis JK, 2007, J BIOL CHEM, V282, P14845, DOI 10.1074/jbc.M606695200; Srinivasan D, 2008, ONCOGENE, V27, P1095, DOI 10.1038/sj.onc.1210714; Srinivasan D, 2006, CANCER RES, V66, P5648, DOI 10.1158/0008-5472.CAN-06-0734; Su J, 1999, CURR BIOL, V9, P505, DOI 10.1016/S0960-9822(99)80234-6; Sun GB, 2012, MOL CELL BIOL, V32, P3776, DOI 10.1128/MCB.00214-12; TABITI K, 1995, CANCER LETT, V93, P239, DOI 10.1016/0304-3835(95)03816-F; Tanis KQ, 2003, MOL CELL BIOL, V23, P3884, DOI 10.1128/MCB.23.11.3884-3896.2003; TENHOEVE J, 1994, CANCER RES, V54, P2563; von Wichert G, 2003, J CELL BIOL, V161, P143, DOI 10.1083/jcb.200211061; Wu CW, 2006, CANCER LETT, V242, P95, DOI 10.1016/j.canlet.2005.10.046; Yaka R, 2002, P NATL ACAD SCI USA, V99, P5710, DOI 10.1073/pnas.062046299; Zeng L, 2003, J CELL BIOL, V160, P137, DOI 10.1083/jcb.200206049	41	6	6	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9886	9895		10.1074/jbc.M114.624247	http://dx.doi.org/10.1074/jbc.M114.624247			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25694432	Green Published, hybrid			2022-12-26	WOS:000352729400047
J	Wongnate, T; Ragsdale, SW				Wongnate, Thanyaporn; Ragsdale, Stephen W.			The Reaction Mechanism of Methyl-Coenzyme M Reductase HOW AN ENZYME ENFORCES STRICT BINDING ORDER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOLOGICAL METHANE FORMATION; METHANOBACTERIUM-THERMOAUTOTROPHICUM; METHANOGENIC ARCHAEA; ANAEROBIC OXIDATION; ALKYL-NICKEL; METHYLREDUCTASE SYSTEM; TITANIUM(III) CITRATE; COMPONENT-C; NI; ACTIVATION	Methyl-coenzyme M reductase (MCR) is a nickel tetrahydro-corphinoid (coenzyme F430) containing enzyme involved in the biological synthesis and anaerobic oxidation of methane. MCR catalyzes the conversion of methyl-2-mercaptoethanesulfonate (methyl-SCoM) and N-7-mercaptoheptanoylthreonine phosphate (CoB7SH) to CH, and the mixed disulfide CoBS-SCoM. In this study, the reaction of MCR from Methanothermobacter marburgensis, with its native substrates was investigated using static binding, chemical quench, and stopped-flow techniques. Rate constants were measured for each step in this strictly ordered ternary complex catalytic mechanism. Surprisingly, in the absence of the other substrate, MCR can bind either substrate; however, only one binary complex (MCR center dot methyl-SCoM) is productive whereas the other (MCR center dot CoB7SH) is inhibitory. Moreover, the kinetic data demonstrate that binding of methyl-SCoM to the inhibitory NICR center dot CoB7SH complex is highly disfavored (K-d = 56 mm). However, binding of CoB7SH to the productive MCR center dot methyl-SCoM complex to form the active ternary complex (CoB7SH.MCR(Ni-1)center dot CH3SCoM) is highly favored (K-d = 79 mu m). Only then can the, chemical reaction occur (k(obs) = 20 s(-1) at 25 degrees C), leading to rapid formation and dissociation of CH4 leaving the binary product complex (MCR(Ni-II)center dot CoB7S-center dot SCoM), which undergoes electron transfer to regenerate Ni(I) and the final product CoBS-SCoM. This first rapid kinetics study of MCR with its natural substrates describes how an enzyme can enforce a strictly ordered ternary complex mechanism and serves as a template for identification of the reaction intermediates.	[Wongnate, Thanyaporn; Ragsdale, Stephen W.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Ragsdale, SW (corresponding author), Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA.	sragsdal@umich.edu			U.S. Dept. of Energy, Office of Science, Office of Basic Energy Sciences [DE-FG02-08ER15931]	U.S. Dept. of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	This work was supported by the U.S. Dept. of Energy, Office of Science, Office of Basic Energy Sciences Award DE-FG02-08ER15931.	Becker DF, 1998, BIOCHEMISTRY-US, V37, P2639, DOI 10.1021/bi972145x; BOBIK TA, 1988, P NATL ACAD SCI USA, V85, P60, DOI 10.1073/pnas.85.1.60; BONACKER LG, 1993, EUR J BIOCHEM, V217, P587, DOI 10.1111/j.1432-1033.1993.tb18281.x; Cedervall PE, 2011, J AM CHEM SOC, V133, P5626, DOI 10.1021/ja110492p; Cedervall PE, 2010, BIOCHEMISTRY-US, V49, P7683, DOI 10.1021/bi100458d; Chen SL, 2012, CHEM-EUR J, V18, P6309, DOI 10.1002/chem.201200274; Chen SL, 2009, J AM CHEM SOC, V131, P9912, DOI 10.1021/ja904301f; Dey M, 2007, BIOCHEMISTRY-US, V46, P11969, DOI 10.1021/bi700925n; Dey M, 2007, J AM CHEM SOC, V129, P11030, DOI 10.1021/ja074556z; Dey M, 2010, BIOCHEMISTRY-US, V49, P10902, DOI 10.1021/bi101562m; DIMARCO AA, 1990, ANNU REV BIOCHEM, V59, P355, DOI 10.1146/annurev.biochem.59.1.355; Ebner S, 2010, J AM CHEM SOC, V132, P567, DOI 10.1021/ja906367h; ELLEFSON WL, 1981, J BIOL CHEM, V256, P4259; ELLERMANN J, 1988, EUR J BIOCHEM, V172, P669, DOI 10.1111/j.1432-1033.1988.tb13941.x; Ermler U, 2005, DALTON T, P3451, DOI 10.1039/b506697b; Ermler U, 1997, SCIENCE, V278, P1457, DOI 10.1126/science.278.5342.1457; Goenrich M, 2005, J BIOL INORG CHEM, V10, P333, DOI 10.1007/s00775-005-0636-6; Goenrich M, 2004, J BIOL INORG CHEM, V9, P691, DOI 10.1007/s00775-004-0552-1; Goubeaud M, 1997, EUR J BIOCHEM, V243, P110, DOI 10.1111/j.1432-1033.1997.00110.x; Grabarse W, 2001, J MOL BIOL, V309, P315, DOI 10.1006/jmbi.2001.4647; Grabarse WG, 2000, J MOL BIOL, V303, P329, DOI 10.1006/jmbi.2000.4136; GUNSALUS RP, 1978, BIOCHEMISTRY-US, V17, P2374, DOI 10.1021/bi00605a019; Horng YC, 2001, BIOCHEMISTRY-US, V40, P12875, DOI 10.1021/bi011196y; Kunz RC, 2008, BIOCHEMISTRY-US, V47, P2661, DOI 10.1021/bi701942w; Kunz RC, 2006, J BIOL CHEM, V281, P34663, DOI 10.1074/jbc.M606715200; LAHIRI GK, 1993, INORG CHEM, V32, P4409, DOI 10.1021/ic00072a041; Li XH, 2010, BIOCHEMISTRY-US, V49, P6866, DOI 10.1021/bi100650m; Mahlert F, 2002, J BIOL INORG CHEM, V7, P500, DOI 10.1007/s00775-001-0325-z; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; NOLL KM, 1987, J BIOL CHEM, V262, P513; Pelmenschikov V, 2003, J BIOL INORG CHEM, V8, P653, DOI 10.1007/s00775-003-0461-8; Pelmenschikov V, 2002, J AM CHEM SOC, V124, P4039, DOI 10.1021/ja011664r; Prakash D, 2014, J BACTERIOL, V196, P2491, DOI 10.1128/JB.01658-14; Scheller S, 2013, J AM CHEM SOC, V135, P14985, DOI 10.1021/ja4064876; Scheller S, 2013, J AM CHEM SOC, V135, P14975, DOI 10.1021/ja406485z; Scheller S, 2010, ANGEW CHEM INT EDIT, V49, P8112, DOI 10.1002/anie.201003214; Scheller S, 2010, NATURE, V465, P606, DOI 10.1038/nature09015; Shima S, 2005, CURR OPIN MICROBIOL, V8, P643, DOI 10.1016/j.mib.2005.10.002; Signor L, 2000, CHEM-EUR J, V6, P3508, DOI 10.1002/1521-3765(20001002)6:19<3508::AID-CHEM3508>3.3.CO;2-N; Thauer RK, 1998, MICROBIOL-UK, V144, P2377, DOI 10.1099/00221287-144-9-2377; Yang N, 2007, J AM CHEM SOC, V129, P11028, DOI 10.1021/ja0734501; ZEHNDER AJB, 1976, SCIENCE, V194, P1165, DOI 10.1126/science.793008; Zhou YZ, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00069	43	37	36	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9322	9334		10.1074/jbc.M115.636761	http://dx.doi.org/10.1074/jbc.M115.636761			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25691570	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000352729400002
J	Diamond, MI; Cai, SR; Boudreau, A; Carey, CJ; Lyle, N; Pappu, RV; Swamidass, SJ; Bissell, M; Piwnica-Worms, H; Shao, J				Diamond, Marc I.; Cai, Shirong; Boudreau, Aaron; Carey, Clifton J., Jr.; Lyle, Nicholas; Pappu, Rohit V.; Swamidass, S. Joshua; Bissell, Mina; Piwnica-Worms, Helen; Shao, Jieya			Subcellular Localization and Ser-137 Phosphorylation Regulate Tumor-suppressive Activity of Profilin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; PANCREATIC-CANCER; NUCLEAR ACTIN; IN-VITRO; APOPTOSIS; PROLIFERATION; CARCINOMA; TUMORIGENICITY; STAUROSPORINE; TRANSCRIPTION	The actin-binding protein profilin-1 (Pfn1) inhibits tumor growth and yet is also required for cell proliferation and survival, an apparent paradox. We previously identified Ser-137 of Pfn1 as a phosphorylation site within the poly-L-proline (PLP) binding pocket. Here we confirm that Ser-137 phosphorylation disrupts Pfn1 binding to its PLP-containing ligands with little effect on actin binding. We find in mouse xenografts of breast cancer cells that mimicking Ser-137 phosphorylation abolishes cell cycle arrest and apoptotic sensitization by Pfn1 and confers a growth advantage to tumors. This indicates a previously unrecognized role of PLP binding in Pfn1 antitumor effects. Spatial restriction of Pfn1 to the nucleus or cytoplasm indicates that inhibition of tumor cell growth by Pfn1 requires its nuclear localization, and this activity is abolished by a phosphomimetic mutation on Ser-137. In contrast, cytoplasmic Pfn1 lacks inhibitory effects on tumor cell growth but rescues morphological and proliferative defects of PFN1 null mouse chondrocytes. These results help reconcile seemingly opposed cellular effects of Pfn1, provide new insights into the antitumor mechanism of Pfn1, and implicate Ser-137 phosphorylation as a potential therapeutic target for breast cancer.	[Diamond, Marc I.] Univ Texas SW Med Ctr Dallas, Ctr Alzheimers & Neurodegenerat Dis, Dallas, TX 75390 USA; [Cai, Shirong; Piwnica-Worms, Helen] Washington Univ, Dept Cell Biol & Physiol, Sch Med, St Louis, MO 63110 USA; [Cai, Shirong; Piwnica-Worms, Helen] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77230 USA; [Boudreau, Aaron] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Dept Lab Med, San Francisco, CA 94143 USA; [Carey, Clifton J., Jr.; Swamidass, S. Joshua] Washington Univ, Sch Med, Dept Pathol & Immunol, Div Lab & Genom Med, St Louis, MO 63110 USA; [Lyle, Nicholas; Pappu, Rohit V.] Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA; [Bissell, Mina] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Shao, Jieya] Washington Univ, Sch Med, Dept Internal Med, Breast Oncol Program,Div Oncol, St Louis, MO 63110 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Washington University (WUSTL); University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Washington University (WUSTL); Washington University (WUSTL); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Washington University (WUSTL)	Shao, J (corresponding author), Washington Univ, Sch Med, Dept Internal Med, Breast Oncol Program,Div Oncol, 660 S Euclid Ave,Campus Box 8069, St Louis, MO 63110 USA.	jshao1@dom.wustl.edu	Swamidass, Sanjay Joshua/H-3331-2019; Piwnica-Worms, Helen/C-5214-2012	Swamidass, Sanjay Joshua/0000-0003-2191-0778; 	Neuroscience Blueprint Core National Institutes of Health [P30 NS057105]; National Institutes of Health Grant NCI Cancer Center Support Grant [P30 CA91842]; National Institutes of Health [P50 CA94056]; P30 Neuroscience Blueprint Interdisciplinary Center [P30 NS057105]; Children's Discovery Institute; NATIONAL CANCER INSTITUTE [P30CA091842, R01CA131226, R01CA140663, U54CA112970, P50CA094056, R37CA064786, U01CA143233, U54CA143836, R01CA057621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050284, P30NS057105, R01NS056114] Funding Source: NIH RePORTER	Neuroscience Blueprint Core National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Grant NCI Cancer Center Support Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); P30 Neuroscience Blueprint Interdisciplinary Center; Children's Discovery Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. Byron Hann for the MDA-MB-231 cell line stably expressing the tri-modal reporter fusion, Dr. Ralph T Bottcher and Dr. Reinhard Fassler for providing the PFN1 null chondrocytes, Dr. Eric Campeau for the pLenti-CMV/TO-Neo-DEST (685-3) destination vector, Dr. Sofia Origanti for scientific advice, Dr. Mingjie Li and Nada Husic for assisting in lentiviral production, Dr. William Eades for assistance with flow cytometry and analysis, Gary London and Dr. Kris Hyrc for assistance with confocal and whole-slide imaging, and Dr. Dyche Mullins and Dr. Brad Zuchero for the PLP-conjugated Sepharose beads. The Hope Center Viral Vectors Core is supported by Neuroscience Blueprint Core National Institutes of Health Grant P30 NS057105 (to Washington University). The Siteman Cancer Center is supported in part by National Institutes of Health Grant NCI Cancer Center Support Grant P30 CA91842. The Molecular Imaging Center is supported in part by National Institutes of Health P50 CA94056 (to Washington University). The Hope Center Alafi Neuroimaging Core is supported by a P30 Neuroscience Blueprint Interdisciplinary Center Core award to Washington University (P30 NS057105). The RNAi consortium at the Genome Institute of Washington University is supported by the Children's Discovery Institute.	Bae YH, 2009, J CELL PHYSIOL, V219, P354, DOI 10.1002/jcp.21677; BALASUBRAMANIAN MK, 1994, J CELL BIOL, V125, P1289, DOI 10.1083/jcb.125.6.1289; Birbach A, 2008, BIOESSAYS, V30, P994, DOI 10.1002/bies.20822; Bottcher RT, 2009, EMBO J, V28, P1157, DOI 10.1038/emboj.2009.58; BOUSQUET PF, 1990, CANCER RES, V50, P1431; Cheng H, 2013, CURR MOL MED, V13, P1368, DOI 10.2174/15665240113139990060; Ding ZJ, 2006, J CELL SCI, V119, P4127, DOI 10.1242/jcs.03178; Fan Y, 2014, NAT CELL BIOL, V16, P445, DOI 10.1038/ncb2954; Fan YH, 2012, SOL PHYS, V277, P1, DOI 10.1007/s11207-011-9913-4; Feng Yunfeng, 2010, Genomics Proteomics & Bioinformatics, V8, P238, DOI 10.1016/S1672-0229(10)60025-3; Giesemann T, 1999, J BIOL CHEM, V274, P37908, DOI 10.1074/jbc.274.53.37908; Gronborg M, 2006, MOL CELL PROTEOMICS, V5, P157, DOI 10.1074/mcp.M500178-MCP200; Harpen M, 2009, J VIROL, V83, P10869, DOI 10.1128/JVI.01271-09; Janke J, 2000, J EXP MED, V191, P1675, DOI 10.1084/jem.191.10.1675; Jockusch BM, 2007, REV PHYSIOL BIOCH P, V159, P131, DOI 10.1007/112_2007_704; Jockusch BM, 2006, TRENDS CELL BIOL, V16, P391, DOI 10.1016/j.tcb.2006.06.006; Lederer M, 2005, J CELL SCI, V118, P331, DOI 10.1242/jcs.01618; Odaka C, 2000, CLIN DIAGN LAB IMMUN, V7, P947, DOI 10.1128/CDLI.7.6.947-952.2000; Percipalle P, 2006, J CELL BIOL, V172, P967, DOI 10.1083/jcb.200512083; Ray P, 2007, CANCER RES, V67, P3085, DOI 10.1158/0008-5472.CAN-06-2402; Schluter K, 1997, BBA-MOL CELL RES, V1359, P97, DOI 10.1016/S0167-4889(97)00100-6; SENDEROWICZ AMJ, 1995, J NATL CANCER I, V87, P46, DOI 10.1093/jnci/87.1.46; Shao JY, 2008, MOL CELL BIOL, V28, P5196, DOI 10.1128/MCB.00079-08; Singh SS, 1996, RECEPT SIGNAL TRANS, V6, P77; Skare P, 2003, EXP CELL RES, V286, P12, DOI 10.1016/S0014-4827(03)00102-2; Soderberg E, 2012, NUCLEUS-PHILA, V3, P290, DOI 10.4161/nucl.20327; Spencer VA, 2011, J CELL SCI, V124, P123, DOI 10.1242/jcs.073197; Stehn JR, 2013, CANCER RES, V73, P5169, DOI 10.1158/0008-5472.CAN-12-4501; Stuven T, 2003, EMBO J, V22, P5928, DOI 10.1093/emboj/cdg565; TAKASUKA T, 1987, EXP CELL RES, V173, P287, DOI 10.1016/0014-4827(87)90355-7; VERHEYEN EM, 1994, DEVELOPMENT, V120, P717; Witke W, 2004, TRENDS CELL BIOL, V14, P461, DOI 10.1016/j.tcb.2004.07.003; Witke W, 2001, P NATL ACAD SCI USA, V98, P3832, DOI 10.1073/pnas.051515498; Wittenmayer N, 2004, MOL BIOL CELL, V15, P1600, DOI 10.1091/mbc.E03-12-0873; Wu N, 2006, PROTEOMICS, V6, P6095, DOI 10.1002/pmic.200500321; Yao W, 2013, CURR MOL MED, V13, P417; Yao WT, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-187; Yao WT, 2012, J CELL MOL MED, V16, P824, DOI 10.1111/j.1582-4934.2011.01369.x; Zheng B, 2009, FEBS J, V276, P2669, DOI 10.1111/j.1742-4658.2009.06986.x; Zoidakis J, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.009449; Zou L, 2007, BRIT J CANCER, V97, P1361, DOI 10.1038/sj.bjc.6604038; Zou L, 2010, J CELL PHYSIOL, V223, P623, DOI 10.1002/jcp.22058	42	18	19	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					9075	9086		10.1074/jbc.M114.619874	http://dx.doi.org/10.1074/jbc.M114.619874			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25681442	Green Published, hybrid			2022-12-26	WOS:000352207100031
J	Ding, Y; Uchida, K; Aizawa, SI; Murphy, K; Berezuk, A; Khursigara, CM; Chong, JPJ; Jarrell, KF				Ding, Yan; Uchida, Kaoru; Aizawa, Shin-Ichi; Murphy, Kathleen; Berezuk, Alison; Khursigara, Cezar M.; Chong, James P. J.; Jarrell, Ken F.			Effects of N-Glycosylation Site Removal in Archaellins on the Assembly and Function of Archaella in Methanococcus maripaludis	PLOS ONE			English	Article							S-LAYER GLYCOPROTEIN; LINKED PROTEIN GLYCOSYLATION; FLAGELLIN GLYCOSYLATION; HELICOBACTER-PYLORI; AMINO-ACIDS; IV PILIN; IDENTIFICATION; GENES; BIOSYNTHESIS; GLYCAN	In Methanococcus maripaludis S2, the swimming organelle, the archaellum, is composed of three archaellins, FlaB1(S2), FlaB2(S2) and FlaB3(S2). All three are modified with an N-linked tetrasaccharide at multiple sites. Disruption of the N-linked glycosylation pathway is known to cause defects in archaella assembly or function. Here, we explored the potential requirement of N-glycosylation of archaellins on archaellation by investigating the effects of eliminating the 4 N-glycosylation sites in the wildtype FlaB2(S2) protein in all possible combinations either by Asn to Glu (N to Q) substitution or Asn to Asp (N to D) substitutions of the N-glycosylation sequon asparagine. The ability of these mutant derivatives to complement a non-archaellated Delta flaB2(S2) strain was examined by electron microscopy (for archaella assembly) and swarm plates (for analysis of swimming). Western blot results showed that all mutated FlaB2(S2) proteins were expressed and of smaller apparent molecular mass compared to wildtype FlaB2(S2), consistent with the loss of glycosylation sites. In the 8 single-site mutant complements, archaella were observed on the surface of Q2, D2 and D4 (numbers after N or Q refer to the 1st to 4th glycosylation site). Of the 6 double-site mutation complementations all were archaellated except D1,3. Of the 4 triple-site mutation complements, only D2,3,4 was archaellated. Elimination of all 4 N-glycosylation sites resulted in non-archaellated cells, indicating some minimum amount of archaellin glycosylation was necessary for their incorporation into stable archaella. All complementations that led to a return of archaella also resulted in motile cells with the exception of the D4 version. In addition, a series of FlaB2(S2) scanning deletions each missing 10 amino acids was also generated and tested for their ability to complement the Delta flaB2(S2) strain. While most variants were expressed, none of them restored archaellation, although FlaB2(S2) harbouring a smaller 3-amino acid deletion was able to partially restore archaellation.	[Ding, Yan; Jarrell, Ken F.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Uchida, Kaoru; Aizawa, Shin-Ichi] Prefectural Univ Hiroshima, Dept Life Sci, Shobara, Hiroshima, Japan; [Murphy, Kathleen; Berezuk, Alison; Khursigara, Cezar M.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Chong, James P. J.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England	Queens University - Canada; University of Guelph; University of York - UK	Jarrell, KF (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.	jarrellk@queensu.ca	Chong, James/AAC-4957-2019	Aizawa, Shin-Ichi/0000-0002-9068-0825; Chong, James/0000-0001-9447-7421	Natural Sciences and Engineering Research Council of Canada (NSERC); Biotechnology and Biological Sciences Research Council (BBSRC); China Scholarship Council [20100622028]; Leverhulme Trust; BBSRC [BB/K006630/1, BB/F003099/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F003099/1, BB/K006630/1] Funding Source: researchfish	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); China Scholarship Council(China Scholarship Council); Leverhulme Trust(Leverhulme Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work is supported by grants from the Natural Sciences and Engineering Research Council of Canada (NSERC) to K.F.J. and C.M.K. and Biotechnology and Biological Sciences Research Council (BBSRC) to J.P.J.C. K.F.J. was the recipient of a Leverhulme Trust Visiting Professorship. Y.D. thanks the China Scholarship Council (20100622028) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Qarn M, 2007, J MOL BIOL, V374, P1224, DOI 10.1016/j.jmb.2007.10.042; Abu-Qarn M, 2006, MOL MICROBIOL, V61, P511, DOI 10.1111/j.1365-2958.2006.05252.x; Aebi M, 2013, BBA-MOL CELL RES, V1833, P2430, DOI 10.1016/j.bbamcr.2013.04.001; Albers SV, 2003, J BACTERIOL, V185, P3918, DOI 10.1128/JB.185.13.3918-3925.2003; Asakura H, 2010, MOL MICROBIOL, V78, P1130, DOI 10.1111/j.1365-2958.2010.07393.x; BALCH WE, 1979, MICROBIOL REV, V43, P260, DOI 10.1128/MMBR.43.2.260-296.1979; Bardy SL, 2003, MOL MICROBIOL, V50, P1339, DOI 10.1046/j.1365-2958.2003.03758.x; Bardy SL, 2002, FEMS MICROBIOL LETT, V208, P53, DOI 10.1016/S0378-1097(01)00579-1; Beznosov SN, 2013, CENT EUR J BIOL, V8, P828, DOI 10.2478/s11535-013-0202-0; Burda P, 1999, BBA-GEN SUBJECTS, V1426, P239, DOI 10.1016/S0304-4165(98)00127-5; CASTRIC P, 1995, MICROBIOL-UK, V141, P1247, DOI 10.1099/13500872-141-5-1247; Chaban B, 2007, MOL MICROBIOL, V66, P596, DOI 10.1111/j.1365-2958.2007.05913.x; Chaban B, 2006, MOL MICROBIOL, V61, P259, DOI 10.1111/j.1365-2958.2006.05226.x; Cohen-Krausz S, 2002, J MOL BIOL, V321, P383, DOI 10.1016/S0022-2836(02)00616-2; CORDER RE, 1983, ARCH MICROBIOL, V134, P28, DOI 10.1007/BF00429402; Ding Y, 2013, J BACTERIOL, V195, P4094, DOI 10.1128/JB.00668-13; Dubuisson J, 2000, J BIOL CHEM, V275, P30605, DOI 10.1074/jbc.M004326200; Eichler J, 2013, NAT REV MICROBIOL, V11, P151, DOI 10.1038/nrmicro2957; Ewing CP, 2009, J BACTERIOL, V191, P7086, DOI 10.1128/JB.00378-09; Gardner WL, 1999, GENETICS, V152, P1439; Ghosh A, 2011, BIOCHEM SOC T, V39, P64, DOI 10.1042/BST0390064; Giltner CL, 2012, MICROBIOL MOL BIOL R, V76, P740, DOI 10.1128/MMBR.00035-12; Guan ZQ, 2012, ENVIRON MICROBIOL, V14, P743, DOI 10.1111/j.1462-2920.2011.02625.x; Harvey H, 2011, J BIOL CHEM, V286, P28128, DOI 10.1074/jbc.M111.255794; Jarrell KF, 2014, MICROBIOL MOL BIOL R, V78, P304, DOI 10.1128/MMBR.00052-13; Jarrell Ken F., 2013, Life-Basel, V3, P86, DOI 10.3390/life3010086; Jarrell KF, 2012, TRENDS MICROBIOL, V20, P307, DOI 10.1016/j.tim.2012.04.007; Jarrell KF, 2009, PILI AND FLAGELLA: CURRENT RESEARCH AND FUTURE TRENDS, P215; Jarrell KF, 2010, ARCHAEA, V2010, DOI 10.1155/2010/612948; Jones GM, 2012, J BACTERIOL, V194, P2693, DOI 10.1128/JB.06686-11; Josenhans C, 2002, FEMS MICROBIOL LETT, V210, P165, DOI 10.1016/S0378-1097(02)00638-9; KALMOKOFF ML, 1991, J BACTERIOL, V173, P7113, DOI 10.1128/jb.173.22.7113-7125.1991; Kaminski L, 2013, MOL PHYLOGENET EVOL, V68, P327, DOI 10.1016/j.ympev.2013.03.024; Kaminski L, 2013, BIOCHEM SOC T, V41, P432, DOI 10.1042/BST20120142; Kaminski L, 2010, J BACTERIOL, V192, P5572, DOI 10.1128/JB.00705-10; Kelly J, 2009, CARBOHYD RES, V344, P648, DOI 10.1016/j.carres.2009.01.006; Keswani J, 1996, INT J SYST BACTERIOL, V46, P727, DOI 10.1099/00207713-46-3-727; Kirn TJ, 2000, MOL MICROBIOL, V35, P896, DOI 10.1046/j.1365-2958.2000.01764.x; KUWAJIMA G, 1988, J BACTERIOL, V170, P3305, DOI 10.1128/jb.170.7.3305-3309.1988; Larkin A, 2011, BIOCHEMISTRY-US, V50, P4411, DOI 10.1021/bi200346n; Lassak K, 2012, RES MICROBIOL, V163, P630, DOI 10.1016/j.resmic.2012.10.024; Leigh JA, 2011, FEMS MICROBIOL REV, V35, P577, DOI 10.1111/j.1574-6976.2011.00265.x; Nguyen LC, 2012, MOL PLANT PATHOL, V13, P764, DOI 10.1111/j.1364-3703.2012.00789.x; Logan SM, 2006, MICROBIOL-SGM, V152, P1249, DOI 10.1099/mic.0.28735-0; Merino S, 2014, INT J MOL SCI, V15, P2840, DOI 10.3390/ijms15022840; Meyer BH, 2014, MICROBIOLOGYOPEN, V3, P531, DOI 10.1002/mbo3.185; Meyer BH, 2013, J BACTERIOL, V195, P2177, DOI 10.1128/JB.00035-13; Meyer BH, 2013, BIOCHEM SOC T, V41, P384, DOI 10.1042/BST20120296; Meyer BH, 2011, MOL MICROBIOL, V82, P1150, DOI 10.1111/j.1365-2958.2011.07875.x; Moore BC, 2005, J BACTERIOL, V187, P972, DOI 10.1128/JB.187.3.972-979.2005; Ng SYM, 2011, J BACTERIOL, V193, P804, DOI 10.1128/JB.00822-10; Nothaft H, 2012, MOL CELL PROTEOMICS, V11, P1203, DOI 10.1074/mcp.M112.021519; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; Paiment A, 2002, J BACTERIOL, V184, P6437, DOI 10.1128/JB.184.23.6437-6447.2002; Papworth C.B., 1996, STRATEGIES, V9, P3, DOI DOI 10.1080/08924562.1996.11000299; Peyfoon E, 2010, ARCHAEA, V2010, DOI 10.1155/2010/754101; Pohlschroder M, 2011, CURR OPIN MICROBIOL, V14, P357, DOI 10.1016/j.mib.2011.03.002; Schirm M, 2003, MOL MICROBIOL, V48, P1579, DOI 10.1046/j.1365-2958.2003.03527.x; Shahapure R, 2014, MOL MICROBIOL, V91, P716, DOI 10.1111/mmi.12486; Smedley JG, 2005, INFECT IMMUN, V73, P7922, DOI 10.1128/IAI.73.12.7922-7931.2005; Stocker B A, 1994, Int Rev Immunol, V11, P167, DOI 10.3109/08830189409061724; Taguchi F, 2006, CELL MICROBIOL, V8, P923, DOI 10.1111/j.1462-5822.2005.00674.x; Taguchi F, 2008, J BACTERIOL, V190, P764, DOI 10.1128/JB.01282-07; Thomas NA, 2001, ARCH MICROBIOL, V175, P263, DOI 10.1007/s002030100254; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Trachtenberg S, 2005, J MOL BIOL, V346, P665, DOI 10.1016/j.jmb.2004.12.010; Tripepi M, 2012, J BACTERIOL, V194, P4876, DOI 10.1128/JB.00731-12; Tripepi M, 2010, J BACTERIOL, V192, P3093, DOI 10.1128/JB.00133-10; TUMBULA DL, 1994, FEMS MICROBIOL LETT, V121, P309, DOI 10.1016/0378-1097(94)90309-3; VanDyke DJ, 2009, MOL MICROBIOL, V72, P633, DOI 10.1111/j.1365-2958.2009.06671.x; Voisin S, 2005, J BIOL CHEM, V280, P16586, DOI 10.1074/jbc.M500329200; Weerapana E, 2006, GLYCOBIOLOGY, V16, p91R, DOI 10.1093/glycob/cwj099; WIELAND F, 1985, J BIOL CHEM, V260, P5180; Wojczyk BS, 2005, GLYCOBIOLOGY, V15, P655, DOI 10.1093/glycob/cwi046; YAMAGUCHI K, 1991, J BIOL CHEM, V266, P20434; Yang Z, 2011, MICROBIOL-SGM, V157, P1920, DOI 10.1099/mic.0.049684-0; Yurist-Doutsch S, 2008, MOL MICROBIOL, V69, P1234, DOI 10.1111/j.1365-2958.2008.06352.x; Yurist-Doutsch S, 2010, MOL MICROBIOL, V75, P1047, DOI 10.1111/j.1365-2958.2009.07045.x	78	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0116402	10.1371/journal.pone.0116402	http://dx.doi.org/10.1371/journal.pone.0116402			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25700084	gold, Green Published, Green Accepted			2022-12-26	WOS:000349789800009
J	Aggarwal, AN; Gupta, D; Agarwal, R; Sethi, S; Thakur, JS; Anjinappa, SM; Chadha, VK; Kumar, R; Sharma, M; Behera, D; Jindal, SK				Aggarwal, Ashutosh N.; Gupta, Dheeraj; Agarwal, Ritesh; Sethi, Sunil; Thakur, Jarnail S.; Anjinappa, Sharada M.; Chadha, Vineet K.; Kumar, Rajesh; Sharma, Meera; Behera, Digambar; Jindal, Surinder K.			Prevalence of Pulmonary Tuberculosis among Adults in a North Indian District	PLOS ONE			English	Article								Background Recent population prevalence estimates of pulmonary tuberculosis (PTB) are not available for several areas in India. We conducted a field-based population survey at a north Indian district to estimate point prevalence of bacteriologically positive PTB. Methods A stratified cluster sampling design was used to conduct the survey in both urban and rural areas within the district. All adults aged more than 15 years, in 18 rural and 12 urban clusters of 3000 subjects each, were interviewed using a symptom card. Two sputum samples were collected from all persons having symptoms suggestive of PTB, or history of antitubercular treatment, for smear microscopy for acid-fast bacilli and mycobacterial culture. Those having at least one sputum specimen positive on microscopy and/or culture were categorized as having PTB. Prevalence was estimated after adjusting for cluster sampling and incomplete data (through individual level analysis with robust standard error). Results Of 91,030 eligible adult participants (47,714 men and 43,316 women), 85,770 (94.2%) completed the symptom cards. Of them, 2,898 persons were considered eligible for sputum examination and 2,839 (98.0%) provided at least one sample. Overall, 21 persons had bacteriologically positive PTB, and cluster level prevalence was estimated at 24.5 per 100,000 population (95% CI 12.8-36.2). Individual level analysis with robust standard error yielded a prevalence estimate of 24.1 per 100,000 populations (95% CI 12.8-35.4). Conclusion The observed prevalence of bacteriologically positive PTB in this district is lower than empiric national estimates, probably as a result of successful implementation of tuberculosis control measures in the area.	[Aggarwal, Ashutosh N.; Gupta, Dheeraj; Agarwal, Ritesh; Behera, Digambar; Jindal, Surinder K.] Postgrad Inst Med Educ & Res, Dept Pulm Med, Chandigarh 160012, India; [Sethi, Sunil; Sharma, Meera] Postgrad Inst Med Educ & Res, Dept Med Microbiol, Chandigarh 160012, India; [Thakur, Jarnail S.; Kumar, Rajesh] Postgrad Inst Med Educ & Res, Sch Publ Hlth, Chandigarh 160012, India; [Anjinappa, Sharada M.; Chadha, Vineet K.] Natl TB Inst, Epidemiol & Res Div, Bangalore, Karnataka, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Gupta, D (corresponding author), Postgrad Inst Med Educ & Res, Dept Pulm Med, Chandigarh 160012, India.	dheeraj1910@gmail.com	Agarwal, Ritesh/A-3063-2009	Agarwal, Ritesh/0000-0003-2547-7668	Central TB Division, Ministry of Health, Government of India	Central TB Division, Ministry of Health, Government of India	The study was funded by the Central TB Division, Ministry of Health, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal A N, 2006, Indian J Chest Dis Allied Sci, V48, P13; [Anonymous], 2005, MIN EXP COMM M EST T; [Anonymous], 2013, 2013 WHO; Central TB Division, 2013, REV TUB CONTR PROGR; Chadha VK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042625; Gopi PG, 2005, INDIAN J MED RES, V122, P243; Indian Council of Medical Research, 1959, ICMR SPEC REP SER, V34; *INT I POP SCI, 2007, NFHS3 INT I POP SCI, V1; Rao VG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043225; Subramani R, 2008, INT J TUBERC LUNG D, V12, P916; Vestal A, 1975, US PHS7682301 CTR DI, P97	11	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0117363	10.1371/journal.pone.0117363	http://dx.doi.org/10.1371/journal.pone.0117363			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695761	Green Published, gold, Green Submitted			2022-12-26	WOS:000350062300022
J	Cabezas, A; Ribeiro, JM; Rodrigues, JR; Lopez-Villamizar, I; Fernandez, A; Canales, J; Pinto, RM; Costas, MJ; Cameselle, JC				Cabezas, Alicia; Meireles Ribeiro, Joao; Rodrigues, Joaquim Rui; Lopez-Villamizar, Iralis; Fernandez, Ascension; Canales, Jose; Maria Pinto, Rosa; Jesus Costas, Maria; Carlos Cameselle, Jose			Molecular Bases of Catalysis and ADP-Ribose Preference of Human Mn2+-Dependent ADP-Ribose/CDP-Alcohol Diphosphatase and Conversion by Mutagenesis to a Preferential Cyclic ADP-Ribose Phosphohydrolase	PLOS ONE			English	Article							LINEAR CONSTRAINT SOLVER; STRUCTURAL BASIS; NUCLEOTIDE PHOSPHODIESTERASE; CYCLASE ACTIVITY; HUMAN PLACENTA; IMMUNE-SYSTEM; ANTIGEN CD38; PROTEIN; HYDROLYSIS; PYROPHOSPHATASE	Among metallo-dependent phosphatases, ADP-ribose/CDP-alcohol diphosphatases form a protein family (ADPRibase-Mn-like) mainly restricted, in eukaryotes, to vertebrates and plants, with preferential expression, at least in rodents, in immune cells. Rat and zebrafish ADPRibase-Mn, the only biochemically studied, are phosphohydrolases of ADP-ribose and, somewhat less efficiently, of CDP-alcohols and 2', 3'-cAMP. Furthermore, the rat but not the zebrafish enzyme displays a unique phosphohydrolytic activity on cyclic ADP-ribose. The molecular basis of such specificity is unknown. Human ADPRibase-Mn showed similar activities, including cyclic ADP-ribose phosphohydrolase, which seems thus common to mammalian ADPRibase-Mn. Substrate docking on a homology model of human ADPRibase-Mn suggested possible interactions of ADP-ribose with seven residues located, with one exception (Cys(253)), either within the metallo-dependent phosphatases signature (Gln(27), Asn(110), His(111)), or in unique structural regions of the ADPRibase-Mn family: s2s3 (Phe(37) and Arg(43)) and h7h8 (Phe(210)), around the active site entrance. Mutants were constructed, and kinetic parameters for ADP-ribose, CDP-choline, 2', 3'-cAMP and cyclic ADP-ribose were determined. Phe(37) was needed for ADP-ribose preference without catalytic effect, as indicated by the increased ADP-ribose K-m and unchanged k(cat) of F37A-ADPRibase-Mn, while the K-m values for the other substrates were little affected. Arg(43) was essential for catalysis as indicated by the drastic efficiency loss shown by R43A-ADPRibase-Mn. Unexpectedly, Cys(253) was hindering for cADPR phosphohydrolase, as indicated by the specific tenfold gain of efficiency of C253A-ADPRibase-Mn with cyclic ADP-ribose. This allowed the design of a triple mutant (F37A+L196F+C253A) for which cyclic ADP-ribose was the best substrate, with a catalytic efficiency of 3.5'10(4) M(-1)s(-1) versus 4'10(3) M(-1)s(-1) of the wild type.	[Cabezas, Alicia; Meireles Ribeiro, Joao; Lopez-Villamizar, Iralis; Fernandez, Ascension; Canales, Jose; Maria Pinto, Rosa; Jesus Costas, Maria; Carlos Cameselle, Jose] Univ Extremadura, Fac Med, Grp Enzimol, Dept Bioquim & Biol Mol & Genet, Badajoz, Spain; [Rodrigues, Joaquim Rui] Inst Politecn Leiria, Escola Super Tecnol & Gestao, Leiria, Portugal	Universidad de Extremadura; Polytechnic Institute of Leiria; Polytechnic Institute of Porto	Cameselle, JC (corresponding author), Univ Extremadura, Fac Med, Grp Enzimol, Dept Bioquim & Biol Mol & Genet, Badajoz, Spain.	camselle@unex.es	Ribeiro, João Meireles/K-6555-2014; Rodrigues, Joaquim Rui/L-4137-2014; Canales, Jose/K-8793-2014; Cameselle, Jose Carlos/K-6421-2014; Pinto, Rosa M/K-6560-2014; Cabezas, Alicia/K-6564-2014; Costas, Maria Jesus/K-7394-2014	Ribeiro, João Meireles/0000-0002-6548-1402; Rodrigues, Joaquim Rui/0000-0002-9756-1124; Canales, Jose/0000-0002-7897-9832; Cameselle, Jose Carlos/0000-0003-0005-081X; Pinto, Rosa M/0000-0003-4594-8113; Cabezas, Alicia/0000-0002-2908-9147; Costas, Maria Jesus/0000-0001-8815-1839	Ministerio de Ciencia e Innovacion del Gobierno de Espana [BFU2009-07296]; Junta de Extremadura or Gobierno de Extremadura [GRU09135, GR10133]; Fondo Europeo de Desarrollo Regional; Fondo Social Europeo	Ministerio de Ciencia e Innovacion del Gobierno de Espana(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Extremadura or Gobierno de Extremadura; Fondo Europeo de Desarrollo Regional(European Commission); Fondo Social Europeo(European Social Fund (ESF)European Commission)	The work was supported by grants from the Ministerio de Ciencia e Innovacion del Gobierno de Espana (BFU2009-07296), and from the Junta de Extremadura or Gobierno de Extremadura (GRU09135, GR10133), cofinanced by Fondo Europeo de Desarrollo Regional and Fondo Social Europeo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Andreeva A, 2014, NUCLEIC ACIDS RES, V42, pD310, DOI 10.1093/nar/gkt1242; ASH DE, 1982, J BIOL CHEM, V257, P9261; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berthelier V, 1998, BIOCHEM J, V330, P1383, DOI 10.1042/bj3301383; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CANALES J, 1995, BBA-PROTEIN STRUCT M, V1246, P167, DOI 10.1016/0167-4838(94)00191-I; Canales J, 2008, BIOCHEM J, V413, P103, DOI 10.1042/BJ20071471; Canales J, 2009, FEBS LETT, V583, P1593, DOI 10.1016/j.febslet.2009.04.023; Carloto A, 2006, BBA-GEN SUBJECTS, V1760, P1545, DOI 10.1016/j.bbagen.2006.06.003; Clementi E, 1996, J BIOL CHEM, V271, P17739, DOI 10.1074/jbc.271.30.17739; De Flora A, 1997, INT J BIOCHEM CELL B, V29, P1149, DOI 10.1016/S1357-2725(97)00062-9; Egea PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034918; Fehrst A, 1998, STRUCTURE MECH PROTE; Ferrero E, 2014, FRONT BIOSCI-LANDMRK, V19, P986, DOI 10.2741/4262; Funhoff EG, 2005, FEBS J, V272, P2968, DOI 10.1111/j.1742-4658.2005.04686.x; GARCIADIAZ M, 1993, EUR J BIOCHEM, V213, P1139, DOI 10.1111/j.1432-1033.1993.tb17864.x; Gasser A, 2006, J BIOL CHEM, V281, P2489, DOI 10.1074/jbc.M506525200; Graeff R, 2009, J BIOL CHEM, V284, P27629, DOI 10.1074/jbc.M109.030965; GU QM, 1994, J AM CHEM SOC, V116, P7481, DOI 10.1021/ja00096a002; Guse AH, 2004, CURR MED CHEM, V11, P847, DOI 10.2174/0929867043455602; Guse AH, 2002, BIOCHEMISTRY-US, V41, P6744, DOI 10.1021/bi020171b; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; HIRATA Y, 1994, FEBS LETT, V356, P244, DOI 10.1016/0014-5793(94)01279-2; HOWARD M, 1993, SCIENCE, V262, P1056, DOI 10.1126/science.8235624; Huang XC, 2010, MOLECULES, V15, P8689, DOI 10.3390/molecules15128689; Hutton JJ, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-82; INAGEDA K, 1995, J BIOCHEM-TOKYO, V117, P125, DOI 10.1093/oxfordjournals.jbchem.a124698; Keppetipola Niroshika, 2008, J Biol Chem, V283, P30942, DOI 10.1074/jbc.M805064200; Khorana HG, 1961, ENZYMES, V5, P79; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; KIM H, 1993, SCIENCE, V261, P1330, DOI 10.1126/science.8395705; Kim YG, 2011, PROTEINS, V79, P1205, DOI 10.1002/prot.22954; Klabunde T, 1996, J MOL BIOL, V259, P737, DOI 10.1006/jmbi.1996.0354; Kolisek M, 2005, MOL CELL, V18, P61, DOI 10.1016/j.molcel.2005.02.033; Kuhn FJP, 2004, J BIOL CHEM, V279, P46431, DOI 10.1074/jbc.M407263200; Kukimoto I, 1996, EUR J BIOCHEM, V239, P177, DOI 10.1111/j.1432-1033.1996.0177u.x; LEE HC, 1991, CELL REGUL, V2, P203, DOI 10.1091/mbc.2.3.203; Lee HC, 2012, J BIOL CHEM, V287, P31633, DOI 10.1074/jbc.R112.349464; Liu Q, 2007, J BIOL CHEM, V282, P5853, DOI 10.1074/jbc.M609093200; Liu Q, 2009, J BIOL CHEM, V284, P27637, DOI 10.1074/jbc.M109.031005; Malavasi F, 2006, MOL MED, V12, P334, DOI 10.2119/2006-00094.Malavasi; Markley John L., 2009, Journal of Structural and Functional Genomics, V10, P165, DOI 10.1007/s10969-008-9057-4; Mertz P, 1997, J BIOL CHEM, V272, P21296, DOI 10.1074/jbc.272.34.21296; Mitic N, 2006, CHEM REV, V106, P3338, DOI 10.1021/cr050318f; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Moreau C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066247; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Ogunbayo OA, 2011, J BIOL CHEM, V286, P9136, DOI 10.1074/jbc.M110.202002; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Partida-Sanchez S, 2007, ADV EXP MED BIOL, V590, P171; Perraud AL, 2005, J BIOL CHEM, V280, P6138, DOI 10.1074/jbc.M411446200; Perraud AL, 2003, J BIOL CHEM, V278, P1794, DOI 10.1074/jbc.M205601200; Postigo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033534; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Rao F, 2010, BIOCHEM BIOPH RES CO, V398, P500, DOI 10.1016/j.bbrc.2010.06.107; RAZZELL WE, 1963, METHOD ENZYMOL, V6, P236, DOI 10.1016/0076-6879(63)06169-3; Ribeiro JM, 2001, BBA-GEN SUBJECTS, V1526, P86, DOI 10.1016/S0304-4165(01)00113-1; Richter W, 2002, PROTEINS, V46, P278, DOI 10.1002/prot.10049; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rodrigues JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042249; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sana TR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060840; Sanner MF, 2005, STRUCTURE, V13, P447, DOI 10.1016/j.str.2005.01.010; Shenoy AR, 2007, J MOL BIOL, V365, P211, DOI 10.1016/j.jmb.2006.10.005; Shrimp JH, 2014, J AM CHEM SOC, V136, P5656, DOI 10.1021/ja411046j; Shuto S, 2004, CURR MED CHEM, V11, P827, DOI 10.2174/0929867043455639; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sillitoe I, 2013, NUCLEIC ACIDS RES, V41, pD490, DOI 10.1093/nar/gks1211; Song EK, 2011, J BIOL CHEM, V286, P44480, DOI 10.1074/jbc.M111.307645; Swarbrick JM, 2014, CHEM COMMUN, V50, P2458, DOI 10.1039/c3cc49249d; Swingle MR, 2004, J BIOL CHEM, V279, P33992, DOI 10.1074/jbc.M402855200; TAKASAWA S, 1993, J BIOL CHEM, V268, P26052; Wu HM, 2010, NEW J CHEM, V34, P956, DOI 10.1039/b9nj00595a; Xu M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071212; Yu PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051028; Zha MW, 2006, J MOL BIOL, V364, P1021, DOI 10.1016/j.jmb.2006.09.078; ZHUO SQ, 1994, J BIOL CHEM, V269, P26234; ZOCCHI E, 1993, BIOCHEM BIOPH RES CO, V196, P1459, DOI 10.1006/bbrc.1993.2416	82	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118680	10.1371/journal.pone.0118680	http://dx.doi.org/10.1371/journal.pone.0118680			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692488	Green Published, gold, Green Submitted			2022-12-26	WOS:000350061500125
J	Jobsri, J; Allen, A; Rajagopal, D; Shipton, M; Kanyuka, K; Lomonossoff, GP; Ottensmeier, C; Diebold, SS; Stevenson, FK; Savelyeva, N				Jobsri, Jantipa; Allen, Alex; Rajagopal, Deepa; Shipton, Michael; Kanyuka, Kostya; Lomonossoff, George P.; Ottensmeier, Christian; Diebold, Sandra S.; Stevenson, Freda K.; Savelyeva, Natalia			Plant Virus Particles Carrying Tumour Antigen Activate TLR7 and Induce High Levels of Protective Antibody	PLOS ONE			English	Article							B-CELL LYMPHOMA; TOBACCO-MOSAIC-VIRUS; FOLLICULAR LYMPHOMA; CONJUGATE VACCINES; COAT PROTEIN; SELF-ANTIGEN; DNA VACCINES; IN-VIVO; VACCINATION; IMMUNITY	Induction of potent antibody is the goal of many vaccines targeted against infections or cancer. Modern vaccine designs that use virus-like particles (VLP) have shown efficacy for prophylactic vaccination against virus-associated cancer in the clinic. Here we used plant viral particles (PVP), which are structurally analogous to VLP, coupled to a weak idiotypic (Id) tumour antigen, as a conjugate vaccine to induce antibody against a murine B-cell malignancy. The Id-PVP vaccine incorporates a natural adjuvant, the viral ssRNA, which acts via TLR7. It induced potent protective anti-Id antibody responses in an in vivo mouse model, superior to the "gold standard" Id vaccine, with prevalence of the IgG2a isotype. Combination with alum further increased antibody levels and maintained the IgG2a bias. Engagement of TLR7 in vivo was followed by secretion of IFN-alpha by plasmacytoid dendritic cells and by activation of splenic CD11c(hi) conventional dendritic cells. The latter was apparent from up-regulation of co-stimulatory molecules and from secretion of a wide range of inflammatory cytokines and chemokines including the Th1-governing cytokine IL-12, in keeping with the IgG2a antibody isotype distribution. PVP conjugates are a novel cancer vaccine design, offering an attractive molecular form, similar to VLP, and providing T-cell help. In contrast to VLP, they also incorporate a safe "in-built" ssRNA adjuvant.	[Jobsri, Jantipa; Allen, Alex; Shipton, Michael; Ottensmeier, Christian; Stevenson, Freda K.; Savelyeva, Natalia] Univ Southampton, Fac Med, Canc Sci Unit, Southampton SO9 5NH, Hants, England; [Rajagopal, Deepa] Kings Coll London, Guys Hosp, Peter Gorer Dept Immunobiol, London, England; [Kanyuka, Kostya] Rothamsted Res, Plant Biol & Crop Sci Dept, Harpenden, Herts, England; [Lomonossoff, George P.] John Innes Ctr, Dept Biol Chem, Norwich, Norfolk, England	University of Southampton; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Savelyeva, N (corresponding author), Univ Southampton, Fac Med, Canc Sci Unit, Southampton SO9 5NH, Hants, England.	N.Savelyeva@soton.ac.uk	Ottensmeier, Christian H/E-8131-2012; Kanyuka, Kostya/F-9156-2016; Ottensmeier, Christian/ABE-9056-2020	Ottensmeier, Christian H/0000-0003-3619-1657; Kanyuka, Kostya/0000-0001-6324-4123; Ottensmeier, Christian/0000-0003-3619-1657; Stevenson, Freda/0000-0002-0933-5021; Shipton, Michael/0000-0002-3031-5447	Leukaemia Research Fund U.K in Southampton; Cancer Research U.K. at King's College, London (DR SSD); strategic programme grant [BB/J004561/1]; Biotechnology and Biological Sciences Research Council; John Innes Foundation; Biotechnology and Biological Sciences Research Council through the Institute Strategic Program; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005203, BBS/E/J/00000166] Funding Source: researchfish; Cancer Research UK [15951, 20613] Funding Source: researchfish; BBSRC [BBS/E/C/00005203] Funding Source: UKRI	Leukaemia Research Fund U.K in Southampton; Cancer Research U.K. at King's College, London (DR SSD); strategic programme grant; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); John Innes Foundation; Biotechnology and Biological Sciences Research Council through the Institute Strategic Program(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work was supported by The Leukaemia Research Fund U.K. (http:// leukaemialymphomaresearch.org.uk/) in Southampton (NS MS AA) and by Cancer Research U.K. (http://www.cancerresearchuk.org/) at King's College, London (DR SSD). At the John Innes Centre (GPL), funding was received from a strategic programme grant (BB/J004561/1) made by the Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk/home/home.aspx) and from the John Innes Foundation (http://www. johninnesfoundation.org.uk/). KK was supported by the Biotechnology and Biological Sciences Research Council through the Institute Strategic Program 20: 20 Wheat. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai WYZ, 2009, BLOOD, V113, P5743, DOI 10.1182/blood-2009-01-201988; Bachmann MF, 2010, NAT REV IMMUNOL, V10, P787, DOI 10.1038/nri2868; BARATOVA LA, 1992, VIROLOGY, V188, P175, DOI 10.1016/0042-6822(92)90747-D; BAULCOMBE D, 1984, PLANT PATHOL, V33, P361, DOI 10.1111/j.1365-3059.1984.tb01331.x; Bekeredjian-Ding IB, 2005, J IMMUNOL, V174, P4043, DOI 10.4049/jimmunol.174.7.4043; Bendandi M, 2010, ANN ONCOL, V21, P2420, DOI 10.1093/annonc/mdq256; Benvenuti F, 2001, GENE THER, V8, P1555, DOI 10.1038/sj.gt.3301546; Browne EP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002293; Byrd JC, 2013, NEW ENGL J MED, V369, P32, DOI 10.1056/NEJMoa1215637; Chackerian B, 2001, J CLIN INVEST, V108, P415, DOI 10.1172/JCI11849; Chackerian B, 2008, J IMMUNOL, V180, P5816, DOI 10.4049/jimmunol.180.9.5816; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Cruz SS, 1996, P NATL ACAD SCI USA, V93, P6286, DOI 10.1073/pnas.93.13.6286; Dalsgaard K, 1997, NAT BIOTECHNOL, V15, P248, DOI 10.1038/nbt0397-248; Davis RE, 2010, NATURE, V463, P88, DOI 10.1038/nature08638; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Edwards AD, 2003, EUR J IMMUNOL, V33, P827, DOI 10.1002/eji.200323797; GEORGE AJT, 1988, J IMMUNOL, V141, P2168; GEORGE AJT, 1987, J IMMUNOL, V138, P628; Gleba Y, 2005, VACCINE, V23, P2042, DOI 10.1016/j.vaccine.2005.01.006; Green NM, 2009, J IMMUNOL, V183, P1569, DOI 10.4049/jimmunol.0803899; Hou BD, 2011, IMMUNITY, V34, P375, DOI 10.1016/j.immuni.2011.01.011; Jegerlehner A, 2007, J IMMUNOL, V178, P2415, DOI 10.4049/jimmunol.178.4.2415; KAMINSKI MS, 1987, J IMMUNOL, V138, P1289; KAMINSKI MS, 1986, J IMMUNOL, V136, P1123; Kemnade JO, 2014, VACCINE, V32, P4228, DOI 10.1016/j.vaccine.2014.04.051; King CA, 1998, NAT MED, V4, P1281, DOI 10.1038/3266; Klamp T, 2011, CANCER RES, V71, P516, DOI 10.1158/0008-5472.CAN-10-2292; Li QL, 2007, J VIROL METHODS, V140, P212, DOI 10.1016/j.jviromet.2006.10.011; Lico C, 2006, J GEN VIROL, V87, P3103, DOI 10.1099/vir.0.82097-0; Lim SH, 2010, HAEMATOL-HEMATOL J, V95, P135, DOI 10.3324/haematol.2008.001628; Marrack P, 2009, NAT REV IMMUNOL, V9, P287, DOI 10.1038/nri2510; McCarthy H, 2003, BRIT J HAEMATOL, V123, P770, DOI 10.1046/j.1365-2141.2003.04698.x; McCormick AA, 2006, BIOCONJUGATE CHEM, V17, P1330, DOI 10.1021/bc060124m; Nanni P, 2001, J EXP MED, V194, P1195, DOI 10.1084/jem.194.9.1195; Palmer KE, 2006, VACCINE, V24, P5516, DOI 10.1016/j.vaccine.2006.04.058; PORTA C, 1994, VIROLOGY, V202, P949, DOI 10.1006/viro.1994.1417; Porta C, 1998, REV MED VIROL, V8, P25, DOI 10.1002/(SICI)1099-1654(199801/03)8:1&lt;25::AID-RMV212&gt;3.0.CO;2-V; Rajagopal D, 2010, BLOOD, V115, P1949, DOI 10.1182/blood-2009-08-238543; Rice J, 2008, NAT REV CANCER, V8, P108, DOI 10.1038/nrc2326; Savelyeva N, 2005, P NATL ACAD SCI USA, V102, P10987, DOI 10.1073/pnas.0505108102; Savelyeva N, 2001, NAT BIOTECHNOL, V19, P760, DOI 10.1038/90816; Savelyeva N, 2011, BLOOD, V118, P650, DOI 10.1182/blood-2011-01-328864; SCHODEL F, 1992, J VIROL, V66, P106; Schuster SJ, 2011, J CLIN ONCOL, V29, P2787, DOI 10.1200/JCO.2010.33.3005; Scotti N, 2013, EXPERT REV VACCINES, V12, P211, DOI [10.1586/erv.12.147, 10.1586/ERV.12.147]; Spohn G, 2008, EUR J IMMUNOL, V38, P877, DOI 10.1002/eji.200737989; Staczek J, 2000, VACCINE, V18, P2266, DOI 10.1016/S0264-410X(99)00571-X; Stevenson FK, 2001, ADV CANCER RES, V83, P81, DOI 10.1016/S0065-230X(01)83004-9; Timmerman JM, 2009, HUM VACCINES, V5, P181, DOI 10.4161/hv.5.3.7476; Tollin P, 1988, THE PLANT VIRUSES, V4, P51; Werner S, 2006, P NATL ACAD SCI USA, V103, P17678, DOI 10.1073/pnas.0608869103	52	49	52	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118096	10.1371/journal.pone.0118096	http://dx.doi.org/10.1371/journal.pone.0118096			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692288	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000350061500094
J	Na, T; Liu, J; Zhang, KH; Ding, M; Yuan, BZ				Na, Tao; Liu, Jing; Zhang, Kehua; Ding, Min; Yuan, Bao-Zhu			The Notch Signaling Regulates CD105 Expression, Osteogenic Differentiation and Immunomodulation of Human Umbilical Cord Mesenchymal Stem Cells	PLOS ONE			English	Article							HUMAN BONE-MARROW; GAMMA-SECRETASE; STROMAL CELLS; INHIBITS INVASION; GENE-EXPRESSION; CANCER CELLS; PROTEIN; PATHWAY; GROWTH; ADIPOGENESIS	Mesenchymal stem cells (MSCs) are a group of multipotent cells with key properties of multi-lineage differentiation, expressing a set of relatively specific surface markers and unique immunomodulatory functions. IDO1, a catabolic enzyme of tryptophan, represents a critical molecule mediating immunomodulatory functions of MSCs. However, the signaling pathways involved in regulating these key properties still remain elusive. To investigate the involvement of Notch signaling as well as other potential signaling pathway(s) in regulating these critical properties of MSCs, we treated human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) with gamma-secreatase inhibitor I (GSI-I), which inhibits both Notch signaling and ubiquitin-proteasome activities. It was shown that the GSI-I treatment resulted in apoptosis, reduced expression of surface markers CD73, CD90 and CD105, reduced osteogenic differentiation, and reduction of the hUC-MSCs-mediated suppression of Th1 lymphocyte proliferation and the IFN-gamma-induced IDO1 expression. Through distinguishing the effects of GSI-I between Notch inhibition and proteasome inhibition, it was further observed that, whereas both Notch inhibition and proteasome inhibition were attributable to the reduced CD105 expression and osteogenic differentiation, but not to the induced apoptosis. However, Notch inhibition, but not proteasome inhibition, only contributed to the significant effect of GSI-I on Th1 proliferation probably through reducing IDO1 promoter activity. In conclusion, the Notch signaling may represent a very important cell signaling capable of regulating multiple critical properties, especially the immunomodulatory functions of MSCs.	[Na, Tao; Liu, Jing; Zhang, Kehua; Yuan, Bao-Zhu] Natl Inst Food & Drug Control, Cell Collect & Res Ctr, Beijing 100050, Peoples R China; [Ding, Min] NIOSH, Morgantown, WV 26505 USA	National Institute of Food & Drug Control - China; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH)	Yuan, BZ (corresponding author), Natl Inst Food & Drug Control, Cell Collect & Res Ctr, Beijing 100050, Peoples R China.	ybao4356@gmail.com			Chinese National Science and Technology Fund [H1609-81172102]	Chinese National Science and Technology Fund	The study was supported by Chinese National Science and Technology Fund (H1609-81172102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslan H, 2006, STEM CELLS, V24, P1728, DOI 10.1634/stemcells.2005-0546; Bin Hafeez B, 2009, CLIN CANCER RES, V15, P452, DOI 10.1158/1078-0432.CCR-08-1631; Biskup E, 2013, BRIT J DERMATOL, V168, P504, DOI 10.1111/bjd.12071; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Charoenpanich A, 2011, TISSUE ENG PT A, V17, P2615, DOI 10.1089/ten.tea.2011.0107; Costa-Pinto AR, 2009, BIOMACROMOLECULES, V10, P2067, DOI 10.1021/bm9000102; Criado G, 2009, ARTHRITIS RHEUM-US, V60, P1342, DOI 10.1002/art.24446; Del Papa B, 2013, EUR J IMMUNOL, V43, P182, DOI 10.1002/eji.201242643; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Fan X, 2010, STEM CELLS, V28, P5, DOI 10.1002/stem.254; Flood F, 2005, BIOCHEM J, V385, P545, DOI 10.1042/BJ20041145; FRIEDENSTEIN AJ, 1968, TRANSPLANTATION, V6, P230, DOI 10.1097/00007890-196803000-00009; Haapasalo A, 2011, J ALZHEIMERS DIS, V25, P3, DOI 10.3233/JAD-2011-101065; Han JX, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2347; Hung SC, 2004, GENE, V340, P141, DOI 10.1016/j.gene.2004.06.028; in't Anker PS, 2004, STEM CELLS, V22, P1338, DOI 10.1634/stemcells.2004-0058; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kolf CM, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2116; Koorella C, 2014, J BIOL CHEM, V289, P7747, DOI 10.1074/jbc.M113.519686; Kornilova AY, 2003, J BIOL CHEM, V278, P16470, DOI 10.1074/jbc.C300019200; Kosmacheva SM, 2008, B EXP BIOL MED+, V145, P141, DOI 10.1007/s10517-008-0028-3; LaVoie MJ, 2003, J BIOL CHEM, V278, P34427, DOI 10.1074/jbc.M302659200; Lee RH, 2004, CELL PHYSIOL BIOCHEM, V14, P311, DOI 10.1159/000080341; Lin GL, 2011, J CELL BIOCHEM, V112, P3491, DOI 10.1002/jcb.23287; Lotfinejad P, 2014, ADV PHARM BULL, V4, P5, DOI 10.5681/apb.2014.002; Lu LL, 2006, HAEMATOLOGICA, V91, P1017; Luz-Crawford P, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt216; Ma S, 2014, CELL DEATH DIFFER, V21, P216, DOI 10.1038/cdd.2013.158; Mark P, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/698076; McAuliffe SM, 2012, P NATL ACAD SCI USA, V109, pE2939, DOI 10.1073/pnas.1206400109; Meng X, 2011, LEUKEMIA, V25, P1135, DOI 10.1038/leu.2011.50; Ode A, 2011, EUR CELLS MATER, V22, P26, DOI 10.22203/eCM.v022a03; Osathanon T, 2013, STEM CELLS DEV, V22, P1220, DOI 10.1089/scd.2012.0430; Park ES, 2010, MOL ENDOCRINOL, V24, P846, DOI 10.1210/me.2009-0392; Romanov YA, 2003, STEM CELLS, V21, P105, DOI 10.1634/stemcells.21-1-105; Romieu-Mourez R, 2009, J IMMUNOL, V182, P7963, DOI 10.4049/jimmunol.0803864; Rosu-Myles M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038954; Shi YF, 2010, CELL RES, V20, P510, DOI 10.1038/cr.2010.44; Soichot M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025470; Soleymaninejadian E, 2012, AM J REPROD IMMUNOL, V67, P1, DOI 10.1111/j.1600-0897.2011.01069.x; Suman S, 2013, BRIT J CANCER, V109, P2587, DOI 10.1038/bjc.2013.642; Ugarte F, 2009, EXP HEMATOL, V37, P867, DOI 10.1016/j.exphem.2009.03.007; VISSERS MCM, 1988, J IMMUNOL METHODS, V110, P203, DOI 10.1016/0022-1759(88)90104-4; Wiesmann Anne, 2006, Head Face Med, V2, P8, DOI 10.1186/1746-160X-2-8; Xu S, 2012, LEUKEMIA, V26, P2546, DOI 10.1038/leu.2012.126; Yan YP, 2010, J IMMUNOL, V185, P5953, DOI 10.4049/jimmunol.1001628; Yuan BZ, 2009, ONCOGENE, V28, P3775, DOI 10.1038/onc.2009.240; Yuan BZ, 2014, FRONT MED-PRC, V8, P190, DOI 10.1007/s11684-014-0323-5; Yuan BZ, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-140; Yuan BZ, 2008, TRANSL ONCOL, V1, P129, DOI 10.1593/tlo.08133; Zhang K, 2014, VACCINE, DOI [10.1016/j.vaccine.2014.12.013, DOI 10.1016/J.VACCINE.2014.12.013]; Zhu FC, 2013, STEM CELLS, V31, P1181, DOI 10.1002/stem.1353	53	18	23	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118168	10.1371/journal.pone.0118168	http://dx.doi.org/10.1371/journal.pone.0118168			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692676	Green Submitted, Green Published, gold			2022-12-26	WOS:000350061500107
J	Palhano-Fontes, F; Andrade, KC; Tofoli, LF; Santos, AC; Crippa, JAS; Hallak, JEC; Ribeiro, S; de Araujo, DB				Palhano-Fontes, Fernanda; Andrade, Katia C.; Tofoli, Luis F.; Santos, Antonio C.; Crippa, Jose Alexandre S.; Hallak, Jaime E. C.; Ribeiro, Sidarta; de Araujo, Draulio B.			The Psychedelic State Induced by Ayahuasca Modulates the Activity and Connectivity of the Default Mode Network	PLOS ONE			English	Article							PROPOFOL-INDUCED LOSS; FUNCTIONAL CONNECTIVITY; SIGMA-1 RECEPTOR; BRAIN NETWORKS; GLOBAL SIGNAL; MEDITATION; SELF; DISEASE; MIND; N,N-DIMETHYLTRYPTAMINE	The experiences induced by psychedelics share a wide variety of subjective features, related to the complex changes in perception and cognition induced by this class of drugs. A remarkable increase in introspection is at the core of these altered states of consciousness. Self-oriented mental activity has been consistently linked to the Default Mode Network (DMN), a set of brain regions more active during rest than during the execution of a goal-directed task. Here we used fMRI technique to inspect the DMN during the psychedelic state induced by Ayahuasca in ten experienced subjects. Ayahuasca is a potion traditionally used by Amazonian Amerindians composed by a mixture of compounds that increase monoaminergic transmission. In particular, we examined whether Ayahuasca changes the activity and connectivity of the DMN and the connection between the DMN and the task-positive network (TPN). Ayahuasca caused a significant decrease in activity through most parts of the DMN, including its most consistent hubs: the Posterior Cingulate Cortex (PCC)/Precuneus and the medial Prefrontal Cortex (mPFC). Functional connectivity within the PCC/Precuneus decreased after Ayahuasca intake. No significant change was observed in the DMN-TPN orthogonality. Altogether, our results support the notion that the altered state of consciousness induced by Ayahuasca, like those induced by psilocybin (another serotonergic psychedelic), meditation and sleep, is linked to the modulation of the activity and the connectivity of the DMN.	[Palhano-Fontes, Fernanda; Andrade, Katia C.; Ribeiro, Sidarta; de Araujo, Draulio B.] Univ Fed Rio Grande do Norte, Inst Brain, BR-59072970 Natal, RN, Brazil; [Tofoli, Luis F.] Univ Estadual Campinas, Dept Med Psychol & Psychiat, Campinas, SP, Brazil; [Santos, Antonio C.; Crippa, Jose Alexandre S.; Hallak, Jaime E. C.] Univ Sao Paulo, Dept Neurosci & Behav, BR-14049 Ribeirao Preto, SP, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Estadual de Campinas; Universidade de Sao Paulo	de Araujo, DB (corresponding author), Univ Fed Rio Grande do Norte, Inst Brain, BR-59072970 Natal, RN, Brazil.	draulio@neuro.ufrn.br	de Souza Crippa, José Alexandre/A-1215-2008; Araujo, Draulio/I-6038-2012; Tófoli, Luís Fernando/F-9221-2012; Ribeiro, Sidarta/C-5794-2016	Araujo, Draulio/0000-0002-6934-2485; Tófoli, Luís Fernando/0000-0003-2262-8272; Ribeiro, Sidarta/0000-0001-9325-9545	Brazilian Federal Agency CNPq; Brazilian Federal Agency CAPES; FINEP; Sao Paulo State financial agency (FAPESP)	Brazilian Federal Agency CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Federal Agency CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FINEP(Financiadora de Inovacao e Pesquisa (Finep)); Sao Paulo State financial agency (FAPESP)	Contract grant sponsor: The Brazilian Federal Agencies: CNPq, CAPES; FINEP; The Sao Paulo State financial agency (FAPESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bossong MG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070074; Boveroux P, 2010, ANESTHESIOLOGY, V113, P1038, DOI 10.1097/ALN.0b013e3181f697f5; Brefczynski-Lewis JA, 2007, P NATL ACAD SCI USA, V104, P11483, DOI 10.1073/pnas.0606552104; Brewer JA, 2011, P NATL ACAD SCI USA, V108, P20254, DOI 10.1073/pnas.1112029108; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Callaway JC, 1999, J ETHNOPHARMACOL, V65, P243, DOI 10.1016/S0378-8741(98)00168-8; Carhart-Harris RL, 2013, SCHIZOPHRENIA BULL, V39, P1343, DOI 10.1093/schbul/sbs117; Carhart-Harris RL, 2012, P NATL ACAD SCI USA, V109, P2138, DOI 10.1073/pnas.1119598109; Bouso JC, 2013, PSYCHOPHARMACOLOGY, V230, P415, DOI 10.1007/s00213-013-3167-9; de Araujo DB, 2012, HUMAN BRAIN MAPPING; dos Santos RG, 2012, PSYCHOPHARMACOLOGY, V219, P1039, DOI 10.1007/s00213-011-2434-x; Fontanilla D, 2009, SCIENCE, V323, P934, DOI 10.1126/science.1166127; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Garrity AG, 2007, AM J PSYCHIAT, V164, P450, DOI 10.1176/appi.ajp.164.3.450; GENTILI C, 2009, PSYCHOL HEALTH S1, V24, P181, DOI DOI 10.1016/J.ADDBEH.2015.01.022; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2008, HUM BRAIN MAPP, V29, P839, DOI 10.1002/hbm.20537; Hasenkamp W, 2012, FRONT HUM NEUROSCI, P6, DOI [10.3389/fnhum.2012.00348, DOI 10.3389/FNHUM.2012.00348]; Hasenkamp W, 2012, NEUROIMAGE, V59, P750, DOI 10.1016/j.neuroimage.2011.07.008; Horovitz SG, 2009, P NATL ACAD SCI USA, V106, P11376, DOI 10.1073/pnas.0901435106; James William, 1982, VARIETIES RELIG EXPE; Jang JH, 2011, NEUROSCI LETT, V487, P358, DOI 10.1016/j.neulet.2010.10.056; Josipovic Z, 2012, FRONT HUM NEUROSCI, V5, DOI [10.3389/fnhum.2011.00184, DOI 10.3389/FNHUM.2011.00184]; Keller CJ, 2013, J NEUROSCI, V33, P6333, DOI 10.1523/JNEUROSCI.4837-12.2013; Kennedy DP, 2008, SOC COGN AFFECT NEUR, V3, P177, DOI 10.1093/scan/nsn011; Kriegeskorte Nikolaus, 2009, NATURE, V535, P540; Laird AR, 2009, J NEUROSCI, V29, P14496, DOI 10.1523/JNEUROSCI.4004-09.2009; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; McGeown WJ, 2009, CONSCIOUS COGN, V18, P848, DOI 10.1016/j.concog.2009.09.001; MCKENNA DJ, 1984, J ETHNOPHARMACOL, V10, P195, DOI 10.1016/0378-8741(84)90003-5; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ray TS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009019; Riba J, 2006, PSYCHOPHARMACOLOGY, V186, P93, DOI 10.1007/s00213-006-0358-7; Riba J, 2001, PSYCHOPHARMACOLOGY, V154, P85, DOI 10.1007/s002130000606; Riba J, 2003, J PHARMACOL EXP THER, V306, P73, DOI 10.1124/jpet.103.049882; Rinpoche YM, 2007, JOY LIVING, DOI [10.1093/jxb/erm028, DOI 10.1093/JXB/ERM028]; Samann PG, 2011, CEREB CORTEX, V21, P2082, DOI 10.1093/cercor/bhq295; Schrouff J, 2011, NEUROIMAGE, V57, P198, DOI 10.1016/j.neuroimage.2011.04.020; Shanon Benny, 2002, ANTIPODES MIND CHART; Sheline YI, 2009, P NATL ACAD SCI USA, V106, P1942, DOI 10.1073/pnas.0812686106; Smallwood J, 2006, PSYCHOL BULL, V132, P946, DOI 10.1037/0033-2909.132.6.946; Smith SM, 2012, NEUROIMAGE, V62, P1257, DOI 10.1016/j.neuroimage.2012.01.022; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Sood A, 2013, EXPLORE-NY, V9, P136, DOI 10.1016/j.explore.2013.02.005; Su TP, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.261pe12; Uddin LQ, 2009, HUM BRAIN MAPP, V30, P625, DOI 10.1002/hbm.20531; van Eimeren T, 2009, ARCH NEUROL-CHICAGO, V66, P877, DOI 10.1001/archneurol.2009.97; WATTS A, 1968, CALIF LAW REV, V56, P74, DOI 10.2307/3479497; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429	54	180	186	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118143	10.1371/journal.pone.0118143	http://dx.doi.org/10.1371/journal.pone.0118143			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693169	Green Published, Green Submitted, gold			2022-12-26	WOS:000350061500102
J	Wang, Q; Wang, D; Wen, XF; Yu, GR; He, NP; Wang, RF				Wang, Qing; Wang, Dan; Wen, Xuefa; Yu, Guirui; He, Nianpeng; Wang, Rongfu			Differences in SOM Decomposition and Temperature Sensitivity among Soil Aggregate Size Classes in a Temperate Grasslands	PLOS ONE			English	Article							ORGANIC-MATTER DECOMPOSITION; CARBON DECOMPOSITION; MICROBIAL BIOMASS; FRACTIONS; QUALITY; RESPIRATION; DEPENDENCE; TURNOVER; OLD; SEQUESTRATION	The principle of enzyme kinetics suggests that the temperature sensitivity (Q10) of soil organic matter (SOM) decomposition is inversely related to organic carbon (C) quality, i.e., the C quality-temperature (CQT) hypothesis. We tested this hypothesis by performing laboratory incubation experiments with bulk soil, macroaggregates (MA, 250-2000 mu m), microaggregates (MI, 53-250 mu m), and mineral fractions (MF, < 53 mu m) collected from an Inner Mongolian temperate grassland. The results showed that temperature and aggregate size significantly affected on SOM decomposition, with notable interactive effects (P < 0.0001). For 2 weeks, the decomposition rates of bulk soil and soil aggregates increased with increasing incubation temperature in the following order: MA > MF > bulk soil > MI(P < 0.05). The Q10 values were highest for MA, followed (in decreasing order) by bulk soil, MF, and MI. Similarly, the activation energies (Ea) for MA, bulk soil, MF, and MI were 48.47, 33.26, 27.01, and 23.18 KJ mol(-1), respectively. The observed significant negative correlations between Q10 and C quality index in bulk soil and soil aggregates (P < 0.05) suggested that the CQT hypothesis is applicable to soil aggregates. Cumulative C emission differed significantly among aggregate size classes (P < 0.0001), with the largest values occurring in MA (1101 mu g g(-1)), followed by MF (976 mu g g(-1)) and MI (879 mu g g(-1)). These findings suggest that feedback from SOM decomposition in response to changing temperature is closely associated withsoil aggregation and highlights the complex responses of ecosystem C budgets to future warming scenarios.	[Wang, Qing; Wang, Dan; Wang, Rongfu] Anhui Agr Univ, Resources & Environm Coll, Hefei, Peoples R China; [Wang, Qing; Wen, Xuefa; Yu, Guirui; He, Nianpeng] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Beijing, Peoples R China	Anhui Agricultural University; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	He, NP (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Beijing, Peoples R China.	henp@igsnrr.ac.cn; rfwang@ahau.edu.cn	于, 贵瑞/C-1768-2014	于, 贵瑞/0000-0002-1859-8966; he, nianpeng/0000-0002-0458-5953	Environmental Public Welfare Scientific Research Project [201209028]; Natural Science Foundation of China [31270519]; Program for "Kezhen" Distinguished Talents in Institute of Geographic Sciences and Natural Resources Research, CAS	Environmental Public Welfare Scientific Research Project; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for "Kezhen" Distinguished Talents in Institute of Geographic Sciences and Natural Resources Research, CAS	Funding for this work partly supported by the Environmental Public Welfare Scientific Research Project (201209028), the Natural Science Foundation of China (31270519), and the Program for "Kezhen" Distinguished Talents in Institute of Geographic Sciences and Natural Resources Research, CAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Billings SA, 2013, GLOBAL CHANGE BIOL, V19, P90, DOI 10.1111/gcb.12029; Boddy E, 2008, SOIL BIOL BIOCHEM, V40, P1557, DOI 10.1016/j.soilbio.2008.01.030; Bosatta E, 1999, SOIL BIOL BIOCHEM, V31, P1889, DOI 10.1016/S0038-0717(99)00105-4; CHENG WX, 1993, SOIL BIOL BIOCHEM, V25, P135, DOI 10.1016/0038-0717(93)90251-6; Chiu CY, 2006, GEODERMA, V130, P265, DOI 10.1016/j.geoderma.2005.01.025; Christensen BT, 2001, EUR J SOIL SCI, V52, P345, DOI 10.1046/j.1365-2389.2001.00417.x; Conen F, 2006, BIOGEOSCIENCES, V3, P515, DOI 10.5194/bg-3-515-2006; Craine JM, 2010, NAT GEOSCI, V3, P854, DOI [10.1038/ngeo1009, 10.1038/NGEO1009]; Creamer CA, 2013, SOIL BIOL BIOCHEM, V57, P496, DOI 10.1016/j.soilbio.2012.09.007; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; De Gryze S, 2005, SOIL BIOL BIOCHEM, V37, P55, DOI 10.1016/j.soilbio.2004.07.024; Dou S, 1992, CHIN J SOIL SCI, V22, P52; Dungait JAJ, 2012, GLOBAL CHANGE BIOL, V18, P1781, DOI 10.1111/j.1365-2486.2012.02665.x; ELLIOTT ET, 1986, SOIL SCI SOC AM J, V50, P627, DOI 10.2136/sssaj1986.03615995005000030017x; Fang C, 2001, SOIL BIOL BIOCHEM, V33, P155, DOI 10.1016/S0038-0717(00)00125-5; Fang CM, 2005, NATURE, V433, P57, DOI 10.1038/nature03138; Farrar J, 2012, SOIL BIOL BIOCHEM, V49, P52, DOI 10.1016/j.soilbio.2012.02.018; Fierer N, 2005, ECOLOGY, V86, P320, DOI 10.1890/04-1254; Gershenson A, 2009, GLOBAL CHANGE BIOL, V15, P176, DOI 10.1111/j.1365-2486.2008.01827.x; Giardina CP, 2000, NATURE, V404, P858, DOI 10.1038/35009076; Hamdi S, 2013, SOIL BIOL BIOCHEM, V58, P115, DOI 10.1016/j.soilbio.2012.11.012; He NP, 2013, ECOL EVOL, V3, P5045, DOI 10.1002/ece3.881; He NP, 2008, SOIL BIOL BIOCHEM, V40, P2952, DOI 10.1016/j.soilbio.2008.08.018; Katterer T, 1998, BIOL FERT SOILS, V27, P258, DOI 10.1007/s003740050430; Kleber M, 2011, GLOBAL CHANGE BIOL, V17, P1097, DOI 10.1111/j.1365-2486.2010.02278.x; Liski J, 1999, AMBIO, V28, P171; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Manna MC, 2013, FIELD CROP RES, V145, P10, DOI 10.1016/j.fcr.2013.02.004; Mikutta R, 2006, BIOGEOCHEMISTRY, V77, P25, DOI 10.1007/s10533-005-0712-6; Monreal CM, 1997, CAN J SOIL SCI, V77, P379, DOI 10.4141/S95-064; Plante AF, 2010, SOIL BIOL BIOCHEM, V42, P1991, DOI 10.1016/j.soilbio.2010.07.022; Qin SP, 2010, APPL SOIL ECOL, V45, P152, DOI 10.1016/j.apsoil.2010.03.007; Riffaldi R, 1996, BIOL FERT SOILS, V22, P293, DOI 10.1007/BF00334572; Roland B, 2003, J PLANT NUTR SOIL SC, V166, P300; Schmidt MWI, 2011, NATURE, V478, P49, DOI 10.1038/nature10386; SEECH AG, 1988, SOIL SCI SOC AM J, V52, P1616, DOI 10.2136/sssaj1988.03615995005200060019x; Sequaris JM, 2010, EUR J SOIL SCI, V61, P940, DOI 10.1111/j.1365-2389.2010.01299.x; Sey BK, 2008, SOIL BIOL BIOCHEM, V40, P2468, DOI 10.1016/j.soilbio.2008.05.012; Sierra CA, 2012, BIOGEOCHEMISTRY, V108, P1, DOI 10.1007/s10533-011-9596-9; Six J, 2000, SOIL BIOL BIOCHEM, V32, P2099, DOI 10.1016/S0038-0717(00)00179-6; Suseela V, 2012, GLOBAL CHANGE BIOL, V18, P336, DOI 10.1111/j.1365-2486.2011.02516.x; Tan WB, 2013, CHINESE SCI BULL, V58, P1936, DOI 10.1007/s11434-012-5660-7; Thiessen S, 2013, SOIL BIOL BIOCHEM, V57, P739, DOI 10.1016/j.soilbio.2012.10.029; TISDALL JM, 1982, J SOIL SCI, V33, P141, DOI 10.1111/j.1365-2389.1982.tb01755.x; Wagai R, 2013, GLOBAL CHANGE BIOL, V19, P1114, DOI 10.1111/gcb.12112; Wang X, 2001, SOIL SCI SOC AM J, V65, P139, DOI 10.2136/sssaj2001.651139x; Wetterstedt JAM, 2010, GLOBAL CHANGE BIOL, V16, P1806, DOI 10.1111/j.1365-2486.2009.02112.x; Whitby TG, 2013, SOIL BIOL BIOCHEM, V60, P202, DOI 10.1016/j.soilbio.2013.01.014; Wilson GWT, 2009, ECOL LETT, V12, P452, DOI 10.1111/j.1461-0248.2009.01303.x; Xu X, 2012, SOIL BIOL BIOCHEM, V50, P142, DOI 10.1016/j.soilbio.2012.03.007; Yamashita T, 2006, SOIL BIOL BIOCHEM, V38, P3222, DOI 10.1016/j.soilbio.2006.04.013; Zhang WW, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0052849, 10.1371/journal.pone.0054779]; Zimmermann M, 2012, BIOGEOCHEMISTRY, V107, P423, DOI 10.1007/s10533-010-9562-y	53	19	24	4	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117033	10.1371/journal.pone.0117033	http://dx.doi.org/10.1371/journal.pone.0117033			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692291	gold, Green Published, Green Submitted			2022-12-26	WOS:000350061500034
J	Yabuki, K; Shiono, O; Komatsu, M; Sano, D; Nishimura, G; Takahashi, M; Taguchi, T; Inoue, T; Oridate, N				Yabuki, Kenichiro; Shiono, Osamu; Komatsu, Masanori; Sano, Daisuke; Nishimura, Goshi; Takahashi, Masahiro; Taguchi, Takahide; Inoue, Tomio; Oridate, Nobuhiko			Predictive and Prognostic Value of Metabolic Tumor Volume (MTV) in Patients with Laryngeal Carcinoma Treated by Radiotherapy (RT)/Concurrent Chemoradiotherapy (CCRT)	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; HYPOPHARYNX	Purpose To evaluate the predictive and prognostic value of pretreatment metabolic tumor volume (MTV) in patients with treated by radiotherapy (RT) or concurrent chemoradiotherapy (CCRT). Methods We reviewed the records of 118 patients with newly diagnosed laryngeal carcinoma, who had been treated by RT or CCRT. Pretreatment positron emission tomography (PET) was performed, and MTV values were obtained by contouring margins of standardized uptake value. Clinical factors and MTV were analyzed for their association with survival. Results Patients with residual disease showed a significantly higher MTV than those with a complete response (CR) after primary treatment. Univariate analysis showed that the patients with a high MTV had a significantly lower disease-free survival (DFS) (p < 0.001). Subsite (p = 0.010), T-stage (p < 0.001), nodal metastasis (p < 0.001) and clinical stage (p < 0.001) also correlated significantly with DFS. In the multivariate analysis, MTV and clinical stage were both found to be independent prognostic factors for DFS (p = 0.001, p = 0.034, respectively). The 3-year DFS for patients with a high MTV were significantly poorer than those with a low MTV (p < 0.001). Conclusions MTV of the primary tumor is a significant prognostic factor for DFS in patients with laryngeal carcinoma treated by RT or CCRT. The results imply that MTV could be an important factor when planning treatment and follow-up for patients with laryngeal carcinoma.	[Yabuki, Kenichiro; Shiono, Osamu; Komatsu, Masanori; Sano, Daisuke; Nishimura, Goshi; Takahashi, Masahiro; Taguchi, Takahide; Oridate, Nobuhiko] Yokohama City Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Yokohama, Kanagawa 232, Japan; [Inoue, Tomio] Yokohama City Univ, Sch Med, Dept Radiol, Yokohama, Kanagawa 232, Japan	Yokohama City University; Yokohama City University	Yabuki, K (corresponding author), Yokohama City Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Yokohama, Kanagawa 232, Japan.	k_yabuki@yokohama-cu.ac.jp	Oridate, Nobuhiko/ABC-4116-2020; Sano, Daisuke/R-6591-2018	Oridate, Nobuhiko/0000-0002-6968-3028; Sano, Daisuke/0000-0002-7686-4724; Yabuki, Kenichiro/0000-0002-5099-1901				Chung MK, 2009, CLIN CANCER RES, V15, P5861, DOI 10.1158/1078-0432.CCR-08-3290; Fletcher JW, 2008, J NUCL MED, V49, P480, DOI 10.2967/jnumed.107.047787; Garsa AA, 2013, J RADIOL ONCOL, V2, P27, DOI 10.1007/s13566-012-0065-4; Kao CH, 2012, EUR J NUCL MED MOL I, V39, P1297, DOI 10.1007/s00259-012-2127-7; Paidpally Vasavi, 2012, Imaging Med, V4, P633; Park GC, 2013, ANN ONCOL, V24, P208, DOI 10.1093/annonc/mds247; Taguchi T, 2014, CANCER CHEMOTH PHARM, V73, P1147, DOI 10.1007/s00280-014-2448-2; Tang C, 2012, INT J RADIAT ONCOL, V83, P1514, DOI 10.1016/j.ijrobp.2011.10.023; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Tsukuda M, 2009, CANCER CHEMOTH PHARM, V64, P945, DOI 10.1007/s00280-009-0946-4	10	22	22	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117924	10.1371/journal.pone.0117924	http://dx.doi.org/10.1371/journal.pone.0117924			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692986	Green Published, Green Submitted, gold			2022-12-26	WOS:000350061500080
J	Brigham, EP; McCormack, MC; Takemoto, CM; Matsui, EC				Brigham, Emily P.; McCormack, Meredith C.; Takemoto, Clifford M.; Matsui, Elizabeth C.			Iron Status is Associated with Asthma and Lung Function in US Women	PLOS ONE			English	Article							SERUM TRANSFERRIN RECEPTOR; EARLY-CHILDHOOD; DEFICIENCY; FERRITIN; DIAGNOSIS; ANEMIA; RISK; SUPPLEMENTATION; HYPERTENSION; CHILDREN	Background Asthma and iron deficiency are common conditions. Whether iron status affects the risk of asthma is unclear. Objective To determine the relationship between iron status and asthma, lung function, and pulmonary inflammation. Methods Relationships between measures of iron status (serum ferritin, serum soluble transferrin receptor (sTfR), and sTfR/log10ferritin (sTfR-F Index)) and asthma, lung function, and pulmonary inflammation were examined in women 20-49 years in the National Health and Nutrition Examination Survey. Logistic, linear, and quadratic regression models accounting for the survey design of NHANES were used to evaluate associations between iron status and asthma-related outcomes and were adjusted for race/ethnicity, age, smoking status, income, and BMI. Results Approximately 16% reported a lifetime history of asthma, 9% reported current asthma, and 5% reported a recent asthma episode/attack (n = 2906). Increased ferritin (iron stores) was associated with decreased odds of lifetime asthma, current asthma, and asthma attacks/episodes in the range of ferritin linearly correlated with iron stores (20-300ng/ml). The highest quintile of ferritin (>76 ng/ml) was also associated with a decreased odds of asthma. Ferritin levels were not associated with FEV1. Increased values of the sTfR-F Index and sTfR, indicating lower body iron and higher tissue iron need, respectively, were associated with decreased FEV1, but neither was associated with asthma. None of the iron indices were associated with FeNO. Conclusion In US women, higher iron stores were inversely associated with asthma and lower body iron and higher tissue iron need were associated with lower lung function. Together, these findings suggest that iron status may play a role in asthma and lung function in US women.	[Brigham, Emily P.; McCormack, Meredith C.] Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care Med, Baltimore, MD USA; [McCormack, Meredith C.; Matsui, Elizabeth C.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Takemoto, Clifford M.] Johns Hopkins Univ, Sch Med, Div Pediat Hematol, Baltimore, MD USA; [Matsui, Elizabeth C.] Johns Hopkins Univ, Sch Med, Div Pediat Allergy & Immunol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University	Matsui, EC (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.	ematsui@jhmi.edu	Takemoto, Clifford M/Y-7558-2018	McCormack, Meredith/0000-0003-1702-3201; Brigham, Emily/0000-0002-8449-5420; Matsui, Elizabeth/0000-0001-8134-5593; Koehl, Rachelle/0000-0002-7797-7456; Pham, Hewlett/0000-0003-0330-6104; Ayers, Andrew/0000-0001-5305-7156	National Institute of Environmental Health Sciences [P50ES015903, P01ES018176, K23ES016819]; Environmental Protection Agency [R832139]; National Institute of Allergy and Infectious Diseases [R01AI070630, U01AI083238]; National Heart, Blood, and Lung Institute [R21HL117772, F32 HL120396-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL120396] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070630, U01AI083238] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K23ES016819, P01ES018176, P50ES015903] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Environmental Protection Agency(United States Environmental Protection Agency); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Heart, Blood, and Lung Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institute of Environmental Health Sciences (P50ES015903, P01ES018176, K23ES016819), the Environmental Protection Agency (R832139), the National Institute of Allergy and Infectious Diseases (R01AI070630 and U01AI083238), and the National Heart, Blood, and Lung Institute (R21HL117772 and F32 HL120396-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALFORD CE, 1991, J EXP MED, V174, P459, DOI 10.1084/jem.174.2.459; Balanos GM, 2002, J APPL PHYSIOL, V92, P2501, DOI 10.1152/japplphysiol.00965.2001; Barnes PJ, 2008, NAT REV IMMUNOL, V8, P183, DOI 10.1038/nri2254; Bousquet J, 2000, AM J RESP CRIT CARE, V161, P1720, DOI 10.1164/ajrccm.161.5.9903102; Brotanek JM, 2007, PEDIATRICS, V120, P568, DOI 10.1542/peds.2007-0572; Bucca C, 2012, INT J CLIN PRACT, V66, P1095, DOI 10.1111/ijcp.12001; Castel R, 2012, CLIN CHEM LAB MED, V50, P1343, DOI 10.1515/cclm-2011-0594; Cavill I, 1999, AM J KIDNEY DIS, V34, pS12, DOI 10.1053/ajkd.1999.v34.aajkd0344b0012; CDC National Center for Environmental Health: Division of Environmental Hazards and Health Effects, 2013, ASTHM IMP NAT DAT CD; Centers for Disease Control and Prevention, 2002, MMWR-MORBID MORTAL W; Centers for Disease Control and Prevention, 2011, IR IR DEF; CHARLTON RW, 1977, CLIN SCI MOL MED, V53, P537, DOI 10.1042/cs0530537; Cogswell ME, 2009, AM J CLIN NUTR, V89, P1334, DOI 10.3945/ajcn.2008.27151; Collins HL, 2002, J IMMUNOL, V168, P3458, DOI 10.4049/jimmunol.168.7.3458; COOK JD, 1982, SEMIN HEMATOL, V19, P6; GUYATT GH, 1992, J GEN INTERN MED, V7, P145, DOI 10.1007/BF02598003; Hale LP, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0045802PMID:23071848, DOI 10.1371/JOURNAL.PONE.0045802]; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Howard LSGE, 2013, PULM CIRC, V3, P100, DOI 10.4103/2045-8932.109923; JACOBS A, 1972, BRIT MED J, V4, P206, DOI 10.1136/bmj.4.5834.206; Jian J, 2013, BMC CANCER, V13, DOI [10.1186/1471-2407-13-619, DOI 10.1186/1471-2407-13-619]; Kantor J, 2003, J INVEST DERMATOL, V121, P985, DOI 10.1046/j.1523-1747.2003.12540.x; Killip S, 2007, AM FAM PHYSICIAN, V75, P671; Kon N, 2010, BRAIN DEV-JPN, V32, P849, DOI 10.1016/j.braindev.2009.12.003; Lemanske RF, 2010, J ALLERGY CLIN IMMUN, V125, pS95, DOI 10.1016/j.jaci.2009.10.047; Leschziner G, 2012, BRIT MED J, DOI [10.1136/bmj.e6430, DOI 10.1136/BMJ.E6430]; Maazi H, 2011, CLIN EXP IMMUNOL, V166, P80, DOI 10.1111/j.1365-2249.2011.04448.x; National Center for Health Statistics, 2013, NAT HLTH NUTR EX SUR; Oppenheimer SJ, 2001, J NUTR, V131, p616S, DOI 10.1093/jn/131.2.616S; Punnonen K, 1997, BLOOD, V89, P1052, DOI 10.1182/blood.V89.3.1052; Ramakrishnan K, 2010, LUNG INDIA, V27, P51, DOI 10.4103/0970-2113.63605; Rhodes CJ, 2011, EUR RESPIR J, V38, P1453, DOI 10.1183/09031936.00037711; Schaible ME, 2004, NAT REV MICROBIOL, V2, P946, DOI 10.1038/nrmicro1046; Shaheen SO, 2004, EUR RESPIR J, V24, P292, DOI 10.1183/09031936.04.00117803; Silverpil E, 2012, EXPERT REV RESP MED, V6, P173, DOI [10.1586/ERS.12.12, 10.1586/ers.12.12]; SKIKNE BS, 1990, BLOOD, V75, P1870; Suominen P, 1998, BLOOD, V92, P2934, DOI 10.1182/blood.V92.8.2934.420k07_2934_2939; Tamura T, 2002, J PEDIATR-US, V140, P165, DOI 10.1067/mpd.2002.120688; Trost LB, 2006, J AM ACAD DERMATOL, V54, P824, DOI 10.1016/j.jaad.2005.11.1104; van Empel VPM, 2014, HEART LUNG CIRC, V23, P287, DOI 10.1016/j.hlc.2013.08.007; WALTERS GO, 1973, J CLIN PATHOL, V26, P770, DOI 10.1136/jcp.26.10.770; WHO, 2011, SER FERR CONC ASS IR; WHO, 2001, IRON DEFICIENCY ANAE	43	37	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117545	10.1371/journal.pone.0117545	http://dx.doi.org/10.1371/journal.pone.0117545			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689633	Green Published, gold, Green Submitted			2022-12-26	WOS:000350322700052
J	Brito-Santos, F; Barbosa, GG; Trilles, L; Nishikawa, MM; Wanke, B; Meyer, W; Carvalho-Costa, FA; Lazera, MD				Brito-Santos, Fabio; Barbosa, Glaucia Goncalves; Trilles, Luciana; Nishikawa, Marilia Martins; Wanke, Bodo; Meyer, Wieland; Carvalho-Costa, Filipe Anibal; Lazera, Marcia dos Santos			Environmental Isolation of Cryptococcus gattii VGII from Indoor Dust from Typical Wooden Houses in the Deep Amazonas of the Rio Negro Basin	PLOS ONE			English	Article							NEOFORMANS VAR. GATTII; AIDS-ASSOCIATED CRYPTOCOCCOSIS; VANCOUVER-ISLAND; FUNGAL PATHOGENS; NATURAL HABITAT; DECAYING WOOD; BUJUMBURA; OUTBREAK; TREE	Cryptococcosis is a human fungal infection of significant mortality and morbidity, especially in the meningoencephalitis form. Cryptococcosis is distributed worldwide and its agents, C. neoformans and C. gattii, present eight major molecular types-VNI-VNIV and VGI-VGIV respectively. The primary cryptococcosis caused by molecular type VGII (serotype B, MAT alpha) prevails in immunocompetent patients in the North and Northeast of Brazil, revealing an endemic regional pattern to this molecular type. Since 1999, C. gattii VGII has been involved in an ongoing outbreak in Canada, and is expanding to the Northwest of the United States, two temperate regions. Exposure to propagules dispersed in the environment, related to various organic substrates, mainly decomposing wood in and around dwellings, initiates the infection process. The present study investigated the presence of the agents of cryptococcosis in dust from dwellings in the upper Rio Negro, municipality of Santa Isabel do Rio Negro in Amazonas state. Indoor dust was collected from 51 houses, diluted and plated on bird seed agar. Dark brown colonies were identified phenotypically, and genotypically by URA5 restriction fragment length polymorphism analysis and multilocus sequence typing (MLST). The mating type was identified using pheromone-specific primers. Three of the 51 houses were positive for C. gattii molecular type VGII, MAT alpha and MATa, showing a high prevalence of this agent. MLST studies identified eight subtypes, VGIIb (ST7), VGIIa (ST20), (ST5) and 5 new subtypes unique to the region. For the first time in the state of Amazonas, C. gattii VGII MAT alpha and MATa were isolated from the environment and correlates with endemic cryptococcosis in this state. This is the first description of MLST subtypes on environmental isolates in the Brazilian Amazon, indicating domiciliary dust as a potential source for human infection with different subtypes of C. gattii VGII MAT alpha and MATa.	[Brito-Santos, Fabio; Barbosa, Glaucia Goncalves; Trilles, Luciana; Wanke, Bodo; Meyer, Wieland; Lazera, Marcia dos Santos] Fiocruz MS, Evandro Chagas Clin Res Inst, Mycol Lab, BR-21045900 Rio De Janeiro, Brazil; [Meyer, Wieland] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Ctr Infect Dis & Microbiol, Mol Mycol Res Lab,Sydney Med Sch,Westmead Hosp,We, Sydney, NSW 2006, Australia; [Carvalho-Costa, Filipe Anibal] Fiocruz MS, Inst Oswaldo Cruz, Lab Mol Epidemiol & Systemat, BR-21045900 Rio De Janeiro, Brazil; [Nishikawa, Marilia Martins] INCQS FIOCRUZ, Natl Inst Qual Control Hlth, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; University of Sydney; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Lazera, MD (corresponding author), Fiocruz MS, Evandro Chagas Clin Res Inst, Mycol Lab, BR-21045900 Rio De Janeiro, Brazil.	marcia.lazera@ipec.fiocruz.br	Meyer, Wieland/G-1204-2015	Meyer, Wieland/0000-0001-9933-8340	"Coordenaao de Aperfeicoamento de Pessoal de Nivel Superior" (CAPES), Brazil [098/2012]	"Coordenaao de Aperfeicoamento de Pessoal de Nivel Superior" (CAPES), Brazil	The work was supported by the "Coordenaao de Aperfeicoamento de Pessoal de Nivel Superior" (CAPES), Brazil, grant # 098/2012 to BW. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bovers M, 2008, EMERG INFECT DIS, V14, P1105, DOI 10.3201/eid1407.080122; Bovers M, 2006, FEMS YEAST RES, V6, P599, DOI 10.1111/j.1567-1364.2006.00082.x; Byrnes Edmond J, 2009, F1000 Biol Rep, V1, DOI 10.3410/B1-62; Carriconde F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016936; CHRISTENSEN WB, 1946, J BACTERIOL, V52, P461, DOI 10.1128/JB.52.4.461-466.1946; Cogliati M, 2013, MED MYCOL, V51, P499, DOI 10.3109/13693786.2012.751642; Correa MP, 1999, BRAZIL REV SOC BRAS, V32, P505, DOI DOI 10.1590/S0037-86821999000500006.(IN; Costa SDSE, 2009, MEM I OSWALDO CRUZ, V104, P662, DOI 10.1590/S0074-02762009000400023; dos Santos WRA, 2008, MEM I OSWALDO CRUZ, V103, P813, DOI 10.1590/S0074-02762008000800012; Ferrer C, 2001, J CLIN MICROBIOL, V39, P2873, DOI 10.1128/JCM.39.8.2873-2879.2001; Fortes ST, 2001, MYCOSES, V44, P137, DOI 10.1046/j.1439-0507.2001.00651.x; Fraser JA, 2005, NATURE, V437, P1360, DOI 10.1038/nature04220; Fraser JA, 2003, EUKARYOT CELL, V2, P1036, DOI 10.1128/EC.2.5.1036-1045.2003; Gomes FS, 2010, REV PAN AMAZ SAUDE, V4, P43, DOI [10.1016/j.rbr.2014.04.003, DOI 10.1016/J.RBR.2014.04.003]; Hagen F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071148; Kidd SE, 2004, P NATL ACAD SCI USA, V101, P17258, DOI 10.1073/pnas.0402981101; Klein KR, 2009, J CLIN MICROBIOL, V47, P3669, DOI 10.1128/JCM.01072-09; Kwon-Chung KJ, 1992, MED MYCOL, P397; Lazera MS, 2000, MED MYCOL, V38, P379, DOI 10.1080/714030957; Lazera MS, 1998, MED MYCOL, V36, P119, DOI 10.1080/02681219880000191; Lazera MS, 1996, J MED VET MYCOL, V34, P127; Freire AKL, 2012, MYCOSES, V55, pe145, DOI 10.1111/j.1439-0507.2012.02173.x; Lockhart SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074737; Meyer W, 2003, EMERG INFECT DIS, V9, P189; Meyer W, 2009, MED MYCOL, V47, P561, DOI 10.1080/13693780902953886; Mitchell TG, 2011, CRYPTOCOCCUS: FROM HUMAN PATHOGEN TO MODEL YEAST, P237; Passoni LFC, 1998, MED MYCOL, V36, P305, DOI 10.1080/02681219880000481; Perfect JR, 2006, FEMS YEAST RES, V6, P463, DOI 10.1111/j.1567-1364.2006.00051.x; Martins LMS, 2011, MEM I OSWALDO CRUZ, V106, P725, DOI 10.1590/S0074-02762011000600012; STAIB F, 1966, ANN I PASTEUR PARIS, V110, P792; SWINNE D, 1991, J MED VET MYCOL, V29, P25; SWINNE D, 1989, AIDS, V3, P389, DOI 10.1097/00002030-198906000-00009; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Trilles L, 2008, MEM I OSWALDO CRUZ, V103, P455, DOI 10.1590/S0074-02762008000500008	34	34	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0115866	10.1371/journal.pone.0115866	http://dx.doi.org/10.1371/journal.pone.0115866			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25688971	gold, Green Published, Green Submitted			2022-12-26	WOS:000350322700007
J	Guess, MG; Barthel, KKB; Harrison, BC; Leinwand, LA				Guess, Martin G.; Barthel, Kristen K. B.; Harrison, Brooke C.; Leinwand, Leslie A.			miR-30 Family microRNAs Regulate Myogenic Differentiation and Provide Negative Feedback on the microRNA Pathway	PLOS ONE			English	Article							SKELETAL-MUSCLE; TRANSCRIPTION FACTOR; DUCHENNE; EXPRESSION; MIR-206; PROTEIN; TARGET; PROLIFERATION; REGENERATION; BODIES	microRNAs (miRNAs) are short non-coding RNAs that can mediate changes in gene expression and are required for the formation of skeletal muscle (myogenesis). With the goal of identifying novel miRNA biomarkers of muscle disease, we profiled miRNA expression using miRNA-seq in the gastrocnemius muscles of dystrophic mdx4cv mice. After identifying a down-regulation of the miR-30 family (miR-30a-5p, -30b, -30c, -30d and -30e) when compared to C57Bl/6 (WT) mice, we found that overexpression of miR-30 family miRNAs promotes differentiation, while inhibition restricts differentiation of myoblasts in vitro. Additionally, miR-30 family miRNAs are coordinately down-regulated during in vivo models of muscle injury (barium chloride injection) and muscle disuse atrophy (hindlimb suspension). Using bioinformatics tools and in vitro studies, we identified and validated Smarcd2, Snai2 and Tnrc6a as miR-30 family targets. Interestingly, we show that by targeting Tnrc6a, miR-30 family miRNAs negatively regulate the miRNA pathway and modulate both the activity of muscle-specific miR-206 and the levels of protein synthesis. These findings indicate that the miR-30 family may be an interesting biomarker of perturbed muscle homeostasis and muscle disease.	[Leinwand, Leslie A.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Leinwand, LA (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	leslie.leinwand@colorado.edu		BJORKMAN, KRISTEN/0000-0002-9540-6657	National Institutes of Health [5R01GM029090-30]; Research Scientist Development Award [K01AR055676]; American Heart Association Postdoctoral Fellowship [13POST14410014];  [2T32HL007822-11A2];  [5T32GM007135-35]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007822] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR055676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007135, R01GM029090] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Scientist Development Award; American Heart Association Postdoctoral Fellowship(American Heart Association); ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health Project Grant (5R01GM029090-30 to LAL), Postdoctoral Training Grant (2T32HL007822-11A2 to KKBB), Predoctoral Training Grant (5T32GM007135-35 to MGG), Research Scientist Development Award (K01AR055676 to BCH), and American Heart Association Postdoctoral Fellowship (13POST14410014 to KKBB). The funding agencies had no role in the study's conception, design, data collection, interpretation, or preparation of the manuscript.	Agrawal R, 2009, DEVELOPMENT, V136, P3927, DOI 10.1242/dev.037432; Alteri A, 2013, CELL CYCLE, V12, P3781, DOI 10.4161/cc.26674; Ardite E, 2012, J CELL BIOL, V196, P163, DOI 10.1083/jcb.201105013; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; CALDWELL CJ, 1990, NEUROPATH APPL NEURO, V16, P225, DOI 10.1111/j.1365-2990.1990.tb01159.x; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Cheung TH, 2012, NATURE, V482, P524, DOI 10.1038/nature10834; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Dey BK, 2011, MOL CELL BIOL, V31, P203, DOI 10.1128/MCB.01009-10; Djuranovic S, 2012, SCIENCE, V336, P237, DOI 10.1126/science.1215691; Duisters RF, 2009, CIRC RES, V104, P170, DOI 10.1161/CIRCRESAHA.108.182535; Eisenberg I, 2007, P NATL ACAD SCI USA, V104, P17016, DOI 10.1073/pnas.0708115104; Emery A E, 1991, Neuromuscul Disord, V1, P19, DOI 10.1016/0960-8966(91)90039-U; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Eystathioy T, 2002, MOL BIOL CELL, V13, P1338, DOI 10.1091/mbc.01-11-0544; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Gaziel-Sovran A, 2011, CANCER CELL, V20, P104, DOI 10.1016/j.ccr.2011.05.027; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Git A, 2010, RNA, V16, P991, DOI 10.1261/rna.1947110; Goljanek-Whysall K, 2012, J CELL SCI, V125, P3590, DOI 10.1242/jcs.101758; Greco S, 2009, FASEB J, V23, P3335, DOI 10.1096/fj.08-128579; Guess MG, 2013, SKELET MUSCLE, V3, DOI 10.1186/2044-5040-3-19; Guglieri M, 2010, CURR OPIN PHARMACOL, V10, P331, DOI 10.1016/j.coph.2010.03.005; Gurtner A, 2003, MOL BIOL CELL, V14, P2706, DOI 10.1091/mbc.E02-09-0600; Hackenberg M, 2011, NUCLEIC ACIDS RES, V39, pW132, DOI 10.1093/nar/gkr247; Hand NJ, 2009, GASTROENTEROLOGY, V136, P1081, DOI 10.1053/j.gastro.2008.12.006; Handschin C, 2007, GENE DEV, V21, P770, DOI 10.1101/gad.1525107; Hanson AM, 2013, MUSCLE NERVE, V48, P393, DOI 10.1002/mus.23753; Harrison BC, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-5; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang ZQ, 2012, BIOCHEM BIOPH RES CO, V423, P265, DOI 10.1016/j.bbrc.2012.05.106; Jakymiw A, 2005, NAT CELL BIOL, V7, P1267, DOI 10.1038/ncb1334; Jentzsch C, 2012, J MOL CELL CARDIOL, V52, P13, DOI 10.1016/j.yjmcc.2011.07.010; Ketley A, 2013, PLOS ONE, DOI [10.1371/journal.pone.0065170.s005, DOI 10.1371/J0URNAL.P0NE.0065170.S005]; Khurana TS, 2003, NAT REV DRUG DISCOV, V2, P379, DOI 10.1038/nrd1085; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li JC, 2010, PLOS GENET, V6, DOI [10.1371/journal.pgen.1000795, 10.1186/1746-4811-6-1]; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; Liu N, 2012, J CLIN INVEST, V122, P2054, DOI 10.1172/JCI62656; NICHOLSON LVB, 1990, ACTA NEUROPATHOL, V80, P239, DOI 10.1007/BF00294640; Nishi K, 2013, RNA, V19, P17, DOI 10.1261/rna.034769.112; O'Rourke JR, 2007, DEV BIOL, V311, P359, DOI 10.1016/j.ydbio.2007.08.032; Philipot O, 2010, PLOS ONE, V5, pe9425, DOI [10.1371/journal.pone.0009425, DOI 10.1371/J0URNAL.P0NE.0009425]; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Soleimani VD, 2012, MOL CELL, V47, P457, DOI 10.1016/j.molcel.2012.05.046; Sommese RF, 2013, P NATL ACAD SCI USA, V110, P12607, DOI 10.1073/pnas.1309493110; Till S, 2007, NAT STRUCT MOL BIOL, V14, P897, DOI 10.1038/nsmb1302; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; WEBSTER C, 1988, CELL, V52, P503, DOI 10.1016/0092-8674(88)90463-1; Wu TT, 2012, J BIOL CHEM, V287, P7503, DOI 10.1074/jbc.M111.292722; Zaragosi LE, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r64; Zhang JC, 2012, BIOCHEM BIOPH RES CO, V417, P1100, DOI 10.1016/j.bbrc.2011.12.121	53	63	64	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0118229	10.1371/journal.pone.0118229	http://dx.doi.org/10.1371/journal.pone.0118229			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689854	Green Submitted, Green Published, gold			2022-12-26	WOS:000350322700107
J	Jeong, JJ; Kim, KA; Jang, SE; Woo, JY; Han, MJ; Kim, DH				Jeong, Jin-Ju; Kim, Kyung-Ah; Jang, Se-Eun; Woo, Jae-Yeon; Han, Myung Joo; Kim, Dong-Hyun			Orally Administrated Lactobacillus pentosus var. plantarum C29 Ameliorates Age-Dependent Colitis by Inhibiting the Nuclear Factor-Kappa B Signaling Pathway via the Regulation of Lipopolysaccharide Production by Gut Microbiota	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ULCERATIVE-COLITIS; OXIDATIVE STRESS; FECAL MICROBIOTA; MICE; PROBIOTICS; PROFILES; PROTEIN; MAPK	To evaluate the anti-inflammaging effect of lactic acid bacteria (LAB) on age-dependent inflammation, we first screened and selected a tumor necrosis factor (TNF)-alpha and reactive oxygen species (ROS)-inhibitory LAB, Lactobacillus pentosus var. plantarum C29, among the LABs isolated from fermented vegetables using LPS-stimulated mouse peritoneal macrophages. Oral administration of C29 (2 x 10(9) CFU/rat) for 8 weeks in aged Fischer 344 rats (age, 16 months) inhibited the expression of the inflammatory markers myeloperoxidase, inducible nitric oxide (NO) synthase, cyclooxygenase-2, pro-inflammatory cytokines tumor necrosis factor (TNF)-alpha and IL-6 and the activation of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappa B), activator protein 1 (AP1), and mitogen-activated protein kinases (MAPKs). Treatment with C29 induced the expression of tight junction proteins ZO-1, occludin, and claudin-1, and reduced intestinal microbial LPS and plasmatic LPS levels and ROS, as well as the Firmicutes to Bacteroidetes ratio, which is significantly higher in aged rats than in young rats. C29 treatment also reduced plasmatic reactive oxygen species, malondialdehyde, C-reactive protein, and TNF-alpha, and suppressed expression of senescence markers p16 and p53 in the colon of the aged rats, but increased SIRT 1 expression. Based on these findings, we concluded that C29 treatment may suppress aging-dependent colitis by inhibiting NF-kappa B, AP1, and MAPK activation via the inhibition of gut microbiota LPS production and the induction of tight junction protein expression.	[Jeong, Jin-Ju; Kim, Kyung-Ah; Jang, Se-Eun; Woo, Jae-Yeon; Kim, Dong-Hyun] Kyung Hee Univ, Dept Life & Nanopharmaceut Sci, Seoul 130701, South Korea; [Jang, Se-Eun; Han, Myung Joo] Kyung Hee Univ, Dept Food & Nutr, Seoul 130701, South Korea	Kyung Hee University; Kyung Hee University	Kim, DH (corresponding author), Kyung Hee Univ, Dept Life & Nanopharmaceut Sci, 1 Hoegi, Seoul 130701, South Korea.	dhkim@khu.ac.kr		Jang, Se-Eun/0000-0003-3279-0871	Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Korean government (MSIP) [2013M3A9B6076413]	Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Korean government (MSIP)(Ministry of Food & Drug Safety (MFDS), Republic of Korea)	This study was supported by grants from the Bio & Medical Technology Development Program (2013M3A9B6076413) of the National Research Foundation (NRF) funded by the Korean government (MSIP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Fernandez Patricia, 2011, Curr Aging Sci, V4, P78; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cammarota G, 2014, INTERN EMERG MED, V9, P365, DOI 10.1007/s11739-014-1069-4; Campieri M, 1999, GASTROENTEROLOGY, V116, P1246, DOI 10.1016/S0016-5085(99)70029-6; Chung HY, 2011, J DENT RES, V90, P830, DOI 10.1177/0022034510387794; Collins MD, 1999, AM J CLIN NUTR, V69, p1052S, DOI 10.1093/ajcn/69.5.1052s; Craft S, 2005, NEUROBIOL AGING, V26, pS65, DOI 10.1016/j.neurobiolaging.2005.08.021; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Federico A, 2007, INT J CANCER, V121, P2381, DOI 10.1002/ijc.23192; Finch CE, 2010, P NATL ACAD SCI USA, V107, P1718, DOI 10.1073/pnas.0909606106; Ghosh S, 2014, J GERONTOL A; Gkouskou KK, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00028; Harman D, 2001, ANN NY ACAD SCI, V928, P1, DOI 10.1111/j.1749-6632.2001.tb05631.x; Hayashi H, 2003, MICROBIOL IMMUNOL, V47, P557, DOI 10.1111/j.1348-0421.2003.tb03418.x; Hirsch EC, 2003, ANN NY ACAD SCI, V991, P214; Hopkins MJ, 2001, GUT, V48, P198, DOI 10.1136/gut.48.2.198; Jang SE, 2013, J APPL MICROBIOL, V115, P888, DOI 10.1111/jam.12273; Joh EH, 2011, BRIT J PHARMACOL, V162, P1731, DOI 10.1111/j.1476-5381.2010.01195.x; Jung IH, 2012, J APPL MICROBIOL, V113, P1498, DOI 10.1111/j.1365-2672.2012.05437.x; Kennedy BJ, 2000, ONCOLOGY-NY, V14, P1731; Kennedy NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088982; Kim KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047713; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; McGeer EG, 1999, CURR PHARM DESIGN, V5, P821; MITSUOKA T, 1990, J IND MICROBIOL, V6, P263, DOI 10.1007/BF01575871; Murray PJ, 2011, J LEUKOCYTE BIOL, V89, P557, DOI 10.1189/jlb.0710409; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Park EJ, 2010, J PEDIATR GASTR NUTR, V50, P321, DOI 10.1097/MPG.0b013e3181ae2ba0; Peris-Bondia F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022448; Putignani L, 2014, PEDIATR RES, V76, P2, DOI 10.1038/pr.2014.49; Rafii F, 1999, DIGEST DIS SCI, V44, P637, DOI 10.1023/A:1026634229934; Rajilic-Stojanovic M, 2009, ENVIRON MICROBIOL, V11, P1736, DOI 10.1111/j.1462-2920.2009.01900.x; Salminen S, 1998, INT J FOOD MICROBIOL, V44, P93, DOI 10.1016/S0168-1605(98)00128-7; Singh T, 2011, AGEING RES REV, V10, P319, DOI 10.1016/j.arr.2010.11.002; Tabuchi M, 2003, BIOSCI BIOTECH BIOCH, V67, P1421, DOI 10.1271/bbb.67.1421; Trivedi PP, 2013, DIGEST DIS SCI, V58, P3460, DOI 10.1007/s10620-013-2831-6; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Xu SH, 2014, AGING DIS, V5, P263, DOI 10.14336/AD.2014.0500263; Yu BP, 1996, ANN NY ACAD SCI, V786, P1, DOI 10.1111/j.1749-6632.1996.tb39047.x	39	54	57	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0116533	10.1371/journal.pone.0116533	http://dx.doi.org/10.1371/journal.pone.0116533			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689583	Green Published, Green Submitted, gold			2022-12-26	WOS:000350322700013
J	Jia, YQ; Zeng, Z; Li, YY; Li, ZW; Jin, L; Zhang, Z; Wang, LF; Wang, FS				Jia, Yiqiong; Zeng, Zhen; Li, Yuanyuan; Li, Zhiwei; Jin, Lei; Zhang, Zheng; Wang, Lifeng; Wang, Fu-Sheng			Impaired Function of CD4+T Follicular Helper (Tfh) Cells Associated with Hepatocellular Carcinoma Progression	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; T-CELLS; IMMUNE LANDSCAPE; POOR SURVIVAL; B-CELLS; CANCER; DISEASE; AUTOIMMUNITY; INFECTION; FREQUENCY	Background and Aims CD4+ T follicular helper (Tfh) cells, a new subset of immune cells, have been demonstrated to be involved in the development and prognosis of tumors. However, their functional role in human hepatocellular carcinoma (HCC) is relatively unknown, and the detailed mechanisms in HCC development remain to be described. Methods A total of 85 HCC patients with hepatitis B virus (HBV) infection, 25 HBV-relative liver cirrhosis (LC) patients, and 20 healthy controls (HC) were randomly enrolled. Flow cytometric analysis, immunohistochemical staining, and relative function (i.e., cytokine secretion, B cell maturation) assays were used to analyze the properties of CXCR5+CD4+T cells. In addition, the relationship between the frequency of CXCR5+CD4+T cells and overall survival rates or disease-free survival rates was also analyzed by the Kaplan-Meier method. Results The frequency of circulating CXCR5+CD4+T cells was significantly decreased in HCC patients compared with HBV-relative liver cirrhosis (LC) patients and healthy controls, and the decrease in circulating CXCR5+CD4+T cells correlated with disease progression. The proportion of infiltrated CXCR5+CD4+T cells was significantly decreased in tumor regions compared with nontumor regions. Furthermore, compared with healthy controls, the function of circulating CXCR5+CD4+T cells in HCC was impaired, with reduced IL-21 secretion and dysfunction in promoting B cell maturation. Importantly, follow-up data indicated that a decreased frequency of circulating CXCR5+CD4+T cells was also associated with reduced disease-free survival time in HCC patients. Conclusions Impairment of CD4+T follicular helper cells may influence the development of HBV-associated HCC. Decreased CD4+T follicular helper cells may represent a potential prognostic marker and serve as a novel therapeutic target for HCC patients.	[Jia, Yiqiong; Wang, Fu-Sheng] Peking Univ, Mil Hosp China 302, Teaching Hosp, Res Ctr Biol Therapy, Beijing 100039, Peoples R China; [Zeng, Zhen; Li, Yuanyuan; Li, Zhiwei; Jin, Lei; Zhang, Zheng; Wang, Lifeng; Wang, Fu-Sheng] Beijing 302 Hosp, Res Ctr Biol Therapy, Beijing 100039, Peoples R China	Fifth Medical Center of Chinese PLA General Hospital; Peking University; Fifth Medical Center of Chinese PLA General Hospital	Wang, FS (corresponding author), Peking Univ, Mil Hosp China 302, Teaching Hosp, Res Ctr Biol Therapy, Beijing 100039, Peoples R China.	biowanglf@163.com; fswang302@163.com	li, yuanyuan/GZA-4435-2022	Wang, Lifeng/0000-0001-5095-6842	National Natural Science Foundation of China [81101589]; National Grand Program on Key Infectious Disease [2012ZX10001006-003-003]; Beijing Municipal & Technology Commission [Z131100004013041]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Grand Program on Key Infectious Disease; Beijing Municipal & Technology Commission	This work was supported by the National Natural Science Foundation of China (81101589), National Grand Program on Key Infectious Disease (2012ZX10001006-003-003) and Beijing Municipal & Technology Commission (Z131100004013041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahearne MJ, 2013, BRIT J HAEMATOL, V162, P360, DOI 10.1111/bjh.12401; Ahearne MJ, 2014, BRIT J HAEMATOL, DOI [10.1111/bjh.13234, DOI 10.1111/BJH.13234]; Alisa A, 2005, CLIN CANCER RES, V11, P6686, DOI 10.1158/1078-0432.CCR-05-0382; Aravalli RN, 2013, WORLD J GASTROENTERO, V19, P7500, DOI 10.3748/wjg.v19.i43.7500; Aravalli RN, 2008, HEPATOLOGY, V48, P2047, DOI 10.1002/hep.22580; Bao Y, 2014, J AUTOIMMUN, DOI [10.1016/j.jaut.2014.11.009, DOI 10.1016/J.JAUT.2014.11.009]; Behboudi S, 2010, WORLD J HEPATOL, V2, P256, DOI 10.4254/wjh.v2.i7.256; Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Cha ZS, 2013, TUMOR BIOL, V34, P3579, DOI 10.1007/s13277-013-0937-2; Chevalier N, 2011, J IMMUNOL, V186, P5556, DOI 10.4049/jimmunol.1002828; Deneys V, 2001, J IMMUNOL METHODS, V253, P23, DOI 10.1016/S0022-1759(01)00338-6; Ding ZC, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/890178; Dobrzanski MJ, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00063; Feng XB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051982; Fremd C, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.25443; Fu JL, 2007, GASTROENTEROLOGY, V132, P2328, DOI 10.1053/j.gastro.2007.03.102; Fu JL, 2013, HEPATOLOGY, V58, P139, DOI 10.1002/hep.26054; Grimm CF, 2000, GASTROENTEROLOGY, V119, P1104, DOI 10.1053/gast.2000.18157; Gu-Trantien C, 2013, J CLIN INVEST, V123, P2873, DOI 10.1172/JCI67428; Hu TT, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-54; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Le Coz C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075319; Li XY, 2012, BIOCHEM BIOPH RES CO, V422, P238, DOI 10.1016/j.bbrc.2012.04.133; Liu SM, 2013, J IMMUNOL, V191, P3501, DOI 10.4049/jimmunol.1301454; Luo CM, 2013, J NEUROIMMUNOL, V256, P55, DOI 10.1016/j.jneuroim.2012.12.001; Ma CS, 2014, IMMUNOL CELL BIOL, V92, P64, DOI 10.1038/icb.2013.55; Ma CS, 2012, BLOOD, V119, P3997, DOI 10.1182/blood-2011-11-392985; Ma CS, 2009, IMMUNOL CELL BIOL, V87, P590, DOI 10.1038/icb.2009.64; Ma CS, 2005, J CLIN INVEST, V115, P1049, DOI 10.1172/JCI23139; Ma J, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/827480; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Mossanen JC, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.26468; Nordenstedt H, 2010, DIGEST LIVER DIS, V42, pS206, DOI 10.1016/S1590-8658(10)60507-5; Pallikkuth S, 2012, CRIT REV IMMUNOL, V32, P173; Schafer DF, 1999, LANCET, V353, P1253, DOI 10.1016/S0140-6736(98)09148-X; Shi L, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-93; Shi WW, 2014, DNA CELL BIOL, V33, P355, DOI 10.1089/dna.2013.2332; Takemori T, 2014, EUR J IMMUNOL, V44, P1258, DOI 10.1002/eji.201343716; Tangye SG, 2013, NAT REV IMMUNOL, V13, P412, DOI 10.1038/nri3447; Tellier J, 2013, CELL MOL LIFE SCI, V70, P4771, DOI 10.1007/s00018-013-1420-3; Um SH, 2004, J IMMUNOL, V173, P1772, DOI 10.4049/jimmunol.173.3.1772; Vitale A, 2011, LANCET ONCOL, V12, P654, DOI 10.1016/S1470-2045(11)70144-9; Wang J, 2013, CLIN EXP IMMUNOL, V174, P212, DOI 10.1111/cei.12162; Wang XD, 2012, J INT MED RES, V40, P307, DOI 10.1177/147323001204000131; Wu S, 2014, MOD RHEUMATOL; Xiao F, 2013, J RHEUMATOL, V40, P2029, DOI 10.3899/jrheum.130125; Xing TJ, 2013, EXP THER MED, V5, P885, DOI 10.3892/etm.2012.864; Zamarron BF, 2011, INT J BIOL SCI, V7, P651, DOI 10.7150/ijbs.7.651; Zhao Y, 2014, RHEUMATOLOGY, V53, P621, DOI 10.1093/rheumatology/ket406	50	62	69	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117458	10.1371/journal.pone.0117458	http://dx.doi.org/10.1371/journal.pone.0117458			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689070	Green Published, Green Submitted, gold			2022-12-26	WOS:000350322700047
J	Kui, B; Balla, Z; Vasas, B; Vegh, ET; Pallagi, P; Kormanyos, ES; Venglovecz, V; Ivanyi, B; Takacs, T; Hegyi, P; Rakonczay, Z				Kui, Balazs; Balla, Zsolt; Vasas, Bela; Vegh, Eszter T.; Pallagi, Petra; Kormanyos, Eszter S.; Venglovecz, Viktoria; Ivanyi, Bela; Takacs, Tamas; Hegyi, Peter; Rakonczay, Zoltan, Jr.			New Insights into the Methodology of L-Arginine-Induced Acute Pancreatitis	PLOS ONE			English	Article							MICE; INJURY; NECROSIS; CELLS; MODEL	Animal models are ideal to study the pathomechanism and therapy of acute pancreatitis (AP). The use of L-arginine-induced AP model is nowadays becoming increasingly popular in mice. However, carefully looking through the literature, marked differences in disease severity could be observed. In fact, while setting up the L-arginine (2x4 g/kg i.p.)-induced AP model in BALB/c mice, we found a relatively low rate (around 15%) of pancreatic necrosis, whereas others have detected much higher rates (up to 55%). We suspected that this may be due to differences between mouse strains. We administered various concentrations (5-30%, pH = 7.4) and doses (2x4, 3x3, or 4x2.5 g/kg) of L-arginine-HCl in BALB/c, FVB/n and C57BL/6 mice. The potential gender-specific effect of L-arginine was investigated in C57BL/6 mice. The fate of mice in response to the i.p. injections of L arginine followed one of three courses. Some mice (1) developed severe AP or (2) remained AP-free by 72 h, whereas others (3) had to be euthanized (to avoid their death, which was caused by the high dose of L-arginine and not AP) within 12 h., In FVB/n and C57BL/6 mice, the pancreatic necrosis rate (about 50%) was significantly higher than that observed in BALB/c mice using 2x4 g/kg 10% L-arginine, but euthanasia was necessary in a large proportion of animals, The i.p. injection of lower L-arginine concentrations (e.g. 5-8%) in case of the 2x4 g/kg dose, or other L-arginine doses (3x3 or 4x2.5 g/kg, 10%) were better for inducing AP. We could not detect any significant differences between the AP severity of male and female mice. Taken together, when setting up the L-arginine-induced AP model, there are several important factors that are worth consideration such as the dose and concentration of the administered L arginine-HCl solution and also the strain of mice.	[Kui, Balazs; Balla, Zsolt; Vegh, Eszter T.; Pallagi, Petra; Kormanyos, Eszter S.; Takacs, Tamas; Hegyi, Peter; Rakonczay, Zoltan, Jr.] Univ Szeged, Dept Med 1, Szeged, Hungary; [Vasas, Bela; Ivanyi, Bela] Univ Szeged, Dept Pathol, Szeged, Hungary; [Venglovecz, Viktoria] Univ Szeged, Dept Pharmacol & Pharmacotherapy, Szeged, Hungary; [Hegyi, Peter] Univ Szeged, Hungarian Acad Sci, Translat Gastroenterol Res Grp, Szeged, Hungary	Szeged University; Szeged University; Szeged University; Hungarian Academy of Sciences; Szeged University	Rakonczay, Z (corresponding author), Univ Szeged, Dept Med 1, Szeged, Hungary.	rakonczay.zoltan@med.u-szeged.hu		Rakonczay Jr., Zoltan/0000-0002-1499-3416	Hungarian National Development Agency [TAMOP-4.2.2.A-11/1/KONV-2012-0035, TAMOP-4.2.2-A-11/1/KONV-2012-0052, TAMOP-4.2.2.A-11/1/KONV-2012-0073]; Hungarian Scientific Research Fund [NF105758, NF100677, K101116]; Hungarian Academy of Sciences [BO 00174/10/5, LP2014-10/2014]	Hungarian National Development Agency; Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Academy of Sciences(Hungarian Academy of Sciences)	Funding from the Hungarian National Development Agency (TAMOP-4.2.2.A-11/1/KONV-2012-0035, TAMOP-4.2.2-A-11/1/KONV-2012-0052 TAMOP-4.2.2.A-11/1/KONV-2012-0073), the Hungarian Scientific Research Fund (NF105758, NF100677, K101116), and the Hungarian Academy of Sciences (BO 00174/10/5, LP2014-10/2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedrosian AS, 2011, GASTROENTEROLOGY, V141, P1915, DOI 10.1053/j.gastro.2011.07.033; Biczo G, 2011, ANTIOXID REDOX SIGN, V15, P2669, DOI 10.1089/ars.2011.4065; Bohus E, 2008, J PROTEOME RES, V7, P4435, DOI 10.1021/pr800407j; Cui HF, 2003, WORLD J GASTROENTERO, V9, P2274; Dawra R, 2012, PANCREAPEDIA EXOCRIN; Dawra R, 2007, AM J PHYSIOL-GASTR L, V292, pG1009, DOI 10.1152/ajpgi.00167.2006; Hegyi P, 2013, PANCREAPEDIA EXOCRIN; Hegyi P, 2004, WORLD J GASTROENTERO, V10, P2003, DOI 10.3748/wjg.v10.i14.2003; Hu GY, 2011, GUT, V60, P820, DOI 10.1136/gut.2010.215178; HUANG L, 2012, CHIN J INTEGR MED; Kuebler W, 1996, INT J MICROCIRC CLIN, P89; Kui B, 2014, LAB INVEST, V94, P138, DOI 10.1038/labinvest.2013.143; LOMBARDI B, 1975, AM J PATHOL, V79, P465; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lunova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039972; MIZUNUMA T, 1984, J NUTR, V114, P467, DOI 10.1093/jn/114.3.467; Pandol SJ, 2007, GASTROENTEROLOGY, V132, P1127, DOI 10.1053/j.gastro.2007.01.055; Rakonczay Z, 2003, FREE RADICAL BIO MED, V34, P696, DOI 10.1016/S0891-5849(02)01373-4; Sakai A, 2012, ARCH BIOCHEM BIOPHYS, V522, P107, DOI 10.1016/j.abb.2012.03.025; Sharif R, 2009, GUT, V58, P813, DOI 10.1136/gut.2008.170423; Shen JQ, 2012, CYTOKINE, V60, P294, DOI 10.1016/j.cyto.2012.05.005; Singh VP, 2007, GUT, V56, P958, DOI 10.1136/gut.2006.094268; Su Kim Hue, 2006, HPB (Oxford), V8, P264, DOI 10.1080/13651820500467358; TANI S, 1990, DIGEST DIS SCI, V35, P367, DOI 10.1007/BF01537416; Toth L A, 2000, ILAR J, V41, P72; TOTH LA, 1995, J NEUROIMMUNOL, V58, P89, DOI 10.1016/0165-5728(94)00193-R; Wang J, 2010, LAB INVEST, V90, P654, DOI 10.1038/labinvest.2010.44; Yuan H, 2009, PANCREAS, V38, P143, DOI 10.1097/MPA.0b013e31818166b4	28	43	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117588	10.1371/journal.pone.0117588	http://dx.doi.org/10.1371/journal.pone.0117588			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25688985	gold, Green Published, Green Submitted			2022-12-26	WOS:000350322700059
J	Lee, IS; Lee, YS; Park, HJ; Lee, H; Chae, Y				Lee, In-Seon; Lee, Ye-Seul; Park, Hi-Joon; Lee, Hyejung; Chae, Younbyoung			Evaluation of Phantom-Based Education System for Acupuncture Manipulation	PLOS ONE			English	Article							NEEDLE MANIPULATION; CHINESE ACUPUNCTURE; HAPTIC SIMULATION; SKILLS	Background Although acupuncture manipulation has been regarded as one of the important factors in clinical outcome, it has been difficult to train novice students to become skillful experts due to a lack of adequate educational program and tools. Objectives In the present study, we investigated whether newly developed phantom acupoint tools would be useful to practice-naive acupuncture students for practicing the three different types of acupuncture manipulation to enhance their skills. Methods We recruited 12 novice students and had them practice acupuncture manipulations on the phantom acupoint (5% agarose gel). We used the Acusensor 2 and compared their acupuncture manipulation techniques, for which the target criteria were depth and time factors, at acupoint LI11 in the human body before and after 10 training sessions. The outcomes were depth of needle insertion, depth error from target criterion, time of rotating, lifting, and thrusting, time error from target criteria and the time ratio. Results After 10 training sessions, the students showed significantly improved outcomes in depth of needle, depth error (rotation, reducing lifting/thrusting), thumb-forward time error, thumbbackward time error (rotation), and lifting time (reinforcing lifting/thrusting). Conclusions The phantom acupoint tool could be useful in a phantom-based education program for acupuncture-manipulation training for students. For advanced education programs for acupuncture manipulation, we will need to collect additional information, such as patient responses, acupoint-specific anatomical characteristics, delicate tissue-like modeling, haptic and visual feedback, and data from an acupuncture practice simulator.	[Lee, In-Seon; Lee, Ye-Seul; Park, Hi-Joon; Lee, Hyejung; Chae, Younbyoung] Kyung Hee Univ, Acupuncture & Meridian Sci Res Ctr, Coll Korean Med, Seoul, South Korea	Kyung Hee University	Chae, Y (corresponding author), Kyung Hee Univ, Acupuncture & Meridian Sci Res Ctr, Coll Korean Med, Seoul, South Korea.	ybchae@khu.ac.kr	Park, Hi-Joon/AAG-1196-2021; Chae, Younbyoung/AAM-1243-2020; Lee, In-Seon/AAM-1252-2020	Lee, In-Seon/0000-0001-9275-3111; Lee, Ye-Seul/0000-0001-6127-5401	National Research Foundation of Korea (NRF) - Korea government (MSIP) [2011-0009913, 2013R1A6A6029251]	National Research Foundation of Korea (NRF) - Korea government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP)(No. 2011-0009913 & 2013R1A6A6029251). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baak JPA, 2002, J PATHOL, V198, P277, DOI 10.1002/path.1233; Gerovich Oleg, 2004, Comput Aided Surg, V9, P243, DOI 10.3109/10929080500190441; Heng PA, 2006, IEEE T INF TECHNOL B, V10, P28, DOI 10.1109/TITB.2005.855567; Hu Yin'e, 2010, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V27, P991; Kim GH, 2010, NEUROL RES, V32, pS92, DOI 10.1179/016164109X12537002794327; Lee IS, 2014, J ALTERN COMPLEM MED, V20, P654, DOI 10.1089/acm.2013.0475; Leung KM, 2003, ST HEAL T, V94, P187; Li J, 2013, ACUPUNCT MED, V31, P172, DOI 10.1136/acupmed-2012-010265; Liu Tang-yi, 2008, Zhongguo Zhen Jiu, V28, P356; Luciano C, 2009, VIRTUAL REAL-LONDON, V13, P69, DOI 10.1007/s10055-009-0112-7; Riener R, 2004, IEEE T INF TECHNOL B, V8, P208, DOI 10.1109/TITB.2004.828885; Seo Y, 2014, ACUPUNCT MED, V32, P394, DOI 10.1136/acupmed-2014-010585; Shi GX, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-42; Sturm LP, 2008, ANN SURG, V248, P166, DOI 10.1097/SLA.0b013e318176bf24; Wang Hai-sheng, 2009, Zhongguo Zhen Jiu, V29, P745; White A, 2008, ACUPUNCT MED, V26, P111, DOI 10.1136/aim.26.2.111	16	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117992	10.1371/journal.pone.0117992	http://dx.doi.org/10.1371/journal.pone.0117992			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689598	gold, Green Submitted, Green Published			2022-12-26	WOS:000350322700091
J	Wiewiora, B; Zurek, G; Panka, D				Wiewiora, Barbara; Zurek, Grzegorz; Panka, Dariusz			Is the Vertical Transmission of Neotyphodium lolii in Perennial Ryegrass the Only Possible Way to the Spread of Endophytes?	PLOS ONE			English	Article							ACREMONIUM ENDOPHYTES; FUNGAL ENDOPHYTES; MEADOW FESCUE; TALL FESCUE; RED FESCUE; GRASSES; ASSOCIATIONS; DROUGHT; ABILITY; CONIDIA	Endophytic fungi live their whole life within host tissues usually without any visible symptoms. Their vertical transmission (seed-plant-seed) has been well described and documented. However, horizontal transmission (plant-plant) needs more clarification. The aim of this study was to assess the extent to which endophytes move vertically in ecotypes of perennial ryegrass and whether there is evidence for the horizontal transmission of endophytes. Ecotypes from grasslands in Poland were collected in the form of living plants and used for vertical transmission analysis. Plants, the seed collected from these plants and plants grown from this collected seed were tested for endophytic infection. Provided that all produced seeds were viable and able to germinate and produce seedlings, the vertical transmission of Neotyphodium endophytes in perennial ryegrass ecotypes was nearly complete. For the horizontal transmission experiment, endophyte-hosting plants (E+) and endophyte-free plants (E-) of four cultivars were planted in the field in close proximity on small plots that were frequently mown. These studies revealed that after 7 months of growth next to E+ plants, the characteristic Neotyphodium spp. mycelia were found in E- plants, which was especially true for plants growing in close proximity to the infected plants. The occurrence of horizontal transmission of endophytes has not been previously demonstrated.	[Wiewiora, Barbara] Natl Res Inst, Plant Breeding & Acclimatizat Inst, Dept Seed Sci & Technol, Radzikow, Poland; [Zurek, Grzegorz] Natl Res Inst, Plant Breeding & Acclimatizat Inst, Dept Grasses Legumes & Energy Plants, Radzikow, Poland; [Panka, Dariusz] Univ Technol & Life Sci, Dept Mol Phytopathol, Bydgoszcz, Poland	Institute of Plant Breeding & Acclimatization; Institute of Plant Breeding & Acclimatization; Bydgoszcz University of Science & Technology	Zurek, G (corresponding author), Natl Res Inst, Plant Breeding & Acclimatizat Inst, Dept Grasses Legumes & Energy Plants, Radzikow, Poland.	g.zurek@ihar.edu.pl	Zurek, Grzegorz/F-3493-2013; Wiewióra, Barbara/AAT-7572-2020; Pańka, Dariusz/AAS-3182-2021	Wiewióra, Barbara/0000-0003-3969-6968; Pańka, Dariusz/0000-0001-5979-0287; Zurek, Grzegorz/0000-0003-2359-2232				Bacon C.W., 1994, BIOTECHNOLOGY ENDOPH, P47; Ball D., 2007, FORAGE MANAGEMENT GR; Cagas B., 2005, RECENT ADV GENETICS, P177; Cheplick G. P., 2009, ECOLOGY EVOLUTION GR, P1; Chlebicki A., 2004, KOSMOS, V53, P33, DOI DOI 10.1371/JOURNAL; CHRISTENSEN MJ, 1995, MYCOL RES, V99, P466, DOI 10.1016/S0953-7562(09)80647-3; Chung KR, 1997, MYCOL RES, V101, P295, DOI 10.1017/S0953756296002602; Clay K, 1999, SCIENCE, V285, P1742, DOI 10.1126/science.285.5434.1742; Cross D.L., 2000, P 4 INT NEOT GRASS I, P219; DAPPRICH P, 1994, IOBC WRPS B, V17, P131; Dombrowski JE, 2006, CROP SCI, V46, P1064, DOI 10.2135/cropsci2005.05-0054; Eerens JPJ, 1998, NEW ZEAL J AGR RES, V41, P39, DOI 10.1080/00288233.1998.9513286; Faeth SH, 1997, ECOLOGY, V78, P810, DOI 10.1890/0012-9658(1997)078[0810:FEIOTL]2.0.CO;2; Gwinn KD, 1998, CROP SCI, V38, P201, DOI 10.2135/cropsci1998.0011183X003800010033x; Hill NS, 2002, SEED SCI TECHNOL, V30, P347; Hume D, 2000, P 4 INT NEOT GRASS I, P97; Hume DE, 2005, NEOTYPHODIUM IN COOL-SEASON GRASSES, P201; Humphreys M, 2010, HANDB PLANT BREED, V5, P211, DOI 10.1007/978-1-4419-0760-8_10; Iannone LJ, 2009, MYCOLOGIA, V101, P340, DOI 10.3852/08-156; International Rules for Seed Testing, INT RUL SEED TEST; JUNG GA, 1996, AGRON MONOGR, V34, P605; Kuldau G, 2008, BIOL CONTROL, V46, P57, DOI 10.1016/j.biocontrol.2008.01.023; Lewis G.C., 1996, IOBC WPRS B, V19, P17; Lewis GC, 2000, P 4 INT NEOT GRASS I, P123; Malinowski DP, 2000, CROP SCI, V40, P923, DOI 10.2135/cropsci2000.404923x; Panka D, 2013, ACTA SCI POL-HORTORU, V12, P67; Panka D, 2011, ACTA SCI POL-HORTORU, V10, P115; Pennell CGL, 2001, P 4 INT NEOT GRASS I, P465; Penrose CD, 2001, PROCEEDINGS OF THE XIX INTERNATIONAL GRASSLAND CONGRESS, P610; Petrini O., 1986, MICROBIOLOGY PHYLLOS, P175; Popay A.J., 1999, GRASSLAND RES PRACTI, V7, P113; Ravel C, 1997, AGRONOMIE, V17, P173, DOI 10.1051/agro:19970304; Rolston MP, 2002, NEW ZEAL J BOT, V40, P365; Rolston MP, 1995, P 3 INT HERB SEED C, P433; SAHA DC, 1988, PHYTOPATHOLOGY, V78, P237, DOI 10.1094/Phyto-78-237; Saikkonen K, 2002, P ROY SOC B-BIOL SCI, V269, P1397, DOI 10.1098/rspb.2002.2006; Schardl CL, 2001, FUNGAL GENET BIOL, V33, P69, DOI 10.1006/fgbi.2001.1275; SIEGEL MR, 1990, J CHEM ECOL, V16, P3301, DOI 10.1007/BF00982100; Tadych M, 2007, MYCOL RES, V111, P466, DOI 10.1016/j.mycres.2007.02.002; Thorogood D, 2003, TURFGRASS BIOL GENET, P75; WHITE JF, 1987, PLANT DIS, V71, P340, DOI 10.1094/PD-71-0340; White JF, 1996, MYCOLOGIA, V88, P174, DOI 10.2307/3760920; WHITE JF, 1993, AGR ECOSYST ENVIRON, V44, P13, DOI 10.1016/0167-8809(93)90037-P; Wiewiora B., 2006, B IHAR, V242, P285; Wiewiora B., 2010, B IHAR, V256, P183; Wiewiora B., 2011, J LIFE SCI, V5, P831; Wiewiora B, 2011, MONOGRAFIE ROZPRAWY, V38, P1; Zabalgogeazcoa I, 2003, GRASS FORAGE SCI, V58, P94, DOI 10.1046/j.1365-2494.2003.00352.x; Zurek G, 2013, FUNGAL ECOL, V6, P554, DOI 10.1016/j.funeco.2013.09.001; Zurek M, 2012, FUNGAL ECOL, V5, P353, DOI 10.1016/j.funeco.2011.07.007	50	24	26	5	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117231	10.1371/journal.pone.0117231	http://dx.doi.org/10.1371/journal.pone.0117231			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680199	Green Published, gold, Green Submitted			2022-12-26	WOS:000350682600055
J	Religa, D; Fereshtehnejad, SM; Cermakova, P; Edlund, AK; Garcia-Ptacek, S; Granqvist, N; Hallback, A; Kawe, K; Farahmand, B; Kilander, L; Mattsson, UB; Nagga, K; Nordstrom, P; Wijk, H; Wimo, A; Winblad, B; Eriksdotter, M				Religa, Dorota; Fereshtehnejad, Seyed-Mohammad; Cermakova, Pavla; Edlund, Ann-Katrin; Garcia-Ptacek, Sara; Granqvist, Nicklas; Hallback, Anne; Kawe, Kerstin; Farahmand, Bahman; Kilander, Lena; Mattsson, Ulla-Britt; Nagga, Katarina; Nordstrom, Peter; Wijk, Helle; Wimo, Anders; Winblad, Bengt; Eriksdotter, Maria			SveDem, the Swedish Dementia Registry - A Tool for Improving the Quality of Diagnostics, Treatment and Care of Dementia Patients in Clinical Practice	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; MORTALITY RISK; OLDER-ADULTS; LEWY BODIES; DRUG-USE; CRITERIA; SWEDEN; MEDICATION; MANAGEMENT; NATIONWIDE	Background The Swedish Dementia Registry (SveDem) was developed with the aim to improve the quality of diagnostic work-up, treatment and care of patients with dementia disorders in Sweden. Methods SveDem is an internet based quality registry where several indicators can be followed over time. It includes information about the diagnostic work-up, medical treatment and community support (www.svedem.se). The patients are diagnosed and followed-up yearly in specialist units, primary care centres or in nursing homes. Results The database was initiated in May 2007 and covers almost all of Sweden. There were 28 722 patients registered with a mean age of 79.3 years during 2007-2012. Each participating unit obtains continuous online statistics from its own registrations and they can be compared with regional and national data. A report from SveDem is published yearly to informmedical and care professionals as well as political and administrative decision-makers about the current quality of diagnostics, treatment and care of patients with dementia disorders in Sweden. Conclusion SveDem provides knowledge about current dementia care in Sweden and serves as a framework for ensuring the quality of diagnostics, treatment and care across the country. It also reflects changes in quality dementia care over time. Data from SveDem can be used to further develop the national guidelines for dementia and to generate new research hypotheses.	[Religa, Dorota; Cermakova, Pavla; Farahmand, Bahman; Wimo, Anders; Winblad, Bengt] Karolinska Inst, Dept Neurobiol, Care Sci & Soc, Ctr Alzheimer Res,Div Neurogeriatr, Huddinge, Sweden; [Religa, Dorota; Edlund, Ann-Katrin; Garcia-Ptacek, Sara; Eriksdotter, Maria] Karolinska Univ Hosp, Geriatr Clin, Stockholm, Sweden; [Fereshtehnejad, Seyed-Mohammad; Garcia-Ptacek, Sara; Eriksdotter, Maria] Karolinska Inst, Dept Neurobiol, Care Sci & Soc, Ctr Alzheimer Res,Div Clin Geriatr, Huddinge, Sweden; [Granqvist, Nicklas] Tradgardstorgets Primary Care Unit, Linkoping, Sweden; [Hallback, Anne] Municipal Norrtalje, Norrtalje, Sweden; [Kawe, Kerstin] Cent Hosp Karlstad, Karlstad, Sweden; [Kilander, Lena] Uppsala Univ, Dept Publ Hlth & Caring Sci Geriatr, Uppsala, Sweden; [Mattsson, Ulla-Britt] Sahlgrens Univ Hosp, Neuropsychiat Clin, Gothenburg, Sweden; [Nagga, Katarina] Lund Univ, Dept Clin Sci Malmo, Clin Memory Res Unit, Malmo, Sweden; [Nordstrom, Peter] Umea Univ, Dept Community Med & Rehabil, Umea, Sweden; [Wijk, Helle] Gothenburg Univ, Inst Hlth & Care Sci, Sahlgrenska Acad, Gothenburg, Sweden; [Wimo, Anders] Uppsala Univ, Cty Council Gavleborg, Ctr Res & Dev, Gavle, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Uppsala University; Sahlgrenska University Hospital; Lund University; Umea University; University of Gothenburg; Uppsala University	Religa, D (corresponding author), Karolinska Inst, Dept Neurobiol, Care Sci & Soc, Ctr Alzheimer Res,Div Neurogeriatr, Huddinge, Sweden.	Dorota.Religa@ki.se	Eriksdotter, Maria/I-5427-2015; Fereshtehnejad, Seyed-Mohammad/ABF-6020-2020; Wimo, Anders/ABA-2678-2021; Cermakova, Pavla/C-5890-2019; Garcia-Ptacek, Sara/AAD-5631-2019; Ptacek, Sara Garcia/AAS-2618-2021; Wijk, Helle/AAY-9660-2021	Eriksdotter, Maria/0000-0003-2498-4000; Fereshtehnejad, Seyed-Mohammad/0000-0001-9255-9351; Cermakova, Pavla/0000-0002-9282-9363; Ptacek, Sara Garcia/0000-0002-1537-6129; Wijk, Helle/0000-0003-2396-6505; Religa, Dorota/0000-0003-4583-4570; Nagga, Katarina/0000-0003-0194-8402; Nordstrom, Peter/0000-0003-2924-508X; Wimo, Anders/0000-0003-0963-5750	Swedish Association of Local Authorities and Regions; Swedish Brain Power network; Svenska Lakaresallskapet; Alzheimerfonden; Swedish Research Council [2012-2291]	Swedish Association of Local Authorities and Regions; Swedish Brain Power network; Svenska Lakaresallskapet; Alzheimerfonden; Swedish Research Council(Swedish Research CouncilEuropean Commission)	SveDem register is supported by the Swedish Association of Local Authorities and Regions and the Swedish Brain Power network. Financial support of Svenska Lakaresallskapet, Alzheimerfonden and Swedish Research Council (Drn 2012-2291) for Dorota Religa is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brandt NJ, 2013, J GERONTOL NURS, V39, P8, DOI 10.3928/00989134-20130315-05; BRUN A, 1994, J NEUROL NEUROSUR PS, V57, P416; Cermakova P, 2014, EUR J NEUROL, V21, P34; Douglas IJ, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1227; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507; Eriksson H, 2014, J ALZHEIMERS DIS, V41, P411, DOI 10.3233/JAD-132273; Falahati F, 2015, DEMENT GERIATR COGN, V39, P81, DOI 10.1159/000366194; Falk H, 2007, INT PSYCHOGERIATR, V19, P1040, DOI 10.1017/S1041610207005777; Faxen-Irving G, 2014, DEMENT GER COGN D EX, V4, P65, DOI 10.1159/000360415; Feldman AL, 2012, NEUROEPIDEMIOLOGY, V38, P186, DOI 10.1159/000336356; Fereshtehnejad SM, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0065-2; Fereshtehnejad SM, 2014, DRUG AGING, V31, P215, DOI 10.1007/s40266-014-0154-8; Fereshtehnejad SM, 2013, NEUROPSYCH DIS TREAT, V9, P927, DOI 10.2147/NDT.S45840; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fratiglioni L, 2000, NEUROLOGY, V54, pS10; Frisoni GB, 2011, LANCET NEUROL, V10, P598, DOI 10.1016/S1474-4422(11)70126-0; Fritsch T, 2001, Am J Alzheimers Dis Other Demen, V16, P369, DOI 10.1177/153331750101600606; Garcia-Ptacek S, 2014, J ALZHEIMERS DIS, V41, P467, DOI 10.3233/JAD-131856; Garcia-Ptacek S, 2014, J AM MED DIR ASSOC, V15, DOI 10.1016/j.jamda.2014.03.001; Gustafsson M, 2013, BMC PHARMACOL TOXICO, V14, DOI 10.1186/2050-6511-14-56; Iliffe S, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-9; Jedenius E, 2011, SCAND J PRIM HEALTH, V29, P181, DOI 10.3109/02813432.2011.585277; Jennings L, 2013, J AM MED DIR ASSOC, V14, P447, DOI 10.1016/j.jamda.2013.03.015; Johannsen P, 2011, AGING MENT HEALTH, V15, P40, DOI 10.1080/13607863.2010.508769; Johnell K, 2013, DEMENT GERIATR COGN, V35, P239, DOI 10.1159/000348408; Johnell K, 2012, DRUG AGING, V29, P751, DOI 10.1007/s40266-012-0002-7; Jonsson L, 2006, ALZ DIS ASSOC DIS, V20, P49; Kling MA, 2013, ALZHEIMERS DEMENT, V9, P76, DOI 10.1016/j.jalz.2012.02.007; Langballe EM, 2014, AM J GERIAT PSYCHIAT, V22, P321, DOI 10.1016/j.jagp.2013.06.007; Matthews FE, 2013, LANCET, V382, P1405, DOI 10.1016/S0140-6736(13)61570-6; McEvoy Phil, 2008, Br J Community Nurs, V13, P127; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; Nordstrom P, 2013, EUR HEART J, V34, P2585, DOI 10.1093/eurheartj/eht182; Qiu CX, 2013, NEUROLOGY, V80, P1888, DOI 10.1212/WNL.0b013e318292a2f9; Religa D, 2012, DEMENT GERIATR COGN, V33, P90, DOI 10.1159/000337038; Rocca WA, 2011, ALZHEIMERS DEMENT, V7, P80, DOI 10.1016/j.jalz.2010.11.002; Rochon PA, 2008, ARCH INTERN MED, V168, P1090, DOI 10.1001/archinte.168.10.1090; Roos LL, 1999, J CLIN EPIDEMIOL, V52, P39, DOI 10.1016/S0895-4356(98)00126-7; Santos M, 2014, QUAL MANAG HEALTH CA, V23, P119, DOI 10.1097/QMH.0000000000000021; Schrijvers EMC, 2012, NEUROLOGY, V78, P1456, DOI 10.1212/WNL.0b013e3182553be6; Schulze J, 2013, PHARMACOEPIDEM DR S, V22, P1308, DOI 10.1002/pds.3527; Skillback T, 2014, NEUROLOGY, V83, P1945, DOI 10.1212/WNL.0000000000001015; Skoldunger A, 2012, INT J GERIATR PSYCH, V27, P1112, DOI 10.1002/gps.2828; Socialstyrelsen, 2010, NATL GUID CAR CAS DE; Sorbi S, 2012, EUR J NEUROL, V19, P1159, DOI 10.1111/j.1468-1331.2012.03784.x; Stromberg C N, 1988, J Arthroplasty, V3, P47, DOI 10.1016/S0883-5403(88)80052-4; SveDem, SVEDEM ANN REPORT 20; Tolppanen AM, 2012, J ALZHEIMERS DIS, V32, P531, DOI 10.3233/JAD-2012-120802; van Vollenhoven RF, 2005, CLIN EXP RHEUMATOL, V23, pS195; WHO, 2012, ICD 10 CLASS MENT BE; Wimo A, UNPUB; Wimo A, 2013, INT J GERIATR PSYCH, V28, P1039, DOI 10.1002/gps.3925; Wimo Anders, 2009, Lakartidningen, V106, P1277	54	93	93	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0116538	10.1371/journal.pone.0116538	http://dx.doi.org/10.1371/journal.pone.0116538			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695768	Green Published, gold			2022-12-26	WOS:000350062300015
J	Mitry, D; Peto, T; Hayat, S; Blows, P; Morgan, J; Khaw, T; Foster, PJ				Mitry, Danny; Peto, Tunde; Hayat, Shabina; Blows, Peter; Morgan, James; Khaw, Tee; Foster, Paul J.			Crowdsourcing as a Screening Tool to Detect Clinical Features of Glaucomatous Optic Neuropathy from Digital Photography	PLOS ONE			English	Article							DISC PHOTOGRAPHS; OPHTHALMOLOGISTS; OPHTHALMOSCOPY; CLASSIFICATION; AGREEMENT; WHITES	Aim Crowdsourcing is the process of simplifying and outsourcing numerous tasks to many untrained individuals. Our aim was to assess the performance and repeatability of crowdsourcing in the classification of normal and glaucomatous discs from optic disc images. Methods Optic disc images (N = 127) with pre-determined disease status were selected by consensus agreement from grading experts from a large cohort study. After reading brief illustrative instructions, we requested that knowledge workers (KWs) from a crowdsourcing platform (Amazon MTurk) classified each image as normal or abnormal. Each image was classified 20 times by different KWs. Two study designs were examined to assess the effect of varying KW experience and both study designs were conducted twice for consistency. Performance was assessed by comparing the sensitivity, specificity and area under the receiver operating characteristic curve (AUC). Results Overall, 2,540 classifications were received in under 24 hours at minimal cost. The sensitivity ranged between 83-88% across both trials and study designs, however the specificity was poor, ranging between 35-43%. In trial 1, the highest AUC (95% CI) was 0.64(0.62-0.66) and in trial 2 it was 0.63(0.61-0.65). There were no significant differences between study design or trials conducted. Conclusions Crowdsourcing represents a cost-effective method of image analysis which demonstrates good repeatability and a high sensitivity. Optimisation of variables such as reward schemes, mode of image presentation, expanded response options and incorporation of training modules should be examined to determine their effect on the accuracy and reliability of this technique in retinal image analysis.	[Mitry, Danny; Peto, Tunde; Blows, Peter; Foster, Paul J.] Moorfields Eye Hosp, NIHR Biomed Res Ctr, London, England; [Mitry, Danny; Peto, Tunde; Blows, Peter; Foster, Paul J.] UCL Inst Ophthalmol, London, England; [Hayat, Shabina] Univ Cambridge, Dept Publ Hlth & Primary Care, Strangeways Res Lab, Cambridge, England; [Morgan, James] Cardiff Univ, Sch Optometry & Vis Sci, Cardiff CF10 3AX, S Glam, Wales; [Khaw, Tee] Univ Cambridge, Addenbrookes Hosp, Dept Clin Gerontol, Cambridge CB2 2QQ, England	University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; University of Cambridge; Cardiff University; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Foster, PJ (corresponding author), Moorfields Eye Hosp, NIHR Biomed Res Ctr, London, England.	p.foster@ucl.ac.uk	Foster, Paul/V-7288-2019; Peto, Tunde/G-8812-2018; Morgan, James/GRO-2905-2022	Foster, Paul/0000-0002-4755-177X; Peto, Tunde/0000-0001-6265-0381; Morgan, James/0000-0002-8920-1065	Fight For Sight grant award [1471/2]; Medical Research Council [G0401527, G1000143] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10114] Funding Source: researchfish; Fight for Sight [1471/72, 1507/08] Funding Source: researchfish	Fight For Sight grant award; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Fight for Sight	The authors would like to acknowledge the Special Trustees of Moorfields Eye Hospital and NIHR Biomedical Research Centre at Moorfields Eye Hospital and UCL Institute of Ophthalmology. This study was funded by a Fight For Sight grant award (Ref: 1471/2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuara-Blanco A, 2003, AM J OPHTHALMOL, V136, P949, DOI 10.1016/S0002-9394(03)00480-X; Badala F, 2007, AM J OPHTHALMOL, V144, P724, DOI 10.1016/j.ajo.2007.07.010; Bock R, 2010, MED IMAGE ANAL, V14, P471, DOI 10.1016/j.media.2009.12.006; Breusegem C, 2011, OPHTHALMOLOGY, V118, P742, DOI 10.1016/j.ophtha.2010.08.019; Bussel II, 2013, BR J OPHTHALMOL; Girkin CA, 2004, INVEST OPHTH VIS SCI, V45, P2272, DOI 10.1167/iovs.03-0996; Girkin CA, 2006, OPHTHALMOLOGY, V113, P2144, DOI 10.1016/j.ophtha.2006.06.035; Jonas JB, 2000, PROG RETIN EYE RES, V19, P1, DOI 10.1016/S1350-9462(99)00002-6; Mitry D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071154; Mowatt G, 2008, INVEST OPHTH VIS SCI, V49, P5373, DOI 10.1167/iovs.07-1501; Nguyen TB, 2012, RADIOLOGY, V262, P824, DOI 10.1148/radiol.11110938; Vessani RM, 2009, J GLAUCOMA, V18, P253, DOI 10.1097/IJG.0b013e31818153da; Wollstein G, 2000, OPHTHALMOLOGY, V107, P2272, DOI 10.1016/S0161-6420(00)00363-8	13	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117401	10.1371/journal.pone.0117401	http://dx.doi.org/10.1371/journal.pone.0117401			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692287	Green Published, gold, Green Submitted			2022-12-26	WOS:000350061500054
J	Platas-Neri, D; Hidalgo-Tobon, S; Alonso, BD; de Leon, FCP; Munoz-Delgado, J; Phillips, KA				Platas-Neri, Diana; Hidalgo-Tobon, Silvia; da Celis Alonso, Benito; Chico-Ponce de Leon, Fernando; Munoz-Delgado, Jairo; Phillips, Kimberley A.			Tractography of the Spider Monkey (Ateles geoffroyi) Corpus Callosum Using Diffusion Tensor Magnetic Resonance Imaging	PLOS ONE			English	Article							ORGANIZATION; SIZE; TOPOGRAPHY; MRI; CONNECTIONS; COMPETITION; EVOLUTION; PRIMATES; CORTEX	The objective of this research was to describe the organization, connectivity and microstructure of the corpus callosum of the spider monkey (Ateles geoffroyi). Non-invasive magnetic resonance imaging and diffusion-tensor imaging were obtained from three subjects using a 3T Philips scanner. We hypothesized that the arrangement of fibers in spider monkeys would be similar to that observed in other non-human primates. A repeated measure (n = 3) of fractional anisotropy values was obtained of each subject and for each callosal subdivision. Measurements of the diffusion properties of corpus callosum fibers exhibited a similar pattern to those reported in the literature for humans and chimpanzees. No statistical difference was reached when comparing this parameter between the different CC regions (p = 0.066). The highest fractional anisotropy values corresponded to regions projecting from the corpus callosum to the posterior cortical association areas, premotor and supplementary motor cortices. The lowest fractional anisotropy corresponded to projections to motor and sensory cortical areas. Analyses indicated that approximately 57% of the fibers projects to the frontal cortex and 43% to the post-central cortex. While this study had a small sample size, the results provided important information concerning the organization of the corpus callosum in spider monkeys.	[Platas-Neri, Diana] Univ Autonoma Estado Morelos, Inst Profes Reg Sur, Jojutla, Morelos, Mexico; [Hidalgo-Tobon, Silvia; Chico-Ponce de Leon, Fernando] Hosp Infantil Mexico Dr Federico Gomez, Dept Neurocirugia, Mexico City, DF, Mexico; [Hidalgo-Tobon, Silvia] Univ Autonoma Metropolitana Iztapalapa, Dept Fis, Mexico City, DF, Mexico; [da Celis Alonso, Benito] Benemerita Univ Puebla, Fac Ciencias Fis & Matemat, Puebla, Puebla, Mexico; [Munoz-Delgado, Jairo] Inst Nacl Psiquiatria Ramon de la Fuente Muniz, Direcc Neurociencias, Mexico City, DF, Mexico; [Munoz-Delgado, Jairo] Univ Nacl Autonoma Mexico, Fac Psicol, Mexico City 04510, DF, Mexico; [Phillips, Kimberley A.] Trinity Univ, Dept Psychol, San Antonio, TX 78212 USA	Universidad Autonoma del Estado de Morelos; Hospital Infantil de Mexico Federico Gomez; Universidad Autonoma Metropolitana - Mexico; Benemerita Universidad Autonoma de Puebla; Instituto Nacional de Psiquiatria Ramon de la Fuente Muniz; Universidad Nacional Autonoma de Mexico; Trinity University	Platas-Neri, D (corresponding author), Univ Autonoma Estado Morelos, Inst Profes Reg Sur, Jojutla, Morelos, Mexico.	dplatasn@gmail.com	, de Celis Alonso Benito/AAP-4512-2021; , db/GRS-6835-2022; Phillips, Kimberley/P-1212-2016	, de Celis Alonso Benito/0000-0003-2124-1084; Platas, Diana/0000-0001-6738-0974; Phillips, Kimberley/0000-0002-5517-3596	Council for Science and Technology, Mexico (CONACYT) [109147]; Fulbright-COMEXUS	Council for Science and Technology, Mexico (CONACYT); Fulbright-COMEXUS	This work was supported by the Council for Science and Technology, Mexico (CONACYT) ( project 109147) and Fulbright-COMEXUS (grant to DPN) (www.cies.org;www.comexus.org.mx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbie AA, 1940, J COMP NEUROL, V72, P9; ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; Aboitiz F, 1992, Biol Res, V25, P51; Alexander AL, 2000, MAGNET RESON MED, V44, P283, DOI 10.1002/1522-2594(200008)44:2<283::AID-MRM16>3.0.CO;2-V; Allman J, 1991, EVOLVING BRAINS; Aureli F, 2011, PRIMATES PERSPECTIVE, P236; Aureli F, 2008, CURR ANTHROPOL, V49, P627, DOI 10.1086/586708; BARBAS H, 1989, J COMP NEUROL, V286, P353, DOI 10.1002/cne.902860306; Basser PJ, 1998, MAGNET RESON MED, V39, P928, DOI 10.1002/mrm.1910390610; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Chao YP, 2009, HUM BRAIN MAPP, V30, P3172, DOI 10.1002/hbm.20739; CHAPMAN CA, 1995, BEHAV ECOL SOCIOBIOL, V36, P59, DOI 10.1007/BF00175729; CHAPMAN CA, 1989, OIKOS, V54, P315, DOI 10.2307/3565291; CHAPMAN CA, 1990, AM J PRIMATOL, V22, P279, DOI 10.1002/ajp.1350220407; Connolly CJ, 1950, EXTERNAL MORPHOLOGY; Di Fiore A., 2011, PRIMATES PERSPECTIVE, P155; DUNBAR RIM, 1992, J HUM EVOL, V22, P469, DOI 10.1016/0047-2484(92)90081-J; Duong TQ, 2010, METHODS, V50, P125, DOI 10.1016/j.ymeth.2009.08.001; Fillard P, 2003, LECT NOTES COMPUT SC, V2879, P16; Hartwig W, 2011, ANAT REC, V294, P2207, DOI 10.1002/ar.21515; Hinkley LBN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039804; Hofer S, 2008, CEREB CORTEX, V18, P1079, DOI 10.1093/cercor/bhm141; Hofer S, 2006, NEUROIMAGE, V32, P989, DOI 10.1016/j.neuroimage.2006.05.044; Hopkins WD, 2000, BEHAV NEUROSCI, V114, P739, DOI 10.1037//0735-7044.114.4.739; Huxley TH, 1861, ZOOL SOC LONDON SCI, P493; Jancke L, 1997, CEREB CORTEX, V7, P48, DOI 10.1093/cercor/7.1.48; Johansen-Berg H, 2005, CEREB CORTEX, V15, P31, DOI 10.1093/cercor/bhh105; Kaufman JA, 2005, ANAT REC PART A, V287A, P1026, DOI 10.1002/ar.a.20264; Kier E.L., 1987, SURG 3 VENTRICLE PP, P37; Kier EL, 1996, AM J NEURORADIOL, V17, P1631; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; LAMANTIA AS, 1990, J COMP NEUROL, V291, P520, DOI 10.1002/cne.902910404; Chico-Ponce de León Fernando, 2009, Rev. Cienc. Salud, V7, P10; Luppino G, 2000, NEWS PHYSIOL SCI, V15, P219; Pajevic S, 1999, MAGNET RESON MED, V42, P526, DOI 10.1002/(SICI)1522-2594(199909)42:3<526::AID-MRM15>3.0.CO;2-J; Phillips KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031941; Platas D., 2011, THESIS U NACL AUTONO; PUBOLS BH, 1972, BRAIN BEHAV EVOLUT, V5, P342; PUBOLS BH, 1971, J COMP NEUROL, V141, P63, DOI 10.1002/cne.901410106; Ramayya AG, 2010, CEREB CORTEX, V20, P507, DOI 10.1093/cercor/bhp141; Ramos-Fernandez G, 2011, PRIMATES PERSPECTIVE, P220; Rilling JK, 1999, NEUROREPORT, V10, P1453, DOI 10.1097/00001756-199905140-00012; Semendeferi K, 2001, EVOLUTIONARY ANATOMY OF THE PRIMATE CEREBRAL CORTEX, P257; STEPHAN H, 1987, J HIRNFORSCH, V28, P571; SYMINGTON MM, 1990, INT J PRIMATOL, V11, P47, DOI 10.1007/BF02193695; SYMINGTON MM, 1988, BEHAVIOUR, V105, P117; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; WITELSON SF, 1985, SCIENCE, V229, P665, DOI 10.1126/science.4023705; Youlatos D, 2011, PRIMATES PERSPECTIVE, P185	50	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117367	10.1371/journal.pone.0117367	http://dx.doi.org/10.1371/journal.pone.0117367			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693078	Green Published, gold, Green Submitted			2022-12-26	WOS:000350061500051
J	Rahman, MS; Akter, S; Abe, SK; Islam, MR; Mondal, MNI; Rahman, JAMS; Rahman, MM				Rahman, Md. Shafiur; Akter, Shamima; Abe, Sarah Krull; Islam, Md. Rafiqul; Mondal, Md. Nazrul Islam; Rahman, J. A. M. Shoquilur; Rahman, Md. Mizanur			Awareness, Treatment, and Control of Diabetes in Bangladesh: A Nationwide Population-Based Study	PLOS ONE			English	Article							RISK-FACTORS; MULTIPLE IMPUTATION; SYSTEMATIC ANALYSIS; PREVALENCE; HYPERTENSION; MELLITUS; DISEASE; ADULTS	Objectives To examine awareness, treatment, and control of diabetes mellitus among the adult population in Bangladesh. Methods The study used data from the 2011 nationally representative Bangladesh Demographic and Health Survey (BDHS). The BDHS sample is comprised of 7,786 adults aged 35 years or older. The primary outcome variables were fasting blood glucose, diagnosis, treatment, and control of diabetes. Multilevel logistic regression models were used to identify the risk factors for diabetes awareness. Results Overall, age-standardized prevalence of diabetes was 9.2%. Among subjects with diabetes, 41.2% were aware of their condition, 36.9% were treated, and 14.2% controlled their condition. A significant inequality in diabetes management was found from poor to wealthy households: 18.2% to 63.2% (awareness), 15.8% to 56.6% (treatment), and 8.2% to 18.4% (control). Multilevel models suggested that participants who had a lower education and lower economic condition were less likely to be aware of their diabetes. Poor management was observed among non-educated, low-income groups, and those who lived in the northwestern region. Conclusions Diabetes has become a national health concern in Bangladesh; however, treatment and control are quite low. Improving detection, awareness, and treatment strategies is urgently needed to prevent the growing burden associated with diabetes.	[Rahman, Md. Shafiur] First Capital Univ Bangladesh, Dept Publ Hlth, Chuadanga, Bangladesh; [Akter, Shamima] Natl Ctr Global Hlth & Med, Dept Epidemiol & Prevent, Ctr Clin Sci, Tokyo, Japan; [Abe, Sarah Krull; Rahman, Md. Mizanur] Univ Tokyo, Dept Global Hlth Policy, Tokyo, Japan; [Islam, Md. Rafiqul; Mondal, Md. Nazrul Islam; Rahman, J. A. M. Shoquilur; Rahman, Md. Mizanur] Rajshahi Univ, Dept Populat Sci & Human Resource Dev, Rajshahi 6205, Bangladesh	National Center for Global Health & Medicine - Japan; University of Tokyo; University of Rajshahi	Rahman, MM (corresponding author), Univ Tokyo, Dept Global Hlth Policy, Tokyo, Japan.	mizanur_rub@yahoo.com	Rahman, Shafiur/R-2964-2019; Abe, Sarah/ABF-2941-2020	Rahman, Shafiur/0000-0003-1911-6807; Abe, Sarah/0000-0003-3991-2739; Islam, Md. Rafiqul/0000-0001-6959-4554				ABUSAYEED M, 1995, DIABETES CARE, V18, P555, DOI 10.2337/diacare.18.4.555; Ahasan H. A. M. N., 2011, Journal of Medicine, V12, P125, DOI 10.3329/jom.v12i2.8419; Akter S, 2014, B WORLD HEALTH ORGAN, V92, P204, DOI 10.2471/BLT.13.128371; Akter S, 2014, DIABETES CARE, V37, pE9, DOI 10.2337/dc13-1647; Anjana RM, 2011, DIABETOLOGIA, V54, P3022, DOI 10.1007/s00125-011-2291-5; Bangladesh Bureau of Statistics (BBS), 2012, BANGL POP HOUS CENS; Bangladesh Bureau of Statistics (BBS), 2011, HOUS INC EXP SURV 20; BEGUM R, 1979, Bangladesh Medical Research Council Bulletin, V5, P1; Berry C, 2007, J AM COLL CARDIOL, V49, P631, DOI 10.1016/j.jacc.2006.09.046; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Chowdhury AMR, 2013, LANCET, V382, P1734, DOI 10.1016/S0140-6736(13)62148-0; Cunningham-Myrie C, 2013, TROP MED INT HEALTH, V18, P1365, DOI 10.1111/tmi.12190; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Di Cesare M, 2013, LANCET, V381, P585, DOI 10.1016/S0140-6736(12)61851-0; Guariguata L, 2013, DIABETES RES CLIN PR; Hu DS, 2008, DIABETES RES CLIN PR, V81, P250, DOI 10.1016/j.diabres.2008.04.008; Hussain A, 2005, DIABETIC MED, V22, P931, DOI 10.1111/j.1464-5491.2005.01558.x; IDF, 2019, IDF DIABETES ATLAS; Islam MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061776; Katulanda P, 2008, DIABETIC MED, V25, P1062, DOI 10.1111/j.1464-5491.2008.02523.x; Khambalia A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-719; Killingsworth JR, 1999, HEALTH POLICY PLANN, V14, P152, DOI 10.1093/heapol/14.2.152; Li MZ, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/753150; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lv SR, 2011, JIANGSU J PREVENTIVE, V22, P10; Mc Donald AJ, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-69; Mendis S., 2011, GLOBAL ATLAS CARDIOV; Mitra and Associates, 2013, BANGL DEM HLTH SURV; Mohan V, 2013, INT J HYPERTENS, V2013, DOI 10.1155/2013/409083; Porapakkham Y, 2008, SINGAP MED J, V49, P868; Rabe-Hesketh S, 2006, J R STAT SOC A STAT, V169, P805, DOI 10.1111/j.1467-985X.2006.00426.x; Rahim M A, 2004, Bangladesh Med Res Counc Bull, V30, P60; Rahim MA, 2007, DIABETES RES CLIN PR, V77, P300, DOI 10.1016/j.diabres.2006.11.010; Rahman MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056873; Rahman MM, 2013, B WORLD HEALTH ORGAN, V91, P449, DOI 10.2471/BLT.12.115428; RODRIGUEZ G, 1995, J ROY STAT SOC A STA, V158, P73, DOI 10.2307/2983404; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Saquib N, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-434; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Sims M, 2011, ANN EPIDEMIOL, V21, P892, DOI 10.1016/j.annepidem.2011.05.006; Singh Arvind Kumar, 2012, Indian J Community Med, V37, P236, DOI 10.4103/0970-0218.103472; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Twisk JWR., 2006, APPL MULTILEVEL ANAL, DOI [10.1017/CBO9780511610806, DOI 10.1017/CBO9780511610806]; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yang YN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035270	47	51	53	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118365	10.1371/journal.pone.0118365	http://dx.doi.org/10.1371/journal.pone.0118365			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692767	Green Published, Green Submitted, gold			2022-12-26	WOS:000350061500118
J	Chen, R; Xu, M; Nagati, JS; Hogg, RT; Das, A; Gerard, RD; Garcia, JA				Chen, Rui; Xu, Min; Nagati, Jason S.; Hogg, Richard T.; Das, Alok; Gerard, Robert D.; Garcia, Joseph A.			The Acetate/ACSS2 Switch Regulates HIF-2 Stress Signaling in the Tumor Cell Microenvironment	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR; ACETYL-COA SYNTHETASE; TRANSCRIPTIONAL ACTIVITY; GLUTAMINE-METABOLISM; HIF-1-ALPHA; OXYGEN; EXPRESSION; PROTEIN; HYPOXIA-INDUCIBLE-FACTOR-1-ALPHA; FACTOR-2-ALPHA	Optimal stress signaling by Hypoxia Inducible Factor 2 (HIF-2) during low oxygen states or hypoxia requires coupled actions of a specific coactivator/lysine acetyltransferase, Creb binding protein (CBP), and a specific deacetylase, Sirtuin 1 (SIRT1). We recently reported that acetylation of HIF-2 by CBP also requires a specific acetyl CoA generator, acetate-dependent acetyl CoA synthetase 2 (ACSS2). In this study, we demonstrate that ACSS2/HIF-2 signaling is active not only during hypoxia, but also during glucose deprivation. Acetate levels increase during stress and coincide with maximal HIF-2 alpha acetylation and CBP/HIF-2 alpha complex formation. Exogenous acetate induces HIF-2 alpha acetylation, CBP/HIF-2 alpha complex formation, and HIF-2 signaling. ACSS2 and HIF-2 are required for maximal colony formation, proliferation, migration, and invasion during stress. Acetate also stimulates flank tumor growth and metastasis in mice in an ACSS2 and HIF-2 dependent manner. Thus, ACSS2/CBP/SIRT1/HIF-2 signaling links nutrient sensing and stress signaling with cancer growth and progression in mammals.	[Chen, Rui; Xu, Min; Nagati, Jason S.; Hogg, Richard T.; Das, Alok; Garcia, Joseph A.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Gerard, Robert D.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Chen, Rui] Southeast Univ, Sch Publ Hlth, Minist Educ, Key Lab Environm Med Engn, Nanjing, Jiangsu, Peoples R China; [Garcia, Joseph A.] Vet Affairs North Texas Hlth Care Syst, Dept Med, Dallas, TX USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Southeast University - China; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System	Chen, R (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA.	101011816@seu.edu.cn; joseph.garcia@utsouthwestern.edu		Nagati, Jason/0000-0002-4507-6581; Garcia, Joseph/0000-0002-5621-7538; Chen, Rui/0000-0002-7003-6602	United States Department of Veterans Affairs [I01BX000446]; United States National Institutes of Health [HL108104]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108104] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000446] Funding Source: NIH RePORTER	United States Department of Veterans Affairs(US Department of Veterans Affairs); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	These studies were supported by funds provided by the United States Department of Veterans Affairs (I01BX000446 - JG), and the United States National Institutes of Health (HL108104 - JG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brusselmans K, 2001, J BIOL CHEM, V276, P39192, DOI 10.1074/jbc.C100428200; Chen R, 2012, J BIOL CHEM, V287, P30800, DOI 10.1074/jbc.M111.244780; Chen R, 2011, J BIOL CHEM, V286, P13869, DOI 10.1074/jbc.M110.175414; Dioum EM, 2009, SCIENCE, V324, P1289, DOI 10.1126/science.1169956; Hackbarth JS, 2004, BIOTECHNIQUES, V37, P835; Hewitson KS, 2002, J BIOL CHEM, V277, P26351, DOI 10.1074/jbc.C200273200; Imamura T, 2009, INT J CANCER, V124, P763, DOI 10.1002/ijc.24032; Jin HO, 2007, CELL SIGNAL, V19, P1393, DOI 10.1016/j.cellsig.2006.12.014; Knowles HJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-372; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Le A, 2012, CELL METAB, V15, P110, DOI 10.1016/j.cmet.2011.12.009; Luong A, 2000, J BIOL CHEM, V275, P26458, DOI 10.1074/jbc.M004160200; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Mathew R, 2005, J PHARMACOL EXP THER, V315, P297, DOI 10.1124/jpet.105.087536; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; Qu AJ, 2011, HEPATOLOGY, V54, P472, DOI 10.1002/hep.24400; Rankin EB, 2009, MOL CELL BIOL, V29, P4527, DOI 10.1128/MCB.00200-09; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Salnikow K, 2008, CARCINOGENESIS, V29, P1493, DOI 10.1093/carcin/bgn088; Scortegagna M, 2003, NAT GENET, V35, P331, DOI 10.1038/ng1266; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Sheta EA, 2001, ONCOGENE, V20, P7624, DOI 10.1038/sj.onc.1204972; Shimazu T, 2010, MECH AGEING DEV, V131, P511, DOI 10.1016/j.mad.2010.05.001; Tokuda Y, 2000, J CELL PHYSIOL, V182, P414, DOI 10.1002/(SICI)1097-4652(200003)182:3<414::AID-JCP12>3.0.CO;2-5; Vordermark D, 2005, CANCER LETT, V230, P122, DOI 10.1016/j.canlet.2004.12.040; Warnecke C, 2008, EXP CELL RES, V314, P2016, DOI 10.1016/j.yexcr.2008.03.003; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; Xu M, 2014, NAT MED, V20, P1018, DOI 10.1038/nm.3587; Yoshii Y, 2009, NUCL MED BIOL, V36, P771, DOI 10.1016/j.nucmedbio.2009.05.006; Yoshii Y, 2009, CANCER SCI, V100, P821, DOI 10.1111/j.1349-7006.2009.01099.x	34	41	43	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0116515	10.1371/journal.pone.0116515	http://dx.doi.org/10.1371/journal.pone.0116515			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689462	Green Published, gold			2022-12-26	WOS:000350322700012
J	de Araujo, AA; Varela, H; de Medeiros, CACX; Brito, GAD; de Lima, KC; de Moura, LM; de Araujo, RF				de Araujo, Aurigena Antunes; Varela, Hugo; Carvalho Xavier de Medeiros, Caroline Addison; de Castro Brito, Gerly Anne; de Lima, Kenio Costa; de Moura, Ligia Moreno; de Araujo Junior, Raimundo Fernandes			Azilsartan Reduced TNF-alpha and IL-1 beta Levels, Increased IL-10 Levels and Upregulated VEGF, FGF, KGF, and TGF-alpha in an Oral Mucositis Model	PLOS ONE			English	Article							GROWTH-FACTORS; WOUND MACROPHAGES; CELL-MIGRATION; PREVENTION; CYTOKINES; THERAPY; RADIOCHEMOTHERAPY; CHEMOTHERAPY; PATHOGENESIS; TELMISARTAN	Oral mucositis (OM) is a common complication of treatments for head and neck cancer, particularly radiotherapy with or without chemotherapy. OM is characterised by oral erythema, ulceration, and pain. The aim of this study was to evaluate the effect of azilsartan (AZT), an angiotensin II receptor antagonist, on 5-fluorouracil (5-FU)-induced oral mucositis (OM) in Syrian hamsters. OM was induced by the intraperitoneal administration of 5-FU on experimental days 1 (60mg/Kg) and 2 (40mg/Kg). Animals were pretreated with oral AZT (1, 5, or 10 mg/kg) or vehicle 30 min before 5-FU injection and daily until day 10. Experimental treatment protocols were approved by the Animal Ethics Committee Use/CEUA (Number 28/2012) of the UFRN. Macroscopic analysis and cheek pouch samples were removed for histopathologic analysis. Myeloperoxidase (MPO), Malonyldialdehyde (MDA), interleukin-1 beta (IL-1 beta), interleukin-10 (IL-10), and tumour necrosis factor-alpha (TNF-alpha) were analysed by Enzyme Linked Immuno Sorbent Assay (ELISA). Vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF), keratinocyte growth factor (KGF), and transforming growth factor (TGF)-alpha were measured by immunohistochemistry. Analysis of variance followed by Bonferroni's test was used to calculate the means of intergroup differences (p <= 0.05). Treatment with 1 mg/kg AZT reduced levels MPO (p<0.01), MDA (p<0.5) and histological inflammatory cell infiltration, and increased the presence of granulation tissue. AZT treatment at 1 mg/kg reduced the TNF-alpha (p<0.05) and IL-1 beta (p<0.05) levels, increased the cheek pouch levels of IL-10 (p<0.01), and upregulated VEGF, FGF, KGF, and TGF-alpha. Administration of AZT at higher doses (5 and 10 mg/kg) did not significantly reverse the OM. AZT at a dose of 1 mg/kg prevented the mucosal damage and inflammation associated with 5-FU-induced OM, increasing granulation and tissue repair.	[de Araujo, Aurigena Antunes] Fed Univ Rio Grande Norte UFRN, Dept Biophys & Pharmacol, Postgrad Program Publ Hlth, Natal, RN, Brazil; [de Araujo, Aurigena Antunes] Fed Univ Rio Grande Norte UFRN, Dept Biophys & Pharmacol, Postgrad Program Pharmaceut Sci, Natal, RN, Brazil; [Varela, Hugo; de Moura, Ligia Moreno] Univ Fed Rio Grande do Norte, Postgrad Program Publ Hlth, Natal, RN, Brazil; [Carvalho Xavier de Medeiros, Caroline Addison] Univ Fed Rio Grande do Norte, Dept Biophys & Pharmacol, Natal, RN, Brazil; [Carvalho Xavier de Medeiros, Caroline Addison] State Univ Rio Grande Norte UERN, Postgrad Program Hlth & Soc, Natal, RN, Brazil; [de Castro Brito, Gerly Anne] Univ Fed Ceara, Postgrad Program Pharmacol & Morphol, Dept Morphol, Fortaleza, CE, Brazil; [de Lima, Kenio Costa] Univ Fed Rio Grande do Norte, Dept Dent, Postgrad Program Publ Hlth & Hlth Sci, Natal, RN, Brazil; [de Moura, Ligia Moreno] Univ Potiguar UnP, Natal, RN, Brazil; [de Araujo Junior, Raimundo Fernandes] Univ Fed Rio Grande do Norte, Dept Morphol, Postgrad Program Funct & Struct Biol & Hlth Sci, Natal, RN, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade do Estado do Rio Grande do Norte (UERN); Universidade Federal do Ceara; Universidade Federal do Rio Grande do Norte; Universidade Potiguar; Universidade Federal do Rio Grande do Norte	de Araujo, AA (corresponding author), Fed Univ Rio Grande Norte UFRN, Dept Biophys & Pharmacol, Postgrad Program Publ Hlth, Natal, RN, Brazil.	aurigena@ufrnet.br	de Castro Brito, Gerly Anne/C-8597-2013; Brito, Gerly/AHB-3965-2022; de Araujo, Aurigena/ABI-8455-2020	de Castro Brito, Gerly Anne/0000-0002-8214-4379; Brito, Gerly/0000-0002-8214-4379; 				Araujo AA, 2013, J CLIN PERIODONTOL, V40, P1104, DOI 10.1111/jcpe.12160; Araujo AA, 2013, N-S ARCH PHARMACOL, V386, P875, DOI 10.1007/s00210-013-0886-8; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Brancato SK, 2011, AM J PATHOL, V178, P19, DOI 10.1016/j.ajpath.2010.08.003; Lopez TCC, 2013, BRAZ ORAL RES, V27, P342, DOI 10.1590/S1806-83242013005000019; Clancy P, 2014, ATHEROSCLEROSIS, V236, P108, DOI 10.1016/j.atherosclerosis.2014.06.011; de Araujo AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096750; de Castro JF, 2013, PHOTOMED LASER SURG; DESOUZA GEP, 1985, AGENTS ACTIONS, V17, P97; Donnelly JP, 2003, LANCET INFECT DIS, V3, P405, DOI 10.1016/S1473-3099(03)00668-6; Elad S, 2013, ALTERN THER HEALTH M, V19, P21; ESTERBAUER H, 1990, METHOD ENZYMOL, V186, P407; Georgiou M, 2012, HIPPOKRATIA, V16, P215; HASENAU C, 1988, LARYNGO RHINO OTOL, V67, P576, DOI 10.1055/s-2007-998565; Kajiya T, 2011, J HYPERTENS, V29, P2476, DOI 10.1097/HJH.0b013e32834c46fd; KENDALL C, 1983, J IMMUNOL METHODS, V56, P329, DOI 10.1016/S0022-1759(83)80022-2; Li Y, 2006, J INVEST DERMATOL, V126, P2096, DOI 10.1038/sj.jid.5700350; Medeiros CACX, 2011, CANCER CHEMOTH PHARM, V67, P1085, DOI 10.1007/s00280-010-1409-7; Meszaros AJ, 1999, J LEUKOCYTE BIOL, V65, P35, DOI 10.1002/jlb.65.1.35; Nagib MM, 2013, TOXICOL APPL PHARM, V271, P106, DOI 10.1016/j.taap.2013.04.026; Nakano A, 2009, HYPERTENS RES, V32, P765, DOI 10.1038/hr.2009.95; Nicolatou-Galitis O, 2013, SUPPORT CARE CANCER, V21, P3179, DOI 10.1007/s00520-013-1847-y; Niu JG, 2007, J BIOL CHEM, V282, P6001, DOI 10.1074/jbc.M606878200; Ojima M, 2011, J PHARMACOL EXP THER, V336, P801, DOI 10.1124/jpet.110.176636; Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165; Raja, 2007, FRONT BIOSCI-LANDMRK, V12, P2249; RAPPOLEE DA, 1988, SCIENCE, V241, P708, DOI 10.1126/science.3041594; Rimulo AL, 2011, EUR ARCH PAEDIATR DE, V12, P124, DOI 10.1007/BF03262792; Rodriguez-Caballero A, 2012, INT J ORAL MAX SURG, V41, P225, DOI 10.1016/j.ijom.2011.10.011; Saavedra JM, 2012, CLIN SCI, V123, P567, DOI 10.1042/CS20120078; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P331, DOI 10.1016/j.cytogfr.2010.09.002; SAFIEHGARABEDIAN B, 1995, BRIT J PHARMACOL, V115, P1265, DOI 10.1111/j.1476-5381.1995.tb15035.x; Scully C, 2003, HEAD NECK-J SCI SPEC, V25, P1057, DOI 10.1002/hed.10318; Senger DR, 1996, AM J PATHOL, V149, P293; Sonis ST, 2004, CANCER-AM CANCER SOC, V100, P1995, DOI 10.1002/cncr.20162; Souza MHLP, 2003, BRAZ J MED BIOL RES, V36, P1383, DOI 10.1590/S0100-879X2003001000015; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Taguchi I, 2013, HYPERTENS RES, V36, P608, DOI 10.1038/hr.2013.3; Tanideh N, 2013, OR SURG OR MED OR PA, V115, P332, DOI 10.1016/j.oooo.2012.08.450; Tsuruoka S, 2013, INTERNAL MED, V52, P303, DOI 10.2169/internalmedicine.52.9066; von Bultzingslowen I, 2006, SUPPORT CARE CANCER, V14, P519, DOI 10.1007/s00520-006-0052-7; White WB, 2011, HYPERTENSION, V57, P413, DOI 10.1161/HYPERTENSIONAHA.110.163402	42	9	9	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0116799	10.1371/journal.pone.0116799	http://dx.doi.org/10.1371/journal.pone.0116799			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689279	Green Published, gold, Green Submitted			2022-12-26	WOS:000350322700023
J	Lewis, RS; Lopez, HO; Bowen, SW; Andres, KR; Steede, WT; Dewey, RE				Lewis, Ramsey S.; Lopez, Harry O.; Bowen, Steve W.; Andres, Karen R.; Steede, William T.; Dewey, Ralph E.			Transgenic and Mutation-Based Suppression of a Berberine Bridge Enzyme-Like (BBL) Gene Family Reduces Alkaloid Content in Field-Grown Tobacco	PLOS ONE			English	Article							NICOTIANA-TABACUM-L; PUTRESCINE N-METHYLTRANSFERASE; METHYLPUTRESCINE OXIDASE; RNA INTERFERENCE; B-LOCI; A-LOCI; BIOSYNTHESIS; NITROSAMINES; INHERITANCE; NORNICOTINE	Motivation exists to develop tobacco cultivars with reduced nicotine content for the purpose of facilitating compliance with expected tobacco product regulations that could mandate the lowering of nicotine levels per se, or the reduction of carcinogenic alkaloid-derived tobacco specific nitrosamines (TSNAs). A berberine bridge enzyme-like (BBL) gene family was recently characterized for N. tabacum and found to catalyze one of the final steps in pyridine alkaloid synthesis for this species. Because this gene family acts downstream in the nicotine biosynthetic pathway, it may represent an attractive target for genetic strategies with the objective of reducing alkaloid content in field-grown tobacco. In this research, we produced transgenic doubled haploid lines of tobacco cultivar K326 carrying an RNAi construct designed to reduce expression of the BBL gene family. Field-grown transgenic lines carrying functional RNAi constructs exhibited average cured leaf nicotine levels of 0.684%, in comparison to 2.454% for the untransformed control. Since numerous barriers would need to be overcome to commercialize transgenic tobacco cultivars, we subsequently pursued a mutation breeding approach to identify EMS-induced mutations in the three most highly expressed isoforms of the BBL gene family. Field evaluation of individuals possessing different homozygous combinations of truncation mutations in BBLa, BBLb, and BBLc indicated that a range of alkaloid phenotypes could be produced, with the triple homozygous knockout genotype exhibiting greater than a 13-fold reduction in percent total alkaloids. The novel source of genetic variability described here may be useful in future tobacco breeding for varied alkaloid levels.	[Lewis, Ramsey S.; Lopez, Harry O.; Bowen, Steve W.; Andres, Karen R.; Steede, William T.; Dewey, Ralph E.] N Carolina State Univ, Dept Crop Sci, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Lewis, RS (corresponding author), N Carolina State Univ, Dept Crop Sci, Raleigh, NC 27695 USA.	ramsey_lewis@ncsu.edu		Dewey, Ralph/0000-0003-1924-3777	Tobacco Education and Research Council/North Carolina Tobacco Foundation	Tobacco Education and Research Council/North Carolina Tobacco Foundation	This work was funded in part by a grant from the Tobacco Education and Research Council/North Carolina Tobacco Foundation. Any opinion, finding, conclusion or recommendation expressed in this publication are those of the authors and do not necessarily reflect the view and policies of the Tobacco Education and Research Council, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was funded in part by a grant from the Tobacco Education and Research Council/North Carolina Tobacco Foundation. Any opinion, finding, conclusion or recommendation expressed in this publication are those of the authors and do not necessarily reflect the view and policies of the Tobacco Education and Research Council, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AN G, 1986, PLANT PHYSIOL, V81, P301, DOI 10.1104/pp.81.1.301; Atwood CL, 1991, EGGSARE9247 ID NAT E; Benowitz NL, 2007, CANCER EPIDEM BIOMAR, V16, P2479, DOI 10.1158/1055-9965.EPI-07-0393; Benowitz NL, 2010, NEW ENGL J MED, V362, P2295, DOI 10.1056/NEJMra0809890; BENOWITZ NL, 1994, NEW ENGL J MED, V331, P123, DOI 10.1056/NEJM199407143310212; Bowman D.T., 1996, TOBACCO SCI, V40, P99; Burk L.G, 1983, CROP SCI, V75, P133; BURK LG, 1979, SCIENCE, V206, P585, DOI 10.1126/science.206.4418.585; Burns DM, 2008, TOB CONTROL, V17, DOI 10.1136/tc.2007.024158; Bush L., 1999, ANAL DETERMINATION N, P13; Bush LP, 2001, REC ADV TOB, V27, P23; Cane KA, 2005, FUNCT PLANT BIOL, V32, P305, DOI 10.1071/FP04008; CHAPLIN JF, 1976, CROP SCI, V16, P416, DOI 10.2135/cropsci1976.0011183X001600030026x; Chintapakorn Y, 2003, PLANT MOL BIOL, V53, P87, DOI 10.1023/B:PLAN.0000009268.45851.95; Davis R.E., 1976, TOBACCO SCI, V20, P139; DeBoer KD, 2011, PHYTOCHEMISTRY, V72, P344, DOI 10.1016/j.phytochem.2010.12.012; DeBoer KD, 2009, PLANT MOL BIOL, V69, P299, DOI 10.1007/s11103-008-9425-2; Dewey RE, 2013, PHYTOCHEMISTRY, V94, P20; Donny EC, 2014, PREV MED, V68, P17, DOI 10.1016/j.ypmed.2014.06.020; Fisher, 2012, 2012 FLUE CURED TOBA, P23; Hatsukami DK, 2010, TOB CONTROL, V19, DOI 10.1136/tc.2009.035584; Hatsukami DK, 2010, ADDICTION, V105, P343, DOI 10.1111/j.1360-0443.2009.02780.x; Hecht SS, 1998, CHEM RES TOXICOL, V11, P559, DOI 10.1021/tx980005y; Hecht SS, 2003, NAT REV CANCER, V3, P733, DOI 10.1038/nrc1190; HECHT SS, 1989, CANCER SURV, V8, P273; Heim WG, 2007, PHYTOCHEMISTRY, V68, P454, DOI 10.1016/j.phytochem.2006.11.003; HIBI N, 1994, PLANT CELL, V6, P723, DOI 10.1105/tpc.6.5.723; Kajikawa M, 2011, PLANT PHYSIOL, V155, P2010, DOI 10.1104/pp.110.170878; Kajikawa M, 2009, PLANT MOL BIOL, V69, P287, DOI 10.1007/s11103-008-9424-3; KASPERBAUER MJ, 1972, CROP SCI, V12, P98, DOI 10.2135/cropsci1972.0011183X001200010034x; Katoh A, 2007, PLANT CELL PHYSIOL, V48, P550, DOI 10.1093/pcp/pcm018; Kerschen A, 2004, FEBS LETT, V566, P223, DOI 10.1016/j.febslet.2004.04.043; Kidd SK, 2006, PLANT MOL BIOL, V60, P699, DOI 10.1007/s11103-005-5546-z; LEGG PD, 1969, J HERED, V60, P213, DOI 10.1093/oxfordjournals.jhered.a107974; LEGG PD, 1971, CAN J GENET CYTOL, V13, P287, DOI 10.1139/g71-047; LEGG PD, 1970, CROP SCI, V10, P212, DOI 10.2135/cropsci1970.0011183X001000020041x; Lewis RS, 2007, THEOR APPL GENET, V115, P169, DOI 10.1007/s00122-007-0552-y; Lewis RS, 2008, PLANT BIOTECHNOL J, V6, P346, DOI 10.1111/j.1467-7652.2008.00324.x; Lewis RS, 2010, PHYTOCHEMISTRY, V71, P1988, DOI 10.1016/j.phytochem.2010.09.011; Reed DG, 2004, PLANT SCI, V167, P1123, DOI 10.1016/j.plantsci.2004.06.006; Riechers DE, 1999, PLANT MOL BIOL, V41, P387, DOI 10.1023/A:1006342018991; SAITOH F, 1985, PHYTOCHEMISTRY, V24, P477, DOI 10.1016/S0031-9422(00)80751-7; Sato F, 2001, P NATL ACAD SCI USA, V98, P367, DOI 10.1073/pnas.011526398; SAUNDERS JA, 1979, PLANT PHYSIOL, V64, P74, DOI 10.1104/pp.64.1.74; Shoji T, 2008, PLANT CELL PHYSIOL, V49, P1209, DOI 10.1093/pcp/pcn096; Shoji T, 2010, PLANT CELL, V22, P3390, DOI 10.1105/tpc.110.078543; Sierro N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4833; Siminszky B, 2005, P NATL ACAD SCI USA, V102, P14919, DOI 10.1073/pnas.0506581102; SISSON VA, 1990, BEITR TABAKFORSCH, V14, P327, DOI 10.2478/cttr-2013-0610; Slade AJ, 2005, NAT BIOTECHNOL, V23, P75, DOI 10.1038/nbt1043; Smith WD, 2003, REC ADV TOB SCI, V29, P5; Steel R., 1997, PRINCIPLES PROCEDURE; Wang P, 2008, J BIOSCIENCES, V33, P177, DOI 10.1007/s12038-008-0035-6; Wang P, 2009, MOL BIOL REP, V36, P2285, DOI 10.1007/s11033-009-9446-1; Xie J, 2004, REC ADV TOB SCI, P17	55	26	30	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117273	10.1371/journal.pone.0117273	http://dx.doi.org/10.1371/journal.pone.0117273			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25688975	gold, Green Submitted, Green Published			2022-12-26	WOS:000350322700033
J	Wu, DH; Xu, L; Wen, CP; Xie, GQ; Ji, JJ; Pan, JL; Jiao, YF; Fan, YS				Wu, De-hong; Xu, Li; Wen, Cheng-ping; Xie, Guan-qun; Ji, Jin-jun; Pan, Jie-li; jiao, Yi-feng; Fan, Yong-sheng			The Effects of Jieduquyuzishen Prescription-Treated Rat Serum on the BAFF/BAFF-R Signal Pathway	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; B-LYMPHOCYTE STIMULATOR; NECROSIS-FACTOR FAMILY; GLUCOCORTICOID-INDUCED APOPTOSIS; DISEASE-ACTIVITY; TNF RECEPTOR; BAFF-R; CELLS; BLYS; PATHOGENESIS	Systemic lupus erythematosus (SLE) is a chronic inflammatory disease mainly characterized by B cell hyperactivity. Glucocorticoid (GC) is widely used in SLE for its potent anti-inflammatory and immunosuppressive effects. Despite its important clinical efficacy, highdose or long-term use of GC can cause severe side effects, such as osteoporosis, osteonecrosis, cataracts, hyperglycemia, coronary heart disease and cognitive impairment. Our early clinical studies have shown that Jieduquyuzishen prescription (JP) can effectively reduce the adverse effects and improve the curative effect of GC in the treatment of SLE. The BAFF/BAFF-R signaling pathway plays an important role in the development of SLE and has been regarded as a potential target for the therapy of SLE. In this study, we attempt to investigate the effect of JP on the BAFF/BAFF-R signaling pathway to explore the mechanism of JP in reducing the toxicity and enhancing the efficacy of GC. YAC-1 cells, isolated rat peripheral blood lymphocytes, polymorphonuclear neutrophils and spleen lymphocytes were treated with drug-containing serum. The results of RT-PCR, Western blot and dual-luciferase reporter gene assays indicate that either JP or GC can inhibit the mBAFF-induced up-regulation of BAFF, BAFF-R, Bcl-2, IL-10 and NF-kappa B in YAC-1 cells and WEHI-231 cells. Furthermore, MTS, flow cytometry and CFSE results reveal that the proliferation and survival of lymphocytes activated by mBAFF are suppressed by JP, GC and their combination. Contrary to GC, JP can reduce the apoptosis and raise the survival of polymorphonuclear neutrophils and can't increase the apoptosis of the peripheral blood lymphocytes and spleen lymphocytes. Therefore, it is possible that JP can down-regulate the BAFF/BAFF-R signaling pathway as effectively as GC, which may result in the dosage reduction of GC, thus decreasing the toxicity and improving the efficacy of GC-based treatment of SLE.	[Wu, De-hong; Fan, Yong-sheng] Zhejiang Chinese Med Univ, Clin Med Coll 1, Hangzhou, Zhejiang, Peoples R China; [Xu, Li; Wen, Cheng-ping; Xie, Guan-qun; Ji, Jin-jun; Pan, Jie-li; jiao, Yi-feng] Zhejiang Chinese Med Univ, Coll Basic Med, Hangzhou, Zhejiang, Peoples R China	Zhejiang Chinese Medical University; Zhejiang Chinese Medical University	Fan, YS (corresponding author), Zhejiang Chinese Med Univ, Clin Med Coll 1, Hangzhou, Zhejiang, Peoples R China.	applezjtcm@126.com		Wu, De-hong/0000-0001-6107-6154; Xu, Li/0000-0001-6883-6590; chengping, Wen/0000-0001-9254-6235	National Basic Research Program of China (973 Program) [2014CB543001]; National Natural Science Foundation of China [81202628, 81403289, 81373633]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Basic Research Program of China (973 Program, No. 2014CB543001) and National Natural Science Foundation of China (No. 81202628, No. 81403289, No. 81373633). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanna IJ, 2003, J IMMUNOL, V170, P4593, DOI 10.4049/jimmunol.170.9.4593; Bishop GA, 2004, NAT REV IMMUNOL, V4, P775, DOI 10.1038/nri1462; Bosch X, 2011, NEW ENGL J MED, V365, P758, DOI 10.1056/NEJMcibr1107085; Chen J, 2014, J HUAZHONG U SCI-MED, V34, P125, DOI 10.1007/s11596-014-1243-y; Courtney PA, 1999, ANN RHEUM DIS, V58, P309, DOI 10.1136/ard.58.5.309; D'Cruz DP, 2007, LANCET, V369, P587, DOI 10.1016/S0140-6736(07)60279-7; Davidson A, 2001, NEW ENGL J MED, V345, P340, DOI 10.1056/NEJM200108023450506; Davidson A, 2006, CURR OPIN RHEUMATOL, V18, P468; Del Poeta G, 2003, BLOOD, V101, P2125, DOI 10.1182/blood-2002-06-1714; Ding XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088223; [范永升 Fan Yongsheng], 2005, [中华中医药杂志, China Journal of Traditional Chinese Medicine and Pharmacy], V20, P667; Fan Yuan-xun, 2006, Journal of Nanjing University of Science and Technology, V30, P199; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; Harless SM, 2001, CURR BIOL, V11, P1986, DOI 10.1016/S0960-9822(01)00598-X; Hsu BL, 2002, J IMMUNOL, V168, P5993, DOI 10.4049/jimmunol.168.12.5993; Isenberg DA, 2005, RHEUMATOLOGY, V44, P902, DOI 10.1093/rheumatology/keh624; Laabi Y, 2000, SCIENCE, V289, P883, DOI 10.1126/science.289.5481.883; Lande R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001180; Lavie F, 2004, J PATHOL, V202, P496, DOI 10.1002/path.1533; Lentz VM, 1998, J IMMUNOL, V160, P3743; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; McConnell JR, 2002, CLIN EXP RHEUMATOL, V20, P653; MESSER J, 1983, NEW ENGL J MED, V309, P21, DOI 10.1056/NEJM198307073090105; MILLS JA, 1994, NEW ENGL J MED, V330, P1871, DOI 10.1056/NEJM199406303302608; MIYAKE K, 1994, J EXP MED, V180, P1217, DOI 10.1084/jem.180.4.1217; Mok CC, 2003, J CLIN PATHOL, V56, P481, DOI 10.1136/jcp.56.7.481; Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260; MOTYKA B, 1995, EUR J IMMUNOL, V25, P1865, DOI 10.1002/eji.1830250711; Mukhopadhyay A, 1999, J BIOL CHEM, V274, P15978, DOI 10.1074/jbc.274.23.15978; Nardelli B, 2001, BLOOD, V97, P198, DOI 10.1182/blood.V97.1.198; Ni CZ, 2004, J IMMUNOL, V173, P7394, DOI 10.4049/jimmunol.173.12.7394; Reyes LI, 2008, CYTOKINE, V42, P170, DOI 10.1016/j.cyto.2007.12.005; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Schneider P, 1999, J EXP MED, V189, P1747, DOI 10.1084/jem.189.11.1747; Shu HB, 2000, P NATL ACAD SCI USA, V97, P9156, DOI 10.1073/pnas.160213497; Sionov RV, 2006, CELL CYCLE, V5, P1017, DOI 10.4161/cc.5.10.2738; Sionov RV, 2008, ADV CANCER RES, V101, P127, DOI 10.1016/S0065-230X(08)00406-5; Thompson JS, 2000, J EXP MED, V192, P129, DOI 10.1084/jem.192.1.129; Thompson JS, 2001, SCIENCE, V293, P2108, DOI 10.1126/science.1061965; Vincent FB, 2014, NAT REV RHEUMATOL, V10, P365, DOI 10.1038/nrrheum.2014.33; WADMAN B, 1972, LANCET, V1, P907; Wen C., 2007, CHIN ARCH TRADITI CH, V25, P1599, DOI DOI 10.3969/j.issn.1673-7717.2007.08.027; Wen C., 2007, J ZHEJIANG U TRADITI, V31, P305, DOI [10.16466/j.issn1005-5509.2007.03.024, DOI 10.16466/J.ISSN1005-5509.2007.03.024]; Yan MH, 2001, CURR BIOL, V11, P1547, DOI 10.1016/S0960-9822(01)00481-X; Zhu XJ, 2009, J CLIN IMMUNOL, V29, P603, DOI 10.1007/s10875-009-9303-y; Zilberman Y, 2004, CELL IMMUNOL, V227, P12, DOI 10.1016/j.cellimm.2004.01.005	47	7	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0118462	10.1371/journal.pone.0118462	http://dx.doi.org/10.1371/journal.pone.0118462			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689512	gold, Green Published, Green Submitted			2022-12-26	WOS:000350322700116
J	Ballard, ME; Weafer, J; Gallo, DA; de Wit, H				Ballard, Michael E.; Weafer, Jessica; Gallo, David A.; de Wit, Harriet			Effects of Acute Methamphetamine on Emotional Memory Formation in Humans: Encoding vs Consolidation	PLOS ONE			English	Article							D-AMPHETAMINE; ORAL METHAMPHETAMINE; RECOGNITION MEMORY; DRUG-ADDICTION; FALSE MEMORY; YOUNG MEN; ALCOHOL; STRESS; SLEEP; DEXTROAMPHETAMINE	Understanding how stimulant drugs affect memory is important for understanding their addictive potential. Here we examined the effects of acute d-methamphetamine (METH), administered either before (encoding phase) or immediately after (consolidation phase) study on memory for emotional and neutral images in healthy humans. Young adult volunteers (N = 60) were randomly assigned to either an encoding group (N = 29) or a consolidation group (N = 31). Across three experimental sessions, they received placebo and two doses of METH (10, 20 mg) either 45 min before (encoding) or immediately after (consolidation) viewing pictures of emotionally positive, neutral, and negative scenes. Memory for the pictures was tested two days later, under drug-free conditions. Half of the sample reported sleep disturbances following the high dose of METH, which affected their memory performance. Therefore, participants were classified as poor sleepers (less than 6 hours; n = 29) or adequate sleepers (6 or more hours; n = 31) prior to analyses. For adequate sleepers, METH (20 mg) administered before encoding significantly improved memory accuracy relative to placebo, especially for emotional (positive and negative), compared to neutral, stimuli. For poor sleepers in the encoding group, METH impaired memory. METH did not affect memory in the consolidation group regardless of sleep quality. These results extend previous findings showing that METH can enhance memory for salient emotional stimuli but only if it is present at the time of study, where it can affect both encoding and consolidation. METH does not appear to facilitate consolidation if administered after encoding. The study also demonstrates the important role of sleep in memory studies.	[Ballard, Michael E.; Weafer, Jessica; de Wit, Harriet] Univ Chicago, Dept Psychiat & Behav Neurosci, Chicago, IL 60637 USA; [Gallo, David A.] Univ Chicago, Dept Psychol, Chicago, IL 60637 USA	University of Chicago; University of Chicago	de Wit, H (corresponding author), Univ Chicago, Dept Psychiat & Behav Neurosci, 5841 S Maryland Ave,MC3077, Chicago, IL 60637 USA.	hdew@uchicago.edu	Weafer, Jessica/GON-8302-2022; Ballard, Michael/F-9146-2013	Ballard, Michael/0000-0002-2651-6588	National Institute on Drug Abuse [DA002812, DA031796, DA033756];  [F31 DA030863]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA002812, F32DA033756, F31DA030863, R21DA031796] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by National Institute on Drug Abuse grants DA002812 and DA031796 (HdW), and DA033756 (JW), and MEB was supported by F31 DA030863. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddeley A., 2002, EPISODIC MEMORY NEW; Ballard ME, 2013, PSYCHOPHARMACOLOGY, V226, P515, DOI 10.1007/s00213-012-2924-5; Ballard ME, 2012, PSYCHOPHARMACOLOGY, V219, P15, DOI 10.1007/s00213-011-2374-5; Ballard ME, 2014, J CLIN PSYCHOPHARM, V34, P85, DOI 10.1097/JCP.0000000000000039; Breitenstein C, 2004, NEUROPSYCHOPHARMACOL, V29, P1704, DOI 10.1038/sj.npp.1300464; Bruce KR, 1999, J STUD ALCOHOL, V60, P130, DOI 10.15288/jsa.1999.60.130; Bruce KR, 1997, EXP CLIN PSYCHOPHARM, V5, P242, DOI 10.1037/1064-1297.5.3.242; Bruce KR, 1999, ALCOHOL CLIN EXP RES, V23, P693, DOI 10.1111/j.1530-0277.1999.tb04171.x; Comer SD, 2001, PSYCHOPHARMACOLOGY, V155, P397, DOI 10.1007/s002130100727; Dean AC, 2013, NEUROPSYCHOPHARMACOL, V38, P259, DOI 10.1038/npp.2012.179; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Everitt BJ, 2001, BRAIN RES REV, V36, P129, DOI 10.1016/S0165-0173(01)00088-1; FISCHMAN MW, 1991, BRIT J ADDICT, V86, P1563; Hariri AR, 2002, NEUROPSYCHOPHARMACOL, V27, P1036, DOI 10.1016/S0893-133X(02)00373-1; Harris DS, 2003, NEUROPSYCHOPHARMACOL, V28, P1677, DOI 10.1038/sj.npp.1300223; Hyman SE, 2005, AM J PSYCHIAT, V162, P1414, DOI 10.1176/appi.ajp.162.8.1414; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; JANAK PH, 1992, PHARMACOL BIOCHEM BE, V41, P837, DOI 10.1016/0091-3057(92)90235-8; Johnson BA, 2000, NEUROPSYCHOPHARMACOL, V22, P504, DOI 10.1016/S0893-133X(99)00116-5; Kensinger EA, 2006, J NEUROSCI, V26, P2564, DOI 10.1523/JNEUROSCI.5241-05.2006; Kensinger EA, 2009, EMOT REV, V1, P120, DOI 10.1177/1754073908100436; Kirkpatrick MG, 2012, PSYCHOPHARMACOLOGY, V219, P191, DOI 10.1007/s00213-011-2390-5; Knowles SKZ, 2004, BEHAV PHARMACOL, V15, P111, DOI 10.1097/00008877-200403000-00003; KRIVANEK J A, 1969, Agents and Actions, V1, P36, DOI 10.1007/BF01977664; Kuhlmann S, 2006, BEHAV NEUROSCI, V120, P217, DOI 10.1037/0735-7044.120.1.217; LAMB RJ, 1994, J EXP ANAL BEHAV, V61, P169, DOI 10.1901/jeab.1994.61-169; Lang P. J., 1999, INT AFFECTIVE PICTUR; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; Larsen JT, 2009, COGNITION EMOTION, V23, P28; Liu DLJ, 2008, NEUROBIOL LEARN MEM, V89, P36, DOI 10.1016/j.nlm.2007.09.001; Mahoney JJ, 2014, PSYCHIAT RES, V219, P367, DOI 10.1016/j.psychres.2014.05.026; MARTIN WR, 1971, CLIN PHARMACOL THER, V12, P245; McNair D., 1971, MANUAL PROFILE MOOD; MEWALDT SP, 1979, PHARMACOL BIOCHEM BE, V10, P205, DOI 10.1016/0091-3057(79)90088-1; MOHS RC, 1980, DRUG ALCOHOL DEPEN, V5, P145, DOI 10.1016/0376-8716(80)90191-X; Nielson KA, 2009, NEUROBIOL LEARN MEM, V92, P70, DOI 10.1016/j.nlm.2009.03.002; Perez AY, 2008, DRUG ALCOHOL DEPEN, V94, P258, DOI 10.1016/j.drugalcdep.2007.10.011; Preuss D, 2009, NEUROBIOL LEARN MEM, V92, P318, DOI 10.1016/j.nlm.2009.03.009; Robbins TW, 2008, ANN NY ACAD SCI, V1141, P1, DOI 10.1196/annals.1441.020; Roozendaal B, 2011, BEHAV NEUROSCI, V125, P797, DOI 10.1037/a0026187; Rothman RB, 2001, SYNAPSE, V39, P32, DOI 10.1002/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3; Simon NW, 2006, NEUROBIOL LEARN MEM, V86, P305, DOI 10.1016/j.nlm.2006.04.005; Smeets T, 2008, PSYCHONEUROENDOCRINO, V33, P1378, DOI 10.1016/j.psyneuen.2008.07.009; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; Soderpalm A, 2003, PSYCHOPHARMACOLOGY, V170, P188, DOI 10.1007/s00213-003-1536-5; SOETENS E, 1993, NEUROSCI LETT, V161, P9, DOI 10.1016/0304-3940(93)90127-7; Thomson PDR, 2011, PHYS DESK REFERENCE; Torregrossa MM, 2011, NEUROBIOL LEARN MEM, V96, P609, DOI 10.1016/j.nlm.2011.02.014; Wachtel SR, 2002, DRUG ALCOHOL DEPEN, V68, P23, DOI 10.1016/S0376-8716(02)00104-7; Wardle MC, 2012, PSYCHOPHARMACOLOGY, V220, P143, DOI 10.1007/s00213-011-2498-7; White TL, 2006, PHARMACOL BIOCHEM BE, V85, P123, DOI 10.1016/j.pbb.2006.07.020; White TL, 2002, PHARMACOL BIOCHEM BE, V73, P729, DOI 10.1016/S0091-3057(02)00818-3; Yonelinas AP, 2011, STRESS, V14, P136, DOI 10.3109/10253890.2010.520376; Zeeuws I, 2007, HUM PSYCHOPHARM CLIN, V22, P279, DOI 10.1002/hup.848	54	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117062	10.1371/journal.pone.0117062	http://dx.doi.org/10.1371/journal.pone.0117062			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679982	Green Submitted, Green Published, gold			2022-12-26	WOS:000350682600046
J	Garcia-Grajales, JA; Rucabado, G; Garcia-Dopico, A; Pena, JM; Jerusalem, A				Garcia-Grajales, Julian A.; Rucabado, Gabriel; Garcia-Dopico, Antonio; Pena, Jose-Maria; Jerusalem, Antoine			Neurite, a Finite Difference Large Scale Parallel Program for the Simulation of Electrical Signal Propagation in Neurites under Mechanical Loading	PLOS ONE			English	Article							MESSAGE-PASSING INTERFACE; NERVE-FIBERS; QUANTITATIVE-ANALYSIS; COMPUTER-SIMULATION; IMPULSE CONDUCTION; MYELINATED FIBERS; ACTION-POTENTIALS; THEORETICAL BASIS; HIGH-PERFORMANCE; MODEL	With the growing body of research on traumatic brain injury and spinal cord injury, computational neuroscience has recently focused its modeling efforts on neuronal functional deficits following mechanical loading. However, in most of these efforts, cell damage is generally only characterized by purely mechanistic criteria, functions of quantities such as stress, strain or their corresponding rates. The modeling of functional deficits in neurites as a consequence of macroscopic mechanical insults has been rarely explored. In particular, a quantitative mechanically based model of electrophysiological impairment in neuronal cells, Neurite, has only very recently been proposed. In this paper, we present the implementation details of this model: a finite difference parallel program for simulating electrical signal propagation along neurites under mechanical loading. Following the application of a macroscopic strain at a given strain rate produced by a mechanical insult, Neurite is able to simulate the resulting neuronal electrical signal propagation, and thus the corresponding functional deficits. The simulation of the coupled mechanical and electrophysiological behaviors requires computational expensive calculations that increase in complexity as the network of the simulated cells grows. The solvers implemented in Neurite-explicit and implicit-were therefore parallelized using graphics processing units in order to reduce the burden of the simulation costs of large scale scenarios. Cable Theory and Hodgkin-Huxley models were implemented to account for the electrophysiological passive and active regions of a neurite, respectively, whereas a coupled mechanical model accounting for the neurite mechanical behavior within its surrounding medium was adopted as a link between electrophysiology and mechanics. This paper provides the details of the parallel implementation of Neurite, along with three different application examples: a long myelinated axon, a segmented dendritic tree, and a damaged axon. The capabilities of the program to deal with large scale scenarios, segmented neuronal structures, and functional deficits under mechanical loading are specifically highlighted.	[Garcia-Grajales, Julian A.] IMDEA Mat Inst, Madrid, Spain; [Garcia-Grajales, Julian A.; Garcia-Dopico, Antonio; Pena, Jose-Maria] Univ Politecn Madrid, DATSI Comp Sci, Madrid, Spain; [Rucabado, Gabriel] Univ Oxford, Madrid Supercomp & Visualizat Ctr, Oxford, England; [Jerusalem, Antoine] Univ Oxford, Dept Engn Sci, Oxford OX1 3PJ, England; [Garcia-Grajales, Julian A.; Jerusalem, Antoine] Univ Oxford, Math Inst, Oxford, England	IMDEA Materials Institute; Universidad Politecnica de Madrid; University of Oxford; University of Oxford; University of Oxford	Jerusalem, A (corresponding author), Univ Oxford, Dept Engn Sci, Parks Rd, Oxford OX1 3PJ, England.	antoine.jerusalem@eng.ox.ac.uk	Dopico, Antonio García/ABH-3119-2020	Dopico, Antonio García/0000-0001-7373-7853; Jerusalem, Antoine/0000-0001-5026-8038	European Union's Seventh Framework Programme (FP7) ERC Grant Agreement [306587]; Spanish Ministry of Science [TIN2010-21289-C02-02]; Cajal Blue Brain project, Spain, the Spanish partner of the Blue Brain Project	European Union's Seventh Framework Programme (FP7) ERC Grant Agreement; Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Cajal Blue Brain project, Spain, the Spanish partner of the Blue Brain Project	Support was provided by the European Union's Seventh Framework Programme (FP7 2007-2013) ERC Grant Agreement no. 306587 [http://cordis.europa.eu/fp7/home_en.html], the Spanish Ministry of Science, (TIN2010-21289-C02-02) [http://www.idi.mineco.gob.es/portal/site/MICINN/], and the Cajal Blue Brain project, Spain, the Spanish partner of the Blue Brain Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford PW, 2011, P NATL ACAD SCI USA, V108, P12705, DOI 10.1073/pnas.1105860108; Ascoli GA, 2006, NAT REV NEUROSCI, V7, P318, DOI 10.1038/nrn1885; Babbs CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067767; Belu R, 2007, ANNUAL ASEE CONFEREN; Ben-Shalom R, 2013, FRONT NEUROINFORM, V7, DOI 10.3389/fninf.2013.00004; BLIGHT AR, 1985, NEUROSCIENCE, V15, P13, DOI 10.1016/0306-4522(85)90119-8; BLIGHT AR, 1985, NEUROSCIENCE, V15, P1, DOI 10.1016/0306-4522(85)90118-6; Boucher PA, 2012, J COMPUT NEUROSCI, V33, P301, DOI 10.1007/s10827-012-0387-7; Bower JM, 1998, BOOK GENESIS EXPLORI; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Cloots RJH, 2013, BIOMECH MODEL MECHAN, V12, P137, DOI 10.1007/s10237-012-0387-6; Connell S, 2011, J NEUROTRAUM, V28, P1229, DOI 10.1089/neu.2011.1832; Dagum L, 1998, IEEE COMPUT SCI ENG, V5, P46, DOI 10.1109/99.660313; Dalton S, 2013, CUSP C TEMPLATED SPA; de Camargo R, 2011, HIPC INT C, P1; de Camargo RY, 2011, CONCURR COMP-PRACT E, V23, P556, DOI 10.1002/cpe.1665; Fidjeland AK, 2013, NEUROINFORMATICS, V11, P267, DOI 10.1007/s12021-012-9174-x; FITZHUGH R, 1962, BIOPHYS J, V2, P11, DOI 10.1016/S0006-3495(62)86837-4; Franze K, 2010, REP PROG PHYS, V73, DOI 10.1088/0034-4885/73/9/094601; GOLDMAN L, 1968, BIOPHYS J, V8, P596, DOI 10.1016/S0006-3495(68)86510-5; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gonzalez C, 2014, SEMIN CELL DEV BIOL, V27, P23, DOI 10.1016/j.semcdb.2013.12.004; Gropp W, 1996, PARALLEL COMPUT, V22, P789, DOI 10.1016/0167-8191(96)00024-5; HAMORI J, 1981, J NEUROCYTOL, V10, P879, DOI 10.1007/BF01262659; Heinecke A, 2012, COMPUT SCI ENG, V14, P78, DOI 10.1109/MCSE.2012.23; Hicks RR, 2010, J TRAUMA, V68, P1257, DOI 10.1097/TA.0b013e3181d8956d; Hines ML, 2008, J NEUROSCI METH, V169, P425, DOI 10.1016/j.jneumeth.2007.09.010; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hui OY, 2008, J NEUROTRAUM, V25, P19, DOI 10.1089/neu.2007.0340; HUTCHINSON NA, 1970, J PHYSIOL-LONDON, V208, P279, DOI 10.1113/jphysiol.1970.sp009119; ISHIZUKA N, 1995, J COMP NEUROL, V362, P17, DOI 10.1002/cne.903620103; Jerusalem A, 2014, BIOMECH MODEL MECHAN, V13, P883, DOI 10.1007/s10237-013-0543-7; Jerusalem A, 2012, ACTA BIOMATER, V8, P3360, DOI 10.1016/j.actbio.2012.04.039; Koch Christof, 1999, P1; KOLES ZJ, 1972, J PHYSIOL-LONDON, V227, P351, DOI 10.1113/jphysiol.1972.sp010036; Kotaleski JH, 2010, NAT REV NEUROSCI, V11, P239, DOI 10.1038/nrn2807; LAX PD, 1956, COMMUN PUR APPL MATH, V9, P267, DOI 10.1002/cpa.3160090206; McIntyre CC, 2002, J NEUROPHYSIOL, V87, P995, DOI 10.1152/jn.00353.2001; MCNEAL DR, 1976, IEEE T BIO-MED ENG, V23, P329, DOI 10.1109/TBME.1976.324593; Meek J, 2001, J COMP NEUROL, V431, P255, DOI 10.1002/1096-9861(20010312)431:3<255::AID-CNE1069>3.0.CO;2-9; Migliore M, 2006, J COMPUT NEUROSCI, V21, P119, DOI 10.1007/s10827-006-7949-5; Minkovich K, 2014, IEEE T NEUR NET LEAR, V25, P316, DOI 10.1109/TNNLS.2013.2276056; MOORE JW, 1978, BIOPHYS J, V21, P147, DOI 10.1016/S0006-3495(78)85515-5; Nickolls John, 2008, ACM Queue, V6, DOI 10.1145/1365490.1365500; nVidia, 2012, CUBLAS LIB US GUID; Ouyang H, 2010, J NEUROTRAUM, V27, P1109, DOI 10.1089/neu.2010.1271; Peng HC, 2010, NAT BIOTECHNOL, V28, P348, DOI 10.1038/nbt.1612; Peter SJ, 2012, BIOPHYS J, V102, P749, DOI 10.1016/j.bpj.2011.11.4024; Richardson AG, 2000, MED BIOL ENG COMPUT, V38, P438, DOI 10.1007/BF02345014; SCHAUF CL, 1974, J NEUROL NEUROSUR PS, V37, P152, DOI 10.1136/jnnp.37.2.152; Segev I, 2000, SCIENCE, V290, P744, DOI 10.1126/science.290.5492.744; Shi R, 2006, J NEUROPHYSIOL, V95, P3384, DOI 10.1152/jn.00350.2005; Stephanova DI, 1997, BIOL CYBERN, V76, P311, DOI 10.1007/s004220050342; Volman V, 2013, NEURAL COMPUT, V25, P2646, DOI 10.1162/NECO_a_00491; WALKER DW, 1994, PARALLEL COMPUT, V20, P657, DOI 10.1016/0167-8191(94)90033-7; Wang JA, 2009, AM J PHYSIOL-CELL PH, V297, pC823, DOI 10.1152/ajpcell.00505.2008; WAXMAN SG, 1978, J NEUROL NEUROSUR PS, V41, P408, DOI 10.1136/jnnp.41.5.408; Wojcik GM, 2007, NEUROCOMPUTING, V70, P2593, DOI 10.1016/j.neucom.2006.12.015	59	16	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0116532	10.1371/journal.pone.0116532	http://dx.doi.org/10.1371/journal.pone.0116532			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680098	Green Published, Green Accepted, gold			2022-12-26	WOS:000350682600026
J	Na, YR; Yoon, YN; Son, D; Jung, D; Gu, GJ; Seok, SH				Na, Yi Rang; Yoon, Yi Na; Son, Dain; Jung, Daun; Gu, Gyo Jeong; Seok, Seung Hyeok			Consistent Inhibition of Cyclooxygenase Drives Macrophages towards the Inflammatory Phenotype	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; ZEBRAFISH LARVAE; GENE-EXPRESSION; ORAL ASPIRIN; ACTIVATION; MONOCYTE; CANCER; VIVO; POLARIZATION; INDUCTION	Macrophages play important roles in defense against infection, as well as in homeostasis maintenance. Thus alterations of macrophage function can have unexpected pathological results. Cyclooxygenase (COX) inhibitors are widely used to relieve pain, but the effects of long-term usage on macrophage function remain to be elucidated. Using bone marrow-derived macrophage culture and long-term COX inhibitor treatments in BALB/c mice and zebrafish, we showed that chronic COX inhibition drives macrophages into an inflammatory state. Macrophages differentiated in the presence of SC-560 (COX-1 inhibitor), NS-398 (COX-2 inhibitor) or indomethacin (COX-1/2 inhibitor) for 7 days produced more TNF alpha or IL-12p70 with enhanced p65/I kappa B phosphoylation. YmI and IRF4 expression was reduced significantly, indicative of a more inflammatory phenotype. We further observed that indomethacin or NS-398 delivery accelerated zebrafish death rates during LPS induced sepsis. When COX inhibitors were released over 30 days from an osmotic pump implant in mice, macrophages from peritoneal cavities and adipose tissue produced more TNFa in both the basal state and under LPS stimulation. Consequently, indomethacin-exposed mice showed accelerated systemic inflammation after LPS injection. Our findings suggest that macrophages exhibit a more inflammatory phenotype when COX activities are chronically inhibited.	[Seok, Seung Hyeok] Seoul Natl Univ, Coll Med, Dept Microbiol & Immunol, Macrophage Lab, Seoul 110799, South Korea; Seoul Natl Univ, Coll Med, Inst Endem Dis, Seoul 110799, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Seok, SH (corresponding author), Seoul Natl Univ, Coll Med, Dept Microbiol & Immunol, Macrophage Lab, 103 Daehak Ro, Seoul 110799, South Korea.	lamseok@snu.ac.kr	Seok, Seung Hyeok/J-3279-2012	Seok, Seung Hyeok/0000-0002-4315-0688	Ministry of Science, ICT and Future planning, Korea [2012R1A1A3013393, 2014R1A1A1008012]; Seoul National University Hospital	Ministry of Science, ICT and Future planning, Korea; Seoul National University Hospital	This work is supported by the Ministry of Science, ICT and Future planning, Korea (Grant number 2012R1A1A3013393, 2014R1A1A1008012). This study was also supported by a grant from Seoul National University Hospital (2014). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aid S, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-17; Aronoff DM, 2004, J IMMUNOL, V173, P559, DOI 10.4049/jimmunol.173.1.559; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; Endres S, 1996, IMMUNOLOGY, V87, P264, DOI 10.1046/j.1365-2567.1996.472535.x; Feng Y, 2012, CURR BIOL, V22, P1253, DOI 10.1016/j.cub.2012.05.010; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Harvie EA, 2013, INFECT IMMUN, V81, P110, DOI 10.1128/IAI.00642-12; Hussain M, 2012, PHARMACOL RES, V66, P7, DOI 10.1016/j.phrs.2012.02.003; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Lang S, 2007, CANCER IMMUNOL IMMUN, V56, P1645, DOI 10.1007/s00262-007-0312-5; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Mizuno H, 1997, GASTROENTEROLOGY, V112, P387, DOI 10.1053/gast.1997.v112.pm9024292; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Na YR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063451; Netea MG, 2000, EUR CYTOKINE NETW, V11, P379; Paul-Clark MJ, 2004, J EXP MED, V200, P69, DOI 10.1084/jem.20040566; PETRINI B, 1991, EUR J CANCER, V27, P591, DOI 10.1016/0277-5379(91)90225-3; Prechel MM, 2000, NEUROCHEM RES, V25, P357, DOI 10.1023/A:1007588903897; Rouzer CA, 2009, J LIPID RES, V50, pS29, DOI 10.1194/jlr.R800042-JLR200; Sadikot RT, 2007, EUR J IMMUNOL, V37, P1001, DOI 10.1002/eji.200636636; SAMUELSSON B, 1987, DRUGS, V33, P2, DOI 10.2165/00003495-198700331-00003; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Shackelford RE, 1997, MOL PHARMACOL, V52, P421, DOI 10.1124/mol.52.3.421; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Stolina M, 2000, J IMMUNOL, V164, P361, DOI 10.4049/jimmunol.164.1.361; Ulrich CM, 2006, NAT REV CANCER, V6, P130, DOI 10.1038/nrc1801; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Zhou FF, 2012, J BIOL CHEM, V287, P11002, DOI 10.1074/jbc.M111.328187	31	21	21	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0118203	10.1371/journal.pone.0118203	http://dx.doi.org/10.1371/journal.pone.0118203			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680189	gold, Green Published, Green Submitted			2022-12-26	WOS:000350682600111
J	Neuwirt, H; Wabnig, E; Feistritzer, C; Eder, IE; Salvador, C; Puhr, M; Culig, Z; Massoner, P; Tiefenthaler, M; Steurer, M; Konwalinka, G				Neuwirt, Hannes; Wabnig, Elisabeth; Feistritzer, Clemens; Eder, Iris E.; Salvador, Christina; Puhr, Martin; Culig, Zoran; Massoner, Petra; Tiefenthaler, Martin; Steurer, Michael; Konwalinka, Guenther			Akacid Medical Formulation Induces Apoptosis in Myeloid and Lymphatic Leukemic Cell Lines In Vitro and In Vivo	PLOS ONE			English	Article							CASPASE-INDEPENDENT APOPTOSIS; POLYMERIC GUANIDINE; CONVERTING-ENZYME; INHIBITOR; BCL-2; CYCLE; ACTIVATION; PHASE; SENSITIVITY; MUTATIONS	Akacid medical formulation (AMF) is an oligoguanidine that exerts biocidal activity against airborne and surface microorganisms including bacteria, viruses, fungi, and molds, while showing relatively low toxicity to humans. We have previously shown that AMF exerts antiproliferative effects on a variety of solid tumor cell lines. In this study we raised the question whether AMF could also substantially inhibit cell growth or induce apoptosis in cell lines derived from hematologic malignancies such as leukemia or lymphoma. We found that AMF has antiproliferative effects on various hematologic cell lines derived from human leukemia and lymphoma. Additionally, we show that AMF induces apoptosis in leukemia cell lines not only via the extrinsic and intrinsic pathway, but also in a caspase-independent manner. This effect was found also in G0-arrested cells. Finally, in our animal experiments utilizing male nu/nu Balb/c mice we found a significant growth retardation, which was immunohistochemically associated with a significantly lower number of KI67-positive cells and caspase-3 induction in AMF-treated mice.	[Neuwirt, Hannes; Wabnig, Elisabeth; Tiefenthaler, Martin] Med Univ Innsbruck, Dept Internal Med 4, A-6020 Innsbruck, Austria; [Feistritzer, Clemens; Steurer, Michael] Med Univ Innsbruck, Dept Internal Med 5, A-6020 Innsbruck, Austria; [Eder, Iris E.; Puhr, Martin; Culig, Zoran; Massoner, Petra] Med Univ Innsbruck, Dept Expt Urol, A-6020 Innsbruck, Austria; [Salvador, Christina] Med Univ Innsbruck, Dept Pediat, A-6020 Innsbruck, Austria; [Konwalinka, Guenther] Med Univ Innsbruck, Dept Internal Med 1, A-6020 Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck	Neuwirt, H (corresponding author), Med Univ Innsbruck, Dept Internal Med 4, A-6020 Innsbruck, Austria.	Hannes.Neuwirt@i-med.ac.at	Salvador, Christina/AAQ-4798-2021; Neuwirt, Hannes/AAF-1090-2019	Tiefenthaler, Martin/0000-0002-5905-7955; Eder, Iris/0000-0003-3716-0027; Neuwirt, Hannes/0000-0003-1064-0098				Albert M, 2003, BIOMACROMOLECULES, V4, P1811, DOI 10.1021/bm0342180; Ashour AA, 2014, APOPTOSIS, V19, P241, DOI 10.1007/s10495-013-0927-2; Ashour ML, 2014, CHIN MED-UK, V9, DOI 10.1186/1749-8546-9-4; Ausserlechner MJ, 2001, J BIOL CHEM, V276, P10984, DOI 10.1074/jbc.M008188200; Bellezza I, 2006, AM J PATHOL, V169, P2199, DOI 10.2353/ajpath.2006.060171; Boyd-Tressler A, 2014, J BIOL CHEM; Buxbaum A, 2006, J ANTIMICROB CHEMOTH, V58, P193, DOI 10.1093/jac/dkl206; Chen JC, 2014, NUTR CANCER, V66, P700, DOI 10.1080/01635581.2014.902974; Chonghaile TN, 2014, CANCER DISCOV, V4, P1074, DOI 10.1158/2159-8290.CD-14-0353; Davids MS, 2014, J CLIN ONCOL S, V32, p5s; Feiertag P, 2003, MACROMOL RAPID COMM, V24, P567, DOI 10.1002/marc.200390085; Fresquet V, 2014, BLOOD, V123, P4111, DOI 10.1182/blood-2014-03-560284; Geley S, 1997, FEBS LETT, V402, P36, DOI 10.1016/S0014-5793(96)01496-2; Geley S, 1997, FEBS LETT, V400, P15, DOI 10.1016/S0014-5793(96)01284-7; Groves MJ, 2013, BRIT J CANCER, V109, P2434, DOI 10.1038/bjc.2013.601; Hartmann BL, 1999, ONCOGENE, V18, P713, DOI 10.1038/sj.onc.1202339; Hsu MJ, 2005, BIOCHEM PHARMACOL, V70, P102, DOI 10.1016/j.bcp.2005.04.014; Iijima N, 1997, BLOOD, V90, P4901, DOI 10.1182/blood.V90.12.4901.4901_4901_4909; Kelly GL, 2014, GENE DEV, V28, P58, DOI 10.1101/gad.232009.113; Kim EA, 2014, APOPTOSIS, V19, P1165, DOI 10.1007/s10495-014-0994-z; Kim JY, 2013, CARDIOVASC TOXICOL, V13, P148, DOI 10.1007/s12012-012-9193-8; KOMIYAMA T, 1994, J BIOL CHEM, V269, P19331; Kratzer C, 2006, J HOSP INFECT, V63, P316, DOI 10.1016/j.jhin.2006.01.024; Kratzer C, 2007, ANTIMICROB AGENTS CH, V51, P3437, DOI 10.1128/AAC.00130-07; Loffler M, 1999, ONCOGENE, V18, P4626, DOI 10.1038/sj.onc.1202820; Matsumoto T, 2014, BIOL PHARM BULL, V37, P633, DOI 10.1248/bpb.b13-00920; Neuwirt H, 2006, INT J ONCOL, V29, P503; Niu X, 2014, LEUKEMIA, V28, P1557, DOI 10.1038/leu.2014.72; Ohgidani M, 2012, J BIOSCI BIOENG, V114, P104, DOI 10.1016/j.jbiosc.2012.02.026; Park C, 2014, NUTR RES PRACT, V8, P132, DOI [10.4162/nrp.2014.8.2.132, 10.4162/nrp.2014.8.1.132]; Pasberg-Gauhl Cornelia, 2014, Drug Discov Today Technol, V11, P109, DOI 10.1016/j.ddtec.2014.04.001; Perri M, 2014, EXP CELL RES; Razzaghi-Abyaneh M, 2006, MYCOPATHOLOGIA, V161, P245, DOI 10.1007/s11046-006-0222-7; Saeed M, 2014, PHYTOMEDICINE, V21, P1525, DOI 10.1016/j.phymed.2014.07.011; Seymour JF DM, 2014, J CLIN ONCOL S, V32, p5s; Shorey LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034975; Strasser A, 1995, EMBO J, V14, P6136, DOI 10.1002/j.1460-2075.1995.tb00304.x; Sun YS, 2014, BIOL PHARM BULL, V37, P608, DOI 10.1248/bpb.b13-00877; Wang J, 2014, CELL BIOCH BIOPHYS; Yang SJ, 2014, ONCOL REP, V31, P2286, DOI 10.3892/or.2014.3066; Ying TH, 2013, ANTICANCER RES, V33, P4411; Zeuner A, 2014, CELL DEATH DIFFER; Zhou YF, 2013, PHARMAZIE, V68, P755, DOI 10.1691/ph.2013.3520	43	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117806	10.1371/journal.pone.0117806	http://dx.doi.org/10.1371/journal.pone.0117806			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680181	Green Published, Green Submitted, gold			2022-12-26	WOS:000350682600090
J	Volpetti, F; Garcia-Cordero, J; Maerkl, SJ				Volpetti, Francesca; Garcia-Cordero, Jose; Maerkl, Sebastian J.			A Microfluidic Platform for High-Throughput Multiplexed Protein Quantitation	PLOS ONE			English	Article							KINETICS	We present a high-throughput microfluidic platform capable of quantitating up to 384 biomarkers in 4 distinct samples by immunoassay. The microfluidic device contains 384 unit cells, which can be individually programmed with pairs of capture and detection antibody. Samples are quantitated in each unit cell by four independent MITOMI detection areas, allowing four samples to be analyzed in parallel for a total of 1,536 assays per device. We show that the device can be pre-assembled and stored for weeks at elevated temperature and we performed proof-of-concept experiments simultaneously quantitating IL-6, IL-1 beta, TNF-alpha, PSA, and GFP. Finally, we show that the platform can be used to identify functional antibody combinations by screening 64 antibody combinations requiring up to 384 unique assays per device.	[Volpetti, Francesca; Garcia-Cordero, Jose; Maerkl, Sebastian J.] Ecole Polytech Fed Lausanne, Sch Engn, Inst Bioengn, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Maerkl, SJ (corresponding author), Ecole Polytech Fed Lausanne, Sch Engn, Inst Bioengn, Lausanne, Switzerland.	sebastian.maerkl@epfl.ch	Garcia-Cordero, Jose L/D-1591-2009; Maerkl, Sebastian J. J/C-5438-2008	Garcia-Cordero, Jose L/0000-0002-3868-7405; Maerkl, Sebastian J. J/0000-0003-1917-5268	Swiss National Science Foundation [CR23I2_140697]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was funded by a grant from the Swiss National Science Foundation (CR23I2_140697). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bange A, 2005, BIOSENS BIOELECTRON, V20, P2488, DOI 10.1016/j.bios.2004.10.016; Bernard A, 2001, ANAL CHEM, V73, P8, DOI 10.1021/ac0008845; Chou HP, 2001, BIOMED MICRODEVICES, V3, P323, DOI 10.1023/A:1012412916446; Ciaccio MF, 2010, NAT METHODS, V7, P148, DOI [10.1038/nmeth.1418, 10.1038/NMETH.1418]; Einav S, 2008, NAT BIOTECHNOL, V26, P1019, DOI 10.1038/nbt.1490; Fan R, 2008, NAT BIOTECHNOL, V26, P1373, DOI 10.1038/nbt.1507; Fidalgo LM, 2011, LAB CHIP, V11, P1612, DOI 10.1039/c0lc00537a; Fordyce PM, 2010, NAT BIOTECHNOL, V28, P970, DOI 10.1038/nbt.1675; Garcia-Cordero JL, 2014, LAB CHIP, V14, P2642, DOI [10.1039/C3LC51153G, 10.1039/c3lc51153g]; Garcia-Cordero JL, 2013, INTEGR BIOL-UK, V5, P650, DOI 10.1039/c3ib20263a; Garcia-Cordero JL, 2013, CHEM COMMUN, V49, P1264, DOI 10.1039/c2cc37740c; Geertz M, 2012, P NATL ACAD SCI USA, V109, P16540, DOI 10.1073/pnas.1206011109; Gerber D, 2009, NAT METHODS, V6, P71, DOI [10.1038/NMETH.1289, 10.1038/nmeth.1289]; Hood L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008665; Kim SH, 2011, ANGEW CHEM INT EDIT, V50, P1171, DOI 10.1002/anie.201004869; Lee H, 2010, NAT MATER, V9, P745, DOI [10.1038/nmat2815, 10.1038/NMAT2815]; Lee MJ, 2012, CELL, V149, P780, DOI 10.1016/j.cell.2012.03.031; Limmer K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089626; Maerkl SJ, 2007, SCIENCE, V315, P233, DOI 10.1126/science.1131007; Gonzalez-Angulo AM, 2010, J CLIN ONCOL, V28, P2777, DOI 10.1200/JCO.2009.27.0777; Martin L, 2012, NAT METHODS, V9, P1192, DOI [10.1038/NMETH.2225, 10.1038/nmeth.2225]; Ng AHC, 2010, ANAL BIOANAL CHEM, V397, P991, DOI 10.1007/s00216-010-3678-8; Niederholtmeyer H, 2013, P NATL ACAD SCI USA, V110, P15985, DOI 10.1073/pnas.1311166110; Pla-Roca M, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011460; Rockel S, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1323; Rockel S, 2012, METHODS MOL BIOL, V786, P97, DOI 10.1007/978-1-61779-292-2_6; Singhal A, 2010, ANAL CHEM, V82, P8671, DOI 10.1021/ac101956e; Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113; Wilson R, 2006, ANGEW CHEM INT EDIT, V45, P6104, DOI 10.1002/anie.200600288; Zheng CH, 2012, LAB CHIP, V12, P2487, DOI [10.1039/c2lc40145b, 10.1039/c21c40145b]	30	30	32	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117744	10.1371/journal.pone.0117744	http://dx.doi.org/10.1371/journal.pone.0117744			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680117	Green Submitted, Green Published, gold			2022-12-26	WOS:000350682600082
J	Aleshcheva, G; Wehland, M; Sahana, J; Bauer, J; Corydon, TJ; Hemmersbach, R; Frett, T; Egli, M; Infanger, M; Grosse, J; Grimm, D				Aleshcheva, Ganna; Wehland, Markus; Sahana, Jayashree; Bauer, Johann; Corydon, Thomas J.; Hemmersbach, Ruth; Frett, Timo; Egli, Marcel; Infanger, Manfred; Grosse, Jirka; Grimm, Daniela			Moderate alterations of the cytoskeleton in human chondrocytes after short-term microgravity produced by parabolic flight maneuvers could be prevented by up-regulation of BMP-2 and SOX-9	FASEB JOURNAL			English	Article						gene expression; F-actin; hypergravity; vibration	HUMAN ENDOTHELIAL-CELLS; THYROID-CANCER CELLS; LEFT-VENTRICULAR HYPERTROPHY; FIBROBLAST-GROWTH-FACTOR; SIMULATED MICROGRAVITY; GENE-EXPRESSION; MAMMALIAN-CELLS; SPHEROID FORMATION; ALTERED GRAVITY; WEIGHTLESSNESS	Real and simulated microgravity induce a variety of changes in human cells. Most importantly, changes in the cytoskeleton have been noted, and studies on microtubules have shown that they are gravisensitive. This study focuses on the effects of short-term real microgravity on gene expression, protein content, and cytoskeletal structure of human chondrocytes. We cultivated human chondrocytes, took them along a parabolic flight during the 24th Deutsches Zentrum fur Luft-und Raumfahrt Parabolic (DLR) Flight Campaign, and fixed them after the 1st and the 31st parabola. Immunofluorescence microscopy revealed no changes after the 1st parabola, but disruptions of beta-tubulin, vimentin, and cytokeratin networks after the 31st parabola. No Factin stress fibers were detected even after 31 parabolas. Furthermore, mRNA and protein quantifications after the 31st parabola showed a clear up-regulation of cytoskeletal genes and proteins. The mRNAs were significantly up-regulated as follows: TUBB, 2-fold; VIM, 1.3-fold; KRT8, 1.8-fold; ACTB, 1.9-fold; ICAM1, 4.8-fold; OPN, 7-fold; ITGA10, 1.5-fold; ITGB1, 1.2-fold; TGFB1, 1.5-fold; CAV1, 2.6-fold; SOX9, 1.7-fold; BMP-2, 5.3-fold. However, SOX5 (-25%) and SOX6 (-28%) gene expression was decreased. Contrary, no significant changes in gene expression levels were observed during vibration and hypergravity experiments. These data suggest that short-term microgravity affects the gene expression of distinct proteins. In contrast to poorly differentiated follicular thyroid cancer cells or human endothelial cells, chondrocytes only exert moderate cytoskeletal alterations. The up-regulation of BMP-2, TGF-beta 1, and SOX9 in chondrocytes may play a key role in preventing cytoskeletal alterations.	[Aleshcheva, Ganna; Wehland, Markus; Infanger, Manfred] Univ Magdeburg, Clin Plast Aesthet & Hand Surg, D-39106 Magdeburg, Germany; [Sahana, Jayashree; Corydon, Thomas J.; Grimm, Daniela] Aarhus Univ, Dept Biomed, DK-8000 Aarhus C, Denmark; [Bauer, Johann] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Hemmersbach, Ruth; Frett, Timo] DLR German Aerosp Ctr, Biomed Res, Gravitat Biol, Cologne, Germany; [Egli, Marcel] Luzerne Univ Appl Sci & Arts, Space Biol Grp, Aerosp Biomed Sci & Technol, Hergiswil, Switzerland; [Grosse, Jirka] Univ Regensburg, Dept Nucl Med, D-93053 Regensburg, Germany	Otto von Guericke University; Aarhus University; Max Planck Society; Helmholtz Association; German Aerospace Centre (DLR); University of Regensburg	Grimm, D (corresponding author), Aarhus Univ, Dept Biomed, Wilhelm Meyers Alle 4, DK-8000 Aarhus C, Denmark.	dgg@biomed.au.dk		Wehland, Markus/0000-0002-8160-859X; Corydon, Thomas Juhl/0000-0003-3588-6350; Frett, Timo/0000-0002-5572-1177; Grimm, Daniela/0000-0002-4991-3105; Sahana, Jayashree/0000-0002-6606-6315	Helmholtz Space Life Sciences Research School (SpaceLife), German Space Agency BMWi Project [50WB1124]; European Space Agency [CORA-GBF-2013-004]	Helmholtz Space Life Sciences Research School (SpaceLife), German Space Agency BMWi Project; European Space Agency(European Space AgencyEuropean Commission)	The authors thank the Helmholtz Space Life Sciences Research School (SpaceLife), German Space Agency BMWi Project 50WB1124 (to D.G.), European Space Agency Grant CORA-GBF-2013-004 (to D.G.), Aarhus University (D.G.), and Deutsche Gesellschaft fur Luft- und Raumfahrtmedizin (DGLRM) (Young Fellow Program) (to G.A.). The data in this publication form a part of the Ph.D. thesis of G.A.	Aleshcheva G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079057; BENJAMIN M, 1994, MICROSC RES TECHNIQ, V28, P372, DOI 10.1002/jemt.1070280503; Blain EJ, 2009, INT J EXP PATHOL, V90, P1, DOI 10.1111/j.1365-2613.2008.00625.x; Boonstra J, 1999, FASEB J, V13, pS35, DOI 10.1096/fasebj.13.9001.s35; Chavagnac C, 2013, ACTA ASTRONAUT, V92, P172, DOI 10.1016/j.actaastro.2012.09.001; Foldes I, 1996, ACTA BIOL HUNG, V47, P145; Freed LE, 1997, P NATL ACAD SCI USA, V94, P13885, DOI 10.1073/pnas.94.25.13885; Gao L, 2013, J CELL SCI, V126, P5704, DOI 10.1242/jcs.135483; Greenwald E., UNDERSTANDING PHYSL; Grimm D, 2002, FASEB J, V16, P604, DOI 10.1096/fj.01-0673fje; Grimm D, 2002, CARDIOVASC PATHOL, V11, P229, DOI 10.1016/S1054-8807(01)00116-8; Grimm D, 2011, EXPERT REV PROTEOMIC, V8, P13, DOI 10.1586/EPR.10.105; Grimm D, 2010, TISSUE ENG PT A, V16, P1559, DOI [10.1089/ten.tea.2009.0524, 10.1089/ten.TEA.2009.0524]; Grimm D, 2009, TISSUE ENG PT A, V15, P2267, DOI 10.1089/ten.tea.2008.0576; Grosse J, 2012, FASEB J, V26, P5124, DOI 10.1096/fj.12-215749; Grosse J, 2012, FASEB J, V26, P639, DOI 10.1096/fj.11-194886; Herranz R, 2013, ASTROBIOLOGY, V13, P1, DOI 10.1089/ast.2012.0876; Hu JJ, 2014, PROTEOME SCI, V12, DOI 10.1186/1477-5956-12-13; Hughes-Fulford M, 2003, ADV SPACE RES-SERIES, V32, P1585, DOI 10.1016/S0273-1177(03)90399-1; Infanger M, 2006, APOPTOSIS, V11, P749, DOI 10.1007/s10495-006-5697-7; Infanger M, 2007, CARDIOVASC PATHOL, V16, P291, DOI 10.1016/j.carpath.2007.04.001; Infanger M, 2007, J CELL BIOCHEM, V101, P1439, DOI 10.1002/jcb.21261; Lee JS, 2005, EXP MOL MED, V37, P427, DOI 10.1038/emm.2005.53; Legate KR, 2009, GENE DEV, V23, P397, DOI 10.1101/gad.1758709; Lewis Marian L, 2002, Adv Space Biol Med, V8, P77; Ma X, 2014, FASEB J, V28, P813, DOI 10.1096/fj.13-243287; MATSUOKA S, 1995, J EXP MED, V181, P2007, DOI 10.1084/jem.181.6.2007; Michigami T, 2013, CELL MOL LIFE SCI, V70, P4213, DOI 10.1007/s00018-013-1346-9; Niu HJ, 2012, ACTA MECH SINICA-PRC, V28, P1488, DOI 10.1007/s10409-012-0150-3; Pietsch J, 2011, CURR MOL MED, V11, P350, DOI 10.2174/156652411795976600; Pietsch J, 2013, BIOMATERIALS, V34, P7694, DOI 10.1016/j.biomaterials.2013.06.054; Pietsch J, 2011, PROTEOMICS, V11, P2095, DOI 10.1002/pmic.201000817; PITZKE P, 1994, ACTA OTO-LARYNGOL, V114, P81, DOI 10.3109/00016489409126021; Riecke K, 2002, ARCH TOXICOL, V76, P360, DOI 10.1007/s00204-002-0338-6; Rossi MA, 1997, AM J TROP MED HYG, V57, P321, DOI 10.4269/ajtmh.1997.57.321; Rothermund L, 2002, AM J HYPERTENS, V15, P644, DOI 10.1016/S0895-7061(02)02956-4; Rothermund L, 2006, J HYPERTENS, V24, P1857, DOI 10.1097/01.hjh.0000242411.50536.b9; Schmidt W, 2004, MICROGRAVITY SCI TEC, V15, P42, DOI 10.1007/BF02870951; Schnabel M, 2002, OSTEOARTHR CARTILAGE, V10, P62, DOI 10.1053/joca.2001.0482; Stamenkovic V, 2010, TISSUE ENG PT A, V16, P1729, DOI 10.1089/ten.tea.2008.0624; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Ulbrich C, 2008, J CELL BIOCHEM, V104, P1324, DOI 10.1002/jcb.21710; Ulbrich C, 2011, CELL PHYSIOL BIOCHEM, V28, P185, DOI 10.1159/000331730; Ulbrich C, 2010, CELL PHYSIOL BIOCHEM, V25, P551, DOI 10.1159/000303059; Unsworth BR, 1998, NAT MED, V4, P901, DOI 10.1038/nm0898-901; Uva BM, 2002, BRAIN RES, V934, P132, DOI 10.1016/S0006-8993(02)02415-0; Wakabayashi T, 2010, BIOCHEM BIOPH RES CO, V391, P1116, DOI 10.1016/j.bbrc.2009.12.034; Wang P, 2011, FASEB J, V25, P3401, DOI 10.1096/fj.11-184861; Weber M, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-124; Wu L, 2014, TISSUE ENG PART C-ME, V20, P160, DOI [10.1089/ten.tec.2013.0056, 10.1089/ten.TEC.2013.0056]; Zayzafoon M, 2005, IMMUNOL REV, V208, P267, DOI 10.1111/j.0105-2896.2005.00330.x; Zimmermann Joshua A., 2011, Molecular & Cellular Biomechanics, V8, P297	52	58	59	0	28	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2303	2314		10.1096/fj.14-268151	http://dx.doi.org/10.1096/fj.14-268151			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	25681461				2022-12-26	WOS:000355209500009
J	Harris, AD; Puts, NAJ; Anderson, BA; Yantis, S; Pekar, JJ; Barker, PB; Edden, RAE				Harris, Ashley D.; Puts, Nicolaas A. J.; Anderson, Brian A.; Yantis, Steven; Pekar, James J.; Barker, Peter B.; Edden, Richard A. E.			Multi-Regional Investigation of the Relationship between Functional MRI Blood Oxygenation Level Dependent (BOLD) Activation and GABA Concentration	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; GAMMA-AMINOBUTYRIC-ACID; HUMAN CEREBRAL GABA; IN-VIVO; MENSTRUAL-CYCLE; BRAIN ACTIVITY; INDIVIDUAL VARIABILITY; FMRI; INHIBITION; IMAGES	Several recent studies have reported an inter-individual correlation between regional GABA concentration, as measured by MRS, and the amplitude of the functional blood oxygenation level dependent (BOLD) response in the same region. In this study, we set out to investigate whether this coupling generalizes across cortex. In 18 healthy participants, we performed edited MRS measurements of GABA and BOLD-fMRI experiments using regionally related activation paradigms. Regions and tasks were the: occipital cortex with a visual grating stimulus; auditory cortex with a white noise stimulus; sensorimotor cortex with a finger-tapping task; frontal eye field with a saccade task; and dorsolateral prefrontal cortex with a working memory task. In contrast to the prior literature, no correlation between GABA concentration and BOLD activation was detected in any region. The origin of this discrepancy is not clear. Subtle differences in study design or insufficient power may cause differing results; these and other potential reasons for the discrepant results are discussed. This negative result, although it should be interpreted with caution, has a larger sample size than prior positive results, and suggests that the relationship between GABA and the BOLD response may be more complex than previously thought.	[Harris, Ashley D.; Puts, Nicolaas A. J.; Pekar, James J.; Barker, Peter B.; Edden, Richard A. E.] Johns Hopkins Univ, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21218 USA; [Harris, Ashley D.; Puts, Nicolaas A. J.; Pekar, James J.; Barker, Peter B.; Edden, Richard A. E.] FM Kirby Ctr Funct Brain Imaging, Kennedy Krieger Inst, Baltimore, MD USA; [Anderson, Brian A.; Yantis, Steven] Johns Hopkins Univ, Dept Psychol & Brain Sci, Baltimore, MD USA	Johns Hopkins University; Kennedy Krieger Institute; Johns Hopkins University	Harris, AD (corresponding author), Johns Hopkins Univ, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21218 USA.	aharr108@jhmi.edu		Pekar, James/0000-0002-9830-0655; Edden, Richard/0000-0002-0671-7374	National Institutes of Health [R21 NS077300, P41 EB015909, R01 EB016089]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015909, R01EB016089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS077300] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grants R21 NS077300 to ADH, SY, JJP, PBB, RAEE, P41 EB015909 to JJP, PPB, RAEE, and R01 EB016089 to ADH, NAJP, PBB, RAEE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre GK, 2012, NEUROIMAGE, V62, P1279, DOI 10.1016/j.neuroimage.2012.04.039; Bogner W, 2010, EUR J RADIOL, V73, P526, DOI 10.1016/j.ejrad.2009.01.014; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Buzsaki G, 2007, NEURON, V56, P771, DOI 10.1016/j.neuron.2007.11.008; Donahue M.J., 2014, J CEREB BLOOD FLOW M; Donahue MJ, 2010, NEUROIMAGE, V53, P392, DOI 10.1016/j.neuroimage.2010.07.017; Edden RAE, 2014, J MAGN RESO IN PRESS; Edden RAE, 2012, MAGN RESON MED, V68, P657, DOI 10.1002/mrm.24391; Epperson CN, 2005, BIOL PSYCHIAT, V57, P44, DOI 10.1016/j.biopsych.2004.09.021; Epperson CN, 2002, ARCH GEN PSYCHIAT, V59, P851, DOI 10.1001/archpsyc.59.9.851; Evans CJ, 2010, J MAGN RESON IMAGING, V31, P204, DOI 10.1002/jmri.21996; Evans CJ, 2012, J MAGN RESON IMAGING; Field AP, 2010, BRIT J MATH STAT PSY, V63, P665, DOI 10.1348/000711010X502733; Gaxiola-Valdez I, 2012, MAGN RESON IMAGING, V30, P1394, DOI 10.1016/j.mri.2012.05.002; Harada M, 2011, HUM BRAIN MAPP, V32, P828, DOI 10.1002/hbm.21086; Harris AD, 2014, MAGN RESON MED, V72, P941, DOI 10.1002/mrm.25009; Henry PG, 2001, MAGNET RESON MED, V45, P517, DOI 10.1002/1522-2594(200103)45:3<517::AID-MRM1068>3.0.CO;2-6; Hetherington HP, 1998, MAGNET RESON MED, V39, P6, DOI 10.1002/mrm.1910390103; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kleiner M., 2007, WHATS NEW PSYCHTOOLB; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Lu HZ, 2013, NMR BIOMED, V26, P932, DOI 10.1002/nbm.2905; MacDonald SWS, 2006, TRENDS NEUROSCI, V29, P474, DOI 10.1016/j.tins.2006.06.011; Mescher M, 1998, NMR BIOMED, V11, P266, DOI 10.1002/(SICI)1099-1492(199810)11:6<266::AID-NBM530>3.0.CO;2-J; Mullins PG, 2014, NEUROIMAGE, V86, P43, DOI 10.1016/j.neuroimage.2012.12.004; Muthukumaraswamy SD, 2012, HUM BRAIN MAPP, V33, P455, DOI 10.1002/hbm.21223; Muthukumaraswamy SD, 2009, P NATL ACAD SCI USA, V106, P8356, DOI 10.1073/pnas.0900728106; Near J, 2014, MAGN RESON IN PRESS; Near J, 2011, NMR BIOMED, V24, P1277, DOI 10.1002/nbm.1688; Northoff G, 2007, NAT NEUROSCI, V10, P1515, DOI 10.1038/nn2001; O'Gorman RL, 2011, J MAGN RESON IMAGING, V33, P1262, DOI 10.1002/jmri.22520; Rae CD, 2014, NEUROCHEM RES, V39, P1, DOI 10.1007/s11064-013-1199-5; Raemaekers M, 2012, NEUROIMAGE, V60, P717, DOI 10.1016/j.neuroimage.2011.11.061; ROTHMAN DL, 1993, P NATL ACAD SCI USA, V90, P5662, DOI 10.1073/pnas.90.12.5662; Sanacora G, 1999, ARCH GEN PSYCHIAT, V56, P1043, DOI 10.1001/archpsyc.56.11.1043; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Stagg Charlotte J, 2011, Commun Integr Biol, V4, P573, DOI 10.4161/cib.4.5.16213; Stagg CJ, 2011, CURR BIOL, V21, P480, DOI 10.1016/j.cub.2011.01.069; Tagamets MA, 2001, BRAIN RES BULL, V54, P267, DOI 10.1016/S0361-9230(00)00435-4; Terpstra M, 2002, MAGNET RESON MED, V47, P1009, DOI 10.1002/mrm.10146; Tkac I, 1999, MAGNET RESON MED, V41, P649, DOI 10.1002/(SICI)1522-2594(199904)41:4<649::AID-MRM2>3.0.CO;2-G; van Gelderen P, 2005, MAGN RESON MED, V54, P569, DOI 10.1002/mrm.20577; Van Horn JD, 2008, BRAIN IMAGING BEHAV, V2, P327, DOI 10.1007/s11682-008-9049-9; Violante IR, 2013, BRAIN, V136, P918, DOI 10.1093/brain/aws368; Wetzels R, 2012, PSYCHON B REV, V19, P1057, DOI 10.3758/s13423-012-0295-x; Wise RG, 2013, NEUROIMAGE, V83, P135, DOI 10.1016/j.neuroimage.2013.06.008; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; Worsley KJ, 2001, FUNCTIONAL MRI INTRO; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	51	36	38	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0117531	10.1371/journal.pone.0117531	http://dx.doi.org/10.1371/journal.pone.0117531			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25699994	Green Published, gold, Green Submitted			2022-12-26	WOS:000349789800026
J	Paiardini, A; Bamert, RS; Kannan-Sivaraman, K; Drinkwater, N; Mistry, SN; Scammells, PJ; McGowan, S				Paiardini, Alessandro; Bamert, Rebecca S.; Kannan-Sivaraman, Komagal; Drinkwater, Nyssa; Mistry, Shailesh N.; Scammells, Peter J.; McGowan, Sheena			Screening the Medicines for Malaria Venture "Malaria Box" against the Plasmodium falciparum Aminopeptidases, M1, M17 and M18	PLOS ONE			English	Article							INHIBITION	Malaria is a parasitic disease that remains a global health burden. The ability of the parasite to rapidly develop resistance to therapeutics drives an urgent need for the delivery of new drugs. The Medicines for Malaria Venture have compounds known for their antimalarial activity, but not necessarily the molecular targets. In this study, we assess the ability of the "MMV 400" compounds to inhibit the activity of three metalloaminopeptidases from Plasmodium falciparum, PfA-M1, PfA-M17 and PfM18 AAP. We have developed a multiplex assay system to allow rapid primary screening of compounds against all three metalloaminopeptidases, followed by detailed analysis of promising compounds. Our results show that there were no PfM18AAP inhibitors, whereas two moderate inhibitors of the neutral aminopeptidases PfA-M1 and PfA-M17 were identified. Further investigation through structure-activity relationship studies and molecular docking suggest that these compounds are competitive inhibitors with novel binding mechanisms, acting through either non-classical zinc coordination or independently of zinc binding altogether. Although it is unlikely that inhibition of PfA-M1 and/or PfA-M17 is the primary mechanism responsible for the antiplasmodial activity reported for these compounds, their detailed characterization, as presented in this work, pave the way for their further optimization as a novel class of dual PfA-M1/PfA-M17 inhibitors utilising non-classical zinc binding groups.	[Paiardini, Alessandro] Univ Roma La Sapienza, Dipartmento Sci Biochim A Rossi Fanelli, I-00185 Rome, Italy; [Bamert, Rebecca S.; Kannan-Sivaraman, Komagal; Drinkwater, Nyssa; McGowan, Sheena] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia; [Mistry, Shailesh N.; Scammells, Peter J.] Monash Univ, Monash Inst Pharmaceut Sci, Melbourne, Vic 3004, Australia	Sapienza University Rome; Monash University; Monash University	McGowan, S (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton Campus, Melbourne, Vic 3004, Australia.	Sheena.McGowan@monash.edu	Mistry, Shailesh/O-2697-2014; McGowan, Sheena/C-4797-2014	Mistry, Shailesh/0000-0002-2252-1689; McGowan, Sheena/0000-0001-6863-1106; Drinkwater, Nyssa/0000-0001-9165-7806; Paiardini, Alessandro/0000-0001-9078-7545; Scammells, Peter/0000-0003-2930-895X	Australian National Health and Medical Research Council [1063786]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The work was supported by an Australian National Health and Medical Research Council Project Grant to SM and PJS (1063786). SM is an Australian Research Council Future Fellow (FT100100690). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2008, CHEMMEDCHEM, V3, P812, DOI 10.1002/cmdc.200700290; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Bramucci E, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S4-S2; Deprez-Poulain R, 2012, J MED CHEM, V55, P10909, DOI 10.1021/jm301506h; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Harbut MB, 2011, P NATL ACAD SCI USA, V108, pE526, DOI 10.1073/pnas.1105601108; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; McGowan S, 2013, CURR OPIN STRUC BIOL, V23, P828, DOI 10.1016/j.sbi.2013.07.015; McGowan S, 2010, P NATL ACAD SCI USA, V107, P2449, DOI 10.1073/pnas.0911813107; McGowan S, 2009, P NATL ACAD SCI USA, V106, P2537, DOI 10.1073/pnas.0807398106; Mucha A, 2010, BIOCHIMIE, V92, P1509, DOI 10.1016/j.biochi.2010.04.026; Ragheb D, 2011, J BIOL CHEM, V286, P27255, DOI 10.1074/jbc.M111.225318; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sivaraman KK, 2013, J MED CHEM, V56, P5213, DOI 10.1021/jm4005972; Sivaraman KK, 2012, J MOL BIOL, V422, P495, DOI 10.1016/j.jmb.2012.06.006; Skinner-Adams TS, 2012, ANTIMICROB AGENTS CH, V56, P3244, DOI 10.1128/AAC.06245-11; Spangenberg T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062906; Stack CM, 2007, J BIOL CHEM, V282, P2069, DOI 10.1074/jbc.M609251200; Teuscher F, 2007, J BIOL CHEM, V282, P30817, DOI 10.1074/jbc.M704938200; Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e; Velmourougane G, 2011, J MED CHEM, V54, P1655, DOI 10.1021/jm101227t; WHO, 2013, WORLD MALARIA REPORT 2013, P1	23	29	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0115859	10.1371/journal.pone.0115859	http://dx.doi.org/10.1371/journal.pone.0115859			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25700165	Green Published, gold, Green Submitted			2022-12-26	WOS:000349789800004
J	Yang, HJ; Wang, M; Wang, L; Cheng, BF; Lin, XY; Feng, ZW				Yang, Hai-Jie; Wang, Mian; Wang, Lei; Cheng, Bin-Feng; Lin, Xiao-Yu; Feng, Zhi-Wei			NF-kappa B Regulates Caspase-4 Expression and Sensitizes Neuroblastoma Cells to Fas-Induced Apoptosis	PLOS ONE			English	Article							MEDIATED APOPTOSIS; DEATH RECEPTOR; T-LYMPHOCYTES; IMMUNE-SYSTEM; STROMAL CELLS; TNF-ALPHA; ACTIVATION; LIGAND; BRAIN; NEUROPROTECTION	Found in neurons and neuroblastoma cells, Fas-induced apoptosis and accompanied activation of NF-kappa B signaling were thought to be associated with neurodegenerative diseases. However, the detailed functions of NF-kappa B activation in Fas killing and the effect of NF-kappa B activation on its downstream events remain unclear. Here, we demonstrated that agonistic Fas antibody induces cell death in a dose-dependent way and NF-kappa B signaling is activated as well, in neuroblastoma cells SH-EP1. Unexpectedly, NF-kappa B activation was shown to be pro-apoptotic, as suggested by the reduction of Fas-induced cell death with either a dominant negative form of I kappa B alpha (DN-I kappa B alpha) or an I kappa B kinase-specific inhibitor. To our interest, when analyzing downstream events of NF-kappa B signaling, we found that DN-I kappa B alpha only suppressed the expression of caspase-4, but not other caspases. Vice versa, enhancement of NF-kappa B activity by p65 (RelA) overexpression increased the expression of caspase-4 at both mRNA and protein levels. More directly, results from dual luciferase reporter assay demonstrated the regulation of caspase-4 promoter activity by NF-kappa B. When caspase-4 activity was blocked by its dominant negative (DN) form, Fas-induced cell death was substantially reduced. Consistently, the cleavage of PARP and caspase-3 induced by Fas was also reduced. In contrast, the cleavage of caspase-8 remained unaffected in caspase-4 DN cells, although caspase-8 inhibitor could rescue Fas-induced cell death. Collectively, these data suggest that caspase-4 activity is required for Fas-induced cell apoptosis and caspase-4 may act upstream of PARP and caspase-3 and downstream of caspase-8. Overall, we demonstrate that NF-kappa B can mediate Fas-induced apoptosis through caspase-4 protease, indicating that caspase-4 is a new mediator of NF-kappa B pro-apoptotic pathway in neuroblastoma cells.	[Yang, Hai-Jie; Wang, Mian; Wang, Lei; Cheng, Bin-Feng; Lin, Xiao-Yu; Feng, Zhi-Wei] Xinxiang Med Univ, Coll Life Sci & Technol, Xinxiang, Peoples R China	Xinxiang Medical University	Feng, ZW (corresponding author), Xinxiang Med Univ, Coll Life Sci & Technol, Xinxiang, Peoples R China.	xxyxy_fzw@163.com			Xinxiang Medical University Scientific Research Foundation [505046, 505047]; Intramural Science Fostering Foundation [2013ZD115]	Xinxiang Medical University Scientific Research Foundation; Intramural Science Fostering Foundation	The authors acknowledge the financial support of Xinxiang Medical University Scientific Research Foundation (contract 505046 and 505047) and the Intramural Science Fostering Foundation (contract 2013ZD115). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslam M, 2012, CYTOKINE, V57, P269, DOI 10.1016/j.cyto.2011.10.016; Bian X, 2004, J BIOL CHEM, V279, P4663, DOI 10.1074/jbc.M306905200; Brint E, 2013, CELL MOL LIFE SCI, V70, P4085, DOI 10.1007/s00018-013-1327-z; Cheema ZF, 1999, J NEUROSCI, V19, P1754; Chinskey ND, 2014, CURR OPIN OPHTHALMOL, V25, P228, DOI 10.1097/ICU.0000000000000043; Choi C, 2004, BRAIN RES REV, V44, P65, DOI 10.1016/j.brainresrev.2003.08.007; Collett GP, 2006, CARCINOGENESIS, V27, P1285, DOI 10.1093/carcin/bgi368; Dietrich PY, 2003, NEUROLOGY, V60, P548, DOI 10.1212/01.WNL.0000042049.74547.7F; Dudley E, 1999, EUR J IMMUNOL, V29, P878, DOI 10.1002/(SICI)1521-4141(199903)29:03<878::AID-IMMU878>3.0.CO;2-9; Eckhardt I, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.457; Fluhr H, 2013, REPROD BIOL, V13, P113, DOI 10.1016/j.repbio.2013.03.001; Frank AK, 2011, MOL CELL BIOL, V31, P1201, DOI 10.1128/MCB.01136-10; Gross N, 2001, MED PEDIATR ONCOL, V36, P111, DOI 10.1002/1096-911X(20010101)36:1<111::AID-MPO1026>3.0.CO;2-3; Han W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071656; Huang XD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071553; Jennewein C, 2012, ONCOGENE, V31, P1468, DOI 10.1038/onc.2011.333; Kamada S, 1997, ONCOGENE, V15, P285, DOI 10.1038/sj.onc.1201192; Kasibhatla S, 1998, MOL CELL, V1, P543, DOI 10.1016/S1097-2765(00)80054-4; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Kuhtrelber WM, 2003, J MOL ENDOCRINOL, V31, P373, DOI 10.1677/jme.0.0310373; Lakshmanan U, 2007, J IMMUNOL, V179, P8480, DOI 10.4049/jimmunol.179.12.8480; Lavrik IN, 2012, CELL DEATH DIFFER, V19, P36, DOI 10.1038/cdd.2011.155; Lipton SA, 1997, NAT MED, V3, P20, DOI 10.1038/nm0197-20; Martin LJ, 2005, J NEUROSCI, V25, P6449, DOI 10.1523/JNEUROSCI.0911-05.2005; Martin-Villalba A, 1999, J NEUROSCI, V19, P3809; Nickles D, 2012, MOL CELL BIOL, V32, P3372, DOI 10.1128/MCB.06739-11; Packham G, 1997, CELL DEATH DIFFER, V4, P130, DOI 10.1038/sj.cdd.4400217; Ponton A, 1996, J BIOL CHEM, V271, P8991, DOI 10.1074/jbc.271.15.8991; Qin YM, 2002, J IMMUNOL, V169, P3536, DOI 10.4049/jimmunol.169.7.3536; Radhakrishnan SK, 2006, BBA-REV CANCER, V1766, P53, DOI 10.1016/j.bbcan.2006.02.001; Raoul C, 1999, J CELL BIOL, V147, P1049, DOI 10.1083/jcb.147.5.1049; Lopez-Huertas MR, 2013, J BIOL CHEM, V288, P7626, DOI 10.1074/jbc.M112.408294; ROSS RA, 1983, J NATL CANCER I, V71, P741; Ryan KM, 2000, NATURE, V404, P892, DOI 10.1038/35009130; Siegel RM, 2000, NAT IMMUNOL, V1, P469, DOI 10.1038/82712; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Suhara T, 2004, HYPERTENSION, V43, P1208, DOI 10.1161/01.HYP.0000127914.94292.76; Valentin-Acevedo A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025467; Villa-Morales M, 2012, EXPERT OPIN THER TAR, V16, P85, DOI 10.1517/14728222.2011.628937; Wajant H, 2002, SCIENCE, V296, P1635, DOI 10.1126/science.1071553; Yang HJ, 2010, NEUROCHEM INT, V56, P128, DOI 10.1016/j.neuint.2009.09.010; Yang HJ, 2008, J BIOL CHEM, V283, P5287, DOI 10.1074/jbc.M706917200	42	27	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0117953	10.1371/journal.pone.0117953	http://dx.doi.org/10.1371/journal.pone.0117953			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695505	Green Published, Green Submitted, gold			2022-12-26	WOS:000350062300035
J	Cuffe, JSM; Steane, S; Moritz, KM; Paravicini, TM				Cuffe, James S. M.; Steane, Sarah; Moritz, Karen M.; Paravicini, Tamara M.			Differential mRNA Expression and Glucocorticoid-Mediated Regulation of TRPM6 and TRPM7 in the Heart and Kidney throughout Murine Pregnancy and Development	PLOS ONE			English	Article							SERUM IONIZED MAGNESIUM; DEXAMETHASONE EXPOSURE; PLACENTAL GROWTH; MG2+ HOMEOSTASIS; DOWN-REGULATION; BLOOD-PRESSURE; HYPOMAGNESEMIA; KINASE; CA2+; SENSITIVITY	The transient receptor potential (TRP) channels TRPM6 and TRPM7 are critically involved in maintaining whole body and cellular Mg2+ homeostasis and ensuring the normal function of organs such as the heart and kidney. However, we do not know how the expression of TRPM6 and TPRM7 in these organs changes throughout fetal development and adult life, and whether this expression can be hormonally regulated. This study determined the ontogeny of TRPM6 and TRPM7 mRNA expression from mid-gestation through to adulthood in the mouse. In a second series of experiments, we examined how maternal administration of the glucocorticoids corticosterone and dexamethasone between embryonic days 12.5-15 affected TRPM6 and TRPM7 channel mRNA expression in the mother and fetus. Whilst renal TRPM7 expression was relatively constant throughout development, renal TRPM6 expression was markedly upregulated after birth. In contrast, cardiac TRPM7 expression was 2-4 fold higher in the fetus than in the adult. Surprisingly, TRPM6 expression was detected in the fetal heart (qPCR and in situ hybridization). Glucocorticoid administration during gestation increased fetal cardiac expression of both channels without affecting renal expression. In contrast, in the dam renal TRPM6 and TRPM7 expression was increased by glucocorticoids with no change in the cardiac channel expression. These data suggest that TRPM6 and TRPM7 channels are important in organogenesis, and that elevated maternal glucocorticoid levels can alter the expression of these channels. This suggests that perturbations in hormonal regulatory systems during pregnancy may adversely impact upon normal fetal development, at least in part by altering expression of TRPM channels.	[Cuffe, James S. M.; Steane, Sarah; Moritz, Karen M.; Paravicini, Tamara M.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia	University of Queensland	Paravicini, TM (corresponding author), Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia.	t.paravicini@uq.edu.au	Cuffe, James/H-1003-2016; Moritz, Karen/G-2508-2015	Cuffe, James/0000-0002-2675-8149; Moritz, Karen/0000-0002-8085-0034; steane, sarah/0000-0001-8594-3486				BARRI M, 1990, EXP PHYSIOL, V75, P681, DOI 10.1113/expphysiol.1990.sp003446; Cao G, 2009, J BIOL CHEM, V284, P14788, DOI 10.1074/jbc.M808752200; Chubanov V, 2004, P NATL ACAD SCI USA, V101, P2894, DOI 10.1073/pnas.0305252101; Cuffe JSM, 2012, ENDOCRINOLOGY, V153, P5500, DOI 10.1210/en.2012-1479; Cuffe JSM, 2011, PLACENTA, V32, P981, DOI 10.1016/j.placenta.2011.09.009; Deason-Towne F, 2011, FEBS LETT, V585, P2275, DOI 10.1016/j.febslet.2011.05.052; Dominguez LJ, 1998, J CLIN ENDOCR METAB, V83, P4402, DOI 10.1210/jc.83.12.4402; Doyle LW, 2000, CLIN SCI, V98, P137, DOI 10.1042/CS19990211; Groenestege WMT, 2006, J AM SOC NEPHROL, V17, P1035, DOI 10.1681/ASN.2005070700; Harris A, 2011, HORM BEHAV, V59, P279, DOI 10.1016/j.yhbeh.2010.06.007; Hoenderop JGJ, 2008, PHYSIOLOGY, V23, P32, DOI 10.1152/physiol.00039.2007; Jin J, 2008, SCIENCE, V322, P756, DOI 10.1126/science.1163493; Jin J, 2012, P NATL ACAD SCI USA, V109, pE225, DOI 10.1073/pnas.1120033109; Kisters K, 1998, GYNECOL OBSTET INVES, V46, P158, DOI 10.1159/000010024; Konrad M, 2004, AM J PHYSIOL-RENAL, V286, pF599, DOI 10.1152/ajprenal.00312.2003; Li M, 2006, J GEN PHYSIOL, V127, P525, DOI 10.1085/jgp.200609502; Li MJ, 2007, J BIOL CHEM, V282, P25817, DOI 10.1074/jbc.M608972200; Meng Z, 2012, TRANSPL P, V44, P1206, DOI 10.1016/j.transproceed.2011.11.068; Moritz KM, 2011, AM J PHYSIOL-REG I, V301, pR500, DOI 10.1152/ajpregu.00818.2010; Muneyyirci-Delale O, 1998, FERTIL STERIL, V69, P958, DOI 10.1016/S0015-0282(98)00053-3; Muneyyirci-Delale O, 1999, FERTIL STERIL, V71, P869, DOI 10.1016/S0015-0282(99)00065-5; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Nijenhuis T, 2004, J AM SOC NEPHROL, V15, P549, DOI 10.1097/01.ASN.0000113318.56023.B6; O'Sullivan L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069149; Rondon LJ, 2008, AM J PHYSIOL-REG I, V294, pR2001, DOI 10.1152/ajpregu.00153.2007; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Ryazanova LV, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1108; Sah R, 2013, P NATL ACAD SCI USA, V110, pE3037, DOI 10.1073/pnas.1311865110; Sah R, 2013, CIRCULATION, V128, P101, DOI 10.1161/CIRCULATIONAHA.112.000768; Sahni J, 2007, BIOCHEM J, V401, P505, DOI 10.1042/BJ20060673; Schlingmann KP, 2005, J AM SOC NEPHROL, V16, P3061, DOI 10.1681/ASN.2004110989; Schlingmann KP, 2002, NAT GENET, V31, P166, DOI 10.1038/ng889; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schmitz C, 2003, CELL, V114, P191, DOI 10.1016/S0092-8674(03)00556-7; Seckl JR, 2007, NAT CLIN PRACT ENDOC, V3, P479, DOI 10.1038/ncpendmet0515; Simmons DG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-352; Singh RR, 2007, AM J PHYSIOL-RENAL, V293, pF548, DOI 10.1152/ajprenal.00156.2007; Singh RR, 2012, CLIN EXP PHARMACOL P, V39, P979, DOI 10.1111/1440-1681.12009; Sontia B, 2008, HYPERTENSION, V51, P915, DOI 10.1161/HYPERTENSIONAHA.107.100339; Tabrizi FM, 2014, INDIAN J CLIN BIOCHE, V29, P174, DOI 10.1007/s12291-013-0336-x; Voets T, 2004, J BIOL CHEM, V279, P19, DOI 10.1074/jbc.M311201200; Walder RY, 2009, HUM MOL GENET, V18, P4367, DOI 10.1093/hmg/ddp392; Walder RY, 2002, NAT GENET, V31, P171, DOI 10.1038/ng901; Wolf FI, 2008, CLIN SCI, V114, P27, DOI 10.1042/CS20070129; Woudenberg-Vrenken TE, 2011, NEPHRON PHYSIOL, V117, pP11, DOI 10.1159/000320580; Zhang Z, 2014, J BIOL CHEM, V289, P5217, DOI 10.1074/jbc.M113.512285	46	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117978	10.1371/journal.pone.0117978	http://dx.doi.org/10.1371/journal.pone.0117978			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692682	Green Submitted, Green Published, gold			2022-12-26	WOS:000350061500087
J	Husemann, M; Habel, JC; Namkung, S; Hochkirch, A; Otte, D; Danley, PD				Husemann, Martin; Habel, Jan Christian; Namkung, Suk; Hochkirch, Axel; Otte, Daniel; Danley, Patrick D.			Molecular Evidence for an Old World Origin of Galapagos and Caribbean Band-Winged Grasshoppers (Acrididae: Oedipodinae: Sphingonotus)	PLOS ONE			English	Article							POPULATION-STRUCTURE; TRANS-ATLANTIC; COLONIZATION; DIVERSIFICATION; ISLANDS; ORTHOPTERA; DISPERSAL; BIOGEOGRAPHY; VICARIANCE; LIZARDS	Patterns of colonization and diversification on islands provide valuable insights into evolutionary processes. Due to their unique geographic position and well known history, the Galapagos Islands are an important model system for evolutionary studies. Here we investigate the evolutionary history of a winged grasshopper genus to infer its origin and pattern of colonization in the Galapagos archipelago. The grasshopper genus Sphingonotus has radiated extensively in the Palaearctic and many species are endemic to islands. In the New World, the genus is largely replaced by the genus Trimerotropis. Oddly, in the Caribbean and on the Galapagos archipelago, two species of Sphingonotus are found, which has led to the suggestion that these might be the result of anthropogenic translocations from Europe. Here, we test this hypothesis using mitochondrial and nuclear DNA sequences from a broad sample of Sphingonotini and Trimerotropini species from the Old World and New World. The genetic data show two distinct genetic clusters representing the New World Trimerotropini and the Old World Sphingonotini. However, the Sphingonotus species from Galapagos and the Caribbean split basally within the Old World Sphingonotini lineage. The Galapagos and Caribbean species appear to be related to Old World taxa, but are not the result of recent anthropogenic translocations as revealed by divergence time estimates. Distinct genetic lineages occur on the four investigated Galapagos Islands, with deep splits among them compared to their relatives from the Palaearctic. A scenario of a past wider distribution of Sphingonotus in the New World with subsequent extinction on the mainland and replacement by Trimerotropis might explain the disjunct distribution.	[Husemann, Martin; Habel, Jan Christian] Tech Univ Munich, Dept Ecol & Ecosyst Management, Terr Ecol Res Grp, Freising Weihenstephan, Bavaria, Germany; [Husemann, Martin; Namkung, Suk; Danley, Patrick D.] Baylor Univ, Dept Biol, Waco, TX 76798 USA; [Husemann, Martin] Univ Halle Wittenberg, Inst Biol, D-06108 Halle An Der Saale, Saxony Anhalt, Germany; [Hochkirch, Axel] Univ Trier, Dept Biogeog, Trier, Rhineland Palat, Germany; [Otte, Daniel] Drexel Univ, Acad Nat Sci, Dept Biodivers Earth & Environm Sci, Philadelphia, PA 19104 USA	Technical University of Munich; Baylor University; Martin Luther University Halle Wittenberg; Universitat Trier; Drexel University	Husemann, M (corresponding author), Tech Univ Munich, Dept Ecol & Ecosyst Management, Terr Ecol Res Grp, Freising Weihenstephan, Bavaria, Germany.	martinhusemann@yahoo.de	Husemann, Martin/C-4414-2015; Hochkirch, Axel/E-7891-2011; Hochkirch, Axel/A-4092-2008; Habel, Jan Christian/H-2112-2019	Husemann, Martin/0000-0001-5536-6681; Hochkirch, Axel/0000-0002-4475-0394; Danley, Patrick/0000-0001-8782-5045; Namkung, Suk/0000-0002-2220-6785; Habel, Jan Christian/0000-0003-1378-9381	Orthopterists' Society; URSA grant from Baylor University; German Research Foundation (DFG); Technische Universitat Munchen	Orthopterists' Society; URSA grant from Baylor University; German Research Foundation (DFG)(German Research Foundation (DFG)); Technische Universitat Munchen	The analysed were financed by a small grant Orthopterists' Society to MH, and an URSA grant from Baylor University to PDD and SN. This work was supported by the German Research Foundation (DFG) and Technische Universitat Munchen within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbogast BS, 2006, EVOLUTION, V60, P370, DOI 10.1111/j.0014-3820.2006.tb01113.x; Blatchley WS., 1920, ORTHOPTERA NE AM; Bollmer JL, 2006, MOL PHYLOGENET EVOL, V39, P237, DOI 10.1016/j.ympev.2005.11.014; Buzzetti Filippo Maria, 2008, Memoirs on Biodiversity, V1, P39; Carranza S., 2003, Systematics and Biodiversity, V1, P275, DOI 10.1017/S1477200003001099; Carranza S, 2000, P ROY SOC B-BIOL SCI, V267, P637, DOI 10.1098/rspb.2000.1050; Chapco William, 2011, Journal of Orthoptera Research, V20, P173, DOI 10.1665/034.020.0205; Clayton JW, 2009, SYST BIOL, V58, P395, DOI 10.1093/sysbio/syp041; Colgan DJ, 1998, AUST J ZOOL, V46, P419, DOI 10.1071/ZO98048; Darwin C., 1859, NATURE; de Queiroz A, 2005, TRENDS ECOL EVOL, V20, P68, DOI 10.1016/j.tree.2004.11.006; DEANGELIS MM, 1995, NUCLEIC ACIDS RES, V23, P4742, DOI 10.1093/nar/23.22.4742; Dirsh V. M., 1969, Bulletin of the British Museum (Natural History) Entomology, V23, P25; Drummond A., 2011, GENEIOUS V5 5; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; FINSTON TL, 1995, HEREDITY, V75, P390, DOI 10.1038/hdy.1995.151; Gentile G, 2009, P NATL ACAD SCI USA, V106, P507, DOI 10.1073/pnas.0806339106; GRANT PR, 1976, P NATL ACAD SCI USA, V73, P257, DOI 10.1073/pnas.73.1.257; Grant PR, 2011, WHY SPECIES MULTIPLY; Harpp KS, 2014, GEOPHYS MONOGR SER, V204, P1, DOI 10.1002/9781118852538; Hebard M., 1920, Proceedings of the California Academy of Science (4th Series), V2; Hochkirch A, 2008, ZOOL STUD, V47, P495; Hollier J, 2012, REV SUISSE ZOOL, V119, P215; Husemann M, 2014, MOL PHYLOGENET EVOL, V81, P174, DOI 10.1016/j.ympev.2014.09.017; Husemann M, 2013, ZOOL J LINN SOC-LOND, V168, P29, DOI 10.1111/zoj.12023; Husemann M, 2013, J BIOGEOGR, V40, P261, DOI 10.1111/jbi.12007; Husemann M, 2012, ZOOL SCR, V41, P515, DOI 10.1111/j.1463-6409.2012.00548.x; Jordan MA, 2008, MOL ECOL, V17, P1224, DOI 10.1111/j.1365-294X.2007.03658.x; Juan C, 2000, TRENDS ECOL EVOL, V15, P104, DOI 10.1016/S0169-5347(99)01776-0; Kavar T, 2006, B ENTOMOL RES, V96, P117, DOI 10.1079/BER2005406; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lovejoy NR, 2006, P ROY SOC B-BIOL SCI, V273, P767, DOI 10.1098/rspb.2005.3381; MAC ARTHUR ROBERT H., 1967; Michalak I, 2010, J BIOGEOGR, V37, P1214, DOI 10.1111/j.1365-2699.2010.02306.x; Mists henko L., 1936, EOS REV ESPANOLA ENT, V12, P65; Otte D, 1984, ACRIDIDAE OEDIPODINA; Parent CE, 2008, PHILOS T R SOC B, V363, P3347, DOI 10.1098/rstb.2008.0118; Parent CE, 2006, EVOLUTION, V60, P2311, DOI 10.1554/06-366.1; Pavlovcic P, 2008, B INSECTOL, V61, P191; Peck SB, 1996, CAN J ZOOL, V74, P1497, DOI 10.1139/z96-164; Poulakakis N, 2012, MOL ECOL, V21, P160, DOI 10.1111/j.1365-294X.2011.05370.x; Rambaut A, 2009, TRACER V1 5; Rambaut A., 2010, FIGTREE 1 3 1; Rassmann K, 1997, MOL PHYLOGENET EVOL, V7, P158, DOI 10.1006/mpev.1996.0386; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sequeira AS, 2000, HEREDITY, V85, P20, DOI 10.1046/j.1365-2540.2000.00690.x; Snodgrass R. E., 1902, P WASH ACAD SCI, V4, P411; Su ZH, 1998, MOL BIOL EVOL, V15, P1026, DOI 10.1093/oxfordjournals.molbev.a026001; White M. J. D, 1973, ANIMAL CYTOLOGY EVOL; WHITE MJD, 1949, GENETICS, V34, P537; WHITE MJD, 1951, GENETICS, V36, P31; WHITE WM, 1993, J GEOPHYS RES-SOL EA, V98, P19533, DOI 10.1029/93JB02018; Yu Y, 2010, MOL PHYLOGENET EVOL, V56, P848, DOI 10.1016/j.ympev.2010.04.011	53	7	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118208	10.1371/journal.pone.0118208	http://dx.doi.org/10.1371/journal.pone.0118208			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692768	gold, Green Published			2022-12-26	WOS:000350061500108
J	Lee, J; Daniels, V; Sands, ZA; Lebon, F; Shi, JY; Biggin, PC				Lee, Joanna; Daniels, Veronique; Sands, Zara A.; Lebon, Florence; Shi, Jiye; Biggin, Philip C.			Exploring the Interaction of SV2A with Racetams Using Homology Modelling, Molecular Dynamics and Site-Directed Mutagenesis	PLOS ONE			English	Article							VESICLE PROTEIN 2A; SECONDARY STRUCTURE; BINDING-SITE; FORCE-FIELD; PREDICTION; EFFICIENT; LEVETIRACETAM; TRANSPORTER; LOCALIZATION; MECHANISM	The putative Major Facilitator Superfamily (MFS) transporter, SV2A, is the target for levetiracetam (LEV), which is a successful anti-epileptic drug. Furthermore, SV2A knock out mice display a severe seizure phenotype and die after a few weeks. Despite this, the mode of action of LEV is not known at the molecular level. It would be extremely desirable to understand this more fully in order to aid the design of improved anti-epileptic compounds. Since there is no structure for SV2A, homology modelling can provide insight into the ligand-binding site. However, it is not a trivial process to build such models, since SV2A has low sequence identity to those MFS transporters whose structures are known. A further level of complexity is added by the fact that it is not known which conformational state of the receptor LEV binds to, as multiple conformational states have been inferred by tomography and ligand binding assays or indeed, if binding is exclusive to a single state. Here, we explore models of both the inward and outward facing conformational states of SV2A (according to the alternating access mechanism for MFS transporters). We use a sequence conservation analysis to help guide the homology modelling process and generate the models, which we assess further with Molecular Dynamics (MD). By comparing the MD results in conjunction with docking and simulation of a LEV-analogue used in radioligand binding assays, we were able to suggest further residues that line the binding pocket. These were confirmed experimentally. In particular, mutation of D670 leads to a complete loss of binding. The results shed light on the way LEV analogues may interact with SV2A and may help with the ongoing design of improved anti-epileptic compounds.	[Lee, Joanna; Biggin, Philip C.] Univ Oxford, Oxford OX1 3QU, England; [Daniels, Veronique; Sands, Zara A.; Lebon, Florence; Shi, Jiye] UCB Pharma S, Chemin Foriest, B-1420 Braine l Alleud, Belgium	University of Oxford	Biggin, PC (corresponding author), Univ Oxford, S Parks Rd, Oxford OX1 3QU, England.	philip.biggin@bioch.ox.ac.uk		Daniels, Veronique/0000-0003-3403-8106; Biggin, Philip/0000-0001-5100-8836	BBSRC - UCB BioPharma SPRL; Walloon Region (Belgium) DGO6 [6536]; Biotechnology and Biological Sciences Research Council [1107134] Funding Source: researchfish	BBSRC - UCB BioPharma SPRL; Walloon Region (Belgium) DGO6; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Joanna Lee is a BBSRC-funded student in receipt of additional financial support from UCB BioPharma SPRL. Zara Sands, Florence Lebon and Jiye Shi are all employees of UCB BioPharma SPRL. During the course of the research reported herein, Veronique Daniels was an employee of UCB BioPharma SPRL and her research was supported by a grant from the Walloon Region (Belgium) DGO6 (Convention 6536). There are no patents or products in development or marketed products to nildeclare that arise from this work. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BAJJALIEH SM, 1992, SCIENCE, V257, P1271, DOI 10.1126/science.1519064; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Benkert P, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-35; Chang WP, 2009, J NEUROSCI, V29, P883, DOI 10.1523/JNEUROSCI.4521-08.2009; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Crevecoeur J, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-87; Crowder KM, 1999, P NATL ACAD SCI USA, V96, P15268, DOI 10.1073/pnas.96.26.15268; Dang SY, 2010, NATURE, V467, P734, DOI 10.1038/nature09406; Daniels V, 2013, BRIT J PHARMACOL, V169, P1091, DOI 10.1111/bph.12192; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Eswar N., 2006, CURR PROT BIOINF, V15, P1, DOI [10.1002/0471250953.bi0506s15, DOI 10.1002/0471250953.BI0506S15]; FEANY MB, 1992, CELL, V70, P861, DOI 10.1016/0092-8674(92)90319-8; Feng GB, 2009, J MOL NEUROSCI, V39, P354, DOI 10.1007/s12031-009-9288-2; Fisher RS, 2005, EPILEPSIA, V46, P470, DOI 10.1111/j.0013-9580.2005.66104.x; Fuks B, 2003, EUR J PHARMACOL, V478, P11, DOI 10.1016/j.ejphar.2003.08.033; Gambardella Antonio, 2008, Neuropsychiatr Dis Treat, V4, P33; GINGRICH JA, 1992, FEBS LETT, V312, P115, DOI 10.1016/0014-5793(92)80917-6; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Janz R, 1999, NEURON, V24, P1003, DOI 10.1016/S0896-6273(00)81046-6; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; JORGENSEN WL, 1981, J AM CHEM SOC, V103, P335, DOI 10.1021/ja00392a016; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Klitgaard H, 1998, EUR J PHARMACOL, V353, P191, DOI 10.1016/S0014-2999(98)00410-5; Loscher W, 2013, NAT REV DRUG DISCOV, V12, P757, DOI 10.1038/nrd4126; Lynch BA, 2004, P NATL ACAD SCI USA, V101, P9861, DOI 10.1073/pnas.0308208101; Lynch BA, 2008, BIOCHEM BIOPH RES CO, V375, P491, DOI 10.1016/j.bbrc.2008.07.145; Madeo M, 2014, J BIOL CHEM; Matveeva EA, 2007, EPILEPSY RES, V73, P266, DOI 10.1016/j.eplepsyres.2006.11.003; Nowack A, 2010, AM J PHYSIOL-CELL PH, V299, pC960, DOI 10.1152/ajpcell.00259.2010; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Shi JY, 2011, BIOCHEM SOC T, V39, P1341, DOI 10.1042/BST0391341; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smirnova I, 2011, BIOCHEMISTRY-US, V50, P9684, DOI 10.1021/bi2014294; Tanner VA, 1996, J HISTOCHEM CYTOCHEM, V44, P1481, DOI 10.1177/44.12.8985140; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Van Gunsteren WF, 1988, MOL SIMULAT, V1, P173, DOI 10.1080/08927028808080941; van Vliet EA, 2009, EPILEPSIA, V50, P422, DOI 10.1111/j.1528-1167.2008.01727.x; Wan QF, 2010, NEURON, V66, P884, DOI 10.1016/j.neuron.2010.05.010; Wolf MG, 2010, J COMPUT CHEM, V31, P2169, DOI 10.1002/jcc.21507; Xu T, 2001, NAT CELL BIOL, V3, P691, DOI 10.1038/35087000; Yao J, 2008, J BIOL CHEM, V283, P20628, DOI 10.1074/jbc.M800738200; Yao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005315	50	16	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0116589	10.1371/journal.pone.0116589	http://dx.doi.org/10.1371/journal.pone.0116589			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692762	Green Published, gold, Green Submitted			2022-12-26	WOS:000350061500018
J	Liu, HY; Li, QR; Cheng, XF; Wang, H; Wang, GJ; Hao, HP				Liu, Huiying; Li, Qingran; Cheng, Xuefang; Wang, Hong; Wang, Guangji; Hao, Haiping			UDP-Glucuronosyltransferase 1A Determinates Intracellular Accumulation and Anti-Cancer Effect of beta-Lapachone in Human Colon Cancer Cells	PLOS ONE			English	Article							INTRINSIC DRUG-RESISTANCE; GENE-EXPRESSION; DOWN-REGULATION; HUMAN LIVER; GLUCURONIDATION; DETOXIFICATION; ACTIVATION; MECHANISM; APOPTOSIS; DEATH	beta-lapachone (beta-lap), an NAD(P) H: quinone oxidoreductase 1 (NQO1) targeting antitumor drug candidate in phase II clinical trials, is metabolically eliminated via NQO1 mediated quinone reduction and subsequent UDP-glucuronosyltransferases (UGTs) catalyzed glucuronidation. This study intends to explore the inner link between the cellular glucuronidation and pharmacokinetics of beta-lap and its apoptotic effect in human colon cancer cells. HT29 cells S9 fractions exhibited high glucuronidation activity towards beta-lap, which can be inhibited by UGT1A9 competitive inhibitor propofol. UGT1A siRNA treated HT29 cells S9 fractions displayed an apparent low glucuronidation activity. Intracellular accumulation of beta-lap in HCT116 cells was much higher than that in HT29 cells, correlated with the absence of UGT1A in HCT116 cells. The cytotoxic and apoptotic effect of beta-lap in HT29 cells were much lower than that in HCT116 cells; moreover, beta-lap triggered activation of SIRT1-FOXO1 apoptotic pathway was observed in HCT116 cells but not in HT29 cells. Pretreatment of HT29 cells with UGT1A siRNA or propofol significantly decreased beta-lap's cytotoxic and apoptotic effects, due to the repression of glucuronidation and the resultant intracellular accumulation. In conclusion, UGT1A is an important determinant, via switching NQO1-triggered redox cycle to metabolic elimination, in the intracellular accumulation of beta-lap and thereafter its cytotoxicity in human colon cancer cells. Together with our previous works, we propose that UGTs determined cellular pharmacokinetics is an important determinant in the apoptotic effects of NQO1 targeting substrates serving as chemotherapeutic drugs.	[Liu, Huiying; Li, Qingran; Cheng, Xuefang; Wang, Hong; Wang, Guangji; Hao, Haiping] China Pharmaceut Univ, Key Lab Drug Metab & Pharmacokinet, State Key Lab Nat Med, Nanjing 210009, Jiangsu, Peoples R China	China Pharmaceutical University	Wang, GJ (corresponding author), China Pharmaceut Univ, Key Lab Drug Metab & Pharmacokinet, State Key Lab Nat Med, Nanjing 210009, Jiangsu, Peoples R China.	guangjiwang@hotmail.com; hhp_770505@hotmail.com	Hao, Haiping/L-8265-2019	Hao, Haiping/0000-0003-2522-7546; Wang, Hong/0000-0002-6192-3082	National Natural Science Foundation of China [81430091, 81325025, 81273586]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Nos. 81430091, 81325025 and 81273586, http://www.nsfc.gov.cn/nsfc/cen/xxgk/slzz.html, National Natural Science Foundation of China (HH). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn KJ, 2013, RADIAT ONCOL J, V31, P57, DOI 10.3857/roj.2013.31.2.57; Belanger AS, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-9; BELINSKY M, 1993, CANCER METAST REV, V12, P103, DOI 10.1007/BF00689804; Bey EA, 2007, P NATL ACAD SCI USA, V104, P11832, DOI 10.1073/pnas.0702176104; Blanco E, 2010, CANCER RES, V70, P3896, DOI 10.1158/0008-5472.CAN-09-3995; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Cheng XF, 2012, MOL PHARMACEUT, V9, P3476, DOI 10.1021/mp300296m; Choi YH, 2003, J BIOCHEM MOL BIOL, V36, P223; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Cummings J, 2004, BIOCHEM PHARMACOL, V67, P31, DOI 10.1016/j.bcp.2003.07.019; Cummings J, 2003, CANCER RES, V63, P8443; D'Anneo A, 2010, J CELL PHYSIOL, V222, P433, DOI 10.1002/jcp.21983; Dellinger RW, 2006, DRUG METAB DISPOS, V34, P943, DOI 10.1124/dmd.105.009100; Gauthier-Landry L, 2014, J STEROID BIOCH MOL; Greer AK, 2014, DRUG METAB DISPOS; Izumi K, 2012, MOL CARCINOGENESIS; Kim YH, 2012, FREE RADICAL BIO MED, V52, P880, DOI 10.1016/j.freeradbiomed.2011.12.007; Li YZ, 2000, MOL MED, V6, P1008, DOI 10.1007/BF03402052; Liu F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042138; Liu M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079172; Menna-Barreto RFS, 2009, PARASITOLOGY, V136, P499, DOI 10.1017/S0031182009005745; Nagar S, 2006, ONCOGENE, V25, P1659, DOI 10.1038/sj.onc.1209375; Nakamura A, 2008, DRUG METAB DISPOS, V36, P1461, DOI 10.1124/dmd.108.021428; Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025; Park E, 2013, CELL DEATH DIS, V5, pe1230, DOI [10.1016/j.bcp.2014.12.018, DOI 10.1016/J.BCP.2014.12.018]; Pink JJ, 2000, EXP CELL RES, V255, P144, DOI 10.1006/excr.1999.4790; PLANCHON SM, 1995, CANCER RES, V55, P3706; Planchon SM, 2001, EXP CELL RES, V267, P95, DOI 10.1006/excr.2001.5234; Poppenberger B, 2003, J BIOL CHEM, V278, P47905, DOI 10.1074/jbc.M307552200; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Sentellas S, 2014, TOXICOL IN VITRO, V28, P1006, DOI 10.1016/j.tiv.2014.04.017; Shin BH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064953; Sieger D, 2000, FREE RADICAL BIO MED, V29, P246, DOI 10.1016/S0891-5849(00)00310-5; Strassburg CP, 1997, CANCER RES, V57, P2979; Sundaresan NR, 2008, MOL CELL BIOL, V28, P6384, DOI 10.1128/MCB.00426-08; Suzuki M, 2006, RADIAT RES, V165, P525, DOI 10.1667/RR3554.1; Tagliarino C, 2001, J BIOL CHEM, V276, P19150, DOI 10.1074/jbc.M100730200; Tagliarino C, 2003, CANCER BIOL THER, V2, P141, DOI 10.4161/cbt.2.2.237; Tang L, 2014, PHARM RES-DORDR, V31, P847, DOI 10.1007/s11095-013-1207-0; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Wang FJ, 2006, J PHARM SCI-US, V95, P2309, DOI 10.1002/jps.20721; Zheng Z, 2002, DRUG METAB DISPOS, V30, P397, DOI 10.1124/dmd.30.4.397	42	33	35	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117051	10.1371/journal.pone.0117051	http://dx.doi.org/10.1371/journal.pone.0117051			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692465	gold, Green Submitted, Green Published			2022-12-26	WOS:000350061500035
J	Torode, TA; Marcus, SE; Jam, M; Tonon, T; Blackburn, RS; Herve, C; Knox, JP				Torode, Thomas A.; Marcus, Susan E.; Jam, Murielle; Tonon, Thierry; Blackburn, Richard S.; Herve, Cecile; Knox, J. Paul			Monoclonal Antibodies Directed to Fucoidan Preparations from Brown Algae	PLOS ONE			English	Article							PLANT-CELL WALLS; FUCUS-SERRATUS; SULFATED POLYSACCHARIDES; LAMPROTHAMNIUM-PAPULOSUM; PECTIC HOMOGALACTURONAN; ECTOCARPUS-SILICULOSUS; EXTRACELLULAR-MATRIX; EVOLUTION; HETEROGENEITY; PHAEOPHYCEAE	Cell walls of the brown algae contain a diverse range of polysaccharides with useful bioactivities. The precise structures of the sulfated fucan/fucoidan group of polysaccharides and their roles in generating cell wall architectures and cell properties are not known in detail. Four rat monoclonal antibodies, BAM1 to BAM4, directed to sulfated fucan preparations, have been generated and used to dissect the heterogeneity of brown algal cell wall polysaccharides. BAM1 and BAM4, respectively, bind to a non-sulfated epitope and a sulfated epitope present in the sulfated fucan preparations. BAM2 and BAM3 identified additional distinct epitopes present in the fucoidan preparations. All four epitopes, not yet fully characterised, occur widely within the major brown algal taxonomic groups and show divergent distribution patterns in tissues. The analysis of cell wall extractions and fluorescence imaging reveal differences in the occurrence of the BAM1 to BAM4 epitopes in various tissues of Fucus vesiculosus. In Ectocarpus subulatus, a species closely related to the brown algal model Ectocarpus siliculosus, the BAM4 sulfated epitope was modulated in relation to salinity levels. This new set of monoclonal antibodies will be useful for the dissection of the highly complex and yet poorly resolved sulfated polysaccharides in the brown algae in relation to their ecological and economic significance.	[Torode, Thomas A.; Marcus, Susan E.; Knox, J. Paul] Univ Leeds, Ctr Plant Sci, Fac Biol Sci, Leeds, W Yorkshire, England; [Jam, Murielle; Tonon, Thierry; Herve, Cecile] Sorbonne Univ, Univ Paris 06, UMR 8227, Stn Biol Roscoff, F-90074 Roscoff, France; [Jam, Murielle; Tonon, Thierry; Herve, Cecile] CNRS, Stn Biol Roscoff, UMR 8227, Roscoff, France; [Blackburn, Richard S.] Univ Leeds, Ctr Tech Text, Sustainable Mat Res Grp, Leeds, W Yorkshire, England	University of Leeds; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; University of Leeds	Knox, JP (corresponding author), Univ Leeds, Ctr Plant Sci, Fac Biol Sci, Leeds, W Yorkshire, England.	j.p.knox@leeds.ac.uk	Tonon, Thierry/A-3214-2009; Knox, Paul/H-4577-2012; Blackburn, Richard Simon/B-3210-2016	Tonon, Thierry/0000-0002-1454-6018; Knox, Paul/0000-0002-9231-6891; Blackburn, Richard Simon/0000-0001-6259-3807; Herve, Cecile/0000-0001-6649-8137; Torode, Thomas/0000-0001-9717-6923	UK Biotechnology and Biological Research Council; Assemble [227799]; European Union FP7 research network; Biotechnology and Biological Sciences Research Council [977478] Funding Source: researchfish	UK Biotechnology and Biological Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Assemble; European Union FP7 research network; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a UK Biotechnology and Biological Research Council (http://www.bbsrc.ac.uk) studentship to TAT. TAT also received two awards from Assemble (#227799), a European Union FP7 research network (http://www.assemblemarine.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ale MT, 2011, MAR DRUGS, V9, P2106, DOI 10.3390/md9102106; Anastyuk SD, 2010, CARBOHYD RES, V345, P2206, DOI 10.1016/j.carres.2010.07.043; Aquino RS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018862; Bilan MI, 2010, CARBOHYD RES, V345, P2038, DOI 10.1016/j.carres.2010.07.009; Brownlee C, 2001, SEMIN CELL DEV BIOL, V12, P345, DOI 10.1006/scdb.2001.0262; Cock JM, 2010, NATURE, V465, P617, DOI 10.1038/nature09016; Coelho SM, 2011, P NATL ACAD SCI USA, V108, P11518, DOI 10.1073/pnas.1102274108; Cornuault V, 2014, PLANT J, V78, P715, DOI 10.1111/tpj.12504; Deniaud-Bouet E, 2014, ANN BOT-LONDON, V114, P1203, DOI 10.1093/aob/mcu096; Descamps V, 2006, MAR BIOTECHNOL, V8, P27, DOI 10.1007/s10126-005-5107-0; Dittami SM, 2012, PLANT J, V71, P366, DOI 10.1111/j.1365-313X.2012.04982.x; Dittami SM, 2011, PLANT CELL ENVIRON, V34, P629, DOI 10.1111/j.1365-3040.2010.02268.x; Dittami SM, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-2; EARDLEY DD, 1990, J PHYCOL, V26, P54, DOI 10.1111/j.0022-3646.1990.00054.x; Enquist-Newman M, 2014, NATURE, V505, P239, DOI 10.1038/nature12771; GREEN JR, 1993, NEW PHYTOL, V124, P397, DOI 10.1111/j.1469-8137.1993.tb03830.x; Hahn T, 2012, PROCESS BIOCHEM, V47, P1691, DOI 10.1016/j.procbio.2012.06.016; JONES JL, 1988, PLANTA, V176, P298, DOI 10.1007/BF00395410; KLEIN MD, 1982, ANAL BIOCHEM, V124, P59, DOI 10.1016/0003-2697(82)90219-6; KLOAREG B, 1986, INT J BIOL MACROMOL, V8, P380, DOI 10.1016/0141-8130(86)90060-7; KLOAREG B., 1988, OCEANOGR MAR BIOL, V26, P259; Kolender AA, 2004, CARBOHYD RES, V339, P1619, DOI 10.1016/j.carres.2004.03.029; Kovalenko I, 2011, SCIENCE, V334, P75, DOI 10.1126/science.1209150; LARSEN B, 1985, CARBOHYD RES, V143, P221, DOI 10.1016/S0008-6215(00)90710-9; LARSEN B, 1966, ACTA CHEM SCAND, V20, P219, DOI 10.3891/acta.chem.scand.20-0219; Le Bail A, 2011, PLANT CELL, V23, P1666, DOI 10.1105/tpc.110.081919; Lee KJD, 2013, PLANT J, V75, P1018, DOI 10.1111/tpj.12263; Lees A, 1996, VACCINE, V14, P190, DOI 10.1016/0264-410X(95)00195-7; MABEAU S, 1987, J EXP BOT, V38, P1573, DOI 10.1093/jxb/38.9.1573; Manabe Y, 2011, PLANT PHYSIOL, V155, P1068, DOI 10.1104/pp.110.168989; Marcus SE, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-60; MARIANI P, 1985, PROTOPLASMA, V128, P208, DOI 10.1007/BF01276343; McCartney L, 2005, J HISTOCHEM CYTOCHEM, V53, P543, DOI 10.1369/jhc.4B6578.2005; MCCULLY ME, 1968, PROTOPLASMA, V66, P205, DOI 10.1007/BF01252533; Michel G, 2010, NEW PHYTOL, V188, P82, DOI 10.1111/j.1469-8137.2010.03374.x; PARSONS TF, 1980, P NATL ACAD SCI-BIOL, V77, P7089, DOI 10.1073/pnas.77.12.7089; Pedersen HL, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.396598; Peters AF, 2010, PHYCOL RES, V58, P157, DOI 10.1111/j.1440-1835.2010.00574.x; Pomin VH, 2008, GLYCOBIOLOGY, V18, P1016, DOI 10.1093/glycob/cwn085; Popper ZA, 2011, ANNU REV PLANT BIOL, V62, P567, DOI 10.1146/annurev-arplant-042110-103809; Seaweeds TD, 2002, NATURAL HIST MUSEUM; Senni K, 2011, MAR DRUGS, V9, P1664, DOI 10.3390/md9091664; Shepherd VA, 1999, J MEMBRANE BIOL, V170, P229, DOI 10.1007/s002329900552; Shepherd VA, 1999, PLANT CELL ENVIRON, V22, P333, DOI 10.1046/j.1365-3040.1999.00414.x; VREELAND V, 1984, PLANTA, V162, P506, DOI 10.1007/BF00399916; Wargacki AJ, 2012, SCIENCE, V335, P308, DOI 10.1126/science.1214547; Wei N, 2013, TRENDS BIOTECHNOL, V31, P70, DOI 10.1016/j.tibtech.2012.10.009; West John A., 1996, Muelleria, V9, P29; Willats WGT, 1998, CARBOHYD RES, V308, P149, DOI 10.1016/S0008-6215(98)00070-6; Willats WGT, 2001, J BIOL CHEM, V276, P19404, DOI 10.1074/jbc.M011242200; WOODWARD MP, 1985, J IMMUNOL METHODS, V78, P143, DOI 10.1016/0022-1759(85)90337-0; Zhao D, 2012, MOL BIOSYST, V8, P753, DOI 10.1039/c1mb05337j	52	40	41	4	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118366	10.1371/journal.pone.0118366	http://dx.doi.org/10.1371/journal.pone.0118366			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692870	Green Published, Green Accepted, gold			2022-12-26	WOS:000350061500119
J	Kayashima, Y; Makhanova, NA; Matsuki, K; Tomita, H; Bennett, BJ; Maeda, N				Kayashima, Yukako; Makhanova, Natalia A.; Matsuki, Kota; Tomita, Hirofumi; Bennett, Brian J.; Maeda, Nobuyo			Identification of Aortic Arch-Specific Quantitative Trait Loci for Atherosclerosis by an Intercross of DBA/2J and 129S6 Apolipoprotein E-Deficient Mice	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; INBRED MOUSE STRAINS; HYALURONAN RECEPTOR; HISTIDINE-DECARBOXYLASE; CORONARY-ARTERY; SUSCEPTIBILITY; STABILIN-2; CLEARANCE; HISTAMINE; PROMOTES	The genetic background of apolipoprotein E (apoE) deficient mice influences atherosclerotic plaque development. We previously reported three quantitative trait loci (QTL), Aath1-Aath3, that affect aortic arch atherosclerosis independently of those in the aortic root in a cross between C57BL6 apoEKO mice (B6-apoE) and 129S6 apoEKO mice (129-apoE). To gain further insight into genetic factors that influence atherosclerosis at different vascular locations, we analyzed 335 F2 mice from an intercross between 129-apoE and apoEKO mice on a DBA/2J genetic background (DBA-apoE). The extent of atherosclerosis in the aortic arch was very similar in the two parental strains. Nevertheless, a genome-wide scan identified two significant QTL for plaque size in the aortic arch: Aath4 on Chromosome (Chr) 2 at 137 Mb and Aath5 on Chr 10 at 51 Mb. The DBA alleles of Aath4 and Aath5 respectively confer susceptibility and resistance to aortic arch atherosclerosis over 129 alleles. Both QTL are also independent of those affecting plaque size at the aortic root. Genome analysis suggests that athero-susceptibility of Aath4 in DBA may be contributed by multiple genes, including Mertk and Cd93, that play roles in phagocytosis of apoptotic cells and modulate inflammation. A candidate gene for Aath5 is Stab2, the DBA allele of which is associated with 10 times higher plasma hyaluronan than the 129 allele. Overall, our identification of two new QTL that affect atherosclerosis in an aortic arch-specific manner further supports the involvement of distinct pathological processes at different vascular locations.	[Kayashima, Yukako; Makhanova, Natalia A.; Matsuki, Kota; Tomita, Hirofumi; Maeda, Nobuyo] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27515 USA; [Bennett, Brian J.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Maeda, N (corresponding author), Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27515 USA.	nobuyo@med.unc.edu		bennett, brian/0000-0002-0766-3195	National Institutes of Health (NIH) [HL042630]; American Heart Association [09POST2250823]; Uehara Memorial Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL042630, R37HL042630] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Uehara Memorial Foundation(Uehara Memorial Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work was supported by a National Institutes of Health (NIH) grant HL042630 to NM (http://www.nih.gov/), an American Heart Association Fellowship Award 09POST2250823 to HT (http://www.heart.org/HEARTORG/), and an Uehara Memorial Foundation Fellowship (http://www.ueharazaidan.or.jp/) to YK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Baetens M, 2011, HUM MUTAT, V32, P1053, DOI 10.1002/humu.21525; Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; Bennett BJ, 2010, GENOME RES, V20, P281, DOI 10.1101/gr.099234.109; Bennett BJ, 2009, ARTERIOSCL THROM VAS, V29, P348, DOI 10.1161/ATVBAHA.108.176685; Bis JC, 2011, NAT GENET, V43, P940, DOI 10.1038/ng.920; Broadbent HM, 2008, HUM MOL GENET, V17, P806, DOI 10.1093/hmg/ddm352; Broman KW, 2009, STAT BIOL HEALTH, P1, DOI 10.1007/978-0-387-92125-9_1; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Chai S, 2005, CIRC RES, V96, P583, DOI 10.1161/01.RES.0000158963.37132.8b; Colinayo VV, 2003, MAMM GENOME, V14, P464, DOI 10.1007/s00335-002-2187-2; Danese C, 2006, Clin Ter, V157, P9; Falkowski M, 2003, HISTOCHEM CELL BIOL, V120, P361, DOI 10.1007/s00418-003-0585-5; FERNS GAA, 1995, ATHEROSCLEROSIS, V114, P157, DOI 10.1016/0021-9150(94)05479-3; GILMOUR RS, 1994, J ENDOCRINOL, V140, P1, DOI 10.1677/joe.0.1400001; Harris EN, 2008, J BIOL CHEM, V283, P17341, DOI 10.1074/jbc.M710360200; Harris EN, 2009, AM J PHYSIOL-GASTR L, V296, pG1191, DOI 10.1152/ajpgi.90717.2008; Higuchi S, 2001, FEBS LETT, V505, P217, DOI 10.1016/S0014-5793(01)02823-X; Hirose Y, 2012, P NATL ACAD SCI USA, V109, P4263, DOI 10.1073/pnas.1117560109; Ishimori N, 2004, ARTERIOSCL THROM VAS, V24, P161, DOI 10.1161/01.ATV.0000104027.52895.D7; Jarinova O, 2009, ARTERIOSCL THROM VAS, V29, P1671, DOI 10.1161/ATVBAHA.109.189522; Kayashima Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088274; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Maeda N, 2007, MOUSE BIOMEDICAL RES, V3, P535; Maeda N, 2007, ATHEROSCLEROSIS, V195, P75, DOI 10.1016/j.atherosclerosis.2006.12.006; MARTIN SAM, 1984, BIOCHEM GENET, V22, P305, DOI 10.1007/BF00484230; MARTIN SAM, 1984, BIOCHEM GENET, V22, P645, DOI 10.1007/BF00485850; McGill HC, 2000, ARTERIOSCL THROM VAS, V20, P836, DOI 10.1161/01.ATV.20.3.836; Nagy N, 2010, CIRCULATION, V122, P2313, DOI 10.1161/CIRCULATIONAHA.110.972653; Norsworthy PJ, 2004, J IMMUNOL, V172, P3406, DOI 10.4049/jimmunol.172.6.3406; O'Donnell CJ, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S4; Papakonstantinou E, 1998, GLYCOBIOLOGY, V8, P821, DOI 10.1093/glycob/8.8.821; Park SY, 2008, CELL DEATH DIFFER, V15, P192, DOI 10.1038/sj.cdd.4402242; Rozenberg I, 2010, ARTERIOSCL THROM VAS, V30, P923, DOI 10.1161/ATVBAHA.109.201079; Sadowitz B, 2012, J SURG RES, V173, pE63, DOI 10.1016/j.jss.2011.09.025; Sampietro ML, 2011, HUM MOL GENET, V20, P4748, DOI 10.1093/hmg/ddr389; Schledzewski K, 2011, J CLIN INVEST, V121, P703, DOI 10.1172/JCI44740; Seidelmann SB, 2005, ARTERIOSCL THROM VAS, V25, P204, DOI 10.1161/01.ATV.0000149146.32385.1b; Smith JD, 2006, ARTERIOSCL THROM VAS, V26, P597, DOI 10.1161/01.ATV.0000201044.33220.5c; Smithies O, 2005, NAT REV GENET, V6, P419, DOI 10.1038/nrg1605; Tamura Y, 2003, J BIOL CHEM, V278, P12613, DOI 10.1074/jbc.M210211200; Tanimoto A, 2006, TRENDS CARDIOVAS MED, V16, P280, DOI 10.1016/j.tcm.2006.06.001; Thorp E, 2008, ARTERIOSCL THROM VAS, V28, P1421, DOI 10.1161/ATVBAHA.108.167197; Thorp E, 2009, J LEUKOCYTE BIOL, V86, P1089, DOI 10.1189/jlb.0209115; Tomita H, 2010, CIRC RES, V106, P1052, DOI 10.1161/CIRCRESAHA.109.207175; VanderLaan PA, 2004, ARTERIOSCL THROM VAS, V24, P12, DOI 10.1161/01.ATV.0000105054.43931.f0; Wang KY, 2011, ARTERIOSCL THROM VAS, V31, P800, DOI 10.1161/ATVBAHA.110.215228; YannarielloBrown J, 1997, GLYCOBIOLOGY, V7, P15, DOI 10.1093/glycob/7.1.15; Yuan R, 2009, AGING CELL, V8, P277, DOI 10.1111/j.1474-9726.2009.00478.x; Zekavat G, 2010, IMMUNOGENETICS, V62, P397, DOI 10.1007/s00251-010-0442-3; Zhang ZM, 2012, CIRC-CARDIOVASC GENE, V5, P190, DOI 10.1161/CIRCGENETICS.111.961649	51	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117478	10.1371/journal.pone.0117478	http://dx.doi.org/10.1371/journal.pone.0117478			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689165	gold, Green Published, Green Submitted			2022-12-26	WOS:000350322700048
J	Ko, YL; Sun, CS; Chung, KM; Lin, YM; Feng, IC; Sheu, MJ; Koay, LB; Lin, CY; Ho, CH; Kuo, HT				Ko, Yen-Ling; Sun, Chi-Shu; Chung, Kun-Ming; Lin, Yu-Min; Feng, I-Che; Sheu, Ming-Jen; Koay, Lok-Beng; Lin, Ching-Yih; Ho, Chung-Han; Kuo, Hsing-Tao			Manifestations of Perihepatic Lymph Nodes in Acute Flare of Chronic Hepatitis B: Association with HBeAg Status and with HBeAg Seroconversion	PLOS ONE			English	Article							E-ANTIGEN SEROCONVERSION; VIRUS-INFECTION; ABDOMINAL LYMPHADENOPATHY; HEPATOCELLULAR-CARCINOMA; ANTIBODY SEROCONVERSION; ACUTE EXACERBATIONS; CHINESE PATIENTS; NATURAL-HISTORY; LIVER-DISEASE; CORE ANTIGEN	It has been observed that enlargement of perihepatic lymph nodes may be seen in patients with chronic hepatitis B, particularly during acute flares of CHB. We hypothesized that there may be a correlation between the nodal change patterns in CHB patients with acute flare and HBeAg status. Perihepatic lymph node sizes of 87 patients with acute flares of CHB were documented, with a median follow up of 43 months. Patients were separated into 3 groups, HBeAg-positive with HBe seroconversion (group 1), HBeAg-positive without HBe seroconversion (group 2), and HBeAg-negative (group 3). Group 1 has the highest incidence of enlarged lymph nodes (92.3%) compared with group 2 (75.8%) and group 3 (46.8%) (p = 0.003). And if nodal width at acute flare was >8mm and interval change of nodal width was >3mm, the incidence of HBeAg seroconversion will be 75% (p<0.001). Conclusion Larger perihepatic lymph nodes are seen in CHB acute flare patients with positive HBeAg and the magnitude of nodal width change may predict HBeAg seroconversion at recovery.	[Sun, Chi-Shu; Lin, Yu-Min; Feng, I-Che; Sheu, Ming-Jen; Koay, Lok-Beng; Lin, Ching-Yih; Kuo, Hsing-Tao] Chi Mei Med Ctr, Div Hepatogastroenterol, Dept Internal Med, Tainan, Taiwan; [Kuo, Hsing-Tao] Chia Nan Univ Pharm & Sci, Dept Senior Citizen Serv Management, Tainan, Taiwan; [Ko, Yen-Ling; Chung, Kun-Ming] Chi Mei Med Ctr, Div Gen Internal Med, Dept Internal Med, Tainan, Taiwan; [Ho, Chung-Han] Chi Mei Med Ctr, Dept Med Res, Yongkang, Taiwan; [Ho, Chung-Han] Chia Nan Univ Pharm & Sci, Dept Hosp & Hlth Care Adm, Tainan, Taiwan	Chi Mei Hospital; Chia Nan University of Pharmacy & Science; Chi Mei Hospital; Chi Mei Hospital; Chia Nan University of Pharmacy & Science	Kuo, HT (corresponding author), Chi Mei Med Ctr, Div Hepatogastroenterol, Dept Internal Med, Tainan, Taiwan.	kuohsu2003@yahoo.com.tw		Ho, Chung-Han/0000-0001-5925-8477				Barbier L, 2012, J HEPATOL, V57, P352, DOI 10.1016/j.jhep.2012.03.023; CASSANI F, 1990, J CLIN GASTROENTEROL, V12, P42, DOI 10.1097/00004836-199002000-00012; CHEN CJ, 1991, HEPATOLOGY, V13, P398, DOI 10.1002/hep.1840130303; Choi MS, 2001, J CLIN GASTROENTEROL, V32, P329, DOI 10.1097/00004836-200104000-00010; Chu CM, 2007, J VIRAL HEPATITIS, V14, P147, DOI 10.1111/j.1365-2893.2006.00810.x; Chu CM, 1987, GASTROENTEROLOGY, V92, P220, DOI 10.1016/0016-5085(87)90863-8; Chu CM, 2004, AM J MED, V116, P829, DOI 10.1016/j.amjmed.2003.12.040; CHU CM, 1985, HEPATOLOGY, V5, P431, DOI 10.1002/hep.1840050315; DUDLEY FJ, 1972, LANCET, V1, P723; European Association For The Study Of The Liver, 2012, J HEPATOL, V57, P167, DOI DOI 10.1016/J.JHEP.2012.02.010; Fattovich G, 2008, GUT, V57, P84, DOI 10.1136/gut.2007.128496; He DM, 2013, HEPATOLOGY, V58, p416A; HOOFNAGLE JH, 1981, ANN INTERN MED, V94, P744, DOI 10.7326/0003-4819-94-6-744; Hsu YS, 2002, HEPATOLOGY, V35, P1522, DOI 10.1053/jhep.2002.33638; Hultkrantz S, 2005, IMMUNOLOGY, V116, P362, DOI 10.1111/j.1365-2567.2005.02236.x; Kao JH, 2004, J MED VIROL, V72, P363, DOI 10.1002/jmv.10534; Kim HS, 2009, GASTROENTEROLOGY, V136, P505, DOI 10.1053/j.gastro.2008.10.089; Kuo HT, 2006, J CLIN ULTRASOUND, V34, P211, DOI 10.1002/jcu.20226; LIAW YF, 1983, GASTROENTEROLOGY, V84, P216; Liaw YF, 2009, LANCET, V373, P582, DOI 10.1016/S0140-6736(09)60207-5; Lin YM, 2011, EUR J GASTROEN HEPAT, V23, P990, DOI 10.1097/MEG.0b013e32834ae825; LOK ASF, 1990, J HEPATOL, V10, P29, DOI 10.1016/0168-8278(90)90069-4; LOK ASF, 1987, GASTROENTEROLOGY, V92, P1839, DOI 10.1016/0016-5085(87)90613-5; Ma SW, 2012, J HEPATOL, V56, P775, DOI 10.1016/j.jhep.2011.10.020; MATSUNO K, 1990, ARCH HISTOL CYTOL, V53, P179, DOI 10.1679/aohc.53.Suppl_179; Muller P, 2003, J HEPATOL, V39, P807, DOI 10.1016/S0168-8278(03)00357-X; Okada Y, 1996, CLIN RADIOL, V51, P160, DOI 10.1016/S0009-9260(96)80316-3; REALDI G, 1980, GASTROENTEROLOGY, V79, P195; SANCHEZTAPIAS JM, 1988, J HEPATOL, V6, P15, DOI 10.1016/S0168-8278(88)80458-6; Shu J, 2013, WORLD J RADIOL, V5, P208, DOI 10.4329/wjr.v5.i5.208; SJOGREN M, 1985, GASTROENTEROLOGY, V89, P252, DOI 10.1016/0016-5085(85)90323-3; Soresi M, 1998, J HEPATOL, V28, P544, DOI 10.1016/S0168-8278(98)80276-6; Soresi M, 1999, AM J GASTROENTEROL, V94, P497, DOI 10.1111/j.1572-0241.1999.00791.x; Tan AT, 2010, J HEPATOL, V52, P330, DOI 10.1016/j.jhep.2009.12.015; TSAI SL, 1992, J CLIN INVEST, V89, P87, DOI 10.1172/JCI115590; Tseng TC, 2012, J INFECT DIS, V206, P1521, DOI 10.1093/infdis/jis569; Vassilopoulos D, 2008, J VIRAL HEPATITIS, V15, P817, DOI 10.1111/j.1365-2893.2008.00996.x; Wu JF, 2010, GASTROENTEROLOGY, V138, P165, DOI 10.1053/j.gastro.2009.09.018; Yang HI, 2002, NEW ENGL J MED, V347, P168, DOI 10.1056/NEJMoa013215; Yuen MF, 2004, J CLIN MICROBIOL, V42, P5036, DOI 10.1128/JCM.42.11.5036-5040.2004; Zheng MJ, 2013, CELL MOL IMMUNOL, V10, P143, DOI 10.1038/cmi.2012.59	41	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117590	10.1371/journal.pone.0117590	http://dx.doi.org/10.1371/journal.pone.0117590			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689069	Green Submitted, gold, Green Published			2022-12-26	WOS:000350322700060
J	Moreira, PVL; Baraldi, LG; Moubarac, JC; Monteiro, CA; Newton, A; Capewell, S; O'Flaherty, M				Moreira, Patricia V. L.; Baraldi, Larissa Galastri; Moubarac, Jean-Claude; Monteiro, Carlos Augusto; Newton, Alex; Capewell, Simon; O'Flaherty, Martin			Comparing Different Policy Scenarios to Reduce the Consumption of Ultra-Processed Foods in UK: Impact on Cardiovascular Disease Mortality Using a Modelling Approach	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; UNITED-KINGDOM; PRIMARY PREVENTION; RISK-FACTORS; DIETARY-FAT; POPULATION; CLASSIFICATION; REDUCTIONS; NUTRITION; PRODUCTS	Background The global burden of non-communicable diseases partly reflects growing exposure to ultra-processed food products (UPPs). These heavily marketed UPPs are cheap and convenient for consumers and profitable for manufacturers, but contain high levels of salt, fat and sugars. This study aimed to explore the potential mortality reduction associated with future policies for substantially reducing ultra-processed food intake in the UK. Methods and Findings We obtained data from the UK Living Cost and Food Survey and from the National Diet and Nutrition Survey. By the NOVA food typology, all food items were categorized into three groups according to the extent of food processing: Group 1 describes unprocessed/minimally processed foods. Group 2 comprises processed culinary ingredients. Group 3 includes all processed or ultra-processed products. Using UK nutrient conversion tables, we estimated the energy and nutrient profile of each food group. We then used the IMPACT Food Policy model to estimate reductions in cardiovascular mortality from improved nutrient intakes reflecting shifts from processed or ultra-processed to unprocessed/minimally processed foods. We then conducted probabilistic sensitivity analyses using Monte Carlo simulation. Results Approximately 175,000 cardiovascular disease (CVD) deaths might be expected in 2030 if current mortality patterns persist. However, halving the intake of Group 3 (processed) foods could result in approximately 22,055 fewer CVD related deaths in 2030 (minimum estimate 10,705, maximum estimate 34,625). An ideal scenario in which salt and fat intakes are reduced to the low levels observed in Group 1 and 2 could lead to approximately 14,235 (minimum estimate 6,680, maximum estimate 22,525) fewer coronary deaths and approximately 7,820 (minimum estimate 4,025, maximum estimate 12,100) fewer stroke deaths, comprising almost 13% mortality reduction. Conclusions This study shows a substantial potential for reducing the cardiovascular disease burden through a healthier food system. It highlights the crucial importance of implementing healthier UK food policies.	[Moreira, Patricia V. L.; Newton, Alex; Capewell, Simon; O'Flaherty, Martin] Univ Liverpool, Dept Publ Hlth, Liverpool L69 3BX, Merseyside, England; [Baraldi, Larissa Galastri; Moubarac, Jean-Claude; Monteiro, Carlos Augusto] Univ Sao Paulo, Ctr Epidemiol Studies Hlth & Nutr, Sao Paulo, Brazil; [Monteiro, Carlos Augusto] Univ Sao Paulo, Sch Publ Hlth, Dept Nutr, Sao Paulo, Brazil	University of Liverpool; Universidade de Sao Paulo; Universidade de Sao Paulo	Moreira, PVL (corresponding author), Univ Liverpool, Dept Publ Hlth, Liverpool L69 3BX, Merseyside, England.	patriciamoreira1111@hotmail.com	Moubarac, Jean-Claude/J-8235-2014; Baraldi, Larissa Galastri/K-9784-2019; Shao, Ruitai/AAU-7642-2021; Moubarac, Jean-Claude/ABE-6439-2020; Monteiro, Carlos Augusto/F-9892-2012	Baraldi, Larissa Galastri/0000-0002-6793-7899; Monteiro, Carlos Augusto/0000-0002-3777-1533; O'Flaherty, Martin/0000-0001-8944-4131	Brazilian higher education agency CNPq (National Council for Scientific and Technological Development), Science Without Borders Program; MRC [G0900847] Funding Source: UKRI; Medical Research Council [G0900847] Funding Source: researchfish	Brazilian higher education agency CNPq (National Council for Scientific and Technological Development), Science Without Borders Program; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This project was funded by Brazilian higher education agency CNPq (National Council for Scientific and Technological Development) as part of Science Without Borders Program. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Agency DoHatFS, 2012, NAT DIET NUTR SURV; Bibbins-Domingo K, 2010, NEW ENGL J MED, V362, P590, DOI 10.1056/NEJMoa0907355; Martins APB, 2013, REV SAUDE PUBL, V47, P656, DOI 10.1590/S0034-8910.2013047004968; Bromley H, 2014, IDENTIFYING MOST EFF; Canella DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092752; Capacci S, 2011, J HEALTH ECON, V30, P87, DOI 10.1016/j.jhealeco.2010.10.006; Capewell S, 2011, LANCET, V378, P752, DOI 10.1016/S0140-6736(10)62302-1; Crovetto M, 2012, REV MED CHILE, V140, P305, DOI 10.4067/S0034-98872012000300004; Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058; Department for Environment FaRA, 2012, FAMILY FOOD, V2011, DOI [10.1080/17437199.2011.587961, DOI 10.1080/17437199.2011.587961]; Fiedler JL, 2012, FOOD NUTR BULL, V33, pS170, DOI 10.1177/15648265120333S205; Fletcher JM, 2011, J POLICY ANAL MANAG, V30, P655, DOI 10.1002/pam.20582; Franco M, 2013, BMJ-BRIT MED J, V346, DOI [10.1136/ bmj. f4242, DOI 10.1136/BMJ.F4242]; He FJ, 2010, PROG CARDIOVASC DIS, V52, P363, DOI 10.1016/j.pcad.2009.12.006; He FJ, 2014, BMJ OPEN, V4, DOI [10.1136/bmjopen-2014-007130, DOI 10.1136/BMJOPEN-2014-007130]; Hu FB, 1999, AM J CLIN NUTR, V70, P1001; Jakobsen MU, 2009, AM J CLIN NUTR, V89, P1425, DOI 10.3945/ajcn.2008.27124; Ji C, 2014, BMJ OPEN, V4, DOI [10.1136/bmjopen-2014-007130, DOI 10.1136/BMJOPEN-2014-007130]; Kabir Z, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-117; Konfino J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073824; Monteiro CA, 2013, OBESITY REV; Monteiro CA., 2012, WORLD NUTR, V3, P527; Monteiro CA, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001252; Monteiro CA, 2009, PUBLIC HEALTH NUTR, V12, P729, DOI 10.1017/S1368980009005291; Monteiro CA, 2011, PUBLIC HEALTH NUTR, V14, P5, DOI 10.1017/S1368980010003241; Monteiro CA, 2010, CAD SAUDE PUBLICA, V26, P2039, DOI 10.1590/S0102-311X2010001100005; Moodie R, 2013, LANCET, V381, P670, DOI 10.1016/S0140-6736(12)62089-3; Moubarac JC, 2014, CURR OBES REP, V3, P256, DOI 10.1007/s13679-014-0092-0; Moubarac JC, 2013, PUBLIC HEALTH NUTR, V16, P2240, DOI 10.1017/S1368980012005009; Moubarac JC, 2013, GLOB PUBLIC HEALTH, V8, P845, DOI 10.1080/17441692.2013.796401; Mozaffarian D, 2009, EUR J CLIN NUTR, V63, pS22, DOI 10.1038/sj.ejcn.1602976; Mozaffarian D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000252; National Centre for Social Research, 2008, ASS DIET SOD LEV AD; O'Flaherty M, 2012, B WORLD HEALTH ORGAN, V90, P522, DOI 10.2471/BLT.11.092643; O'Keeffe C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002837; Oh K, 2005, AM J EPIDEMIOL, V161, P672, DOI 10.1093/aje/kwi085; Pasquale S, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/ bmj. b5657, DOI 10.1136/BMJ.B5657]; Pereira RA, 2014, PUBLIC HEALTH NUTR, V17, P113, DOI 10.1017/S1368980012004892; Pietinen P, 1996, PREV MED, V25, P243, DOI 10.1006/pmed.1996.0053; Rtveladze K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068785; Sadler K, 2012, NATL DIET NUTR SURVY; Sharma A, 2014, HEALTH ECON, V23, P1159, DOI 10.1002/hec.3070; Stuckler D, 2012, PLOS MED, V9, DOI [10.1371/journal.pmed.1001235, 10.1371/journal.pmed.1001242]; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Tavares LF, 2012, PUBLIC HEALTH NUTR, V15, P82, DOI 10.1017/S1368980011001571; Townsend N, 2012, CORONARY HEART DIS S; Unal B, 2005, BMJ-BRIT MED J, V331, P614, DOI 10.1136/bmj.38561.633345.8F; Unal B, 2005, J CLIN EPIDEMIOL, V58, P733, DOI 10.1016/j.jclinepi.2004.09.015; Vandevijvere S, 2013, OBES REV, V14, P135, DOI 10.1111/obr.12082; Watts R, 2008, PROTECTING CHILDREN; Witold AZ, 2005, BMJ, V331; World Health Organization, 2008, 2008 2013 ACT PLAN G; World Health Organization (WHO), 2015, GLOB PREV AN 2011, DOI DOI 10.1017/S1368980008002401; Young F, 2010, AM J PREV MED, V39, P228, DOI 10.1016/j.amepre.2010.05.009	54	49	51	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0118353	10.1371/journal.pone.0118353	http://dx.doi.org/10.1371/journal.pone.0118353			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9IO	25679527	gold, Green Published, Green Submitted			2022-12-26	WOS:000350682600121
J	Siriboon, C; Lin, YH; Kere, M; Chen, CD; Chen, LR; Chen, CH; Tu, CF; Lo, NW; Ju, JC				Siriboon, Chawalit; Lin, Yu-Hsuan; Kere, Michel; Chen, Chun-Da; Chen, Lih-Ren; Chen, Chien-Hong; Tu, Ching-Fu; Lo, Neng-Wen; Ju, Jyh-Cherng			Putative Porcine Embryonic Stem Cell Lines Derived from Aggregated Four-Celled Cloned Embryos Produced by Oocyte Bisection Cloning	PLOS ONE			English	Article							IN-VITRO DEVELOPMENT; NUCLEAR TRANSFER; CULTURE-CONDITIONS; TRICHOSTATIN-A; SOMATIC-CELLS; PIG EMBRYOS; ESTABLISHMENT; BOVINE; DIFFERENTIATION; BLASTOCYSTS	We attempted to isolate ES cell lines using inner cellmasses fromhigh-quality cloned porcine blastocysts. After being seeded onto feeders, embryos had better (P < 0.05) attachment, outgrowth formation and primary colonization in both 2x and 3x aggregated cloned embryos (62.8, 42.6 and 12.8% vs. 76.2, 55.2 and 26.2%, respectively) compared to the non-aggregated group (41.6, 23.4 and 3.9%). Effects of feeder types (STO vs. MEF) and serumsources (FBS vs. KSR) on extraction of cloned embryo-derived porcine ES cells were examined. More (17.1%) ntES cell lines over Passage 3 were generated in the MEF/KSR group. However, ntES cells cultured in KSR-supplemented medium had a low proliferation rate with defective morphology, and eventually underwent differentiation or apoptosis subsequently. Approximately 26.1, 22.7 and 35.7% of primary colonies were formed after plating embryos in DMEM, DMEM/F12 and alpha-MEM media, respectively. Survival rates of ntES cells cultured in a-MEM, DMEM and DMEM/F12 were 16.7, 4.3 and 6.8%, respectively (P > 0.05). We further examined the beneficial effect of TSA treatment of 3x aggregated cloned embryos on establishment of ntES cell lines. Primary colony numbers and survival rates of ntES cells beyond passage 3 were higher (P < 0.05) in those derived from TSA-treated 3x blastocysts (36.7 and 26.7%) than from the non-treated aggregated group (23.1 and 11.5%). These cells, remaining undifferentiated over 25 passages, had alkaline phosphatase activity and expressed ES specific markers Oct4, Nanog, Sox2, and Rex01. Moreover, these ntES cells successfully differentiated into embryoid bodies (EBs) that expressed specific genes of all three germ layers after being cultured in LIF-free medium. In conclusion, we have successfully derived putative porcine ntES cells with high efficiency from quality cloned embryos produced by embryo aggregation, and optimized the ES cell culture system suitable for establishing and maintaining ntES cell lines in undifferentiated state.	[Siriboon, Chawalit; Ju, Jyh-Cherng] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Siriboon, Chawalit; Lin, Yu-Hsuan; Kere, Michel; Chen, Chun-Da; Ju, Jyh-Cherng] Natl Chung Hsing Univ, Dept Anim Sci, Taichung 40227, Taiwan; [Chen, Lih-Ren] Execut Yuan, Council Agr, Livestock Res Inst, Div Physiol, Tainan, Taiwan; [Chen, Chien-Hong; Tu, Ching-Fu] Agr Technol Res Inst 1, Hsinchu 300, Taiwan; [Lo, Neng-Wen] Tunghai Univ 181, Dept Anim Sci & Biotechnol, Taichung 407, Taiwan; [Ju, Jyh-Cherng] China Med Univ Hosp, Dept Med Res, Core Lab Stem Cell Res, Taichung, Taiwan; [Ju, Jyh-Cherng] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung 40227, Taiwan; [Ju, Jyh-Cherng] Natl Chung Hsing Univ, Biotechnol Ctr, Taichung 40227, Taiwan; [Ju, Jyh-Cherng] Asia Univ, Coll Comp Sci, Dept Biomed Informat, Taichung, Taiwan	China Medical University Taiwan; National Chung Hsing University; Taiwan Livestock Research Institute; Agricultural Technology Research Institute; Tunghai University; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Chung Hsing University; National Chung Hsing University; Asia University Taiwan	Ju, JC (corresponding author), China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan.	jcju@mail.cmu.ed.tw	Chen, Chien-Hong/GOP-2714-2022	Chen, Chien-Hong/0000-0002-6352-3437	China Medical University Hospital [DMR-103-104]; National Science Council [96-2313-B-005-013, 98-2628-B005-019-MY3, 101-2313-B-005 -013 -MY3]; Ministry of Education, Taiwan, Republic of China, under the ATU plan; Executive Yuan	China Medical University Hospital; National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan, Republic of China, under the ATU plan; Executive Yuan	This study was supported in part by grants from China Medical University Hospital (DMR-103-104), the National Science Council (NSC# 96-2313-B-005-013, NSC# 98-2628-B005-019-MY3, and NSC# 101-2313-B-005 -013 -MY3), Executive Yuan and the Ministry of Education, Taiwan, Republic of China, under the ATU plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GB, 1996, ANIM REPROD SCI, V45, P231, DOI 10.1016/S0378-4320(96)01581-3; ANDERSON GB, 1994, THERIOGENOLOGY, V42, P204, DOI 10.1016/0093-691X(94)90676-A; Boiani M, 2003, EMBO J, V22, P5304, DOI 10.1093/emboj/cdg507; Brevini TAL, 2010, THERIOGENOLOGY, V74, P544, DOI 10.1016/j.theriogenology.2010.04.020; Brevini TAL, 2007, THERIOGENOLOGY, V67, P54, DOI 10.1016/j.theriogenology.2006.09.019; Brevini TAL, 2010, STEM CELL REV REP, V6, P484, DOI 10.1007/s12015-010-9153-2; Byrne JA, 2007, NATURE, V450, P497, DOI 10.1038/nature06357; Cervera RP, 2009, THERIOGENOLOGY, V72, P1097, DOI 10.1016/j.theriogenology.2009.06.030; Chawalit S, 2012, REPROD SCI, V19, P976, DOI 10.1177/1933719112440049; Chen G, 2005, NAT MED, V11, P1295, DOI 10.1038/nm1330; Chen LR, 1999, THERIOGENOLOGY, V52, P195, DOI 10.1016/S0093-691X(99)00122-3; Cibelli JB, 1998, NAT BIOTECHNOL, V16, P642, DOI 10.1038/nbt0798-642; EVANS MJ, 1990, THERIOGENOLOGY, V33, P125, DOI 10.1016/0093-691X(90)90603-Q; Ezashi T, 2009, P NATL ACAD SCI USA, V106, P10993, DOI 10.1073/pnas.0905284106; Fang ZF, 2006, EXP CELL RES, V312, P3669, DOI 10.1016/j.yexcr.2006.08.013; Fujishiro S, 2013, STEM CELLS DEV, V22, P473, DOI 10.1089/scd.2012.0173; GILES JR, 1995, MOL REPROD DEV, V41, P204, DOI 10.1002/mrd.1080410211; Hall V, 2008, STEM CELL REV, V4, P275, DOI 10.1007/s12015-008-9040-2; Haraguchi S, 2012, J REPROD DEVELOP, V58, P707, DOI 10.1262/jrd.2012-008; HOCHEREAUDEREVIERS MT, 1993, REPROD NUTR DEV, V33, P475, DOI 10.1051/rnd:19930508; Intawicha P, 2009, CLONING STEM CELLS, V11, P27, DOI 10.1089/clo.2008.0040; Kim HS, 2007, ZYGOTE, V15, P55, DOI 10.1017/S0967199406003972; Kim S, 2010, ZYGOTE, V18, P93, DOI 10.1017/S0967199409990372; Kishigami S, 2006, BIOCHEM BIOPH RES CO, V340, P183, DOI 10.1016/j.bbrc.2005.11.164; Koo DB, 2004, THERIOGENOLOGY, V62, P779, DOI 10.1016/j.theriogenology.2003.12.027; Lai LX, 2002, SCIENCE, V295, P1089, DOI 10.1126/science.1068228; Lee SG, 2007, MOL REPROD DEV, V74, P1436, DOI 10.1002/mrd.20728; Li J, 2008, THERIOGENOLOGY, V70, P800, DOI 10.1016/j.theriogenology.2008.05.046; Li M, 2004, J REPROD DEVELOP, V50, P237, DOI 10.1262/jrd.50.237; Li M, 2003, MOL REPROD DEV, V65, P429, DOI 10.1002/mrd.10301; Liao YJ, 2014, STEM CELL RES THERAP, V4, DOI [10.4172/2157-7633.1000208, DOI 10.4172/2157-7633.1000208]; Machaty Z, 1998, REPROD FERT DEVELOP, V10, P599, DOI 10.1071/RD98048; Miyoshi K, 2000, BIOL REPROD, V62, P1640, DOI 10.1095/biolreprod62.6.1640; Moore K, 1997, IN VITRO CELL DEV-AN, V33, P62; Nguyen NT, 2009, REPROD FERT DEVELOP, V21, P805, DOI 10.1071/RD08277; Park JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052481; PIEDRAHITA JA, 1990, THERIOGENOLOGY, V34, P879, DOI 10.1016/0093-691X(90)90559-C; Pratt S L, 2006, Soc Reprod Fertil Suppl, V62, P303; RopeterScharfenstein M, 1996, J ANIM BREED GENET, V113, P427, DOI 10.1111/j.1439-0388.1996.tb00633.x; Shan ZY, 2012, DEV GROWTH DIFFER, V54, P481, DOI 10.1111/j.1440-169X.2012.01335.x; Siriboon C, 2014, REPROD FERT DEVELOP, V26, P395, DOI 10.1071/RD12243; STROJEK RM, 1990, THERIOGENOLOGY, V33, P901, DOI 10.1016/0093-691X(90)90825-E; Sugimura S, 2009, THERIOGENOLOGY, V72, P549, DOI 10.1016/j.theriogenology.2009.04.011; Tachibana M, 2013, CELL, V153, P1228, DOI 10.1016/j.cell.2013.05.006; TALBOT NC, 1993, IN VITRO CELL DEV-AN, V29A, P543; Tang PC, 2000, ZYGOTE, V8, P235, DOI 10.1017/S0967199400001039; Telugu BPVL, 2010, INT J DEV BIOL, V54, P1703, DOI 10.1387/ijdb.103200bt; Telugu BPVL, 2010, STEM CELL REV REP, V6, P31, DOI 10.1007/s12015-009-9101-1; Terashita Y, 2011, REPROD DOMEST ANIM, V46, P189, DOI 10.1111/j.1439-0531.2010.01614.x; Thompson JG, 1997, REPROD FERT DEVELOP, V9, P341, DOI 10.1071/R96079; Vackova I, 2007, J REPROD DEVELOP, V53, P1137, DOI 10.1262/jrd.19108; Vassiliev I, 2011, CELL REPROGRAM, V13, P205, DOI 10.1089/cell.2010.0102; Vassiliev I, 2010, J REPROD DEVELOP, V56, P546, DOI 10.1262/jrd.09-197A; Wakayama T, 2001, SCIENCE, V292, P740, DOI 10.1126/science.1059399; Wang L, 2005, BIOL REPROD, V73, P149, DOI 10.1095/biolreprod.104.037150; Wang WH, 1997, J REPROD FERTIL, V111, P101, DOI 10.1530/jrf.0.1110101; Wianny F, 1997, BIOL REPROD, V57, P756, DOI 10.1095/biolreprod57.4.756; Yamada K, 2005, NAT MED, V11, P32, DOI 10.1038/nm1172; Yang JR, 2009, CLONING STEM CELLS, V11, P235, DOI 10.1089/clo.2008.0050	59	15	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0118165	10.1371/journal.pone.0118165	http://dx.doi.org/10.1371/journal.pone.0118165			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680105	gold, Green Submitted, Green Published			2022-12-26	WOS:000350682600110
J	Gomi, K; Arbelaez, V; Crystal, RG; Walters, MS				Gomi, Kazunori; Arbelaez, Vanessa; Crystal, Ronald G.; Walters, Matthew S.			Activation of NOTCH1 or NOTCH3 Signaling Skews Human Airway Basal Cell Differentiation toward a Secretory Pathway	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; STEM-CELLS; MUCOUS METAPLASIA; CLARA CELLS; IN-VITRO; EPITHELIUM; SMOKING; LUNG; FATE; REGENERATION	Airway basal cells (BC) function as stem/progenitor cells capable of differentiating into the luminal ciliated and secretory cells to replenish the airway epithelium during physiological turnover and repair. The objective of this study was to define the role of Notch signaling in regulating human airway BC differentiation into a pseudostratified mucociliated epithelium. Notch inhibition with gamma-secretase inhibitors demonstrated Notch activation is essential for BC differentiation into secretory and ciliated cells, but more so for the secretory lineage. Sustained cell autonomous ligand independent Notch activation via lentivirus expression of the intracellular domain of each Notch receptor (NICD1-4) demonstrated that the NOTCH2 and 4 pathways have little effect on BC differentiation into secretory and ciliated cells, while activation of the NOTCH1 or 3 pathways has a major influence, with persistent expression of NICD1 or 3 resulting in a skewing toward secretory cell differentiation with a parallel decrease in ciliated cell differentiation. These observations provide insights into the control of the balance of BC differentiation into the secretory vs ciliated cell lineage, a balance that is critical for maintaining the normal function of the airway epithelium in barrier defense against the inhaled environment.	[Gomi, Kazunori; Arbelaez, Vanessa; Crystal, Ronald G.; Walters, Matthew S.] Weill Cornell Med Coll, Dept Med Genet, New York, NY 10065 USA	Cornell University	Walters, MS (corresponding author), Weill Cornell Med Coll, Dept Med Genet, New York, NY 10065 USA.	geneticmedicine@med.cornell.edu		Walters, Matthew/0000-0003-0010-8444	National Institutes of Health [R01HL107882, P50HL084936, UL1TR000457, UL1RR024143]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000457] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL084936, R01HL107882] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	These studies are supported by the National Institutes of Health R01HL107882, P50HL084936, UL1TR000457 and UL1RR024143. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson ER, 2011, DEVELOPMENT, V138, P3593, DOI 10.1242/dev.063610; Beasley MB, 2010, ADV ANAT PATHOL, V17, P270, DOI 10.1097/PAP.0b013e3181e3bf97; Blanpain C, 2007, CELL, V128, P445, DOI 10.1016/j.cell.2007.01.014; Borggrefe T, 2012, CELL CYCLE, V11, P264, DOI 10.4161/cc.11.2.18995; Boucherat O, 2012, BIOL OPEN, V1, P677, DOI 10.1242/bio.20121701; Cole BB, 2010, AM J PATHOL, V177, P362, DOI 10.2353/ajpath.2010.090870; Crystal Ronald G, 2008, Proc Am Thorac Soc, V5, P772, DOI 10.1513/pats.200805-041HR; Gerovac BJ, 2014, AM J RESP CELL MOL, V51, P516, DOI 10.1165/rcmb.2013-0237OC; Guha A, 2012, P NATL ACAD SCI USA, V109, P12592, DOI 10.1073/pnas.1204710109; Guseh JS, 2009, DEVELOPMENT, V136, P1751, DOI 10.1242/dev.029249; Hackett NR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018378; Hackett TL, 2008, STEM CELLS, V26, P2576, DOI 10.1634/stemcells.2008-0171; Hajj R, 2007, STEM CELLS, V25, P139, DOI 10.1634/stemcells.2006-0288; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Hong KU, 2004, AM J PATHOL, V164, P577, DOI 10.1016/S0002-9440(10)63147-1; Hori K, 2013, J CELL SCI, V126, P2135, DOI 10.1242/jcs.127308; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Ito T, 2000, DEVELOPMENT, V127, P3913; Kim V, 2008, COPD, V5, P329, DOI 10.1080/15412550802522445; Knight DA, 2003, RESPIROLOGY, V8, P432, DOI 10.1046/j.1440-1843.2003.00493.x; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kumar PA, 2011, CELL, V147, P525, DOI 10.1016/j.cell.2011.10.001; Li AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062215; Liu JN, 2010, CURR TOP DEV BIOL, V92, P367, DOI [10.1016/S0070-2153(10)92012-7, 10.1016/S0070-2153(10)91012-7]; LUMSDEN AB, 1984, THORAX, V39, P844, DOI 10.1136/thx.39.11.844; Marcet B, 2011, NAT CELL BIOL, V13, P693, DOI 10.1038/ncb2241; McDonough JE, 2011, NEW ENGL J MED, V365, P1567, DOI 10.1056/NEJMoa1106955; Morimoto M, 2012, DEVELOPMENT, V139, P4365, DOI 10.1242/dev.083840; Morimoto M, 2010, J CELL SCI, V123, P213, DOI 10.1242/jcs.058669; Paul MK, 2014, CELL STEM CELL, V15, P199, DOI 10.1016/j.stem.2014.05.009; Rock JR, 2011, CELL STEM CELL, V8, P639, DOI 10.1016/j.stem.2011.04.003; Rock JR, 2010, DIS MODEL MECH, V3, P545, DOI 10.1242/dmm.006031; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Schoch KG, 2004, AM J PHYSIOL-LUNG C, V286, pL631, DOI 10.1152/ajplung.00112.2003; Shan L, 2007, AM J PHYSIOL-LUNG C, V292, pL500, DOI 10.1152/ajplung.00052.2006; Shaykhiev R, 2013, P NATL ACAD SCI USA, V110, P12102, DOI 10.1073/pnas.1303058110; Tam A, 2012, MED CLIN N AM, V96, P681, DOI 10.1016/j.mcna.2012.04.012; Tam Anthony, 2011, Ther Adv Respir Dis, V5, P255, DOI 10.1177/1753465810396539; Tata PR, 2013, AM J RESP CELL MOL, V49, P1048, DOI 10.1165/rcmb.2012-0412OC; Tilley AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022798; Tilley AE, 2009, AM J RESP CRIT CARE, V179, P457, DOI 10.1164/rccm.200705-795OC; Tsao PN, 2011, DEVELOPMENT, V138, P3533, DOI 10.1242/dev.063727; Tsao PN, 2009, DEVELOPMENT, V136, P2297, DOI 10.1242/dev.034884; Walters MS, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-135; Xing YM, 2012, STEM CELLS, V30, P946, DOI 10.1002/stem.1059; Xu KL, 2012, ADV EXP MED BIOL, V727, P89, DOI 10.1007/978-1-4614-0899-4_7; Zhang SB, 2013, DEV DYNAM, V242, P678, DOI 10.1002/dvdy.23965	47	43	44	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0116507	10.1371/journal.pone.0116507	http://dx.doi.org/10.1371/journal.pone.0116507			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25700162	Green Published, Green Submitted, gold			2022-12-26	WOS:000349789800010
J	Zuwala, K; Golda, A; Kabala, W; Burmistrz, M; Zdzalik, M; Nowak, P; Kedracka-Krok, S; Zarebski, M; Dobrucki, J; Florek, D; Zeglen, S; Wojarski, J; Potempa, J; Dubin, G; Pyrc, K				Zuwala, Kaja; Golda, Anna; Kabala, Wojciech; Burmistrz, Michal; Zdzalik, Michal; Nowak, Paulina; Kedracka-Krok, Sylwia; Zarebski, Miroslaw; Dobrucki, Jerzy; Florek, Dominik; Zeglen, Slawomir; Wojarski, Jacek; Potempa, Jan; Dubin, Grzegorz; Pyrc, Krzysztof			The Nucleocapsid Protein of Human Coronavirus NL63	PLOS ONE			English	Article							ACUTE RESPIRATORY SYNDROME; INFECTIOUS-BRONCHITIS VIRUS; N-TERMINAL DOMAIN; DIFFERENTIAL SCANNING CALORIMETRY; DIMERIZATION DOMAIN; AMINOPEPTIDASE-N; DOWN-REGULATION; RNA-BINDING; LOCALIZATION; SEQUENCE	Human coronavirus (HCoV) NL63 was first described in 2004 and is associated with respiratory tract disease of varying severity. At the genetic and structural level, HCoV-NL63 is similar to other members of the Coronavirinae subfamily, especially human coronavirus 229E (HCoV-229E). Detailed analysis, however, reveals several unique features of the pathogen. The coronaviral nucleocapsid protein is abundantly present in infected cells. It is a multi-domain, multi-functional protein important for viral replication and a number of cellular processes. The aim of the present study was to characterize the HCoV-NL63 nucleocapsid protein. Biochemical analyses revealed that the protein shares characteristics with homologous proteins encoded in other coronaviral genomes, with the N-terminal domain responsible for nucleic acid binding and the C-terminal domain involved in protein oligomerization. Surprisingly, analysis of the subcellular localization of the N protein of HCoV-NL63 revealed that, differently than homologous proteins from other coronaviral species except for SARS-CoV, it is not present in the nucleus of infected or transfected cells. Furthermore, no significant alteration in cell cycle progression in cells expressing the protein was observed. This is in stark contrast with results obtained for other coronaviruses, except for the SARS-CoV.	[Zuwala, Kaja; Golda, Anna; Kabala, Wojciech; Burmistrz, Michal; Zdzalik, Michal; Nowak, Paulina; Florek, Dominik; Potempa, Jan; Dubin, Grzegorz; Pyrc, Krzysztof] Jagiellonian Univ, Dept Microbiol, Fac Biochem Biophys & Biotechnol, PL-30387 Krakow, Poland; [Kabala, Wojciech; Kedracka-Krok, Sylwia; Dubin, Grzegorz; Pyrc, Krzysztof] Jagiellonian Univ, Malopolska Ctr Biotechnol, PL-30387 Krakow, Poland; [Kedracka-Krok, Sylwia] Jagiellonian Univ, Dept Phys Biochem, Fac Biochem Biophys & Biotechnol, PL-30387 Krakow, Poland; [Zarebski, Miroslaw; Dobrucki, Jerzy] Jagiellonian Univ, Div Cell Biophys, Fac Biochem Biophys & Biotechnol, PL-30387 Krakow, Poland; [Wojarski, Jacek] Silesian Ctr Heart Dis, Dept Cardiac Surg & Transplantol, PL-41800 Zabrze, Poland; [Potempa, Jan] Univ Louisville, Oral Hlth & Syst Dis Res Grp, Sch Dent, Louisville, KY 40292 USA	Jagiellonian University; Jagiellonian University; Jagiellonian University; Jagiellonian University; Silesian Center for Heart Diseases; University of Louisville	Pyrc, K (corresponding author), Jagiellonian Univ, Dept Microbiol, Fac Biochem Biophys & Biotechnol, Gronostajowa 7, PL-30387 Krakow, Poland.	k.a.pyrc@uj.edu.pl	Dubin, Grzegorz/J-8168-2014; Zuwala, Kaja/L-6124-2017; Burmistrz, Michal/AAQ-1027-2020; Potempa, Jan/AAA-6850-2021	Dubin, Grzegorz/0000-0002-5535-5760; Zuwala, Kaja/0000-0001-6585-4259; Nowak, Paulina/0000-0001-5786-2339; Potempa, Jan/0000-0002-3600-7461; Wojarski, Jacek/0000-0001-7724-8213; Pyrc, Krzysztof/0000-0002-3867-7688; Dobrucki, Jerzy/0000-0002-4432-1522	LIDER grant from the National Centre for Research and Development [Lider/27/55/L-2/10/2011]; Iuventus Plus grant from the Ministry of Science and Higher Education, Poland [IP 2010 033870, IP2011 044371]; National Science Center [UMO-2012/05/B/NZ4/02428, UMO-2011/01/D/NZ1/01169, UMO-2012/07/E/NZ6/01712]; European Union [POIG.02.01.00-12-064/08]	LIDER grant from the National Centre for Research and Development; Iuventus Plus grant from the Ministry of Science and Higher Education, Poland(Ministry of Science and Higher Education, Poland); National Science Center(National Science Centre, Poland); European Union(European Commission)	This work was supported by the LIDER grant from the National Centre for Research and Development (Lider/27/55/L-2/10/2011) (KP) and Iuventus Plus grant from the Ministry of Science and Higher Education, Poland (IP 2010 033870 and IP2011 044371) (KP) and grants from the National Science Center (UMO-2012/05/B/NZ4/02428 (SKK), UMO-2011/01/D/NZ1/01169 (GD) and UMO-2012/07/E/NZ6/01712 (KP)). The Faculty of Biochemistry, Biophysics and Biotechnology of the Jagiellonian University is a beneficiary of the structural funds from the European Union (grant No: POIG.02.01.00-12-064/08 - "Molecular biotechnology for health"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida J D, 1967, J Gen Virol, V1, P175, DOI 10.1099/0022-1317-1-2-175; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Cabeca TK, 2012, J CLIN VIROL, V53, P82, DOI 10.1016/j.jcv.2011.09.006; Cabeca TK, 2013, INFLUENZA OTHER RESP; Chen CY, 2007, J MOL BIOL, V368, P1075, DOI 10.1016/j.jmb.2007.02.069; Chen HY, 2005, J VIROL, V79, P1164, DOI 10.1128/JVI.79.2.1164-1179.2005; DAVIES HA, 1981, J GEN VIROL, V53, P67, DOI 10.1099/0022-1317-53-1-67; Dijkman R, 2012, J GEN VIROL, V93, P1924, DOI 10.1099/vir.0.043919-0; Dijkman R, 2012, J CLIN VIROL, V53, P135, DOI 10.1016/j.jcv.2011.11.011; Dijkman R, 2009, J FORMOS MED ASSOC, V108, P270, DOI 10.1016/S0929-6646(09)60066-8; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fan H, 2005, STRUCTURE, V13, P1859, DOI 10.1016/j.str.2005.08.021; Fields BN, 2013, FIELDS VIROLOGY, DOI [10.1016/j.jfo.2013.06.003, DOI 10.1016/J.JFO.2013.06.003]; Fulcher M Leslie, 2005, Methods Mol Med, V107, P183; Golda A, 2011, J GEN VIROL, V92, P1358, DOI 10.1099/vir.0.028381-0; Grossoehme NE, 2009, J MOL BIOL, V394, P544, DOI 10.1016/j.jmb.2009.09.040; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HAMRE D, 1966, P SOC EXP BIOL MED, V121, P190, DOI 10.3181/00379727-121-30734; Harrison SM, 2007, FEBS LETT, V581, P1275, DOI 10.1016/j.febslet.2007.02.039; HISCOX JA, 1995, VIRUS RES, V36, P119, DOI 10.1016/0168-1702(94)00108-O; Hiscox JA, 2001, J VIROL, V75, P506, DOI 10.1128/JVI.75.1.506-512.2001; Hofmann H, 2005, P NATL ACAD SCI USA, V102, P7988, DOI 10.1073/pnas.0409465102; Hon KL, 2012, HONG KONG MED J, V18, P60; Huynh J, 2012, J VIROL, V86, P12816, DOI 10.1128/JVI.00906-12; Jayaram H, 2006, J VIROL, V80, P6612, DOI 10.1128/JVI.00157-06; Jevsnik M, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-365; Kedracka-Krok S, 2003, EUR J BIOCHEM, V270, P4564, DOI 10.1046/j.1432-1033.2003.03856.x; KENNEDY DA, 1976, INTERVIROLOGY, V6, P197; King A. M. Q, 2012, VIRUS TAXONOMY; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Lo YS, 2013, FEBS LETT, V587, P120, DOI 10.1016/j.febslet.2012.11.016; Lu XL, 2011, VIRUS GENES, V42, P37, DOI 10.1007/s11262-010-0544-x; MACNAUGHTON MR, 1978, J GEN VIROL, V39, P545, DOI 10.1099/0022-1317-39-3-545; Mateos-Gomez PA, 2011, J VIROL, V85, P8968, DOI 10.1128/JVI.00869-11; MCINTOSH K, 1967, P NATL ACAD SCI USA, V58, P2268, DOI 10.1073/pnas.58.6.2268; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; Narayanan K, 2003, VIRUS RES, V98, P131, DOI 10.1016/j.virusres.2003.08.021; Nelson GW, 2000, J GEN VIROL, V81, P181, DOI 10.1099/0022-1317-81-1-181; Oh Jin Sik, 2003, J Vet Sci, V4, P269; Oosterhof L, 2010, BONE MARROW TRANSPL, V45, P1115, DOI 10.1038/bmt.2009.292; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; Peitsch M C, 2000, Pharmacogenomics, V1, P257, DOI 10.1517/14622416.1.3.257; Peng TY, 2008, FEBS J, V275, P4152, DOI 10.1111/j.1742-4658.2008.06564.x; Pfefferle S, 2009, EMERG INFECT DIS, V15, P1377, DOI 10.3201/eid1509.090224; Pyrc K., 2005, RECENT RES DEV INFEC, P25, DOI DOI 10.1016/J.TIG.2014.12.005; Pyrc K, 2007, EXPERT REV ANTI-INFE, V5, P245, DOI 10.1586/14787210.5.2.245; Pyrc K, 2004, VIROL J, V1, DOI 10.1186/1743-422X-1-7; Pyrc Krzysztof, 2008, V454, P73, DOI 10.1007/978-1-59745-181-9_7; REED L. J., 1938, AMER JOUR HYG, V27, P493; Reed ML, 2007, J VIROL, V81, P4298, DOI 10.1128/JVI.02239-06; Rowland RRR, 2005, J VIROL, V79, P11507, DOI 10.1128/JVI.79.17.11507-11512.2005; Saikatendu KS, 2007, J VIROL, V81, P3913, DOI 10.1128/JVI.02236-06; Sanchez-Ruiz J M, 1995, Subcell Biochem, V24, P133; Shapiro HM, 2003, PRACTICAL FLOW CYTOM; Sheval EV, 2005, EUR J HISTOCHEM, V49, P117; STOHLMAN SA, 1988, J VIROL, V62, P4288, DOI 10.1128/JVI.62.11.4288-4295.1988; Sung JY, 2010, PEDIATR INFECT DIS J, V29, P822, DOI [10.1097/INF.0b013e3181e7c18d, 10.1097/INF.0b013e3181de9c2e]; Surjit M, 2006, J BIOL CHEM, V281, P10669, DOI 10.1074/jbc.M509233200; Surjit M, 2004, BIOCHEM J, V383, P13, DOI 10.1042/BJ20040984; Takeda M, 2008, J MOL BIOL, V380, P608, DOI 10.1016/j.jmb.2007.11.093; Tang TK, 2005, PROTEOMICS, V5, P925, DOI 10.1002/pmic.200401204; Timani KA, 2005, VIRUS RES, V114, P23, DOI 10.1016/j.virusres.2005.05.007; Tresnan DB, 1996, J VIROL, V70, P8669, DOI 10.1128/JVI.70.12.8669-8674.1996; TYRRELL DAJ, 1965, BMJ-BRIT MED J, V1, P1467, DOI 10.1136/bmj.1.5448.1467; van der Hoek L, 2005, PLOS MED, V2, P764, DOI 10.1371/journal.pmed.0020240; van der Hoek L, 2004, NAT MED, V10, P368, DOI 10.1038/nm1024; Wang YL, 2004, BIOCHEMISTRY-US, V43, P11103, DOI 10.1021/bi049194b; Woo PCY, 2005, J VIROL, V79, P884, DOI 10.1128/JVI.79.2.884-895.2005; Wu PS, 2008, EUR J PEDIATR, V167, P75, DOI 10.1007/s00431-007-0429-8; Wurm T, 2001, J VIROL, V75, P9345, DOI 10.1128/JVI.75.19.9345-9356.2001; YEAGER CL, 1992, NATURE, V357, P420, DOI 10.1038/357420a0; You JH, 2007, BIOCHEM BIOPH RES CO, V358, P1015, DOI 10.1016/j.bbrc.2007.05.036; You JW, 2005, J GEN VIROL, V86, P3303, DOI 10.1099/vir.0.81076-0; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhao G, 2006, CELL BIOL TOXICOL, V22, P313, DOI 10.1007/s10565-006-0077-1; Zhou B, 2008, J VIROL, V82, P6962, DOI 10.1128/JVI.00133-08; Zuniga S, 2007, VIROLOGY, V357, P215, DOI 10.1016/j.virol.2006.07.046; Zuniga S, 2010, J VIROL, V84, P2169, DOI 10.1128/JVI.02011-09	82	18	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0117833	10.1371/journal.pone.0117833	http://dx.doi.org/10.1371/journal.pone.0117833			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25700263	gold, Green Submitted, Green Published			2022-12-26	WOS:000349789800029
J	Bessonov, N; Levin, M; Morozova, N; Reinberg, N; Tosenberger, A; Volpert, V				Bessonov, Nikolai; Levin, Michael; Morozova, Nadya; Reinberg, Natalia; Tosenberger, Alen; Volpert, Vitaly			On a Model of Pattern Regeneration Based on Cell Memory	PLOS ONE			English	Article							MORPHOGENETIC FIELDS; ORGANIZATION; BEHAVIOR	We present here a new model of the cellular dynamics that enable regeneration of complex biological morphologies. Biological cell structures are considered as an ensemble of mathematical points on the plane. Each cell produces a signal which propagates in space and is received by other cells. The total signal received by each cell forms a signal distribution defined on the cell structure. This distribution characterizes the geometry of the cell structure. If a part of this structure is removed, the remaining cells have two signals. They keep the value of the signal which they had before the amputation (memory), and they receive a new signal produced after the amputation. Regeneration of the cell structure is stimulated by the difference between the old and the new signals. It is stopped when the two signals coincide. The algorithm of regeneration contains certain rules which are essential for its functioning, being the first quantitative model of cellular memory that implements regeneration of complex patterns to a specific target morphology. Correct regeneration depends on the form and the size of the cell structure, as well as on some parameters of regeneration.	[Bessonov, Nikolai; Reinberg, Natalia] Russian Acad Sci, Inst Problems Mech Engn, St Petersburg 199178, Russia; [Levin, Michael] Tufts Univ, Tufts Ctr Regenerat Dev Biol, Dept Biol, Medford, MA 02155 USA; [Morozova, Nadya] CEA, CNRS, Lab Epigenet & Canc, FRE 3377, F-91191 Saclay, France; [Morozova, Nadya; Tosenberger, Alen] Inst Hautes Etud Sci, F-91440 Bures Sur Yvette, France; [Volpert, Vitaly] Univ Lyon 1, CNRS, Inst Camille Jordan, UMR 5208, F-69622 Villeurbanne, France	Russian Academy of Sciences; Tufts University; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Ecole Centrale de Lyon; Institut National des Sciences Appliquees de Lyon - INSA Lyon; Universite Jean Monnet	Volpert, V (corresponding author), Univ Lyon 1, CNRS, Inst Camille Jordan, UMR 5208, F-69622 Villeurbanne, France.	volpert@math.univ-lyon1.fr	Levin, Michael/A-5918-2011; Volpert, Vitaly/E-2969-2019; Reinberg, Natalia/D-6201-2016	Levin, Michael/0000-0001-7292-8084; Reinberg, Natalia/0000-0002-9475-0632; Tosenberger, Alen/0000-0002-9255-7177	National Institutes of Health, NIH [R03 HD81401-01, 1R01HD081326-01]; G. Harold and Leila Y. Mathers Charitable Foundation; NSF [CDI EF-1124651]; Keck foundation; Agence National de la Recherch [ANR-2010-BLAN-0107-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD081326, R03HD081401] Funding Source: NIH RePORTER	National Institutes of Health, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); G. Harold and Leila Y. Mathers Charitable Foundation; NSF(National Science Foundation (NSF)); Keck foundation(W.M. Keck Foundation); Agence National de la Recherch(French National Research Agency (ANR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	ML was supported by the National Institutes of Health, NIH R03 HD81401-01, 1R01HD081326-01; The G. Harold and Leila Y. Mathers Charitable Foundation; NSF CDI EF-1124651; W.M. Keck foundation. VV was supported by Agence National de la Recherch, ANR-2010-BLAN-0107-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Applewhite P.B., 1975, Advances behav Biol, V13, P131; Astor JC, 2000, ARTIF LIFE, V6, P189, DOI 10.1162/106454600568834; Baddour JA, 2012, BIRTH DEFECTS RES C, V96, P1, DOI 10.1002/bdrc.21006; Badugu A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00991; Beane WS, 2011, CHEM BIOL, V18, P77, DOI 10.1016/j.chembiol.2010.11.012; BELINTSEV BN, 1987, J THEOR BIOL, V129, P369, DOI 10.1016/S0022-5193(87)80019-X; Birnbaum KD, 2008, CELL, V132, P697, DOI 10.1016/j.cell.2008.01.040; Casadesus J, 2002, BIOESSAYS, V24, P512, DOI 10.1002/bies.10102; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Deutsch A, 2005, CELLULAR AUTOMATON M; Economou AD, 2012, NAT GENET, V44, P348, DOI 10.1038/ng.1090; Eisenstein E. M., 1975, ANEURAL ORGANISMS NE; Hamilton T.C., 1975, Advances behav Biol, V13, P111; Hampton AN, 2004, Artificial Life IX, P438; Kragl M, 2008, COLD SH Q B, V73, P583, DOI 10.1101/sqb.2008.73.034; Kragl M, 2009, NATURE, V460, P60, DOI 10.1038/nature08152; Kusch I, 1996, J THEOR BIOL, V178, P333, DOI 10.1006/jtbi.1996.0029; Levin M, 2014, J PHYSL, V592, DOI [10.1113/jphysiol.2014, DOI 10.1113/JPHYSIOL.2014]; Levin M, 2012, BIOSYSTEMS, V109, P243, DOI 10.1016/j.biosystems.2012.04.005; Levin M, 2012, ANNU REV BIOMED ENG, V14, P295, DOI [10.1146/annurev-bioeng-071811-150114, 10.1146/annurev.bioeng-071811-150114]; Levin M, 2011, REGEN MED, V6, P667, DOI [10.2217/RME.11.69, 10.2217/rme.11.69]; Maden Malcolm, 2008, V461, P467, DOI 10.1007/978-1-60327-483-8_32; Meinhardt H, 2008, CURR TOP DEV BIOL, V81, P1, DOI 10.1016/S0070-2153(07)81001-5; Nakagaki T, 2001, RES MICROBIOL, V152, P767, DOI 10.1016/S0923-2508(01)01259-1; Oviedo NJ, 2010, DEV BIOL, V339, P188, DOI 10.1016/j.ydbio.2009.12.012; Rauch EM, 2004, J THEOR BIOL, V226, P401, DOI 10.1016/j.jtbi.2003.09.018; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P725, DOI 10.1146/annurev.cellbio.20.010403.095114; Schiffmann Y, 2007, PROG BIOPHYS MOL BIO, V95, P50, DOI 10.1016/j.pbiomolbio.2007.03.001; Stocum DL, 2011, DEV DYNAM, V240, P943, DOI 10.1002/dvdy.22553; Vandenberg LN, 2012, DEV DYNAM, V241, P863, DOI 10.1002/dvdy.23770	30	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0118091	10.1371/journal.pone.0118091	http://dx.doi.org/10.1371/journal.pone.0118091			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695252	Green Submitted, Green Published, gold			2022-12-26	WOS:000350062300041
J	Jiang, Z; Li, C; Manuel, ML; Yuan, S; Kevil, CG; McCarter, KD; Lu, W; Sun, H				Jiang, Zheng; Li, Chun; Manuel, Morganne L.; Yuan, Shuai; Kevil, Christopher G.; McCarter, Kimberly D.; Lu, Wei; Sun, Hong			Role of Hydrogen Sulfide in Early Blood-Brain Barrier Disruption following Transient Focal Cerebral Ischemia	PLOS ONE			English	Article							NITRIC-OXIDE; SIGNALING MOLECULE; SYNTHASE CBS; H2S; VASORELAXANT; RELAXATION; INHIBITORS; PROTECTS; STROKE; INJURY	We determined the role of endogenous hydrogen sulfide (H2S) in cerebral vasodilation/hyperemia and early BBB disruption following ischemic stroke. A cranial window was prepared over the left frontal, parietal and temporal cortex in mice. Transient focal cerebral Ischemia was induced by directly ligating the middle cerebral artery (MCA) for two hours. Regional vascular response and cerebral blood flow (CBF) during ischemia and reperfusion were measured in real time. Early BBB disruption was assessed by Evans Blue (EB) and sodium fluorescein (Na-F) extravasation at 3 hours of reperfusion. Topical treatment with DL-pro-pargylglycine (PAG, an inhibitor for cystathionine. gamma-lyase (CSE)) and aspartate (ASP, inhibitor for cysteine aminotransferase/3-mercaptopyruvate sulfurtransferase (CAT/3-MST)), but not O-(Carboxymethyl) hydroxylamine hemihydrochloride (CHH, an inhibitor for cystathionine beta-synthase (CBS)), abolished postischemic cerebral vasodilation/hyperemia and prevented EB and Na-F extravasation. CSE knockout (CSE-/-) reduced postischemic cerebral vasodilation/hyperemia but only inhibited Na-F extravasation. An upregulated CBS was found in cerebral cortex of CSE-/- mice. Topical treatment with CHH didn't further alter postischemic cerebral vasodilation/hyperemia, but prevented EB extravasation in CSE-/- mice. In addition, L-cysteine-induced hydrogen sulfide (H2S) production similarly increased in ischemic side cerebral cortex of control and CSE-/- mice. Our findings suggest that endogenous production of H2S by CSE and CAT/3-MST during reperfusion may be involved in postischemic cerebral vasodilation/hyperemia and play an important role in early BBB disruption following transient focal cerebral ischemia.	[Jiang, Zheng; Li, Chun; Manuel, Morganne L.; Yuan, Shuai; McCarter, Kimberly D.; Lu, Wei; Sun, Hong] Louisiana State Univ, Hlth Sci Ctr Shreveport, Dept Cellular Biol & Anat, Shreveport, LA 71105 USA; [Kevil, Christopher G.] Louisiana State Univ, Hlth Sci Ctr Shreveport, Dept Pathol, Shreveport, LA 71105 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Sun, H (corresponding author), Louisiana State Univ, Hlth Sci Ctr Shreveport, Dept Cellular Biol & Anat, Shreveport, LA 71105 USA.	hsun1@lsuhsc.edu	Yuan, Shuai/AAU-3108-2020; Yuan, Shuai/N-9282-2018	Yuan, Shuai/0000-0002-9590-6555; Yuan, Shuai/0000-0002-9590-6555; Kevil, Christopher/0000-0003-0863-7260	National Institutes of Health [HL113303]; Louisiana State University Health Sciences Center-Shreveport; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113303] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana State University Health Sciences Center-Shreveport; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by a National Institutes of Health Grant (HL113303) to CGK, and by start-up funds from Louisiana State University Health Sciences Center-Shreveport to HS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asimakopoulou A, 2013, BRIT J PHARMACOL, V169, P922, DOI 10.1111/bph.12171; Belayev L, 1996, BRAIN RES, V739, P88, DOI 10.1016/S0006-8993(96)00815-3; Bleilevens C, 2013, EXP BRAIN RES, V224, P155, DOI 10.1007/s00221-012-3296-0; Bucci M, 2009, EUR UROL, V56, P378, DOI 10.1016/j.eururo.2008.05.014; Chen B, 2009, STROKE, V40, pE666, DOI 10.1161/STROKEAHA.109.551341; Cheng YQ, 2004, AM J PHYSIOL-HEART C, V287, pH2316, DOI 10.1152/ajpheart.00331.2004; Chitnis MK, 2013, EXP EYE RES, V116, P350, DOI 10.1016/j.exer.2013.10.004; Desilles JP, 2013, NEUROLOGY, V80, P844, DOI 10.1212/WNL.0b013e31828406de; Dufton N, 2012, SCI REP-UK, V2, DOI 10.1038/srep00499; Fiorucci S, 2005, HEPATOLOGY, V42, P539, DOI 10.1002/hep.20817; Gheibi S, 2014, J MOL NEUROSCIENCE M; Hosoki R, 1997, BIOCHEM BIOPH RES CO, V237, P527, DOI 10.1006/bbrc.1997.6878; Jiang Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093134; Kabil O, 2011, ANTIOXID REDOX SIGN, V15, P363, DOI 10.1089/ars.2010.3781; Kimura H, 2012, ANTIOXID REDOX SIGN, V17, P45, DOI 10.1089/ars.2011.4345; Latour LL, 2004, ANN NEUROL, V56, P468, DOI 10.1002/ana.20199; Liu X, 2010, NEUROL SCI, V31, P699, DOI 10.1007/s10072-010-0241-5; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Madden JA, 2012, J APPL PHYSIOL, V112, P411, DOI 10.1152/japplphysiol.01049.2011; MALINSKI T, 1993, J CEREBR BLOOD F MET, V13, P355, DOI 10.1038/jcbfm.1993.48; Mustafa AK, 2011, CIRC RES, V109, P1259, DOI 10.1161/CIRCRESAHA.111.240242; Perez-Asensio FJ, 2010, J CEREBR BLOOD F MET, V30, P638, DOI 10.1038/jcbfm.2009.237; Polhemus DJ, 2014, CIRC RES, V114, P730, DOI 10.1161/CIRCRESAHA.114.300505; Qu K, 2008, NEUROCHEM INT, V52, P155, DOI 10.1016/j.neuint.2007.05.016; Qu K, 2006, STROKE, V37, P889, DOI 10.1161/01.STR.0000204184.34946.41; Robert K, 2003, J HISTOCHEM CYTOCHEM, V51, P363, DOI 10.1177/002215540305100311; Shatalin K, 2011, SCIENCE, V334, P986, DOI 10.1126/science.1209855; Shibuya N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2371; Shibuya N, 2009, J BIOCHEM, V146, P623, DOI 10.1093/jb/mvp111; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]; TOMINAGA T, 1994, J CEREBR BLOOD F MET, V14, P715, DOI 10.1038/jcbfm.1994.92; Wang Y, 2014, J NEUROCHEMISTRY; Wang YF, 2008, CHINESE MED J-PEKING, V121, P420, DOI 10.1097/00029330-200803010-00010; Wong PTH, 2006, J NEUROPATH EXP NEUR, V65, P109, DOI 10.1097/01.jnen.0000199571.96472.c7; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Yin J, 2013, BRAIN RES, V1491, P188, DOI 10.1016/j.brainres.2012.10.046; Zhao H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067322; Zhao WM, 2002, AM J PHYSIOL-HEART C, V283, pH474, DOI 10.1152/ajpheart.00013.2002; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008	39	35	37	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0117982	10.1371/journal.pone.0117982	http://dx.doi.org/10.1371/journal.pone.0117982			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695633	Green Published, gold, Green Submitted			2022-12-26	WOS:000350062300036
J	Tjelele, J; Ward, D; Dziba, L				Tjelele, Julius; Ward, David; Dziba, Luthando			The Effects of Seed Ingestion by Livestock, Dung Fertilization, Trampling, Grass Competition and Fire on Seedling Establishment of Two Woody Plant Species	PLOS ONE			English	Article							LARGE MAMMALIAN HERBIVORES; BUSH ENCROACHMENT; BRUCHID BEETLES; AFRICAN SAVANNA; ACACIA; TREE; RECRUITMENT; GERMINATION; DYNAMICS; GROWTH	The increasing rate of woody plant encroachment in grasslands or savannas remains a challenge to livestock farmers. The causes and control measures of woody plant encroachment are of common interest, especially where it negatively affects the objectives of an agricultural enterprise. The objectives of this study were to determine the effects of gut passage (goats, cattle), dung (nutrients), fire, grass competition and trampling on establishment of A. nilotica and D. cinerea seedlings. Germination trials were subjected to the following treatments: 1) seed passage through the gut of cattle and goats and unpassed/untreated seeds (i.e. not ingested), 2) dung and control (no dung), 3) grass and control (mowed grass), 4) fire and control (no fire), 5) trampling and control (no trampling). The interaction of animal species, grass and fire had an effect on seedling recruitment (P < 0.0052). Seeds retrieved from goats and planted with no grass and with fire (6.81% +/- 0.33) had a significant effect on seedling recruitment than seeds retrieved from goats and planted with grass and no fire (2.98% +/- 0.33). Significantly more D. cinerea and A. nilotica seeds germinated following seed ingestion by goats (3.59% +/- 0.16) than cattle (1.93% +/- 0.09) and control or untreated seeds (1.69% +/- 0.11). Less dense grass cover, which resulted in reduced grass competition with tree seedlings for light, space and water, and improved seed scarification due to gut passage were vital for emergence and recruitment of Acacia seedlings. These results will contribute considerably to the understanding of the recruitment phase of woody plant encroachment.	[Tjelele, Julius] Agr Res Council, Anim Prod Inst, ZA-0062 Irene, South Africa; [Tjelele, Julius; Ward, David] Univ KwaZulu Natal, Coll Agr Engn & Sci, Sch Life Sci, ZA-3209 Scottsville, South Africa; [Dziba, Luthando] CSIR Nat Resources & Environm, ZA-0001 Pretoria, South Africa	Agricultural Research Council of South Africa; Animal Production Research Institute, Agricultural Research Council; University of Kwazulu Natal; Council for Scientific & Industrial Research (CSIR) - South Africa	Tjelele, J (corresponding author), Agr Res Council, Anim Prod Inst, ZA-0062 Irene, South Africa.	jtjelele@arc.agric.za		Dziba, Luthando/0000-0001-6974-5578	International Foundation for Science [D/5131-1]; National Research Foundation [80709]	International Foundation for Science(International Foundation for Science); National Research Foundation	This work was supported by International Foundation for Science, Grant No. D/5131-1 (www.ifs.seTJ), and National Research Foundation, Grant No. 80709 (http://www.nrf.ac.za/TJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bodmer Richard, 2006, Conservation Biology Series (Cambridge), V11, P232; Brown J, 2010, APPL SOIL ECOL, V46, P9, DOI 10.1016/j.apsoil.2010.05.010; BROWN JR, 1988, VEGETATIO, V73, P73, DOI 10.1007/BF00031854; BROWN N. A. C, 1967, S AFR J AGR SCI, V10, P659; BUSH JK, 1995, ECOLOGY, V76, P1603, DOI 10.2307/1938161; Campbell ML, 2006, AUSTRAL ECOL, V31, P1016, DOI 10.1111/j.1442-9993.2006.01660.x; COE M, 1987, S AFR J SCI, V83, P624; COFFIN DP, 1990, ECOL MODEL, V49, P229, DOI 10.1016/0304-3800(90)90029-G; COUGHENOUR MB, 1986, AFR J ECOL, V24, P203, DOI 10.1111/j.1365-2028.1986.tb00363.x; Cramer MD, 2007, J ECOL, V95, P1123, DOI 10.1111/j.1365-2745.2007.01285.x; Danell K, 2003, FOREST ECOL MANAG, V181, P67, DOI 10.1016/S0378-1127(03)00116-6; DINERSTEIN E, 1988, ECOLOGY, V69, P1768, DOI 10.2307/1941155; Frost PGH, 1986, BIOL INT SPEC ISSUE, V10, P1; GARDENER CJ, 1993, J APPL ECOL, V30, P63, DOI 10.2307/2404271; GIFFORD GF, 1983, J RANGE MANAGE, V36, P152, DOI 10.2307/3898150; Goheen JR, 2010, J ANIM ECOL, V79, P372, DOI 10.1111/j.1365-2656.2009.01644.x; Grellier S, 2012, PLANT ECOL, V213, P899, DOI 10.1007/s11258-012-0051-3; Henery ML, 2001, OIKOS, V92, P479, DOI 10.1034/j.1600-0706.2001.920309.x; HERRERA CM, 1994, ECOL MONOGR, V64, P315, DOI 10.2307/2937165; Hoffman T., 2001, NATURE DIVIDED LAND; James JJ, 2011, J APPL ECOL, V48, P961, DOI 10.1111/j.1365-2664.2011.02009.x; JANZEN DH, 1984, AM NAT, V123, P338, DOI 10.1086/284208; Jeltsch F, 1996, J ECOL, V84, P583, DOI 10.2307/2261480; Kambatuku JR, 2011, J VEG SCI, V22, P225, DOI 10.1111/j.1654-1103.2010.01239.x; Kgosikoma O. E., 2012, African Journal of Agricultural Research, V7, P2312; KNOOP WT, 1985, J ECOL, V73, P235, DOI 10.2307/2259780; Kraaij T, 2006, PLANT ECOL, V186, P235, DOI 10.1007/s11258-006-9125-4; Kumbasli M, 2010, J ENVIRON BIOL, V31, P185; Leishman M. R., 2000, Seeds: the ecology of regeneration in plant communities, P31, DOI 10.1079/9780851994321.0031; Little TM, 1972, STAT METHODS AGR RES; Maclean JE, 2011, ECOLOGY, V92, P1626, DOI 10.1890/10-2097.1; MCNAUGHTON SJ, 1983, OIKOS, V40, P329, DOI 10.2307/3544305; Meyer SE, 2005, PLANT ECOL, V178, P171, DOI 10.1007/s11258-004-3038-x; MILLER MF, 1995, AFR J ECOL, V33, P194, DOI 10.1111/j.1365-2028.1995.tb00797.x; Moles AT, 2005, SCIENCE, V307, P576, DOI 10.1126/science.1104863; Moles AT, 2002, OIKOS, V99, P241, DOI 10.1034/j.1600-0706.2002.990204.x; Mucina L., 2006, VEGETATION S AFRICA; OCONNOR TG, 1995, OECOLOGIA, V103, P214, DOI 10.1007/BF00329083; Or K, 2007, ENTOMOL EXP APPL, V122, P165, DOI 10.1111/j.1570-7458.2006.00509.x; Or K, 2003, AFR J ECOL, V41, P257, DOI 10.1046/j.1365-2028.2003.00451.x; Rodriguez-Perez J, 2011, OECOLOGIA, V167, P97, DOI 10.1007/s00442-011-1964-6; Rohner C, 1999, CONSERV BIOL, V13, P1162, DOI 10.1046/j.1523-1739.1999.97300.x; Sankaran M, 2004, ECOL LETT, V7, P480, DOI 10.1111/j.1461-0248.2004.00596.x; SAS Institute, 2002, SAS STAT US GUID VER, VSixth; SCHUPP EW, 1995, ECOSCIENCE, V2, P267, DOI 10.1080/11956860.1995.11682293; Schwinning S, 2002, OECOLOGIA, V130, P345, DOI 10.1007/s00442-001-0817-0; Seabloom EW, 2003, ECOL APPL, V13, P575, DOI 10.1890/1051-0761(2003)013[0575:CSLDAR]2.0.CO;2; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Sharam G, 2006, BIOTROPICA, V38, P599, DOI 10.1111/j.1744-7429.2006.00195.x; SNEDECOR G W, 1980; Tjelele J, 2014, RANGELAND ECOL MANAG, V67, P423, DOI 10.2111/REM-D-13-00115.1; Tjelele JT, 2012, RANGELAND ECOL MANAG, V65, P105, DOI 10.2111/REM-D-09-00161.1; Traveset A, 2001, PLANT ECOL, V155, P29, DOI 10.1023/A:1013282313035; Turnbull LA, 1999, J ECOL, V87, P899, DOI 10.1046/j.1365-2745.1999.00405.x; VALENTIN C, 1992, GEODERMA, V55, P225, DOI 10.1016/0016-7061(92)90085-L; Van Auken OW, 2009, J ENVIRON MANAGE, V90, P2931, DOI 10.1016/j.jenvman.2009.04.023; WALTER HEINRICH, 1939, JAHRB WISS BOT, V87, P750; Ward D., 2005, African Journal of Range & Forage Science, V22, P101, DOI 10.2989/10220110509485867; Ward D, 2013, S AFR J BOT, V86, P141, DOI [10.1016/j.sajb.2013.02.016, 10.1007/s00442-012-2538-y]; Weitbrecht K, 2011, J EXP BOT, V62, P3289, DOI 10.1093/jxb/err030; Westoby M, 1996, PHILOS T R SOC B, V351, P1309, DOI 10.1098/rstb.1996.0114; Wiegand K, 2006, PERSPECT PLANT ECOL, V7, P229, DOI 10.1016/j.ppees.2005.10.001; Wiegand K, 2005, J VEG SCI, V16, P311, DOI 10.1111/j.1654-1103.2005.tb02369.x; Wigley BJ, 2009, AFR J ECOL, V47, P62, DOI 10.1111/j.1365-2028.2008.01051.x; Wigley BJ, 2010, GLOBAL CHANGE BIOL, V16, P964, DOI 10.1111/j.1365-2486.2009.02030.x; Wilson TB, 1998, J ARID ENVIRON, V38, P541, DOI 10.1006/jare.1998.0362	66	20	21	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0117788	10.1371/journal.pone.0117788	http://dx.doi.org/10.1371/journal.pone.0117788			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695765	gold, Green Published, Green Submitted			2022-12-26	WOS:000350062300030
J	Han, SB; Yang, HK; Kim, J; Hong, K; Lee, B; Hwang, JM				Han, Sang Beom; Yang, Hee Kyung; Kim, Jonghyun; Hong, Keehoon; Lee, Byoungho; Hwang, Jeong-Min			New Stereoacuity Test Using a 3-Dimensional Display System in Children	PLOS ONE			English	Article							RANDOM-DOT STEREOTEST; RETINAL ILLUMINANCE; FIXATION DISPARITY; SPATIAL-FREQUENCY; STEREOPSIS; ACCOMMODATION; STIMULI	The previously developed 3-dimensional (3D) display stereoacuity tests were validated only at distance. We developed a new stereoacuity test using a 3D display that works both at near and distance and evaluated its validity in children with and without strabismus. Sixty children (age range, 6 to 18 years) with variable ranges of stereoacuity were included. Sideby- side randot images of 4 different simple objects (star, circle, rectangle, and triangle) with a wide range of crossed horizontal disparities (3000 to 20 arcsec) were randomly displayed on a 3D monitor with MATLAB (Matworks, Inc., Natick, MA, USA) and were presented to subjects wearing shutter glasses at 0.5 m and 3 m. The 3D image was located in front of (conventional) or behind (proposed) the background image on the 3D monitor. The results with the new 3D stereotest (conventional and proposed) were compared with those of the near and distance Randot stereotests. At near, the Bland-Altman plots of the conventional and proposed 3D stereotest did not show significant difference, both of which were poorer than the Randot test. At distance, the results of the proposed 3D stereotest were similar to the Randot test, but the conventional 3D stereotest results were better than those of the other two tests. The results of the proposed 3D stereotest and Randot stereotest were identical in 83.3% at near and 88.3% at distance. More than 95% of subjects showed concordance within 2 grades between the 2 tests at both near and distance. In conclusion, the newly proposed 3D stereotest shows good concordance with the Randot stereotests in children with and without strabismus.	[Han, Sang Beom] Kangwon Natl Univ, Kangwon Natl Univ Hosp, Grad Sch Med, Dept Ophthalmol, Chunchon, South Korea; [Yang, Hee Kyung; Hwang, Jeong-Min] Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Ophthalmol, Seoul, South Korea; [Kim, Jonghyun; Hong, Keehoon; Lee, Byoungho] Seoul Natl Univ, Sch Elect Engn, Seoul, South Korea	Kangwon National University; Kangwon National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Lee, B (corresponding author), Seoul Natl Univ, Sch Elect Engn, Seoul, South Korea.	byoungho@snu.ac.kr; hjm@snu.ac.kr		hong, keehoon/0000-0001-7325-1036	Interdisciplinary Research Initiatives Program by College of Engineering and College of Medicine, Seoul National University	Interdisciplinary Research Initiatives Program by College of Engineering and College of Medicine, Seoul National University	This work was supported by the Interdisciplinary Research Initiatives Program by College of Engineering and College of Medicine, Seoul National University (2012). The funder partly had a role in the development of the new stereoacuity test using a 3-dimensional display system, but had no other role in data collection and analysis, decision to publish, or preparation of the manuscript.	Adams WE, 2005, BRIT J OPHTHALMOL, V89, P1438, DOI 10.1136/bjo.2005.071761; Adams WE, 2009, OPHTHALMOLOGY, V116, P281, DOI 10.1016/j.ophtha.2008.09.012; Breyer A, 2006, INVEST OPHTH VIS SCI, V47, P4842, DOI 10.1167/iovs.06-0238; Chang YH, 2006, GRAEF ARCH CLIN EXP, V244, P1083, DOI 10.1007/s00417-005-0196-z; Fawcett SL, 2005, J AAPOS, V9, P572, DOI 10.1016/j.jaapos.2005.06.006; Fujikado T, 1998, JPN J OPHTHALMOL, V42, P101, DOI 10.1016/S0021-5155(97)00120-2; Fujikado T, 1996, ERGONOMICS, V39, P1315, DOI 10.1080/00140139608964551; Howard IP, 1995, BINOCULAR VISION STE; Jainta S, 2009, OPHTHAL PHYSL OPT, V29, P162, DOI 10.1111/j.1475-1313.2008.00624.x; Jaschinski W, 2001, VISION RES, V41, P923, DOI 10.1016/S0042-6989(00)00322-9; Kim J, J DISP TECH; Kim J, 2011, AM J OPHTHALMOL, V151, P1081, DOI 10.1016/j.ajo.2010.09.034; Kriegbaum-Stehberger B, 2008, GRAEF ARCH CLIN EXP, V246, P1, DOI 10.1007/s00417-007-0632-3; LEGGE GE, 1989, VISION RES, V29, P989, DOI 10.1016/0042-6989(89)90114-4; Leske DA, 2006, AM J OPHTHALMOL, V142, P699, DOI 10.1016/j.ajo.2006.04.065; LOVASIK JV, 1985, INVEST OPHTH VIS SCI, V26, P741; Okada Y, 2006, VISION RES, V46, P475, DOI 10.1016/j.visres.2005.07.014; SCHMIDT PP, 1994, OPTOMETRY VISION SCI, V71, P466, DOI 10.1097/00006324-199407000-00007; SIDEROV J, 1995, VISION RES, V35, P2329, DOI 10.1016/0042-6989(94)00307-8; Suzuki D, 2009, 2009 SID INTERNATIONAL SYMPOSIUM DIGEST OF TECHNICAL PAPERS, VOL XL, BOOKS I - III, P428; Wang JY, 2010, J AAPOS, V14, P142, DOI 10.1016/j.jaapos.2009.12.159; Woods A., 2010, 3 DIM SYST APPL C TO; Zaroff CM, 2003, INVEST OPHTH VIS SCI, V44, P891, DOI 10.1167/iovs.02-0361	23	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0116626	10.1371/journal.pone.0116626	http://dx.doi.org/10.1371/journal.pone.0116626			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693034	Green Published, gold, Green Submitted			2022-12-26	WOS:000350061500021
J	Luo, S; Hipler, UC; Munzberg, C; Skerka, C; Zipfel, PF				Luo, Shanshan; Hipler, Uta-Christina; Muenzberg, Christin; Skerka, Christine; Zipfel, Peter F.			Sequence Variations and Protein Expression Levels of the Two Immune Evasion Proteins Gpm1 and Pra1 Influence Virulence of Clinical Candida albicans Isolates	PLOS ONE			English	Article							COMPLEMENT FACTOR-H; BINDING SURFACE PROTEIN; PH-REGULATED ANTIGEN; IN-VITRO; BORRELIA-BURGDORFERI; PLASMINOGEN; GENE; MORTALITY; FAMILY; IDENTIFICATION	Candida albicans, the important human fungal pathogen uses multiple evasion strategies to control, modulate and inhibit host complement and innate immune attack. Clinical C. albicans strains vary in pathogenicity and in serum resistance, in this work we analyzed sequence polymorphisms and variations in the expression levels of two central fungal complement evasion proteins, Gpm1 (phosphoglycerate mutase 1) and Pra1 (pH-regulated antigen 1) in thirteen clinical C. albicans isolates. Four nucleotide (nt) exchanges, all representing synonymous exchanges, were identified within the 747-nt long GPM1 gene. For the 900-nt long PRA1 gene, sixteen nucleotide exchanges were identified, which represented synonymous, as well as non-synonymous exchanges. All thirteen clinical isolates had a homozygous exchange (A to G) at position 73 of the PRA1 gene. Surface levels of Gpm1 varied by 8.2, and Pra1 levels by 3.3 fold in thirteen tested isolates and these differences influenced fungal immune fitness. The high Gpm1/Pra1 expressing candida strains bound the three human immune regulators more efficiently, than the low expression strains. The difference was 44% for Factor H binding, 51% for C4BP binding and 23% for plasminogen binding. This higher Gpm1/Pra1 expressing strains result in enhanced survival upon challenge with complement active, Factor H depleted human serum (difference 40%). In addition adhesion to and infection of human endothelial cells was increased (difference 60%), and C3b surface deposition was less effective (difference 27%). Thus, variable expression levels of central immune evasion protein influences immune fitness of the human fungal pathogen C. albicans and thus contribute to fungal virulence.	[Luo, Shanshan; Muenzberg, Christin; Skerka, Christine; Zipfel, Peter F.] Hans Knoell Inst, Leibniz Inst Nat Product Res & Infect Biol, Dept Infect Biol, Jena, Germany; [Hipler, Uta-Christina] Friedrich Schiller Univ Hosp, Clin Dermatol & Allergol, Jena, Germany; [Zipfel, Peter F.] Univ Jena, Jena, Germany	Hans Knoll Institute (HKI); Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Zipfel, PF (corresponding author), Hans Knoell Inst, Leibniz Inst Nat Product Res & Infect Biol, Dept Infect Biol, Jena, Germany.	peter.zipfel@hki-jena.de	Luo, Shanshan/D-6050-2015		Deutsche Forschungsgemeinschaft, DFG Priority Program [SPP 1161]; Funginet [Zi 432]	Deutsche Forschungsgemeinschaft, DFG Priority Program(German Research Foundation (DFG)); Funginet	This work was support by the Deutsche Forschungsgemeinschaft, DFG Priority Program SPP 1161 and Funginet (Zi 432). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Valle H, 2003, EUR J CLIN MICROBIOL, V22, P254, DOI 10.1007/s10096-003-0890-x; Alves SH, 2006, MYCOSES, V49, P220, DOI 10.1111/j.1439-0507.2006.01226.x; Behnsen J, 2008, INFECT IMMUN, V76, P820, DOI 10.1128/IAI.01037-07; Citiulo F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002777; Crowe JD, 2003, MOL MICROBIOL, V47, P1637, DOI 10.1046/j.1365-2958.2003.03390.x; Filler SG, 2006, PLOS PATHOG, V2, P1099, DOI 10.1371/journal.ppat.0020129; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Gudlaugsson O, 2003, CLIN INFECT DIS, V37, P1172, DOI 10.1086/378745; Hammerschmidt S, 2007, J IMMUNOL, V178, P5848, DOI 10.4049/jimmunol.178.9.5848; Harriott MM, MICROBIOL-SGM 12, V156, P3635, DOI [10.1099/mic.0.039354-0, DOI 10.1099/MIC.0.039354-0]; Haupt K, 2007, J INFECT DIS, V196, P124, DOI 10.1086/518509; Haupt K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000250; Hellwage J, 1999, FEBS LETT, V462, P345, DOI 10.1016/S0014-5793(99)01554-9; Hunter JC, 1999, ENVIRON MANAGE, V24, P65; Iannelli F, 2002, GENE, V284, P63, DOI 10.1016/S0378-1119(01)00896-4; Iannitti RG, TRENDS IMMUNOL; Johnsson E, 1998, J IMMUNOL, V161, P4894; Jong AY, 2001, INFECT IMMUN, V69, P4536, DOI 10.1128/IAI.69.7.4536-4544.2001; Jozsi M, 2008, BLOOD, V111, P1512, DOI 10.1182/blood-2007-09-109876; Kraiczy P, 2001, EUR J IMMUNOL, V31, P1674, DOI 10.1002/1521-4141(200106)31:6&lt;1674::AID-IMMU1674&gt;3.0.CO;2-2; Kunert A, 2007, J IMMUNOL, V179, P2979, DOI 10.4049/jimmunol.179.5.2979; Lesiak-Markowicz I, 2011, J INFECT DIS, V204, P802, DOI 10.1093/infdis/jir455; Lucidarme J, 2010, CLIN VACCINE IMMUNOL, V17, P919, DOI 10.1128/CVI.00027-10; Luo SS, 2013, J INFECT DIS, V207, P594, DOI 10.1093/infdis/jis718; Luo SS, 2011, J BIOL CHEM, V286, P8021, DOI 10.1074/jbc.M110.130138; Luo SS, 2010, J IMMUNOL, V185, P2164, DOI 10.4049/jimmunol.1001011; Luo SS, 2009, MOL IMMUNOL, V47, P541, DOI 10.1016/j.molimm.2009.07.017; Meri T, 2004, INFECT IMMUN, V72, P6633, DOI 10.1128/IAI.72.11.6633-6641.2004; Meri T, 2002, J INFECT DIS, V185, P1786, DOI 10.1086/340649; Meri T, 2002, INFECT IMMUN, V70, P5185, DOI 10.1128/IAI.70.9.5185-5192.2002; MULLER HJ, 1991, P NATL ACAD SCI USA, V88, P10079, DOI 10.1073/pnas.88.22.10079; Olczak-Kowalczyk D, PEDIAT DENT, V32, P189; Pandiripally V, 2003, INFECT IMMUN, V71, P7119, DOI 10.1128/IAI.71.12.7119-7128.2003; Pappas PG, 2003, CLIN INFECT DIS, V37, P634, DOI 10.1086/376906; PEREZCASAL J, 1993, MOL MICROBIOL, V8, P809, DOI 10.1111/j.1365-2958.1993.tb01628.x; Poltermann S, 2007, J BIOL CHEM, V282, P37537, DOI 10.1074/jbc.M707280200; Schaller M, 2003, INFECT IMMUN, V71, P3227, DOI 10.1128/IAI.71.6.3227-3234.2003; Sentandreu M, 1998, J BACTERIOL, V180, P282, DOI 10.1128/JB.180.2.282-289.1998; SKERKA C, 1991, J BIOL CHEM, V266, P12015; SKERKA C, 1992, J IMMUNOL, V148, P3313; SKERKA C, 1993, J BIOL CHEM, V268, P2904; Skerka C, 1997, J BIOL CHEM, V272, P5627, DOI 10.1074/jbc.272.9.5627; Soloviev DA, 2007, J IMMUNOL, V178, P2038, DOI 10.4049/jimmunol.178.4.2038; Tongchusak S, 2008, MICROBIOL IMMUNOL, V52, P231, DOI 10.1111/j.1348-0421.2008.00032.x; Yamamoto T, RINSHO BYORI, V58, P1027; Zipfel PF, 2007, MOL IMMUNOL, V44, P3850, DOI 10.1016/j.molimm.2007.06.149; Zipfel PF, 2007, ADV EXP MED BIOL, V598, P80; Zipfel PF, 2011, INT J MED MICROBIOL, V301, P423, DOI 10.1016/j.ijmm.2011.04.010; Zipfel PF, 2009, IMMUNOL LETT, V126, P1, DOI 10.1016/j.imlet.2009.07.005; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620; Zipfel PF, 1999, IMMUNOPHARMACOLOGY, V42, P53, DOI 10.1016/S0162-3109(99)00015-6; ZIPFEL PF, 1991, BIOCHEM BIOPH RES CO, V181, P179, DOI 10.1016/S0006-291X(05)81398-1	52	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0113192	10.1371/journal.pone.0113192	http://dx.doi.org/10.1371/journal.pone.0113192			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692293	Green Published, Green Submitted, gold			2022-12-26	WOS:000350061500004
J	Mennecart, B				Mennecart, Bastien			The European Ruminants during the "Microbunodon Event" (MP28, Latest Oligocene): Impact of Climate Changes and Faunal Event on the Ruminant Evolution	PLOS ONE			English	Article							SWISS MOLASSE BASIN; RHINE GRABEN URG; EARLY MIOCENE; LATE EOCENE; MAMMALIA; GENUS; ARTIODACTYLA; EXTINCTIONS; MORPHOLOGY; PHYLOGENY	The Earth already experienced numerous episodes of global warming and cooling. One of the latest impressive events of temperature rising was the Late Oligocene Warming that occurred around 25 Mya. An increase of the marine temperature of 2 to 4 degrees C has been observed in a short time interval. In Europe, this major climatic event can be correlated to the continental faunal turnover "Microbunodon Event". This event is marked by a huge faunal turnover (40% of the ungulate fauna during the first 500k years) and environmental changes. Drier conditions associated to the appearance of the seasonality lead to new environmental conditions dominated by wooded savannahs. This is correlated to a major arrival of Asiatic immigrants. Moreover, from a homogenous fauna during the main part of the Oligocene, local climatic variations between the European Western coast and the more central Europe could have provided faunal regionalism during the latest Oligocene and earliest Miocene. Considering the ruminants, this event is the major ever known for this group in Europe. A total renewal at the family level occurred. Thanks to a precise stratigraphic succession, major evolutionary elements are highlighted. Typical Oligocene species, mainly Tragulina, were adapted to wooded environments and were leaves/fruits eaters. They disappeared at the end of MP27 or the early MP28. This corresponds to the appearance of the Asiatic immigrants. The Tragulina (Lophiomerycidae, Bachitheriidae) and stem Pecora gave way to more derived stem and maybe crown Pecora (e.g. "Amphitragulus", Babameryx, Dremotherium). These newcomers were adapted to more open environments and mixed feeding. The disappearance of the Tragulina is probably linked to environmental and vegetation changes, and competition. They give way to more derived ruminants having a more efficient metabolism in drier conditions and a better assimilation of less energetic food.	[Mennecart, Bastien] UPMC, Univ Paris 04, CNRS,UMR 7207, MNHN,CR2P Ctr Rech Paleobiodiversi & Paleoenviron, F-75005 Paris, France; [Mennecart, Bastien] SNMB Bayer Staatssammlung Palaontol & Geol, Munich, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Mennecart, B (corresponding author), UPMC, Univ Paris 04, CNRS,UMR 7207, MNHN,CR2P Ctr Rech Paleobiodiversi & Paleoenviron, CP38,8 Rue Buffon, F-75005 Paris, France.	mennecartbastien@gmail.com	Mennecart, Bastien/W-4477-2017; Mennecart, B/AAO-8772-2020	Mennecart, Bastien/0000-0002-9669-2907; Mennecart, B/0000-0002-9669-2907	Swiss National Science Foundation [PBFRP2_145900]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study has been funded by the Swiss National Science Foundation project PBFRP2_145900. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar J-P., 1997, MEMOIRES TRAVAUX ECO, V21, P769; Aiglstorfer M, 2013, PALAEOBIO PALAEOENV, V94, P83; Antoine PO, 2011, CR PALEVOL, V10, P239, DOI 10.1016/j.crpv.2011.01.004; Barmann EV, 2011, MAMM BIOL, V76, P762, DOI 10.1016/j.mambio.2011.07.002; Ballmann P., 1970, Mitt. bayer. St. Palaont. Hist. Geol., V10, P271; Beamud E, 2003, EARTH PLANET SC LETT, V216, P501, DOI 10.1016/S0012-821X(03)00539-9; Becker D, 2003, GEOFOCUS, V9, P1; Becker D, 2009, NEUES JAHRB GEOL P-A, V254, P5, DOI 10.1127/0077-7749/2009/0002; Berger F. E., 1959, Palaeontographica, VA 112, P1; Berger J.-P., 2011, GEOCHRONIQUES MAGAZI, V117, P44; Berger JP, 2005, INT J EARTH SCI, V94, P711, DOI 10.1007/s00531-005-0479-y; Berger JP, 2005, INT J EARTH SCI, V94, P697, DOI 10.1007/s00531-005-0475-2; Berger JP, 1998, REV PALAEOBOT PALYNO, V101, P95, DOI 10.1016/S0034-6667(97)00071-7; BERGEROT JL, 1990, IEE CONF PUBL, V317, P189; Berthet Didier, 2003, Documents des Laboratoires de Geologie Lyon, V159, P1; Blondel C, 2005, ZOOL J LINN SOC-LOND, V144, P145, DOI 10.1111/j.1096-3642.2005.00166.x; Blondel C, 1997, GEOBIOS-LYON, V30, P573, DOI 10.1016/S0016-6995(97)80123-4; Blondel C, 1998, CR ACAD SCI II A, V326, P527, DOI 10.1016/S1251-8050(98)80081-5; BOUVRAIN G, 1986, CR ACAD SCI II, V302, P101; Bravard J.-P., 2002, TRAITEMENT VERSANTS, DOI [10.1120/jacmp.v15i6.4957, DOI 10.1120/JACMP.V15I6.4957]; Brunet M., 1987, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V10, P225; Brunet M., 1987, MUNCHNER GEOWISSEN A, V10, P13, DOI DOI 10.1111/GCB.12846; Buechler W, 2003, OLIGOCENE MACROFLORA, DOI [10.1594/PANGAEA.106219, DOI 10.1594/PANGAEA.106219]; Costeur L, 2005, THESIS U C BERNARD L; Croizet JB, 1829, B SCI NATURELLES GEO, V16, P276; De Man E, 2004, NETH J GEOSCI, V83, P227, DOI 10.1017/S0016774600020291; Engesser Burkart, 1997, Memoires et Travaux de l'Institut de Montpellier de l'Ecole Pratique des Hautes Etudes, V21, P475; Engessert B., 1987, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V10, P67; Estes R., 1976, B MUSEUM NATL DHISTO, V398, P297; Estes R., 1981, HDB PALAOHERPETOLO 2; Filhol H, 1887, B SOC PHILOMATIQUE P, V7, P12; Filhol H, 1877, RECHERCHES PHOSPHORI; Franzen Jens Lorenz, 2005, Annales de Paleontologie, V91, P329, DOI 10.1016/j.annpal.2005.04.002; Freudenberg H., 1941, Palaeontographica Stuttgart, V92A, P99; Gabunia L., 1964, OLIGOCENE MAMMALIAN; Gentry Alan W., 1999, P225; Geraads D., 1987, Palaeovertebrata (Montpellier), V17, P43; Gervais P., 1848, ZOOLOGIE PALEONTOLOG, V3; Giraud J, 1902, ETUDE GEOLOGIQUE LIM; Gradstein F.M., 2004, A; Groves C, 2011, UNGULATE TAXONOMY, DOI [10.1007/s13197-011-0356-6, DOI 10.1007/S13197-011-0356-6]; Habicht JKA, 1987, COMMISSION GEOLOGIQU, VI, P1; HARDENBOL J., 1998, SEPM SPECIAL PUBLICA, V160, P763, DOI DOI 10.2110/PEC.98.02.0003; Hartenberger JL, 1970, B SOC GEOLOGIQUE FRA, V7, P879; Heissig K., 1969, Abhandlungen der Bayerischen Akademie der Wissenschaften, V138, P1; Heissig K., 1987, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V10, P101; Hugueney Marguerite, 1997, Memoires et Travaux de l'Institut de Montpellier de l'Ecole Pratique des Hautes Etudes, V21, P417; Janis C.M., 1987, Journal of Vertebrate Paleontology, V7, P200; JANIS CM, 1989, PALAEONTOLOGY, V32, P463; Janis CM., 1987, AM MUS NOVIT, V2893, P1; Jehenne Y., 1977, Geobios Lyon Memoire Special, VNo. 1, P233; Jehenne Y., 1992, Geobios Memoire Special (Villeurbanne), P201; JEHENNE Y, 1988, CR ACAD SCI II, V307, P1991; Jehenne Y., 1987, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V10, P131; Kristkoiz, 1992, ABH BAYER AKAD WI MN, V167, P1; Lavocat R, 1951, REVISION FAUNE MAMMI, DOI [10.1038/ncomms?152, DOI 10.1038/NCOMMS?152]; Legendre S., 1989, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V16, P1; Lihoreau Fabrice, 2007, P89; Londeix Laurent, 2014, P294; Lyddeker R, 1885, CATALOGUE FOSSIL MAM; Malcolm JR, 2006, CONSERV BIOL, V20, P538, DOI 10.1111/j.1523-1739.2006.00364.x; MARTINEZ JN, 1995, LETHAIA, V28, P197, DOI 10.1111/j.1502-3931.1995.tb01423.x; Matthews W. D., 1925, American Museum Novitates, V196, P1; Mennecart B., 2012, GEOFOCUS, V32, P1; Mennecart B, 2012, RUMINANTS ANATOMY BE, P205; Mennecart B, 2015, J SYST PALAEONTOL, V13, P581, DOI 10.1080/14772019.2014.948505; Mennecart Bastien, 2012, Swiss Journal of Palaeontology, V131, P161, DOI 10.1007/s13358-011-0031-6; Mennecart B, 2011, SWISS J GEOSCI, V104, pS115, DOI 10.1007/s00015-010-0034-0; Metais Gregoire, 2007, P189; Miao D, 1982, ACTA PALAEONTOLOGICA, V21, P20; Modden C, 2000, ACTA PALAEONTOL POL, V45, P301; OETTINGEN-SPIELBERG THERESE ZU, 1952, NEUES JAHRB F GEOL U PALAONTOL ABHANDL, V94, P401; Picot L., 2002, GEOFOCUS, V5, P1; Popov SV., 2004, COUR FORSCH I SENCKE, V250, P1; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Prothero D.R., 1994, EOCENE OLIGOCENE TRA; Rage JC, 2005, CR PALEVOL, V4, P428, DOI 10.1016/j.crpv.2005.04.001; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Rossner Gertrud E., 2007, P213; Sanchez IM, 2010, PALAEONTOLOGY, V53, P1023, DOI 10.1111/j.1475-4983.2010.00992.x; Scherler L, 2013, SWISS J GEOSCI, V106, P349, DOI 10.1007/s00015-013-0140-x; Scherler L, 2011, J VERTEBR PALEONTOL, V31, P479, DOI 10.1080/02724634.2011.550360; SCHLEICH H H, 1988, Palaeontologische Zeitschrift, V62, P95; Schlosser M, 1925, SOC SCI NATURELLES C, V38, P372, DOI [10.4196/kjpp.2014.18.6.509, DOI 10.4196/KJPP.2014.18.6.509]; Schlosser M., 1886, MORPHOLOGISCHES JB, V12, P1; Stehlin HG., 1909, B SOC GEOLOGIQUE FRA, V4 e surie, Tome IX:, P488; Stinton F.C., 1979, Eclogae Geologicae Helvetiae, V72, P851; Sudre J., 1984, Palaeovertebrata (Montpellier), V14, P1; SUDRE J, 1986, CR ACAD SCI II, V303, P749; Sudre Jean, 1995, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V236, P205; Tobien H., 1974, Mainzer geowiss. Mitt., V3, P95; Trofimov B. A., 1957, Cursillos y Conferencias Instituto Lucas Mallada de Investigaciones Geologicas, V4, P137; Vandenberghe N, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P855, DOI 10.1016/B978-0-444-59425-9.00028-7; Vianey-Liaud Monique, 2003, Coloquios de Paleontologia Volumen Extraordinario, V1, P669; VIANEYLIAUD M, 1991, PALAEOGEOGR PALAEOCL, V85, P15, DOI 10.1016/0031-0182(91)90023-K; Viret J., 1929, ANN U LYON, V47, P1, DOI DOI 10.1016/J.BMCL.2008.01.089; Vislobokova Inesa, 2002, Annalen des Naturhistorischen Museums in Wien A Mineralogie Petrologie Geologie Palaeontologie Archaeozoologie Anthropologie Praehistorie, V103A, P213; Vislobokova Inesa, 1997, Memoires et Travaux de l'Institut de Montpellier de l'Ecole Pratique des Hautes Etudes, V21, P215; Wehrli H, 1932, NOTIZBL VER ERDK, V5, P101; Weidmann Marc, 2014, Revue de Paleobiologie, V33, P463; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588	102	19	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0116830	10.1371/journal.pone.0116830	http://dx.doi.org/10.1371/journal.pone.0116830			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692298	gold, Green Submitted, Green Published			2022-12-26	WOS:000350061500024
J	Wang, B; Wei, XP; Dong, J; Zhang, Q				Wang, Bin; Wei, Xiaopeng; Dong, Jing; Zhang, Qiang			Improved Lower Bounds of DNA Tags Based on a Modified Genetic Algorithm	PLOS ONE			English	Article							BARCODED PRIMERS; DESIGN; PERFORMANCE; ACCURACY; QUALITY	The well-known massively parallel sequencing method is efficient and it can obtain sequence data from multiple individual samples. In order to ensure that sequencing, replication, and oligonucleotide synthesis errors do not result in tags (or barcodes) that are unrecoverable or confused, the tag sequences should be abundant and sufficiently different. Recently, many design methods have been proposed for correcting errors in data using error-correcting codes. The existing tag sets contain small tag sequences, so we used a modified genetic algorithm to improve the lower bound of the tag sets in this study. Compared with previous research, our algorithm is effective for designing sets of DNA tags. Moreover, the GC content determined by existing methods includes an imprecise range. Thus, we improved the GC content determination method to obtain tag sets that control the GC content in a more precise range. Finally, previous studies have only considered perfect self-complementarity. Thus, we considered the crossover between different tags and introduced an improved constraint into the design of tag sets.	[Wang, Bin; Wei, Xiaopeng; Dong, Jing; Zhang, Qiang] Dalian Univ, Lab Adv Design & Intelligent Comp, Minist Educ, Dalian 116622, Peoples R China	Dalian University	Zhang, Q (corresponding author), Dalian Univ, Lab Adv Design & Intelligent Comp, Minist Educ, Dalian 116622, Peoples R China.	zhangq@dlu.edu.cn	wang, bin/B-5533-2011	wang, bin/0000-0002-8800-000X; Zhang, Qiang/0000-0003-3776-9799	National Science Foundation for Distinguished Young Scholars of China [61425002]; National Natural Science Foundation of China [61402066, 61402067]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1109]; Program for Liaoning Innovative Research Team in University [LT2011018]; Program for Liaoning Key Lab of Intelligent Information Processing and Network Technology in University	National Science Foundation for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Program for Liaoning Innovative Research Team in University; Program for Liaoning Key Lab of Intelligent Information Processing and Network Technology in University	This work is supported by the National Science Foundation for Distinguished Young Scholars of China (No. 61425002), the National Natural Science Foundation of China (Nos. 61402066, 61402067), the Program for Changjiang Scholars and Innovative Research Team in University (No. IRT1109), the Program for Liaoning Innovative Research Team in University (No. LT2011018) and by the Program for Liaoning Key Lab of Intelligent Information Processing and Network Technology in University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashlock D, 2002, IEEE C EVOL COMPUTAT, P1296, DOI 10.1109/CEC.2002.1004430; Ashlock D, 2009, CIBCB: 2009 IEEE SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE IN BIOINFORMATICS AND COMPUTATIONAL BIOLOGY, P38; Brenneman A, 2002, THEOR COMPUT SCI, V287, P39, DOI 10.1016/S0304-3975(02)00135-4; Buschmann T, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-272; Bystrykh LV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036852; Chen DH, 1999, NUCLEIC ACIDS RES, V27, P389, DOI 10.1093/nar/27.2.389; Chin CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMoa1012928; Costea PI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057521; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; DUNNING AM, 1988, NUCLEIC ACIDS RES, V16, P10393, DOI 10.1093/nar/16.21.10393; Eckert K A, 1991, PCR Methods Appl, V1, P17; Faircloth BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042543; Faulhammer D, 2000, P NATL ACAD SCI USA, V97, P1385, DOI 10.1073/pnas.97.4.1385; Frank DN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-362; Gilar M, 2001, ANAL BIOCHEM, V298, P196, DOI 10.1006/abio.2001.5386; Gilles A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-245; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; HAMMING RW, 1950, BELL SYST TECH J, V29, P147, DOI 10.1002/j.1538-7305.1950.tb00463.x; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; Hillier LW, 2008, NAT METHODS, V5, P183, DOI 10.1038/NMETH.1179; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/nmeth.1311, 10.1038/NMETH.1311]; Krishnan AR, 2011, ELECTRON LETT, V47, P236, DOI 10.1049/el.2010.3546; Levenshtein VI, 1966, SOV PHYS DOKL, V10, P707; Mali P, 2013, NAT METHODS, V10, P403, DOI [10.1038/nmeth.2407, 10.1038/NMETH.2407]; Meyer M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm566; Mitchell Melanie, 1998, INTRO GENETIC ALGORI; Parameswaran P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm760; Pon RT, 1996, BIOTECHNIQUES, V21, P680; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Schober S, 2012, IEEE INT WORK GENOM, P31, DOI 10.1109/GENSIPS.2012.6507719; TINDALL KR, 1988, BIOCHEMISTRY-US, V27, P6008, DOI 10.1021/bi00416a027; Zhang Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072180; Zhang Q, 2010, IEEE T NANOBIOSCI, V9, P273, DOI 10.1109/TNB.2010.2069570	34	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0110640	10.1371/journal.pone.0110640	http://dx.doi.org/10.1371/journal.pone.0110640			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693135	Green Submitted, Green Published, gold			2022-12-26	WOS:000350061500001
J	Zhang, L; Boeren, S; Hageman, JA; van Hooijdonk, T; Vervoort, J; Hettinga, K				Zhang, Lina; Boeren, Sjef; Hageman, Jos A.; van Hooijdonk, Toon; Vervoort, Jacques; Hettinga, Kasper			Bovine Milk Proteome in the First 9 Days: Protein Interactions in Maturation of the Immune and Digestive System of the Newborn	PLOS ONE			English	Article							CARBOXYL ESTER LIPASE; MAMMARY-GLAND; WHEY PROTEOME; COWS MILK; COLOSTRUM; COMPONENTS; COMPLEMENT; CD59; GENE; QUANTIFICATION	In order to better understand the milk proteome and its changes from colostrum to mature milk, samples taken at seven time points in the first 9 days from 4 individual cows were analyzed using proteomic techniques. Both the similarity in changes from day 0 to day 9 in the quantitative milk proteome, and the differences in specific protein abundance, were observed among four cows. One third of the quantified proteins showed a significant decrease in concentration over the first 9 days after calving, especially in the immune proteins (as much as 40 fold). Three relative high abundant enzymes (XDH, LPL, and RNASE1) and cell division and proliferation protein (CREG1) may be involved in the maturation of the gastro-intestinal tract. In addition, high correlations between proteins involved in complement and blood coagulation cascades illustrates the complex nature of biological interrelationships between milk proteins. The linear decrease of protease inhibitors and proteins involved in innate and adaptive immune system implies a protective role for protease inhibitor against degradation. In conclusion, the results found in this study not only improve our understanding of the role of colostrum in both host defense and development of the newborn calf but also provides guidance for the improvement of infant formula through better understanding of the complex interactions between milk proteins.	[Zhang, Lina; van Hooijdonk, Toon; Hettinga, Kasper] Wageningen Univ, Dairy Sci & Technol Food Qual & Design Grp, NL-6700 AP Wageningen, Netherlands; [Boeren, Sjef; Vervoort, Jacques] Wageningen Univ, Biochem Lab, NL-6700 AP Wageningen, Netherlands; [Hageman, Jos A.] Wageningen Univ, NL-6700 AP Wageningen, Netherlands; [Hageman, Jos A.] Wageningen Univ, Ctr BioSyst Gen, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research; Centre for BioSystems Genomics; Wageningen University & Research	Hettinga, K (corresponding author), Wageningen Univ, Dairy Sci & Technol Food Qual & Design Grp, NL-6700 AP Wageningen, Netherlands.	kasper.hettinga@wur.nl	Hageman, Jos/N-1221-2015	Hageman, Jos/0000-0002-5868-587X				BARNARD EA, 1969, ANNU REV BIOCHEM, V38, P677, DOI 10.1146/annurev.bi.38.070169.003333; Bjorge L, 1996, AM J REPROD IMMUNOL, V35, P43, DOI 10.1111/j.1600-0897.1996.tb00007.x; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; Brooks HJL, 2006, FEMS IMMUNOL MED MIC, V48, P347, DOI 10.1111/j.1574-695X.2006.00151.x; Chowanadisai W, 2002, AM J CLIN NUTR, V76, P828, DOI 10.1093/ajcn/76.4.828; Cortese VS, 2009, VET CLIN N AM-FOOD A, V25, P221, DOI 10.1016/j.cvfa.2008.10.003; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Farrell HM, 2004, J DAIRY SCI, V87, P1641, DOI 10.3168/jds.S0022-0302(04)73319-6; Fritz H, 1979, Ciba Found Symp, P351; Godlewski M M, 2005, J Physiol Pharmacol, V56 Suppl 3, P7; Guilloteau P, 2009, J PHYSIOL PHARMACOL, V60, P37; Hammon HM, 2013, J ANIM SCI, V91, P685, DOI 10.2527/jas.2012-5758; Harrison R, 2002, FREE RADICAL BIO MED, V33, P774, DOI 10.1016/S0891-5849(02)00956-5; Hettinga K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019433; Hui DY, 2002, J LIPID RES, V43, P2017, DOI 10.1194/jlr.R200013-JLR200; Jackson RM, 1999, PROTEIN SCI, V8, P603; Jensen GS, 2012, PREV MED, V54, pS124, DOI 10.1016/j.ypmed.2012.01.004; Kanost MR, 1999, DEV COMP IMMUNOL, V23, P291, DOI 10.1016/S0145-305X(99)00012-9; Kimberley FC, 2007, MOL IMMUNOL, V44, P73, DOI 10.1016/j.molimm.2006.06.019; Krarup A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000623; LARSON BL, 1980, J DAIRY SCI, V63, P665, DOI 10.3168/jds.S0022-0302(80)82988-2; Law RHP, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-216; Le A, 2011, J PROTEOME RES, V10, P692, DOI 10.1021/pr100884z; Levieux D, 1999, J DAIRY RES, V66, P421, DOI 10.1017/S0022029999003581; LIDMER AS, 1995, GENOMICS, V29, P115, DOI 10.1006/geno.1995.1221; LILLIEFORS HW, 1967, J AM STAT ASSOC, V62, P399, DOI 10.2307/2283970; Lonnerdal B, 2010, J PEDIATR-US, V156, pS26, DOI 10.1016/j.jpeds.2009.11.017; Lu J, 2011, J PROTEOMICS, V75, P34, DOI 10.1016/j.jprot.2011.07.031; Moore M, 2005, JAVMA-J AM VET MED A, V226, P1375, DOI 10.2460/javma.2005.226.1375; Nissen A, 2012, PROTEOMICS, V12, P2866, DOI 10.1002/pmic.201200231; Pareek Ravi, 2005, Journal of Applied Genetics, V46, P171; Piantoni P, 2010, BIOINFORM BIOL INSIG, V4, P85; Purup S, 2007, J DAIRY RES, V74, P58, DOI 10.1017/S0022029906002093; QUIGLEY JD, 1995, J DAIRY SCI, V78, P1573, DOI 10.3168/jds.S0022-0302(95)76780-7; Rogers ML, 1996, J ENDOCRINOL, V151, P77, DOI 10.1677/joe.0.1510077; ROLLINS SA, 1990, J IMMUNOL, V144, P3478; Sacher M, 2005, P NATL ACAD SCI USA, V102, P18326, DOI 10.1073/pnas.0505071102; Sanderson-Smith ML, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/272148; Sant'Anna MRV, 2008, INSECT BIOCHEM MOLEC, V38, P652, DOI 10.1016/j.ibmb.2008.03.012; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Senda A, 2011, ANIM SCI J, V82, P698, DOI 10.1111/j.1740-0929.2011.00886.x; Smolenski G, 2007, J PROTEOME RES, V6, P207, DOI 10.1021/pr0603405; Stelwagen K, 2009, J ANIM SCI, V87, P3, DOI 10.2527/jas.2008-1377; Ward RE, 2004, J NUTR, V134, p962S, DOI 10.1093/jn/134.4.962S; Wheeler TT, 2012, ANIMAL, V6, P415, DOI 10.1017/S1751731111002151; Wheeler TT, 2007, J MAMMARY GLAND BIOL, V12, P237, DOI 10.1007/s10911-007-9051-7; Yang YX, 2015, J SCI FOOD AGR, V95, P592, DOI 10.1002/jsfa.6791; Zabielski R, 2002, REGUL PEPTIDES, V103, P93, DOI 10.1016/S0167-0115(01)00362-7; Zhang LY, 2011, ASIAN AUSTRAL J ANIM, V24, P272, DOI 10.5713/ajas.2011.10122	50	44	45	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0116710	10.1371/journal.pone.0116710	http://dx.doi.org/10.1371/journal.pone.0116710			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693162	Green Submitted, Green Published, gold			2022-12-26	WOS:000350061500022
J	Lima, FED; Cibulski, SP; dos Santos, HF; Teixeira, TF; Varela, APM; Roehe, PM; Delwart, E; Franco, AC				de Sales Lima, Francisco Esmaile; Cibulski, Samuel Paulo; dos Santos, Helton Fernandes; Teixeira, Thais Fumaco; Muterle Varela, Ana Paula; Roehe, Paulo Michel; Delwart, Eric; Franco, Ana Claudia			Genomic Characterization of Novel Circular ssDNA Viruses from Insectivorous Bats in Southern Brazil	PLOS ONE			English	Article							PORCINE CIRCOVIRUS; GENETIC DIVERSITY; PATHOGENESIS; DIAGNOSIS; DISEASE; PIGS	Circoviruses are highly prevalent porcine and avian pathogens. In recent years, novel circular ssDNA genomes have recently been detected in a variety of fecal and environmental samples using deep sequencing approaches. In this study the identification of genomes of novel circoviruses and cycloviruses in feces of insectivorous bats is reported. Pan-reactive primers were used targeting the conserved rep region of circoviruses and cycloviruses to screen DNA bat fecal samples. Using this approach, partial rep sequences were detected which formed five phylogenetic groups distributed among the Circovirusand the recently proposed Cyclovirus genera of the Circoviridae. Further analysis using inverse PCR and Sanger sequencing led to the characterization of four new putative members of the family Circoviridae with genome size ranging from 1,608 to 1,790 nt, two inversely arranged ORFs, and canonical nonamer sequences atop a stem loop.	[de Sales Lima, Francisco Esmaile; Cibulski, Samuel Paulo; Roehe, Paulo Michel; Franco, Ana Claudia] Univ Fed Rio Grande do Sul, Inst Basic Hlth Sci, Virol Lab, Dept Microbiol Immunol & Parasitol, Porto Alegre, RS, Brazil; [Cibulski, Samuel Paulo; dos Santos, Helton Fernandes; Teixeira, Thais Fumaco; Muterle Varela, Ana Paula; Roehe, Paulo Michel] Inst Vet Res Desiderio Finamor IPVDF, FEPAGRO Anim Hlth, Eldorado Do Sul, RS, Brazil; [Delwart, Eric] Blood Syst Res Inst, San Francisco, CA USA; [Delwart, Eric] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA	Universidade Federal do Rio Grande do Sul; Vitalant; Vitalant Research Institute; University of California System; University of California San Francisco	Lima, FED (corresponding author), Univ Fed Rio Grande do Sul, Inst Basic Hlth Sci, Virol Lab, Dept Microbiol Immunol & Parasitol, Porto Alegre, RS, Brazil.	esmaile.sales@gmail.com	ROEHE, PAULO MICHEL/K-1208-2012; Franco, Ana Cláudia AC/N-4373-2015; Cibulski, Samuel P/G-5190-2017	ROEHE, PAULO MICHEL/0000-0002-2370-7661; 	National Council for the Improvement of Higher Education (CAPES); National Council for Scientific and Technological Development (CNPq); Financiadora de Estudos e Projetos (FINEP)	National Council for the Improvement of Higher Education (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep))	This work was supported by the National Council for the Improvement of Higher Education (CAPES), the National Council for Scientific and Technological Development (CNPq), and Financiadora de Estudos e Projetos (FINEP). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abe C, 2011, J RADIAT RES, V52, P208, DOI 10.1269/jrr.10122; Acosta-Leal R, 2010, PHYTOPATHOLOGY, V100, P1204, DOI 10.1094/PHYTO-04-10-0103; Allan GM, 2000, J VET DIAGN INVEST, V12, P3, DOI 10.1177/104063870001200102; Bassami MR, 1998, VIROLOGY, V249, P453, DOI 10.1006/viro.1998.9324; Blinkova O, 2009, J CLIN MICROBIOL, V47, P3507, DOI 10.1128/JCM.01062-09; Chae C, 2005, VET J, V169, P326, DOI 10.1016/j.tvjl.2004.01.012; Cheung AK, 2006, J VIROL, V80, P8686, DOI 10.1128/JVI.00655-06; Darwich L, 2004, ARCH VIROL, V149, P857, DOI 10.1007/s00705-003-0280-9; Dayaram A, 2013, J GEN VIROL, V94, P1827, DOI 10.1099/vir.0.052654-0; Lima FED, 2013, VIRUS GENES, V47, P164, DOI 10.1007/s11262-013-0899-x; Delwart E, 2012, VIRUS RES, V164, P114, DOI 10.1016/j.virusres.2011.11.021; Drexler JF, 2010, J VIROL, V84, P11336, DOI 10.1128/JVI.00650-10; Ellis J, 1998, CAN VET J, V39, P44; Firth C, 2009, J VIROL, V83, P12813, DOI 10.1128/JVI.01719-09; Ge XY, 2011, J GEN VIROL, V92, P2646, DOI 10.1099/vir.0.034108-0; Grau-Roma L, 2011, VET J, V187, P23, DOI 10.1016/j.tvjl.2010.01.018; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hattermann K, 2003, ARCH VIROL, V148, P2471, DOI 10.1007/s00705-003-0181-y; King A.M.Q., 2012, VIRUS TAXONOMY, P343, DOI 10.1016/B978-0-12-384684-6.00034-3; King AMQ, 2012, VIRUS TAXONOMY CLASS, DOI [10.1016/j.mjafi.2012.08.017, DOI 10.1016/J.MJAFI.2012.08.017]; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Tan LV, 2013, MBIO, V4, DOI 10.1128/mBio.00231-13; Li LL, 2011, J GEN VIROL, V92, P768, DOI 10.1099/vir.0.028704-0; Li LL, 2010, J VIROL, V84, P6955, DOI 10.1128/JVI.00501-10; Li LL, 2010, J VIROL, V84, P1674, DOI 10.1128/JVI.02109-09; Opriessnig T, 2007, J VET DIAGN INVEST, V19, P591, DOI 10.1177/104063870701900601; Padilla-Rodriguez M, 2013, ARCH VIROL, V158, P1389, DOI 10.1007/s00705-013-1606-x; Rijsewijk FAM, 2011, ARCH VIROL, V156, P1097, DOI 10.1007/s00705-011-0971-6; Rosario K, 2012, ARCH VIROL, V157, P1851, DOI 10.1007/s00705-012-1391-y; Rosario K, 2011, J GEN VIROL, V92, P1302, DOI 10.1099/vir.0.030338-0; Sambrook J., 2001, MOL CLONING LAB MANU; Segales J, 2005, VET MICROBIOL, V111, P223, DOI 10.1016/j.vetmic.2005.10.008; Smits SL, 2013, EMERG INFECT DIS, V19, P1511, DOI 10.3201/eid1909.130404; Stewart ME, 2006, AVIAN PATHOL, V35, P86, DOI 10.1080/03079450600597345; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Todd D, 2001, VIROLOGY, V286, P354, DOI 10.1006/viro.2001.0985; Todd D, 2000, AVIAN PATHOL, V29, P373, DOI 10.1080/030794500750047126; Van Tan L, 2014, SCI REP-UK, V4, DOI 10.1038/srep03967; ZUKER M, 1995, NUCLEIC ACIDS RES, V23, P2791, DOI 10.1093/nar/23.14.2791	39	26	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0118070	10.1371/journal.pone.0118070	http://dx.doi.org/10.1371/journal.pone.0118070			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25688970	Green Published, gold, Green Submitted			2022-12-26	WOS:000350322700098
J	De, W; Jing, K; Huan, Z; Qiong, ZH; Monagin, C; Min, ZJ; Ping, H; Wen, KC; Yan, LJ				De, Wu; Jing, Kou; Huan, Zhang; Qiong, Zhou Hui; Monagin, Corina; Min, Zhong Jian; Ping, Huang; Wen, Ke Chang; Yan, Lin Jin			Scrub Typhus, a Disease with Increasing Threat in Guangdong, China	PLOS ONE			English	Article							ORIENTIA-TSUTSUGAMUSHI; RODENTS; OUTBREAK; PROVINCE; STRAINS	There has been a rapid increase in the number of scrub typhus cases in Guangdong Province, China. For this reason, an epidemiologic study was conducted to understand the characteristics of scrub typhus epidemics in Guangdong. From 2006 to 2013, the incidence of human cases increased from 0.4321 to 3.5917 per 100,000 with a bimodal peak in human cases typically occurring between May and November. To detect the prevalence of Orientia tsutsugamushi among suspected human cases and rodents, we performed ELISA tests of IgM/IgG and nested PCR tests on 59 whole blood samples from the suspected cases and 112 spleen samples from the rodents. Suspected cases tested positive for anti-O. tsutsugamushi IgM and IgG 66.1% (39/59) and 50.8% (30/59) of the time, respectively. Additionally, 20.3% (12/59) of blood samples and 13.4%(15/112) of spleen samples were positive for PCR. Phylogenetic analysis revealed that there were four definable clusters among the 27 nucleotide sequences of the 56-kDa antigen genes: 44.4% Karp (12/27), 25.9% Kato (7/27), 22.2% Gilliam (6/27) and 7.4% TA763 (2/27). We concluded many suspected cases may result in diagnostic errors; therefore, it is necessary to perform laboratory tests on suspected cases in hospitals. The high infection rate of O. tsutsugamushi among the limited rodents tested suggested that further rodent sampling throughout the province is necessary to further define high-risk areas. Furthermore, the multiple co-circulating genotypes of O. tsutsugamushi play a key role in the pervasiveness of scrub typhus in the Guangdong area.	[De, Wu; Jing, Kou; Huan, Zhang; Qiong, Zhou Hui; Ping, Huang; Wen, Ke Chang; Yan, Lin Jin] Ctr Dis Control & Prevent Guangdong, Inst Pathogen Microbiol, Guangzhou, Guangdong, Peoples R China; [Monagin, Corina] Metabiota Inc, San Francisco, CA USA; [Min, Zhong Jian] Humboldt State Univ, Dept Biol Sci, Arcata, CA 95521 USA	California State University System; California State Polytechnic University, Humboldt	De, W (corresponding author), Ctr Dis Control & Prevent Guangdong, Inst Pathogen Microbiol, Guangzhou, Guangdong, Peoples R China.	wu_de68@cdcp.org.cn	ping, huang/GYD-3580-2022		Twelfth Five-Year Medical Research Key Project of PLA [AWS 11L 009]; Metabiota Inc. (formally known as Global Viral Forecasting)	Twelfth Five-Year Medical Research Key Project of PLA; Metabiota Inc. (formally known as Global Viral Forecasting)	Blood sample collection of suspected cases and surveillance data analysis were supported by the Twelfth Five-Year Medical Research Key Project of PLA (AWS 11L 009), samples collection of rodents and sequencing were supported by Metabiota Inc. (formally known as Global Viral Forecasting). Co-author Corina Monagin is employed by Metabiota, Inc. Metabiota, Inc. provided support in the form of salary for author CM, and helped in the preparation of the manuscript, but did not have any additional role in the study design, data collection and analysis, or decision to publish.	[储凯 Chu Kai], 2013, [中华传染病杂志, Chinese Journal of Infections Diseases], V31, P358; Coleman RE, 2002, AM J TROP MED HYG, V67, P497, DOI 10.4269/ajtmh.2002.67.497; Duong V, 2013, INFECT GENET EVOL, V15, P35, DOI 10.1016/j.meegid.2011.01.004; Fang YR, 2013, CHINESE RURAL HLTH S, V33, P426; Kelly DJ, 2009, CLIN INFECT DIS, V48, pS203, DOI 10.1086/596576; Kelly DJ, 2002, CLIN INFECT DIS, V34, pS145, DOI 10.1086/339908; Kim YJ, 2013, J KOREAN MED SCI, V28, P672, DOI 10.3346/jkms.2013.28.5.672; Koh GCKW, 2010, AM J TROP MED HYG, V82, P368, DOI 10.4269/ajtmh.2010.09-0233; Li J, 2005, PRACTICAL PREVENTIVE, V12, P1251; Lin PR, 2011, APPL ENVIRON MICROB, V77, P3398, DOI 10.1128/AEM.02796-10; [刘隽 Liu Jun], 2013, [中华流行病学杂志, Chinese Journal of Epidemiology], V34, P946; Meng Z, 2011, CHIN J EPIDEMIOL, V32, P419; Oaks SCJ, 1983, I MED RES MALAYS B, V21, P1; Ohashi N, 1996, MICROBIOL IMMUNOL, V40, P627, DOI 10.1111/j.1348-0421.1996.tb01120.x; Raina SK, 2013, J POSTGRAD MED, V59, DOI 10.4103/0022-3859.123191; Rodkvamtook W, 2011, AM J TROP MED HYG, V84, P599, DOI 10.4269/ajtmh.2011.09-0768; Ruang-areerate T, 2011, J CLIN MICROBIOL, V49, P2584, DOI 10.1128/JCM.00355-11; Shim SK, 2009, CLIN MICROBIOL INFEC, V15, P311, DOI 10.1111/j.1469-0691.2008.02254.x; Shouyin Z, 2009, FOREIGN MED SCI SECT, V30, P133; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Watt G, 2003, CURR OPIN INFECT DIS, V16, P429, DOI 10.1097/00001432-200310000-00009; Wu G., 2007, INT J MED PARASIT DI, V34, P169, DOI [10.3760/cma.j.issn.1673-4122.2007.04.001, DOI 10.3760/CMA.J.ISSN.1673-4122.2007.04.001]; Yun Z, 2010, CHIN J PUBLIC HLTH, V26, P174; Zhang Lijuan, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P482; Zhang M, 2012, AM J TROP MED HYG, V87, P1099, DOI 10.4269/ajtmh.2012.12-0306; Zhang WY, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002493	26	18	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0113968	10.1371/journal.pone.0113968	http://dx.doi.org/10.1371/journal.pone.0113968			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689778	Green Published, gold, Green Submitted			2022-12-26	WOS:000350322700003
J	Honda, T; Obara, Y; Yamauchi, A; Couvillon, AD; Mason, JJ; Ishii, K; Nakahata, N				Honda, Takuto; Obara, Yutaro; Yamauchi, Arata; Couvillon, Anthony D.; Mason, Justin J.; Ishii, Kuniaki; Nakahata, Norimichi			Phosphorylation of ERK5 on Thr732 Is Associated with ERK5 Nuclear Localization and ERK5-Dependent Transcription	PLOS ONE			English	Article							TARGETED DELETION; SIGNALING PATHWAY; ACTIVATION; GROWTH; BMK1/ERK5; ERK5/BMK1; ERK1/2; PROLIFERATION; INHIBITION; PROMOTES	Extracellular signal-regulated kinases (ERKs) play critical roles in numerous cellular processes, including proliferation and differentiation. ERK5 contains a kinase domain at the N-terminal, and the unique extended C-terminal includes multiple autophosphorylation sites that enhance ERK5-dependent transcription. However, the impact of phosphorylation at the various sites remain unclear. In this study, we examined the role of phosphorylation at the ERK5 C-terminal. We found that a constitutively active MEK5 mutant phosphorylated ERK5 at the TEY motif, resulting in the sequential autophosphorylation of multiple C-terminal residues, including Thr732 and Ser769/773/775. However, when ERK1/2 was selectively activated by an oncogenic RAS mutant, ERK5 phosphorylation at Thr732 was induced without affecting the phosphorylation status at TEY or Ser769/773/775. The Thr732 phosphorylation was U0126-sensitive and was observed in a kinase-dead mutant of ERK5 as well, suggesting that ERK1/2 can phosphorylate ERK5 at Thr732. This phosphorylation was also promoted by epidermal growth factor and nerve growth factor in HEK293 and PC12 cells, respectively. The ERK5-T732A mutant was localized in the cytosol under basal conditions. In contrast, ERK5 phosphorylated at Thr732 via the RAS-ERK1/2 pathway and ERK5T732E, which mimics the phosphorylated form, were localized in both the nucleus and cytosol. Finally, ER-32A and U0126 blocked ERK5-dependent MEF2C transcriptional activity. Based on these findings, we propose a novel cross-talk mechanism in which ERK1/2, following activation by growth factor stimulation, phosphorylates ERK5 at Thr732. This phosphorylation event is responsible for ERK5 nuclear localization and ERK5-dependent transcription.	[Honda, Takuto; Obara, Yutaro; Yamauchi, Arata; Nakahata, Norimichi] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Cellular Signaling, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Obara, Yutaro; Ishii, Kuniaki] Yamagata Univ, Sch Med, Dept Pharmacol, Yamagata 9909585, Japan; [Couvillon, Anthony D.; Mason, Justin J.] Cell Signaling Technol, Danvers, MA 01923 USA	Tohoku University; Yamagata University	Obara, Y (corresponding author), Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Cellular Signaling, Aoba Ku, 6-3 Aoba, Sendai, Miyagi 9808578, Japan.	obaray@med.id.yamagata-u.ac.jp			Japan Society for the Promotion of Science [20790053, 24790063]; Exploratory Research Program for Young Scientists of Tohoku University; Sankyo Foundation of Life Science; NOVARTIS Foundation (Japan) for the Promotion of Science; Nishinomiya Basic Research Fund; Grants-in-Aid for Scientific Research [26670118] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Exploratory Research Program for Young Scientists of Tohoku University; Sankyo Foundation of Life Science; NOVARTIS Foundation (Japan) for the Promotion of Science(Novartis); Nishinomiya Basic Research Fund; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid from the Japan Society for the Promotion of Science (No. 20790053 and 24790063 to Y.O.), The Exploratory Research Program for Young Scientists of Tohoku University (Y.O.), Sankyo Foundation of Life Science (Y.O.), The NOVARTIS Foundation (Japan) for the Promotion of Science (Y.O.), and Nishinomiya Basic Research Fund (Y.O.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buschbeck M, 2005, J BIOL CHEM, V280, P2659, DOI 10.1074/jbc.M412599200; Cavanaugh JE, 2006, J NEUROSCI RES, V84, P1367, DOI 10.1002/jnr.21024; Coulombe P, 2007, BBA-MOL CELL RES, V1773, P1376, DOI 10.1016/j.bbamcr.2006.11.001; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; Diaz-Rodriguez E, 2010, J CELL SCI, V123, P3146, DOI 10.1242/jcs.070516; Drew BA, 2012, BBA-REV CANCER, V1825, P37, DOI 10.1016/j.bbcan.2011.10.002; Hayashi M, 2004, J MOL MED, V82, P800, DOI 10.1007/s00109-004-0602-8; Kamakura S, 1999, J BIOL CHEM, V274, P26563, DOI 10.1074/jbc.274.37.26563; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Kato Y, 1998, NATURE, V395, P713, DOI 10.1038/27234; Khokhlatchev AV, 1998, CELL, V93, P605, DOI 10.1016/S0092-8674(00)81189-7; Kimura TE, 2010, CIRC RES, V106, P961, DOI 10.1161/CIRCRESAHA.109.209320; Kondoh K, 2006, MOL CELL BIOL, V26, P1679, DOI 10.1128/MCB.26.5.1679-1690.2006; Lennartsson J, 2010, CELL SIGNAL, V22, P955, DOI 10.1016/j.cellsig.2010.01.020; Morimoto H, 2007, J BIOL CHEM, V282, P35449, DOI 10.1074/jbc.M704079200; Nakaoka Y, 2003, CIRC RES, V93, P221, DOI 10.1161/01.RES.0000085562.48906.4A; Nishimoto S, 2006, EMBO REP, V7, P782, DOI 10.1038/sj.embor.7400755; Nithianandarajah-Jones GN, 2012, CELL SIGNAL, V24, P2187, DOI 10.1016/j.cellsig.2012.07.007; Obara Y, 2004, J CELL SCI, V117, P6085, DOI 10.1242/jcs.01527; Obara Y, 2008, CELL SIGNAL, V20, P1275, DOI 10.1016/j.cellsig.2008.02.016; Obara Y, 2011, CELL SIGNAL, V23, P666, DOI 10.1016/j.cellsig.2010.11.020; Obara Y, 2010, MOL PHARMACOL, V77, P10, DOI 10.1124/mol.109.060236; Obara Y, 2009, J BIOL CHEM, V284, P23564, DOI 10.1074/jbc.M109.027821; Pan YW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049622; Pan YW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050455; Pan YW, 2012, J NEUROSCI, V32, P6444, DOI 10.1523/JNEUROSCI.6076-11.2012; Pollack V, 2007, AM J PHYSIOL-RENAL, V293, pF1714, DOI 10.1152/ajprenal.00130.2007; Roberts OL, 2009, BIOCHEM SOC T, V37, P1254, DOI 10.1042/BST0371254; Rovida E, 2008, J IMMUNOL, V180, P4166, DOI 10.4049/jimmunol.180.6.4166; Sharma G, 2005, MOL CELL ENDOCRINOL, V245, P93, DOI 10.1016/j.mce.2005.10.027; Sharma G, 2007, BIOCHEM BIOPH RES CO, V354, P1078, DOI 10.1016/j.bbrc.2007.01.102; Su C, 2011, J NEUROSCI RES, V89, P1542, DOI 10.1002/jnr.22683; Wang X, 2006, CELL SIGNAL, V18, P753, DOI 10.1016/j.cellsig.2005.11.003; Wang YP, 2007, J NEUROCHEM, V102, P957, DOI 10.1111/j.1471-4159.2007.04606.x; Wang YP, 2006, J BIOL CHEM, V281, P35965, DOI 10.1074/jbc.M605503200; Watson FL, 2001, NAT NEUROSCI, V4, P981, DOI 10.1038/nn720; Yan C, 2001, J BIOL CHEM, V276, P10870, DOI 10.1074/jbc.M009286200; Yang QK, 2010, CANCER CELL, V18, P258, DOI 10.1016/j.ccr.2010.08.008; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451	39	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117914	10.1371/journal.pone.0117914	http://dx.doi.org/10.1371/journal.pone.0117914			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689862	gold, Green Published, Green Submitted			2022-12-26	WOS:000350322700082
J	Ozturk, H; Ozkirimli, E; Ozgur, A				Ozturk, Hakime; Ozkirimli, Elif; Ozgur, Arzucan			Classification of Beta-Lactamases and Penicillin Binding Proteins Using Ligand-Centric Network Models	PLOS ONE			English	Article							KLEBSIELLA-PNEUMONIAE; BACTERIAL-RESISTANCE; CLASS-A; STRUCTURAL INSIGHT; INTERACTIVE TREE; INHIBITION; EVOLUTION; PSEUDOMONAS; MEROPENEM; COMPLEX	beta-lactamase mediated antibiotic resistance is an important health issue and the discovery of new beta-lactam type antibiotics or beta-lactamase inhibitors is an area of intense research. Today, there are about a thousand beta-lactamases due to the evolutionary pressure exerted by these ligands. While beta-lactamases hydrolyse the beta-lactam ring of antibiotics, rendering them ineffective, Penicillin-Binding Proteins (PBPs), which share high structural similarity with beta-lactamases, also confer antibiotic resistance to their host organism by acquiring mutations that allow them to continue their participation in cell wall biosynthesis. In this paper, we propose a novel approach to include ligand sharing information for classifying and clustering beta-lactamases and PBPs in an effort to elucidate the ligand induced evolution of these beta-lactam binding proteins. We first present a detailed summary of the beta-lactamase and PBP families in the Protein Data Bank, as well as the compounds they bind to. Then, we build two different types of networks in which the proteins are represented as nodes, and two proteins are connected by an edge with a weight that depends on the number of shared identical or similar ligands. These models are analyzed under three different edge weight settings, namely unweighted, weighted, and normalized weighted. A detailed comparison of these six networks showed that the use of ligand sharing information to cluster proteins resulted in modules comprising proteins with not only sequence similarity but also functional similarity. Consideration of ligand similarity highlighted some interactions that were not detected in the identical ligand network. Analysing the beta-lactamases and PBPs using ligand-centric network models enabled the identification of novel relationships, suggesting that these models can be used to examine other protein families to obtain information on their ligand induced evolutionary paths.	[Ozturk, Hakime; Ozgur, Arzucan] Bogazici Univ, Dept Comp Engn, TR-80815 Bebek, Turkey; [Ozkirimli, Elif] Bogazici Univ, Dept Chem Engn, TR-80815 Bebek, Turkey	Bogazici University; Bogazici University	Ozkirimli, E (corresponding author), Bogazici Univ, Dept Chem Engn, TR-80815 Bebek, Turkey.	elif.ozkirimli@boun.edu.tr; arzucan.ozgur@boun.edu.tr	Öztürk, Hakime/J-6103-2018; Ozkirimli, Elif/Q-1586-2015; Ozgur, Arzucan/I-3147-2012	Ozkirimli, Elif/0000-0002-3206-8427; Ozgur, Arzucan/0000-0001-8376-1056; Ozturk, Hakime/0000-0002-2146-5638	Marie Curie FP7-Reintegration-Grants within the 7th European Community Framework Programme; TUBITAK BIDEB	Marie Curie FP7-Reintegration-Grants within the 7th European Community Framework Programme; TUBITAK BIDEB(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This work has been supported by Marie Curie FP7-Reintegration-Grants within the 7th European Community Framework Programme and TUBITAK BIDEB 2210. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM EP, 1988, REV INFECT DIS, V10, P677; AMBLER RP, 1980, PHILOS T R SOC B, V289, P321, DOI 10.1098/rstb.1980.0049; [Anonymous], 2013, CHEM BIOL, V20, P1107, DOI [10.1016/j.chembiol.2013.07.015, DOI 10.1016/J.CHEMBIOL.2013.07.015]; Backman TWH, 2011, NUCLEIC ACIDS RES, V39, pW486, DOI 10.1093/nar/gkr320; Beadle BM, 2002, ANTIMICROB AGENTS CH, V46, P3978, DOI 10.1128/AAC.46.12.3978-3980.2002; Bonfiglio G, 2002, EXPERT OPIN INV DRUG, V11, P529; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Bradford PA, 2001, CLIN MICROBIOL REV, V14, P933, DOI 10.1128/CMR.14.4.933-951.2001; Brown NG, 2010, J MOL BIOL, V404, P832, DOI 10.1016/j.jmb.2010.10.008; BUSH K, 1995, ANTIMICROB AGENTS CH, V39, P1211, DOI 10.1128/AAC.39.6.1211; Bush K, 2010, ANTIMICROB AGENTS CH, V54, P969, DOI 10.1128/AAC.01009-09; Cheng FX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041064; Cheng FX, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002503; Cuzon G, 2008, ANTIMICROB AGENTS CH, V52, P3463, DOI 10.1128/AAC.00543-08; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Fisher JF, 2005, CHEM REV, V105, P395, DOI 10.1021/cr030102i; GEORGOPAPADAKOU NH, 1993, ANTIMICROB AGENTS CH, V37, P2045, DOI 10.1128/AAC.37.10.2045; GHUYSEN JM, 1991, ANNU REV MICROBIOL, V45, P37, DOI 10.1146/annurev.mi.45.100191.000345; Gulmez D, 2008, INT J ANTIMICROB AG, V31, P523, DOI 10.1016/j.ijantimicag.2008.01.017; Hugonnet JE, 2009, SCIENCE, V323, P1215, DOI 10.1126/science.1167498; Kalinina OV, 2012, NUCLEIC ACIDS RES, V40, pD549, DOI 10.1093/nar/gkr1049; Ke W, 2011, ANTIMICROB AGENTS CH, V55, P174, DOI 10.1128/AAC.00930-10; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; KELLY JA, 1986, SCIENCE, V231, P1429, DOI 10.1126/science.3082007; King DT, 2012, J AM CHEM SOC, V134, P11362, DOI 10.1021/ja303579d; KNOTHE H, 1983, INFECTION, V11, P315, DOI 10.1007/BF01641355; Lahiri SD, 2013, ANTIMICROB AGENTS CH, V57, P2496, DOI 10.1128/AAC.02247-12; Lerner TR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002524; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Lin CY, 2008, NUCLEIC ACIDS RES, V36, pW438, DOI 10.1093/nar/gkn257; Lin H, 2013, NAT METHODS, V10, P140, DOI [10.1038/NMETH.2324, 10.1038/nmeth.2324]; Livermore DM, 2006, TRENDS MICROBIOL, V14, P413, DOI 10.1016/j.tim.2006.07.008; Lovering AL, 2007, SCIENCE, V315, P1402, DOI 10.1126/science.1136611; Massova I, 1998, ANTIMICROB AGENTS CH, V42, P1; Mitchell JBO, 2001, J CHEM INF COMP SCI, V41, P1617, DOI 10.1021/ci010364q; Morris JH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-436; Nobeli I, 2005, J MOL BIOL, V347, P415, DOI 10.1016/j.jmb.2005.01.061; Nukaga M, 2003, BIOCHEMISTRY-US, V42, P13152, DOI 10.1021/bi034986b; Orencia MC, 2001, NAT STRUCT BIOL, V8, P238, DOI 10.1038/84981; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Potron A, 2013, EUROSURVEILLANCE, V18, P9, DOI 10.2807/1560-7917.ES2013.18.31.20549; PRYKA RD, 1994, ANN PHARMACOTHER, V28, P1045, DOI 10.1177/106002809402800910; Pucci MJ, 2013, CLIN MICROBIOL REV, V26, P792, DOI 10.1128/CMR.00033-13; ROGERS DJ, 1960, SCIENCE, V132, P1115, DOI 10.1126/science.132.3434.1115; Schneider KD, 2011, J MOL BIOL, V406, P583, DOI 10.1016/j.jmb.2010.12.042; Schneider KD, 2009, BIOCHEMISTRY-US, V48, P11840, DOI 10.1021/bi901690r; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sweden EET, 2013, EUROSURVEILLANCE, V18; Tremblay LW, 2010, BIOCHEMISTRY-US, V49, P3766, DOI 10.1021/bi100232q; Urbach C, 2009, J MOL BIOL, V386, P109, DOI 10.1016/j.jmb.2008.12.001; Watkins RR, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00392; Xu H, 2012, BIOCHEMISTRY-US, V51, P4551, DOI 10.1021/bi300508r; Xue L, 2001, J CHEM INF COMP SCI, V41, P394, DOI 10.1021/ci000305x; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338; Yong Dongeun, 2009, Antimicrob Agents Chemother, V53, P5046, DOI 10.1128/AAC.00774-09	58	30	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117874	10.1371/journal.pone.0117874	http://dx.doi.org/10.1371/journal.pone.0117874			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689853	Green Submitted, Green Published, gold			2022-12-26	WOS:000350322700081
J	Zakharova, NV; Artemenko, EO; Podoplelova, NA; Sveshnikova, AN; Demina, IA; Ataullakhanov, FI; Panteleev, MA				Zakharova, Natalia V.; Artemenko, Elena O.; Podoplelova, Nadezhda A.; Sveshnikova, Anastasia N.; Demina, Irina A.; Ataullakhanov, Fazly I.; Panteleev, Mikhail A.			Platelet Surface-Associated Activation and Secretion-Mediated Inhibition of Coagulation Factor XII	PLOS ONE			English	Article							ALPHA-GRANULE PROTEIN; THROMBUS FORMATION; CONTACT ACTIVATION; BLOOD-COAGULATION; IN-VIVO; PROCOAGULANT PLATELETS; C1 INHIBITOR; WHOLE-BLOOD; SUBPOPULATIONS; POLYPHOSPHATES	Coagulation factor XII (fXII) is important for arterial thrombosis, but its physiological activation mechanisms are unclear. In this study, we elucidated the role of platelets and platelet-derived material in fXII activation. FXII activation was only observed upon potent platelet stimulation (with thrombin, collagen-related peptide, or calcium ionophore, but not ADP) accompanied by phosphatidylserine exposure and was localised to the platelet surface. Platelets from three patients with grey platelet syndrome did not activate fXII, which suggests that platelet-associated fXII-activating material might be released from a-granules. FXII was preferentially bound by phosphotidylserine-positive platelets and annexin V abrogated platelet-dependent fXII activation; however, artificial phosphotidylserine/phosphatidylcholine microvesicles did not support fXII activation under the conditions herein. Confocal microscopy using DAPI as a poly-phosphate marker did not reveal poly-phosphates associated with an activated platelet surface. Experimental data for fXII activation indicates an auto-inhibition mechanism (k(i)/k(a) = 180 molecules/platelet). Unlike surface-associated fXII activation, platelet secretion inhibited activated fXII (fXIIa), particularly due to a released C1-inhibitor. Platelet surface-associated fXIIa formation triggered contact pathway-dependent clotting in recalcified plasma. Computer modelling suggests that fXIIa inactivation was greatly decreased in thrombi under high blood flow due to inhibitor washout. Combined, the surface-associated fXII activation and its inhibition in solution herein may be regarded as a flow-sensitive regulator that can shift the balance between surface-associated clotting and plasma-dependent inhibition, which may explain the role of fXII at high shear and why fXII is important for thrombosis but negligible in haemostasis.	[Zakharova, Natalia V.; Podoplelova, Nadezhda A.; Ataullakhanov, Fazly I.; Panteleev, Mikhail A.] Natl Res Ctr Hematol, Moscow, Russia; [Zakharova, Natalia V.; Artemenko, Elena O.; Podoplelova, Nadezhda A.; Sveshnikova, Anastasia N.; Ataullakhanov, Fazly I.; Panteleev, Mikhail A.] Ctr Theoret Problems Physicochem Pharmacol, Moscow, Russia; [Zakharova, Natalia V.; Artemenko, Elena O.; Podoplelova, Nadezhda A.; Sveshnikova, Anastasia N.; Demina, Irina A.; Ataullakhanov, Fazly I.; Panteleev, Mikhail A.] Fed Res & Clin Ctr Pediat Hematol Oncol & Immunol, Moscow, Russia; [Sveshnikova, Anastasia N.; Ataullakhanov, Fazly I.; Panteleev, Mikhail A.] Moscow MV Lomonosov State Univ, Fac Phys, Moscow, Russia; [Ataullakhanov, Fazly I.; Panteleev, Mikhail A.] Moscow Inst Phys & Technol, Fac Biol & Med Phys, Dolgoprudnyi, Russia	Russian Academy of Medical Sciences; National Medical Research Center for Hematology; Center for Theoretical Problems of Physicochemical Pharmacology of the Russian Academy of Sciences; Dmitry Rogachev National Medical Research Center Of Pediatric Hematology, Oncology & Immunology; Lomonosov Moscow State University; Moscow Institute of Physics & Technology	Panteleev, MA (corresponding author), Natl Res Ctr Hematol, Moscow, Russia.	mapanteleev@yandex.ru	Podoplelova, Nadezhda/AAT-3654-2020; Ataullakhanov, Fazoil/J-8076-2012; Panteleev, Mikhail A/H-5491-2012; Irina, Demina/A-7876-2014; Sveshnikova, Anastasia N/J-9945-2015; Podoplelova, Nadezhda/A-7482-2014; Zakharova, Natalia V/D-8644-2012	Podoplelova, Nadezhda/0000-0001-8013-1112; Panteleev, Mikhail A/0000-0002-8128-7757; Irina, Demina/0000-0002-4317-2094; Sveshnikova, Anastasia N/0000-0003-4720-7319; Podoplelova, Nadezhda/0000-0001-8013-1112; Zakharova, Natalia V/0000-0002-5267-0079	Russian Science Foundation [14-14-00195]	Russian Science Foundation(Russian Science Foundation (RSF))	This study was supported by the Russian Science Foundation grant 14-14-00195 (http://xn-m1afn.xn-p1ai/) (MAP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaeva AA, 2013, J BIOL CHEM, V288, P29621, DOI 10.1074/jbc.M113.474163; Arnljots B, 1997, J VASC SURG, V25, P341, DOI 10.1016/S0741-5214(97)70356-2; Aschar-Sobbi R, 2008, J FLUORESC, V18, P859, DOI 10.1007/s10895-008-0315-4; Back J, 2010, BIOCHEM BIOPH RES CO, V391, P11, DOI 10.1016/j.bbrc.2009.10.123; Boknas N, 2014, BLOOD, V124, P1692, DOI 10.1182/blood-2014-04-566067; CASTALDI PA, 1965, NATURE, V207, P422, DOI 10.1038/207422a0; Cheng QF, 2010, BLOOD, V116, P3981, DOI 10.1182/blood-2010-02-270918; Colman RW, 1997, BLOOD, V90, P3819, DOI 10.1182/blood.V90.10.3819; Faxalv L, 2013, BLOOD, V122, P3818, DOI 10.1182/blood-2013-05-499384; GRIEP MA, 1985, BIOCHEMISTRY-US, V24, P4124, DOI 10.1021/bi00336a047; GRIFFIN JH, 1978, P NATL ACAD SCI USA, V75, P1998, DOI 10.1073/pnas.75.4.1998; Hagedorn I, 2010, CIRCULATION, V121, P1510, DOI 10.1161/CIRCULATIONAHA.109.924761; Heemskerk JWM, 2013, J THROMB HAEMOST, V11, P2, DOI 10.1111/jth.12045; Kempton CL, 2005, ARTERIOSCL THROM VAS, V25, P861, DOI 10.1161/01.ATV.0000155987.26583.9b; Kondratovich AY, 2002, BBA-GEN SUBJECTS, V1569, P86, DOI 10.1016/S0304-4165(01)00247-1; Kotova YN, 2008, J THROMB HAEMOST, V6, P1603, DOI 10.1111/j.1538-7836.2008.03052.x; Kuijpers MJE, 2014, ARTERIOSCL THROM VAS, V34, P1674, DOI 10.1161/ATVBAHA.114.303315; Lipets EN, 2014, PLOS ONE IN PRESS; London FS, 2004, J BIOL CHEM, V279, P19854, DOI 10.1074/jbc.M310624200; Matafonov A, 2014, BLOOD, V123, P1739, DOI 10.1182/blood-2013-04-499111; Muller F, 2009, CELL, V139, P1143, DOI 10.1016/j.cell.2009.11.001; Nickel KF, 2013, BLOOD, V122, P3847, DOI 10.1182/blood-2013-09-525840; Panteleev MA, 2005, J THROMB HAEMOST, V3, P2545, DOI 10.1111/j.1538-7836.2005.01616.x; PIXLEY RA, 1985, J BIOL CHEM, V260, P1723; Ramjee MK, 2000, ANAL BIOCHEM, V277, P11, DOI 10.1006/abio.1999.4380; Ramstrom S, 2003, THROMB HAEMOSTASIS, V89, P132; Renne T, 2005, J EXP MED, V202, P271, DOI 10.1084/jem.20050664; Renne T, 2012, BLOOD, V120, P4296, DOI 10.1182/blood-2012-07-292094; SCHMAIER AH, 1993, BLOOD, V82, P465; SCHMAIER AH, 1985, J CLIN INVEST, V75, P242, DOI 10.1172/JCI111680; Sinauridze EI, 2007, THROMB HAEMOSTASIS, V97, P425, DOI 10.1160/TH06-06-0313; Smith SA, 2010, BLOOD, V116, P4353, DOI 10.1182/blood-2010-01-266791; Spronk HMH, 2009, THROMB HAEMOSTASIS, V101, P1156, DOI 10.1160/TH08-10-0670; Topalov NN, 2012, BRIT J HAEMATOL, V157, P105, DOI 10.1111/j.1365-2141.2011.09021.x; Topalov NN, 2012, ARTERIOSCL THROM VAS, V32, P2475, DOI 10.1161/ATVBAHA.112.253765; van der Meijden PEJ, 2012, J THROMB HAEMOST, V10, P1355, DOI 10.1111/j.1538-7836.2012.04758.x; Walsh P N, 1981, Ann N Y Acad Sci, V370, P241, DOI 10.1111/j.1749-6632.1981.tb29737.x; Yakimenko AO, 2012, BIOPHYS J, V102, P2261, DOI 10.1016/j.bpj.2012.04.004; Zhuo R, 2007, BIOMATERIALS, V28, P4355, DOI 10.1016/j.biomaterials.2007.06.019	39	29	34	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0116665	10.1371/journal.pone.0116665	http://dx.doi.org/10.1371/journal.pone.0116665			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25688860	gold, Green Submitted, Green Published			2022-12-26	WOS:000350322700019
J	Ha, MA; Smith, GJ; Cichocki, JA; Fan, L; Liu, YS; Caceres, AI; Jordt, SE; Morris, JB				Ha, Michael A.; Smith, Gregory J.; Cichocki, Joseph A.; Fan, Lu; Liu, Yi-Shiuan; Caceres, Ana I.; Jordt, Sven Eric; Morris, John B.			Menthol Attenuates Respiratory Irritation and Elevates Blood Cotinine in Cigarette Smoke Exposed Mice	PLOS ONE			English	Article							NICOTINE METABOLISM; CAPSAICIN COUGH; COLD RECEPTOR; TRP CHANNELS; IN-VITRO; SENSITIVITY; IRRITANTS; RESPONSES; MOUSE; PAIN	Addition of menthol to cigarettes may be associated with increased initiation of smoking. The potential mechanisms underlying this association are not known. Menthol, likely due to its effects on cold-sensing peripheral sensory neurons, is known to inhibit the sensation of irritation elicited by respiratory irritants. However, it remains unclear whether menthol modulates cigarette smoke irritancy and nicotine absorption during initial exposures to cigarettes, thereby facilitating smoking initiation. Using plethysmography in a C57Bl/6J mouse model, we examined the effects of L-menthol, the menthol isomer added to cigarettes, on the respiratory sensory irritation response to primary smoke irritants (acrolein and cyclohexanone) and smoke of Kentucky reference 2R4 cigarettes. We also studied L-menthol's effect on blood levels of the nicotine metabolite, cotinine, immediately after exposure to cigarette smoke. L-menthol suppressed the irritation response to acrolein with an apparent IC50 of 4 ppm. Suppression was observed even at acrolein levels well above those necessary to produce a maximal response. Cigarette smoke, at exposure levels of 10 mg/m(3) or higher, caused an immediate and marked sensory irritation response in mice. This response was significantly suppressed by L-menthol even at smoke concentrations as high as 300 mg/m(3). Counterirritation by L-menthol was abolished by treatment with a selective inhibitor of Transient Receptor Potential Melastatin 8 (TRPM8), the neuronal cold/menthol receptor. Inclusion of menthol in the cigarette smoke resulted in roughly a 1.5-fold increase in plasma cotinine levels over those observed in mice exposed to smoke without added menthol. These findings document that, L-menthol, through TRPM8, is a strong suppressor of respiratory irritation responses, even during highly noxious exposures to cigarette smoke or smoke irritants, and increases blood cotinine. Therefore, L-menthol, as a cigarette additive, may promote smoking initiation and nicotine addiction.	[Ha, Michael A.; Smith, Gregory J.; Cichocki, Joseph A.; Morris, John B.] Univ Connecticut, Sch Pharm, Dept Pharmaceut Sci, Toxicol Program, Storrs, CT USA; [Fan, Lu] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Liu, Yi-Shiuan] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Caceres, Ana I.; Jordt, Sven Eric] Duke Univ, Sch Med, Dept Anesthesiol, Durham, NC 27708 USA	University of Connecticut; Yale University; Yale University; Duke University	Jordt, SE (corresponding author), Duke Univ, Sch Med, Dept Anesthesiol, Durham, NC 27708 USA.	sven.jordt@yale.edu	Caceres, Ana I/E-5542-2012; Liu, Yi-Shiuan/AAI-3803-2020; Jordt, Sven-Eric/ABE-6517-2020	Caceres, Ana I/0000-0001-7219-8851; Liu, Yi-Shiuan/0000-0003-3205-8963; Jordt, Sven-Eric/0000-0001-6171-5622	National Institutes of Health of the United States; United States Food and Drug Administration [R01ES015056, R01HL105635, R01HL105635-S1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA036151] Funding Source: NIH RePORTER	National Institutes of Health of the United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Food and Drug Administration; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by grants from the National Institutes of Health of the United States and the United States Food and Drug Administration: R01ES015056 (to SEJ), R01HL105635 and R01HL105635-S1 (to SEJ and JBM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALARIE Y, 1981, FOOD COSMET TOXICOL, V19, P623, DOI 10.1016/0015-6264(81)90513-7; Alarie Y, 1973, CRC Crit Rev Toxicol, V2, P299, DOI 10.3109/10408447309082020; Andre E, 2008, J CLIN INVEST, V118, P2574, DOI 10.1172/JCI34886; Azagba S, 2014, CANC CAUSES CONTROL; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Behrendt HJ, 2004, BRIT J PHARMACOL, V141, P737, DOI 10.1038/sj.bjp.0705652; Benowitz Neal L, 2009, Handb Exp Pharmacol, P29, DOI 10.1007/978-3-540-69248-5_2; Benowitz NL, 2004, J PHARMACOL EXP THER, V310, P1208, DOI 10.1124/jpet.104.066902; Bessac Bret F, 2010, Proc Am Thorac Soc, V7, P269, DOI 10.1513/pats.201001-004SM; Bessac BF, 2008, PHYSIOLOGY, V23, P360, DOI 10.1152/physiol.00026.2008; Buday Tomas, 2012, Cough, V8, P11, DOI 10.1186/1745-9974-8-11; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Chen C, 2011, NICOTINE TOB RES, V13, P741, DOI 10.1093/ntr/ntr031; de Oliveira C, 2014, J NEUROSCI, V34, P4445, DOI 10.1523/JNEUROSCI.5387-13.2014; Delnevo CD, 2011, AM J PREV MED, V41, P357, DOI 10.1016/j.amepre.2011.06.039; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; FDA-TPSAC, 2011, MENTH CIG PUBL HLTH; Gavva NR, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-36; HARIHARAN M, 1991, CLIN CHEM, V37, P1276; Jones MR, 2013, CANCER EPIDEM BIOMAR, V22, P224, DOI 10.1158/1055-9965.EPI-12-0912; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Kanezaki M, 2012, RESP MED, V106, P406, DOI 10.1016/j.rmed.2011.12.007; Klein AH, 2011, CHEM SENSES, V36, P649, DOI 10.1093/chemse/bjr029; Kong G, 2013, NICOTINE TOB RES, V15, P2094, DOI 10.1093/ntr/ntt102; Lanosa MJ, 2010, TOXICOL SCI, V115, P589, DOI 10.1093/toxsci/kfq057; Lee LY, 2010, LUNG, V188, pS23, DOI 10.1007/s00408-009-9191-1; Liu BY, 2013, PAIN, V154, P2169, DOI 10.1016/j.pain.2013.06.043; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Miguez-Burbano MJ, 2014, J ASS NURSES AIDS CA; Millqvist E, 2001, RESP MED, V95, P19, DOI 10.1053/rmed.2000.0965; Millqvist E, 2013, RESP MED, V107, P433, DOI 10.1016/j.rmed.2012.11.017; Mitka M, 2013, JAMA-J AM MED ASSOC, V310, P784, DOI 10.1001/jama.2013.276273; MORICE AH, 1994, THORAX, V49, P1024, DOI 10.1136/thx.49.10.1024; Morris JB, 2005, TOXICOL SCI, V83, P380, DOI 10.1093/toxsci/kfi038; NEURATH GB, 1987, INT ARCH OCC ENV HEA, V59, P199, DOI 10.1007/BF00378497; NSDUH, 2011, NSDUH REP REC TRENDS; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Proudfoot CJ, 2006, CURR BIOL, V16, P1591, DOI 10.1016/j.cub.2006.07.061; Raunio H, 2008, XENOBIOTICA, V38, P34, DOI 10.1080/00498250701708539; Rogers DF, 2002, CURR OPIN PHARMACOL, V2, P249, DOI 10.1016/S1471-4892(02)00146-7; Rojewski AM, 2014, NICOTINE TOB RES, V16, P115, DOI 10.1093/ntr/ntt137; Rosenbloom J, 2012, TOB INDUC DIS, V10, DOI 10.1186/1617-9625-10-19; Saunders C J, 2013, F1000Res, V2, P74, DOI 10.12688/f1000research.2-74.v1; Shusterman D, 1997, ARCH ENVIRON HEALTH, V52, P334, DOI 10.1080/00039899709602208; Silver WL, 2006, CHEM SENSES, V31, P807, DOI 10.1093/chemse/bjl022; Siu ECK, 2007, MOL PHARMACOL, V71, P826, DOI 10.1124/mol.106.032086; Smith SS, 2014, ADDICTION; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; VIJAYARAGHAVAN R, 1993, ARCH TOXICOL, V67, P478, DOI 10.1007/BF01969919; Vozoris NT, 2012, ARCH INTERN MED, V172, P590, DOI 10.1001/archinternmed.2012.320; Washam C, 2011, ENVIRON HEALTH PERSP, V119, pA286, DOI 10.1289/ehp.119-a286; Willis DN, 2011, FASEB J, V25, P4434, DOI 10.1096/fj.11-188383	52	43	44	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117128	10.1371/journal.pone.0117128	http://dx.doi.org/10.1371/journal.pone.0117128			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679525	Green Published, Green Submitted, gold			2022-12-26	WOS:000350682600051
J	Petterson, LJ; Dixson, BJ; Little, AC; Vasey, PL				Petterson, Lanna J.; Dixson, Barnaby J.; Little, Anthony C.; Vasey, Paul L.			Viewing Time Measures of Sexual Orientation in Samoan Cisgender Men Who Engage in Sexual Interactions with Fa'afafine	PLOS ONE			English	Article							AROUSAL; HOMOSEXUALITY; BISEXUALITY; SEARCH	Androphilia refers to attraction to adult males, whereas gynephilia refers to attraction to adult females. The current study employed self-report and viewing time (response time latency) measures of sexual attraction to determine the sexual orientation of Samoan cisgender men (i.e., males whose gender presentation and identity is concordant with their biological sex) who engage in sexual interactions with transgender male androphiles (known locally as fa'afafine) compared to: (1) Samoan cisgender men who only engage in sexual interactions with women, and (2) fa'afafine. As expected, both measures indicated that cisgender men who only engaged in sexual interactions with women exhibited a gynephilic pattern of sexual attraction, whereas fa'afafine exhibited an androphilic one. In contrast, both measures indicated that cisgender men who engaged in sexual interactions with fa'afafine demonstrated a bisexual pattern of sexual attraction. Most of the cisgender men who exhibited bisexual viewing times did not engage in sexual activity with both men and women indicating that the manner in which bisexual patterns of sexual attraction manifest behaviorally vary from one culture to the next.	[Petterson, Lanna J.; Vasey, Paul L.] Univ Lethbridge, Dept Psychol, Lab Comparat Sexual, Lethbridge, AB T1K 3M4, Canada; [Dixson, Barnaby J.] Univ New S Wales, Evolut & Ecol Res Ctr, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Little, Anthony C.] Univ Stirling, Sch Nat Sci, Behav & Evolut Res Grp, Stirling, Scotland	University of Lethbridge; University of New South Wales Sydney; University of Stirling	Petterson, LJ (corresponding author), Univ Lethbridge, Dept Psychol, Lab Comparat Sexual, Lethbridge, AB T1K 3M4, Canada.	l.petterson@uleth.ca	Little, Anthony/W-2732-2019	Little, Anthony/0000-0001-9100-1903; Dixson, Barnaby/0000-0003-0911-1244	University of Lethbridge; Victoria University of Wellington; Social Sciences and Humanities Research Council of Canada Grant; New Zealand International Doctoral Scholarship; American Institute of Bisexuality Grant; Natural Sciences and Engineering Research Council of Canada Discovery Grant; Alberta Innovates-Health Solutions Grant	University of Lethbridge; Victoria University of Wellington; Social Sciences and Humanities Research Council of Canada Grant; New Zealand International Doctoral Scholarship; American Institute of Bisexuality Grant; Natural Sciences and Engineering Research Council of Canada Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Innovates-Health Solutions Grant	Various stages of this research were supported by the University of Lethbridge (www.uleth.ca) and Victoria University of Wellington (www.victoria.ac.nz); by a Social Sciences and Humanities Research Council of Canada Grant (www.sshrc.ca) to LJP; by a New Zealand International Doctoral Scholarship (http://www.enz.govt.nz/how-we-work/scholarships/nzidrs) to BJD; by an American Institute of Bisexuality Grant (www.americaninstituteofbisexuality.org), a Natural Sciences and Engineering Research Council of Canada Discovery Grant (www.nserc.ca), and an Alberta Innovates-Health Solutions Grant (www.aihealthsolutions.ca/) to PLV. The funders had no role in the study design, data, collection, and analysis, decision to publish, or preparation of the manuscript.	Asthana S, 2001, SOC SCI MED, V52, P707, DOI 10.1016/S0277-9536(00)00167-2; Bailey JM, 2011, ARCH SEX BEHAV, V40, P1293, DOI 10.1007/s10508-011-9778-5; Bailey JM, 2000, J PERS SOC PSYCHOL, V78, P524, DOI 10.1037//0022-3514.78.3.524; Bailey JM, 2008, CONTEMPORARY PERSPEC, P43; BENSON PJ, 1993, PERCEPTION, V22, P257, DOI 10.1068/p220257; BLANCHARD R, 1993, J NERV MENT DIS, V181, P570, DOI 10.1097/00005053-199309000-00008; Carballo-Dieguez A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027447; Cerny JA, 2011, ARCH SEX BEHAV, V40, P687, DOI 10.1007/s10508-011-9746-0; Chinas B, 1992, THE ISTHMUS ZAPOTECS; DIAMOND M, 1993, ARCH SEX BEHAV, V22, P291, DOI 10.1007/BF01542119; Ebsworth M, 2012, ARCH SEX BEHAV, V41, P161, DOI 10.1007/s10508-012-9923-9; Gangestad SW, 2000, J PERS SOC PSYCHOL, V78, P1109, DOI 10.1037//0022-3514.78.6.1109; Gaudio Rudi, 2009, ALLAH MADE US SEXUAL; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; Herdt G, 1996, THIRD SEX THIRD GEND; Imhoff R, 2012, ARCH SEX BEHAV, V41, P1389, DOI 10.1007/s10508-011-9879-1; Imhoff R, 2010, ARCH SEX BEHAV, V39, P1275, DOI 10.1007/s10508-009-9595-2; Israel E, 2009, ARCH SEX BEHAV, V38, P551, DOI 10.1007/s10508-007-9246-4; Janssen E, 2011, ARCH SEX BEHAV, V40, P1297, DOI 10.1007/s10508-011-9826-1; Kottak Conrad, 2006, MIRROR FOR HUMANITY; Lauman EO, 1994, THE SOCIAL ORGANIZAT; Letourneau Elizabeth J, 2002, Sex Abuse, V14, P207, DOI 10.1177/107906320201400302; Lippa RA, 2013, ARCH SEX BEHAV, V42, P187, DOI 10.1007/s10508-012-9981-z; Little AC, 2002, BRIT J PSYCHOL, V93, P451, DOI 10.1348/000712602761381349; Murray S. O., 2000, HOMOSEXUALITIES; Nanda S, 1999, NEITHER MAN NOR WOMA; Peletz M., 2009, GENDER PLURALISM SE; Perrett DI, 1998, NATURE, V394, P884, DOI 10.1038/29772; Quinsey VL, 1996, ETHOL SOCIOBIOL, V17, P341, DOI 10.1016/S0162-3095(96)00060-X; Ramanathan S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-827; Rieger G, 2005, PSYCHOL SCI, V16, P579, DOI 10.1111/j.1467-9280.2005.01578.x; Rieger G, 2015, BIOL PSYCHOL, V104, P56, DOI 10.1016/j.biopsycho.2014.11.009; Rieger G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040256; Rosenthal AM, 2012, ARCH SEX BEHAV, V41, P135, DOI 10.1007/s10508-011-9881-7; Rullo JE, 2010, ARCH SEX BEHAV, V39, P874, DOI 10.1007/s10508-009-9497-3; SINGER B, 1984, J SEX RES, V20, P230, DOI 10.1080/00224498409551222; Tiddeman B, 2001, IEEE COMPUT GRAPH, V21, P42, DOI 10.1109/38.946630; Tollison CD., 1979, J BEHAV ASSESS, V1, P305, DOI [10.1007/BF01321372, DOI 10.1007/BF01321372]; VanderLaan DP, 2013, HUM NATURE-INT BIOS, V24, P375, DOI 10.1007/s12110-013-9182-z; Vasey PL, 2014, NEUROSCI BIOBEHAV R, V46, P573, DOI 10.1016/j.neubiorev.2014.09.002; Vasey PL, 2014, THE EVOLUTION OF HUM, P185; Whitam F, 1986, MALE HOMOSEXUALITY I; WIKAN U, 1977, MAN, V12, P304, DOI 10.2307/2800801	43	29	29	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0116529	10.1371/journal.pone.0116529	http://dx.doi.org/10.1371/journal.pone.0116529			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9IO	25679961	gold, Green Submitted, Green Published			2022-12-26	WOS:000350682600025
J	Xi, S; Inchauste, S; Guo, H; Shan, J; Xiao, Z; Xu, H; Miettenen, M; Zhang, MR; Hong, JA; Raiji, MT; Altorki, NK; Casson, AG; Beer, DG; Robles, AI; Bowman, ED; Harris, CC; Steinberg, SM; Schrump, DS				Xi, S.; Inchauste, S.; Guo, H.; Shan, J.; Xiao, Z.; Xu, H.; Miettenen, M.; Zhang, M. R.; Hong, J. A.; Raiji, M. T.; Altorki, N. K.; Casson, A. G.; Beer, D. G.; Robles, A. I.; Bowman, E. D.; Harris, C. C.; Steinberg, S. M.; Schrump, D. S.			Cigarette smoke mediates epigenetic repression of miR-217 during esophageal adenocarcinogenesis	ONCOGENE			English	Article							MESENCHYMAL TRANSITION; LINEAGE PROGRESSION; MICRORNA EXPRESSION; BARRETTS-ESOPHAGUS; CARCINOMA-CELLS; CANCER; PATHOGENESIS; INVASION; OVEREXPRESSION; KALLIKREIN-7	Although microRNAs (miRs) have been implicated in the pathogenesis of various human malignancies, limited information is available regarding mechanisms by which these noncoding RNAs contribute to initiation and progression of tobacco-induced esophageal cancers. In this study, array and quantitative reverse transcriptase-PCR techniques were used to examine miR expression in immortalized esophageal epithelia (IEE) and esophageal adenocarcinoma (EAC) cells cultured in normal media with or without cigarette smoke condensate (CSC). Under relevant exposure conditions, CSC significantly decreased miR-217 expression in these cells. Endogenous levels of miR-217 expression in cultured EAC cells (EACC)/primary EACs were significantly lower than those observed in IEE/paired normal esophageal tissues. RNA crosslink immunoprecipitation, quantitative reverse transcriptase-PCR (qRT-PCR) and immunoblot experiments demonstrated direct interaction of miR-217 with kallikrein 7 (KLK7), encoding a putative oncogene not previously implicated in EAC. Repression of miR-217 correlated with increased levels of KLK7 in primary EACs, particularly those from smokers. Chromatin and methylated DNA immunoprecipitation experiments demonstrated that CSC-mediated repression of miR-217 coincided with DNMT3b-dependent hypermethylation and decreased occupancy of nuclear factor 1 within the miR-217 genomic locus. Deoxyazacytidine induced miR-217 expression and downregulated KLK7 in EACC; deoxyazacytidine also attenuated CSC-mediated miR-217 repression and upregulation of KLK7 in IEE and EACC. Overexpression of miR-217 significantly decreased, whereas overexpression of KLK7 increased proliferation, invasion and tumorigenicity of EACC. Collectively, these data demonstrate that epigenetic repression of miR-217 contributes to the pathogenesis of EAC via upregulation of KLK7 and suggest that restoration of miR-217 expression may be a novel treatment strategy for these malignancies.	[Xi, S.; Inchauste, S.; Zhang, M. R.; Hong, J. A.; Raiji, M. T.; Schrump, D. S.] NCI, Thorac Surg Sect, Thorac & GI Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Guo, H.] Shandong Tumor Hosp & Inst, Gastrointestinal Surg, Jinan, Shandong, Peoples R China; [Shan, J.] NCI, Adv Biomed Comp Ctr, SAIC Frederick, Frederick, MD 21701 USA; [Xiao, Z.] NCI, Canc & Inflammat Lab, Frederick, MD 21701 USA; [Xu, H.] NCI, Lab Canc Prevent, Frederick, MD 21701 USA; [Miettenen, M.] NCI, Pathol Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Altorki, N. K.] Weill Cornell Univ, Med Ctr, Dept Thorac Surg, New York, NY USA; [Casson, A. G.] Univ Saskatchewan, Dept Surg, Saskatoon, SK, Canada; [Beer, D. G.] Univ Michigan, Sect Thorac Surg, Ann Arbor, MI 48109 USA; [Robles, A. I.; Bowman, E. D.; Harris, C. C.] NCI, Lab Human Carcinogenesis, Ctr Canc Res, Bethesda, MD 20892 USA; [Steinberg, S. M.] NCI, Biostat & Data Management Sect, Ctr Canc Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Shandong First Medical University & Shandong Academy of Medical Sciences; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Cornell University; University of Saskatchewan; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Schrump, DS (corresponding author), NCI, Thorac Surg Sect, Thorac & GI Oncol Branch, Ctr Canc Res, Bldg 10,Room 4-3942,10 Ctr Dr, Bethesda, MD 20892 USA.	David_Schrump@nih.gov		Robles, Ana/0000-0001-5019-4374	NIH intramural funding; Stephen J. Solarz Memorial Fund; NATIONAL CANCER INSTITUTE [ZIABC011492, ZIABC011115, Z01BC005480] Funding Source: NIH RePORTER	NIH intramural funding(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stephen J. Solarz Memorial Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Ms Jan Pappas for assistance with manuscript preparation. This study was supported by NIH intramural funding and the Stephen J. Solarz Memorial Fund.	Agrawal N, 2012, CANCER DISCOV, V2, P899, DOI 10.1158/2159-8290.CD-12-0189; [Anonymous], 2013, CURR PROB SURG, V50, P192, DOI 10.1067/j.cpsurg.2013.01.004; Carr Jacquelyn S, 2013, J Gastrointest Cancer, V44, P143, DOI 10.1007/s12029-013-9480-z; Cook MB, 2010, JNCI-J NATL CANCER I, V102, P1344, DOI 10.1093/jnci/djq289; David S, 2011, CURR OPIN PHARMACOL, V11, P612, DOI 10.1016/j.coph.2011.09.006; Devetzi M, 2013, THROMB HAEMOSTASIS, V109, P716, DOI 10.1160/TH12-07-0518; Diaz-Lopez A, 2014, CANCER MANAG RES, V6, P205, DOI 10.2147/CMAR.S38156; Dong Y, 2010, CANCER RES, V70, P2624, DOI 10.1158/0008-5472.CAN-09-3415; Dulak AM, 2012, CANCER RES, V72, P4383, DOI 10.1158/0008-5472.CAN-11-3893; Ek WE, 2013, JNCI-J NATL CANCER I, V105, P1711, DOI 10.1093/jnci/djt303; Fassan M, 2011, INT J CANCER, V129, P1661, DOI 10.1002/ijc.25823; Frankel A, 2014, GENE CHROMOSOME CANC, V53, P324, DOI 10.1002/gcc.22143; Grabowska MM, 2012, FRONT BIOSCI-LANDMRK, V17, P1948, DOI 10.2741/4031; Gu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081032; Hardikar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052192; Iakovlev V, 2012, CANCER EPIDEM BIOMAR, V21, P1135, DOI 10.1158/1055-9965.EPI-11-1079; Johnson SK, 2007, CANCER, V109, P1811, DOI 10.1002/cncr.22606; Kemp CD, 2012, CLIN CANCER RES, V18, P77, DOI 10.1158/1078-0432.CCR-11-0962; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Leidner RS, 2012, GENE CHROMOSOME CANC, V51, P473, DOI 10.1002/gcc.21934; Li H, 2013, NEOPLASMA, V60, P511, DOI 10.4149/neo_2013_066; Mathe EA, 2009, CLIN CANCER RES, V15, P6192, DOI 10.1158/1078-0432.CCR-09-1467; Mayne GC, 2013, CURR PHARM DESIGN, V19, P1211; Mo LJ, 2010, ANTICANCER RES, V30, P3413; Napier KJ, 2014, WORLD J GASTRO ONCOL, V6, P112, DOI 10.4251/wjgo.v6.i5.112; Nishioka C, 2014, CANCER SCI, V105, P297, DOI 10.1111/cas.12339; Prezas P, 2006, BIOL CHEM, V387, P807, DOI 10.1515/BC.2006.102; Prezas P, 2006, BIOL CHEM, V387, P1607, DOI 10.1515/BC.2006.200; Ramani VC, 2011, BBA-MOL CELL RES, V1813, P1525, DOI 10.1016/j.bbamcr.2011.05.007; Ramani VC, 2008, PANCREAS, V37, P399, DOI 10.1097/MPA.0b013e31817f76f7; Rao M, 2011, CANCER RES, V71, P4192, DOI 10.1158/0008-5472.CAN-10-2442; Shaw JLV, 2007, CLIN CHEM, V53, P1423, DOI 10.1373/clinchem.2007.088104; Song JH, 2012, GASTROENTEROLOGY, V143, P35, DOI 10.1053/j.gastro.2012.05.003; Spechler SJ, 2013, JAMA-J AM MED ASSOC, V310, P627, DOI 10.1001/jama.2013.226450; Su J, 2014, MOL CELL BIOCHEM, V392, P289, DOI 10.1007/s11010-014-2039-x; Talieri M, 2009, THROMB HAEMOSTASIS, V101, P741, DOI 10.1160/TH08-07-0471; Tramacere I, 2011, EPIDEMIOLOGY, V22, P344, DOI 10.1097/EDE.0b013e31821092cd; Xi SC, 2013, J CLIN INVEST, V123, P1241, DOI 10.1172/JCI61271; Xi SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013764; Xu EP, 2013, CARCINOGENESIS, V34, P2750, DOI 10.1093/carcin/bgt286; Zhang Y, 2012, J BIOL CHEM, V287, P21926, DOI 10.1074/jbc.M112.340398; Zhang Y, 2011, P NATL ACAD SCI USA, V108, P9863, DOI 10.1073/pnas.1018493108; Zhao WG, 2010, CARCINOGENESIS, V31, P1726, DOI 10.1093/carcin/bgq160	43	27	27	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 29	2015	34	44					5548	5559		10.1038/onc.2015.10	http://dx.doi.org/10.1038/onc.2015.10			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CV9FX	25703328	Green Accepted			2022-12-26	WOS:000364594000004
J	Lin, YG; Shen, J; Yoo, E; Liu, R; Yen, HY; Mehta, A; Rajaei, A; Yang, W; Mhawech-Fauceglia, P; DeMayo, FJ; Lydon, J; Gill, P; Lee, AS				Lin, Y. G.; Shen, J.; Yoo, E.; Liu, R.; Yen, H-Y; Mehta, A.; Rajaei, A.; Yang, W.; Mhawech-Fauceglia, P.; DeMayo, F. J.; Lydon, J.; Gill, P.; Lee, A. S.			Targeting the glucose-regulated protein-78 abrogates Pten-null driven AKT activation and endometrioid tumorigenesis	ONCOGENE			English	Article							ENDOPLASMIC-RETICULUM STRESS; TUMOR-GROWTH; GRP78; CANCER; EXPRESSION; CHAPERONE; CELLS; KNOCKOUT; PROGRESSION; PREDICTOR	Rates of the most common gynecologic cancer, endometrioid adenocarcinoma (EAC), continue to rise, mirroring the global epidemic of obesity, a well-known EAC risk factor. Thus, identifying novel molecular targets to prevent and/or mitigate EAC is imperative. The prevalent Type 1 EAC commonly harbors loss of the tumor suppressor, Pten, leading to AKT activation. The major endoplasmic reticulum (ER) chaperone, GRP78, is a potent pro-survival protein to maintain ER homeostasis, and as a cell surface protein, is known to regulate the phosphatidylinositol 3-kinase (PI3K)/AKT pathway. To determine whether targeting GRP78 could suppress EAC development, we created a conditional knockout mouse model using progesterone receptor-Cre-recombinase to achieve Pten and Grp78 (cPten(f/f)Grp78(f/f)) deletion in the endometrial epithelium. Mice with a single Pten (cPten(f/f)) deletion developed well-differentiated EAC by 4 weeks. In contrast, no cPten(f/f)Grp78(f/f) mice developed EAC, even after more than 8 months of observation. Histologic examination of uteri from cPten(f/f)Grp78(f/f) mice also revealed no complex atypical hyperplasia, a well-established EAC precursor. These histologic observations among the cPten(f/f)Grp78(f/f) murine uteri also corresponded to abrogation of AKT activation within the endometrium. We further observed that GRP78 co-localized with activated AKT on the surface of EAC, thus providing an opportunity for therapeutic targeting. Consistent with previous findings that cell surface GRP78 is an upstream regulator of PI3K/AKT signaling, we show here that in vivo short-term systemic treatment with a highly specific monoclonal antibody against GRP78 suppressed AKT activation and increased apoptosis in the cPtenf/f tumors. Collectively, these findings present GRP78-targeting therapy as an efficacious therapeutic option for EAC.	[Lin, Y. G.; Yoo, E.] Univ So Calif, Keck Sch Med, Dept Obstet & Gynecol, Div Gynecol Oncol,USC Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA; [Shen, J.; Lee, A. S.] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, USC Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA; [Liu, R.; Yen, H-Y; Mehta, A.; Rajaei, A.; Yang, W.; Gill, P.] Univ So Calif, Keck Sch Med, Dept Hematol Oncol, USC Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA; [Mhawech-Fauceglia, P.] Univ So Calif, Keck Sch Med, Dept Pathol, USC Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA; [DeMayo, F. J.; Lydon, J.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; Baylor College of Medicine	Lee, AS (corresponding author), Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, USC Norris Comprehens Canc Ctr, 1441 Eastlake Ave,NOR 5308, Los Angeles, CA 90089 USA.	yvonne.g.lin@gmail.com; amylee@usc.edu	MEHTA, ARJUN/AAH-2251-2021; DeMayo, Francesco/C-6255-2019; Mehta, Arjun/AFO-2449-2022	DeMayo, Francesco/0000-0002-9480-7336; Lee, Amy/0000-0002-0378-5443; mehta, arjun/0000-0002-8778-7832; Shen, Jieli/0000-0003-1905-9101	USC Department of Obstetrics & Gynecology Seed Grant; Stop Cancer Career Development Award; NIH [R01 CA027607, K08 CA175161, P30 DK048522]; NCI Cancer Center Support Grant [P30 CA014089]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042311] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA014089, R01CA027607, K08CA175161] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES103311] Funding Source: NIH RePORTER	USC Department of Obstetrics & Gynecology Seed Grant; Stop Cancer Career Development Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank the USC Norris Comprehensive Cancer Center Translational Pathology Core for tissue processing and the USC Research Center for Liver Diseases Cell and Tissue Imaging Core. We also thank the members of the Lee lab, particularly Wan-Ting Chen, Genyuan Zhu and Michelle Pong for their input and assistance throughout this project. This work was supported by the USC Department of Obstetrics & Gynecology Seed Grant (YGL), Stop Cancer Career Development Award (YGL), NIH Grant R01 CA027607 (ASL), NIH Grant K08 CA175161 (YGL) and NCI Cancer Center Support Grant (P30 CA014089, ASL/YGL). Microscopy at the Cell and Tissue Imaging Core of the USC Research Center for Liver Diseases was supported by NIH Grant P30 DK048522.	Arap MA, 2004, CANCER CELL, V6, P275, DOI 10.1016/j.ccr.2004.08.018; Bifulco G, 2012, GYNECOL ONCOL, V125, P220, DOI 10.1016/j.ygyno.2011.11.045; BOKHMAN JV, 1985, GYNECOL ONCOL, V20, P139, DOI 10.1016/0090-8258(85)90135-0; Cali G, 2014, J CELL PHYSIOL, V229, P1417, DOI 10.1002/jcp.24578; Chen WT, 2014, HEPATOLOGY, V59, P947, DOI 10.1002/hep.26711; Conley-LaComb MK, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-85; Cordero-Espinoza L, 2013, J BIOL CHEM, V288, P36020, DOI 10.1074/jbc.M113.510289; Daikoku T, 2008, CANCER RES, V68, P5619, DOI 10.1158/0008-5472.CAN-08-1274; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Fu Y, 2008, P NATL ACAD SCI USA, V105, P19444, DOI 10.1073/pnas.0807691105; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Gonzalez-Gronow M, 2009, ANTIOXID REDOX SIGN, V11, P2299, DOI [10.1089/ars.2009.2568, 10.1089/ARS.2009.2568]; Gray MJ, 2013, INT J CANCER, V133, P21, DOI 10.1002/ijc.27994; He LN, 2010, AM J PATHOL, V176, P2302, DOI 10.2353/ajpath.2010.090931; Hill R, 2012, MOL CANCER THER, V11, P2127, DOI 10.1158/1535-7163.MCT-12-0342; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Iglesias David A, 2012, Clin Adv Hematol Oncol, V10, P797; Lee AS, 2014, NAT REV CANCER, V14, P263, DOI 10.1038/nrc3701; Lee E, 2006, CANCER RES, V66, P7849, DOI 10.1158/0008-5472.CAN-06-1660; Lee E, 2011, INT J CANCER, V128, P726, DOI 10.1002/ijc.25370; Leslie KK, 2012, OBSTET GYN CLIN N AM, V39, P255, DOI 10.1016/j.ogc.2012.04.001; Li JZ, 2006, CURR MOL MED, V6, P45, DOI 10.2174/156652406775574523; Liu R, 2013, CLIN CANCER RES, V19, P6802, DOI 10.1158/1078-0432.CCR-13-1106; Liu R, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-269; Luo B, 2013, ONCOGENE, V32, P805, DOI 10.1038/onc.2012.130; Ma YJ, 2004, NAT REV CANCER, V4, P966, DOI 10.1038/nrc1505; Mahadevan NR, 2011, P NATL ACAD SCI USA, V108, P6561, DOI 10.1073/pnas.1008942108; Matsuo K, 2013, GYNECOL ONCOL, V128, P552, DOI 10.1016/j.ygyno.2012.11.024; Misra UK, 2006, J BIOL CHEM, V281, P13694, DOI 10.1074/jbc.M511694200; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Ni M, 2011, BIOCHEM J, V434, P181, DOI 10.1042/BJ20101569; Pootrakul L, 2006, CLIN CANCER RES, V12, P5987, DOI 10.1158/1078-0432.CCR-06-0133; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sato M, 2010, ADV GENET, V69, P97, DOI 10.1016/S0065-2660(10)69006-2; Schmandt RE, 2011, AM J OBSTET GYNECOL, V205, P518, DOI 10.1016/j.ajog.2011.05.042; Shin BK, 2003, J BIOL CHEM, V278, P7607, DOI 10.1074/jbc.M210455200; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Wey S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039047; Wey S, 2012, BLOOD, V119, P817, DOI 10.1182/blood-2011-06-357384; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Zhang LH, 2011, BRAIN RES, V1371, P23, DOI 10.1016/j.brainres.2010.11.063; Zhang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080071; Zhang Y, 2010, J BIOL CHEM, V285, P15065, DOI 10.1074/jbc.M109.087445; Zhuang LQ, 2009, HISTOPATHOLOGY, V54, P462, DOI 10.1111/j.1365-2559.2009.03242.x	44	25	25	0	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2015	34	43					5418	5426		10.1038/onc.2015.4	http://dx.doi.org/10.1038/onc.2015.4			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CU4EM	25684138	Green Accepted			2022-12-26	WOS:000363479700002
J	Koc, C; Gerlach, D; Beck, S; Peschel, A; Xia, GQ; Stehle, T				Koc, Cengiz; Gerlach, David; Beck, Sebastian; Peschel, Andreas; Xia, Guoqing; Stehle, Thilo			Structural and Enzymatic Analysis of TarM Glycosyltransferase from Staphylococcus aureus Reveals an Oligomeric Protein Specific for the Glycosylation of Wall Teichoic Acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHICILLIN RESISTANCE; BIOSYNTHESIS; INSIGHTS; LIPOPOLYSACCHARIDE; ORGANIZATION; VIRULENCE; REFMAC5; BINDING; FAMILY; CELLS	Anionic glycopolymers known as wall teichoic acids (WTAs) functionalize the peptidoglycan layers of many Gram-positive bacteria. WTAs play central roles in many fundamental aspects of bacterial physiology, and they are important determinants of pathogenesis and antibiotic resistance. A number of enzymes that glycosylate WTA in Staphylococcus aureus have recently been identified. Among these is the glycosyltransferase TarM, a component of the WTA de novo biosynthesis pathway. TarM performs the synthesis of alpha-O-N-acetylglycosylated poly-5'-phosphoribitol in the WTA structure. We have solved the crystal structure ofTarMat 2.4 angstrom resolution, and we have also determined a structure of the enzyme in complex with its substrate UDPGlcNAcat2.8A angstrom resolution. Theproteinassemblesintoapropellerlike homotrimer in which each blade contains a GT-B-type glycosyltransferase domain with a typical Rossmann fold. The enzymatic reaction retains the stereochemistry of the anomeric center of the transferred GlcNAc-moiety on the polyribitol backbone. TarM assembles into a trimer using a novel trimerization domain, here termed the HUB domain. Structure-guided mutagenesis experiments of TarM identify residues critical for enzyme activity, assign a putative role for the HUB in TarM function, and allow us to propose a likely reaction mechanism.	[Koc, Cengiz; Stehle, Thilo] Univ Tubingen, Interfac Inst Biochem, D-72076 Tubingen, Germany; [Gerlach, David; Beck, Sebastian; Peschel, Andreas; Xia, Guoqing] Univ Tubingen, Interfac Inst Microbiol & Infect Med, Cellular & Mol Microbiol Sect, D-72076 Tubingen, Germany; [Peschel, Andreas; Stehle, Thilo] German Ctr Infect Res DZIF, D-72076 Tubingen, Germany; [Xia, Guoqing] Univ Manchester, Fac Med & Human Sci, Inst Inflammat & Repair, Stopford Bld,Oxford Rd, Manchester M13 9PT, Lancs, England; [Stehle, Thilo] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN USA	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; German Center for Infection Research; University of Manchester; Vanderbilt University	Xia, GQ (corresponding author), Univ Manchester, Fac Med & Human Sci, Inst Inflammat & Repair, Stopford Bld,Oxford Rd, Manchester M13 9PT, Lancs, England.	guoqing.xia@manchester.ac.uk; thilo.stehle@uni-tuebingen.de	Xia, Guoqing/C-2365-2015	Xia, Guoqing/0000-0003-4492-9156	German Research Foundation [SFB766, TRR34]; German Center for Infection Research (DZIF)	German Research Foundation(German Research Foundation (DFG)); German Center for Infection Research (DZIF)	This work was supported by Collaborative Research Grant SFB766 (to A.P., G.X., and T.S.) and TRR34 (to T.S. and A. P.) from the German Research Foundation and by the German Center for Infection Research (DZIF; to G. X. and A. P.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Atilano ML, 2010, P NATL ACAD SCI USA, V107, P18991, DOI 10.1073/pnas.1004304107; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baron, 1996, VIRAL PATHOGENESIS M; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Batt SM, 2010, J BIOL CHEM, V285, P37741, DOI 10.1074/jbc.M110.165407; Baur S, 2009, J BACTERIOL, V191, P1200, DOI 10.1128/JB.01120-08; Bera A, 2007, J BACTERIOL, V189, P280, DOI 10.1128/JB.01221-06; Breton C, 2012, CURR OPIN STRUC BIOL, V22, P540, DOI 10.1016/j.sbi.2012.06.007; Brown S, 2008, CHEM BIOL, V15, P12, DOI 10.1016/j.chembiol.2007.11.011; Brown S, 2013, ANNU REV MICROBIOL, V67, P313, DOI 10.1146/annurev-micro-092412-155620; Brown S, 2012, P NATL ACAD SCI USA, V109, P18909, DOI 10.1073/pnas.1209126109; Campeotto I, 2014, J BIOL CHEM, V289, P28054, DOI 10.1074/jbc.M114.590570; DeLano WL., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Greenfield LK, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.412577; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kawai Y, 2011, EMBO J, V30, P4931, DOI 10.1038/emboj.2011.358; KOJIMA N, 1985, J BACTERIOL, V161, P299, DOI 10.1128/JB.161.1.299-306.1985; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kristian SA, 2003, J INFECT DIS, V188, P414, DOI 10.1086/376533; Kurokawa K, 2013, J BIOL CHEM, V288, P30956, DOI 10.1074/jbc.M113.509893; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Leonard PG, 2013, P NATL ACAD SCI USA, V110, P8525, DOI 10.1073/pnas.1302819110; Li M, 2007, P NATL ACAD SCI USA, V104, P9469, DOI 10.1073/pnas.0702159104; Lovering AL, 2010, NAT STRUCT MOL BIOL, V17, P582, DOI 10.1038/nsmb.1819; MAKI H, 1994, J BACTERIOL, V176, P4993, DOI 10.1128/jb.176.16.4993-5000.1994; Martinez-Fleites C, 2006, CHEM BIOL, V13, P1143, DOI 10.1016/j.chembiol.2006.09.005; MULDER GJ, 1975, BIOCHEM J, V151, P131, DOI 10.1042/bj1510131; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Parsonage D, 2010, BIOCHEMISTRY-US, V49, P8398, DOI 10.1021/bi100698n; Peschel A, 2006, NAT REV MICROBIOL, V4, P529, DOI 10.1038/nrmicro1441; Qamar A, 2012, ANTIMICROB AGENTS CH, V56, P3797, DOI 10.1128/AAC.00187-12; Schaffer C, 2005, MICROBIOL-SGM, V151, P643, DOI 10.1099/mic.0.27749-0; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Shi WW, 2014, J BIOL CHEM, V289, P20898, DOI 10.1074/jbc.M114.581934; Steiner K, 2010, J MOL BIOL, V397, P436, DOI 10.1016/j.jmb.2010.01.035; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Velloso LM, 2008, EMBO REP, V9, P199, DOI 10.1038/sj.embor.7401154; Vetting MW, 2008, J BIOL CHEM, V283, P15834, DOI 10.1074/jbc.M801017200; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Weidenmaier C, 2005, INFECT IMMUN, V73, P8033, DOI 10.1128/IAI.73.12.8033-8038.2005; Weidenmaier C, 2005, J INFECT DIS, V191, P1771, DOI 10.1086/429692; Weidenmaier C, 2004, NAT MED, V10, P243, DOI 10.1038/nm991; Weidenmaier C, 2008, NAT REV MICROBIOL, V6, P276, DOI 10.1038/nrmicro1861; Wendlinger G, 1996, MICROBIOL-UK, V142, P985, DOI 10.1099/00221287-142-4-985; Winstel V, 2014, MBIO, V5, DOI 10.1128/mBio.00869-14; WRIGHT AK, 1973, BIOPHYS J, V13, P795, DOI 10.1016/S0006-3495(73)86025-4; Xia GQ, 2011, J BACTERIOL, V193, P4006, DOI 10.1128/JB.01412-10; Xia GQ, 2010, J BIOL CHEM, V285, P13405, DOI 10.1074/jbc.M109.096172; Xiang Y, 2010, J VIROL, V84, P12265, DOI 10.1128/JVI.01303-10	55	15	17	1	23	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9874	9885		10.1074/jbc.M114.619924	http://dx.doi.org/10.1074/jbc.M114.619924			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25697358	Green Published, hybrid			2022-12-26	WOS:000352729400046
J	Zheng, YH; Zou, FY; Wang, JJ; Yin, GF; Le, V; Fei, ZW; Liu, JW				Zheng, Yuanhong; Zou, Fangyuan; Wang, Jingjing; Yin, Guifang; Le, Vanminh; Fei, Zhewei; Liu, Jianwen			Photodynamic Therapy-mediated Cancer Vaccination Enhances Stem-like Phenotype and Immune Escape, Which Can Be Blocked by Thrombospondin-1 Signaling through CD47 Receptor Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOGENOUS INHIBITOR; TUMOR-CELLS; T-CELLS; IMMUNOTHERAPY; PATHWAY; IDENTIFICATION; GROWTH; ANGIOGENESIS; RESISTANCE; POPULATION	Like most of the strategies for cancer immunotherapy, photodynamic therapy-mediated vaccination has shown poor clinical outcomes in application. The aim of this study is to offer a glimpse at the mechanisms that are responsible for the failure based on cancer immuno-editing theory and to search for a positive solution. In this study we found that tumor cells were able to adapt themselves to the immune pressure exerted by vaccination. The survived tumor cells exhibited enhanced tumorigenic and stem-like phenotypes as well as undermined immunogenicity. Viewed as a whole, immune-selected tumor cells showed more malignant characteristics and the ability of immune escape, which might contribute to the eventual relapse. Thrombospondin-1 signaling via CD47 helped prevent tumor cells from becoming stem-like and rendered them vulnerable to immune attack. These findings prove that the TSP-1/CD47/SIRP-alpha signal axis is important to the evolution of tumor cells in the microenvironment of immunotherapy and identify thrombospondin-1 as a key signal with therapeutic benefits in overcoming long term relapse, providing new evidence for the clinical promise of cancer vaccination.	[Zheng, Yuanhong; Zou, Fangyuan; Wang, Jingjing; Yin, Guifang; Le, Vanminh; Liu, Jianwen] E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Biomed Nanotechnol Ctr, Sch Pharm,Dept Mol & Cellular Pharmacol, Shanghai 200237, Peoples R China; [Zheng, Yuanhong; Zou, Fangyuan; Wang, Jingjing; Yin, Guifang; Le, Vanminh; Liu, Jianwen] E China Univ Sci & Technol, Shanghai Key Lab New Drug Design, Sch Pharm, Shanghai 200237, Peoples R China; [Fei, Zhewei] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Gen Surg,Chongming Branch, Chengqiaozhen 202150, Chongming Shang, Peoples R China	East China University of Science & Technology; East China University of Science & Technology; Shanghai Jiao Tong University	Fei, ZW (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Gen Surg,Chongming Branch, 25 Nanmen Rd, Chengqiaozhen 202150, Chongming Shang, Peoples R China.	zheweifei@xinhuamed.com.cn; liujian@ecust.edu.cn	WANG, JINGYI/GSJ-1241-2022; wang, jing/GRS-7509-2022		Shanghai Committee of Science and Technology [13140902300, 11DZ2260600]	Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee)	This work was supported by Shanghai Committee of Science and Technology Grants 13140902300 and 11DZ2260600.	Agostinis P, 2011, CA-CANCER J CLIN, V61, P250, DOI 10.3322/caac.20114; Aptsiauri N, 2008, CANCER IMMUNOL IMMUN, V57, P1727, DOI 10.1007/s00262-008-0532-3; Baek KH, 2013, J CLIN INVEST, V123, P4375, DOI 10.1172/JCI67465; Bornstein P, 2009, J CELL COMMUN SIGNAL, V3, P189, DOI 10.1007/s12079-009-0060-8; Brown EJ, 2001, TRENDS CELL BIOL, V11, P130, DOI 10.1016/S0962-8924(00)01906-1; Burger P, 2012, BLOOD, V119, P5512, DOI 10.1182/blood-2011-10-386805; Chao MP, 2012, CURR OPIN IMMUNOL, V24, P225, DOI 10.1016/j.coi.2012.01.010; Chiou SH, 2010, CANCER RES, V70, P10433, DOI 10.1158/0008-5472.CAN-10-2638; Dasgupta P, 2011, JNCI-J NATL CANCER I, V103, P317, DOI 10.1093/jnci/djq541; Di Stefano B, 2009, STEM CELLS DEV, V18, P707, DOI 10.1089/scd.2008.0180; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Fucikova J, 2011, CANCER RES, V71, P4821, DOI 10.1158/0008-5472.CAN-11-0950; Galluzzi L, 2012, EMBO J, V31, P1055, DOI 10.1038/emboj.2012.2; Garg AD, 2012, EMBO J, V31, P1062, DOI 10.1038/emboj.2011.497; Garg AD, 2012, CANCER IMMUNOL IMMUN, V61, P215, DOI 10.1007/s00262-011-1184-2; Garg AD, 2010, APOPTOSIS, V15, P1050, DOI 10.1007/s10495-010-0479-7; Grimbert P, 2006, J IMMUNOL, V177, P3534, DOI 10.4049/jimmunol.177.6.3534; Herreros-Villanueva M, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.23; Huang CP, 2013, CANCER LETT, V328, P144, DOI 10.1016/j.canlet.2012.08.021; Isenberg JS, 2009, J BIOL CHEM, V284, P1116, DOI 10.1074/jbc.M804860200; Jung NC, 2012, CANCER LETT, V324, P58, DOI 10.1016/j.canlet.2012.04.024; Kabingu E, 2007, BRIT J CANCER, V96, P1839, DOI 10.1038/sj.bjc.6603792; Kaur S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01673; Kaur S, 2010, J BIOL CHEM, V285, P38923, DOI 10.1074/jbc.M110.172304; Korbelik M, 2012, CANCER IMMUNOL IMMUN, V61, P1387, DOI 10.1007/s00262-012-1206-8; Lawler J, 2002, J CELL MOL MED, V6, P1, DOI 10.1111/j.1582-4934.2002.tb00307.x; Liu TC, 2010, INT J ONCOL, V36, P777, DOI 10.3892/ijo_00000553; Liu W, 2012, P NATL ACAD SCI USA, V109, P8983, DOI 10.1073/pnas.1203244109; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma L, 2014, BIOCHEM BIOPH RES CO, V450, P353, DOI 10.1016/j.bbrc.2014.05.110; Miller TW, 2013, MATRIX BIOL, V32, P316, DOI 10.1016/j.matbio.2013.02.009; Morrison BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049752; Mroz P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015194; Noh KH, 2012, CANCER RES, V72, P1717, DOI 10.1158/0008-5472.CAN-11-3758; Palucka K, 2012, NAT REV CANCER, V12, P265, DOI 10.1038/nrc3258; Ramakrishnan R, 2010, J CLIN INVEST, V120, P1111, DOI 10.1172/JCI40269; Rivera C, 2011, J ONCOL, V2011, DOI 10.1155/2011/549181; Sarfati M, 2008, CURR DRUG TARGETS, V9, P842, DOI 10.2174/138945008785909310; Schatton T, 2009, ANN NY ACAD SCI, V1176, P154, DOI 10.1111/j.1749-6632.2009.04568.x; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Sharma P, 2011, NAT REV CANCER, V11, P805, DOI 10.1038/nrc3153; Shen K, 2012, BIOCHEM PHARMACOL, V84, P320, DOI 10.1016/j.bcp.2012.04.017; Shirota Y, 2012, J IMMUNOL, V188, P1592, DOI 10.4049/jimmunol.1101304; Taraboletti G, 2010, ONCOTARGET, V1, P662; Tirino V, 2009, EUR J CARDIO-THORAC, V36, P446, DOI 10.1016/j.ejcts.2009.03.063; Vermeer DW, 2013, INT J CANCER, V133, P120, DOI 10.1002/ijc.28015; Wang WJ, 2013, CANCER RES, V73, P1219, DOI 10.1158/0008-5472.CAN-12-1408; Wilczynski JR, 2010, ARCH IMMUNOL THER EX, V58, P435, DOI 10.1007/s00005-010-0102-1; Willingham SB, 2012, P NATL ACAD SCI USA, V109, P6662, DOI 10.1073/pnas.1121623109; Zhang AM, 2012, ASIAN PAC J CANCER P, V13, P761, DOI 10.7314/APJCP.2012.13.3.761; Zhao XW, 2011, P NATL ACAD SCI USA, V108, P18342, DOI 10.1073/pnas.1106550108; Zheng YH, 2013, CELL STRESS CHAPERON, V18, P203, DOI 10.1007/s12192-012-0374-y	52	17	18	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					8975	8986		10.1074/jbc.M114.624965	http://dx.doi.org/10.1074/jbc.M114.624965			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25697354	Green Published, hybrid			2022-12-26	WOS:000352207100024
J	Staubert, C; Bhuiyan, H; Lindahl, A; Broom, OJ; Zhu, YF; Islam, S; Linnarsson, S; Lehtio, J; Nordstrom, A				Staeubert, Claudia; Bhuiyan, Hasanuzzaman; Lindahl, Anna; Broom, Oliver Jay; Zhu, Yafeng; Islam, Saiful; Linnarsson, Sten; Lehtio, Janne; Nordstrom, Anders			Rewired Metabolism in Drug-resistant Leukemia Cells A METABOLIC SWITCH HALLMARKED BY REDUCED DEPENDENCE ON EXOGENOUS GLUTAMINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; FATTY-ACID OXIDATION; MULTIDRUG-RESISTANCE; CANCER; EXPRESSION; CHAIN; DAUNORUBICIN; METHYLATION; RELAPSE; ORIGIN	Cancer cells that escape induction therapy are a major cause of relapse. Understanding metabolic alterations associated with drug resistance opens up unexplored opportunities for the development of new therapeutic strategies. Here, we applied a broad spectrum of technologies including RNA sequencing, global untargeted metabolomics, and stable isotope labeling mass spectrometry to identify metabolic changes in P-glycoprotein overexpressing T-cell acute lymphoblastic leukemia (ALL) cells, which escaped a therapeutically relevant daunorubicin treatment. We show that compared with sensitive ALL cells, resistant leukemia cells possess a fundamentally rewired central metabolism characterized by reduced dependence on glutamine despite a lack of expression of glutamate-ammonia ligase (GLUL), a higher demand for glucose and an altered rate of fatty acid beta-xidation, accompanied by a decreased pantothenic acid uptake capacity. We experimentally validate our findings by selectively targeting components of this metabolic switch, using approved drugs and starvation approaches followed by cell viability analyses in both the ALL cells and in an acute myeloid leukemia (AML) sensitive/resistant cell line pair. We demonstrate how comparative metabolomics andRNAexpression profiling of drug-sensitive and -resistant cells expose targetable metabolic changes and potential resistance markers. Our results show that drug resistance is associated with significant metabolic costs in cancer cells, which could be exploited using new therapeutic strategies.	[Staeubert, Claudia; Broom, Oliver Jay; Nordstrom, Anders] Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden; [Staeubert, Claudia; Nordstrom, Anders] Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, S-90183 Umea, Sweden; [Islam, Saiful; Linnarsson, Sten] Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; [Bhuiyan, Hasanuzzaman; Lindahl, Anna; Zhu, Yafeng; Lehtio, Janne; Nordstrom, Anders] Karolinska Inst, Dept Oncol Pathol, Sci Life Lab, S-17177 Stockholm, Sweden; [Staeubert, Claudia] Univ Leipzig, Inst Biochem, Fac Med, D-04103 Leipzig, Germany	Umea University; Swedish University of Agricultural Sciences; Karolinska Institutet; Karolinska Institutet; Leipzig University	Nordstrom, A (corresponding author), Dept Mol Biol, SE-90187 Umea, Sweden.	anders.nordstrom@molbiol.umu.se	Linnarsson, Sten/HCH-3909-2022; Stäubert, Claudia/I-7397-2015	Stäubert, Claudia/0000-0003-0721-8507; Lehtio, Janne/0000-0002-8100-9562	Swedish Research Council [2007-5143, 2012-5145]; Erling-Persson family foundation; Swedish Foundation for Strategic Research; Swedish Cancer Society; Jane and Dan Olsson Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Erling-Persson family foundation; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Cancer Society(Swedish Cancer Society); Jane and Dan Olsson Foundation	This work was supported by Swedish Research Council Grants 2007-5143 (to A. N.) and 2012-5145 (to J. L.), grants from the Erling-Persson family foundation (to Umea University), the Swedish Foundation for Strategic Research (to A. N.), the Swedish Cancer Society (to J. L.), and Jane and Dan Olsson Foundation (to A. N.).	Amiri-Kordestani L, 2012, DRUG RESIST UPDATE, V15, P50, DOI 10.1016/j.drup.2012.02.002; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Araki Y, 2001, EUR J GASTROEN HEPAT, V13, P107, DOI 10.1097/00042737-200102000-00004; Bogason A, 2011, BRIT J CLIN PHARMACO, V71, P514, DOI 10.1111/j.1365-2125.2010.03894.x; Borst P, 2013, J CLIN INVEST, V123, P4131, DOI 10.1172/JCI70430; Carracedo A, 2013, NAT REV CANCER, V13, P227, DOI 10.1038/nrc3483; Castro-Perez J, 2011, J LIPID RES, V52, P159, DOI 10.1194/jlr.D009787; Castro-Perez JM, 2011, J PROTEOME RES, V10, P4281, DOI 10.1021/pr200480g; Chen KG, 2012, CLIN CANCER RES, V18, P1863, DOI 10.1158/1078-0432.CCR-11-1590; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P8674, DOI 10.1073/pnas.1016627108; Clappier E, 2011, J EXP MED, V208, P653, DOI 10.1084/jem.20110105; Clendening JW, 2012, ONCOGENE, V31, P4967, DOI 10.1038/onc.2012.6; Daye D, 2012, SEMIN CELL DEV BIOL, V23, P362, DOI 10.1016/j.semcdb.2012.02.002; Galluzzi L, 2013, NAT REV DRUG DISCOV, V12, P829, DOI 10.1038/nrd4145; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Haffner MC, 2013, J CLIN INVEST, V123, P4918, DOI 10.1172/JCI70354; Hatle KM, 2007, MOL CELL BIOL, V27, P2952, DOI 10.1128/MCB.01804-06; Hatle KM, 2013, MOL CELL BIOL, V33, P2302, DOI 10.1128/MCB.00189-13; Hoffmann K, 2008, BRIT J HAEMATOL, V140, P656, DOI 10.1111/j.1365-2141.2008.06981.x; Islam S, 2012, NAT PROTOC, V7, P813, DOI 10.1038/nprot.2012.022; Islam S, 2011, GENOME RES, V21, P1160, DOI 10.1101/gr.110882.110; JONSSON K, 1995, BIOCHEM PHARMACOL, V49, P755, DOI 10.1016/0006-2952(94)00511-J; Kanda M, 2015, GASTRIC CANCER, V18, P288, DOI 10.1007/s10120-014-0372-0; Kerner J, 2007, FEBS LETT, V581, P4491, DOI 10.1016/j.febslet.2007.08.026; Kung HN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002229; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lindsey JC, 2006, INT J CANCER, V118, P346, DOI 10.1002/ijc.21353; Ling B, 2013, LUNG CANCER, V79, P104, DOI 10.1016/j.lungcan.2012.10.012; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Munoz-Pinedo C, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.123; Nordstrom A, 2008, ANAL CHEM, V80, P421, DOI 10.1021/ac701982e; Oosterveer MH, 2009, J BIOL CHEM, V284, P34036, DOI 10.1074/jbc.M109.051052; Panigrahy D, 2008, P NATL ACAD SCI USA, V105, P985, DOI 10.1073/pnas.0711281105; Roe DS, 2000, MOL GENET METAB, V69, P69, DOI 10.1006/mgme.1999.2950; Shridhar V, 2001, CANCER RES, V61, P4258; Singh B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036510; Stock W, 2013, CANCER-AM CANCER SOC, V119, P90, DOI 10.1002/cncr.27617; Strathdee G, 2004, CARCINOGENESIS, V25, P693, DOI 10.1093/carcin/bgh066; Styczynski J, 2007, J CANCER RES CLIN, V133, P875, DOI 10.1007/s00432-007-0274-1; Tein I, 2013, HAND CLINIC, V113, P1675, DOI 10.1016/B978-0-444-59565-2.00035-6; TSERNG KY, 1991, BIOCHEMISTRY-US, V30, P2508, DOI 10.1021/bi00223a030; Violante S, 2013, BBA-MOL BASIS DIS, V1832, P773, DOI 10.1016/j.bbadis.2013.02.012; Witham J, 2008, INT J CANCER, V122, P2641, DOI 10.1002/ijc.23427; Zahreddine H, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00028; Zajac P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085270; Zhao Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.60	46	54	56	1	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8348	8359		10.1074/jbc.M114.618769	http://dx.doi.org/10.1074/jbc.M114.618769			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25697355	Green Published, hybrid			2022-12-26	WOS:000351662600029
J	O'Loughlin, JL; Eucker, TP; Chavez, JD; Samuelson, DR; Neal-McKinney, J; Gourley, CR; Bruce, JE; Konkel, ME				O'Loughlin, Jason L.; Eucker, Tyson P.; Chavez, Juan D.; Samuelson, Derrick R.; Neal-McKinney, Jason; Gourley, Christopher R.; Bruce, James E.; Konkel, Michael E.			Analysis of the Campylobacter jejuni Genome by SMRT DNA Sequencing Identifies Restriction-Modification Motifs	PLOS ONE			English	Article							VIRULENCE GENE; REVEALS; INFECTION; DIVERSITY; ENTERITIS	Campylobacter jejuni is a leading bacterial cause of human gastroenteritis. The goal of this study was to analyze the C. jejuni F38011 strain, recovered from an individual with severe enteritis, at a genomic and proteomic level to gain insight into microbial processes. The C. jejuni F38011 genome is comprised of 1,691,939 bp, with a mol.% (G+C) content of 30.5%. PacBio sequencing coupled with REBASE analysis was used to predict C. jejuni F38011 genomic sites and enzymes that may be involved in DNA restriction-modification. A total of five putative methylation motifs were identified as well as the C. jejuni enzymes that could be responsible for the modifications. Peptides corresponding to the deduced amino acid sequence of the C. jejuni enzymes were identified using proteomics. This work sets the stage for studies to dissect the precise functions of the C. jejuni putative restrictionmodification enzymes. Taken together, the data generated in this study contributes to our knowledge of the genomic content, methylation profile, and encoding capacity of C. jejuni.	[O'Loughlin, Jason L.; Eucker, Tyson P.; Samuelson, Derrick R.; Neal-McKinney, Jason; Gourley, Christopher R.; Konkel, Michael E.] Washington State Univ, Coll Vet Med, Sch Mol Biosci, Pullman, WA 99164 USA; [Chavez, Juan D.; Bruce, James E.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	Washington State University; University of Washington; University of Washington Seattle	Konkel, ME (corresponding author), Washington State Univ, Coll Vet Med, Sch Mol Biosci, Pullman, WA 99164 USA.	konkel@vetmed.wsu.edu	Samuelson, Derrick/AAR-4230-2021; Samuelson, Derrick/AAC-9132-2019	Samuelson, Derrick/0000-0002-5356-1413; Chavez, Juan/0000-0001-8849-0304; Konkel, Michael/0000-0002-8950-0903	National Institutes of Health (NIH) [R56 AI088518-01A1, 5R01GM086688]; National Institutes of Health T32 Training program in Infectious Diseases and Microbial Immunology [5 T32 AI 7025-33]; National Institute of General Medical Sciences (NIGMS) [T32GM008336, T32GM083864]; NIGMS [T32GM083864]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007025, R56AI088518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008336, R01GM086688, T32GM083864] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health T32 Training program in Infectious Diseases and Microbial Immunology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funds awarded by the National Institutes of Health (NIH) to Michael E. Konkel (Award Number R56 AI088518-01A1). Jason L. O'Loughlin was supported, in part, by funds awarded by the National Institutes of Health T32 Training program in Infectious Diseases and Microbial Immunology (Award Number 5 T32 AI 7025-33). Tyson P. Eucker was supported, in part, by funds awarded by the National Institute of General Medical Sciences (NIGMS, Award Number T32GM008336 and T32GM083864). Derrick R. Samuelson was supported, in part, by funds awarded by NIGMS (T32GM083864). James E. Bruce and Juan D. Chavez were supported by funds awarded by the NIH (Award Number 5R01GM086688). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa K, 2012, CURR GENOMICS, V13, P4, DOI 10.2174/138920212799034749; Batchelor RA, 2004, MICROBIOL-SGM, V150, P3507, DOI 10.1099/mic.0.27112-0; Biggs PJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027121; BLACK RE, 1988, J INFECT DIS, V157, P472, DOI 10.1093/infdis/157.3.472; BLASER MJ, 1979, ANN INTERN MED, V91, P179, DOI 10.7326/0003-4819-91-2-179; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; Casadesus J, 2006, MICROBIOL MOL BIOL R, V70, P830, DOI 10.1128/MMBR.00016-06; Champion OL, 2005, P NATL ACAD SCI USA, V102, P16043, DOI 10.1073/pnas.0503252102; Choe W, 2005, BIOCHEM BIOPH RES CO, V334, P1233, DOI 10.1016/j.bbrc.2005.07.017; Christensen JE, 2009, MOL MICROBIOL, V73, P650, DOI 10.1111/j.1365-2958.2009.06797.x; Clark TA, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1146; Cooper KK, 2011, J BACTERIOL, V193, P1491, DOI 10.1128/JB.01475-10; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DEKEYSER P, 1972, J INFECT DIS, V125, P390, DOI 10.1093/infdis/125.4.390; Dorrell N, 2001, GENOME RES, V11, P1706, DOI 10.1101/gr.185801; Duong T, 2009, CURR OPIN BIOTECH, V20, P158, DOI 10.1016/j.copbio.2009.03.004; Feng ZX, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002935; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; Gilbert M, 2007, CHEMBIOCHEM, V8, P625, DOI 10.1002/cbic.200600508; Gundogdu O, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-162; Konkel M E, 2001, Curr Issues Intest Microbiol, V2, P55; KONKEL ME, 1992, J MED MICROBIOL, V37, P30, DOI 10.1099/00222615-37-1-30; Konkel ME, 1999, J CLIN MICROBIOL, V37, P510, DOI 10.1128/JCM.37.3.510-517.1999; Kramer JM, 2000, J FOOD PROTECT, V63, P1654, DOI 10.4315/0362-028X-63.12.1654; Krebes J, 2014, NUCLEIC ACIDS RES, V42, P2415, DOI 10.1093/nar/gkt1201; Malik-Kale P, 2008, J BACTERIOL, V190, P2286, DOI 10.1128/JB.01736-07; Malik-Kale P, 2007, APPL ENVIRON MICROB, V73, P3123, DOI 10.1128/AEM.01399-06; Miller WG, 2005, MICROBIOL-SGM, V151, P337, DOI 10.1099/mic.0.27327-0; Murray IA, 2012, NUCLEIC ACIDS RES, V40, P11450, DOI 10.1093/nar/gks891; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Pearson BM, 2003, FEBS LETT, V554, P224, DOI 10.1016/S0014-5793(03)01164-5; Poly F, 2005, J CLIN MICROBIOL, V43, P2330, DOI 10.1128/JCM.43.5.2330-2338.2005; Raphael BH, 2005, CAMPYLOBACTER: MOLECULAR AND CELLULAR BIOLOGY, P397; Ratel D, 2006, FEBS LETT, V580, P3179, DOI 10.1016/j.febslet.2006.04.074; Samuelson DR, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-79; Schwerer B, 2002, MICROBES INFECT, V4, P373, DOI 10.1016/S1286-4579(02)01550-2; SEBALD M, 1963, ANN I PASTEUR PARIS, V105, P897; Stothard P, 2005, BIOINFORMATICS, V21, P537, DOI 10.1093/bioinformatics/bti054; Tock MR, 2005, CURR OPIN MICROBIOL, V8, P466, DOI 10.1016/j.mib.2005.06.003; Weisbrod CR, 2013, J PROTEOMICS, V88, P109, DOI 10.1016/j.jprot.2013.04.009; Wilson DJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000203; Wilson MK, 2009, MICROB ECOL, V58, P843, DOI 10.1007/s00248-009-9571-3; Wu CH, 2006, NUCLEIC ACIDS RES, V34, pD187, DOI 10.1093/nar/gkj161; YUKI N, 1993, J EXP MED, V178, P1771, DOI 10.1084/jem.178.5.1771; Zhang MJ, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00256-13	45	14	14	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0118533	10.1371/journal.pone.0118533	http://dx.doi.org/10.1371/journal.pone.0118533			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695747	Green Published, gold, Green Submitted			2022-12-26	WOS:000350062300054
J	Ball, A; Sanchez-Azofeifa, A; Portillo-Quintero, C; Rivard, B; Castro-Contreras, S; Fernandes, G				Ball, Aaron; Sanchez-Azofeifa, Arturo; Portillo-Quintero, Carlos; Rivard, Benoit; Castro-Contreras, Saulo; Fernandes, Geraldo			Patterns of Leaf Biochemical and Structural Properties of Cerrado Life Forms: Implications for Remote Sensing	PLOS ONE			English	Article							SPECTRAL REFLECTANCE; WATER-CONTENT; CHLOROPHYLL; BIODIVERSITY; TREES; VEGETATION; LIANAS; AREA; DISCRIMINATION; CONSERVATION	Aim The general goal of this study is to investigate and analyze patterns of ecophysiological leaf traits and spectral response among life forms (trees, shrubs and lianas) in the Cerrado ecosystem. In this study, we first tested whether life forms are discriminated through leaf level functional traits. We then explored the correlation between leaf-level plant functional traits and spectral reflectance. Location Serra do Cipo National Park, Minas Gerais, Brazil. Methods Six ecophysiological leaf traits were selected to best characterize differences between life forms in the woody plant community of the Cerrado. Results were compared to spectral vegetation indices to determine if plant groups provide means to separate leaf spectral responses. Results Values obtained from leaf traits were similar to results reported from other tropical dry sites. Trees and shrubs significantly differed from lianas in terms of the percentage of leaf water content and Specific Leaf Area. Spectral indices were insufficient to capture the differences of these key traits between groups, though indices were still adequately correlated to overall trait variation. Conclusion The importance of life forms as biochemical and structurally distinctive groups is a significant finding for future remote sensing studies of vegetation, especially in arid and semi-arid environments. The traits we found as indicative of these groups (SLA and water content) are good candidates for spectral characterization. Future studies need to use the full wavelength (400 nm-2500 nm) in order to capture the potential response of these traits. The ecological linkage to water balance and life strategies encourages these traits as starting points for modeling plant communities using hyperspectral remote sensing.	[Ball, Aaron; Sanchez-Azofeifa, Arturo; Portillo-Quintero, Carlos; Rivard, Benoit; Castro-Contreras, Saulo] Univ Alberta, Earth & Atmospher Sci Dept, Edmonton, AB T6G 2E3, Canada; [Fernandes, Geraldo] Univ Fed Minas Gerais, ICB, Ecol Evolut Herbivoros Tropicais DBG, BR-30161970 Belo Horizonte, MG, Brazil	University of Alberta; Universidade Federal de Minas Gerais	Sanchez-Azofeifa, A (corresponding author), Univ Alberta, Earth & Atmospher Sci Dept, Edmonton, AB T6G 2E3, Canada.	arturo.sanchez@ualberta.ca	Sánchez, Arturo/L-3622-2019; Fernandes, Geraldo/AAN-5602-2021; Sanchez-Azofeifa, Arturo/F-4700-2014	Sánchez, Arturo/0000-0002-4946-1559; Fernandes, Geraldo/0000-0003-1559-6049; Sanchez-Azofeifa, Arturo/0000-0001-7768-6600	Inter-American Institute for Global Change Research (IAI) [CRN3 025]; US National Science Foundation [GEO-1128040]; University of Alberta; National Science and Engineering Research Council of Canada (NSERC-Discovery); Conselho Nacional de Pesquisa; Fundacao de Desenvolvimento da Pesquisa de Minas Gerais; CAPES; ICER [1128040] Funding Source: National Science Foundation	Inter-American Institute for Global Change Research (IAI); US National Science Foundation(National Science Foundation (NSF)); University of Alberta(University of Alberta); National Science and Engineering Research Council of Canada (NSERC-Discovery)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Conselho Nacional de Pesquisa; Fundacao de Desenvolvimento da Pesquisa de Minas Gerais; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); ICER(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was carried out with the aid of a grant from the Inter-American Institute for Global Change Research (IAI) CRN3 025, which is supported by the US National Science Foundation (Grant GEO-1128040). We acknowledge the support provided by University of Alberta, the National Science and Engineering Research Council of Canada (NSERC-Discovery), Conselho Nacional de Pesquisa, Fundacao de Desenvolvimento da Pesquisa de Minas Gerais, and CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Anorve Mariana, 2008, P27, DOI 10.1201/9781420053432.ch2; Alvarez-Anorve MY, 2012, AM J BOT, V99, P816, DOI 10.3732/ajb.1100200; Sanchez-Azofeifa GA, 2009, REMOTE SENS ENVIRON, V113, P2076, DOI 10.1016/j.rse.2009.05.013; Asner GP, 2009, FRONT ECOL ENVIRON, V7, P269, DOI 10.1890/070152; Blackburn GA, 2007, J EXP BOT, V58, P855, DOI 10.1093/jxb/erl123; Bucci SJ, 2006, PLANT CELL ENVIRON, V29, P2153, DOI 10.1111/j.1365-3040.2006.01591.x; Cartelat A, 2005, FIELD CROP RES, V91, P35, DOI 10.1016/j.fcr.2004.05.002; Castro-Esau KL, 2006, REMOTE SENS ENVIRON, V103, P276, DOI 10.1016/j.rse.2005.01.019; Castro-Esau KL, 2006, AM J BOT, V93, P517, DOI 10.3732/ajb.93.4.517; Castro-Esau KL, 2004, REMOTE SENS ENVIRON, V90, P353, DOI 10.1016/j.rse.2004.01.013; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; de Carvalho F, 2012, APPL SOIL ECOL, V52, P9, DOI 10.1016/j.apsoil.2011.10.001; De Souza AA, 2001, AN 14 S BRAS SENS RE, P3095; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Gillespie TW, 2008, PROG PHYS GEOG, V32, P203, DOI 10.1177/0309133308093606; Gitelson AA, 1997, INT J REMOTE SENS, V18, P2691, DOI 10.1080/014311697217558; Goulas Y, 2004, APPL OPTICS, V43, P4488, DOI 10.1364/AO.43.004488; Hoffmann WA, 2005, FUNCT ECOL, V19, P932, DOI 10.1111/j.1365-2435.2005.01045.x; Holden M, 1976, CHEM BIOCH PLANT PIG, P1; Holdridge L. R., 1967, Life zone ecology.; Kalacska M, 2007, REMOTE SENS ENVIRON, V109, P406, DOI 10.1016/j.rse.2007.01.012; Klink CA, 2005, CONSERV BIOL, V19, P707, DOI 10.1111/j.1523-1739.2005.00702.x; Meyer S, 2006, PLANT CELL ENVIRON, V29, P1338, DOI 10.1111/j.1365-3040.2006.01514.x; Miura T, 2003, AN 11 SBSR BEL HOR B, P1077; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nagendra H, 2001, INT J REMOTE SENS, V22, P2377, DOI 10.1080/01431160117096; Oliveira-Filho A., 2002, CERRADOS BRAZIL, P91, DOI [10.1590/1519-6984.02016, DOI 10.7312/OLIV12042-007]; Phillips OL, 2002, NATURE, V418, P770, DOI 10.1038/nature00926; Pooter H, 1999, NEW PHYTOL, V143, P163; PRICE JC, 1994, REMOTE SENS ENVIRON, V49, P181, DOI 10.1016/0034-4257(94)90013-2; Ratter JA, 1997, ANN BOT-LONDON, V80, P223, DOI 10.1006/anbo.1997.0469; Ratter JA, 2006, SYST ASSOC SPEC VOL, P31; Sims DA, 2003, REMOTE SENS ENVIRON, V84, P526, DOI 10.1016/S0034-4257(02)00151-7; Sims DA, 2002, REMOTE SENS ENVIRON, V81, P337, DOI 10.1016/S0034-4257(02)00010-X; TERASHIMA I, 1995, PLANT CELL ENVIRON, V18, P1111, DOI 10.1111/j.1365-3040.1995.tb00623.x; TUCKER CJ, 1980, REMOTE SENS ENVIRON, V10, P23, DOI 10.1016/0034-4257(80)90096-6; TUCKER CJ, 1979, REMOTE SENS ENVIRON, V8, P127, DOI 10.1016/0034-4257(79)90013-0; Turner W, 2003, TRENDS ECOL EVOL, V18, P306, DOI 10.1016/S0169-5347(03)00070-3; WELLBURN AR, 1994, J PLANT PHYSIOL, V144, P307, DOI 10.1016/S0176-1617(11)81192-2; Wright IJ, 2007, ANN BOT-LONDON, V99, P1003, DOI 10.1093/aob/mcl066; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Wright IJ, 2001, FUNCT ECOL, V15, P423, DOI 10.1046/j.0269-8463.2001.00542.x; Zhang JK, 2006, REMOTE SENS ENVIRON, V105, P129, DOI 10.1016/j.rse.2006.06.010	43	15	15	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117659	10.1371/journal.pone.0117659	http://dx.doi.org/10.1371/journal.pone.0117659			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692675	gold, Green Submitted, Green Published			2022-12-26	WOS:000350061500067
J	Samanas, NB; Commers, TW; Dennison, KL; Harenda, QE; Kurz, SG; Lachel, CM; Wavrin, KL; Bowler, M; Nijman, IJ; Guryev, V; Cuppen, E; Hubner, N; Sullivan, R; Vezina, CM; Shull, JD				Samanas, Nyssa Becker; Commers, Tessa W.; Dennison, Kirsten L.; Harenda, Quincy Eckert; Kurz, Scott G.; Lachel, Cynthia M.; Wavrin, Kristen Leland; Bowler, Michael; Nijman, Isaac J.; Guryev, Victor; Cuppen, Edwin; Hubner, Norbert; Sullivan, Ruth; Vezina, Chad M.; Shull, James D.			Genetic Etiology of Renal Agenesis: Fine Mapping of Renag1 and Identification of Kit as the Candidate Functional Gene	PLOS ONE			English	Article							INDUCED MAMMARY-CANCER; CONGENITAL BILATERAL ABSENCE; INDUCED PITUITARY GROWTH; COPENHAGEN RAT STRAINS; AFFECTED SIB-PAIRS; URINARY-TRACT; VESICOURETERAL REFLUX; VAS-DEFERENS; ACI RAT; UROGENITAL TRACT	Congenital anomalies of the kidney and urogenital tract (CAKUT) occur in approximately 0.5% of live births and represent the most frequent cause of end-stage renal disease in neonates and children. The genetic basis of CAKUT is not well defined. To understand more fully the genetic basis of one type of CAKUT, unilateral renal agenesis (URA), we are studying inbred ACI rats, which spontaneously exhibit URA and associated urogenital anomalies at an incidence of approximately 10%. URA is inherited as an incompletely dominant trait with incomplete penetrance in crosses between ACI and Brown Norway (BN) rats and a single responsible genetic locus, designated Renag1, was previously mapped to rat chromosome 14 (RNO14). The goals of this study were to fine map Renag1, identify the causal genetic variant responsible for URA, confirm that the Renag1 variant is the sole determinant of URA in the ACI rat, and define the embryologic basis of URA in this rat model. Data presented herein localize Renag1 to a 379 kilobase (kb) interval that contains a single protein coding gene, Kit (v-kit Hardy-Zukerman 4 feline sarcoma viral oncogene homolog); identify an endogenous retrovirus-derived long terminal repeat located within Kit intron 1 as the probable causal variant; demonstrate aberrant development of the nephric duct in the anticipated number of ACI rat embryos; and demonstrate expression of Kit and Kit ligand (Kitlg) in the nephric duct. Congenic rats that harbor ACI alleles at Renag1 on the BN genetic background exhibit the same spectrum of urogenital anomalies as ACI rats, indicating that Renag1 is necessary and sufficient to elicit URA and associated urogenital anomalies. These data reveal the first genetic link between Kit and URA and illustrate the value of the ACI rat as a model for defining the mechanisms and cell types in which Kit functions during urogenital development.	[Samanas, Nyssa Becker; Dennison, Kirsten L.; Harenda, Quincy Eckert; Wavrin, Kristen Leland; Bowler, Michael; Shull, James D.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Oncol, McArdle Lab Canc Res, Madison, WI 53706 USA; [Commers, Tessa W.; Kurz, Scott G.; Lachel, Cynthia M.; Wavrin, Kristen Leland; Shull, James D.] Univ Nebraska, Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE USA; [Nijman, Isaac J.; Guryev, Victor; Cuppen, Edwin] Hubrecht Inst, Utrecht, Netherlands; [Hubner, Norbert] Max Delbruck Ctr Mol Med, Berlin, Germany; [Sullivan, Ruth] Univ Wisconsin, Grad Sch, Res Anim Resources Ctr, Madison, WI 53706 USA; [Sullivan, Ruth; Vezina, Chad M.; Shull, James D.] Univ Wisconsin, Sch Med & Publ Hlth, Carbone Canc Ctr, Madison, WI USA; [Vezina, Chad M.] Univ Wisconsin, Sch Vet Med, Dept Comparat Biosci, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Nebraska System; University of Nebraska Medical Center; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Shull, JD (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Oncol, McArdle Lab Canc Res, Madison, WI 53706 USA.	shull@oncology.wisc.edu	Cuppen, Edwin/F-5696-2011; Cuppen, Edwin/H-2389-2016; Vezina, Chad/GRO-2299-2022	Cuppen, Edwin/0000-0002-0400-9542; Cuppen, Edwin/0000-0002-0400-9542; Vezina, Chad/0000-0001-7058-5399; Guryev, Victor/0000-0002-5810-6022	National Institutes of Health [DK070669, CA68529, CA77876]; Cancer Center Support, from the National Cancer Institute [P30-CA036727, P30-CA014520]; NATIONAL CANCER INSTITUTE [R01CA077876, R01CA068529, P30CA014520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK070669] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support, from the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants DK070669 (JDS), CA68529 (JDS) and CA77876 (JDS) from the National Institutes of Health (http://www.nih.gov/). Shared research resources at the University of Nebraska Medical Center and the University of Wisconsin-Madison were supported by Cancer Center Support Grants P30-CA036727 (JDS) and P30-CA014520 (JDS), respectively, from the National Cancer Institute (http://www.cancer.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abler LL, 2011, JOVE-J VIS EXP, DOI 10.3791/2912; Abler LL, 2011, DEV DYNAM, V240, P2364, DOI 10.1002/dvdy.22730; Acien P, 2010, ACTA OBSTET GYN SCAN, V89, P1424, DOI 10.3109/00016349.2010.512067; Acien P, 2009, FERTIL STERIL, V91, P2369, DOI 10.1016/j.fertnstert.2008.01.079; Amakasu K, 2009, COMPARATIVE MED, V59, P249; ARFEEN S, 1993, AM J KIDNEY DIS, V21, P663, DOI 10.1016/S0272-6386(12)80041-2; ASHLEY DJB, 1960, J UROLOGY, V83, P211, DOI 10.1016/S0022-5347(17)65695-7; Ashraf S, 2010, NEPHROL DIAL TRANSPL, V25, P1496, DOI 10.1093/ndt/gfp650; AUGARTEN A, 1994, LANCET, V344, P1473, DOI 10.1016/S0140-6736(94)90292-5; Aveiro AC, 2011, BMJ CASE REP, V2011; BARAKAT AJ, 1991, UROLOGY, V38, P347, DOI 10.1016/0090-4295(91)80150-6; Batourina E, 2001, NAT GENET, V27, P74, DOI 10.1038/83792; Baud A, 2013, NAT GENET, V45, P767, DOI 10.1038/ng.2644; Bellone RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078280; Bernex F, 1996, DEVELOPMENT, V122, P3023; BOWES C, 1993, P NATL ACAD SCI USA, V90, P2955, DOI 10.1073/pnas.90.7.2955; Briggs CE, 2010, EUR J HUM GENET, V18, P245, DOI 10.1038/ejhg.2009.142; BULTMAN SJ, 1994, GENE DEV, V8, P481, DOI 10.1101/gad.8.4.481; CARTER CO, 1979, J MED GENET, V16, P176, DOI 10.1136/jmg.16.3.176; Chia I, 2011, DEVELOPMENT, V138, P2089, DOI 10.1242/dev.056838; Cohen CJ, 2009, GENE, V448, P105, DOI 10.1016/j.gene.2009.06.020; Colletti JA, 2014, G3-GENES GENOM GENET, V4, P1385, DOI 10.1534/g3.114.011163; Conte ML, 2008, PEDIATR NEPHROL, V23, P587, DOI 10.1007/s00467-007-0675-z; CRAMER DV, 1975, TERATOLOGY, V12, P27, DOI 10.1002/tera.1420120104; Darlow JM, 2014, MOL GENET GENOM MED, V2, P7, DOI 10.1002/mgg3.22; DERINGER MK, 1956, P SOC EXP BIOL MED, V91, P312; Doray B, 1999, GENET COUNSEL, V10, P251; Feather SA, 2000, AM J HUM GENET, V66, P1420, DOI 10.1086/302864; FUJIKURA T, 1970, TERATOLOGY, V3, P245, DOI 10.1002/tera.1420030306; FUJITA K, 1979, LAB ANIM, V13, P325, DOI 10.1258/002367779780943323; Gholoum S, 2006, J PEDIATR SURG, V41, P987, DOI 10.1016/j.jpedsurg.2006.01.021; Gould KA, 2004, GENETICS, V168, P2113, DOI 10.1534/genetics.104.033878; HOSTETTER TH, 1981, AM J PHYSIOL, V241, pF85, DOI 10.1681/ASN.V1261315; Hwang DY, 2014, KIDNEY INT, V85, P1429, DOI 10.1038/ki.2013.508; Ichikawa I, 2002, KIDNEY INT, V61, P889, DOI 10.1046/j.1523-1755.2002.00188.x; Kerecuk L, 2008, NAT CLIN PRACT NEPHR, V4, P312, DOI 10.1038/ncpneph0807; Kolettis PN, 2002, UROLOGY, V60, P1073, DOI 10.1016/S0090-4295(02)01973-8; Kuramoto T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043059; Kurz SG, 2014, MAMM GENOME, V25, P244, DOI 10.1007/s00335-014-9504-4; Lachel CM, 2003, COL SPRING HARB LAB, P83; Laulederkind SJF, 2013, BRIEF BIOINFORM, V14, P520, DOI 10.1093/bib/bbt007; Lawrence MG, 2012, ENDOCRINOLOGY, V153, P3199, DOI 10.1210/en.2012-1267; Lennartsson J, 2012, PHYSIOL REV, V92, P1619, DOI 10.1152/physrev.00046.2011; MACKIE GG, 1975, J UROLOGY, V114, P274, DOI 10.1016/S0022-5347(17)67007-1; MANOVA K, 1991, DEV BIOL, V146, P312, DOI 10.1016/0012-1606(91)90233-S; Marchini GS, 2012, BJU INT, V109, P1709, DOI 10.1111/j.1464-410X.2011.10634.x; MARSHALL F F, 1978, Urology, V11, P58, DOI 10.1016/0090-4295(78)90201-7; MARSHALL FF, 1982, J UROLOGY, V127, P155, DOI 10.1016/S0022-5347(17)53651-4; McCallum TJ, 2001, HUM REPROD, V16, P282, DOI 10.1093/humrep/16.2.282; MENDELSOHN C, 1994, DEVELOPMENT, V120, P2749; Mendelsohn C, 2009, ORGANOGENESIS, V5, P306; MIHARA M, 1992, ACTA PAEDIATR, V81, P326, DOI 10.1111/j.1651-2227.1992.tb12236.x; MORGAN WC, 1953, ANAT REC, V115, P635, DOI 10.1002/ar.1091150405; Nigam R, 2013, PHYSIOL GENOMICS, V45, P809, DOI 10.1152/physiolgenomics.00065.2013; NIWA Y, 1991, BLOOD, V78, P1936; Pohl M, 2002, KIDNEY INT, V61, P10, DOI 10.1046/j.1523-1755.2002.00086.x; Pye SM, 2008, BLOOD, V111, P5505, DOI 10.1182/blood-2007-10-114900; R Core Team, 2013, R LANG ENV STAT COMP, DOI [10.1002/cpp.1875, DOI 10.1002/CPP.1875]; ROODHOOFT M, 1984, NEW ENGL J MED, V310, P1341, DOI 10.1056/NEJM198405243102101; Rozen S, 2000, Methods Mol Biol, V132, P365; Saisawat P, 2012, KIDNEY INT, V81, P196, DOI 10.1038/ki.2011.315; Sanna-Cherchi S, 2013, NEW ENGL J MED, V369, P621, DOI 10.1056/NEJMoa1214479; Sanna-Cherchi S, 2007, PEDIATR NEPHROL, V22, P1675, DOI 10.1007/s00467-007-0479-1; Sanna-Cherchi S, 2009, KIDNEY INT, V76, P528, DOI 10.1038/ki.2009.220; Schaffer BS, 2006, CANCER RES, V66, P7793, DOI 10.1158/0008-5472.CAN-06-0143; Schaffer BS, 2013, CANCER PREV RES, V6, P59, DOI 10.1158/1940-6207.CAPR-12-0346-T; SCHIMKE RN, 1980, CLIN GENET, V18, P417; Schmidt-Ott KM, 2006, DEV BIOL, V299, P238, DOI 10.1016/j.ydbio.2006.07.026; Schwaderer AL, 2007, PEDIATR NEPHROL, V22, P52, DOI 10.1007/s00467-006-0295-z; SERIKAWA T, 1992, GENETICS, V131, P701; SHEIH CP, 1989, PEDIATRICS, V84, P1086; Shull JD, 2006, MAMM GENOME, V17, P751, DOI 10.1007/s00335-006-0004-z; SOLLEVELD H A, 1986, Toxicologic Pathology, V14, P168, DOI 10.1177/019262338601400204; Soofi A, 2012, DEV BIOL, V365, P241, DOI 10.1016/j.ydbio.2012.02.032; Spady TJ, 1999, ENDOCRINOLOGY, V140, P2828, DOI 10.1210/en.140.6.2828; SPRITZ RA, 1992, AM J MED GENET, V44, P492, DOI 10.1002/ajmg.1320440422; Strecker TE, 2005, GENETICS, V169, P2189, DOI 10.1534/genetics.104.039370; Torigoe D, 2011, J VET MED SCI, V73, P707, DOI 10.1292/jvms.10-0529; TSUJIMURA T, 1991, BLOOD, V78, P1942; Vercellini P, 2007, FERTIL STERIL, V87, P719, DOI 10.1016/j.fertnstert.2007.01.173; Wang X, 2014, J AM SOC NEPHROL; Wang YM, 2010, GENOME RES, V20, P19, DOI 10.1101/gr.100073.109; Weber S, 2006, J AM SOC NEPHROL, V17, P2864, DOI 10.1681/ASN.2006030277; Weng PL, 2009, J AM SOC NEPHROL, V20, P1633, DOI 10.1681/ASN.2008111199; Westland R, 2013, PEDIATRICS, V131, pE478, DOI 10.1542/peds.2012-2088; Westland R, 2012, NEPHROL DIAL TRANSPL, V27, P2603, DOI 10.1093/ndt/gfr625; Woods LCS, 2010, AM J PHYSIOL-RENAL, V298, pF1484, DOI 10.1152/ajprenal.00002.2010; YAMAMOTO Y, 1989, AM J MED GENET, V32, P520, DOI 10.1002/ajmg.1320320419; Yamashita S, 2005, CANCER RES, V65, P2610, DOI 10.1158/0008-5472.CAN-04-2932; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	91	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118147	10.1371/journal.pone.0118147	http://dx.doi.org/10.1371/journal.pone.0118147			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693193	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000350061500103
J	Weiland, TJ; Jelinek, GA; Marck, CH; Hadgkiss, EJ; van der Meer, DM; Pereira, NG; Taylor, KL				Weiland, Tracey J.; Jelinek, George A.; Marck, Claudia H.; Hadgkiss, Emily J.; van der Meer, Dania M.; Pereira, Naresh G.; Taylor, Keryn L.			Clinically Significant Fatigue: Prevalence and Associated Factors in an International Sample of Adults with Multiple Sclerosis Recruited via the Internet	PLOS ONE			English	Article							QUALITY-OF-LIFE; ENVIRONMENTAL-FACTORS; PHYSICAL-ACTIVITY; NARCOMS-REGISTRY; DEPRESSION; DISEASE; DISABILITY; VALIDITY; BEHAVIOR; IMPACT	Background Fatigue contributes a significant burden of disease for people with multiple sclerosis (PwMS). Modifiable lifestyle factors have been recognized as having a role in a range of morbidity outcomes in PwMS. There is significant potential to prevent and treat fatigue in PwMS by addressing modifiable risk factors. Objectives To explore the associations between clinically significant fatigue and demographic factors, clinical factors (health-related quality of life, disability and relapse rate) and modifiable lifestyle, disease-modifying drugs (DMD) and supplement use in a large international sample of PwMS. Methods PwMS were recruited to the study via Web 2.0 platforms and completed a comprehensive survey measuring demographic, lifestyle and clinical characteristics, including health-related quality of life, disability, and relapse rate. Results Of 2469 participants with confirmed MS, 2138 (86.6%) completed a validated measure of clinically significant fatigue, the Fatigue Severity Scale. Participants were predominantly female from English speaking countries, with relatively high levels of education, and due to recruitment methods may have been highly pro-active about engaging in lifestyle management and self-help. Approximately two thirds of our sample (1402/2138; 65.6% 95% CI 63.7-67.7)) screened positive for clinically significant fatigue. Bivariate associations were present between clinically significant fatigue and several demographic, clinical, lifestyle, and medication variables. After controlling for level of disability and a range of stable socio-demographic variables, we found increased odds of fatigue associated with obesity, DMD use, poor diet, and reduced odds of fatigue with exercise, fish consumption, moderate alcohol use, and supplementation with vitamin D and flaxseed oil. Conclusion This study supports strong and significant associations between clinically significant fatigue and modifiable lifestyle factors. Longitudinal follow-up of this sample may help clarify the contribution of reverse causation to our findings. Further research is required to explore these associations including randomized controlled trials of lifestyle interventions that may	[Weiland, Tracey J.; Jelinek, George A.; Marck, Claudia H.; Hadgkiss, Emily J.; van der Meer, Dania M.] St Vincents Hosp, Emergency Practice Innovat Ctr, Melbourne, Vic, Australia; [Weiland, Tracey J.; Jelinek, George A.; Taylor, Keryn L.] Univ Melbourne, St Vincents Hosp, Dept Med, Melbourne, Vic, Australia; [Pereira, Naresh G.] Notre Dame Univ, Fac Med, Fremantle, WA 6959, Australia; [Taylor, Keryn L.] St Vincents Hosp Melbourne, Dept Psychiat, Melbourne, Vic, Australia; [Jelinek, George A.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia	St Vincent's Hospital Melbourne; St Vincent's Hospital Melbourne; University of Melbourne; University of Notre Dame Australia; St Vincent's Hospital Melbourne; Monash University	Weiland, TJ (corresponding author), St Vincents Hosp, Emergency Practice Innovat Ctr, Melbourne, Vic, Australia.	Tracey.Weiland@svhm.org.au	Weiland, Tracey/Y-2029-2018	Weiland, Tracey/0000-0002-4053-5507; TAYLOR, KERYN/0000-0001-7543-4362; Jelinek, George/0000-0001-6157-0910; Marck, Claudia/0000-0002-3173-1522	Bloom Foundation; Horne Family Charitable Trust; Elizabeth Schefferle	Bloom Foundation; Horne Family Charitable Trust; Elizabeth Schefferle	The authors thank all the participants in the HOLISM study for taking the survey. The authors thank the Bloom Foundation, the Horne Family Charitable Trust, and Elizabeth Schefferle for their grants and donations supporting this study. Professor George Jelinek obtained the funding for this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato MP, 2001, MULT SCLER J, V7, P340, DOI 10.1191/135245801681138059; Asano M, 2014, MULT SCLER INT, V2014, DOI 10.1155/2014/798285; BLAKE RL, 1986, J FAM PRACTICE, V22, P82; Blikman LJ, 2013, ARCH PHYS MED REHAB, V94, P1360, DOI 10.1016/j.apmr.2013.01.025; Bol Y, 2010, J BEHAV MED, V33, P355, DOI 10.1007/s10865-010-9266-8; Bol Y, 2009, J PSYCHOSOM RES, V66, P3, DOI 10.1016/j.jpsychores.2008.05.003; Braley TJ, 2010, SLEEP, V33, P1061, DOI 10.1093/sleep/33.8.1061; Branas P., 2000, HLTH TECHNOL ASSESS, V4, P1, DOI [DOI 10.3310/HTA4270, 10.3310/hta4270]; Carter A, 2014, MULT SCLER J, V20, P1112, DOI 10.1177/1352458513519354; COLOSIMO C, 1995, ACTA NEUROL SCAND, V92, P353; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; de Ridder D, 2004, J PSYCHOSOM RES, V56, P341, DOI 10.1016/S0022-3999(03)00034-5; Feinstein A, 1999, CLIN NEUROPSYCHIATRY; FISK JD, 1994, CAN J NEUROL SCI, V21, P9, DOI 10.1017/S0317167100048691; Flachenecker P, 2004, MULT SCLER J, V10, P165, DOI 10.1191/1352458504ms991oa; Flensner G, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-224; Flensner G, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-27; Ford H, 1998, J PSYCHOSOM RES, V45, P33, DOI 10.1016/S0022-3999(98)00004-X; FREAL JE, 1984, ARCH PHYS MED REHAB, V65, P135; Gold SM, 2003, MULT SCLER J, V9, P404, DOI 10.1191/1352458503ms927oa; Grossman P, 2010, NEUROLOGY, V75, P1141, DOI 10.1212/WNL.0b013e3181f4d80d; Hadgkiss EJ, 2014, NUTR NEUROSCI; Hadgkiss EJ, 2013, NEUROL RES INT, V2013, DOI 10.1155/2013/580596; Hadjimichael O, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-100; Heesen C, 2006, J NEUROL NEUROSUR PS, V77, P34, DOI 10.1136/jnnp.2005.065805; HIRSCH RL, 1985, J CLIN IMMUNOL, V5, P386, DOI 10.1007/BF00915335; Hohol MJ, 1999, MULT SCLER, V5, P349, DOI 10.1177/135245859900500508; Holper L, 2010, J NEUROL, V257, P103, DOI 10.1007/s00415-009-5282-4; Ingram G, 2010, MULT SCLER J, V16, P472, DOI 10.1177/1352458509358902; Janardhan V, 2002, J NEUROL SCI, V205, P51, DOI 10.1016/S0022-510X(02)00312-X; Kos D, 2008, NEUROREHAB NEURAL RE, V22, P91, DOI 10.1177/1545968306298934; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Krupp L, 2006, MULT SCLER J, V12, P367, DOI 10.1191/135248506ms1373ed; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; KRUPP LB, 1988, ARCH NEUROL-CHICAGO, V45, P435, DOI 10.1001/archneur.1988.00520280085020; Lerdal A, 2007, EUR J NEUROL, V14, P1338, DOI 10.1111/j.1468-1331.2007.01974.x; Lerdal A, 2003, MULT SCLER J, V9, P509, DOI 10.1191/1352458503ms943oa; Marrie RA, 2007, MULT SCLER, V13, P770, DOI 10.1177/1352458506075031; Marrie RA, 2005, MULT SCLER, V11, P583, DOI 10.1191/1352458505ms1216oa; Marrie RA, 2011, NEUROL CLIN, V29, P323, DOI 10.1016/j.ncl.2010.12.004; McKellar S, 2008, AUSTR J PRIMARY HLTH; Minden SL, 2006, MULT SCLER J, V12, P24, DOI 10.1191/135248506ms1262oa; Moore P, 2013, MULT SCLER J, V19, P1647, DOI 10.1177/1352458513481396; Patrick E, 2009, MULT SCLER J, V15, P258, DOI 10.1177/1352458508097466; Penner IK, 2007, MULT SCLER, V13, P1161, DOI 10.1177/1352458507079267; Pittion-Vouyovitch S, 2006, J NEUROL SCI, V243, P39, DOI 10.1016/j.jns.2005.11.025; Ramagopalan SV, 2010, EUR J NEUROL, V17, P634, DOI 10.1111/j.1468-1331.2009.02850.x; Rocca MA, 2014, RADIOLOGY; Sangelaji B, 2014, IRAN RED CRESCENT ME, V16, DOI 10.5812/ircmj.17173; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Simioni S, 2007, SWISS MED WKLY, V137, P496; Sjonnesen K, 2012, POSTGRAD MED, V124, P69, DOI 10.3810/pgm.2012.09.2595; Smedal T, 2011, EUR J NEUROL, V18, P114, DOI 10.1111/j.1468-1331.2010.03090.x; Smith MM, 2005, MULT SCLER J, V11, P602, DOI 10.1191/1352458505ms1204oa; TACHIBANA N, 1994, EUR NEUROL, V34, P320, DOI 10.1159/000117070; Taylor KL, 2014, LIFESTYLE FACTORS DE; Thomas PW, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-109; Trojan DA, 2007, MULT SCLER J, V13, P985, DOI 10.1177/1352458507077175; van der Mei IAF, 2011, NEUROL CLIN, V29, P233, DOI 10.1016/j.ncl.2010.12.007; van Kessel K, 2008, PSYCHOSOM MED, V70, P205, DOI 10.1097/PSY.0b013e3181643065; VICKREY BG, 1995, QUAL LIFE RES, V4, P187, DOI 10.1007/BF02260859; Weikert M, 2010, J NEUROL SCI, V290, P6, DOI 10.1016/j.jns.2009.12.021; Weiland TJ, 2013, J NEUROL SCI, DOI [10.1016/j.ins.2013.12.037, DOI 10.1016/J.INS.2013.12.037]; Weiland TJ, 2014, J NEUROL SCI, V336, P211, DOI 10.1016/j.jns.2013.10.046; World Health Organization, 2006, GLOB DAT BOD MASS IN	65	82	82	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0115541	10.1371/journal.pone.0115541	http://dx.doi.org/10.1371/journal.pone.0115541			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC0WZ	25692993	gold, Green Published			2022-12-26	WOS:000350061500010
J	Yang, XJ; Yuan, YL; Pang, Y; Wang, B; Bai, YL; Wang, YH; Yu, BZ; Zhang, ZY; Fan, M; Zhao, YL				Yang, Xiujun; Yuan, Yanli; Pang, Yu; Wang, Bo; Bai, Yunlong; Wang, Yanhua; Yu, Baozhu; Zhang, Zhiying; Fan, Ming; Zhao, Yanlin			The Burden of MDR/XDR Tuberculosis in Coastal Plains Population of China	PLOS ONE			English	Article							DRUG-RESISTANT TUBERCULOSIS; MULTIDRUG-RESISTANCE; TREATMENT OUTCOMES; SURVEILLANCE; PREVALENCE	Background We conducted a first baseline survey in Jilin Province of China to determine the proportion of drug-resistant tuberculosis (TB), and to analyze risk factors associated with the emergence of drug-resistance. Methodology/Principal Findings Thirty counties in Jilin Province were randomly selected as survey sites using a stratified cluster sampling method. People enrolled in the survey were new and re-treated, smear-positive pulmonary TB patients newly enrolled in local TB control and prevention institutions during the survey period. Sputum samples were collected, and the susceptibility of bacterial strains to anti-TB drugs was analyzed by proportion method. Based on the survey results, we estimated the number of drug-resistant TB patients and analyzed the risk factors associated with the emergence of drug resistance. Of 1,174 new TB patients and 597 re-treated TB patients, 8.6% and 23.2% were multi-drug resistant (MDR)-TB patients, respectively. Approximately 12% of MDR-TB patients were extensively drug-resistant. We estimate that approximately 1,290 new MDR-TB cases develop in Jilin Province every year. Of these, 810 cases would be new patients, and 480 cases would involve re-treated patients. Risk factors associated with MDR-TB include employment status, educational background, and income level. Conclusions/Significance Jilin Province remains one of the highest-burden areas in China for drug-resistant TB. The higher number of MDR-TB among new cases suggested that the transmission of drug-resistant strains in Jilin is an urgent problem in the MDR-TB control and prevention system of Jilin Province. Improving the treatment compliance of TB patients and the quality of medical care in public health institutions is urgently needed.	[Yang, Xiujun; Yuan, Yanli; Wang, Bo; Bai, Yunlong; Wang, Yanhua; Yu, Baozhu; Fan, Ming] Jilin Prov Ctr Dis Control & Prevent, Changchun, Peoples R China; [Pang, Yu; Zhao, Yanlin] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China; [Zhang, Zhiying] PATH Off, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention	Fan, M (corresponding author), Jilin Prov Ctr Dis Control & Prevent, Changchun, Peoples R China.	jk7977068@163.com; zhaoyanlin@chinatb.org	wang, yan/GSE-6489-2022; wang, yi/GVT-8516-2022; Wang, Yanbo/HFZ-8018-2022					[Anonymous], 2003, WHOCDCTB2003313; Ayisi JG, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-515; Bashour H, 2003, East Mediterr Health J, V9, P757; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Chakravorty S, 2011, J CLIN MICROBIOL, V49, P932, DOI 10.1128/JCM.02271-10; Chonde TM, 2010, INT J TUBERC LUNG D, V14, P967; Evans CA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001064; Faustini A, 2005, EUR RESPIR J, V26, P503, DOI 10.1183/09031936.05.00103504; Franke MF, 2008, CLIN INFECT DIS, V46, P1844, DOI 10.1086/588292; He GX, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-166; Huang Fei, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P1276; Javaid A, 2008, INT J TUBERC LUNG D, V12, P326; Kritski AL, 1997, CHEST, V111, P1162, DOI 10.1378/chest.111.5.1162; Orenstein EW, 2009, LANCET INFECT DIS, V9, P153, DOI 10.1016/S1473-3099(09)70041-6; Pang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032976; Ramachandran R, 2009, INT J TUBERC LUNG D, V13, P1154; Wang LD, 2007, LANCET, V369, P691, DOI 10.1016/S0140-6736(07)60316-X; Wang XM, 2012, EMERG INFECT DIS, V18, P496, DOI 10.3201/eid1803.110760; World Health Organization, 2014, WHOHTMTB201408; World Health Organization, 2010, WHOHTMTB20103; Wright A, 2009, LANCET, V373, P1861, DOI 10.1016/S0140-6736(09)60331-7; Wu Z, 2010, J ACQ IMMUN DEF SYND, V53, P1, DOI DOI 10.1097/QAI.0B013E3181C7D379; Yang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020343; Yumo HA, 2011, INT J TUBERC LUNG D, V15, P352; Zhao YL, 2012, NEW ENGL J MED, V366, P2161, DOI 10.1056/NEJMoa1108789; Zhao YD, 2012, INFECT GENET EVOL, V12, P718, DOI 10.1016/j.meegid.2011.09.022; Zignol M, 2012, B WORLD HEALTH ORGAN, V90, P111, DOI 10.2471/BLT.11.092585	28	17	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117361	10.1371/journal.pone.0117361	http://dx.doi.org/10.1371/journal.pone.0117361			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689373	Green Published, Green Submitted, gold			2022-12-26	WOS:000350322700037
J	Ahnis, A; Figura, A; Hofmann, T; Stengel, A; Elbelt, U; Klapp, BF				Ahnis, Anne; Figura, Andrea; Hofmann, Tobias; Stengel, Andreas; Elbelt, Ulf; Klapp, Burghard F.			Surgically and Conservatively Treated Obese Patients Differ in Psychological Factors, Regardless of Body Mass Index or Obesity-Related Co-Morbidities: A Comparison between Groups and an Analysis of Predictors	PLOS ONE			English	Article							QUALITY-OF-LIFE; ICD-10-SYMPTOM-RATING ISR; METABOLIC SYNDROME; BARIATRIC SURGERY; FOLLOW-UP; QUESTIONNAIRE; VALIDATION; DEPRESSION; IMPACT; RISK	Objective For the treatment of obesity, both conservative and surgical procedures are available. Psychological factors are likely to influence the choice of treatment; however, to date, systematic studies that investigate these factors are few in number. The aim of our study was to analyze whether patients who undergo a surgical treatment differ from those who require a conservative treatment in regard to psychological factors, regardless of their somatic conditions. Furthermore, predictors of treatment choice will be examined. Methods A total of 244 patients (189 women), with a mean body mass index of 45.1 kg/m(2), underwent a weight reduction treatment, with 126 patients undergoing bariatric surgery and 118 patients participating in a conservative, multimodal outpatient weight reduction program. Differences in the results of the psychological questionnaires between conservatively and surgically treated patients were evaluated through the use of t-tests, chi(2)-tests and an ANCOVA. For the analysis of the predictors, logistic regression models were calculated. Results Surgically and conservatively treated obese patients differ in psychological, somatic, and socio-demographic factors. The psychological differences between the groups are independent of obesity-related co-morbidities, such as body mass index (BMI), type 2 diabetes mellitus, hypertension and coronary heart disease. The following psychological and somatic factors equally predict the choice of bariatric surgery: apathy, delegated active coping, a sense of coherence, complaints, type 2 diabetes mellitus, BMI, and age. Conclusion Longitudinal studies are required to assess the predictive value of the psychological factors in regard to the postsurgical weight course to improve the pre-surgical screening and treatment selection process. The pre-surgical identification of psychological predictors should result in a more personalized medicine course and may ensure long term outcomes.	[Ahnis, Anne; Figura, Andrea; Hofmann, Tobias; Stengel, Andreas; Klapp, Burghard F.] Charite, Ctr Internal Med & Dermatol, Div Gen Internal & Psychosomat Med, D-13353 Berlin, Germany; [Elbelt, Ulf] Charite, Ctr Internal Med Gastroenterol & Nephrol, Div Endocrinol Diabet & Nutr, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Ahnis, A (corresponding author), Charite, Ctr Internal Med & Dermatol, Div Gen Internal & Psychosomat Med, D-13353 Berlin, Germany.	anne.ahnis@charite.de	Elbelt, Ulf/AAJ-6469-2020	Figura, Andrea/0000-0002-1240-1501; Hofmann, Tobias/0000-0002-4002-3552; Stengel, Andreas/0000-0003-3294-4340; Elbelt, Ulf/0000-0002-7510-9284				Ahnis A, 2010, DGPM DKPM K 2010 BER, V5, P210; Ahnis A, 2012, PATIENT PREFER ADHER, V6, P165, DOI 10.2147/PPA.S28022; Arnlov J, 2011, DIABETES CARE, V34, P61, DOI 10.2337/dc10-0955; Arnlov J, 2010, CIRCULATION, V121, P230, DOI 10.1161/CIRCULATIONAHA.109.887521; Brahler E, 2000, PSYCHOTHER PSYCH MED, V50, P14, DOI 10.1055/s-2000-13233; Brahler E., 2008, GBB 24 GIESSENER BES, V3rd; Buddeberg-Fischer B, 2006, OBES SURG, V16, P321, DOI 10.1381/096089206776116471; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; Deutsche Gesellschaft fur Allgemein- und Viszeralchirurgie Deutsche Adipositas-Gesellschaft Deutsche Gesellschaft fur Psychosomatische Medizin und Psychotherapie Deutsche Gesellschaft fur Ernahrungsmedizin, 2010, S3 LEITL CHIR AD; Elbelt U, BIOPSYCHOSOCIA UNPUB; Ellert U, 2005, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, V48, P1330, DOI 10.1007/s00103-005-1168-5; Fischer HF, 2010, PSYCHOTHER PSYCH MED, V60, P307, DOI 10.1055/s-0029-1214419; Fliege H, 2001, DIAGNOSTICA, V47, P510; Gradaschi R, 2013, J HUM NUTR DIET, V26, P34, DOI 10.1111/jhn.12080; HORHOLD M, 1993, Z MED PSYCHOL, V2, P27; Karlsson J, 1998, INT J OBESITY, V22, P113, DOI 10.1038/sj.ijo.0800553; Karlsson J, 2007, INT J OBESITY, V31, P1248, DOI 10.1038/sj.ijo.0803573; Keating CL, 2012, OBESITY, V20, P2412, DOI 10.1038/oby.2012.124; Knoll N, 2002, THESIS FREIE U BERLI; Lapidoth JD, 2008, OBES SURG, V18, P715, DOI 10.1007/s11695-007-9250-8; Lowe B, 2002, GESUNDHEITSFRAGEBOGE, DOI [10.1111/j.1439-0388.1994.tb00458.x.Implications, DOI 10.1111/J.1439-0388.1994.TB00458.X]; Paul T., 2004, EDI 2 EATING DISORDE; Pudel V, 1989, FEV FRAGEBOGEN ESSVE; Riedl A, 2010, ADIPOSITAS, V4, P2; Rief W, 2004, J AFFECT DISORDERS, V82, P271, DOI 10.1016/j.jad.2003.11.006; Ryden A, 2004, INT J OBESITY, V28, P1485, DOI 10.1038/sj.ijo.0802768; Ryden A, 2001, BRIT J CLIN PSYCHOL, V40, P177, DOI 10.1348/014466501163625; Sadhasivam S, 2007, SURG OBES RELAT DIS, V3, P531, DOI 10.1016/j.soard.2007.07.004; Scholler G, 1999, PSYCHOTHER PSYCH MED, V49, P275; Schowalter M, 2008, OBES SURG, V18, P314, DOI 10.1007/s11695-007-9316-7; Schulz U, 2003, DIAGNOSTICA, V49, P73, DOI 10.1026//0012-1924.49.2.73; Schumacher J, 2000, PSYCHOTHER PSYCH MED, V50, P472, DOI 10.1055/s-2000-9207; STUNKARD AJ, 1985, J PSYCHOSOM RES, V29, P71, DOI 10.1016/0022-3999(85)90010-8; Tritt K., 2010, FRAGEBOGEN ICD 10 SY; Tritt K, 2008, Z PSYCHOSOM MED PSYC, V54, P409, DOI 10.13109/zptm.2008.54.4.409; Ware JE Jr, 2001, SCORE INTERPRET SING	36	9	10	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117460	10.1371/journal.pone.0117460	http://dx.doi.org/10.1371/journal.pone.0117460			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9IO	25679521	Green Published, gold, Green Submitted			2022-12-26	WOS:000350682600065
J	Bodewes, FAJA; Bijvelds, MJ; de Vries, W; Baller, JFW; Gouw, ASH; de Jonge, HR; Verkade, HJ				Bodewes, Frank A. J. A.; Bijvelds, Marcel J.; de Vries, Willemien; Baller, Juul F. W.; Gouw, Annette S. H.; de Jonge, Hugo R.; Verkade, Henkjan J.			Cholic Acid Induces a Cftr Dependent Biliary Secretion and Liver Growth Response in Mice	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS MOUSE; DUCT EPITHELIAL-CELLS; FARNESOID-X RECEPTOR; P-GLYCOPROTEIN GENE; BILE-SALTS; DISEASE; MODEL; MDR2; RAT	The cause of Cystic fibrosis liver disease (CFLD), is unknown. It is well recognized that hepatic exposure to hydrophobic bile salts is associated with the development of liver disease. For this reason, we hypothesize that, CFTR dependent variations, in the hepatic handling of hydrophobic bile salts, are related to the development CFLD. To test our hypothesis we studied, in Cftr(-/-) and control mice, bile production, bile composition and liver pathology, in normal feeding condition and during cholate exposure, either acute (intravenous) or chronic (three weeks via the diet). In Cftr(-/-) and control mice the basal bile production was comparable. Intravenous taurocholate increased bile production to the same extent in Cftr(-/-) and control mice. However, chronic cholate exposure increased the bile flow significantly less in Cftr(-/-) mice than in controls, together with significantly higher biliary bile salt concentration in Cftr(-/-) mice. Prolonged cholate exposure, however, did not induce CFLD like pathology in Cftr(-/-) mice. Chronic cholate exposure did induce a significant increase in liver mass in controls that was absent in Cftr(-/-) mice. Chronic cholate administration induces a cystic fibrosis-specific hepatobiliary phenotype, including changes in bile composition. These changes could not be associated with CFLD like pathological changes in CFmouse livers. However, chronic cholate administration induces liver growth in controls that is absent in Cftr(-/-) mice. Our findings point to an impaired adaptive homeotrophic liver response to prolonged hydrophobic bile salt exposure in CF conditions.	[Bodewes, Frank A. J. A.; de Vries, Willemien; Baller, Juul F. W.; Verkade, Henkjan J.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Pediat, NL-9700 AB Groningen, Netherlands; [Bijvelds, Marcel J.; de Jonge, Hugo R.] Erasmus Univ, Med Ctr, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands; [Gouw, Annette S. H.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol, NL-9713 AV Groningen, Netherlands	University of Groningen; Erasmus University Rotterdam; Erasmus MC; University of Groningen	Bodewes, FAJA (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Pediat, NL-9700 AB Groningen, Netherlands.	f.a.j.a.bodewes@umcg.nl		Verkade, Henkjan J/0000-0002-7034-2861; Bijvelds, Marcel/0000-0003-0814-188X				Benedetti A, 1997, HEPATOLOGY, V26, P9; Beuers U, 2010, HEPATOLOGY, V52, P1489, DOI 10.1002/hep.23810; Bijvelds MJC, 2005, AM J PHYSIOL-GASTR L, V288, pG646, DOI 10.1152/ajpgi.00295.2004; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bodewes FAJA, 2012, AM J PHYSIOL-GASTR L, V302, pG1035, DOI 10.1152/ajpgi.00258.2011; BOTTCHER CJF, 1961, J ATHEROSCLER RES, V1, P36, DOI 10.1016/S0368-1319(61)80052-5; COHN JA, 1993, GASTROENTEROLOGY, V105, P1857, DOI 10.1016/0016-5085(93)91085-V; COLLINS FS, 1992, SCIENCE, V256, P774, DOI 10.1126/science.1375392; Corbett K, 2004, J PEDIATR-US, V145, P327, DOI 10.1016/j.jpeds.2004.05.051; De Lisle RC, 2006, J PEDIATR GASTR NUTR, V42, P46, DOI 10.1097/01.mpg.0000189322.34582.3e; De Lisle RC, 2011, J PEDIATR GASTR NUTR, V53, P371, DOI 10.1097/MPG.0b013e318219c397; Debray D, 2012, GASTROENTEROLOGY, V142, P1581, DOI 10.1053/j.gastro.2012.02.033; Debray D, 2011, J CYST FIBROS, V10, pS29, DOI 10.1016/S1569-1993(11)60006-4; Durie PR, 2004, AM J PATHOL, V164, P1481, DOI 10.1016/S0002-9440(10)63234-8; Feranchak AP, 2001, SEMIN LIVER DIS, V21, P471, DOI 10.1055/s-2001-19030; Fiorotto R, 2011, GASTROENTEROLOGY, V141, P1498, DOI 10.1053/j.gastro.2011.06.052; Fitz JG, 2002, SEMIN LIVER DIS, V22, P241, DOI 10.1055/s-2002-34502; FITZ JG, 1993, J CLIN INVEST, V91, P319, DOI 10.1172/JCI116188; Freudenberg F, 2010, AM J PHYSIOL-GASTR L, V299, pG205, DOI 10.1152/ajpgi.00341.2009; HEUMAN DM, 1989, J LIPID RES, V30, P1161; Huang WD, 2006, SCIENCE, V312, P233, DOI 10.1126/science.1121435; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Kok T, 2003, J BIOL CHEM, V278, P41930, DOI 10.1074/jbc.M306309200; Lindblad A, 1999, HEPATOLOGY, V30, P1151, DOI 10.1002/hep.510300527; MASHIGE F, 1976, CLIN CHIM ACTA, V70, P79, DOI 10.1016/0009-8981(76)90007-3; MAUAD TH, 1994, AM J PATHOL, V145, P1237; Moyer K, 2009, CURR OPIN GASTROEN, V25, P272, DOI 10.1097/MOG.0b013e3283298865; Nash KL, 2008, J CYST FIBROS, V7, P252, DOI 10.1016/j.jcf.2007.10.004; RATCLIFF R, 1993, NAT GENET, V4, P35, DOI 10.1038/ng0593-35; Rowland M, 2011, AM J GASTROENTEROL, V106, P104, DOI 10.1038/ajg.2010.316; Scholte Bob J, 2004, J Cyst Fibros, V3 Suppl 2, P183, DOI 10.1016/j.jcf.2004.05.039; SCOTTJUPP R, 1991, ARCH DIS CHILD, V66, P698, DOI 10.1136/adc.66.6.698; Sinaasappel M, 1988, ACTA PAEDIATR SCAND, V363, P50; SINAASAPPEL M, 1988, ACTA PAEDIATR SCAND, V363, P45; Sokol TJ, 2005, J PEDIATR GASTR NUTR, V41, P235, DOI 10.1097/01.MPG.0000170600.80640.88; Song PZ, 2011, TOXICOL SCI, V123, P359, DOI 10.1093/toxsci/kfr177; Tormos AM, 2013, FREE RADICAL RES, V47, P905, DOI 10.3109/10715762.2013.821200; Uriarte I, 2013, GUT, V62, P899, DOI 10.1136/gutjnl-2012-302945; VANDOORNINCK JH, 1995, EMBO J, V14, P4403, DOI 10.1002/j.1460-2075.1995.tb00119.x; vanNieuwerk CMJ, 1997, J HEPATOL, V26, P138, DOI 10.1016/S0168-8278(97)80020-7; vanNieuwkerk CMJ, 1996, GASTROENTEROLOGY, V111, P165, DOI 10.1053/gast.1996.v111.pm8698195; Verkade HJ, 2007, J LIPID RES, V48, P2058, DOI 10.1194/jlr.M700278-JLR200; Wang YD, 2008, CELL RES, V18, P1087, DOI 10.1038/cr.2008.289; Wilke M, 2011, J CYST FIBROS, V10, pS152, DOI 10.1016/S1569-1993(11)60020-9; Wouthuyzen-Bakker M, 2012, PEDIATR RES, V71, P4, DOI 10.1038/pr.2011.4; Wu AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017868; Zhang LS, 2012, HEPATOLOGY, V56, P2336, DOI 10.1002/hep.25905	47	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117599	10.1371/journal.pone.0117599	http://dx.doi.org/10.1371/journal.pone.0117599			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680200	Green Published, Green Submitted, gold			2022-12-26	WOS:000350682600076
J	Smith, HK; Gil, CD; Oliani, SM; Gavins, FNE				Smith, Helen K.; Gil, Cristiane Damas; Oliani, Sonia M.; Gavins, Felicity N. E.			Targeting formyl peptide receptor 2 reduces leukocyte-endothelial interactions in a murine model of stroke	FASEB JOURNAL			English	Article						ischemia /reperfusion; inflammation; FPR2/ALX; Annexin A1	BLOOD-BRAIN-BARRIER; ADHESION MOLECULE-1 EXPRESSION; VIVO NEUTROPHIL ACTIVATION; CEREBRAL-ARTERY OCCLUSION; LIPOXIN A(4); IN-VIVO; MICROGLIAL ACTIVATION; MOUSE MODEL; INFLAMMATORY CYTOKINES; ISCHEMIA-REPERFUSION	Ischemia/reperfusion (I/R) injury following stroke can worsen patient outcome through excess inflammation. This study investigated the pharmacologic potential of targeting an endogenous anti-inflammatory circuit via formyl peptide receptor (FPR) 2/lipoxin receptor (ALX) (Fpr2/3 in mouse) in global cerebral I/R. Mice (C57BL/6 and Fpr2/3(-/-)) were subjected to bilateral common carotid artery occlusion, followed by reperfusion and treatment with FPR agonists: AnxA1(Ac2-26) [Annexin A1 mimetic peptide (Ac-AMVSEFLKQAWFIENEEQEYVQTVK), 2.5 mu/kg] and 15-epimer-lipoxin A4 (15-epi-LXA(4); FPR2/ALX specific, 12.5 and 100 ng/kg). Leukocyte-endothelial (L-E) interactions in the cerebral microvasculature were then quantified in vivo using intravital fluorescence microscopy. 15-epi-LXA(4) administration at the start of reperfusion reduced L-E interactions after 40 min (which was sustained at 2 h with high-dose 15-epi-LXA(4)) to levels seen in sham-operated animals. AnxA1(Ac2-26) treatment decreased leukocyte adhesion at 40 min and all L-E interactions at 2 h (up to 95%). Combined treatment with AnxA1(Ac2-26) plus FPR antagonists t-Boc-FLFLF (250 ng/kg) or WRW4 (FPR2/ALX selective, 1.4 mu/kg) abrogated the effects of AnxA1(Ac2-26) fully at 40 min. Antagonists were less effective at 2 h, which we demonstrate is likely because of their impact on early L-E interactions. Our findings indicate that FPR2/ALX activity elicits considerable control over vascular inflammatory responses during cerebral I/R and, therefore, provide evidence that targeting FPR2/ALX may be beneficial for patients who suffered from stroke.	[Smith, Helen K.; Gavins, Felicity N. E.] Louisiana State Univ, Hlth Sci Ctr, Mol & Cellular Physiol Dept, Shreveport, LA 71105 USA; [Smith, Helen K.; Gavins, Felicity N. E.] Univ London Imperial Coll Sci Technol & Med, Dept Med, Div Brain Sci, London W12 0NN, England; [Gil, Cristiane Damas] Univ Fed Sao Paulo, Dept Morphol & Genet, Sao Paulo, Brazil; [Oliani, Sonia M.] Univ Fed Sao Paulo, Dept Biol, Sao Paulo, Brazil	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Imperial College London; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Gavins, FNE (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Med, Div Brain Sci, Burlington Danes Bldg,Du Cane Rd, London W12 0NN, England.	f.gavins@imperial.ac.uk	Damas Gil, Cristiane/E-1187-2012; DAMAS GIL, CRISTIANE/GQA-9650-2022; Oliani, Sonia Maria/E-3476-2012; Gavins, Felicity N. E./AAU-6010-2020	Damas Gil, Cristiane/0000-0001-6979-4126; Oliani, Sonia Maria/0000-0003-0918-2130; Gavins, Felicity N. E./0000-0001-7008-5423	Higher Education Funding Council for England; MRC [MC_PC_12015] Funding Source: UKRI	Higher Education Funding Council for England(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by Higher Education Funding Council for England.	Abbott NJ, 2002, J ANAT, V200, P629, DOI 10.1046/j.1469-7580.2002.00064.x; Antonenko D, 2013, AM J SURG, V206, P845; Bena S., 2012, E J BRIT SOC PHARM; Biscaro B, 2012, NEURODEGENER DIS, V9, P187, DOI 10.1159/000330363; Campagne MV, 1999, J CEREBR BLOOD F MET, V19, P1354, DOI 10.1097/00004647-199912000-00009; Cooray SN, 2013, P NATL ACAD SCI USA, V110, P18232, DOI 10.1073/pnas.1308253110; Dalli J, 2012, BLOOD, V120, pE60, DOI 10.1182/blood-2012-04-423525; de Coupade C, 2003, BRIT J PHARMACOL, V140, P133, DOI 10.1038/sj.bjp.0705413; Devosse T, 2009, J IMMUNOL, V182, P4974, DOI 10.4049/jimmunol.0803128; Dufton N, 2010, J IMMUNOL, V184, P2611, DOI 10.4049/jimmunol.0903526; El Kebir D, 2009, AM J RESP CRIT CARE, V180, P311, DOI 10.1164/rccm.200810-1601OC; Fierro IM, 2003, J IMMUNOL, V170, P2688, DOI 10.4049/jimmunol.170.5.2688; Folco G, 2006, PHARMACOL REV, V58, P375, DOI 10.1124/pr.58.3.8; Gavins FNE, 2007, FASEB J, V21, P1751, DOI 10.1096/fj.06-7842com; Gavins FNE, 2012, FASEB J, V26, P4977, DOI 10.1096/fj.12-205971; Gavins FNE, 2004, FASEB J, V18, P100, DOI 10.1096/fj.04-2178fje; Guilford WJ, 2004, J MED CHEM, V47, P2157, DOI 10.1021/jm030569l; Hoyte LC, 2010, J CEREBR BLOOD F MET, V30, P1178, DOI 10.1038/jcbfm.2009.287; Ishikawa M, 2003, STROKE, V34, P1777, DOI 10.1161/01.STR.0000074921.17767.F2; Ishikawa M, 2007, AM J PHYSIOL-HEART C, V292, pH2306, DOI 10.1152/ajpheart.00601.2006; Kitagawa K, 1998, J CEREBR BLOOD F MET, V18, P570, DOI 10.1097/00004647-199805000-00012; Lambertsen KL, 2012, J CEREBR BLOOD F MET, V32, P1677, DOI 10.1038/jcbfm.2012.88; Le YY, 2002, TRENDS IMMUNOL, V23, P541, DOI 10.1016/S1471-4906(02)02316-5; Levy BD, 2007, FASEB J, V21, P3877, DOI 10.1096/fj.07-8653com; Liesz A, 2009, STROKE, V40, P2849, DOI 10.1161/STROKEAHA.109.549618; Maderna P, 2010, FASEB J, V24, P4240, DOI 10.1096/fj.10-159913; MATSUO Y, 1994, BRAIN RES, V656, P344, DOI 10.1016/0006-8993(94)91478-8; Murakami K, 1998, BRAIN RES, V780, P304, DOI 10.1016/S0006-8993(97)01217-1; Murray PJ, 2005, P NATL ACAD SCI USA, V102, P8686, DOI 10.1073/pnas.0500419102; Norris PC, 2014, P NATL ACAD SCI USA, V111, P12746, DOI 10.1073/pnas.1404372111; OKADA Y, 1994, STROKE, V25, P202, DOI 10.1161/01.STR.25.1.202; Pascual JL, 2013, AM J SURG, V206, P840, DOI 10.1016/j.amjsurg.2013.07.016; Patel FJ, 2014, CYTOKINE, V69, P234, DOI 10.1016/j.cyto.2014.06.011; Prestigiacomo CJ, 1999, STROKE, V30, P1110, DOI 10.1161/01.STR.30.5.1110; Rezkalla SH, 2002, CIRCULATION, V105, P656, DOI 10.1161/hc0502.102867; Riazi K, 2008, P NATL ACAD SCI USA, V105, P17151, DOI 10.1073/pnas.0806682105; Shouval DS, 2014, IMMUNITY, V40, P706, DOI 10.1016/j.immuni.2014.03.011; Strausbaugh HJ, 2001, J IMMUNOL, V166, P6294, DOI 10.4049/jimmunol.166.10.6294; Tikka TM, 2001, J IMMUNOL, V166, P7527, DOI 10.4049/jimmunol.166.12.7527; TODD NV, 1986, STROKE, V17, P460, DOI 10.1161/01.STR.17.3.460; Wellons JC, 2000, BRAIN RES, V868, P14, DOI 10.1016/S0006-8993(00)02216-2; Yan BY, 2014, BRAIN RES, V1573, P63, DOI 10.1016/j.brainres.2014.05.023; Yang GM, 1997, BRAIN RES, V752, P209, DOI 10.1016/S0006-8993(96)01453-9; Ye XH, 2010, BRAIN RES, V1323, P174, DOI 10.1016/j.brainres.2010.01.079; Yenari MA, 2006, STROKE, V37, P1087, DOI 10.1161/01.STR.0000206281.77178.ac; Yenari MA, 2010, NEUROTHERAPEUTICS, V7, P378, DOI 10.1016/j.nurt.2010.07.005; Yoshioka H, 2011, J NEUROTRAUM, V28, P649, DOI 10.1089/neu.2010.1662; Yrjanheikki J, 1998, P NATL ACAD SCI USA, V95, P15769, DOI 10.1073/pnas.95.26.15769; Zhang LL, 2014, NEUROPSYCH DIS TREAT, V10, P1103, DOI 10.2147/NDT.S64236; ZHANG RL, 1995, BRAIN RES, V682, P182, DOI 10.1016/0006-8993(95)00346-R	50	51	51	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2015	29	5					2161	2171		10.1096/fj.14-263160	http://dx.doi.org/10.1096/fj.14-263160			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZJ	25690650				2022-12-26	WOS:000354114600046
J	Hara, T; Mizuguchi, M; Fujii, M; Nakamura, M				Hara, Toshifumi; Mizuguchi, Mariko; Fujii, Masahiro; Nakamura, Masataka			Kruppel-like Factor 2 Represses Transcription of the Telomerase Catalytic Subunit Human Telomerase Reverse Transcriptase (hTERT) in Human T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATED EXPRESSION; HUMAN-LYMPHOCYTES; UP-REGULATION; GENE; TRAFFICKING; QUIESCENCE; ACTIVATION; GROWTH; KLF2	In normal human T cells, telomerase activity is strictly regulated. T cells are thought to express telomerase to avoid replicative senescence, unlike most normal somatic cells with definite replicative lifespan. T cells in blood and tissues are usually in a state of quiescence without expression of the limiting catalytic subunit of telomerase, human telomerase reverse transcriptase (hTERT). In contrast to activation, repression of hTERT transcription has not been studied well. Our previous studies have found an hTERT promoter element with repressive function. Here we identified KLF2, which represses hTERT transcription by binding to the putative promoter element. KLF2 and hTERT exhibited reciprocal mRNA expression patterns in primary human T cells. In activated T cells, KLF2 binding to the hTERT promoter was eliminated, relieving the repression of hTERT transcription found in resting T cells. Our results suggest that KLF2 is involved in strict repression of hTERT expression through binding to the promoter in primary human T cells.	[Hara, Toshifumi; Mizuguchi, Mariko; Nakamura, Masataka] Tokyo Med & Dent Univ, Human Gene Sci Ctr, Tokyo 1138510, Japan; [Hara, Toshifumi; Fujii, Masahiro] Niigata Univ, Grad Sch Med & Dent Sci, Div Virol, Niigata 9518510, Japan	Tokyo Medical & Dental University (TMDU); Niigata University	Nakamura, M (corresponding author), Tokyo Med & Dent Univ, Human Gene Sci Ctr, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	naka.gene@tmd.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for Promotion of Science	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan and Japan Society for Promotion of Science.	Akbar AN, 2007, J IMMUNOL, V178, P6689, DOI 10.4049/jimmunol.178.11.6689; Bai AL, 2007, J IMMUNOL, V178, P7632, DOI 10.4049/jimmunol.178.12.7632; Buchkovich KJ, 1996, MOL BIOL CELL, V7, P1443, DOI 10.1091/mbc.7.9.1443; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Deng YB, 2008, NAT REV CANCER, V8, P450, DOI 10.1038/nrc2393; Ducrest AL, 2002, ONCOGENE, V21, P541, DOI 10.1038/sj.onc.1205081; Funato N, 2001, MOL CELL BIOL, V21, P7416, DOI 10.1128/MCB.21.21.7416-7428.2001; Hara T, 2008, CANCER SCI, V99, P1155, DOI 10.1111/j.1349-7006.2008.00798.x; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HIYAMA K, 1995, J IMMUNOL, V155, P3711; Hodes RJ, 2002, NAT REV IMMUNOL, V2, P699, DOI 10.1038/nri890; Horikawa L, 2005, P NATL ACAD SCI USA, V102, P18437, DOI 10.1073/pnas.0508964102; Janknecht R, 2004, FEBS LETT, V564, P9, DOI 10.1016/S0014-5793(04)00356-4; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Kawauchi K, 2005, J IMMUNOL, V174, P5261, DOI 10.4049/jimmunol.174.9.5261; Kuo CT, 1997, SCIENCE, V277, P1986, DOI 10.1126/science.277.5334.1986; Liu KB, 1999, P NATL ACAD SCI USA, V96, P5147, DOI 10.1073/pnas.96.9.5147; Masutomi K, 2003, CELL, V114, P241, DOI 10.1016/S0092-8674(03)00550-6; Nugent CI, 1998, GENE DEV, V12, P1073, DOI 10.1101/gad.12.8.1073; Odumade OA, 2010, J IMMUNOL, V184, P6060, DOI 10.4049/jimmunol.1000511; Poole JC, 2001, GENE, V269, P1, DOI 10.1016/S0378-1119(01)00440-1; PROWSE KR, 1995, P NATL ACAD SCI USA, V92, P4818, DOI 10.1073/pnas.92.11.4818; Takada K, 2011, J IMMUNOL, V186, P775, DOI 10.4049/jimmunol.1000094; Weng NP, 1996, J EXP MED, V183, P2471, DOI 10.1084/jem.183.6.2471; Wu JH, 2004, ONCOGENE, V23, P8088, DOI 10.1038/sj.onc.1207996; Zhang XL, 2004, BIOCHEM BIOPH RES CO, V316, P139, DOI 10.1016/j.bbrc.2004.02.033; Zhao YJ, 2014, NUCLEIC ACIDS RES, V42, P10385, DOI 10.1093/nar/gku721	28	5	5	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					8758	8763		10.1074/jbc.M114.610386	http://dx.doi.org/10.1074/jbc.M114.610386			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25694435	hybrid, Green Published			2022-12-26	WOS:000352207100007
J	Du, F; Babcock, JJ; Yu, HB; Zou, BY; Li, M				Du, Fang; Babcock, Joseph J.; Yu, Haibo; Zou, Beiyan; Li, Min			Global Analysis Reveals Families of Chemical Motifs Enriched for hERG Inhibitors	PLOS ONE			English	Article							POTASSIUM CHANNELS; LONG-QT; MODEL; COMPOUND; QSAR; CLASSIFICATION; PHARMACOPHORE; PREDICTION; DIVERSE; CARDIOTOXICITY	Promiscuous inhibition of the human ether-a-go-go-related gene (hERG) potassium channel by drugs poses a major risk for life threatening arrhythmia and costly drug withdrawals. Current knowledge of this phenomenon is derived from a limited number of known drugs and tool compounds. However, in a diverse, naive chemical library, it remains unclear which and to what degree chemical motifs or scaffolds might be enriched for hERG inhibition. Here we report electrophysiology measurements of hERG inhibition and computational analyses of >300,000 diverse small molecules. We identify chemical 'communities' with high hERG liability, containing both canonical scaffolds and structurally distinctive molecules. These data enable the development of more effective classifiers to computationally assess hERG risk. The resultant predictive models now accurately classify naive compound libraries for tendency of hERG inhibition. Together these results provide a more complete reference map of characteristic chemical motifs for hERG liability and advance a systematic approach to rank chemical collections for cardiotoxicity risk.	Johns Hopkins Univ, High Throughput Biol Ctr, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, JHICC, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Li, M (corresponding author), GSK, King Of Prussia, PA 19406 USA.	min.x.li@gsk.com			National Institutes of Health [GM078579, MH084691]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078579, T32GM008752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084691] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work is supported by grants to ML from the National Institutes of Health (GM078579, MH084691). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Aronov AM, 2006, J MED CHEM, V49, P6917, DOI 10.1021/jm060500o; Aronov AM, 2004, BIOORGAN MED CHEM, V12, P2307, DOI 10.1016/j.bmc.2004.02.003; Bickerton GR, 2012, NAT CHEM, V4, P90, DOI [10.1038/nchem.1243, 10.1038/NCHEM.1243]; Bolton EE, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-32; Bolton EE, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-13; Braga RC, 2014, CURR TOP MED CHEM, V14, P1399, DOI 10.2174/1568026614666140506124442; Bridal TR, 2010, ASSAY DRUG DEV TECHN, V8, P755, DOI 10.1089/adt.2010.0267; Bridgland-Taylor M. H., 2006, Journal of Pharmacological and Toxicological Methods, V54, P189, DOI 10.1016/j.vascn.2006.02.003; Cavalli A, 2002, J MED CHEM, V45, P3844, DOI 10.1021/jm0208875; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Colizza V, 2006, NAT PHYS, V2, P110, DOI 10.1038/nphys209; Czodrowski P, 2013, J CHEM INF MODEL, V53, P2240, DOI 10.1021/ci400308z; Doddareddy MR, 2010, CHEMMEDCHEM, V5, P716, DOI 10.1002/cmdc.201000024; Drwal MN, 2014, NUCLEIC ACIDS RES, V42, pW53, DOI 10.1093/nar/gku401; Du F, 2011, ASSAY DRUG DEV TECHN, V9, P580, DOI 10.1089/adt.2011.0425; Du LP, 2004, BIOORG MED CHEM LETT, V14, P4771, DOI 10.1016/j.bmcl.2004.06.070; Ekins S, 2002, J PHARMACOL EXP THER, V301, P427, DOI 10.1124/jpet.301.2.427; Fanoe S, 2009, BRIT J CLIN PHARMACO, V67, P172, DOI 10.1111/j.1365-2125.2008.03327.x; Fowler JH, 2011, P NATL ACAD SCI USA, V108, P1993, DOI 10.1073/pnas.1011687108; Gavaghan CL, 2007, J COMPUT AID MOL DES, V21, P189, DOI 10.1007/s10822-006-9095-6; Grant JA, 1996, J COMPUT CHEM, V17, P1653, DOI 10.1002/(SICI)1096-987X(19961115)17:14<1653::AID-JCC7>3.0.CO;2-K; Guha R, 2008, J COMPUT AID MOL DES, V22, P367, DOI 10.1007/s10822-008-9192-9; Guo Liang, 2005, Journal of Pharmacological and Toxicological Methods, V52, P123, DOI 10.1016/j.vascn.2005.04.002; Huang XP, 2010, ASSAY DRUG DEV TECHN, V8, P727, DOI 10.1089/adt.2010.0331; Hussain J, 2010, J CHEM INF MODEL, V50, P339, DOI 10.1021/ci900450m; Kannankeril PJ, 2007, CURR OPIN CARDIOL, V22, P39, DOI 10.1097/HCO.0b013e32801129eb; Kim S, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-26; Koes DR, 2011, J CHEM INF MODEL, V51, P1307, DOI 10.1021/ci200097m; Kolbe K, 2010, J PHYSIOL-LONDON, V588, P2999, DOI 10.1113/jphysiol.2010.192468; Li QY, 2008, MOL PHARMACEUT, V5, P117, DOI 10.1021/mp700124e; Matyus P, 1998, INT J QUANTUM CHEM, V69, P21, DOI 10.1002/(SICI)1097-461X(1998)69:1<21::AID-QUA4>3.0.CO;2-Z; Morgan T K Jr, 1992, Prog Med Chem, V29, P65, DOI 10.1016/S0079-6468(08)70005-5; Papadatos G, 2010, J CHEM INF MODEL, V50, P1872, DOI 10.1021/ci100258p; Pearlstein RA, 2003, BIOORG MED CHEM LETT, V13, P1829, DOI 10.1016/S0960-894X(03)00196-3; Robinson RLM, 2011, MOL INFORM, V30, P443, DOI 10.1002/minf.201000159; Roche O, 2002, CHEMBIOCHEM, V3, P455, DOI 10.1002/1439-7633(20020503)3:5<455::AID-CBIC455>3.0.CO;2-L; Roden DM, 2004, NEW ENGL J MED, V350, P1013, DOI 10.1056/NEJMra032426; Rogers D, 2010, J CHEM INF MODEL, V50, P742, DOI 10.1021/ci100050t; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Seierstad M, 2006, CHEM BIOL DRUG DES, V67, P284, DOI 10.1111/j.1747-0285.2006.00379.x; Shen MY, 2011, CHEM RES TOXICOL, V24, P934, DOI 10.1021/tx200099j; Testai L, 2004, CURR MED CHEM, V11, P2691, DOI 10.2174/0929867043364351; Thai KM, 2009, MOL DIVERS, V13, P321, DOI 10.1007/s11030-009-9117-0; Thomas D, 2004, N-S ARCH PHARMACOL, V369, P462, DOI 10.1007/s00210-004-0931-8; Varin T, 2011, J CHEM INF MODEL, V51, P1528, DOI 10.1021/ci2000924; Wang YL, 2012, NUCLEIC ACIDS RES, V40, pD400, DOI [10.1093/nar/gkr1132, 10.1093/nar/gkr1293]; Wetzel S, 2009, NAT CHEM BIOL, V5, P581, DOI 10.1038/nchembio.187; Zhou S, 2004, IEEE COMMUN LETT, V8, P180, DOI 10.1109/LCOMM.2004.823426; Zou BY, 2010, ASSAY DRUG DEV TECHN, V8, P743, DOI 10.1089/adt.2010.0339	51	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0118324	10.1371/journal.pone.0118324	http://dx.doi.org/10.1371/journal.pone.0118324			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25700001	Green Published, gold, Green Submitted			2022-12-26	WOS:000349789800038
J	Llarena, AK; Huneau, A; Hakkinen, M; Hanninen, ML				Llarena, Ann-Katrin; Huneau, Adeline; Hakkinen, Marjaana; Hanninen, Marja-Liisa			Predominant Campylobacter jejuni Sequence Types Persist in Finnish Chicken Production	PLOS ONE			English	Article							BROILER FLOCKS; SPP.; RISK; COLI; COLONIZATION; EPIDEMIOLOGY; ASSOCIATION; INFECTIONS; PREVALENCE; HUMANS	Consumption and handling of chicken meat are well-known risk factors for acquiring campylobacteriosis. This study aimed to describe the Campylobacter jejuni population in Finnish chickens and to investigate the distribution of C. jejuni genotypes on Finnish chicken farms over a period of several years. We included 89.8% of the total C. jejuni population recovered in Finnish poultry during 2004, 2006, 2007, 2008, and 2012 and used multilocus sequence typing (MLST) and pulsed-field gel electrophoresis (PFGE) to characterize the 380 isolates. The typing data was combined with isolate information on collection-time and farm of origin. The C. jejuni prevalence in chicken slaughter batches was low (mean 3.0%, CI95% [1.8%, 4.2%]), and approximately a quarter of Finnish chicken farms delivered at least one positive chicken batch yearly. In general, the C. jejuni population was diverse as represented by a total of 63 sequence types (ST), but certain predominant MLST lineages were identified. ST-45 clonal complex (CC) accounted for 53% of the isolates while ST-21 CC and ST-677 CC covered 11% and 9% of the isolates, respectively. Less than half of the Campylobacter positive farms (40.3%) delivered C. jejuni-contaminated batches in multiple years, but the genotypes (ST and PFGE types) generally varied from year to year. Therefore, no evidence for a persistent C. jejuni source for the colonization of Finnish chickens emerged. Finnish chicken farms are infrequently contaminated with C. jejuni compared to other European Union (EU) countries, making Finland a valuable model for further epidemiological studies of the C. jejuni in poultry flocks.	[Llarena, Ann-Katrin; Hanninen, Marja-Liisa] Univ Helsinki, Fac Vet Med, Dept Food Hyg & Environm Hlth, Helsinki, Finland; [Huneau, Adeline] Anses, Ploufragan Plouzane Lab, F-22440 Ploufragan, France; [Hakkinen, Marjaana] Evira, Finnish Food Safety Author, Res & Lab Dept, Food & Feed Microbiol Res Unit, Helsinki, Finland	University of Helsinki; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Finnish Food Authority	Llarena, AK (corresponding author), Univ Helsinki, Fac Vet Med, Dept Food Hyg & Environm Hlth, Helsinki, Finland.	ann-katrin.llarena@helsinki.fi		Llarena, Ann-Katrin/0000-0001-5278-7253; Huneau-Salaun, Adeline/0000-0002-2343-5176	Finnish Ministry of Agriculture and Forestry [MMM2054/312/11]; Coordination of European Research on Emerging and Major Infectious Diseases of Livestock (EMIDA ERA-NET) [Dnro 776/312/2012]	Finnish Ministry of Agriculture and Forestry; Coordination of European Research on Emerging and Major Infectious Diseases of Livestock (EMIDA ERA-NET)	This work was supported by Finnish Ministry of Agriculture and Forestry grant [No. MMM2054/312/11] and by Coordination of European Research on Emerging and Major Infectious Diseases of Livestock (EMIDA ERA-NET) (Dnro 776/312/2012) through the project entitled Biology and Control of Campylobacter in the Chicken Supply Chain (CamChain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agunos A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104905; Allen VM, 2008, J FOOD PROTECT, V71, P264, DOI 10.4315/0362-028X-71.2.264; Andreoletti O, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1437; Blaser MJ, 2008, CAMPYLOBACTER, 3RD EDITION, P99; Bull SA, 2006, APPL ENVIRON MICROB, V72, P645, DOI 10.1128/AEM.72.1.645-652.2006; de Haan CPA, 2010, APPL ENVIRON MICROB, V76, P5228, DOI 10.1128/AEM.00581-10; de Haan CPA, 2012, APPL ENVIRON MICROB, V78, P5550, DOI 10.1128/AEM.01023-12; de Haan CPA, 2014, CAMPYLOBACTER ECOLOG, P241; EFSA, 2011, EFSA J, V9, P2105, DOI DOI 10.2903/J.EFSA.2011.2105; EFSA (European Food Safety Authority), 2009, EFSA J, V7, P358, DOI [10.2903/j.efsa.2009.1438, DOI 10.2903/J.EFSA.2009.1438, 10.2903/j.efsa.2010.1496]; European Food Safety Authority, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3547; European Food Safety Authority, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2597; Evira (Finnish Food Safety Authority), 2012, 35125 EV; Fajo-Pascual M, 2010, EUR J PUBLIC HEALTH, V20, P443, DOI 10.1093/eurpub/ckp206; French N., 2014, CAMPYLOBACTER ECOLOG, P221; Griekspoor P, 2013, MOL ECOL, V22, P1463, DOI 10.1111/mec.12144; Griekspoor P, 2010, VET MICROBIOL, V140, P180, DOI 10.1016/j.vetmic.2009.07.022; Gripp E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-584; Hakkinen M, 2007, APPL ENVIRON MICROB, V73, P3232, DOI 10.1128/AEM.02579-06; Hakkinen M, 2009, APPL ENVIRON MICROB, V75, P5244, DOI 10.1128/AEM.00374-09; Hald B, 2004, EMERG INFECT DIS, V10, P1490, DOI 10.3201/eid1008.040129; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hansson I, 2007, J APPL MICROBIOL, V103, P640, DOI 10.1111/j.1365-2672.2007.03291.x; Hartnett E, 2001, EPIDEMIOL INFECT, V127, P195, DOI 10.1017/S0950268801005866; Hook H, 2005, VET MICROBIOL, V106, P109, DOI 10.1016/j.vetmic.2004.12.017; Hulkko T, 2008, THL RAPORTTI, V17, P1; Jaakola S, 2013, THL LAITOS, V10, P1; Jonsson ME, 2012, PREV VET MED, V107, P95, DOI 10.1016/j.prevetmed.2012.05.002; Kapperud G, 2003, AM J EPIDEMIOL, V158, P234, DOI 10.1093/aje/kwg139; Karenlampi R, 2007, APPL ENVIRON MICROB, V73, P148, DOI 10.1128/AEM.01488-06; Klena JD, 2005, CAMPYLOBACTER: MOLECULAR AND CELLULAR BIOLOGY, P165; Korczak BM, 2009, J CLIN MICROBIOL, V47, P1996, DOI 10.1128/JCM.00237-09; Levesque S, 2008, J CLIN MICROBIOL, V46, P3404, DOI 10.1128/JCM.00042-08; Llarena AK, 2015, ZOONOSES PUBLIC HLTH, V62, P209, DOI 10.1111/zph.12141; Maa-ja Metsatalousministerio, 2007, 10EEO2007 MAA JA MET; Makela P, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3129; McCarthy ND, 2012, EPIDEMIOL INFECT, V140, P2247, DOI 10.1017/S0950268812000192; McDowell SWJ, 2008, PREV VET MED, V84, P261, DOI 10.1016/j.prevetmed.2007.12.010; Miller WG, 2005, J CLIN MICROBIOL, V43, P2315, DOI 10.1128/JCM.43.5.2315-2329.2005; Newell DG, 2003, APPL ENVIRON MICROB, V69, P4343, DOI 10.1128/AEM.69.8.4343-4351.2003; Niemi J, 2013, MAA JA ELINTARVIKETA, V114, P1; O'Mahony E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028490; Perko-Makela P, 2002, EPIDEMIOL INFECT, V129, P187, DOI 10.1017/S0950268802007367; Perko-Makela P, 2011, THESIS U HELSINKI; Pirinen P., 2012, FINN METEOROL I REP, V2012, P1; Revez J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-768; Ridley AM, 2011, APPL ENVIRON MICROB, V77, P98, DOI 10.1128/AEM.01388-10; Sabat AJ, 2013, EUROSURVEILLANCE, V18, P17; Schonberg-Norio D, 2004, EMERG INFECT DIS, V10, P1474, DOI 10.3201/eid1008.030924; Sheppard SK, 2009, CLIN INFECT DIS, V48, P1072, DOI 10.1086/597402; Tike, 2013, YB FARM STAT; Vidal A, 2014, CAMPYLOBACTER ECOLOG, P288	53	34	34	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0116585	10.1371/journal.pone.0116585	http://dx.doi.org/10.1371/journal.pone.0116585			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25700264	gold, Green Published, Green Submitted			2022-12-26	WOS:000349789800011
J	Kalmar, Z; Cozma, V; Sprong, H; Jahfari, S; D'Amico, G; Marcutan, DI; Ionica, AM; Magdas, C; Modry, D; Mihalca, AD				Kalmar, Zsuzsa; Cozma, Vasile; Sprong, Hein; Jahfari, Setareh; D'Amico, Gianluca; Marcutan, Daniel I.; Ionica, Angela M.; Magdas, Cristian; Modry, David; Mihalca, Andrei D.			Transstadial Transmission of Borrelia turcica in Hyalomma aegyptium Ticks	PLOS ONE			English	Article							BURGDORFERI-SENSU-LATO; BORNE RELAPSING FEVER; ACARI IXODIDAE; LYME-DISEASE; IMPORTED REPTILES; IXODES-SCAPULARIS; 1ST ISOLATION; EXOTIC TICKS; HARD TICK; HUMANS	Borrelia turcica comprises the third major group of arthropod-transmitted borreliae and is phylogenetically divergent from other Borrelia groups. The novel group of Borrelia was initially isolated from Hyalomma aegyptium ticks in Turkey and it was recently found in blood and multiple organs of tortoises exported from Jordan to Japan. However, the ecology of these spirochetes and their development in ticks or the vertebrate hosts were not investigated in detail; our aims were to isolate the pathogen and to evaluate the possibility of transstadial transmission of Borrelia turcica by H. aegyptium ticks. Ticks were collected from Testudo graeca tortoises during the summer of 2013 from southeastern Romania. Engorged nymphs were successfully molted to the adult stage. Alive B. turcica was isolated from molted ticks by using Barbour-Stoenner-Kelly (BSK) II medium. Four pure cultures of spirochetes were obtained and analyzed by PCR and sequencing. Sequence analysis of glpQ, gyrB and flaB revealed 98%-100% similarities with B. turcica. H. aegyptium ticks collected from T. graeca tortoises were able to pass the infection with B. turcica via transstadial route, suggesting its vectorial capacity.	[Kalmar, Zsuzsa; Cozma, Vasile; D'Amico, Gianluca; Marcutan, Daniel I.; Ionica, Angela M.; Magdas, Cristian; Mihalca, Andrei D.] Univ Agr Sci & Vet Med Cluj Napoca, Dept Parasitol & Parasit Dis, Cluj Napoca, Romania; [Sprong, Hein; Jahfari, Setareh] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands; [Modry, David] Univ Vet & Pharmaceut Sci, Fac Vet Med, Dept Pathol & Parasitol, Brno, Czech Republic; [Modry, David] Acad Sci Czech Republ, Inst Parasitol, Ctr Biol, CR-37005 Ceske Budejovice, Czech Republic	University of Agricultural Sciences & Veterinary Medicine Cluj Napoca; Netherlands National Institute for Public Health & the Environment; University of Veterinary Sciences Brno; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences	Cozma, V (corresponding author), Univ Agr Sci & Vet Med Cluj Napoca, Dept Parasitol & Parasit Dis, Cluj Napoca, Romania.	vasile.cozma@usamvcluj.ro	Kalmar, Zsuzsa/A-1791-2017; Ionica, Angela/HDM-8313-2022; Mihalca, Andrei Daniel/A-1561-2008; Modry, David/G-7815-2014; Cozma, Vasile/GVT-2461-2022; D'Amico, Gianluca/A-8708-2019; Kalmar, Zsuzsa/AAD-7178-2021	Mihalca, Andrei Daniel/0000-0001-6076-7914; Modry, David/0000-0001-9649-6255; Cozma, Vasile/0000-0002-8587-3753; Kalmar, Zsuzsa/0000-0002-4492-8383; Sprong, Hein/0000-0002-0218-4320; Ionica, Angela/0000-0002-1438-2498	European Social Fund, Human Resources Development Operational Programme [POSDRU/159/1.5/S/136893]; EurNegVec COST Action [TD1303];  [IDEI PCE 236/2011]	European Social Fund, Human Resources Development Operational Programme; EurNegVec COST Action(European Cooperation in Science and Technology (COST)); 	This paper was published under the frame of: 1. European Social Fund, Human Resources Development Operational Programme 2007-2013, project no. POSDRU/159/1.5/S/136893 (http://www.usamvcluj.ro/POSDRU136893/); 2. Grant IDEI PCE 236/2011 (http://www.geo-parasite.org/about.html); 3. The work of ZK, GD, DIM, AMI, DM, HS, VC, ADM was done under the frame of EurNegVec COST Action TD1303 (http://www.eurnegvec.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeolu M, 2014, ANTON LEEUW INT J G, V105, P1049, DOI 10.1007/s10482-014-0164-x; ALGWAIZ LA, 1995, ANN SAUDI MED, V15, P165, DOI 10.5144/0256-4947.1995.165; Apanaskevich D. A., 2004, Parazitologiya (St. Petersburg), V38, P515; Bacon RM, 2004, J CLIN MICROBIOL, V42, P2326, DOI 10.1128/JCM.42.5.2326-2328.2004; Banerjee SN, 1998, J CLIN MICROBIOL, V36, P3505, DOI 10.1128/JCM.36.12.3505-3508.1998; Barbour AG, 2005, INFECT IMMUN, V73, P6165, DOI 10.1128/IAI.73.9.6165-6168.2005; Bitam I, 2009, CLIN MICROBIOL INFEC, V15, P253, DOI 10.1111/j.1469-0691.2008.02274.x; Burridge MJ, 2000, J PARASITOL, V86, P700, DOI 10.1645/0022-3395(2000)086[0700:IOPHVA]2.0.CO;2; Burridge MJ, 2011, NON NATIVE AND INVAS, P4; Burridge ML, 2003, VET PARASITOL, V113, P289, DOI 10.1016/S0304-4017(03)00060-8; Bursali A, 2010, J VECTOR ECOL, V35, P180, DOI 10.1111/j.1948-7134.2010.00045.x; Cutler SJ, 2006, EMERG INFECT DIS, V12, P369, DOI 10.3201/eid1203.050899; Dantas-Torres F, 2012, TRENDS PARASITOL, V28, P437, DOI 10.1016/j.pt.2012.07.003; Dolan MC, 1997, J MED ENTOMOL, V34, P128, DOI 10.1093/jmedent/34.2.128; Eisen L, 2002, LYME BORRELIOSIS BIO, P102; Elbir H, 2013, AM J TROP MED HYG, V89, P288, DOI 10.4269/ajtmh.12-0691; Feider Z, 1965, ARACHNIDA, VV, P2; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Franke J, 2013, TICKS TICK-BORNE DIS, V4, P11, DOI 10.1016/j.ttbdis.2012.06.007; Gern L, 1998, WIEN KLIN WOCHENSCHR, V110, P856; Guner ES, 2004, INT J SYST EVOL MICR, V54, P1649, DOI 10.1099/ijs.0.03050-0; Guner ES, 2003, J MED MICROBIOL, V52, P807, DOI 10.1099/jmm.0.05205-0; Harris DJ, 2011, J PARASITOL, V97, P106, DOI 10.1645/GE-2470.1; Kalmar Z, 2014, PARASIT VECTORS SUPP, V7, P6; Kar S, 2013, EXP APPL ACAROL, V61, P349, DOI 10.1007/s10493-013-9698-2; Kar S, 2011, CLIN EXP HEALTH SCI, V1, P166; Kolonin GV, 1983, RODY HYALOMMA APONOM; Masuzawa T, 2004, JPN J INFECT DIS, V57, P229; Mihalca AD, 2012, EXP APPL ACAROL, V58, P183, DOI 10.1007/s10493-012-9566-5; Orkun O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003067; Paperna I, 2002, PARASITE, V9, P17, DOI 10.1051/parasite/200209117; Pastiu AI, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-301; POSTIC D, 1994, INT J SYST BACTERIOL, V44, P743, DOI 10.1099/00207713-44-4-743; Rar VA, 2005, EMERG INFECT DIS, V11, P1708, DOI 10.3201/eid1111.041195; RAY HN, 1950, T ROY SOC TROP MED H, V44, P93, DOI 10.1016/0035-9203(50)90074-5; Rizzoli A, 2011, EUROSURVEILLANCE, V16, P2; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SANDERS FH, 1995, J MED ENTOMOL, V32, P402, DOI 10.1093/jmedent/32.4.402; Schwan TG, 2005, J CLIN MICROBIOL, V43, P3851, DOI 10.1128/JCM.43.8.3851-3859.2005; Schwan TG, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001924; Siroky P, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-101; Siroky P, 2011, EXP APPL ACAROL, V54, P277, DOI 10.1007/s10493-011-9442-8; Siroky P, 2010, PARASITOL RES, V107, P1515, DOI 10.1007/s00436-010-2037-1; Siroky P, 2009, J PARASITOL, V95, P728, DOI 10.1645/GE-1842.1; Stanek G, 2011, CLIN MICROBIOL INFEC, V17, P487, DOI 10.1111/j.1469-0691.2011.03492.x; Takano A, 2011, ENV MICROBIOL REP, V3, P632, DOI 10.1111/j.1758-2229.2011.00280.x; Takano A, 2012, TICKS TICK-BORNE DIS, V3, P259, DOI 10.1016/j.ttbdis.2012.06.003; Takano A, 2010, ENVIRON MICROBIOL, V12, P134, DOI 10.1111/j.1462-2920.2009.02054.x; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; van Dam AP, 1999, J CLIN MICROBIOL, V37, P2027, DOI 10.1128/JCM.37.6.2027-2030.1999; Vatansever Z, 2008, PARASITOL RES, V102, P551, DOI 10.1007/s00436-007-0809-z	52	26	26	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0115520	10.1371/journal.pone.0115520	http://dx.doi.org/10.1371/journal.pone.0115520			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695663	gold, Green Published, Green Submitted			2022-12-26	WOS:000350062300005
J	Li, GL; Zhang, JR; Guo, Q; Jiang, Y; Wei, JH; Zhao, LL; Zhao, XQ; Lu, JX; Wan, KL				Li, Guilian; Zhang, Jingrui; Guo, Qian; Jiang, Yi; Wei, Jianhao; Zhao, Li-li; Zhao, Xiuqin; Lu, Jianxin; Wan, Kanglin			Efflux Pump Gene Expression in Multidrug-Resistant Mycobacterium tuberculosis Clinical Isolates	PLOS ONE			English	Article							INTRINSIC DRUG-RESISTANCE; ISONIAZID RESISTANCE; RIFAMPIN RESISTANCE; MICROARRAY ANALYSIS; GENOME SEQUENCE; MECHANISM; SMEGMATIS; SUSCEPTIBILITY; TRANSPORTERS; ETHAMBUTOL	Isoniazid (INH) and rifampicin (RIF) are the two most effective drugs in tuberculosis therapy. Understanding the molecular mechanisms of resistance to these two drugs is essential to quickly diagnose multidrug-resistant (MDR) tuberculosis and extensive drug-resistant tuberculosis. Nine clinical Mycobacterium tuberculosis isolates resistant to only INH and RIF and 10 clinical pan-sensitive isolates were included to evaluate the expression of 20 putative drug efflux pump genes and sequence mutations in rpoB (RIF), katG (INH), the inhA promoter (INH), and oxyR-ahpC (INH). Nine and three MDR isolates were induced to overexpress efflux pump genes by INH and RIF, respectively. Eight and two efflux pump genes were induced to overexpress by INH and RIF in MDR isolates, respectively. drrA, drrB, efpA, jefA (Rv2459), mmr, Rv0849, Rv1634, and Rv1250 were overexpressed under INH or RIF stress. Most efflux pump genes were overexpressed under INH stress in a MDR isolates that carried the wild-type katG, inhA, and oxyR-ahpC associated with INH resistance than in those that carried mutations. The expression levels of 11 genes (efpA, Rv0849, Rv1250, P55 (Rv1410c), Rv1634, Rv2994, stp, Rv2459, pstB, drrA, and drrB) without drug inducement were significantly higher (P < 0.05) in nine MDR isolates than in 10 pansensitive isolates. In conclusion, efflux pumps may play an important role in INH acquired resistance in MDR M. tuberculosis, especially in those strains having no mutations in genes associated with INH resistance; basal expression levels of some efflux pump genes are higher in MDR isolates than in pan-sensitive isolates and the basal expressional differences may be helpful to diagnose and treat resistant tuberculosis.	[Li, Guilian; Zhang, Jingrui; Guo, Qian; Jiang, Yi; Wei, Jianhao; Zhao, Li-li; Zhao, Xiuqin; Wan, Kanglin] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, TB Branch, State Key Lab Infect Dis Prevent & Control, Beijing 102206, Peoples R China; [Li, Guilian; Zhang, Jingrui; Guo, Qian; Jiang, Yi; Wei, Jianhao; Zhao, Li-li; Zhao, Xiuqin; Wan, Kanglin] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Jingrui; Wei, Jianhao; Lu, Jianxin] Wenzhou Med Coll, Key Lab Lab Med, Wenzhou 325035, Zhejiang, Peoples R China; [Zhang, Jingrui] Shijiazhuang Gynecol & Obstetr Hosp, Shijiazhuang 050000, Hebei, Peoples R China; [Guo, Qian] South China Univ, Pathogen Biol Inst, Hengyang 421001, Hunan, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Wenzhou Medical University	Wan, KL (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, TB Branch, State Key Lab Infect Dis Prevent & Control, Beijing 102206, Peoples R China.	wankanglin@icdc.cn			National Key Programme of Mega Infectious Diseases [2013ZX10003002-001]; State Key Laboratory for Infectious Disease Prevention and Control [2014SKLID104]	National Key Programme of Mega Infectious Diseases; State Key Laboratory for Infectious Disease Prevention and Control	This work was financially supported by projects 2013ZX10003002-001 of the National Key Programme of Mega Infectious Diseases and the key project 2014SKLID104 of the State Key Laboratory for Infectious Disease Prevention and Control. The funders had no role in the study design, data collection and analysis, decision to publish, or manuscript preparation.	da Silva PEA, 2011, FEMS IMMUNOL MED MIC, V63, P1, DOI 10.1111/j.1574-695X.2011.00831.x; Aslan G, 2008, JPN J INFECT DIS, V61, P255; Balganesh M, 2012, ANTIMICROB AGENTS CH, V56, P2643, DOI 10.1128/AAC.06003-11; Balganesh M, 2010, ANTIMICROB AGENTS CH, V54, P5167, DOI 10.1128/AAC.00610-10; Banerjee A, 1998, MICROBIOL-SGM, V144, P2697, DOI 10.1099/00221287-144-10-2697; Betts JC, 2003, ANTIMICROB AGENTS CH, V47, P2903, DOI 10.1128/AAC.47.9.2903-2913.2003; Brennan PJ, 2003, TUBERCULOSIS, V83, P91, DOI 10.1016/S1472-9792(02)00089-6; Bustin SA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-74; Camus JC, 2002, MICROBIOL-SGM, V148, P2967, DOI 10.1099/00221287-148-10-2967; Choudhuri BS, 2002, BIOCHEM J, V367, P279, DOI 10.1042/BJ20020615; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; De Rossi E, 2006, FEMS MICROBIOL REV, V30, P36, DOI 10.1111/j.1574-6976.2005.00000.x; De Rossi E, 1998, J BACTERIOL, V180, P6068, DOI 10.1128/JB.180.22.6068-6071.1998; De Rossi Edda, 2002, Molecular Medicine (Baltimore), V8, P714; DeMarco CE, 2007, ANTIMICROB AGENTS CH, V51, P3235, DOI 10.1128/AAC.00430-07; Doustdar F, 2008, MICROB DRUG RESIST, V14, P273, DOI 10.1089/mdr.2008.0842; Escribano I, 2007, CHEMOTHERAPY, V53, P397, DOI 10.1159/000109769; Fu LM, 2006, TUBERCULOSIS, V86, P134, DOI 10.1016/j.tube.2005.07.004; Gupta AK, 2010, INDIAN J MED RES, V132, P176; Gupta AK, 2010, MICROB DRUG RESIST, V16, P21, DOI 10.1089/mdr.2009.0054; Jiang X, 2008, MICROB DRUG RESIST, V14, P7, DOI 10.1089/mdr.2008.0772; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kiepiela P, 2000, TUBERCLE LUNG DIS, V80, P47, DOI 10.1054/tuld.1999.0231; Leonard B, 2008, J CLIN MICROBIOL, V46, P3526, DOI 10.1128/JCM.02083-07; Li XZ, 2004, ANTIMICROB AGENTS CH, V48, P2415, DOI 10.1128/AAC.48.7.2415-2423.2004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louw GE, 2011, AM J RESP CRIT CARE, V184, P269, DOI 10.1164/rccm.201011-1924OC; McCammon MT, 2005, ANTIMICROB AGENTS CH, V49, P2200, DOI 10.1128/AAC.49.6.2200-2209.2005; MCCLURE WR, 1978, J BIOL CHEM, V253, P8949; Mokrousov I, 2002, ANTIMICROB AGENTS CH, V46, P1417, DOI 10.1128/AAC.46.5.1417-1424.2002; Mukaigawa Jun, 2005, Kansenshogaku Zasshi, V79, P388; Niederweis M, 2003, MOL MICROBIOL, V49, P1167, DOI 10.1046/j.1365-2958.2003.03662.x; Pang Y, 2013, ANTIMICROB AGENTS CH, V57, P893, DOI 10.1128/AAC.01024-12; Pasca MR, 2005, ANTIMICROB AGENTS CH, V49, P4775, DOI 10.1128/AAC.49.11.4775-4777.2005; Piddock LJV, 2000, J ANTIMICROB CHEMOTH, V45, P159, DOI 10.1093/jac/45.2.159; Ramon-Garcia S, 2009, ANTIMICROB AGENTS CH, V53, P3675, DOI 10.1128/AAC.00550-09; Rodrigues L, 2012, INFECT GENET EVOL, V12, P695, DOI 10.1016/j.meegid.2011.08.009; Sacchettini JC, 1996, RES MICROBIOL, V147, P36, DOI 10.1016/0923-2508(96)80201-4; Sekiguchi J, 2007, J CLIN MICROBIOL, V45, P179, DOI 10.1128/JCM.00750-06; Somoskovi A, 2001, RESP RES, V2, P164, DOI 10.1186/rr54; Waddell SJ, 2004, TUBERCULOSIS, V84, P263, DOI 10.1016/j.tube.2003.12.005; World Health Organization, 2012, 2012 UPD CRIT CONC 1; World Health Organization, 2008, WHOHTMTB2008392; Zhang Jing-rui, 2013, Zhonghua Liu Xing Bing Xue Za Zhi, V34, P379; ZHANG Y, 1992, NATURE, V358, P591, DOI 10.1038/358591a0	45	66	70	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0119013	10.1371/journal.pone.0119013	http://dx.doi.org/10.1371/journal.pone.0119013			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695504	Green Published, Green Submitted, gold			2022-12-26	WOS:000350062300059
J	McDowell, KS; Zahid, S; Vadakkumpadan, F; Blauer, J; MacLeod, RS; Trayanova, NA				McDowell, Kathleen S.; Zahid, Sohail; Vadakkumpadan, Fijoy; Blauer, Joshua; MacLeod, Rob S.; Trayanova, Natalia A.			Virtual Electrophysiological Study of Atrial Fibrillation in Fibrotic Remodeling	PLOS ONE			English	Article							CATHETER ABLATION; SINUS RHYTHM; COMPUTATIONAL TECHNIQUES; CONVENTIONAL ABLATION; IMPULSE CONDUCTION; ROTOR MODULATION; CARDIAC TISSUE; WAVE DYNAMICS; FOCAL IMPULSE; FIBROSIS	Research has indicated that atrial fibrillation (AF) ablation failure is related to the presence of atrial fibrosis. However it remains unclear whether this information can be successfully used in predicting the optimal ablation targets for AF termination. We aimed to provide a proof-of-concept that patient-specific virtual electrophysiological study that combines i) atrial structure and fibrosis distribution from clinical MRI and ii) modeling of atrial electrophysiology, could be used to predict: (1) how fibrosis distribution determines the locations from which paced beats degrade into AF; (2) the dynamic behavior of persistent AF rotors; and (3) the optimal ablation targets in each patient. Four MRI-based patient-specific models of fibrotic left atria were generated, ranging in fibrosis amount. Virtual electrophysiological studies were performed in these models, and where AF was inducible, the dynamics of AF were used to determine the ablation locations that render AF non-inducible. In 2 of the 4 models patient-specific models AF was induced; in these models the distance between a given pacing location and the closest fibrotic region determined whether AF was inducible from that particular location, with only the mid-range distances resulting in arrhythmia. Phase singularities of persistent rotors were found to move within restricted regions of tissue, which were independent of the pacing location from which AF was induced. Electrophysiological sensitivity analysis demonstrated that these regions changed little with variations in electrophysiological parameters. Patient-specific distribution of fibrosis was thus found to be a critical component of AF initiation and maintenance. When the restricted regions encompassing the meander of the persistent phase singularities were modeled as ablation lesions, AF could no longer be induced. The study demonstrates that a patient-specific modeling approach to identify non-invasively AF ablation targets prior to the clinical procedure is feasible.	[McDowell, Kathleen S.; Zahid, Sohail; Vadakkumpadan, Fijoy; Trayanova, Natalia A.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21202 USA; [Blauer, Joshua; MacLeod, Rob S.] Univ Utah, Sch Med, Comprehens Arrhythmia Res & Management Ctr, Salt Lake City, UT USA	Johns Hopkins University; Utah System of Higher Education; University of Utah	Trayanova, NA (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21202 USA.	ntrayanova@jhu.edu		Trayanova, Natalia/0000-0002-8661-063X	National Institutes of Health (NIH) [PD1 HL123271]; U.S. National Science Foundation [NSF-OCI-108849]; NIH [P41 GM103545-14]; Center for Integrative Biomedical Computing (CIBC) at the University of Utah; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [DP1HL123271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103545, T32GM007057] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Integrative Biomedical Computing (CIBC) at the University of Utah; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (NIH) Director's Pioneer Award to N.T. (PD1 HL123271, "Virtual Electrophysiology Laboratory" and by American Heart Association Predoctoral Fellowship to K.M. This work was also supported in part by the U.S. National Science Foundation, grant NSF-OCI-108849. The authors also acknowledge support for image processing and model generation software from the Center for Integrative Biomedical Computing (CIBC) at the University of Utah, sponsored by NIH Grant P41 GM103545-14. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akoum N, 2011, J CARDIOVASC ELECTR, V22, P16, DOI 10.1111/j.1540-8167.2010.01876.x; Andrade J, 2014, CIRC RES, V114, P1453, DOI 10.1161/CIRCRESAHA.114.303211; Arevalo H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068872; Ashihara T, 2012, CIRC RES, V110, P275, DOI 10.1161/CIRCRESAHA.111.255026; Atienza F, 2009, HEART RHYTHM, V6, P33, DOI 10.1016/j.hrthm.2008.10.024; Cappato R, 2010, CIRC-ARRHYTHMIA ELEC, V3, P32, DOI 10.1161/CIRCEP.109.859116; Colman MA, 2014, EUROPACE, V16, P416, DOI 10.1093/europace/eut349; Courtemanche M, 1999, CARDIOVASC RES, V42, P477, DOI 10.1016/S0008-6363(99)00034-6; FEINBERG WM, 1995, ARCH INTERN MED, V155, P469, DOI 10.1001/archinte.155.5.469; Gray RA, 1998, NATURE, V392, P75, DOI 10.1038/32164; Haissaguerre M, 2000, CIRCULATION, V101, P1409, DOI 10.1161/01.CIR.101.12.1409; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Kohl P, 2014, J MOL CELL CARDIOL, V70, P37, DOI 10.1016/j.yjmcc.2013.12.024; Krueger MW, 2014, J ELECTROCARDIOL, V47, P324, DOI 10.1016/j.jelectrocard.2013.11.003; Krummen DE, 2012, CIRC-ARRHYTHMIA ELEC, V5, P1149, DOI 10.1161/CIRCEP.111.969022; KUO CS, 1983, CIRCULATION, V67, P1356, DOI 10.1161/01.CIR.67.6.1356; Lardo AC, 2000, CIRCULATION, V102, P698, DOI 10.1161/01.CIR.102.6.698; Larson C, 2003, ANN BIOMED ENG, V31, P768, DOI 10.1114/1.1581289; Mahnkopf C, 2010, HEART RHYTHM, V7, P1475, DOI 10.1016/j.hrthm.2010.06.030; Maleckar MM, 2009, BIOPHYS J, V97, P2179, DOI [10.1016/j.bpj.2009.07.054, 10.1016/j.bpj.2009.07.0.54]; Maleckar MM, 2008, PROG BIOPHYS MOL BIO, V98, P161, DOI 10.1016/j.pbiomolbio.2009.01.010; Marrouche NF, 2014, JAMA-J AM MED ASSOC, V311, P498, DOI 10.1001/jama.2014.3; McDowell KS, 2013, BIOPHYS J, V104, P2764, DOI 10.1016/j.bpj.2013.05.025; McDowell KS, 2012, J ELECTROCARDIOL, V45, P640, DOI 10.1016/j.jelectrocard.2012.08.005; McDowell KS, 2011, BIOPHYS J, V101, P1307, DOI 10.1016/j.bpj.2011.08.009; McGann C, 2014, CIRC-ARRHYTHMIA ELEC, V7, P23, DOI 10.1161/CIRCEP.113.000689; Miragoli M, 2006, CIRC RES, V98, P801, DOI 10.1161/01.RES.0000214537.44195.a3; Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140; Nademanee K, 2004, J AM COLL CARDIOL, V43, P2044, DOI 10.1016/j.jacc.2003.12.054; Narayan SM, 2013, J AM COLL CARDIOL, V62, P138, DOI 10.1016/j.jacc.2013.03.021; Narayan SM, 2012, J AM COLL CARDIOL, V60, P628, DOI 10.1016/j.jacc.2012.05.022; Nattel S, 2008, CIRC-ARRHYTHMIA ELEC, V1, P62, DOI 10.1161/CIRCEP.107.754564; Pedrotty DM, 2009, CARDIOVASC RES, V83, P688, DOI 10.1093/cvr/cvp164; Plank G, 2008, HEART RHYTHM; Plank G, 2008, PHILOS T R SOC A, V366, P3381, DOI 10.1098/rsta.2008.0112; Prassl AJ, 2009, IEEE T BIO-MED ENG, V56, P1318, DOI 10.1109/TBME.2009.2014243; Quinn TA, 2014, CIRCULATION, V130; Sanchez JE, 2003, J INTERV CARD ELECTR, V8, P9, DOI 10.1023/A:1022315308803; Tanaka K, 2007, CIRC RES, V101, P839, DOI 10.1161/CIRCRESAHA.107.153858; Tanner H, 2005, J AM COLL CARDIOL, V46, P338, DOI 10.1016/j.jacc.2005.03.063; Trayanova NA, 2014, CIRC RES, V114, P1516, DOI 10.1161/CIRCRESAHA.114.302240; Vadakkumpadan F, 2012, IEEE ENG MED BIO, P4067, DOI 10.1109/EMBC.2012.6346860; Vasquez C, 2010, CIRC RES, V107, P1011, DOI 10.1161/CIRCRESAHA.110.227421; Vigmond EJ, 2003, J ELECTROCARDIOL, V36, P69, DOI 10.1016/j.jelectrocard.2003.09.017; Vigmond EJ, 2002, IEEE T BIO-MED ENG, V49, P1260, DOI 10.1109/TBME.2002.804597; Xu J, 2004, CIRCULATION, V109, P363, DOI 10.1161/01.CIR.0000109495.02213.52	46	89	90	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117110	10.1371/journal.pone.0117110	http://dx.doi.org/10.1371/journal.pone.0117110			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692857	Green Published, gold, Green Submitted			2022-12-26	WOS:000350061500039
J	McLellan, ML; McLellan, BN				McLellan, Michelle L.; McLellan, Bruce N.			Effect of Season and High Ambient Temperature on Activity Levels and Patterns of Grizzly Bears (Ursus arctos)	PLOS ONE			English	Article							BLACK BEARS; BODY-SIZE; CIRCADIAN-RHYTHMS; TIME BUDGETS; ECOLOGY; CONSTRAINTS; THIBETANUS; MOUNTAINS; SALMON; DIET	Understanding factors that influence daily and annual activity patterns of a species provides insights to challenges facing individuals, particularly when climate shifts, and thus is important in conservation. Using GPS collars with dual-axis motion sensors that recorded the number of switches every 5 minutes we tested the hypotheses: 1. Grizzly bears (Ursus arctos) increase daily activity levels and active bout lengths when they forage on berries, the major high-energy food in this ecosystem, and 2. Grizzly bears become less active and more nocturnal when ambient temperature exceeds 20 degrees C. We found support for hypothesis 1 with both male and female bears being active from 0.7 to 2.8 h longer in the berry season than in other seasons. Our prediction under hypothesis 2 was not supported. When bears foraged on berries on a dry, open mountainside, there was no relationship between daily maximum temperature (which varied from 20.4 to 40.1 degrees C) and the total amount of time bears were active, and no difference in activity levels during day or night between warm (20.4-27.3 degrees C) and hot (27.9-40.1 degrees C) days. Our results highlight the strong influence that food acquisition has on activity levels and patterns of grizzly bears and is a challenge to the heat dissipation limitation theory.	[McLellan, Michelle L.] South Coast Grizzly Bear Project, Nelson, BC, Canada; [McLellan, Bruce N.] British Columbia Fish Wildlife & Habitat Manageme, DArcy, BC, Canada		McLellan, ML (corresponding author), South Coast Grizzly Bear Project, Nelson, BC, Canada.	mclellan.wildlife.research@gmail.com			Habitat Conservation Trust Foundation; BC Hydro Fish and Wildlife Compensation Program; British Columbia Ministry of Forests, Lands, and Natural Resource Operations	Habitat Conservation Trust Foundation; BC Hydro Fish and Wildlife Compensation Program; British Columbia Ministry of Forests, Lands, and Natural Resource Operations	This work was supported by the following sources of funding (to BNM): Habitat Conservation Trust Foundation (http://www.hctf.ca/); BC Hydro Fish and Wildlife Compensation Program (www.bchydro.com/about/sustainability/environmental_responsibility/compensation_programs.html); and British Columbia Ministry of Forests, Lands, and Natural Resource Operations (http://www.gov.bc.ca/for/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacigalupe LD, 2003, J MAMMAL, V84, P311, DOI 10.1644/1545-1542(2003)084<0311:AASUBD>2.0.CO;2; Bacon E.S., 1976, IUCN Publs (New Series), VNo. 40, P27; BELOVSKY GE, 1986, OECOLOGIA, V70, P53, DOI 10.1007/BF00377110; du Toit JT, 2005, OECOLOGIA, V143, P317, DOI 10.1007/s00442-004-1789-7; Fortin JK, 2013, J MAMMAL, V94, P833, DOI 10.1644/12-MAMM-A-238.1; GARSHELIS DL, 1980, J MAMMAL, V61, P8, DOI 10.2307/1379952; Hilderbrand GV, 1999, CAN J ZOOL, V77, P132, DOI 10.1139/cjz-77-1-132; Hwang MH, 2007, J ZOOL, V271, P203, DOI 10.1111/j.1469-7998.2006.00203.x; Klinka DR, 2002, CAN J ZOOL, V80, P1317, DOI 10.1139/Z02-123; Kozakai C, 2013, J MAMMAL, V94, P351, DOI 10.1644/11-MAMM-A-246.1; Kuznetsova A, 2014, LMERTEST TESTS RANDO; LARIVIERE S, 1994, J MAMMAL, V75, P613, DOI 10.2307/1382508; Mace RD, 1999, CONSERV BIOL, V13, P367, DOI 10.1046/j.1523-1739.1999.013002367.x; Machutchon AG, 1998, URSUS-SERIES, V10, P539; MacHutchon AG, 2001, URSUS-SERIES, V12, P189; McCann RK, 1991, ACTIVITY MEASURES FR; McLellan BN, 2011, CAN J ZOOL, V89, P546, DOI 10.1139/Z11-026; MCLELLAN BN, 1995, CAN J ZOOL, V73, P704, DOI 10.1139/z95-082; McLellan BN, 2001, J WILDLIFE MANAGE, V65, P92, DOI 10.2307/3803280; Mistlberger RE, 2004, BIOL REV, V79, P533, DOI 10.1017/S1464793103006353; Nelson RA, 1983, BEARS THEIR BIOL MAN, V5, P284, DOI [DOI 10.2307/3872551, 10.2307/3872551]; Nielsen S.E., 2009, J CONSERVATION PLANN, V5, P38; Olson TL, 1987, URSUS, V10, P547; Owen-Smith N, 1998, J ZOOL, V246, P183, DOI 10.1111/j.1469-7998.1998.tb00147.x; PRITCHARD GT, 1990, CAN J ZOOL, V68, P1645, DOI 10.1139/z90-244; REID D, 1991, MAMMALIA, V55, P221, DOI 10.1515/mamm.1991.55.2.221; Robbins CT, 2004, URSUS, V15, P161, DOI 10.2192/1537-6176(2004)015<0161:NEOUAR>2.0.CO;2; Rode KD, 2001, OECOLOGIA, V128, P62, DOI 10.1007/s004420100637; Rogers L., 1976, Transactions N Am Wildl nat Resour Conf, VNo. 41, P431; Schwartz CC, 2010, J WILDLIFE MANAGE, V74, P1628, DOI 10.2193/2009-571; Shrestha AK, 2014, INT J BIOMETEOROL, V58, P41, DOI 10.1007/s00484-012-0622-y; Speakman JR, 2010, J ANIM ECOL, V79, P726, DOI 10.1111/j.1365-2656.2010.01689.x; Stelmock JJ, 1986, INT C BEAR RES MAN, V6, P155, DOI DOI 10.2307/3872820; Team RDC, 2010, R PROJECT STAT COMPU; van der Vinne V, 2014, PHYSIOL BEHAV, V128, P295, DOI 10.1016/j.physbeh.2014.01.019; Vieira EM, 2010, CAN J ZOOL, V88, P259, DOI 10.1139/Z09-142; Ware JV, 2012, AM J PHYSIOL-REG I, V303, pR890, DOI 10.1152/ajpregu.00313.2012; Welch CA, 1997, ECOLOGY, V78, P1105, DOI 10.2307/2265862; Yamazaki K, 2008, URSUS, V19, P154, DOI 10.2192/07GR009.1	39	21	23	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117734	10.1371/journal.pone.0117734	http://dx.doi.org/10.1371/journal.pone.0117734			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692979	gold, Green Published, Green Submitted			2022-12-26	WOS:000350061500070
J	Patel, N; Itakura, T; Jeong, S; Liao, CP; Roy-Burman, P; Zandi, E; Groshen, S; Pinski, J; Coetzee, GA; Gross, ME; Fini, ME				Patel, Nitin; Itakura, Tatsuo; Jeong, Shinwu; Liao, Chun-Peng; Roy-Burman, Pradip; Zandi, Ebrahim; Groshen, Susan; Pinski, Jacek; Coetzee, Gerhard A.; Gross, Mitchell E.; Fini, M. Elizabeth			Expression and Functional Role of Orphan Receptor GPR158 in Prostate Cancer Growth and Progression	PLOS ONE			English	Article							ANDROGEN RECEPTOR; NEUROENDOCRINE DIFFERENTIATION; LNCAP CELLS; INDEPENDENT GROWTH; RNA INTERFERENCE; GENE; DEPRIVATION; PATHWAY; TRANSDIFFERENTIATION; ADENOCARCINOMA	Prostate cancer (PCa) is the second-leading cause of cancer-related mortality, after lung cancer, in men from developed countries. In its early stages, primary tumor growth is dependent on androgens, thus generally can be controlled by androgen deprivation therapy (ADT). Eventually however, the disease progresses to castration-resistant prostate cancer (CRPC), a lethal form in need of more effective treatments. G-protein coupled receptors (GPCRs) comprise a large clan of cell surface proteins that have been implicated as therapeutic targets in PCa growth and progression. The findings reported here provide intriguing evidence of a role for the newly characterized glutamate family member GPR158 in PCa growth and progression. We found that GPR158 promotes PCa cell proliferation independent of androgen receptor (AR) functionality and that this requires its localization in the nucleus of the cell. This suggests that GPR158 acts by mechanisms different from other GPCRs. GPR158 expression is stimulated by androgens and GPR158 stimulates AR expression, implying a potential to sensitize tumors to low androgen conditions during ADT via a positive feedback loop. Further, we found GPR158 expression correlates with a neuroendocrine (NE) differentiation phenotype and promotes anchorage-independent colony formation implying a role for GPR158 in therapeutic progression and tumor formation. GPR158 expression was increased at the invading front of prostate tumors that formed in the genetically defined conditional Pten knockout mouse model, and co-localized with elevated AR expression in the cell nucleus. Kaplan-Meier analysis on a dataset from the Memorial Sloan Kettering cancer genome portal showed that increased GPR158 expression in tumors is associated with lower disease-free survival. Our findings strongly suggest that pharmaceuticals targeting GPR158 activities could represent a novel and innovative approach to the prevention and management of CRPC.	[Patel, Nitin; Itakura, Tatsuo; Jeong, Shinwu; Liao, Chun-Peng; Gross, Mitchell E.; Fini, M. Elizabeth] Univ So Calif, Inst Med Genet, Los Angeles, CA 90089 USA; [Liao, Chun-Peng; Gross, Mitchell E.] Ctr Appl Mol Med, Los Angeles, CA USA; [Liao, Chun-Peng; Gross, Mitchell E.] Univ So Calif, Westside Prostate Canc Ctr, Los Angeles, CA USA; [Roy-Burman, Pradip; Zandi, Ebrahim; Groshen, Susan; Pinski, Jacek; Coetzee, Gerhard A.; Gross, Mitchell E.; Fini, M. Elizabeth] Univ So Calif, Norris Comprehens Canc Ctr, Los Angeles, CA USA; [Fini, M. Elizabeth] Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90033 USA; [Pinski, Jacek; Gross, Mitchell E.] Univ So Calif, Keck Sch Med, Dept Med, Los Angeles, CA 90033 USA; [Zandi, Ebrahim] Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA; [Jeong, Shinwu; Fini, M. Elizabeth] Univ So Calif, Keck Sch Med, Dept Ophthalmol, Los Angeles, CA 90033 USA; [Roy-Burman, Pradip] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA; [Groshen, Susan; Coetzee, Gerhard A.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Coetzee, Gerhard A.; Gross, Mitchell E.] Univ So Calif, Keck Sch Med, Dept Urol, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California	Patel, N (corresponding author), Univ So Calif, Inst Med Genet, Los Angeles, CA 90089 USA.	nitinpat@usc.edu	coetzee, Gerhard/AAT-6203-2020; Coetzee, Gerhard/AAG-8439-2019	Coetzee, Gerhard/0000-0001-8820-8364; Liao, Chun-Peng/0000-0001-8920-4322; Jeong, Shinwu/0000-0002-4847-813X; Gross, Mitchell/0000-0002-1691-921X	National Institutes of Health [R01-EY09828, R01-CA136924]; Robert E. and May R. Wright Foundation; NATIONAL CANCER INSTITUTE [R01CA136924] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY009828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048522] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert E. and May R. Wright Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants [R01-EY09828] to MEF and [R01-CA136924] to GAC. The Robert E. and May R. Wright Foundation award to NP and MEF also provided support for conducting this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsson PA, 1999, PROSTATE, V39, P135, DOI 10.1002/(SICI)1097-0045(19990501)39:2<135::AID-PROS9>3.0.CO;2-S; Abrahamsson PA, 1999, ENDOCR-RELAT CANCER, V6, P503, DOI 10.1677/erc.0.0060503; Agrawal P, 2010, CELL CYCLE, V9, P4908, DOI 10.4161/cc.9.24.14199; Ahler E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064561; Audo I, 2012, AM J HUM GENET, V90, P321, DOI 10.1016/j.ajhg.2011.12.007; BANG YJ, 1994, P NATL ACAD SCI USA, V91, P5330, DOI 10.1073/pnas.91.12.5330; Bhola NE, 2008, FRONT BIOSCI-LANDMRK, V13, P1857, DOI 10.2741/2805; Bjarndottir TK, 2005, GENE, V362, P70, DOI 10.1016/j.gene.2005.07.029; Bonkhoff H, 1998, PROSTATE, P18; Buchanan G, 2004, PROSTATE, V60, P352, DOI 10.1002/pros.20079; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; Chen SY, 2006, P NATL ACAD SCI USA, V103, P15969, DOI 10.1073/pnas.0604193103; El-Haibi CP, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-64; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Filmore D., 2004, MOD DRUG DISCOV, V7, P24; Gillies K, 2013, CELL PHYSIOL BIOCHEM, V32, P74, DOI 10.1159/000350126; Gioeli D, 1999, CANCER RES, V59, P279; Imberg-Kazdan K, 2013, GENOME RES, V23, P581, DOI 10.1101/gr.144774.112; Jongsma J, 2000, PROSTATE, V42, P34, DOI 10.1002/(SICI)1097-0045(20000101)42:1<34::AID-PROS5>3.0.CO;2-2; Jongsma J, 2000, CANCER RES, V60, P741; Karantanos T, 2013, ONCOGENE, V32, P5501, DOI 10.1038/onc.2013.206; Koivisto P, 1997, CANCER RES, V57, P314; KUIPER GGJM, 1992, J STEROID BIOCHEM, V41, P697, DOI 10.1016/0960-0760(92)90407-A; Kupershmidt I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013066; LABRIE F, 1993, CLIN INVEST MED, V16, P475; Lee JG, 2009, MOL CARCINOGEN, V48, P141, DOI 10.1002/mc.20462; Lee LF, 2001, MOL CELL BIOL, V21, P8385, DOI 10.1128/MCB.21.24.8385-8397.2001; Li Z, 2013, ASIAN J ANDROL, V15, P328, DOI 10.1038/aja.2013.7; Liao CP, 2007, CANCER RES, V67, P7525, DOI 10.1158/0008-5472.CAN-07-0668; Linja MJ, 2001, CANCER RES, V61, P3550; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Marques RB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013500; MCDONNELL TJ, 1992, CANCER RES, V52, P6940; Miyamoto-Sato E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009289; Mori R, 2009, PROSTATE, V69, P12, DOI 10.1002/pros.20851; NELSON JB, 1995, NAT MED, V1, P944, DOI 10.1038/nm0995-944; Patel N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057843; Peachey NS, 2012, AM J HUM GENET, V90, P331, DOI 10.1016/j.ajhg.2011.12.006; Pi M, 2012, PROSTATE, V72, P399, DOI 10.1002/pros.21442; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Ponten F, 2008, J PATHOL, V216, P387, DOI 10.1002/path.2440; Price DT, 1999, J UROLOGY, V162, P1537, DOI 10.1016/S0022-5347(05)68354-1; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Rockstroh M MS, 2011, J INTEGR OMICS, V1, P135, DOI DOI 10.5584/JI0MICS; Sagnak L, 2011, CLIN GENITOURIN CANC, V9, P73, DOI 10.1016/j.clgc.2011.07.003; Salazar MD, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2827; Sarker D, 2009, CLIN CANCER RES, V15, P4799, DOI 10.1158/1078-0432.CCR-08-0125; Schayek H, 2012, HORM METAB RES, V44, P511, DOI 10.1055/s-0032-1311566; Shen R, 1997, Urol Oncol, V3, P67, DOI 10.1016/S1078-1439(97)00039-2; Shin KJ, 2006, P NATL ACAD SCI USA, V103, P13759, DOI 10.1073/pnas.0606179103; SHIN SI, 1975, P NATL ACAD SCI USA, V72, P4435, DOI 10.1073/pnas.72.11.4435; Shiota M, 2011, J MOL ENDOCRINOL, V47, pR25, DOI 10.1530/JME-11-0018; Siddiqui EJ, 2006, J UROLOGY, V176, P1648, DOI 10.1016/j.juro.2006.06.087; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Spans L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090002; Sun Y, 2009, AM J TRANSL RES, V1, P148; Taub JS, 2003, CANCER RES, V63, P2037; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Thalmann GN, 2000, PROSTATE, V44, P91; VELDSCHOLTE J, 1992, BIOCHEMISTRY-US, V31, P2393, DOI 10.1021/bi00123a026; VELDSCHOLTE J, 1992, J STEROID BIOCHEM, V41, P665, DOI 10.1016/0960-0760(92)90401-4; Waltering KK, 2009, CANCER RES, V69, P8141, DOI 10.1158/0008-5472.CAN-09-0919; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wellendorph P, 2009, BRIT J PHARMACOL, V156, P869, DOI 10.1111/j.1476-5381.2008.00078.x; Wright ME, 2003, MOL ENDOCRINOL, V17, P1726, DOI 10.1210/me.2003-0031; WU HC, 1994, INT J CANCER, V57, P406, DOI 10.1002/ijc.2910570319; Wu JT, 2000, ANN CLIN LAB SCI, V30, P175; Yuan TC, 2007, ENDOCR-RELAT CANCER, V14, P531, DOI 10.1677/ERC-07-0061; Yuan TC, 2006, ENDOCR-RELAT CANCER, V13, P151, DOI 10.1677/erc.1.01043; Zelivianski S, 2001, BBA-MOL CELL RES, V1539, P28, DOI 10.1016/S0167-4889(01)00087-8	71	24	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117758	10.1371/journal.pone.0117758	http://dx.doi.org/10.1371/journal.pone.0117758			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693195	Green Published, Green Submitted, gold			2022-12-26	WOS:000350061500073
J	Smith, TJS; Wolfson, JA; Jiao, D; Crupain, MJ; Rangan, U; Sapkota, A; Bleich, SN; Nachman, KE				Smith, Tyler J. S.; Wolfson, Julia A.; Jiao, Ding; Crupain, Michael J.; Rangan, Urvashi; Sapkota, Amir; Bleich, Sara N.; Nachman, Keeve E.			Caramel Color in Soft Drinks and Exposure to 4-Methylimidazole: A Quantitative Risk Assessment	PLOS ONE			English	Article							BEVERAGES	Caramel color is added to many widely-consumed beverages as a colorant. Consumers of these beverages can be exposed to 4-methylimidazole (4-MEI), a potential carcinogen formed during its manufacture. California's Proposition 65 law requires that beverages containing 4-MEI concentrations corresponding to exposures that pose excess cancer risks >1 case per 100,000 exposed persons (29 mu g 4-MEI/day) carry warning labels. Using ultrahigh-performance liquid chromatography-tandem mass spectrometry, we assessed 4-MEI concentrations in 12 beverages purchased in California and a geographically distant metropolitan area (New York) in which warning labels are not required. In addition, we characterized beverage consumption by age and race/ethnicity (using weighted means calculated from logistic regressions) and assessed 4-MEI exposure and resulting cancer risks and US population cancer burdens attributable to beverage consumption. Data on beverage consumption were obtained from the National Health and Nutrition Examination Survey, dose-response data for 4-MEI were obtained from the California Environmental Protection Agency Office of Environmental Health Hazards Assessment, and data on population characteristics were obtained from the U.S. Census Bureau. Of the 12 beverages, Malta Goya had the highest 4-MEI concentration (915.8 to 963.3 mu g/L), lifetime average daily dose (LADD - 8.04x10(-3) mg/kgBWday), lifetime excess cancer risk (1.93x10(-4)) and burden (5,011 cancer cases in the U.S. population over 70 years); Coca-Cola had the lowest value of each (4-MEI: 9.5 to 11.7 mu g/L; LADD: 1.01x10(-4) mg/kgBW-day; risk: 1.92x10(-6); and burden: 76 cases). 4-MEI concentrations varied considerably by soda and state/area of purchase, but were generally consistent across lots of the same beverage purchased in the same state/area. Routine consumption of certain beverages can result in 4-MEI exposures >29 mu g/day. State regulatory standards	[Smith, Tyler J. S.; Wolfson, Julia A.; Crupain, Michael J.; Nachman, Keeve E.] Johns Hopkins Univ, Johns Hopkins Ctr Livable Future, Baltimore, MD 21205 USA; [Smith, Tyler J. S.; Nachman, Keeve E.] Johns Hopkins Univ, Dept Environm Hlth Sci, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Wolfson, Julia A.; Bleich, Sara N.; Nachman, Keeve E.] Johns Hopkins Univ, Dept Hlth Policy & Management, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA; [Jiao, Ding; Crupain, Michael J.; Rangan, Urvashi] Consumer Reports, Food Safety & Sustainabil Ctr, Yonkers, NY USA; [Sapkota, Amir] Univ Maryland, Sch Publ Hlth, Maryland Inst Appl Environm Hlth, College Pk, MD 20742 USA; [Nachman, Keeve E.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Risk Sci & Publ Policy Inst, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University System of Maryland; University of Maryland College Park; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Nachman, KE (corresponding author), Johns Hopkins Univ, Johns Hopkins Ctr Livable Future, Baltimore, MD 21205 USA.	knachman@jhu.edu	Sapkota, Amir/A-5968-2011; Wolfson, Julia/D-9854-2018	Nachman, Keeve/0000-0003-4925-4151; Wolfson, Julia/0000-0001-9155-2609; Smith, Tyler/0000-0003-4692-2206	Consumers Union; GRACE Communications Foundation; National Heart, Lung, and Blood Institute [1K01HL096409]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD041041] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL096409] Funding Source: NIH RePORTER	Consumers Union; GRACE Communications Foundation; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	TJSS, AS and KEN were supported by a grant from Consumers Union (the grant was not given a specific number). TJSS and KEN are also funded by the GRACE Communications Foundation (who did not provide funding specific to this project) (URL: http://www.gracelinks.org/). JAW and SNB are funded by a grant from the National Heart, Lung, and Blood Institute (1K01HL096409). JAW is also a CLF-Lerner Doctoral Fellow. With the exception of MJC, UR and DJ, who are employees of Consumers Union and part of the study team, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubrey A, 2014, POTENTIAL CARCINOGEN; Aubrey A, 2013, COKE CHANGED CARAMEL; Bleich S. N., 2008, AM J CLIN NUTR; Centers for Disease Control and Prevention, 2014, 2009 2010 DAT DOC CO; Consumer Reports, 2014, CAR COL HLTH RISK MA; Folmer D, 2014, 206 REFINED EXPOSURE; International Agency for Research on Cancer, 2010, 4 METH; Kamuf W, 2003, CEREAL FOOD WORLD, V48, P64; Moon JK, 2011, J AGR FOOD CHEM, V59, P615, DOI 10.1021/jf104098a; National Toxicology Program, 2007, NTP TECHN REP TOX CA; Office of Environmental Health Hazard Assessment, 2011, PROP 65 PLAIN LANG; Office of Environmental Health Hazard Assessment, 2011, NO SIGN RISK LEV NSR; Schoeny R, 2008, ACCEPTABLE RISK LEVE; United States Census Bureau, 2013, NSTEST201201 US CENS; United States Environmental Protection Agency, 2014, TECHN TRANSF NETW 19; United States Food and Drug Administration, 2002, FED REGISTER, V67, P78172; United States Food and Drug Administration, 2014, QUEST ANSW CAR COL 4; United States Food and Drug Administration, 2014, COL ADD STAT LIST; US EPA, 2011, EXPOSURE FACTORS HDB, DOI DOI 10.2903/J.EFSA.2011.2392.2011.EPA/600/R-09/052F; Wang JY, 2012, J AGR FOOD CHEM, V60, P917, DOI 10.1021/jf204476x; Wang YC, 2008, PEDIATRICS, V121, pE1604, DOI 10.1542/peds.2007-2834	21	57	58	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118138	10.1371/journal.pone.0118138	http://dx.doi.org/10.1371/journal.pone.0118138			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693062	Green Published, gold, Green Submitted			2022-12-26	WOS:000350061500101
J	Koshoji, NH; Bussadori, SK; Bortoletto, CC; Prates, RA; Oliveira, MT; Deana, AM				Koshoji, Nelson H.; Bussadori, Sandra K.; Bortoletto, Carolina C.; Prates, Renato A.; Oliveira, Marcelo T.; Deana, Alessandro M.			Laser Speckle Imaging: A Novel Method for Detecting Dental Erosion	PLOS ONE			English	Article							ENAMEL	Erosion is a highly prevalent condition known as a non-carious lesion that causes progressive tooth wear due to chemical processes that do not involve the action of bacteria. Speckle images proved sensitive to even minimal mineral loss from the enamel. The aim of the present study was to investigate the use of laser speckle imaging analysis in the spatial domain to quantify shifts in the microstructure of the tooth surface in an erosion model. 32 fragments of the vestibular surface of bovine incisors were divided in for groups (10 min, 20 min. 30 min and 40 min of acid etching) immersed in a cola-based beverage (pH approximately 2.5) twice a day during 7 days to create an artificial erosion. By analyzing the laser speckle contrast map (LASCA) in the eroded region compared to the sound it was observed that the LASCA map shifts, proportionally to the acid each duration, by: 18%; 23%; 39% and 44% for the 10 min; 20 min; 30 min and 40 min groups, respectively. To the best of our knowledge, this is the first study to demonstrate the correlation between speckle patterns and erosion progression.	[Koshoji, Nelson H.; Bussadori, Sandra K.; Bortoletto, Carolina C.; Prates, Renato A.; Oliveira, Marcelo T.; Deana, Alessandro M.] Nove de Julho Univ UNINOVE, Dept Biophoton, Sao Paulo, Brazil; [Bussadori, Sandra K.; Bortoletto, Carolina C.; Prates, Renato A.; Oliveira, Marcelo T.] Nove de Julho Univ UNINOVE, Sch Dent, Sao Paulo, Brazil; [Deana, Alessandro M.] Nove de Julho Univ UNINOVE, Sch Informat Technol, Sao Paulo, Brazil; [Koshoji, Nelson H.] Nove de Julho Univ UNINOVE, Sch Engn, Sao Paulo, Brazil	Universidade Nove de Julho; Universidade Nove de Julho; Universidade Nove de Julho; Universidade Nove de Julho	Deana, AM (corresponding author), Nove de Julho Univ UNINOVE, Dept Biophoton, Sao Paulo, Brazil.	amdeana@uninove.br	Oliveira, Marcelo T/C-9236-2011; Prates, Renato A/F-8235-2014; Deana, Alessandro M/K-4787-2012; Bussadori, Sandra/J-5458-2014	Oliveira, Marcelo T/0000-0002-3859-6933; Prates, Renato A/0000-0002-8115-9237; Bussadori, Sandra/0000-0002-9853-1138; Deana, Alessandro Melo/0000-0002-0014-6953				Amaechi BT, 2005, J DENT, V33, P243, DOI 10.1016/j.jdent.2004.10.014; Barron Robert P, 2003, J Can Dent Assoc, V69, P84; Bartlett D, 2013, J AM DENT ASS S1, V138, p21S; Briers J D, 1996, J Biomed Opt, V1, P174, DOI 10.1117/12.231359; Cheng ZJ, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/1/015020; Deana AM, 2013, LASER PHYS, V23, DOI 10.1088/1054-660X/23/7/075607; Goodman, 1984, STAT PROPERTIES LASE; Grenby TH, 1669, EUROPEAN J ORAL SCI, V104, P207; Grippo JO, 2004, J AM DENT ASSOC, V135, P1109, DOI 10.14219/jada.archive.2004.0369; Jager DHJ, 2012, J DENT, V40, P1103, DOI 10.1016/j.jdent.2012.09.004; Koshoji NH, 2015, P SPIE IN PRESS; Lussi A, 2008, CLIN ORAL INVEST, V12, pS5, DOI 10.1007/s00784-007-0179-z; Murakami C, 2011, CARIES RES, V45, P121, DOI 10.1159/000324807; O'driscoll P, 1998, INT ENDOD J, P376; Scheutzel P, 1996, EUR J ORAL SCI, V104, P178, DOI 10.1111/j.1600-0722.1996.tb00066.x; Schlueter N, 2011, CARIES RES, V45, P13, DOI 10.1159/000326819; Shellis RP, 2011, CARIES RES, V45, P69, DOI 10.1159/000325971; Uchino M, 2004, KEY ENG MAT, V261-263, P1581, DOI 10.4028/www.scientific.net/KEM.261-263.1581; West NX, 2001, J ORAL REHABIL, V28, P860, DOI 10.1046/j.1365-2842.2001.00778.x; Young A, 2011, CARIES RES, V45, P33, DOI 10.1159/000325943; Zero DT, 2005, INT DENT J, V55, P285; Zhou SL, 2012, J DENT, V40, P255, DOI 10.1016/j.jdent.2011.12.016	22	17	18	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0118429	10.1371/journal.pone.0118429	http://dx.doi.org/10.1371/journal.pone.0118429			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679807	Green Published, gold, Green Submitted			2022-12-26	WOS:000350682600122
J	Wu, KR; Fukuda, K; Xing, F; Zhang, YY; Sharma, S; Liu, Y; Chan, MD; Zhou, XB; Qasem, SA; Pochampally, R; Mo, YY; Watabe, K				Wu, Kerui; Fukuda, Koji; Xing, Fei; Zhang, Yingyu; Sharma, Sambad; Liu, Yin; Chan, Michael D.; Zhou, Xiaobo; Qasem, Shadi A.; Pochampally, Radhika; Mo, Yin-Yuan; Watabe, Kounosuke			Roles of the Cyclooxygenase 2 Matrix Metalloproteinase 1 Pathway in Brain Metastasis of Breast Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TIGHT-JUNCTION PROTEINS; CAPILLARY ENDOTHELIAL-CELLS; NERVOUS-SYSTEM LEUKEMIA; TUMOR MICROENVIRONMENT; POOR-PROGNOSIS; BARRIER; EXPRESSION; PERMEABILITY; OCCLUDIN; GROWTH	Brain is one of the major sites of metastasis in breast cancer; however, the pathological mechanism of brain metastasis is poorly understood. One of the critical rate-limiting steps of brain metastasis is the breaching of blood-brain barrier, which acts as a selective interface between the circulation and the central nervous system, and this process is considered to involve tumor-secreted proteinases. We analyzed clinical significance of 21 matrix metalloproteinases on brain metastasis-free survival of breast cancer followed by verification in brain metastatic cell lines and found that only matrix metalloproteinase 1 (MMP1) is significantly correlated with brain metastasis. We have shown that MMP1 is highly expressed in brain metastatic cells and is capable of degrading Claudin and Occludin but not Zo-1, which are key components of blood-brain barrier. Knockdown of MMP1 in brain metastatic cells significantly suppressed their ability of brain metastasis in vivo, whereas ectopic expression of MMP1 significantly increased the brain metastatic ability of the cells that are not brain metastatic. We also found that COX2 was highly up-regulated in brain metastatic cells and that COX2-induced prostaglandins were directly able to promote the expression of MMP1 followed by augmenting brain metastasis. Furthermore, we found that COX2 and prostaglandin were able to activate astrocytes to release chemokine (C-C motif) ligand 7 (CCL7), which in turn promoted self-renewal of tumor-initiating cells in the brain and that knockdown of COX2 significantly reduced the brain metastatic ability of tumor cells. Our results suggest the COX2-MMP1/CCL7 axis as a novel therapeutic target for brain metastasis.	[Wu, Kerui; Xing, Fei; Sharma, Sambad; Liu, Yin; Chan, Michael D.; Zhou, Xiaobo; Qasem, Shadi A.; Watabe, Kounosuke] Wake Forest Univ, Bowman Gray Sch Med, Dept Canc Biol, 300 S Hawthorne Rd, Winston Salem, NC 27157 USA; [Zhang, Yingyu; Pochampally, Radhika; Mo, Yin-Yuan] Univ Mississippi, Med Ctr, Inst Canc, Jackson, MS 39216 USA; [Fukuda, Koji] Kanazawa Univ, Canc Res Inst, Kanazawa, Ishikawa 9200934, Japan	Wake Forest University; Wake Forest Baptist Medical Center; University of Mississippi; University of Mississippi Medical Center; Kanazawa University	Watabe, K (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Canc Biol, 300 S Hawthorne Rd, Winston Salem, NC 27157 USA.	kwatabe@wakehealth.edu	Mo, Yin-Yuan/R-8255-2019	Pochampally, Radhika/0000-0002-4263-0364	Comprehensive Cancer Center of Wake Forest University NCI, National Institutes of Health [CCSG P30CA012197]; NATIONAL CANCER INSTITUTE [P30CA012197, R01CA124650, R01CA151851, R01CA129000, U01CA166886, R01CA173499] Funding Source: NIH RePORTER	Comprehensive Cancer Center of Wake Forest University NCI, National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The Tumor Tissue Core is supported by the Comprehensive Cancer Center of Wake Forest University NCI, National Institutes of Health Grant CCSG P30CA012197.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Armstrong L, 2006, HUM MOL GENET, V15, P1894, DOI 10.1093/hmg/ddl112; Asahi M, 2001, J NEUROSCI, V21, P7724, DOI 10.1523/JNEUROSCI.21-19-07724.2001; Bauer AT, 2010, J CEREBR BLOOD F MET, V30, P837, DOI 10.1038/jcbfm.2009.248; Benson CS, 2013, DIS MARKERS, V34, P395, DOI [10.3233/DMA-130986, 10.1155/2013/420914]; Bertucci F, 2002, HUM MOL GENET, V11, P863, DOI 10.1093/hmg/11.8.863; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Broek IV, 2003, BRIT J CANCER, V88, P855, DOI 10.1038/sj.bjc.6600833; Cheng X, 2007, CANCER METAST REV, V26, P635, DOI 10.1007/s10555-007-9083-x; Cunnea P, 2010, ACTA NEUROPATHOL, V119, P601, DOI 10.1007/s00401-009-0618-9; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Fedwick JP, 2005, INFECT IMMUN, V73, P7844, DOI 10.1128/IAI.73.12.7844-7852.2005; Feng S, 2011, MED HYPOTHESES, V76, P618, DOI 10.1016/j.mehy.2010.12.001; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Giebel SJ, 2005, LAB INVEST, V85, P597, DOI 10.1038/labinvest.3700251; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Greenwald RA, 1999, ANN NY ACAD SCI, V878, P413, DOI 10.1111/j.1749-6632.1999.tb07699.x; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Gurney KJ, 2006, NEUROBIOL DIS, V23, P87, DOI 10.1016/j.nbd.2006.02.006; Heinecke JL, 2014, P NATL ACAD SCI USA, V111, P6323, DOI 10.1073/pnas.1401799111; Hirase T, 1997, J CELL SCI, V110, P1603; HONN KV, 1981, PROSTAG OTH LIPID M, V21, P833, DOI 10.1016/0090-6980(81)90240-9; Hwang TL, 2012, WORLD J GASTROENTERO, V18, P1249, DOI 10.3748/wjg.v18.i11.1249; Ichikawa Y, 2006, ONCOL REP, V15, P311; Ii M, 2006, EXP BIOL MED, V231, P20; Jung DW, 2010, INT J CANCER, V127, P332, DOI 10.1002/ijc.25060; Laningham FH, 2007, NEURORADIOLOGY, V49, P873, DOI 10.1007/s00234-007-0300-7; Latorre IJ, 2005, J CELL SCI, V118, P4283, DOI 10.1242/jcs.02560; Lee KY, 2011, ANTICANCER RES, V31, P4307; Li HJ, 2012, CANCER DISCOV, V2, P840, DOI 10.1158/2159-8290.CD-12-0101; Liebner S, 2000, EUR J CELL BIOL, V79, P707, DOI 10.1078/0171-9335-00101; Liu H, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-583; Liu J, 2012, J NEUROSCI, V32, P3044, DOI 10.1523/JNEUROSCI.6409-11.2012; Liu SL, 2012, J MAMMARY GLAND BIOL, V17, P15, DOI 10.1007/s10911-012-9242-8; Louie E, 2013, ONCOGENE, V32, P4064, DOI 10.1038/onc.2012.417; Lu X, 2009, GENE DEV, V23, P1882, DOI 10.1101/gad.1824809; Mendes O, 2007, CLIN EXP METASTAS, V24, P341, DOI 10.1007/s10585-007-9071-0; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Moss LAS, 2012, AM J PATHOL, V181, P1895, DOI 10.1016/j.ajpath.2012.08.044; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Ohtsuki S, 2008, J NEUROCHEM, V104, P147, DOI 10.1111/j.1471-4159.2007.05008.x; Ohtsuki S, 2007, J CELL PHYSIOL, V210, P81, DOI 10.1002/jcp.20823; Ong VH, 2009, EXP CELL RES, V315, P151, DOI 10.1016/j.yexcr.2008.11.001; Oskarsson T, 2014, CELL STEM CELL, V14, P306, DOI 10.1016/j.stem.2014.02.002; Poola I, 2005, NAT MED, V11, P481, DOI 10.1038/nm1243; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Rajaram M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003789; Reel B, 2011, BRIT J PHARMACOL, V163, P1679, DOI 10.1111/j.1476-5381.2011.01298.x; Romero IA, 2003, NEUROSCI LETT, V344, P112, DOI 10.1016/S0304-3940(03)00348-3; Schenk S, 2007, STEM CELLS, V25, P245, DOI 10.1634/stemcells.2006-0293; Sternlicht MD, 1999, CELL, V98, P137, DOI 10.1016/S0092-8674(00)81009-0; Valiente M, 2014, CELL, V156, P1002, DOI 10.1016/j.cell.2014.01.040; Wachtel M, 1999, J CELL SCI, V112, P4347; Xing F, 2013, EMBO MOL MED, V5, P384, DOI 10.1002/emmm.201201623; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	59	76	82	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9842	9854		10.1074/jbc.M114.602185	http://dx.doi.org/10.1074/jbc.M114.602185			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25691572	hybrid, Green Published			2022-12-26	WOS:000352729400043
J	Liu, Y; Yang, YF; Fan, JL; He, RN; Luo, M; Zheng, XF				Liu, Yong; Yang, Yongfeng; Fan, Jialin; He, Ruina; Luo, Ming; Zheng, Xiaofeng			The Crystal Structure of the PB2 Cap-binding Domain of Influenza B Virus Reveals a Novel Cap Recognition Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN EIF4E; POLYMERASE; ENDONUCLEASE; 1ST-IN-CLASS; TRANSLATION; INFECTIONS; INHIBITOR; VX-787	The influenza RNA-dependent RNA polymerase is a core enzyme required for both transcription and replication of the virus RNA genome, making it a potential drug target for the influenza virus. To detect the feature of cap-dependent transcription of influenza B virus (FluB) polymerase, we determined the crystal structures of the wild-type FluB polymerase PB2 subunit cap-binding domain (PB2(cap)) with bound GDP and the mutant FluB Q325F PB2(cap) with bound m(7)GDP or GDP. These structures revealed that, distinct from influenza A virus (FluA) PB2(cap), the guanine and ribose moieties of substrates invert in FluB PB2(caps). Moreover, we characterized the substrate specificity and affinity of the PB2(caps) using isothermal titration calorimetry. FluB PB2(cap) has a weaker affinity for m(7)GDP than FluA PB2(cap). Unlike FluA PB2(cap) that has a preference for m(7)GDP in comparison with GDP, FluB PB2(cap) shows an analogous affinity for both substrates. Replacement of FluB PB2 Glu(325) by Phe, the corresponding residue of FluA PB2, increased the binding affinity of FluB PB2(cap) for m(7)GDP to a level approximate to that of FluA PB2(cap) and caused a significant higher affinity to GDP. This study indicated that FluB PB2(cap) has a unique cap recognition mechanism compared with FluA PB2(cap), providing molecular insight into inhibitor design targeting FluB PB2(cap).	[Liu, Yong; Yang, Yongfeng; Fan, Jialin; He, Ruina; Zheng, Xiaofeng] Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China; [Liu, Yong; Yang, Yongfeng; Fan, Jialin; He, Ruina; Zheng, Xiaofeng] Peking Univ, Sch Life Sci, Dept Biochem & Mol Biol, Beijing 100871, Peoples R China; [Luo, Ming] Georgia State Univ, Dept Chem, Atlanta, GA 30302 USA	Peking University; Peking University; University System of Georgia; Georgia State University	Zheng, XF (corresponding author), Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China.	xiaofengz@pku.edu.cn	Fan, Jialin/GRY-1253-2022		Beijing Natural Science Foundation [5152012]; National Science Foundation of China [31470754, 31170709]; Ministry of Education of China [20130001130003]	Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China)	This work was supported by Beijing Natural Science Foundation Grant 5152012, National Science Foundation of China Grants 31470754 and 31170709, and Doctoral Fund Grant 20130001130003 of the Ministry of Education of China.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blanton Lenee, 2011, Morbidity and Mortality Weekly Report, V60, P1233; Bodewes R, 2013, EMERG INFECT DIS, V19, P511, DOI 10.3201/eid1903.120965; BOULOY M, 1980, P NATL ACAD SCI-BIOL, V77, P3952, DOI 10.1073/pnas.77.7.3952; Byrn RA, 2015, ANTIMICROB AGENTS CH, V59, P1574, DOI 10.1128/AAC.04623-14; Clark MP, 2014, J MED CHEM, V57, P6668, DOI 10.1021/jm5007275; Culjkovic B, 2007, CELL CYCLE, V6, P65, DOI 10.4161/cc.6.1.3688; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Graff JR, 2003, CLIN EXP METASTAS, V20, P265, DOI 10.1023/A:1022943419011; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Kinkelin K, 2012, RNA, V18, P1624, DOI 10.1261/rna.033639.112; Liu Y, 2013, J BIOL CHEM, V288, P11013, DOI 10.1074/jbc.M112.392878; Liu Y, 2013, ACTA CRYSTALLOGR F, V69, P280, DOI 10.1107/S1744309113002388; Marcotrigiano J, 1997, CELL, V89, P951, DOI 10.1016/S0092-8674(00)80280-9; Mazza C, 2002, EMBO J, V21, P5548, DOI 10.1093/emboj/cdf538; McCullers JA, 2012, J INFECT DIS, V205, P870, DOI 10.1093/infdis/jir865; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Mukherjee TR, 2013, INFECT GENET EVOL, V16, P419, DOI 10.1016/j.meegid.2013.02.014; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Osborne MJ, 2013, P NATL ACAD SCI USA, V110, P3877, DOI 10.1073/pnas.1216862110; Osterhaus ADME, 2000, SCIENCE, V288, P1051, DOI 10.1126/science.288.5468.1051; Paddock CD, 2012, J INFECT DIS, V205, P895, DOI 10.1093/infdis/jir861; Pautus S, 2013, J MED CHEM, V56, P8915, DOI 10.1021/jm401369y; Pflug A, 2014, NATURE, V516, P355, DOI 10.1038/nature14008; PLOTCH SJ, 1981, CELL, V23, P847, DOI 10.1016/0092-8674(81)90449-9; Reich S, 2014, NATURE, V516, P361, DOI 10.1038/nature14009; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rosettani P, 2007, J MOL BIOL, V368, P691, DOI 10.1016/j.jmb.2007.02.019; Taylor NR, 1998, J MED CHEM, V41, P798, DOI 10.1021/jm9703754; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Tsurumura T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082020; von der Haar T, 2004, NAT STRUCT MOL BIOL, V11, P503, DOI 10.1038/nsmb779; Wakai C, 2011, J VIROL, V85, P7504, DOI 10.1128/JVI.02375-10; Yuan PW, 2009, NATURE, V458, P909, DOI 10.1038/nature07720	37	13	15	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					9141	9149		10.1074/jbc.M115.636464	http://dx.doi.org/10.1074/jbc.M115.636464			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25691568	Green Published, hybrid			2022-12-26	WOS:000352207100037
J	Tsay, JCJ; Li, ZG; Yie, TA; Wu, F; Segal, L; Greenberg, AK; Leibert, E; Weiden, MD; Pass, H; Munger, J; Statnikov, A; Tchou-Wong, KM; Rom, WN				Tsay, Jun-Chieh J.; Li, Zhiguo; Yie, Ting-An; Wu, Feng; Segal, Leopoldo; Greenberg, Alissa K.; Leibert, Eric; Weiden, Michael D.; Pass, Harvey; Munger, John; Statnikov, Alexander; Tchou-Wong, Kam-Meng; Rom, William N.			Molecular Characterization of the Peripheral Airway Field of Cancerization in Lung Adenocarcinoma	PLOS ONE			English	Article							MICRORNA EXPRESSION; PROTEIN EXPRESSION; GENE-EXPRESSION; NEUROENDOCRINE DIFFERENTIATION; RESPIRATORY EPITHELIUM; CANCER; KINASE; CELLS; RECEPTOR; MIR-483-5P	Field of cancerization in the airway epithelium has been increasingly examined to understand early pathogenesis of non-small cell lung cancer. However, the extent of field of cancerization throughout the lung airways is unclear. Here we sought to determine the differential gene and microRNA expressions associated with field of cancerization in the peripheral airway epithelial cells of patients with lung adenocarcinoma. We obtained peripheral airway brushings from smoker controls (n=13) and from the lung contralateral to the tumor in cancer patients (n=17). We performed gene and microRNA expression profiling on these peripheral airway epithelial cells using Affymetrix GeneChip and TaqMan Array. Integrated gene and microRNA analysis was performed to identify significant molecular pathways. We identified 26 mRNAs and 5 miRNAs that were significantly (FDR <0.1) upregulated and 38 mRNAs and 12 miRNAs that were significantly down-regulated in the cancer patients when compared to smoker controls. Functional analysis identified differential transcriptomic expressions related to tumorigenesis. Integration of miRNA-mRNA data into interaction network analysis showed modulation of the extracellular signal-regulated kinase/mitogen-activated protein kinase (ERK/MAPK) pathway in the contralateral lung field of cancerization. In conclusion, patients with lung adenocarcinoma have tumor related molecules and pathways in histologically normal appearing peripheral airway epithelial cells, a substantial distance from the tumor itself. This finding can potentially provide new biomarkers for early detection of lung cancer and novel therapeutic targets.	[Tsay, Jun-Chieh J.; Yie, Ting-An; Segal, Leopoldo; Greenberg, Alissa K.; Leibert, Eric; Weiden, Michael D.; Munger, John; Tchou-Wong, Kam-Meng; Rom, William N.] NYU, Sch Med, Dept Med, Div Pulm Crit Care & Sleep Med, New York, NY 10012 USA; [Li, Zhiguo; Statnikov, Alexander] NYU, Langone Med Ctr, Ctr Hlth Informat & Bioinformat, New York, NY USA; [Wu, Feng; Tchou-Wong, Kam-Meng; Rom, William N.] NYU, Sch Med, Dept Environm Med, New York, NY USA; [Pass, Harvey] NYU, Sch Med, Dept Cardiothorac Surg, Div Thorac Surg, New York, NY USA; [Statnikov, Alexander] NYU, Sch Med, Dept Med, Div Translat Med, New York, NY USA	New York University; New York University; NYU Langone Medical Center; New York University; New York University; New York University	Tsay, JCJ (corresponding author), NYU, Sch Med, Dept Med, Div Pulm Crit Care & Sleep Med, New York, NY 10012 USA.	tsayj01@nyumc.org		Tsay, Jun-Chieh/0000-0002-2282-2510; Segal, Leopoldo/0000-0003-3559-9431; Rom, William/0000-0002-8793-7028; Pass, Harvey/0000-0003-3222-3471; Munger, John/0000-0002-9679-2983	National Institutes of Health [T32 ES007267, UO1 CA086137, UL1 TR000038, RO1 HL090316, K24 AI080298A]; Stony-Wold Herbert Fund Fellowship; NATIONAL CANCER INSTITUTE [P30CA016087, U01CA086137] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000038, UL1TR001445] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090316] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007267] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stony-Wold Herbert Fund Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	JJT is funded by National Institutes of Health grant T32 ES007267, UO1 CA086137, UL1 TR000038, and Stony-Wold Herbert Fund Fellowship (http://www.stonywoldherbertfund.com).WNR is funded by National Institutes of Health grant T32 ES007267, UO1 CA086137, UL1 TR000038, RO1 HL090316 and K24 AI080298A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belinsky SA, 1998, P NATL ACAD SCI USA, V95, P11891, DOI 10.1073/pnas.95.20.11891; Boeri M, 2011, P NATL ACAD SCI USA, V108, P3713, DOI 10.1073/pnas.1100048108; Borges M, 1997, NATURE, V386, P852, DOI 10.1038/386852a0; Chen Y, 2014, J THORAC ONCOL, V9, P50, DOI 10.1097/JTO.0000000000000034; Dang XM, 2012, CANCER GENET-NY, V205, P113, DOI 10.1016/j.cancergen.2012.01.002; Franklin WA, 1997, J CLIN INVEST, V100, P2133, DOI 10.1172/JCI119748; Fukui S, 2013, TUMOR DORMANCY QUIES, V1, P270; Gaedcke J, 2012, CLIN CANCER RES, V18, P4919, DOI 10.1158/1078-0432.CCR-12-0016; Gkirtzimanaki K, 2013, P NATL ACAD SCI USA, V110, pE1470, DOI 10.1073/pnas.1215938110; Gomperts BN, 2013, CANCER PREV RES, V6, P4, DOI 10.1158/1940-6207.CAPR-12-0470; Grant JL, 2013, CANCER PREV RES PHIL; Greenberg AK, 2002, AM J RESP CELL MOL, V26, P558, DOI 10.1165/ajrcmb.26.5.4689; GUEDDARI N, 1993, BIOCHIMIE, V75, P811, DOI 10.1016/0300-9084(93)90132-C; Guo MZ, 2004, CLIN CANCER RES, V10, P5131, DOI 10.1158/1078-0432.CCR-03-0763; Gustafson AM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000251; Harvey BG, 2007, J MOL MED, V85, P39, DOI 10.1007/s00109-006-0103-z; Heguy A, 2006, J MOL MED, V84, P318, DOI 10.1007/s00109-005-0008-2; Henschke CI, 2006, NEW ENGL J MED, V355, P1763, DOI 10.1056/NEJMoa060476; Hirota T, 2012, LUNG CANCER, V77, P16, DOI 10.1016/j.lungcan.2011.12.018; Holla VR, 2006, J BIOL CHEM, V281, P2676, DOI 10.1074/jbc.M507752200; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Jang JS, 2012, CLIN CANCER RES, V18, P3658, DOI 10.1158/1078-0432.CCR-11-2857; Kadara H, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju004; Kadara H, 2013, CANCER PREV RES, V6, P8, DOI 10.1158/1940-6207.CAPR-12-0290; Kang YJ, 2014, J CLIN PATHOL, V67, P86, DOI 10.1136/jclinpath-2013-201841; Kao DD, 2013, MOL CELL BIOCHEM, V382, P153, DOI 10.1007/s11010-013-1730-7; Kapur M, 2012, EMBO REP, V13, P1021, DOI 10.1038/embor.2012.140; Khatlani TS, 2007, ONCOGENE, V26, P2658, DOI 10.1038/sj.onc.1210050; Klein RM, 2009, CANCER RES, V69, P2224, DOI 10.1158/0008-5472.CAN-08-3201; Kosari F, 2014, ONCOGENE, V33, P3776, DOI 10.1038/onc.2013.359; Lee S, 2007, BIOCHEM BIOPH RES CO, V362, P853, DOI 10.1016/j.bbrc.2007.08.060; Li Y, 2012, AM J RESP CELL MOL, V47, P768, DOI 10.1165/rcmb.2012-0027OC; Lin C, 2014, ONCOGENE; Linnoila RI, 2000, CANCER RES, V60, P4005; Liu BN, 2012, BBA-MOL BASIS DIS, V1822, P1692, DOI 10.1016/j.bbadis.2012.07.019; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mascaux C, 2009, EUR RESPIR J, V33, P352, DOI 10.1183/09031936.00084108; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Nelson MA, 1996, CANCER LETT, V103, P115, DOI 10.1016/0304-3835(96)04202-4; Peng Y, 2013, PROCEEDINGS OF THE N; Perdomo C, 2013, P NATL ACAD SCI USA, V110, P18946, DOI 10.1073/pnas.1220319110; Perdomo C, 2011, MUTAT RES-FUND MOL M, V717, P32, DOI 10.1016/j.mrfmmm.2011.04.005; Pirola L, 2003, J BIOL CHEM, V278, P15641, DOI 10.1074/jbc.M208984200; Powell CA, 1999, CLIN CANCER RES, V5, P2025; Prudkin L, 2008, CLIN CANCER RES, V14, P41, DOI 10.1158/1078-0432.CCR-07-1252; Sanjo H, 1998, J BIOL CHEM, V273, P29066, DOI 10.1074/jbc.273.44.29066; Shen H, 2012, BIOMED PHARMACOTHER, V66, P89, DOI 10.1016/j.biopha.2011.09.013; Shen J, 2013, CANCER EPIDEM BIOMAR, V22, P2364, DOI 10.1158/1055-9965.EPI-13-0237; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; SLAUGHTER DP, 1953, CANCER, V6, P963, DOI 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q; Song QC, 2014, CANCER RES, V74, P3031, DOI 10.1158/0008-5472.CAN-13-2193; Spira A, 2007, NAT MED, V13, P361, DOI 10.1038/nm1556; Staudt MR, 2014, AM J RESP CRIT CARE, V190, P955, DOI 10.1164/rccm.201406-1167LE; Steiling K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005043; Tang XN, 2005, CANCER RES, V65, P7568, DOI 10.1158/0008-5472.CAN-05-1705; Tsay JJ, 2013, ANTICANCER RES, V33, P1247; Ueki K, 2002, P NATL ACAD SCI USA, V99, P419, DOI 10.1073/pnas.012581799; Vicent S, 2004, BRIT J CANCER, V90, P1047, DOI 10.1038/sj.bjc.6601644; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Vosa U, 2011, GENE CHROMOSOME CANC, V50, P812, DOI 10.1002/gcc.20902; Wang L, 2012, FEBS LETT, V586, P1312, DOI 10.1016/j.febslet.2012.03.035; Wang YQ, 2011, J BIOL CHEM, V286, P41095, DOI 10.1074/jbc.M111.296806; Wistuba II, 2000, CANCER RES, V60, P1949; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Zhang JG, 2010, CLIN CHIM ACTA, V411, P846, DOI 10.1016/j.cca.2010.02.074	66	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118132	10.1371/journal.pone.0118132	http://dx.doi.org/10.1371/journal.pone.0118132			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25705890	Green Published, Green Submitted, gold			2022-12-26	WOS:000350662100145
J	Imai, M; Miyazaki, M; Yeung, HH; Hidaka, S; Kantartzis, K; Okada, H; Kita, S				Imai, Mutsumi; Miyazaki, Michiko; Yeung, H. Henny; Hidaka, Shohei; Kantartzis, Katerina; Okada, Hiroyuki; Kita, Sotaro			Sound Symbolism Facilitates Word Learning in 14-Month-Olds	PLOS ONE			English	Article							PHONETIC DETAIL; LANGUAGE; CORRESPONDENCES; SPEECH; OBJECTS; ACCESS; SHAPE	Sound symbolism, or the nonarbitrary link between linguistic sound and meaning, has often been discussed in connection with language evolution, where the oral imitation of external events links phonetic forms with their referents (e.g., Ramachandran & Hubbard, 2001). In this research, we explore whether sound symbolism may also facilitate synchronic language learning in human infants. Sound symbolism may be a useful cue particularly at the earliest developmental stages of word learning, because it potentially provides a way of bootstrapping word meaning from perceptual information. Using an associative word learning paradigm, we demonstrated that 14-month-old infants could detect Khler-type (1947) shape-sound symbolism, and could use this sensitivity in their effort to establish a wordreferent association.	[Imai, Mutsumi] Keio Univ, Dept Environm & Informat Studies, Fujisawa, Kanagawa 2528520, Japan; [Miyazaki, Michiko] Otsuma Womens Univ, Sch Social Informat Studies, Tokyo 2068540, Japan; [Yeung, H. Henny] CNRS, Paris, France; [Yeung, H. Henny] Univ Paris 05, Sorbonne Paris Cite, Lab Psychol Percept, Paris, France; [Hidaka, Shohei] Japan Adv Inst Sci & Technol, Sch Knowledge Sci, Nomi, Ishikawa 9231292, Japan; [Kantartzis, Katerina] Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England; [Miyazaki, Michiko; Okada, Hiroyuki] Tamagawa Univ, Brain Sci Inst, Machida, Tokyo 1948610, Japan; [Kita, Sotaro] Univ Warwick, Dept Psychol, Coventry CV4 7AL, W Midlands, England	Keio University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Japan Advanced Institute of Science & Technology (JAIST); University of Birmingham; University of Warwick	Imai, M (corresponding author), Keio Univ, Dept Environm & Informat Studies, 5322 Endo, Fujisawa, Kanagawa 2528520, Japan.	imai@sfc.keio.ac.jp	Kita, Sotaro/B-2860-2008; Okada, HIroyuki/AAN-8999-2020	Kita, Sotaro/0000-0002-0088-3654; Yeung, Henny/0000-0003-4601-6924; Kantartzis, Katerina/0000-0002-8008-144X	JSPS KAKENHI [15300088, 22243043, 23300099]; MEXT (Ministry of Education, Culture, Sports, Science and Technology) [23120003, 25119510]; MEXT GCOE program to Tamagawa University; Biotechnology and Biological Sciences Research Council's Research Development Fellowship [BB/G023069/1]; BBSRC [BB/G023069/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G023069/1] Funding Source: researchfish; Grants-in-Aid for Scientific Research [26580078, 25330176, 23300099] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT (Ministry of Education, Culture, Sports, Science and Technology)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT GCOE program to Tamagawa University; Biotechnology and Biological Sciences Research Council's Research Development Fellowship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by JSPS KAKENHI to MI (#15300088, #22243043), MEXT ( Ministry of Education, Culture, Sports, Science and Technology) Grant-in-Aid for Scientific Research on Innovative Areas to MI (#23120003), MEXT Grant-in-Aid for Scientific Research on Innovative Areas to MM (#25119510), JSPS KAKENHI to SH (#23300099), MEXT GCOE program to Tamagawa University, and Biotechnology and Biological Sciences Research Council's Research Development Fellowship [BB/G023069/1] to SK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar N, 1996, BRIT J DEV PSYCHOL, V14, P79, DOI 10.1111/j.2044-835X.1996.tb00695.x; Arbib MA, 2005, BEHAV BRAIN SCI, V28, P105, DOI 10.1017/S0140525X05000038; Asano M, CORTEX IN PRESS; DAVIS R, 1961, BRIT J PSYCHOL, V52, P259, DOI 10.1111/j.2044-8295.1961.tb00788.x; Farmer TA, 2006, P NATL ACAD SCI USA, V103, P12203, DOI 10.1073/pnas.0602173103; Fennell CT, 2010, CHILD DEV, V81, P1376, DOI 10.1111/j.1467-8624.2010.01479.x; Fennell CT, 2003, LANG SPEECH, V46, P245, DOI 10.1177/00238309030460020901; Fernald A, 2006, DEV PSYCHOL, V42, P98, DOI 10.1037/0012-1649.42.1.98; Firth J. R., 1935, T PHILOL SOC, V34, P36, DOI DOI 10.1111/J.1467-968X.1935.TB01254.X; Gogate LJ, 2010, PSYCHOL REV, V117, P496, DOI 10.1037/a0019049; Gogate LJ, 2000, STUDY MULTIMODAL MOT; Goldstein MH, 2010, INFANCY, V15, P362, DOI 10.1111/j.1532-7078.2009.00020.x; Gonzalez-Gomez PL, 2013, GEN COMP ENDOCR, V191, P1, DOI 10.1016/j.ygcen.2013.05.007; Hamano Shoko., 1998, SOUND SYMBOLIC SYSTE; HOLLAND MK, 1964, PERCEPT MOTOR SKILL, V19, P111, DOI 10.2466/pms.1964.19.1.111; Hollich G, 2007, DEV PSYCHOL, V43, P1051, DOI 10.1037/0012-1649.43.5.1051; Imai M, 1997, COGNITION, V62, P169, DOI 10.1016/S0010-0277(96)00784-6; Imai M, 2008, COGNITION, V109, P54, DOI 10.1016/j.cognition.2008.07.015; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; Kantartzis K, 2011, JAPANESE SOUND SYMBO; Kelly SD, 2002, DEV NEUROPSYCHOL, V22, P323, DOI 10.1207/S15326942dn2201_1; Kita S, 1997, LINGUISTICS, V35, P379, DOI 10.1515/ling.1997.35.2.379; Kita S, 2010, EVOLUTION OF LANGUAGE, PROCEEDINGS, P206, DOI 10.1142/9789814295222_0027; [Китаев С.В. Kitayev S.V.], 2008, [Онкоурология, Onkourologiya], P25; Kohler W, 1929, GESTALT PSYCHOL INTR; Mani N, 2008, DEVELOPMENTAL SCI, V11, P53, DOI 10.1111/j.1467-7687.2007.00645.x; Markman E. M., 1989, CATEGORIZATION NAMIN; Maurer D, 2006, DEVELOPMENTAL SCI, V9, P316, DOI 10.1111/j.1467-7687.2006.00495.x; Mazuka R., 2008, ORIGINS LANGUAGE UNR, P39; Monaghan P, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0299; Monaghan P, 2012, J EXP PSYCHOL LEARN, V38, P1152, DOI 10.1037/a0027747; Monaghan P, 2011, J EXP PSYCHOL GEN, V140, P325, DOI 10.1037/a0022924; Mondloch CJ, 2004, COGN AFFECT BEHAV NE, V4, P133, DOI 10.3758/CABN.4.2.133; Ogura T, 2004, MACARTHUR COMMUNICAT; Ogura T, 2009, INFANTS RECEPTIVE VO; Ozturk O, 2013, J EXP CHILD PSYCHOL, V114, P173, DOI 10.1016/j.jecp.2012.05.004; Pena M, 2011, PSYCHOL SCI, V22, P1419, DOI 10.1177/0956797611421791; Quine W. V. O., 1960, WORD OBJECT; Ramachandran VS, 2001, P ROY SOC B-BIOL SCI, V268, P979, DOI 10.1098/rspb.2000.1576; Saussure Ferdinandde., 1986, COURSE GEN LINGUISTI; Senghas A, 2004, SCIENCE, V305, P1779, DOI 10.1126/science.1100199; Smith L. B., 2002, BECOMING WORD LEARNE; Spiegel C, 2011, J EXP CHILD PSYCHOL, V109, P132, DOI 10.1016/j.jecp.2010.10.013; Stager CL, 1997, NATURE, V388, P381, DOI 10.1038/41102; Swingley D, 2002, PSYCHOL SCI, V13, P480, DOI 10.1111/1467-9280.00485; Tomasello M, 1995, CULTURAL ORIGINS HUM; Voeltz Friedrich K. Erhard, 2001, IDEOPHONES; Wagenmakers EJ, 2010, COGNITIVE PSYCHOL, V60, P158, DOI 10.1016/j.cogpsych.2009.12.001; Werker JF, 1998, DEV PSYCHOL, V34, P1289, DOI 10.1037/0012-1649.34.6.1289; Westbury C, 2005, BRAIN LANG, V93, P10, DOI 10.1016/j.bandl.2004.07.006; Woodward AL, 1999, CHILD DEV, V70, P65, DOI 10.1111/1467-8624.00006; Yoshida KA, 2009, DEVELOPMENTAL SCI, V12, P412, DOI 10.1111/j.1467-7687.2008.00789.x; Yurovsky D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047419; Zangl R, 2005, J COGN DEV, V6, P179, DOI 10.1207/s15327647jcd0602_2; Zesiger P, 2012, INFANCY, V17, P591, DOI 10.1111/j.1532-7078.2011.00111.x	55	37	38	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0116494	10.1371/journal.pone.0116494	http://dx.doi.org/10.1371/journal.pone.0116494			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC0XE	25695741	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000350062300014
J	Soares, RC; Zani, MB; Arruda, ACBB; de Arruda, LHF; Paulino, LC				Soares, Renan Cardoso; Zani, Marcelo Bergamin; Belini Bazan Arruda, Ana Carolina; Favaro de Arruda, Lucia Helena; Paulino, Luciana Campos			Malassezia Intra-Specific Diversity and Potentially New Species in the Skin Microbiota from Brazilian Healthy Subjects and Seborrheic Dermatitis Patients	PLOS ONE			English	Article							REAL-TIME PCR; ATOPIC-DERMATITIS; MOLECULAR ANALYSIS; DANDRUFF/SEBORRHOEIC DERMATITIS; PITYRIASIS-VERSICOLOR; QUANTITATIVE-ANALYSIS; CUTANEOUS MALASSEZIA; HUMAN KERATINOCYTES; PSORIATIC LESIONS; GENUS MALASSEZIA	Malassezia yeasts are part of the resident cutaneous microbiota, and are also associated with skin diseases such as seborrheic dermatitis (SD). The role these fungi play in skin diseases and why they are pathogenic for only some individuals remain unclear. This study aimed to characterize Malassezia microbiota from different body sites in healthy and SD subjects from Brazil. Scalp and forehead samples from healthy, mild SD and severe SD subjects were collected. Non-scalp lesions from severe SD patients were also sampled. 5.8S rDNA/ITS2 amplicons from Malassezia sp. were analyzed by RFLP and sequencing. Results indicate that Malassezia microbiota did not group according to health condition or body area. Phylogenetic analysis revealed that three groups of sequences did not cluster together with any formally described species, suggesting that they might belong to potential new species. One of them was found in high proportions in scalp samples. A large variety of Malassezia subtypes were detected, indicating intra-specific diversity. Higher Malassezia globosa proportions were found in non-scalp lesions from severe SD subjects compared with other areas, suggesting closer association of this species with SD lesions from areas other than scalp. Our results show the first panorama of Malassezia microbiota in Brazilian subjects using molecular techniques and provide new perspectives for further studies to elucidate the association between Malassezia microbiota and skin diseases.	[Soares, Renan Cardoso; Zani, Marcelo Bergamin; Paulino, Luciana Campos] Univ Fed ABC, Ctr Ciencias Nat & Humanas, Santo Andre, SP, Brazil; [Belini Bazan Arruda, Ana Carolina; Favaro de Arruda, Lucia Helena] Hosp & Maternidade Celso Pierro, Campinas, SP, Brazil	Universidade Federal do ABC (UFABC)	Paulino, LC (corresponding author), Univ Fed ABC, Ctr Ciencias Nat & Humanas, Santo Andre, SP, Brazil.	luciana.paulino@ufabc.edu.br	PAULINO, LUCIANA CAMPOS/ABD-9425-2021; Paulino, Luciana Campos/R-4172-2019	PAULINO, LUCIANA CAMPOS/0000-0003-2421-5236; 	Sao Paulo Research Foundation (FAPESP); FAPESP research grant [2008/08183-9]; FAPESP scholarship [2011/16543-8]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP research grant(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP scholarship(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Sao Paulo Research Foundation (FAPESP) (http://fapesp.br/en/). LCP was awarded a FAPESP research grant (2008/08183-9) and RCS received a FAPESP scholarship (2011/16543-8). No additional external funding source was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Arsenijevic VSA, 2014, BMC DERMATOL, V14, DOI 10.1186/1471-5945-14-5; Ashbee HR, 2007, MED MYCOL, V45, P287, DOI 10.1080/13693780701191373; Ashbee HR, 2010, MALASSEZIA AND THE SKIN: SCIENCE AND CLINICAL PRACTICE, P139, DOI 10.1007/978-3-642-03616-3_5; Baroni A, 2006, ARCH DERMATOL RES, V297, P280, DOI 10.1007/s00403-005-0594-4; Baroni A, 2004, J CUTAN PATHOL, V31, P35, DOI 10.1046/j.0303-6987.2004.0135.x; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Cabanes FJ, 2011, MED MYCOL, V49, P40, DOI 10.3109/13693786.2010.493562; Cabanes FJ, 2007, FEMS YEAST RES, V7, P1064, DOI 10.1111/j.1567-1364.2007.00217.x; Castella G, 2014, MED MYCOL, V52, P99, DOI 10.3109/13693786.2013.815372; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clavaud C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058203; Colwell RK, 2013, ESTIMATES STAT ESTIM; DeAngelis YM, 2005, J INVEST DERM SYMP P, V10, P295, DOI 10.1111/j.1087-0024.2005.10119.x; DeAngelis YM, 2007, J INVEST DERMATOL, V127, P2138, DOI 10.1038/sj.jid.5700844; Dessinioti C, 2013, CLIN DERMATOL, V31, P343, DOI 10.1016/j.clindermatol.2013.01.001; Duarte ER, 2010, MYCOSES, V53, P48, DOI 10.1111/j.1439-0507.2008.01658.x; Duarte ER, 1999, MED MYCOL, V37, P159, DOI 10.1046/j.1365-280X.1999.00212.x; Emtestam L, 2012, MYCOSES, V55, P393, DOI 10.1111/j.1439-0507.2011.02126.x; Faergemann J, 2001, BRIT J DERMATOL, V144, P549, DOI 10.1046/j.1365-2133.2001.04082.x; Findley K, 2013, NATURE, V498, P367, DOI 10.1038/nature12171; Gaitanis G, 2013, CLIN DERMATOL, V31, P455, DOI 10.1016/j.clindermatol.2013.01.012; Gaitanis G, 2012, CLIN MICROBIOL REV, V25, P106, DOI 10.1128/CMR.00021-11; Gandra RF, 2008, MYCOPATHOLOGIA, V165, P21, DOI 10.1007/s11046-007-9079-7; Gemmer CM, 2002, J CLIN MICROBIOL, V40, P3350, DOI 10.1128/JCM.40.9.3350-3357.2002; Gioti A, 2013, MBIO, V4, DOI 10.1128/mBio.00572-12; Giusiano G, 2010, REV IBEROAM MICOL, V27, P71, DOI 10.1016/j.riam.2009.12.005; Gorley C.K., 2006, GETTING STARTED PRIM; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Grimalt R, 2007, J INVEST DERM SYMP P, V12, P10, DOI 10.1038/sj.jidsymp.5650048; Gueho E, 1996, ANTON LEEUW INT J G, V69, P337, DOI 10.1007/BF00399623; Gueho-Kellermann E, 2010, MALASSEZIA AND THE SKIN: SCIENCE AND CLINICAL PRACTICE, P17, DOI 10.1007/978-3-642-03616-3_2; GUILLOT J, 1995, ANTON LEEUW INT J G, V67, P297, DOI 10.1007/BF00873693; Gupta AK, 2000, J CLIN MICROBIOL, V38, P1869, DOI 10.1128/JCM.38.5.1869-1875.2000; Gupta AK, 2004, J AM ACAD DERMATOL, V51, P785, DOI 10.1016/j.jaad.2003.12.034; Hernandez Hernandez Francisca, 2003, Revista Iberoamericana de Micologia, V20, P141; Hirai A, 2004, INT J SYST EVOL MICR, V54, P623, DOI 10.1099/ijs.0.02776-0; Hiruma M, 2014, MYCOPATHOLOGIA, V177, P263, DOI 10.1007/s11046-014-9748-2; Juntachai W, 2011, MICROBIOL-SGM, V157, P3492, DOI 10.1099/mic.0.054528-0; Juntachai W, 2009, MED MYCOL, V47, P477, DOI 10.1080/13693780802314825; Kaga M, 2011, MYCOSES, V54, pE24, DOI 10.1111/j.1439-0507.2009.01821.x; Kerr K, 2011, ACTA DERM-VENEREOL, V91, P404, DOI 10.2340/00015555-1073; Kerr K, 2011, INT J DERMATOL, V50, P102, DOI 10.1111/j.1365-4632.2010.04629.x; Lee YW, 2011, ANN DERMATOL, V23, P156, DOI 10.5021/ad.2011.23.2.156; Lian CH, 2014, MYCOSES, DOI [10.1111/myc.12280, DOI 10.1111/MYC.12280]; Lyakhovitsky A, 2013, INT J DERMATOL, V52, P231, DOI [10.1111/j.1365-4632.2012.05595.x, 10.1111/ijd.12167]; Machado MLS, 2011, VET DERMATOL, V22, P46, DOI 10.1111/j.1365-3164.2010.00909.x; Machado MLS, 2010, MED MYCOL, V48, P889, DOI 10.3109/13693780903532080; Midgley G, 2000, MED MYCOL, V38, P9, DOI 10.1080/mmy.38.s1.9.16; Mills KJ, 2012, BRIT J DERMATOL, V166, P33, DOI 10.1111/j.1365-2133.2012.10863.x; Mokos ZB, 2012, ACTA DERMATOVENER CR, V20, P98; Munoz-Perez MA, 1998, BRIT J DERMATOL, V139, P33; Nagata R, 2012, PEDIATR INT, V54, P350, DOI 10.1111/j.1442-200X.2012.03563.x; Paulino LC, 2008, FEMS YEAST RES, V8, P460, DOI 10.1111/j.1567-1364.2008.00359.x; Paulino LC, 2006, J CLIN MICROBIOL, V44, P2933, DOI 10.1128/JCM.00785-06; Perkins MA, 2002, SKIN RES TECHNOL, V8, P187, DOI 10.1034/j.1600-0846.2002.20337.x; Petry V, 2011, AN BRAS DERMATOL, V86, P803, DOI 10.1590/S0365-05962011000400032; Rendic E, 2003, REV MED CHILE, V131, P1295; Rincón Sandra, 2005, Biomed., V25, P189; Saunders CW, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002701; Selene CED, 2007, ACTA VET HUNG, V55, P471, DOI 10.1556/AVet.55.2007.4.6; Sugita T, 2004, MICROBIOL IMMUNOL, V48, P579, DOI 10.1111/j.1348-0421.2004.tb03554.x; Sugita T, 2003, J CLIN MICROBIOL, V41, P4695, DOI 10.1128/JCM.41.10.4695-4699.2003; Sugita T, 2003, J CLIN MICROBIOL, V41, P3022, DOI 10.1128/JCM.41.7.3022-3027.2003; Sugita T, 2002, J CLIN MICROBIOL, V40, P1363, DOI 10.1128/JCM.40.4.1363-1367.2002; Sugita T, 2001, J CLIN MICROBIOL, V39, P3486, DOI [10.1128/JCM.39.10.3486-3490.2001, 10.3314/jjmm.42.217]; Sugita T, 2006, MICROBIOL IMMUNOL, V50, P549, DOI 10.1111/j.1348-0421.2006.tb03825.x; Tajima M, 2008, J INVEST DERMATOL, V128, P345, DOI 10.1038/sj.jid.5701017; Takahata Y, 2007, BRIT J DERMATOL, V157, P1178, DOI 10.1111/j.1365-2133.2007.08193.x; Takahata Y, 2007, BRIT J DERMATOL, V157, P670, DOI 10.1111/j.1365-2133.2007.08090.x; Trznadel-Grodzka E, 2012, POSTEP HIG MED DOSW, V66, P843, DOI 10.5604/17322693.1019642; Xu J, 2007, P NATL ACAD SCI USA, V104, P18730, DOI 10.1073/pnas.0706756104; Zhang H, 2013, MYCOPATHOLOGIA, V175, P83, DOI 10.1007/s11046-012-9606-z	75	25	27	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0117921	10.1371/journal.pone.0117921	http://dx.doi.org/10.1371/journal.pone.0117921			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695430	gold, Green Submitted, Green Published			2022-12-26	WOS:000350062300034
J	Czaczkes, TJ; Heinze, J; Ruther, J				Czaczkes, Tomer J.; Heinze, Juergen; Ruther, Joachim			Nest Etiquette-Where Ants Go When Nature Calls	PLOS ONE			English	Article							DIVISION-OF-LABOR; WASTE MANAGEMENT; BEHAVIOR; HYMENOPTERA; FORMICIDAE; SANITATION; DISEASE; BROOD	Sanitary behaviour is an important, but seldom studied, aspect of social living. Social insects have developed several strategies for dealing with waste and faecal matter, including dumping waste outside the nest and forming specialised waste-storage chambers. In some cases waste material and faeces are put to use, either as a construction material or as a long-lasting signal, suggesting that faeces and waste may not always be dangerous. Here we examine a previously undescribed behaviour in ants - the formation of well-defined faecal patches. Lasius niger ants were housed in plaster nests and provided with coloured sucrose solution. After two months, 1-4 well defined dark patches, the colour of the sucrose solution, formed within each of the plaster nests. These patches never contained other waste material such as uneaten food items, or nestmate corpses. Such waste was collected in waste piles outside the nest. The coloured patches were thus distinct from previously described 'kitchen middens' in ants, and are best described as 'toilets'. Why faeces is not removed with other waste materials is unclear. The presence of the toilets inside the nest suggests that they may not be an important source of pathogens, and may have a beneficial role.	[Czaczkes, Tomer J.; Heinze, Juergen; Ruther, Joachim] Univ Regensburg, D-93053 Regensburg, Bavaria, Germany	University of Regensburg	Czaczkes, TJ (corresponding author), Univ Regensburg, D-93053 Regensburg, Bavaria, Germany.	tomer.czaczkes@biologie.uni-regensburg.de	Ruther, Joachim/AAE-3568-2019	Czaczkes, Tomer/0000-0002-1350-4975; Ruther, Joachim/0000-0002-1295-347X	Alexander von Humboldt foundation	Alexander von Humboldt foundation(Alexander von Humboldt Foundation)	This work was supported by the Alexander von Humboldt foundation, http://www.humboldt-foundation.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1974, SOCIAL BEHAV BEES; Arganda S, 2014, J INSECT PHYSL; Bailey L, 1955, ANN APPL BIOL, V43, P379, DOI 10.1111/j.1744-7348.1955.tb02488.x; Ballari S, 2007, J INSECT BEHAV, V20, P87, DOI 10.1007/s10905-006-9065-9; BEUGNON G, 1992, INSECT SOC, V39, P341, DOI 10.1007/BF01323954; BUCHER GE, 1957, CAN J MICROBIOL, V3, P695, DOI 10.1139/m57-077; Devigne C, 2002, INSECT SOC, V49, P357, DOI 10.1007/PL00012659; Diez L, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0306; Dussutour A, 2009, CURR BIOL, V19, P740, DOI 10.1016/j.cub.2009.03.015; Fernandez-Marin H, 2006, P ROY SOC B-BIOL SCI, V273, P1689, DOI 10.1098/rspb.2006.3492; Hart AG, 2002, BEHAV ECOL, V13, P224, DOI 10.1093/beheco/13.2.224; Hart AG, 2001, BEHAV ECOL SOCIOBIOL, V49, P387, DOI 10.1007/s002650000312; HOLLDOBLER B, 1977, SCIENCE, V195, P900, DOI 10.1126/science.841318; Holldobler B., 1990, pi; HOLLDOBLER B, 1976, SCIENCE, V192, P912, DOI 10.1126/science.192.4242.912; Jarau S, 2009, CONTEMP TOP ENTOMOL, P1, DOI 10.1201/9781420075618; Kerr A. S., 1999, Revista Brasileira de Biologia, V59, P119, DOI 10.1590/S0034-71081999000100015; Korb J, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P349, DOI 10.1007/978-90-481-3977-4_13; Noirot C., 1970, P73; PEETERS C, 1994, INSECT SOC, V41, P211, DOI 10.1007/BF01240479; Poulsen M, 2005, SCIENCE, V307, P741, DOI 10.1126/science.1106688; Poulsen M, 2002, BEHAV ECOL SOCIOBIOL, V52, P151, DOI 10.1007/s00265-002-0489-8; Rettenmeyer C. W., 1963, Kansas University Science Bulletin, V44, P281; Rosengaus RB, 1998, J CHEM ECOL, V24, P1697, DOI 10.1023/A:1020872729671; Sato Y, 2003, ETHOLOGY, V109, P713, DOI 10.1046/j.1439-0310.2003.00905.x; Sato Y, 2006, ETHOLOGY, V112, P664, DOI 10.1111/j.1439-0310.2005.01184.x; Tragust S, 2013, CURR BIOL, V23, P76, DOI 10.1016/j.cub.2012.11.034; Tranter C, 2014, BEHAV ECOL SOCIOBIOL, V68, P499, DOI 10.1007/s00265-013-1664-9; Vencl FV, 1999, J CHEM ECOL, V25, P549, DOI 10.1023/A:1020905920952; Weiss MR, 2006, ANNU REV ENTOMOL, V51, P635, DOI 10.1146/annurev.ento.49.061802.123212; Weiss MR, 2003, ECOL LETT, V6, P361, DOI 10.1046/j.1461-0248.2003.00442.x; WILSON EO, 1984, INSECT SOC, V31, P408, DOI 10.1007/BF02223657	32	17	17	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118376	10.1371/journal.pone.0118376	http://dx.doi.org/10.1371/journal.pone.0118376			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692971	gold, Green Published, Green Submitted			2022-12-26	WOS:000350061500120
J	Machulska, A; Zlomuzica, A; Adolph, D; Rinck, M; Margraf, J				Machulska, Alla; Zlomuzica, Armin; Adolph, Dirk; Rinck, Mike; Margraf, Juergen			"A Cigarette a Day Keeps the Goodies Away": Smokers Show Automatic Approach Tendencies for Smoking-But Not for Food-Related Stimuli	PLOS ONE			English	Article							INCENTIVE-SENSITIZATION THEORY; APPROACH-BIAS; ADDICTION; CUES; ALCOHOL; DYSREGULATION; NONSMOKERS; DEPENDENCE; BEHAVIORS; RESPONSES	Smoking leads to the development of automatic tendencies that promote approach behavior toward smoking-related stimuli which in turn may maintain addictive behavior. The present study examined whether automatic approach tendencies toward smoking-related stimuli can be measured by using an adapted version of the Approach-Avoidance Task (AAT). Given that progression of addictive behavior has been associated with a decreased reactivity of the brain reward system for stimuli signaling natural rewards, we also used the AAT to measure approach behavior toward natural rewarding stimuli in smokers. During the AAT, 92 smokers and 51 non-smokers viewed smoking-related vs. non-smoking-related pictures and pictures of natural rewards (i.e. highly palatable food) vs. neutral pictures. They were instructed to ignore image content and to respond to picture orientation by either pulling or pushing a joystick. Within-group comparisons revealed that smokers showed an automatic approach bias exclusively for smoking-related pictures. Contrary to our expectations, there was no difference in smokers' and non-smokers' approach bias for nicotine-related stimuli, indicating that non-smokers also showed approach tendencies for this picture category. Yet, in contrast to non-smokers, smokers did not show an approach bias for food-related pictures. Moreover, self-reported smoking attitude could not predict approach-avoidance behavior toward nicotine-related pictures in smokers or non-smokers. Our findings indicate that the AAT is suited for measuring smoking-related approach tendencies in smokers. Furthermore, we provide evidence for a diminished approach tendency toward food-related stimuli in smokers, suggesting a decreased sensitivity to natural rewards in the course of nicotine addiction. Our results indicate that in contrast to similar studies conducted in alcohol, cannabis and heroin users, the AAT might only be partially suited for measuring smoking-related approach tendencies in smokers. Nevertheless, our findings are of special importance for current etiological models and smoking cessation programs aimed at modifying nicotine-related approach tendencies in the context of a nicotine addiction.	[Machulska, Alla; Zlomuzica, Armin; Adolph, Dirk; Rinck, Mike; Margraf, Juergen] Ruhr Univ Bochum, Mental Hlth Res & Treatment Ctr, Univ Str 150, Bochum, Germany; [Rinck, Mike] Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands	Ruhr University Bochum; Radboud University Nijmegen	Margraf, J (corresponding author), Ruhr Univ Bochum, Mental Hlth Res & Treatment Ctr, Univ Str 150, Bochum, Germany.	juergen.margraf@rub.de	Margraf, Jürgen/A-6873-2008; Rinck, Mike/A-6944-2010	Margraf, Jürgen/0000-0001-5207-7016; Machulska, Alla/0000-0001-5968-429X	Alexander von Humboldt Foundation	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	This study was funded by a research grant to Jurgen Margraf by the Alexander von Humboldt Foundation (http://www.humboldt-foundation.de/web/start.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradley BP, 2008, J PSYCHOPHARMACOL, V22, P737, DOI 10.1177/0269881107083844; Cousijn J, 2011, ADDICTION, V106, P1667, DOI 10.1111/j.1360-0443.2011.03475.x; Crawford JR, 2003, BRIT J CLIN PSYCHOL, V42, P111, DOI 10.1348/014466503321903544; De Houwer J, 2003, PSYCHOLOGY OF EVALUATION, P219; Deutsch R, 2006, PSYCHOL INQ, V17, P166, DOI 10.1207/s15327965pli1703_2; Eberl C, 2013, DEV COGN NEUROS-NETH, V4, P38, DOI 10.1016/j.dcn.2012.11.002; Ernst LH, 2014, ADDICT BIOL, V19, P497, DOI 10.1111/adb.12005; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; HEINZ A, 1994, PHARMACOPSYCHIATRY, V27, P7, DOI 10.1055/s-2007-1014317; Kassel JD, 2003, PSYCHOL BULL, V129, P270, DOI 10.1037/0033-2909.129.2.270; Koob GF, 2001, NEUROPSYCHOPHARMACOL, V24, P97, DOI 10.1016/S0893-133X(00)00195-0; Koob GF, 1997, SCIENCE, V278, P52, DOI 10.1126/science.278.5335.52; Kroemer NB, 2013, NEUROPSYCHOPHARMACOL, V38, P2307, DOI 10.1038/npp.2013.133; Lang PJ, 1995, INT AFFECTIVE PICTUR; Lovibond SH, 1995, MANUAL DEPRESSION AN, V2nd; Lubman DI, 2009, ARCH GEN PSYCHIAT, V66, P205, DOI 10.1001/archgenpsychiatry.2008.522; McCabe RE, 2004, J ANXIETY DISORD, V18, P7, DOI 10.1016/j.janxdis.2003.07.003; Mogg K, 2005, PSYCHOPHARMACOLOGY, V180, P333, DOI 10.1007/s00213-005-2158-x; Peters J, 2011, AM J PSYCHIAT, V168, P540, DOI 10.1176/appi.ajp.2010.10071024; Rinck M, 2007, J BEHAV THER EXP PSY, V38, P105, DOI 10.1016/j.jbtep.2006.10.001; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Robinson TE, 2008, PHILOS T R SOC B, V363, P3137, DOI 10.1098/rstb.2008.0093; Rubinstein ML, 2011, NICOTINE TOB RES, V13, P751, DOI 10.1093/ntr/ntr046; Stippekohl B, 2012, PSYCHOPHARMACOLOGY, V222, P593, DOI 10.1007/s00213-012-2670-8; Stippekohl B, 2010, NEUROPSYCHOPHARMACOL, V35, P1209, DOI 10.1038/npp.2009.227; Strack F, 2004, PERS SOC PSYCHOL REV, V8, P220, DOI 10.1207/s15327957pspr0803_1; Swanson JE, 2001, COGNITION EMOTION, V15, P207, DOI 10.1080/0269993004200060; Waters AJ, 2003, ADDICTION, V98, P1409, DOI 10.1046/j.1360-0443.2003.00465.x; Watson P, 2013, J EXP PSYCHOPATHOL, V4, P250, DOI 10.5127/jep.030512; Wiers CE, 2013, PSYCHOPHARMACOLOGY, V229, P187, DOI 10.1007/s00213-013-3098-5; Wiers RW, 2009, GENES BRAIN BEHAV, V8, P101, DOI 10.1111/j.1601-183X.2008.00454.x; Wiers RW, 2007, PHARMACOL BIOCHEM BE, V86, P263, DOI 10.1016/j.pbb.2006.09.021; Wiers RW, 2013, CLIN PSYCHOL SCI, V1, P192, DOI 10.1177/2167702612466547; Wiers RW, 2011, PSYCHOL SCI, V22, P490, DOI 10.1177/0956797611400615; Wiers RW, 2010, ADDICTION, V105, P279, DOI 10.1111/j.1360-0443.2009.02775.x; Zhou YY, 2012, PSYCHOPHARMACOLOGY, V221, P171, DOI 10.1007/s00213-011-2557-0	36	38	38	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0116464	10.1371/journal.pone.0116464	http://dx.doi.org/10.1371/journal.pone.0116464			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC0WZ	25692468	Green Published, Green Submitted, gold			2022-12-26	WOS:000350061500015
J	Bussiere, FI; Brossier, F; Le Vern, Y; Niepceron, A; Silvestre, A; de Sablet, T; Lacroix-Lamande, S; Laurent, F				Bussiere, Francoise I.; Brossier, Fabien; Le Vern, Yves; Niepceron, Alisson; Silvestre, Anne; de Sablet, Thibaut; Lacroix-Lamande, Sonia; Laurent, Fabrice			Reduced Parasite Motility and Micronemal Protein Secretion by a p38 MAPK Inhibitor Leads to a Severe Impairment of Cell Invasion by the Apicomplexan Parasite Eimeria tenella	PLOS ONE			English	Article							TOXOPLASMA-GONDII; HOST-CELL; KINASE INHIBITORS; MOLECULAR CHARACTERIZATION; ACTIN CYTOSKELETON; IDENTIFICATION; ANTIGEN; PHOSPHORYLATION; ANTIBODIES; INFECTION	E. tenella infection is associated with a severe intestinal disease leading to high economic losses in poultry industry. Mitogen activated protein kinases (MAPKs) are implicated in early response to infection and are divided in three pathways: p38, extracellular signal-regulated protein kinase (ERK) and c-Jun N-terminal kinase (JNK). Our objective was to determine the importance of these kinases on cell invasion by E. tenella. We evaluated the effect of specific inhibitors (ERK: PD98059, JNKII: SP600125, p38 MAPK: SB203580) on the invasion of epithelial cells. Incubation of SP600125 and SB203580 with epithelial cells and parasites significantly inhibited cell invasion with the highest degree of inhibition (90%) for SB203580. Silencing of the host p38 alpha MAPK expression by siRNA led to only 20% decrease in cell invasion. In addition, when mammalian epithelial cells were pre-treated with SB203580, and washed prior infection, a 30% decrease in cell invasion was observed. This decrease was overcome when a p38 MAPK activator, anisomycin was added during infection. This suggests an active but limited role of the host p38 MAPK in this process. We next determined whether SB203580 has a direct effect on the parasite. Indeed, parasite motility and secretion of micronemal proteins (EtMIC1, 2, 3 and 5) that are involved in cell invasion were both decreased in the presence of the inhibitor. After chasing the inhibitor, parasite motility and secretion of micronemal proteins were restored and subsequently cell invasion. SB203580 inhibits cell invasion by acting partly on the host cell and mainly on the parasite.	[Bussiere, Francoise I.; Brossier, Fabien; Niepceron, Alisson; Silvestre, Anne; de Sablet, Thibaut; Lacroix-Lamande, Sonia; Laurent, Fabrice] INRA, Apicomplexes & Immun Mucosale, UMR1282, Infectiol & Sante Publ, F-37380 Nouzilly, France; [Bussiere, Francoise I.; Brossier, Fabien; Le Vern, Yves; Niepceron, Alisson; Silvestre, Anne; de Sablet, Thibaut; Lacroix-Lamande, Sonia; Laurent, Fabrice] Univ Tours, UMR1282, Infectiol & Sante Publ, F-37000 Tours, France; [Le Vern, Yves] INRA, Plate Forme Anal Integrat Biomol, Lab Cytometrie & Fluorimetrie, UMR1282,Infectiol & Sante Publ, F-37380 Nouzilly, France	INRAE; Universite de Tours; INRAE	Bussiere, FI (corresponding author), INRA, Apicomplexes & Immun Mucosale, UMR1282, Infectiol & Sante Publ, F-37380 Nouzilly, France.	Francoise.Bussiere@tours.inra.fr	de Sablet, Thibaut/AAI-4513-2020; Laurent, fabrice/AAC-2266-2019; Silvestre, Anne/V-1165-2017	Laurent, fabrice/0000-0002-9687-7952; Silvestre, Anne/0000-0001-6824-7868; Bussiere, Francoise I/0000-0001-9365-6831; LAMANDE, Sonia/0000-0002-7865-4587	Institut National de la Recherche Agronomique (INRA)	Institut National de la Recherche Agronomique (INRA)	Funding from the Institut National de la Recherche Agronomique (INRA).	Alexander DL, 2005, PLOS PATHOG, V1, P137, DOI 10.1371/journal.ppat.0010017; Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; Becker S, 1997, PARASITOL RES, V83, P273, DOI 10.1007/s004360050246; Behnke MS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002992; Bens M, 1996, AM J PHYSIOL-CELL PH, V270, pC1666, DOI 10.1152/ajpcell.1996.270.6.C1666; Besteiro S, 2011, CELL MICROBIOL, V13, P797, DOI 10.1111/j.1462-5822.2011.01597.x; Brossier F, 2003, J BIOL CHEM, V278, P6229, DOI 10.1074/jbc.M209837200; Brumlik M. J., 2011, J SIGNAL TRANSDUCT, V2011, DOI [10.1155/2011/971968, DOI 10.1155/2011/971968]; Brumlik MJ, 2011, EXP PARASITOL, V128, P170, DOI 10.1016/j.exppara.2011.02.016; Bumstead J, 2000, MOL BIOCHEM PARASIT, V110, P311, DOI 10.1016/S0166-6851(00)00280-2; Bumstead JM, 1998, PARASITOLOGY, V117, P39, DOI 10.1017/S0031182098002741; Carruthers VB, 1999, MOL MICROBIOL, V31, P421, DOI 10.1046/j.1365-2958.1999.01174.x; Carruthers VB, 1997, EUR J CELL BIOL, V73, P114; Carruthers Vern B., 2008, V47, P33; Chapman HD, 2013, ADV PARASIT, V83, P93, DOI 10.1016/B978-0-12-407705-8.00002-1; Chen XM, 2003, GASTROENTEROLOGY, V125, P216, DOI 10.1016/S0016-5085(03)00662-0; Coulthard LR, 2009, TRENDS MOL MED, V15, P369, DOI 10.1016/j.molmed.2009.06.005; Delorme-Walker V, 2012, J CELL SCI, V125, P4333, DOI 10.1242/jcs.103648; Dobrowolski JM, 1996, CELL, V84, P933, DOI 10.1016/S0092-8674(00)81071-5; Donald RGK, 2006, MOL BIOCHEM PARASIT, V149, P86, DOI 10.1016/j.molbiopara.2006.05.003; DVORAK JA, 1981, SCIENCE, V214, P1034, DOI 10.1126/science.7029713; ENTZEROTH R, 1989, PARASITOL RES, V76, P174, DOI 10.1007/BF00930842; ENTZEROTH R, 1992, EUR J CELL BIOL, V59, P405; Esnault E, 2011, VIRUS RES, V159, P32, DOI 10.1016/j.virusres.2011.04.022; Fentress SJ, 2010, CELL HOST MICROBE, V8, P484, DOI 10.1016/j.chom.2010.11.005; Gomez-Marin JE, 1998, PARASITE IMMUNOL, V20, P631, DOI 10.1046/j.1365-3024.1998.00194.x; Gonzalez V, 2009, CELL HOST MICROBE, V5, P259, DOI 10.1016/j.chom.2009.01.011; Grimwood J, 1996, INFECT IMMUN, V64, P4099, DOI 10.1128/IAI.64.10.4099-4104.1996; Gurnett AM, 2002, J BIOL CHEM, V277, P15913, DOI 10.1074/jbc.M108393200; Han HY, 2013, PARASITOLOGY, V140, P746, DOI 10.1017/S0031182012002107; Hanks SK, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-5-111; Healer J, 2004, MOL MICROBIOL, V52, P159, DOI 10.1111/j.1365-2958.2003.03974.x; Huang DZ, 2010, BIOINFORMATICS, V26, P198, DOI 10.1093/bioinformatics/btp650; JENSEN JB, 1976, J PARASITOL, V62, P988, DOI 10.2307/3279196; Kipper M, 2013, VET PARASITOL, V196, P77, DOI 10.1016/j.vetpar.2013.01.013; LAURENT F, 1994, MOL BIOCHEM PARASIT, V63, P79, DOI 10.1016/0166-6851(94)90010-8; Lourido S, 2010, NATURE, V465, P359, DOI 10.1038/nature09022; Lovett JL, 2003, J CELL SCI, V116, P3009, DOI 10.1242/jcs.00596; MILLER LH, 1988, MOL BIOCHEM PARASIT, V31, P217, DOI 10.1016/0166-6851(88)90151-X; Niedelman W, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002784; Richard D, 2010, J BIOL CHEM, V285, P14815, DOI 10.1074/jbc.M109.080770; Robert-Gangneux F, 2000, PARASITE, V7, P95, DOI 10.1051/parasite/2000072095; Santos JM, 2012, MOL BIOCHEM PARASIT, V182, P27, DOI 10.1016/j.molbiopara.2011.11.010; Sharman PA, 2010, PARASITE IMMUNOL, V32, P590, DOI 10.1111/j.1365-3024.2010.01209.x; Shirley MW, 1995, BIOTECHNOLOGY GUIDEL, VXII, P1; SIM BKL, 1990, J CELL BIOL, V111, P1877, DOI 10.1083/jcb.111.5.1877; Singh AP, 2002, MOL BIOCHEM PARASIT, V121, P21, DOI 10.1016/S0166-6851(02)00017-8; Sukhumayasi W, 2010, EXP PARASITOL, V126, P415, DOI 10.1016/j.exppara.2010.01.019; Sweeney KR, 2010, EUKARYOT CELL, V9, P1680, DOI 10.1128/EC.00079-10; Talevich E, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-321; Taylor S, 2006, SCIENCE, V314, P1776, DOI 10.1126/science.1133643; Tomley FM, 1996, MOL BIOCHEM PARASIT, V79, P195, DOI 10.1016/0166-6851(96)02662-X; VIEIRA MCF, 1994, BIOCHEM BIOPH RES CO, V203, P967, DOI 10.1006/bbrc.1994.2276; WARD GE, 1994, EXP PARASITOL, V79, P480, DOI 10.1006/expr.1994.1109; Wei F, 2013, PARASITOL RES, V112, P2121, DOI 10.1007/s00436-013-3451-y; Wei S, 2002, INT J PARASITOL, V32, P969, DOI 10.1016/S0020-7519(02)00061-9; Wei S, 2007, ANTIMICROB AGENTS CH, V51, P4324, DOI 10.1128/AAC.00680-07; Wiersma HI, 2004, INT J PARASITOL, V34, P369, DOI 10.1016/j.ijpara.2003.11.019; Yamamoto M, 2009, J EXP MED, V206, P2747, DOI 10.1084/jem.20091703; Yan WC, 2009, INT J PARASITOL, V39, P109, DOI 10.1016/j.ijpara.2008.06.013; Young PR, 1997, J BIOL CHEM, V272, P12116, DOI 10.1074/jbc.272.18.12116	61	11	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0116509	10.1371/journal.pone.0116509	http://dx.doi.org/10.1371/journal.pone.0116509			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689363	Green Published, Green Submitted, gold			2022-12-26	WOS:000350322700011
J	Chen, YY; Chu, DC; Chou, P				Chen, Yu-Yen; Chu, Dachen; Chou, Pesus			Enhancing the Early Differential Diagnosis of Plateau Iris and Pupillary Block Using A-Scan Ultrasonography	PLOS ONE			English	Article							ANGLE-CLOSURE GLAUCOMA; LASER PERIPHERAL IRIDOPLASTY; STATISTICAL POWER; ANTERIOR; CHINESE; EYES	Purpose To distinguish the frequently misdiagnosed plateau iris eyes from pupillary block group and normal group, we compared the ocular biometrical parameters of them by A-scan ultrasongraphy. Methods In total, we retrospectively reviewed general characteristics and ocular findings including ocular biometric measurements of 71 normal, 39 plateau iris, and 83 pupillary block eyes. Results The normal controls, plateau iris group and pupillary block group were significantly different in age, but not in gender. The anterior chamber depth tended to decrease and the lens thickness tended to increase from normal to plateau iris to pupillary block eyes. Compared to those of plateau iris group, the pupillary block group had significantly shallower anterior chamber depth (2.90mm vs. 2.33mm; p<0.001), thicker lens (4.77 mm vs. 5.11mm; p<0.001), shorter axial length (23.16mm vs. 22.63mm; p<0.001), smaller relative lens position (2.28 vs. 2.16; p<0.001) and larger lens/axial length factor (2.06 vs. 2.26; p<0.001). However, when comparing plateau iris and normal eyes, only axial length and lens/axial length factor were significantly different (23.16 vs. 23.54; p<0.05 and 2.06 vs. 1.96; p<0.05). Conclusions Measured by A-scan ultrasonography, the ocular biometrics of plateau iris were significantly different from those of pupillary block eyes. However, our A-scan ultrasongraphy generally found no significant biometric differences between plateau iris and normal eyes. These findings suggest that while A-scan ultrasonography might be used as a practical tool for differentiating plateau iris and papillary block eyes, a more meticulous gonioscopy and other assessments may be necessary to distinguish plateau iris from normal eyes.	[Chen, Yu-Yen; Chu, Dachen; Chou, Pesus] Natl Yang Ming Univ, Community Med Res Ctr, Taipei 112, Taiwan; [Chen, Yu-Yen; Chu, Dachen; Chou, Pesus] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Chen, Yu-Yen] Yang Ming Univ Hosp, Dept Ophthalmol, Yilan City, Ilan County, Taiwan; [Chu, Dachen] Taipei City Hosp, Zhongxing Branch, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei City Hospital	Chou, P (corresponding author), Natl Yang Ming Univ, Community Med Res Ctr, Taipei 112, Taiwan.	pschou@ym.edu.tw						COHEN J, 1962, J ABNORM PSYCHOL, V65, P145, DOI 10.1037/h0045186; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cohen P., 2014, APPL MULTIPLE REGRES, DOI [10.4324/9781410606266, DOI 10.4324/9780203774441]; Diniz Filho Alberto, 2010, Arq. Bras. Oftalmol., V73, P155, DOI 10.1590/S0004-27492010000200011; Fox N, 1997, FAM PRACT, V14, P324, DOI 10.1093/fampra/14.4.324; Garudadri CS, 2002, J GLAUCOMA, V11, P502, DOI 10.1097/00061198-200212000-00009; He MG, 2007, OPHTHALMOLOGY, V114, P1513, DOI 10.1016/j.ophtha.2006.11.032; HUNG PT, 1979, ARCH OPHTHALMOL-CHIC, V97, P1862; Hung PT, 1996, ASIA PAC J OPHTHALMO, V2, P82; Johnson GJ, 2005, EYE LOND, V19; Klimek Katarzyna M, 2008, Wiad Lek, V61, P211; Kumar RS, 2008, OPHTHALMOLOGY, V115, P430, DOI 10.1016/j.ophtha.2007.07.026; Kumar RS, 2009, ARCH OPHTHALMOL-CHIC, V127, P1269, DOI 10.1001/archophthalmol.2009.241; Lan YW, 2007, OPHTHALMOLOGICA, V221, P388, DOI 10.1159/000107498; Mandell MA, 2003, AM J OPHTHALMOL, V136, P900, DOI 10.1016/S0002-9394(03)00578-6; MARKOWITZ SN, 1985, AM J OPHTHALMOL, V99, P400, DOI 10.1016/0002-9394(85)90005-4; Pavlin CJ, 1999, AM J OPHTHALMOL, V128, P288, DOI 10.1016/S0002-9394(99)00149-X; Ritch R, 2004, OPHTHALMOLOGY, V111, P104, DOI 10.1016/j.ophtha.2003.05.001; Ritch R, 2003, OPHTHALMOLOGY, V110, P1880, DOI 10.1016/S0161-6420(03)00563-3; Ritch R., 1992, J GLAUCOMA, V1, P23; Ritch R, 1989, GLAUCOMAS, V1; Ritch R, 2007, SURV OPHTHALMOL, V52, P279, DOI 10.1016/j.survophthal.2007.02.006; Sihota R, 2000, CLIN EXP OPHTHALMOL, V28, P253, DOI 10.1046/j.1442-9071.2000.00324.x; Sihota R, 2000, J GLAUCOMA, V9, P208; Silver DM, 2004, J GLAUCOMA, V13, P100, DOI 10.1097/00061198-200404000-00004; Tran HV, 2003, AM J OPHTHALMOL, V135, P40; Wang NL, 2002, CHINESE MED J-PEKING, V115, P1706; Zhang Y, 2014, OPHTHAL EPIDEMIOL, V21, P268, DOI 10.3109/09286586.2014.929707	28	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0118811	10.1371/journal.pone.0118811	http://dx.doi.org/10.1371/journal.pone.0118811			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689856	Green Published, Green Submitted, gold			2022-12-26	WOS:000350322700120
J	Crespo, E; Lucia, M; Cruzado, JM; Luque, S; Melilli, E; Manonelles, A; Lloberas, N; Torras, J; Grinyo, JM; Bestard, O				Crespo, Elena; Lucia, Marc; Cruzado, Josep M.; Luque, Sergio; Melilli, Edoardo; Manonelles, Anna; Lloberas, Nuria; Torras, Joan; Grinyo, Josep M.; Bestard, Oriol			Pre-Transplant Donor-Specific T-Cell Alloreactivity Is Strongly Associated with Early Acute Cellular Rejection in Kidney Transplant Recipients Not Receiving T-Cell Depleting Induction Therapy	PLOS ONE			English	Article							GRAFT FUNCTION; ELISPOT ASSAY; HETEROLOGOUS IMMUNITY; RENAL-FUNCTION; TOLERANCE; RESPONSES; PANEL; IMMUNOSUPPRESSION; SENSITIZATION; ALLOIMMUNITY	Preformed T-cell immune-sensitization should most likely impact allograft outcome during the initial period after kidney transplantation, since donor-specific memory T-cells may rapidly recognize alloantigens and activate the effector immune response, which leads to allograft rejection. However, the precise time-frame in which acute rejection is fundamentally triggered by preformed donor-specific memory T cells rather than by de novo activated naive T cells is still to be established. Here, preformed donor-specific alloreactive T-cell responses were evaluated using the IFN-gamma ELISPOT assay in a large consecutive cohort of kidney transplant patients (n = 90), to assess the main clinical variables associated with cellular sensitization and its predominant time-frame impact on allograft outcome, and was further validated in an independent new set of kidney transplant recipients (n = 67). We found that most highly T-cell sensitized patients were elderly patients with particularly poor HLA class-I matching, without any clinically recognizable sensitizing events. While one-year incidence of all types of biopsy-proven acute rejection did not differ between T-cell alloreactive and non-alloreactive patients, Receiver Operating Characteristic curve analysis indicated the first two months after transplantation as the highest risk time period for acute cellular rejection associated with baseline T-cell sensitization. This effect was particularly evident in young and highly alloreactive individuals that did not receive T-cell depletion immunosuppression. Multivariate analysis confirmed preformed T-cell sensitization as an independent predictor of early acute cellular rejection. In summary, monitoring anti-donor T-cell sensitization before transplantation may help to identify patients at increased risk of acute cellular rejection, particularly in the early phases after kidney transplantation, and thus guide decision-making regarding the use of induction therapy.	[Crespo, Elena; Lucia, Marc; Cruzado, Josep M.; Luque, Sergio; Manonelles, Anna; Lloberas, Nuria; Torras, Joan; Grinyo, Josep M.; Bestard, Oriol] Bellvitge Biomed Res Inst IDIBELL, Expt Nephrol Lab, Barcelona, Spain; [Cruzado, Josep M.; Melilli, Edoardo; Manonelles, Anna; Torras, Joan; Grinyo, Josep M.; Bestard, Oriol] Bellvitge Univ Hosp, Dept Nephrol, Renal Transplant Unit, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona	Bestard, O (corresponding author), Bellvitge Biomed Res Inst IDIBELL, Expt Nephrol Lab, Barcelona, Spain.	obestard@bellvitgehospital.cat	Crespo, Elena/ABI-7633-2020; Torras, Joan/AAH-8131-2021; Lloberas, Nuria/U-7497-2019	Crespo, Elena/0000-0002-2121-5196; LUQUE, SONIA/0000-0002-3215-320X; Torras, Juan/0000-0002-1135-7588; Manonelles Montero, Anna/0000-0003-2456-388X; Melilli, Edoardo/0000-0001-6965-3745	European Commission grant from the Biomarker-Driven Immunosuppression Minimization (BIO-DRIM) Consortium (Bio-Drim) [12CEE014]; Spanish Red de Investigacion Renal (REDinREN) [RD12/0021];  [FIS PI10/01786];  [PI13/01263]	European Commission grant from the Biomarker-Driven Immunosuppression Minimization (BIO-DRIM) Consortium (Bio-Drim); Spanish Red de Investigacion Renal (REDinREN); ; 	We acknowledge the expert assistance of our lab technician Gema Cerezo for carefully managing all biological samples, and Yolanda Perez, our bio-bank coordinator at our center. We also thank all the renal transplant unit staff for their support and care of the patients. This work was supported in part by two national public grants (FIS PI10/01786 and PI13/01263), a European Commission grant from the Biomarker-Driven Immunosuppression Minimization (BIO-DRIM) Consortium (Bio-Drim, 12CEE014), and the Spanish Red de Investigacion Renal (REDinREN, RD12/0021).	Adams AB, 2003, J CLIN INVEST, V111, P1887, DOI 10.1172/JCI200317477; Andree H, 2006, J AM SOC NEPHROL, V17, P573, DOI 10.1681/ASN.2005030299; Augustine JJ, 2005, AM J TRANSPLANT, V5, P1971, DOI 10.1111/j.1600-6143.2005.00958.x; Augustine JF, 2007, J AM SOC NEPHROL, V18, P1602, DOI 10.1681/ASN.2006101105; Augustine JJ, 2008, TRANSPLANTATION, V86, P529, DOI 10.1097/TP.0b013e31818046db; Baxter-Lowe LA, 2003, AM SOC HISTOCOMPAT I, V2; Bestard O, 2013, AM J TRANSPLANT, V13, P1880, DOI 10.1111/ajt.12285; Bestard O, 2008, J AM SOC NEPHROL, V19, P1419, DOI 10.1681/ASN.2007050539; Bestard O, 2007, J IMMUNOL, V179, P4901, DOI 10.4049/jimmunol.179.7.4901; Bestard O, 2013, KIDNEY INT, V84, P1226, DOI 10.1038/ki.2013.236; Bestard O, 2011, TRANSPL INT, V24, P451, DOI 10.1111/j.1432-2277.2011.01223.x; Brehm MA, 2003, J IMMUNOL, V170, P4077, DOI 10.4049/jimmunol.170.8.4077; Brook MO, 2006, TRANSPLANTATION, V82, P1, DOI 10.1097/01.tp.0000226082.17507.da; Cherkassky L, 2011, AM J TRANSPLANT, V11, P1388, DOI 10.1111/j.1600-6143.2011.03540.x; Cicin-Sain L, 2010, J IMMUNOL, V184, P6739, DOI 10.4049/jimmunol.0904193; Gamadia LE, 2004, TRANSPLANTATION, V77, P1879, DOI 10.1097/01.tp.0000131158.81346.64; Gebel HM, 2000, TRANSPLANTATION, V69, P1370, DOI 10.1097/00007890-200004150-00027; Heeger PS, 2003, AM J TRANSPLANT, V3, P525, DOI 10.1034/j.1600-6143.2003.00123.x; Hricik DE, 2003, AM J TRANSPLANT, V3, P878, DOI 10.1034/j.1600-6143.2003.00132.x; Hricik DE, 2013, TRANSPLANTATION, V95, P1254, DOI 10.1097/TP.0b013e31828ad866; Issa F, 2010, EXPERT REV CLIN IMMU, V6, P155, DOI 10.1586/ECI.09.64; Kim SH, 2007, TRANSPL P, V39, P3057, DOI 10.1016/j.transproceed.2007.06.080; Kim SK, 2002, J IMMUNOL, V169, P90, DOI 10.4049/jimmunol.169.1.90; Kohlmeier JE, 2010, J IMMUNOL, V185, P3456, DOI 10.4049/jimmunol.1001745; Martins PNA, 2014, INT REV IMMUNOL, V33, P162, DOI 10.3109/08830185.2013.829469; Nickel P, 2004, TRANSPLANTATION, V78, P1640, DOI 10.1097/01.TP.0000144057.31799.6A; Pearl JP, 2005, AM J TRANSPLANT, V5, P465, DOI 10.1111/j.1600-6143.2005.00759.x; Poggio ED, 2007, TRANSPLANTATION, V83, P847, DOI 10.1097/01.tp.0000258730.75137.39; Poggio ED, 2006, J AM SOC NEPHROL, V17, P564, DOI 10.1681/ASN.2005030293; Trzonkowski P, 2008, AM J TRANSPLANT, V8, P338, DOI 10.1111/j.1600-6143.2007.02078.x; Valujskikh A, 2007, ADV EXP MED BIOL, V601, P247; Zeevi A, 2007, AM J TRANSPLANT, V7, P471, DOI 10.1111/j.1600-6143.2006.01641.x	32	45	46	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117618	10.1371/journal.pone.0117618	http://dx.doi.org/10.1371/journal.pone.0117618			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689405	Green Published, gold, Green Submitted			2022-12-26	WOS:000350322700063
J	Long, Z; Chen, Z; Wang, CR; Huang, FZ; Peng, HR; Hou, X; Ding, DX; Ye, W; Wang, JL; Pan, Q; Li, JD; Xia, K; Tang, BS; Ashizawa, T; Jiang, H				Long, Zhe; Chen, Zhao; Wang, Chunrong; Huang, Fengzhen; Peng, Huirong; Hou, Xuan; Ding, Dongxue; Ye, Wei; Wang, Junling; Pan, Qian; Li, Jiada; Xia, Kun; Tang, Beisha; Ashizawa, Tetsuo; Jiang, Hong			Two Novel SNPs in ATXN3 3 ' UTR May Decrease Age at Onset of SCA3/MJD in Chinese Patients	PLOS ONE			English	Article								Spinocerebellar ataxia type 3 (SCA3), or Machado-Joseph disease (MJD), is an autosomal dominantly-inherited disease that produces progressive problems with movement. It is caused by the expansion of an area of CAG repeats in a coding region of ATXN3. The number of repeats is inversely associated with age at disease onset (AO) and is significantly associated with disease severity; however, the degree of CAG expansion only explains 50 to 70% of variance in AO. We tested two SNPs, rs709930 and rs910369, in the 3' UTR of ATXN3 gene for association with SCA3/MJD risk and with SCA3/MJD AO in an independent cohort of 170 patients with SCA3/MJD and 200 healthy controls from mainland China. rs709930 genotype frequencies were statistically significantly different between patients and controls (p = 0.001, alpha = 0.05). SCA3/MJD patients carrying the rs709930 A allele and rs910369 T allele experienced an earlier onset, with a decrease in AO of approximately 2 to 4 years. The two novel SNPs found in this study might be genetic modifiers for AO in SCA3/MJD.	[Long, Zhe; Chen, Zhao; Wang, Chunrong; Huang, Fengzhen; Peng, Huirong; Hou, Xuan; Ding, Dongxue; Ye, Wei; Wang, Junling; Tang, Beisha; Jiang, Hong] Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha 410008, Hunan, Peoples R China; [Wang, Junling; Tang, Beisha; Jiang, Hong] Cent S Univ, Key Lab Hunan Prov Neurodegenerat Disorders, Changsha 410008, Hunan, Peoples R China; [Wang, Junling; Pan, Qian; Li, Jiada; Xia, Kun; Tang, Beisha; Jiang, Hong] Cent S Univ, State Key Lab Med Genet, Changsha 410078, Hunan, Peoples R China; [Ashizawa, Tetsuo] Univ Florida, Dept Neurol, Gainesville, FL USA; [Wang, Chunrong] Xiangtan Cent Hosp, Dept Neurol, Xiangtan 411100, Hunan, Peoples R China; [Huang, Fengzhen] Univ South China, Peoples Hosp Chenzhou 1, Dept Neurol, Chenzhou 423000, Hunan, Peoples R China; [Huang, Fengzhen] Univ South China, Peoples Hosp Chenzhou 1, Inst Translat Med, Chenzhou 423000, Hunan, Peoples R China	Central South University; Central South University; Central South University; State University System of Florida; University of Florida; University of South China; University of South China	Jiang, H (corresponding author), Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha 410008, Hunan, Peoples R China.	jianghong73868@126.com	XIA, KUN/AAO-3525-2020	Li, Jia-Da/0000-0002-4236-3518	National Basic Research Program (973 Program) [2012CB944601, 2012CB517902, 2011CB510002]; New Century Excellent Talents in University [NCET-10-0836]; National Natural Science Foundation of China [81410308019, 81471156, 81271260, 30971585]; Hunan Funds for Distinguished Young Scientists [14JJ1008]; Xinjiang Natural Science Foundation [201318101-4]; Undergraduate Innovation Project of Central South University [YB13028, 201410533324]; Graduate Innovation Project of Central South University [2014zzts078]; High-Level Medical Personnel of Hunan Province 225 Project	National Basic Research Program (973 Program)(National Basic Research Program of China); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Funds for Distinguished Young Scientists; Xinjiang Natural Science Foundation; Undergraduate Innovation Project of Central South University; Graduate Innovation Project of Central South University; High-Level Medical Personnel of Hunan Province 225 Project	This study was supported by the National Basic Research Program (973 Program) (Nos. 2012CB944601, 2012CB517902 and 2011CB510002 to Hong Jiang), the New Century Excellent Talents in University (No. NCET-10-0836 to Hong Jiang), the National Natural Science Foundation of China (Nos. 81410308019, 81471156, 81271260, 30971585 to Hong Jiang), Hunan Funds for Distinguished Young Scientists (No. 14JJ1008 to Hong Jiang), Xinjiang Natural Science Foundation (No. 201318101-4 to Hong Jiang), the Undergraduate Innovation Project of Central South University (No. YB13028, 201410533324 to Hong Jiang), Graduate Innovation Project of Central South University (No. 2014zzts078 to Zhao Chen) and High-Level Medical Personnel of Hunan Province 225 Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bettencourt C, 2012, CEREBELLUM, V11, P1045, DOI 10.1007/s12311-012-0373-7; Bettencourt C, 2011, ARCH NEUROL-CHICAGO, V68, P1580, DOI 10.1001/archneurol.2011.636; Carvalho DR, 2008, PEDIATR NEUROL, V38, P296, DOI 10.1016/j.pediatrneurol.2007.12.006; Costa MD, 2012, PROG NEUROBIOL, V97, P239, DOI 10.1016/j.pneurobio.2011.11.006; du Montcel ST, 2014, BRAIN, V137, P2444, DOI 10.1093/brain/awu174; Durr A, 1996, ANN NEUROL, V39, P490, DOI 10.1002/ana.410390411; MACIEL P, 1995, AM J HUM GENET, V57, P54; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Peng HR, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.03.020; SEQUEIROS J, 1993, ADV NEUROL, V61, P139; Shi YT, 2014, INT J NEUROSCI, V124, P97, DOI 10.3109/00207454.2013.827679; Wang Junling, 2011, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V36, P482, DOI 10.3969/j.issn.1672-7347.2011.06.003; Warrenburg BPCV, 2005, ANN NEUROL, V57, P505, DOI 10.1002/ana.20424	13	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117488	10.1371/journal.pone.0117488	http://dx.doi.org/10.1371/journal.pone.0117488			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689313	Green Published, Green Submitted, gold			2022-12-26	WOS:000350322700049
J	Monette, MM; Evans, DL; Krunkosky, T; Camus, A; Jaso-Friedmann, L				Monette, Margaret Mariscal; Evans, Donald Lee; Krunkosky, Thomas; Camus, Alvin; Jaso-Friedmann, Liliana			Nonspecific Cytotoxic Cell Antimicrobial Protein (NCAMP-1): A Novel Alarmin Ligand Identified in Zebrafish	PLOS ONE			English	Article							DENDRITIC CELLS; RECEPTOR; RELEASE; ATP; ACTIVATION; PEPTIDE; MODEL; LIPOPOLYSACCHARIDE; CATHELICIDIN; EXPRESSION	Cells from the coelomic cavity of adult zebrafish (zf) were used to study the alarmin-like activities of nonspecific cytotoxic cell antimicrobial protein-1 (NCAMP-1). Immunohistochemistry studies using polyclonal anti-NCAMP-1 identified constitutive NCAMP-1 in epithelial cells of the zf anterior kidney, in liver parenchyma and in the lamina propria of the intestine. NCAMP-1 was also located in the cytosol of mononuclear cells in these tissues. Cytosolic NCAMP-1 was detected in a diverse population of coelomic cells (CC) using confocal microscopy and polyclonal anti-NCAMP-1 staining. Large mononuclear and heterophil-like CC had intracellular NCAMP-1. These studies indicated that NCAMP-1 is constitutively found in epithelial cells and in ZFCC. To establish a relationship between NCAMP-1 and the alarmin functions of ATP, a stimulation-secretion model was initiated using zf coelomic cells (ZFCC). ZFCCs treated with the alarmin ATP secreted NCAMP-1 into culture supernatants. Treatment of ZFCC with either ATP or NCAMP-1 activated purinergic receptor induced pore formation detected by the ZFCC uptake of the dye YO-PRO-1. ATP induced YO-PRO-1 uptake was inhibited by antagonists oxidized-ATP, KN62, or CBB. These antagonists did not compete with NCAMP-1 induced YO-PRO-1 uptake. Binding of ZFCC by both ATP and NCAMP-1 produced an influx of Ca2+. Combined treatment of ZFCC with ATP and NCAMP-1 increased target cell cytotoxicity. Individually NCAMP-1 or ATP treatment did not produce target cell damage. Similar to ATP, NCAMP-1 activates cellular pore formation, calcium influx and cytotoxicity.	[Monette, Margaret Mariscal; Evans, Donald Lee; Jaso-Friedmann, Liliana] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA; [Krunkosky, Thomas] Univ Georgia, Coll Vet Med, Dept Vet Biosci & Diagnost Imaging, Athens, GA USA; [Camus, Alvin] Univ Georgia, Coll Vet Med, Dept Pathol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Jaso-Friedmann, L (corresponding author), Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA.	ljaso@uga.edu			National Science Foundation	National Science Foundation(National Science Foundation (NSF))	This material is based upon work supported while serving at the National Science Foundation. Any opinion, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg KM, 2008, J INVEST DERMATOL, V128, P917, DOI 10.1038/sj.jid.5701099; Bao BL, 2006, MOL IMMUNOL, V43, P367, DOI 10.1016/j.molimm.2005.02.014; Barbazuk WB, 2000, GENOME RES, V10, P1351, DOI 10.1101/gr.144700; Bianchi BR, 1999, EUR J PHARMACOL, V376, P127, DOI 10.1016/S0014-2999(99)00350-7; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Bonaldi T, 2003, EMBO J, V22, P5551, DOI 10.1093/emboj/cdg516; Cole AM, 2000, ANTIMICROB AGENTS CH, V44, P2039, DOI 10.1128/AAC.44.8.2039-2045.2000; Dorschner RA, 2001, J INVEST DERMATOL, V117, P91, DOI 10.1046/j.1523-1747.2001.01340.x; Elssner A, 2004, J IMMUNOL, V172, P4987, DOI 10.4049/jimmunol.172.8.4987; Evans DL, 2005, DEV COMP IMMUNOL, V29, P1049, DOI 10.1016/j.dci.2005.03.011; Evans DL, 2009, J LEUKOCYTE BIOL, V86, P133, DOI [10.1189/JLB.1108682, 10.1189/jlb.1108682]; Flohe SB, 2008, INNATE IMMUN-LONDON, V14, P333, DOI 10.1177/1753425908100016; Gallucci S, 2001, CURR OPIN IMMUNOL, V13, P114, DOI 10.1016/S0952-7915(00)00191-6; Gardella S, 2002, EMBO REP, V3, P995, DOI 10.1093/embo-reports/kvf198; HOGQUIST KA, 1991, J IMMUNOL, V147, P2181; Jaso-Friedmann L, 2014, J LEUKOCYTE BIOL, V95, P785, DOI 10.1189/jlb.0313171; Jiang LH, 2000, MOL PHARMACOL, V58, P82, DOI 10.1124/mol.58.1.82; Kaur H, 2005, SCAND J IMMUNOL, V62, P361, DOI 10.1111/j.1365-3083.2005.01665.x; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Le Feuvre RA, 2002, J BIOL CHEM, V277, P3210, DOI 10.1074/jbc.M104388200; Lin B, 2007, MOL IMMUNOL, V44, P295, DOI 10.1016/j.molimm.2006.03.001; Lopez-Castejon G, 2007, MOL IMMUNOL, V44, P1286, DOI 10.1016/j.molimm.2006.05.015; Meeker ND, 2008, DEV COMP IMMUNOL, V32, P745, DOI 10.1016/j.dci.2007.11.011; Mehta VB, 2001, J BIOL CHEM, V276, P3820, DOI 10.1074/jbc.M006814200; Michel AD, 2000, BRIT J PHARMACOL, V130, P513, DOI 10.1038/sj.bjp.0703368; Miller JD, 2004, ACTA TROP, V91, P53, DOI 10.1016/j.actatropica.2003.10.020; Moss LD, 2009, DEV COMP IMMUNOL, V33, P1077, DOI 10.1016/j.dci.2009.05.009; MURGIA M, 1993, J BIOL CHEM, V268, P8199; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Oppenheim JJ, 2005, CURR OPIN IMMUNOL, V17, P359, DOI 10.1016/j.coi.2005.06.002; Palic D, 2007, DEV COMP IMMUNOL, V31, P805, DOI 10.1016/j.dci.2006.11.010; Palic D, 2007, J IMMUNOL METHODS, V319, P87, DOI 10.1016/j.jim.2006.11.003; Palumbo R, 2004, J CELL BIOL, V164, P441, DOI 10.1083/jcb.200304135; Pelegrin P, 2004, DEV COMP IMMUNOL, V28, P229, DOI 10.1016/j.dci.2003.08.002; Pelegrin P, 2001, CYTOKINE, V16, P67, DOI 10.1006/cyto.2001.0949; Phelps HA, 2005, ZEBRAFISH, V2, P87, DOI 10.1089/zeb.2005.2.87; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Reimann J, 2004, IMMUNOL REV, V199, P54, DOI 10.1111/j.0105-2896.2004.00136.x; Roberts JA, 2004, J BIOL CHEM, V279, P9043, DOI 10.1074/jbc.M308964200; Robinette D, 1998, CELL MOL LIFE SCI, V54, P467, DOI 10.1007/s000180050175; Rovere-Querini P, 2008, EMBO, V5, P825; Schilling WP, 1999, AM J PHYSIOL-CELL PH, V277, pC766, DOI 10.1152/ajpcell.1999.277.4.C766; Semino C, 2005, BLOOD, V106, P609, DOI 10.1182/blood-2004-10-3906; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Traver D, 2003, ADV IMMUNOL, V81, P253; Vabulas RM, 2002, J BIOL CHEM, V277, P15107, DOI 10.1074/jbc.M111204200; Vabulas RM, 2002, J BIOL CHEM, V277, P20847, DOI 10.1074/jbc.M200425200; Vojtech LN, 2009, INFECT IMMUN, V77, P914, DOI 10.1128/IAI.01201-08; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; Yang D, 2010, BBA-GENE REGUL MECH, V1799, P157, DOI 10.1016/j.bbagrm.2009.11.002; Yang D, 2009, TRENDS IMMUNOL, V30, P531, DOI 10.1016/j.it.2009.07.004; Zanetti M, 2004, J LEUKOCYTE BIOL, V75, P39, DOI 10.1189/jlb.0403147; Zhang X, 2008, J PATHOL, V214, P161, DOI 10.1002/path.2284	55	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0116576	10.1371/journal.pone.0116576	http://dx.doi.org/10.1371/journal.pone.0116576			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689842	gold, Green Published, Green Submitted			2022-12-26	WOS:000350322700016
J	Steinhilber, J; Bonin, M; Walter, M; Fend, F; Bonzheim, I; Quintanilla-Martinez, L				Steinhilber, Julia; Bonin, Michael; Walter, Michael; Fend, Falko; Bonzheim, Irina; Quintanilla-Martinez, Leticia			Next-Generation Sequencing Identifies Deregulation of MicroRNAs Involved in Both Innate and Adaptive Immune Response in ALK plus ALCL	PLOS ONE			English	Article							ANAPLASTIC LYMPHOMA KINASE; BINDING-PROTEIN-BETA; LARGE-CELL LYMPHOMAS; C/EBP-BETA; CYCLIN D1; EXPRESSION; MIRNAS; SURVIVAL; DIFFERENTIATION; PROLIFERATION	Anaplastic large cell lymphoma (ALCL) is divided into two systemic diseases according to the expression of the anaplastic lymphoma kinase (ALK). We investigated the differential expression of miRNAs between ALK+ ALCL, ALK-ALCL cells and normal T-cells using next generation sequencing (NGS). In addition, a C/EBP beta-dependent miRNA profile was generated. The data were validated in primary ALCL cases. NGS identified 106 miRNAs significantly differentially expressed between ALK+ and ALK-ALCL and 228 between ALK+ ALCL and normal T-cells. We identified a signature of 56 miRNAs distinguishing ALK+ ALCL, ALK-ALCL and T-cells. The top candidates significant differentially expressed between ALK+ and ALK-ALCL included 5 upregulated miRNAs: miR-340, miR-203, miR-135b, miR-182, miR-183; and 7 downregulated: miR-196b, miR-155, miR-146a, miR-424, miR-503, miR-424*, miR-542-3p. The miR-17-92 cluster was also upregulated in ALK+ cells. Additionally, we identified a signature of 3 miRNAs significantly regulated by the transcription factor C/EBP beta, which is specifically overexpressed in ALK+ ALCL, including the miR-181 family. Of interest, miR-181a, which regulates T-cell differentiation and modulates TCR signalling strength, was significantly downregulated in ALK+ ALCL cases. In summary, our data reveal a miRNA signature linking ALK+ ALCL to a deregulated immune response and may reflect the abnormal TCR antigen expression known in ALK+ ALCL.	[Steinhilber, Julia; Fend, Falko; Bonzheim, Irina; Quintanilla-Martinez, Leticia] Inst Pathol & Neuropathol, Tubingen, Germany; [Steinhilber, Julia; Fend, Falko; Bonzheim, Irina; Quintanilla-Martinez, Leticia] Ctr Comprehens Canc, Tubingen, Germany; [Bonin, Michael; Walter, Michael] Univ Tubingen, Univ Hosp Tubingen, MFT Serv, Dept Med Genet & Appl Genom, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Quintanilla-Martinez, L (corresponding author), Inst Pathol & Neuropathol, Tubingen, Germany.	irina.bonzheim@med.uni-tuebingen.de; Leticia.Quintanilla-Fend@med.uni-tuebingen.de			University of Tubingen [SFB 685, TP B8]; IZKF fortune program, University of Tubingen [1924-0-0]	University of Tubingen; IZKF fortune program, University of Tubingen	This work was supported by the SFB 685 "Immunotherapy" of the University of Tubingen, TP B8 (LQM and FF, http://www.sfb685.de/) and by the IZKF fortune program (1924-0-0), University of Tubingen (IB, https://www.medizin.uni-tuebingen.de/Forschung/Forschungsf%C3%B6rderung/Interne+Forschungsf%C3%B6rderung/fort%C3% BCne.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastasov N, 2010, HAEMATOL-HEMATOL J, V95, P760, DOI 10.3324/haematol.2009.014050; Anastasov Natasa, 2009, J Hematop, V2, P9, DOI 10.1007/s12308-008-0020-x; Baehrecke EH, 2003, CURR BIOL, V13, pR473, DOI 10.1016/S0960-9822(03)00405-6; Bai RY, 2000, BLOOD, V96, P4319, DOI 10.1182/blood.V96.13.4319; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bellon M, 2009, BLOOD, V113, P4914, DOI 10.1182/blood-2008-11-189845; Bi YJ, 2009, J CELL PHYSIOL, V218, P467, DOI 10.1002/jcp.21639; Bonzheim I, 2004, BLOOD, V104, P3358, DOI 10.1182/blood-2004-03-1037; Bonzheim I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064544; Buck M, 2001, MOL CELL, V8, P807, DOI 10.1016/S1097-2765(01)00374-4; Campo E, 2011, BLOOD, V117, P5019, DOI 10.1182/blood-2011-01-293050; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Chiarle R, 2003, BLOOD, V101, P1919, DOI 10.1182/blood-2002-05-1343; Chiarle R, 2008, NAT REV CANCER, V8, P11, DOI 10.1038/nrc2291; Cock PJA, 2010, NUCLEIC ACIDS RES, V38, P1767, DOI 10.1093/nar/gkp1137; Desjobert C, 2011, BLOOD, V117, P6627, DOI 10.1182/blood-2010-09-301994; Drexler HG, 2004, LEUKEMIA, V18, P1569, DOI 10.1038/sj.leu.2403465; Facchetti F., 2008, WHO CLASSIFICATION T, V4th ed; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fukao T, 2007, CELL, V129, P617, DOI 10.1016/j.cell.2007.02.048; Gao J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065138; Greenbaum LE, 1998, J CLIN INVEST, V102, P996, DOI 10.1172/JCI3135; Hackenberg M, 2011, NUCLEIC ACIDS RES, V39, pW132, DOI 10.1093/nar/gkr247; Hackenberg M, 2009, NUCLEIC ACIDS RES, V37, pW68, DOI 10.1093/nar/gkp347; Huber R, 2012, CELL SIGNAL, V24, P1287, DOI 10.1016/j.cellsig.2012.02.007; Ito M, 2014, BLOOD, V123, P1499, DOI 10.1182/blood-2013-09-527739; Iwahara T, 1997, ONCOGENE, V14, P439, DOI 10.1038/sj.onc.1200849; Kinney MC, 2011, ARCH PATHOL LAB MED, V135, P19, DOI 10.1043/2010-0507-RAR.1; Klier M, 2008, LEUKEMIA, V22, P2097, DOI 10.1038/leu.2008.213; Kluiver J, 2006, LEUKEMIA, V20, P1931, DOI 10.1038/sj.leu.2404387; Koch I, 2006, DIAGN MOL PATHOL, V15, P149, DOI 10.1097/01.pdm.0000213450.99655.54; Kriegel AJ, 2012, PHYSIOL GENOMICS, V44, P237, DOI 10.1152/physiolgenomics.00141.2011; Kutty RK, 2010, MOL VIS, V16, P1475; Lamant L, 2007, BLOOD, V109, P2156, DOI 10.1182/blood-2006-06-028969; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Liu B, 2014, BRIEF BIOINFORM, V15, P1, DOI 10.1093/bib/bbs075; Liu CL, 2013, BLOOD, V122, P2083, DOI 10.1182/blood-2012-08-447375; Lodish HF, 2008, NAT REV IMMUNOL, V8, P120, DOI 10.1038/nri2252; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Matsuyama H, 2011, BLOOD, V118, P6881, DOI 10.1182/blood-2011-05-354654; Merkel O, 2010, P NATL ACAD SCI USA, V107, P16228, DOI 10.1073/pnas.1009719107; Mukherjee A, 2014, J VIROL, V88, P7929, DOI 10.1128/JVI.00787-14; Palmer RH, 2009, BIOCHEM J, V420, P345, DOI 10.1042/BJ20090387; Piva R, 2006, J CLIN INVEST, V116, P3171, DOI 10.1172/JCI29401; Quintanilla-Martinez L, 2006, BLOOD, V108, P2029, DOI 10.1182/blood-2005-10-014258; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Rusca N, 2012, MOL CELL BIOL, V32, P4432, DOI 10.1128/MCB.00824-12; Schambach A, 2006, MOL THER, V13, P391, DOI 10.1016/j.ymthe.2005.08.012; Schickel R, 2008, ONCOGENE, V27, P5959, DOI 10.1038/onc.2008.274; SHIMAKAGE M, 1993, INTERVIROLOGY, V36, P215, DOI 10.1159/000150340; Sonkoly E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000610; Specht K, 2002, CLIN CANCER RES, V8, P2902; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Xi SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013764; Yang LL, 2012, J EXP MED, V209, P1655, DOI 10.1084/jem.20112218; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Zhu SY, 2002, P NATL ACAD SCI USA, V99, P207, DOI 10.1073/pnas.012437299	60	23	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117780	10.1371/journal.pone.0117780	http://dx.doi.org/10.1371/journal.pone.0117780			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25688981	Green Submitted, Green Published, gold			2022-12-26	WOS:000350322700072
J	Zhao, WJ; Wang, YP; Liu, SY; Huang, JJ; Zhai, ZX; He, C; Ding, JM; Wang, J; Wang, HJ; Fan, WB; Zhao, JG; Meng, H				Zhao, Wenjing; Wang, Yapeng; Liu, Shuyun; Huang, Jiaojiao; Zhai, Zhengxiao; He, Chuan; Ding, Jinmei; Wang, Jun; Wang, Huijuan; Fan, Weibing; Zhao, Jianguo; Meng, He			The Dynamic Distribution of Porcine Microbiota across Different Ages and Gastrointestinal Tract Segments	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; GUT MICROBIOTA; BACTERIAL COMMUNITY; DIVERSITY; STABILITY; OBESE; GENE; MICE	Metagenome of gut microbes has been implicated in metabolism, immunity, and health maintenance of its host. However, in most of previous studies, the microbiota was sampled from feces instead of gastrointestinal (GI) tract. In this study, we compared the microbial populations from feces at four different developmental stages and contents of four intestinal segments at maturity to examine the dynamic shift of microbiota in pigs and investigated whether adult porcine fecal samples could be used to represent samples of the GI tract. Analysis results revealed that the ratio of Firmicutes to Bacteroidetes from the feces of the older pigs (2-, 3-, 6-month) were 10 times higher compared to those from piglets (1-month). As the pigs matured, so did it seem that the composition of microbiome became more stable in feces. In adult pigs, there were significant differences in microbial profiles between the contents of the small intestine and large intestine. The dominant genera in the small intestine belonged to aerobe or facultative anaerobe categories, whereas the main genera in the large intestine were all anaerobes. Compared to the GI tract, the composition of microbiome was quite different in feces. The microbial profile in large intestine was more similar to feces than those in the small intestine, with the similarity of 0.75 and 0.38 on average, respectively. Microbial functions, predicted by metagenome profiles, showed the enrichment associated with metabolism pathway and metabolic disease in large intestine and feces while higher abundance of infectious disease, immune function disease, and cancer in small intestine. Fecal microbes also showed enriched function in metabolic pathways compared to microbes from pooled gut contents. Our study extended the understanding of dynamic shift of gut microbes during pig growth and also characterized the profiles of bacterial communities across GI tracts of mature pigs.	[Zhao, Wenjing; Liu, Shuyun; Zhai, Zhengxiao; He, Chuan; Ding, Jinmei; Meng, He] Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai Key Lab Vet Biotechnol, Shanghai 200030, Peoples R China; [Wang, Yapeng; Huang, Jiaojiao; Zhao, Jianguo] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China; [He, Chuan; Wang, Jun; Wang, Huijuan; Fan, Weibing] Shanghai Personal Biotechnol Ltd Co, Shanghai, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences; Institute of Zoology, CAS	Zhao, JG (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China.	zhaojg@ioz.ac.cn; menghe@sjtu.edu.cn	ding, jin/GVT-5062-2022; He, Chuan/AAN-4356-2020; wang, hui/GRS-4730-2022	He, Chuan/0000-0002-8532-2898; 	National High Technology Research and Development Program of China [2011AA100901]; National Science Foundation of China [31272430]; Agriculture Development through Science and Technology Key Project of Shanghai [2012, 2-3]; Shanghai Personal Biotechnology Limited Company	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agriculture Development through Science and Technology Key Project of Shanghai; Shanghai Personal Biotechnology Limited Company	This work was supported by (1) the National High Technology Research and Development Program of China (grant No. 2011AA100901), http://program.most.gov.cn/; (2) the National Science Foundation of China (grant No. 31272430), http://www.nsfc.gov.cn/; and (3) Agriculture Development through Science and Technology Key Project of Shanghai (grant No. 2012,2-3), http://www.xmgl.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-authors Chuan He, Jun Wang, Huijuan Wang, and Weibing Fan are employed by Shanghai Personal Biotechnology Limited Company. Shanghai Personal Biotechnology Limited Company provided support in the form of salaries for authors Chuan He, Jun Wang, Huijuan Wang, and Weibing Fan but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlerberth I, 2009, ACTA PAEDIATR, V98, P229, DOI 10.1111/j.1651-2227.2008.01060.x; Allen HK, 2011, MBIO, V2, DOI 10.1128/mBio.00260-11; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Bauer Eva, 2006, Current Issues in Intestinal Microbiology, V7, P35; Boudry G, 2004, J NUTR, V134, P2256, DOI 10.1093/jn/134.9.2256; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Choi JH, 2014, POULTRY SCI, V93, P1942, DOI 10.3382/ps.2014-03974; Conte MP, 2006, GUT, V55, P1760, DOI 10.1136/gut.2005.078824; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; David LA, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-7-r89; DiBaise JK, 2008, MAYO CLIN PROC, V83, P460, DOI 10.4065/83.4.460; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Gu SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074957; Guilloteau P, 2010, NUTR RES REV, V23, P4, DOI 10.1017/S0954422410000077; Guo X, 2008, LETT APPL MICROBIOL, V47, P367, DOI 10.1111/j.1472-765X.2008.02408.x; Hopwood DE, 2003, WEANING THE PIG: CONCEPTS AND CONSEQUENCES, P199; Kohl KD, 2014, ENVIRON MICROBIOL, V16, P2869, DOI 10.1111/1462-2920.12376; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li XQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040666; Liu XF, 2014, CURR MICROBIOL, V68, P657, DOI 10.1007/s00284-014-0528-5; Looft T, 2014, ISME J, V8, P1566, DOI 10.1038/ismej.2014.12; Looft T, 2012, P NATL ACAD SCI USA, V109, P1691, DOI 10.1073/pnas.1120238109; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Pang XY, 2007, ISME J, V1, P156, DOI 10.1038/ismej.2007.23; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Penders J, 2007, GUT, V56, P661, DOI 10.1136/gut.2006.100164; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Pfefferle Petra Ina, 2014, F1000Prime Rep, V6, P11, DOI 10.12703/P6-11; Poroyko V, 2011, NUTR HOSP, V26, P1283, DOI [10.3305/nh.2011.26.6.5362, 10.1590/S0212-16112011000600015]; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Rawls JF, 2006, CELL, V127, P423, DOI 10.1016/j.cell.2006.08.043; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Wei S, 2013, POULTRY SCI, V92, P671, DOI 10.3382/ps.2012-02822; Zhao LL, 2013, SCI REP-UK, V3, DOI 10.1038/srep01163; Zoetendal EG, 1998, APPL ENVIRON MICROB, V64, P3854	42	219	233	10	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117441	10.1371/journal.pone.0117441	http://dx.doi.org/10.1371/journal.pone.0117441			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25688558	Green Submitted, Green Published, gold			2022-12-26	WOS:000350322700044
J	Singh, VK; Vaish, M; Johansson, TR; Baum, KR; Ring, RP; Singh, S; Shukla, SK; Moskovitz, J				Singh, Vineet K.; Vaish, Manisha; Johansson, Trintje R.; Baum, Kyle R.; Ring, Robert P.; Singh, Saumya; Shukla, Sanjay K.; Moskovitz, Jackob			Significance of Four Methionine Sulfoxide Reductases in Staphylococcus aureus	PLOS ONE			English	Article							OXIDATIVE STRESS; STREPTOCOCCUS-GORDONII; VIRULENCE DETERMINANT; ENTEROCOCCUS-FAECALIS; RESISTANCE; EXPRESSION; MSRA; GENE; IDENTIFICATION; MAINTENANCE	Staphylococcus aureus is a major human pathogen and emergence of antibiotic resistance in clinical staphylococcal isolates raises concerns about our ability to control these infections. Cell wall-active antibiotics cause elevated synthesis of methionine sulfoxide reductases (Msrs: MsrA1 and MsrB) in S. aureus. MsrA and MsrB enzymes reduce S-epimers and R-epimers of methionine sulfoxide, respectively, that are generated under oxidative stress. In the S. aureus chromosome, there are three msrA genes (msrA1, msrA2 and msrA3) and one msrB gene. To understand the precise physiological roles of Msr proteins in S. aureus, mutations in msrA1, msrA2 and msrA3 and msrB genes were created by site-directed mutagenesis. These mutants were combined to create a triple msrA (msrA1, msrA2 and msrA3) and a quadruple msrAB (msrA1, msrA2, msrA3, msrB) mutant. These mutants were used to determine the roles of Msr proteins in staphylococcal growth, antibiotic resistance, adherence to human lung epithelial cells, pigment production, and survival in mice relative to the wild-type strains. MsrA1-deficient strains were sensitive to oxidative stress conditions, less pigmented and less adherent to human lung epithelial cells, and showed reduced survival in mouse tissues. In contrast, MsrB-deficient strains were resistant to oxidants and were highly pigmented. Lack of MsrA2 and MsrA3 caused no apparent growth defect in S. aureus. In complementation experiments with the triple and quadruple mutants, it was MsrA1 and not MsrB that was determined to be critical for adherence and phagocytic resistance of S. aureus. Overall, the data suggests that MsrA1 may be an important virulence factor and MsrB probably plays a balancing act to counter the effect of MsrA1 in S. aureus.	[Singh, Vineet K.; Vaish, Manisha; Johansson, Trintje R.; Baum, Kyle R.; Ring, Robert P.; Singh, Saumya] AT Still Univ Hlth Sci, Dept Microbiol & Immunol, Kirksville, MO 63501 USA; [Shukla, Sanjay K.] Marshfield Clin Res Fdn, Marshfield, WI USA; [Moskovitz, Jackob] Univ Kansas, Sch Pharm, Dept Pharmacol & Toxicol, Lawrence, KS 66045 USA	A.T. Still University of Health Sciences; University of Kansas	Singh, VK (corresponding author), AT Still Univ Hlth Sci, Dept Microbiol & Immunol, Kirksville, MO 63501 USA.	vsingh@atsu.edu			Warner/Fermaturo grant Fund; A.T. Still University Board of Trustees Research Fund; National Institutes of Health [1R15AI090680-01]; Kirksville College of Osteopathic Medicine Biomedical Sciences Graduate Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI090680] Funding Source: NIH RePORTER	Warner/Fermaturo grant Fund; A.T. Still University Board of Trustees Research Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kirksville College of Osteopathic Medicine Biomedical Sciences Graduate Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by a Warner/Fermaturo grant and A.T. Still University Board of Trustees Research Funds, by grant 1R15AI090680-01 from the National Institutes of Health to VKS, and grants from the Kirksville College of Osteopathic Medicine Biomedical Sciences Graduate Program to TRJ and KRB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar J, 2010, MEDICINE, V89, P117, DOI 10.1097/MD.0b013e3181d5453d; Atack JM, 2008, MICROBIOL-SGM, V154, P2219, DOI 10.1099/mic.0.2008/019711-0; AUGUSTIN J, 1992, EUR J BIOCHEM, V204, P1149, DOI 10.1111/j.1432-1033.1992.tb16740.x; Ayala A, 1996, J BIOL CHEM, V271, P23105, DOI 10.1074/jbc.271.38.23105; Bong SM, 2010, J BIOL CHEM, V285, P25044, DOI 10.1074/jbc.M110.103119; Brady RA, 2006, INFECT IMMUN, V74, P3415, DOI 10.1128/IAI.00392-06; Clauditz A, 2006, INFECT IMMUN, V74, P4950, DOI 10.1128/IAI.00204-06; Deleo FR, 2009, INFECT DIS CLIN N AM, V23, P17, DOI 10.1016/j.idc.2008.10.003; Denkel LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026974; Dhandayuthapani S, 2001, J BACTERIOL, V183, P5645, DOI 10.1128/JB.183.19.5645-5650.2001; Dhandayuthapani S, 2009, TUBERCULOSIS, V89, pS26, DOI 10.1016/S1472-9792(09)70008-3; Ezraty B, 2005, BBA-PROTEINS PROTEOM, V1703, P221, DOI 10.1016/j.bbapap.2004.08.017; Gordon RJ, 2008, CLIN INFECT DIS, V46, pS350, DOI 10.1086/533591; Grimaud R, 2001, J BIOL CHEM, V276, P48915, DOI 10.1074/jbc.M105509200; Horsburgh MJ, 2002, J BACTERIOL, V184, P5457, DOI 10.1128/JB.184.19.5457-5467.2002; Kavanagh KT, 2014, ANTIMICROB RESIST IN, V3, DOI 10.1186/2047-2994-3-18; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Kuboniwa M, 2006, MOL MICROBIOL, V60, P121, DOI 10.1111/j.1365-2958.2006.05099.x; Lan LF, 2010, J BACTERIOL, V192, P3068, DOI 10.1128/JB.00928-09; Lee WL, 2009, MOL MICROBIOL, V71, P583, DOI 10.1111/j.1365-2958.2008.06548.x; Lei Y, 2011, MOL MICROBIOL, V80, P726, DOI 10.1111/j.1365-2958.2011.07603.x; Liang XD, 2006, INFECT IMMUN, V74, P4655, DOI 10.1128/IAI.00322-06; Liu GY, 2005, J EXP MED, V202, P209, DOI 10.1084/jem.20050846; MARSHALL JH, 1981, J BACTERIOL, V147, P900, DOI 10.1128/JB.147.3.900-913.1981; MEAD DA, 1986, PROTEIN ENG, V1, P67, DOI 10.1093/protein/1.1.67; Mei JM, 1997, MOL MICROBIOL, V26, P399, DOI 10.1046/j.1365-2958.1997.5911966.x; Mishra NN, 2011, ANTIMICROB AGENTS CH, V55, P526, DOI 10.1128/AAC.00680-10; Moskovitz J, 1997, P NATL ACAD SCI USA, V94, P9585, DOI 10.1073/pnas.94.18.9585; Moskovitz J, 2000, J BIOL CHEM, V275, P14167, DOI 10.1074/jbc.275.19.14167; MOSKOVITZ J, 1995, J BACTERIOL, V177, P502, DOI 10.1128/jb.177.3.502-507.1995; Moskovitz J, 2001, P NATL ACAD SCI USA, V98, P12920, DOI 10.1073/pnas.231472998; Oien DB, 2008, CURR TOP DEV BIOL, V80, P93, DOI 10.1016/S0070-2153(07)80003-2; Pang YY, 2014, J INNATE IMMUN, V6, P353, DOI 10.1159/000355915; Pierce D, 2012, AM FAM PHYSICIAN, V85, P981; Romsang A, 2013, J BACTERIOL, V195, P3299, DOI 10.1128/JB.00167-13; RYFFEL C, 1991, J BACTERIOL, V173, P7416, DOI 10.1128/jb.173.23.7416-7422.1991; Saleh M, 2013, EMBO MOL MED, V5, P1852, DOI 10.1002/emmm.201202435; Sasindran SJ, 2007, FUTURE MICROBIOL, V2, P619, DOI 10.2217/17460913.2.6.619; Singer AJ, 2014, NEW ENGL J MED, V370, P1039, DOI 10.1056/NEJMra1212788; Singh Kuldeep, 2012, Int J Microbiol, V2012, P719594, DOI 10.1155/2012/719594; Singh VK, 2008, APPL ENVIRON MICROB, V74, P5882, DOI 10.1128/AEM.00882-08; Singh VK, 2007, MICROBIOL-SGM, V153, P3162, DOI 10.1099/mic.0.2007/009506-0; Singh VK, 2014, CAN J MICROBIOL, V60, P625, DOI 10.1139/cjm-2014-0360; Singh VK, 2003, MICROBIOL-SGM, V149, P2739, DOI 10.1099/mic.0.26442-0; Singh VK, 2003, INT J ANTIMICROB AG, V21, P256, DOI 10.1016/S0924-8579(02)00359-X; Singh VK, 2001, FEMS MICROBIOL LETT, V199, P79, DOI 10.1016/S0378-1097(01)00163-X; Singh VK, 2001, MICROBIOL-SGM, V147, P3037, DOI 10.1099/00221287-147-11-3037; SMYTH DG, 1964, BIOCHEM J, V91, P589, DOI 10.1042/bj0910589; Vaish Manisha, 2013, Int J Microbiol, V2013, P312146, DOI 10.1155/2013/312146; Voyich JA, 2005, J IMMUNOL, V175, P3907, DOI 10.4049/jimmunol.175.6.3907; Watkins RR, 2012, J MED MICROBIOL, V61, P1179, DOI 10.1099/jmm.0.043513-0; Wizemann TM, 1996, P NATL ACAD SCI USA, V93, P7985, DOI 10.1073/pnas.93.15.7985; Zhao C, 2013, MICROBIOL-SGM, V159, P615, DOI 10.1099/mic.0.065037-0; Zhao C, 2010, INFECT IMMUN, V78, P3889, DOI 10.1128/IAI.00165-10	54	30	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117594	10.1371/journal.pone.0117594	http://dx.doi.org/10.1371/journal.pone.0117594			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680075	Green Published, gold, Green Submitted			2022-12-26	WOS:000350682600074
J	Sinreih, M; Zukunft, S; Sosic, I; Cesar, J; Gobec, S; Adamski, J; Rizner, TL				Sinreih, Masa; Zukunft, Sven; Sosic, Izidor; Cesar, Jozko; Gobec, Stanislav; Adamski, Jerzy; Rizner, Tea Lanisnik			Combined Liquid Chromatography-Tandem Mass Spectrometry Analysis of Progesterone Metabolites	PLOS ONE			English	Article							KETO REDUCTASE SUPERFAMILY; ENDOMETRIAL CANCER; NEUROACTIVE STEROIDS; RECEPTOR; AKR1C1-AKR1C4; EXPRESSION; PREGNANCY; PROTEINS; ESTROGEN; HORMONES	Progesterone has a number of important functions throughout the human body. While the roles of progesterone are well known, the possible actions and implications of progesterone metabolites in different tissues remain to be determined. There is a growing body of evidence that these metabolites are not inactive, but can have significant biological effects, as anesthetics, anxiolytics and anticonvulsants. Furthermore, they can facilitate synthesis of myelin components in the peripheral nervous system, have effects on human pregnancy and onset of labour, and have a neuroprotective role. For a better understanding of the functions of progesterone metabolites, improved analytical methods are essential. We have developed a combined liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for detection and quantification of progesterone and 16 progesterone metabolites that has femtomolar sensitivity and good reproducibility in a single chromatographic run. MS/MS analyses were performed in positive mode and under constant electrospray ionization conditions. To increase the sensitivity, all of the transitions were recorded using the Scheduled MRM algorithm. This LC-MS/MS method requires small sample volumes and minimal sample preparation, and there is no need for derivatization. Here, we show the application of this method for evaluation of progesterone metabolism in the HES endometrial cell line. In HES cells, the metabolism of progesterone proceeds mainly to (20S)-20-hydroxy- pregn-4-ene-3-one, (20S)-20-hydroxy-5 alpha-pregnane-3-one and (20S)-5 alpha-pregnane-3 alpha,20-diol. The investigation of possible biological effects of these metabolites on the endometrium is currently undergoing.	[Sinreih, Masa; Rizner, Tea Lanisnik] Univ Ljubljana, Fac Med, Inst Biochem, Ljubljana 61000, Slovenia; [Zukunft, Sven; Adamski, Jerzy] Helmholtz Zentrum Munchen, Genome Anal Ctr, Inst Expt Genet, Munich, Germany; [Sosic, Izidor; Cesar, Jozko; Gobec, Stanislav] Univ Ljubljana, Fac Pharm, Ljubljana, Slovenia; [Adamski, Jerzy] Tech Univ Munich, Lehrstuhl Expt Genet, Freising Weihenstephan, Germany; [Adamski, Jerzy] German Ctr Diabet Res, Neuherberg, Germany	University of Ljubljana; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Ljubljana; Technical University of Munich	Rizner, TL (corresponding author), Univ Ljubljana, Fac Med, Inst Biochem, Ljubljana 61000, Slovenia.	Tea.Lanisnik-Rizner@mf.uni-lj.si		Gobec, Stanislav/0000-0002-9678-3083; Sosic, Izidor/0000-0002-3370-4587; Lanisnik Rizner, Tea/0000-0002-3453-4081; Adamski, Jerzy/0000-0001-9259-0199	Slovenian Research Agency [J3-5510]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This study was supported by an ICGEB grant to T. L. R., a Young Researcher Grant to M.S. and a J3-5510 Grant to T. L. R., both from the Slovenian Research Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahboucha S, 2008, NEUROGASTROENT MOTIL, V20, P671, DOI 10.1111/j.1365-2982.2007.01080.x; Arici A, 1999, STEROIDS, V64, P530, DOI 10.1016/S0039-128X(99)00029-X; ATHERDEN LM, 1959, BIOCHEM J, V71, P411, DOI 10.1042/bj0710411; DESAI NN, 1994, FERTIL STERIL, V61, P760; Epperson CN, 2002, ARCH GEN PSYCHIAT, V59, P851, DOI 10.1001/archpsyc.59.9.851; Graham JD, 1997, ENDOCR REV, V18, P502, DOI 10.1210/er.18.4.502; Hevir N, 2011, CHEM-BIOL INTERACT, V191, P217, DOI 10.1016/j.cbi.2011.01.003; Hill M, 2011, PHYSIOL RES, V60, P225, DOI 10.33549/physiolres.932077; Hill M, 2007, J STEROID BIOCHEM, V105, P166, DOI 10.1016/j.jsbmb.2006.10.010; Hill M, 2010, J STEROID BIOCHEM, V122, P114, DOI 10.1016/j.jsbmb.2010.05.007; Hill M, 2010, J STEROID BIOCHEM, V121, P594, DOI 10.1016/j.jsbmb.2009.10.012; Ismail PM, 2003, STEROIDS, V68, P779, DOI 10.1016/S0039-128X(03)00133-8; Jin Y, 2011, BIOCHEM J, V437, P53, DOI 10.1042/BJ20101804; Kaore SN, 2012, J PHARM PHARMACOL, V64, P1040, DOI 10.1111/j.2042-7158.2012.01464.x; Kim YS, 2000, ANAL BIOCHEM, V277, P187, DOI 10.1006/abio.1999.4384; Krone N, 2010, J STEROID BIOCHEM, V121, P496, DOI 10.1016/j.jsbmb.2010.04.010; Leb CR, 1997, J CLIN ENDOCR METAB, V82, P4064, DOI 10.1210/jc.82.12.4064; Martini L, 2003, STEROIDS, V68, P825, DOI 10.1016/S0039-128X(03)00134-X; Murphy BEP, 2000, J STEROID BIOCHEM, V74, P137, DOI 10.1016/S0960-0760(00)00098-4; Murphy BEP, 2004, PSYCHONEUROENDOCRINO, V29, P245, DOI 10.1016/S0306-4530(03)00026-X; Penning TM, 2000, BIOCHEM J, V351, P67, DOI 10.1042/0264-6021:3510067; Penning TM, 2004, MOL CELL ENDOCRINOL, V215, P63, DOI 10.1016/j.mce.2003.11.006; Penning TM, 2010, J STEROID BIOCHEM, V121, P546, DOI 10.1016/j.jsbmb.2010.01.005; Quinkler M, 1999, J CLIN ENDOCR METAB, V84, P4165, DOI 10.1210/jc.84.11.4165; Quinkler M, 2002, EUR J ENDOCRINOL, V146, P789, DOI 10.1530/eje.0.1460789; SATYASWAROOP PG, 1980, STEROIDS, V35, P21, DOI 10.1016/0039-128X(80)90108-7; Schindler AE, 2009, MATURITAS, V62, P334, DOI 10.1016/j.maturitas.2008.12.018; Singh M, 2013, HORM BEHAV, V63, P284, DOI 10.1016/j.yhbeh.2012.06.003; Sinreih M, 2013, CHEM-BIOL INTERACT, V202, P210, DOI 10.1016/j.cbi.2012.11.012; Smuc T, 2009, MOL CELL ENDOCRINOL, V301, P74, DOI 10.1016/j.mce.2008.09.019; Smuc T, 2009, MOL CELL ENDOCRINOL, V301, P59, DOI 10.1016/j.mce.2008.07.020; Stanczyk FZ, 2010, J STEROID BIOCHEM, V121, P491, DOI 10.1016/j.jsbmb.2010.05.001; Wiebe JP, 2000, CANCER RES, V60, P936; Wiebe JP, 2005, J STEROID BIOCHEM, V93, P201, DOI 10.1016/j.jsbmb.2004.12.003; WIEBE JP, 1986, STEROIDS, V47, P249, DOI 10.1016/0039-128X(86)90095-4; WU L, 1993, J BIOL CHEM, V268, P12964; Zhang YH, 2009, MOL CELL ENDOCRINOL, V298, P76, DOI 10.1016/j.mce.2008.09.034	37	7	7	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117984	10.1371/journal.pone.0117984	http://dx.doi.org/10.1371/journal.pone.0117984			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680188	Green Published, Green Submitted, gold			2022-12-26	WOS:000350682600097
J	Berstad, MB; Cheung, LH; Berg, K; Peng, Q; Fremstedal, ASV; Patzke, S; Rosenblum, MG; Weyergang, A				Berstad, M. B.; Cheung, L. H.; Berg, K.; Peng, Q.; Fremstedal, A. S. V.; Patzke, S.; Rosenblum, M. G.; Weyergang, A.			Design of an EGFR-targeting toxin for photochemical delivery: in vitro and in vivo selectivity and efficacy	ONCOGENE			English	Article							GROWTH-FACTOR RECEPTOR; SQUAMOUS-CELL CARCINOMA; PHOTODYNAMIC THERAPY; ACQUIRED-RESISTANCE; ANTITUMOR-ACTIVITY; ENDOTHELIAL-CELLS; FACTOR-ALPHA; INTERNALIZATION; EXPRESSION; GELONIN	The number of epidermal growth factor receptor (EGFR)-targeting drugs in the development for cancer treatment is continuously increasing. Currently used EGFR-targeted monoclonal antibodies and tyrosine kinase inhibitors have specific limitations related to toxicity and development of resistance, and there is a need for alternative treatment strategies to maximize the clinical potential of EGFR as a molecular target. This study describes the design and production of a novel EGFR-targeted fusion protein, rGel/EGF, composed of the recombinant plant toxin gelonin and EGF. rGel/EGF was custom-made for administration by photochemical internalization (PCI), a clinically tested modality for cytosolic release of macromolecular therapeutics. rGel/EGF lacks efficient mechanisms for endosomal escape and is therefore minimally toxic as monotherapy. However, PCI induces selective and efficient cytosolic release of rGel/EGF in EGFR-expressing target cells by light-directed activation of photosensitizers accumulated selectively in tumor tissue. PCI of rGel/EGF was shown to be highly effective against EGFR-expressing cell lines, including head and neck squamous cell carcinoma (HNSCC) cell lines resistant to cetuximab (Erbitux). Apoptosis, necrosis and autophagy were identified as mechanisms of action following PCI of rGel/EGF in vitro. PCI of rGel/EGF was further shown as a highly tumor-specific and potent modality in vivo, with growth inhibitory effects demonstrated on A-431 squamous cell carcinoma (SCC) xenografts and reduction of tumor perfusion and necrosis induction in SCC-026 HNSCC tumors. Considering the small amount of rGel/EGF injected per animal (0.1 mg/kg), the presented in vivo results are highly promising and warrant optimization and production of rGel/EGF for further preclinical evaluation with PCI.	[Berstad, M. B.; Berg, K.; Fremstedal, A. S. V.; Patzke, S.; Weyergang, A.] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Dept Radiat Biol, N-0424 Oslo, Norway; [Cheung, L. H.; Rosenblum, M. G.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Immunopharmacol & Targeted Therapy Lab, Houston, TX 77030 USA; [Peng, Q.] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Pathol, N-0424 Oslo, Norway	University of Oslo; University of Texas System; UTMD Anderson Cancer Center; University of Oslo	Weyergang, A (corresponding author), Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Dept Radiat Biol, POB 4950, N-0424 Oslo, Norway.	anette.weyergang@rr-research.no	Weyergang, Anette/AAB-9938-2021; Weyergang, Anette/I-2934-2018; Patzke, Sebastian/G-9909-2019	Weyergang, Anette/0000-0003-0147-1763; Weyergang, Anette/0000-0003-0147-1763; Patzke, Sebastian/0000-0001-6821-197X; Berg, Kristian/0000-0002-7816-7543	South-Eastern Norway Regional Health Authority; NCI Grant [CA16672]; Norwegian Radium Hospital Legacies; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	South-Eastern Norway Regional Health Authority; NCI Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Norwegian Radium Hospital Legacies; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Kine Mari Bakke at the MRI Core Facility for technical assistance and valuable evaluation of the MRI results, Idun Dale Rein at The Flow Cytometry Core Facility (FCCF) for excellent technical expertise and sample analysis and Khalid A Mohamedali for fruitful discussion. We also thank Karen-Marie Heintz from the Department of Tumorbiology, Norwegian Radium Hospital and the RPPA Core Facility, MD Anderson Cancer Center for assistance in performing DNA fingerprinting assay. The project was supported by the South-Eastern Norway Regional Health Authority. Research was conducted, in part, by the Clayton Foundation for Research and supported by NCI Grant CA16672. Instrumentation for MRI, IVIS and flow cytometry has been financed by the Norwegian Radium Hospital Legacies.	Ahmad N, 2001, ONCOGENE, V20, P2314, DOI 10.1038/sj.onc.1204313; Akimoto T, 1999, CLIN CANCER RES, V5, P2884; Amin DN, 2006, CANCER RES, V66, P2173, DOI 10.1158/0008-5472.CAN-05-3387; Ang KK, 2002, CANCER RES, V62, P7350; BARBIERI L, 1993, BIOCHIM BIOPHYS ACTA, V1154, P237, DOI 10.1016/0304-4157(93)90002-6; Berg K, 1999, CANCER RES, V59, P1180; Berg K, 2011, PHOTOCH PHOTOBIO SCI, V10, P1637, DOI 10.1039/c1pp05128h; Bruell D, 2005, INT J MOL MED, V15, P305; Bull-Hansen B, 2014, J CONTROL RELEASE, V182, P58, DOI 10.1016/j.jconrel.2014.03.014; Cao Y, 2012, MOL CANCER THER, V11, P143, DOI 10.1158/1535-7163.MCT-11-0519; Cao Y, 2009, CANCER RES, V69, P8987, DOI 10.1158/0008-5472.CAN-09-2693; Chong CR, 2013, NAT MED, V19, P1389, DOI 10.1038/nm.3388; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; EIKLID K, 1980, EXP CELL RES, V126, P321, DOI 10.1016/0014-4827(80)90270-0; GRANDIS JR, 1993, CANCER RES, V53, P3579; Gregoire V, 2010, ANN ONCOL, V21, pv184, DOI 10.1093/annonc/mdq185; Hale ML, 2001, PHARMACOL TOXICOL, V88, P255, DOI 10.1034/j.1600-0773.2001.d01-113.x; HARBURY PB, 1994, NATURE, V371, P80, DOI 10.1038/371080a0; Kim SM, 2010, CANCER LETT, V296, P150, DOI 10.1016/j.canlet.2010.04.006; Lackner MR, 2012, FUTURE ONCOL, V8, P999, DOI [10.2217/fon.12.86, 10.2217/FON.12.86]; Li SQ, 2005, CANCER CELL, V7, P301, DOI 10.1016/j.ccr.2005.03.003; Lippman S M, 1995, Cancer Treat Res, V74, P89; Liu TF, 2005, CLIN CANCER RES, V11, P329; Martin CL, 2008, ORAL ONCOL, V44, P369, DOI 10.1016/j.oraloncology.2007.05.003; Martinez-Torrecuadrada JL, 2008, MOL CANCER THER, V7, P862, DOI 10.1158/1535-7163.MCT-07-0394; Norum OJ, 2009, PHOTOCHEM PHOTOBIOL, V85, P740, DOI 10.1111/j.1751-1097.2008.00477.x; Pastan I, 2007, ANNU REV MED, V58, P221, DOI 10.1146/annurev.med.58.070605.115320; PHILLIPS PC, 1994, CANCER RES, V54, P1008; Piette J, 2003, BIOCHEM PHARMACOL, V66, P1651, DOI 10.1016/S0006-2952(03)00539-2; Pirie CM, 2011, J BIOL CHEM, V286, P4165, DOI 10.1074/jbc.M110.186973; Rebucci M, 2011, INT J ONCOL, V38, P189, DOI 10.3892/ijo_00000838; Reiners JJ, 2010, AUTOPHAGY, V6, P7, DOI 10.4161/auto.6.1.10220; ROSENBLUM MG, 1995, J INTERF CYTOK RES, V15, P547, DOI 10.1089/jir.1995.15.547; Selbo PK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006691; Selbo PK, 2010, J CONTROL RELEASE, V148, P2, DOI 10.1016/j.jconrel.2010.06.008; Selbo PK, 2000, INT J CANCER, V87, P853, DOI 10.1002/1097-0215(20000915)87:6<853::AID-IJC15>3.0.CO;2-0; Selbo PK, 2000, BBA-GEN SUBJECTS, V1475, P307, DOI 10.1016/S0304-4165(00)00082-9; Selbo PK, 2001, INT J CANCER, V92, P761, DOI 10.1002/1097-0215(20010601)92:5<761::AID-IJC1238>3.0.CO;2-4; STIRPE F, 1980, J BIOL CHEM, V255, P6947; Thomas SM, 2004, CLIN CANCER RES, V10, P7079, DOI 10.1158/1078-0432.CCR-04-0587; Veenendaal LM, 2002, P NATL ACAD SCI USA, V99, P7866, DOI [10.1073/pnas.122157899, 10.1073/pnas.162346299]; Vikdal M, 2013, PHOTOCHEM PHOTOBIOL, V89, P1185, DOI 10.1111/php.12126; Wang Q, 2005, EMBO REP, V6, P942, DOI 10.1038/sj.embor.7400491; WEISHAUPT KR, 1976, CANCER RES, V36, P2326; Weyergang A, 2008, MOL CANCER THER, V7, P1740, DOI 10.1158/1535-7163.MCT-08-0020; Weyergang A, 2014, J CONTROL RELEASE, V180, P1, DOI 10.1016/j.jconrel.2014.02.003; Weyergang A, 2013, BBA-GEN SUBJECTS, V1830, P2659, DOI 10.1016/j.bbagen.2012.11.010; Weyergang A, 2011, LASER SURG MED, V43, P721, DOI 10.1002/lsm.21084; Weyeyang A, 2007, BIOCHEM PHARMACOL, V74, P226, DOI 10.1016/j.bcp.2007.04.018; Zhou H, 2011, MOL CANCER THER, V10, P1276, DOI 10.1158/1535-7163.MCT-11-0161; Zhou XK, 2012, J CANCER RES CLIN, V138, P1081, DOI 10.1007/s00432-012-1181-7	51	28	28	1	18	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 29	2015	34	44					5582	5592		10.1038/onc.2015.15	http://dx.doi.org/10.1038/onc.2015.15			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CV9FX	25684137				2022-12-26	WOS:000364594000007
J	Ramesh, M; Krishnan, N; Muthuswamy, SK; Tonks, NK				Ramesh, Mathangi; Krishnan, Navasona; Muthuswamy, Senthil K.; Tonks, Nicholas K.			A Novel Phosphatidic Acid-Protein-tyrosine Phosphatase D2 Axis Is Essential for ERBB2 Signaling in Mammary Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METASTATIC BREAST-CANCER; PHOSPHOLIPASE-D; KINASE; 1B; TUMORIGENESIS; ACTIVATION; RECEPTOR; SURVIVAL; SRC; PHOSPHORYLATION	We used a loss-of-function screen to investigate the role of classical protein-tyrosine phosphatases (PTPs) in three-dimensional mammary epithelial cell morphogenesis and ERBB2 signaling. The study revealed a novel role for PTPD2 as a positive regulator of ERBB2 signaling. Suppression of PT PD2 attenuated the ERBB2-induced multiacinar phenotype in three-dimensional cultures specifically by inhibiting ERBB2-mediated loss of polarity and lumen filling. In contrast, overexpression of PTPD2 enhanced the ERBB2 phenotype. We also found that a lipid second messenger, phosphatidic acid, bound PTPD2 in vitro and enhanced its catalytic activity. Small molecule inhibitors of phospholipase D (PLD), an enzyme that produces phosphatidic acid in cells, also attenuated the ERBB2 phenotype. Exogenously added phosphatidic acid rescued the PLD-inhibition phenotype, but only when PTPD2 was present. These findings illustrate a novel pathway involving PTPD2 and the lipid second messenger phosphatidic acid that promotes ERBB2 function.	[Ramesh, Mathangi; Krishnan, Navasona; Muthuswamy, Senthil K.; Tonks, Nicholas K.] Cold Spring Harbor Lab, One Bungtown Rd, Cold Spring Harbor, NY 11724 USA; [Ramesh, Mathangi] SUNY Stony Brook, Grad Program Mol & Cellular Biol, Stony Brook, NY 11794 USA; [Muthuswamy, Senthil K.] Univ Toronto, Campbell Family Inst Breast Canc Res, Ontario Canc Inst, Dept Med Biophys, Toronto, ON M5G 2M9, Canada	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Tonks, NK (corresponding author), Cold Spring Harbor Lab, One Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	tonks@cshl.edu	Muthuswamy, Senthil K/AGY-2834-2022	Muthuswamy, Senthil K/0000-0001-6564-9634	National Institutes of Health [CA53840]; Cold Spring Harbor Laboratory Cancer Center [CA45508]; Gladowsky Breast Cancer Foundation; Don Monti Memorial Research Foundation; Hansen Memorial Foundation; West Islip Breast Cancer Coalition for Long Island; Glen Cove CARES; Find a Cure Today (FACT); Constance Silveri; Robertson Research Fund; Masthead Cove Yacht Club Carol Marcincuk Fund; NATIONAL CANCER INSTITUTE [R01CA053840, P30CA045508, R37CA053840] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cold Spring Harbor Laboratory Cancer Center; Gladowsky Breast Cancer Foundation; Don Monti Memorial Research Foundation; Hansen Memorial Foundation; West Islip Breast Cancer Coalition for Long Island; Glen Cove CARES; Find a Cure Today (FACT); Constance Silveri; Robertson Research Fund; Masthead Cove Yacht Club Carol Marcincuk Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA53840 and Cold Spring Harbor Laboratory Cancer Center Support Grant CA45508 (to N. K. T.).r Supported by the Gladowsky Breast Cancer Foundation, the Don Monti Memorial Research Foundation, Hansen Memorial Foundation, West Islip Breast Cancer Coalition for Long Island, Glen Cove CARES, Find a Cure Today (FACT), Constance Silveri, Robertson Research Fund, and the Masthead Cove Yacht Club Carol Marcincuk Fund. To whom correspondence should be addressed: Cold Spring Harbor Laboratory, One Bungtown Road, Cold Spring Harbor, NY 11724. Tel.: 516-367-8815; E-mail: tonks@cshl.edu.	Aranda V, 2006, NAT CELL BIOL, V8, P1235, DOI 10.1038/ncb1485; Arias-Romero LE, 2009, CANCER RES, V69, P4582, DOI 10.1158/0008-5472.CAN-08-4001; Barr AJ, 2006, PROTEINS, V63, P1132, DOI 10.1002/prot.20958; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Belsches-Jablonski AP, 2001, ONCOGENE, V20, P1465, DOI 10.1038/sj.onc.1204205; Bentires-Alj M, 2006, NAT MED, V12, P114, DOI 10.1038/nm1341; Bentires-Alj M, 2007, CANCER RES, V67, P2420, DOI 10.1158/0008-5472.CAN-06-4610; Boivin B, 2013, J BIOL CHEM, V288, P36926, DOI 10.1074/jbc.M113.527564; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639, DOI 10.1200/JCO.1999.17.9.2639; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Fan GF, 2013, J BIOL CHEM, V288, P24923, DOI 10.1074/jbc.M113.482737; Fiucci G, 2000, INT J CANCER, V85, P882, DOI 10.1002/(SICI)1097-0215(20000315)85:6<882::AID-IJC24>3.0.CO;2-E; Frank C, 1999, BIOCHEMISTRY-US, V38, P11993, DOI 10.1021/bi982586w; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Ghosh S, 1997, BIOCHEM SOC T, V25, P561, DOI 10.1042/bst0250561; Grassian AR, 2011, COLD SH Q B, V76, P313, DOI 10.1101/sqb.2011.76.010967; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; Huang JM, 2013, ONCOGENE, V32, P2220, DOI 10.1038/onc.2012.231; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Jenkins GM, 2005, CELL MOL LIFE SCI, V62, P2305, DOI 10.1007/s00018-005-5195-z; Julien SG, 2007, NAT GENET, V39, P338, DOI 10.1038/ng1963; Julien SG, 2011, NAT REV CANCER, V11, P35, DOI 10.1038/nrc2980; KING CR, 1985, SCIENCE, V229, P974, DOI 10.1126/science.2992089; Krishnan N, 2014, NAT CHEM BIOL, V10, P558, DOI [10.1038/NCHEMBIO.1528, 10.1038/nchembio.1528]; Lavieri R, 2009, BIOORG MED CHEM LETT, V19, P2240, DOI 10.1016/j.bmcl.2009.02.125; Lavieri RR, 2010, J MED CHEM, V53, P6706, DOI 10.1021/jm100814g; Lin G, 2011, GENE DEV, V25, P1412, DOI 10.1101/gad.2018911; LISCOVITCH M, 1994, CELL, V77, P329, DOI 10.1016/0092-8674(94)90148-1; Liu X, 2013, ONCOGENE, V32, P1266, DOI 10.1038/onc.2012.147; Meng TC, 2005, METHODS, V35, P28, DOI 10.1016/j.ymeth.2004.07.005; Muthuswamy SK, 1999, MOL CELL BIOL, V19, P6845; MUTHUSWAMY SK, 1994, MOL CELL BIOL, V14, P735, DOI 10.1128/MCB.14.1.735; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Nemoz G, 1997, MOL PHARMACOL, V51, P242, DOI 10.1124/mol.51.2.242; Nishikimi A, 2009, SCIENCE, V324, P384, DOI 10.1126/science.1170179; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; Rosenbluh J, 2012, CELL, V151, P1457, DOI 10.1016/j.cell.2012.11.026; Slaaby R, 1998, J BIOL CHEM, V273, P33722, DOI 10.1074/jbc.273.50.33722; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Sliwkowski MX, 2013, SCIENCE, V341, P1192, DOI 10.1126/science.1241145; Su W, 2009, MOL PHARMACOL, V75, P437, DOI 10.1124/mol.108.053298; TONKS NK, 1988, J BIOL CHEM, V263, P6722; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719; Wang WQ, 2012, GENE DEV, V26, P1959, DOI 10.1101/gad.192955.112; WELSH CJ, 1994, BIOCHEM BIOPH RES CO, V202, P211, DOI 10.1006/bbrc.1994.1914; Wyatt L, 2007, J CELL BIOL, V178, P1223, DOI 10.1083/jcb.200705035; Yang WT, 2013, NATURE, V499, P491, DOI 10.1038/nature12396; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yu DH, 2000, ONCOGENE, V19, P6115, DOI 10.1038/sj.onc.1203972; Zhao RX, 2003, J BIOL CHEM, V278, P22609, DOI 10.1074/jbc.M301560200	53	8	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9646	9659		10.1074/jbc.M114.627968	http://dx.doi.org/10.1074/jbc.M114.627968			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25681440	hybrid, Green Published			2022-12-26	WOS:000352729400028
J	Clowez, S; Godaux, D; Cardol, P; Wollman, FA; Rappaport, F				Clowez, Sophie; Godaux, Damien; Cardol, Pierre; Wollman, Francis-Andre; Rappaport, Fabrice			The Involvement of Hydrogen-producing and ATP-dependent NADPH-consuming Pathways in Setting the Redox Poise in the Chloroplast of Chlamydomonas reinhardtii in Anoxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC ELECTRON FLOW; STATE TRANSITIONS; PHOTOSYSTEM-II; GENE-EXPRESSION; OXYGEN EVOLUTION; MUTANTS; PHOTOSYNTHESIS; METABOLISM; TRANSPORT; DARK	Photosynthetic microalgae are exposed to changing environmental conditions. In particular, microbes found in ponds or soils often face hypoxia or even anoxia, and this severely impacts their physiology. Chlamydomonas reinhardtii is one among such photosynthetic microorganisms recognized for its unusual wealth of fermentative pathways and the extensive remodeling of its metabolism upon the switch to anaerobic conditions. As regards the photosynthetic electron transfer, this remodeling encompasses a strong limitation of the electron flow downstream of photosystem I. Here, we further characterize the origin of this limitation. We show that it stems from the strong reducing pressure that builds up upon the onset of anoxia, and this pressure can be relieved either by the light-induced synthesis of ATP, which promotes the consumption of reducing equivalents, or by the progressive activation of the hydrogenase pathway, which provides an electron transfer pathway alternative to the CO2 fixation cycle.	[Clowez, Sophie; Wollman, Francis-Andre; Rappaport, Fabrice] Inst Biol Phys Chim, UMR CNRS UPMC 7141, F-75005 Paris, France; [Godaux, Damien; Cardol, Pierre] Univ Liege, Lab Genet & Physiol Microalgues Phyosyst, Dept Life Sci, Inst Bot, B-4000 Liege, Belgium	UDICE-French Research Universities; Sorbonne Universite; University of Liege	Rappaport, F (corresponding author), Inst Biol Phys Chim, UMR CNRS UPMC 7141, 13 Rue P&M Curie, F-75005 Paris, France.	Fabrice.Rappaport@ibpc.fr	Cardol, Pierre/AAA-3090-2019	Cardol, Pierre/0000-0001-9799-0546	Universite Pierre et Marie Curie; CNRS; "Initiative d'Excellence" Program from French State Grant "DYNAMO" [ANR-11-LABX-0011-01]; Belgian Fonds de la Recherche Scientifique-Fonds National de la Recherche Fondamentale Collective Grant [2.4597.11]; Mandat d'Impulsion Scientifique [F.4520]	Universite Pierre et Marie Curie; CNRS(Centre National de la Recherche Scientifique (CNRS)); "Initiative d'Excellence" Program from French State Grant "DYNAMO"; Belgian Fonds de la Recherche Scientifique-Fonds National de la Recherche Fondamentale Collective Grant(Fonds de la Recherche Scientifique - FNRS); Mandat d'Impulsion Scientifique	Recipient of a Ph.D. fellowship from Universite Pierre et Marie Curie.; Supported by CNRS and the "Initiative d'Excellence" Program from French State Grant "DYNAMO," ANR-11-LABX-0011-01.; Supported by the Belgian Fonds de la Recherche Scientifique-Fonds National de la Recherche Fondamentale Collective Grant 2.4597.11 and Mandat d'Impulsion Scientifique Grant F.4520.	Allen JF, 2003, TRENDS PLANT SCI, V8, P15, DOI 10.1016/S1360-1385(02)00006-7; Alric J, 2014, BBA-BIOENERGETICS, V1837, P825, DOI 10.1016/j.bbabio.2014.01.024; Alric J, 2010, PHOTOSYNTH RES, V106, P47, DOI 10.1007/s11120-010-9566-4; Alric J, 2010, BBA-BIOENERGETICS, V1797, P44, DOI 10.1016/j.bbabio.2009.07.009; Antal TK, 2013, PHOTOSYNTH RES, V117, P1, DOI 10.1007/s11120-013-9945-8; Armbruster U, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6439; Baker NR, 2007, PLANT CELL ENVIRON, V30, P1107, DOI 10.1111/j.1365-3040.2007.01680.x; BASSHAM JA, 1950, J BIOL CHEM, V185, P781; BENDALL DS, 1995, BBA-BIOENERGETICS, V1229, P23, DOI 10.1016/0005-2728(94)00195-B; BOHME H, 1978, EUR J BIOCHEM, V83, P137, DOI 10.1111/j.1432-1033.1978.tb12077.x; BONAVENTURA C, 1969, BIOCHIM BIOPHYS ACTA, V189, P366, DOI 10.1016/0005-2728(69)90168-6; Brettel K, 1997, BBA-BIOENERGETICS, V1318, P322, DOI 10.1016/S0005-2728(96)00112-0; BULTE L, 1990, BIOCHIM BIOPHYS ACTA, V1020, P72, DOI 10.1016/0005-2728(90)90095-L; CAMMACK R, 1977, BIOCHEM J, V168, P205, DOI 10.1042/bj1680205; Cardol P, 2003, PLANT PHYSIOL, V133, P2010, DOI 10.1104/pp.103.028076; Carraretto L, 2013, SCIENCE, V342, P114, DOI 10.1126/science.1242113; Cassan N, 2005, J BIOL CHEM, V280, P25960, DOI 10.1074/jbc.M503742200; Catalanotti C, 2012, PLANT CELL, V24, P692, DOI 10.1105/tpc.111.093146; de Lavalette AD, 2009, J BIOL CHEM, V284, P20822, DOI 10.1074/jbc.M109.016709; Del Campo JA, 2004, METHOD ENZYMOL, V381, P604; Delosme R, 1996, BBA-BIOENERGETICS, V1273, P150, DOI 10.1016/0005-2728(95)00143-3; Dubini A, 2009, J BIOL CHEM, V284, P7201, DOI 10.1074/jbc.M803917200; Finazzi G, 1998, BIOCHEMISTRY-US, V37, P9999, DOI 10.1021/bi980320j; Finazzi G, 1997, BIOCHEMISTRY-US, V36, P2867, DOI 10.1021/bi962717y; Finazzi G, 2002, EMBO REP, V3, P280, DOI 10.1093/embo-reports/kvf047; Finazzi G, 1999, BBA-BIOENERGETICS, V1413, P117, DOI 10.1016/S0005-2728(99)00089-4; Forestier M, 2003, EUR J BIOCHEM, V270, P2750, DOI 10.1046/j.1432-1033.2003.03656; Ghysels B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064161; Godaux D, 2013, INT J HYDROGEN ENERG, V38, P1826, DOI 10.1016/j.ijhydene.2012.11.081; Grossman AR, 2007, CURR OPIN PLANT BIOL, V10, P190, DOI 10.1016/j.pbi.2007.01.012; Harris EH, 1989, CHLAMYDOMONAS SOURCE, P25, DOI [DOI 10.1016/B978-0-12-326880-8.50007-9, DOI 10.1126/SCIENCE.246.4936.1503-A]; Hemschemeier A, 2005, BIOCHEM SOC T, V33, P39, DOI 10.1042/BST0330039; Hemschemeier A, 2011, BBA-BIOENERGETICS, V1807, P919, DOI 10.1016/j.bbabio.2011.02.010; Hemschemeier A, 2009, PHOTOSYNTH RES, V102, P523, DOI 10.1007/s11120-009-9415-5; HIYAMA T, 1971, ARCH BIOCHEM BIOPHYS, V147, P99, DOI 10.1016/0003-9861(71)90314-6; Houille-Vernes L, 2011, P NATL ACAD SCI USA, V108, P20820, DOI 10.1073/pnas.1110518109; Iwai M, 2010, NATURE, V464, P1210, DOI 10.1038/nature08885; Iwai M, 2010, P NATL ACAD SCI USA, V107, P2337, DOI 10.1073/pnas.0908808107; Jans F, 2008, P NATL ACAD SCI USA, V105, P20546, DOI 10.1073/pnas.0806896105; Johnson X, 2012, J BIOL CHEM, V287, P26445, DOI 10.1074/jbc.M112.370205; Johnson X, 2010, PLANT CELL, V22, P234, DOI 10.1105/tpc.109.066266; Joliot P, 2005, P NATL ACAD SCI USA, V102, P4913, DOI 10.1073/pnas.0501268102; Joliot P, 2004, BBA-BIOENERGETICS, V1656, P166, DOI 10.1016/j.bbabio.2004.03.010; JOLIOT P, 1985, BIOCHIM BIOPHYS ACTA, V806, P398, DOI 10.1016/0005-2728(85)90247-6; JUNGE W, 1968, Z NATURFORSCH PT B, VB 23, P244, DOI 10.1515/znb-1968-0222; KLUGHAMMER C, 1994, PLANTA, V192, P261, DOI 10.1007/BF01089043; Kramer DM, 2011, PLANT PHYSIOL, V155, P70, DOI 10.1104/pp.110.166652; KRAMER DM, 1993, BIOCHIM BIOPHYS ACTA, V1183, P72, DOI 10.1016/0005-2728(93)90006-2; Kuchenreuther JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045850; Leister D, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00161; LEMAIRE C, 1989, J BIOL CHEM, V264, P10235; Lucker B, 2013, PHOTOSYNTH RES, V117, P449, DOI 10.1007/s11120-013-9932-0; Maughan SC, 2010, P NATL ACAD SCI USA, V107, P2331, DOI 10.1073/pnas.0913689107; Melis A, 2000, PLANT PHYSIOL, V122, P127, DOI 10.1104/pp.122.1.127; MILLER AG, 1989, PLANT PHYSIOL, V91, P1044, DOI 10.1104/pp.91.3.1044; Miyake C, 2010, PLANT CELL PHYSIOL, V51, P1951, DOI 10.1093/pcp/pcq173; Moal G, 2012, BBA-BIOENERGETICS, V1817, P1635, DOI 10.1016/j.bbabio.2012.05.015; Mus F, 2007, J BIOL CHEM, V282, P25475, DOI 10.1074/jbc.M701415200; Nagy G, 2014, P NATL ACAD SCI USA, V111, P5042, DOI 10.1073/pnas.1322494111; Posewitz MC, 2004, J BIOL CHEM, V279, P25711, DOI 10.1074/jbc.M403206200; QUINN J, 1993, J BIOL CHEM, V268, P7832; Quinn JM, 2002, PLANT PHYSIOL, V128, P463, DOI 10.1104/pp.010694; Rimbault B, 2000, MOL GEN GENET, V264, P486, DOI 10.1007/s004380000332; Roach T, 2014, CURR PROTEIN PEPT SC, V15, P351, DOI 10.2174/1389203715666140327105143; Sacksteder CA, 2000, PHOTOSYNTH RES, V66, P145, DOI 10.1023/A:1010785912271; Schottler MA, 2004, PLANT PHYSIOL, V136, P4265, DOI 10.1104/pp.104.052324; Steunou AS, 2008, ISME J, V2, P364, DOI 10.1038/ismej.2007.117; Subramanian V, 2014, J PROTEOME RES, V13, P5431, DOI 10.1021/pr500342j; Takahashi H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2954; Takahashi S, 2005, BBA-BIOENERGETICS, V1708, P352, DOI 10.1016/j.bbabio.2005.04.003; Terashima M, 2012, P NATL ACAD SCI USA, V109, P17717, DOI 10.1073/pnas.1207118109; Terashima M, 2010, MOL CELL PROTEOMICS, V9, P1514, DOI 10.1074/mcp.M900421-MCP200; Tikkanen M, 2014, TRENDS PLANT SCI, V19, P10, DOI 10.1016/j.tplants.2013.09.003; Unlu C, 2014, P NATL ACAD SCI USA, V111, P3460, DOI 10.1073/pnas.1319164111; VALLON O, 1991, P NATL ACAD SCI USA, V88, P8262, DOI 10.1073/pnas.88.18.8262; WOESSNER JP, 1984, PLANT MOL BIOL, V3, P177, DOI 10.1007/BF00016065; WOLLMAN FA, 1989, ENER BIOMAS, V5, P198; Wollman FA, 2001, EMBO J, V20, P3623, DOI 10.1093/emboj/20.14.3623; WOLLMAN FA, 1988, BIOCHIM BIOPHYS ACTA, V933, P85, DOI 10.1016/0005-2728(88)90058-8; Yang WQ, 2014, PLANT CELL, V26, P4499, DOI 10.1105/tpc.114.129965; Zito F, 1999, EMBO J, V18, P2961, DOI 10.1093/emboj/18.11.2961	81	21	21	1	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8666	8676		10.1074/jbc.M114.632588	http://dx.doi.org/10.1074/jbc.M114.632588			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25691575	hybrid, Green Published			2022-12-26	WOS:000351662600056
J	Karim, MR; Dong, HJ; Li, TY; Yu, FC; Li, DZ; Zhang, LX; Li, JQ; Wang, RJ; Li, SY; Li, XF; Rume, FI; Ning, CS				Karim, Md Robiul; Dong, Haiju; Li, Tongyi; Yu, Fuchang; Li, Dezhong; Zhang, Longxian; Li, Junqiang; Wang, Rongjun; Li, Shouyi; Li, Xiaofeng; Rume, Farzana Islam; Ning, Changshen			Predomination and New Genotypes of Enterocytozoon bieneusi in Captive Nonhuman Primates in Zoos in China: High Genetic Diversity and Zoonotic Significance	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; GIARDIA-DUODENALIS; HOST-SPECIFICITY; MICROSPORIDIA; PREVALENCE; SEQUENCE; ANIMALS; SWINE; CATS	To appreciate the genetic diversity and zoonotic implications of Enterocytozoon bieneusi in nonhuman primates (NHPs) in zoos, we genotyped E. bieneusi in captive NHPs in seven zoos located at six major cities in China, using ribosomal internal transcribed spacer (ITS)based PCR and sequence analyses. A total of 496 fecal specimens from 36 NHP species under nine families were analyzed and E. bieneusi was detected in 148 (29.8%) specimens of 25 NHP species from six families, including Cercopithecidae (28.7%), Cebidae (38.0%), Aotidae (75.0%), Lemuridae (26.0%), Hylobatidae (50.0%) and Hominidae (16.2%) (P = 0.0605). The infection rates were 29.0%, 15.2%, 18.2%, 37.3%, 29.2%, 37.7% and 44.8% in Shijiazhuang Zoo, Wuhan Zoo, Taiyuan Zoo, Changsha Wild Animal Zoo, Beijing Zoo, Shanghai Zoo and Shanghai Wild Animal Park, respectively (P = 0.0146). A total of 25 ITS genotypes were found: 14 known (D, O, EbpC, EbpA, Type IV, Henan-IV, BEB6, BEB4, Peru8, PigEBITS5, EbpD, CM1, CM4 and CS-1) and 11 new (CM8 to CM18). Genotype D was the most prevalent one (40/148), followed by CM4 (20/148), CM1 (15/148), O (13/148), CM16 (13/148), EbpC (11/148). Of them, genotypes D, EbpC, CM4 and O were widely distributed in NHPs (seen in 9 to 12 species) whereas genotypes CM1 and CM16 were restricted to one to three NHP species. In phylogenetic analysis, 20 genotypes (121/148, 81.8%), excluding genotypes BEB4, BEB6, CM9, CM4 and CM18, belonged to group 1 with zoonotic potential. New genotype CM9 clustered in group 2 with BEB4 and BEB6. The remaining two genotypes CM4 and CM18 formed new cluster (group 9) in between two other genotypic clusters found in primates. The findings of high diversity in E. bieneusi genotypes and their zoonotic potentiality concluded the importance of captive NHPs as reservoir hosts for human microsporidiosis.	[Karim, Md Robiul; Dong, Haiju; Yu, Fuchang; Zhang, Longxian; Li, Junqiang; Wang, Rongjun; Li, Shouyi; Li, Xiaofeng; Ning, Changshen] Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou 450002, Peoples R China; [Li, Tongyi; Li, Dezhong] Zhengzhou Zoo, Zhengzhou 45000, Peoples R China; [Rume, Farzana Islam] Patuakhali Sci & Technol Univ, Dept Microbiol, Patuakhali 8602, Bangladesh	Henan Agricultural University	Zhang, LX (corresponding author), Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou 450002, Peoples R China.	zhanglx8999@gmail.com	Li, Junqiang/AAG-2200-2020; Zhang, Longxian/I-9223-2019; Zhang, Longxian/HGE-1918-2022; Yu, Fuchang/T-3390-2017; Zhang, Longxian/R-7799-2019; Yu, Fuchang/ABF-4800-2021	Zhang, Longxian/0000-0002-5706-131X; Yu, Fuchang/0000-0003-0031-1549; Yu, Fuchang/0000-0003-0031-1549; Karim, Md Robiul/0000-0002-0712-5573	Innovation Scientists and Technicians Troop Construction Projects of Henan Province [134200510012]; State Key Program of National Natural Science Foundation of China [31330079]; Key National Science and Technology Specific Projects [2012ZX10004220]; Program for Science and Technology Innovative Research Team in University of Henan Province [012IRTSTHN005]	Innovation Scientists and Technicians Troop Construction Projects of Henan Province; State Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key National Science and Technology Specific Projects; Program for Science and Technology Innovative Research Team in University of Henan Province	This study was supported in part by Innovation Scientists and Technicians Troop Construction Projects of Henan Province (134200510012, http://www.hnkjt.gov.cn/new/index.eiip), the State Key Program of National Natural Science Foundation of China (No. 31330079, http://npd.nsfc.gov.cn/), the Key National Science and Technology Specific Projects (No. 2012ZX10004220, http://www.nmp.gov.cn/), the Program for Science and Technology Innovative Research Team in University of Henan Province (012IRTSTHN005, http://est.haedu.gov.cn/Article/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinbo FO, 2012, AM J TROP MED HYG, V86, P441, DOI 10.4269/ajtmh.2012.11-0548; Anane S, 2010, GASTROEN CLIN BIOL, V34, P450, DOI 10.1016/j.gcb.2010.07.003; Buckholt MA, 2002, APPL ENVIRON MICROB, V68, P2595, DOI 10.1128/AEM.68.5.2595-2599.2002; DESPORTES I, 1985, J PROTOZOOL, V32, P250; Ghosh Kaya, 2009, Interdiscip Perspect Infect Dis, V2009, P926521, DOI 10.1155/2009/926521; Guo YQ, 2014, APPL ENVIRON MICROB, V80, P218, DOI 10.1128/AEM.02997-13; Henriques-Gil N, 2010, APPL ENVIRON MICROB, V76, P3333, DOI 10.1128/AEM.03026-09; Karim MR, 2014, J CLIN MICROBIOL, V52, P3297, DOI 10.1128/JCM.01352-14; Karim MR, 2014, PARASITOL RES, V113, P3041, DOI 10.1007/s00436-014-3967-9; Karim MR, 2014, APPL ENVIRON MICROB, V80, P1893, DOI 10.1128/AEM.03845-13; Karim MR, 2014, VET PARASITOL, V200, P13, DOI 10.1016/j.vetpar.2013.12.004; Li N, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001809; Li W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097623; Li W, 2014, PARASITOL RES, V113, P1147, DOI 10.1007/s00436-014-3752-9; Li W, 2011, J CLIN MICROBIOL, V49, P4326, DOI 10.1128/JCM.05051-11; Lores B, 2002, MEM I OSWALDO CRUZ, V97, P941, DOI 10.1590/S0074-02762002000700003; Matos Olga, 2012, J Parasitol Res, V2012, P981424, DOI 10.1155/2012/981424; Mori H, 2013, VET PARASITOL, V197, P696, DOI 10.1016/j.vetpar.2013.07.025; Mori H, 2013, PARASITE, V20, DOI 10.1051/parasite/2013014; Santin M, 2011, RES VET SCI, V90, P363, DOI 10.1016/j.rvsc.2010.07.014; Santin M, 2010, J PARASITOL, V96, P157, DOI 10.1645/GE-2184.1; Santin M, 2009, J EUKARYOT MICROBIOL, V56, P34, DOI 10.1111/j.1550-7408.2008.00380.x; Sulaiman IM, 2003, APPL ENVIRON MICROB, V69, P4495, DOI 10.1128/AEM.69.8.4495-4501.2003; Thellier M, 2008, PARASITE, V15, P349, DOI 10.1051/parasite/2008153349; Wagnerova P, 2012, VET PARASITOL, V190, P573, DOI 10.1016/j.vetpar.2012.07.013; Wang L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002437; Wang L, 2013, J CLIN MICROBIOL, V51, P557, DOI 10.1128/JCM.02758-12; Ye JB, 2014, PARASITOL INT, V63, P132, DOI 10.1016/j.parint.2013.10.007; Ye JB, 2012, EMERG INFECT DIS, V18, P1640, DOI 10.3201/eid1810.120653; Zhang X, 2011, J CLIN MICROBIOL, V49, P2006, DOI 10.1128/JCM.00372-11; Zhao W, 2014, APPL ENVIRON MICROB, V80, P3699, DOI 10.1128/AEM.00807-14	31	93	96	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117991	10.1371/journal.pone.0117991	http://dx.doi.org/10.1371/journal.pone.0117991			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25705879	Green Published, gold, Green Submitted			2022-12-26	WOS:000350662100135
J	Gray, C; Vickers, MH; Segovia, SA; Zhang, XD; Reynolds, CM				Gray, Clint; Vickers, Mark H.; Segovia, Stephanie A.; Zhang, Xiaohuan D.; Reynolds, Clare M.			A Maternal High Fat Diet Programmes Endothelial Function and Cardiovascular Status in Adult Male Offspring Independent of Body Weight, Which is Reversed by Maternal Conjugated Linoleic Acid (CLA) Supplementation	PLOS ONE			English	Article							ATHEROSCLEROSIS; APOE(-/-); RESPONSES; OBESITY	Maternal high fat intake during pregnancy and lactation can result in obesity and adverse cardio-metabolic status in offspring independent of postnatal diet. While it is clear that maternal high fat intake can cause hypertension in adult offspring, there is little evidence regarding the role of dietary interventions in terms of reversing these adverse effects. Conjugated linoleic acid (CLA) is an omega 6 fatty acid with beneficial effects in obesity and metabolic status. However, the impact of CLA supplementation in the context of pregnancy disorders and high fat diet-induced developmental programming of offspring cardio-metabolic dysfunction has not been investigated. We have utilised a model of maternal overnutrition to examine the effects of CLA supplementation on programmed endothelial dysfunction during adulthood. Female Sprague-Dawley rats were fed either a purified control diet (CON) or purified control diet supplemented with 1% CLA (of total fat), a purified high fat (HF) diet (45% kcal from fat) and a purified HF diet supplemented with 1% CLA (of total fat) (HFCLA). All dams were fed ad libitum throughout pregnancy and lactation. Offspring were fed a standard chow diet from weaning (day 21) until the end of the study (day 150). Systolic blood pressure (SBP) was measured at day 85 and 130 by tail cuff plethysmography. At day 150, offspring mesenteric vessels were mounted on a pressure myograph and vascular responses to agonist-induced constriction and endothelium-dependent vasodilators were investigated. SBP was increased at day 85 and 130 in HF and HFCLA adult male offspring compared to CON and CLA groups with no effect of CLA supplementation. An overall effect of a maternal HF diet was observed in adult male vessels with a reduced vasoconstrictor response to phenylephrine and blunted vasodilatory response to acetylcholine (ACh). Furthermore, HF and HFCLA offspring displayed a reduction in nitric oxide pathway function and an increased compensatory EDHF function when compared to CON and CLA groups. These data suggest that a maternal HF diet causes a developmental programming of endothelial dysfunction and hypertension in male offspring which can be partially improved by maternal CLA supplementation, independent of offspring body weight.	[Gray, Clint] Univ Auckland, Liggins Inst, Auckland 1, New Zealand; Univ Auckland, Gravida Natl Ctr Growth & Dev, Auckland 1, New Zealand	University of Auckland; University of Auckland	Gray, C (corresponding author), Univ Auckland, Liggins Inst, Auckland 1, New Zealand.	c.gray@auckland.ac.nz		Vickers, Mark/0000-0003-4876-9356; Reynolds, Clare/0000-0001-5782-6303	Gravida: National Centre for Growth and Development; Kelliher Trust; Auckland Medical Research Foundation; Lottery Health Research Fellowship	Gravida: National Centre for Growth and Development; Kelliher Trust; Auckland Medical Research Foundation; Lottery Health Research Fellowship	The authors acknowledge the technical support from Angelica Bernal, Rachna Patel (Liggins Institute) and the Vernon Jansen Unit, University of Auckland. This work was supported by Gravida: National Centre for Growth and Development, the Kelliher Trust and the Auckland Medical Research Foundation and Lottery Health Research Fellowship.	Armitage JA, 2004, J PHYSIOL-LONDON, V561, P355, DOI 10.1113/jphysiol.2004.072009; Atkinson RL, 1999, ADV CONJUGATED LINOL, V1, P328; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Bassaganya-Riera J, 2010, CURR OPIN CLIN NUTR, V13, P569, DOI 10.1097/MCO.0b013e32833b648e; Fan L, 2013, INT J OBESITY, V37, P254, DOI 10.1038/ijo.2012.42; Gaullier JM, 2004, AM J CLIN NUTR, V79, P1118; Gebauer SK, 2011, ADV NUTR, V2, P332, DOI 10.3945/an.111.000521; GIBBONS GH, 1994, NEW ENGL J MED, V330, P1431; Gray C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053505; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Howie GJ, 2009, J PHYSIOL-LONDON, V587, P905, DOI 10.1113/jphysiol.2008.163477; Jelinska M, 2014, BBA-MOL BASIS DIS, V1842, P2230, DOI 10.1016/j.bbadis.2014.08.013; Khan I, 2004, CIRCULATION, V110, P1097, DOI 10.1161/01.CIR.0000139843.05436.A0; Li ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076961; Martin ASG, 2006, AM J CLIN NUTR, V83, p461S, DOI 10.1093/ajcn/83.2.461s; Moloney F, 2007, DIABETES, V56, P574, DOI 10.2337/db06-0384; Penedo LA, 2013, J NUTR BIOCHEM, V24, P2144, DOI 10.1016/j.jnutbio.2013.08.006; Reynolds CM, 2010, PROSTAG LEUKOTR ESS, V82, P199, DOI 10.1016/j.plefa.2010.02.021; Reynolds CM, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12110; Reynolds CM, 2013, J NUTR BIOCHEM, V24, P401, DOI 10.1016/j.jnutbio.2011.12.006; Taylor JSW, 2006, ARTERIOSCL THROM VAS, V26, P307, DOI 10.1161/01.ATV.0000199679.40501.ac; Teng KT, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-12; Tonkiss J, 1998, HYPERTENSION, V32, P108, DOI 10.1161/01.HYP.32.1.108; Toomey S, 2003, BIOCHEM SOC T, V31, P1075, DOI 10.1042/BST0311075; Toomey S, 2006, ATHEROSCLEROSIS, V187, P40, DOI 10.1016/j.atherosclerosis.2005.08.024; Torrens C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050671	26	34	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0115994	10.1371/journal.pone.0115994	http://dx.doi.org/10.1371/journal.pone.0115994			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695432	gold, Green Submitted, Green Published			2022-12-26	WOS:000350062300010
J	Humplik, JF; Bergougnoux, V; Jandova, M; Simura, J; Pencik, A; Tomanec, O; Rolcik, J; Novaak, O; Fellner, M				Humplik, Jan F.; Bergougnoux, Veronique; Jandova, Michaela; Simura, Jan; Pencik, Ales; Tomanec, Ondrej; Rolcik, Jakub; Novak, Ondrej; Fellner, Martin			Endogenous Abscisic Acid Promotes Hypocotyl Growth and Affects Endoreduplication during Dark-Induced Growth in Tomato (Solanum lycopersicum L.)	PLOS ONE			English	Article							DEPENDENT KINASE INHIBITOR; DEFICIENT MUTANT SITIENS; ARABIDOPSIS-THALIANA; SHOOT GROWTH; GENE-EXPRESSION; WATER RELATIONS; WILTY MUTANTS; ROOT-GROWTH; PROTEIN-KINASE; DE-ETIOLATION	Dark-induced growth (skotomorphogenesis) is primarily characterized by rapid elongation of the hypocotyl. We have studied the role of abscisic acid (ABA) during the development of young tomato (Solanum lycopersicum L.) seedlings. We observed that ABA deficiency caused a reduction in hypocotyl growth at the level of cell elongation and that the growth in ABA-deficient plants could be improved by treatment with exogenous ABA, through which the plants show a concentration dependent response. In addition, ABA accumulated in dark-grown tomato seedlings that grew rapidly, whereas seedlings grown under blue light exhibited low growth rates and accumulated less ABA. We demonstrated that ABA promotes DNA endoreduplication by enhancing the expression of the genes encoding inhibitors of cyclin-dependent kinases SIKRP1 and SIKRP3 and by reducing cytokinin levels. These data were supported by the expression analysis of the genes which encode enzymes involved in ABA and CK metabolism. Our results show that ABA is essential for the process of hypocotyl elongation and that appropriate control of the endogenous level of ABA is required in order to drive the growth of etiolated seedlings.	[Humplik, Jan F.; Simura, Jan; Pencik, Ales; Rolcik, Jakub; Novak, Ondrej; Fellner, Martin] Palacky Univ, Fac Sci, Ctr Reg Hana Biotechnol & Agr Res, Lab Growth Regulators, CR-77147 Olomouc, Czech Republic; [Humplik, Jan F.; Simura, Jan; Pencik, Ales; Rolcik, Jakub; Novak, Ondrej; Fellner, Martin] Palacky Univ, Fac Sci, Ctr Reg Hana Biotechnol & Agr Res, Dept Chem Biol & Genet, CR-77147 Olomouc, Czech Republic; [Humplik, Jan F.; Simura, Jan; Pencik, Ales; Rolcik, Jakub; Novak, Ondrej; Fellner, Martin] Inst Expt Bot ASCR, Olomouc, Czech Republic; [Bergougnoux, Veronique] Palacky Univ, Fac Sci, Ctr Reg Hana Biotechnol & Agr Res, Dept Mol Biol, CR-77147 Olomouc, Czech Republic; [Jandova, Michaela] Palacky Univ, Fac Sci, Dept Bot, CR-77147 Olomouc, Czech Republic; [Tomanec, Ondrej] Palacky Univ, Dept Phys Chem, Reg Ctr Adv Technol & Mat, CR-77147 Olomouc, Czech Republic	Palacky University Olomouc; Palacky University Olomouc; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; Palacky University Olomouc; Palacky University Olomouc; Palacky University Olomouc	Humplik, JF (corresponding author), Palacky Univ, Fac Sci, Ctr Reg Hana Biotechnol & Agr Res, Lab Growth Regulators, CR-77147 Olomouc, Czech Republic.	jan.humplik@upol.cz	Humplik, Jan F./H-4444-2019; NOVAK, Ondrej/F-7031-2014; Pencik, Ales/D-4488-2018; Simura, Jan/I-3560-2014; Fellner, Martin/B-2068-2010; Bergougnoux, Veronique/GZK-3304-2022	Humplik, Jan F./0000-0002-8915-4369; NOVAK, Ondrej/0000-0003-3452-0154; Pencik, Ales/0000-0002-1314-2249; Simura, Jan/0000-0002-1567-2278; Bergougnoux, Veronique/0000-0003-0681-311X	Ministry of Education, Youth and Sports of the Czech Republic (National Program of Sustainability) [LO1204, LO1305]; Operational Programs Education for Competitiveness - European Social Fund [CZ.1.07/2.3.00/20.0165, CZ.1.07/2.3.00/30.0004]; Palacky University [IGA-PrF-2013-003, IGA-PrF-2014001]	Ministry of Education, Youth and Sports of the Czech Republic (National Program of Sustainability); Operational Programs Education for Competitiveness - European Social Fund; Palacky University	This work was supported by the Ministry of Education, Youth and Sports of the Czech Republic grants no. LO1204 and LO1305 (National Program of Sustainability). V. Bergougnoux and M. Fellner were supported by the Operational Programs Education for Competitiveness - European Social Fund, project no. CZ.1.07/2.3.00/20.0165 and project no. CZ.1.07/2.3.00/30.0004, respectively. M. Jandova was supported by internal grants from Palacky University (IGA-PrF-2013-003; IGA-PrF-2014001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabadi D, 2008, PLANT J, V53, P324, DOI 10.1111/j.1365-313X.2007.03346.x; Aroca R, 2008, MICROB ECOL, V56, P704, DOI 10.1007/s00248-008-9390-y; Arsovski Andrej A, 2012, Arabidopsis Book, V10, pe0147, DOI 10.1199/tab.0147; Assmann SM, 2010, PLANT HORMONES BIOSY, P339; Barrero JM, 2005, J EXP BOT, V56, P2071, DOI 10.1093/jxb/eri206; Barrero JM, 2008, PLANT CELL ENVIRON, V31, P227, DOI 10.1111/j.1365-3040.2007.01759.x; Bergougnoux V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045255; Bisbis B, 2006, J BIOL CHEM, V281, P7374, DOI 10.1074/jbc.M506587200; Brocard-Gifford I, 2004, PLANT CELL, V16, P406, DOI 10.1105/tpc.018077; Brugiere N, 2003, PLANT PHYSIOL, V132, P1228, DOI 10.1104/pp.102.017707; Burbidge A, 1999, PLANT J, V17, P427, DOI 10.1046/j.1365-313X.1999.00386.x; Castellano MD, 2004, PLANT CELL, V16, P2380, DOI 10.1105/tpc.104.022400; Chen H, 2008, P NATL ACAD SCI USA, V105, P4495, DOI 10.1073/pnas.0710778105; CREELMAN RA, 1990, PLANT PHYSIOL, V92, P205, DOI 10.1104/pp.92.1.205; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Dekkers BJW, 2012, PLANT CELL PHYSIOL, V53, P28, DOI 10.1093/pcp/pcr113; Dobrev PI, 2002, J CHROMATOGR A, V950, P21, DOI 10.1016/S0021-9673(02)00024-9; Dolezal K, 2006, BIOORGAN MED CHEM, V14, P875, DOI 10.1016/j.bmc.2005.09.004; Dolezel J, 2007, NAT PROTOC, V2, P2233, DOI 10.1038/nprot.2007.310; Finkelstein Ruth, 2013, Arabidopsis Book, V11, pe0166, DOI 10.1199/tab.0166; Gonzalez-Guzman M, 2012, PLANT CELL, V24, P2483, DOI 10.1105/tpc.112.098574; GROOT SPC, 1991, PHYSIOL PLANTARUM, V81, P73, DOI 10.1111/j.1399-3054.1991.tb01715.x; Guan CM, 2014, PLANT PHYSIOL, V164, P1515, DOI 10.1104/pp.113.234740; Hansen H, 2000, PLANT PHYSIOL, V124, P1437, DOI 10.1104/pp.124.3.1437; Hayashi Y, 2014, PLANT CELL PHYSIOL, V55, P845, DOI 10.1093/pcp/pcu028; Hoyerova K, 2006, PHYTOCHEMISTRY, V67, P1151, DOI 10.1016/j.phytochem.2006.03.010; JONES HG, 1987, J EXP BOT, V38, P1848, DOI 10.1093/jxb/38.11.1848; Kitahata N, 2011, J PLANT RES, V124, P549, DOI 10.1007/s10265-011-0415-0; KRAEPIEL Y, 1994, PLANT J, V6, P665, DOI 10.1046/j.1365-313X.1994.6050665.x; LeNoble ME, 2004, J EXP BOT, V55, P237, DOI 10.1093/jxb/erh031; Leung J, 1998, ANN REV PLANT PHYSL; Makela P, 2003, PHYSIOL PLANTARUM, V117, P58, DOI 10.1034/j.1399-3054.2003.1170107.x; Munns R, 1996, PLANT SOIL, V185, P33, DOI 10.1007/BF02257563; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nafati M, 2010, NEW PHYTOL, V188, P136, DOI 10.1111/j.1469-8137.2010.03364.x; NAGEL OW, 1994, PHYSIOL PLANTARUM, V92, P102, DOI 10.1111/j.1399-3054.1994.tb06661.x; Nambara E, 2005, ANNU REV PLANT BIOL, V56, P165, DOI 10.1146/annurev.arplant.56.032604.144046; NEILL SJ, 1985, J EXP BOT, V36, P1222, DOI 10.1093/jxb/36.8.1222; Nitsch LMC, 2009, PLANTA, V229, P1335, DOI 10.1007/s00425-009-0913-7; Parks BM, 1999, P NATL ACAD SCI USA, V96, P14142, DOI 10.1073/pnas.96.24.14142; Parks BM, 1998, PLANT PHYSIOL, V118, P609, DOI 10.1104/pp.118.2.609; Pencik A, 2009, TALANTA, V80, P651, DOI 10.1016/j.talanta.2009.07.043; Perrot-Rechenmann C, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001446; Pettko-Szandtner A, 2006, PLANT J, V46, P111, DOI 10.1111/j.1365-313X.2006.02677.x; Quarrie S., 1987, HORMONE ACTION PLANT, P89, DOI [10.1016/B978-0-408-00796-2.50011-6, DOI 10.1016/B978-0-408-00796-2.50011-6]; Rai MK, 2011, PLANT CELL TISS ORG, V106, P179, DOI 10.1007/s11240-011-9923-9; Rivero RM, 2010, PLANT CELL PHYSIOL, V51, P1929, DOI 10.1093/pcp/pcq143; Rushton DL, 2012, PLANT BIOTECHNOL J, V10, P2, DOI 10.1111/j.1467-7652.2011.00634.x; SAAB IN, 1990, PLANT PHYSIOL, V93, P1329, DOI 10.1104/pp.93.4.1329; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scofield S, 2013, PLANT J, V75, P53, DOI 10.1111/tpj.12198; Sharp RE, 2000, J EXP BOT, V51, P1575, DOI 10.1093/jexbot/51.350.1575; Sharp RE, 2002, PLANT CELL ENVIRON, V25, P211, DOI 10.1046/j.1365-3040.2002.00798.x; SINDHU RK, 1988, PLANT PHYSIOL, V88, P178, DOI 10.1104/pp.88.1.178; Svacinova J, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-17; Symons GM, 2003, PLANTA, V216, P422, DOI 10.1007/s00425-002-0860-z; Taiz L, 2006, PLANT PHYSIOL, P485, DOI [10.1016/j.ijsu.2006.06.025, DOI 10.1016/J.IJSU.2006.06.025]; TAKAHASHI K, 1972, NATURE-NEW BIOL, V238, P92, DOI 10.1038/newbio238092a0; Takahashi N, 2013, CURR BIOL, V23, P1812, DOI 10.1016/j.cub.2013.07.051; TAL M, 1973, BIOCHEM GENET, V8, P291, DOI 10.1007/BF00486182; TAYLOR IB, 1988, PLANT CELL ENVIRON, V11, P739, DOI 10.1111/j.1365-3040.1988.tb01158.x; Thompson AJ, 2004, PLANT CELL ENVIRON, V27, P459, DOI 10.1111/j.1365-3040.2003.01164.x; Traas J, 1998, CURR OPIN PLANT BIOL, V1, P498, DOI 10.1016/S1369-5266(98)80042-3; Valente P, 1998, PLANT SCI, V134, P207, DOI 10.1016/S0168-9452(98)00062-4; WAKABAYASHI K, 1989, PHYSIOL PLANTARUM, V75, P151, DOI 10.1111/j.1399-3054.1989.tb06162.x; Wang H, 1998, PLANT J, V15, P501, DOI 10.1046/j.1365-313X.1998.00231.x; Weatherwax SC, 1996, PLANT PHYSIOL, V111, P363, DOI 10.1104/pp.111.2.363; Wen B, 2013, J EXP BOT, V64, P1135, DOI 10.1093/jxb/ert009; Yamburenko MV, 2013, J EXP BOT, V64, P4491, DOI 10.1093/jxb/ert258; ZHANG JH, 1990, J EXP BOT, V41, P1125, DOI 10.1093/jxb/41.9.1125	70	14	14	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0117793	10.1371/journal.pone.0117793	http://dx.doi.org/10.1371/journal.pone.0117793			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695830	Green Submitted, Green Published, gold			2022-12-26	WOS:000350062300031
J	Lowe, AS; Walton, JP				Lowe, Andrea S.; Walton, Joseph P.			Alterations in Peripheral and Central Components of the Auditory Brainstem Response: A Neural Assay of Tinnitus	PLOS ONE			English	Article							DORSAL COCHLEAR NUCLEUS; SALICYLATE-INDUCED TINNITUS; SENSORINEURAL HEARING-LOSS; INFERIOR COLLICULUS; BEHAVIORAL PARADIGM; DETECTION DEFICITS; EVOKED POTENTIALS; STARTLE PARADIGM; TEMPORAL ACUITY; C57BL/6 MOUSE	Chronic tinnitus, or "ringing of the ears", affects upwards of 15% of the adult population. Identifying a cost-effective and objective measure of tinnitus is needed due to legal concerns and disability issues, as well as for facilitating the effort to assess neural biomarkers. We developed a modified gap-in-noise (GIN) paradigm to assess tinnitus in mice using the auditory brainstem response (ABR). We then compared the commonly used acoustic startle reflex gap-prepulse inhibition (gap-PPI) and the ABR GIN paradigm in young adult CBA/CaJ mice before and after administrating sodium salicylate (SS), which is known to reliably induce a 16 kHz tinnitus percept in rodents. Post-SS, gap-PPI was significantly reduced at 12 and 16 kHz, consistent with previous studies demonstrating a tinnitus-induced gap-PPI reduction in this frequency range. ABR audiograms indicated thresholds were significantly elevated post-SS, also consistent with previous studies. There was a significant increase in the peak 2 (P2) to peak 1 (P1) and peak 4 (P4) to P1 amplitude ratios in the mid-frequency range, along with decreased latency of P4 at higher intensities. For the ABR GIN, peak amplitudes of the response to the second noise burst were calculated as a percentage of the first noise burst response amplitudes to quantify neural gap processing. A significant decrease in this ratio (i.e. recovery) was seen only at 16 kHz for P1, indicating the presence of tinnitus near this frequency. Thus, this study demonstrates that GIN ABRs can be used as an efficient, non-invasive, and objective method of identifying the approximate pitch and presence of tinnitus in a mouse model. This technique has the potential for application in human subjects and also indicates significant, albeit different, deficits in temporal processing in peripheral and brainstem circuits following drug induced tinnitus.	[Walton, Joseph P.] Univ S Florida, Dept Commun Sci & Disorders, Tampa, FL 33606 USA; [Lowe, Andrea S.; Walton, Joseph P.] Univ S Florida, Dept Chem & Biomed Engn, Tampa, FL USA; [Lowe, Andrea S.; Walton, Joseph P.] Univ S Florida, Global Ctr Hearing & Speech Res, Tampa, FL USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Walton, JP (corresponding author), Univ S Florida, Dept Commun Sci & Disorders, Tampa, FL 33606 USA.	jwalton1@usf.edu		Vanneste, Sven/0000-0003-1513-5752; Walton, Joseph/0000-0002-3059-1695	National Institutes of Health - National Institute on Aging [P01 AG009524]; NATIONAL INSTITUTE ON AGING [P01AG009524] Funding Source: NIH RePORTER	National Institutes of Health - National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health - National Institute on Aging P01 AG009524 under JW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JC, 1979, J COMP NEUROL, V183, P519, DOI 10.1002/cne.901830305; Baizer JS, 2012, BRAIN RES, V1485, P40, DOI 10.1016/j.brainres.2012.03.044; Boettcher FA, 1996, HEARING RES, V102, P167, DOI 10.1016/S0378-5955(96)90016-7; Brozoski TJ, 2002, J NEUROSCI, V22, P2383, DOI 10.1523/JNEUROSCI.22-06-02383.2002; Campolo J, 2013, NOISE HEALTH, V15, P398, DOI 10.4103/1463-1741.121232; Chen GD, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/658741; Chen GD, 2013, HEARING RES, V295, P100, DOI 10.1016/j.heares.2012.11.016; Chen GD, 2012, BRAIN RES, V1485, P63, DOI 10.1016/j.brainres.2012.03.016; Chen GD, 2010, HEARING RES, V265, P63, DOI 10.1016/j.heares.2010.02.010; Coomber B, 2014, EUR J NEUROSCI; Dehmel S, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00042; Dehmel S, 2012, J NEUROSCI, V32, P1660, DOI 10.1523/JNEUROSCI.4608-11.2012; Deng AC, 2010, BRAIN RES, V1344, P96, DOI 10.1016/j.brainres.2010.04.077; Eggermont JJ, 2012, OBJECTIVE ASSESSMENT; Eggermont JJ, 2012, NEUROSCIENCE TINNITU; Engineer ND, 2011, NATURE, V470, P101, DOI 10.1038/nature09656; Fournier P, 2013, HEARING RES, V295, P16, DOI 10.1016/j.heares.2012.05.011; Gu JW, 2012, JARO-J ASSOC RES OTO, V13, P819, DOI 10.1007/s10162-012-0344-1; Hall JW, 2007, NEW HDB AUDITORY EVO, Vc2007, DOI [10.1093/jxb/erm028, DOI 10.1093/JXB/ERM028]; Henry KS, 2011, HEARING RES, V280, P236, DOI 10.1016/j.heares.2011.06.002; Hickox AE, 2014, J NEUROPHYSIOL, V111, P552, DOI 10.1152/jn.00184.2013; ISON JR, 1982, J COMP PHYSIOL PSYCH, V96, P945, DOI 10.1037/0735-7036.96.6.945; JASTREBOFF PJ, 1986, ARCH OTOLARYNGOL, V112, P1050; JASTREBOFF PJ, 1988, BEHAV NEUROSCI, V102, P811, DOI 10.1037/0735-7044.102.6.811; Kaltenbach JA, 2000, HEARING RES, V140, P165, DOI 10.1016/S0378-5955(99)00197-5; Kurata K, 1997, J VET MED SCI, V59, P9, DOI 10.1292/jvms.59.9; Lin HW, 2011, JARO-J ASSOC RES OTO, V12, P605, DOI 10.1007/s10162-011-0277-0; Liu XP, 2012, BRAIN RES, V1485, P88, DOI 10.1016/j.brainres.2012.04.048; Lobarinas E, 2004, HEARING RES, V190, P109, DOI 10.1016/S0378-5955(04)00019-X; Lobarinas E, 2013, HEARING RES, V295, P150, DOI 10.1016/j.heares.2012.06.001; Longenecker RJ, 2012, BRAIN RES, V1485, P54, DOI 10.1016/j.brainres.2012.02.067; Longenecker RJ, 2011, JARO-J ASSOC RES OTO, V12, P647, DOI 10.1007/s10162-011-0276-1; Lu J, 2011, NEUROSCIENCE, V189, P187, DOI 10.1016/j.neuroscience.2011.04.073; Mehdizade Gilani Vahid, 2013, Iran J Otorhinolaryngol, V25, P221; Moller AR, 2011, TEXTBOOK OF TINNITUS, P29, DOI 10.1007/978-1-60761-145-5_5; Musiek FE, 2007, AUDITORY SYSTEM ANAT, DOI [10.1093/jxb/erm028, DOI 10.1093/JXB/ERM028]; NIST/SEMATECH, 2012, E HDB STAT METHODS; Nouvian R, 2012, COCHLEA AUDITORY NER, P83; PARHAM K, 1990, BEHAV NEUROSCI, V104, P831, DOI 10.1037/0735-7044.104.6.831; PHARM K, 1988, BEHAV NEUROSCI, V102, P881; Ralli M, 2010, OTOL NEUROTOL, V31, P823, DOI 10.1097/MAO.0b013e3181de4662; Ruttiger L, 2003, HEARING RES, V180, P39, DOI 10.1016/S0378-5955(03)00075-3; Stolzberg D, 2011, NEUROSCIENCE, V180, P157, DOI 10.1016/j.neuroscience.2011.02.005; Sun W, 2009, NEUROSCIENCE, V159, P325, DOI 10.1016/j.neuroscience.2008.12.024; Turner JG, 2008, AM J AUDIOL, V17, pS185, DOI 10.1044/1059-0889(2008/08-0006); Turner JG, 2006, BEHAV NEUROSCI, V120, P188, DOI 10.1037/0735-7044.120.1.188; U. S. Department of Veterans Affairs Veterans Benefits Administration, 2012, ANN BEN REP FISC YEA; Walton JP, 2008, JARO-J ASSOC RES OTO, V9, P90, DOI 10.1007/s10162-007-0101-z; WALTON JP, 1995, HEARING RES, V88, P19, DOI 10.1016/0378-5955(95)00093-J; Wang H, 2009, NEUROSCIENCE, V164, P747, DOI 10.1016/j.neuroscience.2009.08.026; Willott JF, 2001, HDB MOUSE AUDITORY R; Yang G, 2007, HEARING RES, V226, P244, DOI 10.1016/j.heares.2006.06.013; Zhou XM, 2006, BRAIN RES, V1091, P16, DOI 10.1016/j.brainres.2006.01.107	53	30	31	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0117228	10.1371/journal.pone.0117228	http://dx.doi.org/10.1371/journal.pone.0117228			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695496	Green Published, gold, Green Submitted			2022-12-26	WOS:000350062300019
J	Rajala, N; Hensen, F; Wessels, HJCT; Ives, D; Gloerich, J; Spelbrink, JN				Rajala, Nina; Hensen, Fenna; Wessels, Hans J. C. T.; Ives, Daniel; Gloerich, Jolein; Spelbrink, Johannes N.			Whole Cell Formaldehyde Cross-Linking Simplifies Purification of Mitochondrial Nucleoids and Associated Proteins Involved in Mitochondrial Gene Expression	PLOS ONE			English	Article							FUNCTIONAL-ORGANIZATION; MTDNA REPLICATION; MASS-SPECTROMETRY; DNA NUCLEOIDS; RNA; MEMBRANE; IDENTIFICATION; MUTATIONS; TWINKLE; MAINTENANCE	Mitochondrial DNA/protein complexes (nucleoids) appear as discrete entities inside the mitochondrial network when observed by live-cell imaging and immunofluorescence. This somewhat trivial observation in recent years has spurred research towards isolation of these complexes and the identification of nucleoid-associated proteins. Here we show that whole cell formaldehyde crosslinking combined with affinity purification and tandem mass-spectrometry provides a simple and reproducible method to identify potential nucleoid associated proteins. The method avoids spurious mitochondrial isolation and subsequent multifarious nucleoid enrichment protocols and can be implemented to allow for label-free quantification (LFQ) by mass-spectrometry. Using expression of a Flag-tagged Twinkle helicase and appropriate controls we show that this method identifies many previously identified nucleoid associated proteins. Using LFQ to compare HEK293 cells with and without mtDNA, but both expressing Twinkle-FLAG, identifies many proteins that are reduced or absent in the absence of mtDNA. This set not only includes established mtDNA maintenance proteins but also many proteins involved in mitochondrial RNA metabolism and translation and therefore represents what can be considered an mtDNA gene expression proteome. Our data provides a very valuable resource for both basic mitochondrial researchers as well as clinical geneticists working to identify novel disease genes on the basis of exome sequence data.	[Rajala, Nina; Spelbrink, Johannes N.] BioMediTech, Mitochondrial DNA Maintenance Grp, FI-33014 Tampere, Finland; [Hensen, Fenna; Wessels, Hans J. C. T.; Gloerich, Jolein; Spelbrink, Johannes N.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mitochondrial Disorders, Dept Pediat, NL-6500 HB Nijmegen, Netherlands; [Wessels, Hans J. C. T.; Gloerich, Jolein] Radboud Univ Nijmegen, Med Ctr, Radboud Prote Ctr, Dept Lab Med,Lab Genet Endocrine & Metab Disorder, NL-6500 HB Nijmegen, Netherlands; [Ives, Daniel] Natl Inst Med Res, MRC, London NW7 1AA, England	Radboud University Nijmegen; Radboud University Nijmegen; MRC National Institute for Medical Research	Spelbrink, JN (corresponding author), BioMediTech, Mitochondrial DNA Maintenance Grp, FI-33014 Tampere, Finland.	hans.spelbrink@radboudumc.nl	Hensen, Fenna/P-5719-2015; Gloerich, Jolein/L-4327-2015; Spelbrink, Johannes N/L-4661-2015; Wessels, Hans J/P-6248-2015	Gloerich, Jolein/0000-0001-5976-8426; Spelbrink, Johannes N/0000-0002-9756-2602; Wessels, Hans J/0000-0001-5957-3127	Academy of Finland; Netherlands Organization for Scientific Research [NWO: VICI] [865.10.004]	Academy of Finland(Academy of Finland); Netherlands Organization for Scientific Research [NWO: VICI](Netherlands Organization for Scientific Research (NWO))	This work was supported by the Academy of Finland [Centre of Excellence funding to JNS] http://www.aka.fi/en-GB/A/Programmes-andcooperation/Centres-of-Excellence-/; the Netherlands Organization for Scientific Research [NWO: VICI grant 865.10.004 to JNS] http://www.nwo.nl/financiering/onze-financieringsinstrumenten/nwo/vernieuwingsimpuls/vici/index. html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam TI, 2003, NUCLEIC ACIDS RES, V31, P1640, DOI 10.1093/nar/gkg251; ALBRING M, 1977, P NATL ACAD SCI USA, V74, P1348, DOI 10.1073/pnas.74.4.1348; ALLEN RD, 1995, PROTOPLASMA, V189, P1, DOI 10.1007/BF01280286; Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021; BARAT M, 1985, EXP CELL RES, V157, P207, DOI 10.1016/0014-4827(85)90163-6; Boesch P, 2010, NUCLEIC ACIDS RES, V38, P1478, DOI 10.1093/nar/gkp1143; Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200; Bogenhagen DF, 2014, CELL METAB, V19, P618, DOI 10.1016/j.cmet.2014.03.013; Busch KB, 2014, PHILOS T R SOC LON B, V369, DOI [10.1098/rstb.2014.0022, DOI 10.1098/RSTB.2014.0022]; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Chen XJ, 2005, SCIENCE, V307, P714, DOI 10.1126/science.1106391; Chen XJ, 2005, NAT REV GENET, V6, P815, DOI 10.1038/nrg1708; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dalla Rosa I, 2014, NUCLEIC ACIDS RES, V42, P8500, DOI 10.1093/nar/gku513; Di Re M, 2009, NUCLEIC ACIDS RES, V37, P5701, DOI 10.1093/nar/gkp614; FISHER RP, 1988, MOL CELL BIOL, V8, P3496, DOI 10.1128/MCB.8.8.3496; Fukuoh A, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145117; Garrido N, 2003, MOL BIOL CELL, V14, P1583, DOI 10.1091/mbc.E02-07-0399; Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359; He J, 2012, NUCLEIC ACIDS RES, V40, P6109, DOI 10.1093/nar/gks266; He J, 2012, NUCLEIC ACIDS RES, V40, P6097, DOI 10.1093/nar/gks257; He JY, 2007, J CELL BIOL, V176, P141, DOI 10.1083/jcb.200609158; Hensen F, 2014, BIOCHIMIE, V100, P219, DOI 10.1016/j.biochi.2013.09.017; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Iborra FJ, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-9; Ishihama Y, 2002, J CHROMATOGR A, V979, P233, DOI 10.1016/S0021-9673(02)01402-4; Kaufman BA, 2000, P NATL ACAD SCI USA, V97, P7772, DOI 10.1073/pnas.140063197; Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257; Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501; Kucej M, 2008, J CELL SCI, V121, P1861, DOI 10.1242/jcs.028605; Kucej M, 2007, TRENDS CELL BIOL, V17, P586, DOI 10.1016/j.tcb.2007.08.007; Lee KW, 2013, J BIOL CHEM, V288, P31386, DOI 10.1074/jbc.M113.515692; Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134; MacAlpine DM, 2000, EMBO J, V19, P767, DOI 10.1093/emboj/19.4.767; Meeusen S, 2003, J CELL BIOL, V163, P503, DOI 10.1083/jcb.200304040; MIGNOTTE B, 1986, NUCLEIC ACIDS RES, V14, P5969, DOI 10.1093/nar/14.15.5969; NASS MMK, 1969, J MOL BIOL, V42, P521, DOI 10.1016/0022-2836(69)90240-X; NASS MMK, 1963, J CELL BIOL, V19, P593, DOI 10.1083/jcb.19.3.593; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; Rajala N, 2014, NUCLEIC ACIDS RES, V42, P952, DOI 10.1093/nar/gkt988; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Reyes A, 2011, NUCLEIC ACIDS RES, V39, P5098, DOI 10.1093/nar/gkr052; Richman TR, 2014, NUCLEIC ACIDS RES, V42, P5483, DOI 10.1093/nar/gku179; Richter R, 2010, EMBO J, V29, P1116, DOI 10.1038/emboj.2010.14; Rorbach J, 2008, NUCLEIC ACIDS RES, V36, P5787, DOI 10.1093/nar/gkn576; Rorbach J, 2014, MOL BIOL CELL, V25, P2542, DOI 10.1091/mbc.E14-01-0014; SCHATZ G, 1964, BIOCHEM BIOPH RES CO, V15, P127, DOI 10.1016/0006-291X(64)90311-0; Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058; Spelbrink JN, 2000, J BIOL CHEM, V275, P24818, DOI 10.1074/jbc.M000559200; Spelbrink JN, 2010, IUBMB LIFE, V62, P19, DOI 10.1002/iub.282; Sutherland BW, 2008, J MASS SPECTROM, V43, P699, DOI 10.1002/jms.1415; Szczesny RJ, 2013, NUCLEIC ACIDS RES, V41, P3144, DOI 10.1093/nar/gkt029; VANTUYLE GC, 1981, J BIOL CHEM, V256, P2772; Wang YS, 2006, J BIOL CHEM, V281, P25791, DOI 10.1074/jbc.M604501200; Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215; Wessels HJCT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068340; Wolf AR, 2014, CELL REP, V7, P918, DOI 10.1016/j.celrep.2014.03.035; Zick M, 2009, BBA-MOL CELL RES, V1793, P5, DOI 10.1016/j.bbamcr.2008.06.013	58	21	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0116726	10.1371/journal.pone.0116726	http://dx.doi.org/10.1371/journal.pone.0116726			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695250	gold, Green Published, Green Submitted			2022-12-26	WOS:000350062300017
J	Felappi, JF; Vieira, RC; Fagundes, NJR; Verrastro, LV				Felappi, Jessica F.; Vieira, Renata C.; Fagundes, Nelson J. R.; Verrastro, Laura V.			So Far Away, Yet So Close: Strong Genetic Structure in Homonota uruguayensis (Squamata, Phyllodactylidae), a Species with Restricted Geographic Distribution in the Brazilian and Uruguayan Pampas	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; PHENOTYPIC EVOLUTION; HEMIDACTYLUS GECKOS; GUINEA ISLANDS; DNA; MITOCHONDRIAL; PHYLOGEOGRAPHY; BIOGEOGRAPHY; DIVERSIFICATION; GEKKONIDAE	The Pampas is a biologically rich South American biome, but is poorly represented in phylogeographic studies. While the Pleistocene glacial cycles may have affected the evolutionary history of species distributed in forested biomes, little is known about their effects on the habitats that remained stable through glacial cycles. The South American Pampas have been covered by grasslands during both glacial and interglacial periods and therefore represent an interesting system to test whether the genetic structure in such environments is less pronounced. In this study, we sampled Pampean populations of Homonota uruguayensis from Southern Brazil and Uruguay to assess the tempo and mode of population divergence, using both morphological measurements and molecular markers. Our results indicate that, in spite of its narrow geographic distribution, populations of H. uruguayensis show high levels of genetic structure. We found four major well-supported mtDNA clades with strong geographic associations. Estimates of their divergence times fell between 3.16 and 1.82 million years before the present. Populations from the central portion of the species distribution, on the border between Uruguay and Brazil, have high genetic diversity and may have undergone a population expansion approximately 250,000 years before the present. The high degree of genetic structure is reflected in the analyses of morphological characters, and most individuals could be correctly assigned to their parental population based on morphology alone. Finally, we discuss the biogeographic and conservation implications of these findings.	[Felappi, Jessica F.; Vieira, Renata C.; Verrastro, Laura V.] Univ Fed Rio Grande do Sul, Dept Zool, Porto Alegre, RS, Brazil; [Fagundes, Nelson J. R.] Univ Fed Rio Grande do Sul, Dept Genet, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Fagundes, NJR (corresponding author), Univ Fed Rio Grande do Sul, Dept Genet, Porto Alegre, RS, Brazil.	nelson.fagundes@ufrgs.br; lauraver@ufrgs.br	Verrastro, Laura/I-3243-2012; Fagundes, Nelson/F-7490-2014	Verrastro, Laura/0000-0002-3094-8906; Felappi, Jessica/0000-0003-3814-5646; Fagundes, Nelson/0000-0003-0456-0323	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [479412/2008-1]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors received funding for this study from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq-http://www.cnpq.br/), grant # 479412/2008-1 to LVV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achaval F, 2007, ANFIBIOS REPTILES UR; Arnold EN, 2008, ZOOL SCR, V37, P619, DOI 10.1111/j.1463-6409.2008.00351.x; Austin JJ, 2004, MOL PHYLOGENET EVOL, V31, P109, DOI 10.1016/j.ympev.2003.07.011; Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beheregaray LB, 2008, MOL ECOL, V17, P3754, DOI 10.1111/j.1365-294X.2008.03857.x; Behling H, 2005, REV PALAEOBOT PALYNO, V133, P235, DOI 10.1016/j.revpalbo.2004.10.004; BILENCA D, 2004, IDENTIFICACION AREAS; Boldrini I., 2009, CAMPOS SULINOS CONSE, P63; Brown RP, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-271; Cabrera AL, 1980, BIOGEOGRAFIA AM LATI, DOI [10.1016/j.ympev.2015.01.003, DOI 10.1016/J.YMPEV.2015.01.003]; Carnaval AC, 2008, J BIOGEOGR, V35, P1187, DOI 10.1111/j.1365-2699.2007.01870.x; Carnaval AC, 2009, SCIENCE, V323, P785, DOI 10.1126/science.1166955; Carranza S, 2000, P ROY SOC B-BIOL SCI, V267, P637, DOI 10.1098/rspb.2000.1050; Carreira S., 2005, REPTILES URUGUAY; Clegg SM, 2002, EVOLUTION, V56, P2090; Crisp MD, 2009, NATURE, V458, P754, DOI 10.1038/nature07764; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Felsenstein J, 2006, MOL BIOL EVOL, V23, P691, DOI 10.1093/molbev/msj079; Fernandes FA, 2009, GENETICA, V136, P449, DOI 10.1007/s10709-008-9345-8; Fontoura-Rodrigues ML, 2013, THESIS PONTIFICIA U; Freitas TRO, 2012, J MAMMAL, V93, P1355, DOI DOI 10.1644/12-MAMM-A-007.1; Fu YX, 1997, GENETICS, V147, P915; Gamble T, 2011, J EVOLUTION BIOL, V24, P231, DOI 10.1111/j.1420-9101.2010.02184.x; Gamble T, 2008, ZOOL SCR, V37, P355, DOI 10.1111/j.1463-6409.2008.00330.x; Gamble T, 2008, MOL PHYLOGENET EVOL, V46, P269, DOI 10.1016/j.ympev.2007.08.013; Garzione CN, 2008, SCIENCE, V320, P1304, DOI 10.1126/science.1148615; Grazziotin FG, 2006, MOL ECOL, V15, P3969, DOI 10.1111/j.1365-294X.2006.03057.x; Grela I.A., 2004, THESIS U REPUBLICA U; Gudynas E., 1981, ASRA Journal, V1, P13; Gudynas E., 1986, Contribuciones en Biologia Centro Educativo Don Orione, P1; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harris DJ, 2004, MOL PHYLOGENET EVOL, V30, P855, DOI 10.1016/S1055-7903(03)00260-4; Heller R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062992; Hickerson MJ, 2010, MOL PHYLOGENET EVOL, V54, P291, DOI 10.1016/j.ympev.2009.09.016; Jesus J, 2005, MOL PHYLOGENET EVOL, V34, P480, DOI 10.1016/j.ympev.2004.11.006; Jesus J, 2006, HERPETOL J, V16, P291; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Kuhner MK, 2006, BIOINFORMATICS, V22, P768, DOI 10.1093/bioinformatics/btk051; LANDE R, 1980, AM NAT, V116, P463, DOI 10.1086/283642; Lanfear R, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-82; Ljubisavljevic Katarina, 2007, Zootaxa, V1613, P1; LYNCH M, 1986, EVOLUTION, V40, P915, DOI 10.1111/j.1558-5646.1986.tb00561.x; MANTEL N, 1967, CANCER RES, V27, P209; Mathys BA, 2011, P ROY SOC B-BIOL SCI, V278, P2392, DOI 10.1098/rspb.2010.2302; MEDRANO JF, 1990, BIOTECHNIQUES, V8, P43; Miller JR, 2008, GENETICS, V180, P1023, DOI 10.1534/genetics.108.092031; Miller MP, 2005, J HERED, V96, P722, DOI 10.1093/jhered/esi119; Morando M, 2014, ZOOL SCR, V43, P249, DOI 10.1111/zsc.12052; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Nascimento FF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061924; Oliver PM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-386; Ortiz-Jaureguizar E, 2006, J ARID ENVIRON, V66, P498, DOI 10.1016/j.jaridenv.2006.01.007; Overbeck GE, 2007, PERSPECT PLANT ECOL, V9, P101, DOI 10.1016/j.ppees.2007.07.005; Passoni JC, 2008, MOL PHYLOGENET EVOL, V46, P403, DOI 10.1016/j.ympev.2007.10.022; Pellegrino KCM, 2005, BIOL J LINN SOC, V85, P13, DOI 10.1111/j.1095-8312.2005.00472.x; Piantoni C, 2006, AMPHIBIA-REPTILIA, V27, P393, DOI 10.1163/156853806778190060; Polly P.D., 2004, PALAEONTOL ELECTRON, V7, p7A; Pook CE, 2000, MOL PHYLOGENET EVOL, V15, P269, DOI 10.1006/mpev.1999.0756; Prugnolle F, 2002, HEREDITY, V88, P161, DOI 10.1038/sj.hdy.6800060; Siedchlag AC, 2010, MOL PHYLOGENET EVOL, V56, P622, DOI 10.1016/j.ympev.2010.04.027; Soriano A., 1991, ECOSYSTEMS WORLD A, P367; Speranza PR, 2007, J BIOGEOGR, V34, P427, DOI 10.1111/j.1365-2699.2006.01622.x; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Torres-Perez F, 2007, J ZOOL SYST EVOL RES, V45, P72, DOI 10.1111/j.1439-0469.2006.00392.x; Turchetto C, 2014, MOL ECOL, V23, P374, DOI 10.1111/mec.12632; Turchetto-Zolet AC, 2013, MOL ECOL, V22, P1193, DOI 10.1111/mec.12164; Vaz-Ferreira R, 1973, B SOC ZOOLOGICA URUG, V2, P53, DOI [10.1016/j.anireprosci.2014.07.023, DOI 10.1016/J.ANIREPROSCI.2014.07.023]; Vaz-Ferreira R, 1965, REV FACULTAD HUMANID, V22, P239; Vieira RC, 2012, THESIS U FEDERAL RIO; Werneck FP, 2012, EVOLUTION, V66, P3014, DOI 10.1111/j.1558-5646.2012.01682.x; Wlasiuk G, 2003, EVOLUTION, V57, P913; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Xia XH, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P615; Zamudio KR, 1997, BIOL J LINN SOC, V62, P421, DOI 10.1111/j.1095-8312.1997.tb01634.x	83	8	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118162	10.1371/journal.pone.0118162	http://dx.doi.org/10.1371/journal.pone.0118162			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692471	Green Published, gold, Green Submitted			2022-12-26	WOS:000350061500105
J	Jarczok, MN; Kleber, ME; Koenig, J; Loerbroks, A; Herr, RM; Hoffmann, K; Fischer, JE; Benyamini, Y; Thayer, JF				Jarczok, Marc N.; Kleber, Marcus E.; Koenig, Julian; Loerbroks, Adrian; Herr, Raphael M.; Hoffmann, Kristina; Fischer, Joachim E.; Benyamini, Yael; Thayer, Julian F.			Investigating the Associations of Self-Rated Health: Heart Rate Variability Is More Strongly Associated than Inflammatory and Other Frequently Used Biomarkers in a Cross Sectional Occupational Sample	PLOS ONE			English	Article							OVERNIGHT URINARY NOREPINEPHRINE; OLDER-ADULTS; NEUROVISCERAL INTEGRATION; NEURAL REGULATION; GLYCEMIC STATUS; GLUCOSE; MORTALITY; MODEL; STIMULATION; STRESS	The present study aimed to investigate the possible mechanisms linking a single-item measure of global self-rated health (SRH) with morbidity by comparing the association strengths between SRH with markers of autonomic nervous system (ANS) function, inflammation, blood glucose and blood lipids. Cross-sectional comprehensive health-check data of 3947 working adults (age 42 +/- 11) was used to calculate logistic regressions, partial correlations and compare correlation strength using Olkins Z. Adjusted logistic regression models showed a negative association between SRH (higher values indicating worse health) and measures of heart rate variability (HRV). Glycemic markers were positively associated with poor SRH. No adjusted association was found with inflammatory markers, BP or lipids. In both unadjusted and adjusted linear models Pearson's correlation strength was significantly higher between SRH with HRV measures compared to SRH with other biomarkers. This is the first study investigating the association of ANS function and SRH. We showed that a global measure of SRH is associated with HRV, and that all measures of ANS function were significantly more strongly associated with SRH than any other biomarker. The current study supports the hypothesis that the extent of brain-body communication, as indexed by HRV, is associated with self-rated health.	[Jarczok, Marc N.; Kleber, Marcus E.; Herr, Raphael M.; Hoffmann, Kristina; Fischer, Joachim E.; Thayer, Julian F.] Heidelberg Univ, Mannheim Med Fac, Mannheim Inst Publ Hlth Social & Prevent Med, Mannheim, Germany; [Koenig, Julian; Thayer, Julian F.] Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA; [Loerbroks, Adrian] Univ Dusseldorf, Fac Med, Inst Occupat & Social Med, Dusseldorf, Germany; [Herr, Raphael M.] Univ Amsterdam, Dept Clin Psychol, NL-1018 WB Amsterdam, Netherlands; [Benyamini, Yael] Tel Aviv Univ, Bob Shapell Sch Social Work, IL-69978 Tel Aviv, Israel	Ruprecht Karls University Heidelberg; University System of Ohio; Ohio State University; Heinrich Heine University Dusseldorf; University of Amsterdam; Tel Aviv University	Koenig, J (corresponding author), Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA.	Koenig.393@osu.edu	Koenig, Julian/J-8863-2017; Thayer, Julian/AAA-1161-2020; Jarczok, Marc N/A-2383-2014; Jarczok, M/GZN-2543-2022; Benyamini, Yael/G-8367-2012; Herr, Raphael/GYU-5115-2022	Koenig, Julian/0000-0003-1009-9625; Thayer, Julian/0000-0001-9385-3421; Jarczok, Marc N/0000-0002-6055-385X; Benyamini, Yael/0000-0001-5110-8212; Herr, Raphael/0000-0003-0079-2792; Kleber, Marcus/0000-0003-0663-7275	Mannheim Institute of Public Health (Heidelberg University); Humboldt Senior Research Award	Mannheim Institute of Public Health (Heidelberg University); Humboldt Senior Research Award	The work was supported by internal funds of the Mannheim Institute of Public Health (Heidelberg University). The Director of this Institute JEF is co-author of the manuscript and as such played a role in preparation and approval of this manuscript. He had no role in study design, analysis and decision to publish the manuscript. Julian F. Thayer was supported by a Humboldt Senior Research Award. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner JM, 2011, AM J EPIDEMIOL, V173, P882, DOI 10.1093/aje/kwq445; Barger SD, 2007, HEALTH PSYCHOL, V26, P85, DOI 10.1037/0278-6133.26.1.85; Benyamini Y, 1999, RES AGING, V21, P477, DOI 10.1177/0164027599213007; Benyamini Y, 1999, RES AGING, V21, P392, DOI 10.1177/0164027599213002; Benyamini Y, 2014, HEALTH PSYCHOL, V33, P317, DOI 10.1037/a0031371; Benyamini Y, 2011, PSYCHOL HEALTH, V26, P1407, DOI 10.1080/08870446.2011.621703; Cameron OG, 2001, PSYCHOSOM MED, V63, P697, DOI 10.1097/00006842-200109000-00001; Camm AJ, 1996, CIRCULATION, V93, P1043; Chapman BP, 2006, J GERONTOL B-PSYCHOL, V61, pP362, DOI 10.1093/geronb/61.6.P362; Christian LM, 2011, PSYCHONEUROENDOCRINO, V36, P1495, DOI 10.1016/j.psyneuen.2011.04.003; DeSalvo KB, 2006, QUAL LIFE RES, V15, P191, DOI 10.1007/s11136-005-0887-2; Dowd JB, 2010, ANN EPIDEMIOL, V20, P743, DOI 10.1016/j.annepidem.2010.06.007; Fagundes CP, 2011, PSYCHONEUROENDOCRINO, V36, P1137, DOI 10.1016/j.psyneuen.2011.02.005; Geiger SD, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/518263; Goldman N, 2004, ANN EPIDEMIOL, V14, P49, DOI 10.1016/S1047-2797(03)00077-2; Groves DA, 2005, NEUROSCI BIOBEHAV R, V29, P493, DOI 10.1016/j.neubiorev.2005.01.004; Hall M, 2004, PSYCHOSOM MED, V66, P56, DOI 10.1097/01.PSY.0000106884.58744.09; Haring R, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-103; Haseli-Mashhadi N, 2009, BMC PUBLIC HEALTH, V9, DOI [10.1186/1471-2458-9-130, 10.1186/1471-2458-9-368]; Henderson LA, 2007, PAIN, V128, P20, DOI 10.1016/j.pain.2006.08.013; Hillebrand S, 2013, EUROPACE, V15, P742, DOI 10.1093/europace/eus341; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Janszky I, 2005, BRAIN BEHAV IMMUN, V19, P555, DOI 10.1016/j.bbi.2005.01.001; Jarczok MN, 2014, J INTERN MED, V276, P667, DOI 10.1111/joim.12295; Jarczok MN, 2013, INT J CARDIOL, V168, P3025, DOI 10.1016/j.ijcard.2013.04.147; Jarczok MN, 2013, NEUROSCI BIOBEHAV R, V37, P1810, DOI 10.1016/j.neubiorev.2013.07.004; Jarczok MN, 2013, INT J CARDIOL, V167, P855, DOI 10.1016/j.ijcard.2012.02.002; JENKINS CD, 1988, J CLIN EPIDEMIOL, V41, P313, DOI 10.1016/0895-4356(88)90138-2; Jylha M, 2006, J CLIN EPIDEMIOL, V59, P465, DOI 10.1016/j.jclinepi.2005.12.004; Jylha M, 2009, SOC SCI MED, V69, P307, DOI 10.1016/j.socscimed.2009.05.013; Kemp AH, 2010, BIOL PSYCHIAT, V67, P1067, DOI [10.1016/j.biopsych.2009.11.019, 10.1016/j.biopsych.2009.12.012]; Kim JH, 2013, J CLIN SLEEP MED, V9, P1057, DOI 10.5664/jcsm.3082; Kissler HJ, 2005, METABOLISM, V54, P881, DOI 10.1016/j.metabol.2005.01.036; Koenig J, 2014, EUR J PAIN, V18, P301, DOI 10.1002/j.1532-2149.2013.00379.x; Lane RD, 2009, NEUROIMAGE, V47, P1135, DOI 10.1016/j.neuroimage.2009.06.013; Li J, 2013, INT J BEHAV MED, V20, P495, DOI 10.1007/s12529-012-9255-0; Li J, 2012, AM J IND MED, V55, P808, DOI 10.1002/ajim.22018; Lima-Costa MF, 2012, AM J EPIDEMIOL, V175, P228, DOI 10.1093/aje/kwr290; Loerbroks A, 2010, J PSYCHOSOM RES, V69, P151, DOI 10.1016/j.jpsychores.2010.03.004; Luft FC, 2012, J AM SOC HYPERTENS, V6, P23, DOI 10.1016/j.jash.2011.09.006; Mantyselka PT, 2003, JAMA-J AM MED ASSOC, V290, P2435, DOI 10.1001/jama.290.18.2435; Martinez DJ, 2010, J GERONTOL B-PSYCHOL, V65, P715, DOI 10.1093/geronb/gbp115; Marty N, 2007, PHYSIOLOGY, V22, P241, DOI 10.1152/physiol.00010.2007; Page KA, 2013, JAMA-J AM MED ASSOC, V309, P63, DOI 10.1001/jama.2012.116975; Page KA, 2011, J CLIN INVEST, V121, P4161, DOI 10.1172/JCI57873; Pereira EAC, 2007, STEREOT FUNCT NEUROS, V85, P175, DOI 10.1159/000101296; Pinquart M, 2001, PSYCHOL AGING, V16, P414, DOI 10.1037//0882-7974.16.3.414; Pocai A, 2005, CELL METAB, V1, P53, DOI 10.1016/j.cmet.2004.11.001; Roy M, 2012, TRENDS COGN SCI, V16, P147, DOI 10.1016/j.tics.2012.01.005; Schmidt B, 2014, INT J BEHAV MED, V21, P750, DOI 10.1007/s12529-013-9345-7; Schnittker J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084933; Shirom A, 2008, HEALTH PSYCHOL, V27, P567, DOI 10.1037/0278-6133.27.5.567; Singh-Manoux A, 2006, J EPIDEMIOL COMMUN H, V60, P364, DOI 10.1136/jech.2005.039883; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; Thayer JF, 2009, J INTERN MED, V265, P439, DOI 10.1111/j.1365-2796.2008.02023.x; Thayer J.F., 2004, CRIT PERSPECT, P567; Thayer JF, 2002, SCAND J PSYCHOL, V43, P123, DOI 10.1111/1467-9450.00277; Thayer JF, 2000, J AFFECT DISORDERS, V61, P201, DOI 10.1016/S0165-0327(00)00338-4; Thayer JF, 2006, ANN NY ACAD SCI, V1088, P361, DOI 10.1196/annals.1366.014; Thayer JF, 2013, INT J CARDIOL, V162, P240, DOI 10.1016/j.ijcard.2011.05.058; Thayer JF, 2012, NEUROSCI BIOBEHAV R, V36, P747, DOI 10.1016/j.neubiorev.2011.11.009; Thayer JF, 2011, RESP PHYSIOL NEUROBI, V178, P387, DOI 10.1016/j.resp.2011.05.016; Thayer JF, 2010, BRAIN BEHAV IMMUN, V24, P1223, DOI 10.1016/j.bbi.2010.07.247; Thayer JF, 2010, INT J CARDIOL, V141, P122, DOI 10.1016/j.ijcard.2009.09.543; Thayer JF, 2009, ANN BEHAV MED, V37, P141, DOI 10.1007/s12160-009-9101-z; Thayer JF, 2009, NEUROSCI BIOBEHAV R, V33, P81, DOI 10.1016/j.neubiorev.2008.08.004; Tracey KJ, 2010, NAT IMMUNOL, V11, P561, DOI 10.1038/ni0710-561; Wagner DC, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130241; Weiss T, 2008, NEUROIMAGE, V41, P1372, DOI 10.1016/j.neuroimage.2008.03.047; Wittling A, 2014, ANS EXPLORER; Yamada Chizumi, 2012, Environmental Health and Preventive Medicine, V17, P457, DOI 10.1007/s12199-012-0274-x	72	60	60	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117196	10.1371/journal.pone.0117196	http://dx.doi.org/10.1371/journal.pone.0117196			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC0WZ	25693164	Green Published, Green Submitted, gold			2022-12-26	WOS:000350061500042
J	Zhang, L; Chen, P; Chen, L; Weng, TJ; Zhang, SC; Zhou, X; Zhang, B; Liu, LC				Zhang, Li; Chen, Peng; Chen, Lin; Weng, Tujun; Zhang, Shichang; Zhou, Xia; Zhang, Bo; Liu, Luchuan			Inhibited Wnt Signaling Causes Age-Dependent Abnormalities in the Bone Matrix Mineralization in the Apert Syndrome FGFR2(S252W/+) Mice	PLOS ONE			English	Article							RECEPTOR-RELATED PROTEIN-5; FRIZZLED-RELATED PROTEIN-1; FIBROBLAST GROWTH-FACTORS; MESENCHYMAL STEM-CELLS; OSTEOBLAST DIFFERENTIATION; PARATHYROID-HORMONE; FGFR2 MUTATIONS; MOUSE MODEL; MASS; CRANIOSYNOSTOSIS	Apert syndrome (AS) is a type of autosomal dominant disease characterized by premature fusion of the cranial sutures, severe syndactyly, and other abnormalities in internal organs. Approximately 70% of AS cases are caused by a single mutation, S252W, in fibroblast growth factor receptor 2 (FGFR2). Two groups have generated FGFR2 knock-in mice Fgfr2 (S252W/+) that exhibit features of AS. During the present study of AS using the Fgfr2 (S252W/+) mouse model, an age-related phenotype of bone homeostasis was discovered. The long bone mass was lower in 2 month old mutant mice than in age-matched controls but higher in 5 month old mutant mice. This unusual phenotype suggested that bone marrow-derived mesenchymal stem cells (BMSCs), which are vital to maintain bone homeostasis, might be involved. BMSCs were isolated from Fgfr2 (S252W/+) mice and found that S252W mutation could impair osteogenic differentiation BMSCs but enhance mineralization of more mature osteoblasts. A microarray analysis revealed that Wnt pathway inhibitors SRFP1/2/4 were up-regulated in mutant BMSCs. This work provides evidence to show that the Wnt/beta-catenin pathway is inhibited in both mutant BMSCs and osteoblasts, and differentiation defects of these cells can be ameliorated by Wnt3a treatment. The present study suggested that the bone abnormalities caused by deregulation of Wnt pathway may underlie the symptoms of AS.	[Zhang, Li; Chen, Lin; Zhou, Xia; Liu, Luchuan] Third Mil Med Univ, Daping Hosp, Dept Stomatol, Chongqing 400042, Peoples R China; [Zhang, Li; Chen, Lin; Zhou, Xia; Liu, Luchuan] Third Mil Med Univ, Inst Surg Res, Chongqing 400042, Peoples R China; [Zhang, Li; Chen, Peng; Weng, Tujun; Zhang, Shichang; Zhang, Bo] Third Mil Med Univ, Daping Hosp, Dept 4, State Key Lab Trauma Burns & Combined Injury, Chongqing 400042, Peoples R China; [Zhang, Li; Chen, Peng; Weng, Tujun; Zhang, Shichang; Zhang, Bo] Third Mil Med Univ, Inst Surg Res, State Key Lab Trauma Burns & Combined Injury, Chongqing 400042, Peoples R China; [Chen, Peng] PLA 324 Hosp, Dept Neurosurg, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University; Army Medical University	Zhang, B (corresponding author), Third Mil Med Univ, Daping Hosp, Dept 4, State Key Lab Trauma Burns & Combined Injury, Chongqing 400042, Peoples R China.	zhangbo67184@163.com; liuluchuan1957@126.com	Zhang, Shichang/K-1715-2019	Zhang, Shichang/0000-0002-6587-2518	Special Funds for Major State Basic Research Program of China (973 program) [2011CB964701]; Natural Science Foundation Project of CQ CSTC [cstc2012jjA0427]	Special Funds for Major State Basic Research Program of China (973 program)(National Basic Research Program of China); Natural Science Foundation Project of CQ CSTC(Natural Science Foundation Project of CQ CSTC)	The work was supported by the Special Funds for Major State Basic Research Program of China (973 program) (No. 2011CB964701), Natural Science Foundation Project of CQ CSTC (No. cstc2012jjA0427). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Bodine PVN, 2004, MOL ENDOCRINOL, V18, P1222, DOI 10.1210/me.2003-0498; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; BRUDER SP, 1994, J CELL BIOCHEM, V56, P283, DOI 10.1002/jcb.240560303; Chen L, 2003, BONE, V33, P169, DOI 10.1016/S8756-3282(03)00222-9; Cho HY, 2010, BONE, V47, P263, DOI 10.1016/j.bone.2010.05.010; Cohen Jr MM, 2000, CRANIOSYNOSTOSIS DIA, P331; Cruciat CM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a015081; Eijken M, 2008, J CELL BIOCHEM, V104, P568, DOI 10.1002/jcb.21651; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Fragale A, 1999, AM J PATHOL, V154, P1465, DOI 10.1016/S0002-9440(10)65401-6; Gimble JM, 2006, J CELL BIOCHEM, V98, P251, DOI 10.1002/jcb.20777; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Hehr U, 1999, MOL GENET METAB, V68, P139, DOI 10.1006/mgme.1999.2915; Holmes G, 2009, DEV BIOL, V328, P273, DOI 10.1016/j.ydbio.2009.01.026; Hurley MM, 2006, BIOCHEM BIOPH RES CO, V341, P989, DOI 10.1016/j.bbrc.2006.01.044; Ibrahimi OA, 2001, P NATL ACAD SCI USA, V98, P7182, DOI 10.1073/pnas.121183798; Jilka RL, 2013, J GERONTOL A-BIOL, V68, P1209, DOI 10.1093/gerona/glt046; Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4; Lemonnier J, 2001, AM J PATHOL, V158, P1833, DOI 10.1016/S0002-9440(10)64139-9; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Lomri A, 1998, J CLIN INVEST, V101, P1310; Mansukhani A, 2000, J CELL BIOL, V149, P1297, DOI 10.1083/jcb.149.6.1297; Mansukhani A, 2005, J CELL BIOL, V168, P1065, DOI 10.1083/jcb.200409182; MCLEOD MJ, 1980, TERATOLOGY, V22, P299, DOI 10.1002/tera.1420220306; Miraoui H, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3146re9; Montero A, 2000, J CLIN INVEST, V105, P1085, DOI 10.1172/JCI8641; Nakanishi R, 2008, J BONE MINER RES, V23, P271, DOI 10.1359/JBMR.071007; Nuckolls GH, 1999, CLEFT PALATE-CRAN J, V36, P12, DOI 10.1597/1545-1569(1999)036<0012:PTUCM>2.3.CO;2; Ornitz DM, 2001, GENOME BIOL, V2; PARK WJ, 1995, AM J HUM GENET, V57, P321; Passos-Bueno MR, 1999, HUM MUTAT, V14, P115; ROUSSEAU F, 1994, NATURE, V371, P252, DOI 10.1038/371252a0; Shukla V, 2007, NAT GENET, V39, P1145, DOI 10.1038/ng2096; Slaney SF, 1996, AM J HUM GENET, V58, P923; So N, 2008, BIOCHEM BIOPH RES CO, V376, P454, DOI 10.1016/j.bbrc.2008.08.165; Su N, 2010, HUM MOL GENET, V19, P1199, DOI 10.1093/hmg/ddp590; Takeda S, 2003, ANNU REV NUTR, V23, P403, DOI 10.1146/annurev.nutr.23.011702.073312; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Thisse B, 2005, DEV BIOL, V287, P390, DOI 10.1016/j.ydbio.2005.09.011; von Gernet S, 2000, CLIN GENET, V57, P137, DOI 10.1034/j.1399-0004.2000.570208.x; Wang YL, 2005, DEVELOPMENT, V132, P3537, DOI 10.1242/dev.01914; WILKIE AOM, 1995, NAT GENET, V9, P165, DOI 10.1038/ng0295-165; Yao W, 2010, J BONE MINER RES, V25, P190, DOI 10.1359/jbmr.090719; Yu K, 2000, P NATL ACAD SCI USA, V97, P14536, DOI 10.1073/pnas.97.26.14536; Zhou X, 2013, AM J MED GENET A, V161A, P983, DOI 10.1002/ajmg.a.35824	47	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e112716	10.1371/journal.pone.0112716	http://dx.doi.org/10.1371/journal.pone.0112716			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693202	Green Published, Green Submitted, gold			2022-12-26	WOS:000350061500003
J	Tao, ZC; Li, CL; Sun, S				Tao, Zhencheng; Li, Chaolun; Sun, Song			Grazing and Metabolism of Euphausia pacifica in the Yellow Sea	PLOS ONE			English	Article							SPATIAL-DISTRIBUTION; TROPHIC INTERACTIONS; POPULATION-STRUCTURE; NITROGEN BUDGETS; ANTARCTIC KRILL; CHLOROPHYLL-A; JAPAN SEA; CARBON; GROWTH; ZOOPLANKTON	Grazing and metabolism of Euphausia pacifica in the Yellow Sea were studied from September 2006 to August 2007. Euphausia pacifica is a selective-feeding omnivore and grazing rates among different months were monitored using a Coulter Counter and batch culture feeding experiments. Euphausia pacifica mainly grazed microzooplankton in August and September, which resulted in an increase in chlorophyll a concentration. Oxygen consumption rate of E. pacifica was 38.7-42.5 mu mol O-2 g(-1) DW h(-1) in March, which was four times higher than the oxygen consumption rates in September and December. The vigorous metabolism of E. pacifica in March consumed 3.1% of body carbon daily, which is likely related to its high reproduction and grazing rate. Respiration and metabolism of E. pacifica in September and December were similar and were lower. O:N ratio of E. pacifica was the highest (17.3-23.8) in March when spawning activity occurred and when food was abundant. The energetic source of E. pacifica during September and December was mostly protein from eating a carnivorous diet, including such items as microzooplankton. Euphausia pacifica was found in cold water at the bottom of the Yellow Sea in summer and autumn and maintained a low consumption status. O: N ratios of E. pacifica in March, September, and December were negatively correlated with SSTs and no significant correlation was found between O: N ratios and chlorophyll a concentration. Seawater temperature is clearly the most important parameter influencing the metabolism of E. pacifica.	[Tao, Zhencheng; Li, Chaolun; Sun, Song] Chinese Acad Sci, Inst Oceanol, Key Lab Marine Ecol & Environm Sci, Qingdao, Peoples R China; [Sun, Song] Chinese Acad Sci, Inst Oceanol, Jiaozhou Bay Marine Ecosyst Res Stn, Qingdao, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; Institute of Oceanology, CAS	Sun, S (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Marine Ecol & Environm Sci, Qingdao, Peoples R China.	sunsong@qdio.ac.cn	Li, Chao/GSM-8117-2022	Li, Chao/0000-0001-6110-6210; Li, Chaolun/0000-0003-1890-0587; Zhencheng, TAO/0000-0002-5948-0171	National Natural Science Foundation of P. R. China [41306155, 41230963]; National Key Basic Research Program of China [2011CB403604]	National Natural Science Foundation of P. R. China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of P. R. China (No. 41306155 and 41230963), and National Key Basic Research Program of China (No. 2011CB403604).	ALLDREDGE AL, 1988, PROG OCEANOGR, V20, P41, DOI 10.1016/0079-6611(88)90053-5; [Anonymous], 1984, J OCEANOL SOC KOREA; BODEN BRIAN P., 1955, BULL SCRIPPS INST OCEANOGR TECH SER, V6, P287; Brinton E., 1962, B SCRIPPS I OCEANOGR, V8, P21; Bryan AK, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0051204, DOI 10.1371/JOURNAL.PONE.0051204]; Cai B, 1986, S CHINESE CRUSTACEAN, V1, P140; Calbet A, 1999, LIMNOL OCEANOGR, V44, P1370, DOI 10.4319/lo.1999.44.6.1370; CARPENTER SR, 1985, BIOSCIENCE, V35, P634, DOI 10.2307/1309989; Chang J, 2003, DEEP-SEA RES PT II, V50, P1237, DOI 10.1016/S0967-0645(03)00020-1; da Costa RM, 2012, HARMFUL ALGAE, V17, P75, DOI 10.1016/j.hal.2012.03.002; Dilling L, 1998, MAR ECOL PROG SER, V170, P189, DOI 10.3354/meps170189; Du XN, 2014, J PLANKTON RES, V36, P1031, DOI 10.1093/plankt/fbu027; Endo Y, 1981, ECOLOGICAL STUDIES E; FROST BW, 1972, LIMNOL OCEANOGR, V17, P805, DOI 10.4319/lo.1972.17.6.0805; Gnaiger E., 1983, CALCULATION ENERGETI, P337, DOI [10.1007/978-3-642-81863-9_30, DOI 10.1007/978-3-642-81863-9_30]; Guo DH, 2003, ACTA OCEANOL SIN, V22, P265; He C.B., 1959, OCEANOL LIMNOL SINIC, V2, P11; Iguchi N, 2004, PROG OCEANOGR, V61, P213, DOI 10.1016/j.pocean.2004.06.007; IGUCHI N, 1995, J PLANKTON RES, V17, P1757, DOI 10.1093/plankt/17.9.1757; IKEDA T, 1974, Memoirs of the Faculty of Fisheries Hokkaido University, V22, P1; IKEDA T, 1984, POLAR BIOL, V3, P1, DOI 10.1007/BF00265561; Kang YD, 1966, S 9 C W PAC FISH RES; Kim HS, 2010, DEEP-SEA RES PT II, V57, P1733, DOI 10.1016/j.dsr2.2010.03.017; Kim H, 2013, LIMNOL OCEANOGR-METH, V11, P382, DOI 10.4319/lom.2013.11.382; LANDRY MR, 1982, MAR BIOL, V67, P283, DOI 10.1007/BF00397668; LASKER R, 1966, J FISH RES BOARD CAN, V23, P1291, DOI 10.1139/f66-121; LIE HJ, 1986, PROG OCEANOGR, V17, P229, DOI 10.1016/0079-6611(86)90046-7; Lu SG, 2009, CHIN J OCEANOL LIMN, V27, P793, DOI 10.1007/s00343-009-9221-0; MACKAS D, 1976, J EXP MAR BIOL ECOL, V25, P77, DOI 10.1016/0022-0981(76)90077-0; Mauchline J, 1969, Adv. mar. Biol., V7, P1; MAYZAUD P, 1973, MAR BIOL, V21, P19, DOI 10.1007/BF00351188; MAYZAUD P, 1988, MAR ECOL PROG SER, V45, P289, DOI 10.3354/meps045289; [孟田湘 Meng Tianxiang], 2003, [海洋水产研究, Marine Fisheries Research], V24, P1; Nakagawa Y, 2004, MAR ECOL PROG SER, V271, P261, DOI 10.3354/meps271261; Nakagawa Yoshizumi, 2001, Plankton Biology and Ecology, V48, P68; OHMAN MD, 1984, MAR ECOL PROG SER, V19, P125, DOI 10.3354/meps019125; Pagano M, 2003, ESTUAR COAST SHELF S, V56, P433, DOI 10.1016/S0272-7714(02)00193-2; Pagano M, 1998, HYDROBIOLOGIA, V390, P83, DOI 10.1023/A:1003561821745; Pinchuk AI, 2007, MAR BIOL, V151, P257, DOI 10.1007/s00227-006-0483-1; Ponomareva LA, 1966, EUPHAUSIIDS N PACIFI; Pu XM, 2004, J PLANKTON RES, V26, P1049, DOI 10.1093/plankt/fbh097; PUTT M, 1989, LIMNOL OCEANOGR, V34, P1097, DOI 10.4319/lo.1989.34.6.1097; ROSS RM, 1982, MAR BIOL, V68, P15, DOI 10.1007/BF00393136; ROSS RM, 1981, LIMNOL OCEANOGR, V26, P235, DOI 10.4319/lo.1981.26.2.0235; ROSS RM, 1982, MAR BIOL, V68, P1, DOI 10.1007/BF00393135; Saborowski R, 2002, MAR BIOL, V140, P547; Shaw CT, 2010, DEEP-SEA RES PT II, V57, P584, DOI 10.1016/j.dsr2.2009.10.008; Shaw T.L., 2006, PROTOCOLS MEASURING; SMALL LF, 1967, LIMNOL OCEANOGR, V12, P272, DOI 10.4319/lo.1967.12.2.0272; SUH HL, 1991, MAR BIOL, V111, P45, DOI 10.1007/BF01986344; Sun S, 2011, J PLANKTON RES, V33, P873, DOI 10.1093/plankt/fbq160; Sun S, 2010, DEEP-SEA RES PT II, V57, P1006, DOI 10.1016/j.dsr2.2010.02.002; Swadling KM, 2005, MAR BIOL, V146, P1169, DOI 10.1007/s00227-004-1519-z; Taki K, 2010, J PLANKTON RES, V32, P761, DOI 10.1093/plankt/fbq027; TORRES JJ, 1983, MAR BIOL, V74, P79, DOI 10.1007/BF00394278; Wang R, 2003, J FISH CHINA S, V27, P31; Wang Rong, 2004, Ocean Science Journal, V39, P1; Wang XJ, 2005, FISHERY MODERNIZATIO, V3, P37; WIDDOWS J, 1978, J MAR BIOL ASSOC UK, V58, P125, DOI 10.1017/S0025315400024450; Winkler, 1888, BER DTSCH CHEM GES, V21, P2843, DOI [10.1002/cber.188802102122, DOI 10.1002/CBER.188802102122]; Xue Ying, 2004, Journal of Fishery Sciences of China, V11, P420; Yoon WD, 2000, J PLANKTON RES, V22, P939, DOI 10.1093/plankt/22.5.939; Yu Y, 2014, MAR BIOL RES, V10, P641, DOI 10.1080/17451000.2013.852683; Zhang WC, 2006, HYDROBIOLOGIA, V553, P357, DOI 10.1007/s10750-005-0857-2; Zhang WC, 2002, AQUAT MICROB ECOL, V27, P249, DOI 10.3354/ame027249	65	11	11	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0115825	10.1371/journal.pone.0115825	http://dx.doi.org/10.1371/journal.pone.0115825			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25688560	Green Published, gold, Green Submitted			2022-12-26	WOS:000350322700005
J	Chakraborty, A; Mahapatra, T; Mahapatra, S; Ansari, S; Siddhanta, S; Banerjee, S; Banerjee, D; Sarkar, RN; Guha, SK; Chakraborty, N				Chakraborty, Avirup; Mahapatra, Tanmay; Mahapatra, Sanchita; Ansari, Sabbir; Siddhanta, Sattik; Banerjee, Siwalik; Banerjee, Dipanjan; Sarkar, Rathindra Nath; Guha, Subhashish Kamal; Chakraborty, Nilanjan			Distribution and Determinants of Cytomegalovirus Induced End Organ Disease/s among People Living with HIV/AIDS in a Poor Resource Setting: Observation from India	PLOS ONE			English	Article							ACQUIRED-IMMUNODEFICIENCY-SYNDROME; HIV-INFECTED PATIENTS; ANTIRETROVIRAL THERAPY; AIDS; MORTALITY; SURVIVAL; VIRUS; VIREMIA; PREDICTORS; AUTOPSY	Background In India, despite well-established anti-retroviral treatment programs, Cytomegalovirus (CMV) infection-related end-organ diseases (EODs) still remain a major concern resulting in exacerbation of morbidity and mortality among HIV/AIDS patients. A prospective study was designed to understand the distribution and prognosis of CMV associated EODs and to determine a standardized cut-off value for serum CMV viral load associated with the development of EODs amongst HIV/AIDS subjects. Methods In a cohort of 400 late-diagnosed HAART naive HIV/AIDS subjects attending anti-retroviral centers of Kolkata during 2008-2014, the median duration of follow-up was 560 days, and at least 3 visits subsequent to the baseline were mandatory for eligibility. HIV-1 and CMV viral load were estimated by performing Real-Time Polymerase Chain Reactions (PCR). Results Among subjects, 40.5% (162/400) had CMV EODs which were more common at lower CD4 counts. Poor prognosis and higher death rate were associated with a low CD4 count and increased HIV-1 and CMV viral loads. Subjects having higher CD4 count responded better to therapy [for CD4 = 60-100: Risk Ratio: RR = 1.48 (95% Confidence Interval: 95% CI = 1.181.82) and for CD4 = 30-59: RR = 1.64 (95% CI = 1.18-2.27)]. The cut off value of the serum CMV viral load (expressed as log10DNA/ml serum) associated with the development of EODs and disseminated CMV EODs was determined as 5.4 (p<0.0001) and 6.4 (p<0.0001) respectively. These cut offs were found to have satisfactorily high sensitivity, specificity, positive and negative predictive values. Conclusion Prognosis of CMV EOD was poor as indicated by higher death rates among subjects with lower CD4 count, and specific cut-off values were found to have useful potential for identification and treatment of CMV infected HIV/AIDS patients in due time to avoid CMV EODs among HIV/AIDS subjects. Targeted intervention programs seemed to be required urgently to make these cut-offs operational in order to minimize the burden of CMV EOD in this vulnerable population.	[Chakraborty, Avirup; Ansari, Sabbir; Chakraborty, Nilanjan] ID & BG Hosp, ICMR Virus Unit, Kolkata 700010, India; [Mahapatra, Tanmay; Mahapatra, Sanchita] Univ Calif Los Angeles, Jonathan & Karin Fielding Sch Publ Hlth, Los Angeles, CA USA; [Siddhanta, Sattik; Banerjee, Siwalik; Sarkar, Rathindra Nath] Calcutta Med Coll & Hosp, Dept Gen Med, Kolkata 700073, India; [Banerjee, Dipanjan] Calcutta Med Coll & Hosp, Apex Clin, Kolkata 700073, India; [Guha, Subhashish Kamal] Sch Trop Med, Dept Virol, Kolkata 700073, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); ICMR - Virus Unit, Kolkata; University of California System; University of California Los Angeles; Calcutta School of Tropical Medicine (CSTM)	Chakraborty, N (corresponding author), ID & BG Hosp, ICMR Virus Unit, GB4,57 Dr SC Banerjee Rd Beliaghata, Kolkata 700010, India.	nilanjan_19@yahoo.com			Institutional Intramural Funding of Indian Council of Medical Research, Virus Unit, Government of India	Institutional Intramural Funding of Indian Council of Medical Research, Virus Unit, Government of India	The current research (Principal Investigator: NC) was funded by the Institutional Intramural Funding of Indian Council of Medical Research, Virus Unit, Government of India (http://icmrvirusunit.org.in/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arama V, 2014, J MED VIROL, V86, P1821, DOI 10.1002/jmv.24027; Brooks GF, 2007, JAWETZ MELNICK ADELB, P428; COLLIER AC, 1987, AM J MED, V82, P593, DOI 10.1016/0002-9343(87)90105-7; Crum NF, 2006, JAIDS-J ACQ IMM DEF, V41, P194, DOI 10.1097/01.qai.0000179459.31562.16; DREW WL, 1992, CLIN INFECT DIS, V14, P608, DOI 10.1093/clinids/14.2.608-a; Erice A, 2003, CLIN INFECT DIS, V37, P567, DOI 10.1086/375843; GERNA G, 1990, AIDS, V4, P1027, DOI 10.1097/00002030-199010000-00014; Goldberg DE, 2005, RETINA-J RET VIT DIS, V25, P633, DOI 10.1097/00006982-200507000-00015; GOODGAME RW, 1993, ANN INTERN MED, V119, P924, DOI 10.7326/0003-4819-119-9-199311010-00010; JABS DA, 1989, ARCH OPHTHALMOL-CHIC, V107, P75, DOI 10.1001/archopht.1989.01070010077031; JACOBSON MA, 1988, ANN INTERN MED, V108, P585, DOI 10.7326/0003-4819-108-4-585; Jain MK, 2003, CLIN INFECT DIS, V36, P1030, DOI 10.1086/368186; KALAYJIAN RC, 1993, MEDICINE, V72, P67, DOI 10.1097/00005792-199303000-00001; Kovacs A, 1999, NEW ENGL J MED, V341, P77, DOI 10.1056/NEJM199907083410203; Mermin J, 2008, LANCET, V371, P752, DOI 10.1016/S0140-6736(08)60345-1; Monforte AD, 1997, AIDS, V11, P517, DOI 10.1097/00002030-199704000-00016; MORGELLO S, 1987, HUM PATHOL, V18, P289, DOI 10.1016/S0046-8177(87)80012-6; RodriguezBarradas MC, 1996, CLIN INFECT DIS, V23, P76, DOI 10.1093/clinids/23.1.76; Shepp DH, 1996, J ACQ IMMUN DEF SYND, V11, P460, DOI 10.1097/00042560-199604150-00006; Spector SA, 1996, J INT ASS PHYS AIDS, V2, P15; Walmsley SL, 2001, ANTIVIR THER, V6, P47; Wohl DA, 2009, HIV CLIN TRIALS, V10, P143, DOI 10.1310/hct1003-143; Wohl DA, 2005, JAIDS-J ACQ IMM DEF, V38, P538, DOI 10.1097/01.qai.0000155204.96973.c3	23	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117466	10.1371/journal.pone.0117466	http://dx.doi.org/10.1371/journal.pone.0117466			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679798	Green Published, gold, Green Submitted			2022-12-26	WOS:000350682600066
J	Heskamp, S; Boerman, OC; Molkenboer-Kuenen, JDM; Wauters, CA; Strobbe, LJA; Mandigers, CMPW; Bult, P; Oyen, WJG; van der Graaf, WTA; van Laarhoven, HWM				Heskamp, Sandra; Boerman, Otto C.; Molkenboer-Kuenen, Janneke D. M.; Wauters, Carla A.; Strobbe, Luc J. A.; Mandigers, Caroline M. P. W.; Bult, Peter; Oyen, Wim J. G.; van der Graaf, Winette T. A.; van Laarhoven, Hanneke W. M.			Upregulation of IGF-1R Expression during Neoadjuvant Therapy Predicts Poor Outcome in Breast Cancer Patients	PLOS ONE			English	Article							GROWTH-FACTOR-I; MONOCLONAL-ANTIBODY; FACTOR RECEPTOR; TRASTUZUMAB RESISTANCE; COLORECTAL-CANCER; EWING SARCOMA; PHASE-II; CELLS; PATHWAY; SENSITIVITY	Introduction The insulin-like growth factor 1 receptor (IGF-1R) may be involved in the development of resistance against conventional cancer treatment. The aim of this study was to assess whether IGF-1R expression of breast tumors changes during neoadjuvant therapy and to study whether these changes were associated with survival. Methods Paraffin embedded tumor tissue was collected from pretreatment biopsies and surgical resections of 62 breast cancer patients who were treated with neoadjuvant chemotherapy or endocrine therapy. IGF-1R expression was determined immunohistochemically and compared before and after treatment. Results High membranous IGF-1R expression at diagnosis correlated significantly with ER positivity, low tumor stage (stage I/II) and longer overall survival (p < 0.05). After neoadjuvant treatment, membranous IGF-1R expression remained the same in 41 (65%) tumors, was upregulated in 11 (18%) tumors and downregulated in 11 (18%) tumors. Changes in membranous IGF-1R expression were associated with overall survival (log-rank test: p = 0.013, multivariate cox-regression: p = 0.086). Mean overall survival time for upregulation, no change, and downregulation in IGF-1R expression was 3.0 +/- 0.5 years, 7.3 +/- 1.0 years and 15.0 +/- 1.8 years, respectively. Changes in other parameters were not significantly associated with survival. Conclusion Neoadjuvant therapy can induce changes in IGF-1R expression. Upregulation of IGF-1R expression after neoadjuvant treatment is a poor prognostic factor in breast cancer patients, providing a rationale for incorporating anti-IGF-1R drugs in the management of these patients.	[Heskamp, Sandra; Boerman, Otto C.; Molkenboer-Kuenen, Janneke D. M.; Oyen, Wim J. G.] Radboud Univ Nijmegen, Med Ctr, Dept Nucl Med, Nijmegen, Netherlands; [Heskamp, Sandra; van der Graaf, Winette T. A.; van Laarhoven, Hanneke W. M.] Radboud Univ Nijmegen, Med Ctr, Dept Med Oncol, Nijmegen, Netherlands; [Wauters, Carla A.] Canisius Wilhelmina Hosp, Dept Pathol, Nijmegen, Netherlands; [Strobbe, Luc J. A.] Canisius Wilhelmina Hosp, Dept Surg, Nijmegen, Netherlands; [Mandigers, Caroline M. P. W.] Canisius Wilhelmina Hosp, Dept Internal Med, Nijmegen, Netherlands; [Bult, Peter] Radboud Univ Nijmegen, Med Ctr, Dept Pathol, NL-6525 ED Nijmegen, Netherlands; [van Laarhoven, Hanneke W. M.] Univ Amsterdam, Acad Med Ctr, Dept Med Oncol, NL-1105 AZ Amsterdam, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Canisius-Wilhelmina Hospital; Canisius-Wilhelmina Hospital; Canisius-Wilhelmina Hospital; Radboud University Nijmegen; University of Amsterdam; Academic Medical Center Amsterdam	Heskamp, S (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Nucl Med, Nijmegen, Netherlands.	sandra.heskamp@radboudumc.nl	van Laarhoven, Hanneke/AAW-3464-2021; Boerman, Otto C/A-8112-2014; Strobbe, Luc JA/N-8760-2018; van der Graaf, Winette T/A-5006-2014; Heskamp, Sandra/O-8762-2015; Bult, Peter/L-4236-2015; Oyen, Wim J.G./D-4178-2009; Oyen, Wim J.G./AAD-3373-2020	Boerman, Otto C/0000-0001-6832-101X; van der Graaf, Winette T/0000-0001-7549-3338; Heskamp, Sandra/0000-0001-7250-0846; Bult, Peter/0000-0001-6427-9889; Oyen, Wim J.G./0000-0001-8235-7078; Oyen, Wim J.G./0000-0001-8235-7078; van Laarhoven, H.W.M./0000-0003-1274-5643	Dutch Research Council for Hanneke van Laarhoven [016.096.010]	Dutch Research Council for Hanneke van Laarhoven	This study was financially supported by a personal research grant of the Dutch Research Council for Hanneke van Laarhoven (016.096.010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnedos M, 2009, ANN ONCOL, V20, P1948, DOI 10.1093/annonc/mdp234; Asmane I, 2012, EUR J CANCER, V48, P3027, DOI 10.1016/j.ejca.2012.05.009; Cao L, 2008, CANCER RES, V68, P8039, DOI 10.1158/0008-5472.CAN-08-1712; Dallas NA, 2009, CANCER RES, V69, P1951, DOI 10.1158/0008-5472.CAN-08-2023; Drury SC, 2011, ENDOCR-RELAT CANCER, V18, P565, DOI 10.1530/ERC-10-0046; Dunn SE, 1997, CANCER RES, V57, P2687; Eckstein N, 2009, CANCER RES, V69, P2996, DOI 10.1158/0008-5472.CAN-08-3153; Fagan DH, 2012, CANCER RES, V72, P3372, DOI 10.1158/0008-5472.CAN-12-0684; Feldser D, 1999, CANCER RES, V59, P3915; FOEKENS JA, 1989, CANCER, V63, P2139, DOI 10.1002/1097-0142(19890601)63:11<2139::AID-CNCR2820631112>3.0.CO;2-D; Fu PF, 2011, BREAST CANCER RES TR, V130, P307, DOI 10.1007/s10549-011-1605-0; Gallardo A, 2012, BRIT J CANCER, V106, P1367, DOI 10.1038/bjc.2012.85; Gooch JL, 1999, BREAST CANCER RES TR, V56, P1, DOI 10.1023/A:1006208721167; Guo YS, 1998, J CELL PHYSIOL, V175, P141, DOI 10.1002/(SICI)1097-4652(199805)175:2<141::AID-JCP3>3.0.CO;2-O; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Harris LN, 2007, CLIN CANCER RES, V13, P1198, DOI 10.1158/1078-0432.CCR-06-1304; Hartog H, 2007, EUR J CANCER, V43, P1895, DOI 10.1016/j.ejca.2007.05.021; Hartog H, 2011, BREAST CANCER RES TR, V129, P725, DOI 10.1007/s10549-010-1256-6; Heskamp S, 2014, MOL IMAGING BIOL, V16, P529, DOI 10.1007/s11307-014-0723-6; Kaufman PA, 2010, CANCER RES, V70, DOI 10.1158/0008-5472.SABCS10-S1-4; Kim JH, 2010, ONCOL REP, V23, P989, DOI 10.3892/or_00000724; Lee AV, 1999, MOL ENDOCRINOL, V13, P787, DOI 10.1210/me.13.5.787; Malempati S, 2012, J CLIN ONCOL, V30, P256, DOI 10.1200/JCO.2011.37.4355; Nahta R, 2005, CANCER RES, V65, P11118, DOI 10.1158/0008-5472.CAN-04-3841; Olmos D, 2010, LANCET ONCOL, V11, P129, DOI 10.1016/S1470-2045(09)70354-7; PAPA V, 1993, CANCER RES, V53, P3736; Pappo AS, 2011, J CLIN ONCOL, V29, P4541, DOI 10.1200/JCO.2010.34.0000; PEYRAT JP, 1988, CANCER RES, V48, P6429; Pinhel IF, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2719; RAILO MJ, 1994, EUR J CANCER, V30A, P307, DOI 10.1016/0959-8049(94)90247-X; Ramalingam SS, 2011, J CLIN ONCOL, V29, P4574, DOI 10.1200/JCO.2011.36.6799; Samani AA, 2007, ENDOCR REV, V28, P20, DOI 10.1210/er.2006-0001; STEWART AJ, 1990, J BIOL CHEM, V265, P21172; Tolcher AW, 2009, J CLIN ONCOL, V27, P5800, DOI 10.1200/JCO.2009.23.6745; Tong LC, 2011, AM J SURG PATHOL, V35, P545, DOI 10.1097/PAS.0b013e31820e6237; Watkins D, 2011, J CLIN ONCOL S, V29; Yerushalmi R, 2012, BREAST CANCER RES TR, V132, P131, DOI 10.1007/s10549-011-1529-8; Zha JP, 2009, MOL CANCER THER, V8, P2110, DOI 10.1158/1535-7163.MCT-09-0381	38	28	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117745	10.1371/journal.pone.0117745	http://dx.doi.org/10.1371/journal.pone.0117745			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680198	Green Published, gold, Green Submitted			2022-12-26	WOS:000350682600083
J	Franceschini, A; Capece, M; Chiozzi, P; Falzoni, S; Sanz, JM; Sarti, AC; Bonora, M; Pinton, P; Di Virgilio, F				Franceschini, Alessia; Capece, Marina; Chiozzi, Paola; Falzoni, Simonetta; Sanz, Juana Maria; Sarti, Alba Clara; Bonora, Massimo; Pinton, Paolo; Di Virgilio, Francesco			The P2X7 receptor directly interacts with the NLRP3 inflammasome scaffold protein	FASEB JOURNAL			English	Article						purinergic receptors; extracellular ATP; inflammation	P2X(7) RECEPTOR; EXTRACELLULAR ATP; PLASMA-MEMBRANE; ACTIVATION; IMMUNITY; CELLS; MECHANISMS; RELEASE; TOXINS; BETA	The P2X7 receptor (P2X7R) is a known and powerful activator of the NOD-like receptor (NLR) P3 inflammasome; however, the underlying pathways are poorly understood. Thus, we investigated the molecular mechanisms involved. The effect of P2X7R expression and activation on NLRP3 expression and recruitment was investigated by Western blot, RT-PCR, coimmunoprecipitation, and confocal microscopy in microglial mouse cell lines selected for reduced P2X7R expression and in primary cells from P2X7R(-/-) C57BL/6 mice. We show here that P2X7R activation by ATP (EC50 = 1 mM) or benzoyl-ATP (EC50 = 300 mM) and P2X7R down-modulation caused a 2- to 8-fold up-regulation of NLRP3 mRNA in mouse N13 microglial cells. Moreover, NLRP3 mRNA was also up-regulated in primary microglial and macrophage cells from P2X7R(-/-) mice. Confocal microscopy and immunoprecipitation assays showed that P2X7R and NLRP3 closely interacted at discrete subplasmalemmal sites. Finally, P2X7R stimulation caused a transient (3-4 min) cytoplasmic Ca2+ increase localized to small (2-3 mu m wide) discrete subplasmalemmal regions. The Ca2+ increase drove P2X7R recruitment and a 4-fold increase in P2X7R/NLRP3 association within 1-2 min. These data show a close P2X7R and NLRP3 interaction and highlight the role of P2X7R in the localized cytoplasmic ion changes responsible for both NLRP3 recruitment and activation.	[Franceschini, Alessia; Capece, Marina; Chiozzi, Paola; Falzoni, Simonetta; Sarti, Alba Clara; Bonora, Massimo; Pinton, Paolo; Di Virgilio, Francesco] Univ Ferrara, Sect Pathol Oncol & Expt Biol, Dept Morphol Surg & Expt Med, I-44121 Ferrara, Italy; [Sanz, Juana Maria] Univ Ferrara, Sect Internal Med Gerontol & Clin Nutr, Dept Med Sci, I-44121 Ferrara, Italy; [Bonora, Massimo; Pinton, Paolo; Di Virgilio, Francesco] Univ Ferrara, Lab Technol Adv Therapies, I-44121 Ferrara, Italy	University of Ferrara; University of Ferrara; University of Ferrara	Di Virgilio, F (corresponding author), Univ Ferrara, Sect Pathol Oncol & Expt Biol, Dept Morphol Surg & Expt Med, Via Borsari 46, I-44121 Ferrara, Italy.	fdv@unife.it	Bonora, Massimo/AAC-3609-2022; DI VIRGILIO, Francesco/O-4634-2019; Pinton, Paolo/J-8025-2012; Sanz, Juana/AAF-7941-2020; Franceschini, Alessia/H-4992-2017; Franceschini, Alessia/K-3426-2018; Sarti, Alba Clara/AAO-7737-2020; Di Virgilio, Francesco/J-3754-2018	Bonora, Massimo/0000-0002-5752-3318; DI VIRGILIO, Francesco/0000-0003-3566-1362; Pinton, Paolo/0000-0001-7108-6508; Franceschini, Alessia/0000-0001-7122-6232; Franceschini, Alessia/0000-0001-7122-6232; Di Virgilio, Francesco/0000-0003-3566-1362; Chiozzi, Paola/0000-0003-4952-334X; Sanz, Juana M/0000-0003-3372-2758; Falzoni, Simonetta/0000-0002-6594-0357	Italian Association for Cancer Research Grant [IG 5354, IG 14442]; Telethon of Italy [GGP06070]; European Research Area Network Neuron Joint Transnational Project "Nanostroke" grant; Ministry of Health of Italy [RF-2011-02348435]; Italian Ministry of Education, University and Research Grant [RBAP11FXBC_001]; University of Ferrara; Commission of European Communities (7th Framework Program) [HEALTH-F2-2007-202231]; Italian Ministry of Education, University and Research [20129JLHSY_002, RBAP11FXBC_002, RBFR10EGVP_001]	Italian Association for Cancer Research Grant(Fondazione AIRC per la ricerca sul cancro); Telethon of Italy(Fondazione Telethon); European Research Area Network Neuron Joint Transnational Project "Nanostroke" grant; Ministry of Health of Italy(Ministry of Health, Italy); Italian Ministry of Education, University and Research Grant; University of Ferrara; Commission of European Communities (7th Framework Program)(European Commission); Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR))	F.D.V. is supported by Italian Association for Cancer Research Grant IG 5354, Telethon of Italy Grant GGP06070, an European Research Area Network Neuron Joint Transnational Project "Nanostroke" grant, Ministry of Health of Italy Grant RF-2011-02348435, Italian Ministry of Education, University and Research Grant RBAP11FXBC_001, and institutional funds from the University of Ferrara. F.D.V. was also supported by a grant from the Commission of European Communities (7th Framework Program HEALTH-F2-2007-202231 "ATPBone"). P.P. is supported by Italian Association for Cancer Research Grant IG 14442 and grants from the Italian Ministry of Education, University and Research (Progetti Ricerca Interesse Nazionale 20129JLHSY_002, and RBAP11FXBC_002, and Futuro in Ricerca RBFR10EGVP_001).	Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bours Martijn Jan Leo, 2011, Front Biosci (Schol Ed), V3, P1443; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; Di Virgilio F, 2007, TRENDS PHARMACOL SCI, V28, P465, DOI 10.1016/j.tips.2007.07.002; Di Virgilio F, 2013, PHARMACOL REV, V65, P872, DOI 10.1124/pr.112.006171; Di Virgilio F, 2009, PURINERG SIGNAL, V5, P251, DOI 10.1007/s11302-009-9145-3; DIVIRGILIO F, 1989, J IMMUNOL, V143, P1955; DIVIRGILIO F, 1995, IMMUNOL TODAY, V16, P524, DOI 10.1016/0167-5699(95)80045-X; Ferrari D, 1996, J IMMUNOL, V156, P1531; Franchi L, 2007, J BIOL CHEM, V282, P18810, DOI 10.1074/jbc.M610762200; Gross O, 2011, IMMUNOL REV, V243, P136, DOI 10.1111/j.1600-065X.2011.01046.x; Haneklaus M, 2013, CURR OPIN IMMUNOL, V25, P40, DOI 10.1016/j.coi.2012.12.004; Harder J, 2009, J IMMUNOL, V183, P5823, DOI 10.4049/jimmunol.0900444; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Huggett JF, 2013, CLIN CHEM, V59, P892, DOI 10.1373/clinchem.2013.206375; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lemaire I, 2006, J IMMUNOL, V177, P7257, DOI 10.4049/jimmunol.177.10.7257; Lu B, 2012, NATURE, V488, P670, DOI 10.1038/nature11290; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Rayah A, 2012, MICROBES INFECT, V14, P1254, DOI 10.1016/j.micinf.2012.07.006; Sanz JM, 2009, J IMMUNOL, V182, P4378, DOI 10.4049/jimmunol.0803612; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; STEINBERG TH, 1987, J BIOL CHEM, V262, P8884; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	31	131	141	1	23	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2450	2461		10.1096/fj.14-268714	http://dx.doi.org/10.1096/fj.14-268714			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	25690658	Green Submitted			2022-12-26	WOS:000355209500022
J	Shi, XZ; Zirbes, KM; Rasnnussen, TL; Ferdous, A; Garry, MG; Koyano-Nakagawa, N; Garry, DJ				Shi, Xiaozhong; Zirbes, Katie M.; Rasnnussen, Tara L.; Ferdous, Anwarul; Garry, Mary G.; Koyano-Nakagawa, Naoko; Garry, Daniel J.			The Transcription Factor Mesp1 Interacts with cAMP-responsive Element Binding Protein 1 (Creb1) and Coactivates Ets Variant 2 (Etv2) Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCIBLE CASSETTE EXCHANGE; GENOME-WIDE ANALYSIS; MICE LACKING; PROGENITOR SPECIFICATION; MYOGENIC PROGENITORS; CELL DEVELOPMENT; ACTS DOWNSTREAM; EMBRYONIC STEM; YOLK-SAC; BLOOD	Mesoderm posterior 1 (Mesp1) is well recognized for its role in cardiac development, although it is expressed broadly in mesodermal lineages. We have previously demonstrated important roles for Mesp land Ets variant 2 (Etv2) during lineage specification, but their relationship has not been defined. This study reveals that Mesp1 binds to the proximal promoter and transactivates Etv2 gene expression via the CRE motif. We also demonstrate the protein-protein interaction between Mesp 1 and cAMP-responsive element binding protein 1 (Creb1) in vitro and in vivo. Utilizing transgenesis, lineage tracing, flow cytometry, and immunostaining technologies, we define the lineage relationship between Mesp1- and Etv2-expressing cell populations. We observe that the majority of Etv2-EYFP+ cells are derived from Mesp1-Cre(+) cells in both the embryo and yolk sac. Furthermore, we observe that the conditional deletion of Etv2, using a Mesp1-Cre transgenic strategy, results in vascular and hematopoietic detects similar to those observed in the global deletion of Etv2 and that it has embryonic lethality by embryonic day 9.5. In summary, our study supports the hypothesis that Mesp1 is a direct upstream transactivator of Etv2 during embryogenesis and that Creb1 is an important cofactor of Mesp1 in the transcriptional regulation of Etv2 gene expression.	[Shi, Xiaozhong; Zirbes, Katie M.; Rasnnussen, Tara L.; Garry, Mary G.; Koyano-Nakagawa, Naoko; Garry, Daniel J.] Univ Minnesota, Lillehei Heart Inst, Sch Med, Minneapolis, MN 55455 USA; [Ferdous, Anwarul] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; University of Texas Southwestern Medical Center Dallas	Garry, DJ (corresponding author), Univ Minnesota, Lillehei Heart Inst, 22316th St SE,4-146 CCRB, Minneapolis, MN 55455 USA.	garry@umn.edu			National Institutes of Health [U01 HL100407, R01 HL122576]; American Heart Association [0970499N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100407, R01HL122576] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants U01 HL100407 and R01 HL122576 (to D. J. G.). This work was also supported by the American Heart Association (Jon Holden DeHaan Four) dation Grant 0970499N) (to D. J. G.).	Abedin MJ, 2014, CIRC RES, V114, P1690, DOI 10.1161/CIRCRESAHA.1134303145; Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; Behrens AN, 2014, STEM CELLS DEV, V23, P2004, DOI 10.1089/scd.2013.0525; BENBROOK DM, 1994, NUCLEIC ACIDS RES, V22, P1463, DOI 10.1093/nar/22.8.1463; Bleckmann SC, 2002, MOL CELL BIOL, V22, P1919, DOI 10.1128/MCB.22.6.1919-1925.2002; Blendy JA, 1996, NATURE, V380, P162, DOI 10.1038/380162a0; Bondue A, 2008, CELL STEM CELL, V3, P69, DOI 10.1016/j.stem.2008.06.009; Bondue A, 2010, CIRC RES, V107, P1414, DOI 10.1161/CIRCRESAHA.110.227058; Bowlin KM, 2013, DIFFERENTIATION, V86, P184, DOI 10.1016/j.diff.2013.08.002; Chan SSK, 2013, CELL STEM CELL, V12, P587, DOI 10.1016/j.stem.2013.03.004; David R, 2008, NAT CELL BIOL, V10, P338, DOI 10.1038/ncb1696; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Ferdous A, 2009, P NATL ACAD SCI USA, V106, P814, DOI 10.1073/pnas.0807583106; Ferkowicz MJ, 2005, EXP HEMATOL, V33, P1041, DOI 10.1016/j.exphem.2005.06.006; Fujii Y, 2000, NAT STRUCT BIOL, V7, P889; Garry DJ, 2000, P NATL ACAD SCI USA, V97, P5416, DOI 10.1073/pnas.100501197; Iacovino M, 2014, METHODS MOL BIOL, V1101, P339, DOI 10.1007/978-1-62703-721-1_16; Iacovino M, 2011, STEM CELLS, V29, P1580, DOI 10.1002/stem.715; Kataoka H, 2011, BLOOD, V118, P6975, DOI 10.1182/blood-2011-05-352658; Keller G, 1999, EXP HEMATOL, V27, P777, DOI 10.1016/S0301-472X(99)00024-7; Kitajima S, 2000, DEVELOPMENT, V127, P3215; Koyano-Nakagawa N, 2012, STEM CELLS, V30, P1611, DOI 10.1002/stem.1131; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lee D, 2008, CELL STEM CELL, V2, P497, DOI 10.1016/j.stem.2008.03.008; Li WM, 2005, STEM CELLS DEV, V14, P44, DOI 10.1089/scd.2005.14.44; Lindsley RC, 2008, CELL STEM CELL, V3, P55, DOI 10.1016/j.stem.2008.04.004; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Magenta A, 2003, MOL CELL BIOL, V23, P2893, DOI 10.1128/MCB.23.8.2893-2906.2003; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; Matsuo N, 2006, J BIOL CHEM, V281, P5445, DOI 10.1074/jbc.M509923200; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Moignard V, 2013, BLOOD CELL MOL DIS, V51, P239, DOI 10.1016/j.bcmd.2013.07.007; Muir T, 2008, MOL REPROD DEV, V75, P1637, DOI 10.1002/mrd.20902; Nantel F, 1996, NATURE, V380, P159, DOI 10.1038/380159a0; Palencia-Desai S, 2011, DEVELOPMENT, V138, P4721, DOI 10.1242/dev.064998; Rasmussen TL, 2013, GENESIS, V51, P471, DOI 10.1002/dvg.22396; Rasmussen TL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050103; Rasmussen TL, 2011, DEVELOPMENT, V138, P4801, DOI 10.1242/dev.070912; Rudolph D, 1998, P NATL ACAD SCI USA, V95, P4481, DOI 10.1073/pnas.95.8.4481; Saga Y, 1999, DEVELOPMENT, V126, P3437; Saga Y, 1996, DEVELOPMENT, V122, P2769; Sands WA, 2008, CELL SIGNAL, V20, P460, DOI 10.1016/j.cellsig.2007.10.005; Schupp MO, 2014, DEV BIOL, V393, P71, DOI 10.1016/j.ydbio.2014.06.019; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Shi XZ, 2014, DEV BIOL, V389, P208, DOI 10.1016/j.ydbio.2014.02.018; Shi XZ, 2012, BIOCHEM J, V446, P349, DOI 10.1042/BJ20120563; Shi XZ, 2010, BIOCHEM J, V428, P213, DOI 10.1042/BJ20091906; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; van Bueren KL, 2012, CURR OPIN HEMATOL, V19, P199, DOI 10.1097/MOH.0b013e3283523e07; Veldman MB, 2012, CIRC RES, V110, P220, DOI 10.1161/CIRCRESAHA.111.251298; Wareing S, 2012, DEV DYNAM, V241, P1454, DOI 10.1002/dvdy.23825; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Yamamizu K, 2012, STEM CELLS, V30, P687, DOI 10.1002/stem.1041; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102; Zhao L, 2009, J BONE MINER RES, V24, P826, DOI [10.1359/JBMR.081236, 10.1359/jbmr.081236]	55	22	26	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9614	9625		10.1074/jbc.M114.614628	http://dx.doi.org/10.1074/jbc.M114.614628			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25694434	Green Published, hybrid			2022-12-26	WOS:000352729400026
J	Stanicka, J; Russell, EG; Woolley, JF; Cotter, TG				Stanicka, Joanna; Russell, Eileen G.; Woolley, John F.; Cotter, Thomas G.			NADPH Oxidase-generated Hydrogen Peroxide Induces DNA Damage in Mutant FLT3-expressing Leukemia Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; INTERNAL TANDEM DUPLICATION; GENOMIC INSTABILITY; OXIDATIVE STRESS; CONSTITUTIVE ACTIVATION; FLT3 INHIBITORS; ROS; REPAIR; NOX4; MUTATIONS	Internal tandem duplication of the FMS-like tyrosine kinase (FLT3-ITD) receptor is present in 20% of acute myeloid leukemia (AML) patients and it has been associated with an aggressive AML phenotype. FLT3-ITD expressing cell lines have been shown to generate increased levels of reactive oxygen species (ROS) and DNA double strand breaks (DSBs). However, the molecular basis of how FLT3-ITD-driven ROS leads to the aggressive form of AML is not clearly understood. Our group has previously reported that inhibition of FLT3-ITD signaling results in post-translational down-regulation of p22(Phox), a small membrane-bound subunit of the NADPH oxidase (NOX) complex. Here we demonstrated that 32D cells, a myeloblast-like cell line transfected with FLT3-ITD, have a higher protein level of p22(Phox) and p22(Phox)-interacting NOX isoforms than 32D cells transfected with the wild type FIT 3 receptor (ITT3-WT). The inhibition of NOX proteins, p22(phox), and NOX protein knockdowns caused a reduction in ROS, as measured with a hydrogen peroxide (H2O2)-specific dye, peroxy orange 1 (PO1), and nuclear H2O2, as measured with nuclear peroxy emerald 1 (NucPE1). These reductions in the level of H2O2 following the NOX knockdowns were accompanied by a decrease in the number of DNA DS Bs. We showed that 32D cells that express FLT3-ITD have a higher level of both oxidized DNA and DNA DSBs than their wild type counterparts. We also observed that NOX4 and p22(phox) localize to the nuclear membrane in MV4-11 cells expressing FLT3-LTD. Taken together these data indicate that NOX and p22(phox) mediate the ROS production from FLT3-ITD that signal to the nucleus causing genomic instability.	[Stanicka, Joanna; Russell, Eileen G.; Woolley, John F.; Cotter, Thomas G.] Natl Univ Ireland Univ Coll Cork, Sch Biochem & Cell Biol, Tumour Biol Lab, Biosci Res Inst, Cork, Ireland	University College Cork	Cotter, TG (corresponding author), Natl Univ Ireland Univ Coll Cork, Sch Biochem & Cell Biol, Tumour Biol Lab, Biosci Res Inst, Cork, Ireland.	t.cotter@ucc.ie		Woolley, John/0000-0001-7885-8515; Cotter, Thomas/0000-0003-4626-5613	Irish Cancer Society Research Scholarship Award [CRS11STA]	Irish Cancer Society Research Scholarship Award	This work was supported by Irish Cancer Society Research Scholarship Award CRS11STA.	Ambasta RK, 2004, J BIOL CHEM, V279, P45935, DOI 10.1074/jbc.M406486200; Anilkumar N, 2013, ARTERIOSCL THROM VAS, V33, pE104, DOI 10.1161/ATVBAHA.112.300956; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Block K, 2012, NAT REV CANCER, V12, P627, DOI 10.1038/nrc3339; Block K, 2009, P NATL ACAD SCI USA, V106, P14385, DOI 10.1073/pnas.0906805106; Brandts CH, 2005, CANCER RES, V65, P9643, DOI 10.1158/0008-5472.CAN-05-0422; Case AJ, 2013, AM J PHYSIOL-HEART C, V305, pH19, DOI 10.1152/ajpheart.00974.2012; Chen K, 2008, J CELL BIOL, V181, P1129, DOI 10.1083/jcb.200709049; Choudhary C, 2009, MOL CELL, V36, P326, DOI 10.1016/j.molcel.2009.09.019; Dickinson BC, 2011, CHEM BIOL, V18, P943, DOI 10.1016/j.chembiol.2011.07.005; Edderkaoui M, 2011, J BIOL CHEM, V286, P7779, DOI 10.1074/jbc.M110.200063; Fan JS, 2010, BLOOD, V116, P5298, DOI 10.1182/blood-2010-03-272591; Gilliland DG, 2002, CURR OPIN HEMATOL, V9, P274, DOI 10.1097/00062752-200207000-00003; Godfrey R, 2012, BLOOD, V119, P4499, DOI 10.1182/blood-2011-02-336446; Grunwald MR, 2013, INT J HEMATOL, V97, P683, DOI 10.1007/s12185-013-1334-8; Hajas G, 2013, FREE RADICAL BIO MED, V61, P384, DOI 10.1016/j.freeradbiomed.2013.04.011; Hayakawa F, 2000, ONCOGENE, V19, P624, DOI 10.1038/sj.onc.1203354; Heidel F, 2006, BLOOD, V107, P293, DOI 10.1182/blood-2005-06-2469; Helmcke I, 2009, ANTIOXID REDOX SIGN, V11, P1279, DOI [10.1089/ars.2008.2383, 10.1089/ARS.2008.2383]; Hole PS, 2011, BLOOD, V117, P5816, DOI 10.1182/blood-2011-01-326025; Irwin ME, 2013, ANTIOXID REDOX SIGN, V18, P1349, DOI 10.1089/ars.2011.4258; Kim KT, 2005, BLOOD, V105, P1759, DOI 10.1182/blood-2004-05-2006; Kiyoi H, 1998, LEUKEMIA, V12, P1333, DOI 10.1038/sj.leu.2401130; Koptyra M, 2006, BLOOD, V108, P319, DOI 10.1182/blood-2005-07-2815; Kuroda J, 2005, GENES CELLS, V10, P1139, DOI 10.1111/j.1365-2443.2005.00907.x; Kuzminov A, 2001, P NATL ACAD SCI USA, V98, P8241, DOI 10.1073/pnas.131009198; Landry WD, 2013, LEUKEMIA RES, V37, P183, DOI 10.1016/j.leukres.2012.11.003; Loeb LA, 2003, P NATL ACAD SCI USA, V100, P776, DOI 10.1073/pnas.0334858100; Lu AL, 2001, CELL BIOCHEM BIOPHYS, V35, P141, DOI 10.1385/CBB:35:2:141; Matsushima S, 2013, CIRC RES, V112, P651, DOI 10.1161/CIRCRESAHA.112.279760; Mizuki M, 2000, BLOOD, V96, P3907, DOI 10.1182/blood.V96.12.3907; Moiseeva O, 2009, MOL CELL BIOL, V29, P4495, DOI 10.1128/MCB.01868-08; Nakao M, 1996, LEUKEMIA, V10, P1911; Naughton R, 2009, LEUKEMIA, V23, P1432, DOI 10.1038/leu.2009.49; Nowicki MO, 2004, BLOOD, V104, P3746, DOI 10.1182/blood-2004-05-1941; Pazhanisamy SK, 2011, MUTAGENESIS, V26, P431, DOI 10.1093/mutage/ger001; Piloto O, 2007, BLOOD, V109, P1643, DOI 10.1182/blood-2006-05-023804; Rassool FV, 2007, CANCER RES, V67, P8762, DOI 10.1158/0008-5472.CAN-06-4807; Reddy MM, 2011, LEUKEMIA, V25, P281, DOI 10.1038/leu.2010.263; Sallmyr A, 2008, CANCER LETT, V270, P1, DOI 10.1016/j.canlet.2008.03.036; Sallmyr A, 2008, BLOOD, V111, P3173, DOI 10.1182/blood-2007-05-092510; Sato T, 2011, BLOOD, V117, P3286, DOI 10.1182/blood-2010-01-266742; Seedhouse CH, 2006, LEUKEMIA, V20, P2130, DOI 10.1038/sj.leu.2404439; Sieber OM, 2003, NAT REV CANCER, V3, P701, DOI 10.1038/nrc1170; Smith CC, 2012, NATURE, V485, P260, DOI 10.1038/nature11016; Spencer NY, 2011, J BIOL CHEM, V286, P8977, DOI 10.1074/jbc.M110.193821; Stirewalt DL, 2003, NAT REV CANCER, V3, P650, DOI 10.1038/nrc1169; Thiede C, 2002, BLOOD, V99, P4326, DOI 10.1182/blood.V99.12.4326; Wang Y, 2010, FREE RADICAL BIO MED, V48, P348, DOI 10.1016/j.freeradbiomed.2009.11.005; Weyemi U, 2012, ONCOGENE, V31, P1117, DOI 10.1038/onc.2011.327; Weyemi U, 2012, MUTAT RES-REV MUTAT, V751, P77, DOI 10.1016/j.mrrev.2012.04.002; Woolley JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034050; Zhang LL, 2011, BIOCHIMIE, V93, P457, DOI 10.1016/j.biochi.2010.11.001; Zhou FL, 2010, J BIOL CHEM, V285, P15010, DOI 10.1074/jbc.M110.103713; Zhou SY, 1997, P NATL ACAD SCI USA, V94, P11345, DOI 10.1073/pnas.94.21.11345	55	55	56	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9348	9361		10.1074/jbc.M113.510495	http://dx.doi.org/10.1074/jbc.M113.510495			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25697362	hybrid, Green Published			2022-12-26	WOS:000352729400004
J	Astakhova, LN; Zatsepina, OG; Funikov, SY; Zelentsova, ES; Schostak, NG; Orishchenko, KE; Evgen'ev, MB; Garbuz, DG				Astakhova, Lyubov N.; Zatsepina, Olga G.; Funikov, Sergei Yu.; Zelentsova, Elena S.; Schostak, Natalia G.; Orishchenko, Konstantin E.; Evgen'ev, Michael B.; Garbuz, David G.			Activity of Heat Shock Genes' Promoters in Thermally Contrasting Animal Species	PLOS ONE			English	Article							GAGA-FACTOR; DROSOPHILA GENES; FACTOR-BINDING; IN-VIVO; TRANSCRIPTION; EXPRESSION; PROTEIN; POLYMERASE; CHROMATIN; CELLS	Heat shock gene promoters represent a highly conserved and universal system for the rapid induction of transcription after various stressful stimuli. We chose pairs of mammalian and insect species that significantly differ in their thermoresistance and constitutive levels of Hsp70 to compare hsp promoter strength under normal conditions and after heat shock (HS). The first pair includes the HSPA1 gene promoter of camel (Camelus dromedarius) and humans. It was demonstrated that the camel HSPA1A and HSPA1L promoters function normally in vitro in human cell cultures and exceed the strength of orthologous human promoters under basal conditions. We used the same in vitro assay for Drosophila melanogaster Schneider- 2 (S2) cells to compare the activity of the hsp70 and hsp83 promoters of the second species pair represented by Diptera, i.e., Stratiomys singularior and D. melanogaster, which dramatically differ in thermoresistance and the pattern of Hsp70 accumulation. Promoter strength was also monitored in vivo in D. melanogaster strains transformed with constructs containing the S. singularior hsp70 ORF driven either by its own promoter or an orthologous promoter from the D. melanogaster hsp70Aa gene. Analysis revealed low S. singularior hsp70 promoter activity in vitro and in vivo under basal conditions and after HS in comparison with the endogenous promoter in D. melanogaster cells, which correlates with the absence of canonical GAGA elements in the promoters of the former species. Indeed, the insertion of GAGA elements into the S. singularior hsp70 regulatory region resulted in a dramatic increase in promoter activity in vitro but only modestly enhanced the promoter strength in the larvae of the transformed strains. In contrast with hsp70 promoters, hsp83 promoters from both of the studied Diptera species demonstrated high conservation and universality.	[Astakhova, Lyubov N.; Zatsepina, Olga G.; Funikov, Sergei Yu.; Zelentsova, Elena S.; Schostak, Natalia G.; Evgen'ev, Michael B.; Garbuz, David G.] RAS, Engelhardt Inst Mol Biol, Moscow 119991, Russia; [Evgen'ev, Michael B.] RAS, Inst Cell Biophys, Pushchino 142290, Moscow Region, Russia; [Orishchenko, Konstantin E.] RAS, Inst Cytol & Genet, Siberian Branch, Novosibirsk 630090, Russia	Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Cell Biophysics RAS; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS	Evgen'ev, MB (corresponding author), RAS, Engelhardt Inst Mol Biol, Vavilov Str 32, Moscow 119991, Russia.	misha672011@yahoo.com	Orishchenko, Konstantin/AFR-5367-2022; Funikov, Sergei/F-7161-2017; Orishchenko, Konstantin/Q-6630-2016; Garbuz, David/Q-7522-2016	Funikov, Sergei/0000-0002-3336-6119; 	Russian Academy of Sciences; RFFI [12-04-00810-a, 12-04-00069-a, N14Z50.31.0014]	Russian Academy of Sciences(Russian Academy of Sciences); RFFI(Russian Foundation for Basic Research (RFBR))	The work was supported by a grant from the Russian Academy of Sciences (Cell and Molecular Biology Program to M. E.) and RFFI grants 12-04-00810-a and 12-04-00069-a, and MGrant N14Z50.31.0014 to M. E. The funders had no role in the study, design, data collection and analysis, decision to publish or preparation of the manuscript.	Adkins NL, 2006, BIOCHEM CELL BIOL, V84, P559, DOI 10.1139/O06-062; AMIN J, 1987, MOL CELL BIOL, V7, P1055, DOI 10.1128/MCB.7.3.1055; Astakhova LN, 2013, INSECT MOL BIOL, V22, P284, DOI 10.1111/imb.12020; ATKINSON PW, 1992, INSECT BIOCHEM MOLEC, V22, P423, DOI 10.1016/0965-1748(92)90137-4; BERGER EM, 1985, SOMAT CELL MOLEC GEN, V11, P371, DOI 10.1007/BF01534414; Bevilacqua A, 2000, DEVELOPMENT, V127, P1541; Brocchieri L, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-19; Chen B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020308; CORCES V, 1981, P NATL ACAD SCI-BIOL, V78, P7038, DOI 10.1073/pnas.78.11.7038; ENENSTEIN J, 1984, J CELL BIOL, V99, P464, DOI 10.1083/jcb.99.2.464; Evgen'ev MB, 2007, J BIOSCIENCES, V32, P489, DOI 10.1007/s12038-007-0048-6; Garbuz DG, 2008, MOL ECOL, V17, P4763, DOI 10.1111/j.1365-294X.2008.03947.x; Garbuz DG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027205; Garbuz DG, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-74; Georgel PT, 2005, BIOCHEM CELL BIOL, V83, P555, DOI 10.1139/O05-060; GILMOUR DS, 1989, SCIENCE, V245, P1487, DOI 10.1126/science.2781290; Gong WJ, 2004, GENETICS, V168, P1467, DOI 10.1534/genetics.104.030874; GRANOK H, 1995, CURR BIOL, V5, P238, DOI 10.1016/S0960-9822(95)00048-0; Guertin MJ, 2010, COLD SH Q B, V75, P1, DOI 10.1101/sqb.2010.75.039; Guertin MJ, 2013, CURR OPIN GENET DEV, V23, P116, DOI 10.1016/j.gde.2012.11.008; Guertin MJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001114; Gunther M, 2000, MOL CELL BIOCHEM, V210, P131, DOI 10.1023/A:1007177623283; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; JUDD BH, 1995, GENETICS, V141, P245; Kalosaka K, 2006, INSECT MOL BIOL, V15, P373, DOI 10.1111/j.1365-2583.2006.00650.x; Lebedeva LA, 2005, P NATL ACAD SCI USA, V102, P18087, DOI 10.1073/pnas.0509063102; LEE HS, 1992, GENE DEV, V6, P284, DOI 10.1101/gad.6.2.284; Lefevre G., 1976, GENET BIOL DROSOPHIL, P31; Leibovitch BA, 2002, MOL CELL BIOL, V22, P6148, DOI 10.1128/MCB.22.17.6148-6157.2002; Lim JK, 1993, DROSOPHILA INFORMATI, V72, P73; LIS J, 1982, HEAT SHOCK BACTERIA, P57; Lis JT, 2007, NATURE, V450, P198, DOI 10.1038/nature06324; MCMAHON AP, 1984, P NATL ACAD SCI-BIOL, V81, P7490, DOI 10.1073/pnas.81.23.7490; MOSSER DD, 1988, MOL CELL BIOL, V8, P4736, DOI 10.1128/MCB.8.11.4736; OBRIEN T, 1995, GENE DEV, V9, P1098, DOI 10.1101/gad.9.9.1098; Omelina ES, 2011, COMPUT BIOL CHEM, V35, P363, DOI 10.1016/j.compbiolchem.2011.10.008; PELHAM HRB, 1982, EMBO J, V1, P1473, DOI 10.1002/j.1460-2075.1982.tb01340.x; PURNELL BA, 1994, GENE DEV, V8, P830, DOI 10.1101/gad.8.7.830; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; ROBERTSON HM, 1988, GENETICS, V118, P461; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tian SB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010669; TSUKIYAMA T, 1994, NATURE, V367, P525, DOI 10.1038/367525a0; Uhlirova M, 2002, DEV GENES EVOL, V212, P145, DOI 10.1007/s00427-002-0221-8; ULMASOV HA, 1993, COMP BIOCHEM PHYS B, V106, P867, DOI 10.1016/0305-0491(93)90043-5; VOELLMY R, 1982, P NATL ACAD SCI-BIOL, V79, P1776, DOI 10.1073/pnas.79.6.1776; Wang YV, 2005, MOL CELL BIOL, V25, P3543, DOI 10.1128/MCB.25.9.3543-3552.2005; Widlak W, 2007, ACTA BIOCHIM POL, V54, P107; Wilkerson DC, 2009, REPRODUCTION, V137, P923, DOI 10.1530/REP-09-0015; Wilkins RC, 1998, NUCLEIC ACIDS RES, V26, P2672, DOI 10.1093/nar/26.11.2672; Wilkins RC, 1997, NUCLEIC ACIDS RES, V25, P3963, DOI 10.1093/nar/25.20.3963	53	13	14	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0115536	10.1371/journal.pone.0115536	http://dx.doi.org/10.1371/journal.pone.0115536			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25700087	gold, Green Published, Green Submitted			2022-12-26	WOS:000349789800003
J	de Vos, AF; Dessing, MC; Lammers, AJJ; de Porto, APNA; Florquin, S; de Boer, OJ; de Beer, R; Terpstra, S; Bootsma, HJ; Hermans, PW; Veer, C; van der Poll, T				de Vos, Alex F.; Dessing, Mark C.; Lammers, Adriana J. J.; de Porto, Alexander P. N. A.; Florquin, Sandrine; de Boer, Onno J.; de Beer, Regina; Terpstra, Sanne; Bootsma, Hester J.; Hermans, Peter W.; Veer, Cornelis van 't; van der Poll, Tom			The Polysaccharide Capsule of Streptococcus pneumonia Partially Impedes MyD88-Mediated Immunity during Pneumonia in Mice	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-4; COMMUNITY-ACQUIRED PNEUMONIA; LIPOTEICHOIC ACID LTA; PNEUMOCOCCAL PNEUMONIA; INFLAMMATORY RESPONSE; ANTIBACTERIAL DEFENSE; EPITHELIAL-CELLS; INFECTION; TOLL-LIKE-RECEPTOR-2; COLONIZATION	Toll-like receptors (TLR) and the downstream adaptor protein MyD88 are considered crucial for protective immunity during bacterial infections. Streptococcus (S.) pneumoniae is a human respiratory pathogen and a large majority of clinical pneumococcal isolates expresses an external polysaccharide capsule. We here sought to determine the role of pneumococcal capsule in MyD88-mediated antibacterial defense during S. pneumonia pneumonia. Wild type (WT) and Myd88(-/-) mice were inoculated intranasally with serotype 2 S. pneumoniae D39 or with an isogenic capsule locus deletion mutant (D39 Delta cps), and analysed for bacterial outgrowth and inflammatory responses in the lung. As compared to WT mice, Myd88(-/-) mice infected with D39 demonstrated a modestly impaired bacterial clearance accompanied by decreased inflammatory responses in the lung. Strikingly, while WT mice rapidly cleared D39 Delta cps, Myd88(-/-) mice showed 10(5)-fold higher bacterial burdens in their lungs and dissemination to blood 24 hours after infection. These data suggest that the pneumococcal capsule impairs recognition of TLR ligands expressed by S. pneumoniae and thereby partially impedes MyD88-mediated antibacterial defense.	[de Vos, Alex F.; Dessing, Mark C.; Lammers, Adriana J. J.; de Porto, Alexander P. N. A.; de Beer, Regina; Terpstra, Sanne; Veer, Cornelis van 't; van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, NL-1105 AZ Amsterdam, Netherlands; [de Vos, Alex F.; Dessing, Mark C.; Lammers, Adriana J. J.; de Porto, Alexander P. N. A.; de Beer, Regina; Terpstra, Sanne; Veer, Cornelis van 't; van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands; [Dessing, Mark C.; Florquin, Sandrine; de Boer, Onno J.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Bootsma, Hester J.; Hermans, Peter W.] Radboud Univ Nijmegen, Med Ctr, Lab Pediat Infect Dis, NL-6525 ED Nijmegen, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Radboud University Nijmegen	de Vos, AF (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	a.f.devos@amc.uva.nl	Hermans, Peter W.M./H-8042-2014	de Boer, Onno/0000-0001-8844-1326; Florquin, Sandrine/0000-0002-9676-1722; de Porto, Alexander/0000-0002-1201-0754				Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Albiger B, 2005, CELL MICROBIOL, V7, P1603, DOI 10.1111/j.1462-5822.2005.00578.x; Albiger B, 2007, CELL MICROBIOL, V9, P633, DOI 10.1111/j.1462-5822.2006.00814.x; Bernstein JM, 1999, CHEST, V115, p9S, DOI 10.1378/chest.115.suppl_1.9S; Beutler B, 2009, IMMUNOL REV, V227, P248, DOI 10.1111/j.1600-065X.2008.00733.x; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Bootsma HJ, 2007, INFECT IMMUN, V75, P5489, DOI 10.1128/IAI.01823-06; Branger J, 2004, INFECT IMMUN, V72, P788, DOI 10.1128/IAI.72.2.788-794.2004; Coll RC, 2010, J INNATE IMMUN, V2, P406, DOI 10.1159/000315469; Dessing MC, 2008, CELL MICROBIOL, V10, P237, DOI 10.1111/j.1462-5822.2007.01035.x; Dessing MC, 2008, J INFECT DIS, V197, P245, DOI 10.1086/524873; Dessing MC, 2007, AM J RESP CRIT CARE, V175, P604, DOI 10.1164/rccm.200606-824OC; Han SH, 2003, INFECT IMMUN, V71, P5541, DOI 10.1128/IAI.71.10.5541-5548.2003; Hyams C, 2010, INFECT IMMUN, V78, P716, DOI 10.1128/IAI.01056-09; Kadioglu A, 2004, TRENDS IMMUNOL, V25, P143, DOI 10.1016/j.it.2003.12.006; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; KELLY T, 1994, INFECT IMMUN, V62, P1813, DOI 10.1128/IAI.62.5.1813-1819.1994; Knapp S, 2004, J IMMUNOL, V172, P3132, DOI 10.4049/jimmunol.172.5.3132; Koppe U, 2012, J IMMUNOL, V188, P811, DOI 10.4049/jimmunol.1004143; Lammers AJ, 2011, IMMUNOBIOLOGY, V216, P863, DOI 10.1016/j.imbio.2011.02.004; Littmann M, 2009, EMBO MOL MED, V1, P211, DOI 10.1002/emmm.200900025; Magee AD, 2001, INFECT IMMUN, V69, P3755, DOI 10.1128/IAI.69.6.3755-3761.2001; Malley R, 2003, P NATL ACAD SCI USA, V100, P1966, DOI 10.1073/pnas.0435928100; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Melin M, 2010, INFECT IMMUN, V78, P5262, DOI 10.1128/IAI.00740-10; Mogensen TH, 2006, J LEUKOCYTE BIOL, V80, P267, DOI 10.1189/jlb.1105626; Morona JK, 2004, J INFECT DIS, V189, P1905, DOI 10.1086/383352; Nelson AL, 2007, INFECT IMMUN, V75, P83, DOI 10.1128/IAI.01475-06; Paterson GK, 2006, MICROBIOL-SGM, V152, P285, DOI 10.1099/mic.0.28551-0; Ribes S, 2010, INFECT IMMUN, V78, P865, DOI 10.1128/IAI.01110-09; Schroder NWJ, 2003, J BIOL CHEM, V278, P15587, DOI 10.1074/jbc.M212829200; Srivastava A, 2005, INFECT IMMUN, V73, P6479, DOI 10.1128/IAI.73.10.6479-6487.2005; van der Poll T, 2009, LANCET, V374, P1543, DOI 10.1016/S0140-6736(09)61114-4; Wartha F, 2007, CELL MICROBIOL, V9, P1162, DOI 10.1111/j.1462-5822.2006.00857.x; Weinberger DM, 2010, CLIN INFECT DIS, V51, P692, DOI 10.1086/655828; Wilson RP, 2008, CELL MICROBIOL, V10, P876, DOI 10.1111/j.1462-5822.2007.01090.x; Wu MF, 2009, INFECT IMMUN, V77, P615, DOI 10.1128/IAI.00931-08; Yoshimura A, 1999, J IMMUNOL, V163, P1	38	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0118181	10.1371/journal.pone.0118181	http://dx.doi.org/10.1371/journal.pone.0118181			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25700108	Green Published, Green Submitted, gold			2022-12-26	WOS:000349789800033
J	Ortiz, MTL; Rosario, PBL; Luna-Nevarez, P; Gamez, AS; Martinez-del Campo, A; Del Rio, G				Lara Ortiz, Maria Teresa; Leon Rosario, Pablo Benjamn; Luna-Nevarez, Pablo; Savin Gamez, Alba; Martinez-del Campo, Ana; Del Rio, Gabriel			Quality Control Test for Sequence-Phenotype Assignments	PLOS ONE			English	Article							CRITICAL RESIDUES; PROTEIN; PREDICTION; NETWORK; SET	Relating a gene mutation to a phenotype is a common task in different disciplines such as protein biochemistry. In this endeavour, it is common to find false relationships arising from mutations introduced by cells that may be depurated using a phenotypic assay; yet, such phenotypic assays may introduce additional false relationships arising from experimental errors. Here we introduce the use of high-throughput DNA sequencers and statistical analysis aimed to identify incorrect DNA sequence-phenotype assignments and observed that 10-20% of these false assignments are expected in large screenings aimed to identify critical residues for protein function. We further show that this level of incorrect DNA sequence-phenotype assignments may significantly alter our understanding about the structure-function relationship of proteins. We have made available an implementation of our method at http://bis.ifc.unam.mx/en/software/chispas.	[Lara Ortiz, Maria Teresa; Leon Rosario, Pablo Benjamn; Savin Gamez, Alba; Del Rio, Gabriel] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Biochem & Struct Biol, Mexico City 04510, DF, Mexico; [Luna-Nevarez, Pablo] Sonora Inst Technol, Dept Agron Sci & Vet, Obregon City 85000, Mexico; [Martinez-del Campo, Ana] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Genet, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Del Rio, G (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Biochem & Struct Biol, Mexico City 04510, DF, Mexico.	gdelrio@ifc.unam.mx			PAPIIT [IN205911]; Instituto de fisiologia celular from UNAM	PAPIIT(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); Instituto de fisiologia celular from UNAM	This work was supported by PAPIIT (IN205911) and the Instituto de fisiologia celular from UNAM to GDR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Aguirre B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021035; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Cordes FS, 2002, J MOL BIOL, V323, P951, DOI 10.1016/S0022-2836(02)01006-9; Cusack MP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000421; Dykxhoorn DM, 1996, GENE, V177, P133, DOI 10.1016/0378-1119(96)00289-2; Huang WZ, 1996, J MOL BIOL, V258, P688, DOI 10.1006/jmbi.1996.0279; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Kinde I, 2011, P NATL ACAD SCI USA, V108, P9530, DOI 10.1073/pnas.1105422108; LANDT O, 1990, GENE, V96, P125, DOI 10.1016/0378-1119(90)90351-Q; Lin XY, 2013, BIOSTATISTICS, V14, P667, DOI 10.1093/biostatistics/kxt006; Lindsey JK, 1999, STAT MED, V18, P2223, DOI 10.1002/(SICI)1097-0258(19990915/30)18:17/18<2223::AID-SIM251>3.0.CO;2-6; Lindsey JK, 1998, STAT MED, V17, P59, DOI 10.1002/(SICI)1097-0258(19980115)17:1<59::AID-SIM733>3.3.CO;2-Z; Ma BY, 2001, CURR OPIN STRUC BIOL, V11, P364, DOI 10.1016/S0959-440X(00)00216-5; Marco Ambriz-Rivas NP, 2012, PROTEIN INTERACTIONS; Martinez MA, 1996, EMBO J, V15, P1203, DOI 10.1002/j.1460-2075.1996.tb00461.x; POULSEN LK, 1989, MOL MICROBIOL, V3, P1463, DOI 10.1111/j.1365-2958.1989.tb00131.x; POULSEN LK, 1991, MOL MICROBIOL, V5, P1627, DOI 10.1111/j.1365-2958.1991.tb01910.x; Quezada H, 2008, MICROBIOL-SGM, V154, P1656, DOI 10.1099/mic.0.2008/017103-0; RENNELL D, 1991, J MOL BIOL, V222, P67, DOI 10.1016/0022-2836(91)90738-R; Romero PA, 2009, NAT REV MOL CELL BIO, V10, P866, DOI 10.1038/nrm2805; SHORTLE D, 1992, Q REV BIOPHYS, V25, P205, DOI 10.1017/S0033583500004674; Somarowthu S, 2012, BIOINFORMATICS, V28, P2078, DOI 10.1093/bioinformatics/bts321; Thibert B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-213	25	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0118288	10.1371/journal.pone.0118288	http://dx.doi.org/10.1371/journal.pone.0118288			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25700273	Green Submitted, gold, Green Published			2022-12-26	WOS:000349789800035
J	Assi, J; Srivastava, G; Matta, A; MacMillan, C; Ralhan, R; Walfish, PG				Assi, Jasmeet; Srivastava, Gunjan; Matta, Ajay; MacMillan, Christina; Ralhan, Ranju; Walfish, Paul G.			Nuclear Ep-ICD Expression Is a Predictor of Poor Prognosis in "Low Risk" Prostate Adenocarcinomas	PLOS ONE			English	Article							IMMUNOTHERAPEUTIC TARGET; MESENCHYMAL TRANSITION; EPCAM ANTIBODY; BREAST-CANCER; CAM; OVEREXPRESSION; PROGRESSION; SURVIVAL; MARKER; COLON	Introduction Molecular markers for predicting prostate cancer (PCa) that would have poor prognosis are urgently needed for a more personalized treatment for patients. Regulated intramembrane proteolysis of Epithelial cell adhesion molecule results in shedding of the extracellular domain (EpEx) and release of its intracellular domain (Ep-ICD) which triggers oncogenic signaling and might correlate to tumor aggressiveness. This study aimed to explore the potential of Ep-ICD and EpEx to identify PCa that have poor prognosis. Methods Immunohistochemical analysis of Ep-ICD and EpEx was carried out in normal prostate tissues (n = 100), benign prostate hyperplasia (BPH, n = 83), and prostate cancer (n = 249) using domain specific antibodies. The expression of Ep-ICD and EpEx was correlated with clinico-pathological parameters and disease free survival (DFS). Results Reduced expression of nuclear Ep-ICD and membrane EpEx was observed in PCa in comparison with BPH and normal prostate tissues (p = 0.006, p < 0.001 respectively). For patients who had PCa with Gleason Score less than 7, preserved nuclear Ep-ICD emerged as the most significant marker in multivariate analysis for prolonged DFS, where these patients did not have recurrence during follow up of up to 12 years (p = 0.001). Conclusion Reduced expression of nuclear Ep-ICD was associated with shorter disease free survival in patients with a Gleason Score less than 7 and may be useful in identifying patients likely to have aggressive tumors with poor prognosis. Furthermore, nuclear Ep-ICD can differentiate between normal and prostate cancer tissues for ambiguous cases.	[Assi, Jasmeet; Srivastava, Gunjan; Matta, Ajay; Ralhan, Ranju; Walfish, Paul G.] Mt Sinai Hosp, Dept Pathol & Lab Med, Alex & Simona Shnaider Lab Mol Oncol, Toronto, ON, Canada; [MacMillan, Christina; Ralhan, Ranju; Walfish, Paul G.] Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON, Canada; [MacMillan, Christina] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Ralhan, Ranju; Walfish, Paul G.] Mt Sinai Hosp, Joseph & Mildred Sonshine Family Ctr Head & Neck, Toronto, ON, Canada; [Ralhan, Ranju; Walfish, Paul G.] Mt Sinai Hosp, Dept Med, Div Endocrine, Toronto, ON M5G 1X5, Canada; [Ralhan, Ranju; Walfish, Paul G.] Univ Toronto, Toronto, ON, Canada; [Ralhan, Ranju; Walfish, Paul G.] Mt Sinai Hosp, Dept Otolaryngol Head & Neck Surg, Toronto, ON, Canada; [Ralhan, Ranju; Walfish, Paul G.] Univ Toronto, Dept Otolaryngol Head & Neck Surg, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Ralhan, R (corresponding author), Mt Sinai Hosp, Dept Pathol & Lab Med, Alex & Simona Shnaider Lab Mol Oncol, 600 Univ Ave, Toronto, ON, Canada.	rralhan@mtsinai.on.ca; pwalfish@mtsinai.on.ca	MATTA, AJAY/AFT-2977-2022		Canadian Institutes of Health Research for Chair in Advanced Cancer Diagnostics; Mount Sinai Foundation of Toronto Da Vinci Gala Fundraiser; Alex and Simona Shnaider Chair in Thyroid Oncology; Mount Sinai Hospital Department of Medicine Research Fund	Canadian Institutes of Health Research for Chair in Advanced Cancer Diagnostics(Canadian Institutes of Health Research (CIHR)); Mount Sinai Foundation of Toronto Da Vinci Gala Fundraiser; Alex and Simona Shnaider Chair in Thyroid Oncology; Mount Sinai Hospital Department of Medicine Research Fund	The financial support of this work from the Canadian Institutes of Health Research for Chair in Advanced Cancer Diagnostics (RR), Mount Sinai Foundation of Toronto Da Vinci Gala Fundraiser, Alex and Simona Shnaider Chair in Thyroid Oncology, and the Mount Sinai Hospital Department of Medicine Research Fund (PGW) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anose BM, 2008, ADV EXP MED BIOL, V617, P541, DOI 10.1007/978-0-387-69080-3_55; Baeuerle PA, 2007, BRIT J CANCER, V96, P417, DOI 10.1038/sj.bjc.6603494; Benko G, 2013, UROL ONCOL-SEMIN ORI, V31, P468, DOI 10.1016/j.urolonc.2011.03.007; Carpenter G, 2009, CANCER CELL, V15, P165, DOI 10.1016/j.ccr.2009.02.005; Chaudry MA, 2007, BRIT J CANCER, V96, P1013, DOI 10.1038/sj.bjc.6603505; Cooperberg MR, 2007, J UROLOGY, V178, pS14, DOI 10.1016/j.juro.2007.03.135; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; de Resende MF, 2013, TUMOR BIOL, V34, P2665, DOI 10.1007/s13277-013-0817-9; Ensinger C, 2006, J IMMUNOTHER, V29, P569, DOI 10.1097/01.cji.0000211303.52503.da; Epstein JI, 2006, J UROLOGY, V175, P820, DOI 10.1016/S0022-5347(05)00337-X; Epstein JI, 2004, MODERN PATHOL, V17, P307, DOI 10.1038/modpathol.3800050; Epstein JI, 2002, PROSTATE BIOPSY INTE, Vxiii; Fields ALA, 2009, J CLIN ONCOL, V27, P1941, DOI 10.1200/JCO.2008.18.5710; Fong D, 2013, HISTOPATHOLOGY; Fujita K, 2009, J UROLOGY, V182, P2664, DOI 10.1016/j.juro.2009.08.044; Gadalla SE, 2013, BIOCHEM BIOPH RES CO, V439, P203, DOI 10.1016/j.bbrc.2013.08.059; Gastl G, 2000, LANCET, V356, P1981, DOI 10.1016/S0140-6736(00)03312-2; Gires O, 2010, J CLIN ONCOL, V28, pE239, DOI 10.1200/JCO.2009.26.8540; Gravdal K, 2007, CLIN CANCER RES, V13, P7003, DOI 10.1158/1078-0432.CCR-07-1263; Hu CY, 2014, J BUON, V19, P215; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kawamoto K, 2007, CLIN CANCER RES, V13, P2541, DOI 10.1158/1078-0432.CCR-06-2225; Kisner H J, 1998, Clin Lab Manage Rev, V12, P277; Koochekpour S, 2012, CLIN CANCER RES, V18, P5888, DOI 10.1158/1078-0432.CCR-12-1308; Lin CW, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.386235; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; Mukherjee S, 2009, AM J PATHOL, V175, P2277, DOI 10.2353/ajpath.2009.090013; Munz M, 2009, CANCER RES, V69, P5627, DOI 10.1158/0008-5472.CAN-09-0654; Ni J, 2012, CANCER METAST REV, V31, P779, DOI 10.1007/s10555-012-9389-1; Nonn L, 2009, PROSTATE, V69, P1470, DOI 10.1002/pros.20983; Poczatek RB, 1999, J UROLOGY, V162, P1462, DOI 10.1016/S0022-5347(05)68341-3; Ralhan R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014130; Ralhan R, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-331; Riethmuller G, 1998, J CLIN ONCOL, V16, P1788, DOI 10.1200/JCO.1998.16.5.1788; Saadatmand S, 2013, BRIT J SURG, V100, P252, DOI 10.1002/bjs.8980; Schmidt M, 2012, ANN ONCOL, V23, P2306, DOI 10.1093/annonc/mdr625; Schmidt M, 2010, ANN ONCOL, V21, P275, DOI 10.1093/annonc/mdp314; Schmoll HJ, 2009, J CLIN ONCOL, V27, P1926, DOI 10.1200/JCO.2008.20.6284; Schnell U, 2013, BBA-BIOMEMBRANES, V1828, P1989, DOI 10.1016/j.bbamem.2013.04.018; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Simon M, 2013, EXPERT OPIN DRUG DEL, V10, P451, DOI 10.1517/17425247.2013.759938; Songun I, 2005, BRIT J CANCER, V92, P1767, DOI 10.1038/sj.bjc.6602519; Soysal SD, 2013, BRIT J CANCER, V108, P1480, DOI 10.1038/bjc.2013.80; Spizzo G, 2004, BREAST CANCER RES TR, V86, P207, DOI 10.1023/B:BREA.0000036787.59816.01; Tripathi SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019213; Trujillo KA, 2012, PROSTATE CANCER, V2012, DOI 10.1155/2012/302894; van der Gun BTF, 2010, CARCINOGENESIS, V31, P1913, DOI 10.1093/carcin/bgq187; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Varga M, 2004, CLIN CANCER RES, V10, P3131, DOI 10.1158/1078-0432.CCR-03-0528; Wang J, 2013, ASIAN PAC J CANCER P, V14, P2023, DOI 10.7314/APJCP.2013.14.3.2023; Wang L, 2013, PROSTATE CANCER P D, V16, P301, DOI 10.1038/pcan.2013.25; Warneke VS, 2013, BRIT J CANCER, V109, P2217, DOI 10.1038/bjc.2013.536; Went P, 2006, BRIT J CANCER, V94, P128, DOI 10.1038/sj.bjc.6602924; Went PT, 2004, HUM PATHOL, V35, P122, DOI 10.1016/j.humpath.2003.08.026; Yu JD, 2010, CANCER CELL, V17, P443, DOI 10.1016/j.ccr.2010.03.018; Zellweger T, 2005, INT J CANCER, V113, P619, DOI 10.1002/ijc.20615; Zhao ZG, 2004, JPN J CLIN ONCOL, V34, P414, DOI 10.1093/jjco/hyh073	57	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0107586	10.1371/journal.pone.0107586	http://dx.doi.org/10.1371/journal.pone.0107586			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695234	Green Published, Green Submitted, gold			2022-12-26	WOS:000350062300001
J	Ehsan, AM; Geurden, T; Casaert, S; Parvin, SM; Islam, TM; Ahmed, UM; Levecke, B; Vercruysse, J; Claerebout, E				Ehsan, Amimul M.; Geurden, Thomas; Casaert, Stijn; Parvin, Sonia M.; Islam, Taohidul M.; Ahmed, Uddin M.; Levecke, Bruno; Vercruysse, Jozef; Claerebout, Edwin			Assessment of Zoonotic Transmission of Giardia and Cryptosporidium between Cattle and Humans in Rural Villages in Bangladesh	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; SURFACE-WATER; ASSEMBLAGE-A; DUODENALIS; DIARRHEA; PREVALENCE; INDIA; IDENTIFICATION; EPIDEMIOLOGY; INFECTIONS	Giardia and Cryptosporidium are important causes of diarrhoea in Bangladesh. The high prevalence of both parasites in humans and cattle in rural Bangladesh and the common use of water ponds by village inhabitants and their animals suggest a potential for zoonotic transmission. Direct transmission of Giardia and Cryptosporidium between cattle and their handlers and indirect transmission through water ponds was investigated. Faecal/stool samples were collected from 623 calves and 125 calf handlers in a cross-sectional survey. In two villages, water samples were collected monthly from water ponds and faecal/stool samples were collected monthly from inhabitants and their cattle. Giardia cysts and Cryptosporidium oocysts were detected in water samples and in faecal/stool samples and positive samples were genotyped, to determine their human or animal origin. The prevalence of Giardia and Cryptosporidium in calves was 22% and 5% respectively. In calf handlers, the prevalence of Giardia and Cryptosporidium was 11.2% and 3.2% respectively. Both in the cross-sectional survey and in the longitudinal study in the villages, G. duodenalis assemblage E was most prevalent in calves, while in humans assemblage AII, BIII and BIV were found. In cattle, Cryptosporidium parvum, C. bovis and C. andersoni were identified, but no Cryptosporidium sequences were obtained from humans. Giardia and Cryptosporidium were detected in 14/24 and 12/24 water samples respectively. G. duodenalis assemblage E and BIV (-like), as well as C. andersoni and C. hominis were identified. Although the presence of Giardia and Cryptosporidium in both water ponds suggests that water-borne transmission of Giardia and Cryptosporidium is possible, the genotyping results indicate that there is no significant direct or indirect (water-borne) transmission of Giardia between cattle and people in this area of rural Bangladesh. No conclusions could be drawn for Cryptosporidium, because of the low number of sequences that were obtained from human and water samples.	[Ehsan, Amimul M.; Geurden, Thomas; Casaert, Stijn; Levecke, Bruno; Vercruysse, Jozef; Claerebout, Edwin] Univ Ghent, Dept Virol Parasitol & Immunol, Merelbeke, Belgium; [Ehsan, Amimul M.; Parvin, Sonia M.; Islam, Taohidul M.; Ahmed, Uddin M.] Bangladesh Agr Univ, Dept Med, Mymensingh, Bangladesh	Ghent University; Bangladesh Agricultural University (BAU)	Claerebout, E (corresponding author), Univ Ghent, Dept Virol Parasitol & Immunol, Merelbeke, Belgium.	edwin.claerebout@ugent.be	Islam, Md. Taohidul/AAL-3539-2020	Islam, Md. Taohidul/0000-0003-4213-2784; Claerebout, Edwin/0000-0002-8292-2791; Levecke, Bruno/0000-0001-8912-5595	Ghent University [01W05309]	Ghent University(Ghent University)	AME was supported by a doctoral scholarship for candidates from developing countries from Ghent University (grant No 01W05309) (http://www.ugent.be/en/research/funding/phd/bof/dos/docos.htm). BL is a postdoctoral fellow of the Fund for Scientific Research-Flanders (Belgium) (F.W.O.-Vlaanderen) (http://www.fwo.be/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayaz S, 2012, AFR J MICROBIOL RES, V6, P5383, DOI 10.5897/AJMR12.697; Caccio SM, 2005, TRENDS PARASITOL, V21, P430, DOI 10.1016/j.pt.2005.06.013; Cringoli G, 2002, VET PARASITOL, V108, P137, DOI 10.1016/S0304-4017(02)00183-8; Elwin K, 2012, INT J PARASITOL, V42, P675, DOI 10.1016/j.ijpara.2012.04.016; Fayer R, 2004, VET PARASITOL, V126, P37, DOI 10.1016/j.vetpar.2004.09.004; Fayer R, 2010, EXP PARASITOL, V124, P90, DOI 10.1016/j.exppara.2009.03.005; Geurden T, 2008, INT J PARASITOL, V38, P259, DOI 10.1016/j.ijpara.2007.07.016; Geurden T, 2004, INT J PARASITOL, V34, P1121, DOI 10.1016/j.ijpara.2004.05.007; Gormley FJ, 2011, EMERG INFECT DIS, V17, P151, DOI 10.3201/eid1701.100902; Haque R, 2005, J INFECT DIS, V192, P2171, DOI 10.1086/498169; Haque R, 2009, CLIN INFECT DIS, V48, P1191, DOI 10.1086/597580; Hasan KZ, 2006, J HEALTH POPUL NUTR, V24, P25; Karn SK, 2001, ENVIRON MANAGE, V28, P483; Khan SM, 2011, VET PARASITOL, V178, P342, DOI 10.1016/j.vetpar.2011.01.029; Khan WA, 2004, AM J TROP MED HYG, V71, P412, DOI 10.4269/ajtmh.2004.71.412; Kosek M, 2003, B WORLD HEALTH ORGAN, V81, P197; Laishram S, 2012, EPIDEMIOL INFECT, V140, P2023, DOI 10.1017/S0950268811002767; Lalle M, 2005, INT J PARASITOL, V35, P207, DOI 10.1016/j.ijpara.2004.10.022; Levecke B, 2009, INT J PARASITOL, V39, P1595, DOI 10.1016/j.ijpara.2009.05.013; McCuin RM, 2003, APPL ENVIRON MICROB, V69, P267, DOI 10.1128/AEM.69.1.267-274.2003; Morgan UM, 2001, INT J PARASITOL, V31, P289, DOI 10.1016/S0020-7519(00)00164-8; Paul S, 2008, VET PARASITOL, V153, P143, DOI 10.1016/j.vetpar.2008.01.044; Peng MM, 2001, J EUKARYOT MICROBIOL, p28S; Quilez J, 1996, VET PARASITOL, V66, P139, DOI 10.1016/S0304-4017(96)01015-1; Rahman AKMA, 2013, PREV VET MED, V110, P242, DOI 10.1016/j.prevetmed.2012.11.029; RAHMAN ASMH, 1985, INDIAN J MED RES, V82, P510; RAHMAN M, 1990, AM J TROP MED HYG, V42, P127, DOI 10.4269/ajtmh.1990.42.127; Rahman S, 2008, WATER RESOUR MANAG, V22, P377, DOI 10.1007/s11269-007-9167-y; Robertson LJ, 2010, VET PARASITOL, V171, P140, DOI 10.1016/j.vetpar.2010.03.014; Roy SS, 2006, VET PARASITOL, V141, P330, DOI 10.1016/j.vetpar.2006.06.017; Ryan U, 2003, APPL ENVIRON MICROB, V69, P4302, DOI 10.1128/AEM.69.7.4302-4307.2003; Smith HV, 2007, VET PARASITOL, V149, P29, DOI 10.1016/j.vetpar.2007.07.015; Sprong H, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000558; Sulaiman IM, 2003, EMERG INFECT DIS, V9, P1444, DOI 10.3201/eid0911.030084; Thompson RCA, 2011, VET PARASITOL, V182, P70, DOI 10.1016/j.vetpar.2011.07.016; World Health Organisation, 2005, WORLD HLTH REP MAK E; Xiao LH, 2001, APPL ENVIRON MICROB, V67, P1097, DOI 10.1128/AEM.67.3.1097-1101.2001; Xiao LH, 2010, EXP PARASITOL, V124, P80, DOI 10.1016/j.exppara.2009.03.018	38	27	29	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0118239	10.1371/journal.pone.0118239	http://dx.doi.org/10.1371/journal.pone.0118239			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695662	Green Published, gold, Green Submitted			2022-12-26	WOS:000350062300045
J	Lu, J; He, Q; Huang, LY; Cai, XF; Guo, WW; He, J; Zhang, LL; Li, AY				Lu, Jin; He, Qiang; Huang, Luyao; Cai, Xiaofeng; Guo, Wenwen; He, Jing; Zhang, Lili; Li, Aiying			Accumulation of a Bioactive Benzoisochromanequinone Compound Kalafungin by a Wild Type Antitumor-Medermycin-Producing Streptomycete Strain	PLOS ONE			English	Article							BIOSYNTHETIC GENE-CLUSTER; ACTINORHODIN; ANTIBIOTICS; EXPRESSION; KETOREDUCTASE; DISCOVERY; AM-7161; SYSTEMS; CLONING	Medermycin and kalafungin, two antibacterial and antitumor antibiotics isolated from different streptomycetes, share an identical polyketide skeleton core. The present study reported the discovery of kalafungin in a medermycin-producing streptomycete strain for the first time. A mutant strain obtained through UV mutagenesis showed a 3-fold increase in the production of this antibiotic, compared to the wild type strain. Heterologous expression experiments suggested that its production was severely controlled by the gene cluster for medermycin biosynthesis. In all, these findings suggested that kalafungin and medermycin could be accumulated by the same streptomycete and share their biosynthetic pathway to some extent in this strain.	[Lu, Jin; Li, Aiying] Shandong Univ, Shandong Univ Helmholtz Joint Inst Biotechnol, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Lu, Jin; Li, Aiying] Shandong Univ, Sch Life Sci, Jinan 250100, Peoples R China; [He, Qiang; Huang, Luyao; Cai, Xiaofeng; Guo, Wenwen; Li, Aiying] Cent China Normal Univ, Sch Life Sci, Wuhan 430079, Peoples R China; [He, Jing] Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China; [Zhang, Lili] Tarim Univ, Xinjiang Prod & Construct Corps, Key Lab Protect & Utilizat Biol Resources Tarim B, Alar 843300, Xinjiang, Peoples R China	Shandong University; Shandong University; Central China Normal University; Huazhong Agricultural University; Tarim University	Li, AY (corresponding author), Shandong Univ, Shandong Univ Helmholtz Joint Inst Biotechnol, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	ayli@sdu.edu.cn	He, Jing/ABB-7225-2020		National Natural Science Foundation of China [31170050, 30770036]; Xinjiang Production & Construction Corps Key Laboratory of Protection and Utilization of Biological Resources in Tarim Basin [BRZD1401]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Xinjiang Production & Construction Corps Key Laboratory of Protection and Utilization of Biological Resources in Tarim Basin	The authors got financial support from (1) National Natural Science Foundation of China (URL: http://www.nsfc.gov.cn/) (No. 31170050 and 30770036); (2) Xinjiang Production & Construction Corps Key Laboratory of Protection and Utilization of Biological Resources in Tarim Basin (URL: http://lab.taru.edu.cn/)( No. BRZD1401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Challis GL, 2008, J MED CHEM, V51, P2618, DOI 10.1021/jm700948z; Deng HQ, 2010, J BASIC MICROB, V50, P299, DOI 10.1002/jobm.200900240; Donner CD, 2013, TETRAHEDRON, V69, P377, DOI 10.1016/j.tet.2012.10.012; Ichinose K, 2003, MICROBIOL-SGM, V149, P1633, DOI 10.1099/mic.0.26310-0; Ichinose K., 1998, ACTINOMYCETOL, V12, P99; JOHNSON LE, 1968, APPL MICROBIOL, V16, P1815, DOI 10.1128/AEM.16.12.1815-1821.1968; KAKINUMA S, 1990, J ANTIBIOT, V43, P391, DOI 10.7164/antibiotics.43.391; KAKINUMA S, 1991, J ANTIBIOT, V44, P995, DOI 10.7164/antibiotics.44.995; KAKINUMA S, 1995, J ANTIBIOT, V48, P484, DOI 10.7164/antibiotics.48.484; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Li AY, 2005, BIOORGAN MED CHEM, V13, P6856, DOI 10.1016/j.bmc.2005.07.060; Liu G, 2013, MICROBIOL MOL BIOL R, V77, P112, DOI 10.1128/MMBR.00054-12; Metsa-Ketela M, 2013, CURR OPIN CHEM BIOL, V17, P562, DOI 10.1016/j.cbpa.2013.06.032; Moore BS, 2002, NAT PROD REP, V19, P70, DOI 10.1039/b003939j; OCHI K, 1990, J BACTERIOL, V172, P4008, DOI 10.1128/jb.172.7.4008-4016.1990; Okamoto S, 2009, CHEM BIOL, V16, P226, DOI 10.1016/j.chembiol.2009.01.015; Sambrook J., 2001, MOL CLONING LAB MANU; Singh R, 2010, J ANTIMICROB CHEMOTH, V65, P1955, DOI 10.1093/jac/dkq257; Sun Rui, 2012, Weishengwu Xuebao, V52, P60; Takano E, 2005, MOL MICROBIOL, V56, P465, DOI 10.1111/j.1365-2958.2005.04543.x; TAKANO S, 1976, J ANTIBIOT, V29, P765, DOI 10.7164/antibiotics.29.765; Toral-Barza L, 2007, MOL CANCER THER, V6, P3028, DOI 10.1158/1535-7163.MCT-07-0211; TSUJIBO H, 1990, CHEM PHARM BULL, V38, P2299, DOI 10.1248/cpb.38.2299; Zaburannyi N, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-97; Zhang HY, 2012, FEMS MICROBIOL LETT, V332, P105, DOI 10.1111/j.1574-6968.2012.02582.x; Zhou Z, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S10-S8	28	7	7	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0117690	10.1371/journal.pone.0117690	http://dx.doi.org/10.1371/journal.pone.0117690			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695632	Green Published, Green Submitted, gold			2022-12-26	WOS:000350062300028
J	Rommler, F; Hammel, M; Waldhuber, A; Muller, T; Jurk, M; Uhlmann, E; Wagner, H; Vollmer, J; Miethke, T				Roemmler, Franziska; Hammel, Monika; Waldhuber, Anna; Mueller, Tina; Jurk, Marion; Uhlmann, Eugen; Wagner, Hermann; Vollmer, Joerg; Miethke, Thomas			Guanine-Modified Inhibitory Oligonucleotides Efficiently Impair TLR7-and TLR9-Mediated Immune Responses of Human Immune Cells	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; PLASMACYTOID DENDRITIC CELLS; NUCLEIC-ACIDS; I INTERFERON; CPG; TLR9; IDENTIFICATION; UNC93B1; RNA; TOLL-LIKE-RECEPTOR-7	Activation of TLR7 and TLR9 by endogenous RNA-or DNA-containing ligands, respectively, is thought to contribute to the complicated pathophysiology of systemic lupus erythematosus (SLE). These ligands induce the release of type-I interferons by plasmacytoid dendritic cells and autoreactive antibodies by B-cells, both responses being key events in perpetuating SLE. We recently described the development of inhibitory oligonucleotides (INH-ODN), which are characterized by a phosphorothioate backbone, a CC(T) XXX(3-5)GGG motif and a chemical modification of the G-quartet to avoid the formation of higher order structures via intermolecular G-tetrads. These INH-ODNs were equally or significantly more efficient to impair TLR7- and TLR9-stimulated murine B-cells, macrophages, conventional and plasmacytoid dendritic cells than the parent INH-ODN 2088, which lacks G-modification. Here, we evaluate the inhibitory/therapeutic potential of our set of G-modified INH-ODN on human immune cells. We report the novel finding that G-modified INH-ODNs efficiently inhibited the release of IFN-alpha by PBMC stimulated either with the TLR7-ligand oligoribonucleotide (ORN) 22075 or the TLR9-ligand CpG-ODN 2216. G-modification of INH-ODNs significantly improved inhibition of IL-6 release by PBMCs and purified human B-cells stimulated with the TLR7-ligand imiquimod or the TLR9-ligand CpG-ODN 2006. Furthermore, inhibition of B-cell activation analyzed by expression of activation markers and intracellular ATP content was significantly improved by G-modification. As observed with murine B-cells, high concentrations of INH-ODN 2088 but not of G-modified INH-ODNs stimulated IL-6 secretion by PBMCs in the absence of TLR-ligands thus limiting its blocking efficacy. In summary, G-modification of INH-ODNs improved their ability to impair TLR7- and TLR9-mediated signaling in those human immune cells which are considered as crucial in the pathophysiology of SLE.	[Roemmler, Franziska; Hammel, Monika; Waldhuber, Anna; Mueller, Tina; Wagner, Hermann] Tech Univ Munich, Inst Med Mikrobiol Immunol & Hyg, D-80290 Munich, Germany; [Jurk, Marion] Miltenyi Biotec GmbH, Bergisch Gladbach, Germany; [Uhlmann, Eugen] Adiutide Pharmaceut GmbH, Frankfurt, Germany; [Vollmer, Joerg] Nexigen GmbH, Cologne, Germany; [Miethke, Thomas] Heidelberg Univ, Med Fac Mannheim, Inst Med Microbiol & Hyg, Mannheim, Germany	Technical University of Munich; Miltenyi Biotec; Ruprecht Karls University Heidelberg	Miethke, T (corresponding author), Heidelberg Univ, Med Fac Mannheim, Inst Med Microbiol & Hyg, Mannheim, Germany.	Thomas.Miethke@medma.uni-heidelberg.de			Coley Pharmaceutical GmbH; Bundesministerium fur Bildung und Forschung (BMBF) [01EX1022Q]; Nexigen GmbH	Coley Pharmaceutical GmbH; Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Nexigen GmbH	This project was integrated into the m4 cluster in Munich, and funded by Coley Pharmaceutical GmbH and the Bundesministerium fur Bildung und Forschung (BMBF, grant 01EX1022Q). The funders had no role in study design, data collection and analysis, decision to publish, or in the preparation of the manuscript. Coauthor Marion Jurk is employed by Miltenyi Biotec GmbH. Co-author Eugen Uhlmann is employed by Adiutide Pharmaceuticals GmbH and co-author Jorg Vollmer is employed by Nexigen GmbH. Miltenyi Biotec GmbH, Adiutide Pharmaceuticals GmbH and Nexigen GmbH provided support in the form of salaries for authors MJ, EU and JV, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section..	Armstrong DL, 2009, GENES IMMUN, V10, P446, DOI 10.1038/gene.2009.38; Ashman RF, 2011, INT IMMUNOPHARMACOL, V11, P1032, DOI 10.1016/j.intimp.2011.02.023; Ashman RF, 2011, INT IMMUNOL, V23, P203, DOI 10.1093/intimm/dxq473; AUSTIN HA, 1986, NEW ENGL J MED, V314, P614, DOI 10.1056/NEJM198603063141004; Avalos AM, 2011, EUR J IMMUNOL, V41, P2820, DOI 10.1002/eji.201141563; Baccala R, 2007, NAT MED, V13, P543, DOI 10.1038/nm1590; Barrat FJ, 2005, J EXP MED, V202, P1131, DOI 10.1084/jem.20050914; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; CROUCH SPM, 1993, J IMMUNOL METHODS, V160, P81, DOI 10.1016/0022-1759(93)90011-U; Demaria O, 2010, J CLIN INVEST, V120, P3651, DOI 10.1172/JCI42081; Duramad O, 2005, J IMMUNOL, V174, P5193, DOI 10.4049/jimmunol.174.9.5193; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Forsbach A, 2008, J IMMUNOL, V180, P3729, DOI 10.4049/jimmunol.180.6.3729; Fukui R, 2011, IMMUNITY, V35, P69, DOI 10.1016/j.immuni.2011.05.010; Guiducci C, 2010, NATURE, V465, P937, DOI 10.1038/nature09102; Hartmann G, 2000, J IMMUNOL, V164, P944, DOI 10.4049/jimmunol.164.2.944; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Jurk M, 2006, EUR J IMMUNOL, V36, P1815, DOI 10.1002/eji.200535806; Kawasaki T, 2011, IMMUNOL REV, V243, P61, DOI 10.1111/j.1600-065X.2011.01048.x; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Koh YT, 2013, J IMMUNOL, V190, P4982, DOI 10.4049/jimmunol.1202986; Kono DH, 2013, CURR OPIN IMMUNOL, V25, P720, DOI 10.1016/j.coi.2013.10.006; Krug A, 2001, EUR J IMMUNOL, V31, P2154, DOI 10.1002/1521-4141(200107)31:7<2154::AID-IMMU2154>3.0.CO;2-U; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Latz E, 2007, NAT IMMUNOL, V8, P772, DOI 10.1038/ni1479; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Lenert P, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2710; Lenert PS, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/986596; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Means TK, 2005, J CLIN INVEST, V115, P407, DOI 10.1172/JCI200523025; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Peter M, 2008, IMMUNOLOGY, V123, P118, DOI 10.1111/j.1365-2567.2007.02718.x; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; Rommler F, 2013, J IMMUNOL, V191, P3240, DOI 10.4049/jimmunol.1300706; Rovin BH, 2014, AM J KIDNEY DIS; Sasai M, 2011, IMMUNITY, V35, P3, DOI 10.1016/j.immuni.2011.07.006; Savarese E, 2006, BLOOD, V107, P3229, DOI 10.1182/blood-2005-07-2650; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Stunz LL, 2002, EUR J IMMUNOL, V32, P1212, DOI 10.1002/1521-4141(200205)32:5<1212::AID-IMMU1212>3.0.CO;2-D; Subramanian S, 2006, P NATL ACAD SCI USA, V103, P9970, DOI 10.1073/pnas.0603912103; Vollmer J, 2005, J EXP MED, V202, P1575, DOI 10.1084/jem.20051696; Yanai H, 2009, NATURE, V462, P99, DOI 10.1038/nature08512; Yoshida H, 2005, NAT IMMUNOL, V6, P49, DOI 10.1038/ni1146	44	21	25	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0116703	10.1371/journal.pone.0116703	http://dx.doi.org/10.1371/journal.pone.0116703			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695778	Green Published, gold			2022-12-26	WOS:000350062300016
J	Ahn, SB; Chan, C; Dent, OF; Mohamedali, A; Kwun, SY; Clarke, C; Fletcher, J; Chapuis, PH; Nice, EC; Baker, MS				Ahn, Seong Beom; Chan, Charles; Dent, Owen F.; Mohamedali, Abidali; Kwun, Sun Young; Clarke, Candice; Fletcher, Julie; Chapuis, Pierre H.; Nice, Edouard C.; Baker, Mark S.			Epithelial and Stromal Cell Urokinase Plasminogen Activator Receptor Expression Differentially Correlates with Survival in Rectal Cancer Stages B and C Patients	PLOS ONE			English	Article							HUMAN COLORECTAL-CANCER; HUMAN COLON-CANCER; PROGNOSTIC VALUE; CRYSTAL-STRUCTURE; TUMOR FRONT; IN-VIVO; UPAR; CARCINOMA; METASTASIS; SYSTEM	Urokinase plasminogen activator receptor (uPAR) has been proposed as a potential prognostic factor for colorectal cancer (CRC) patient survival. However, CRC uPAR expression remains controversial, especially regarding cell types where uPAR is overexpressed (e.g., epithelium (uPAR(E)) or stroma-associated cells (uPAR(S))) and associated prognostic relevance. In this study, two epitope-specific anti-uPAR monoclonal antibodies (MAbs) could discriminate expression of uPAR(E) from uPAR(S) and were used to examine this association with survival of stages B and C rectal cancer (RC) patients. Using immunohistochemistry, MAbs #3937 and R4 were used to discriminate uPAR(E) from uPAR(S) respectively in the central and invasive frontal regions of 170 stage B and 179 stage C RC specimens. Kaplan-Meier and Cox regression analyses were used to determine association with survival. uPAR expression occurred in both epithelial and stromal compartments with differential expression observed in many cases, indicating uPAR(E) and uPAR(S) have different cellular roles. In the central and invasive frontal regions, uPAR(E) was adversely associated with overall stage B survival (HR = 1.9; p = 0.014 and HR = 1.5; p = 0.031, respectively) reproducing results from previous studies. uPARS at the invasive front was associated with longer stage C survival (HR = 0.6; p = 0.007), reflecting studies demonstrating that macrophage peritumoural accumulation is associated with longer survival. This study demonstrates that different uPAR epitopes should be considered as being expressed on different cell types during tumour progression and at different stages in RC. Understanding how uPAR(E) and uPAR(S) expression affects survival is anticipated to be a useful clinical prognostic marker of stages B and C RC.	[Ahn, Seong Beom; Mohamedali, Abidali; Baker, Mark S.] Macquarie Univ, Fac Human Sci, Australian Sch Adv Med, N Ryde, NSW 2109, Australia; [Chan, Charles; Kwun, Sun Young; Clarke, Candice; Fletcher, Julie] Univ Sydney, Concord Hosp, Dept Anat Pathol, Concord, NSW 2139, Australia; [Chan, Charles; Kwun, Sun Young; Clarke, Candice; Fletcher, Julie] Univ Sydney, Discipline Pathol, Concord, NSW 2139, Australia; [Dent, Owen F.; Chapuis, Pierre H.] Univ Sydney, Concord Hosp, Dept Colorectal Surg, Concord, NSW 2139, Australia; [Dent, Owen F.; Chapuis, Pierre H.] Univ Sydney, Discipline Surg, Concord, NSW 2139, Australia; [Nice, Edouard C.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia	Macquarie University; Concord Repatriation General Hospital; University of Sydney; University of Sydney; Concord Repatriation General Hospital; University of Sydney; University of Sydney; Monash University	Baker, MS (corresponding author), Macquarie Univ, Fac Human Sci, Australian Sch Adv Med, N Ryde, NSW 2109, Australia.	mark.baker@mq.edu.au	Mohamedali, Abidali/AGZ-8179-2022	Baker, Mark/0000-0001-5858-4035; Ahn, Seong Beom/0000-0001-5907-3544; Mohamedali, Abidali/0000-0001-5627-4105	NHMRC [1010303]; Cancer Council NSW [RG10-04, RG08-16]; Macquarie University MQSN grant; Australian School of Advanced Medicine (ASAM), Macquarie University; Concord Repatriation General Hospital Diagnostic Pathology, MQ Biofocus, and Biomolecular Frontiers Research Centres	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council NSW(Cancer Council New South Wales); Macquarie University MQSN grant; Australian School of Advanced Medicine (ASAM), Macquarie University; Concord Repatriation General Hospital Diagnostic Pathology, MQ Biofocus, and Biomolecular Frontiers Research Centres	This study was supported with research project grant funding from the NHMRC (#1010303), Cancer Council NSW (RG10-04 & RG08-16), and a Macquarie University MQSN grant; and supported through the Australian School of Advanced Medicine (ASAM), Macquarie University, Concord Repatriation General Hospital Diagnostic Pathology, MQ Biofocus, and Biomolecular Frontiers Research Centres. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097248; Bates RC, 2005, CELL CYCLE, V4, P1350, DOI 10.4161/cc.4.10.2053; Bates RC, 2005, J CLIN INVEST, V115, P339, DOI 10.1172/JCI200523183; Bokey EL, 1999, BRIT J SURG, V86, P1164, DOI 10.1046/j.1365-2168.1999.01216.x; Boonstra MC, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-269; Boonstra MC, 2011, CURR PHARM DESIGN, V17, P1890; DAVIS NC, 1983, AUST NZ J SURG, V53, P211, DOI 10.1111/j.1445-2197.1983.tb02430.x; de Bock CE, 2004, MED RES REV, V24, P13, DOI 10.1002/med.10054; Duriseti S, 2010, J BIOL CHEM, V285, P26878, DOI 10.1074/jbc.M109.077677; Eden G, 2011, CURR PHARM DESIGN, V17, P1874, DOI 10.2174/138161211796718215; Erreni M, 2011, CANCER MICROENVIRON, V4, P141, DOI 10.1007/s12307-010-0052-5; Ferlay J, 2012, IARC CANCERBASE, V11; FIELDING LP, 1991, J GASTROEN HEPATOL, V6, P325, DOI 10.1111/j.1440-1746.1991.tb00867.x; Forssell J, 2007, CLIN CANCER RES, V13, P1472, DOI 10.1158/1078-0432.CCR-06-2073; Funada Y, 2003, ONCOL REP, V10, P309; Gardsvoll H, 2011, J BIOL CHEM, V286, P33544, DOI 10.1074/jbc.M111.220087; Genua M, 2014, GUT; Hoyer-Hansen G, 2001, BIOCHEM J, V358, P673, DOI 10.1042/0264-6021:3580673; Hoyer-Hansen G, 2007, ADV CLIN CHEM, V44, P65, DOI 10.1016/S0065-2423(07)44003-3; Illemann M, 2014, CANC MED, V1002, P242; Illemann M, 2009, INT J CANCER, V124, P1860, DOI 10.1002/ijc.24166; Kaneko I, 2007, WORLD J GASTROENTERO, V13, P3829; Kenny HA, 2011, CLIN CANCER RES, V17, P459, DOI 10.1158/1078-0432.CCR-10-2258; Kho PSS, 2012, INT J COLORECTAL DIS, V27, P1409, DOI 10.1007/s00384-012-1469-8; Khorana AA, 2003, CANCER, V97, P960, DOI 10.1002/cncr.11152; LeBeau AM, 2014, THERANOSTICS, V4, P267, DOI 10.7150/thno.7323; Li YD, 2007, J MOL BIOL, V365, P1117, DOI 10.1016/j.jmb.2006.10.059; Llinas P, 2005, EMBO J, V24, P1655, DOI 10.1038/sj.emboj.7600635; Lomholt AF, 2010, ACTA ONCOL, V49, P805, DOI 10.3109/0284186X.2010.491086; Minoo P, 2010, HUM PATHOL, V41, P70, DOI 10.1016/j.humpath.2009.05.013; NEWLAND RC, 1981, CANCER, V47, P1424, DOI 10.1002/1097-0142(19810315)47:6<1424::AID-CNCR2820470630>3.0.CO;2-O; NEWLAND RC, 1987, CANCER, V60, P852, DOI 10.1002/1097-0142(19870815)60:4<852::AID-CNCR2820600422>3.0.CO;2-5; OHTANI H, 1995, INT J CANCER, V62, P691, DOI 10.1002/ijc.2910620608; OSSOWSKI L, 1991, J CELL BIOL, V115, P1107, DOI 10.1083/jcb.115.4.1107; PYKE C, 1994, HISTOPATHOLOGY, V24, P131, DOI 10.1111/j.1365-2559.1994.tb01291.x; Rabbani SA, 2010, NEOPLASIA, V12, P778, DOI 10.1593/neo.10296; Rasch MG, 2008, FRONT BIOSCI-LANDMRK, V13, P6752, DOI 10.2741/3186; Richards DM, 2013, CANCER MICROENVIRON, V6, P179, DOI 10.1007/s12307-012-0123-x; RONNE E, 1991, FEBS LETT, V288, P233, DOI 10.1016/0014-5793(91)81042-7; Saito K, 2000, INT J CANCER, V86, P24, DOI 10.1002/(SICI)1097-0215(20000401)86:1<24::AID-IJC4>3.0.CO;2-A; Saldanha RG, 2007, J PROTEOME RES, V6, P1016, DOI 10.1021/pr060518n; Seetoo DQ, 2003, J SURG ONCOL, V82, P184, DOI 10.1002/jso.10210; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Sugita J, 2002, JPN J CANCER RES, V93, P320, DOI 10.1111/j.1349-7006.2002.tb02175.x; Suzuki S, 1998, GUT, V43, P798, DOI 10.1136/gut.43.6.798; Takeha S, 1997, JPN J CANCER RES, V88, P72, DOI 10.1111/j.1349-7006.1997.tb00304.x; Thuno M, 2009, DIS MARKERS, V27, P157, DOI [10.1155/2009/504294, 10.3233/DMA-2009-0657]; Trujillo KA, 2011, INT J CANCER, V129, P1310, DOI 10.1002/ijc.25788; Xu X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085349; Yang JL, 2000, INT J CANCER, V89, P431, DOI 10.1002/1097-0215(20000920)89:5<431::AID-IJC6>3.0.CO;2-V	50	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117786	10.1371/journal.pone.0117786	http://dx.doi.org/10.1371/journal.pone.0117786			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692297	Green Published, gold, Green Submitted			2022-12-26	WOS:000350061500074
J	Thompson, PL; Davies, TJ; Gonzalez, A				Thompson, Patrick L.; Davies, T. Jonathan; Gonzalez, Andrew			Ecosystem Functions across Trophic Levels Are Linked to Functional and Phylogenetic Diversity	PLOS ONE			English	Article							TOP-DOWN CONTROL; SPECIES RICHNESS; BIODIVERSITY; PRODUCTIVITY; COMMUNITIES; ECOLOGY; LAKES; COMPLEMENTARITY; PHYTOPLANKTON; EXTINCTION	In experimental systems, it has been shown that biodiversity indices based on traits or phylogeny can outperform species richness as predictors of plant ecosystem function. However, it is unclear whether this pattern extends to the function of food webs in natural ecosystems. Here we tested whether zooplankton functional and phylogenetic diversity explains the functioning of 23 natural pond communities. We used two measures of ecosystem function: (1) zooplankton community biomass and (2) phytoplankton abundance (Chl a). We tested for diversity-ecosystem function relationships within and across trophic levels. We found a strong correlation between zooplankton diversity and ecosystem function, whereas local environmental conditions were less important. Further, the positive diversity- ecosystem function relationships were more pronounced for measures of functional and phylogenetic diversity than for species richness. Zooplankton and phytoplankton biomass were best predicted by different indices, suggesting that the two functions are dependent upon different aspects of diversity. Zooplankton community biomass was best predicted by zooplankton trait-based functional richness, while phytoplankton abundance was best predicted by zooplankton phylogenetic diversity. Our results suggest that the positive relationship between diversity and ecosystem function can extend across trophic levels in natural environments, and that greater insight into variation in ecosystem function can be gained by combining functional and phylogenetic diversity measures.	[Thompson, Patrick L.; Davies, T. Jonathan; Gonzalez, Andrew] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	McGill University	Thompson, PL (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.	patrick.thompson@mail.mcgill.ca	Thompson, Patrick L/B-6213-2012; Gonzalez, Andrew/F-2247-2010	Thompson, Patrick L/0000-0002-5278-9045; Gonzalez, Andrew/0000-0001-6075-8081	NSERC Postgraduate Fellowship; Vineberg Fellowship in Freshwater/Limnology; NSERC Discovery Grant; Canada Research Chair program; Quebec Centre for Biodiversity Science	NSERC Postgraduate Fellowship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Vineberg Fellowship in Freshwater/Limnology; NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair program(Canada Research Chairs); Quebec Centre for Biodiversity Science	PLT was supported by an NSERC Postgraduate Fellowship (http://www.nserc-crsng.gc.ca) and a Vineberg Fellowship in Freshwater/Limnology (http://biology.mcgill.ca/grad/grad_gen_awards&scholarsh.html). AG was supported by an NSERC Discovery Grant (http://www.nserc-crsng.gc.ca), the Canada Research Chair program (http://www.chairs-chaires.gc.ca/home-accueil-eng.aspx), and the Quebec Centre for Biodiversity Science (http://qcbs.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, COPEPOD EVOLUTION; Barnett AJ, 2007, FRESHWATER BIOL, V52, P796, DOI 10.1111/j.1365-2427.2007.01733.x; Best RJ, 2013, ECOL LETT, V16, P72, DOI 10.1111/ele.12016; Brandl Z, 1998, J MARINE SYST, V15, P87, DOI 10.1016/S0924-7963(97)00042-0; Burkepile DE, 2008, P NATL ACAD SCI USA, V105, P16201, DOI 10.1073/pnas.0801946105; Cadotte MW, 2013, P NATL ACAD SCI USA, V110, P8996, DOI 10.1073/pnas.1301685110; Cadotte MW, 2011, J APPL ECOL, V48, P1079, DOI 10.1111/j.1365-2664.2011.02048.x; Cadotte MW, 2010, ECOL LETT, V13, P96, DOI 10.1111/j.1461-0248.2009.01405.x; Cadotte MW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005695; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; Cardinale BJ, 2009, ECOLOGY, V90, P1227, DOI 10.1890/08-1038.1; CARLSON RE, 1977, LIMNOL OCEANOGR, V22, P361, DOI 10.4319/lo.1977.22.2.0361; Clark CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052821; Dinnage R, 2012, ECOL LETT, V15, P1308, DOI 10.1111/j.1461-0248.2012.01854.x; Duffy JE, 2007, ECOL LETT, V10, P522, DOI 10.1111/j.1461-0248.2007.01037.x; ELSER JJ, 1990, CAN J FISH AQUAT SCI, V47, P1468, DOI 10.1139/f90-165; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Flynn DFB, 2011, ECOLOGY, V92, P1573, DOI 10.1890/10-1245.1; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Fritz SA, 2010, CONSERV BIOL, V24, P1042, DOI 10.1111/j.1523-1739.2010.01455.x; Gamfeldt L, 2005, ECOL LETT, V8, P696, DOI 10.1111/j.1461-0248.2005.00765.x; Grace JB., 2015, STRUCTURAL EQUATION; Griffin JN, 2013, ECOLOGY, V94, P2180, DOI 10.1890/13-0179.1; Haney J. F, 2010, AN IMAGE BASED KEY Z; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Helmus MR, 2010, ECOL LETT, V13, P162, DOI 10.1111/j.1461-0248.2009.01411.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Jeppesen E, 1997, HYDROBIOLOGIA, V342, P151, DOI 10.1023/A:1017046130329; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Laliberte E., 2014, FD MEASURING FUNCTIO; Legendre P, 2013, LMODEL2 MODEL 2 REGR; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Lumley T., 2009, LEAPS REGRESSION SUB; McCauley E., 1984, IBP HDB, P228; MCQUEEN DJ, 1986, CAN J FISH AQUAT SCI, V43, P1571, DOI 10.1139/f86-195; Mittelbach GG, 2001, ECOLOGY, V82, P2381, DOI 10.1890/0012-9658(2001)082[2381:WITORB]2.0.CO;2; Mouillot D, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001569; Naeem S, 2012, SCIENCE, V336, P1401, DOI 10.1126/science.1215855; Oksanen J., 2016, R PACKAG; Orme D., 2018, R PACKAGE VERSION, V5, P1; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Pavoine S, 2013, J VEG SCI, V24, P781, DOI 10.1111/jvs.12051; Petchey OL, 1999, NATURE, V402, P69, DOI 10.1038/47023; Petchey OL, 2004, ECOLOGY, V85, P847, DOI 10.1890/03-0226; Petchey OL, 2009, BIODIVERSITY ECOSYST, DOI [10.1093/acprof:oso/9780199547951.003.0004, DOI 10.1093/ACPROF:OSO/9780199547951.003.0004]; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; R Development Core Team, 2014, R LANG ENV STAT COMP; Reiss J, 2009, TRENDS ECOL EVOL, V24, P505, DOI 10.1016/j.tree.2009.03.018; SCHINDLER DW, 1977, SCIENCE, V195, P260, DOI 10.1126/science.195.4275.260; Schmitz OJ, 2009, ECOLOGY, V90, P2339, DOI 10.1890/08-1919.1; Srivastava DS, 2012, ECOL LETT, V15, P637, DOI 10.1111/j.1461-0248.2012.01795.x; Villeger S, 2008, ECOLOGY, V89, P2290, DOI 10.1890/07-1206.1; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Wetzel RG., 1979, LIMNOLOGICAL ANAL; Ye L, 2013, J ANIM ECOL, V82, P1052, DOI 10.1111/1365-2656.12067; Zavaleta ES, 2010, P NATL ACAD SCI USA, V107, P1443, DOI 10.1073/pnas.0906829107	57	54	57	4	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117595	10.1371/journal.pone.0117595	http://dx.doi.org/10.1371/journal.pone.0117595			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693188	Green Submitted, Green Published, gold			2022-12-26	WOS:000350061500063
J	Avanzino, L; Bove, M; Pelosin, E; Ogliastro, C; Lagravinese, G; Martino, D				Avanzino, Laura; Bove, Marco; Pelosin, Elisa; Ogliastro, Carla; Lagravinese, Giovanna; Martino, Davide			The Cerebellum Predicts the Temporal Consequences of Observed Motor Acts	PLOS ONE			English	Article							MAGNETIC STIMULATION; TIME PERCEPTION; EXPECTATION; PRECISION; PATHWAYS; RTMS	It is increasingly clear that we extract patterns of temporal regularity between events to optimize information processing. The ability to extract temporal patterns and regularity of events is referred as temporal expectation. Temporal expectation activates the same cerebral network usually engaged in action selection, comprising cerebellum. However, it is unclear whether the cerebellum is directly involved in temporal expectation, when timing information is processed to make predictions on the outcome of a motor act. Healthy volunteers received one session of either active (inhibitory, 1Hz) or sham repetitive transcranial magnetic stimulation covering the right lateral cerebellum prior the execution of a temporal expectation task. Subjects were asked to predict the end of a visually perceived human body motion (right hand handwriting) and of an inanimate object motion (a moving circle reaching a target). Videos representing movements were shown in full; the actual tasks consisted of watching the same videos, but interrupted after a variable interval from its onset by a dark interval of variable duration. During the 'dark' interval, subjects were asked to indicate when the movement represented in the video reached its end by clicking on the spacebar of the keyboard. Performance on the timing task was analyzed measuring the absolute value of timing error, the coefficient of variability and the percentage of anticipation responses. The active group exhibited greater absolute timing error compared with the sham group only in the human body motion task. Our findings suggest that the cerebellum is engaged in cognitive and perceptual domains that are strictly connected to motor control.	[Avanzino, Laura; Bove, Marco; Lagravinese, Giovanna] Univ Genoa, Sect Human Physiol, Dept Expt Med, Genoa, Italy; [Pelosin, Elisa; Ogliastro, Carla] Univ Genoa, Dept Neurosci DiNOGMI, Genoa, Italy; [Martino, Davide] Kings Coll Hosp London, Dept Neurol, London, England; [Martino, Davide] Queen Elizabeth Hosp, London, England; [Martino, Davide] Queen Mary Univ London, Ctr Neurosci & Trauma, London, England	University of Genoa; University of Genoa; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; Queen Mary University London	Avanzino, L (corresponding author), Univ Genoa, Sect Human Physiol, Dept Expt Med, Genoa, Italy.	lavanzino76@gmail.com	Lagravinese, Giovanna/AAB-1007-2021; Pelosin, Elisa/AAA-9637-2019; Avanzino, Laura/K-6623-2016	Lagravinese, Giovanna/0000-0002-6570-3626; AVANZINO, LAURA/0000-0001-6286-1509; Pelosin, Elisa/0000-0002-9880-2241				Assmus A, 2005, NEUROSCIENCE, V132, P923, DOI 10.1016/j.neuroscience.2005.01.047; Avanzino L, 2012, BASAL GANGLIA, V2, P231, DOI 10.1016/j.baga.2012.05.003; Avanzino L, 2013, BRAIN, V136, P444, DOI 10.1093/brain/aws328; Avanzino L, 2009, EUR J NEUROSCI, V30, P1971, DOI 10.1111/j.1460-9568.2009.06984.x; Bangert AS, 2011, ACTA PSYCHOL, V136, P20, DOI 10.1016/j.actpsy.2010.09.006; Bastian AJ, 2006, CURR OPIN NEUROBIOL, V16, P645, DOI 10.1016/j.conb.2006.08.016; Bell CC, 2008, ANNU REV NEUROSCI, V31, P1, DOI 10.1146/annurev.neuro.30.051606.094225; Broadway JM, 2011, ACTA PSYCHOL, V137, P115, DOI 10.1016/j.actpsy.2011.03.008; Brouwer AM, 2003, EXP BRAIN RES, V152, P368, DOI 10.1007/s00221-003-1556-8; Buckner RL, 2013, NEURON, V80, P807, DOI 10.1016/j.neuron.2013.10.044; Christensen A, 2014, J NEUROSCI, V34, P6707, DOI 10.1523/JNEUROSCI.3276-13.2014; Coull JT, 2008, CURR OPIN NEUROBIOL, V18, P137, DOI 10.1016/j.conb.2008.07.011; Craighero L, 2008, BRAIN RES BULL, V75, P770, DOI 10.1016/j.brainresbull.2008.01.014; Decety J, 1997, BRAIN, V120, P1763, DOI 10.1093/brain/120.10.1763; Del Olmo MF, 2007, J NEUROPHYSIOL, V98, P145, DOI 10.1152/jn.01088.2006; Field DT, 2005, CURR BIOL, V15, P453, DOI 10.1016/j.cub.2004.12.081; Fierro B, 2007, EXP BRAIN RES, V176, P440, DOI 10.1007/s00221-006-0628-y; Gazzola V, 2009, CEREB CORTEX, V19, P1239, DOI 10.1093/cercor/bhn181; Gooch CM, 2010, NEUROPSYCHOLOGIA, V48, P1022, DOI 10.1016/j.neuropsychologia.2009.11.028; Grondin S, 2012, J EXP PSYCHOL HUMAN, V38, P880, DOI 10.1037/a0027188; Ito M, 2005, PROG BRAIN RES, V148, P95, DOI 10.1016/S0079-6123(04)48009-1; Ito M, 2008, NAT REV NEUROSCI, V9, P304, DOI 10.1038/nrn2332; Ivry RB, 2004, CURR OPIN NEUROBIOL, V14, P225, DOI 10.1016/j.conb.2004.03.013; Izawa J, 2012, J NEUROSCI, V32, P4230, DOI 10.1523/JNEUROSCI.6353-11.2012; Kilner JM, 2009, J NEUROSCI, V29, P10153, DOI 10.1523/JNEUROSCI.2668-09.2009; Koch G, 2007, EXP BRAIN RES, V179, P291, DOI 10.1007/s00221-006-0791-1; Lee KH, 2007, J COGNITIVE NEUROSCI, V19, P147, DOI 10.1162/jocn.2007.19.1.147; Lewis PA, 2009, PHILOS T R SOC B, V364, P1897, DOI 10.1098/rstb.2009.0020; Meck WH, 2005, BRAIN COGNITION, V58, P1, DOI 10.1016/j.bandc.2004.09.004; MIALL RC, 1993, J MOTOR BEHAV, V25, P203, DOI 10.1080/00222895.1993.9942050; Nobrel AC, 2007, CURR OPIN NEUROBIOL, V17, P465, DOI 10.1016/j.conb.2007.07.006; Nowak DA, 2004, CEREBELLUM, V3, P227, DOI 10.1080/14734220410019057; O'Reilly JX, 2008, J NEUROSCI, V28, P2252, DOI 10.1523/JNEUROSCI.2742-07.2008; Oliveri M, 2005, NEUROSCI LETT, V376, P188, DOI 10.1016/j.neulet.2004.11.053; PAULIN MG, 1993, BRAIN BEHAV EVOLUT, V41, P39, DOI 10.1159/000113822; Ptito M, 2003, NEUROIMAGE, V19, P246, DOI 10.1016/S1053-8119(03)00082-X; Roth MJ, 2013, CURR BIOL, V23, P930, DOI 10.1016/j.cub.2013.04.027; Sadnicka A, 2012, CLIN NEUROPHYSIOL, V123, P65, DOI 10.1016/j.clinph.2011.04.027; Schmahmann JD, 2006, BRAIN, V129, P290, DOI 10.1093/brain/awh729; Sokolov AA, 2010, CEREB CORTEX, V20, P486, DOI 10.1093/cercor/bhp117; Strick PL, 2009, ANNU REV NEUROSCI, V32, P413, DOI 10.1146/annurev.neuro.31.060407.125606; Sultan F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1912; Synofzik M, 2008, CURR BIOL, V18, P814, DOI 10.1016/j.cub.2008.04.071; Timmann D, 2007, CEREBELLUM, V6, P159, DOI 10.1080/14734220701496448; Torriero S, 2004, J COGNITIVE NEUROSCI, V16, P1605, DOI 10.1162/0898929042568488; Torriero S, 2007, NEUROPSYCHOLOGIA, V45, P1208, DOI 10.1016/j.neuropsychologia.2006.10.007; UGAWA Y, 1995, ANN NEUROL, V37, P703, DOI 10.1002/ana.410370603; Vierordt K., 1868, ZEITSINN NACH VERSUC; Wolpert DM, 2001, CURR BIOL, V11, pR729, DOI 10.1016/S0960-9822(01)00432-8	49	22	22	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0116607	10.1371/journal.pone.0116607	http://dx.doi.org/10.1371/journal.pone.0116607			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689858	Green Published, gold, Green Submitted			2022-12-26	WOS:000350322700017
J	Capoccia, S; Maccarinelli, F; Buffoli, B; Rodella, LF; Cremona, O; Arosio, P; Cirulli, F				Capoccia, Sara; Maccarinelli, Federica; Buffoli, Barbara; Rodella, Luigi F.; Cremona, Ottavio; Arosio, Paolo; Cirulli, Francesca			Behavioral Characterization of Mouse Models of Neuroferritinopathy	PLOS ONE			English	Article							LIGHT-CHAIN GENE; BRAIN IRON ACCUMULATION; PARKINSONS-DISEASE; CLINICAL-FEATURES; FTL MUTATION; HEREDITARY FERRITINOPATHY; NATURAL-HISTORY; JAPANESE FAMILY; NEURODEGENERATION; MICE	Ferritin is the main intracellular protein of iron storage with a central role in the regulation of iron metabolism and detoxification. Nucleotide insertions in the last exon of the ferritin light chain cause a neurodegenerative disease known as Neuroferritinopathy, characterized by iron deposition in the brain, particularly in the cerebellum, basal ganglia and motor cortex. The disease progresses relentlessly, leading to dystonia, chorea, motor disability and neuropsychiatry features. The characterization of a good animal model is required to compare and contrast specific features with the human disease, in order to gain new insights on the consequences of chronic iron overload on brain function and behavior. To this aim we studied an animal model expressing the pathogenic human FTL mutant 498InsTC under the phosphoglycerate kinase (PGK) promoter. Transgenic (Tg) mice showed strong accumulation of the mutated protein in the brain, which increased with age, and this was accompanied by brain accumulation of ferritin/iron bodies, the main pathologic hallmark of human neuroferritinopathy. Tg-mice were tested throughout development and aging at 2-, 8- and 18-months for motor coordination and balance (Beam Walking and Footprint tests). The Tg-mice showed a significant decrease in motor coordination at 8 and 18 months of age, with a shorter latency to fall and abnormal gait. Furthermore, one group of aged naive subjects was challenged with two herbicides (Paraquat and Maneb) known to cause oxidative damage. The treatment led to a paradoxical increase in behavioral activation in the transgenic mice, suggestive of altered functioning of the dopaminergic system. Overall, data indicate that mice carrying the pathogenic FTL498InsTC mutation show motor deficits with a developmental profile suggestive of a progressive pathology, as in the human disease. These mice could be a powerful tool to study the neurodegenerative mechanisms leading to the disease and help developing specific therapeutic targets.	[Capoccia, Sara; Cirulli, Francesca] Ist Super Sanita, Dept Cell Biol, Sect Behav Neurosci, I-00161 Rome, Italy; [Maccarinelli, Federica; Arosio, Paolo] Univ Brescia, Dept Mol & Translat Med, Sect Biotechnol, Brescia, Italy; [Buffoli, Barbara; Rodella, Luigi F.] Univ Brescia, Sect Anat & Physiopathol, Dept Clin & Expt Sci, Brescia, Italy; [Cremona, Ottavio] Univ Vita Salute San Raffaele, Milan, Italy; [Cremona, Ottavio] Ist Sci San Raffaele, Ctr Imaging Sperimentale, Milan, Italy	Istituto Superiore di Sanita (ISS); University of Brescia; University of Brescia; Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Arosio, P (corresponding author), Univ Brescia, Dept Mol & Translat Med, Sect Biotechnol, Brescia, Italy.	paolo.arosio@unibs.it	Maccarinelli, Federica/AAW-4212-2020; Cirulli, Francesca/B-1581-2013; arosio, paolo/E-6817-2010; Cremona, Ottavio/AAB-8793-2019; Buffoli, Barbara/E-9934-2010	Cirulli, Francesca/0000-0001-9440-1873; Cremona, Ottavio/0000-0001-9462-1040; Buffoli, Barbara/0000-0002-8531-7730; arosio, paolo/0000-0002-5343-8992; MACCARINELLI, Federica/0000-0002-0328-4673; Rodella, Luigi Fabrizio/0000-0002-9497-4708	Telethon project [GGP 10099]; MIUR-PRIN-11; AIRC; Ricerca Finalizzata	Telethon project(Fondazione Telethon); MIUR-PRIN-11; AIRC(Fondazione AIRC per la ricerca sul cancro); Ricerca Finalizzata(Ministry of Health, ItalyMinistry of Health Italy - Ricerca Finalizzata (MOH-RF))	The work was partially supported by Telethon project n. GGP 10099 grant to P.A. and O.C., by Grant MIUR-PRIN-11 to P.A., and by AIRC and Ricerca Finalizzata 2011-2012 to O.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arosio P, 2010, BBA-GEN SUBJECTS, V1800, P783, DOI 10.1016/j.bbagen.2010.02.005; Auerbach W, 2001, HUM MOL GENET, V10, P2515, DOI 10.1093/hmg/10.22.2515; Ayton S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/581256; Beard JL, 2003, ANNU REV NUTR, V23, P41, DOI 10.1146/annurev.nutr.23.020102.075739; Benturquia N, 2008, BRAIN RES, V1211, P1, DOI 10.1016/j.brainres.2008.03.016; Berry A, 2013, NEUROSCI BIOBEHAV R, V37, P790, DOI 10.1016/j.neubiorev.2013.03.005; Berry A, 2012, PSYCHONEUROENDOCRINO, V37, P762, DOI 10.1016/j.psyneuen.2011.09.007; Borchelt DR, 1996, CHEM BIOL, V3, P619, DOI 10.1016/S1074-5521(96)90128-3; Brunelin J, 2008, SCHIZOPHR RES, V100, P206, DOI 10.1016/j.schres.2007.11.009; Carter RJ, 1999, J NEUROSCI, V19, P3248; Chinnery PF, 2007, BRAIN, V130, P110, DOI 10.1093/brain/awl319; Cozzi A, 2004, BLOOD, V103, P2377, DOI 10.1182/blood-2003-06-1842; Crawley J. N., 2007, WHATS WRONG MY MOUSE; Crichton RR, 2011, J NEURAL TRANSM, V118, P301, DOI 10.1007/s00702-010-0470-z; Crompton DE, 2002, BLOOD CELL MOL DIS, V29, P522, DOI 10.1006/bcmd.2002.0589; Curtis ARJ, 2001, NAT GENET, V28, P350, DOI 10.1038/ng571; Devos D, 2009, BRAIN, V132, DOI 10.1093/brain/awn274; Dusek P, 2012, NEUROBIOL DIS, V46, P1, DOI 10.1016/j.nbd.2011.12.054; Farrall AJ, 2009, NEUROBIOL AGING, V30, P337, DOI 10.1016/j.neurobiolaging.2007.07.015; Faucheux BA, 1999, LANCET, V353, P981, DOI 10.1016/S0140-6736(99)00641-8; Ferreira C, 2000, J BIOL CHEM, V275, P3021, DOI 10.1074/jbc.275.5.3021; Fleming RE, 2012, NEW ENGL J MED, V366, P348, DOI 10.1056/NEJMra1004967; Girirajan S, 2008, EUR J HUM GENET, V16, P941, DOI 10.1038/ejhg.2008.21; Hale MW, 2008, NEUROSCIENCE, V155, P659, DOI 10.1016/j.neuroscience.2008.05.054; HALLGREN B, 1958, J NEUROCHEM, V3, P41, DOI 10.1111/j.1471-4159.1958.tb12607.x; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Hayflick SJ, 2006, AM J NEURORADIOL, V27, P1230; Horowitz MP, 2010, J ALZHEIMERS DIS, V20, pS551, DOI 10.3233/JAD-2010-100354; Jin L, 2012, EUR J NEUROL, V19, P969, DOI 10.1111/j.1468-1331.2011.03658.x; Kaur D, 2007, BRAIN RES, V1140, P188, DOI 10.1016/j.brainres.2006.03.006; Keogh MJ, 2013, INT REV NEUROBIOL, V110, P91, DOI 10.1016/B978-0-12-410502-7.00006-5; Kubota A, 2009, MOVEMENT DISORD, V24, P441, DOI 10.1002/mds.22435; Le Weidong, 2014, Parkinsonism Relat Disord, V20 Suppl 1, pS158, DOI 10.1016/S1353-8020(13)70038-5; Lewis MM, 2011, NEUROSCIENCE, V177, P230, DOI 10.1016/j.neuroscience.2010.12.060; Luscieti S, 2010, J BIOL CHEM, V285, P11948, DOI 10.1074/jbc.M109.096404; LUZZAGO A, 1986, BIOCHIM BIOPHYS ACTA, V872, P61, DOI 10.1016/0167-4838(86)90147-0; Maccarinelli F, 2015, NEUROBIOL DIS, V81, P119, DOI 10.1016/j.nbd.2014.10.023; Maciel P, 2005, NEUROLOGY, V65, P603, DOI 10.1212/01.wnl.0000178224.81169.c2; Mancuso M, 2005, J NEUROPATH EXP NEUR, V64, P280, DOI 10.1093/jnen/64.4.280; Matsunaga T, 2004, J BIOL CHEM, V279, P28614, DOI 10.1074/jbc.M400977200; McCormack AL, 2002, NEUROBIOL DIS, V10, P119, DOI 10.1006/nbdi.2002.0507; Mineur YS, 2002, BRAIN RES BULL, V57, P41, DOI 10.1016/S0361-9230(01)00635-9; Moutton S, 2014, PARKINSONISM RELAT D, V20, P935, DOI 10.1016/j.parkreldis.2014.04.026; Muhoberac BB, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00032; Murray-Kolb LE, 2003, AM J CLIN NUTR, V77, P180, DOI 10.1093/ajcn/77.1.180; Nishida K, 2014, J NEUROL SCI, V342, P173, DOI 10.1016/j.jns.2014.03.060; Norbury R, 2003, EXP GERONTOL, V38, P109, DOI 10.1016/S0531-5565(02)00166-3; Ohta E, 2008, NEUROLOGY, V70, P1493, DOI 10.1212/01.wnl.0000310428.74624.95; Ohta E, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/197438; Ory-Magne F, 2009, MOVEMENT DISORD, V24, P1676, DOI 10.1002/mds.22669; Pani L, 2000, MOL PSYCHIATR, V5, P14, DOI 10.1038/sj.mp.4000589; Schneider SA, 2013, J NEURAL TRANSM, V120, P695, DOI 10.1007/s00702-012-0922-8; Storti E, 2013, MOVEMENT DISORD, V28, P252, DOI 10.1002/mds.25275; TAKETO M, 1991, P NATL ACAD SCI USA, V88, P2065, DOI 10.1073/pnas.88.6.2065; Thiruchelvam M, 2003, EUR J NEUROSCI, V18, P589, DOI 10.1046/j.1460-9568.2003.02781.x; Varga Gabor, 2011, Neuropsychopharmacol Hung, V13, P93; Vidal R, 2004, J NEUROPATH EXP NEUR, V63, P363, DOI 10.1093/jnen/63.4.363; Vidal R, 2008, J NEUROSCI, V28, P60, DOI 10.1523/JNEUROSCI.3962-07.2008; Zaidel A, 2009, CURR OPIN NEUROL, V22, P387, DOI 10.1097/WCO.0b013e32832d9d67	59	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0118990	10.1371/journal.pone.0118990	http://dx.doi.org/10.1371/journal.pone.0118990			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689865	Green Submitted, gold, Green Published			2022-12-26	WOS:000350322700121
J	Grimm, SK; Battles, MB; Ackerman, ME				Grimm, Sebastian K.; Battles, Michael B.; Ackerman, Margaret E.			Directed Evolution of a Yeast-Displayed HIV-1 SOSIP gp140 Spike Protein toward Improved Expression and Affinity for Conformational Antibodies	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ENVELOPE GLYCOPROTEIN COMPLEX; HUMAN MONOCLONAL-ANTIBODY; SURFACE DISPLAY; BINDING-SITE; NEUTRALIZING ANTIBODIES; EMERGING CONCEPTS; IMMUNOGEN DESIGN; EPITOPE; GP120	Design of an envelope-based immunogen capable of inducing a broadly neutralizing antibody response is thought to be key to the development of a protective HIV-1 vaccine. However, the broad diversity of viral variants and a limited ability to produce native envelope have hampered such design efforts. Here we describe adaptation of the yeast display system and use of a combinatorial protein engineering approach to permit directed evolution of HIV envelope variants. Because the intrinsic instability and complexity of this trimeric glycoprotein has greatly impeded the development of immunogens that properly represent the structure of native envelope, this platform addresses an essential need for methodologies with the capacity to rapidly engineer HIV spike proteins towards improved homogeneity, stability, and presentation of neutralizing epitopes. We report for the first time the display of a designed SOSIP gp140 on yeast, and the in vitro evolution of derivatives with greatly improved expression and binding to conformation-dependent antibodies. These efforts represent an initial and critical step toward the ability to rapidly engineer HIV-1 envelope immunogens via directed evolution.	[Grimm, Sebastian K.; Battles, Michael B.; Ackerman, Margaret E.] Thayer Sch Engn Dartmouth, Hanover, NH 03755 USA	Dartmouth College	Ackerman, ME (corresponding author), Thayer Sch Engn Dartmouth, Hanover, NH 03755 USA.	margaret.e.ackerman@dartmouth.edu		Battles, Michael/0000-0002-5321-7460	National Institute of Health, National Institute of Allergy and Infectious Disease [1R01AI102691]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI102691] Funding Source: NIH RePORTER	National Institute of Health, National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Health, National Institute of Allergy and Infectious Disease 1R01AI102691 to MEA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman M, 2013, NEW ENGL J MED, V369, P389, DOI 10.1056/NEJMcibr1304437; Ackerman ME, 2012, ANNU REV MED, V63, P113, DOI 10.1146/annurev-med-050310-085221; Ahmed FK, 2012, VACCINE, V30, P922, DOI 10.1016/j.vaccine.2011.11.089; Antipov E, 2008, P NATL ACAD SCI USA, V105, P17694, DOI 10.1073/pnas.0809851105; Azoitei ML, 2011, SCIENCE, V334, P373, DOI 10.1126/science.1209368; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Binley JM, 2010, J VIROL, V84, P5637, DOI 10.1128/JVI.00105-10; Binley JM, 2000, J VIROL, V74, P627, DOI 10.1128/JVI.74.2.627-643.2000; Boder ET, 2000, METHOD ENZYMOL, V328, P430, DOI 10.1016/S0076-6879(00)28410-3; Boder ET, 2000, P NATL ACAD SCI USA, V97, P10701, DOI 10.1073/pnas.170297297; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Boder ET, 2005, BIOTECHNOL BIOENG, V92, P485, DOI 10.1002/bit.20616; Brien JD, 2010, J VIROL, V84, P10630, DOI 10.1128/JVI.01190-10; Brodsky JL, 2011, CURR OPIN CELL BIOL, V23, P464, DOI 10.1016/j.ceb.2011.05.004; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; Correia BE, 2010, STRUCTURE, V18, P1116, DOI 10.1016/j.str.2010.06.010; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Crameri A, 1998, NATURE, V391, P288, DOI 10.1038/34663; Dai K, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-S2-P23; De Pourcq K, 2010, APPL MICROBIOL BIOT, V87, P1617, DOI 10.1007/s00253-010-2721-1; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Frey G, 2008, P NATL ACAD SCI USA, V105, P3739, DOI 10.1073/pnas.0800255105; FROMANT M, 1995, ANAL BIOCHEM, V224, P347, DOI 10.1006/abio.1995.1050; Grimm SK, 2013, CURR OPIN BIOTECH, V24, P1078, DOI 10.1016/j.copbio.2013.02.015; Hackel BJ, 2008, J MOL BIOL, V381, P1238, DOI 10.1016/j.jmb.2008.06.051; Hamilton SR, 2003, SCIENCE, V301, P1244, DOI 10.1126/science.1088166; Hamilton SR, 2006, SCIENCE, V313, P1441, DOI 10.1126/science.1130256; Han T, 2011, BIOCHEM BIOPH RES CO, V409, P253, DOI 10.1016/j.bbrc.2011.04.139; Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Hoxie JA, 2010, ANNU REV MED, V61, P135, DOI 10.1146/annurev.med.60.042507.164323; Jacobs PP, 2009, NAT PROTOC, V4, P58, DOI 10.1038/nprot.2008.213; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Kim YS, 2006, PROTEINS, V62, P1026, DOI 10.1002/prot.20618; Klausner RD, 2003, SCIENCE, V300, P2036, DOI 10.1126/science.1086916; Klein JS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000908; Kovacs JM, 2012, P NATL ACAD SCI USA, V109, P12111, DOI 10.1073/pnas.1204533109; Labrijn AF, 2003, J VIROL, V77, P10557, DOI 10.1128/JVI.77.19.10557-10565.2003; Leaman DP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003184; Lee CC, 2005, PLASMID, V54, P80, DOI 10.1016/j.plasmid.2004.12.001; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Mata-Fink J, 2013, J MOL BIOL, V425, P444, DOI 10.1016/j.jmb.2012.11.010; McElrath MJ, 2010, IMMUNITY, V33, P542, DOI 10.1016/j.immuni.2010.09.011; McGuire AT, 2013, J EXP MED, V210, P655, DOI 10.1084/jem.20122824; Mikell I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001251; Morner A, 2009, J VIROL, V83, P540, DOI 10.1128/JVI.01102-08; Moore PL, 2012, NAT MED, V18, P1688, DOI 10.1038/nm.2985; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; Ofek G, 2010, P NATL ACAD SCI USA, V107, P17880, DOI 10.1073/pnas.1004728107; Oliphant T, 2006, J VIROL, V80, P12149, DOI 10.1128/JVI.01732-06; Pantophlet R, 2004, PROTEIN ENG DES SEL, V17, P749, DOI 10.1093/protein/gzh085; Pantophlet R, 2003, J VIROL, V77, P642, DOI 10.1128/JVI.77.1.642-658.2003; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; Rakestraw JA, 2011, PROTEIN ENG DES SEL, V24, P525, DOI 10.1093/protein/gzr008; Rakestraw JA, 2006, BIOTECHNOL PROGR, V22, P1200, DOI 10.1021/bp0600233; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Ringe RP, 2013, P NATL ACAD SCI USA, V110, P18256, DOI 10.1073/pnas.1314351110; Sabo MC, 2011, J VIROL, V85, P7005, DOI 10.1128/JVI.00586-11; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Sanders RW, 2002, J VIROL, V76, P8875, DOI 10.1128/JVI.76.17.8875-8889.2002; Saphire EO, 2007, J MOL BIOL, V369, P696, DOI 10.1016/j.jmb.2007.01.060; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Schief WR, 2009, CURR OPIN HIV AIDS, V4, P431, DOI 10.1097/COH.0b013e32832e6184; Schulke N, 2002, J VIROL, V76, P7760, DOI 10.1128/JVI.76.15.7760-7776.2002; Shusta EV, 1999, J MOL BIOL, V292, P949, DOI 10.1006/jmbi.1999.3130; Srivastava IK, 2008, VIROLOGY, V372, P273, DOI 10.1016/j.virol.2007.10.022; STEMMER WPC, 1994, P NATL ACAD SCI USA, V91, P10747, DOI 10.1073/pnas.91.22.10747; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Van Regenmortel MHV, 2011, J MOL RECOGNIT, V24, P741, DOI 10.1002/jmr.1116; Villalobos A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-285; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2010, CURR OPIN IMMUNOL, V22, P358, DOI 10.1016/j.coi.2010.02.012; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Zhang XP, 2009, VIRAL IMMUNOL, V22, P407, DOI 10.1089/vim.2009.0046	83	5	5	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117227	10.1371/journal.pone.0117227	http://dx.doi.org/10.1371/journal.pone.0117227			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25688555	gold, Green Published, Green Submitted			2022-12-26	WOS:000350322700031
J	Jeong, CW; Park, GT; Yun, H; Hsieh, TF; Do Choi, Y; Choi, Y; Lee, JS				Jeong, Cheol Woong; Park, Guen Tae; Yun, Hyein; Hsieh, Tzung-Fu; Do Choi, Yang; Choi, Yeonhee; Lee, Jong Seob			Control of Paternally Expressed Imprinted UPWARD CURLY LEAF1, a Gene Encoding an F-Box Protein That Regulates CURLY LEAF Polycomb Protein, in the Arabidopsis Endosperm	PLOS ONE			English	Article							SEED DEVELOPMENT; DNA METHYLATION; LIFE-CYCLE; MEDEA; THALIANA; DEMETER; PHERES1; PLANT; METHYLTRANSFERASE; IDENTIFICATION	Genomic imprinting, an epigenetic process in mammals and flowering plants, refers to the differential expression of alleles of the same genes in a parent-of-origin-specific manner. In Arabidopsis, imprinting occurs primarily in the endosperm, which nourishes the developing embryo. Recent high-throughput sequencing analyses revealed that more than 200 loci are imprinted in Arabidopsis; however, only a few of these imprinted genes and their imprinting mechanisms have been examined in detail. Whereas most imprinted loci characterized to date are maternally expressed imprinted genes (MEGs), PHERES1 (PHE1) and ADMETOS (ADM) are paternally expressed imprinted genes (PEGs). Here, we report that UPWARD CURLY LEAF1 (UCL1), a gene encoding an E3 ligase that degrades the CURLY LEAF (CLF) polycomb protein, is a PEG. After fertilization, paternally inherited UCL1 is expressed in the endosperm, but not in the embryo. The expression pattern of a beta-glucuronidase (GUS) reporter gene driven by the UCL1 promoter suggests that the imprinting control region (ICR) of UCL1 is adjacent to a transposable element in the UCL1 5'-up-stream region. Polycomb Repressive Complex 2 (PRC2) silences the maternal UCL1 allele in the central cell prior to fertilization and in the endosperm after fertilization. The UCL1 imprinting pattern was not affected in paternal PRC2 mutants. We found unexpectedly that the maternal UCL1 allele is reactivated in the endosperm of Arabidopsis lines with mutations in cytosine DNA METHYLTRANSFERASE 1 (MET1) or the DNA glycosylase DEME-TER (DME), which antagonistically regulate CpG methylation of DNA. By contrast, maternal UCL1 silencing was not altered in mutants with defects in non-CpG methylation. Thus, silencing of the maternal UCL1 allele is regulated by both MET1 and DME as well as by PRC2, suggesting that divergent mechanisms for the regulation of PEGs evolved in Arabidopsis.	[Jeong, Cheol Woong; Park, Guen Tae; Yun, Hyein; Choi, Yeonhee; Lee, Jong Seob] Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea; [Hsieh, Tzung-Fu] N Carolina State Univ, Plants Human Hlth Inst, Kannapolis, NC USA; [Hsieh, Tzung-Fu] N Carolina State Univ, Dept Plant & Microbial Biol, Kannapolis, NC USA; [Do Choi, Yang] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea	Seoul National University (SNU); University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; Seoul National University (SNU)	Choi, Y (corresponding author), Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea.	yhc@snu.ac.kr; 08jongs@snu.ac.kr	Choi, Yeonhee/AAF-5906-2020	Hsieh, Tzung-Fu/0000-0001-7584-3721	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2011-0022425]; Brain Korea 21 Program	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; Brain Korea 21 Program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2011-0022425 to JSL) and by the Brain Korea 21 Program (to GTP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARLOW DP, 1993, SCIENCE, V260, P309, DOI 10.1126/science.8469984; Baroux U, 2006, GENE DEV, V20, P1081, DOI 10.1101/gad.378106; Bartolomei MS, 2009, GENE DEV, V23, P2124, DOI 10.1101/gad.1841409; Berger F, 2003, CURR OPIN PLANT BIOL, V6, P42, DOI 10.1016/S1369526602000043; Berger F, 2006, CURR OPIN PLANT BIOL, V9, P664, DOI 10.1016/j.pbi.2006.09.015; Choi YH, 2002, CELL, V110, P33, DOI 10.1016/S0092-8674(02)00807-3; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dilkes BP, 2004, PLANT CELL, V16, P3174, DOI 10.1105/tpc.104.161230; Feil R, 2007, TRENDS GENET, V23, P192, DOI 10.1016/j.tig.2007.02.004; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Frost JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001015; Fujimoto R, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000048; Garnier O, 2008, EPIGENETICS-US, V3, P14, DOI 10.4161/epi.3.1.5554; Gehring M, 2006, CELL, V124, P495, DOI 10.1016/j.cell.2005.12.034; Gehring M, 2013, ANNU REV GENET, V47, P187, DOI 10.1146/annurev-genet-110711-155527; Gehring M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023687; Gehring M, 2009, SCIENCE, V324, P1447, DOI 10.1126/science.1171609; Haig D, 1997, P ROY SOC B-BIOL SCI, V264, P1657, DOI 10.1098/rspb.1997.0230; HAIG D, 1989, AM NAT, V134, P147, DOI 10.1086/284971; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Hsieh TF, 2011, P NATL ACAD SCI USA, V108, P1755, DOI 10.1073/pnas.1019273108; Hsieh TF, 2009, SCIENCE, V324, P1451, DOI [10.1126/science.1172417, 10.1126/science.112417]; Huh JH, 2008, CELL, V132, P735, DOI 10.1016/j.cell.2008.02.018; Iwasa Y, 1998, CURR TOP DEV BIOL, V40, P255, DOI 10.1016/S0070-2153(08)60369-5; Jeong CW, 2011, P NATL ACAD SCI USA, V108, P8036, DOI 10.1073/pnas.1104232108; Johnston AJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r204; Jullien PE, 2008, PLOS BIOL, V6, P1693, DOI 10.1371/journal.pbio.0060194; Jullien PE, 2006, PLANT CELL, V18, P1360, DOI 10.1105/tpc.106.041178; Jullien PE, 2009, CURR OPIN PLANT BIOL, V12, P637, DOI 10.1016/j.pbi.2009.07.004; Jullien PE, 2006, CURR BIOL, V16, P486, DOI 10.1016/j.cub.2006.01.020; Kankel MW, 2003, GENETICS, V163, P1109; Kinoshita T, 1999, PLANT CELL, V11, P1945, DOI 10.1105/tpc.11.10.1945; Kinoshita T, 2004, SCIENCE, V303, P521, DOI 10.1126/science.1089835; Kinoshita Y, 2007, PLANT J, V49, P38, DOI 10.1111/j.1365-313X.2006.02936.x; Kohler C, 2010, HEREDITY, V105, P57, DOI 10.1038/hdy.2009.176; Kohler C, 2005, NAT GENET, V37, P28, DOI 10.1038/ng1495; Kradolfer D, 2013, DEV CELL, V26, P525, DOI 10.1016/j.devcel.2013.08.006; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lord EM, 2002, ANNU REV CELL DEV BI, V18, P81, DOI 10.1146/annurev.cellbio.18.012502.083438; Makarevich G, 2008, J CELL SCI, V121, P906, DOI 10.1242/jcs.023077; Martienssen R, 2004, COLD SPRING HARB SYM, V69, P371, DOI 10.1101/sqb.2004.69.371; McKeown PC, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-113; Morales-Ruiz T, 2006, P NATL ACAD SCI USA, V103, P6853, DOI 10.1073/pnas.0601109103; Ohad N, 1999, PLANT CELL, V11, P407, DOI 10.1105/tpc.11.3.407; Ohad N, 1996, P NATL ACAD SCI USA, V93, P5319, DOI 10.1073/pnas.93.11.5319; Scott RJ, 1998, DEVELOPMENT, V125, P3329; Sleutels F, 2002, ADV GENET, V46, P119; Surani MA, 1998, CELL, V93, P309, DOI 10.1016/S0092-8674(00)81156-3; Tilghman SM, 1999, CELL, V96, P185, DOI 10.1016/S0092-8674(00)80559-0; Villar CBR, 2009, MOL PLANT, V2, P654, DOI 10.1093/mp/ssp014; Walbot V, 2003, NAT REV GENET, V4, P369, DOI 10.1038/nrg1064; Wang DF, 2006, P NATL ACAD SCI USA, V103, P13244, DOI 10.1073/pnas.0605551103; Weinhofer I, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001152; Wohrmann HJP, 2012, GENE DEV, V26, P1837, DOI 10.1101/gad.195123.112; Wolff P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002126; Xiao WY, 2003, DEV CELL, V5, P891, DOI 10.1016/S1534-5807(03)00361-7	56	5	5	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117431	10.1371/journal.pone.0117431	http://dx.doi.org/10.1371/journal.pone.0117431			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689861	Green Published, Green Submitted, gold			2022-12-26	WOS:000350322700043
J	Jin, JH; Qin, Q; Guo, HY; Liu, SL; Ge, SY; Zhang, HX; Cui, JY; Ren, FZ				Jin, Junhua; Qin, Qian; Guo, Huiyuan; Liu, Songling; Ge, Shaoyang; Zhang, Hongxing; Cui, Jianyun; Ren, Fazheng			Effect of Pre-Stressing on the Acid-Stress Response in Bifidobacterium Revealed Using Proteomic and Physiological Approaches	PLOS ONE			English	Article							LACTOCOCCUS-LACTIS; TOLERANCE RESPONSE; ESCHERICHIA-COLI; ADAPTATION; PATHWAYS; ARGININE; PH	Weak acid resistance limits the application of Bifidobacteria as a probiotic in food. The acid tolerance response (ATR), caused by pre-stressing cells at a sublethal pH, could improve the acid resistance of Bifidobacteria to subsequent acid stress. In this study, we used Bifidobacterium longum sub. longum BBMN68 to investigate the effect of the ATR on the acid stress response (ASR), and compared the difference between the ATR and the ASR by analyzing the two-dimensional-PAGE protein profiles and performing physiological tests. The results revealed that a greater abundance of proteins involved in carbohydrate metabolism and protein protection was present after the ASR than after the ATR in Bifidobacterium. Pre-stressing cells increased the abundance of proteins involved in energy production, amino acid metabolism, and peptidoglycan synthesis during the ASR of Bifidobacterium. Moreover, after the ASR, the content of ATP, NH3, thiols, and peptidoglycan, the activity of H+-ATPase, and the maintenance of the intracellular pH in the pre-stressed Bifidobacterium cells was significantly higher than in the uninduced cells. These results provide the first explanation as to why the resistance of Bifidobacterium to acid stress improved after pre-stressing.	[Jin, Junhua; Zhang, Hongxing] Beijing Univ Agr, Food Sci & Engn Coll, Beijing Lab Food Qual & Safety, Beijing 102206, Peoples R China; [Qin, Qian; Guo, Huiyuan; Liu, Songling; Ge, Shaoyang; Cui, Jianyun; Ren, Fazheng] China Agr Univ, Coll Food Sci & Nutr Engn, Beijing 100083, Peoples R China; [Guo, Huiyuan] Beijing Higher Inst Engn Res Ctr Anim Prod, Beijing 100083, Peoples R China; [Liu, Songling] China Agr Univ, Key Lab Funct Dairy, Beijing 100083, Peoples R China; [Ge, Shaoyang] Beijing Resources Yatai Feed Technol Co LTD, Beijing, Peoples R China	Beijing University of Agriculture; China Agricultural University; China Agricultural University	Ren, FZ (corresponding author), China Agr Univ, Coll Food Sci & Nutr Engn, Beijing 100083, Peoples R China.	renfazheng@263.net	Qin, Qin/GVT-5910-2022; qin, qin x/GXG-6164-2022		Ministry of Science and Technology of China [2011AA100903, 2012BAD12B08]; Beijing Municipal Commission of Education Co-constructed Program; Great Northern Agriculture Group [13ZK006]; Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions [20140315]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Beijing Municipal Commission of Education Co-constructed Program; Great Northern Agriculture Group; Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions	This study was supported by Ministry of Science and Technology of China (2011AA100903, 2012BAD12B08), (http://program.most.gov.cn/); Beijing Municipal Commission of Education Co-constructed Program; Great Northern Agriculture Group (13ZK006); The Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions (20140315). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bracey D, 1990, J MICROBIOL METH, V3, P113; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Carlsson N, 2011, ANAL BIOCHEM, V411, P116, DOI 10.1016/j.ab.2010.12.026; Champagne CP, 2005, CRIT REV FOOD SCI, V45, P61, DOI 10.1080/10408690590900144; Chang YY, 1999, MOL MICROBIOL, V33, P249, DOI 10.1046/j.1365-2958.1999.01456.x; Doi Y, 2007, J AM CHEM SOC, V129, P14458, DOI 10.1021/ja075557u; Even S, 2002, MOL MICROBIOL, V45, P1143, DOI 10.1046/j.1365-2958.2002.03086.x; Jin JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050777; Jin JH, 2011, CURR MICROBIOL, V62, P612, DOI 10.1007/s00284-010-9751-x; Kim EK, 2008, BIOCHEM BIOPH RES CO, V369, P1047, DOI 10.1016/j.bbrc.2008.02.139; KRAUSE I, 1995, J CHROMATOGR A, V715, P67, DOI 10.1016/0021-9673(95)00578-B; LAZDUNSKI AM, 1989, FEMS MICROBIOL LETT, V63, P265, DOI 10.1111/j.1574-6968.1989.tb03400.x; Leverrier P, 2004, ARCH MICROBIOL, V181, P215, DOI 10.1007/s00203-003-0646-0; Masco L, 2005, INT J FOOD MICROBIOL, V102, P221, DOI 10.1016/j.ijfoodmicro.2004.11.018; Matsui R, 2010, FUTURE MICROBIOL, V5, P403, DOI 10.2217/FMB.09.129; Matsumoto M, 2004, INT J FOOD MICROBIOL, V93, P109, DOI 10.1016/j.ijfoodmicro.2003.10.009; Miao Y, 2005, BEIJING DA XUEXUEBAO, V2, P201; O'May GA, 2005, J CLIN MICROBIOL, V43, P3059, DOI 10.1128/JCM.43.7.3059-3065.2005; Rallu F, 1996, ANTON LEEUW INT J G, V70, P243, DOI 10.1007/BF00395935; Sanchez B, 2007, APPL ENVIRON MICROB, V73, P6450, DOI 10.1128/AEM.00886-07; Thi MHT, 2011, APPL ENVIRON MICROB, V77, P3327, DOI 10.1128/AEM.02518-10; Tonon T, 2000, J APPL MICROBIOL, V89, P526, DOI 10.1046/j.1365-2672.2000.01142.x; Waddington L, 2010, J APPL MICROBIOL, V108, P1408, DOI 10.1111/j.1365-2672.2009.04540.x; Wu CD, 2012, APPL MICROBIOL BIOT, V93, P707, DOI 10.1007/s00253-011-3757-6; Wu RN, 2011, INT J FOOD MICROBIOL, V147, P181, DOI 10.1016/j.ijfoodmicro.2011.04.003; Xiao M, 2011, MICROBIOL-SGM, V157, P1573, DOI 10.1099/mic.0.044297-0; Zhang J, 2007, APPL ENVIRON MICROB, V73, P5268, DOI 10.1128/AEM.02787-06; Zuniga M, 1998, J BACTERIOL, V180, P4154	28	23	25	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117702	10.1371/journal.pone.0117702	http://dx.doi.org/10.1371/journal.pone.0117702			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689631	gold, Green Submitted, Green Published			2022-12-26	WOS:000350322700065
J	Majumder, N; Ram, F				Majumder, Nabanita; Ram, Faujdar			Explaining the Role of Proximate Determinants on Fertility Decline among Poor and Non-Poor in Asian Countries	PLOS ONE			English	Article							INDUCED-ABORTION; MARRIAGE; TRENDS; CONTRACEPTION; POSTPARTUM; AMENORRHEA; FRAMEWORK; NUTRITION; EDUCATION; INDIA	Objectives We examined the overall contributions of the poor and non-poor in fertility decline across the Asian countries. Further, we analyzed the direct and indirect factors that determine the reproductive behaviour of two distinct population sub-groups. Design Data from several new rounds of DHS surveys are available over the past few years. The DHS provides cross-nationally comparable and useful data on fertility, family planning, maternal and child health along with the other information. Six selected Asian countries namely: Bangladesh, India, Indonesia, Nepal, Philippines, and Vietnam are considered for the purpose of the study. Three rounds of DHS surveys for each country (except Vietnam) are considered in the present study. Methods Economic status is measured by computing a "wealth index", i.e. a composite indicator constructed by aggregating data on asset ownership and housing characteristics using principal components analysis (PCA). Computed household wealth index has been broken into three equal parts (33.3 percent each) and the lowest and the highest 33.3 percent is considered as poor and non-poor respectively. The Bongaarts model was employed to quantify the contribution of each of the proximate determinants of fertility among poor and non-poor women. Results Fertility reduction across all population subgroups is now an established fact despite the diversity in the level of socio-economic development in Asian countries. It is clear from the analysis that fertility has declined irrespective of economic status at varying degrees within and across the countries which can be attributed to the increasing level of contraceptive use especially among poor women. Over the period of time changing marriage pattern and induced abortion are playing an important role in reducing fertility among poor women. Conclusions Fertility decline among majority of the poor women across the Asian countries is accompanied by high prevalence of contraceptive use followed by changing marriage pattern and induced abortion.	[Majumder, Nabanita; Ram, Faujdar] Int Inst Populat Sci, Bombay, Maharashtra, India	International Institute for Population Sciences	Majumder, N (corresponding author), Int Inst Populat Sci, Bombay, Maharashtra, India.	nabanitamajumder.iips@gmail.com						Adioetomo SM, 1983, MAJALAH DEMOGRAFI IN, V10, P49; Ahmed S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011190; Amin S, 2009, 18 POP COUNC; [Anonymous], [No title captured]; [Anonymous], 2006, DHS METHODOLOGICAL R; [Anonymous], 2003, REV INCOME WEALTH; Arnold F, 1990, IRD ASSESSMENT DHS 1; Arokiasamy P., 2009, Economic and Political Weekly, V44, P55; Bbaale E, 2011, J SUSTAINABLE DEV, V6, P20; Bernstein S, 2002, ASIA PACIFIC POPULAT, V17; Bhat PNM, 2002, WORLD DEV, V30, P1791, DOI 10.1016/S0305-750X(02)00065-7; BLACKER J, 1994, POPUL DEV REV, V20, P200, DOI 10.2307/2137639; Boerma JT, 2008, LANCET, V371, P1259, DOI 10.1016/S0140-6736(08)60560-7; Bollen KA, 2002, POP STUD-J DEMOG, V56, P81, DOI 10.1080/00324720213796; BONGAARTS J, 1982, STUD FAMILY PLANN, V13, P179, DOI 10.2307/1965445; Bongaarts J, 1996, POPUL DEV REV, V22, P639, DOI 10.2307/2137804; BONGAARTS J, 1984, POPUL DEV REV, V10, P341, DOI 10.2307/1973086; BONGAARTS J, 1978, POPUL DEV REV, V4, P105, DOI 10.2307/1972149; Bongaarts J, 1983, FERTILITY BIOL BEHAV; Bongaarts J, 2002, P EXP GROUP COMPL FE, V172, P288; Bongaarts J, 1993, WORKING PAPERS POPUL; Bracher M, 1992, Health Transit Rev, V2, P19; Bulatao RA., 1983, DETERMINANTS FERTILI, P1; Caldwell J. C., 1982, THEORY FERTILITY DEC; Caldwell JC, 1993, REVOLUTION ASIAN FER; Chen LC, 1974, POPULATION STUDIES, V28, P278; Cheng KW, 2011, J FAM ECON ISS, V32, P257, DOI 10.1007/s10834-011-9248-1; Chidambaram VC, 1980, WFS COMP STUDIES INT; Choi Y, 2010, 2010 PAA M DALL; CLELAND J, 1987, POP STUD-J DEMOG, V41, P5, DOI 10.1080/0032472031000142516; Cleland J, 1994, BANGLADESH FERTILITY; COALE AJ, 1974, POPUL INDEX, V40, P185, DOI 10.2307/2733910; Coale Ansley., 1986, DECLINE FERTILITY EU; DAVIS K, 1956, ECON DEV CULT CHANGE, V4, P211, DOI 10.1086/449714; Dreze J, 2001, POPUL DEV REV, V27, P33, DOI 10.1111/j.1728-4457.2001.00033.x; Dwivedi Laxmi Kant, 2007, Genus, V63, P19; EASTERLIN RA, 1975, STUD FAMILY PLANN, V6, P54, DOI 10.2307/1964934; Fabic MS, 2012, B WORLD HEALTH ORGAN, V90, P4; Feyisetan B, 2000, INT FAM PLAN PERSPEC, V26, P100, DOI 10.2307/2648298; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Filmer D, 2012, DEMOGRAPHY, V49, P359, DOI 10.1007/s13524-011-0077-5; Freedman R, 1995, ASIAS RECENT FERTILI; Frejka T, 1985, INT FAMILY PLANNING, V11, P125; Gakidou E, 2007, PLOS MED, V4, P381, DOI 10.1371/journal.pmed.0040031; Ginneken J. K. van, 1977, Journal of Biosocial Science, P41, DOI 10.1017/S0021932000023828; Goldman N, 1985, WFS COMP STUDIES INT; GOODKIND D, 1994, STUD FAMILY PLANN, V25, P342, DOI 10.2307/2137878; GWATKIN DR, 2000, SOCIOECONOMIC DIFFER; GWATKIN DR, 2007, SOCIOECONOMIC DIFFER; Hajnal J, 1953, POP STUD-J DEMOG, V7, P111, DOI 10.2307/2172028; Hajnal John, 1965, POPULATION HIST ESSA, P101, DOI DOI 10.4324/9781315127019-7; Haughton J, 1997, POP STUD-J DEMOG, V51, P203, DOI 10.1080/0032472031000149916; HUFFMAN SL, 1987, POP STUD-J DEMOG, V41, P447, DOI 10.1080/0032472031000142996; HUNTINGTON D, 1993, STUD FAMILY PLANN, V24, P120; Hussein E, 1995, PERSPECTIVES FERTILI, P31; Johnston HB, 1996, INT FAM PLAN PERSPEC, V22, P108, DOI 10.2307/2950751; Jones G. W., 2007, ASIA PAC POPULAT J, V22, P13; Jones R. E., 1990, 9006; JONES RE, 1989, J BIOSOC SCI, V21, P83, DOI 10.1017/S0021932000017740; JONES RE, 1988, HUM BIOL, V60, P853; Juarez F, 2005, INT FAM PLAN PERSPEC, V31, P140, DOI 10.1363/3114005; Knodel J, 1978, NATURAL FERTILITY PA, P273; Leridon H., 1977, HUMAN FERTILITY BASI; LUNN PG, 1981, LANCET, V1, P1428; Magadi MA, 2003, STUD FAMILY PLANN, V34, P149, DOI 10.1111/j.1728-4465.2003.00149.x; Maitra P, 2001, DISCUSSION PAPERS MO; Marston C, 2003, INT FAM PLAN PERSPEC, V29, P6, DOI 10.2307/3180995; McNay K, 2003, POP STUD-J DEMOG, V57, P21, DOI 10.1080/0032472032000061703; Merli MG, 2000, DEMOGRAPHY, V37, P109, DOI 10.2307/2648100; Montgomery MR, 2000, DEMOGRAPHY, V37, P155, DOI 10.2307/2648118; Notestein F. W., 1953, P 8 INT C AGR EC, P13; Pallikadavath S, 2006, INT FAM PLAN PERSPEC, V32, P120, DOI 10.1363/3212006; Rodriguez G, 1988, SEM BIOM DEM DET HUM; Ross J, 2001, INT FAM PLAN PERSPEC, V27, P119, DOI 10.2307/2673833; Ross J, 2002, INT FAMILY PLANNING, V28; Rutstein S. O., 2004, DHS COMP REPORTS; SANTOW G, 1987, POP STUD-J DEMOG, V41, P147, DOI 10.1080/0032472031000142576; Shah IH, 1994, PROGR SOCIAL SCI RES, P139; Singh G, 2006, INTERNET J PEDIAT NE, V7; Singh G, 2007, J OBSTET GYN INDIA, V57, P53; SINGH S, 1985, POP STUD-J DEMOG, V39, P113, DOI 10.1080/0032472031000141316; Singh S, 1997, INT FAM PLAN PERSPEC, V23, P59, DOI 10.2307/2950825; Singh S, 1996, INT FAM PLAN PERSPEC, V22, P148, DOI 10.2307/2950812; Singh S, 2006, INT FAM PLAN PERSPEC, V32, P136, DOI 10.1363/3213606; SMITH PC, 1980, J FAM HIST, V5, P58, DOI 10.1177/036319908000500104; Sun T, 2001, PAA ANN M MARCH 28 3; Teerawichitchainan B, 2010, INT PERSPECT SEX R H, V36, P80, DOI 10.1363/ipsrh.36.080.10; TSUI AO, 1981, STUD FAMILY PLANN, V12, P381, DOI 10.2307/1965995; United Nations, 1990, PATT 1 MARR TIM PREV; United Nations, 1987, POP STUD DEP INT EC; Vaessen M, 2004, HOUSEHOLD SAMPLE SUR; Van De Walle E, 1973, IPPF Med Bull, V7, P1; Vidal-Zeballos D, 1994, DEMOGRAPHIC HLTH SUR; Vu L, 2009, AGE 1 MARRIAGE VIETN; Wood J W, 1985, J Biosoc Sci Suppl, V9, P159; Xenos PC, 1992, WORKING PAPERS PROGR	96	19	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0115441	10.1371/journal.pone.0115441	http://dx.doi.org/10.1371/journal.pone.0115441			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC4KQ	25689843	Green Published, gold, Green Submitted			2022-12-26	WOS:000350322700004
J	Ouellette-Kuntz, H; Coo, H; Cobigo, V; Wilton, AS				Ouellette-Kuntz, Helene; Coo, Helen; Cobigo, Virginie; Wilton, Andrew S.			Uptake of Colorectal Cancer Screening among Ontarians with Intellectual and Developmental Disabilities	PLOS ONE			English	Article							LIFE EXPECTANCY; DOWN-SYNDROME; PRIMARY-CARE; ADULTS; INDIVIDUALS; PROGRAMS; PEOPLE; TESTS; WOMEN	Under-screening for cancer may contribute to a greater disease burden in individuals with intellectual and developmental disabilities (IDD) as their life expectancy increases. In 2008, the province of Ontario launched Canada's first population-based colorectal cancer screening program. Our objectives were to compare the proportions of Ontarians with and without IDD who have undergone colorectal cancer screening and to examine factors associated with screening uptake among Ontarians with IDD. Records for Ontario residents 50-64 years of age were linked across various administrative health and social services datasets to identify individuals with IDD and to select a random sample of the age-equivalent Ontario population without IDD as a comparison group. Logistic regression models were fit to examine the odds of screening uptake among individuals with IDD while controlling for age, sex, urban or rural residence, neighbourhood income quintile, expected use of health care resources, and being enrolled with or seeing a physician in a patient enrolment model (any of several primary care practice models designed to improve patient access and quality of care in Ontario), and to examine the association between these variables and colorectal cancer screening in the IDD population. The odds of having had a fecal occult blood test in the previous two years and being up-to-date with colorectal tests were 32% and 46% lower, respectively, for Ontarians with IDD compared to those without IDD. Being older, female, having a greater expected use of health care resources, and being enrolled with or seeing a physician in a primary care patient enrolment model were all significantly associated with higher odds of having been screened for colorectal cancer in the IDD population. These findings underscore the need for targeted interventions aimed at making colorectal cancer screening more equitable.	[Ouellette-Kuntz, Helene; Coo, Helen] Queens Univ, Dept Publ Hlth Sci, Kingston, ON, Canada; [Ouellette-Kuntz, Helene] Ongwanada Resource Ctr, Kingston, ON, Canada; [Ouellette-Kuntz, Helene; Cobigo, Virginie; Wilton, Andrew S.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Cobigo, Virginie] Univ Ottawa, Sch Psychol, Ottawa, ON K1N 6N5, Canada	Queens University - Canada; University of Toronto; University of Ottawa	Ouellette-Kuntz, H (corresponding author), Queens Univ, Dept Publ Hlth Sci, Kingston, ON, Canada.	helene.kuntz@queensu.ca			Canadian Institutes of Health Research (CIHR) [103973]; Ontario Ministry of Community and Social Services (MCSS); Surrey Place Centre; Health Care Access Research and Developmental Disabilities (H-CARDD) Program; Centre for Addiction and Mental Health (CAMH); Institute for Clinical Evaluative Sciences (ICES); Ontario Ministry of Health and Long Term Care (MOHLTC); Fonds de Recherche en Sante du Quebec	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Community and Social Services (MCSS); Surrey Place Centre; Health Care Access Research and Developmental Disabilities (H-CARDD) Program; Centre for Addiction and Mental Health (CAMH); Institute for Clinical Evaluative Sciences (ICES)(University of Toronto); Ontario Ministry of Health and Long Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario); Fonds de Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This study was funded by a Canadian Institutes of Health Research (CIHR; www.cihr-irsc.gc.ca/) Partnerships in Health Systems Improvement grant (PHE#103973) in partnership with the Ontario Ministry of Community and Social Services (MCSS) and Surrey Place Centre, and is part of the Health Care Access Research and Developmental Disabilities (H-CARDD) Program. The work was also supported by the Centre for Addiction and Mental Health (CAMH) and the Institute for Clinical Evaluative Sciences (ICES), which receive annual grants from the Ontario Ministry of Health and Long Term Care (MOHLTC), as well as by CAMH and Fonds de Recherche en Sante du Quebec postdoctoral support for R. Balogh and V. Cobigo, respectively. The opinions, results and conclusions reported in this paper are those of the authors and are not necessarily those of the funding sources. No endorsement by CIHR, CAMH, ICES, the Ontario MCSS, the Ontario MOHLTC, or the Fonds de Recherche en Sante du Quebec is intended or should be inferred. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya K, 2011, DEV DISABIL RES REV, V17, P27, DOI 10.1002/ddrr.135; Bittles AH, 2004, DEV MED CHILD NEUROL, V46, P282, DOI 10.1017/S0012162204000441; Bonardi A., 2011, EXPANDING SURVEILLAN; Brouwers M, 2009, INTERVENTIONS INCREA; Burgess DJ, 2009, PREV MED, V48, P99, DOI 10.1016/j.ypmed.2008.11.014; Canadian Cancer Society's Advisory Committee on Cancer Statistics, 2013, CAN CANC STAT 2013; Cobigo V, 2013, J INTELL DISABIL RES, V57, P478, DOI 10.1111/jir.12035; dos Santos Silva I., 1999, CANC EPIDEMIOLOGY PR, P83; Eaker S, 2001, PREV MED, V32, P482, DOI 10.1006/pmed.2001.0844; Fischer LS, 2012, INTELLECT DEV DISAB, V50, P383, DOI 10.1352/1934-9556-50.5.383; Hasle H, 2000, LANCET, V355, P165, DOI 10.1016/S0140-6736(99)05264-2; Havercamp SM, 2004, PUBLIC HEALTH REP, V119, P418, DOI 10.1016/j.phr.2004.05.006; Honein-AbouHaidar GN, 2013, CANCER EPIDEMIOL, V37, P946, DOI 10.1016/j.canep.2013.04.007; Jaakkimainen L., 2006, PRIMARY CARE ONTARIO; Javanparast S, 2010, PREV MED, V50, P165, DOI 10.1016/j.ypmed.2010.02.003; Klabunde CN, 2013, MMWR-MORBID MORTAL W, V62, P881; Kralj B, 2012, ONTARIO MED REV, V79, P18; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Lin E, 2013, J INTELL DISABIL RES, V57, P462, DOI 10.1111/jir.12002; Lofters AK, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-20; Lunsky Y, 2013, ATLAS PRIMARY CARE A; Ontario Cancer Care, 2012, COLONCANCERCHECK2010; Ontario Ministry of Health and Long-term Care, 2012, INF PROC CLAIM CUM P; Ontario Ministry of Health and Long-Term Care, 2008, B COLONCANCERCHECK P; OUELETTEKUNTZ H, 2010, J DEV DISABILITIES, V0015; Patja K, 2000, J INTELL DISABIL RES, V44, P591, DOI 10.1046/j.1365-2788.2000.00280.x; Rabeneck L, 2012, CAN J GASTROENTEROL, V26, P131, DOI 10.1155/2012/486328; Reynolds F, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-30; Statistics Canada, 2014, TABL 051 0005 EST PO; Sullivan SG, 2004, CANCER CAUSE CONTROL, V15, P1021, DOI 10.1007/s10552-004-1256-0; Sullivan WF, 2011, CAN FAM PHYSICIAN, V57, P541; The Johns Hopkins University Bloomberg School of Public Health, 2005, J HOPK ACG CAS MIX S; Tinmouth J, 2012, CAN FAM PHYSICIAN, V58, pE570; Tyler CV, 2010, INTELLECT DEV DISAB, V48, P271, DOI 10.1352/1934-9556-48.4.271; Ward Paul R, 2009, Qual Prim Care, V17, P49; Westerinen H, 2007, J INTELL DISABIL RES, V51, P715, DOI 10.1111/j.1365-2788.2007.00970.x; Wilkinson JE, 2007, J AM BOARD FAM MED, V20, P399, DOI 10.3122/jabfm.2007.04.060210; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701	38	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0118023	10.1371/journal.pone.0118023	http://dx.doi.org/10.1371/journal.pone.0118023			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC4KQ	25689849	Green Submitted, Green Published, gold			2022-12-26	WOS:000350322700094
J	Pohlkamp, T; Durakoglugil, M; Lane-Donovan, C; Xian, XD; Johnson, EB; Hammer, RE; Herz, J				Pohlkamp, Theresa; Durakoglugil, Murat; Lane-Donovan, Courtney; Xian, Xunde; Johnson, Eric B.; Hammer, Robert E.; Herz, Joachim			Lrp4 Domains Differentially Regulate Limb/Brain Development and Synaptic Plasticity	PLOS ONE			English	Article							RECEPTOR-RELATED PROTEIN-4; AMYLOID PRECURSOR PROTEIN; LIMB DEVELOPMENT; MICE LACKING; REELIN; AGRIN; MUTATIONS; DISEASE; COMPLEX; BRAIN	Apolipoprotein E (ApoE) genotype is the strongest predictor of Alzheimer's Disease (AD) risk. ApoE is a cholesterol transport protein that binds to members of the Low-Density Lipoprotein (LDL) Receptor family, which includes LDL Receptor Related Protein 4 (Lrp4). Lrp4, together with one of its ligands Agrin and its co-receptors Muscle Specific Kinase (MuSK) and Amyloid Precursor Protein (APP), regulates neuromuscular junction (NMJ) formation. All four proteins are also expressed in the adult brain, and APP, MuSK, and Agrin are required for normal synapse function in the CNS. Here, we show that Lrp4 is also required for normal hippocampal plasticity. In contrast to the closely related Lrp8/Apoer2, the intracellular domain of Lrp4 does not appear to be necessary for normal expression and maintenance of long-term potentiation at central synapses or for the formation and maintenance of peripheral NMJs. However, it does play a role in limb development.	[Pohlkamp, Theresa; Durakoglugil, Murat; Lane-Donovan, Courtney; Xian, Xunde; Johnson, Eric B.; Herz, Joachim] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Hammer, Robert E.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Herz, Joachim] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Herz, Joachim] Univ Texas SW Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA; [Pohlkamp, Theresa; Durakoglugil, Murat; Lane-Donovan, Courtney; Xian, Xunde; Herz, Joachim] Univ Texas SW Med Ctr Dallas, Ctr Translat Neurodegenerat Res, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Pohlkamp, T (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA.	Theresa@Herzlab.org; Joachim.Herz@UTSouthwestern.edu	Xian, Xunde/B-9490-2012; Pohlkamp, Theresa/H-2705-2019	Xian, Xunde/0000-0003-3059-1254; Pohlkamp, Theresa/0000-0003-3923-1917; Hammer, Robert E./0000-0001-5487-7551	National Institutes of Health (NIH) [R37 HL63762, F30 AG047799]; American Health Assistance Foundation; Consortium for Frontotemporal Dementia Research; Bright Focus Foundation; Lupe Murchison Foundation; Ted Nash Long Life Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL063762, R01HL063762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG047799] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Health Assistance Foundation(BrightFocus Foundation); Consortium for Frontotemporal Dementia Research; Bright Focus Foundation(BrightFocus Foundation); Lupe Murchison Foundation; Ted Nash Long Life Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health (NIH), grant R37 HL63762 (to J.H.) and NIH grant F30 AG047799 (to C.L.D.). J.H. is further supported by the American Health Assistance Foundation, the Consortium for Frontotemporal Dementia Research, the Bright Focus Foundation, the Lupe Murchison Foundation, The Ted Nash Long Life Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedlack RS, 2000, ARCH NEUROL-CHICAGO, V57, P1561, DOI 10.1001/archneur.57.11.1561; Beffert U, 2005, NEURON, V47, P567, DOI 10.1016/j.neuron.2005.07.007; Bouche E, 2013, CELL RES, V23, P473, DOI 10.1038/cr.2013.7; Chen Y, 2010, P NATL ACAD SCI USA, V107, P12011, DOI 10.1073/pnas.0914984107; Choi HY, 2013, ELIFE, V2, DOI 10.7554/eLife.00220; Daniels MP, 2012, NEUROCHEM INT, V61, P848, DOI 10.1016/j.neuint.2012.02.028; Drogemuller C, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-5; Durakoglugil MS, 2009, P NATL ACAD SCI USA, V106, P15938, DOI 10.1073/pnas.0908176106; Garcia-Osta A, 2006, J NEUROSCI, V26, P7919, DOI 10.1523/JNEUROSCI.1674-06.2006; Gomez AM, 2014, ELIFE, V3, DOI 10.7554/eLife.04287; Gomez AM, 2011, DEV DYNAM, V240, P2626, DOI 10.1002/dvdy.22772; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Herz J, 2001, NEURON, V29, P571, DOI 10.1016/S0896-6273(01)00234-3; Hoe HS, 2009, J NEUROSCI, V29, P7459, DOI 10.1523/JNEUROSCI.4872-08.2009; Huang YZ, 2001, J BIOL CHEM, V276, P19318, DOI 10.1074/jbc.M100494200; Jo K, 1999, J NEUROSCI, V19, P4189, DOI 10.1523/jneurosci.19-11-04189.1999; Johnson EB, 2005, HUM MOL GENET, V14, P3523, DOI 10.1093/hmg/ddi381; Johnson EB, 2007, ANAL FUNCTION MEGF7; Johnson EB, 2006, GENOMICS, V88, P600, DOI 10.1016/j.ygeno.2006.08.005; Karner CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010418; Kim N, 2008, CELL, V135, P334, DOI 10.1016/j.cell.2008.10.002; Krieglstein K, 2011, TRENDS NEUROSCI, V34, P421, DOI 10.1016/j.tins.2011.06.002; Lane-Donovan C, 2014, NEURON, V83, P771, DOI 10.1016/j.neuron.2014.08.005; Li Yonghe, 2005, Future Oncol, V1, P673, DOI 10.2217/14796694.1.5.673; Li Y, 2010, AM J HUM GENET, V86, P696, DOI 10.1016/j.ajhg.2010.03.004; Liu ZH, 2006, J ENDOCRINOL, V189, P409, DOI 10.1677/joe.1.06420; Pohlkamp T, 2013, CEREB CORTEX; Priller C, 2006, J NEUROSCI, V26, P7212, DOI 10.1523/JNEUROSCI.1450-06.2006; Qi Y, 2013, NEUROSCI LETT, V542, P53, DOI 10.1016/j.neulet.2013.03.012; Serpinskaya AS, 1999, DEV BIOL, V205, P65, DOI 10.1006/dbio.1998.9112; Simon-Chazottes D, 2006, GENOMICS, V87, P673, DOI 10.1016/j.ygeno.2006.01.007; Spoelgen R, 2005, DEVELOPMENT, V132, P405, DOI 10.1242/dev.01580; Tao YM, 2013, NAT NEUROSCI, V16, P290, DOI 10.1038/nn.3320; Tian QB, 2006, EUR J NEUROSCI, V23, P2864, DOI 10.1111/j.1460-9568.2006.04846.x; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Weatherbee SD, 2006, DEVELOPMENT, V133, P4993, DOI 10.1242/dev.02696; Weber H, 2014, EUR NEUROPSYCHOPHARM, V24, P65, DOI 10.1016/j.euroneuro.2013.09.005; Weeber EJ, 2002, J BIOL CHEM, V277, P39944, DOI 10.1074/jbc.M205147200; Willnow TE, 1996, P NATL ACAD SCI USA, V93, P8460, DOI 10.1073/pnas.93.16.8460; Yano H, 2006, NAT NEUROSCI, V9, P1009, DOI 10.1038/nn1730; Zhang B, 2008, NEURON, V60, P285, DOI 10.1016/j.neuron.2008.10.006; Zhang W, 2011, J BIOL CHEM, V286, P40624, DOI 10.1074/jbc.M111.279307	42	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0116701	10.1371/journal.pone.0116701	http://dx.doi.org/10.1371/journal.pone.0116701			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25688974	Green Published, gold, Green Submitted			2022-12-26	WOS:000350322700020
J	Rycroft, D; Sosabowski, J; Coulstock, E; Davies, M; Morrey, J; Friel, S; Kelly, F; Hamatake, R; Ovecka, M; Prince, R; Goodall, L; Sepp, A; Walker, A				Rycroft, Daniel; Sosabowski, Jane; Coulstock, Edward; Davies, Marie; Morrey, John; Friel, Sarah; Kelly, Fiona; Hamatake, Robert; Ovecka, Milan; Prince, Rob; Goodall, Laura; Sepp, Armin; Walker, Adam			Pharmacokinetic Characteristics, Pharmacodynamic Effect and In Vivo Antiviral Efficacy of Liver-Targeted Interferon Alpha	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; ASIALOGLYCOPROTEIN RECEPTOR; DOMAIN ANTIBODIES; CELLS; INHIBITION; THERAPY; GENE; MECHANISMS; LIPOSOMES; DELIVERY	Interferon alpha (IFN alpha) is used for the treatment of hepatitis B virus infection, and whilst efficacious, it is associated with multiple adverse events caused by systemic exposure to interferon. We therefore hypothesise that targeting IFN directly to the intended site of action in the liver would reduce exposure in blood and peripheral tissue and hence improve the safety and tolerability of IFNa therapy. Furthermore we investigated whether directing IFN to the reservoir of infection in the liver may improve antiviral efficacy by increasing local concentration in target organs and tissues. Our previous results show that the mIFN alpha 2 fused to an ASGPR specific liver targeting antibody, DOM26h-196-61, results in a fusion protein which retains the activity of both fusion partners when measured in vitro. In vivo targeting of the liver by mIFN alpha 2-DOM26h-196-61, hereafter referred to as targeted mIFN alpha 2, was observed in microSPECT imaging studies in mice. In this study we show by pharmacokinetic analysis that antibody mediated liver-targeting results in increased uptake and exposure of targeted mIFNa2 in target tissues, and correspondingly reduced uptake and exposure in systemic circulation, clearance organs and non-target tissues. We also show that cytokine activity and antiviral activity of liver-targeted IFN is observed in vivo, but that, contrary to expectations, liver-targeting of mIFN alpha 2 using ASGPR specific dAbs actually leads to a reduced pharmacodynamic effect in target organs and lower antiviral activity in vivo when compared to non-targeted mIFN alpha 2-dAb fusions.	[Rycroft, Daniel; Coulstock, Edward; Davies, Marie; Friel, Sarah; Ovecka, Milan; Goodall, Laura; Sepp, Armin; Walker, Adam] GlaxoSmithKline, Biopharm Innovat Unit, Biopharm Res & Dev, Cambridge, England; [Sosabowski, Jane] Queen Mary Univ London, Barts Canc Inst, Ctr Mol Oncol, London, England; [Morrey, John] Utah State Univ, Inst Antiviral Res, Logan, UT 84322 USA; [Kelly, Fiona] GlaxoSmithKline, Biopharm R&D, Biopharm Translat Med, Stevenage, Herts, England; [Hamatake, Robert] GlaxoSmithKline, Res Triangle Pk, NC USA; [Prince, Rob] GlaxoSmithKline, Biopharm R&D, Biopharm Discovery, Stevenage, Herts, England	GlaxoSmithKline; University of London; Queen Mary University London; Utah System of Higher Education; Utah State University; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Walker, A (corresponding author), GlaxoSmithKline, Clin Unit Cambridge, Cambridge, England.	adam.z.walker@gsk.com			National Institutes of Health (NIH) [HHSN272201000039I/HHSN27200001/A19]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Work carried out by JM was funded by the National Institutes of Health (NIH). NIH contract number is HHSN272201000039I/HHSN27200001/A19. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buster EHCJ, 2008, GASTROENTEROLOGY, V135, P459, DOI 10.1053/j.gastro.2008.05.031; Cooksley WGE, 2003, J VIRAL HEPATITIS, V10, P298, DOI 10.1046/j.1365-2893.2003.00450.x; Coulstock E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057263; Deal KA, 1998, NUCL MED BIOL, V25, P379, DOI 10.1016/S0969-8051(97)00222-9; Dieperink E, 2003, PSYCHOSOMATICS, V44, P104, DOI 10.1176/appi.psy.44.2.104; DUNCAN R, 1986, BIOCHIM BIOPHYS ACTA, V880, P62, DOI 10.1016/0304-4165(86)90120-0; Dusheiko G, 1997, HEPATOLOGY, V26, pS112, DOI 10.1002/hep.510260720; Eto T, 1999, NAT MED, V5, P577, DOI 10.1038/8462; Holt LJ, 2003, TRENDS BIOTECHNOL, V21, P484, DOI 10.1016/j.tibtech.2003.08.007; Holt LJ, 2008, PROTEIN ENG DES SEL, V21, P283, DOI 10.1093/protein/gzm067; Iorio R, 1997, PEDIATR INFECT DIS J, V16, P984, DOI 10.1097/00006454-199710000-00016; Iyer U, 2011, J PHARMACOL TOX MET, V64, P207, DOI 10.1016/j.vascn.2011.07.005; Jeong YI, 2005, INT J PHARMACEUT, V296, P151, DOI 10.1016/j.ijpharm.2005.02.027; Morrey JD, 2008, ANTIVIR RES, V79, P71, DOI 10.1016/j.antiviral.2008.01.157; Pacifico F, 2003, MOL CELL ENDOCRINOL, V208, P51, DOI 10.1016/j.mce.2003.06.001; Pardridge WM, 2010, J DRUG TARGET, V18, P157, DOI 10.3109/10611860903548354; Park JH, 1998, BIOCHEM BIOPH RES CO, V244, P304, DOI 10.1006/bbrc.1998.8256; Peng DJ, 2007, CANCER GENE THER, V14, P66, DOI 10.1038/sj.cgt.7700985; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Seow YYT, 2002, NEPHRON, V91, P431, DOI 10.1159/000064283; SPIESS M, 1985, P NATL ACAD SCI USA, V82, P6465, DOI 10.1073/pnas.82.19.6465; Treichel U, 1997, ARCH VIROL, V142, P493, DOI 10.1007/s007050050095; van Broekhoven CL, 2004, CANCER RES, V64, P4357, DOI 10.1158/0008-5472.CAN-04-0138; WARD ES, 1989, NATURE, V341, P544, DOI 10.1038/341544a0; Wu AM, 2005, NAT BIOTECHNOL, V23, P1137, DOI 10.1038/nbt1141; Zhang XQ, 2005, J CONTROL RELEASE, V102, P749, DOI 10.1016/j.jconrel.2004.10.024; Zhang Y, 2007, J CONTROL RELEASE, V117, P281, DOI 10.1016/j.jconrel.2006.11.006	27	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117847	10.1371/journal.pone.0117847	http://dx.doi.org/10.1371/journal.pone.0117847			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689509	Green Published, gold, Green Submitted			2022-12-26	WOS:000350322700077
J	Wade, D; Diaw, PA; Daneau, G; Diallo, AA; Mboup, S; Dieye, TN; Kestens, L				Wade, Djibril; Diaw, Papa Alassane; Daneau, Geraldine; Diallo, Abdoul Aziz; Mboup, Souleymane; Dieye, Tandakha Ndiaye; Kestens, Luc			Laboratory and Field Evaluation of the Partec CyFlow MiniPOC for Absolute and Relative CD4 T-Cell Enumeration	PLOS ONE			English	Article							HIV-INFECTED INDIVIDUALS; PERFORMANCE EVALUATION; FLOW CYTOMETER; SINGLE-PLATFORM; POINT; PIMA; SETTINGS; ANALYZER; COUNTS; SYSTEM	Background A new CD4 point-of-care instrument, the CyFlow miniPOC, which provides absolute and percentage CD4 T-cells, used for screening and monitoring of HIV-infected patients in resource-limited settings, was introduced recently. We assessed the performance of this novel instrument in a reference laboratory and in a field setting in Senegal. Methodology A total of 321 blood samples were obtained from 297 adults and 24 children, all HIV-patients attending university hospitals in Dakar, or health centers in Ziguinchor. Samples were analyzed in parallel on CyFlow miniPOC, FACSCount CD4 and FACSCalibur to assess CyFlow miniPOC precision and accuracy. Results At the reference lab, CyFlow miniPOC, compared to FACSCalibur, showed an absolute mean bias of -12.6 cells/mm(3) and a corresponding relative mean bias of -2.3% for absolute CD4 counts. For CD4 percentages, the absolute mean bias was -0.1%. Compared to FACSCount CD4, the absolute and relative mean biases were -31.2 cells/mm3 and -4.7%, respectively, for CD4 counts, whereas the absolute mean bias for CD4 percentages was 1.3%. The CyFlow miniPOC was able to classify HIV-patients eligible for ART with a sensitivity of >= 95% at the different ART-initiation thresholds (200, 350 and 500 CD4 cells/mm(3)). In the field lab, the room temperature ranged from 30 to 35 degrees C during the working hours. At those temperatures, the CyFlow miniPOC, compared to FACSCount CD4, had an absolute and relative mean bias of 7.6 cells/mm(3) and 2.8%, respectively, for absolute CD4 counts, and an absolute mean bias of 0.4% for CD4 percentages. The CyFlow miniPOC showed sensitivity equal or greater than 94%. Conclusion The CyFlow miniPOC showed high agreement with FACSCalibur and FACSCount CD4. The CyFlow miniPOC provides both reliable absolute CD4 counts and CD4 percentages even under the field conditions, and is suitable for monitoring HIV-infected patients in resource-limited settings.	[Wade, Djibril; Diaw, Papa Alassane; Diallo, Abdoul Aziz; Mboup, Souleymane; Dieye, Tandakha Ndiaye] Le Dantec Hosp, Immunol Unit, Lab Bacteriol Virol, Dakar, Senegal; [Wade, Djibril; Daneau, Geraldine; Kestens, Luc] Inst Trop Med, Immunol Lab, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Wade, Djibril; Kestens, Luc] Univ Antwerp, Dept Biomed Sci, B-2020 Antwerp, Belgium	Institute of Tropical Medicine (ITM); University of Antwerp	Wade, D (corresponding author), Le Dantec Hosp, Immunol Unit, Lab Bacteriol Virol, Dakar, Senegal.	wadedjibril@yahoo.fr	Wade, Djibril/AAK-1418-2021	Wade, Djibril/0000-0002-1321-365X; Daneau, Geraldine/0000-0002-2570-0893	Belgian Directorate General of Development	Belgian Directorate General of Development	This study was funded by Belgian Directorate General of Development. The funder had no role in study design, data collection and analysis, decision too publish, or preparation of the manuscript.	Balakrishnan P, 2006, JAIDS-J ACQ IMM DEF, V43, P23, DOI 10.1097/01.qai.0000227791.92203.d5; Bergeron M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041166; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BROUGHTON PM, 1974, ANN CLIN BIOCHEM, V11, P207, DOI 10.1177/000456327401100164; Cheng XH, 2007, JAIDS-J ACQ IMM DEF, V45, P257; Diaw PA, 2011, JAIDS-J ACQ IMM DEF, V58, pE103, DOI 10.1097/QAI.0b013e318235b378; Dunn DT, 2006, AIDS, V20, P1289, DOI 10.1097/01.aids.0000232237.20792.68; Fryland M, 2006, T ROY SOC TROP MED H, V100, P980, DOI 10.1016/j.trstmh.2005.11.014; Glencross DK, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-3; Glynn MT, 2013, LAB CHIP, V13, P2731, DOI 10.1039/c3lc50213a; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Jani IV, 2011, LANCET, V378, P1572, DOI 10.1016/S0140-6736(11)61052-0; Jani IV, 2011, AIDS, V25, P807, DOI 10.1097/QAD.0b013e328344f424; Kandathil AJ, 2005, CLIN DIAGN LAB IMMUN, V12, P1006, DOI 10.1128/CDLI.12.8.1006-1009.2005; Li X, 2010, CYTOM PART B-CLIN CY, V78B, P31, DOI 10.1002/cyto.b.20488; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Logan C, 2013, J IMMUNOL METHODS, V387, P107, DOI 10.1016/j.jim.2012.10.002; Lopez A, 1999, CYTOMETRY, V38, P231, DOI 10.1002/(SICI)1097-0320(19991015)38:5<231::AID-CYTO5>3.0.CO;2-Y; Lynen L, 2006, JAIDS-J ACQ IMM DEF, V43, P179, DOI 10.1097/01.qai.0000242447.82403.c2; Manabe YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034319; Manasa J, 2007, CLIN VACCINE IMMUNOL, V14, P293, DOI 10.1128/CVI.00416-06; Mandy F, 2008, CYTOM PART B-CLIN CY, V74B, pS27, DOI 10.1002/cyto.b.20414; Mandy Francis F, 2003, MMWR Recomm Rep, V52, P1; Mbopi-Keou FX, 2012, CLIN VACCINE IMMUNOL, V19, P609, DOI 10.1128/CVI.00023-12; Mnyani CN, 2012, JAIDS-J ACQ IMM DEF, V60, P260, DOI 10.1097/QAI.0b013e318256b651; Mtapuri-Zinyowera S, 2010, JAIDS-J ACQ IMM DEF, V55, P1, DOI 10.1097/QAI.0b013e3181e93071; Mwau M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067612; PASSING H, 1983, J CLIN CHEM CLIN BIO, V21, P709; Pattanapanyasat K, 2005, CLIN DIAGN LAB IMMUN, V12, P1416, DOI 10.1128/CDLI.12.12.1416-1424.2005; Pattanapanyasat K, 2008, JAIDS-J ACQ IMM DEF, V49, P339, DOI 10.1097/QAI.0b013e31818c1721; Pattanapanyasat K, 2008, CYTOM PART B-CLIN CY, V74B, pS98, DOI 10.1002/cyto.b.20415; Pattanapanyasat K, 2007, CYTOM PART B-CLIN CY, V72B, P387, DOI 10.1002/cyto.b.20167; POLLOCK MA, 1992, ANN CLIN BIOCHEM, V29, P556, DOI 10.1177/000456329202900512; Renault Cybele A, 2010, Open AIDS J, V4, P171, DOI 10.2174/1874613601004010171; Reynolds SJ, 2011, AIDS, V25, P473, DOI 10.1097/QAD.0b013e3283437c2b; Rodriguez WR, 2005, PLOS MED, V2, P663, DOI 10.1371/journal.pmed.0020182; Scott LE, 2003, CYTOM PART B-CLIN CY, V54B, P46, DOI 10.1002/cyto.b.10016; Strauss K, 1996, CYTOMETRY, V26, P52; Sukapirom K, 2011, JAIDS-J ACQ IMM DEF, V58, P141, DOI 10.1097/QAI.0b013e31822866a2; Thakar M, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-26; Thakar Madhuri R, 2006, AIDS Res Ther, V3, P26, DOI 10.1186/1742-6405-3-26; UNITAID, 2013, HIV AIDS DIAGN TECHN; Wade D, 2014, JAIDS-J ACQ IMM DEF, V66, pE98, DOI 10.1097/QAI.0000000000000214; Wade D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075484; World Health Organization, 2010, ANT THER HIV INF INF; Zachariah R, 2011, TROP MED INT HEALTH, V16, P37, DOI 10.1111/j.1365-3156.2010.02669.x; Zijenah LS, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-33	47	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0116663	10.1371/journal.pone.0116663	http://dx.doi.org/10.1371/journal.pone.0116663			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25688553	gold, Green Published			2022-12-26	WOS:000350322700018
J	Liu, Y; Ye, X; Zhang, JB; Ouyang, H; Shen, Z; Wu, Y; Wang, W; Wu, J; Tao, S; Yang, X; Qiao, K; Zhang, J; Liu, J; Fu, Q; Xie, Y				Liu, Y.; Ye, X.; Zhang, J-B; Ouyang, H.; Shen, Z.; Wu, Y.; Wang, W.; Wu, J.; Tao, S.; Yang, X.; Qiao, K.; Zhang, J.; Liu, J.; Fu, Q.; Xie, Y.			PROX1 promotes hepatocellular carcinoma proliferation and sorafenib resistance by enhancing beta-catenin expression and nuclear translocation	ONCOGENE			English	Article							CELL-PROLIFERATION; GENE; LIVER; TRANSCRIPTION; GROWTH; METASTASIS; MODULATION; MUTATIONS; SURVIVAL; PROTEIN	Aberrant activation of the Wnt/beta-catenin pathway is frequent in hepatocellular carcinoma (HCC) and contributes to HCC initiation and progression. This abnormal activation may result from somatic mutations in the genes of the Wnt/beta-catenin pathway and/or dysregulation of the Wnt/beta-catenin pathway. The mechanism for the latter remains poorly understood. Prospero-related homeobox 1 (PROX1) is a downstream target of the Wnt/beta-catenin pathway in human colorectal cancer and elevated PROX1 expression promotes malignant progression. However, the Wnt/beta-catenin pathway does not regulate PROX1 expression in the liver and HCC cells. Here we report that PROX1 promotes HCC cell proliferation in vitro and tumor growth in HCC xenograft mice. PROX1 and beta-catenin levels are positively correlated in tumor tissues as well as in cultured HCC cells. PROX1 can upregulate beta-catenin transcription by stimulating the beta-catenin promoter and enhance the nuclear translocation of beta-catenin in HCC cells, which leads to the activation of the Wnt/beta-catenin pathway. Moreover, we show that increase in PROX1 expression renders HCC cells more resistant to sorafenib treatment, which is the standard therapy for advanced HCC. Overall, we have pinpointed PROX1 as a critical factor activating the Wnt/beta-catenin pathway in HCC, which promotes HCC proliferation and sorafenib resistance.	[Liu, Y.; Ye, X.; Ouyang, H.; Shen, Z.; Wu, Y.; Wang, W.; Wu, J.; Tao, S.; Yang, X.; Qiao, K.; Zhang, J.; Liu, J.; Fu, Q.; Xie, Y.] Fudan Univ, Shanghai Med Coll, Inst Biomed Sci, Key Lab Med Mol Virol MOE, Shanghai 200032, Peoples R China; [Liu, Y.; Ye, X.; Ouyang, H.; Shen, Z.; Wu, Y.; Wang, W.; Wu, J.; Tao, S.; Yang, X.; Qiao, K.; Zhang, J.; Liu, J.; Fu, Q.; Xie, Y.] Fudan Univ, Shanghai Med Coll, Inst Biomed Sci, MOH, Shanghai 200032, Peoples R China; [Liu, Y.] Fudan Univ, Dept Surg, Huashan Hosp, Shanghai 200032, Peoples R China; [Zhang, J-B] Zhongshan Hosp, Liver Canc Inst, Shanghai, Peoples R China; [Zhang, J-B] Fudan Univ, Key Lab Carcinogenesis & Canc Invas MOE, Shanghai 200032, Peoples R China; [Ouyang, H.] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai, Peoples R China; [Fu, Q.] Binzhou Med Univ, Dept Immunol, Yantai 264003, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University; Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Binzhou Medical University	Liu, J (corresponding author), Fudan Univ, Shanghai Med Coll, Inst Biomed Sci, Key Lab Med Mol Virol MOE, Yixueyuan Rd 138, Shanghai 200032, Peoples R China.	liujing212@fudan.edu.cn; qiangfu11@fudan.edu.cn; yhxie@fudan.edu.cn			National Key Project for Infectious Diseases [2012ZX10002-006, 2012ZX10004-503, 2012ZX10002012-003]; National Basic Research Program [2012CB519002]; Natural Science Foundation of China [31071143, 31170148, 81472226, 81372654, 81370730]; Shanghai Municipal Health Committee [GWDTR201216]; Nature Science Foundation from Shandong province [ZR2011HQ006]; Municipal Science and Technology Committee [13ZR1407100]	National Key Project for Infectious Diseases; National Basic Research Program(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Health Committee; Nature Science Foundation from Shandong province; Municipal Science and Technology Committee	We thank Prof RH Dashwood of Oregon State University and Prof Long Yu of Fudan University for kindly providing the beta-catenin promoter luciferase reporters. This work is supported by the grants from the National Key Project for Infectious Diseases (2012ZX10002-006, 2012ZX10004-503, 2012ZX10002012-003), National Basic Research Program (2012CB519002), Natural Science Foundation of China (31071143, 31170148, 81472226, 81372654 and 81370730), Shanghai Municipal Health Committee (GWDTR201216), Nature Science Foundation from Shandong province (ZR2011HQ006) and Municipal Science and Technology Committee (13ZR1407100).	Boyault S, 2007, HEPATOLOGY, V45, P42, DOI 10.1002/hep.21467; Burke Z, 2002, MECH DEVELOP, V118, P147, DOI 10.1016/S0925-4773(02)00240-X; Chai H, 2010, INT J CLIN EXP PATHO, V3, P408; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cui J, 2001, J CANCER RES CLIN, V127, P577, DOI 10.1007/s004320100259; de La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847; Dyer MA, 2003, NAT GENET, V34, P53, DOI 10.1038/ng1144; Elsir T, 2012, CANCER METAST REV, V31, P793, DOI 10.1007/s10555-012-9390-8; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Guigon CJ, 2010, ENDOCRINOLOGY, V151, P5528, DOI 10.1210/en.2010-0475; Han L, 2010, BRAIN RES, V1366, P9, DOI 10.1016/j.brainres.2010.09.097; Hong YK, 2002, DEV DYNAM, V225, P351, DOI 10.1002/dvdy.10163; Iyer R, 2010, EXPERT OPIN PHARMACO, V11, P1943, DOI 10.1517/14656566.2010.496453; Kaltezioti V, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000565; Kamiya A, 2008, HEPATOLOGY, V48, P252, DOI 10.1002/hep.22303; Karalay O, 2011, P NATL ACAD SCI USA, V108, P5807, DOI 10.1073/pnas.1013456108; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Lachenmayer A, 2012, CLIN CANCER RES, V18, P4997, DOI 10.1158/1078-0432.CCR-11-2322; Lai TY, 2011, ONCOL REP, V26, P415, DOI 10.3892/or.2011.1323; Lavado A, 2007, DEV DYNAM, V236, P518, DOI 10.1002/dvdy.21024; Li QJ, 2004, GENOMICS, V83, P231, DOI 10.1016/j.ygeno.2003.08.004; Liu GY, 2012, HEPATOLOGY, V55, P1830, DOI 10.1002/hep.25564; Liu YF, 2013, HEPATOLOGY, V58, P692, DOI 10.1002/hep.26398; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Ouyang HF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062192; Petrova TV, 2008, CANCER CELL, V13, P407, DOI 10.1016/j.ccr.2008.02.020; Qin J, 2004, MOL ENDOCRINOL, V18, P2424, DOI 10.1210/me.2004-0009; Riazi AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005698; Risebro CA, 2009, DEVELOPMENT, V136, P495, DOI 10.1242/dev.030007; Satoh S, 2000, NAT GENET, V24, P245, DOI 10.1038/73448; Song KH, 2006, J BIOL CHEM, V281, P10081, DOI 10.1074/jbc.M513420200; Sosa-Pineda B, 2000, NAT GENET, V25, P254, DOI 10.1038/76996; Ye QH, 2003, NAT MED, V9, P416, DOI 10.1038/nm843; Zhu XD, 2008, J CLIN ONCOL, V26, P2707, DOI 10.1200/JCO.2007.15.6521	34	50	51	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 29	2015	34	44					5524	5535		10.1038/onc.2015.7	http://dx.doi.org/10.1038/onc.2015.7			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CV9FX	25684142				2022-12-26	WOS:000364594000002
J	Cheng, Y; Feng, Y; Jansson, L; Sato, Y; Deguchi, M; Kawamura, K; Hsueh, AJ				Cheng, Yuan; Feng, Yi; Jansson, Lina; Sato, Yorino; Deguchi, Masashi; Kawamura, Kazuhiro; Hsueh, Aaron J.			Actin polymerization-enhancing drugs promote ovarian follicle growth mediated by the Hippo signaling effector YAP	FASEB JOURNAL			English	Article						Jasplakinolide; sphingosine-1-phosphate; connective tissue growth factor	SPHINGOSINE 1-PHOSPHATE; CELL-MIGRATION; ORGAN SIZE; F-ACTIN; PROTEIN; SPHINGOSINE-1-PHOSPHATE; DISRUPTION; PATHWAY; INDUCTION; REGULATOR	Hippo signaling pathway consists of conserved serine/threonine kinases to maintain optimal organ sizes. Studies have demonstrated that fragmentation of murine ovaries increases actin polymerization and disrupts Hippo signaling, leading to nuclear translocation of Hippo signaling effector Yes-associated protein (YAP) in ovarian follicles and follicle growth. For patients with polycystic ovarian syndrome showing follicle arrest, ovarian wedge resection and laser drilling promote follicle growth. Because these damaging procedures likely involve actin polymerization, we tested whether actin polymerization-promoting drugs could promote YAP translocation and stimulate follicle growth. Treatment of murine ovaries with mu M Jasplakinolide (JASP), an actin polymerization-promoting cyclic peptide, or sphingosine-1-phosphate (S1P), a follicular fluid constituent known to promote actin polymerization, increased the conversion of globular actin to the filamentous form, followed by increased nuclear YAP and expression of downstream connective tissue growth factor (CCN2). After short-term treatments with JASP or S1P, in vitro cultured and in vivo grafted ovaries showed follicle growth. Furthermore, induction of constitutively active YAP in ovarian grafts of transgenic mice enhanced follicle development, whereas treatment of human ovarian cortices with JASP or S1P increased CCN2 expression. Thus, JASP and S1P stimulate follicle growth and are potential therapeutic agents for treating polycystic ovarian syndrome and other ovarian disorders.	[Cheng, Yuan; Feng, Yi; Deguchi, Masashi; Hsueh, Aaron J.] Stanford Univ, Dept Obstet & Gynecol, Sch Med, Stanford, CA 94305 USA; [Jansson, Lina] Stanford Univ, Dept Otolaryngol, Sch Med, Stanford, CA 94305 USA; [Sato, Yorino; Kawamura, Kazuhiro] St Mariana Univ, Dept Obstet & Gynecol, Kawasaki, Kanagawa, Japan; [Kawamura, Kazuhiro] Akita Univ, Grad Sch Med, Dept Obstet & Gynecol, Akita 010, Japan	Stanford University; Stanford University; Saint Marianna University; Akita University	Hsueh, AJ (corresponding author), 300 Pasteur Dr,Room A344, Stanford, CA 94305 USA.	aaron.hsueh@stanford.edu			U.S. National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development (Specialized Cooperative Centers Program in Reproduction and Infertility Research) [U54-HD068158]; Smoking Research Foundation; Takeda Science Foundation; Coordination, Support and Training Program for Translational Research, Seeds B;  [24390376];  [24659722];  [26114510]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD068158] Funding Source: NIH RePORTER	U.S. National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development (Specialized Cooperative Centers Program in Reproduction and Infertility Research); Smoking Research Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Coordination, Support and Training Program for Translational Research, Seeds B; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the U.S. National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development (Grant U54-HD068158 to A.H., as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research); Grant-in-Aid for Scientific Research (Research B [24390376], Challenging Exploratory Research [24659722], and Innovative Areas, Mechanisms Regulating Gamete Formation in Animals [26114510]); and by research funds from the Smoking Research Foundation, the Takeda Science Foundation, and the Coordination, Support and Training Program for Translational Research, Seeds B (to K.K.).	Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Becker S, 2011, BIOL REPROD, V84, P604, DOI 10.1095/biolreprod.110.084152; Boggiano JC, 2012, DEV CELL, V22, P695, DOI 10.1016/j.devcel.2012.03.013; BUBB MR, 1994, J BIOL CHEM, V269, P14869; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Cheng Y, 2013, FASEB J, V27, P2175, DOI 10.1096/fj.12-223412; Farquhar C, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001122.pub4; Fernandez BG, 2011, DEVELOPMENT, V138, P2337, DOI 10.1242/dev.063545; Fukui H, 2014, DEV CELL, V31, P128, DOI 10.1016/j.devcel.2014.08.014; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Hendriks ML, 2007, HUM REPROD UPDATE, V13, P249, DOI 10.1093/humupd/dml058; Hergovich A, 2012, BIOCHEM SOC T, V40, P124, DOI 10.1042/BST20110619; Holbourn KP, 2008, TRENDS BIOCHEM SCI, V33, P461, DOI 10.1016/j.tibs.2008.07.006; Hsueh AJW, 2015, ENDOCR REV, V36, P1, DOI 10.1210/er.2014-1020; Jansson L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032013; Kappos L, 2006, NEW ENGL J MED, V355, P1124, DOI 10.1056/NEJMoa052643; Kawamura K, 2013, P NATL ACAD SCI USA, V110, P17474, DOI 10.1073/pnas.1312830110; Li J, 2010, P NATL ACAD SCI USA, V107, P10280, DOI 10.1073/pnas.1001198107; Miller E, 2012, CHEM BIOL, V19, P955, DOI 10.1016/j.chembiol.2012.07.005; Morita Y, 2000, NAT MED, V6, P1109, DOI 10.1038/80442; Pan DJ, 2007, GENE DEV, V21, P886, DOI 10.1101/gad.1536007; Rosen H, 2009, ANNU REV BIOCHEM, V78, P743, DOI 10.1146/annurev.biochem.78.072407.103733; Sansores-Garcia L, 2011, EMBO J, V30, P2325, DOI 10.1038/emboj.2011.157; SENDEROWICZ AMJ, 1995, J NATL CANCER I, V87, P46, DOI 10.1093/jnci/87.1.46; Soleimani R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019475; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Stein IF, 1935, AM J OBSTET GYNECOL, V29, P181, DOI 10.1016/S0002-9378(15)30642-6; Visser-Grieve S, 2011, CELL RES, V21, P1513, DOI 10.1038/cr.2011.122; Wada KI, 2011, DEVELOPMENT, V138, P3907, DOI 10.1242/dev.070987; Yatomi Y, 2006, CURR PHARM DESIGN, V12, P575, DOI 10.2174/138161206775474404; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zelinski MB, 2011, FERTIL STERIL, V95, P1440, DOI 10.1016/j.fertnstert.2011.01.012; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408	33	67	73	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2423	2430		10.1096/fj.14-267856	http://dx.doi.org/10.1096/fj.14-267856			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	25690654	Green Published			2022-12-26	WOS:000355209500019
J	Winkle, M; van den Berg, A; Tayari, M; Sietzema, J; Terpstra, M; Kortman, G; de Jong, D; Visser, L; Diepstra, A; Kok, K; Kluiver, J				Winkle, Melanie; van den Berg, Anke; Tayari, Masoumeh; Sietzema, Jantine; Terpstra, Martijn; Kortman, Gertrud; de Jong, Debora; Visser, Lydia; Diepstra, Arjan; Kok, Klaas; Kluiver, Joost			Long noncoding RNAs as a novel component of the Myc transcriptional network	FASEB JOURNAL			English	Article						B-cell lymphoma; cancer; regulation	GENOME-WIDE ANALYSIS; LARGE GENE LISTS; C-MYC; CELL-LINE; EXPRESSION; CANCER; ACTIVATION; DIFFERENTIATION; COMPLEXES; CHROMATIN	Myc is a well-known transcription factor with important roles in cell cycle, apoptosis, and cellular transformation. Long noncoding RNAs (lncRNAs) have recently emerged as an important class of regulatory RNAs. Here, we show that lncRNAs are a main component of the Myc-regulated transcriptional program using the P493-6 tetracycline-repressible myc model. We demonstrate that both Myc-induced mRNAs and lncRNAs are significantly enriched for Myc binding sites. In contrast to Myc-repressed mRNAs, Myc-repressed lncRNAs are significantly enriched for Myc binding sites. Subcellular localization analysis revealed that compared to mRNAs, lncRNAs more often have a specific subcellular localization with a markedly higher percentage of nuclear enrichment within the Myc-repressed lncRNA set. Parallel analysis of differentially expressed lncRNAs and mRNAs identified 105 juxtaposed lncRNA-mRNA pairs, indicative for regulation in cis. To support the potential relevance of the Myc-regulated lncRNAs in cellular transformation, we analyzed their expression in primary Myc-high and Myc-low B-cell lymphomas. In total, 54% of the lncRNAs differentially expressed between the lymphoma subsets were identified as Myc-regulated in P493-6 cells. This study is the first to show that lncRNAs are an important factor within the Myc-regulated transcriptional program and indicates a marked difference between Myc-repressed lncRNAs and mRNAs.	[Winkle, Melanie; van den Berg, Anke; Tayari, Masoumeh; Sietzema, Jantine; Kortman, Gertrud; de Jong, Debora; Visser, Lydia; Diepstra, Arjan; Kluiver, Joost] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, NL-9700 RB Groningen, Netherlands; [Terpstra, Martijn; Kok, Klaas] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands	University of Groningen; University of Groningen	Kluiver, J (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Hanzepl 1, NL-9700 RB Groningen, Netherlands.	j.l.kluiver@umcg.nl	van den Berg, Anke/H-1718-2011; Kluiver, Joost/G-6406-2014	van den Berg, Anke/0000-0002-8894-2638; Kluiver, Joost/0000-0001-7650-2937; Tayari, Mina/0000-0003-3521-8782; Diepstra, Arjan/0000-0001-9239-1050	Pediatric Oncology Foundation Groningen [SKOG 14-001]; Jan Kornelis de Cock Foundation; UMCG [681564, 611006]	Pediatric Oncology Foundation Groningen; Jan Kornelis de Cock Foundation; UMCG	P493-6 B cells were the kind gift of Prof. D. Eick (Helmholtz Center Munich, Germany). The authors thank Dr. J. Guikema (Academic Medical Center, University of Amsterdam, The Netherlands) for contributing BL cases. This study is supported by a grant from the Pediatric Oncology Foundation Groningen (SKOG 14-001, to A.V.D.B., K.K., and J.K.), the Jan Kornelis de Cock Foundation (to M.W.), and UMCG (681564 to M.W. and 611006 to M.T.).	Atmadibrata B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088112; Barsyte-Lovejoy D, 2006, CANCER RES, V66, P5330, DOI 10.1158/0008-5472.CAN-06-0037; Bui Thi V, 2010, Genes Cancer, V1, P568; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Chen LL, 2008, EMBO J, V27, P1694, DOI 10.1038/emboj.2008.94; Clark MB, 2012, GENOME RES, V22, P885, DOI 10.1101/gr.131037.111; Clark MB, 2011, SEMIN CELL DEV BIOL, V22, P366, DOI 10.1016/j.semcdb.2011.01.001; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Deng KY, 2014, TUMOR BIOL, V35, P9497, DOI 10.1007/s13277-014-2511-y; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Guil S, 2012, NAT STRUCT MOL BIOL, V19, P1068, DOI 10.1038/nsmb.2428; Gutschner T, 2012, RNA BIOL, V9, P703, DOI 10.4161/rna.20481; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Hu GQ, 2013, NAT IMMUNOL, V14, P1190, DOI 10.1038/ni.2712; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kallen AN, 2013, MOL CELL, V52, P101, DOI 10.1016/j.molcel.2013.08.027; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li C, 2009, BLOOD, V113, P6681, DOI 10.1182/blood-2009-01-202028; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Lu LN, 2013, EMBO J, V32, P2575, DOI 10.1038/emboj.2013.182; Mattick JS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000459; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Mestdagh P, 2010, ONCOGENE, V29, P3583, DOI 10.1038/onc.2010.106; Mondal T, 2010, GENOME RES, V20, P899, DOI 10.1101/gr.103473.109; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Pajic A, 2000, INT J CANCER, V87, P787, DOI 10.1002/1097-0215(20000915)87:6<787::AID-IJC4>3.0.CO;2-6; Rabani M, 2011, NAT BIOTECHNOL, V29, P436, DOI 10.1038/nbt.1861; Sabo A, 2014, NATURE, V511, P488, DOI 10.1038/nature13537; Sati S, 2012, NUCLEIC ACIDS RES, V40, P10018, DOI 10.1093/nar/gks776; Schrader A, 2012, INT J CANCER, V131, pE348, DOI 10.1002/ijc.26423; Schuhmacher M, 2001, NUCLEIC ACIDS RES, V29, P397, DOI 10.1093/nar/29.2.397; Seitz V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026837; Slezak-Prochazka I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076647; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Swerdlow SH, 2008, WHO CLASSIFICATION T; Taft RJ, 2010, J PATHOL, V220, P126, DOI 10.1002/path.2638; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Walz S, 2014, NATURE, V511, P483, DOI 10.1038/nature13473; Wan GH, 2013, CELL SIGNAL, V25, P1086, DOI 10.1016/j.cellsig.2013.02.006; Yang F, 2013, J CANCER RES CLIN, V139, P437, DOI 10.1007/s00432-012-1324-x; Yoon JH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3939; Zhang B, 2012, CELL REP, V2, P111, DOI 10.1016/j.celrep.2012.06.003; Zhang YF, 2012, MED SCI MONITOR, V18, pRA12, DOI 10.12659/MSM.882192; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zheng GXY, 2014, NAT STRUCT MOL BIOL, V21, P585, DOI 10.1038/nsmb.2842	50	40	40	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2338	2346		10.1096/fj.14-263889	http://dx.doi.org/10.1096/fj.14-263889			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	25690653				2022-12-26	WOS:000355209500012
J	Choi, SW; Song, JK; Yim, YS; Yun, HG; Chun, KH				Choi, Seung-Won; Song, Jun-Kyu; Yim, Ye-Seal; Yun, Ho-Geun; Chun, Kyung-Hee			Glucose Deprivation Triggers Protein Kinase C-dependent beta-Catenin Proteasomal Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GASTRIC-CANCER; COLON-CARCINOMA; MELANOMA-CELLS; BREAST-CANCER; PATHWAY; AUTOPHAGY; WNT; INACTIVATION; SENESCENCE; EXPRESSION	Autophagy is a conserved process that contributes to cell homeostasis. It is well known that induction mainly occurs in response to nutrient starvation, such as starvation of amino acids and insulin, and its mechanisms have been extensively characterized. However, the mechanisms behind cellular glucose deprivation-induced autophagy are as of now poorly understood. In the present study, we determined a mechanism by which glucose deprivation induced the PKC-dependent proteasomal degradation of beta-catenin, leading to autophagy. Glucose deprivation was shown to cause a sub-G(1) transition and enhancement of the LC3-II protein levels, whereas beta-catenin protein underwent degradation in a proteasome-dependent manner. Moreover, the inhibition of GSK3 beta was unable to abolish the glucose deprivation-mediated beta-catenin degradation or up-regulation of LC3-II protein levels, which suggested GSK3 beta-independent protein degradation. Intriguingly, the inhibition of PKC beta using a pharmacological inhibitor and transfection of siRNA for PKC alpha was observed to effectively block glucose deprivation- induced beta-catenin degradation as well as the increase in LC3-II levels and the accumulation of a sub-G(1) population. Together, our results demonstrated a molecular mechanism by which glucose deprivation can induce the GSK3 beta-independent protein degradation of beta-catenin, leading to autophagy.	[Choi, Seung-Won; Song, Jun-Kyu; Yim, Ye-Seal; Yun, Ho-Geun; Chun, Kyung-Hee] Yonsei Univ, Coll Med, Dept Biochem & Mol Biol, 50 Yonsei Ro, Seoul 120752, South Korea; [Song, Jun-Kyu; Yim, Ye-Seal; Yun, Ho-Geun; Chun, Kyung-Hee] Yonsei Univ, Brain Korea Plus Project Med Sci 21, Seoul 120752, South Korea	Yonsei University; Yonsei University Health System; Yonsei University	Chun, KH (corresponding author), Yonsei Univ, Coll Med, Dept Biochem & Mol Biol, 50 Yonsei Ro, Seoul 120752, South Korea.	khchun@yuhs.ac			National Research Foundation of Korea (NRF) - Korean government (Ministry of Science, ICT and Future Planning) [NRF-2014R1A2A1A11050600, NRF-2011-0030086]; Korea Health Technology RAMP;D Project, Ministry of Health and Welfare [A121982]	National Research Foundation of Korea (NRF) - Korean government (Ministry of Science, ICT and Future Planning); Korea Health Technology RAMP;D Project, Ministry of Health and Welfare	This work was supported by National Research Foundation of Korea (NRF) grants funded by the Korean government (Ministry of Science, ICT and Future Planning) (Grants NRF-2014R1A2A1A11050600 and NRF-2011-0030086) and by the Korea Health Technology R&D Project, Ministry of Health and Welfare, Grant A121982.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Ahn YH, 2012, CLIN EXP METASTAS, V29, P359, DOI 10.1007/s10585-012-9458-4; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Bikkavilli RK, 2008, J CELL SCI, V121, P3598, DOI 10.1242/jcs.032854; Bikkavilli Rama Kamesh, 2009, Commun Integr Biol, V2, P46; Chang HW, 2013, CELL SIGNAL, V25, P839, DOI 10.1016/j.cellsig.2012.12.020; Cheong TC, 2010, CANCER SCI, V101, P94, DOI 10.1111/j.1349-7006.2009.01364.x; Daniels DL, 2005, NAT STRUCT MOL BIOL, V12, P364, DOI 10.1038/nsmb912; de Candia P, 2011, AM J PATHOL, V178, P1814, DOI 10.1016/j.ajpath.2010.12.047; Dejmek J, 2006, MOL CELL BIOL, V26, P6024, DOI 10.1128/MCB.02354-05; Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009; Dissanayake SK, 2007, J BIOL CHEM, V282, P17259, DOI 10.1074/jbc.M700075200; Flentke GR, 2014, J NEUROCHEM, V128, P523, DOI 10.1111/jnc.12464; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Gwak J, 2006, J CELL SCI, V119, P4702, DOI 10.1242/jcs.03256; Jelluma N, 2006, MOL CANCER RES, V4, P319, DOI 10.1158/1541-7786.MCR-05-0061; Jiang HB, 2010, BIOCHEM BIOPH RES CO, V395, P471, DOI 10.1016/j.bbrc.2010.04.030; Kim SJ, 2014, CELL DEATH DIFFER, V21, P1769, DOI 10.1038/cdd.2014.88; Kim Sangsoo, 2011, Genomics & Informatics, V9, P1; Kim SJ, 2013, ONCOTARGET, V4, P1461, DOI 10.18632/oncotarget.1219; Kim SJ, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3098; Kim SJ, 2011, J CONTROL RELEASE, V155, P427, DOI 10.1016/j.jconrel.2011.06.026; Kim YM, 2010, ANN NY ACAD SCI, V1201, P65, DOI 10.1111/j.1749-6632.2010.05617.x; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Knecht E, 2009, CELL MOL LIFE SCI, V66, P2427, DOI 10.1007/s00018-009-0030-6; Kohn AD, 2005, CELL CALCIUM, V38, P439, DOI 10.1016/j.ceca.2005.06.022; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lee EH, 2012, IEEE PHOTONIC TECH L, V24, P3, DOI 10.1109/LPT.2011.2178738; Lee HW, 2014, BMB REP, V47, P697, DOI 10.5483/BMBRep.2014.47.12.069; Lee MH, 2009, FASEB J, V23, P3874, DOI 10.1096/fj.08-117804; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Lin NY, 2013, ANN RHEUM DIS, V72, P761, DOI 10.1136/annrheumdis-2012-201671; Ma L, 2007, J BIOL CHEM, V282, P28980, DOI 10.1074/jbc.M702840200; Ma L, 2006, J BIOL CHEM, V281, P30990, DOI 10.1074/jbc.M603603200; Munoz-Pinedo C, 2003, J BIOL CHEM, V278, P12759, DOI 10.1074/jbc.M212392200; Petherick KJ, 2013, EMBO J, V32, P1903, DOI 10.1038/emboj.2013.123; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Sadot E, 2002, J CELL SCI, V115, P2771; Sakaki K, 2008, J BIOL CHEM, V283, P15370, DOI 10.1074/jbc.M710209200; Saneyoshi T, 2002, NATURE, V417, P295, DOI 10.1038/417295a; Seo YH, 2008, AGING CELL, V7, P894, DOI 10.1111/j.1474-9726.2008.00436.x; Tan SH, 2012, J BIOL CHEM, V287, P14364, DOI 10.1074/jbc.M111.294157; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Thornton TM, 2008, SCIENCE, V320, P667, DOI 10.1126/science.1156037; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Wang YG, 2012, EXP MOL MED, V44, P387, DOI 10.3858/emm.2012.44.6.044; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Westfall TA, 2003, J CELL BIOL, V162, P889, DOI 10.1083/jcb.200303107; Yun MS, 2005, J CELL SCI, V118, P313, DOI 10.1242/jcs.01601	50	18	20	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9863	9873		10.1074/jbc.M114.606756	http://dx.doi.org/10.1074/jbc.M114.606756			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25691573	Green Published, hybrid			2022-12-26	WOS:000352729400045
J	Maruyama, K; Fukasaka, M; Uematsu, S; Takeuchi, O; Kondo, T; Saitoh, T; Martino, MM; Akira, S				Maruyama, Kenta; Fukasaka, Masahiro; Uematsu, Satoshi; Takeuchi, Osamu; Kondo, Takeshi; Saitoh, Tatsuya; Martino, Mikael M.; Akira, Shizuo			5-Azacytidine-induced Protein 2 (AZI2) Regulates Bone Mass by Fine-tuning Osteoclast Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PULMONARY ALVEOLAR PROTEINOSIS; NF-KAPPA-B; COLONY-STIMULATING FACTOR; T-CELLS NFAT; TRANSCRIPTION FACTOR; C-FOS; NEGATIVE REGULATOR; NUCLEAR FACTOR; TNF-ALPHA; DIFFERENTIATION	5-Azacytidine-induced protein 2 (AZI2) is a TNF receptor (TNFR)-associated factor family member-associated NF-kappa B activator-binding kinase 1-binding protein that regulates the production of IFNs. A previous in vitro study showed that AZI2 is involved in dendritic cell differentiation. However, the roles of AZI2 in immunity and its pleiotropic functions are unknown in vivo. Here we report that AZI2 knock-out mice exhibit normal dendritic cell differentiation in vivo. However, we found that adult AZI2 knock-out mice have severe osteoporosis due to increased osteoclast longevity. We revealed that the higher longevity of AZI2-deficient osteodasts is due to an augmented activation of proto-oncogene tyrosine-protein kinase Src (c-Src), which is a critical player in osteoclast survival. We found that AZI2 inhibits c-Src activity by regulating the activation of heat shock protein 90 (Hsp90), a chaperone involved in c-Src dephosphorylation. Furthermore, we demonstrated that AZI2 indirectly inhibits c-Src by interacting with the Hsp90 co-chaperone Cdc37. Strikingly, administration of a c-Src inhibitor markedly prevented bone loss in AZI2 knock-out mice. Together, these findings indicate that AZI2 regulates bone mass by fine-tuning osteoclast survival.	[Maruyama, Kenta; Fukasaka, Masahiro; Kondo, Takeshi; Saitoh, Tatsuya; Martino, Mikael M.; Akira, Shizuo] Osaka Univ, Host Def Lab, WPI Immunol Frontier Res Ctr IFReC, Suita, Osaka 5650871, Japan; [Uematsu, Satoshi] Univ Tokyo, Div Innate Immune Regulat, Int Res & Dev Ctr Mucosal Vaccine, Inst Med Sci,Minato Ku, Tokyo 1088639, Japan; [Saitoh, Tatsuya; Akira, Shizuo] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Fukasaka, Masahiro] Nitto Denko Corp, Corp R&D Dev Div, Life Sci Res Ctr, Ibaraki, Osaka 5678680, Japan; [Takeuchi, Osamu] Kyoto Univ, Inst Virus Res, Lab Infect & Prevent, Sakyo Ku, Kyoto 6068507, Japan	Osaka University; University of Tokyo; Osaka University; Nitto Denko Corporation; Kyoto University	Maruyama, K (corresponding author), Osaka Univ, Host Def Lab, WPI Immunol Frontier Res Ctr, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan.	maruyama@biken.osaka-u.ac.jp; sakira@biken.osaka-u.ac.jp	Takeuchi, Osamu/AAG-9359-2019; Akira, Shizuo/C-3134-2009; Martino, Mikaël M/N-9345-2013; KONDO, Takeshi/AGV-4963-2022	Takeuchi, Osamu/0000-0002-1260-6232; Martino, Mikaël M/0000-0002-5012-4605; 	Japan Society for the Promotion of Science (JSPS); JSPS KAKENHI; Osaka University MEET project; Astellas Foundation for Research on Metabolic Disorders; Naito Foundation; SENSHIN Medical Research Foundation; Japan Intractable Disease Research Foundation; Takeda Science Foundation; Grants-in-Aid for Scientific Research [25670027] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Osaka University MEET project; Astellas Foundation for Research on Metabolic Disorders; Naito Foundation(Naito Memorial Foundation); SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); Japan Intractable Disease Research Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a research fellowship from the Japan Society for the Promotion of Science (JSPS) for the Promotion of Science for Young Scientists, JSPS KAKENHI for a grant-in-aid for challenging exploratory research, a grant from the Osaka University MEET project, a grant from the Astellas Foundation for Research on Metabolic Disorders, a grant from the Naito Foundation, a grant from the SENSHIN Medical Research Foundation, a grant from the Japan Intractable Disease Research Foundation, and a visionary research grant from Takeda Science Foundation (to K. M.).	Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Fukasaka M, 2013, J IMMUNOL, V190, P5702, DOI 10.4049/jimmunol.1203155; Gao BX, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2081; Glantschnig H, 2003, CELL DEATH DIFFER, V10, P1165, DOI 10.1038/sj.cdd.4401285; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kawagoe T, 2009, NAT IMMUNOL, V10, P965, DOI 10.1038/ni.1771; Kawaida R, 2003, J EXP MED, V197, P1029, DOI 10.1084/jem.20021321; Kuroda Y, 2008, P NATL ACAD SCI USA, V105, P8643, DOI 10.1073/pnas.0800642105; Lee SE, 2001, J BIOL CHEM, V276, P49343, DOI 10.1074/jbc.M103642200; MacLean M, 2003, CELL STRESS CHAPERON, V8, P114, DOI 10.1379/1466-1268(2003)008<0114:CGBHAK>2.0.CO;2; Maruyama K, 2006, J IMMUNOL, V177, P3799, DOI 10.4049/jimmunol.177.6.3799; Maruyama K, 2012, IMMUNITY, V37, P1024, DOI 10.1016/j.immuni.2012.08.022; Maruyama K, 2012, J BIOL CHEM, V287, P29114, DOI 10.1074/jbc.M112.347799; Matsuo K, 2004, J BIOL CHEM, V279, P26475, DOI 10.1074/jbc.M313973200; ROSEN SH, 1958, NEW ENGL J MED, V258, P1123, DOI 10.1056/NEJM195806052582301; Sato K, 2006, J EXP MED, V203, P2673, DOI 10.1084/jem.20061775; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; STANLEY E, 1994, P NATL ACAD SCI USA, V91, P5592, DOI 10.1073/pnas.91.12.5592; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2002, NATURE, V416, P744, DOI 10.1038/416744a; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tanabe N, 2011, J BIOL CHEM, V286, P39871, DOI 10.1074/jbc.M111.295048; Thomassen MJ, 2007, J LIPID RES, V48, P2762, DOI 10.1194/jlr.P700022-JLR200; Trapnell BC, 2003, NEW ENGL J MED, V349, P2527, DOI 10.1056/NEJMra023226; Xing LP, 2001, GENE DEV, V15, P241, DOI 10.1101/gad.840301; Yano A, 2008, P NATL ACAD SCI USA, V105, P15541, DOI 10.1073/pnas.0805354105; Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012; Zhu H, 2010, NAT PROTOC, V5, P550, DOI 10.1038/nprot.2009.238	30	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9377	9386		10.1074/jbc.M114.631374	http://dx.doi.org/10.1074/jbc.M114.631374			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25691576	hybrid, Green Published			2022-12-26	WOS:000352729400007
J	Jaitovich, A; Angulo, M; Lecuona, E; Dada, LA; Welch, LC; Cheng, Y; Gusarova, G; Ceco, E; Liu, C; Shigemura, M; Barreiro, E; Patterson, C; Nader, GA; Sznajder, JI				Jaitovich, Ariel; Angulo, Martin; Lecuona, Emilia; Dada, Laura A.; Welch, Lynn C.; Cheng, Yuan; Gusarova, Galina; Ceco, Ermelinda; Liu, Chang; Shigemura, Masahiko; Barreiro, Esther; Patterson, Cam; Nader, Gustavo A.; Sznajder, Jacob I.			High CO2 Levels Cause Skeletal Muscle Atrophy via AMP-activated Kinase (AMPK), FoxO3a Protein, and Muscle-specific Ring Finger Protein 1 (MuRF1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTORS; ENERGY SENSOR; UBIQUITIN-PROTEASOME; HYPERCAPNIC ACIDOSIS; MUSCULAR-DYSTROPHY; OXIDATIVE STRESS; HYPERTROPHY; DYSFUNCTION; EXPRESSION; RNA	Patients with chronic obstructive pulmonary disease, acute lung injury, and critical care illness may develop hypercapnia. Many of these patients often have muscle dysfunction which increases morbidity and impairs their quality of life. Here, we investigated whether hypercapnia leads to skeletal muscle atrophy. Mice exposed to high CO2 had decreased skeletal muscle wet weight, fiber diameter, and strength. Cultured myotubes exposed to high CO2 had reduced fiber diameter, protein/DNA ratios, and anabolic capacity. High CO2 induced the expression of MuRF1 in vivo and in vitro, whereas MuRF1(-/-) mice exposed to high CO2 did not develop muscle atrophy. AMP-activated kinase AMPK), a metabolic sensor, was activated in myotubes exposed to high CO2, and loss-of-function studies showed that the AMPK alpha 2 isoform is necessary for muscle-specific ring finger protein 1 MuRF1) up-regulation and myofiber size reduction. High CO2 induced AMPK alpha 2 activation, triggering the phosphorylation and nuclear translocation of FoxO3a, and leading to an increase in MuRF1 expression and myotube atrophy. Accordingly, we provide evidence that high CO2 activates skeletal muscle atrophy via AMPK alpha 2-FoxO3a-MuRF1, which is of biological and potentially clinical significance in patients with lung diseases and hypercapnia.	[Jaitovich, Ariel; Angulo, Martin; Lecuona, Emilia; Dada, Laura A.; Welch, Lynn C.; Cheng, Yuan; Gusarova, Galina; Ceco, Ermelinda; Shigemura, Masahiko; Sznajder, Jacob I.] Northwestern Univ, Div Pulm & Crit Care Med, Chicago, IL 60611 USA; [Angulo, Martin] Univ Republica, Fac Med, Dept Fisiopatol, Montevideo, Uruguay; [Liu, Chang; Nader, Gustavo A.] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Barreiro, Esther] Univ Pompeu Fabra, Mol Mech Lung Canc Predisposit Res Grp IMIM, Muscle & Resp Syst Res Unit, Pulmonol Dept,Hosp del Mar,IMIM,Dept Expt & Hlth, Barcelona, Spain; [Barreiro, Esther] Inst Salud Carlos III, Ctr Invest Red Enfermedades Resp CIBERES, Madrid, Spain; [Patterson, Cam] Univ N Carolina, McAllister Heart Inst, Chapel Hill, NC USA	Northwestern University; Universidad de la Republica, Uruguay; Karolinska Institutet; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; University of North Carolina; University of North Carolina Chapel Hill	Sznajder, JI (corresponding author), Northwestern Univ, Div Pulm & Crit Care Med, Chicago, IL 60611 USA.	j-sznajder@northwestern.edu	Shigemura, Masahiko/AAL-3185-2020	Shigemura, Masahiko/0000-0001-7767-6584; Angulo, Martin/0000-0002-3326-5764	National Institutes of Health [CA060553, HL-85534, HL-71643, HL-T32-76139]; Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (CIBERES); Instituto de Salud Carlos III, Spain [FIS 11/02029, FIS 12/02534]; Ministry of Competitiveness, Spain [SAF-2011-26908]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL076139, P01HL071643, R01HL085534] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (CIBERES); Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III); Ministry of Competitiveness, Spain; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grants CA060553 (to the Robert H. Lurie Comprehensive Cancer Center Cores: Center for Advanced Microscopy Center, Genomics Core, and Mouse Phenotyping and Histology Laboratory), HL-85534, HL-71643, and HL-T32-76139. This work was also supported by Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (CIBERES) and Grants FIS 11/02029 and FIS 12/02534 (Instituto de Salud Carlos III), Spain and SAF-2011-26908 from Ministry of Competitiveness, Spain.	Baehr LM, 2011, J PHYSIOL-LONDON, V589, P4759, DOI 10.1113/jphysiol.2011.212845; Barreiro E, 2005, AM J RESP CRIT CARE, V171, P1116, DOI 10.1164/rccm.200407-887OC; Barreiro E, 2013, J APPL PHYSIOL, V114, P1220, DOI 10.1152/japplphysiol.00162.2013; Batt J, 2014, AM J RESP CELL MOL, V50, P74, DOI 10.1165/rcmb.2012-0506OC; Batt J, 2013, AM J RESP CRIT CARE, V187, P238, DOI 10.1164/rccm.201205-0954SO; Belkin RA, 2006, AM J RESP CRIT CARE, V173, P659, DOI 10.1164/rccm.200410-1369OC; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bonaldo P, 2013, DIS MODEL MECH, V6, P25, DOI 10.1242/dmm.010389; Briguet A, 2004, NEUROMUSCULAR DISORD, V14, P675, DOI 10.1016/j.nmd.2004.06.008; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Caples SM, 2009, AM J PHYSIOL-LUNG C, V296, pL140, DOI 10.1152/ajplung.90339.2008; Ceco E, 2013, FEBS J, V280, P4198, DOI 10.1111/febs.12266; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; Clarke BA, 2007, CELL METAB, V6, P376, DOI 10.1016/j.cmet.2007.09.009; Cummins EP, 2014, CELL MOL LIFE SCI, V71, P831, DOI 10.1007/s00018-013-1470-6; Dick CR, 1997, AM J RESP CRIT CARE, V155, P609, DOI 10.1164/ajrccm.155.2.9032202; Doerr CH, 2005, AM J RESP CRIT CARE, V171, P1371, DOI 10.1164/rccm.200309-1223OC; Doucet M, 2007, AM J RESP CRIT CARE, V176, P261, DOI 10.1164/rccm.200605-704OC; ENGELEN MPKJ, 1994, EUR RESPIR J, V7, P1793, DOI 10.1183/09031936.94.07101793; Fermoselle C, 2012, EUR RESPIR J, V40, P851, DOI 10.1183/09031936.00137211; Files DC, 2012, AM J RESP CRIT CARE, V185, P825, DOI 10.1164/rccm.201106-1150OC; Gajic O, 2003, AM J RESP CRIT CARE, V167, P1057, DOI 10.1164/rccm.200208-889OC; Gates KL, 2013, AM J RESP CELL MOL, V49, P821, DOI 10.1165/rcmb.2012-0487OC; Glass DJ, 2003, NAT CELL BIOL, V5, P87, DOI 10.1038/ncb0203-87; Glass DJ, 2005, INT J BIOCHEM CELL B, V37, P1974, DOI 10.1016/j.biocel.2005.04.018; Gowans GJ, 2014, BIOCHEM SOC T, V42, P71, DOI 10.1042/BST20130244; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Guo YT, 2013, AM J RESP CRIT CARE, V188, P1313, DOI 10.1164/rccm.201304-0732OC; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hayward LJ, 2008, J CLIN INVEST, V118, P1437, DOI 10.1172/JCI32638; He WA, 2013, J CLIN INVEST, V123, P4821, DOI 10.1172/JCI68523; Hedrick SM, 2012, NAT REV IMMUNOL, V12, P649, DOI 10.1038/nri3278; Helenius IT, 2009, P NATL ACAD SCI USA, V106, P18710, DOI 10.1073/pnas.0905925106; Hoppe S, 2009, P NATL ACAD SCI USA, V106, P17781, DOI 10.1073/pnas.0909873106; Kok MO, 2012, EUR ADDICT RES, V18, P70, DOI 10.1159/000333600; Landbo C, 1999, AM J RESP CRIT CARE, V160, P1856, DOI 10.1164/ajrccm.160.6.9902115; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Machida M, 2012, J CELL PHYSIOL, V227, P1569, DOI 10.1002/jcp.22871; Meyer O A, 1979, Neurobehav Toxicol, V1, P233; MOSS T, 1995, PROG NUCLEIC ACID RE, V50, P25, DOI 10.1016/S0079-6603(08)60810-7; Nakashima K, 2007, BIOSCI BIOTECH BIOCH, V71, P1650, DOI 10.1271/bbb.70057; Nystrom G, 2009, METABOLISM, V58, P787, DOI 10.1016/j.metabol.2009.01.015; Nystrom GJ, 2008, INT J CLIN EXP MED, V1, P50; Plant PJ, 2010, AM J RESP CELL MOL, V42, P461, DOI 10.1165/rcmb.2008-0382OC; Puhan M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005305.pub2; Romanello V, 2010, EMBO J, V29, P1774, DOI 10.1038/emboj.2010.60; Salt I, 1998, BIOCHEM J, V334, P177, DOI 10.1042/bj3340177; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sandri M, 2013, INT J BIOCHEM CELL B, V45, P2121, DOI 10.1016/j.biocel.2013.04.023; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Schols AMWJ, 1998, AM J RESP CRIT CARE, V157, P1791, DOI 10.1164/ajrccm.157.6.9705017; Vadasz I, 2008, J CLIN INVEST, V118, P752, DOI 10.1172/JCI29723; Vadasz I, 2012, AM J RESP CELL MOL, V46, P417, DOI 10.1165/rcmb.2011-0395PS; Vohwinkel CU, 2011, J BIOL CHEM, V286, P37067, DOI 10.1074/jbc.M111.290056; von Walden F, 2012, AM J PHYSIOL-CELL PH, V302, pC1523, DOI 10.1152/ajpcell.00460.2011; Wang NZ, 2010, FASEB J, V24, P2178, DOI 10.1096/fj.09-136895; Weathington NM, 2013, AM J RESP CRIT CARE, V188, P530, DOI 10.1164/rccm.201304-0754PP; WEINBERGER SE, 1989, NEW ENGL J MED, V321, P1223; Williamson DL, 2009, AM J PHYSIOL-ENDOC M, V297, pE304, DOI 10.1152/ajpendo.91007.2008; Willis MS, 2007, CIRC RES, V100, P456, DOI 10.1161/01.RES.0000259559.48597.32	60	85	87	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					9183	9194		10.1074/jbc.M114.625715	http://dx.doi.org/10.1074/jbc.M114.625715			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25691571	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000352207100041
J	Simpson, MA; Bradley, WD; Harburger, D; Parsons, M; Calderwood, DA; Koleske, AJ				Simpson, Mark A.; Bradley, William D.; Harburger, David; Parsons, Maddy; Calderwood, David A.; Koleske, Anthony J.			Direct Interactions with the Integrin beta 1 Cytoplasmic Tail Activate the Abl2/Arg Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABL TYROSINE KINASE; CELL EDGE PROTRUSION; C-ABL; FAMILY KINASES; SIGNAL-TRANSDUCTION; STRUCTURAL BASIS; N-WASP; ARG; PHOSPHORYLATION; ADHESION	Integrins are heterodimeric alpha/beta extracellular matrix adhesion receptors that couple physically to the actin cytoskeleton and regulate kinase signaling pathways to control cytoskeletal remodeling and adhesion complex formation and disassembly. beta 1 integrins signal through the Abl2/Arg ( Abl-related gene) nonreceptor tyrosine kinase to control fibroblast cell motility, neuronal dendrite morphogenesis and stability, and cancer cell invasiveness, but the molecular mechanisms by which integrin beta 1 activates Arg are unknown. We report here that the Arg kinase domain interacts directly with a lysine-rich membraneproximal segment in the integrin beta 1 cytoplasmic tail, that Arg phosphorylates the membrane-proximal Tyr-783 in the beta 1 tail, and that the Arg Src homology domain then engages this phosphorylated region in the tail. We show that these interactions mediate direct binding between integrin beta 1 and Arg in vitro and in cells and activate Arg kinase activity. These findings provide a model for understanding how beta 1-containing integrins interact with and activate Abl family kinases.	[Simpson, Mark A.; Bradley, William D.; Koleske, Anthony J.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA; [Harburger, David; Calderwood, David A.] Yale Univ, Dept Pharmacol, New Haven, CT 06510 USA; [Calderwood, David A.] Yale Univ, Dept Cell Biol, New Haven, CT 06510 USA; [Koleske, Anthony J.] Yale Univ, Dept Neurobiol, New Haven, CT 06510 USA; [Parsons, Maddy] Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England	Yale University; Yale University; Yale University; Yale University; University of London; King's College London	Koleske, AJ (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 208024, New Haven, CT 06520 USA.	anthony.koleske@yale.edu	Calderwood, David A/AAC-6954-2019; Parsons, Maddy/B-2203-2013	Calderwood, David A/0000-0002-0791-4142; Parsons, Maddy/0000-0002-2021-8379	National Institutes of Health [CA133346, GM100411, RO1 GM068600]; NIGMS, National Institutes of Health [T32GM007223-40]; American Heart Association Founders Affiliate Predoctoral Fellowship Award [12PRE12080140]; Royal Society; NATIONAL CANCER INSTITUTE [R01CA133346] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100411, R01GM068600, T32GM007223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS089662] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Heart Association Founders Affiliate Predoctoral Fellowship Award(American Heart Association); Royal Society(Royal Society of London); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA133346 and GM100411 (to A. J. K.).; Supported by T32GM007223-40 from NIGMS, National Institutes of Health and American Heart Association Founders Affiliate Predoctoral Fellowship Award #12PRE12080140.; Supported by the Royal Society.; Supported by National Institutes of Health Grant RO1 GM068600.	Anthis NJ, 2009, J BIOL CHEM, V284, P36700, DOI 10.1074/jbc.M109.061275; Anthis NJ, 2009, EMBO J, V28, P3623, DOI 10.1038/emboj.2009.287; Arias-Salgado EG, 2005, J BIOL CHEM, V280, P29699, DOI 10.1074/jbc.M503508200; Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Beaty BT, 2013, MOL BIOL CELL, V24, P1661, DOI 10.1091/mbc.E12-12-0908; Bledzka K, 2010, J BIOL CHEM, V285, P30370, DOI 10.1074/jbc.C110.134247; Boyle SN, 2007, BIOCHEMISTRY-US, V46, P11614, DOI 10.1021/bi701119s; Boyle SN, 2007, CURR BIOL, V17, P445, DOI 10.1016/j.cub.2007.01.057; Bradley WD, 2006, MOL BIOL CELL, V17, P4827, DOI 10.1091/mbc.E06-02-0132; Bradley WD, 2009, J CELL SCI, V122, P3441, DOI 10.1242/jcs.039859; Campbell DH, 1999, CANCER RES, V59, P5376; Campbell ID, 2011, COLD SPRING HARB PER, V1, P3, DOI DOI 10.1101/CSHPERSPECT; Cao XQ, 2008, J BIOL CHEM, V283, P31401, DOI 10.1074/jbc.M804002200; FOX JEB, 1993, J BIOL CHEM, V268, P25973; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Gifford SM, 2014, J BIOL CHEM, V289, P19704, DOI 10.1074/jbc.M114.556480; Hantschel O, 2003, CELL, V112, P845, DOI 10.1016/S0092-8674(03)00191-0; Harburger DS, 2009, J BIOL CHEM, V284, P11485, DOI 10.1074/jbc.M809233200; Harrison SC, 2003, CELL, V112, P737, DOI 10.1016/S0092-8674(03)00196-X; Hernandez SE, 2004, CURR BIOL, V14, P691, DOI 10.1016/j.cub.2004.03.062; Kerrisk ME, 2013, J NEUROSCI, V33, P6742, DOI 10.1523/JNEUROSCI.0528-13.2013; Koleske AJ, 1998, NEURON, V21, P1259, DOI 10.1016/S0896-6273(00)80646-7; Lapetina S, 2009, J CELL BIOL, V185, P503, DOI 10.1083/jcb.200809085; Lewis JM, 1998, J BIOL CHEM, V273, P14225, DOI 10.1074/jbc.273.23.14225; Lewis JM, 1996, P NATL ACAD SCI USA, V93, P15174, DOI 10.1073/pnas.93.26.15174; Li R, 2011, CURR BIOL, V21, P1534, DOI 10.1016/j.cub.2011.08.023; Mader CC, 2011, CANCER RES, V71, P1730, DOI 10.1158/0008-5472.CAN-10-1432; Miller AL, 2004, J CELL BIOL, V165, P407, DOI 10.1083/jcb.200308055; Miller MM, 2010, BIOCHEMISTRY-US, V49, P2227, DOI 10.1021/bi901721u; Moresco EMY, 2005, J NEUROSCI, V25, P6105, DOI 10.1523/JNEUROSCI.1432-05.2005; Morse EM, 2014, BIOCHEMISTRY-US, V53, P810, DOI 10.1021/bi401596q; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Nagar B, 2006, MOL CELL, V21, P787, DOI 10.1016/j.molcel.2006.01.035; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Oser M, 2009, J CELL BIOL, V186, P571, DOI 10.1083/jcb.200812176; Parsons M, 2008, J CELL SCI, V121, P265, DOI 10.1242/jcs.018440; Peacock JG, 2007, MOL BIOL CELL, V18, P3860, DOI 10.1091/mbc.E07-01-0075; Tanis KQ, 2003, MOL CELL BIOL, V23, P3884, DOI 10.1128/MCB.23.11.3884-3896.2003; Warren MS, 2012, J NEUROSCI, V32, P2824, DOI 10.1523/JNEUROSCI.3942-11.2012; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Yang JS, 2011, CHEM BIOL, V18, P177, DOI 10.1016/j.chembiol.2010.12.013	41	32	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8360	8372		10.1074/jbc.M115.638874	http://dx.doi.org/10.1074/jbc.M115.638874			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25694433	Green Published, hybrid			2022-12-26	WOS:000351662600030
J	Vitvitsky, V; Yadav, PK; Kurthen, A; Banerjee, R				Vitvitsky, Victor; Yadav, Pramod K.; Kurthen, Angelika; Banerjee, Ruma			Sulfide Oxidation by a Noncanonical Pathway in Red Blood Cells Generates Thiosulfate and Polysulfides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTATHIONINE BETA-SYNTHASE; HYDROGEN-SULFIDE; GAMMA-CYSTATHIONASE; H2S; REACTIVITY; MECHANISM; ASSAY	A cardioprotectant at low concentrations, H2S is a toxin at high concentrations and inhibits cytochrome c oxidase. A conundrum in H2S homeostasis is its fate in red blood cells (RBCs), which produce H2S but lack the canonical mitochondrial sulfide oxidation pathway for its clearance. The sheer abundance of RBCs in circulation enhances the metabolic significance of their clearance strategy for H2S, necessary to avoid systemic toxicity. In this study, we demonstrate that H2S generation by RBCs is catalyzed by mercaptopyruvate sulfurtransferase. Furthermore, we have discovered the locus of sulfide oxidation in RBCs and describe a new role for an old protein, hemoglobin, which in the ferric or methemoglobin state binds H2S and oxidizes it to a mixture of thiosulfate and hydropolysulfides. Our study reveals a previously undescribed route for the biogenesis of hydropolysulfides, which are increasingly considered important for H2S-based signaling, but their origin in mammalian cells is unknown. An NADPH/ flavoprotein oxidoreductase system restores polysulfide-carrying hemoglobin derivatives to ferrous hemoglobin, thus completing the methemoglobin- dependent sulfide oxidation cycle. Methemoglobindependent sulfide oxidation in mammals is complex and has similarities to chemistry reported for the dissolution of iron oxides in sulfidic waters and during bioleaching of metal sulfides. The catalytic oxidation of H2S by hemoglobin explains how RBCs maintain low steady-state H2S levels in circulation, and suggests that additional hemeproteins might be involved in sulfide homeostasis in other tissues.	[Vitvitsky, Victor; Yadav, Pramod K.; Kurthen, Angelika; Banerjee, Ruma] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Banerjee, R (corresponding author), Univ Michigan, 4220C MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu	Yadav, Pramod K./A-6166-2010; Vitvitsky, Victor/ABA-2967-2021	Yadav, Pramod K./0000-0003-0026-1684; Vitvitsky, Victor/0000-0001-6251-6115	National Institutes of Health [GM112455]; American Heart Association [14POST18760003]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112455] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM112455 (to R. B.). This work was also supported by American Heart Association Grant 14POST18760003 (to P. K. Y.).	Carballal S, 2011, FREE RADICAL BIO MED, V50, P196, DOI 10.1016/j.freeradbiomed.2010.10.705; CHEN KY, 1972, ENVIRON SCI TECHNOL, V6, P529, DOI 10.1021/es60065a008; Chiku T, 2009, J BIOL CHEM, V284, P11601, DOI 10.1074/jbc.M808026200; Cuevasanta E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034562; Das TN, 1999, J PHYS CHEM A, V103, P5221, DOI 10.1021/jp9907544; Hildebrandt TM, 2008, FEBS J, V275, P3352, DOI 10.1111/j.1742-4658.2008.06482.x; Hoppe-Seyler F., 1983, ZENTBL MED WISS, V1, P433; Kabil O, 2014, ANNU REV NUTR, V34, P171, DOI 10.1146/annurev-nutr-071813-105654; Kabil O, 2014, BBA-PROTEINS PROTEOM, V1844, P1355, DOI 10.1016/j.bbapap.2014.01.002; Kabil O, 2014, ANTIOXID REDOX SIGN, V20, P770, DOI 10.1089/ars.2013.5339; Kabil O, 2011, ANTIOXID REDOX SIGN, V15, P363, DOI 10.1089/ars.2010.3781; Keilin D, 1933, P R SOC LOND B-CONTA, V113, P393, DOI 10.1098/rspb.1933.0056; Kimura H, 2015, ANTIOXID REDOX SIGN, V22, P347, DOI 10.1089/ars.2014.6082; Kimura H, 2010, ANTIOXID REDOX SIGN, V12, P1111, DOI 10.1089/ars.2009.2919; King AL, 2014, P NATL ACAD SCI USA, V111, P3182, DOI 10.1073/pnas.1321871111; KRAUS DW, 1990, J BIOL CHEM, V265, P16054; Mathai JC, 2009, P NATL ACAD SCI USA, V106, P16633, DOI 10.1073/pnas.0902952106; NICHOL AW, 1968, BIOCHIM BIOPHYS ACTA, V156, P97, DOI 10.1016/0304-4165(68)90108-6; NICHOLLS P, 1982, CAN J BIOCHEM CELL B, V60, P613, DOI 10.1139/o82-076; Ogasawara Y, 2002, J BIOCHEM BIOPH METH, V51, P139, DOI 10.1016/S0165-022X(02)00010-6; Olteanu H, 2001, J BIOL CHEM, V276, P35558, DOI 10.1074/jbc.M103707200; Pavlik JW, 2010, INORG CHEM, V49, P1017, DOI 10.1021/ic901853p; Pietri R, 2011, ANTIOXID REDOX SIGN, V15, P393, DOI 10.1089/ars.2010.3698; Pietri R, 2009, BIOCHEMISTRY-US, V48, P4881, DOI 10.1021/bi801738j; Riahi S, 2014, J AM CHEM SOC, V136, P15111, DOI 10.1021/ja508063s; Sakaguchi M, 2014, ANESTHESIOLOGY, V121, P1248, DOI 10.1097/ALN.0000000000000456; Schippers A, 1999, APPL ENVIRON MICROB, V65, P319; Singh S, 2009, J BIOL CHEM, V284, P22457, DOI 10.1074/jbc.M109.010868; SMITH RP, 1966, TOXICOL APPL PHARM, V8, P159, DOI 10.1016/0041-008X(66)90112-8; Snijder P. M., 2014, BRIT J PHARMACOL, V172, P1494; SORBO B, 1956, BIOCHIM BIOPHYS ACTA, V21, P393, DOI 10.1016/0006-3002(56)90034-8; Taoka S, 1998, J BIOL CHEM, V273, P25179, DOI 10.1074/jbc.273.39.25179; Theissen U, 2003, MOL BIOL EVOL, V20, P1564, DOI 10.1093/molbev/msg174; VALENTINE WN, 1974, CLIN CHIM ACTA, V51, P205, DOI 10.1016/0009-8981(74)90031-X; Vitvitsky V, 2012, ANTIOXID REDOX SIGN, V17, P22, DOI 10.1089/ars.2011.4310; WOOD JL, 1987, METHOD ENZYMOL, V143, P25; Yadav PK, 2013, J BIOL CHEM, V288, P20002, DOI 10.1074/jbc.M113.466177; Yao WS, 1996, MAR CHEM, V52, P1, DOI 10.1016/0304-4203(95)00072-0; Zhong FF, 2014, P NATL ACAD SCI USA, V111, pE306, DOI 10.1073/pnas.1317173111	39	110	114	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8310	8320		10.1074/jbc.M115.639831	http://dx.doi.org/10.1074/jbc.M115.639831			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25688092	Green Published, hybrid			2022-12-26	WOS:000351662600026
J	Wang, XF; Zhang, RW; Gu, LQ; Zhang, YY; Zhao, X; Bi, KS; Chen, XH				Wang, Xiaofan; Zhang, Ruowen; Gu, Liqiang; Zhang, Yuanyuan; Zhao, Xu; Bi, Kaishun; Chen, Xiaohui			Cell-Based Screening Identifies the Active Ingredients from Traditional Chinese Medicine Formula Shixiao San as the Inhibitors of Atherosclerotic Endothelial Dysfunction	PLOS ONE			English	Article							NF-KAPPA-B; HYDROGEN-PEROXIDE; NITRIC-OXIDE; EXPRESSION; FLAVONOIDS; CONSTITUENTS; ACTIVATION; APOPTOSIS; OXIDATION; EXTRACTS	In this study, we performed a phenotypic screening in human endothelial cells exposed to oxidized low density lipoprotein (an in vitro model of atherosclerotic endothelial dysfunction) to identify the effective compounds in Shixiao San. After investigating the suitability and reliability of the cell-based screening method using atorvastatin as the positive control drug, this method was applied in screening Shixiao San and its extracts. The treatment of n-butanol fraction on endothelial cells exhibited stronger healing effects against oxidized low density lipoprotein-induced insult when compared with other fractions. Cell viability, the level of nitric oxide, endothelial nitric oxide synthase and endothelin-1 were measured, respectively. The assays revealed n-butanol fraction significantly elevated the survival ratio of impaired cells in culture. In parallel, n-butanol fraction exhibited the highest inhibition of inflammation. The generation of prostaglandin-2 and adhesion molecule (soluble intercellular adhesion molecule-1) was obviously declined. Furthermore, n-butanol fraction suppressed the production of reactive oxygen species and malondialdehyde, and restored the activity of superoxide dismutase. Compounds identification of the n-butanol fraction was carried out by ultra high liquid chromatography coupled to quadrupole time-of-flight tandem mass spectrometry. The active ingredients including quercetin-3-O-(2(G)-alpha-l-rhamnosyl)-rutinoside, quercetin-3-O-neohesperidoside, isorhamnetin-3-O-neohesperidoside and isorhamnetin-3-O-rutinoside revealed the ability of anti-atherosclerosis after exposing on endothelial cells. The current work illustrated the pharmacology effect of Shixiao San and clearly indicated the major active components in Shixiao San. More importantly, the proposed cell-based screening method might be particularly suitable for fast evaluating the anti-atherosclerosis efficacy of Traditional Chinese Medicines and screening out the interesting ingredients of Traditional Chinese Medicines.	[Wang, Xiaofan; Gu, Liqiang; Zhang, Yuanyuan; Bi, Kaishun; Chen, Xiaohui] Shenyang Pharmaceut Univ, Sch Pharm, Shenyang, Peoples R China; [Zhang, Ruowen] Univ N Dakota, Sch Med & Hlth Sci, Dept Pathol, Grand Forks, ND 58201 USA; [Zhao, Xu] Shenyang Pharmaceut Univ, Sch Tradit Chinese Mat Med, Shenyang, Peoples R China	Shenyang Pharmaceutical University; University of North Dakota Grand Forks; Shenyang Pharmaceutical University	Chen, XH (corresponding author), Shenyang Pharmaceut Univ, Sch Pharm, Shenyang, Peoples R China.	cxh_syphu@hotmail.com	chen, xia/GXM-5435-2022; chen, xia/GYR-3948-2022; zhang, yuanyuan/GYA-4428-2022	Zhang, Ruowen/0000-0003-1403-2356				Ahmadi N, 2010, AM J CARDIOL, V105, P459, DOI 10.1016/j.amjcard.2009.09.052; Boudjeltia KZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038810; Bouhlel I, 2010, J APPL TOXICOL, V30, P551, DOI 10.1002/jat.1525; Bouhlel I, 2009, DRUG CHEM TOXICOL, V32, P258, DOI 10.1080/01480540902882192; Chao CY, 2011, J AGR FOOD CHEM, V59, P5263, DOI 10.1021/jf104003y; Chen CY, 2007, LIFE SCI, V81, P1602, DOI 10.1016/j.lfs.2007.09.028; Chen XF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0091830, 10.1371/journal.pone.0085716, 10.1371/journal.pone.0115462, 10.1371/journal.pone.0103330, 10.1371/journal.pone.0091809, 10.1371/journal.pone.0087752]; Chunye C, 2011, CELL BIOCH BIOPHYS, V61, P337, DOI [10.1007/s12013-011-9216-2, DOI 10.1007/S12013-011-9216-2]; Fang X, 1998, CIRC RES, V82, P1289, DOI 10.1161/01.RES.82.12.1289; Garg AK, 2002, MOL IMMUNOL, V39, P509, DOI 10.1016/S0161-5890(02)00207-9; Guo S, 2012, CIRC RES, V110, P948, DOI 10.1161/CIRCRESAHA.111.263715; Haendeler J, 1999, VITAM HORM, V57, P49; Heizter T, 2000, CIRC RES, V86, P36; Hirase T, 2012, AM J PHYSIOL-HEART C, V302, pH499, DOI 10.1152/ajpheart.00325.2011; Iljin K, 2009, CLIN CANCER RES, V15, P6070, DOI 10.1158/1078-0432.CCR-09-1035; Jia LQ, 2012, J ETHNOPHARMACOL, V143, P100, DOI 10.1016/j.jep.2012.06.007; Jiang Y, 2010, ANAL CHIM ACTA, V657, P9, DOI 10.1016/j.aca.2009.10.024; Kang YH, 2001, MOL CELL BIOCHEM, V216, P37, DOI 10.1023/A:1011040026620; Kuruppu S, 2012, FEBS LETT, V586, P2212, DOI 10.1016/j.febslet.2012.06.020; Li HG, 2000, J PATHOL, V190, P244, DOI 10.1002/(SICI)1096-9896(200002)190:3<244::AID-PATH575>3.0.CO;2-8; Lopez-Alarcon C, 2013, ANAL CHIM ACTA, V763, P1, DOI 10.1016/j.aca.2012.11.051; MARSDEN PA, 1992, AM J PHYSIOL, V262, pC854, DOI 10.1152/ajpcell.1992.262.4.C854; Minuz P, 2006, BRIT J CLIN PHARMACO, V61, P774, DOI 10.1111/j.1365-2125.2006.02681.x; Morales AI, 2006, TOXICOL APPL PHARM, V210, P128, DOI 10.1016/j.taap.2005.09.006; Non AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094474; PHIPPS RP, 1991, IMMUNOL TODAY, V12, P349, DOI 10.1016/0167-5699(91)90064-Z; RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9; Seto Y, 2010, J PHARMACEUT BIOMED, V52, P781, DOI 10.1016/j.jpba.2010.02.029; Shibano M, 2008, J NAT MED-TOKYO, V62, P349, DOI 10.1007/s11418-008-0244-1; Sreelatha S, 2009, FOOD CHEM TOXICOL, V47, P702, DOI 10.1016/j.fct.2008.12.022; Tian Long, 2004, Zhonghua Yi Xue Za Zhi, V84, P954; Tsakadze NL, 2004, AM J PHYSIOL-CELL PH, V287, pC55, DOI 10.1152/ajpcell.00585.2003; Wakabayashi I, 2000, EUR J PHARMACOL, V406, P477, DOI 10.1016/S0014-2999(00)00695-6; Wang X, 2014, ASIAN J PHARM SCI, V9, P17, DOI 10.1016/j.ajps.2013.11.008; Wang XF, 2014, J CHROMATOGR B, V953, P1, DOI 10.1016/j.jchromb.2014.01.042; Wang YK, 2005, PHARMACOL RES, V52, P174, DOI 10.1016/j.phrs.2005.02.023; Weller CL, 2007, P NATL ACAD SCI USA, V104, P11712, DOI 10.1073/pnas.0701700104; Wolfrum S, 2003, ARTERIOSCL THROM VAS, V23, P729, DOI 10.1161/01.ATV.0000063385.12476.A7; Xue X, 2013, J CHROMATOGR A, V1280, P75, DOI 10.1016/j.chroma.2013.01.033; Yan XT, 2014, BIOORG MED CHEM LETT, V24, P1397, DOI 10.1016/j.bmcl.2014.01.028; Yi L, 2011, INT J MOL SCI, V12, P5471, DOI 10.3390/ijms12095471; Zheng ZG, 2013, J PHARMACEUT BIOMED, V77, P44, DOI 10.1016/j.jpba.2013.01.003; Zhou W, 2010, MOLECULES, V15, P6217, DOI 10.3390/molecules15096217; Zhu Z, 2011, PLOS ONE, V6, DOI [10.1371/ journal. pone. 0023554, DOI 10.1371/J0URNAL.P0NE.0023554]	44	13	17	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0116601	10.1371/journal.pone.0116601	http://dx.doi.org/10.1371/journal.pone.0116601			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25699522	Green Published, gold, Green Submitted			2022-12-26	WOS:000349789800012
J	Paradis, AN; Gay, MS; Wilson, CG; Zhang, LB				Paradis, Alexandra N.; Gay, Maresha S.; Wilson, Christopher G.; Zhang, Lubo			Newborn Hypoxia/Anoxia Inhibits Cardiomyocyte Proliferation and Decreases Cardiomyocyte Endowment in the Developing Heart: Role of Endothelin-1	PLOS ONE			English	Article							CELL-CYCLE CONTROL; INDUCIBLE FACTOR-I; FETAL HYPOXIA; MYOCARDIAL-CELLS; PRETERM INFANTS; CARDIAC-MUSCLE; EXPRESSION; GROWTH; RAT; GENE	In the developing heart, cardiomyocytes undergo terminal differentiation during a critical window around birth. Hypoxia is a major stress to preterm infants, yet its effect on the development and maturation of the heart remains unknown. We tested the hypothesis in a rat model that newborn anoxia accelerates cardiomyocyte terminal differentiation and results in reduced cardiomyocyte endowment in the developing heart via an endothelin-1-dependent mechanism. Newborn rats were exposed to anoxia twice daily from postnatal day 1 to 3, and hearts were isolated and studied at postnatal day 4 (P4), 7 (P7), and 14 (P14). Anoxia significantly increased HIF-1 alpha protein expression and pre-proET-1 mRNA abundance in P4 neonatal hearts. Cardiomyocyte proliferation was significantly decreased by anoxia in P4 and P7, resulting in a significant reduction of cardiomyocyte number per heart weight in the P14 neonates. Furthermore, the expression of cyclin D2 was significantly decreased due to anoxia, while p27 expression was increased. Anoxia has no significant effect on cardiomyocyte binucleation or myocyte size. Consistently, prenatal hypoxia significantly decreased cardiomyocyte proliferation but had no effect on binucleation in the fetal heart. Newborn administration of PD156707, an ETA-receptor antagonist, significantly increased cardiomyocyte proliferation at P4 and cell size at P7, resulting in an increase in the heart to body weight ratio in P7 neonates. In addition, PD156707 abrogated the anoxia-mediated effects. The results suggest that hypoxia and anoxia via activation of endothelin-1 at the critical window of heart development inhibits cardiomyocyte proliferation and decreases myocyte endowment in the developing heart, which may negatively impact cardiac function later in life.	[Paradis, Alexandra N.; Gay, Maresha S.; Wilson, Christopher G.; Zhang, Lubo] Loma Linda Univ, Sch Med, Ctr Perinatal Biol, Dept Basic Sci,Div Pharmacol, Loma Linda, CA 92354 USA; [Wilson, Christopher G.] Loma Linda Univ, Sch Med, Div Neonatol, Loma Linda, CA USA	Loma Linda University; Loma Linda University	Zhang, LB (corresponding author), Loma Linda Univ, Sch Med, Ctr Perinatal Biol, Dept Basic Sci,Div Pharmacol, Loma Linda, CA 92354 USA.	lzhang@llu.edu		Zhang, Lubo/0000-0002-9386-8938	National Institutes of Health [HL118861]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118861] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the National Institutes of Health grant HL118861 (to L. Zhang). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapitov AV, 2002, J RENIN-ANGIO-ALDO S, V3, P1, DOI 10.3317/jraas.2002.001; Ahuja P, 2007, PHYSIOL REV, V87, P521, DOI 10.1152/physrev.00032.2006; ANVERSA P, 1975, LAB INVEST, V33, P696; ARAI H, 1990, NATURE, V348, P730, DOI 10.1038/348730a0; Bae S, 2003, AM J PHYSIOL-HEART C, V285, pH983, DOI 10.1152/ajpheart.00005.2003; Banerjee I, 2007, AM J PHYSIOL-HEART C, V293, pH1883, DOI 10.1152/ajpheart.00514.2007; BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171; Baudino TA, 2006, AM J PHYSIOL-HEART C, V291, pH1015, DOI 10.1152/ajpheart.00023.2006; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; BOLIVAR JM, 1995, J PEDIATR-US, V127, P767, DOI 10.1016/S0022-3476(95)70171-0; Botting KJ, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000531; Bubb KJ, 2007, J PHYSIOL-LONDON, V578, P871, DOI 10.1113/jphysiol.2006.121160; BUGAISKY L, 1979, TEX REP BIOL MED, V39, P123; Camelliti P, 2005, CARDIOVASC RES, V65, P40, DOI 10.1016/j.cardiores.2004.08.020; Chlopcikova Sarka, 2001, Biomedical Papers (Olomouc), V145, P49; CLUBB FJ, 1984, LAB INVEST, V50, P571; Coe Y, 2002, J PHARMACOL EXP THER, V302, P672, DOI 10.1124/jpet.302.2.672; Cooper AL, 1999, AM J PHYSIOL-HEART C, V277, pH1326, DOI 10.1152/ajpheart.1999.277.4.H1326; Dimaguila MAVT, 1997, J PEDIATR-US, V130, P577, DOI 10.1016/S0022-3476(97)70242-7; DRANSFIELD DA, 1983, AM J DIS CHILD, V137, P441, DOI 10.1001/archpedi.1983.02140310023005; Gardner LB, 2003, MOL CELL BIOL, V23, P9032, DOI 10.1128/MCB.23.24.9032-9045.2003; Goldie RG, 1999, CLIN EXP PHARMACOL P, V26, P145, DOI 10.1046/j.1440-1681.1999.03014.x; HARVEY PR, 1999, HEART DEV; HASHIGUCHI K, 1991, J CARDIOVASC PHARM, V17, pS509, DOI 10.1097/00005344-199100177-00145; HOSODA K, 1991, FEBS LETT, V287, P23, DOI 10.1016/0014-5793(91)80007-P; Hu J, 1998, BIOCHEM BIOPH RES CO, V245, P894, DOI 10.1006/bbrc.1998.8543; Kakinuma Y, 2001, CIRCULATION, V103, P2387; Kawanabe Y, 2011, CELL MOL LIFE SCI, V68, P195, DOI 10.1007/s00018-010-0518-0; Kedzierski RM, 2001, ANNU REV PHARMACOL, V41, P851, DOI 10.1146/annurev.pharmtox.41.1.851; Kohan DE, 2011, PHYSIOL REV, V91, P1, DOI 10.1152/physrev.00060.2009; KOMURO I, 1988, FEBS LETT, V238, P249, DOI 10.1016/0014-5793(88)80489-7; Li FQ, 1996, J MOL CELL CARDIOL, V28, P1737, DOI 10.1006/jmcc.1996.0163; Li GH, 2003, J SOC GYNECOL INVEST, V10, P265, DOI 10.1016/S1071-5576(03)00074-1; Louey S, 2007, J PHYSIOL-LONDON, V580, P639, DOI 10.1113/jphysiol.2006.122200; MandarimdeLacerda CA, 1995, ACTA ANAT, V154, P261; Martin RJ, 2011, NEONATOLOGY, V100, P303, DOI 10.1159/000329922; Minchenko A, 2000, MOL CELL BIOCHEM, V208, P53, DOI 10.1023/A:1007042729486; Morrison JL, 2007, AM J PHYSIOL-REG I, V293, pR306, DOI 10.1152/ajpregu.00798.2006; NAG AC, 1980, CYTOBIOS, V28, P41; Ostlund E, 2000, ACTA OBSTET GYN SCAN, V79, P276, DOI 10.1034/j.1600-0412.2000.079004276.x; Paradis A, 2014, INT J MED SCI, V11, P373, DOI 10.7150/ijms.7802; Patterson AJ, 2012, CARDIOVASC RES, V93, P302, DOI 10.1093/cvr/cvr322; REYNOLDS EE, 1995, J PHARMACOL EXP THER, V273, P1410; RUBANYI GM, 1994, PHARMACOL REV, V46, P325; Rubart M, 2006, ANNU REV PHYSIOL, V68, P29, DOI 10.1146/annurev.physiol.68.040104.124530; SAKURAI T, 1990, NATURE, V348, P732, DOI 10.1038/348732a0; SMITH HE, 1977, DEV BIOL, V57, P109, DOI 10.1016/0012-1606(77)90358-X; SMOLICH JJ, 1989, AM J PHYSIOL, V257, pH1, DOI 10.1152/ajpheart.1989.257.1.H1; Tong W, 2013, AM J PHYSL REGULATOR; Tong WN, 2011, AM J PHYSIOL-HEART C, V301, pH2113, DOI 10.1152/ajpheart.00356.2011; Walsh S, 2010, CARDIOVASC RES, V86, P365, DOI 10.1093/cvr/cvq005; WILKES BM, 1993, J HISTOCHEM CYTOCHEM, V41, P535, DOI 10.1177/41.4.8450193; Xiao YJ, 2000, J PHARMACOL EXP THER, V292, P8; Xue Q, 2011, CARDIOVASC RES, V89, P300, DOI 10.1093/cvr/cvq303; Yamada J, 2001, J Matern Fetal Med, V10, P409; Yamashita K, 2001, J BIOL CHEM, V276, P12645, DOI 10.1074/jbc.M011344200; YANAGISAWA M, 1994, CIRCULATION, V89, P1320, DOI 10.1161/01.CIR.89.3.1320; ZAK R, 1974, CIRC RES, V35, P17; Zhang FX, 2007, ACTA PHARMACOL SIN, V28, P44, DOI 10.1111/j.1745-7254.2007.00488.x	59	20	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0116600	10.1371/journal.pone.0116600	http://dx.doi.org/10.1371/journal.pone.0116600			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692855	Green Published, gold, Green Submitted			2022-12-26	WOS:000350061500019
J	Simpson, MJ				Simpson, Matthew J.			Exact Solutions of Linear Reaction-Diffusion Processes on a Uniformly Growing Domain: Criteria for Successful Colonization	PLOS ONE			English	Article							NEURAL CREST CELLS; PATTERN-FORMATION; MIGRATION; GROWTH; MODELS; TIME; EMBRYO	Many processes during embryonic development involve transport and reaction of molecules, or transport and proliferation of cells, within growing tissues. Mathematical models of such processes usually take the form of a reaction-diffusion partial differential equation (PDE) on a growing domain. Previous analyses of such models have mainly involved solving the PDEs numerically. Here, we present a framework for calculating the exact solution of a linear reaction-diffusion PDE on a growing domain. We derive an exact solution for a general class of one-dimensional linear reaction-diffusion process on 0<x<L(t), where L(t) is the length of the growing domain. Comparing our exact solutions with numerical approximations confirms the veracity of the method. Furthermore, our examples illustrate a delicate interplay between: (i) the rate at which the domain elongates, (ii) the diffusivity associated with the spreading density profile, (iii) the reaction rate, and (iv) the initial condition. Altering the balance between these four features leads to different outcomes in terms of whether an initial profile, located near x = 0, eventually overcomes the domain growth and colonizes the entire length of the domain by reaching the boundary where x = L(t).	Queensland Univ Technol, Brisbane, Qld 4001, Australia	Queensland University of Technology (QUT)	Simpson, MJ (corresponding author), Queensland Univ Technol, Brisbane, Qld 4001, Australia.	matthew.simpson@qut.edu.au		Simpson, Matthew/0000-0001-6254-313X	Australian Research Council [FT130100148]	Australian Research Council(Australian Research Council)	The author acknowledges the support from the Australian Research Council (FT130100148) (http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, PRINCIPLES DEV; Baker RE, 2010, B MATH BIOL, V72, P719, DOI 10.1007/s11538-009-9467-x; Binder BJ, 2009, J THEOR BIOL, V259, P541, DOI 10.1016/j.jtbi.2009.04.025; Chisholm RH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012857; Crampin EJ, 2002, B MATH BIOL, V64, P747, DOI 10.1006/bulm.2002.0295; Crampin EJ, 1999, B MATH BIOL, V61, P1093, DOI 10.1006/bulm.1999.0131; Crank J., 1975, MATH DIFFUSION; Ellery AJ, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.041135; Farlow S.J., 1982, PARTIAL DIFFERENTIAL; Gershon Michael D, 2004, Semin Pediatr Surg, V13, P224, DOI 10.1053/j.sempedsurg.2004.10.019; Haberman R, 2004, APPL PARTIAL DIFFERE; Hickson RI, 2011, INT J HEAT MASS TRAN, V54, P2642, DOI 10.1016/j.ijheatmasstransfer.2011.01.019; Hywood JD, 2013, ANZIAM J, V55, P93, DOI 10.1017/S1446181113000369; Jazaei F, 2014, J HYDROL, V519, P1642, DOI 10.1016/j.jhydrol.2014.09.018; KONDO S, 1995, NATURE, V376, P765, DOI 10.1038/376765a0; Kulesa PM, 1998, DEV BIOL, V204, P327, DOI 10.1006/dbio.1998.9082; Landman K. A., 2000, J APPL MATH DECIS SC, V4, P125, DOI [10.155/S1173912600000092, DOI 10.1155/S1173912600000092]; Landman KA, 2003, B MATH BIOL, V65, P235, DOI 10.1016/S0092-8240(02)00098-8; Landman KA, 1997, AICHE J, V43, P3147, DOI 10.1002/aic.690431204; LEDOUARI.NM, 1973, J EMBRYOL EXP MORPH, V30, P31; Meinhardt H., 1982, MODELS BIOL PATTERN; Murray, 2002, MATH BIOL I INTRO IN; Newgreen DF, 1996, ACTA ANAT, V157, P105; NEWGREEN DF, 1986, INT REV CYTOL, V103, P89, DOI 10.1016/S0074-7696(08)60834-7; Newgreen DF, 2013, DEV BIOL, V382, P305, DOI 10.1016/j.ydbio.2013.06.029; Painter KJ, 1999, P NATL ACAD SCI USA, V96, P5549, DOI 10.1073/pnas.96.10.5549; Simpson MJ, 2006, J COMPUT APPL MATH, V192, P282, DOI 10.1016/j.cam.2005.05.003; Simpson MJ, 2014, J HYDROL, V513, P7, DOI 10.1016/j.jhydrol.2014.03.035; Simpson MJ, 2013, J HYDROL, V501, P241, DOI 10.1016/j.jhydrol.2013.08.005; Simpson MJ, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0007; Sun YW, 1999, TRANSPORT POROUS MED, V37, P327, DOI 10.1023/A:1006507514019; Swanson KR, 2008, MATH COMPUT MODEL, V47, P638, DOI 10.1016/j.mcm.2007.02.024; Thompson RN, 2012, B MATH BIOL, V74, P2793, DOI 10.1007/s11538-012-9779-0; Witelski TP, 2005, ADV WATER RESOUR, V28, P1133, DOI 10.1016/j.advwatres.2004.06.006; Yates CA, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.021921; Young HM, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-23	36	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117949	10.1371/journal.pone.0117949	http://dx.doi.org/10.1371/journal.pone.0117949			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693183	Green Submitted, gold, Green Published			2022-12-26	WOS:000350061500082
J	Wu, Y; He, JC; Zhou, XT; Chu, RY				Wu, Ying; He, Ji C.; Zhou, Xing T.; Chu, Ren Y.			A Limitation of Hartmann-Shack System in Measuring Wavefront Aberrations for Patients Received Laser Refractive Surgery	PLOS ONE			English	Article							HIGHER-ORDER ABERRATIONS; IN-SITU KERATOMILEUSIS; PUPIL SIZE; SPHERICAL-ABERRATION; CONTACT-LENSES; HUMAN EYE; OFF-EYE; ON-EYE; LASIK; MYOPIA	Purpose To explore the relationship between ablation parameters of myopic laser surgery and measurement area of wavefront aberration (WA) with Hartmann-Shack wavefront sensor. Methods 58 subjects undergone myopic laser surgeries and 74 uncorrected myopic subjects were enrolled in this experiment. The laser ablation parameters were obtained from surgical records, which included spherical error (Rx), depth, and optical zone (OZ) of ablation. The measured area of WA was tested by the WASCA, and the real pupil size was tested by Pentacam. The corneal eccentricity (E value) and curvature was also measured with the Pentacam. All the measurements were performed under mydriatic condition. Results For uncorrected myopic eyes, the measured area of WA was similar with the real pupil size. But for the corrected eyes, the measured area of WA was smaller than the real pupil size with a mean difference of 0.66 +/- 0.54 mm for moderate myopia (t = 6.45, p < 0.0001) and 1.76 +/- 0.55 mm for high myopia (t = 18.92, p < 0.0001), but not for mild myopia. The Rx (t = -3.20, p = 0.0017), OZ (t = 64.4, p < 0.0001) and postoperative corneal E value (t = 2.52, p = 0.017) were the independent factors of measured area of WA. Measured area of WA = -0.81*Rx + 1.13*OZ + 0.49* postoperative corneal E value (r(2) = 0.997). Conclusions The WASCA has a limitation in measuring wavefront aberration over the whole pupil area when it's used for patients received myopic laser surgery. The measured area is smaller than the real pupil size and depends linearly on ablation depth, optical zone and corneal eccentricity.	[Wu, Ying; Zhou, Xing T.; Chu, Ren Y.] Fudan Univ, Eye & ENT Hosp, Shanghai 200433, Peoples R China; [He, Ji C.] New England Coll Optometry, Boston, MA USA	Fudan University	Zhou, XT (corresponding author), Fudan Univ, Eye & ENT Hosp, Shanghai 200433, Peoples R China.	xingtaozhou@163.com	zhou, xt/GWZ-9212-2022		National Natural Science Foundation of China [11074052]; Special Fund for Public Health Service Research of China [201302015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Public Health Service Research of China	YW received funding from the National Natural Science Foundation of China (No. 11074052) (www.nsfc.gov.cn) and the Special Fund for Public Health Service Research of China (No. 201302015) (www.moh.gov.cn) for data collection and analysis and preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon A, 2012, J REFRACT SURG, V28, P901, DOI 10.3928/1081597X-20121106-01; Bellucci R, 2007, CURR OPIN OPHTHALMOL, V18, P67, DOI 10.1097/ICU.0b013e3280121af1; Buzzonetti L, 2004, J CATARACT REFR SURG, V30, P1929, DOI 10.1016/j.jcrs.2004.01.036; Chalita MR, 2004, OPHTHALMOLOGY, V111, P447, DOI 10.1016/j.ophtha.2003.06.022; Charman W N, 2005, Cont Lens Anterior Eye, V28, P75, DOI 10.1016/j.clae.2005.02.003; Choi J, 2007, OPTOMETRY VISION SCI, V84, P42, DOI 10.1097/01.opx.0000254036.45989.65; Dietze HH, 2003, OPTOMETRY VISION SCI, V80, P126, DOI 10.1097/00006324-200302000-00008; Goes FJ, 2005, J REFRACT SURG, V21, P691; Helgesen A, 2004, ACTA OPHTHALMOL SCAN, V82, P454, DOI 10.1111/j.1395-3907.2004.00278.x; Kashani S, 2009, AM J OPHTHALMOL, V147, P417, DOI 10.1016/j.ajo.2008.09.017; Kosaki R, 2009, J REFRACT SURG, V25, P331, DOI 10.3928/1081597X-20090401-06; Kremer I, 2005, J CATARACT REFR SURG, V31, P1366, DOI 10.1016/j.jcrs.2004.12.055; LIANG JZ, 1994, J OPT SOC AM A, V11, P1949, DOI 10.1364/JOSAA.11.001949; Liang JZ, 1997, J OPT SOC AM A, V14, P2873, DOI 10.1364/JOSAA.14.002873; MacRae S, 1999, J CATARACT REFR SURG, V25, P1191, DOI 10.1016/S0886-3350(99)00144-3; Marcos S, 2001, INVEST OPHTH VIS SCI, V42, P3349; Mello GR, 2012, J CATARACT REFR SURG, V38, P1671, DOI 10.1016/j.jcrs.2012.07.004; MUNNERLYN CR, 1988, J CATARACT REFR SURG, V14, P46, DOI 10.1016/S0886-3350(88)80063-4; Schallhorn SC, 2003, OPHTHALMOLOGY, V110, P1606, DOI 10.1016/S0161-6420(03)00494-9; Sharma M, 2007, J REFRACT SURG, V23, P252; Yamaguchi T, 2009, J CATARACT REFR SURG, V35, P57, DOI 10.1016/j.jcrs.2008.09.012	21	4	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117256	10.1371/journal.pone.0117256	http://dx.doi.org/10.1371/journal.pone.0117256			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692489	Green Published, gold, Green Submitted			2022-12-26	WOS:000350061500045
J	Jin, PY; Zhu, JF; Zou, HD; Lu, LN; Zhao, HJ; Li, QQ; He, XG				Jin, Peiyao; Zhu, Jianfeng; Zou, Haidong; Lu, Lina; Zhao, Huijuan; Li, Qiangqiang; He, Xiangui			Screening for Significant Refractive Error Using a Combination of Distance Visual Acuity and Near Visual Acuity	PLOS ONE			English	Article							CHILDREN; ASTIGMATISM; PREVALENCE; MYOPIA	Purpose To explore the effectiveness of using a series of tests combining near visual acuity (NVA) and distance visual acuity (DVA) for large-scale screenings for significant refractive error (SRE) in primary school children. Method Each participant underwent DVA, NVA and cycloplegic autorefraction measurements. SREs, including high myopia, high hyperopia and high astigmatism were analyzed. Cycloplegic refraction results were considered to be the gold standard for the comparison of different screening measurements. Receiver-operating characteristic (ROC) curves were constructed to compare the area under the curve (AUC) and the Youden index among DVA, NVA and the series combined tests of DVA and NVA. The efficacies (including sensitivity, specificity, positive predictive value, and negative predictive value) of each test were evaluated. Only the right eye data of each participant were analysed for statistical purpose. Result A total of 4416 children aged 6 to 12 years completed the study, among which 486 students had right eye SRE (SRE prevalence rate = 11.01%). There was no difference in the prevalence of high hyperopia and high astigmatism among different age groups. However, the prevalence of high myopia significantly increased with the age (chi(2) = 381.81, p<0.01). High hyperopia was the biggest SRE factor associated with amblyopia p 0.01, OR = 167.40, 95% CI: 75.14 similar to 372.94). The DVA test was better than the NVA test for detecting high myopia (Z = 2.71, p<0.01), but the NVA test was better for detecting high hyperopia (Z = 2.35, p = 0.02) and high astigmatism (Z = 4.45, p<0.01). The series combined DVA and NVA test had the biggest AUC and the highest Youden Index for detecting high hyperopia, myopia, astigmatism, as well as all of the SREs (all p<0.01). Conclusion The series combined DVA and NVA test was more accurate for detecting SREs than either of the two tests alone. This new method could be applied to large-scale SRE screening of children, aged 6 to 12, in areas that are less developed.	[Jin, Peiyao; Zhu, Jianfeng; Zou, Haidong; Lu, Lina; He, Xiangui] Shanghai Eye Dis Prevent & Treatment Ctr, Dept Preventat Ophthalmol, Shanghai, Peoples R China; [Jin, Peiyao; Zou, Haidong] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Ophthalmol, Shanghai 200030, Peoples R China; [Zhao, Huijuan; Li, Qiangqiang] Baoshan Ctr Dis Prevent & Control, Dept Eye Dis Prevent & Control, Shanghai, Peoples R China	Shanghai Jiao Tong University	He, XG (corresponding author), Shanghai Eye Dis Prevent & Treatment Ctr, Dept Preventat Ophthalmol, Shanghai, Peoples R China.	xianhezi@163.com		Zou, Haidong/0000-0002-6831-7560	National Natural Science Foundation of China for Young Staff [81402695]; Three-year Action Program of Shanghai Municipality for Strengthening the Construction of the Public Health System [20112013, 2011-15]; Shanghai Municipal Health Bureau [20114127, 20134263]	National Natural Science Foundation of China for Young Staff; Three-year Action Program of Shanghai Municipality for Strengthening the Construction of the Public Health System; Shanghai Municipal Health Bureau	The research was funded by: 1. National Natural Science Foundation of China for Young Staff (Grant no. 81402695); 2. Three-year Action Program of Shanghai Municipality for Strengthening the Construction of the Public Health System (20112013)(Grant no. 2011-15); 3. Shanghai Municipal Health Bureau (Grant no. 20114127 and 20134263). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamford J, 1998, QUAL HEALTH CARE, V7, P240, DOI 10.1136/qshc.7.4.240; Colburn JD, 2010, J AAPOS, V14, P211, DOI 10.1016/j.jaapos.2010.02.006; Comm Practice Ambulatory Med Secti, 2003, OPHTHALMOLOGY, V110, P860, DOI 10.1016/S0161-6420(03)00414-7; Cotter SA, 2011, OPHTHALMOLOGY, V118, P2251, DOI 10.1016/j.ophtha.2011.06.032; Donahue SP, 2003, J AAPOS, V7, P314, DOI 10.1016/S1091-8531(03)00182-4; Fan DS, 2004, CLIN EXP OPHTHALMOL, V32, P462, DOI 10.1111/j.1442-9071.2004.00863.x; Goertz AD, 2014, ACTA OPHTHALMOL, V92, P497, DOI 10.1111/aos.12308; Hamasaki I, 2007, JPN J OPHTHALMOL, V51, P111, DOI 10.1007/s10384-006-0400-7; He MG, 2007, OPHTHALMOLOGY, V114, P374, DOI 10.1016/j.ophtha.2006.08.020; Huang YQ, 2014, INT J OPHTHALMOL-CHI, V7, P457, DOI 10.3980/j.issn.2222-3959.2014.03.13; KOHLER L, 1978, ACTA PAEDIATR SCAND, V67, P373, DOI 10.1111/j.1651-2227.1978.tb16337.x; Lai YH, 2013, OPHTHALMOLOGY, V120, P271, DOI 10.1016/j.ophtha.2012.08.009; Leone JF, 2010, ARCH OPHTHALMOL-CHIC, V128, P894, DOI 10.1001/archophthalmol.2010.134; LOVASIK JV, 1986, AM J OPTOM PHYS OPT, V63, P787; Ma YY, 2013, OPTOMETRY VISION SCI, V90, P1479, DOI 10.1097/OPX.0000000000000095; O'Donoghue L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034441; Rajavi Zhale, 2012, J Ophthalmic Vis Res, V7, P3; Robaei D, 2006, OPHTHALMOLOGY, V113, P1567, DOI 10.1016/j.ophtha.2006.02.066; Weinstein S, 2005, AM J ROENTGENOL, V184, P14, DOI 10.2214/ajr.184.1.01840014; Wen G, 2013, OPHTHALMOLOGY, V120, P2109, DOI 10.1016/j.ophtha.2013.06.039; Wu JB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0082763, 10.1371/journal.pone.0081986, 10.1371/journal.pone.0081982]; Xiao X, 2014, OPTOMETRY VISION SCI, V91, P390, DOI 10.1097/OPX.0000000000000221; Zhao JL, 2000, AM J OPHTHALMOL, V129, P427, DOI 10.1016/S0002-9394(99)00452-3	23	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117399	10.1371/journal.pone.0117399	http://dx.doi.org/10.1371/journal.pone.0117399			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689600	Green Published, Green Submitted, gold			2022-12-26	WOS:000350322700039
J	Pourbadie, HG; Naderi, N; Mehranfard, N; Janahmadi, M; Khodagholi, F; Motamedi, F				Pourbadie, Hamid Gholami; Naderi, Nima; Mehranfard, Nasrin; Janahmadi, Mahyar; Khodagholi, Fariba; Motamedi, Fereshteh			Preventing Effect of L-Type Calcium Channel Blockade on Electrophysiological Alterations in Dentate Gyrus Granule Cells Induced by Entorhinal Amyloid Pathology	PLOS ONE			English	Article							HIPPOCAMPAL PYRAMIDAL NEURONS; DETERMINING INPUT RESISTANCE; RAT CEREBELLAR GRANULE; ALZHEIMERS-DISEASE; SYNAPTIC INPUTS; CORTEX LESIONS; BETA PEPTIDES; MEMORY; EXCITABILITY; CA1	The entorhinal cortex (EC) is one of the earliest affected brain regions in Alzheimer's disease (AD). EC-amyloid pathology induces synaptic failure in the dentate gyrus (DG) with resultant behavioral impairment, but there is little known about its impact on neuronal properties in the DG. It is believed that calcium dyshomeostasis plays a pivotal role in the etiology of AD. Here, the effect of the EC amyloid pathogenesis on cellular properties of DG granule cells and also possible neuroprotective role of L-type calcium channel blockers (CCBs), nimodipine and isradipine, were investigated. The amyloid beta (A beta) 1-42 was injected bilaterally into the EC of male rats and one week later, electrophysiological properties of DG granule cells were assessed. Voltage clamp recording revealed appearance of giant sIPSC in combination with a decrease in sEPSC frequency which was partially reversed by CCBs in granule cells from A beta treated rats. EC amyloid pathogenesis induced a significant reduction of input resistance (R-in) accompanied by a profound decreased excitability in the DG granule cells. However, daily administration of CCBs, isradipine or nimodipine (i.c.v. for 6 days), almost preserved the normal excitability against A beta. In conclusion, lower tendency to fire AP along with reduced Rin suggest that DG granule cells might undergo an alteration in the membrane ion channel activities which finally lead to the behavioral deficits observed in animal models and patients with early-stage Alzheimer's disease.	[Pourbadie, Hamid Gholami] Pasteur Inst Iran, Dept Physiol & Pharmacol, Tehran, Iran; [Pourbadie, Hamid Gholami; Naderi, Nima; Mehranfard, Nasrin; Motamedi, Fereshteh] Shahid Beheshti Univ Med Sci, Neurosci Res Ctr, Tehran, Iran; [Pourbadie, Hamid Gholami; Mehranfard, Nasrin] Shahid Beheshti Univ Med Sci, Dept Physiol, Fac Med, Tehran, Iran; [Naderi, Nima] Shahid Beheshti Univ Med Sci, Sch Pharm, Dept Pharmacol & Toxicol, Tehran, Iran; [Janahmadi, Mahyar] Shahid Beheshti Univ Med Sci, Neurophysiol Res Ctr, Fac Med, Tehran, Iran; [Khodagholi, Fariba] Shahid Beheshti Univ Med Sci, Neurobiol Res Ctr, Tehran, Iran	Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences	Motamedi, F (corresponding author), Shahid Beheshti Univ Med Sci, Neurosci Res Ctr, Tehran, Iran.	motamedi@ams.ac.ir	Janahmadi, Mahyar/AAU-6425-2021; Naderi, Nima/U-5410-2018; Gholami Pourbadie, Hamid/K-9674-2017; Mehranfard, Nasrin/L-5766-2017; Khodagholi, Fariba/AAZ-4436-2020	Naderi, Nima/0000-0003-4591-8918; Gholami Pourbadie, Hamid/0000-0002-7634-7428; Mehranfard, Nasrin/0000-0002-7298-0189; Khodagholi, Fariba/0000-0002-4911-4530; Motamedi, Fereshteh/0000-0003-4030-8627	Neuroscience Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran	Neuroscience Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran	This work was supported by a grant from Neuroscience Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anekonda TS, 2011, NEUROBIOL DIS, V41, P62, DOI 10.1016/j.nbd.2010.08.020; Antri M, 2009, J NEUROSCI, V29, P1140, DOI 10.1523/JNEUROSCI.3073-08.2009; Bezprozvanny I, 2008, TRENDS NEUROSCI, V31, P454, DOI 10.1016/j.tins.2008.06.005; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Bott JB, 2013, NEUROBIOL AGING, V34, P2683, DOI 10.1016/j.neurobiolaging.2013.04.018; BRAAK E, 1991, CELL TISSUE RES, V264, P33, DOI 10.1007/BF00305720; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P35; Brown JT, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.05.025; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Cameron WE, 2000, J NEUROPHYSIOL, V84, P2330, DOI 10.1152/jn.2000.84.5.2330; Cano-Abad MF, 2001, J BIOL CHEM, V276, P39695, DOI 10.1074/jbc.M102334200; Chan SL, 2000, J BIOL CHEM, V275, P18195, DOI 10.1074/jbc.M000040200; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; DEYO RA, 1989, SCIENCE, V243, P809, DOI 10.1126/science.2916127; Eichenbaum H, 2008, HIPPOCAMPUS, V18, P1314, DOI 10.1002/hipo.20500; Finkbeiner S, 1997, BIOESSAYS, V19, P657, DOI 10.1002/bies.950190803; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Funk GD, 2000, CLIN EXP PHARMACOL P, V27, P120, DOI 10.1046/j.1440-1681.2000.03202.x; Gholamipour-Badie H, 2013, BEHAV BRAIN RES, V237, P190, DOI 10.1016/j.bbr.2012.09.045; Glenner GG, 2012, BIOCHEM BIOPH RES CO, V425, P534, DOI 10.1016/j.bbrc.2012.08.020; GomezIsla T, 1996, J NEUROSCI, V16, P4491; Green KN, 2009, J CELL MOL MED, V13, P2787, DOI 10.1111/j.1582-4934.2009.00861.x; Green KN, 2001, J NEUROCHEM, V77, P953, DOI 10.1046/j.1471-4159.2001.00338.x; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Haghani M, 2012, CELL PHYSIOL BIOCHEM, V29, P391, DOI 10.1159/000338494; Hardman R, 1997, BRAIN RES, V758, P187, DOI 10.1016/S0006-8993(97)00223-0; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hardy J, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P151; Harris JA, 2010, NEURON, V68, P428, DOI 10.1016/j.neuron.2010.10.020; Yun SH, 2006, NEUROSCI LETT, V403, P162, DOI 10.1016/j.neulet.2006.04.065; Kerrigan TL, 2014, NEUROPHARMACOLOGY, V79, P515, DOI 10.1016/j.neuropharm.2013.09.004; Kim S, 2011, MOL CELLS, V32, P289, DOI 10.1007/s10059-011-0075-x; Kirkby DL, 1998, EUR J NEUROSCI, V10, P823, DOI 10.1046/j.1460-9568.1998.00087.x; Lazarov O, 2002, J NEUROSCI, V22, P9785; Luo CX, 2005, J NEUROCHEM, V94, P1077, DOI 10.1111/j.1471-4159.2005.03262.x; Mattson MP, 2007, AGING CELL, V6, P337, DOI 10.1111/j.1474-9726.2007.00275.x; Mattson MP, 2001, J MOL NEUROSCI, V17, P205, DOI 10.1385/JMN:17:2:205; MOYER JR, 1992, J NEUROPHYSIOL, V68, P2100, DOI 10.1152/jn.1992.68.6.2100; Mudher AK, 2001, NEUROSCI LETT, V301, P5, DOI 10.1016/S0304-3940(01)01593-2; NAGAHARA AH, 1995, BEHAV NEUROSCI, V109, P3, DOI 10.1037/0735-7044.109.1.3; Nunez-Abades PA, 2000, J NEUROPHYSIOL, V84, P2317, DOI 10.1152/jn.2000.84.5.2317; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Paxinos G, 2005, RAT BRAIN STREOTAXIC; Plant LD, 2006, NEUROBIOL AGING, V27, P1673, DOI 10.1016/j.neurobiolaging.2005.09.038; Price SA, 1998, NEUROREPORT, V9, P539; Ramirez JJ, 2007, NEUROBIOL LEARN MEM, V87, P264, DOI 10.1016/j.nlm.2006.09.002; Ramsden M, 2001, J NEUROCHEM, V79, P699, DOI 10.1046/j.1471-4159.2001.00618.x; Randall AD, 2010, NEUROPHARMACOLOGY, V59, P243, DOI 10.1016/j.neuropharm.2010.02.011; Remondes M, 2004, NATURE, V431, P699, DOI 10.1038/nature02965; Rocher AB, 2008, NEUROBIOL DIS, V32, P309, DOI 10.1016/j.nbd.2008.07.014; Rovira C, 2002, BIOCHEM BIOPH RES CO, V296, P1317, DOI 10.1016/S0006-291X(02)02072-7; Schulz DJ, 2006, J NEUROSCI, V26, P10362, DOI 10.1523/JNEUROSCI.3194-06.2006; Sipos E, 2007, NEUROSCIENCE, V147, P28, DOI 10.1016/j.neuroscience.2007.04.011; Small DH, 2009, NEUROCHEM RES, V34, P1824, DOI 10.1007/s11064-009-9960-5; Spencer JP, 2006, NEUROSCIENCE, V137, P795, DOI 10.1016/j.neuroscience.2005.10.007; Spowart-Manning L, 2005, BEHAV BRAIN RES, V156, P269, DOI 10.1016/j.bbr.2004.05.031; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Steffenach HA, 2005, NEURON, V45, P301, DOI 10.1016/j.neuron.2004.12.044; Supnet C, 2010, CELL CALCIUM, V47, P183, DOI 10.1016/j.ceca.2009.12.014; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Texido L, 2011, CELL CALCIUM, V49, P184, DOI 10.1016/j.ceca.2011.02.001; THOMPSON LT, 1990, BRAIN RES, V535, P119, DOI 10.1016/0006-8993(90)91830-A; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Ueda K, 1997, J NEUROCHEM, V68, P265; van Groen T, 2003, HIPPOCAMPUS, V13, P133, DOI 10.1002/hipo.10037; van Strien NM, 2009, NAT REV NEUROSCI, V10, P272, DOI 10.1038/nrn2614; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Wang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008366; White F, 2001, NEUROBIOL DIS, V8, P611, DOI 10.1006/nbdi.2001.0401; Wykes R, 2012, NEUROBIOL AGING, V33, P1609, DOI 10.1016/j.neurobiolaging.2011.05.001; Young CC, 2009, J PHYSIOL-LONDON, V587, P4213, DOI 10.1113/jphysiol.2009.170746	72	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117555	10.1371/journal.pone.0117555	http://dx.doi.org/10.1371/journal.pone.0117555			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689857	Green Submitted, Green Published, gold			2022-12-26	WOS:000350322700055
J	Prandi, F; Piola, M; Soncini, M; Colussi, C; D'Alessandra, Y; Penza, E; Agrifoglio, M; Vinci, MC; Polvani, G; Gaetano, C; Fiore, GB; Pesce, M				Prandi, Francesca; Piola, Marco; Soncini, Monica; Colussi, Claudia; D'Alessandra, Yuri; Penza, Eleonora; Agrifoglio, Marco; Vinci, Maria Cristina; Polvani, Gianluca; Gaetano, Carlo; Fiore, Gianfranco Beniamino; Pesce, Maurizio			Adventitial Vessel Growth and Progenitor Cells Activation in an Ex Vivo Culture System Mimicking Human Saphenous Vein Wall Strain after Coronary Artery Bypass Grafting	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; TO-MESENCHYMAL TRANSITION; STEM-CELLS; CYCLIC STRETCH; DIFFERENTIATION; NEOINTIMA; PROLIFERATION; FAILURE; ATHEROSCLEROSIS; CONTRIBUTES	Saphenous vein graft disease is a timely problem in coronary artery bypass grafting. Indeed, after exposure of the vein to arterial blood flow, a progressive modification in the wall begins, due to proliferation of smooth muscle cells in the intima. As a consequence, the graft progressively occludes and this leads to recurrent ischemia. In the present study we employed a novel ex vivo culture system to assess the biological effects of arterial-like pressure on the human saphenous vein structure and physiology, and to compare the results to those achieved in the presence of a constant low pressure and flow mimicking the physiologic vein perfusion. While under both conditions we found an activation of Matrix Metallo-Proteases 2/9 and of microRNAs-21/146a/221, a specific effect of the arterial-like pressure was observed. This consisted in a marked geometrical remodeling, in the suppression of Tissue Inhibitor of Metallo-Protease-1, in the enhanced expression of TGF-beta(1) and BMP-2 mRNAs and, finally, in the upregulation of microRNAs-138/200b/200c. In addition, the veins exposed to arterial-like pressure showed an increase in the density of the adventitial vasa vasorum and of cells co-expressing NG2, CD44 and SM22 alpha markers in the adventitia. Cells with nuclear expression of Sox-10, a transcription factor characterizing multipotent vascular stem cells, were finally found in adventitial vessels. Our findings suggest, for the first time, a role of arterial-like wall strain in the activation of pro-pathologic pathways resulting in adventitial vessels growth, activation of vasa vasorumcells, and upregulation of specific gene products associated to vascular remodeling and inflammation.	[Prandi, Francesca; Vinci, Maria Cristina; Pesce, Maurizio] IRCCS, Ctr Cardiol Monzino, Unita Ingn Tissutale, Milan, Italy; [Piola, Marco; Soncini, Monica; Fiore, Gianfranco Beniamino] Politecn Milan, Dipartimento Elettron Informaz & Bioingn, I-20133 Milan, Italy; [Colussi, Claudia] Univ Cattolica Sacro Cuore, Ist Patol Med, Rome, Italy; [D'Alessandra, Yuri] IRCCS, Ctr Cardiol Monzino, Unita Immunol & Genom Funz, Milan, Italy; [Penza, Eleonora] IRCCS, Ctr Cardiol Monzino, Div Cardiochirurg 2, Milan, Italy; [Agrifoglio, Marco; Polvani, Gianluca] Univ Milan, Dipartimento Sci Clin & Comunita, Milan, Italy; [Gaetano, Carlo] Goethe Univ Frankfurt, Div Cardiovasc Epigenet, D-60054 Frankfurt, Germany	IRCCS Centro Cardiologico Monzino; Polytechnic University of Milan; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; IRCCS Centro Cardiologico Monzino; IRCCS Centro Cardiologico Monzino; University of Milan; Goethe University Frankfurt	Pesce, M (corresponding author), IRCCS, Ctr Cardiol Monzino, Unita Ingn Tissutale, Milan, Italy.	maurizio.pesce@ccfm.it	POLVANI, GIANLUCA/I-4656-2018; Vinci, Maria Cristina/E-7401-2016; Agrifoglio, Marco/I-4555-2018; Gaetano, Carlo/P-9997-2019; Colussi, Claudia/H-8609-2019; D'Alessandra, Yuri/K-4098-2016; Pesce, Maurizio/AAA-4207-2019; Pesce, Maurizio/B-4260-2010; Piola, Marco/N-9298-2017; Soncini, Monica/E-9609-2018	POLVANI, GIANLUCA/0000-0003-1055-0965; Vinci, Maria Cristina/0000-0001-6323-147X; Agrifoglio, Marco/0000-0003-4453-295X; Gaetano, Carlo/0000-0002-5238-1832; D'Alessandra, Yuri/0000-0002-3440-2353; Pesce, Maurizio/0000-0002-3097-8961; Pesce, Maurizio/0000-0002-3097-8961; Colussi, Claudia/0000-0002-7727-8911; Piola, Marco/0000-0002-4501-2385; Soncini, Monica/0000-0001-8607-7196	Institutional Research Grant (Ricerca Corrente, Maurizio Pesce) at Centro Cardiologico Monzino-IRCCS	Institutional Research Grant (Ricerca Corrente, Maurizio Pesce) at Centro Cardiologico Monzino-IRCCS	The present research was granted by an Institutional Research Grant (Ricerca Corrente, Maurizio Pesce) at Centro Cardiologico Monzino-IRCCS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balderman JAF, 2012, JOURNAL OF THE AMERI, V1, DOI [10.1161/JAHA.112.006213, DOI 10.1161/JAHA.112.006213]; BATELLIER J, 1993, ARTERIOSCLER THROMB, V13, P379, DOI 10.1161/01.ATV.13.3.379; Berard X, 2013, J VASC SURG, V57, P1371, DOI 10.1016/j.jvs.2012.09.041; Birukov KG, 2009, ANTIOXID REDOX SIGN, V11, P1651, DOI 10.1089/ARS.2008.2390; Campagnolo P, 2010, CIRCULATION, V121, P1735, DOI 10.1161/CIRCULATIONAHA.109.899252; Chen YK, 2013, ARTERIOSCL THROM VAS, V33, P1844, DOI 10.1161/ATVBAHA.113.300902; Cooley BC, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3006927; Corselli M, 2012, STEM CELLS DEV, V21, P1299, DOI 10.1089/scd.2011.0200; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; D'Alessandra Y, 2010, EUR HEART J, V31, P2765, DOI 10.1093/eurheartj/ehq167; Dangwal S, 2014, ANNUAL REVIEW OF PHA, V54, DOI [10.1146/annurev-pharmtox-011112-140338, DOI 10.1146/ANNUREV-PHARMTOX-011112-140338]; Daniel JM, 2010, ARTERIOSCL THROM VAS, V30, P1890, DOI 10.1161/ATVBAHA.110.209692; Dashwood MR, 2013, VASC PHARMACOL, V58, P240, DOI 10.1016/j.vph.2012.07.008; Davis-Dusenbery BN, 2011, ARTERIOSCL THROM VAS, V31, P2370, DOI 10.1161/ATVBAHA.111.226670; de Waard V, 2006, AM J PATHOL, V168, P2027, DOI 10.2353/ajpath.2006.050932; Diez M, 2010, CARDIOVASC RES, V88, P502, DOI 10.1093/cvr/cvq236; Fogelstrand P, 2005, CARDIOVASC RES, V67, P326, DOI 10.1016/j.cardiores.2005.03.027; Gasper WJ, 2013, J VASC SURG, V57, P9, DOI 10.1016/j.jvs.2012.06.098; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gregory PA, 2011, MOL BIOL CELL, V22, P1686, DOI 10.1091/mbc.E11-02-0103; Grudzinska MK, 2013, ARTERIOSCL THROM VAS, V33, P1271, DOI 10.1161/ATVBAHA.112.300773; Hoglund VJ, 2010, ARTERIOSCL THROM VAS, V30, P1877, DOI 10.1161/ATVBAHA.110.211433; Hu YH, 2011, ARTERIOSCL THROM VAS, V31, P1523, DOI 10.1161/ATVBAHA.110.221176; Hu YH, 2004, J CLIN INVEST, V113, P1258, DOI 10.1172/JCI200419628; Hu YH, 2002, CIRC RES, V91, pE13, DOI 10.1161/01.RES.0000037090.34760.EE; Klein D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020540; Konstantinov IE, 1997, ANN THORAC SURG, V64, P1522, DOI 10.1016/S0003-4975(97)00928-4; Kudo FA, 2007, ARTERIOSCL THROM VAS, V27, P1562, DOI 10.1161/ATVBAHA.107.143032; Kumarswamy R, 2012, ARTERIOSCL THROM VAS, V32, P361, DOI 10.1161/ATVBAHA.111.234286; Li FH, 2010, ARTERIOSCL THROM VAS, V30, P1787, DOI 10.1161/ATVBAHA.110.208520; Locker C, 2012, CIRCULATION, V126, P1023, DOI 10.1161/CIRCULATIONAHA.111.084624; Magenta A, 2011, CELL DEATH DIFFER, V18, P1628, DOI 10.1038/cdd.2011.42; Majesky MW, 2012, CELLS TISSUES ORGANS, V195, P73, DOI 10.1159/000331413; McDonald RA, 2013, EUR HEART J, V34, P1636, DOI 10.1093/eurheartj/eht105; McDonald RA, 2012, CARDIOVASC RES, V93, P594, DOI 10.1093/cvr/cvr299; McGah PM, 2012, J VASC SURG, V56, P403, DOI 10.1016/j.jvs.2012.01.045; MCGEACHIE J, 1981, ANN SURG, V194, P100, DOI 10.1097/00000658-198107000-00018; Morrow D, 2005, AM J PHYSIOL-CELL PH, V289, pC1188, DOI 10.1152/ajpcell.00198.2005; Newby AC, 2013, CARDIOVASC RES, V97, P193, DOI 10.1093/cvr/cvs351; Owens CD, 2010, J VASC SURG, V51, P736, DOI 10.1016/j.jvs.2009.07.102; Passman JN, 2008, P NATL ACAD SCI USA, V105, P9349, DOI 10.1073/pnas.0711382105; Pesce M, 2003, CIRC RES, V93, pE51, DOI 10.1161/01.RES.0000090624.04507.45; Piola M, 2012, RECENT PAT CARDIOVAS; Piola M, 2013, J TISSUE ENG REGEN M, DOI [10.1002/term.1858, DOI 10.1002/TERM.1858]; Qi YX, 2010, J CELL BIOCHEM, V109, P906, DOI 10.1002/jcb.22465; Reddy MA, 2012, ARTERIOSCL THROM VAS, V32, P721, DOI 10.1161/ATVBAHA.111.241109; Robertson KE, 2012, PHARMACOL THERAPEUT, V136, P23, DOI 10.1016/j.pharmthera.2012.07.002; Sankaran S, 2012, ANN BIOMED ENG, V40, P2228, DOI 10.1007/s10439-012-0579-3; Shukla N, 2012, CURR OPIN PHARMACOL, V12, P114, DOI 10.1016/j.coph.2012.01.001; Stenmark KR, 2013, ANNU REV PHYSIOL, V75, P23, DOI 10.1146/annurev-physiol-030212-183802; Tang ZY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1867; Thomas AC, 2012, CURR OPIN PHARMACOL, V12, P121, DOI 10.1016/j.coph.2012.01.002; Torsney E, 2005, TRENDS CARDIOVAS MED, V15, P64, DOI 10.1016/j.tcm.2005.02.003; Wallitt EJW, 2007, ANN THORAC SURG, V84, P317, DOI 10.1016/j.athoracsur.2007.02.035; Wei YY, 2013, AM J PHYSIOL-HEART C, V304, pH1050, DOI 10.1152/ajpheart.00267.2012; Wong AP, 2008, ATHEROSCLEROSIS, V196, P580, DOI 10.1016/j.atherosclerosis.2007.06.029	56	22	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117409	10.1371/journal.pone.0117409	http://dx.doi.org/10.1371/journal.pone.0117409			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689822	gold, Green Published, Green Submitted			2022-12-26	WOS:000350322700041
J	Gonzalez-Escalona, N; Gavilan, RG; Brown, EW; Martinez-Urtaza, J				Gonzalez-Escalona, Narjol; Gavilan, Ronnie G.; Brown, Eric W.; Martinez-Urtaza, Jaime			Transoceanic Spreading of Pathogenic Strains of Vibrio parahaemolyticus with Distinctive Genetic Signatures in the recA Gene	PLOS ONE			English	Article							GENOME SEQUENCE DATA; O3-K6; EPIDEMIOLOGY; EMERGENCE; OUTBREAKS; CLUSTERS; DIARRHEA; SEROTYPE; OYSTERS; CLONE	Vibrio parahaemolyticus is an important human pathogen whose transmission is associated with the consumption of contaminated seafood. Consistent multilocus sequence typing for V. parahaemolyticus has shown difficulties in the amplification of the recA gene by PCR associated with a lack of amplification or a larger PCR product than expected. In one strain (090-96, Peru, 1996), the produced PCR product was determined to be composed of two recA fragments derived from different Vibrio species. To better understand this phenomenon, we sequenced the whole genome of this strain. The hybrid recA gene was found to be the result of a fragmentation of the original lineage-specific recA gene resulting from a DNA insertion of approximately 30 kb in length. This insert had a G+C content of 38.8%, lower than that of the average G+C content of V. parahaemolyticus (45.2%), and contained 19 ORFs, including a complete recA gene. This new acquired recA gene deviated 24% in sequence from the original recA and was distantly related to recA genes from bacteria of the Vibrionaceae family. The reconstruction of the original recA gene (recA3) identified the precursor as belonging to ST189, a sequence type reported previously only in Asian countries. The identification of this singular genetic feature in strains from Asia reveals new evidence for genetic connectivity between V. parahaemolyticus populations at both sides of the Pacific Ocean that, in addition to the previously described pandemic clone, supports the existence of a recurrent transoceanic spreading of pathogenic V. parahaemolyticus with the corresponding potential risk of pandemic expansion.	[Gonzalez-Escalona, Narjol; Brown, Eric W.] US FDA, Ctr Food & Appl Nutr, College Pk, MD 20740 USA; [Gavilan, Ronnie G.] Inst Nacl Salud, Ctr Nacl Salud Publ, Lima, Peru; [Martinez-Urtaza, Jaime] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	US Food & Drug Administration (FDA); Instituto Nacional de Salud - Peru; University of Bath	Gonzalez-Escalona, N (corresponding author), US FDA, Ctr Food & Appl Nutr, College Pk, MD 20740 USA.	narjol.gonzalez-escalona@fda.hhs.gov	Martinez-Urtaza, Jaime/ABG-5429-2020; Gonzalez-Escalona, Narjol/A-7598-2009; Gonzalez-Escalona, Narjol/H-6161-2019	Martinez-Urtaza, Jaime/0000-0001-6219-0418; Gonzalez-Escalona, Narjol/0000-0003-4568-0022; Gavilan, Ronnie/0000-0003-1437-5607	FDA Foods Program Intramural Funds	FDA Foods Program Intramural Funds	This project was supported by the FDA Foods Program Intramural Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Chao GX, 2011, INT J FOOD MICROBIOL, V145, P459, DOI 10.1016/j.ijfoodmicro.2011.01.022; Chowdhury NR, 2000, EMERG INFECT DIS, V6, P631, DOI 10.3201/eid0606.000612; DePaola A, 2000, APPL ENVIRON MICROB, V66, P4649, DOI 10.1128/AEM.66.11.4649-4654.2000; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Gavilan RG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002210; Gil AI, 2007, INT J INFECT DIS, V11, P324, DOI 10.1016/j.ijid.2006.08.003; Gonzalez-Escalona N, 2005, EMERG INFECT DIS, V11, P129, DOI 10.3201/eid1101.040762; Gonzalez-Escalona N, 2008, J BACTERIOL, V190, P2831, DOI 10.1128/JB.01808-07; Haendiges J, 2014, EMERG INFECT DIS, V20, P718, DOI 10.3201/eid2004.130818; Harth E, 2009, EMERG INFECT DIS, V15, P163, DOI 10.3201/eid1502.071269; Johnson CN, 2009, MICROB ECOL, V57, P437, DOI 10.1007/s00248-008-9418-3; Jolley KA, 2013, EUROSURVEILLANCE, V18, P41; Jolley KA, 2012, J CLIN MICROBIOL, V50, P3046, DOI 10.1128/JCM.01312-12; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Klimke W, 2009, NUCLEIC ACIDS RES, V37, pD216, DOI 10.1093/nar/gkn734; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Li YH, 2014, EMERG INFECT DIS, V20, P685, DOI 10.3201/eid2004.130744; Makino K, 2003, LANCET, V361, P743, DOI 10.1016/S0140-6736(03)12659-1; Martinez-Urtaza J, 2005, EMERG INFECT DIS, V11, P1319, DOI 10.3201/eid1108.050322; Martinez-Urtaza J, 2008, EPIDEMIOLOGY, V19, P829, DOI 10.1097/EDE.0b013e3181883d43; Martinez-Urtaza J, 2013, NEW ENGL J MED, V369, P1573, DOI 10.1056/NEJMc1305535; Matsumoto C, 2000, J CLIN MICROBIOL, V38, P578, DOI 10.1128/JCM.38.2.578-585.2000; Nair GB, 2007, CLIN MICROBIOL REV, V20, P39, DOI 10.1128/CMR.00025-06; Rapa RA, 2015, ENVIRON MICROBIOL, V17, P1090, DOI 10.1111/1462-2920.12512; RZHETSKY A, 1992, J MOL EVOL, V35, P367, DOI 10.1007/BF00161174; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Stine OC, 2000, INFECT IMMUN, V68, P7180, DOI 10.1128/IAI.68.12.7180-7185.2000; Sullivan MJ, 2011, BIOINFORMATICS, V27, P1009, DOI 10.1093/bioinformatics/btr039; Thompson CC, 2004, INT J SYST EVOL MICR, V54, P919, DOI 10.1099/ijs.0.02963-0; Turner JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055726; Yan YF, 2011, INT J FOOD MICROBIOL, V145, P106, DOI 10.1016/j.ijfoodmicro.2010.11.038	34	25	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117485	10.1371/journal.pone.0117485	http://dx.doi.org/10.1371/journal.pone.0117485			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679989	gold, Green Published, Green Submitted			2022-12-26	WOS:000350682600067
J	Massoudi, R; Van Wanrooij, MM; Versnel, H; Van Opstal, AJ				Massoudi, Roohollah; Van Wanrooij, Marc M.; Versnel, Huib; Van Opstal, A. John			Spectrotemporal Response Properties of Core Auditory Cortex Neurons in Awake Monkey	PLOS ONE			English	Article							RECEPTIVE-FIELDS; INFERIOR COLLICULUS; SOUND FEATURES; MODULATIONS; REPRESENTATION; FREQUENCY; SUBDIVISIONS; SELECTIVITY; LINEARITY; DYNAMICS	So far, most studies of core auditory cortex (AC) have characterized the spectral and temporal tuning properties of cells in non-awake, anesthetized preparations. As experiments in awake animals are scarce, we here used dynamic spectral-temporal broadband ripples to study the properties of the spectrotemporal receptive fields (STRFs) of AC cells in awake monkeys. We show that AC neurons were typically most sensitive to low ripple densities (spectral) and low velocities (temporal), and that most cells were not selective for a particular spectrotemporal sweep direction. A substantial proportion of neurons preferred amplitude-modulated sounds (at zero ripple density) to dynamic ripples (at non-zero densities). The vast majority (>93%) of modulation transfer functions were separable with respect to spectral and temporal modulations, indicating that time and spectrum are independently processed in AC neurons. We also analyzed the linear predictability of AC responses to natural vocalizations on the basis of the STRF. We discuss our findings in the light of results obtained from the monkey midbrain inferior colliculus by comparing the spectrotemporal tuning properties and linear predictability of these two important auditory stages.	[Massoudi, Roohollah; Van Wanrooij, Marc M.; Van Opstal, A. John] Radboud Univ Nijmegen, Dept Biophys, Donders Inst Brain Cognit & Behav, NL-6525 AJ Nijmegen, Netherlands; [Van Wanrooij, Marc M.] Radboud Univ Nijmegen, Dept Otorhinolaryngol, Donders Inst Brain Cognit & Behav, Med Ctr, NL-6525 AJ Nijmegen, Netherlands; [Versnel, Huib] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Otorhinolaryngol Head & Neck Surg, NL-3508 GA Utrecht, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center	Van Opstal, AJ (corresponding author), Radboud Univ Nijmegen, Dept Biophys, Donders Inst Brain Cognit & Behav, Heyendaalseweg 135, NL-6525 AJ Nijmegen, Netherlands.	J.vanOpstal@donders.ru.nl	van Opstal, John/D-1907-2010; van Wanrooij, Marc/J-3385-2012	van Wanrooij, Marc/0000-0003-4180-1835; van Opstal, John/0000-0001-5957-5712; Massoudi, Roohollah/0000-0002-9011-783X	VICI and Open Competition grant of the Earth and Life Sciences of NWO [ALW 865.05.003, 821.02.009]; Radboud University Nijmegen	VICI and Open Competition grant of the Earth and Life Sciences of NWO; Radboud University Nijmegen	This research was supported by a VICI and Open Competition grant of the Earth and Life Sciences of NWO (ALW 865.05.003 and 821.02.009; AJVO; RM), and the Radboud University Nijmegen (AJVO, RM, MVW, HV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AERTSEN AMHJ, 1981, BIOL CYBERN, V42, P133, DOI 10.1007/BF00336731; Ahmed B, 2006, J PHYSIOL-LONDON, V572, P763, DOI 10.1113/jphysiol.2005.104380; ALLON N, 1985, BRAIN RES, V360, P75, DOI 10.1016/0006-8993(85)91222-3; Andoni S, 2007, J NEUROSCI, V27, P4882, DOI 10.1523/JNEUROSCI.4342-06.2007; Atencio CA, 2008, J NEUROSCI, V28, P3897, DOI 10.1523/JNEUROSCI.5366-07.2008; Atencio CA, 2012, J NEUROPHYSIOL, V107, P2594, DOI 10.1152/jn.01025.2011; Atencio CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031537; Bendor D, 2012, J NEUROSCI, V32, P16149, DOI 10.1523/JNEUROSCI.2563-12.2012; Bendor D, 2010, J NEUROPHYSIOL, V103, P1809, DOI 10.1152/jn.00281.2009; Blake DT, 2002, J NEUROPHYSIOL, V88, P3409, DOI 10.1152/jn.00233.2002; Britvina T, 2008, NEUROSCIENCE, V154, P1576, DOI 10.1016/j.neuroscience.2008.04.035; Brosch M, 2005, J NEUROSCI, V25, P6797, DOI 10.1523/JNEUROSCI.1571-05.2005; Brosch M, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00005; Burkard RF, 2007, AUDITORY EVOKED POTE, P200; Chi TS, 1999, J ACOUST SOC AM, V106, P2719, DOI 10.1121/1.428100; David SV, 2009, J NEUROSCI, V29, P3374, DOI 10.1523/JNEUROSCI.5249-08.2009; deCharms RC, 1998, SCIENCE, V280, P1439, DOI 10.1126/science.280.5368.1439; Depireux DA, 2001, J NEUROPHYSIOL, V85, P1220, DOI 10.1152/jn.2001.85.3.1220; Eggermont JJ, 2011, HEARING RES, V271, P123, DOI 10.1016/j.heares.2010.01.014; Escabi MA, 2002, J NEUROSCI, V22, P4114, DOI 10.1523/JNEUROSCI.22-10-04114.2002; Felsheim C, 1996, HEARING RES, V98, P137, DOI 10.1016/0378-5955(96)00078-0; Garcia-Lazaro JA, 2006, CURR BIOL, V16, P264, DOI 10.1016/j.cub.2005.12.013; Gourevitch B, 2009, CEREB CORTEX, V19, P1448, DOI 10.1093/cercor/bhn184; Jenison RL, 2001, J NEUROSCI, V21, P4408, DOI 10.1523/JNEUROSCI.21-12-04408.2001; Kaas JH, 2000, P NATL ACAD SCI USA, V97, P11793, DOI 10.1073/pnas.97.22.11793; Klein DJ, 2006, J COMPUT NEUROSCI, V20, P111, DOI 10.1007/s10827-005-3589-4; KOWALSKI N, 1995, J NEUROPHYSIOL, V73, P1513, DOI 10.1152/jn.1995.73.4.1513; Kowalski N, 1996, J NEUROPHYSIOL, V76, P3524, DOI 10.1152/jn.1996.76.5.3524; Kowalski N, 1996, J NEUROPHYSIOL, V76, P3503, DOI 10.1152/jn.1996.76.5.3503; Langers DRM, 2003, NEUROIMAGE, V20, P265, DOI 10.1016/S1053-8119(03)00258-1; Linden JF, 2003, J NEUROPHYSIOL, V90, P2660, DOI 10.1152/jn.00751.2002; Machens CK, 2004, J NEUROSCI, V24, P1089, DOI 10.1523/JNEUROSCI.4445-03.2004; Malone BJ, 2007, J NEUROPHYSIOL, V98, P1451, DOI 10.1152/jn.01203.2006; Massoudi R, 2014, EUR J NEUROSCI, V39, P1538, DOI 10.1111/ejn.12532; Massoudi R, 2013, EUR J NEUROSCI, V37, P1830, DOI 10.1111/ejn.12180; MENDELSON JR, 1985, BRAIN RES, V327, P331, DOI 10.1016/0006-8993(85)91530-6; Miller CT, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00128; Miller LM, 2002, J NEUROPHYSIOL, V87, P516, DOI 10.1152/jn.00395.2001; Nagel KI, 2008, NEURON, V58, P938, DOI 10.1016/j.neuron.2008.04.028; Niwa M, 2012, J NEUROSCI, V32, P3193, DOI 10.1523/JNEUROSCI.0767-11.2012; Paxinos G., 2000, RHESUS MONKEY BRAIN; Populin LC, 2005, J NEUROSCI, V25, P5903, DOI 10.1523/JNEUROSCI.1147-05.2005; Recanzone GH, 2000, J NEUROPHYSIOL, V83, P2315, DOI 10.1152/jn.2000.83.4.2315; Recanzone GH, 2011, HEARING RES, V271, P115, DOI 10.1016/j.heares.2010.03.084; Recanzone GH, 2008, J NEUROSCI, V28, P13184, DOI 10.1523/JNEUROSCI.3619-08.2008; RYAN A, 1977, J NEUROPHYSIOL, V40, P943, DOI 10.1152/jn.1977.40.4.943; Sadagopan S, 2009, J NEUROSCI, V29, P11192, DOI 10.1523/JNEUROSCI.1286-09.2009; Sahani M, 2003, ADV NEURAL INFORM PR, P125; Schnupp JWH, 2001, NATURE, V414, P200, DOI 10.1038/35102568; Shamma SA, 1995, AUD NEUROSCI; Simon JZ, 2007, NEURAL COMPUT, V19, P583, DOI 10.1162/neco.2007.19.3.583; Theunissen FE, 2000, J NEUROSCI, V20, P2315; Tian BA, 2013, P NATL ACAD SCI USA, V110, P7892, DOI 10.1073/pnas.1221062110; Versnel H, 1998, J ACOUST SOC AM, V103, P2502, DOI 10.1121/1.422771; Versnel H., 1995, AUDIT NEUROSCI, V1, P271; Versnel H, 2009, J NEUROSCI, V29, P9725, DOI 10.1523/JNEUROSCI.5459-08.2009; Walker KMM, 2011, J NEUROSCI, V31, P14565, DOI 10.1523/JNEUROSCI.2074-11.2011; Wang XQ, 2005, NATURE, V435, P341, DOI 10.1038/nature03565; Werner-Reiss U, 2003, CURR BIOL, V13, P554, DOI 10.1016/S0960-9822(03)00168-4; Woolley SMN, 2005, NAT NEUROSCI, V8, P1371, DOI 10.1038/nn1536; YESHURUN Y, 1989, B MATH BIOL, V51, P337, DOI 10.1007/BF02460112; Yin PB, 2011, J NEUROPHYSIOL, V105, P582, DOI 10.1152/jn.00621.2010	62	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0116118	10.1371/journal.pone.0116118	http://dx.doi.org/10.1371/journal.pone.0116118			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680187	Green Published, gold, Green Submitted			2022-12-26	WOS:000350682600013
J	Rampazo, EV; Amorim, KNS; Yamamoto, MM; Panatieri, RH; Rodrigues, MM; Boscardin, SB				Rampazo, Eline V.; Amorim, Kelly N. S.; Yamamoto, Marcio M.; Panatieri, Raquel Hoffmann; Rodrigues, Mauricio M.; Boscardin, Silvia B.			Antigen Targeting to Dendritic Cells Allows the Identification of a CD4 T-Cell Epitope within an Immunodominant Trypanosoma cruzi Antigen	PLOS ONE			English	Article							AMASTIGOTE SURFACE PROTEIN-2; SUSCEPTIBLE MOUSE STRAIN; LCRV VIRULENCE PROTEIN; PROTECTIVE IMMUNITY; TRANS-SIALIDASE; IN-VIVO; GENETIC IMMUNIZATION; STEADY-STATE; PLASMID DNA; INFECTION	Targeting antigens to dendritic cells (DCs) by using hybrid monoclonal antibodies (mAbs) directed against DC receptors is known to improve activation and support long-lasting T cell responses. In the present work, we used the mAb alpha DEC205 fused to the Trypanosoma cruzi amastigote surface protein 2 (ASP-2) to identify a region of this protein recognized by specific T cells. The hybrid alpha DEC-ASP2 mAb was successfully generated and preserved its ability to bind the DEC205 receptor. Immunization of BALB/c mice with the recombinant mAb in the presence of polyriboinosinic: polyribocytidylic acid (poly (I:C)) specifically enhanced the number of IFN-gamma producing cells and CD4+ T cell proliferation when compared to mice immunized with a mAb without receptor affinity or with the non-targeted ASP-2 protein. The strong immune response induced in mice immunized with the hybrid alpha DEC-ASP2 mAb allowed us to identify an ASP-2-specific CD4+ T cell epitope recognized by the BALB/c MHCII haplotype. We conclude that targeting parasite antigens to DCs is a useful strategy to enhance T cell mediated immune responses facilitating the identification of new T-cell epitopes.	[Rampazo, Eline V.; Amorim, Kelly N. S.; Yamamoto, Marcio M.; Panatieri, Raquel Hoffmann; Boscardin, Silvia B.] Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Lab Antigen Targeting Dendrit Cells, Sao Paulo, Brazil; [Rodrigues, Mauricio M.] Univ Fed Sao Paulo, CTCMol, Sao Paulo, Brazil; [Rodrigues, Mauricio M.; Boscardin, Silvia B.] Natl Inst Sci & Technol Vaccines, Belo Horizonte, MG, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Boscardin, SB (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Lab Antigen Targeting Dendrit Cells, Sao Paulo, Brazil.	sbboscardin@usp.br	Boscardin, Silvia Beatriz/C-3397-2012	Boscardin, Silvia Beatriz/0000-0002-7845-7110	Brazilian National Research Council (CNPq)/National Institutes of Science and Technology in Vaccines (INCTV) [15203*12]; Sao Paulo State Research Funding Agency (FAPESP) [2007/08648-9]; BNP-Paribas Bank; CNPq; commercial source BNP-Paribas Bank	Brazilian National Research Council (CNPq)/National Institutes of Science and Technology in Vaccines (INCTV)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo State Research Funding Agency (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); BNP-Paribas Bank; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); commercial source BNP-Paribas Bank	This research was supported by the Brazilian National Research Council (CNPq)/National Institutes of Science and Technology in Vaccines (INCTV, 15203*12), Sao Paulo State Research Funding Agency (FAPESP, 2007/08648-9) and BNP-Paribas Bank. E.V. Rampazo, K.N.S. Amorim and R. H. Panatieri received fellowships from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors acknowledge that partial funding for this study was provided by the commercial source BNP-Paribas Bank. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Araujo AFS, 2005, INFECT IMMUN, V73, P6017, DOI 10.1128/IAI.73.9.6017-6025.2005; Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; Boscardin SB, 2003, INFECT IMMUN, V71, P2744, DOI 10.1128/IAI.71.5.2744-2757.2003; Boscardin SB, 2006, J EXP MED, V203, P599, DOI 10.1084/jem.20051639; Charalambous A, 2006, J IMMUNOL, V177, P8410, DOI 10.4049/jimmunol.177.12.8410; Claser C, 2007, MICROBES INFECT, V9, P1011, DOI 10.1016/j.micinf.2007.04.006; Costa F, 1998, VACCINE, V16, P768, DOI 10.1016/S0264-410X(97)00277-6; de Alencar BCG, 2009, INFECT IMMUN, V77, P4383, DOI 10.1128/IAI.01459-08; Do Y, 2008, EUR J IMMUNOL, V38, P20, DOI 10.1002/eji.200737799; Do Y, 2010, EUR J IMMUNOL, V40, P2791, DOI 10.1002/eji.201040511; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Fralish BH, 2003, VACCINE, V21, P3070, DOI 10.1016/S0264-410X(03)00121-X; Fujimura AE, 2001, INFECT IMMUN, V69, P5477, DOI 10.1128/IAI.69.9.5477-5486.2001; Garg N, 2002, INFECT IMMUN, V70, P5547, DOI 10.1128/IAI.70.10.5547-5555.2002; Gurer C, 2008, BLOOD, V112, P1231, DOI 10.1182/blood-2008-03-148072; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Henriques HR, 2013, PLOS NEGLECT TROP D, V7, DOI [10.1371/journal.pntd.0002330, 10.1371/journal.pntd.0002469]; Idoyaga J, 2011, P NATL ACAD SCI USA, V108, P2384, DOI 10.1073/pnas.1019547108; INABA K, 1995, CELL IMMUNOL, V163, P148, DOI 10.1006/cimm.1995.1109; Machado AV, 2006, HUM GENE THER, V17, P898, DOI 10.1089/hum.2006.17.898; Matos I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067453; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Ribeiro SP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011072; Soares H, 2007, J EXP MED, V204, P1095, DOI 10.1084/jem.20070176; Stahl-Hennig C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000373; Steinman RM, 2010, IMMUNOL REV, V234, P5, DOI 10.1111/j.0105-2896.2009.00888.x; Trumpfheller C, 2006, J EXP MED, V203, P607, DOI 10.1084/jem.20052005; Trumpfheller C, 2008, P NATL ACAD SCI USA, V105, P2574, DOI 10.1073/pnas.0711976105; Vasconcelos JR, 2004, HUM GENE THER, V15, P878, DOI 10.1089/hum.2004.15.878; Wang B, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3135; Wizel B, 1998, INFECT IMMUN, V66, P5073, DOI 10.1128/IAI.66.11.5073-5081.1998	31	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117778	10.1371/journal.pone.0117778	http://dx.doi.org/10.1371/journal.pone.0117778			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679777	Green Published, Green Submitted, gold			2022-12-26	WOS:000350682600087
J	Skunca, N; Dessimoz, C				Skunca, Nives; Dessimoz, Christophe			Phylogenetic Profiling: How Much Input Data Is Enough?	PLOS ONE			English	Article							GENE ONTOLOGY; PROTEIN; IDENTIFICATION; PREDICTION	Phylogenetic profiling is a well-established approach for predicting gene function based on patterns of gene presence and absence across species. Much of the recent developments have focused on methodological improvements, but relatively little is known about the effect of input data size on the quality of predictions. In this work, we ask: how many genomes and functional annotations need to be considered for phylogenetic profiling to be effective? Phylogenetic profiling generally benefits from an increased amount of input data. However, by decomposing this improvement in predictive accuracy in terms of the contribution of additional genomes and of additional annotations, we observed diminishing returns in adding more than similar to 100 genomes, whereas increasing the number of annotations remained strongly beneficial throughout. We also observed that maximising phylogenetic diversity within a clade of interest improves predictive accuracy, but the effect is small compared to changes in the number of genomes under comparison. Finally, we show that these findings are supported in light of the Open World Assumption, which posits that functional annotation databases are inherently incomplete. All the tools and data used in this work are available for reuse from http://lab.dessimoz.org/14_phylprof. Scripts used to analyse the data are available on request from the authors.	[Skunca, Nives] ETH, Dept Comp Sci, CH-8092 Zurich, Switzerland; [Skunca, Nives; Dessimoz, Christophe] Swiss Inst Bioinformat, CH-8092 Zurich, Switzerland; [Skunca, Nives; Dessimoz, Christophe] UCL, London WC1E 6BT, England	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Institute of Bioinformatics; University of London; University College London	Skunca, N (corresponding author), ETH, Dept Comp Sci, Univ Str 19, CH-8092 Zurich, Switzerland.	skuncan@inf.ethz.ch; c.dessimoz@ucl.ac.uk	Dessimoz, Christophe/D-3678-2011	Dessimoz, Christophe/0000-0002-2170-853X	Biotechnology and Biological Sciences Research Council [BB/L018241/1]; Department of Computer Science at ETH Zurich; BBSRC [BB/L018241/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Department of Computer Science at ETH Zurich; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work was funded by a Biotechnology and Biological Sciences Research Council grant (BB/L018241/1) to CD and by funds from the Department of Computer Science at ETH Zurich to NS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chang GS, 2008, P NATL ACAD SCI USA, V105, P13474, DOI 10.1073/pnas.0803860105; Chen LF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r17; Cokus S, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S4-S7; Date SV, 2003, NAT BIOTECHNOL, V21, P1055, DOI 10.1038/nbt861; Dessimoz C, 2013, TRENDS GENET, V29, P609, DOI 10.1016/j.tig.2013.09.005; du Plessis L, 2011, BRIEF BIOINFORM, V12, P723, DOI 10.1093/bib/bbr002; Gutierrez RA, 2004, PLANT PHYSIOL, V135, P1888, DOI 10.1104/pp.104.043687; Jothi R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-173; Kensche PR, 2008, J R SOC INTERFACE, V5, P151, DOI 10.1098/rsif.2007.1047; Muley VY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042057; Pagani I, 2012, NUCLEIC ACIDS RES, V40, pD571, DOI 10.1093/nar/gkr1100; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Rodionov DA, 2005, TRENDS GENET, V21, P385, DOI 10.1016/j.tig.2005.05.011; Roth ACJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-518; Ruano-Rubio V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-383; Schietgat L, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-2; Schneider A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003124; Simonsen M, 2012, BIOINFORMATICS, V28, P851, DOI 10.1093/bioinformatics/btr720; Skunca N, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002852; Skunca N, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002533; Snitkin ES, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-420; Sun JC, 2007, BIOCHEM BIOPH RES CO, V353, P985, DOI 10.1016/j.bbrc.2006.12.146; Thomas PD, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002386; Vens C, 2008, MACH LEARN, V73, P185, DOI 10.1007/s10994-008-5077-3; Wu J, 2003, BIOINFORMATICS, V19, P1524, DOI 10.1093/bioinformatics/btg187	28	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0114701	10.1371/journal.pone.0114701	http://dx.doi.org/10.1371/journal.pone.0114701			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679783	Green Published, Green Submitted, gold			2022-12-26	WOS:000350682600003
J	Zhao, J; Wang, J; Du, JF; Xu, HL; Zhang, W; Ni, QX; Yu, H; Risch, HA; Gao, YT; Gao, Y				Zhao, Jing; Wang, Jing; Du, Jinfeng; Xu, Hongli; Zhang, Wei; Ni, Quan-Xing; Yu, Herbert; Risch, Harvey A.; Gao, Yu-Tang; Gao, Ying			Urinary Prostaglandin E-2 Metabolite and Pancreatic Cancer Risk: Case-Control Study in Urban Shanghai	PLOS ONE			English	Article							ANTIINFLAMMATORY DRUG-USE; CYCLOOXYGENASE-2 EXPRESSION; INTRAEPITHELIAL NEOPLASIA; PGE-M; ASSOCIATION; INFLAMMATION; EICOSANOIDS; BIOMARKER; ASPIRIN; GROWTH	Pancreatic cancer has been increasing in importance in Shanghai over the last four decades. The etiology of the disease is still unclear. Evidence suggests that the COX-2 pathway, an important component of inflammation, may be involved in the disease. We aimed to evaluate the association between urinary prostaglandin E-2 metabolite (PGE-M) level and risk of pancreatic cancer. From a recent population-based case-control study in Shanghai, 200 pancreatic ductal adenocarcinoma cases and 200 gender-and age-frequency matched controls were selected for the present analysis. Urinary PGE-M was measured with a liquid chromatography/mass spectrometric assay. Adjusted unconditional logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs). A positive association was observed between PGE-M leve and pancreatic cancer risk: OR = 1.63 (95% CI 1.01-2.63) for the third tertile compared to the first. Though the interactions were not statistically significant, the associations tended to be stronger among subjects with diabetes history (OR = 3.32; 95% CI 1.20-9.19) and higher meat intake (OR = 2.12; 95% CI 1.10-4.06). The result suggests that higher urinary PGE-M level may be associated with increased risk of pancreatic ductal adenocarcinoma.	[Zhao, Jing; Du, Jinfeng; Gao, Ying] Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Nutr & Metab,Inst Nutr Sci, Shanghai, Peoples R China; [Wang, Jing; Xu, Hongli; Zhang, Wei; Gao, Yu-Tang] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Epidemiol,Shanghai Canc Inst, Shanghai 200030, Peoples R China; [Ni, Quan-Xing] Fudan Univ, Shanghai Canc Ctr, Dept Pancreat & Hepatobiliary Surg, Shanghai 200433, Peoples R China; [Yu, Herbert] Univ Hawaii, Ctr Canc, Program Epidemiol, Honolulu, HI 96822 USA; [Risch, Harvey A.] Yale Univ, Sch Publ Hlth, Dept Chron Dis Epidemiol, New Haven, CT USA; [Risch, Harvey A.] Yale Canc Ctr, New Haven, CT USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Shanghai Jiao Tong University; Fudan University; Cancer Research Center of Hawaii; University of Hawaii System; Yale University; Yale University	Gao, YT (corresponding author), Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Epidemiol,Shanghai Canc Inst, Shanghai 200030, Peoples R China.	ytgao@vip.sina.com; yinggao@sibs.ac.cn	Gao, Y./GWZ-3665-2022; gao, yi/HCI-8298-2022; Gao, Yu/HGE-1937-2022	Zhao, Jing/0000-0001-8698-2436	U.S. National Cancer Institute [5R01CA114421]; Science and Technology Commission of Shanghai Municipality [08411954100]; 100 talented plan of Chinese Academy of Sciences; NATIONAL CANCER INSTITUTE [R01CA114421] Funding Source: NIH RePORTER	U.S. National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); 100 talented plan of Chinese Academy of Sciences; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the U.S. National Cancer Institute (5R01CA114421, HAR), the Science and Technology Commission of Shanghai Municipality (08411954100, YTG) and the 100 talented plan of Chinese Academy of Sciences (YG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAM O, 1992, CLIN INVESTIGATOR, V70, P721; Anderson KE, 2002, J NATL CANCER I, V94, P1168, DOI 10.1093/jnci/94.15.1168; Bradley MC, 2010, BRIT J CANCER, V102, P1415, DOI 10.1038/sj.bjc.6605636; Cai QY, 2006, J CLIN ONCOL, V24, P5010, DOI 10.1200/JCO.2006.06.4931; Cui Y, 2014, CANCER EPIDEM BIOMAR, V23, P2866, DOI 10.1158/1055-9965.EPI-14-0685; Ding Xian-Zhong, 2003, Mol Cancer, V2, P10, DOI 10.1186/1476-4598-2-10; Dong LM, 2009, CANCER EPIDEM BIOMAR, V18, P3075, DOI 10.1158/1055-9965.EPI-09-0680; Duell EJ, 2012, ANN ONCOL, V23, P2964, DOI 10.1093/annonc/mds140; Funahashi H, 2007, CANCER RES, V67, P7068, DOI 10.1158/0008-5472.CAN-07-0970; Gao Y-T, 2007, CANC INCIDENCE MORTA, P69, DOI [10.1016/j.fsigen.2007.08.013, DOI 10.1016/J.FSIGEN.2007.08.013]; Gong ZH, 2011, AM J EPIDEMIOL, V174, P1373, DOI 10.1093/aje/kwr267; Gross ND, 2005, CLIN CANCER RES, V11, P6087, DOI 10.1158/1078-0432.CCR-05-0733; Ito H, 2004, CANCER RES, V64, P7439, DOI 10.1158/0008-5472.CAN-04-1177; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Johnson JC, 2006, CLIN GASTROENTEROL H, V4, P1358, DOI 10.1016/j.cgh.2006.07.015; Kelley DS, 1998, LIPIDS, V33, P125, DOI 10.1007/s11745-998-0187-9; Kim S, 2013, CANCER PREV RES, V6, P511, DOI 10.1158/1940-6207.CAPR-13-0040; Larsson SC, 2006, CANCER EPIDEM BIOMAR, V15, P2561, DOI 10.1158/1055-9965.EPI-06-0574; Li D, 1998, LIPIDS, V33, P437, DOI 10.1007/s11745-998-0225-7; Lowenfels AB, 2005, J CELL BIOCHEM, V95, P649, DOI 10.1002/jcb.20461; Maitra A, 2002, AM J CLIN PATHOL, V118, P194, DOI 10.1309/TPG4-CK1C-9V8V-8AWC; Mckay CJ, 2008, BEST PRACT RES CL GA, V22, P65, DOI 10.1016/j.bpg.2007.11.007; Molina MA, 1999, CANCER RES, V59, P4356; Morris PG, 2013, CANCER PREV RES, V6, P428, DOI 10.1158/1940-6207.CAPR-12-0431; Murphey LJ, 2004, ANAL BIOCHEM, V334, P266, DOI 10.1016/j.ab.2004.08.019; Okami J, 1999, CLIN CANCER RES, V5, P2018; Risch HA, 2014, CANCER EPIDEM BIOMAR, V23, P172, DOI 10.1158/1055-9965.EPI-13-0447; Risch HA, 2013, AM J EPIDEMIOL, V177, P1326, DOI 10.1093/aje/kws458; Shrubsole MJ, 2012, CANCER PREV RES, V5, P336, DOI 10.1158/1940-6207.CAPR-11-0426; Tucker ON, 1999, CANCER RES, V59, P987; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Wang D, 2006, GUT, V55, P115, DOI 10.1136/gut.2004.047100; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; Wang J, 2012, CANCER EPIDEMIOL, V36, pE354, DOI 10.1016/j.canep.2012.08.004; Wenger FA, 2002, CLIN EXP METASTAS, V19, P681, DOI 10.1023/A:1021387826867; Wu XY, 2010, CANCER EPIDEM BIOMAR, V19, P947, DOI 10.1158/1055-9965.EPI-10-0046; Zhou H, 2009, CANCER LETT, V273, P292, DOI 10.1016/j.canlet.2008.08.006; 李连弟, 2003, [中华流行病学杂志, Chinese Journal of Epidemiology], V24, P520	38	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0118004	10.1371/journal.pone.0118004	http://dx.doi.org/10.1371/journal.pone.0118004			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679523	Green Submitted, gold, Green Published			2022-12-26	WOS:000350682600100
J	Etoh, K; Fukuda, M				Etoh, Kan; Fukuda, Mitsunori			Structure-Function Analyses of the Small GTPase Rab35 and Its Effector Protein Centaurin-beta 2/ACAP2 during Neurite Outgrowth of PC12 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUCCESSFUL CYTOKINESIS; RECYCLING ENDOSOMES; MEMBRANE IDENTITY; BINDING PROTEINS; ARF6; RECRUITMENT; DOMAIN; FAMILY; ACAP2; GAPS	The small GTPase Rab35 is a molecular switch for membrane trafficking that regulates a variety of cellular events. We previously showed that Rab35 promotes neurite outgrowth of nerve growth factor-stimulated PC12 cells through interaction with centaurin-beta 2 (also called ACAP2). Centaurin-beta 2 is the only Rab35-binding protein reported thus far that exclusively recognizes Rab35 and does not recognize any of the other 59 Rabs identified in mammals, but the molecular basis for the exclusive specificity of centaurin-beta 2 for Rab35 has remained completely unknown. In this study, we performed deletion and mutation analyses and succeeded in identifying the residues of Rab35 and centaurin-beta 2 that are crucial for formation of a Rab35 center dot centaurin-beta 2 complex. We found that two threonine residues (Thr-76 and Thr-81) in the switch II region of Rab35 are responsible for binding centaurin-beta 2 and that the same residues are dispensable for Rab35 recognition by other Rab35-binding proteins. We also determined the minimal Rab35-binding site of centaurin-beta 2 and identified two asparagine residues (Asn-610 and Asn-691) in the Rab35-binding site as key residues for its specific Rab35 recognition. We further showed by knockdown-rescue approaches that neither a centaurin-beta 2 binding-deficient Rab35(T76S/T81A) mutant nor a Rab35 binding-deficient centaurin-beta 2(N610A/N691A) mutant supported neurite outgrowth of PC12 cells, thereby demonstrating the functional significance of the Rab35/centaurin-beta 2 interaction during neurite outgrowth of PC12 cells.	[Etoh, Kan; Fukuda, Mitsunori] Tohoku Univ, Lab Membrane Trafficking Mech, Dept Dev Biol & Neurosci, Grad Sch Life Sci,Aoba Ku, Sendai, Miyagi 9808578, Japan	Tohoku University	Fukuda, M (corresponding author), Tohoku Univ, Lab Membrane Trafficking Mech, Dept Dev Biol & Neurosci, Grad Sch Life Sci,Aoba Ku, Sendai, Miyagi 9808578, Japan.	nori@m.tohoku.ac.jp	Fukuda, MItsunori/I-1511-2015	Fukuda, MItsunori/0000-0002-8620-5853	Ministry of Education, Culture, Sports, and Technology of Japan	Ministry of Education, Culture, Sports, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, and Technology of Japan (to M. F.).	Allaire PD, 2013, J CELL SCI, V126, P722, DOI 10.1242/jcs.112375; Barr F, 2010, CURR OPIN CELL BIOL, V22, P461, DOI 10.1016/j.ceb.2010.04.007; Barr FA, 2013, J CELL BIOL, V202, P191, DOI 10.1083/jcb.201306010; Chesneau L, 2012, CURR BIOL, V22, P147, DOI 10.1016/j.cub.2011.11.058; Chevallier J, 2009, FEBS LETT, V583, P1096, DOI 10.1016/j.febslet.2009.03.012; Dambournet D, 2011, NAT CELL BIOL, V13, P981, DOI 10.1038/ncb2279; Eathiraj S, 2005, NATURE, V436, P415, DOI 10.1038/nature03798; Eathiraj S, 2006, J MOL BIOL, V364, P121, DOI 10.1016/j.jmb.2006.08.064; Egami Y, 2011, J CELL SCI, V124, P3557, DOI 10.1242/jcs.083881; Fukuda M, 2008, CELL MOL LIFE SCI, V65, P2801, DOI 10.1007/s00018-008-8351-4; Fukuda M, 2005, METHOD ENZYMOL, V403, P445, DOI 10.1016/S0076-6879(05)03039-9; Fukuda M, 1999, J BIOL CHEM, V274, P31421, DOI 10.1074/jbc.274.44.31421; FUKUDA M, 1995, J BIOL CHEM, V270, P26523, DOI 10.1074/jbc.270.44.26523; Fukuda M, 2002, J BIOL CHEM, V277, P40118, DOI 10.1074/jbc.M205765200; Fukuda M, 2008, MOL CELL PROTEOMICS, V7, P1031, DOI 10.1074/mcp.M700569-MCP200; Fukuda M, 2011, CELL STRUCT FUNCT, V36, P155, DOI 10.1247/csf.11001; Fukuda M, 2011, BIOSCIENCE REP, V31, P159, DOI 10.1042/BSR20100112; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Hesketh GG, 2014, DEV CELL, V29, P591, DOI 10.1016/j.devcel.2014.04.010; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Inoue H, 2007, TRAFFIC, V8, P1465, DOI 10.1111/j.1600-0854.2007.00624.x; Jackson TR, 2000, J CELL BIOL, V151, P627, DOI 10.1083/jcb.151.3.627; James P, 1996, GENETICS, V144, P1425; Johansson M, 2007, J CELL BIOL, V176, P459, DOI 10.1083/jcb.200606077; Kahn RA, 2008, J CELL BIOL, V182, P1039, DOI 10.1083/jcb.200806041; Kanno E, 2010, TRAFFIC, V11, P491, DOI 10.1111/j.1600-0854.2010.01038.x; Kobayashi H, 2014, BIOL OPEN, V3, P803, DOI 10.1242/bio.20148771; Kobayashi H, 2013, J CELL SCI, V126, P2424, DOI 10.1242/jcs.117846; Kobayashi H, 2012, J CELL SCI, V125, P2235, DOI 10.1242/jcs.098657; Kouranti I, 2006, CURR BIOL, V16, P1719, DOI 10.1016/j.cub.2006.07.020; Kukimoto-Niino M, 2008, STRUCTURE, V16, P1478, DOI 10.1016/j.str.2008.07.014; Matsui T, 2012, J BIOL CHEM, V287, P28619, DOI 10.1074/jbc.M112.370544; Miyamotoa Y, 2014, MOL BIOL CELL, V25, P1532, DOI 10.1091/mbc.E13-10-0600; Patino-Lopez G, 2008, J BIOL CHEM, V283, P18323, DOI 10.1074/jbc.M800056200; Pereira-Leal JB, 2001, J MOL BIOL, V313, P889, DOI 10.1006/jmbi.2001.5072; Pfeffer SR, 2013, CURR OPIN CELL BIOL, V25, P414, DOI 10.1016/j.ceb.2013.04.002; Rahajeng J, 2012, TRAFFIC, V13, P82, DOI 10.1111/j.1600-0854.2011.01294.x; Recacha R, 2009, STRUCTURE, V17, P21, DOI 10.1016/j.str.2008.10.014; Shim J, 2010, MOL CELL BIOL, V30, P1421, DOI 10.1128/MCB.01463-09; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Tamura K, 2009, MOL BIOL CELL, V20, P2900, DOI 10.1091/mbc.E08-12-1161; Zhang J, 2009, SCIENCE, V325, P1250, DOI 10.1126/science.1174921; Zhu YC, 2013, CELL SIGNAL, V25, P1075, DOI 10.1016/j.cellsig.2013.01.015	43	12	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					9064	9074		10.1074/jbc.M114.611301	http://dx.doi.org/10.1074/jbc.M114.611301			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25694427	Green Published, hybrid			2022-12-26	WOS:000352207100030
J	Perry, MM; Durham, AL; Austin, PJ; Adcock, IM; Chung, KF				Perry, Mark M.; Durham, Andrew L.; Austin, Philip J.; Adcock, Ian M.; Chung, Kian Fan			BET Bromodomains Regulate Transforming Growth Factor-beta-induced Proliferation and Cytokine Release in Asthmatic Airway Smooth Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RELATIVE CORTICOSTEROID INSENSITIVITY; ALVEOLAR MACROPHAGES; SELECTIVE-INHIBITION; PAUSE RELEASE; RAPID CHANGES; INFLAMMATION; EXPRESSION; CELLS; PROTEIN; MECHANISMS	Airway smooth muscle (ASM) mass is increased in asthma, and ASM cells from patients with asthma are hyperproliferative and release more IL-6 and CXCL8. The BET (bromo- and extra-terminal) family of proteins (Brd2, Brd3, and Brd4) govern the assembly of histone acetylation-dependent chromatin complexes. We have examined whether they modulate proliferation and cytokine expression in asthmatic ASM cells by studying the effect of BET bromodomain mimics JQ1/SGCBD01 and I-BET762. ASM cells from healthy individuals and nonsevere and severe asthmatics were pretreated with JQ1/SGCBD01 and I-BET762 prior to stimulation with FCS and TGF-beta. Proliferation was measured by BrdU incorporation. IL-6 and CXCL8 release was measured by ELISA, and mRNA expression was measured by quantitative RT-PCR. ChIP using a specific anti-Brd4 antibody and PCR primers directed against the transcriptional start site of IL-6 and CXCL8 gene promoters was performed. Neither JQ1/SGCBD01 nor I-BET762 had any effect on ASM cell viability. JQ1/SGCBD01 and I-BET762 inhibited FCS + TGF-beta-induced ASM cell proliferation and IL-6 and CXCL8 release in healthy individuals (>= 30 nM) and in nonsevere and severe asthma patients (>= 100 nM), with the latter requiring higher concentrations of these mimics. JQ1/SGCBD01 reduced Brd4 binding to IL8 and IL6 promoters induced by FCS + TGF-beta. Mimics of BET bromodomains inhibit aberrant ASM cell proliferation and inflammation with lesser efficiency in those from asthmatic patients. They may be effective in reducing airway remodeling in asthma.	Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Expt Studies, London SW3 6LY, England; Royal Brompton Natl Inst Hlth Res, Biomed Res Unit, London SW3 6LY, England	Imperial College London	Perry, MM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Dovehouse St, London SW3 6LY, England.	m.perry@imperial.ac.uk	Chung, Kian Fan/B-1872-2012; Adcock, Ian/L-3217-2019	Chung, Kian Fan/0000-0001-7101-1426; Durham, Andrew/0000-0003-2372-4688; Adcock, Ian/0000-0003-2101-8843; Austin, Philip/0000-0002-8855-220X; Perry, Mark/0000-0002-8145-8042	Asthma UK [08/041]; Wellcome Trust [085935]; National Institute for Health Research Respiratory Disease Biomedical Research Unit at the Royal Brompton National Health Service Foundation Trust and Imperial College London; Innovative Medicines Initiative; Medical Research Council [G1000758] Funding Source: researchfish; Asthma UK [10/066] Funding Source: researchfish	Asthma UK; Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research Respiratory Disease Biomedical Research Unit at the Royal Brompton National Health Service Foundation Trust and Imperial College London; Innovative Medicines Initiative; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Asthma UK	This work was supported by Asthma UK Grant 08/041 and Wellcome Trust Grant 085935 (to K. F. C.). It was also supported by the National Institute for Health Research Respiratory Disease Biomedical Research Unit at the Royal Brompton National Health Service Foundation Trust and Imperial College London and the Innovative Medicines Initiative.	Adcock IM, 2008, CURR ALLERGY ASTHM R, V8, P171, DOI 10.1007/s11882-008-0028-4; Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Anand P, 2013, CELL, V154, P569, DOI 10.1016/j.cell.2013.07.013; [Anonymous], 2000, AM J RESP CRIT CARE, V162, P2341; Bandukwala HS, 2012, P NATL ACAD SCI USA, V109, P14532, DOI 10.1073/pnas.1212264109; Belkina AC, 2013, J IMMUNOL, V190, P3670, DOI 10.4049/jimmunol.1202838; Benayoun L, 2003, AM J RESP CRIT CARE, V167, P1360, DOI 10.1164/rccm.200209-1030OC; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bhavsar P, 2008, THORAX, V63, P784, DOI 10.1136/thx.2007.090027; Boardman C, 2014, PULM PHARMACOL THER, V29, P129, DOI 10.1016/j.pupt.2014.08.008; Bousquet J, 2000, AM J RESP CRIT CARE, V161, P1720, DOI 10.1164/ajrccm.161.5.9903102; Chang PJ, 2012, J ALLERGY CLIN IMMUN, V130, P877, DOI 10.1016/j.jaci.2012.07.017; Cheng ZX, 2013, CLIN CANCER RES, V19, P1748, DOI 10.1158/1078-0432.CCR-12-3066; Chung KF, 1999, EUR RESPIR J, V13, P1198; Chung Kian Fan, 2007, Expert Rev Respir Med, V1, P209, DOI 10.1586/17476348.1.2.209; Cosio BG, 2004, AM J RESP CRIT CARE, V170, P141, DOI 10.1164/rccm.200305-659OC; Denis GV, 2010, DISCOV MED, V10, P489; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Durham AL, 2011, BBA-GEN SUBJECTS, V1810, P1103, DOI 10.1016/j.bbagen.2011.03.006; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Goupille O, 2012, BIOCHEM BIOPH RES CO, V429, P1, DOI 10.1016/j.bbrc.2012.10.112; Halayko AJ, 2003, RESP PHYSIOL NEUROBI, V137, P209, DOI 10.1016/S1569-9048(03)00148-4; Hassan M, 2010, J ALLERGY CLIN IMMUN, V125, P1037, DOI 10.1016/j.jaci.2010.02.031; Hew M, 2006, AM J RESP CRIT CARE, V174, P134, DOI 10.1164/rccm.200512-1930OC; Hewings DS, 2012, J MED CHEM, V55, P9393, DOI 10.1021/jm300915b; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Johnson PRA, 2001, AM J RESP CRIT CARE, V164, P474, DOI 10.1164/ajrccm.164.3.2010109; Larner-Svensson HM, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-68; Li J, 2011, CURR OPIN GENET DEV, V21, P231, DOI 10.1016/j.gde.2011.01.010; Macedo P, 2009, CLIN EXP ALLERGY, V39, P1668, DOI 10.1111/j.1365-2222.2009.03319.x; Meng S, 2014, J DENT RES, V93, P657, DOI 10.1177/0022034514534261; Michaeloudes C, 2011, AM J RESP CRIT CARE, V184, P894, DOI 10.1164/rccm.201011-1780OC; Michaeloudes C, 2011, AM J PHYSIOL-LUNG C, V300, pL295, DOI 10.1152/ajplung.00134.2010; Moschos SA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-240; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Oliver SS, 2011, CHEMBIOCHEM, V12, P299, DOI 10.1002/cbic.201000474; Patel MC, 2013, MOL CELL BIOL, V33, P2497, DOI 10.1128/MCB.01180-12; Perry MM, 2008, J IMMUNOL, V180, P5689, DOI 10.4049/jimmunol.180.8.5689; Perry MM, 2014, AM J RESP CELL MOL, V50, P7, DOI 10.1165/rcmb.2013-0067OC; Perry MM, 2011, AM J RESP CELL MOL, V45, P746, DOI 10.1165/rcmb.2010-0304OC; Rohn J, 2012, NAT BIOTECHNOL, V30, P305, DOI 10.1038/nbt0412-305; Shimamura T, 2013, CLIN CANCER RES, V19, P6183, DOI 10.1158/1078-0432.CCR-12-3904; Tang XY, 2013, MOL PHARMACOL, V83, P283, DOI 10.1124/mol.112.081661; Trian T, 2007, J EXP MED, V204, P3173, DOI 10.1084/jem.20070956; Zirath H, 2013, P NATL ACAD SCI USA, V110, P10258, DOI 10.1073/pnas.1222404110; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	47	46	50	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					9111	9121		10.1074/jbc.M114.612671	http://dx.doi.org/10.1074/jbc.M114.612671			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25697361	hybrid, Green Published			2022-12-26	WOS:000352207100034
J	Zhao, GP; Lu, HY; Li, C				Zhao, Guoping; Lu, Huayi; Li, Chi			Proapoptotic Activities of Protein Disulfide Isomerase (PDI) and PDIA3 Protein, a Role of the Bcl-2 Protein Bak	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; INDUCED APOPTOSIS; MEDIATED APOPTOSIS; CELL-DEATH; CYTOCHROME-C; ER STRESS; X-L; FAMILY; MITOCHONDRIA; INHIBITION	Protein disulfide isomerase (PDI) family proteins are classified as enzymatic chaperones for reconstructing misfolded proteins. Previous studies have shown that several PDI members possess potential proapoptotic functions. However, the detailed molecular mechanisms of PDI-mediated apoptosis are not completely known. In this study, we investigated how two members of PDI family, PDI and PDIA3, modulate apoptotic signaling. Inhibiting PDI and PDIA3 activities pharmacologically alleviates apoptosis induced by various apoptotic stimuli. Although a decrease of PDIA3 expression alleviates apoptotic responses, overexpression of PDIA3 exacerbates apoptotic signaling. Importantly, Bak, but not Bax, is essential for PDIA3-induced proapoptotic signaling. Furthermore, both purified PDI and PDIA3 proteins induce Bak-dependent, but not Bax-dependent, mitochondrial outer membrane permeabilization in vitro, probably through triggering Bak oligomerization on mitochondria. Our results suggest that both of PDI and PDIA3 possess Bak-dependent proapoptotic function through inducing mitochondrial outer membrane permeabilization, which provides a new mechanism linking ER chaperone proteins and apoptotic signaling.	[Zhao, Guoping; Li, Chi] Univ Louisville, Mol Targets Program, Dept Med, Louisville, KY 40202 USA; [Zhao, Guoping; Li, Chi] Univ Louisville, Mol Targets Program, Dept Pharmacol, Louisville, KY 40202 USA; [Zhao, Guoping; Li, Chi] Univ Louisville, Mol Targets Program, Dept Toxicol, Louisville, KY 40202 USA; [Lu, Huayi] Jilin Univ, Hosp 2, Changchun 130041, Jilin Province, Peoples R China	University of Louisville; University of Louisville; University of Louisville; Jilin University	Li, C (corresponding author), Univ Louisville, James Graham Brown Canc Ctr, Clinical & Translat Res Bldg,Rm 418, Louisville, KY 40202 USA.	chi.li@louisville.edu			National Institutes of Health [CA106599, CA175003, RR018733]; National Natural Science Foundation of China [81300769]; James Graham Brown Cancer Center; University of Louisville School of Medicine Research Committee; NATIONAL CANCER INSTITUTE [K01CA106599, R01CA175003] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018733] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); James Graham Brown Cancer Center; University of Louisville School of Medicine Research Committee; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants CA106599, CA175003, and RR018733 (to C. L.). This work was also supported by National Natural Science Foundation of China Grant 81300769 (to H. L.), the James Graham Brown Cancer Center, and the University of Louisville School of Medicine Research Committee (to C. L.).	Burikhanov R, 2009, CELL, V138, P377, DOI 10.1016/j.cell.2009.05.022; Cartron PF, 2003, MOL CELL BIOL, V23, P4701, DOI 10.1128/MCB.23.13.4701-4712.2003; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Coe H, 2010, INT J BIOCHEM CELL B, V42, P796, DOI 10.1016/j.biocel.2010.01.009; Corazzari M, 2007, BRIT J CANCER, V96, P1062, DOI 10.1038/sj.bjc.6603672; Dickerhof N, 2011, FEBS J, V278, P2034, DOI 10.1111/j.1742-4658.2011.08119.x; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Eno CO, 2012, BIOCHEM J, V444, P69, DOI 10.1042/BJ20112023; FREEDMAN RB, 1994, TRENDS BIOCHEM SCI, V19, P331, DOI 10.1016/0968-0004(94)90072-8; Galligan JJ, 2012, HUM GENOMICS, V6, DOI 10.1186/1479-7364-6-6; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Harding HP, 2002, DIABETES, V51, pS455, DOI 10.2337/diabetes.51.2007.S455; Helton ES, 2007, J CELL BIOCHEM, V100, P883, DOI 10.1002/jcb.21091; Hetz C, 2005, J NEUROSCI, V25, P2793, DOI 10.1523/JNEUROSCI.4090-04.2005; Hoffstrom BG, 2010, NAT CHEM BIOL, V6, P900, DOI [10.1038/nchembio.467, 10.1038/NCHEMBIO.467]; Huber-Ruano I, 2010, J CELL PHYSIOL, V225, P620, DOI 10.1002/jcp.22254; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Kepp O, 2007, EMBO J, V26, P825, DOI 10.1038/sj.emboj.7601533; Kuwana T, 2003, CURR OPIN CELL BIOL, V15, P691, DOI 10.1016/j.ceb.2003.10.004; Lindenboim L, 2005, CELL DEATH DIFFER, V12, P713, DOI 10.1038/sj.cdd.4401638; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Llambi F, 2011, MOL CELL, V44, P517, DOI 10.1016/j.molcel.2011.10.001; Lovat PE, 2008, CANCER RES, V68, P5363, DOI 10.1158/0008-5472.CAN-08-0035; Madesh M, 2009, MOL CELL BIOL, V29, P3099, DOI 10.1128/MCB.01845-08; Mossuto M. F., 2013, INT J CELL BIOL, V2013; Muller C, 2013, ANTIOXID REDOX SIGN, V18, P731, DOI 10.1089/ars.2012.4577; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Obeid M, 2007, CELL DEATH DIFFER, V14, P1848, DOI 10.1038/sj.cdd.4402201; Renault TT, 2014, CHEM BIOL, V21, P114, DOI 10.1016/j.chembiol.2013.10.009; Roberson EC, 2012, AM J RESP CELL MOL, V46, P573, DOI 10.1165/rcmb.2010-0460OC; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Ryu EJ, 2002, J NEUROSCI, V22, P10690; Shimazu T, 2007, GENE DEV, V21, P929, DOI 10.1101/gad.1522007; Sliskovic I, 2006, FEBS LETT, V580, P2233, DOI 10.1016/j.febslet.2006.03.031; Tanaka S, 2000, J BIOL CHEM, V275, P10388, DOI 10.1074/jbc.275.14.10388; Turano C, 2002, J CELL PHYSIOL, V193, P154, DOI 10.1002/jcp.10172; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Wang C, 2012, ONCOGENE, V31, P3177, DOI 10.1038/onc.2011.497; Wang SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038221; Wang X, 2011, CELL DEATH DIFFER, V18, P38, DOI 10.1038/cdd.2010.68; Wang XD, 2001, GENE DEV, V15, P2922; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; White C, 2005, NAT CELL BIOL, V7, P1021, DOI 10.1038/ncb1302; Xu D, 2009, AM J PHYSIOL-LUNG C, V297, pL44, DOI 10.1152/ajplung.90626.2008; Zhao GP, 2014, MOL CELL BIOL, V34, P1198, DOI 10.1128/MCB.00996-13	47	36	38	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					8949	8963		10.1074/jbc.M114.619353	http://dx.doi.org/10.1074/jbc.M114.619353			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25697356	Green Published, hybrid			2022-12-26	WOS:000352207100022
J	Charpentier, MS; Tandon, P; Trincot, CE; Koutleva, EK; Conlon, FL				Charpentier, Marta S.; Tandon, Panna; Trincot, Claire E.; Koutleva, Elitza K.; Conlon, Frank L.			A Distinct Mechanism of Vascular Lumen Formation in Xenopus Requires EGFL7	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; MOUSE YOLK-SAC; ENDOTHELIAL-CELLS; IN-VIVO; TUBE FORMATION; ZEBRAFISH EMBRYO; CAPILLARY LUMEN; MOLECULAR-BASIS; VESSEL FUSION; DORSAL AORTA	During vertebrate blood vessel development, lumen formation is the critical process by which cords of endothelial cells transition into functional tubular vessels. Here, we use Xenopus embryos to explore the cellular and molecular mechanisms underlying lumen formation of the dorsal aorta and the posterior cardinal veins, the primary major vessels that arise via vasculogenesis within the first 48 hours of life. We demonstrate that endothelial cells are initially found in close association with one another through the formation of tight junctions expressing ZO-1. The emergence of vascular lumens is characterized by elongation of endothelial cell shape, reorganization of junctions away from the cord center to the periphery of the vessel, and onset of Claudin-5 expression within tight junctions. Furthermore, unlike most vertebrate vessels that exhibit specialized apical and basal domains, we show that early Xenopus vessels are not polarized. Moreover, we demonstrate that in embryos depleted of the extracellular matrix factor Epidermal Growth Factor-Like Domain 7 (EGFL7), an evolutionarily conserved factor associated with vertebrate vessel development, vascular lumens fail to form. While Claudin-5 localizes to endothelial tight junctions of EGFL7-depleted embryos in a timely manner, endothelial cells of the aorta and veins fail to undergo appropriate cell shape changes or clear junctions from the cell-cell contact. Taken together, we demonstrate for the first time the mechanisms by which lumens are generated within the major vessels in Xenopus and implicate EGFL7 in modulating cell shape and cell-cell junctions to drive proper lumen morphogenesis.	[Charpentier, Marta S.; Tandon, Panna; Trincot, Claire E.; Koutleva, Elitza K.; Conlon, Frank L.] Univ N Carolina, McAllister Heart Inst, Chapel Hill, NC 27514 USA; [Charpentier, Marta S.; Tandon, Panna; Trincot, Claire E.; Conlon, Frank L.] UNC CH, Dept Genet & Mol Biol, Chapel Hill, NC USA; [Koutleva, Elitza K.; Conlon, Frank L.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA; [Conlon, Frank L.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Conlon, FL (corresponding author), Univ N Carolina, McAllister Heart Inst, Chapel Hill, NC 27514 USA.	frank_conlon@med.unc.edu	Ariel, Pablo/AGJ-4118-2022	Trincot, Claire/0000-0002-5125-2297	National Institutes of Health, National Heart, Lung, and Blood Institute [RO1 DE018825, RO1 HL089641]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018825] Funding Source: NIH RePORTER	National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work is supported by grants to F.L.C. from National Institutes of Health, National Heart, Lung, and Blood Institute (RO1 DE018825 and RO1 HL089641).	Argaw AT, 2009, P NATL ACAD SCI USA, V106, P1977, DOI 10.1073/pnas.0808698106; Assemat E, 2008, BBA-BIOMEMBRANES, V1778, P614, DOI 10.1016/j.bbamem.2007.08.029; Baluk P, 2003, AM J PATHOL, V163, P1801, DOI 10.1016/S0002-9440(10)63540-7; Bayless KJ, 2002, J CELL SCI, V115, P1123; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; Blum Y, 2008, DEV BIOL, V316, P312, DOI 10.1016/j.ydbio.2008.01.038; Brown RC, 2007, BRAIN RES, V1130, P17, DOI 10.1016/j.brainres.2006.10.083; Campagnolo L, 2005, AM J PATHOL, V167, P275, DOI 10.1016/S0002-9440(10)62972-0; Carmeliet P, 2011, NAT REV DRUG DISCOV, V10, P417, DOI 10.1038/nrd3455; Charpentier MS, 2013, DEV CELL, V25, P132, DOI 10.1016/j.devcel.2013.03.003; Charpentier MS, 2013, BIOESSAYS; Chen J, 2013, EXP CELL RES, V319, P1357, DOI 10.1016/j.yexcr.2013.03.021; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Ciau-Uitz A, 2000, CELL, V102, P787, DOI 10.1016/S0092-8674(00)00067-2; Ciau-Uitz A, 2013, DEVELOPMENT, V140, P2632, DOI 10.1242/dev.090829; Cleaver O, 2000, DEVELOPMENT, V127, P869; Cleaver O, 1998, DEVELOPMENT, V125, P3905; Cleaver O, 1997, DEV DYNAM, V210, P66, DOI 10.1002/(SICI)1097-0177(199709)210:1<66::AID-AJA7>3.3.CO;2-S; Davis GE, 1996, EXP CELL RES, V224, P39, DOI 10.1006/excr.1996.0109; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; Doherty JR, 2007, DEV DYNAM, V236, P2808, DOI 10.1002/dvdy.21321; Eilken HM, 2010, CURR OPIN CELL BIOL, V22, P617, DOI 10.1016/j.ceb.2010.08.010; Fan C, 2013, INT J BIOL MARKER, V28, P71, DOI 10.5301/JBM.2013.10568; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Fitch MJ, 2004, DEV DYNAM, V230, P316, DOI 10.1002/dvdy.20063; Flamme I, 1997, J CELL PHYSIOL, V173, P206, DOI 10.1002/(SICI)1097-4652(199711)173:2<206::AID-JCP22>3.0.CO;2-C; Goel S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006486; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Helker CS, 2013, DEVELOPMENT; Herbert SP, 2011, NAT REV MOL CELL BIO, V12, P551, DOI 10.1038/nrm3176; Herwig L, 2011, CURR BIOL, V21, P1942, DOI 10.1016/j.cub.2011.10.016; Iden S, 2006, EMBO REP, V7, P1239, DOI 10.1038/sj.embor.7400819; Imamura Y, 1999, J CELL BIOL, V144, P1311, DOI 10.1083/jcb.144.6.1311; Itoh M, 1997, J CELL BIOL, V138, P181, DOI 10.1083/jcb.138.1.181; Jinn SW, 2005, DEVELOPMENT, V132, P5199, DOI 10.1242/dev.02087; Johnson L, 2013, J CLIN INVEST, V123, P3997, DOI 10.1172/JCI67892; Kamei M, 2006, NATURE, V442, P453, DOI 10.1038/nature04923; KAU CL, 1983, J IMMUNOL, V131, P2262; Kucera T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004132; Lammert E, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006619; Lampugnani MG, 2010, J CELL SCI, V123, P1073, DOI 10.1242/jcs.059329; Lelievre E, 2008, EMBO J, V27, P1658, DOI 10.1038/emboj.2008.103; Lenard A, 2013, DEV CELL, V25, P492, DOI 10.1016/j.devcel.2013.05.010; Levine AJ, 2003, DEV BIOL, V254, P50, DOI 10.1016/S0012-1606(02)00029-5; Lizama CO, 2013, EXP CELL RES, V319, P1247, DOI 10.1016/j.yexcr.2013.03.028; Lucitti JL, 2007, DEVELOPMENT, V134, P3317, DOI 10.1242/dev.02883; Maddox AS, 2003, J CELL BIOL, V160, P255, DOI 10.1083/jcb.200207130; Mandel EM, 2010, DEVELOPMENT, V137, P1919, DOI 10.1242/dev.043588; Marcelo KL, 2013, CIRC RES, V112, P1272, DOI 10.1161/CIRCRESAHA.113.300506; Meadows KL, 2012, COLD SPRING HARB PER, V2; Morita K, 1999, J CELL BIOL, V147, P185, DOI 10.1083/jcb.147.1.185; Nakagawa S, 2009, NEUROCHEM INT, V54, P253, DOI 10.1016/j.neuint.2008.12.002; Nichol D, 2012, BLOOD, V119, P1345, DOI 10.1182/blood-2011-10-322446; Nichol D, 2010, BLOOD, V116, P6133, DOI 10.1182/blood-2010-03-274860; Nielsen JS, 2008, J CELL SCI, V121, P3683, DOI 10.1242/jcs.037507; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Nikolic Iva, 2010, J Angiogenes Res, V2, P9, DOI 10.1186/2040-2384-2-9; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Pardanaud L, 1996, DEVELOPMENT, V122, P1363; Park TJ, 2005, CURR BIOL, V15, P1039, DOI 10.1016/j.cub.2005.04.062; Parker LH, 2004, NATURE, V428, P754, DOI 10.1038/nature02416; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Sato Y, 2008, DEV CELL, V14, P890, DOI 10.1016/j.devcel.2008.03.024; Showell C, 2006, DEV DYNAM, V235, P1623, DOI 10.1002/dvdy.20714; Soncin F, 2003, EMBO J, V22, P5700, DOI 10.1093/emboj/cdg549; Stratman AN, 2009, BLOOD, V114, P5091, DOI 10.1182/blood-2009-05-222364; Strilic B, 2010, CURR BIOL, V20, P2003, DOI 10.1016/j.cub.2010.09.061; Strilic B, 2009, DEV CELL, V17, P505, DOI 10.1016/j.devcel.2009.08.011; Swift MR, 2009, CIRC RES, V104, P576, DOI 10.1161/CIRCRESAHA.108.188805; Tandon P, 2013, DEVELOPMENT, V140, P2409, DOI 10.1242/dev.093385; Tandon P, 2012, METHODS MOL BIOL, V843, P29, DOI 10.1007/978-1-61779-523-7_4; Trindade A, 2008, BLOOD, V112, P1720, DOI 10.1182/blood-2007-09-112748; Udan RS, 2013, DEVELOPMENT, V140, P4041, DOI 10.1242/dev.096255; Udan RS, 2013, WIRES DEV BIOL, V2, P327, DOI 10.1002/wdev.91; Vokes SA, 2002, DEVELOPMENT, V129, P775; Walmsley M, 2002, DEVELOPMENT, V129, P5683, DOI 10.1242/dev.00169; Wang Y, 2010, DEVELOPMENT, V137, P3119, DOI 10.1242/dev.048785; Welti J, 2013, J CLIN INVEST, V123, P3190, DOI 10.1172/JCI70212; Xie J, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-76; Xu K, 2011, SEMIN CELL DEV BIOL; Xu K, 2011, DEV CELL, V20, P526, DOI 10.1016/j.devcel.2011.02.010; Yousif LF, 2013, CELL ADHES MIGR, V7, P101, DOI 10.4161/cam.22680; Zhong HB, 2011, CELL RES, V21, P1080, DOI 10.1038/cr.2011.41	86	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0116086	10.1371/journal.pone.0116086	http://dx.doi.org/10.1371/journal.pone.0116086			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25705891	Green Published, gold, Green Submitted			2022-12-26	WOS:000350662100025
J	Zhao, L; Feng, CH; Hou, CT; Hu, LY; Wang, QC; Wu, YF				Zhao, Lei; Feng, Chaohong; Hou, Caiting; Hu, Lingyun; Wang, Qiaochun; Wu, Yunfeng			First Discovery of Acetone Extract from Cottonseed Oil Sludge as a Novel Antiviral Agent against Plant Viruses	PLOS ONE			English	Article							TOBACCO-MOSAIC-VIRUS; BETA-SITOSTEROL; ANTIBACTERIAL ACTIVITY; CANCER CELLS; GOSSYPOL; DERIVATIVES; CHEMISTRY; APOPTOSIS; RATS; ROOT	A novel acetone extract from cottonseed oil sludge was firstly discovered against plant viruses including Tobacco mosaic virus (TMV), Rice stripe virus (RSV) and Southern rice black streaked dwarf virus (SRBSDV). Gossypol and beta-sitosterol separated from the acetone extract were tested for their effects on anti-TMV and analysed by nuclear magnetic resonance (NMR) assay. In vivo and field trials in different geographic distributions and different host varieties declared that this extract mixture was more efficient than the commercial agent Ningnanmycin with a broad spectrum of anti-plant-viruses activity. No phytotoxic activity was observed in the treated plants and environmental toxicology showed that this new acetone extract was environmentally friendly, indicating that this acetone extract has potential application in the control of plant virus in the future.	[Zhao, Lei; Hou, Caiting; Wu, Yunfeng] Northwest A&F Univ, Minist Educ, Coll Plant Protect,Minist Agr,Key Lab Plant Protec, State Key Lab Crop Stress Biol Arid Areas,Key Lab, Yangling, Shaanxi, Peoples R China; [Feng, Chaohong; Hu, Lingyun; Wang, Qiaochun] Northwest A&F Univ, Minist Educ, Coll Hort,Minist Agr,Key Lab Plant Protect Resourc, State Key Lab Crop Stress Biol Arid Areas,Key Lab, Yangling, Shaanxi, Peoples R China	Ministry of Agriculture & Rural Affairs; Northwest A&F University - China; Ministry of Agriculture & Rural Affairs; Northwest A&F University - China	Wu, YF (corresponding author), Northwest A&F Univ, Minist Educ, Coll Plant Protect,Minist Agr,Key Lab Plant Protec, State Key Lab Crop Stress Biol Arid Areas,Key Lab, Yangling, Shaanxi, Peoples R China.	qiaochunwang@nwsuaf.edu.cn; wuyf@nwsuaf.edu.cn			Special Fund for Agro-scientific Research in the Public Interest [200903052]; Education Ministry of China [B07049]	Special Fund for Agro-scientific Research in the Public Interest; Education Ministry of China(Ministry of Education, China)	The study was supported by the Special Fund for Agro-scientific Research in the Public Interest (No. 200903052) and the 111 Project from the Education Ministry of China (No. B07049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An T, 2012, ANTIVIR RES, V94, P276, DOI 10.1016/j.antiviral.2012.02.014; Awad AB, 2000, INT J MOL MED, V5, P541; Baskar AA, 2012, J MED FOOD, V15, P335, DOI 10.1089/jmf.2011.1780; Bauer JA, 2005, MOL CANCER THER, V4, P1096, DOI 10.1158/1535-7163.MCT-05-0081; Beltrame FL, 2002, BRAZ ARCH BIOL TECHN, V45, P21, DOI 10.1590/S1516-89132002000100004; Bouic PJD, 1996, INT J IMMUNOPHARMACO, V18, P693, DOI 10.1016/S0192-0561(97)85551-8; Cheng ZB, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-307; Chou CH, 1999, CRIT REV PLANT SCI, V18, P609, DOI 10.1016/S0735-2689(99)00393-7; Gebre-Mariam T, 2006, J ETHNOPHARMACOL, V104, P182, DOI 10.1016/j.jep.2005.08.071; GOODING GV, 1967, PHYTOPATHOLOGY, V57, P1285; Hari V, 1998, PLANT VIRUS DISEASE CONTROL, P417; Huang HungChang, 2005, Plant Pathology Bulletin, V14, P1; JANERO DR, 1988, BIOCHEM PHARMACOL, V37, P3335, DOI 10.1016/0006-2952(88)90647-8; Karen-Beth G, 2011, MOL PLANT PATHOL, V12, P938, DOI [10.1111/j.1364-3703.2011.00752.x, DOI 10.1111/J.1364-3703.2011.00752.X]; Keller PA, 2003, J MOL GRAPH MODEL, V21, P365, DOI 10.1016/S1093-3263(02)00183-3; Lall N, 2000, J ETHNOPHARMACOL, V72, P313, DOI 10.1016/S0378-8741(00)00231-2; Lin CW, 2005, ANTIVIR RES, V68, P36, DOI 10.1016/j.antiviral.2005.07.002; LIN TS, 1993, BIOCHEM PHARMACOL, V46, P251, DOI 10.1016/0006-2952(93)90411-O; Ouyang MA, 2007, J AGR FOOD CHEM, V55, P6460, DOI 10.1021/jf0709808; Park C, 2007, BIOL PHARM BULL, V30, P1317, DOI 10.1248/bpb.30.1317; Peres MTLP, 1997, J ETHNOPHARMACOL, V56, P223, DOI 10.1016/S0378-8741(97)00039-1; Prieto JM, 2006, B LATINOAM CARIBE PL, V5, P57; Qian XH, 2010, J AGR FOOD CHEM, V58, P2613, DOI 10.1021/jf904098w; Scholthof KBG, 2004, ANNU REV PHYTOPATHOL, V42, P13, DOI 10.1146/annurev.phyto.42.040803.140322; Seiber JN, 2011, J AGR FOOD CHEM, V59, P1, DOI 10.1021/jf1046078; SUGANO M, 1977, J NUTR, V107, P2011, DOI 10.1093/jn/107.11.2011; Vivancos M, 2005, FREE RADICAL BIO MED, V39, P91, DOI 10.1016/j.freeradbiomed.2005.02.025; Wang ZW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052933; Wei TY, 2009, J GEN VIROL, V90, P1025, DOI 10.1099/vir.0.006858-0; Yang JQ, 2010, J AGR FOOD CHEM, V58, P2730, DOI 10.1021/jf902861m; Yang J, 2012, BIOORG MED CHEM LETT, V22, P1415, DOI 10.1016/j.bmcl.2011.12.076; Yasuhara-Bell J, 2010, ANTIVIR RES, V86, P231, DOI 10.1016/j.antiviral.2010.03.009; Zak A, 1990, Cas Lek Cesk, V129, P1320	33	13	15	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117496	10.1371/journal.pone.0117496	http://dx.doi.org/10.1371/journal.pone.0117496			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25705894	Green Published, Green Submitted, gold			2022-12-26	WOS:000350662100095
J	Gong, S; Miao, YL; Jiao, GZ; Sun, MJ; Li, H; Lin, J; Luo, MJ; Tan, JH				Gong, Shuai; Miao, Yi-Long; Jiao, Guang-Zhong; Sun, Ming-Ju; Li, Hong; Lin, Juan; Luo, Ming-Jiu; Tan, Jing-He			Dynamics and Correlation of Serum Cortisol and Corticosterone under Different Physiological or Stressful Conditions in Mice	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; RESTRAINT STRESS; ESTROUS-CYCLE; PLASMA-CORTICOSTERONE; BIOMEDICAL-RESEARCH; RESTRICTION STRESS; IN-VITRO; MOUSE; RAT; ADRENOCORTICOTROPIN	Although plasma corticosterone is considered the main glucocorticoid involved in regulation of stress responses in rodents, the presence of plasma cortisol and whether its level can be used as an indicator for rodent activation of stress remain to be determined. In this study, effects of estrous cycle stage, circadian rhythm, and acute and chronic (repeated or unpredictable) stressors of various severities on dynamics and correlation of serum cortisol and corticosterone were examined in mice. A strong (r = 0.6-0.85) correlation between serum cortisol and corticosterone was observed throughout the estrous cycle, all day long, and during acute or repeated restraints, chronic unpredictable stress and acute forced swimming or heat stress. Both hormones increased to the highest level on day 1 of repeated-restraint or unpredictable stresses, but after that, whereas the concentration of cortisol did not change, that of corticosterone showed different dynamics. Thus, whereas corticosterone declined dramatically during repeated restraints, it remained at the high level during unpredictable stress. During forced swimming or heat stress, whereas cortisol increased to the highest level within 3 min., corticosterone did not reach maximum until 40 min. of stress. Analysis with HPLC and HPLC-MS further confirmed the presence of cortisol in mouse serum. Taken together, results (i) confirmed the presence of cortisol in mouse serum and (ii) suggested that mouse serum cortisol and corticosterone are closely correlated in dynamics under different physiological or stressful conditions, but, whereas corticosterone was a more adaptation-related biomarker than cortisol during chronic stress, cortisol was a quicker responder than corticosterone during severe acute stress.	[Gong, Shuai; Miao, Yi-Long; Jiao, Guang-Zhong; Sun, Ming-Ju; Li, Hong; Lin, Juan; Luo, Ming-Jiu; Tan, Jing-He] Shandong Agr Univ, Coll Anim Sci & Vet Med, Tai An 271018, Shandong, Peoples R China	Shandong Agricultural University	Tan, JH (corresponding author), Shandong Agr Univ, Coll Anim Sci & Vet Med, Tai An 271018, Shandong, Peoples R China.	tanjh@sdau.edu.cn	Luo, Mingjiu/AAU-8570-2021		National Basic Research Program of China [2014CB138503, 2012CB944403]; China National Natural Science Foundation [31272444, 30972096]	National Basic Research Program of China(National Basic Research Program of China); China National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Basic Research Program of China (Nos. 2014CB138503 and 2012CB944403) and the China National Natural Science Foundation (Nos. 31272444 and 30972096). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson HC, 2006, J NEUROENDOCRINOL, V18, P526, DOI 10.1111/j.1365-2826.2006.01444.x; Atkinson HC, 1997, ENDOCRINOLOGY, V138, P3842, DOI 10.1210/en.138.9.3842; Ayada K, 2002, PHYSIOL BEHAV, V77, P161, DOI 10.1016/S0031-9384(02)00844-2; Bhat MS, 2007, EVID-BASED COMPL ALT, V4, P35, DOI 10.1093/ecam/nel049; BINGEL AS, 1969, J REPROD FERTIL, V19, P215; CAREY MP, 1995, J ENDOCRINOL, V144, P311, DOI 10.1677/joe.0.1440311; Cavigelli SA, 2003, P NATL ACAD SCI USA, V100, P16131, DOI 10.1073/pnas.2535721100; CHAMPLIN AK, 1973, BIOL REPROD, V8, P491, DOI 10.1093/biolreprod/8.4.491; Champlin AK, 1969, THESIS U ROCHESTER R; Chen Y, 2005, J ETHNOPHARMACOL, V96, P451, DOI 10.1016/j.jep.2004.09.033; Cheng Yiyong, 2004, Wei Sheng Yan Jiu, V33, P179; CHOURAQUI J, 1970, ACTA ENDOCRINOL-COP, V65, P650, DOI 10.1530/acta.0.0650650; Dickmeis T, 2009, J ENDOCRINOL, V200, P3, DOI 10.1677/JOE-08-0415; FAZEKAS G, 1966, ENDOKRINOLOGIE, V50, P130; FEVOLD HR, 1969, BIOCHEMISTRY-US, V8, P3433, DOI 10.1021/bi00836a045; GLAVIN GB, 1994, NEUROSCI BIOBEHAV R, V18, P223, DOI 10.1016/0149-7634(94)90027-2; Golub MS, 2004, BIRTH DEFECTS RES B, V71, P26, DOI 10.1002/bdrb.10058; Hafez E. S. E., 1993, P94; Ide S, 2010, NEUROPHARMACOLOGY, V58, P241, DOI 10.1016/j.neuropharm.2009.07.005; IUDAEV N A, 1965, Probl Endokrinol Gormonoter, V11, P81; IUDAEV N A, 1960, Probl Endokrinol Gormonoter, V6, P19; KASS EH, 1954, P SOC EXP BIOL MED, V85, P583; Kim JY, 2008, NEUROREPORT, V19, P1373, DOI 10.1097/WNR.0b013e32830e4c1d; KITAY JI, 1961, NATURE, V192, P358, DOI 10.1038/192358b0; Koren L, 2012, GEN COMP ENDOCR, V177, P113, DOI 10.1016/j.ygcen.2012.02.020; KRUM AA, 1964, P SOC EXP BIOL MED, V118, P255; Liu Y, 2013, PHARMACOL BIOCHEM BE, V103, P474, DOI 10.1016/j.pbb.2012.09.009; Magiakou M A, 1994, Curr Ther Endocrinol Metab, V5, P120; Mizobe K, 1997, J NEUROIMMUNOL, V73, P81, DOI 10.1016/S0165-5728(96)00169-5; NAKAMURA K, 1990, J NEUROIMMUNOL, V30, P23, DOI 10.1016/0165-5728(90)90049-S; NAKAMURA K, 1989, SCAND J GASTROENTERO, V24, P47, DOI 10.3109/00365528909091122; NICHOLS DJ, 1981, EXPERIENTIA, V37, P319, DOI 10.1007/BF01991678; Ovejero R, 2013, J EXP ZOOL PART A, V319, P539, DOI 10.1002/jez.1833; PARE WP, 1986, NEUROSCI BIOBEHAV R, V10, P339, DOI 10.1016/0149-7634(86)90017-5; Podsevatkin V. G., 2008, Eksperimental'naya i Klinicheskaya Farmakologiya, V71, P22; SNELL GD, 1941, BIOL LAB MOUSE, P53; Taves MD, 2014, ENDOCRINOLOGY; THURSTON JH, 1989, METAB BRAIN DIS, V4, P177, DOI 10.1007/BF01000294; Walker QD, 2001, J PHARMACOL EXP THER, V297, P291; WON SJ, 1995, J APPL PHYSIOL, V79, P732, DOI 10.1152/jappl.1995.79.3.732; Wu LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052331; Yin YY, 2007, CHINESE MED J-PEKING, V120, P1088, DOI 10.1097/00029330-200706020-00011; Zhang SY, 2011, BIOL REPROD, V84, P672, DOI 10.1095/biolreprod.110.087890	43	238	245	9	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0117503	10.1371/journal.pone.0117503	http://dx.doi.org/10.1371/journal.pone.0117503			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25699675	Green Submitted, gold, Green Published			2022-12-26	WOS:000349789800025
J	Sinke, C; Schmidt, K; Forkmann, K; Bingel, U				Sinke, Christopher; Schmidt, Katharina; Forkmann, Katarina; Bingel, Ulrike			Phasic and Tonic Pain Differentially Impact the Interruptive Function of Pain	PLOS ONE			English	Article							STEREOTYPE THREAT; CATASTROPHIC THINKING; ATTENTION; PERFORMANCE; CONNECTIVITY; INFORMATION; SENSITIVITY; MODULATION; NETWORK; PLACEBO	The interruptive effect of painful experimental stimulation on cognitive processes is a well-known phenomenon. This study investigated the influence of pain duration on the negative effects of pain on cognition. Thirty-four healthy volunteers performed a rapid serial visual presentation task (RSVP) in which subjects had to detect (visual detection task) and count the occurrence of a target letter (working memory task) in two separate sessions while being stimulated on the left volar forearm with either short (2 sec) or long (18 sec) painful heat stimuli of equal subjective intensity. The results show that subjects performed significantly worse in the long pain session as indexed by decreased detection and counting performance. Interestingly, this effect on performance was also observed during control trials of the long pain session in which participants did not receive any painful stimulation. Moreover, subjects expected long painful stimulation to have a greater impact on their performance and individual expectation correlated with working memory performance. These findings suggest that not only the length of painful stimulation but also its expected ability to impair cognitive functioning might influence the interruptive function of pain. The exact relevance of expectation for the detrimental effects of pain on cognitive processes needs to be explored in more detail in future studies.	[Sinke, Christopher; Schmidt, Katharina; Bingel, Ulrike] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany; [Schmidt, Katharina; Forkmann, Katarina; Bingel, Ulrike] Essen Univ Hosp, Dept Neurol, Essen, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Duisburg Essen	Bingel, U (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany.	Ulrike.Bingel@uk-essen.de	Sinke, Christopher/U-8412-2017	Sinke, Christopher/0000-0003-1716-6229	German Research Foundation [SFB936/A4]	German Research Foundation(German Research Foundation (DFG))	This work was supported by the German Research Foundation, SFB936/A4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber SJ, 2013, PSYCHOL SCI, V24, P2522, DOI 10.1177/0956797613497023; Bingel U, 2007, NEURON, V55, P157, DOI 10.1016/j.neuron.2007.05.032; Buhle J, 2010, PAIN, V149, P19, DOI 10.1016/j.pain.2009.10.027; Colagiuri B, 2011, PSYCHON B REV, V18, P399, DOI 10.3758/s13423-010-0041-1; Crombez G, 1998, PAIN, V75, P187, DOI 10.1016/S0304-3959(97)00219-4; Crombez G, 2002, Pain Res Manag, V7, P31; CROMBEZ G, 1994, BEHAV RES THER, V32, P611, DOI 10.1016/0005-7967(94)90015-9; Eccleston C, 1999, PSYCHOL BULL, V125, P356, DOI 10.1037/0033-2909.125.3.356; ECCLESTON C, 1995, BEHAV RES THER, V33, P391, DOI 10.1016/0005-7967(94)00057-Q; Enck P, 2013, NAT REV DRUG DISCOV, V12, P191, DOI 10.1038/nrd3923; Forkmann K, 2013, J NEUROSCI, V33, P2571, DOI 10.1523/JNEUROSCI.2994-12.2013; FRUHSTORFER H, 1976, J NEUROL NEUROSUR PS, V39, P1071, DOI 10.1136/jnnp.39.11.1071; Grisart J, 2007, BEHAV RES THER, V45, P1077, DOI 10.1016/j.brat.2006.05.002; Grisart JM, 1999, EUR J PAIN-LONDON, V3, P325, DOI 10.1016/S1090-3801(99)90014-9; Kahneman D., 1973, ATTENTION EFFORT; Keogh E, 2001, J ANXIETY DISORD, V15, P299, DOI 10.1016/S0887-6185(01)00065-2; Keogh E, 2001, PAIN, V91, P91, DOI 10.1016/S0304-3959(00)00422-X; Kit KA, 2008, NEUROPSYCHOL REV, V18, P132, DOI 10.1007/s11065-008-9059-9; Koyama T, 2005, P NATL ACAD SCI USA, V102, P12950, DOI 10.1073/pnas.0408576102; Kuhajda MC, 2002, PAIN, V97, P213, DOI 10.1016/S0304-3959(01)00488-2; Lautenbacher S, 2009, CLIN J PAIN, V25, P92, DOI 10.1097/AJP.0b013e3181850dce; Laux L, 1992, STATE TRAIT ANGSTINV; Legrain V, 2009, J NEUROPHYSIOL, V102, P2423, DOI 10.1152/jn.00372.2009; Leknes S, 2008, NAT REV NEUROSCI, V9, P314, DOI 10.1038/nrn2333; MCCRACKEN LM, 1992, PAIN, V50, P67, DOI 10.1016/0304-3959(92)90113-P; Moore DJ, 2013, PAIN, V154, P82, DOI 10.1016/j.pain.2012.09.009; Moore DJ, 2012, Q J EXP PSYCHOL, V65, P565, DOI 10.1080/17470218.2011.626865; Moriarty O, 2011, PROG NEUROBIOL, V93, P385, DOI 10.1016/j.pneurobio.2011.01.002; NORMAN DA, 1975, COGNITIVE PSYCHOL, V7, P44, DOI 10.1016/0010-0285(75)90004-3; Oosterman JM, 2012, PAIN RES MANAG, V17, P159, DOI 10.1155/2012/962786; PATIL PG, 1995, PHYSIOL BEHAV, V58, P1281, DOI 10.1016/0031-9384(95)02071-3; Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041; Seminowicz DA, 2004, PAIN, V112, P48, DOI 10.1016/j.pain.2004.07.027; Seminowicz DA, 2007, PAIN, V130, P8, DOI 10.1016/j.pain.2007.03.036; Seminowicz DA, 2007, J NEUROPHYSIOL, V97, P3651, DOI 10.1152/jn.01210.2006; Spencer SJ, 1999, J EXP SOC PSYCHOL, V35, P4, DOI 10.1006/jesp.1998.1373; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Tiemann L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035068; Tiemann L, 2010, PAIN, V150, P302, DOI 10.1016/j.pain.2010.05.014; Tracey I, 2010, NAT MED, V16, P1277, DOI 10.1038/nm.2229; Van Damme S, 2004, PAIN, V107, P70, DOI 10.1016/j.pain.2003.09.023; Vancleef LMG, 2006, J PAIN, V7, P23, DOI 10.1016/j.jpain.2005.04.003; Walter B, 2002, SCHMERZ, V16, P83; Yerkes RM, 1908, J COMP NEUROL PSYCHO, V18, P459, DOI 10.1002/cne.920180503	45	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0118363	10.1371/journal.pone.0118363	http://dx.doi.org/10.1371/journal.pone.0118363			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695254	Green Published, Green Submitted, gold			2022-12-26	WOS:000350062300049
J	Bei, YH; Zhou, QL; Fu, SY; Lv, DC; Chen, P; Chen, YY; Wang, F; Xiao, JJ				Bei, Yihua; Zhou, Qiulian; Fu, Siyi; Lv, Dongchao; Chen, Ping; Chen, Yuanyuan; Wang, Fei; Xiao, Junjie			Cardiac Telocytes and Fibroblasts in Primary Culture: Different Morphologies and Immunophenotypes	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; SKELETAL-MUSCLE INTERSTITIUM; ELECTRON-MICROSCOPE EVIDENCE; LUNG TELOCYTES; MYOCARDIAL-INFARCTION; SYSTEMIC-SCLEROSIS; LAMINA PROPRIA; STROMAL CELLS; DISTINCT TYPE; MOUSE LUNG	Telocytes (TCs) are a peculiar type of interstitial cells with very long prolongations termed telopodes. TCs have previously been identified in different anatomic structures of the heart, and have also been isolated and cultured from heart tissues in vitro. TCs and fibroblasts, both located in the interstitial spaces of the heart, have different morphologies and functionality. However, other than microscopic observation, a reliable means to make differential diagnosis of cardiac TCs from fibroblasts remains unclear. In the present study, we isolated and cultured cardiac TCs and fibroblasts from heart tissues, and observed their different morphological features and immunophenotypes in primary culture. Morphologically, TCs had extremely long and thin telopodes with moniliform aspect, stretched away from cell bodies, while cell processes of fibroblasts were short, thick and cone shaped. Furthermore, cardiac TCs were positive for CD34/c-kit, CD34/vimentin, and CD34/PDGFR-beta, while fibroblasts were only vimentin and PDGFR-beta positive. In addition, TCs were also different from pericytes as TCs were CD34 positive and alpha-SMA weak positive while pericytes were CD34 negative but alpha-SMA positive. Besides that, we also showed cardiac TCs were homogenously positive for mesenchymal marker CD29 but negative for hematopoietic marker CD45, indicating that TCs could be a source of cardiac mesenchymal cells. The differences in morphological features and immunophenotypes between TCs and fibroblasts will provide more compelling evidence to differentiate cardiac TCs from fibroblasts.	[Bei, Yihua; Zhou, Qiulian; Fu, Siyi; Lv, Dongchao; Chen, Ping; Chen, Yuanyuan; Xiao, Junjie] Shanghai Univ, Expt Ctr Life Sci, Regenerat & Ageing Lab, Shanghai 200444, Peoples R China; [Bei, Yihua; Zhou, Qiulian; Fu, Siyi; Lv, Dongchao; Chen, Ping; Chen, Yuanyuan; Xiao, Junjie] Shanghai Univ, Innovat Drug Res Ctr, Sch Life Sci, Shanghai 200444, Peoples R China; [Bei, Yihua; Xiao, Junjie] Shanghai Univ, Sch Life Sci, Shanghai Key Lab Bioenergy Crops, Shanghai 200444, Peoples R China; [Wang, Fei; Xiao, Junjie] Tongji Univ, Tongji Hosp, Sch Med, Digest Dis Inst,Div Gastroenterol & Hepatol, Shanghai 200065, Peoples R China	Shanghai University; Shanghai University; Shanghai University; Tongji University	Xiao, JJ (corresponding author), Shanghai Univ, Expt Ctr Life Sci, Regenerat & Ageing Lab, Shanghai 200444, Peoples R China.	junjiexiao@shu.edu.cn	Chen, Yuanyuan/GXG-2130-2022		National Natural Science Foundation of China [81200169]; Innovation Program of Shanghai Municipal Education Commission [13YZ014]; Foundation for University Young Teachers by Shanghai Municipal Education Commission; Shanghai University [sdcx2012038]; Shanghai Municipal Education Commission	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); Foundation for University Young Teachers by Shanghai Municipal Education Commission; Shanghai University(Shanghai University); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC))	This work was supported by the grants from National Natural Science Foundation of China (81200169 to J. Xiao), Innovation Program of Shanghai Municipal Education Commission (13YZ014 to J. Xiao), Foundation for University Young Teachers by Shanghai Municipal Education Commission (year 2012, to J. Xiao), Innovation fund from Shanghai University (sdcx2012038 to J. Xiao), and Program for the integration of production, teaching and research for University Teachers supported by Shanghai Municipal Education Commission (year 2014, to J. Xiao).	Bani D, 2010, J CELL MOL MED, V14, P2531, DOI 10.1111/j.1582-4934.2010.01119.x; Bojin FM, 2011, J CELL MOL MED, V15, P2269, DOI 10.1111/j.1582-4934.2011.01386.x; Bosco C, 2013, AUTON NEUROSCI-BASIC, V177, P224, DOI 10.1016/j.autneu.2013.05.002; Campeanu RA, 2014, LASER MED SCI, V29, P1867, DOI 10.1007/s10103-014-1589-1; Carmona IC, 2011, J CELL MOL MED, V15, P26, DOI 10.1111/j.1582-4934.2010.01207.x; Cantarero I, 2011, J CELL MOL MED, V15, P2594, DOI 10.1111/j.1582-4934.2011.01312.x; Ceafalan L, 2012, J CELL MOL MED, V16, P1405, DOI 10.1111/j.1582-4934.2012.01580.x; Chen L, 2014, BIOSCI TRENDS, V8, P111, DOI 10.5582/bst.8.111; Chen XK, 2013, J CELL MOL MED, V17, P1506, DOI 10.1111/jcmm.12149; Cismasiu VB, 2011, J CELL MOL MED, V15, P1071, DOI 10.1111/j.1582-4934.2011.01325.x; Corradi LS, 2013, J CELL MOL MED, V17, P398, DOI 10.1111/jcmm.12021; Cretoiu D, 2012, HISTOL HISTOPATHOL, V27, P1067, DOI 10.14670/HH-27.1067; Cretoiu SM, 2013, REPRODUCTION, V145, P357, DOI 10.1530/REP-12-0369; Diaz-Flores L, 2014, HISTOL HISTOPATHOL, V29, P831, DOI 10.14670/HH-29.831; Edelstein L, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00041; Faussone Pellegrini MS, 2011, BIOMOL CONCEPTS, V2, P481, DOI DOI 10.1515/BMC.2011.039; Faussone-Pellegrini MS, 2010, J CELL MOL MED, V14, P1061, DOI 10.1111/j.1582-4934.2010.01074.x; Galiger C, 2014, J CELL MOL MED, V18, P1321, DOI 10.1111/jcmm.12295; Gherghiceanu M, 2012, CELL TISSUE RES, V348, P265, DOI 10.1007/s00441-012-1333-8; Gherghiceanu M, 2011, J CELL MOL MED, V15, P1005, DOI 10.1111/j.1582-4934.2011.01299.x; Gherghiceanu M, 2010, J CELL MOL MED, V14, P2330, DOI 10.1111/j.1582-4934.2010.01133.x; Gherghiceanu M, 2010, J CELL MOL MED, V14, P871, DOI 10.1111/j.1582-4934.2010.01060.x; Hatta K, 2012, J CELL MOL MED, V16, P1392, DOI 10.1111/j.1582-4934.2012.01583.x; HE Q, 1995, J MOL CELL CARDIOL, V27, P1173, DOI 10.1016/0022-2828(95)90053-5; Hinescu ME, 2011, CELL TISSUE RES, V343, P389, DOI 10.1007/s00441-010-1095-0; Luesma MJ, 2013, J CELL MOL MED, V17, P1016, DOI 10.1111/jcmm.12111; Kostin S, 2009, J CELL MOL MED, V13, P295, DOI 10.1111/j.1582-4934.2008.00668.x; Kostin S, 2010, J CELL MOL MED, V14, P1917, DOI 10.1111/j.1582-4934.2010.01111.x; Li H, 2014, J CELL MOL MED, V18, P975, DOI 10.1111/jcmm.12337; Li LP, 2014, J CELL MOL MED, V18, P1144, DOI 10.1111/jcmm.12274; Manetti M, 2014, J CELL MOL MED, V18, P253, DOI 10.1111/jcmm.12228; Manetti M, 2013, J CELL MOL MED, V17, P482, DOI 10.1111/jcmm.12028; Manole CG, 2011, J CELL MOL MED, V15, P2284, DOI 10.1111/j.1582-4934.2011.01449.x; Milia AF, 2013, J CELL MOL MED, V17, P1525, DOI 10.1111/jcmm.12177; Nicolescu MI, 2012, PANCREAS, V41, P949, DOI 10.1097/MPA.0b013e31823fbded; Nicolescu MI, 2012, ANAT REC, V295, P378, DOI 10.1002/ar.21540; Popescu BO, 2012, NEUROSCI LETT, V516, P265, DOI 10.1016/j.neulet.2012.04.006; Popescu LM, 2013, RESIDENT STEM CELLS AND REGENERATIVE THERAPY, P205, DOI 10.1016/B978-0-12-416012-5.00011-6; Popescu LM, 2011, J CELL MOL MED, V15, P1379, DOI 10.1111/j.1582-4934.2011.01330.x; Popescu LM, 2010, J CELL MOL MED, V14, P2085, DOI 10.1111/j.1582-4934.2010.01129.x; Popescu LM, 2010, J CELL MOL MED, V14, P729, DOI 10.1111/j.1582-4934.2010.01059.x; Popescu LM, 2011, CELL TISSUE RES, V345, P391, DOI 10.1007/s00441-011-1229-z; Qi GS, 2012, J CELL MOL MED, V16, P3116, DOI 10.1111/j.1582-4934.2012.01582.x; Rusu MC, 2012, ANN ANAT, V194, P359, DOI 10.1016/j.aanat.2011.11.007; Rusu MC, 2012, J CELL MOL MED, V16, P401, DOI 10.1111/j.1582-4934.2011.01465.x; Rusu MC, 2011, ANN ANAT, V193, P403, DOI 10.1016/j.aanat.2011.06.005; Rusu MC, 2012, CELL BIOL INT, V36, P1079, DOI 10.1042/CBI20120007; Suciu L, 2010, J CELL MOL MED, V14, P2687, DOI 10.1111/j.1582-4934.2010.01185.x; Suciu L, 2010, CELLS TISSUES ORGANS, V192, P325, DOI 10.1159/000319467; Suciu LC, 2012, J CELL MOL MED, V16, P701, DOI 10.1111/j.1582-4934.2011.01505.x; Sun XR, 2014, J CELL MOL MED, V18, P801, DOI 10.1111/jcmm.12302; Vannucchi MG, 2013, J CELL MOL MED, V17, P1099, DOI 10.1111/jcmm.12134; Wang F, 2014, J CELL MOL MED, V18, P1720, DOI 10.1111/jcmm.12355; Xiao JJ, 2013, J CELL MOL MED, V17, P1537, DOI 10.1111/jcmm.12195; Yang Y, 2014, J CELL MOL MED, V18, P759, DOI 10.1111/jcmm.12285; Zhao BY, 2014, J CELL MOL MED, V18, P780, DOI 10.1111/jcmm.12259; Zhao BY, 2013, J CELL MOL MED, V17, P123, DOI 10.1111/j.1582-4934.2012.01655.x; Zheng Y, 2011, J CELL MOL MED, V15, P2262, DOI 10.1111/j.1582-4934.2011.01404.x; Zheng YH, 2014, J CELL MOL MED, V18, P568, DOI 10.1111/jcmm.12290; Zheng YH, 2013, J CELL MOL MED, V17, P567, DOI 10.1111/jcmm.12052; Zheng YH, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-188; Zhou J, 2010, J CELL MOL MED, V14, P2641, DOI 10.1111/j.1582-4934.2010.01186.x; Zhou Y, 2010, J HISTOCHEM CYTOCHEM, V58, P309, DOI 10.1369/jhc.2009.955146	63	81	82	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0115991	10.1371/journal.pone.0115991	http://dx.doi.org/10.1371/journal.pone.0115991			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693182	gold, Green Published, Green Submitted			2022-12-26	WOS:000350061500012
J	Lee, EH; Lee, K; Hwang, KY; Kim, HY				Lee, Eun Hye; Lee, Kitaik; Hwang, Kwang Yeon; Kim, Hwa-Young			Essential Role of the C-Terminal Helical Domain in Active Site Formation of Selenoprotein MsrA from Clostridium oremlandii	PLOS ONE			English	Article							METHIONINE SULFOXIDE REDUCTASE; CATALYTIC MECHANISM; KINETIC CHARACTERIZATION; EXPRESSION; SYSTEM	We previously determined the crystal structures of 1-Cys type selenoprotein MsrA from Clostridium oremlandii (CoMsrA). The overall structure of CoMsrA is unusual, consisting of two domains, the N-terminal catalytic domain and the C-terminal distinct helical domain which is absent from other known MsrA structures. Deletion of the helical domain almost completely abolishes the catalytic activity of CoMsrA. In this study, we determined the crystal structure of the helical domain-deleted (Delta H-domain) form of CoMsrA at a resolution of 1.76 angstrom. The monomer structure is composed of the central rolled mixed beta-sheet surrounded by a-helices. However, there are significant conformational changes in the N- and C-termini and loop regions of the Delta H-domain protein relative to the catalytic domain structure of full-length CoMsrA. The active site structure in the Delta H-domain protein completely collapses, thereby causing loss of catalytic activity of the protein. Interestingly, dimer structures are observed in the crystal formed by N-terminus swapping between two molecules. The Delta H-domain protein primarily exists as a dimer in solution, whereas the full-length CoMsrA exists as a monomer. Collectively, this study provides insight into the structural basis of the essential role of the helical domain of CoMsrA in its catalysis.	[Lee, Eun Hye; Lee, Kitaik; Hwang, Kwang Yeon] Korea Univ, Coll Life Sci & Biotechnol, Div Biotechnol, Seoul, South Korea; [Kim, Hwa-Young] Yeungnam Univ, Coll Med, Dept Biochem & Mol Biol, Taegu, South Korea	Korea University; Yeungnam University	Hwang, KY (corresponding author), Korea Univ, Coll Life Sci & Biotechnol, Div Biotechnol, Seoul, South Korea.	chahong@korea.ac.kr; hykim@ynu.ac.kr		Lee, Kitaik/0000-0002-7761-5586	Yeungnam University Research Grant	Yeungnam University Research Grant	This work was supported by the 2014 Yeungnam University Research Grant (HYK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Antoine M, 2003, J BIOL CHEM, V278, P45352, DOI 10.1074/jbc.M307471200; BENNETT MJ, 1995, PROTEIN SCI, V4, P2455, DOI 10.1002/pro.5560041202; Boschi-Muller S, 2000, J BIOL CHEM, V275, P35908, DOI 10.1074/jbc.M006137200; Boschi-Muller S, 2001, PROTEIN SCI, V10, P2272, DOI 10.1110/ps.10701; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Kim HY, 2013, ANTIOXID REDOX SIGN, V19, P958, DOI 10.1089/ars.2012.5081; Kim HY, 2012, ACTA BIOCH BIOPH SIN, V44, P623, DOI 10.1093/abbs/gms038; Kim HY, 2009, PROTEINS, V74, P1008, DOI 10.1002/prot.22212; Kim MJ, 2011, MOL MICROBIOL, V79, P1194, DOI 10.1111/j.1365-2958.2010.07500.x; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee EH, 2014, ARCH BIOCHEM BIOPHYS, V545, P1, DOI 10.1016/j.abb.2013.12.024; Lowther WT, 2000, BIOCHEMISTRY-US, V39, P13307, DOI 10.1021/bi0020269; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MOSKOVITZ J, 1995, J BACTERIOL, V177, P502, DOI 10.1128/jb.177.3.502-507.1995; Olry A, 2004, BIOCHEMISTRY-US, V43, P11616, DOI 10.1021/bi049306z; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rouhier N, 2007, J BIOL CHEM, V282, P3367, DOI 10.1074/jbc.M605007200; Shingate P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039305; Singh VK, 2003, MICROBIOL-SGM, V149, P2739, DOI 10.1099/mic.0.26442-0; Skaar EP, 2002, P NATL ACAD SCI USA, V99, P10108, DOI 10.1073/pnas.152334799; Taylor AB, 2003, J BACTERIOL, V185, P4119, DOI 10.1128/JB.185.14.4119-4126.2003; Tete-Favier F, 2000, STRUCTURE, V8, P1167, DOI 10.1016/S0969-2126(00)00526-8	24	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117836	10.1371/journal.pone.0117836	http://dx.doi.org/10.1371/journal.pone.0117836			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692691	gold, Green Published, Green Submitted			2022-12-26	WOS:000350061500077
J	Pokrovsky, I; Ehrich, D; Ims, RA; Kondratyev, AV; Kruckenberg, H; Kulikova, O; Mihnevich, J; Pokrovskaya, L; Shienok, A				Pokrovsky, Ivan; Ehrich, Dorothee; Ims, Rolf A.; Kondratyev, Alexander V.; Kruckenberg, Helmut; Kulikova, Olga; Mihnevich, Julia; Pokrovskaya, Liya; Shienok, Alexander			Rough-Legged Buzzards, Arctic Foxes and Red Foxes in a Tundra Ecosystem without Rodents	PLOS ONE			English	Article							CLIMATE-CHANGE; ALOPEX-LAGOPUS; CONFIDENCE-INTERVALS; POPULATION-DYNAMICS; BREEDING SUCCESS; LEMMING CYCLES; PREY; DIET; FLUCTUATIONS; HYPOTHESIS	Small rodents with multi-annual population cycles strongly influence the dynamics of food webs, and in particular predator-prey interactions, across most of the tundra biome. Rodents are however absent from some arctic islands, and studies on performance of arctic predators under such circumstances may be very instructive since rodent cycles have been predicted to collapse in a warming Arctic. Here we document for the first time how three normally rodent-dependent predator species-rough-legged buzzard, arctic fox and red fox-perform in a low-arctic ecosystem with no rodents. During six years (in 2006-2008 and 2011-2013) we studied diet and breeding performance of these predators in the rodent-free Kolguev Island in Arctic Russia. The rough-legged buzzards, previously known to be a small rodent specialist, have only during the last two decades become established on Kolguev Island. The buzzards successfully breed on the island at stable low density, but with high productivity based on goslings and willow ptarmigan as their main prey -altogether representing a novel ecological situation for this species. Breeding density of arctic fox varied from year to year, but with stable productivity based on mainly geese as prey. The density dynamic of the arctic fox appeared to be correlated with the date of spring arrival of the geese. Red foxes breed regularly on the island but in very low numbers that appear to have been unchanged over a long period - a situation that resemble what has been recently documented from Arctic America. Our study suggests that the three predators found breeding on Kolguev Island possess capacities for shifting to changing circumstances in low-arctic ecosystem as long as other small -medium sized terrestrial herbivores are present in good numbers.	[Pokrovsky, Ivan] Max Planck Inst Ornithol, Dept Migrat & Immunoecol, D-78315 Radolfzell am Bodensee, Germany; [Ehrich, Dorothee; Ims, Rolf A.] Univ Tromso, Dept Arctic & Marine Biol, NO-9037 Tromso, Norway; [Kondratyev, Alexander V.] Russian Acad Sci, Far East Branch, Inst Biol Problems North, Magadan 685000, Russia; [Kruckenberg, Helmut] Inst Waterbird & Wetlands Res IWWR eV, D-27283 Verden, Aller, Germany; [Kulikova, Olga] Moscow MV Lomonosov State Univ, Fac Geog, RU-119991 Moscow, Russia; [Mihnevich, Julia; Pokrovskaya, Liya; Shienok, Alexander] Moscow MV Lomonosov State Univ, Fac Biol, RU-119991 Moscow, Russia	Max Planck Society; UiT The Arctic University of Tromso; Institute of Biological Problems of the North; Russian Academy of Sciences; Lomonosov Moscow State University; Lomonosov Moscow State University	Pokrovsky, I (corresponding author), Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Obstberg 1, D-78315 Radolfzell am Bodensee, Germany.	ivanpok@mail.ru	Kondratyev, Alexander AV/J-8301-2012; Kulikova, Olga/AAO-2204-2020; Pokrovsky, Ivan/B-5144-2010; Ehrich, Dorothee/F-6492-2015	Kondratyev, Alexander AV/0000-0002-4657-3336; Kulikova, Olga/0000-0002-4029-9452; Pokrovsky, Ivan/0000-0002-6533-674X; Ehrich, Dorothee/0000-0002-3028-9488; Pokrovskaya, Liya/0000-0003-1751-7260	Institute for Waterbird and Wetlands Research (IWWR) e.V.; UiT - Arctic University of Norway; Norwegian Environment Agency; Conservation Arctic Flora and Fauna (CAFF); Max-Planck Institute for Ornithology; ECORA GEF Project; Federal Agency for Nature Conservation under the Federal Ministry for the Environment, Nature Conservation and Nuclear Safety [FKZ 3510 860 1000]; NiedersAochsische Wattenmeerstiftung and the Committee for Bird Protection VsK	Institute for Waterbird and Wetlands Research (IWWR) e.V.; UiT - Arctic University of Norway; Norwegian Environment Agency; Conservation Arctic Flora and Fauna (CAFF); Max-Planck Institute for Ornithology; ECORA GEF Project; Federal Agency for Nature Conservation under the Federal Ministry for the Environment, Nature Conservation and Nuclear Safety; NiedersAochsische Wattenmeerstiftung and the Committee for Bird Protection VsK	This study was funded by Institute for Waterbird and Wetlands Research (IWWR) e.V., UiT - Arctic University of Norway, The Norwegian Environment Agency, Conservation Arctic Flora and Fauna (CAFF) and Max-Planck Institute for Ornithology. The authors would also like to thank the German Committee for Bird Protection (VsK, Hamburg) and the ECORA GEF Project for financial support of their expeditions 2006-2012. In 2011 and 2012 this study was part of a project of the Institute of Avian Research, the Department of Biology and Environmental Science, University of Oldenburg, IWWR e.V. and the Wadden Sea National Park Administration of Lower Saxony, which was funded by the Federal Agency for Nature Conservation under the Federal Ministry for the Environment, Nature Conservation and Nuclear Safety (FKZ 3510 860 1000), the NiedersAochsische Wattenmeerstiftung and the Committee for Bird Protection VsK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angerbjorn A, 2013, J APPL ECOL, V50, P59, DOI 10.1111/1365-2664.12033; [Anonymous], 2011, GOOSE B; [Anonymous], [No title captured]; BATZLI GO, 1980, US IBP SYNTHESIS SER, P335; Cornulier T, 2013, SCIENCE, V340, P63, DOI 10.1126/science.1228992; Ehrich D, 2015, ECOSYSTEMS, V18, P404, DOI 10.1007/s10021-014-9834-9; Eide NE, 2012, J ANIM ECOL, V81, P640, DOI 10.1111/j.1365-2656.2011.01936.x; Elmhagen B, 2000, J ZOOL, V251, P139, DOI 10.1111/j.1469-7998.2000.tb00599.x; Elton CS, 1924, BR J EXP BIOL, V2, P119; Fuglei E, 2003, POLAR BIOL, V26, P93, DOI 10.1007/s00300-002-0458-8; Fuglei Eva, 2008, Science Progress, V91, P175, DOI 10.3184/003685008X327468; Gallant D, 2012, POLAR BIOL, V35, P1421, DOI 10.1007/s00300-012-1181-8; GALUSHIN VM, 1974, IBIS, V116, P127, DOI 10.1111/j.1474-919X.1974.tb00232.x; Ganter B, 2013, ARCTIC BIODIVERSITY; GARDNER MJ, 1986, BMJ-BRIT MED J, V292, P746, DOI 10.1136/bmj.292.6522.746; Gilg O, 2012, ANN NY ACAD SCI, V1249, P166, DOI 10.1111/j.1749-6632.2011.06412.x; Gilg O, 2009, GLOBAL CHANGE BIOL, V15, P2634, DOI 10.1111/j.1365-2486.2009.01927.x; Glazov MV, 1997, ARCTIC BIRDS INT BRE; Goltsman ME, 2011, BIOL BULL+, V38, P709, DOI 10.1134/S1062359010151014; HERSTEINSSON P, 1992, OIKOS, V64, P505, DOI 10.2307/3545168; Ims RA, 2005, BIOSCIENCE, V55, P311, DOI 10.1641/0006-3568(2005)055[0311:TICITE]2.0.CO;2; Ims RA, 2013, ARCTIC BIODIVERSITY; Ims RA, 2011, P NATL ACAD SCI USA, V108, P1970, DOI 10.1073/pnas.1012714108; Jefferies RL, 2006, ECOL STUD-ANAL SYNTH, V190, P293; Kalyakin V. N., 1989, BIRDS COMMUNITIES TU, P51; Kausrud KL, 2008, NATURE, V456, P93, DOI 10.1038/nature07442; Killengreen ST, 2011, J ANIM ECOL, V80, P1049, DOI 10.1111/j.1365-2656.2011.01840.x; Kondratyev A., 2013, IMPORTANCE BARENTS S; KORPIMAKI E, 1994, OIKOS, V69, P504, DOI 10.2307/3545862; Krasnov Yu. V., 2008, Ornitologiya, V35, P83; Krebs CJ, 2003, CAN J ZOOL, V81, P827, DOI [10.1139/z03-061, 10.1139/Z03-061]; Kruckenberg H, 2006, ANGEW FELDBIOLOGIE, V2, P1; Kruckenberg Helmut, 2012, Wader Study Group Bulletin, V119, P102; Marti Carl D., 2007, P129; McCann K.S., 2011, FOOD WEBS; Mechnikova SA, 2009, RAPTORS SO YAMAL BRE; Morozov V.V., 2004, Ornitologiya, V31, P9; Pasanen S, 1971, Aquilo (Ser Zool), V12, P53; Pokrovsky I, 2014, POLAR BIOL, V37, P447, DOI 10.1007/s00300-013-1441-2; POOLE A, 2002, BIRDS N AM ONLINE; Post E, 2009, SCIENCE, V325, P1355, DOI 10.1126/science.1173113; Redpath SM, 2001, CONDOR, V103, P184, DOI 10.1650/0010-5422(2001)103[0184:ARDCPP]2.0.CO;2; Reid DG, 2012, ARCTIC REPORT CARD; Reif V, 2001, ECOGRAPHY, V24, P267, DOI 10.1034/j.1600-0587.2001.240304.x; Roth JD, 2003, J ANIM ECOL, V72, P668, DOI 10.1046/j.1365-2656.2003.00739.x; Schenker N, 2001, AM STAT, V55, P182, DOI 10.1198/000313001317097960; Schmidt NM, 2012, P ROY SOC B-BIOL SCI, V279, P4417, DOI 10.1098/rspb.2012.1490; SIMMONS R E, 1991, Journal of Raptor Research, V25, P63; Sokolov A. A., 2002, FUNCTIONAL LINKS ROU; Steenhof K., 2007, RAPTOR RES MANAGEMEN, P181; Sundell J, 2004, J ANIM ECOL, V73, P167, DOI 10.1111/j.1365-2656.2004.00795.x; Syroechkovski EE, 1995, BREEDING CONDITIONS; Tannerfeldt M, 1998, OIKOS, V83, P545, DOI 10.2307/3546681; Tarroux A, 2010, POLAR BIOL, V33, P1021, DOI 10.1007/s00300-010-0780-5; Tast J, 2010, KILPISJARVI NOTES, V22, P10; Tast J., 2010, KILPISJ RVI NOTES, V22, P1; Tomkovich P.S., 1998, INT WADER STUDIES, V10, P132; Tornberg R, 2007, ORNIS FENNICA, V84, P21; van Wijk RE, 2012, OIKOS, V121, P655, DOI 10.1111/j.1600-0706.2011.20083.x; Walker DA, 2005, J VEG SCI, V16, P267, DOI 10.1111/j.1654-1103.2005.tb02365.x; Wiklund CG, 1999, AMBIO, V28, P281; Yoccoz N.G., 1991, B ECOL SOC AM, V72, P106; Yurlov AK, 1998, INT WADER STUDIES, V10, P105	63	12	12	2	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118740	10.1371/journal.pone.0118740	http://dx.doi.org/10.1371/journal.pone.0118740			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692786	Green Published, gold, Green Submitted			2022-12-26	WOS:000350061500128
J	Snijders, L; van der Eijk, J; van Rooij, EP; de Goede, P; van Oers, K; Naguib, M				Snijders, Lysanne; van der Eijk, Jerine; van Rooij, Erica P.; de Goede, Piet; van Oers, Kees; Naguib, Marc			Song Trait Similarity in Great Tits Varies with Social Structure	PLOS ONE			English	Article							PARUS-MAJOR; DAWN CHORUS; BIRD SONG; HONEST ADVERTISEMENT; EXTRAPAIR PATERNITY; TERRITORY DEFENSE; NEIGHBORS; BEHAVIOR; COMMUNICATION; HERITABILITY	For many animals, long-range signalling is essential to maintain contact with conspecifics. In territorial species, individuals often have to balance signalling towards unfamiliar potential competitors (to solely broadcast territory ownership) with signalling towards familiar immediate neighbours (to also maintain so-called "dear enemy" relations). Hence, to understand how signals evolve due to these multilevel relationships, it is important to understand how general signal traits vary in relation to the overall social environment. For many territorial songbirds dawn is a key signalling period, with several neighbouring individuals singing simultaneously without immediate conflict. In this study we tested whether sharing a territory boundary, rather than spatial proximity, is related to similarity in dawn song traits between territorial great tits (Parus major) in a wild personality-typed population. We collected a large dataset of automatized dawn song recordings from 72 unique male great tits, during the fertile period of their mate, and compared specific song traits between neighbours and non-neighbours. We show here that both song rate and start time of dawn song were repeatable song traits. Moreover, neighbours were significantly more dissimilar in song rate compared to non-neighbours, while there was no effect of proximity on song rate similarity. Additionally, similarity in start time of dawn song was unrelated to sharing a territory boundary, but birds were significantly more similar in start time of dawn song when they were breeding in close proximity of each other. We suggest that the dissimilarity in dawn song rate between neighbours is either the result of neighbouring great tits actively avoiding similar song rates to possibly prevent interference, or a passive consequence of territory settlement preferences relative to the types of neighbours. Neighbourhood structuring is therefore likely to be a relevant selection pressure shaping variation in territorial birdsong.	[Snijders, Lysanne; van der Eijk, Jerine; van Rooij, Erica P.; Naguib, Marc] Wageningen Univ, Behav Ecol Grp, NL-6700 AP Wageningen, Netherlands; [Snijders, Lysanne; de Goede, Piet; van Oers, Kees] Netherlands Inst Ecol NIOO KNAW, Dept Anim Ecol, Wageningen, Netherlands	Wageningen University & Research; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	Snijders, L (corresponding author), Wageningen Univ, Behav Ecol Grp, NL-6700 AP Wageningen, Netherlands.	lysanne.snijders@wur.nl	van Oers, Kees/B-2562-2009; Snijders, Lysanne/I-1384-2019; Naguib, Marc/C-2650-2009; KNAW, NIOO-KNAW/A-4320-2012	van Oers, Kees/0000-0001-6984-906X; Snijders, Lysanne/0000-0003-0911-3418; KNAW, NIOO-KNAW/0000-0002-3835-159X; Naguib, Marc/0000-0003-0494-4888	Netherlands Organisation for Scientific Research (NWO) [821.01.01]; Dobberke Stichting [UPS/BP/5215]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Dobberke Stichting	The Netherlands Organisation for Scientific Research (NWO) funded this project with an ALW open competition grant 821.01.01 to MN. A grant from the Dobberke Stichting was awarded to MN (UPS/BP/5215) which allowed the authors to acquire a number of the automatic song recorders used in this study. (https://www.knaw.nl/nl/prijzen/subsidies/dobberke-stichting-voor-vergelijkende-psychologie) (http://www.nwo.nl/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrhein V, 2004, P ROY SOC B-BIOL SCI, V271, pS167, DOI 10.1098/rsbl.2003.0133; Amrhein V, 2008, BEHAV ECOL SOCIOBIOL, V62, P1633, DOI 10.1007/s00265-008-0592-6; Amy M, 2010, P ROY SOC B-BIOL SCI, V277, P3685, DOI 10.1098/rspb.2010.0598; Arroyo-Solis A, 2013, J AVIAN BIOL, V44, P288, DOI 10.1111/j.1600-048X.2012.05796.x; Beecher MD, 2000, ANIM BEHAV, V59, P21, DOI 10.1006/anbe.1999.1276; BIRKHEAD TR, 1992, BIOL J LINN SOC, V45, P363, DOI 10.1111/j.1095-8312.1992.tb00649.x; Boncoraglio G, 2007, FUNCT ECOL, V21, P134, DOI 10.1111/j.1365-2435.2006.01207.x; Both C, 2000, J ANIM ECOL, V69, P1021, DOI 10.1046/j.1365-2656.2000.00458.x; Catchpole Clive K, 2003, BIRD SONG BIOL THEME; CLAYTON DA, 1978, Q REV BIOL, V53, P373, DOI 10.1086/410789; CUTHILL IC, 1990, BEHAV ECOL SOCIOBIOL, V26, P209; Dingemanse NJ, 2002, ANIM BEHAV, V64, P929, DOI 10.1006/anbe.2002.2006; Drent PJ, 2003, P ROY SOC B-BIOL SCI, V270, P45, DOI 10.1098/rspb.2002.2168; Foote JR, 2008, BEHAV ECOL, V19, P1192, DOI 10.1093/beheco/arn087; Foote JR, 2011, ANIM BEHAV, V81, P871, DOI 10.1016/j.anbehav.2011.01.028; Gil D, 2002, TRENDS ECOL EVOL, V17, P133, DOI 10.1016/S0169-5347(02)02410-2; GODARD R, 1991, NATURE, V350, P228, DOI 10.1038/350228a0; Godfrey JD, 2000, J ANIM ECOL, V69, P301, DOI 10.1046/j.1365-2656.2000.00393.x; Goodwin SE, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2013.1083; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Grabowska-Zhang AM, 2012, BIOL LETTERS, V8, P544, DOI 10.1098/rsbl.2012.0183; Halupka K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102801; Hasselquist D, 1996, NATURE, V381, P229, DOI 10.1038/381229a0; KACELNIK A, 1983, BEHAVIOUR, V83, P287, DOI 10.1163/156853983X00200; Kempenaers B, 2010, CURR BIOL, V20, P1735, DOI 10.1016/j.cub.2010.08.028; Krebs J.R., 1977, P47; KREBS JR, 1982, BEHAV ECOL SOCIOBIOL, V11, P185, DOI 10.1007/BF00300061; Kunc HP, 2005, ANIM BEHAV, V70, P1265, DOI 10.1016/j.anbehav.2005.02.010; LAMBRECHTS M, 1986, BEHAV ECOL SOCIOBIOL, V19, P57, DOI 10.1007/BF00303843; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; MACE R, 1986, ANIM BEHAV, V34, P621, DOI 10.1016/S0003-3472(86)80139-7; Maynard DF, 2012, ANIM BEHAV, V84, P563, DOI 10.1016/j.anbehav.2012.06.008; MCGREGOR PK, 1989, BEHAVIOUR, V108, P139, DOI 10.1163/156853989X00105; MCGREGOR PK, 1982, BEHAVIOUR, V79, P126, DOI 10.1163/156853982X00210; McGregor PK, 2005, ANIMAL COMMUNICATION; Mennill DJ, 2002, SCIENCE, V296, P873, DOI 10.1126/science.296.5569.873; MYRBERG AA, 1985, ANIM BEHAV, V33, P411, DOI 10.1016/S0003-3472(85)80065-8; Naguib M, 2001, ANIM BEHAV, V62, P825, DOI 10.1006/anbe.2001.1860; Naguib M, 2010, ANIM BEHAV, V80, pE11, DOI 10.1016/j.anbehav.2010.06.001; Nowicki S, 1998, BEHAVIOUR, V135, P615, DOI 10.1163/156853998792897888; Otter K, 1997, BEHAV ECOL, V8, P167, DOI 10.1093/beheco/8.2.167; Peake TM, 2005, ANIM BEHAV, V69, P1063, DOI 10.1016/j.anbehav.2004.08.009; Poesel A, 2006, ANIM BEHAV, V72, P531, DOI 10.1016/j.anbehav.2005.10.022; Qvarnstrom A, 1998, TRENDS ECOL EVOL, V13, P498, DOI 10.1016/S0169-5347(98)01513-4; Rivera-Gutierrez HF, 2010, ANIM BEHAV, V80, P451, DOI 10.1016/j.anbehav.2010.06.002; Searcy WA, 2009, ANIM BEHAV, V78, P1281, DOI 10.1016/j.anbehav.2009.08.011; Smith TB, 2013, EVOL APPL, V6, P865, DOI 10.1111/eva.12072; Snijders L, 2014, ANIM BEHAV, V98, P95, DOI 10.1016/j.anbehav.2014.09.029; Sprau P, 2010, BEHAV ECOL, V21, P1011, DOI 10.1093/beheco/arq097; Staicer CA, 1996, ANIM BEHAV, V51, P375, DOI 10.1006/anbe.1996.0036; TEMELES EJ, 1994, ANIM BEHAV, V47, P339, DOI 10.1006/anbe.1994.1047; Todt D, 2000, ADV STUD BEHAV, V29, P247, DOI 10.1016/S0065-3454(08)60107-2; Van Oers K, 2008, ANIM BEHAV, V76, P555, DOI 10.1016/j.anbehav.2008.03.011; Verhulst S, 2003, ANIM BIOL, V53, P159, DOI 10.1163/157075603769700359; Videan EN, 2005, AM J PRIMATOL, V66, P131, DOI 10.1002/ajp.20133; Wolf M, 2011, P ROY SOC B-BIOL SCI, V278, P440, DOI 10.1098/rspb.2010.1051; York JE, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2013.0970	57	16	16	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0116881	10.1371/journal.pone.0116881	http://dx.doi.org/10.1371/journal.pone.0116881			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692873	gold, Green Submitted, Green Published			2022-12-26	WOS:000350061500029
J	Wu, XN; Lu, HF; Huang, K; Wu, SJ; Qiao, WB				Wu, Xiaonan; Lu, Hongfang; Huang, Kun; Wu, Shijuan; Qiao, Weibiao			Frequency Spectrum Method-Based Stress Analysis for Oil Pipelines in Earthquake Disaster Areas	PLOS ONE			English	Article							NONCLASSICALLY DAMPED STRUCTURES; TIME HISTORY ANALYSIS; SOIL MECHANICS MODEL; RESPONSE SPECTRA; TECTONIC STRESS; GROUND MOTIONS; SRSS; SIMULATION; EXCITATION; CALIFORNIA	When a long distance oil pipeline crosses an earthquake disaster area, inertial force and strong ground motion can cause the pipeline stress to exceed the failure limit, resulting in bending and deformation failure. To date, researchers have performed limited safety analyses of oil pipelines in earthquake disaster areas that include stress analysis. Therefore, using the spectrum method and theory of one-dimensional beam units, CAESAR II is used to perform a dynamic earthquake analysis for an oil pipeline in the XX earthquake disaster area. This software is used to determine if the displacement and stress of the pipeline meet the standards when subjected to a strong earthquake. After performing the numerical analysis, the primary seismic action axial, longitudinal and horizontal displacement directions and the critical section of the pipeline can be located. Feasible project enhancement suggestions based on the analysis results are proposed. The designer is able to utilize this stress analysis method to perform an ultimate design for an oil pipeline in earthquake disaster areas; therefore, improving the safe operation of the pipeline.	[Wu, Xiaonan; Lu, Hongfang; Huang, Kun; Wu, Shijuan] Southwest Petr Univ, State Key Lab Oil & Gas Reservoir Geol & Exploita, Chengdu, Sichuan, Peoples R China; [Wu, Xiaonan] Southwest Petr Univ, Sch Civil Engn & Architecture, Chengdu, Sichuan, Peoples R China; [Lu, Hongfang; Huang, Kun; Wu, Shijuan] Southwest Petr Univ, Sch Petr Engn, Chengdu, Sichuan, Peoples R China; [Qiao, Weibiao] China Petr Univ, Coll Pipeline & Civil Engn, Qingdao, Shandong, Peoples R China; [Qiao, Weibiao] Liaoning Shihua Univ, Coll Petr Engn, Fushun, Liaoning, Peoples R China	Southwest Petroleum University; Southwest Petroleum University; Southwest Petroleum University; China University of Petroleum; Liaoning Petrochemical University	Lu, HF (corresponding author), Southwest Petr Univ, State Key Lab Oil & Gas Reservoir Geol & Exploita, Chengdu, Sichuan, Peoples R China.	luhongfang_sci@126.com; swpuhk@126.com	Qiao, Weibiao/V-1376-2019; Lu, Hongfang/T-1016-2019	Lu, Hongfang/0000-0002-5172-9008	Sichuan Provincial Key Disciplinary Development Project Fund [SZD0416]	Sichuan Provincial Key Disciplinary Development Project Fund	This research is supported by Sichuan Provincial Key Disciplinary Development Project Fund (SZD0416). And special acknowledgement should be given to the Project-Research on stress analysis of oil pipeline from Southwest Petroleum University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKI K, 1984, J GEOPHYS RES, V89, P5867, DOI 10.1029/JB089iB07p05867; AKI K, 1969, J GEOPHYS RES, V74, P615, DOI 10.1029/JB074i002p00615; [Anonymous], 1995, EARTHQ SPECTRA, DOI DOI 10.1193/1.1585831; ASCE, 2005, 705 ASCE, DOI [10.1016/j.febslet.2014.10.035, DOI 10.1016/J.FEBSLET.2014.10.035]; ASME, 2013, B3142012 ASME, DOI [10.1115/1.4028414, DOI 10.1115/1.4028414]; Atkinson GM, 1997, B SEISMOL SOC AM, V87, P97; BOORE DM, 1983, B SEISMOL SOC AM, V73, P1865; BRUNE JN, 1970, J GEOPHYS RES, V75, P4997, DOI 10.1029/JB075i026p04997; Chen LQ, 2014, OPEN CIVIL ENG J, V8, P239; CHENG M, 1994, EARTHQ ENG STRUCT D, V23, P303, DOI 10.1002/eqe.4290230306; China National Petroleum Corporation, 2009, 504702008 GB CHIN NA; CNPC, 2007, 502532006 CNPC GB; FRANKEL A, 1991, J GEOPHYS RES-SOLID, V96, P6291, DOI 10.1029/91JB00237; George M., 1998, PIPE STRESS ANAL THE; GUPTA AK, 1976, NUCL ENG DES, V36, P96, DOI 10.1016/0029-5493(76)90146-1; Gysi M, 2001, SOIL TILL RES, V61, P133, DOI 10.1016/S0167-1987(01)00161-1; HANKS TC, 1979, J GEOPHYS RES, V84, P2235, DOI 10.1029/JB084iB05p02235; Hao JB, 2009, OIL GAS STORAGE TRAN, V28, P27; HETTIARATCHI DRP, 1987, SOIL USE MANAGE, V3, P94, DOI 10.1111/j.1475-2743.1987.tb00718.x; Huang K., 2013, DEVELOPMENT, V5, P1249; Huang K., 2012, NATURE GAS OIL, V30, P1; Huang K., 2013, ADV J FOOD SCI TECHN, V5, P1249; Ji C, 2002, B SEISMOL SOC AM, V92, P1192, DOI 10.1785/0120000916; Jiang X, 2013, NATURAL GAS OIL, V31, P26; Kim S., 1999, EARTHQ SPECTRA, V15, P417, DOI [10.1193/1.1586051, DOI 10.1193/1.1586051]; Li J., 2011, ELECT MEASUREMENT IN, V4, P25; Lopez OA, 2000, EARTHQUAKE ENG STRUC, V29, P1759, DOI 10.1002/1096-9845(200012)29:12<1759::AID-EQE984>3.3.CO;2-B; Menun C., 1998, EARTHQ SPECTRA, P153, DOI DOI 10.1193/1.1585993; Metropolo PL, 2004, PROCESS SAF PROG, V23, P307, DOI 10.1002/prs.10054; Ministry of Housing and Urban-Rural Development of the People's Republic of China, 2009, GB 50011 2010 COD SE, DOI [10.1016/j.vetimm.2014.02.004, DOI 10.1016/J.VETIMM.2014.02.004]; Naeim F., 1995, EARTHQ SPECTRA, V11, P111, DOI DOI 10.1193/1.1585805; Peng L.C., 1978, PIPE LINE IND, V47, P65; Penzien J, 1997, EARTHQUAKE ENG STRUC, V26, P849; PYKE R, 1979, J GEOTECH ENG-ASCE, V105, P715; RAJANI BB, 1995, CAN GEOTECH J, V32, P309, DOI 10.1139/t95-032; RAUTIAN TG, 1978, B SEISMOL SOC AM, V68, P923; ROSCOE KH, 1970, GEOTECHNIQUE, V20, P129, DOI 10.1680/geot.1970.20.2.129; Sabetta F, 1996, B SEISMOL SOC AM, V86, P337; SCANLAN RH, 1974, J ENG MECH DIV-ASCE, V100, P635; SINGH MP, 1986, EARTHQUAKE ENG STRUC, V14, P133, DOI 10.1002/eqe.4290140110; SINGH MP, 1980, J ENG MECH DIV-ASCE, V106, P1405; SINHA R, 1995, EARTHQUAKE ENG STRUC, V24, P615, DOI 10.1002/eqe.4290240410; SMEBY W, 1985, EARTHQUAKE ENG STRUC, V13, P1, DOI 10.1002/eqe.4290130103; Spanos P.D., 1985, INT J SOIL DYN EARTH, V4, P2; Sreejith B, 2004, NUCL ENG DES, V227, P313, DOI 10.1016/j.nucengdes.2003.11.005; TING JM, 1989, J GEOTECH ENG-ASCE, V115, P379, DOI 10.1061/(ASCE)0733-9410(1989)115:3(379); Wang W. S., 2012, THESIS; Watkins R.K., 1999, STRUCTURAL MECH BURI; WILSON EL, 1981, EARTHQUAKE ENG STRUC, V9, P187, DOI 10.1002/eqe.4290090207; Wu X. N., 2012, OIL GAS STORAGE TRAN, V31, P927; Wu XG, 2014, PIPELINE TECHNIQUE E, V2, P16; [吴晓南 Wu Xiaonan], 2014, [天然气工业, Natural Gas Industry], V34, P152; Wu XN, 2014, APPL MECH MATER, V501-504, P2331, DOI 10.4028/www.scientific.net/AMM.501-504.2331; [吴晓南 Wu Xiaonan], 2013, [天然气工业, Natural Gas Industry], V33, P73; WYSS M, 1973, GEOPHYS J ROY ASTR S, V31, P341, DOI 10.1111/j.1365-246X.1973.tb06506.x; Yu G. Q., 2008, GAS HEAT, V28, P20; Zeng J, 2007, GAS HEAT, V5, P55, DOI [10.1016/ j. ijscr. 2014.10.038, DOI 10.1016/J.IJSCR.2014.10.038]; Zhang DH, 1999, OIL GAS STORAGE TRAN, V18, P13; Zhang HB, 2010, OIL GAS STORAGE TRAN, V29, P15, DOI DOI 10.13595/J; Zhang P, 1998, NATURAL GAS IND, V18, P72	60	10	11	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0115299	10.1371/journal.pone.0115299	http://dx.doi.org/10.1371/journal.pone.0115299			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692790	gold, Green Published			2022-12-26	WOS:000350061500008
J	Arends, F; Nowald, C; Pflieger, K; Boettcher, K; Zahler, S; Lieleg, O				Arends, Fabienna; Nowald, Constantin; Pflieger, Kerstin; Boettcher, Kathrin; Zahler, Stefan; Lieleg, Oliver			The Biophysical Properties of Basal Lamina Gels Depend on the Biochemical Composition of the Gel	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; HYDROGELS; GROWTH; MORPHOGENESIS; DIFFUSION; CELLS	The migration of cells within a three-dimensional extracellular matrix (ECM) depends sensitively on the biochemical and biophysical properties of the matrix. An example for a biological ECM is given by reconstituted basal lamina gels purified from the Engelbreth-HolmSwarm sarcoma of mice. Here, we compare four different commercial variants of this ECM, which have all been purified according to the same protocol. Nevertheless, in those gels, we detect strong differences in the migration behavior of leukocyte cells as well as in the Brownian motion of nanoparticles. We show that these differences correlate with the mechanical properties and the microarchitecture of the gels which in turn arise from small variations in their biochemical composition.	[Arends, Fabienna; Nowald, Constantin; Boettcher, Kathrin; Lieleg, Oliver] Tech Univ Munich, Inst Med Engn IMETUM, D-85748 Garching, Germany; [Arends, Fabienna; Nowald, Constantin; Boettcher, Kathrin; Lieleg, Oliver] Tech Univ Munich, Dept Mech Engn, D-85748 Garching, Germany; [Pflieger, Kerstin; Zahler, Stefan] Univ Munich, Dept Pharm, Ctr Drug Res, D-81377 Munich, Germany	Technical University of Munich; Technical University of Munich; University of Munich	Lieleg, O (corresponding author), Tech Univ Munich, Inst Med Engn IMETUM, Boltzmannstr 11, D-85748 Garching, Germany.	oliver.lieleg@tum.de		Lieleg, Oliver/0000-0002-6874-7456; Zahler, Stefan/0000-0002-5140-7287	Deutsche Forschungsgemeinschaft [SFB 1032]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft through project B7 "Nanoagents in 3-dimensional biopolymer hydrogels" and project B8 "Controlling Cellular Function by Structured Surfaces: Artificial Angiogenesis" in the framework of SFB 1032 (http://www.dfg.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a; Arends F, 2013, LANGMUIR, V29, P15965, DOI 10.1021/la404016y; AUMAILLEY M, 1991, EXP CELL RES, V196, P177, DOI 10.1016/0014-4827(91)90248-S; Aumailley M, 2013, CELL ADHES MIGR, V7, P48, DOI 10.4161/cam.22826; Bruce A., 2002, MOL BIOL CELL, V4th ed.; COLLINS SJ, 1977, NATURE, V270, P347, DOI 10.1038/270347a0; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Desban N, 2006, J CELL SCI, V119, P3206, DOI 10.1242/jcs.03057; Hughes CS, 2010, PROTEOMICS, V10, P1886, DOI 10.1002/pmic.200900758; Jokerst JV, 2011, NANOMEDICINE-UK, V6, P715, DOI [10.2217/NNM.11.19, 10.2217/nnm.11.19]; KLEINMAN HK, 1982, BIOCHEMISTRY-US, V21, P6188, DOI 10.1021/bi00267a025; Kleinman HK, 2003, CURR OPIN BIOTECH, V14, P526, DOI 10.1016/j.copbio.2003.08.002; Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004; KLEINMAN HK, 1986, BIOCHEMISTRY-US, V25, P312, DOI 10.1021/bi00350a005; KLEINMAN HK, 1987, ANAL BIOCHEM, V166, P1, DOI 10.1016/0003-2697(87)90538-0; LeBleu VS, 2007, EXP BIOL MED, V232, P1121, DOI 10.3181/0703-MR-72; Lieleg O, 2007, PHYS REV LETT, V99; Lieleg O, 2010, SOFT MATTER, V6, P218, DOI 10.1039/b912163n; Lieleg O, 2011, TRENDS CELL BIOL, V21, P543, DOI 10.1016/j.tcb.2011.06.002; Lieleg O, 2009, BIOPHYS J, V97, P1569, DOI 10.1016/j.bpj.2009.07.009; Lodish H, 2008, MOL CELL BIOL; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; Miyazaki T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2231; NICOSIA RF, 1990, IN VITRO CELL DEV B, V26, P119; Otsuka H, 2003, ADV DRUG DELIVER REV, V55, P403, DOI 10.1016/S0169-409X(02)00226-0; Owens DE, 2006, INT J PHARMACEUT, V307, P93, DOI 10.1016/j.ijpharm.2005.10.010; Philip D, 2005, STEM CELLS, V23, P288, DOI 10.1634/stemcells.2002-0109; Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0; Schuster BS, 2013, BIOMATERIALS, V34, P3439, DOI 10.1016/j.biomaterials.2013.01.064; Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361; Yurchenco PD, 2009, CURR PHARM DESIGN, V15, P1277, DOI 10.2174/138161209787846766	31	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0118090	10.1371/journal.pone.0118090	http://dx.doi.org/10.1371/journal.pone.0118090			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689062	Green Published, Green Submitted, gold			2022-12-26	WOS:000350322700099
J	Bigdeli, S; Dettloff, RO; Frank, CW; Davis, RW; Crosby, LD				Bigdeli, Saharnaz; Dettloff, Roger O.; Frank, Curtis W.; Davis, Ronald W.; Crosby, Laurel D.			A Simple Method for Encapsulating Single Cells in Alginate Microspheres Allows for Direct PCR and Whole Genome Amplification	PLOS ONE			English	Article								Microdroplets are an effective platform for segregating individual cells and amplifying DNA. However, a key challenge is to recover the contents of individual droplets for downstream analysis. This paper offers a method for embedding cells in alginate microspheres and performing multiple serial operations on the isolated cells. Rhodobacter sphaeroides cells were diluted in alginate polymer and sprayed into microdroplets using a fingertip aerosol sprayer. The encapsulated cells were lysed and subjected either to conventional PCR, or whole genome amplification using either multiple displacement amplification (MDA) or a two-step PCR protocol. Microscopic examination after PCR showed that the lumen of the occupied microspheres contained fluorescently stained DNA product, but multiple displacement amplification with phi29 produced only a small number of polymerase colonies. The 2-step WGA protocol was successful in generating fluorescent material, and quantitative PCR from DNA extracted from aliquots of microspheres suggested that the copy number inside the microspheres was amplified up to 3 orders of magnitude. Microspheres containing fluorescent material were sorted by a dilution series and screened with a fluorescent plate reader to identify single microspheres. The DNA was extracted from individual isolates, re-amplified with full-length sequencing adapters, and then a single isolate was sequenced using the Illumina MiSeq platform. After filtering the reads, the only sequences that collectively matched a genome in the NCBI nucleotide database belonged to Rhodobacter sphaeroides. This demonstrated that sequencing-ready DNA could be generated from the contents of a single microsphere without culturing. However, the 2-step WGA strategy showed limitations in terms of low genome coverage and an uneven frequency distribution of reads across the genome. This paper offers a simple method for embedding cells in alginate microspheres and performing PCR on isolated cells in common bulk reactions, although further work must be done to improve the amplification coverage of single genomes.	[Bigdeli, Saharnaz; Dettloff, Roger O.; Davis, Ronald W.; Crosby, Laurel D.] Stanford Univ, Dept Biochem, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA; [Bigdeli, Saharnaz; Frank, Curtis W.] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Dettloff, Roger O.] Caerus Mol Diagnost, Mountain View, CA USA	Stanford University; Stanford University	Crosby, LD (corresponding author), Stanford Univ, Dept Biochem, Stanford Genome Technol Ctr, 3165 Porter Dr, Palo Alto, CA 94304 USA.	laurel@stanford.edu	t, lf/AAJ-4924-2020		Human Microbiome Project, NIH [1R21HG005820]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG005820] Funding Source: NIH RePORTER	Human Microbiome Project, NIH; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This project was funded by a grant from the Human Microbiome Project, NIH 1R21HG005820. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOHLANDER SK, 1992, GENOMICS, V13, P1322, DOI 10.1016/0888-7543(92)90057-Y; Breguet V, 2007, BIOTECHNOL PROGR, V23, P1223, DOI 10.1021/bp070150e; Camacho C, 2008, BLAST COMMAND LINE A; Haight F. A., 1967, HDB POISSON DISTRIBU; Ho J, 2001, STP PHARMA SCI, V11, P109; Kurihara T, 2011, J BIOMOL TECH S, V22, pS51; LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628; Rodrigue S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006864; Thu B, 2000, BIOPOLYMERS, V53, P60, DOI 10.1002/(SICI)1097-0282(200001)53:1<60::AID-BIP6>3.0.CO;2-F; WADOWSKY RM, 1994, J CLIN MICROBIOL, V32, P1054, DOI 10.1128/JCM.32.4.1054-1057.1994; Walser M, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp160; Wang D, 2002, P NATL ACAD SCI USA, V99, P15687, DOI 10.1073/pnas.242579699; Zong CH, 2012, SCIENCE, V338, P1622, DOI 10.1126/science.1229164	13	13	13	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117738	10.1371/journal.pone.0117738	http://dx.doi.org/10.1371/journal.pone.0117738			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689864	Green Published, Green Submitted, gold			2022-12-26	WOS:000350322700069
J	Gilmartin, JFM; Vaatainen, S; Tormalehto, S; Bell, JS; Lonnroos, E; Salo, L; Hallikainen, I; Martikainen, J; Koivisto, AM				Gilmartin, Julia Fiona-Maree; Vaatainen, Saku; Tormalehto, Soili; Bell, J. Simon; Lonnroos, Eija; Salo, Lotta; Hallikainen, Ilona; Martikainen, Janne; Koivisto, Anne M.		ALSOVA Study Grp	Depressive Symptoms Are Associated with Analgesic Use in People with Alzheimer's Disease: Kuopio ALSOVA Study	PLOS ONE			English	Article							GENERALIZED ESTIMATING EQUATIONS; NURSING-HOME PATIENTS; QUALITY-OF-LIFE; INCREASED RISK; DEMENTIA; PAIN; DIAGNOSIS; MILD; INVENTORY	Neuropsychiatric symptoms of Alzheimer's disease (AD) such as depression may be associated with pain, which according to the literature may be inadequately recognized and managed in this population. This study aimed to identify the factors associated with analgesic use in persons with AD; in particular, how AD severity, functional status, neuropsychiatric symptoms of AD, co-morbidities and somatic symptoms are associated with analgesic use. 236 community-dwelling persons with very mild or mild AD at baseline, and their caregivers, were interviewed over five years as part of the prospective ALSOVA study. Generalized Estimating Equations (GEEs) were used to estimate unadjusted and adjusted odds ratios (ORs) for the factors associated with analgesic use over a five year follow-up. The proportion of persons with AD using any analgesic was low (13.6%) at baseline and remained relatively constant during the follow-up (15.3% at Year 5). Over time, the most prevalent analgesic changed from non-steroidal anti-inflammatories (8.1% of persons with AD at Year 1) to acetaminophen (11.1% at Year 5). Depressive symptoms (measured by the Beck Depression Inventory, BDI) were independently associated with analgesic use, after effects of age, gender, education, AD severity, co-morbidities and somatic symptoms were taken into account. For every one unit increase in BDI, the odds of analgesic use increased by 4% (OR = 1.04, 95% confidence interval CI = 1.02-1.07). Caregiver depressive symptoms were not statistically significantly associated with analgesic use of the person with AD. Depressive symptoms were significantly associated with analgesic use during the five year follow-up period. Possible explanations warranting investigation are that persons with AD may express depressive symptoms as painful somatic complaints, or untreated pain may cause depressive symptoms. Greater awareness of the association between depressive symptoms and analgesic use may lead to safer and more effective prescribing for these conditions.	[Gilmartin, Julia Fiona-Maree; Salo, Lotta; Hallikainen, Ilona; Koivisto, Anne M.] Univ Eastern Finland, Sch Med, Inst Clin Med, Neurol, Kuopio, Finland; [Gilmartin, Julia Fiona-Maree; Bell, J. Simon] Monash Univ, Ctr Med Use & Safety, Parkville, Vic, Australia; [Gilmartin, Julia Fiona-Maree] UCL, Sch Pharm, London, England; [Vaatainen, Saku; Tormalehto, Soili; Martikainen, Janne] Univ Eastern Finland, Sch Pharm, Pharmacoecon & Outcomes Res Unit PHORU, Kuopio, Finland; [Bell, J. Simon] Univ Eastern Finland, Sch Pharm, Kuopio Res Ctr Geriatr Care, Fac Hlth Sci, Kuopio, Finland; [Bell, J. Simon; Lonnroos, Eija] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Dept Geriatr, Kuopio, Finland; [Hallikainen, Ilona] Univ Eastern Finland, Sch Educ Sci & Psychol, Kuopio, Finland; [Koivisto, Anne M.] Kuopio Univ Hosp, Neurol NeuroCtr, SF-70210 Kuopio, Finland	University of Eastern Finland; Monash University; University of London; University College London; University of London School of Pharmacy; University of Eastern Finland; University of Eastern Finland; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland	Gilmartin, JFM (corresponding author), Univ Eastern Finland, Sch Med, Inst Clin Med, Neurol, Kuopio, Finland.	j.gilmartin@ucl.ac.uk		Tormalehto, Soili/0000-0003-0138-2285; Valimaki, Tarja/0000-0001-6178-5671; von und zu Fraunberg, Mikael/0000-0002-8457-4639; Gilmartin-Thomas, Julia/0000-0002-1783-0161	Jahnsson Foundation; Kuopio University Hospital EVO/VTR-grant [5220/5772728]; Alzheimer's Australia Dementia Research Foundation	Jahnsson Foundation; Kuopio University Hospital EVO/VTR-grant; Alzheimer's Australia Dementia Research Foundation	The ALSOVA project is supported by grants from the Jahnsson Foundation and Kuopio University Hospital EVO/VTR-grant (5220/5772728). The authors are grateful for funding provided for this study by the Alzheimer's Australia Dementia Research Foundation (http:// dementiaresearchfoundation.org.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Ancoli-Israel S, 2008, J AM GERIATR SOC, V56, P2076, DOI 10.1111/j.1532-5415.2008.01934.x; Andreasen P, 2014, EUR J PUBLIC HEALTH, V24, P40, DOI 10.1093/eurpub/ckt014; [Anonymous], 2014, WHO COLL CTR DRUG ST; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Beck IR, 2014, INT J GERIATR PSYCH, V29, P624, DOI 10.1002/gps.4045; Bell JS, 2011, PAIN, V152, P543, DOI 10.1016/j.pain.2010.11.003; Burton P, 1998, STAT MED, V17, P1261, DOI 10.1002/(SICI)1097-0258(19980615)17:11<1261::AID-SIM846>3.0.CO;2-Z; Byrne GJ, 2005, AUST PRESCR, V28, P67, DOI 10.18773/austprescr.2005.052; Cole LJ, 2006, BRAIN, V129, P2957, DOI 10.1093/brain/awl228; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Dillon C, 2013, NEUROPSYCH DIS TREAT, V9, P1443, DOI 10.2147/NDT.S47133; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Engedal K, 2011, INT J GERIATR PSYCH, V26, P944, DOI 10.1002/gps.2631; Galasko D, 1997, ALZ DIS ASSOC DIS, V11, pS33; Gallini A, 2013, DRUG AGING, V30, P439, DOI 10.1007/s40266-013-0070-3; Gruber-Baldini AL, 2005, GERONTOLOGIST, V45, P50, DOI 10.1093/geront/45.suppl_1.50; Haasum Y, 2011, DRUG AGING, V28, P283, DOI 10.2165/11587040-000000000-00000; Hadjistavropoulos T, 2008, PAIN MANAG NURS, V9, P48, DOI 10.1016/j.pmn.2007.12.004; Hallikainen I, 2013, INT PSYCHOGERIATR, V25, P1335, DOI 10.1017/S1041610213000653; Hallikainen I, 2012, DEMENT GER COGN D EX, V2, P209, DOI 10.1159/000338231; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Hjelm C, 2014, J CARDIOVASC NURS, V29, P82, DOI 10.1097/JCN.0b013e318275543d; Hoffmann F, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-20; Holtzer R, 2005, J AM GERIATR SOC, V53, P2083, DOI 10.1111/j.1532-5415.2005.00535.x; Husebo BS, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4065; Husebo BS, 2008, J AM MED DIR ASSOC, V9, P427, DOI 10.1016/j.jamda.2008.03.001; Jensen-Dahm C, 2014, PAIN, V155, P1439, DOI 10.1016/j.pain.2013.12.031; Jensen-Dahm C, 2012, J AM GERIATR SOC, V60, P1274, DOI 10.1111/j.1532-5415.2012.04036.x; Karttunen K, 2011, INT J GERIATR PSYCH, V26, P473, DOI 10.1002/gps.2550; Laiho K, 2001, RHEUMATOL INT, V20, P85, DOI 10.1007/s002960000087; Lovheim H, 2008, PHARMACOEPIDEM DR S, V17, P912, DOI 10.1002/pds.1600; Lyketsos CG, 2004, DEMENT GERIATR COGN, V17, P55, DOI 10.1159/000074277; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Morrison RS, 2000, J PAIN SYMPTOM MANAG, V19, P240, DOI 10.1016/S0885-3924(00)00113-5; Nygaard HA, 2005, INT J GERIATR PSYCH, V20, P730, DOI 10.1002/gps.1350; O'Bryant SE, 2008, ARCH NEUROL-CHICAGO, V65, P1091, DOI 10.1001/archneur.65.8.1091; Onder G, 2013, J AM MED DIR ASSOC, V14, DOI 10.1016/j.jamda.2013.03.014; Perneczky R, 2006, AM J GERIAT PSYCHIAT, V14, P139, DOI 10.1097/01.JGP.0000192478.82189.a8; Phung KTT, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003584; ROVNER BW, 1989, AM J PSYCHIAT, V146, P350; Scherder EJA, 2000, PSYCHIATRY, V63, P1; Scherder EJA, 1997, ALZ DIS ASSOC DIS, V11, P171, DOI 10.1097/00002093-199709000-00010; Schmader KE, 1998, AGE AGEING, V27, P493, DOI 10.1093/ageing/27.4.493; SCHUG SA, 1992, DRUG SAFETY, V7, P200, DOI 10.2165/00002018-199207030-00005; Sintonen H, 2001, ANN MED, V33, P328, DOI 10.3109/07853890109002086; Tamura BK, 2012, CLIN GERIATR MED, V28, P199, DOI 10.1016/j.cger.2012.01.004; Tan ECK, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005757; TERI L, 1992, J CONSULT CLIN PSYCH, V60, P379, DOI 10.1037/0022-006X.60.3.379; Teri L, 1997, J GERONTOL B-PSYCHOL, V52, pP159, DOI 10.1093/geronb/52B.4.P159; Tune L E, 1998, Depress Anxiety, V8 Suppl 1, P91, DOI 10.1002/(SICI)1520-6394(1998)8:1+<91::AID-DA14>3.0.CO;2-M; Valimaki T, 2012, THESIS U E FINLAND; Whitehead A, 2004, INT J GERIATR PSYCH, V19, P624, DOI 10.1002/gps.1133; Xavier AJ, 2014, J GERONTOL A-BIOL, V69, P1117, DOI 10.1093/gerona/glu105; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	56	12	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117926	10.1371/journal.pone.0117926	http://dx.doi.org/10.1371/journal.pone.0117926			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25688858	Green Accepted, Green Published, gold			2022-12-26	WOS:000350322700084
J	Lim, D; Condon, P; DeSteno, D				Lim, Daniel; Condon, Paul; DeSteno, David			Mindfulness and Compassion: An Examination of Mechanism and Scalability	PLOS ONE			English	Article							MEDITATION; EMOTION; ATTENTION; INCREASES; RESPONSES; GRATITUDE	Emerging evidence suggests that meditation engenders prosocial behaviors meant to benefit others. However, the robustness, underlying mechanisms, and potential scalability of such effects remain open to question. The current experiment employed an ecologically valid situation that exposed participants to a person in visible pain. Following three-week, mobile-app based training courses in mindfulness meditation or cognitive skills (i.e., an active control condition), participants arrived at a lab individually to complete purported measures of cognitive ability. Upon entering a public waiting area outside the lab that contained three chairs, participants seated themselves in the last remaining unoccupied chair; confederates occupied the other two. As the participant sat and waited, a third confederate using crutches and a large walking boot entered the waiting area while displaying discomfort. Compassionate responding was assessed by whether participants gave up their seat to allow the uncomfortable confederate to sit, thereby relieving her pain. Participants' levels of empathic accuracy was also assessed. As predicted, participants assigned to the mindfulness meditation condition gave up their seats more frequently than did those assigned to the active control group. In addition, empathic accuracy was not increased by mindfulness practice, suggesting that mindfulness-enhanced compassionate behavior does not stem from associated increases in the ability to decode the emotional experiences of others.	[Lim, Daniel; Condon, Paul; DeSteno, David] Northeastern Univ, Dept Psychol, Boston, MA 02115 USA	Northeastern University	DeSteno, D (corresponding author), Northeastern Univ, Dept Psychol, Boston, MA 02115 USA.	d.desteno@gmail.com	Lim, Daniel/Y-3206-2019		Headspace, Inc.	Headspace, Inc.	Headspace, Inc. provided the authors with free subscription accounts for participants so that participants would have free access to the web-based meditation sessions.	Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Bartlett MY, 2006, PSYCHOL SCI, V17, P319, DOI 10.1111/j.1467-9280.2006.01705.x; Cahn BR, 2006, PSYCHOL BULL, V132, P180, DOI 10.1037/0033-2909.132.2.180; Condon P, 2013, PSYCHOL SCI, V24, P2125, DOI 10.1177/0956797613485603; DARLEY JM, 1968, J PERS SOC PSYCHOL, V8, P377, DOI 10.1037/h0025589; Davidson RJ, 2010, EMOTION, V10, P8, DOI 10.1037/a0018480; DeSteno D, 2010, EMOTION, V10, P289, DOI 10.1037/a0017883; Ekman Paul, 1972, NEBRASKA S MOTIVATIO, V19, P207, DOI DOI 10.1037/0022-3514.53.4.712; Gethin Rupert., 1998, FDN BUDDHISM; Holzel BK, 2011, PERSPECT PSYCHOL SCI, V6, P537, DOI 10.1177/1745691611419671; Holzel BK, 2011, PSYCHIAT RES-NEUROIM, V191, P36, DOI 10.1016/j.pscychresns.2010.08.006; Hofmann SG, 2010, J CONSULT CLIN PSYCH, V78, P169, DOI 10.1037/a0018555; Jacobs TL, 2011, PSYCHONEUROENDOCRINO, V36, P664, DOI 10.1016/j.psyneuen.2010.09.010; Klimecki OM, 2014, SOC COGN AFFECT NEUR, V9, P873, DOI 10.1093/scan/nst060; Leiberg S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017798; Lutz A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001897; Lutz A, 2008, TRENDS COGN SCI, V12, P163, DOI 10.1016/j.tics.2008.01.005; Lutz A, 2009, J NEUROSCI, V29, P13418, DOI 10.1523/JNEUROSCI.1614-09.2009; MacLean KA, 2010, PSYCHOL SCI, V21, P829, DOI 10.1177/0956797610371339; Mascaro JS, 2013, SOC COGN AFFECT NEUR, V8, P48, DOI 10.1093/scan/nss095; Scherer KR, 2011, J NONVERBAL BEHAV, V35, P305, DOI 10.1007/s10919-011-0115-4; Scherer KR, 2001, J CROSS CULT PSYCHOL, V32, P76, DOI 10.1177/0022022101032001009; Slagter HA, 2007, PLOS BIOL, V5, P1228, DOI 10.1371/journal.pbio.0050138; Vago DR, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00296; Weng HY, 2013, PSYCHOL SCI, V24, P1171, DOI 10.1177/0956797612469537	25	122	122	5	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0118221	10.1371/journal.pone.0118221	http://dx.doi.org/10.1371/journal.pone.0118221			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC4KQ	25689827	Green Published, gold, Green Submitted			2022-12-26	WOS:000350322700106
J	Liu, LY; Xu, XF; Jing, LL; Zhou, GY; Cao, Z; Han, YC; Zhou, RL				Liu, Luying; Xu, Xuefang; Jing, Lili; Zhou, Gengyin; Cao, Zhang; Han, Yanchun; Zhou, Rouli			Lysosomal-Associated Protein Transmembrane 4 Beta-35 Overexpression Is a Novel Independent Prognostic Marker for Gastric Carcinoma	PLOS ONE			English	Article							LAPTM4B GENE POLYMORPHISM; TETRATRANSMEMBRANE PROTEIN; POOR-PROGNOSIS; CANCER; EXPRESSION; SUSCEPTIBILITY; PROGRESSION; POPULATION; RESISTANCE; TOLERANCE	Objective The purpose of this work was to analyze the relationships between the expression status of Lysosomal-associated protein transmembrane-4 beta 35 (LAPTM4B-35) in cancerous tissues and clinicopathological characteristics and prognosis of the patients with gastric carcinoma (GC). Methods The GC samples from 157 patients in a discovery cohort and 148 patients in a testing cohort with follow-up data were used to validate the feasibility of expression of LAPTM4B-35 protein in predicting GC prognosis. Immunohistochemical staining was used to determine the expression of LAPTM4B-35 protein in precancerous gastric lesions and gastric carcinomas. The correlation between the expression of LAPTM4B-35 and clinicopathologic characteristics of patients with gastric carcinoma was analyzed using chi-square test. Univariate and multivariate analyses were performed to determine the association between LAPTM4B-35 expression and prognosis. Results LAPTM4B-35 expression was increased steadily in sequential stages of precancerous gastric lesions. Positive LAPTM4B-35 expression was more frequently detected in patients with distant metastasis (P = 0.023) and III+ IV TNM stages (P = 0.042) in the discovery cohort. Kaplan-Meier survival curves and univariate analysis showed that expression of LAPTM4B-35 had a significant impact on overall survival of patients with gastric carcinoma in discovery cohort (P < 0.001) and testing cohort (P = 0.001). LAPTM4B-35 expression was an independent prognostic indicator for the overall survival of patients with gastric carcinoma in both cohorts. Conclusions The present research demonstrated that LAPTM4B-35 over-expression was an independent factor in gastric carcinoma prognosis. LAPTM4B gene may be a useful target of interventions slowing the progression of precancerous gastric lesions and a new therapy method to improve the prognosis of gastric carcinoma.	[Liu, Luying; Xu, Xuefang; Cao, Zhang; Han, Yanchun] Binzhou Med Univ, Dept Pathol, Yantai, Shandong, Peoples R China; [Liu, Luying; Zhou, Gengyin] Shandong Univ, Sch Med, Dept Pathol & Pathophysiol, Jinan 250100, Shandong, Peoples R China; [Jing, Lili] Binzhou Med Univ, Yantai Affiliated Hosp, Dept Pathol, Yantai, Shandong, Peoples R China; [Zhou, Rouli] Peking Univ, Dept Cell Biol & Genet, Sch Basic Med Sci, Beijing 100871, Peoples R China	Binzhou Medical University; Shandong University; Binzhou Medical University; Peking University	Liu, LY (corresponding author), Binzhou Med Univ, Dept Pathol, Yantai, Shandong, Peoples R China.	llixq@126.com; rlzhou@bjmu.edu.cn			Natural Science Foundation of Shandong Province [ZR2011HM073, ZR2011HQ025]	Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This work was supported by grants from the Natural Science Foundation of Shandong Province (No. ZR2011HM073 and No. ZR2011HQ025, http://www.sdnsf.gov.cn/portal/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen J, 2014, HEPATO-GASTROENTEROL, V61, P518, DOI 10.5754/hge12954; Cheng XJ, 2008, ANN ONCOL, V19, P527, DOI 10.1093/annonc/mdm469; CORREA P, 1992, CANCER RES, V52, P6735; Cui JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017819; He Jing, 2003, Beijing Da Xue Xue Bao Yi Xue Ban, V35, P348; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kang Y, 2012, AM J SURG, V204, P677, DOI 10.1016/j.amjsurg.2012.02.003; Li L, 2010, ONCOGENE, V29, P5785, DOI 10.1038/onc.2010.303; Li Y, 2012, AUTOPHAGY, V8, P273, DOI 10.4161/auto.8.2.18941; Li Y, 2011, CANCER RES, V71, P7481, DOI 10.1158/0008-5472.CAN-11-0940; Li Y, 2010, NAT MED, V16, P214, DOI 10.1038/nm.2090; Liu XR, 2004, WORLD J GASTROENTERO, V10, P1555, DOI 10.3748/wjg.v10.i11.1555; Liu Xinrong, 2003, Beijing Da Xue Xue Bao Yi Xue Ban, V35, P340; Liu XR, 2009, CANCER SCI, V100, P2335, DOI 10.1111/j.1349-7006.2009.01346.x; Liu Y, 2007, ANN ONCOL, V18, P311, DOI 10.1093/annonc/mdl394; Meng FL, 2010, INT J GYNECOL CANCER, V20, P745, DOI 10.1111/IGC.0b013e3181e02f90; Meng FL, 2010, INT J GYNECOL PATHOL, V29, P587, DOI 10.1097/PGP.0b013e3181e0898e; Peng C, 2005, WORLD J GASTROENTERO, V11, P2704, DOI 10.3748/wjg.v11.i18.2704; Shao GZ, 2003, ONCOGENE, V22, P5060, DOI 10.1038/sj.onc.1206832; Sun Y, 2004, CLIN CANCER RES, V10, P5087, DOI 10.1158/1078-0432.CCR-03-0622; Sun Y, 2012, CHINESE J CANCER RES, V24, P18, DOI 10.1007/s11670-012-0018-x; Xiao M, 2013, J CANCER RES CLIN, V139, P661, DOI 10.1007/s00432-012-1368-y; Yamada Y, 2008, CANCER SCI, V99, P2193, DOI 10.1111/j.1349-7006.2008.00935.x; Yang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034984; Yang H, 2011, SURG TODAY, V41, P810, DOI 10.1007/s00595-010-4338-5; Yang H, 2010, CANCER LETT, V294, P236, DOI 10.1016/j.canlet.2010.02.006; Yang H, 2010, J SURG ONCOL, V101, P363, DOI 10.1002/jso.21489; Yang H, 2010, J CANCER RES CLIN, V136, P275, DOI 10.1007/s00432-009-0659-4; Yang Y, 2008, ONCOL REP, V20, P1077, DOI 10.3892/or_00000112; Yin MZ, 2011, J SURG ONCOL, V104, P29, DOI 10.1002/jso.21912; Yin MZ, 2011, INT J CANCER, V129, P629, DOI 10.1002/ijc.25689; You WC, 1999, INT J CANCER, V83, P615, DOI 10.1002/(SICI)1097-0215(19991126)83:5&lt;615::AID-IJC8&gt;3.0.CO;2-L; Zhang G, 2012, J INT MED RES, V40, P1275, DOI 10.1177/147323001204000406; Zhou L, 2008, CANCER LETT, V264, P209, DOI 10.1016/j.canlet.2008.01.025; Zhou L, 2007, EUR J CANCER, V43, P809, DOI 10.1016/j.ejca.2006.10.025; Zhou L, 2010, HEPATO-GASTROENTEROL, V57, P207; Zhou L, 2010, AM J SURG, V199, P515, DOI 10.1016/j.amjsurg.2009.03.031	37	10	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0118026	10.1371/journal.pone.0118026	http://dx.doi.org/10.1371/journal.pone.0118026			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689860	Green Published, gold, Green Submitted			2022-12-26	WOS:000350322700095
J	Johnson, MD; De Leon, YL				Johnson, Matthew D.; De Leon, Yesenia L.			Effect of an Invasive Plant and Moonlight on Rodent Foraging Behavior in a Coastal Dune Ecosystem	PLOS ONE			English	Article							PREDATION RISK; BUSH LUPINE; PATCH USE; APPARENT COMPETITION; TIME ALLOCATION; SEED PREDATION; SELECTION; SIZE; MANAGEMENT; VIGILANCE	Understanding how invasive plants may alter predator avoidance behaviors is important for granivorous rodents because their foraging can trigger ripple effects in trophic webs. Previous research has shown that European beach grass Ammophila arenaria, an invasive species in coastal California, affects the predation of other seeds by the rodents Microtus californicus, Peromyscus maniculatus, and Reithrodontomys megalotis. This may be due to lower perceived predation risk by rodents foraging in close proximity to the cover provided by Ammophila, but this mechanism has not yet been tested. We examined the perceived predation risk of rodents by measuring the 'giving up density' of food left behind in experimental patches of food in areas with and without abundant cover from Ammophila and under varying amount of moonlight. We found strong evidence that giving up density was lower in the thick uniform vegetation on Ammophila-dominated habitat than it was in the more sparsely and diversely vegetated restored habitat. There was also evidence that moonlight affected giving up density and that it mediated the effects of habitat, although with our design we were unable to distinguish the effects of lunar illumination and moon phase. Our findings illustrate that foraging rodents, well known to be risk-averse during moonlit nights, are also affected by the presence of an invasive plant. This result has implications for granivory and perhaps plant demography in invaded and restored coastal habitats. Future research in this system should work to unravel the complex trophic links formed by a non-native invasive plant (i.e., Ammophila) providing cover favored by native rodents, which likely forage on and potentially limit the recruitment of native and non-native plants, some of which have ecosystem consequences of their own.	[Johnson, Matthew D.; De Leon, Yesenia L.] Humboldt State Univ, Dept Wildlife, Arcata, CA 95521 USA	California State University System; California State Polytechnic University, Humboldt	Johnson, MD (corresponding author), Humboldt State Univ, Dept Wildlife, Arcata, CA 95521 USA.	matt.johnson@humboldt.edu			National Science Foundation [0934022]; Direct For Biological Sciences [0934022] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was made possible by funding from National Science Foundation (Undergraduate Research and Mentoring award #0934022) to Dr. Bruce O'Gara (PI) and Johnson (co-PI) at Humboldt State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATZLI G O, 1970, Ecology (Washington D C), V51, P1027, DOI 10.2307/1933629; BATZLI GO, 1971, J MAMMAL, V52, P141, DOI 10.2307/1378438; Blumstein DT, 2010, PRIMER OF CONSERVATION BEHAVIOR, P1; BOUSKILA A, 1992, AM NAT, V139, P161, DOI 10.1086/285318; Brown JH, 2002, BIOSCIENCE, V52, P979, DOI 10.1641/0006-3568(2002)052[0979:RARCDO]2.0.CO;2; BROWN JS, 1988, BEHAV ECOL SOCIOBIOL, V22, P37, DOI 10.1007/BF00395696; Brown JS, 2004, ECOL LETT, V7, P999, DOI 10.1111/j.1461-0248.2004.00661.x; Buell AC, 1995, CONSERV BIOL, V9, P1587, DOI 10.1046/j.1523-1739.1995.09061587.x; Bureau of Land Management, 2011, OV COAST DUN NAT PLA; Chaneton EJ, 2000, OIKOS, V88, P380, DOI 10.1034/j.1600-0706.2000.880217.x; Dangremond EM, 2010, ECOLOGY, V91, P2261, DOI 10.1890/09-0418.1; Embar K, 2011, OIKOS, V120, P1657, DOI 10.1111/j.1600-0706.2011.19278.x; Falcy MR, 2013, ECOLOGY, V94, P2632, DOI 10.1890/13-0426.1; Gordon DR, 1998, ECOL APPL, V8, P975, DOI 10.1890/1051-0761(1998)008[0975:EOINIP]2.0.CO;2; Gutman R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023446; HUGHES JJ, 1993, ANIM BEHAV, V46, P1243, DOI 10.1006/anbe.1993.1320; HULME PE, 1994, J ECOL, V82, P645, DOI 10.2307/2261271; Janzen D. H., 1971, A Rev Ecol Syst, V2, P465, DOI 10.1146/annurev.es.02.110171.002341; Johnson MD, 2008, WEST N AM NATURALIST, V68, P444, DOI 10.3398/1527-0904-68.4.444; KERLEY GIH, 1991, OECOLOGIA, V86, P261, DOI 10.1007/BF00317539; KOTLER BP, 1988, OIKOS, V53, P145, DOI 10.2307/3566056; Kotler BP, 2010, P ROY SOC B-BIOL SCI, V277, P1469, DOI 10.1098/rspb.2009.2036; LONGLAND WS, 1994, AM MIDL NAT, V132, P82, DOI 10.2307/2426203; LONGLAND WS, 1991, ECOLOGY, V72, P2261, DOI 10.2307/1941576; Maron JL, 1996, OECOLOGIA, V105, P302, DOI 10.1007/BF00328732; Maron JL, 1997, OECOLOGIA, V111, P76, DOI 10.1007/s004420050210; Maron JL, 2001, J ECOL, V89, P578, DOI 10.1046/j.1365-2745.2001.00560.x; Mattos KJ, 2010, BEHAV ECOL, V21, P556, DOI 10.1093/beheco/arq020; Mooney H.A., 2000, INVASIVE SPECIES CHA; Morris DW, 2000, ECOLOGY, V81, P2061, DOI 10.1890/0012-9658(2000)081[2061:OFMMPU]2.0.CO;2; MURRAY BR, 1994, WILDLIFE RES, V21, P647, DOI 10.1071/WR9940647; Orrock JL, 2004, BEHAV ECOL, V15, P433, DOI 10.1093/beheco/arh031; Pickart AJ, 1998, RESTOR ECOL, V6, P59, DOI 10.1046/j.1526-100x.1998.00618.x; PRICE MV, 1984, J MAMMAL, V65, P353, DOI 10.2307/1381183; PRICE MV, 1983, OECOLOGIA, V60, P259, DOI 10.1007/BF00379529; Prugh LR, 2014, J ANIM ECOL, V83, P504, DOI 10.1111/1365-2656.12148; R Core Team, 2018, R LANG ENV STAT COMP; Seastedt TR, 2008, FRONT ECOL ENVIRON, V6, P547, DOI 10.1890/070046; U.S. Naval Observatory, 2014, COMPL SUN MOON DAT O; Vitousek PM, 1996, AM SCI, V84, P468; Vitousek PM, 1986, ECOLOGY BIOL INVASIO, V58; Wiedemann AM, 1996, LANDSCAPE URBAN PLAN, V34, P287, DOI 10.1016/0169-2046(95)00240-5; Zimecki Michal, 2006, Postepy Hig Med Dosw (Online), V60, P1	43	9	9	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117903	10.1371/journal.pone.0117903	http://dx.doi.org/10.1371/journal.pone.0117903			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679785	gold, Green Submitted, Green Published			2022-12-26	WOS:000350682600094
J	Liu, LB; Li, M; Zhuo, WY; Zhang, YS; Xu, AD				Liu, Li-Bin; Li, Mu; Zhuo, Wen-Yan; Zhang, Yu-Sheng; Xu, An-Ding			The Role of Hs-CRP, D-Dimer and Fibrinogen in Differentiating Etiological Subtypes of Ischemic Stroke	PLOS ONE			English	Article							C-REACTIVE PROTEIN; SEVERITY; ASSOCIATION; INFARCTION; DIAGNOSIS; RISK	The aim of this study was to evaluate the diagnostic value of the serum biochemical markers high-sensitivity C-reactive protein (hs-CRP), D-dimer (DD) and fibrinogen (Fg) in differentiating etiological subtypes of ischemic stroke. This study was a retrospective case-only study, consecutively including patients with acute ischemic stroke. All patients were classified into subtypes using the TOAST classification system. A total of 317 patients were evaluated. Hs-CRP and DD levels were significantly different among the subtypes and were the highest in CE, followed by LAA and SAA; no significant difference between the subtypes was found for Fg. Hs-CRP > 6.96 mg/L was classified as the CE subtype, with a sensitivity of 41% and a specificity of 74%; DD > 791.30 ng/mL was classified as CE, with a sensitivity of 58% and a specificity of 78%. The combination of hs-CRP and DD classification as CE yielded a sensitivity of 65% and a specificity of 91%. DD > 791.30 ng/mL was considered an independent predictive factor of CE. Hs-CRP and DD could be useful for identifying the etiological subtypes of acute ischemic stroke, especially for predicting CE. The diagnostic value of DD was higher than that of hs-CRP.	[Liu, Li-Bin; Li, Mu; Zhang, Yu-Sheng; Xu, An-Ding] Jinan Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou, Guangdong, Peoples R China; [Liu, Li-Bin; Zhuo, Wen-Yan] Jinan Univ, Zhuhai Hosp, Dept Neurol, Zhuhai, Peoples R China	Jinan University; Jinan University	Xu, AD (corresponding author), Jinan Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou, Guangdong, Peoples R China.	ADX63@sohu.com		Xu, An-Ding/0000-0003-3154-0985				ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Ageno W, 2002, ARCH INTERN MED, V162, P2589, DOI 10.1001/archinte.162.22.2589; Anderson JL, 2004, AM J CARDIOL, V94, P1255, DOI 10.1016/j.amjcard.2004.07.108; Beer C, 2011, MED SCI MONITOR, V17, pCR467, DOI 10.12659/MSM.881931; Cao JJ, 2003, CIRCULATION, V108, P166, DOI 10.1161/01.CIR.0000079160.07364.6A; Carter AM, 1997, ARTERIOSCL THROM VAS, V17, P589, DOI 10.1161/01.ATV.17.3.589; Chapman CML, 2004, STROKE, V35, P1619, DOI 10.1161/01.STR.0000130857.19423.ad; Chuang SY, 2009, STROKE, V40, P1578, DOI 10.1161/STROKEAHA.108.540492; Eidelman RS, 2003, EUR HEART J, V24, P501, DOI 10.1016/S0195-668X(02)00810-2; Eikelboom John W, 2003, J Stroke Cerebrovasc Dis, V12, P74, DOI 10.1053/jscd.2003.16; Giannopoulos S, 2008, NEUROL RES, V30, P727, DOI 10.1179/174313208X297904; Habib SS, 2013, PAK J MED SCI, V29, P1425; Isenegger J, 2010, CEREBROVASC DIS, V29, P82, DOI 10.1159/000256652; Kara H, 2014, NEUROPSYCH DIS TREAT, V10, P1451, DOI 10.2147/NDT.S67665; Koch Horst J, 2005, J Stroke Cerebrovasc Dis, V14, P75, DOI 10.1016/j.jstrokecerebrovasdis.2004.12.002; Ladenvall C, 2006, STROKE, V37, P2018, DOI 10.1161/01.STR.0000231872.86071.68; Lorenz MW, 2007, STROKE, V38, P1774, DOI 10.1161/STROKEAHA.106.476135; Luo Y, 2012, CAN J NEUROL SCI, V39, P69, DOI 10.1017/S0317167100012713; MARDER VJ, 1983, ANN NY ACAD SCI, V408, P397, DOI 10.1111/j.1749-6632.1983.tb23260.x; Matsumoto M, 2013, CEREBROVASC DIS, V35, P64, DOI 10.1159/000345336; Montaner J, 2008, STROKE, V39, P2280, DOI 10.1161/STROKEAHA.107.505354; Pandey A, 2014, NEUROCHEM RES, V39, P1426, DOI 10.1007/s11064-014-1328-9; Siegerink B, 2009, J THROMB HAEMOST, V7, P385, DOI 10.1111/j.1538-7836.2008.03266.x; Terruzzi A, 2008, NEUROL SCI, V29, P245, DOI 10.1007/s10072-008-0975-5; Tombul T, 2005, J CLIN NEUROSCI, V12, P429, DOI 10.1016/j.jocn.2004.06.013; Turaj Wojciech, 2006, Neurol Neurochir Pol, V40, P297; Vibo R, 2007, FREE RADICAL RES, V41, P282, DOI 10.1080/10715760601083235; Zi WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086465	28	23	28	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0118301	10.1371/journal.pone.0118301	http://dx.doi.org/10.1371/journal.pone.0118301			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680111	Green Published, gold, Green Submitted			2022-12-26	WOS:000350682600117
J	Xu, Q; Liu, LZ; Yin, Y; He, J; Li, Q; Qian, X; You, Y; Lu, Z; Peiper, SC; Shu, Y; Jiang, BH				Xu, Q.; Liu, L-Z; Yin, Y.; He, J.; Li, Q.; Qian, X.; You, Y.; Lu, Z.; Peiper, S. C.; Shu, Y.; Jiang, B-H			Regulatory circuit of PKM2/NF-kappa B/miR-148a/152-modulated tumor angiogenesis and cancer progression	ONCOGENE			English	Article							PYRUVATE-KINASE M2; GENE-TRANSCRIPTION; GLUCOSE-METABOLISM; GROWTH; PROMOTES; CELLS; PKM2; APOPTOSIS; INSULIN; TRANSFORMATION	Upregulation of the embryonic M2 isoform of pyruvate kinase (PKM2) emerges as a critical player in the cancer development and metabolism, yet the underlying mechanism of PKM2 overexpression remains to be elucidated. Here we demonstrate that IGF-1/IGF-IR regulates PKM2 expression by enhancing HIF-1 alpha-p65 complex binding to PKM2 promoter. PKM2 expression is regulated by miR-148a/152 suppression. PKM2 directly interacts with NF-kappa B p65 subunit to promote EGR1 expression for regulating miR-148a/152 feedback circuit in normal cells, but not in cancer cells because of the DNA hypermethylation of miR-148a and miR-152 gene promoters. The silencing of miR-148a/152 contributes to the overexpression of PKM2, NF-kappa B or/and IGF-IR in some cancer cells. We show that disruption of PKM2/NF-kappa B/miR-148a/152 feedback loop can regulate cancer cell growth and angiogenesis, and is also associated with triple-negative breast cancer (TNBC) phenotype, which may have clinical implication for providing novel biomarker(s) of TNBC and potential therapeutic target(s) in the future.	[Xu, Q.; Li, Q.; Qian, X.; Jiang, B-H] Nanjing Med Univ, Collaborat Innovat Ctr Canc Personalized Med, State Key Lab Reprod Med, Dept Pathol,Canc Ctr, Nanjing, Jiangsu, Peoples R China; [Liu, L-Z; He, J.; Peiper, S. C.; Jiang, B-H] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [Shu, Y.] Nanjing Med Univ, Affiliated Hosp 1, Dept Oncol, Collaborat Innovat Ctr Canc Personalized Med,Canc, Nanjing, Jiangsu, Peoples R China; [You, Y.] Nanjing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China; [Lu, Z.] Univ Texas MD Anderson Canc Ctr, Brain Tumor Ctr, Houston, TX 77030 USA; [Lu, Z.] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA; [Yin, Y.] Anhui Med Univ, Dept Pathol, Hefei, Peoples R China	Nanjing Medical University; Jefferson University; Nanjing Medical University; Nanjing Medical University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Anhui Medical University	Shu, Y (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Oncol, Nanjing, Jiangsu, Peoples R China.	shuyongqian@csco.org.cn; binghjiang@yahoo.com	Shu, Yongqian/ABD-5698-2021	Jiang, Bing-Hua/0000-0003-4526-2031; Hartl, Carla/0000-0001-9769-7462; He, Jun/0000-0002-5162-6041; Liu, Ling-Zhi/0000-0001-9234-457X	National Natural Science Foundation of China [81320108019, 81270736, 81071642]; Jiangsu Province Clinical Science and Technology Project [BL2012008]; Priority Academic Program Development of Jiangsu Higher Education Institutions [JX10231801]; Jiangsu Province's Key Discipline of Medicine [XK201117]; National Institutes of Health [R01ES020868, R21CA175975]; NATIONAL CANCER INSTITUTE [R21CA175975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020868] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province Clinical Science and Technology Project; Priority Academic Program Development of Jiangsu Higher Education Institutions; Jiangsu Province's Key Discipline of Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by National Natural Science Foundation of China (81320108019, 81270736, 81071642), by Jiangsu Province Clinical Science and Technology Project (BL2012008), the Priority Academic Program Development of Jiangsu Higher Education Institutions (JX10231801), Jiangsu Province's Key Discipline of Medicine (XK201117), and by National Institutes of Health grants R01ES020868 and R21CA175975.	Badve S, 2011, MODERN PATHOL, V24, P157, DOI 10.1038/modpathol.2010.200; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Ferguson EC, 2008, TRENDS BIOCHEM SCI, V33, P359, DOI 10.1016/j.tibs.2008.05.006; Gao XL, 2012, MOL CELL, V45, P598, DOI 10.1016/j.molcel.2012.01.001; GULER HP, 1987, NEW ENGL J MED, V317, P137, DOI 10.1056/NEJM198707163170303; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Iqbal MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036764; Jung CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027740; Kefas B, 2010, NEURO-ONCOLOGY, V12, P1102, DOI 10.1093/neuonc/noq080; Kitamura K, 2011, J HEPATOL, V55, P846, DOI 10.1016/j.jhep.2011.01.038; Kosugi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028234; Kwon OH, 2012, BIOCHEM BIOPH RES CO, V423, P38, DOI 10.1016/j.bbrc.2012.05.063; Lehmann U, 2008, J PATHOL, V214, P17, DOI 10.1002/path.2251; Liu CT, 1998, CANCER GENE THER, V5, P3; Liu XG, 2010, J IMMUNOL, V185, P7244, DOI 10.4049/jimmunol.1001573; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Lv L, 2011, MOL CELL, V42, P719, DOI 10.1016/j.molcel.2011.04.025; Macintyre AN, 2011, MOL CELL, V42, P713, DOI 10.1016/j.molcel.2011.06.003; Mazurek S, 2003, ANTICANCER RES, V23, P1149; Mitsiades CS, 2004, CANCER CELL, V5, P221, DOI 10.1016/S1535-6108(04)00050-9; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Schmidt M, 2010, J CANCER RES CLIN, V136, P219, DOI 10.1007/s00432-009-0652-y; Schultz NA, 2012, WORLD J SURG, V36, P2699, DOI 10.1007/s00268-012-1705-y; Sun QA, 2011, P NATL ACAD SCI USA, V108, P4129, DOI 10.1073/pnas.1014769108; Takahashi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046684; Tamada M, 2012, CANCER RES, V72, P1438, DOI 10.1158/0008-5472.CAN-11-3024; Thyss R, 2005, EMBO J, V24, P128, DOI 10.1038/sj.emboj.7600501; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Xu Q, 2013, J MOL CELL BIOL, V5, P3, DOI 10.1093/jmcb/mjs049; Yang WW, 2012, MOL CELL, V48, P771, DOI 10.1016/j.molcel.2012.09.028; Yang WW, 2012, CELL, V150, P685, DOI 10.1016/j.cell.2012.07.018; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598; Zhang H, 2011, CELL DEATH DIFFER, V18, P1702, DOI 10.1038/cdd.2011.28; Zhang R, 2014, TUMOR BIOL, V35, P837, DOI 10.1007/s13277-013-1115-2	36	69	72	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2015	34	43					5482	5493		10.1038/onc.2015.6	http://dx.doi.org/10.1038/onc.2015.6			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CU4EM	25703326				2022-12-26	WOS:000363479700008
J	Gonzalez-Garcia, VA; Pulido-Cid, M; Garcia-Doval, C; Bocanegra, R; van Raaij, MJ; Martin-Benito, J; Cuervo, A; Carrascosa, JL				Gonzalez-Garcia, Veronica A.; Pulido-Cid, Mar; Garcia-Doval, Carmela; Bocanegra, Rebeca; van Raaij, Mark J.; Martin-Benito, Jaime; Cuervo, Ana; Carrascosa, Jose L.			Conformational Changes Leading to T7 DNA Delivery upon Interaction with the Bacterial Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacteriophage; DNA Viruses; Electron Microscopy (EM); Protein Complex; Virus Entry; Virus Structure	ELECTRON-MICROSCOPY; BACTERIOPHAGE SPP1; STRUCTURAL-CHANGES; IN-VITRO; TERMINAL DOMAIN; GENOME; HOST; EJECTION; MECHANISM; INFECTION	The majority of bacteriophages protect their genetic material by packaging the nucleic acid in concentric layers to an almost crystalline concentration inside protein shells (capsid). This highly condensed genome also has to be efficiently injected into the host bacterium in a process named ejection. Most phages use a specialized complex (often a tail) to deliver the genome without disrupting cell integrity. Bacteriophage T7 belongs to the Podoviridae family and has a short, non-contractile tail formed by a tubular structure surrounded by fibers. Here we characterize the kinetics and structure of bacteriophage T7 DNA delivery process. We show that T7 recognizes lipopolysaccharides (LPS) from Escherichia coli rough strains through the fibers. Rough LPS acts as the main phage receptor and drives DNA ejection in vitro. The structural characterization of the phage tail after ejection using cryo-electron microscopy (cryo-EM) and single particle reconstruction methods revealed the major conformational changes needed for DNA delivery at low resolution. Interaction with the receptor causes fiber tilting and opening of the internal tail channel by untwisting the nozzle domain, allowing release of DNA and probably of the internal head proteins.	[Gonzalez-Garcia, Veronica A.; Pulido-Cid, Mar; Garcia-Doval, Carmela; Bocanegra, Rebeca; van Raaij, Mark J.; Martin-Benito, Jaime; Cuervo, Ana; Carrascosa, Jose L.] CSIC, Ctr Nacl Biotecnol, Struct Macromol Dept, E-28049 Madrid, Spain; [Carrascosa, Jose L.] IMDEA Nanociencia, Inst Madrileno Estudios Avanzados Nanociencia, Madrid 28049, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); IMDEA Nanociencia	Cuervo, A (corresponding author), Ctr Nacl Biotecnol, CSIC C Darwin 3,Cantoblanco, Madrid 28049, Spain.	acuervo@cnb.csic.es; jlcarras@cnb.csic.es	van Raaij, Mark J/B-3678-2009; Bocanegra, Rebeca/AAO-3887-2020; Cuervo, Ana/AAB-1464-2020	van Raaij, Mark J/0000-0002-4781-1375; Bocanegra, Rebeca/0000-0002-9024-9365; Martin-Benito Romero, Jaime/0000-0002-8541-4709; Garcia Doval, Carmela/0000-0002-3422-9490; Cuervo, Ana/0000-0001-9414-503X	Spanish Ministry of Economy and Competitiveness [BFU2011-29038, BFU2011-25090, BFU2011-24843]	Spanish Ministry of Economy and Competitiveness(Spanish Government)	This work was supported by the Spanish Ministry of Economy and Competitiveness Grants BFU2011-29038 (to J. L. C.), BFU2011-25090 (to J. M.-B.), and BFU2011-24843 (to M. J. v. R.).	Agirrezabala X, 2005, EMBO J, V24, P3820, DOI 10.1038/sj.emboj.7600840; Andres D, 2012, MOL MICROBIOL, V83, P1244, DOI 10.1111/j.1365-2958.2012.08006.x; Andres D, 2010, J BIOL CHEM, V285, P36768, DOI 10.1074/jbc.M110.169003; Bertin A, 2011, CURR OPIN MICROBIOL, V14, P492, DOI 10.1016/j.mib.2011.07.010; Bhardwaj A, 2014, CURR OPIN STRUC BIOL, V25, P1, DOI 10.1016/j.sbi.2013.10.005; Casjens SR, 2012, ADV EXP MED BIOL, V726, P143, DOI 10.1007/978-1-4614-0980-9_7; Chang CY, 2010, VIROLOGY, V398, P176, DOI 10.1016/j.virol.2009.12.002; Chang JT, 2010, J MOL BIOL, V402, P731, DOI 10.1016/j.jmb.2010.07.058; Chiaruttini N, 2010, BIOPHYS J, V99, P447, DOI 10.1016/j.bpj.2010.04.048; Cuervo A., 2013, BACTERIOPHAGE, DOI [10.4161/bact.27011, DOI 10.4161/BACT.27011]; Cuervo A, 2013, J BIOL CHEM, V288, P26290, DOI 10.1074/jbc.M113.491209; Cuervo Ana, 2013, Subcell Biochem, V68, P361, DOI 10.1007/978-94-007-6552-8_12; Cuervo A, 2012, CURR OPIN BIOTECH, V23, P529, DOI 10.1016/j.copbio.2011.11.029; de la Rosa-Trevin JM, 2013, J STRUCT BIOL, V184, P321, DOI 10.1016/j.jsb.2013.09.015; Garcia-Doval C, 2012, P NATL ACAD SCI USA, V109, P9390, DOI 10.1073/pnas.1119719109; Garcia-Doval C, 2012, ACTA CRYSTALLOGR F, V68, P166, DOI 10.1107/S1744309111051049; HERSHEY AD, 1952, J GEN PHYSIOL, V36, P39, DOI 10.1085/jgp.36.1.39; Hu B, 2013, SCIENCE, V339, P576, DOI 10.1126/science.1231887; Jiang W, 2006, NATURE, V439, P612, DOI 10.1038/nature04487; Kemp P, 2005, VIROLOGY, V340, P307, DOI 10.1016/j.virol.2005.06.039; KOIKE M, 1971, J BACTERIOL, V108, P1402, DOI 10.1128/JB.108.3.1402-1411.1971; Kostyuchenko VA, 2005, NAT STRUCT MOL BIOL, V12, P810, DOI 10.1038/nsmb975; KRUGER DH, 1981, MICROBIOL REV, V45, P9; Leiman PG, 2007, J MOL BIOL, V371, P836, DOI 10.1016/j.jmb.2007.05.083; Lhuillier S, 2009, P NATL ACAD SCI USA, V106, P8507, DOI 10.1073/pnas.0812407106; LINDBERG AA, 1973, ANNU REV MICROBIOL, V27, P205, DOI 10.1146/annurev.mi.27.100173.001225; Liu XA, 2010, NAT STRUCT MOL BIOL, V17, P830, DOI 10.1038/nsmb.1823; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Molineux IJ, 2013, NAT REV MICROBIOL, V11, P194, DOI 10.1038/nrmicro2988; Molineux IJ, 2001, MOL MICROBIOL, V40, P1, DOI 10.1046/j.1365-2958.2001.02357.x; Oliveira L, 2005, J MOL BIOL, V353, P529, DOI 10.1016/j.jmb.2005.08.063; Parent KN, 2014, MOL MICROBIOL, V92, P47, DOI 10.1111/mmi.12536; Peralta B, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001667; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plisson C, 2007, EMBO J, V26, P3720, DOI 10.1038/sj.emboj.7601786; Qimron U, 2006, P NATL ACAD SCI USA, V103, P19039, DOI 10.1073/pnas.0609428103; Rakonjac J, 2011, CURR ISSUES MOL BIOL, V13, P51, DOI 10.21775/cimb.013.051; Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Sorzano COS, 2010, J STRUCT BIOL, V171, P197, DOI 10.1016/j.jsb.2010.03.011; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; Sun L, 2014, NATURE, V505, P432, DOI 10.1038/nature12816; Veesler D, 2011, MICROBIOL MOL BIOL R, V75, P423, DOI 10.1128/MMBR.00014-11; Vinga I., 2006, MODERN BACTERIOPHAGE, P167; Xiang Y, 2006, EMBO J, V25, P5229, DOI 10.1038/sj.emboj.7601386; Zhao XN, 2013, J VIROL, V87, P12260, DOI 10.1128/JVI.01948-13	46	38	39	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10038	10044		10.1074/jbc.M114.614222	http://dx.doi.org/10.1074/jbc.M114.614222			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25697363	Green Published, hybrid			2022-12-26	WOS:000353241100011
J	Wang, YB; Tan, B; Mu, R; Chang, Y; Wu, M; Tu, HQ; Zhang, YC; Guo, SS; Qin, XH; Li, T; Li, WH; Li, AL; Zhang, XM; Li, HY				Wang, Yu-Bo; Tan, Bo; Mu, Rui; Chang, Yan; Wu, Min; Tu, Hai-Qing; Zhang, Yu-Cheng; Guo, Sai-Sai; Qin, Xuan-He; Li, Tao; Li, Wei-Hua; Li, Ai-Ling; Zhang, Xue-Min; Li, Hui-Yan			Ubiquitin-associated Domain-containing Ubiquitin Regulatory X (UBX) Protein UBXN1 Is a Negative Regulator of Nuclear Factor kappa B (NF-kappa B) Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Inflammation; NF-B; Polyubiquitin Chain; Signal Transduction; Tumor Necrosis Factor (TNF); UBXN1; cIAPs	IKK ACTIVATION; KINASE IKK; AAA-ATPASE; CANCER; INFLAMMATION; PATHWAY; SYSTEM; NEMO; P47	Excessive nuclear factor B (NF-B) activation should be precisely controlled as it contributes to multiple immune and inflammatory diseases. However, the negative regulatory mechanisms of NF-B activation still need to be elucidated. Various types of polyubiquitin chains have proved to be involved in the process of NF-B activation. Many negative regulators linked to ubiquitination, such as A20 and CYLD, inhibit IB kinase activation in the NF-B signaling pathway. To find new NF-B signaling regulators linked to ubiquitination, we used a small scale siRNA library against 51 ubiquitin-associated domain-containing proteins and screened out UBXN1, which contained both ubiquitin-associated and ubiquitin regulatory X (UBX) domains as a negative regulator of TNF-triggered NF-B activation. Overexpression of UBXN1 inhibited TNF-triggered NF-B activation, although knockdown of UBXN1 had the opposite effect. UBX domain-containing proteins usually act as valosin-containing protein (VCP)/p97 cofactors. However, knockdown of VCP/p97 barely affected UBXN1-mediated NF-B inhibition. At the same time, we found that UBXN1 interacted with cellular inhibitors of apoptosis proteins (cIAPs), E3 ubiquitin ligases of RIP1 in the TNF receptor complex. UBXN1 competitively bound to cIAP1, blocked cIAP1 recruitment to TNFR1, and sequentially inhibited RIP1 polyubiquitination in response to TNF. Therefore, our findings demonstrate that UBXN1 is an important negative regulator of the TNF-triggered NF-B signaling pathway by mediating cIAP recruitment independent of VCP/p97.	[Wang, Yu-Bo; Tan, Bo; Mu, Rui; Chang, Yan; Wu, Min; Tu, Hai-Qing; Zhang, Yu-Cheng; Guo, Sai-Sai; Qin, Xuan-He; Li, Tao; Li, Wei-Hua; Li, Ai-Ling; Zhang, Xue-Min; Li, Hui-Yan] Natl Ctr Biomed Anal, Inst Basic Med Sci, Beijing 100850, Peoples R China		Li, HY (corresponding author), Natl Ctr Biomed Anal, Inst Basic Med Sci, Beijing 100850, Peoples R China.	hyli@ncba.ac.cn		Li, Tao/0000-0002-0746-8322	National Basic Research Program of China [2013CB910302, 2012CB910701, 2012CB910801]; National Natural Science Foundation of China [81325014, 81130037, 31370761, 81221004, 81025010]; National Science and Technology Major Projects for "Major New Drugs Innovation and Development" [2012ZX09301003-001-001]; International S&T Corporation Program of China [2013DFA31710]; National Science and Technology Support Program [2012BAK25B00]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Projects for "Major New Drugs Innovation and Development"; International S&T Corporation Program of China; National Science and Technology Support Program	This work was supported by National Basic Research Program of China Grants 2013CB910302, 2012CB910701, and 2012CB910801, National Natural Science Foundation of China Grants 81325014, 81130037, 31370761, 81221004, and 81025010, National Science and Technology Major Projects for "Major New Drugs Innovation and Development" Grant 2012ZX09301003-001-001, International S&T Corporation Program of China Grant 2013DFA31710, and National Science and Technology Support Program Grant 2012BAK25B00.	Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Chen ZJJ, 2012, IMMUNOL REV, V246, P95, DOI 10.1111/j.1600-065X.2012.01108.x; Chernorudskiy AL, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004251; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; Ghosh S, 2012, IMMUNOL REV, V246, P5, DOI 10.1111/j.1600-065X.2012.01111.x; Harhaj EW, 2012, IMMUNOL REV, V246, P107, DOI 10.1111/j.1600-065X.2012.01100.x; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Hofmann K, 1996, TRENDS BIOCHEM SCI, V21, P172, DOI 10.1016/0968-0004(96)30015-7; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; Li HY, 2008, NAT IMMUNOL, V9, P533, DOI 10.1038/ni.1600; Meyer H, 2014, J CELL SCI, V127, P3877, DOI 10.1242/jcs.093831; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Park MY, 2007, J BIOL CHEM, V282, P27572, DOI 10.1074/jbc.C700106200; Schuberth C, 2008, CELL MOL LIFE SCI, V65, P2360, DOI 10.1007/s00018-008-8072-8; Shibata Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2068; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wang PH, 2013, CELL REP, V3, P1057, DOI 10.1016/j.celrep.2013.02.027; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wu-Baer F, 2010, MOL CELL BIOL, V30, P2787, DOI 10.1128/MCB.01056-09	24	20	20	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10395	10405		10.1074/jbc.M114.631689	http://dx.doi.org/10.1074/jbc.M114.631689			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25681446	Green Published, hybrid			2022-12-26	WOS:000353241100040
J	Blaisdell, GK; Roy, BA; Pfeifer-Meister, L; Bridgham, SD				Blaisdell, G. Kai; Roy, Bitty A.; Pfeifer-Meister, Laurel; Bridgham, Scott D.			An Exploration of Hypotheses that Explain Herbivore and Pathogen Attack in Restored Plant Communities	PLOS ONE			English	Article							VEGETATIONAL DIVERSITY; SPECIES-DIVERSITY; POPULATION-DYNAMICS; NITROGEN DEPOSITION; ECOLOGY; DISEASE; LEAF; DOMINANCE; SUSCEPTIBILITY; CONSEQUENCES	Many hypotheses address the associations of plant community composition with natural enemies, including: (i) plant species diversity may reduce enemy attack, (ii) attack may increase as host abundance increases, (iii) enemy spillover may lead to increased attack on one host species due to transmission from another host species, or enemy dilution may lead to reduced attack on a host that would otherwise have more attack, (iv) physical characteristics of the plant community may influence attack, and (v) plant vigor may affect attack. Restoration experiments with replicated plant communities provide an exceptional opportunity to explore these hypotheses. To explore the relative predictive strengths of these related hypotheses and to investigate the potential effect of several restoration site preparation techniques, we surveyed arthropod herbivore and fungal pathogen attack on the six most common native plant species in a restoration experiment. Multi-model inference revealed a weak but consistent negative correlation with pathogen attack and host diversity across the plant community, and no correlation between herbivory and host diversity. Our analyses also revealed host species-specific relationships between attack and abundance of the target host species, other native plant species, introduced plant species, and physical community characteristics. We found no relationship between enemy attack and plant vigor. We found minimal differences in plant community composition among several diverse site preparation techniques, and limited effects of site preparation techniques on attack. The strongest associations of community characteristics with attack varied among plant species with no community-wide patterns, suggesting that no single hypothesis successfully predicts the dominant community-wide trends in enemy attack.	[Blaisdell, G. Kai; Roy, Bitty A.; Pfeifer-Meister, Laurel; Bridgham, Scott D.] Univ Oregon, Dept Biol, Inst Ecol & Evolut, Eugene, OR 97403 USA	University of Oregon	Blaisdell, GK (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	blaisdell@berkeley.edu	Bridgham, Scott/R-1557-2017	Bridgham, Scott/0000-0003-0614-2678; Roy, Bitty A./0000-0003-1666-5624	National Science Foundation [NSF DEB-0515777, DGE-0742540]; United States Environmental Protection Agency (EPA); City of Eugene; EPA-STAR fellowship	National Science Foundation(National Science Foundation (NSF)); United States Environmental Protection Agency (EPA)(United States Environmental Protection Agency); City of Eugene; EPA-STAR fellowship(United States Environmental Protection Agency)	This study was conducted on property owned by the City of Eugene, Oregon, United States of America, in collaboration with the West Eugene Wetlands Partnership, and Lane Council of Governments. Support for this study came from the National Science Foundation, grant number NSF DEB-0515777 granted to BAR (http://www.nsf.gov/div/index.jsp?div=DEB). Funding for the restoration experiment was provided by a wetland program development grant from the United States Environmental Protection Agency (EPA) to SDB, BAR, and B. Johnson, with matching funds provided by the City of Eugene, and by an EPA-STAR fellowship granted to LPM (http://water.epa.gov/grants_funding/wetlands/grantguidelines/, http://www.epa.gov/ncer/). GKB was supported by the National Science Foundation Graduate STEM Fellows in K-12 Education program under Grant No. DGE-0742540 (http://pages.uoregon.edu/msiuo/GK12/Overview.html). The West Eugene Wetlands Partnership and Lane Council of Governments were involved in selection and implementation of the restoration techniques that were used in the restoration experiment. Beyond this, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2006, Q REV BIOL, V81, P349, DOI 10.1086/511529; Alexander H. M., 1992, The fungal community: its organization and role in the ecosystem., P481; ANDOW DA, 1991, ANNU REV ENTOMOL, V36, P561, DOI 10.1146/annurev.en.36.010191.003021; ANTONOVICS J, 1995, AM NAT, V145, P661, DOI 10.1086/285761; Beckstead J, 2010, J ECOL, V98, P168, DOI 10.1111/j.1365-2745.2009.01599.x; Blaisdell GK, 2011, THESIS U OREGON; Borer ET, 2007, P NATL ACAD SCI USA, V104, P5473, DOI 10.1073/pnas.0608573104; Bradley DJ, 2003, AM J BOT, V90, P857, DOI 10.3732/ajb.90.6.857; Burdon JJ., 1987, DIS PLANT POPULATION; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cobb RC, 2010, ECOLOGY, V91, P327, DOI 10.1890/09-0680.1; COLLINGE SK, 1988, OECOLOGIA, V75, P559, DOI 10.1007/BF00776420; Cornelissen T, 2008, OIKOS, V117, P1121, DOI 10.1111/j.0030-1299.2008.16588.x; DEJONG TM, 1975, OIKOS, V26, P222, DOI 10.2307/3543712; DeWalt SJ, 2004, ECOLOGY, V85, P471, DOI 10.1890/02-0728; Dizney LJ, 2009, EMERG INFECT DIS, V15, P1012, DOI [10.3201/eid1507.081621, 10.3201/eid1507.081083]; Dobson A, 2004, AM NAT, V164, pS64, DOI 10.1086/424681; Elton C. S., 1958, ECOLOGY INVASIONS AN; Fitzpatrick G. S., 2004, TECHNIQUES RESTORING; Folgarait PJ, 1995, ENVIRON ENTOMOL, V24, P1487, DOI 10.1093/ee/24.6.1487; Gaborcik N, 2003, PHOTOSYNTHETICA, V41, P285, DOI 10.1023/B:PHOT.0000011963.43628.15; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; Harmon JP, 2003, POPUL ECOL, V45, P75, DOI 10.1007/s10144-003-0146-8; HOLT RD, 1994, AM NAT, V144, P741, DOI 10.1086/285705; Huberty AF, 2004, ECOLOGY, V85, P1383, DOI 10.1890/03-0352; JONASSON S, 1988, OIKOS, V52, P101, DOI 10.2307/3565988; JOSHI J, 2004, INSECTS ECOSYSTEM FU; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; KRANZ J, 1990, NEW PHYTOL, V116, P383, DOI 10.1111/j.1469-8137.1990.tb00525.x; Krokene P, 2012, PLANT PATHOL, V61, P57, DOI 10.1111/j.1365-3059.2011.02487.x; Lau JA, 2008, ECOLOGY, V89, P226, DOI 10.1890/07-0423.1; LETOURNEAU DK, 1987, ECOLOGY, V68, P1616, DOI 10.2307/1939853; LoGiudice K, 2003, P NATL ACAD SCI USA, V100, P567, DOI 10.1073/pnas.0233733100; Mac Nally R, 2000, BIODIVERS CONSERV, V9, P655, DOI 10.1023/A:1008985925162; Malmstrom CM, 2007, J ECOL, V95, P1153, DOI 10.1111/j.1365-2745.2007.01307.x; Mazerolle MJ, 2006, AMPHIBIA-REPTILIA, V27, P169, DOI 10.1163/156853806777239922; Mitchell CE, 2002, ECOLOGY, V83, P1713, DOI 10.1890/0012-9658(2002)083[1713:EOGPSD]2.0.CO;2; Neumann S, 2004, PLANT PATHOL, V53, P725, DOI 10.1111/j.1365-3059.2004.01107.x; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Pagan I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002796; Parker JD, 2006, SCIENCE, V311, P1459, DOI 10.1126/science.1121407; Pfeifer-Meister L, 2008, THESIS U OREGON; Pfeifer-Meister L, 2012, PLANT ECOL, V213, P637, DOI 10.1007/s11258-012-0028-2; Power AG, 2004, AM NAT, V164, pS79, DOI 10.1086/424610; PRICE PW, 1991, OIKOS, V62, P244, DOI 10.2307/3545270; Ricciardi A, 2006, SCIENCE, V313, DOI 10.1126/science.1128946; Richardson AD, 2002, NEW PHYTOL, V153, P185, DOI 10.1046/j.0028-646X.2001.00289.x; Rizzo DM, 2003, FRONT ECOL ENVIRON, V1, P197, DOI 10.1890/1540-9295(2003)001[0197:SODECA]2.0.CO;2; ROOT RB, 1973, ECOL MONOGR, V43, P95, DOI 10.2307/1942161; Roy BA, 2011, ECOLOGY, V92, P665, DOI 10.1890/09-2006.1; Schellhorn NA, 1997, OECOLOGIA, V111, P233, DOI 10.1007/s004420050230; Seabloom EW, 2009, J ECOL, V97, P1264, DOI 10.1111/j.1365-2745.2009.01550.x; Smith AC, 2009, LANDSCAPE ECOL, V24, P1271, DOI 10.1007/s10980-009-9383-3; Stanton ML, 2004, AM NAT, V164, P736, DOI 10.1086/425331; Throop HL, 2004, ECOSYSTEMS, V7, P109, DOI 10.1007/s10021-003-0225-x; Tompkins DM, 2003, ECOL LETT, V6, P189, DOI 10.1046/j.1461-0248.2003.00417.x; Vazquez DP, 2005, J ANIM ECOL, V74, P946, DOI 10.1111/j.1365-2656.2005.00992.x; WHITE TCR, 1974, OECOLOGIA, V16, P279, DOI 10.1007/BF00344738; Whittingham MJ, 2006, J ANIM ECOL, V75, P1182, DOI 10.1111/j.1365-2656.2006.01141.x; Wilson HE, 2014, MYCOLOGIA, V106, P22, DOI 10.3852/12-330; YODER BJ, 1995, REMOTE SENS ENVIRON, V53, P199, DOI 10.1016/0034-4257(95)00135-N; Young WC, 1999, AGRON J, V91, P671, DOI 10.2134/agronj1999.914671x; Yukawa J, 2000, POPUL ECOL, V42, P105, DOI 10.1007/PL00011989; Zehnder CB, 2008, ECOL ENTOMOL, V33, P24, DOI 10.1111/j.1365-2311.2007.00945.x	64	0	0	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0116650	10.1371/journal.pone.0116650	http://dx.doi.org/10.1371/journal.pone.0116650			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25699672	Green Published, Green Submitted, gold			2022-12-26	WOS:000349789800013
J	Chen, JP; Han, MM; Liao, ZJ; Dai, ZZ; Liu, L; Chen, H; Wen, XY; Hu, S; Que, P; Wen, W; Peng, B				Chen, Jiang-Peng; Han, Ming-Ming; Liao, Zi-Jun; Dai, Zhen-Zhen; Liu, Liang; Chen, Hua; Wen, Xiao-Yan; Hu, Shan; Que, Ping; Wen, Wen; Peng, Bin			HIV-Related Behaviors, Social Support and Health-Related Quality of Life among Men Who Have Sex with Men and Women (MSMW): A Cross-Sectional Study in Chongqing, China	PLOS ONE			English	Article							WENCHUAN EARTHQUAKE SURVIVORS; BLACK-MEN; RISK BEHAVIOR; CONDOM USE; PREVALENCE; WHOQOL; CITY; DEPRESSION; MODERATOR; SYPHILIS	Background Health-related quality of life (HRQOL) has become commonly used both as a concept and as a field of research. However, little is known about the HRQOL of men who have sex with men and women (MSMW). The aim of this study was to examine HIV-related behaviors, social support, and HRQOL status and explore its predictors among MSMW. Methods An anonymous cross-sectional study was conducted by snowball sampling method in 2013. A total of 563 Chinese MSM completed a structured questionnaire. The HRQOL and social support were measured with the Chinese version of the World Health Organization Quality of Life Scale (WHOQOL-BRFE) and the Social Support Rating Scale (SSRS), respectively. Results Of the 563 MSM analyzed, 77 (13.68%) were MSMW who had a higher proportion of in-marriage and preference for an insertive role as compared with the men who have sex with men only (MSMO) (P<0.05). As high as 70.13% of MSMW had no regular sex partners and 72.73% of MSMW reported engaging in unprotected anal sex in the last six months. 36.36% had tested for HIV, while only 12.99% had accepted HIV voluntary counseling and testing (VCT) services. The scores of objective support and subjective support in MSMW were significantly higher than that of MSMO (P<0.05). No statistically significant difference was found in scores of all the four domains of the HRQOL between MSMW and MSMO. When comparing the HRQOL scores of MSMW with the Chinese general population reference group, the scores of MSMW were significantly lower in physical health domain. In a multivariate regression model, age, monthly income, sexual role, VCT acceptability, subjective support were associated with variability in HRQOL. Conclusions To improve the HRQOL among MSMW, more attention needs to be paid to those with low social support, low-income, the old and those prefer a receptive role during anal sex populations.	[Chen, Jiang-Peng; Han, Ming-Ming; Dai, Zhen-Zhen; Chen, Hua; Wen, Xiao-Yan; Hu, Shan; Que, Ping; Wen, Wen; Peng, Bin] Chongqing Med Univ, Sch Publ Hlth & Management, Dept Hlth Stat & Informat Management, Chongqing, Peoples R China; [Liao, Zi-Jun] Peking Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Beijing 100871, Peoples R China; [Liu, Liang] Beichuan Ctr Dis Control & Prevent, Mianyang, Sichuan Provinc, Peoples R China	Chongqing Medical University; Peking University	Peng, B (corresponding author), Chongqing Med Univ, Sch Publ Hlth & Management, Dept Hlth Stat & Informat Management, Chongqing, Peoples R China.	pengbin@cqmu.edu.cn						Ayala G, 2012, AM J PUBLIC HEALTH, V102, pS242, DOI 10.2105/AJPH.2011.300641; Tran BX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041062; Chow EPF, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-549; COBB S, 1976, PSYCHOSOM MED, V38, P300, DOI 10.1097/00006842-197609000-00003; D'Anna LH, 2012, AIDS CARE, V24, P1028, DOI 10.1080/09540121.2012.668285; Deng MH, 2013, TUMOR BIOL, V34, P2809, DOI 10.1007/s13277-013-0839-3; Dodge B, 2008, ARCH SEX BEHAV, V37, P683, DOI 10.1007/s10508-008-9356-7; Fang, 2000, MEASUREMENT APPL QUA; Hoff CC, 2012, AIDS PATIENT CARE ST, V26, P738, DOI 10.1089/apc.2012.0198; Jin MH, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1101; Jung YE, 2012, QUAL LIFE RES, V21, P967, DOI 10.1007/s11136-011-0006-5; KUYKEN W, 1995, SOC SCI MED, V41, P1403, DOI 10.1016/0277-9536(95)00112-k; Lau JTF, 2013, PREV MED, V57, P813, DOI 10.1016/j.ypmed.2013.09.005; Lin LY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109567; Mimiaga MJ, 2013, AIDS CARE, V25, P1109, DOI 10.1080/09540121.2012.749340; Nedjat S, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-61; Nglazi MD, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-676; Okaka E I, 2014, West Afr J Med, V33, P125; Ruan YH, 2007, SEX TRANSM DIS, V34, P592, DOI 10.1097/01.olq.0000253336.64324.ef; Skevington SM, 2002, QUAL LIFE RES, V11, P135, DOI 10.1023/A:1015013312456; Soares GB, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-28; Tieu HV, 2012, AIDS CARE, V24, P1111, DOI 10.1080/09540121.2012.672723; Vyavaharkar M, 2007, AIDS PATIENT CARE ST, V21, P667, DOI 10.1089/apc.2006.0131; Wang KL, 2012, INT J EPIDEMIOL, V41, P423, DOI 10.1093/ije/dyr182; Williams CT, 2009, J URBAN HEALTH, V86, pS93, DOI 10.1007/s11524-009-9367-2; Wilson PA, 2014, HEALTH PSYCHOL, V33, P681, DOI 10.1037/a0035405; World Health Organization [WHO], 1996, WHOQOL BREF INTR ADM; Xiao S., 1994, J CLIN PSYCHIAT, V4, P98, DOI DOI 10.1186/S12913-016-1423-5; Xu J, 2014, PUBLIC HEALTH, V128, P430, DOI 10.1016/j.puhe.2014.03.002; Zeng G, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/602719; Zhang B., 2000, CHIN J STD AIDS PREV, V3, P155; Zhang L, 2013, LANCET INFECT DIS, V13, P955, DOI 10.1016/S1473-3099(13)70245-7; Zhao CY, 2013, QUAL LIFE RES, V22, P733, DOI 10.1007/s11136-012-0197-4; Zheng Y, 2009, CLIN RHEUMATOL, V28, P265, DOI 10.1007/s10067-008-1033-7; Zou HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051919	35	18	21	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0118651	10.1371/journal.pone.0118651	http://dx.doi.org/10.1371/journal.pone.0118651			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB7EQ	25700107	Green Published, Green Submitted, gold			2022-12-26	WOS:000349789800039
J	Rugman-Jones, PF; Seybold, SJ; Graves, AD; Stouthamer, R				Rugman-Jones, Paul F.; Seybold, Steven J.; Graves, Andrew D.; Stouthamer, Richard			Phylogeography of the Walnut Twig Beetle, Pityophthorus juglandis, the Vector of Thousand Cankers Disease in North American Walnut Trees	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; THYSANOPTERA THRIPIDAE; POPULATION-GENETICS; MAXIMUM-LIKELIHOOD; FUNGUS SYMBIOSES; BARK; COLEOPTERA; GEOSMITHIA; INSECTS; ASSOCIATIONS	Thousand cankers disease (TCD) of walnut trees (Juglans spp.) results from aggressive feeding in the phloem by the walnut twig beetle (WTB), Pityophthorus juglandis, accompanied by inoculation of its galleries with a pathogenic fungus, Geosmithia morbida. In 1960, WTB was only known from four U.S. counties (in Arizona, California, and New Mexico), but the species has now (2014) invaded over 115 counties, representing much of the western USA, and at least six states in the eastern USA. The eastern expansion places TCD in direct proximity to highly valuable (> $500 billion) native timber stands of eastern black walnut, Juglans nigra. Using mitochondrial DNA sequences, from nearly 1100 individuals, we examined variation among 77 samples of WTB populations across its extended range in the USA, revealing high levels of polymorphism and evidence of two divergent lineages. The highest level of genetic diversity for the different lineages was found in the neighboring Madrean Sky Island and Western New Mexico regions, respectively. Despite their proximity, there was little evidence of mixing between these regions, with only a single migrant detected among 179 beetles tested. Indeed, geographic overlap of the two lineages was only common in parts of Colorado and Utah. Just two haplotypes, from the same lineage, predominated over the vast majority of the recently expanded range. Tests for Wolbachia proved negative suggesting it plays no role in "driving" the spread of particular haplotypes, or in maintaining deep levels of intraspecific divergence in WTB. Genotyping of ribosomal RNA corroborated the mitochondrial lineages, but also revealed evidence of hybridization between them. Hybridization was particularly prevalent in the sympatric areas, also apparent in all invaded areas, but absent from the most haplotype-rich area of each mitochondrial lineage. Hypotheses about the specific status of WTB, its recent expansion, and potential evolutionary origins of TCD are discussed.	[Rugman-Jones, Paul F.; Stouthamer, Richard] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Seybold, Steven J.] USDA, Forest Serv, Pacific Southwest Res Stn, Davis, CA USA; [Graves, Andrew D.] USDA, Forest Serv, Forest Hlth Protect, Albuquerque, NM USA	University of California System; University of California Riverside; United States Department of Agriculture (USDA); United States Forest Service; United States Department of Agriculture (USDA); United States Forest Service	Rugman-Jones, PF (corresponding author), Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.	paul.rugman-jones@ucr.edu			USDA Forest Service; Pacific Southwest Research Station; USDA Forest Service, Washington Office Forest Health Protection; USDA APHIS CPHST [10-CA-11272172-058]	USDA Forest Service(United States Department of Agriculture (USDA)United States Forest Service); Pacific Southwest Research Station; USDA Forest Service, Washington Office Forest Health Protection; USDA APHIS CPHST	Funding for this work was provided by the USDA Forest Service, Pacific Southwest Research Station, and by grants from the USDA Forest Service, Washington Office Forest Health Protection and USDA APHIS CPHST administered by Mary Louise Flint through cooperative agreement #10-CA-11272172-058 between the USDA FS PSW Station and the UC-Riverside Department of Entomology. The authors are especially grateful to Bruce Moltzan for facilitating the funding from the USDA FS and to David Lance for facilitating the funding from USDA APHIS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Arthofer W, 2009, ENVIRON MICROBIOL, V11, P1923, DOI 10.1111/j.1462-2920.2009.01914.x; ATKINSON TH, 1993, FLA ENTOMOL, V76, P608, DOI 10.2307/3495794; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bright D. E., 2014, Insecta Mundi, P1; BRIGHT DE, 1985, GREAT BASIN NAT, V45, P476; Bright DE, 1981, MEMOIRS ENTOMOLOGICA, V118; Campbell B., 2000, P59; Campbell B.C., 1993, Insect Molecular Biology, V2, P225; Carolin V.M., 1977, MISCELLANEOUS PUBLIC, P1; CDFA, 2014, CAL AGR STAT REV 201, DOI 10.1016/j.jad; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cognato AI, 2006, J ECON ENTOMOL, V99, P1037, DOI 10.1603/0022-0493-99.4.1037; Cranshaw W, 2008, PEST ALERT WALNUT TW; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dowton M, 2004, GENETICS, V167, P1027, DOI 10.1534/genetics.103.024885; ELDER JF, 1995, Q REV BIOL, V70, P297, DOI 10.1086/419073; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Flint ML, 2010, CAPCA ADVISOR MAGAZI, V8, P36; Forgan AH, 2007, PHYTOPATHOLOGY, V97, P650, DOI 10.1094/PHYTO-97-5-0650; Graves AD, 2011, MONITORING WALNUT HL; Graves AD, 2009, UC IPM WEBSITE PUBLI; Graves AD, 2010, 1000 CANKERS DIS WAL; Griffin JR, 1972, PSW82 USDA FOR SERV; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hudson RR, 2000, GENETICS, V155, P2011; Hulcr J, 2011, P ROY SOC B-BIOL SCI, V278, P2866, DOI 10.1098/rspb.2011.1130; Hurst GDD, 2005, P ROY SOC B-BIOL SCI, V272, P1525, DOI 10.1098/rspb.2005.3056; Jordal BH, 2014, MOL ECOL RESOUR, V14, P7, DOI 10.1111/1755-0998.12150; Kolarik M, 2011, MYCOLOGIA, V103, P325, DOI 10.3852/10-124; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lu M, 2011, ECOLOGY, V92, P2013, DOI 10.1890/11-0687.1; MALLET J, 1995, TRENDS ECOL EVOL, V10, P294, DOI 10.1016/0169-5347(95)90031-4; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; McDonald BA, 2002, EUPHYTICA, V124, P163, DOI 10.1023/A:1015678432355; Montecchio L, 2014, PLANT DIS, V98, P696, DOI 10.1094/PDIS-10-13-1027-PDN; Newton L, 2009, PATHWAY ASSESSMENT G, V1; Ogawa H, 1997, MYCOLOGIA, V89, P756, DOI 10.2307/3761132; Rubinoff D, 2005, SYST BIOL, V54, P952, DOI 10.1080/10635150500234674; Rubinoff D, 2006, J HERED, V97, P581, DOI 10.1093/jhered/esl036; Rugman-Jones PF, 2012, B ENTOMOL RES, V102, P698, DOI 10.1017/S0007485312000302; Rugman-Jones PF, 2010, J ECON ENTOMOL, V103, P877, DOI 10.1603/EC09300; Seybold SJ, 2013, U.S Patent Publication, Patent No. [2013/0014428 A1, 20130014428]; Seybold SJ, 2013, DETECTING IDENTIFYIN; Seybold SJ, 2013, NAPR0210 USDA FOR SE; Seybold SJ, 2010, USDA FOR SERV N RES, V75, P55; Seybold SJ, 2012, PAN-PAC ENTOMOL, V88, P277, DOI 10.3956/2012-32.1; Shao RF, 2003, MOL BIOL EVOL, V20, P1612, DOI 10.1093/molbev/msg176; Simoes PM, 2011, MOL ECOL RESOUR, V11, P567, DOI 10.1111/j.1755-0998.2010.02955.x; Six DL, 2013, J CHEM ECOL, V39, P989, DOI 10.1007/s10886-013-0318-8; Six DL, 2011, ANNU REV ENTOMOL, V56, P255, DOI 10.1146/annurev-ento-120709-144839; Sonnenberg R, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-6; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TEMPLETON AR, 1992, GENETICS, V132, P619; Tisserat N., 2011, Plant Health Progress, pPHP; Tisserat N, 2009, PHYTOPATHOLOGY, V99, pS128; Turcotte RM, 2013, ENTOMOL NEWS, V123, P311, DOI 10.3157/021.123.0404; USDA Forest Service, 2002, SW REG FOR FOR HLTH; Utley C, 2013, PLANT DIS, V97, P601, DOI 10.1094/PDIS-07-12-0636-RE; Werren JH, 2000, P ROY SOC B-BIOL SCI, V267, P1277, DOI 10.1098/rspb.2000.1139; Wiggins GJ, 2014, FORESTS, V5, P1185, DOI 10.3390/f5061185; Wingfield Michael J., 2010, New Zealand Journal of Forestry Science, V40, pS95; Wood SL, 1992, GREAT BASIN NAT, V13, P1005; Wood SL, 2007, BARK AMBROSIA BEETLE, DOI [10.1093/jxb/erm028, DOI 10.1093/JXB/ERM028]; Zerillo MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112847	70	35	38	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0118264	10.1371/journal.pone.0118264	http://dx.doi.org/10.1371/journal.pone.0118264			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695760	Green Published, gold, Green Submitted			2022-12-26	WOS:000350062300046
J	West, AM; Kumar, S; Wakie, T; Brown, CS; Stohlgren, TJ; Laituri, M; Bromberg, J				West, Amanda M.; Kumar, Sunil; Wakie, Tewodros; Brown, Cynthia S.; Stohlgren, Thomas J.; Laituri, Melinda; Bromberg, Jim			Using High-Resolution Future Climate Scenarios to Forecast Bromus tectorum Invasion in Rocky Mountain National Park	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; SAMPLE-SIZE; DISTRIBUTIONS; PERFORMANCE; HABITAT; SCALE; PREDICTIONS; EVOLUTION; ELEVATION; VARIABLES	National Parks are hallmarks of ecosystem preservation in the United States. The introduction of alien invasive plant species threatens protection of these areas. Bromus tectorum L. (commonly called downy brome or cheatgrass), which is found in Rocky Mountain National Park (hereafter, the Park), Colorado, USA, has been implicated in early spring competition with native grasses, decreased soil nitrogen, altered nutrient and hydrologic regimes, and increased fire intensity. We estimated the potential distribution of Bromus tectorum in the Park based on occurrence records (n = 211), current and future climate, and distance to roads and trails. An ensemble of six future climate scenarios indicated the habitable area of Bromus tectorum may increase from approximately 5.5% currently to 20.4% of the Park by the year 2050. Using ordination methods we evaluated the climatic space occupied by Bromus tectorum in the Park and how this space may shift given future climate change. Modeling climate change at a small extent (1,076 km2) and at a fine spatial resolution (90 m) is a novel approach in species distribution modeling, and may provide inference for microclimates not captured in coarse-scale models. Maps from our models serve as high-resolution hypotheses that can be improved over time by land managers to set priorities for surveys and removal of invasive species such as Bromus tectorum.	[West, Amanda M.; Kumar, Sunil; Wakie, Tewodros; Stohlgren, Thomas J.] Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA; [West, Amanda M.; Brown, Cynthia S.] Colorado State Univ, Dept Bioagr Sci & Pest Management, Ft Collins, CO 80523 USA; [West, Amanda M.; Kumar, Sunil; Wakie, Tewodros; Brown, Cynthia S.; Laituri, Melinda] Colorado State Univ, Grad Degree Program Ecol, Ft Collins, CO 80523 USA; [Laituri, Melinda] Colorado State Univ, Dept Ecosystem Sci & Sustainabil, Ft Collins, CO 80523 USA; [Laituri, Melinda] Rocky Mt Natl Pk, Estes Pk, CO USA	Colorado State University; Colorado State University; Colorado State University; Colorado State University	West, AM (corresponding author), Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA.	amanda.west@colostate.edu	Kumar, Sunil/A-6730-2009	West, Amanda/0000-0002-9318-7139; Brown, Cynthia/0000-0001-8486-7119	National Institute of Food and Agriculture, U.S. Department of Agriculture [2010-03280]; Rocky Mountain Club Foundation Fellowship	National Institute of Food and Agriculture, U.S. Department of Agriculture(United States Department of Agriculture (USDA)); Rocky Mountain Club Foundation Fellowship	AW and TW received funding from the National Institute of Food and Agriculture, U.S. Department of Agriculture (Award No. -2010-03280), http://www.csrees.usda.gov/fo/nationalneedsgraduatefellowships.cfm. AW received funding from Rocky Mountain Club Foundation Fellowship (no award #), http://www.cmc.org/About/CMCFoundation.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DR, 2002, J WILDLIFE MANAGE, V66, P912, DOI 10.2307/3803155; [Anonymous], [No title captured]; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Araujo MB, 2012, ECOLOGY, V93, P1527, DOI 10.1890/11-1930.1; Ashcroft MB, 2009, GLOBAL CHANGE BIOL, V15, P656, DOI 10.1111/j.1365-2486.2008.01762.x; Austin MP, 2011, J BIOGEOGR, V38, P1, DOI 10.1111/j.1365-2699.2010.02416.x; Ball DA, 2004, WEED SCI, V52, P518, DOI 10.1614/WS-03-067; Banks ER, 2011, NAT AREA J, V31, P377, DOI 10.3375/043.031.0408; Bradford JB, 2006, J VEG SCI, V17, P693, DOI 10.1111/j.1654-1103.2006.tb02493.x; Bradley BA, 2009, GLOBAL CHANGE BIOL, V15, P196, DOI 10.1111/j.1365-2486.2008.01709.x; Bremond L, 2012, GLOBAL CHANGE BIOL, V18, P2324, DOI 10.1111/j.1365-2486.2012.02690.x; Broennimann O, 2012, GLOBAL ECOL BIOGEOGR, V21, P481, DOI 10.1111/j.1466-8238.2011.00698.x; Bromberg JE, 2011, INVAS PLANT SCI MANA, V4, P173, DOI 10.1614/IPSM-D-10-00022.1; Clements DR, 2011, WEED RES, V51, P227, DOI 10.1111/j.1365-3180.2011.00850.x; Compagnoni A, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00047.1; DANTONIO CM, 1992, ANNU REV ECOL SYST, V23, P63, DOI 10.1146/annurev.es.23.110192.000431; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Dormann CF, 2012, J BIOGEOGR, V39, P2119, DOI 10.1111/j.1365-2699.2011.02659.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Ellstrand NC, 2006, EUPHYTICA, V148, P35, DOI 10.1007/s10681-006-5939-3; Evangelista PH, 2008, DIVERS DISTRIB, V14, P808, DOI 10.1111/j.1472-4642.2008.00486.x; Flory AR, 2012, J APPL ECOL, V49, P680, DOI 10.1111/j.1365-2664.2012.02129.x; Franklin J, 2013, GLOBAL CHANGE BIOL, V19, P473, DOI 10.1111/gcb.12051; Gallien L, 2012, GLOBAL ECOL BIOGEOGR, V21, P1126, DOI 10.1111/j.1466-8238.2012.00768.x; Gillingham PK, 2012, DIVERS DISTRIB, V18, P990, DOI 10.1111/j.1472-4642.2012.00933.x; Gillingham PK, 2012, ECOGRAPHY, V35, P831, DOI 10.1111/j.1600-0587.2011.07434.x; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hamann A, 2006, ECOLOGY, V87, P2773, DOI 10.1890/0012-9658(2006)87[2773:PEOCCO]2.0.CO;2; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Jarnevich CS, 2009, BIOL INVASIONS, V11, P1373, DOI 10.1007/s10530-008-9345-8; Jimenez-Valverde A, 2011, BIOL INVASIONS, V13, P2785, DOI 10.1007/s10530-011-9963-4; Kearney MR, 2010, CONSERV LETT, V3, P203, DOI 10.1111/j.1755-263X.2010.00097.x; Kriticos DJ, 2012, METHODS ECOL EVOL, V3, P53, DOI 10.1111/j.2041-210X.2011.00134.x; Kumar S., 2009, J ECOLOGY NATURAL EN, V1, P94, DOI 10.5897/ JENE.9000071; Kumar S, 2009, FRONT ECOL ENVIRON, V7, P415, DOI 10.1890/080054; Leger EA, 2009, MOL ECOL, V18, P4366, DOI 10.1111/j.1365-294X.2009.04357.x; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; MACK RN, 1981, AGRO-ECOSYSTEMS, V7, P145, DOI 10.1016/0304-3746(81)90027-5; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Miller ME, 2006, PLANT SOIL, V288, P1, DOI 10.1007/s11104-006-0058-4; NOVAK SJ, 1993, CAN J BOT, V71, P1441, DOI 10.1139/b93-174; Paruelo JM, 1996, ECOL APPL, V6, P1212, DOI 10.2307/2269602; Pearman PB, 2008, TRENDS ECOL EVOL, V23, P149, DOI 10.1016/j.tree.2007.11.005; Pearson RG, 2007, SYNTH AM MUS NAT HIS, V50; Pederson GT, 2013, GEOPHYS RES LETT, V40, P1811, DOI 10.1002/grl.50424; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Randin CF, 2009, GLOBAL CHANGE BIOL, V15, P1557, DOI 10.1111/j.1365-2486.2008.01766.x; Raupach MR, 2007, P NATL ACAD SCI USA, V104, P10288, DOI 10.1073/pnas.0700609104; Shabani F, 2014, AGR ECOSYST ENVIRON, V197, P96, DOI 10.1016/j.agee.2014.08.005; Shabani F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048021; Sheppard CS, 2013, WEED RES, V53, P259, DOI 10.1111/wre.12021; Stanton JC, 2012, METHODS ECOL EVOL, V3, P349, DOI 10.1111/j.2041-210X.2011.00157.x; STOHLGREN TJ, 1995, VEGETATIO, V117, P113, DOI 10.1007/BF00045503; Taylor S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035565; Upadhyaya, 1986, CAN J PLANT SCI, V66, P689; Wang TL, 2012, J APPL METEOROL CLIM, V51, P16, DOI 10.1175/JAMC-D-11-043.1; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Zelikova TJ, 2013, ECOL EVOL, V3, P1374, DOI 10.1002/ece3.542	64	29	32	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0117893	10.1371/journal.pone.0117893	http://dx.doi.org/10.1371/journal.pone.0117893			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695255	Green Published, gold			2022-12-26	WOS:000350062300033
J	Kanao, R; Masuda, Y; Deguchi, S; Yumoto-Sugimoto, M; Hanaoka, F; Masutani, C				Kanao, Rie; Masuda, Yuji; Deguchi, Saori; Yumoto-Sugimoto, Mayumi; Hanaoka, Fumio; Masutani, Chikahide			Relevance of Simultaneous Mono-Ubiquitinations of Multiple Units of PCNA Homo-Trimers in DNA Damage Tolerance	PLOS ONE			English	Article							NUCLEAR ANTIGEN PCNA; POLYMERASE-ETA; TRANSLESION SYNTHESIS; MONOUBIQUITINATED PCNA; XERODERMA-PIGMENTOSUM; FAMILY MODIFICATIONS; STALLED REPLICATION; BINDING DOMAINS; DVC1 C1ORF124; POL-ETA	DNA damage tolerance (DDT) pathways, including translesion synthesis (TLS) and additional unknown mechanisms, enable recovery from replication arrest at DNA lesions. DDT pathways are regulated by post-translational modifications of proliferating cell nuclear antigen (PCNA) at its K164 residue. In particular, mono-ubiquitination by the ubiquitin ligase RAD18 is crucial for Pol eta-mediated TLS. Although the importance of modifications of PCNA to DDT pathways is well known, the relevance of its homo-trimer form, in which three K164 residues are present in a single ring, remains to be elucidated. Here, we show that multiple units of a PCNA homo-trimer are simultaneously mono-ubiquitinated in vitro and in vivo. RAD18 catalyzed sequential mono-ubiquitinations of multiple units of a PCNA homo-trimer in a reconstituted system. Exogenous PCNA formed hetero-trimers with endogenous PCNA in WI38VA13 cell transformants. When K164R-mutated PCNA was expressed in these cells at levels that depleted endogenous PCNA homo-trimers, multiple modifications of PCNA complexes were reduced and the cells showed defects in DDT after UV irradiation. Notably, ectopic expression of mutant PCNA increased the UV sensitivities of Pol eta-proficient, Pol eta-deficient, and REV1-depleted cells, suggesting the disruption of a DDT pathway distinct from the Pol eta-and REV1-mediated pathways. These results suggest that simultaneous modifications of multiple units of a PCNA homo-trimer are required for a certain DDT pathway in human cells.	[Kanao, Rie; Masuda, Yuji; Masutani, Chikahide] Nagoya Univ, Environm Med Res Inst, Dept Genome Dynam, Nagoya, Aichi 4648601, Japan; [Kanao, Rie; Deguchi, Saori; Yumoto-Sugimoto, Mayumi; Hanaoka, Fumio; Masutani, Chikahide] Osaka Univ, Grad Sch Frontier Biosci, Osaka, Japan; [Masuda, Yuji] Nagoya Univ, Grad Sch Med, Dept Toxicogen, Nagoya, Aichi 4648601, Japan; [Hanaoka, Fumio] Gakushuin Univ, Fac Sci, Tokyo 171, Japan	Nagoya University; Osaka University; Nagoya University; Gakushuin University	Masutani, C (corresponding author), Nagoya Univ, Environm Med Res Inst, Dept Genome Dynam, Nagoya, Aichi 4648601, Japan.	masutani@riem.nagoya-u.ac.jp	Masuda, Yuji/I-6315-2014; Masutani, Chikahide/I-6160-2014	Masuda, Yuji/0000-0002-6229-1988; Masutani, Chikahide/0000-0002-8600-8227	KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology of Japan [26740017, 24310040, 26550024, 22131008, 25241011]; Mitsubishi Foundation; Takeda Science Foundation; Uehara Memorial Foundation; Grants-in-Aid for Scientific Research [22131008] Funding Source: KAKEN	KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Mitsubishi Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by KAKENHI [26740017 to RK, 24310040 and 26550024 to YM, 22131008 to FH, and 25241011 to CM] from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by the Mitsubishi Foundation, the Takeda Science Foundation, and the Uehara Memorial Foundation [to CM]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi JI, 2009, DNA REPAIR, V8, P585, DOI 10.1016/j.dnarep.2008.12.006; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Branzei D, 2011, FEBS LETT, V585, P2810, DOI 10.1016/j.febslet.2011.04.053; Centore RC, 2012, MOL CELL, V46, P625, DOI 10.1016/j.molcel.2012.05.020; Davis EJ, 2012, NAT STRUCT MOL BIOL, V19, P1093, DOI 10.1038/nsmb.2394; Day TA, 2010, J CELL BIOL, V191, P953, DOI 10.1083/jcb.201006043; Durando M, 2013, NUCLEIC ACIDS RES, V41, P3079, DOI 10.1093/nar/gkt016; Edmunds CE, 2008, MOL CELL, V30, P519, DOI 10.1016/j.molcel.2008.03.024; Ghosal G, 2012, J BIOL CHEM, V287, P34225, DOI 10.1074/jbc.M112.400135; GIRARDI AJ, 1966, ANN MED EXP BIOL FEN, V44, P242; Hendel A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002262; Hibbert RG, 2012, J BIOL CHEM, V287, P39216, DOI 10.1074/jbc.M112.389890; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Huang TT, 2006, NAT CELL BIOL, V8, P339, DOI 10.1038/ncb1378; Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; Juhasz S, 2012, NUCLEIC ACIDS RES, V40, P10795, DOI 10.1093/nar/gks850; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Langerak P, 2007, J EXP MED, V204, P1989, DOI 10.1084/jem.20070902; Lee KY, 2010, J BIOL CHEM, V285, P10362, DOI 10.1074/jbc.M109.092544; Lehmann AR, 2011, FEBS LETT, V585, P2772, DOI 10.1016/j.febslet.2011.06.005; Lin JR, 2011, MOL CELL, V42, P237, DOI 10.1016/j.molcel.2011.02.026; Livneh Z, 2010, CELL CYCLE, V9, P729, DOI 10.4161/cc.9.4.10727; Machida Y, 2012, CELL CYCLE, V11, P3395, DOI 10.4161/cc.21694; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Mailand N, 2013, NAT REV MOL CELL BIO, V14, P269, DOI 10.1038/nrm3562; Masuda Y, 2012, NUCLEIC ACIDS RES, V40, P10394, DOI 10.1093/nar/gks763; Masuda Y, 2012, NUCLEIC ACIDS RES, V40, P1065, DOI 10.1093/nar/gkr805; Masuda Y, 2010, J MOL BIOL, V396, P487, DOI 10.1016/j.jmb.2010.01.003; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Mosbech A, 2012, NAT STRUCT MOL BIOL, V19, P1084, DOI 10.1038/nsmb.2395; Parker JL, 2007, NUCLEIC ACIDS RES, V35, P881, DOI 10.1093/nar/gkl1102; Pastushok L, 2010, NUCLEIC ACIDS RES, V38, P5047, DOI 10.1093/nar/gkq239; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Plosky BS, 2004, CURR OPIN GENET DEV, V14, P113, DOI 10.1016/j.gde.2004.02.002; Qin ZS, 2013, NUCLEIC ACIDS RES, V41, P7356, DOI 10.1093/nar/gkt542; Ramasubramanyan S, 2010, DNA REPAIR, V9, P777, DOI 10.1016/j.dnarep.2010.03.015; Sale JE, 2012, NAT REV MOL CELL BIO, V13, P141, DOI 10.1038/nrm3289; Terai K, 2010, MOL CELL, V37, P143, DOI 10.1016/j.molcel.2009.12.018; Ulrich HD, 2013, CHROMOSOMA, V122, P259, DOI 10.1007/s00412-013-0410-4; Ulrich HD, 2009, DNA REPAIR, V8, P461, DOI 10.1016/j.dnarep.2009.01.006; Unk I, 2010, DNA REPAIR, V9, P257, DOI 10.1016/j.dnarep.2009.12.013; Yanagihara H, 2011, MOL CELL, V43, P788, DOI 10.1016/j.molcel.2011.07.026; Zhang SF, 2008, CELL CYCLE, V7, P3399, DOI 10.4161/cc.7.21.6949; Zhang ZT, 2012, CELL CYCLE, V11, P2128, DOI 10.4161/cc.20595	44	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118775	10.1371/journal.pone.0118775	http://dx.doi.org/10.1371/journal.pone.0118775			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692884	Green Published, gold, Green Submitted			2022-12-26	WOS:000350061500129
J	Zhang, FQ; Wang, JP; Kim, J; Parrish, T; Wong, PCM				Zhang, Fengqing; Wang, Ji-Ping; Kim, Jieun; Parrish, Todd; Wong, Patrick C. M.			Decoding Multiple Sound Categories in the Human Temporal Cortex Using High Resolution fMRI	PLOS ONE			English	Article							MULTIVARIATE-ANALYSIS; PATTERN-ANALYSIS; GENE SELECTION; NATURAL IMAGES; CLASSIFICATION; REPRESENTATION; SIMILARITY; SPEECH	Perception of sound categories is an important aspect of auditory perception. The extent to which the brain's representation of sound categories is encoded in specialized subregions or distributed across the auditory cortex remains unclear. Recent studies using multivariate pattern analysis (MVPA) of brain activations have provided important insights into how the brain decodes perceptual information. In the large existing literature on brain decoding using MVPA methods, relatively few studies have been conducted on multi-class categorization in the auditory domain. Here, we investigated the representation and processing of auditory categories within the human temporal cortex using high resolution fMRI and MVPA methods. More importantly, we considered decoding multiple sound categories simultaneously through multi-class support vector machine-recursive feature elimination (MSVM-RFE) as our MVPA tool. Results show that for all classifications the model MSVM-RFE was able to learn the functional relation between the multiple sound categories and the corresponding evoked spatial patterns and classify the unlabeled sound-evoked patterns significantly above chance. This indicates the feasibility of decoding multiple sound categories not only within but across subjects. However, the across-subject variation affects classification performance more than the within-subject variation, as the across-subject analysis has significantly lower classification accuracies. Sound category-selective brain maps were identified based on multi-class classification and revealed distributed patterns of brain activity in the superior temporal gyrus and the middle temporal gyrus. This is in accordance with previous studies, indicating that information in the spatially distributed patterns may reflect a more abstract perceptual level of representation of sound categories. Further, we show that the across-subject classification performance can be significantly improved by averaging the fMRI images over items, because the irrelevant variations between different items of the same sound category are reduced and in turn the proportion of signals relevant to sound categorization increases.	[Zhang, Fengqing; Wang, Ji-Ping] Northwestern Univ, Dept Stat, Evanston, IL 60208 USA; [Zhang, Fengqing] Drexel Univ, Dept Psychol, Philadelphia, PA 19104 USA; [Kim, Jieun; Wong, Patrick C. M.] Northwestern Univ, Roxelyn & Richard Pepper Dept Commun Sci & Disord, Evanston, IL 60208 USA; [Parrish, Todd] Northwestern Univ, Dept Radiol, Feinberg Sch Med, Chicago, IL 60611 USA; [Wong, Patrick C. M.] Chinese Univ Hong Kong, Dept Linguist & Modern Languages, Shatin, Hong Kong, Peoples R China; [Wong, Patrick C. M.] Northwestern Univ, Dept Otolaryngol Head & Neck Surg, Chicago, IL 60611 USA	Northwestern University; Drexel University; Northwestern University; Northwestern University; Feinberg School of Medicine; Chinese University of Hong Kong; Northwestern University	Wong, PCM (corresponding author), Northwestern Univ, Roxelyn & Richard Pepper Dept Commun Sci & Disord, Evanston, IL 60208 USA.	pwong@northwestern.edu		Wong, Patrick/0000-0002-6105-5027; Parrish, Todd/0000-0002-1184-1572	National Science Foundation [BCS-1125144]; National Institutes of Health [R01DC008333]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008333] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The authors would like to acknowledge the financial support of grants from the National Science Foundation (BCS-1125144) and the National Institutes of Health (R01DC008333) awarded to P.W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariely D, 2001, PSYCHOL SCI, V12, P157, DOI 10.1111/1467-9280.00327; Balas B, 2009, J VISION, V9, DOI [10.1167/9.2.16, 10.1167/9.12.13]; Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512; Boersma Paul, 2002, GLOT INT, V5, P341; Chong SC, 2003, VISION RES, V43, P393, DOI 10.1016/S0042-6989(02)00596-5; Clithero JA, 2011, NEUROIMAGE, V56, P699, DOI 10.1016/j.neuroimage.2010.03.057; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Crammer K., 2000, P 13 ANN C COMP LEAR, P35; De Martino F, 2008, NEUROIMAGE, V43, P44, DOI 10.1016/j.neuroimage.2008.06.037; Dubois D, 2006, ACTA ACUST UNITED AC, V92, P865; Etzel JA, 2011, NEUROIMAGE, V54, P1159, DOI 10.1016/j.neuroimage.2010.08.050; Fan RE, 2008, J MACH LEARN RES, V9, P1871; Formisano E, 2008, SCIENCE, V322, P970, DOI 10.1126/science.1164318; Formisano E, 2008, MAGN RESON IMAGING, V26, P921, DOI 10.1016/j.mri.2008.01.052; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Gygi B, 2007, PERCEPT PSYCHOPHYS, V69, P839, DOI 10.3758/BF03193921; Hanke M, 2009, NEUROINFORMATICS, V7, P37, DOI 10.1007/s12021-008-9041-y; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; Kaplan JT, 2012, NEUROIMAGE, V60, P204, DOI 10.1016/j.neuroimage.2011.12.059; Kay KN, 2008, NATURE, V452, P352, DOI 10.1038/nature06713; Kumar S, 2012, J NEUROSCI, V32, P13348, DOI 10.1523/JNEUROSCI.3812-12.2012; Leaver AM, 2010, J NEUROSCI, V30, P7604, DOI 10.1523/JNEUROSCI.0296-10.2010; Ley A, 2012, J NEUROSCI, V32, P13273, DOI 10.1523/JNEUROSCI.0584-12.2012; McDermott JH, 2013, NAT NEUROSCI, V16, P493, DOI 10.1038/nn.3347; Meier JD, 2008, J NEUROPHYSIOL, V100, P1800, DOI 10.1152/jn.90531.2008; Meyer K, 2010, NAT NEUROSCI, V13, P667, DOI 10.1038/nn.2533; Naselaris T, 2009, NEURON, V63, P902, DOI 10.1016/j.neuron.2009.09.006; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; NOSOFSKY RM, 1986, J EXP PSYCHOL GEN, V115, P39, DOI 10.1037/0096-3445.115.1.39; Raizada RDS, 2010, INT J IMAG SYST TECH, V20, P31, DOI 10.1002/ima.20225; Rauschecker JP, 2009, NAT NEUROSCI, V12, P718, DOI 10.1038/nn.2331; Shinkareva SV, 2011, NEUROIMAGE, V54, P2418, DOI 10.1016/j.neuroimage.2010.10.042; Staeren N, 2009, CURR BIOL, V19, P498, DOI 10.1016/j.cub.2009.01.066; Tice B, 1997, TONE; Tong F, 2012, ANNU REV PSYCHOL, V63, P483, DOI 10.1146/annurev-psych-120710-100412; Vapnik V., 1998, STAT LEARNING THEORY; Weil RS, 2010, CURR OPIN NEUROL, V23, P649, DOI 10.1097/WCO.0b013e32834028c7; Witten DM, 2011, J R STAT SOC B, V73, P753, DOI 10.1111/j.1467-9868.2011.00783.x; Zhou X, 2007, BIOINFORMATICS, V23, P1106, DOI 10.1093/bioinformatics/btm036	40	11	11	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117303	10.1371/journal.pone.0117303	http://dx.doi.org/10.1371/journal.pone.0117303			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692885	Green Published, Green Submitted, gold			2022-12-26	WOS:000350061500049
J	Lin, YC; Kao, CH; Chen, CC; Ke, CJ; Yao, CH; Chen, YS				Lin, Yu-Ching; Kao, Chia-Hong; Chen, Chung-Chia; Ke, Cherng-Jyh; Yao, Chun-Hsu; Chen, Yueh-Sheng			Time-Course Effect of Electrical Stimulation on Nerve Regeneration of Diabetic Rats	PLOS ONE			English	Article							PERIPHERAL-NERVES; INJURY; IMPROVES; NEUROPATHY; REINNERVATION; DEGENERATION; RECOVERY; DEFICIT; MUSCLE; CELLS	Background Electrical stimulation (ES) has been shown to promote nerve regeneration in rats with experimental diabetes induced using streptozotocin (STZ). However, the time-course effect of ES on nerve regeneration of diabetic animals has not been reported in previous studies. The present study attempted to examine the effect of different timing of ES after peripheral nerve transection in diabetic rats. Methodology/Findings Fifty Sprague-Dawley rats were used in the study. They were classified into five groups. STZ-induced diabetes was created in groups A to D. Normal animals in group E were used as the non-diabetic controls. The sciatic nerve was transected and repaired using a silicone rubber conduit across a 10-mm gap in all groups. Groups A to C received ES for 15 minutes every other day for 2 weeks. Stimulation was initiated on day 1 following the nerve repair for group A, day 8 for group B, and day 15 for group C. The diabetic control group D and the normal control group E received no ES. At 30 days after surgery in group A, histological evaluations showed a higher success percentage of regeneration across the 10-mm nerve gap, and the electrophysiological results showed significantly larger mean values of evoked muscle action potential area and amplitude of the reinnervated gastrocnemius muscle compared with group D. Conclusions/Significance It is concluded that an immediate onset of ES may improve the functional recovery of large nerve defect in diabetic animals.	[Lin, Yu-Ching; Kao, Chia-Hong; Chen, Chung-Chia; Yao, Chun-Hsu; Chen, Yueh-Sheng] China Med Univ, Sch Chinese Med, Lab Biomat, Taichung, Taiwan; [Kao, Chia-Hong] Taipei Med Univ Hosp, Dept Chinese Med, Taipei, Taiwan; [Chen, Chung-Chia] Taipei City Hosp, Linsen Chinese Med Branch, Taipei, Taiwan; [Ke, Cherng-Jyh] Natl Taiwan Univ, Dept Orthoped, Coll Med, Taipei 10764, Taiwan; [Chen, Yueh-Sheng] Asia Univ, Dept Biomed Informat, Taichung, Taiwan; [Chen, Yueh-Sheng] China Med Univ, Res Ctr Chinese Med & Acupuncture, Taichung, Taiwan	China Medical University Taiwan; Taipei Medical University; Taipei Medical University Hospital; Taipei City Hospital; National Taiwan University; Asia University Taiwan; China Medical University Taiwan	Chen, YS (corresponding author), China Med Univ, Sch Chinese Med, Lab Biomat, Taichung, Taiwan.	yuehsc@mail.cmu.edu.tw			China Medical University under the Aim for Top University Plan of the Ministry of Education, Taiwan; National Science Council of the Republic of China, Taiwan [NSC102-2221-E-039-007-MY3]; China Medical University [CMU102-S-24]; Linsen (Chinese Medicine) Branch, Taipei City Hospital [TPH103-67]; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW103-TDU-B-212-113002]	China Medical University under the Aim for Top University Plan of the Ministry of Education, Taiwan; National Science Council of the Republic of China, Taiwan(Ministry of Science and Technology, Taiwan); China Medical University(China Medical University); Linsen (Chinese Medicine) Branch, Taipei City Hospital; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence	This study was supported by China Medical University under the Aim for Top University Plan of the Ministry of Education, Taiwan. The authors would also like to thank National Science Council of the Republic of China, Taiwan (NSC102-2221-E-039-007-MY3), China Medical University (CMU102-S-24), Linsen (Chinese Medicine) Branch, Taipei City Hospital (TPH103-67), and Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW103-TDU-B-212-113002) for financially supporting this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Majed AA, 2000, EUR J NEUROSCI, V12, P4381, DOI 10.1046/j.1460-9568.2000.01341.x; Alrashdan MS, 2010, ACTA NEUROL BELG, V110, P168; Biscetti F, 2013, MOL CELL ENDOCRINOL, V381, P80, DOI 10.1016/j.mce.2013.07.011; Brenner MJ, 2008, MICROSURG, V28, P265, DOI 10.1002/micr.20483; Chen YS, 2010, J NEUROPATH EXP NEUR, V69, P294, DOI 10.1097/NEN.0b013e3181d26487; Cull G, 2003, J GLAUCOMA, V12, P301, DOI 10.1097/00061198-200308000-00003; DEMEDINACELI L, 1995, J NEUROSCI METH, V58, P29, DOI 10.1016/0165-0270(94)00156-B; Dubovy P, 2013, INT REV NEUROBIOL, V108, P173, DOI 10.1016/B978-0-12-410499-0.00007-1; Federici T, 2009, NEUROSURGERY, V65, pA87, DOI 10.1227/01.NEU.0000335653.52938.F2; Fu SY, 1997, MOL NEUROBIOL, V14, P67, DOI 10.1007/BF02740621; Ghayemi N, 2014, INT J SURG, V12, P457, DOI 10.1016/j.ijsu.2014.03.018; Gordon T, 2010, EXP NEUROL, V223, P192, DOI 10.1016/j.expneurol.2009.09.020; Gu XS, 2014, BIOMATERIALS, V35, P6143, DOI 10.1016/j.biomaterials.2014.04.064; Haastert-Talini K, 2013, INT REV NEUROBIOL, V109, P111, DOI 10.1016/B978-0-12-420045-6.00005-5; Hashikawa-Hobara N, 2012, J PHARMACOL SCI, V119, P117, DOI 10.1254/jphs.12R02CP; Huang JH, 2013, EUR J NEUROSCI, V38, P3691, DOI 10.1111/ejn.12370; Hundepool CA, 2014, J NEUROSURG, V121, P195, DOI 10.3171/2014.4.JNS131260; Jolivalt CG, 2008, J NEUROPATH EXP NEUR, V67, P702, DOI 10.1097/NEN.0b013e31817e23f4; Jung Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094054; Kao CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079078; Kennedy JM, 2000, BRAIN, V123, P2118, DOI 10.1093/brain/123.10.2118; Kennedy JM, 2005, J PERIPHER NERV SYST, V10, P144, DOI 10.1111/j.1085-9489.2005.0010205.x; Koppes AN, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/4/046002; Kosacka J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032881; Lin YC, 2014, RESTOR NEUROL NEUROS, V32, P437, DOI 10.3233/RNN-130381; Lu MC, 2009, J TRAUMA, V67, P1066, DOI 10.1097/TA.0b013e318182351a; Ma WY, 1999, EXP NEUROL, V159, P459, DOI 10.1006/exnr.1999.7149; McLoughlin TJ, 2003, J APPL PHYSIOL, V94, P876, DOI 10.1152/japplphysiol.00766.2002; Nakamura H, 2009, NEUROREPORT, V20, P1481, DOI 10.1097/WNR.0b013e32833283e6; Nishida N, 2013, J DIABETES INVEST, V4, P533, DOI 10.1111/jdi.12115; Pabari A, 2014, PLAST RECONSTR SURG, V133, P1420, DOI 10.1097/PRS.0000000000000226; Piao YL, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/191632; Schgoer W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074029; Serafin A, 2010, MUSCLE NERVE, V41, P630, DOI 10.1002/mus.21564; Singh B, 2014, BRAIN, V137, P1051, DOI 10.1093/brain/awu031; Tarabal O, 1996, EUR J NEUROSCI, V8, P829, DOI 10.1111/j.1460-9568.1996.tb01269.x; Teodori RM, 2011, BRAZ J PHYS THER, V15, P325, DOI 10.1590/S1413-35552011005000008; Terenghi G, 1999, J ANAT, V194, P1, DOI 10.1046/j.1469-7580.1999.19410001.x; TESFAYE S, 1994, DIABETOLOGIA, V37, P847, DOI 10.1007/BF00400938; VanBuren T, 1996, EUR J PHARMACOL, V296, P277, DOI 10.1016/0014-2999(95)00718-0; Vivo M, 2008, EXP NEUROL, V211, P180, DOI 10.1016/j.expneurol.2008.01.020; Xu CG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105045; Yao CH, 2012, J TRAUMA ACUTE CARE, V72, P199, DOI 10.1097/TA.0b013e31822d233c; YASUDA H, 1993, J NEUROL SCI, V120, P64, DOI 10.1016/0022-510X(93)90026-U; Yeh CC, 2010, NEUROREHAB NEURAL RE, V24, P730, DOI 10.1177/1545968310376758; Yin Q, 1998, J HAND SURG-BRIT EUR, V23B, P433, DOI 10.1016/S0266-7681(98)80117-4; Zheng LF, 2008, BRAIN RES, V1187, P20, DOI 10.1016/j.brainres.2007.10.044; Zochodne DW, 2007, DIABETES-METAB RES, V23, P490, DOI 10.1002/dmrr.716	48	41	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0116711	10.1371/journal.pone.0116711	http://dx.doi.org/10.1371/journal.pone.0116711			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689049	Green Submitted, gold, Green Published			2022-12-26	WOS:000350322700021
J	Vermeersch, KA; Wang, LJ; Mezencev, R; McDonald, JF; Styczynski, MP				Vermeersch, Kathleen A.; Wang, Lijuan; Mezencev, Roman; McDonald, John F.; Styczynski, Mark P.			OVCAR-3 Spheroid-Derived Cells Display Distinct Metabolic Profiles	PLOS ONE			English	Article							CANCER STEM-CELLS; OVARIAN-CANCER; SIDE POPULATION; 3T3-L1 FIBROBLASTS; GAS-CHROMATOGRAPHY; DIFFERENTIATION; PROLINE; POLYAMINES; IDENTIFICATION; PATHOGENESIS	Introduction Recently, multicellular spheroids were isolated from a well-established epithelial ovarian cancer cell line, OVCAR-3, and were propagated in vitro. These spheroid-derived cells displayed numerous hallmarks of cancer stem cells, which are chemo- and radioresistant cells thought to be a significant cause of cancer recurrence and resultant mortality. Gene set enrichment analysis of expression data from the OVCAR-3 cells and the spheroid-derived putative cancer stem cells identified several metabolic pathways enriched in differentially expressed genes. Before this, there had been little previous knowledge or investigation of systems-scale metabolic differences between cancer cells and cancer stem cells, and no knowledge of such differences in ovarian cancer stem cells. Methods To determine if there were substantial metabolic changes corresponding with these transcriptional differences, we used two-dimensional gas chromatography coupled to mass spectrometry to measure the metabolite profiles of the two cell lines. Results These two cell lines exhibited significant metabolic differences in both intracellular and extracellular metabolite measurements. Principal components analysis, an unsupervised dimensional reduction technique, showed complete separation between the two cell types based on their metabolite profiles. Pathway analysis of intracellular metabolomics data revealed close overlap with metabolic pathways identified from gene expression data, with four out of six pathways found enriched in gene-level analysis also enriched in metabolitelevel analysis. Some of those pathways contained multiple metabolites that were individually statistically significantly different between the two cell lines, with one of the most broadly and consistently different pathways, arginine and proline metabolism, suggesting an interesting hypothesis about cancerous and stem-like metabolic phenotypes in this pair of cell lines. Conclusions Overall, we demonstrate for the first time that metabolism in an ovarian cancer stem cell line is distinct from that of more differentiated isogenic cancer cells, supporting the potential importance of metabolism in the differences between cancer cells and cancer stem cells.	[Vermeersch, Kathleen A.; Styczynski, Mark P.] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA; [Wang, Lijuan; Mezencev, Roman; McDonald, John F.] Georgia Inst Technol, Ovarian Canc Inst, Atlanta, GA 30332 USA; [Wang, Lijuan; Mezencev, Roman; McDonald, John F.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Styczynski, MP (corresponding author), Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA.	Mark.Styczynski@chbe.gatech.edu	Mezencev, Roman/O-8489-2019; Mezencev, Roman/A-8573-2009	Mezencev, Roman/0000-0003-4361-7628; 	Integrative BioSystems Institute; Defense Advanced Research Projects Agency Young Faculty Award [DARPA YFA N66001-11-1-4128]; Ovarian Cycle; Deborah Nash Endowment Fund; Josephine Robinson Family Fund; J.D. Rhodes Trust	Integrative BioSystems Institute; Defense Advanced Research Projects Agency Young Faculty Award; Ovarian Cycle; Deborah Nash Endowment Fund; Josephine Robinson Family Fund; J.D. Rhodes Trust	KAV and MPS were supported by the Integrative BioSystems Institute (http://www.ibsi.gatech.edu/) and Defense Advanced Research Projects Agency Young Faculty Award (DARPA YFA N66001-11-1-4128) (http://www.darpa.mil/default.aspx). RM, LW, and JFM were supported by Ovarian Cycle, Deborah Nash Endowment Fund, Josephine Robinson Family Fund, and the J.D. Rhodes Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvero AB, 2009, CELL CYCLE, V8, P158, DOI 10.4161/cc.8.1.7533; Anderson AS, 2014, EXP CELL RES, V328, P44, DOI 10.1016/j.yexcr.2014.08.028; Battaglia V, 2014, AMINO ACIDS, V46, P511, DOI 10.1007/s00726-013-1529-6; Casalino L, 2011, J MOL CELL BIOL, V3, P108, DOI 10.1093/jmcb/mjr001; Casero RA, 2007, NAT REV DRUG DISCOV, V6, P373, DOI 10.1038/nrd2243; Ciavardelli D, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.285; Cipolleschi MG, 2014, CELL CYCLE, V13, P268, DOI 10.4161/cc.27031; Comes S, 2013, STEM CELL REP, V1, P307, DOI 10.1016/j.stemcr.2013.09.001; D'Aguanno S, 2014, J PROTEOME RES, V13, P2120, DOI 10.1021/pr4012574; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; Denkert C, 2006, CANCER RES, V66, P10795, DOI 10.1158/0008-5472.CAN-06-0755; Dunn WB, 2011, NAT PROTOC, V6, P1060, DOI 10.1038/nprot.2011.335; ERWIN BG, 1984, AM J PHYSIOL, V246, pC293, DOI 10.1152/ajpcell.1984.246.3.C293; EWTON DZ, 1984, J CELL PHYSIOL, V120, P263, DOI 10.1002/jcp.1041200302; Feng WG, 2014, STEM CELLS, V32, P1734, DOI 10.1002/stem.1662; Fong MY, 2010, HISTOL HISTOPATHOL, V25, P113, DOI 10.14670/HH-25.113; Gammon L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062493; Gao QL, 2009, ULTRASTRUCT PATHOL, V33, P175, DOI 10.1080/01913120903086072; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; HAMILTON TC, 1983, CANCER RES, V43, P5379; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Herzog TJ, 2004, CLIN CANCER RES, V10, P7439, DOI 10.1158/1078-0432.CCR-04-0683; Hyvonen MT, 2013, BIOCHEM J, V453, P467, DOI 10.1042/BJ20130263; Iarashi K, 2010, INT J BIOCHEM CELL B, V42, P39, DOI 10.1016/j.biocel.2009.07.009; Isayev O, 2014, ONCOTARGET, V5, P5177, DOI 10.18632/oncotarget.2120; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Kim TH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/132702; Kind T, 2009, ANAL CHEM, V81, P10038, DOI 10.1021/ac9019522; Kurman RJ, 2010, AM J SURG PATHOL, V34, P433, DOI 10.1097/PAS.0b013e3181cf3d79; Lee MJ, 2013, J CELL BIOCHEM, V114, P2718, DOI 10.1002/jcb.24620; Liao JQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084941; Lim D, 2013, PATHOLOGY, V45, P229, DOI 10.1097/PAT.0b013e32835f2264; Liu PP, 2014, CELL DEATH DIFFER, V21, P124, DOI 10.1038/cdd.2013.131; Liu W, 2012, P NATL ACAD SCI USA, V109, P8983, DOI 10.1073/pnas.1203244109; Lu X, 2010, J BIOL CHEM, V285, P9317, DOI 10.1074/jbc.C110.104448; Meissen JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046770; Menendez JA, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00262; Mlynarik V, 2012, NMR BIOMED, V25, P506, DOI 10.1002/nbm.1763; Palorini R, 2014, J CELL BIOCHEM, V115, P368, DOI 10.1002/jcb.24671; Phang JM, 2008, AMINO ACIDS, V35, P681, DOI 10.1007/s00726-008-0063-4; Phang JM, 2013, EPIGENETICS-US, V8, P231, DOI 10.4161/epi.24042; Phang JM, 2012, FRONT BIOSCI-LANDMRK, V17, P1835, DOI 10.2741/4022; Sebastian Carlos, 2014, Critical Reviews in Oncogenesis, V19, P363; Shen YA, 2015, CELL CYCLE, V14, P86, DOI 10.4161/15384101.2014.974419; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sudarshan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021037; SUGIURA M, 1984, CANCER RES, V44, P1440; Tedeschi PM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.393; Teja-Isavadharm P, 2010, MOLECULES, V15, P8747, DOI 10.3390/molecules15128747; Vincent Zangiacomi, 2014, Genes Cancer, V5, P250; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Vlashi E, 2015, FREE RADICAL BIO MED, V79, P264, DOI 10.1016/j.freeradbiomed.2014.10.732; Vlashi E, 2014, BREAST CANCER RES TR, V146, P525, DOI 10.1007/s10549-014-3051-2; Vlashi E, 2011, P NATL ACAD SCI USA, V108, P16062, DOI 10.1073/pnas.1106704108; Vuohelainen S, 2010, J CELL MOL MED, V14, P1683, DOI 10.1111/j.1582-4934.2009.00808.x; Wallace HM, 2003, BIOCHEM J, V376, P1, DOI 10.1042/BJ20031327; Wang LJ, 2012, MOL CELL BIOCHEM, V363, P257, DOI 10.1007/s11010-011-1178-6; Washington JM, 2010, AM J PHYSIOL-CELL PH, V298, pC982, DOI 10.1152/ajpcell.00498.2009; Wei XL, 2013, BIOINFORMATICS, V29, P1786, DOI 10.1093/bioinformatics/btt275; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Xie H, 2014, CELL METAB, V19, P795, DOI 10.1016/j.cmet.2014.03.003; Zhang T, 2013, J PROTEOME RES, V12, P505, DOI 10.1021/pr3009572; Zhou MS, 2010, CANCER EPIDEM BIOMAR, V19, P2262, DOI 10.1158/1055-9965.EPI-10-0126	65	25	25	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0118262	10.1371/journal.pone.0118262	http://dx.doi.org/10.1371/journal.pone.0118262			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25688563	Green Published, Green Submitted, gold			2022-12-26	WOS:000350322700109
J	Wang, L; Chopp, M; Szalad, A; Jia, LF; Lu, XR; Lu, M; Zhang, L; Zhang, Y; Zhang, RL; Zhang, ZG				Wang, Lei; Chopp, Michael; Szalad, Alexandra; Jia, LongFei; Lu, XueRong; Lu, Mei; Zhang, Li; Zhang, Yi; Zhang, RuiLan; Zhang, Zheng Gang			Sildenafil Ameliorates Long Term Peripheral Neuropathy in Type II Diabetic Mice	PLOS ONE			English	Article							NITRIC-OXIDE; ENDOTHELIAL-CELLS; VASA NERVORUM; ANGIOGENESIS; RATS; NEUROGENESIS; STROKE; ACTIVATION; PROMOTES; MOUSE	Diabetic peripheral neuropathy is a common complication of long-standing diabetes mellitus. To mimic clinical trials in which patients with diabetes enrolled have advanced peripheral neuropathy, we investigated the effect of sildenafil, a specific inhibitor of phosphodiesterase type 5 enzyme, on long term peripheral neuropathy in middle aged male mice with type II diabetes. Treatment of diabetic mice (BKS. Cg-m+/+Lepr(db)/J, db/db) at age 36 weeks with sildenafil significantly increased functional blood vessels and regional blood flow in the sciatic nerve, concurrently with augmentation of intra-epidermal nerve fiber density in the skin and myelinated axons in the sciatic nerve. Functional analysis showed that the sildenafil treatment considerably improved motor and sensory conduction velocities in the sciatic nerve and peripheral thermal stimulus sensitivity compared with the saline treatment. In vitro studies showed that mouse dermal endothelial cells (MDE) cultured under high glucose levels exhibited significant down regulation of angiopoietin 1 (Ang1) expression and reduction of capillary-like tube formation, which were completely reversed by sildenafil. In addition, incubation of dorsal root ganglia (DRG) neurons with conditioned medium harvested from MDE under high glucose levels suppressed neurite outgrowth, where as conditional medium harvested from MDE treated with sildenafil under high glucose levels did not inhibit neurite outgrowth of DRG neurons. Moreover, blockage of the Ang1 receptor, Tie2, with a neutralized antibody against Tie2 abolished the beneficial effect of sildenafil on tube formation and neurite outgrowth. Collectively, our data indicate that sildenafil has a therapeutic effect on long term peripheral neuropathy of middle aged diabetic mice and that improvement of neurovascular dysfunction by sildenafil likely contributes to the amelioration of nerve function. The Ang1/Tie2 signaling pathway may play an important role in these restorative processes.	[Wang, Lei; Chopp, Michael; Szalad, Alexandra; Jia, LongFei; Lu, XueRong; Lu, Mei; Zhang, Li; Zhang, Yi; Zhang, RuiLan; Zhang, Zheng Gang] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI 48309 USA	Henry Ford Health System; Henry Ford Hospital; Oakland University	Wang, L (corresponding author), Henry Ford Hosp, Dept Neurol, 2799 W Grand Blvd, Detroit, MI 48202 USA.	leiwang@neuro.hfh.edu	zhang, zheng/HCH-9684-2022	ZHANG, YI/0000-0001-8373-017X	Dykstra Foundation; United States National Institutes of Health [RO1 NS075084, RO1 AG037506, RO1 NS075156, RO1 DK097519]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079612, R01NS075156, R01NS075084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG037506] Funding Source: NIH RePORTER	Dykstra Foundation; United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Dykstra Foundation, and the United States National Institutes of Health (RO1 NS075084, RO1 AG037506, RO1 NS075156 and RO1 DK097519). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora N., 2007, FASEB J, V21, pA747, DOI [10.1096/FASEBJ.21.6.A747-A, DOI 10.1096/FASEBJ.21.6.A747-A]; Boucek Petr, 2006, Review of Diabetic Studies, V3, P143, DOI 10.1900/RDS.2006.3.143; Cameron NE, 2005, ANN NY ACAD SCI, V1043, P784, DOI 10.1196/annals.1333.091; Cameron NE, 1999, DIABETES RES CLIN PR, V45, P137, DOI 10.1016/S0168-8227(99)00043-1; Charnogursky Gerald, 2014, Handb Clin Neurol, V120, P773, DOI 10.1016/B978-0-7020-4087-0.00051-6; Chen JX, 2008, ARTERIOSCL THROM VAS, V28, P1606, DOI 10.1161/ATVBAHA.108.169235; Corbin JD, 1999, J BIOL CHEM, V274, P13729, DOI 10.1074/jbc.274.20.13729; Di Scipio F, 2008, MICROSC RES TECHNIQ, V71, P497, DOI 10.1002/jemt.20577; Di Wu Q, 1999, AM J PHYSIOL-CELL PH, V277, pC1229, DOI 10.1152/ajpcell.1999.277.6.C1229; Ebenezer GJ, 2011, BRAIN, V134, P1853, DOI 10.1093/brain/awr086; Griffin JW, 2001, CURR OPIN NEUROL, V14, P655, DOI 10.1097/00019052-200110000-00016; Hackett G, 2006, INT J CLIN PRACT, V60, P1123, DOI 10.1111/j.1742-1241.2006.01087.x; IGNARRO LJ, 1991, BLOOD VESSELS, V28, P67; Ii M, 2005, CIRCULATION, V112, P93, DOI 10.1161/CIRCULATIONAHA.104.511964; Kim HK, 2008, STEM CELLS DEV, V17, P669, DOI 10.1089/scd.2008.0141; Koneru S, 2008, J CELL MOL MED, V12, P2651, DOI 10.1111/j.1582-4934.2008.00319.x; Kosacka J, 2005, CELL TISSUE RES, V320, P11, DOI 10.1007/s00441-004-1068-2; Kusano KF, 2004, ARTERIOSCL THROM VAS, V24, P2102, DOI 10.1161/01.ATV.0000144813.44650.75; Lauria G, 2005, EUR J NEUROL, V12, P747, DOI 10.1111/j.1468-1331.2005.01260.x; Lee OH, 1999, BIOCHEM BIOPH RES CO, V264, P743, DOI 10.1006/bbrc.1999.1586; Markus A, 2002, NEURON, V35, P65, DOI 10.1016/S0896-6273(02)00752-3; Neeraj Arora DK, 2007, FASEB J, V21, P7066; NORIDO F, 1984, EXP NEUROL, V83, P221, DOI 10.1016/S0014-4886(84)90094-3; Obrosova IG, 2007, DIABETES, V56, P2598, DOI 10.2337/db06-1176; Patil CS, 2004, PHARMACOLOGY, V72, P190, DOI 10.1159/000080104; Perrone L, 2008, J CELL PHYSIOL, V217, P60, DOI 10.1002/jcp.21474; Russell JW, 1999, NEUROBIOL DIS, V6, P347, DOI 10.1006/nbdi.1999.0254; Sameni H R, 2008, Pak J Biol Sci, V11, P1994, DOI 10.3923/pjbs.2008.1994.2000; SHIRASAKI N, 1991, J NEUROCYTOL, V20, P573, DOI 10.1007/BF01215265; SIMA AAF, 1978, ACTA NEUROPATHOL, V41, P85, DOI 10.1007/BF00689757; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Teichert-Kuliszewska K, 2001, CARDIOVASC RES, V49, P659, DOI 10.1016/S0008-6363(00)00231-5; Tuo QH, 2008, AM J PHYSIOL-HEART C, V294, pH2547, DOI 10.1152/ajpheart.01250.2007; Wang L, 2004, STROKE, V35, P1732, DOI 10.1161/01.STR.0000132196.49028.a4; Wang L, 2005, J CEREBR BLOOD F MET, V25, P1150, DOI 10.1038/sj.jcbfm.9600112; Wang L, 2011, NEUROSCIENCE, V193, P399, DOI 10.1016/j.neuroscience.2011.07.039; Wang L, 2006, J NEUROSCI, V26, P5996, DOI 10.1523/JNEUROSCI.5380-05.2006; Wang L, 2012, NEUROBIOL DIS, V48, P546, DOI 10.1016/j.nbd.2012.08.002; Zhang AG, 1997, J CEREBR BLOOD F MET, V17, P123, DOI 10.1097/00004647-199702000-00001; Zhang RL, 2004, J CEREBR BLOOD F MET, V24, P441, DOI 10.1097/00004647-200404000-00009; Zhang RL, 2003, CIRC RES, V92, P308, DOI 10.1161/01.RES.0000056757.93432.8C; Zhang RL, 2001, ANN NEUROL, V50, P602, DOI 10.1002/ana.1249; Zhang ZG, 1999, J CEREBR BLOOD F MET, V19, P68, DOI 10.1097/00004647-199901000-00008; ZHUO M, 1994, NATURE, V368, P635, DOI 10.1038/368635a0	44	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0118134	10.1371/journal.pone.0118134	http://dx.doi.org/10.1371/journal.pone.0118134			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689401	Green Submitted, Green Published, gold			2022-12-26	WOS:000350322700102
J	Ding, J; Zhao, L; Chang, YQ; Zhao, WM; Du, ZL; Hao, ZL				Ding, Jun; Zhao, Le; Chang, Yaqing; Zhao, Wenming; Du, Zhenlin; Hao, Zhenlin			Transcriptome Sequencing and Characterization of Japanese Scallop Patinopecten yessoensis from Different Shell Color Lines	PLOS ONE			English	Article							GENERATION; EXPRESSION; PROTEINS; REVEALS; TOOL	Shell color is an important trait that is used in breeding the Japanese scallop Patinopecten yessoensis, the most economically important scallop species in China. We constructed four transcriptome libraries from different shell color lines of P. yessoensis: the left and right shell mantles of ordinary strains of P. yessoensis and the left shell mantles of the 'Ivory' and 'Maple' strains. These four libraries were paired-end sequenced using the Illumina HiSeq 2000 platform and contained 54,802,692 sequences, 40,798,962 sequences, 74,019,262 sequences, and 44,466,166 sequences, respectively. A total of 214,087,082 expressed sequence tags were assembled into 73,522 unigenes with an average size of 1,163 bp. When the data were compared against the public Nr and Swiss-Prot databases using BlastX, nearly 30.55% (22,458) of the unigenes were significantly matched to known unique proteins. Gene Ontology annotation and pathway mapping analysis using the Kyoto Encyclopedia of Genes and Genomes categorized unigenes according to their diverse biological functions and processes and identified candidate genes that were potentially involved in growth, pigmentation, metal transcription, and immunity. Expression profile analysis was performed on all four libraries and many differentially expressed genes were identified. In addition, 5,772 simple sequence repeats were obtained from the P. yessoensis transcriptomes, and 464,197, 395,646, and 310,649 single nucleotide polymorphisms were revealed in the ordinary strains, the 'Ivory' strain, and the 'Maple' strain, respectively. These results provide valuable information for future genomic studies on P. yessoensis and improve our understanding of the molecular mechanisms involved in the growth, immunity, shell coloring, and shell biomineralization of this species. These resources also may be used in a variety of applications, such as trait mapping, marker-assisted breeding, studies of population genetics and genomics, and work on functional genomics.	[Ding, Jun; Zhao, Le; Chang, Yaqing; Hao, Zhenlin] Dalian Ocean Univ, Minist Agr, Key Lab Mariculture & Stock Enhancement North Chi, Dalian, Peoples R China; [Zhao, Wenming; Du, Zhenlin] Chinese Acad Sci, Beijing Inst Genom, Beijing, Peoples R China	Dalian Ocean University; Ministry of Agriculture & Rural Affairs; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Chang, YQ (corresponding author), Dalian Ocean Univ, Minist Agr, Key Lab Mariculture & Stock Enhancement North Chi, Dalian, Peoples R China.	yaqingchang@hotmail.com		Zhao, Le/0000-0003-0505-9936	National High-Tech Research and Development Program of China [2012AA10A410]; Introduction of Advanced Agricultural Science and Technology Key Project ("948" Project) [2011-G12]	National High-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Introduction of Advanced Agricultural Science and Technology Key Project ("948" Project)	This research was supported by the National High-Tech Research and Development Program of China (No 2012AA10A410) and the Introduction of Advanced Agricultural Science and Technology Key Project ("948" Project: 2011-G12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andersen JR, 2003, TRENDS PLANT SCI, V8, P554, DOI 10.1016/j.tplants.2003.09.010; Anderson Robert S., 1988, American Fisheries Society Special Publication, V18, P238; Au C, 2008, NEUROTOXICOLOGY, V29, P569, DOI 10.1016/j.neuro.2008.04.022; Canesi L, 2002, MICROSC RES TECHNIQ, V57, P469, DOI 10.1002/jemt.10100; Chang Ya-Qing, 2007, Acta Ecologica Sinica, V27, P1145; Charles GH., 1966, PHYSIOL MOLLUSCA, V2, P455; Chen S, 2007, J ZHEJIANG OCEAN U, V26, P160; Clark MS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-362; Collins JF, 2010, NUTR REV, V68, P133, DOI 10.1111/j.1753-4887.2010.00271.x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; [丁君 DING Jun], 2011, [中国农业科技导报, Journal of Agricultural Science and Technology], V13, P121; Duan CH, 2005, J JILIN U INFORM SCI, V19, P32; Feng C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-19; Fu BD, 2012, DNA RES, V19, P131, DOI 10.1093/dnares/dsr046; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; GUO SW, 2010, BMC GENOMICS S2, V11, DOI DOI 10.1186/1471-; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jackson DJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-160; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Ke JY, 2009, J NINGDE TEACHERS CO, V21, P113; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li J.Z., 2001, J JIANGSU OCEAN U, V1, P22; Li N, 2009, THESIS OCEAN U CHINA; [刘美剑 Liu Meijian], 2011, [中国农业科技导报, Journal of Agricultural Science and Technology], V13, P129; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu YZ, 2012, THESIS GUANGDONG OCE; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Morse M. Patricia, 1997, P7; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Ohgami RS, 2006, BLOOD, V108, P1388, DOI 10.1182/blood-2006-02-003681; Philipp EER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044621; Riley PA, 1997, INT J BIOCHEM CELL B, V29, P1235, DOI 10.1016/S1357-2725(97)00013-7; Shi MJ, 2013, MAR BIOTECHNOL, V15, P706, DOI 10.1007/s10126-013-9517-0; SKILLMAN AG, 1992, J AM CHEM SOC, V114, P9538, DOI 10.1021/ja00050a037; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Tanaka Y, 2008, PLANT J, V54, P733, DOI 10.1111/j.1365-313X.2008.03447.x; Varshney RK, 2009, TRENDS BIOTECHNOL, V27, P522, DOI 10.1016/j.tibtech.2009.05.006; Wang LL, 2007, AQUACULTURE, V271, P252, DOI 10.1016/j.aquaculture.2007.06.020; Wang QC, 1984, FISHERIES SCI, V3, P24; Wang T, 2009, J YANTAI U NATURAL S, V22, P35; Xue QG, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-213; Yano M, 2006, COMP BIOCHEM PHYS B, V144, P254, DOI 10.1016/j.cbpb.2006.03.004; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zhang HF, 2005, J CHEM EDUC, V26, P3; [张婧 Zhang Jing], 2011, [中国农学通报, Chinese Agricultural Science Bulletin], V27, P83; Zhang LL, 2014, MAR BIOTECHNOL, V16, P17, DOI 10.1007/s10126-013-9526-z	53	54	56	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0116406	10.1371/journal.pone.0116406	http://dx.doi.org/10.1371/journal.pone.0116406			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680107	Green Published, gold, Green Submitted			2022-12-26	WOS:000350682600019
J	Kang, JY; Song, SH; Yun, J; Jeon, MS; Kim, HP; Han, SW; Kim, TY				Kang, J. Y.; Song, S. H.; Yun, J.; Jeon, M. S.; Kim, H. P.; Han, S. W.; Kim, T. Y.			Disruption of CTCF/cohesin-mediated high-order chromatin structures by DNA methylation downregulates PTGS2 expression	ONCOGENE			English	Article							GENE-EXPRESSION; CTCF; COHESIN; CYCLOOXYGENASE-2; BINDING; CANCER; TRANSCRIPTION; ORGANIZATION; GENOME; PARENT	The CCCTC-binding factor (CTCF)/cohesin complex regulates gene transcription via high-order chromatin organization of the genome. De novo methylation of CpG islands in the promoter region is an epigenetic hallmark of gene silencing in cancer. Although the CTCF/cohesin complex preferentially targets hypomethylated DNA, it remains unclear whether the CTCF/cohesin-mediated high-order chromatin structure is affected by DNA methylation during tumorigenesis. We found that DNA methylation downregulates the expression of prostaglandin-endoperoxide synthase 2 (PTGS2), which is an inducible, rate-limiting enzyme for prostaglandin synthesis, by disrupting CTCF/cohesin-mediated chromatin looping. We show that the CTCF/cohesin complex is enriched near a CpG island associated with PTGS2 and that the PTGS2 locus forms chromatin loops through methylation-sensitive binding of the CTCF/cohesin complex. DNA methylation abolishes the association of the CTCF/cohesin complex with the PTGS2 CpG island. Disruption of chromatin looping by DNA methylation abrogates the enrichment of transcriptional components, such as positive elongation factor b, at the transcriptional start site of the PTGS2 locus. These alterations result in the downregulation of PTGS2. Our results provide evidence that CTCF/cohesin-mediated chromatin looping of the PTGS2 locus is dynamically influenced by the DNA methylation status.	[Kang, J. Y.; Song, S. H.; Yun, J.; Jeon, M. S.; Kim, H. P.; Han, S. W.; Kim, T. Y.] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea; [Kang, J. Y.; Yun, J.; Jeon, M. S.; Kim, T. Y.] Seoul Natl Univ, Coll Med, Dept Mol Med & Biopharmaceut Sci, Grad Sch Convergence Sci & Technol, Seoul, South Korea; [Han, S. W.; Kim, T. Y.] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Kim, TY (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, 28 Yongon Dong, Seoul 110744, South Korea.	kimty@snu.ac.kr	/Y-5959-2019		National R&D Program for Cancer Control (MOHW) [0720540]; Basic Science Research Program (MOE) [NRF-2011-0021123]; Mid-career Researcher Program (MSIP) [NRF-2013R1A2A2A01009297]; Korea Health Technology R&D Project (MOHW), Republic of Korea [HI14C1277]	National R&D Program for Cancer Control (MOHW); Basic Science Research Program (MOE); Mid-career Researcher Program (MSIP); Korea Health Technology R&D Project (MOHW), Republic of Korea	The authors are grateful to all members of our group for their helpful advice. This research was supported by a grant from the National R&D Program for Cancer Control (MOHW, 0720540), the Basic Science Research Program (MOE, NRF-2011-0021123), the Mid-career Researcher Program (MSIP, NRF-2013R1A2A2A01009297) and the Korea Health Technology R&D Project (MOHW, HI14C1277), Republic of Korea.	Batlle-Lopez A, 2015, ONCOGENE, V34, P246, DOI 10.1038/onc.2013.535; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Chang JF, 2010, P NATL ACAD SCI USA, V107, P21836, DOI 10.1073/pnas.1002130107; Coward WR, 2014, FASEB J, V28, P3183, DOI 10.1096/fj.13-241760; de Maat MFG, 2007, J CLIN ONCOL, V25, P4887, DOI 10.1200/JCO.2006.09.8921; de Wit E, 2013, NATURE, V501, P227, DOI 10.1038/nature12420; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; DeMare LE, 2013, GENOME RES, V23, P1224, DOI 10.1101/gr.156570.113; Dorsett D, 2012, CURR BIOL, V22, pR240, DOI 10.1016/j.cub.2012.02.046; Easwaran H, 2012, GENOME RES, V22, P837, DOI 10.1101/gr.131169.111; Egloff S, 2012, TRENDS GENET, V28, P333, DOI 10.1016/j.tig.2012.03.007; Gilroy DW, 2001, FASEB J, V15, P288; Gomes NP, 2010, GENE DEV, V24, P1022, DOI 10.1101/gad.1881010; Hadjur S, 2009, NATURE, V460, P410, DOI 10.1038/nature08079; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hou CH, 2010, P NATL ACAD SCI USA, V107, P3651, DOI 10.1073/pnas.0912087107; Jin BL, 2013, ADV EXP MED BIOL, V754, P3, DOI 10.1007/978-1-4419-9967-2_1; Kanduri C, 2000, CURR BIOL, V10, P853, DOI 10.1016/S0960-9822(00)00597-2; Krivega I, 2012, CURR OPIN GENET DEV, V22, P79, DOI 10.1016/j.gde.2011.11.001; Lai AY, 2010, J EXP MED, V207, P1939, DOI 10.1084/jem.20100204; McGarvey KM, 2008, CANCER RES, V68, P5753, DOI 10.1158/0008-5472.CAN-08-0700; Murrell A, 2004, NAT GENET, V36, P889, DOI 10.1038/ng1402; Nagano T, 2013, NATURE, V502, P59, DOI 10.1038/nature12593; Nitzsche A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019470; Ong CT, 2014, NAT REV GENET, V15, P234, DOI 10.1038/nrg3663; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Rhodes JM, 2011, MOL CANCER RES, V9, P1587, DOI 10.1158/1541-7786.MCR-11-0382; Rizzo MT, 2011, CLIN CHIM ACTA, V412, P671, DOI 10.1016/j.cca.2010.12.026; Rodriguez C, 2010, BIOCHEM BIOPH RES CO, V392, P129, DOI 10.1016/j.bbrc.2009.12.159; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Rubio ED, 2008, P NATL ACAD SCI USA, V105, P8309, DOI 10.1073/pnas.0801273105; Schaaf CA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003382; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Seitan VC, 2013, GENOME RES, V23, P2066, DOI 10.1101/gr.161620.113; Song SH, 2007, MOL CELL, V28, P810, DOI 10.1016/j.molcel.2007.09.025; Song SH, 2001, CANCER RES, V61, P4628; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Toyota M, 2000, CANCER RES, V60, P4044; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Yan J, 2013, CELL, V154, P801, DOI 10.1016/j.cell.2013.07.034; Yun J, 2012, LAB INVEST, V92, P1033, DOI 10.1038/labinvest.2012.61	45	25	28	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 5	2015	34	45					5677	5684		10.1038/onc.2015.17	http://dx.doi.org/10.1038/onc.2015.17			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CV9GA	25703332	Bronze			2022-12-26	WOS:000364594300008
J	Park, TS; Lee, HG; Moon, JK; Lee, HJ; Yoon, JW; Yun, BNR; Kang, SC; Kim, J; Kim, H; Han, JY; Han, BK				Park, Tae Sub; Lee, Hyo Gun; Moon, Jong Kook; Lee, Hong Jo; Yoon, Jong Won; Yun, Bit Na Rae; Kang, Sang-Chul; Kim, Jiho; Kim, Hyunil; Han, Jae Yong; Han, Beom Ku			Deposition of bioactive human epidermal growth factor in the egg white of transgenic hens using an oviduct-specific minisynthetic promoter	FASEB JOURNAL			English	Article						bioreactor; piggyBac transposon; primordial germ cell	PRIMORDIAL GERM-CELLS; LINE TRANSMISSION; RETROVIRAL VECTOR; FUSION GENES; CHICKENS; PIGGYBAC; MICE; TRANSPOSITION; EXPRESSION; MICROINJECTION	Currently, transgenic animals have found a wide range of industrial applications and are invaluable in various fields of basic research. Notably, deposition of transgene-encoded proteins in the egg white (EW) of hens affords optimal production of genetically engineered biomaterials. In the present study, we developed a minisynthetic promoter modulating transgene transcription specifically in the hen's oviduct, and assayed the bioactivity of human epidermal growth factor (hEGF) driven by that promoter, after partial purification of epidermal growth factor (EGF) from transgenic hen eggs. Our minisynthetic promoter driving expression of chicken codon-optimized human epidermal growth factor (cEGF) features 2 consecutive estrogen response elements of the ovalbumin (OV) promoter, ligated with a 3.0 kb OV promoter region carrying OV regulatory elements, and a 5'-UTR. Subsequently, a 3'-UTR carrying the poly-A tail sequence of the OV gene was added after incorporation of the cEGF transgene. Finally, we partially purified cEGF from transgenic hen eggs and evaluated the biofunctional activities thereof in vitro and in vivo. In the in vitro assay, EW-derived hEGF exhibited a proliferative effect on HeLa cells similar to that of commercial hEGF. In the in vivo assay, compared to the nontreated control, transgenic hen egg-derived EGF afforded slightly higher levels of re-epithelialization (via fibroplasia) and neovascularization of wounded skin of miniature pigs than did the commercial material. In conclusion, transgenic hens may be used to produce genetically engineered bioactive biomaterials driven by an oviduct-specific minisynthetic promoter.	[Park, Tae Sub] Seoul Natl Univ, Grad Sch Int Agr Technol, Gangwon Do, South Korea; [Park, Tae Sub] Seoul Natl Univ, Inst Green Bio Sci & Technol, Gangwon Do, South Korea; [Lee, Hyo Gun; Lee, Hong Jo; Yoon, Jong Won; Han, Jae Yong] Seoul Natl Univ, Coll Agr & Life Sci, Dept Agr Biotechnol, Seoul 151921, South Korea; [Moon, Jong Kook; Yun, Bit Na Rae; Kang, Sang-Chul; Kim, Jiho; Kim, Hyunil; Han, Beom Ku] Optipharm, Cheongju 363954, Chungcheongbku, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Han, JY (corresponding author), Seoul Natl Univ, Coll Agr & Life Sci, Dept Agr Biotechnol, Seoul 151921, South Korea.	jaehan@snu.ac.kr; bkhan@optipharm.co.kr		Lee, Hyo Gun/0000-0002-3286-7368	Bio-industry Technology Development Program [IPET-312060-5-2-SB020]; Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea; Technological Innovation R&D Program - Small and Medium Business Administration (Korea) [SA112684]	Bio-industry Technology Development Program; Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea; Technological Innovation R&D Program - Small and Medium Business Administration (Korea)	This work was supported by the Bio-industry Technology Development Program (IPET-312060-5-2-SB020), Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea. This research was also supported by the Technological Innovation R&D Program (SA112684) funded by the Small and Medium Business Administration (Korea).	Agate RJ, 2009, P NATL ACAD SCI USA, V106, P17963, DOI 10.1073/pnas.0909139106; CARPENTER G, 1990, J BIOL CHEM, V265, P7709; Choi JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012968; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; GORDON JW, 1980, P NATL ACAD SCI-BIOL, V77, P7380, DOI 10.1073/pnas.77.12.7380; Harvey AJ, 2002, NAT BIOTECHNOL, V20, P396, DOI 10.1038/nbt0402-396; Herbst RS, 2004, INT J RADIAT ONCOL, V59, P21, DOI 10.1016/j.ijrobp.2003.11.041; Kamihira M, 2005, J VIROL, V79, P10864, DOI 10.1128/JVI.79.17.10864-10874.2005; Kwon SC, 2010, BIOL REPROD, V82, P1057, DOI 10.1095/biolreprod.109.081687; Lillico SG, 2007, P NATL ACAD SCI USA, V104, P1771, DOI 10.1073/pnas.0610401104; LOVE J, 1994, BIO-TECHNOL, V12, P60, DOI 10.1038/nbt0194-60; Macdonald J, 2012, P NATL ACAD SCI USA, V109, pE1466, DOI 10.1073/pnas.1118715109; Macdonald J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015518; Mizuarai S, 2001, BIOCHEM BIOPH RES CO, V286, P456, DOI 10.1006/bbrc.2001.5422; Motono M, 2010, J BIOSCI BIOENG, V109, P315, DOI 10.1016/j.jbiosc.2009.10.007; PALMITER RD, 1982, CELL, V29, P701, DOI 10.1016/0092-8674(82)90186-6; PALMITER RD, 1986, ANNU REV GENET, V20, P465, DOI 10.1146/annurev.ge.20.120186.002341; PALMITER RD, 1983, SCIENCE, V222, P809, DOI 10.1126/science.6356363; Park SH, 2010, THERIOGENOLOGY, V74, P805, DOI 10.1016/j.theriogenology.2010.04.005; Park TS, 2014, P NATL ACAD SCI USA, V111, P12716, DOI 10.1073/pnas.1410555111; Park TS, 2012, P NATL ACAD SCI USA, V109, P9337, DOI 10.1073/pnas.1203823109; SALTER DW, 1986, POULTRY SCI, V65, P1445, DOI 10.3382/ps.0651445; Schusser B, 2013, P NATL ACAD SCI USA, V110, P20170, DOI 10.1073/pnas.1317106110; Shin SS, 2008, FASEB J, V22, P2435, DOI 10.1096/fj.07-101485; Song G, 2011, ANN NY ACAD SCI, V1229, P69, DOI 10.1111/j.1749-6632.2011.06087.x; van de Lavoir MC, 2006, NATURE, V441, P766, DOI 10.1038/nature04831; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105; Zhu L, 2005, NAT BIOTECHNOL, V23, P1159, DOI 10.1038/nbt1132	28	36	40	0	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2386	2396		10.1096/fj.14-264739	http://dx.doi.org/10.1096/fj.14-264739			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	25690652				2022-12-26	WOS:000355209500016
J	Labbe, SM; Caron, A; Bakan, I; Laplante, M; Carpentier, AC; Lecomte, R; Richard, D				Labbe, Sebastien M.; Caron, Alexandre; Bakan, Inan; Laplante, Mathieu; Carpentier, Andre C.; Lecomte, Roger; Richard, Denis			In vivo measurement of energy substrate contribution to cold-induced brown adipose tissue thermogenesis	FASEB JOURNAL			English	Article						positron emission tomography; glucose uptake; glycogenesis; lipogenesis; NEFA uptake	FATTY-ACID SYNTHESIS; DE-NOVO LIPOGENESIS; ACCLIMATED RATS; NONSHIVERING THERMOGENESIS; LIPID-METABOLISM; ACTIVATION; MECHANISMS; EXPOSURE; GLUCOSE; CALORIGENESIS	The present study was designed to investigate the effects of cold on brown adipose tissue (BAT) energy substrate utilization in vivo using the positron emission tomography tracers [F-18]fluorodeoxyglucose (glucose uptake), 14(R,S)-[F-18]fluoro-6-thia-heptadecanoic acid [nonesterified fatty acid (NEFA) uptake], and [C-11]acetate (oxidative activity). The measurements were performed in rats adapted to 27 degrees C, which were acutely subjected to cold (10 degrees C) for 2 and 6 hours, and in rats chronically adapted to 10 degrees C for 21 days, which were returned to 27 degrees C for 2 and 6 hours. Cold exposure (acutely and chronically) led to increases in BAT oxidative activity, which was accompanied by concomitant increases in glucose and NEFA uptake. The increases were particularly high in cold-adapted rats and largely readily reduced by the return to a warm environment. The cold-induced increase in oxidative activity was meaningfully blunted by nicotinic acid, a lipolysis inhibitor, which emphasizes in vivo the key role of intracellular lipid in BAT thermogenesis. The changes in BAT oxidative activity and glucose and NEFA uptakes were paralleled by inductions of genes involved in not only oxidative metabolism but also in energy substrate replenishment (triglyceride and glycogen synthesis). The capacity of BAT for energy substrate replenishment is remarkable.	[Labbe, Sebastien M.; Caron, Alexandre; Bakan, Inan; Laplante, Mathieu; Richard, Denis] Univ Laval, Ctr Rech, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [Carpentier, Andre C.] Ctr Hosp, Ctr Rech, Dept Med, Sherbrooke, PQ, Canada; [Lecomte, Roger] Univ Sherbrooke, Dept Nucl Med, Ctr Imagerie Mol Sherbrooke, Sherbrooke, PQ J1K 2R1, Canada; [Lecomte, Roger] Univ Sherbrooke, Dept Radiobiol, Ctr Imagerie Mol Sherbrooke, Sherbrooke, PQ J1K 2R1, Canada	Laval University; University of Sherbrooke; University of Sherbrooke	Richard, D (corresponding author), Inst Univ Cardiol & Pneumol Quebec, 2725 Chemin St Foy, Ste Foy, PQ G1V 4G5, Canada.	denis.richard@criucpq.ulaval.ca	LECOMTE, Roger/F-2582-2011; Caron, Alexandre/J-3151-2015	LECOMTE, Roger/0000-0002-8541-0783; Caron, Alexandre/0000-0001-6939-6136	Natural Sciences and Engineering Research Council of Canada [2014-06721]; Canadian Institutes of Health Research (CIHR); CIHR-GlaxoSmithKline Chair in Diabetes	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR-GlaxoSmithKline Chair in Diabetes	The authors are grateful to Jean-Francois Beaudoin for his helpful positron emission tomography scan assistance and Serge Phoenix for radiotracer synthesis. This work was supported by a grant from the Natural Sciences and Engineering Research Council of Canada (2014-06721). S.M.L. is the recipient of a Canadian Institutes of Health Research (CIHR) postdoctoral fellowship. A.C. holds a fellowship from the CIHR Training Program in Obesity/Healthy Body Weight Research. A.C.C. is the recipient of the CIHR-GlaxoSmithKline Chair in Diabetes. S.M.L. and D.R. conceived and designed the experiments. S.M.L., A.C., I.B., and D.R. collected, analyzed, and interpreted the data. All authors drafted the article or revised it critically for important intellectual content.	AHERNE W, 1966, J PATHOL BACTERIOL, V91, P223, DOI 10.1002/path.1700910126; Baba S, 2010, J NUCL MED, V51, P246, DOI 10.2967/jnumed.109.068775; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; BERTIN R, 1976, EUR J BIOCHEM, V69, P177, DOI 10.1111/j.1432-1033.1976.tb10871.x; Blondin DP, 2014, J CLIN ENDOCR METAB, V99, pE438, DOI 10.1210/jc.2013-3901; BOBBIONIHARSCH E, 1994, J APPL PHYSIOL, V76, P1106, DOI 10.1152/jappl.1994.76.3.1106; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; CARLSON LA, 1965, ANN NY ACAD SCI, V131, P119, DOI 10.1111/j.1749-6632.1965.tb34784.x; Cohade C, 2003, J NUCL MED, V44, P170; COONEY GJ, 1982, FEBS LETT, V148, P198, DOI 10.1016/0014-5793(82)80807-7; Cypess AM, 2012, P NATL ACAD SCI USA, V109, P10001, DOI 10.1073/pnas.1207911109; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; DEPOCAS F, 1978, CAN J PHYSIOL PHARM, V56, P168, DOI 10.1139/y78-023; Dulloo AG, 2004, INT J OBESITY, V28, pS29, DOI 10.1038/sj.ijo.0802861; Festuccia William T, 2011, Front Endocrinol (Lausanne), V2, P84, DOI 10.3389/fendo.2011.00084; FOSTER DO, 1974, CAN J PHYSIOL PHARM, V52, P1051, DOI 10.1139/y74-139; FOSTER DO, 1984, CAN J BIOCHEM CELL B, V62, P618, DOI 10.1139/o84-082; FOSTER DO, 1978, CAN J PHYSIOL PHARM, V56, P110, DOI 10.1139/y78-015; Fredriksson JM, 2005, FEBS LETT, V579, P5680, DOI 10.1016/j.febslet.2005.09.044; Friedli C, 1978, Experientia Suppl, V32, P259; Gille A, 2008, ANNU REV PHARMACOL, V48, P79, DOI 10.1146/annurev.pharmtox.48.113006.094746; GOUBERN M, 1986, ANN NUTR METAB, V30, P380, DOI 10.1159/000177219; Hausman GJ, 2004, J ANIM SCI, V82, P925; HIMMSHAGEN J, 1965, CAN J PHYSIOL PHARM, V43, P379, DOI 10.1139/y65-039; Li YG, 2014, EMBO REP, V15, P1069, DOI 10.15252/embr.201438775; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; LUBOSHITZKY R, 1983, INT J OBESITY, V7, P241; Mantha L, 1998, AM J PHYSIOL-REG I, V274, pR1769; MCCORMACK JG, 1977, BIOCHEM J, V166, P627, DOI 10.1042/bj1660627; Menard SL, 2010, AM J PHYSIOL-ENDOC M, V298, pE1049, DOI 10.1152/ajpendo.00560.2009; Mirbolooki MR, 2014, NUCL MED BIOL, V41, P10, DOI 10.1016/j.nucmedbio.2013.08.009; Mirbolooki MR, 2011, EJNMMI RES, V1, DOI 10.1186/2191-219X-1-30; Monge-Roffarello B, 2014, ENDOCRINOLOGY, V155, P3448, DOI 10.1210/en.2013-2092; Mottillo EP, 2014, J LIPID RES, V55, P2276, DOI 10.1194/jlr.M050005; Moura MAF, 2005, PFLUG ARCH EUR J PHY, V449, P463, DOI 10.1007/s00424-004-1353-7; Moura MAF, 2001, METABOLISM, V50, P1493, DOI 10.1053/meta.2001.27197; NICHOLLS DG, 1984, PHYSIOL REV, V64, P1, DOI 10.1152/physrev.1984.64.1.1; NIKAMI H, 1992, BIOCHEM BIOPH RES CO, V185, P1078, DOI 10.1016/0006-291X(92)91736-A; Orava J, 2011, CELL METAB, V14, P272, DOI 10.1016/j.cmet.2011.06.012; Ouellet V, 2012, J CLIN INVEST, V122, P545, DOI 10.1172/JCI60433; PATLAK CS, 1985, J CEREBR BLOOD F MET, V5, P584, DOI 10.1038/jcbfm.1985.87; PORTET R, 1976, ARCH INT PHYSIOL BIO, V84, P89, DOI 10.3109/13813457609072350; Richard D, 2011, FRONT BIOSCI-LANDMRK, V16, P1233, DOI 10.2741/3786; Ricquier Daniel, 2011, Front Endocrinol (Lausanne), V2, P85, DOI 10.3389/fendo.2011.00085; Schlogl M, 2013, J CLIN ENDOCR METAB, V98, pE1956, DOI 10.1210/jc.2013-2387; Shabalina IG, 2013, CELL REP, V5, P1196, DOI 10.1016/j.celrep.2013.10.044; Toczek J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099441; Townsend KL, 2014, TRENDS ENDOCRIN MET, V25, P168, DOI 10.1016/j.tem.2013.12.004; TRAYHURN P, 1979, FEBS LETT, V104, P13, DOI 10.1016/0014-5793(79)81075-3; van den Hoff J, 2001, J NUCL MED, V42, P1174; van der Lans AAJJ, 2013, J CLIN INVEST, V123, P3395, DOI 10.1172/JCI68993; vandenHoff J, 1996, J NUCL MED, V37, P521; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wu QW, 2006, DIABETES, V55, P3229, DOI 10.2337/db06-0749; Xue Y, 2009, CELL METAB, V9, P99, DOI 10.1016/j.cmet.2008.11.009; Yamamoto T, 2011, BIOTECHNOL LETT, V33, P237, DOI 10.1007/s10529-010-0444-0; Yoneshiro T, 2013, J CLIN INVEST, V123, P3404, DOI 10.1172/JCI67803; YOUNG JB, 1982, J CLIN INVEST, V69, P1061, DOI 10.1172/JCI110541; Zaninovich AA, 2002, AM J PHYSIOL-ENDOC M, V283, pE496, DOI 10.1152/ajpendo.00540.2001	59	142	146	1	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2015	29	5					2046	2058		10.1096/fj.14-266247	http://dx.doi.org/10.1096/fj.14-266247			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZJ	25681456				2022-12-26	WOS:000354114600037
J	Llavero, F; Urzelai, B; Osinalde, N; Galvez, P; Lacerda, HM; Parada, LA; Zugaza, JL				Llavero, Francisco; Urzelai, Bakarne; Osinalde, Nerea; Galvez, Patricia; Lacerda, Hadriano M.; Parada, Luis A.; Zugaza, Jose L.			Guanine Nucleotide Exchange Factor alpha PIX Leads to Activation of the Rac 1 GTPase/Glycogen Phosphorylase Pathway in Interleukin (IL)-2-stimulated T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; PKC-THETA; GLYCOGEN-PHOSPHORYLASE; GDP/GTP EXCHANGE; DEPENDENT ACTIVATION; SIGNALING PATHWAY; RHO GTPASES; FAMILY; IL-2; TIAM1	Recently, we have reported that the active form of Rac 1 GTPase binds to the glycogen phosphorylase muscle isoform (PYGM) and modulates its enzymatic activity leading to T cell proliferation. In the lymphoid system, Rac 1 and in general other small GTPases of the Rho family participate in the signaling cascades that are activated after engagement of the T cell antigen receptor. However, little is known about the IL-2-dependent Rac 1 activator molecules. For the first time, a signaling pathway leading to the activation of Rac 1/PYGM in response to IL-2-stimulated T cell proliferation is described. More specifically, alpha PIX, a known guanine nucleotide exchange factor for the small GTPases of the Rho family, preferentially Rac 1, mediates PYGM activation in Kit 225 T cells stimulated with IL-2. Using directed mutagenesis, phosphorylation of alpha PIX Rho-GEF serines 225 and 488 is required for activation of the Rac 1/PYGM pathway. IL-2-stimulated serine phosphorylation was corroborated in Kit 225 T cells cultures. A parallel pharmacological and genetic approach identified PKC theta as the serine/threonine kinase responsible for alpha PIX serine phosphorylation. The phosphorylated state of alpha PIX was required to activate first Rac 1 and subsequently PYGM. These results demonstrate that the IL-2 receptor activation, among other early events, leads to activation of PKC theta. To activate Rac 1 and consequently PYGM, PKC theta phosphorylates alpha PIX in T cells. The biological significance of this PKC theta/alpha PIX/Rac 1 GTPase/PYGM signaling pathway seems to be the control of different cellular responses such as migration and proliferation.	[Llavero, Francisco; Urzelai, Bakarne; Zugaza, Jose L.] Univ Basque Country, Dept Genet Phys Anthropol & Anim Physiol, Leioa 48940, Spain; [Llavero, Francisco; Zugaza, Jose L.] Achucarro Basque Ctr Neurosci, Zamudio 48170, Spain; [Osinalde, Nerea] Univ Southern Denmark, Dept Biochem & Mol Biol, DK-5230 Odense, Denmark; [Galvez, Patricia] Technol Pk Hlth Sci, Pharmasci Div, Granada 18100, Spain; [Lacerda, Hadriano M.] Univ Turin, Dept Biomed Sci & Human Oncol, Canc Epidemiol Unit, I-10124 Turin, Italy; [Parada, Luis A.] Univ Nacl Salta, Inst Patol Expt, RA-4400 Salta, Argentina; [Zugaza, Jose L.] Basque Fdn Sci, Ikerbasque, Bilbao 48013, Spain	University of Basque Country; University of Southern Denmark; University of Turin; Basque Foundation for Science	Zugaza, JL (corresponding author), Univ Basque Country, Dept Genet Phys Anthropol & Anim Physiol, Barrio Sarriena S-N, Leioa 48940, Spain.	joseluis.zugaza@ehu.es	Bustelo, Xose R./A-9526-2010	Bustelo, Xose R./0000-0001-9398-6072; ZUGAZA GURRUCHAGA, JOSE LUIS/0000-0003-2287-6671; Osinalde, Nerea/0000-0001-8850-7794	Dept. of Industry of the Basque Government [S-PE11UN018, S-PE13UN028]; University of the Basque Country [EHU11/08, UFI 11/20]; Dept. of Education, Basque Government [BFI-2010-184]	Dept. of Industry of the Basque Government(Basque Government); University of the Basque Country; Dept. of Education, Basque Government	Supported by Dept. of Education, Basque Government Grant BFI-2010-184.; Supported by Dept. of Industry of the Basque Government Grants S-PE11UN018 and S-PE13UN028 and University of the Basque Country Grants EHU11/08 and UFI 11/20.	Andersen B, 2002, BIOCHEM J, V367, P443, DOI 10.1042/BJ20020153; Arendt CW, 2002, CURR OPIN IMMUNOL, V14, P323, DOI 10.1016/S0952-7915(02)00346-1; Arnaud M, 2004, BIOCHEM J, V382, P545, DOI 10.1042/BJ20040103; Arrieumerlou C, 1998, EUR J IMMUNOL, V28, P1877, DOI 10.1002/(SICI)1521-4141(199806)28:06<1877::AID-IMMU1877>3.3.CO;2-9; Arrizabalaga O, 2012, J BIOL CHEM, V287, P11878, DOI 10.1074/jbc.M111.297804; BaierBitterlich G, 1996, MOL CELL BIOL, V16, P1842; Beier I, 2008, ATHEROSCLEROSIS, V196, P92, DOI 10.1016/j.atherosclerosis.2007.02.003; Billadeau DD, 2007, NAT REV IMMUNOL, V7, P131, DOI 10.1038/nri2021; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Brockdorff J, 2000, EUR CYTOKINE NETW, V11, P225; Bustelo XR, 2007, BIOESSAYS, V29, P356, DOI 10.1002/bies.20558; Caloca MJ, 2008, J BIOL CHEM, V283, P36454, DOI 10.1074/jbc.M803814200; Caloca MJ, 2003, J BIOL CHEM, V278, P33465, DOI 10.1074/jbc.M302807200; Caloca MJ, 2003, EMBO J, V22, P3326, DOI 10.1093/emboj/cdg316; Cannon JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078940; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; Chiariello M, 2010, METHODS MOL BIOL, V661, P137, DOI 10.1007/978-1-60761-795-2_8; Collard JG, 1996, CURR TOP MICROBIOL, V213, P253; Cordey M, 2006, J NEUROCHEM, V96, P204, DOI 10.1111/j.1471-4159.2005.03545.x; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; EVANS GA, 1993, BIOCHEM J, V294, P339, DOI 10.1042/bj2940339; Feng QY, 2004, EMBO J, V23, P3492, DOI 10.1038/sj.emboj.7600331; Fleming IN, 1997, J BIOL CHEM, V272, P33105, DOI 10.1074/jbc.272.52.33105; Freeley M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00227; Gerard A, 2009, BLOOD, V113, P6138, DOI 10.1182/blood-2008-07-167668; Gomez J, 1997, J IMMUNOL, V158, P1516; Goto A, 2011, MOL BIOL CELL, V22, P1780, DOI 10.1091/mbc.E10-09-0783; GSCHWENDT M, 1994, BIOCHEM BIOPH RES CO, V199, P93, DOI 10.1006/bbrc.1994.1199; HORI T, 1987, BLOOD, V70, P1069; Isakov N, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00273; Kadamur G, 2013, ANNU REV PHYSIOL, V75, P127, DOI 10.1146/annurev-physiol-030212-183750; Lan RY, 2008, J AUTOIMMUN, V31, P7, DOI 10.1016/j.jaut.2008.03.002; Letschka T, 2008, BLOOD, V112, P4617, DOI 10.1182/blood-2007-11-121111; Llorca O, 2005, EMBO J, V24, P1330, DOI 10.1038/sj.emboj.7600617; Malek TR, 2010, IMMUNITY, V33, P153, DOI 10.1016/j.immuni.2010.08.004; Manicassamy S, 2006, CELL MOL IMMUNOL, V3, P263; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; Manterola L, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2012.147; Matsuo N, 2002, J BIOL CHEM, V277, P2860, DOI 10.1074/jbc.M106186200; McInerney M, 2002, BBA-GEN SUBJECTS, V1570, P53, DOI 10.1016/S0304-4165(02)00154-X; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; Nishizuka Y, 2001, ALCOHOL CLIN EXP RES, V25, p3S, DOI 10.1111/j.1530-0277.2001.tb02367.x; Obermeier A, 1998, EMBO J, V17, P4328, DOI 10.1093/emboj/17.15.4328; Osinalde N, 2011, J PROTEOMICS, V75, P177, DOI 10.1016/j.jprot.2011.06.007; Parri M, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-23; Pei Y, 2008, J IMMUNOL, V180, P222, DOI 10.4049/jimmunol.180.1.222; Pelletier S, 2003, MOL CELL BIOL, V23, P1316, DOI 10.1128/MCB.23.4.1316-1333.2003; Phanstiel DH, 2011, NAT METHODS, V8, P821, DOI [10.1038/NMETH.1699, 10.1038/nmeth.1699]; Poppe D, 2006, J IMMUNOL, V176, P640, DOI 10.4049/jimmunol.176.1.640; Ravichandran KS, 1996, P NATL ACAD SCI USA, V93, P5275, DOI 10.1073/pnas.93.11.5275; Ravichandran KS, 1995, ANN NY ACAD SCI, V766, P202, DOI 10.1111/j.1749-6632.1995.tb26663.x; Shiromizu T, 2013, J PROTEOME RES, V12, P2414, DOI 10.1021/pr300825v; SMITH KA, 1988, IMMUNOL TODAY, V9, P36, DOI 10.1016/0167-5699(88)91255-8; Thomas RM, 2005, J IMMUNOL, V174, P4639, DOI 10.4049/jimmunol.174.8.4639; Villalba M, 1999, J IMMUNOL, V163, P5813; von Essen MR, 2013, EUR J IMMUNOL, V43, P1659, DOI 10.1002/eji.201243140; Wang XH, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00197; Weber C, 2012, J PROTEOMICS, V75, P1343, DOI 10.1016/j.jprot.2011.11.004; Wery-Zennaro S, 2000, ONCOGENE, V19, P1596, DOI 10.1038/sj.onc.1203458; Yang Yong Ryoul, 2013, Advances in Biological Regulation, V53, P232, DOI 10.1016/j.jbior.2013.08.003; Yoshii S, 1999, ONCOGENE, V18, P5680, DOI 10.1038/sj.onc.1202936; Zaldua N, 2007, FEBS LETT, V581, P5814, DOI 10.1016/j.febslet.2007.11.053; Zugaza JL, 2004, ONCOGENE, V23, P5823, DOI 10.1038/sj.onc.1207768	63	15	16	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					9171	9182		10.1074/jbc.M114.608414	http://dx.doi.org/10.1074/jbc.M114.608414			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25694429	Green Published, hybrid			2022-12-26	WOS:000352207100040
J	Lemoine, NP				Lemoine, Nathan P.			Climate Change May Alter Breeding Ground Distributions of Eastern Migratory Monarchs (Danaus plexippus) via Range Expansion of Asclepias Host Plants	PLOS ONE			English	Article							BUTTERFLIES; SHIFTS; LEPIDOPTERA; TEMPERATURE; PERFORMANCE; PREDICTION; PREFERENCE; RESPONSES; MILKWEED; IMPACTS	Climate change can profoundly alter species' distributions due to changes in temperature, precipitation, or seasonality. Migratory monarch butterflies (Danaus plexippus) may be particularly susceptible to climate-driven changes in host plant abundance or reduced overwintering habitat. For example, climate change may significantly reduce the availability of overwintering habitat by restricting the amount of area with suitable microclimate conditions. However, potential effects of climate change on monarch northward migrations remain largely unknown, particularly with respect to their milkweed (Asclepias spp.) host plants. Given that monarchs largely depend on the genus Asclepias as larval host plants, the effects of climate change on monarch northward migrations will most likely be mediated by climate change effects on Asclepias. Here, I used MaxEnt species distribution modeling to assess potential changes in Asclepias and monarch distributions under moderate and severe climate change scenarios. First, Asclepias distributions were projected to extend northward throughout much of Canada despite considerable variability in the environmental drivers of each individual species. Second, Asclepias distributions were an important predictor of current monarch distributions, indicating that monarchs may be constrained as much by the availability of Asclepias host plants as environmental variables per se. Accordingly, modeling future distributions of monarchs, and indeed any tightly coupled plant-insect system, should incorporate the effects of climate change on host plant distributions. Finally, MaxEnt predictions of Asclepias and monarch distributions were remarkably consistent among general circulation models. Nearly all models predicted that the current monarch summer breeding range will become slightly less suitable for Asclepias and monarchs in the future. Asclepias, and consequently monarchs, should therefore undergo expanded northern range limits in summer months while encountering reduced habitat suitability throughout the northern migration.	Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA	State University System of Florida; Florida International University	Lemoine, NP (corresponding author), Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA.	nlemo001@fiu.edu			Smithsonian Predoctoral Fellowship; FIU Dissertation Evidence Acquisition Grant; FIU Dissertation Year Fellowship; Florida International University Open Access Publishing Fund	Smithsonian Predoctoral Fellowship(Smithsonian Institution); FIU Dissertation Evidence Acquisition Grant; FIU Dissertation Year Fellowship; Florida International University Open Access Publishing Fund	Funding for this project was provided by a Smithsonian Predoctoral Fellowship, an FIU Dissertation Evidence Acquisition Grant, and an FIU Dissertation Year Fellowship. Publication of this article was funded in part by Florida International University Open Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MB, 2012, ECOLOGY, V93, P1527, DOI 10.1890/11-1930.1; Bartholomew CS, 2001, J KANSAS ENTOMOL SOC, V74, P211; Batalden RV, 2007, ENVIRON ENTOMOL, V36, P1365, DOI 10.1603/0046-225X(2007)36[1365:ENISGO]2.0.CO;2; Battisti A, 2005, ECOL APPL, V15, P2084, DOI 10.1890/04-1903; Berzitis EA, 2014, GLOBAL CHANGE BIOL, V20, P2778, DOI 10.1111/gcb.12557; Brindza LJ, 2008, J LEPID SOC, V62, P189; Brower LP, 2012, INSECT CONSERV DIVER, V5, P95, DOI 10.1111/j.1752-4598.2011.00142.x; Brower Lincoln P., 1995, Journal of the Lepidopterists' Society, V49, P304; Cavanaugh KC, 2014, P NATL ACAD SCI USA, V111, P723, DOI 10.1073/pnas.1315800111; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Crozier L, 2004, ECOLOGY, V85, P231, DOI 10.1890/02-0607; Davis Andrew K., 2005, Journal of the Lepidopterists' Society, V59, P1; Diamond SE, 2012, ECOLOGY, V93, P2305, DOI 10.1890/11-2296.1; DiTommaso A, 2003, ENTOMOL EXP APPL, V108, P205, DOI 10.1046/j.1570-7458.2003.00089.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Feeley KJ, 2013, GLOBAL CHANGE BIOL, V19, P3472, DOI 10.1111/gcb.12300; Flockhart DTT, 2015, J ANIM ECOL, V84, P155, DOI 10.1111/1365-2656.12253; Flockhart DTT, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1087; Fourcade Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097122; Goehring L, 2002, ECOL ENTOMOL, V27, P674, DOI 10.1046/j.1365-2311.2002.00454.x; Guerra PA, 2013, CURR BIOL, V23, P419, DOI 10.1016/j.cub.2013.01.052; Hijmans R.J., 2013, DISMO SPECIES DISTRI, V0, P8; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; Kramer-Schadt S, 2013, DIVERS DISTRIB, V19, P1366, DOI 10.1111/ddi.12096; Ladner DT, 2005, ENTOMOL EXP APPL, V116, P9, DOI 10.1111/j.1570-7458.2005.00308.x; Mattila HR, 2003, ENTOMOL EXP APPL, V107, P193, DOI 10.1046/j.1570-7458.2003.00049.x; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Oberhauser K, 2003, P NATL ACAD SCI USA, V100, P14063, DOI 10.1073/pnas.2331584100; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Pateman RM, 2012, SCIENCE, V336, P1028, DOI 10.1126/science.1216980; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pleasants JM, 2013, INSECT CONSERV DIVER, V6, P135, DOI 10.1111/j.1752-4598.2012.00196.x; Reppert SM, 2010, TRENDS NEUROSCI, V33, P399, DOI 10.1016/j.tins.2010.04.004; Saenz-Romero C, 2012, FOREST ECOL MANAG, V275, P98, DOI 10.1016/j.foreco.2012.03.004; Sheldon KS, 2014, ECOLOGY, V95, P2134, DOI 10.1890/13-1703.1; Sheldon KS, 2011, ECOL LETT, V14, P1191, DOI 10.1111/j.1461-0248.2011.01689.x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sorte CJB, 2010, GLOBAL ECOL BIOGEOGR, V19, P303, DOI 10.1111/j.1466-8238.2009.00519.x; Tao LL, 2014, FUNCT ECOL, V28, P190, DOI 10.1111/1365-2435.12163; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Wassenaar LI, 1998, P NATL ACAD SCI USA, V95, P15436, DOI 10.1073/pnas.95.26.15436; Wolkovich EM, 2012, NATURE, V485, P494, DOI 10.1038/nature11014; WOODSON ROBERT E., 1954, ANN MISSOURI BOT GARD, V41, P1, DOI 10.2307/2394652; Yeargan KV, 2005, J KANSAS ENTOMOL SOC, V78, P247, DOI 10.2317/0407.40.1; York HA, 2002, J KANSAS ENTOMOL SOC, V75, P290; Zalucki MR, 2004, MONARCH BUTTERFLY BIOLOGY AND CONSERVATION, P219; Zipkin EF, 2012, GLOBAL CHANGE BIOL, V18, P3039, DOI 10.1111/j.1365-2486.2012.02751.x	48	57	59	11	162	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118614	10.1371/journal.pone.0118614	http://dx.doi.org/10.1371/journal.pone.0118614			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25705876	Green Submitted, gold, Green Published			2022-12-26	WOS:000350662100195
J	Huynh, HN; Pradana, A; Chew, LY				Huynh, Hoai Nguyen; Pradana, Andri; Chew, Lock Yue			The Complexity of Sequences Generated by the Arc-Fractal System	PLOS ONE			English	Article							SYMBOLIC DYNAMICS	We study properties of the symbolic sequences extracted from the fractals generated by the arc-fractal system introduced earlier by Huynh and Chew. The sequences consist of only a few symbols yet possess several nontrivial properties. First using an operator approach, we show that the sequences are not periodic, even though they are constructed from very simple rules. Second by employing the epsilon-machine approach developed by Crutchfield and Young, we measure the complexity and randomness of the sequences and show that they are indeed complex, i.e. neither periodic nor random, with the value of complexity measure being significant as compared to the known example of logistic map at the edge of chaos. The complexity and randomness of the sequences are then discussed in relation with the properties of associated fractal objects, such as their fractal dimension, symmetry and orientations of the arcs.	[Huynh, Hoai Nguyen; Chew, Lock Yue] Nanyang Technol Univ, Complex Inst, Singapore 639798, Singapore; [Pradana, Andri; Chew, Lock Yue] Nanyang Technol Univ, Div Phys & Appl Phys, Sch Phys & Math Sci, Singapore 639798, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Chew, LY (corresponding author), Nanyang Technol Univ, Complex Inst, Singapore 639798, Singapore.	lockyue@ntu.edu.sg	Pradana, Andri/W-2725-2018	Pradana, Andri/0000-0002-9749-8882; Huynh, Nguyen/0000-0002-8432-7435; Chew, Lock Yue/0000-0003-1366-8205				Barnsley M, 1993, FRACTALS EVERYWHERE; Bennett CH, 1985, EMERGING SYNTHESES S, P297; CHAITIN GJ, 1966, J ACM, V13, P547, DOI 10.1145/321356.321363; Crutchfield JP, 2012, NAT PHYS, V8, P17, DOI 10.1038/nphys2190; CRUTCHFIELD JP, 1989, PHYS REV LETT, V63, P105, DOI 10.1103/PhysRevLett.63.105; CRUTCHFIELD JP, 1982, INT J THEOR PHYS, V21, P433, DOI 10.1007/BF02650178; Emmert-Streib F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012256; FEIGENBAUM MJ, 1978, J STAT PHYS, V19, P25, DOI 10.1007/BF01020332; Gordon DM, 2002, COMPLEXITY, V8, P43, DOI [10.1002/cplx.10048, DOI 10.1002/CPLX.10048]; GRANOVSKAYA RM, 1980, PATTERN RECOGN, V12, P17, DOI 10.1016/0031-3203(80)90050-3; GRASSBERGER P, 1986, INT J THEOR PHYS, V25, P907, DOI 10.1007/BF00668821; Huynh HN, 2011, FRACTALS, V19, P141, DOI 10.1142/S0218348X11005178; Huynh HN, 2013, THESIS NANYANG TECHN; Kolmogorov A. N., 1968, International Journal of Computer Mathematics, V2, P157, DOI 10.1080/00207166808803030; KOLMOGOROV AN, 1959, DOKL AKAD NAUK SSSR+, V124, P754; LEMPEL A, 1976, IEEE T INFORM THEORY, V22, P75, DOI 10.1109/TIT.1976.1055501; LLOYD S, 1988, ANN PHYS-NEW YORK, V188, P186, DOI 10.1016/0003-4916(88)90094-2; LopezRuiz R, 1995, PHYS LETT A, V209, P321, DOI 10.1016/0375-9601(95)00867-5; McElroy M.W., 2000, J KNOWL MANAG, V4, P195, DOI [10.1108/13673270010377652, DOI 10.1108/13673270010377652]; Metropolis N., 1973, Journal of Combinatorial Theory, Series A, V15, P25, DOI 10.1016/0097-3165(73)90033-2; Pastor G, 1998, PHYSICA A, V256, P369, DOI 10.1016/S0378-4371(98)00083-1; Rasband SN., 1990, CHAOTIC DYNAMICS NON; Ribeiro HV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040689; Rogers James, 2011, Journal of Logic, Language and Information, V20, P329, DOI 10.1007/s10849-011-9140-2; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Shiner JS, 1999, PHYS REV E, V59, P1459, DOI 10.1103/PhysRevE.59.1459; SHORT KM, 1993, J COMPUT PHYS, V104, P162, DOI 10.1006/jcph.1993.1018; SINAI I, 1959, DOKL AKAD NAUK SSSR+, V124, P768; Sterling D, 1999, PHYSICA D, V134, P153, DOI 10.1016/S0167-2789(99)00125-6; Xiao FH, 2004, ACTA PHYS SIN-CH ED, V53, P2877, DOI 10.7498/aps.53.2876	30	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0117365	10.1371/journal.pone.0117365	http://dx.doi.org/10.1371/journal.pone.0117365			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25700034	Green Published, gold			2022-12-26	WOS:000349789800021
J	Nanri, A; Mizoue, T; Kurotani, K; Goto, A; Oba, S; Noda, M; Sawada, N; Tsugane, S				Nanri, Akiko; Mizoue, Tetsuya; Kurotani, Kayo; Goto, Atsushi; Oba, Shino; Noda, Mitsuhiko; Sawada, Norie; Tsugane, Shoichiro		Japan Public Hlth Ctr-Based Prospe	Low-Carbohydrate Diet and Type 2 Diabetes Risk in Japanese Men and Women: The Japan Public Health Center-Based Prospective Study	PLOS ONE			English	Article							FOOD FREQUENCY QUESTIONNAIRE; FOLLOW-UP SURVEY; FATTY-ACIDS; COHORT-I; JPHC; REPRODUCIBILITY; METAANALYSIS; VALIDITY; PROTEIN; SCORE	Objective Evidence is sparse and contradictory regarding the association between low-carbohydrate diet score and type 2 diabetes risk, and no prospective study examined the association among Asians, who consume greater amount of carbohydrate. We prospectively investigated the association of low-carbohydrate diet score with type 2 diabetes risk. Methods Participants were 27,799 men and 36,875 women aged 45-75 years who participated in the second survey of the Japan Public Health Center-Based Prospective Study and who had no history of diabetes. Dietary intake was ascertained by using a validated food-frequency questionnaire, and low-carbohydrate diet score was calculated from total carbohydrate, fat, and protein intake. The scores for high animal protein and fat or for high plant protein and fat were also calculated. Odds ratios of self-reported, physician-diagnosed type 2 diabetes over 5-year were estimated by using logistic regression. Results During the 5-year period, 1191 new cases of type 2 diabetes were self-reported. Low-carbohydrate diet score for high total protein and fat was significantly associated with a decreased risk of type 2 diabetes in women (P for trend < 0.001); the multivariable-adjusted odds ratio of type 2 diabetes for the highest quintile of the score were 0.63 (95% confidence interval 0.46-0.84), compared with those for the lowest quintile. Additional adjustment for dietary glycemic load attenuated the association (odds ratio 0.75, 95% confidence interval 0.45-1.25). When the score separated for animal and for plant protein and fat, the score for high animal protein and fat was inversely associated with type 2 diabetes in women, whereas the score for high plant protein and fat was not associated in both men and women. Discussion Low-carbohydrate diet was associated with decreased risk of type 2 diabetes in Japanese women and this association may be partly attributable to high intake of white rice. The association for animal-based and plant-based low-carbohydrate diet warrants further investigation.	[Nanri, Akiko; Mizoue, Tetsuya; Kurotani, Kayo] Natl Ctr Global Hlth & Med, Ctr Clin Sci, Dept Epidemiol & Prevent, Tokyo, Japan; [Goto, Atsushi; Noda, Mitsuhiko] Natl Ctr Global Hlth & Med, Dept Diabet Res, Tokyo, Japan; [Oba, Shino] Natl Inst Publ Hlth, Dept Hlth Promot, Wako, Saitama 3510197, Japan; [Sawada, Norie; Tsugane, Shoichiro] Natl Canc Ctr, Res Ctr Canc Prevent & Screening, Epidemiol & Prevent Grp, Tokyo 104, Japan	National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; National Institute of Public Health - Japan; National Cancer Center - Japan	Nanri, A (corresponding author), Natl Ctr Global Hlth & Med, Ctr Clin Sci, Dept Epidemiol & Prevent, Tokyo, Japan.	nanri@ri.ncgm.go.jp	Oba, Shino/AAC-5473-2021; Noda, Mitsuhiko/W-3905-2019; Tsugane, Shoichiro/A-2424-2015	Oba, Shino/0000-0002-7388-5861; Noda, Mitsuhiko/0000-0003-0413-4631; Tsugane, Shoichiro/0000-0003-4105-2774; Goto, Atsushi/0000-0003-0669-654X	National Cancer Center Research and Development Fund [23-A-31[toku], 26-A-2]; Ministry of Health, Labour and Welfare of Japan	National Cancer Center Research and Development Fund(National Cancer Center - Japan); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by National Cancer Center Research and Development Fund (23-A-31[toku] and 26-A-2) (since 2011) and a Grant-in-Aid for Cancer Research from the Ministry of Health, Labour and Welfare of Japan (from 1989 to 2010). The funders had no role in study design, datacollection and analysis, decision to publish, or preparation of the manuscript.	Alhazmi A, 2012, J AM COLL NUTR, V31, P243, DOI 10.1080/07315724.2012.10720425; COLDITZ GA, 1992, AM J CLIN NUTR, V55, P1018, DOI 10.1093/ajcn/55.5.1018; de Koning L, 2011, AM J CLIN NUTR, V93, P844, DOI 10.3945/ajcn.110.004333; Ericson U, 2013, BRIT J NUTR, V109, P1143, DOI 10.1017/S0007114512003017; Forouhi NG, 2014, LANCET DIABETES ENDO, V2, P810, DOI 10.1016/S2213-8587(14)70146-9; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Halton TL, 2008, AM J CLIN NUTR, V87, P339, DOI 10.1093/ajcn/87.2.339; Halton TL, 2006, NEW ENGL J MED, V355, P1991, DOI 10.1056/NEJMoa055317; Hu EA, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1454; Huxley R, 2008, EPIDEMIOLOGY DIABETE, P57; Ishihara J, 2003, J EPIDEMIOL, V13, pS134; KADOWAKI T, 1984, DIABETOLOGIA, V26, P44, DOI 10.1007/BF00252262; Kato M, 2009, ENDOCR J, V56, P459, DOI 10.1507/endocrj.K09E-003; Kurotani K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064758; Ministry of Health Labour and Walfare, 2012, NAT HLTH NUTR SURV J; Ministry of Health Labour and Walfare, 2011, NAT HLTH NUTR SURV J; Mitri J, 2011, EUR J CLIN NUTR, V65, P1005, DOI 10.1038/ejcn.2011.118; Nakamura Y, 2014, BRIT J NUTR, V112, P916, DOI 10.1017/S0007114514001627; Nanri A, 2010, AM J CLIN NUTR, V92, P1468, DOI 10.3945/ajcn.2010.29512; Noto H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055030; O'Neil CE, 2012, NUTRIENTS, V4, P2097, DOI 10.3390/nu4122097; Oba S, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-165; Salmeron J, 2001, AM J CLIN NUTR, V73, P1019; Sasaki S, 2003, J EPIDEMIOL, V13, pS115; Sasaki S, 2003, J EPIDEMIOL, V13, pS13; Schulze MB, 2008, BRIT J NUTR, V99, P1107, DOI 10.1017/S0007114507853360; Simila ME, 2012, EUR J CLIN NUTR, V66, P716, DOI 10.1038/ejcn.2012.24; Sluijs I, 2010, DIABETES CARE, V33, P43, DOI 10.2337/dc09-1321; Tsugane S, 2003, J EPIDEMIOL, V13, pS51; Tsugane S, 2001, J Epidemiol, V11, pS24; Wallin A, 2012, DIABETES CARE, V35, P918, DOI 10.2337/dc11-1631; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; Wright Jacqueline D, 2010, NCHS Data Brief, P1; Wu JHY, 2012, BRIT J NUTR, V107, pS214, DOI 10.1017/S0007114512001602	34	45	47	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0118377	10.1371/journal.pone.0118377	http://dx.doi.org/10.1371/journal.pone.0118377			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695497	Green Submitted, Green Published, gold			2022-12-26	WOS:000350062300051
J	Wang, XL; He, YX; Guo, BS; Tsang, MC; Tu, FJ; Dai, Y; Yao, ZH; Zheng, LZ; Xie, XH; Wang, N; Yao, XS; Zhang, G; Qin, L				Wang, Xinluan; He, Yixin; Guo, Baosheng; Tsang, Man-Ching; Tu, Fengjuan; Dai, Yi; Yao, Zhihong; Zheng, Lizhen; Xie, Xinhui; Wang, Nan; Yao, Xinsheng; Zhang, Ge; Qin, Ling			In Vivo Screening for Anti-Osteoporotic Fraction from Extract of Herbal Formula Xianlinggubao in Ovariectomized Mice	PLOS ONE			English	Article							POSTMENOPAUSAL OSTEOPOROSIS; BONE LOSS; BIOCHEMICAL MARKERS; CONTROLLED TRIAL; TOTAL SAPONINS; RADIX-DIPSACI; RATS; FLAVONOIDS; DIFFERENTIATION; IDENTIFICATION	Background and Objectives Traditional Chinese Medicine (TCM) Fufang or formula Xianlinggubao (XLGB) is a prescribed TCM drug in China registered for prevention and treatment of osteoporosis. Fufang in TCM is comprised of a group of herbal compounds contributing in group to the treatment efficacy. The present study aims to identify the bioactive fraction(s) in XLGB extract that account(s) dominantly for its osteogenic effects. Methods The extract of XLGB formula was separated into three fractions using chromatography, i.e., XLGB-A, XLGB-B and XLGB-C. They were administrated to 4-month old ovariectomized (OVX) mice for 6 weeks to determine which bioactive fraction(s) were more effective for preventing OVX-induced bone loss evaluated by microCT, biomechanical testing and biochemical markers. The main peaks of the key fraction were identified using reference compounds isolated from the fraction. In addition, the effects of the composite compounds in XLGB-B on osteoblasts' proliferation and mineralization were evaluated in UMR 106 cells. Results XLGB-B with a yield of 13.0% from herbal Fufang XLGB was identified as the most potential one among the three fractions for prevention of OVX-induced bone loss confirmed with bone mass, bonemicroarchitecture, bone strength and bone turnover markers. Nine compounds in HPLC fingerprint were identified in the XLGB-B fraction, including phenylpropanoids from Herba Epimedii, terpenes from Radix Dipsaci and coumarins from Fructus Psoraleae. In addition, the identified compounds effectively promoted proliferation and/or mineralization of osteoblast-like UMR 106 cells in vitro. Conclusion XLGB-B with defined phytochemical structures was screened as the key fraction that demonstrated preventive effects on OVX-induced bone loss in mice. The present study laid down a foundation towards a new generation of herbal Fufang characterized with "less herbal materials for achieving equal treatment efficacy" in development strategy of TCM for prevention of OVX-induced osteoporosis.	[Wang, Xinluan; Wang, Nan; Qin, Ling] Chinese Acad Sci, Translat Med R&D Ctr, Shenzhen Inst Adv Technol, Inst Biomed Engn & Hlth Tec, Shenzhen 518000, Peoples R China; [Wang, Xinluan; He, Yixin; Guo, Baosheng; Tsang, Man-Ching; Zheng, Lizhen; Xie, Xinhui; Zhang, Ge; Qin, Ling] Chinese Univ Hong Kong, Dept Orthopaed & Traumatol, Musculoskeletal Res Lab, Hong Kong, Hong Kong, Peoples R China; [Tu, Fengjuan; Dai, Yi; Yao, Zhihong; Yao, Xinsheng] Jinan Univ, Coll Pharm, Inst Tradit Chinese Med & Nat Prod, Guangzhou 510632, Guangdong, Peoples R China	Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Chinese University of Hong Kong; Jinan University	Yao, XS (corresponding author), Jinan Univ, Coll Pharm, Inst Tradit Chinese Med & Nat Prod, Guangzhou 510632, Guangdong, Peoples R China.	tyaoxs@jnu.edu.cn; zhangge@hkbu.edu.hk; lingqin@cuhk.edu.hk	Qin, Ling/J-9047-2018; Guo, Baosheng/ABD-4800-2021; GUO, Baosheng/M-6023-2013; Wang, Nan/GRY-3150-2022; Zhang, Ge/K-9118-2019	Qin, Ling/0000-0001-6173-6167; Guo, Baosheng/0000-0002-4510-5418; Zhang, Ge/0000-0002-7807-7695	Ministry of Science and Technology of the People's Republic of China [2011ZX09201-201-01]; National Natural Science Foundation of China [81220108028]; Ministry of Education of the People's Republic of China [B13038]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of the People's Republic of China(Ministry of Education, China)	The work was supported by Ministry of Science and Technology of the People's Republic of China (2011ZX09201-201-01, Prof. Ling Qin), National Natural Science Foundation of China (81220108028, Prof. Xinsheng Yao) and Ministry of Education of the People's Republic of China (B13038, Prof. Xinsheng Yao). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen WF, 2011, BRIT J NUTR, V105, P180, DOI 10.1017/S0007114510003247; Cheng TO, 2007, INT J CARDIOL, V121, P9, DOI 10.1016/j.ijcard.2007.01.004; Cremers S, 2006, DRUGS, V66, P2031, DOI 10.2165/00003495-200666160-00001; Deng WM, 2012, J BONE MINER METAB, V30, P517, DOI 10.1007/s00774-012-0351-7; Don MJ, 2012, PHYTOMEDICINE, V19, P551, DOI 10.1016/j.phymed.2012.01.006; Dong GC, 2008, J BIOMED MATER RES A, V84A, P167, DOI 10.1002/jbm.a.31261; Gao XZ, 2010, ASIA PAC TRADIT MED, V6, P142; Guan XY, 2011, J PHARMACEUT BIOMED, V55, P923, DOI 10.1016/j.jpba.2011.03.021; Gui Li, 2007, Zhongguo Xinyao yu Linchuang Zazhi, V26, P619; Hu CX, 2000, CHINESE TRADITIONAL, V22, P246; Huang J., 2004, CHIN J CLIN PHARM TH, V09, P1069; Li QQ, 2010, CHIN MOD MED, V17, P96; [李晓龙 Li Xiaolong], 2010, [药物分析杂志, Chinese Journal of Pharmaceutical Analysis], V30, P891; Li Y, 2014, CHIN J NAT MEDICINES, V12, P204, DOI 10.1016/S1875-5364(14)60034-0; Lim SH, 2009, BRIT J NUTR, V101, P1031, DOI 10.1017/S0007114508066750; Liu CM, 2003, CHEM J CHINESE U, V24, P2215; Liu MJ, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-67; Liu YW, 2012, J ETHNOPHARMACOL, V139, P194, DOI 10.1016/j.jep.2011.11.004; Liu ZG, 2009, J ETHNOPHARMACOL, V123, P74, DOI 10.1016/j.jep.2009.02.025; Lock CA, 2006, OSTEOPOROSIS INT, V17, P20, DOI 10.1007/s00198-005-1942-0; Luo GA, 1997, TRADITIONAL CHINESE, V19, P44; Malaval L, 1998, J BONE MINER RES, V13, P175, DOI 10.1359/jbmr.1998.13.2.175; [茅月娟 MAO Yuejuan], 2006, [中国现代应用药学, Chinese Journal of Modern Applied Pharmacy], V23, P416; Mok SK, 2010, BRIT J PHARMACOL, V159, P939, DOI 10.1111/j.1476-5381.2009.00593.x; Niu YB, 2012, OSTEOPOROSIS INT, V23, P2649, DOI 10.1007/s00198-012-1932-y; Notelovitz M, 1997, AM J MED SCI, V313, P2, DOI 10.1097/00000441-199701000-00002; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Park CK, 2008, BIOCHEM PHARMACOL, V75, P2175, DOI 10.1016/j.bcp.2008.03.007; Qin L, 2005, J BONE MINER METAB, V23, P55, DOI 10.1007/BF03026324; Qin L, 2014, J ORTHOP TRANSL, V2, P43, DOI 10.1016/j.jot.2013.12.001; Reginster JY, 2011, DRUGS, V71, P65, DOI 10.2165/11587570-000000000-00000; Rissanen JP, 2008, CALCIFIED TISSUE INT, V82, P155, DOI 10.1007/s00223-007-9101-6; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Songlin P, 2009, BONE, V45, P534, DOI [DOI 10.1016/J.B0NE.2009.05.022, 10.1016/j.bone.2009.05.022]; Sorensen MG, 2007, BIOMARKERS, V12, P266, DOI 10.1080/13547500601070842; Tan W, 2012, INT J BIOL MACROMOL, V50, P59, DOI 10.1016/j.ijbiomac.2011.09.019; [陶玲 TAO Ling], 2009, [中国医院药学杂志, Chinese Journal of Hospital Pharmacy], V29, P1431; Tsai MH, 2007, AM J CHINESE MED, V35, P669, DOI 10.1142/S0192415X07005168; Varea O, 2010, STEROIDS, V75, P565, DOI 10.1016/j.steroids.2009.09.006; Wang N, 2014, J ORTHOPAEDIC TRANSL, V2, P218; Wang N, 2013, CHIN MED-UK, V8, DOI 10.1186/1749-8546-8-17; Wang XL, 2008, CHEM PHARM BULL, V56, P46, DOI 10.1248/cpb.56.46; Wang XL, 2011, PHYTOMEDICINE, V18, P868, DOI 10.1016/j.phymed.2011.01.022; Wong RWK, 2010, PHYTOTHER RES, V24, pS155, DOI 10.1002/ptr.3049; Wong RWK, 2007, PHYTOTHER RES, V21, P596, DOI 10.1002/ptr.2126; Wu Huichao, 2011, Zhongguo Zhong Yao Za Zhi, V36, P992; Xiao HH, 2011, BRIT J NUTR, V106, P1802, DOI 10.1017/S0007114511002546; Yang Z, 2012, MENOPAUSE, V19, P1156, DOI 10.1097/gme.0b013e3182507e18; Zhang G, 2006, BONE, V38, P818, DOI 10.1016/j.bone.2005.11.019; Zhang G, 2007, J BONE MINER RES, V22, P1072, DOI 10.1359/JBMR.070405; Zhang G, 2012, NAT MED, V18, P307, DOI 10.1038/nm.2617; Zhang RX, 2008, J ETHNOPHARMACOL, V117, P199, DOI 10.1016/j.jep.2008.02.018; Zhu HM, 2012, OSTEOPOROSIS INT, V23, P1317, DOI 10.1007/s00198-011-1577-2; Zhu ZY, 2007, RAPID COMMUN MASS SP, V21, P1855, DOI 10.1002/rcm.3023	54	34	37	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0118184	10.1371/journal.pone.0118184	http://dx.doi.org/10.1371/journal.pone.0118184			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695519	Green Submitted, Green Published, gold			2022-12-26	WOS:000350062300044
J	Green, ML; Herzing, DL; Baldwin, JD				Green, Michelle L.; Herzing, Denise L.; Baldwin, John D.			Molecular Assessment of Mating Strategies in a Population of Atlantic Spotted Dolphins	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; MALE REPRODUCTIVE SUCCESS; STENELLA-FRONTALIS; SOCIAL-STRUCTURE; TURSIOPS-TRUNCATUS; COMPUTER-PROGRAM; NORTH-ATLANTIC; MICROSATELLITE MARKERS; PATERNITY INFERENCE; NATURAL-POPULATIONS	Similar to other small cetacean species, Atlantic spotted dolphins (Stenella frontalis) have been the object of concentrated behavioral study. Although mating and courtship behaviors occur often and the social structure of the population is well-studied, the genetic mating system of the species is unknown. To assess the genetic mating system, we genotyped females and their progeny at ten microsatellite loci. Genotype analysis provided estimates of the minimum number of male sires necessary to account for the allelic diversity observed among the progeny. Using the estimates of male sires, we determined whether females mated with the same or different males during independent estrus events. Using GERUD2.0, a minimum of two males was necessary to account for the genetic variation seen among progeny arrays of all tested females. ML-RELATE assigned the most likely relationship between offspring pairs; half or full sibling. Relationship analysis supported the conservative male estimates of GERUD2.0 but in some cases, half or full sibling relationships between offspring could not be fully resolved. Integrating the results from GERUD2.0, ML-RELATE with previous observational and paternity data, we constructed two-, three-, and four-male pedigree models for each genotyped female. Because increased genetic diversity of offspring may explain multi-male mating, we assessed the internal genetic relatedness of each offspring's genotype to determine whether parent pairs of offspring were closely related. We found varying levels of internal relatedness ranging from unrelated to closely related (range -0.136-0.321). Because there are several hypothesized explanations for multi-male mating, we assessed our data to determine the most plausible explanation for multi-male mating in our study system. Our study indicated females may benefit from mating with multiple males by passing genes for long-term viability to their young.	[Green, Michelle L.; Baldwin, John D.] Florida Atlantic Univ, Dept Biol, Davie, FL 33314 USA; [Herzing, Denise L.] Wild Dolphin Project, Jupiter, FL 33468 USA; [Herzing, Denise L.] Florida Atlantic Univ, Dept Biol, Dept Psychol, Boca Raton, FL 33431 USA	State University System of Florida; Florida Atlantic University; State University System of Florida; Florida Atlantic University	Green, ML (corresponding author), Univ Illinois, Illinois Nat Hist Survey, Dept Anim Sci, 1503 S Maryland Dr, Urbana, IL 61801 USA.	mgreen31@gmail.com						Acevedo-Whitehouse K, 2003, NATURE, V422, P35, DOI 10.1038/422035a; Adams LD, 2006, MAR BIOL, V148, P671, DOI 10.1007/s00227-005-0094-2; AMOS B, 1993, SCIENCE, V260, P670, DOI 10.1126/science.8480176; Amos W, 2001, P ROY SOC B-BIOL SCI, V268, P2021, DOI 10.1098/rspb.2001.1751; Aparicio JM, 2006, MOL ECOL, V15, P4659, DOI 10.1111/j.1365-294X.2006.03111.x; Aureli F, 2008, CURR ANTHROPOL, V49, P627, DOI 10.1086/586708; Birkhead TR, 2000, PROMISCUITY, DOI [10.1007/BF02879286, DOI 10.1007/BF02879286]; Bossart Gregory D., 2005, Aquatic Mammals, V31, P473, DOI 10.1578/AM.31.4.2005.473; Caldwell M, 2002, MOL ECOL NOTES, V2, P393, DOI 10.1046/j.1471-8286.2002.00270.x; Cerchio S, 2005, ANIM BEHAV, V70, P267, DOI 10.1016/j.anbehav.2004.10.028; Clapham PJ, 1997, P ROY SOC B-BIOL SCI, V264, P95, DOI 10.1098/rspb.1997.0014; CLUTTONBROCK TH, 1989, PROC R SOC SER B-BIO, V236, P339, DOI 10.1098/rspb.1989.0027; Cohas A, 2007, J ANIM ECOL, V76, P771, DOI 10.1111/j.1365-2656.2007.01253.x; Coltman DW, 1999, MOL ECOL, V8, P1199, DOI 10.1046/j.1365-294x.1999.00683.x; Coltman DW, 1999, EVOLUTION, V53, P1259, DOI [10.2307/2640828, 10.1111/j.1558-5646.1999.tb04538.x]; Connor RC, 1996, BEHAVIOUR, V133, P37, DOI 10.1163/156853996X00026; Connor RC, 2000, CETACEAN SOCIETIES, P247; Connor RC, 2000, CETACEAN SOCIETIES, P91; Csillery K, 2006, GENETICS, V173, P2091, DOI 10.1534/genetics.106.057331; De Waal Frans B. M., 1992, P1; Dearolf JL, 2000, J MORPHOL, V244, P203, DOI 10.1002/(SICI)1097-4687(200006)244:3<203::AID-JMOR5>3.0.CO;2-V; Duffield Deborah A., 2002, P3; Dunn DG, 2002, J WILDLIFE DIS, V38, P505, DOI 10.7589/0090-3558-38.3.505; Elliser CR, 2014, MAR MAMMAL SCI, V30, P308, DOI 10.1111/mms.12039; Elliser CR, 2014, MAR MAMMAL SCI, V30, P329, DOI 10.1111/mms.12038; Elliser CR, 2012, MAR MAMMAL SCI, V00, P1; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Frasier TR, 2007, MOL ECOL, V16, P5277, DOI 10.1111/j.1365-294X.2007.03570.x; Nery MF, 2009, MAR MAMMAL SCI, V25, P450, DOI 10.1111/j.1748-7692.2008.00275.x; GERLOFF U, 1995, MOL ECOL, V4, P515, DOI 10.1111/j.1365-294X.1995.tb00247.x; Glaubitz JC, 2004, MOL ECOL NOTES, V4, P309, DOI 10.1111/j.1471-8286.2004.00597.x; Green ML, 2007, MOL ECOL NOTES, V7, P1287, DOI 10.1111/j.1471-8286.2007.01858.x; Green ML, 2011, CAN J ZOOL, V89, P239, DOI 10.1139/Z10-111; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Herzing D. L., 1997, Aquatic Mammals, V23, P85; Herzing D. L., 1997, Aquatic Mammals, V23, P155; Herzing Denise L., 1996, Aquatic Mammals, V22, P61; Herzing DL, 1997, MAR MAMMAL SCI, V13, P576, DOI 10.1111/j.1748-7692.1997.tb00085.x; Herzing DL., 2013, INT J COMP PSYCHOL, V26, P124, DOI [10.46867/ijcp.2013.26.02.04, DOI 10.5811/WESTJEM.2011.5.6700]; Hoelzel AR, 1998, J HERED, V89, P121, DOI 10.1093/jhered/89.2.121; HRDY SB, 1979, ETHOL SOCIOBIOL, V1, P13, DOI 10.1016/0162-3095(79)90004-9; Hughes C, 1998, ECOLOGY, V79, P383, DOI 10.1890/0012-9658(1998)079[0383:IMTWFM]2.0.CO;2; Isvaran K, 2007, P ROY SOC B-BIOL SCI, V274, P219, DOI 10.1098/rspb.2006.3723; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Jones AG, 2005, MOL ECOL NOTES, V5, P708, DOI 10.1111/j.1471-8286.2005.01029.x; Kalinowski ST, 2006, MOL ECOL NOTES, V6, P576, DOI 10.1111/j.1471-8286.2006.01256.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Krutzen M, 2004, MOL ECOL, V13, P1975, DOI 10.1111/j.1365-294X.2004.02192.x; Krutzen M, 2003, P ROY SOC B-BIOL SCI, V270, P497, DOI 10.1098/rspb.2002.2229; MacLeod CD, 1998, J ZOOL, V244, P71, DOI 10.1017/S0952836998001083; MADSEN T, 1992, NATURE, V355, P440, DOI 10.1038/355440a0; Mann J, 2000, BEHAV ECOL, V11, P210, DOI 10.1093/beheco/11.2.210; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Miquel C, 2006, MOL ECOL NOTES, V6, P985, DOI 10.1111/j.1471-8286.2006.01413.x; Murphy S, 2005, J MAMMAL, V86, P1247, DOI 10.1644/1545-1542(2005)86[1247:MSITMC]2.0.CO;2; Nielsen R, 2001, GENETICS, V157, P1673; Owen ECG, 2003, THESIS, P326; PACKER C, 1991, NATURE, V351, P562, DOI 10.1038/351562a0; Parsons KM, 2006, MAR MAMMAL SCI, V22, P276, DOI 10.1111/j.1748-7692.2006.00019.x; Parsons KM, 2003, ANIM BEHAV, V66, P185, DOI 10.1006/anbe.2003.2186; Patterson IAP, 1998, P ROY SOC B-BIOL SCI, V265, P1167, DOI 10.1098/rspb.1998.0414; PERRIN WF, 1969, ZOOLOGICA-N Y, V54, P135; Perrin WF, 2003, MAR MAMMAL SCI, V19, P462, DOI 10.1111/j.1748-7692.2003.tb01315.x; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; RALLS K, 1979, SCIENCE, V206, P1101, DOI 10.1126/science.493997; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reynolds JD, 1996, TRENDS ECOL EVOL, V11, pA68, DOI 10.1016/0169-5347(96)81045-7; Rogers CA, 2004, MAR MAMMAL SCI, V20, P688, DOI 10.1111/j.1748-7692.2004.tb01188.x; Rosas FCW, 2002, J MAMMAL, V83, P507; Rosel PE, 2005, MOL ECOL NOTES, V5, P830, DOI 10.1111/j.1471-8286.2005.01078.x; Shinohara M, 1997, MOL ECOL, V6, P695, DOI 10.1046/j.1365-294X.1997.00231.x; Slate J, 2000, MOL ECOL, V9, P801, DOI 10.1046/j.1365-294x.2000.00930.x; SLOOTEN E, 1994, J MAMMAL, V75, P956, DOI 10.2307/1382477; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189; Valsecchi E, 1996, MOL ECOL, V5, P151, DOI 10.1111/j.1365-294X.1996.tb00301.x; Van Horn RC, 2008, ANIM BEHAV, V75, P1173, DOI 10.1016/j.anbehav.2007.08.027; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; VanBressem MF, 1996, DIS AQUAT ORGAN, V26, P1, DOI 10.3354/dao026001; Vanpe C, 2009, BIOL J LINN SOC, V97, P128, DOI 10.1111/j.1095-8312.2009.01196.x; VANWAEREBEEK K, 1994, J MAMMAL, V75, P1054, DOI 10.2307/1382489; Watts DP, 1998, BEHAV ECOL SOCIOBIOL, V44, P43, DOI 10.1007/s002650050513; Wells RS, 1991, DOLPHIN SOC DISCOVER, P198; Wells RS, 2000, BIOL MARINE MAMMALS, P324; Welsh LS, 2007, BIOL SCI MASTERS, P35; Wolff JO, 2004, TRENDS ECOL EVOL, V19, P127, DOI 10.1016/j.tree.2003.12.009	85	4	4	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118227	10.1371/journal.pone.0118227	http://dx.doi.org/10.1371/journal.pone.0118227			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692972	Green Published, gold, Green Submitted			2022-12-26	WOS:000350061500110
J	Hsu, JL; Chen, WH; Bai, CH; Leu, JG; Hsu, CY; Viergever, MA; Leemans, A				Hsu, Jung-Lung; Chen, Wei-Hung; Bai, Chyi-Huey; Leu, Jyu-Gang; Hsu, Chien-Yeh; Viergever, Max A.; Leemans, Alexander			Microstructural White Matter Tissue Characteristics Are Modulated by Homocysteine: A Diffusion Tensor Imaging Study	PLOS ONE			English	Article							ENDOTHELIAL DYSFUNCTION; ELEVATED HOMOCYSTEINE; MEAN DIFFUSIVITY; RISK PROFILE; BRAIN; VOLUME; DISEASE; LEUKOARAIOSIS; STROKE; MRI	Homocysteine level can lead to adverse effects on the brain white matter through endothelial dysfunction, microstructural inflammation, and neurotoxin effects. Despite previously observed associations between elevated homocysteine and macroscopic structural brain changes, it is still unknown whether microstructural associations of homocysteine on brain tissue properties can be observed in healthy subjects with routine MRI. To this end, we investigated potential relationships between homocysteine levels and microstructural measures computed with diffusion tensor imaging (DTI) in a cohort of 338 healthy participants. Significant positive correlations were observed between homocysteine levels and diffusivity measures in the bilateral temporal WM, the brainstem, and the bilateral cerebellar peduncle. This is the first study demonstrating that DTI is sufficiently sensitive to relate microstructural WM properties to homocysteine levels in healthy subjects.	[Hsu, Jung-Lung; Hsu, Chien-Yeh] Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Biomed Informat, Taipei, Taiwan; [Hsu, Jung-Lung] Chang Gung Mem Hosp, Dept Neurol, Sect Dementia & Cognit Impairment, Linkou, Taiwan; [Hsu, Jung-Lung; Viergever, Max A.; Leemans, Alexander] Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands; [Chen, Wei-Hung] Shin Kong Wu Ho Su Mem Hosp, Dept Neurol, Taipei, Taiwan; [Bai, Chyi-Huey] Taipei Med Univ, Coll Med, Dept Publ Hlth, Taipei, Taiwan; [Leu, Jyu-Gang] Fu Jen Catholic Univ, Coll Med, Taipei, Taiwan	Taipei Medical University; Chang Gung Memorial Hospital; Utrecht University; Utrecht University Medical Center; Shin Kong Wu Ho Su Memorial Hospital; Taipei Medical University; Fu Jen Catholic University	Hsu, JL (corresponding author), Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Biomed Informat, Taipei, Taiwan.	tulu@ms36.hinet.net	Leemans, Alexander/A-1784-2011; Viergever, Max A/J-1215-2014	Leemans, Alexander/0000-0002-9306-6126; 	National Science Council [NSC 101-2221-E-038 -006]; Netherlands Organization for Scientific Research (NWO) [639.072.411]	National Science Council(Ministry of Science and Technology, Taiwan); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by the National Science Council (NSC 101-2221-E-038 -006). The research of A.L. is supported by VIDI Grant 639.072.411 from the Netherlands Organization for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AL, 2001, MAGN RESON MED, V45, P770, DOI 10.1002/mrm.1105; [Anonymous], 2009, P INT SOC MAGN RESON; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Atmaca M, 2005, PSYCHIAT CLIN NEUROS, V59, P616, DOI 10.1111/j.1440-1819.2005.01425.x; Ayesa-Arriola R, 2012, EUR ARCH PSY CLIN N, V262, P557, DOI 10.1007/s00406-012-0302-2; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Blom HJ, 2011, J INHERIT METAB DIS, V34, P75, DOI 10.1007/s10545-010-9177-4; Clark KA, 2011, J PSYCHIATR RES, V45, P980, DOI 10.1016/j.jpsychires.2011.01.006; da Cunha AA, 2010, METAB BRAIN DIS, V25, P199, DOI 10.1007/s11011-010-9188-8; DAGOSTINO RB, 1994, STROKE, V25, P40, DOI 10.1161/01.STR.25.1.40; Della Nave R, 2007, AM J NEURORADIOL, V28, P1313, DOI 10.3174/ajnr.A0555; Deprez S, 2013, BRAIN IMAGING BEHAV, V7, P409, DOI 10.1007/s11682-012-9220-1; Feng L, 2013, AM J GERIAT PSYCHIAT, V21, P164, DOI 10.1016/j.jagp.2012.10.017; Ford AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033345; Geller V, 2013, PSYCHIAT RES, V210, P769, DOI 10.1016/j.psychres.2013.08.016; Harold P, 2005, HDB CEREBROVASCULAR; Hooshmand B, 2013, BRAIN, V136, P2707, DOI 10.1093/brain/awt206; Hsu JL, 2008, NEUROIMAGE, V39, P566, DOI 10.1016/j.neuroimage.2007.09.017; Hsu JL, 2010, NEUROIMAGE, V49, P32, DOI 10.1016/j.neuroimage.2009.08.031; Jeurissen B, 2013, HUM BRAIN MAPP, V34, P2747, DOI 10.1002/hbm.22099; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Jones DK, 2011, METHODS MOL BIOL, V711, P127, DOI 10.1007/978-1-61737-992-5_6; Kim SR, 2009, J CLIN NEUROL, V5, P85, DOI 10.3988/jcn.2009.5.2.85; Leemans A, 2005, LEC NOTES COMPUT SCI, P3708; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Maillard P, 2011, STROKE, V42, P1917, DOI 10.1161/STROKEAHA.110.609768; McCully KS, 2009, ANN CLIN LAB SCI, V39, P219; Moreto F, 2013, INFLAMMATION, V36, P15, DOI 10.1007/s10753-012-9515-9; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Newton LAA, 2010, EXPERT REV MOL DIAGN, V10, P489, DOI 10.1586/ERM.10.19; O'Dwyer L, 2011, J ALZHEIMERS DIS, V26, P667, DOI 10.3233/JAD-2011-110137; O'Sullivan M, 2001, NEUROLOGY, V57, P2307, DOI 10.1212/WNL.57.12.2307; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Pikula A, 2012, CIRCULATION, V125, P2100, DOI 10.1161/CIRCULATIONAHA.110.989145; Rajagopalan P, 2011, NEUROREPORT, V22, P391, DOI 10.1097/WNR.0b013e328346bf85; Ruef A, 2012, J PSYCHIATR NEUROSCI, V37, P305, DOI 10.1503/jpn.110057; Sachdev P, 2004, J NEUROL SCI, V226, P25, DOI 10.1016/j.jns.2004.09.006; Sachdev P, 2004, ARCH NEUROL-CHICAGO, V61, P1369, DOI 10.1001/archneur.61.9.1369; SELHUB J, 1993, JAMA-J AM MED ASSOC, V270, P2693, DOI 10.1001/jama.270.22.2693; Seshadri S, 2008, ARCH NEUROL-CHICAGO, V65, P642, DOI 10.1001/archneur.65.5.642; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Tournier JD, 2011, MAGN RESON MED, V65, P1532, DOI 10.1002/mrm.22924; Van Hecke W, 2008, NEUROIMAGE, V43, P69, DOI 10.1016/j.neuroimage.2008.07.006; Van Hecke W, 2007, IEEE T MED IMAGING, V26, P1598, DOI 10.1109/TMI.2007.906786; Vermeer SE, 2002, ANN NEUROL, V51, P285, DOI 10.1002/ana.10111; Vos SB, 2012, NEUROIMAGE, V59, P2208, DOI 10.1016/j.neuroimage.2011.09.086; Vos SB, 2011, NEUROIMAGE, V55, P1566, DOI 10.1016/j.neuroimage.2011.01.048; Wahlund LO, 2001, STROKE, V32, P1318, DOI 10.1161/01.STR.32.6.1318; Weinstock RS, 2013, DIABETES CARE, V36, P1758, DOI 10.2337/dc12-2388; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; Willette AA, 2012, NEUROBIOL AGING, V33, P670, DOI 10.1016/j.neurobiolaging.2010.06.003; Wiseman S, 2014, CEREBROVASC DIS, V37, P64, DOI 10.1159/000356789; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Wong A, 2006, J NEUROL, V253, P441, DOI 10.1007/s00415-005-0022-x; Wright CB, 2005, STROKE, V36, P1207, DOI 10.1161/01.STR.0000165923.02318.22; Zarei M, 2011, BIOL PSYCHIAT, V70, P1083, DOI 10.1016/j.biopsych.2011.06.032	59	4	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0116330	10.1371/journal.pone.0116330	http://dx.doi.org/10.1371/journal.pone.0116330			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693199	Green Published, gold, Green Submitted			2022-12-26	WOS:000350061500013
J	Lee, BH; Kim, MH; Lee, JH; Seliktar, D; Cho, NJ; Tan, LP				Lee, Bae Hoon; Kim, Myung Hee; Lee, Jae Ho; Seliktar, Dror; Cho, Nam-Joon; Tan, Lay Poh			Modulation of Huh7.5 Spheroid Formation and Functionality Using Modified PEG-Based Hydrogels of Different Stiffness	PLOS ONE			English	Article							MAGNETIC-RESONANCE ELASTOGRAPHY; CELL-LINE; PRIMARY HEPATOCYTES; COLLAGEN SANDWICH; STEM-CELLS; CULTURE; MATRIX; PLATFORM; MODEL; ENCAPSULATION	Physical cues, such as cell microenvironment stiffness, are known to be important factors in modulating cellular behaviors such as differentiation, viability, and proliferation. Apart from being able to trigger these effects, mechanical stiffness tuning is a very convenient approach that could be implemented readily into smart scaffold designs. In this study, fibrinogen-modified poly(ethylene glycol)-diacrylate (PEG-DA) based hydrogels with tunable mechanical properties were synthesized and applied to control the spheroid formation and liver-like function of encapsulated Huh7.5 cells in an engineered, three-dimensional liver tissue model. By controlling hydrogel stiffness (0.1-6 kPa) as a cue for mechanotransduction representing different stiffness of a normal liver and a diseased cirrhotic liver, spheroids ranging from 50 to 200 mu m were formed over a three week time-span. Hydrogels with better compliance (i.e. lower stiffness) promoted formation of larger spheroids. The highest rates of cell proliferation, albumin secretion, and CYP450 expression were all observed for spheroids in less stiff hydrogels like a normal liver in a healthy state. We also identified that the hydrogel modification by incorporation of PEGylated-fibrinogen within the hydrogel matrix enhanced cell survival and functionality possibly owing to more binding of autocrine fibronectin. Taken together, our findings establish guidelines to control the formation of Huh7.5 cell spheroids in modified PEGDA based hydrogels. These spheroids may serve as models for applications such as screening of pharmacological drug candidates.	[Lee, Bae Hoon; Kim, Myung Hee; Lee, Jae Ho; Cho, Nam-Joon; Tan, Lay Poh] Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore; [Seliktar, Dror] Technion Israel Inst Technol, Dept Biomed Engn, IL-32000 Haifa, Israel	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Technion Israel Institute of Technology	Cho, NJ (corresponding author), Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore.	NJCho@ntu.edu.sg; LPTan@ntu.edu.sg	Tan, LP/A-2229-2011; Cho, Nam-Joon/J-7816-2012	Tan, LP/0000-0002-0172-1569; Cho, Nam-Joon/0000-0002-8692-8955; Seliktar, Dror/0000-0001-6964-8567	National Research Foundation (NRF) Competitive Research Programme grant in Singapore [NRF-CRP10-2012-07]	National Research Foundation (NRF) Competitive Research Programme grant in Singapore	This research is financially supported by the National Research Foundation (NRF) Competitive Research Programme (NRF-CRP10-2012-07) grant in Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananthanarayanan A, 2014, MOL PHARMACEUT, V11, P2106, DOI 10.1021/mp500063y; Castell JV, 2006, EXPERT OPIN DRUG MET, V2, P183, DOI 10.1517/17425255.2.2.183; Chang TT, 2009, TISSUE ENG PT A, V15, P559, DOI 10.1089/ten.tea.2007.0434; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Cho NJ, 2009, BIOMED MATER, V4, DOI [10.1088/1748-6041/4/1/011001, 10.1088/1748-6041/25/1/011001]; Dikovsky D, 2006, BIOMATERIALS, V27, P1496, DOI 10.1016/j.biomaterials.2005.09.038; Donato MT, 2008, CELL TRANSPLANT, V17, P1211, DOI 10.3727/096368908787236620; DUNN JCY, 1992, J CELL BIOL, V116, P1043, DOI 10.1083/jcb.116.4.1043; DUNN JCY, 1993, BIOTECHNOL BIOENG, V41, P593, DOI 10.1002/bit.260410512; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fey SJ, 2012, TOXICOL SCI, V127, P403, DOI 10.1093/toxsci/kfs122; Freudenberg U, 2009, BIOMATERIALS, V30, P5049, DOI 10.1016/j.biomaterials.2009.06.002; Friedrich J, 2009, NAT PROTOC, V4, P309, DOI 10.1038/nprot.2008.226; Georges PC, 2005, J APPL PHYSIOL, V98, P1547, DOI 10.1152/japplphysiol.01121.2004; Godoy P, 2013, ARCH TOXICOL, V87, P1315, DOI 10.1007/s00204-013-1078-5; Hou YT, 2010, J BIOSCI BIOENG, V110, P208, DOI 10.1016/j.jbiosc.2010.01.016; Ivascu A, 2007, INT J ONCOL, V31, P1403; Kamphues C, 2012, ROFO-FORTSCHR RONTG, V184, P1013, DOI 10.1055/s-0032-1313126; Khaitan D, 2006, EXPERT OPIN DRUG DIS, V1, P663, DOI 10.1517/17460441.1.7.663; Klatt D, 2010, BIORHEOLOGY, V47, P133, DOI 10.3233/BIR-2010-0565; Lam CRI, 2014, MOL PHARMACEUT, V11, P2016, DOI 10.1021/mp500059q; Lee BH, 2014, J BIOMAT SCI-POLYM E, V25, P394, DOI 10.1080/09205063.2013.862401; Lee W, 2010, P NATL ACAD SCI USA, V107, P20709, DOI 10.1073/pnas.1005211107; Leong WS, 2010, BIOCHEM BIOPH RES CO, V401, P287, DOI 10.1016/j.bbrc.2010.09.052; Li C.Y., 2014, TISSUE ENG A; Liang Y, 2011, BIOMATERIALS, V32, P9308, DOI 10.1016/j.biomaterials.2011.08.045; Lin Ruei-Zhen, 2008, Biotechnology Journal, V3, P1172, DOI 10.1002/biot.200700228; Lin RZ, 2006, CELL TISSUE RES, V324, P411, DOI 10.1007/s00441-005-0148-2; Lin TY, 2014, BIOMATERIALS, V35, P6898, DOI 10.1016/j.biomaterials.2014.04.118; Mahou R, 2012, J MATER SCI-MATER M, V23, P171, DOI 10.1007/s10856-011-4512-3; Makogonenko E, 2002, BIOCHEMISTRY-US, V41, P7907, DOI 10.1021/bi025770x; Molina-Jimenez F, 2012, VIROLOGY, V425, P31, DOI 10.1016/j.virol.2011.12.021; Mueller S, 2010, HEPATIC MED-EVID RES, V2, P49; Nakazawa K, 2002, INT J ARTIF ORGANS, V25, P51, DOI 10.1177/039139880202500109; Napolitano AP, 2007, TISSUE ENG, V13, P2087, DOI 10.1089/ten.2006.0190; Nelson LJ, 2010, CELLS TISSUES ORGANS, V192, P125, DOI 10.1159/000308893; Nguyen KT, 2002, BIOMATERIALS, V23, P4307, DOI 10.1016/S0142-9612(02)00175-8; Tran NM, 2013, TISSUE ENG PT A, V19, P103, DOI [10.1089/ten.TEA.2012.0139, 10.1089/ten.tea.2012.0139]; Peshwa MV, 1996, IN VITRO CELL DEV-AN, V32, P197; Phelps EA, 2012, ADV MATER, V24, P64, DOI 10.1002/adma.201103574; Ringel M, 2005, TOXICOLOGY, V206, P153, DOI 10.1016/j.tox.2004.07.017; Robinson EE, 2004, MOL BIOL CELL, V15, P973, DOI 10.1091/mbc.E03-07-0528; Semler EJ, 2005, BIOTECHNOL BIOENG, V89, P296, DOI 10.1002/bit.20328; Semler EJ, 2001, BIOTECHNOL BIOENG, V75, P510, DOI 10.1002/bit.10113; STAMATOGLOU SC, 1987, J CELL BIOL, V105, P2417, DOI 10.1083/jcb.105.5.2417; Subramanian K, 2014, STEM CELLS DEV, V23, P124, DOI 10.1089/scd.2013.0097; Tay CY, 2011, SMALL, V7, P1416, DOI 10.1002/smll.201002298; Underhill GH, 2007, BIOMATERIALS, V28, P256, DOI 10.1016/j.biomaterials.2006.08.043; Wang S, 2008, TISSUE ENG PT A, V14, P227, DOI 10.1089/tea.2007.0143; Weber LM, 2006, ACTA BIOMATER, V2, P1, DOI 10.1016/j.actbio.2005.10.005; Wells RG, 2008, HEPATOLOGY, V47, P1394, DOI 10.1002/hep.22193; Williams CM, 2011, TISSUE ENG PT A, V17, P1055, DOI [10.1089/ten.tea.2010.0398, 10.1089/ten.TEA.2010.0398]; Yu HY, 2013, ADV HEALTHC MATER, V2, P442, DOI 10.1002/adhm.201200142	53	46	47	4	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118123	10.1371/journal.pone.0118123	http://dx.doi.org/10.1371/journal.pone.0118123			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692976	Green Published, gold			2022-12-26	WOS:000350061500100
J	Ashraf, JM; Ahmad, S; Rabbani, G; Hasan, Q; Jan, AT; Lee, EJ; Khan, RH; Alam, K; Choi, I				Ashraf, Jalaluddin M.; Ahmad, Saheem; Rabbani, Gulam; Hasan, Qambar; Jan, Arif Tasleem; Lee, Eun Ju; Khan, Rizwan Hasan; Alam, Khursheed; Choi, Inho			3-Deoxyglucosone: A Potential Glycating Agent Accountable for Structural Alteration in H3 Histone Protein through Generation of Different AGEs	PLOS ONE			English	Article							END-PRODUCTS; PHYSICOCHEMICAL ANALYSIS; ASSAY; METHYLGLYOXAL; ENDPRODUCTS; PENTOSIDINE; FRUCTOSE; SERUM; STATE	Advanced glycation end-products (AGEs) are heterogeneous group of compounds, known to be implicated in diabetic complications. One of the consequences of the Maillard reaction is attributed to the production of reactive intermediate products such as a-oxoaldehydes. 3deoxyglucosone (3-DG), an alpha-oxoaldehyde has been found to be involved in accelerating vascular damage during diabetes. In the present study, calf thymus histone H3 was treated with 3-deoxyglucosone to investigate the generation of AGEs (N-epsilon-carboxymethyllysine, pentosidine), by examining the degree of side chain modifications and formation of different intermediates and employing various physicochemical techniques. The results clearly indicate the formation of AGEs and structural changes upon glycation of H3 by 3-deoxyglucosone, which may hamper the normal functioning of H3 histone, that may compromise the veracity of chromatin structures and function in secondary complications of diabetes.	[Ashraf, Jalaluddin M.; Hasan, Qambar; Jan, Arif Tasleem; Lee, Eun Ju; Choi, Inho] Yeungnam Univ, Sch Biotechnol, Gyongsan, South Korea; [Ahmad, Saheem] Integral Univ, Dept Biotechnol, Lucknow, Uttar Pradesh, India; [Rabbani, Gulam; Khan, Rizwan Hasan] Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh, Uttar Pradesh, India; [Alam, Khursheed] Aligarh Muslim Univ, Jawaharlal Nehru Med Coll, Dept Biochem, Aligarh, Uttar Pradesh, India	Yeungnam University; Integral University; Aligarh Muslim University; Aligarh Muslim University	Ashraf, JM (corresponding author), Yeungnam Univ, Sch Biotechnol, Gyongsan, South Korea.	jmashraf@gmail.com; inhochoi@ynu.ac.kr	Khan, Rizwan/GXZ-5789-2022; Ahmad, Saheem/R-7016-2017; Khan, Rizwan Hasan/F-8276-2014; Rabbani, Gulam/AAE-5629-2022; Jan, Arif Tasleem/AAX-6531-2020; Ashraf, Jalauddin M/P-5391-2014; Ahmad, Saheem/T-2609-2019	Ahmad, Saheem/0000-0003-1215-0279; Khan, Rizwan Hasan/0000-0002-9965-8982; Rabbani, Gulam/0000-0002-5293-8231; Jan, Arif Tasleem/0000-0002-3607-543X; Ashraf, Jalauddin M/0000-0001-7885-2551; Ahmad, Saheem/0000-0003-1215-0279; Alam, Khursheed/0000-0001-9729-9966	National Research Foundation of Korea grant - Korea government (MSIP) [2014R1A2A2A01006324]	National Research Foundation of Korea grant - Korea government (MSIP)	This work was supported by National Research Foundation of Korea grant funded by the Korea government (MSIP) (No. 2014R1A2A2A01006324).	Afrin S, 2014, J LUMIN, V151, P219, DOI 10.1016/j.jlumin.2014.02.028; Ahmad S, 2012, IUBMB LIFE, V64, P151, DOI 10.1002/iub.582; Ahmed N, 2007, DIABETES OBES METAB, V9, P233, DOI 10.1111/j.1463-1326.2006.00595.x; Ahmed N, 2002, BIOCHEM J, V364, P1; Amiri Majd A. M., 2013, J BASIC APPL SCI RES, V3, P878; Arfat MY, 2014, INT J BIOL MACROMOL, V69, P408, DOI 10.1016/j.ijbiomac.2014.05.069; Ashraf JM, 2014, IUBMB LIFE, V66, P686, DOI 10.1002/iub.1318; Ashraf JM, 2012, INT J BIOL MACROMOL, V51, P604, DOI 10.1016/j.ijbiomac.2012.06.013; Corbin J, 1998, J BIOL CHEM, V273, P771, DOI 10.1074/jbc.273.2.771; Degenhardt TP, 1998, CELL MOL BIOL, V44, P1139; DILL KA, 1990, BIOCHEMISTRY-US, V29, P7133, DOI 10.1021/bi00483a001; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; FOJO AT, 1983, ARCH BIOCHEM BIOPHYS, V224, P636, DOI 10.1016/0003-9861(83)90251-5; Garay-Sevilla ME, 2005, J ENDOCRINOL INVEST, V28, P223, DOI 10.1007/BF03345377; GRANDHEE SK, 1991, J BIOL CHEM, V266, P11649; HODGE JE, 1955, ADV CARBOHYD CHEM, V10, P169, DOI 10.1016/S0096-5332(08)60392-6; Ikeda K, 1996, BIOCHEMISTRY-US, V35, P8075, DOI 10.1021/bi9530550; Jairajpuri DS, 2007, CLIN CHIM ACTA, V378, P86, DOI 10.1016/j.cca.2006.10.020; JOHNSON RN, 1983, CLIN CHIM ACTA, V127, P87, DOI 10.1016/0009-8981(83)90078-5; Kessel L, 2002, PHOTOCHEM PHOTOBIOL, V76, P549, DOI 10.1562/0031-8655(2002)076<0549:TRASSF>2.0.CO;2; Khalifah RG, 1999, BIOCHEM BIOPH RES CO, V257, P251, DOI 10.1006/bbrc.1999.0371; LEVINE RL, 1994, METHOD ENZYMOL, V233, P346; Liu Y, 2003, SPECTROCHIM ACTA A, V59, P2747, DOI 10.1016/S1386-1425(03)00055-6; Misselwitz J, 2002, PEDIATR NEPHROL, V17, P316, DOI 10.1007/s00467-001-0815-9; Niwa T, 1999, J CHROMATOGR B, V731, P23, DOI 10.1016/S0378-4347(99)00113-9; Oya T, 1999, J BIOL CHEM, V274, P18492, DOI 10.1074/jbc.274.26.18492; Rabbani G, 2012, CELL BIOCHEM BIOPHYS, V62, P487, DOI 10.1007/s12013-011-9335-9; Rabbani G, 2011, CELL BIOCHEM BIOPHYS, V61, P551, DOI 10.1007/s12013-011-9237-x; Rahim M, 2014, COLLOID SURFACE B, V117, P473, DOI 10.1016/j.colsurfb.2013.12.008; Raj DSC, 2000, AM J KIDNEY DIS, V35, P365, DOI 10.1016/S0272-6386(00)70189-2; Schmitt A, 2005, ANAL BIOCHEM, V346, P101, DOI 10.1016/j.ab.2005.07.035; Schmitt A, 2005, ANAL BIOCHEM, V338, P201, DOI 10.1016/j.ab.2004.12.003; Sima AAF, 1999, DIABETOLOGIA, V42, P773, DOI 10.1007/s001250051227; Singh R, 2001, DIABETOLOGIA, V44, P129, DOI 10.1007/s001250051591; SMITH RE, 1978, ANAL BIOCHEM, V90, P246, DOI 10.1016/0003-2697(78)90029-5; Stefek M, 1999, REDOX REP, V4, P43, DOI 10.1179/135100099101534738; Suzuki D, 1999, J AM SOC NEPHROL, V10, P822; Talasz H, 2002, J CELL BIOCHEM, V85, P24, DOI 10.1002/jcb.10103; Thornalley PJ, 1999, BIOCHEM J, V344, P109, DOI 10.1042/0264-6021:3440109; UDENFRIEND S, 1972, SCIENCE, V178, P871, DOI 10.1126/science.178.4063.871; Wolffe A., 1998, CHROMATIN STRUCTURE; Zheng N, 2010, J HUAZHONG U SCI-MED, V30, P546, DOI 10.1007/s11596-010-0466-9	42	47	47	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0116804	10.1371/journal.pone.0116804	http://dx.doi.org/10.1371/journal.pone.0116804			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689368	gold, Green Submitted, Green Published			2022-12-26	WOS:000350322700024
J	Demitto, FD; do Amaral, RCR; Maltempe, FG; Siqueira, VLD; Scodro, RBD; Lopes, MA; Caleffi-Ferracioli, KR; Canezin, PH; Cardoso, RF				Demitto, Fernanda de Oliveira; Ribeiro do Amaral, Renata Claro; Maltempe, Flaviane Granero; Dias Siqueira, Vera Lucia; de Lima Scodro, Regiane Bertin; Lopes, Mariana Aparecida; Caleffi-Ferracioli, Katiany R.; Canezin, Pedro Henrique; Cardoso, Rosilene Fressatti			In Vitro Activity of Rifampicin and Verapamil Combination in Multidrug-Resistant Mycobacterium tuberculosis	PLOS ONE			English	Article							EFFLUX PUMP; DRUG-RESISTANCE; P-GLYCOPROTEIN; INHIBITOR; SUSCEPTIBILITY; OFLOXACIN; ISOLATE; GENE	The aim of the present study was to evaluate the effect of the combination of rifampicin (RIF) and verapamil (VP) against the Mycobacterium tuberculosis H(37)Rv reference strain and six multidrug-resistant (MDR) M. tuberculosis clinical isolates by determining Time-Kill Curves and the ability to efflux drug by fluorometry. The RIF+VP combination showed synergism in one MDR clinical isolate. For the other five MDR clinical isolates, the drug combination showed no interaction. The MDR clinical isolate had lower ethidium bromide (EtBr) accumulation when exposed to the RIF+VP combination, compared with RIF and VP exposure alone. The other MDR clinical isolates showed no significant difference in EtBr accumulation. These results suggest greater efflux action in one of the MDR clinical isolates compared with the M. tuberculosis H37Rv reference strain. The other five MDR isolates may have additional mechanisms of drug resistance to RIF. The use of the RIF+VP combination made one MDR bacillus more susceptible to RIF probably by inhibiting efflux pumps, and this combination therapy, in some cases, may contribute to a reduction of resistance to RIF in M. tuberculosis.	[Demitto, Fernanda de Oliveira; Canezin, Pedro Henrique] Univ Estadual Maringa, Hlth Sci, BR-87020900 Maringa, Parana, Brazil; [Ribeiro do Amaral, Renata Claro; Maltempe, Flaviane Granero; Lopes, Mariana Aparecida] Univ Estadual Maringa, Biosci & Pathophysiol, BR-87020900 Maringa, Parana, Brazil; [Dias Siqueira, Vera Lucia; de Lima Scodro, Regiane Bertin; Caleffi-Ferracioli, Katiany R.; Cardoso, Rosilene Fressatti] Univ Estadual Maringa, Lab Med Bacteriol, Dept Clin Anal & Biomed, BR-87020900 Maringa, Parana, Brazil	Universidade Estadual de Maringa; Universidade Estadual de Maringa; Universidade Estadual de Maringa	Cardoso, RF (corresponding author), Univ Estadual Maringa, Lab Med Bacteriol, Dept Clin Anal & Biomed, Ave Colombo 5790, BR-87020900 Maringa, Parana, Brazil.	rfressatticardoso@gmail.com	de Lima Scodro, Regiane Bertin/Y-9234-2019; Caleffi Ferracioli, Katiany Rizzieri/AAX-9056-2021; Cardoso, Rosilene F/J-4796-2015; Cardoso, Rosilene Fressatti/AAX-9166-2021	de Lima Scodro, Regiane Bertin/0000-0002-9129-2445; Caleffi Ferracioli, Katiany Rizzieri/0000-0003-0345-1600; Cardoso, Rosilene F/0000-0001-6228-4780; Cardoso, Rosilene Fressatti/0000-0001-6228-4780; de Oliveira Demitto Tamogami, Fernanda/0000-0002-0939-9615				Caleffi-Ferracioli KR, 2013, TUBERCULOSIS, V93, P660, DOI 10.1016/j.tube.2013.09.001; CANETTI G, 1963, Rev Tuberc Pneumol (Paris), V27, P217; CHAN EL, 1987, DIAGN MICR INFEC DIS, V6, P157, DOI 10.1016/0732-8893(87)90101-5; Danilchanka O, 2008, ANTIMICROB AGENTS CH, V52, P2503, DOI 10.1128/AAC.00298-08; de Knegt GJ, 2013, TUBERCULOSIS, V93, P96, DOI 10.1016/j.tube.2012.10.013; de Steenwinkel JEM, 2010, J ANTIMICROB CHEMOTH, V65, P2582, DOI 10.1093/jac/dkq374; Germann UA, 1996, EUR J CANCER, V32A, P927, DOI 10.1016/0959-8049(96)00057-3; Gupta AK, 2010, MICROB DRUG RESIST, V16, P21, DOI 10.1089/mdr.2009.0054; Gupta S, 2013, AM J RESP CRIT CARE, V188, P600, DOI 10.1164/rccm.201304-0650OC; Haydel SE, 2010, PHARMACEUTICALS-BASE, V3, P2268, DOI 10.3390/ph3072268; Jiang X, 2008, MICROB DRUG RESIST, V14, P7, DOI 10.1089/mdr.2008.0772; Jin J, 2010, MOLECULES, V15, P7750, DOI 10.3390/molecules15117750; Jones K, 2001, AIDS, V15, P1353, DOI 10.1097/00002030-200107270-00004; Louw GE, 2009, ANTIMICROB AGENTS CH, V53, P3181, DOI 10.1128/AAC.01577-08; Louw GE, 2011, AM J RESP CRIT CARE, V184, P269, DOI 10.1164/rccm.201011-1924OC; LUNAHERRERA J, 1995, ANTIMICROB AGENTS CH, V39, P440, DOI 10.1128/AAC.39.2.440; Machado D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034538; Machado L, 2011, IN VIVO, V25, P769; Molhuizen HOF, 1998, METH MOL B, V101, P381, DOI 10.1385/0-89603-471-2:381; Paixao Laura, 2009, J Biol Eng, V3, P18, DOI 10.1186/1754-1611-3-18; Palomino JC, 2002, ANTIMICROB AGENTS CH, V46, P2720, DOI 10.1128/AAC.46.8.2720-2722.2002; Piddock LJV, 2006, CLIN MICROBIOL REV, V19, P382, DOI 10.1128/CMR.19.2.382-402.2006; Piddock LJV, 2000, J ANTIMICROB CHEMOTH, V45, P159, DOI 10.1093/jac/45.2.159; Pillai SK, 2005, ANTIBIOTICS LAB MED, V5, P365; Putman M, 2000, MICROBIOL MOL BIOL R, V64, P672, DOI 10.1128/MMBR.64.4.672-693.2000; Ramon-Garcia S, 2009, ANTIMICROB AGENTS CH, V53, P3675, DOI 10.1128/AAC.00550-09; Rodrigues L, 2013, ANTIMICROB AGENTS CH, V57, P751, DOI 10.1128/AAC.01482-12; Rodrigues L, 2012, INFECT GENET EVOL, V12, P695, DOI 10.1016/j.meegid.2011.08.009; Rodrigues L, 2009, INT J ANTIMICROB AG, V34, P529, DOI 10.1016/j.ijantimicag.2009.07.010; Sharma S, 2010, J ANTIMICROB CHEMOTH, V65, P1694, DOI 10.1093/jac/dkq186; Shi R, 2007, MINI-REV MED CHEM, V7, P1177, DOI 10.2174/138955707782331740; Siddiqi N, 2004, INFECTION, V32, P109, DOI 10.1007/s15010-004-3097-x; Singh M, 2011, INDIAN J MED RES, V133, P535; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; van Veen HW, 1998, NATURE, V391, P291, DOI 10.1038/34669; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1	36	13	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0116545	10.1371/journal.pone.0116545	http://dx.doi.org/10.1371/journal.pone.0116545			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689777	gold, Green Submitted, Green Published			2022-12-26	WOS:000350322700015
J	Muller, HM; Steringer, JP; Wegehingel, S; Bleicken, S; Munster, M; Dimou, E; Unger, S; Weidmann, G; Andreas, H; Garcia-Saez, AJ; Wild, K; Sinning, I; Nickel, W				Mueller, Hans-Michael; Steringer, Julia P.; Wegehingel, Sabine; Bleicken, Stephanie; Muenster, Maximilian; Dimou, Eleni; Unger, Sebastian; Weidmann, Georg; Andreas, Helena; Garcia-Saez, Ana J.; Wild, Klemens; Sinning, Irmgard; Nickel, Walter			Formation of Disulfide Bridges Drives Oligomerization, Membrane Pore Formation, and Translocation of Fibroblast Growth Factor 2 to Cell Surfaces	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNCONVENTIONAL PROTEIN SECRETION; HEPARAN-SULFATE PROTEOGLYCANS; FGF-2; FIBROBLAST-GROWTH-FACTOR-2; MECHANISMS; EXPORT; GLUTAREDOXINS; MACHINERY; PATHWAY; CANCER	Fibroblast growth factor 2 (FGF2) is a key signaling molecule in tumor-induced angiogenesis. FGF2 is secreted by an unconventional secretory mechanism that involves phosphatidylinositol 4,5-bisphosphate-dependent insertion of FGF2 oligomers into the plasma membrane. This process is regulated by Tec kinase-mediated tyrosine phosphorylation of FGF2. Molecular interactions driving FGF2 monomers into membrane-inserted FGF2 oligomers are unknown. Here we identify two surface cysteines that are critical for efficient unconventional secretion of FGF2. They represent unique features of FGF2 as they are absent from all signal-peptide-containing members of the FGF protein family. We show that phosphatidylinositol 4,5-bisphosphate-dependent FGF2 oligomerization concomitant with the generation of membrane pores depends on FGF2 surface cysteines as either chemical alkylation or substitution with alanines impairs these processes. We further demonstrate that the FGF2 variant forms lacking the two surface cysteines are not secreted from cells. These findings were corroborated by experiments redirecting a signal-peptide-containing FGF family member from the endoplasmic reticulum/Golgi-dependent secretory pathway into the unconventional secretory pathway of FGF2. Cis elements known to be required for unconventional secretion of FGF2, including the two surface cysteines, were transplanted into a variant form of FGF4 without signal peptide. The resulting FGF4/2 hybrid protein was secreted by unconventional means. We propose that the formation of disulfide bridges drives membrane insertion of FGF2 oligomers as intermediates in unconventional secretion of FGF2.	[Mueller, Hans-Michael; Steringer, Julia P.; Wegehingel, Sabine; Muenster, Maximilian; Dimou, Eleni; Unger, Sebastian; Weidmann, Georg; Andreas, Helena; Wild, Klemens; Sinning, Irmgard; Nickel, Walter] Heidelberg Univ, Biochem Ctr, D-69120 Heidelberg, Germany; [Bleicken, Stephanie; Garcia-Saez, Ana J.] Univ Tubingen, Interfac Inst Biochem, D-72076 Tubingen, Germany; [Bleicken, Stephanie; Garcia-Saez, Ana J.] Max Planck Inst Intelligent Syst, D-70569 Stuttgart, Germany	Ruprecht Karls University Heidelberg; Eberhard Karls University of Tubingen; Max Planck Society	Nickel, W (corresponding author), Heidelberg Univ, Biochem Ctr BZH, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	walter.nickel@bzh.uni-heidelberg.de	Saez, Ana J. Garcia/U-1611-2019	Bleicken, Stephanie/0000-0002-4789-0974; Muller, Hans-Michael/0000-0002-2384-7285; Dimou, Eleni/0000-0003-4885-135X	German Research Council [DFG-SFB 638, DFG-SFB/TRR 83, DFG-GRK1188]; AID-NET program of the Federal Ministry for Education and Research of Germany; Deutsche Forschungsgemeinschaft cluster of excellence CellNetworks	German Research Council(German Research Foundation (DFG)); AID-NET program of the Federal Ministry for Education and Research of Germany; Deutsche Forschungsgemeinschaft cluster of excellence CellNetworks	This work was supported by the German Research Council (DFG-SFB 638, DFG-SFB/TRR 83, and DFG-GRK1188), the AID-NET program of the Federal Ministry for Education and Research of Germany, and the Deutsche Forschungsgemeinschaft cluster of excellence CellNetworks.	Antos JM, 2009, J AM CHEM SOC, V131, P10800, DOI 10.1021/ja902681k; Backhaus R, 2004, J CELL SCI, V117, P1727, DOI 10.1242/jcs.01027; Bradshaw JM, 2010, CELL SIGNAL, V22, P1175, DOI 10.1016/j.cellsig.2010.03.001; Ebert AD, 2010, TRAFFIC, V11, P813, DOI 10.1111/j.1600-0854.2010.01059.x; Engling A, 2002, J CELL SCI, V115, P3619, DOI 10.1242/jcs.00036; Garcia-Saez AJ, 2009, NAT STRUCT MOL BIOL, V16, P1178, DOI 10.1038/nsmb.1671; Garcia-Saez AJ, 2008, METHODS, V46, P116, DOI 10.1016/j.ymeth.2008.06.011; Hanschmann EM, 2013, ANTIOXID REDOX SIGN, V19, P1539, DOI 10.1089/ars.2012.4599; Lillig CH, 2013, ANTIOXID REDOX SIGN, V18, P1654, DOI 10.1089/ars.2012.5007; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Nickel W, 2003, EUR J BIOCHEM, V270, P2109, DOI 10.1046/j.1432-1033.2003.03577.x; Nickel W, 2008, ANNU REV CELL DEV BI, V24, P287, DOI 10.1146/annurev.cellbio.24.110707.175320; Nickel W, 2007, J CELL SCI, V120, P2295, DOI 10.1242/jcs.011080; Nickel W, 2011, TRAFFIC, V12, P799, DOI 10.1111/j.1600-0854.2011.01187.x; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; Pardo OE, 2006, EMBO J, V25, P3078, DOI 10.1038/sj.emboj.7601198; Popp MW, 2007, NAT CHEM BIOL, V3, P707, DOI 10.1038/nchembio.2007.31; Presta M, 2005, CYTOKINE GROWTH F R, V16, P159, DOI 10.1016/j.cytogfr.2005.01.004; Rabouille C, 2012, J CELL SCI, V125, P5251, DOI 10.1242/jcs.103630; REISFELD RA, 1962, NATURE, V195, P281, DOI 10.1038/195281a0; Steringer JP, 2015, J MOL BIOL, V427, P1202, DOI 10.1016/j.jmb.2014.07.012; Steringer JP, 2012, J BIOL CHEM, V287, P27659, DOI 10.1074/jbc.M112.381939; Temmerman K, 2008, TRAFFIC, V9, P1204, DOI 10.1111/j.1600-0854.2008.00749.x; Temmerman K, 2009, J LIPID RES, V50, P1245, DOI 10.1194/jlr.D800043-JLR200; Torrado LC, 2009, J CELL SCI, V122, P3322, DOI 10.1242/jcs.049791; Wegehingel S, 2008, FEBS LETT, V582, P2387, DOI 10.1016/j.febslet.2008.05.042; Young TS, 2010, J MOL BIOL, V395, P361, DOI 10.1016/j.jmb.2009.10.030; Zehe C, 2006, P NATL ACAD SCI USA, V103, P15479, DOI 10.1073/pnas.0605997103; Zhang M, 2013, SCIENCE, V340, P559, DOI 10.1126/science.1234740	29	35	35	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					8925	8937		10.1074/jbc.M114.622456	http://dx.doi.org/10.1074/jbc.M114.622456			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25694424	hybrid, Green Published			2022-12-26	WOS:000352207100020
J	Cristofari, R; Trucchi, E; Whittington, JD; Vigetta, S; Gachot-Neveu, H; Stenseth, NC; Le Maho, Y; Le Bohec, C				Cristofari, Robin; Trucchi, Emiliano; Whittington, Jason D.; Vigetta, Stephanie; Gachot-Neveu, Helene; Stenseth, Nils Christian; Le Maho, Yvon; Le Bohec, Celine			Spatial Heterogeneity as a Genetic Mixing Mechanism in Highly Philopatric Colonial Seabirds	PLOS ONE			English	Article							PENGUIN APTENODYTES-PATAGONICUS; POPULATION-STRUCTURE; KING PENGUIN; NATAL DISPERSAL; SITE FIDELITY; R-PACKAGE; RELATEDNESS; DYNAMICS; CROZET; DIFFERENTIATION	How genetic diversity ismaintained in philopatric colonial systems remains unclear, and under-standing the dynamic balance of philopatry and dispersal at all spatial scales is essential to the study of the evolution of coloniality. In the King penguin, Aptenodytes patagonicus, return rates of post-fledging chicks to their natal sub-colony are remarkably high. Empirical studies have shown that adults return year after year to their previous breeding territories within a radius of a few meters. Yet, little reliable data are available on intra-and inter-colonial dispersal in this species. Here, we present the first fine-scale study of the genetic structure in a king penguin colony in the Crozet Archipelago. Samples were collected from individual chicks and analysed at 8 microsatellite loci. Precise geolocation data of hatching sites and selective pressures associated with habitat features were recorded for all sampling locations. We found that despite strong natal and breeding site fidelity, king penguins retain a high degree of panmixia and genetic diversity. Yet, genetic structure appears markedly heterogeneous across the colony, with higher-than-expected inbreeding levels, and local inbreeding and relatedness hotspots that overlap predicted higher-quality nesting locations. This points towards heterogeneous population structure at the sub-colony level, in which fine-scale environmental features drive local philopatric behaviour, while lower-quality patches may act as genetic mixing mechanisms at the colony level. These findings show how a lack of global genetic structuring can emerge from small-scale heterogeneity in ecological parameters, as opposed to the classical model of homogeneous dispersal. Our results also emphasize the importance of sampling design for estimation of population parameters in colonial seabirds, as at high spatial resolution, basic genetic features are shown to be location-dependent. Finally, this study stresses the importance of understanding intra-colonial dispersal and genetic mixing mechanisms in order to better estimate species-wide gene flows and population dynamics.	[Cristofari, Robin; Whittington, Jason D.; Vigetta, Stephanie; Gachot-Neveu, Helene; Le Maho, Yvon] Univ Strasbourg UdS, Inst Pluridisciplinaire Hubert Curien, Lab Int Associe LIA BioSensib CSM CNRS UdS 647, Strasbourg 02, France; [Cristofari, Robin; Whittington, Jason D.; Vigetta, Stephanie; Gachot-Neveu, Helene; Le Maho, Yvon] CNRS, UMR 7178, LIA BioSensib 647, Strasbourg 02, France; [Cristofari, Robin; Whittington, Jason D.; Le Maho, Yvon; Le Bohec, Celine] CSM, LIA BioSensib 647, Monaco, Monaco; [Cristofari, Robin; Trucchi, Emiliano; Whittington, Jason D.; Stenseth, Nils Christian; Le Bohec, Celine] Univ Oslo, Ctr Ecol & Evolutionary Synth, Dept Biosci, Oslo, Norway	Centre National de la Recherche Scientifique (CNRS); University of Oslo	Cristofari, R (corresponding author), Univ Strasbourg UdS, Inst Pluridisciplinaire Hubert Curien, Lab Int Associe LIA BioSensib CSM CNRS UdS 647, Strasbourg 02, France.	robin.cristofari@iphc.cnrs.fr	Stenseth, Nils Chr./G-5212-2016; LE BOHEC, CELINE/AAD-3589-2022; Cristofari, Robin/AAO-8097-2021	Stenseth, Nils Chr./0000-0002-1591-5399; LE BOHEC, Celine/0000-0003-0149-6477	Institut Polaire Francais Paul-Emile Victor (Programme 137); Centre National de la Recherche Scientifique (Programme Zone Atelier de Recherches sur l'Environnement Antarctique et Subantarctique); Fondation de France / Fondation Ars Cuttoli; Marie Curie Intra European Fellowships (European Commission) [235962, 252252]	Institut Polaire Francais Paul-Emile Victor (Programme 137); Centre National de la Recherche Scientifique (Programme Zone Atelier de Recherches sur l'Environnement Antarctique et Subantarctique); Fondation de France / Fondation Ars Cuttoli; Marie Curie Intra European Fellowships (European Commission)	This study was supported by the Institut Polaire Francais Paul-Emile Victor (Programme 137), the Centre National de la Recherche Scientifique (Programme Zone Atelier de Recherches sur l'Environnement Antarctique et Subantarctique), the Fondation de France / Fondation Ars Cuttoli (to JDW), and Marie Curie Intra European Fellowships (FP7-PEOPLE-IEF-2008, European Commission, project No 235962 to CLB, and FP7-PEOPLE-IEF-2010, European Commission, project No 252252 to ET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2009, MOL ECOL RESOUR, V9, P1530, DOI 10.1111/j.1755-0998.2009.02710.x; Akst EP, 2002, CONSERV GENET, V3, P375, DOI 10.1023/A:1020555303124; Arnaud CM, 2012, MOL ECOL, V21, P493, DOI 10.1111/j.1365-294X.2011.05219.x; Ballou JD, 1997, J HERED, V88, P169, DOI 10.1093/oxfordjournals.jhered.a023085; Balloux F, 2004, MOL ECOL, V13, P3021, DOI 10.1111/j.1365-294X.2004.02318.x; Balloux F, 2002, MOL ECOL, V11, P155, DOI 10.1046/j.0962-1083.2001.01436.x; Banks SC, 2012, MOL ECOL, V21, P2092, DOI 10.1111/j.1365-294X.2012.05485.x; Barlow EJ, 2013, IBIS, V155, P762, DOI 10.1111/ibi.12060; Barrat A, 1976, COM NAT FR RECH ANTA, V40, P9, DOI DOI 10.1016/J.ATHEROSCLEROSIS.2014.12.010; Bicknell AWJ, 2012, MOL ECOL, V21, P2863, DOI 10.1111/j.1365-294X.2012.05558.x; Billing TM, 2007, MOL ECOL NOTES, V7, P425, DOI 10.1111/j.1471-8286.2006.01607.x; Bivand R., 2020, SPDEP SPATIAL DEPEND; Bouzat JL, 2009, AUK, V126, P326, DOI 10.1525/auk.2009.07122; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Bried J, 2007, J ZOOL, V272, P20, DOI 10.1111/j.1469-7998.2006.00242.x; Bried J, 2001, IBIS, V143, P670, DOI 10.1111/j.1474-919X.2001.tb04895.x; Brodin A, 1998, AUK, V115, P767, DOI 10.2307/4089426; Clarke AL, 1997, OIKOS, V79, P429, DOI 10.2307/3546885; Cote SD, 2000, ANIM BEHAV, V59, P813, DOI 10.1006/anbe.1999.1384; Coulson John C., 2002, P87; Danchin E, 1997, TRENDS ECOL EVOL, V12, P342, DOI 10.1016/S0169-5347(97)01124-5; Delord K, 2004, POLAR BIOL, V27, P793, DOI 10.1007/s00300-004-0651-z; Descamps S, 2005, POLAR BIOL, V28, P303, DOI 10.1007/s00300-004-0684-3; Descamps Sebastien, 2002, Avian Science, V2, P87; Descamps S, 2009, CONDOR, V111, P81, DOI 10.1525/cond.2009.080066; Double MC, 2005, EVOLUTION, V59, P625, DOI 10.1111/j.0014-3820.2005.tb01021.x; Dugger KM, 2010, P NATL ACAD SCI USA, V107, P12375, DOI 10.1073/pnas.1000623107; DUNFORD C, 1977, AM NAT, V111, P782, DOI 10.1086/283206; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Epperson BK, 2005, HEREDITY, V95, P7, DOI 10.1038/sj.hdy.6800680; Falla RA, 1937, BIRDS BRIT AUSTR NZ, DOI [10.4997/JRCPE.2011.319., DOI 10.4997/JRCPE.2011.319]; Falush D, 2003, GENETICS, V164, P1567; Fernandez-Chacon A, 2013, ECOGRAPHY, V26, P1; Frankham R, 2005, J EVOLUTION BIOL, V18, P750, DOI 10.1111/j.1420-9101.2005.00885.x; FRANKHAM R, 1995, CONSERV BIOL, V9, P792, DOI 10.1046/j.1523-1739.1995.09040792.x; Frederiksen M, 1999, WATERBIRDS, V22, P274, DOI 10.2307/1522215; Friesen VL, 2007, MOL ECOL, V16, P1765, DOI 10.1111/j.1365-294X.2006.03197.x; GALES R, 1988, AUST WILDLIFE RES, V15, P579; Gauthier-Clerc M, 2004, P ROY SOC B-BIOL SCI, V271, pS423, DOI 10.1098/rsbl.2004.0201; Gendner JP, 2005, J FIELD ORNITHOL, V76, P138, DOI 10.1648/0273-8570-76.2.138; Gomez-Diaz E, 2009, MAR ECOL PROG SER, V382, P197, DOI 10.3354/meps07974; Gorospe KD, 2013, MOL ECOL, V22, P3721, DOI 10.1111/mec.12335; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Heg D, 2011, BEHAV ECOL, V22, P82, DOI 10.1093/beheco/arq170; Holsinger KE, 2009, NAT REV GENET, V10, P639, DOI 10.1038/nrg2611; HUNTER S, 1991, IBIS, V133, P343, DOI 10.1111/j.1474-919X.1991.tb04581.x; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jones OR, 2012, ECOL EVOL, V2, P1048, DOI 10.1002/ece3.237; Kanno Y, 2011, MOL ECOL, V20, P3711, DOI 10.1111/j.1365-294X.2011.05210.x; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Le Bohec C, 2007, J ANIM ECOL, V76, P1149, DOI 10.1111/j.1365-2656.2007.01268.x; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Lecomte N, 2006, ANIM BEHAV, V71, P457, DOI 10.1016/j.anbehav.2005.07.007; Mangin S, 2003, J AVIAN BIOL, V34, P30, DOI 10.1034/j.1600-048X.2003.02916.x; Matthiopoulos J, 2005, J ANIM ECOL, V74, P716, DOI 10.1111/j.1365-2656.2005.00970.x; Miller JA, 2012, PROGR PHYS GEOGRAPHY, V37, P161; Milot E, 2008, MOL ECOL, V17, P1658, DOI 10.1111/j.1365-294X.2008.03700.x; Murrell DJ, 2002, OIKOS, V97, P229, DOI 10.1034/j.1600-0706.2002.970209.x; Osborne PE, 2007, DIVERS DISTRIB, V13, P313, DOI 10.1111/j.1472-4642.2007.00344.x; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pearce JM, 2005, CONSERV GENET, V6, P743, DOI 10.1007/s10592-005-9034-4; Pearce JM, 2008, AUK, V125, P711, DOI 10.1525/auk.2008.07154; Pritchard JK, 2000, GENETICS, V155, P945; Prugnolle F, 2002, HEREDITY, V88, P161, DOI 10.1038/sj.hdy.6800060; Ritland K, 1996, GENET RES, V67, P175, DOI 10.1017/S0016672300033620; Rivers NM, 2005, MOL ECOL, V14, P4299, DOI 10.1111/j.1365-294X.2005.02748.x; ROUNSEVELL DE, 1982, AUST WILDLIFE RES, V9, P519; Ruzzante DE, 2001, MOL ECOL, V10, P2107, DOI 10.1046/j.1365-294X.2001.01352.x; Ryman N, 2006, MOL ECOL, V15, P2031, DOI 10.1111/j.1365-294X.2006.02839.x; Saraux C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020407; Serrano D, 2004, ECOLOGY, V85, P3438, DOI 10.1890/04-0463; Shepherd LD, 2005, J HERED, V96, P566, DOI 10.1093/jhered/esi070; Steiner UK, 2005, BEHAV ECOL, V16, P634, DOI 10.1093/beheco/ari035; Stevens EL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002287; Stonehouse B., 1960, KING PENGUIN APTENOD; Travis JMJ, 1999, P ROY SOC B-BIOL SCI, V266, P723, DOI 10.1098/rspb.1999.0696; Viblanc VA, 2014, OECOLOGIA, P1, DOI [10.1007/s00442-014-3116-2, DOI 10.1007/S00442-014-3116-2]; Vogl C, 2002, J EVOLUTION BIOL, V15, P433, DOI 10.1046/j.1420-9101.2002.00404.x; Wang JL, 2011, MOL ECOL RESOUR, V11, P141, DOI 10.1111/j.1755-0998.2010.02885.x; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; WEIMERSKIRCH H, 1992, IBIS, V134, P107, DOI 10.1111/j.1474-919X.1992.tb08387.x; Weir B.S., 1990, GENETIC DATA ANAL ME; Wheelwright NT, 1998, ECOLOGY, V79, P755, DOI 10.1890/0012-9658(1998)079[0755:PNDAIA]2.0.CO;2; Whitlock MC, 1999, HEREDITY, V82, P117, DOI 10.1038/sj.hdy.6884960; Winters JB, 2003, MOL ECOL, V12, P2251, DOI 10.1046/j.1365-294X.2003.01896.x; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; Wright S., 1969, THEORY GENE FREQUENC, V2, P520	88	14	16	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117981	10.1371/journal.pone.0117981	http://dx.doi.org/10.1371/journal.pone.0117981			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680103	Green Published, gold, Green Submitted			2022-12-26	WOS:000350682600096
J	Dhakal, R; Park, E; Lee, SW; Baek, KH				Dhakal, Radhika; Park, Euiho; Lee, Se-Weon; Baek, Kwang-Hyun			Soybean (Glycine max L. Merr.) Sprouts Germinated under Red Light Irradiation Induce Disease Resistance against Bacterial Rotting Disease	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; SALICYLIC-ACID; GENE-EXPRESSION; JASMONIC ACID; SIGNALING PATHWAYS; DEFENSE RESPONSES; BOTRYTIS-CINEREA; FUSARIUM-WILT; SEED SPROUTS; RICE LEAVES	Specific wavelengths of light can exert various physiological changes in plants, including effects on responses to disease incidence. To determine whether specific light wavelength had effects on rotting disease caused by Pseudomonas putida 229, soybean sprouts were germinated under a narrow range of wavelengths from light emitting diodes (LEDs), including red (650-660), far red (720-730) and blue (440-450 nm) or broad range of wavelength from daylight fluorescence bulbs. The controls were composed of soybean sprouts germinated in darkness. After germination under different conditions for 5 days, the soybean sprouts were inoculated with P. putida 229 and the disease incidence was observed for 5 days. The sprouts exposed to red light showed increased resistance against P. putida 229 relative to those grown under other conditions. Soybean sprouts germinated under red light accumulated high levels of salicylic acid (SA) accompanied with up-regulation of the biosynthetic gene ICS and the pathogenesis-related (PR) gene PR-1, indicating that the resistance was induced by the action of SA via de novo synthesis of SA in the soybean sprouts by red light irradiation. Taken together, these data suggest that only the narrow range of red light can induce disease resistance in soybean sprouts, regulated by the SA-dependent pathway via the de novo synthesis of SA and up-regulation of PR genes.	[Dhakal, Radhika; Park, Euiho; Baek, Kwang-Hyun] Yeungnam Univ, Sch Biotechnol, Gyongsan, Gyeongbuk, South Korea; [Lee, Se-Weon] Rural Dev Adm, Int Technol Cooperat Ctr, Jeonju, South Korea	Yeungnam University; Rural Development Administration (RDA)	Baek, KH (corresponding author), Yeungnam Univ, Sch Biotechnol, Gyongsan, Gyeongbuk, South Korea.	khbaek@ynu.ac.kr			Yeungnam University	Yeungnam University	This research was conducted under a research fund provided by Yeungnam University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Monaim Montaser Fawzy, 2011, Mycobiology, V39, P290, DOI 10.5941/MYCO.2011.39.4.290; Achuo EA, 2004, PLANT PATHOL, V53, P65, DOI 10.1111/j.1365-3059.2004.00947.x; Ahn SY, 2013, J PLANT PATHOL, V95, P477; An CF, 2011, J INTEGR PLANT BIOL, V53, P412, DOI 10.1111/j.1744-7909.2011.01043.x; Borsani O, 2001, PLANT PHYSIOL, V126, P1024, DOI 10.1104/pp.126.3.1024; BRIDGE MA, 1973, PHYTOPATHOLOGY, V63, P606, DOI 10.1094/Phyto-63-606; Cannon SB, 2009, PLANT PHYSIOL, V151, P970, DOI 10.1104/pp.109.144659; Carviel JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088608; Dong XN, 1998, CURR OPIN PLANT BIOL, V1, P316, DOI 10.1016/1369-5266(88)80053-0; DOUPNIK B, 1993, PLANT DIS, V77, P1170; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; GUO A, 1993, PHYSIOL MOL PLANT P, V42, P413, DOI 10.1006/pmpp.1993.1031; Harmon S, 1987, J FOOD PROTECT; Heil M, 2002, ANN BOT-LONDON, V89, P503, DOI 10.1093/aob/mcf076; Holt S, 1997, J KOR SOYBEAN DIG, V14, P77; Islam SZ, 2008, J PHYTOPATHOL, V156, P708, DOI 10.1111/j.1439-0434.2008.01435.x; Islam SZ, 2002, HORTSCIENCE, V37, P678, DOI 10.21273/HORTSCI.37.4.678; Islam SZ, 1998, J PHYTOPATHOL, V146, P479, DOI 10.1111/j.1439-0434.1998.tb04609.x; Jia CG, 2013, J EXP BOT, V64, P637, DOI 10.1093/jxb/ers360; Kang SG, 2009, PLANT PATHOLOGY J, V25, P381, DOI 10.5423/PPJ.2009.25.4.381; KATO H, 1994, PHYTOCHEMISTRY, V36, P299, DOI 10.1016/S0031-9422(00)97064-X; Khanam NN, 2005, PHYSIOL MOL PLANT P, V66, P20, DOI 10.1016/j.pmpp.2005.03.006; KODAMA O, 1992, PHYTOCHEMISTRY, V31, P3807, DOI 10.1016/S0031-9422(00)97532-0; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Kunkel BN, 2002, CURR OPIN PLANT BIOL, V5, P325, DOI 10.1016/S1369-5266(02)00275-3; LEEMAN M, 1995, EUR J PLANT PATHOL, V101, P655, DOI 10.1007/BF01874869; Libault M, 2010, PLANT J, V63, P86, DOI 10.1111/j.1365-313X.2010.04222.x; Liu K., 1997, SOYBEANS CHEM TECHNO, P137, DOI DOI 10.1079/BJN/2002529; MALAMY J, 1990, SCIENCE, V250, P1002, DOI 10.1126/science.250.4983.1002; Marek G, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-21; METRAUX JP, 1990, SCIENCE, V250, P1004, DOI 10.1126/science.250.4983.1004; Muller M, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-37; Niki T, 1998, PLANT CELL PHYSIOL, V39, P500, DOI 10.1093/oxfordjournals.pcp.a029397; Noda S, 2009, NAT PHOTONICS, V3, P129, DOI 10.1038/nphoton.2009.15; PENACORTES H, 1993, PLANTA, V191, P123, DOI 10.1007/BF00240903; Pieterse CMJ, 1996, PLANT CELL, V8, P1225, DOI 10.1105/tpc.8.8.1225; Rahman MZ, 2003, J PHYTOPATHOL, V151, P86, DOI 10.1046/j.1439-0434.2003.00685.x; Robertson LJ, 2002, INT J FOOD MICROBIOL, V75, P119, DOI 10.1016/S0168-1605(01)00738-3; Sanchez L, 2012, PLANT PHYSIOL, V160, P1630, DOI 10.1104/pp.112.201913; Sandhu D, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-105; Sano H, 1996, PLANT CELL PHYSIOL, V37, P762, DOI 10.1093/oxfordjournals.pcp.a029011; Schaller A, 2009, PHYTOCHEMISTRY, V70, P1532, DOI 10.1016/j.phytochem.2009.07.032; Shirasu K, 1997, PLANT CELL, V9, P261, DOI 10.1105/tpc.9.2.261; Taormina PJ, 1999, EMERG INFECT DIS, V5, P626, DOI 10.3201/eid0505.990503; TU JC, 1978, PHYSIOL PLANT PATHOL, V12, P233, DOI 10.1016/0048-4059(78)90065-6; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vallad GE, 2004, CROP SCI, V44, P1920, DOI 10.2135/cropsci2004.1920; Wang H, 2010, EUR J PLANT PATHOL, V127, P125, DOI 10.1007/s10658-009-9577-1; WARD ER, 1991, PLANT CELL, V3, P1085, DOI 10.1105/tpc.3.10.1085; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Xiao CW, 2008, J NUTR, V138, p1244S, DOI 10.1093/jn/138.6.1244S; Zarate SI, 2007, PLANT PHYSIOL, V143, P866, DOI 10.1104/pp.106.090035; Zeier J, 2004, PLANTA, V219, P673, DOI 10.1007/s00425-004-1272-z	53	8	9	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117712	10.1371/journal.pone.0117712	http://dx.doi.org/10.1371/journal.pone.0117712			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679808	gold, Green Published, Green Submitted			2022-12-26	WOS:000350682600080
J	Kelc, R; Trapecar, M; Gradisnik, L; Rupnik, MS; Vogrin, M				Kelc, Robi; Trapecar, Martin; Gradisnik, Lidija; Rupnik, Marjan Slak; Vogrin, Matjaz			Platelet-Rich Plasma, Especially When Combined with a TGF-beta Inhibitor Promotes Proliferation, Viability and Myogenic Differentiation of Myoblasts In Vitro	PLOS ONE			English	Article							TRANSFORMING-GROWTH-FACTOR; IMPROVE MUSCLE RECOVERY; SKELETAL-MUSCLE; ANTIFIBROTIC AGENT; CELL-PROLIFERATION; MYOSTATIN; DECORIN; DESMIN; EXPRESSION; INJURIES	Regeneration of skeletal muscle after injury is limited by scar formation, slow healing time and a high recurrence rate. A therapy based on platelet-rich plasma (PRP) has become a promising lead for tendon and ligament injuries in recent years, however concerns have been raised that PRP-derived TGF-beta could contribute to fibrotic remodelling in skeletal muscle after injury. Due to the lack of scientific grounds for a PRP -based muscle regeneration therapy, we have designed a study using human myogenic progenitors and evaluated the potential of PRP alone and in combination with decorin (a TGF-beta inhibitor), to alter myoblast proliferation, metabolic activity, cytokine profile and expression of myogenic regulatory factors (MRFs). Advanced imaging multicolor single-cell analysis enabled us to create a valuable picture on the ratio of quiescent, activated and terminally committed myoblasts in treated versus control cell populations. Finally high-resolution confocal microscopy validated the potential of PRP and decorin to stimulate the formation of polynucleated myotubules. PRP was shown to down-regulate fibrotic cytokines, increase cell viability and proliferation, enhance the expression of MRFs, and contribute to a significant myogenic shift during differentiation. When combined with decorin further synergistc effects were identified. These results suggest that PRP could not only prevent fibrosis but could also stimulate muscle commitment, especially when combined with a TGF-beta inhibitor.	[Kelc, Robi; Vogrin, Matjaz] Univ Med Ctr Maribor, Dept Orthopaed Surg, Maribor, Slovenia; [Trapecar, Martin; Gradisnik, Lidija; Rupnik, Marjan Slak] Univ Maribor, Fac Med, Inst Physiol, SLO-2000 Maribor, Slovenia	University of Maribor; University of Maribor	Kelc, R (corresponding author), Univ Med Ctr Maribor, Dept Orthopaed Surg, Maribor, Slovenia.	robi.kelc@gmail.com	Slak Rupnik, Marjan/E-6246-2015; Trapecar, Martin/AAL-5800-2020; Rupnik, Marjan Slak/R-4738-2019	Slak Rupnik, Marjan/0000-0002-3744-4882; Trapecar, Martin/0000-0002-0860-8948; Rupnik, Marjan Slak/0000-0002-3744-4882				ALLEN RE, 1989, J CELL PHYSIOL, V138, P311, DOI 10.1002/jcp.1041380213; Beiner J M, 2001, J Am Acad Orthop Surg, V9, P227; BERGAMINI A, 1992, J VIROL METHODS, V40, P275, DOI 10.1016/0166-0934(92)90086-S; Borrione P, 2012, 32 WORLD C SPORTS ME, P301; Borrione P, 2010, AM J PHYS MED REHAB, V89, P854, DOI 10.1097/PHM.0b013e3181f1c1c7; Cencic J, 2012, CURRENT MED CHEM, P135; Cencic J, 2009, ANN C INT DRUG DISC; Chan YS, 2005, AM J SPORT MED, V33, P43, DOI 10.1177/0363546504265190; Doucet C, 2005, J CELL PHYSIOL, V205, P228, DOI 10.1002/jcp.20391; Fakhfakh R, 2011, MOL THER, V19, P204, DOI 10.1038/mt.2010.171; FILVAROFF EH, 1994, DEVELOPMENT, V120, P1085; Fukushima K, 2001, AM J SPORT MED, V29, P394, DOI 10.1177/03635465010290040201; Furutani Y, 2011, J CELL BIOCHEM, V112, P614, DOI 10.1002/jcb.22953; Hamid MSA, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-138; Hammond JW, 2009, AM J SPORT MED, V37, P1135, DOI 10.1177/0363546508330974; Huard J, 2002, J BONE JOINT SURG AM, V84A, P822, DOI 10.2106/00004623-200205000-00022; Husmann Irene, 1996, Cytokine and Growth Factor Reviews, V7, P249, DOI 10.1016/S1359-6101(96)00029-9; Jarvinen TAH, 2007, BEST PRACT RES CL RH, V21, P317, DOI 10.1016/j.berh.2006.12.004; Kasemkijwattana C, 2000, CLIN ORTHOP RELAT R, P272; Kishioka Y, 2008, J CELL PHYSIOL, V215, P856, DOI 10.1002/jcp.21371; Kollias HD, 2008, J APPL PHYSIOL, V104, P579, DOI 10.1152/japplphysiol.01091.2007; LI H, 1994, J CELL BIOL, V124, P827, DOI 10.1083/jcb.124.5.827; Li HS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064923; Li Y, 2002, AM J PATHOL, V161, P895, DOI 10.1016/S0002-9440(10)64250-2; Li Y, 2004, AM J PATHOL, V164, P1007, DOI 10.1016/S0002-9440(10)63188-4; Li Y, 2007, MOL THER, V15, P1616, DOI 10.1038/sj.mt.6300250; Li ZL, 1997, J CELL BIOL, V139, P129, DOI 10.1083/jcb.139.1.129; Liu YB, 2010, NUCLEIC ACIDS RES, V38, P6857, DOI 10.1093/nar/gkq585; MASSAGUE J, 1986, P NATL ACAD SCI USA, V83, P8206, DOI 10.1073/pnas.83.21.8206; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; Meligy FY, 2012, IN VITRO CELL DEV-AN, V48, P203, DOI 10.1007/s11626-012-9488-x; Menetrey J, 2000, J BONE JOINT SURG BR, V82B, P131, DOI 10.1302/0301-620X.82B1.8954; Miura T, 2006, BIOCHEM BIOPH RES CO, V340, P675, DOI 10.1016/j.bbrc.2005.12.060; OLSON EN, 1986, J CELL BIOL, V103, P1799, DOI 10.1083/jcb.103.5.1799; Peault B, 2007, MOL THER, V15, P867, DOI 10.1038/mt.sj.6300145; Portilho DM, 2012, EUR J PHARMACOL, V694, P1, DOI 10.1016/j.ejphar.2012.07.035; ROBERTS AB, 1985, P NATL ACAD SCI USA, V82, P119, DOI 10.1073/pnas.82.1.119; Sanchez M, 2009, SPORTS MED, V39, P345, DOI 10.2165/00007256-200939050-00002; SAOTOME K, 1989, TOXICOL IN VITRO, V3, P317, DOI 10.1016/0887-2333(89)90039-8; Schallmoser K, 2009, JOVE-J VIS EXP, DOI [10.3791/1656, DOI 10.3791/1656]; Schallmoser K, 2007, TRANSFUSION, V47, P1436, DOI 10.1111/j.1537-2995.2007.01220.x; Shen W, 2008, J CELL PHYSIOL, V214, P405, DOI 10.1002/jcp.21212; Smith C, 2008, SPORTS MED, V38, P947, DOI 10.2165/00007256-200838110-00005; Terada S, 2013, J BONE JOINT SURG AM, V95A, P980, DOI 10.2106/JBJS.L.00266; Tripathi AK, 2011, J MUSCLE RES CELL M, DOI [10.1007/s10974-011-9281-6, DOI 10.1007/S10974-011-9281-6]; UNGEFROREN H, 1995, BIOL REPROD, V52, P1095, DOI 10.1095/biolreprod52.5.1095; Wright-Carpenter T, 2004, INT J SPORTS MED, V25, P588, DOI 10.1055/s-2004-821304; Yamane A, 1998, ARCH ORAL BIOL, V43, P407, DOI 10.1016/S0003-9969(98)00018-1; Zhu J, 2007, J BIOL CHEM, V282, P25852, DOI 10.1074/jbc.M704146200	51	28	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117302	10.1371/journal.pone.0117302	http://dx.doi.org/10.1371/journal.pone.0117302			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679956	Green Published, Green Submitted, gold			2022-12-26	WOS:000350682600060
J	Malin, D; Strekalova, E; Petrovic, V; Rajanala, H; Sharma, B; Ugolkov, A; Gradishar, WJ; Cryns, VL				Malin, D.; Strekalova, E.; Petrovic, V.; Rajanala, H.; Sharma, B.; Ugolkov, A.; Gradishar, W. J.; Cryns, V. L.			ERK-regulated alpha B-crystallin induction by matrix detachment inhibits anoikis and promotes lung metastasis in vivo	ONCOGENE			English	Article							CIRCULATING TUMOR-CELLS; BREAST-CANCER; INDUCED APOPTOSIS; ACTIVATION; RESISTANCE; CARCINOMA; MARKER; EXPRESSION; CASPASE-3; MORPHOGENESIS	Evasion of extracellular matrix detachment-induced apoptosis ('anoikis') is a defining characteristic of metastatic tumor cells. The ability of metastatic carcinoma cells to survive matrix detachment and escape anoikis enables them to disseminate as viable circulating tumor cells and seed distant organs. Here we report that alpha B-crystallin, an antiapoptotic molecular chaperone implicated in the pathogenesis of diverse poor-prognosis solid tumors, is induced by matrix detachment and confers anoikis resistance. Specifically, we demonstrate that matrix detachment downregulates extracellular signal-regulated kinase (ERK) activity and increases alpha B-crystallin protein and messenger RNA (mRNA) levels. Moreover, we show that ERK inhibition in adherent cancer cells mimics matrix detachment by increasing alpha B-crystallin protein and mRNA levels, whereas constitutive ERK activation suppresses alpha B-crystallin induction during matrix detachment. These findings indicate that ERK inhibition is both necessary and sufficient for alpha B-crystallin induction by matrix detachment. To examine the functional consequences of alpha B-crystallin induction in anoikis, we stably silenced alpha B-crystallin in two different metastatic carcinoma cell lines. Strikingly, silencing alpha B-crystallin increased matrix detachment-induced caspase activation and apoptosis but did not affect cell viability of adherent cancer cells. In addition, silencing alpha B-crystallin in metastatic carcinoma cells reduced the number of viable circulating tumor cells and inhibited lung metastasis in two orthotopic models, but had little or no effect on primary tumor growth. Taken together, our findings point to alpha B-crystallin as a novel regulator of anoikis resistance that is induced by matrix detachment-mediated suppression of ERK signaling and promotes lung metastasis. Our results also suggest that alpha B-crystallin represents a promising molecular target for antimetastatic therapies.	[Malin, D.; Strekalova, E.; Petrovic, V.; Rajanala, H.; Sharma, B.; Cryns, V. L.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Carbone Canc Ctr, Madison, WI 53705 USA; [Ugolkov, A.] Northwestern Univ, Ctr Dev Therapeut, Evanston, IL USA; [Gradishar, W. J.] Northwestern Univ, Dept Med, Robert H Lurie Comprehens Canc Ctr, Feinberg Sch Med, Chicago, IL USA	University of Wisconsin System; University of Wisconsin Madison; Northwestern University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center	Cryns, VL (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Carbone Canc Ctr, MFCB 4144,1685 Highland Ave, Madison, WI 53705 USA.	vlcryns@medicine.wisc.edu	Ugolkov, Andrey/T-3012-2019	Rajanala, Sai Harisha/0000-0002-7096-3756; SHARMA, BHAWNA/0000-0002-4570-2335	Susan G. Komen; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER	Susan G. Komen(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are indebted to Dr Janet Price for providing the MDA-MB-435-LvBr1 cell line. We also thank Dr Caroline Alexander and members of the Cryns lab for their critical reading of the manuscript. Breast Cancer Research Foundation (VLC and WJG), Susan G. Komen for the Cure Postdoctoral Fellowship Award (DM and VP) and P30CA014520 University of Wisconsin Comprehensive Cancer Center core facility support.	Arrigo AP, 2014, CANCERS, V6, P333, DOI 10.3390/cancers6010333; Avivar-Valderas A, 2013, ONCOGENE, V32, P4932, DOI 10.1038/onc.2012.512; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Boisvert-Adamo K, 2009, MOL CANCER RES, V7, P549, DOI 10.1158/1541-7786.MCR-08-0358; Brunquell C, 2012, MOL CANCER RES, V10, P1482, DOI 10.1158/1541-7786.MCR-12-0144; Chelouche-Lev D, 2004, CANCER-AM CANCER SOC, V100, P2543, DOI 10.1002/cncr.20304; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; Dimberg A, 2008, BLOOD, V111, P2015, DOI 10.1182/blood-2007-04-087841; Frankel A, 2001, CANCER RES, V61, P4837; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Gorges TM, 2013, CANCER IMMUNOL IMMUN, V62, P931, DOI 10.1007/s00262-012-1387-1; Guadamillas MC, 2011, J CELL SCI, V124, P3189, DOI 10.1242/jcs.072165; Haenssen KK, 2010, J CELL SCI, V123, P1373, DOI 10.1242/jcs.050906; Hou JM, 2012, J CLIN ONCOL, V30, P525, DOI 10.1200/JCO.2010.33.3716; Huang XY, 2013, HEPATOLOGY, V57, P2235, DOI 10.1002/hep.26255; Ivanov O, 2008, BREAST CANCER RES TR, V111, P411, DOI 10.1007/s10549-007-9796-0; Kamradt MC, 2005, J BIOL CHEM, V280, P11059, DOI 10.1074/jbc.M413382200; Kamradt MC, 2001, J BIOL CHEM, V276, P16059, DOI 10.1074/jbc.C100107200; Kase S, 2010, BLOOD, V115, P3398, DOI 10.1182/blood-2009-01-197095; Kim HS, 2011, J BREAST CANCER, V14, P14, DOI 10.4048/jbc.2011.14.1.14; Laguinge LM, 2008, CANCER RES, V68, P909, DOI 10.1158/0008-5472.CAN-06-1806; Malin D, 2014, CLIN CANCER RES, V20, DOI 10.1158/1078-0432.CCR-13-1255; Malin D, 2011, CLIN CANCER RES, V17, P5005, DOI 10.1158/1078-0432.CCR-11-0099; Mao Y, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-101; Mao YW, 2004, CELL DEATH DIFFER, V11, P512, DOI 10.1038/sj.cdd.4401384; Marconi A, 2004, J CELL SCI, V117, P5815, DOI 10.1242/jcs.01490; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Mehlen P, 1996, EMBO J, V15, P2695, DOI 10.1002/j.1460-2075.1996.tb00630.x; Moyano JV, 2006, J CLIN INVEST, V116, P261, DOI 10.1172/JCI25888; Nam DH, 2008, CLIN CANCER RES, V14, P4059, DOI 10.1158/1078-0432.CCR-07-4039; PINDER SE, 1994, J PATHOL, V174, P209, DOI 10.1002/path.1711740310; Puthalakath H, 2001, SCIENCE, V293, P1829, DOI 10.1126/science.1062257; Reginato MJ, 2003, NAT CELL BIOL, V5, P733, DOI 10.1038/ncb1026; Rytomaa M, 1999, CURR BIOL, V9, P1043, DOI 10.1016/S0960-9822(99)80454-0; Schmelzle T, 2007, P NATL ACAD SCI USA, V104, P3787, DOI 10.1073/pnas.0700115104; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Sitterding SM, 2008, ANN DIAGN PATHOL, V12, P33, DOI 10.1016/j.anndiagpath.2007.02.004; Stegh AH, 2008, P NATL ACAD SCI USA, V105, P10703, DOI 10.1073/pnas.0712034105; Valentijn AJ, 2003, J CELL BIOL, V162, P599, DOI 10.1083/jcb.200302154; Windham TC, 2002, ONCOGENE, V21, P7797, DOI 10.1038/sj.onc.1205989	40	21	22	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 5	2015	34	45					5626	5634		10.1038/onc.2015.12	http://dx.doi.org/10.1038/onc.2015.12			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CV9GA	25684139	Green Accepted			2022-12-26	WOS:000364594300004
J	Liu, YF; Yang, AJ; Liu, W; Wang, CY; Wang, M; Zhang, LH; Wang, DC; Dong, JF; Li, M				Liu, Yan-fei; Yang, Aijun; Liu, Wei; Wang, Chenyu; Wang, Min; Zhang, Lihan; Wang, Dongcang; Dong, Jing-fei; Li, Min			NME2 Reduces Proliferation, Migration and Invasion of Gastric Cancer Cells to Limit Metastasis	PLOS ONE			English	Article							DIPHOSPHATE KINASE; MESSENGER-RNA; INVERSE CORRELATION; SUPPRESSOR NM23-H2; N-MYC; EXPRESSION; GENE; LINE; OVEREXPRESSION; CARCINOMA	Gastric cancer is one of the most common malignancies and has a high rate of metastasis. We hypothesize that NME2 (Nucleoside Diphosphate Kinase 2), which has previously been considered as an anti-metastatic gene, plays a role in the invasiveness of gastric cancer cells. Using a tissue chip technology and immunohistochemistry, we demonstrated that NME2 expression was associated with levels of differentiation of gastric cancer cells and their metastasis into the lymph nodes. When the NME2 gene product was over-expressed by; in vitro stable transfection, cells from BGC823 and MKN45 gastric cancer cell lines had reduced rates of proliferation, migration, and invasion through the collagen matrix, suggesting an inhibitory activity of NME2 in the propagation and invasion of gastric cancer. NME2 could, therefore, severe as a risk marker for gastric cancer invasiveness and a potential new target for gene therapy to enhance or induce NME2 expression.	[Liu, Yan-fei; Yang, Aijun; Liu, Wei; Wang, Chenyu; Wang, Min; Zhang, Lihan; Wang, Dongcang; Li, Min] Lanzhou Univ, Sch Basic Med Sci, Inst Pathol, Lanzhou 730000, Peoples R China; [Liu, Yan-fei] Xian Childrens Hosp, Dept Pathol, Xian, Peoples R China; [Dong, Jing-fei] Puget Sound Blood Ctr, Seattle, WA 98104 USA; [Dong, Jing-fei] Univ Washington, Sch Med, Dept Med, Div Hematol, Seattle, WA 98195 USA; [Li, Min] Lanzhou Univ, Key Lab Preclin Study New Drugs Gansu Prov, Lanzhou 730000, Peoples R China	Lanzhou University; Puget Sound Blood Center; University of Washington; University of Washington Seattle; Lanzhou University	Li, M (corresponding author), Lanzhou Univ, Sch Basic Med Sci, Inst Pathol, Lanzhou 730000, Peoples R China.	limin@lzu.edu.cn	min, Li/GQQ-2169-2022		program supports for Chang-Jiang Scholars and Innovative Research Team in University [PCSIRT:IRT1137]; Basic Research Funds for the Central Universities [lzujbky-2013-ct06]	program supports for Chang-Jiang Scholars and Innovative Research Team in University; Basic Research Funds for the Central Universities	This study was supported by the program supports for Chang-Jiang Scholars and Innovative Research Team in University (PCSIRT:IRT1137) and the Basic Research Funds for the Central Universities (lzujbky-2013-ct06). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Aihara M, 1997, INFECT IMMUN, V65, P3218, DOI 10.1128/IAI.65.8.3218-3224.1997; Aktary Z, 2010, ONCOGENE, V29, P2118, DOI 10.1038/onc.2009.495; ARAI T, 1993, AM J PATHOL, V142, P1938; BABA H, 1995, CANCER RES, V55, P1977; Boissan M, 2009, MOL CELL BIOCHEM, V329, P51, DOI 10.1007/s11010-009-0120-7; Chen DQ, 2013, INT J ONCOL, V42, P1763, DOI 10.3892/ijo.2013.1872; FLORENES VA, 1992, CANCER RES, V52, P6088; Fukuda M, 1996, INT J CANCER, V65, P531, DOI 10.1002/(SICI)1097-0215(19960208)65:4<531::AID-IJC23>3.0.CO;2-B; Godfried MB, 2002, ONCOGENE, V21, P2097, DOI 10.1038/sj.onc.1205259; HENNESSY C, 1991, J NATL CANCER I, V83, P281, DOI 10.1093/jnci/83.4.281; Huang B, 2013, ONCOLOGY REPORTS; IIZUKA N, 1995, CANCER RES, V55, P652; Kar A, 2012, NUCLEIC ACIDS RES, V40, P2554, DOI 10.1093/nar/gkr1109; Lee MJ, 2012, EXP MOL MED, V44, P214, DOI 10.3858/emm.2012.44.3.016; LEONE A, 1991, CELL, V65, P25, DOI 10.1016/0092-8674(91)90404-M; LEONE A, 1993, ONCOGENE, V8, P2325; LEONE A, 1993, ONCOGENE, V8, P855; MANDAI M, 1994, CANCER RES, V54, P1825; Marone M, 1996, BRIT J CANCER, V74, P1063, DOI 10.1038/bjc.1996.490; MARTINEZ JA, 1995, GUT, V37, P712, DOI 10.1136/gut.37.5.712; Miyazaki H, 1999, CLIN CANCER RES, V5, P4301; Oda Y, 2000, HUM PATHOL, V31, P709, DOI 10.1053/hupa.2000.8230; PARHAR RS, 1995, INT J CANCER, V60, P204; Polanski R, 2011, CARCINOGENESIS, V32, P1133, DOI 10.1093/carcin/bgr070; Rajan N, 2006, NAT PROTOC, V1, P2753, DOI 10.1038/nprot.2006.430; Saitoh T, 2001, INT J ONCOL, V19, P1187; STAHL JA, 1991, CANCER RES, V51, P445; STEEG PS, 1988, J NATL CANCER I, V80, P200, DOI 10.1093/jnci/80.3.200; Syed V, 2005, ONCOGENE, V24, P1774, DOI 10.1038/sj.onc.1207991; Tagashira H, 1998, INT J MOL MED, V2, P65; Thakur RK, 2011, N-S ARCH PHARMACOL, V384, P397, DOI 10.1007/s00210-011-0631-0; Thakur RK, 2009, NUCLEIC ACIDS RES, V37, P172, DOI 10.1093/nar/gkn919; Valentijn LJ, 2005, CANCER RES, V65, P3136, DOI 10.1158/0008-5472.CAN-04-2469; WATANABE J, 1995, BRIT J CANCER, V72, P1469, DOI 10.1038/bjc.1995.531	34	22	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0115968	10.1371/journal.pone.0115968	http://dx.doi.org/10.1371/journal.pone.0115968			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25700270	gold, Green Submitted, Green Published			2022-12-26	WOS:000349789800005
J	Zhang, W; Wang, LM; Zhou, P; Song, GC; Shen, M; Gan, SQ; Shi, GQ				Zhang, Wei; Wang, Limin; Zhou, Ping; Song, Guangchao; Shen, Min; Gan, Shangquan; Shi, Guoqing			Identification and Analysis of Genetic Variations in Pri-MiRNAs Expressed Specifically or at a High Level in Sheep Skeletal Muscle	PLOS ONE			English	Article							CANCER RISK; MICRORNA; BINDING; SNPS; PROLIFERATION; POLYMORPHISMS; ASSOCIATION; BIOGENESIS; SURVIVAL; TARGETS	MicroRNAs (miRNAs) are key regulators in miRNA-mediated gene regulatory networks and play important roles in many biological processes, such as growth and development of mammals. In this study, we used microarrays to detect 261 miRNAs that are expressed in sheep skeletal muscle. We found 22 miRNAs that showed high levels of expression and equated to 89% of the total miRNA. Genetic variations in these 22 pri-miRNAs were further investigated using polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP) and sequencing. A total of 49 genetic variations, which included 41 single nucleotide polymorphisms (SNPs) and 8 deletions/insertions, were identified in four sheep breeds. Three variations were further researched in a larger sample set, including five sheep breeds with different meat production performances. We found that the genotype and allele frequencies of the CCC deletion/insertion in pri-miR-133a were significantly related to the sheep meat production trait. Finally, cell assays and quantitative reverse transcription PCR (qRT-PCR) were employed to investigate the effect of pri-miRNA genetic variation on the miRNA biogenesis process. The results confirmed that genetic variations can influence miRNA biogenesis and increase or decrease the levels of mature miRNAs, in accordance with the energy and stability change of hair-pin secondary structures. Our findings will help to further the understanding of the functions of genetic variations in sheep pri-miRNAs in skeletal muscle growth and development.	[Zhang, Wei; Song, Guangchao; Shi, Guoqing] Shihezi Univ, Coll Anim Sci & Technol, Shihezi 832003, Peoples R China; [Zhang, Wei; Wang, Limin; Zhou, Ping; Song, Guangchao; Shen, Min; Gan, Shangquan; Shi, Guoqing] Xinjiang Acad Agr & Reclamat Sci, Inst Anim Husb & Vet Med, Shihezi 832000, Peoples R China	Shihezi University	Gan, SQ (corresponding author), Xinjiang Acad Agr & Reclamat Sci, Inst Anim Husb & Vet Med, Shihezi 832000, Peoples R China.	shangquangan@163.com; nkkxyxms@163.com		Gan, Shangquan/0000-0003-2880-7677	Natural Science Foundation of China [31160452]; National Basic Research Program of China (973 Program) [2012CB723002]; Guide Plan of Xinjiang Academy of Agricultural and Reclamation Sciences [YYD2010-9]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Guide Plan of Xinjiang Academy of Agricultural and Reclamation Sciences	This work was supported by the Natural Science Foundation of China (31160452), and grants from the National Basic Research Program of China (973 Program, 2012CB723002) and the Guide Plan of Xinjiang Academy of Agricultural and Reclamation Sciences (YYD2010-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Anderson C, 2006, NUCLEIC ACIDS RES, V34, P5863, DOI 10.1093/nar/gkl743; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bensen JT, 2013, CANCER CAUSE CONTROL, V24, P1099, DOI 10.1007/s10552-013-0187-z; Bizuayehu TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061378; Chekulaeva M, 2009, CURR OPIN CELL BIOL, V21, P452, DOI 10.1016/j.ceb.2009.04.009; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Dikeakos P, 2014, MOL BIOL REP, V41, P1075, DOI 10.1007/s11033-013-2953-0; Ebhardt HA, 2009, NUCLEIC ACIDS RES, V37, P2461, DOI 10.1093/nar/gkp093; Ehrenreich IM, 2008, PLANT PHYSIOL, V146, P1974, DOI 10.1104/pp.108.116582; Gong J, 2012, HUM MUTAT, V33, P254, DOI 10.1002/humu.21641; Hobert O, 2007, CELL, V131, P22, DOI 10.1016/j.cell.2007.09.031; Hong JS, 2012, GENE, V506, P211, DOI 10.1016/j.gene.2012.06.050; Huang TH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003225; Kim MC, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0093662, 10.1371/journal.pone.0101486]; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lee JS, 2013, ANIM GENET, V44, P101, DOI 10.1111/j.1365-2052.2012.02362.x; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu QP, 2013, RICE, V6, DOI 10.1186/1939-8433-6-10; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; McDaneld TG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042039; McDaneld TG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-77; Muroya S, 2013, J ANIM SCI, V91, P90, DOI 10.2527/jas.2012-5371; Piskounova E, 2008, J BIOL CHEM, V283, P21310, DOI 10.1074/jbc.C800108200; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Schmittgen TD, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh040; Sharbati-Tehrani S, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-34; Silvia M, 2013, BMC GENOMICS, V14, P1, DOI DOI 10.1186/1471-2164-14-1; Solda G, 2012, HUM MOL GENET, V21, P577, DOI 10.1093/hmg/ddr493; Sun GH, 2009, RNA, V15, P1640, DOI 10.1261/rna.1560209; Sun GL, 2012, PLANT MOL BIOL, V80, P17, DOI 10.1007/s11103-011-9817-6; Torella D, 2011, CIRC RES, V109, P880, DOI 10.1161/CIRCRESAHA.111.240150; Wei W, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.184; Yin H, 2013, CELL METAB, V17, P210, DOI 10.1016/j.cmet.2013.01.004; Zeng Y, 2005, J BIOL CHEM, V280, P27595, DOI 10.1074/jbc.M504714200	39	6	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0117327	10.1371/journal.pone.0117327	http://dx.doi.org/10.1371/journal.pone.0117327			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25699993	Green Submitted, Green Published, gold			2022-12-26	WOS:000349789800020
J	Bozic, I; Savic, D; Laketa, D; Bjelobaba, I; Milenkovic, I; Pekovic, S; Nedeljkovic, N; Lavrnja, I				Bozic, Iva; Savic, Danijela; Laketa, Danijela; Bjelobaba, Ivana; Milenkovic, Ivan; Pekovic, Sanja; Nedeljkovic, Nadezda; Lavrnja, Irena			Benfotiamine Attenuates Inflammatory Response in LPS Stimulated BV-2 Microglia	PLOS ONE			English	Article							NF-KAPPA-B; SIGNALING PATHWAYS; EXTRACELLULAR ATP; TERMINAL KINASES; DOWN-REGULATION; NITRIC-OXIDE; CELLS; ACTIVATION; THIAMINE; EXPRESSION	Microglial cells are resident immune cells of the central nervous system (CNS), recognized as key elements in the regulation of neural homeostasis and the response to injury and repair. As excessive activation of microglia may lead to neurodegeneration, therapeutic strategies targeting its inhibition were shown to improve treatment of most neurodegenerative diseases. Benfotiamine is a synthetic vitamin B1 (thiamine) derivate exerting potentially anti-inflammatory effects. Despite the encouraging results regarding benfotiamine potential to alleviate diabetic microangiopathy, neuropathy and other oxidative stress-induced pathological conditions, its activities and cellular mechanisms during microglial activation have yet to be elucidated. In the present study, the anti-inflammatory effects of benfotiamine were investigated in lipopolysaccharide (LPS)-stimulated murine BV-2 microglia. We determined that benfotiamine remodels activated microglia to acquire the shape that is characteristic of non-stimulated BV-2 cells. In addition, benfotiamine significantly decreased production of pro-inflammatory mediators such as inducible form of nitric oxide synthase (iNOS) and NO; cyclooxygenase-2 (COX-2), heat-shock protein 70 (Hsp70), tumor necrosis factor alpha a (TNF-alpha), interleukin-6 (IL-6), whereas it increased anti-inflammatory interleukin-10 (IL-10) production in LPS stimulated BV-2 microglia. Moreover, benfotiamine suppressed the phosphorylation of extracellular signal-regulated kinases 1/2 (ERK1/2), c-Jun N-terminal kinases (JNK) and protein kinase B Akt/PKB. Treatment with specific inhibitors revealed that benfotiamine-mediated suppression of NO production was via JNK1/2 and Akt pathway, while the cytokine suppression includes ERK1/2, JNK1/2 and Akt pathways. Finally, the potentially protective effect is mediated by the suppression of translocation of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappa B) in the nucleus. Therefore, benfotiamine may have therapeutic potential for neurodegenerative diseases by inhibiting inflammatory mediators and enhancing anti-inflammatory factor production in activated microglia.	[Bozic, Iva; Savic, Danijela; Bjelobaba, Ivana; Pekovic, Sanja; Lavrnja, Irena] Univ Belgrade, Inst Biol Res Sinisa Stankovic, Dept Neurobiol, Belgrade, Serbia; [Laketa, Danijela; Nedeljkovic, Nadezda] Univ Belgrade, Fac Biol, Inst Physiol & Biochem, Belgrade, Serbia; [Milenkovic, Ivan] Univ Leipzig, Fac Med, Carl Ludwig Inst Physiol, Leipzig, Germany	University of Belgrade; University of Belgrade; Leipzig University	Lavrnja, I (corresponding author), Univ Belgrade, Inst Biol Res Sinisa Stankovic, Dept Neurobiol, Belgrade, Serbia.	irenam@ibiss.bg.ac.rs	Lavrnja, Irena/ABA-1558-2020; Bjelobaba, Ivana/ABA-1538-2020; Savic, Danijela/I-7471-2019	Lavrnja, Irena/0000-0002-0607-5594; Bjelobaba, Ivana/0000-0002-7649-0304; Savic, Danijela/0000-0001-7411-4527; Bozic, Iva/0000-0002-8550-0359; Nedeljkovic, Nadezda/0000-0003-3046-0983	Ministry of Education, Science and Technological Development of the Republic of Serbia [III 41014]	Ministry of Education, Science and Technological Development of the Republic of Serbia	This work was supported by Ministry of Education, Science and Technological Development of the Republic of Serbia Grant III 41014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-El-Basset E, 2000, MED PRIN PRACT, V9, P81, DOI 10.1159/000026123; Abd-El-Basset EM, 2004, MED PRIN PRACT, V13, P325, DOI 10.1159/000080469; Ba A, 2008, CELL MOL NEUROBIOL, V28, P923, DOI 10.1007/s10571-008-9297-7; Bajic A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076383; Balakumar P, 2010, PHARMACOL RES, V61, P482, DOI 10.1016/j.phrs.2010.02.008; BECKER JT, 1990, NEUROPSYCHOLOGIA, V28, P171, DOI 10.1016/0028-3932(90)90099-A; Berrone E, 2006, J BIOL CHEM, V281, P9307, DOI 10.1074/jbc.M600418200; BITSCH R, 1991, ANN NUTR METAB, V35, P292, DOI 10.1159/000177659; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bordt EA, 2014, FREE RADICAL BIO MED, V76, P34, DOI 10.1016/j.freeradbiomed.2014.07.033; Ceylan-Isik AF, 2006, J APPL PHYSIOL, V100, P150, DOI 10.1152/japplphysiol.00988.2005; Eggen BJL, 2013, J NEUROIMMUNE PHARM, V8, P807, DOI 10.1007/s11481-013-9490-4; ENOMOTO KI, 1985, BRAIN RES, V358, P316, DOI 10.1016/0006-8993(85)90976-X; Fiebich BL, 2002, J NEUROIMMUNOL, V132, P18, DOI 10.1016/S0165-5728(02)00279-5; FUJIWARA M, 1964, J VITAMINOL, V10, P79, DOI 10.5925/jnsv1954.10.79; FUJIWARA M, 1954, J BIOCHEM-TOKYO, V41, P273, DOI 10.1093/oxfordjournals.jbchem.a126438; Gertig U, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00101; Giri S, 2004, J IMMUNOL, V173, P5196, DOI 10.4049/jimmunol.173.8.5196; Graeber MB, 2010, ACTA NEUROPATHOL, V119, P89, DOI 10.1007/s00401-009-0622-0; Gunzl P, 2010, J LEUKOCYTE BIOL, V88, P1259, DOI 10.1189/jlb.0110001; Hammes HP, 2003, NAT MED, V9, P294, DOI 10.1038/nm834; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hanisch UK, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00065; Hehlgans T, 2005, IMMUNOLOGY, V115, P1, DOI 10.1111/j.1365-2567.2005.02143.x; Honda S, 2001, J NEUROSCI, V21, P1975, DOI 10.1523/JNEUROSCI.21-06-01975.2001; Horvath RJ, 2008, J NEUROCHEM, V107, P557, DOI 10.1111/j.1471-4159.2008.05633.x; Huang WC, 2009, IMMUNOLOGY, V128, pe275, DOI 10.1111/j.1365-2567.2008.02959.x; Jhala SS, 2011, NEUROCHEM INT, V58, P248, DOI 10.1016/j.neuint.2010.11.019; Ji Z, 2014, J IMMUNOL, V193, P2157, DOI 10.4049/jimmunol.1302702; Kacimi R, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-7; Kaminska B, 2009, ANAT REC, V292, P1902, DOI 10.1002/ar.21047; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kim YH, 2010, INT IMMUNOPHARMACOL, V10, P1560, DOI 10.1016/j.intimp.2010.09.007; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Lee JY, 2006, NEUROSCI LETT, V396, P1, DOI 10.1016/j.neulet.2005.11.004; Luo XG, 2012, TRANSL NEURODEGENER, V1, DOI 10.1186/2047-9158-1-9; Manzardo AM, 2013, DRUG ALCOHOL DEPEN, V133, P562, DOI 10.1016/j.drugalcdep.2013.07.035; McCarty MF, 2006, MED HYPOTHESES, V67, P251, DOI 10.1016/j.mehy.2006.01.013; Minghetti L, 2004, J NEUROPATH EXP NEUR, V63, P901, DOI 10.1093/jnen/63.9.901; Murphy S, 2000, GLIA, V29, P1, DOI 10.1002/(SICI)1098-1136(20000101)29:1<1::AID-GLIA1>3.0.CO;2-N; Nakamichi K, 2007, NEUROSCI LETT, V414, P222, DOI 10.1016/j.neulet.2006.12.058; Nam KN, 2008, NEUROPHARMACOLOGY, V55, P819, DOI 10.1016/j.neuropharm.2008.06.065; Ohsawa K, 2012, J NEUROCHEM, V121, P217, DOI 10.1111/j.1471-4159.2012.07693.x; Pacal L, 2014, WORLD J DIABETES, V5, P288, DOI 10.4239/wjd.v5.i3.288; Pan XL, 2010, BRAIN, V133, P1342, DOI 10.1093/brain/awq069; Park KM, 2010, CELL SIGNAL, V22, P977, DOI 10.1016/j.cellsig.2010.01.010; Patterson H, 2014, CLIN EXP IMMUNOL, V176, P1, DOI 10.1111/cei.12248; Pautz A, 2010, NITRIC OXIDE-BIOL CH, V23, P75, DOI 10.1016/j.niox.2010.04.007; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Prinz M, 2011, GLIA, V59, P177, DOI 10.1002/glia.21104; Saponaro C, 2012, IMMUNOPHARM IMMUNOT, V34, P858, DOI 10.3109/08923973.2012.665461; Savic D, 2014, IMMUNOPHARM IMMUNOT, V36, P433, DOI 10.3109/08923973.2014.971962; Sawada M, 1999, J NEUROCHEM, V72, P1466, DOI 10.1046/j.1471-4159.1999.721466.x; Seo DR, 2004, NEUROREPORT, V15, P1157, DOI 10.1097/00001756-200405190-00015; Shafer LL, 2002, NEUROIMMUNOMODULAT, V10, P295, DOI 10.1159/000069973; Shoeb M, 2012, FREE RADICAL BIO MED, V52, P182, DOI 10.1016/j.freeradbiomed.2011.10.444; Smith JA, 2012, BRAIN RES BULL, V87, P10, DOI 10.1016/j.brainresbull.2011.10.004; Sun XJ, 2012, NEUROSCI BULL, V28, P561, DOI 10.1007/s12264-012-1264-0; Svensson C, 2010, BRAIN RES, V1322, P1, DOI 10.1016/j.brainres.2010.01.082; Volvert Marie-Laure, 2008, BMC Pharmacology, V8, P10, DOI 10.1186/1471-2210-8-10; Waetzig V, 2005, GLIA, V50, P235, DOI 10.1002/glia.20173; Waetzig V, 2004, NEUROSCI LETT, V361, P64, DOI 10.1016/j.neulet.2004.02.041; Wang DM, 2010, BIOCHEM BIOPH RES CO, V402, P123, DOI 10.1016/j.bbrc.2010.09.128; Watters JJ, 2002, J BIOL CHEM, V277, P9077, DOI 10.1074/jbc.M104385200; Wen J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-38; Woelk H, 1998, ALCOHOL ALCOHOLISM, V33, P631, DOI 10.1093/alcalc/33.6.631; Wu S, 2006, NEUROSCI LETT, V394, P158, DOI 10.1016/j.neulet.2005.10.022; Yadav UCS, 2010, FREE RADICAL BIO MED, V48, P1423, DOI 10.1016/j.freeradbiomed.2010.02.031; Yadav UCS, 2009, INVEST OPHTH VIS SCI, V50, P2276, DOI 10.1167/iovs.08-2816; Zhao H, 2014, J MOL NEUROSCI, V52, P186, DOI 10.1007/s12031-013-0120-7	72	62	64	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0118372	10.1371/journal.pone.0118372	http://dx.doi.org/10.1371/journal.pone.0118372			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695433	gold, Green Published, Green Submitted			2022-12-26	WOS:000350062300050
J	NDong, C; Tate, JA; Kett, WC; Batra, J; Demidenko, E; Lewis, LD; Hoopes, PJ; Gerngross, TU; Griswold, KE				NDong, Christian; Tate, Jennifer A.; Kett, Warren C.; Batra, Jaya; Demidenko, Eugene; Lewis, Lionel D.; Hoopes, P. Jack; Gerngross, Tillman U.; Griswold, Karl E.			Tumor Cell Targeting by Iron Oxide Nanoparticles Is Dominated by Different Factors In Vitro versus In Vivo	PLOS ONE			English	Article							MAGNETIC FLUID HYPERTHERMIA; BREAST-CANCER; SUPERPARAMAGNETIC NANOPARTICLES; MULTIFUNCTIONAL NANOPARTICLES; BIOMEDICAL APPLICATIONS; ANTIBODY; DELIVERY; THERAPY; MRI; EFFICIENCY	Realizing the full potential of iron oxide nanoparticles (IONP) for cancer diagnosis and therapy requires selective tumor cell accumulation. Here, we report a systematic analysis of two key determinants for IONP homing to human breast cancers: (i) particle size and (ii) active vs passive targeting. In vitro, molecular targeting to the HER2 receptor was the dominant factor driving cancer cell association. In contrast, size was found to be the key determinant of tumor accumulation in vivo, where molecular targeting increased tumor tissue concentrations for 30 nm but not 100 nm IONP. Similar to the in vitro results, PEGylation did not influence in vivo IONP biodistribution. Thus, the results reported here indicate that the in vitro advantages of molecular targeting may not consistently extend to pre-clinical in vivo settings. These observations may have important implications for the design and clinical translation of advanced, multifunctional, IONP platforms.	[NDong, Christian; Tate, Jennifer A.; Kett, Warren C.; Batra, Jaya; Gerngross, Tillman U.; Griswold, Karl E.] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA; [Demidenko, Eugene; Lewis, Lionel D.; Hoopes, P. Jack] Geisel Sch Med Dartmouth, Dept Biostat & Med, Lebanon, NH USA; [Griswold, Karl E.] Program Mol & Cellular Biol, Hanover, NH USA; [Gerngross, Tillman U.; Griswold, Karl E.] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; [Gerngross, Tillman U.] Dartmouth Coll, Dept Chem, Hanover, NH 03755 USA	Dartmouth College; Dartmouth College; Dartmouth College; Dartmouth College	Griswold, KE (corresponding author), Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA.	karl.e.griswold@dartmouth.edu			NCI [1U54CA151662-01]; NATIONAL CANCER INSTITUTE [P30CA023108, U54CA151662] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NCI grant number 1U54CA151662-01.	Bergey EJ, 2002, BIOMED MICRODEVICES, V4, P293, DOI 10.1023/A:1020906307053; Chen HW, 2013, INT J NANOMED, V8, P3781, DOI 10.2147/IJN.S49069; Chen TJ, 2009, J BIOL INORG CHEM, V14, P253, DOI 10.1007/s00775-008-0445-9; Chithrani BD, 2007, NANO LETT, V7, P1542, DOI 10.1021/nl070363y; Chouly C, 1996, J MICROENCAPSUL, V13, P245, DOI 10.3109/02652049609026013; Corsi F, 2011, ACS NANO, V5, P6383, DOI 10.1021/nn201570n; DeNardo SJ, 2007, J NUCL MED, V48, P437; DeNardo SJ, 2005, CLIN CANCER RES, V11, p7087S, DOI 10.1158/1078-0432.CCR-1004-0022; Douziech-Eyrolles L, 2007, INT J NANOMED, V2, P541; Fiandra L, 2013, ACS NANO, V7, P6092, DOI 10.1021/nn4018922; GILCHRIST RK, 1957, ANN SURG, V146, P596, DOI 10.1097/00000658-195710000-00007; Giustini AJ, 2010, NANO LIFE, V1, P17, DOI 10.1142/S1793984410000067; Gong XW, 2007, TALANTA, V71, P381, DOI 10.1016/j.talanta.2006.04.010; Hadjipanayis CG, 2010, CANCER RES, V70, P6303, DOI 10.1158/0008-5472.CAN-10-1022; Hilger I, 2002, INVEST RADIOL, V37, P580, DOI 10.1097/00004424-200210000-00008; Hilger I, 2006, J PHYS-CONDENS MAT, V18, pS2951, DOI 10.1088/0953-8984/18/38/S28; Hilger I, 2012, NANOMEDICINE-UK, V7, P1443, DOI 10.2217/NNM.12.112; Ito A, 2004, CANCER LETT, V212, P167, DOI 10.1016/j.canlet.2004.03.038; Jain TK, 2008, MOL PHARMACEUT, V5, P316, DOI 10.1021/mp7001285; Johannsen M, 2005, PROSTATE, V64, P283, DOI 10.1002/pros.20213; Jones SK, 2002, INT J HYPERTHER, V18, P117, DOI 10.1080/02656730110103519; Jordan A, 1999, J MAGN MAGN MATER, V201, P413, DOI 10.1016/S0304-8853(99)00088-8; Kievit FM, 2011, ACCOUNTS CHEM RES, V44, P853, DOI 10.1021/ar2000277; Kievit FM, 2012, ACS NANO, V6, P2591, DOI 10.1021/nn205070h; Kikumori T, 2009, BREAST CANCER RES TR, V113, P435, DOI 10.1007/s10549-008-9948-x; Liu DF, 2011, ADV FUNCT MATER, V21, P1498, DOI 10.1002/adfm.201001658; Lu RM, 2011, BIOMATERIALS, V32, P3265, DOI 10.1016/j.biomaterials.2010.12.061; Minamimura T, 2000, INT J ONCOL, V16, P1153; Modi S, 2006, CURR PHARM DESIGN, V12, P4785, DOI 10.2174/138161206779026272; Moroz P, 2002, INT J HYPERTHER, V18, P267, DOI 10.1080/02656730110108785; Na HB, 2009, ADV MATER, V21, P2133, DOI 10.1002/adma.200802366; Neuberger T, 2005, J MAGN MAGN MATER, V293, P483, DOI 10.1016/j.jmmm.2005.01.064; Nimmerjahn F, 2007, CURR OPIN IMMUNOL, V19, P239, DOI 10.1016/j.coi.2007.01.005; Perrault SD, 2009, NANO LETT, V9, P1909, DOI 10.1021/nl900031y; Prasad NK, 2007, J MATER CHEM, V17, P5042, DOI 10.1039/b708156a; Ramchand CN, 2001, INDIAN J PURE AP PHY, V39, P683; Roger J, 1999, EUR PHYS J-APPL PHYS, V5, P321, DOI 10.1051/epjap:1999144; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Rosen JE, 2012, NANOMED-NANOTECHNOL, V8, P275, DOI 10.1016/j.nano.2011.08.017; Shang L, 2014, J NANOBIOTECHNOL, V12, DOI 10.1186/1477-3155-12-5; Sun C, 2008, ADV DRUG DELIVER REV, V60, P1252, DOI 10.1016/j.addr.2008.03.018; Toraya-Brown S, 2013, INTEGR BIOL-UK, V5, P159, DOI 10.1039/c2ib20180a; van der Zee J, 2002, ANN ONCOL, V13, P1173, DOI 10.1093/annonc/mdf280; Varanda LC, 2008, IEEE T MAGN, V44, P4448, DOI 10.1109/TMAG.2008.2002250; Villanueva A, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/11/115103; Wahajuddin, 2012, INT J NANOMED, V7, P3445, DOI 10.2147/IJN.S30320; Yan SY, 2005, J NANOSCI NANOTECHNO, V5, P1185, DOI 10.1166/jnn.2005.219; Yang LL, 2009, SMALL, V5, P235, DOI 10.1002/smll.200800714; Yu MK, 2012, THERANOSTICS, V2, P3, DOI 10.7150/thno.3463; Zhang JP, 2011, INT J HYPERTHER, V27, P682, DOI 10.3109/02656736.2011.609863	50	39	40	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0115636	10.1371/journal.pone.0115636	http://dx.doi.org/10.1371/journal.pone.0115636			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695795	Green Published, Green Submitted, gold			2022-12-26	WOS:000350062300008
J	Hu, YM; Liu, A; Vaudrey, J; Vaiciunaite, B; Moigboi, C; McTavish, SM; Kearns, A; Coates, A				Hu, Yanmin; Liu, Alexander; Vaudrey, James; Vaiciunaite, Brigita; Moigboi, Christiana; McTavish, Sharla M.; Kearns, Angela; Coates, Anthony			Combinations of beta-Lactam or Aminoglycoside Antibiotics with Plectasin Are Synergistic against Methicillin-Sensitive and Methicillin-Resistant Staphylococcus aureus	PLOS ONE			English	Article							ACINETOBACTER-BAUMANNII; BACTERICIDAL ACTIVITY; INFECTIOUS-DISEASES; STATIONARY-PHASE; POLYMYXIN-B; GENTAMICIN; NZ2114; VANCOMYCIN; DAPTOMYCIN; MEMBRANE	Bacterial infections remain the leading killer worldwide which is worsened by the continuous emergence of antibiotic resistance. In particular, methicillin-sensitive (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA) are prevalent and the latter can be difficult to treat. The traditional strategy of novel therapeutic drug development inevitably leads to emergence of resistant strains, rendering the new drugs ineffective. Therefore, rejuvenating the therapeutic potentials of existing antibiotics offers an attractive novel strategy. Plectasin, a defensin antimicrobial peptide, potentiates the activities of other antibiotics such as beta-lactams, aminoglycosides and glycopeptides against MSSA and MRSA. We performed in vitro and in vivo investigations to test against genetically diverse clinical isolates of MSSA (n = 101) and MRSA (n = 115). Minimum inhibitory concentrations (MIC) were determined by the broth microdilution method. The effects of combining plectasin with beta-lactams, aminoglycosides and glycopeptides were examined using the chequerboard method and time kill curves. A murine neutropenic thigh model and a murine peritoneal infection model were used to test the effect of combination in vivo. Determined by factional inhibitory concentration index (FICI), plectasin in combination with aminoglycosides (gentamicin, neomycin or amikacin) displayed synergistic effects in 76-78% of MSSA and MRSA. A similar synergistic response was observed when plectasin was combined with beta-lactams (penicillin, amoxicillin or flucloxacillin) in 87-89% of MSSA and MRSA. Interestingly, no such interaction was observed when plectasin was paired with vancomycin. Time kill analysis also demonstrated significant synergistic activities when plectasin was combined with amoxicillin, gentamicin or neomycin. In the murine models, plectasin at doses as low as 8 mg/kg augmented the activities of amoxicillin and gentamicin in successful treatment of MSSA and MRSA infections. We demonstrated that plectasin strongly rejuvenates the therapeutic potencies of existing antibiotics in vitro and in vivo. This is a novel strategy that can have major clinical implications in our fight against bacterial infections.	[Hu, Yanmin; Vaudrey, James; Vaiciunaite, Brigita; Coates, Anthony] St Georges Univ London, Inst Infect & Immun, London, England; [Liu, Alexander] Univ Oxford, Ctr Clin Magnet Resonance Res, Oxford, England; [Moigboi, Christiana; McTavish, Sharla M.; Kearns, Angela] Publ Hlth England, Antimicrobial Resistance & Healthcare Associated, London, England	St Georges University London; University of Oxford; Public Health England	Hu, YM (corresponding author), St Georges Univ London, Inst Infect & Immun, London, England.	ymhu@sgul.ac.uk		Coates, Anthony/0000-0001-8052-3175; McTavish, Sharla/0000-0002-8794-4981; Hu, Yanmin/0000-0003-0630-5342	European Commission under BacAttack [278998]; Helperby Therapeutics Group Ltd.	European Commission under BacAttack; Helperby Therapeutics Group Ltd.	This work was funded with support from the European Commission under grant agreement no: 278998, BacAttack. This communication reflects the views only of the author, and the Commission cannot be held responsible for any use which may be made of the information contained therein. The authors are also grateful for financial support from Helperby Therapeutics Group Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeschlimann JR, 1999, ANTIMICROB AGENTS CH, V43, P335, DOI 10.1128/AAC.43.2.335; ALBORN WE, 1991, ANTIMICROB AGENTS CH, V35, P2282, DOI 10.1128/AAC.35.11.2282; Aligholi M, 2011, ACTA MICROBIOL IMM H, V58, P219, DOI 10.1556/AMicr.58.2011.3.5; Anantharaman A, 2010, ANTIMICROB AGENTS CH, V54, P1693, DOI 10.1128/AAC.01231-09; Andes D, 2009, ANTIMICROB AGENTS CH, V53, P3003, DOI 10.1128/AAC.01584-08; Arias CA, 2009, NEW ENGL J MED, V360, P439, DOI 10.1056/NEJMp0804651; Barry AL, 1999, METHODS DETERMINING; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Brinch KS, 2010, J ANTIMICROB CHEMOTH, V65, P1720, DOI 10.1093/jac/dkq159; CHAN EL, 1987, DIAGN MICR INFEC DIS, V6, P157, DOI 10.1016/0732-8893(87)90101-5; Coates ARM, 2011, BRIT J PHARMACOL, V163, P184, DOI 10.1111/j.1476-5381.2011.01250.x; Cottagnoud P, 2003, ANTIMICROB AGENTS CH, V47, P144, DOI 10.1128/AAC.47.1.144-147.2003; Cui L, 2003, J CLIN MICROBIOL, V41, P5, DOI 10.1128/JCM.41.1.5-14.2003; Elemam A, 2010, J CLIN MICROBIOL, V48, P3558, DOI 10.1128/JCM.01106-10; Fry DE, 2011, SURG INFECT, V12, P191, DOI 10.1089/sur.2011.068; Giacometti A, 2000, ANTIMICROB AGENTS CH, V44, P1716, DOI 10.1128/AAC.44.6.1716-1719.2000; Gordon NC, 2010, ANTIMICROB AGENTS CH, V54, P5316, DOI 10.1128/AAC.00922-10; HANCOCK REW, 1981, J ANTIMICROB CHEMOTH, V8, P429, DOI 10.1093/jac/8.6.429; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Hill RLR, 2010, J ANTIMICROB CHEMOTH, V65, P442, DOI 10.1093/jac/dkp494; Hiramatsu K, 2001, Lancet Infect Dis, V1, P147, DOI 10.1016/S1473-3099(01)00091-3; Hu Y, 2012, J ANTIMICROB CHEMOTH, DOI [10.1093/jac/dks475, DOI 10.1093/JAC/DKS475]; Hu YM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011818; Kalan L, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399410001766; Lam H, 2009, SCIENCE, V325, P1552, DOI 10.1126/science.1178123; Magret M, 2011, CRIT CARE, V15, DOI 10.1186/cc10036; Mascio CTM, 2007, ANTIMICROB AGENTS CH, V51, P4255, DOI 10.1128/AAC.00824-07; Mazurek B, 2012, NEUROSCI LETT, V506, P107, DOI 10.1016/j.neulet.2011.10.060; MOELLERI.RC, 1971, J CLIN INVEST, V50, P2580, DOI 10.1172/JCI106758; Mygind PH, 2005, NATURE, V437, P975, DOI 10.1038/nature04051; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; Ostergaard C, 2009, ANTIMICROB AGENTS CH, V53, P1581, DOI 10.1128/AAC.01202-08; Pages JM, 2010, CURR TOP MED CHEM, V10, P1848, DOI 10.2174/156802610793176620; Quiros Y, 2011, TOXICOL SCI, V119, P245, DOI 10.1093/toxsci/kfq267; REYNOLDS PE, 1989, EUR J CLIN MICROBIOL, V8, P943, DOI 10.1007/BF01967563; Schneider T, 2010, SCIENCE, V328, P1168, DOI 10.1126/science.1185723; Shahid M, 2009, CRIT REV MICROBIOL, V35, P81, DOI 10.1080/10408410902733979; Toone Eric J, 2011, Adv Enzymol Relat Areas Mol Biol, V77, pxi; Wu MH, 1999, J BIOL CHEM, V274, P29, DOI 10.1074/jbc.274.1.29; Xiong YQ, 2011, ANTIMICROB AGENTS CH, V55, P5325, DOI 10.1128/AAC.00453-11; Yoon J, 2004, ANTIMICROB AGENTS CH, V48, P753, DOI 10.1128/AAC.48.3.753-757.2004; Yuan WC, 2013, J ANTIMICROB CHEMOTH, V68, P1089, DOI 10.1093/jac/dks522; Zechini Barbara, 2009, Recent Pat Antiinfect Drug Discov, V4, P37; Zhang Y, 2014, APPL MICROBIOL BIOT, V98, P681, DOI 10.1007/s00253-013-4881-2; Zuluaga AF, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-55	45	31	31	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117664	10.1371/journal.pone.0117664	http://dx.doi.org/10.1371/journal.pone.0117664			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692771	Green Published, Green Accepted, gold			2022-12-26	WOS:000350061500068
J	Keren, IN; Menalled, FD; Weaver, DK; Robison-Cox, JF				Keren, Ilai N.; Menalled, Fabian D.; Weaver, David K.; Robison-Cox, James F.			Interacting Agricultural Pests and Their Effect on Crop Yield: Application of a Bayesian Decision Theory Approach to the Joint Management of Bromus tectorum and Cephus cinctus	PLOS ONE			English	Article							STEM SAWFLY HYMENOPTERA; OVIPOSITION BEHAVIOR; STALK INSECTS; SPRING WHEATS; CEPHIDAE; WEEDS; COMPETITIVENESS; PERSPECTIVE; RESISTANCE; INFERENCE	Worldwide, the landscape homogeneity of extensive monocultures that characterizes conventional agriculture has resulted in the development of specialized and interacting multitrophic pest complexes. While integrated pest management emphasizes the need to consider the ecological context where multiple species coexist, management recommendations are often based on single-species tactics. This approach may not provide satisfactory solutions when confronted with the complex interactions occurring between organisms at the same or different trophic levels. Replacement of the single-species management model with more sophisticated, multi-species programs requires an understanding of the direct and indirect interactions occurring between the crop and all categories of pests. We evaluated a modeling framework to make multi-pest management decisions taking into account direct and indirect interactions among species belonging to different trophic levels. We adopted a Bayesian decision theory approach in combination with path analysis to evaluate interactions between Bromus tectorum (downy brome, cheatgrass) and Cephus cinctus (wheat stem sawfly) in wheat (Triticum aestivum) systems. We assessed their joint responses to weed management tactics, seeding rates, and cultivar tolerance to insect stem boring or competition. Our results indicated that C. cinctus oviposition behavior varied as a function of B. tectorum pressure. Crop responses were more readily explained by the joint effects of management tactics on both categories of pests and their interactions than just by the direct impact of any particular management scheme on yield. In accordance, a C. cinctus tolerant variety should be planted at a low seeding rate under high insect pressure. However as B. tectorum levels increase, the C. cinctus tolerant variety should be replaced by a competitive and drought tolerant cultivar at high seeding rates despite C. cinctus infestation. This study exemplifies the necessity of accounting for direct and indirect biological interactions occurring within agroecosystems and propagating this information from the statistical analysis stage to the management stage.	[Keren, Ilai N.] Washington Dept Fish & Wildlife, Olympia, WA USA; [Menalled, Fabian D.; Weaver, David K.] Montana State Univ, Dept Land Resources & Environm Sci, Bozeman, MT 59717 USA; [Robison-Cox, James F.] Montana State Univ, Dept Math Sci, Bozeman, MT 59717 USA	Washington Department of Fish & Wildlife (WDFW); Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman	Menalled, FD (corresponding author), Montana State Univ, Dept Land Resources & Environm Sci, Bozeman, MT 59717 USA.	menalled@montana.edu			USDA NIFA [0210928]; Montana Wheat and Barley Committee	USDA NIFA(United States Department of Agriculture (USDA)); Montana Wheat and Barley Committee	This work was supported by USDA NIFA grant 0210928 and the Montana Wheat and Barley Committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainslie CN, 1929, USDA TECHNICAL B, V157; Beres BL, 2011, CAN ENTOMOL, V143, P105, DOI 10.4039/n10-056; Beres BL, 2012, CROP SCI, V52, P1316, DOI 10.2135/cropsci2011.05.0239; Berger J.O., 1995, STAT DECISION THEORY, V2nd ed; Bhimasankaram P, 1997, LINEAR ALGEBRA APPL, V264, P329, DOI 10.1016/S0024-3795(97)00011-6; BLACKSHAW RE, 1991, WEED TECHNOL, V5, P557, DOI 10.1017/S0890037X00027329; Buteler M, 2010, CAN ENTOMOL, V142, P222, DOI 10.4039/n09-072; Buteler M, 2009, ENVIRON ENTOMOL, V38, P1707, DOI 10.1603/022.038.0624; Capinera JL, 2005, WEED SCI, V53, P892, DOI 10.1614/WS-04-049R.1; Delaney KJ, 2010, J ECON ENTOMOL, V103, P516, DOI 10.1603/EC09229; Ellison AM, 1996, ECOL APPL, V6, P1036, DOI 10.2307/2269588; Ferrari SLP, 2004, J APPL STAT, V31, P799, DOI 10.1080/0266476042000214501; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Grant WE, 1998, ECOL MODEL, V108, P67, DOI 10.1016/S0304-3800(98)00019-2; HOLMES N. D., 1962, CANADIAN ENTOMOL, V94, P348; HOLMES ND, 1984, CAN ENTOMOL, V116, P677, DOI 10.4039/Ent116677-5; HOLMES ND, 1977, CAN ENTOMOL, V109, P1591, DOI 10.4039/Ent1091591-12; HULBERT LC, 1955, ECOL MONOGR, V25, P181, DOI 10.2307/1943550; JAENIKE J, 1978, THEOR POPUL BIOL, V14, P350, DOI 10.1016/0040-5809(78)90012-6; Keren IN, 2012, DEV TOTAL SYSTEMS AP; Knodel JJ, 2009, J AGR URBAN ENTOMOL, V26, P183, DOI 10.3954/1523-5475-26.4.183; Kogan M, 1998, ANNU REV ENTOMOL, V43, P243, DOI 10.1146/annurev.ento.43.1.243; Larocque GR, 2011, ENVIRON MODELL SOFTW, V26, P280, DOI 10.1016/j.envsoft.2010.03.009; Lehnhoff EA, 2013, PLOS ONE, P8; Lemerle D, 2004, J AGR SCI-CAMBRIDGE, V142, P395, DOI 10.1017/S002185960400454X; Lemerle D, 2001, AUST J AGR RES, V52, P527, DOI 10.1071/AR00056; Lewis WJ, 1997, P NATL ACAD SCI USA, V94, P12243, DOI 10.1073/pnas.94.23.12243; Link WA, 2012, METHODS ECOL EVOL, V3, P112, DOI 10.1111/j.2041-210X.2011.00131.x; LUGINBILL P, 1958, J ECON ENTOMOL, V51, P804, DOI 10.1093/jee/51.6.804; Mack RN, 2011, FIFTY YEARS OF INVASION ECOLOGY: THE LEGACY OF CHARLES ELTON, P253; Michaud JP, 2009, J ECON ENTOMOL, V102, P1044, DOI 10.1603/029.102.0324; Miller ZJ, 2013, WEED RES, V53, P102, DOI 10.1111/wre.12007; Norris RF, 2005, ANNU REV ENTOMOL, V50, P479, DOI 10.1146/annurev.ento.49.061802.123218; Orloff N, 2013, WEED RES, V53, P192, DOI 10.1111/wre.12016; Pearl J, 2010, SOCIOL METHODOL, V40, P75, DOI 10.1111/j.1467-9531.2010.01228.x; Perez-Mendoza J, 2006, ENVIRON ENTOMOL, V35, P1279, DOI 10.1603/0046-225X(2006)35[1279:IOWADB]2.0.CO;2; Plummer M, 2003, PROC 3 INT WORK DIST, V3, P1; Plummer M, 2010, JAGS VERSION 2 2 0 U; Qureshi JA, 2007, INSECT SCI, V14, P425, DOI 10.1111/j.1744-7917.2007.00170.x; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Reganold JP, 2011, SCIENCE, V332, P670, DOI 10.1126/science.1202462; Robertson GP, 2014, BIOSCIENCE, V64, P404, DOI 10.1093/biosci/biu037; Shennan C, 2008, PHILOS T R SOC B, V363, P717, DOI 10.1098/rstb.2007.2180; Shiple B, 2000, CAUSE CORRELATION BI; STAHLMAN PW, 1990, WEED SCI, V38, P224, DOI 10.1017/S0043174500056447; USDA-NASS, 2010, CHEM US DAT WHEAT; Weaver DH, 2009, J ECON ENTOMOL, V102, P1009, DOI 10.1603/029.102.0320; Weaver DK, 2004, J AGR URBAN ENTOMOL, V21, P271; Zimdahl R.L., 2004, WEED CROP COMPETITIO, V2nd	49	14	14	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118111	10.1371/journal.pone.0118111	http://dx.doi.org/10.1371/journal.pone.0118111			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692673	Green Published, Green Submitted, gold			2022-12-26	WOS:000350061500097
J	Lee, JS; Kang, CH; Park, SQ; Choi, HA; Sim, KB				Lee, Jung Seok; Kang, Chul-hoo; Park, Sukh Que; Choi, H. Alex; Sim, Ki-Bum			Clinical Significance of Cerebral Microbleeds Locations in CADASIL with R544C NOTCH3 Mutation	PLOS ONE			English	Article							AUTOSOMAL-DOMINANT ARTERIOPATHY; SUBCORTICAL INFARCTS; STROKE; HEMORRHAGES; ONSET	Background and Purpose Although cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopath (CADASIL) is the most common single-gene disorder of cerebral small blood vessels caused by NOTCH3 mutations, little has been described about the variation in the clinical findings between its underlying types of mutations. In particular, the presence of cerebral microbleeds (CMBs) has been an increasingly recognized magnetic resonance imaging finding in CADASIL, but their clinical significance is not clear. The purpose of this study is to assess whether CMBs are associated with symptomatic stroke in the CADASIL patients with R544C mutation and to compare the cerebral distribution of CMBs between CADASIL patients with and without symptomatic stroke. Methods This is a cohort study of patients who were diagnosed with genotype-confirmed R544C-mutation CADASIL. Primary neurologic symptoms were recorded. Symptomatic strokes were defined as transient ischemic attack, ischemic strokes and hemorrhagic strokes. CMBs were defined as focal areas of round signal loss on T2*-weighted gradient echo planar images with a diameter of less than 10 mm. The locations of CMBs were divided into lobar, basal ganglia, thalamus, brain stem and cerebellum. Multiple logistic regressions were performed to identify the epidemiologic or vascular risk factors associated with symptomatic stroke in patients with CADASIL. Results Among total of 51 subjects in this cohort, CMBs were present in 20 of 32 patients (64.5%) in the symptomatic stroke-group and in 8 of 19 patients (42.1%) in the non-stroke group (p = 0.16). CMBs were observed more frequently in the basal ganglia (p<0.001) and the cerebellum (p<0.018) in the symptomatic stoke group compared to the non-stroke group. The mean number of CMBs was significantly higher in the symptomatic stroke group (15.4 +/- 18.0 lesions per patients with CMBs) versus those without symptomatic stroke (3.3 +/- 3.0 lesions per patients with CMBs) (p = 0.003). Hypertension was an independent risk factor for symptomatic stroke in CADASIL (p = 0.014). It was independently associated with CMBs locations as basal ganglia (p = 0.016), thalamus (p = 0.010), brainstem (p = 0.044), and cerebellum (p = 0.049). However, It was not independently associated with CMBs on lobar lesion (p = 0.152). Conclusions In this study hypertension was an independent predictor of CMBs presence in specific brain locations, as well as symptomatic stroke in the CADASIL patients. The distribution and burden of CMBs might be a clinically useful marker for the risk of symptomatic stroke. However, further prospective studies on the relationship between CMBs distribution and syThis study was supported by a grant of the Jeju National University Hospital Research Fund (2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript mptomatic stroke are required in order to support these preliminary findings.	[Lee, Jung Seok; Kang, Chul-hoo] Jeju Natl Univ, Coll Med, Jeju Natl Univ Hosp, Dept Neurol, Cheju, South Korea; [Park, Sukh Que] Soonchunhyang Univ, Coll Med, Soonchunhyang Univ Seoul Hosp, Dept Neurosurg, Seoul, South Korea; [Choi, H. Alex] Univ Texas Med Sch Houston, Dept Neurol & Neurosurg, Houston, TX USA; [Sim, Ki-Bum] Jeju Natl Univ, Coll Med, Jeju Natl Univ Hosp, Dept Neurosurg, Cheju, South Korea	Jeju National University; Soonchunhyang University; University of Texas System; University of Texas Health Science Center Houston; Jeju National University	Sim, KB (corresponding author), Jeju Natl Univ, Coll Med, Jeju Natl Univ Hosp, Dept Neurosurg, Cheju, South Korea.	kibumsim@gmail.com			Jeju National University Hospital Research Fund	Jeju National University Hospital Research Fund	This study was supported by a grant of the Jeju National University Hospital Research Fund (2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arboleda-Velasquez JF, 2002, NEUROLOGY, V59, P277, DOI 10.1212/WNL.59.2.277; Boulanger JM, 2006, STROKE, V37, P911, DOI 10.1161/01.STR.0000204237.66466.5f; CHABRIAT H, 1995, LANCET, V346, P934, DOI 10.1016/S0140-6736(95)91557-5; Chabriat H, 2009, LANCET NEUROL, V8, P643, DOI 10.1016/S1474-4422(09)70127-9; Choi JC, 2013, J STROKE CEREBROVASC, V22, P126, DOI 10.1016/j.jstrokecerebrovasdis.2011.07.002; Choi JC, 2010, J CLIN NEUROL, V6, P1, DOI 10.3988/jcn.2010.6.1.1; Choi JC, 2006, NEUROLOGY, V67, P2042, DOI 10.1212/01.wnl.0000246601.70918.06; Dichgans M, 2002, STROKE, V33, P67, DOI 10.1161/hs0102.100885; Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Lee JS, 2011, J CLIN NEUROL, V7, P210, DOI 10.3988/jcn.2011.7.4.210; Lee SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025930; Lee SH, 2005, HYPERTENS RES, V28, P895, DOI 10.1291/hypres.28.895; Lee SH, 2004, J NEUROL, V251, P1183, DOI 10.1007/s00415-004-0500-6; Lee SH, 2004, J NEUROL NEUROSUR PS, V75, P423, DOI 10.1136/jnnp.2003.015990; Oberstein SAJL, 2001, NEUROLOGY, V57, P1066, DOI 10.1212/WNL.57.6.1066; Opherk C, 2004, BRAIN, V127, P2533, DOI 10.1093/brain/awh282; Rinnoci V, 2013, J NEUROL SCI, V330, P45, DOI 10.1016/j.jns.2013.04.002; Vermeer SE, 2007, LANCET NEUROL, V6, P611, DOI 10.1016/S1474-4422(07)70170-9; Viswanathan A, 2006, BRAIN, V129, P2375, DOI 10.1093/brain/awl177	20	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118163	10.1371/journal.pone.0118163	http://dx.doi.org/10.1371/journal.pone.0118163			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692567	Green Published, Green Submitted, gold			2022-12-26	WOS:000350061500106
J	Nadol, P; O'connor, S; Duong, H; Le, LVN; Thang, PH; Tram, TH; Ha, HTT; Mcconnell, MS; Partridge, J; Kaldor, J; Law, M; Nguyen, TA				Nadol, Patrick; O'connor, Siobhan; Duong, Hao; Le, Linh-Vi N.; Pham Hong Thang; Tran Hong Tram; Hoang Thi Thanh Ha; Mcconnell, Michelle S.; Partridge, Jeff; Kaldor, John; Law, Matthew; Tuan Anh Nguyen			Findings from Integrated Behavioral and Biologic Survey among Males Who Inject Drugs (MWID) - Vietnam, 2009-2010: Evidence of the Need for an Integrated Response to HIV, Hepatitis B Virus, and Hepatitis C Virus	PLOS ONE			English	Article							GLOBAL EPIDEMIOLOGY; INFECTION; COINFECTION; PEOPLE; USERS; RISK	Introduction Given the overlapping modes of transmission of HIV, hepatitis B virus (HBV), and hepatitis C virus (HCV), understanding the burden and relationship of these infections is critical for an effective response. Representative data on these infections among males who inject drugs (MWID), the key high-risk population for HIV in Vietnam, are currently lacking. Methods Data and stored specimens from Vietnam's 2009-2010 Integrated Biologic and Behavioral Survey, a cross-sectional study among high-risk populations, were used for this analysis. Plasma samples were tested for HIV, HBV, and HCV using commercial assays. A questionnaire was administered to provide demographic, behavior, and service-uptake information. Provincial-level analyses were conducted to profile MWID enrollees and to provide estimates on the prevalence of HIV, HBV, and HCV infection. Results Among 3010 MWID sampled across 10 provinces, the median (range) HIV prevalence was 28.1% (1.0%-55.5%). Median prevalence for current HBV infection (HBsAg+) was 14.1% (11.7%-28.0%), for previous exposure to HBV (total anti-HBc+) was 71.4% (49.9%-83.1%), and for current or past HCV infection (HCV Ag/Ab+) was 53.8%(10.9%-80.8%). In adjusted analysis, HBsAg+ (aOR: 2.09, 1.01-4.34) and HCV Ag/Ab+ (aOR: 19.58, 13.07-29.33) status were significantly associated with HIV infection; the association with total anti-HBc+ approached significance (aOR: 1.29, 0.99-1.68). Conclusion The prevalence and association between HIV, HBV, and HCV are high among MWID in Vietnam. These findings indicate the need for integrated policies and practice that for the surveillance, prevention, screening, and treatment of both HIV and viral hepatitis among MWID in Vietnam.	[Nadol, Patrick; Duong, Hao; Le, Linh-Vi N.; Mcconnell, Michelle S.] US Ctr Dis Control & Prevent, Div Global HIV AIDS, Hanoi, Vietnam; [Nadol, Patrick; Kaldor, John; Law, Matthew] Univ New S Wales, Kirby Inst Infect & Immun, Sydney, NSW, Australia; [O'connor, Siobhan] US Ctr Dis Control & Prevent, Div Viral Hepatitis, Atlanta, GA USA; [Pham Hong Thang; Tran Hong Tram; Hoang Thi Thanh Ha; Tuan Anh Nguyen] Natl Inst Hyg & Epidemiol, Hanoi, Vietnam; [Partridge, Jeff] US Ctr Dis Control & Prevent, Div Influenza Control, Atlanta, GA USA	University of New South Wales Sydney; Kirby Institute; Centers for Disease Control & Prevention - USA; National Institute of Hygiene & Epidemiology (NIHE); Centers for Disease Control & Prevention - USA	Nadol, P (corresponding author), US Ctr Dis Control & Prevent, Div Global HIV AIDS, Hanoi, Vietnam.	pen5@cdc.gov		Law, Matthew/0000-0002-3540-8837	President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention (CDC) [5U2GGH000116]	President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention (CDC)	The research has been supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention (CDC) under the terms of 5U2GGH000116. CDC staff were directly engaged in the study design, analysis, decision to publish, and preparation of the manuscript.	Ameringer S, 2009, NURS RES, V58, P123, DOI 10.1097/NNR.0b013e318199b517; Anderson JP, 2014, CLIN INFECT DIS, V58, P719, DOI 10.1093/cid/cit779; [Anonymous], 1998, MMWR MORB MORTAL WKL, V47; [Anonymous], 2014, FEW ADD GET METH REL; Belani Hrishikesh, 2012, Morbidity and Mortality Weekly Report, V61, P1; Sy BT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078094; Centers for Disease Control and Prevention, MMWR MORB MORTAL W S, V38, P3; Cuong HN, 2011, J MED VIROL, V83, P399, DOI 10.1002/jmv.21978; Degenhardt L, 2013, LANCET, V382, P1564, DOI 10.1016/S0140-6736(13)61530-5; Department of Health and Human Services, 2013, GUID US ANT AG HIV I; DiaSorin S.p.A, 2013, TECHN ASS DET PERF S, DOI [10.1016/j.jfo.2013.06.003, DOI 10.1016/J.JFO.2013.06.003]; Garten RJ, 2004, INT J EPIDEMIOL, V33, P182, DOI 10.1093/ije/dyh019; Gile KJ, 2010, SOCIOL METHODOL, V40, P285, DOI 10.1111/j.1467-9531.2010.01223.x; Hernando V, 2012, J HEPATOL, V57, P743, DOI 10.1016/j.jhep.2012.06.010; Kim AY, 2013, J INFECT DIS, V207, pS1, DOI 10.1093/infdis/jis927; Mark S., 2012, DEDUCER RDSANALYST G; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Nelson PK, 2011, LANCET, V378, P571, DOI 10.1016/S0140-6736(11)61097-0; Nguyen Tam T M, 2012, Adv Prev Med, V2012, P732484, DOI 10.1155/2012/732484; Nguyen VTT, 2012, ASIA-PAC J PUBLIC HE, V24, P361, DOI 10.1177/1010539510385220; Nguyen VTT, 2007, HEPATOL INT, V1, P387, DOI 10.1007/s12072-007-9008-3; Nguyen VTT, 2007, J GASTROEN HEPATOL, V22, P2093, DOI 10.1111/j.1440-1746.2007.05010.x; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Quan VM, 2009, AIDS CARE, V21, P7, DOI 10.1080/09540120802017610; Sereno Leandro, 2012, J Int Assoc Physicians AIDS Care (Chic), V11, P311, DOI 10.1177/1545109712453939; StataCorp, 2011, STAT STAT SOFTW REL, P173; Sulkowski MS, 2008, J HEPATOL, V48, P353, DOI 10.1016/j.jhep.2007.11.009; Sulkowski Mark S, 2003, Clin Liver Dis, V7, P179, DOI 10.1016/S1089-3261(02)00074-0; Sun HY, 2014, WORLD J GASTROENTERO, V20, P14598, DOI 10.3748/wjg.v20.i40.14598; Sy Theodore, 2006, Int J Med Sci, V3, P41; Taylor LE, 2013, CLIN INFECT DIS, V57, pS118, DOI 10.1093/cid/cit326; Taylor LE, 2012, CLIN INFECT DIS, V55, pS33, DOI 10.1093/cid/cis367; Vietnam General Statistics Office, POP EMPL STAT; Vietnam Ministry of Health, 2012, VIET NAM HIV AIDS ES; Vietnam Ministry of Health, 2010, NAT STRAT HIV AIDS P; Vietnam Ministry of Health, 2011, EV EP IMP HARM RED P; Vietnam Ministry of Health (MOH), 2012, VIETN HIV AIDS EST P; Vietnam Ministry of Health NI of H and E, 2011, INT BIOL BEH SURV IB; Volz E., 2012, RESPONDENT DRIVEN SA; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632; World Health Organization, 2012, GUID PREV VIR HEP B; World Health Organization, 2012, WHO UNODC UNAIDS TEC, DOI [10.1016/j.drugpo.2007.12.002, DOI 10.1016/J.DRUGPO.2007.12.002]; World Health Organization, 2013, GLOB POL REP PREV CO, DOI [10.1016/j.jhep.2013.06.029, DOI 10.1016/J.JHEP.2013.06.029]; Worm SW, 2010, AIDS, V24, P1537, DOI 10.1097/QAD.0b013e32833a0918	44	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118304	10.1371/journal.pone.0118304	http://dx.doi.org/10.1371/journal.pone.0118304			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692469	Green Published, gold, Green Submitted			2022-12-26	WOS:000350061500115
J	Sakuma, K; Komatsu, H; Maruyama, M; Imaichi, S; Habata, Y; Mori, M				Sakuma, Kensuke; Komatsu, Hidetoshi; Maruyama, Minoru; Imaichi, Sachiko; Habata, Yugo; Mori, Masaaki			Temporal and Spatial Transcriptional Fingerprints by Antipsychotic or Propsychotic Drugs in Mouse Brain	PLOS ONE			English	Article							IMMEDIATE-EARLY GENE; DOPAMINE-RECEPTOR; STRIATAL NEURONS; MESSENGER-RNA; FOS EXPRESSION; NMDA CURRENTS; GROWTH-FACTOR; AMPHETAMINE; ACTIVATION; ARC	Various types of antipsychotics have been developed for the treatment of schizophrenia since the accidental discovery of the antipsychotic activity of chlorpromazine. Although all clinically effective antipsychotic agents have common properties to interact with the dopamine D2 receptor (D2R) activation, their precise mechanisms of action remain elusive. Antipsychotics are well known to induce transcriptional changes of immediate early genes (IEGs), raising the possibility that gene expressions play an essential role to improve psychiatric symptoms. Here, we report that while different classes of antipsychotics have complex pharmacological profiles against D2R, they share common transcriptome fingerprint (TFP) profile of IEGs in the murine brain in vivo by quantitative real-time PCR (qPCR). Our data showed that various types of antipsychotics with a profound interaction of D2R including haloperidol (antagonist), olanzapine (antagonist), and aripiprazole (partial agonist) all share common spatial TFPs closely homologous to those of D2R antagonist sulpiride, and elicited greater transcriptional responses in the striatum than in the nucleus accumbens. Meanwhile, D2R agonist quinpirole and propsychotic NMDA antagonists such as MK-801 and phencyclidine (PCP) exhibited the contrasting TFP profiles. Clozapine and propsychotic drug methamphetamine (MAP) displayed peculiar TFPs that reflect their unique pharmacological property. Our results suggest that transcriptional responses are conserved across various types of antipsychotics clinically effective in positive symptoms of schizophrenia and also show that temporal and spatial TFPs may reflect the pharmacological features of the drugs. Thus, we propose that a TFP approach is beneficial to evaluate novel drug candidates for antipsychotic development.	[Sakuma, Kensuke; Maruyama, Minoru; Habata, Yugo; Mori, Masaaki] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Cardiovasc & Metab Drug Discovery Unit, Fujisawa, Kanagawa, Japan; [Komatsu, Hidetoshi] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Cent Nervous Syst Drug Discovery Unit, Fujisawa, Kanagawa, Japan; [Imaichi, Sachiko] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Integrated Technol Res Labs, Fujisawa, Kanagawa, Japan	Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd	Sakuma, K (corresponding author), Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Cardiovasc & Metab Drug Discovery Unit, Fujisawa, Kanagawa, Japan.	kensuke.sakuma@takeda.com		Maruyama, Minoru/0000-0002-1478-9415; Komatsu, Hidetoshi/0000-0003-1630-0537	Takeda Pharmaceutical Company Limited	Takeda Pharmaceutical Company Limited(Takeda Pharmaceutical Company Ltd)	This study was financially supported by Takeda Pharmaceutical Company Limited. The authors as employees of Takeda played their roles in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arguello PA, 2006, NEURON, V52, P179, DOI 10.1016/j.neuron.2006.09.023; Beazely MA, 2006, J NEUROCHEM, V98, P1657, DOI 10.1111/j.1471-4159.2006.04064.x; Benturquia N, 2008, BRAIN RES, V1211, P1, DOI 10.1016/j.brainres.2008.03.016; Bertran-Gonzalez J, 2008, J NEUROSCI, V28, P5671, DOI 10.1523/JNEUROSCI.1039-08.2008; Boulay D, 2010, NEUROPSYCHOPHARMACOL, V35, P416, DOI 10.1038/npp.2009.144; Clayton DF, 2000, NEUROBIOL LEARN MEM, V74, P185, DOI 10.1006/nlme.2000.3967; Coba MP, 2008, J BIOL CHEM, V283, P34101, DOI 10.1074/jbc.M804951200; Coyle Joseph T, 2010, Dialogues Clin Neurosci, V12, P359; DEUTCH AY, 1992, MOL CELL NEUROSCI, V3, P332, DOI 10.1016/1044-7431(92)90030-6; Ferguson SM, 2003, J NEUROCHEM, V86, P33, DOI 10.1046/j.1471-4159.2003.01815.x; Flores-Hernandez J, 2002, J NEUROPHYSIOL, V88, P3010, DOI 10.1152/jn.00361.2002; Gonzalez-Maeso J, 2003, J NEUROSCI, V23, P8836; Gonzalez-Maeso J, 2007, NEURON, V53, P439, DOI 10.1016/j.neuron.2007.01.008; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; Gunduz-Bruce H, 2009, BRAIN RES REV, V60, P279, DOI 10.1016/j.brainresrev.2008.07.006; Haleem Darakshan J, 2002, Med Sci Monit, V8, pBR354; Hirose Tsuyoshi, 2005, J Med Invest, V52 Suppl, P284, DOI 10.2152/jmi.52.284; Horacek J, 2006, CNS DRUGS, V20, P389, DOI 10.2165/00023210-200620050-00004; Ikemoto S, 2007, BRAIN RES REV, V56, P27, DOI 10.1016/j.brainresrev.2007.05.004; Insel TR, 2010, NATURE, V468, P187, DOI 10.1038/nature09552; Ito T, 2007, INT J NEUROPSYCHOPH, V10, P717, DOI 10.1017/S1461145707007882; Jacobson C, 2004, P NATL ACAD SCI USA, V101, P12218, DOI 10.1073/pnas.0404240101; Kantrowitz J, 2012, CURR OPIN PSYCHIATR, V25, P96, DOI 10.1097/YCO.0b013e32835035b2; Konradi C, 1996, J NEUROSCI, V16, P4231; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199, DOI 10.1001/archpsyc.1994.03950030035004; Laruelle M, 2005, CLIN THER, V27, pS16, DOI 10.1016/j.clinthera.2005.07.017; Leslie JH, 2011, PROG NEUROBIOL, V94, P223, DOI 10.1016/j.pneurobio.2011.05.002; Leucht S, 2009, LANCET, V373, P31, DOI 10.1016/S0140-6736(08)61764-X; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; Ma M, 2013, PHARMACOL BIOCHEM BE, V110, P98, DOI 10.1016/j.pbb.2013.06.005; Manji Husseini K, 2003, Sci STKE, V2003, ppe49; Masri B, 2008, P NATL ACAD SCI USA, V105, P13656, DOI 10.1073/pnas.0803522105; MELTZER HY, 1989, J PHARMACOL EXP THER, V251, P238; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; Okuno H, 2012, CELL, V149, P886, DOI 10.1016/j.cell.2012.02.062; Okuno H, 2011, NEUROSCI RES, V69, P175, DOI 10.1016/j.neures.2010.12.007; Panenka WJ, 2013, DRUG ALCOHOL DEPEN, V129, P167, DOI 10.1016/j.drugalcdep.2012.11.016; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pratt J, 2012, NAT REV DRUG DISCOV, V11, P560, DOI 10.1038/nrd3649; Robbins MJ, 2008, J PSYCHOPHARMACOL, V22, P536, DOI 10.1177/0269881107081521; Roth BL, 2004, NAT REV DRUG DISCOV, V3, P353, DOI 10.1038/nrd1346; Ruxton GD, 2006, BEHAV ECOL, V17, P688, DOI 10.1093/beheco/ark016; Schotte A, 1996, PSYCHOPHARMACOLOGY, V124, P57, DOI 10.1007/BF02245606; Sharp FR, 2001, TRENDS NEUROSCI, V24, P330, DOI 10.1016/S0166-2236(00)01817-8; Stahl S.M., 2021, ESSENTIAL PSYCHOPHAR; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; Tsai KJ, 2002, P NATL ACAD SCI USA, V99, P3990, DOI 10.1073/pnas.062405399; Wirtshafter D, 2003, BRAIN RES BULL, V62, P77, DOI 10.1016/j.brainresbull.2003.09.002; Wood S, 2014, PHARMACOL REV, V66, P193, DOI 10.1124/pr.112.007054; Yamada K, 2007, P NATL ACAD SCI USA, V104, P2815, DOI 10.1073/pnas.0610765104; Yamagata K, 2000, ANN NY ACAD SCI, V914, P22, DOI 10.1111/j.1749-6632.2000.tb05180.x; Yui K, 2000, ANN NY ACAD SCI, V914, P1, DOI 10.1111/j.1749-6632.2000.tb05178.x	55	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118510	10.1371/journal.pone.0118510	http://dx.doi.org/10.1371/journal.pone.0118510			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693194	gold, Green Published, Green Submitted			2022-12-26	WOS:000350061500123
J	Cheng, H; Zheng, H; Wu, JX; Xu, W; Zhou, LH; Leong, KC; Fitzgerald, E; Rajagopalan, R; Too, HP; Choi, WK				Cheng, He; Zheng, Han; Wu, Jia Xin; Xu, Wei; Zhou, Lihan; Leong, Kam Chew; Fitzgerald, Eugene; Rajagopalan, Raj; Too, Heng Phon; Choi, Wee Kiong			Photo-Attachment of Biomolecules for Miniaturization on Wicking Si-Nanowire Platform	PLOS ONE			English	Article							SELF-ASSEMBLED MONOLAYERS; ENHANCED-PERFORMANCE; THIN-FILMS; DNA; SURFACE; MICROARRAY; ACID; HYBRIDIZATION; IMMOBILIZATION; DESIGN	We demonstrated the surface functionalization of a highly three-dimensional, superhydrophilic wicking substrate using light to immobilize functional biomolecules for sensor or microarray applications. We showed here that the three-dimensional substrate was compatible with photo-attachment and the performance of functionalization was greatly improved due to both increased surface capacity and reduced substrate reflectivity. In addition, photo-attachment circumvents the problems induced by wicking effect that was typically encountered on superhydrophilic three-dimensional substrates, thus reducing the difficulty of producing miniaturized sites on such substrate. We have investigated various aspects of photo-attachment process on the nanowire substrate, including the role of different buffers, the effect of wavelength as well as how changing probe structure may affect the functionalization process. We demonstrated that substrate fabrication and functionalization can be achieved with processes compatible with microelectronics processes, hence reducing the cost of array fabrication. Such functionalization method coupled with the high capacity surface makes the substrate an ideal candidate for sensor or microarray for sensitive detection of target analytes.	[Cheng, He; Fitzgerald, Eugene; Choi, Wee Kiong] Singapore MIT Alliance, Adv Mat Micro & Nano Syst, Singapore, Singapore; [Zheng, Han; Xu, Wei; Choi, Wee Kiong] Natl Univ Singapore, Dept Elect & Comp Engn, Singapore 117548, Singapore; [Wu, Jia Xin; Choi, Wee Kiong] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; [Zhou, Lihan; Too, Heng Phon] Bioproc Technol Inst, Singapore, Singapore; [Leong, Kam Chew] GLOBALFOUNDRIES Singapore Private Ltd, Singapore, Singapore; [Fitzgerald, Eugene] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Rajagopalan, Raj] Skolkovo Inst Sci & Technol, Moscow, Russia; [Too, Heng Phon] Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore	Massachusetts Institute of Technology (MIT); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Singapore-MIT Alliance for Research & Technology Centre (SMART); National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Bioprocessing Technology Institute (BTI); GlobalFoundries; Massachusetts Institute of Technology (MIT); Skolkovo Institute of Science & Technology; National University of Singapore	Choi, WK (corresponding author), Singapore MIT Alliance, Adv Mat Micro & Nano Syst, Singapore, Singapore.	elechoi@nus.edu.sg	Wu, Jiaxin/GVT-3486-2022		National Research Foundation (Singapore)-POC [R-263-000-A11-281]	National Research Foundation (Singapore)-POC	This study was supported by the National Research Foundation (Singapore)-POC R-263-000-A11-281, www.nrf.gov.sg (RR, HPT and WKC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2012, BIOCHIP J, V6, P174, DOI 10.1007/s13206-012-6210-8; Bodla KK, 2013, J HEAT TRANSFER, V135, P1; CIMINO GD, 1985, ANNU REV BIOCHEM, V54, P1151, DOI 10.1146/annurev.bi.54.070185.005443; Dandy DS, 2007, P NATL ACAD SCI USA, V104, P8223, DOI 10.1073/pnas.0606054104; Dankbar DM, 2006, ANAL BIOANAL CHEM, V386, P1967, DOI 10.1007/s00216-006-0871-x; Dawood MK, 2012, LAB CHIP, V12, P5016, DOI 10.1039/c2lc40673j; Dawood MK, 2011, LANGMUIR, V27, P4126, DOI 10.1021/la1050783; Dolan PL, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.21.e107; Dufva M, 2005, BIOMOL ENG, V22, P173, DOI 10.1016/j.bioeng.2005.09.003; Eischeid AC, 2011, APPL ENVIRON MICROB, V77, P1145, DOI 10.1128/AEM.00403-10; Elaissari A, 1998, J COLLOID INTERF SCI, V202, P251, DOI 10.1006/jcis.1998.5517; Extrand CW, 2007, LANGMUIR, V23, P8882, DOI 10.1021/la700816n; FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438; Forman JE, 2003, METHOD ENZYMOL, V361, P530; Fuchs J, 2010, ANAL BIOCHEM, V397, P132, DOI 10.1016/j.ab.2009.09.044; Gardner SN, 2013, J MICROBIOL METH, V94, P303, DOI 10.1016/j.mimet.2013.07.006; Gong P, 2008, P NATL ACAD SCI USA, V105, P5301, DOI 10.1073/pnas.0709416105; Han KS, 2011, SOL ENERG MAT SOL C, V95, P288, DOI 10.1016/j.solmat.2010.04.064; Higashi N, 1999, LANGMUIR, V15, P111, DOI 10.1021/la9803427; Kim H, 2006, LANGMUIR, V22, P8121, DOI 10.1021/la0610708; Krishnan Y, 2011, ANGEW CHEM INT EDIT, V50, P3124, DOI 10.1002/anie.200907223; Kusnezow W, 2006, MOL CELL PROTEOMICS, V5, P1681, DOI 10.1074/mcp.T500035-MCP200; Lai CQ, 2013, J PHYS CHEM C, V117, P20802, DOI 10.1021/jp407561k; Le Goff GC, 2013, MACROMOL BIOSCI, V13, P227, DOI 10.1002/mabi.201200370; Li B, 2009, ACS APPL MATER INTER, V1, P1013, DOI 10.1021/am900001h; Li YC, 2007, ANAL CHEM, V79, P426, DOI 10.1021/ac061134j; Lianto P, 2012, NANOSCALE, V4, P7532, DOI 10.1039/c2nr32350h; Lundberg AJ, 2001, EIGHTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOL I, PROCEEDINGS, P225, DOI 10.1109/ICCV.2001.937522; Miyachi H, 2004, BIOSENS BIOELECTRON, V20, P184, DOI 10.1016/j.bios.2004.02.022; Mocanu D, 2008, ANAL BIOCHEM, V380, P84, DOI 10.1016/j.ab.2008.05.034; Nakano K, 2006, ANAL CHIM ACTA, V578, P93, DOI 10.1016/j.aca.2006.04.085; Oh SJ, 2002, LANGMUIR, V18, P1764, DOI 10.1021/la0113522; Pan N, 2006, TEXT PROG, V38, P1, DOI 10.1533/tepr.2006.0002; Ranjan R, 2011, NANOSC MICROSC THERM, V15, P179, DOI 10.1080/15567265.2011.597492; Ressine A, 2007, BIOTECHNOL ANN REV, V13, P149, DOI 10.1016/S1387-2656(07)13007-6; Roy S, 2011, LAB CHIP, V11, P1886, DOI 10.1039/c0lc00638f; Sefiane K, 2004, J COLLOID INTERF SCI, V272, P411, DOI 10.1016/j.jcis.2003.10.039; Shigdel UK, 2008, ANGEW CHEM INT EDIT, V47, P90, DOI 10.1002/anie.200703625; Sim AYL, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.021901; Srivastava SK, 2009, SILICON NANOWIRE ARR; Steel AB, 1998, ANAL CHEM, V70, P4670, DOI 10.1021/ac980037q; Sun YL, 2003, P SOC PHOTO-OPT INS, V5016, P91, DOI 10.1117/12.477358; Templin MF, 2002, TRENDS BIOTECHNOL, V20, P160, DOI 10.1016/S0167-7799(01)01910-2; USSERY DW, 1992, METHOD ENZYMOL, V212, P242; Vamvakaki V, 2008, ELECTROANAL, V20, P1845, DOI 10.1002/elan.200804268; Wong IY, 2010, BIOPHYS J, V98, P2954, DOI 10.1016/j.bpj.2010.03.017; Wu JX, 2014, LANGMUIR, V30, P2206, DOI 10.1021/la404419h; Wu X, 2011, APPL SURF SCI, V257, P7415, DOI 10.1016/j.apsusc.2011.02.106; Xu BJ, 2007, SENSOR ACTUAT A-PHYS, V135, P292, DOI 10.1016/j.sna.2006.07.003; Yang P, 2013, CHEM REV, V113, P5547, DOI 10.1021/cr300246p; Yang WS, 2002, NAT MATER, V1, P253, DOI 10.1038/nmat779; Zhu Y, 2014, J MATER CHEM B, V2, P3582, DOI 10.1039/c4tb00281d	52	2	2	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0116539	10.1371/journal.pone.0116539	http://dx.doi.org/10.1371/journal.pone.0116539			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689680	Green Published, gold			2022-12-26	WOS:000350322700014
J	Hsieh, YT; Chen, KC; Cheng, CM; Cheng, TL; Tao, MH; Roffler, SR				Hsieh, Yuan-Ting; Chen, Kai-Chuan; Cheng, Chiu-Min; Cheng, Tian-Lu; Tao, Mi-Hua; Roffler, Steve R.			Impediments to Enhancement of CPT-11 Anticancer Activity by E. coli Directed Beta-Glucuronidase Therapy	PLOS ONE			English	Article							ENZYME PRODRUG THERAPY; INHIBIT TUMOR-GROWTH; ESCHERICHIA-COLI; CANCER-THERAPY; IRINOTECAN CPT-11; SALMONELLA-TYPHIMURIUM; SELECTIVE LOCALIZATION; ANTITUMOR-ACTIVITY; TARGETED DELIVERY; GENE-THERAPY	CPT-11 is a camptothecin analog used for the clinical treatment of colorectal adenocarcinoma. CPT-11 is converted into the therapeutic anti-cancer agent SN-38 by liver enzymes and can be further metabolized to a non-toxic glucuronide SN-38G, resulting in low SN-38 but high SN-38G concentrations in the circulation. We previously demonstrated that adenoviral expression of membrane-anchored beta-glucuronidase could promote conversion of SN-38G to SN-38 in tumors and increase the anticancer activity of CPT-11. Here, we identified impediments to effective tumor therapy with E. coli that were engineered to constitutively express highly active E. coli beta-glucuronidase intracellularly to enhance the anticancer activity of CPT-11. The engineered bacteria, E. coli (lux/beta G), could hydrolyze SN-38G to SN-38, increased the sensitivity of cultured tumor cells to SN-38G by about 100 fold and selectively accumulated in tumors. However, E. coli (lux/beta G) did not more effectively increase CPT-11 anticancer activity in human tumor xenografts as compared to non-engineered E. coli. SN-38G conversion to SN-38 by E. coli (lux/beta G) appeared to be limited by slow uptake into bacteria as well as by segregation of E. coli in necrotic regions of tumors that may be relatively inaccessible to systemically-administered drug molecules. Studies using a fluorescent glucuronide probe showed that significantly greater glucuronide hydrolysis could be achieved in mice pretreated with E. coli (lux/beta G) by direct intratumoral injection of the glucuronide probe or by intratumoral lysis of bacteria to release intracellular beta-glucuronidase. Our study suggests that the distribution of beta-glucuronidase, and possibly other therapeutic proteins, in the tumor microenvironment might be an important barrier for effective bacterial- based tumor therapy. Expression of secreted therapeutic proteins or induction of therapeutic protein release from bacteria might therefore be a promising strategy to enhance anti-tumor activity.	[Hsieh, Yuan-Ting] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan; [Hsieh, Yuan-Ting; Chen, Kai-Chuan; Tao, Mi-Hua; Roffler, Steve R.] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; [Cheng, Chiu-Min] Natl Kaohsiung Marine Univ, Dept Aquaculture, Kaohsiung, Taiwan; [Cheng, Tian-Lu] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan	National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; National Kaohsiung University of Science & Technology; Kaohsiung Medical University	Roffler, SR (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan.	sroff@ibms.sinica.edu.tw	Tao, Mi-Hua/S-7020-2018; Roffler, Steve R/N-7791-2018	Roffler, Steve R/0000-0003-2543-7295; Cheng, Tian-Lu/0000-0002-7263-2766; Tao, Mi-Hua/0000-0002-4307-5729	National Science Council, Taipei, Taiwan [NSC102-2320-B-001-013-MY3]	National Science Council, Taipei, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the research grant from the National Science Council, Taipei, Taiwan (NSC102-2320-B-001-013-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basili S, 2009, EXPERT OPIN THER PAT, V19, P555, DOI 10.1517/13543770902773437; BOUCHER Y, 1990, CANCER RES, V50, P4478; Chang DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083239; Chart H, 2000, J APPL MICROBIOL, V89, P1048, DOI 10.1046/j.1365-2672.2000.01211.x; Chen CP, 2012, PROTEIN ENG DES SEL, V25, P367, DOI 10.1093/protein/gzs033; Chen KC, 2007, CANCER GENE THER, V14, P187, DOI 10.1038/sj.cgt.7700999; Chen KC, 2011, BIOCONJUGATE CHEM, V22, P938, DOI 10.1021/bc1005784; Cheng CM, 2008, CANCER GENE THER, V15, P393, DOI 10.1038/cgt.2008.10; Cheng CM, 2013, CANCER GENE THER, V20, P276, DOI 10.1038/cgt.2013.17; Cheng TL, 1997, CANCER IMMUNOL IMMUN, V44, P305, DOI 10.1007/s002620050387; Cheng TL, 1999, BIOCONJUGATE CHEM, V10, P520, DOI 10.1021/bc980143z; Chu YW, 1997, AM J RESP CELL MOL, V17, P353, DOI 10.1165/ajrcmb.17.3.2837; Chung-Faye G, 2001, CLIN CANCER RES, V7, P2662; Clairmont C, 2000, J INFECT DIS, V181, P1996, DOI 10.1086/315497; Critchley R, 2004, GENE THER, V11, P1224, DOI 10.1038/sj.gt.3302281; Cronin M, 2014, MOL THER, V22, P1188, DOI 10.1038/mt.2014.23; Fonseca MJ, 2003, PHARMACEUT RES, V20, P423, DOI 10.1023/A:1022608321861; Forbes NS, 2010, NAT REV CANCER, V10, P784, DOI 10.1038/nrc2934; Friedlos F, 2008, CLIN CANCER RES, V14, P4259, DOI 10.1158/1078-0432.CCR-07-4800; Heine M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036258; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; Hess C, 2014, PROTEIN ENG DES SEL, V27, P207, DOI 10.1093/protein/gzu013; Huang PT, 2011, CANCER GENE THER, V18, P381, DOI 10.1038/cgt.2011.3; Iyer L, 1998, J CLIN INVEST, V101, P847, DOI 10.1172/JCI915; Jang JK, 2013, MOL CANCER THER, V12, P2827, DOI 10.1158/1535-7163.MCT-13-0383; Jiang SN, 2013, MOL THER, V21, P1985, DOI 10.1038/mt.2013.183; Jiang SN, 2010, MOL THER, V18, P635, DOI 10.1038/mt.2009.295; Jiang SN, MOL THER, V18, P635; KAWATO Y, 1991, CANCER RES, V51, P4187; KIMURA NT, 1980, CANCER RES, V40, P2061; Lehouritis P, 2013, J CONTROL RELEASE, V170, P120, DOI 10.1016/j.jconrel.2013.05.005; Liang WJ, 2005, J BACTERIOL, V187, P2377, DOI 10.1128/JB.187.7.2377-2385.2005; Lin TP, 1999, J BACTERIOL, V181, P5060, DOI 10.1128/JB.181.16.5060-5067.1999; Liu M, 2014, MOL PHARMACEUT, V11, P2305, DOI 10.1021/mp400759d; Liu SC, 2008, CANCER RES, V68, P7995, DOI 10.1158/0008-5472.CAN-08-1698; Loeffler M, 2007, P NATL ACAD SCI USA, V104, P12879, DOI 10.1073/pnas.0701959104; Loeffler M, 2009, CANCER IMMUNOL IMMUN, V58, P769, DOI 10.1007/s00262-008-0555-9; Loessner H, 2009, MICROBES INFECT, V11, P1097, DOI 10.1016/j.micinf.2009.08.002; MALMGREN RA, 1955, CANCER RES, V15, P473; Mathijssen RHJ, 2001, CLIN CANCER RES, V7, P2182; Min JJ, 2008, MOL IMAGING BIOL, V10, P54, DOI 10.1007/s11307-007-0120-5; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; NOVEL G, 1974, J BACTERIOL, V120, P89, DOI 10.1128/JB.120.1.89-95.1974; Pawelek JM, 1997, CANCER RES, V57, P4537; PRESS OW, 1993, NEW ENGL J MED, V329, P1219, DOI 10.1056/NEJM199310213291702; Prijovich ZM, 2009, MOL CANCER THER, V8, P940, DOI 10.1158/1535-7163.MCT-08-0812; Qhattal HSS, 2014, ACS NANO, V8, P5423, DOI 10.1021/nn405839n; Reddy S, 2011, CLIN CANCER RES, V17, P1509, DOI 10.1158/1078-0432.CCR-10-1654; Rivory LP, 1997, CLIN CANCER RES, V3, P1261; Rivory LP, 1996, BIOCHEM PHARMACOL, V52, P1103, DOI 10.1016/0006-2952(96)00457-1; Roffler SR, 2006, GENE THER, V13, P412, DOI 10.1038/sj.gt.3302671; Simonsen TG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040006; Springer C. J., 1997, ADV DRUG DELIV REV, V26, P151; Sreeramoju P, 2010, ADV GENET, V69, P135, DOI 10.1016/S0065-2660(10)69015-3; Staker BL, 2002, P NATL ACAD SCI USA, V99, P15387, DOI 10.1073/pnas.242259599; Stritzker J, 2007, INT J MED MICROBIOL, V297, P151, DOI 10.1016/j.ijmm.2007.01.008; Westphal K, 2008, CANCER RES, V68, P2952, DOI 10.1158/0008-5472.CAN-07-2984; Wu CH, 2004, BIOTECHNOL APPL BIOC, V40, P167, DOI 10.1042/BA20030184; Xu G, 2001, CLIN CANCER RES, V7, P3314; Yazawa K, 2000, CANCER GENE THER, V7, P269, DOI 10.1038/sj.cgt.7700122; Yu YA, 2004, NAT BIOTECHNOL, V22, P313, DOI 10.1038/nbt937; Zhang HY, 2010, CANCER GENE THER, V17, P334, DOI 10.1038/cgt.2009.76; Zhang L, 2014, J CONTROL RELEASE, V183, P114, DOI 10.1016/j.jconrel.2014.03.043	63	5	5	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0118028	10.1371/journal.pone.0118028	http://dx.doi.org/10.1371/journal.pone.0118028			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25688562	Green Published, gold, Green Submitted			2022-12-26	WOS:000350322700096
J	Ito, T; Tsubahara, A; Shinkoda, K; Yoshimura, Y; Kobara, K; Osaka, H				Ito, Tomotaka; Tsubahara, Akio; Shinkoda, Koichi; Yoshimura, Yosuke; Kobara, Kenichi; Osaka, Hiroshi			Excitability Changes in Intracortical Neural Circuits Induced by Differentially Controlled Walking Patterns	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; MOTOR CORTEX; CORTICOMOTOR EXCITABILITY; ELECTRICAL-STIMULATION; INHIBITION; MUSCLE; GAIT; PLASTICITY; MODULATION; EXERCISE	Our previous single-pulse transcranial magnetic stimulation (TMS) study revealed that excitability in the motor cortex can be altered by conscious control of walking relative to less conscious normal walking. However, substantial elements and underlying mechanisms for inducing walking-related cortical plasticity are still unknown. Hence, in this study we aimed to examine the characteristics of electromyographic (EMG) recordings obtained during different walking conditions, namely, symmetrical walking (SW), asymmetrical walking 1 (AW1), and asymmetrical walking 2 (AW2), with left to right stance duration ratios of 1: 1, 1: 2, and 2: 1, respectively. Furthermore, we investigated the influence of three types of walking control on subsequent changes in the intracortical neural circuits. Prior to each type of 7-min walking task, EMG analyses of the left tibialis anterior (TA) and soleus (SOL) muscles during walking were performed following approximately 3 min of preparative walking. Paired-pulse TMS was used to measure short-interval intracortical inhibition (SICI) and intracortical facilitation (ICF) in the left TA and SOL at baseline, immediately after the 7-min walking task, and 30 min post-task. EMG activity in the TA was significantly increased during AW1 and AW2 compared to during SW, whereas a significant difference in EMG activity of the SOL was observed only between AW1 and AW2. As for intracortical excitability, there was a significant alteration in SICI in the TA between SWand AW1, but not between SW and AW2. For the same amount of walking exercise, we found that the different methods used to control walking patterns induced different excitability changes in SICI. Our research shows that activation patterns associated with controlled leg muscles can alter post-exercise excitability in intracortical circuits. Therefore, how leg muscles are activated in a clinical setting could influence the outcome of walking in patients with stroke.	[Ito, Tomotaka; Tsubahara, Akio; Yoshimura, Yosuke; Kobara, Kenichi; Osaka, Hiroshi] Kawasaki Univ Med Welf, Fac Hlth Sci & Technol, Dept Rehabil, Okayama, Japan; [Shinkoda, Koichi] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Biomech, Hiroshima, Japan	Hiroshima University	Ito, T (corresponding author), Kawasaki Univ Med Welf, Fac Hlth Sci & Technol, Dept Rehabil, Okayama, Japan.	s-ito@mw.kawasaki-m.ac.jp		Ito, Tomotaka/0000-0002-2833-3945				Blicher JU, 2009, NEUROREHAB NEURAL RE, V23, P143, DOI 10.1177/1545968308317973; Capaday C, 1999, J NEUROPHYSIOL, V81, P129, DOI 10.1152/jn.1999.81.1.129; Di Lazzaro V, 2001, J PHYSIOL-LONDON, V537, P1047, DOI 10.1113/jphysiol.2001.012572; Dobkin BH, 2004, NEUROIMAGE, V23, P370, DOI 10.1016/j.neuroimage.2004.06.008; Donoghue JP, 1995, CURR OPIN NEUROBIOL, V5, P749, DOI 10.1016/0959-4388(95)80102-2; EIDELBERG E, 1981, PROG NEUROBIOL, V17, P185, DOI 10.1016/0301-0082(81)90013-7; Fedirchuk B, 1998, EXP BRAIN RES, V122, P351, DOI 10.1007/s002210050523; Forrester LW, 2006, ARCH PHYS MED REHAB, V87, P229, DOI 10.1016/j.apmr.2005.10.016; Fujiwara T, 2005, CRIT REV PHYS REHABI, V17, P163, DOI [DOI 10.1615/CRITREVPHYSREHABILMED.V17.I3.10, 10.1615/CritRevPhysRehabilMed.v17.i3.10]; Fukuyama H, 1997, NEUROSCI LETT, V228, P183, DOI 10.1016/S0304-3940(97)00381-9; Gallasch E, 2009, EUR J APPL PHYSIOL, V105, P47, DOI 10.1007/s00421-008-0871-y; Gorassini MA, 2004, BRAIN, V127, P2247, DOI 10.1093/brain/awh243; Hornby TG, 2008, STROKE, V39, P1786, DOI 10.1161/STROKEAHA.107.504779; Ito T, 2014, NEUROREPORT, V25, P44, DOI 10.1097/WNR.0000000000000041; Jayaram G, 2011, CEREB CORTEX, V21, P1901, DOI 10.1093/cercor/bhq263; Kamibayashi K, 2009, EUR J NEUROSCI, V30, P100, DOI 10.1111/j.1460-9568.2009.06795.x; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; Liepert J, 1998, EXP BRAIN RES, V118, P421, DOI 10.1007/s002210050296; Lotze M, 2003, BRAIN, V126, P866, DOI 10.1093/brain/awg079; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Miyai I, 2001, NEUROIMAGE, V14, P1186, DOI 10.1006/nimg.2001.0905; Nielsen JB, 2003, NEUROSCIENTIST, V9, P195, DOI 10.1177/1073858403009003012; Perez MA, 2004, EXP BRAIN RES, V159, P197, DOI 10.1007/s00221-004-1947-5; Perry J, 2010, GAIT ANALYSIS: NORMAL AND PATHOLOGICAL FUNCTION, SECOND EDITION, P51; Petersen NT, 2001, J PHYSIOL-LONDON, V537, P651, DOI 10.1111/j.1469-7793.2001.00651.x; Raasch CC, 1999, J NEUROPHYSIOL, V82, P515, DOI 10.1152/jn.1999.82.2.515; Sanes JN, 2000, ANNU REV NEUROSCI, V23, P393, DOI 10.1146/annurev.neuro.23.1.393; Stinear CM, 2003, J NEUROPHYSIOL, V89, P2014, DOI 10.1152/jn.00925.2002; Stinear JW, 2005, J PHYSIOL-LONDON, V567, P701, DOI 10.1113/jphysiol.2005.090654; Thompson AK, 2004, EXP BRAIN RES, V159, P491, DOI 10.1007/s00221-004-1972-4; Werhahn KJ, 1999, J PHYSIOL-LONDON, V517, P591, DOI 10.1111/j.1469-7793.1999.0591t.x; Yamaguchi T, 2012, EXP BRAIN RES, V218, P401, DOI 10.1007/s00221-012-3026-7; Yang JF, 2006, NEUROSCIENTIST, V12, P379, DOI 10.1177/1073858406292151; Yen CL, 2008, NEUROREHAB NEURAL RE, V22, P22, DOI 10.1177/1545968307301875; Ziemann U, 1996, EXP BRAIN RES, V109, P127; Ziemann U, 2001, BRAIN, V124, P1171, DOI 10.1093/brain/124.6.1171; Zoghi M, 2003, J PHYSIOL-LONDON, V550, P933, DOI 10.1113/jphysiol.2003.042606	37	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117931	10.1371/journal.pone.0117931	http://dx.doi.org/10.1371/journal.pone.0117931			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25688972	Green Published, gold			2022-12-26	WOS:000350322700085
J	Maninchedda, U; Lepage, OM; Gangl, M; Hilairet, S; Remandet, B; Meot, F; Penarier, G; Segard, E; Cortez, P; Jorgensen, C; Steinberg, R				Maninchedda, Ugo; Lepage, Olivier M.; Gangl, Monika; Hilairet, Sandrine; Remandet, Bernard; Meot, Francoise; Penarier, Geraldine; Segard, Emilie; Cortez, Pierre; Jorgensen, Christian; Steinberg, Regis			Development of an Equine Groove Model to Induce Metacarpophalangeal Osteoarthritis: A Pilot Study on 6 Horses	PLOS ONE			English	Article							SUBCHONDRAL BONE FAILURE; INERTIAL SENSOR SYSTEM; POSTTRAUMATIC OSTEOARTHRITIS; ARTICULAR-CARTILAGE; OVERLOAD ARTHROSIS; SYNOVIAL-FLUID; JOINT; EXERCISE; INJURY; IMMOBILIZATION	The aim of this work was to develop an equine metacarpophalangeal joint model that induces osteoarthritis that is not primarily mediated by instability or inflammation. The study involved six Standardbred horses. Standardized cartilage surface damage or "grooves" were created arthroscopically on the distal dorsal aspect of the lateral and medial metacarpal condyles of a randomly chosen limb. The contralateral limb was sham operated. After 2 weeks of stall rest, horses were trotted 30 minutes every other day for 8 weeks, then evaluated for lameness and radiographed. Synovial fluid was analyzed for cytology and biomarkers. At 10 weeks post-surgery, horses were euthanized for macroscopic and histologic joint evaluation. Arthroscopic grooving allowed precise and identical damage to the cartilage of all animals. Under the controlled exercise regime, this osteoarthritis groove model displayed significant radiographic, macroscopic, and microscopic degenerative and reactive changes. Histology demonstrated consistent surgically induced grooves limited to non-calcified cartilage and accompanied by secondary adjacent cartilage lesions, chondrocyte necrosis, chondrocyte clusters, cartilage matrix softening, fissuring, mild subchondral bone inflammation, edema, and osteoblastic margination. Synovial fluid biochemistry and cytology demonstrated significantly elevated total protein without an increase in prostaglandin E2, neutrophils, or chondrocytes. This equine metacarpophalangeal groove model demonstrated that standardized non-calcified cartilage damage accompanied by exercise triggered altered osteochondral morphology and cartilage degeneration with minimal or inefficient repair and little inflammatory response. This model, if validated, would allow for assessment of disease processes and the effects of therapy.	[Maninchedda, Ugo; Lepage, Olivier M.; Gangl, Monika; Segard, Emilie] Univ Lyon, Equine Res Ctr, VetAgro Sup, GREMERES ICE, Marcy Letoile, France; [Hilairet, Sandrine; Remandet, Bernard; Meot, Francoise; Penarier, Geraldine; Cortez, Pierre; Steinberg, Regis] Sanofi Aventis Rech, Exploratory Unit, Montpellier, France; [Jorgensen, Christian] CHU Lapeyronie Univ Hosp, Clin Unit Osteoarticular Dis, Montpellier, France	VetAgro Sup; Sanofi-Aventis; Sanofi France; Universite de Montpellier; CHU de Montpellier	Maninchedda, U (corresponding author), Univ Lyon, Equine Res Ctr, VetAgro Sup, GREMERES ICE, Vet Campus Lyon, Marcy Letoile, France.	u.maninchedda@gmail.com		jorgensen, christian/0000-0001-6947-8094	GREMERES (Groupe de Recherche en Medecine et Reeducation des Equides de Sport); Veterinary Campus of Lyon (VetAgro Sup); Exploratory unit at Sanofi-Aventis contract service; Sanofi-Aventis	GREMERES (Groupe de Recherche en Medecine et Reeducation des Equides de Sport); Veterinary Campus of Lyon (VetAgro Sup); Exploratory unit at Sanofi-Aventis contract service; Sanofi-Aventis(Sanofi-Aventis)	The research was supported by GREMERES (Groupe de Recherche en Medecine et Reeducation des Equides de Sport), Veterinary Campus of Lyon (VetAgro Sup) and the Exploratory unit at Sanofi-Aventis contract service. SH, BR, FM, GP, PC, RS received funding from Sanofi-Aventis in the form of salary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAEP Horse Show Committee, 1999, GUID VET SERV HORS S, V7; Boyce MK, 2013, OSTEOARTHR CARTILAGE, V21, P746, DOI 10.1016/j.joca.2013.02.653; Buckwalter JA, 1997, J BONE JOINT SURG AM, V79A, P612, DOI 10.2106/00004623-199704000-00022; Callender GR, 1938, AM J PATHOL, V14, P253; CHANDNANI VP, 1991, RADIOLOGY, V178, P557, DOI 10.1148/radiology.178.2.1987624; Cleary OB, 2010, AM J VET RES, V71, P33, DOI 10.2460/ajvr.71.1.33; FOLAND JW, 1994, VET SURG, V23, P369, DOI 10.1111/j.1532-950X.1994.tb00497.x; Frisbie DD, 2008, OSTEOARTHR CARTILAGE, V16, P1196, DOI 10.1016/j.joca.2008.03.008; Frisbie DD, 1997, EQUINE VET J, V29, P349, DOI 10.1111/j.2042-3306.1997.tb03138.x; Frisbie DD, 2003, CLIN ORTHOP RELAT R, P215, DOI 10.1097/01.blo.0000030514.43495.f3; Frisbie DD, 2002, GENE THER, V9, P12, DOI 10.1038/sj.gt.3301608; Gossec L, 2008, OSTEOARTHR CARTILAGE, V16, P742, DOI 10.1016/j.joca.2008.02.021; Kawcak CE, 2008, OSTEOARTHR CARTILAGE, V16, P1519, DOI 10.1016/j.joca.2008.04.015; Kawcak CE, 2001, EQUINE VET J, V33, P120, DOI 10.1111/j.2042-3306.2001.tb00589.x; Keegan KG, 2012, AM J VET RES, V73, P368, DOI 10.2460/ajvr.73.3.368; Marijnissen ACA, 2002, OSTEOARTHR CARTILAGE, V10, P145, DOI 10.1053/joca.2001.0491; Marijnissen ACA, 2002, OSTEOARTHR CARTILAGE, V10, P282, DOI 10.1053/joca.2001.0507; Mastbergen SC, 2008, OSTEOARTHR CARTILAGE, V16, P919, DOI 10.1016/j.joca.2007.11.010; Mastbergen SC, 2006, OSTEOARTHR CARTILAGE, V14, P39, DOI 10.1016/j.joca.2004.07.009; McCracken MJ, 2012, EQUINE VET J, V44, P652, DOI 10.1111/j.2042-3306.2012.00571.x; McIlwraith CW, 2010, OSTEOARTHR CARTILAGE, V18, pS93, DOI 10.1016/j.joca.2010.05.031; Mcllwraith CW, 1988, EQUINE VET J S, VS6, P3; Neundorf RH, 2010, AM J VET RES, V71, P1284, DOI 10.2460/ajvr.71.11.1284; Norrdin R. W., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P251; Norrdin R. W., 2001, Journal of Musculoskeletal & Neuronal Interactions, V1, P357; Norrdin RW, 1998, BONE, V22, P133, DOI 10.1016/S8756-3282(97)00253-6; RICHARDSON DW, 1993, AM J VET RES, V54, P449; Rickey EJ, 2012, AM J VET RES, V73, P1540, DOI 10.2460/ajvr.73.10.1540; Simmons EJ, 1999, AM J VET RES, V60, P7; van Harreveld PD, 2002, AM J VET RES, V63, P276, DOI 10.2460/ajvr.2002.63.276	30	17	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0115089	10.1371/journal.pone.0115089	http://dx.doi.org/10.1371/journal.pone.0115089			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680102	gold, Green Published, Green Submitted			2022-12-26	WOS:000350682600005
J	Palacios-Garcia, I; Lara-Vasquez, A; Montiel, JF; Diaz-Veliz, GF; Sepulveda, H; Utreras, E; Montecino, M; Gonzalez-Billault, C; Aboitiz, F				Palacios-Garcia, Ismael; Lara-Vasquez, Ariel; Montiel, Juan F.; Diaz-Veliz, Gabriela F.; Sepulveda, Hugo; Utreras, Elias; Montecino, Martin; Gonzalez-Billault, Christian; Aboitiz, Francisco			Prenatal Stress Down-Regulates Reelin Expression by Methylation of Its Promoter and Induces Adult Behavioral Impairments in Rats	PLOS ONE			English	Article							PUTATIVE VULNERABILITY FACTOR; ELEVATED PLUS-MAZE; PREFRONTAL CORTEX; SYNAPTIC PLASTICITY; LEARNING-DEFICITS; BRAIN-DEVELOPMENT; BIPOLAR DISORDER; CAJAL-RETZIUS; EXPLORATORY-BEHAVIOR; GESTATIONAL STRESS	Prenatal stress causes predisposition to cognitive and emotional disturbances and is a risk factor towards the development of neuropsychiatric conditions like depression, bipolar disorders and schizophrenia. The extracellular protein Reelin, expressed by Cajal-Retzius cells during cortical development, plays critical roles on cortical lamination and synaptic maturation, and its deregulation has been associated with maladaptive conditions. In the present study, we address the effect of prenatal restraint stress (PNS) upon Reelin expression and signaling in pregnant rats during the last 10 days of pregnancy. Animals from one group, including control and PNS exposed fetuses, were sacrificed and analyzed using immunohistochemical, biochemical, cell biology and molecular biology approaches. We scored changes in the expression of Reelin, its signaling pathway and in the methylation of its promoter. A second group included control and PNS exposed animals maintained until young adulthood for behavioral studies. Using the optical dissector, we show decreased numbers of Reelin-positive neurons in cortical layer I of PNS exposed animals. In addition, neurons from PNS exposed animals display decreased Reelin expression that is paralleled by changes in components of the Reelin-signaling cascade, both in vivo and in vitro. Furthermore, PNS induced changes in the DNA methylation levels of the Reelin promoter in culture and in histological samples. PNS adult rats display excessive spontaneous locomotor activity, high anxiety levels and problems of learning and memory consolidation. No significant visuo-spatial memory impairment was detected on the Morris water maze. These results highlight the effects of prenatal stress on the Cajal-Retzius neuronal population, and the persistence of behavioral consequences using this treatment in adults, thereby supporting a relevant role of PNS in the genesis of neuropsychiatric diseases. We also propose an in vitro model that can yield new insights on the molecular mechanisms behind the effects of prenatal stress.	[Palacios-Garcia, Ismael; Lara-Vasquez, Ariel; Aboitiz, Francisco] Pontificia Univ Catolica Chile, Escuela Med, Dept Psiquiatria, Santiago, Chile; [Palacios-Garcia, Ismael; Lara-Vasquez, Ariel; Aboitiz, Francisco] Pontificia Univ Catolica Chile, Ctr Interdisciplinario Neurociencia, Santiago, Chile; [Montiel, Juan F.] Univ Diego Portales, Fac Med, Ctr Invest Biomed, Santiago, Chile; [Diaz-Veliz, Gabriela F.] Univ Chile, Inst Ciencias Biomed, Programa Farmacol Mol & Clin, Santiago, Chile; [Palacios-Garcia, Ismael; Utreras, Elias; Gonzalez-Billault, Christian] Univ Chile, Fac Sci, Dept Biol, Lab Cell & Neuronal Dynam Cenedyn, Santiago, Chile; [Sepulveda, Hugo; Montecino, Martin] Univ Andres Bello, Fac Biol Sci, Ctr Biomed Res, Santiago, Chile; [Sepulveda, Hugo; Montecino, Martin] Univ Andres Bello, Fac Med, Santiago, Chile; [Sepulveda, Hugo; Montecino, Martin] Univ Andres Bello, Fondo Areas Prioritarias FONDAP, Ctr Genome Regulat, Santiago, Chile	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; University Diego Portales; Universidad de Chile; Universidad de Chile; Universidad Andres Bello; Universidad Andres Bello; Universidad Andres Bello	Gonzalez-Billault, C (corresponding author), Univ Chile, Fac Sci, Dept Biol, Lab Cell & Neuronal Dynam Cenedyn, Santiago, Chile.	chrgonza@uchile.cl; faboitiz@puc.cl	Gonzalez-Billault, Christian/P-2393-2019; Utreras, Elias/I-1038-2013; Gonzalez-Billault, Christian/K-9622-2013	Utreras, Elias/0000-0002-1004-0466; Diaz-Veliz, Gabriela/0000-0001-9549-4485; Gonzalez-Billault, Christian/0000-0003-0335-1482; Montiel, Juan F/0000-0001-8919-4662	Millennium Center for the Neuroscience of Memory, Chile [NC10-001-F]; program for Innovation for Competitivity of the Ministry for Economics, Fomentation and Tourism, Chile; FONDAP [15090007]; Becas Chile postdoctoral fellowship;  [ACT114]	Millennium Center for the Neuroscience of Memory, Chile; program for Innovation for Competitivity of the Ministry for Economics, Fomentation and Tourism, Chile; FONDAP; Becas Chile postdoctoral fellowship; 	This work has been supported by the Millennium Center for the Neuroscience of Memory, Chile, (NC10-001-F), developed with funds from the program for Innovation for Competitivity of the Ministry for Economics, Fomentation and Tourism, Chile (to FA). Also supported by ACT114 (to CG-B) and FONDAP 15090007 (to MM). JFM is a recipient of Becas Chile postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdolmaleky HM, 2005, AM J MED GENET B, V134B, P60, DOI 10.1002/ajmg.b.30140; Aboitiz F, 1999, CEREB CORTEX, V9, P655, DOI 10.1093/cercor/9.7.655; Aboitiz F, 2011, BRAIN RES BULL, V84, P125, DOI 10.1016/j.brainresbull.2010.12.003; Alcantara S, 2006, CEREB CORTEX, V16, P487, DOI 10.1093/cercor/bhi128; Alcantara S, 1998, J NEUROSCI, V18, P7779; Andrus BM, 2010, MOL PSYCHIAT; Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; Badea A, 2007, NEUROIMAGE, V34, P1363, DOI 10.1016/j.neuroimage.2006.09.053; Baker S, 2009, BRAIN RES, V1302, P194, DOI 10.1016/j.brainres.2009.09.023; Ballif BA, 2004, CURR BIOL, V14, P606, DOI 10.1016/j.cub.2004.03.038; Baquedano E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027549; BAYER SA, 1993, NEUROTOXICOLOGY, V14, P83; Bielle F, 2005, NAT NEUROSCI, V8, P1002, DOI 10.1038/nn1511; Bland ST, 2005, BRAIN RES, V1051, P90, DOI 10.1016/j.brainres.2005.05.065; Calabrese F., 2009, PSYCHONEUROENDOCRINO, V34, pS208, DOI DOI 10.1016/J.PSYNEUEN.2009.05.014; Chai XJ, 2009, J NEUROSCI, V29, P288, DOI 10.1523/JNEUROSCI.2934-08.2009; Charil A, 2010, BRAIN RES REV, V65, P56, DOI 10.1016/j.brainresrev.2010.06.002; Charles Paxinos GaW, 2007, RAT BRAIN STEREOTAXI; Chen Y, 2005, J NEUROSCI, V25, P8209, DOI 10.1523/JNEUROSCI.1951-05.2005; Contreras-Vallejos E, 2012, CELL SIGNAL, V24, P44, DOI 10.1016/j.cellsig.2011.08.022; CRUZORIVE LM, 1990, AM J PHYSIOL, V258, pL148, DOI 10.1152/ajplung.1990.258.4.L148; Curran T, 1998, BRAIN RES REV, V26, P285, DOI 10.1016/S0165-0173(97)00035-0; Dagnino-Subiabre A, 2006, BRAIN RES, V1086, P27, DOI 10.1016/j.brainres.2006.02.118; Dayan J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012942; DEMINIERE JM, 1992, BRAIN RES, V586, P135, DOI 10.1016/0006-8993(92)91383-P; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Diaz-Veliz G, 2004, NEUROTOX RES, V5, P629; DIAZVELIZ G, 1989, PHYSIOL BEHAV, V46, P397, DOI 10.1016/0031-9384(89)90010-3; Emack J, 2008, HORM BEHAV, V54, P514, DOI 10.1016/j.yhbeh.2008.02.025; Estanislau C, 2006, INT J DEV NEUROSCI, V24, P255, DOI 10.1016/j.ijdevneu.2006.03.001; Fatemi SH, 2011, NEUROPSYCHOPHARMACOL, V36, P2371, DOI 10.1038/npp.2011.169; Fatemi SH, 2000, MOL PSYCHIATR, V5, P654, DOI 10.1038/sj.mp.4000783; Feng LB, 2009, MOL CELL BIOL, V29, P324, DOI 10.1128/MCB.00663-08; Folsom TD, 2013, NEUROPHARMACOLOGY, V68, P122, DOI 10.1016/j.neuropharm.2012.08.015; Frotscher M, 2010, TRENDS NEUROSCI, V33, P407, DOI 10.1016/j.tins.2010.06.001; Fujioka A, 2006, NEUROSCIENCE, V141, P907, DOI 10.1016/j.neuroscience.2006.04.046; Gonzalez-Billault C, 2005, CEREB CORTEX, V15, P1134, DOI 10.1093/cercor/bhh213; Gray TS, 1996, CRIT REV NEUROBIOL, V10, P155, DOI 10.1615/CritRevNeurobiol.v10.i2.10; Grayson DR, 2006, PHARMACOL THERAPEUT, V111, P272, DOI 10.1016/j.pharmthera.2005.01.007; Green MK, 2011, NEUROSCIENCE, V192, P438, DOI 10.1016/j.neuroscience.2011.06.041; Gue M, 2004, BEHAV BRAIN RES, V150, P149, DOI 10.1016/S0166-4328(03)00250-X; Guidotti A, 2000, ARCH GEN PSYCHIAT, V57, P1061, DOI 10.1001/archpsyc.57.11.1061; Gupta A, 2002, NAT REV GENET, V3, P342, DOI 10.1038/nrg799; Hosseini-Sharifabad M, 2007, ANAT SCI INT, V82, P211, DOI 10.1111/j.1447-073x.2007.00186.x; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Impagnatiello F, 1998, P NATL ACAD SCI USA, V95, P15718, DOI 10.1073/pnas.95.26.15718; Martinez-Tellez RI, 2009, SYNAPSE, V63, P794, DOI 10.1002/syn.20664; Jope RS, 2006, CURR DRUG TARGETS, V7, P1421, DOI 10.2174/1389450110607011421; Kolb B, 2012, P NATL ACAD SCI USA, V109, P17186, DOI 10.1073/pnas.1121251109; Krueger DD, 2006, PSYCHOPHARMACOLOGY, V189, P95, DOI 10.1007/s00213-006-0530-0; Kupferman JV, 2014, CELL, V158, P1335, DOI 10.1016/j.cell.2014.07.035; Lemaire V, 2000, P NATL ACAD SCI USA, V97, P11032, DOI 10.1073/pnas.97.20.11032; Levenson JM, 2008, BBA-GENE REGUL MECH, V1779, P422, DOI 10.1016/j.bbagrm.2008.01.001; Liu WS, 2001, P NATL ACAD SCI USA, V98, P3477, DOI 10.1073/pnas.051614698; Lordi B, 1997, PHYSIOL BEHAV, V62, P1087, DOI 10.1016/S0031-9384(97)00261-8; Lui CC, 2011, NEUROCHEM INT, V58, P434, DOI 10.1016/j.neuint.2011.01.002; Lussier AL, 2011, NEUROPHARMACOLOGY, V60, P1064, DOI 10.1016/j.neuropharm.2010.09.007; Lussier AL, 2009, NEUROSCI LETT, V460, P170, DOI 10.1016/j.neulet.2009.05.050; Marrone MC, 2006, EUR J NEUROSCI, V24, P2061, DOI 10.1111/j.1460-9568.2006.05083.x; Matrisciano F, 2012, NEUROPHARMACOLOGY; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mychasiuk R, 2011, NEUROSCIENCE, V180, P105, DOI 10.1016/j.neuroscience.2011.02.026; Negron-Oyarzo I, 2014, CEREB CORTEX; Niu S, 2004, NEURON, V41, P71, DOI 10.1016/S0896-6273(03)00819-5; Ognibene E, 2007, BRAIN RES, V1131, P173, DOI 10.1016/j.brainres.2006.11.007; Ohmiya M, 2002, NEUROSCI LETT, V317, P21, DOI 10.1016/S0304-3940(01)02412-0; Ordyan N E, 2003, Neurosci Behav Physiol, V33, P899, DOI 10.1023/A:1025952906715; Pappas GD, 2001, J NEUROCYTOL, V30, P413; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; PETERS DAV, 1986, PHARMACOL BIOCHEM BE, V25, P873, DOI 10.1016/0091-3057(86)90400-4; Podhorna J, 2004, BEHAV BRAIN RES, V153, P43, DOI 10.1016/j.bbr.2003.10.033; Poltyrev T, 1996, DEV PSYCHOBIOL, V29, P453, DOI 10.1002/(SICI)1098-2302(199607)29:5<453::AID-DEV4>3.0.CO;2-N; Qin LN, 2011, BEHAV BRAIN RES, V217, P142, DOI 10.1016/j.bbr.2010.10.018; Qiu SF, 2006, J NEUROSCI, V26, P12943, DOI 10.1523/JNEUROSCI.2561-06.2006; Qui SF, 2006, NEUROBIOL LEARN MEM, V85, P228, DOI 10.1016/j.nlm.2005.11.001; Richardson HN, 2006, ENDOCRINOLOGY, V147, P2506, DOI 10.1210/en.2005-1054; Ringstedt T, 1998, NEURON, V21, P305, DOI 10.1016/S0896-6273(00)80540-1; ROUTTENBERG A, 1978, DEV PSYCHOBIOL, V11, P469, DOI 10.1002/dev.420110510; Salm AK, 2004, DEV BRAIN RES, V148, P159, DOI 10.1016/j.devbrainres.2003.11.005; Seckl JR, 2007, NAT CLIN PRACT ENDOC, V3, P479, DOI 10.1038/ncpendmet0515; Seckl JR, 2001, MOL CELL ENDOCRINOL, V185, P61, DOI 10.1016/S0303-7207(01)00633-5; Sharaf A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071091; SMITH MA, 1995, ENDOCRINOLOGY, V136, P3743, DOI 10.1210/en.136.9.3743; Stranahan AM, 2013, AGEING RES REV, V12, P815, DOI 10.1016/j.arr.2013.01.005; Stranahan AM, 2011, NEUROBIOL LEARN MEM, V96, P150, DOI 10.1016/j.nlm.2011.03.009; Szymanska M, 2009, PHARMACOL REP, V61, P612, DOI 10.1016/S1734-1140(09)70113-6; Tamura M, 2011, J NEUROSCI, V31, P11505, DOI 10.1523/JNEUROSCI.3447-10.2011; Teixeira CM, 2011, NEUROPSYCHOPHARMACOL, V36, P2395, DOI 10.1038/npp.2011.153; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Tueting P, 1999, NEUROREPORT, V10, P1329, DOI 10.1097/00001756-199904260-00032; Tueting P, 2006, NEUROSCI BIOBEHAV R, V30, P1065, DOI 10.1016/j.neubiorev.2006.04.001; Ulupinar E, 2011, NEUROTOXICOL TERATOL, V33, P548, DOI 10.1016/j.ntt.2011.07.009; Utreras E, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-24; Utreras E, 2013, NEUROCHEM INT, V62, P848, DOI 10.1016/j.neuint.2013.02.011; Vallee M, 1997, J NEUROSCI, V17, P2626; Ventruti A, 2011, NEUROSCIENCE, V189, P32, DOI 10.1016/j.neuroscience.2011.05.050; Villagra A, 2002, J CELL BIOCHEM, V85, P112, DOI 10.1002/jcb.10113; Vyas A, 2002, J NEUROSCI, V22, P6810; Weeber EJ, 2002, J BIOL CHEM, V277, P39944, DOI 10.1074/jbc.M205147200; Weinstock M, 2001, PROG NEUROBIOL, V65, P427, DOI 10.1016/S0301-0082(01)00018-1; WILLIAMS DI, 1979, PERCEPT MOTOR SKILL, V49, P46, DOI 10.2466/pms.1979.49.1.46; Wu J, 2007, BRAIN RES, V1141, P205, DOI 10.1016/j.brainres.2007.01.024; Zagron G, 2006, BEHAV BRAIN RES, V175, P323, DOI 10.1016/j.bbr.2006.09.003	104	43	45	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117680	10.1371/journal.pone.0117680	http://dx.doi.org/10.1371/journal.pone.0117680			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679528	Green Published, Green Submitted, gold			2022-12-26	WOS:000350682600079
J	Daringer, NM; Schwarz, KA; Leonard, JN				Daringer, Nichole M.; Schwarz, Kelly A.; Leonard, Joshua N.			Contributions of Unique Intracellular Domains to Switchlike Biosensing by Toll-like Receptor 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEGATIVE REGULATION; IMMUNE-RESPONSES; CELL-ACTIVATION; PLASMA-MEMBRANE; PROTEIN TMED7; TLR4; TOLL-LIKE-RECEPTOR-4; COMPLEX; INNATE; DIMERIZATION	Toll-like receptors (TLRs) mediate immune recognition of both microbial infections and tissue damage. Aberrant TLR signaling promotes disease; thus, understanding the regulation of TLR signaling is of medical relevance. Although downstream mediators of TLR signaling have been identified, the detailed mechanism by which ligand binding-mediated dimerization induces downstream signaling remains poorly understood. Here, we investigate this question for TLR4, which mediates responsiveness to bacterial LPS and drives inflammatory disease. TLR4 exhibits structural and functional features that are unique among TLRs, including responsiveness to a wide variety of ligands. However, the connection between these structural features and the regulation of signaling is not clear. Here, we investigated how the unique intracellular structures of TLR4 contribute to receptor signaling. Key conclusions include the following. 1) The unique intracellular linker of TLR4 is important for achieving LPS-inducible signaling via Toll/IL-1 receptor (TIR) domain-containing adapter-inducing interferon-beta (TRIF) but less so for signaling via myeloid differentiation primary response 88 (MyD88). 2) Membrane-bound TLR4 TIR domains were sufficient to induce signaling. However, introducing long, flexible intracellular linkers neither induced constitutive signaling nor ablated LPS-inducible signaling. Thus, the initiation of TLR4 signaling is regulated by a mechanism that does not require tight geometric constraints. Together, these observations necessitate refining the model of TLR4 signal initiation. We hypothesize that TLR4 may interact with an inhibitory partner in the absence of ligand, via both TIR and extracellular domains of TLR4. In this speculative model, ligand binding induces dissociation of the inhibitory partner, triggering spontaneous, switchlike TIR domain homodimerization to initiate downstream signaling.	[Daringer, Nichole M.; Schwarz, Kelly A.; Leonard, Joshua N.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA; [Leonard, Joshua N.] Northwestern Univ, Chem Life Proc Inst, Evanston, IL 60208 USA; [Leonard, Joshua N.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60208 USA	Northwestern University; Northwestern University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center	Leonard, JN (corresponding author), Northwestern Univ, Dept Chem & Biol Engn, 2145 Sheridan Rd,Rm E136, Evanston, IL 60208 USA.	j-leonard@northwestern.edu	Leonard, Joshua/B-7649-2009	Leonard, Joshua/0000-0003-4359-6126	National Institutes of Health, NCI, Cancer Center Support Grant [CA060553]; Defense Advanced Research Projects Agency [W911NF-11-2-0066]; National Academies Keck Futures Initiative [NAKFI-SB6]; National Institutes of Health T32 Training Grant through Northwestern University's Biotechnology Training Program [GM 008449]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008449] Funding Source: NIH RePORTER	National Institutes of Health, NCI, Cancer Center Support Grant; Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); National Academies Keck Futures Initiative; National Institutes of Health T32 Training Grant through Northwestern University's Biotechnology Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health, NCI, Cancer Center Support Grant CA060553. This work was also supported by Defense Advanced Research Projects Agency Award W911NF-11-2-0066 and by the National Academies Keck Futures Initiative (NAKFI-SB6).; Supported in part by National Institutes of Health T32 Training Grant GM 008449 through Northwestern University's Biotechnology Training Program.	Bell JK, 2006, P NATL ACAD SCI USA, V103, P8792, DOI 10.1073/pnas.0603245103; Daringer NM, 2014, ACS SYNTH BIOL, V3, P892, DOI 10.1021/sb400128g; Divanovic S, 2005, J ENDOTOXIN RES, V11, P363, DOI 10.1179/096805105X67300; Divanovic S, 2005, NAT IMMUNOL, V6, P571, DOI 10.1038/ni1198; Doyle SL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1706; Fekonja O, 2012, CURR PROTEIN PEPT SC, V13, P776, DOI 10.2174/138920312804871148; Gay NJ, 2014, NAT REV IMMUNOL, V14, P546, DOI 10.1038/nri3713; Georgel P, 2007, VIROLOGY, V362, P304, DOI 10.1016/j.virol.2006.12.032; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gioannini TL, 2004, P NATL ACAD SCI USA, V101, P4186, DOI 10.1073/pnas.0306906101; Godfroy JI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048875; Hennessy EJ, 2010, NAT REV DRUG DISCOV, V9, P293, DOI 10.1038/nrd3203; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kang JY, 2011, ANNU REV BIOCHEM, V80, P917, DOI 10.1146/annurev-biochem-052909-141507; Kim S, 2013, MOL MED, V19, P88, DOI 10.2119/molmed.2012.00306; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Kondo T, 2012, TRENDS IMMUNOL, V33, P449, DOI 10.1016/j.it.2012.05.002; Lee CC, 2012, NAT REV IMMUNOL, V12, P168, DOI 10.1038/nri3151; Leonard JN, 2008, P NATL ACAD SCI USA, V105, P258, DOI 10.1073/pnas.0710779105; Liaunardy-Jopeace A, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00473; Liaunardy-Jopeace A, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005275; Marr N, 2012, INNATE IMMUN-LONDON, V18, P856, DOI 10.1177/1753425912444479; Miguel RN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000788; Mills KHG, 2011, NAT REV IMMUNOL, V11, P807, DOI 10.1038/nri3095; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Nishiya T, 2006, BIOCHEM BIOPH RES CO, V341, P1128, DOI 10.1016/j.bbrc.2006.01.074; Panter G, 2011, J BIOL CHEM, V286, P23334, DOI 10.1074/jbc.M110.205419; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Raghavan B, 2012, EMBO REP, V13, P1109, DOI 10.1038/embor.2012.155; Reuven EM, 2014, BBA-BIOMEMBRANES, V1838, P1586, DOI 10.1016/j.bbamem.2014.01.020; Savva A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00387; Schmidt M, 2010, NAT IMMUNOL, V11, P814, DOI 10.1038/ni.1919; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Smiley ST, 2001, J IMMUNOL, V167, P2887, DOI 10.4049/jimmunol.167.5.2887; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Treeby M, 2009, BIOCHEM BIOPH RES CO, V381, P65, DOI 10.1016/j.bbrc.2009.02.017; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Visintin A, 2006, J LEUKOCYTE BIOL, V80, P1584, DOI 10.1189/jlb.0606388; Wang D, 2010, P NATL ACAD SCI USA, V107, P13806, DOI 10.1073/pnas.1009428107; Wang JQ, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00367; Zhang HF, 2002, FEBS LETT, V532, P171, DOI 10.1016/S0014-5793(02)03669-4	44	4	4	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					8764	8777		10.1074/jbc.M114.610063	http://dx.doi.org/10.1074/jbc.M114.610063			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25694428	Green Published, hybrid			2022-12-26	WOS:000352207100008
J	Monaco, G; Decrock, E; Arbel, N; van Vliet, AR; La Rovere, RM; De Smedt, H; Parys, JB; Agostinis, P; Leybaert, L; Shoshan-Barmatz, V; Bultynck, G				Monaco, Giovanni; Decrock, Elke; Arbel, Nir; van Vliet, Alexander R.; La Rovere, Rita M.; De Smedt, Humbert; Parys, Jan B.; Agostinis, Patrizia; Leybaert, Luc; Shoshan-Barmatz, Varda; Bultynck, Geert			The BH4 Domain of Anti-apoptotic Bcl-XL, but Not That of the Related Bcl-2, Limits the Voltage-dependent Anion Channel 1 (VDAC1)-mediated Transfer of Pro-apoptotic Ca2+ Signals to Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE; ENDOPLASMIC-RETICULUM; CALCIUM-RELEASE; CELL-DEATH; VDAC; MEMBRANE; PROTEIN; ER; BCL-X(L); MODULATION	Excessive Ca2+ fluxes from the endoplasmic reticulum to the mitochondria result in apoptotic cell death. Bcl-2 and Bcl-XL proteins exert part of their anti-apoptotic function by directly targeting Ca2+-transport systems, like the endoplasmic reticulum-localized inositol 1,4,5-trisphosphate receptors (IP(3)Rs) and the voltage-dependent anion channel 1 (VDAC1) at the outer mitochondrial membranes. We previously demonstrated that the Bcl-2 homology 4 (BH4) domain of Bcl-2 protects against Ca2+-dependent apoptosis by binding and inhibiting IP(3)Rs, although the BH4 domain of Bcl-XL was protective independently of binding IP(3)Rs. Here, we report that in contrast to the BH4 domain of Bcl-2, the BH4 domain of Bcl-XL binds and inhibits VDAC1. In intact cells, delivery of the BH4-Bcl-XL peptide via electroporation limits agonist-induced mitochondrial Ca2+ uptake and protects against staurosporine-induced apoptosis, in line with the results obtained with VDAC1(-/-) cells. Moreover, the delivery of the N-terminal domain of VDAC1 as a synthetic peptide (VDAC1-NP) abolishes the ability of BH4-Bcl-XL to suppress mitochondrial Ca2+ uptake and to protect against apoptosis. Importantly, VDAC1-NP did not affect the ability of BH4-Bcl-2 to suppress agonist-induced Ca2+ release in the cytosol or to prevent apoptosis, as done instead by an IP3R-derived peptide. In conclusion, our data indicate that the BH4 domain of Bcl-XL, but not that of Bcl-2, selectively targets VDAC1 and inhibits apoptosis by decreasing VDAC1-mediated Ca2+ uptake into the mitochondria.	[Monaco, Giovanni; La Rovere, Rita M.; De Smedt, Humbert; Parys, Jan B.; Bultynck, Geert] Katholieke Univ Leuven, Dept Cellular & Mol Med, Lab Mol & Cellular Signaling, B-3000 Leuven, Belgium; [van Vliet, Alexander R.; Agostinis, Patrizia] Katholieke Univ Leuven, Dept Cellular & Mol Med, Lab Cell Death Res & Therapy, B-3000 Leuven, Belgium; [Decrock, Elke; Leybaert, Luc] Univ Ghent, Fac Med & Hlth Sci, Dept Basic Med Sci, Physiol Grp, B-9000 Ghent, Belgium; [Arbel, Nir; Shoshan-Barmatz, Varda] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Arbel, Nir; Shoshan-Barmatz, Varda] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel; [La Rovere, Rita M.] Univ G DAnnunzio, Fac Pharm, Dept Neurosci Imaging & Clin Sci, Lab Cellular Physiol, I-66013 Chieti, Italy	KU Leuven; KU Leuven; Ghent University; Ben Gurion University; Ben Gurion University; G d'Annunzio University of Chieti-Pescara	Monaco, G (corresponding author), Katholieke Univ Leuven, Dept Cellular & Mol Med, Lab Mol & Cellular Signaling, Campus Gasthuisberg,Herestr 49,O&N1,Bus 802, B-3000 Leuven, Belgium.	giovanni.monaco@med.kuleuven.be; geert.bultynck@med.kuleuven.be	van Vliet, Alexander R/G-8588-2016; Agostinis, Patrizia/ABI-1177-2020; Leybaert, Luc/F-4079-2015; Monaco, Giovanni/J-2957-2019; Agostinis, Patrizia/AAO-2468-2020	van Vliet, Alexander R/0000-0003-4729-4379; Agostinis, Patrizia/0000-0003-1314-2115; Leybaert, Luc/0000-0001-6452-6982; Monaco, Giovanni/0000-0001-5209-4326; Parys, Jan/0000-0002-3591-4967; Bultynck, Geert/0000-0002-5968-4828	Research Foundation-Flanders [6.057.12, G.0134.09N]; Research Council of the KU Leuven [STRT1/10/044, OT/14/101]; Interuniversity Attraction Poles Program, Belgian Science Policy [P7/13]; Israel Science Foundation [649/09, 307/13]; Research Foundation-Flanders; Innovation by Science and Technology (IWT) Vlaanderen	Research Foundation-Flanders(FWO); Research Council of the KU Leuven(KU Leuven); Interuniversity Attraction Poles Program, Belgian Science Policy(Belgian Federal Science Policy Office); Israel Science Foundation(Israel Science Foundation); Research Foundation-Flanders(FWO); Innovation by Science and Technology (IWT) Vlaanderen(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This work was supported in part by Research Foundation-Flanders Grants 6.057.12 (to G. B. and L. L.) and G.0134.09N (to L. L.), Research Council of the KU Leuven Grants STRT1/10/044 and OT/14/101 (to G. B.), Interuniversity Attraction Poles Program, Belgian Science Policy P7/13 (to G. B. and J. B. P.), and Israel Science Foundation Grants 649/09 and 307/13 (to V. S.-B. and N. A.).; Supported by postdoctoral fellowships provided by the Research Foundation-Flanders.; Recipient of a fellowship from Innovation by Science and Technology (IWT) Vlaanderen.	Abu-Hamad S, 2009, J CELL SCI, V122, P1906, DOI 10.1242/jcs.040188; Arbel N, 2012, J BIOL CHEM, V287, P23152, DOI 10.1074/jbc.M112.345918; Arbel N, 2010, J BIOL CHEM, V285, P6053, DOI 10.1074/jbc.M109.082990; Arzoine L, 2009, J BIOL CHEM, V284, P3946, DOI 10.1074/jbc.M803614200; Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Bultynck G, 2004, BIOCHEM J, V381, P87, DOI 10.1042/BJ20040072; Chen R, 2004, J CELL BIOL, V166, P193, DOI 10.1083/jcb.200309146; Csordas G, 1999, EMBO J, V18, P96, DOI 10.1093/emboj/18.1.96; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; De Stefani D, 2012, CELL DEATH DIFFER, V19, P267, DOI 10.1038/cdd.2011.92; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Decrock E, 2009, CELL DEATH DIFFER, V16, P151, DOI 10.1038/cdd.2008.138; Decrock E., 2014, CALCIUM TECHNIQUES L, P93; Decuypere JP, 2011, BBA-MOL CELL RES, V1813, P1003, DOI 10.1016/j.bbamcr.2010.11.023; Deniaud A, 2007, LANGMUIR, V23, P3898, DOI 10.1021/la063105+; Distelhorst CW, 2011, CELL CALCIUM, V50, P234, DOI 10.1016/j.ceca.2011.05.011; Eckenrode EF, 2010, J BIOL CHEM, V285, P13678, DOI 10.1074/jbc.M109.096040; Eno CO, 2012, MOL BIOL CELL, V23, P2605, DOI 10.1091/mbc.E12-02-0090; Gincel D, 2001, BIOCHEM J, V358, P147, DOI 10.1042/0264-6021:3580147; Giorgi C, 2009, INT J BIOCHEM CELL B, V41, P1817, DOI 10.1016/j.biocel.2009.04.010; Gunter TE, 1998, BBA-BIOENERGETICS, V1366, P5, DOI 10.1016/S0005-2728(98)00117-0; Harr MW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005579; Heiden MGV, 2001, J BIOL CHEM, V276, P19414, DOI 10.1074/jbc.M101590200; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Huang H, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.419; Huang HY, 2013, J BIOL CHEM, V288, P19870, DOI 10.1074/jbc.M112.448290; Ivanova H, 2014, BBA-MOL CELL RES, V1843, P2164, DOI 10.1016/j.bbamcr.2014.03.007; Jonas EA, 2004, P NATL ACAD SCI USA, V101, P13590, DOI 10.1073/pnas.0401372101; Kaufmann T, 2003, J CELL BIOL, V160, P53, DOI 10.1083/jcb.200210084; Kerner J, 2012, BBA-BIOMEMBRANES, V1818, P1520, DOI 10.1016/j.bbamem.2011.11.013; Kutuk O, 2008, CURR MOL MED, V8, P102; Lemasters JJ, 2006, BBA-MOL BASIS DIS, V1762, P181, DOI 10.1016/j.bbadis.2005.10.006; Lemeshko VV, 2006, EUR BIOPHYS J BIOPHY, V36, P57, DOI 10.1007/s00249-006-0101-7; Lewis A, 2014, J BIOENERG BIOMEMBR, V46, P1, DOI 10.1007/s10863-013-9527-7; Liu YQ, 2011, BIOCHEM BIOPH RES CO, V404, P364, DOI 10.1016/j.bbrc.2010.11.124; Malia TJ, 2007, BIOCHEMISTRY-US, V46, P514, DOI 10.1021/bi061577h; McNally MA, 2013, MITOCHONDRION, V13, P119, DOI 10.1016/j.mito.2013.01.004; Mertins B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047938; Meunier J, 2010, J PHARMACOL EXP THER, V332, P388, DOI 10.1124/jpet.109.160960; Michels Judith, 2013, Int J Cell Biol, V2013, P705294, DOI 10.1155/2013/705294; Monaco G, 2012, CELL DEATH DIFFER, V19, P295, DOI 10.1038/cdd.2011.97; Monaco G, 2013, CELL MOL LIFE SCI, V70, P1171, DOI 10.1007/s00018-012-1118-y; Monaco G, 2012, BIOCHEM BIOPH RES CO, V428, P31, DOI 10.1016/j.bbrc.2012.10.002; Naon D, 2014, BBA-MOL CELL RES, V1843, P2184, DOI 10.1016/j.bbamcr.2014.05.011; Pastorino JG, 2003, CURR MED CHEM, V10, P1535, DOI 10.2174/0929867033457269; Patergnani S, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-19; Pinton P, 2008, ONCOGENE, V27, P6407, DOI 10.1038/onc.2008.308; Porcelli AM, 2005, BIOCHEM BIOPH RES CO, V326, P799, DOI 10.1016/j.bbrc.2004.11.105; Putt KS, 2006, NAT CHEM BIOL, V2, P543, DOI 10.1038/nchembio814; Rapizzi E, 2002, J CELL BIOL, V159, P613, DOI 10.1083/jcb.200205091; Raturi A, 2013, BBA-MOL CELL RES, V1833, P213, DOI 10.1016/j.bbamcr.2012.04.013; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; Rong YP, 2008, MOL CELL, V31, P255, DOI 10.1016/j.molcel.2008.06.014; Rong YP, 2009, P NATL ACAD SCI USA, V106, P14397, DOI 10.1073/pnas.0907555106; Sabirov RZ, 2006, J BIOL CHEM, V281, P1897, DOI 10.1074/jbc.M509482200; Shi Y, 2003, BIOCHEM BIOPH RES CO, V305, P989, DOI 10.1016/S0006-291X(03)00871-4; Shimizu S, 2000, P NATL ACAD SCI USA, V97, P3100, DOI 10.1073/pnas.97.7.3100; Shoshan-Barmatz V, 2004, BBA-BIOENERGETICS, V1657, P105, DOI 10.1016/j.bbabio.2004.02.009; Shoshan-Barmatz V, 2012, CURR MED CHEM, V19, P714, DOI 10.2174/092986712798992110; Shoshan-Barmatz V, 2008, J BIOENERG BIOMEMBR, V40, P183, DOI 10.1007/s10863-008-9147-9; Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002; Szabadkai G, 2006, J CELL BIOL, V175, P901, DOI 10.1083/jcb.200608073; Tajeddine N, 2008, ONCOGENE, V27, P4221, DOI 10.1038/onc.2008.63; Tan WZ, 2007, BBA-BIOMEMBRANES, V1768, P2510, DOI 10.1016/j.bbamem.2007.06.002; Thinnes FP, 2012, MOL GENET METAB, V106, P253, DOI 10.1016/j.ymgme.2012.04.008; Tornero D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020423; Van Moorhem M, 2010, CELL CALCIUM, V47, P287, DOI 10.1016/j.ceca.2010.01.001; Vander Heiden MG, 1999, MOL CELL, V3, P159; Villinger S, 2014, J BIOL CHEM, V289, P13397, DOI 10.1074/jbc.M113.524173; White C, 2005, NAT CELL BIOL, V7, P1021, DOI 10.1038/ncb1302; Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151; Yehezkel G, 2006, J BIOL CHEM, V281, P5938, DOI 10.1074/jbc.M510104200; Yuan SP, 2008, FASEB J, V22, P2809, DOI 10.1096/fj.08-107417; Zachariae U, 2012, STRUCTURE, V20, P1540, DOI 10.1016/j.str.2012.06.015; ZIZI M, 1994, J BIOL CHEM, V269, P1614	77	95	100	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					9150	9161		10.1074/jbc.M114.622514	http://dx.doi.org/10.1074/jbc.M114.622514			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25681439	hybrid, Green Published			2022-12-26	WOS:000352207100038
J	Toth, A; Brozik, A; Szakacs, G; Sarkadi, B; Hegedus, T				Toth, Attila; Brozik, Anna; Szakacs, Gergely; Sarkadi, Balazs; Hegedus, Tamas			A Novel Mathematical Model Describing Adaptive Cellular Drug Metabolism and Toxicity in the Chemoimmune System	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE; ENZYMES; BIOLOGY; TRANSPORTERS; CANCER; ARSENIC(III); HEPATOCYTES; MECHANISM; PATHWAY; SBML	Cells cope with the threat of xenobiotic stress by activating a complex molecular network that recognizes and eliminates chemically diverse toxic compounds. This "chemoimmune system" consists of cellular Phase I and Phase II metabolic enzymes, Phase 0 and Phase III ATP Binding Cassette (ABC) membrane transporters, and nuclear receptors regulating these components. In order to provide a systems biology characterization of the chemoimmune network, we designed a reaction kinetic model based on differential equations describing Phase 0-III participants and regulatory elements, and characterized cellular fitness to evaluate toxicity. In spite of the simplifications, the model recapitulates changes associated with acquired drug resistance and allows toxicity predictions under variable protein expression and xenobiotic exposure conditions. Our simulations suggest that multidrug ABC transporters at Phase 0 significantly facilitate the defense function of successive network members by lowering intracellular drug concentrations. The model was extended with a novel toxicity framework which opened the possibility of performing in silico cytotoxicity assays. The alterations of the in silico cytotoxicity curves show good agreement with in vitro cell killing experiments. The behavior of the simplified kinetic model suggests that it can serve as a basis for more complex models to efficiently predict xenobiotic and drug metabolism for human medical applications.	[Toth, Attila; Sarkadi, Balazs; Hegedus, Tamas] Hungarian Acad Sci, MTA SE Mol Biophys Res Grp, H-1094 Budapest, Hungary; [Toth, Attila; Sarkadi, Balazs; Hegedus, Tamas] Semmelweis Univ, Dept Biophys & Radiat Biol, H-1094 Budapest, Hungary; [Toth, Attila; Brozik, Anna; Szakacs, Gergely; Sarkadi, Balazs] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, H-1113 Budapest, Hungary	Hungarian Academy of Sciences; Semmelweis University; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Hegedus, T (corresponding author), Hungarian Acad Sci, MTA SE Mol Biophys Res Grp, H-1094 Budapest, Hungary.	hegedus@hegelab.org	Szakacs, Gergely/A-2580-2009; Hegedus, Tamas/P-8625-2015; Sarkadi, Balazs/I-5024-2013	Szakacs, Gergely/0000-0002-9311-7827; Hegedus, Tamas/0000-0002-5195-749X; 	Momentum ("Lendulet") Program of the Hungarian Academy of Sciences; Hungarian Scientific Research Fund [OTKA 83533, OTKA 111678]; Hungarian Research and Technology Innovation Fund ("Kutatasi es Technologiai Innovacios Alap") [KTIA-AIK-12-2012-0025]	Momentum ("Lendulet") Program of the Hungarian Academy of Sciences; Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Research and Technology Innovation Fund ("Kutatasi es Technologiai Innovacios Alap")	This work was supported by Momentum ("Lendulet") Program of the Hungarian Academy of Sciences (http://mta.hu/articles/momentum-program-of-the-hungarian-academy-of-sciences-130009; GS), the Hungarian Scientific Research Fund (http://www.otka.hu/en; OTKA 83533 to BS; OTKA 111678 to TH), and the Hungarian Research and Technology Innovation Fund ("Kutatasi es Technologiai Innovacios Alap"; KTIA-AIK-12-2012-0025; http://ktia.kormany.hu/; TH). TH is a Bolyai Fellow of the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiri-Kordestani L, 2012, DRUG RESIST UPDATE, V15, P50, DOI 10.1016/j.drup.2012.02.002; Bornstein BJ, 2008, BIOINFORMATICS, V24, P880, DOI 10.1093/bioinformatics/btn051; Chen J, 2006, DRUG METAB DISPOS, V34, P1650, DOI 10.1124/dmd.106.009837; Chen YK, 2012, BIOCHEM PHARMACOL, V83, P1112, DOI 10.1016/j.bcp.2012.01.030; Corsini A, 2013, J CLIN PHARMACOL, V53, P463, DOI 10.1002/jcph.23; Csermely P, 2013, STRUCTURE DYNAMICS M; Elsherbiny ME, 2011, DRUG METAB REV, V43, P457, DOI 10.3109/03602532.2011.596204; Emoto C, 2013, CURR DRUG METAB, V14, P239; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Hornberg JJ, 2006, BIOSYSTEMS, V83, P81, DOI 10.1016/j.biosystems.2005.05.014; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; ISHIKAWA T, 1992, TRENDS BIOCHEM SCI, V17, P463, DOI 10.1016/0968-0004(92)90489-V; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Le Novere N, 2009, NAT BIOTECHNOL, V27, P735, DOI 10.1038/nbt.1558; Li HY, 2012, HEPATO-GASTROENTEROL, V59, P2238, DOI 10.5754/hge11781; Lotsch J, 2001, CLIN PHARMACOKINET, V40, P485; Mattson MP, 2008, AGEING RES REV, V7, P1, DOI 10.1016/j.arr.2007.08.007; Nebert DW, 2006, NAT REV CANCER, V6, P947, DOI 10.1038/nrc2015; Sarkadi B, 2006, PHYSIOL REV, V86, P1179, DOI 10.1152/physrev.00037.2005; Sarkadi B, 2010, NAT REV DRUG DISCOV, V9, DOI 10.1038/nrd3187-c1; Shen DW, 2012, PHARMACOL REV, V64, P706, DOI 10.1124/pr.111.005637; Shen GX, 2009, BIOPHARM DRUG DISPOS, V30, P345, DOI 10.1002/bdd.680; SLADEK NE, 1988, PHARMACOL THERAPEUT, V37, P301, DOI 10.1016/0163-7258(88)90004-6; Stamatelos SK, 2013, J THEOR BIOL, V317, P244, DOI 10.1016/j.jtbi.2012.09.019; Stamatelos SK, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-16; Suzuki T, 2013, TRENDS PHARMACOL SCI, V34, P340, DOI 10.1016/j.tips.2013.04.005; Szakacs G, 2008, DRUG DISCOV TODAY, V13, P379, DOI 10.1016/j.drudis.2007.12.010; Townsend DM, 2003, ONCOGENE, V22, P7369, DOI 10.1038/sj.onc.1206940; Vuilhorgne M, 1994, TAXANE ANTICANCER AG, P98; Wang D, 2012, ACTA PHARM SIN B, V2, P107, DOI 10.1016/j.apsb.2012.02.004; Wu CP, 2011, MOL PHARMACEUT, V8, P1996, DOI 10.1021/mp200261n; Zhang Q, 2007, PLOS COMPUT BIOL, V3, P345, DOI 10.1371/journal.pcbi.0030024; Zhang Q, 2009, TOXICOL APPL PHARM, V237, P345, DOI 10.1016/j.taap.2009.04.005	33	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0115533	10.1371/journal.pone.0115533	http://dx.doi.org/10.1371/journal.pone.0115533			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25699998	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000349789800002
J	Feeney, SJ; McGrath, MJ; Sriratana, A; Gehrig, SM; Lynch, GS; D'Arcy, CE; Price, JT; McLean, CA; Tupler, R; Mitchell, CA				Feeney, Sandra J.; McGrath, Meagan J.; Sriratana, Absorn; Gehrig, Stefan M.; Lynch, Gordon S.; D'Arcy, Colleen E.; Price, John T.; McLean, Catriona A.; Tupler, Rossella; Mitchell, Christina A.			FHL1 Reduces Dystrophy in Transgenic Mice Overexpressing FSHD Muscular Dystrophy Region Gene 1 (FRG1)	PLOS ONE			English	Article							FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY; REGION GENE-1 FRG1; ACTIN-BUNDLING PROTEIN; HUMAN-CHROMOSOME 4Q35; SKELETAL-MUSCLE; SATELLITE CELL; MYOGENIC DIFFERENTIATION; MYOTONIC-DYSTROPHY; MYOBLAST FUSION; CANDIDATE GENE	Facioscapulohumeral muscular dystrophy (FSHD) is an autosomal-dominant disease with no effective treatment. The genetic cause of FSHD is complex and the primary pathogenic insult underlying the muscle disease is unknown. Several disease candidate genes have been proposed including DUX4 and FRG1. Expression analysis studies of FSHD report the deregulation of genes which mediate myoblast differentiation and fusion. Transgenic mice overexpressing FRG1 recapitulate the FSHD muscular dystrophy phenotype. Our current study selectively examines how increased expression of FRG1 may contribute to myoblast differentiation defects. We generated stable C2C12 cell lines overexpressing FRG1, which exhibited a myoblast fusion defect upon differentiation. To determine if myoblast fusion defects contribute to the FRG1 mouse dystrophic phenotype, this strain was crossed with skeletal muscle specific FHL1-transgenic mice. We previously reported that FHL1 promotes myoblast fusion in vitro and FHL1-transgenic mice develop skeletal muscle hypertrophy. In the current study, FRG1 mice overexpressing FHL1 showed an improvement in the dystrophic phenotype, including a reduced spinal kyphosis, increased muscle mass and myofiber size, and decreased muscle fibrosis. FHL1 expression in FRG1 mice, did not alter satellite cell number or activation, but enhanced myoblast fusion. Primary myoblasts isolated from FRG1 mice showed a myoblast fusion defect that was rescued by FHL1 expression. Therefore, increased FRG1 expression may contribute to a muscular dystrophy phenotype resembling FSHD by impairing myoblast fusion, a defect that can be rescued by enhanced myoblast fusion via expression of FHL1.	[Feeney, Sandra J.; McGrath, Meagan J.; Sriratana, Absorn; D'Arcy, Colleen E.; Price, John T.; Mitchell, Christina A.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Gehrig, Stefan M.; Lynch, Gordon S.] Univ Melbourne, Dept Physiol, Basic & Clin Myol Lab, Melbourne, Vic 3010, Australia; [Price, John T.] Victoria Univ, Ctr Chron Dis Prevent & Management, Coll Hlth & Biomed, Melbourne, Vic 8001, Australia; [McLean, Catriona A.] Alfred Hosp, Dept Anat Pathol, Prahran, Vic 3004, Australia; [McLean, Catriona A.] Monash Univ, Cent Clin Sch, Dept Med, Clayton, Vic 3800, Australia; [Tupler, Rossella] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01655 USA; [Tupler, Rossella] Univ Modena & Reggio Emilia, Dipartimento Sci Vita, I-41125 Modena, Italy	Monash University; University of Melbourne; Victoria University; Florey Institute of Neuroscience & Mental Health; Monash University; University of Massachusetts System; University of Massachusetts Worcester; Universita di Modena e Reggio Emilia	Mitchell, CA (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.	christina.mitchell@monash.edu	Tupler, Rossella/C-9500-2015; Lynch, Gordon/G-9553-2015	Tupler, Rossella/0000-0002-3797-1789; Lynch, Gordon/0000-0001-9220-9810; McGrath, Meagan/0000-0002-9414-6558; Mitchell, Christina A/0000-0001-9372-3192; McLean, Catriona/0000-0002-0302-5727; Price, John/0000-0002-8244-1023	FSHD Global Research Foundation Ltd Australian Research Grants; National Institute of Health (NIAMS) [RO1AR056129]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056129] Funding Source: NIH RePORTER	FSHD Global Research Foundation Ltd Australian Research Grants; National Institute of Health (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the FSHD Global Research Foundation Ltd Australian Research Grants (to C.A.M. and M.J.M.; http://www.fshdglobal.org/); and the National Institute of Health (NIAMS, RO1AR056129 to R.T; http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bavner A, 2005, NUCLEIC ACIDS RES, V33, P3561, DOI 10.1093/nar/gki667; BRENNAN KJ, 1993, J BIOL CHEM, V268, P719; Briguet A, 2004, NEUROMUSCULAR DISORD, V14, P675, DOI 10.1016/j.nmd.2004.06.008; Brown S, 1999, J BIOL CHEM, V274, P27083, DOI 10.1074/jbc.274.38.27083; Bruusgaard JC, 2008, J CLIN INVEST, V118, P1450, DOI 10.1172/JCI34022; Cabianca DS, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.035; Celegato B, 2006, PROTEOMICS, V6, P5303, DOI 10.1002/pmic.200600056; Chatterjee S, 2013, J CELL SCI, V126, P2213, DOI 10.1242/jcs.120519; Cheli S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020966; Chen SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019780; Cohen TV, 2012, NEUROMUSCULAR DISORD, V22, P648, DOI 10.1016/j.nmd.2012.03.002; Cottle DL, 2007, J CELL SCI, V120, P1423, DOI 10.1242/jcs.004739; Cowling BS, 2008, J CELL BIOL, V183, P1033, DOI 10.1083/jcb.200804077; D'Arcy CE, 2014, HUM MOL GENET, V23, P618, DOI 10.1093/hmg/ddt449; Dandapat A, 2014, CELL REP, V8, P1484, DOI 10.1016/j.celrep.2014.07.056; Deenen JCW, 2014, NEUROLOGY, V83, P1056, DOI 10.1212/WNL.0000000000000797; Dixit M, 2007, P NATL ACAD SCI USA, V104, P18157, DOI 10.1073/pnas.0708659104; Ferri G, 2014, HUM MOL GENET, P1; Flanigan KM, 2001, NEUROMUSCULAR DISORD, V11, P525, DOI 10.1016/S0960-8966(01)00201-2; Fu WX, 2014, P NATL ACAD SCI USA, V111, P9151, DOI 10.1073/pnas.1323265111; Furling D, 2001, NEUROMUSCULAR DISORD, V11, P728, DOI 10.1016/S0960-8966(01)00226-7; Gabellini D, 2006, NATURE, V439, P973, DOI 10.1038/nature04422; Gabellini D, 2002, CELL, V110, P339, DOI 10.1016/S0092-8674(02)00826-7; Gabriels J, 1999, GENE, V236, P25, DOI 10.1016/S0378-1119(99)00267-X; Ge XJ, 2011, CELL RES, V21, P1591, DOI 10.1038/cr.2011.72; Gehrig SM, 2012, NATURE, V484, P394, DOI 10.1038/nature10980; Geng LN, 2012, DEV CELL, V22, P38, DOI 10.1016/j.devcel.2011.11.013; Grewal PK, 1998, GENE, V216, P13, DOI 10.1016/S0378-1119(98)00334-5; Gueneau L, 2009, AM J HUM GENET, V85, P338, DOI 10.1016/j.ajhg.2009.07.015; Hanel ML, 2011, DIFFERENTIATION, V81, P107, DOI 10.1016/j.diff.2010.09.185; Hanel ML, 2009, DEV DYNAM, V238, P1502, DOI 10.1002/dvdy.21830; Heredia JE, 2013, CELL, V153, P376, DOI 10.1016/j.cell.2013.02.053; Hochreiter-Hufford AE, 2013, NATURE, V497, P263, DOI 10.1038/nature12135; Horsley V, 2003, CELL, V113, P483, DOI 10.1016/S0092-8674(03)00319-2; Horsley V, 2001, J CELL BIOL, V153, P329, DOI 10.1083/jcb.153.2.329; Jiang GC, 2003, HUM MOL GENET, V12, P2909, DOI 10.1093/hmg/ddg323; Jorgensen LH, 2007, AM J PATHOL, V171, P1599, DOI 10.2353/ajpath.2007.070435; Joven A, 2013, J COMP NEUROL, V521, P3913, DOI 10.1002/cne.23385; Katsetos CD, 2003, CELL MOTIL CYTOSKEL, V55, P77, DOI 10.1002/cm.10116; Kim JE, 2010, J COMP NEUROL, V518, P4612, DOI 10.1002/cne.22482; Klooster R, 2009, EUR J HUM GENET, V17, P1615, DOI 10.1038/ejhg.2009.62; Kobayashi N, 2013, J COMP NEUROL, V521, P2987, DOI 10.1002/cne.23326; Krom YD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003415; Lemmers RJLF, 2010, SCIENCE, V329, P1650, DOI 10.1126/science.1189044; Li XA, 2011, CELL STEM CELL, V8, P46, DOI 10.1016/j.stem.2010.11.027; Liu Q, 2010, J CELL SCI, V123, P1116, DOI 10.1242/jcs.058958; Loh KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037218; Masny PS, 2010, EUR J HUM GENET, V18, P448, DOI 10.1038/ejhg.2009.183; Mastroyiannopoulos NP, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0051204, DOI 10.1371/JOURNAL.PONE.0051204]; Millay DP, 2013, NATURE, V499, P301, DOI 10.1038/nature12343; Minetti GC, 2014, MOL CELL BIOL, V34, P619, DOI 10.1128/MCB.00957-13; Miniou P, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.19.e27; Mitsuhashi H, 2013, HUM MOL GENET, V22, P568, DOI 10.1093/hmg/dds467; Mostacciuolo ML, 2009, CLIN GENET, V75, P550, DOI 10.1111/j.1399-0004.2009.01158.x; Neguembor MV, 2013, J MOL CELL BIOL, V5, P294, DOI 10.1093/jmcb/mjt018; Nicole S, 2003, J CELL BIOL, V161, P571, DOI 10.1083/jcb.200210117; Osborne RJ, 2007, NEUROLOGY, V68, P569, DOI 10.1212/01.wnl.0000251269.31442.d9; PADBERG GW, 1995, MUSCLE NERVE, pS81, DOI 10.1002/mus.880181315; Pandey SN, 2012, BIOL OPEN, V1, P629, DOI 10.1242/bio.20121305; Pavlath GK, 2003, CELL CYCLE, V2, P420, DOI 10.4161/cc.2.5.497; Pistoni M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003186; Quinn LS, 2007, AM J PHYSIOL-ENDOC M, V293, pE1538, DOI 10.1152/ajpendo.00160.2007; Quinzi CM, 2008, AM J HUM GENET, V82, P208, DOI 10.1016/j.ajhg.2007.09.013; Sakuma K, 2003, ACTA NEUROPATHOL, V105, P271, DOI 10.1007/s00401-002-0647-0; Sancisi V, 2014, AM J PHYSIOL-REG I, V306, pR124, DOI 10.1152/ajpregu.00379.2013; Schessl J, 2008, J CLIN INVEST, V118, P904, DOI 10.1172/JCI34450; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Springer ML, 2002, CURR PROTOC HUM GENE; Storbeck CJ, 2004, HUM MOL GENET, V13, P589, DOI 10.1093/hmg/ddh064; Sun CYJ, 2011, J MOL BIOL, V411, P397, DOI 10.1016/j.jmb.2011.06.014; Tassin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051865; Tawil R, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-12; Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009; Timchenko NA, 2001, MOL CELL BIOL, V21, P6927, DOI 10.1128/MCB.21.20.6927-6938.2001; Tsumagari K, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-67; Tupler R, 1996, J MED GENET, V33, P366, DOI 10.1136/jmg.33.5.366; van Koningsbruggen S, 2007, CHROMOSOMA, V116, P53, DOI 10.1007/s00412-006-0083-3; van Rooij E, 2002, J BIOL CHEM, V277, P48617, DOI 10.1074/jbc.M206532200; vanDeutekom JCT, 1996, HUM MOL GENET, V5, P581, DOI 10.1093/hmg/5.5.581; Wallace GQ, 2009, ANNU REV PHYSIOL, V71, P37, DOI 10.1146/annurev.physiol.010908.163216; Wang CH, 2012, NEUROMUSCULAR DISORD, V22, P331, DOI 10.1016/j.nmd.2011.10.018; White RB, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-21; WIJMENGA C, 1991, GENOMICS, V9, P570, DOI 10.1016/0888-7543(91)90348-I; Wilding BR, 2014, J CELL SCI, V127, P2269, DOI 10.1242/jcs.140905; Windpassinger C, 2008, AM J HUM GENET, V82, P88, DOI 10.1016/j.ajhg.2007.09.004; Winokur ST, 2003, HUM MOL GENET, V12, P2895, DOI 10.1093/hmg/ddg327; Wuebbles RD, 2009, DIS MODEL MECH, V2, P267, DOI 10.1242/dmm.002261; Xynos A, 2013, J CELL SCI, V126, P2236, DOI 10.1242/jcs.121533; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Young JM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003947; Zammit PS, 2006, J HISTOCHEM CYTOCHEM, V54, P1177, DOI 10.1369/jhc.6R6995.2006	91	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0117665	10.1371/journal.pone.0117665	http://dx.doi.org/10.1371/journal.pone.0117665			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695429	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000350062300026
J	Cao, C; Hu, JX; Dong, YF; Zhan, R; Li, P; Su, H; Peng, Q; Wu, T; Lei, L; Huang, X; Wu, QH; Cheng, XS				Cao, Cheng; Hu, Jianxin; Dong, Yifei; Zhan, Rui; Li, Ping; Su, Hai; Peng, Qiang; Wu, Tao; Lei, Liang; Huang, Xiao; Wu, Qinghua; Cheng, Xiaoshu			Gender Differences in the Risk Factors for Endothelial Dysfunction in Chinese Hypertensive Patients: Homocysteine Is an Independent Risk Factor in Females	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; PLASMA HOMOCYSTEINE; CARDIOVASCULAR-DISEASE; ISCHEMIC-STROKE; SEX-DIFFERENCES; LIFE-STYLE; FOLIC-ACID; MENOPAUSE; WOMEN; AGE	Objectives Endothelial dysfunction plays a key role in the pathogenesis of cardiovascular disease. However, the gender-related differences in risk factors for endothelial dysfunction are controversial. We investigated the gender differences in the risk factor profiles for endothelial dysfunction in Chinese hypertensive patients. Methods Vascular endothelial functions in 213 hypertensive patients were measured by digital reactive hyperemia peripheral arterial tonometry (RH-PAT). Peripheral blood samples were collected, and the self-reported smoking and alcohol consumption status, age, body mass index, heart rate, blood pressure and drug administrations were recorded. Results RH-PAT indexes were attenuated in both male and female hypertensive patients [1.60 (1.38-2.02) vs. 1.63 (1.44-1.98)]. Multivariate logistic regression analysis identified plasma creatinine (p < 0.001), total cholesterol (p = 0.001), homocysteine (p = 0.002) and smoking (p < 0.001) as the independent factors correlated with gender (male). Multivariate linear regression analysis further identified homocysteine as the factor that is significantly and independently correlated with the decrease in the RH-PAT indexes in female patients (odds ratio: -0.166, 95% confidence interval: -0.292 to -0.040, p = 0.01). However, none of these four factors were correlated with the RH-PAT indexes in male patients. Conclusions There are gender-related differences in the risk factors for endothelial dysfunction in Chinese hypertensive patients. Homocysteine is an independent factor for endothelial dysfunction in female hypertensive patients.	[Cao, Cheng; Hu, Jianxin; Dong, Yifei; Zhan, Rui; Li, Ping; Su, Hai; Peng, Qiang; Wu, Tao; Lei, Liang; Huang, Xiao; Wu, Qinghua; Cheng, Xiaoshu] Nanchang Univ, Affiliated Hosp 2, Dept Cardiovasc Med, Nanchang City, Jiangxi, Peoples R China; [Dong, Yifei] Key Lab Mol Biol Jiangxi Prov, Nanchang City, Jiangxi, Peoples R China	Nanchang University	Dong, YF (corresponding author), Nanchang Univ, Affiliated Hosp 2, Dept Cardiovasc Med, Nanchang City, Jiangxi, Peoples R China.	yf_dong66@126.com	Huang, Xiao/ABB-9211-2020		National Natural Science Foundation of China [81200187]; Natural Science Foundation in Jiangxi Province [20122BAB21504]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation in Jiangxi Province	This work was supported by a grant from National Natural Science Foundation of China (Grant NO. 81200187) and a grant from Natural Science Foundation in Jiangxi Province (Grant NO. 20122BAB21504). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atsma F, 2006, MENOPAUSE, V13, P265, DOI 10.1097/01.gme.0000218683.97338.ea; Benjamin EJ, 2004, CIRCULATION, V109, P613, DOI 10.1161/01.CIR.0000112565.60887.1E; Berger JS, 2009, JAMA-J AM MED ASSOC, V302, P874, DOI 10.1001/jama.2009.1227; Billups KL, 2011, INT J CLIN PRACT, V65, P134, DOI 10.1111/j.1742-1241.2010.02564.x; Bittner V, 2009, J AM COLL CARDIOL, V54, P2374, DOI 10.1016/j.jacc.2009.10.008; Bushnell C, 2014, STROKE, V45, P1545, DOI 10.1161/01.str.0000442009.06663.48; CELERMAJER DS, 1994, J AM COLL CARDIOL, V24, P471, DOI 10.1016/0735-1097(94)90305-0; Centers for Disease Control and Prevention. National Center for Health Statistics, 2010, HLTH US 2009 SPEC FE; Ervin RB, 2009, 17 NAT HLTH STAT; Fukagawa NK, 2000, AM J CLIN NUTR, V72, P22; Ganji V, 2009, J NUTR, V139, P345, DOI 10.3945/jn.108.092726; Graham IM, 1997, JAMA-J AM MED ASSOC, V277, P1775, DOI 10.1001/jama.277.22.1775; Hochman JS, 1999, NEW ENGL J MED, V341, P226, DOI 10.1056/NEJM199907223410402; Holmes MV, 2011, LANCET, V378, P584, DOI 10.1016/S0140-6736(11)60872-6; Hung MY, 2013, INT J MED SCI, V10, P255, DOI 10.7150/ijms.5383; Juonala M, 2008, EUR HEART J, V29, P1198, DOI 10.1093/eurheartj/ehm556; KANNEL WB, 1976, ANN INTERN MED, V85, P447, DOI 10.7326/0003-4819-85-4-447; Kuvin JT, 2003, AM J CARDIOL, V92, P275, DOI 10.1016/S0002-9149(03)00623-4; Kuvin JT, 2003, AM HEART J, V146, P168, DOI 10.1016/S0002-8703(03)00094-2; Lonn E, 2006, NEW ENGL J MED, V354, P1567, DOI 10.1056/NEJMoa060900; Luscher TF, 2014, CIRC RES, V114, P171, DOI 10.1161/CIRCRESAHA.114.300935; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Madsen JS, 2002, AM J OBSTET GYNECOL, V187, P33, DOI 10.1067/mob.2002.123030; Marti CN, 2012, J AM COLL CARDIOL, V60, P1455, DOI 10.1016/j.jacc.2011.11.082; Moreau KL, 2012, J CLIN ENDOCR METAB, V97, P4692, DOI 10.1210/jc.2012-2244; Mosca L, 2011, CIRCULATION, V124, P2145, DOI 10.1161/CIRCULATIONAHA.110.968792; Naik S, 2011, INT J VITAM NUTR RES, V81, P306, DOI 10.1024/0300-9831/a000078; Patel Pawan D, 2008, Ther Adv Cardiovasc Dis, V2, P89, DOI 10.1177/1753944707088904; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Sacco RL, 2004, STROKE, V35, P2263, DOI 10.1161/01.STR.0000142374.33919.92; Schoenaker DAJM, 2014, INT J EPIDEMIOL, V43, P1542, DOI 10.1093/ije/dyu094; Stramba-Badiale M, 2006, EUR HEART J, V27, P994, DOI 10.1093/eurheartj/ehi819; Tunstall-Pedoe H, 1998, LANCET, V351, P1425, DOI 10.1016/S0140-6736(97)11321-6; Vita JA, 2011, CIRCULATION, V124, pE906, DOI 10.1161/CIRCULATIONAHA.111.078824; Wang CY, 2014, EUR J INTERN MED, V25, P538, DOI 10.1016/j.ejim.2014.04.011; Woo KS, 1997, CIRCULATION, V96, P2542, DOI 10.1161/01.CIR.96.8.2542; Xu J, 2009, CIRCULATION, V120, P1266, DOI 10.1161/CIRCULATIONAHA.108.835223; Yao FJ, 2014, J ULTRAS MED, V33, P281, DOI 10.7863/ultra.33.2.281; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	39	23	26	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118686	10.1371/journal.pone.0118686	http://dx.doi.org/10.1371/journal.pone.0118686			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692574	Green Published, Green Submitted, gold			2022-12-26	WOS:000350061500126
J	Krenz, WDC; Rodgers, EW; Baro, DJ				Krenz, Wulf-Dieter C.; Rodgers, Edmund W.; Baro, Deborah J.			Tonic 5nM DA Stabilizes Neuronal Output by Enabling Bidirectional Activity-Dependent Regulation of the Hyperpolarization Activated Current via PKA and Calcineurin	PLOS ONE			English	Article							LOBSTER STOMATOGASTRIC GANGLION; TRANSIENT POTASSIUM CURRENT; PATTERN GENERATOR NETWORK; AKAP SIGNALING COMPLEXES; LOW-FREQUENCY DEPRESSION; CHANNEL MESSENGER-RNA; LONG-TERM DEPRESSION; SMALL NEURAL-NETWORK; I-H; DOPAMINE MODULATION	Volume transmission results in phasic and tonic modulatory signals. The actions of tonic dopamine (DA) at type 1 DA receptors (D1Rs) are largely undefined. Here we show that tonic 5nM DA acts at D1Rs to stabilize neuronal output over minutes by enabling activity-dependent regulation of the hyperpolarization activated current (I-h). In the presence but not absence of 5nM DA, I-h maximal conductance (G(max)) was adjusted according to changes in slow wave activity in order to maintain spike timing. Our study on the lateral pyloric neuron (LP), which undergoes rhythmic oscillations in membrane potential with depolarized plateaus, demonstrated that incremental, bi-directional changes in plateau duration produced corresponding alterations in LP I-h G(max) when preparations were superfused with saline containing 5nM DA. However, when preparations were superfused with saline alone there was no linear correlation between LP I-h G(max) and duty cycle. Thus, tonic nM DA modulated the capacity for activity to modulate LP I-h G(max); this exemplifies metamodulation (modulation of modulation). Pretreatment with the Ca2+-chelator, BAPTA, or the specific PKA inhibitor, PKI, prevented all changes in LP I-h in 5nM DA. Calcineurin inhibitors blocked activity-dependent changes enabled by DA and revealed a PKA-mediated, activity-independent enhancement of LP I-h G(max). These data suggested that tonic 5nM DA produced two simultaneous, PKA-dependent effects: a direct increase in LP I-h G(max) and a priming event that permitted calcineurin regulation of LP I-h. The latter produced graded reductions in LP I-h G(max) with increasing duty cycles. We also demonstrated that this metamodulation preserved the timing of LP's first spike when network output was perturbed with bath-applied 4AP. In sum, 5nM DA permits slow wave activity to provide feedback that maintains spike timing, suggesting that one function of low-level, tonic modulation is to stabilize specific features of a dynamic output.	[Krenz, Wulf-Dieter C.; Rodgers, Edmund W.; Baro, Deborah J.] Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University	Baro, DJ (corresponding author), Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA.	dbaro@gsu.edu			National Institutes of Health [RO1, DA024039]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024039] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by a National Institutes of Health RO1, DA024039, to DJB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Ayali A, 1998, BRAIN RES, V794, P155, DOI 10.1016/S0006-8993(98)00258-3; Ayali A, 1998, J NEUROPHYSIOL, V79, P2063, DOI 10.1152/jn.1998.79.4.2063; Ayali A, 1999, J NEUROSCI, V19, P6712; Ballo AW, 2012, J NEUROSCI, V32, P5106, DOI 10.1523/JNEUROSCI.6320-11.2012; Ballo AW, 2010, J NEUROSCI, V30, P8425, DOI 10.1523/JNEUROSCI.0405-10.2010; Baro DJ, 1997, J NEUROSCI, V17, P6597; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Beaumont V, 2001, NEURON, V32, P489, DOI 10.1016/S0896-6273(01)00483-4; Bonin RP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058679; Brager DH, 2007, J NEUROSCI, V27, P13926, DOI 10.1523/JNEUROSCI.3520-07.2007; Brager DH, 2012, CELL REP, V1, P225, DOI 10.1016/j.celrep.2012.02.002; Breton JD, 2009, J PHYSIOL-LONDON, V587, P5107, DOI 10.1113/jphysiol.2009.180943; Bucher D, 2003, J NEUROSCI, V23, P6866; Bucher D, 2005, J NEUROSCI, V25, P1611, DOI 10.1523/JNEUROSCI.3679-04.2005; Burdakov D, 2005, NEURAL COMPUT, V17, P991, DOI 10.1162/0899766053491841; Chan CS, 2011, NAT NEUROSCI, V14, P85, DOI 10.1038/nn.2692; Chen XD, 2010, J NEUROSCI, V30, P2611, DOI 10.1523/JNEUROSCI.3771-09.2010; Clark MC, 2006, COMP BIOCHEM PHYS B, V143, P294, DOI 10.1016/j.cbpb.2005.11.017; Clark MC, 2008, J NEUROCHEM, V104, P1006, DOI 10.1111/j.1471-4159.2007.05029.x; Clark MC, 2007, COMP BIOCHEM PHYS B, V146, P9, DOI 10.1016/j.cbpb.2006.08.018; Cleland TA, 1997, J NEUROPHYSIOL, V78, P3450, DOI 10.1152/jn.1997.78.6.3450; Dacher M, 2013, J NEUROSCI, V33, P2650, DOI 10.1523/JNEUROSCI.2037-12.2013; Devinney MJ, 2013, ANN NY ACAD SCI, V1279, P143, DOI 10.1111/nyas.12085; Dittmer PJ, 2014, CELL REP, V7, P1410, DOI 10.1016/j.celrep.2014.04.039; DIXON D, 1989, J NEUROPHYSIOL, V62, P1251, DOI 10.1152/jn.1989.62.6.1251; Fan Y, 2005, NAT NEUROSCI, V8, P1542, DOI 10.1038/nn1568; Few WP, 2007, P NATL ACAD SCI USA, V104, P5187, DOI 10.1073/pnas.0611619104; FLAMM RE, 1986, J NEUROPHYSIOL, V55, P866, DOI 10.1152/jn.1986.55.5.866; FLAMM RE, 1986, J NEUROPHYSIOL, V55, P847, DOI 10.1152/jn.1986.55.5.847; Goaillard JM, 2009, NAT NEUROSCI, V12, P1424, DOI 10.1038/nn.2404; GRACE AA, 1991, NEUROSCIENCE, V41, P1, DOI 10.1016/0306-4522(91)90196-U; Gruhn M, 2005, J NEUROPHYSIOL, V94, P2888, DOI 10.1152/jn.00434.2005; Harris -Warrick R.M., 1992, DYNAMIC BIOL NETWORK; HARRISWARRICK RM, 1995, J NEUROSCI, V15, P342; HARRISWARRICK RM, 1995, J NEUROPHYSIOL, V74, P1404, DOI 10.1152/jn.1995.74.4.1404; Hassfurth B, 2009, EUR J NEUROSCI, V30, P1227, DOI 10.1111/j.1460-9568.2009.06925.x; Hedrich UBS, 2011, J NEUROPHYSIOL, V105, P1671, DOI 10.1152/jn.01105.2010; Hoshi N, 2005, NAT CELL BIOL, V7, P1066, DOI 10.1038/ncb1315; Huang Z, 2011, NAT NEUROSCI, V14, P478, DOI 10.1038/nn.2757; Hudson AE, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000838; Hutcheon B, 2000, TRENDS NEUROSCI, V23, P216, DOI 10.1016/S0166-2236(00)01547-2; Johnson BR, 2005, J NEUROPHYSIOL, V94, P3101, DOI 10.1152/jn.00440.2005; Johnson BR, 2003, J NEUROPHYSIOL, V90, P631, DOI 10.1152/jn.00037.2003; JOHNSON BR, 1990, J NEUROSCI, V10, P2066; Johnson BR, 1997, J NEUROPHYSIOL, V78, P3210, DOI 10.1152/jn.1997.78.6.3210; Johnson BR, 2011, J NEUROPHYSIOL, V105, P293, DOI 10.1152/jn.00809.2010; Kadiri LR, 2011, J NEUROPHYSIOL, V106, P1288, DOI 10.1152/jn.00456.2011; Khorkova O, 2007, J NEUROSCI, V27, P8709, DOI 10.1523/JNEUROSCI.1274-07.2007; KIEHN O, 1992, J NEUROPHYSIOL, V68, P496, DOI 10.1152/jn.1992.68.2.496; Kirby MS, 2007, J NEUROPHYSIOL, V98, P3206, DOI 10.1152/jn.00795.2006; Kloppenburg P, 1999, J NEUROPHYSIOL, V81, P29, DOI 10.1152/jn.1999.81.1.29; Kloppenburg P, 2000, J NEUROSCI, V20, P2523; Kloppenburg P, 2007, J NEUROPHYSIOL, V98, P2910, DOI 10.1152/jn.00660.2007; Krenz WDC, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00039; Krenz WDC, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00169; Li X, 2013, J BIOL CHEM, V288, P33797, DOI 10.1074/jbc.M113.470559; Lin L, 2011, J NEUROSCI, V31, P1323, DOI 10.1523/JNEUROSCI.5383-10.2011; Lin L, 2010, MOL CELL NEUROSCI, V43, P315, DOI 10.1016/j.mcn.2009.12.005; Ma YN, 2013, MOL CELL BIOL, V33, P3994, DOI 10.1128/MCB.00623-13; MacLean JN, 2005, J NEUROPHYSIOL, V94, P3601, DOI 10.1152/jn.00281.2005; MacLean JN, 2003, NEURON, V37, P109, DOI 10.1016/S0896-6273(02)01104-2; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Marder E, 2011, P NATL ACAD SCI US; Marder E, 2007, ANNU REV PHYSIOL, V69, P291, DOI 10.1146/annurev.physiol.69.031905.161516; Marder E, 2014, ANNU REV NEUROSCI, V37, P329, DOI 10.1146/annurev-neuro-071013-013958; McLean DL, 2004, J NEUROSCI, V24, P9561, DOI 10.1523/JNEUROSCI.1817-04.2004; Mesce KA, 2002, BRAIN BEHAV EVOLUT, V60, P339, DOI 10.1159/000067793; Mitchell GS, 2003, J APPL PHYSIOL, V94, P358, DOI 10.1152/japplphysiol.00523.2002; Murphy JG, 2014, CELL REP, V7, P1577, DOI 10.1016/j.celrep.2014.04.027; Narayanan R, 2010, NEURON, V68, P921, DOI 10.1016/j.neuron.2010.11.033; Narayanan R, 2010, J NEUROPHYSIOL, V104, P1020, DOI 10.1152/jn.01129.2009; Nikolaev VO, 2006, CIRC RES, V99, P1084, DOI 10.1161/01.RES.0000250046.69918.d5; Noam Y, 2014, J BIOL CHEM, V289, P5889, DOI 10.1074/jbc.M113.522060; Noam Y, 2010, J BIOL CHEM, V285, P14724, DOI 10.1074/jbc.M109.070391; Nowotny T, 2007, NEURAL COMPUT, V19, P1985, DOI 10.1162/neco.2007.19.8.1985; O'Leary T, 2014, NEURON, V82, P809, DOI 10.1016/j.neuron.2014.04.002; O'Leary T, 2013, P NATL ACAD SCI USA, V110, pE2645, DOI 10.1073/pnas.1309966110; O'Leary T, 2011, J PHYSIOL-LONDON, V589, P4811, DOI 10.1113/jphysiol.2011.210179; Oginsky MF, 2010, J COMP NEUROL, V518, P255, DOI 10.1002/cne.22225; Oliveria SF, 2007, NEURON, V55, P261, DOI 10.1016/j.neuron.2007.06.032; Oliveria SF, 2003, J CELL BIOL, V160, P101, DOI 10.1083/jcb.200209127; Peck JH, 2006, J NEUROPHYSIOL, V96, P2931, DOI 10.1152/jn.00423.2005; Peck JH, 2001, J NEUROPHYSIOL, V86, P2957, DOI 10.1152/jn.2001.86.6.2957; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Poolos NP, 2002, NAT NEUROSCI, V5, P767, DOI 10.1038/nn891; Pulver SR, 2003, J COMP NEUROL, V462, P400, DOI 10.1002/cne.10767; Ransdell JL, 2013, J NEUROPHYSIOL, V110, P42, DOI 10.1152/jn.00009.2013; Ransdell JL, 2012, J NEUROSCI, V32, P9649, DOI 10.1523/JNEUROSCI.1945-12.2012; Ribeiro JA, 2010, ACTA PHYSIOL, V199, P161, DOI 10.1111/j.1748-1716.2010.02115.x; Rodgers EW, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-143; Rodgers EW, 2011, J NEUROSCI, V31, P16387, DOI 10.1523/JNEUROSCI.3770-11.2011; Rodgers EW, 2011, J NEUROSCI, V31, P13046, DOI 10.1523/JNEUROSCI.2194-11.2011; Sanderson JL, 2011, NEUROSCIENTIST, V17, P321, DOI 10.1177/1073858410384740; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Schulz DJ, 2006, NAT NEUROSCI, V9, P356, DOI 10.1038/nn1639; Selverston A I, 1976, Prog Neurobiol, V7, P215, DOI 10.1016/0301-0082(76)90008-3; Shah MM, 2014, J PHYSIOL-LONDON, V592, P2711, DOI 10.1113/jphysiol.2013.270058; Shivdasani RA, 2006, BLOOD, V108, P3646, DOI 10.1182/blood-2006-01-030015; Silverman-Gavrila LB, 2005, J NEUROSCI, V25, P3168, DOI 10.1523/JNEUROSCI.4908-04.2005; Silverman-Gavrila LB, 2009, J NEUROCHEM, V109, P716, DOI 10.1111/j.1471-4159.2009.05973.x; Simms BA, 2014, NEURON, V82, P24, DOI 10.1016/j.neuron.2014.03.016; Snyder SH, 1998, TRENDS PHARMACOL SCI, V19, P21, DOI 10.1016/S0165-6147(97)01146-2; Song QJ, 2008, J BIOL CHEM, V283, P31531, DOI 10.1074/jbc.M804902200; Soofi W, 2012, J COMPUT NEUROSCI, V33, P77, DOI 10.1007/s10827-011-0375-3; Stegen M, 2012, CEREB CORTEX, V22, P2087, DOI 10.1093/cercor/bhr294; Sun Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083067; Svensson E, 2001, J NEUROSCI, V21, P5984, DOI 10.1523/JNEUROSCI.21-16-05984.2001; Szucs A, 2006, J NEUROBIOL, V66, P1584, DOI 10.1002/neu.20325; Temporal S, 2014, CURR BIOL, V24, P1899, DOI 10.1016/j.cub.2014.06.067; Temporal S, 2012, J NEUROPHYSIOL, V107, P718, DOI 10.1152/jn.00622.2011; Thirumalai V, 2006, J NEUROPHYSIOL, V95, P1762, DOI 10.1152/jn.00764.2005; Thoby-Brisson M, 1998, J NEUROSCI, V18, P2212; TIERNEY AJ, 1992, J NEUROPHYSIOL, V67, P599, DOI 10.1152/jn.1992.67.3.599; Tobin AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006742; van Welie I, 2004, P NATL ACAD SCI USA, V101, P5123, DOI 10.1073/pnas.0307711101; Wahl-Schott C, 2009, CELL MOL LIFE SCI, V66, P470, DOI 10.1007/s00018-008-8525-0; Weaver AL, 2003, J NEUROPHYSIOL, V89, P1327, DOI 10.1152/jn.00704.2002; Xiang M, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004497; Ying SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042756; Zhang HM, 2010, J NEUROPHYSIOL, V104, P873, DOI 10.1152/jn.00195.2010; Zhao SB, 2012, J NEUROSCI, V32, P13380, DOI 10.1523/JNEUROSCI.6500-11.2012; Zoli M, 1998, BRAIN RES REV, V26, P136, DOI 10.1016/S0165-0173(97)00048-9	124	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117965	10.1371/journal.pone.0117965	http://dx.doi.org/10.1371/journal.pone.0117965			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692473	Green Submitted, Green Published, gold			2022-12-26	WOS:000350061500085
J	Castro, M; Deane, SM; Ruiz, L; Rawlings, DE; Guiliani, N				Castro, Matias; Deane, Shelly M.; Ruiz, Lina; Rawlings, Douglas E.; Guiliani, Nicolas			Diguanylate Cyclase Null Mutant Reveals That C-Di-GMP Pathway Regulates the Motility and Adherence of the Extremophile Bacterium Acidithiobacillus caldus	PLOS ONE			English	Article							LONG-TERM SURVIVAL; PSEUDOMONAS-AERUGINOSA; THIOBACILLUS-CALDUS; RESPONSE REGULATOR; CYCLIC DIGUANYLATE; VIBRIO-CHOLERAE; ALLOSTERIC CONTROL; BIOFILM FORMATION; RDAR MORPHOTYPE; DOMAIN PROTEINS	An understanding of biofilm formation is relevant to the design of biological strategies to improve the efficiency of the bioleaching process and to prevent environmental damages caused by acid mine/rock drainage. For this reason, our laboratory is focused on the characterization of the molecular mechanisms involved in biofilm formation in different biomining bacteria. In many bacteria, the intracellular levels of c-di-GMP molecules regulate the transition from the motile planktonic state to sessile community-based behaviors, such as biofilm development, through different kinds of effectors. Thus, we recently started a study of the c-di-GMP pathway in several biomining bacteria including Acidithiobacillus caldus. C-di-GMP molecules are synthesized by diguanylate cyclases (DGCs) and degraded by phosphodiesterases (PDEs). We previously reported the existence of intermediates involved in c-di-GMP pathway from different Acidithiobacillus species. Here, we report our work related to At. caldus ATCC 51756. We identified several putative-ORFs encoding DGC and PDE and effector proteins. By using total RNA extracted from At. caldus cells and RT-PCR, we demonstrated that these genes are expressed. We also demonstrated the presence of c-di-GMP by mass spectrometry and showed that genes for several of the DGC enzymes were functional by heterologous genetic complementation in Salmonella enterica serovar Typhimurium mutants. Moreover, we developed a DGC defective mutant strain (Delta c1319) that strongly indicated that the c-di-GMP pathway regulates the swarming motility and adherence to sulfur surfaces by At. caldus. Together, our results revealed that At. caldus possesses a functional c-di-GMP pathway which could be significant for ores colonization during the bioleaching process.	[Castro, Matias; Ruiz, Lina; Guiliani, Nicolas] Univ Chile, Fac Ciencias, Dept Biol, Lab Comunicac Bacteriana, Santiago, Chile; [Deane, Shelly M.; Rawlings, Douglas E.] Univ Stellenbosch, Dept Microbiol, ZA-7600 Stellenbosch, South Africa	Universidad de Chile; Stellenbosch University	Guiliani, N (corresponding author), Univ Chile, Fac Ciencias, Dept Biol, Lab Comunicac Bacteriana, Santiago, Chile.	nguilian@uchile.cl	Hincapié, Lina María Ruiz/H-9593-2019; Guiliani, Nicolas/F-6536-2015	Hincapié, Lina María Ruiz/0000-0002-9363-2730; Rawlings, Douglas/0000-0002-2521-8167; Castro, Matias/0000-0002-2013-3041; Guiliani, Nicolas/0000-0002-9950-7316	FONDECYT [1080441, 1120295]; MECESUP [UCH0407, UCH-0604]; VID-Universidad de Chile	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); MECESUP; VID-Universidad de Chile	This work was supported by FONDECYT grants 1080441 and 1120295, MECESUP UCH0407, UCH-0604 and VID-Universidad de Chile. NG: Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) (http://www.conicyt.cl/fondecyt/); MC: Programa de Mejoramiento de la Calidad y la Equidad de la Educacion Superior (MECESUP) (http://www.mecesup.cl/), Universidad de Chile, UCH-0604 and VID-Universidad de Chile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003744; An SW, 2010, APPL ENVIRON MICROB, V76, P8160, DOI 10.1128/AEM.01233-10; Ausmees N, 2001, FEMS MICROBIOL LETT, V204, P163, DOI 10.1111/j.1574-6968.2001.tb10880.x; Berne C, 2013, J PHYS CHEM B, V117, P10492, DOI 10.1021/jp405802e; Bharati BK, 2012, MICROBIOL-SGM, V158, P1415, DOI 10.1099/mic.0.053892-0; Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101; Chang AL, 2001, BIOCHEMISTRY-US, V40, P3420, DOI 10.1021/bi0100236; Chen LX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039470; Chen MW, 2012, J BACTERIOL, V194, P4837, DOI 10.1128/JB.00560-12; Christen B, 2006, J BIOL CHEM, V281, P32015, DOI 10.1074/jbc.M603589200; De N, 2009, J MOL BIOL, V393, P619, DOI 10.1016/j.jmb.2009.08.030; Dopson M, 1999, APPL ENVIRON MICROB, V65, P36; Dopson M, 2004, MICROB ECOL, V48, P19, DOI 10.1007/s00248-003-2028-1; Draper J, 2011, J BACTERIOL, V193, P4338, DOI 10.1128/JB.05140-11; Edwards KJ, 2000, ENVIRON MICROBIOL, V2, P324, DOI 10.1046/j.1462-2920.2000.00111.x; Farah C, 2005, APPL ENVIRON MICROB, V71, P7033, DOI 10.1128/AEM.71.11.7033-7040.2005; Fazli M, 2011, MOL MICROBIOL, V82, P327, DOI 10.1111/j.1365-2958.2011.07814.x; Foucher S, 2003, HYDROMETALLURGY, V71, P5, DOI 10.1016/S0304-386X(03)00142-7; Franklin MJ, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00167; Galperin MY, 2010, CURR OPIN MICROBIOL, V13, P150, DOI 10.1016/j.mib.2010.01.005; Galperin MY, 2010, MOL BIOSYST, V6, P721, DOI 10.1039/b908047c; Galperin MY, 2001, FEMS MICROBIOL LETT, V203, P11, DOI 10.1111/j.1574-6968.2001.tb10814.x; Gonzalez A, 2013, APPL MICROBIOL BIOT, V97, P3729, DOI 10.1007/s00253-012-4229-3; HALLBERG KB, 1994, MICROBIOL-SGM, V140, P3451, DOI 10.1099/13500872-140-12-3451; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Hickman JW, 2008, MOL MICROBIOL, V69, P376, DOI 10.1111/j.1365-2958.2008.06281.x; Kader A, 2006, MOL MICROBIOL, V60, P602, DOI 10.1111/j.1365-2958.2006.05123.x; Koestler BJ, 2013, APPL ENVIRON MICROB, V79, P5233, DOI 10.1128/AEM.01596-13; Krasteva PV, 2010, SCIENCE, V327, P866, DOI 10.1126/science.1181185; Kumar M, 2008, MICROBIOL-SGM, V154, P2942, DOI 10.1099/mic.0.2008/017806-0; Lee VT, 2007, MOL MICROBIOL, V65, P1474, DOI 10.1111/j.1365-2958.2007.05879.x; Lindenberg S, 2013, EMBO J, V32, P2001, DOI 10.1038/emboj.2013.120; Malone JG, 2007, MICROBIOL-SGM, V153, P980, DOI 10.1099/mic.0.2006/002824-0; Merighi M, 2007, MOL MICROBIOL, V65, P876, DOI 10.1111/j.1365-2958.2007.05817.x; Merritt JH, 2010, MBIO, V1, DOI 10.1128/mBio.00183-10; Mills E, 2011, CELL MICROBIOL, V13, P1122, DOI 10.1111/j.1462-5822.2011.01619.x; Morgan JLW, 2014, NAT STRUCT MOL BIOL, V21, P489, DOI 10.1038/nsmb.2803; Navarro MVAS, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000588; Okibe N, 2003, APPL ENVIRON MICROB, V69, P1936, DOI 10.1128/AEM.69.4.1936-1943.2003; Pelicic V, 2008, MOL MICROBIOL, V68, P827, DOI 10.1111/j.1365-2958.2008.06197.x; Pratt JT, 2007, J BIOL CHEM, V282, P12860, DOI 10.1074/jbc.M611593200; Rawlings DE, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-13; Rawlings DE, 1999, PROCESS MET, V9, P777; Rivas M, 2005, BIOL RES, V38, P283, DOI 10.4067/S0716-97602005000200018; Rohwerder T, 2003, APPL MICROBIOL BIOT, V63, P239, DOI 10.1007/s00253-003-1448-7; Romling U, 2005, CELL MOL LIFE SCI, V62, P1234, DOI 10.1007/s00018-005-4557-x; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; Romling U, 2009, CONTRIB MICROBIOL, V16, P161, DOI 10.1159/000219379; Ruiz LM, 2008, HYDROMETALLURGY, V94, P133, DOI 10.1016/j.hydromet.2008.05.028; Ryan RP, 2012, TRENDS MICROBIOL, V20, P235, DOI 10.1016/j.tim.2012.02.008; Ryan RP, 2006, P NATL ACAD SCI USA, V103, P6712, DOI 10.1073/pnas.0600345103; Ryjenkov DA, 2005, J BACTERIOL, V187, P1792, DOI 10.1128/JB.187.5.1792-1798.2005; Sand W, 2006, RES MICROBIOL, V157, P49, DOI 10.1016/j.resmic.2005.07.012; Savakis P, 2012, MOL MICROBIOL, V85, P239, DOI 10.1111/j.1365-2958.2012.08106.x; Schirmer T, 2009, NAT REV MICROBIOL, V7, P724, DOI 10.1038/nrmicro2203; Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005; Semenza M, 2002, LAT AM APPL RES, V32, P303; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; Sondermann H, 2012, CURR OPIN MICROBIOL, V15, P140, DOI 10.1016/j.mib.2011.12.008; Tischler AD, 2004, MOL MICROBIOL, V53, P857, DOI 10.1111/j.1365-2958.2004.04155.x; Tuckerman JR, 2011, J MOL BIOL, V407, P633, DOI 10.1016/j.jmb.2011.02.019; Wassmann P, 2007, STRUCTURE, V15, P915, DOI 10.1016/j.str.2007.06.016; Weber H, 2006, MOL MICROBIOL, V62, P1014, DOI 10.1111/j.1365-2958.2006.05440.x; Wilksch JJ, 2011, PLOS PATHOG, V7, DOI [10.1371/journal.ppat.1002204, 10.1371/journal.ppat.1002179]; Wolfe AJ, 2008, J BACTERIOL, V190, P463, DOI 10.1128/JB.01418-07; Yang CY, 2011, ACTA CRYSTALLOGR D, V67, P997, DOI 10.1107/S090744491104039X; Zogaj X, 2001, MOL MICROBIOL, V39, P1452, DOI 10.1046/j.1365-2958.2001.02337.x	67	16	16	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0116399	10.1371/journal.pone.0116399	http://dx.doi.org/10.1371/journal.pone.0116399			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689133	Green Published, Green Submitted, gold			2022-12-26	WOS:000350322700009
J	Costanzo, JP; Reynolds, AM; do Amaral, MCF; Rosendale, AJ; Lee, RE				Costanzo, Jon P.; Reynolds, Alice M.; do Amaral, M. Clara F.; Rosendale, Andrew J.; Lee, Richard E., Jr.			Cryoprotectants and Extreme Freeze Tolerance in a Subarctic Population of the Wood Frog	PLOS ONE			English	Article							RANA-SYLVATICA; SEASONAL-VARIATION; UREA SYNTHESIS; METABOLIC CONSEQUENCES; SCAPHIOPUS-COUCHI; SPADEFOOT TOADS; XENOPUS-LAEVIS; BUFO-VIRIDIS; DEHYDRATION; ACCLIMATION	Wood frogs (Rana sylvatica) exhibit marked geographic variation in freeze tolerance, with subarctic populations tolerating experimental freezing to temperatures at least 10-13 degrees Celsius below the lethal limits for conspecifics from more temperate locales. We determined how seasonal responses enhance the cryoprotectant system in these northern frogs, and also investigated their physiological responses to somatic freezing at extreme temperatures. Alaskan frogs collected in late summer had plasma urea levels near 10 mu mol ml(-1), but this level rose during preparation for winter to 85.5 +/- 2.9 mu mol ml(-1) (mean +/- SEM) in frogs that remained fully hydrated, and to 186.9 +/- 12.4 mu mol ml(-1) in frogs held under a restricted moisture regime. An osmolality gap indicated that the plasma of winter-conditioned frogs contained an as yet unidentified osmolyte(s) that contributed about 75 mOsmol kg(-1) to total osmotic pressure. Experimental freezing to -8 degrees C, either directly or following three cycles of freezing/thawing between -4 and 0 degrees C, or -16 degrees C increased the liver's synthesis of glucose and, to a lesser extent, urea. Concomitantly, organs shed up to one-half (skeletal muscle) or two-thirds (liver) of their water, with cryoprotectant in the remaining fluid reaching concentrations as high as 0.2 and 2.1 M, respectively. Freeze/thaw cycling, which was readily survived by winter-conditioned frogs, greatly increased hepatic glycogenolysis and delivery of glucose (but not urea) to skeletal muscle. We conclude that cryoprotectant accrual in anticipation of and in response to freezing have been greatly enhanced and contribute to extreme freeze tolerance in northern R. sylvatica.	[Costanzo, Jon P.; Reynolds, Alice M.; do Amaral, M. Clara F.; Rosendale, Andrew J.; Lee, Richard E., Jr.] Miami Univ, Dept Zool, Oxford, OH 45056 USA	University System of Ohio; Miami University	Costanzo, JP (corresponding author), Miami Univ, Dept Zool, Oxford, OH 45056 USA.	costanjp@miamioh.edu			National Science Foundation Grant IOS [1022788]; Portuguese Science and Technology Foundation (Fundaeao para a Ciencia e Tecnologia, Ministerio da Educacao e Ciencia, Portugal) Grant [SFRH/BD/63151/2009]	National Science Foundation Grant IOS(National Science Foundation (NSF)); Portuguese Science and Technology Foundation (Fundaeao para a Ciencia e Tecnologia, Ministerio da Educacao e Ciencia, Portugal) Grant	This work was funded by the National Science Foundation Grant IOS 1022788 to JPC and the Portuguese Science and Technology Foundation (Fundacao para a Ciencia e Tecnologia, Ministerio da Educaeao e Ciencia, Portugal) Grant SFRH/BD/63151/2009 to MCFDA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALINSKY JB, 1967, COMP BIOCHEM PHYSIOL, V22, P59, DOI 10.1016/0010-406X(67)90166-1; Boardman L, 2013, J INSECT PHYSIOL, V59, P781, DOI 10.1016/j.jinsphys.2013.05.005; CARPENTER JF, 1988, CRYOBIOLOGY, V25, P244, DOI 10.1016/0011-2240(88)90032-6; CHURCHILL TA, 1993, AM J PHYSIOL, V265, pR1324, DOI 10.1152/ajpregu.1993.265.6.R1324; CHURCHILL TA, 1989, J INSECT PHYSIOL, V35, P579, DOI 10.1016/0022-1910(89)90147-9; Costanzo JP, 2008, J EXP BIOL, V211, P2969, DOI 10.1242/jeb.019695; Costanzo JP, 2013, J EXP BIOL, V216, P3461, DOI 10.1242/jeb.089342; Costanzo JP, 2013, J EXP BIOL, V216, P1961, DOI 10.1242/jeb.070268; Costanzo JP, 1997, PHYSIOL ZOOL, V70, P158, DOI 10.1086/639568; Costanzo JP, 2005, J EXP BIOL, V208, P4079, DOI 10.1242/jeb.01859; COSTANZO JP, 1991, J COMP PHYSIOL B, V161, P225, DOI 10.1007/BF00262302; Cowan KJ, 2000, EXP BIOL ONLINE, V5, P61; do Amaral MCF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079169; do Amaral MC, 2014, GEOGRAPHIC VARIATION, P85; Doelling ARW, 2014, J INSECT PHYSIOL, V67, P20, DOI 10.1016/j.jinsphys.2014.05.024; Fincel EA, 2006, UREA A NATURAL CRYOP, P65; Goller K, 1999, J MOL CATAL B-ENZYM, V7, P37, DOI 10.1016/S1381-1177(99)00043-0; GRABLY S, 1981, COMP BIOCHEM PHYS A, V69, P683, DOI 10.1016/0300-9629(81)90156-0; Hermes-Lima M, 2002, COMP BIOCHEM PHYS C, V133, P537, DOI 10.1016/S1532-0456(02)00080-7; Higgins SA, 2013, COMP BIOCHEM PHYS A, V164, P344, DOI 10.1016/j.cbpa.2012.11.002; Hochachka P., 2002, BIOCH ADAPTATION MEC; HOFFMAN J, 1990, COMP BIOCHEM PHYS A, V97, P423; Hoffman J, 1998, PHYSIOL ZOOL, V71, P85, DOI 10.1086/515886; Hudson NJ, 2002, J EXP BIOL, V205, P2297; Irwin JT, 2003, J EXP BIOL, V206, P2859, DOI 10.1242/jeb.00500; JONES RM, 1980, J EXP ZOOL, V212, P255, DOI 10.1002/jez.1402120212; Jorgensen CB, 1997, COMP BIOCHEM PHYS A, V117, P161, DOI 10.1016/S0300-9629(96)00356-8; JUNGREIS AM, 1970, COMP BIOCHEM PHYSIOL, V32, P417, DOI 10.1016/0010-406X(70)90459-7; Kirton MP, 1974, FALL MOVEMENTS AND H, P57; Kiss AJ, 2011, INT J MOL SCI, V12, P8406, DOI 10.3390/ijms12128406; Kostal V, 2012, P NATL ACAD SCI USA, V109, P3270, DOI 10.1073/pnas.1119986109; KRUUV J, 1992, CRYOBIOLOGY, V29, P291, DOI 10.1016/0011-2240(92)90028-Z; LAGERSPETZ KYH, 1977, J THERM BIOL, V2, P223, DOI 10.1016/0306-4565(77)90035-3; Larson DJ, 2014, J EXP BIOL, V217, P2193, DOI 10.1242/jeb.101931; LAYNE JR, 1987, CAN J ZOOL, V65, P2062, DOI 10.1139/z87-315; Layne JR, 2003, CAN J ZOOL, V81, P2061, DOI 10.1139/Z03-202; Layne JR, 1999, J EXP ZOOL, V283, P221, DOI 10.1002/(SICI)1097-010X(19990215)283:3<221::AID-JEZ1>3.0.CO;2-Q; LeBoucher J, 1997, CLIN CHEM, V43, P1421; LEE AR, 1982, J EXP ZOOL, V221, P169, DOI 10.1002/jez.1402210207; Lee RE, 1998, ANNU REV PHYSIOL, V60, P55, DOI 10.1146/annurev.physiol.60.1.55; LIPPERT K, 1992, APPL MICROBIOL BIOT, V37, P61; Marshall KE, 2011, J EXP BIOL, V214, P1205, DOI 10.1242/jeb.054569; MCCLANAHAN L, 1967, COMP BIOCHEM PHYSIOL, V20, P73, DOI 10.1016/0010-406X(67)90726-8; McCue MD, 2010, COMP BIOCHEM PHYS A, V156, P1, DOI 10.1016/j.cbpa.2010.01.002; MORTON ML, 1981, COPEIA, P234, DOI 10.2307/1444067; Muir TJ, 2008, J EXP ZOOL PART A, V309A, P111, DOI 10.1002/jez.436; Muir TJ, 2007, J COMP PHYSIOL B, V177, P917, DOI 10.1007/s00360-007-0190-3; Regosin JV, 2003, J HERPETOL, V37, P390, DOI 10.1670/0022-1511(2003)037[0390:THUAWD]2.0.CO;2; Rosendale AJ, 2014, BBA-GEN SUBJECTS, V1840, P1701, DOI 10.1016/j.bbagen.2013.12.011; Rosendale AJ, 2012, J EXP ZOOL PART A, V317A, P401, DOI 10.1002/jez.1733; SCAPIN S, 1992, GEN COMP ENDOCR, V86, P128, DOI 10.1016/0016-6480(92)90134-6; Schiller TM, 2008, J EXP ZOOL PART A, V309A, P484, DOI 10.1002/jez.479; SCHLAGHECKE R, 1981, GEN COMP ENDOCR, V43, P479, DOI 10.1016/0016-6480(81)90232-X; SCHMID WD, 1968, ECOLOGY, V49, P180, DOI 10.2307/1933581; SCHMID WD, 1982, SCIENCE, V215, P697, DOI 10.1126/science.7058335; SCHMID WD, 1965, ECOLOGY, V46, P261, DOI 10.2307/1936329; SEYMOUR RS, 1973, COPEIA, P435; SHPUN S, 1992, COMP BIOCHEM PHYS A, V103, P473, DOI 10.1016/0300-9629(92)90274-T; SINSCH U, 1991, COMP BIOCHEM PHYS A, V98, P469, DOI 10.1016/0300-9629(91)90433-D; SOMASEKHAR T, 1987, INDIAN J EXP BIOL, V25, P173; SRIDHARA S, 1979, Proceedings of the Indian Academy of Sciences Section B, V88, P137; STOREY KB, 1987, AM J PHYSIOL, V253, pR292, DOI 10.1152/ajpregu.1987.253.2.R292; STOREY KB, 1986, CAN J ZOOL, V64, P49, DOI 10.1139/z86-008; STOREY KB, 1984, J COMP PHYSIOL B, V155, P29, DOI 10.1007/BF00688788; STOREY KB, 1988, PHYSIOL REV, V68, P27, DOI 10.1152/physrev.1988.68.1.27; SUGDEN PH, 1991, BIOCHEM J, V273, P21, DOI 10.1042/bj2730021; Sunny NE, 2011, J ANIM SCI, V89, P3945, DOI 10.2527/jas.2011-3985; Teets NM, 2011, J EXP BIOL, V214, P806, DOI 10.1242/jeb.051912; Voituron Y, 2004, J EXP ZOOL PART A, V301A, P367, DOI 10.1002/jez.a.20042; West TG, 2006, J EXP BIOL, V209, P1159, DOI 10.1242/jeb.02101; Withers PC, 1996, J EXP BIOL, V199, P1809; WRAY S, 1995, J EXP BIOL, V198, P373	72	39	39	18	182	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117234	10.1371/journal.pone.0117234	http://dx.doi.org/10.1371/journal.pone.0117234			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25688861	gold, Green Submitted, Green Published			2022-12-26	WOS:000350322700032
J	Ferrette, BLD; Mendonca, FF; Coelho, R; de Oliveira, PGV; Hazin, FHV; Romanov, EV; Oliveira, C; Santos, MN; Foresti, F				da Silva Ferrette, Bruno Lopes; Mendonca, Fernando Fernandes; Coelho, Rui; Vasconcelos de Oliveira, Paulo Guilherme; Vieira Hazin, Fabio Hissa; Romanov, Evgeny V.; Oliveira, Claudio; Santos, Miguel Neves; Foresti, Fausto			High Connectivity of the Crocodile Shark between the Atlantic and Southwest Indian Oceans: Highlights for Conservation	PLOS ONE			English	Article							GULF-OF-MEXICO; MITOCHONDRIAL-DNA; RHIZOPRIONODON-LALANDII; POPULATION-GENETICS; NORTHWEST ATLANTIC; STATISTICAL TESTS; WESTERN ATLANTIC; RHINCODON-TYPUS; WHALE SHARK; PHYLOGEOGRAPHY	Among the various shark species that are captured as bycatch in commercial fishing operations, the group of pelagic sharks is still one of the least studied and known. Within those, the crocodile shark, Pseudocarcharias kamoharai, a small-sized lamnid shark, is occasionally caught by longline vessels in certain regions of the tropical oceans worldwide. However, the population dynamics of this species, as well as the impact of fishing mortality on its stocks, are still unknown, with the crocodile shark currently one of the least studied of all pelagic sharks. Given this, the present study aimed to assess the population structure of P. kamoharai in several regions of the Atlantic and Indian Oceans using genetic molecular markers. The nucleotide composition of the mitochondrial DNA control region of 255 individuals was analyzed, and 31 haplotypes were found, with an estimated diversity Hd = 0.627, and a nucleotide diversity pi = 0.00167. An analysis of molecular variance (AMOVA) revealed a fixation index phi(ST) = -0.01118, representing an absence of population structure among the sampled regions of the Atlantic Ocean, and between the Atlantic and Indian Oceans. These results show a high degree of gene flow between the studied areas, with a single genetic stock and reduced population variability. In panmictic populations, conservation efforts can be concentrated in more restricted areas, being these representative of the total biodiversity of the species. When necessary, this strategy could be applied to the genetic maintenance of P. kamoharai.	[da Silva Ferrette, Bruno Lopes; Oliveira, Claudio; Foresti, Fausto] Univ Estadual Paulista, UNESP, Inst Biociencias Botucatu, Lab Biol & Genet Peixes, Sao Paulo, Brazil; [Mendonca, Fernando Fernandes] Univ Fed Sao Paulo, UNIFESP, Inst Mar, Dept Ciencias Mar, Santos, Brazil; [Coelho, Rui; Santos, Miguel Neves] IPMA, IP, Olhao, Portugal; [Coelho, Rui] Univ Algarve, Ctr Ciencias Mar, CCMAR, Faro, Portugal; [Vasconcelos de Oliveira, Paulo Guilherme; Vieira Hazin, Fabio Hissa] Univ Fed Rural Pernambuco, UFRPE, Dept Pesca & Aquicultura, Pernambuco, Recife, Brazil; [Romanov, Evgeny V.] ARDA, Ctr Tech Appui Peche ReUNionnaise CAP RUN, Le Port, Reunion, France	Instituto de Botanica - Sao Paulo; Universidade Estadual Paulista; Universidade Federal de Sao Paulo (UNIFESP); Instituto Portugues do Mar e da Atmosfera; Universidade do Algarve; Universidade Federal Rural de Pernambuco (UFRPE)	Mendonca, FF (corresponding author), Univ Fed Sao Paulo, UNIFESP, Inst Mar, Dept Ciencias Mar, Santos, Brazil.	fernando.mendonca@unifesp.br	Coelho, Rui/C-1163-2008; MENDONCA, FERNANDO FERNANDES/AAG-7078-2019; Mendonça, Fernando/ABC-7750-2021; Fapesp, Biota/F-8655-2017; Oliveira, Claudio/D-7713-2012	Coelho, Rui/0000-0003-3813-5157; Fapesp, Biota/0000-0002-9887-8449; Oliveira, Claudio/0000-0002-7010-8880; Hazin, Fabio/0000-0003-3755-5379; Mendonca, Fernando/0000-0002-4806-9897; Ferrette, Bruno/0000-0002-3108-9867	Foundation for Research Support of the Sao Paulo State - FAPESP [2011/23787-0, 2010/51903-2]; Portuguese Foundation for Science and Technology (FCT) [SFRH/BPD/93936/2013]; Foundation for Research Support of the Sao Paulo State - FAPESP [2011/23787-0, 2010/51903-2]; Portuguese Foundation for Science and Technology (FCT) [SFRH/BPD/93936/2013]	Foundation for Research Support of the Sao Paulo State - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); Foundation for Research Support of the Sao Paulo State - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology)	This work was funded by the Foundation for Research Support of the Sao Paulo State - FAPESP (Ref: 2011/23787-0 and 2010/51903-2). Rui Coelho was supported by a Post-Doc grant from the Portuguese Foundation for Science and Technology (FCT, Ref: SFRH/BPD/93936/2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahonen H, 2009, MOL ECOL, V18, P4409, DOI 10.1111/j.1365-294X.2009.04377.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Baum JK, 2005, FISHERIES, V30, P27; Burgess GH, 2005, FISHERIES, V30, P19, DOI 10.1577/1548-8446(2005)30[19:ITCOSP]2.0.CO;2; Castro ALF, 2007, MOL ECOL, V16, P5183, DOI 10.1111/j.1365-294X.2007.03597.x; Coelho R, 2012, AQUAT LIVING RESOUR, V25, P311, DOI 10.1051/alr/2012030; Compagno L. J. V., 2001, FAO SPECIES CATALOGU, V2; Dulvy NK, 2008, AQUAT CONSERV, V18, P459, DOI 10.1002/aqc.975; Duncan KM, 2006, MOL ECOL, V15, P2239, DOI 10.1111/j.1365-294X.2006.02933.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fu YX, 1997, GENETICS, V147, P915; Gilman E, 2008, MAR POLICY, V32, P1, DOI 10.1016/j.marpol.2007.05.001; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HARPENDING HC, 1994, HUM BIOL, V66, P591; HAZIN F H V, 1990, Journal of the Tokyo University of Fisheries, V77, P51; Karl SA, 2012, MAR BIOL, V159, P489, DOI 10.1007/s00227-011-1828-y; Keeney DB, 2006, MOL ECOL, V15, P3669, DOI 10.1111/j.1365-294X.2006.03036.x; Lack M., 2009, TRENDS GLOBAL SHARK; Mendonca FF, 2013, AQUAT CONSERV, V23, P850, DOI 10.1002/aqc.2342; Mendonca FF, 2009, NEOTROP ICHTHYOL, V7, P213, DOI 10.1590/S1679-62252009000200012; Oliveira P, 2010, J FISH BIOL, V76, P1655, DOI 10.1111/j.1095-8649.2010.02606.x; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Hoelzel AR, 2006, BIOL LETTERS, V2, P639, DOI 10.1098/rsbl.2006.0513; Schmidt JV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004988; TAJIMA F, 1989, GENETICS, V123, P585; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673	28	13	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117549	10.1371/journal.pone.0117549	http://dx.doi.org/10.1371/journal.pone.0117549			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689742	Green Published, Green Submitted, gold			2022-12-26	WOS:000350322700053
J	Gong, AD; Li, HP; Yuan, QS; Song, XS; Yao, W; He, WJ; Zhang, JB; Liao, YC				Gong, An-Dong; Li, He-Ping; Yuan, Qing-Song; Song, Xiu-Shi; Yao, Wei; He, Wei-Jie; Zhang, Jing-Bo; Liao, Yu-Cai			Antagonistic Mechanism of Iturin A and Plipastatin A from Bacillus amyloliquefaciens S76-3 from Wheat Spikes against Fusarium graminearum	PLOS ONE			English	Article							ANTIFUNGAL ACTIVITY; HEAD BLIGHT; BIOLOGICAL-CONTROL; GENETIC DIVERSITY; GIBBERELLA-ZEAE; PLANT-PATHOGENS; SUBTILIS; LIPOPEPTIDES; FENGYCIN; IDENTIFICATION	Controlling toxigenic Fusarium graminearum (FG) is challenging. A bacterial strain (S76- 3, identified as Bacillus amyloliquefaciens) that was isolated from diseased wheat spikes in the field displayed strong antifungal activity against FG. Reverse-phase high performance liquid chromatography and electrospray ionization mass spectrometry analyses revealed that S76- 3 produced three classes of cyclic lipopeptides including iturin, plipastatin and surfactin. Each class consisted of several different molecules. The iturin and plipastatin fractions strongly inhibited FG; the surfactin fractions did not. The most abundant compound that had antagonistic activity from the iturin fraction was iturin A (m/z 1043.35); the most abundant active compound from the plipastatin fraction was plipastatin A (m/z 1463.90). These compounds were analyzed with collision-induced dissociation mass spectrometry. The two purified compounds displayed strong fungicidal activity, completely killing conidial spores at the minimal inhibitory concentration range of 50 mu g/ml (iturin A) and 100 mu g/ml (plipastatin A). Optical and fluorescence microscopy analyses revealed severe morphological changes in conidia and substantial distortions in FG hyphae treated with iturin A or plipastatin A. Iturin A caused leakage and/or inactivation of FG cellular contents and plipastatin A caused vacuolation. Time- lapse imaging of dynamic antagonistic processes illustrated that iturin A caused distortion and conglobation along hyphae and inhibited branch formation and growth, while plipastatin A caused conglobation in young hyphae and branch tips. Transmission electron microscopy analyses demonstrated that the cell walls of conidia and hyphae of iturin A and plipastatin A treated FG had large gaps and that their plasma membranes were severely damaged and separated from cell walls.	[Gong, An-Dong; Li, He-Ping; Yuan, Qing-Song; Song, Xiu-Shi; Yao, Wei; He, Wei-Jie; Zhang, Jing-Bo; Liao, Yu-Cai] Huazhong Agr Univ, Mol Biotechnol Lab Triticeae Crops, Wuhan 430070, Peoples R China; [Gong, An-Dong; Yuan, Qing-Song; Song, Xiu-Shi; Yao, Wei; Zhang, Jing-Bo; Liao, Yu-Cai] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan 430070, Peoples R China; [Li, He-Ping; He, Wei-Jie] Huazhong Agr Univ, Coll Life Sci & Technol, Wuhan 430070, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Huazhong Agricultural University	Liao, YC (corresponding author), Huazhong Agr Univ, Mol Biotechnol Lab Triticeae Crops, Wuhan 430070, Peoples R China.	yucailiao@mail.hzau.edu.cn	Zhang, Jing/GWZ-7332-2022; yuan, qingsong/GXV-9897-2022		National Basic Research Program of China [2013CB127801]; National Natural Science Foundation of China [31201475, 31271718, 31272004]; Ministry of Agriculture of China [2014ZX0800202B-001]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs)	This work was supported by the National Basic Research Program of China (2013CB127801), the National Natural Science Foundation of China (31201475, 31271718, 31272004), and the Ministry of Agriculture of China (2014ZX0800202B-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arguelles-Arias A, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-63; Bie XM, 2009, J MICROBIOL METH, V79, P272, DOI 10.1016/j.mimet.2009.09.013; Chen H, 2008, LETT APPL MICROBIOL, V47, P180, DOI 10.1111/j.1472-765X.2008.02412.x; Chen XH, 2007, NAT BIOTECHNOL, V25, P1007, DOI 10.1038/nbt1325; Connor N, 2010, APPL ENVIRON MICROB, V76, P1349, DOI 10.1128/AEM.01988-09; Crane JM, 2013, PHYTOPATHOLOGY, V103, P146, DOI 10.1094/PHYTO-07-12-0154-R; de Silva S, 1998, SYST APPL MICROBIOL, V21, P398, DOI 10.1016/S0723-2020(98)80049-0; Deacon JW, 2006, FUNGAL BIOL-UK; Deleu M, 2005, J COLLOID INTERF SCI, V283, P358, DOI 10.1016/j.jcis.2004.09.036; Falardeau J, 2013, J CHEM ECOL, V39, P869, DOI 10.1007/s10886-013-0319-7; Fickers P, 2009, APPL ENVIRON MICROB, V75, P4636, DOI 10.1128/AEM.00548-09; Gong M, 2006, ACTA BIOCH BIOPH SIN, V38, P233, DOI 10.1111/j.1745-7270.2006.00157.x; Honma M, 2012, BIOORGAN MED CHEM, V20, P3793, DOI 10.1016/j.bmc.2012.04.040; Horn JN, 2013, BIOPHYS J, V105, P1612, DOI 10.1016/j.bpj.2013.08.034; Huang XQ, 2008, CURR MICROBIOL, V56, P376, DOI 10.1007/s00284-007-9066-8; Latge JP, 2007, MOL MICROBIOL, V66, P279, DOI 10.1111/j.1365-2958.2007.05872.x; Liu X, 2010, PLANT DIS, V94, P1137, DOI 10.1094/PDIS-94-9-1137; LOGAN NA, 1984, J GEN MICROBIOL, V130, P1871; MAGETDANA R, 1985, BIOCHIM BIOPHYS ACTA, V815, P405, DOI 10.1016/0005-2736(85)90367-0; MAGETDANA R, 1994, TOXICOLOGY, V87, P151, DOI 10.1016/0300-483X(94)90159-7; MAGETDANA R, 1992, BIOCHIMIE, V74, P1047, DOI 10.1016/0300-9084(92)90002-V; Nasir MN, 2010, COLLOID SURFACE B, V78, P17, DOI 10.1016/j.colsurfb.2010.01.034; Nasir MN, 2011, LANGMUIR, V27, P10785, DOI 10.1021/la200767e; Ndoye M, 2012, J PHYTOPATHOL, V160, P519, DOI 10.1111/j.1439-0434.2012.01944.x; Nganje W. E., 2002, 2002 NAT FUS HEAD BL, P275; Ongena M, 2008, TRENDS MICROBIOL, V16, P115, DOI 10.1016/j.tim.2007.12.009; Patel H, 2011, BBA-BIOMEMBRANES, V1808, P2000, DOI 10.1016/j.bbamem.2011.04.008; Pestka JJ, 2005, J TOXICOL ENV HEAL B, V8, P39, DOI 10.1080/10937400590889458; PRIEST FG, 1987, INT J SYST BACTERIOL, V37, P69, DOI 10.1099/00207713-37-1-69; Qu B, 2008, PLANT PATHOL, V57, P15, DOI 10.1111/j.1365-3059.2007.01711.x; Romero D, 2007, MOL PLANT MICROBE IN, V20, P430, DOI 10.1094/MPMI-20-4-0430; Song B, 2013, APPL MICROBIOL BIOT, V97, P7141, DOI 10.1007/s00253-013-5000-0; Song B, 2013, FUNGAL GENET BIOL, V54, P60, DOI 10.1016/j.fgb.2013.02.010; Tao Y, 2011, J MICROBIOL, V49, P146, DOI 10.1007/s12275-011-0171-9; Tendulkar SR, 2007, J APPL MICROBIOL, V103, P2331, DOI 10.1111/j.1365-2672.2007.03501.x; VANITTANAKOM N, 1986, J ANTIBIOT, V39, P888, DOI 10.7164/antibiotics.39.888; Wang J, 2007, APPL MICROBIOL BIOT, V76, P889, DOI 10.1007/s00253-007-1054-1; Wang JH, 2011, TOXINS, V3, P1020, DOI 10.3390/toxins3081020; Windels CE, 2000, PHYTOPATHOLOGY, V90, P17, DOI 10.1094/PHYTO.2000.90.1.17; Wise C, 2014, PHYTOPATHOLOGY; Xu HM, 2014, APPL MICROBIOL BIOT, V98, P127, DOI 10.1007/s00253-013-5291-1; Xu YB, 2010, FUNGAL GENET BIOL, V47, P205, DOI 10.1016/j.fgb.2009.11.003; Yuan SK, 2005, CAN J PLANT PATHOL, V27, P58; Zeriouh H, 2011, MOL PLANT MICROBE IN, V24, P1540, DOI 10.1094/MPMI-06-11-0162; Zhang JB, 2013, PLANT PATHOL, V62, P92, DOI 10.1111/j.1365-3059.2012.02639.x; Zhang XY, 2013, APPL MICROBIOL BIOT, V97, P9525, DOI 10.1007/s00253-013-5198-x; Zhang YJ, 2009, MOL PLANT MICROBE IN, V22, P1143, DOI 10.1094/MPMI-22-9-1143; Zhao PC, 2013, J BASIC MICROB, V00, P1; Zhao YJ, 2014, PLOS ONE, DOI [10.1371/journal.pone.0092486, DOI 10.1371/J0URNAL.P0NE.0092486]; Zhou WW, 2008, J APPL MICROBIOL, V105, P912, DOI 10.1111/j.1365-2672.2008.03822.x	50	121	141	6	115	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0116871	10.1371/journal.pone.0116871	http://dx.doi.org/10.1371/journal.pone.0116871			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689464	Green Published, Green Submitted, gold			2022-12-26	WOS:000350322700025
J	Hu, ZY; Zhou, ZG; Hu, YH; Wu, JH; Li, YM; Huang, WL				Hu, Zheyi; Zhou, Zaigang; Hu, Yahui; Wu, Jinhui; Li, Yunman; Huang, Wenlong			HZ08 Reverse P-Glycoprotein Mediated Multidrug Resistance In Vitro and In Vivo	PLOS ONE			English	Article							CHEMOTHERAPEUTIC DRUG-RESISTANCE; ABC-TRANSPORTERS; INHIBITORS; SUBSTRATE; MEMBRANE; MECHANISMS; CANCER; ASSAYS; GP; IDENTIFICATION	Background Multidrug efflux transporter P-glycoprotein ( P-gp) is highly expressed on membrane of tumor cells and is implicated in resistance to tumor chemotherapy. HZ08 is synthesized and studied in order to find a novel P-gp inhibitor. Methods MDCK-MDR1 monolayer transport, calcein-AM P-gp inhibition and P-gp ATPase assays were used to confirm the P-gp inhibition capability of HZ08. Furthermore, KB-WT and KBVCR cells were used to evaluate the P-gp inhibitory activity of HZ08 both in vitro and in vivo. Results Results showed that HZ08 was more potent than verapamil in MDCK-MDR1 monolayer transportation model. Meanwhile, P-gp ATPase assay and calcein-AM P-gp inhibition assay confirmed that HZ08 inhibited P-gp ATPase with a calcein-AM IC50 of 2.44 +/- 0.31 mu M. In addition, significantly greater in vitro multidrug resistance reversing effects were observed when vincristine or paclitaxel was used in combination with 10 mu M HZ08 compared with 10 mu M verapamil. Moreover, HZ08 could significantly enhance the sensitivity of vincristine with a similar effect like verapamil in both KB-WT and KB-VCR tumor xenograft models. Conclusions The novel structure HZ08 could be a potent P-gp inhibitor.	[Hu, Zheyi; Hu, Yahui; Li, Yunman] China Pharmaceut Univ, Dept Physiol, State Key Lab Nat Med, Nanjing 210009, Jiangsu, Peoples R China; [Zhou, Zaigang; Wu, Jinhui] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Jiangsu, Peoples R China; [Huang, Wenlong] China Pharmaceut Univ, Ctr Drug Discovery, Nanjing 210009, Jiangsu, Peoples R China	China Pharmaceutical University; Nanjing University; China Pharmaceutical University	Wu, JH (corresponding author), Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Jiangsu, Peoples R China.	wuj@nju.edu.cn; yunmanlicpu@hotmail.com	Wu, Jinhui/N-8386-2019; Wu, Jinhui/J-9476-2012	Wu, Jinhui/0000-0001-8809-1290; Wu, Jinhui/0000-0001-8809-1290; Zhou, Zaigang/0000-0002-5853-1395	National Nature Science Foundation of P.R. China [81173088]; National Science and Technology Major Project [2002AA233071]; Scientific Research and Innovation Project of College Students of Jiangsu Province [CXLX13 317]	National Nature Science Foundation of P.R. China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project; Scientific Research and Innovation Project of College Students of Jiangsu Province	This work was supported by the National Nature Science Foundation of P.R. China (No. 81173088), National Science and Technology Major Project (No. 2002AA233071), Scientific Research and Innovation Project of College Students of Jiangsu Province (No. CXLX13 317). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanismaa P, 2007, BIOCHEMISTRY-US, V46, P3394, DOI 10.1021/bi0619526; Akan I, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-22; Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; Bartels AL, 2009, NEUROBIOL AGING, V30, P1818, DOI 10.1016/j.neurobiolaging.2008.02.002; Bikadi Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025815; Borst P, 2000, JNCI-J NATL CANCER I, V92, P1295, DOI 10.1093/jnci/92.16.1295; Ceckova-Novotna M, 2006, REPROD TOXICOL, V22, P400, DOI 10.1016/j.reprotox.2006.01.007; Cen JA, 2010, EUR J PHARMACOL, V647, P21, DOI 10.1016/j.ejphar.2010.08.013; Chang C, 2006, DRUG METAB DISPOS, V34, P1976, DOI 10.1124/dmd.106.012351; Choi CH, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-30; Colabufo NA, 2008, BIOORGAN MED CHEM, V16, P362, DOI [10.1016/j.bmc.2008.01.055, 10.1016/j.bmc.2007.09.039]; Constantinides PP, 2007, J PHARM SCI-US, V96, P235, DOI 10.1002/jps.20780; Dong XW, 2009, CANCER RES, V69, P3918, DOI 10.1158/0008-5472.CAN-08-2747; dos Santos SM, 2007, BIOCHEM BIOPH RES CO, V354, P216, DOI 10.1016/j.bbrc.2006.12.202; Ecker G, 1999, MOL PHARMACOL, V56, P791; Ekins S, 2002, MOL PHARMACOL, V61, P974, DOI 10.1124/mol.61.5.974; Ernst R, 2010, FEBS J, V277, P540, DOI 10.1111/j.1742-4658.2009.07485.x; Fang W, 2007, J PHARM PHARMACOL, V59, P1649, DOI 10.1211/jpp.59.12.0006; Feng B, 2008, DRUG METAB DISPOS, V36, P268, DOI 10.1124/dmd.107.017434; Feng YD, 2013, EUR J PHARMACOL, V712, P53, DOI 10.1016/j.ejphar.2013.04.028; Fojo T, 2007, ANN ONCOL, V18, pV3, DOI 10.1093/annonc/mdm172; Globisch C, 2006, BIOORGAN MED CHEM, V14, P1588, DOI 10.1016/j.bmc.2005.10.058; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; Grellier P, 2008, PARASITE, V15, P219, DOI 10.1051/parasite/2008153219; Hiessbock R, 1999, J MED CHEM, V42, P1921, DOI 10.1021/jm980517+; Irvine JD, 1999, J PHARM SCI, V88, P28, DOI 10.1021/js9803205; Kim RB, 2002, DRUG METAB REV, V34, P47, DOI 10.1081/DMR-120001389; Lage H, 2003, INT J ANTIMICROB AG, V22, P188, DOI 10.1016/S0924-8579(03)00203-6; Liu FS, 2009, TAIWAN J OBSTET GYNE, V48, P239, DOI 10.1016/S1028-4559(09)60296-5; Martin C, 1999, BRIT J PHARMACOL, V128, P403, DOI 10.1038/sj.bjp.0702807; Matsson P, 2009, PHARM RES-DORDR, V26, P1816, DOI 10.1007/s11095-009-9896-0; Nozinic D, 2010, CROAT CHEM ACTA, V83, P323; Polli JW, 2001, J PHARMACOL EXP THER, V299, P620; Polli JW, 1999, PHARM RES-DORDR, V16, P1206, DOI 10.1023/A:1018941328702; Rautio J, 2006, DRUG METAB DISPOS, V34, P786, DOI 10.1124/dmd.105.008615; Schinkel AH, 2003, ADV DRUG DELIVER REV, V55, P3, DOI 10.1016/S0169-409X(02)00169-2; Seelig A, 1998, EUR J BIOCHEM, V251, P252, DOI 10.1046/j.1432-1327.1998.2510252.x; Shi Z, 2011, CANCER RES, V71, P3029, DOI 10.1158/0008-5472.CAN-10-3820; Tiwari AK, 2011, CURR PHARM BIOTECHNO, V12, P570; Tran TT, 2004, J PHARM SCI-US, V93, P2108, DOI 10.1002/jps.20105; UCHIDA M, 1989, CHEM PHARM BULL, V37, P2109; Umsumarng S, 2013, INHIBITION OF P GLYC; vanAsperen J, 1997, J PHARM SCI, V86, P881, DOI 10.1021/js9701364; Varma MVS, 2006, CURR OPIN CHEM BIOL, V10, P367, DOI 10.1016/j.cbpa.2006.06.015; Varma MVS, 2003, PHARMACOL RES, V48, P347, DOI 10.1016/S1043-6618(03)00158-0; Wang EJ, 2001, PHARM RES-DORDR, V18, P800, DOI 10.1023/A:1011036428972; Wartenberg M, 2010, J CELL BIOCHEM, V109, P434, DOI 10.1002/jcb.22422; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Zhang YY, 2014, TOXICOL APPL PHARM, V274, P232, DOI 10.1016/j.taap.2013.11.019; Zhao XQ, 2012, MOL PHARMACOL, V82, P47, DOI 10.1124/mol.111.076299	51	7	7	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0116886	10.1371/journal.pone.0116886	http://dx.doi.org/10.1371/journal.pone.0116886			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689592	Green Submitted, Green Published, gold			2022-12-26	WOS:000350322700026
J	Xu, F; Wang, Q; Zhang, H; Chen, SP; Ao, HS				Xu, Fei; Wang, Qian; Zhang, Heng; Chen, Sipeng; Ao, Hushan			Use of Pulmonary Artery Catheter in Coronary Artery Bypass Graft. Costs and Long-Term Outcomes	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; CONTROLLED TRIAL; CARE	Background Pulmonary artery catheters (PAC) are used widely to monitor hemodynamics in patients undergoing coronary bypass graft (CABG) surgery. However, recent studies have raised concerns regarding both the effectiveness and safety of PAC. Therefore, our aim was to determine the effects of the use of PAC on the short- and long-term health and economic outcomes of patients undergoing CABG. Methods 1361 Chinese patients who consecutively underwent isolated, primary CABG at the Cardiovascular Institute of Fuwai Hospital from June 1, 2012 to December 31, 2012 were included in this study. Of all the patients, 453 received PAC during operation (PAC group) and 908 received no PAC therapy (control group). Short-term and long-term mortality and major complications were analyzed with multivariate regression analysis and propensity score matched-pair analysis was used to yield two well-matched groups for further comparison. Results The patients who were managed with PAC more often received intraoperative vasoactive drugs dopamine (70.9% vs. 45.5%; P<0.001) and epinephrine (7.7% vs. 2.6%; P<0.001). In addition, costs for initial hospitalization were higher for PAC patients ($14,535 vs. $13,873, respectively, p = 0.004). PAC use was neither associated with the perioperative mortality or major complications, nor was it associated with long-term mortality and major adverse cardiac and cerebrovascular events. In addition, comparison between two well-matched groups showed no significant differences either in baseline characteristics or in short- term and long-term outcomes. Conclusions There is no clear indication of any benefit or harm in managing CABG patients with PAC. However, use of PAC in CABG is more expensive. That is, PAC use increased costs without benefit and thus appears unjustified for routine use in CABG surgery.	[Xu, Fei; Ao, Hushan] Chinese Acad Med Sci, Dept Anesthesiol, Cardiovasc Inst, Beijing 100730, Peoples R China; [Xu, Fei; Zhang, Heng; Ao, Hushan] Chinese Acad Med Sci, Fuwai Hosp, Beijing 100730, Peoples R China; [Wang, Qian] Inner Mongolia Med Univ, Dept Anesthesiol, Huhhot Inner Mongolia, Peoples R China; [Zhang, Heng] Chinese Acad Med Sci, Dept Cardiothorac Surg, Cardiovasc Inst, Beijing 100730, Peoples R China; [Chen, Sipeng] Capital Med Univ, Dept Biostat Unit, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Inner Mongolia Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Capital Medical University	Ao, HS (corresponding author), Chinese Acad Med Sci, Dept Anesthesiol, Cardiovasc Inst, Beijing 100730, Peoples R China.	aohushan@sina.com		Xu, Fei/0000-0003-0569-661X				Am Soc Anesthesiologists Task Forc, 2003, ANESTHESIOLOGY, V99, P988; [Anonymous], 1997, CRIT CARE MED; BROHET CR, 1989, J ELECTROCARDIOL, V22, P158; Chernow B, 1997, CHEST, V111, P261, DOI 10.1378/chest.111.2.261; Connors AF, 1996, JAMA-J AM MED ASSOC, V276, P889, DOI 10.1001/jama.276.11.889; DAVIES MJ, 1982, ANAESTH INTENS CARE, V10, P9, DOI 10.1177/0310057X8201000103; Harvey S, 2005, LANCET, V366, P472, DOI 10.1016/S0140-6736(05)67061-4; Iantorno Micaela, 2012, Acute Card Care, V14, P125, DOI 10.3109/17482941.2012.741245; Jacka MJ, 2002, CAN J ANAESTH, V49, P276, DOI 10.1007/BF03020527; Judge O, 2015, J CARDIOTHOR VASC AN, V29, P69, DOI 10.1053/j.jvca.2014.07.016; MIMOZ O, 1994, CRIT CARE MED, V22, P573, DOI 10.1097/00003246-199404000-00011; PEARSON KS, 1989, ANESTH ANALG, V69, P336; Ramsey SD, 2000, J CARDIOTHOR VASC AN, V14, P113, DOI 10.1016/S1053-0770(00)90001-6; Resano FG, 2006, J CARDIOTHOR VASC AN, V20, P300, DOI 10.1053/j.jvca.2006.01.017; Rhodes A, 2002, INTENS CARE MED, V28, P256, DOI 10.1007/s00134-002-1206-9; Richard C, 2003, JAMA-J AM MED ASSOC, V290, P2713, DOI 10.1001/jama.290.20.2713; Sandham JD, 2003, NEW ENGL J MED, V348, P5, DOI 10.1056/NEJMoa021108; Schwann NM, 2011, ANESTH ANALG, V113, P994, DOI 10.1213/ANE.0b013e31822c94a8; Shah MR, 2005, JAMA-J AM MED ASSOC, V294, P1664, DOI 10.1001/jama.294.13.1664; Shahian DM, 2009, ANN THORAC SURG, V88, pS2, DOI 10.1016/j.athoracsur.2009.05.053; SHOEMAKER WC, 1988, CHEST, V94, P1176, DOI 10.1378/chest.94.6.1176; Stevenson LW, 2005, JAMA-J AM MED ASSOC, V294, P1625; TUMAN KJ, 1989, ANESTHESIOLOGY, V70, P199, DOI 10.1097/00000542-198902000-00004; Wang XQ, 2010, ANN THORAC SURG, V89, P1489, DOI 10.1016/j.athoracsur.2010.02.006; Wheeler AP, 2006, NEW ENGL J MED, V354, P2213	25	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117610	10.1371/journal.pone.0117610	http://dx.doi.org/10.1371/journal.pone.0117610			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689312	Green Published, Green Submitted, gold			2022-12-26	WOS:000350322700062
J	Nedergaard, MK; Michaelsen, SR; Urup, T; Broholm, H; El Ali, H; Poulsen, HS; Stockhausen, MT; Kjaer, A; Lassen, U				Nedergaard, Mette Kjoelhede; Michaelsen, Signe Regner; Urup, Thomas; Broholm, Helle; El Ali, Henrik; Poulsen, Hans Skovgaard; Stockhausen, Marie-Therese; Kjaer, Andreas; Lassen, Ulrik			F-18-FET MicroPET and MicroMRI for Anti-VEGF and Anti-PlGF Response Assessment in an Orthotopic Murine Model of Human Glioblastoma	PLOS ONE			English	Article							TUMOR-GROWTH; ANGIOGENESIS; PET; INHIBITION; EXPRESSION; ANTIBODIES; ANTITUMOR; EFFICACY; RECEPTOR; CANCER	Background Conflicting data exist for anti-cancer effects of anti-placental growth factor (anti-PlGF) in combination with anti-VEGF. Still, this treatment combination has not been evaluated in intracranial glioblastoma (GBM) xenografts. In clinical studies, position emission tomography (PET) using the radiolabeled amino acid O-(2-F-18-fluoroethyl)-L-tyrosine (F-18-FET) and magnetic resonance imaging (MRI) add complementary but distinct information about glioma growth; however, the value of F-18-FET MicroPET combined with MicroMRI has not been investigated preclinically. Here we examined the use of F-18-FET MicroPET and MicroMRI for evaluation of anti-VEGF and anti-PlGF treatment response in GBM xenografts. Methods Mice with intracranial GBM were treated with anti-VEGF, anti-PlGF + anti-VEGF or saline. Bioluminescence imaging (BLI), F-18-FET MicroPET and T2-weighted (T2w)-MRI were used to follow tumour development. Primary end-point was survival, and tumours were subsequently analysed for Ki67 proliferation index and micro-vessel density (MVD). Further, PlGF and VEGFR-1 expression were examined in a subset of the xenograft tumours and in 13 GBM patient tumours. Results Anti-VEGF monotherapy increased survival and decreased F-18-FET uptake, BLI and MVD, while no additive effect of anti-PlGF was observed. F-18-FET SUVmax tumour-to-brain (T/B) ratio was significantly lower after one week (114 +/- 6%, n = 11 vs. 143 +/- 8%, n = 13; p = 0.02) and two weeks of treatment (116 +/- 12%, n = 8 vs. 190 +/- 24%, n = 5; p = 0.02) in the anti-VEGF group as compared with the control group. In contrast, T2w-MRI volume was unaffected by anti-VEGF. Gene expression of PlGF and VEGFR-1 in xenografts was significantly lower than in patient tumours. Conclusion F-18-FET PET was feasible for anti-angiogenic response evaluation and superior to T2w-MRI; however, no additive anti-cancer effect of anti-PlGF and anti-VEGF was observed. Thus, this study supports use of 18F-FET PET for response evaluation in future studies.	[Nedergaard, Mette Kjoelhede; El Ali, Henrik; Kjaer, Andreas] Rigshosp, Nucl Med & PET, Dept Clin Physiol, DK-2100 Copenhagen, Denmark; [Nedergaard, Mette Kjoelhede; El Ali, Henrik; Kjaer, Andreas] Rigshosp, Cluster Mol Imaging, DK-2100 Copenhagen, Denmark; [Nedergaard, Mette Kjoelhede; El Ali, Henrik; Kjaer, Andreas] Univ Copenhagen, Copenhagen, Denmark; [Michaelsen, Signe Regner; Urup, Thomas; Poulsen, Hans Skovgaard; Stockhausen, Marie-Therese] Rigshosp, Finsen Ctr, Dept Radiat Biol, DK-2100 Copenhagen, Denmark; [Broholm, Helle] Rigshosp, Ctr Diagnost Invest, Dept Neuropathol, DK-2100 Copenhagen, Denmark; [Lassen, Ulrik] Rigshosp, Dept Oncol, Phase Unit 1, Finsen Ctr, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Nedergaard, MK (corresponding author), Rigshosp, Nucl Med & PET, Dept Clin Physiol, DK-2100 Copenhagen, Denmark.	Mette.Kjoelhede.Nedergaard@regionh.dk	Michaelsen, Signe/ABB-1451-2020; Urup, Thomas/AAC-9953-2020; ALI, Henrik El/C-6164-2017; Lassen, Ulrik/AAH-2799-2021; Kjaer, Andreas/E-8932-2015	Michaelsen, Signe/0000-0001-9047-6384; ALI, Henrik El/0000-0001-8226-3055; Kjaer, Andreas/0000-0002-2706-5547; Lassen, Ulrik/0000-0002-3865-4574	Danish Cancer Research Foundation; Danish Cancer Society; Danish National Advanced Technology Foundation; AP Moller Foundation; Lundbeck Foundation; Novo Nordisk Foundation; Svend Andersen Foundation; John and Birgitte Meyer Foundation; Danish Research Council; Rigshospitalets Research Foundation; Novo Nordisk Fonden [NNF13OC0007149] Funding Source: researchfish; The Danish Cancer Society [R90-A6057] Funding Source: researchfish	Danish Cancer Research Foundation; Danish Cancer Society(Danish Cancer Society); Danish National Advanced Technology Foundation; AP Moller Foundation; Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Svend Andersen Foundation; John and Birgitte Meyer Foundation; Danish Research Council(Det Frie Forskningsrad (DFF)); Rigshospitalets Research Foundation; Novo Nordisk Fonden(Novo Nordisk Foundation); The Danish Cancer Society(Danish Cancer Society)	Danish Cancer Research Foundation; The Danish Cancer Society; Danish National Advanced Technology Foundation; AP Moller Foundation; The Lundbeck Foundation; Novo Nordisk Foundation; Svend Andersen Foundation; The John and Birgitte Meyer Foundation; Danish Research Council; Rigshospitalets Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagley RG, 2011, CLIN CANCER RES, V17, P976, DOI 10.1158/1078-0432.CCR-10-2687; Bais C, 2010, CELL, V141, P166, DOI 10.1016/j.cell.2010.01.033; Chi AS, 2009, ONCOLOGIST, V14, P621, DOI 10.1634/theoncologist.2008-0272; Christoph S, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-10; Eriksson A, 2002, CANCER CELL, V1, P99, DOI 10.1016/S1535-6108(02)00028-4; Fischer C, 2007, CELL, V131, P463, DOI 10.1016/j.cell.2007.08.038; Galldiks N, 2013, EUR J NUCL MED MOL I, V40, P22, DOI 10.1007/s00259-012-2251-4; Hedlund EME, 2013, P NATL ACAD SCI USA, V110, P654, DOI 10.1073/pnas.1209310110; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hutterer M, 2011, J NUCL MED, V52, P856, DOI 10.2967/jnumed.110.086645; Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175; Jalali S, 2014, NEURO-ONCOLOGY, V16, P868, DOI 10.1093/neuonc/nou040; James ML, 2012, PHYSIOL REV, V92, P897, DOI 10.1152/physrev.00049.2010; Jarzabek MA, 2013, MOL IMAGING, V12, DOI 10.2310/7290.2012.00029; Kerber M, 2008, CANCER RES, V68, P7342, DOI 10.1158/0008-5472.CAN-07-6241; Khalil Ashraf A, 2013, Int J Mol Imaging, V2013, P287697, DOI 10.1155/2013/287697; Kienast Y, 2013, CLIN CANCER RES, V19, P6730, DOI 10.1158/1078-0432.CCR-13-0081; Lassen UN, 2013, J CLIN ONCOL, V31; Liang WC, 2006, J BIOL CHEM, V281, P951, DOI 10.1074/jbc.M508199200; Motzer RJ, 2006, J CLIN ONCOL, V24, P16, DOI 10.1200/JCO.2005.02.2574; Munnink THO, 2013, J NUCL MED, V54, P929, DOI 10.2967/jnumed.112.112086; Nedergaard MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100009; Nomura M, 1998, J NEURO-ONCOL, V40, P123, DOI 10.1023/A:1006198422718; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Popperl G, 2006, EUR J NUCL MED MOL I, V33, P792, DOI 10.1007/s00259-005-0053-7; Pope WB, 2011, CURR NEUROL NEUROSCI, V11, P336, DOI 10.1007/s11910-011-0179-x; Popperl G, 2005, EUR J NUCL MED MOL I, V32, P1018, DOI 10.1007/s00259-005-1819-7; Rosen LS, 2007, J CLIN ONCOL, V25, P2369, DOI 10.1200/JCO.2006.07.8170; Stockhausen MT, 2011, EXP CELL RES, V317, P1513, DOI 10.1016/j.yexcr.2011.04.001; Tuominen VJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2615; Van de Veire S, 2010, CELL, V141, P178, DOI 10.1016/j.cell.2010.02.039; von Baumgarten L, 2011, CLIN CANCER RES, V17, P6192, DOI 10.1158/1078-0432.CCR-10-1868; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Xu L, 2006, CANCER RES, V66, P3971, DOI 10.1158/0008-5472.CAN-04-3085; Yao J, 2011, P NATL ACAD SCI USA, V108, P11590, DOI 10.1073/pnas.1109029108; Zins K, 2013, INT J MOL SCI, V14, P17958, DOI 10.3390/ijms140917958	36	8	8	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0115315	10.1371/journal.pone.0115315	http://dx.doi.org/10.1371/journal.pone.0115315			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680186	Green Published, Green Submitted, gold			2022-12-26	WOS:000350682600006
J	Priya, RS; Veena, M; Kalisz, I; Whitney, S; Priyanka, D; LaBranche, CC; Teja, MS; Montefiori, DC; Pal, R; Mahalingam, S; Kalyanaraman, VS				Priya, Rangasamy Sneha; Veena, Menon; Kalisz, Irene; Whitney, Stephen; Priyanka, Dhopeshwarkar; LaBranche, Celia C.; Teja, Mullapudi Sri; Montefiori, David C.; Pal, Ranajit; Mahalingam, Sundarasamy; Kalyanaraman, Vaniambadi S.			Antigenicity and Immunogenicity of a Trimeric Envelope Protein from an Indian Clade C HIV-1 Isolate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN MONOCLONAL-ANTIBODIES; CROSS-CLADE; SUBTYPE-C; NEUTRALIZING ANTIBODIES; CHIMERIC VIRUS; ENV CLONES; VACCINE; RESPONSES; GLYCOPROTEIN	Human immunodeficiency virus type 1 (HIV-1) isolates from India mainly belong to clade C and are quite distinct from clade C isolates from Africa in terms of their phylogenetic makeup, serotype, and sensitivity to known human broadly neutralizing monoclonal antibodies. Because many of these properties are associated with the envelope proteins of HIV-1, it is of interest to study the envelope proteins of Indian clade C isolates as part of the ongoing efforts to develop a vaccine against HIV-1. To this end, we purified trimeric uncleaved gp145 of a CCR5 tropic Indian clade C HIV-1 (93IN101) from the conditioned medium of 293 cells. The purified protein was shown to be properly folded with stable structure by circular dichroism. Conformational integrity was further demonstrated by its high affinity binding to soluble CD4, CD4 binding site antibodies such as b12 and VRC01, quaternary epitope-specific antibody PG9, and CD4-induced epitope-specific antibody 17b. Sera from rabbits immunized with gp145 elicited high titer antibodies to various domains of gp120 and neutralized a broad spectrum of cladeBand clade C HIV-1 isolates. Similar to other clade B and clade C envelope immunogens, most of the Tier 1 neutralizing activity could be absorbed with the V3-specific peptide. Subsequent boosting of these rabbits with a clade B HIV-1 Bal gp145 resulted in an expanded breadth of neutralization of HIV-1 isolates. The present study strongly supports the inclusion of envelopes from Indian isolates in a future mixture of HIV-1 vaccines.	[Priya, Rangasamy Sneha; Teja, Mullapudi Sri; Mahalingam, Sundarasamy] Indian Inst Technol, Lab Mol Virol & Cell Biol, Dept Biotechnol, Bhupat & Jyoti Mehta Sch Biosci, Chennai 600036, Tamil Nadu, India; [Veena, Menon; Kalisz, Irene; Whitney, Stephen; Priyanka, Dhopeshwarkar; Pal, Ranajit; Kalyanaraman, Vaniambadi S.] Adv Biosci Labs Inc, Rockville, MD 20850 USA; [LaBranche, Celia C.; Montefiori, David C.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras; Duke University	Mahalingam, S (corresponding author), Indian Inst Technol, Lab Mol Virol & Cell Biol, Dept Biotechnol, Bhupat & Jyoti Mehta Sch Biosci, Chennai 600036, Tamil Nadu, India.	mahalingam@iitm.ac.in		Mahalingam, Sundarasamy/0000-0003-4460-3949	Department of Science and Technology, Government of India [DST/TSG/ME/2010/50(G)]; Ministry of Human Resource and Development, Government of India	Department of Science and Technology, Government of India(Department of Science & Technology (India)); Ministry of Human Resource and Development, Government of India(Ministry of Human Resource Development (MHRD), Government of India)	This work was supported in part by Grant DST/TSG/ME/2010/50(G) from the Department of Science and Technology, Government of India (to S. M.) and a fellowship from the Ministry of Human Resource and Development, Government of India (to R. S. P.).	Amara RR, 2005, VIROLOGY, V334, P124; Baba TW, 2000, NAT MED, V6, P200, DOI 10.1038/72309; Bhattacharyya S, 2010, J BIOL CHEM, V285, P27100, DOI 10.1074/jbc.M110.152272; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Bontjer I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067484; Brown BK, 2005, J VIROL, V79, P6089, DOI 10.1128/JVI.79.10.6089-6101.2005; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; BURTON DR, 1991, P NATL ACAD SCI USA, V88, P10134, DOI 10.1073/pnas.88.22.10134; Chen B, 2000, J BIOL CHEM, V275, P34946, DOI 10.1074/jbc.M004905200; Chung HK, 2010, VIRUS RES, V151, P229, DOI 10.1016/j.virusres.2010.04.006; Davenport TM, 2011, J VIROL, V85, P7095, DOI 10.1128/JVI.00411-11; deCamp A, 2014, J VIROL, V88, P2489, DOI 10.1128/JVI.02853-13; Derdeyn CA, 2014, CURR OPIN HIV AIDS, V9, P210, DOI 10.1097/COH.0000000000000057; DIETRICH U, 1993, AIDS, V7, P23, DOI 10.1097/00002030-199301000-00003; Diskin R, 2011, SCIENCE, V334, P1289, DOI 10.1126/science.1213782; Feng Y, 2012, J BIOL CHEM, V287, P5673, DOI 10.1074/jbc.M111.317776; Gharu L, 2011, VIRUS RES, V158, P216, DOI 10.1016/j.virusres.2011.04.003; Gilbert PB, 2005, J INFECT DIS, V191, P666, DOI 10.1086/428405; Gottardo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075665; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Kang Y, 2009, VACCINE, V27, P5120, DOI 10.1016/j.vaccine.2009.06.037; Kim M, 2005, AIDS RES HUM RETROV, V21, P58, DOI 10.1089/aid.2005.21.58; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; Kong Leopold, 2012, J AIDS Clin Res, VS8, P3; Kovacs JM, 2012, P NATL ACAD SCI USA, V109, P12111, DOI 10.1073/pnas.1204533109; Kraus MH, 2010, VIROLOGY, V397, P346, DOI 10.1016/j.virol.2009.11.019; Kulkarni SS, 2009, VIROLOGY, V385, P505, DOI 10.1016/j.virol.2008.12.032; Kwong PD, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a007278; Liao HX, 2013, J VIROL, V87, P4185, DOI 10.1128/JVI.02297-12; Mascola JR, 2003, CURR MOL MED, V3, P209, DOI 10.2174/1566524033479799; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Matano T, 2004, J EXP MED, V199, P1709, DOI 10.1084/jem.20040432; McGuire AT, 2013, J EXP MED, V210, P655, DOI 10.1084/jem.20122824; Mochizuki N, 1999, AIDS RES HUM RETROV, V15, P1321, DOI 10.1089/088922299310223; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Polonis V, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-S2-P323; PURTSCHER M, 1994, AIDS RES HUM RETROV, V10, P1651, DOI 10.1089/aid.1994.10.1651; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Ringe R, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-76; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Sellhorn G, 2012, J VIROL, V86, P128, DOI 10.1128/JVI.06363-11; Selvarajah S, 2005, J VIROL, V79, P12148, DOI 10.1128/JVI.79.19.12148-12163.2005; Shen CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025956; Shibata R, 1999, NAT MED, V5, P204, DOI 10.1038/5568; Smith DH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012076; Srivastava IK, 2008, VIROLOGY, V372, P273, DOI 10.1016/j.virol.2007.10.022; Stamatatos L, 2000, AIDS RES HUM RETROV, V16, P981, DOI 10.1089/08892220050058407; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; THALI M, 1991, J VIROL, V65, P6188, DOI 10.1128/JVI.65.11.6188-6193.1991; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; Tong T, 2014, VIROLOGY, V456, P55, DOI 10.1016/j.virol.2014.03.015; Vaine M, 2008, J VIROL, V82, P7369, DOI 10.1128/JVI.00562-08; VANCOTT TC, 1995, J IMMUNOL METHODS, V183, P103, DOI 10.1016/0022-1759(95)00038-C; Visciano ML, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-165; Walker LM, 2010, CURR OPIN IMMUNOL, V22, P358, DOI 10.1016/j.coi.2010.02.012; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659	67	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					9195	9208		10.1074/jbc.M114.621185	http://dx.doi.org/10.1074/jbc.M114.621185			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25691567	Green Published, hybrid			2022-12-26	WOS:000352207100042
J	Kim, JS; Saint-Andre, C; Lim, HS; Hwang, CS; Egly, JM; Cho, Y				Kim, Jin Seok; Saint-Andre, Charlotte; Lim, Hye Seong; Hwang, Cheol-Sang; Egly, Jean Marc; Cho, Yunje			Crystal Structure of the Rad3/XPD Regulatory Domain of Ssl1/p44	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; NUCLEOTIDE EXCISION-REPAIR; XERODERMA-PIGMENTOSUM; XPD HELICASE; CANCER RISK; TRANSCRIPTION; COMPLEX; TFIIH; DNA; MUTATIONS	The Ssl1/p44 subunit is a core component of the yeast/mammalian general transcription factor TFIIH, which is involved in transcription and DNA repair. Ssl1/p44 binds to and stimulates the Rad3/XPD helicase activity of TFIIH. To understand the helicase stimulatory mechanism of Ssl1/p44, we determined the crystal structure of the N-terminal regulatory domain of Ssl1 from Saccharomyces cerevisiae. Ssl1 forms a von Willebrand factor A fold in which a central six-stranded beta-sheet is sandwiched between three alpha helices on both sides. Structural and biochemical analyses of Ssl1/p44 revealed that the beta 4-alpha 5 loop, which is frequently found at the interface between von Willebrand factor A family proteins and cellular counterparts, is critical for the stimulation of Rad3/XPD. Yeast genetics analyses showed that double mutation of Leu-239 and Ser-240 in the beta 4-alpha 5 loop of Ssl1 leads to lethality of a yeast strain, demonstrating the importance of the Rad3-Ssl1 interactions to cell viability. Here, we provide a structural model for the Rad3/XPD-Ssl1/p44 complex and insights into how the binding of Ssl1/p44 contributes to the helicase activity of Rad3/XPD and cell viability.	[Kim, Jin Seok; Lim, Hye Seong; Hwang, Cheol-Sang; Cho, Yunje] Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, South Korea; [Saint-Andre, Charlotte; Egly, Jean Marc] CNRS INSERM UdS, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, Cu Strasbourg, France	Pohang University of Science & Technology (POSTECH); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Egly, JM (corresponding author), CNRS INSERM UdS, Inst Genet & Biol Mol & Cellulaire, BP163, F-67404 Illkirch Graffenstaden, Cu Strasbourg, France.	jean-marc.egly@igbmc.fr; yunje@postech.ac.kr	Hwang, Cheol-Sang/Q-7391-2019	Hwang, Cheol-Sang/0000-0002-0105-5957	National R&D Program for Cancer Control, Ministry for Health and Welfare [1020280]; National Research Foundation of Korea - Korea government (Ministry of Education, Science and Technology; MEST) [2012R1A2A1A01004028, 2013M3A6A4044580, 2010-0019706]; Pohang University of Science and Technology rising star program; Ministry of Education BK21 Program; European Research Council; European Research Council Advanced Scientists; Agence Nationale de la Recherche [ANR-08-MIEN-022-03, ANR-10-BLANC-1231-02]; Association de la Recherche contre le Cancer [SL220100601335]	National R&D Program for Cancer Control, Ministry for Health and Welfare; National Research Foundation of Korea - Korea government (Ministry of Education, Science and Technology; MEST)(National Research Foundation of KoreaMinistry of Education, Science & Technology (MEST), Republic of Korea); Pohang University of Science and Technology rising star program; Ministry of Education BK21 Program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); European Research Council(European Research Council (ERC)European Commission); European Research Council Advanced Scientists; Agence Nationale de la Recherche(French National Research Agency (ANR)); Association de la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer)	This work was supported by National R&D Program for Cancer Control, Ministry for Health and Welfare Grant 1020280; National Research Foundation of Korea Grants 2012R1A2A1A01004028, 2013M3A6A4044580, and 2010-0019706 funded by the Korea government (Ministry of Education, Science and Technology; MEST); the Pohang University of Science and Technology rising star program; the Ministry of Education BK21 Program (to Y. C.); and a European Research Council advanced grant (to J. M. E.). This work was also supported by grants from the European Research Council Advanced Scientists; Agence Nationale de la Recherche Grants ANR-08-MIEN-022-03, ANR-10-BLANC-1231-02, and FRETNET; and Association de la Recherche contre le Cancer Grant SL220100601335.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BARDWELL L, 1994, P NATL ACAD SCI USA, V91, P3926, DOI 10.1073/pnas.91.9.3926; Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; Cho EJ, 1997, GENE DEV, V11, P3319, DOI 10.1101/gad.11.24.3319; Cleaver JE, 1999, HUM MUTAT, V14, P9, DOI 10.1002/(SICI)1098-1004(1999)14:1<9::AID-HUMU2>3.3.CO;2-Y; Coin F, 1998, NAT GENET, V20, P184, DOI 10.1038/2491; Coin F, 2007, MOL CELL, V26, P245, DOI 10.1016/j.molcel.2007.03.009; Compe E, 2012, NAT REV MOL CELL BIO, V13, P343, DOI 10.1038/nrm3350; Ding DP, 2012, MOL BIOL REP, V39, P2533, DOI 10.1007/s11033-011-1005-x; Dubaele S, 2003, MOL CELL, V11, P1635, DOI 10.1016/S1097-2765(03)00182-5; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans E, 1997, EMBO J, V16, P6559, DOI 10.1093/emboj/16.21.6559; Fan L, 2008, CELL, V133, P789, DOI 10.1016/j.cell.2008.04.030; Fribourg S, 2000, J BIOL CHEM, V275, P31963, DOI 10.1074/jbc.M004960200; Gibbons BJ, 2012, P NATL ACAD SCI USA, V109, P1949, DOI 10.1073/pnas.1105266109; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huizinga EG, 2002, SCIENCE, V297, P1176, DOI 10.1126/science.107355; Kim TK, 2000, SCIENCE, V288, P1418, DOI 10.1126/science.288.5470.1418; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Kuper J, 2012, EMBO J, V31, P494, DOI 10.1038/emboj.2011.374; Lehmann AR, 2001, GENE DEV, V15, P15, DOI 10.1101/gad.859501; Liu H, 2008, CELL, V133, P801, DOI 10.1016/j.cell.2008.04.029; Maines S, 1998, GENETICS, V150, P963; MATSUI P, 1995, NUCLEIC ACIDS RES, V23, P767, DOI 10.1093/nar/23.5.767; Murakami K, 2013, SCIENCE, V342, P709, DOI 10.1126/science.1238724; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pabalan N, 2010, BREAST CANCER RES TR, V124, P531, DOI 10.1007/s10549-010-0863-6; Pei JM, 2007, BIOINFORMATICS, V23, P802, DOI 10.1093/bioinformatics/btm017; Riedinger C, 2010, J BIOL CHEM, V285, P33992, DOI 10.1074/jbc.M110.134510; Sandrock B, 2001, J BIOL CHEM, V276, P35328, DOI 10.1074/jbc.M105570200; Santelli E, 2004, NATURE, V430, P905, DOI 10.1038/nature02763; Schmitt DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102389; Schultz P, 2000, CELL, V102, P599, DOI 10.1016/S0092-8674(00)00082-9; SERIZAWA H, 1993, NATURE, V363, P371, DOI 10.1038/363371a0; Song G, 2005, P NATL ACAD SCI USA, V102, P3366, DOI 10.1073/pnas.0500200102; Springer TA, 2006, STRUCTURE, V14, P1611, DOI 10.1016/j.str.2006.10.001; Takagi Y, 2005, MOL CELL, V18, P237, DOI 10.1016/j.molcel.2005.03.007; Taylor EM, 1997, P NATL ACAD SCI USA, V94, P8658, DOI 10.1073/pnas.94.16.8658; Tirode F, 1999, MOL CELL, V3, P87, DOI 10.1016/S1097-2765(00)80177-X; Tremeau-Bravard A, 2001, J BIOL CHEM, V276, P27693, DOI 10.1074/jbc.M102457200; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Wang ML, 2009, J TOXICOL ENV HEAL A, V72, P698, DOI 10.1080/15287390902841029; WANG ZG, 1995, MOL CELL BIOL, V15, P2288; Wolski SC, 2008, PLOS BIOL, V6, P1332, DOI 10.1371/journal.pbio.0060149; Xue HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043431; Yang Z, 2012, J STRUCT BIOL, V179, P269, DOI 10.1016/j.jsb.2011.09.006; YOON H, 1992, GENE DEV, V6, P2463, DOI 10.1101/gad.6.12b.2463; Zhang Y, 2011, INT J COLORECTAL DIS, V26, P1257, DOI 10.1007/s00384-011-1222-8; Zhu JQ, 2010, BLOOD, V116, P5050, DOI 10.1182/blood-2010-04-281154	49	10	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8321	8330		10.1074/jbc.M115.636514	http://dx.doi.org/10.1074/jbc.M115.636514			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25681444	hybrid, Green Published			2022-12-26	WOS:000351662600027
J	Lyu, Y; Su, XY; Deng, JN; Liu, SX; Zou, LQ; Zhao, XJ; Wei, SN; Geng, B; Xu, GH				Lyu, Ying; Su, Xueying; Deng, Jingna; Liu, Shangxin; Zou, Liangqiang; Zhao, Xiaojing; Wei, Suning; Geng, Bin; Xu, Guoheng			Defective Differentiation of Adipose Precursor Cells from Lipodystrophic Mice Lacking Perilipin 1	PLOS ONE			English	Article							FAMILIAL PARTIAL LIPODYSTROPHY; PRIMARY RAT ADIPOCYTES; LIPID DROPLETS; IN-VIVO; GENERALIZED LIPODYSTROPHY; PROGENITOR CELLS; GENE-EXPRESSION; UP-REGULATION; TISSUE; LIPOLYSIS	Perilipin 1 (Plin1) localizes at the surface of lipid droplets to regulate triglyceride storage and hydrolysis in adipocytes. Plin1 defect leads to low adiposity in mice and partial lipodystrophy in human. This study investigated the roles of Plin1 in adipocyte differentiation. Plin1 null (-/-) mice showed plenty of multilocular adipocytes and small unilocular adipocytes in adipose tissue, along with lack of a subpopulation of adipose progenitor cells capable of in vivo adipogenesis and along with downregulation of adipogenic pathway. Before initiation of differentiation, adipose stromal-vascular cells (SVCs) from Plin1-/-mice already accumulated numerous tiny lipid droplets, which increased in number and size during the first 12-h induction but thereafter became disappeared at day 1 of differentiation. The adipogenic signaling was dysregulated despite protein level of PPAR. was near normal in Plin1-/-SVCs like in Plin1-/-adipose tissue. Heterozygous Plin1+/-SVCs were able to develop lipid droplets, with both the number and size more than in Plin1-/-SVCs but less than in Plin1+/+ SVCs, indicating that Plin1 haploinsufficiency accounts for attenuated adipogenesis. Aberrant lipid droplet growth and differentiation of Plin1-/-SVCs were rescued by adenoviral Plin1 expression and were ameliorated by enhanced or prolonged adipogenic stimulation. Our finding suggests that Plin1 plays an important role in adipocyte differentiation and provides an insight into the pathology of partial lipodystrophy in patients with Plin1 mutation.	[Lyu, Ying; Su, Xueying; Deng, Jingna; Liu, Shangxin; Zou, Liangqiang; Zhao, Xiaojing; Wei, Suning; Geng, Bin; Xu, Guoheng] Peking Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Beijing 100191, Peoples R China	Peking University	Xu, GH (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Beijing 100191, Peoples R China.	xug@bjmu.edu.cn	Geng, Bin/ABB-6045-2020	Geng, Bin/0000-0001-7573-8710	National Natural Science Foundation of China [91439119]; Beijing Natural Science Foundation [7152080]; National Basic Research Program of China [2012CB517505, 2012CB517806]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China [91439119] (to GX) and by Beijing Natural Science Foundation [7152080 to GX] and by the National Basic Research Program of China [2012CB517505 to GX, 2012CB517806 to BG]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal AK, 2002, NAT GENET, V31, P21, DOI 10.1038/ng880; Arimura N, 2004, J BIOL CHEM, V279, P10070, DOI 10.1074/jbc.M308522200; Berry R, 2013, NAT CELL BIOL, V15, P302, DOI 10.1038/ncb2696; Boguslavsky RL, 2006, HUM MOL GENET, V15, P653, DOI 10.1093/hmg/ddi480; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brasaemle DL, 1997, J LIPID RES, V38, P2249; Brasaemle DL, 2000, J BIOL CHEM, V275, P38486, DOI 10.1074/jbc.M007322200; Cao H, 2000, HUM MOL GENET, V9, P109, DOI 10.1093/hmg/9.1.109; Castro-Chavez F, 2003, DIABETES, V52, P2666, DOI 10.2337/diabetes.52.11.2666; Chen WQ, 2009, ENDOCRINOLOGY, V150, P4552, DOI 10.1210/en.2009-0236; Cui X, 2011, HUM MOL GENET, V20, P3022, DOI 10.1093/hmg/ddr205; Fei WH, 2011, TRENDS ENDOCRIN MET, V22, P204, DOI 10.1016/j.tem.2011.02.004; Gale SE, 2006, J BIOL CHEM, V281, P11082, DOI 10.1074/jbc.M509612200; Gandotra S, 2011, NEW ENGL J MED, V364, P740, DOI 10.1056/NEJMoa1007487; Garg Abhimanyu, 2006, Clin Cornerstone, V8 Suppl 4, pS7, DOI 10.1016/S1098-3597(06)80039-6; Garg A, 2009, BBA-MOL CELL BIOL L, V1791, P507, DOI 10.1016/j.bbalip.2008.12.014; Gong JY, 2011, J CELL BIOL, V195, P953, DOI 10.1083/jcb.201104142; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; GREENBERG AS, 1991, J BIOL CHEM, V266, P11341; Hausman Dorothy B., 2008, V456, P201, DOI 10.1007/978-1-59745-245-8_15; He JH, 2006, BBA-MOL CELL BIOL L, V1761, P247, DOI 10.1016/j.bbalip.2006.02.001; Hegele RA, 2002, DIABETES, V51, P3586, DOI 10.2337/diabetes.51.12.3586; Hutley LJ, 2001, AM J PHYSIOL-ENDOC M, V281, pE1037, DOI 10.1152/ajpendo.2001.281.5.E1037; Jiang HF, 2007, BBA-MOL CELL BIOL L, V1771, P66, DOI 10.1016/j.bbalip.2006.10.004; Kim CA, 2008, J CLIN ENDOCR METAB, V93, P1129, DOI 10.1210/jc.2007-1328; Kimmel AR, 2010, J LIPID RES, V51, P468, DOI 10.1194/jlr.R000034; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; Li D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-446; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; Maumus M, 2008, J CLIN ENDOCR METAB, V93, P4098, DOI 10.1210/jc.2008-0044; Nagayama M, 2007, J LIPID RES, V48, P9, DOI 10.1194/jlr.M600155-JLR200; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Payne VA, 2008, DIABETES, V57, P2055, DOI 10.2337/db08-0184; Puri V, 2008, ACTA PHYSIOL, V192, P103, DOI 10.1111/j.1748-1716.2007.01786.x; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rubio-Cabezas O, 2009, EMBO MOL MED, V1, P280, DOI 10.1002/emmm.200900037; Sawada T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014006; SPIEGELMAN BM, 1980, J BIOL CHEM, V255, P8811; Sun ZQ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2581; Sztalryd C, 2003, J CELL BIOL, V161, P1093, DOI 10.1083/jcb.200210169; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Toh SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002890; Wang SM, 2003, HISTOCHEM CELL BIOL, V120, P285, DOI 10.1007/s00418-003-0575-7; WIEDERER O, 1987, J LIPID RES, V28, P649; Wolins NE, 2005, J BIOL CHEM, V280, P19146, DOI 10.1074/jbc.M500978200; Xu C, 2009, MOL ENDOCRINOL, V23, P1161, DOI 10.1210/me.2008-0464; Xu GH, 2005, J BIOL CHEM, V280, P42841, DOI 10.1074/jbc.M506569200; Zhai W, 2010, HORM METAB RES, V42, P247, DOI 10.1055/s-0029-1243599; Zu LX, 2008, MOL PHARMACOL, V73, P215, DOI 10.1124/mol.107.039479; Zu LX, 2009, J BIOL CHEM, V284, P5915, DOI 10.1074/jbc.M807852200	51	20	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0117536	10.1371/journal.pone.0117536	http://dx.doi.org/10.1371/journal.pone.0117536			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695774	Green Published, gold, Green Submitted			2022-12-26	WOS:000350062300023
J	He, XG; Zou, HD; Lu, L; Zhao, R; Zhao, HJ; Li, QQ; Zhu, JF				He, Xiangui; Zou, Haidong; Lu, Lina; Zhao, Rong; Zhao, Huijuan; Li, Qiangqiang; Zhu, Jianfeng			Axial Length/Corneal Radius Ratio: Association with Refractive State and Role on Myopia Detection Combined with Visual Acuity in Chinese Schoolchildren	PLOS ONE			English	Article							OCULAR COMPONENTS; CHILDHOOD MYOPIA; RISK-FACTORS; CHILDREN; LENGTH; EYE; PREVALENCE; ERROR; PARAMETERS; ONSET	Purpose To evaluate the association between the AL/CR ratio and refractive state and explore the effectiveness of this ratio in the assessment of myopia, especially when combined with uncorrected visual acuity in schoolchildren among whom myopia is common. Methods Cross sectional study. 4686 children from 6 primary schools, aged from 6 to 12 years were selected using the clusteredstratified random sampling method. Uncorrected visual acuity (UCVA), axial length (AL), corneal radius of curvature (CR), and cycloplegic refraction were tested. Refraction was measured as the spherical equivalent (SE). Results 3922 children were included in the analysis. The mean AL/CR ratio was 2.973 +/- 0.002, increased with age, and different in gender. The coefficients of correlations of the SE with the AL/CR ratio, AL, and CR were -0.811, -0.657, and 0.095, respectively. Linear regression showed a 10.72 D shift towards myopia with every 1 unit increase in the AL/CR ratio (P <0.001, r(2) = 66.4%). The estimated SE values obtained by substituting the AL/CR ratio and gender back to the regression model that were within a difference of +/- 0.50 D in ATE/LER (allowable total error and limits for erroneous results) zones compared to the actual measured values was 51%. The area under the ROC curve of the AL/CR ratio, AL, and UCVA for myopia detection were 0.910, 0.822, and 0.889, respectively, and the differences between each pair were statistically significant (P <0.01). At a specificity of 90%, the sensitivities were 72.98%, 50.50%, 71.99%, and 82.96%, respectively, for the AL/CR ratio, AL, UCVA, and the combination of the AL/CR ratio and UCVA. Conclusions The AL/CR ratio was found to explain the total variance in SE better than AL alone. The effectiveness of the AL/CR ratio was statistically significantly better than UCVA for detecting myopia in children, and combining the two produced increased sensitivity without significantly decreasing specificity.	[He, Xiangui; Zou, Haidong; Lu, Lina; Zhao, Rong; Zhu, Jianfeng] Shanghai Eye Dis Prevent & Treatment Ctr, Dept Eye Dis Prevent, Shanghai, Peoples R China; [Zou, Haidong] Affiliated Shanghai Jiaotong Univ, Shanghai Peoples 1, Dept Ophthalmol, Shanghai, Peoples R China; [Zhao, Huijuan; Li, Qiangqiang] Baoshan Ctr Dis Prevent & Control, Dept Sch Hlth, Shanghai, Peoples R China	Shanghai Jiao Tong University	Zhu, JF (corresponding author), Shanghai Eye Dis Prevent & Treatment Ctr, Dept Eye Dis Prevent, Shanghai, Peoples R China.	jfzhu1974@hotmail.com		Zou, Haidong/0000-0002-6831-7560	Three-year Action Program of Shanghai Municipality for Strengthening the Construction of the Public Health System [2011-15]; Shanghai Municipal Health Bureau [2010Y113]	Three-year Action Program of Shanghai Municipality for Strengthening the Construction of the Public Health System; Shanghai Municipal Health Bureau	This study was supported by Three-year Action Program of Shanghai Municipality for Strengthening the Construction of the Public Health System (2011-2013) (Grant NO. 2011-15) and Research Fund for Young Medical Staff (Grant NO. 2010Y113) from Shanghai Municipal Health Bureau. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMIN B, 1957, Spec Rep Ser Med Res Counc (G B), V11, P1; Cheng SCK, 2013, OPHTHAL PHYSL OPT, V33, P652, DOI 10.1111/opo.12082; Chu Ren-Yuan, 2009, Zhonghua Yan Ke Za Zhi, V45, P577; COOK RC, 1951, AM J OPHTHALMOL, V34, P1407, DOI 10.1016/0002-9394(51)90481-3; Fan DSP, 2004, INVEST OPHTH VIS SCI, V45, P1071, DOI 10.1167/iovs.03-1151; French AN, 2013, OPHTHALMOLOGY, V120, P2100, DOI 10.1016/j.ophtha.2013.02.035; Blanco FG, 2008, OPTOMETRY VISION SCI, V85, P89, DOI 10.1097/OPX.0b013e3181622602; GORDON RA, 1985, ARCH OPHTHALMOL-CHIC, V103, P785; Goss DA, 1995, OPTOMETRY VISION SCI, V72, P870, DOI 10.1097/00006324-199512000-00005; GROSVENOR T, 1994, OPTOMETRY VISION SCI, V71, P573, DOI 10.1097/00006324-199409000-00005; GROSVENOR T, 1988, AM J OPTOM PHYS OPT, V65, P689; Grosvenor T, 1998, OPTOMETRY VISION SCI, V75, P132, DOI 10.1097/00006324-199802000-00017; Guo Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075260; Guo Y, 2013, OPHTHALMOLOGY, V120, P277, DOI 10.1016/j.ophtha.2012.07.086; Hamasaki I, 2007, JPN J OPHTHALMOL, V51, P111, DOI 10.1007/s10384-006-0400-7; He MG, 2004, INVEST OPHTH VIS SCI, V45, P793, DOI 10.1167/iovs.03-1051; He MG, 2009, OPTOMETRY VISION SCI, V86, P40, DOI 10.1097/OPX.0b013e3181940719; Hiraoka T, 2012, INVEST OPHTH VIS SCI, V53, P3913, DOI 10.1167/iovs.11-8453; Ip JM, 2008, EYE, V22, P649, DOI 10.1038/sj.eye.6702701; Ip JM, 2007, INVEST OPHTH VIS SCI, V48, P4846, DOI 10.1167/iovs.07-0101; Iribarren R, 2012, INVEST OPHTH VIS SCI, V53, P5124, DOI 10.1167/iovs.12-9637; Iyamu Eghosasere, 2011, ISRN Ophthalmol, V2011, P138941, DOI 10.5402/2011/138941; Jones LA, 2005, INVEST OPHTH VIS SCI, V46, P2317, DOI 10.1167/iovs.04-0945; Jung SK, 2012, INVEST OPHTH VIS SCI, V53, P5579, DOI 10.1167/iovs.12-10106; Kimura S, 2007, JPN J OPHTHALMOL, V51, P105, DOI 10.1007/s10384-006-0410-5; Lai YH, 2013, OPHTHALMOLOGY, V120, P271, DOI 10.1016/j.ophtha.2012.08.009; LARSEN JS, 1971, ACTA OPHTHALMOL, V49, P873; Leone JF, 2010, ARCH OPHTHALMOL-CHIC, V128, P894, DOI 10.1001/archophthalmol.2010.134; Lin LLK, 2004, ANN ACAD MED SINGAP, V33, P27; Lin LLK, 1999, OPTOMETRY VISION SCI, V76, P275, DOI 10.1097/00006324-199905000-00013; Ma YY, 2013, OPTOMETRY VISION SCI, V90, P1479, DOI 10.1097/OPX.0000000000000095; Manny RE, 2001, INVEST OPHTH VIS SCI, V42, P1728; Mayer DL, 2001, ARCH OPHTHALMOL-CHIC, V119, P1625; Morgan IG, 2012, LANCET, V379, P1739, DOI 10.1016/S0140-6736(12)60272-4; MUTTI DO, 1995, VISION RES, V35, P1345, DOI 10.1016/0042-6989(94)00225-B; Mutti DO, 2007, INVEST OPHTH VIS SCI, V48, P2510, DOI 10.1167/iovs.06-0562; Mutti DO, 2012, OPTOMETRY VISION SCI, V89, P251, DOI 10.1097/OPX.0b013e3182418213; Negrel AD, 2000, AM J OPHTHALMOL, V129, P421, DOI 10.1016/S0002-9394(99)00455-9; O'Donoghue L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034441; Ojaimi E, 2005, INVEST OPHTH VIS SCI, V46, P4424, DOI 10.1167/iovs.05-0077; Ojaimi E, 2005, INVEST OPHTH VIS SCI, V46, P2748, DOI 10.1167/iovs.04-1324; Olsen T, 2007, ACTA OPHTHALMOL SCAN, V85, P361, DOI 10.1111/j.1600-0420.2006.00847.x; Resnikoff S, 2008, B WORLD HEALTH ORGAN, V86, P63, DOI 10.2471/BLT.07.041210; Saw SM, 2002, OPHTHALMOLOGY, V109, P2065, DOI 10.1016/S0161-6420(02)01220-4; Schmidt P, 2004, OPHTHALMOLOGY, V111, P637, DOI 10.1016/j.ophtha.2004.01.022; Seet B, 2001, BRIT J OPHTHALMOL, V85, P521, DOI 10.1136/bjo.85.5.521; Sherwin JC, 2012, OPHTHALMOLOGY, V119, P2141, DOI 10.1016/j.ophtha.2012.04.020; Song YY, 2011, J OCUL PHARMACOL TH, V27, P361, DOI 10.1089/jop.2011.0017; STENSTROM SOLVE, 1948, AMER JOUR OPTOM, V25, P218; Twelker JD, 2009, OPTOMETRY VISION SCI, V86, P918, DOI 10.1097/OPX.0b013e3181b2f903; van ALPHEN G, 1961, Opt Acta (Lond), V142(Suppl), P1; Vision in Preschoolers (VIP) Study Group, 2005, INVEST OPHTH VIS SCI, V46; Wu JB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0082763, 10.1371/journal.pone.0081986, 10.1371/journal.pone.0081982]; Xiang F, 2012, OPHTHALMOLOGY, V119, P1478, DOI 10.1016/j.ophtha.2012.01.017; Yebra-Pimentel E, 2004, Arch Soc Esp Oftalmol, V79, P317; Zadnik K, 1999, INVEST OPHTH VIS SCI, V40, P1936; ZADNIK K, 1993, OPTOMETRY VISION SCI, V70, P750, DOI 10.1097/00006324-199309000-00012; Zadnik K, 2003, OPTOMETRY VISION SCI, V80, P226, DOI 10.1097/00006324-200303000-00012; Zhang J, 2011, ARCH OPHTHALMOL-CHIC, V129, P63, DOI 10.1001/archophthalmol.2010.323; Zhou YH, 2011, J CLIN LAB ANAL, V25, P83, DOI 10.1002/jcla.20437	60	46	59	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0111766	10.1371/journal.pone.0111766	http://dx.doi.org/10.1371/journal.pone.0111766			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693186	Green Published, gold, Green Submitted			2022-12-26	WOS:000350061500002
J	Hoskins, AJ; Costa, DP; Arnould, JPY				Hoskins, Andrew J.; Costa, Daniel P.; Arnould, John P. Y.			Utilisation of Intensive Foraging Zones by Female Australian Fur Seals	PLOS ONE			English	Article							AREA-RESTRICTED SEARCH; SOUTHERN ELEPHANT SEALS; LIONS PHOCARCTOS-HOOKERI; AEROBIC DIVE LIMIT; OPTIMAL PATCH USE; 1ST PASSAGE TIME; MARINE PREDATOR; DIVING BEHAVIOR; 1ST-PASSAGE TIME; HABITAT USE	Within a heterogeneous environment, animals must efficiently locate and utilise foraging patches. One way animals can achieve this is by increasing residency times in areas where foraging success is highest (area-restricted search). For air-breathing diving predators, increased patch residency times can be achieved by altering both surface movements and diving patterns. The current study aimed to spatially identify the areas where female Australian fur seals allocated the most foraging effort, while simultaneously determining the behavioural changes that occur when they increase their foraging intensity. To achieve this, foraging behaviour was successfully recorded with a FastLoc GPS logger and dive behaviour recorder from 29 individual females provisioning pups. Females travelled an average of 118 +/- 50 km from their colony during foraging trips that lasted 7.3 +/- 3.4 days. Comparison of two methods for calculating foraging intensity (first-passage time and first-passage time modified to include diving behaviour) determined that, due to extended surface intervals where individuals did not travel, inclusion of diving behaviour into foraging analyses was important for this species. Foraging intensity 'hot spots' were found to exist in a mosaic of patches within the Bass Basin, primarily to the south-west of the colony. However, the composition of benthic habitat being targeted remains unclear. When increasing their foraging intensity, individuals tended to perform dives around 148 s or greater, with descent/ascent rates of approximately 1.9 m.s(-1) or greater and reduced postdive durations. This suggests individuals were maximising their time within the benthic foraging zone. Furthermore, individuals increased tortuosity and decreased travel speeds while at the surface to maximise their time within a foraging location. These results suggest Australian fur seals will modify both surface movements and diving behaviour to maximise their time within a foraging patch.	[Hoskins, Andrew J.; Arnould, John P. Y.] Deakin Univ, Sch Life & Environm Sci, 221 Burwood Highway, Burwood, Vic 3125, Australia; [Costa, Daniel P.] Univ Calif Santa Cruz, Ctr Ocean Hlth, Santa Cruz, CA 95060 USA	Deakin University; University of California System; University of California Santa Cruz	Hoskins, AJ (corresponding author), Deakin Univ, Sch Life & Environm Sci, 221 Burwood Highway, Burwood, Vic 3125, Australia.	Andrew.Hoskins@csiro.au	Hoskins, Andrew/T-2694-2019; Costa, Daniel/E-2616-2013	Hoskins, Andrew/0000-0001-8907-6682; Costa, Daniel/0000-0002-0233-5782	Australian Research Council; Winnifred Violet Scott Charitable Trust; Holsworth Wildlife Research Endowment	Australian Research Council(Australian Research Council); Winnifred Violet Scott Charitable Trust; Holsworth Wildlife Research Endowment	This project was support by research funding received from the Australian Research Council, Winnifred Violet Scott Charitable Trust and the Holsworth Wildlife Research Endowment. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, BIOSPHERE CONSERVATI; Arnould JPY, 2006, LOW WAKE FI, P309; Arnould JPY, 2011, MAR ECOL PROG SER, V422, P291, DOI 10.3354/meps08933; Arnould JPY, 2007, AQUAT CONSERV, V17, pS53, DOI 10.1002/aqc.908; Arnould JPY, 2001, CAN J ZOOL, V79, P35, DOI 10.1139/cjz-79-1-35; Auge AA, 2011, CAN J ZOOL, V89, P1195, DOI 10.1139/Z11-098; Bailleul F, 2008, J ANIM ECOL, V77, P948, DOI 10.1111/j.1365-2656.2008.01407.x; Bailleul F, 2010, ECOL MODEL, V221, P1665, DOI 10.1016/j.ecolmodel.2010.04.001; Bakun A, 2006, SCI MAR, V70, P105, DOI 10.3989/scimar.2006.70s2105; Barry J.P., 1991, Ecological Studies, P270; Baylis AMM, 2008, CAN J ZOOL, V86, P774, DOI 10.1139/Z08-055; Bhattacharyya A, 1946, SANKHYA, V7, P401; BOVET P, 1991, ANIM BEHAV, V42, P57, DOI 10.1016/S0003-3472(05)80605-0; BOYD IL, 1991, J ANIM ECOL, V60, P577, DOI 10.2307/5299; BOYD IL, 1994, J ANIM ECOL, V63, P703, DOI 10.2307/5235; Bradshaw CJA, 2007, ECOL APPL, V17, P628, DOI 10.1890/06-0964; Breed GA, 2009, ECOLOGY, V90, P3209, DOI 10.1890/07-1483.1; Chilvers BL, 2009, NEW ZEAL J ECOL, V33, P106; Cook TR, 2008, ANIM BEHAV, V76, P565, DOI 10.1016/j.anbehav.2008.02.010; Costa DP, 2001, COMP BIOCHEM PHYS A, V129, P771, DOI 10.1016/S1095-6433(01)00346-4; Costa DP, 2000, J EXP BIOL, V203, P3655; de Bruyn PJN, 2009, MAR ECOL PROG SER, V394, P263, DOI 10.3354/meps08292; Deagle BE, 2009, MOL ECOL, V18, P2022, DOI 10.1111/j.1365-294X.2009.04158.x; Dorville N, 2013, THESIS; Dragon AC, 2010, PROG OCEANOGR, V87, P61, DOI 10.1016/j.pocean.2010.09.025; Fauchald P, 2003, ECOLOGY, V84, P282, DOI 10.1890/0012-9658(2003)084[0282:UFPTIT]2.0.CO;2; FELDKAMP SD, 1987, J EXP BIOL, V131, P117; Field I, 2001, ANTARCT SCI, V13, P371, DOI 10.1017/S0954102001000529; Gales NJ, 1998, MAR MAMMAL SCI, V14, P355, DOI 10.1111/j.1748-7692.1998.tb00727.x; Goldsworthy SD, 2010, MAR ECOL PROG SER, V409, P255, DOI 10.3354/meps08611; Hoskins AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079484; Humphries NE, 2010, NATURE, V465, P1066, DOI 10.1038/nature09116; KASPARI M, 1991, OIKOS, V60, P307, DOI 10.2307/3545072; Kirkwood R, 2008, MAR ECOL PROG SER, V369, P297, DOI 10.3354/meps07633; Kirkwood R, 2011, AUST J ZOOL, V59, P216, DOI 10.1071/ZO11080; Kirkwood R, 2010, MAR FRESHWATER RES, V61, P695, DOI 10.1071/MF09213; KREBS JR, 1974, ANIM BEHAV, V22, P953, DOI 10.1016/0003-3472(74)90018-9; Lander ME, 2009, ECOL APPL, V19, P1645, DOI 10.1890/08-0159.1; Lea MA, 2002, MAR ECOL PROG SER, V245, P281, DOI 10.3354/meps245281; Leung ES, 2013, NEW ZEAL J MAR FRESH, V47, P38, DOI 10.1080/00288330.2012.732584; Lowther AD, 2011, MAR ECOL PROG SER, V443, P249, DOI 10.3354/meps09392; Luque SP., 2007, R NEWS, V7, P8, DOI DOI 10.1155/2007/92385; MCCONNELL BJ, 1992, ANTARCT SCI, V4, P393, DOI 10.1017/S0954102092000580; McKenzie H, 2009, B MATH BIOL, V71, P107, DOI 10.1007/s11538-008-9354-x; Mori Y, 1998, J ZOOL, V245, P279, DOI 10.1111/j.1469-7998.1998.tb00102.x; Mori Y, 2002, J EVOLUTION BIOL, V15, P269, DOI 10.1046/j.1420-9101.2002.00382.x; Mori Y, 1998, J THEOR BIOL, V190, P187, DOI 10.1006/jtbi.1997.0550; Mori Y, 1999, BEHAV ECOL, V10, P155, DOI 10.1093/beheco/10.2.155; Orians G.H., 1979, P155; Passlow V., 2006, SEDIMENTS BENTHIC BI; Patterson TA, 2009, J ANIM ECOL, V78, P1113, DOI 10.1111/j.1365-2656.2009.01583.x; Pinaud D, 2005, J ANIM ECOL, V74, P852, DOI 10.1111/j.1365-2656.2005.00984.x; Pinaud D, 2008, J APPL ECOL, V45, P91, DOI 10.1111/j.1365-2664.2007.01370.x; PYKE GH, 1984, ANNU REV ECOL SYST, V15, P523, DOI 10.1146/annurev.es.15.110184.002515; R Core Team, 2012, R LANG ENV STAT COMP, DOI [10.1007/s12070-012-0514-9, DOI 10.1007/S12070-012-0514-9]; Riet-Sapriza FG, 2012, DEEP SEA RES 2; Robinson PW, 2007, DEEP-SEA RES PT II, V54, P356, DOI 10.1016/j.dsr2.2006.11.020; Robinson PW, 2010, J ANIM ECOL, V79, P1146, DOI 10.1111/j.1365-2656.2010.01735.x; Ropert-Coudert Y, 2006, MAR BIOL, V149, P139, DOI 10.1007/s00227-005-0188-x; Rosen DAS, 2007, PHILOS T R SOC B, V362, P2151, DOI 10.1098/rstb.2007.2108; Sigler MF, 2004, CAN J FISH AQUAT SCI, V61, P1475, DOI 10.1139/F04-086; Sigler MF, 2009, MAR ECOL PROG SER, V388, P243, DOI 10.3354/meps08144; SIH A, 1982, AM NAT, V120, P666, DOI 10.1086/284019; Simmons SE, 2007, MAR ECOL PROG SER, V346, P265, DOI 10.3354/meps07014; Sims DW, 2008, NATURE, V451, P1098, DOI 10.1038/nature06518; Suryan RM, 2006, DEEP-SEA RES PT II, V53, P370, DOI 10.1016/j.dsr2.2006.01.012; Thums M, 2013, J ANIM ECOL, V82, P72, DOI 10.1111/j.1365-2656.2012.02021.x; Tremblay Y, 2007, J EXP BIOL, V210, P935, DOI 10.1242/jeb.02710; Trillmich F, 1986, ATTENDANCE DIVING BE; Villegas-Amtmann S, 2008, MAR ECOL PROG SER, V363, P299, DOI 10.3354/meps07457; Walsh PD, 1996, J THEOR BIOL, V183, P351, DOI 10.1006/jtbi.1996.0227; Warneke R.M., 1985, P53; Weimerskirch H, 2007, AM NAT, V170, P734, DOI 10.1086/522059; Werner R, 1995, CAN J ZOOL, V73, P1975, DOI 10.1139/z95-232; Williams TM, 2004, J EXP BIOL, V207, P973, DOI 10.1242/jeb.00822; Zuur Alain F., 2009, P1	76	21	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117997	10.1371/journal.pone.0117997	http://dx.doi.org/10.1371/journal.pone.0117997			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692978	Green Published, gold, Green Submitted			2022-12-26	WOS:000350061500090
J	Pacheco, AG; Grinsztejn, B; da Fonseca, MDM; Moreira, RI; Veloso, VG; Friedman, RK; Santini-Oliveira, M; Cardoso, SW; Falcao, M; Mill, JG; Bensenor, I; Lotufo, P; Chor, D				Pacheco, Antonio G.; Grinsztejn, Beatriz; da Fonseca, Maria de Jesus M.; Moreira, Ronaldo I.; Veloso, Valdilea G.; Friedman, Ruth K.; Santini-Oliveira, Marilia; Cardoso, Sandra W.; Falcao, Melissa; Mill, Jose G.; Bensenor, Isabela; Lotufo, Paulo; Chor, Dora			Traditional Risk Factors Are More Relevant than HIV-Specific Ones for Carotid Intima-Media Thickness (cIMT) in a Brazilian Cohort of HIV-Infected Patients	PLOS ONE			English	Article							CARDIOVASCULAR RISK; HAART ERA; ATHEROSCLEROSIS; PROGRESSION; MORTALITY; DISEASE; EVENTS; DEATH; EQUATION	Background Combination antiretroviral therapy (cART) had a dramatic impact on the mortality profile in human immunodeficiency virus (HIV) infected individuals and increased their life-expectancy. Conditions associated with the aging process have been diagnosed more frequently among HIV-infected patients, particularly, cardiovascular diseases. Methods Patients followed in the Instituto de Pesquisa Clinica Evandro Chagas (IPEC) prospective cohort in Rio de Janeiro were submitted to the general procedures from the Brazilian Longitudinal Study of Adult Health, comprising several anthropometric, laboratory and imaging data. Carotid intima-media thickness (cIMT) was measured by ultrasonography, following the Mannheim protocol. Linear regression and proportional odds models were used to compare groups and covariables in respect to cIMT. The best model was chosen with the adaptive lasso procedure. Results A valid cIMT exam was available for 591 patients. Median cIMT was significantly larger for men than women (0.56mm vs. 0.53mm; p = 0.002; overall = 0.54mm). In univariable linear regression analysis, both traditional risk factors for cardiovascular diseases (CVD) and HIV-specific characteristics were significantly associated with cIMT values, but the best multivariable model chosen included only traditional characteristics. Hypertension presented the strongest association with higher cIMT terciles (OR = 2.51; 95% CI = 1.69-3.73), followed by current smoking (OR = 1,82; 95% CI = 1.19-2.79), family history of acute myocardial infarction or stroke (OR = 1.60; 95% CI = 1.10-2.32) and age (OR per year = 1.12; 95% CI = 1.10-1.14). Conclusions Our results show that traditional cardiovascular disease (CVD) risk factors are the major players in determining increased cIMT among HIV infected patients in Brazil. This finding reinforces the need for thorough assessment of those risk factors in these patients to guarantee the incidence of CVD events remain under control.	[Pacheco, Antonio G.; Falcao, Melissa] Fiocruz MS, Programa Comp Cientif, BR-21045900 Rio De Janeiro, Brazil; [Grinsztejn, Beatriz; Moreira, Ronaldo I.; Veloso, Valdilea G.; Friedman, Ruth K.; Santini-Oliveira, Marilia; Cardoso, Sandra W.] Fiocruz MS, Inst Pesquisa Clin Evandro Chagas, BR-21045900 Rio De Janeiro, Brazil; [da Fonseca, Maria de Jesus M.] Fiocruz MS, Dept Epidemiol & Metodos Quantitati Saude, BR-21045900 Rio De Janeiro, Brazil; [Mill, Jose G.] Univ Fed Espirito Santo, Dept Ciencias Fisiol, Vitoria, Brazil; [Bensenor, Isabela; Lotufo, Paulo] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal do Espirito Santo; Universidade de Sao Paulo	Pacheco, AG (corresponding author), Fiocruz MS, Programa Comp Cientif, BR-21045900 Rio De Janeiro, Brazil.	antgui@gmail.com	Cardoso, Sandra W/D-7965-2015; Lotufo, Paulo/A-9843-2008; Pacheco, Antonio Guilherme/E-6378-2013; Bensenor, Isabela Judith Martins/L-3306-2017	Cardoso, Sandra W/0000-0001-5230-0003; Lotufo, Paulo/0000-0002-4856-8450; Pacheco, Antonio Guilherme/0000-0003-3095-1774; 	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Programa Estrategico de Apoio a Pesquisa em Saude (PAPES)-Fundacao Oswaldo Cruz; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069476, U01AI069476] Funding Source: NIH RePORTER	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Programa Estrategico de Apoio a Pesquisa em Saude (PAPES)-Fundacao Oswaldo Cruz; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study has been supported by the Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Programa Estrategico de Apoio a Pesquisa em Saude (PAPES)-Fundacao Oswaldo Cruz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquino EML, 2012, AM J EPIDEMIOL, V175, P315, DOI 10.1093/aje/kwr294; Baker JV, 2011, CLIN INFECT DIS, V53, P826, DOI 10.1093/cid/cir497; Bavinger C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059551; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Bozzette SA, 2003, NEW ENGL J MED, V348, P702, DOI 10.1056/NEJMoa022048; Falcao MDBD, 2012, ARQ BRAS CARDIOL, V99, P971; Calza L, 2008, J INFECTION, V57, P16, DOI 10.1016/j.jinf.2008.02.006; Ceccarelli G, 2013, INT J CLIN PRACT, V67, P1, DOI 10.1111/ijcp.12066; Crum NF, 2006, JAIDS-J ACQ IMM DEF, V41, P194, DOI 10.1097/01.qai.0000179459.31562.16; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Duprez DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044454; Fitch KV, 2013, AIDS, V27, P49, DOI 10.1097/QAD.0b013e328358b29c; Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723, DOI 10.1056/NEJMoa062744; Fuchs SC, 2013, SCI WORLD J, DOI 10.1155/2013/163418; Gill J, 2010, CLIN INFECT DIS, V50, P1387, DOI 10.1086/652283; Albuquerque VMG, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-274; Grinsztejn B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059768; Grinsztejn B, 2009, AIDS, V23, P2107, DOI 10.1097/QAD.0b013e32832ec494; Grunfeld C, 2009, AIDS, V23, P1841, DOI 10.1097/QAD.0b013e32832d3b85; Hsue PY, 2012, J INFECT DIS, V205, pS375, DOI 10.1093/infdis/jis200; Hsue PY, 2004, CIRCULATION, V109, P1603, DOI 10.1161/01.CIR.0000124480.32233.8A; Justice Amy C, 2012, AIDS, V26 Suppl 1, pS11; Kelesidis T, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-23; Law MG, 2006, HIV MED, V7, P218, DOI 10.1111/j.1468-1293.2006.00362.x; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Mangili A, 2011, JAIDS-J ACQ IMM DEF, V58, P148, DOI [10.1097/QAI.0B013E31822D4993, 10.1097/QAI.0b013e31822d4993]; Masia M, 2012, ENFERM INFEC MICR CL, V30, P517, DOI 10.1016/j.eimc.2012.02.014; Mill JG, 2013, REV SAUDE PUBL, V47, P54, DOI 10.1590/S0034-8910.2013047003851; Mugavero MJ, 2011, CLIN INFECT DIS, V53, P927, DOI 10.1093/cid/cir526; Pacheco AG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001531; Pacheco AG, 2009, JAIDS-J ACQ IMM DEF, V51, P624, DOI 10.1097/QAI.0b013e3181a4ecf5; Paula AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094636; Paula AA, 2013, AIDS RES THER, V10, DOI 10.1186/1742-6405-10-32; Polak JF, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000087; R Development Core Team, 2014, R LANG ENV STAT COMP; Ssinabulya I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089537; Stein JH, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.001396; Stein James H, 2012, Top Antivir Med, V20, P129; Stein JH, 2012, TOP ANTIVIR MED, V20, P123; Touboul PJ, 2012, CEREBROVASC DIS, V34, P290, DOI 10.1159/000343145; Volpe GE, 2013, JAIDS-J ACQ IMM DEF, V64, P51, DOI 10.1097/QAI.0b013e31829ed726; Zou H, 2006, J AM STAT ASSOC, V101, P1418, DOI 10.1198/016214506000000735	43	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117461	10.1371/journal.pone.0117461	http://dx.doi.org/10.1371/journal.pone.0117461			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692764	Green Published, gold, Green Submitted			2022-12-26	WOS:000350061500058
J	Fei, XF; Wu, JP; Kong, Z; Christakos, G				Fei, Xufeng; Wu, Jiaping; Kong, Zhe; Christakos, George			Urban-Rural Disparity of Breast Cancer and Socioeconomic Risk Factors in China	PLOS ONE			English	Article							ENVIRONMENTAL-POLLUTANTS; MORTALITY; CONTRACEPTIVES; DETERMINANTS; DIAGNOSIS; MODELS; LEVEL; WOMEN; STAGE; AGE	Breast cancer is one of the most commonly diagnosed cancers worldwide. The primary aim of this work is the study of breast cancer disparity among Chinese women in urban vs. rural regions and its associations with socioeconomic factors. Data on breast cancer incidence were obtained from the Chinese cancer registry annual report (2005-2009). The ten socio-economic factors considered in this study were obtained from the national population 2000 census and the Chinese city/county statistical yearbooks. Student's T test was used to assess disparities of female breast cancer and socioeconomic factors in urban vs. rural regions. Pearson correlation and ordinary least squares (OLS) models were employed to analyze the relationships between socioeconomic factors and cancer incidence. It was found that the breast cancer incidence was significantly higher in urban than in rural regions. Moreover, in urban regions, breast cancer incidence remained relatively stable, whereas in rural regions it displayed an annual percentage change (APC) of 8.55. Among the various socioeconomic factors considered, breast cancer incidence exhibited higher positive correlations with population density, percentage of non-agriculture population, and second industry output. On the other hand, the incidence was negatively correlated with the percentage of population employed in primary industry. Overall, it was observed that higher socioeconomic status would lead to a higher breast cancer incidence in China. When studying breast cancer etiology, special attention should be paid to environmental pollutants, especially endocrine disruptors produced during industrial activities. Lastly, the present work's findings strongly recommend giving high priority to the development of a systematic nationwide breast cancer screening program for women in China; with sufficient participation, mammography screening can considerably reduce mortality among women.	[Fei, Xufeng; Kong, Zhe] Zhejiang Univ, Coll Environm & Resource Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Wu, Jiaping; Christakos, George] Zhejiang Univ, Inst Isl & Coastal Ecosyst, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Wu, JP (corresponding author), Zhejiang Univ, Inst Isl & Coastal Ecosyst, Hangzhou 310003, Zhejiang, Peoples R China.	jw67@zju.edu.cn	Wu, Jiaping/AAD-8800-2022	Christakos, George/0000-0002-1865-5764	Ministry of Education, China [20120101110131]; Department of Science and Technology, Zhejiang Province [2013C03045]	Ministry of Education, China(Ministry of Education, China); Department of Science and Technology, Zhejiang Province(Department of Science & Technology (India))	This work was supported partially by the Ministry of Education, China (20120101110131) and the Department of Science and Technology, Zhejiang Province (2013C03045). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2004, BRIT MED J, V329, P142, DOI 10.1136/bmj.38114.679387.AE; [Anonymous], 2000, CHINESE 5 CENSUS DAT; Bliss JM, 2003, LANCET, V362, P1328, DOI 10.1016/S0140-6736(03)14591-6; Bray F, 2004, BREAST CANCER RES, V6, P229, DOI 10.1186/bcr932; Brody JG, 2003, ENVIRON HEALTH PERSP, V111, P1007, DOI 10.1289/ehp.6310; Bryere J, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-87; Calle EE, 1996, LANCET, V347, P1713, DOI 10.1016/S0140-6736(96)90806-5; Chen WQ, 2013, THORAC CANCER, V4, P59, DOI 10.1111/j.1759-7714.2012.00165.x; Cheraghi Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051446; Christakos G, 1997, SOC SCI MED, V45, P1503, DOI 10.1016/S0277-9536(97)00080-4; Clarke CA, 2010, CANCER EPIDEM BIOMAR, V19, P2727, DOI 10.1158/1055-9965.EPI-10-0692; COLDITZ GA, 1995, CANCER EPIDEM BIOMAR, V4, P567; Couto E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055374; Curado M., 2007, IARC SCI PUB, VIX; Dey S, 2010, BREAST, V19, P417, DOI 10.1016/j.breast.2010.04.005; Fei XF, 2014, STOCH ENV RES RISK A, V28, P1075, DOI 10.1007/s00477-014-0876-5; Feng W, 2002, INT MIGR REV, V36, P520, DOI 10.1111/j.1747-7379.2002.tb00091.x; Ferlay J, 2001, GLOBOCAN 2000 CANC I; Gentil J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-351; Hampton T, 2008, JAMA-J AM MED ASSOC, V300, P1641, DOI 10.1001/jama.300.14.1641; Hao J, 2008, CHINESE CANC REGISTR; Harper S, 2009, CANCER EPIDEM BIOMAR, V18, P121, DOI 10.1158/1055-9965.EPI-08-0679; Heitz F, 2013, ONKOLOGIE, V36, P477, DOI 10.1159/000354624; HENDERSON BE, 1988, CANCER RES, V48, P246; Hongyuan S., 2004, EC RES J, V11, P4; KELSEY JL, 1993, EPIDEMIOL REV, V15, P7, DOI 10.1093/oxfordjournals.epirev.a036118; Larson SL, 2003, MED CARE, V41, P65, DOI 10.1097/01.MLR.0000076053.28108.F2; LewisMichl EL, 1996, ARCH ENVIRON HEALTH, V51, P255, DOI 10.1080/00039896.1996.9936024; Li Ni, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P703; Marchbanks PA, 2002, NEW ENGL J MED, V346, P2025, DOI 10.1056/NEJMoa013202; Merletti F, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-S1-S7; Morrell S, 2012, J MED SCREEN, V19, P26, DOI 10.1258/jms.2012.011127; National Statistics Bureau, 2005, CHIN COUNT STAT YB; National Statistics Bureau, 2005, CHIN CIT STAT YB; Newcomb PA, 2002, CANCER EPIDEM BIOMAR, V11, P593; Pezzotti A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005356; PIKE MC, 1983, NATURE, V303, P767, DOI 10.1038/303767a0; Pornet C, 2012, J EPIDEMIOL COMMUN H, V66, P982, DOI 10.1136/jech-2011-200311; Portier CJ, 2000, STOCH ENV RES RISK A, V14, P173, DOI 10.1007/PL00009780; Robert SA, 2004, EPIDEMIOLOGY, V15, P442, DOI 10.1097/01.ede.0000129512.61698.03; Wang B, 2013, PREV CHRONIC DIS, V10, DOI [10.5888/pcd10.130183, DOI 10.5888/PCD10.130183]; Wang JF, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-52; White MC, 2014, AM J PREV MED, V46, pS7, DOI 10.1016/j.amepre.2013.10.029; Wong DFK, 2007, INT J SOC WELF, V16, P32, DOI 10.1111/j.1468-2397.2007.00475.x; Yost K, 2001, CANCER CAUSE CONTROL, V12, P703, DOI 10.1023/A:1011240019516; Yu HL, 2007, STOCH ENV RES RISK A, V21, P555, DOI 10.1007/s00477-007-0135-0; Zeng HM, 2013, THORAC CANCER, V4, P400, DOI 10.1111/1759-7714.12037; Zhang Y, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0387-5	49	29	30	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117572	10.1371/journal.pone.0117572	http://dx.doi.org/10.1371/journal.pone.0117572			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC4KQ	25688556	Green Published, Green Submitted, gold			2022-12-26	WOS:000350322700057
J	Jena, J; Kumar, R; Dixit, A; Pandey, S; Das, T				Jena, Jyotsnarani; Kumar, Ravindra; Dixit, Anshuman; Pandey, Sony; Das, Trupti			Evaluation of Simultaneous Nutrient and COD Removal with Polyhydroxybutyrate (PHB) Accumulation Using Mixed Microbial Consortia under Anoxic Condition and Their Bioinformatics Analysis	PLOS ONE			English	Article							BIOLOGICAL PHOSPHORUS REMOVAL; WASTE-WATER TREATMENT; ACTIVATED-SLUDGE; PHOSPHATE REMOVAL; POLYHYDROXYALKANOATES PHA; SIMULTANEOUS NITROGEN; OPERATING PARAMETERS; TREATMENT PLANTS; ORGANISMS PAOS; STORAGE	Simultaneous nitrate-N, phosphate and COD removal was evaluated from synthetic waste water using mixed microbial consortia in an anoxic environment under various initial carbon load (ICL) in a batch scale reactor system. Within 6 hours of incubation, enriched DNPAOs (Denitrifying Polyphosphate Accumulating Microorganisms) were able to remove maximum COD (87%) at 2g/L of ICL whereas maximum nitrate-N (97%) and phosphate (87%) removal along with PHB accumulation (49 mg/L) was achieved at 8 g/L of ICL. Exhaustion of nitrate-N, beyond 6 hours of incubation, had a detrimental effect on COD and phosphate removal rate. Fresh supply of nitrate-N to the reaction medium, beyond 6 hours, helped revive the removal rates of both COD and phosphate. Therefore, it was apparent that in spite of a high carbon load, maximum COD and nutrient removal can be maintained, with adequate nitrate-N availability. Denitrifying condition in the medium was evident from an increasing pH trend. PHB accumulation by the mixed culture was directly proportional to ICL; however the time taken for accumulation at higher ICL was more. Unlike conventional EBPR, PHB depletion did not support phosphate accumulation in this case. The unique aspect of all the batch studies were PHB accumulation was observed along with phosphate uptake and nitrate reduction under anoxic conditions. Bioinformatics analysis followed by pyrosequencing of the mixed culture DNA from the seed sludge revealed the dominance of denitrifying population, such as Corynebacterium, Rhodocyclus and Paraccocus (Alphaproteobacteria and Betaproteobacteria). Rarefaction curve indicated complete bacterial population and corresponding number of OTUs through sequence analysis. Chao1 and Shannon index (H') was used to study the diversity of sampling. "UCI95" and "LCI95" indicated 95% confidence level of upper and lower values of Chao1 for each distance. Values of Chao1 index supported the results of rarefaction curve.	[Jena, Jyotsnarani; Pandey, Sony; Das, Trupti] CSIR Inst Minerals & Mat Technol, Bhubaneswar, Odisha, India; [Kumar, Ravindra; Dixit, Anshuman] Inst Life Sci, Bhubaneswar, Odisha, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Minerals & Materials Technology (IMMT); Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS)	Das, T (corresponding author), CSIR Inst Minerals & Mat Technol, Bhubaneswar, Odisha, India.	trupti.sreyas@gmail.com	Jena, Jyotsnarani/N-8431-2017; Kumar, Ravindra/GQP-2547-2022; Pandey, Sony/D-6965-2013	Jena, Jyotsnarani/0000-0002-8593-6021; Kumar, Ravindra/0000-0001-5577-9048; Pandey, Sony/0000-0001-7584-6447	Council of Scientific and Industrial Research, Government of India; Department of Biotechnology, Government of India; Council of Scientific and Industrial Research (Sustainable Environmental Technologies for Chemical and Allied Industries) [CSC-0113]	Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (Sustainable Environmental Technologies for Chemical and Allied Industries)	JJ is thankful to the Council of Scientific and Industrial Research (http://www.csirhrdg.res.in/), Government of India, for her fellowship. RK is thankful to the Department of Biotechnology (http://www.dbtindia.nic.in/index.asp), Government of India, for his fellowship. The authors are thankful to Council of Scientific and Industrial Research (Sustainable Environmental Technologies for Chemical and Allied Industries: CSC-0113) for funding that aided the study design, data collection and analysis.	Ahn J, 2002, BIOTECHNOL BIOENG, V79, P83, DOI 10.1002/bit.10292; American Public Health Association (APHA), 1998, AM PHYS ED REV, V20th; ARUN V, 1989, WATER SCI TECHNOL, V21, P363, DOI 10.2166/wst.1989.0238; Barak Y, 2000, APPL ENVIRON MICROB, V66, P1209, DOI 10.1128/AEM.66.3.1209-1212.2000; Bassin JP, 2012, WATER RES, V46, P3805, DOI 10.1016/j.watres.2012.04.015; Bengtsson S, 2008, BIORESOURCE TECHNOL, V99, P509, DOI 10.1016/j.biortech.2007.01.020; Beun JJ, 2000, BIOTECHNOL BIOENG, V68, P496, DOI 10.1002/(SICI)1097-0290(20000605)68:5<496::AID-BIT3>3.0.CO;2-S; Bucci V, 2012, ENVIRON SCI TECHNOL, V46, P3244, DOI 10.1021/es204052p; Chua ASM, 2003, WATER RES, V37, P3602, DOI 10.1016/S0043-1354(03)00252-5; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Crocetti GR, 2002, MICROBIOL-SGM, V148, P3353, DOI 10.1099/00221287-148-11-3353; Dionisi D, 2001, WATER RES, V35, P2661, DOI 10.1016/S0043-1354(00)00562-5; Ferguson SJ, 1979, BIOCHEM SOC T, V7, P176, DOI 10.1042/bst0070176; Fernandez-Nava Y, 2010, J HAZARD MATER, V173, P682, DOI 10.1016/j.jhazmat.2009.08.140; Fogler L, 2004, BIORESOURCE TECHNOL, P1; Freitas F, 2009, BIORESOURCE TECHNOL, V100, P1969, DOI 10.1016/j.biortech.2008.10.031; Gebremariam SY, 2011, WATER ENVIRON RES, V83, P195, DOI 10.2175/106143010X12780288628534; Harper WF, 2003, WATER ENVIRON RES, V75, P216, DOI 10.2175/106143003X140999; Hu JY, 2003, WATER RES, V37, P3463, DOI 10.1016/S0043-1354(03)00205-7; Hu M, 2012, BIORESOURCE TECHNOL, V117, P72, DOI 10.1016/j.biortech.2012.04.061; Hu ZR, 2002, WATER RES, V36, P4927, DOI 10.1016/S0043-1354(02)00186-0; Jena J, 2013, J SCI IND RES INDIA, V72, P127; Johnson K, 2010, WATER RES, V44, P2141, DOI 10.1016/j.watres.2009.12.031; Juretschko S, 2002, SYST APPL MICROBIOL, V25, P84, DOI 10.1078/0723-2020-00093; Kapagiannidis AG, 2012, BIOPROC BIOSYST ENG, V35, P371, DOI 10.1007/s00449-011-0575-2; Kasemsap C, 2007, BIORESOURCE TECHNOL, V98, P1020, DOI 10.1016/j.biortech.2006.04.035; Kathiraser Y, 2007, J CHEM TECHNOL BIOT, V82, P847, DOI 10.1002/jctb.1751; Kong Y, 2007, MICROBIOLOGY, V153, P124061, DOI [10.1099/mic.0.2007/007245-, DOI 10.1099/MIC.0.2007/007245-]; Kragelund C, 2006, MICROBIOL-SGM, V152, P3003, DOI 10.1099/mic.0.29249-0; KUBA T, 1993, WATER SCI TECHNOL, V27, P241, DOI 10.2166/wst.1993.0504; KUBA T, 1994, WATER SCI TECHNOL, V30, P263, DOI 10.2166/wst.1994.0277; Kumar MS, 2004, BIORESOURCE TECHNOL, V95, P327, DOI 10.1016/j.biortech.2004.02.019; Lemos PC, 2006, J BIOTECHNOL, V122, P226, DOI 10.1016/j.jbiotec.2005.09.006; Liao RH, 2013, BIORESOURCE TECHNOL, V134, P190, DOI 10.1016/j.biortech.2012.12.057; Meinhold J, 1999, WATER RES, V33, P1871, DOI 10.1016/S0043-1354(98)00411-4; Merzouki M, 2001, ENVIRON TECHNOL, V22, P397, DOI 10.1080/09593332208618269; MINO T, 1995, WATER SCI TECHNOL, V31, P25, DOI 10.1016/0273-1223(95)00177-O; Mulkerrins D, 2004, ENVIRON INT, V30, P249, DOI 10.1016/S0160-4120(03)00177-6; Nawrocki EP, 2007, PLOS COMPUT BIOL, V3, P540, DOI 10.1371/journal.pcbi.0030056; Nielsen PH, 2010, WATER RES, V44, P5070, DOI 10.1016/j.watres.2010.07.036; Perez-Feito R, 2006, WATER ENVIRON RES, V78, P770, DOI 10.2175/106143006X99803; Qingjuan MENG, 2008, Journal of Environmental Sciences, V20, P933; Reddy MV, 2012, BIORESOURCE TECHNOL, V103, P313, DOI 10.1016/j.biortech.2011.09.040; Rene ER, 2007, BIRESOUR TECHNOL, V4, P839; Salehizadeh H, 2004, BIOTECHNOL ADV, V22, P261, DOI 10.1016/j.biotechadv.2003.09.003; Samantaray S, 2011, APPL ENVIRON MICROB, V77, P8735, DOI 10.1128/AEM.05275-11; Schuler AJ, 2003, WATER ENVIRON RES, V75, P485, DOI 10.2175/106143003X141286; Serafim LS, 2008, APPL MICROBIOL BIOT, V81, P615, DOI 10.1007/s00253-008-1757-y; Seviour RJ, 2003, FEMS MICROBIOL REV, V27, P99, DOI 10.1016/S0168-6445(03)00021-4; Shi HP, 2006, INT BIODETER BIODEGR, V57, P121, DOI 10.1016/j.ibiod.2006.01.001; Shi J, 2014, SAUDI J BIOL SCI, V21, P71, DOI 10.1016/j.sjbs.2013.06.003; SMOLDERS GJF, 1994, BIOTECHNOL BIOENG, V44, P837, DOI 10.1002/bit.260440709; Takabatake H, 2000, WATER SCI TECHNOL, V42, P351, DOI 10.2166/wst.2000.0402; Tsuneda S, 2006, BIOCHEM ENG J, V27, P191, DOI 10.1016/j.bej.2005.07.004; Valappil SP, 2007, J BIOTECHNOL, V132, P251, DOI 10.1016/j.jbiotec.2007.03.013; vanLoosdrecht MCM, 1997, WATER SCI TECHNOL, V35, P41, DOI 10.1016/S0273-1223(96)00877-3; Wagner M, 2002, CURR OPIN BIOTECH, V13, P218, DOI 10.1016/S0958-1669(02)00315-4; WALLEN LL, 1974, ENVIRON SCI TECHNOL, V8, P576, DOI 10.1021/es60091a007; Wang Y, 2012, J CHROMATOGR A, V1228, P99, DOI 10.1016/j.chroma.2011.08.085; Watanabe T, 2001, WATER RES, V35, P4102, DOI 10.1016/S0043-1354(01)00158-0; WENTZEL MC, 1989, WATER SA, V15, P71; Wright ES, 2012, APPL ENVIRON MICROB, V78, P717, DOI 10.1128/AEM.06516-11; Ye L, 2011, ENVIRON SCI TECHNOL, V45, P7173, DOI 10.1021/es201045e; Zeng RJ, 2003, BIOTECHNOL BIOENG, V81, P397, DOI 10.1002/bit.10484; Zhang SH, 2010, BIORESOURCE TECHNOL, V101, P3870, DOI 10.1016/j.biortech.2009.12.134; Zhang T, 2012, ISME J, V6, P1137, DOI 10.1038/ismej.2011.188; Zhou SF, 2013, BIOTECHNOL BIOENG, V110, P3177, DOI 10.1002/bit.24980; Zhou Y, 2008, WATER RES, V42, P2361, DOI 10.1016/j.watres.2008.01.003; Zou H, 2006, WORLD J MICROB BIOT, V22, P701, DOI 10.1007/s11274-005-9093-1	69	11	11	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0116230	10.1371/journal.pone.0116230	http://dx.doi.org/10.1371/journal.pone.0116230			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689047	gold, Green Submitted, Green Published			2022-12-26	WOS:000350322700008
J	Mendes, TK; Novakovic, S; Raymant, G; Bertram, SE; Esmaillie, R; Nadarajan, S; Breugelmans, B; Hofmann, A; Gasser, RB; Colaiacovo, MP; Boag, PR				Mendes, Tasha K.; Novakovic, Stevan; Raymant, Greta; Bertram, Sonja E.; Esmaillie, Reza; Nadarajan, Saravanapriah; Breugelmans, Bert; Hofmann, Andreas; Gasser, Robin B.; Colaiacovo, Monica P.; Boag, Peter R.			Investigating the Role of RIO Protein Kinases in Caenorhabditis elegans	PLOS ONE			English	Article							PRE-RIBOSOMAL-RNA; FAMILY; MATURATION; SKN-1	RIO protein kinases (RIOKs) are a relatively conserved family of enzymes implicated in cell cycle control and ribosomal RNA processing. Despite their functional importance, they remain a poorly understood group of kinases in multicellular organisms. Here, we show that the C. elegans genome contains one member of each of the three RIOK sub-families and that each of the genes coding for them has a unique tissue expression pattern. Our analysis showed that the gene encoding RIOK-1 (riok-1) was broadly and strongly expressed. Interestingly, the intestinal expression of riok-1 was dependent upon two putative binding sites for the oxidative and xenobiotic stress response transcription factor SKN-1. RNA interference (RNAi)-mediated knock down of riok-1 resulted in germline defects, including defects in germ line stem cell proliferation, oocyte maturation and the production of endomitotic oocytes. Taken together, our findings indicate new functions for RIOK-1 in post mitotic tissues and in reproduction.	[Mendes, Tasha K.; Novakovic, Stevan; Raymant, Greta; Boag, Peter R.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Bertram, Sonja E.; Esmaillie, Reza] Univ Cologne, Inst Genet, Cologne, Germany; [Nadarajan, Saravanapriah; Colaiacovo, Monica P.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Breugelmans, Bert; Gasser, Robin B.] Univ Melbourne, Fac Vet Sci, Parkville, Vic 3052, Australia; [Hofmann, Andreas] Griffith Univ, Eskitis Inst Cell & Drug Discovery, Brisbane, Qld 4111, Australia	Monash University; University of Cologne; Harvard University; Harvard Medical School; University of Melbourne; Griffith University	Boag, PR (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia.	peter.boag@monash.edu	Hofmann, Andreas/M-9870-2019; Gasser, Robin/ABH-6185-2020; Hofmann, Andreas/B-9515-2008	Hofmann, Andreas/0000-0003-4408-5467; Gasser, Robin/0000-0002-4423-1690; Hofmann, Andreas/0000-0003-4408-5467; Novakovic, Stevan/0000-0002-9823-6411; Boag, Peter/0000-0002-0889-0859	National Health and Medical Research Council [APP1044022]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105853, R01GM072551] Funding Source: NIH RePORTER	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a National Health and Medical Research Council grant, APP1044022 (RBG, PRB & AH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Anaya P, 1998, GENE, V211, P323, DOI 10.1016/S0378-1119(98)00115-2; Angermayr M, 2003, BIOL CHEM, V384, P1287, DOI 10.1515/BC.2003.143; Angermayr M, 2002, FEBS LETT, V524, P31, DOI 10.1016/S0014-5793(02)02993-9; Baumas K, 2012, RNA BIOL, V9, DOI [10.4161/rna.9.2.18810, 10.4161/rna.18810]; Boag PR, 2008, J CELL BIOL, V182, P543, DOI 10.1083/jcb.200801183; Breugelmans B, 2014, INT J PARASITOL, V44, P827, DOI 10.1016/j.ijpara.2014.06.005; Clandinin TR, 1998, CELL, V92, P523, DOI 10.1016/S0092-8674(00)80945-9; Feng J, 2014, J VIROL, V88, P7987, DOI 10.1128/JVI.00643-14; Ferreira-Cerca S, 2012, NAT STRUCT MOL BIOL, V19, P1316, DOI 10.1038/nsmb.2403; Geerlings TH, 2003, J BIOL CHEM, V278, P22537, DOI 10.1074/jbc.M300759200; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Kelly WG, 1997, GENETICS, V146, P227; Kimmelman AC, 2008, P NATL ACAD SCI USA, V105, P19372, DOI 10.1073/pnas.0809966105; Krupa A, 2002, PROTEIN SCI, V11, P1580, DOI 10.1110/ps.3560102; Kudron MM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000181; Kumsta C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035428; LaRonde-LeBlanc N, 2005, J BIOL CHEM, V280, P37297, DOI 10.1074/jbc.R500013200; LaRonde-LeBlanc N, 2005, FEBS J, V272, P3698, DOI 10.1111/j.1742-4658.2005.04796.x; LaRonde-LeBlanc N, 2004, STRUCTURE, V12, P1585, DOI 10.1016/j.str.2004.06.016; MacQueen AJ, 2002, GENE DEV, V16, P2428, DOI 10.1101/gad.1011602; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Manning G, 2005, GENOMIC OVERVIEW PRO, P1; McCarter J, 1999, DEV BIOL, V205, P111, DOI 10.1006/dbio.1998.9109; McCormick JA, 2011, PHYSIOL REV, V91, P177, DOI 10.1152/physrev.00017.2010; Mello C, 1995, METHOD CELL BIOL, V48, P451; Papp D, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002673; Read RD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003253; Scheeff ED, 2005, PLOS COMPUT BIOL, V1, P359, DOI 10.1371/journal.pcbi.0010049; Shan JX, 2009, MOL CELL BIOCHEM, V332, P113, DOI 10.1007/s11010-009-0180-8; Stiernagle T, 2006, MAINTENANCE OF C ELE; Strunk BS, 2012, CELL, V150, P111, DOI 10.1016/j.cell.2012.04.044; Tariki M, 2013, CELL SIGNAL, V25, P2668, DOI 10.1016/j.cellsig.2013.08.037; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Vaglio P, 2003, NUCLEIC ACIDS RES, V31, P237, DOI 10.1093/nar/gkg092; Vanrobays E, 2003, MOL CELL BIOL, V23, P2083, DOI 10.1128/MCB.23.6.2083-2095.2003; Vanrobays E, 2001, EMBO J, V20, P4204, DOI 10.1093/emboj/20.15.4204; Wang JG, 2010, MAGNETIC FRINGE FIELDS AND INTERFERENCE IN HIGH INTENSITY ACCELERATORS, P1	38	10	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117444	10.1371/journal.pone.0117444	http://dx.doi.org/10.1371/journal.pone.0117444			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25688864	Green Published, gold			2022-12-26	WOS:000350322700045
J	Saha, MK; Mahapatra, T; Biswas, S; Ghosh, P; Kire, M				Saha, Malay Kumar; Mahapatra, Tanmay; Biswas, Subrata; Ghosh, Piyali; Kire, Medo			Burden and Correlates of HIV Risk among Men Who Have Sex with Men in Nagaland, India: Analysis of Sentinel Surveillance Data	PLOS ONE			English	Article							BEHAVIOR; CHENNAI; INFECTION; MSM; PREVENTION; PREVALENCE; WOMEN; INCOME; MUMBAI	Background Dynamics of HIV epidemic are largely understudied among men having sex with men (MSM) in India, while their potentially critical role in HIV spread is often stressed. Unfortunately, the epidemic has probably concentrated in this hard-to-reach population in the north-eastern high HIV-prevalent areas, especially in the bordering state of Nagaland, where HIV prevalence among MSM was found to be 2nd highest in the whole country. Dearth of information regarding the socio-behavioral correlates of HIV acquisition among MSM in this remote hilly region thus called for detailed analyses of the HIV Sentinel Surveillance (HSS) data. Methods During the first ever conducted HSS among MSM in Nagaland, between March and May, 2011, as per the operational guideline of Indian National AIDS Control Program, 243 MSM were recruited, interviewed and tested for HIV. Anonymous data on socio-demographics, sexual behavior and laboratory results were analyzed using SAS version-9.2 to conduct descriptive and logistic regression analyses. Results Among the recruited MSM, mean age was 28.30 years, 46.09% were illiterate, 27.16% were unemployed, 57.02% identified them as Kothi (predominantly receptive anal sex partner), 14.81% were bisexual, 19.75% exchanged money for sex (within last 1 year) with men and 13.58% were HIV sero-positive. Increasing age (for 25-34yrs, adjusted odds ratio: AOR = 3.89, p = 0.046; reference = <25yrs), middle school (AOR = 3.44, p = 0.046) or higher (AOR = 4.47, p = 0.034) education (reference = illiterate), being Kothi [AOR = 3.60, p = 0.026; reference = double-decker: (involved in both insertive and receptive roles)] and having paid and received money for sex with a man (AOR = 7.32, p = 0.026; reference = didn't exchange money) were strongly associated with higher risk of HIV in both bivariate and multivariate analyses. Conclusion HIV burden was found to be alarmingly high among MSM in Nagaland. Targeted interventions for high-risk MSM, especially those who were older, educated, self-identified as kothis and involved in paid sex, seemed to be the need of the hour.	[Saha, Malay Kumar; Biswas, Subrata; Ghosh, Piyali] Natl Inst Cholera & Enter Dis, Div Virol, Kolkata, W Bengal, India; [Mahapatra, Tanmay] Natl Inst Cholera & Enter Dis, Div Epidemiol, Kolkata, W Bengal, India; [Kire, Medo] Nagaland State AIDS Control Soc, Monitoring & Evaluat Div, Kohima, Nagaland, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED)	Saha, MK (corresponding author), Natl Inst Cholera & Enter Dis, Div Virol, Kolkata, W Bengal, India.	sahamk@yahoo.com			National AIDS Control Organization, New Delhi, Regional Institute for HIV Sentinel Surveillance	National AIDS Control Organization, New Delhi, Regional Institute for HIV Sentinel Surveillance	National AIDS Control Organization, New Delhi, funded the study as a part of Regional Institute for HIV Sentinel Surveillance. MKS received the funding. The funder designed the HIV sentinel surveillance and its implementation but had no role in this study design, data compilation and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, MAN QUAL STAND HIV T, DOI [10.1093/jxb/erm028, DOI 10.1093/JXB/ERM028]; [Anonymous], 2011, NAGALAND POPULATION; [Anonymous], 2009, ANN REP 2008 09 GOV; [Anonymous], 2012, ANN REP 2011 2012 GO; [Anonymous], 2012, TAL 2 STAT EV HIV EP, DOI [10.1016/j.asjsur.2012.06.010, DOI 10.1016/J.ASJSUR.2012.06.010]; [Anonymous], 2011, NAG POP CENS DAT, DOI [10.1080/17437199.2011.587961, DOI 10.1080/17437199.2011.587961]; [Anonymous], 2011, ANN REP 2010 2011 NA; [Anonymous], 2013, ANN REP 2012 2013 GO; Asthana S, 2001, SOC SCI MED, V52, P707, DOI 10.1016/S0277-9536(00)00167-2; Bai X, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18848; Banik S, 2009, J LGBT HLTH RES, V4, P45; Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Bechani D, 2009, SAARC J TUBERCULOSIS, V6, P1; Brahmam GNV, 2008, AIDS, V22, pS45, DOI 10.1097/01.aids.0000343763.54831.15; Calzavara L, 2002, AIDS, V16, P1655, DOI 10.1097/00002030-200208160-00011; Chakrapani V, 2008, CULT HEALTH SEX, V10, P313, DOI 10.1080/13691050701816714; Dandona L, 2005, AIDS, V19, P611, DOI 10.1097/01.aids.0000163938.01188.e4; Das A, 2014, INT J STD AIDS; Deb Soumya, 2009, Indian J Community Med, V34, P206, DOI 10.4103/0970-0218.55285; German D, 2011, JAIDS-J ACQ IMM DEF, V57, P77, DOI 10.1097/QAI.0b013e318211b41e; Go VF, 2004, JAIDS-J ACQ IMM DEF, V35, P314, DOI 10.1097/00126334-200403010-00014; Gupta A, 2006, JAIDS-J ACQ IMM DEF, V43, P483; Hernandez AL, 2006, AIDS BEHAV, V10, pS5, DOI 10.1007/s10461-006-9129-z; Kerr LRFS, 2013, AIDS, V27, P427, DOI 10.1097/QAD.0b013e32835ad504; KUMAR B, 1991, INT J STD AIDS, V2, P442, DOI 10.1177/095646249100200611; Kumta S, 2010, JAIDS-J ACQ IMM DEF, V53, P227, DOI 10.1097/QAI.0b013e3181c354d8; Lane T, 2011, AIDS BEHAV, V15, P626, DOI 10.1007/s10461-009-9598-y; National AIDS Control Organisation, 2013, HIV SENT SURV 2012 1; National AIDS Control Organisation, 2012, HIV SENT SURV 2010 1; National AIDS Control Organization, 2010, HIV SENT SURV 2010 O; Newman PA, 2008, SEX TRANSM INFECT, V84, P434, DOI 10.1136/sti.2008.031484; Newman PA, 2012, PREV SCI, V13, P483, DOI 10.1007/s11121-012-0275-4; Newmann S, 2000, INT J STD AIDS, V11, P250, DOI 10.1258/0956462001915796; Pappas G, 2001, AIDS PUBLIC POLICY J, V16, P4; Perez-Brumer AG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059072; Safren SA, 2006, AIDS EDUC PREV, V18, P323, DOI 10.1521/aeap.2006.18.4.323; Setia Maninder Singh, 2006, Indian J Dermatol Venereol Leprol, V72, P425; Solomon SS, 2010, AIDS BEHAV, V14, P1001, DOI 10.1007/s10461-010-9711-2; Tang WM, 2013, AIDS BEHAV, V17, P1415, DOI 10.1007/s10461-013-0413-4; Thomas B, 2012, AIDS EDUC PREV, V24, P483, DOI 10.1521/aeap.2012.24.6.483; Thomas B, 2011, INDIAN J MED RES, V134, P920, DOI 10.4103/0971-5916.92637; Thomas B, 2009, AIDS EDUC PREV, V21, P372, DOI 10.1521/aeap.2009.21.4.372; Verma RK, 2004, AIDS, V18, P1845, DOI 10.1097/00002030-200409030-00014	43	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117385	10.1371/journal.pone.0117385	http://dx.doi.org/10.1371/journal.pone.0117385			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC4KQ	25689469	Green Published, Green Submitted, gold			2022-12-26	WOS:000350322700038
J	Berglund, AMM; Rainio, MJ; Eeva, T				Berglund, Asa M. M.; Rainio, Miia J.; Eeva, Tapio			Temporal Trends in Metal Pollution: Using Bird Excrement as Indicator	PLOS ONE			English	Article							FLYCATCHERS FICEDULA-HYPOLEUCA; PLASMA-MASS SPECTROMETRY; TITS PARUS-MAJOR; CU-NI SMELTER; HEAVY-METAL; BREEDING SUCCESS; COPPER SMELTER; FOREST SOIL; WILD BIRDS; SW FINLAND	Past mining and smelting activities have resulted in metal polluted environments all over the world, but long-term monitoring data is often scarce, especially in higher trophic levels. In this study we used bird (Parus major and Ficedula hypoleuca) excrement to monitor metal pollution in the terrestrial environment following 16 years of continuously reduced emissions from a copper/nickel smelter in Finland. In the early 1990s, lead and cadmium concentrations dropped significantly in excrement, but the reduction did not directly reflect the changes in atmospheric emission from the smelter. This is likely due to a continuous contribution of metals also from the soil pool. We conclude that bird excrement can be used to assess changes in the environment as a whole but not specifically changes in atmospheric emission. Inter-annual variation in excrement concentration of especially copper and nickel demonstrates the importance of long-term monitoring to discern significant trends.	[Berglund, Asa M. M.; Rainio, Miia J.; Eeva, Tapio] Univ Turku, Sect Ecol, Turku, Finland	University of Turku	Berglund, AMM (corresponding author), Umea Univ, Dept Ecol & Environm Sci, Umea, Sweden.	asa.berglund@emg.umu.se	Rainio, Miia Johanna/H-9450-2019; Eeva, Tapio/V-8922-2018	Rainio, Miia Johanna/0000-0003-0420-9314; Eeva, Tapio/0000-0002-0395-1536	Academy of Finland [265859]	Academy of Finland(Academy of Finland)	This study was financed by the Academy of Finland (project 265859, http://www.aka.fi/en-GB/A/) by a grant to TE. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backor M, 2004, ENVIRON EXP BOT, V52, P149, DOI 10.1016/j.envexpbot.2004.01.014; Barcan V, 2002, ENVIRON INT, V28, P63, DOI 10.1016/S0160-4120(02)00005-3; BELSKII EA, 1995, RUSS J ECOL+, V26, P38; Belskii E, 2013, ECOTOX ENVIRON SAFE, V97, P67, DOI 10.1016/j.ecoenv.2013.07.014; BERGKVIST B, 1989, WATER AIR SOIL POLL, V47, P217, DOI 10.1007/BF00279328; Berglund AMM, 2011, ENVIRON POLLUT, V159, P2368, DOI 10.1016/j.envpol.2011.07.001; Berglund AMM, 2011, SCI TOTAL ENVIRON, V409, P4326, DOI 10.1016/j.scitotenv.2011.07.004; Berglund AMM, 2012, ENVIRON TOXICOL CHEM, V31, P1317, DOI 10.1002/etc.1814; Berglund AMM, 2009, ENVIRON SCI TECHNOL, V43, P208, DOI 10.1021/es801723q; Beyer WN, 2004, ARCH ENVIRON CON TOX, V48, P108, DOI 10.1007/s00244-004-0010-7; Costa RA, 2013, ENVIRON MONIT ASSESS, V185, P5339, DOI 10.1007/s10661-012-2949-6; Cramp S, 1993, FLYCATCHERS SHRIEKS, VVII; Dauwe T, 2000, ARCH ENVIRON CON TOX, V39, P541, DOI 10.1007/s002440010138; Dauwe T, 2004, ENVIRON POLLUT, V131, P373, DOI 10.1016/j.envpol.2004.03.009; Derome J, 1998, CHEMOSPHERE, V36, P1131, DOI 10.1016/S0045-6535(97)10184-9; Derome J, 1998, ENVIRON POLLUT, V99, P225, DOI 10.1016/S0269-7491(97)00185-1; Eeva T, 2005, OECOLOGIA, V145, P629, DOI 10.1007/s00442-005-0145-x; Eeva T, 1997, ECOLOGY, V78, P1120, DOI 10.1890/0012-9658(1997)078[1120:PRVIFS]2.0.CO;2; Eeva T, 1996, OECOLOGIA, V108, P631, DOI 10.1007/BF00329036; Eeva T, 2000, NATURE, V403, P851, DOI 10.1038/35002672; Eeva T, 2009, ENVIRON POLLUT, V157, P3126, DOI 10.1016/j.envpol.2009.05.040; Eeva T, 2009, ENVIRON POLLUT, V157, P1857, DOI 10.1016/j.envpol.2009.01.015; Eeva T, 2012, BIOL CONSERV, V150, P33, DOI 10.1016/j.biocon.2012.03.004; EFSA (Europaen Food Safety Authority), 2010, MAN LEFT CENS DAT DI; FITZNER RE, 1995, B ENVIRON CONTAM TOX, V55, P398; Furness R.W., 1993, P86; Gunn J, 1995, WATER AIR SOIL POLL, V85, P1783, DOI 10.1007/BF00477238; Harmens H, 2010, ENVIRON POLLUT, V158, P3144, DOI 10.1016/j.envpol.2010.06.039; Heikens A, 2001, ENVIRON POLLUT, V113, P385, DOI 10.1016/S0269-7491(00)00179-2; Helsel DR, 1990, ENVIRON SCI TECHNOL, V24, P1776; Johns C, 2012, ENVIRON MONIT ASSESS, V184, P5371, DOI 10.1007/s10661-011-2346-6; Kiikkila O, 2003, SILVA FENN, V37, P399, DOI 10.14214/sf.497; Koptsik S, 2003, J ENVIRON MONITOR, V5, P441, DOI 10.1039/b210397b; Kozlov MV, 2009, ENVIRON POLLUT SER, V15, P1, DOI 10.1007/978-90-481-2467-1; Kozlov MV, 2005, ENVIRON POLLUT, V135, P91, DOI 10.1016/j.envpol.2004.10.005; Kubin E, 2000, FOR SCI, V65, P60; Kumar G, 2012, FOOD ADDIT CONTAM B, V5, P140, DOI 10.1080/19393210.2012.680612; Lange B, 2008, MICROCHIM ACTA, V160, P97, DOI 10.1007/s00604-007-0849-1; Malkonen E, 1999, NUTR CYCL AGROECOSYS, V55, P239, DOI 10.1023/A:1009851326584; Miksa IR, 2005, J VET DIAGN INVEST, V17, P331, DOI 10.1177/104063870501700405; Morrissey CA, 2005, ENVIRON TOXICOL CHEM, V24, P836, DOI 10.1897/04-110R.1; Mukhacheva SV, 2010, RUSS J ECOL+, V41, P513, DOI 10.1134/S1067413610060081; Nieminen T, 2009, SOILS CHANG WORLD 5, P89; Nieminen TM, 2005, THESIS U HELSINKI HE; Nriagu JO, 1984, ENV IMPACTS SMELTERS, P1; Palmer CD, 2006, SPECTROCHIM ACTA B, V61, P980, DOI 10.1016/j.sab.2006.09.001; Poikolainen J, 2004, SCI TOTAL ENVIRON, V318, P171, DOI 10.1016/S0048-9697(03)00396-6; Sardans J, 2010, SPECTROCHIM ACTA B, V65, P97, DOI 10.1016/j.sab.2009.11.009; SAS Institute Inc, 2008, SAS STAT 9 2 US GUID; Swiergosz R, 1998, ENVIRON POLLUT, V102, P213, DOI 10.1016/S0269-7491(98)00093-1; Vidic T, 2006, ENVIRON SCI TECHNOL, V40, P4119, DOI 10.1021/es052339x; von Haartman L, 1956, IBIS, V98, P460, DOI DOI 10.1111/J.1474-919X.1956.TB01431.X; Wilkin TA, 2009, OECOLOGIA, V159, P463, DOI 10.1007/s00442-008-1222-8	53	26	26	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117071	10.1371/journal.pone.0117071	http://dx.doi.org/10.1371/journal.pone.0117071			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680108	Green Submitted, gold, Green Published			2022-12-26	WOS:000350682600047
J	Camerini, AL; Schulz, PJ				Camerini, Anne-Linda; Schulz, Peter J.			Health Literacy and Patient Empowerment: Separating Con-joined Twins in the Context of Chronic Low Back Pain	PLOS ONE			English	Article							CULTURAL-ADAPTATION; COMMUNICATION; CARE; VALIDATION; OUTCOMES; MODEL	Objectives While health literacy has been widely considered key to patient empowerment, an alternative approach separates both concepts and distinguishes between dif-ferent types of patients according to their levels of health literacy and empowerment. These types are deemed to vary in their health-related actions and outcomes. In this study, we exam-ine the relationship between health literacy and patient empowerment and compare socio-demographic characteristics, health-related activities, and health outcomes in four types of patients suffering from chronic low back pain (cLBP). Methods In a cross-sectional study, 273 cLBP patients from four Swiss can-tons (Vaud, Geneva, Fribourg, Ticino) and Lombardy (Italy) were invited by their healthcare providers to complete a self-administered paper-and-pencil questionnaire which assessed pa-tients' health literacy, empowerment, involvement in the medical encounter, medication non-adherence, and perceived pain and functionality as a measure of health outcomes. Results Health literacy and patient empowerment were not significantly correlated with each other, r(271) = .09, p > .05, allowing to differentiate be-tween four types of patients based on their levels of health literacy and patient empowerment. Subsequent chi-square tests and analyses of variances revealed significant differences among patients that could, however, only be attributed to health literacy, as in the case of age and ed-ucational attainment, or patient empowerment, as in the case of patients' involvement in the medical encounter. No significant differences were evident for gender, medication non-adherence, and health outcomes. Conclusion The study provides empirical evidence for the need to consider health literacy and patient empowerment as independent concepts in the context of cLBP but calls for further studies to be able to conclude on how the two concepts interact and determine health-related activities and outcomes.	[Camerini, Anne-Linda; Schulz, Peter J.] Univ Svizzera Italiana, Inst Commun & Hlth, Lugano, Switzerland	Universita della Svizzera Italiana	Camerini, AL (corresponding author), Univ Svizzera Italiana, Inst Commun & Hlth, Lugano, Switzerland.	anne.linda.camerini@usi.ch	Schulz, Peter/GQQ-1290-2022; Schulz, Peter/AAM-9816-2020	Schulz, Peter/0000-0003-4281-489X; Schulz, Peter/0000-0003-4281-489X; Camerini, Anne-Linda/0000-0002-2316-6228	Swiss National Science Foundation [FN 130030]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was funded by the Swiss National Science Foundation (Grant number: FN 130030). The funding body had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LL, 2004, J PAIN SYMPTOM MANAG, V27, P440, DOI 10.1016/j.jpainsymman.2003.10.009; Baker DW, 2000, J GERONTOL B-PSYCHOL, V55, pS368, DOI 10.1093/geronb/55.6.S368; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Berkman ND, 2011, ANN INTERN MED, V155, P97, DOI 10.7326/0003-4819-155-2-201107190-00005; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P2469, DOI 10.1001/jama.288.19.2469; Chinn D, 2011, SOC SCI MED, V73, P60, DOI 10.1016/j.socscimed.2011.04.004; DeWalt DA, 2004, J GEN INTERN MED, V19, P1228, DOI 10.1111/j.1525-1497.2004.40153.x; DEYO RA, 1991, ANNU REV PUBL HEALTH, V12, P141, DOI 10.1146/annurev.pu.12.050191.001041; Diviani N, 2014, J PUBLIC HEALTH RES, V3, P92, DOI 10.4081/jphr.2014.295; Dubowicz A, 2013, PATIENT EDUC COUNS, V93, P224, DOI 10.1016/j.pec.2013.06.024; FLOR H, 1992, PAIN, V49, P221, DOI 10.1016/0304-3959(92)90145-2; Freburger JK, 2009, ARCH INTERN MED, V169, P251, DOI 10.1001/archinternmed.2008.543; Frisch AL, 2012, HEALTH PROMOT INT, V27, P117, DOI 10.1093/heapro/dar043; Ishikawa H, 2008, HEALTH EXPECT, V11, P113, DOI 10.1111/j.1369-7625.2008.00497.x; Londono AMM, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-12; Maciel SC, 2009, CLINICS, V64, P1167, DOI 10.1590/S1807-59322009001200006; Maetzel A, 2002, BEST PRACT RES CL RH, V16, P23, DOI 10.1053/berh.2001.0204; Menon ST, 2002, NURS EDUC TODAY, V22, P28, DOI 10.1054/nedt.2001.0721; Ngoh LN, 2009, J AM PHARM ASSOC, V49, pE132, DOI 10.1331/JAPhA.2009.07075; Nunez M, 2006, QUAL LIFE RES, V15, P93, DOI 10.1007/s11136-005-0448-8; Nutbeam D, 2000, HEALTH PROMOT INT, V15, P259, DOI 10.1093/heapro/15.3.259; Nutbeam D, 2009, INT J PUBLIC HEALTH, V54, P303, DOI 10.1007/s00038-009-0050-x; ONG LML, 1995, SOC SCI MED, V40, P903, DOI 10.1016/0277-9536(94)00155-M; Paasche-Orlow MK, 2007, AM J HEALTH BEHAV, V31, pS19; Parikh NS, 1996, PATIENT EDUC COUNS, V27, P33, DOI 10.1016/0738-3991(95)00787-3; Parker RM, 1999, JAMA-J AM MED ASSOC, V281, P552; Roter D, 2006, DOCTORS TALKING PATI, DOI [10.1016/j.jalz.2006.06.001, DOI 10.1016/J.JALZ.2006.06.001]; Schulz PJ, 2013, PATIENT EDUC COUNS, V90, P4, DOI 10.1016/j.pec.2012.09.006; Schulz PJ, 2012, SCI ENV HLTH RENEWED, P69, DOI [10.1002/pmh.1213, DOI 10.1002/PMH.1213]; SCHWARTZ L, 1991, PAIN, V44, P61, DOI 10.1016/0304-3959(91)90148-Q; Sidani S, 2010, RES NURS HEALTH, V33, P133, DOI 10.1002/nur.20364; Smith MY, 2006, J PAIN SYMPTOM MANAG, V32, P71, DOI 10.1016/j.jpainsymman.2006.01.007; Smith SG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074373; Sorensen K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-80; SPREITZER GM, 1995, ACAD MANAGE J, V38, P1442, DOI 10.2307/256865; THOMAS KW, 1990, ACAD MANAGE REV, V15, P666, DOI 10.2307/258687; von Wagner C, 2009, HEALTH EDUC BEHAV, V36, P860, DOI 10.1177/1090198108322819; VONKORFF M, 1992, PAIN, V50, P133, DOI 10.1016/0304-3959(92)90154-4; Wieser S, 2011, EUR J HEALTH ECON, V12, P455, DOI 10.1007/s10198-010-0258-y; Willems S, 2005, PATIENT EDUC COUNS, V56, P139, DOI 10.1016/j.pec.2004.02.011; World Health Organization, 1998, HLTH PROM GLOSS	41	18	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0118032	10.1371/journal.pone.0118032	http://dx.doi.org/10.1371/journal.pone.0118032			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9IO	25680195	Green Published, gold, Green Submitted			2022-12-26	WOS:000350682600104
J	Fujita, M; Watanabe, S; Yoshizawa, M; Yamamoto, J; Iwai, S				Fujita, Masashi; Watanabe, Shun; Yoshizawa, Mariko; Yamamoto, Junpei; Iwai, Shigenori			Analysis of Structural Flexibility of Damaged DNA Using Thiol-Tethered Oligonucleotide Duplexes	PLOS ONE			English	Article							INTRASTRAND CROSS-LINK; ANTICANCER DRUG CISPLATIN; RESONANCE ENERGY-TRANSFER; CRYSTAL-STRUCTURE; ABASIC SITE; DODECAMER DUPLEX; 6-4 PHOTOPRODUCT; MAJOR ADDUCT; MOLECULAR-DYNAMICS; AQUEOUS-SOLUTION	Bent structures are formed in DNA by the binding of small molecules or proteins. We developed a chemical method to detect bent DNA structures. Oligonucleotide duplexes in which two mercaptoalkyl groups were attached to the positions facing each other across the major groove were prepared. When the duplex contained the cisplatin adduct, which was proved to induce static helix bending, interstrand disulfide bond formation under an oxygen atmosphere was detected by HPLC analyses, but not in the non-adducted duplex, when the two thiol-tethered nucleosides were separated by six base pairs. When the insert was five and seven base pairs, the disulfide bond was formed and was not formed, respectively, regardless of the cisplatin adduct formation. The same reaction was observed in the duplexes containing an abasic site analog and the (6-4) photoproduct. Compared with the cisplatin case, the disulfide bond formation was slower in these duplexes, but the reaction rate was nearly independent of the linker length. These results indicate that dynamic structural changes of the abasic site- and (6-4) photoproduct-containing duplexes could be detected by our method. It is strongly suggested that the UV-damaged DNA-binding protein, which specifically binds these duplexes and functions at the first step of global-genome nucleotide excision repair, recognizes the easily bendable nature of damaged DNA.	[Fujita, Masashi; Watanabe, Shun; Yoshizawa, Mariko; Yamamoto, Junpei; Iwai, Shigenori] Osaka Univ, Grad Sch Engn Sci, Div Chem, Toyonaka, Osaka 5608531, Japan	Osaka University	Iwai, S (corresponding author), Osaka Univ, Grad Sch Engn Sci, Div Chem, 1-3 Machikaneyama, Toyonaka, Osaka 5608531, Japan.	iwai@chem.es.osaka-u.ac.jp			Japan Society for the Promotion of Science [24310158]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Grant-in-Aid for Scientific Research (24310158) from Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/index.html) to SI. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayadi L, 2000, J BIOMOL STRUCT DYN, V17, P645, DOI 10.1080/07391102.2000.10506555; Banerjee A, 2005, NATURE, V434, P612, DOI 10.1038/nature03458; Barsky D, 2000, NUCLEIC ACIDS RES, V28, P2613, DOI 10.1093/nar/28.13.2613; Beger RD, 1998, J BIOL CHEM, V273, P15565, DOI 10.1074/jbc.273.25.15565; BELLON SF, 1990, BIOPHYS CHEM, V35, P179, DOI 10.1016/0301-4622(90)80007-T; Blair RH, 2012, BIOCHEMISTRY-US, V51, P7444, DOI 10.1021/bi300491j; BORER PN, 1975, HDB BIOCH MOL BIOL N, V1, P589; Bruner SD, 2000, NATURE, V403, P859, DOI 10.1038/35002510; Chen J, 2008, NUCLEIC ACIDS RES, V36, P253, DOI 10.1093/nar/gkm622; Chen JY, 2007, BIOCHEMISTRY-US, V46, P3096, DOI 10.1021/bi6024269; Chiba J, 2014, CHEM COMMUN, V50, P11126, DOI 10.1039/c4cc04513k; Cline SD, 1999, BIOCHEMISTRY-US, V38, P15500, DOI 10.1021/bi991750s; Coppel Y, 1997, BIOCHEMISTRY-US, V36, P4817, DOI 10.1021/bi962677y; CRICK FHC, 1975, NATURE, V255, P530, DOI 10.1038/255530a0; Curuksu J, 2008, NUCLEIC ACIDS RES, V36, P2268, DOI 10.1093/nar/gkm1135; Friedman JI, 2010, BIOCHEMISTRY-US, V49, P4957, DOI 10.1021/bi100593a; Fujiwara Y, 1999, J BIOL CHEM, V274, P20027, DOI 10.1074/jbc.274.28.20027; Gelasco A, 1998, BIOCHEMISTRY-US, V37, P9230, DOI 10.1021/bi973176v; GOLJER I, 1995, J BIOL CHEM, V270, P22980, DOI 10.1074/jbc.270.39.22980; Hoehn ST, 2001, NUCLEIC ACIDS RES, V29, P3413, DOI 10.1093/nar/29.16.3413; Iwai S, 1999, NUCLEIC ACIDS RES, V27, P2299, DOI 10.1093/nar/27.11.2299; Iwai S, 1996, J AM CHEM SOC, V118, P7642, DOI 10.1021/ja9603158; KAHN JD, 1994, NATURE, V368, P163, DOI 10.1038/368163a0; KIM JK, 1995, EUR J BIOCHEM, V228, P849, DOI 10.1111/j.1432-1033.1995.0849m.x; KIM JL, 1993, NATURE, V365, P520, DOI 10.1038/365520a0; MANOHARAN M, 1994, GENE, V149, P147, DOI 10.1016/0378-1119(94)90423-5; MANOHARAN M, 1993, BIOORG MED CHEM LETT, V3, P2765, DOI 10.1016/S0960-894X(01)80760-5; Marathias VM, 1999, NUCLEIC ACIDS RES, V27, P1854, DOI 10.1093/nar/27.8.1854; Mizukoshi T, 2001, NUCLEIC ACIDS RES, V29, P4948, DOI 10.1093/nar/29.24.4948; NIKOLOV DB, 1995, NATURE, V377, P119, DOI 10.1038/377119a0; Noronha AM, 2000, BIOCHEMISTRY-US, V39, P7050, DOI 10.1021/bi000280v; Park S, 2012, BIOCHEMISTRY-US, V51, P6728, DOI 10.1021/bi300649v; RICE JA, 1988, P NATL ACAD SCI USA, V85, P4158, DOI 10.1073/pnas.85.12.4158; Scrima A, 2008, CELL, V135, P1213, DOI 10.1016/j.cell.2008.10.045; Shi XS, 2014, P NATL ACAD SCI USA, V111, pE1473, DOI 10.1073/pnas.1317032111; Spector TI, 1997, J AM CHEM SOC, V119, P7095, DOI 10.1021/ja964372c; Spingler B, 2001, INORG CHEM, V40, P5596, DOI 10.1021/ic010790t; Steenken S, 1997, J AM CHEM SOC, V119, P617, DOI 10.1021/ja962255b; TAKAHARA PM, 1995, NATURE, V377, P649, DOI 10.1038/377649a0; Todd RC, 2010, J INORG BIOCHEM, V104, P902, DOI 10.1016/j.jinorgbio.2010.04.005; Tsutakawa SE, 2012, MECH AGEING DEV, V133, P195, DOI 10.1016/j.mad.2011.11.009; Tubbs JL, 2010, CELL MOL LIFE SCI, V67, P3749, DOI 10.1007/s00018-010-0405-8; Wang KY, 1997, BIOCHEMISTRY-US, V36, P11629, DOI 10.1021/bi971464l; Werner MH, 1996, SCIENCE, V271, P778, DOI 10.1126/science.271.5250.778; WU HM, 1984, NATURE, V308, P509, DOI 10.1038/308509a0; Wu YB, 2007, BIOCHEMISTRY-US, V46, P6477, DOI 10.1021/bi062291f; YANG DZ, 1995, BIOCHEMISTRY-US, V34, P12912, DOI 10.1021/bi00039a054; Yang W, 2006, DNA REPAIR, V5, P654, DOI 10.1016/j.dnarep.2006.02.004	50	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117798	10.1371/journal.pone.0117798	http://dx.doi.org/10.1371/journal.pone.0117798			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679955	Green Published, gold, Green Submitted			2022-12-26	WOS:000350682600088
J	Kessinger, CW; Kim, JW; Henke, PK; Thompson, B; McCarthy, JR; Hara, T; Sillesen, M; Margey, RJP; Libby, P; Weissleder, R; Lin, CP; Jaffer, FA				Kessinger, Chase W.; Kim, Jin Won; Henke, Peter K.; Thompson, Brian; McCarthy, Jason R.; Hara, Tetsuya; Sillesen, Martin; Margey, Ronan J. P.; Libby, Peter; Weissleder, Ralph; Lin, Charles P.; Jaffer, Farouc A.			Statins Improve the Resolution of Established Murine Venous Thrombosis: Reductions in Thrombus Burden and Vein Wall Scarring	PLOS ONE			English	Article							INFERIOR VENA-CAVA; IN-VIVO; POSTTHROMBOTIC SYNDROME; ENDOTHELIAL-CELLS; MOUSE MODELS; EXPRESSION; MICE; INFLAMMATION; INHIBITION; ROSUVASTATIN	Despite anticoagulation therapy, up to one-half of patients with deep vein thrombosis (DVT) will develop the post-thrombotic syndrome (PTS). Improving the long-term outcome of DVT patients at risk for PTS will therefore require new approaches. Here we investigate the effects of statins-lipid-lowering agents with anti-thrombotic and anti-inflammatory properties -in decreasing thrombus burden and decreasing vein wall injury, mediators of PTS, in established murine stasis and non-stasis chemical-induced venous thrombosis (N = 282 mice). Treatment of mice with daily atorvastatin or rosuvastatin significantly reduced stasis venous thrombus burden by 25% without affecting lipid levels, blood coagulation parameters, or blood cell counts. Statin-driven reductions in VT burden (thrombus mass for stasis thrombi, intravital microscopy thrombus area for non-stasis thrombi) compared similarly to the therapeutic anticoagulant effects of low molecular weight heparin. Blood from statin-treated mice showed significant reductions in platelet aggregation and clot stability. Statins additionally reduced thrombus plasminogen activator inhibitor-1 (PAI-1), tissue factor, neutrophils, myeloperoxidase, neutrophil extracellular traps (NETs), and macrophages, and these effects were most notable in the earlier timepoints after DVT formation. In addition, statins reduced DVT-induced vein wall scarring by 50% durably up to day 21 in stasis VT, as shown by polarized light microscopy of picrosirius red-stained vein wall collagen. The overall results demonstrate that statins improve VT resolution via profibrinolytic, anticoagulant, antiplatelet, and anti-vein wall scarring effects. Statins may therefore offer a new pharmacotherapeutic approach to improve DVT resolution and to reduce the post-thrombotic syndrome, particularly in subjects who are ineligible for anticoagulation therapy.	[Kessinger, Chase W.; Kim, Jin Won; Hara, Tetsuya; Margey, Ronan J. P.; Jaffer, Farouc A.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Cardiol,Cardiovasc Res Ctr, Boston, MA 02163 USA; [Kim, Jin Won] Korea Univ, Guro Hosp, Multimodal Imaging & Theranost Lab, Ctr Cardiovasc, Seoul, South Korea; [Henke, Peter K.] Univ Michigan, Dept Surg, Vasc Surg Sect, Ann Arbor, MI 48109 USA; [Thompson, Brian; Lin, Charles P.; Jaffer, Farouc A.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Wellman Ctr Photomed, Boston, MA USA; [McCarthy, Jason R.; Weissleder, Ralph; Jaffer, Farouc A.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Mol Imaging Res, Boston, MA USA; [McCarthy, Jason R.; Weissleder, Ralph; Lin, Charles P.] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Sillesen, Martin] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Div Trauma Emergency Surg & Surg Crit Care, Boston, MA USA; [Libby, Peter] Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Korea University; Korea University Medicine (KU Medicine); University of Michigan System; University of Michigan; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital	Jaffer, FA (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Cardiol,Cardiovasc Res Ctr, Boston, MA 02163 USA.	fjaffer@mgh.harvard.edu	Jaffer, Farouc/AAK-8803-2020; Libby, Peter/AAY-6404-2021; Margey, Ronan/AAE-3746-2022	Jaffer, Farouc/0000-0001-7980-384X; Libby, Peter/0000-0002-1502-502X; Sillesen, Martin/0000-0001-9494-5475; /0000-0003-0828-4143	Merck, Ltd.; Kowa, Ltd.; U.S. National Institutes of Health (NIH) [R01 HL108229, T32 HL076136, UO1-HL080731]; American Heart Association Scientist Development Grant [0830352N, 13GRNT17060040]; Howard Hughes Medical Institute Early Career Award; Cardiovascular Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122208, R01HL108229, U01HL080731, T32HL076136, R01HL122388] Funding Source: NIH RePORTER	Merck, Ltd.; Kowa, Ltd.; U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Scientist Development Grant(American Heart Association); Howard Hughes Medical Institute Early Career Award(Howard Hughes Medical Institute); Cardiovascular Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	F. Jaffer, Research Support, Merck and Kowa, Ltd. This research was supported in part by grants from the U.S. National Institutes of Health (NIH R01 HL108229, F.A.J.); T32 HL076136 (C.W.K).; and UO1-HL080731, (R.W., J.R.M., and P.L.); by an American Heart Association Scientist Development Grant (#0830352N, F.A.J.) and Grant-In-Aid (#13GRNT17060040, F.A.J.), by a Howard Hughes Medical Institute Early Career Award (F.A.J.), and by the Cardiovascular Research Foundation (J.W.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali T, 2006, J VASC SURG, V43, P601, DOI 10.1016/j.jvs.2005.10.073; Baldwin MJ, 2013, J THROMB HAEMOST, V11, P795, DOI 10.1111/jth.12180; Baxi S, 2008, THROMB HAEMOSTASIS, V99, P749, DOI 10.1160/TH07-11-0669; Becattini C, 2012, NEW ENGL J MED, V366, P1959, DOI 10.1056/NEJMoa1114238; Bourcier T, 2000, ARTERIOSCL THROM VAS, V20, P556, DOI 10.1161/01.ATV.20.2.556; Brill A, 2012, J THROMB HAEMOST, V10, P136, DOI 10.1111/j.1538-7836.2011.04544.x; Brill A, 2011, BLOOD, V117, P1400, DOI 10.1182/blood-2010-05-287623; CARDINAL DC, 1980, J PHARMACOL METHOD, V3, P135, DOI 10.1016/0160-5402(80)90024-8; Carroll MD, 2012, JAMA-J AM MED ASSOC, V308, P1545, DOI 10.1001/jama.2012.13260; Chang K, 2010, ARTERIOSCL THROM VAS, V30, P1933, DOI 10.1161/ATVBAHA.110.206342; Chitsike RS, 2012, J THROMB HAEMOST, V10, P2039, DOI 10.1111/j.1538-7836.2012.04872.x; Deroo S, 2010, THROMB HAEMOSTASIS, V104, DOI [10.1160/TH10-05-0328, DOI 10.1160/TH10-05-0328]; Diaz JA, 2012, ARTERIOSCL THROM VAS, V32, P556, DOI 10.1161/ATVBAHA.111.244608; Diaz JA, 2010, THROMB HAEMOSTASIS, V104, P366, DOI 10.1160/TH09-09-0672; Duszak R, 2011, J AM COLL RADIOL, V8, P483, DOI 10.1016/j.jacr.2010.12.021; Enden T, 2012, LANCET, V379, P31, DOI 10.1016/S0140-6736(11)61753-4; Eto M, 2002, CIRCULATION, V105, P1756, DOI 10.1161/01.CIR.0000015465.73933.3B; Gertz K, 2003, STROKE, V34, P551, DOI 10.1161/01.STR.0000054055.28435.BF; Glynn RJ, 2009, NEW ENGL J MED, V360, P1851, DOI 10.1056/NEJMoa0900241; Guenther F, 2013, J THROMB HAEMOST, V11, P1154, DOI 10.1111/jth.12206; Henke PK, 2006, J IMMUNOL, V177, P3388, DOI 10.4049/jimmunol.177.5.3388; Henke PK, 2011, ARTERIOSCL THROM VAS, V31, P43, DOI 10.1161/ATVBAHA.110.216317; Henke PK, 2011, J VASC SURG, V53, P500, DOI 10.1016/j.jvs.2010.08.050; Henke PK, 2006, THROMB HAEMOSTASIS, V95, P272, DOI 10.1160/Th05-02-0099; Henke PK, 2004, ARTERIOSCL THROM VAS, V24, P1130, DOI 10.1161/01.ATV.0000129537.72553.73; Holschermann H, 2006, ATHEROSCLEROSIS, V185, P240, DOI 10.1016/j.atherosclerosis.2005.06.019; Hull RD, 2013, THROMB HAEMOSTASIS, V110, DOI [10.1160/TH13-10-0886, DOI 10.1160/TH13-10-0886]; Jaff MR, 2011, CIRCULATION, V123, P1788, DOI 10.1161/CIR.0b013e318214914f; Jaffer FA, 2002, ARTERIOSCL THROM VAS, V22, P1929, DOI 10.1161/01.ATV.0000033089.56970.2D; Jaffer FA, 2004, CIRCULATION, V110, P170, DOI 10.1161/01.CIR.0000134484.11052.44; Jain MK, 2005, NAT REV DRUG DISCOV, V4, P977, DOI 10.1038/nrd1901; Kahn SR, 2008, J THROMB HAEMOST, V6, P1105, DOI 10.1111/j.1538-7836.2008.03002.x; Kahn SR, 2011, THROMB RES, V127, pS89, DOI 10.1016/S0049-3848(11)70024-X; Kearon C, 2012, CHEST, V141, pE419S, DOI 10.1378/chest.11-2301; Kircher MF, 2008, CIRCULATION, V117, P388, DOI 10.1161/CIRCULATIONAHA.107.719765; Koopman K, 2009, THROMB RES, V124, P185, DOI 10.1016/j.thromres.2008.12.032; Mackman N, 2004, THROMB HAEMOSTASIS, V92, P440, DOI 10.1160/TH04-07-0414; Masamura K, 2003, ARTERIOSCL THROM VAS, V23, P512, DOI 10.1161/01.ATV.0000060461.64771.F0; Matsuno H, 2002, THROMB HAEMOSTASIS, V87, P98; Ni R, 2012, ARTERIOSCL THROM VAS, V32, P2609, DOI 10.1161/ATVBAHA.112.300090; Nosaka M, 2011, J CLIN INVEST, V121, P2911, DOI 10.1172/JCI40782; Obi AT, JOURNAL OF VASCULAR, V2; Owens AP, 2012, J CLIN INVEST, V122, P558, DOI 10.1172/JCI58969; Patterson KA, 2013, THROMB RES, V131, P268, DOI 10.1016/j.thromres.2012.12.006; Pignatelli P, 2012, CIRCULATION, V126, P92, DOI 10.1161/CIRCULATIONAHA.112.095554; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Quartermain D, 2007, NEUROL RES, V29, P469, DOI 10.1179/016164107X164102; Rahimi K, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001310; Ripplinger CM, 2012, ARTERIOSCL THROM VAS, V32, P2616, DOI 10.1161/ATVBAHA.112.251983; Rodriguez AL, 2012, J THROMB THROMBOLYS, V33, P371, DOI 10.1007/s11239-012-0687-9; Saha P, 2011, ARTERIOSCL THROM VAS, V31, P506, DOI 10.1161/ATVBAHA.110.213405; Sen-Banerjee S, 2005, CIRCULATION, V112, P720, DOI 10.1161/CIRCULATIONAHA.104.525774; Sood V, 2010, THROMB HAEMOSTASIS, V104, P1174, DOI 10.1160/TH10-03-0184; Spiezia L, 2008, BLOOD COAGUL FIBRIN, V19, P355, DOI 10.1097/MBC.0b013e328309044b; Taqueti VR, 2013, INTEGR BIOL-UK, V5, P278, DOI 10.1039/c2ib20194a; Thorson CM, 2012, CRIT CARE MED, V40, P2967, DOI 10.1097/CCM.0b013e31825bcb60; Toth O, 2006, THROMB HAEMOSTASIS, V96, P781, DOI 10.1160/TH06-05-0242; Van Dongen CJJ, 2005, J THROMB HAEMOST, V3, P939; Varma MR, 2003, J VASC SURG, V38, P1090, DOI 10.1016/S0741-5214(03)00431-2; Veilleux I, 2008, IEEE J SEL TOP QUANT, V14, P10, DOI 10.1109/JSTQE.2007.912751; Violi F, 2013, CIRCULATION, V127, P251, DOI 10.1161/CIRCULATIONAHA.112.145334; von Bruhl ML, 2012, J EXP MED, V209, P819, DOI 10.1084/jem.20112322	62	40	40	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0116621	10.1371/journal.pone.0116621	http://dx.doi.org/10.1371/journal.pone.0116621			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680183	Green Published, gold, Green Submitted			2022-12-26	WOS:000350682600027
J	Seok, J				Seok, Junhee			Evidence-Based Translation for the Genomic Responses of Murine Models for the Study of Human Immunity	PLOS ONE			English	Article							GENE-EXPRESSION; ANIMAL-MODELS; HUMAN-DISEASE; MOUSE MODELS	Murine models are an essential tool to study human immune responses and related diseases. However, the use of traditional murine models has been challenged by recent systemic surveys that show discordance between human and model immune responses in their gene expression. This is a significant problem in translational biomedical research for human immunity. Here, we describe evidence-based translation (EBT) to improve the analysis of genomic responses of murine models in the translation to human immune responses. Based on evidences from prior experiments, EBT introduces pseudo variances, penalizes gene expression changes in a model experiment, and finally detects false positive translations of model genomic responses that poorly correlate with human responses. Demonstrated over multiple data sets, EBT significantly improves the agreement of overall responses (up to 56%), experiment-specific responses (up to 143%), and enriched biological contexts (up to 100%) between human and model systems. In addition, we provide the category of genes specifically benefiting from EBT and the factors affecting the performance of EBT. The overall result indicates the usefulness of the proposed computational translation in biomedical research for human immunity using murine models.	Korea Univ, Sch Elect Engn, Seoul, South Korea	Korea University	Seok, J (corresponding author), Korea Univ, Sch Elect Engn, Seoul, South Korea.	jseok14@korea.ac.kr			National Research Foundation of Korea(NRF) - Korea government(MEST) [NRF-2014R1A1A2A16050527]	National Research Foundation of Korea(NRF) - Korea government(MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government)	his work was supported by the National Research Foundation of Korea(NRF) grant funded by the Korea government(MEST) (No. NRF-2014R1A1A2A16050527). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0048979; Anvar SY, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002258; Bedell MA, 1997, GENE DEV, V11, P11, DOI 10.1101/gad.11.1.11; Bushberg JT, 2012, ESSENTIAL PHYS MED I; Dankar SK, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-243; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Gelman A., 2004, BAYESIAN DATA ANAL; Hackam DG, 2006, JAMA-J AM MED ASSOC, V296, P1731, DOI 10.1001/jama.296.14.1731; Hotchkiss RS, 2010, NEW ENGL J MED, V363, P87, DOI 10.1056/NEJMcibr1004371; Hotchkiss RS, 2009, NAT MED, V15, P496, DOI 10.1038/nm0509-496; Huh D, 2010, SCIENCE, V328, P1662, DOI 10.1126/science.1188302; Ito R, 2012, CELL MOL IMMUNOL, V9, P208, DOI 10.1038/cmi.2012.2; Karr JR, 2012, CELL, V150, P389, DOI 10.1016/j.cell.2012.05.044; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Nabhan AR, 2014, J BIOMED INFORM, V47, P178, DOI 10.1016/j.jbi.2013.10.011; Rice J, 2012, NATURE, V484, pS9, DOI 10.1038/nature11102; Schroder K, 2012, P NATL ACAD SCI USA, V109, pE944, DOI 10.1073/pnas.1110156109; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Sirota M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001318; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szanto A, 2010, IMMUNITY, V33, P699, DOI 10.1016/j.immuni.2010.11.009; Takao K, 2014, P NATL ACAD SCI US; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Winslow RL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003528; Woodcock J, 2008, ANNU REV MED, V59, P1, DOI 10.1146/annurev.med.59.090506.155819	28	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0118017	10.1371/journal.pone.0118017	http://dx.doi.org/10.1371/journal.pone.0118017			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680113	gold, Green Submitted, Green Published			2022-12-26	WOS:000350682600103
J	Yoshimatsu, G; Sakata, N; Tsuchiya, H; Minowa, T; Takemura, T; Morita, H; Hata, T; Fukase, M; Aoki, T; Ishida, M; Motoi, F; Naitoh, T; Katayose, Y; Egawa, S; Unno, M				Yoshimatsu, Gumpei; Sakata, Naoaki; Tsuchiya, Haruyuki; Minowa, Takashi; Takemura, Taro; Morita, Hiromi; Hata, Tatsuo; Fukase, Masahiko; Aoki, Takeshi; Ishida, Masaharu; Motoi, Fuyuhiko; Naitoh, Takeshi; Katayose, Yu; Egawa, Shinichi; Unno, Michiaki			The Co-Transplantation of Bone Marrow Derived Mesenchymal Stem Cells Reduced Inflammation in Intramuscular Islet Transplantation	PLOS ONE			English	Article							SEVERE ACUTE-PANCREATITIS; GRAFT-SURVIVAL; PORTAL-VEIN; RAT ISLETS; LIVER; MODEL; LIPOTOXICITY	Aims/Hypothesis Although the muscle is one of the preferable transplant sites in islet transplantation, its transplant efficacy is poor. Here we attempted to determine whether an intramuscular co-transplantation of mesenchymal stem cells (MSCs) could improve the outcome. Methods We co-cultured murine islets with MSCs and then analyzed the morphological changes, viability, insulin-releasing function (represented by the stimulation index), and gene expression of the islets. We also transplanted 500 islets intramuscularly with or without 5 x 10(5) MSCs to diabetic mice and measured their blood glucose level, the glucose changes in an intraperitoneal glucose tolerance test, and the plasma IL-6 level. Inflammation, apoptosis, and neovascularization in the transplantation site were evaluated histologically. Results The destruction of islets tended to be prevented by co-culture with MSCs. The stimulation index was significantly higher in islets co-cultured with MSCs (1.78 +/- 0.59 vs. 7.08 +/- 2.53; p = 0.0025). In terms of gene expression, Sult1c2, Gstm1, and Rab37 were significantly upregulated in islets co-cultured with MSCs. Although MSCs were effective in the in vitro assays, they were only partially effective in facilitating intramuscular islet transplantation. Co-transplanted MSCs prevented an early inflammatory reaction from the islets (plasma IL-6; p = 0.0002, neutrophil infiltration; p = 0.016 inflammatory area; p = 0.021), but could not promote neovascularization in the muscle, resulting in the failure of many intramuscular transplanted islets to engraft. Conclusions In conclusion, co-culturing and co-transplanting MSCs is potentially useful in islet transplantation, especially in terms of anti-inflammation, but further augmentation for an anti-apoptosis effect and neovascularization is necessary.	[Yoshimatsu, Gumpei; Sakata, Naoaki; Tsuchiya, Haruyuki; Hata, Tatsuo; Fukase, Masahiko; Aoki, Takeshi; Ishida, Masaharu; Motoi, Fuyuhiko; Naitoh, Takeshi; Katayose, Yu; Unno, Michiaki] Tohoku Univ, Grad Sch Med, Dept Surg, Sendai, Miyagi 980, Japan; [Minowa, Takashi; Takemura, Taro; Morita, Hiromi] Natl Inst Mat Sci, Nanotechnol Innovat Stn, Tsukuba, Ibaraki, Japan; [Katayose, Yu] Tohoku Univ Hosp, Div Integrated Surg & Oncol, Sendai, Miyagi, Japan; [Egawa, Shinichi] Tohoku Univ, Div Int Cooperat Disaster Med, Sendai, Miyagi 980, Japan	Tohoku University; National Institute for Materials Science; Tohoku University; Tohoku University	Sakata, N (corresponding author), Tohoku Univ, Grad Sch Med, Dept Surg, Sendai, Miyagi 980, Japan.	n-sakata@surg1.med.tohoku.ac.jp	Naitoh, Takeshi/K-1693-2014; Unno, Michiaki/A-8633-2010; Unno, Michiaki/AAX-5246-2020; Sakata, Naoaki/H-4738-2019; Egawa, Shinichi/S-4055-2019	Naitoh, Takeshi/0000-0003-4169-6334; Unno, Michiaki/0000-0002-2145-6416; Unno, Michiaki/0000-0002-2145-6416; Sakata, Naoaki/0000-0002-3495-4270; Egawa, Shinichi/0000-0002-1115-4932; Minowa, Takashi/0000-0003-0046-5230	Ministry of Education, Culture, Sports, Science, and Technology of Japan [22390253, 22390252]; Challenging Exploratory Research [24659582]; Gonryo Medical Foundation; Suzuken Memorial Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Challenging Exploratory Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Gonryo Medical Foundation; Suzuken Memorial Foundation	This study was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (B: 22390253 (SE); B: 22390252 to YK); Challenging Exploratory Research: 24659582 (to NS), the Gonryo Medical Foundation, and the Suzuken Memorial Foundation (to NS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augello A, 2007, ARTHRITIS RHEUM-US, V56, P1175, DOI 10.1002/art.22511; Beattie GM, 2000, CELL TRANSPLANT, V9, P431, DOI 10.1177/096368970000900314; Bennet W, 2000, UPSALA J MED SCI, V105, P125, DOI 10.1517/03009734000000059; Bottino R, 1998, DIABETES, V47, P316, DOI 10.2337/diabetes.47.3.316; Brunner Y, 2007, MOL CELL PROTEOMICS, V6, P1007, DOI 10.1074/mcp.M600443-MCP200; Brunt Keith R., 2007, V139, P197; Dadbinpour A, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-48; Fiorina P, 2011, ENDOCR REV, V32, P725, DOI 10.1210/er.2011-0008; Fiorina P, 2009, J IMMUNOL, V183, P993, DOI 10.4049/jimmunol.0900803; Florina P, 2007, ENDOCRIN METAB CLIN, V36, P999, DOI 10.1016/j.ecl.2007.07.004; GOTOH M, 1985, TRANSPLANTATION, V40, P437, DOI 10.1097/00007890-198510000-00018; Griscelli F, 2012, AM J PATHOL, V180, P2084, DOI 10.1016/j.ajpath.2012.01.011; Hematti P, 2013, TRANSPLANT REV-ORLAN, V27, P21, DOI 10.1016/j.trre.2012.11.003; Hovatta O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010263; Ishiyama K, 2011, TRANSPLANTATION, V91, P952, DOI 10.1097/TP.0b013e3182139dc1; Ito T, 2010, TRANSPLANTATION, V89, P1438, DOI 10.1097/TP.0b013e3181db09c4; Kawahara T, 2011, AM J TRANSPLANT, V11, P2700, DOI 10.1111/j.1600-6143.2011.03717.x; KEMP CB, 1973, NATURE, V244, P447, DOI 10.1038/244447a0; Kim HI, 2010, J KOREAN MED SCI, V25, P203, DOI 10.3346/jkms.2010.25.2.203; Kin T, 2003, AM J TRANSPLANT, V3, P281, DOI 10.1034/j.1600-6143.2003.00049.x; Lee Y, 2007, DIABETES, V56, P2295, DOI 10.2337/db07-0460; Leitao CB, 2010, DIABETES CARE, V33, P658, DOI 10.2337/dc09-1387; Ljubicic S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068255; Lund T, 2010, J SURG RES, V160, P145, DOI 10.1016/j.jss.2008.11.009; Maffi P, 2013, DIABETES, V62, P3523, DOI 10.2337/db13-0465; Meng HB, 2013, INT J CLIN EXP PATHO, V6, P2703; Miura M, 2006, STEM CELLS, V24, P1095, DOI 10.1634/stemcells.2005-0403; Mojibian M, 2013, DIABETOLOGIA, V56, P2213, DOI 10.1007/s00125-013-3004-z; Park KS, 2010, TRANSPLANTATION, V89, P509, DOI 10.1097/TP.0b013e3181c7dc99; Paul P, 2012, ANAL BIOANAL CHEM, V403, P1491, DOI 10.1007/s00216-012-5944-4; Petyuk VA, 2008, J PROTEOME RES, V7, P3114, DOI 10.1021/pr800205b; Rajab A, 2010, CURR DIABETES REP, V10, P332, DOI 10.1007/s11892-010-0130-6; Sakata N, 2009, TRANSPL P, V41, P346, DOI 10.1016/j.transproceed.2008.08.155; Sakata N, 2008, PANCREAS, V36, P417, DOI 10.1097/MPA.0b013e31815ccad2; Sakata N, 2014, DIABETES-METAB RES, V30, P1, DOI 10.1002/dmrr.2463; Sakata N, 2013, TRANSPLANTATION, V96, pE38, DOI 10.1097/TP.0b013e3182a01333; Sakata N, 2011, WORLD J GASTROENTERO, V17, P5150, DOI 10.3748/wjg.v17.i47.5150; Sakata N, 2010, TRANSPLANTATION, V89, P686, DOI 10.1097/TP.0b013e3181cb3e8d; Sakata N, 2009, TRANSPLANTATION, V87, P825, DOI 10.1097/TP.0b013e318199c7d2; Sakata N, 2009, ISLETS, V1, P26, DOI 10.4161/isl.1.1.8563; Stagner JI, 2007, J PANCREAS, V8, P628; Svensson J, 2011, CELL TRANSPLANT, V20, P783, DOI 10.3727/096368910X536527; Tu XH, 2012, WORLD J GASTROENTERO, V18, P2270, DOI 10.3748/wjg.v18.i18.2270; Yoshimatsu G, 2013, TRANSPL P, V45, P1875, DOI 10.1016/j.transproceed.2013.01.043	44	34	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117561	10.1371/journal.pone.0117561	http://dx.doi.org/10.1371/journal.pone.0117561			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679812	Green Submitted, Green Published, gold			2022-12-26	WOS:000350682600073
J	Zhang, J; Fan, SK; Du, XM; Yang, JC; Wang, WY; Hou, H				Zhang, Juan; Fan, Shukai; Du, Xiaoming; Yang, Juncheng; Wang, Wenyan; Hou, Hong			Accumulation, Allocation, and Risk Assessment of Polycyclic Aromatic Hydrocarbons (PAHs) in Soil-Brassica chinensis System	PLOS ONE			English	Article							FRASER-RIVER BASIN; SEDIMENTS; VEGETABLES; CHROMATOGRAPHY; VEGETATION; STRAIT; CROPS; CHINA; COAL	Farmland soil and leafy vegetables accumulate more polycyclic aromatic hydrocarbons (PAHs) in suburban sites. In this study, 13 sampling areas were selected from vegetable fields in the outskirts of Xi'an, the largest city in northwestern China. The similarity of PAH composition in soil and vegetation was investigated through principal components analysis and redundancy analysis (RDA), rather than discrimination of PAH congeners from various sources. The toxic equivalent quantity of PAHs in soil ranged from 7 to 202 mu g/kg d.w., with an average of 41 mu g/kg d.w., which exceeded the agricultural/horticultural soil acceptance criteria for New Zealand. However, the cancer risk level posed by combined direct ingestion, dermal contact, inhalation of soil particles, and inhalation of surface soil vapor met the rigorous international criteria (1x10(-6)). The concentration of total PAHs was (1052 +/- 73) mu g/kg d.w. in vegetation (mean +/- standard error). The cancer risks posed by ingestion of vegetation ranged from 2x10(-5) to 2x10(-4) with an average of 1.66x10(-4), which was higher than international excess lifetime risk limits for carcinogens (1x10(-4)). The geochemical indices indicated that the PAHs in soil and vegetables were mainly from vehicle and crude oil combustion. Both the total PAHs in vegetation and bioconcentration factor for total PAHs (the ratio of total PAHs in vegetation to total PAHs in soil) increased with increasing pH as well as decreasing sand in soil. The total variation in distribution of PAHs in vegetation explained by those in soil reached 98% in RDA, which was statistically significant based on Monte Carlo permutation. Common pollution source and notable effects of soil contamination on vegetation would result in highly similar distribution of PAHs in soil and vegetation.	[Zhang, Juan; Du, Xiaoming; Wang, Wenyan; Hou, Hong] Chinese Res Inst Environm Sci, State Key Lab Environm Criteria & Risk Assessment, Beijing, Peoples R China; [Zhang, Juan] Univ Sci & Technol Beijing, Sch Met & Ecol Engn, Beijing 100083, Peoples R China; [Fan, Shukai] Beijing Gen Res Inst Min & Met, Inst Environm Engn, Beijing, Peoples R China; [Yang, Juncheng] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Beijing 100193, Peoples R China	Chinese Research Academy of Environmental Sciences; University of Science & Technology Beijing; Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS	Hou, H (corresponding author), Chinese Res Inst Environm Sci, State Key Lab Environm Criteria & Risk Assessment, Beijing, Peoples R China.	houhong@craes.org.cn	Zhang, Juan/E-5475-2016	Zhang, Juan/0000-0002-9405-9024	Postdoctoral Science Foundation of China [2013M530686]; National Basic Research Program of China [2013CB127406]; Opening fund of State Key Laboratory of Environmental Criteria and Risk Assessment [SKLECRA2013OFP04]	Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation); National Basic Research Program of China(National Basic Research Program of China); Opening fund of State Key Laboratory of Environmental Criteria and Risk Assessment	This work was sponsored by the Postdoctoral Science Foundation of China (No. 2013M530686), the National Basic Research Program of China (2013CB127406), and the Opening fund of State Key Laboratory of Environmental Criteria and Risk Assessment (No. SKLECRA2013OFP04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai C, 2012, J ENVIRON MONITOR, V14, P3111, DOI 10.1039/c2em30554b; Carlon C., 2007, 22805EN EUR JOINT RE; Cavanagh JA, 2006, COMP SOIL GUIDELINE, P1; CCME, CAN SOIL QUAL GUID C, P235; Chin C.R., 2014, GUIDELINES RISK ASSE, P1; Connor J.A., 2007, SOFTWARE GUIDANCE MA, P1; Cornelissen G, 2005, ENVIRON SCI TECHNOL, V39, P6881, DOI 10.1021/es050191b; Dionex, 2007, ENVIRON CHEM, V27, P721; Doong RA, 2004, WATER RES, V38, P1733, DOI 10.1016/j.watres.2003.12.042; Grimalt JO, 2004, ENVIRON POLLUT, V131, P13, DOI 10.1016/j.envpol.2004.02.024; [郭伟 GUO Wei], 2007, [环境科学学报, Acta Scientiae Circumstantiae], V27, P824; He FP, 2009, J ENVIRON SCI-CHINA, V21, P675, DOI 10.1016/S1001-0742(08)62323-2; He LL, 2008, ENVIRON POLLUT, V156, P769, DOI 10.1016/j.envpol.2008.06.003; Khan S, 2012, J SOIL SEDIMENT, V12, P178, DOI 10.1007/s11368-011-0427-3; Kipopoulou AM, 1999, ENVIRON POLLUT, V106, P369, DOI 10.1016/S0269-7491(99)00107-4; Leps J, 2003, MULTIVARIATE ANAL EC; Ling WT, 2009, SOIL BIOL BIOCHEM, V41, P2187, DOI 10.1016/j.soilbio.2009.08.003; Liu JJ, 2012, J ENVIRON MONITOR, V14, P2634, DOI 10.1039/c2em30433c; Liu Y, 2008, ENVIRON POLLUT, V154, P298, DOI 10.1016/j.envpol.2007.10.020; Lu R, 2000, ANAL METHODS AGROCHE; [梅凡民 MEI Fanmin], 2008, [水土保持研究, Research of Soil and Water Conservation], V15, P223; Nadal M, 2004, ENVIRON POLLUT, V132, P1, DOI 10.1016/j.envpol.2004.04.003; NISBET ICT, 1992, REGUL TOXICOL PHARM, V16, P290, DOI 10.1016/0273-2300(92)90009-X; Northcott GL, 2001, ENVIRON SCI TECHNOL, V35, P1103, DOI 10.1021/es000071y; Okuda T, 2010, SCI TOTAL ENVIRON, V408, P1909, DOI 10.1016/j.scitotenv.2010.01.040; Orecchio S, 2009, J HAZARD MATER, V164, P876, DOI 10.1016/j.jhazmat.2008.08.083; Oyo-Ita OE, 2013, ENVIRON GEOCHEM HLTH, V35, P185, DOI 10.1007/s10653-012-9475-x; Rattan RK, 2005, AGR ECOSYST ENVIRON, V109, P310, DOI 10.1016/j.agee.2005.02.025; Richter BE, 2000, J CHROMATOGR A, V874, P217, DOI 10.1016/S0021-9673(00)00073-X; Rocher V, 2004, SCI TOTAL ENVIRON, V323, P107, DOI 10.1016/j.scitotenv.2003.10.010; Sany SBT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094907; Tao S, 2004, SCI TOTAL ENVIRON, V320, P11, DOI 10.1016/S0048-9697(03)00453-4; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; US EPA, 2007, 3051A USEPA, V3, P1, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CB09781107415324.004]; USEPA, 2010, REG NEW ACT INGR AM, P1; USEPA (United States Environmental Protection Agency), 2007, TECHNICAL RESOURCE D, P1; Vacha R, 2010, PLANT SOIL ENVIRON, V56, P434, DOI 10.17221/7/2010-PSE; Van de Weghe H, 2006, J CHROMATOGR A, V1137, P91, DOI 10.1016/j.chroma.2006.10.014; Voutsa D, 1998, SCI TOTAL ENVIRON, V218, P203, DOI 10.1016/S0048-9697(98)00206-X; Wagrowski DM, 1997, ENVIRON SCI TECHNOL, V31, P279, DOI 10.1021/es960419i; Wang XC, 2006, MAR POLLUT BULL, V52, P129, DOI 10.1016/j.marpolbul.2005.08.010; Wang Y, 2012, SCI TOTAL ENVIRON, V439, P187, DOI 10.1016/j.scitotenv.2012.08.018; WILD SR, 1992, ENVIRON POLLUT, V76, P25, DOI 10.1016/0269-7491(92)90113-O; WILD SR, 1994, WASTE MANAGE RES, V12, P49, DOI 10.1177/0734242X9401200106; You SJ, 1999, SCI TOTAL ENVIRON, V227, P155, DOI 10.1016/S0048-9697(99)00024-8; Yunker MB, 1999, SCI TOTAL ENVIRON, V225, P181, DOI 10.1016/S0048-9697(98)00362-3; Yunker MB, 2002, ORG GEOCHEM, V33, P489, DOI 10.1016/S0146-6380(02)00002-5; Yunker MB, 2003, ORG GEOCHEM, V34, P1429, DOI 10.1016/S0146-6380(03)00136-0; Zhai F. Y., 2008, LONGITUDINAL STUDY C; Zhang J, 2013, SCI TOTAL ENVIRON, V463, P1, DOI 10.1016/j.scitotenv.2013.05.066	50	20	23	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0115863	10.1371/journal.pone.0115863	http://dx.doi.org/10.1371/journal.pone.0115863			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679782	Green Submitted, Green Published, gold			2022-12-26	WOS:000350682600010
J	Dang, XT; Eliceiri, BP; Baird, A; Costantini, TW				Dang, Xitong; Eliceiri, Brian P.; Baird, Andrew; Costantini, Todd W.			CHRFAM7A: a human-specific alpha 7-nicotinic acetylcholine receptor gene shows differential responsiveness of human intestinal epithelial cells to LPS	FASEB JOURNAL			English	Article						CHRNA7; alpha 7nAChR; dup-alpha 7nAChR; human-specific genes	PERIPHERAL-BLOOD LYMPHOCYTES; NEURONAL NICOTINIC RECEPTORS; ENTERIC GLIA CELLS; KAPPA-B EXPRESSION; BIPOLAR DISORDER; PARTIAL DUPLICATION; LINKAGE DISEQUILIBRIUM; IMMUNE HOMEOSTASIS; CHROMOSOME 15Q14; TOBACCO TOXICITY	The human genome contains a unique, distinct, and human-specific alpha 7-nicotinic acetylcholine receptor (alpha 7nAChR) gene [CHRNA7 (gene-encoding alpha 7-nicotinic acetylcholine receptor)] called CHRFAM7A (gene-encoding dup-alpha 7-nicotinic acetylcholine receptor) on a locus of chromosome 15 associated with mental illness, including schizophrenia. Located 59 upstream from the "wild-type" CHRNA7 gene that is found in other vertebrates, we demonstrate CHRFAM7A expression in a broad range of epithelial cells and sequenced the CHRFAM7A transcript found in normal human fetal small intestine epithelial (FHs) cells to prove its identity. We then compared its expression to CHRNA7 in 11 gut epithelial cell lines, showed that there is a differential response to LPS when compared to CHRNA7, and characterized the CHRFAM7A promoter. We report that both CHRFAM7A and CHRNA7 gene expression are widely distributed in human epithelial cell lines but that the levels of CHRFAM7A gene expression vary up to 5000-fold between different gut epithelial cells. A 3-hour treatment of epithelial cells with 100 ng/ml LPS increased CHRFAM7A gene expression by almost 1000-fold but had little effect on CHRNA7 gene expression. Mapping the regulatory elements responsible for CHRFAM7A gene expression identifies a 1 kb sequence in the UTR of the CHRFAM7A gene that ismodulated by LPS. Taken together, these data establish the presence, identity, and differential regulation of the human-specific CHRFAM7A gene in human gut epithelial cells. In light of the fact that CHRFAM7A expression is reported to modulate ligand binding to, and alter the activity of, the wild-type alpha 7nAChR ligand-gated pentameric ion channel, the findings point to the existence of a species-specific alpha 7nAChR response that might regulate gut epithelial function in a human-specific fashion.	[Dang, Xitong; Eliceiri, Brian P.; Baird, Andrew; Costantini, Todd W.] Univ Calif San Diego, San Diego Hlth Sci, Dept Surg, Div Trauma Surg Crit Care Burns & Acute Care Surg, San Diego, CA 92103 USA; [Dang, Xitong] Luzhou Med Coll, Cardiovasc Res Ctr, Luzhou, Sichuan, Peoples R China	University of California System; University of California San Diego; Southwest Medical University	Baird, A (corresponding author), Univ Calif San Diego, San Diego Hlth Sci, Dept Surg, Div Trauma Surg Crit Care Burns & Acute Care Surg, 212 Dickinson St,MC 8236, San Diego, CA 92103 USA.	anbaird@ucsd.edu		Baird, Andrew/0000-0003-0027-9905; Costantini, Todd/0000-0002-0215-5327; Eliceiri, Brian/0000-0003-1811-1916	NATIONAL CANCER INSTITUTE [R01CA170140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM078421] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA170140] Funding Source: Medline; NIGMS NIH HHS [P20 GM078421] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abbruscato TJ, 2004, J PHARMACOL EXP THER, V310, P459, DOI 10.1124/jpet.104.066274; Araud T, 2011, BIOCHEM PHARMACOL, V82, P904, DOI 10.1016/j.bcp.2011.06.018; Arredondo J, 2005, AM J PATHOL, V166, P597, DOI 10.1016/S0002-9440(10)62281-X; Arredondo J, 2007, BIOCHEM PHARMACOL, V74, P1315, DOI 10.1016/j.bcp.2007.06.026; Bakanidze George, 2013, Front Psychiatry, V4, P133, DOI 10.3389/fpsyt.2013.00133; Benfante R, 2011, J NEUROIMMUNOL, V230, P74, DOI 10.1016/j.jneuroim.2010.09.008; Canastar A, 2012, J MOL NEUROSCI, V47, P389, DOI 10.1007/s12031-011-9663-7; Carlisle DL, 2004, RESP RES, V5, DOI 10.1186/1465-9921-5-27; Casey JP, 2012, HUM GENET, V131, P565, DOI 10.1007/s00439-011-1094-6; Catassi A, 2008, MUTAT RES-REV MUTAT, V659, P221, DOI 10.1016/j.mrrev.2008.04.002; Chan KYY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036977; CHAN KY, 2012, PLOS ONE, P7; Cheadle GA, 2014, SURG INFECT, V15, P387, DOI 10.1089/sur.2013.103; Cheadle GA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069042; Chen RJ, 2008, TOXICOL SCI, V104, P283, DOI 10.1093/toxsci/kfn086; Chernyavsky AI, 2010, AM J PHYSIOL-CELL PH, V299, pC903, DOI 10.1152/ajpcell.00216.2010; Conrad B, 2007, ANNU REV GENOM HUM G, V8, P17, DOI 10.1146/annurev.genom.8.021307.110233; Conti-Fine BM, 2000, EUR J PHARMACOL, V393, P279, DOI 10.1016/S0014-2999(00)00036-4; Cooper David N., 2011, Human Genomics, V5, P99; Costantini TW, 2015, J LEUKOCYTE BIOL, V97, P247, DOI 10.1189/jlb.4RU0814-381R; Costantini TW, 2012, AM J PATHOL, V181, P478, DOI 10.1016/j.ajpath.2012.04.005; Costantini TW, 2010, AM J PHYSIOL-GASTR L, V299, pG1308, DOI 10.1152/ajpgi.00156.2010; Costantini TW, 2010, J TRAUMA, V68, P1349, DOI 10.1097/TA.0b013e3181dccea0; Costantini TW, 2009, LIFE SCI, V84, P18, DOI 10.1016/j.lfs.2008.10.007; Dalton SO, 2006, BRIT J CANCER, V95, P934, DOI 10.1038/sj.bjc.6603259; Dasgupta P, 2006, P NATL ACAD SCI USA, V103, P6332, DOI 10.1073/pnas.0509313103; Dasgupta P, 2006, CELL CYCLE, V5, P2324, DOI 10.4161/cc.5.20.3366; De Luca V, 2006, ACTA PSYCHIAT SCAND, V114, P211, DOI 10.1111/j.1600-0447.2006.00785.x; de Lucas-Cerrillo AM, 2011, J BIOL CHEM, V286, P594, DOI 10.1074/jbc.M110.180067; Egleton RD, 2008, TRENDS PHARMACOL SCI, V29, P151, DOI 10.1016/j.tips.2007.12.006; Egleton RD, 2009, PHARMACOL THERAPEUT, V121, P205, DOI 10.1016/j.pharmthera.2008.10.007; Fadgyas-Stanculete Mihaela, 2014, J Mol Psychiatry, V2, P4, DOI 10.1186/2049-9256-2-4; Flomen RH, 2006, AM J MED GENET B, V141B, P571, DOI 10.1002/ajmg.b.30306; Freedman R, 2006, GENES BRAIN BEHAV, V5, P14, DOI 10.1111/j.1601-183X.2006.00190.x; Freedman R, 2001, AM J MED GENET, V105, P20, DOI 10.1002/1096-8628(20010108)105:1<20::AID-AJMG1047>3.3.CO;2-3; Gal G, 2012, SCHIZOPHR RES, V139, P189, DOI 10.1016/j.schres.2012.04.018; Garakani Amir, 2003, Am J Ther, V10, P61, DOI 10.1097/00045391-200301000-00014; Gault J, 1998, GENOMICS, V52, P173, DOI 10.1006/geno.1998.5363; Gotti C, 2004, PROG NEUROBIOL, V74, P363, DOI 10.1016/j.pneurobio.2004.09.006; Guo JJ, 2008, EVID-BASED MENT HEAL, V11, P93, DOI 10.1136/ebmh.11.3.93; Hawiger J, 2001, IMMUNOL RES, V23, P99, DOI 10.1385/IR:23:2-3:099; Hawkins BT, 2005, AM J PHYSIOL-HEART C, V289, pH212, DOI 10.1152/ajpheart.01210.2004; Hawkins BT, 2004, BRAIN RES, V1027, P48, DOI 10.1016/j.brainres.2004.08.043; Heeschen C, 2002, J CLIN INVEST, V110, P527, DOI 10.1172/JCI200214676; Hippisley-Cox J, 2007, ARCH GEN PSYCHIAT, V64, P1368, DOI 10.1001/archpsyc.64.12.1368; Hong CJ, 2004, NEUROSCI LETT, V355, P69, DOI 10.1016/j.neulet.2003.10.043; Horie M, 2010, NATURE, V463, P84, DOI 10.1038/nature08695; Iwata Y, 2007, NEUROSCI RES, V57, P194, DOI 10.1016/j.neures.2006.10.002; Khalturin K, 2009, TRENDS GENET, V25, P404, DOI 10.1016/j.tig.2009.07.006; Kim HL, 2010, PHILOS T R SOC B, V365, P2451, DOI 10.1098/rstb.2010.0004; Lam DCL, 2007, CANCER RES, V67, P4638, DOI 10.1158/0008-5472.CAN-06-4628; Long M, 2003, NAT REV GENET, V4, P865, DOI 10.1038/nrg1204; Long MY, 2013, ANNU REV GENET, V47, P307, DOI 10.1146/annurev-genet-111212-133301; Lopez-Diez R, 2013, GENOME BIOL EVOL, V5, P2420, DOI 10.1093/gbe/evt188; Maouche K, 2013, P NATL ACAD SCI USA, V110, P4099, DOI 10.1073/pnas.1216939110; Maouche K, 2009, AM J PATHOL, V175, P1868, DOI 10.2353/ajpath.2009.090212; Morishita K, 2014, J TRAUMA ACUTE CARE, V76, P610, DOI 10.1097/TA.0000000000000137; Papke RL, 1996, NEUROSCI LETT, V213, P201; Pasparakis M, 2008, MUCOSAL IMMUNOL, V1, pS54, DOI 10.1038/mi.2008.53; Perl O, 2006, NEUROPSYCHOBIOLOGY, V53, P88, DOI 10.1159/000091725; Peterson LW, 2014, NAT REV IMMUNOL, V14, P141, DOI 10.1038/nri3608; Pillai S, 2012, CURR DRUG TARGETS, V13, P671, DOI 10.2174/138945012800398847; Riley B, 2002, GENOMICS, V79, P197, DOI 10.1006/geno.2002.6694; Savidge TC, 2006, PEDIATR RES, V59, P89, DOI 10.1203/01.pdr.0000195101.74184.e3; SCHULLER HM, 1989, BIOCHEM PHARMACOL, V38, P3439, DOI 10.1016/0006-2952(89)90112-3; Severance EG, 2009, J NEURAL TRANSM, V116, P213, DOI 10.1007/s00702-008-0164-y; Sharma G, 2002, J NEUROBIOL, V53, P524, DOI 10.1002/neu.10114; Sinkus ML, 2009, BRAIN RES, V1291, P1, DOI 10.1016/j.brainres.2009.07.041; Slominski A, 2010, AM J PHYSIOL-CELL PH, V299, pC885, DOI 10.1152/ajpcell.00324.2010; Smith NGC, 2003, GENE, V318, P169, DOI 10.1016/S0378-1119(03)00772-8; Stahl PD, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.289pe59; Tautz D, 2011, NAT REV GENET, V12, P692, DOI 10.1038/nrg3053; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; Thomsen MS, 2011, BIPOLAR DISORD, V13, P701, DOI 10.1111/j.1399-5618.2011.00961.x; Tracey KJ, 2007, J CLIN INVEST, V117, P289, DOI 10.1172/JCI30555; Truyers C, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-132; Tsurutani J, 2005, CARCINOGENESIS, V26, P1182, DOI 10.1093/carcin/bgi072; van der Zanden EP, 2012, NEUROIMMUNOMODULAT, V19, P255, DOI 10.1159/000335185; Villiger Y, 2002, J NEUROIMMUNOL, V126, P86, DOI 10.1016/S0165-5728(02)00057-7; Wang Y, 2014, J BIOL CHEM, V289, P26451, DOI 10.1074/jbc.M114.582858; Wessler I, 2008, BRIT J PHARMACOL, V154, P1558, DOI 10.1038/bjp.2008.185; Wolf SE, 2010, J TRAUMA, V68, P1354; Zhu BQ, 2003, CANCER CELL, V4, P191, DOI 10.1016/S1535-6108(03)00219-8	83	22	23	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2292	2302		10.1096/fj.14-268037	http://dx.doi.org/10.1096/fj.14-268037			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	25681457	Green Published			2022-12-26	WOS:000355209500008
J	Singh, D; Gawel, D; Itsko, M; Hochkoeppler, A; Krahn, JM; London, RE; Schaaper, RM				Singh, Deepa; Gawel, Damian; Itsko, Mark; Hochkoeppler, Alejandro; Krahn, Juno M.; London, Robert E.; Schaaper, Roel M.			Structure of Escherichia coli dGTP Triphosphohydrolase A HEXAMERIC ENZYME WITH DNA EFFECTOR MOLECULES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric Regulation; Cooperativity; Crystal Structure; DNA-binding Protein; Escherichia coli (E; coli); dGTPase; Mutator Phenotype	DEOXYGUANOSINE TRIPHOSPHATE TRIPHOSPHOHYDROLASE; RESTRICTION FACTOR SAMHD1; GENE 1.2 PROTEIN; DNTP TRIPHOSPHOHYDROLASE; ALLOSTERIC ACTIVATION; INHIBITION; INSIGHT; SYSTEM; GROWTH; DOMAIN	Background: The Escherichia coli Dgt enzyme hydrolyzes the important DNA building block dGTP, but the cellular role of this activity is still unclear. Results: The enzyme is shown to be a hexameric structure containing regulatory DNA molecules. Conclusion: DNA mediates the regulation of dGTPase activity in the cell. Significance: This is the first demonstration of regulation of dNTPase by DNA. The Escherichia coli dgt gene encodes a dGTP triphosphohydrolase whose detailed role still remains to be determined. Deletion of dgt creates a mutator phenotype, indicating that the dGTPase has a fidelity role, possibly by affecting the cellular dNTP pool. In the present study, we have investigated the structure of the Dgt protein at 3.1- resolution. One of the obtained structures revealed a protein hexamer that contained two molecules of single-stranded DNA. The presence of DNA caused significant conformational changes in the enzyme, including in the catalytic site of the enzyme. Dgt preparations lacking DNA were able to bind single-stranded DNA with high affinity (K-d approximate to 50 nm). DNA binding positively affected the activity of the enzyme: dGTPase activity displayed sigmoidal (cooperative) behavior without DNA but hyperbolic (Michaelis-Menten) kinetics in its presence, consistent with a specific lowering of the apparent K-m for dGTP. A mutant Dgt enzyme was also created containing residue changes in the DNA binding cleft. This mutant enzyme, whereas still active, was incapable of DNA binding and could no longer be stimulated by addition of DNA. We also created an E. coli strain containing the mutant dgt gene on the chromosome replacing the wild-type gene. The mutant also displayed a mutator phenotype. Our results provide insight into the allosteric regulation of the enzyme and support a physiologically important role of DNA binding.	[Singh, Deepa; Itsko, Mark; Krahn, Juno M.; London, Robert E.; Schaaper, Roel M.] NIEHS, Genome Integr & Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Gawel, Damian] Ctr Postgrad Med Educ, Dept Biochem & Mol Biol, PL-01813 Warsaw, Poland; [Hochkoeppler, Alejandro] Univ Bologna, Dept Ind Chem, I-40136 Bologna, Italy	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Centre of Postgraduate Medical Education - Poland; University of Bologna	Schaaper, RM (corresponding author), POB 12233, Res Triangle Pk, NC 27709 USA.	schaaper@niehs.nih.gov	Schaaper, Roel M/E-6680-2019; Gawel, Damian/U-4218-2019; London, Robert E/F-7990-2019; Hochkoeppler, Alejandro/HGA-5916-2022	Schaaper, Roel M/0000-0003-1344-3196; Gawel, Damian/0000-0002-1270-5505; London, Robert E/0000-0001-9108-8463; 	United States Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES101905, ZIAES101905] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Drs. K. Bebenek and L. Pedersen, NIEHS, for helpful comments on the manuscript. Crystallographic data were collected at the Southeast Regional Collaborative Access Team 22-ID beam line at the Advanced Photon Source, Argonne National Laboratory. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract W-31-109-Eng-38.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amie SM, 2013, J BIOL CHEM, V288, P25001, DOI 10.1074/jbc.C113.493619; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P469, DOI 10.1016/S0968-0004(98)01293-6; BEAUCHAMP BB, 1988, P NATL ACAD SCI USA, V85, P2563, DOI 10.1073/pnas.85.8.2563; Benson RW, 2011, J MICROBIOL METH, V84, P479, DOI 10.1016/j.mimet.2010.12.020; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; COHEN SS, 1954, P NATL ACAD SCI USA, V40, P885, DOI 10.1073/pnas.40.10.885; Cowtan KD, 1999, PROG BIOPHYS MOL BIO, V72, P245, DOI 10.1016/S0079-6107(99)00008-5; CUPPLES CG, 1989, P NATL ACAD SCI USA, V86, P5345, DOI 10.1073/pnas.86.14.5345; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Franzolin E, 2013, P NATL ACAD SCI USA, V110, P14272, DOI 10.1073/pnas.1312033110; Gawel D, 2008, J BACTERIOL, V190, P6931, DOI 10.1128/JB.00935-08; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; HEYDUK T, 1990, P NATL ACAD SCI USA, V87, P1744, DOI 10.1073/pnas.87.5.1744; Hill A.V, 1910, J PHYSL, V40, piv, DOI DOI 10.1113/JPHYSIOL.1910.SP001386; HUBER HE, 1988, J BIOL CHEM, V263, P13549; Itsko M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004310; Itsko M, 2011, MOL MICROBIOL, V81, P1221, DOI 10.1111/j.1365-2958.2011.07756.x; Ji XY, 2013, NAT STRUCT MOL BIOL, V20, P1304, DOI 10.1038/nsmb.2692; Kleywegt GJ, 1997, STRUCTURE, V5, P1557, DOI 10.1016/S0969-2126(97)00305-5; Kondo N, 2004, J BIOCHEM, V136, P221, DOI 10.1093/jb/mvh115; Kondo N, 2007, ACTA CRYSTALLOGR D, V63, P230, DOI 10.1107/S0907444906049262; KORNBERG SR, 1958, J BIOL CHEM, V233, P159; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Mega R, 2009, FEBS J, V276, P3211, DOI 10.1111/j.1742-4658.2009.07035.x; MYERS JA, 1987, J BIOL CHEM, V262, P5288; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Powell RD, 2011, J BIOL CHEM, V286, P43596, DOI 10.1074/jbc.C111.317628; QUIRK S, 1989, MOL MICROBIOL, V3, P1391, DOI 10.1111/j.1365-2958.1989.tb00121.x; QUIRK S, 1990, GENE, V89, P13, DOI 10.1016/0378-1119(90)90200-B; SAITO H, 1981, J VIROL, V37, P343, DOI 10.1128/JVI.37.1.343-351.1981; SETO D, 1988, J BIOL CHEM, V263, P1494; Tungler V, 2013, J MOL MED, V91, P759, DOI 10.1007/s00109-013-0995-3; Vorontsov II, 2014, J BIOL CHEM, V289, P2815, DOI 10.1074/jbc.M113.524207; Vorontsov II, 2011, J BIOL CHEM, V286, P33158, DOI 10.1074/jbc.M111.250456; WILLIAMS KR, 1983, J BIOL CHEM, V258, P3346; WURGLER SM, 1993, J BIOL CHEM, V268, P20046; Yan JP, 2013, J BIOL CHEM, V288, P10406, DOI 10.1074/jbc.M112.443796; Zhu CF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3722	40	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10418	10429		10.1074/jbc.M115.636936	http://dx.doi.org/10.1074/jbc.M115.636936			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25694425	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000353241100042
J	Chancey, ST; Bai, XH; Kumar, N; Drabek, EF; Daugherty, SC; Colon, T; Ott, S; Sengamalay, N; Sadzewicz, L; Tallon, LJ; Fraser, CM; Tettelin, H; Stephens, DS				Chancey, Scott T.; Bai, Xianhe; Kumar, Nikhil; Drabek, Elliott F.; Daugherty, Sean C.; Colon, Thomas; Ott, Sandra; Sengamalay, Naomi; Sadzewicz, Lisa; Tallon, Luke J.; Fraser, Claire M.; Tettelin, Herve; Stephens, David S.			Transcriptional Attenuation Controls Macrolide Inducible Efflux and Resistance in Streptococcus pneumoniae and in Other Gram-Positive Bacteria Containing mef/mel (msr(D)) Elements	PLOS ONE			English	Article							MESSENGER-RNA STABILITY; BACILLUS-SUBTILIS; SECONDARY STRUCTURE; GENE-EXPRESSION; ERYTHROMYCIN; SEQUENCE; ENTEROCOCCI; PYOGENES; ERMK; LICHENIFORMIS	Macrolide resistance, emerging in Streptococcus pneumoniae and other Gram-positive bacteria, is increasingly due to efflux pumps encoded by mef/mel(msr) operons found on discrete mobile genetic elements. The regulation of mef/mel(msr) in these elements is not well understood. We identified the mef(E)/mel transcriptional start, localized the mef(E)/mel promoter, and demonstrated attenuation of transcription as a mechanism of regulation of macrolide-inducible mef-mediated macrolide resistance in S. pneumoniae. The mef(E)/mel transcriptional start site was a guanine 327 bp upstream of mef(E). Consensus pneumococcal promoter -10 (5 '-TATACT-3 ') and -35 (5 '-TTGAAC-3 ') boxes separated by 17 bp were identified 7 bp upstream of the start site. Analysis of the predicted secondary structure of the 327 5' region identified four pairs of inverted repeats R1-R8 predicted to fold into stem-loops, a small leader peptide [MTASMRLR, (Mef(E) L)] required for macrolide induction and a Rho-independent transcription terminator. RNA-seq analyses provided confirmation of transcriptional attenuation. In addition, expression of mef(E) L was also influenced by mef(E) L-dependent mRNA stability. The regulatory region 5 ' of mef(E) was highly conserved in other mef/mel(msr)-containing elements including Tn1207.1 and the 5612IQ complex in pneumococci and Tn1207.3 in Group A streptococci, indicating a regulatory mechanism common to a wide variety of Gram-positive bacteria containing mef/mel(msr) elements.	[Chancey, Scott T.; Bai, Xianhe; Stephens, David S.] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA; [Chancey, Scott T.; Bai, Xianhe; Stephens, David S.] Dept Vet Affairs Med Ctr, Labs Microbial Pathogenesis, Atlanta, GA USA; [Kumar, Nikhil; Drabek, Elliott F.; Daugherty, Sean C.; Colon, Thomas; Ott, Sandra; Sengamalay, Naomi; Sadzewicz, Lisa; Tallon, Luke J.; Fraser, Claire M.; Tettelin, Herve] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Fraser, Claire M.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Tettelin, Herve] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA	Emory University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Stephens, DS (corresponding author), Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA.	dstep01@emory.edu		Fraser, Claire/0000-0003-1462-2428	National Institutes of Health [R01 AI070829]; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HSN272200900009C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070829] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded in part with an R01 grant from the National Institutes of Health (#R01 AI070829 (to DSS) and with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services under contract number HHSN272200900009C. The funders had no role in study design, data collection and analysis, or preparation of the manuscript, but signed off on the publication after the authors sent them a copy for review.	Ambrose KD, 2005, ANTIMICROB AGENTS CH, V49, P4203, DOI 10.1128/AAC.49.10.4203-4209.2005; BECHHOFER DH, 1987, P NATL ACAD SCI USA, V84, P498, DOI 10.1073/pnas.84.2.498; BECHHOFER DH, 1989, J BACTERIOL, V171, P5803, DOI 10.1128/jb.171.11.5803-5811.1989; Chancey ST, 2012, FUTURE MICROBIOL, V7, P959, DOI [10.2217/fmb.12.63, 10.2217/FMB.12.63]; Chancey ST, 2011, ANTIMICROB AGENTS CH, V55, P3413, DOI 10.1128/AAC.00060-11; Chancey ST, 2008, MACROLIDE EFFLUX SYS; Choi SS, 1997, J BACTERIOL, V179, P2065, DOI 10.1128/jb.179.6.2065-2067.1997; Darty K, 2009, BIOINFORMATICS, V25, P1974, DOI 10.1093/bioinformatics/btp250; de Vries Lisbeth E, 2012, Mob Genet Elements, V2, P72; Drider D, 2002, MOL MICROBIOL, V43, P1319, DOI 10.1046/j.1365-2958.2002.02830.x; DUNNY GM, 1991, APPL ENVIRON MICROB, V57, P1194, DOI 10.1128/AEM.57.4.1194-1201.1991; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Farley Monica M, 2002, J Med Assoc Ga, V91, P20; FROHMAN MA, 1993, METHOD ENZYMOL, V218, P340; Gay K, 2001, J INFECT DIS, V184, P56, DOI 10.1086/321001; GRYCZAN T, 1984, MOL GEN GENET, V194, P349, DOI 10.1007/BF00425543; Gupta P, 2013, MOL CELL, V52, P629, DOI 10.1016/j.molcel.2013.10.013; Halfmann A, 2007, FEMS MICROBIOL LETT, V268, P217, DOI 10.1111/j.1574-6968.2006.00584.x; Hu P, 2011, J BACTERIOL, V193, P2375, DOI 10.1128/JB.00083-11; Hummel A, 2007, SYST APPL MICROBIOL, V30, P1, DOI 10.1016/j.syapm.2006.02.004; KIM HS, 1993, J GEN MICROBIOL, V139, P601, DOI 10.1099/00221287-139-3-601; KWAK JH, 1991, J BACTERIOL, V173, P4725, DOI 10.1128/jb.173.15.4725-4735.1991; Kwon AR, 2006, ARCH PHARM RES, V29, P1154, DOI 10.1007/BF02969307; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Malhotra-Kumar S, 2009, J ANTIMICROB CHEMOTH, V63, P42, DOI 10.1093/jac/dkn432; MCCASKILL JS, 1990, BIOPOLYMERS, V29, P1105, DOI 10.1002/bip.360290621; McGee L, 2001, J CLIN MICROBIOL, V39, P2565, DOI 10.1128/JCM.39.7.2565-2571.2001; Miller JH, 1972, EXPT MOL GENETICS LA; Min YH, 2008, ARCH PHARM RES, V31, P377, DOI [10.1007/s12272-001-1167-8, 10.1007/s00000-001-1167-8]; Mingoia M, 2007, ANTIMICROB AGENTS CH, V51, P3983, DOI 10.1128/AAC.00790-07; Rosato A, 1999, J ANTIMICROB CHEMOTH, V43, P559, DOI 10.1093/jac/43.4.559; ROSS JI, 1990, MOL MICROBIOL, V4, P1207, DOI 10.1111/j.1365-2958.1990.tb00696.x; SABELNIKOV AG, 1995, J MOL BIOL, V250, P144, DOI 10.1006/jmbi.1995.0366; SANDLER P, 1989, J BACTERIOL, V171, P6680, DOI 10.1128/jb.171.12.6680-6688.1989; Santagati M, 2003, MICROB DRUG RESIST, V9, P243, DOI 10.1089/107662903322286445; Santagati M, 2000, ANTIMICROB AGENTS CH, V44, P2585, DOI 10.1128/AAC.44.9.2585-2587.2000; Sharma D, 2013, PEDIATR INFECT DIS J, V32, pE45, DOI 10.1097/INF.0b013e3182788fdd; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sutcliffe J, 1996, ANTIMICROB AGENTS CH, V40, P1817, DOI 10.1128/AAC.40.8.1817; Vazquez-Laslop N, 2008, MOL CELL, V30, P190, DOI 10.1016/j.molcel.2008.02.026; WILSON KS, 1995, P NATL ACAD SCI USA, V92, P8793, DOI 10.1073/pnas.92.19.8793; Zahner D, 2010, ANTIMICROB AGENTS CH, V54, P3516, DOI 10.1128/AAC.01756-09; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133	43	27	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0116254	10.1371/journal.pone.0116254	http://dx.doi.org/10.1371/journal.pone.0116254			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695510	Green Published, Green Submitted, gold			2022-12-26	WOS:000350062300012
J	Bordi, L; Lalle, E; Caglioti, C; Travaglini, D; Lapa, D; Marsella, P; Quartu, S; Kis, Z; Arien, KK; Huemer, HP; Meschi, S; Ippolito, G; Di Caro, A; Capobianchi, MR; Castilletti, C				Bordi, Licia; Lalle, Eleonora; Caglioti, Claudia; Travaglini, Damiano; Lapa, Daniele; Marsella, Patrizia; Quartu, Serena; Kis, Zoltan; Arien, Kevin K.; Huemer, Hartwig P.; Meschi, Silvia; Ippolito, Giuseppe; Di Caro, Antonino; Capobianchi, Maria R.; Castilletti, Concetta			Antagonistic Antiviral Activity between IFN-Lambda and IFN-Alpha against Lethal Crimean-Congo Hemorrhagic Fever Virus In Vitro	PLOS ONE			English	Article							HUMAN MXA PROTEIN; INTERFERON-LAMBDA; REPLICATION; DISTINCT; ACTIVATION; OUTBREAK; CELLS	Background and Aims Crimean Congo Hemorrhagic fever virus (CCHFV) is the causative agent of Crimean-Congo hemorrhagic fever, a severe disease with a mortality rate of around 30% in humans. Previous studies demonstrate that pre-treatment with type I IFNs have an antiviral effect against CCHFV, while established CCHFV infection is almost insensitive to subsequent IFN-alpha treatment. No data concerning type III IFNs antiviral activity against CCHFV are available so far. The aim of the present study was to explore the capability of IFN-lambda 1 to inhibit the replication of CCHFV and the possible synergism/antagonism between IFN-alpha and IFN-lambda 1 both in the inhibition of CCHFV replication and in the activation of intracellular pathways of IFN response. Methods Human A549 and HuH7 cells were treated with increasing amounts of IFN-lambda 1, or IFN-alpha or a combination of them, infected with CCHF; the extent of virus yield inhibition and the induction of MxA and 2'-5' OAS mRNA was measured. Results and Conclusions Our study pointed out that type III IFN possess an antiviral activity against CCHFV, even if lower than type I IFN. Moreover, a clear antagonism between IFN-lambda and IFN-alpha was observed in both cell lines (A549 and HuH7 cells), in terms of antiviral effect and activation of pivotal ISGs, i.e. MxA and 2'-5' OAS. Elucidating the interplay between type I and III IFNs will help to better understand innate defence mechanisms against viral infections and may provide novel scientific evidence for a more rational planning of available and future treatments, particularly against human diseases caused by high concern viruses.	[Bordi, Licia; Lalle, Eleonora; Caglioti, Claudia; Travaglini, Damiano; Lapa, Daniele; Marsella, Patrizia; Quartu, Serena; Meschi, Silvia; Capobianchi, Maria R.; Castilletti, Concetta] Natl Inst Infect Dis L Spallanzani, Virol Lab, Rome, Italy; [Kis, Zoltan] Natl Ctr Epidemiol, Div Virol, Budapest, Hungary; [Arien, Kevin K.] Inst Trop Med, Virol Unit, B-2000 Antwerp, Belgium; [Huemer, Hartwig P.] Med Univ Innsbruck, Dept Hyg Microbiol & Social Med, A-6020 Innsbruck, Austria; [Ippolito, Giuseppe] Natl Inst Infect Dis L Spallanzani, Sci Direct, Rome, Italy; [Di Caro, Antonino] Natl Inst Infect Dis L Spallanzani, Lab Microbiol & Biorepository, Rome, Italy	IRCCS Lazzaro Spallanzani; Institute of Tropical Medicine (ITM); Medical University of Innsbruck; IRCCS Lazzaro Spallanzani; IRCCS Lazzaro Spallanzani	Capobianchi, MR (corresponding author), Natl Inst Infect Dis L Spallanzani, Virol Lab, Rome, Italy.	maria.capobianchi@inmi.it	Bordi, Licia/B-6827-2017; Ippolito, Giuseppe/J-7207-2017; Di Caro, Antonino/K-6854-2016; Castilletti, Concetta/AAA-8408-2019; Castilletti, Concetta/B-6545-2016	Bordi, Licia/0000-0003-3962-3646; Di Caro, Antonino/0000-0001-6027-3009; Castilletti, Concetta/0000-0001-9819-236X; Castilletti, Concetta/0000-0001-9819-236X; Capobianchi, Maria Rosaria/0000-0003-3465-0071; Ippolito, Giuseppe/0000-0002-1076-2979; lalle, eleonora/0000-0002-7063-9905; meschi, silvia/0000-0003-0924-993X	Italian Ministry of Health; Ricerca Corrente; Ricerca Finalizzata	Italian Ministry of Health(Ministry of Health, Italy); Ricerca Corrente(Ministry of Health, ItalyMinistry of Health Italy - Ricerca Corrente (MOH-RC)); Ricerca Finalizzata(Ministry of Health, ItalyMinistry of Health Italy - Ricerca Finalizzata (MOH-RF))	This study has been partly supported by grants from Italian Ministry of Health, Ricerca Corrente and Ricerca Finalizzata	Andersson I, 2006, J MED VIROL, V78, P216, DOI 10.1002/jmv.20530; Andersson I, 2004, J VIROL, V78, P4323, DOI 10.1128/JVI.78.8.4323-4329.2004; Andersson I, 2008, J MED VIROL, V80, P1397, DOI 10.1002/jmv.21222; Ank N, 2006, J VIROL, V80, P4501, DOI 10.1128/JVI.80.9.4501-4509.2006; Ank N, 2006, J INTERF CYTOK RES, V26, P373, DOI 10.1089/jir.2006.26.373; Bente DA, 2013, ANTIVIR RES, V100, P159, DOI 10.1016/j.antiviral.2013.07.006; Bonjardim CA, 2009, IMMUNOL LETT, V122, P1, DOI 10.1016/j.imlet.2008.11.002; Bordi L, 2013, J BIOL REG HOMEOS AG, V27, P1001; BURNEY MI, 1980, AM J TROP MED HYG, V29, P941, DOI 10.4269/ajtmh.1980.29.941; Capobianchi MR, 2006, CELL MOL BIOL, V52, P3, DOI 10.1170/T692; Chinikar S, 2004, J MED VIROL, V73, P404, DOI 10.1002/jmv.20106; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Egli A, 2014, J INFECT DI IN PRESS; Francois-Newton V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022200; Frese M, 1996, J VIROL, V70, P915, DOI 10.1128/JVI.70.2.915-923.1996; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Keshtkar-Jahromi M, 2011, ANTIVIR RES, V90, P85, DOI 10.1016/j.antiviral.2011.02.010; Kohli A, 2012, J VIRAL HEPATITIS, V19, P843, DOI 10.1111/j.1365-2893.2012.01610.x; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Marcello T, 2006, GASTROENTEROLOGY, V131, P1887, DOI 10.1053/j.gastro.2006.09.052; NICHOL ST, 2001, FIELDS VIROLOGY, P1603; Pagliaccetti NE, 2008, J BIOL CHEM, V283, P30079, DOI 10.1074/jbc.M804296200; PAVLOVIC J, 1995, J VIROL, V69, P4506, DOI 10.1128/JVI.69.7.4506-4510.1995; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Shindo H, 2013, J VIRAL HEPATITIS, V20, P281, DOI 10.1111/j.1365-2893.2012.01649.x; SULEIMAN MNEH, 1980, LANCET, V2, P939; Whitehouse CA, 2004, ANTIVIR RES, V64, P145, DOI 10.1016/j.antiviral.2004.08.001	29	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0116816	10.1371/journal.pone.0116816	http://dx.doi.org/10.1371/journal.pone.0116816			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693189	Green Published, gold			2022-12-26	WOS:000350061500023
J	Carlsson, T; Bergman, G; Marttala, UM; Wadensten, B; Mattsson, E				Carlsson, Tommy; Bergman, Gunnar; Marttala, Ulla Melander; Wadensten, Barbro; Mattsson, Elisabet			Information following a Diagnosis of Congenital Heart Defect: Experiences among Parents to Prenatally Diagnosed Children	PLOS ONE			English	Article							DECISION-MAKING; HEALTH LITERACY; ULTRASOUND; PREGNANCY; INTERNET	Background Prenatal screening of pregnant women in Sweden has improved the detection of major congenital heart defects (CHD). The aim was to explore parental experiences and need for information following a prenatal diagnosis of CHD. Methods Semi-structured interviews conducted with six fathers and five mothers to seven prenatally diagnosed children. Data were analyzed through content analysis. Results Three themes and 9 categories emerged. Theme 1, Grasping the facts today while reflecting on the future, containing five categories: Difficulties sorting out information when in emotional chaos; Respectful information regarding termination of pregnancy; Early information is crucial; Understanding the facts regarding the anomaly; Preparing for the future. Theme 2, Personal contact with medical specialists who give honest and trustworthy information is valued, containing two categories: Trust in information received from medical specialists and Truth and honesty is valued. Theme 3, An overwhelming amount of information on the Internet, containing two categories: Difficulties in finding relevant information and Easy to focus on cases with a poor outcome when searching the Internet. Conclusion Early and honest information in line with individual preferences is crucial to support the decisional process regarding whether to continue or terminate the pregnancy. The use of illustrations is recommended, as a complement to oral information, as it increases comprehension and satisfaction with obtained information. Furthermore, the overwhelming amount of information on the Internet calls for compilation of easily accessible and reliable information sources via the Internet.	[Carlsson, Tommy; Wadensten, Barbro; Mattsson, Elisabet] Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden; [Bergman, Gunnar] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Marttala, Ulla Melander] Uppsala Univ, Dept Scandinavian Languages, Uppsala, Sweden; [Mattsson, Elisabet] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden	Uppsala University; Karolinska Institutet; Uppsala University; Uppsala University	Carlsson, T (corresponding author), Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden.	tommy.carlsson@pubcare.uu.se		Carlsson, Tommy/0000-0003-4141-8692	foundation Riksbankens Jubileumsfond (RJ)	foundation Riksbankens Jubileumsfond (RJ)	Dr. Bergman was supported by the foundation Riksbankens Jubileumsfond (RJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahman A, 2012, MIDWIFERY, V28, pE667, DOI 10.1016/j.midw.2011.07.008; [Anonymous], 2007, AUSTRAL ASIAN J CANC; Askelsdottir Bjork, 2008, Adv Neonatal Care, V8, P348, DOI 10.1097/01.ANC.0000342768.94734.23; Asplin N, 2012, SEX REPROD HEALTHC, V3, P73, DOI 10.1016/j.srhc.2011.12.002; Bergman Gunnar, 2008, Lakartidningen, V105, P899; Brosig CL, 2007, J PERINATOL, V27, P687, DOI 10.1038/sj.jp.7211807; Caldera K, 2013, FETAL DIAGN THER, V33, P61, DOI 10.1159/000339655; Cho RN, 2007, PRENATAL DIAG, V27, P463, DOI 10.1002/pd.1712; Erlen Judith A, 2004, Orthop Nurs, V23, P150, DOI 10.1097/00006416-200403000-00015; Fox Susannah, 2013, INFORM TRIAGE; Garcia J, 2002, BIRTH-ISS PERINAT C, V29, P225, DOI 10.1046/j.1523-536X.2002.00198.x; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Green JM, 2004, HEALTH TECHNOL ASSES, V8, P1; Hedrick J, 2005, JOGNN-J OBST GYN NEO, V34, P732, DOI 10.1177/0884217505282020; Houts PS, 2006, PATIENT EDUC COUNS, V61, P173, DOI 10.1016/j.pec.2005.05.004; Ikemba CM, 2002, PEDIATRICS, V109, P419, DOI 10.1542/peds.109.3.419; Johnson A., 2003, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD003716; Karlsson AM, 2014, SVENSKANS BESKRIVNIN, V33, P193; Lalor JG, 2007, BIRTH-ISS PERINAT C, V34, P80, DOI 10.1111/j.1523-536X.2006.00148.x; Lincoln Y.S., 1985, NATURALISTIC ENQUIRY; Lindau ST, 2002, AM J OBSTET GYNECOL, V186, P938, DOI 10.1067/mob.2002.122091; Massin MM, 2006, ACTA CARDIOL, V61, P406, DOI 10.2143/AC.61.4.2017300; Menahem Samuel, 2004, Heart Lung Circ, V13, P261, DOI 10.1016/j.hlc.2004.06.009; Murphy E., 1998, HLTH TECHNOLOGY ASSE, V2, P1, DOI DOI 10.3310/HTA2160; Nielsen-Bohlman L, 2004, HLTH LITERACY PRESCR; Ohman SG, 2006, BIRTH-ISS PERINAT C, V33, P64; Patton M, 2002, QUALITATIVE RES EVAL, DOI [10.1111/zph.12179, DOI 10.1111/ZPH.12179]; Polkinghorne DE, 2005, J COUNS PSYCHOL, V52, P137, DOI 10.1037/0022-0167.52.2.137; Rempel GR, 2004, JOGNN, V33, P64, DOI 10.1177/0884217503261092; Sharland G, 2010, ARCH DIS CHILD-FETAL, V95, pF64, DOI 10.1136/adc.2008.151225; Swallow V, 2012, HEALTH EXPECT, V15, P157, DOI 10.1111/j.1369-7625.2011.00674.x; The Swedish Council for Technology Assessment, 1998, ROUT ULTR SCREEN PRE; Thomson G, 2013, MIDWIFERY, V29, P211, DOI 10.1016/j.midw.2012.01.002; Vandvik IH, 2000, ACTA PAEDIATR, V89, P1129, DOI 10.1080/713794571; Whitworth M, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007058.pub2	35	33	33	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117995	10.1371/journal.pone.0117995	http://dx.doi.org/10.1371/journal.pone.0117995			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC0WZ	25692879	Green Submitted, gold, Green Published			2022-12-26	WOS:000350061500089
J	Gassman, NR; Coskun, E; Stefanick, DF; Horton, JK; Jaruga, P; Dizdaroglu, M; Wilson, SH				Gassman, Natalie R.; Coskun, Erdem; Stefanick, Donna F.; Horton, Julie K.; Jaruga, Pawel; Dizdaroglu, Miral; Wilson, Samuel H.			Bisphenol A Promotes Cell Survival Following Oxidative DNA Damage in Mouse Fibroblasts	PLOS ONE			English	Article							BASE-EXCISION-REPAIR; BREAST-CANCER; GLYCOSYLASE; EXPOSURE; ENZYME; NEIL1; IDENTIFICATION; GENOTOXICITY; EXPRESSION; RESPONSES	Bisphenol A (BPA) is a biologically active industrial chemical used in production of consumer products. BPA has become a target of intense public scrutiny following concerns about its association with human diseases such as obesity, diabetes, reproductive disorders, and cancer. Recent studies link BPA with the generation of reactive oxygen species, and base excision repair (BER) is responsible for removing oxidatively induced DNA lesions. Yet, the relationship between BPA and BER has yet to be examined. Further, the ubiquitous nature of BPA allows continuous exposure of the human genome concurrent with the normal endogenous and exogenous insults to the genome, and this co-exposure may impact the DNA damage response and repair. To determine the effect of BPA exposure on base excision repair of oxidatively induced DNA damage, cells compromised in double-strand break repair were treated with BPA alone or co-exposed with either potassium bromate (KBrO3) or laser irradiation as oxidative damaging agents. In experiments with KBrO3, co-treatment with BPA partially reversed the KBrO3-induced cytotoxicity observed in these cells, and this was coincident with an increase in guanine base lesions in genomic DNA. The improvement in cell survival and the increase in oxidatively induced DNA base lesions were reminiscent of previous results with alkyl adenine DNA glycosylase-deficient cells, suggesting that BPA may prevent initiation of repair of oxidized base lesions. With laser irradiation-induced DNA damage, treatment with BPA suppressed DNA repair as revealed by several indicators. These results are consistent with the hypothesis that BPA can induce a suppression of oxidized base lesion DNA repair by the base excision repair pathway.	[Gassman, Natalie R.; Stefanick, Donna F.; Horton, Julie K.; Wilson, Samuel H.] NIEHS, Genom Integr & Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Coskun, Erdem; Jaruga, Pawel; Dizdaroglu, Miral] NIST, Biomol Measurement Div, Gaithersburg, MD 20899 USA; [Coskun, Erdem] Gazi Univ, Fac Pharm, Ankara, Turkey	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institute of Standards & Technology (NIST) - USA; Gazi University	Wilson, SH (corresponding author), NIEHS, Genom Integr & Struct Biol Lab, NIH, 111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	wilson5@niehs.nih.gov	Jaruga, Pawel/M-4378-2015; Wilson, Samuel H/E-6644-2019; Coskun, Erdem/AAR-8312-2020	Wilson, Samuel H/0000-0002-1702-5293; Coskun, Erdem/0000-0002-9927-4188; Jaruga, Pawel/0000-0001-9192-6084; Gassman, Natalie/0000-0002-8488-2332	Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences [Z01-ES050158, Z01-ES050159];  [1K99ES023813-01]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES050159, ZIAES050159, ZIAES050158, Z01ES050158] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); ; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by Research Project Numbers Z01-ES050158 and Z01-ES050159 in the Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences. NRG is funded by 1K99ES023813-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Certain commercial equipment or materials are identified in this paper in order to specify adequately the experimental procedure. Such identification does not imply recommendation or endorsement by the National Institute of Standards and Technology, nor does it imply that the materials or equipment identified are necessarily the best available for the purpose.	Allard P, 2011, CELL CYCLE, V10, P183, DOI 10.4161/cc.10.2.14478; ATKINSON A, 1995, ENVIRON MOL MUTAGEN, V26, P60, DOI 10.1002/em.2850260109; ATKINSON A, 1995, BIOCHEM BIOPH RES CO, V210, P424, DOI 10.1006/bbrc.1995.1678; Audebert M, 2011, ARCH TOXICOL, V85, P1463, DOI 10.1007/s00204-011-0721-2; Bjoras M, 1997, EMBO J, V16, P6314, DOI 10.1093/emboj/16.20.6314; BUTLER WB, 1984, ANAL BIOCHEM, V141, P70, DOI 10.1016/0003-2697(84)90426-3; Chan MK, 2009, DNA REPAIR, V8, P786, DOI 10.1016/j.dnarep.2009.03.001; Choi YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086358; Dizdaroglu M, 2003, MUTAT RES-FUND MOL M, V531, P109, DOI 10.1016/j.mrfmmm.2003.07.003; Dizdaroglu M, 2011, J MOL BIOMARK DIAG S, VS2; Dobrzynska MM, 2013, DRUG CHEM TOXICOL, V36, P19, DOI 10.3109/01480545.2011.644561; Edmonds JS, 2004, BIOCHEM BIOPH RES CO, V319, P556, DOI 10.1016/j.bbrc.2004.05.024; Fernandez SV, 2010, TOXICOL PATHOL, V38, P110, DOI 10.1177/0192623309354108; Fernandez SV, 2012, INT J ONCOL, V41, P369, DOI 10.3892/ijo.2012.1444; Gama V, 2009, CELL DEATH DIFFER, V16, P758, DOI 10.1038/cdd.2009.6; Gassman NR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049301; Hazra TK, 2002, P NATL ACAD SCI USA, V99, P3523, DOI 10.1073/pnas.062053799; Horton JK, 2013, DNA REPAIR, V12, P774, DOI 10.1016/j.dnarep.2013.06.004; Iso T, 2006, BIOL PHARM BULL, V29, P206, DOI 10.1248/bpb.29.206; Izzotti A, 2009, MUTAT RES-GEN TOX EN, V679, P28, DOI 10.1016/j.mrgentox.2009.07.011; Jaruga P, 2010, BIOCHEMISTRY-US, V49, P1053, DOI 10.1021/bi902161f; Jaruga P, 2008, FREE RADICAL BIO MED, V45, P1601, DOI 10.1016/j.freeradbiomed.2008.09.019; Lan L, 2004, P NATL ACAD SCI USA, V101, P13738, DOI 10.1073/pnas.0406048101; LaPensee EW, 2009, ENVIRON HEALTH PERSP, V117, P175, DOI 10.1289/ehp.11788; Li H, 2013, MUTAT RES-FUND MOL M, V745, P16, DOI 10.1016/j.mrfmmm.2013.03.010; Masaoka A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066801; Masaoka A, 2012, J BIOL CHEM, V287, P27648, DOI 10.1074/jbc.M112.370759; Nishimura Y, 2014, CELL BIOL INT, V38, P868, DOI 10.1002/cbin.10269; Reddy PT, 2013, J PROTEOME RES, V12, P1049, DOI 10.1021/pr301037t; Richter CA, 2007, REPROD TOXICOL, V24, P199, DOI 10.1016/j.reprotox.2007.06.004; RoldanArjona T, 1997, P NATL ACAD SCI USA, V94, P8016, DOI 10.1073/pnas.94.15.8016; Rosenquist TA, 1997, P NATL ACAD SCI USA, V94, P7429, DOI 10.1073/pnas.94.14.7429; Roth RB, 2002, CANCER RES, V62, P656; Sobol RW, 2003, J BIOL CHEM, V278, P39951, DOI 10.1074/jbc.M306592200; Tiwari D, 2012, MUTAT RES-GEN TOX EN, V743, P83, DOI 10.1016/j.mrgentox.2011.12.023; Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010; vom Saal FS, 2007, REPROD TOXICOL, V24, P131, DOI 10.1016/j.reprotox.2007.07.005; Wu HJ, 2013, MUTAT RES-GEN TOX EN, V752, P57, DOI 10.1016/j.mrgentox.2013.01.005; Xin F, 2014, MUTAT RES-GEN TOX EN, V769, P29, DOI 10.1016/j.mrgentox.2014.04.019; Yang YJ, 2009, ENVIRON RES, V109, P797, DOI 10.1016/j.envres.2009.04.014; Yin R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098635	41	34	34	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118819	10.1371/journal.pone.0118819	http://dx.doi.org/10.1371/journal.pone.0118819			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693136	Green Published, gold, Green Submitted			2022-12-26	WOS:000350061500131
J	Gu, J; Lau, JTF; Wang, Z; Wu, AMS; Tan, X				Gu, Jing; Lau, Joseph T. F.; Wang, Zixin; Wu, Anise M. S.; Tan, Xuhui			Perceived Empathy of Service Providers Mediates the Association between Perceived Discrimination and Behavioral Intention to Take Up HIV Antibody Testing Again among Men Who Have Sex with Men	PLOS ONE			English	Article							INJECTING DRUG-USERS; HONG-KONG; SELF-STIGMA; RISK BEHAVIORS; UNITED-STATES; CARE MEASURE; TRANSGENDER WOMEN; PLANNED BEHAVIOR; PUBLIC-HEALTH; CONDOM USE	HIV antibody testing is a key measure of HIV prevention for men who have sex with men (MSM). The World Health Organization recommends sexually active and at-risk MSM to take up HIV antibody testing regularly. This study aimed to investigate the prevalence of behavioral intention to take up HIV antibody testing in the next six months among Hong Kong MSM who were ever-testers. An anonymous cross-sectional survey recruited 326 MSM who had taken up HIV antibody testing from gay-friendly venues and internet in Hong Kong. Of the participants, 40.8% had had unprotected anal intercourse with regular or non-regular male sex partners in the last six months; they were at risk of HIV transmission despite experience in HIV antibody testing. Only 37.2% showed a strong intention to take up HIV antibody testing again in the next six months. Adjusted analysis showed that both perceived discrimination toward Hong Kong MSM (AOR = .60, 95% CI:.36-.98) and the CARE Measure assessing perceived empathy of service providers (AOR = 1.05, 95% CI: 1.02-1.08) were significantly associated with intention for retesting. Perceived discrimination, however, became statistically non-significant (AOR = .68, 95% CI:.41-1.14), when both CARE Measure and perceived discrimination entered into the adjusted model. It is warranted to increase HIV retesting rate by removing perceived discrimination and reducing the negative effect of perceived discrimination through enhancement of empathy of service providers.	[Gu, Jing] Sun Yat Sen Univ, Sch Publ Hlth, Guangzhou 510275, Guangdong, Peoples R China; [Lau, Joseph T. F.; Wang, Zixin] Chinese Univ Hong Kong, Fac Med, Sch Publ Hlth & Primary Care, Ctr Hlth Behav Res, Hong Kong, Hong Kong, Peoples R China; [Lau, Joseph T. F.; Wang, Zixin] Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Peoples R China; [Wu, Anise M. S.] Univ Macau, Fac Social Sci, Dept Psychol, Macau, Peoples R China; [Tan, Xuhui] Southern Med Univ, Sch Publ Hlth & Trop Med, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Chinese University of Hong Kong; Chinese University of Hong Kong, Shenzhen; University of Macau; Southern Medical University - China	Lau, JTF (corresponding author), Chinese Univ Hong Kong, Fac Med, Sch Publ Hlth & Primary Care, Ctr Hlth Behav Res, Hong Kong, Hong Kong, Peoples R China.	jlau@cuhk.edu.hk	Wu, Anise M.S./AAJ-4293-2020	Wu, Anise M.S./0000-0001-8174-6581	Hong Kong Council for the AIDS Trust Fund [SPF028]; JTFL	Hong Kong Council for the AIDS Trust Fund; JTFL	The study was funded by Hong Kong Council for the AIDS Trust Fund (ref#SPF028): http://www.atf.gov.hk/eindex.html. The funding was received by JTFL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajzen I., 1985, ACTION CONTROL, P11, DOI [10.1007/978-3-642-69746-3_2, DOI 10.1007/978-3-642-69746-3_2]; Altiner A, 2007, J ANTIMICROB CHEMOTH, V60, P638, DOI 10.1093/jac/dkm254; [Anonymous], 2007, PRISM HIV PREV RISK; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Baxter EA, 1995, JEFFERSON J PSYCHIAT, V12, P6; Beyrer C, 2010, CLIN INFECT DIS, V50, pS108, DOI 10.1086/651481; Bonell C, 2006, HEALTH EDUC RES, V21, P452, DOI 10.1093/her/cyh071; Brick N, 2013, PUBLIC HEALTH NURS, V30, P382, DOI 10.1111/phn.12037; Brohan E, 2010, SCHIZOPHR RES, V122, P232, DOI 10.1016/j.schres.2010.02.1065; Cahill S, 2013, J PUBLIC HEALTH POL, V34, P69, DOI 10.1057/jphp.2012.59; Choi KH, 2006, AIDS EDUC PREV, V18, P33, DOI 10.1521/aeap.2006.18.1.33; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Corrigan PW, 2010, J COMMUNITY PSYCHOL, V38, P259, DOI 10.1002/jcop.20363; Corrigan PW, 2002, CLIN PSYCHOL-SCI PR, V9, P35, DOI 10.1093/clipsy/9.1.35; Department of Health The Government of Hong Kong Special Adminstrative Region, 2012, FAC PRISM HIV PREV R; Edwards N, 2006, PATIENT EDUC COUNS, V63, P3, DOI 10.1016/j.pec.2006.07.008; Emdadi SH, 2007, J RES HEALTH SCI, V7, P25; Foster MD, 2000, J SOC PSYCHOL, V140, P93, DOI 10.1080/00224540009600448; Fung CSC, 2009, FAM PRACT, V26, P398, DOI 10.1093/fampra/cmp044; Golub SA, 2013, AIDS PATIENT CARE ST, V27, P621, DOI 10.1089/apc.2013.0245; Gu J, 2011, PUBLIC HEALTH, V125, P275, DOI 10.1016/j.puhe.2011.01.010; Gu J, 2008, DRUG ALCOHOL DEPEN, V97, P257, DOI 10.1016/j.drugalcdep.2008.03.029; Gu J, 2009, AIDS CARE, V21, P967, DOI 10.1080/09540120802657548; Heijnders Miriam, 2006, Psychol Health Med, V11, P353, DOI 10.1080/13548500600595327; Juan S, 2011, CHINA DAILY; Kilmarx PH, 2013, CURR OPIN HIV AIDS, V8, P59, DOI 10.1097/COH.0b013e32835b806e; Lau JTF, 2008, AIDS CARE, V20, P820, DOI 10.1080/09540120701694048; Lau JTF, 2011, PUBLIC HEALTH, V125, P260, DOI 10.1016/j.puhe.2011.01.007; Lau JTF, 2013, PREV MED, V57, P813, DOI 10.1016/j.ypmed.2013.09.005; Lau JTF, 2012, AIDS CARE, V24, P59, DOI 10.1080/09540121.2011.592813; Lau JT, 2013, ARCH SEX BEHAV; Lau JTF, 2005, SEX TRANSM INFECT, V81, P113, DOI 10.1136/sti.2004.011767; Li L, 2013, AIDS EDUC PREV, V25, P327, DOI 10.1521/aeap.2013.25.4.327; Liu Hongjie, 2011, Stigma Res Action, V1, P27; Liu JX, 2006, AIDS BEHAV, V10, pS25, DOI 10.1007/s10461-006-9123-5; Liu J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-356; Liu SY, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-250; Mak WWS, 2010, AM J ORTHOPSYCHIAT, V80, P267, DOI 10.1111/j.1939-0025.2010.01030.x; McDaid LM, 2011, SEX TRANSM INFECT, V87, P221, DOI 10.1136/sti.2010.044560; Mercer SW, 2005, FAM PRACT, V22, P328, DOI 10.1093/fampra/cmh730; Mercer SW, 2004, FAM PRACT, V21, P699, DOI 10.1093/fampra/cmh621; Mercer SW, 2002, BRIT J GEN PRACT, V52, pS9; Mugavero MJ, 2013, CLIN INFECT DIS, V57, P1164, DOI 10.1093/cid/cit420; Nelson JM, 2014, J CLIN NURS, V23, P461, DOI 10.1111/jocn.12183; Norfolk T, 2007, MED EDUC, V41, P690, DOI 10.1111/j.1365-2923.2007.02789.x; Nuwaha F, 2002, East Afr Med J, V79, P626; Oster Alexandra M., 2011, Morbidity and Mortality Weekly Report, V60, P694; PROCHASKA JO, 1992, AM PSYCHOL, V47, P1102, DOI 10.1037/0003-066X.47.9.1102; PROCHASKA JO, 1994, HEALTH PSYCHOL, V13, P47, DOI 10.1037/0278-6133.13.1.47; Reynolds W J, 1999, J Psychiatr Ment Health Nurs, V6, P363, DOI 10.1046/j.1365-2850.1999.00228.x; Rogers SJ, 2014, AIDS CARE, V26, P538, DOI 10.1080/09540121.2013.844762; Rotheram-Borus MJ, 2000, J ACQ IMMUN DEF SYND, V25, pS105, DOI 10.1097/00126334-200012152-00004; Rothman AJ, 2000, HEALTH PSYCHOL, V19, P64, DOI 10.1037/0278-6133.19.Suppl1.64; Rusch N, 2009, BRIT J PSYCHIAT, V195, P551, DOI 10.1192/bjp.bp.109.067157; Sengupta S, 2011, AIDS BEHAV, V15, P1075, DOI 10.1007/s10461-010-9847-0; Shiono Satoshi, 2013, Nihon Koshu Eisei Zasshi, V60, P639; Smith A., 2010, Morbidity and Mortality Weekly Report, V59, P1201; Steward WT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071778; Takacs J, 2013, SEX RES SOC POLICY, V10, P24, DOI 10.1007/s13178-012-0102-5; van Boekel LC, 2013, DRUG ALCOHOL DEPEN, V131, P23, DOI 10.1016/j.drugalcdep.2013.02.018; van Ryn M, 2003, AM J PUBLIC HEALTH, V93, P248, DOI 10.2105/AJPH.93.2.248; Wang Yi, 2010, Zhonghua Yu Fang Yi Xue Za Zhi, V44, P636; Wei CY, 2011, SEX TRANSM INFECT, V87, P225, DOI 10.1136/sti.2010.047407; Wong LP, 2013, AIDS CARE, V25, P1356, DOI 10.1080/09540121.2013.766302; World Health Organization, 2011, GLOB HLTH SECT STRAT; World Health Organization, 2007, GUID PROV IN HIV TES; Wu Z, 2009, WHO M MSM; Wu ZY, 2013, CLIN INFECT DIS, V57, P298, DOI 10.1093/cid/cit210; Xu JJ, 2010, SEX TRANSM DIS, V37, P432, DOI 10.1097/OLQ.0b013e3181d13eed; Yap MBH, 2012, PSYCHIAT RES, V196, P315, DOI 10.1016/j.psychres.2011.10.004; Zhang HB, 2010, JAIDS-J ACQ IMM DEF, V53, pS88, DOI 10.1097/QAI.0b013e3181c7de63; Zhang L, 2013, SEX TRANSM DIS, V40, P235, DOI 10.1097/OLQ.0b013e31827ca6b9; Zhang YQ, 2012, SEX TRANSM INFECT, V88, P444, DOI 10.1136/sextrans-2011-050295; Zou HC, 2010, JAIDS-J ACQ IMM DEF, V53, pS81, DOI 10.1097/QAI.0b013e3181c7dd2b	74	14	14	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117376	10.1371/journal.pone.0117376	http://dx.doi.org/10.1371/journal.pone.0117376			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC0WZ	25693179	Green Submitted, Green Published, gold			2022-12-26	WOS:000350061500052
J	Portilho, DM; Alves, MR; Kratassiouk, G; Roche, S; Magdinier, F; de Santana, EC; Polesskaya, A; Harel-Bellan, A; Mouly, V; Savino, W; Butler-Browne, G; Dumonceaux, J				Portilho, Debora Morueco; Alves, Marcelo Ribeiro; Kratassiouk, Gueorgui; Roche, Stephane; Magdinier, Frederique; de Santana, Eliane Correa; Polesskaya, Anna; Harel-Bellan, Annick; Mouly, Vincent; Savino, Wilson; Butler-Browne, Gillian; Dumonceaux, Julie			miRNA Expression in Control and FSHD Fetal Human Muscle Biopsies	PLOS ONE			English	Article							FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; TARGET GENES; MICRORNAS; D4Z4; HYPERTROPHY; MYOBLASTS; LOCATION; DISEASE; FAMILY	Background Facioscapulohumeral muscular dystrophy (FSHD) is an autosomal-dominant disorder and is one of the most common forms of muscular dystrophy. We have recently shown that some hallmarks of FSHD are already expressed in fetal FSHD biopsies, thus opening a new field of investigation for mechanisms leading to FSHD. As microRNAs (miRNAs) play an important role in myogenesis and muscle disorders, in this study we compared miRNAs expression levels during normal and FSHD muscle development. Methods Muscle biopsies were obtained from quadriceps of both healthy control and FSHD1 fetuses with ages ranging from 14 to 33 weeks of development. miRNA expression profiles were analyzed using TaqMan Human MicroRNA Arrays. Results During human skeletal muscle development, in control muscle biopsies we observed changes for 4 miRNAs potentially involved in secondary muscle fiber formation and 5 miRNAs potentially involved in fiber maturation. When we compared the miRNA profiles obtained from control and FSHD biopsies, we did not observe any differences in the muscle specific miRNAs. However, we identified 8 miRNAs exclusively expressed in FSHD1 samples (miR-330, miR-331-5p, miR-34a, miR-380-3p, miR-516b, miR-582-5p, miR-517* and miR-625) which could represent new biomarkers for this disease. Their putative targets are mainly involved in muscle development and morphogenesis. Interestingly, these FSHD1 specific miRNAs do not target the genes previously described to be involved in FSHD. Conclusions This work provides new candidate mechanisms potentially involved in the onset of FSHD pathology. Whether these FSHD specific miRNAs cause deregulations during fetal development, or protect against the appearance of the FSHD phenotype until the second decade of life still needs to be investigated.	[Portilho, Debora Morueco; Mouly, Vincent; Butler-Browne, Gillian; Dumonceaux, Julie] Univ Paris 06, Sorbonne Univ, Ctr Res Myol, UM76, Paris, France; [Portilho, Debora Morueco; Mouly, Vincent; Butler-Browne, Gillian; Dumonceaux, Julie] INSERM, UMRS974, Paris, France; [Portilho, Debora Morueco; Mouly, Vincent; Butler-Browne, Gillian; Dumonceaux, Julie] CNRS, FRE 3617, F-75013 Paris, France; [Portilho, Debora Morueco; Mouly, Vincent; Butler-Browne, Gillian; Dumonceaux, Julie] Inst Myol, F-75013 Paris, France; [Portilho, Debora Morueco; Alves, Marcelo Ribeiro; de Santana, Eliane Correa; Savino, Wilson] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Pesquisas Timo, Rio De Janeiro, RJ, Brazil; [Alves, Marcelo Ribeiro] Fundacao Oswaldo Cruz, Inst Pesquisa Clin Evandro Chagas, Lab Pesquisa Clin DST AIDS, Rio De Janeiro, RJ, Brazil; [Kratassiouk, Gueorgui] Univ Paris 11, CEA Saclay, CNRS, FRE 3377, Gif Sur Yvette, France; [Roche, Stephane; Magdinier, Frederique] Aix Marseille Univ, Fac Med Timone, INSERM, Lab Genet Med & Genom Fonctionnelle,UMRS 910, Marseille, France	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Dumonceaux, J (corresponding author), Univ Paris 06, Sorbonne Univ, Ctr Res Myol, UM76, Paris, France.	julie.dumonceaux@upmc.fr	Harel-Bellan, Annick/M-9795-2015; Roche, Stephane/B-6974-2009; Magdinier, Frederique/I-4735-2016; Mouly, Gillian/G-6595-2017	Roche, Stephane/0000-0001-6660-1317; Magdinier, Frederique/0000-0002-0159-9559; butler-browne, gillian/0000-0002-3431-242X; Ribeiro-Alves, Marcelo/0000-0002-8663-3364; Mouly, Vincent/0000-0003-3809-4033; Kratassiouk, Gueorgui/0000-0003-1174-004X; Harel-Bellan, Annick/0000-0002-2339-153X	FSH Society Delta Railroad Construction Company [FSHS-DRRC-2008]; Association Francaise contre les Myopathies (AFM-Telethon, France); Agence Nationale de la Recherche (FSHDecrypt) [ANR-09-GENO-038, ANR-13-BSV1-0004]; CNPq-Inserm French-Brazilian International Laboratory of Cell Therapy and Immunotherapy [490272/2008-8]	FSH Society Delta Railroad Construction Company; Association Francaise contre les Myopathies (AFM-Telethon, France); Agence Nationale de la Recherche (FSHDecrypt)(French National Research Agency (ANR)); CNPq-Inserm French-Brazilian International Laboratory of Cell Therapy and Immunotherapy	Research reported in this publication was supported by FSH Society Delta Railroad Construction Company Fellowship Grant to JD (FSHS-DRRC-2008; https://www.fshsociety.org), Association Francaise contre les Myopathies to JD and FM (AFM-Telethon, France; www.afm-telethon.fr), the Agence Nationale de la Recherche to SR, FM and JD(FSHDecrypt, ANR-09-GENO-038 and FSHDecipher, ANR-13-BSV1-0004; www.agencenationale-recherche.fr) and CNPq-Inserm French-Brazilian International Laboratory of Cell Therapy and Immunotherapy to DMP, MRA, WS, VM and GBB (490272/2008-8; www.inserm.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; [Anonymous], 2013, ORPH REP SER 2013, V2013; Arashiro P, 2009, P NATL ACAD SCI USA, V106, P6220, DOI 10.1073/pnas.0901573106; Attarian S, 2012, REV NEUROL-FRANCE, V168, P910, DOI 10.1016/j.neurol.2011.11.008; Barbet J. Patrick, 1994, Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales, V188, P585; BARBET JP, 1991, MECH DEVELOP, V35, P3, DOI 10.1016/0925-4773(91)90036-6; Basso D, 2009, STATISTICS, V194, P1; Brock M, 2014, EUR HEART J, V35, P3203, DOI 10.1093/eurheartj/ehs060; Broucqsault N, 2013, HUM MOL GENET, V22, P4206, DOI 10.1093/hmg/ddt272; BUTLERBROWNE GS, 1990, ANAT EMBRYOL, V181, P513; Cacchiarelli D, 2011, EMBO MOL MED, V3, P258, DOI 10.1002/emmm.201100133; Caruso N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003550; Cheli S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020966; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Crist CG, 2009, P NATL ACAD SCI USA, V106, P13383, DOI 10.1073/pnas.0900210106; de Greef JC, 2010, NEUROLOGY, V75, P1548, DOI 10.1212/WNL.0b013e3181f96175; Deng ZL, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-115; Dmitriev P, 2013, J BIOL CHEM, V288, P34989, DOI 10.1074/jbc.M113.504522; Dmitriev P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-265; Eisenberg I, 2007, P NATL ACAD SCI USA, V104, P17016, DOI 10.1073/pnas.0708115104; Ferreboeuf M, 2014, HUM MOL GENET, V23, P171, DOI 10.1093/hmg/ddt409; Flynt AS, 2007, NAT GENET, V39, P259, DOI 10.1038/ng1953; Gabellini D, 2006, NATURE, V439, P973, DOI 10.1038/nature04422; Gabriels J, 1999, GENE, V236, P25, DOI 10.1016/S0378-1119(99)00267-X; Geng LN, 2012, DEV CELL, V22, P38, DOI 10.1016/j.devcel.2011.11.013; Greco S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039732; Guller I, 2010, J PHYSIOL-LONDON, V588, P4075, DOI 10.1113/jphysiol.2010.194175; Harafuji N, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-55; He J, 2013, J INVEST MED, V61, P604, DOI [10.2310/JIM.0b013e3182819ac6, 10.231/JIM.0b013e3182819ac6]; Huang LJS, 1997, P NATL ACAD SCI USA, V94, P11184, DOI 10.1073/pnas.94.21.11184; Huang TH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003225; KILMER DD, 1995, AM J PHYS MED REHAB, V74, pS131, DOI 10.1097/00002060-199509001-00007; Koutsoulidou A, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-34; Kuang W, 2009, BIOCHEM BIOPH RES CO, V378, P259, DOI 10.1016/j.bbrc.2008.11.041; Lassche S, 2013, NEUROLOGY, V80, P733, DOI 10.1212/WNL.0b013e318282513b; Legesse-Miller A, 2009, J BIOL CHEM, V284, P6605, DOI 10.1074/jbc.C900002200; Lemmers RJLF, 2012, NAT GENET, V44, P1370, DOI 10.1038/ng.2454; LUNT PW, 1988, J NEUROL SCI, V88, P287, DOI 10.1016/0022-510X(88)90225-0; Luo W, 2013, J GENET GENOMICS, V40, P107, DOI 10.1016/j.jgg.2013.02.002; Mcnab FW, 2011, CURR OPIN IMMUNOL, V23, P46, DOI 10.1016/j.coi.2010.10.021; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; Reed PW, 2007, EXP NEUROL, V205, P583, DOI 10.1016/j.expneurol.2007.03.009; Ritz C, 2008, BIOINFORMATICS, V24, P1549, DOI 10.1093/bioinformatics/btn227; Roberts TC, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.26; Sacconi S, 2013, AM J HUM GENET, V93, P744, DOI 10.1016/j.ajhg.2013.08.004; SARFARAZI M, 1992, AM J HUM GENET, V51, P396; Shan SW, 2009, NAT CELL BIOL, V11, P1031, DOI 10.1038/ncb1917; Song DW, 2014, BIOCHEM J, V457, P151, DOI 10.1042/BJ20130833; Takada S, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl653; Tang YP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028730; Tawil R, 2006, MUSCLE NERVE, V34, P1, DOI 10.1002/mus.20522; Tawil R, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-12; Townley-Tilson WHD, 2010, INT J BIOCHEM CELL B, V42, P1252, DOI 10.1016/j.biocel.2009.03.002; van der Maarel SM, 2012, CURR OPIN NEUROL, V25, P614, DOI 10.1097/WCO.0b013e328357f22d; van Overveld PGM, 2003, NAT GENET, V35, P315, DOI 10.1038/ng1262; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Vanderplanck C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026820; VANDEUTEKOM JCT, 1993, HUM MOL GENET, V2, P2037; Wallace LM, 2011, ANN NEUROL, V69, P540, DOI 10.1002/ana.22275; Wang XNH, 2011, J AM SOC NEPHROL, V22, P2068, DOI 10.1681/ASN.2010121278; Wijmenga C, 1990, LANCET, V336, P651, DOI 10.1016/0140-6736(90)92148-B; Winokur ST, 2003, NEUROMUSCULAR DISORD, V13, P322, DOI 10.1016/S0960-8966(02)00284-5; Winston J, 2015, EUR J HUM GENET, V23, P67, DOI 10.1038/ejhg.2014.58	64	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0116853	10.1371/journal.pone.0116853	http://dx.doi.org/10.1371/journal.pone.0116853			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692472	Green Published, Green Submitted, gold			2022-12-26	WOS:000350061500025
J	Razgado-Hernandez, LF; Espadas-Alvarez, AJ; Reyna-Velazquez, P; Sierra-Sanchez, A; Anaya-Martinez, V; Jimenez-Estrada, I; Bannon, MJ; Martinez-Fong, D; Aceves-Ruiz, J				Razgado-Hernandez, Luis F.; Espadas-Alvarez, Armando J.; Reyna-Velazquez, Patricia; Sierra-Sanchez, Arturo; Anaya-Martinez, Veronica; Jimenez-Estrada, Ismael; Bannon, Michael J.; Martinez-Fong, Daniel; Aceves-Ruiz, Jorge			The Transfection of BDNF to Dopamine Neurons Potentiates the Effect of Dopamine D3 Receptor Agonist Recovering the Striatal Innervation, Dendritic Spines and Motor Behavior in an Aged Rat Model of Parkinson's Disease	PLOS ONE			English	Article							BASAL GANGLIA DYSFUNCTION; SUBSTANTIA-NIGRA; D-3 RECEPTOR; NEUROTROPHIC FACTOR; MESSENGER-RNA; SUBVENTRICULAR ZONE; OPEN-FIELD; IN-VIVO; SOMATOTOPIC ORGANIZATION; HEMIPARKINSONIAN RATS	The progressive degeneration of the dopamine neurons of the pars compacta of substantia nigra and the consequent loss of the dopamine innervation of the striatum leads to the impairment of motor behavior in Parkinson's disease. Accordingly, an efficient therapy of the disease should protect and regenerate the dopamine neurons of the substantia nigra and the dopamine innervation of the striatum. Nigral neurons express Brain Derived Neurotropic Factor (BDNF) and dopamine D3 receptors, both of which protect the dopamine neurons. The chronic activation of dopamine D3 receptors by their agonists, in addition, restores, in part, the dopamine innervation of the striatum. Here we explored whether the over-expression of BDNF by dopamine neurons potentiates the effect of the activation of D3 receptors restoring nigrostriatal innervation. Twelve-month old Wistar rats were unilaterally injected with 6-hydroxydopamine into the striatum. Five months later, rats were treated with the D3 agonist 7-hydroxy-N, N-di-n-propyl-2-aminotetralin (7-OH-DPAT) administered i.p. during 41/2 months via osmotic pumps and the BDNF gene transfection into nigral cells using the neurotensin-polyplex nanovector (a non-viral transfection) that selectively transfect the dopamine neurons via the high-affinity neurotensin receptor expressed by these neurons. Two months after the withdrawal of 7-OH-DPAT when rats were aged (24 months old), immunohistochemistry assays were made. The over-expression of BDNF in rats receiving the D3 agonist normalized gait and motor coordination; in addition, it eliminated the muscle rigidity produced by the loss of dopamine. The recovery of motor behavior was associated with the recovery of the nigral neurons, the dopamine innervation of the striatum and of the number of dendritic spines of the striatal neurons. Thus, the over-expression of BDNF in dopamine neurons associated with the chronic activation of the D3 receptors appears to be a promising strategy for restoring dopamine neurons in Parkinson's disease.	[Razgado-Hernandez, Luis F.; Espadas-Alvarez, Armando J.; Reyna-Velazquez, Patricia; Sierra-Sanchez, Arturo; Jimenez-Estrada, Ismael; Martinez-Fong, Daniel; Aceves-Ruiz, Jorge] CINVESTAV, Dept Fisiol Biofis & Neurociencias, Mexico City 14000, DF, Mexico; [Anaya-Martinez, Veronica] Univ Nacl Autonoma Mexico, Neuromorphol Lab, Fac Estudios Super Iztacala, Tlalnepantla, Estado De Mexic, Mexico; [Bannon, Michael J.] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA; [Martinez-Fong, Daniel] CINVESTAV, Programa Nanociencias & Nanotecnol, Mexico City 14000, DF, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Universidad Nacional Autonoma de Mexico; Wayne State University; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Aceves-Ruiz, J (corresponding author), CINVESTAV, Dept Fisiol Biofis & Neurociencias, Mexico City 14000, DF, Mexico.	jaceves@fisio.cinvestav.mx		Espadas, Armando J/0000-0002-5776-9713	El Consejo Nacional de Ciencia y Tecnologia (CONACYT) [166638]; El Fondo Sectorial de Innovacion (FINNOVA) [224222]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA006470] Funding Source: NIH RePORTER	El Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); El Fondo Sectorial de Innovacion (FINNOVA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by El Consejo Nacional de Ciencia y Tecnologia (CONACYT) grant #166638 (JA) and El Fondo Sectorial de Innovacion (FINNOVA) grant #224222 (DMF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. LFRH, AEA and PRV were fellows from El Consejo Nacional de Ciencia y Tecnologia (CONACYT).	Alvarez-Maya I, 2001, MOL MED, V7, P186, DOI 10.1007/BF03401952; Arango-Rodriguez ML, 2006, BBA-GEN SUBJECTS, V1760, P1009, DOI 10.1016/j.bbagen.2006.02.021; Avila-Costa MR, 2004, NEUROCHEM RES, V29, P1365, DOI 10.1023/B:NERE.0000026398.86113.7d; Avila-Costa MR, 1999, NEUROSCI LETT, V270, P107, DOI 10.1016/S0304-3940(99)00458-9; BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5; Blochl A, 1996, J BIOL CHEM, V271, P21100; BROWN LL, 1992, P NATL ACAD SCI USA, V89, P7403, DOI 10.1073/pnas.89.16.7403; BROWN LL, 1995, BRAIN RES, V686, P207, DOI 10.1016/0006-8993(95)00457-2; Carola V, 2002, BEHAV BRAIN RES, V134, P49, DOI 10.1016/S0166-4328(01)00452-1; Casarrubea M, 2006, PHYSIOL BEHAV, V89, P552, DOI 10.1016/j.physbeh.2006.07.014; CENCI MA, 1992, EUR J NEUROSCI, V4, P376, DOI 10.1111/j.1460-9568.1992.tb00885.x; CHIO CL, 1994, MOL PHARMACOL, V45, P51; Collo G, 2008, EUR J NEUROSCI, V28, P1231, DOI 10.1111/j.1460-9568.2008.06423.x; Connor B, 1999, GENE THER, V6, P1936, DOI 10.1038/sj.gt.3301033; Connor B, 1998, BRAIN RES REV, V27, P1, DOI 10.1016/S0165-0173(98)00004-6; Coronas V, 2004, J NEUROCHEM, V91, P1292, DOI 10.1111/j.1471-4159.2004.02823.x; Diaz J, 1997, J NEUROSCI, V17, P4282; Dickerson JW, 2009, NEUROSCIENCE, V163, P482, DOI 10.1016/j.neuroscience.2009.06.008; DOUBLE KL, 1995, P NATL ACAD SCI USA, V92, P1669, DOI 10.1073/pnas.92.5.1669; Du F, 2005, EUR J NEUROSCI, V22, P2422, DOI 10.1111/j.1460-9568.2005.04438.x; Durieux PF, 2012, EMBO J, V31, P640, DOI 10.1038/emboj.2011.400; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Filipe VM, 2006, J NEUROSCI METH, V153, P55, DOI 10.1016/j.jneumeth.2005.10.006; Fleming Sheila M, 2005, NeuroRx, V2, P495, DOI 10.1602/neurorx.2.3.495; Fritsch B, 2010, NEURON, V66, P198, DOI 10.1016/j.neuron.2010.03.035; Glajch KE, 2012, BEHAV BRAIN RES, V230, P309, DOI 10.1016/j.bbr.2011.12.007; Goggi J, 2002, BRAIN RES, V941, P34, DOI 10.1016/S0006-8993(02)02505-2; Gonzalez-Barrios JA, 2006, MOL THER, V14, P857, DOI 10.1016/j.ymthe.2006.09.001; Graybiel AM, 2005, CURR OPIN NEUROBIOL, V15, P638, DOI 10.1016/j.conb.2005.10.006; Griffon N, 1997, J NEUROCHEM, V68, P1; Guillin O, 2001, NATURE, V411, P86, DOI 10.1038/35075076; Hernandez-Baltazar D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051341; Howells DW, 2000, EXP NEUROL, V166, P127, DOI 10.1006/exnr.2000.7483; HYMAN C, 1991, NATURE, V350, P230, DOI 10.1038/350230a0; Im SH, 2010, NEUROSCIENCE, V169, P259, DOI 10.1016/j.neuroscience.2010.04.038; Ingham CA, 1998, J NEUROSCI, V18, P4732; Jaunarajs KLE, 2010, BEHAV PHARMACOL, V21, P627, DOI 10.1097/FBP.0b013e32833e7e80; Kim Y, 2010, J NEUROCHEM, V114, P750, DOI 10.1111/j.1471-4159.2010.06799.x; Kirik D, 1998, EXP NEUROL, V152, P259, DOI 10.1006/exnr.1998.6848; Lee HY, 2012, MED BIOL ENG COMPUT, V50, P937, DOI 10.1007/s11517-012-0933-5; LEVESQUE D, 1995, P NATL ACAD SCI USA, V92, P1719, DOI 10.1073/pnas.92.5.1719; Lindner MD, 1999, BEHAV BRAIN RES, V102, P1, DOI 10.1016/S0166-4328(98)00160-0; LINDSAY RM, 1995, NATURE, V373, P289, DOI 10.1038/373289a0; Ma YL, 2011, BRIT MED BULL, V100, P173, DOI 10.1093/bmb/ldr040; Martinez-Fong D, 2012, NANOMED-NANOTECHNOL, V8, P1052, DOI 10.1016/j.nano.2012.02.009; Metz GA, 2005, EUR J NEUROSCI, V22, P735, DOI 10.1111/j.1460-9568.2005.04238.x; Mogi M, 1999, NEUROSCI LETT, V270, P45, DOI 10.1016/S0304-3940(99)00463-2; Navarro-Quiroga I, 2002, MOL BRAIN RES, V105, P86, DOI 10.1016/S0169-328X(02)00396-0; PILON C, 1994, EUR J PHARM-MOLEC PH, V268, P129, DOI 10.1016/0922-4106(94)90182-1; Polinski NK, 2014, NEUROBIOL AGING, DOI [10.1016/j.neurobiolaging.2014.11.019, DOI 10.1016/J.NEUROBIOLAGING.2014.11.019]; Politis M, 2011, MOVEMENT DISORD, V26, P1997, DOI 10.1002/mds.23743; Porritt M, 2005, MOVEMENT DISORD, V20, P810, DOI 10.1002/mds.20399; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Razgado LF, 2013, SOC NEUROSCI; Rozas G, 1997, BRAIN RES, V749, P188, DOI 10.1016/S0006-8993(96)01162-6; Rozas G, 1998, J NEUROSCI METH, V83, P165, DOI 10.1016/S0165-0270(98)00078-8; Ryoo HL, 1998, MOVEMENT DISORD, V13, P788, DOI 10.1002/mds.870130506; Sacchetti P, 1999, MOL BRAIN RES, V74, P167, DOI 10.1016/S0169-328X(99)00275-2; SHEN RY, 1994, P NATL ACAD SCI USA, V91, P8920, DOI 10.1073/pnas.91.19.8920; Shin E, 2014, NEUROBIOL DIS, V62, P233, DOI 10.1016/j.nbd.2013.09.021; Singh Shalini, 2006, Indian Journal of Experimental Biology, V44, P699; Soderstrom KE, 2010, EUR J NEUROSCI, V31, P478, DOI 10.1111/j.1460-9568.2010.07077.x; Sokoloff P, 2002, NEUROTOX RES, V4, DOI 10.1080/1029842021000045499; Solis O, 2007, SYNAPSE, V61, P450, DOI 10.1002/syn.20381; Stephens B, 2005, NEUROSCIENCE, V132, P741, DOI 10.1016/j.neuroscience.2005.01.007; Takakusaki K, 2003, NEUROSCIENCE, V119, P293, DOI 10.1016/S0306-4522(03)00095-2; Takakusaki K, 2008, J NEUROL, V255, P19, DOI 10.1007/s00415-008-4004-7; Unsicker Klaus, 1994, Progress in Growth Factor Research, V5, P73, DOI 10.1016/0955-2235(94)90018-3; Van Kampen JM, 2006, J NEUROSCI, V26, P7272, DOI 10.1523/JNEUROSCI.0837-06.2006; Van Kampen JM, 2005, NEUROSCIENCE, V136, P381, DOI 10.1016/j.neuroscience.2005.07.054; Van Kampen JM, 2004, EUR J NEUROSCI, V19, P2377, DOI 10.1111/j.0953-816X.2004.03342.x; VENERO JL, 1994, NEUROREPORT, V5, P429, DOI 10.1097/00001756-199401120-00014; Vinuela A, 2008, BRAIN, V131, P3361, DOI 10.1093/brain/awn192; Voorn P, 2004, TRENDS NEUROSCI, V27, P468, DOI 10.1016/j.tins.2004.06.006; WALSH RN, 1976, PSYCHOL BULL, V83, P482, DOI 10.1037/0033-2909.83.3.482; Wang XH, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-142; WICTORIN K, 1989, NEUROSCIENCE, V30, P313, DOI 10.1016/0306-4522(89)90256-X; Yurek DM, 1996, EXP NEUROL, V137, P105, DOI 10.1006/exnr.1996.0011; Zaja-Milatovic S, 2005, NEUROLOGY, V64, P545, DOI 10.1212/01.WNL.0000150591.33787.A4; Zheng J, 2008, J BIOL CHEM, V283, P13280, DOI 10.1074/jbc.M709930200; ZHOU JW, 1994, BRAIN RES, V656, P147, DOI 10.1016/0006-8993(94)91376-5; Zhou JW, 1997, DEV BRAIN RES, V100, P43, DOI 10.1016/S0165-3806(97)00019-9	82	55	56	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117391	10.1371/journal.pone.0117391	http://dx.doi.org/10.1371/journal.pone.0117391			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693197	Green Published, gold, Green Submitted			2022-12-26	WOS:000350061500053
J	Svalo, J; Sheykhzade, M; Nordling, J; Matras, C; Bouchelouche, P				Svalo, Julie; Sheykhzade, Majid; Nordling, Jorgen; Matras, Christina; Bouchelouche, Pierre			Functional and Molecular Evidence for K(v)7 Channel Subtypes in Human Detrusor from Patients with and without Bladder Outflow Obstruction	PLOS ONE			English	Article							KCNQ POTASSIUM CHANNELS; URINARY-BLADDER; SMOOTH-MUSCLE; BETA-ADRENOCEPTORS; PROTEIN-KINASE; KV7 CHANNELS; K+ CHANNELS; RELAXATION; RETIGABINE; EXPRESSION	The aim of the study was to investigate whether K(v)7 channels and their ancillary beta-subunits, KCNE, are functionally expressed in the human urinary bladder. K(v)7 channels were examined at the molecular level and by functional studies using RT-qPCR and myography, respectively. We found mRNA expression of KCNQ1, KCNQ3-KCNQ5 and KCNE1-5 in the human urinary bladder from patients with normal bladder function (n = 7) and in patients with bladder outflow obstruction (n = 3). Interestingly, a 3.4-fold up-regulation of KCNQ1 was observed in the latter. The K(v)7 channel subtype selective modulators, ML277 (activator of K(v)7.1 channels, 10 mu M) and ML213 (activator of K(v)7.2, K(v)7.4, K(v)7.4/7.5 and K(v)7.5 channels, 10 mu M), reduced the tone of 1 mu M carbachol pre-constricted bladder strips. XE991 (blocker of K(v)7.1-7.5 channels, 10 mu M) had opposing effects as it increased contractions achieved with 20 mM KPSS. Furthermore, we investigated if there is interplay between K(v)7 channels and beta-adrenoceptors. Using cumulative additions of isoprenaline (beta-adrenoceptor agonist) and forskolin (adenylyl cyclase activator) in combination with the K(v)7 channel activator and blocker, retigabine and XE991, we did not find interplay between K(v)7 channels and beta-adrenoceptors in the human urinary bladder. The performed gene expression analysis combined with the organ bath studies imply that compounds that activate K(v)7 channels could be useful for treatment of overactive bladder syndrome.	[Svalo, Julie; Bouchelouche, Pierre] Copenhagen Univ Hosp, Dept Clin Biochem, Smooth Muscle Res Ctr, Koege, Denmark; [Svalo, Julie; Sheykhzade, Majid] Univ Copenhagen, Dept Drug Design & Pharmacol, Copenhagen, Denmark; [Nordling, Jorgen] Copenhagen Univ Hosp, Dept Urol, Herlev, Denmark; [Matras, Christina] Copenhagen Univ Hosp, Dept Urol, Naestved, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen	Svalo, J (corresponding author), Copenhagen Univ Hosp, Dept Clin Biochem, Smooth Muscle Res Ctr, Koege, Denmark.	juliesvaloe@hotmail.com		Bouchelouche, Pierre/0000-0002-0441-8194; Sheykhzade, Majid/0000-0002-4561-0326	Region Zealand Health Foundation	Region Zealand Health Foundation	This work was supported by Region Zealand Health Foundation, http://www.regionsjaelland.dk/Sundhed/forskning/forskningsfinansiering/Sider/oekonomi.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott GW, 2014, NEW J SCI, V2014, P1, DOI [10.1155/2014/237431, DOI 10.1155/2014/237431]; Abrams P, 2003, UROLOGY, V61, P37, DOI 10.1016/S0090-4295(02)02243-4; Afeli SAY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075875; Anderson UA, 2013, BRIT J PHARMACOL, V169, P1290, DOI 10.1111/bph.12210; Anderson UA, 2009, J UROLOGY, V182, P330, DOI 10.1016/j.juro.2009.02.108; Andersson KE, 2013, J UROLOGY, V190, P1173, DOI 10.1016/j.juro.2013.02.104; Andersson KE, 2004, PHYSIOL REV, V84, P935, DOI 10.1152/physrev.00038.2003; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Biers SM, 2006, BJU INT, V98, P1310, DOI 10.1111/j.1464-410X.2006.06564.x; Brickel N, 2012, EPILEPSIA, V53, P606, DOI 10.1111/j.1528-1167.2012.03441.x; Brueggemann LI, 2014, MOL PHARM; Brueggemann LI, 2014, J BIOL CHEM, V289, P2099, DOI 10.1074/jbc.M113.527820; Brueggemann LI, 2012, AM J PHYSIOL-LUNG C, V302, pL120, DOI 10.1152/ajplung.00194.2011; Chadha PS, 2012, HYPERTENSION, V59, P877, DOI 10.1161/HYPERTENSIONAHA.111.187427; Chambard JM, 2005, PFLUG ARCH EUR J PHY, V450, P34, DOI 10.1007/s00424-004-1366-2; Ferro A, 2006, N-S ARCH PHARMACOL, V373, P183, DOI 10.1007/s00210-006-0065-2; Frazier EP, 2005, J PHARMACOL EXP THER, V313, P260, DOI 10.1124/jpet.104.077768; French JA, 2011, NEUROLOGY, V76, P1555, DOI 10.1212/WNL.0b013e3182194bd3; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Igawa Y, 2001, J UROLOGY, V165, P240, DOI 10.1097/00005392-200101000-00071; Irwin DE, 2006, EUR UROL, V50, P1306, DOI 10.1016/j.eururo.2006.09.019; Joshi S, 2009, J PHARMACOL EXP THER, V329, P368, DOI 10.1124/jpet.108.147785; King CH, 2014, J COMP NEUROL, V522, P3262, DOI 10.1002/cne.23595; Kurokawa J, 2004, P NATL ACAD SCI USA, V101, P16374, DOI 10.1073/pnas.0405583101; Linley JE, 2012, J PHYSIOL-LONDON, V590, P793, DOI 10.1113/jphysiol.2011.223404; Mani BK, 2013, J CARDIOVASC PHARM, V61, P51, DOI 10.1097/FJC.0b013e3182771708; Marx SO, 2002, SCIENCE, V295, P496, DOI 10.1126/science.1066843; Mattmann ME, 2012, BIOORG MED CHEM LETT, V22, P5936, DOI 10.1016/j.bmcl.2012.07.060; McCallum LA, 2011, J CELL MOL MED, V15, P577, DOI 10.1111/j.1582-4934.2010.01021.x; McCrossan ZA, 2004, NEUROPHARMACOLOGY, V47, P787, DOI 10.1016/j.neuropharm.2004.06.018; Michel MC, 2006, BRIT J PHARMACOL, V147, pS88, DOI 10.1038/sj.bjp.0706619; Mucha M, 2010, J NEUROSCI, V30, P13235, DOI 10.1523/JNEUROSCI.1981-10.2010; Ng FL, 2011, BRIT J PHARMACOL, V162, P42, DOI 10.1111/j.1476-5381.2010.01027.x; Nomiya M, 2003, J UROLOGY, V170, P649, DOI 10.1097/01.ju.0000067621.62736.7c; Potet F, 2001, AM J PHYSIOL-HEART C, V280, pH2038, DOI 10.1152/ajpheart.2001.280.5.H2038; Robbins J, 2001, PHARMACOL THERAPEUT, V90, P1, DOI 10.1016/S0163-7258(01)00116-4; Rode F, 2010, EUR J PHARMACOL, V638, P121, DOI 10.1016/j.ejphar.2010.03.050; Rose K, 2011, PAIN, V152, P742, DOI 10.1016/j.pain.2010.12.028; Rosenbaum ST, 2012, J CELL MOL MED, V16, P3001, DOI 10.1111/j.1582-4934.2012.01627.x; Sacco E, 2012, THER ADV UROL, V4, P315, DOI 10.1177/1756287212457114; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; SCHAAP P, 1993, J BIOL CHEM, V268, P6323; Schroeder BC, 1998, NATURE, V396, P687, DOI 10.1038/25367; Schroeder BC, 2000, NATURE, V403, P196, DOI 10.1038/35003200; Stott JB, 2014, DRUG DISCOV TODAY, V19, P413, DOI 10.1016/j.drudis.2013.12.003; Streng T, 2004, J UROLOGY, V172, P2054, DOI 10.1097/01.ju.0000138155.33749.f4; Svalo J, 2011, BASIC CLIN PHARM TOX; Svalo J, 2013, EUR J PHARMACOL, V715, P312, DOI 10.1016/j.ejphar.2013.05.005; Uchida H, 2005, EUR J PHARMACOL, V518, P195, DOI 10.1016/j.ejphar.2005.06.029; Yamaguchi O, 2009, WORLD J UROL, V27, P722, DOI 10.1007/s00345-009-0470-5; Yu HB, 2011, ACS CHEM NEUROSCI, V2, P572, DOI 10.1021/cn200065b; Zaika O, 2007, J NEUROSCI, V27, P8914, DOI 10.1523/JNEUROSCI.1739-07.2007; Zaika O, 2006, J PHYSIOL-LONDON, V575, P49, DOI 10.1113/jphysiol.2006.114074; Zhang J, 2012, NEURON, V76, P1133, DOI 10.1016/j.neuron.2012.10.019	54	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117350	10.1371/journal.pone.0117350	http://dx.doi.org/10.1371/journal.pone.0117350			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692982	Green Submitted, gold, Green Published			2022-12-26	WOS:000350061500050
J	Voda, R; Dapporto, L; Dinca, V; Vila, R				Voda, Raluca; Dapporto, Leonardo; Dinca, Vlad; Vila, Roger			Why Do Cryptic Species Tend Not to Co-Occur? A Case Study on Two Cryptic Pairs of Butterflies	PLOS ONE			English	Article							BIOTIC INTERACTIONS; REPRODUCTIVE INTERFERENCE; DISTRIBUTIONS; PATTERNS; BIOGEOGRAPHY; LEPIDOPTERA; MIGRATION; CLIMATE; PREDICTIONS; NESTEDNESS	As cryptic diversity is being discovered, mostly thanks to advances in molecular techniques, it is becoming evident that many of these taxa display parapatric distributions in mainland and that they rarely coexist on islands. Genetic landscapes, haplotype networks and ecological niche modeling analyses were performed for two pairs of non-sister cryptic butterfly species, Aricia agestis-A. cramera and Polyommatus icarus-P. celina (Lycaenidae), to specifically assess non-coexistence on western Mediterranean islands, and to test potential causes producing such chequered distribution patterns. We show that the morphologically and ecologically equivalent pairs of species do not coexist on any of the studied islands, although nearly all islands are colonized by one of them. According to our models, the cryptic pairs displayed marked climatic preferences and 'precipitation during the driest quarter' was recovered as the most important climatic determinant. However, neither dispersal capacity, nor climatic or ecological factors fully explain the observed distributions across particular sea straits, and the existence of species interactions resulting in mutual exclusion is suggested as a necessary hypothesis. Given that the studied species are habitat generalists, feeding on virtually unlimited resources, we propose that reproductive interference, together with climatic preferences, sustain density-dependent mechanisms like "founder takes all" and impede coexistence on islands. Chequered distributions among cryptic taxa, both sister and non-sister, are common in butterflies, suggesting that the phenomenon revealed here could be important in determining biodiversity patterns.	[Voda, Raluca; Dinca, Vlad; Vila, Roger] Univ Pompeu Fabra, CSIC, Inst Biol Evolut, Butterfly Divers & Evolut Lab, Barcelona, Spain; [Voda, Raluca] Univ Autonoma Barcelona, Dept Genet & Microbiol, Bellaterra, Spain; [Dapporto, Leonardo] Oxford Brookes Univ, Dept Biol & Med Sci, Oxford OX3 0BP, England; [Dinca, Vlad] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; Autonomous University of Barcelona; Oxford Brookes University; University of Guelph	Vila, R (corresponding author), Univ Pompeu Fabra, CSIC, Inst Biol Evolut, Butterfly Divers & Evolut Lab, Barcelona, Spain.	roger.vila@csic.es	Vila, Roger/A-1817-2012; Dinca, Vlad Eugen/O-3879-2014; Voda, Raluca/E-6817-2015; Dapporto, Leonardo/E-5752-2010	Vila, Roger/0000-0002-2447-4388; Dinca, Vlad Eugen/0000-0003-1791-2148; Voda, Raluca/0000-0003-1970-5628; Dapporto, Leonardo/0000-0001-7129-4526	Spanish Ministerio de Economia y Competitividad [CGL2010-21226/BOS, CGL201348277-P]; Spanish Ministerio de Economia y Competitividad (predoctoral fellowship) [AP-2010-5409]; European Commission through Marie Curie International Outgoing Fellowship for Career Development [625997]; project "Barcoding Italian Butterflies"; project "Barcoding Butterflies of the Tuscan Archipelago National Park"	Spanish Ministerio de Economia y Competitividad(Spanish Government); Spanish Ministerio de Economia y Competitividad (predoctoral fellowship); European Commission through Marie Curie International Outgoing Fellowship for Career Development; project "Barcoding Italian Butterflies"; project "Barcoding Butterflies of the Tuscan Archipelago National Park"	Funding for this research was provided by the Spanish Ministerio de Economia y Competitividad (Projects CGL2010-21226/BOS and CGL201348277-P and a predoctoral fellowship to R. Voda, AP-2010-5409), by the European Commission through a Marie Curie International Outgoing Fellowship for Career Development to V. Dinca (project no. 625997), and by the projects "Barcoding Italian Butterflies" and "Barcoding Butterflies of the Tuscan Archipelago National Park." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biermann Heinrich, 1996, Atalanta (Marktleuthen), V27, P253; Blach-Overgaard A, 2010, ECOGRAPHY, V33, P380, DOI 10.1111/j.1600-0587.2010.06273.x; Boillat Harry, 2002, Alexanor, V22, P243; Borcard D, 2011, NUMERICAL ECOLOGY R, Vxi; Dapporto L, 2013, BIOL CONSERV, V157, P229, DOI 10.1016/j.biocon.2012.09.016; Dapporto L, 2012, DIVERS DISTRIB, V18, P1066, DOI 10.1111/j.1472-4642.2012.00903.x; Dapporto L, 2012, ORG DIVERS EVOL, V12, P39, DOI 10.1007/s13127-011-0065-z; Dapporto L, 2010, J ZOOL SYST EVOL RES, V48, P229, DOI 10.1111/j.1439-0469.2009.00550.x; Dasmahapatra KK, 2010, MOL ECOL, V19, P4283, DOI 10.1111/j.1365-294X.2010.04802.x; Dennis RLH, 2010, RESOURCE BASED HABIT, Vxii; Dennis RLH, 2012, J BIOGEOGR, V39, P1412, DOI 10.1111/j.1365-2699.2012.02698.x; Descimon Henri, 2009, P219; Devictor V, 2012, NAT CLIM CHANGE, V2, P121, DOI 10.1038/NCLIMATE1347; DeWaard Jeremy R., 2008, V410, P275; Dinca V, 2013, J EVOLUTION BIOL, V26, P2095, DOI 10.1111/jeb.12211; Dinca V, 2011, MOL ECOL, V20, P3921, DOI 10.1111/j.1365-294X.2011.05223.x; Dinca V, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1329; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Friberg M, 2013, J EVOLUTION BIOL, V26, P971, DOI 10.1111/jeb.12106; Friberg M, 2008, BEHAV ECOL SOCIOBIOL, V62, P873, DOI 10.1007/s00265-007-0511-2; Gillespie RG, 2012, TRENDS ECOL EVOL, V27, P47, DOI 10.1016/j.tree.2011.08.009; Grill A, 2013, CONTRIB ZOOL, V82, P27, DOI 10.1163/18759866-08201002; Groning J, 2008, Q REV BIOL, V83, P257, DOI 10.1086/590510; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Habel JC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-215; Harrell FE, 2001, REGRESSION MODELING, Vxxii; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Heikkinen RK, 2007, GLOBAL ECOL BIOGEOGR, V16, P754, DOI 10.1111/j.1466-8238.2007.00345.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hill JK, 2002, P ROY SOC B-BIOL SCI, V269, P2163, DOI 10.1098/rspb.2002.2134; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Isaac NJB, 2004, TRENDS ECOL EVOL, V19, P464, DOI 10.1016/j.tree.2004.06.004; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; KEDDY PA, 1992, FUNCT ECOL, V6, P621, DOI 10.2307/2389954; Keis M, 2013, J BIOGEOGR, V40, P915, DOI 10.1111/jbi.12043; Kishi S, 2009, J ANIM ECOL, V78, P1043, DOI 10.1111/j.1365-2656.2009.01560.x; Kudrna Otakar, 2011, P1; Liu CR, 2013, J BIOGEOGR, V40, P778, DOI 10.1111/jbi.12058; Mallet J, 2010, ECOL ENTOMOL, V35, P90, DOI 10.1111/j.1365-2311.2009.01137.x; McBride CS, 2009, MOL ECOL, V18, P3639, DOI 10.1111/j.1365-294X.2009.04309.x; Meier ES, 2010, ECOGRAPHY, V33, P1038, DOI 10.1111/j.1600-0587.2010.06229.x; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Nazari V, 2010, SYST ENTOMOL, V35, P132, DOI 10.1111/j.1365-3113.2009.00493.x; Ord TJ, 2011, EVOLUTION, V65, P2572, DOI 10.1111/j.1558-5646.2011.01319.x; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pianka E.R., 1979, P67; Pigot AL, 2013, ECOL LETT, V16, P330, DOI 10.1111/ele.12043; Porter Adam H., 2009, P296; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Sammut P, 1984, NEUE ENTOMOLOGISCHE, V13, P1; Santos H, 2014, BIOL J LINN SOC, V112, P150, DOI 10.1111/bij.12247; Sanudo-Restrepo CP, 2013, MOL PHYLOGENET EVOL, V66, P369, DOI 10.1016/j.ympev.2012.10.010; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Talavera G, 2013, MOL PHYLOGENET EVOL, V69, P469, DOI 10.1016/j.ympev.2013.08.004; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tarrier MR, 2008, PAPILLONS JOUR MOROC; TENNENT WJ, 1996, BUTTERFLIES MOROCCO; Thuiller W, 2003, GLOBAL CHANGE BIOL, V9, P1353, DOI 10.1046/j.1365-2486.2003.00666.x; Tobias JA, 2014, NATURE, V506, P359, DOI 10.1038/nature12874; Toews DPL, 2014, EVOLUTION, V68, P241, DOI 10.1111/evo.12260; Ulrich W, 2007, OIKOS, V116, P2053, DOI 10.1111/j.2007.0030-1299.16173.x; Vandergast AG, 2011, MOL ECOL RESOUR, V11, P158, DOI 10.1111/j.1755-0998.2010.02904.x; Voda R, 2015, ECOGRAPHY, V38, P405, DOI 10.1111/ecog.00762; Wardle DA, 1998, J ECOL, V86, P405, DOI 10.1046/j.1365-2745.1998.00268.x; Wickman Per-Olof, 2009, P17; Wiemers M, 2010, EUR J ENTOMOL, V107, P325, DOI 10.14411/eje.2010.041; Wisz MS, 2013, BIOL REV, V88, P15, DOI 10.1111/j.1469-185X.2012.00235.x; Zhou ZS, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.1001	69	51	54	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117802	10.1371/journal.pone.0117802	http://dx.doi.org/10.1371/journal.pone.0117802			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692577	Green Submitted, Green Published, gold			2022-12-26	WOS:000350061500076
J	Yamashita, M; Konishi, T; Sato, T				Yamashita, Momo; Konishi, Takuya; Sato, Tamaki			Sclerotic Rings in Mosasaurs (Squamata: Mosasauridae): Structures and Taxonomic Diversity	PLOS ONE			English	Article							CRETACEOUS BEARPAW FORMATION; PRESERVED SPECIMEN; SOUTHERN ALBERTA; NIOBRARA-CHALK; FEATURES; CANADA; PHYLOGENY; REPTILES; GENUS; EYE	Mosasaurs (Squamata: Mosasauridae) were a highly diverse, globally distributed group of aquatic lizards in the Late Cretaceous (98-66 million years ago) that exhibited a high degree of adaptation to life in water. To date, despite their rich fossil record, the anatomy of complete mosasaur sclerotic rings, embedded in the sclera of the eyeball, has not been thoroughly investigated. We here describe and compare sclerotic rings of four mosasaur genera, Tylosaurus, Platecarpus, Clidastes, and Mosasaurus, for the first time. Two specimens of Tylosaurus and Platecarpus share an exact scleral ossicle arrangement, excepting the missing portion in the specimen of Platecarpus. Furthermore, the exact arrangement and the total count of 14 ossicles per ring are shared between Tylosaurus and numerous living terrestrial lizard taxa, pertaining to both Iguania and Scleroglossa. In contrast, two species of Mosasaurus share the identical count of 12 ossicles and the arrangement with each other, while no living lizard taxa share exactly the same arrangement. Such a mosaic distribution of these traits both among squamates globally and among obligatorily aquatic mosasaurs specifically suggests that neither the ossicle count nor their arrangement played major roles in the aquatic adaptation in mosasaur eyes. All the mosasaur sclerotic rings examined consistently exhibit aperture eccentricity and the scleral ossicles with gently convex outer side. Hitherto unknown to any squamate taxa, one specimen of Platecarpus unexpectedly shows a raised, concentric band of roughened surface on the inner surface of the sclerotic ring. It is possible that one or both of these latter features may have related to adaptation towards aquatic vision in mosasaurs, but further quantitative study of extant reptilian clades containing both terrestrial and aquatic taxa is critical and necessary in order to understand possible adaptive significances of such osteological features.	[Yamashita, Momo; Sato, Tamaki] Tokyo Gakugei Univ, Dept Astron & Earth Sci, Koganei, Tokyo, Japan; [Konishi, Takuya] Royal Tyrrell Museum Palaeontol, Drumheller, AB, Canada	Tokyo Gakugei University	Yamashita, M (corresponding author), Univ Tokyo, Dept Earth & Planetary Sci, Bunkyo Ku, Tokyo, Japan.	myamashita@eps.s.u-tokyo.ac.jp						[Anonymous], VERTEBRATE EYE ITS A, DOI 10.1097/00005053-194409000-00057; Bell GL, 2005, NETH J GEOSCI, V84, P177, DOI 10.1017/S0016774600020965; Brudenall DK, 2008, VET OPHTHALMOL, V11, P99, DOI 10.1111/j.1463-5224.2008.00607.x; Caldwell MW, 1996, ZOOL J LINN SOC-LOND, V116, P407, DOI 10.1006/zjls.1996.0027; Caldwell MW, 2002, AM J MED GENET, V112, P236, DOI 10.1002/ajmg.10773; Carroll Robert L., 1997, P467, DOI 10.1016/B978-012155210-7/50025-9; COULOMBRE AJ, 1973, DEV BIOL, V33, P257, DOI 10.1016/0012-1606(73)90136-X; Dollo L., 1889, B SOC BELG GEOL, V3, P271; EDINGER TILLY, 1929, ZOOL JAHRB ABT ANAT U ONTOGEN TIERE, V51, P163; Everhart Michael J., 2001, Transactions of the Kansas Academy of Science, V104, P59, DOI 10.1660/0022-8443(2001)104[0059:RTTBOT]2.0.CO;2; Everhart MJ, 2005, NETH J GEOSCI, V84, P231, DOI 10.1017/S0016774600021016; Gauthier JA, 2012, B PEABODY MUS NAT HI, V53, P3, DOI 10.3374/014.053.0101; Goldfuss A., 1845, NOVA ACTA ACAD CEASA, V21, P1; Hall MI, 2009, ANAT REC, V292, P798, DOI 10.1002/ar.20889; Hattin DE, 1996, CRETACEOUS RES, V17, P443, DOI 10.1006/cres.1996.0027; Humphries S, 2002, J EXP BIOL, V205, P439; Jacobs LL, 2005, NETH J GEOSCI, V84, P257, DOI 10.1017/S0016774600021041; Kauffman E.G., 1977, Mountain Geologist, V14, P75; Konishi T, 2014, J VERTEBR PALEONTOL, V34, P802, DOI 10.1080/02724634.2014.838573; Konishi T, 2012, J VERTEBR PALEONTOL, V32, P1313, DOI 10.1080/02724634.2012.699811; Konishi T, 2011, J VERTEBR PALEONTOL, V31, P1026, DOI 10.1080/02724634.2011.601714; Konishi T, 2011, J VERTEBR PALEONTOL, V31, P754, DOI 10.1080/02724634.2011.579023; Konishi T, 2010, J VERTEBR PALEONTOL, V30, P1410, DOI 10.1080/02724634.2010.501464; Konishi T, 2009, J VERTEBR PALEONTOL, V29, P417, DOI 10.1671/039.029.0225; Land MF, 2002, ANIMAL EYES; LEMMRICH WERNER, 1931, JENAISCHE ZEITSCHR NATURWISS, V65, P513; Lima F.C., 2009, Brazilian Journal of Morphological Sciences, V26, P165; Lindgren J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3423; Lindgren J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011998; Longrich N, 2010, ROYAL TYRR MUS CER S, P308; Marsh O.C., 1872, AM J SCI, V16, P290; Marsh O. C., 1880, AM J SCI, V109, P83; Martin G.R., 1994, P5; Mass AM, 2007, ANAT REC, V290, P701, DOI 10.1002/ar.20529; MCNEIL DH, 1984, CANADIAN SOC PETROLE, V9, P145; Motani R, 1999, NATURE, V402, P747, DOI 10.1038/45435; NATTIN D., 1982, BULLETIN, V225; NICHOLLS EL, 1988, THESIS U CALGARY CAL; Obradovich JD, 1993, EVOLUTION W INTERIOR, V39, P379; Ott M, 2006, J COMP PHYSIOL A, V192, P97, DOI 10.1007/s00359-005-0049-6; Pianka E.R., 2003, LIZARDS WINDOWS EVOL; Plisnier-Ladame F, 1969, Bull. Soc. belge Geol. Paleont. Hydrol., V78, P253; Romer A.S, 1956, OSTEOLOGY REPTILES; Russell D. A., 1967, Bulletin of the Peabody Museum of Natural History, V23, P1; Schmitz L, 2011, SCIENCE, V332, P705, DOI 10.1126/science.1200043; Schmitz L, 2009, J MORPHOL, V270, P759, DOI 10.1002/jmor.10720; SIVAK J, 1987, PROC R SOC SER B-BIO, V229, P467, DOI 10.1098/rspb.1987.0005; Sivak J.G., 1975, P289; Sivak JG, 2004, INVEST OPHTH VIS SCI, V45, P740, DOI 10.1167/iovs.03-0466; Thewissen JGM, 2008, SENSORY EVOLUTION ON THE THRESHOLD: ADAPTATIONS IN SECONDARILY AQUATIC VERTEBRATES, P1; Torres-Carvajal O, 2003, J MORPHOL, V255, P94, DOI 10.1002/jmor.10051; Tsujita CJ, 1998, PALAEOGEOGR PALAEOCL, V144, P135, DOI 10.1016/S0031-0182(98)00090-X; TSUJITA CJ, 1995, PALAIOS, V10, P408, DOI 10.2307/3515044; UNDERWOOD G, 1970, BIOLOGY REPTILIA, V2, P1; Vikaryous MV, 2006, REV CRANIOFACIAL DEV, V235, P1244; Williston S. W., 1914, WATER REPTILES PRESE; WILLISTON SW, 1898, PALAEONTOLOGY, V4, P81	57	5	5	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117079	10.1371/journal.pone.0117079	http://dx.doi.org/10.1371/journal.pone.0117079			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692667	Green Published, Green Submitted, gold			2022-12-26	WOS:000350061500037
J	Arnal, ME; Zhang, J; Erridge, C; Smidt, H; Lalles, JP				Arnal, Marie-Edith; Zhang, Jing; Erridge, Clett; Smidt, Hauke; Lalles, Jean-Paul			Maternal Antibiotic-Induced Early Changes in Microbial Colonization Selectively Modulate Colonic Permeability and Inducible Heat Shock Proteins, and Digesta Concentrations of Alkaline Phosphatase and TLR-Stimulants in Swine Offspring	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; PHYSIOLOGICAL EXPRESSION; INTESTINAL PERMEABILITY; GASTROINTESTINAL-TRACT; LINKING INFLAMMATION; DIFFERENT REGIONS; BARRIER FUNCTION; GENE-EXPRESSION; GUT MICROBIOTA; HEAT-SHOCK-PROTEIN-25	Elevated intake of high energy diets is a risk factor for the development of metabolic diseases and obesity. High fat diets cause alterations in colonic microbiota composition and increase gut permeability to bacterial lipopolysaccharide, and subsequent low-grade chronic inflammation in mice. Chronic inflammatory bowel diseases are increasing worldwide and may involve alterations in microbiota-host dialog. Metabolic disorders appearing in later life are also suspected to reflect changes in early programming. However, how the latter affects the colon remains poorly studied. Here, we hypothesized that various components of colonic physiology, including permeability, ion exchange and protective inducible heat shock proteins (HSP) are influenced in the short-and long-terms by early disturbances in microbial colonization. The hypothesis was tested in a swine model. Offspring were born to control mothers (n = 12) or mothers treated with the antibiotic (ATB) amoxicillin around parturition (n = 11). Offspring were slaughtered between 14 and 42 days of age to study short-term effects. For long-term effects, young adult offspring from the same litters consumed a normal or a palm oil-enriched diet for 4 weeks between 140 and 169 days of age. ATB treatment transiently modified maternal fecal microbiota although the minor differences observed for offspring colonic microbiota were nonsignificant. In the short-term, consistently higher HSP27 and HSP70 levels and transiently increased horseradish peroxidase permeability in ATB offspring colon were observed. Importantly, long-term consequences included reduced colonic horseradish peroxidase permeability, and increased colonic digesta alkaline phosphatase (AP) and TLR2-and TLR4-stimulant concentrations in rectal digesta in adult ATB offspring. Inducible HSP27 and HSP70 did not change. Interactions between early ATB treatment and later diet were noted for paracellular permeability and concentrations of colonic digesta AP. In conclusion, our data suggest that early ATB-induced changes in bacterial colonization modulate important aspects of colonic physiology in the short- and longterms.	[Arnal, Marie-Edith; Lalles, Jean-Paul] INRA, Food & Digest, Cent & Behav Adaptat Dept, St Gilles, France; [Zhang, Jing; Smidt, Hauke] Wageningen Univ, Microbiol Lab, NL-6700 AP Wageningen, Netherlands; [Erridge, Clett] Univ Leicester, Glenfield Gen Hosp, Dept Cardiovasc Sci, Leicester, Leics, England	INRAE; Wageningen University & Research; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital	Lalles, JP (corresponding author), INRA, Food & Digest, Cent & Behav Adaptat Dept, St Gilles, France.	jean-paul.lalles@rennes.inra.fr	Smidt, Hauke/D-7054-2014	Smidt, Hauke/0000-0002-6138-5026; Erridge, Clett/0000-0003-2978-346X; Lalles, Jean-Paul/0000-0003-2732-5350	European Union [227549]; INRA Human Nutrition Division; Region Bretagne, France; China Scholarship Council (CSC)	European Union(European Commission); INRA Human Nutrition Division; Region Bretagne, France(Region Bretagne); China Scholarship Council (CSC)(China Scholarship Council)	This work was financially supported by the European Union (contract No. 227549) through the Interplay project. The authors are solely responsible for the work described in this paper, and their opinions are not necessarily those of the European Union. MEA was the recipient of a PhD thesis grant from INRA Human Nutrition Division and the Region Bretagne, France which are acknowledged. JZ was supported by a PhD fellowship of the China Scholarship Council (CSC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnal ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087967; Arvans DL, 2005, AM J PHYSIOL-GASTR L, V288, pG696, DOI 10.1152/ajpgi.00206.2004; Cani PD, 2009, CURR PHARM DESIGN, V15, P1546, DOI 10.2174/138161209788168164; Chatelais L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019594; David JC, 2002, J NUTR, V132, P2551, DOI 10.1093/jn/132.9.2551; Erridge C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009125; Fak F, 2008, AM J PHYSIOL-GASTR L, V294, pG148, DOI 10.1152/ajpgi.00023.2007; Fanca-Berthon P, 2010, J PEDIATR GASTR NUTR, V51, P402, DOI 10.1097/MPG.0b013e3181d75d52; Farkas K, 2011, INFLAMM BOWEL DIS, V17, P884, DOI 10.1002/ibd.21432; Goldberg RF, 2008, P NATL ACAD SCI USA, V105, P3551, DOI 10.1073/pnas.0712140105; Haenen D, 2013, J NUTR, V143, P274, DOI 10.3945/jn.112.169672; Heegaard PMH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068110; Hu SE, 2010, AM J PHYSIOL-GASTR L, V299, pG1266, DOI 10.1152/ajpgi.00357.2010; Janczyk P, 2007, ISME J, V1, P180, DOI 10.1038/ismej.2007.29; Jin CC, 2013, J ALLERGY CLIN IMMUN, V132, P287, DOI 10.1016/j.jaci.2013.06.022; Keely S, 2012, GUT MICROBES, V3, P250, DOI [10.4161/gutmic.20529, 10.4161/gmic.20529]; Kim KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047713; Konner AC, 2011, TRENDS ENDOCRIN MET, V22, P16, DOI 10.1016/j.tem.2010.08.007; Kojima K, 2004, AM J PHYSIOL-GASTR L, V286, pG645, DOI 10.1152/ajpgi.00080.2003; Kojima K, 2003, GASTROENTEROLOGY, V124, P1395, DOI 10.1016/S0016-5085(03)00215-4; Lalles JP, 2012, J ANIM SCI, V90, P421, DOI 10.2527/jas.53904; Lalles JP, 2014, NUTR REV, V72, P82, DOI 10.1111/nure.12082; Lalles JP, 2012, J NUTR BIOCHEM, V23, P1490, DOI 10.1016/j.jnutbio.2011.10.001; Lalles JP, 2010, NUTR REV, V68, P323, DOI 10.1111/j.1753-4887.2010.00292.x; Lalles JP, 2006, BRIT J NUTR, V95, P488, DOI 10.1079/BJN20051673; Le Gall M, 2009, BRIT J NUTR, V102, P1285, DOI 10.1017/S0007114509990213; Lebeer S, 2008, MICROBIOL MOL BIOL R, V72, P728, DOI 10.1128/MMBR.00017-08; Liu HY, 2014, AM J PHYSIOL-GASTR L, V306, pC1033, DOI 10.1152/ajpgi.00299.2013; Lopez-Posadas R, 2011, INFLAMM BOWEL DIS, V17, P543, DOI 10.1002/ibd.21381; Mani V, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-6; Menard S, 2010, MUCOSAL IMMUNOL, V3, P247, DOI 10.1038/mi.2010.5; Musch MW, 1999, GASTROENTEROLOGY, V117, P115, DOI 10.1016/S0016-5085(99)70557-3; Pastorelli L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00280; Perez Gutierrez O, 2010, THESIS WAGENINGEN U; Petrof EO, 2008, AM J PHYSIOL-GASTR L, V294, pG808, DOI 10.1152/ajpgi.00362.2007; Petrof Elaine O, 2004, Chin J Dig Dis, V5, P45, DOI 10.1111/j.1443-9573.2004.00154.x; Petrof EO, 2009, INFLAMM BOWEL DIS, V15, P1537, DOI 10.1002/ibd.20930; Qian SB, 2006, NATURE, V440, P551, DOI 10.1038/nature04600; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Ren HY, 2001, GASTROENTEROLOGY, V121, P631, DOI 10.1053/gast.2001.27028; Reyns T, 2007, J VET PHARMACOL THER, V30, P550, DOI 10.1111/j.1365-2885.2007.00910.x; Ruel J, 2014, NAT REV GASTRO HEPAT, V11, P88, DOI 10.1038/nrgastro.2013.240; Schumann A, 2005, PHYSIOL GENOMICS, V23, P235, DOI 10.1152/physiolgenomics.00057.2005; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Stenman LK, 2012, WORLD J GASTROENTERO, V18, P923, DOI 10.3748/wjg.v18.i9.923; Van den Brink PJ, 1999, ENVIRON TOXICOL CHEM, V18, P138, DOI [10.1897/1551-5028(1999)018&lt;0138:PRCAOT&gt;2.3.CO;2, 10.1002/etc.5620180207]; Van Driessche W, 2007, AM J PHYSIOL-LUNG C, V293, pL520, DOI 10.1152/ajplung.00218.2007; Voellmy R, 2007, ADV EXP MED BIOL, V594, P89; Wallon C, 2009, ANN NY ACAD SCI, V1165, P206, DOI 10.1111/j.1749-6632.2009.04030.x; Westerheide SD, 2012, CURR PROTEIN PEPT SC, V13, P86; Wijtten PJA, 2011, BRIT J NUTR, V105, P967, DOI 10.1017/S0007114510005660; Yan H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059581	52	22	24	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0118092	10.1371/journal.pone.0118092	http://dx.doi.org/10.1371/journal.pone.0118092			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689154	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000350322700100
J	Borst, C; Xia, SQ; Bistrup, C; Tepel, M				Borst, Christoffer; Xia, Shengqiang; Bistrup, Claus; Tepel, Martin			Interleukin-8 Transcripts in Mononuclear Cells Determine Impaired Graft Function after Kidney Transplantation	PLOS ONE			English	Article							RENAL-ALLOGRAFTS; REPERFUSION; EXPRESSION; BIOMARKERS; INJURY; INHIBITION; CYTOKINES; MARKERS	Objective Interleukin-8 (IL-8) has been associated with ischemia reperfusion injury after renal allograft transplantation. Impaired allograft function may cause major impact on patient morbidity and health care costs. We investigated whether transcript levels in mononuclear cells including IL-8 on the first postoperative day may be involved in immediate allograft dysfunction as defined by reduced relative change in plasma creatinine at the first postoperative day. Methods We performed a single center, prospective-cohort study of 113 patients receiving kidney transplants. Peripheral blood mononuclear cells were harvested within 24 hours after transplantation. Transcripts were measured using quantitative RT-PCR. Results Transcript levels of IL-8 and S100A8 were significantly lower in patients with relative change in plasma creatinine less than 10% at the first postoperative day. Receiver-operator characteristic curves showed that IL-8 predicted the relative change in plasma creatinine less than 10% (area under curve (AUC), 0.80; P = 0.0007). Multivariate analyses showed that lower IL-8 transcripts, longer time on dialysis, higher recipient body mass index and deceased donor type were associated with relative change in plasma creatinine at the first postoperative day less than 10%. Conclusion Reduced levels of IL-8 transcripts in peripheral mononuclear cells predict immediate graft dysfunction and delayed graft function.	[Borst, Christoffer; Xia, Shengqiang; Bistrup, Claus; Tepel, Martin] Odense Univ Hosp, Dept Nephrol, DK-5000 Odense, Denmark; [Borst, Christoffer; Xia, Shengqiang; Tepel, Martin] Univ Southern Denmark, Inst Mol Med Cardiovasc & Renal Res, Inst Clin Res, Odense, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark	Tepel, M (corresponding author), Odense Univ Hosp, Dept Nephrol, DK-5000 Odense, Denmark.	mtepel@health.sdu.dk	Bistrup, Claus/F-3960-2019; Tepel, Martin/GRS-9581-2022	Bistrup, Claus/0000-0002-9280-916X; Tepel, Martin/0000-0002-0086-0997	European Union [62-1.2-10]	European Union(European Commission)	This study was supported by the European Union (Interreg 4A, grant number 62-1.2-10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMOND PS, 1991, TRANSPLANT P, V23, P1304; Araki M, 2006, TRANSPLANTATION, V81, P783, DOI 10.1097/01.tp.0000198736.69527.32; Ascon M, 2009, KIDNEY INT, V75, P526, DOI 10.1038/ki.2008.602; Balato A, 2014, MYCOSES, V57, P176, DOI 10.1111/myc.12140; Boom H, 2000, KIDNEY INT, V58, P859, DOI 10.1046/j.1523-1755.2000.00235.x; Budde K, 1997, AM J KIDNEY DIS, V29, P871, DOI 10.1016/S0272-6386(97)90461-3; Burkhardt K, 2001, J AM SOC NEPHROL, V12, P1947, DOI 10.1681/ASN.V1291947; Cheadle C, 2011, CLIN TRANSPLANT, V25, P766, DOI 10.1111/j.1399-0012.2010.01365.x; Cugini D, 2005, KIDNEY INT, V67, P1753, DOI 10.1111/j.1523-1755.2005.00272.x; Daemen MARC, 1999, J CLIN INVEST, V104, P541, DOI 10.1172/JCI6974; Eikmans M, 2005, J AM SOC NEPHROL, V16, P3771, DOI 10.1681/ASN.2005040412; Fontaine M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100909; Hall IE, 2010, J AM SOC NEPHROL, V21, P189, DOI 10.1681/ASN.2009030264; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Jung DY, 2008, TRANSPL IMMUNOL, V18, P338, DOI 10.1016/j.trim.2007.10.004; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Liu DZ, 2014, BIOMARKERS, V19, P424, DOI 10.3109/1354750X.2014.924997; Liu KD, 2009, CRIT CARE, V13, DOI 10.1186/cc7940; Mota APL, 2013, CYTOKINE, V62, P302, DOI 10.1016/j.cyto.2013.03.001; Mallon DH, 2013, TRANSPLANTATION, V96, P885, DOI 10.1097/TP.0b013e3182a19348; Perico N, 2004, LANCET, V364, P1814, DOI 10.1016/S0140-6736(04)17406-0; Prencipe G, 2014, J IMMUNOL, V192, P3345, DOI 10.4049/jimmunol.1300825; Rammes A, 1997, J BIOL CHEM, V272, P9496; ROSENTHAL JT, 1991, TRANSPLANTATION, V51, P1115; Shaffi K, 2014, AM J KIDNEY DIS, V63, P1007, DOI 10.1053/j.ajkd.2014.01.436; Vilar E, 2010, TRANSPLANTATION, V89, P97, DOI 10.1097/TP.0b013e3181be3dd1; Yarlagadda SG, 2009, NEPHROL DIAL TRANSPL, V24, P1039, DOI 10.1093/ndt/gfn667	27	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117315	10.1371/journal.pone.0117315	http://dx.doi.org/10.1371/journal.pone.0117315			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689147	Green Published, gold, Green Submitted			2022-12-26	WOS:000350322700035
J	Garcia-Torres, L; Caballero-Novella, JJ; Gomez-Candon, D; Pena, JM				Garcia-Torres, Luis; Caballero-Novella, Juan J.; Gomez-Candon, David; Manuel Pena, Jose			Census Parcels Cropping System Classification from Multitemporal Remote Imagery: A Proposed Universal Methodology	PLOS ONE			English	Article							DECISION TREE CLASSIFICATION; LAND-COVER; TIME-SERIES; AGRICULTURE; NDVI; AREA; TM	A procedure named CROPCLASS was developed to semi-automate census parcel crop assessment in any agricultural area using multitemporal remote images. For each area, CROPCLASS consists of a) a definition of census parcels through vector files in all of the images; b) the extraction of spectral bands (SB) and key vegetation index (VI) average values for each parcel and image; c) the conformation of a matrix data (MD) of the extracted information; d) the classification of MD decision trees (DT) and Structured Query Language (SQL) crop predictive model definition also based on preliminary land-use ground-truth work in a reduced number of parcels; and e) the implementation of predictive models to classify unidentified parcels land uses. The software named CROPCLASS-2.0 was developed to semi-automatically perform the described procedure in an economically feasible manner. The CROPCLASS methodology was validated using seven GeoEye-1 satellite images that were taken over the LaVentilla area (Southern Spain) from April to October 2010 at 3- to 4-week intervals. The studied region was visited every 3 weeks, identifying 12 crops and others land uses in 311 parcels. The DT training models for each cropping system were assessed at a 95% to 100% overall accuracy (OA) for each crop within its corresponding cropping systems. The DT training models that were used to directly identify the individual crops were assessed with 80.7% OA, with a user accuracy of approximately 80% or higher for most crops. Generally, the DT model accuracy was similar using the seven images that were taken at approximately one-month intervals or a set of three images that were taken during early spring, summer and autumn, or set of two images that were taken at about 2 to 3 months interval. The classification of the unidentified parcels for the individual crops was achieved with an OA of 79.5%.	[Garcia-Torres, Luis; Caballero-Novella, Juan J.; Gomez-Candon, David; Manuel Pena, Jose] Spanish Council Sci Res CSIC, Inst Sustainable Agr, Cordoba, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Agricultura Sostenible (IAS)	Garcia-Torres, L (corresponding author), Spanish Council Sci Res CSIC, Inst Sustainable Agr, Cordoba, Spain.	lgarciatorres@ias.csic.es	Peña, Jose M/K-4201-2014	Peña, Jose M/0000-0003-4592-3792; Gomez-Candon, David/0000-0002-4216-6709	Ministry of Economy and Competitivity [AGL-2010-15506]; Spanish Council for Scientific Research (CSIC)	Ministry of Economy and Competitivity; Spanish Council for Scientific Research (CSIC)	Funded by Spanish Council for Scientific Research (CSIC)(https:/www.csic.es), Ministry of Economy and Competitivity (https://sede.micinn.gob.es/) through the project AGL-2010-15506. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler-Golden M, 1998, 1998 AVIRIS GEOSC WO; Bernstein LS, 2012, OPT ENG, V51, DOI 10.1117/1.OE.51.11.111719; Breiman L., 1984, CLASSIFICATION REGRE; de Colstoun ECB, 2003, REMOTE SENS ENVIRON, V85, P316, DOI 10.1016/S0034-4257(03)00010-5; EU-LPIS, 2014, LAND PARC INF SYST I; Friedl MA, 1997, REMOTE SENS ENVIRON, V61, P399, DOI 10.1016/S0034-4257(97)00049-7; Fritz S, 2010, INT J REMOTE SENS, V31, P2237, DOI 10.1080/01431160902946598; Garcia-Torres L, 2014, CROPCLASS 2 O SOFTWA; Garcia-Torres L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091275; Ghose MK, 2010, INT J ADV COMPUT SC, V1, P93; Gitelson AA, 2002, REMOTE SENS ENVIRON, V80, P76, DOI 10.1016/S0034-4257(01)00289-9; Gomez-Candon D, 2011, PRECIS AGRIC, V12, P876, DOI 10.1007/s11119-011-9228-3; Inoue Y, 2003, PLANT PROD SCI, V6, P3, DOI 10.1626/pps.6.3; Jiang ZY, 2006, REMOTE SENS ENVIRON, V101, P366, DOI 10.1016/j.rse.2006.01.003; Lobell DB, 2004, REMOTE SENS ENVIRON, V93, P412, DOI 10.1016/j.rse.2004.08.002; Lunetta RS, 2010, INT J APPL EARTH OBS, V12, P81, DOI 10.1016/j.jag.2009.11.005; Maxwell SK, 2008, AGR ECOSYST ENVIRON, V127, P141, DOI 10.1016/j.agee.2008.03.012; ODENWELLER JB, 1984, REMOTE SENS ENVIRON, V14, P39, DOI 10.1016/0034-4257(84)90006-3; Ozdogan M, 2010, REMOTE SENS ENVIRON, V114, P1190, DOI 10.1016/j.rse.2010.01.006; Pal M, 2003, REMOTE SENS ENVIRON, V86, P554, DOI 10.1016/S0034-4257(03)00132-9; Pena-Barragan JM, 2011, REMOTE SENS ENVIRON, V115, P1301, DOI 10.1016/j.rse.2011.01.009; Serra P, 2008, INT J REMOTE SENS, V29, P2293, DOI 10.1080/01431160701408444; Sesnie SE, 2008, REMOTE SENS ENVIRON, V112, P2145, DOI 10.1016/j.rse.2007.08.025; Simonneaux V, 2008, INT J REMOTE SENS, V29, P95, DOI 10.1080/01431160701250390; South S, 2004, REMOTE SENS ENVIRON, V91, P90, DOI 10.1016/j.rse.2004.03.001; Thenkabail PS, 2012, PHOTOGRAMM ENG REM S, V78, P773; Wardlow BD, 2008, REMOTE SENS ENVIRON, V112, P1096, DOI 10.1016/j.rse.2007.07.019; Wardlow BD, 2007, REMOTE SENS ENVIRON, V108, P290, DOI 10.1016/j.rse.2006.11.021; Wright C, 2007, REMOTE SENS ENVIRON, V107, P582, DOI 10.1016/j.rse.2006.10.019; Xie YC, 2008, J PLANT ECOL, V1, P9, DOI 10.1093/jpe/rtm005; Zambon M, 2006, PHOTOGRAMM ENG REM S, V72, P25, DOI 10.14358/PERS.72.1.25; Zhong LH, 2014, REMOTE SENS ENVIRON, V140, P1, DOI 10.1016/j.rse.2013.08.023	33	2	2	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117551	10.1371/journal.pone.0117551	http://dx.doi.org/10.1371/journal.pone.0117551			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689830	Green Submitted, Green Published, gold			2022-12-26	WOS:000350322700054
J	Han, D; Walsh, MC; Kim, KS; Hong, SW; Lee, J; Yi, J; Rivas, G; Surh, CD; Choi, Y				Han, Daehee; Walsh, Matthew C.; Kim, Kwang Soon; Hong, Sung-Wook; Lee, Junyoung; Yi, Jaeu; Rivas, Gloriany; Surh, Charles D.; Choi, Yongwon			Microbiota-Independent Ameliorative Effects of Antibiotics on Spontaneous Th2-Associated Pathology of the Small Intestine	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; GUT MICROBIOTA; T-CELLS; HOMEOSTASIS; PROBIOTICS; INDUCTION; MICE	We have previously generated a mouse model of spontaneous Th2-associated disease of the small intestine called TRAF6 Delta DC, in which dendritic cell (DC)-intrinsic expression of the signaling mediator TRAF6 is ablated. Interestingly, broad-spectrum antibiotic treatment ameliorates TRAF6 Delta DC disease, implying a role for commensal microbiota in disease development. However, the relationship between the drug effects and commensal microbiota status remains to be formally demonstrated. To directly assess this relationship, we have now generated TRAF6 Delta DC bone marrow chimera mice under germ-free (GF) conditions lacking commensal microbiota, and found, unexpectedly, that Th2-associated disease is actually exacerbated in GF TRAF6 Delta DC mice compared to specific pathogen-free (SPF) TRAF6 Delta DC mice. At the same time, broad-spectrum antibiotic treatment of GF TRAF6 Delta DC mice has an ameliorative effect similar to that observed in antibiotics-treated SPF TRAF6 Delta DC mice, implying a commensal microbiota-independent effect of broad-spectrum antibiotic treatment. We further found that treatment of GF TRAF6 Delta DC mice with broadspectrum antibiotics increases Foxp3(+) Treg populations in lymphoid organs and the small intestine, pointing to a possible mechanism by which treatment may directly exert an immunomodulatory effect. To investigate links between the exacerbated phenotype of the small intestines of GF TRAF6 Delta DC mice and local microbiota, we performed microbiotic profiling of the luminal contents specifically within the small intestines of diseased TRAF6 Delta DC mice, and, when compared to co-housed control mice, found significantly increased total bacterial content characterized by specific increases in Firmicutes Lactobacillus species. These data suggest a protective effect of Firmicutes Lactobacillus against the spontaneous Th2-related inflammation of the small intestine of the TRAF6 Delta DC model, and may represent a potential mechanism for related disease phenotypes.	[Han, Daehee; Kim, Kwang Soon; Hong, Sung-Wook; Lee, Junyoung; Yi, Jaeu; Surh, Charles D.] Inst for Basic Sci Korea, Acad Immunol & Microbiol, Pohang 790784, South Korea; [Han, Daehee; Kim, Kwang Soon; Hong, Sung-Wook; Lee, Junyoung; Yi, Jaeu; Surh, Charles D.] Pohang Univ Sci & Technol, Dept Integrat Biosci & Biotechnol, Pohang 790784, South Korea; [Walsh, Matthew C.; Rivas, Gloriany; Choi, Yongwon] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Surh, Charles D.] La Jolla Inst Allergy & Immunol, Div Dev Immunol, La Jolla, CA 92037 USA	Institute for Basic Science - Korea (IBS); Pohang University of Science & Technology (POSTECH); University of Pennsylvania; Pennsylvania Medicine; La Jolla Institute for Immunology	Surh, CD (corresponding author), Inst for Basic Sci Korea, Acad Immunol & Microbiol, Pohang 790784, South Korea.	csurh@ibs.re.kr; ychoi3@mail.med.upenn.edu			Institute for Basic Science [IBS-R005-D1-2014-a00]; Korea Institute of Oriental Medicine (KIOM); Ministry of Education, Science and Technology (MEST), Korea [K13050]; National Institutes of Health [AI064909, AI108627]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI108627, R01AI064909] Funding Source: NIH RePORTER	Institute for Basic Science; Korea Institute of Oriental Medicine (KIOM); Ministry of Education, Science and Technology (MEST), Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Institute for Basic Science (IBS-R005-D1-2014-a00 to DH, KSK, SH, JL, JY, CDS), the Korea Institute of Oriental Medicine (KIOM), Ministry of Education, Science and Technology (MEST), Korea (K13050 to YC), and the National Institutes of Health (AI064909, AI108627 to YC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Bamias G, 2002, J IMMUNOL, V169, P5308, DOI 10.4049/jimmunol.169.9.5308; Bindels LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037971; Han D, 2013, IMMUNITY, V38, P1211, DOI 10.1016/j.immuni.2013.05.012; HAUSER WE, 1982, AM J MED, V72, P711, DOI 10.1016/0002-9343(82)90534-4; Kim BS, 2014, J ETHNOPHARMACOL, V152, P532, DOI 10.1016/j.jep.2014.01.038; Koboziev I, 2014, FREE RADICAL BIO MED, V68, P122, DOI 10.1016/j.freeradbiomed.2013.11.008; Lin PW, 2009, FREE RADICAL BIO MED, V47, P1205, DOI 10.1016/j.freeradbiomed.2009.07.033; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Matsumoto S, 1998, GUT, V43, P71, DOI 10.1136/gut.43.1.71; MORIKAWA K, 1994, ANTIMICROB AGENTS CH, V38, P2643, DOI 10.1128/AAC.38.11.2643; MORRISSEY PJ, 1994, RES IMMUNOL, V145, P357, DOI 10.1016/S0923-2494(94)80200-9; Mowat C, 2011, GUT, V60, P571, DOI 10.1136/gut.2010.224154; Ouwehand AC, 2002, ANTON LEEUW INT J G, V82, P279, DOI 10.1023/A:1020620607611; Quigley EMM, 2006, GASTROENTEROLOGY, V130, pS78, DOI 10.1053/j.gastro.2005.11.046; Reading NC, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00148; Rezaie A, 2007, DIGEST DIS SCI, V52, P2015, DOI 10.1007/s10620-006-9622-2; ROSZKOWSKI W, 1985, MED MICROBIOL IMMUN, V173, P279, DOI 10.1007/BF02124944; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; VanVlem B, 1996, INFECTION, V24, P275, DOI 10.1007/BF01743360; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; Yan F, 2011, J CLIN INVEST, V121, P2242, DOI 10.1172/JCI44031	22	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0118795	10.1371/journal.pone.0118795	http://dx.doi.org/10.1371/journal.pone.0118795			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689829	gold, Green Submitted, Green Published			2022-12-26	WOS:000350322700119
J	Jury, NJ; McCormick, BA; Horseman, ND; Benoit, SC; Gregerson, KA				Jury, Nicholas J.; McCormick, Betsy A.; Horseman, Nelson D.; Benoit, Stephen C.; Gregerson, Karen A.			Enhanced Responsiveness to Selective Serotonin Reuptake Inhibitors during Lactation	PLOS ONE			English	Article							NEUROENDOCRINE STRESS RESPONSES; DORSAL RAPHE NUCLEUS; FORCED SWIMMING TEST; POSTPARTUM DEPRESSION; MATERNAL-BEHAVIOR; MAJOR DEPRESSION; POSTNATAL DEPRESSION; PLASMA TRYPTOPHAN; CONTAINING FIBERS; BODY-TEMPERATURE	The physiology of mood regulation in the postpartum is poorly understood despite the fact that postpartum depression (PPD) is a common pathology. Serotonergic mechanisms and their dysfunction are widely presumed to be involved, which has led us to investigate whether lactation induces changes in central or peripheral serotonin (5-HT) systems and related affective behaviors. Brain sections from lactating (day 10 postpartum) and age-matched nulliparous (non-pregnant) C57BL/6J mice were processed for 5-HT immunohistochemistry. The total number of 5-HT immunostained cells and optical density were measured. Lactating mice exhibited lower immunoreactive 5-HT and intensity in the dorsal raphe nucleus when compared with nulliparous controls. Serum 5-HT was quantified from lactating and nulliparous mice using radioimmunoassay. Serum 5-HT concentrations were higher in lactating mice than in nulliparous controls. Affective behavior was assessed in lactating and non-lactating females ten days postpartum, as well as in nulliparous controls using the forced swim test (FST) and marble burying task (MBT). Animals were treated for the preceding five days with a selective serotonin reuptake inhibitor (SSRI, citalopram, 5mg/kg/day) or vehicle. Lactating mice exhibited a lower baseline immobility time during the FST and buried fewer marbles during the MBT as compared to nulliparous controls. Citalopram treatment changed these behaviors in lactating mice with further reductions in immobility during the FST and decreased marble burying. In contrast, the same regimen of citalopram treatment had no effect on these behaviors in either non-lactating postpartum or nulliparous females. Our findings demonstrate changes in both central and peripheral 5-HT systems associated with lactation, independent of pregnancy. They also demonstrate a significant interaction of lactation and responsiveness to SSRI treatment, which has important implications in the treatment of PPD. Although recent evidence has cast doubt on the effectiveness of SSRIs, these results support their therapeutic use in the treatment of PPD.	[Jury, Nicholas J.; Horseman, Nelson D.; Gregerson, Karen A.] Univ Cincinnati, Coll Med, Neurosci Grad Program, Cincinnati, OH 45267 USA; [Gregerson, Karen A.] Univ Cincinnati, Div Pharmaceut Sci, James L Winkle Coll Pharm, Cincinnati, OH 45267 USA; [Horseman, Nelson D.; Gregerson, Karen A.] Univ Cincinnati, Dept Mol & Cellular Physiol, Cincinnati, OH 45267 USA; [McCormick, Betsy A.] Univ Cincinnati, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, Cincinnati, OH 45267 USA; [Benoit, Stephen C.] Univ Cincinnati, Coll Med, Dept Psychiat, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Jury, NJ (corresponding author), NIAAA, Lab Behav & Genom Neurosci, NIH, 5625 Fishers Lane,Room 2N09, Rockville, MD 20852 USA.	Nick.Jury@nih.gov		Jury, Nicholas/0000-0002-4233-117X	National Institutes of Health [DK-54966]; United States Department of Agriculture NRI grant [2007-35206-17898]; National Institutes of Health training grant [DK-059803]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054966, T32DK059803] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture NRI grant; National Institutes of Health training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	KAG received National Institutes of Health grant DK-54966. NDH received United States Department of Agriculture NRI grant #2007-35206-17898. NJJ received a predoctoral fellowship on National Institutes of Health training grant DK-059803. The funders had a significant role in study design, data collection, analysis, decision to publish, and preparation of the manuscript.	AGGLETON JP, 1993, TRENDS NEUROSCI, V16, P328, DOI 10.1016/0166-2236(93)90110-8; ALDER E, 1988, PSYCHOL MED, V18, P389, DOI 10.1017/S0033291700007935; ALDER EM, 1983, J PSYCHOSOM RES, V27, P139, DOI 10.1016/0022-3999(83)90090-9; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, DOI [10.1002/cpp.1875, DOI 10.1002/CPP.1875]; ARLETTI R, 1987, LIFE SCI, V41, P1725, DOI 10.1016/0024-3205(87)90600-X; Axelson DA, 2005, AM J PSYCHIAT, V162, P802, DOI 10.1176/appi.ajp.162.4.802; Bakowska JC, 1997, J COMP NEUROL, V386, P161, DOI 10.1002/(SICI)1096-9861(19970922)386:2<161::AID-CNE1>3.0.CO;2-#; Bale TL, 2001, J NEUROSCI, V21, P2546, DOI 10.1523/JNEUROSCI.21-07-02546.2001; BARTER R, 1955, J PATHOL BACTERIOL, V69, P25, DOI 10.1002/path.1700690106; BAUMANN P, 1995, INT CLIN PSYCHOPHARM, V10, P15, DOI 10.1097/00004850-199503001-00004; BRIDGES RS, 1990, P NATL ACAD SCI USA, V87, P8003, DOI 10.1073/pnas.87.20.8003; Brown RE, 1999, PHYSIOL BEHAV, V67, P599, DOI 10.1016/S0031-9384(99)00109-2; Brummelte S, 2010, HORM BEHAV, V58, P769, DOI 10.1016/j.yhbeh.2010.07.012; Cervo L, 2005, J NEUROSCI, V25, P8165, DOI 10.1523/JNEUROSCI.1816-05.2005; Chenu F, 2006, BEHAV BRAIN RES, V172, P256, DOI 10.1016/j.bbr.2006.05.011; Christensen HR, 2013, ENDOCRINOLOGY, V154, P4777, DOI 10.1210/en.2013-1476; Cooke HJ, 2000, ANN NY ACAD SCI, V915, P77; COWEN PJ, 1989, J AFFECT DISORDERS, V16, P27, DOI 10.1016/0165-0327(89)90051-7; Craft RM, 2010, PHARMACOL BIOCHEM BE, V96, P402, DOI 10.1016/j.pbb.2010.06.012; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P547, DOI 10.1016/j.neubiorev.2005.03.008; DAPRADA M, 1979, BRIT J PHARMACOL, V65, P653; Dawson PA, 2004, BEHAV BRAIN RES, V154, P457, DOI 10.1016/j.bbr.2004.03.013; DELGADO PL, 1991, PSYCHOPHARMACOL BULL, V27, P321; Dennis CL, 2009, PEDIATRICS, V123, pE736, DOI 10.1542/peds.2008-1629; Dietz PM, 2007, AM J PSYCHIAT, V164, P1515, DOI 10.1176/appi.ajp.2007.06111893; Doornbos B, 2008, PROG NEURO-PSYCHOPH, V32, P1320, DOI 10.1016/j.pnpbp.2008.04.010; Dossett EC, 2008, OBSTET GYN CLIN N AM, V35, P419, DOI 10.1016/j.ogc.2008.04.004; Emiliano ABF, 2007, NEUROPSYCHOPHARMACOL, V32, P977, DOI 10.1038/sj.npp.1301206; Epperson N, 2001, AM J PSYCHIAT, V158, P1631, DOI 10.1176/appi.ajp.158.10.1631; EYNARD N, 1993, CLIN CHEM, V39, P2337; Fergerson SS, 2002, AM J OBSTET GYNECOL, V186, P899, DOI 10.1067/mob.2002.123404; FLACHAIRE E, 1990, CLIN CHEM, V36, P2117; FLIERS E, 1986, BRAIN RES, V375, P363, DOI 10.1016/0006-8993(86)90759-6; Foldi CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018152; Fournier JC, 2010, JAMA-J AM MED ASSOC, V303, P47, DOI 10.1001/jama.2009.1943; Gibbons RD, 2012, ARCH GEN PSYCHIAT, V69, P572, DOI 10.1001/archgenpsychiatry.2011.2044; Green AD, 2009, PHYSIOL BEHAV, V97, P259, DOI 10.1016/j.physbeh.2009.02.020; Grider JR, 1996, AM J PHYSIOL-GASTR L, V270, pG778, DOI 10.1152/ajpgi.1996.270.5.G778; Halligan SL, 2007, J AFFECT DISORDERS, V97, P145, DOI 10.1016/j.jad.2006.06.010; Hammond KA, 1997, J MAMMARY GLAND BIOL, V2, P243, DOI 10.1023/A:1026332304435; HANNAH P, 1992, BRIT J PSYCHIAT, V160, P777, DOI 10.1192/bjp.160.6.777; Hay DF, 2008, J CHILD PSYCHOL PSYC, V49, P1079, DOI 10.1111/j.1469-7610.2008.01959.x; Hebert MF, 2013, J POPUL THER CLIN PH, V20, pE350; Horder J, 2011, J PSYCHOPHARMACOL, V25, P1277, DOI 10.1177/0269881110372544; Huot RL, 2004, PSYCHONEUROENDOCRINO, V29, P279, DOI 10.1016/S0306-4530(03)00028-3; INSEL TR, 1995, BEHAV NEUROSCI, V109, P782, DOI 10.1037/0735-7044.109.4.782; Johnson MS, 2001, J EXP BIOL, V204, P1925; JORGENSEN H, 1992, NEUROENDOCRINOLOGY, V56, P371, DOI 10.1159/000126251; Kendall-Tackett K, 2010, J HUM LACT, V26, P187, DOI 10.1177/0890334409342071; KENDELL RE, 1981, J AFFECT DISORDERS, V3, P317, DOI 10.1016/0165-0327(81)90001-X; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; KITTRELL EMW, 1988, PHYSIOL BEHAV, V42, P477; Kiyasova V, 2011, J NEUROSCI, V31, P2756, DOI 10.1523/JNEUROSCI.4080-10.2011; KOHLER C, 1982, J COMP NEUROL, V209, P91, DOI 10.1002/cne.902090109; KORDON C, 1973, NEUROENDOCRINOLOGY, V13, P213, DOI 10.1159/000122206; Kosten TA, 2010, INT J DEV NEUROSCI, V28, P53, DOI 10.1016/j.ijdevneu.2009.09.005; Lambert R, 2007, BREEDING STRATEGIES, DOI [10.1093/jxb/erm028, DOI 10.1093/JXB/ERM028]; Leng G, 2005, VITAM HORM, V71, P27, DOI 10.1016/S0083-6729(05)71002-5; LESCH KP, 1993, J NEUROCHEM, V60, P2319, DOI 10.1111/j.1471-4159.1993.tb03522.x; LI YQ, 1993, BRAIN RES, V623, P267, DOI 10.1016/0006-8993(93)91437-W; Lohoff FW, 2010, CURR PSYCHIAT REP, V12, P539, DOI 10.1007/s11920-010-0150-6; Lonstein JS, 2005, HORM BEHAV, V47, P241, DOI 10.1016/j.yhbeh.2004.11.001; Lowry CA, 2008, ANN NY ACAD SCI, V1148, P86, DOI 10.1196/annals.1410.004; Maguire J, 2008, NEURON, V59, P207, DOI 10.1016/j.neuron.2008.06.019; Marazziti D, 2012, EUR NEUROPSYCHOPHARM, V22, P578, DOI 10.1016/j.euroneuro.2011.12.010; Matsuda M, 2004, DEV CELL, V6, P193, DOI 10.1016/S1534-5807(04)00022-X; Maurer-Spurej E, 2007, J PSYCHIATR NEUROSCI, V32, P23; McCoy SJB, 2006, J AM OSTEOPATH ASSOC, V106, P193; MERCHENTHALER I, 1993, ENDOCRINOLOGY, V133, P2645, DOI 10.1210/en.133.6.2645; Michaels CC, 2006, PHYSIOL BEHAV, V89, P735, DOI 10.1016/j.physbeh.2006.08.015; Misri S, 1997, CAN J PSYCHIAT, V42, P1061, DOI 10.1177/070674379704201007; MOOS F, 1983, NEUROENDOCRINOLOGY, V36, P300, DOI 10.1159/000123471; Navarre BM, 2010, PHYSIOL BEHAV, V99, P59, DOI 10.1016/j.physbeh.2009.10.011; Neumann ID, 2000, NEUROSCIENCE, V95, P567; Newport DJ, 2004, J PSYCHIATR RES, V38, P467, DOI 10.1016/j.jpsychires.2004.01.011; Ng RC, 2010, PHARMACOTHERAPY, V30, P928, DOI 10.1592/phco.30.9.928; Nicolas LB, 2006, EUR J PHARMACOL, V547, P106, DOI 10.1016/j.ejphar.2006.07.015; NJUNGE K, 1991, PHARMACOL BIOCHEM BE, V38, P63, DOI 10.1016/0091-3057(91)90590-X; NJUNGE K, 1991, BRIT J PHARMACOL, V104, P105, DOI 10.1111/j.1476-5381.1991.tb12392.x; NORDSTROM P, 1992, INT CLIN PSYCHOPHARM, V6, P12, DOI 10.1097/00004850-199206006-00003; OHara MW, 1996, INT REV PSYCHIATR, V8, P37, DOI 10.3109/09540269609037816; OWENS MJ, 1994, CLIN CHEM, V40, P288; Pawluski JL, 2012, BEHAV BRAIN RES, V228, P159, DOI 10.1016/j.bbr.2011.11.043; Pawuski JL, 2009, BEHAV BRAIN RES, V197, P55, DOI 10.1016/j.bbr.2008.08.001; Paxinos G, 2001, MOUSE BRAIN STEREOTA, P71, DOI [10.1023/A:1014088919546, DOI 10.1023/A:1014088919546]; Pearlstein T, 2009, AM J OBSTET GYNECOL, V200, P357, DOI 10.1016/j.ajog.2008.11.033; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Schrader JA, 2009, PHYSIOL BEHAV, V98, P547, DOI 10.1016/j.physbeh.2009.08.012; SCRIBNER SJ, 1994, PHYSIOL BEHAV, V55, P361, DOI 10.1016/0031-9384(94)90147-3; Singewald GM, 2011, NEUROPSYCHOPHARMACOL, V36, P793, DOI 10.1038/npp.2010.213; SOFRONIEW MV, 1980, J HISTOCHEM CYTOCHEM, V28, P475, DOI 10.1177/28.5.7381192; Theodosis DT, 2002, FRONT NEUROENDOCRIN, V23, P101, DOI 10.1006/frne.2001.0226; Torner L, 2002, EUR J NEUROSCI, V15, P1381, DOI 10.1046/j.1460-9568.2002.01965.x; VANPRAAG HM, 1984, NEUROBIOLOGY MOOD DI, P601; Yonkers KA, 2003, J CLIN PSYCHIAT, V64, P8; Yonkers KA, 2001, AM J PSYCHIAT, V158, P1856, DOI 10.1176/appi.ajp.158.11.1856	97	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117339	10.1371/journal.pone.0117339	http://dx.doi.org/10.1371/journal.pone.0117339			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689282	Green Published, Green Submitted, gold			2022-12-26	WOS:000350322700036
J	Satzer, D; DiBartolomeo, C; Ritchie, MM; Storino, C; Liimatainen, T; Hakkarainen, H; Idiyatullin, D; Mangia, S; Michaeli, S; Parr, AM; Low, WC				Satzer, David; DiBartolomeo, Christina; Ritchie, Michael M.; Storino, Christine; Liimatainen, Timo; Hakkarainen, Hanne; Idiyatullin, Djaudat; Mangia, Silvia; Michaeli, Shalom; Parr, Ann M.; Low, Walter C.			Assessment of Dysmyelination with RAFFn MRI: Application to Murine MPS I	PLOS ONE			English	Article							MUCOPOLYSACCHARIDOSIS TYPE-I; STORAGE DISORDER; MOUSE MODEL; BRAIN MRI; RELAXATION; MYELIN; PULSES; CONTRAST; MUTANT; CELL	Type I mucopolysaccharidosis (MPS I) is an autosomal recessive lysosomal storage disorder with neurological features. Humans and laboratory animals with MPS I exhibit various white matter abnormalities involving the corpus callosum and other regions. In this study, we first validated a novel MRI technique, entitled Relaxation Along a Fictitious Field in the rotating frame of rank n (RAFFn), as a measure of myelination and dysmyelination in mice. We then examined differences between MPS I mice and heterozygotes using RAFF5 and histology. RAFF5 (i.e., RAFFn with n = 5) relaxation time constants were highly correlated with histological myelin density (R2 = 0.68, P<0.001), and RAFF5 clearly distinguished between the hypomyelinated and dysmyelinated shiverer mouse and the wild-type mouse. Bloch-McConnell theoretical analysis revealed slower exchange correlation times and smaller exchange-induced relaxation rate constants for RAFF4 and RAFF5 compared to RAFF1-3, T-1 rho, and T-2 rho. These data suggest that RAFF5 may assess methylene protons in myelin lipids and proteins, though other mechanisms (e.g. detection of myelin-bound water) may also explain the sensitivity of RAFF5 to myelin. In MPS I mice, mean RAFF5 relaxation time constants were significantly larger for the striatum (P = 0.004) and internal capsule (P = 0.039), and marginally larger for the fornix (P = 0.15). Histological assessment revealed no differences between MPS I mice and heterozygotes in myelin density or corpus callosum thickness. Taken together, these findings support subtle dysmyelination in the brains of mice with MPS I. Dysmyelination may result from myelin lipid abnormalities caused by the absence of alpha-L-iduronidase. Our findings may help to explain locomotor and cognitive deficits seen in mice with MPS I.	[Satzer, David; DiBartolomeo, Christina; Ritchie, Michael M.; Parr, Ann M.; Low, Walter C.] Univ Minnesota, Dept Neurosurg, Minneapolis, MN 55455 USA; [Storino, Christine; Idiyatullin, Djaudat; Mangia, Silvia; Michaeli, Shalom] Univ Minnesota, Ctr Magnet Resonance Res, Minneapolis, MN USA; [Liimatainen, Timo; Hakkarainen, Hanne] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Kuopio, Finland	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Eastern Finland	Low, WC (corresponding author), Univ Minnesota, Dept Neurosurg, Minneapolis, MN 55455 USA.	lowwalt@umn.edu	Mangia, Silvia/I-7348-2013; Liimatainen, Timo/F-9235-2019	Mangia, Silvia/0000-0001-6341-4516; Liimatainen, Timo/0000-0001-7472-9900; Satzer, David/0000-0001-8573-1555	University of Minnesota Foundation; National Institutes of Health (NIH) [P01HD032652, KL2 RR033182, UL1TR000114]; Academy of Finland; Sigrid Juselius Foundation; Fulbright-Saastamoinen Foundation Grant in Health and Environmental Science; NIH [P41 EB015894, P30 NS057091, R01 NS061866, S10 RR023730, S10 RR027290]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD032652] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000114, KL2TR000113] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027290, KL2RR033182, S10RR023730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015894] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061866, P30NS076408, P30NS057091] Funding Source: NIH RePORTER	University of Minnesota Foundation(University of Minnesota System); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Fulbright-Saastamoinen Foundation Grant in Health and Environmental Science; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study is supported by the University of Minnesota Foundation as well as National Institutes of Health (NIH) grants P01HD032652, KL2 RR033182, and UL1TR000114. Additional assistance came from the Academy of Finland, Sigrid Juselius Foundation, and Fulbright-Saastamoinen Foundation Grant in Health and Environmental Science. Research at the Center for Magnetic Resonance Research (CMRR) is funded by NIH grants P41 EB015894, P30 NS057091, R01 NS061866, S10 RR023730, and S10 RR027290. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BHUVANESWARAN C, 1982, AM J PATHOL, V108, P160; BIRD TD, 1978, J NEUROCHEM, V31, P387, DOI 10.1111/j.1471-4159.1978.tb12479.x; Clarke LA, 1997, HUM MOL GENET, V6, P503, DOI 10.1093/hmg/6.4.503; Clarke Lorne A., 2007, P389, DOI 10.1007/978-0-387-70909-3_24; Gabrielli O, 2004, AM J MED GENET A, V125A, P224, DOI 10.1002/ajmg.a.20515; Garcia-Rivera MF, 2007, BRAIN RES BULL, V74, P429, DOI 10.1016/j.brainresbull.2007.07.018; Garwood M, 2001, J MAGN RESON, V153, P155, DOI 10.1006/jmre.2001.2340; Heinecke KA, 2011, NEUROCHEM RES, V36, P1669, DOI 10.1007/s11064-011-0400-y; Horch RA, 2011, MAGN RESON MED, V66, P24, DOI 10.1002/mrm.22980; Idiyatullin D, 2008, J MAGN RESON, V193, P267, DOI 10.1016/j.jmr.2008.05.009; Idiyatullin D, 2006, J MAGN RESON, V181, P342, DOI 10.1016/j.jmr.2006.05.014; Jones MZ, 1998, J NEUROPATH EXP NEUR, V57, P148, DOI 10.1097/00005072-199802000-00006; KOLODNY EH, 1993, CURR OPIN NEUROL NEU, V6, P379; Koshimori Y, 2014, BRAIN STRUCT FUNCT; Kumar M, 2014, J NEUROPATH EXP NEUR, V73, P39, DOI 10.1097/NEN.0000000000000023; Laule C, 2007, NEUROTHERAPEUTICS, V4, P460, DOI 10.1016/j.nurt.2007.05.004; LEE C, 1993, AM J NEURORADIOL, V14, P1285; Liimatainen T, 2014, MAGN RESON MED; Liimatainen T, 2011, J MAGN RESON, V209, P269, DOI 10.1016/j.jmr.2011.01.022; Liimatainen T, 2010, MAGN RESON MED, V64, P983, DOI 10.1002/mrm.22372; Liu CL, 2011, NEUROIMAGE, V56, P930, DOI 10.1016/j.neuroimage.2011.02.024; Mangia S, 2011, MAGN RESON IMAGING, V29, P1346, DOI 10.1016/j.mri.2011.04.002; Matheus MG, 2004, NEURORADIOLOGY, V46, P666, DOI 10.1007/s00234-004-1215-1; Michaeli S, 2004, J MAGN RESON, V169, P293, DOI 10.1016/j.jmr.2004.05.010; Michaeli S, 2006, J MAGN RESON, V181, P135, DOI 10.1016/j.jmr.2006.04.002; Nolte J, 2009, THE HUMAN BRAIN AN I; Ohmi K, 2003, P NATL ACAD SCI USA, V100, P1902, DOI 10.1073/pnas.252784899; Ou L, 2014, MOL GENET METAB, V111, P116, DOI 10.1016/j.ymgme.2013.09.008; Patay Z, 2005, EUR RADIOL, V15, P2284, DOI 10.1007/s00330-005-2846-2; PRIVAT A, 1979, NEUROSCI LETT, V12, P107, DOI 10.1016/0304-3940(79)91489-7; Savaskan NE, 2009, CELL TISSUE RES, V337, P213, DOI 10.1007/s00441-009-0815-9; Sener RN, 2004, ACTA RADIOL, V45, P561, DOI 10.1080/02841850410006128; SERESS L, 1995, HIPPOCAMPUS, V5, P217, DOI 10.1002/hipo.450050308; SEYFRIED TN, 1985, MOL CELL BIOCHEM, V68, P3; Shapiro E, 2012, MOL GENET METAB, V107, P116, DOI 10.1016/j.ymgme.2012.07.016; STEWART WA, 1993, MAGNET RESON MED, V29, P767, DOI 10.1002/mrm.1910290608; Tannus A, 1996, J MAGN RESON SER A, V120, P133, DOI 10.1006/jmra.1996.0110; Vite CH, 2013, COMPARATIVE MED, V63, P163; Walterfang M, 2006, NEUROSCI BIOBEHAV R, V30, P918, DOI 10.1016/j.neubiorev.2006.02.001; WATANABE I, 1972, J NEUROPATH EXP NEUR, V3, P352, DOI 10.1097/00005072-197204000-00010; WATTS RWE, 1986, J INHERIT METAB DIS, V9, P261, DOI 10.1007/BF01799658; WEINTRAUB H, 1987, ACTA NEUROPATHOL, V74, P374, DOI 10.1007/BF00687215; Wilkinson FL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035787; Wolf DA, 2011, NEUROBIOL DIS, V43, P123, DOI 10.1016/j.nbd.2011.02.015; YU RK, 1975, J NEUROCHEM, V25, P229, DOI 10.1111/j.1471-4159.1975.tb06957.x; Zhang J, 2013, PROC INTL SOC MAG RE, P764; Zheng Y, 2003, MOL GENET METAB, V79, P233, DOI 10.1016/S1096-7192(03)00116-1	47	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0116788	10.1371/journal.pone.0116788	http://dx.doi.org/10.1371/journal.pone.0116788			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680196	Green Published, Green Submitted, gold			2022-12-26	WOS:000350682600034
J	Komatsu, N; Fujita, Y; Matsuda, M; Aoki, K				Komatsu, N.; Fujita, Y.; Matsuda, M.; Aoki, K.			mTORC1 upregulation via ERK-dependent gene expression change confers intrinsic resistance to MEK inhibitors in oncogenic KRas-mutant cancer cells	ONCOGENE			English	Article							RAS; ACTIVATION; KINASE; ADDICTION; PATHWAYS; SENSITIVITY; EFFICACY; 3-KINASE; COMPLEX	Cancer cells harboring oncogenic BRaf mutants, but not oncogenic KRas mutants, are sensitive to MEK inhibitors (MEKi). The mechanism underlying the intrinsic resistance to MEKi in KRas-mutant cells is under intensive investigation. Here, we pursued this mechanism by live imaging of extracellular signal-regulated kinases (ERK) and mammalian target of rapamycin complex 1 (mTORC1) activities in oncogenic KRas or BRaf-mutant cancer cells. We established eight cancer cell lines expressing Forster resonance energy transfer (FRET) biosensors for ERK activity and S6K activity, which was used as a surrogate marker for mTORC1 activity. Under increasing concentrations of MEKi, ERK activity correlated linearly with the cell growth rate in BRaf-mutant cancer cells, but not KRas-mutant cancer cells. The administration of PI3K inhibitors resulted in a linear correlation between ERK activity and cell growth rate in KRas-mutant cancer cells. Intriguingly, mTORC1 activity was correlated linearly with the cell growth rate in both BRaf-mutant cancer cells and KRas-mutant cancer cells. These observations suggested that mTORC1 activity had a pivotal role in cell growth and that the mTORC1 activity was maintained primarily by the ERK pathway in BRaf-mutant cancer cells and by both the ERK and PI3K pathways in KRas-mutant cancer cells. FRET imaging revealed that MEKi inhibited mTORC1 activity with slow kinetics, implying transcriptional control of mTORC1 activity by ERK. In agreement with this observation, MEKi induced the expression of negative regulators of mTORC1, including TSC1, TSC2 and Deptor, which occurred more significantly in BRaf-mutant cells than in KRas-mutant cells. These findings suggested that the suppression of mTORC1 activity and induction of negative regulators of mTORC1 in cancer cells treated for at least 1 day could be used as surrogate markers for the MEKi sensitivity of cancer cells.	[Komatsu, N.; Matsuda, M.] Kyoto Univ, Lab Bioimaging & Cell Signaling, Grad Sch Biostudies, Kyoto 6068501, Japan; [Fujita, Y.; Matsuda, M.] Kyoto Univ, Dept Pathol & Biol Dis, Grad Sch Med, Kyoto 6068501, Japan; [Aoki, K.] Kyoto Univ, Imaging Platform Spatio Temporal Informat, Grad Sch Med, Kyoto 6068501, Japan	Kyoto University; Kyoto University; Kyoto University	Aoki, K (corresponding author), Kyoto Univ, Imaging Platform Spatio Temporal Informat, Grad Sch Med, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	k-aoki@lif.kyoto-u.ac.jp	Aoki, Kazuhiro/I-5483-2019; Aoki, Kazuhiro/B-5777-2013	Aoki, Kazuhiro/0000-0001-7263-1555; Aoki, Kazuhiro/0000-0001-7263-1555; Fujita, Yoshihisa/0000-0002-5086-8188; Matsuda, Michiyuki/0000-0002-5876-9969	Research Program of Innovative Cell Biology by Innovative Technology (the 'Cell Innovation' Program); Platform for Dynamic Approaches to Living System from the Ministry of Education, Culture, Sports and Science, Japan;  [23701052]; Grants-in-Aid for Scientific Research [23701052, 26290053] Funding Source: KAKEN	Research Program of Innovative Cell Biology by Innovative Technology (the 'Cell Innovation' Program); Platform for Dynamic Approaches to Living System from the Ministry of Education, Culture, Sports and Science, Japan; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We are grateful to the members of the Matsuda Laboratory for their helpful input. Y Inaoka, K Hirano, A Katsumata, N Nishimoto, N Nonaka and A Kawagishi are also to be thanked for their technical assistance. KA and MM were supported by the Research Program of Innovative Cell Biology by Innovative Technology (the 'Cell Innovation' Program) and Platform for Dynamic Approaches to Living System from the Ministry of Education, Culture, Sports and Science, Japan. KA was supported by a Grant-in-Aid for Young Scientists (B) (23701052) and a Grant-in-Aid for Scientific Research (B). NK and YF were supported by a Grant-in-Aid for JSPS Fellows.	Akagi T, 2003, P NATL ACAD SCI USA, V100, P13567, DOI 10.1073/pnas.1834876100; Aoki K, 2013, MOL CELL, V52, P529, DOI 10.1016/j.molcel.2013.09.015; Aoki K, 2009, NAT PROTOC, V4, P1623, DOI 10.1038/nprot.2009.175; Bean GR, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003483; Carriere A, 2011, J BIOL CHEM, V286, P567, DOI 10.1074/jbc.M110.159046; Corcoran RB, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005753; Corcoran RB, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001148; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Friday BB, 2008, CANCER RES, V68, P6145, DOI 10.1158/0008-5472.CAN-08-1430; Fujita Y, 2014, FEBS J, V281, P3177, DOI 10.1111/febs.12852; Hatzivassiliou G, 2013, NATURE, V501, P232, DOI 10.1038/nature12441; Kawakami K, 2004, GENETICS, V166, P895, DOI 10.1534/genetics.166.2.895; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Klinger B, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.29; Komatsu N, 2011, MOL BIOL CELL, V22, P4647, DOI 10.1091/mbc.E11-01-0072; LoRusso P, 2012, J CLIN ONCOL, P30; LoRusso PM, 2010, CLIN CANCER RES, V16, P1924, DOI 10.1158/1078-0432.CCR-09-1883; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Mirzoeva OK, 2009, CANCER RES, V69, P565, DOI 10.1158/0008-5472.CAN-08-3389; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Neuzillet C, 2014, PHARMACOL THERAPEUT, V141, P160, DOI 10.1016/j.pharmthera.2013.10.001; NISHIDA E, 1993, TRENDS BIOCHEM SCI, V18, P128, DOI 10.1016/0968-0004(93)90019-J; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Pratilas CA, 2009, P NATL ACAD SCI USA, V106, P4519, DOI 10.1073/pnas.0900780106; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Rebucci M, 2013, BIOCHEM PHARMACOL, V85, P1219, DOI 10.1016/j.bcp.2013.02.017; RodriguezViciana P, 1996, EMBO J, V15, P2442, DOI 10.1002/j.1460-2075.1996.tb00602.x; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Sharma SV, 2007, GENE DEV, V21, P3214, DOI 10.1101/gad.1609907; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; She QB, 2010, CANCER CELL, V18, P39, DOI 10.1016/j.ccr.2010.05.023; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Sos ML, 2009, P NATL ACAD SCI USA, V106, P18351, DOI 10.1073/pnas.0907325106; Speranza G, 2012, J CLIN ONCOL, P30; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Yusa K, 2009, NAT METHODS, V6, P363, DOI [10.1038/NMETH.1323, 10.1038/nmeth.1323]	40	27	28	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 5	2015	34	45					5607	5616		10.1038/onc.2015.16	http://dx.doi.org/10.1038/onc.2015.16			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CV9GA	25703330				2022-12-26	WOS:000364594300002
J	Narita, K; Sasamoto, S; Koizumi, S; Okazaki, S; Nakamura, H; Inoue, T; Takeda, S				Narita, Keishi; Sasamoto, Shohei; Koizumi, Schuichi; Okazaki, Shizuka; Nakamura, Hideki; Inoue, Takafumi; Takeda, Sen			TRPV4 regulates the integrity of the blood-cerebrospinal fluid barrier and modulates transepithelial protein transport	FASEB JOURNAL			English	Article						subcellular localization; calcium imaging; actin	CHOROID-PLEXUS EPITHELIUM; CATION CHANNEL TRPV4; BRAIN-BARRIER; RECEPTOR; EXPRESSION; RECRUITMENT; ACTIVATION; CELLS; ENTRY; CA2+	The diffusion of materials from systemic circulation to the central nervous system (CNS) is restricted by the blood-brain barrier (BBB) and the blood-cerebrospinal fluid barrier (BCSFB). Choroid plexus epithelial cells (CPECs) of the brain ventricles constitute the BCSFB and regulate the infiltration of plasma proteins as well as immune cells into the interstitium of the CNS. The barrier function is altered in pathologic conditions. However, the regulatory mechanism of BCSFB is not fully understood. Here, we investigated the function of transient receptor potential vanilloid 4 (TRPV4), a polymodally gated divalent cation channel that is highly expressed in CPECs. TRPV4 was localized broadly on the apical membrane in swine CPECs, in contrast with an intense ciliary localization found on other cell types. Treatment with the TRPV4-specific agonist, GSK1016790A (GSK; EC50 34 nM), induced a robust calcium influx and an immediate serine/threonine protein phosphorylation. The agonist treatment induced a marked decrease in the amount of filamentous actin and disintegrated the cell junctions in 10-20 minutes. In contrast, inhibition of the basal TRPV4 activity with the TRPV4-specific antagonist, HC067047 (HC; IC50 74 nM), reduced the basolateral-to-apical transport of alpha-2-macroglobulin (A2M). Overall, this study demonstrated a novel physiologic function of TRPV4 in the regulation of BCSFB permeability.	[Narita, Keishi; Sasamoto, Shohei; Takeda, Sen] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Anat & Cell Biol, Chuo Ku, Yamanashi 4093898, Japan; [Koizumi, Schuichi] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Neuropharmacol, Chuo Ku, Yamanashi 4093898, Japan; [Okazaki, Shizuka; Nakamura, Hideki; Inoue, Takafumi] Waseda Univ, Dept Life Sci & Med Biosci, Shinjuku Ku, Tokyo, Japan	University of Yamanashi; University of Yamanashi; Waseda University	Takeda, S (corresponding author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Anat & Cell Biol, Chuo Ku, Yamanashi 4093898, Japan.	stakeda@yamanashi.ac.jp	Inoue, Takafumi/AAM-9533-2020; Takeda, Sen/I-8462-2012; Narita, Keishi/E-3539-2010; Koizumi, Schuichi/E-8568-2010	Inoue, Takafumi/0000-0002-2728-0060; Takeda, Sen/0000-0001-7090-2139; Narita, Keishi/0000-0002-7602-8523; Koizumi, Schuichi/0000-0001-6184-3106; Nakamura, Hideki/0000-0003-2749-8323	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [19590188]; Yamada Science Foundation; MEXT [22770190, 26440094]	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yamada Science Foundation; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The authors acknowledge contributions from the following colleagues: Prof. Ryohei Kato and Mikiko Yoda for preparation of tissue sections; Drs. Youichi Shinozaki, Keisuke Shibata, and Eiji Shigetomi for helping with Ca<SUP>2+</SUP> imaging; Dr. Ryohei Komatsu for helping with the ATP assay; Prof. Masao Saito for TEER measurement; the staff of Yamanashi Meat Logistics Center and Yamanashi Meat Hygiene Inspection Office for isolation of swine choroid plexus tissue; Mamiko Otagiri for performing routine laboratory works; and Kazuko Sawanobori for secretarial assistance. This research was supported by the Grant-in-Aid for Scientific Research (C) from Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT; 19590188), and the Yamada Science Foundation to S.T., and Grants-in-Aid for Young Scientists (B) (22770190) and Scientific Research (C) (26440094) from MEXT to K.N.	BORTH W, 1992, FASEB J, V6, P3345, DOI 10.1096/fasebj.6.15.1281457; Brightman M W, 1968, Prog Brain Res, V29, P19; Brown RC, 2008, MICROCIRCULATION, V15, P359, DOI 10.1080/10739680701762656; Everaerts W, 2010, P NATL ACAD SCI USA, V107, P19084, DOI 10.1073/pnas.1005333107; Fernandez J, 1998, ELECTROPHORESIS, V19, P1036, DOI 10.1002/elps.1150190619; Filosa JA, 2013, J CARDIOVASC PHARM, V61, P113, DOI 10.1097/FJC.0b013e318279ba42; Gradilone SA, 2007, P NATL ACAD SCI USA, V104, P19138, DOI 10.1073/pnas.0705964104; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Honda A, 2010, J BIOL CHEM, V285, P31362, DOI 10.1074/jbc.M110.150540; Imura A, 2007, SCIENCE, V316, P1615, DOI 10.1126/science.1135901; Imura Y, 2013, GLIA, V61, P1320, DOI 10.1002/glia.22517; Kanoh Y, 1997, BIOCHEM MOL BIOL INT, V43, P269; KLUGE H, 1986, J NEUROL, V233, P195, DOI 10.1007/BF00314017; Knowland D, 2014, NEURON, V82, P603, DOI 10.1016/j.neuron.2014.03.003; Kohler R, 2006, ARTERIOSCL THROM VAS, V26, P1495, DOI 10.1161/01.ATV.0000225698.36212.6a; Kotttgen M, 2008, J CELL BIOL, V182, P437, DOI 10.1083/jcb.200805124; Kottgen M, 2005, PFLUG ARCH EUR J PHY, V451, P286, DOI 10.1007/s00424-005-1417-3; Lechner SG, 2011, NEURON, V69, P332, DOI 10.1016/j.neuron.2010.12.028; Lehtinen MK, 2011, NEURON, V69, P893, DOI 10.1016/j.neuron.2011.01.023; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Lorenzo IM, 2008, P NATL ACAD SCI USA, V105, P12611, DOI 10.1073/pnas.0803970105; Mochizuki T, 2009, J BIOL CHEM, V284, P21257, DOI 10.1074/jbc.M109.020206; Narita K, 2012, BIOL OPEN, V1, P815, DOI 10.1242/bio.20121081; Narita K, 2010, TRAFFIC, V11, P287, DOI 10.1111/j.1600-0854.2009.01016.x; Nonami Y, 2013, CYTOSKELETON, V70, P797, DOI 10.1002/cm.21132; Ottervald J, 2010, J PROTEOMICS, V73, P1117, DOI 10.1016/j.jprot.2010.01.004; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Redzic ZB, 2005, CURR TOP DEV BIOL, V71, P1, DOI 10.1016/S0070-2153(05)71001-2; Redzic Z, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-3; Reiter B, 2006, FASEB J, V20, P1802, DOI 10.1096/fj.06-5772com; Sawamoto K, 2006, SCIENCE, V311, P629, DOI 10.1126/science.1119133; Schwartz M, 2014, EMBO J, V33, P7, DOI 10.1002/embj.201386609; Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012; Shibasaki K, 2007, J NEUROSCI, V27, P1566, DOI 10.1523/JNEUROSCI.4284-06.2007; Shigetomi E, 2008, J NEUROSCI, V28, P6659, DOI 10.1523/JNEUROSCI.1717-08.2008; Sonkusare SK, 2012, SCIENCE, V336, P597, DOI 10.1126/science.1216283; Stockinger W, 1998, J BIOL CHEM, V273, P32213, DOI 10.1074/jbc.273.48.32213; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Takayama Y, 2014, FASEB J, V28, P2238, DOI 10.1096/fj.13-243436; Thorneloe KS, 2008, J PHARMACOL EXP THER, V326, P432, DOI 10.1124/jpet.108.139295; Tian W, 2004, AM J PHYSIOL-RENAL, V287, pF17, DOI 10.1152/ajprenal.00397.2003; URADE Y, 1993, P NATL ACAD SCI USA, V90, P9070, DOI 10.1073/pnas.90.19.9070; VANDEURS B, 1979, J CELL BIOL, V80, P662, DOI 10.1083/jcb.80.3.662; Wang FS, 2013, J NEUROSCI, V33, P17404, DOI 10.1523/JNEUROSCI.2178-13.2013; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Willette RN, 2008, J PHARMACOL EXP THER, V326, P443, DOI 10.1124/jpet.107.134551; Xu XP, 2009, CHANNELS, V3, P156, DOI 10.4161/chan.3.3.8555; Zlokovic BV, 2000, ENDOCRINOLOGY, V141, P1434, DOI 10.1210/en.141.4.1434	50	27	27	2	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2247	2259		10.1096/fj.14-261396	http://dx.doi.org/10.1096/fj.14-261396			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	25681460				2022-12-26	WOS:000355209500004
J	Wang, Y; Zhang, YL; Han, SL; Hu, X; Zhou, Y; Mu, JF; Pei, RJ; Wu, CC; Chen, XW				Wang, Yun; Zhang, Yongli; Han, Shili; Hu, Xue; Zhou, Yuan; Mu, Jingfang; Pei, Rongjuan; Wu, Chunchen; Chen, Xinwen			Identification of a Novel Regulatory Sequence of Actin Nucleation Promoting Factor Encoded by Autographa californica Multiple Nucleopolyhedrovirus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALDRICH-SYNDROME PROTEIN; ARP2/3 COMPLEX; CELLULAR CONTROL; WASP; BV/ODV-C42; POLYMERIZATION; DEGRADATION; MOTILITY; SURFACE; P78/83	Actin polymerization induced by nucleation promoting factors (NPFs) is one of the most fundamental biological processes in eukaryotic cells. NPFs contain a conserved output domain (VGA domain) near the C terminus, which interacts with and activates the cellular actin-related protein 2/3 complex (Arp2/3) to induce actin polymerization and a diverse regulatory domain near the N terminus. Autographa californica multiple nucleopolyhedrovirus (AcMNPV) nudeocapsid protein P78/83 is a virus-encoded NPF that contains a C-terminal VGA domain and induces actin polymerization in virus-infected cells. However, there is no similarity between the N terminus of P78/83 and that of other identified NPFs, suggesting that P78/83 may possess a unique regulatory mechanism. In this study, we identified a multifunctional regulatory sequence (MRS) located near the N terminus of P78/83 and determined that one of its functions is to serve as a degron to mediate P78/83 degradation in a proteasome-dependent manner. In AcMNPV-infected cells, the MRS also binds to another nucleocapsid protein. BV/ODV-C42, which stabilizes P78/83 and modulates the P78/83-Arp2/3 interaction to orchestrate actin polymerization. In addition, the MRS is also essential for the incorporation of P78/83 into the nudeocapsid, ensuring virion mobility powered by P78/83-induced actin polymerization. The triple functions of the MRS enable P78/83 to serve as an essential viral protein in the AcMNPV replication cycle, and the possible roles of the MRS in orchestrating the virus-induced actin polymerization and viral genuine decapsidation are discussed.	[Wang, Yun; Zhang, Yongli; Hu, Xue; Zhou, Yuan; Mu, Jingfang; Pei, Rongjuan; Wu, Chunchen; Chen, Xinwen] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Peoples R China; [Zhang, Yongli; Mu, Jingfang] Univ Chinese Acad Sci, Beijing, Peoples R China; [Han, Shili] Cent China Normal Univ, Wuhan 430000, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Central China Normal University	Wang, Y (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Peoples R China.	wangyun@wh.iov.cn; chenxw@wh.iov.cn			National Natural Science Foundation of China [31030027, 31270191, 31321001]; Royal Dutch Academy of Science and Arts [08-PSA-BD-01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Royal Dutch Academy of Science and Arts	This work was supported by National Natural Science Foundation of China Grants 31030027, 31270191, and 31321001 and Royal Dutch Academy of Science and Arts Grant 08-PSA-BD-01.	Braunagel SC, 2001, J VIROL, V75, P12331, DOI 10.1128/JVI.75.24.12331-12338.2001; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Chen YR, 2013, J VIROL, V87, P6391, DOI 10.1128/JVI.00194-13; Goley ED, 2006, SCIENCE, V314, P464, DOI 10.1126/science.1133348; Gouin E, 2004, NATURE, V427, P457, DOI 10.1038/nature02318; Han Shi-li, 2012, Chinese Journal of Virology, V28, P601; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; King SJ, 2011, EMBO J, V30, P1705, DOI 10.1038/emboj.2011.82; KOCKS C, 1992, CELL, V68, P521, DOI 10.1016/0092-8674(92)90188-I; Li K, 2010, J VIROL, V84, P7857, DOI 10.1128/JVI.00174-10; Machesky LM, 1999, CURR OPIN CELL BIOL, V11, P117, DOI 10.1016/S0955-0674(99)80014-3; Machesky LM, 2001, TRENDS CELL BIOL, V11, P286, DOI 10.1016/S0962-8924(01)02009-8; Mueller J, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001765; Nie YC, 2006, VIRUS RES, V116, P129, DOI 10.1016/j.virusres.2005.09.007; Ohkawa T, 1999, VIROLOGY, V264, P1, DOI 10.1006/viro.1999.0008; Ohkawa T, 2010, J CELL BIOL, V190, P187, DOI 10.1083/jcb.201001162; Pan F, 2004, J BIOL CHEM, V279, P54629, DOI 10.1074/jbc.M402357200; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Reicher B, 2012, MOL CELL BIOL, V32, P3153, DOI 10.1128/MCB.00161-12; Rohrmann G.F., 2019, BACULOVIRUS MOL BIOL; Russell RLQ, 1997, VIROLOGY, V227, P142, DOI 10.1006/viro.1996.8304; Stevens MP, 2005, MOL MICROBIOL, V56, P40, DOI 10.1111/j.1365-2958.2004.04528.x; Symons M, 1996, CELL, V84, P723, DOI 10.1016/S0092-8674(00)81050-8; VARSHAVSKY A, 1991, CELL, V64, P13, DOI 10.1016/0092-8674(91)90202-A; Wang Y, 2008, J VIROL, V82, P4554, DOI 10.1128/JVI.02510-07; Welch MD, 2002, ANNU REV CELL DEV BI, V18, P247, DOI 10.1146/annurev.cellbio.18.040202.112133	27	9	12	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9533	9541		10.1074/jbc.M114.635441	http://dx.doi.org/10.1074/jbc.M114.635441			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25691574	Green Published, hybrid			2022-12-26	WOS:000352729400020
J	Burnett, SF; Farre, JC; Nazarko, TY; Subramani, S				Burnett, Sarah F.; Farre, Jean-Claude; Nazarko, Taras Y.; Subramani, Suresh			Peroxisomal Pex3 Activates Selective Autophagy of Peroxisomes via Interaction with the Pexophagy Receptor Atg30	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST PICHIA-PASTORIS; MEMBRANE-PROTEIN; SACCHAROMYCES-CEREVISIAE; TAGS PEROXISOMES; PEX19P; DEGRADATION; BIOGENESIS; MITOPHAGY; PATHWAYS; DOCKING	Pexophagy is a process that selectively degrades peroxisomes by autophagy. The Pichia pastoris pexophagy receptor Atg30 is recruited to peroxisomes under peroxisome proliferation conditions. During pexophagy, Atg30 undergoes phosphorylation, a prerequisite for its interactions with the autophagy scaffold protein Atg11 and the ubiquitin-like protein Atg8. Atg30 is subsequently shuttled to the vacuole along with the targeted peroxisome for degradation. Here, we defined the binding site for Atg30 on the peroxisomal membrane protein Pex3 and uncovered a role for Pex3 in the activation of Atg30 via phosphorylation and in the recruitment of Atg11 to the receptor protein complex. Pex3 is classically a docking protein for other proteins that affect peroxisome biogenesis, division, and segregation. We conclude that Pex3 has a role beyond simple docking of Atg30 and that its interaction with Atg30 regulates pexophagy in the yeast P. pastoris.	[Burnett, Sarah F.; Farre, Jean-Claude; Nazarko, Taras Y.; Subramani, Suresh] Univ Calif San Diego, Mol Biol Sect, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Subramani, S (corresponding author), Univ Calif San Diego, Mol Biol Sect, Div Biol Sci, La Jolla, CA 92093 USA.	ssubramani@ucsd.edu			National Institutes of Health [GM069373]; Mentored Research Scientist Development Award [K01DK094843]; National Science Foundation [0742551]; Chancellor Associates Chair; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK094843] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069373] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mentored Research Scientist Development Award; National Science Foundation(National Science Foundation (NSF)); Chancellor Associates Chair; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM069373 (to S. S.) and Mentored Research Scientist Development Award K01DK094843 (to T. Y. N.).; Supported by Graduate STEM Fellows in K-12 Education Grant 0742551 from the National Science Foundation (to Dr. Maarten Chrispeels) and by a Chancellor Associates Chair (to S. S.).	Aoki Y, 2011, MOL BIOL CELL, V22, P3206, DOI 10.1091/mbc.E11-02-0145; Chang JL, 2009, J CELL BIOL, V187, P233, DOI 10.1083/jcb.200902117; Cheong H, 2005, MOL BIOL CELL, V16, P3438, DOI 10.1091/mbc.E04-10-0894; Deosaran E, 2013, J CELL SCI, V126, P939, DOI 10.1242/jcs.114819; Fang Y, 2004, J CELL BIOL, V164, P863, DOI 10.1083/jcb.200311131; Farre JC, 2008, DEV CELL, V14, P365, DOI 10.1016/j.devcel.2007.12.011; Farre JC, 2013, EMBO REP, V14, P441, DOI 10.1038/embor.2013.40; Feng YC, 2014, CELL RES, V24, P24, DOI 10.1038/cr.2013.168; GOULD SJ, 1992, YEAST, V8, P613, DOI 10.1002/yea.320080805; Hattula K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103101; Hettema EH, 2000, EMBO J, V19, P223, DOI 10.1093/emboj/19.2.223; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Kanki T, 2013, EMBO REP, V14, P788, DOI 10.1038/embor.2013.114; Kanki T, 2009, DEV CELL, V17, P98, DOI 10.1016/j.devcel.2009.06.014; Kim J, 2001, J CELL BIOL, V153, P381, DOI 10.1083/jcb.153.2.381; Kim PK, 2008, P NATL ACAD SCI USA, V105, P20567, DOI 10.1073/pnas.0810611105; Knoblach B, 2013, EMBO J, V32, P2439, DOI 10.1038/emboj.2013.170; Ma CL, 2011, J CELL BIOL, V193, P7, DOI 10.1083/jcb.201010022; Manjithaya R, 2010, J CELL BIOL, V189, P303, DOI 10.1083/jcb.200909154; Motley AM, 2012, EMBO J, V31, P2852, DOI 10.1038/emboj.2012.151; Munck JM, 2009, J CELL BIOL, V187, P463, DOI 10.1083/jcb.200906161; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Nazarko TY, 2014, J CELL BIOL, V204, P541, DOI 10.1083/jcb.201307050; Nazarko TY, 2009, MOL BIOL CELL, V20, P3828, DOI 10.1091/mbc.E09-03-0221; Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013; Pfaffenwimmer T, 2014, EMBO REP, V15, P862, DOI 10.15252/embr.201438932; Pinto MP, 2006, J BIOL CHEM, V281, P34492, DOI 10.1074/jbc.M607183200; Sato Y, 2010, EMBO J, V29, P4083, DOI 10.1038/emboj.2010.293; Schmidt F, 2012, TRAFFIC, V13, P1244, DOI 10.1111/j.1600-0854.2012.01380.x; Schmidt F, 2010, J BIOL CHEM, V285, P25410, DOI 10.1074/jbc.M110.138503; Schueller N, 2010, EMBO J, V29, P2491, DOI 10.1038/emboj.2010.115; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; Snyder WB, 1999, MOL BIOL CELL, V10, P1745, DOI 10.1091/mbc.10.6.1745; Suzuki K, 2010, J BIOL CHEM, V285, P30019, DOI 10.1074/jbc.M110.143511; Tan CC, 2014, NEUROBIOL AGING, V35, P941, DOI 10.1016/j.neurobiolaging.2013.11.019; Tanaka C, 2014, J CELL BIOL, V207, P91, DOI 10.1083/jcb.201402128; Till Andreas, 2012, Int J Cell Biol, V2012, P512721, DOI 10.1155/2012/512721; Vasko R, 2013, ANTIOXID REDOX SIGN, V19, P211, DOI 10.1089/ars.2012.4768; Wiemer EAC, 1996, J BIOL CHEM, V271, P18973, DOI 10.1074/jbc.271.31.18973; Williams C, 2013, BIOCHEM BIOPH RES CO, V438, P395, DOI 10.1016/j.bbrc.2013.07.086; Yamashita SI, 2014, AUTOPHAGY, V10, P1549, DOI 10.4161/auto.29329; Yang ZF, 2009, CURR TOP MICROBIOL, V335, P1, DOI 10.1007/978-3-642-00302-8_1; Zhang JW, 2013, NAT CELL BIOL, V15, P1186, DOI 10.1038/ncb2822	43	35	36	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8623	8631		10.1074/jbc.M114.619338	http://dx.doi.org/10.1074/jbc.M114.619338			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25694426	hybrid, Green Published			2022-12-26	WOS:000351662600052
J	Liu, J; Yuan, YZ; Wu, Z; Li, N; Chen, YL; Qin, TT; Geng, H; Xiong, L; Liu, DL				Liu, Jing; Yuan, Yongze; Wu, Zhi; Li, Na; Chen, Yuanlei; Qin, Tingting; Geng, Hui; Xiong, Li; Liu, Deli			A Novel Sterol Regulatory Element-Binding Protein Gene (sreA) Identified in Penicillium digitatum Is Required for Prochloraz Resistance, Full Virulence and erg11 (cyp51) Regulation	PLOS ONE			English	Article							TRANSCRIPTION FACTOR UPC2P; CITRUS GREEN MOLD; CANDIDA-ALBICANS; DRUG-RESISTANCE; UP-REGULATION; 14-ALPHA-DEMETHYLASE GENE; FUNGICIDE RESISTANCE; IMAZALIL RESISTANCE; EXPRESSION; MRR1	Penicillium digitatum is the most destructive postharvest pathogen of citrus fruits, causing fruit decay and economic loss. Additionally, control of the disease is further complicated by the emergence of drug-resistant strains due to the extensive use of triazole antifungal drugs. In this work, an orthologus gene encoding a putative sterol regulatory element-binding protein (SREBP) was identified in the genome of P. digitatum and named sreA. The putative SreA protein contains a conserved domain of unknown function (DUF2014) at its carboxyl terminus and a helix-loop-helix (HLH) leucine zipper DNA binding domain at its amino terminus, domains that are functionally associated with SREBP transcription factors. The deletion of sreA (Delta sreA) in a prochloraz-resistant strain (PdHS-F6) by Agrobacterium tumefaciens-mediated transformation led to increased susceptibility to prochloraz and a significantly lower EC50 value compared with the HS-F6 wild-type or complementation strain (COsreA). A virulence assay showed that the Delta sreA strain was defective in virulence towards citrus fruits, while the complementation of sreA could restore the virulence to a large extent. Further analysis by quantitative real-time PCR demonstrated that prochloraz-induced expression of cyp51A and cyp51B in PdHS-F6 was completely abolished in the Delta sreA strain. These results demonstrate that sreA is a critical transcription factor gene required for prochloraz resistance and full virulence in P. digitatum and is involved in the regulation of cyp51 expression.	[Liu, Jing; Yuan, Yongze; Wu, Zhi; Li, Na; Chen, Yuanlei; Qin, Tingting; Geng, Hui; Xiong, Li; Liu, Deli] Cent China Normal Univ, Sch Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan 430079, Peoples R China	Central China Normal University	Liu, DL (corresponding author), Cent China Normal Univ, Sch Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan 430079, Peoples R China.	ldl@mail.ccnu.edu.cn			National Natural Science Foundations of China [31371893, 31071653, 31101595]	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundations of China (NO. 31371893, 31071653, 31101595). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bien CM, 2010, EUKARYOT CELL, V9, P352, DOI 10.1128/EC.00358-09; Blatzer M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002374; Blosser SJ, 2012, ANTIMICROB AGENTS CH, V56, P248, DOI 10.1128/AAC.05027-11; Bowyer P., 2001, MOL CELLULAR BIOL FI, P33; De Backer MD, 2001, ANTIMICROB AGENTS CH, V45, P1660, DOI 10.1128/AAC.45.6.1660-1670.2001; Dharia NV, 2010, P NATL ACAD SCI USA, V107, P20045, DOI 10.1073/pnas.1003776107; Dunkel N, 2008, MOL MICROBIOL, V69, P827, DOI 10.1111/j.1365-2958.2008.06309.x; Dunkel N, 2008, EUKARYOT CELL, V7, P1180, DOI 10.1128/EC.00103-08; ECKERT JW, 1994, PLANT DIS, V78, P971, DOI 10.1094/PD-78-0971; Fan JR, 2013, NEW PHYTOL, V198, P821, DOI 10.1111/nph.12193; Flaherty JE, 1997, APPL ENVIRON MICROB, V63, P3995, DOI 10.1128/AEM.63.10.3995-4000.1997; Flowers SA, 2012, EUKARYOT CELL, V11, P1289, DOI 10.1128/EC.00215-12; Gallo-Ebert C, 2014, ANTIMICROB AGENTS CH, V58, P258, DOI 10.1128/AAC.01677-13; Ghosoph JM, 2007, POSTHARVEST BIOL TEC, V44, P9, DOI 10.1016/j.postharvbio.2006.11.008; Hamamoto H, 2001, PESTIC BIOCHEM PHYS, V70, P19, DOI 10.1006/pest.2001.2530; Hamamoto H, 2000, APPL ENVIRON MICROB, V66, P3421, DOI 10.1128/AEM.66.8.3421-3426.2000; Han R, 2010, J AGR FOOD CHEM, V58, P12810, DOI 10.1021/jf103243m; Holmes GJ, 1999, PHYTOPATHOLOGY, V89, P716, DOI 10.1094/PHYTO.1999.89.9.716; Hoot SJ, 2011, ANTIMICROB AGENTS CH, V55, P940, DOI 10.1128/AAC.00995-10; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hughes AL, 2005, CELL, V120, P831, DOI 10.1016/j.cell.2005.01.012; JosephHorne T, 1997, FEMS MICROBIOL LETT, V149, P141, DOI 10.1111/j.1574-6968.1997.tb10321.x; Li WJ, 2013, J AGR FOOD CHEM, V61, P1419, DOI 10.1021/jf305355u; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohberger A, 2014, EUKARYOT CELL, V13, P127, DOI 10.1128/EC.00245-13; Luo CX, 2008, APPL ENVIRON MICROB, V74, P359, DOI 10.1128/AEM.02159-07; MacPherson S, 2005, ANTIMICROB AGENTS CH, V49, P1745, DOI 10.1128/AAC.49.5.1745-1752.2005; Maguire SL, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004076; Malonek S, 2001, CURR GENET, V40, P152, DOI 10.1007/s002940100236; Marcet-Houben M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-646; Marie C, 2008, FUNGAL GENET BIOL, V45, P1430, DOI 10.1016/j.fgb.2008.07.004; Mogavero S, 2011, ANTIMICROB AGENTS CH, V55, P2061, DOI 10.1128/AAC.01467-10; Oerke E. C., 1994, CROP PROTECTION CROP; Parraga A, 1998, STRUCT FOLD DES, V6, P661, DOI 10.1016/S0969-2126(98)00067-7; Sanchez-Torres P, 2011, POSTHARVEST BIOL TEC, V59, P159, DOI 10.1016/j.postharvbio.2010.08.017; Sanglard D, 2009, FEMS YEAST RES, V9, P1029, DOI 10.1111/j.1567-1364.2009.00578.x; Schubert S, 2011, ANTIMICROB AGENTS CH, V55, P2212, DOI 10.1128/AAC.01343-10; Silver PM, 2004, EUKARYOT CELL, V3, P1391, DOI 10.1128/EC.3.6.1391-1397.2004; Smilanick JL, 2006, POSTHARVEST BIOL TEC, V42, P75, DOI 10.1016/j.postharvbio.2006.05.008; Sun XP, 2013, FEMS MICROBIOL LETT, V348, P11, DOI 10.1111/1574-6968.12235; Sun XP, 2011, APPL MICROBIOL BIOT, V91, P1107, DOI 10.1007/s00253-011-3355-7; Todd BL, 2006, MOL CELL BIOL, V26, P2817, DOI 10.1128/MCB.26.7.2817-2831.2006; Vasicek EM, 2014, EUKARYOT CELL, V13, P933, DOI 10.1128/EC.00221-13; Vinggaard AM, 2006, INT J ANDROL, V29, P186, DOI 10.1111/j.1365-2605.2005.00604.x; Wang JY, 2008, J ZHEJIANG UNIV-SC B, V9, P823, DOI 10.1631/jzus.B0860006; Wang JY, 2012, AFR J MICROBIOL RES, V6, P95, DOI 10.5897/AJMR11.1045; Wang JL, 2014, J MICROBIOL, V52, P762, DOI 10.1007/s12275-014-4112-2; White TC, 2005, BIOCHEM SOC T, V33, P1215, DOI 10.1042/BST20051215; White TC, 1998, CLIN MICROBIOL REV, V11, P382, DOI 10.1128/CMR.11.2.382; Willger SD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000200; Wolfger H, 2001, RES MICROBIOL, V152, P375, DOI 10.1016/S0923-2508(01)01209-8; Zhang JH, 2010, PEST MANAG SCI, V66, P1344, DOI 10.1002/ps.2021; Zhao L, 2007, FEMS MICROBIOL LETT, V277, P37, DOI 10.1111/j.1574-6968.2007.00929.x; Znaidi S, 2007, MOL MICROBIOL, V66, P440, DOI 10.1111/j.1365-2958.2007.05931.x	54	92	95	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0117115	10.1371/journal.pone.0117115	http://dx.doi.org/10.1371/journal.pone.0117115			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25699519	Green Published, gold, Green Submitted			2022-12-26	WOS:000349789800018
J	Prince, K; Lorrilliere, R; Barbet-Massin, M; Leger, F; Jlguet, F				Prince, Karine; Lorrilliere, Romain; Barbet-Massin, Morgane; Leger, Francois; Jlguet, Frederic			Forecasting the Effects of Land Use Scenarios on Farmland Birds Reveal a Potential Mitigation of Climate Change Impacts	PLOS ONE			English	Article							AGRICULTURAL INTENSIFICATION; POPULATION TRENDS; BIODIVERSITY; LANDSCAPE; ABUNDANCE; MODELS; CONSERVATION; RANGE; DISTRIBUTIONS; MANAGEMENT	Climate and land use changes are key drivers of current biodiversity trends, but interactions between these drivers are poorly modeled, even though they could amplify or mitigate negative impacts of climate change. Here, we attempt to predict the impacts of different agricultural change scenarios on common breeding birds within farmland included in the potential future climatic suitable areas for these species. We used the Special Report on Emissions Scenarios (SRES) to integrate likely changes in species climatic suitability, based on species distribution models, and changes in area of farmland, based on the IMAGE model, inside future climatic suitable areas. We also developed six farmland cover scenarios, based on expert opinion, which cover a wide spectrum of potential changes in livestock farming and cropping patterns by 2050. We ran generalized linear mixed models to calibrate the effects of farmland cover and climate change on bird specific abundance within 386 small agricultural regions. We used model outputs to predict potential changes in bird populations on the basis of predicted changes in regional farmland cover, in area of farmland and in species climatic suitability. We then examined the species sensitivity according to their habitat requirements. A scenario based on extensification of agricultural systems (i.e., low-intensity agriculture) showed the greatest potential to reduce reverse current declines in breeding birds. To meet ecological requirements of a larger number of species, agricultural policies accounting for regional disparities and landscape structure appear more efficient than global policies uniformly implemented at national scale. Interestingly, we also found evidence that farmland cover changes can mitigate the negative effect of climate change. Here, we confirm that there is a potential for countering negative effects of climate change by adaptive management of landscape. We argue that such studies will help inform sustainable agricultural policies for the future.	[Prince, Karine; Lorrilliere, Romain; Barbet-Massin, Morgane; Jlguet, Frederic] UPMC, CNRS, Ctr Rech Biol Populat Oiseaux, Museum Natl Hist Nat,UMR MNHN 7204, Paris, France; [Prince, Karine] Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI USA; [Barbet-Massin, Morgane] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA; [Leger, Francois] AgroParisTech, UMR SAD APT INRA, Paris, France	Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; University of Wisconsin System; University of Wisconsin Madison; Yale University; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Prince, K (corresponding author), UPMC, CNRS, Ctr Rech Biol Populat Oiseaux, Museum Natl Hist Nat,UMR MNHN 7204, CP 51, Paris, France.	karine.prince@gmail.com	Lorrilliere, Romain/F-4888-2013; Princé, Karine/T-4491-2017	Lorrilliere, Romain/0000-0003-1870-0278; Princé, Karine/0000-0001-7739-7438	ANR (Agence Nationale de la Recherche); French National Research Agency under the Systerra program-Ecosystems and Sustainable Development [ANR-08-STRA-007]; FRB (Fondation pour la Recherche en Biodiversite); MOBILIS program-Modeling for Scenarios and Sustainable Management of Biodiversity, Farming and Forestry Facing Climate Change	ANR (Agence Nationale de la Recherche)(French National Research Agency (ANR)); French National Research Agency under the Systerra program-Ecosystems and Sustainable Development(French National Research Agency (ANR)); FRB (Fondation pour la Recherche en Biodiversite); MOBILIS program-Modeling for Scenarios and Sustainable Management of Biodiversity, Farming and Forestry Facing Climate Change	This work was carried out with the financial support of both the ANR (Agence Nationale de la Recherche) and The French National Research Agency under the Systerra program-Ecosystems and Sustainable Development (project ANR-08-STRA-007, FARMBIRD-Coviability models of FARMing and BIRD biodiversity) and the FRB (Fondation pour la Recherche en Biodiversite) with the MOBILIS program-Modeling for Scenarios and Sustainable Management of Biodiversity, Farming and Forestry Facing Climate Change. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agreste, 2011, UT TERR 2010, P4; [AND International CNASEA], 2008, EV EXP PLAN DEV RUR; ANDERSON G. Q., 2004, BIOMASS AGR SUSTAINA, V572, P199; Anderson GQA, 2006, IBIS, V148, P180, DOI 10.1111/j.1474-919X.2006.00535.x; Araujo MB, 2008, ENVIRON SCI POLICY, V11, P38, DOI 10.1016/j.envsci.2007.07.002; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Araujo MB, 2009, P NATL ACAD SCI USA, V106, pE45, DOI 10.1073/pnas.0813294106; Barbet-Massin M, 2012, GLOBAL CHANGE BIOL, V18, P881, DOI 10.1111/j.1365-2486.2011.02552.x; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; BirdLife International, 2011, EUR BIRD POP EST TRE; BirdLife International, 2004, BIRDS EUR POP EST TR; Bouwman AF, 2006, INTEGRATED MODELLING, P228; Britschgi A, 2006, BIOL CONSERV, V130, P193, DOI 10.1016/j.biocon.2005.12.013; Busch G, 2006, AGR ECOSYST ENVIRON, V114, P121, DOI 10.1016/j.agee.2005.11.007; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Butler SJ, 2007, SCIENCE, V315, P381, DOI 10.1126/science.1136607; Butler SJ, 2010, AGR ECOSYST ENVIRON, V137, P348, DOI 10.1016/j.agee.2010.03.005; BWPi, 2006, BIRDS W PAL INT; Chamberlain D, 2012, IBIS, V154, P205, DOI 10.1111/j.1474-919X.2011.01196.x; Chamberlain DE, 1999, J APPL ECOL, V36, P856, DOI 10.1046/j.1365-2664.1999.00453.x; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Coetzee BWT, 2009, GLOBAL ECOL BIOGEOGR, V18, P701, DOI 10.1111/j.1466-8238.2009.00485.x; Collins M, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1029; Concepcion ED, 2012, J APPL ECOL, V49, P695, DOI 10.1111/j.1365-2664.2012.02131.x; Concepcion ED, 2011, AGR ECOSYST ENVIRON, V142, P303, DOI 10.1016/j.agee.2011.05.028; de Chazal J, 2009, GLOBAL ENVIRON CHANG, V19, P306, DOI 10.1016/j.gloenvcha.2008.09.007; Devictor V, 2012, NAT CLIM CHANGE, V2, P121, DOI 10.1038/NCLIMATE1347; Donald PF, 2006, AGR ECOSYST ENVIRON, V116, P189, DOI 10.1016/j.agee.2006.02.007; Donald PF, 2001, P ROY SOC B-BIOL SCI, V268, P25, DOI 10.1098/rspb.2000.1325; Donald PF, 2006, J APPL ECOL, V43, P209, DOI 10.1111/j.1365-2664.2006.01146.x; Dormann CF, 2008, ECOL LETT, V11, P235, DOI 10.1111/j.1461-0248.2007.01142.x; Dormann CF, 2007, BASIC APPL ECOL, V8, P387, DOI 10.1016/j.baae.2006.11.001; Doxa A, 2010, J APPL ECOL, V47, P1348, DOI 10.1111/j.1365-2664.2010.01869.x; Eglington SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030407; Elston DA, 2001, PARASITOLOGY, V122, P563, DOI 10.1017/S0031182001007740; European Commission, 2011, EC AN EV CAP 2020; Fahrig L, 2011, ECOL LETT, V14, P101, DOI 10.1111/j.1461-0248.2010.01559.x; Field C.B., 2014, SPEC REP GLOB WARM 1, DOI 10.1017/cbo9780511976988.002; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Filippi-Codaccioni O, 2010, BIOL CONSERV, V143, P1493, DOI 10.1016/j.biocon.2010.03.031; Firbank LG, 2008, PHILOS T R SOC B, V363, P777, DOI 10.1098/rstb.2007.2183; Fischer J, 2011, SCIENCE, V334, P593, DOI 10.1126/science.334.6056.593-a; Fuller RJ, 1997, ECOGRAPHY, V20, P295, DOI 10.1111/j.1600-0587.1997.tb00374.x; Fuller RJ, 1995, CONSERV BIOL, V9, P1425, DOI 10.1046/j.1523-1739.1995.09061425.x; GATZ DF, 1995, ATMOS ENVIRON, V29, P1185, DOI 10.1016/1352-2310(94)00210-C; Gordon LJ, 2008, TRENDS ECOL EVOL, V23, P211, DOI 10.1016/j.tree.2007.11.011; Gottschalk TK, 2010, ECOL INDIC, V10, P15, DOI 10.1016/j.ecolind.2009.05.008; Gregory RD, 2010, ORNITHOL SCI, V9, P3, DOI 10.2326/osj.9.3; Guerrero I, 2012, BIOL CONSERV, V152, P74, DOI 10.1016/j.biocon.2012.04.001; Guinde L., 2008, REV ETUDES AGR ENV, V89, P55; Guyomard H, 2008, PROSPECTIVE AGR 2013, P24; Harding JW, 2007, GEN LINEAR MODELS EX, P192; Heikkinen RK, 2004, J APPL ECOL, V41, P824, DOI 10.1111/j.0021-8901.2004.00938.x; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Huntley B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001439; Huntley B, 2006, IBIS, V148, P8, DOI 10.1111/j.1474-919X.2006.00523.x; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Jiguet F, 2012, ACTA OECOL, V44, P58, DOI 10.1016/j.actao.2011.05.003; Jiguet F, 2010, P ROY SOC B-BIOL SCI, V277, P3601, DOI 10.1098/rspb.2010.0796; Julliard R, 2006, ECOL LETT, V9, P1237, DOI 10.1111/j.1461-0248.2006.00977.x; Krebs JR, 1999, NATURE, V400, P611, DOI 10.1038/23127; Lemoine N, 2007, CONSERV BIOL, V21, P495, DOI 10.1111/j.1523-1739.2006.00633.x; Luoto M, 2006, J BIOGEOGR, V33, P1764, DOI 10.1111/j.1365-2699.2005.01395.x; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; Matson PA, 1997, SCIENCE, V277, P504, DOI 10.1126/science.277.5325.504; Mcneely J. A, 2003, ECOAGRICULTURE STRAT; Mouysset L, 2014, CONSERV BIOL, V28, P187, DOI 10.1111/cobi.12184; Mouysset L, 2013, ECOL APPL, V23, P96, DOI 10.1890/11-1887.1; Mouysset L, 2012, ECOL INDIC, V14, P209, DOI 10.1016/j.ecolind.2011.08.012; Mouysset L, 2011, ECOL ECON, V70, P617, DOI 10.1016/j.ecolecon.2010.12.006; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nielsen SE, 2005, ECOGRAPHY, V28, P197, DOI 10.1111/j.0906-7590.2005.04002.x; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Phalan B, 2011, SCIENCE, V333, P1289, DOI 10.1126/science.1208742; Pigot AL, 2010, ECOL LETT, V13, P705, DOI 10.1111/j.1461-0248.2010.01462.x; Pinheiro J., 2011, PACKAGE R SOFTWARE S, P21; R Core Team, 2016, R FDN STAT COMP; Rademaekers K, 2010, POLICY OPTIONS FUTUR, P160, DOI DOI 10.1017/S1744133109990338; Reino L, 2013, DIVERS DISTRIB, V19, P423, DOI 10.1111/ddi.12019; Rigby RA, 2008, COMPUT STAT DATA AN, V53, P381, DOI 10.1016/j.csda.2008.07.043; Rondinini C, 2011, PHILOS T R SOC B, V366, P2633, DOI 10.1098/rstb.2011.0113; ROOT T, 1988, J BIOGEOGR, V15, P489, DOI 10.2307/2845278; Sanderson FJ, 2013, AGR ECOSYST ENVIRON, V168, P16, DOI 10.1016/j.agee.2013.01.015; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stoate C, 2001, J ENVIRON MANAGE, V63, P337, DOI 10.1006/jema.2001.0473; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Trivino M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029373; VanDerWal J, 2009, AM NAT, V174, P282, DOI 10.1086/600087; Vert J, 2010, PROSPECTIVE AGR ENER, P245; Wilson JD, 2010, IBIS, V152, P176, DOI 10.1111/j.1474-919X.2009.00992.x; World Health Organization, 2005, EC HUM WELL BEING SY; Wretenberg J, 2010, BIOL CONSERV, V143, P375, DOI 10.1016/j.biocon.2009.11.001	95	17	17	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0117850	10.1371/journal.pone.0117850	http://dx.doi.org/10.1371/journal.pone.0117850			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25699673	Green Submitted, Green Published, gold			2022-12-26	WOS:000349789800031
J	Yan, Y; Luo, J; Guo, D; Wen, SZ				Yan, Ying; Luo, Jing; Guo, Dan; Wen, Shizhu			Dynamic Dielectrophoresis Model of Multi-Phase Ionic Fluids	PLOS ONE			English	Article							AC-ELECTROKINETICS; DROPLET; MICROFLUIDICS; FLOW	Ionic-based dielectrophoretic microchips have attracted significant attention due to their wide-ranging applications in electro kinetic and biological experiments. In this work, a numerical method is used to simulate the dynamic behaviors of ionic droplets in a microchannel under the effect of dielectrophoresis. When a discrete liquid dielectric is encompassed within a continuous fluid dielectric placed in an electric field, an electric force is produced due to the dielectrophoresis effect. If either or both of the fluids are ionic liquids, the magnitude and even the direction of the force will be changed because the net ionic charge induced by an electric field can affect the polarization degree of the dielectrics. However, using a dielectrophoresis model, assuming ideal dielectrics, results in significant errors. To avoid the inaccuracy caused by the model, this work incorporates the electrode kinetic equation and defines a relationship between the polarization charge and the net ionic charge. According to the simulation conditions presented herein, the electric force obtained in this work has an error exceeding 70% of the actual value if the false effect of net ionic charge is not accounted for, which would result in significant issues in the design and optimization of experimental parameters. Therefore, there is a clear motivation for developing a model adapted to ionic liquids to provide precise control for the dielectrophoresis of multi-phase ionic liquids.	[Yan, Ying; Luo, Jing; Guo, Dan; Wen, Shizhu] Tsinghua Univ, State Key Lab Tribol, Beijing 100084, Peoples R China	Tsinghua University	Guo, D (corresponding author), Tsinghua Univ, State Key Lab Tribol, Beijing 100084, Peoples R China.	guodan26@mail.tsinghua.edu.cn	Guo, Dan/S-8823-2019		National Natural Science Foundation of China [51375255, 51321092]; International Science&Technology Cooperation Project [2011DFA70980]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Science&Technology Cooperation Project	This research is supported by National Natural Science Foundation of China (No. 51375255 and No. 51321092) (http://www.nsfc.gov.cn/publish/portal1/) and the International Science&Technology Cooperation Project (No. 2011DFA70980) (http://www.most.gov.cn/eng/cooperation/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astle MJ, 1988, CRC HDB CHEM PHYS, V69, pD; Braff WA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076751; Chang HC, 2010, ELECTROKINETICALLY D; deMello AJ, 2006, NATURE, V442, P394, DOI 10.1038/nature05062; Fryd MM, 2014, SOFT MATTER, V10, P4662, DOI 10.1039/c4sm00453a; Gallo-Villanueva RC, 2014, ELECTROPHORESIS, V35, P352, DOI 10.1002/elps.201300171; Jones J, 2003, PHYS FLUIDS, V16, P393, DOI [10.1063/1.1694354, DOI 10.1063/1.1694354]; Jones T. B., 2005, ELECTROMECHANICS PAR; Jung YM, 2008, J COLLOID INTERF SCI, V322, P617, DOI 10.1016/j.jcis.2008.04.019; Kang KH, 2002, LANGMUIR, V18, P10318, DOI 10.1021/la0263615; Kirby B., 2010, MICRO NANOSCALE FLUI; Kiss MM, 2008, ANAL CHEM, V80, P8975, DOI 10.1021/ac801276c; Koo HJ, 2013, BIOMICROFLUIDICS, V7, DOI 10.1063/1.4804249; Lee DW, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4723633; Li D. Q., 2004, ELECTROKINETICS MICR, V2; Luo J, 2011, ELECTROPHORESIS, V32, P414, DOI 10.1002/elps.201000345; Moncada-Hernandez H, 2011, ELECTROPHORESIS, V32, P2502, DOI 10.1002/elps.201100168; Ng WY, 2011, LAB CHIP, V11, P4241, DOI 10.1039/c1lc20495e; Nilsson E, 2000, THESIS ROYAL I TECHN; Plecis A, 2011, LAB CHIP, V11, P795, DOI 10.1039/c0lc00079e; Ramos A, 1998, J PHYS D APPL PHYS, V31, P2338, DOI 10.1088/0022-3727/31/18/021; Singh P, 2007, ELECTROPHORESIS, V28, P644, DOI 10.1002/elps.200600549; Squires TM, 2005, REV MOD PHYS, V77, P977, DOI 10.1103/RevModPhys.77.977; Studer V, 2004, ANALYST, V129, P944, DOI 10.1039/b408382m; Vaillier C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095231; Wu CY, 2011, LAB CHIP, V11, P1740, DOI [10.1039/c0lc00620c, 10.1039/c01c00620c]; Yi CQ, 2006, ANAL CHIM ACTA, V560, P1, DOI 10.1016/j.aca.2005.12.037; Young PM, 2008, J FLUID ENG-T ASME, V130, DOI 10.1115/1.2956606; Zeng J, 2004, LAB CHIP, V4, P265, DOI 10.1039/b403082f	29	1	1	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0117456	10.1371/journal.pone.0117456	http://dx.doi.org/10.1371/journal.pone.0117456			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25699513	gold, Green Published, Green Submitted			2022-12-26	WOS:000349789800024
J	Jobanputra, K; Parker, LA; Azih, C; Okello, V; Maphalala, G; Kershberger, B; Khogali, M; Lujan, J; Antierens, A; Teck, R; Ellman, T; Kosgei, R; Reid, T				Jobanputra, Kiran; Parker, Lucy Anne; Azih, Charles; Okello, Velephi; Maphalala, Gugu; Kershberger, Bernard; Khogali, Mohammed; Lujan, Johnny; Antierens, Annick; Teck, Roger; Ellman, Tom; Kosgei, Rose; Reid, Tony			Factors Associated with Virological Failure and Suppression after Enhanced Adherence Counselling, in Children, Adolescents and Adults on Antiretroviral Therapy for HIV in Swaziland	PLOS ONE			English	Article								ntroduction This study explores factors associated with virological detectability, and viral re-suppression after enhanced adherence counselling, in adults and children on antiretroviral therapy (ART) in Swaziland. Methods This descriptive study used laboratory data from 7/5/2012 to 30/9/2013, which were linked with the national ART database to provide information on time on ART and CD4 count; information on enhanced adherence counselling was obtained from file review in health facilities. Multivariable logistic regression was used to explore the relationship between viral load, gender, age, time on ART, CD4 count and receiving (or not receiving) enhanced adherence counselling. Results From 12,063 patients undergoing routine viral load monitoring, 1941 (16%) had detectable viral loads. Children were more likely to have detectable viral loads (AOR 2.6, 95%CI 1.5-4.5), as were adolescents (AOR 3.2, 95%CI 2.2-4.8), patients with last CD4<350 cells/mu l (AOR 2.2, 95%CI 1.7-2.9) or WHO Stage 3/4 disease (AOR 1.3, 95%CI 1.1-1.6), and patients on ART for longer (AOR 1.1, 95%CI 1.1-1.2). At retesting, 450 (54% of those tested) showed viral re-suppression. Children were less likely to re-suppress (AOR 0.2, 95%CI 0.1-0.7), as were adolescents (AOR 0.3, 95%CI 0.2-0.8), those with initial viral load> 1000 copies/ml (AOR 0.3, 95%CI 0.1-0.7), and those with last CD4<350 cells/mu l (AOR 0.4, 95%CI 0.2-0.7). Receiving (or not receiving) enhanced adherence counselling was not associated with likelihood of re-suppression. Conclusions Children, adolescents and those with advanced disease were most likely to have high viral loads and least likely to achieve viral suppression at retesting; receiving adherence counselling was not associated with higher likelihood of viral suppression. Although the level of viral resistance was not quantified, this study suggests the need for ART treatment support that addresses the adherence problems of younger people; and to define the elements of optimal enhanced adherence support for patients of all ages with detectable viral loads.	[Jobanputra, Kiran; Parker, Lucy Anne; Kershberger, Bernard] Med Sans Frontieres Operat Ctr Geneva, Mbabane, Eswatini; [Azih, Charles; Okello, Velephi] Minist Hlth, Swaziland Natl ART Program, Mbabane, Eswatini; [Maphalala, Gugu] Swaziland Natl Reference Lab, Mbabane, Eswatini; [Khogali, Mohammed; Kosgei, Rose; Reid, Tony] Med Sans Frontieres Operat Res Unit, Luxembourg, Luxembourg; [Lujan, Johnny; Antierens, Annick; Teck, Roger] Med Sans Frontieres Operat Ctr Geneva, Geneva, Switzerland; [Ellman, Tom] Med Sans Frontieres Southern Africa Med Unit, Cape Town, South Africa	Doctors Without Borders	Jobanputra, K (corresponding author), Med Sans Frontieres Operat Ctr Geneva, Mbabane, Eswatini.	kiranjimmy@gmail.com	; Parker, Lucy Anne/R-3622-2017	Jobanputra, Kiran/0000-0002-7378-0189; Parker, Lucy Anne/0000-0002-2362-4057				Cheti E, 2013, IS SYSTEMAT IN PRESS; Fox MP, 2012, JAIDS-J ACQ IMM DEF, V60, P428, DOI 10.1097/QAI.0b013e3182557785; Greig JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071407; Jobanputra Kiran, 2014, J Acquir Immune Defic Syndr, V67, P45, DOI 10.1097/QAI.0000000000000224; Laprise C, 2013, CLIN INFECT DIS, V57, P1489, DOI 10.1093/cid/cit529; Lee PK, 2006, J ANTIMICROB CHEMOTH, V57, P803, DOI 10.1093/jac/dkl092; Ma Y, 2010, CLIN INFECT DIS, V50, P264, DOI 10.1086/649215; Mutwa PR, 2014, PEDIATR INFECT DIS J, V33, P63, DOI 10.1097/INF.0b013e31829e6b9f; Nkambule R, 2012, SHIMS SWAZILAND HIV; Penazzato M, 2013, 5 INT WORKSH HIV PAE; Strategic Information Department-Ministry of Health-Kingdom of Swaziland, 2012, ART PROGRAM ANN REPO, V2012, P0; van Griensven J, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-39; von Elm E, 2008, REV ESP SALUD PUBLIC, V82, P251; WHO, 2013, HIV AD GUID HIV TEST; World Health Organization, 2013, CONSOLIDATED GUIDELI	15	109	110	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0116144	10.1371/journal.pone.0116144	http://dx.doi.org/10.1371/journal.pone.0116144			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695494	Green Published, gold, Green Submitted			2022-12-26	WOS:000350062300011
J	Fuso, A; Ferraguti, G; Scarpa, S; Ferrer, I; Lucarelli, M				Fuso, Andrea; Ferraguti, Giampiero; Scarpa, Sigfrido; Ferrer, Isidre; Lucarelli, Marco			Disclosing Bias in Bisulfite Assay: MethPrimers Underestimate High DNA Methylation	PLOS ONE			English	Article							NON-CPG METHYLATION; EMBRYONIC STEM-CELLS; MAMMALIAN-CELLS; GENOME; DIFFERENTIATION; GENE; DEMETHYLATION; EXPRESSION; TISSUES; REGION	Discordant results obtained in bisulfite assays using MethPrimers (PCR primers designed using MethPrimer software or assuming that non-CpGs cytosines are non methylated) versus primers insensitive to cytosine methylation lead us to hypothesize a technical bias. We therefore used the two kinds of primers to study different experimental models and methylation statuses. We demonstrated that MethPrimers negatively select hypermethylated DNA sequences in the PCR step of the bisulfite assay, resulting in CpG methylation underestimation and non-CpG methylation masking, failing to evidence differential methylation statuses. We also describe the characteristics of "Methylation-Insensitive Primers" (MIPs), having degenerated bases (G/A) to cope with the uncertain C/U conversion. As CpG and non-CpG DNA methylation patterns are largely variable depending on the species, developmental stage, tissue and cell type, a variable extent of the bias is expected. The more the methylome is methylated, the greater is the extent of the bias, with a prevalent effect of non-CpG methylation. These findings suggest a revision of several DNA methylation patterns so far documented and also point out the necessity of applying unbiased analyses to the increasing number of epigenomic studies.	[Fuso, Andrea] Univ Roma La Sapienza, Dept Psychol, I-00185 Rome, Italy; [Fuso, Andrea] Santa Lucia Fdn, IRCCS, European Ctr Brain Res CERC, Rome, Italy; [Ferraguti, Giampiero; Lucarelli, Marco] Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, I-00185 Rome, Italy; [Scarpa, Sigfrido] Univ Roma La Sapienza, Dept Surg P Valdoni, I-00185 Rome, Italy; [Ferrer, Isidre] Bellvitge Univ Hosp, Inst Neuropathol, IDIBELL, Lhospitalet De Llobregat, Spain; [Ferrer, Isidre] Univ Barcelona, CIBERNED, Lhospitalet De Llobregat, Spain; [Lucarelli, Marco] Univ Roma La Sapienza, Inst Pasteur, Cenci Bolognetti Fdn, I-00185 Rome, Italy	Sapienza University Rome; IRCCS Santa Lucia; Sapienza University Rome; Sapienza University Rome; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; CIBERNED; University of Barcelona; Fondazione Cenci Bolognetti; Sapienza University Rome	Fuso, A (corresponding author), Univ Roma La Sapienza, Dept Psychol, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	andrea.fuso@uniroma1.it	Lucarelli, Marco/AAC-1667-2019	Fuso, Andrea/0000-0001-9467-5671; FERRAGUTI, Giampiero/0000-0001-6129-4071; Lucarelli, Marco/0000-0002-5538-2494	European Community [278486 "DEVELAGE"]; Sapienza Universita di Roma	European Community(European Commission); Sapienza Universita di Roma	This research is supported by funding from: European Community 7th Framework program (FP7/2007-2013) grant no 278486 "DEVELAGE" to AF and SS; Sapienza Universita di Roma, Scientific Research Programs 2012 and 2013 to ML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arand J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002750; Barres R, 2009, CELL METAB, V10, P189, DOI 10.1016/j.cmet.2009.07.011; CLARK SJ, 1995, NAT GENET, V10, P20, DOI 10.1038/ng0595-20; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Fouse SD, 2010, EPIGENOMICS-UK, V2, P105, DOI 10.2217/EPI.09.35; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Fuso A, 2006, ANAL BIOCHEM, V350, P24, DOI 10.1016/j.ab.2005.12.008; Fuso A, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.12.013; Fuso A, 2011, NEUROBIOL AGING, V32, P187, DOI 10.1016/j.neurobiolaging.2009.02.013; Fuso A, 2010, CELL CYCLE, V9, P3965, DOI 10.4161/cc.9.19.13193; Genereux DP, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn691; Guo JU, 2014, NAT NEUROSCI, V17, P215, DOI 10.1038/nn.3607; Guo WL, 2014, NUCLEIC ACIDS RES, V42, P3009, DOI 10.1093/nar/gkt1306; Gupta R, 2010, BIOTECHNIQUES, V49, pIII, DOI 10.2144/000113493; Kozlenkov A, 2014, NUCLEIC ACIDS RES, V42, P109, DOI 10.1093/nar/gkt838; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Lister R, 2009, GENOME RES, V19, P959, DOI 10.1101/gr.083451.108; Lucarelli M, 2001, J BIOL CHEM, V276, P7500, DOI 10.1074/jbc.M008234200; Nishino K, 2011, J REPROD DEVELOP, V57, P586, DOI 10.1262/jrd.11-033A; Patil V, 2014, EPIGENETICS-US, V9, P823, DOI 10.4161/epi.28741; Ramsahoye BH, 2000, P NATL ACAD SCI USA, V97, P5237, DOI 10.1073/pnas.97.10.5237; Teng C, 2004, BIOMETALS, V17, P317, DOI 10.1023/B:BIOM.0000027711.13818.8a; Tomizawa S, 2011, DEVELOPMENT, V138, P811, DOI 10.1242/dev.061416; Varley KE, 2013, GENOME RES, V23, P555, DOI 10.1101/gr.147942.112; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; Xie W, 2012, CELL, V148, P816, DOI 10.1016/j.cell.2011.12.035; Yan J, 2011, EXP CELL RES, V317, P2555, DOI 10.1016/j.yexcr.2011.08.019; Ziller MJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002389	31	36	38	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118318	10.1371/journal.pone.0118318	http://dx.doi.org/10.1371/journal.pone.0118318			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692551	gold, Green Published, Green Submitted			2022-12-26	WOS:000350061500116
J	Guzman-Venegas, RA; Picand, JLB; de la Rosa, FJB				Guzman-Venegas, Rodrigo A.; Biotti Picand, Jorge L.; Berral de la Rosa, Francisco J.			Functional Compartmentalization of the Human Superficial Masseter Muscle	PLOS ONE			English	Article							FIBER-TYPE COMPOSITION; HUMAN JAW MUSCLES; BITE FORCE; ELECTROMYOGRAPHIC HETEROGENEITY; MOTOR UNITS; SPATIAL-DISTRIBUTION; HUMAN TEMPORALIS; MYOSIN; EMG; MOTONEURONS	Some muscles have demonstrated a differential recruitment of their motor units in relation to their location and the nature of the motor task performed; this involves functional compartmentalization. There is little evidence that demonstrates the presence of a compartmentalization of the superficial masseter muscle during biting. The aim of this study was to describe the topographic distribution of the activity of the superficial masseter (SM) muscle's motor units using high-density surface electromyography (EMGs) at different bite force levels. Twenty healthy natural dentate participants (men: 4; women: 16; age 20 +/- 2 years; mass: 60 +/- 12 kg, height: 163 +/- 7 cm) were selected from 316 volunteers and included in this study. Using a gnathodynamometer, bites from 20 to 100% maximum voluntary bite force (MVBF) were randomly requested. Using a two-dimensional grid (four columns, six electrodes) located on the dominant SM, EMGs in the anterior, middle-anterior, middle-posterior and posterior portions were simultaneously recorded. In bite ranges from 20 to 60% MVBF, the EMG activity was higher in the anterior than in the posterior portion (p-value = 0.001). The center of mass of the EMG activity was displaced towards the posterior part when bite force increased (p-value = 0.001). The topographic distribution of EMGs was more homogeneous at high levels of MVBF (p-value = 0.001). The results of this study show that the superficial masseter is organized into three functional compartments: an anterior, a middle and a posterior compartment. However, this compartmentalization is only seen at low levels of bite force (20-60% MVBF).	[Guzman-Venegas, Rodrigo A.] Univ Los Andes, Fac Med, Escuela Kinesiol, Lab Integrat Biomecan & Fisiol Esfuerzo, Santiago, Chile; [Biotti Picand, Jorge L.] Univ Los Andes, Fac Odontol, Santiago, Chile; [Berral de la Rosa, Francisco J.] Univ Pablo Olavide, Lab Biomecan Kinesiol & Cineantropometria, Seville, Spain	Universidad de los Andes - Chile; Universidad de los Andes - Chile; Universidad Pablo de Olavide	Guzman-Venegas, RA (corresponding author), Univ Los Andes, Fac Med, Escuela Kinesiol, Lab Integrat Biomecan & Fisiol Esfuerzo, Santiago, Chile.	rguzman@uandes.cl	Berral de la Rosa, Francisco José/C-6553-2013; De La Rosa, Francisco/GWU-4894-2022	Guzman-Venegas, Rodrigo/0000-0003-0567-4867	"Fondo de Ayuda a la Investigacion" of los Andes University [IN0GTO201157KIN-001-11]	"Fondo de Ayuda a la Investigacion" of los Andes University	This study was supported by "Fondo de Ayuda a la Investigacion" of los Andes University (IN0GTO201157KIN-001-11). The authors declare no potential conflicts of interest with respect to the authorship and/or publication of this article. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAYA R, 1992, SOC PSYCH PSYCH EPID, V27, P168, DOI 10.1007/BF00789001; Arima T, 2013, J ORAL REHABIL, V40, P900, DOI 10.1111/joor.12097; BLANKSMA NG, 1995, J DENT RES, V74, P1318, DOI 10.1177/00220345950740061201; BLANKSMA NG, 1992, J DENT RES, V71, P47, DOI 10.1177/00220345920710010801; Blanksma NG, 1997, J DENT RES, V76, P542, DOI 10.1177/00220345970760010401; Castroflorio T, 2005, J ORAL REHABIL, V32, P708, DOI 10.1111/j.1365-2842.2005.01490.x; Castroflorio T, 2012, J ORAL REHABIL, V39, P81, DOI 10.1111/j.1365-2842.2011.02246.x; De Leeuw R., 2008, OROFACIAL PAIN GUIDE, V4th; Dworkin Samuel F., 1992, Journal of Craniomandibular Disorders, V6, P301; Farina D, 2008, J ELECTROMYOGR KINES, V18, P16, DOI 10.1016/j.jelekin.2006.08.005; Fitton LC, 2012, J ANAT, V221, P55, DOI 10.1111/j.1469-7580.2012.01516.x; GASPARD M, 1973, J BIOL BUCCALE, V1, P7; Groning F, 2012, ANAT REC, V295, P853, DOI 10.1002/ar.22455; HENNEMAN E, 1965, J NEUROPHYSIOL, V28, P599, DOI 10.1152/jn.1965.28.3.599; Hoh JFY, 2002, J EXP BIOL, V205, P2203; Korfage JAM, 2005, J DENT RES, V84, P784, DOI 10.1177/154405910508400902; Korfage JAM, 2005, J DENT RES, V84, P774, DOI 10.1177/154405910508400901; MASUDA T, 1991, J ELECTROMYOGR KINES, V1, P107, DOI 10.1016/1050-6411(91)90004-O; MCMILLAN AS, 1992, ARCH ORAL BIOL, V37, P849, DOI 10.1016/0003-9969(92)90119-S; Merletti R, 2004, ELECTROMYOGRAPHY PHY; Merletti R, 2008, J ELECTROMYOGR KINES, V18, P879, DOI 10.1016/j.jelekin.2008.09.002; Ogawa T, 2006, J ORAL REHABIL, V33, P729, DOI 10.1111/j.1365-2842.2006.01617.x; Osterlund C, 2011, ANAT REC, V294, P1158, DOI 10.1002/ar.21272; Sano R, 2007, J ANAT, V211, P464, DOI 10.1111/j.1469-7580.2007.00783.x; SCIOTE JJ, 1994, J NEUROL SCI, V126, P15, DOI 10.1016/0022-510X(94)90089-2; Scutter SD, 2000, ARCH ORAL BIOL, V45, P617, DOI 10.1016/S0003-9969(99)00146-6; Serra CM, 2013, J ORAL REHABIL, V40, P563, DOI 10.1111/joor.12068; SERRATRICE G, 1976, J NEUROL SCI, V30, P189, DOI 10.1016/0022-510X(76)90266-5; Shi JF, 2012, J THEOR BIOL, V310, P21, DOI 10.1016/j.jtbi.2012.06.006; Stedman HH, 2004, NATURE, V428, P415, DOI 10.1038/nature02358; van Kampen FMC, 2002, J DENT RES, V81, P170, DOI 10.1177/154405910208100305; Yang J, 2001, ARCH ORAL BIOL, V46, P989, DOI 10.1016/S0003-9969(01)00075-9; Yoshikawa T., 1969, Anatomischer Anzeiger, V125, P363	33	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0116923	10.1371/journal.pone.0116923	http://dx.doi.org/10.1371/journal.pone.0116923			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692977	Green Published, gold, Green Submitted			2022-12-26	WOS:000350061500030
J	Liu, C; Chen, J; Li, ET; Fan, Q; Wang, DY; Zhang, CS; Li, P; Li, XP; Chen, XY; Qiu, SL; Gao, ZZ; Li, HQ; Hu, YL				Liu, Cui; Chen, Jin; Li, Entao; Fan, Qiang; Wang, Deyun; Zhang, Cunshuai; Li, Peng; Li, Xiuping; Chen, Xingying; Qiu, Shulei; Gao, Zhenzhen; Li, Hongquan; Hu, Yuanliang			Solomonseal Polysaccharide and Sulfated Codonopsis pilosula Polysaccharide Synergistically Resist Newcastle Disease Virus	PLOS ONE			English	Article							INDIRECT IMMUNOFLUORESCENCE ASSAY; CELLULAR INFECTIVITY; ANTIVIRAL ACTIVITY; IN-VITRO; EPIMEDIUM POLYSACCHARIDE; ND VACCINE; MODIFIERS; CHICKENS; ENHANCE; TISSUE	Five combinations of three ratios (PS9-sPS(1), PS7-sPS(3) and PS6-sPS(4)) were prepared with polysaccharide (PS) and sulfated polysaccharide (sPS). The antiviral activities of these compounds were subsequently compared in vitro using the MTT assay, observation of the virus structure and immunofluorescence. The results demonstrated that SP9-sCP(1), CP7-sCA(3), EP7-sAP(3), CA(9)-sEP(1) and EP7-sCA(3) presented higher activities, and SP9-sCP(1) displayed the highest virus inhibition rate and clearly killed the virus and inhibited viral antigen expression. In an in vivo test, 28-day-old chickens were challenged with Newcastle disease virus (NDV) and were administered the five drug combinations. On day 14 after the challenge, the morbidity, mortality and cure rate in each group were calculated. The results indicated that SP9-sCP(1) presented the lowest morbidity and mortality and the highest cure rate. These results indicate that Solomonseal polysaccharide and sulfated Codonopsis pilosula polysaccharide synergistically resist NDV. Moreover, SP9-sCP(1) had the highest efficacy and may be used as a new antiviral drug.	[Liu, Cui; Li, Entao; Wang, Deyun; Li, Peng; Li, Xiuping; Chen, Xingying; Qiu, Shulei; Gao, Zhenzhen; Hu, Yuanliang] Nanjing Agr Univ, Coll Vet Med, Inst Tradit Chinese Vet Med, Nanjing 210095, Jiangsu, Peoples R China; [Chen, Jin] Jiangsu Acad Agr Sci, Natl Res Ctr Vet Biol Engn & Technol, Nanjing 210014, Jiangsu, Peoples R China; [Fan, Qiang; Zhang, Cunshuai] China Inst Vet Drug Control, Beijing 100081, Peoples R China; [Li, Hongquan] Shanxi Agr Univ, Coll Anim Sci & Vet Med, Taigu 030801, Shanxi, Peoples R China	Nanjing Agricultural University; Jiangsu Academy of Agricultural Sciences; China Institute of Veterinary Drug Control; Shanxi Agricultural University	Hu, YL (corresponding author), Nanjing Agr Univ, Coll Vet Med, Inst Tradit Chinese Vet Med, Nanjing 210095, Jiangsu, Peoples R China.	ylhu@njau.edu.cn			National Special Fund for Agro-Scientific Research in the Public Interest of China [201403051]; National Natural Science Foundation of China [30871887, 31272596]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Key Scientific and Technological Grant from Shanxi Province [2010311047]	National Special Fund for Agro-Scientific Research in the Public Interest of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; Key Scientific and Technological Grant from Shanxi Province	The project was supported by the National Special Fund for Agro-Scientific Research in the Public Interest of China (201403051), the National Natural Science Foundation of China (30871887, 31272596), the Priority Academic Program Development of Jiangsu Higher Education Institutions, and a Key Scientific and Technological Grant from Shanxi Province (2010311047). The funders had no role in study design, data collectionand analysis, decision to publish, or preparation of the manuscript.	Alban S, 2002, CARBOHYD POLYM, V47, P267, DOI 10.1016/S0144-8617(01)00178-3; Amornrut C, 1999, CARBOHYD RES, V321, P121, DOI 10.1016/S0008-6215(99)00188-3; Antarasena C, 2007, RES VET SCI, V83, P279, DOI 10.1016/j.rvsc.2006.12.007; Bedekovic T, 2011, J VIROL METHODS, V178, P59, DOI 10.1016/j.jviromet.2011.08.012; Bogoyavlenskiy A, 2009, VIRUS GENES, V39, P94, DOI 10.1007/s11262-009-0370-1; Fan YP, 2010, INT J BIOL MACROMOL, V47, P87, DOI 10.1016/j.ijbiomac.2010.05.017; Ghosh P, 2004, PHYTOCHEMISTRY, V65, P3151, DOI 10.1016/j.phytochem.2004.07.025; [辜红梅 Gu Hongmei], 2003, [应用与环境生物学报, Chinese Journal of Applied and Environmental Biology], V9, P21; Guo ZH, 2009, VACCINE, V27, P660, DOI 10.1016/j.vaccine.2008.11.038; Han SQ, 2010, CARBOHYD POLYM, V80, P1111, DOI 10.1016/j.carbpol.2010.01.031; Hong W, 2014, ANTIVIR RES, V102, P1, DOI 10.1016/j.antiviral.2013.11.013; Huang XY, 2008, INT J BIOL MACROMOL, V42, P166, DOI 10.1016/j.ijbiomac.2007.10.019; Kim M, 2013, ANTIVIR RES, V100, P460, DOI 10.1016/j.antiviral.2013.08.002; Li T, 2013, ANTIVIR RES, V97, P1, DOI 10.1016/j.antiviral.2012.10.006; Liu L, 2007, CARBOHYD POLYM, V70, P304, DOI 10.1016/j.carbpol.2007.04.012; Lu Y, 2008, CARBOHYD POLYM, V71, P180, DOI 10.1016/j.carbpol.2007.05.024; Rahman MM, 2012, VACCINE, V30, P7165, DOI 10.1016/j.vaccine.2012.10.011; Saxena P, 2011, J SURG RES, V171, P311, DOI 10.1016/j.jss.2009.11.011; Sun YX, 2008, INT J BIOL MACROMOL, V43, P279, DOI 10.1016/j.ijbiomac.2008.06.009; TAKEUCHI H, 1991, J VIROL METHODS, V33, P61, DOI 10.1016/0166-0934(91)90008-N; Talarico LB, 2005, ANTIVIR RES, V66, P103, DOI 10.1016/j.antiviral.2005.02.001; Talorete TPN, 2006, CYTOTECHNOLOGY, V52, P189, DOI 10.1007/s10616-007-9057-4; Nguyen TL, 2012, CARBOHYD POLYM, V90, P1254, DOI 10.1016/j.carbpol.2012.06.060; Wang C, 2000, ADV BIO PRO, V2, P3; Wang JM, 2010, INT J BIOL MACROMOL, V46, P212, DOI 10.1016/j.ijbiomac.2009.11.011; Yang S J, 2009, THESIS NANJING AGR U; Yin Z, 1997, VIROLOGY ANIMAL, P204, DOI [10.1007/BF02899922, DOI 10.1007/BF02899922]; Zhang XH, 2005, CHIN J CHROMATOGR, V23, P394; [张玉清 Zhang Yuqing], 2012, [南京农业大学学报, Journal of Nanjing Agricultural University], V35, P105; Zhao XN, 2011, INT J BIOL MACROMOL, V49, P44, DOI 10.1016/j.ijbiomac.2011.03.010; 任丽靖, 2008, [中草药, Chinese Traditional and Herbal Drugs], V39, P986	31	6	12	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							0117916	10.1371/journal.pone.0117916	http://dx.doi.org/10.1371/journal.pone.0117916			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692886	Green Published, gold, Green Submitted			2022-12-26	WOS:000350061500079
J	Ohnishi, A; Asayama, R; Mogi, M; Nakaoka, H; Kan-No, H; Tsukuda, K; Chisaka, T; Wang, XL; Bai, HY; Shan, BS; Kukida, M; Iwanami, J; Horiuchi, M				Ohnishi, Arika; Asayama, Rie; Mogi, Masaki; Nakaoka, Hirotomo; Kan-no, Harumi; Tsukuda, Kana; Chisaka, Toshiyuki; Wang, Xiao-Li; Bai, Hui-Yu; Shan, Bao-Shuai; Kukida, Masayoshi; Iwanami, Jun; Horiuchi, Masatsugu			Drinking Citrus Fruit Juice Inhibits Vascular Remodeling in Cuff-Induced Vascular Injury Mouse Model	PLOS ONE			English	Article							BLOOD-PRESSURE; ORANGE JUICE; UNSHIU; RISK; CELLS; MARKERS; DIETS	Citrus fruits are thought to have inhibitory effects on oxidative stress, thereby attenuating the onset and progression of cancer and cardiovascular disease; however, there are few reports assessing their effect on vascular remodeling. Here, we investigated the effect of drinking the juice of two different citrus fruits on vascular neointima formation using a cuff-induced vascular injury mouse model. Male C57BL6 mice were divided into five groups as follows: 1) Control (water) (C), 2) 10% Citrus unshiu (CU) juice (CU10), 3) 40% CU juice (CU40), 4) 10% Citrus iyo (CI) juice (CI10), and 5) 40% CI juice (CI40). After drinking them for 2 weeks from 8 weeks of age, cuff injury was induced by polyethylene cuff placement around the femoral artery. Neointima formation was significantly attenuated in CU40, CI10 and CI40 compared with C; however, no remarkable preventive effect was observed in CU10. The increases in levels of various inflammatory markers including cytokines such as monocyte chemotactic protein-1, interleukin-6 (IL-6), IL-1 beta, and tumor necrosis factor-alpha in response to vascular injury did not differ significantly between C, CU10 and CI10. The increases in cell proliferation and superoxide anion production were markedly attenuated in CI10, but not in CU10 compared with C. The increase in phosphorylated ERK expression was markedly attenuated both in CU10 and CI10 without significant difference between CU10 and CI10. Accumulation of immune cells did not differ between CU10 and CI10. These results indicate that drinking citrus fruit juice attenuates vascular remodeling partly via a reduction of oxidative stress. Interestingly, the preventive efficacy on neointima formation was stronger in CI than in CU at least in part due to more prominent inhibitory effects on oxidative stress by CI.	[Ohnishi, Arika; Asayama, Rie; Mogi, Masaki; Nakaoka, Hirotomo; Kan-no, Harumi; Tsukuda, Kana; Chisaka, Toshiyuki; Wang, Xiao-Li; Bai, Hui-Yu; Shan, Bao-Shuai; Kukida, Masayoshi; Iwanami, Jun; Horiuchi, Masatsugu] Ehime Univ, Grad Sch Med, Dept Mol Cardiovasc Biol & Pharmacol, Tohon, Ehime, Japan; [Chisaka, Toshiyuki] Ehime Univ, Grad Sch Med, Dept Pediat, Tohon, Ehime, Japan; [Kukida, Masayoshi] Ehime Univ, Grad Sch Med, Dept Cardiol Pulmonol Hypertens & Nephrol, Tohon, Ehime, Japan	Ehime University; Ehime University; Ehime University	Mogi, M (corresponding author), Ehime Univ, Grad Sch Med, Dept Mol Cardiovasc Biol & Pharmacol, Tohon, Ehime, Japan.	mmogi@m.ehime-u.ac.jp			JSPS KAKENHI [25293310, 25462220]; pharmaceutical company: Astellas Pharma Inc.; pharmaceutical company: Bayer Yakuhin, Ltd.; pharmaceutical company: Daiichi-Sankyo Pharmaceutical Co. Ltd.; pharmaceutical company: Nippon Boehringer Ingelheim Co. Ltd.; pharmaceutical company: Novartis Pharma K.K.; pharmaceutical company: Shionogi Co., Ltd.; pharmaceutical company: Takeda Pharmaceutical Co. Ltd.	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); pharmaceutical company: Astellas Pharma Inc.; pharmaceutical company: Bayer Yakuhin, Ltd.; pharmaceutical company: Daiichi-Sankyo Pharmaceutical Co. Ltd.; pharmaceutical company: Nippon Boehringer Ingelheim Co. Ltd.; pharmaceutical company: Novartis Pharma K.K.; pharmaceutical company: Shionogi Co., Ltd.; pharmaceutical company: Takeda Pharmaceutical Co. Ltd.	This study was supported by JSPS KAKENHI Grant Numbers 25293310 (MH) and 25462220 (MM), and research grants from pharmaceutical companies: Astellas Pharma Inc., Bayer Yakuhin, Ltd., Daiichi-Sankyo Pharmaceutical Co. Ltd., Nippon Boehringer Ingelheim Co. Ltd., Novartis Pharma K.K., Shionogi & Co., Ltd., and Takeda Pharmaceutical Co. Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Ascherio A, 1996, HYPERTENSION, V27, P1065, DOI 10.1161/01.HYP.27.5.1065; Buscemi S, 2012, AM J CLIN NUTR, V95, P1089, DOI 10.3945/ajcn.111.031088; Codoner-Franch P, 2008, J PEDIATR GASTR NUTR, V47, P349, DOI 10.1097/MPG.0b013e31816a8cdb; Codoner-Franch P, 2013, INT J FOOD SCI NUTR, V64, P815, DOI 10.3109/09637486.2013.798267; Codoner-Franch P, 2010, ACTA PAEDIATR, V99, P1841, DOI 10.1111/j.1651-2227.2010.01903.x; Devaraj S, 2011, CLIN NUTR, V30, P668, DOI 10.1016/j.clnu.2011.03.009; Foschi R, 2010, CANCER CAUSE CONTROL, V21, P237, DOI 10.1007/s10552-009-9454-4; Fujita T, 2009, HYPERTENSION, V53, P688, DOI 10.1161/HYPERTENSIONAHA.108.128140; Gaziano J. Michael, 1995, Annals of Epidemiology, V5, P255, DOI 10.1016/1047-2797(94)00090-G; Ghanim H, 2010, AM J CLIN NUTR, V91, P940, DOI 10.3945/ajcn.2009.28584; Ihara H, 2012, BIOSCI BIOTECH BIOCH, V76, P1843, DOI 10.1271/bbb.120215; Jaganathan SK, 2014, WORLD J GASTROENTERO, V20, P4618, DOI 10.3748/wjg.v20.i16.4618; Jin H, 2013, ONCOL REP, V30, P2336, DOI 10.3892/or.2013.2711; Joshipura KJ, 1999, JAMA-J AM MED ASSOC, V282, P1233, DOI 10.1001/jama.282.13.1233; KREGE JH, 1995, HYPERTENSION, V25, P1111, DOI 10.1161/01.HYP.25.5.1111; Lee S, 2011, J ETHNOPHARMACOL, V133, P973, DOI 10.1016/j.jep.2010.07.018; Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079; Manners GD, 2007, J AGR FOOD CHEM, V55, P8285, DOI 10.1021/jf071797h; Matsumoto Ryoji, 2008, Horticultural Research (Japan), V7, P481, DOI 10.2503/hrj.7.481; Ministry of Education Culture Sports Science and Technology Japan, 2010, STAND TABL FOOD COMP; Miura K, 2004, AM J EPIDEMIOL, V159, P572, DOI 10.1093/aje/kwh085; Morand C, 2011, AM J CLIN NUTR, V93, P73, DOI 10.3945/ajcn.110.004945; Muraki I, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5001; Nogata Y, 2006, BIOSCI BIOTECH BIOCH, V70, P178, DOI 10.1271/bbb.70.178; Nunez-Cordoba JM, 2009, EUR J CLIN NUTR, V63, P605, DOI 10.1038/ejcn.2008.22; Oude Griep LM, 2011, EUR J CLIN NUTR, V65, P791, DOI 10.1038/ejcn.2011.36; Oude Griep LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013609; Steevens J, 2011, INT J CANCER, V129, P2681, DOI 10.1002/ijc.25928; Suzuki J, 2002, CIRCULATION, V106, P847, DOI 10.1161/01.CIR.0000024103.04821.86; Suzuki R, 2007, INT J CANCER, V120, P252, DOI 10.1002/ijc.22240; Tanabe S, 2007, BIOSCI BIOTECH BIOCH, V71, P2852, DOI 10.1271/bbb.70397; Unno K, 2011, BIOL PHARM BULL, V34, P311, DOI 10.1248/bpb.34.311; Wu L, 2001, CIRCULATION, V104, P2716, DOI 10.1161/hc4601.099404; Xu CW, 2013, BIOL PHARM BULL, V36, P1549, DOI 10.1248/bpb.b13-00247; Yamada T, 2011, J EPIDEMIOL, V21, P169, DOI 10.2188/jea.JE20100084	36	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117616	10.1371/journal.pone.0117616	http://dx.doi.org/10.1371/journal.pone.0117616			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692290	gold, Green Published, Green Submitted			2022-12-26	WOS:000350061500064
J	Katzen, JB; Raparia, K; Agrawal, R; Patel, JD; Rademaker, A; Varga, J; Dematte, JE				Katzen, Jeremy B.; Raparia, Kirtee; Agrawal, Rishi; Patel, Jyoti D.; Rademaker, Alfred; Varga, John; Dematte, Jane E.			Early Stage Lung Cancer Detection in Systemic Sclerosis Does Not Portend Survival Benefit: A Cross Sectional Study	PLOS ONE			English	Article							RISK-FACTORS; SCLERODERMA; ASSOCIATION; DISEASE; METAANALYSIS; KRAS	Background Systemic Sclerosis (SSc) is a rare connective tissue disorder associated with an increased risk of malignancy including lung cancer. Methods A single center review of all cases of lung cancer in patients with SSc was conducted. Clinical, radiographic, and detailed pathologic data was collected. Risk factors were compared with our center's SSc Registry. Cancer characteristics were compared with the National Cancer Institute SEER Cancer Statistics (NCI SEER) data. Results 17 cases were identified; the majority were females (82%) with the lung cancers diagnosed after the onset of SSc (88%). Tobacco use was identified in 65% of cases. Serologic testing showed 50% of cases were Scl-70 positive. Twelve cases had radiographic evidence of SSc lung involvement, however only 6 had restrictive physiology on pulmonary function testing. Thirteen cases had pulmonary nodules preceding lung cancer. Thirteen of the cancers were adenocarcinoma. Ten underwent molecular mutational profiling: 2/8 had KRAS mutation and 1/10 had EGFR mutation. More of the non-small cell lung cancers were diagnosed at localized disease (56%) than in the NCI SEER database. However, 5 years survival among the stage I cases was 25% versus an expected survival of 54%. Conclusions The high proportion of adenocarcinomas seen in our study is different from that reported in the literature. Lung cancers were diagnosed at an early stage, likely due to our center's practice of radiographic screening for SSc associated lung involvement, however this did not confer a survival advantage. A high proportion of patients who developed lung cancer had interstitial lung disease.	[Katzen, Jeremy B.; Dematte, Jane E.] Northwestern Univ, Dept Med, Div Pulm & Crit Care Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Raparia, Kirtee] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA; [Agrawal, Rishi] Northwestern Univ, Feinberg Sch Med, Dept Radiol, Chicago, IL 60611 USA; [Patel, Jyoti D.] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Hematol & Oncol, Chicago, IL 60611 USA; [Rademaker, Alfred] Northwestern Univ, Dept Prevent Med, Div Biostat, Chicago, IL 60611 USA; [Varga, John] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Rheumatol, Chicago, IL 60611 USA; [Varga, John] Northwestern Univ, Feinberg Sch Med, Northwestern Scleroderma Program, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Katzen, JB (corresponding author), Northwestern Univ, Dept Med, Div Pulm & Crit Care Med, Feinberg Sch Med, Chicago, IL 60611 USA.	Jeremy-Katzen@northwestern.edu	Varga, John/AAK-6472-2021		U.S. Department of Health and Human Services-National Institutes of Health-National Cancer Institute [P30CA060553]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL076139] Funding Source: NIH RePORTER	U.S. Department of Health and Human Services-National Institutes of Health-National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding from the U.S. Department of Health and Human Services-National Institutes of Health-National Cancer Institute (P30CA060553). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Thoracic Society, 2002, Am J Respir Crit Care Med, V165, P277; [Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; [Anonymous], 2004, HLTH CONS SMOK REP S; Aubry MC, 2002, MAYO CLIN PROC, V77, P763, DOI 10.4065/77.8.763; Bonifazi M, 2013, RHEUMATOLOGY, V52, P143, DOI 10.1093/rheumatology/kes303; Church TR, 2013, NEW ENGL J MED, V368, P1980, DOI 10.1056/NEJMoa1209120; Colaci M, 2013, AUTOIMMUN REV, V12, P374, DOI 10.1016/j.autrev.2012.06.003; D'Angelo SP, 2012, J THORAC ONCOL, V7, P1815, DOI 10.1097/JTO.0b013e31826bb7b2; Derk CT, 2006, J RHEUMATOL, V33, P1113; Dufort S, 2009, ANAL BIOCHEM, V391, P166, DOI 10.1016/j.ab.2009.05.027; Gabrielli A, 2009, NEW ENGL J MED, V360, P1989, DOI 10.1056/NEJMra0806188; Howlader N, 2011, SURVEILLANCE EPIDEMI, DOI [10.1016/j.healun.2014.01.862, DOI 10.1016/J.HEALUN.2014.01.862]; Hubbard R, 2000, AM J RESP CRIT CARE, V161, P5, DOI 10.1164/ajrccm.161.1.9906062; Joseph CG, 2014, SCIENCE, V343, P152, DOI 10.1126/science.1246886; Kuo CF, 2012, SCAND J RHEUMATOL, V41, P44, DOI 10.3109/03009742.2011.618145; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Moinzadeh P, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4486; Olesen AB, 2010, BRIT J DERMATOL, V163, P800, DOI 10.1111/j.1365-2133.2010.09861.x; Onishi A, 2013, ARTHRITIS RHEUM-US, V65, P1913, DOI 10.1002/art.37969; Park J, 2001, EUR RESPIR J, V17, P1216, DOI 10.1183/09031936.01.99055301; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; PETERSGOLDEN M, 1985, J RHEUMATOL, V12, P1136; Pontifex EK, 2007, ANN RHEUM DIS, V66, P551, DOI 10.1136/ard.2006.056424; Raparia K, 2014, ARCH PATHOL LAB MED, DOI [10.5858/arpa.2013-0301-RS, DOI 10.5858/ARPA.2013-0301-RS]; Reveille JD, 2003, ARTHRIT RHEUM-ARTHR, V49, P399, DOI 10.1002/art.11113; Rho JK, 2009, MOL CANCER RES, V7, P1736, DOI 10.1158/1541-7786.MCR-08-0504; Roberts PJ, 2010, J CLIN ONCOL, V28, P4769, DOI 10.1200/JCO.2009.27.4365; TRAVIS WD, 2011, J THORAC ONCOL, V6, P244, DOI DOI 10.1097/JT0.0B013E318206A221; Tyndall AJ, 2010, ANN RHEUM DIS, V69, P1809, DOI 10.1136/ard.2009.114264; Vancheri C, 2010, EUR RESPIR J, V35, P496, DOI 10.1183/09031936.00077309; Villa C, 2014, ARCH PATHOL LAB MED, DOI [10.5858/1543-2165-139.1.140, DOI 10.5858/1543-2165-139.1.140]; Zhang JQ, 2013, CANCER EPIDEMIOL, V37, P523, DOI 10.1016/j.canep.2013.04.014	32	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117829	10.1371/journal.pone.0117829	http://dx.doi.org/10.1371/journal.pone.0117829			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689302	Green Published, gold, Green Submitted			2022-12-26	WOS:000350322700075
J	Lu, XX; Fan, QL; Xu, L; Li, L; Yue, Y; Xu, YY; Su, Y; Zhang, DC; Wang, LN				Lu, Xinxing; Fan, Qiuling; xu, Li; Li, Lin; Yue, Yuan; Xu, Yanyan; Su, Yan; Zhang, Dongcheng; Wang, Lining			Ursolic Acid Attenuates Diabetic Mesangial Cell Injury through the Up-Regulation of Autophagy via miRNA-21/PTEN/Akt/mTOR Suppression	PLOS ONE			English	Article							INDUCED APOPTOSIS; I COLLAGEN; KIDNEY; 3-KINASE-AKT; NEPHROPATHY; EXPRESSION; EFFECTORS; TARGET; GROWTH; MODEL	Objective To investigate the effect of ursolic acid on autophagy mediated through the miRNA-21-targeted phosphoinositide 3 kinase (PI3K)/protein kinase B (Akt)/mammalian target of rapamycin (mTOR) pathway in rat mesangial cells cultured under high glucose (HG) conditions. Methods Rat glomerular mesangial cells were cultured under normal glucose, HG, HG with the PI3K inhibitor LY294002 or HG with ursolic acid conditions. Cell proliferation and hypertrophy were assayed using an MTT assay and the ratio of total protein to cell number, respectively. The miRNA-21 expression was detected using RT-qPCR. The expression of phosphatase and tensin homolog (PTEN)/AKT/mTOR signaling signatures, autophagy-associated protein and collagen I was detected by western blotting and RT-qPCR. Autophagosomes were observed using electron microscopy. Results Compared with mesangial cells cultured under normal glucose conditions, the cells exposed to HG showed up-regulated miRNA-21 expression, down-regulated PTEN protein and mRNA expression, up-regulated p85PI3K, pAkt, pmTOR, p62/SQSTMI, and collagen I expression and down-regulated LC3II expression. Ursolic acid and LY294002 inhibited HG-induced mesangial cell hypertrophy and proliferation, down-regulated p85PI3K, pAkt, pmTOR, p62/SQSTMI, and collagen I expression and up-regulated LC3II expression. However, LY294002 did not affect the expression of miRNA-21 and PTEN. Ursolic acid down-regulated miRNA-21 expression and up-regulated PTEN protein and mRNA expression. Conclusions Ursolic acid inhibits the glucose-induced up-regulation of mesangial cell miRNA-21 expression, up-regulates PTEN expression, inhibits the activation of PI3K/Akt/mTOR signaling pathway, and enhances autophagy to reduce the accumulation of the extracellular matrix and ameliorate cell hypertrophy and proliferation.	[Lu, Xinxing; Fan, Qiuling; xu, Li; Li, Lin; Yue, Yuan; Xu, Yanyan; Wang, Lining] China Med Univ, Hosp 1, Dept Nephrol, Shenyang 110001, Peoples R China; [Lu, Xinxing; Su, Yan; Zhang, Dongcheng] Peoples Hosp Liaoning Prov, Dept Nephrol, Shenyang 110001, Peoples R China	China Medical University	Fan, QL (corresponding author), China Med Univ, Hosp 1, Dept Nephrol, Shenyang 110001, Peoples R China.	cmufql@163.com			National Natural Science Foundation of China [81270808]; Science and technology plan of Liaoning Provincial technology Department [2012225019]; Science and technology plan project of Shenyang Cityi1/4 [F11-264-1-38]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and technology plan of Liaoning Provincial technology Department; Science and technology plan project of Shenyang Cityi1/4	This work is supported by National Natural Science Foundation of China (No. 81270808), Science and technology plan of Liaoning Provincial technology Department (2012225019), and Science and technology plan project of Shenyang Cityi1/4 F11-264-1-38). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achiwa Y, 2007, BIOSCI BIOTECH BIOCH, V71, P31, DOI 10.1271/bbb.60288; Aranguiz-Urroz P, 2011, BBA-MOL BASIS DIS, V1812, P23, DOI 10.1016/j.bbadis.2010.07.003; Chandrasekaran K, 2012, KIDNEY INT, V81, P617, DOI 10.1038/ki.2011.448; Chin BY, 2001, AM J PHYSIOL-RENAL, V280, pF495, DOI 10.1152/ajprenal.2001.280.3.F495; Dey N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042316; Dey N, 2011, J BIOL CHEM, V286, P25586, DOI 10.1074/jbc.M110.208066; Estacio R O, 2001, Adv Intern Med, V46, P359; Garcia Z, 2006, EMBO J, V25, P655, DOI 10.1038/sj.emboj.7600967; Hafizi S, 2004, AM J PHYSIOL-HEART C, V287, pH1232, DOI 10.1152/ajpheart.00040.2004; Hartleben B, 2010, J CLIN INVEST, V120, P1084, DOI 10.1172/JCI39492; Hers I, 2011, CELL SIGNAL, V23, P1515, DOI 10.1016/j.cellsig.2011.05.004; HOSTETTER TH, 1995, ANNU REV PHYSIOL, V57, P263, DOI 10.1146/annurev.ph.57.030195.001403; Hostetter TH, 2003, SEMIN NEPHROL, V23, P194, DOI 10.1053/snep.2003.50017; Hyun S, 2009, CELL, V139, P1096, DOI 10.1016/j.cell.2009.11.020; Ikeda Y, 2008, MOL NUTR FOOD RES, V52, P26, DOI 10.1002/mnfr.200700389; Ishida Y, 2009, MOL BIOL CELL, V20, P2744, DOI 10.1091/mbc.E08-11-1092; Jayaprakasam B, 2006, J AGR FOOD CHEM, V54, P243, DOI 10.1021/jf0520342; Kasinath BS, 2011, KIDNEY INT, V80, P334, DOI 10.1038/ki.2011.165; Kim SI, 2007, AM J PHYSIOL-RENAL, V292, pF1471, DOI 10.1152/ajprenal.00485.2006; Kim SI, 2012, J BIOL CHEM, V287, P11677, DOI 10.1074/jbc.M111.308460; Kitada M, 2011, EXP DIABETES RES, DOI 10.1155/2011/908185; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kume S, 2010, J CLIN INVEST, V120, P1043, DOI 10.1172/JCI41376; Kunkel SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039332; Lee J, 2010, CHEM-BIOL INTERACT, V188, P635, DOI 10.1016/j.cbi.2010.09.019; Leng SL, 2013, INT J CANCER, V133, P2781, DOI 10.1002/ijc.28301; Li Jin, 2012, Nan Fang Yi Ke Da Xue Xue Bao, V32, P467; Lieberthal W, 2009, J AM SOC NEPHROL, V20, P2493, DOI 10.1681/ASN.2008111186; Liobikas J, 2011, J NAT PROD, V74, P1640, DOI 10.1021/np200060p; Mavroeidi V, 2013, J HISTOCHEM CYTOCHEM, V61, P433, DOI 10.1369/0022155413482925; Mizushima N, 2009, CURR TOP MICROBIOL, V335, P71, DOI 10.1007/978-3-642-00302-8_3; Molitch ME, 2004, DIABETES CARE, V27, P1240, DOI 10.2337/diacare.27.5.1240-a; Pai Preethi G, 2012, ISRN Pharmacol, V2012, P410902, DOI 10.5402/2012/410902; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Sekulic A, 2000, CANCER RES, V60, P3504; Shin SW, 2012, BBA-MOL CELL RES, V1823, P451, DOI 10.1016/j.bbamcr.2011.10.014; Somova LO, 2003, PHYTOMEDICINE, V10, P115, DOI 10.1078/094471103321659807; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Wang J, 2012, BASIC CLIN PHARMACOL, V111, P106, DOI 10.1111/j.1742-7843.2012.00870.x; Wang X, 2011, J HEPATOL, V55, P379, DOI 10.1016/j.jhep.2010.10.040; Wang Yuan-Yuan, 2011, Shengli Xuebao, V63, P325; Wu B, 2012, ARCH PHARM RES, V35, P543, DOI 10.1007/s12272-012-0318-1; YOSHIOKA K, 1990, J PATHOL, V162, P141, DOI 10.1002/path.1711620207; Zhou Y, 2010, INT J MOL MED, V26, P565, DOI 10.3892/ijmm_00000500	44	48	57	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117400	10.1371/journal.pone.0117400	http://dx.doi.org/10.1371/journal.pone.0117400			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689721	Green Published, Green Submitted, gold			2022-12-26	WOS:000350322700040
J	Voordouw, MJ; Lachish, S; Dolan, MC				Voordouw, Maarten J.; Lachish, Shelly; Dolan, Marc C.			The Lyme Disease Pathogen Has No Effect on the Survival of Its Rodent Reservoir Host	PLOS ONE			English	Article							WHITE-FOOTED MICE; IXODES-SCAPULARIS ACARI; BORRELIA-BURGDORFERI INFECTION; POLYMERASE-CHAIN-REACTION; SENSU-STRICTO STRAINS; WILD BIRD POPULATION; PEROMYSCUS-LEUCOPUS; ENDEMIC MALARIA; DAMMINI ACARI; HUMAN RISK	Zoonotic pathogens that cause devastating morbidity and mortality in humans may be relatively harmless in their natural reservoir hosts. The tick-borne bacterium Borrelia burgdorferi causes Lyme disease in humans but few studies have investigated whether this pathogen reduces the fitness of its reservoir hosts under natural conditions. We analyzed four years of capture-mark-recapture (CMR) data on a population of white-footed mice, Peromyscus leucopus, to test whether B. burgdorferi and its tick vector affect the survival of this important reservoir host. We used a multi-state CMR approach to model mouse survival and mouse infection rates as a function of a variety of ecologically relevant explanatory factors. We found no effect of B. burgdorferi infection or tick burden on the survival of P. leucopus. Our estimates of the probability of infection varied by an order of magnitude (0.051 to 0.535) and were consistent with our understanding of Lyme disease in the Northeastern United States. B. burgdorferi establishes a chronic avirulent infection in their rodent reservoir hosts because this pathogen depends on rodent mobility to achieve transmission to its sedentary tick vector. The estimates of B. burgdorferi infection risk will facilitate future theoretical studies on the epidemiology of Lyme disease.	[Voordouw, Maarten J.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Lachish, Shelly] Univ Oxford, Dept Zool, Edward Grey Inst, Oxford, England; [Dolan, Marc C.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Natl Ctr Enter & Zoonot Infect Dis, Ft Collins, CO USA	University of Pennsylvania; University of Oxford; Centers for Disease Control & Prevention - USA	Voordouw, MJ (corresponding author), Univ Neuchatel, Inst Biol, CH-2000 Neuchatel, Switzerland.	maarten.voordouw@unine.ch	Voordouw, Maarten J./G-3686-2013	Voordouw, Maarten J./0000-0001-9384-0436	Centers for Diseases Control and Prevention [CK000170]; National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIAID) [AI076342]; Swiss National Science Foundation [FN 31003A_141153]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076342] Funding Source: NIH RePORTER	Centers for Diseases Control and Prevention; National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIAID); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was supported by grant CK000170 from the Centers for Diseases Control and Prevention and AI076342 from the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIAID). This work was also supported by a grant from the Swiss National Science Foundation to Maarten Voordouw (FN 31003A_141153). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JF, 1988, ANN NY ACAD SCI, V539, P180, DOI 10.1111/j.1749-6632.1988.tb31852.x; ANDERSON JF, 1985, J CLIN MICROBIOL, V22, P36, DOI 10.1128/JCM.22.1.36-38.1985; ANDERSON JF, 1987, J CLIN MICROBIOL, V25, P1564, DOI 10.1128/JCM.25.8.1564-1566.1987; ANDERSON JF, 1987, APPL ENVIRON MICROB, V53, P892, DOI 10.1128/AEM.53.4.892-894.1987; Bergstrom S, 1999, INT J PARASITOL, V29, P1359, DOI 10.1016/S0020-7519(99)00088-0; Boulinier T, 1996, IBIS, V138, P326, DOI 10.1111/j.1474-919X.1996.tb04345.x; Brisson D, 2004, GENETICS, V168, P713, DOI 10.1534/genetics.104.028738; Brisson D, 2008, P ROY SOC B-BIOL SCI, V275, P227, DOI 10.1098/rspb.2007.1208; Brunner JL, 2008, ECOLOGY, V89, P2259, DOI 10.1890/07-0665.1; Bunikis J, 2004, J INFECT DIS, V189, P1515, DOI 10.1086/382594; Bunikis J, 2004, MICROBIOL-SGM, V150, P1741, DOI 10.1099/mic.0.26944-0; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Burns CE, 2005, ECOLOGY, V86, P753, DOI 10.1890/03-0735; Chambert T, 2012, J ANIM ECOL, V81, P986, DOI 10.1111/j.1365-2656.2012.01979.x; Choquet R., 2005, U CARE 2 2 USERS MAN; Conn PB, 2009, J APPL ECOL, V46, P486, DOI 10.1111/j.1365-2664.2008.01597.x; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Derdakova M, 2004, APPL ENVIRON MICROB, V70, P6783, DOI 10.1128/AEM.70.11.6783-6788.2004; Devevey G, 2012, PARASITOLOGY, V139, P915, DOI 10.1017/S003118201200008X; Devevey G, 2009, PARASITOLOGY, V136, P1351, DOI 10.1017/S0031182009990746; Diuk-Wasser MA, 2012, AM J TROP MED HYG, V86, P320, DOI 10.4269/ajtmh.2012.11-0395; Dolan MC, 2004, J MED ENTOMOL, V41, P1043, DOI 10.1603/0022-2585-41.6.1043; DONAHUE JG, 1987, AM J TROP MED HYG, V36, P92, DOI 10.4269/ajtmh.1987.36.92; Faustino CR, 2004, J ANIM ECOL, V73, P651, DOI 10.1111/j.0021-8790.2004.00840.x; Fokidis HB, 2006, WILDLIFE SOC B, V34, P764, DOI 10.2193/0091-7648(2006)34[764:KTARMS]2.0.CO;2; GERN L, 1994, EUR J EPIDEMIOL, V10, P75, DOI 10.1007/BF01717456; Hanincova K, 2008, APPL ENVIRON MICROB, V74, P153, DOI 10.1128/AEM.01567-07; Hawlena H, 2006, OECOLOGIA, V148, P30, DOI 10.1007/s00442-005-0345-4; Hofmeister EK, 1999, AM J TROP MED HYG, V60, P598, DOI 10.4269/ajtmh.1999.60.598; HOFMEISTER EK, 1992, J CLIN MICROBIOL, V30, P2625, DOI 10.1128/JCM.30.10.2625-2631.1992; Hudson P., 2002, ECOLOGY WILDLIFE DIS; JACQUOT JJ, 1995, BEHAV ECOL SOCIOBIOL, V37, P407, DOI 10.1007/BF00170588; Jaffe G, 2005, J MAMMAL, V86, P39, DOI 10.1644/1545-1542(2005)086&lt;0039:LPOBPI&gt;2.0.CO;2; Jennelle CS, 2007, ECOL APPL, V17, P154, DOI 10.1890/1051-0761(2007)017[0154:SDPADP]2.0.CO;2; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kiffner C, 2011, PARASITOL RES, V108, P323, DOI 10.1007/s00436-010-2065-x; Kurtenbach K, 2006, NAT REV MICROBIOL, V4, P660, DOI 10.1038/nrmicro1475; Lachish S, 2007, J ANIM ECOL, V76, P926, DOI 10.1111/j.1365-2656.2007.01272.x; Lachish S, 2011, J ANIM ECOL, V80, P1207, DOI 10.1111/j.1365-2656.2011.01893.x; Lachish S, 2011, J ANIM ECOL, V80, P1196, DOI 10.1111/j.1365-2656.2011.01836.x; Lebl K, 2010, ECOL RES, V25, P251, DOI 10.1007/s11284-009-0629-y; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; LEVINE JF, 1985, AM J TROP MED HYG, V34, P355, DOI 10.4269/ajtmh.1985.34.355; Lindsay LR, 1997, J WILDLIFE DIS, V33, P766, DOI 10.7589/0090-3558-33.4.766; LoGiudice K, 2003, P NATL ACAD SCI USA, V100, P567, DOI 10.1073/pnas.0233733100; LOYE J, 1995, TRENDS ECOL EVOL, V10, P232, DOI 10.1016/S0169-5347(00)89072-2; MAGNARELLI LA, 1987, J INFECT DIS, V156, P234, DOI 10.1093/infdis/156.1.234; MAIN AJ, 1982, J MED ENTOMOL, V19, P655, DOI 10.1093/jmedent/19.6.655; MANNELLI A, 1994, J PARASITOL, V80, P1038, DOI 10.2307/3283457; Marsot M, 2011, APPL ENVIRON MICROB, V77, P5716, DOI 10.1128/AEM.01846-10; Mather TN, 1996, AM J EPIDEMIOL, V144, P1066, DOI 10.1093/oxfordjournals.aje.a008879; MATHER TN, 1989, AM J EPIDEMIOL, V130, P143, DOI 10.1093/oxfordjournals.aje.a115306; McClintock BT, 2010, ECOL LETT, V13, P659, DOI 10.1111/j.1461-0248.2010.01472.x; MOLLER AP, 1993, J ANIM ECOL, V62, P309, DOI 10.2307/5362; MOODY KD, 1994, J WILDLIFE DIS, V30, P155, DOI 10.7589/0090-3558-30.2.155; Moore J., 2002, PARASITES BEHAV ANIM; Neuhaus P, 2003, P ROY SOC B-BIOL SCI, V270, pS213, DOI 10.1098/rsbl.2003.0073; Ogden NH, 2007, PARASITOLOGY, V134, P209, DOI 10.1017/S0031182006001417; Ostfeld RS, 2006, PLOS BIOL, V4, P1058, DOI 10.1371/journal.pbio.0040145; Ostfeld RS, 2006, BIOSCIENCE, V56, P383, DOI 10.1641/0006-3568(2006)056[0383:CTATZW]2.0.CO;2; Ostfeld RS, 1996, J MAMMAL, V77, P266, DOI 10.2307/1382727; Patrican LA, 1997, J MED ENTOMOL, V34, P52, DOI 10.1093/jmedent/34.1.52; Perkins SE, 2003, INT J PARASITOL, V33, P909, DOI 10.1016/S0020-7519(03)00128-0; Phelps KL, 2010, SOUTHWEST NAT, V55, P363, DOI 10.1894/MLK-08.1; Piesman J, 2004, PARASITOLOGY, V129, pS191, DOI 10.1017/S0031182003004694; RANDOLPH SE, 1975, J ANIM ECOL, V44, P451, DOI 10.2307/3606; Randolph SE, 1998, PARASITOL TODAY, V14, P186, DOI 10.1016/S0169-4758(98)01224-1; Randolph SE, 2004, PARASITOLOGY, V129, pS37, DOI 10.1017/S0031182004004925; Randolph SE, 1999, PARASITOLOGY, V118, P177, DOI 10.1017/S0031182098003643; Retallick RWR, 2004, PLOS BIOL, V2, P1965, DOI 10.1371/journal.pbio.0020351; Schmidt KA, 1999, J MED ENTOMOL, V36, P749, DOI 10.1093/jmedent/36.6.749; SCHUG MD, 1991, J MAMMAL, V72, P360, DOI 10.2307/1382107; Schwanz LE, 2011, VECTOR-BORNE ZOONOT, V11, P117, DOI 10.1089/vbz.2009.0215; Scott MC, 2012, J MED ENTOMOL, V49, P697, DOI 10.1603/ME11162; Senar J. C., 2004, Animal Biodiversity and Conservation, V27, P133; SHIH CM, 1995, J CLIN MICROBIOL, V33, P3164, DOI 10.1128/JCM.33.12.3164-3168.1995; SINSKY RJ, 1989, J CLIN MICROBIOL, V27, P1723, DOI 10.1128/JCM.27.8.1723-1727.1989; Stearns S.C., 1992, pi; Telfer S, 2002, J ANIM ECOL, V71, P558, DOI 10.1046/j.1365-2656.2002.00623.x; Tsao JI, 2009, VET RES, V40, DOI 10.1051/vetres/2009019; Tsao JI, 2004, P NATL ACAD SCI USA, V101, P18159, DOI 10.1073/pnas.0405763102; Tschirren B, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0364; Tschirren B, 2012, EVOLUTION, V66, P720, DOI 10.1111/j.1558-5646.2011.01473.x; Vandegrift KJ, 2008, ECOLOGY, V89, P2251, DOI 10.1890/07-1935.1; Vessey SH, 2007, INTEGR ZOOL, V2, P123, DOI 10.1111/j.1749-4877.2007.00053.x; Williams B. K., 2002, ANAL MANAGEMENT ANIM	86	33	34	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0118265	10.1371/journal.pone.0118265	http://dx.doi.org/10.1371/journal.pone.0118265			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25688863	Green Published, gold			2022-12-26	WOS:000350322700110
J	Shen, LB; Liu, GB; Zou, YY; Zhou, Z; Su, ZX; Gu, X				Shen, Libing; Liu, Gangbiao; Zou, Yangyun; Zhou, Zhan; Su, Zhixi; Gu, Xun			The Evolutionary Panorama of Organ-Specifically Expressed or Repressed Orthologous Genes in Nine Vertebrate Species	PLOS ONE			English	Article							DUPLICATE GENES; PROTEIN EVOLUTION; RNA-SEQ; GENOME; FAMILIES; TREES; LISTS; REST	RNA sequencing (RNA-Seq) technology provides the detailed transcriptomic information for a biological sample. Using the RNA-Seq data of six organs from nine vertebrate species, we identified a number of organ-specifically expressed or repressed orthologous genes whose expression patterns are mostly conserved across nine species. Our analyses show the following results: (i) About 80% of these genes have a chordate or more ancient origin and more than half of them are the legacy of one or multiple rounds of large-scale gene duplication events. (ii) Their evolutionary rates are shaped by the organ in which they are expressed or repressed, e.g. the genes specially expressed in testis and liver generally evolve more than twice as fast as the ones specially expressed in brain and cerebellum. The organ-specific transcription factors were discriminated from these genes. The ChIP-seq data from the ENCODE project also revealed the transcription-related factors that might be involved in regulating human organ-specifically expressed or repressed genes. Some of them are shared by all six human organs. The comparison of ENCODE data with mouse/chicken ChIP-seq data proposes that organ-specifically expressed or repressed orthologous genes are regulated in various combinatorial fashions in different species, although their expression features are conserved among these species. We found that the duplication events in some gene families might help explain the quick organ/tissue divergence in vertebrate lineage. The phylogenetic analysis of testis-specifically expressed genes suggests that some of them are prone to develop new functions for other organs/tissues.	[Shen, Libing; Liu, Gangbiao; Zou, Yangyun; Zhou, Zhan; Su, Zhixi; Gu, Xun] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Shen, Libing; Liu, Gangbiao; Zou, Yangyun; Zhou, Zhan; Su, Zhixi; Gu, Xun] Fudan Univ, Sch Life Sci, MOE Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Gu, Xun] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA USA	Fudan University; Fudan University; Iowa State University	Gu, X (corresponding author), Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.	xungufudan@gmail.com	Su, Zhixi/B-6487-2012; Zhou, Zhan/I-2372-2013	Zhou, Zhan/0000-0002-2730-5483	Ministry of Science and Technology China [2012CB910101]; National Science Foundation of China [31272299]; Fudan University; Iowa State University; Shanghai Pujiang Program [13PJD005]; National Natural Science Foundation of China [31301034]; China Postdoctoral Science Foundation [2013M531117]	Ministry of Science and Technology China(Ministry of Science and Technology, ChinaMinistry of Science, ICT & Future Planning, Republic of Korea); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fudan University; Iowa State University; Shanghai Pujiang Program(Shanghai Pujiang Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was partly supported by a grant from the Ministry of Science and Technology China (2012CB910101) and a grant from the National Science Foundation of China (31272299). XG was supported by grants from Fudan University and Iowa State University. ZS was supported by the Shanghai Pujiang Program (13PJD005). YZ was supported by the National Natural Science Foundation of China (31301034). ZZ was supported by a General Financial Grant from the China Postdoctoral Science Foundation (2013M531117). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosa-Morais NL, 2012, SCIENCE, V338, P1587, DOI 10.1126/science.1230612; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Dong D, 2011, NUCLEIC ACIDS RES, V39, P837, DOI 10.1093/nar/gkq874; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eizaguirre C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1632; Force A, 1999, GENETICS, V151, P1531; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; GOJOBORI T, 1990, P NATL ACAD SCI USA, V87, P10015, DOI 10.1073/pnas.87.24.10015; Gu X, 2007, P NATL ACAD SCI USA, V104, P2779, DOI 10.1073/pnas.0610797104; Ha M, 2009, P NATL ACAD SCI USA, V106, P2295, DOI 10.1073/pnas.0807350106; Halfon MS, 2002, PHYSIOL GENOMICS, V10, P131, DOI 10.1152/physiolgenomics.00072.2002; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kaessmann H, 2010, GENOME RES, V20, P1313, DOI 10.1101/gr.101386.109; Krylov DM, 2003, GENOME RES, V13, P2229, DOI 10.1101/gr.1589103; McLysaght A, 2002, NAT GENET, V31, P200, DOI 10.1038/ng884; Merkin J, 2012, SCIENCE, V338, P1593, DOI 10.1126/science.1228186; Mooney M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061088; Negre N, 2011, NATURE, V471, P527, DOI 10.1038/nature09990; Nei M, 1997, P NATL ACAD SCI USA, V94, P7799, DOI 10.1073/pnas.94.15.7799; Nookaew I, 2012, NUCLEIC ACIDS RES, V40, P10084, DOI 10.1093/nar/gks804; Ohno S., 1970, EVOLUTION GENE DUPLI; Ooi L, 2007, NAT REV GENET, V8, P544, DOI 10.1038/nrg2100; Pal C, 2006, NAT REV GENET, V7, P337, DOI 10.1038/nrg1838; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Rama SS, 2012, RAPIDLY EVOLVING GEN, DOI [10.3390/jpm2020050, DOI 10.3390/JPM2020050]; Rastogi S, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-28; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Soumillon M, 2013, CELL REP, V3, P2179, DOI 10.1016/j.celrep.2013.05.031; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Wilhelm BT, 2009, METHODS, V48, P249, DOI 10.1016/j.ymeth.2009.03.016; Wolf U, 2009, J NEUROPSYCH CLIN N, V21, P245, DOI 10.1176/appi.neuropsych.21.3.245; Yang JH, 2013, NUCLEIC ACIDS RES, V41, pD177, DOI 10.1093/nar/gks1060	39	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0116872	10.1371/journal.pone.0116872	http://dx.doi.org/10.1371/journal.pone.0116872			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679776	Green Published, Green Submitted, gold			2022-12-26	WOS:000350682600038
J	Joseph, BK; Liu, HY; Francisco, J; Pandya, D; Donigan, M; Gallo-Ebert, C; Giordano, C; Bata, A; Nickels, JT				Joseph, Biny K.; Liu, Hsing-Yin; Francisco, Jamie; Pandya, Devanshi; Donigan, Melissa; Gallo-Ebert, Christina; Giordano, Caroline; Bata, Adam; Nickels, Joseph T., Jr.			Inhibition of AMP Kinase by the Protein Phosphatase 2A Heterotrimer, PP2A(Ppp2r2d)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE THREONINE PHOSPHATASES; ACETYL-COA CARBOXYLASE; REGULATORY SUBUNITS; INSULIN; GLUCOSE; CELL; ACTIVATION; EXPRESSION; MECHANISM; LIPOLYSIS	AMP kinase is a heterotrimeric serine/threonine protein kinase that regulates a number of metabolic processes, including lipid biosynthesis and metabolism. AMP kinase activity is regulated by phosphorylation, and the kinases involved have been uncovered. The particular phosphatases counteracting these kinases remain elusive. Here we discovered that the protein phosphatase 2A heterotrimer, PP2A(Ppp2r2d), regulates the phosphorylation state of AMP kinase by dephosphorylating Thr-172, a residue that activates kinase activity when phosphorylated. Co-immunoprecipitation and co-localization studies indicated that PP2A(Ppp2r2d) directly interacted with AMP kinase. PP2A(Ppp2r2d) dephosphorylated Thr-172 in rat aortic and human vascular smooth muscle cells. A positive correlation existed between decreased phosphorylation, decreased acetyl-CoA carboxylase Acc1 phosphorylation, and sterol response element-binding protein 1c-dependent gene expression. PP2APpp2r2d protein expression was up-regulated in the aortas of mice fed a high fat diet, and the increased expression correlated with increased blood lipid levels. Finally, we found that the aortas of mice fed a high fat diet had decreased AMP kinase Thr-172 phosphorylation, and contained an Ampk-PP2A(Ppp2r2d) complex. Thus, PP2A(Ppp2r2d) may antagonize the aortic AMP kinase activity necessary for maintaining normal aortic lipid metabolism. Inhibiting PP2A(Ppp2r2d) or activating AMP kinase represents a potential pharmacological treatment for many lipid-related diseases.	[Joseph, Biny K.; Liu, Hsing-Yin; Francisco, Jamie; Pandya, Devanshi; Donigan, Melissa; Gallo-Ebert, Christina; Nickels, Joseph T., Jr.] Inst Metab Disorders, Hamilton, NJ 08691 USA; [Giordano, Caroline; Bata, Adam] Genesis Biotechnol Grp, Invivotek, Hamilton, NJ 08691 USA		Nickels, JT (corresponding author), Inst Metab Disorders, Hamilton, NJ 08691 USA.	jnickels@venenumbiodesign.com		Gallo-Ebert, Christina/0000-0003-0985-3547	Genesis Biotechnology Group	Genesis Biotechnology Group	This work was supported by the Genesis Biotechnology Group.	Boon H, 2008, DIABETOLOGIA, V51, P1893, DOI 10.1007/s00125-008-1108-7; CARLING D, 1987, FEBS LETT, V223, P217, DOI 10.1016/0014-5793(87)80292-2; CARLING D, 1989, EUR J BIOCHEM, V186, P129, DOI 10.1111/j.1432-1033.1989.tb15186.x; Carling D, 2011, NAT CHEM BIOL, V7, P512, DOI [10.1038/nchembio.610, 10.1038/NCHEMBIO.610]; Chen L, 2013, NATURE, V498, pE8, DOI 10.1038/nature12189; Chen L, 2009, NATURE, V459, P1146, DOI 10.1038/nature08075; CLARKE PR, 1990, EMBO J, V9, P2439, DOI 10.1002/j.1460-2075.1990.tb07420.x; COHEN PTW, 1990, FEBS LETT, V268, P355, DOI 10.1016/0014-5793(90)81285-V; DEPAOLIROACH AA, 1994, ADV ENZYME REGUL, V34, P199, DOI 10.1016/0065-2571(94)90017-5; DOBROWSKY RT, 1993, J BIOL CHEM, V268, P15523; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Galbo T, 2013, AGING-US, V5, P770, DOI 10.18632/aging.100611; Galbo T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027424; Garcia-Haro L, 2010, FASEB J, V24, P5080, DOI 10.1096/fj.10-166306; GARTON AJ, 1989, EUR J BIOCHEM, V179, P249, DOI 10.1111/j.1432-1033.1989.tb14548.x; Gimeno-Alcaniz JV, 2003, J MOL BIOL, V333, P201, DOI 10.1016/j.jmb.2003.08.022; Hardie DG, 2015, CURR OPIN CELL BIOL, V33, P1, DOI 10.1016/j.ceb.2014.09.004; Hardie DG, 2012, CHEM BIOL, V19, P1222, DOI 10.1016/j.chembiol.2012.08.019; Hardie DG, 2011, TRENDS BIOCHEM SCI, V36, P470, DOI 10.1016/j.tibs.2011.06.004; HARDIE DG, 1990, SYM SOC EXP BIOL, V44, P241; Hojlund K, 2002, EUR J CLIN INVEST, V32, P918, DOI 10.1046/j.1365-2362.2002.01098.x; Jump DB, 2011, CURR OPIN CLIN NUTR, V14, P115, DOI 10.1097/MCO.0b013e328342991c; Jun HS, 2008, OBESITY, V16, P1226, DOI 10.1038/oby.2008.220; Khoo Michael C K, 2013, IEEE Rev Biomed Eng, V6, P143, DOI 10.1109/RBME.2012.2232651; King TD, 2006, BIOCHEM PHARMACOL, V71, P1637, DOI 10.1016/j.bcp.2006.03.005; Kinney BP, 2010, ENDOCRINOLOGY, V151, P3624, DOI 10.1210/en.2010-0245; Kowluru A, 1997, FEBS LETT, V418, P179, DOI 10.1016/S0014-5793(97)01379-3; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Lian ZQ, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-67; MOORE F, 1991, EUR J BIOCHEM, V199, P691, DOI 10.1111/j.1432-1033.1991.tb16172.x; MUMBY MC, 1993, PHYSIOL REV, V73, P673, DOI 10.1152/physrev.1993.73.4.673; Munday MR, 1999, ADV ENZYME REGUL, V39, P205, DOI 10.1016/S0065-2571(98)00016-8; Nagata D, 2010, HYPERTENS RES, V33, P22, DOI 10.1038/hr.2009.187; O'Neill HM, 2011, P NATL ACAD SCI USA, V108, P16092, DOI 10.1073/pnas.1105062108; Ogris E, 1999, J BIOL CHEM, V274, P14382, DOI 10.1074/jbc.274.20.14382; Park S, 2013, CELL CALCIUM, V53, P217, DOI 10.1016/j.ceca.2012.12.001; Pawlyk AC, 2014, DIABETES, V63, P2590, DOI 10.2337/db13-1367; Rana S, 2015, J MED CHEM, V58, P2, DOI 10.1021/jm401994c; Rice LM, 2014, J BIOL CHEM, V289, P17268, DOI 10.1074/jbc.M114.570390; Sanders MJ, 2007, J BIOL CHEM, V282, P32539, DOI 10.1074/jbc.M706543200; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Sontag E, 2001, CELL SIGNAL, V13, P7, DOI 10.1016/S0898-6568(00)00123-6; Steinberg GR, 2006, CAN J PHYSIOL PHARM, V84, P655, DOI 10.1139/Y06-005; SULLIVAN JE, 1994, FEBS LETT, V353, P33, DOI 10.1016/0014-5793(94)01006-4; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; TAMURA S, 1980, EUR J BIOCHEM, V104, P347, DOI 10.1111/j.1432-1033.1980.tb04435.x; Tokumitsu H, 2002, J BIOL CHEM, V277, P15813, DOI 10.1074/jbc.M201075200; Ugi S, 2004, MOL CELL BIOL, V24, P8778, DOI 10.1128/MCB.24.19.8778-8789.2004; Valentine RJ, 2014, ARCH BIOCHEM BIOPHYS, V562, P62, DOI 10.1016/j.abb.2014.08.013; Viollet B, 2009, FRONT BIOSCI-LANDMRK, V14, P19, DOI 10.2741/3229; Wang PY, 2003, EMBO J, V22, P2658, DOI 10.1093/emboj/cdg255; Wang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013096; Witczak CA, 2008, CELL MOL LIFE SCI, V65, P3737, DOI 10.1007/s00018-008-8244-6; Wu J, 2013, J BIOL CHEM, V288, P35904, DOI 10.1074/jbc.M113.508747; Xiao B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms4017; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932; Zhu XN, 2014, CELL SIGNAL, V26, P825, DOI 10.1016/j.cellsig.2014.01.002	57	53	53	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					10588	10598		10.1074/jbc.M114.626259	http://dx.doi.org/10.1074/jbc.M114.626259			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25694423	hybrid, Green Published			2022-12-26	WOS:000353404500002
J	Shim, SY; de Castro, IP; Neumayer, G; Wang, J; Park, SK; Sanada, K; Nguyen, MD				Shim, Su Yeon; Perez de Castro, Ignacio; Neumayer, Gernot; Wang, Jian; Park, Sang Ki; Sanada, Kamon; Minh Dang Nguyen			Phosphorylation of Targeting Protein for Xenopus Kinesin-like Protein 2 (TPX2) at Threonine 72 in Spindle Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASES; AURORA-A ACTIVATION; QUANTITATIVE PHOSPHOPROTEOMICS; MICROTUBULE NUCLEATION; IDENTIFICATION; STABILITY; CDK2; CDC2; PHOSPHOSITEPLUS; LOCALIZATION	The human ortholog of the targeting protein for Xenopus kinesin-like protein 2 (TPX2) is a cytoskeletal protein that plays a major role in spindle assembly and is required for mitosis. During spindle morphogenesis, TPX2 cooperates with Aurora A kinase and Eg5 kinesin to regulate microtubule organization. TPX2 displays over 40 putative phosphorylation sites identified from various high-throughput proteomic screenings. In this study, we characterize the phosphorylation of threonine 72 (Thr(72)) in human TPX2, a residue highly conserved across species. We find that Cdk1/2 phosphorylate TPX2 in vitro and in vivo. Using homemade antibodies specific for TPX2 phosphorylated at Thr(72), we show that this phosphorylation is cell cycle-dependent and peaks at M phase. Endogenous TPX2 phosphorylated at Thr(72) does not associate with the mitotic spindle. Furthermore, ectopic GFP-TPX2 T72A preferentially concentrates on the spindle, whereas GFP-TPX2 WT distributes to both spindle and cytosol. The T72A mutant also increases the proportion of cells with multipolar spindles phenotype. This effect is associated with increased Aurora A activity and abnormally elongated spindles, indicative of higher Eg5 activity. In summary, we propose that phosphorylation of Thr(72) regulates TPX2 localization and impacts spindle assembly via Aurora A and Eg5.	[Shim, Su Yeon; Neumayer, Gernot; Wang, Jian; Minh Dang Nguyen] Univ Calgary, Dept Clin Neurosci, Calgary, AB T2N 4N1, Canada; [Shim, Su Yeon; Neumayer, Gernot; Wang, Jian; Minh Dang Nguyen] Univ Calgary, Dept Cell Biol & Anat, Calgary, AB T2N 4N1, Canada; [Shim, Su Yeon; Neumayer, Gernot; Wang, Jian; Minh Dang Nguyen] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; [Shim, Su Yeon; Neumayer, Gernot; Wang, Jian; Minh Dang Nguyen] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB T2N 4N1, Canada; [Park, Sang Ki] Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, South Korea; [Sanada, Kamon] Univ Tokyo, Grad Sch Sci, Mol Genet Res Lab, Bunkyo Ku, Tokyo 1130033, Japan; [Perez de Castro, Ignacio] CNIO, Cell Div, Madrid 28029, Spain; [Perez de Castro, Ignacio] CNIO, Canc Grp, Madrid 28029, Spain	University of Calgary; University of Calgary; University of Calgary; University of Calgary; Pohang University of Science & Technology (POSTECH); University of Tokyo; Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO)	Nguyen, MD (corresponding author), Univ Calgary, Dept Clin Neurosci, Calgary, AB T2N 4N1, Canada.	mdnguyen@ucalgary.ca	de Castro, Ignacio Pérez/A-6260-2012	de Castro, Ignacio Pérez/0000-0002-8822-8274; Sanada, Kamon/0000-0002-0280-8957	Canadian Institutes of Health Research (CIHR); Alberta Innovates Health Solutions (AIHS); Spanish Ministry of Economy and Competitiveness Programa de Accion Estrategica de Salud [PI14-00227]; Framework of International Cooperation Program [2012K2A1A2033117]; Ministry of Education, Culture, Sports, Science and Technology of Japan; Daiichi Sankyo Foundation of Life Science; Austrian Academy of Science; Human Frontier Science Program Organization; CIHR; AIHS; Grants-in-Aid for Scientific Research [26640005] Funding Source: KAKEN	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Health Solutions (AIHS); Spanish Ministry of Economy and Competitiveness Programa de Accion Estrategica de Salud; Framework of International Cooperation Program; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Daiichi Sankyo Foundation of Life Science; Austrian Academy of Science; Human Frontier Science Program Organization(Human Frontier Science Program); CIHR(Canadian Institutes of Health Research (CIHR)); AIHS; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Canadian Institutes of Health Research (CIHR) (to M. D. N.), Alberta Innovates Health Solutions (AIHS) (to M. D. N.), the Spanish Ministry of Economy and Competitiveness Programa de Accion Estrategica de Salud, 2014, Grant PI14-00227 (to I. P. dC), Framework of International Cooperation Program, managed by National Research Foundation of Korea, Grant 2012K2A1A2033117 (to M. D. N. and S. K. P.), a Grant-in-Aid for Exploratory Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and a research grant from Daiichi Sankyo Foundation of Life Science (to K. S.).; Received a DOC scholarship from the Austrian Academy of Science.; Held a Career Development Award from the Human Frontier Science Program Organization, a New Investigator Award from the CIHR, and a Scholar Award from the AIHS.	Aguirre-Portoles C, 2012, CANCER RES, V72, P1518, DOI 10.1158/0008-5472.CAN-11-1971; Anand S, 2003, CANCER CELL, V3, P51, DOI 10.1016/S1535-6108(02)00235-0; Asteriti IA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-131; Asteriti IA, 2010, BBA-REV CANCER, V1806, P230, DOI 10.1016/j.bbcan.2010.08.001; Bayliss R, 2003, MOL CELL, V12, P851, DOI 10.1016/S1097-2765(03)00392-7; BELENGUER P, 1990, MOL CELL BIOL, V10, P3607, DOI 10.1128/MCB.10.7.3607; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Brunet S, 2004, MOL BIOL CELL, V15, P5318, DOI 10.1091/mbc.E04-05-0385; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Chen RQ, 2009, CANCER RES, V69, P2663, DOI 10.1158/0008-5472.CAN-08-3222; Chi Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r149; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; DeAzevedo WF, 1997, EUR J BIOCHEM, V243, P518, DOI 10.1111/j.1432-1033.1997.0518a.x; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Eckerdt F, 2008, CURR BIOL, V18, P519, DOI 10.1016/j.cub.2008.02.077; Eckerdt F, 2009, CELL CYCLE, V8, P2413, DOI 10.4161/cc.8.15.9086; Eyers PA, 2004, J BIOL CHEM, V279, P9008, DOI 10.1074/jbc.M312424200; Franz-Wachtel M, 2012, MOL CELL PROTEOMICS, V11, P160, DOI 10.1074/mcp.M111.016014; Garrett S, 2002, CURR BIOL, V12, P2055, DOI 10.1016/S0960-9822(02)01277-0; Giubettini M, 2011, J CELL SCI, V124, P113, DOI 10.1242/jcs.075457; Grosstessner-Hain K, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.008540; Gruss OJ, 2002, NAT CELL BIOL, V4, P871, DOI 10.1038/ncb870; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Havlicek L, 1997, J MED CHEM, V40, P408, DOI 10.1021/jm960666x; Heidebrecht HJ, 1997, BLOOD, V90, P226; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Kapoor TM, 2000, J CELL BIOL, V150, P975, DOI 10.1083/jcb.150.5.975; Kettenbach AN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001497; Kufer TA, 2002, J CELL BIOL, V158, P617, DOI 10.1083/jcb.200204155; Ma N, 2007, J CELL SCI, V120, P2091, DOI 10.1242/jcs.008771; Ma N, 2011, J CELL BIOL, V195, P87, DOI 10.1083/jcb.201106149; Malik R, 2009, J PROTEOME RES, V8, P4553, DOI 10.1021/pr9003773; Mayya V, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000007; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Neumayer G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110994; Neumayer G, 2014, CELL MOL LIFE SCI, V71, P3027, DOI 10.1007/s00018-014-1582-7; Neumayer G, 2012, J BIOL CHEM, V287, P42206, DOI 10.1074/jbc.M112.385674; Nguyen MD, 2001, NEURON, V30, P135, DOI 10.1016/S0896-6273(01)00268-9; Nousiainen M, 2006, P NATL ACAD SCI USA, V103, P5391, DOI 10.1073/pnas.0507066103; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Perez de Castro Ignacio, 2012, Genes Cancer, V3, P721, DOI 10.1177/1947601912473306; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; PETER M, 1990, CELL, V60, P791, DOI 10.1016/0092-8674(90)90093-T; Petry S, 2013, CELL, V152, P768, DOI 10.1016/j.cell.2012.12.044; Schatz CA, 2003, EMBO J, V22, P2060, DOI 10.1093/emboj/cdg195; Sharma P, 1999, P NATL ACAD SCI USA, V96, P11156, DOI 10.1073/pnas.96.20.11156; Shiromizu T, 2013, J PROTEOME RES, V12, P2414, DOI 10.1021/pr300825v; Sillars-Hardebol AH, 2012, GUT, V61, P1568, DOI 10.1136/gutjnl-2011-301153; Skoufias DA, 2007, J CELL BIOL, V179, P671, DOI 10.1083/jcb.200704117; Stewart S, 2005, MOL CELL BIOL, V25, P10516, DOI 10.1128/MCB.25.23.10516-10527.2005; Thompson SL, 2010, CURR BIOL, V20, pR285, DOI 10.1016/j.cub.2010.01.034; Trieselmann N, 2003, J CELL SCI, V116, P4791, DOI 10.1242/jcs.00798; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; Weber C, 2012, J PROTEOMICS, V75, P1343, DOI 10.1016/j.jprot.2011.11.004; Wittmann T, 1998, J CELL BIOL, V143, P673, DOI 10.1083/jcb.143.3.673; Wittmann T, 2000, J CELL BIOL, V149, P1405, DOI 10.1083/jcb.149.7.1405; Zheng M, 1998, J NEUROBIOL, V35, P141, DOI 10.1002/(SICI)1097-4695(199805)35:2<141::AID-NEU2>3.0.CO;2-4; Zhou HJ, 2013, J PROTEOME RES, V12, P260, DOI 10.1021/pr300630k	59	15	16	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					9122	9134		10.1074/jbc.M114.591545	http://dx.doi.org/10.1074/jbc.M114.591545			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25688093	hybrid, Green Published			2022-12-26	WOS:000352207100035
J	Haakenson, JK; Khokhlatchev, AV; Choi, YJ; Linton, SS; Zhang, P; Zaki, PM; Fu, CL; Cooper, TK; Manni, A; Zhu, JJ; Fox, TE; Dong, C; Kester, M				Haakenson, Jeremy K.; Khokhlatchev, Andrei V.; Choi, Younhee J.; Linton, Samuel S.; Zhang, Pu; Zaki, Peter M.; Fu, Changliang; Cooper, Timothy K.; Manni, Andrea; Zhu, Junjia; Fox, Todd E.; Dong, Cheng; Kester, Mark			Lysosomal Degradation of CD44 Mediates Ceramide Nanoliposome-induced Anoikis and Diminished Extravasation in Metastatic Carcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; STRUCTURED MEMBRANE MICRODOMAINS; HYDRODYNAMIC SHEAR; MELANOMA ADHESION; INDUCED APOPTOSIS; IN-VITRO; DELIVERY; TRANSLOCATION; PROSTATE; PROMOTES	The ceramide nanoliposome (CNL) has shown promise in being able to treat a variety of primary tumors. However, its potential for treating metastatic cancer remains unknown. In this study, we demonstrate that CNL increases anoikis while preventing cancer cell extravasation under both static and physiological fluid flow conditions. Mechanistically, CNL limits metastases by decreasing CD44 protein levels in human breast and pancreatic cancer cells via lysosomal degradation of CD44, independent of palmitoylation or proteasome targeting. siRNA down-regulation of CD44 mimics CNL-induced anoikis and diminished extravasation of cancer cells. Taken together, our data indicate that ceramide limits CD44-dependent cancer cell migration, suggesting that CNL could be used to prevent and treat solid tumor metastasis.	[Haakenson, Jeremy K.; Linton, Samuel S.; Kester, Mark] Penn State Univ, Coll Med, Dept Pharmacol, Hershey, PA 17033 USA; [Cooper, Timothy K.] Penn State Univ, Coll Med, Dept Comparat Med, Hershey, PA 17033 USA; [Manni, Andrea] Penn State Univ, Coll Med, Dept Med, Hershey, PA 17033 USA; [Zhu, Junjia] Penn State Univ, Coll Med, Dept Publ Hlth Sci, Hershey, PA 17033 USA; [Khokhlatchev, Andrei V.; Choi, Younhee J.; Fox, Todd E.; Kester, Mark] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [Zhang, Pu; Zaki, Peter M.; Fu, Changliang; Dong, Cheng] Penn State Univ, Dept Bioengn, State Coll, PA 16801 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Virginia; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Kester, M (corresponding author), Univ Virginia, POB 800334, Charlottesville, VA 22908 USA.	mkester@virginia.edu	Kester, Mark/ABG-4615-2020	Linton, Samuel/0000-0003-2419-0673	National Institutes of Health [CA-125707]; National Science Foundation [CBET-0729091, CBET-1330633]; G. Thomas Passananti Endowment from the Penn State College of Medicine; NATIONAL CANCER INSTITUTE [R01CA125707] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); G. Thomas Passananti Endowment from the Penn State College of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA-125707 (to C. D.). This work was also supported by National Science Foundation Grants CBET-0729091 and CBET-1330633 (to C. D.) and funds from the G. Thomas Passananti Endowment from the Penn State College of Medicine (to M. K.). Penn State Research Foundation has licensed CNL technology to Keystone Nano, Inc. (State College, PA). M. K. is chief medical officer and co-founder of Keystone Nano.	Adiseshaiah PP, 2013, CANCER LETT, V337, P254, DOI 10.1016/j.canlet.2013.04.034; Chiarugi P, 2008, BIOCHEM PHARMACOL, V76, P1352, DOI 10.1016/j.bcp.2008.07.023; Dimitroff CJ, 2001, J CELL BIOL, V153, P1277, DOI 10.1083/jcb.153.6.1277; Draffin JE, 2004, CANCER RES, V64, P5702, DOI 10.1158/0008-5472.CAN-04-0389; Fox TE, 2007, J BIOL CHEM, V282, P12450, DOI 10.1074/jbc.M700082200; Gauger KJ, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-11; HART IR, 1989, CURR OPIN IMMUNOL, V1, P900, DOI 10.1016/0952-7915(89)90068-X; Heakal Y, 2009, MOL CANCER RES, V7, P724, DOI 10.1158/1541-7786.MCR-08-0322; Hu W, 2005, MOL BIOL CELL, V16, P1555, DOI 10.1091/mbc.E04-07-0594; Jiang YX, 2011, CANCER BIOL THER, V12, P574, DOI 10.4161/cbt.12.7.15971; Kaiser JM, 2013, NANOMED-NANOTECHNOL, V9, P130, DOI 10.1016/j.nano.2012.03.004; Kim HJ, 2008, CANCER LETT, V260, P88, DOI 10.1016/j.canlet.2007.10.030; Lakshman M, 2004, EXP MOL PATHOL, V77, P18, DOI 10.1016/j.yexmp.2004.03.002; Lesley J, 1997, GLYCOCONJUGATE J, V14, P611, DOI 10.1023/A:1018540610858; Liang S, 2005, EXP CELL RES, V310, P282, DOI 10.1016/j.yexcr.2005.07.028; Liang S, 2008, ANN BIOMED ENG, V36, P661, DOI 10.1007/s10439-008-9445-8; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Liu X, 2010, BLOOD, V116, P4192, DOI 10.1182/blood-2010-02-271080; Lou W, 1999, CANCER RES, V59, P2329; Martin TA, 2003, CRIT REV ONCOL HEMAT, V46, P165, DOI 10.1016/S1040-8428(02)00172-5; Ouhtit A, 2007, AM J PATHOL, V171, P2033, DOI 10.2353/ajpath.2007.070535; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875; Radotra B, 1997, J PATHOL, V181, P434; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Slattery MJ, 2005, AM J PHYSIOL-CELL PH, V288, pC831, DOI 10.1152/ajpcell.00439.2004; Stover T, 2003, J PHARMACOL EXP THER, V307, P468, DOI 10.1124/jpet.103.054056; Stover TC, 2005, CLIN CANCER RES, V11, P3465, DOI 10.1158/1078-0432.CCR-04-1770; Su YJ, 2011, EMBO J, V30, P3186, DOI 10.1038/emboj.2011.211; Tagaram HRS, 2011, GUT, V60, P695, DOI 10.1136/gut.2010.216671; Thankamony SP, 2006, J BIOL CHEM, V281, P34601, DOI 10.1074/jbc.M601530200; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; Widau RC, 2010, J BIOL CHEM, V285, P13827, DOI 10.1074/jbc.M109.085076; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023; Zohar R, 2000, J CELL PHYSIOL, V184, P118, DOI 10.1002/(SICI)1097-4652(200007)184:1<118::AID-JCP13>3.3.CO;2-P; ZOLLER M, 1995, J MOL MED, V73, P425	37	13	13	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8632	8643		10.1074/jbc.M114.609677	http://dx.doi.org/10.1074/jbc.M114.609677			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25681441	Green Published, hybrid			2022-12-26	WOS:000351662600053
J	Bacallao, K; Monje, PV				Bacallao, Ketty; Monje, Paula V.			Requirement of cAMP Signaling for Schwann Cell Differentiation Restricts the Onset of Myelination	PLOS ONE			English	Article							SOLUBLE ADENYLYL-CYCLASE; BASAL LAMINA; INHIBITION; GPR126; PROLIFERATION; ACTIVATION; PROTEINS; DEFINES; INVITRO; EVENTS	Isolated Schwann cells (SCs) respond to cAMP elevation by adopting a differentiated postmitotic state that exhibits high levels of Krox-20, a transcriptional enhancer of myelination, and mature SC markers such as the myelin lipid galactocerebroside (O1). To address how cAMP controls myelination, we performed a series of cell culture experiments which compared the differentiating responses of isolated and axon-related SCs to cAMP analogs and ascorbate, a known inducer of axon ensheathment, basal lamina formation and myelination. In axon-related SCs, cAMP induced the expression of Krox-20 and O1 without a concomitant increase in the expression of myelin basic protein (MBP) and without promoting axon ensheathment, collagen synthesis or basal lamina assembly. When cAMP was provided together with ascorbate, a dramatic enhancement of MBP expression occurred, indicating that cAMP primes SCs to form myelin only under conditions supportive of basal lamina formation. Experiments using a combination of cell permeable cAMP analogs and type-selective adenylyl cyclase (AC) agonists and antagonists revealed that selective transmembrane AC (tmAC) activation with forskolin was not sufficient for full SC differentiation and that the attainment of an O1 positive state also relied on the activity of the soluble AC (sAC), a bicarbonate sensor that is insensitive to forskolin and GPCR activation. Pharmacological and immunological evidence indicated that SCs expressed sAC and that sAC activity was required for morphological differentiation and the expression of myelin markers such as O1 and protein zero. To conclude, our data indicates that cAMP did not directly drive myelination but rather the transition into an O1 positive state, which is perhaps the most critical cAMP-dependent rate limiting step for the onset of myelination. The temporally restricted role of cAMP in inducing differentiation independently of basal lamina formation provides a clear example of the uncoupling of signals controlling differentiation and myelination in SCs.	[Bacallao, Ketty; Monje, Paula V.] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Monje, Paula V.] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA	University of Miami; University of Miami	Monje, PV (corresponding author), Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA.	pmonje@med.miami.edu	Monje, Paula/AAB-9099-2020		NIH-NINDS [NS009923]; Miami Project to Cure Paralysis; Buoniconti Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS009923] Funding Source: NIH RePORTER	NIH-NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Miami Project to Cure Paralysis; Buoniconti Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH-NINDS Grant NS009923, The Miami Project to Cure Paralysis, and The Buoniconti Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacallao K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082354; Birchmeier C, 2008, GLIA, V56, P1491, DOI 10.1002/glia.20753; Bitterman JL, 2013, J PHARMACOL EXP THER, V347, P589, DOI 10.1124/jpet.113.208496; BROCKES JP, 1979, BRAIN RES, V165, P105, DOI 10.1016/0006-8993(79)90048-9; BUNGE MB, 1990, ANN NY ACAD SCI, V580, P281, DOI 10.1111/j.1749-6632.1990.tb17937.x; BUNGE RP, 1986, ANNU REV NEUROSCI, V9, P305; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; Corredor RG, 2012, J NEUROSCI, V32, P7734, DOI 10.1523/JNEUROSCI.5288-11.2012; Court FA, 2006, CURR OPIN NEUROBIOL, V16, P501, DOI 10.1016/j.conb.2006.08.005; ELDRIDGE CF, 1987, J CELL BIOL, V105, P1023, DOI 10.1083/jcb.105.2.1023; ELDRIDGE CF, 1989, J NEUROSCI, V9, P625; ELDRIDGE CF, 1988, EXP CELL RES, V174, P491, DOI 10.1016/0014-4827(88)90318-7; Fabbri E, 1991, J Enzyme Inhib, V5, P87, DOI 10.3109/14756369109069062; FERNANDEZVALLE C, 1993, DEVELOPMENT, V119, P867; Geng WD, 2009, J CELL PHYSIOL, V220, P332, DOI 10.1002/jcp.21767; Glenn TD, 2013, DEVELOPMENT, V140, P3167, DOI 10.1242/dev.093401; Guo L, 2012, J NEUROSCI, V32, P17251, DOI 10.1523/JNEUROSCI.2461-12.2012; Hess KC, 2005, DEV CELL, V9, P249, DOI 10.1016/j.devcel.2005.06.007; Howe DG, 2000, J NEUROSCI, V20, P3513, DOI 10.1523/JNEUROSCI.20-10-03513.2000; JESSEN KR, 1991, ANN NY ACAD SCI, V633, P78; Jessen KR, 2008, GLIA, V56, P1552, DOI 10.1002/glia.20761; Litvin TN, 2003, J BIOL CHEM, V278, P15922, DOI 10.1074/jbc.M212475200; Maurel P, 2007, J CELL BIOL, V178, P861, DOI 10.1083/jcb.200705132; Mogha A, 2013, J NEUROSCI, V33, P17976, DOI 10.1523/JNEUROSCI.1809-13.2013; Monje PV, 2010, J BIOL CHEM, V285, P31024, DOI 10.1074/jbc.M110.116970; Monje PV, 2009, GLIA, V57, P947, DOI 10.1002/glia.20819; Monje PV, 2008, J BIOL CHEM, V283, P34087, DOI 10.1074/jbc.M802318200; Monk KR, 2011, DEVELOPMENT, V138, P2673, DOI 10.1242/dev.062224; Monk KR, 2009, SCIENCE, V325, P1402, DOI 10.1126/science.1173474; MORRISSEY TK, 1991, J NEUROSCI, V11, P2433; Navel KA, 2006, CURR OPIN NEUROBIOL, V16, P492, DOI 10.1016/j.conb.2006.08.008; Parkinson DB, 2008, J CELL BIOL, V181, P625, DOI 10.1083/jcb.200803013; Quintes S, 2010, J PERIPHER NERV SYST, V15, P10, DOI 10.1111/j.1529-8027.2010.00247.x; Rosenberg SS, 2007, CELL MOL LIFE SCI, V64, P3059, DOI 10.1007/s00018-007-7265-x; SOBUE G, 1986, BRAIN RES, V362, P23, DOI 10.1016/0006-8993(86)91394-6; Sparrow N, 2012, J NEUROSCI, V32, P5284, DOI 10.1523/JNEUROSCI.6207-11.2012; Steegborn C, 2005, J BIOL CHEM, V280, P31754, DOI 10.1074/jbc.M507144200; Stessin AM, 2006, J BIOL CHEM, V281, P17253, DOI 10.1074/jbc.M603500200; TAUSSIG R, 1995, J BIOL CHEM, V270, P1, DOI 10.1074/jbc.270.1.1; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; Wake H, 2011, SCIENCE, V333, P1647, DOI 10.1126/science.1206998; WOOD PM, 1976, BRAIN RES, V115, P361, DOI 10.1016/0006-8993(76)90355-3; Yoon C, 2008, J NEUROSCI, V28, P3738, DOI 10.1523/JNEUROSCI.4439-07.2008; Zippin JH, 2004, J CELL BIOL, V164, P527, DOI 10.1083/jcb.200311119; Zippin JH, 2002, FASEB J, V16, P82, DOI 10.1096/fj.02-0598fje	45	39	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0116948	10.1371/journal.pone.0116948	http://dx.doi.org/10.1371/journal.pone.0116948			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25705874	gold, Green Published, Green Submitted			2022-12-26	WOS:000350662100055
J	Stone, JW; Bleckley, S; Lavelle, S; Schroeder, SJ				Stone, Jonathan W.; Bleckley, Samuel; Lavelle, Sean; Schroeder, Susan J.			A Parallel Implementation of the Wuchty Algorithm with Additional Experimental Filters to More Thoroughly Explore RNA Conformational Space	PLOS ONE			English	Article							MOSAIC-VIRUS RNA; SECONDARY STRUCTURES; PREDICTION; CONSTRAINTS; ENSEMBLE	We present new modifications to the Wuchty algorithm in order to better define and explore possible conformations for an RNA sequence. The new features, including parallelization, energy-independent lonely pair constraints, context-dependent chemical probing constraints, helix filters, and optional multibranch loops, provide useful tools for exploring the landscape of RNA folding. Chemical probing alone may not necessarily define a single unique structure. The helix filters and optional multibranch loops are global constraints on RNA structure that are an especially useful tool for generating models of encapsidated viral RNA for which cryoelectron microscopy or crystallography data may be available. The computations generate a combinatorially complete set of structures near a free energy minimum and thus provide data on the density and diversity of structures near the bottom of a folding funnel for an RNA sequence. The conformational landscapes for some RNA sequences may resemble a low, wide basin rather than a steep funnel that converges to a single structure.	[Stone, Jonathan W.; Bleckley, Samuel; Lavelle, Sean; Schroeder, Susan J.] Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA; [Stone, Jonathan W.; Bleckley, Samuel; Lavelle, Sean; Schroeder, Susan J.] Univ Oklahoma, Dept Microbiol & Plant Biol, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman	Schroeder, SJ (corresponding author), Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA.	sjschroeder114@gmail.com		Schroeder, Susan/0000-0003-4755-2294	National Science Foundation CAREER [0844913]; Oklahoma Center for the Advancement of Science and Technology [HR13-206]; Pharmaceutical Research and Manufacturers of America Foundation; Div Of Molecular and Cellular Bioscience [0844913] Funding Source: National Science Foundation	National Science Foundation CAREER(National Science Foundation (NSF)); Oklahoma Center for the Advancement of Science and Technology; Pharmaceutical Research and Manufacturers of America Foundation; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by grants from the National Science Foundation CAREER grant no. 0844913, the Oklahoma Center for the Advancement of Science and Technology HR13-206, and the Pharmaceutical Research and Manufacturers of America Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amman F, 2013, LECT NOTES COMPUT SC, V8213, P1, DOI 10.1007/978-3-319-02624-4_1; Bleckley S, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0051204, DOI 10.1371/JOURNAL.PONE.0051204]; Bleckley S, 2012, RNA, V18, P1309, DOI 10.1261/rna.032326.112; Bompfunewerer AF, 2008, J MATH BIOL, V56, P129, DOI 10.1007/s00285-007-0107-5; Ding Y, 2003, NUCLEIC ACIDS RES, V31, P7280, DOI 10.1093/nar/gkg938; Ding Y, 2001, NUCLEIC ACIDS RES, V29, P1034, DOI 10.1093/nar/29.5.1034; Ding Y, 2006, J MOL BIOL, V359, P554, DOI 10.1016/j.jmb.2006.01.056; Forum MP, 1994, MPI MESSAGE PASSING; Giegerich R, 2004, NUCLEIC ACIDS RES, V32, P4843, DOI 10.1093/nar/gkh779; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Guo F, 2004, MOL CELL, V16, P351, DOI 10.1016/S1097-2765(04)00592-1; Hofacker IL, 2014, METHODS MOL BIOL, V1097, P71, DOI 10.1007/978-1-62703-709-9_4; Janssen S, 2014, METHODS MOL BIOL, V1097, P215, DOI 10.1007/978-1-62703-709-9_11; Larson SB, 1998, J MOL BIOL, V277, P37, DOI 10.1006/jmbi.1997.1570; Larson SB, 2001, CURR OPIN STRUC BIOL, V11, P59, DOI 10.1016/S0959-440X(00)00166-4; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; Mathews DH, 2006, J MOL BIOL, V359, P526, DOI 10.1016/j.jmb.2006.01.067; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; MCCASKILL JS, 1990, BIOPOLYMERS, V29, P1105, DOI 10.1002/bip.360290621; PIPAS JM, 1975, P NATL ACAD SCI USA, V72, P2017, DOI 10.1073/pnas.72.6.2017; Proctor JR, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt174; Rudinger-Thirion J, 2011, P NATL ACAD SCI USA, V108, pE794, DOI 10.1073/pnas.1103698108; Schroeder SJ, 2014, BIOCHEMISTR IN PRESS; Schroeder SJ, 2011, BIOPHYS J, V101, P167, DOI 10.1016/j.bpj.2011.05.053; Schroeder SJ, 2009, J VIROL, V83, P6326, DOI 10.1128/JVI.00251-09; Shepherd CM, 2006, NUCLEIC ACIDS RES, V34, pD386, DOI 10.1093/nar/gkj032; Turner DH, 2010, NUCLEIC ACIDS RES, V38, pD280, DOI 10.1093/nar/gkp892; Washietl S, 2012, NUCLEIC ACIDS RES, V40, P4261, DOI 10.1093/nar/gks009; Wuchty S, 1999, BIOPOLYMERS, V49, P145, DOI 10.1002/(SICI)1097-0282(199902)49:2<145::AID-BIP4>3.3.CO;2-7; ZUKER M, 1989, SCIENCE, V244, P48, DOI 10.1126/science.2468181; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133	33	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0117217	10.1371/journal.pone.0117217	http://dx.doi.org/10.1371/journal.pone.0117217			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695434	Green Published, gold, Green Submitted			2022-12-26	WOS:000350062300018
J	Aspden, JW; Armstrong, CL; Gutierrez-Ibanez, CI; Hawkes, R; Iwaniuk, AN; Kohl, T; Graham, DJ; Wylie, DR				Aspden, Joel W.; Armstrong, Carol L.; Gutierrez-Ibanez, Cristian I.; Hawkes, Richard; Iwaniuk, Andrew N.; Kohl, Tobias; Graham, David J.; Wylie, Douglas R.			Zebrin II/Aldolase C Expression in the Cerebellum of the Western Diamondback Rattlesnake (Crotalus atrox)	PLOS ONE			English	Article							PURKINJE-CELL COMPARTMENTATION; CLIMBING FIBER PROJECTIONS; PIGEONS COLUMBA-LIVIA; ALDOLASE-C; ANTIGENIC COMPARTMENTATION; FUNCTIONAL-ORGANIZATION; COMPARATIVE MORPHOLOGY; ZONAL ORGANIZATION; VENTRAL UVULA; II EXPRESSION	Aldolase C, also known as Zebrin II (ZII), is a glycolytic enzyme that is expressed in cerebellar Purkinje cells of the vertebrate cerebellum. In both mammals and birds, ZII is expressed heterogeneously, such that there are sagittal stripes of Purkinje cells with high ZII expression (ZII+), alternating with stripes of Purkinje cells with little or no expression (ZII-). The patterns of ZII+ and ZII- stripes in the cerebellum of birds and mammals are strikingly similar, suggesting that it may have first evolved in the stem reptiles. In this study, we examined the expression of ZII in the cerebellum of the western diamondback rattlesnake (Crotalus atrox). In contrast to birds and mammals, the cerebellum of the rattlesnake is much smaller and simpler, consisting of a small, unfoliated dome of cells. A pattern of alternating ZII+ and ZII- sagittal stripes cells was not observed: rather all Purkinje cells were ZII+. This suggests that ZII stripes have either been lost in snakes or that they evolved convergently in birds and mammals.	[Aspden, Joel W.; Gutierrez-Ibanez, Cristian I.; Graham, David J.; Wylie, Douglas R.] Univ Alberta, Neurosci & Mental Hlth Inst, Edmonton, AB T6G 2E9, Canada; [Armstrong, Carol L.] Mt Royal Univ, Dept Biol, Calgary, AB T3E 6K6, Canada; [Gutierrez-Ibanez, Cristian I.; Kohl, Tobias] Tech Univ Munich, Lehrstuhl Zool, D-85354 Freising Weihenstephan, Germany; [Hawkes, Richard] Univ Calgary, Dept Cell Biol & Anat, Genes & Dev Res Grp, Calgary, AB T2N 4N1, Canada; [Hawkes, Richard] Univ Calgary, Hotchkiss Brain Inst, Cumming Sch Med, Calgary, AB T2N 4N1, Canada; [Iwaniuk, Andrew N.] Univ Lethbridge, Dept Neurosci, Canadian Ctr Behav Neurosci, Lethbridge, AB T1K 3M4, Canada	University of Alberta; Mount Royal University; Technical University of Munich; University of Calgary; University of Calgary; University of Lethbridge	Wylie, DR (corresponding author), Univ Alberta, Neurosci & Mental Hlth Inst, Edmonton, AB T6G 2E9, Canada.	dwylie@ualberta.ca	Iwaniuk, Andrew/H-7255-2019; Hawkes, Richard/F-7971-2011	Iwaniuk, Andrew/0000-0001-9273-3655; Gutierrez-Ibanez, Cristian/0000-0002-0468-8223	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Supported by funding from the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/Index_eng.asp) to DRW and ANI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHN AH, 1994, DEVELOPMENT, V120, P2081; AKINTUNDE A, 1994, J CHEM NEUROANAT, V7, P75, DOI 10.1016/0891-0618(94)90009-4; ANDERSSON G, 1978, EXP BRAIN RES, V32, P565; Apps R, 2005, NAT REV NEUROSCI, V6, P297, DOI 10.1038/nrn1646; Apps R, 2009, NAT REV NEUROSCI, V10, P670, DOI 10.1038/nrn2698; Armstrong CL, 2000, J COMP NEUROL, V416, P383, DOI 10.1002/(SICI)1096-9861(20000117)416:3<383::AID-CNE9>3.0.CO;2-M; BANGMA GC, 1984, J COMP NEUROL, V228, P447, DOI 10.1002/cne.902280311; BANGMA GC, 1983, J COMP NEUROL, V215, P258, DOI 10.1002/cne.902150303; Bastianelli E, 2003, CEREBELLUM, V2, P242, DOI 10.1080/14734220310022289; Black D. G., 1983, THESIS MONASH U CLAY; BROCHU G, 1990, J COMP NEUROL, V291, P538, DOI 10.1002/cne.902910405; CHOCKKAN V, 1994, J COMP NEUROL, V345, P33, DOI 10.1002/cne.903450103; DAVIS CA, 1993, METHOD ENZYMOL, V225, P502; DENT JA, 1989, DEVELOPMENT, V105, P61; DEZEEUW CI, 1994, J COMP NEUROL, V349, P428, DOI 10.1002/cne.903490308; Ebner TJ, 2012, CEREBELLUM, V11, P418, DOI 10.1007/s12311-011-0347-1; EISENMAN LM, 1993, J COMP NEUROL, V335, P586, DOI 10.1002/cne.903350410; EKEROT CF, 1973, BRAIN RES, V64, P446, DOI 10.1016/0006-8993(73)90203-5; Fong JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048990; Fujita H, 2010, J COMP NEUROL, V518, P1764, DOI 10.1002/cne.22301; Gao WC, 2006, J NEUROSCI, V26, P8377, DOI 10.1523/JNEUROSCI.2434-06.2006; Graham DJ, 2012, J NEUROSCI, V32, P12769, DOI 10.1523/JNEUROSCI.0197-12.2012; GRAVEL C, 1990, J COMP NEUROL, V291, P79, DOI 10.1002/cne.902910107; HAWKES R, 1992, BIOCHEM SOC T, V20, P391, DOI 10.1042/bst0200391; HAWKES R, 1991, PROG NEUROBIOL, V36, P309, DOI 10.1016/0301-0082(91)90004-K; Hawkes R, 1995, J MOL NEUROSCI, V6, P147, DOI 10.1007/BF02736761; Hedges SB, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-64; Herrup K, 1997, ANNU REV NEUROSCI, V20, P61, DOI 10.1146/annurev.neuro.20.1.61; Horn KM, 2010, J NEUROSCI, V30, P9411, DOI 10.1523/JNEUROSCI.0440-10.2010; Iwaniuk AN, 2006, BRAIN BEHAV EVOLUT, V67, P53, DOI 10.1159/00089120; Iwaniuk AN, 2007, BRAIN BEHAV EVOLUT, V69, P196, DOI 10.1159/000096987; Iwaniuk AN, 2009, J CHEM NEUROANAT, V37, P55, DOI 10.1016/j.jchemneu.2008.10.001; JI Z, 1994, NEUROSCIENCE, V61, P935, DOI 10.1016/0306-4522(94)90414-6; Karam SD, 2001, J COMP NEUROL, V440, P127, DOI 10.1002/cne.1374; Kim JY, 2009, J COMP NEUROL, V517, P193, DOI 10.1002/cne.22147; Larsell O, 1967, CEREBELLUM MYXINOIDS; LECLERC N, 1988, J COMP NEUROL, V273, P399, DOI 10.1002/cne.902730310; Lee MSY, 2013, CURR BIOL, V23, pR513, DOI 10.1016/j.cub.2013.05.011; LLINAS R, 1989, EUR J NEUROSCI, V1, P587, DOI 10.1111/j.1460-9568.1989.tb00365.x; Llinas R., 1969, NEUROBIOLOGY CEREBEL, P43; Lyson TR, 2012, BIOL LETTERS, V8, P1028, DOI 10.1098/rsbl.2012.0462; Marzban H, 2004, J NEUROCYTOL, V33, P117, DOI 10.1023/B:NEUR.0000029652.96456.0d; Marzban H, 2003, BRAIN RES, V974, P176, DOI 10.1016/S0006-8993(03)02576-9; Marzban H, 2012, BRAIN BEHAV EVOLUT, V80, P196, DOI 10.1159/000340069; Marzban H, 2011, CEREBELLUM, V10, P422, DOI 10.1007/s12311-010-0208-3; Marzban H, 2011, CEREBELLUM, V10, P435, DOI 10.1007/s12311-011-0251-8; Marzban H, 2010, J COMP NEUROL, V518, P2221, DOI 10.1002/cne.22328; MATSUSHITA M, 1991, EXP BRAIN RES, V84, P133; Mostofi A, 2010, J NEUROSCI, V30, P8920, DOI 10.1523/JNEUROSCI.6117-09.2010; Pakan JMP, 2008, NEUROSCIENCE, V157, P57, DOI 10.1016/j.neuroscience.2008.08.062; Pakan JMP, 2007, J COMP NEUROL, V501, P619, DOI 10.1002/cne.21266; Pakan JMP, 2014, J COMP NEUROL, V522, P3629, DOI 10.1002/cne.23626; Pakan JMP, 2011, VISUAL NEUROSCI, V28, P163, DOI 10.1017/S0952523810000532; Pakan JMP, 2010, J COMP NEUROL, V518, P175, DOI 10.1002/cne.22192; Paukert M, 2010, J NEUROSCI, V30, P7290, DOI 10.1523/JNEUROSCI.5118-09.2010; Redies C, 2002, BRAIN RES BULL, V57, P341, DOI 10.1016/S0361-9230(01)00724-9; Rieppel Olivier, 2008, P345; Rivkin A, 2003, MOL CELL NEUROSCI, V24, P887, DOI 10.1016/S1044-7431(03)00240-9; Ruigrok TJH, 2003, J COMP NEUROL, V466, P278, DOI 10.1002/cne.10889; Sanchez M, 2002, J COMP NEUROL, V444, P159, DOI 10.1002/cne.10144; Sillitoe RV, 2005, PROG BRAIN RES, V148, P283, DOI 10.1016/S0079-6123(04)48022-4; Sillitoe RV, 2002, J HISTOCHEM CYTOCHEM, V50, P235, DOI 10.1177/002215540205000211; Sites JW, 2011, ANNU REV ECOL EVOL S, V42, P227, DOI 10.1146/annurev-ecolsys-102710-145051; Steida L, 1875, Z WISS ZOOL, V20, P1; Sugihara I, 2004, J NEUROSCI, V24, P8771, DOI 10.1523/JNEUROSCI.1961-04.2004; Sugihara I, 2007, J NEUROSCI, V27, P9696, DOI 10.1523/JNEUROSCI.1579-07.2007; Sugihara I, 2007, J COMP NEUROL, V500, P1076, DOI 10.1002/cne.21219; Sugihara I, 2007, J COMP NEUROL, V501, P13, DOI 10.1002/cne.21223; Sugihara I, 2011, CEREBELLUM, V10, P449, DOI 10.1007/s12311-010-0226-1; Sugihara I, 2009, J COMP NEUROL, V512, P282, DOI 10.1002/cne.21889; TANO D, 1992, J COMP NEUROL, V323, P128, DOI 10.1002/cne.903230111; ten Donkelaar H.J., 1998, P1315; TENDONKELAAR HJ, 1992, BIOL REPTIL, V17, P496; Voogd J, 2004, J NEUROCYTOL, V33, P5, DOI 10.1023/B:NEUR.0000029645.72074.2b; Voogd J, 2003, J NEUROSCI, V23, P4645; Voogd J, 1967, Prog Brain Res, V25, P94; Voogd J, 1998, TRENDS COGN SCI, V2, P307, DOI 10.1016/S1364-6613(98)01210-8; Voogd J., 1980, INFERIOR OLIVARY NUC, P207; Wadiche JI, 2005, NAT NEUROSCI, V8, P1329, DOI 10.1038/nn1539; Winship IR, 2003, J COMP NEUROL, V456, P127, DOI 10.1002/cne.10507; Wu HS, 1999, J COMP NEUROL, V411, P97, DOI 10.1002/(SICI)1096-9861(19990816)411:1<97::AID-CNE8>3.0.CO;2-O; Wylie DR, 2013, J CHEM NEUROANAT, V52, P95, DOI 10.1016/j.jchemneu.2013.07.005; Wylie DR, 2012, J COMP NEUROL, V520, P1532, DOI 10.1002/cne.22810; Wylie DRW, 2003, J COMP NEUROL, V465, P179, DOI 10.1002/cne.10857; Xiao JQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105633; Zhou HB, 2014, ELIFE, V3, DOI 10.7554/eLife.02536	86	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117539	10.1371/journal.pone.0117539	http://dx.doi.org/10.1371/journal.pone.0117539			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692946	Green Submitted, Green Published, gold			2022-12-26	WOS:000350061500060
J	Bertrand, S; de Bex, GDL; Wildemauwe, C; Lunguya, O; Phoba, MF; Ley, B; Jacobs, J; Vanhoof, R; Mattheus, W				Bertrand, Sophie; de Bex, Guillaume De lamine; Wildemauwe, Christa; Lunguya, Octavie; Phoba, Marie France; Ley, Benedikt; Jacobs, Jan; Vanhoof, Raymond; Mattheus, Wesley			Multi Locus Variable-Number Tandem Repeat (MLVA) Typing Tools Improved the Surveillance of Salmonella Enteritidis: A 6 Years Retrospective Study	PLOS ONE			English	Article							ENTERICA SEROVAR ENTERITIDIS; FIELD GEL-ELECTROPHORESIS; ANTIMICROBIAL RESISTANCE; SUSCEPTIBILITY; TYPHI	Surveillance of Salmonella enterica subsp. enterica serovar Enteritidis is generally considered to benefit from molecular techniques like multiple-locus variable-number of tandem repeats analysis (MLVA), which allow early detection and confinement of outbreaks. Here, a surveillance study, including phage typing, antimicrobial susceptibility testing and MLVA on 1,535 Salmonella Enteritidis isolates collected between 2007 and 2012, was used to evaluate the added value of MLVA for public health surveillance in Belgium. Phage types PT4, PT8, PT21, PT1, PT6, PT14b, PT28 and PT13 dominate the Belgian Salmonella Enteritidis population. The isolates of Salmonella Enteritidis were most frequently susceptible to all antibiotics tested. 172 different MLVA profiles were detected, of which 9 frequent profiles included 67.2% of the Salmonella Enteritidis population. During a serial passage experiment on selected isolates to investigate the in vitro stability of the 5 MLVA loci, no variations over time were observed indicating that the MLVA profiles were stable. The MLVA profile of isolates originating from different outbreaks in the Democratic Republic of the Congo (DRC) between 2010 and 2011 were distinct from any of the MLVA profiles found in Belgian isolates throughout the six year observational period and demonstrates that MLVA improves public health surveillance of Salmonella Enteritidis. However, MLVA should be complemented with other subtyping methods when investigating outbreaks is caused by the most common MLVA profile.	[Bertrand, Sophie; de Bex, Guillaume De lamine; Wildemauwe, Christa; Vanhoof, Raymond; Mattheus, Wesley] Natl Reference Ctr Salmonellas, Sci Inst Publ Hlth, Div Bacterial Dis, Brussels, Belgium; [Lunguya, Octavie; Phoba, Marie France] Natl Inst Biomed Res, Dept Clin Microbiol, Kinshasa, DEM REP CONGO; [Ley, Benedikt; Jacobs, Jan] Inst Trop Med Antwerp, Antwerp, Belgium; [Jacobs, Jan] Univ Leuven, Fac Med, Dept Microbiol & Immunol, Louvain, Belgium	Institute Nacional de Recherche Biomedical; Institute of Tropical Medicine (ITM); KU Leuven	Bertrand, S (corresponding author), Natl Reference Ctr Salmonellas, Sci Inst Publ Hlth, Div Bacterial Dis, Brussels, Belgium.	sophie.bertrand@wiv-isp.be	Jacobs, Jan/GRX-7316-2022	Ley, Benedikt/0000-0002-5734-0845	Belgian Ministry of Social Affairs within Health Insurance System	Belgian Ministry of Social Affairs within Health Insurance System	The authors received no specific funding for this work, but the Belgian reference center for Salmonella is partially supported by the Belgian Ministry of Social Affairs through a fund within the Health Insurance System. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON ES, 1961, ZBL BAKT PARASIT, V181, P368; Asai T, 2008, NEW MICROBIOL, V31, P555; Bertrand S, 2013, D2012250530; Boxrud D, 2007, J CLIN MICROBIOL, V45, P536, DOI 10.1128/JCM.01595-06; Collard JM, 2008, EPIDEMIOL INFECT, V136, P771, DOI 10.1017/S095026880700920X; Danoff-Burg J, MEASURING BIOL DIVER; Dewaele I, 2013, ZOONOSES PUBLIC HLTH, DOI [10.1111/zph.12096, DOI 10.1111/ZPH.12096]; Grimont P. A. D., 2007, ANTIGENIC FORMULAE S; HICKMANBRENNER FW, 1983, J CLIN MICROBIOL, V17, P172, DOI 10.1128/JCM.17.1.172-174.1983; Holtby I, 2006, PUBLIC HEALTH, V120, P817, DOI 10.1016/j.puhe.2006.05.010; Hopkins KL, 2011, EURO SURVEILL, V16, ppii; Hrivniakova L, 2011, EURO SURVEILL, V16; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Hur J, 2011, CAN J VET RES, V75, P49; Lunguya O, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002103; Makela P, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3129; Malorny B, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-84; Mezal EH, 2014, FOOD MICROBIOL, V38, P67, DOI 10.1016/j.fm.2013.08.003; Mossong J, 2012, Bull Soc Sci Med Grand Duche Luxemb, P49; Nadon CA, 2013, EURO SURVEILL, V18; National Committee for Clinical Laboratory Standards, 2001, MS100S12 NCCLS; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Struelens M. J., 1996, Clin Microbiol Infect, V2, P2, DOI 10.1111/j.1469-0691.1996.tb00193.x; The European Committee on Antimicrobial Susceptibility Testing, 2013, 31 EUCAST; THRELFALL EJ, 1990, J APPL BACTERIOL, V68, P5, DOI 10.1111/j.1365-2672.1990.tb02542.x; Wattiau P, 2011, APPL ENVIRON MICROB, V77, P7877, DOI 10.1128/AEM.05527-11; Wuyts V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084055	27	15	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117950	10.1371/journal.pone.0117950	http://dx.doi.org/10.1371/journal.pone.0117950			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693200	Green Submitted, Green Published, gold			2022-12-26	WOS:000350061500083
J	Kumar, J; Dhar, P; Tayade, AB; Gupta, D; Chaurasia, OP; Upreti, DK; Toppo, K; Arora, R; Suseela, MR; Srivastava, RB				Kumar, Jatinder; Dhar, Priyanka; Tayade, Amol B.; Gupta, Damodar; Chaurasia, Om P.; Upreti, Dalip K.; Toppo, Kiran; Arora, Rajesh; Suseela, M. R.; Srivastava, Ravi B.			Chemical Composition and Biological Activities of Trans-Himalayan Alga Spirogyra porticalis (Muell.) Cleve	PLOS ONE			English	Article							COLD DESERT LADAKH; TRADITIONAL MEDICINAL-PLANTS; FUNCTIONAL FOOD INGREDIENTS; TOTAL PHENOLIC CONTENT; ANTIOXIDANT ACTIVITY; ETHYL LINOLEATE; OXIDATIVE STRESS; HYPOBARIC HYPOXIA; CAPSICUM-ANNUUM; DRUG DISCOVERY	The freshwater alga Spirogyra porticalis (Muell.) Cleve, a filamentous charophyte, collected from the Indian trans-Himalayan cold desert, was identified on the basis of morpho-anatomical characters. Extracts of this alga were made using solvents of varying polarity viz. n-hexane, acetonitrile, methanol and water. The antioxidant capacities and phenolic profile of the extracts were estimated. The methanol extract showing highest antioxidant capacity and rich phenolic attributes was further investigated and phytochemical profiling was conducted by gas chromatography-mass spectrometry (GC/MS) hyphenated technique. The cytotoxic activity of methanol extract was evaluated on human hepatocellular carcinoma HepG2 and colon carcinoma RKO cell lines. The anti-hypoxic effect of methanol extract of the alga was tested on in vivo animal system to confirm its potential to ameliorate oxidative stress. The antioxidant assays viz. ferric reducing antioxidant power (FRAP), 2,2'-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS), 1,1-diphenyl-2-picrylhydrazyl (DPPH) and nitric oxide (NO) radical scavenging capacities, beta-carotene-linoleic acid bleaching property and lipid peroxidation exhibited analogous results, wherein the algal extracts showed significantly high antioxidant potential. The extracts were also found to possess high content of total proanthocyanidin, flavonoid and polyphenol. GC/MS analysis revealed the presence of thirteen chemotypes in the methanol extract representing different phytochemical groups like fatty acid esters, sterols, unsaturated alcohols, alkynes etc. with substantial phyto-pharmaceutical importance. The methanol extract was observed to possess anticancer activity as revealed from studies on HepG2 and RKO cell lines. In the present study, Spirogyra porticalis methanol extract also provided protection from hypoxia-induced oxidative stress and accelerated the onset of adaptative changes in rats during exposure to hypobaric hypoxia. The bioactive phytochemicals present in this trans-Himalayan alga are of enormous interest and can be utilized sustainably for discovery of novel drugs against oxidative stress.	[Kumar, Jatinder; Dhar, Priyanka; Tayade, Amol B.; Chaurasia, Om P.; Srivastava, Ravi B.] Def Res & Dev Org, Def Inst High Altitude Res, Leh Ladakh, Jammu & Kashmir, India; [Gupta, Damodar; Arora, Rajesh] Def Res & Dev Org, Inst Nucl Med & Allied Sci, Med & Aromat Plants Lab, Radiat Biotechnol Grp, Delhi, India; [Arora, Rajesh] Off Director General Life Sci, New Delhi, India; [Upreti, Dalip K.; Toppo, Kiran; Suseela, M. R.] Natl Bot Res Inst, Lucknow 226001, Uttar Pradesh, India	Defence Research & Development Organisation (DRDO); Defence Institute of High Altitude Research (DIHAR); Defence Research & Development Organisation (DRDO); Institute of Nuclear Medicine & Allied Sciences (INMAS); Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Botanical Research Institute (NBRI)	Chaurasia, OP (corresponding author), Def Res & Dev Org, Def Inst High Altitude Res, Leh Ladakh, Jammu & Kashmir, India.	dropchaurasiadihardrdo@gmail.com	CHAURASIA, OM/AAW-6347-2021; Arora, Rajesh/AAE-4596-2021; CHAURASIA, OM PRAKASH/AAP-3358-2021	Arora, Rajesh/0000-0001-7307-9221; CHAURASIA, OM PRAKASH/0000-0003-2921-2755	Defence Research & Development Organisation (DRDO), Ministry of Defence, Government of India	Defence Research & Development Organisation (DRDO), Ministry of Defence, Government of India	The study was entirely supported by Defence Research & Development Organisation (DRDO), Ministry of Defence, Government of India. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z., 2007, ETHNOBOTANY PLANTS T, P1, DOI DOI 10.1007/S12033-007-0062-9; Ando H, 1998, ARCH DERMATOL RES, V290, P375, DOI 10.1007/s004030050320; Ando H, 2006, BIOCHEM J, V394, P43, DOI 10.1042/BJ20051419; Australasian College for Emergency Medicine, 2013, G24 AUSTR COLL EM ME, P1, DOI [10.1097/ACC.0b013e31829c6877, DOI 10.1097/ACC.0B013E31829C6877]; Bajpai PK, 2014, LWT-FOOD SCI TECHNOL, V59, P981, DOI 10.1016/j.lwt.2014.07.055; Balboa EM, 2013, FOOD CHEM, V138, P1764, DOI 10.1016/j.foodchem.2012.11.026; Ballabh B, 2008, J ETHNOPHARMACOL, V118, P331, DOI 10.1016/j.jep.2008.04.022; Ballabh B, 2007, J ETHNOPHARMACOL, V112, P341, DOI 10.1016/j.jep.2007.03.020; Ballabh B, 2009, INDIAN J TRADIT KNOW, V8, P185; BOYD MR, 1995, DRUG DEVELOP RES, V34, P91, DOI 10.1002/ddr.430340203; Boyd MR, 1992, ANTITUMOR DRUG DISCO, P11; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Brieger K, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13659; Burritt DJ, 2002, PLANTA, V215, P829, DOI 10.1007/s00425-002-0805-6; Cardozo KHM, 2007, COMP BIOCHEM PHYS C, V146, P60, DOI 10.1016/j.cbpc.2006.05.007; Chacon-Lee TL, 2010, COMPR REV FOOD SCI F, V9, P655, DOI 10.1111/j.1541-4337.2010.00132.x; Chandrasekar MJN, 2006, PHARM BIOL, V44, P100, DOI 10.1080/13880200600592046; Charakida A, 2007, BRIT J DERMATOL, V157, P569, DOI 10.1111/j.1365-2133.2007.08083.x; COMPERE P, 1983, B SOC ROY BOT BELG, V116, P141; Cragg GM, 2014, J NAT PROD, V77, P703, DOI 10.1021/np5000796; Dai F, 2009, BIOL PLANTARUM, V53, P257, DOI 10.1007/s10535-009-0048-5; Dapkevicius A, 1998, J SCI FOOD AGR, V77, P140, DOI 10.1002/(SICI)1097-0010(199805)77:1&lt;140::AID-JSFA18&gt;3.0.CO;2-K; De Rosa S, 2003, Z NATURFORSCH C, V58, P325; Dhar P, 2013, THESIS BHARATHIAR U; Dhar P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083008; Dhar P, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-259; DOWNING DT, 1986, J AM ACAD DERMATOL, V14, P221, DOI 10.1016/S0190-9622(86)70025-X; Duval B, 1999, J APPL PHYCOL, V11, P559, DOI 10.1023/A:1008178208949; Frankel EN, 2000, J SCI FOOD AGR, V80, P1925, DOI 10.1002/1097-0010(200010)80:13&lt;1925::AID-JSFA714&gt;3.0.CO;2-4; Freile-Pelegriin Y, 2014, BIOACTIVE COMPOUNDS, P113; Frikha F, 2011, CIENC MAR, V37, P113, DOI 10.7773/cm.v37i2.1712; Gad HA, 2013, PHYTOCHEM ANALYSIS, V24, P1, DOI 10.1002/pca.2378; Gao XQ, 2000, J AGR FOOD CHEM, V48, P1485, DOI 10.1021/jf991072g; Goiris K, 2012, J APPL PHYCOL, V24, P1477, DOI 10.1007/s10811-012-9804-6; Guiry MD, 2014, SPIROGYRA PORTICALIS; Gullberg J, 2004, ANAL BIOCHEM, V331, P283, DOI 10.1016/j.ab.2004.04.037; Hajimahmoodi M, 2010, J APPL PHYCOL, V22, P43, DOI 10.1007/s10811-009-9424-y; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; HOLMER G, 1962, Z ERNAHRUNGSWISS, V2, P223, DOI 10.1007/BF02020814; Hota KB, 2011, INNOVATIONS AGROANIM, P277; Huang DJ, 2005, J AGR FOOD CHEM, V53, P1841, DOI 10.1021/jf030723c; HUTSELL TC, 1967, LIPIDS, V2, P342, DOI 10.1007/BF02532123; Ikram EHK, 2009, J FOOD COMPOS ANAL, V22, P388, DOI 10.1016/j.jfca.2009.04.001; ILAVAZHAGAN G, 1996, DIPAS2696; Ismail Amin Jr, 2002, Malays J Nutr, V8, P167; JELENKO C, 1975, ANN SURG, V182, P562, DOI 10.1097/00000658-197511000-00005; Jeong WY, 2011, J SEP SCI, V34, P2967, DOI 10.1002/jssc.201100524; Junthip R., 2013, ADV MATER RES-KR, V699, P693; Kashiwagi T, 2005, Z NATURFORSCH C, V60, P739; Khalid MN, 2012, PAK J BOT, V44, P1815; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kimura J, 2002, J NAT PROD, V65, P57, DOI 10.1021/np0103057; Korekar G, 2014, LWT-FOOD SCI TECHNOL, V55, P157, DOI 10.1016/j.lwt.2013.09.006; Kovacik J, 2010, PHOTOCHEM PHOTOBIOL, V86, P612, DOI 10.1111/j.1751-1097.2010.00708.x; Kumar J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098696; Kumar KS, 2008, FOOD CHEM, V107, P289, DOI 10.1016/j.foodchem.2007.08.016; Lagunin AA, 2014, NAT PROD REP, V31, P1585, DOI 10.1039/c4np00068d; LEBEL CP, 1990, TOXICOL APPL PHARM, V104, P17, DOI 10.1016/0041-008X(90)90278-3; Lee Seung-Hong, 2010, Algae, V25, P45, DOI 10.4490/algae.2010.25.1.045; Li HB, 2007, FOOD CHEM, V102, P771, DOI 10.1016/j.foodchem.2006.06.022; Lifongo LL, 2014, NAT PRODUCT BIOPROSP, V4, P1, DOI 10.1007/s13659-014-0005-7; Lordan S, 2011, MAR DRUGS, V9, P1056, DOI 10.3390/md9061056; Maiti P, 2006, NEUROCHEM INT, V49, P709, DOI 10.1016/j.neuint.2006.06.002; MIZUGUCHI K, 1993, EUR J PHARMACOL, V235, P221, DOI 10.1016/0014-2999(93)90140-D; MONKS A, 1991, J NATL CANCER I, V83, P757, DOI 10.1093/jnci/83.11.757; Mungmai L, 2014, CHIANG MAI J SCI, V41, P14; Nabavi SF, 2013, J AQUAT FOOD PROD T, V22, P58, DOI 10.1080/10498850.2011.624292; Naik A.A., 2012, INT MULTIDISCIPLINAR, V2, P13; Nakanishi I, 1995, J PHYSIOL-LONDON, V489, P869, DOI 10.1113/jphysiol.1995.sp021099; Natrah FMI, 2007, J APPL PHYCOL, V19, P711, DOI 10.1007/s10811-007-9192-5; Nyska A, 2002, TOXICOL PATHOL, V30, P620, DOI 10.1080/01926230290166724; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; OKADA N, 1994, PHYTOCHEMISTRY, V37, P281, DOI 10.1016/0031-9422(94)85042-9; OKUNADE AL, 1985, J NAT PROD, V48, P472, DOI 10.1021/np50039a020; Ontawong A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/820786; Ordonez AAL, 2006, FOOD CHEM, V97, P452, DOI 10.1016/j.foodchem.2005.05.024; Percot A, 2009, NAT PROD RES, V23, P460, DOI 10.1080/14786410802076069; Plaza M, 2008, TRENDS FOOD SCI TECH, V19, P31, DOI 10.1016/j.tifs.2007.07.012; Ponnamma S. U, 2012, ANDERS INT J PHARM B, V3, P570; PRASAD TK, 1994, PLANT CELL, V6, P65, DOI 10.1105/tpc.6.1.65; Prescott GW, 1951, ALGAE W GREAT LAKES, P318; Priyadarshani I., 2012, J ALGAL BIOMASS UTIL, V3, P89; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; RILEY V, 1960, P SOC EXP BIOL MED, V104, P751; Rodriguez-Garcia I, 2008, FOOD CHEM, V108, P1023, DOI 10.1016/j.foodchem.2007.11.059; Roessner U, 2001, PLANT CELL, V13, P11, DOI 10.1105/tpc.13.1.11; Ruberto G, 2000, PLANTA MED, V66, P687, DOI 10.1055/s-2000-9773; RUBINSTEIN LV, 1990, J NATL CANCER I, V82, P1113, DOI 10.1093/jnci/82.13.1113; Rubio L, 2013, CRIT REV FOOD SCI, V53, P943, DOI 10.1080/10408398.2011.574802; SaiRam M, 1998, INT J BIOMETEOROL, V42, P55, DOI 10.1007/s004840050084; Sarker Satyajit D, 2012, Methods Mol Biol, V864, P301, DOI 10.1007/978-1-61779-624-1_12; Satoh N, 2007, DIABETES CARE, V30, P144, DOI 10.2337/dc06-1179; Shalaby EA, 2011, PLANT SIGNAL BEHAV, V6, P1338, DOI 10.4161/psb.6.9.16779; Shellie RA, 2009, J SEP SCI, V32, P3720, DOI 10.1002/jssc.200900422; Singh B., 2000, Acta Horticulturae, P65; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Solecka D, 1997, ACTA PHYSIOL PLANT, V19, P257, DOI 10.1007/s11738-997-0001-1; Sun JS, 1998, BURNS, V24, P225, DOI 10.1016/S0305-4179(97)00115-0; Tayade AB, 2013, J FOOD SCI, V78, pC402, DOI 10.1111/1750-3841.12054; Tayade AB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052797; Thumvijit Tarika, 2013, Interdiscip Toxicol, V6, P152, DOI 10.2478/intox-2013-0024; Wang ZH, 2009, FOOD CHEM, V112, P914, DOI 10.1016/j.foodchem.2008.06.078; Yano T, 1997, LIFE SCI, V61, P2007, DOI 10.1016/S0024-3205(97)00859-X; YANO T, 1995, YAKUGAKU ZASSHI, V115, P843, DOI 10.1248/yakushi1947.115.10_843; Yoshimura Y, 1997, ARCTIC ALPINE RES, V29, P126, DOI 10.2307/1551843; Zhang DL, 2004, FOOD CHEM, V88, P503, DOI 10.1016/j.foodchem.2004.01.065; Zheng W, 2001, J AGR FOOD CHEM, V49, P5165, DOI 10.1021/jf010697n; Ziboh VA, 2000, AM J CLIN NUTR, V71, p361S, DOI 10.1093/ajcn/71.1.361s	108	15	16	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118255	10.1371/journal.pone.0118255	http://dx.doi.org/10.1371/journal.pone.0118255			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693168	Green Published, Green Submitted, gold			2022-12-26	WOS:000350061500112
J	Kung, LHW; Rajpar, MH; Preziosi, R; Briggs, MD; Boot-Handford, RP				Kung, Louise H. W.; Rajpar, M. Helen; Preziosi, Richard; Briggs, Michael D.; Boot-Handford, Raymond P.			Increased Classical Endoplasmic Reticulum Stress Is Sufficient to Reduce Chondrocyte Proliferation Rate in the Growth Plate and Decrease Bone Growth	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOCHONDRAL OSSIFICATION; EPIPHYSEAL DYSPLASIA; CONGENITAL GOITER; TRANSGENIC MICE; MURINE MODEL; ER STRESS; CARTILAGE; MUTATION; PSEUDOACHONDROPLASIA	Mutations in genes encoding cartilage oligomeric matrix protein and matrilin-3 cause a spectrum of chondrodysplasias called multiple epiphyseal dysplasia (MED) and pseudoachondroplasia (PSACH). The majority of these diseases feature classical endoplasmic reticulum (ER) stress and activation of the unfolded protein response (UPR) as a result of misfolding of the mutant protein. However, the importance and the pathological contribution of ER stress in the disease pathogenesis are unknown. The aim of this study was to investigate the generic role of ER stress and the UPR in the pathogenesis of these diseases. A transgenic mouse line (ColllTg(cog)) was generated using the collagen II promoter to drive expression of an ER stress-inducing protein (Tg(cog)) in chondrocytes. The skeletal and histological phenotypes of these ColllTg(cog) mice were characterised. The expression and intracellular retention of Tg(cog) induced ER stress and activated the UPR as characterised by increased BiP expression, phosphorylation of eIF2 alpha and spliced Xbp1. ColllTg(cog) mice exhibited decreased long bone growth and decreased chondrocyte proliferation rate. However, there was no disruption of chondrocyte morphology or growth plate architecture and perturbations in apoptosis were not apparent. Our data demonstrate that the targeted induction of ER stress in chondrocytes was sufficient to reduce the rate of bone growth, a key clinical feature associated with MED and PSACH, in the absence of any growth plate dysplasia. This study establishes that classical ER stress is a pathogenic factor that contributes to the disease mechanism of MED and PSACH. However, not all the pathological features of MED and PSACH were recapitulated, suggesting that a combination of intra- and extra-cellular factors are likely to be responsible for the disease pathology as a whole	[Kung, Louise H. W.; Rajpar, M. Helen; Boot-Handford, Raymond P.] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester, Lancs, England; [Preziosi, Richard] Univ Manchester, Fac Life Sci, Environm Ecol & Evolut Res Grp, Manchester, Lancs, England; [Briggs, Michael D.] Newcastle Univ, Int Ctr Life, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Manchester; University of Manchester; Newcastle University - UK	Boot-Handford, RP (corresponding author), Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester, Lancs, England.	Ray.Boot-Handford@manchester.ac.uk	Preziosi, Richard F/A-8626-2010	Preziosi, Richard F/0000-0003-0468-6655; Boot-Handford, Raymond/0000-0002-6167-8419; Kung, Louise/0000-0002-1959-7009	Arthritis Research UK [19501]; Wellcome Trust Institutional Strategic Support Fund [097820/Z/11/A, 084353/Z/07/Z]; Versus Arthritis [19501] Funding Source: researchfish	Arthritis Research UK(Versus Arthritis); Wellcome Trust Institutional Strategic Support Fund(Wellcome Trust); Versus Arthritis(Versus Arthritis)	This work was supported by Arthritis Research UK (19501) to RPBH and MDB, the Wellcome Trust Institutional Strategic Support Fund [097820/Z/11/A] to RPBH and MDB, the BBSRC through a PhD studentship (to LHWK) and the Wellcome Trust Senior Research Fellowship in Basic Biomedical Science (Grant 084353/Z/07/Z) to MDB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell PA, 2013, BIOL OPEN, V2, P802, DOI 10.1242/bio.20135280; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Boot-Handford RP, 2010, CELL TISSUE RES, V339, P197, DOI 10.1007/s00441-009-0877-8; Briggs MD, 2002, HUM MUTAT, V19, P465, DOI 10.1002/humu.10066; Cameron TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024600; Furuichi T, 2011, MAMM GENOME, V22, P318, DOI 10.1007/s00335-011-9329-3; Goeckeler JL, 2010, DIABETES OBES METAB, V12, P32, DOI 10.1111/j.1463-1326.2010.01273.x; Gualeni B, 2013, DIS MODEL MECH, V6, P1414, DOI 10.1242/dmm.013342; Hall CM, 2002, AM J MED GENET, V113, P65, DOI 10.1002/ajmg.10828; HUNZIKER EB, 1994, MICROSC RES TECHNIQ, V28, P505, DOI 10.1002/jemt.1070280606; Kim PS, 1996, J CELL BIOL, V133, P517, DOI 10.1083/jcb.133.3.517; Kim PS, 1998, P NATL ACAD SCI USA, V95, P9909, DOI 10.1073/pnas.95.17.9909; Kung LHW, 2012, J HISTOCHEM CYTOCHEM, V60, P734, DOI 10.1369/0022155412458436; Leighton MP, 2007, HUM MOL GENET, V16, P1728, DOI 10.1093/hmg/ddm121; Liang GY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086894; Long FX, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008334; Mackie EJ, 2008, INT J BIOCHEM CELL B, V40, P46, DOI 10.1016/j.biocel.2007.06.009; Mackie EJ, 2011, J ENDOCRINOL, V211, P109, DOI 10.1530/JOE-11-0048; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Newman B, 2003, CLIN GENET, V63, P241, DOI 10.1034/j.1399-0004.2003.00046.x; Nundlall S, 2010, CELL STRESS CHAPERON, V15, P835, DOI 10.1007/s12192-010-0193-y; Patra D, 2007, J CELL BIOL, V179, P687, DOI 10.1083/jcb.200708092; Patterson SE, 2014, DEV DYNAM, V243, P875, DOI [10.1002/DVDY.24131, 10.1002/dvdy.24131]; Pirog KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085145; Pirog-Garcia KA, 2007, HUM MOL GENET, V16, P2072, DOI 10.1093/hmg/ddm155; Posey KL, 2008, CELL MOL LIFE SCI, V65, P687, DOI 10.1007/s00018-007-7485-0; Posey KL, 2009, AM J PATHOL, V175, P1555, DOI 10.2353/ajpath.2009.090184; Rajpar MH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000691; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Saito A, 2011, J BIOL CHEM, V286, P4809, DOI 10.1074/jbc.M110.152900; Saito A, 2009, NAT CELL BIOL, V11, P1197, DOI 10.1038/ncb1962; Sakai K, 2001, MATRIX BIOL, V19, P761, DOI 10.1016/S0945-053X(00)00122-0; Schmitz M, 2008, MATRIX BIOL, V27, P67, DOI 10.1016/j.matbio.2007.08.001; Schroder M, 2008, CELL MOL LIFE SCI, V65, P862, DOI 10.1007/s00018-007-7383-5; Suleman F, 2012, HUM MUTAT, V33, P218, DOI 10.1002/humu.21631; Tsang KY, 2007, PLOS BIOL, V5, P568, DOI 10.1371/journal.pbio.0050044; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Warman ML, 2011, AM J MED GENET A, V155A, P943, DOI 10.1002/ajmg.a.33909; Wei JW, 2008, J CELL PHYSIOL, V217, P693, DOI 10.1002/jcp.21543; Yamaguchi Y, 2008, J BIOL CHEM, V283, P17020, DOI 10.1074/jbc.M802466200; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002	42	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117016	10.1371/journal.pone.0117016	http://dx.doi.org/10.1371/journal.pone.0117016			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693198	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000350061500033
J	Molnar, J; Frank, E; Minorics, R; Kadar, Z; Ocsovszki, I; Schonecker, B; Wolfling, J; Zupko, I				Molnar, Judit; Frank, Eva; Minorics, Renata; Kadar, Zalan; Ocsovszki, Imre; Schoenecker, Bruno; Woelfling, Janos; Zupko, Istvan			A Click Approach to Novel D-Ring-Substituted 16 alpha-Triazolylestrone Derivatives and Characterization of Their Antiproliferative Properties	PLOS ONE			English	Article							AZIDE-ALKYNE CYCLOADDITION; STEREOSELECTIVE-SYNTHESIS; PRESUMED INHIBITORS; SOLANIDINE ANALOGS; CYTOTOXIC ACTIVITY; CANCER-CELLS; ANTICANCER; STEROIDS; CDC25B; 1,2,3-TRIAZOLES	A simple and efficient synthesis of novel, D-ring substituted estrone derivatives containing a 16 alpha-triazolyl moiety is described. Two epimeric azido alcohols (16 alpha-azido-17 alpha-hydroxy and 16 alpha-azido-17 beta-hydroxy) of estra-1,3,5(10)-triene-3-methyl ether were prepared, followed by copper(I)-catalyzed azide-alkyne cycloaddition with various terminal alkynes. The steroidal triazoles were obtained in high yields and their activities against three human cancer cell lines (HeLa, MCF7 and A431) were screened. The most effective analogs were submitted to additional experiments in order to characterize their antiproliferative properties. As evidenced by flow cytometry, the selected steroids induced a disturbance in the HeLa cell cycle in a concentration- and exposure-dependent manner, through an increase of the hypodiploid population (subG1) and a cell cycle arrest in the G2/M phase. A noncancerous human fibroblast cell line (MRC5) was used to determine the selectivities of these compounds. Fluorescent microscopy after Hoechst 33258 - propidium iodide (HOPI) double staining revealed nuclear condensation and disturbed cell membrane integrity. The enhanced activities of caspase-3 and caspase-9 without activation of caspase-8 in the treated cells indicated the activation of the intrinsic pathway of apoptosis. The levels of cell cycle regulators (CDK1, cyclin B1/B2 and cdc25B) were decreased and the ratio Bax/Bcl-2 was increased 24 h after the treatment of HeLa cells (determined at an mRNA level by means of an RT-PCR technique). Under the same conditions, two agents elicited substantially increased degrees of phosphorylation of stathmin, as evidenced by Western blotting. The presented results demonstrate that these steroids can be regarded as appropriate structural scaffolds for the design and synthesis of further steroid analogs as innovative drug candidates with good efficacy.	[Molnar, Judit; Minorics, Renata; Zupko, Istvan] Univ Szeged, Dept Pharmacodynam & Biopharm, Szeged, Hungary; [Frank, Eva; Kadar, Zalan; Woelfling, Janos] Univ Szeged, Dept Organ Chem, Szeged, Hungary; [Ocsovszki, Imre] Univ Szeged, Dept Biochem, Szeged, Hungary; [Schoenecker, Bruno] Univ Jena, Inst Organ Chem & Macromol Chem, Jena, Germany	Szeged University; Szeged University; Szeged University; Friedrich Schiller University of Jena	Wolfling, J (corresponding author), Univ Szeged, Dept Organ Chem, Szeged, Hungary.	wolfling@chem.u-szeged.hu; zupko@pharm.u-szeged.hu	Frank, Eva/C-7870-2013; Zupkó, István/E-3687-2013; Minorics, Renata/AAC-7677-2020; Wolfling, Janos/A-3922-2008	Frank, Eva/0000-0002-1332-0551; Minorics, Renata/0000-0001-9685-813X; Wolfling, Janos/0000-0002-3037-309X	Hungarian Scientific Research Fund [OTKA K-109293, K-101659]; European Union; European Social Fund [TAMOP-4.2.2.A-11/1/KONV-2012-0035]	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); European Union(European Commission); European Social Fund(European Social Fund (ESF))	Financial support from the Hungarian Scientific Research Fund (http://www.otka.hu/en) is gratefully acknowledged. Grant numbers: OTKA K-109293 (IZ) and K-101659 (JW). This study was supported by the European Union and co-financed by the European Social Fund (JM, RM, IZ); project number: TAMOP-4.2.2.A-11/1/KONV-2012-0035 (http://www.u-szeged.hu/tamop422a0035-index). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZ R, 1994, J MED CHEM, V37, P4185, DOI 10.1021/jm00050a015; Anstead GM, 1997, STEROIDS, V62, P268, DOI 10.1016/S0039-128X(96)00242-5; Banday AH, 2010, STEROIDS, V75, P801, DOI 10.1016/j.steroids.2010.02.015; Berenyi A, 2013, STEROIDS, V78, P69, DOI 10.1016/j.steroids.2012.10.009; Boutros R, 2007, NAT REV CANCER, V7, P495, DOI 10.1038/nrc2169; Bray F, 2012, LANCET ONCOL, V13, P790, DOI 10.1016/S1470-2045(12)70211-5; Brinkmann K, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.61; Brodie A, 1999, United States Patent, Patent No. [5,994,335, 5994335]; BUCKLE DR, 1986, J MED CHEM, V29, P2262, DOI 10.1021/jm00161a022; Cassimeris L, 2002, CURR OPIN CELL BIOL, V14, P18, DOI 10.1016/S0955-0674(01)00289-7; Connolly PF, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00149; Ferguson AM, 2005, MOL CELL BIOL, V25, P2853, DOI 10.1128/MCB.25.7.2853-2860.2005; Frank E, 2013, J STEROID BIOCHEM, V137, P301, DOI 10.1016/j.jsbmb.2013.02.018; Frank E, 2011, STEROIDS, V76, P1141, DOI 10.1016/j.steroids.2011.05.002; Gabrielli BG, 1996, J CELL SCI, V109, P1081; Genin MJ, 2000, J MED CHEM, V43, P953, DOI 10.1021/jm990373e; Gupta A, 2013, J STEROID BIOCHEM, V137, P242, DOI 10.1016/j.jsbmb.2013.05.011; Hein CD, 2008, PHARM RES-DORDR, V25, P2216, DOI 10.1007/s11095-008-9616-1; Hofmeister H, 1992, United States Patent, Patent No. [5,389,624, 5389624]; Kadar Z, 2012, BIOORGAN MED CHEM, V20, P1396, DOI 10.1016/j.bmc.2012.01.008; Kadar Z, 2011, ORG BIOMOL CHEM, V9, P8051, DOI 10.1039/c1ob06086d; Kadar Z, 2011, MOLECULES, V16, P4786, DOI 10.3390/molecules16064786; Kamal A, 2011, BIOORGAN MED CHEM, V19, P2565, DOI 10.1016/j.bmc.2011.03.015; Kambhampati S, 2013, MOL CANCER THER, V12, P255, DOI 10.1158/1535-7163.MCT-12-0777; Krivopalov V.P., 2005, RUSS CHEM REV, V74, P339, DOI DOI 10.1070/RC2005V074N04ABEH000893; Kumar S, 2007, CELL DEATH DIFFER, V14, P32, DOI 10.1038/sj.cdd.4402060; Lee CH, 2007, CANCER SCI, V98, P795, DOI 10.1111/j.1349-7006.2007.00473.x; Lee KR, 2004, J AGR FOOD CHEM, V52, P2832, DOI 10.1021/jf030526d; Lindqvist A, 2005, J CELL BIOL, V171, P35, DOI 10.1083/jcb.200503066; Liu JF, 2013, EUR J MED CHEM, V64, P621, DOI 10.1016/j.ejmech.2013.03.068; Majeed R, 2013, EUR J MED CHEM, V63, P782, DOI 10.1016/j.ejmech.2013.03.028; Meldal M, 2008, CHEM REV, V108, P2952, DOI 10.1021/cr0783479; Mijatovic T, 2007, BBA-REV CANCER, V1776, P32, DOI 10.1016/j.bbcan.2007.06.002; Minorics R, 2011, STEROIDS, V76, P156, DOI 10.1016/j.steroids.2010.10.006; Molnar J, 2013, CURR SIGNAL TRANSD T, V8, P148, DOI 10.2174/15743624113086660006; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Peyrat JF, 2012, CURR MED CHEM, V19, P4142, DOI 10.2174/092986712802430072; Ribble D, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-12; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Salvador JAR, 2013, J STEROID BIOCHEM, V137, P199, DOI 10.1016/j.jsbmb.2013.04.006; SCHONECKER B, 1975, TETRAHEDRON, V31, P1113, DOI 10.1016/0040-4020(75)80134-7; Stenkvist B, 1999, ONCOL REP, V6, P493; Tolomeo M., 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P387, DOI 10.2174/1568011024606361; Tornoe CW, 2002, J ORG CHEM, V67, P3057, DOI 10.1021/jo011148j; Vermes I, 2000, J IMMUNOL METHODS, V243, P167, DOI 10.1016/S0022-1759(00)00233-7; Wolfling J, 2006, STEROIDS, V71, P809, DOI 10.1016/j.steroids.2006.05.011; Wolfting J, 2004, STEROIDS, V69, P451, DOI 10.1016/j.steroids.2004.04.003; Wu P, 2007, ALDRICHIM ACTA, V40, P7; Xu T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105768; Zhang CH, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001501; Zupko I, 2014, MOLECULES, V19, P2061, DOI 10.3390/molecules19022061	51	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118104	10.1371/journal.pone.0118104	http://dx.doi.org/10.1371/journal.pone.0118104			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692552	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000350061500096
J	Saloma, C; Perez, GJ; Gavile, CA; Ick-Joson, JJ; Palmes-Saloma, C				Saloma, Caesar; Perez, Gay Jane; Gavile, Catherine Ann; Ick-Joson, Jacqueline Judith; Palmes-Saloma, Cynthia			Prior Individual Training and Self-Organized Queuing during Group Emergency Escape of Mice from Water Pool	PLOS ONE			English	Article							BEHAVIOR; DYNAMICS; DESIGN	We study the impact of prior individual training during group emergency evacuation using mice that escape from an enclosed water pool to a dry platform via any of two possible exits. Experimenting with mice avoids serious ethical and legal issues that arise when dealing with unwitting human participants while minimizing concerns regarding the reliability of results obtained from simulated experiments using 'actors'. First, mice were trained separately and their individual escape times measured over several trials. Mice learned quickly to swim towards an exit-they achieved their fastest escape times within the first four trials. The trained mice were then placed together in the pool and allowed to escape. No two mice were permitted in the pool beforehand and only one could pass through an exit opening at any given time. At first trial, groups of trained mice escaped seven and five times faster than their corresponding control groups of untrained mice at pool occupancy rate. of 11.9% and 4%, respectively. Faster evacuation happened because trained mice: (a) had better recognition of the available pool space and took shorter escape routes to an exit, (b) were less likely to form arches that blocked an exit opening, and (c) utilized the two exits efficiently without preference. Trained groups achieved continuous egress without an apparent leader-coordinator (self-organized queuing)-a collective behavior not experienced during individual training. Queuing was unobserved in untrained groups where mice were prone to wall seeking, aimless swimming and/or blind copying that produced circuitous escape routes, biased exit use and clogging. The experiments also reveal that faster and less costly group training at rho= 4%, yielded an average individual escape time that is comparable with individualized training. However, group training in a more crowded pool (rho = 11.9%) produced a longer average individual escape time.	[Saloma, Caesar; Perez, Gay Jane] Univ Philippines, Coll Sci, Natl Inst Phys, Quezon City 1101, Philippines; [Gavile, Catherine Ann; Ick-Joson, Jacqueline Judith; Palmes-Saloma, Cynthia] Univ Philippines, Coll Sci, Natl Inst Mol Biol & Biotechnol, Quezon City 1101, Philippines	University of the Philippines System; University of the Philippines Diliman; University of the Philippines System; University of the Philippines Diliman	Saloma, C (corresponding author), Univ Philippines, Coll Sci, Natl Inst Phys, Quezon City 1101, Philippines.	csaloma@nip.upd.edu.ph	Saloma, Caesar/HHZ-5074-2022		University of the Philippines System; University of the Philippines Diliman	University of the Philippines System; University of the Philippines Diliman	This work was supported by the University of the Philippines System (www.up.edu.ph) and University of the Philippines Diliman (www.upd.edu.ph). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arita C, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.051128; Ball Philip, 2003, ComPlexUs, V1, P190, DOI 10.1159/000082449; Bode NWF, 2013, ANIM BEHAV, V86, P347, DOI 10.1016/j.anbehav.2013.05.025; BRYAN J. L., 2002, FIRE PROTECTION ENG, V16, P4; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; Helbing D, 2005, TRANSPORT SCI, V39, P1, DOI 10.1287/trsc.1040.0108; Helbing D, 2000, NATURE, V407, P487, DOI 10.1038/35035023; Helbing D, 2001, REV MOD PHYS, V73, P1067, DOI 10.1103/RevModPhys.73.1067; Helbing D, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.046109; Juanico DE, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.041905; Levitt SD, 2008, SCIENCE, V319, P909, DOI 10.1126/science.1153640; Morris R, 1984, NEUROSCI METH, V11, P47; Nolfi Stefano, 2004, ComPlexUs, V2, P195, DOI 10.1159/000093690; Parrish JK, 1999, SCIENCE, V284, P99, DOI 10.1126/science.284.5411.99; Perez GJ, 2009, PHYSICA A, V388, P2469, DOI 10.1016/j.physa.2009.02.037; Perez GJ, 2002, PHYSICA A, V312, P609, DOI 10.1016/S0378-4371(02)00987-1; Saloma C, 2003, P NATL ACAD SCI USA, V100, P11947, DOI 10.1073/pnas.2031912100; Schadschneider A., 2009, ENCY COMPLEXITY SYST, V3, P3142; Sobel Robert., 1988, PANIC WALL STREET CL; Still G. K., CROWD DISASTERS; Sumpter DJT, 2006, PHILOS T R SOC B, V361, P5, DOI 10.1098/rstb.2005.1733; Waldau N., 2007, PEDESTRIAN EVACUATIO; Wenk G, 1998, CURRENT PROTOCOLS NE; Zhao DL, 2006, J FIRE PROT ENG, V16, P269, DOI 10.1177/1042391506061523	25	21	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118508	10.1371/journal.pone.0118508	http://dx.doi.org/10.1371/journal.pone.0118508			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693170	Green Published, Green Submitted, gold			2022-12-26	WOS:000350061500122
J	Kurnosov, AA; Ustyugova, SV; Nazarov, VI; Minervina, AA; Komkov, AY; Shugay, M; Pogorelyy, MV; Khodosevich, KV; Mamedov, IZ; Lebedev, YB				Kurnosov, Alexey A.; Ustyugova, Svetlana V.; Nazarov, Vadim I.; Minervina, Anastasia A.; Komkov, Alexander Yu.; Shugay, Mikhail; Pogorelyy, Mikhail V.; Khodosevich, Konstantin V.; Mamedov, Ilgar Z.; Lebedev, Yuri B.			The Evidence for Increased L1 Activity in the Site of Human Adult Brain Neurogenesis	PLOS ONE			English	Article							SOMATIC RETROTRANSPOSITION; HIPPOCAMPAL NEUROGENESIS; INTERSPERSED REPEATS; ALU ELEMENTS; GENOME; LINE-1; CELLS; IDENTIFICATION; NEUROBLASTS; LANDSCAPE	Retroelement activity is a common source of polymorphisms in human genome. The mechanism whereby retroelements contribute to the intraindividual genetic heterogeneity by inserting into the DNA of somatic cells is gaining increasing attention. Brain tissues are suspected to accumulate genetic heterogeneity as a result of the retroelements somatic activity. This study aims to expand our understanding of the role retroelements play in generating somatic mosaicism of neural tissues. Whole-genome Alu and L1 profiling of genomic DNA extracted from the cerebellum, frontal cortex, subventricular zone, dentate gyrus, and the myocardium revealed hundreds of somatic insertions in each of the analyzed tissues. Interestingly, the highest concentration of such insertions was detected in the dentate gyrus-the hotspot of adult neurogenesis. Insertions of retroelements and their activity could produce genetically diverse neuronal subsets, which can be involved in hippocampal-dependent learning and memory.	[Kurnosov, Alexey A.; Ustyugova, Svetlana V.; Nazarov, Vadim I.; Minervina, Anastasia A.; Komkov, Alexander Yu.; Shugay, Mikhail; Pogorelyy, Mikhail V.; Mamedov, Ilgar Z.; Lebedev, Yuri B.] Russ Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Lab Comparat & Funct Genom, Moscow, Russia; [Ustyugova, Svetlana V.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Nazarov, Vadim I.] Natl Res Univ, Higher Sch Econ, Dept Informat Technol & Automated Syst, Moscow, Russia; [Khodosevich, Konstantin V.] Univ Heidelberg Hosp, German Canc Res Ctr DKFZ, Dept Clin Neurobiol, Heidelberg, Germany	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; California Institute of Technology; HSE University (National Research University Higher School of Economics); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Mamedov, IZ (corresponding author), Russ Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Lab Comparat & Funct Genom, Moscow, Russia.	khodosevich@urz.uni-hd.de; Imamedov@mx.ibch.ru	Pogorelyy, Mikhail V/H-9610-2014; Lebedev, Yury B/G-6738-2012; Minervina, Anastasia A/P-7067-2016; Mamedov, Ilgar Z/H-9559-2014; Komkov, Alexander Y/L-4643-2016; Shugay, Mikhail/O-1073-2016; Komkov, Alexander/AAX-4816-2021; Nazarov, Vadim/K-8762-2015	Pogorelyy, Mikhail V/0000-0003-0773-1204; Lebedev, Yury B/0000-0003-4554-4733; Minervina, Anastasia A/0000-0001-9884-6351; Mamedov, Ilgar Z/0000-0002-3992-9285; Shugay, Mikhail/0000-0001-7826-7942; Komkov, Alexander/0000-0001-9113-698X; Nazarov, Vadim/0000-0003-3659-2709; Khodosevich, Konstantin/0000-0001-7232-5558	Russian Foundation for Basic Research [RFBR-12-04-33065, RFBR-11-04-01159];  [14.604.21.0118]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); 	Funding provided by RFBR-12-04-33065 Russian Foundation for Basic Research http://www.rfbr.ru/rffi/eng to IZM, RFBR-11-04-01159 Russian Foundation for Basic Research http://www.rfbr.ru/rffi/eng to YBL and state contract 14.604.21.0118 https://sstp.ru to YBL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amosova A L, 2009, Bioorg Khim, V35, P779; Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Arokium H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108682; Baillie JK, 2011, NATURE, V479, P534, DOI 10.1038/nature10531; Bannert N, 2004, P NATL ACAD SCI USA, V101, P14572, DOI 10.1073/pnas.0404838101; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Belancio VP, 2006, NUCLEIC ACIDS RES, V34, P1512, DOI 10.1093/nar/gkl027; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Bundo M, 2014, NEURON, V81, P306, DOI 10.1016/j.neuron.2013.10.053; Callinan P, 2006, GENOME DYN, V1, P104, DOI 10.1159/000092503; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Curtis MA, 2007, SCIENCE, V315, P1243, DOI 10.1126/science.1136281; Deininger PL, 1999, MOL GENET METAB, V67, P183, DOI 10.1006/mgme.1999.2864; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Erwin JA, 2014, NAT REV NEUROSCI, V15, P497, DOI 10.1038/nrn3730; Evrony GD, 2012, CELL, V151, P483, DOI 10.1016/j.cell.2012.09.035; Ewing AD, 2010, GENOME RES, V20, P1262, DOI 10.1101/gr.106419.110; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; Garcia-Perez JL, 2007, HUM MOL GENET, V16, P1569, DOI 10.1093/hmg/ddm105; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Iskow RC, 2010, CELL, V141, P1253, DOI 10.1016/j.cell.2010.05.020; Kano H, 2009, GENE DEV, V23, P1303, DOI 10.1101/gad.1803909; Khatua AK, 2010, VIROLOGY, V400, P68, DOI 10.1016/j.virol.2010.01.021; Kuwabara T, 2009, NAT NEUROSCI, V12, P1097, DOI 10.1038/nn.2360; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lebedev YB, 2007, GENE, V390, P122, DOI 10.1016/j.gene.2006.09.031; Lee E, 2012, SCIENCE, V337, P967, DOI 10.1126/science.1222077; Mamedov I, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf071; Mamedov IZ, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni018; Muotri AR, 2010, NATURE, V468, P443, DOI 10.1038/nature09544; Muotri AR, 2009, HIPPOCAMPUS, V19, P1002, DOI 10.1002/hipo.20564; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Nakashiba T, 2012, CELL, V149, P188, DOI 10.1016/j.cell.2012.01.046; Polak P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-133; R Core Team, 2014, R LANG ENV STAT COMP, DOI [10.1016/j.jcis.2014.12.029, DOI 10.1016/J.JCIS.2014.12.029]; Reilly MT, 2013, J NEUROSCI, V33, P17577, DOI 10.1523/JNEUROSCI.3369-13.2013; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Sanai N, 2011, NATURE, V478, P382, DOI 10.1038/nature10487; Scrucca L, 2004, R NEWS, V4, P22; Shukla R, 2013, CELL, V153, P101, DOI 10.1016/j.cell.2013.02.032; Smalheiser NR, 2006, TRENDS GENET, V22, P532, DOI 10.1016/j.tig.2006.08.007; Solyom S, 2012, GENOME RES, V22, P2328, DOI 10.1101/gr.145235.112; Spalding KL, 2013, CELL, V153, P1219, DOI 10.1016/j.cell.2013.05.002; Wang CM, 2011, CELL RES, V21, P1534, DOI 10.1038/cr.2011.83; Wei W, 2001, MOL CELL BIOL, V21, P1429, DOI 10.1128/MCB.21.4.1429-1439.2001; Yang N, 2006, NAT STRUCT MOL BIOL, V13, P763, DOI 10.1038/nsmb1141; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	52	32	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117854	10.1371/journal.pone.0117854	http://dx.doi.org/10.1371/journal.pone.0117854			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689626	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000350322700078
J	Oshida, K; Vasani, N; Thomas, RS; Applegate, D; Rosen, M; Abbott, B; Lau, C; Guo, G; Aleksunes, LM; Klaassen, C; Corton, JC				Oshida, Keiyu; Vasani, Naresh; Thomas, Russell S.; Applegate, Dawn; Rosen, Mitch; Abbott, Barbara; Lau, Christopher; Guo, Grace; Aleksunes, Lauren M.; Klaassen, Curtis; Corton, J. Christopher			Identification of Modulators of the Nuclear Receptor Peroxisome Proliferator-Activated Receptor alpha (PPAR alpha) in a Mouse Liver Gene Expression Compendium	PLOS ONE			English	Article							FATTY-ACID OXIDATION; NONGENOTOXIC CARCINOGEN; MICE; EXPOSURE; STEATOHEPATITIS; ACCUMULATION; SIGNATURES; PATHWAYS; KNOCKOUT; PROTECTS	The nuclear receptor family member peroxisome proliferator-activated receptor alpha (PPAR alpha) is activated by therapeutic hypolipidemic drugs and environmentally-relevant chemicals to regulate genes involved in lipid transport and catabolism. Chronic activation of PPAR alpha in rodents increases liver cancer incidence, whereas suppression of PPAR alpha activity leads to hepatocellular steatosis. Analytical approaches were developed to identify biosets (i.e., gene expression differences between two conditions) in a genomic database in which PPAR alpha activity was altered. A gene expression signature of 131 PPAR alpha-dependent genes was built using microarray profiles from the livers of wild-type and PPAR alpha-null mice after exposure to three structurally diverse PPAR alpha activators (WY-14,643, fenofibrate and perfluorohexane sulfonate). A fold-change rank-based test (Running Fisher's test (p-value <= 10(-4))) was used to evaluate the similarity between the PPAR alpha signature and a test set of 48 and 31 biosets positive or negative, respectively for PPAR alpha activation; the test resulted in a balanced accuracy of 98%. The signature was then used to identify factors that activate or suppress PPAR alpha in an annotated mouse liver/primary hepatocyte gene expression compendium of similar to 1850 biosets. In addition to the expected activation of PPAR alpha by fibrate drugs, di(2-ethylhexyl) phthalate, and perfluorinated compounds, PPAR alpha was activated by benzofuran, galactosamine, and TCDD and suppressed by hepatotoxins acetaminophen, lipopolysaccharide, silicon dioxide nanoparticles, and trovafloxacin. Additional factors that activate (fasting, caloric restriction) or suppress (infections) PPAR alpha were also identified. This study 1) developed methods useful for future screening of environmental chemicals, 2) identified chemicals that activate or suppress PPAR alpha, and 3) identified factors including diets and infections that modulate PPAR alpha activity and would be hypothesized to affect chemical-induced PPAR alpha activity.	[Oshida, Keiyu; Vasani, Naresh; Rosen, Mitch; Abbott, Barbara; Lau, Christopher; Corton, J. Christopher] US EPA, Natl Hlth & Environm Effects Res Lab, Res Triangle Pk, NC 27711 USA; [Thomas, Russell S.] Hamner Inst Hlth Sci, Res Triangle Pk, NC USA; [Applegate, Dawn] RegeneMed, San Diego, CA USA; [Guo, Grace; Aleksunes, Lauren M.] Rutgers State Univ, Dept Pharmacol & Toxicol, Ernest Mario Sch Pharm, Piscataway, NJ 08854 USA; [Klaassen, Curtis] Univ Washington, Seattle, WA 98195 USA	United States Environmental Protection Agency; The Hamner Institutes for Health Sciences; Rutgers State University New Brunswick; University of Washington; University of Washington Seattle	Corton, JC (corresponding author), US EPA, Natl Hlth & Environm Effects Res Lab, Res Triangle Pk, NC 27711 USA.	corton.chris@epa.gov	Vasani, Naresh B/K-9082-2019	Thomas, Russell/0000-0002-2340-0301; Aleksunes, Lauren/0000-0002-0032-1037; Vasani, Naresh/0000-0003-4814-3310; Abbott, Barbara/0000-0001-8996-5842				Aleksunes LM, 2012, DRUG METAB DISPOS, V40, P1366, DOI 10.1124/dmd.112.045112; Anderson SP, 2004, J BIOL CHEM, V279, P52390, DOI 10.1074/jbc.M409347200; Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34; BICHET N, 1990, TOXICOL APPL PHARM, V106, P509, DOI 10.1016/0041-008X(90)90345-U; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Chen C, 2009, CHEM RES TOXICOL, V22, P699, DOI 10.1021/tx800464q; Chen F, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-240; Corton JC, 2014, CRIT REV TOXICOL, V44, P1, DOI 10.3109/10408444.2013.835784; Corton JC, 2000, ANNU REV PHARMACOL, V40, P491, DOI 10.1146/annurev.pharmtox.40.1.491; Costet P, 1998, J BIOL CHEM, V273, P29577, DOI 10.1074/jbc.273.45.29577; Cowart LA, 2002, J BIOL CHEM, V277, P35105, DOI 10.1074/jbc.M201575200; Currie RA, 2005, TOXICOL SCI, V86, P453, DOI 10.1093/toxsci/kfi207; Delerive P, 1999, J BIOL CHEM, V274, P32048, DOI 10.1074/jbc.274.45.32048; DeLuca JG, 2000, MOL PHARMACOL, V58, P470, DOI 10.1124/mol.58.3.470; Diani-Moore S, 2014, DRUG METAB DISPOS, V42, P294, DOI 10.1124/dmd.113.055368; Fisher P, 2007, NUCLEIC ACIDS RES, V35, P5625, DOI 10.1093/nar/gkm623; Frohnert BI, 1999, J BIOL CHEM, V274, P3970, DOI 10.1074/jbc.274.7.3970; Galindo CL, 2009, COMP FUNCT GENOM, DOI 10.1155/2009/914762; Hashimoto T, 2000, J BIOL CHEM, V275, P28918, DOI 10.1074/jbc.M910350199; Hays T, 2005, CARCINOGENESIS, V26, P219, DOI 10.1093/carcin/bgh285; He JH, 2013, MOL CELL BIOL, V33, P2047, DOI 10.1128/MCB.01658-12; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Howroyd P, 2004, TOXICOL PATHOL, V32, P591, DOI 10.1080/01926230490515283; Hunt MC, 2012, BBA-MOL BASIS DIS, V1822, P1397, DOI 10.1016/j.bbadis.2012.03.009; Inoue I, 2002, BIOCHEM BIOPH RES CO, V290, P131, DOI 10.1006/bbrc.2001.6141; Ip E, 2003, HEPATOLOGY, V38, P123, DOI 10.1053/jhep.2003.50307; Kawano Y, 2013, J GASTROENTEROL, V48, P434, DOI 10.1007/s00535-013-0758-5; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Kupershmidt I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013066; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473; Liu HH, 2010, GENOME RES, V20, P28, DOI 10.1101/gr.097212.109; Lu XY, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/5/055101; Marmugi A, 2012, HEPATOLOGY, V55, P395, DOI 10.1002/hep.24685; Masaki T, 2004, HEPATOLOGY, V40, P177, DOI 10.1002/hep.20282; Matsubara T, 2012, CELL METAB, V16, P634, DOI 10.1016/j.cmet.2012.10.006; Mohapatra SK, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-10; Nakajima T, 2004, HEPATOLOGY, V40, P972, DOI 10.1002/hep.20399; Ohhira M, 2007, J GASTROENTEROL, V42, P969, DOI 10.1007/s00535-007-2119-8; Oyadomari S, 2008, CELL METAB, V7, P520, DOI 10.1016/j.cmet.2008.04.011; Pery ARR, 2013, SCI TOTAL ENVIRON, V456, P307, DOI 10.1016/j.scitotenv.2013.03.099; Peters JM, 1998, CARCINOGENESIS, V19, P1989, DOI 10.1093/carcin/19.11.1989; Peters JM, 1997, CARCINOGENESIS, V18, P2029, DOI 10.1093/carcin/18.11.2029; Pyper Sean R, 2010, Nucl Recept Signal, V8, pe002, DOI 10.1621/nrs.08002; Rakhshandehroo M, 2007, PPAR RES, V2007, DOI 10.1155/2007/26839; Ren HZ, 2009, REPROD TOXICOL, V27, P266, DOI 10.1016/j.reprotox.2008.12.011; Rosen MB, 2010, PPAR RES, V2010, DOI 10.1155/2010/794739; Rosen MB, 2009, REPROD TOXICOL, V27, P278, DOI 10.1016/j.reprotox.2009.01.007; Ross PK, 2009, TOXICOL APPL PHARM, V235, P199, DOI 10.1016/j.taap.2008.12.011; SAKAI M, 1995, CANCER RES, V55, P5370; Sanderson LM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001681; Schaap MM, 2012, ARCH TOXICOL, V86, P1717, DOI 10.1007/s00204-012-0883-6; Shaw PJ, 2009, TOXICOL SCI, V107, P270, DOI 10.1093/toxsci/kfn205; Shi LM, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S2-S12; Simon R, 2007, CANCER INFORM, V3, P11; Staudinger J, 2001, DRUG METAB DISPOS, V29, P1467; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tai ES, 2003, FEBS LETT, V546, P237, DOI 10.1016/S0014-5793(03)00578-7; Tailleux A, 2012, BBA-MOL CELL BIOL L, V1821, P809, DOI 10.1016/j.bbalip.2011.10.016; Thomas AM, 2010, HEPATOLOGY, V51, P1410, DOI 10.1002/hep.23450; Thomas RS, 2001, MOL PHARMACOL, V60, P1189, DOI 10.1124/mol.60.6.1189; Thomas RS, 2007, TOXICOL SCI, V96, P40, DOI 10.1093/toxsci/kfl171; Wilson CL, 2005, BIOINFORMATICS, V21, P3683, DOI 10.1093/bioinformatics/bti605; Wu Q, 2008, J APPL TOXICOL, V28, P724, DOI 10.1002/jat.1331; Yates MS, 2009, CARCINOGENESIS, V30, P1024, DOI 10.1093/carcin/bgp100	65	51	53	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0112655	10.1371/journal.pone.0112655	http://dx.doi.org/10.1371/journal.pone.0112655			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689681	gold, Green Submitted, Green Published			2022-12-26	WOS:000350322700002
J	Shi, JJ; Jiang, Q; Ding, XW; Xu, WH; Wang, DW; Chen, ML				Shi, Jiaojiao; Jiang, Qi; Ding, Xiangwei; Xu, Wenhua; Wang, Dao W.; Chen, Minglong			The ER Stress-Mediated Mitochondrial Apoptotic Pathway and MAPKs Modulate Tachypacing-Induced Apoptosis in HL-1 Atrial Myocytes	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; CELL-DEATH; DOWN-REGULATION; FIBRILLATION; KINASE; INHIBITION; HEART; PHOSPHORYLATION; DYSFUNCTION	Background and Object Cell apoptosis is a contributing factor in the initiation, progression and relapse of atrial fibrillation (AF), a life-threatening illness accompanied with stroke and heart failure. However, the regulatory cascade of apoptosis is intricate and remains unidentified, especially in the setting of AF. The aim of this study was to explore the roles of endoplasmic reticulum (ER) stress, mitochondrial apoptotic pathway (MAP), mitogen-activated protein kinases (MAPKs), and their cross-talking in tachypacing-induced apoptosis. Methods and Results HL-1 cells were cultured in the presence of tachypacing for 24 h to simulate atrial tachycardia remodeling. Results showed that tachypacing reduced cell viability measured by the cell counting kit-8, dissipated mitochondrial membrane potential detected by JC-1 staining and resulted in approximately 50% apoptosis examined by Hoechst staining and annexin V/propidium iodide staining. In addition, the proteins involved in ER stress, MAP and MAPKs were universally up-regulated or activated via phosphorylation, as confirmed by western blotting; and reversely silencing of ER stress, caspase-3 (the ultimate executor of MAP) and MAPKs with specific inhibitors prior to pacing partially alleviated apoptosis. An inhibitor of ER stress was applied to further investigate the responses of mitochondria and MAPKs to ER stress, and results indicated that suppression of ER stress comprehensively but incompletely attenuated the activation of MAP and MAPKs aroused by tachypacing, with the exception of ERK1/2, one branch of MAPKs. Conclusions Our study suggested tachypacing-induced apoptosis is regulated by ER stress-mediated MAP and MAPKs. Thus, the above three components are all promising anti-apoptotic targets in AF patients and ER stress appears to play a dominant role due to its comprehensive effects.	[Shi, Jiaojiao; Jiang, Qi; Ding, Xiangwei; Xu, Wenhua; Wang, Dao W.; Chen, Minglong] Nanjing Med Univ, Div Cardiol, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Chen, ML (corresponding author), Nanjing Med Univ, Div Cardiol, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China.	chenminglong@njmu.edu.cn		Jiang, Qi/0000-0001-7835-1335	National Natural and Science Foundation of China [81070156, 81470455, 81170159]	National Natural and Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural and Science Foundation of China (grant numbers 81070156, 81470455, 81170159 to MC and DW; http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aime-Sempe C, 1999, J AM COLL CARDIOL, V34, P1577, DOI 10.1016/S0735-1097(99)00382-4; Brundel BJJM, 2006, CIRC RES, V99, P1394, DOI 10.1161/01.RES.0000252323.83137.fe; Brundel BJJM, 2004, CARDIOVASC RES, V62, P521, DOI 10.1016/j.cardiores.2004.02.007; Bulavin DV, 1999, EMBO J, V18, P6845, DOI 10.1093/emboj/18.23.6845; Cano M, 2014, FREE RADICAL BIO MED, V69, P1, DOI 10.1016/j.freeradbiomed.2014.01.004; Chen YF, 2014, CELL PHYSIOL BIOCHEM, V33, P1975, DOI 10.1159/000362974; Darling NJ, 2014, BBA-MOL CELL RES, V1843, P2150, DOI 10.1016/j.bbamcr.2014.01.009; De Jong AM, 2011, CARDIOVASC RES, V89, P754, DOI 10.1093/cvr/cvq357; Ding WX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094545; Dispersyn GD, 1999, CARDIOVASC RES, V43, P947, DOI 10.1016/S0008-6363(99)00096-6; George I, 2011, CARDIOVASC RES, V91, P447, DOI 10.1093/cvr/cvr106; Jiang Q, 2014, BIOCHEM BIOPH RES CO, V449, P278, DOI 10.1016/j.bbrc.2014.05.041; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kang EB, 2013, APOPTOSIS, V18, P1332, DOI 10.1007/s10495-013-0884-9; KLINE RP, 1993, J CARDIOVASC ELECTR, V4, P642, DOI 10.1111/j.1540-8167.1993.tb01251.x; Kubli DA, 2012, CIRC RES, V111, P1208, DOI 10.1161/CIRCRESAHA.112.265819; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Liang SH, 2006, BIOCHEM J, V393, P201, DOI 10.1042/BJ20050374; Liu H, 2011, CARDIOVASC RES, V89, P119, DOI 10.1093/cvr/cvq265; Muller P, 2013, J CARDIOVASC ELECTR, V24, P1110, DOI 10.1111/jce.12191; Negrin G, 2010, MOL CARCINOGEN, V49, P488, DOI 10.1002/mc.20629; Oh CD, 2003, J BIOL CHEM, V278, P36563, DOI 10.1074/jbc.M304857200; Osmancik P, 2010, CARDIOLOGY, V116, P302, DOI 10.1159/000319619; Sepulveda M, 2013, J MOL CELL CARDIOL, V63, P135, DOI 10.1016/j.yjmcc.2013.07.013; STEINHELPER ME, 1990, AM J PHYSIOL, V259, pH1826, DOI 10.1152/ajpheart.1990.259.6.H1826; Thuerauf DJ, 1998, J BIOL CHEM, V273, P20636, DOI 10.1074/jbc.273.32.20636; Tong JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016781; Verma G, 2010, APOPTOSIS, V15, P864, DOI 10.1007/s10495-010-0498-4; Villegas R, 2014, J NEUROSCI, V34, P7179, DOI 10.1523/JNEUROSCI.4784-13.2014; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yang Zhenjiang, 2005, J Mol Cell Cardiol, V38, P299, DOI 10.1016/j.yjmcc.2004.11.015; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982; Zou X, 2014, EXP PHYSIOL, DOI [10.1113/expphysiol.2014.082149, DOI 10.1113/EXPPHYSIOL.2014.082149]	33	19	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117567	10.1371/journal.pone.0117567	http://dx.doi.org/10.1371/journal.pone.0117567			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689866	Green Submitted, Green Published, gold			2022-12-26	WOS:000350322700056
J	Wheeler, HE; Wing, C; Delaney, SM; Komatsu, M; Dolan, ME				Wheeler, Heather E.; Wing, Claudia; Delaney, Shannon M.; Komatsu, Masaaki; Dolan, M. Eileen			Modeling Chemotherapeutic Neurotoxicity with Human Induced Pluripotent Stem Cell-Derived Neuronal Cells	PLOS ONE			English	Article							INDUCED PERIPHERAL NEUROPATHY; ROOT GANGLION NEURONS; GENOME-WIDE ASSOCIATION; CLINICAL-TRIAL; IMAGE-ANALYSIS; ANIMAL-MODELS; CALGB 40101; PACLITAXEL; PREVENTION; CISPLATIN	There are no effective agents to prevent or treat chemotherapy-induced peripheral neuropathy (CIPN), the most common non-hematologic toxicity of chemotherapy. Therefore, we sought to evaluate the utility of human neuron-like cells derived from induced pluripotent stem cells (iPSCs) as a means to study CIPN. We used high content imaging measurements of neurite outgrowth phenotypes to compare the changes that occur to iPSC-derived neuronal cells among drugs and among individuals in response to several classes of chemotherapeutics. Upon treatment of these neuronal cells with the neurotoxic drug paclitaxel, vincristine or cisplatin, we identified significant differences in five morphological phenotypes among drugs, including total outgrowth, mean/median/maximum process length, and mean outgrowth intensity (P < 0.05). The differences in damage among drugs reflect differences in their mechanisms of action and clinical CIPN manifestations. We show the potential of the model for gene perturbation studies by demonstrating decreased expression of TUBB2A results in significantly increased sensitivity of neurons to paclitaxel (0.23 +/- 0.06 decrease in total neurite outgrowth, P = 0.011). The variance in several neurite outgrowth and apoptotic phenotypes upon treatment with one of the neurotoxic drugs is significantly greater between than within neurons derived from four different individuals (P < 0.05), demonstrating the potential of iPSC-derived neurons as a genetically diverse model for CIPN. The human neuron model will allow both for mechanistic studies of specific genes and genetic variants discovered in clinical studies and for screening of new drugs to prevent or treat CIPN.	[Wheeler, Heather E.; Wing, Claudia; Delaney, Shannon M.; Komatsu, Masaaki; Dolan, M. Eileen] Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA	University of Chicago	Dolan, ME (corresponding author), Univ Chicago, Dept Med, Hematol Oncol Sect, 5841 S Maryland Ave, Chicago, IL 60637 USA.	edolan@medicine.bsd.uchicago.edu	Wheeler, Heather/I-9279-2019; Komatsu, Masaaki/ABC-7821-2020	Wheeler, Heather/0000-0003-1365-9667; Komatsu, Masaaki/0000-0003-0421-8085; Wing, Claudia/0000-0002-8243-5598	National Institutes of Health, National Cancer Institute, National Research Service [F32CA165823]; National Institutes of Health, National Institute of General Medical Sciences Pharmacogenomics of Anticancer Agents Research [U01GM61393]; University of Chicago Breast Cancer SPORE Grant National Cancer Institute [P50 CA125183]; National Institutes of Health, National Cancer Institute [R01 CA136765, R01 CA157823]; NATIONAL CANCER INSTITUTE [R01CA136765, P50CA125183, F32CA165823, R01CA157823] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061393] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute, National Research Service; National Institutes of Health, National Institute of General Medical Sciences Pharmacogenomics of Anticancer Agents Research; University of Chicago Breast Cancer SPORE Grant National Cancer Institute; National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by the National Institutes of Health, National Cancer Institute, National Research Service Award F32CA165823 (HEW); National Institutes of Health, National Institute of General Medical Sciences Pharmacogenomics of Anticancer Agents Research Grant U01GM61393 (MED); University of Chicago Breast Cancer SPORE Grant National Cancer Institute P50 CA125183 (MED); National Institutes of Health, National Cancer Institute R01 CA136765 (MED) and National Institutes of Health, National Cancer Institute R01 CA157823 (MED). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argyriou AA, 2012, CRIT REV ONCOL HEMAT, V82, P51, DOI 10.1016/j.critrevonc.2011.04.012; Authier N, 2009, NEUROTHERAPEUTICS, V6, P620, DOI 10.1016/j.nurt.2009.07.003; Baldwin RM, 2012, CLIN CANCER RES, V18, P5099, DOI 10.1158/1078-0432.CCR-12-1590; Carozzi VA, 2010, EXP NEUROL, V226, P301, DOI 10.1016/j.expneurol.2010.09.004; Cavaletti G, 2010, NAT REV NEUROL, V6, P657, DOI 10.1038/nrneurol.2010.160; Cavaletti G, 2010, EUR J CANCER, V46, P479, DOI 10.1016/j.ejca.2009.12.008; Chamberlain SJ, 2010, P NATL ACAD SCI USA, V107, P17668, DOI 10.1073/pnas.1004487107; Chhibber A, 2014, PHARMACOGENOMICS J, V14, P336, DOI 10.1038/tpj.2014.2; Diouf B, 2014, GENOME WIDE IN PRESS; Elena JW, 2013, JNCI-J NATL CANCER I, V105, P85, DOI 10.1093/jnci/djs473; Flatters SJL, 2006, PAIN, V122, P245, DOI 10.1016/j.pain.2006.01.037; Gamazon ER, 2013, BLOOD, V121, P4366, DOI 10.1182/blood-2012-10-464149; Gill JS, 1998, J CLIN INVEST, V101, P2842, DOI 10.1172/JCI1130; GRUNBERG SM, 1989, CANCER CHEMOTH PHARM, V25, P62, DOI 10.1007/BF00694340; Ha NN, 2011, CELL STEM CELL, V8, P267, DOI 10.1016/j.stem.2011.01.013; Hershman DL, 2014, J CLIN ONCOL, V32, P1941, DOI 10.1200/JCO.2013.54.0914; Hoke A, 2012, NEUROTHERAPEUTICS, V9, P262, DOI 10.1007/s13311-012-0116-y; Ingle JN, 2010, J CLIN ONCOL, V28, P4674, DOI 10.1200/JCO.2010.28.5064; Jiang YL, 2008, CANCER RES, V68, P6425, DOI 10.1158/0008-5472.CAN-08-1173; LaPointe NE, 2013, NEUROTOXICOLOGY, V37, P231, DOI 10.1016/j.neuro.2013.05.008; Leandro-Garcia LJ, 2013, J MED GENET, V50, P599, DOI 10.1136/jmedgenet-2012-101466; Leandro-Garcia LJ, 2012, CLIN CANCER RES, V18, P4441, DOI 10.1158/1078-0432.CCR-12-1221; Loprinzi CL, 2011, J CLIN ONCOL, V29, P1472, DOI 10.1200/JCO.2010.33.0308; MALGRANGE B, 1994, J NEUROSCI METH, V53, P111, DOI 10.1016/0165-0270(94)90151-1; Matimba A, 2014, PHARMACOGENOMICS, V15, P433, DOI 10.2217/pgs.13.226; Njiaju UO, 2012, PHARMACOGENET GENOM, V22, P498, DOI 10.1097/FPC.0b013e328352f436; Pachman DR, 2014, J CLIN INVEST, V124, P72, DOI 10.1172/JCI73908; Pasca SP, 2011, NAT MED, V17, P1657, DOI 10.1038/nm.2576; Persohn E, 2005, EUR J CANCER, V41, P1460, DOI 10.1016/j.ejca.2005.04.006; Piccolo J, 2014, AM J HEALTH-SYST PH, V71, P19, DOI 10.2146/ajhp130126; Pinto N, 2014, CLIN PHARMACOL THER, V95, P644, DOI 10.1038/clpt.2014.37; Pittman SK, 2014, EXP NEUROL, V253, P146, DOI 10.1016/j.expneurol.2013.12.011; Quasthoff S, 2002, J NEUROL, V249, P9, DOI 10.1007/PL00007853; Rajesh D, 2011, BLOOD, V118, P1797, DOI 10.1182/blood-2011-01-332064; Rouhani F, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004432; Schloss JM, 2013, CLIN NUTR, V32, P888, DOI 10.1016/j.clnu.2013.04.007; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SETHI VS, 1981, CANCER RES, V41, P3551; Smith EML, 2013, JAMA-J AM MED ASSOC, V309, P1359, DOI 10.1001/jama.2013.2813; Topp KS, 2000, J COMP NEUROL, V424, P563; Urien S, 2004, BRIT J CLIN PHARMACO, V57, P756, DOI 10.1111/j.1365-2125.2004.02082.x; Wheeler HE, 2013, CLIN CANCER RES, V19, P491, DOI 10.1158/1078-0432.CCR-12-2618; Wheeler HE, 2013, NAT REV GENET, V14, P23, DOI 10.1038/nrg3352; Wheeler HE, 2012, PHARMACOGENOMICS, V13, P55, DOI [10.2217/PGS.11.121, 10.2217/pgs.11.121]; Wolf S, 2008, EUR J CANCER, V44, P1507, DOI 10.1016/j.ejca.2008.04.018; Zasadil LM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007965; Zhang J, 2014, BRAIN BEHAV IMMUN	47	65	67	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0118020	10.1371/journal.pone.0118020	http://dx.doi.org/10.1371/journal.pone.0118020			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689802	Green Published, gold, Green Submitted			2022-12-26	WOS:000350322700093
J	Xia, L; Ma, SH; Zhang, Y; Wang, T; Zhou, MY; Wang, ZQ; Zhang, JF				Xia, Lin; Ma, Shihong; Zhang, Ying; Wang, Tao; Zhou, Mengyi; Wang, Zhongqiu; Zhang, Jianfa			Daily Variation in Global and Local DNA Methylation in Mouse Livers	PLOS ONE			English	Article							ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY; S-ADENOSYLHOMOCYSTEINE; MAMMALIAN DNA; 5-METHYLCYTOSINE; EXPRESSION; ADENOSYLMETHIONINE; HYPOMETHYLATION; HOMOCYSTEINE; DNMT3A; METHYLTRANSFERASES	DNA methylation is one of the best-characterized epigenetic modifications and has an important biological relevance. Here we showed that global DNA methylation level in mouse livers displayed a daily variation where the peak phases occurred during the end of the day and the lowest level at the beginning of the day in the light-dark or dark-dark cycles. Typical repeat sequence long interspersed nucleotide element-1 (LINE-1) had a similar methylation rhythm to global DNA. DNA methyltransferase 3A (DNMT3A) and ratio of S-adenosylmethionine (SAM) to S-adenosylhomocysteine (SAH) brought a relative forward daily variation to global DNA methylation, and the temporary change in ratio of SAM to SAH had no influence on the DNA methylation level. The rhythm of global DNA methylation was lost and DNA methylation level was increased in Per1(-/-)Per2(-/-) double knockout mice, which were in accordance with changes of Dnmt3a mRNA levels and its rhythm. Our results suggest that the daily variation in global DNA methylation was associated with the change of Dnmt3a expression rather than ratio of SAM to SAH.	[Xia, Lin; Wang, Tao; Zhou, Mengyi; Zhang, Jianfa] Nanjing Univ Sci & Technol, Ctr Mol Metab, Nanjing 210094, Jiangsu, Peoples R China; [Ma, Shihong] Nanjing Inst Comprehens Utilizat Wild Plant, Nanjing 210042, Jiangsu, Peoples R China; [Zhang, Ying] Jiangsu Univ, Sch Med, Dept Biochem & Mol Biol, Zhenjiang 212013, Peoples R China; [Wang, Zhongqiu] Nanjing Univ Chinese Med, Dept Radiol, Nanjing 210000, Jiangsu, Peoples R China	Nanjing University of Science & Technology; Jiangsu University; Nanjing University of Chinese Medicine	Wang, ZQ (corresponding author), Nanjing Univ Chinese Med, Dept Radiol, Nanjing 210000, Jiangsu, Peoples R China.	zhq2001us@163.com; jfzhang@mail.njust.edu.cn			National Basic Research Program of China [2012CB517505, 2013CB945203]; National Science Foundation of China [31171125]	National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (2012CB517505 and 2013CB945203), and the National Science Foundation of China (31171125). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando H, 2003, J BIOL; Azzi A, 2014, NAT NEUROSCI, V17, P377, DOI 10.1038/nn.3651; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Baric I, 2004, P NATL ACAD SCI USA, V101, P4234, DOI 10.1073/pnas.0400658101; Benbrahim-Tallaa L, 2007, ENVIRON HEALTH PERSP, V115, P1454, DOI 10.1289/ehp.10207; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bonsch D, 2007, CHRONOBIOL INT, V24, P315, DOI 10.1080/07420520701290565; Bogdanovic O, 2009, CHROMOSOMA, V118, P549, DOI 10.1007/s00412-009-0221-9; Buist NRM, 2006, J INHERIT METAB DIS, V29, P538, DOI 10.1007/s10545-006-0240-0; Bujnicki JM, 2003, PROTEINS, V52, P624, DOI 10.1002/prot.10446; Castro R, 2003, CLIN CHEM, V49, P1292, DOI 10.1373/49.8.1292; CATANIA J, 1987, ANAL BIOCHEM, V167, P347, DOI 10.1016/0003-2697(87)90175-8; Cermakian N, 2000, NAT REV MOL CELL BIO, V1, P59, DOI 10.1038/35036078; Cheng XD, 2008, STRUCTURE, V16, P341, DOI 10.1016/j.str.2008.01.004; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Clark SJ, 2006, NAT PROTOC, V1, P2353, DOI 10.1038/nprot.2006.324; DESANCHEZ VC, 1991, INT J BIOCHEM, V23, P1439, DOI 10.1016/0020-711X(91)90287-W; Dou S, 2012, J CONTROL RELEASE, V161, P875, DOI 10.1016/j.jconrel.2012.05.015; Florl AR, 1999, BRIT J CANCER, V80, P1312, DOI 10.1038/sj.bjc.6690524; Fryer Anthony A, 2009, Epigenetics, V4, P394; Gallou-Kabani C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014398; Garzon R, 2009, BLOOD, V113, P6411, DOI 10.1182/blood-2008-07-170589; Hermes M, 2004, EXP CELL RES, V294, P325, DOI 10.1016/j.yexcr.2003.12.001; Javierre BM, 2010, GENOME RES, V20, P170, DOI 10.1101/gr.100289.109; Jeltsch A, 2002, CHEMBIOCHEM, V3, P275, DOI 10.1002/1439-7633(20020402)3:4<274::AID-CBIC274>3.0.CO;2-S; Jeong KS, 2005, BIOCHEM BIOPH RES CO, V335, P1211, DOI 10.1016/j.bbrc.2005.08.015; JUPE ER, 1986, J BACTERIOL, V165, P420, DOI 10.1128/jb.165.2.420-423.1986; Jurkowska RZ, 2011, CHEMBIOCHEM, V12, P206, DOI 10.1002/cbic.201000195; Kinney SRM, 2008, MOL CANCER RES, V6, P1365, DOI 10.1158/1541-7786.MCR-08-0040; Kinney SRM, 2011, PROG MOL BIOL TRANSL, V101, P311, DOI 10.1016/B978-0-12-387685-0.00009-3; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Lin IG, 2002, MOL CELL BIOL, V22, P704, DOI 10.1128/MCB.22.3.704-723.2002; Lin JQ, 2011, PROSTATE, V71, P333, DOI 10.1002/pros.21247; Lowrey PL, 2000, ANNU REV GENET, V34, P533, DOI 10.1146/annurev.genet.34.1.533; Lu QJ, 2002, ARTHRITIS RHEUM, V46, P1282, DOI 10.1002/art.10234; Maekawa F, 2012, EPIGENETICS-US, V7, P1046, DOI 10.4161/epi.21539; Mason JB, 2003, J NUTR, V133, p941S, DOI 10.1093/jn/133.3.941S; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; MILLER OJ, 1974, NATURE, V251, P636, DOI 10.1038/251636a0; NELSON W, 1979, CHRONOBIOLOGIA, V6, P305; Oka M, 2006, J BIOL CHEM, V281, P9901, DOI 10.1074/jbc.M511100200; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; SELHUB J, 1992, AM J CLIN NUTR, V55, P131, DOI 10.1093/ajcn/55.1.131; SHE QB, 1994, BIOCHEM BIOPH RES CO, V205, P1748, DOI 10.1006/bbrc.1994.2871; Stenvinkel P, 2007, J INTERN MED, V261, P488, DOI 10.1111/j.1365-2796.2007.01777.x; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; VANYUSHI.BF, 1973, GERONTOLOGY, V19, P138, DOI 10.1159/000211967; VANYUSHIN BF, 1970, NATURE, V225, P948, DOI 10.1038/225948a0; Vollmers C, 2012, CELL METAB, V16, P833, DOI 10.1016/j.cmet.2012.11.004; Weaver DR, 1998, J BIOL RHYTHM, V13, P100, DOI 10.1177/074873098128999952; Williams-Karnesky RL, 2013, J CLIN INVEST, V123, P3552, DOI 10.1172/JCI65636; WILSON VL, 1987, J BIOL CHEM, V262, P9948; Wu H, 2011, GENE DEV, V25, P2436, DOI 10.1101/gad.179184.111; Zhang Y, 2012, AM J PHYSIOL-ENDOC M, V302, pE325, DOI 10.1152/ajpendo.00424.2011; Zhang ZY, 2002, MECH AGEING DEV, V123, P1257, DOI 10.1016/S0047-6374(02)00014-3; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4	56	29	32	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0118101	10.1371/journal.pone.0118101	http://dx.doi.org/10.1371/journal.pone.0118101			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689298	Green Submitted, Green Published, gold			2022-12-26	WOS:000350322700101
J	Holme, AM; Roland, MCP; Lorentzen, B; Michelsen, TM; Henriksen, T				Holme, Ane M.; Roland, Marie Cecilie P.; Lorentzen, Bjorg; Michelsen, Trond M.; Henriksen, Tore			Placental Glucose Transfer: A Human In Vivo Study	PLOS ONE			English	Article							CORD PLASMA; BLOOD-FLOW; FETAL; INSULIN; GROWTH; PREGNANCY; FETUS; GRADIENTS; GLUCAGON; ENERGY	Objectives The placental transfer of nutrients is influenced by maternal metabolic state, placenta function and fetal demands. Human in vivo studies of this interplay are scarce and challenging. We aimed to establish a method to study placental nutrient transfer in humans. Focusing on glucose, we tested a hypothesis that maternal glucose concentrations and uteroplacental arterio-venous difference (reflecting maternal supply) determines the fetal venous-arterial glucose difference (reflecting fetal consumption). Methods Cross-sectional in vivo study of 40 healthy women with uncomplicated term pregnancies undergoing planned caesarean section. Glucose and insulin were measured in plasma from maternal and fetal sides of the placenta, at the incoming (radial artery and umbilical vein) and outgoing vessels (uterine vein and umbilical artery). Results There were significant mean (SD) uteroplacental arterio-venous 0.29 (0.23) mmol/L and fetal venous-arterial 0.38 (0.31) mmol/L glucose differences. The transplacental maternalfetal glucose gradient was 1.22 (0.42) mmol/L. The maternal arterial glucose concentration was correlated to the fetal venous glucose concentration (r = 0.86, p < 0.001), but not to the fetal venous-arterial glucose difference. The uteroplacental arterio-venous glucose difference was neither correlated to the level of glucose in the umbilical vein, nor fetal venous-arterial glucose difference. The maternal-fetal gradient was correlated to fetal venous-arterial glucose difference (r = 0.8, p < 0.001) and the glucose concentration in the umbilical artery (r = -0.45, p = 0.004). Glucose and insulin concentrations were correlated in the mother (r = 0.52, p = 0.001), but not significantly in the fetus. We found no significant correlation between maternal and fetal insulin values. Conclusions We did not find a relation between indicators of maternal glucose supply and the fetal venous-arterial glucose difference. Our findings indicate that the maternal-fetal glucose gradient is significantly influenced by the fetal venous-arterial difference and not merely dependent on maternal glucose concentration or the arterio-venous difference on the maternal side of the placenta.	[Holme, Ane M.; Roland, Marie Cecilie P.; Lorentzen, Bjorg; Michelsen, Trond M.; Henriksen, Tore] Oslo Univ Hosp, Dept Obstet, Oslo, Norway; [Michelsen, Trond M.] Oslo Univ Hosp, Norwegian Natl Advisory Unit Womens Hlth, Oslo, Norway; [Henriksen, Tore] Univ Oslo, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo	Holme, AM (corresponding author), Oslo Univ Hosp, Dept Obstet, Oslo, Norway.	sbhmoa@ous-hf.no			South-Eastern Norway Regional Health Authority [2013043]; Norwegian National Advisory Unit on Women's Health, Oslo University Hospital, Oslo, Norway; ExtraFoundation for Health and Rehabilitation, through The National Assosiation for Public Health; University of Oslo	South-Eastern Norway Regional Health Authority; Norwegian National Advisory Unit on Women's Health, Oslo University Hospital, Oslo, Norway; ExtraFoundation for Health and Rehabilitation, through The National Assosiation for Public Health; University of Oslo	AMH recieved a PhD grant from South-Eastern Norway Regional Health Authority, grant number 2013043 (http://www.helse-sorost.no/omoss_/english_/) and was partly funded by the Norwegian National Advisory Unit on Women's Health, Oslo University Hospital, Oslo, Norway (http://ous-research.no/nrcwh/). MCPR recieved a PhD grant from the ExtraFoundation for Health and Rehabilitation, through The National Assosiation for Public Health (http://www.extrastiftelsen.no/). TMM is funded by the Norwegian National Advisory Unit on Women's Health, Oslo University Hospital, Oslo, Norway (http://ous-research.no/nrcwh/). The study also received funding from University of Oslo, the Institute of Clinical Medicine, Thematic Research (http://www.med.uio.no/klinmed/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker DJP, 2013, CLIN OBSTET GYNECOL, V56, P511, DOI 10.1097/GRF.0b013e31829cb9ca; Baumann MU, 2002, ENDOCRINE, V19, P13, DOI 10.1385/ENDO:19:1:13; COLTART TM, 1969, BRIT MED J, V4, P17, DOI 10.1136/bmj.4.5674.17; Friis CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057467; Gude NM, 2004, THROMB RES, V114, P397, DOI 10.1016/j.thromres.2004.06.038; Haugen G, 2004, ULTRASOUND OBST GYN, V24, P599, DOI 10.1002/uog.1744; Hay Jr WW, 2006, T AM CLIN CLIMATOLOG, V117, P339; Hay William W Jr, 2006, Trans Am Clin Climatol Assoc, V117, P321; HAY WW, 1990, AM J PHYSIOL, V258, pR569, DOI 10.1152/ajpregu.1990.258.3.R569; HAY WW, 1991, P NUTR SOC, V50, P321, DOI 10.1079/PNS19910042; Illsley NP, 2000, PLACENTA, V21, P14, DOI 10.1053/plac.1999.0448; JANSSON T, 1993, J CLIN ENDOCR METAB, V77, P1554, DOI 10.1210/jc.77.6.1554; Kalhan S, 2000, SEMIN PERINATOL, V24, P94, DOI 10.1053/sp.2000.6360; Kessler J, 2008, PEDIATR RES, V63, P315, DOI 10.1203/PDR.0b013e318163a1de; KUO PL, 1991, J PERINAT MED, V19, P421, DOI 10.1515/jpme.1991.19.6.421; LIND T, 1975, BRIT J OBSTET GYNAEC, V82, P562, DOI 10.1111/j.1471-0528.1975.tb00687.x; METZGER BE, 1985, PLACENTA, V6, P347, DOI 10.1016/S0143-4004(85)80044-8; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Metzger BE, 2009, DIABETES, V58, P453, DOI 10.2337/db08-1112; Moore MC, 2012, ADV NUTR, V3, P286, DOI 10.3945/an.112.002089; PALMER SK, 1992, OBSTET GYNECOL, V80, P1000; PEDERSEN J, 1954, ACTA ENDOCRINOL-COP, V15, P33, DOI 10.1530/acta.0.0150033; Roland MCP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039324; Schneider H, 2003, PLACENTA, V24, P27, DOI 10.1053/plac.2002.0869; SIMMONS MA, 1978, PEDIATR RES, V12, P90, DOI 10.1203/00006450-197802000-00004; SPELLACY WN, 1964, AM J OBSTET GYNECOL, V90, P753, DOI 10.1016/0002-9378(64)90938-X; SPELLACY WN, 1976, OBSTET GYNECOL, V47, P291; SPELLACY WN, 1973, OBSTET GYNECOL, V41, P323; STEINGRIMSDOTTIR T, 1993, EUR J OBSTET GYN R B, V51, P209, DOI 10.1016/0028-2243(93)90037-D; Voldner N, 2008, ACTA OBSTET GYN SCAN, V87, P423, DOI 10.1080/00016340801989825; Zamudio S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008551	31	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117084	10.1371/journal.pone.0117084	http://dx.doi.org/10.1371/journal.pone.0117084			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680194	Green Published, Green Submitted, gold			2022-12-26	WOS:000350682600048
J	Yu, XY; Liu, SP; Li, JB; Fan, XH; Chen, YJ; Bi, XY; Liu, SR; Deng, XM				Yu, Xiya; Liu, Shupeng; Li, Jinbao; Fan, Xiaohua; Chen, Yuanjie; Bi, Xiaoying; Liu, Shanrong; Deng, Xiaoming			MicroRNA-572 Improves Early Post-Operative Cognitive Dysfunction by Down-Regulating Neural Cell Adhesion Molecule 1	PLOS ONE			English	Article							ELDERLY-PATIENTS; AGED RATS; SURGERY; IMPAIRMENT; EXPRESSION; PLASTICITY; DECLINE; DISEASE; BYPASS; SERUM	Post-operative cognitive dysfunction (POCD) is a commonly-seen postoperative complication in elderly patients. However, the underlying mechanisms of POCD remain unclear. miRNAs, which are reported to be involved in the pathogenesis of the nervous system diseases, may also affect POCD. In this study, miRNA microarray technology was used to analyze the circulating miRNA expression profile of POCD patients. Among the altered miRNAs, miR-572 had the greatest decrease, which was also verified in vivo in rat POCD model. Further analysis found that miR-572 could regulate the expression of NCAM1 in the hippocampal neurons and interfering miR-572 expression could facilitate the restoration of cognitive function in vivo. Moreover, clinical correlation analysis found that the miR-572 expression was associated with the incidence of POCD. Collectively, miR-572 is involved in the development and restoration of POCD and it may serve as a biological marker for early diagnosis of POCD.	[Yu, Xiya; Li, Jinbao; Fan, Xiaohua; Chen, Yuanjie; Deng, Xiaoming] Second Mil Med Univ, Changhai Hosp, Dept Anesthesiol, Shanghai 200433, Peoples R China; [Liu, Shupeng; Liu, Shanrong] Second Mil Med Univ, Changhai Hosp, Clin Res Ctr, Shanghai 200433, Peoples R China; [Bi, Xiaoying] Second Mil Med Univ, Changhai Hosp, Dept Neurol, Shanghai 200433, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University	Liu, SR (corresponding author), Second Mil Med Univ, Changhai Hosp, Clin Res Ctr, Shanghai 200433, Peoples R China.	liushanrong@hotmail.com; dengx@yahoo.com	Deng, Xiaoming/E-2876-2010		National Natural Science Foundation [81350001]; Program of the Shanghai Science and Technology Committee [11JC1415500]; Program of Shanghai Municipal Health Bureau [2009059]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Program of the Shanghai Science and Technology Committee; Program of Shanghai Municipal Health Bureau	This study was supported by National Natural Science Foundation No. 81350001 (XYY), Program of the Shanghai Science and Technology Committee No. 11JC1415500 (XYY), and Program of Shanghai Municipal Health Bureau No. 2009059 (XYY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An LN, 2013, BIOL TRACE ELEM RES, V151, P277, DOI 10.1007/s12011-012-9564-9; Arora SS, 2014, INT J NEUROSCI, V124, P236, DOI 10.3109/00207454.2013.833919; Ballard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037410; Barrientos RM, 2012, J NEUROSCI, V32, P14641, DOI 10.1523/JNEUROSCI.2173-12.2012; Biedler A, 1999, ANAESTHESIST, V48, P884, DOI 10.1007/s001010050802; Cheng HH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069239; Dallerac G, 2011, LEARN MEMORY, V18, P306, DOI 10.1101/lm.2154311; Engelhard K, 2008, ANASTH INTENSIV NOTF, V43, P606, DOI 10.1055/s-0028-1090023; Fareed M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109585; Gao J, 2010, NATURE, V466, P1105, DOI 10.1038/nature09271; Goldberg TE, 2004, TRENDS COGN SCI, V8, P325, DOI 10.1016/j.tics.2004.05.011; Gu H, 2012, J NEUROCHEM, V122, P641, DOI 10.1111/j.1471-4159.2012.07812.x; Guo FJ, 2013, J INT MED RES, V41, P1456, DOI 10.1177/0300060513487652; Hartholt KA, 2012, Z GERONTOL GERIATR, V45, P411, DOI 10.1007/s00391-012-0326-2; Ji MH, 2013, J ANESTH, V27, P942, DOI 10.1007/s00540-013-1633-5; Kocerha J, 2009, P NATL ACAD SCI USA, V106, P3507, DOI 10.1073/pnas.0805854106; Kong FJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061385; Lee ST, 2011, EXP NEUROL, V227, P172, DOI 10.1016/j.expneurol.2010.10.012; Li S, 2013, J NEUROSCI, V33, P790, DOI 10.1523/JNEUROSCI.1238-12.2013; Li SY, 2013, BRAIN RES, V1496, P84, DOI 10.1016/j.brainres.2012.12.025; Liu J, 2009, LIFE SCI, V84, P267, DOI 10.1016/j.lfs.2008.12.008; Murchison EP, 2004, CURR OPIN CELL BIOL, V16, P223, DOI 10.1016/j.ceb.2004.04.003; Patron E, 2013, GEN HOSP PSYCHIAT, V35, P472, DOI 10.1016/j.genhosppsych.2013.05.004; Steinmetz J, 2009, ANESTHESIOLOGY, V110, P548, DOI 10.1097/ALN.0b013e318195b569; Trovo L, 2013, NAT NEUROSCI, V16, P449, DOI 10.1038/nn.3342; Wang X, 2013, MOL NEUROBIOL, V47, P373, DOI 10.1007/s12035-012-8355-9; Xu JH, 2013, NEUROL SCI, V34, P2123, DOI 10.1007/s10072-013-1347-3; Xu T, 2013, J CARDIOTHORAC SURG, V8, DOI 10.1186/1749-8090-8-204; Yakoot M, 2013, CLIN INTERV AGING, V8, P975, DOI 10.2147/CIA.S44777; Zen K, 2012, MED RES REV, V32, P326, DOI 10.1002/med.20215	30	24	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0118511	10.1371/journal.pone.0118511	http://dx.doi.org/10.1371/journal.pone.0118511			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680004	Green Submitted, Green Published, gold			2022-12-26	WOS:000350682600123
J	Stolzenburg, S; Beltran, AS; Swift-Scanlan, T; Rivenbark, AG; Rashwan, R; Blancafort, P				Stolzenburg, S.; Beltran, A. S.; Swift-Scanlan, T.; Rivenbark, A. G.; Rashwan, R.; Blancafort, P.			Stable oncogenic silencing in vivo by programmable and targeted de novo DNA methylation in breast cancer	ONCOGENE			English	Article							TRANSCRIPTION FACTOR SOX2; STEM-CELLS; EXPRESSION; GENES; DIFFERENTIATION; REPRESSION; EFFECTORS; PROTEINS; MEMORY; TUMORS	With the recent comprehensive mapping of cancer genomes, there is now a need for functional approaches to edit the aberrant epigenetic state of key cancer drivers to reprogram the epi-pathology of the disease. In this study we utilized a programmable DNA-binding methyltransferase to induce targeted incorporation of DNA methylation (DNAme) in the SOX2 oncogene in breast cancer through a six zinc finger (ZF) protein linked to DNA methyltransferase 3A (ZF-DNMT3A). We demonstrated long-lasting oncogenic repression, which was maintained even after suppression of ZF-DNMT3A expression in tumor cells. The de novo DNAme was faithfully propagated and maintained through cell generations even after the suppression of the expression of the chimeric methyltransferase in the tumor cells. Xenograft studies in NUDE mice demonstrated stable SOX2 repression and long-term breast tumor growth inhibition, which lasted for >100 days post implantation of the tumor cells in mice. This was accompanied with a faithful maintenance of DNAme in the breast cancer implants. In contrast, downregulation of SOX2 by ZF domains engineered with the Krueppel-associated box repressor domain resulted in a transient and reversible suppression of oncogenic gene expression. Our results indicated that targeted de novo DNAme of the SOX2 oncogenic promoter was sufficient to induce long-lasting epigenetic silencing, which was not only maintained during cell division but also significantly delayed the tumorigenic phenotype of cancer cells in vivo, even in the absence of treatment. Here, we outline a genome-based targeting approach to long-lasting tumor growth inhibition with potential applicability to many other oncogenic drivers that are currently refractory to drug design.	[Stolzenburg, S.; Rashwan, R.; Blancafort, P.] Harry Perkins Inst Med Res, Canc Epigenet Grp, Nedlands, WA, Australia; [Stolzenburg, S.; Rashwan, R.; Blancafort, P.] Univ Western Australia, Sch Anat Physiol & Human Biol, Nedlands, WA 6009, Australia; [Stolzenburg, S.; Beltran, A. S.; Blancafort, P.] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC USA; [Swift-Scanlan, T.] Univ N Carolina, Sch Nursing, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA; [Rivenbark, A. G.] Univ N Carolina, Sch Med, Dept Pathol & Lab Med, Chapel Hill, NC USA	Harry Perkins Institute of Medical Research; University of Western Australia; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Blancafort, P (corresponding author), Harry Perkins Inst Med Res, Canc Epigenet Grp, Nedlands, WA, Australia.	pilar.blancafort@uwa.edu.au		Rashwan, Rabab/0000-0001-9557-0062; Blancafort, Pilar/0000-0002-3881-7396	Australian Research Council (ARC) Future Fellowship [FT130101767]; Cancer Council of Western Australia Research Fellowship; National Health and Medical Research Council [APP1069308]; National Institutes of Health [R01CA170370, R01DA036906]; National Breast Cancer Foundation [NC-14-024]; Barbara Senich Genomics Innovation Award; Barbara Senich Genomics Innovation Endowment Fund; Susan G Komen Foundation [KG090180]; NATIONAL CANCER INSTITUTE [R01CA170370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA036906] Funding Source: NIH RePORTER	Australian Research Council (ARC) Future Fellowship(Australian Research Council); Cancer Council of Western Australia Research Fellowship(Cancer Council Western Australia); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Breast Cancer Foundation; Barbara Senich Genomics Innovation Award; Barbara Senich Genomics Innovation Endowment Fund; Susan G Komen Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by an Australian Research Council (ARC) Future Fellowship FT130101767, the Cancer Council of Western Australia Research Fellowship, National Health and Medical Research Council grant APP1069308, National Institutes of Health grants R01CA170370, R01DA036906, the National Breast Cancer Foundation NC-14-024 (PB) and the Barbara Senich Genomics Innovation Award, the Barbara Senich Genomics Innovation Endowment Fund and the Susan G Komen Foundation KG090180 (TSS).	Alonso MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026740; Bareiss PM, 2013, CANCER RES, V73, P5544, DOI 10.1158/0008-5472.CAN-12-4177; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Beisel C, 2011, NAT REV GENET, V12, P123, DOI 10.1038/nrg2932; Beltran AS, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3019; Blancafort P, 2013, MOL PHARMACOL, V83, P563, DOI 10.1124/mol.112.080697; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brazel CY, 2005, AGING CELL, V4, P197, DOI 10.1111/j.1474-9726.2005.00158.x; Chaikind B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096931; Chen YP, 2008, J BIOL CHEM, V283, P17969, DOI 10.1074/jbc.M802917200; CHOO Y, 1994, NATURE, V372, P642, DOI 10.1038/372642a0; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; de Groote ML, 2012, NUCLEIC ACIDS RES, V40, P10596, DOI 10.1093/nar/gks863; Esteve PO, 2006, GENE DEV, V20, P3089, DOI 10.1101/gad.1463706; Fuks F, 2000, NAT GENET, V24, P88, DOI 10.1038/71750; Hathaway NA, 2012, CELL, V149, P1447, DOI 10.1016/j.cell.2012.03.052; Heyn H, 2012, NAT REV GENET, V13, P679, DOI 10.1038/nrg3270; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Konermann S, 2013, NATURE; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lange UC, 2010, BIOESSAYS, V32, P659, DOI 10.1002/bies.201000030; Lara H, 2012, J BIOL CHEM, V287, P29873, DOI 10.1074/jbc.M112.360768; Li FY, 2007, NUCLEIC ACIDS RES, V35, P100, DOI 10.1093/nar/gkl1035; Nunna S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087703; Rivenbark AG, 2012, EPIGENETICS-US, V7, P350, DOI 10.4161/epi.19507; Rodriguez J, 2008, P NATL ACAD SCI USA, V105, P19809, DOI 10.1073/pnas.0810133105; Sandoval J, 2012, CURR OPIN GENET DEV, V22, P50, DOI 10.1016/j.gde.2012.02.008; Schmitz M, 2007, BRIT J CANCER, V96, P1293, DOI 10.1038/sj.bjc.6603696; Siddique A, 2013, J MOL BIOL, V425, P479, DOI 10.1016/j.jmb.2012.11.038; Sikorska M, 2008, J NEUROSCI RES, V86, P1680, DOI 10.1002/jnr.21635; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Stolzenburg S, 2012, NUCLEIC ACIDS RES, V40, P6725, DOI 10.1093/nar/gks360; Stolzenburg S, 2010, METHODS MOL BIOL, V649, P117, DOI 10.1007/978-1-60761-753-2_7; Sussman RT, 2013, J BIOL CHEM, V288, P24234, DOI 10.1074/jbc.M113.469783; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Xiang R, 2011, BRIT J CANCER, V104, P1410, DOI 10.1038/bjc.2011.94	39	57	58	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2015	34	43					5427	5435		10.1038/onc.2014.470	http://dx.doi.org/10.1038/onc.2014.470			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CU4EM	25684141	Green Published, hybrid			2022-12-26	WOS:000363479700003
J	Repmann, S; Olivera-Harris, M; Jiricny, J				Repmann, Simone; Olivera-Harris, Maite; Jiricny, Josef			Influence of Oxidized Purine Processing on Strand Directionality of Mismatch Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Base Excision Repair (BER); DNA Damage; DNA Mismatch Repair; DNA Repair; Oxidative Stress	BASE-EXCISION-REPAIR; HUMAN MUTY HOMOLOG; MUTAGENIC SUBSTRATE; DNA-REPLICATION; ATPASE ACTIVITY; PROTEIN; ALPHA; 8-OXOGUANINE; GLYCOSYLASE; EXTRACTS	Replicative DNA polymerases are high fidelity enzymes that misincorporate nucleotides into nascent DNA with a frequency lower than [1/10(5)], and this precision is improved to about [1/10(7)] by their proofreading activity. Because this fidelity is insufficient to replicate most genomes without error, nature evolved postreplicative mismatch repair (MMR), which improves the fidelity of DNA replication by up to 3 orders of magnitude through correcting biosynthetic errors that escaped proofreading. MMR must be able to recognize non-Watson-Crick base pairs and excise the misincorporated nucleotides from the nascent DNA strand, which carries by definition the erroneous genetic information. In eukaryotes, MMR is believed to be directed to the nascent strand by preexisting discontinuities such as gaps between Okazaki fragments in the lagging strand or breaks in the leading strand generated by the mismatch-activated endonuclease of the MutL homologs PMS1 in yeast and PMS2 in vertebrates. We recently demonstrated that the eukaryotic MMR machinery can make use also of strand breaks arising during excision of uracils or ribonucleotides from DNA. We now show that intermediates of MutY homolog-dependent excision of adenines mispaired with 8-oxoguanine (G(O)) also act as MMR initiation sites in extracts of human cells or Xenopus laevis eggs. Unexpectedly, G(O)/C pairs were not processed in these extracts and failed to affect MMR directionality, but extracts supplemented with exogenous 8-oxoguanine DNA glycosylase (OGG1) did so. Because OGG1-mediated excision of G(O) might misdirect MMR to the template strand, our findings suggest that OGG1 activity might be inhibited during MMR.	[Repmann, Simone; Olivera-Harris, Maite; Jiricny, Josef] Univ Zurich, Inst Mol Canc Res, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Repmann, Simone; Olivera-Harris, Maite; Jiricny, Josef] Swiss Inst Technol Zurich, CH-8057 Zurich, Switzerland	University of Zurich	Jiricny, J (corresponding author), Univ Zurich, Inst Mol Canc Res, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	jiricny@imcr.uzh.ch			Swiss National Science Foundation [310030B-133123, 31003A-149989]; European Research Council ["MIRIAM" 294537]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council(European Research Council (ERC)European Commission)	This work was supported by Swiss National Science Foundation Grants 310030B-133123 and 31003A-149989 and European Research Council Grant "MIRIAM" 294537.	Avkin S, 2002, MUTAT RES-FUND MOL M, V510, P81, DOI 10.1016/S0027-5107(02)00254-3; Baerenfaller K, 2006, METHOD ENZYMOL, V408, P285, DOI 10.1016/S0076-6879(06)08018-9; Boldogh I, 2001, NUCLEIC ACIDS RES, V29, P2802, DOI 10.1093/nar/29.13.2802; BROOKS P, 1989, P NATL ACAD SCI USA, V86, P4425, DOI 10.1073/pnas.86.12.4425; Burrows CJ, 1998, CHEM REV, V98, P1109, DOI 10.1021/cr960421s; Collins AR, 1999, BIOESSAYS, V21, P238, DOI 10.1002/(SICI)1521-1878(199903)21:3<238::AID-BIES8>3.0.CO;2-3; Colussi C, 2002, CURR BIOL, V12, P912, DOI 10.1016/S0960-9822(02)00863-1; David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978; Dherin C, 1999, NUCLEIC ACIDS RES, V27, P4001, DOI 10.1093/nar/27.20.4001; DIANOV G, 1992, MOL CELL BIOL, V12, P1605, DOI 10.1128/MCB.12.4.1605; Dianov GL, 2013, NUCLEIC ACIDS RES, V41, P3483, DOI 10.1093/nar/gkt076; Dufner P, 2000, J BIOL CHEM, V275, P36550, DOI 10.1074/jbc.M005987200; Einolf HJ, 2001, J BIOL CHEM, V276, P3764, DOI 10.1074/jbc.M006696200; FANG WH, 1993, J BIOL CHEM, V268, P11838; Fortini P, 2003, MUTAT RES-FUND MOL M, V531, P127, DOI 10.1016/j.mrfmmm.2003.07.004; Frosina G, 1996, J BIOL CHEM, V271, P9573, DOI 10.1074/jbc.271.16.9573; Gedik CM, 2005, FASEB J, V19, P82, DOI 10.1096/fj.04-1767fje; Ghodgaonkar MM, 2013, MOL CELL, V50, P323, DOI 10.1016/j.molcel.2013.03.019; Gillespie PJ, 2012, METHODS, V57, P203, DOI 10.1016/j.ymeth.2012.03.029; Gu YS, 2002, J BIOL CHEM, V277, P11135, DOI 10.1074/jbc.M108618200; Hashimoto Y, 2010, NAT STRUCT MOL BIOL, V17, P1305, DOI 10.1038/nsmb.1927; HOLMES J, 1990, P NATL ACAD SCI USA, V87, P5837, DOI 10.1073/pnas.87.15.5837; Iaccarino I, 1998, EMBO J, V17, P2677, DOI 10.1093/emboj/17.9.2677; Jacobs AL, 2012, CHROMOSOMA, V121, P1, DOI 10.1007/s00412-011-0347-4; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Klungland A, 1997, EMBO J, V16, P3341, DOI 10.1093/emboj/16.11.3341; KOI M, 1994, CANCER RES, V54, P4308; KUBOTA Y, 1993, J CELL BIOL, V123, P1321, DOI 10.1083/jcb.123.6.1321; LAHUE RS, 1988, MUTAT RES, V198, P37, DOI 10.1016/0027-5107(88)90037-1; Larson ED, 2003, DNA REPAIR, V2, P1199, DOI 10.1016/S1568-7864(03)00140-X; MAKI H, 1992, NATURE, V355, P273, DOI 10.1038/355273a0; Mazurek A, 2002, J BIOL CHEM, V277, P8260, DOI 10.1074/jbc.M111269200; MCAULEYHECHT KE, 1994, BIOCHEMISTRY-US, V33, P10266, DOI 10.1021/bi00200a006; MICHAELS ML, 1992, J BACTERIOL, V174, P6321, DOI 10.1128/JB.174.20.6321-6325.1992; MO JY, 1992, P NATL ACAD SCI USA, V89, P11021, DOI 10.1073/pnas.89.22.11021; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Modrich P, 2006, J BIOL CHEM, V281, P30305, DOI 10.1074/jbc.R600022200; Nash HM, 1996, CURR BIOL, V6, P968, DOI 10.1016/S0960-9822(02)00641-3; Neuberger MS, 2005, NAT REV IMMUNOL, V5, P171, DOI 10.1038/nri1553; Ohtsubo T, 2000, NUCLEIC ACIDS RES, V28, P1355, DOI 10.1093/nar/28.6.1355; Pena-Diaz J, 2012, MOL CELL, V47, P669, DOI 10.1016/j.molcel.2012.07.006; Pena-Diaz J, 2010, P NATL ACAD SCI USA, V107, P16409, DOI 10.1073/pnas.1011692107; Pluciennik A, 2010, P NATL ACAD SCI USA, V107, P16066, DOI 10.1073/pnas.1010662107; Russo MT, 2004, MOL CELL BIOL, V24, P465, DOI 10.1128/MCB.24.1.465-474.2004; SAKUMI K, 1993, J BIOL CHEM, V268, P23524; Schanz S, 2009, P NATL ACAD SCI USA, V106, P5593, DOI 10.1073/pnas.0901726106; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; THOMAS DC, 1991, J BIOL CHEM, V266, P3744; Ushijima Y, 2005, NUCLEIC ACIDS RES, V33, P672, DOI 10.1093/nar/gki214; van Loon B, 2009, P NATL ACAD SCI USA, V106, P18201, DOI 10.1073/pnas.0907280106; Warren JJ, 2007, MOL CELL, V26, P579, DOI 10.1016/j.molcel.2007.04.018	52	14	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					9986	9999		10.1074/jbc.M114.629907	http://dx.doi.org/10.1074/jbc.M114.629907			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25694431	Green Accepted, hybrid, Green Published			2022-12-26	WOS:000353241100008
J	Liao, P; Yu, DJ; Hu, ZY; Liang, MC; Wang, JJ; Yu, CY; Ng, G; Yong, TF; Soon, JL; Chua, YL; Soong, TW				Liao, Ping; Yu, Dejie; Hu, Zhenyu; Liang, Mui Cheng; Wang, Jue Jin; Yu, Chye Yun; Ng, Gandi; Yong, Tan Fong; Soon, Jia Lin; Chua, Yeow Leng; Soong, Tuck Wah			Alternative Splicing Generates a Novel Truncated Ca(v)1.2 Channel in Neonatal Rat Heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED CALCIUM-CHANNEL; CA2+ CHANNEL; BETA-SUBUNIT; N-TERMINUS; SENSITIVITY; PREDICTS; PROTEIN	L-type Ca(v)1.2 Ca2+ channel undergoes extensive alternative splicing, generating functionally different channels. Alternatively spliced Ca(v)1.2 Ca2+ channels have been found to be expressed in a tissue-specific manner or under pathological conditions. To provide a more comprehensive understanding of alternative splicing in Ca(v)1.2 channel, we systematically investigated the splicing patterns in the neonatal and adult rat hearts. The neonatal heart expresses a novel 104-bp exon 33L at the IVS3-4 linker that is generated by the use of an alternative acceptor site. Inclusion of exon 33L causes frameshift and C-terminal truncation. Whole-cell electrophysiological recordings of Ca(v)1.2(33L) channels expressed in HEK 293 cells did not detect any current. However, when co-expressed with wild type Ca(v)1.2 channels, Ca(v)1.2(33L) channels reduced the current density and altered the electrophysiological properties of the wild type Ca(v)1.2 channels. Interestingly, the truncated 3.5-domain Ca(v)1.2(33L) channels also yielded a dominant negative effect on Ca(v)1.3 channels, but not on Ca(v)3.2 channels, suggesting that Ca-v beta subunits is required for Ca(v)1.2(33L) regulation. A biochemical study provided evidence that Ca(v)1.2(33L) channels enhanced protein degradation of wild type channels via the ubiquitin-proteasome system. Although the physiological significance of the Ca(v)1.2(33L) channels in neonatal heart is still unknown, our report demonstrates the ability of this novel truncated channel to modulate the activity of the functional Ca(v)1.2 channels. Moreover, the human Ca(v)1.2 channel also contains exon 33L that is developmentally regulated in heart. Unexpectedly, human exon 33L has a one-nucleotide insertion that allowed in-frame translation of a full Ca(v)1.2 channel. An electrophysiological study showed that human Ca(v)1.2(33L) channel is a functional channel but conducts Ca2+ ions at a much lower level.	[Liao, Ping; Yu, Chye Yun; Ng, Gandi; Soong, Tuck Wah] Natl Inst Neurosci, Singapore 308433, Singapore; [Liao, Ping] Duke NUS Grad Med Sch Singapore, Singapore 169857, Singapore; [Yu, Dejie; Hu, Zhenyu; Liang, Mui Cheng; Wang, Jue Jin; Yong, Tan Fong; Soong, Tuck Wah] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117597, Singapore; [Soon, Jia Lin; Chua, Yeow Leng] Natl Heart Ctr Singapore, Singapore 169609, Singapore	National Neuroscience Institute (NNI); National University of Singapore; National University of Singapore; National Heart Centre Singapore	Soong, TW (corresponding author), Natl Inst Neurosci, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore.	ping_liao@nni.com.sg; tuck_wah_soong@nuhs.edu.sg	Juejin, Wang/ABA-7017-2020; Wang, Jue/GVU-0480-2022	Liang, Mui Cheng/0000-0003-1208-0733	Singapore Ministry of Health's National Medical Research Council	Singapore Ministry of Health's National Medical Research Council(National Medical Research Council, Singapore)	This work was supported by a grant from Singapore Ministry of Health's National Medical Research Council (to T. W. S.) and a grant from Singapore Ministry of Health's National Medical Research Council (to P. L.).	Abernethy DR, 2002, J PHARMACOL EXP THER, V300, P724, DOI 10.1124/jpet.300.3.724; Ahern CA, 2001, P NATL ACAD SCI USA, V98, P6935, DOI 10.1073/pnas.111001898; Altier C, 2011, NAT NEUROSCI, V14, P173, DOI 10.1038/nn.2712; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Cheng XY, 2007, J BIOL CHEM, V282, P29211, DOI 10.1074/jbc.M610623200; CHIEN AJ, 1995, J BIOL CHEM, V270, P30036; DIEBOLD RJ, 1992, P NATL ACAD SCI USA, V89, P1497, DOI 10.1073/pnas.89.4.1497; Ebihara T, 2002, FEBS LETT, V529, P203, DOI 10.1016/S0014-5793(02)03340-9; GIDHJAIN M, 1995, BIOCHEM BIOPH RES CO, V216, P892, DOI 10.1006/bbrc.1995.2705; Huang H, 2013, MOL PHARMACOL, V84, P643, DOI 10.1124/mol.113.087155; Kobrinsky E, 2005, J BIOL CHEM, V280, P12474, DOI 10.1074/jbc.M412140200; Liao P, 2005, CARDIOVASC RES, V68, P197, DOI 10.1016/j.cardiores.2005.06.024; Liao P, 2004, J BIOL CHEM, V279, P50329, DOI 10.1074/jbc.M409436200; Liao P, 2007, J BIOL CHEM, V282, P35133, DOI 10.1074/jbc.M705478200; Liao P, 2009, PFLUG ARCH EUR J PHY, V458, P701, DOI 10.1007/s00424-009-0652-4; Liao P, 2009, PFLUG ARCH EUR J PHY, V458, P481, DOI 10.1007/s00424-009-0635-5; Plummer NW, 1997, J BIOL CHEM, V272, P24008, DOI 10.1074/jbc.272.38.24008; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; Raghib A, 2001, J NEUROSCI, V21, P8495, DOI 10.1523/JNEUROSCI.21-21-08495.2001; Takahashi SX, 2004, P NATL ACAD SCI USA, V101, P7193, DOI 10.1073/pnas.0306665101; Tang ZZ, 2009, MOL CELL BIOL, V29, P4757, DOI 10.1128/MCB.00608-09; Tang ZZ, 2004, J BIOL CHEM, V279, P44335, DOI 10.1074/jbc.M407023200; Tao J, 2008, MOL PHARMACOL, V73, P1596, DOI 10.1124/mol.107.043612; Tiwari S, 2006, P NATL ACAD SCI USA, V103, P17024, DOI 10.1073/pnas.0606539103; Vornanen M, 1996, CARDIOVASC RES, V32, P400, DOI 10.1016/0008-6363(96)00083-1; Vornanen M, 1996, MOL CELL BIOCHEM, V164, P5, DOI 10.1007/BF00408635; Welling A, 1997, CIRC RES, V81, P526, DOI 10.1161/01.RES.81.4.526; Wielowieyski PA, 2001, J BIOL CHEM, V276, P1398, DOI 10.1074/jbc.M006868200; Yang YB, 2000, J MOL CELL CARDIOL, V32, P973, DOI 10.1006/jmcc.2000.1138; Zuhlke RD, 1998, FEBS LETT, V427, P220, DOI 10.1016/S0014-5793(98)00425-6	30	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					9262	9272		10.1074/jbc.M114.594911	http://dx.doi.org/10.1074/jbc.M114.594911			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25694430	Green Published, hybrid			2022-12-26	WOS:000352207100047
J	Okon, IS; Coughlan, KA; Zhang, M; Wang, QX; Zou, MH				Okon, Imoh S.; Coughlan, Kathleen A.; Zhang, Miao; Wang, Qiongxin; Zou, Ming-Hui			Gefitinib-mediated Reactive Oxygen Specie (ROS) Instigates Mitochondrial Dysfunction and Drug Resistance in Lung Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; EPITHELIAL-MESENCHYMAL TRANSITION; ADHESION MOLECULES; OXIDATIVE STRESS; KINASE DOMAIN; EGFR KINASE; FASCIN; CD44; MUTATIONS; VIMENTIN	Therapeutic benefits offered by tyrosine kinase inhibitors (TKIs), such as gefitinib (Iressa) and erlotinib (Tarceva), are limited due to the development of resistance, which contributes to treatment failure and cancer-related mortality. The aim of this study was to elucidate mechanistic insight into cellular perturbations that accompany acquired gefitinib resistance in lung cancer cells. Several lung adenocarcinoma (LAD) cell lines were screened to characterize epidermal growth factor receptor (EGFR) expression and mutation profile. To circumvent intrinsic variations between cell lines with respect to response to drug treatments, we generated gefitinib-resistant H1650 clone by long-term, chronic culture under gefitinib selection of parental cell line. Isogenic cells were analyzed by microarray, Western blot, flow cytometry, and confocal and transmission electron microscope. We observed that although chronic gefitinib treatment provided effective action against its primary target (aberrant EGFR activity), secondary effects resulted in increased cellular reactive oxygen species (ROS). Gefitinib-mediated ROS correlated with epithelial-mesenchymal transition, as well as striking perturbation of mitochondrial morphology and function. However, gefitinib treatment in the presence of ROS scavenger provided a partial rescue of mitochondrial aberrations. Furthermore, withdrawal of gefitinib from previously resistant clones correlated with normalized expression of epithelial-mesenchymal transition genes. These findings demonstrate that chronic gefitinib treatment promotes ROS and mitochondrial dysfunction in lung cancer cells. Antioxidants may alleviate ROS-mediated resistance.	[Okon, Imoh S.; Coughlan, Kathleen A.; Zhang, Miao; Wang, Qiongxin; Zou, Ming-Hui] Univ Oklahoma, Hlth Sci Ctr, Sect Mol Med, Oklahoma City, OK 73104 USA; [Zou, Ming-Hui] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Zou, MH (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Med, BSEB 306A,941 Stanton L Young Blvd, Oklahoma City, OK 73104 USA.	ming-hui-zou@ouhsc.edu	Kim, Han/AAA-5787-2021; Kim, Jonghan/AAH-9562-2021	Kim, Jonghan/0000-0002-6473-6186	National Institutes of Health [HL079584, HL080499, HL074399, HL089920, HL096032, HL105157, HL110488, AG047776]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074399, R01HL110488, R01HL080499, R01HL089920, R01HL096032, R01HL105157, R01HL079584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG047776] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants (HL079584, HL080499, HL074399, HL089920, HL096032, HL105157, HL110488, and AG047776) from the National Institutes of Health to M. H. Z.	Adams JC, 2004, CURR OPIN CELL BIOL, V16, P590, DOI 10.1016/j.ceb.2004.07.009; Alam H, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-32; Amann J, 2005, CANCER RES, V65, P226; Arumugam T, 2009, CANCER RES, V69, P5820, DOI 10.1158/0008-5472.CAN-08-2819; Bourguignon LYW, 1997, J BIOL CHEM, V272, P27913, DOI 10.1074/jbc.272.44.27913; Cabiscol E, 2000, J BIOL CHEM, V275, P27393; Calvert TJ, 2008, AM J PHYSIOL-HEART C, V294, pH1621, DOI 10.1152/ajpheart.01008.2007; Chang L, 2004, NAT REV MOL CELL BIO, V5, P601, DOI 10.1038/nrm1438; Chen JL, 2014, ADV MECH ENG, DOI 10.1155/2014/712740; Chernoivanenko IS, 2013, RUSS J DEV BIOL+, V44, P144, DOI 10.1134/S1062360413030016; Cichy J, 2003, J CELL BIOL, V161, P839, DOI 10.1083/jcb.200302098; Cragg MS, 2007, PLOS MED, V4, P1681, DOI 10.1371/journal.pmed.0040316; Dutsch-Wicherek M, 2010, AM J REPROD IMMUNOL, V63, P181, DOI 10.1111/j.1600-0897.2009.00803.x; Gazdar AF, 2009, ONCOGENE, V28, pS24, DOI 10.1038/onc.2009.198; Goodison S, 1999, J CLIN PATHOL-MOL PA, V52, P189; Gschwind A, 2004, NAT REV CANCER, V4, P361, DOI 10.1038/nrc1360; Hashimoto Y, 2005, INT J BIOCHEM CELL B, V37, P1787, DOI 10.1016/j.biocel.2005.05.004; Hoelzle MK, 2012, MOL BIOL CELL, V23, P310, DOI 10.1091/mbc.E11-08-0719; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Ivaska J, 2007, EXP CELL RES, V313, P2050, DOI 10.1016/j.yexcr.2007.03.040; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Martin E, 2005, J NEUROSCI RES, V79, P240, DOI 10.1002/jnr.20293; Mendez MG, 2010, FASEB J, V24, P1838, DOI 10.1096/fj.09-151639; Nieminen M, 2006, NAT CELL BIOL, V8, P156, DOI 10.1038/ncb1355; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167; Sayin VI, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007653; Shan YB, 2012, CELL, V149, P860, DOI 10.1016/j.cell.2012.02.063; SOMMERS CL, 1992, CANCER RES, V52, P5190; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Stewart CJR, 2012, J CLIN PATHOL, V65, P213, DOI 10.1136/jclinpath-2011-200425; THOMPSON EW, 1994, CLIN EXP METASTAS, V12, P181, DOI 10.1007/BF01753886; Uramoto H, 2010, ANTICANCER RES, V30, P2513; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Voulgari A, 2009, BBA-REV CANCER, V1796, P75, DOI 10.1016/j.bbcan.2009.03.002; Willcox JK, 2004, CRIT REV FOOD SCI, V44, P275, DOI 10.1080/10408690490468489; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zanet J, 2012, J CELL BIOL, V197, P477, DOI 10.1083/jcb.201110135; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023	44	64	68	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					9101	9110		10.1074/jbc.M114.631580	http://dx.doi.org/10.1074/jbc.M114.631580			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25681445	hybrid, Green Published			2022-12-26	WOS:000352207100033
J	Kelwick, R; Kopniczky, M; Bower, I; Chi, WQ; Chin, MHW; Fan, S; Pilcher, J; Strutt, J; Webb, AJ; Jensen, K; Stan, GB; Kitney, R; Freemont, P				Kelwick, Richard; Kopniczky, Margarita; Bower, Iain; Chi, Wenqiang; Chin, Matthew Ho Wai; Fan, Sisi; Pilcher, Jemma; Strutt, James; Webb, Alexander J.; Jensen, Kirsten; Stan, Guy-Bart; Kitney, Richard; Freemont, Paul			A Forward-Design Approach to Increase the Production of Poly-3-Hydroxybutyrate in Genetically Engineered Escherichia coli	PLOS ONE			English	Article							RALSTONIA-EUTROPHA; POLY(3-HYDROXYBUTYRATE); POLYHYDROXYALKANOATES	Biopolymers, such as poly-3-hydroxybutyrate (P(3HB)) are produced as a carbon store in an array of organisms and exhibit characteristics which are similar to oil-derived plastics, yet have the added advantages of biodegradability and biocompatibility. Despite these advantages, P(3HB) production is currently more expensive than the production of oil-derived plastics, and therefore, more efficient P(3HB) production processes would be desirable. In this study, we describe the model-guided design and experimental validation of several engineered P(3HB) producing operons. In particular, we describe the characterization of a hybrid phaCAB operon that consists of a dual promoter (native and J23104) and RBS (native and B0034) design. P(3HB) production at 24 h was around six-fold higher in hybrid phaCAB engineered Escherichia coli in comparison to E. coli engineered with the native phaCAB operon from Ralstonia eutropha H16. Additionally, we describe the utilization of non-recyclable waste as a low-cost carbon source for the production of P(3HB).	[Kelwick, Richard; Kopniczky, Margarita; Bower, Iain; Chi, Wenqiang; Chin, Matthew Ho Wai; Fan, Sisi; Pilcher, Jemma; Strutt, James; Webb, Alexander J.; Jensen, Kirsten; Stan, Guy-Bart; Kitney, Richard; Freemont, Paul] Ctr Synthet Biol & Innovat, London, England; [Kelwick, Richard; Kopniczky, Margarita; Webb, Alexander J.; Jensen, Kirsten; Freemont, Paul] Dept Med, London, England; [Bower, Iain; Fan, Sisi; Pilcher, Jemma; Strutt, James] Dept Life Sci, London, England; [Chi, Wenqiang; Chin, Matthew Ho Wai; Stan, Guy-Bart; Kitney, Richard] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England	Imperial College London	Kelwick, R (corresponding author), Ctr Synthet Biol & Innovat, South Kensington Campus, London, England.	r.kelwick@imperial.ac.uk; r.kitney@imperial.ac.uk; p.freemont@imperial.ac.uk		Kelwick, Richard/0000-0002-0054-6893; Kitney, Richard/0000-0002-6499-5209; Webb, Alexander/0000-0002-7782-269X; Stan, Guy-Bart/0000-0002-5560-902X; Chin, Matthew/0000-0003-1633-7786	EPSRC [EP/K034359/1, EP/J02175X/1]; Bill and Melinda Gates Foundation [OPP1046311]; Wellcome Trust [084369/Z/07/Z]; ERASysBio; GeneArt; Eppendorf; Bioline; Powerday; EPSRC [EP/M002187/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/M002187/1, EP/J02175X/1, EP/K034359/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); ERASysBio; GeneArt; Eppendorf; Bioline; Powerday; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	EPSRC [EP/K034359/1; EP/J02175X/1], Bill and Melinda Gates Foundation [OPP1046311], The Wellcome Trust [084369/Z/07/Z]. The authors would also like to thank the companies Eppendorf (http://www.eppendorf.com/UK-en/), Bioline (www.bioline.com/), GeneArt (http://www.lifetechnologies.com/uk/en/home/life-science/cloning/gene-synthesis/geneart-gene-synthesis.html), Powerday (http://www.powerday.co.uk/), and additionally ERASysBio (www.erasysbio.net/) for sponsoring the 2013 Imperial College London iGEM project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Harding KG, 2007, J BIOTECHNOL, V130, P57, DOI 10.1016/j.jbiotec.2007.02.012; Heinrich D, 2012, AMB EXPRESS, V2, DOI 10.1186/2191-0855-2-59; Hiroe A, 2012, APPL ENVIRON MICROB, V78, P3177, DOI 10.1128/AEM.07715-11; Jensen JW, 2013, METHODS PROCESSING M; Kelly Jason R, 2009, J Biol Eng, V3, P4, DOI 10.1186/1754-1611-3-4; Kelwick R, 2014, FRONTIERS BIOENGINEE, V2, DOI [10.3389/fbioe.2014.00083, DOI 10.3389/FBIOE.2014.00083]; Le Meur S, 2013, MICROB CELL FACT, V12, DOI [10.1186/1475-2859-12-129, DOI 10.1186/1475-2859-12-129]; Lee JH, 2013, APPL BIOCHEM BIOTECH, V170, P1767, DOI 10.1007/s12010-013-0311-2; Li MJ, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-19; Li ZJ, 2009, APPL MICROBIOL BIOT, V83, P939, DOI 10.1007/s00253-009-1943-6; Muller S, 1999, J BIOTECHNOL, V75, P81, DOI 10.1016/S0168-1656(99)00130-3; Philp JC, 2013, NEW BIOTECHNOL, V30, P635, DOI 10.1016/j.nbt.2012.11.021; Quinn JP, 2013, 93 BBF RFC; Raberg M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095907; Salehizadeh H, 2004, BIOTECHNOL ADV, V22, P261, DOI 10.1016/j.biotechadv.2003.09.003; Shakeri S, 2011, JUNDISHAPUR J MICROB, V4, P229; SLATER SC, 1988, J BACTERIOL, V170, P4431, DOI 10.1128/jb.170.10.4431-4436.1988; Sudesh K, 2000, PROG POLYM SCI, V25, P1503, DOI 10.1016/S0079-6700(00)00035-6; Verlinden RAJ, 2007, J APPL MICROBIOL, V102, P1437, DOI 10.1111/j.1365-2672.2007.03335.x; Weaver DS, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-79; Yang JE, 2014, APPL MICROBIOL BIOT, V98, P95, DOI 10.1007/s00253-013-5285-z	21	6	6	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0117202	10.1371/journal.pone.0117202	http://dx.doi.org/10.1371/journal.pone.0117202			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25699671	Green Published, Green Submitted, gold			2022-12-26	WOS:000349789800019
J	Bales, EK; Hyman, OJ; Loudon, AH; Harris, RN; Lipps, G; Chapman, E; Roblee, K; Kleopfer, JD; Terrell, KA				Bales, Emma K.; Hyman, Oliver J.; Loudon, Andrew H.; Harris, Reid N.; Lipps, Gregory; Chapman, Eric; Roblee, Kenneth; Kleopfer, John D.; Terrell, Kimberly A.			Pathogenic Chytrid Fungus Batrachochytrium dendrobatidis, but Not B. salamandrivorans, Detected on Eastern Hellbenders	PLOS ONE			English	Article							CRYPTOBRANCHUS-ALLEGANIENSIS-ALLEGANIENSIS; EMERGING DISEASE; CHYTRIDIOMYCOSIS; AMPHIBIANS; POPULATIONS; INFECTION; USA	Recent worldwide declines and extinctions of amphibian populations have been attributed to chytridiomycosis, a disease caused by the pathogenic fungus Batrachochytrium dendrobatidis (Bd). Until recently, Bd was thought to be the only Batrachochytrium species that infects amphibians; however a newly described species, Batrachochytrium salamandrivorans (Bs), is linked to die-offs in European fire salamanders (Salamandra salamandra). Little is known about the distribution, host range, or origin of Bs. In this study, we surveyed populations of an aquatic salamander that is declining in the United States, the eastern hellbender (Cryptobranchus alleganiensis alleganiensis), for the presence of Bs and Bd. Skin swabs were collected from a total of 91 individuals in New York, Pennsylvania, Ohio, and Virginia, and tested for both pathogens using duplex qPCR. Bs was not detected in any samples, suggesting it was not present in these hellbender populations (0% prevalence, 95% confidence intervals of 0.0-0.04). Bd was found on 22 hellbenders (24% prevalence, 95% confidence intervals of 0.16 <= 0.24 <= 0.34), representing all four states. All positive samples had low loads of Bd zoospores (12.7 +/- 4.9 S.E.M. genome equivalents) compared to other Bd susceptible species. More research is needed to determine the impact of Batrachochytrium infection on hellbender fitness and population viability. In particular, understanding how hellbenders limit Bd infection intensity in an aquatic environment may yield important insights for amphibian conservation. This study is among the first to evaluate the distribution of Bs in the United States, and is consistent with another, which failed to detect Bs in the U.S. Knowledge about the distribution, host-range, and origin of Bs may help control the spread of this pathogen, especially to regions of high salamander diversity, such as the eastern United States.	[Bales, Emma K.; Hyman, Oliver J.; Loudon, Andrew H.; Harris, Reid N.] James Madison Univ, Dept Biol, Harrisonburg, VA 22807 USA; [Lipps, Gregory] Gregory Lipps LLC, Toledo, OH USA; [Chapman, Eric] Western Penn Conservancy, Pittsburgh, PA USA; [Roblee, Kenneth] New York Dept Environm Conservat, Albany, NY USA; [Kleopfer, John D.] Virginia Dept Game & Inland Fisheries, Richmond, VA USA; [Terrell, Kimberly A.] Smithsonian Conservat Biol Inst, Front Royal, VA 22630 USA	James Madison University; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Terrell, KA (corresponding author), Smithsonian Conservat Biol Inst, Front Royal, VA 22630 USA.	terrellk@si.edu	Lipps, Gregory J/A-5995-2018	Lipps, Gregory J/0000-0002-8518-873X	Columbus Zoo; Aquarium Conservation fund; National Science Foundation [1136602]	Columbus Zoo; Aquarium Conservation fund; National Science Foundation(National Science Foundation (NSF))	Funding was provided by the Columbus Zoo and Aquarium Conservation fund (Grant awarded to RNH and AHL) https://globalimpact. columbuszoo.org/about/columbus-zoo-fund-forconservation and National Science Foundation grant 1136602 (awarded to RNH) http://www.nsf.gov/funding/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Author GL is the owner and sole employee of Gregory Lipps, LLC. Gregory Lipps, LLC provided support in the form of salary for author GL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the author contributions' section.	[Anonymous], 2010, SALAMANDERS US CANAD; Becker MH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010957; Blooi M, 2013, J CLIN MICROBIOL, V51, P4173, DOI 10.1128/JCM.02313-13; Bodinof CM, 2011, DIS AQUAT ORGAN, V96, P1, DOI 10.3354/dao02380; Briggler Jeffrey T., 2008, Herpetological Review, V39, P443; Briggler Jeffrey T., 2007, Herpetological Review, V38, P174; Burgmeier NG, 2011, J WILDLIFE DIS, V47, P836, DOI 10.7589/0090-3558-47.4.836; Furniss L.L., 2003, CONSERVATION ASSESSM; Garmyn A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035038; Goka K, 2009, MOL ECOL, V18, P4757, DOI 10.1111/j.1365-294X.2009.04384.x; Goyner JL, 2011, HERPETOLOGICAL REV, V42, P58; Harris RN, 2009, ISME J, V3, P818, DOI 10.1038/ismej.2009.27; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; Hyman OJ, 2012, DIS AQUAT ORGAN, V97, P185, DOI 10.3354/dao02423; Junge RE, 2012, FOWLERS ZOO WILD ANI, V7, P260; Kilpatrick AM, 2010, TRENDS ECOL EVOL, V25, P109, DOI 10.1016/j.tree.2009.07.011; Kolby JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089660; Martel A, 2013, P NATL ACAD SCI USA, V110, P15325, DOI 10.1073/pnas.1307356110; Mayasich J., 2003, E HELLBENDER STATUS; McMahon TA, 2013, P NATL ACAD SCI USA, V110, P210, DOI 10.1073/pnas.1200592110; Muletz C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103728; Nickerson CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028906; Nickerson M, 1973, HELLBENDERS N AM GIA; Parris MJ, 2004, ECOLOGY, V85, P3385, DOI 10.1890/04-0383; PETERSON CL, 1983, COPEIA, P225, DOI 10.2307/1444718; Reeder NMM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033567; Regester Kurt J., 2012, Herpetological Review, V43, P90; Schulte-Hostedde AI, 2005, ECOLOGY, V86, P155, DOI 10.1890/04-0232; Souza MJ, 2012, J WILDLIFE DIS, V48, P560, DOI 10.7589/0090-3558-48.3.560; Terrell KA, 2013, J EXP BIOL, V216, P4204, DOI 10.1242/jeb.089896; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Wheeler BA, 2003, BIOL CONSERV, V109, P151, DOI 10.1016/S0006-3207(02)00136-2; Wyngaard G.A., 1982, P485; Zhu W, 2014, CURR ZOOL, V60, P729, DOI 10.1093/czoolo/60.6.729; Zhu W, 2014, ECOHEALTH, V11, P241, DOI 10.1007/s10393-013-0894-7	35	30	32	2	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0116405	10.1371/journal.pone.0116405	http://dx.doi.org/10.1371/journal.pone.0116405			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695636	Green Submitted, Green Published, gold			2022-12-26	WOS:000350062300013
J	Hong, M; Kim, SW; Han, SH; Kim, DJ; Suk, KT; Kim, YS; Kim, MJ; Kim, MY; Baik, SK; Ham, YL				Hong, Meegun; Kim, Seung Woo; Han, Sang Hak; Kim, Dong Joon; Suk, Ki Tae; Kim, Yeon Soo; Kim, Myong Jo; Kim, Moon Young; Baik, Soon Koo; Ham, Young Lim			Probiotics (Lactobacillus rhamnosus R0011 and acidophilus R0052) Reduce the Expression of Toll-Like Receptor 4 in Mice with Alcoholic Liver Disease	PLOS ONE			English	Article							RHUS-VERNICIFERA STOKES; GINSENG PANAX-GINSENG; URUSHIOL COMPONENT; INJURY; CELLS; STEATOHEPATITIS; ANTIBACTERIAL; INFLAMMATION; MODULATION; ACTIVATION	Objective The role of lipopolysaccharide (LPS) and toll-like receptor 4 (TLR 4) in the pathogenesis of alcoholic liver disease (ALD) has been widely established. We evaluated the biological effects of probiotics (Lactobacillus rhamnosus R0011 and acidophilus R0052), KRG (Korea red ginseng), and urushiol (Rhus verniciflua Stokes) on ALD, including their effects on normal and high-fat diet in mice. Methods One hundred C57BL/6 mice were classified into normal (N) and high-fat diet (H) groups. Each group was divided into 5 sub-groups: control, alcohol, alcohol+probiotics, alcohol+KRG, and alcohol+urushiol. A liver function test, histology, electron-microscopy, interleukin (IL)-1 beta, tumor necrosis factor (TNF)-alpha, IL-6, and IL-10, and TLR 4 were evaluated and compared. Results In the N group, probiotics, KRG, and urushiol significantly reduced levels of TNF-alpha (12.3 +/- 5.1, 13.4 +/- 3.9, and 12.1 +/- 4.3 vs. 27.9 +/- 15.2 pg/mL) and IL-1 beta (108.4 +/- 39.4, 75.0 +/- 51.0, and 101.1 +/- 26.8 vs. 162.4 +/- 37.5 pg/mL), which were increased by alcohol. Alcohol-induced TLR 4 expression was reduced by probiotics and urushiol (0.7 +/- 0.2, and 0.8 +/- 0.1 vs. 1.0 +/- 0.3, p<0.001). In the H group, IL-10 was significantly increased by probiotics and KRG, compared with alcohol (25.3 +/- 15.6 and 20.4 +/- 6.2 vs. 7.6 +/- 5.6 pg/mL) and TLR 4 expression was reduced by probiotics (0.8 +/- 0.2 vs. 1.0 +/- 0.3, p = 0.007). Conclusions Alcohol-induced TLR 4 expression was down-regulated by probiotics in the normal and high-fat diet groups. Probiotics, KRG, and urushiol might be effective in the treatment of ALD by regulating the gut-liver axis.	[Hong, Meegun; Kim, Dong Joon; Suk, Ki Tae; Kim, Yeon Soo] Hallym Univ, Coll Med, Dept Internal Med, Chunchon, South Korea; [Kim, Seung Woo] Hallym Univ, Dept Biomed Sci, Coll Med, Chunchon, South Korea; [Han, Sang Hak] Hallym Univ, Coll Med, Dept Pathol, Chunchon, South Korea; [Suk, Ki Tae] Columbia Univ, Dept Med, New York, NY USA; [Kim, Myong Jo] Kangwon Natl Univ, Coll Agr & Life Sci, Chunchon, South Korea; [Kim, Moon Young; Baik, Soon Koo] Yonsei Univ, Wonju Coll Med, Dept Internal Med, Wonju, South Korea; [Ham, Young Lim] Daewon Univ Coll, Dept Emergency Med Technol, Jecheon, South Korea	Hallym University; Hallym University; Hallym University; Columbia University; Kangwon National University; Yonsei University	Suk, KT (corresponding author), Hallym Univ, Coll Med, Dept Internal Med, Chunchon, South Korea.	ktsuk@hallym.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2010-0021482]; Cooperative Research Program for Agriculture Science and Technology Development, Rural Development Administration, Republic of Korea [PJ009859]; Hallym University Research Fund	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; Cooperative Research Program for Agriculture Science and Technology Development, Rural Development Administration, Republic of Korea; Hallym University Research Fund	This research was partly supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-2010-0021482), and by a grant of from the support of Cooperative Research Program for Agriculture Science and Technology Development (Project No. PJ009859) Rural Development Administration, Republic of Korea. This research was supported by Hallym University Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bang CS, 2014, J GINSENG RES, V38, P167, DOI 10.1016/j.jgr.2014.04.002; Bergheim I, 2011, ANN NY ACAD SCI, V1216, P41, DOI 10.1111/j.1749-6632.2010.05833.x; Brandon-Warner E, 2012, ALCOHOL, V46, P715, DOI 10.1016/j.alcohol.2012.08.004; Bull-Otterson L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053028; De Vito R, 2012, INT J MOL MED, V30, P49, DOI 10.3892/ijmm.2012.965; dos Santos B, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/594958; Dunn W, 2008, HEPATOLOGY, V47, P1947, DOI 10.1002/hep.22292; Elamin E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035008; Enomoto N, 1998, GASTROENTEROLOGY, V115, P443, DOI 10.1016/S0016-5085(98)70211-2; Estadella D, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/137579; Forsyth CB, 2009, ALCOHOL, V43, P163, DOI 10.1016/j.alcohol.2008.12.009; Foster LM, 2011, BENEF MICROBES, V2, P319, DOI 10.3920/BM2011.0032; Gabbard SL, 2013, DIG DIS SCI; Gao B, 2012, J GASTROEN HEPATOL, V27, P89, DOI 10.1111/j.1440-1746.2011.07003.x; Hong SH, 2013, FOOD CHEM TOXICOL, V55, P586, DOI 10.1016/j.fct.2013.01.022; Inokuchi S, 2011, ALCOHOL CLIN EXP RES, V35, P1509, DOI 10.1111/j.1530-0277.2011.01487.x; Karlsson M, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-15; Kim TW, 2012, INT IMMUNOPHARMACOL, V12, P110, DOI 10.1016/j.intimp.2011.10.023; Ko JH, 2006, ENVIRON TOXICOL PHAR, V22, P8, DOI 10.1016/j.etap.2005.10.005; Koretz RL, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008344.pub2; Lee DS, 2010, INT IMMUNOPHARMACOL, V10, P850, DOI 10.1016/j.intimp.2010.04.019; Li N, 2009, PEDIATR RES, V66, P203, DOI 10.1203/PDR.0b013e3181aabd4f; Li YG, 2010, ALCOHOL ALCOHOLISM, V45, P320, DOI 10.1093/alcalc/agq034; Liu Q, 2004, HEPATOLOGY, V39, P1441, DOI 10.1002/hep.20194; Liu YY, 2012, AM J PHYSIOL-GASTR L, V302, pG608, DOI 10.1152/ajpgi.00266.2011; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Nettleton JA, 2010, ATHEROSCLEROSIS, V212, P260, DOI 10.1016/j.atherosclerosis.2010.04.026; Ozer J, 2008, TOXICOLOGY, V245, P194, DOI 10.1016/j.tox.2007.11.021; Park HM, 2012, J ETHNOPHARMACOL, V141, P1071, DOI 10.1016/j.jep.2012.03.038; Park SM, 2012, BIOL PHARM BULL, V35, P1546, DOI 10.1248/bpb.b12-00393; Peng JH, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/234987; Peng XD, 2009, BIOCHEM BIOPH RES CO, V388, P31, DOI 10.1016/j.bbrc.2009.07.099; Petrasek J, 2013, ADV CLIN CHEM, V59, P155, DOI 10.1016/B978-0-12-405211-6.00006-1; Plauth M, 2006, CLIN NUTR, V25, P285, DOI 10.1016/j.clnu.2006.01.018; Rao R, 2009, HEPATOLOGY, V50, P638, DOI 10.1002/hep.23009; Ren YA, 2011, MOL BIOL REP, V38, P879, DOI 10.1007/s11033-010-0180-5; Roh YS, 2013, J GASTROEN HEPATOL, V28, P38, DOI 10.1111/jgh.12019; Room R, 2005, LANCET, V365, P519, DOI 10.1016/S0140-6736(05)70276-2; Seth D, 2011, J GASTROEN HEPATOL, V26, P1089, DOI 10.1111/j.1440-1746.2011.06756.x; Suk KT, 2011, HELICOBACTER, V16, P434, DOI 10.1111/j.1523-5378.2011.00864.x; Suk KT, 2010, J KOREAN MED SCI, V25, P399, DOI 10.3346/jkms.2010.25.3.399; Szabo G, 2010, WORLD J GASTROENTERO, V16, P1321, DOI 10.3748/wjg.v16.i11.1321; Theise ND, 2007, MODERN PATHOL, V20, pS3, DOI 10.1038/modpathol.3800693; Wang YH, 2011, AM J PATHOL, V179, P2866, DOI 10.1016/j.ajpath.2011.08.039; Wang YZ, 2013, INT IMMUNOPHARMACOL, V15, P30, DOI 10.1016/j.intimp.2012.10.026	45	47	50	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117451	10.1371/journal.pone.0117451	http://dx.doi.org/10.1371/journal.pone.0117451			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692549	Green Published, Green Submitted, gold			2022-12-26	WOS:000350061500056
J	Parsons, TE; Downey, CM; Jirik, FR; Hallgrimsson, B; Jamniczky, HA				Parsons, Trish E.; Downey, Charlene M.; Jirik, Frank R.; Hallgrimsson, Benedikt; Jamniczky, Heather A.			Mind the Gap: Genetic Manipulation of Basicranial Growth within Synchondroses Modulates Calvarial and Facial Shape in Mice through Epigenetic Interactions	PLOS ONE			English	Article							MORPHOLOGICAL INTEGRATION; EVOLUTION; MODULARITY; BRAIN; EVOLVABILITY; CONSTRAINT; FOREBRAIN; SULFATE; MATRIX; MOUSE	Phenotypic integration patterns in the mammalian skull have long been a focus of intense interest as a result of their suspected influence on the trajectory of hominid evolution. Here we test the hypothesis that perturbation of cartilage growth, which directly affects only the chondrocranium during development, will produce coordinated shape changes in the adult calvarium and face regardless of mechanism. Using two murine models of cartilage undergrowth that target two very different mechanisms, we show that strong reduction in cartilage growth produces a short, wide, and more flexed cranial base. This in turn produces a short, wide face in both models. Cranial base and face are already correlated early in ontogeny, and the relationship between these modules gains structure through postnatal growth and development. These results provide further evidence that there exist physical interactions between developing parts of the phenotype that produce variation at a distance from the actual locus upon which a particular selective pressure is acting. Phenotypic changes observed over the course of evolution may not all require adaptationist explanations; rather, it is likely that a substantial portion of observed phenotypic variation over the history of a clade is not directly adaptive but rather a secondary consequence of some local response to selection.	[Parsons, Trish E.; Downey, Charlene M.; Jirik, Frank R.; Hallgrimsson, Benedikt; Jamniczky, Heather A.] Univ Calgary, McCaig Inst Bone & Joint Hlth, Calgary, AB, Canada; [Parsons, Trish E.; Hallgrimsson, Benedikt; Jamniczky, Heather A.] Univ Calgary, Cumming Sch Med, Dept Cell Biol & Anat, Calgary, AB, Canada; [Downey, Charlene M.; Jirik, Frank R.] Univ Calgary, Dept Biochem & Mol Biol, Cumming Sch Med, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary	Jamniczky, HA (corresponding author), Univ Calgary, McCaig Inst Bone & Joint Hlth, Calgary, AB, Canada.	hajamnic@ucalgary.ca	Hallgrimsson, Benedikt/A-9616-2008	Hallgrimsson, Benedikt/0000-0002-7192-9103; Jamniczky, Heather/0000-0002-2514-8226	Natural Sciences and Engineering Research Council of Canada [238992-12]; Genome Canada; National Institutes of Health [1R01DE01963, 1R01DE021708]; Canadian Institute for Health Research (multiple); Canada Research Chairs Program; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019638, R01DE021708] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Genome Canada(Genome Canada); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institute for Health Research (multiple)(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs Program(Canada Research Chairs); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Support was provided to BH by: the Natural Sciences and Engineering Research Council of Canada 238992-12; Genome Canada; and to FRJ by the National Institutes of Health 1R01DE01963; National Institutes of Health 1R01DE021708; Canadian Institute for Health Research (multiple); Canada Research Chairs Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann RR, 2004, PHENOTYPIC INTEGRATION: STUDYING THE ECOLOGY AND EVOLUTION OF COMPLEX PHENOTYPES, P302; Bastir M, 2006, ARCH ORAL BIOL, V51, P814, DOI 10.1016/j.archoralbio.2006.03.009; Bastir M, 2010, J HUM EVOL, V58, P424, DOI 10.1016/j.jhevol.2010.03.001; Biegert J., 1963, Publications in Anthropology Viking Fund, V37, P116; Boughner JC, 2008, J ANAT, V213, P646, DOI 10.1111/j.1469-7580.2008.00999.x; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; CHEVERUD JM, 1982, EVOLUTION, V36, P499, DOI 10.1111/j.1558-5646.1982.tb05070.x; Cheverud JM, 1996, AM ZOOL, V36, P44; Darwin C, 1859, ORIGIN SPECIES MEANS; de Beer G., 1937, DEV VERTEBRATE SKULL; Downey CM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000616; Enlow D. H., 1990, FACIAL GROWTH; Ford-Hutchinson AF, 2007, J BONE MINER RES, V22, P1245, DOI 10.1359/JBMR.070420; GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086; Hallgrimsson B, 2007, EVOL DEV, V9, P76, DOI 10.1111/j.1525-142X.2006.00139.x; Hallgrimsson B, 2006, EVOL DEV, V8, P61, DOI 10.1111/j.1525-142X.2006.05075.x; Hallgrimsson B, 2008, INTEGR COMP BIOL, V48, P373, DOI 10.1093/icb/icn076; Hallgrimsson B, 2009, EVOL BIOL, V36, P355, DOI 10.1007/s11692-009-9076-5; Hansen TF, 2008, J EVOLUTION BIOL, V21, P1201, DOI 10.1111/j.1420-9101.2008.01573.x; Hendrikse JL, 2007, EVOL DEV, V9, P393, DOI 10.1111/j.1525-142X.2007.00176.x; Hu D, 2009, DEVELOPMENT, V136, P107, DOI 10.1242/dev.026583; Jamniczky HA, 2014, BIOL J LINN SOC, V111, P375, DOI 10.1111/bij.12203; Jamniczky HA, 2011, EVOL DEV, V13, P28, DOI 10.1111/j.1525-142X.2010.00453.x; Jamniczky HA, 2010, BIOESSAYS, V32, P553, DOI 10.1002/bies.200900189; Jamniczky HA, 2009, EVOLUTION, V63, P1540, DOI 10.1111/j.1558-5646.2009.00651.x; Jernvall J, 2000, P NATL ACAD SCI USA, V97, P2641, DOI 10.1073/pnas.050586297; Jones AG, 2007, EVOLUTION, V61, P727, DOI 10.1111/j.1558-5646.2007.00071.x; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Klingenberg CP, 2009, EVOL DEV, V11, P405, DOI 10.1111/j.1525-142X.2009.00347.x; Kurima K, 1998, P NATL ACAD SCI USA, V95, P8681, DOI 10.1073/pnas.95.15.8681; Lieberman DE, 2008, J ANAT, V212, P720, DOI 10.1111/j.1469-7580.2008.00900.x; Lieberman DE, 2000, J HUM EVOL, V38, P291, DOI 10.1006/jhev.1999.0335; Lieberman DE, 2011, EVOLUTION HUMAN HEAD, DOI [10.1080/17437199.2011.587961, DOI 10.1080/17437199.2011.587961]; LYNCH M, 1990, AM NAT, V136, P727, DOI 10.1086/285128; Marcucio RS, 2011, GENESIS, V49, P177, DOI 10.1002/dvg.20710; Marcucio RS, 2005, DEV BIOL, V284, P48, DOI 10.1016/j.ydbio.2005.04.030; Marroig G, 2004, AM J PHYS ANTHROPOL, V125, P266, DOI 10.1002/ajpa.10421; Mitteroecker P, 2008, EVOLUTION, V62, P943, DOI 10.1111/j.1558-5646.2008.00321.x; Mitteroecker P, 2007, SYST BIOL, V56, P818, DOI 10.1080/10635150701648029; Mitteroecker P, 2011, EVOL BIOL, V38, P100, DOI 10.1007/s11692-011-9109-8; Newman SA, 2005, J EXP ZOOL PART B, V304B, P593, DOI 10.1002/jez.b.21066; ORKIN RW, 1976, DEV BIOL, V50, P82, DOI 10.1016/0012-1606(76)90069-5; Parsons KJ, 2012, AM NAT, V179, P64, DOI 10.1086/663200; Parsons TE, 2011, DEV DYNAM, V240, P2233, DOI 10.1002/dvdy.22729; Porto A, 2013, EVOLUTION, V67, P3305, DOI 10.1111/evo.12177; Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9; Richtsmeier JT, 2006, J EXP ZOOL PART B, V306B, P360, DOI 10.1002/jez.b.21092; Rohlf F. James, 1993, Monografias del Museo Nacional de Ciencias Naturales, V1993, P131; Rohlf FJ, 2000, SYST BIOL, V49, P740, DOI 10.1080/106351500750049806; Roseman CC, 2004, P NATL ACAD SCI USA, V101, P12824, DOI 10.1073/pnas.0402637101; ROSS CF, 1993, AM J PHYS ANTHROPOL, V91, P305, DOI 10.1002/ajpa.1330910306; Sanger TJ, 2011, J EXP ZOOL PART B, V316B, P146, DOI 10.1002/jez.b.21388; SCOTT JH, 1958, AM J PHYS ANTHROPOL, V16, P319, DOI 10.1002/ajpa.1330160305; Sperber G., 2010, CRANIOFACIAL EMBRYOG; WAGNER GP, 1990, Z ZOOL SYST EVOL, V28, P48; Wagner GP, 1996, EVOLUTION, V50, P967, DOI [10.2307/2410639, 10.1111/j.1558-5646.1996.tb02339.x]; Waters MJ, 2002, GROWTH HORM IGF RES, V12, P137, DOI 10.1016/S1096-6374(02)00018-7; Wiley DF, 2005, IEEE VISUALIZATION 2005, PROCEEDINGS, P431	58	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118355	10.1371/journal.pone.0118355	http://dx.doi.org/10.1371/journal.pone.0118355			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692674	gold, Green Published, Green Submitted			2022-12-26	WOS:000350061500117
J	Schulte, EM; Avena, NM; Gearhardt, AN				Schulte, Erica M.; Avena, Nicole M.; Gearhardt, Ashley N.			Which Foods May Be Addictive? The Roles of Processing, Fat Content, and Glycemic Load	PLOS ONE			English	Article							MULTILOCUS GENETIC PROFILE; BODY-MASS INDEX; OBESITY EPIDEMIC; ABUSE LIABILITY; MECHANICAL TURK; PALATABLE FOOD; ANIMAL-MODEL; DOPAMINE; REWARD; SUGAR	Objectives We propose that highly processed foods share pharmacokinetic properties (e.g. concentrated dose, rapid rate of absorption) with drugs of abuse, due to the addition of fat and/or refined carbohydrates and the rapid rate the refined carbohydrates are absorbed into the system, indicated by glycemic load (GL). The current study provides preliminary evidence for the foods and food attributes implicated in addictive-like eating. Design Cross-sectional. Setting University (Study One) and community (Study Two). Participants 120 undergraduates participated in Study One and 384 participants recruited through Amazon MTurk participated in Study Two. Measurements In Study One, participants (n = 120) completed the Yale Food Addiction Scale (YFAS) followed by a forced-choice task to indicate which foods, out of 35 foods varying in nutritional composition, were most associated with addictive-like eating behaviors. Using the same 35 foods, Study Two utilized hierarchical linear modeling to investigate which food attributes (e.g., fat grams) were related to addictive-like eating behavior (at level one) and explored the influence of individual differences for this association (at level two). Results In Study One, processed foods, higher in fat and GL, were most frequently associated with addictive-like eating behaviors. In Study Two, processing was a large, positive predictor for whether a food was associated with problematic, addictive-like eating behaviors. BMI and YFAS symptom count were small-to-moderate, positive predictors for this association. In a separate model, fat and GL were large, positive predictors of problematic food ratings. YFAS symptom count was a small, positive predictor of the relationship between GL and food ratings. Conclusion The current study provides preliminary evidence that not all foods are equally implicated in addictive-like eating behavior, and highly processed foods, which may share characteristics with drugs of abuse (e.g. high dose, rapid rate of absorption) appear to be particularly associated with "food addiction."	[Schulte, Erica M.; Gearhardt, Ashley N.] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA; [Avena, Nicole M.] Mt Sinai St Lukes Hosp, New York Obes Res Ctr, Dept Med, New York, NY USA	University of Michigan System; University of Michigan; Mount Sinai St. Luke's	Gearhardt, AN (corresponding author), Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA.	agearhar@umich.edu		LaFata, Erica/0000-0002-8505-6366; Gearhardt, Ashley/0000-0003-3843-5731	National Institute of Drug Abuse (NIDA) [DA-03123]; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA031230] Funding Source: NIH RePORTER	National Institute of Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institute of Drug Abuse (NIDA) DA-03123 (NA); URL: http://www.drugabuse.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avena NM, 2008, PHYSIOL BEHAV, V94, P309, DOI 10.1016/j.physbeh.2008.01.008; Avena NM, 2010, APPETITE, V55, P734, DOI 10.1016/j.appet.2010.09.010; Avena NM, 2009, J NUTR, V139, P623, DOI 10.3945/jn.108.097584; Bailey A, 2005, SYNAPSE, V57, P160, DOI 10.1002/syn.20168; Bartoshuk LM, 2004, PHYSIOL BEHAV, V82, P109, DOI 10.1016/j.physbeh.2004.02.033; Berinsky AJ, 2012, POLIT ANAL, V20, P351, DOI 10.1093/pan/mpr057; Bierut LJ, 2011, NEURON, V69, P618, DOI 10.1016/j.neuron.2011.02.015; Boggiano MM, 2007, INT J OBESITY, V31, P1357, DOI 10.1038/sj.ijo.0803614; Bulik CM, 2003, INT J EAT DISORDER, V33, P293, DOI 10.1002/eat.10140; Colantuoni C, 2001, NEUROREPORT, V12, P3549, DOI 10.1097/00001756-200111160-00035; Cottone P, 2008, NEUROPSYCHOPHARMACOL, V33, P524, DOI 10.1038/sj.npp.1301430; Davis C, 2013, PHYSIOL BEHAV, V118, P63, DOI 10.1016/j.physbeh.2013.05.014; Davis C, 2011, APPETITE, V57, P711, DOI 10.1016/j.appet.2011.08.017; Ebbeling C B, 2001, Adv Pediatr, V48, P179; Ebbeling CB, 2003, ARCH PEDIAT ADOL MED, V157, P773, DOI 10.1001/archpedi.157.8.773; Fowler L, 2014, EAT BEHAV, V15, P505, DOI 10.1016/j.eatbeh.2014.06.009; Galic MA, 2002, PSYCHOL REP, V90, P58, DOI 10.2466/pr0.2002.90.1.58; Gearhardt A, 2013, J LAW MED ETHICS, V41, P46, DOI 10.1111/jlme.12038; Gearhardt AN, 2013, BIOL PSYCHIAT, V73, P802, DOI 10.1016/j.biopsych.2012.07.024; Gearhardt Ashley N, 2011, Curr Drug Abuse Rev, V4, P201; Gearhardt Ashley N, 2011, Curr Drug Abuse Rev, V4, P140; Gearhardt AN, 2011, ARCH GEN PSYCHIAT, V68, P808, DOI 10.1001/archgenpsychiatry.2011.32; Gearhardt AN, 2011, ADDICTION, V106, P1208, DOI 10.1111/j.1360-0443.2010.03301.x; Gearhardt AN, 2009, J ADDICT MED, V3, P1, DOI 10.1097/ADM.0b013e318193c993; Gearhardt AN, 2009, APPETITE, V52, P430, DOI 10.1016/j.appet.2008.12.003; Grabenhorst F, 2014, HUM BRAIN MAPP, V35, P2521, DOI 10.1002/hbm.22346; HANNA JM, 1977, B NARCOTICS, V29, P63; HENNINGFIELD JE, 1993, J CONSULT CLIN PSYCH, V61, P743, DOI 10.1037/0022-006X.61.5.743; Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519; KLATSKY AL, 1990, BRIT J ADDICT, V85, P1279; Klump KL, 2013, INT J EAT DISORDER, V46, P729, DOI 10.1002/eat.22139; Koob GF, 2005, NAT NEUROSCI, V8, P1442, DOI 10.1038/nn1105-1442; Kuczmarski MF, 2001, J AM DIET ASSOC, V101, P28, DOI 10.1016/S0002-8223(01)00008-6; Lennerz BS, 2013, AM J CLIN NUTR, V98, P641, DOI 10.3945/ajcn.113.064113; Mokdad AH, 2000, JAMA-J AM MED ASSOC, V284, P1650, DOI 10.1001/jama.284.13.1650; Monteiro CA, 2010, CAD SAUDE PUBLICA, V26, P2039, DOI 10.1590/S0102-311X2010001100005; Nikolova YS, 2011, NEUROPSYCHOPHARMACOL, V36, P1940, DOI 10.1038/npp.2011.82; Oishi S, 2009, J EXP SOC PSYCHOL, V45, P913, DOI 10.1016/j.jesp.2009.04.028; Oswald KD, 2011, INT J EAT DISORDER, V44, P203, DOI 10.1002/eat.20808; Paolacci G, 2014, CURR DIR PSYCHOL SCI, V23, P184, DOI 10.1177/0963721414531598; Pelchat ML, 2002, PHYSIOL BEHAV, V76, P347, DOI 10.1016/S0031-9384(02)00757-6; Rada P, 2005, NEUROSCIENCE, V134, P737, DOI 10.1016/j.neuroscience.2005.04.043; Raudenbush SW, 2002, HIERARCHICAL LINEAR; RODIN J, 1991, APPETITE, V17, P177, DOI 10.1016/0195-6663(91)90020-S; Schneider W., 2002, E PRIME USERS GUIDE; Stice E, 2013, AM J CLIN NUTR, V98, P1377, DOI 10.3945/ajcn.113.069443; Stice E, 2012, J NEUROSCI, V32, P10093, DOI 10.1523/JNEUROSCI.1506-12.2012; Taubes G, 1998, SCIENCE, V280, P1367, DOI 10.1126/science.280.5368.1367; Thornley S, 2008, MED HYPOTHESES, V71, P709, DOI 10.1016/j.mehy.2008.07.006; VEREBEY K, 1988, PSYCHIAT ANN, V18, P513, DOI 10.3928/0048-5713-19880901-06; Volkow ND, 2013, OBES REV, V14, P2, DOI 10.1111/j.1467-789X.2012.01031.x; Volkow N D, 2012, Curr Top Behav Neurosci, V11, P1, DOI 10.1007/7854_2011_169; Wadden TA, 2004, OBES RES, V12, p151S, DOI 10.1038/oby.2004.282; Wang YF, 2008, OBESITY, V16, P2323, DOI 10.1038/oby.2008.351; White MA, 2010, OBESITY, V18, P1266, DOI 10.1038/oby.2009.347; Willett W, 2002, AM J CLIN NUTR, V76, p274S, DOI 10.1093/ajcn/76.1.274S; WOLEVER TMS, 1991, AM J CLIN NUTR, V54, P846, DOI 10.1093/ajcn/54.5.846; Wright SM, 2012, ABDOM IMAGING, V37, P730, DOI 10.1007/s00261-012-9862-x	58	317	321	3	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117959	10.1371/journal.pone.0117959	http://dx.doi.org/10.1371/journal.pone.0117959			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC0WZ	25692302	Green Published, gold, Green Submitted			2022-12-26	WOS:000350061500084
J	Tan, QQ; Zhu, L; Li, Y; Liu, W; Ma, WH; Lei, CL; Wang, XP				Tan, Qian-Qian; Zhu, Li; Li, Yi; Liu, Wen; Ma, Wei-Hua; Lei, Chao-Liang; Wang, Xiao-Ping			A De Novo Transcriptome and Valid Reference Genes for Quantitative Real-Time PCR in Colaphellus bowringi	PLOS ONE			English	Article							CABBAGE BEETLE; BACILLUS-THURINGIENSIS; DIAPAUSE; EXPRESSION; LEPIDOPTERA; COLEOPTERA; RESISTANCE; SELECTION; CLONING; MODEL	Background The cabbage beetle Colaphellus bowringi Baly is a serious insect pest of crucifers and undergoes reproductive diapause in soil. An understanding of the molecular mechanisms of diapause regulation, insecticide resistance, and other physiological processes is helpful for developing new management strategies for this beetle. However, the lack of genomic information and valid reference genes limits knowledge on the molecular bases of these physiological processes in this species. Results Using Illumina sequencing, we obtained more than 57 million sequence reads derived from C. bowringi, which were assembled into 39,390 unique sequences. A Clusters of Orthologous Groups classification was obtained for 9,048 of these sequences, covering 25 categories, and 16,951 were assigned to 255 Kyoto Encyclopedia of Genes and Genomes pathways. Eleven candidate reference gene sequences from the transcriptome were then identified through reverse transcriptase polymerase chain reaction. Among these candidate genes, EF1a, ACT1, and RPL19 proved to be the most stable reference genes for different reverse transcriptase quantitative polymerase chain reaction experiments in C. bowringi. Conversely, aTUB and GAPDH were the least stable reference genes. Conclusion The abundant putative C. bowringi transcript sequences reported enrich the genomic resources of this beetle. Importantly, the larger number of gene sequences and valid reference genes provide a valuable platform for future gene expression studies, especially with regard to exploring the molecular mechanisms of different physiological processes in this species.	[Tan, Qian-Qian; Zhu, Li; Li, Yi; Liu, Wen; Wang, Xiao-Ping] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Peoples R China; [Tan, Qian-Qian; Ma, Wei-Hua; Lei, Chao-Liang] Huazhong Agr Univ, Hubei Insect Resources Utilizat & Sustainable Pes, Wuhan, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University	Ma, WH (corresponding author), Huazhong Agr Univ, Hubei Insect Resources Utilizat & Sustainable Pes, Wuhan, Peoples R China.	weihuama@mail.hzau.edu.cn; xpwang@mail.hzau.edu.cn	Liu, Wen/S-8027-2019	Liu, Wen/0000-0002-4985-0618; Wang, Xiao-Ping/0000-0002-1718-1026; MA, WEIHUA/0000-0001-9521-2038	Natural Science Foundation of China [31272045]; Program for New Century Excellent Talents in University [NCET-12-0864]; Fundamental Research Funds for the Central Universities [2012ZYTS044, 2013PY028]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The research was supported by grants of the Natural Science Foundation of China (31272045), the Program for New Century Excellent Talents in University (NCET-12-0864) and the Fundamental Research Funds for the Central Universities (2012ZYTS044, 2013PY028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; Baker MB, 2008, AGR FOREST ENTOMOL, V10, P181, DOI 10.1111/j.1461-9563.2008.00370.x; Caron V, 2008, B ENTOMOL RES, V98, P317, DOI 10.1017/S0007485307005597; Chapuis MP, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-7; de Boer ME, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-54; Eisner E, 1997, LEADING EDGE, V16, P171; Fu W, 2013, INT J BIOL SCI, V9, P792, DOI 10.7150/ijbs.5862; Gao YL, 2011, PEST MANAG SCI, V67, P1076, DOI 10.1002/ps.2149; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Homma T, 2006, BIOCHEM BIOPH RES CO, V344, P386, DOI 10.1016/j.bbrc.2006.03.085; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kim M, 2010, J COMP PHYSIOL B, V180, P171, DOI 10.1007/s00360-009-0406-9; Kumar A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086012; Li RM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053006, 10.1371/journal.pone.0058597]; Lu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068059; Ma CH, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.14501; Mitsumasu K, 2008, INSECT MOL BIOL, V17, P185, DOI 10.1111/j.1365-2583.2008.00792.x; Paim Rafaela M., 2012, BMC Research Notes, V5, DOI 10.1186/1756-0500-5-128; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poelchau MF, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0143; Poelchau MF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-619; Ponton F, 2011, J INSECT PHYSIOL, V57, P840, DOI 10.1016/j.jinsphys.2011.03.014; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Rajarapu SP, 2012, INSECT SCI, V19, P41, DOI 10.1111/j.1744-7917.2011.01447.x; Rubio RO, 2011, INSECT BIOCHEM MOLEC, V41, P378, DOI 10.1016/j.ibmb.2011.02.007; Scharlaken B, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.3301; Schuster SC, 2008, NAT METHODS, V5, P16, DOI [10.1038/nmeth1156, 10.1038/NMETH1156]; Shen GM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-76; Shi Xiao-Qin, 2013, BMC Res Notes, V6, P93, DOI 10.1186/1756-0500-6-93; Sim C, 2008, P NATL ACAD SCI USA, V105, P6777, DOI 10.1073/pnas.0802067105; Sparks ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061190; Teng XL, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.6001; Van Hiel MB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-56; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang XP, 2004, J INSECT PHYSIOL, V50, P373, DOI 10.1016/j.jinsphys.2004.01.002; Xie FL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026980; Xue Fang-Sen, 2002, Acta Entomologica Sinica, V45, P494; Xue FS, 2002, J INSECT PHYSIOL, V48, P279, DOI 10.1016/S0022-1910(01)00172-X; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233; Zhou SS, 2014, COMP BIOCHEM PHYS D, V9, P31, DOI 10.1016/j.cbd.2013.12.002; Zhu JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081096	43	46	52	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118693	10.1371/journal.pone.0118693	http://dx.doi.org/10.1371/journal.pone.0118693			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692689	Green Submitted, Green Published, gold			2022-12-26	WOS:000350061500127
J	Xu, QL; Liu, JX; Wang, ZL; Guo, XH; Zhou, GB; Liu, YA; Huang, QB; Su, L				Xu, Qiulin; Liu, Jingxian; Wang, Zhenglian; Guo, Xiaohua; Zhou, Gengbiao; Liu, Yanan; Huang, Qiaobing; Su, Lei			Heat Stress-Induced Disruption of Endothelial Barrier Function Is via PAR1 Signaling and Suppressed by Xuebijing Injection	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; EZRIN/RADIXIN/MOESIN PROTEINS; MOESIN PHOSPHORYLATION; CELLS; PERMEABILITY; MICE; STROKE; INCREASES; INJURY	Increased vascular permeability leading to acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) is central to the pathogenesis of heatstroke. Protease-activated receptor 1 (PAR1), the receptor for thrombin, plays a key role in disruption of endothelial barrier function in response to extracellular stimuli. However, the role of PAR1 in heat stress-induced endothelial hyper-permeability is unknown. In this study, we measured PAR1 protein expression in heat-stressed human umbilical venous endothelial cells (HUVECs), investigated the influences of PAR1 on endothelial permeability, F-actin rearrangement, and moesin phosphorylation by inhibiting PAR1 with its siRNA, neutralizing antibody (anti-PAR1), specific inhibitor(RWJ56110), and Xuebijing injection (XBJ), a traditional Chinese medicine used for sepsis treatment, and evaluated the role of PAR1 in heatstroke- related ALI/ARDS in mice by suppressing PAR1 with RWJ56110, anti-PAR1and XBJ. We found that heat stress induced PAR1 protein expression 2h after heat stress in endothelial cells, caused the release of endothelial matrix metalloprotease 1, an activator of PAR1, after 60 or 120 min of heat stimulation, as well as promoted endothelial hyper-permeability and F-actin rearrangement, which were inhibited by suppressing PAR1 with RWJ56110, anti-PAR1 and siRNA. PAR1 mediated moesin phosphorylation, which caused F-actin rearrangement and disruption of endothelial barrier function. To corroborate findings from in vitro experiments, we found that RWJ56110 and the anti-PAR1 significantly decreased lung edema, pulmonary microvascular permeability, protein exudation, and leukocytes infiltrations in heatstroke mice. Additionally, XBJ was found to suppress PAR1-moesin signal pathway and confer protective effects on maintaining endothelial barrier function both in vitro and in vivo heat-stressed model, similar to those observed above with the inhibition of PAR1. These results suggest that PAR1 is a potential therapeutic target in heatstroke.	[Xu, Qiulin; Su, Lei] Guangzhou Mil Command, Gen Hosp, Dept ICU, Key Lab Trop Zone Trauma Care & Tissue Repair PLA, Guangzhou, Guangdong, Peoples R China; [Xu, Qiulin] Huabo Biopharmaceut Res Inst, Postdoctoral Workstn, Guangzhou, Guangdong, Peoples R China; [Liu, Jingxian; Liu, Yanan] Southern Med Univ, Guangzhou, Guangdong, Peoples R China; [Wang, Zhenglian; Zhou, Gengbiao] Guangzhou Univ Chinese Med, Guangzhou, Guangdong, Peoples R China; [Guo, Xiaohua; Huang, Qiaobing] Southern Med Univ, Dept Pathophysiol, Guangzhou, Guangdong, Peoples R China	Southern Theater Command General Hospital; Southern Medical University - China; Guangzhou University of Chinese Medicine; Southern Medical University - China	Huang, QB (corresponding author), Southern Med Univ, Dept Pathophysiol, Guangzhou, Guangdong, Peoples R China.	bing@smu.edu.cn; slei_icu@163.com			Natural Science Foundation of Guangdong Province, China [S2013040015661]; China Postdoctoral Science Foundation [2014M552180]; National Natural Science Foundation of China [31300950]; Project of Medical Research of People's Liberation Army [BWS12J108]	Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Medical Research of People's Liberation Army	This work was supported by the PhD Start-up Fund of Natural Science Foundation of Guangdong Province, China (S2013040015661, http://pro.gdstc.gov.cn/egrantweb/), China Postdoctoral Science Foundation(2014M552180, http://jj.chinapostdoctor.org.cn/V1/Program1/Default.aspx), National Natural Science Foundation of China (31300950, http://www.nsfc.gov.cn/), and Project of Medical Research of People's Liberation Army (BWS12J108). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adyshev DM, 2013, AM J PHYSIOL-LUNG C, V305, P1240, DOI 10.1152/ajplung.00355.2012; Asehnoune K, 2013, CRIT CARE, V17, DOI 10.1186/cc12502; Austin KM, 2013, BLOOD, V121, P431, DOI 10.1182/blood-2012-09-355958; Broquet A, 2014, CRIT CARE MED, V42, pE441, DOI 10.1097/CCM.0000000000000311; Chen Y, 2013, J TRADIT CHIN MED, V33, P243, DOI 10.1016/S0254-6272(13)60133-8; Chui A., 2014, PLACENTA; Dematte JE, 1998, ANN INTERN MED, V129, P173, DOI 10.7326/0003-4819-129-3-199808010-00001; Guo XH, 2009, AM J PHYSIOL-HEART C, V297, pH238, DOI 10.1152/ajpheart.00196.2009; Helwig BG, 2011, PHYSIOL GENOMICS, V43, P1096, DOI 10.1152/physiolgenomics.00076.2011; Hirano Katsuya, 2003, J Atheroscler Thromb, V10, P211; Jeon S, 2010, NEUROCHEM INT, V56, P810, DOI 10.1016/j.neuint.2010.03.005; Ji J, 2014, EXP THER MED, V7, P1745, DOI 10.3892/etm.2014.1639; Juncker-Jensen A, 2013, CANCER RES, V73, P4196, DOI 10.1158/0008-5472.CAN-12-4495; Kim HS, 2010, J NEUROCHEM, V113, P1565, DOI 10.1111/j.1471-4159.2010.06713.x; Koss M, 2006, J IMMUNOL, V176, P1218, DOI 10.4049/jimmunol.176.2.1218; Li QQ, 2011, BRAIN RES, V1373, P1, DOI 10.1016/j.brainres.2010.12.032; Ng KY, 2004, J PHARM SCI-US, V93, P896, DOI 10.1002/jps.20015; Pirot N, 2014, AM J PHYSIOL-LUNG C, V306, pL775, DOI 10.1152/ajplung.00200.2013; SHARMA HS, 1990, ACT NEUR S, V51, P383; Tressel SL, 2011, EMBO MOL MED, V3, P370, DOI 10.1002/emmm.201100145; Varghese GM, 2005, EMERG MED J, V22, P185, DOI 10.1136/emj.2003.009365; Wang JP, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-7; Wang LJ, 2012, ACTA DIABETOL, V49, P47, DOI 10.1007/s00592-011-0267-z; Wang LQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090472; WIJSMAN JA, 1993, ACTA NEUROPATHOL, V86, P49, DOI 10.1007/BF00454898; Zhang YL, 2013, J MOL MED, V91, P117, DOI 10.1007/s00109-012-0940-x	26	9	15	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118057	10.1371/journal.pone.0118057	http://dx.doi.org/10.1371/journal.pone.0118057			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693178	gold, Green Submitted, Green Published			2022-12-26	WOS:000350061500092
J	Jang, JP; Baek, IC; Choi, EJ; Kim, TG				Jang, Jung-Pil; Baek, In-Cheol; Choi, Eun-Jeong; Kim, Tai-Gyu			Multiplex Genotyping of Cytokine Gene SNPs Using Fluorescence Bead Array	PLOS ONE			English	Article							NUCLEOTIDE POLYMORPHISM ANALYSIS; HIGH-THROUGHPUT; XMAP(TM) TECHNOLOGY; FLOW-CYTOMETRY; PCR; DISEASE; ASSAY; IL-6; SUSCEPTIBILITY; AMPLIFICATION	Single nucleotide polymorphisms (SNPs) of genes that affect cytokine production and function are known to influence the susceptibility and progression of immune-related conditions such as infection, autoimmune diseases, transplantation, and cancer. We established a multiplex genotyping method to analyze the SNPs of cytokine genes by combining the multiplex PCR and bead array platform. Thirteen cytokine gene regions, including 20 SNPs, were amplified, and allele-specific primer extension was performed in a single tube. High-quality allele-specific primers were selected for signals greater than 1000 median fluorescence intensity (MFI) for positive alleles, and less than 500 MFI for negative alleles. To select and improve the extension primers, modifications for the reverse direction, length or refractory were performed. 24 primers in the forward or reverse direction step and 12 primers in length or refractory modifications were selected and showed high concordance with results by nucleotide sequencing. Among the 13 candidate cytokine genes, the SNPs of 12 cytokine genes, including IL-1 alpha, IL-1R, IL-1RA, IL-1 beta, IL-2, IL-4, IL-4R alpha, IL-6, IL-10, IL-12, TGF-beta 1, and TNF-alpha, were successfully defined with the selected allele-specific primers in healthy Korean subjects. Our genotyping system provides a fast and accurate detection for SNPs of multiple cytokine genes to investigate their association with immunerelated diseases and transplantation outcomes.	[Jang, Jung-Pil; Baek, In-Cheol; Kim, Tai-Gyu] Catholic Univ Korea, Coll Med, Dept Microbiol, Seoul, South Korea; [Choi, Eun-Jeong; Kim, Tai-Gyu] Catholic Univ Korea, Coll Med, Hematopoiet Stem Cell Bank, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea	Kim, TG (corresponding author), Catholic Univ Korea, Coll Med, Dept Microbiol, Seoul, South Korea.	kimtg@catholic.ac.kr		Baek, In-Cheol/0000-0003-3630-3364	Korean Health Technology R&D Project, Ministry for Health & Welfare, Republic of Korea [HI09C1555]	Korean Health Technology R&D Project, Ministry for Health & Welfare, Republic of Korea	This study was supported by a grant of the Korean Health Technology R&D Project, Ministry for Health & Welfare, Republic of Korea (HI09C1555). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong B, 2000, CYTOMETRY, V40, P102, DOI 10.1002/(SICI)1097-0320(20000601)40:2<102::AID-CYTO3>3.3.CO;2-W; Bagheri M, 2006, INT J IMMUNOGENET, V33, P193, DOI 10.1111/j.1744-313X.2006.00595.x; BEJ AK, 1990, MOL CELL PROBE, V4, P353, DOI 10.1016/0890-8508(90)90026-V; Bidwell J, 1999, GENES IMMUN, V1, P3, DOI 10.1038/sj.gene.6363645; Bortolin Susan, 2009, V496, P59, DOI 10.1007/978-1-59745-553-4_6; Cai H, 2000, GENOMICS, V66, P135, DOI 10.1006/geno.2000.6218; Carnt NA, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.01.031; Chen JW, 2000, GENOME RES, V10, P549, DOI 10.1101/gr.10.4.549; Dinarello CA, 2007, EUR J IMMUNOL, V37, pS34, DOI 10.1002/eji.200737772; Dunbar SA, 2006, CLIN CHIM ACTA, V363, P71, DOI 10.1016/j.cccn.2005.06.023; Elnifro EM, 2000, CLIN MICROBIOL REV, V13, P559, DOI 10.1128/CMR.13.4.559-570.2000; Fu GL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030340; Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128; Gupta S, 1988, Scand J Rheumatol Suppl, V76, P189; Hamza IA, 2014, J VIROL METHODS, V204, P65, DOI 10.1016/j.jviromet.2014.04.002; Iannone MA, 2000, CYTOMETRY, V39, P131, DOI 10.1002/(SICI)1097-0320(20000201)39:2<131::AID-CYTO6>3.3.CO;2-L; Iannone Marie A, 2003, Methods Mol Biol, V226, P123; Johnson VJ, 2004, CYTOKINE, V27, P135, DOI 10.1016/j.cyto.2004.05.002; Karabon L, 2005, HUM IMMUNOL, V66, P700, DOI 10.1016/j.humimm.2005.02.003; Kim MS, 2011, MOL DIAGN THER, V15, P285, DOI 10.2165/11592520-000000000-00000; Kimura A, 2010, EUR J IMMUNOL, V40, P1830, DOI 10.1002/eji.201040391; Krjutskov K, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn357; Meenagh A, 2002, HUM IMMUNOL, V63, P1055, DOI 10.1016/S0198-8859(02)00440-8; Mosmann TR, 1996, IMMUNOL TODAY, V17, P138, DOI 10.1016/0167-5699(96)80606-2; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; Noack M, 2014, AUTOIMMUN REV, V13, P668, DOI 10.1016/j.autrev.2013.12.004; Ollier WER, 2004, CYTOKINE, V28, P174, DOI 10.1016/j.cyto.2004.07.014; Otani S, 2009, CLIN BIOCHEM, V42, P1387, DOI 10.1016/j.clinbiochem.2009.06.005; Ozaki S, 2014, J VIROL METHODS, V204, P73, DOI 10.1016/j.jviromet.2014.04.010; Pyo CW, 2003, HUM IMMUNOL, V64, P979, DOI 10.1016/S0198-8859(03)00173-3; Shoskes DA, 2002, J UROLOGY, V168, P331, DOI 10.1016/S0022-5347(05)64916-6; Smith AJP, 2009, CYTOKINE GROWTH F R, V20, P43, DOI 10.1016/j.cytogfr.2008.11.006; Soler S, 2011, CLIN CHIM ACTA, V412, P430, DOI 10.1016/j.cca.2010.11.012; Steemers Frank J., 2007, Biotechnology Journal, V2, P41, DOI 10.1002/biot.200600213; Tomiuk S, 2001, Brief Bioinform, V2, P329, DOI 10.1093/bib/2.4.329; Tsuchihashi Z., 2002, Pharmacogenomics Journal, V2, P103, DOI 10.1038/sj.tpj.6500094; Ye F, 2001, HUM MUTAT, V17, P305, DOI 10.1002/humu.28	37	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0118008	10.1371/journal.pone.0118008	http://dx.doi.org/10.1371/journal.pone.0118008			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689696	Green Published, Green Submitted, gold			2022-12-26	WOS:000350322700092
J	Kato, M; Mugitani, R				Kato, Masaharu; Mugitani, Ryoko			Pareidolia in Infants	PLOS ONE			English	Article							FACE-LIKE OBJECTS; PHONETIC INFORMATION; PERCEPTION; SPEECH; LIPS; CORTEX; MOUTH; VOICE; FOCUS; EYES	Faces convey primal information for our social life. This information is so primal that we sometimes find faces in non-face objects. Such illusory perception is called pareidolia. In this study, using infants' orientation behavior toward a sound source, we demonstrated that infants also perceive pareidolic faces. An image formed by four blobs and an outline was shown to infants with or without pure tones, and the time they spent looking at each blob was compared. Since the mouth is the unique sound source in a face and the literature has shown that infants older than 6 months already have sound-mouth association, increased looking time towards the bottom blob (pareidolic mouth area) during sound presentation indicated that they illusorily perceive a face in the image. Infants aged 10 and 12 months looked longer at the bottom blob under the upright-image condition, whereas no differences in looking time were observed for any blob under the inverted-image condition. However, 8month-olds did not show any difference in looking time under both the upright and inverted conditions, suggesting that the perception of pareidolic faces, through sound association, comes to develop at around 8 to 10 months after birth.	[Kato, Masaharu; Mugitani, Ryoko] NTT Commun Sci Labs, Human Informat Sci Lab, Atsugi, Kanagawa, Japan	Nippon Telegraph & Telephone Corporation	Kato, M (corresponding author), NTT Commun Sci Labs, Human Informat Sci Lab, Atsugi, Kanagawa, Japan.	kato.masaharu@lab.ntt.co.jp						Burnham D, 2004, DEV PSYCHOBIOL, V45, P204, DOI 10.1002/dev.20032; Cassia VM, 2004, PSYCHOL SCI, V15, P379, DOI 10.1111/j.0956-7976.2004.00688.x; Churches O, 2009, NEUROREPORT, V20, P1290, DOI 10.1097/WNR.0b013e3283305a65; Deffke I, 2007, NEUROIMAGE, V35, P1495, DOI 10.1016/j.neuroimage.2007.01.034; Hadjikhani N, 2009, NEUROREPORT, V20, P403, DOI 10.1097/WNR.0b013e328325a8e1; HAITH MM, 1977, SCIENCE, V198, P853, DOI 10.1126/science.918670; Ichikawa H, 2011, PERCEPTION, V40, P500, DOI 10.1068/p6926; Itier RJ, 2004, NEUROREPORT, V15, P1261, DOI 10.1097/01.wnr.0000127827.73576.d8; JANIK SW, 1978, PERCEPT MOTOR SKILL, V47, P857, DOI 10.2466/pms.1978.47.3.857; Johnson MH, 2005, NAT REV NEUROSCI, V6, P766, DOI 10.1038/nrn1766; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kato M, 2013, INFANT BEHAV DEV, V36, P32, DOI 10.1016/j.infbeh.2012.10.005; Kobayashi M, 2012, J EXP CHILD PSYCHOL, V111, P22, DOI 10.1016/j.jecp.2011.07.008; Kushnerenko E, 2008, P NATL ACAD SCI USA, V105, P11442, DOI 10.1073/pnas.0804275105; Lewkowicz DJ, 2012, P NATL ACAD SCI USA, V109, P1431, DOI 10.1073/pnas.1114783109; Liu JG, 2014, CORTEX, V53, P60, DOI 10.1016/j.cortex.2014.01.013; MAURER D, 1976, CHILD DEV, V47, P523, DOI 10.2307/1128813; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; MORTON J, 1991, PSYCHOL REV, V98, P164, DOI 10.1037/0033-295X.98.2.164; Patterson ML, 2003, DEVELOPMENTAL SCI, V6, P191, DOI 10.1111/1467-7687.00271; Patterson ML, 1999, INFANT BEHAV DEV, V22, P237, DOI 10.1016/S0163-6383(99)00003-X; Teinonen T, 2008, COGNITION, V108, P850, DOI 10.1016/j.cognition.2008.05.009; Tenenbaum EJ, 2013, INFANCY, V18, P534, DOI 10.1111/j.1532-7078.2012.00135.x; Watanabe H, 2013, HUM BRAIN MAPP, V34, P543, DOI 10.1002/hbm.21453; Windhager S, 2008, HUM NATURE-INT BIOS, V19, P331, DOI 10.1007/s12110-008-9047-z; Windhager S, 2010, COLLEGIUM ANTROPOL, V34, P1075	26	22	23	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0118539	10.1371/journal.pone.0118539	http://dx.doi.org/10.1371/journal.pone.0118539			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689630	Green Published, gold, Green Submitted			2022-12-26	WOS:000350322700117
J	Kalbitz, M; Grailer, JJ; Fattahi, F; Jajou, L; Herron, TJ; Campbell, KF; Zetoune, FS; Bosmann, M; Sarma, JV; Huber-Lang, M; Gebhard, F; Loaiza, R; Valdivia, HH; Jalife, J; Russell, MW; Ward, PA				Kalbitz, Miriam; Grailer, Jamison J.; Fattahi, Fatemeh; Jajou, Lawrence; Herron, Todd J.; Campbell, Katherine F.; Zetoune, Firas S.; Bosmann, Markus; Sarma, J. Vidya; Huber-Lang, Markus; Gebhard, Florian; Loaiza, Randall; Valdivia, Hector H.; Jalife, Jose; Russell, Mark W.; Ward, Peter A.			Role of extracellular histones in the cardiomyopathy of sepsis	FASEB JOURNAL			English	Article						complement; NLRP3 inflammasome; cardiomyocytes; echocardiogram/Doppler; polymicrobial sepsis	VII-ACTIVATING PROTEASE; MAMMALIAN EPITHELIUM; DIASTOLIC FUNCTION; CECAL LIGATION; INDUCED DAMAGE; MECHANISMS; CALCIUM; HEART; MEDIATORS; TLR2	The purpose of this study was to define the relationship in polymicrobial sepsis (in adult male C57BL/6 mice) between heart dysfunction and the appearance in plasma of extracellular histones. Procedures included induction of sepsis by cecal ligation and puncture and measurement of heart function using echocardiogram/Doppler parameters. We assessed the ability of histones to cause disequilibrium in the redox status and intracellular [Ca2+](i) levels in cardiomyocytes (CMs) (from mice and rats). We also studied the ability of histones to disturb both functional and electrical responses of hearts perfused with histones. Main findings revealed that extracellular histones appearing in septic plasma required C5a receptors, polymorphonuclear leukocytes (PMNs), and the Nacht-, LRR-, and PYD-domains-containing protein 3 (NLRP3) inflammasome. In vitro exposure of CMs to histones caused loss of homeostasis of the redox system and in [Ca2+](i), as well as defects in mitochondrial function. Perfusion of hearts with histones caused electrical and functional dysfunction. Finally, in vivo neutralization of histones in septic mice markedly reduced the parameters of heart dysfunction. Histones caused dysfunction in hearts during polymicrobial sepsis. These events could be attenuated by histone neutralization, suggesting that histones may be targets in the setting of sepsis to reduce cardiac dysfunction.	[Kalbitz, Miriam; Grailer, Jamison J.; Fattahi, Fatemeh; Jajou, Lawrence; Zetoune, Firas S.; Sarma, J. Vidya; Ward, Peter A.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Russell, Mark W.] Univ Michigan, Sch Med, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; [Kalbitz, Miriam; Huber-Lang, Markus; Gebhard, Florian] Univ Hosp Ulm, Dept Orthopaed Trauma Hand Plast & Reconstruct Su, Ulm, Germany; [Herron, Todd J.; Campbell, Katherine F.; Loaiza, Randall; Valdivia, Hector H.; Jalife, Jose] Univ Michigan, Ctr Arrhythmia Res, Ann Arbor, MI 48109 USA; [Bosmann, Markus] Univ Med Ctr, Ctr Thrombosis & Hemostasis, Mainz, Germany; [Bosmann, Markus] Univ Med Ctr, Dept Hematol Oncol & Pneumol, Mainz, Germany	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Ulm University; University of Michigan System; University of Michigan; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Ward, PA (corresponding author), Univ Michigan, Sch Med, Dept Pathol, 1301 Catherine Rd,7520 MSRB I,Box 5602, Ann Arbor, MI 48109 USA.	pward@umich.edu	Huber-Lang, Markus/AAJ-2209-2020; Jalife, Jose/L-4833-2015; Jalife, Jose/AAJ-9156-2021	Jalife, Jose/0000-0003-0080-3500; Jalife, Jose/0000-0003-0080-3500; Bosmann, Markus/0000-0003-2773-1033	U.S. National Institutes of Health (NIH) National Cancer Institute; O'Brien Renal Center; University of Michigan Medical School; Endowment for the Basic Sciences; Department of Cell and Developmental Biology (University of Michigan); NIH [GM-29507, GM-61656, T32-HL007517-29]; Deutsche Forschungsgemeinschaft [KA 3740, BO 3482/3-1, HU823/302]; Federal Ministry of Education and Research [01EO1003]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007517, R01HL122352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061656, R37GM029507, R01GM029507] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); O'Brien Renal Center; University of Michigan Medical School; Endowment for the Basic Sciences; Department of Cell and Developmental Biology (University of Michigan); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dr. Rainer Muche (University of Ulm, Institute for Epidemiology and Biometric Medicine) for assistance with statistical analyses. They also thank Beverly Schumann, Sue Scott, Melissa Rennells, and Robin Kunkel for excellent assistance in the preparation of the manuscript. The authors acknowledge support from the Microscopy and Image-analysis Laboratory, which is a multiuser imaging facility supported by a grant from the U.S. National Institutes of Health (NIH) National Cancer Institute, the O'Brien Renal Center, the University of Michigan Medical School, by the Endowment for the Basic Sciences, and by the Department of Cell and Developmental Biology (University of Michigan). This study was supported by grants from the NIH (GM-29507 and GM-61656 to P.A.W. and T32-HL007517-29 to J.J.G.), the Deutsche Forschungsgemeinschaft Fellowship (Project KA 3740) to M.K., Deutsche Forschungsgemeinschaft (BO 3482/3-1) to M.B., Federal Ministry of Education and Research (01EO1003) to M.B., and Deutsche Forschungsgemeinschaft (HU823/302) to M.H.L. The authors declare no conflicts of interest.	Abrams ST, 2013, AM J RESP CRIT CARE, V187, P160, DOI 10.1164/rccm.201206-1037OC; Allam R, 2012, J AM SOC NEPHROL, V23, P1375, DOI 10.1681/ASN.2011111077; BAKER CC, 1983, SURGERY, V94, P331; Boluyt MO, 2004, J APPL PHYSIOL, V96, P822, DOI 10.1152/japplphysiol.01026.2003; Bosmann M, 2013, FASEB J, V27, P5010, DOI 10.1096/fj.13-236380; Boyd JH, 2006, CARDIOVASC RES, V72, P384, DOI 10.1016/j.cardiores.2006.09.011; Celes MRN, 2013, PATHOBIOLOGY, V80, P70, DOI 10.1159/000341640; Charpentier J, 2004, CRIT CARE MED, V32, P660, DOI 10.1097/01.CCM.0000114827.93410.D8; Denk S, 2012, EUR SURG RES, V48, P171, DOI 10.1159/000338194; Dessap AM, 2014, INTENS CARE MED, V40, P1746, DOI 10.1007/s00134-014-3428-z; Feng Y, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/170352; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; Gerard NP, 2005, J BIOL CHEM, V280, P39677, DOI 10.1074/jbc.C500287200; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; Grailer JJ, 2014, J IMMUNOL, V192, P5974, DOI 10.4049/jimmunol.1400368; Hanson CJ, 2004, CURR BIOL, V14, pR933, DOI 10.1016/j.cub.2004.10.019; Hassoun SM, 2008, CRIT CARE MED, V36, P2590, DOI 10.1097/CCM.0b013e3181844276; Herron TJ, 2007, CIRC RES, V100, P1182, DOI 10.1161/01.RES.0000264102.00706.4e; Hopken UE, 1996, NATURE, V383, P86, DOI 10.1038/383086a0; Huber-Lang M, 2006, NAT MED, V12, P682, DOI 10.1038/nm1419; JAFRI SM, 1990, CRIT CARE MED, V18, P709, DOI 10.1097/00003246-199007000-00005; Kaestner L, 2009, J VIS EXP; Kanse SM, 2012, J IMMUNOL, V188, P2858, DOI 10.4049/jimmunol.1103029; Kleine TJ, 1997, AM J PHYSIOL-CELL PH, V273, pC1925, DOI 10.1152/ajpcell.1997.273.6.C1925; KLEINE TJ, 1995, AM J PHYSIOL-CELL PH, V268, pC1114, DOI 10.1152/ajpcell.1995.268.5.C1114; Knowlton A. A., 2013, J CARDIOVASC PHARM; Kutcher ME, 2012, J TRAUMA ACUTE CARE, V73, P1389, DOI 10.1097/TA.0b013e318270d595; Louch WE, 2011, J MOL CELL CARDIOL, V51, P288, DOI 10.1016/j.yjmcc.2011.06.012; Mignotte B, 1998, EUR J BIOCHEM, V252, P1, DOI 10.1046/j.1432-1327.1998.2520001.x; Minamikawa T, 1999, J CELL SCI, V112, P2419; MONESTIER M, 1993, MOL IMMUNOL, V30, P1069, DOI 10.1016/0161-5890(93)90153-3; Munt B, 1998, CRIT CARE MED, V26, P1829, DOI 10.1097/00003246-199811000-00023; Nakahara M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075961; Oikonomopoulou K, 2012, SEMIN IMMUNOPATHOL, V34, P151, DOI 10.1007/s00281-011-0280-x; Ostrowski SR, 2013, J CRIT CARE, V28, P586, DOI 10.1016/j.jcrc.2013.04.010; PARKER MM, 1984, ANN INTERN MED, V100, P483, DOI 10.7326/0003-4819-100-4-483; Pieske B, 1999, CIRC RES, V85, P38; Rittirsch D, 2008, NAT MED, V14, P551, DOI 10.1038/nm1753; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Rudiger A, 2007, CRIT CARE MED, V35, P1599, DOI 10.1097/01.CCM.0000266683.64081.02; Rudiger A, 2013, CURR VASC PHARMACOL, V11, P187; Santos CXC, 2011, FREE RADICAL BIO MED, V50, P777, DOI 10.1016/j.freeradbiomed.2011.01.003; Semeraro F, 2011, BLOOD, V118, P1952, DOI 10.1182/blood-2011-03-343061; Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372; Takasu O, 2013, AM J RESP CRIT CARE, V187, P509, DOI 10.1164/rccm.201211-1983OC; Tingare A, 2013, BIOCHEM SOC T, V41, P789, DOI 10.1042/BST20130012; Xu J, 2011, J IMMUNOL, V187, P2626, DOI 10.4049/jimmunol.1003930; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053; Xu KY, 1997, CIRC RES, V80, P76, DOI 10.1161/01.RES.80.1.76; Yamamichi S, 2011, BIOCHEM BIOPH RES CO, V409, P483, DOI 10.1016/j.bbrc.2011.05.030; Zhang YX, 2012, FREE RADICAL BIO MED, V53, P1531, DOI 10.1016/j.freeradbiomed.2012.07.010; Zima AV, 2006, CARDIOVASC RES, V71, P310, DOI 10.1016/j.cardiores.2006.02.019	52	74	82	0	23	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2015	29	5					2185	2193		10.1096/fj.14-268730	http://dx.doi.org/10.1096/fj.14-268730			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZJ	25681459	Green Published, Green Submitted			2022-12-26	WOS:000354114600048
J	Jun, E; Kim, S; Kim, JH; Cha, K; So, IS; Son, HN; Lee, BH; Kim, K; Kwon, IC; Kim, SY; Kim, IS				Jun, Eunsung; Kim, Soyoun; Kim, Jong-Ho; Cha, Kiweon; So, In-Seop; Son, Hye-Nam; Lee, Byung-Heon; Kim, Kwangmeyung; Kwon, Ick Chan; Kim, Sang Yoon; Kim, In-San			Design of a Multicomponent Peptide-Woven Nanocomplex for Delivery of siRNA	PLOS ONE			English	Article							DE-NOVO PEPTIDE; STRUCTURE PREDICTION; INTRACELLULAR DELIVERY; MOLECULAR-DYNAMICS; ENDOSOMAL ESCAPE; INTERFERING RNA; CELLULAR UPTAKE; CANCER-THERAPY; PEP-FOLD; GENE	We developed and tested a multicomponent peptide-woven siRNA nanocomplex (PwSN) comprising different peptides designed for efficient cellular targeting, endosomal escape, and release of siRNA. To enhance tumor-specific cellular uptake, we connected an interleukin-4 receptor-targeting peptide (I4R) to a nine-arginine peptide (9r), yielding I4R-9r. To facilitate endosomal escape, we blended endosomolytic peptides into the I4R-9r to form a multicomponent nanocomplex. Lastly, we modified 9r peptides by varying the number and positions of positive charges to obtain efficient release of siRNA from the nanocomplex in the cytosol. Using this step-wise approach for overcoming the biological challenges of siRNA delivery, we obtained an optimized PwSN with significant biological activity in vitro and in vivo. Interestingly, surface plasmon resonance analyses and three-dimensional peptide models demonstrated that our designed peptide adopted a unique structure that was correlated with faster complex disassembly and a better gene-silencing effect. These studies further elucidate the siRNA nanocomplex delivery pathway and demonstrate the applicability of our stepwise strategy to the design of siRNA carriers capable of overcoming multiple challenges and achieving efficient delivery.	[Jun, Eunsung; Kim, Soyoun; So, In-Seop; Son, Hye-Nam; Lee, Byung-Heon] Kyungpook Natl Univ, Sch Med, Cell & Matrix Res Inst, Dept Biochem & Cell Biol, Daegu, South Korea; [Kim, Jong-Ho] Kyung Hee Univ, Coll Pharm, Dept Pharmaceut Sci, Seoul, South Korea; [Cha, Kiweon] Korea Ctr Dis Control & Prevent KCDC, Korea Natl Inst Hlth, Div High Risk Pathogen Res, Osong, Chungbuk, South Korea; [Jun, Eunsung; Kim, Kwangmeyung; Kwon, Ick Chan; Kim, Sang Yoon; Kim, In-San] Korea Inst Sci & Technol, Ctr Theragnosis, Biomed Res Inst, Seoul, South Korea; [Kim, Sang Yoon] Univ Ulsan, Coll Med, Dept Otolaryngol, Seoul, South Korea	Kyungpook National University; Kyung Hee University; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Infectious Disease; Korea Institute of Science & Technology (KIST); University of Ulsan	Kim, IS (corresponding author), Korea Inst Sci & Technol, Ctr Theragnosis, Biomed Res Inst, Seoul, South Korea.	iskim14@kist.re.kr	김, 인산/I-8988-2014; Kim, In-San/D-3956-2017; Kim, Soyoun/Y-1276-2018; Kim, Kwangmeyung/ABB-2882-2021; KWON, ICK CHAN/AAS-4776-2020	KWON, ICK CHAN/0000-0003-1272-7074	National Research Foundation of Korea(NRF) - Korea government(MEST) [2010-0029206]; National Research Foundation of Korea( NRF) - Korea government [2014R1A5A2009242]; KIST Institutional Program [2E25000]	National Research Foundation of Korea(NRF) - Korea government(MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government); National Research Foundation of Korea( NRF) - Korea government; KIST Institutional Program(Korea Institute of Science & Technology (KIST))	This work was supported by the National Research Foundation of Korea(NRF) grant funded by the Korea government(MEST) (2010-0029206); by the National Research Foundation of Korea( NRF) grant funded by the Korea government (2014R1A5A2009242); by the KIST Institutional Program (Project No. 2E25000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliabadi HM, 2012, BIOMATERIALS, V33, P2546, DOI 10.1016/j.biomaterials.2011.11.079; Beloor J, 2012, BIOMATERIALS, V33, P1640, DOI 10.1016/j.biomaterials.2011.11.008; Bruno K, 2011, ADV DRUG DELIVER REV, V63, P1210, DOI 10.1016/j.addr.2011.09.003; Choi KM, 2011, ACS NANO, V5, P8690, DOI 10.1021/nn202597c; Ding Y, 2012, BIOMATERIALS, V33, P8893, DOI 10.1016/j.biomaterials.2012.08.057; Dominska M, 2010, J CELL SCI, V123, P1183, DOI 10.1242/jcs.066399; Futaki S, 2001, J BIOL CHEM, V276, P5836, DOI 10.1074/jbc.M007540200; Han L, 2012, ACS NANO, V6, P7340, DOI 10.1021/nn3024688; Nguyen J, 2012, ACCOUNTS CHEM RES, V45, P1153, DOI 10.1021/ar3000162; Jung HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040010; Kanasty R, 2013, NAT MATER, V12, P967, DOI [10.1038/NMAT3765, 10.1038/nmat3765]; Kaur H, 2007, PROTEIN PEPTIDE LETT, V14, P626; Kim JH, 2012, J CONTROL RELEASE, V157, P493, DOI 10.1016/j.jconrel.2011.09.070; Kumar P, 2007, NATURE, V448, P39, DOI 10.1038/nature05901; Kwok A, 2011, NANOMED-NANOTECHNOL, V7, P210, DOI 10.1016/j.nano.2010.07.005; Kwon EJ, 2008, BIOCONJUGATE CHEM, V19, P920, DOI 10.1021/bc700448h; Kwon EJ, 2010, MOL PHARMACEUT, V7, P1260, DOI 10.1021/mp1000668; Kwon YJ, 2012, ACCOUNTS CHEM RES, V45, P1077, DOI 10.1021/ar200241v; Lee MY, 2011, ACS NANO, V5, P6138, DOI 10.1021/nn2017793; Lee SY, 2010, J CONTROL RELEASE, V141, P339, DOI 10.1016/j.jconrel.2009.10.007; Li X, 2013, BIOMATERIALS, V34, P1391, DOI 10.1016/j.biomaterials.2012.10.072; Lobovkina T, 2011, ACS NANO, V5, P9977, DOI 10.1021/nn203745n; Lundberg P, 2007, FASEB J, V21, P2664, DOI 10.1096/fj.06-6502com; Maupetit J, 2010, J COMPUT CHEM, V31, P726, DOI 10.1002/jcc.21365; Maupetit J, 2009, NUCLEIC ACIDS RES, V37, pW498, DOI 10.1093/nar/gkp323; Nam JO, 2012, MOL CANCER RES, V10, P1010, DOI 10.1158/1541-7786.MCR-11-0600; Ouyang DF, 2010, J PHYS CHEM B, V114, P9220, DOI 10.1021/jp911906e; Ouyang DF, 2010, J PHYS CHEM B, V114, P9231, DOI 10.1021/jp911913c; Paredes-Gamero EJ, 2012, MOL PHARMACEUT, V9, P2686, DOI 10.1021/mp300251j; Petros RA, 2010, NAT REV DRUG DISCOV, V9, P615, DOI 10.1038/nrd2591; Pulford B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011085; Ren Y, 2012, ACS NANO, V6, P8620, DOI 10.1021/nn301975s; SAHLIN S, 1983, J IMMUNOL METHODS, V60, P115, DOI 10.1016/0022-1759(83)90340-X; Sakurai Y, 2011, BIOMATERIALS, V32, P5733, DOI 10.1016/j.biomaterials.2011.04.047; Sethi D, 2012, BIOCONJUGATE CHEM, V23, P158, DOI 10.1021/bc2004507; Sonawane ND, 2003, J BIOL CHEM, V278, P44826, DOI 10.1074/jbc.M308643200; Strumberg D, 2012, INT J CLIN PHARM TH, V50, P76, DOI 10.5414/CPP50076; Thevenet P, 2012, NUCLEIC ACIDS RES, V40, pW288, DOI 10.1093/nar/gks419; van Asbeck AH, 2013, ACS NANO, V7, P3797, DOI 10.1021/nn305754c; Vasumathi V, 2013, SOFT MATTER, V9, P1372, DOI 10.1039/c2sm26804c; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Wang YH, 2006, BIOCHEM BIOPH RES CO, V346, P758, DOI 10.1016/j.bbrc.2006.05.205; Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742; Wu XL, 2010, BIOCONJUGATE CHEM, V21, P208, DOI 10.1021/bc9005283; Ye SF, 2012, NANOMED-NANOTECHNOL, V8, P833, DOI 10.1016/j.nano.2011.10.003	45	6	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118310	10.1371/journal.pone.0118310	http://dx.doi.org/10.1371/journal.pone.0118310			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25705892	Green Published, gold, Green Submitted			2022-12-26	WOS:000350662100165
J	Boivin, V; Beyersdorf, N; Palm, D; Nikolaev, VO; Schlipp, A; Muller, J; Schmidt, D; Kocoski, V; Kerkau, T; Hunig, T; Ertl, G; Lohse, MJ; Jahns, R				Boivin, Valerie; Beyersdorf, Niklas; Palm, Dieter; Nikolaev, Viacheslav O.; Schlipp, Angela; Mueller, Justus; Schmidt, Doris; Kocoski, Vladimir; Kerkau, Thomas; Huenig, Thomas; Ertl, Georg; Lohse, Martin J.; Jahns, Roland			Novel Receptor-Derived Cyclopeptides to Treat Heart Failure Caused by Anti-beta(1)-Adrenoceptor Antibodies in a Human-Analogous Rat Model	PLOS ONE			English	Article							IDIOPATHIC DILATED CARDIOMYOPATHY; PROTEIN-COUPLED-RECEPTOR; 2ND EXTRACELLULAR LOOP; FAILING HUMAN HEART; BETA(1)-ADRENERGIC RECEPTORS; AUTOIMMUNE-DISEASE; CARDIAC AUTOANTIBODIES; CLINICAL CARDIOLOGY; PLASMA-CELLS; IN-VIVO	Despite recent therapeutic advances the prognosis of heart failure remains poor. Recent research suggests that heart failure is a heterogeneous syndrome and that many patients have stimulating auto-antibodies directed against the second extracellular loop of the beta(1) adrenergic receptor (beta(1)EC2). In a human-analogous rat model such antibodies cause myocyte damage and heart failure. Here we used this model to test a novel antibody-directed strategy aiming to prevent and/or treat antibody-induced cardiomyopathy. To generate heart failure, we immunised n = 76/114 rats with a fusion protein containing the human beta(1)EC2 (amino-acids 195-225) every 4 weeks; n = 38/114 rats were control-injected with 0.9% NaCl. Intravenous application of a novel cyclic peptide mimicking beta(1)EC2 (beta(1)EC2-CP, 1.0 mg/kg every 4 weeks) or administration of the beta(1)-blocker bisoprolol (15 mg/kg/day orally) was initiated either 6 weeks (cardiac function still normal, prevention-study, n = 24 (16 treated vs. 8 untreated)) or 8.5 months after the 1st immunisation (onset of cardiomyopathy, therapy-study, n = 52 (40 treated vs. 12 untreated)); n = 8/52 rats from the therapy-study received beta(1)EC2-CP/bisoprolol co-treatment. We found that beta(1)EC2-CP prevented and (alone or as add-on drug) treated antibody-induced cardiac damage in the rat, and that its efficacy was superior to mono-treatment with bisoprolol, a standard drug in heart failure. While bisoprolol mono-therapy was able to stop disease-progression, beta(1)EC2-CP mono-therapy -or as an add-on to bisoprolol-almost fully reversed antibody-induced cardiac damage. The cyclo-peptide acted both by scavenging free anti-beta(1)EC2-antibodies and by targeting beta(1)EC2-specific memory B-cells involved in antibody-production. Our model provides the basis for the clinical translation of a novel double-acting therapeutic strategy that scavenges harmful anti-beta(1)EC2-antibodies and also selectively depletes memory B-cells involved in the production of such antibodies. Treatment with immuno-modulating cyclopeptides alone or as an add-on to beta(1)-blockade represents a promising new therapeutic option in immune-mediated heart failure.	[Boivin, Valerie; Nikolaev, Viacheslav O.; Schlipp, Angela; Lohse, Martin J.; Jahns, Roland] Univ Wurzburg, Inst Pharmacol & Toxicol, D-97070 Wurzburg, Germany; [Boivin, Valerie; Palm, Dieter; Schlipp, Angela; Lohse, Martin J.; Jahns, Roland] Univ Wurzburg, Rudolf Virchow Ctr, DFG Res Ctr Expt Biomed, D-97070 Wurzburg, Germany; [Beyersdorf, Niklas; Schmidt, Doris; Kocoski, Vladimir; Kerkau, Thomas; Huenig, Thomas] Univ Wurzburg, Inst Virol & Immunobiol, D-97070 Wurzburg, Germany; [Mueller, Justus] Univ Wurzburg, Inst Pathol, D-97070 Wurzburg, Germany; [Boivin, Valerie; Ertl, Georg; Lohse, Martin J.; Jahns, Roland] Univ Hosp Wurzburg, Comprehens Heart Failure Ctr CHFC, Wurzburg, Germany; [Schlipp, Angela] Univ Munchen LMU, Lehrstuhl Anat 1, Munich, Germany	University of Wurzburg; German Research Foundation (DFG); University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Munich	Boivin, V (corresponding author), Univ Wurzburg, Inst Pharmacol & Toxicol, D-97070 Wurzburg, Germany.	valerie.jahns@toxi.uni-wuerzburg.de	Nikolaev, Vyacheslav/AAT-7746-2020; Kerkau, Thomas/ABE-8007-2020; Lohse, Martin J/A-7160-2012; Beyersdorf, Niklas/S-3845-2016	Lohse, Martin J/0000-0002-0599-3510; Beyersdorf, Niklas/0000-0002-9236-5415	German Research Foundation ("Deutsche Forschungs-gemeinschaft") [Ja 706/2-4]; Interdisciplinary Center for Clinical Research (IZKF) Wurzburg [A-52]; German Ministry of Research and Education ("Bundesministerium fur Bildung und Forschung" (BMBF)) [GoBio-1, FKZ 0315031, FKZ 0315363, MolDiag FKZ 01ES0901]	German Research Foundation ("Deutsche Forschungs-gemeinschaft")(German Research Foundation (DFG)); Interdisciplinary Center for Clinical Research (IZKF) Wurzburg; German Ministry of Research and Education ("Bundesministerium fur Bildung und Forschung" (BMBF))(Federal Ministry of Education & Research (BMBF))	The present work was publicly funded by grants of the German Research Foundation ("Deutsche Forschungs-gemeinschaft" [Grant Ja 706/2-4]), by the Interdisciplinary Center for Clinical Research (IZKF) Wurzburg, [Project A-52], and by the German Ministry of Research and Education ("Bundesministerium fur Bildung und Forschung" (BMBF) [Grants GoBio-1, FKZ 0315031, FKZ 0315363, and MolDiag FKZ 01ES0901]). All authors have read and approved submission of the final manuscript.	Bornholz B, 2013, CARDIOVASC RES, V97, P472, DOI 10.1093/cvr/cvs350; Bristow MR, 2011, CIRC RES, V109, P1176, DOI 10.1161/CIRCRESAHA.111.245092; BRISTOW MR, 1993, J AM COLL CARDIOL, V22, pA61, DOI 10.1016/0735-1097(93)90465-D; Caforio ALP, 2007, CIRCULATION, V115, P76, DOI 10.1161/CIRCULATIONAHA.106.641472; Caforio ALP, 2002, EUR J HEART FAIL, V4, P411, DOI 10.1016/S1388-9842(02)00010-7; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; COHN JN, 1984, NEW ENGL J MED, V311, P819, DOI 10.1056/NEJM198409273111303; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Edwards JCW, 2006, NAT REV IMMUNOL, V6, P394, DOI 10.1038/nri1838; ENDO K, 1978, J CLIN ENDOCR METAB, V46, P734, DOI 10.1210/jcem-46-5-734; Eriksson U, 2003, NAT MED, V9, P1484, DOI 10.1038/nm960; Freedman NJ, 2004, J CLIN INVEST, V113, P1379, DOI 10.1172/JCI200421748; FRIELLE T, 1987, P NATL ACAD SCI USA, V84, P7920, DOI 10.1073/pnas.84.22.7920; FU LX, 1993, J CLIN INVEST, V91, P1964, DOI 10.1172/JCI116416; Goser S, 2006, CIRCULATION, V114, P1693, DOI 10.1161/CIRCULATIONAHA.106.635664; Haberland A, 2011, CIRC RES, V109, P986, DOI 10.1161/CIRCRESAHA.111.253849; Hebert TE, 2007, CARDIOVASC RES, V76, P5, DOI 10.1016/j.cardiores.2007.07.011; Hershko AY, 2005, ANN NY ACAD SCI, V1051, P635, DOI 10.1196/annals.1361.108; Hoebeke J, 1996, INT J CARDIOL, V54, P103, DOI 10.1016/0167-5273(96)02586-7; Hoyer PF, 2004, TRANSPL P, V36, p197S, DOI 10.1016/j.transproceed.2004.01.051; Ireland DC, 2006, J MOL BIOL, V357, P1522, DOI 10.1016/j.jmb.2006.01.051; Iwata M, 2001, CIRC RES, V88, P578, DOI 10.1161/01.RES.88.6.578; Iwata M, 2001, J AM COLL CARDIOL, V37, P418, DOI 10.1016/S0735-1097(00)01109-8; Jahns R, 1996, EUR J PHARMACOL, V316, P111, DOI 10.1016/S0014-2999(96)00654-1; Jahns R, 2000, J AM COLL CARDIOL, V36, P1280, DOI 10.1016/S0735-1097(00)00881-0; Jahns R, 2004, J CLIN INVEST, V113, P1419, DOI 10.1172/JCI200420149; Jahns R, 1999, CIRCULATION, V99, P649, DOI 10.1161/01.CIR.99.5.649; Jane-Wit D, 2007, CIRCULATION, V116, P399, DOI 10.1161/CIRCULATIONAHA.106.683193; KAISER E, 1970, ANAL BIOCHEM, V34, P595, DOI 10.1016/0003-2697(70)90146-6; Kaliyaperumal A, 1999, J IMMUNOL, V162, P5775; Kim YM, 2006, P NATL ACAD SCI USA, V103, P3327, DOI 10.1073/pnas.0511315103; Kuhl U, 2005, CIRCULATION, V112, P1965, DOI 10.1161/CIRCULATIONAHA.105.548156; Limas CJ, 2004, AM J CARDIOL, V93, P1189, DOI 10.1016/j.amjcard.2004.01.060; LITWIN SE, 1994, CIRCULATION, V89, P345, DOI 10.1161/01.CIR.89.1.345; Lohse MJ, 2003, CIRC RES, V93, P896, DOI 10.1161/01.RES.0000102042.83024.CA; Luppi P, 1998, CIRCULATION, V98, P777, DOI 10.1161/01.CIR.98.8.777; MacLellan WR, 2003, NAT MED, V9, P1455, DOI 10.1038/nm1203-1455; MAGNUSSON Y, 1994, CIRCULATION, V89, P2760, DOI 10.1161/01.CIR.89.6.2760; MAGNUSSON Y, 1989, CLIN EXP IMMUNOL, V78, P42; Manz RA, 1998, INT IMMUNOL, V10, P1703, DOI 10.1093/intimm/10.11.1703; Maron BJ, 2006, CIRCULATION, V113, P1807, DOI 10.1161/CIRCULATIONAHA.106.174287; Martini JS, 2008, P NATL ACAD SCI USA, V105, P12457, DOI 10.1073/pnas.0803153105; NAPARSTEK Y, 1993, ANNU REV IMMUNOL, V11, P79, DOI 10.1146/annurev.iy.11.040193.000455; Neubert K, 2008, NAT MED, V14, P748, DOI 10.1038/nm1763; Nikolaev VO, 2007, J AM COLL CARDIOL, V50, P423, DOI 10.1016/j.jacc.2007.03.051; Noutsias M, 2011, EUR J HEART FAIL, V13, P611, DOI 10.1093/eurjhf/hfr014; Orciuolo E, 2007, BRIT J HAEMATOL, V138, P396, DOI 10.1111/j.1365-2141.2007.06659.x; Penela P, 2006, CARDIOVASC RES, V69, P46, DOI 10.1016/j.cardiores.2005.09.011; Rose NR, 2001, J CLIN INVEST, V107, P943, DOI 10.1172/JCI12673; Savelyeva N, 2005, P NATL ACAD SCI USA, V102, P10987, DOI 10.1073/pnas.0505108102; Schmidt J, 2003, J NEUROIMMUNOL, V140, P143, DOI 10.1016/S0165-5728(03)00182-6; SCHULZE K, 1990, CIRCULATION, V81, P959, DOI 10.1161/01.CIR.81.3.959; Staudt A, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.06.027; Stork S, 2006, AM HEART J, V152, P697, DOI 10.1016/j.ahj.2006.05.004; Thorstenson KM, 2001, J IMMUNOL, V167, P188, DOI 10.4049/jimmunol.167.1.188; TZARTOS SJ, 1982, P NATL ACAD SCI-BIOL, V79, P188, DOI 10.1073/pnas.79.1.188; UNGERER M, 1993, CIRCULATION, V87, P454, DOI 10.1161/01.CIR.87.2.454; UNGERER M, 1994, CIRC RES, V74, P206, DOI 10.1161/01.RES.74.2.206; Wallukat G, 2002, NEW ENGL J MED, V347, P1806, DOI 10.1056/NEJM200211283472220; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101	60	21	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0117589	10.1371/journal.pone.0117589	http://dx.doi.org/10.1371/journal.pone.0117589			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25700031	gold, Green Submitted, Green Published			2022-12-26	WOS:000349789800027
J	Fraser, SDS; Aitken, G; Taal, MW; Mindell, JS; Moon, G; Day, J; O'Donoghue, D; Roderick, PJ				Fraser, Simon D. S.; Aitken, Grant; Taal, Maarten W.; Mindell, Jennifer S.; Moon, Graham; Day, Julie; O'Donoghue, Donal; Roderick, Paul J.			Exploration of Chronic Kidney Disease Prevalence Estimates Using New Measures of Kidney Function in the Health Survey for England	PLOS ONE			English	Article							SERUM CYSTATIN-C; GLOMERULAR-FILTRATION-RATE; RENAL-DISEASE; UNITED-STATES; ALL-CAUSE; CREATININE; EQUATION; RISK; ASSOCIATION; DIET	Background Chronic kidney disease (CKD) diagnosis relies on glomerular filtration rate (eGFR) estimation, traditionally using the creatinine-based Modification of Diet in Renal Disease (MDRD) equation. The Chronic Kidney Disease Epidemiology Collaboration (CKDEPI) equation performs better in estimating eGFR and predicting mortality and CKD progression risk. Cystatin C is an alternative glomerular filtration marker less influenced by muscle mass. CKD risk stratification is improved by combining creatinine eGFR with cystatin C and urinary albumin to creatinine ratio (uACR). We aimed to identify the impact of introducing CKDEPI and cystatin C on the estimated prevalence and risk stratification of CKD in England and to describe prevalence and associations of cystatin C. Methods and Findings Cross sectional study of 5799 people in the nationally representative 2009 and 2010 Health Surveys for England. Primary outcome measures: prevalence of MDRD, CKDEPI and cystatin C-defined eGFR<60ml/min/1.73m(2); prevalence of CKD biomarker combinations (creatinine, cystatin C, uACR). Using CKDEPI instead of MDRD reduced the prevalence of eGFR<60ml/min/1.73m(2) from 6.0% (95% CI 5.4-6.6%) to 5.2% (4.7-5.8%) equivalent to around 340,000 fewer individuals in England. Those reclassified as not having CKD evidenced a lower risk profile. Prevalence of cystatin C eGFR<60ml/min/1.73m(2) was 7.7% and independently associated with age, lack of qualifications, being an ex-smoker, BMI, hypertension, and albuminuria. Measuring cystatin C in the 3.9% people with CKDEPI-defined eGFR<60ml/min/1.73m(2) without albuminuria (CKD Category G3a A1) reclassified about a third into a lower risk group with one of three biomarkers and two thirds into a group with two of three. Measuring cystatin C in the 6.7% people with CKDEPI eGFR >60ml/min/1.73m(2) with albuminuria (CKD Category G1-2) reclassified almost a tenth into a higher risk group. Limitations Cross sectional study, single eGFR measure, no measured ('true') GFR. Conclusions Introducing the CKDEPI equation and targeted cystatin C measurement reduces estimated CKD prevalence and improves risk stratification.	[Fraser, Simon D. S.; Roderick, Paul J.] Univ Southampton, Fac Med, Acad Unit Primary Care & Populat Sci, Southampton SO16 6YD, Hants, England; [Aitken, Grant; Moon, Graham] Univ Southampton, Fac Social & Human Sci, Southampton SO17 1BJ, Hants, England; [Taal, Maarten W.] Univ Nottingham, Div Med Sci & Grad Entry Med, Derby DE22 3DT, England; [Mindell, Jennifer S.] UCL, Res Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; [Day, Julie] Royal Victoria Infirm, Newcastle Upon Tyne Hosp NHS Fdn Trust, Dept Clin Biochem, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [O'Donoghue, Donal] Salford Royal NHS Fdn Trust, Renal Unit, Salford M6 8HD, Lancs, England	University of Southampton; University of Southampton; University of Nottingham; University of London; University College London; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Salford Royal NHS Foundation Trust	Fraser, SDS (corresponding author), Univ Southampton, Fac Med, Acad Unit Primary Care & Populat Sci, Southampton SO16 6YD, Hants, England.	s.fraser@soton.ac.uk	Mindell, Jennifer S/G-2241-2011; Fraser, Simon DS/HCH-3208-2022	Mindell, Jennifer S/0000-0002-7604-6131; Taal, Maarten/0000-0002-9065-212X; Fraser, Simon D/0000-0002-4172-4406	NHS Kidney Care; University of Southampton PhD scholarship; National Institute for Health Research [CL-2014-26-002] Funding Source: researchfish	NHS Kidney Care; University of Southampton PhD scholarship; National Institute for Health Research(National Institute for Health Research (NIHR))	Kidney function testing in the Health Surveys for England was funded by NHS Kidney Care. GA is funded by a University of Southampton PhD scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, NATL I HLTH CLIN EXC; Baxmann AC, 2008, CLIN J AM SOC NEPHRO, V3, P348, DOI 10.2215/CJN.02870707; Craig R, 2010, HLTH SURVEY ENGLAND; de Lusignan S, 2011, NEPHRON CLIN PRACT, V117, pC213, DOI 10.1159/000320341; Grams ME, 2013, AM J KIDNEY DIS, V62, P253, DOI 10.1053/j.ajkd.2013.03.013; Grubb A, 2005, CLIN CHEM, V51, P1420, DOI 10.1373/clinchem.2005.051557; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Jordan H, 2004, J EPIDEMIOL COMMUN H, V58, P250, DOI 10.1136/jech.2003.013011; KDIGO. (Kidney Disease: Improving Global Outcomes) CKD Work Group, 2012, KIDNEY INT S, V2013, P150; Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group, 2013, KIDNEY INT S, P1; Kottgen A, 2008, AM J KIDNEY DIS, V51, P385, DOI 10.1053/j.ajkd.2007.11.019; KYHSEANDERSEN J, 1994, CLIN CHEM, V40, P1921; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Matsushita K, 2012, JAMA-J AM MED ASSOC, V307, P1941, DOI 10.1001/jama.2012.3954; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Mindell J., 2011, HLTH SURVEY ENGLAND; Moynihan R, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4298; Muntner P, 2008, AM J MED, V121, P341, DOI 10.1016/j.amjmed.2008.01.003; National Institute for Health and Care Excellence, 2014, COST STAT CHRON KIDN; National Institute for Health and Care Excellence, 2014, CHRON KIDN DIS EARL; National Institute for Health and Clinical Excellence, 2006, NICE CLIN GUID 43 OB; National Kidney Foundation, 2002, AM J KIDNEY DIS S, V39, pS17; NHS Employers, 2011, QUAL OUTC FRAM GUID; NHS Employers and British Medical Association, 2011, QUALITY AND OUTCOMES; NHS Health Check Programme, 2013, NHS HLTH CHECK PROGR; Nitsch D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f324; O'Callaghan CA, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000308; Office for National Statistics, 2012, 2011 CENS POP HOUS E; Peralta CA, 2011, JAMA-J AM MED ASSOC, V305, P1545, DOI 10.1001/jama.2011.468; Peralta CA, 2011, J AM SOC NEPHROL, V22, P147, DOI 10.1681/ASN.2010050483; Rule AD, 2013, CLIN J AM SOC NEPHRO, V8, P1414, DOI 10.2215/CJN.01240213; Servais A, 2008, AM J MED, V121, P426, DOI 10.1016/j.amjmed.2008.01.040; Shlipak MG, 2005, NEW ENGL J MED, V352, P2049, DOI 10.1056/NEJMoa043161; Shlipak MG, 2013, NEW ENGL J MED, V369, P932, DOI 10.1056/NEJMoa1214234; Shlipak MG, 2011, CLIN CHEM, V57, P737, DOI 10.1373/clinchem.2010.158915; Stevens LA, 2008, AM J KIDNEY DIS, V51, P395, DOI 10.1053/j.ajkd.2007.11.018; Stevens LA, 2007, J AM SOC NEPHROL, V18, P2749, DOI 10.1681/ASN.2007020199; Stevens LA, 2010, AM J KIDNEY DIS, V56, P486, DOI 10.1053/j.ajkd.2010.03.026; Tangri N, 2013, ANN INTERN MED, V158, P596, DOI 10.7326/0003-4819-158-8-201304160-00004; Tangri N, 2011, KIDNEY INT, V79, P471, DOI 10.1038/ki.2010.431; The National Service Framework for Renal Services, 2005, CHRON KIDN DIS AC 2; Voskoboev NV, 2012, CLIN CHEM LAB MED, V50, P1591, DOI 10.1515/cclm-2012-0063; Voskoboev NV, 2011, CLIN CHEM, V57, P1209, DOI 10.1373/clinchem.2011.164798; Waheed S, 2013, CLIN J AM SOC NEPHRO, V8, P434, DOI 10.2215/CJN.04960512; White SL, 2010, AM J KIDNEY DIS, V55, P660, DOI 10.1053/j.ajkd.2009.12.011	46	25	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0118676	10.1371/journal.pone.0118676	http://dx.doi.org/10.1371/journal.pone.0118676			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25700182	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000349789800040
J	Ghisolfi, RD; da Silva, MP; dos Santos, FT; Servino, RN; Cirano, M; Thompson, FL				Ghisolfi, Renato David; da Silva, Meyre Pereira; dos Santos, Felipe Thomaz; Servino, Ricardo Nogueira; Cirano, Mauro; Thompson, Fabiano Lopes			Physical Forcing Mechanisms Controlling the Variability of Chlorophyll-a over the Royal-Charlotte and Abrolhos Banks-Eastern Brazilian Shelf	PLOS ONE			English	Article							CORAL-REEFS; SEASONAL-VARIATIONS; CONTINENTAL-SHELF; GLOBAL OCEAN; CIRCULATION; SEAWIFS; BLOOM; SEA; ALGORITHMS; PATTERNS	The Abrolhos Bank is part of the so-called Eastern Brazilian Shelf and is an area of high ecological and economic importance. The bank supports the largest and richest coral reefs in the South Atlantic and the largest rhodolith bed in the world. The spatial and seasonal variation of phytoplankton concentration, however, and the dynamic processes controlling that variability have remained poorly known. The present study investigates the seasonal and spatial distributions of chlorophyll-a (Chl-a) and water conditions by analyzing nine years (2003-2011) of level-3 Moderate-resolution Imaging Spectroradiometer (MODIS) derived Chl-a, National Centers for Environmental Prediction (NCEP)/ETA model-derived winds, NCEP model-derived heat fluxes, thermohaline and velocity results from the Hybrid Circulation Ocean Model (HYCOM) 1/12 degrees assimilated simulation. The results show that low/high concentrations occurred in austral spring-summer (wet season)/autumn-winter (dry season), with the highest values observed in the northern portion of the Abrolhos Bank. The typical meteorological and oceanographic conditions during austral summer favor the development of strong stratification. These conditions are 1) N-NE winds that favor an upwelling-type Ekman circulation; 2) coupling between the open ocean and the continental shelf through the western boundary current, which promotes cooler subsurface water to rise onto the shelf break; and 3) positive net heat flux. In contrast, the S-SE winds during autumn are in the opposite direction of the predominant current system over the Abrolhos Bank, thus reducing their speed and inducing an inverse shear. The warmer ocean and a somewhat cool and dry atmosphere promote the evaporative cooling of the surface layer. The above processes drive mixed layer cooling and deepening that reaches its maximum in winter. The blooming of phytoplankton in the Abrolhos Bank waters appears to be regulated by changes in the mixed layer depth, with Chl-a levels that start to increase during autumn and reach their peak in June-July.	[Ghisolfi, Renato David; da Silva, Meyre Pereira; dos Santos, Felipe Thomaz; Servino, Ricardo Nogueira] Univ Fed Espirito Santo, Oceanog & Ecol Dept, Vitoria, ES, Brazil; [Cirano, Mauro] Univ Fed Bahia, Inst Fis, Dept Fis Terra & Meio Ambiente, Rede Modelagem & Observ Oceanog REMO, Salvador, Bahia, Brazil; [Thompson, Fabiano Lopes] Univ Fed Rio de Janeiro, Inst Biol, Rio De Janeiro, RJ, Brazil; [Thompson, Fabiano Lopes] Univ Fed Rio de Janeiro, COPPE, SAGE, Rio De Janeiro, RJ, Brazil	Universidade Federal do Espirito Santo; Universidade Federal da Bahia; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Ghisolfi, RD (corresponding author), Univ Fed Espirito Santo, Oceanog & Ecol Dept, Vitoria, ES, Brazil.	renato.ghisolfi@ufes.br	Cirano, Mauro/AAT-7082-2020; CIRANO, M/G-6392-2012	Cirano, Mauro/0000-0002-0789-1120; CIRANO, M/0000-0002-0789-1120; Thompson, Fabiano/0000-0002-7562-1683	Conservation International-Brazil; Conselho Nacional de Pesquisa e Inovacao [307240/2012-6]; Fundacao de Apoio a Pesquisa do Espirito SantoConselho Nacional de Pesquisa e Inovacao [55108385]	Conservation International-Brazil; Conselho Nacional de Pesquisa e Inovacao; Fundacao de Apoio a Pesquisa do Espirito SantoConselho Nacional de Pesquisa e Inovacao	This study was funded by Conservation International-Brazil. Mauro Cirano was supported by a grant (number 307240/2012-6) from Conselho Nacional de Pesquisa e Inovacao (www.cnpq.br) and Meyre P. da Silva has a research support from Fundacao de Apoio a Pesquisa do Espirito Santo (www.fapes.es.gov.br)/Conselho Nacional de Pesquisa e Inovacao (www.cnpq.br) (Grant number 55108385). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar AL, 2014, CONT SHELF RES, V85, P42, DOI 10.1016/j.csr.2014.04.013; Amado GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035171; BLACK TL, 1994, WEATHER FORECAST, V9, P265, DOI 10.1175/1520-0434(1994)009<0265:TNNMEM>2.0.CO;2; Bleck R, 2002, OCEAN MODEL, V4, P55, DOI 10.1016/S1463-5003(01)00012-9; Brodie J, 2007, MAR FRESHWATER RES, V58, P342, DOI 10.1071/MF06236; Bruce T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036687; Castro BM, 2013, CONT SHELF RES, V70, P3, DOI 10.1016/j.csr.2013.09.025; Ciotti A.M., 2007, CARACTERISTICAS HIDR, P61, DOI DOI 10.3978/J.ISSN.2072-1439.2013.06.23; Ciotti A.M., 2010, J AQUAT SCI, V5, P236; Ciotti AM, 2000, 15 OC OPT S, P1; Costa OS, 2006, J MARINE SYST, V60, P63, DOI 10.1016/j.jmarsys.2005.11.006; Costa OS, 2000, HYDROBIOLOGIA, V440, P307, DOI 10.1023/A:1004104118208; Costa OS, 2008, J S AM EARTH SCI, V25, P257, DOI 10.1016/j.jsames.2007.10.002; Cupelo ACG, 2000, THESIS U SAO PAULO S; DANDONNEAU Y, 1984, DEEP-SEA RES, V31, P1377, DOI 10.1016/0198-0149(84)90078-5; Darecki M, 2004, REMOTE SENS ENVIRON, V89, P326, DOI 10.1016/j.rse.2003.10.012; Dierssen HM, 2010, P NATL ACAD SCI USA, V107, P17073, DOI 10.1073/pnas.0913800107; Dogliotti AI, 2009, INT J REMOTE SENS, V30, P251, DOI 10.1080/01431160802311133; Dutra LXC, 2006, J COASTAL RES, P633; Emery W.J., 2001, DATA ANAL METHODS PH; Falkowski P.G., 2013, AQUATIC PHOTOSYNTHES; Gaeta SA, 1999, ARCH FISH MAR RES, V47, P253; Kahru M, 2011, GLOBAL CHANGE BIOL, V17, P1733, DOI 10.1111/j.1365-2486.2010.02312.x; Kampel M, 2013, CARACTERIZACAO BLOOM; Knoppers B, 1999, ARCH FISH MAR RES, V47, P285; Knoppers B, 1999, GEO-MAR LETT, V19, P171, DOI 10.1007/s003670050106; KNOPPERS B, 2002, BIOL MARINHA, P353; Ku┬ppen, 1900, GEOGR Z, V6, P657, DOI DOI 10.2307/27803939; Leao ZMAN, 2005, MAR POLLUT BULL, V51, P599, DOI 10.1016/j.marpolbul.2005.04.024; Levitus S., 1982, CLIMATOLOGICAL ATLAS; Lopes RM, 2013, CONT SHELF RES, V70, P1, DOI 10.1016/j.csr.2013.11.008; Mahiny AS, 2013, INDIAN J GEO-MAR SCI, V42, P924; Mesinger F, 2012, METEOROL ATMOS PHYS, V116, P63, DOI 10.1007/s00703-012-0182-z; Morel A, 2007, BIOGEOSCIENCES, V4, P913, DOI 10.5194/bg-4-913-2007; Moura RL, 2013, CONT SHELF RES, V70, P109, DOI 10.1016/j.csr.2013.04.036; Navarro G, 2012, ADV SPACE RES, V50, P1164, DOI 10.1016/j.asr.2011.11.034; Nemeth RS, 1999, USVI B MAR SCI, V69, P759; Noernberg MA, 2007, ESTUDO VARABILIDADE; O'Reilly JE, 1998, J GEOPHYS RES-OCEANS, V103, P24937, DOI 10.1029/98JC02160; Pereira CS, 1988, REV BRAS METEOROL, V3, P233; PETERSON RG, 1991, PROG OCEANOGR, V26, P1, DOI 10.1016/0079-6611(91)90006-8; Platt T, 2003, NATURE, V423, P398, DOI 10.1038/423398b; Platt T, 2008, REMOTE SENS ENVIRON, V112, P3426, DOI 10.1016/j.rse.2007.10.016; Platt T, 2007, ICES J MAR SCI, V64, P863, DOI 10.1093/icesjms/fsm072; Platt T, 2009, ECOL MODEL, V220, P3057, DOI 10.1016/j.ecolmodel.2008.11.022; Racault MF, 2012, ECOL INDIC, V14, P152, DOI 10.1016/j.ecolind.2011.07.010; Ryan JP, 2001, DEEP-SEA RES PT II, V48, P159, DOI 10.1016/S0967-0645(00)00117-X; Silveira I.C.A., 2000, REV BRAS OCEANOGR, V48, P171, DOI [10.1590/S1413-77392000000200008, DOI 10.1590/S1413-77392000000200008]; Soutelino RG, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046276; Souza RB, 2007, CLIMATOLOGIA VARIABI; Susini-Ribeiro SMM, 1999, ARCH FISH MAR RES, V47, P271; Sverdrup H.U., 1953, ICES J MAR SCI, V18, P287, DOI [10.1093/icesjms/18.3.287, DOI 10.1093/ICESJMS/18.3.287]; Teixeira CEP, 2013, CONT SHELF RES, V70, P13, DOI 10.1016/j.csr.2013.09.003; Tenenbaum D. R., 2007, SERIE DOCUMENTOS REV, P83, DOI [DOI 10.3978/J.ISSN.2072-1439.2013.06.23, 10.3978/j.issn.2072-1439.2013.06.23]; Tomczak M., 1994, REGIONAL OCEANOGRAPH; Wilkin JL, 2013, J GEOPHYS RES-OCEANS, V118, P2919, DOI 10.1002/jgrc.20223; Xu Y, 2011, CONT SHELF RES, V31, P1640, DOI 10.1016/j.csr.2011.05.019; Yamada K, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024792; Yoder JA, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001942; YODER JA, 1993, GLOBAL BIOGEOCHEM CY, V7, P181, DOI 10.1029/93GB02358; Yu LS, 2006, J CLIMATE, V19, P6153, DOI 10.1175/JCLI3970.1; Zar J, 2010, BIOESTATISTICAL ANAL	62	25	25	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0117082	10.1371/journal.pone.0117082	http://dx.doi.org/10.1371/journal.pone.0117082			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25700269	Green Published, Green Submitted, gold			2022-12-26	WOS:000349789800017
J	Paynter, L; Koehler, E; Howard, AG; Herring, AH; Gordon-Larsen, P				Paynter, Lauren; Koehler, Elizabeth; Howard, Annie Green; Herring, Amy H.; Gordon-Larsen, Penny			Characterizing Long-Term Patterns of Weight Change in China Using Latent Class Trajectory Modeling	PLOS ONE			English	Article							BODY-MASS INDEX; EARLY ADULTHOOD; SAS PROCEDURE; HEALTH; NUTRITION; OBESITY; URBANIZATION; TRANSITION; OVERWEIGHT; URBAN	Background Over the past three decades, obesity-related diseases have increased tremendously in China, and are now the leading causes of morbidity and mortality. Patterns of weight change can be used to predict risk of obesity-related diseases, increase understanding of etiology of disease risk, identify groups at particularly high risk, and shape prevention strategies. Methods Latent class trajectory modeling was used to compute weight change trajectories for adults aged 18 to 66 using the China Health and Nutrition Survey (CHNS) data (n = 12,611). Weight change trajectories were computed separately for males and females by age group at baseline due to differential age-related patterns of weight gain in China with urbanization. Generalized linear mixed effects models examined the association between weight change trajectories and baseline characteristics including urbanicity, BMI category, age, and year of study entry. Results Trajectory classes were identified for each of six age-sex subgroups corresponding to various degrees of weight loss, maintenance and weight gain. Baseline BMI status was a significant predictor of trajectory membership for all age-sex subgroups. Baseline overweight/ obesity increased odds of following 'initial loss with maintenance' trajectories. We found no significant association between baseline urbanization and trajectory membership after controlling for other covariates. Conclusion Trajectory analysis identified patterns of weight change for age by gender groups. Lack of association between baseline urbanization status and trajectory membership suggests that living in a rural environment at baseline was not protective. Analyses identified age-specific nuances in weight change patterns, pointing to the importance of subgroup analyses in future research.	[Paynter, Lauren; Gordon-Larsen, Penny] Univ N Carolina, Dept Nutr, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27514 USA; [Koehler, Elizabeth; Howard, Annie Green; Herring, Amy H.] Univ N Carolina, Dept Biostat, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Howard, Annie Green; Herring, Amy H.; Gordon-Larsen, Penny] Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Gordon-Larsen, P (corresponding author), Univ N Carolina, Dept Nutr, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27514 USA.	pglarsen@unc.edu		Herring, Amy/0000-0003-1552-8871	NIH: NIDDK [R21DK089306]; NHLBI [R01-HL108427]; NIH: NICHD [R01-HD30880]; Carolina Population Center [R24 HD050924]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050924, R01HD030880] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK089306] Funding Source: NIH RePORTER	NIH: NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH: NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Carolina Population Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH: NIDDK (R21DK089306) and NHLBI (R01-HL108427). NIH had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript. This research uses data from the China Health and Nutrition Survey, funded by NIH: NICHD (R01-HD30880), although no direct support was received from the grant for this analysis. The authors also are grateful to the Carolina Population Center (R24 HD050924) for general support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andruff H, 2009, TUTOR QUANT METHODS, V5, P11, DOI 10.20982/tqmp.05.1.p011; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Clarke P, 2009, INT J EPIDEMIOL, V38, P499, DOI 10.1093/ije/dyn214; Clarke PJ, 2010, AM J EPIDEMIOL, V172, P540, DOI 10.1093/aje/kwq156; Croudace TJ, 2003, AM J EPIDEMIOL, V157, P834, DOI 10.1093/aje/kwg049; Hamil-Luker J, 2004, SOC SCI RES, V33, P300, DOI 10.1016/S0049-089X(03)00060-7; Hu Y., 2003, CHINA REV, V3, P49, DOI DOI 10.2307/23461904; Hunter AM, 2010, J PSYCHIATR RES, V44, P90, DOI 10.1016/j.jpsychires.2009.06.006; *INT DIAB I, 2000, AS PAC PERSP RED OB; Jaacks LM, 2013, INT J EPIDEMIOL, V42, P828, DOI 10.1093/ije/dyt052; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; Jones BL, 2007, SOCIOL METHOD RES, V35, P542, DOI 10.1177/0049124106292364; Jun HJ, 2012, AM J PREV MED, V42, P348, DOI 10.1016/j.amepre.2011.11.011; Jung T, 2008, SOC PERSONAL PSYCHOL, V2, P302, DOI 10.1111/j.1751-9004.2007.00054.x; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Li C, 2007, OBESITY SILVER SPRIN, V15, P76; Muthen B, 2002, BIOSTATISTICS, V3, P459, DOI 10.1093/biostatistics/3.4.459; Nagin D, 1999, CHILD DEV, V70, P1181, DOI 10.1111/1467-8624.00086; Nagin DS, 2010, ANNU REV CLIN PSYCHO, V6, P109, DOI 10.1146/annurev.clinpsy.121208.131413; Nagin DS, 1999, PSYCHOL METHODS, V4, P139, DOI 10.1037/1082-989X.4.2.139; Ostbye T, 2011, INT J EPIDEMIOL, V40, P240, DOI 10.1093/ije/dyq142; Padmadas SS, 2006, PUBLIC HEALTH NUTR, V9, P204, DOI 10.1079/PHN2005842; Popkin BM, 2001, ASIA PAC J CLIN NUTR, V10, pS13, DOI 10.1046/j.1440-6047.2001.00211.x; POPKIN BM, 1995, AM J PUBLIC HEALTH, V85, P690, DOI 10.2105/AJPH.85.5.690; Popkin BM, 2010, INT J EPIDEMIOL, V19, P853; Prentice AM, 2006, INT J EPIDEMIOL, V35, P93, DOI 10.1093/ije/dyi272; Ramachandran A, 2008, DIABETES CARE, V31, P893, DOI 10.2337/dc07-1207; Sotres-Alvarez D, 2013, AM J EPIDEMIOL, V177, P852, DOI 10.1093/aje/kws303; Tremblay RE, 2004, PEDIATRICS, V114, pE43, DOI 10.1542/peds.114.1.e43; Yadav K, 2008, OBES REV, V9, P400, DOI 10.1111/j.1467-789X.2008.00505.x; Zhang KH, 2003, CHINA ECON REV, V14, P386, DOI 10.1016/j.chieco.2003.09.018	31	10	10	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0116190	10.1371/journal.pone.0116190	http://dx.doi.org/10.1371/journal.pone.0116190			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB7EQ	25699674	Green Published, Green Submitted, gold			2022-12-26	WOS:000349789800007
J	Revilla, TA; Encinas-Viso, F				Revilla, Tomas A.; Encinas-Viso, Francisco			Dynamical Transitions in a Pollination-Herbivory Interaction: A Conflict between Mutualism and Antagonism	PLOS ONE			English	Article							MANDUCA-SEXTA; POPULATION INTERACTIONS; DATURA-WRIGHTII; COMPETITION; STABILITY; TOBACCO; BENEFITS; DENSITY; NECTAR; GROWTH	Plant-pollinator associations are often seen as purely mutualistic, while in reality they can be more complex. Indeed they may also display a diverse array of antagonistic interactions, such as competition and victim-exploiter interactions. In some cases mutualistic and antagonistic interactions are carried-out by the same species but at different life-stages. As a consequence, population structure affects the balance of inter-specific associations, a topic that is receiving increased attention. In this paper, we developed a model that captures the basic features of the interaction between a flowering plant and an insect with a larval stage that feeds on the plant's vegetative tissues (e. g. leaves) and an adult pollinator stage. Our model is able to display a rich set of dynamics, the most remarkable of which involves victim-exploiter oscillations that allow plants to attain abundances above their carrying capacities and the periodic alternation between states dominated by mutualism or antagonism. Our study indicates that changes in the insect's life cycle can modify the balance between mutualism and antagonism, causing important qualitative changes in the interaction dynamics. These changes in the life cycle could be caused by a variety of external drivers, such as temperature, plant nutrients, pesticides and changes in the diet of adult pollinators.	[Revilla, Tomas A.] CNRS, Ctr Biodivers Theory & Modelling, Stn Ecol Expt, Moulis, France; [Encinas-Viso, Francisco] Univ Groningen, Ctr Ecol & Evolutionary Studies, Community & Conservat Ecol Grp, Groningen, Netherlands	Centre National de la Recherche Scientifique (CNRS); University of Groningen	Revilla, TA (corresponding author), Acad Sci Czech Republic, Ctr Biol, Ceske Budejovice, Czech Republic.	tomrevilla@gmail.com	Revilla, Tomás Augusto/K-6470-2015; Encinas-Viso, Francisco/M-8408-2013	Revilla, Tomás Augusto/0000-0001-6772-3412; 	TULIP Laboratory of Excellence [ANR-10-LABX-41]; OCE postdoctoral fellowship at CSIRO	TULIP Laboratory of Excellence; OCE postdoctoral fellowship at CSIRO	TAR was supported by the TULIP Laboratory of Excellence (ANR-10-LABX-41). FEV was supported by the OCE postdoctoral fellowship at CSIRO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS PA, 1987, OECOLOGIA, V73, P272, DOI 10.1007/BF00377518; Adler LS, 2004, ECOLOGY, V85, P1519, DOI 10.1890/03-0409; Alarcon R, 2008, ECOL ENTOMOL, V33, P503, DOI 10.1111/j.1365-2311.2008.00996.x; Allmann S, 2010, SCIENCE, V329, P1075, DOI 10.1126/science.1191634; Altermatt F, 2011, AM NAT, V178, P372, DOI 10.1086/661248; BALDWIN IT, 1988, OECOLOGIA, V77, P378, DOI 10.1007/BF00378046; Barron-Gafford GA, 2012, PHOTOSYNTH RES, V113, P249, DOI 10.1007/s11120-012-9741-x; Bonhomme R, 2000, EUR J AGRON, V13, P1, DOI 10.1016/S1161-0301(00)00058-7; BRONSTEIN JL, 1994, TRENDS ECOL EVOL, V9, P214, DOI 10.1016/0169-5347(94)90246-1; Bronstein JL, 2006, NEW PHYTOL, V172, P412, DOI 10.1111/j.1469-8137.2006.01864.x; Bronstein JL, 2009, ANN BOT-LONDON, V103, P1435, DOI 10.1093/aob/mcp053; CAMPBELL CD, 1991, J ECON ENTOMOL, V84, P1662, DOI 10.1093/jee/84.6.1662; Case T. J, 2000, ILLUSTRATED GUIDE TH; DEV S, 1986, Proceedings of the Indian National Science Academy Part B Biological Sciences, V52, P17; Eaton J. W., 2008, GNU OCTAVE MANUAL VE; Encinas-Viso F, 2014, J THEOR BIOL, V352, P24, DOI 10.1016/j.jtbi.2014.02.030; Ermentrout B, 2003, XPPAUT 5 41 DIFFEREN; Fagan WF, 2014, THEOR ECOL-NETH, V7, P289, DOI 10.1007/s12080-014-0218-8; FREEDMAN HI, 1976, MATH BIOSCI, V31, P207, DOI 10.1016/0025-5564(76)90080-8; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Hernandez MJ, 2009, J THEOR BIOL, V261, P107, DOI 10.1016/j.jtbi.2009.07.001; Hernandez MJ, 1998, P ROY SOC B-BIOL SCI, V265, P1433, DOI 10.1098/rspb.1998.0454; Holland JN, 2013, THEOR ECOL-NETH, V6, P475, DOI 10.1007/s12080-013-0181-9; Holland JN, 2010, ECOLOGY, V91, P1286, DOI 10.1890/09-1163.1; Holland JN, 2002, AM NAT, V159, P231, DOI 10.1086/338510; HOLT RD, 1977, THEOR POPUL BIOL, V12, P197, DOI 10.1016/0040-5809(77)90042-9; HUNT WF, 1976, PLANT PHYSIOL, V57, P802, DOI 10.1104/pp.57.5.802; Irwin RE, 2010, CURR BIOL, V20, pR100, DOI 10.1016/j.cub.2009.12.005; Johnson CA, 2013, J THEOR BIOL, V328, P54, DOI 10.1016/j.jtbi.2013.03.016; Jones EI, 2012, ANN NY ACAD SCI, V1256, P66, DOI 10.1111/j.1749-6632.2012.06552.x; Kearns CA, 1998, ANNU REV ECOL SYST, V29, P83, DOI 10.1146/annurev.ecolsys.29.1.83; Kennedy GG, 2003, ANNU REV ENTOMOL, V48, P51, DOI 10.1146/annurev.ento.48.091801.112733; Kessler D, 2010, CURR BIOL, V20, P237, DOI 10.1016/j.cub.2009.11.071; MATLAB, 2010, MATLAB VERS 7 14 0 R; MCFADDEN MW, 1968, J ECON ENTOMOL, V61, P352, DOI 10.1093/jee/61.2.352; Miller TEX, 2011, TRENDS ECOL EVOL, V26, P457, DOI 10.1016/j.tree.2011.05.005; Perkins MC, 2004, ARCH INSECT BIOCHEM, V55, P153, DOI 10.1002/arch.10133; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; PRIMACK RB, 1985, ANNU REV ECOL SYST, V16, P15, DOI 10.1146/annurev.es.16.110185.000311; REINECKE JP, 1980, BIOL BULL-US, V158, P129, DOI 10.2307/1540764; Rinaldi S, 2000, ECOSYSTEMS, V3, P507, DOI 10.1007/s100210000045; ROSENZWE.ML, 1971, SCIENCE, V171, P385, DOI 10.1126/science.171.3969.385; ROSENZWEIG ML, 1963, AM NAT, V97, P209, DOI 10.1086/282272; Rudolf VHW, 2011, ECOL LETT, V14, P75, DOI 10.1111/j.1461-0248.2010.01558.x; SCHOENER TW, 1978, THEOR POPUL BIOL, V13, P365, DOI 10.1016/0040-5809(78)90052-7; Stephens PA, 1999, OIKOS, V87, P185, DOI 10.2307/3547011; Vasseur DA, 2005, AM NAT, V166, P184, DOI 10.1086/431285; Wackers FL, 2007, ANNU REV ENTOMOL, V52, P301, DOI 10.1146/annurev.ento.52.110405.091352; Wang YS, 2012, MATH BIOSCI ENG, V9, P431, DOI 10.3934/mbe.2012.9.431; Wolfram Research Inc., 2010, MATH VERS 8 0; Woods HA, 1999, PHYSIOL BIOCHEM ZOOL, V72, P445, DOI 10.1086/316678; ZIEGLER R, 1991, J COMP PHYSIOL B, V161, P125, DOI 10.1007/BF00262874	52	12	12	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0117964	10.1371/journal.pone.0117964	http://dx.doi.org/10.1371/journal.pone.0117964			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25700003	Green Submitted, Green Published, gold			2022-12-26	WOS:000349789800032
J	Jiang, HJ; Chen, KH; Jaw, FS				Jiang, Han-Jia; Chen, Kuang-Hsuan; Jaw, Fu-Shan			Deep-Brain Electrical Microstimulation Is an Effective Tool to Explore Functional Characteristics of Somatosensory Neurons in the Rat Brain	PLOS ONE			English	Article							STIMULATION	In neurophysiology researches, peripheral stimulation is used along with recordings of neural activities to study the processing of somatosensory signals in the brain. However, limited precision of peripheral stimulation makes it difficult to activate the neuron with millisecond resolution and study its functional properties in this scale. Also, tissue/receptor damage that could occur in some experiments often limits the amount of responses that can be recorded and hence reduces data reproducibility. To overcome these limitations, electrical microstimulation (ES) of the brain could be used to directly and more precisely evoke neural responses. For this purpose, a deep-brain ES protocol for rat somatosensory relay neurons was developed in this study. Three male Wistar rats were used in the experiment. The ES was applied to the thalamic region responsive to hindpaw tactile stimulation (TS) via a theta glass microelectrode. The resulting ES-evoked cortical responses showed action potentials and thalamocortical relay latencies very similar to those evoked by TS. This result shows that the developed deep-brain ES protocol is an effective tool to bypass peripheral tissue for in vivo functional analysis of specific types of somatosensory neurons. This protocol could be readily applied in researches of nociception and other somatosensory systems to allow more extensive exploration of the neural functional networks.	[Jiang, Han-Jia; Chen, Kuang-Hsuan; Jaw, Fu-Shan] Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan	National Taiwan University	Jaw, FS (corresponding author), Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan.	jaw@ntu.edu.tw		Jiang, Han-Jia/0000-0002-9633-2573	Ministry of Science and Technology [MOST 103-2221-E-002-014-MY2]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This study was supported by Ministry of Science and Technology (http://www.most.gov.tw) under grant number MOST 103-2221-E-002-014-MY2. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARENDTNIELSEN L, 1988, J NEUROL NEUROSUR PS, V51, P35, DOI 10.1136/jnnp.51.1.35; Benabid AL, 2003, CURR OPIN NEUROBIOL, V13, P696, DOI 10.1016/j.conb.2003.11.001; Clark KL, 2011, P ROY SOC B-BIOL SCI, V278, P1121, DOI 10.1098/rspb.2010.2211; Histed MH, 2013, PROG NEUROBIOL, V103, P115, DOI 10.1016/j.pneurobio.2012.01.006; Krack P, 1999, CURR OPIN NEUROL, V12, P417, DOI 10.1097/00019052-199908000-00008; Le Bars D, 2001, PHARMACOL REV, V53, P597; McCreery DB, 2008, HEARING RES, V242, P64, DOI 10.1016/j.heares.2007.11.014; Neagu B, 2005, J NEUROSCI METH, V144, P153, DOI 10.1016/j.jneumeth.2004.10.021; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pikov V, 2008, P IEEE, V96, P1120, DOI 10.1109/JPROC.2008.922583; Tehovnik EJ, 2006, J NEUROPHYSIOL, V96, P512, DOI 10.1152/jn.00126.2006; Tsai MF, 2000, THESIS NATL TAIWAN U	12	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0117289	10.1371/journal.pone.0117289	http://dx.doi.org/10.1371/journal.pone.0117289			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695538	Green Published, Green Submitted, gold			2022-12-26	WOS:000350062300020
J	Kiss, B; Laszlo, JF; Szalai, A; Porszasz, R				Kiss, Balazs; Laszlo, Janos F.; Szalai, Andrea; Porszasz, Robert			Analysis of the Effect of Locally Applied Inhomogeneous Static Magnetic Field-Exposure on Mouse Ear Edema - A Double Blind Study	PLOS ONE			English	Article							PAIN; RESPONSES; CHANNELS	The effect static magnetic field (SMF)-exposure may exert on edema development has been investigated. A 6 h long whole-body (WBSMF) or local (LSMF), continuous, inhomogeneous SMF-exposure was applied on anesthetized mice in an in vivo model of mustard oil (MO)-induced ear edema. LSMF was applied below the treated ear, below the lumbar spine, or below the mandible. Ear thickness (v) was checked 8 times during the exposure period (at 0, 0.25, 1, 2, 3, 4, 5, and 6 h). The effect size of the applied treatment (eta) on ear thickness was calculated by the formula eta = 100% x (1-v(j)/v(i)), where group i is the control group and j is the treated group. Results showed that MO treatment in itself induced a significant ear edema with an effect of 9% (p< 0.001). WBSMF or LSMF on the spine in combination with MO treatment increased ear thickness even further resulting in an effect eta> 11% in both cases compared to SMF-exposure alone (p< 0.001). In these cases SMF-exposure alone without MO treatment reduced ear thickness significantly (p< 0.05), but within estimated experimental error. In cases of LSMF-exposure on the head, a significant SMF-exposure induced ear thickness reduction was found (eta = 5%, p< 0.05). LSMF-exposure on the spine affected ear thickness with and without MO treatment almost identically, which provides evidence that the place of local SMF action may be in the lower spinal region.	[Kiss, Balazs] Semmelweis Univ, Dept Biophys & Radiat Biol, H-1085 Budapest, Hungary; [Kiss, Balazs] Semmelweis Univ, MTA SE Mol Biophys Res Grp, H-1085 Budapest, Hungary; [Laszlo, Janos F.] Univ Debrecen, Dept Comp Sci, Debrecen, Hungary; [Laszlo, Janos F.] E Comers LLC, Budapest, Hungary; [Szalai, Andrea; Porszasz, Robert] Univ Debrecen, Med & Hlth Sci Ctr, Dept Pharmacol & Pharmacotherapy, Debrecen, Hungary	Semmelweis University; Semmelweis University; University of Debrecen; University of Debrecen	Kiss, B (corresponding author), Semmelweis Univ, Dept Biophys & Radiat Biol, H-1085 Budapest, Hungary.	balazs.kiss@eok.sote.hu	Kiss, Balazs/J-8371-2017; Porszasz, Robert/HGD-4008-2022	Kiss, Balazs/0000-0002-2347-5928; Porszasz, Robert/0000-0001-7910-9145				AlChaer ED, 1997, NEUROREPORT, V8, P3267, DOI 10.1097/00001756-199710200-00016; Alves LA, 2013, MOLECULES, V18, P10953, DOI 10.3390/molecules180910953; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Gabor Miklos, 2003, Methods Mol Biol, V225, P129; Gyires K, 2008, BIOELECTROMAGNETICS, V29, P456, DOI 10.1002/bem.20413; He YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054376; Holcomb RR, 1994, USA Patents, Patent No. [US 5312321 A, 5312321]; Jokela K, 2011, HEALTH PHYS, V100, P641, DOI 10.1097/HP.0b013e318202ec7e; Kiss B, 2013, BIOELECTROMAGNETICS, V34, P385, DOI 10.1002/bem.21781; Laszlo J, 2011, HORIZONS NEUROSCIENC, P106; Laszlo J, 2007, BIOELECTROMAGNETICS, V28, P615, DOI 10.1002/bem.20341; Laszlo J, 2009, LIFE SCI, V84, P12, DOI 10.1016/j.lfs.2008.10.009; Laszlo JF, 2012, INT J RADIAT BIOL, V88, P430, DOI 10.3109/09553002.2012.661916; LASZLO JF, 2010, PROGR ELECTROMAGNETI, V6, P307, DOI DOI 10.2529/PIERS091005062944; Li ZY, 2007, IN VIVO, V21, P61; Moran MM, 2004, CURR OPIN NEUROBIOL, V14, P362, DOI 10.1016/j.conb.2004.05.003; Morris C, 2005, BIOELECTROMAGNETICS, V26, P1, DOI 10.1002/bem.20047; Morris CE, 2008, AM J PHYSIOL-HEART C, V294, pH50, DOI 10.1152/ajpheart.00529.2007; Morris CE, 2007, J APPL PHYSIOL, V103, P629, DOI 10.1152/japplphysiol.01133.2006; Ohkubo C, 1997, IN VIVO, V11, P221; Okano H, 1999, BIOELECTROMAGNETICS, V20, P161, DOI 10.1002/(SICI)1521-186X(1999)20:3<161::AID-BEM2>3.0.CO;2-O; Okano H, 2005, BIOELECTROMAGNETICS, V26, P611, DOI 10.1002/bem.20144; Okano H, 2001, BIOELECTROMAGNETICS, V22, P408, DOI 10.1002/bem.68; Pereda J, 2006, BRIT J PHARMACOL, V149, P450, DOI 10.1038/sj.bjp.0706871; Rosen AD, 2003, BIOELECTROMAGNETICS, V24, P517, DOI 10.1002/bem.10124; Sandor K, 2007, LIFE SCI, V81, P97, DOI 10.1016/j.lfs.2007.04.029; Sprenger C, 2012, CURR BIOL, V22, P1019, DOI 10.1016/j.cub.2012.04.006; Valet M, 2004, PAIN, V109, P399, DOI 10.1016/j.pain.2004.02.033; Vergallo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072374; Waltham MA, 2012, COMP ANATOMY HISTOLO	30	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0118089	10.1371/journal.pone.0118089	http://dx.doi.org/10.1371/journal.pone.0118089			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695832	Green Published, gold, Green Submitted			2022-12-26	WOS:000350062300040
J	Taylor, DL; Ante, VM; Bina, XR; Howard, MF; Bina, JE				Taylor, Dawn L.; Ante, Vanessa M.; Bina, X. Renee; Howard, Mondraya F.; Bina, James E.			Substrate-Dependent Activation of the Vibrio cholerae vexAB RND Efflux System Requires vexR	PLOS ONE			English	Article							FAMILY TRANSCRIPTIONAL REGULATOR; VIRULENCE FACTOR PRODUCTION; ESCHERICHIA-COLI; TETR-FAMILY; MULTIDRUG EFFLUX; CRYSTAL-STRUCTURE; BILE RESISTANCE; EPIPHYTIC FITNESS; EXPRESSION; PROTEIN	Vibrio cholerae encodes six resistance-nodulation-division (RND) efflux systems which function in antimicrobial resistance, virulence factor production, and intestinal colonization. Among the six RND efflux systems, VexAB exhibited broad substrate specificity and played a predominant role in intrinsic antimicrobial resistance. The VexAB system was encoded in an apparent three gene operon that included vexR; which encodes an uncharacterized TetR family regulator. In this work we examined the role of vexR in vexRAB expression. We found that VexR bound to the vexRAB promoter and vexR deletion resulted in decreased vexRAB expression and increased susceptibility to VexAB antimicrobial substrates. Substrate-dependent induction of vexRAB was dependent on vexR and episomal vexR expression provided a growth advantage in the presence of the VexAB substrate deoxycholate. The expression of vexRAB increased, in a vexR-dependent manner, in response to the loss of RND efflux activity. This suggested that VexAB may function to export intracellular metabolites. Support for this hypothesis was provided by data showing that vexRAB was upregulated in several metabolic mutants including tryptophan biosynthetic mutants that were predicted to accumulate indole. In addition, vexRAB was found to be upregulated in response to exogenous indole and to contribute to indole resistance. The collective results indicate that vexR is required for vexRAB expression in response to VexAB substrates and that the VexAB RND efflux system modulates the intracellular levels of metabolites that could otherwise accumulate to toxic levels.	[Taylor, Dawn L.; Ante, Vanessa M.; Bina, X. Renee; Howard, Mondraya F.; Bina, James E.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bina, JE (corresponding author), Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA.	JBina@pitt.edu		Ante, Vanessa/0000-0002-7762-3930	National Institutes of Health (NIH) award [R01AI091845]; NIH training grant [T32AI049820]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI049820, R01AI091845] Funding Source: NIH RePORTER	National Institutes of Health (NIH) award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) award R01AI091845. DLT and MFH were supported by NIH training grant T32AI049820. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050562; Akama H, 2004, J BIOL CHEM, V279, P25939, DOI 10.1074/jbc.C400164200; Ali M, 2012, B WORLD HEALTH ORGAN, V90, P209, DOI 10.2471/BLT.11.093427; Alonso A, 2001, ENVIRON MICROBIOL, V3, P1, DOI 10.1046/j.1462-2920.2001.00161.x; Alvarez-Ortega C, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00007; Bina J, 2003, P NATL ACAD SCI USA, V100, P2801, DOI 10.1073/pnas.2628026100; Bina JE, 2006, ARCH MICROBIOL, V186, P171, DOI 10.1007/s00203-006-0133-5; Bina JE, 2001, INFECT IMMUN, V69, P4681, DOI 10.1128/IAI.69.7.4681-4685.2001; Bina XR, 2008, INFECT IMMUN, V76, P3595, DOI 10.1128/IAI.01620-07; Bina XWR, 2009, J ANTIMICROB CHEMOTH, V63, P103, DOI 10.1093/jac/dkn466; Cameron DE, 2008, P NATL ACAD SCI USA, V105, P8736, DOI 10.1073/pnas.0803281105; Cerda-Maira FA, 2008, J BACTERIOL, V190, P7441, DOI 10.1128/JB.00584-08; Chatterjee A, 2007, APPL ENVIRON MICROB, V73, P3684, DOI 10.1128/AEM.02445-06; Chattoraj P, 2011, J BACTERIOL, V193, P6605, DOI 10.1128/JB.06122-11; Childers BM, 2007, FUTURE MICROBIOL, V2, P335, DOI 10.2217/17460913.2.3.335; Christen S, 2006, J BIOL CHEM, V281, P23129, DOI 10.1074/jbc.M603486200; Cuthbertson L, 2013, MICROBIOL MOL BIOL R, V77, P440, DOI 10.1128/MMBR.00018-13; Delmar JA, 2014, ANNU REV BIOPHYS, V43, P93, DOI 10.1146/annurev-biophys-051013-022855; Eswaran J, 2004, CURR OPIN STRUC BIOL, V14, P741, DOI 10.1016/j.sbi.2004.10.003; Franke I, 2003, J BACTERIOL, V185, P1161, DOI 10.1128/JB.185.4.1161-1166.2003; Goulart CL, 2010, MICROBIOL-SGM, V156, P3011, DOI 10.1099/mic.0.043117-0; Grkovic S, 2002, MICROBIOL MOL BIOL R, V66, P671, DOI 10.1128/MMBR.66.4.671-701.2002; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hankins JV, 2012, P NATL ACAD SCI USA, V109, P8722, DOI 10.1073/pnas.1201313109; Hatzios SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043175; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; Helling RB, 2002, J BACTERIOL, V184, P3699, DOI 10.1128/JB.184.13.3699-3703.2002; Hirano S, 2008, MICROBIOL-SGM, V154, P905, DOI 10.1099/mic.0.2007/014381-0; Hu B, 2012, J BACTERIOL, V194, P2802, DOI 10.1128/JB.00061-12; IMAI Y, 1991, NUCLEIC ACIDS RES, V19, P2785, DOI 10.1093/nar/19.10.2785; de Eugenio LI, 2010, ENVIRON MICROBIOL, V12, P207, DOI [10.1111/j.1462-2920.2009.02061.x, 10.1111/j.1462-2920.2010.02199.x]; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; Kawamura-Sato K, 1999, FEMS MICROBIOL LETT, V179, P345, DOI 10.1016/S0378-1097(99)00433-4; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Li XZ, 2004, ANTIMICROB AGENTS CH, V48, P2415, DOI 10.1128/AAC.48.7.2415-2423.2004; Ma D, 1996, MOL MICROBIOL, V19, P101, DOI 10.1046/j.1365-2958.1996.357881.x; Martinez JL, 2009, P ROY SOC B-BIOL SCI, V276, P2521, DOI 10.1098/rspb.2009.0320; Mathur J, 2004, INFECT IMMUN, V72, P3577, DOI 10.1128/IAI.72.6.3577-3583.2004; Merrell DS, 2001, J BACTERIOL, V183, P2746, DOI 10.1128/JB.183.9.2746-2754.2001; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Morin CE, 2009, FEMS IMMUNOL MED MIC, V57, P69, DOI 10.1111/j.1574-695X.2009.00580.x; Mueller RS, 2007, J BACTERIOL, V189, P5348, DOI 10.1128/JB.01867-06; Mueller RS, 2009, J BACTERIOL, V191, P3504, DOI 10.1128/JB.01240-08; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Park H, 2011, J BACTERIOL, V193, P6288, DOI 10.1128/JB.05649-11; Pompeani AJ, 2008, MOL MICROBIOL, V70, P76, DOI 10.1111/j.1365-2958.2008.06389.x; Provenzano D, 2000, P NATL ACAD SCI USA, V97, P10220, DOI 10.1073/pnas.170219997; Provenzano D, 2000, INFECT IMMUN, V68, P1491, DOI 10.1128/IAI.68.3.1491-1497.2000; Quinones B, 2004, MOL PLANT MICROBE IN, V17, P521, DOI 10.1094/MPMI.2004.17.5.521; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Rosner JL, 2013, J BACTERIOL, V195, P1042, DOI 10.1128/JB.01996-12; Rosner JL, 2009, J BACTERIOL, V191, P5283, DOI 10.1128/JB.00507-09; Ruiz C, 2014, J ANTIMICROB CHEMOTH, V69, P390, DOI 10.1093/jac/dkt352; Sahota G, 2010, BIOINFORMATICS, V26, P2672, DOI 10.1093/bioinformatics/btq501; Schild S, 2007, CELL HOST MICROBE, V2, P264, DOI 10.1016/j.chom.2007.09.004; Slamti L, 2009, J BACTERIOL, V191, P5044, DOI 10.1128/JB.00406-09; Aoki Kiyoko F, 2005, Curr Protoc Bioinformatics, VChapter 1, DOI [10.1002/0471250953.bi0112s38, 10.1002/0471250953.bi0112s11]; Taylor DL, 2014, INFECT IMMUN, V82, P2980, DOI 10.1128/IAI.00025-14; Taylor DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038208; Thelin KH, 1996, INFECT IMMUN, V64, P2853, DOI 10.1128/IAI.64.7.2853-2856.1996; Uguru GC, 2005, MOL MICROBIOL, V58, P131, DOI 10.1111/j.1365-2958.2005.04817.x; Van Bambeke F, 2003, J ANTIMICROB CHEMOTH, V51, P1055, DOI 10.1093/jac/dkg224	64	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0117890	10.1371/journal.pone.0117890	http://dx.doi.org/10.1371/journal.pone.0117890			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695834	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000350062300032
J	Feldman, CH; Hiraki, LT; Lii, HC; Seeger, JD; Kim, SC				Feldman, Candace H.; Hiraki, Linda T.; Lii, Huichuan; Seeger, John D.; Kim, Seoyoung C.			Human Papillomavirus Vaccine Uptake among Individuals with Systemic Inflammatory Diseases	PLOS ONE			English	Article							CARE PROVIDER RECOMMENDATION; LUPUS-ERYTHEMATOSUS; HPV VACCINE; UNITED-STATES; WOMEN; IMMUNIZATION; COMPLETION; RISK; AUTOIMMUNE	Objectives The human papillomavirus (HPV) vaccine is safe and efficacious in patients with systemic inflammatory diseases (SID) who have higher rates of persistent HPV infection. We compared HPV vaccine uptake among SID and non-SID patients. Methods Using a U.S. insurance claims database (2006-2012), we identified individuals 9-26 years with >= 2 SID diagnosis codes >= 7 days apart with >= 12 months of continuous enrollment prior to the second code (index date). We matched SID patients by age, sex and index date to randomly selected non-SID subjects and selected those with >= 24 months of post-index date continuous follow-up. We also identified a non-SID subcohort with >= 1 diagnosis code for asthma. We defined initiation as >= 1 HPV vaccination claim after 2007, and completion as 3 claims. We used multivariable logistic regression to assess uptake in females 11-26 years comparing SID, non-SID and asthma cohorts, adjusting for demographics, region, comorbidities, and healthcare utilization. Results We identified 5,642 patients 9-26 years with SID and 20,643 without. The mean age was 18.1 years (SD 4.9). We identified 1,083 patients with asthma; the mean age was 17.2 (SD 5.1). Among females, 20.6% with SID, 23.1% without SID and 22.9% with asthma, received >= 1 HPV vaccine. In our adjusted models, the odds of receipt of >= 1 vaccine was 0.87 times lower in SID (95% CI 0.77-0.98) compared to non-SID and did not differ for 3 vaccines (OR 1.03, 95% CI 0.83-1.26). The odds of initiation and completion were not statistically different between SID and non-SID asthma cohorts. Conclusions In this nationwide cohort, HPV vaccine uptake was extremely low. Despite the heightened risk of persistent HPV infection among those with SID, no increase in HPV vaccine uptake was observed. Public health efforts to promote HPV vaccination overall are needed, and may be particularly beneficial for those at higher risk.	[Feldman, Candace H.; Kim, Seoyoung C.] Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Hiraki, Linda T.] Hosp Sick Children, Div Rheumatol, Toronto, ON M5G 1X8, Canada; [Lii, Huichuan; Seeger, John D.; Kim, Seoyoung C.] Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Harvard University; Brigham & Women's Hospital	Feldman, CH (corresponding author), Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA.	chfeldman@partners.org	Hiraki, Linda/AAN-6411-2021; Kim, Seoyoung/L-6561-2019	Kim, Seoyoung/0000-0002-2517-3579	Lupus Foundation Career Development Award; Pfizer Pharmaceuticals; Canadian Institute of Health Research (CIHR) Fellowship Award; NIH [K23 AR059677]; Pfizer; Pharmaceutical Research and Manufacturers of America (PhRMA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K23AR059677] Funding Source: NIH RePORTER	Lupus Foundation Career Development Award; Pfizer Pharmaceuticals(Pfizer); Canadian Institute of Health Research (CIHR) Fellowship Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer(Pfizer); Pharmaceutical Research and Manufacturers of America (PhRMA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Candace H. Feldman is supported by the Lupus Foundation Career Development Award and receives research support from Pfizer Pharmaceuticals. Linda T. Hiraki is supported by the Canadian Institute of Health Research (CIHR) Fellowship Award. Huichuan Lii has nothing to disclose. John D. Seeger is a paid consultant to Optum Insight and WHISCON. Seoyoung C. Kim is supported by the NIH grant K23 AR059677. She received research support from Pfizer and tuition support for the Pharmacoepidemiology Program at the Harvard School of Public Health partially funded by the Pharmaceutical Research and Manufacturers of America (PhRMA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnheim-Dahlstom L, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5906; Avery RK, 1999, RHEUM DIS CLIN N AM, V25, P567, DOI 10.1016/S0889-857X(05)70087-9; Bernatsky SR, 2006, J RHEUMATOL, V33, P45; BLUMENFELD Z, 1994, LUPUS, V3, P59, DOI 10.1177/096120339400300112; Caskey R, 2009, J ADOLESCENT HEALTH, V45, P453, DOI 10.1016/j.jadohealth.2009.04.021; Chao C, 2012, J INTERN MED, V271, P193, DOI 10.1111/j.1365-2796.2011.02467.x; Chao C, 2009, MAYO CLIN PROC, V84, P864, DOI 10.1016/S0025-6196(11)60503-X; Chesson HW., 2014, MORBIDITY MORTALITY; Cibere J, 2001, LUPUS, V10, P394, DOI 10.1191/096120301678646128; Conroy K, 2009, J WOMENS HEALTH, V18, P1679, DOI 10.1089/jwh.2008.1329; Deal CL, 2007, ARTHRITIS RHEUM, V56, P722, DOI 10.1002/art.22437; Dempsey A, 2011, VACCINE, V29, P528, DOI 10.1016/j.vaccine.2010.10.051; Gudeman R, 2007, J NATL CTR YOUTH LAW, V28, P1; Heijstek MW, 2013, ANN RHEUM DIS; Kane S, 2008, AM J GASTROENTEROL, V103, P631, DOI 10.1111/j.1572-0241.2007.01582.x; Kiefe CI, 1998, J GEN INTERN MED, V13, P357, DOI 10.1046/j.1525-1497.1998.00115.x; Kim SC, 2014, ANN RHEUM DIS; Krueger KP, 2001, DIS MANAGEMENT, V4, P155; Lau M, 2012, VACCINE, V30, P3112, DOI 10.1016/j.vaccine.2012.02.034; Lawrence JM, 2014, AM J EPIDEMIOL, V179, P27, DOI 10.1093/aje/kwt230; Malveaux FJ, 2009, PEDIATRICS, V123, pS129, DOI 10.1542/peds.2008-2233B; Mok CC, 2013, ANN RHEUM DIS, V72, P659, DOI 10.1136/annrheumdis-2012-201393; Prevention CfDCa, 2013, HUM PAP VACC COV AD; Rahman M, 2014, VACCINE, V32, P2394, DOI 10.1016/j.vaccine.2014.02.097; Rahman M, 2013, VACCINE, V31, P5495, DOI 10.1016/j.vaccine.2013.09.022; Ramsey-Goldman R, 1998, J INVEST MED, V46, P217; Rojo-Contreras W, 2012, LUPUS, V21, P365, DOI 10.1177/0961203311425517; Rosenthal SL, 2011, VACCINE, V29, P890, DOI 10.1016/j.vaccine.2009.12.063; Satterwhite CL, 2013, SEX TRANSM DIS, V40, P187, DOI 10.1097/OLQ.0b013e318286bb53; Schluterman NH, 2011, VACCINE, V29, P3767, DOI 10.1016/j.vaccine.2011.03.032; Soldevilla HF, 2012, LUPUS, V21, P158, DOI 10.1177/0961203311429556; Suris JC, 2008, PEDIATRICS, V122, pE1113, DOI 10.1542/peds.2008-1479; Tam LS, 2010, J RHEUMATOL, V37, P330, DOI 10.3899/jrheum.090644; Widdice LE, 2011, PEDIATRICS, V127, P77, DOI 10.1542/peds.2010-0812; Yazdany J, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3011; Ylitalo KR, 2013, AM J PUBLIC HEALTH, V103, P164, DOI 10.2105/AJPH.2011.300600; Zendehdel K, 2003, JNCI-J NATL CANCER I, V95, P1797, DOI 10.1093/jnci/djg105	37	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117620	10.1371/journal.pone.0117620	http://dx.doi.org/10.1371/journal.pone.0117620			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC0WZ	25692470	Green Submitted, gold, Green Published			2022-12-26	WOS:000350061500065
J	Holwerda, FM; Pol, D; Rauhut, OWM				Holwerda, Femke M.; Pol, Diego; Rauhut, Oliver W. M.			Using Dental Enamel Wrinkling to Define Sauropod Tooth Morphotypes from the Canadon Asfalto Formation, Patagonia, Argentina	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; THEROPOD DINOSAUR; EARLY EVOLUTION; TEETH; REDESCRIPTION; DENTITION; JUVENILE; REASSESSMENT; PROVINCE; ANATOMY	The early Middle Jurassic is regarded as the period when sauropods diversified and became major components of the terrestrial ecosystems. Not many sites yield sauropod material of this time; however, both cranial and postcranial material of eusauropods have been found in the Canadon Asfalto Formation (latest Early Jurassic-early Middle Jurassic) in Central Patagonia (Argentina), which may help to shed light on the early evolution of eusauropods. These eusauropod remains include teeth associated with cranial and mandibular material as well as isolated teeth found at different localities. In this study, an assemblage of sauropod teeth from the Canadon Asfalto Formation found in four different localities in the area of Cerro Condor (Chubut, Argentina) is used as a mean of assessing sauropod species diversity at these sites. By using dental enamel wrinkling, primarily based on the shape and orientation of grooves and crests of this wrinkling, we define and describe three different morphotypes. With the exception of one taxon, for which no cranial material is currently known, these morphotypes match the local eusauropod diversity as assessed based on postcranial material. Morphotype I is tentatively assigned to Patagosaurus, whereas morphotypes II and III correspond to new taxa, which are also distinguished by associated postcranial material. This study thus shows that enamel wrinkling can be used as a tool in assessing sauropod diversity.	[Holwerda, Femke M.; Rauhut, Oliver W. M.] SNSB, Bayer Staatssammlung Palaontol & Geol, Munich, Germany; [Holwerda, Femke M.] Univ Nova Lisboa, GeoBioTec, FCT, Dept Ciencias Terra, Caparica, Portugal; [Holwerda, Femke M.; Rauhut, Oliver W. M.] Univ Munich, Dept Earth & Environm Sci, Munich, Germany; [Holwerda, Femke M.; Rauhut, Oliver W. M.] Univ Munich, GeoBioCenter, Munich, Germany; [Pol, Diego] Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina; [Pol, Diego] Museo Paleontol Egidio Feruglio, Trelew, Argentina	Universidade Nova de Lisboa; University of Munich; University of Munich; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Holwerda, FM (corresponding author), SNSB, Bayer Staatssammlung Palaontol & Geol, Munich, Germany.	F.M.Holwerda@gmail.com	Rauhut, Oliver/AAG-1029-2020; Pol, Diego/A-8007-2008	Pol, Diego/0000-0002-9690-7517; Holwerda, Femke/0000-0003-3446-5693; Rauhut, Oliver/0000-0003-3958-603X	DFG (Deutsche Forschungs Gemeinschaft) [RA 1012/13-1]; PICT [0808]	DFG (Deutsche Forschungs Gemeinschaft)(German Research Foundation (DFG)); PICT(ANPCyT)	FH is funded by DFG (Deutsche Forschungs Gemeinschaft) project RA 1012/13-1 (to OR). Part of this research was funded by PICT 0808 to DP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain R, 2004, CR PALEVOL, V3, P199, DOI 10.1016/j.crpv.2004.03.001; Apesteguia S, 2012, ZOOL J LINN SOC-LOND, V166, P342, DOI 10.1111/j.1096-3642.2012.00837.x; Baez AM, 2008, J INF, V82; Barrett PM, 2006, T ROY SOC EDIN-EARTH, V97, P25, DOI 10.1017/S0263593300001383; Barrett PM, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P125; Barrett Paul M., 2007, Palaeoworld, V16, P265, DOI 10.1016/j.palwor.2007.07.001; Becerra MG, 2013, HIST BIOL, P1; BONAPARTE J F, 1986, Annales de Paleontologie, V72, P325; BONAPARTE J F, 1986, Annales de Paleontologie, V72, P247; Bonaparte JF, 1999, AMEGHINIANA, V36, P115; BONAPARTE JF, 1979, SCIENCE, V205, P1377, DOI 10.1126/science.205.4413.1377; Britt Brooks B., 1994, P256; Buckley LG, 2010, CAN J EARTH SCI, V47, P1227, DOI 10.1139/E10-029; Buffetaut E, 2005, B SOC GEOL FR, V176, P467, DOI 10.2113/176.5.467; Buscalioni AD, 1997, GEOLOGICAL SOC DENMA, V1; Cabaleri N., 2010, S AM S IS GEOL BRAS, P190; Calvo Jorge O., 1994, Gaia, V10, P183; Carpenter K, 2005, LIFE O PAST, P78; Chatterjee S, 2002, ZOOL J LINN SOC-LOND, V136, P145, DOI 10.1046/j.1096-3642.2002.00037.x; Chiappe LM, 2001, SCIENCE, V293, P2444, DOI 10.1126/science.1063723; Chiappe LM, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P285; Chure D, 2010, NATURWISSENSCHAFTEN, V97, P379, DOI 10.1007/s00114-010-0650-6; Cuneo R, 2013, GONDWANA RES, V24, P1267, DOI 10.1016/j.gr.2013.01.010; Currie P.J., 1990, P107, DOI 10.1017/CBO9780511608377.011; D'Emic MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069235; Diaz VD, 2014, CRETACEOUS RES, V51, P285, DOI 10.1016/j.cretres.2014.07.003; Diaz VD, 2013, ANN PALEONTOL, V99, P119, DOI 10.1016/j.annpal.2012.12.002; Diaz VD, 2012, GEOBIOS-LYON, V45, P265, DOI 10.1016/j.geobios.2011.10.002; Escapa Ignacio H., 2008, Rev. Asoc. Geol. Argent., V63, P613; Fiorillo Anthony R., 1998, Historical Biology, V13, P1; FIORILLO AR, 1994, J VERTEBR PALEONTOL, V14, P74, DOI 10.1080/02724634.1994.10011539; Garcia RA, 2010, PALAEONTOLOGY, V53, P335, DOI 10.1111/j.1475-4983.2010.00937.x; Gilmore C. W., 1925, Memoirs of the Carnegie Museum, V10, P347; He X, 1988, MIDDLE JURASSIC DINO, V4; Hendrickx C, 2014, ZOOTAXA, V 3759, P1, DOI 10.11646/zootaxa.3759.1.1; Holwerda F, 2011, J VERTEBR PALEONTOL, V31, P127; KUES BS, 1980, J PALEONTOL, V54, P864; Larson D, 2009, J VERTEBR PALEONTOL, V29, p132A; Larson DW, 2010, CAN J EARTH SCI, V47, P1159, DOI 10.1139/E10-005; Larson DW, 2008, CAN J EARTH SCI, V45, P1455, DOI 10.1139/E08-070; Li LG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085979; Lim JD, 2001, NATURWISSENSCHAFTEN, V88, P82, DOI 10.1007/s001140000201; Lu JC, 2006, ACTA GEOL SIN-ENGL, V80, P1; Carballido JL, 2010, CR PALEVOL, V9, P83, DOI 10.1016/j.crpv.2010.01.003; Mahammed F, 2005, CR PALEVOL, V4, P707, DOI 10.1016/j.crpv.2005.07.001; Mannion PD, 2010, PALAEONTOLOGY, V53, P277, DOI 10.1111/j.1475-4983.2009.00919.x; Martin T, 2005, J VERTEBR PALEONTOL, V25, P414, DOI 10.1671/0272-4634(2005)025[0414:MADOAP]2.0.CO;2; McIntosh J.S., 1990, P53, DOI 10.1017/CBO9780511608377.007; McIntosh J.S., 1990, P345; Mo J., 2013, TOPICS CHINESE DINOS, P231; Monbaron M, 1999, CR ACAD SCI II A, V329, P519, DOI 10.1016/S1251-8050(00)80026-9; Otero A, 2013, J VERTEBR PALEONTOL, V33, P1138, DOI 10.1080/02724634.2013.769444; Peng Z, 2005, JURASSIC DINOSAUR FA, P69; Pol D, 2009, SKULL ANATOMY NEW BA; Pol Diego, 2007, Historical Biology, V19, P125, DOI 10.1080/08912960601140085; Pol D, 2012, P ROY SOC B-BIOL SCI, V279, P3170, DOI 10.1098/rspb.2012.0660; Pol D, 2011, NATURWISSENSCHAFTEN, V98, P369, DOI 10.1007/s00114-011-0780-5; Rauhut OWM, 2007, AMEGHINIANA, V44, P479; Rauhut OWM, 2012, P NATL ACAD SCI USA, V109, P11746, DOI 10.1073/pnas.1203238109; Rauhut Oliver W.M., 2003, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V6, P173; Rauhut Oliver W. M., 2008, Rev. Asoc. Geol. Argent., V63, P557; Rauhut OWM, 2005, PALAEONTOLOGY, V48, P87, DOI 10.1111/j.1475-4983.2004.00436.x; Rauhut OWM, 2003, AMEGHINIANA, V40, P425; Rauhut OWM, 2002, NATURE, V416, P165, DOI 10.1038/416165a; Rauhut OWM, 2002, DINOSAUR EVOLUTION J, V3; Remes K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006924; Rougier GW, 2007, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2007)507[1:NJMFPA]2.0.CO;2; Rougier GW, 2007, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2007)3580[1:FJTFSA]2.0.CO;2; Salani FM, 2007, APORTE EDAD FORMACIO, P44; Silva Nieto D. G., 2002, 15 C GEOL ARG EL CAL, VI, P238; Smith JB, 2003, J VERTEBR PALEONTOL, V23, P1, DOI 10.1671/0272-4634(2003)23[1:APFAST]2.0.CO;2; Sterli J, 2008, BIOL LETTERS, V4, P286, DOI 10.1098/rsbl.2008.0022; Sterli J, 2011, J VERTEBR PALEONTOL, V31, P1210, DOI 10.1080/02724634.2011.615685; Tang F., 2001, COMPLETE SAUROPOD JI, P128; TASCH P, 1970, University of Kansas Paleontological Contributions Paper, P1; Unwin DM, 2004, 1 RHAMPHORHYNCHOID S, P235, DOI [10.1016/j.scitotenv.2015.01.065, DOI 10.1016/J.SCITOTENV.2015.01.065]; Upchurch P, 1998, ZOOL J LINN SOC-LOND, V124, P43, DOI 10.1111/j.1096-3642.1998.tb00569.x; UPCHURCH P, 1995, PHILOS T R SOC B, V349, P365, DOI 10.1098/rstb.1995.0125; Upchurch P, 2004, DINOSAURIA, 2ND EDITION, P259; Volkheimer Wolfgang, 2008, Rev. Asoc. Geol. Argent., V63, P549; Weishampel DB., 2004, DINOSAURIA; Whitlock JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018304; Whitlock JA, 2010, J VERTEBR PALEONTOL, V30, P442, DOI 10.1080/02724631003617647; Wilson JA, 1998, J VERTEBR PALEONTOL, V18, P1, DOI 10.1080/02724634.1998.10011115; Wilson JA, 2002, ZOOL J LINN SOC-LOND, V136, P217; Wilson JA, 2005, J SYST PALAEONTOL, V3, P283, DOI 10.1017/S1477201905001628; Wilson JA, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P15; Wilson JA, 2009, J SYST PALAEONTOL, V7, P199, DOI 10.1017/S1477201908002691; Xing LD, 2015, ACTA PALAEONTOL POL, V60, P145, DOI 10.4202/app.2012.0151; Zaher H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016663; Zavattieri AM, 2010, 10 C ARG PAL BIOESTR; Zinke Jens, 1998, Palaeontologische Zeitschrift, V72, P179	92	21	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118100	10.1371/journal.pone.0118100	http://dx.doi.org/10.1371/journal.pone.0118100			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692466	Green Published, gold, Green Submitted			2022-12-26	WOS:000350061500095
J	Ueda, S; Nagano, Y; Kataoka, Y; Komatsu, T; Itioka, T; Shimizu-kaya, U; Inui, Y; Itino, T				Ueda, Shouhei; Nagano, Yusuke; Kataoka, Yowsuke; Komatsu, Takashi; Itioka, Takao; Shimizu-kaya, Usun; Inui, Yoko; Itino, Takao			Congruence of Microsatellite and Mitochondrial DNA Variation in Acrobat Ants (Crematogaster Subgenus Decacrema, Formicidae: Myrmicinae) Inhabiting Macaranga (Euphorbiaceae) Myrmecophytes	PLOS ONE			English	Article							ANTIHERBIVORE DEFENSE; SPECIES-SPECIFICITY; PLANT ASSOCIATION; INFERENCE; SELECTION; PARTNER; QUEENS; ADAPTATIONS; COEVOLUTION; HYMENOPTERA	A previously reported mitochondrial DNA (mtDNA) phylogeny of Crematogaster (subgenus Decacrema) ants inhabiting Macaranga myrmecophytes indicated that the partners diversified synchronously and their specific association has been maintained for 20 million years. However, the mtDNA clades did not exactly match morphological species, probably owing to introgressive hybridization among younger species. In this study, we determined the congruence between nuclear simple sequence repeat (SSR, also called microsatellite) genotyping and mtDNA phylogeny to confirm the suitability of the mtDNA phylogeny for inferring the evolutionary history of Decacrema ants. Analyses of ant samples from Lambir Hills National park, northeastern Borneo, showed overall congruence between the SSR and mtDNA groupings, indicating that mtDNA markers are useful for delimiting species, at least at the local level. We also found overall high host-plant specificity of the SSR genotypes of Decacrema ants, consistent with the specificity based on the mtDNA phylogeny. Further, we detected cryptic genetic assemblages exhibiting high specificity toward particular plant species within a single mtDNA clade. This finding, which may be evidence for rapid ecological and genetic differentiation following a host shift, is a new insight into the previously suggested long-term codiversification of Decacrema ants and Macaranga plants.	[Ueda, Shouhei; Nagano, Yusuke; Kataoka, Yowsuke; Komatsu, Takashi; Itino, Takao] Shinshu Univ, Fac Sci, Dept Biol, Matsumoto, Nagano 3908621, Japan; [Itioka, Takao; Shimizu-kaya, Usun] Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Kyoto 6068501, Japan; [Itioka, Takao] Kyoto Univ, Grad Sch Global Environm Studies, Sakyo Ku, Kyoto 6068501, Japan; [Inui, Yoko] Osaka Kyoiku Univ, Fac Educ, Dept Arts & Sci, Div Nat Sci, Kashiwara, Osaka 5828582, Japan; [Itino, Takao] Shinshu Univ, Inst Mt Sci, Matsumoto, Nagano 3908621, Japan	Shinshu University; Kyoto University; Kyoto University; Osaka University of Education; Shinshu University	Ueda, S (corresponding author), Shinshu Univ, Fac Sci, Dept Biol, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	ueda32@shinshu-u.ac.jp	Ueda, Shouhei/AAI-6275-2020	Ueda, Shouhei/0000-0002-9051-5504	Japan Society for the Promotion of Science [22255001, 23770018]; Grants-in-Aid for Scientific Research [22255001] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research (A), Grant Numbers 22255001 for T. Itino (URL: http://kaken.nii.ac.jp/d/p/22255001/2010/3/ja.en.html); the Japan Society for the Promotion of Science, Grant-in-Aid for Young Scientists (B), Grant Numbers 23770018 for SU (URL: http://kaken.nii.ac.jp/d/p/23770018/2011/1/ja.	Althoff DM, 2012, MOL PHYLOGENET EVOL, V62, P898, DOI 10.1016/j.ympev.2011.11.024; Buhay JE, 2009, J CRUSTACEAN BIOL, V29, P96, DOI 10.1651/08-3020.1; Cook JM, 2010, ECOL ENTOMOL, V35, P54, DOI 10.1111/j.1365-2311.2009.01148.x; Dasmahapatra KK, 2010, MOL ECOL RESOUR, V10, P264, DOI 10.1111/j.1755-0998.2009.02763.x; Davies SJ, 2001, EVOLUTION, V55, P1542, DOI 10.1111/j.0014-3820.2001.tb00674.x; Davies Stuart J., 2001, Harvard Papers in Botany, V6, P371; de Vienne DM, 2013, NEW PHYTOL, V198, P347, DOI 10.1111/nph.12150; Eck G, 2001, J CHEM ECOL, V27, P1979, DOI 10.1023/A:1012234702403; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Federle W, 2005, BIOL J LINN SOC, V84, P177, DOI 10.1111/j.1095-8312.2005.000423.x; Federle W, 1997, OECOLOGIA, V112, P217, DOI 10.1007/s004420050303; Federle W, 2002, OECOLOGIA, V132, P264, DOI 10.1007/s00442-002-0947-z; Feldhaar H, 2004, MOL ECOL NOTES, V4, P409, DOI 10.1111/j.1471-8286.2004.00668.x; Feldhaar H, 2003, INSECT SOC, V50, P9, DOI 10.1007/s000400300002; Feldhaar H, 2008, PHILOS T R SOC B, V363, P2891, DOI 10.1098/rstb.2008.0022; Feldhaar H, 2010, EVOLUTION IN ACTION: CASE STUDIES IN ADAPTIVE RADIATION, SPECIATION AND THE ORIGIN OF BIODIVERSITY, P193, DOI 10.1007/978-3-642-12425-9_10; Fiala B, 1999, BIOL J LINN SOC, V66, P305, DOI 10.1006/bijl.1998.0279; FIALA B, 1989, OECOLOGIA, V79, P463, DOI 10.1007/BF00378662; FIALA B, 1990, INSECT SOC, V37, P212, DOI 10.1007/BF02224049; Frederickson ME, 2006, OECOLOGIA, V149, P418, DOI 10.1007/s00442-006-0460-x; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; Grangier J, 2009, BIOL J LINN SOC, V97, P90, DOI 10.1111/j.1095-8312.2008.01188.x; Gullan PJ, 1997, ANNU REV ENTOMOL, V42, P23, DOI 10.1146/annurev.ento.42.1.23; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heckroth HP, 1998, J TROP ECOL, V14, P427, DOI 10.1017/S0266467498000327; Heil M, 2001, P NATL ACAD SCI USA, V98, P1083, DOI 10.1073/pnas.031563398; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hyodo F, 2011, INSECT SOC, V58, P417, DOI 10.1007/s00040-011-0159-9; Inui Y, 2001, J CHEM ECOL, V27, P2029, DOI 10.1023/A:1012290820150; Inui Y, 2007, J CHEM ECOL, V33, P2054, DOI 10.1007/s10886-007-9369-z; Itino T, 2001, ECOL RES, V16, P787, DOI 10.1046/j.1440-1703.2001.00442.x; Itino T, 2001, ECOL RES, V16, P765, DOI 10.1046/j.1440-1703.2001.00432.x; Itino T, 2001, ECOL RES, V16, P775, DOI 10.1046/j.1440-1703.2001.00433.x; Itino T, 2005, ECOL STU AN, V174, P172; Itioka T, 2000, BIOTROPICA, V32, P318, DOI 10.1111/j.1744-7429.2000.tb00475.x; Itioka T, 2005, ECOL STU AN, V174, P158; Jobb G, 2008, TREEFINDER VERSION O; Jukes T., 1969, MAMMALIAN PROTEIN ME, P21; Jurgens A, 2006, BIOCHEM SYST ECOL, V34, P97, DOI 10.1016/j.bse.2005.08.005; Linnen CR, 2007, EVOLUTION, V61, P1417, DOI 10.1111/j.1558-5646.2007.00114.x; Morrison H., 1921, Philippine Journal of Science, V18, P637; Murase K, 2002, J ETHOL, V20, P19, DOI 10.1007/s10164-002-0049-8; Murase K, 2010, SOCIOBIOLOGY, V55, P883; Nomura M, 2000, ECOL RES, V15, P1, DOI 10.1046/j.1440-1703.2000.00318.x; Nomura M, 2011, PLANT ECOL, V212, P143, DOI 10.1007/s11258-010-9810-1; Pritchard JK, 2000, GENETICS, V155, P945; Quek SP, 2007, MOL ECOL, V16, P2045, DOI 10.1111/j.1365-294X.2007.03294.x; Quek SP, 2004, EVOLUTION, V58, P554, DOI 10.1111/j.0014-3820.2004.tb01678.x; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ross KG, 2010, SYST BIOL, V59, P162, DOI 10.1093/sysbio/syp089; Schlick-Steiner BC, 2010, ANNU REV ENTOMOL, V55, P421, DOI 10.1146/annurev-ento-112408-085432; Seppa P, 2011, MYRMECOL NEWS, V15, P31; Shaw KL, 2002, P NATL ACAD SCI USA, V99, P16122, DOI 10.1073/pnas.242585899; Sota T, 2001, SYST BIOL, V50, P39, DOI 10.1080/713849547; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Tanabe AS, 2007, MOL ECOL NOTES, V7, P962, DOI 10.1111/j.1471-8286.2007.01807.x; Ueda S, 2008, P ROY SOC B-BIOL SCI, V275, P2319, DOI 10.1098/rspb.2008.0573; Ueda S, 2010, POPUL ECOL, V52, P137, DOI 10.1007/s10144-009-0162-4; Whitmore T. C., 1969, Biological Journal of the Linnean Society, V1, P223, DOI 10.1111/j.1095-8312.1969.tb01821.x; Whitmore TC, 1975, KEW B ADDITIONAL SER, P140; Whitmore TC, 2008, GENUS MACARANGA PROD; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; YANG ZB, 1994, J MOL EVOL, V39, P105	65	6	7	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0116602	10.1371/journal.pone.0116602	http://dx.doi.org/10.1371/journal.pone.0116602			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692953	gold, Green Published, Green Submitted			2022-12-26	WOS:000350061500020
J	Gourbiere, S; Morand, S; Waxman, D				Gourbiere, Sebastien; Morand, Serge; Waxman, David			Fundamental Factors Determining the Nature of Parasite Aggregation in Hosts	PLOS ONE			English	Article							INFECTION; TRANSMISSION; RESISTANCE; STABILITY; DYNAMICS; PATTERNS; POPULATIONS; MECHANISMS; STRATEGIES; IMMUNITY	The distribution of parasites in hosts is typically aggregated: a few hosts harbour many parasites, while the remainder of hosts are virtually parasite free. The origin of this almost universal pattern is central to our understanding of host-parasite interactions; it affects many facets of their ecology and evolution. Despite this, the standard statistical framework used to characterize parasite aggregation does not describe the processes generating such a pattern. In this work, we have developed a mathematical framework for the distribution of parasites in hosts, starting from a simple statistical description in terms of two fundamental processes: the exposure of hosts to parasites and the infection success of parasites. This description allows the level of aggregation of parasites in hosts to be related to the random variation in these two processes and to true host heterogeneity. We show that random variation can generate an aggregated distribution and that the common view, that encounters and success are two equivalent filters, applies to the average parasite burden under neutral assumptions but it does not apply to the variance of the parasite burden, and it is not true when heterogeneity between hosts is incorporated in the model. We find that aggregation decreases linearly with the number of encounters, but it depends non-linearly on parasite success. We also find additional terms in the variance of the parasite burden which contribute to the actual level of aggregation in specific biological systems. We have derived the formal expressions of these contributions, and these provide new opportunities to analyse empirical data and tackle the complexity of the origin of aggregation in various hostparasite associations.	[Gourbiere, Sebastien] Univ Perpignan, IMAGES, EA 4218, F-66100 Perpignan, France; [Gourbiere, Sebastien] Univ Sussex, Sch Life Sci, Ctr Study Evolut, Brighton BN1 9QG, E Sussex, England; [Morand, Serge] Univ Montpellier 2, Dept Genet Environm, CC065, Inst Sci Evolut,CNRS, F-34095 Montpellier 05, France; [Waxman, David] Fudan Univ, Ctr Computat Syst Biol, Shanghai 200433, Peoples R China	Universite Perpignan Via Domitia; University of Sussex; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Fudan University	Waxman, D (corresponding author), Fudan Univ, Ctr Computat Syst Biol, Shanghai 200433, Peoples R China.	davidwaxman@fudan.edu.cn	Morand, Serge/M-5433-2018	Morand, Serge/0000-0003-3986-7659; Gourbiere, Sebastien/0000-0002-6701-4795	European Union EU-FP7-PEOPLE-Intra-European Fellowship for career development (IEF) [253483]; 'Bonus Quality Research' grant of the Universite de Perpignan Via Domitia; "Investissements d'Avenir" grant managed by Agence Nationale de la Recherche (CEBA) [ANR-10-LABX-25-01]; Universite de Lyon, within the program "Investissements d'Avenir" [ANR-11-LABX-0048, ANR-11-IDEX-0007]; European Union EU-FP7-PEOPLE-Intra-European Fellowship for career development (IEF) [253483]; 'Bonus Quality Research' grant of the Universite de Perpignan Via Domitia; "Investissements d'Avenir" grant managed by Agence Nationale de la Recherche (CEBA) [ANR-10-LABX-25-01]; Universite de Lyon, within the program "Investissements d'Avenir" [ANR-11-LABX-0048, ANR-11-IDEX-0007]	European Union EU-FP7-PEOPLE-Intra-European Fellowship for career development (IEF); 'Bonus Quality Research' grant of the Universite de Perpignan Via Domitia; "Investissements d'Avenir" grant managed by Agence Nationale de la Recherche (CEBA)(French National Research Agency (ANR)); Universite de Lyon, within the program "Investissements d'Avenir"(French National Research Agency (ANR)); European Union EU-FP7-PEOPLE-Intra-European Fellowship for career development (IEF); 'Bonus Quality Research' grant of the Universite de Perpignan Via Domitia; "Investissements d'Avenir" grant managed by Agence Nationale de la Recherche (CEBA)(French National Research Agency (ANR)); Universite de Lyon, within the program "Investissements d'Avenir"(French National Research Agency (ANR))	This investigation received financial support from: the European Union EU-FP7-PEOPLE-Intra-European Fellowship for career development (IEF) grant no. 253483; a 'Bonus Quality Research' grant of the Universite de Perpignan Via Domitia; an "Investissements d'Avenir" grant managed by Agence Nationale de la Recherche (CEBA, ref. ANR-10-LABX-25-01). This work was performed within the framework of the LABEX ECOFECT (ANR-11-LABX-0048) of Universite de Lyon, within the program "Investissements d'Avenir" (ANR-11-IDEX-0007) operated by the French National Research Agency	ADLER FR, 1992, PARASITOLOGY, V104, P199, DOI 10.1017/S0031182000061631; ANDERSON R M, 1991; ANDERSON RM, 1978, J ANIM ECOL, V47, P219, DOI 10.2307/3933; ANDERSON RM, 1982, PARASITOLOGY, V85, P373, DOI 10.1017/S0031182000055347; Barbu C, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001045; Ben-Ami F, 2008, P R SOC B, V275, P853, DOI 10.1098/rspb.2007.1544; Ben-Ami F, 2010, AM NAT, V175, P106, DOI 10.1086/648672; Bize P, 2008, AM NAT, V171, P107, DOI 10.1086/523943; Boag B, 2001, INT J PARASITOL, V31, P1421, DOI 10.1016/S0020-7519(01)00270-3; Bordes F, 2007, BIOL LETTERS, V3, P692, DOI 10.1098/rsbl.2007.0393; Bordes F, 2009, AM NAT, V173, P467, DOI 10.1086/597227; Bulmer M.G., 1979, PRINCIPLES STAT; Calabrese JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029215; Combes Claude, 2005, ART BEING PARASITE; COTE IM, 1995, BEHAV ECOL, V6, P159, DOI 10.1093/beheco/6.2.159; CROFTON HD, 1971, PARASITOLOGY, V62, P179, DOI 10.1017/S0031182000071420; de Bellocq JG, 2007, EUR J WILDLIFE RES, V53, P315, DOI 10.1007/s10344-007-0094-2; Dumonteil E, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002466; Gaba S, 2008, J R SOC INTERFACE, V5, P919, DOI 10.1098/rsif.2007.1282; Galvani AP, 2003, J PARASITOL, V89, P232, DOI 10.1645/0022-3395(2003)089[0232:IAHAAO]2.0.CO;2; Gotelli NJ, 2006, ECOGRAPHY, V29, P793, DOI 10.1111/j.2006.0906-7590.04714.x; Gourbiere S, 2012, HEREDITY, V108, P190, DOI 10.1038/hdy.2011.71; Guilhem R, 2012, J R SOC INTERFACE, V9, P2936, DOI 10.1098/rsif.2012.0358; HART BL, 1994, PARASITOLOGY, V109, pS139, DOI 10.1017/S0031182000085140; Hoby S, 2006, VET PARASITOL, V138, P337, DOI 10.1016/j.vetpar.2006.01.028; Hutchings MR, 2002, OIKOS, V96, P235, DOI 10.1034/j.1600-0706.2002.960205.x; Johnson NL, 2005, WILEY SER PROBAB ST, P1, DOI 10.1002/0471715816; Karvonen A, 2004, PARASITOL RES, V92, P183, DOI 10.1007/s00436-003-1035-y; Khalife J, 2000, PARASITOL INT, V49, P339, DOI 10.1016/S1383-5769(00)00059-3; Klein SL, 2004, PARASITE IMMUNOL, V26, P247, DOI 10.1111/j.0141-9838.2004.00710.x; Knudsen R, 2004, J PARASITOL, V90, P1, DOI 10.1645/GE-3184; LAFFERTY KD, 1992, AM NAT, V140, P854, DOI 10.1086/285444; Leung B, 1998, INT J PARASITOL, V28, P1709, DOI 10.1016/S0020-7519(98)00128-3; LOEHLE C, 1995, ECOLOGY, V76, P326, DOI 10.2307/1941192; MAY RM, 1978, J ANIM ECOL, V47, P833, DOI 10.2307/3674; MOORING MS, 1992, BEHAVIOUR, V123, P173, DOI 10.1163/156853992X00011; Morand S, 2002, PARASITOLOGY, V124, P401, DOI 10.1017/S0031182001001342; Morand S, 2009, ECOLOGY EVOLUTION PA; Morand S, 2008, TRENDS PARASITOL, V24, P304, DOI 10.1016/j.pt.2008.04.003; Navarro-Gonzalez N, 2011, EUR J WILDLIFE RES, V57, P639, DOI 10.1007/s10344-010-0474-x; Nouvellet P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002505; Nouvellet P, 2011, INFECT GENET EVOL, V11, P1243, DOI 10.1016/j.meegid.2011.04.008; Poulin R, 2007, PARASITOLOGY, V134, P763, DOI 10.1017/S0031182006002150; Poulin R., 2007, EVOL ECOL, V2; Pugliese A, 1998, J MATH BIOL, V36, P419; Raberg L, 2009, PHILOS T R SOC B, V364, P37, DOI 10.1098/rstb.2008.0184; Ramirez-Sierra MJ, 2010, TROP MED INT HEALTH, V15, P77, DOI 10.1111/j.1365-3156.2009.02422.x; Rascalou G, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.1108; Rascalou G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036858; Regoes RR, 2003, EPIDEMIOL INFECT, V131, P957, DOI 10.1017/S0950268803008793; Richardson DJ, 2011, VECTOR-BORNE ZOONOT, V11, P1151, DOI 10.1089/vbz.2010.0151; Ross S.M., 2010, INTRO PROBABILITY MO; Pacheco-Tucuch FS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036207; Schmid-Hempel P, 2009, PHILOS T R SOC B, V364, P85, DOI 10.1098/rstb.2008.0157; Shaw DJ, 1995, PARASITOLOGY, V111, pS111, DOI 10.1017/S0031182000075855; Tschirren B, 2007, FUNCT ECOL, V21, P372, DOI 10.1111/j.1365-2435.2007.01235.x; Vale PF, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.1145; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338; YAMADA M, 1992, IMMUNOLOGY, V75, P36; Young LJ, 1998, STAT ECOLOGY	60	15	16	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0116893	10.1371/journal.pone.0116893	http://dx.doi.org/10.1371/journal.pone.0116893			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689685	Green Published, Green Submitted, gold			2022-12-26	WOS:000350322700027
J	Su, QD; Yi, Y; Qiu, F; Lu, XX; Ding, JY; Jia, ZY; Tian, RG; Gao, Y; Bi, SL				Su, Qiudong; Yi, Yao; Qiu, Feng; Lu, Xuexin; Ding, Junying; Jia, Zhiyuan; Tian, Ruiguang; Gao, Yan; Bi, Shengli			Immune Responses to HBsAg Conjugated to Protein D of Non-Typeable Haemophilus influenzae in Mice	PLOS ONE			English	Article							HEPATITIS-B-VACCINE; T-CELL; ANTIGENS; IMMUNOGENICITY; LIPOPROTEIN	Background Hepatitis B vaccine that contains an aluminum hydroxide adjuvant induces apoptotic death of Hepa 1-6 cells. Difficult-to-degrade chemical additives in vaccines effectively enhance vaccine immunogenicity, but also affect the host tissue. Identification of bio-molecules that are readily degraded and compatible in vivo as an adjuvant is important for vaccine research. The hapten-carrier effect suggests that stimulation of helper T (Th) cells by carrier adjuvants is feasible. Protein D (PD) of non-typeable Haemophilus influenzae covalently conjugated to some polysaccharide vaccines has been confirmed to convert T-cell independent (TI) antigens into T-cell dependent (TD) antigens, and elicit strong T-cell responses ultimately. Herein, we would substitube PD for aluminum hydroxide adjuvant in Hepatitis B vaccine. Methods and results Truncated PD (amino acids 20-364) was expressed in Escherichia coli and purified by (NH4)(2)SO4 precipitation and DEAE chromatography. After evaluation of antigenicity by western blotting, PD was covalently conjugated to yeast-derived recombinant HBsAg by cross-linking with glutaraldehyde. Intramuscular immunization with the conjugate induced higher level of HBsAg-specific antibody than did HBsAg alone (p < 0.05), and was comparable to commercial Hepatitis B vaccine. During the surveillance period (days 35-105), anti-HBs titers were hold high. Moreover, the conjugated vaccine enhanced Th1 immune responses, while Th2 responses were also activated and induced an antibody response, as determined by IFN-gamma ELISPOT and IgG1/IgG2a ratio assays. Conclusions Recombinant truncated PD covalently conjugated to HBsAg antigen enhanced the immunogenicity of the antigen in mice simultaneously by humoral and cellular immune response, which would facilitate therapeutic hepatitis B vaccines.	[Su, Qiudong; Yi, Yao; Qiu, Feng; Lu, Xuexin; Ding, Junying; Jia, Zhiyuan; Tian, Ruiguang; Gao, Yan; Bi, Shengli] China Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Bi, SL (corresponding author), China Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.	shengli_bi@163.com		Bi, Shengli/0000-0002-0380-5790	Chinese Ministry of Science and Technology Program for Important Infectious Diseases Control and Prevention [2012ZX10002-001]	Chinese Ministry of Science and Technology Program for Important Infectious Diseases Control and Prevention	This work was supported by a grant from the Chinese Ministry of Science and Technology Program for Important Infectious Diseases Control and Prevention (2012ZX10002-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkoyunlu M, 1996, INFECT IMMUN, V64, P4586, DOI 10.1128/IAI.64.11.4586-4592.1996; Andre FE, 1990, VACCINE, V8, P574; Bordet AL, 2001, ANN PATHOL, V21, P149; Dicko A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-882; Duclos Philippe, 2003, Expert Opin Drug Saf, V2, P225, DOI 10.1517/14740338.2.3.225; Forsgren A, 2008, CLIN INFECT DIS, V46, P726, DOI 10.1086/527396; Hamza H, 2012, APOPTOSIS, V17, P516, DOI 10.1007/s10495-011-0690-1; Han HR, 2000, J VET MED SCI, V62, P237, DOI 10.1292/jvms.62.237; Harwood NE, 2008, IMMUNITY, V28, P609, DOI 10.1016/j.immuni.2008.04.007; Heijne GV, 1981, EUR J BIOCHEM, V120, P275; Hourvitz A, 1996, J VIRAL HEPATITIS, V3, P37, DOI 10.1111/j.1365-2893.1996.tb00079.x; JANSON H, 1992, INFECT IMMUN, V60, P1336, DOI 10.1128/IAI.60.4.1336-1342.1992; Kakimi K, 2002, J VIROL, V76, P8609, DOI 10.1128/JVI.76.17.8609-8620.2002; Lin YJ, 2010, P NATL ACAD SCI USA, V107, P9340, DOI 10.1073/pnas.1004762107; MILICH DR, 1988, IMMUNOL TODAY, V9, P380, DOI 10.1016/0167-5699(88)91239-X; Sanvictores Diozele Hazel M, 2012, BMC Res Notes, V5, P274, DOI 10.1186/1756-0500-5-274; Shen LP, 2012, VACCINE, V30, P6623, DOI 10.1016/j.vaccine.2012.08.067; Shouval D, 2003, J HEPATOL, V39, pS70, DOI 10.1016/S0168-8278(03)00125-1; SNAPPER CM, 1995, J IMMUNOL, V155, P5582; Su L, 2000, J Epidemiol Biostat, V5, P359; Yalcin K, 2003, INFECTION, V31, P221, DOI 10.1007/s15010-003-3187-1	21	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117736	10.1371/journal.pone.0117736	http://dx.doi.org/10.1371/journal.pone.0117736			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689855	Green Published, Green Submitted, gold			2022-12-26	WOS:000350322700068
J	Yang, YF; Liu, XY; Xiao, FJ; Xue, SY; Xu, QQ; Yin, Y; Sun, HY; Xu, J; Wang, HX; Zhang, QW; Wang, H; Wang, LS				Yang, Yuefeng; Liu, Xiaoyun; Xiao, Fengjun; Xue, Shuya; Xu, Qinqin; Yin, Yue; Sun, Huiyan; Xu, Jie; Wang, Hengxiang; Zhang, Qunwei; Wang, Hua; Wang, Lisheng			Spred2 Modulates the Erythroid Differentiation Induced by Imatinib in Chronic Myeloid Leukemia Cells	PLOS ONE			English	Article							BCR-ABL; TRANSCRIPTION-FACTOR; SIGNAL-TRANSDUCTION; TYROSINE KINASE; DOWN-REGULATION; RESISTANCE; INHIBITORS; APOPTOSIS; PATHWAY; CML	Differentiation induction is currently considered as an alternative strategy for treating chronic myelogenous leukemia (CML). Our previous work has demonstrated that Sprouty-related EVH1 domainprotein2 (Spred2) was involved in imatinib mediated cytotoxicity in CML cells. However, its roles in growth and lineage differentiation of CML cells remain unknown. In this study, we found that CML CD34(+) cells expressed lower level of Spred2 compared with normal hematopoietic progenitor cells, and adenovirus mediated restoration of Spred2 promoted the erythroid differentiation of CML cells. Imatinib could induce Spred2 expression and enhance erythroid differentiation in K562 cells. However, the imatinib induced erythroid differentiation could be blocked by Spred2 silence using lentiviral vector PLKO.1-shSpred2. Spred2 interference activated phosphorylated-ERK (p-ERK) and inhibited erythroid differentiation, while ERK inhibitor, PD98059, could restore the erythroid differentiation, suggesting Spred2 regulated the erythroid differentiation partly through ERK signaling. Furthermore, Spred2 interference partly restored p-ERK level leading to inhibition of erythroid differentiation in imatinib treated K562 cells. In conclusion, Spred2 was involved in erythroid differentiation of CML cells and participated in imatinib induced erythroid differentiation partly through ERK signaling.	[Yang, Yuefeng; Xiao, Fengjun; Xue, Shuya; Sun, Huiyan; Xu, Jie; Zhang, Qunwei; Wang, Hua; Wang, Lisheng] Beijing Inst Radiat Med, Dept Expt Hematol, Beijing, Peoples R China; [Liu, Xiaoyun] Lanzhou Command, Ctr Dis Control & Prevent, Lanzhou, Peoples R China; [Yin, Yue] Peking Univ, Hosp 1, Dept Hematol, Beijing 100871, Peoples R China; [Wang, Hengxiang] Gen Hosp Air Force, Dept Hematol, Beijing, Peoples R China; [Xu, Qinqin] Qinghai Prov Peoples Hosp, Dept Oncol, Xining, Peoples R China	Academy of Military Medical Sciences - China; Chinese Center for Disease Control & Prevention; Peking University	Wang, H (corresponding author), Beijing Inst Radiat Med, Dept Expt Hematol, Beijing, Peoples R China.	wanghua@bmi.ac.cn; wangls@bmi.ac.cn			Chinese National Basic Research and Development (973 Program) [2012CB518205]; National Natural Science Foundation of China [81170460]; National High Technology Research and Development Program of China (863 Program) [2012AA02A211, SS2014AA020515]	Chinese National Basic Research and Development (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work was supported by Chinese National Basic Research and Development (973 Program) (No. 2012CB518205), National Natural Science Foundation of China (No. 81170460), and National High Technology Research and Development Program of China (863 Program) (Nos. 2012AA02A211 and SS2014AA020515). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birkenkamp KU, 2007, J BIOL CHEM, V282, P2211, DOI 10.1074/jbc.M606669200; Corrado P, 2009, LEUKEMIA, V23, P405, DOI 10.1038/leu.2008.186; Dorsey JF, 2002, BLOOD, V99, P1388, DOI 10.1182/blood.V99.4.1388; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Essafi A, 2005, ONCOGENE, V24, P2317, DOI 10.1038/sj.onc.1208421; Gomez-Casares MT, 2013, ONCOGENE, V32, P2239, DOI 10.1038/onc.2012.246; Hochhaus A, 2013, J CANCER RES CLIN, V139, P1971, DOI 10.1007/s00432-013-1488-z; Ida C, 2009, BIOSCI BIOTECH BIOCH, V73, P79, DOI 10.1271/bbb.80483; Jabbour EJ, 2013, CL LYMPH MYELOM LEUK, V13, P515, DOI 10.1016/j.clml.2013.03.018; Jacquel A, 2003, FASEB J, V17, P2160, DOI 10.1096/fj.03-0322fje; Jain N, 2013, EXPERT REV HEMATOL, V6, P575, DOI 10.1586/17474086.2013.835697; Kawano T, 2004, MOL CELL BIOCHEM, V258, P25, DOI 10.1023/B:MCBI.0000012830.96393.b9; Kuzelova K, 2005, J CELL BIOCHEM, V95, P268, DOI 10.1002/jcb.20407; La Rosee P, 2010, SEMIN HEMATOL, V47, P335, DOI 10.1053/j.seminhematol.2010.06.005; Lee YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061939; Liu XY, 2010, BIOCHEM BIOPH RES CO, V393, P637, DOI 10.1016/j.bbrc.2010.02.044; Marega M, 2010, LEUKEMIA, V24, P1445, DOI 10.1038/leu.2010.101; Meshkini A, 2007, J BIOCHEM MOL BIOL, V40, P944; Milojkovic D, 2009, CLIN CANCER RES, V15, P7519, DOI 10.1158/1078-0432.CCR-09-1068; Miranda MB, 2007, LEUKEMIA, V21, P1363, DOI 10.1038/sj.leu.2404690; Miyamoto K, 2008, BLOOD, V112, P4485, DOI 10.1182/blood-2008-05-159848; Miyoshi K, 2004, ONCOGENE, V23, P5567, DOI 10.1038/sj.onc.1207759; Murphy T, 2010, INT J CANCER, V127, P2491, DOI 10.1002/ijc.25542; Naka K, 2010, NATURE, V463, P676, DOI 10.1038/nature08734; Nobuhisa I, 2004, J EXP MED, V199, P737, DOI 10.1084/jem.20030830; Packer LM, 2011, CANCER CELL, V20, P715, DOI 10.1016/j.ccr.2011.11.004; Radujkovic A, 2005, LEUKEMIA, V19, P1198, DOI 10.1038/sj.leu.2403764; Schnekenburger M, 2011, BIOCHEM PHARMACOL, V81, P364, DOI 10.1016/j.bcp.2010.10.013; Schuster C, 2003, BLOOD, V101, P655, DOI 10.1182/blood-2002-01-0043; Sell S, 2005, STEM CELL REV, V1, P197, DOI 10.1385/SCR:1:3:197; Wakioka T, 2001, NATURE, V412, P647, DOI 10.1038/35088082; Wang Q, 2005, LEUKEMIA, V19, P1812, DOI 10.1038/sj.leu.2403916; Woessmann W, 2004, CELL BIOL INT, V28, P403, DOI 10.1016/j.cellbi.2004.03.009; Yan J, 2012, ANTI-CANCER DRUG, V23, P22, DOI 10.1097/CAD.0b013e32834a099c; Yin L, 2010, CANCER BIOL THER, V10, DOI 10.4161/cbt.10.5.12584; Yoshida T, 2006, ONCOGENE, V25, P6056, DOI 10.1038/sj.onc.1209635; Zhou Min, 2013, Zhonghua Xue Ye Xue Za Zhi, V34, P395, DOI 10.3760/cma.j.issn.0253-2727.2013.05.004; Zhu JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023720	38	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117573	10.1371/journal.pone.0117573	http://dx.doi.org/10.1371/journal.pone.0117573			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25688862	Green Published, Green Submitted, gold			2022-12-26	WOS:000350322700058
J	De Angelis, A; Ricotta, C; Conedera, M; Pezzatti, GB				De Angelis, Antonella; Ricotta, Carlo; Conedera, Marco; Pezzatti, Gianni Boris			Modelling the Meteorological Forest Fire Niche in Heterogeneous Pyrologic Conditions	PLOS ONE			English	Article							DANGER RATING SYSTEM; SPECIES DISTRIBUTION; PERFORMANCE; PREDICTION; WILDFIRES; REGION; INDEX; AREA; SUSCEPTIBILITY; DISTRIBUTIONS	Fire regimes are strongly related to weather conditions that directly and indirectly influence fire ignition and propagation. Identifying the most important meteorological fire drivers is thus fundamental for daily fire risk forecasting. In this context, several fire weather indices have been developed focussing mainly on fire-related local weather conditions and fuel characteristics. The specificity of the conditions for which fire danger indices are developed makes its direct transfer and applicability problematic in different areas or with other fuel types. In this paper we used the low-to-intermediate fire-prone region of Canton Ticino as a case study to develop a new daily fire danger index by implementing a niche modelling approach (Maxent). In order to identify the most suitable weather conditions for fires, different combinations of input variables were tested (meteorological variables, existing fire danger indices or a combination of both). Our findings demonstrate that such combinations of input variables increase the predictive power of the resulting index and surprisingly even using meteorological variables only allows similar or better performances than using the complex Canadian Fire Weather Index (FWI). Furthermore, the niche modelling approach based on Maxent resulted in slightly improved model performance and in a reduced number of selected variables with respect to the classical logistic approach. Factors influencing final model robustness were the number of fire events considered and the specificity of the meteorological conditions leading to fire ignition.	[De Angelis, Antonella; Conedera, Marco; Pezzatti, Gianni Boris] WSL Swiss Fed Res Inst, Insubr Ecosyst Res Grp, CH-6500 Bellinzona, Switzerland; [Ricotta, Carlo] Univ Roma La Sapienza, Dept Environm Biol, I-00185 Rome, Italy	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Sapienza University Rome	De Angelis, A (corresponding author), WSL Swiss Fed Res Inst, Insubr Ecosyst Res Grp, Via Belsoggiorno 22, CH-6500 Bellinzona, Switzerland.	antonella.deangelis@wsl.ch	Pezzatti, Gianni Boris/D-5102-2017	Pezzatti, Gianni Boris/0000-0003-2564-3435; RICOTTA, Carlo/0000-0003-0818-3959; Conedera, Marco/0000-0003-3980-2142	European Project ALP FFIRS - European Regional Development fund of Alpine Space Program; Canton Ticino; Valais; BAFU; BAFU/WSL Swiss program forest and climate change	European Project ALP FFIRS - European Regional Development fund of Alpine Space Program; Canton Ticino; Valais; BAFU; BAFU/WSL Swiss program forest and climate change	This work was supported by the European Project ALP FFIRS, funded by the European Regional Development fund of Alpine Space Program, and by Canton Ticino, Valais and BAFU. It was also partly supported by BAFU/WSL Swiss program forest and climate change. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen R. G., 1998, FAO Irrigation and Drainage Paper; [Anonymous], 2010, MAPPING SPECIES DIST; Austin MP, 2002, ECOL MODEL, V157, P101, DOI 10.1016/S0304-3800(02)00205-3; Bar Massada A, 2013, INT J WILDLAND FIRE, V22, P174, DOI 10.1071/WF11178; Baumgartner A., 1967, MITT STAATSFORSTVERW, V36, P57; Bradley AP, 1997, PATTERN RECOGN, V30, P1145, DOI 10.1016/S0031-3203(96)00142-2; Cardille JA, 2001, ECOL APPL, V11, P111, DOI 10.1890/1051-0761(2001)011[0111:EASFIW]2.0.CO;2; Chandler C, 1983, FIRE FORESTRY, V1; Conedera M., 2004, Schweizerische Zeitschrift fur Forstwesen, V155, P263, DOI 10.3188/szf.2004.0263; Conedera M, 2006, 5 INT C FOR FIR RES; Cumming SG, 2001, ECOL APPL, V11, P97, DOI 10.1890/1051-0761(2001)011[0097:FTAWIT]2.0.CO;2; de Vicente J, 2012, INT J WILDLAND FIRE, V21, P1030, DOI 10.1071/WF11046; DeLeo J. M., 1993, [1993] Proceedings Second International Symposium on Uncertainty Modeling and Analysis, P318, DOI 10.1109/ISUMA.1993.366750; Dimitrakopoulos AP, 2010, INT J WILDLAND FIRE, V19, P29, DOI 10.1071/WF08124; Dube OP, 2007, ENVIRON SCI ENG, P223, DOI 10.1007/978-3-540-72438-4_12; Eastaugh CS, 2012, AUSTRIAN J FOR SCI, V129, P228; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ECOGRAPHY, V32, P66, DOI 10.1111/j.1600-0587.2008.05505.x; Ellenberg H., 1974, MITT SCHWEIZ ANST FO, V48, P587; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; FOGARTY LG, 1998, P 3 INT C FOR FIR RE, P01011; Fosberg M.A., 1978, P C SIERR NEV MET LA; Francois D, 2007, NEUROCOMPUTING, V70, P1276, DOI 10.1016/j.neucom.2006.11.019; Gibson L, 2007, DIVERS DISTRIB, V13, P704, DOI 10.1111/j.1472-4642.2007.00365.x; Guisan A, 2002, ECOL MODEL, V157, P89, DOI 10.1016/S0304-3800(02)00204-1; Gustafson EJ, 2004, LANDSCAPE ECOL, V19, P327, DOI 10.1023/B:LAND.0000030431.12912.7f; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hardy CC, 2007, INT J WILDLAND FIRE, V16, P217, DOI 10.1071/WF06076; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Holsten A, 2013, FOREST ECOL MANAG, V287, P123, DOI 10.1016/j.foreco.2012.08.035; Keetch J., 1968, DROUGHT INDEX FOREST; Kohavi R., 1995, PROC 14 INT JOINT C, P1137; Krebs P, 2010, THEOR BIOSCI, V129, P53, DOI 10.1007/s12064-010-0082-z; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Mandallaz D, 1997, CAN J FOREST RES, V27, P1685, DOI 10.1139/cjfr-27-10-1685; Marini MA, 2010, J ORNITHOL, V151, P857, DOI 10.1007/s10336-010-0523-y; McArthur AG, 1967, FIRE BEHAV EUCALYPT; McCullagh P, 1989, GEN LINEAR MODELS; Mermoz M, 2005, ECOLOGY, V86, P2705, DOI 10.1890/04-1850; Molders N, 2010, ATMOS RES, V95, P290, DOI 10.1016/j.atmosres.2009.03.010; Munger T. T., 1916, MONTHLY WEATHER REV, V44, P642, DOI DOI 10.1175/1520-0493(1916)44<642:GMORAC>2.0.CO;2; Nesterov V. G., 1949, COMBUSTIBILITY FORES; Orieux A, 1974, REV FORESTIERE FRANC, P122; Parisien MA, 2009, ECOL MONOGR, V79, P127, DOI 10.1890/07-1289.1; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Pezzatti GB, 2009, PLANT BIOSYST, V143, P609, DOI 10.1080/11263500903233292; Pezzatti GB, 2013, FOREST POLICY ECON, V29, P7, DOI 10.1016/j.forpol.2011.07.002; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pontius RG, 2014, LANDSCAPE ECOL, V29, P367, DOI 10.1007/s10980-013-9984-8; R Core Team, 2021, R LANGUAGE ENV STAT; Reineking B, 2010, INT J WILDLAND FIRE, V19, P541, DOI 10.1071/WF08206; Renard Q, 2012, INT J WILDLAND FIRE, V21, P368, DOI 10.1071/WF10109; Roura-Pascual N, 2009, BIOL INVASIONS, V11, P1017, DOI 10.1007/s10530-008-9313-3; Sharples JJ, 2009, ENVIRON MODELL SOFTW, V24, P637, DOI 10.1016/j.envsoft.2008.10.012; Sharples JJ, 2009, ENVIRON MODELL SOFTW, V24, P764, DOI 10.1016/j.envsoft.2008.11.004; Siljander M, 2009, INT J APPL EARTH OBS, V11, P380, DOI 10.1016/j.jag.2009.06.004; Spinedi F, 2004, DATI STAT SOC, V4, P4; STOCKS BJ, 1989, FOREST CHRON, V65, P450, DOI 10.5558/tfc65450-6; Sturm T, 2012, EUR J FOREST RES, V131, P829, DOI 10.1007/s10342-011-0556-7; Syphard AD, 2007, ECOL APPL, V17, P1388, DOI 10.1890/06-1128.1; Taylor S., 2001, CONSIDERATIONS APPL; Taylor SW, 2006, INT J WILDLAND FIRE, V15, P121, DOI 10.1071/WF05021; Tian XR, 2011, INT J WILDLAND FIRE, V20, P963, DOI 10.1071/WF09120; Tibshirani R., 2009, SPRINGER SERIES STAT, DOI [10.1007/978-0-387-84858-7, DOI 10.1007/978-0-387-84858-7]; Tognelli MF, 2009, REV CHIL HIST NAT, V82, P347, DOI 10.4067/S0716-078X2009000300003; Van Wagner C. E., 1987, CANADIAN FORESTRY SE; VEGA GARCIA C, 1995, INT J WILDLAND FIRE, V5, P101, DOI 10.1071/WF9950101; Viedma O, 2009, INT J WILDLAND FIRE, V18, P575, DOI 10.1071/WF08030; Viegas DX, 1999, INT J WILDLAND FIRE, V9, P235, DOI 10.1071/WF00015; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Wiley E. O., 2003, OCEANOGRAPHY, V16, P120, DOI [http://dx.doi.org/10.5670/oceanog.2003.42, DOI 10.5670/OCEANOG.2003.42, 10.5670/oceanog.2003.42]; Wotton BM, 2009, ENVIRON ECOL STAT, V16, P107, DOI 10.1007/s10651-007-0084-2; Zumbrunnen T, 2012, REG ENVIRON CHANGE, V12, P935, DOI 10.1007/s10113-012-0307-4; ZWEIG MH, 1993, CLIN CHEM, V39, P561	75	31	31	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0116875	10.1371/journal.pone.0116875	http://dx.doi.org/10.1371/journal.pone.0116875			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679957	Green Published, gold			2022-12-26	WOS:000350682600039
J	Lin, YH; Hung, GY; Wu, LC; Chen, SW; Lin, LY; Horng, JL				Lin, Yuan-Hsiang; Hung, Giun-Yi; Wu, Liang-Chun; Chen, Sheng-Wen; Lin, Li-Yih; Horng, Jiun-Lin			Anion Exchanger 1b in Stereocilia Is Required for the Functioning of Mechanotransducer Channels in Lateral-Line Hair Cells of Zebrafish	PLOS ONE			English	Article							ACID-BASE TRANSPORT; PLASMA-MEMBRANE; RICH CELLS; LOCALIZATION; COCHLEA; LARVAE; CA2+; MECHANISM; DEAFNESS; ATPASE	The anion exchanger (AE) plays critical roles in physiological processes including CO2 transport and volume regulation in erythrocytes and acid-base regulation in renal tubules. Although expression of the AE in inner-ear hair cells was reported, its specific localization and function are still unclear. Using in situ hybridization, we found that the AE1b transcript is expressed in lateral-line hair cells of zebrafish larvae. An immunohistochemical analysis with a zebrafish-specific antibody localized AE1b to stereocilia of hair cells, and the expression was eliminated by morpholino knockdown of AE1b. A non-invasive, scanning ion-selective electrode technique was applied to analyze mechanotransducer (MET) channel-mediated Ca2+ influx at stereocilia of hair cells of intact fish. Ca2+ influx was effectively suppressed by AE1b morpholino knockdown and inhibitor (DIDS) treatment. Elevating external Ca2+ (0.2 to 2 mM) neutralized the inhibition of DIDS. Taken together, this study provides solid evidence to show that AE1b in stereocilia is required for the proper functioning of MET channels.	[Lin, Yuan-Hsiang] Natl Taiwan Univ Sci & Technol, Dept Elect & Comp Engn, Taipei, Taiwan; [Hung, Giun-Yi] Taipei Vet Gen Hosp, Dept Pediat, Taipei, Taiwan; [Hung, Giun-Yi] Natl Yang Ming Univ, Fac Med, Dept Pediat, Taipei 112, Taiwan; [Wu, Liang-Chun; Lin, Li-Yih] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan; [Chen, Sheng-Wen; Horng, Jiun-Lin] Taipei Med Univ, Coll Med, Sch Med, Dept Anat & Cell Biol, Taipei, Taiwan	National Taiwan University of Science & Technology; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Taiwan Normal University; Taipei Medical University	Lin, LY (corresponding author), Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan.	jlhorng@tmu.edu.tw	Wu, Liang-Chun/GVS-9655-2022		Taipei Medical University - National Taiwan University of Science and Technology Joint Research Program [TMU-NTUST-101-04]; Ministry of Science and Technology, Taiwan [101-2311-b-003-004-my3]	Taipei Medical University - National Taiwan University of Science and Technology Joint Research Program; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by Taipei Medical University - National Taiwan University of Science and Technology Joint Research Program (TMU-NTUST-101-04) and grants to J. L. Horng and L. Y. Lin (101-2311-b-003-004-my3) from the Ministry of Science and Technology, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alharazneh A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022347; Batlle D, 2012, NEPHROL DIAL TRANSPL, V27, P3691, DOI 10.1093/ndt/gfs442; Bonar PT, 2008, CHANNELS, V2, P337, DOI 10.4161/chan.2.5.6899; Chiu LL, 2008, JARO-J ASSOC RES OTO, V9, P178, DOI 10.1007/s10162-008-0118-y; Coffin AB, 2009, HEARING RES, V253, P42, DOI 10.1016/j.heares.2009.03.004; Fettiplace R, 2009, PFLUG ARCH EUR J PHY, V458, P1115, DOI 10.1007/s00424-009-0683-x; Froehlicher M, 2009, AQUAT TOXICOL, V95, P307, DOI 10.1016/j.aquatox.2009.04.007; Garber SS, 2005, J MEMBRANE BIOL, V203, P101, DOI 10.1007/s00232-005-0735-x; Ghysen A, 2007, GENE DEV, V21, P2118, DOI 10.1101/gad.1568407; Giacomello M, 2012, INT J BIOCHEM CELL B, V44, P679, DOI 10.1016/j.biocel.2012.02.006; Griffith AJ, 2011, HEARING RES, V281, P11, DOI 10.1016/j.heares.2011.05.009; Hailey DW, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002971; Kalinec F, 1997, HEARING RES, V110, P141, DOI 10.1016/S0378-5955(97)00076-2; Kazmierczak P, 2012, TRENDS NEUROSCI, V35, P220, DOI 10.1016/j.tins.2011.10.007; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kreitzer MA, 2007, J GEN PHYSIOL, V130, P169, DOI 10.1085/jgp.200709737; Lee YC, 2011, AM J PHYSIOL-CELL PH, V300, pC295, DOI 10.1152/ajpcell.00263.2010; Lin LY, 2013, AM J PHYSIOL-CELL PH, V305, pC1060, DOI 10.1152/ajpcell.00077.2013; Lin LY, 2006, AM J PHYSIOL-CELL PH, V290, pC371, DOI 10.1152/ajpcell.00281.2005; Marcotti W, 2005, J PHYSIOL-LONDON, V567, P505, DOI 10.1113/jphysiol.2005.085951; Martinac B, 2014, BBA-BIOMEMBRANES, V1838, P682, DOI 10.1016/j.bbamem.2013.07.015; Mhatre AN, 1998, BBA-BIOMEMBRANES, V1414, P1, DOI 10.1016/S0005-2736(98)00110-2; Ou HC, 2010, DRUG DISCOV TODAY, V15, P265, DOI 10.1016/j.drudis.2010.01.001; Raible DW, 2000, J COMP NEUROL, V421, P189, DOI 10.1002/(SICI)1096-9861(20000529)421:2<189::AID-CNE5>3.0.CO;2-K; Shen WP, 2011, AM J PHYSIOL-REG I, V300, pR858, DOI 10.1152/ajpregu.00705.2010; Shih TH, 2012, AM J PHYSIOL-REG I, V302, pR84, DOI 10.1152/ajpregu.00318.2011; Smith PJS, 1999, MICROSC RES TECHNIQ, V46, P398, DOI 10.1002/(SICI)1097-0029(19990915)46:6<398::AID-JEMT8>3.0.CO;2-H; Stankovic KM, 1997, HEARING RES, V114, P21, DOI 10.1016/S0378-5955(97)00072-5; van den Akker E, 2010, BLOOD CELL MOL DIS, V45, P1, DOI 10.1016/j.bcmd.2010.02.019; Vollrath MA, 2007, ANNU REV NEUROSCI, V30, P339, DOI 10.1146/annurev.neuro.29.051605.112917; Wagner CA, 2006, NEPHRON PHYSIOL, V103, P1, DOI 10.1159/000090217; Wagner CA, 2009, PFLUG ARCH EUR J PHY, V458, P137, DOI 10.1007/s00424-009-0657-z; Walsh SB, 2010, INT J BIOCHEM CELL B, V42, P1919, DOI 10.1016/j.biocel.2010.08.016; Wangemann P, 2007, AM J PHYSIOL-RENAL, V292, pF1345, DOI 10.1152/ajprenal.00487.2006; Wu F, 2011, BIOCHEM CELL BIOL, V89, P106, DOI [10.1139/O10-146, 10.1139/o10-146]; Wulff Heike, 2008, ACS Chem Biol, V3, P399, DOI 10.1021/cb800140m; Zimmermann U, 2000, MOL CELL BIOCHEM, V205, P25, DOI 10.1023/A:1007002916772; Zine A, 1997, NEUROSCIENCE, V80, P1247, DOI 10.1016/S0306-4522(97)00163-2	38	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117041	10.1371/journal.pone.0117041	http://dx.doi.org/10.1371/journal.pone.0117041			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679789	Green Published, gold, Green Submitted			2022-12-26	WOS:000350682600045
J	Wang, Y; Ng, WC; Ng, KS; Yu, K; Wu, T; Li, X				Wang, Yue; Ng, Wu Chun; Ng, Khoon Siong; Yu, Ke; Wu, Tiecheng; Li, Xiaoping			An Electroencephalography Network and Connectivity Analysis for Deception in Instructed Lying Tasks	PLOS ONE			English	Article							EEG FUNCTIONAL CONNECTIVITY; MEDIAL TEMPORAL-LOBE; PREFRONTAL CORTEX; SPEECH; BRAIN; GYRUS; PERCEPTION; MEMORY; DISCRIMINATION; COMPREHENSION	Deception is an impactful social event that has been the focus of an abundance of researches over recent decades. In this paper, an electroencephalography (EEG) study is presented regarding the cognitive processes of an instructed liar/truth-teller during the time window of stimulus (question) delivery period (SDP) prior to their deceptive/truthful responses towards questions related to authentic (WE: with prior experience) and fictional experience (NE: no prior experience). To investigate deception in non-experienced events, the subjects were given stimuli in a mock interview scenario that induced them to fabricate lies. To analyze the data, frequency domain network and connectivity analysis was performed in the source space in order to provide a more systematic level understanding of deception during SDP. This study reveals several groups of neuronal generators underlying both the instructed lying (IL) and the instructed truth-telling (IT) conditions for both tasks during the SDP. Despite the similarities existed in these group components, significant differences were found in the intra- and inter-group connectivity between the IL and IT conditions in either task. Additionally, the response time was found to be positively correlated with the clustering coefficient of the inferior frontal gyrus (44R) in the WE-IL condition and positively correlated with the clustering coefficient of the precuneus (7L) and the angular gyrus (39R) in the WE-IT condition. However, the response time was found to be marginally negatively correlated with the clustering coefficient of the secondary auditory cortex (42L) in the NE-IL condition and negatively correlated with the clustering coefficient of the somatosensory association cortex (5L, R) in the NE-IT condition. Therefore, these results provide complementary and intuitive evidence for the differences between the IL and IT conditions in SDP for two types of deception tasks, thus elucidating the electrophysiological mechanisms underlying SDP of deception from regional, inter-regional, network, and inter-network scale analyses.	[Wang, Yue; Ng, Wu Chun; Ng, Khoon Siong; Yu, Ke; Wu, Tiecheng; Li, Xiaoping] Natl Univ Singapore, Dept Mech Engn, Neuroengn Lab, Singapore 117548, Singapore	National University of Singapore	Li, X (corresponding author), Natl Univ Singapore, Dept Mech Engn, Neuroengn Lab, Singapore 117548, Singapore.	mpelixp@nus.edu.sg						Abe N, 2006, CEREB CORTEX, V16, P192, DOI 10.1093/cercor/bhi097; Abootalebi V, 2009, COMPUT METH PROG BIO, V94, P48, DOI 10.1016/j.cmpb.2008.10.001; Aminoff EM, 2013, TRENDS COGN SCI, V17, P379, DOI 10.1016/j.tics.2013.06.009; Asma L, 2008, THESIS U TWENTE; Astolfi L, 2007, HUM BRAIN MAPP, V28, P143, DOI 10.1002/hbm.20263; Baccala LA, 2001, BIOL CYBERN, V84, P463, DOI 10.1007/PL00007990; Barrett AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029072; BLAIR RC, 1993, PSYCHOPHYSIOLOGY, V30, P518, DOI 10.1111/j.1469-8986.1993.tb02075.x; Blaizot X, 2004, CEREB CORTEX, V14, P231, DOI 10.1093/cercor/bhg123; Bridge H, 2012, J NEUROL, V259, P1062, DOI 10.1007/s00415-011-6299-z; Brodbeck V, 2011, BRAIN, V134, P2887, DOI 10.1093/brain/awr243; Brodmann K., 2006, BRODMANNS LOCALISATI, DOI DOI 10.1016/j.bbadis.2017.07.008; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Campbell Ian G, 2009, Curr Protoc Neurosci, VChapter 10, DOI 10.1002/0471142301.ns1002s49; Canto Cathrin B., 2008, Neural Plasticity, V2008, P1, DOI 10.1155/2008/381243; Canuet L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027863; Carmel D, 2003, J EXP PSYCHOL-APPL, V9, P261, DOI 10.1037/1076-898X.9.4.261; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Champoux F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022829; Chen JL, 2013, HUM BRAIN MAPP, V34, P852, DOI 10.1002/hbm.21475; Chu CJ, 2012, J NEUROSCI, V32, P2703, DOI 10.1523/JNEUROSCI.5669-11.2012; De Clercq W, 2005, P ANN INT IEEE EMBS, P944, DOI 10.1109/IEMBS.2005.1616571; Dehaene-Lambertz G, 2005, NEUROIMAGE, V24, P21, DOI 10.1016/j.neuroimage.2004.09.039; Dressler O, 2004, BRIT J ANAESTH, V93, P806, DOI 10.1093/bja/aeh270; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Fadiga L, 2002, EUR J NEUROSCI, V15, P399, DOI 10.1046/j.0953-816x.2001.01874.x; Farwell LA, 2013, COGN NEURODYNAMICS, V7, P263, DOI 10.1007/s11571-012-9230-0; Forstmann BU, 2008, J COGNITIVE NEUROSCI, V20, P1854, DOI 10.1162/jocn.2008.20122; Friederici AD, 2003, CEREB CORTEX, V13, P170, DOI 10.1093/cercor/13.2.170; Gabrieli JDE, 1998, P NATL ACAD SCI USA, V95, P906, DOI 10.1073/pnas.95.3.906; Ganis G, 2003, CEREB CORTEX, V13, P830, DOI 10.1093/cercor/13.8.830; Ganis G, 2009, SOC NEUROSCI-UK, V4, P539, DOI 10.1080/17470910801928271; German G-H, 2008, AUTOMATIC ARTIFACT R; Gomez-Herrero G, 2006, 2006 7TH NORDIC SIGNAL PROCESSING SYMPOSIUM, P130; Gotlib IH, 2005, NEUROREPORT, V16, P1731, DOI 10.1097/01.wnr.0000183901.70030.82; Greene JD, 2009, P NATL ACAD SCI USA, V106, P12506, DOI 10.1073/pnas.0900152106; Groppe DM, 2011, PSYCHOPHYSIOLOGY, V48, P1711, DOI 10.1111/j.1469-8986.2011.01273.x; Groppe DM., 2010, ONE SAMPLE PAIRED SA; Groppe DM, 2012, CORRELATION PERMUTAT; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hamilton JP, 2011, HUM BRAIN MAPP, V32, P22, DOI 10.1002/hbm.20997; Hebart MN, 2012, J NEUROSCI, V32, P8107, DOI 10.1523/JNEUROSCI.1462-12.2012; Hindley EL, 2014, LEARN MEMORY, V21, P171, DOI 10.1101/lm.032516.113; Ito T, 2009, P NATL ACAD SCI USA, V106, P1245, DOI 10.1073/pnas.0810063106; Jancke L, 2011, J NEUROPSYCHOL, V5, P178, DOI 10.1111/j.1748-6653.2011.02004.x; Kim S, 2012, INT J PSYCHOPHYSIOL, V85, P230, DOI 10.1016/j.ijpsycho.2012.04.009; Kumar V., 2014, INTELLIGENT COMPUTIN, P183, DOI [10.1007/978-81-322-1665-0_17, DOI 10.1007/978-81-322-1665-0_17]; Langleben DD, 2002, NEUROIMAGE, V15, P727, DOI 10.1006/nimg.2001.1003; Leff AP, 2009, BRAIN, V132, P3401, DOI 10.1093/brain/awp273; LIBERMAN AM, 1967, PSYCHOL REV, V74, P431, DOI 10.1037/h0020279; LIBERMAN AM, 1985, COGNITION, V21, P1, DOI 10.1016/0010-0277(85)90021-6; Lou HC, 2004, P NATL ACAD SCI USA, V101, P6827, DOI 10.1073/pnas.0400049101; Ludwig KA, 2009, J NEUROPHYSIOL, V101, P1679, DOI 10.1152/jn.90989.2008; MacEvoy SP, 2011, NAT NEUROSCI, V14, P1323, DOI 10.1038/nn.2903; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; Meister IG, 2007, CURR BIOL, V17, P1692, DOI 10.1016/j.cub.2007.08.064; Michael SG, 2009, COGNITIVE NEUROSCIEN, P395; Michel CM., 2009, ELECT NEUROIMAGING, P111; Murray EA, 2007, ANNU REV NEUROSCI, V30, P99, DOI 10.1146/annurev.neuro.29.051605.113046; National Research Council, 2003, POL LIE DET; Pascual-Marqui R. D., 2007, ARXIV07111455; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Pulvermuller F, 2006, P NATL ACAD SCI USA, V103, P7865, DOI 10.1073/pnas.0509989103; Purves D, 2001, NEUROSCIENCE, DOI [10.4249/scholarpedia.7204, DOI 10.4249/SCHOLARPEDIA.7204]; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Sabri M, 2008, NEUROIMAGE, V39, P1444, DOI 10.1016/j.neuroimage.2007.09.052; Schutter DJLG, 2006, J PSYCHIATR NEUROSCI, V31, P101; Seghier ML, 2013, NEUROSCIENTIST, V19, P43, DOI 10.1177/1073858412440596; Seth AK, 2006, NEUROIMAGE, V32, P465, DOI 10.1016/j.neuroimage.2006.02.050; Shafi MM, 2014, BRAIN TOPOGR, V27, P172, DOI 10.1007/s10548-013-0277-y; Stam CJ, 2007, HUM BRAIN MAPP, V28, P1178, DOI 10.1002/hbm.20346; Thakor Nitish V., 2009, P169; Wang Y, 2013, I IEEE EMBS C NEUR E, P468, DOI 10.1109/NER.2013.6695973; Watkins KE, 2003, NEUROPSYCHOLOGIA, V41, P989, DOI 10.1016/S0028-3932(02)00316-0; Wise RJS, 2001, BRAIN, V124, P83, DOI 10.1093/brain/124.1.83; Yoshimura S, 2009, BRAIN COGNITION, V69, P218, DOI 10.1016/j.bandc.2008.07.010	76	7	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0116522	10.1371/journal.pone.0116522	http://dx.doi.org/10.1371/journal.pone.0116522			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679784	Green Published, Green Submitted, gold			2022-12-26	WOS:000350682600024
J	Yasuda, D; Imura, Y; Ishii, S; Shimizu, T; Nakamura, M				Yasuda, Daisuke; Imura, Yuki; Ishii, Satoshi; Shimizu, Takao; Nakamura, Motonao			The atypical N-glycosylation motif, Asn-Cys-Cys, in human GPR109A is required for normal cell surface expression and intracellular signaling	FASEB JOURNAL			English	Article						Nicotinic acid receptor; N-linked glycosylation; Asn-X-Cys motif; STT3B; receptor activation	SITE-DIRECTED MUTAGENESIS; NICOTINIC-ACID RECEPTOR; MUSCARINIC ACETYLCHOLINE-RECEPTOR; LINKED GLYCOSYLATION; QUALITY-CONTROL; MOLECULAR-IDENTIFICATION; ENDOPLASMIC-RETICULUM; PROTEIN-STRUCTURE; PUMA-G; SEQUENCE	Asparagine-linked glycosylation (N-glycosylation) is necessary for the proper folding of secreted and membrane proteins, including GPCRs. Thus, many GPCRs possess the N-glycosylation motif Asn-X-Ser/Thr at their N-termini and/or extracellular loops. We found that human GPR109A (hGPR109A) has an N-glycosylation site at Asn(17) in the N-terminal atypical motif, Asn(17)-Cys(18)-Cys(19). Why does hGPR109A require the atypical motif, rather than the typical sequence? Here we show that Asn(17)-Cys(18)-Cys(19) sequence of hGPR109A possesses 2 biologic roles. First, Asn(17)-X-Cys(19) contributed to hGPR109A N-glycosylation by acting as an atypical motif. This modification is required for the normal surface expression of hGPR109A, as evidenced by the reduced surface expression of the nonglycosylated mutants, hGPR109A/N17A, and the finding that hGPR109A/C19S and hGPR109A/C19T, which are N-glycosylated at Asn(17), exhibited expression similar to the wild-type receptor. Second, the X-Cys(18)-Cys(19) dicysteine is indispensable for hGPR109A function. Substitution of Cys(18) or Cys(19) residue to Ala impaired G(i)-mediated signaling via hGPR109A. We propose the disulfide bond formations of these residues with other Cys existed in the extracellular loops for the proper folding. Together, these results suggest that the atypical motif Asn(17)-Cys(18)-Cys(19) is crucial for the normal surface trafficking and function of hGPR109A.	[Yasuda, Daisuke; Imura, Yuki; Shimizu, Takao; Nakamura, Motonao] Univ Tokyo, Fac Med, Dept Biochem & Mol Biol, Tokyo 113, Japan; [Yasuda, Daisuke; Ishii, Satoshi] Akita Univ, Fac Med, Dept Immunol, Akita 010, Japan; [Shimizu, Takao] Natl Ctr Global Hlth & Med, Dept Lipid Signaling, Tokyo, Japan; [Shimizu, Takao] Okayama Univ Sci, Fac Sci, Dept Life Sci, Okayama, Okayama 7000005, Japan	University of Tokyo; Akita University; National Center for Global Health & Medicine - Japan; Okayama University of Science	Nakamura, M (corresponding author), Okayama Univ Sci, Fac Sci, Dept Life Sci, Kita Ku, 1-1 Ridai Cho, Okayama, Okayama 7000005, Japan.	moto-nakamura@dls.ous.ac.jp	Shimizu, Takao/AAV-7052-2021	Yasuda, Daisuke/0000-0001-5513-0695	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science (Global COE program); Center for NanoBio Integration at the University of Tokyo; Grants-in-Aid for Scientific Research [25116703] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (Global COE program); Center for NanoBio Integration at the University of Tokyo; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors are grateful to Dr. Y. Kita (University of Tokyo), Dr. H. Shindou (National Center for Global Health and Medicine), and Drs. N. Akahoshi and T. Ohto (Akita University), and to all members of their laboratory for technical advice and useful discussions. The authors also thank Mrs. C. Kanokoda and Mrs. Y. Sugimoto-Aruga for their technical support. This work was supported in part by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to D.Y., M.N., and T.S.), and grants from the Japan Society for the Promotion of Science (Global COE program) and the Center for NanoBio Integration at the University of Tokyo.	Araki T, 1998, ARCH BIOCHEM BIOPHYS, V351, P250, DOI 10.1006/abbi.1997.0564; BAUSE E, 1979, FEBS LETT, V108, P341, DOI 10.1016/0014-5793(79)80559-1; Bisello A, 1996, BIOCHEMISTRY-US, V35, P15890, DOI 10.1021/bi962111+; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen QA, 2010, AM J PHYSIOL-ENDOC M, V299, pE62, DOI 10.1152/ajpendo.00067.2010; Couvineau A, 1996, BIOCHEMISTRY-US, V35, P1745, DOI 10.1021/bi952022h; DAVIS D, 1995, MOL ENDOCRINOL, V9, P159, DOI 10.1210/me.9.2.159; Digby JE, 2012, ARTERIOSCL THROM VAS, V32, P582, DOI 10.1161/ATVBAHA.111.236315; Dong CM, 2007, BBA-BIOMEMBRANES, V1768, P853, DOI 10.1016/j.bbamem.2006.09.008; FUKUSHIMA Y, 1995, BIOCHEM J, V310, P553, DOI 10.1042/bj3100553; Gil GC, 2009, PROTEOMICS, V9, P2555, DOI 10.1002/pmic.200800775; Giuffrida MG, 1997, J PROTEIN CHEM, V16, P747, DOI 10.1023/A:1026359715821; Hirota N, 2010, J BIOL CHEM, V285, P5931, DOI 10.1074/jbc.M109.066282; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Innamorati G, 1996, MOL PHARMACOL, V50, P467; JENSEN CH, 1994, EUR J BIOCHEM, V225, P83, DOI 10.1111/j.1432-1033.1994.00083.x; Kohno T, 2002, FASEB J, V16, P983, DOI 10.1096/fj.01-0809com; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Krogh TN, 1997, EUR J BIOCHEM, V244, P334, DOI 10.1111/j.1432-1033.1997.00334.x; Kuei C, 2011, MOL PHARMACOL, V80, P848, DOI 10.1124/mol.111.074500; Markkanen PMH, 2008, J BIOL CHEM, V283, P29086, DOI 10.1074/jbc.M801880200; Marshall R D, 1974, Biochem Soc Symp, P17; Matsui T, 2011, GLYCOBIOLOGY, V21, P994, DOI 10.1093/glycob/cwq198; Michineau S, 2004, BIOL CHEM, V385, P49, DOI 10.1515/BC.2004.007; NODA K, 1994, J BIOL CHEM, V269, P6743; Offermanns S, 2006, TRENDS PHARMACOL SCI, V27, P384, DOI 10.1016/j.tips.2006.05.008; RANDS E, 1990, J BIOL CHEM, V265, P10759; Ray K, 1998, J BIOL CHEM, V273, P34558, DOI 10.1074/jbc.273.51.34558; Ruddock LW, 2006, J CELL SCI, V119, P4373, DOI 10.1242/jcs.03225; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; Rutz C, 2006, J BIOL CHEM, V281, P24910, DOI 10.1074/jbc.M601554200; Sato C, 2000, J BIOCHEM-TOKYO, V127, P65, DOI 10.1093/oxfordjournals.jbchem.a022585; SAVARESE TM, 1992, J BIOL CHEM, V267, P11439; SAWUTZ DG, 1987, MOL PHARMACOL, V32, P565; Shukla AK, 2006, BIOCHEM BIOPH RES CO, V349, P6, DOI 10.1016/j.bbrc.2006.07.210; Siffroi-Fernandez S, 2002, EUR J BIOCHEM, V269, P4930, DOI 10.1046/j.1432-1033.2002.03192.x; Soga T, 2003, BIOCHEM BIOPH RES CO, V303, P364, DOI 10.1016/S0006-291X(03)00342-5; STENFLO J, 1982, J BIOL CHEM, V257, P2180; Tan CM, 2003, J BIOL CHEM, V278, P35678, DOI 10.1074/jbc.M301888200; TITANI K, 1986, BIOCHEMISTRY-US, V25, P3171, DOI 10.1021/bi00359a015; Tunaru S, 2005, MOL PHARMACOL, V68, P1271, DOI 10.1124/mol.105.015750; Tunaru S, 2003, NAT MED, V9, P352, DOI 10.1038/nm824; Valliere-Douglass JF, 2010, J BIOL CHEM, V285, P16012, DOI 10.1074/jbc.M109.096412; Vance BA, 1997, J BIOL CHEM, V272, P23117, DOI 10.1074/jbc.272.37.23117; VANKOPPEN CJ, 1990, J BIOL CHEM, V265, P20887; Wanders D, 2011, DIABETES OBES METAB, V13, P685, DOI 10.1111/j.1463-1326.2011.01400.x; Whitaker GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032675; Wise A, 2003, J BIOL CHEM, V278, P9869, DOI 10.1074/jbc.M210695200; Xiao YP, 2011, J BIOL CHEM, V286, P22991, DOI 10.1074/jbc.M110.204271; Yasuda D, 2009, FASEB J, V23, P1470, DOI 10.1096/fj.08-125385; Zielinska DF, 2010, CELL, V141, P897, DOI 10.1016/j.cell.2010.04.012	51	12	12	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2412	2422		10.1096/fj.14-267096	http://dx.doi.org/10.1096/fj.14-267096			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	25690651	Green Published			2022-12-26	WOS:000355209500018
J	De Re, V; Caggiari, L; De Zorzi, M; Repetto, O; Zignego, AL; Izzo, F; Tornesello, ML; Buonaguro, FM; Mangia, A; Sansonno, D; Racanelli, V; De Vita, S; Pioltelli, P; Vaccher, E; Beretta, M; Mazzaro, C; Libra, M; Gini, A; Zucchetto, A; Cannizzaro, R; De Paoll, P				De Re, Valli; Caggiari, Laura; De Zorzi, Mariangela; Repetto, Ombretta; Zignego, Anna Linda; Izzo, Francesco; Tornesello, Maria Lina; Buonaguro, Franco Maria; Mangia, Alessandra; Sansonno, Domenico; Racanelli, Vito; De Vita, Salvatore; Pioltelli, Pietro; Vaccher, Emanuela; Beretta, Massimiliano; Mazzaro, Cesare; Libra, Massimo; Gini, Andrea; Zucchetto, Antonella; Cannizzaro, Renato; De Paoll, Paolo			Genetic Diversity of the KIR/HLA System and Susceptibility to Hepatitis C Virus-Related Diseases	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; HEPATOCELLULAR-CARCINOMA; HEPATOMA-CELLS; RECEPTOR GENES; INCREASED RISK; HCV INFECTION; HLA; LYMPHOMA; GENOTYPE; INNATE	Background The variability in the association of host innate immune response to Hepatitis C virus (HCV) infection requires ruling out the possible role of host KIR and HLA genotypes in HCV-related disorders: therefore, we therefore explored the relationships between KIR/HLA genotypes and chronic HCV infection (CHC) as they relate to the risk of HCV-related hepatocarcinoma (HCC) or lymphoproliferative disease progression. Methods and Findings We analyzed data from 396 HCV-positive patients with CHC (n = 125), HCC (118), and lymphoproliferative diseases (153), and 501 HCV-negative patients. All were HIV and HBV negative. KIR-SSO was used to determine the KIR typing. KIR2DL5 and KIR2DS4 variants were performed using PCR and GeneScan analysis. HLA/class-I genotyping was performed using PCR-sequence-based typing. The interaction between the KIR gene and ligand HLA molecules was investigated. Differences in frequencies were estimated using Fisher's exact test, and Cochran-Armitage trend test. The non-random association of KIR alleles was estimated using the linkage disequilibrium test. We found an association of KIR2DS2/KIR2DL2 genes, with the HCV-related lymphoproliferative disorders. Furthermore, individuals with a HLA-Bw6 KIR3DL1+ combination of genes showed higher risk of developing lymphoma than cryoglobulinemia. KIR2DS3 gene was found to be the principal gene associated with chronic HCV infection, while a reduction of HLA-Bw4 + KIR3DS1+ was associated with an increased risk of developing HCC. Conclusions Our data highlight a role of the innate-systemin developing HCV-related disorders and specifically KIR2DS3 and KIR2D genes demonstrated an ability to direct HCV disease progression, and mainly towards lymphoproliferative disorders. Moreover the determination of KIR3D/HLA combination of genes direct the HCV progression towards a lymphoma rather than an hepatic disease. In this contest IFN-alpha therapy, a standard therapy for HCV-infection and lymphoproliferative diseases, known to be able to transiently enhance the cytotoxicity of NK-cells support the role of NK cells to counterstain HCV-related and lymphoproliferative diseases.	[De Re, Valli; Caggiari, Laura; De Zorzi, Mariangela; Repetto, Ombretta; De Paoll, Paolo] CRO Natl Canc Inst, Facil Bioproteom Dir Sc, Aviano, Pordenone, Italy; [Zignego, Anna Linda] Univ Florence, Florence, Italy; [Izzo, Francesco] Natl Canc Inst Fdn Pascale, Hepatobiliary Unit, Naples, Italy; [Tornesello, Maria Lina; Buonaguro, Franco Maria] Natl Canc Inst Fdn Pascale, Naples, Italy; [Mangia, Alessandra] IRCCS, Casa Sollievo Sofferenza Hosp, San Giovanni Rotondo, Italy; [Sansonno, Domenico; Racanelli, Vito] Univ Bari, Sch Med, Bari, Italy; [De Vita, Salvatore] Univ Hosp Santa Maria Misericordia, Udine, Italy; [Pioltelli, Pietro] Univ Milano Bicocca, San Gerardo Hosp, Hematol & Transplant Unit, Monza, Italy; [Vaccher, Emanuela; Beretta, Massimiliano; Mazzaro, Cesare] Ctr Riferimento Oncol, Aviano, Pordenone, Italy; [Libra, Massimo] Univ Catania, Catania, Italy; [Gini, Andrea; Zucchetto, Antonella; Cannizzaro, Renato] CRO Natl Canc Inst, Aviano, Pordenone, Italy	IRCCS Aviano (CRO); University of Florence; IRCCS Fondazione Pascale; IRCCS Fondazione Pascale; IRCCS Casa Sollievo Della Sofferenza; Universita degli Studi di Bari Aldo Moro; Hospital Santa Maria della Misericordia; San Gerardo Hospital; University of Milano-Bicocca; IRCCS Aviano (CRO); University of Catania; IRCCS Aviano (CRO)	De Re, V (corresponding author), CRO Natl Canc Inst, Facil Bioproteom Dir Sc, Aviano, Pordenone, Italy.	vdere@cro.it	Mazzaro, Cesare/P-7794-2019; CAGGIARI, LAURA/Q-6125-2019; Maria, Buonaguro Franco/AAF-4888-2019; De Zorzi, Mariangela/AAA-8832-2019; Zucchetto, Antonella/ABC-8649-2020; Repetto, Ombretta/V-6342-2019; Buonaguro, Franco M./T-6028-2019; Cannizzaro, Renato/V-3804-2018; Gini, Andrea/GLN-7977-2022; DE RE, VALLI/AAA-1374-2019; Libra, Massimo/ABF-6654-2020; Mangia, A/AAL-5357-2020; Zignego, Anna Linda/AAL-8205-2021; Tornesello, Maria Lina/A-1964-2008; De Re, Valli/K-4121-2016; Racanelli, Vito/J-8511-2018; Libra, Massimo/L-8241-2018; Vaccher, Emanuela/AAC-9372-2020; De Paoli, Paolo/AAG-2586-2021; Pizzichetta, Maria Antonietta/F-5407-2019; Berretta, Massimiliano/None; Izzo, Francesco/K-5261-2016	Mazzaro, Cesare/0000-0002-0305-6574; CAGGIARI, LAURA/0000-0003-1651-6653; De Zorzi, Mariangela/0000-0002-3794-270X; Zucchetto, Antonella/0000-0003-2812-6345; Repetto, Ombretta/0000-0002-0785-5066; Buonaguro, Franco M./0000-0002-7491-7220; Cannizzaro, Renato/0000-0002-2020-222X; Gini, Andrea/0000-0002-7696-0580; DE RE, VALLI/0000-0001-6100-9373; Libra, Massimo/0000-0002-7232-7737; Mangia, A/0000-0002-2600-3555; Tornesello, Maria Lina/0000-0002-3523-3264; De Re, Valli/0000-0001-6100-9373; Racanelli, Vito/0000-0002-8639-1940; Libra, Massimo/0000-0002-7232-7737; Vaccher, Emanuela/0000-0003-3386-5142; Pizzichetta, Maria Antonietta/0000-0002-4201-8490; Berretta, Massimiliano/0000-0002-9837-9148; Izzo, Francesco/0000-0003-3093-5408; De Paoli, Paolo/0000-0002-9502-1781; SANSONNO, Domenico Ettore/0000-0001-6520-1653; , Salvatore/0000-0002-2757-3373	Italian Association for Cancer Research (AIRC) [10266]; Dir Sc. CRO	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Dir Sc. CRO	Italian Association for Cancer Research (AIRC n. 10266) grant funding to part of the research reagents. Laura caggiari, Mariangela De Zorzi and Ombretta Repetto fellowships are funded by 5% Dir Sc. CRO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Ahlenstiel G, 2008, J CLIN INVEST, V118, P1017, DOI 10.1172/JCI32400; Bray SM, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/249281; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Caggiari L, 2011, INT J BIOL MARKER, V26, P221, DOI 10.5301/JBM.2011.8903; Cai L, 2008, CLIN IMMUNOL, V129, P428, DOI 10.1016/j.clim.2008.08.012; Cariani E, 2013, CLIN CANCER RES, V19, P5465, DOI 10.1158/1078-0432.CCR-13-0986; Chang KC, 2013, BRIT J CANCER, V109, P2481, DOI 10.1038/bjc.2013.564; Cheent K, 2011, GUT, V60, P268, DOI 10.1136/gut.2010.212555; Crotta S, 2010, J HEPATOL, V52, P183, DOI 10.1016/j.jhep.2009.11.003; de Arias AE, 2009, LIVER TRANSPLANT, V15, P390, DOI 10.1002/lt.21673; De Re V, 2010, TISSUE ANTIGENS, V75, P127, DOI 10.1111/j.1399-0039.2009.01414.x; De Re V, 2008, BLOOD, V111, P5760, DOI 10.1182/blood-2008-04-149567; De Re V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084940; DERE V, 2014, BIOMED RES INT, V2014, DOI DOI 10.1155/2014/710642EPUB;%2014FEB26.:710642; Dring MM, 2011, P NATL ACAD SCI USA, V108, P5736, DOI 10.1073/pnas.1016358108; Fadda L, 2011, J VIROL, V85, P5970, DOI 10.1128/JVI.00412-11; Gao B, 2009, J LEUKOCYTE BIOL, V86, P513, DOI [10.1189/JLB.0309135, 10.1189/jlb.0309135]; Gomez-Lozano N, 2002, IMMUNOGENETICS, V54, P314, DOI 10.1007/s00251-002-0476-2; Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128; Gourraud PA, 2010, IMMUNOGENETICS, V62, P729, DOI 10.1007/s00251-010-0478-4; Hu XL, 2014, J INTERF CYTOK RES, V34, P366, DOI 10.1089/jir.2013.0049; Kawamura Y, 2007, AM J MED, V120, P1034, DOI 10.1016/j.amjmed.2007.06.022; Khakoo SI, 2004, SCIENCE, V305, P872, DOI 10.1126/science.1097670; Knapp S, 2010, HEPATOLOGY, V51, P1168, DOI 10.1002/hep.23477; Larkin J, 2006, J INTERF CYTOK RES, V26, P854, DOI 10.1089/jir.2006.26.854; Lee MH, 2010, J CLIN ONCOL, V28, P4587, DOI 10.1200/JCO.2010.29.1500; Legaz I, 2013, TRANSPLANTATION, V95, P1037, DOI 10.1097/TP.0b013e318286486c; Li Y, 2004, J LEUKOCYTE BIOL, V76, P1171, DOI 10.1189/jlb.0604372; Littera R, 2013, HUM IMMUNOL, V74, P1288, DOI 10.1016/j.humimm.2013.05.007; Lopez-Vazquez A, 2005, J INFECT DIS, V192, P162, DOI 10.1086/430351; Martin AM, 2004, GENE, V335, P121, DOI 10.1016/j.gene.2004.03.018; Miyagi T, 2004, HEPATOLOGY, V40, P1190, DOI 10.1002/hep.20447; Miyagi T, 2003, INT J CANCER, V106, P81, DOI 10.1002/ijc.11163; Moesta AK, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00336; Orange JS, 2002, MICROBES INFECT, V4, P1545, DOI 10.1016/S1286-4579(02)00038-2; Park SH, 2012, GASTROENTEROLOGY, V143, P1048, DOI 10.1053/j.gastro.2012.06.005; Parsons MS, 2012, J VIROL, V86, P4488, DOI 10.1128/JVI.06112-11; Pyo CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015115; Quartuccio L, 2014, RHEUMATOLOGY, V53, P2209, DOI 10.1093/rheumatology/keu271; Schonberg K, 2011, BLOOD, V117, P98, DOI 10.1182/blood-2010-03-273656; Sharma D, 2009, J IMMUNOL, V183, P4569, DOI 10.4049/jimmunol.0901734; Shindoh J, 2013, J CLIN ONCOL, V31, P766, DOI 10.1200/JCO.2012.44.3234; Stegmann KA, 2012, J INFECT DIS, V205, P1351, DOI 10.1093/infdis/jis210; Stegmann KA, 2010, GASTROENTEROLOGY, V138, P1885, DOI 10.1053/j.gastro.2010.01.051; Tatsumi T, 2007, HEPATOLOGY, V45, P22, DOI 10.1002/hep.21447; Thimme R, 2012, FEMS MICROBIOL REV, V36, P663, DOI 10.1111/j.1574-6976.2011.00319.x; Winter CC, 1998, J IMMUNOL, V161, P571; X-Jaffe ES, 2001, PATHOLOGY GENETICS T; Yamagiwa S, 2008, HEPATOL RES, V38, P664, DOI 10.1111/j.1872-034X.2008.00317.x; Zhao F, 2012, DIGEST DIS, V30, P477, DOI 10.1159/000341695; Zuniga J, 2009, MOL IMMUNOL, V46, P2723, DOI 10.1016/j.molimm.2009.05.014	52	40	40	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0117420	10.1371/journal.pone.0117420	http://dx.doi.org/10.1371/journal.pone.0117420			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25700262	Green Published, Green Submitted, gold			2022-12-26	WOS:000349789800023
J	Guo, SY; Lucas, RM; Joshy, G; Banks, E				Guo, Shuyu; Lucas, Robyn M.; Joshy, Grace; Banks, Emily			Cardiovascular Disease Risk Factor Profiles of 263,356 Older Australians According to Region of Birth and Acculturation, with a Focus on Migrants Born in Asia	PLOS ONE			English	Article							BODY-MASS INDEX; UNITED-STATES; PHYSICAL-ACTIVITY; PREVALENCE; AMERICANS; SMOKING; IMMIGRANTS; MORTALITY; HEALTH; ASSOCIATION	Risk factors for cardiovascular disease (CVD), such as obesity, diabetes, hypertension and physical inactivity, are common in Australia, but the prevalence varies according to cultural background. We examined the relationship between region of birth, measures of acculturation, and CVD risk profiles in immigrant, compared to Australian-born, older Australians. Cross-sectional data from 263,356 participants aged 45 and over joining the population-based 45 and Up Study cohort from 2006-2008 were used. Prevalence ratios for CVD risk factors in Australian-versus overseas-born participants were calculated using modified Poisson regression, adjusting for age, sex and socioeconomic factors and focusing on Asian migrants. The association between time resident in Australia and age at migration and CVD risk factors in Asian migrants was also examined. Migrants from Northeast (n = 3,213) and South-east Asia (n = 3,942) had lower levels of overweight/obesity, physical activity and female smoking than Australian-born participants (n = 199,356), although differences in prevalence of overweight/obesity were sensitive to body-mass-index cut-offs used. Compared to Australian-born participants, migrants from Northeast Asia were 20-30% less likely, and from-Southeast Asia 10-20% more likely, to report being treated for hypertension and/or hypercholesterolaemia; Southeast Asian migrants were 40-60% more likely to report diabetes. Northeast Asian-born individuals were less likely than Australian-born to have 3 or more CVD risk factors. Diabetes, treated hypertension and hypercholesterolaemia occurred at relatively low average body-mass-index in Southeast Asian migrants. The CVD risk factor profiles of migrants tended to approximate those of Australian-born with increasing acculturation, in both favourable (e.g., increased physical activity) and unfavourable directions (e.g., increased female smoking). Minimizing CVD risk in migrant populations may be achieved through efforts to retain the healthy facets of the traditional lifestyle, such as a normal body mass index and low prevalence of smoking in women, in addition to adopting healthy aspects of the host country lifestyle, such as increased physical activity.	[Guo, Shuyu; Lucas, Robyn M.; Joshy, Grace; Banks, Emily] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Res Sch Populat Hlth, Canberra, ACT, Australia; [Banks, Emily] Sax Inst, Sydney, NSW, Australia; [Lucas, Robyn M.] Univ Western Australia, Telethon Kids Inst, Perth, WA 6009, Australia	Australian National University; University of Sydney; Telethon Kids Institute; University of Western Australia	Guo, SY (corresponding author), Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Res Sch Populat Hlth, Canberra, ACT, Australia.	Shuyu.guo@anu.edu.au		Banks, Emily/0000-0002-4617-1302; Lucas, Robyn/0000-0003-2736-3541; Joshy, Grace/0000-0002-0718-6368	National Heart Foundation, NSW Cardiovascular Research Network through 45 and Up Study Cardiovascular Research Collaboration	National Heart Foundation, NSW Cardiovascular Research Network through 45 and Up Study Cardiovascular Research Collaboration	This specific project was supported by a development grant from the National Heart Foundation, NSW Cardiovascular Research Network, made available through the 45 and Up Study Cardiovascular Research Collaboration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouzeid M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-252; An N, 2008, NICOTINE TOB RES, V10, P579, DOI 10.1080/14622200801979126; [Anonymous], 2011, WHO TECH REP SER; [Anonymous], 2005, NAT PHYS ACT GUID AD; Aoki Yutaka, 2014, NCHS Data Brief, P1; Australian Bureau of Statistics, 2010, MIGR AUSTR 2008 09; Banks E, 2008, INT J EPIDEMIOL, V37, P941, DOI 10.1093/ije/dym184; BENNETT SA, 1993, AUST J PUBLIC HEALTH, V17, P251; Chiu M, 2012, CAN J CARDIOL, V28, P20, DOI 10.1016/j.cjca.2011.06.002; Cho Juhee, 2006, Prev Chronic Dis, V3, pA79; Comino EJ, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-481; de Looper M., 2002, AIHW B, V2; Tran DT, 2014, J COMMUN HEALTH, V39, P99, DOI 10.1007/s10900-013-9745-2; Frank ATH, 2014, CIRCULATION, V129, P570, DOI 10.1161/CIRCULATIONAHA.113.005757; Goel MS, 2004, JAMA-J AM MED ASSOC, V292, P2860, DOI 10.1001/jama.292.23.2860; Hauck K, 2011, HEALTH PLACE, V17, P78, DOI 10.1016/j.healthplace.2010.08.016; HSUHAGE BHH, 1993, AUST J PUBLIC HEALTH, V17, P306; Kandula NR, 2008, DIABETES CARE, V31, P1621, DOI 10.2337/dc07-2182; Kandula NR, 2005, ANN EPIDEMIOL, V15, P257, DOI 10.1016/j.annepidem.2004.06.006; Koya DL, 2007, J GEN INTERN MED, V22, P841, DOI 10.1007/s11606-007-0163-y; Lauderdale DS, 2000, INT J OBESITY, V24, P1188, DOI 10.1038/sj.ijo.0801365; Lear SA, 2007, AM J CLIN NUTR, V86, P353, DOI 10.1093/ajcn/86.2.353; Ma GX, 2004, HEALTH EDUC RES, V19, P615, DOI 10.1093/her/cyg070; McNeely MJ, 2004, DIABETES CARE, V27, P66, DOI 10.2337/diacare.27.1.66; Mealing NM, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-26; Nakagami T, 2003, DIABETOLOGIA, V46, P1063, DOI 10.1007/s00125-003-1158-9; Ng SP, 2011, AUST NZ J PUBL HEAL, V35, P557, DOI 10.1111/j.1753-6405.2011.00742.x; Ngo-Metzger Q, 2004, MED CARE, V42, P893, DOI 10.1097/01.mlr.0000135819.15178.bc; NHDC & AIHW, 1992, IMM AUSTR HLTH PROF; Poulter N, 1999, AM J HYPERTENS, V12, p92S; SAS, 2011, SAS VERS 9 3; Singh GK, 2004, CAN J PUBLIC HEALTH, V95, pI14, DOI 10.1007/BF03403660; Singh GK, 2002, HUM BIOL, V74, P83, DOI 10.1353/hub.2002.0011; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; Tang H, 2005, CANCER-AM CANCER SOC, V104, P2982, DOI 10.1002/cncr.21523; Tremblay MS, 2006, CAN J PUBLIC HEALTH, V97, P277, DOI 10.1007/BF03405603; Trevisan M, 1998, AM J EPIDEMIOL, V148, P958; United Nations, 2013, INT MIGR REP 2013; Weber MF, 2011, DRUG ALCOHOL REV, V30, P597, DOI 10.1111/j.1465-3362.2010.00247.x; Weber MF, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-144; WHO, 2010, GLOB STAT REP NONC D; Wong RJ, 2014, J COMMUN HEALTH, V39, P437, DOI 10.1007/s10900-013-9792-8; World Health Organization, 2011, GLOB ATL CARD DIS PR, DOI [10.1080/17437199.2011.587961, DOI 10.1080/17437199.2011.587961]; Zhang J, 2008, NICOTINE TOB RES, V10, P791, DOI 10.1080/14622200802027230	44	19	19	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0115627	10.1371/journal.pone.0115627	http://dx.doi.org/10.1371/journal.pone.0115627			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC0XE	25695771	Green Published, gold, Green Submitted			2022-12-26	WOS:000350062300007
J	Silva, RR; Mariante, RM; Silva, AA; dos Santos, ALB; Roffe, E; Santiago, H; Gazzinelli, RT; Lannes-Vieira, J				Silva, Rafael Rodrigues; Mariante, Rafael M.; Silva, Andrea Alice; Barbosa dos Santos, Ana Luiza; Roffe, Ester; Santiago, Helton; Gazzinelli, Ricardo Tostes; Lannes-Vieira, Joseli			Interferon-Gamma Promotes Infection of Astrocytes by Trypanosoma cruzi	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; CENTRAL-NERVOUS-SYSTEM; TUMOR-NECROSIS-FACTOR; IFN-GAMMA; CHAGAS-DISEASE; T-CELLS; TOXOPLASMA-GONDII; OXIDATIVE STRESS; BETA; EXPRESSION	The inflammatory cytokine interferon-gamma (IFN gamma) is crucial for immunity against intracellular pathogens such as the protozoan parasite Trypanosoma cruzi, the causative agent of Chagas disease (CD). IFN gamma is a pleiotropic cytokine which regulates activation of immune and non-immune cells; however, the effect of IFN. in the central nervous system (CNS) and astrocytes during CD is unknown. Here we show that parasite persists in the CNS of C3H/He mice chronically infected with the Colombian T. cruzi strain despite the increased expression of IFN gamma mRNA. Furthermore, most of the T. cruzi-bearing cells were astrocytes located near IFN gamma(+) cells. Surprisingly, in vitro experiments revealed that pretreatment with IFN gamma promoted the infection of astrocytes by T. cruzi increasing uptake and proliferation of intracellular forms, despite inducing increased production of nitric oxide (NO). Importantly, the effect of IFN gamma on T. cruzi uptake and growth is completely blocked by the anti-tumor necrosis factor (TNF) antibody Infliximab and partially blocked by the inhibitor of nitric oxide synthesis L-NAME. These data support that IFN gamma fuels astrocyte infection by T. cruzi and critically implicate IFN gamma-stimulated T. cruzi-infected astrocytes as sources of TNF and NO, which may contribute to parasite persistence and CNS pathology in CD.	[Silva, Rafael Rodrigues; Mariante, Rafael M.; Barbosa dos Santos, Ana Luiza; Roffe, Ester; Lannes-Vieira, Joseli] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Interacoes, BR-21045900 Rio De Janeiro, Brazil; [Silva, Andrea Alice] Univ Fed Fluminense, Dept Clin Med, Lab Multidisciplinar Apoio Pesquisa, Rio De Janeiro, Brazil; [Silva, Andrea Alice] Univ Fed Fluminense, Fac Med, Dept Patol, Rio De Janeiro, Brazil; [Roffe, Ester] Fiocruz MS, Ctr Pesquisas Rene Rachou, Lab Imunol Celular & Mol, Belo Horizonte, MG, Brazil; [Santiago, Helton; Gazzinelli, Ricardo Tostes] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Immunol, Belo Horizonte, MG, Brazil	Fundacao Oswaldo Cruz; Universidade Federal Fluminense; Universidade Federal Fluminense; Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais	Lannes-Vieira, J (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Interacoes, BR-21045900 Rio De Janeiro, Brazil.	lannes@ioc.fiocruz.br	Santiago, Helton/F-8704-2012; Santiago, Helton/AAA-8558-2021; Roffê, Ester/H-4688-2012; Silva, Andrea Alice/J-6729-2012; Mariante, Rafael/AAM-6010-2021	Santiago, Helton/0000-0002-5695-8256; Silva, Andrea Alice/0000-0001-5856-6128; Mariante, Rafael/0000-0001-8024-9612; Gazzinelli, Ricardo/0000-0003-2427-7699	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro/FAPERJ [APQ1-E-26/111.756/2008, CNE/E-26/101.549/2010, E-26/110.153/2013, E-26/111.709/2013]; Brazilian Research Council?CNPq [474234/2012-6-Universal, 302534/2008-3, 403979/2012-9-DECIT]	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro/FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Brazilian Research Council?CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported in part by grants from Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro/FAPERJ (Grants # APQ1-E-26/111.756/2008 and CNE/E-26/101.549/2010, E-26/110.153/2013, E-26/111.709/2013) and the Brazilian Research Council?CNPq (Grants #474234/2012-6-Universal and #302534/2008-3; National Institute for Science and Technology for Vaccines - INCTV?CNPq; #403979/2012-9-DECIT). J. Lannes-Vieira and R.T. Gazzinelli are research fellows of the CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov AY, 2004, J NEUROSCI, V24, P565, DOI 10.1523/JNEUROSCI.4042-03.2004; Aebischer J, 2011, CELL DEATH DIFFER, V18, P754, DOI 10.1038/cdd.2010.143; Aliberti JCS, 1999, INFECT IMMUN, V67, P4819, DOI 10.1128/IAI.67.9.4819-4826.1999; Aliberti JCS, 2001, AM J PATHOL, V158, P1433, DOI 10.1016/S0002-9440(10)64094-1; Antunes ACM, 2002, ARQ NEURO-PSIQUIAT, V60, P730, DOI 10.1590/S0004-282X2002000500009; Arankowsky-Sandoval G, 2001, NEUROSCI LETT, V306, P65, DOI 10.1016/S0304-3940(01)01866-3; Berenson LS, 2004, IMMUNOL REV, V202, P157, DOI 10.1111/j.0105-2896.2004.00208.x; Bombeiro AL, 2010, NEUROIMMUNOMODULAT, V17, P67, DOI 10.1159/000258689; Vargas-Zambrano JC, 2013, MEM I OSWALDO CRUZ, V108, P212, DOI 10.1590/0074-0276108022013014; Carroll-Anzinger D, 2006, J VIROL, V80, P541, DOI 10.1128/JVI.80.1.541-544.2006; Ceravolo IP, 1999, INFECT IMMUN, V67, P2233; Cole C, 2012, IMMUNITY, V36, P807, DOI 10.1016/j.immuni.2012.03.011; Croitoru-Lamoury J, 2003, GLIA, V41, P354, DOI 10.1002/glia.10181; Da Mata JR, 2000, BRAIN RES BULL, V53, P153, DOI 10.1016/S0361-9230(00)00326-9; Diniz LP, 2014, GLIA, V62, P1917, DOI 10.1002/glia.22713; Dong YS, 2001, GLIA, V36, P180, DOI 10.1002/glia.1107; dos Santos PVA, 2001, MICROBES INFECT, V3, P971, DOI 10.1016/S1286-4579(01)01461-7; Drechsel DA, 2012, NEUROTOX RES, V22, P251, DOI 10.1007/s12640-012-9322-y; ENG LF, 1985, J NEUROIMMUNOL, V8, P203, DOI 10.1016/S0165-5728(85)80063-1; Eugenin EA, 2006, J NEUROSCI, V26, P1098, DOI 10.1523/JNEUROSCI.3863-05.2006; Falsig J, 2006, J NEUROCHEM, V96, P893, DOI 10.1111/j.1471-4159.2005.03622.x; Fichera LE, 2004, INFECT IMMUN, V72, P359, DOI 10.1128/IAI.72.1.359-363.2004; FIERZ W, 1985, J IMMUNOL, V134, P3785; Freeman MR, 2010, SCIENCE, V330, P774, DOI 10.1126/science.1190928; Fu YY, 2014, CELL MOL NEUROBIOL, V34, P651, DOI 10.1007/s10571-014-0039-8; GAZZINELLI RT, 1992, EUR J IMMUNOL, V22, P2501, DOI 10.1002/eji.1830221006; Gimsa U, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/320519; GREEN LC, 1981, SCIENCE, V212, P56, DOI 10.1126/science.6451927; He F, 2007, INT J BIOCHEM CELL B, V39, P661, DOI 10.1016/j.biocel.2006.10.022; HIRSCH MR, 1983, NEUROSCI LETT, V41, P199, DOI 10.1016/0304-3940(83)90247-1; Hua LWL, 2002, J NEUROCHEM, V83, P1120, DOI 10.1046/j.1471-4159.2002.01226.x; Jensen CJ, 2013, J NEUROIMMUNE PHARM, V8, P824, DOI 10.1007/s11481-013-9480-6; Jorg ME, 1981, MEM I O CRUZ, V67, P353; Kawanokuchi J, 2006, MULT SCLER J, V12, P558, DOI 10.1177/1352458506070763; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kim JH, 2010, J NEUROCHEM, V115, P1161, DOI 10.1111/j.1471-4159.2010.07004.x; Koehler RC, 2006, J APPL PHYSIOL, V100, P307, DOI 10.1152/japplphysiol.00938.2005; Koppula S, 2012, INT J MOL SCI, V13, P10608, DOI 10.3390/ijms130810608; Lannes-Vieira J, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000645; Laureys G, 2014, J NEUROINFLAMM, V11, P1, DOI [10.1186/1687-9856-2014-11, DOI 10.1186/1687-9856-2014-11]; LEE SC, 1993, J NEUROIMMUNOL, V46, P19, DOI 10.1016/0165-5728(93)90229-R; Li W, 2011, J IMMUNOL, V186, P6771, DOI 10.4049/jimmunol.1100099; LIEBERMAN AP, 1989, P NATL ACAD SCI USA, V86, P6348, DOI 10.1073/pnas.86.16.6348; Machado FS, 2000, CIRCULATION, V102, P3003, DOI 10.1161/01.CIR.102.24.3003; Meeuwsen S, 2003, GLIA, V43, P243, DOI 10.1002/glia.10259; Michailowsky V, 2001, AM J PATHOL, V159, P1723, DOI 10.1016/S0002-9440(10)63019-2; MING M, 1995, CELL, V82, P287, DOI 10.1016/0092-8674(95)90316-X; Moncada GB, 1987, ARCH VENEZ PUERIC PE, V50, P106, DOI 10.1016/j.jad.2014.08.011; Otsmane B, 2014, NEUROREPORT, V25, P49, DOI 10.1097/WNR.0000000000000043; Paiva CN, 2012, J CLIN INVEST, V122, P2531, DOI 10.1172/JCI58525; Paiva CN, 2009, J LEUKOCYTE BIOL, V86, P1239, DOI 10.1189/jlb.0309187; Pereira IR, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/798078; Perez AR, 2011, J NEUROIMMUNOL, V235, P84, DOI 10.1016/j.jneuroim.2011.03.010; Pinto AMT, 2011, CELL MICROBIOL, V13, P1518, DOI 10.1111/j.1462-5822.2011.01636.x; PLATA F, 1984, EUR J IMMUNOL, V14, P930, DOI 10.1002/eji.1830141013; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; ROCHA A, 1994, AM J TROP MED HYG, V50, P261, DOI 10.4269/ajtmh.1994.50.261; Roffe E, 2003, J NEUROIMMUNOL, V142, P17, DOI 10.1016/S0165-5728(03)00254-6; Rosenblat JD, 2014, PROG NEURO-PSYCHOPH, V53, P23, DOI 10.1016/j.pnpbp.2014.01.013; Rossi D, 2009, BRAIN RES BULL, V80, P224, DOI 10.1016/j.brainresbull.2009.07.012; Rozenfeld C, 2003, INFECT IMMUN, V71, P2047, DOI 10.1128/IAI.71.4.2047-2057.2003; Seth P, 2008, J BIOSCIENCES, V33, P405, DOI 10.1007/s12038-008-0060-5; Silva AA, 1999, CLIN IMMUNOL, V92, P56, DOI 10.1006/clim.1999.4716; Silva AA, 2010, J NEUROPARASITOL, V1, P1, DOI DOI 10.4303/JNP/N100901; Silverio JC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002645; Tarassishin L, 2014, GLIA, V62, P999, DOI 10.1002/glia.22657; Teixeira MM, 2002, TRENDS PARASITOL, V18, P262, DOI 10.1016/S1471-4922(02)02283-3; VESPA GNR, 1994, INFECT IMMUN, V62, P5177, DOI 10.1128/IAI.62.11.5177-5182.1994; Vilar-Pereira G, 2012, BRAIN BEHAV IMMUN, V26, P1136, DOI 10.1016/j.bbi.2012.07.009; Villela E., 1926, MEM I O CRUZ, V19, P199; Wang XS, 2007, J INTERF CYTOK RES, V27, P599, DOI 10.1089/jir.2006.0157; Zingales B, 2012, INFECT GENET EVOL, V12, P240, DOI 10.1016/j.meegid.2011.12.009	72	33	34	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0118600	10.1371/journal.pone.0118600	http://dx.doi.org/10.1371/journal.pone.0118600			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695249	Green Published, Green Submitted, gold			2022-12-26	WOS:000350062300057
J	Greenberg, JA; Santos, MJ; Dobrowski, SZ; Vanderbilt, VC; Ustin, SL				Greenberg, Jonathan A.; Santos, Maria J.; Dobrowski, Solomon Z.; Vanderbilt, Vern C.; Ustin, Susan L.			Quantifying Environmental Limiting Factors on Tree Cover Using Geospatial Data	PLOS ONE			English	Article							SPECIES DISTRIBUTIONS; CLIMATE-CHANGE; REGRESSION; ECOSYSTEMS; ABUNDANCE; DENSITY	Environmental limiting factors (ELFs) are the thresholds that determine the maximum or minimum biological response for a given suite of environmental conditions. We asked the following questions: 1) Can we detect ELFs on percent tree cover across the eastern slopes of the Lake Tahoe Basin, NV? 2) How are the ELFs distributed spatially? 3) To what extent are unmeasured environmental factors limiting tree cover? ELFs are difficult to quantify as they require significant sample sizes. We addressed this by using geospatial data over a relatively large spatial extent, where the wall-to-wall sampling ensures the inclusion of rare data points which define the minimum or maximum response to environmental factors. We tested mean temperature, minimum temperature, potential evapotranspiration (PET) and PET minus precipitation (PET-P) as potential limiting factors on percent tree cover. We found that the study area showed system-wide limitations on tree cover, and each of the factors showed evidence of being limiting on tree cover. However, only 1.2% of the total area appeared to be limited by the four (4) environmental factors, suggesting other unmeasured factors are limiting much of the tree cover in the study area. Where sites were near their theoretical maximum, non-forest sites (tree cover <25%) were primarily limited by coldmean temperatures, open-canopy forest sites (tree cover between 25% and 60%) were primarily limited by evaporative demand, and closed-canopy forests were not limited by any particular environmental factor. The detection of ELFs is necessary in order to fully understand the width of limitations that species experience within their geographic range.	[Greenberg, Jonathan A.] Univ Illinois, Dept Geog & Geog Informat Sci, Champaign, IL 61820 USA; [Santos, Maria J.] Univ Utrecht, Dept Innovat Environm & Energy Sci, Utrecht, Netherlands; [Dobrowski, Solomon Z.] Univ Montana, Coll Forestry & Conservat, Dept Forest Management, Missoula, MT 59812 USA; [Vanderbilt, Vern C.] NASA, Ames Res Ctr, Mountain View, CA USA; [Ustin, Susan L.] Univ Calif Davis, CSTARS, Dept Land Air & Water Resources, Davis, CA 95616 USA	University of Illinois System; University of Illinois Urbana-Champaign; Utrecht University; University of Montana System; University of Montana; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of California System; University of California Davis	Greenberg, JA (corresponding author), Univ Illinois, Dept Geog & Geog Informat Sci, Champaign, IL 61820 USA.	jgm@illinois.edu	Dobrowski, Solomon Z/Q-7132-2019; Santos, Maria Joao/M-5034-2013	Dobrowski, Solomon Z/0000-0003-2561-3850; Greenberg, Jonathan/0000-0001-8435-9077; Santos, Maria Joao/0000-0002-6558-7477; Ustin, Susan/0000-0001-8551-0461				Allen R. G., 1998, FAO Irrigation and Drainage Paper; Belyea LR, 2007, HYDROL PROCESS, V21, P675, DOI 10.1002/hyp.6275; Bond WJ, 2005, NEW PHYTOL, V165, P525, DOI 10.1111/j.1469-8137.2004.01252.x; Cade BS, 2003, FRONT ECOL ENVIRON, V1, P412, DOI 10.1890/1540-9295(2003)001[0412:AGITQR]2.0.CO;2; Cade BS, 1999, ECOLOGY, V80, P311, DOI 10.1890/0012-9658(1999)080[0311:EEOLFW]2.0.CO;2; Cade BS, 2000, OIKOS, V91, P245, DOI 10.1034/j.1600-0706.2000.910205.x; Cadenasso ML, 2003, BIOSCIENCE, V53, P717, DOI 10.1641/0006-3568(2003)053[0717:AIASAT]2.0.CO;2; Cramer W, 2001, GLOBAL CHANGE BIOL, V7, P357, DOI 10.1046/j.1365-2486.2001.00383.x; Dobrowski SZ, 2009, AGR FOREST METEOROL, V149, P1751, DOI 10.1016/j.agrformet.2009.06.006; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Forthofer J. M., 2007, THESIS; GESSLER PE, 1995, INT J GEOGR INF SYST, V9, P421, DOI 10.1080/02693799508902047; Greenberg JA, 2009, REMOTE SENS ENVIRON, V113, P94, DOI 10.1016/j.rse.2008.08.014; Hansen MC, 2002, REMOTE SENS ENVIRON, V83, P303, DOI 10.1016/S0034-4257(02)00079-2; Heinsch FA, 2003, USERS GUIDE GPP NPP, V2, P666; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Husch B., 2002, FOREST MENSURATION; Kearney M, 2004, ECOLOGY, V85, P3119, DOI 10.1890/03-0820; Knyazikhin Y., 1999, MODIS ATBD; Koenker R, 2001, J ECON PERSPECT, V15, P143, DOI 10.1038/s41592-019-0406-y; Korner C, 1998, OECOLOGIA, V115, P445, DOI 10.1007/s004420050540; Lancaster J, 2006, FRESHWATER BIOL, V51, P783, DOI 10.1111/j.1365-2427.2006.01518.x; Littell JS, 2008, ECOL MONOGR, V78, P349, DOI 10.1890/07-0712.1; Lutz JA, 2010, J BIOGEOGR, V37, P936, DOI 10.1111/j.1365-2699.2009.02268.x; MALLER RA, 1990, J CONSEIL, V46, P140; McKenzie D, 2003, J BIOGEOGR, V30, P1093, DOI 10.1046/j.1365-2699.2003.00921.x; Rehfeldt GE, 2006, INT J PLANT SCI, V167, P1123, DOI 10.1086/507711; Sankaran M, 2005, NATURE, V438, P846, DOI 10.1038/nature04070; Sprengel C., 1828, J TECNISCHE OKONOMIS, V2, P423; Taylor AH, 2004, ECOL APPL, V14, P1903, DOI 10.1890/02-5257; Urban DL, 2000, LANDSCAPE ECOL, V15, P603, DOI 10.1023/A:1008183331604; Vaz S, 2008, J APPL ECOL, V45, P204, DOI 10.1111/j.1365-2664.2007.01392.x; Vegetation Subcommittee Federal Geographic Data Committee, 1997, FGDCSTD005 US GEOL S; Vetaas OR, 2002, J BIOGEOGR, V29, P545, DOI 10.1046/j.1365-2699.2002.00694.x; Zeng ZZ, 2013, SCI REP-UK, V3, DOI 10.1038/srep01951	35	9	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0114648	10.1371/journal.pone.0114648	http://dx.doi.org/10.1371/journal.pone.0114648			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692604	Green Published, gold			2022-12-26	WOS:000350061500006
J	Kim, CT; Lim, YH; Woodward, A; Kim, H				Kim, Clara T.; Lim, Youn-Hee; Woodward, Alistair; Kim, Ho			Heat-Attributable Deaths between 1992 and 2009 in Seoul, South Korea	PLOS ONE			English	Article							CAUSE-SPECIFIC MORTALITY; AMBIENT-TEMPERATURE; CLIMATE-CHANGE; AIR-POLLUTION; UNITED-STATES; HEALTH; WAVES; ASSOCIATIONS; WEATHER; DISEASE	Background Climate change may significantly affect human health. The possible effects of high ambient temperature must be better understood, particularly in terms of certain diseases' sensitivity to heat (as reflected in relative risks [RR]) and the consequent disease burden (number or fraction of cases attributable to high temperatures), in order to manage the threat. Purpose This study investigated the number of deaths attributable to abnormally high ambient temperatures in Seoul, South Korea, for a wide range of diseases. Method The relationship between mortality and daily maximum temperature using a generalized linear model was analyzed. The threshold temperature was defined as the 90th percentile of maximum daily temperatures. Deaths were classified according to ICD-10 codes, and for each disease, the RR and attributable fractions were determined. Using these fractions, the total number of deaths attributable to daily maximum temperatures above the threshold value, from 1992 to 2009, was calculated. Data analyses were conducted in 2012-2013. Results Heat-attributable deaths accounted for 3,177 of the 271,633 deaths from all causes. Neurological (RR 1.07; 95% CI, 1.04-1.11) and mental and behavioral disorders (RR 1.04; 95% CI, 1.01-1.07) had relatively high increases in the RR of mortality. The most heat-sensitive diseases (those with the highest RRs) were not the diseases that caused the largest number of deaths attributable to high temperatures. Conclusion This study estimated RRs and deaths attributable to high ambient temperature for a wide variety of diseases. Prevention-related policies must account for both particular vulnerabilities (heat-sensitive diseases with high RRs) and the major causes of the heat mortality burden (common conditions less sensitive to high temperatures).	[Kim, Clara T.; Kim, Ho] Seoul Natl Univ, Sch Publ Hlth, Seoul, South Korea; [Kim, Clara T.; Kim, Ho] Seoul Natl Univ, Inst Hlth & Environm, Seoul, South Korea; [Lim, Youn-Hee] Seoul Natl Univ, Med Res Ctr, Inst Environm Med, Seoul, South Korea; [Lim, Youn-Hee] Seoul Natl Univ, Coll Med, Ctr Environm Hlth, Seoul, South Korea; [Woodward, Alistair] Univ Auckland, Sch Populat Hlth, Auckland 1, New Zealand	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); University of Auckland	Kim, H (corresponding author), Seoul Natl Univ, Sch Publ Hlth, Seoul, South Korea.	hokim@snu.ac.kr	Kim, Ho/AAS-2402-2021	Kim, Ho/0000-0001-7472-3752; Lim, Youn-Hee/0000-0002-1290-5814; Kim, Clara Tammy/0000-0001-7381-7044; Woodward, Alistair/0000-0001-5425-6018	Basic Science Research Program [2010-0009581]; Global Research Lab [K21004000001-10A0500-00710]; Women Scientist Research Program [2012R1A1A3005549]; International Research & Development Program through the National Research Foundation of Korea - Ministry of Education, Science, and Technology [2012K1A3A1A12054839]	Basic Science Research Program; Global Research Lab; Women Scientist Research Program; International Research & Development Program through the National Research Foundation of Korea - Ministry of Education, Science, and Technology	This work was supported by the Basic Science Research Program (#2010-0009581), Global Research Lab (#K21004000001-10A0500-00710), Women Scientist Research Program (#2012R1A1A3005549) and International Research & Development Program (#2012K1A3A1A12054839) through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BG, 2009, EPIDEMIOLOGY, V20, P205, DOI 10.1097/EDE.0b013e318190ee08; Armstrong BG, 2011, J EPIDEMIOL COMMUN H, V65, P340, DOI 10.1136/jech.2009.093161; Armstrong B, 2006, EPIDEMIOLOGY, V17, P624, DOI 10.1097/01.ede.0000239732.50999.8f; Baccini M, 2008, EPIDEMIOLOGY, V19, P711, DOI 10.1097/EDE.0b013e318176bfcd; Basagana X, 2011, EPIDEMIOLOGY, V22, P765, DOI 10.1097/EDE.0b013e31823031c5; Basu R, 2005, EPIDEMIOLOGY, V16, P58, DOI 10.1097/01.ede.0000147117.88386.fe; Basu R, 2002, EPIDEMIOL REV, V24, P190, DOI 10.1093/epirev/mxf007; Basu R, 2008, AM J EPIDEMIOL, V168, P632, DOI 10.1093/aje/kwn170; Basu R, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-40; Bouchama A, 2002, NEW ENGL J MED, V346, P1978, DOI 10.1056/NEJMra011089; Bouchama A, 2007, ARCH INTERN MED, V167, P2170, DOI 10.1001/archinte.167.20.ira70009; Braga ALF, 2002, ENVIRON HEALTH PERSP, V110, P859, DOI 10.1289/ehp.02110859; Campbell-Lendrum D, 2006, ENVIRON HEALTH PERSP, V114, P1935, DOI 10.1289/ehp.8432; Chung JY, 2009, SCI TOTAL ENVIRON, V408, P390, DOI 10.1016/j.scitotenv.2009.09.009; Curriero FC, 2002, AM J EPIDEMIOL, V155, P80, DOI 10.1093/aje/155.1.80; Ding YH, 2005, METEOROL ATMOS PHYS, V89, P117, DOI 10.1007/s00703-005-0125-z; Dominici F, 2003, INT STAT REV, V71, P243; Gasparrini A, 2012, OCCUP ENVIRON MED, V69, P56, DOI 10.1136/oem.2010.059782; Gosling SN, 2009, CLIMATIC CHANGE, V92, P299, DOI [10.1007/s10584-008-9441-x, 10.1007/S10584-008-9441-X]; Hajat S, 2005, EPIDEMIOLOGY, V16, P613, DOI 10.1097/01.ede.0000164559.41092.2a; Hajat S, 2006, EPIDEMIOLOGY, V17, P632, DOI 10.1097/01.ede.0000239688.70829.63; Hajat S, 2010, LANCET, V375, P856, DOI 10.1016/S0140-6736(09)61711-6; Hansen A, 2008, ENVIRON HEALTH PERSP, V116, P1369, DOI 10.1289/ehp.11339; Hansen AL, 2008, INT J EPIDEMIOL, V37, P1359, DOI 10.1093/ije/dyn165; Honda Yasushi, 2007, Environmental Health and Preventive Medicine, V12, P209, DOI 10.1265/ehpm.12.209; Hung T, 2006, INT J APPL EARTH OBS, V8, P34, DOI 10.1016/j.jag.2005.05.003; Kilbourne EM, 1999, AM J PREV MED, V16, P359; Koppe C., 2004, HEAT WAVES RISKS RES; Kovats RS, 2006, EUR J PUBLIC HEALTH, V16, P592, DOI 10.1093/eurpub/ckl049; Kovats RS, 2005, RISK ANAL, V25, P1409, DOI 10.1111/j.1539-6924.2005.00688.x; LAU KM, 1984, B AM METEOROL SOC, V65, P114, DOI 10.1175/1520-0477(1984)065<0114:TMOEAA>2.0.CO;2; Leon LR, 2010, J APPL PHYSIOL, V109, P1980, DOI 10.1152/japplphysiol.00301.2010; Lerman PM., 1980, APPL STATIST, V29, P77, DOI [DOI 10.2307/2346413, 10.2307/2346413]; LEVIN M L, 1953, Acta Unio Int Contra Cancrum, V9, P531; Luber G, 2008, AM J PREV MED, V35, P429, DOI 10.1016/j.amepre.2008.08.021; MacCullagh P., 1989, GEN LINEAR MODELS; Mathers C, 2009, GLOB HLTH RISKS MORT; McMichael A., 2004, COMP QUANTIFICATION, V2, P1543; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Muggeo VMR, 2003, STAT MED, V22, P3055, DOI 10.1002/sim.1545; O'Neill MS, 2003, AM J EPIDEMIOL, V157, P1074, DOI 10.1093/aje/kwg096; Parry M. L., 2007, CLIMATE CHANGE 2007; Pascal M, 2013, INT J BIOMETEOROL, V57, P21, DOI 10.1007/s00484-012-0530-1; Pattenden S, 2003, J EPIDEMIOL COMMUN H, V57, P628, DOI 10.1136/jech.57.8.628; Peng RD, 2006, J R STAT SOC A STAT, V169, P179, DOI 10.1111/j.1467-985X.2006.00410.x; Rey G, 2007, INT ARCH OCC ENV HEA, V80, P615, DOI 10.1007/s00420-007-0173-4; Semenza JC, 1996, NEW ENGL J MED, V335, P84, DOI 10.1056/NEJM199607113350203; Semenza JC, 1999, AM J PREV MED, V17, P97; Stafoggia M, 2006, EPIDEMIOLOGY, V17, P315, DOI 10.1097/01.ede.0000208477.36665.34; Stollberger C, 2009, EUR J NEUROL, V16, P879, DOI 10.1111/j.1468-1331.2009.02581.x; Turner LR, 2012, EPIDEMIOLOGY, V23, P594, DOI 10.1097/EDE.0b013e3182572795; ULM K, 1991, STAT MED, V10, P341, DOI 10.1002/sim.4780100306; WALTER SD, 1976, BIOMETRICS, V32, P829, DOI 10.2307/2529268; Yaqub B, 1998, J NEUROL SCI, V156, P144, DOI 10.1016/S0022-510X(98)00037-9; Yoon S.J., 2010, KOREAN CLIMATE CHANG; Zanobetti A, 2008, EPIDEMIOLOGY, V19, P563, DOI 10.1097/EDE.0b013e31816d652d	56	22	22	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118577	10.1371/journal.pone.0118577	http://dx.doi.org/10.1371/journal.pone.0118577			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692296	gold, Green Published, Green Submitted			2022-12-26	WOS:000350061500124
J	Rostro-Garcia, S; Kamler, JF; Hunter, LTB				Rostro-Garcia, Susana; Kamler, Jan F.; Hunter, Luke T. B.			To Kill, Stay or Flee: The Effects of Lions and Landscape Factors on Habitat and Kill Site Selection of Cheetahs in South Africa	PLOS ONE			English	Article							BLACK-BACKED JACKALS; KRUGER-NATIONAL-PARK; ACINONYX-JUBATUS; RESOURCE SELECTION; PREDATOR AVOIDANCE; FEEDING ECOLOGY; HOME-RANGE; COMPETITION; CARNIVORES; SAVANNA	Understanding how animals utilize available space is important for their conservation, as it provides insight into the ecological needs of the species, including those related to habitat, prey and inter and intraspecific interactions. We used 28 months of radio telemetry data and information from 200 kill locations to assess habitat selection at the 3rd order (selection of habitats within home ranges) and 4th order (selection of kill sites within the habitats used) of a reintroduced population of cheetahs Acinonyx jubatus in Phinda Private Game Reserve, South Africa. Along with landscape characteristics, we investigated if lion Panthera leo presence affected habitat selection of cheetahs. Our results indicated that cheetah habitat selection was driven by a trade-off between resource acquisition and lion avoidance, and the balance of this trade-off varied with scale: more open habitats with high prey densities were positively selected within home ranges, whereas more closed habitats with low prey densities were positively selected for kill sites. We also showed that habitat selection, feeding ecology, and avoidance of lions differed depending on the sex and reproductive status of cheetahs. The results highlight the importance of scale when investigating a species' habitat selection. We conclude that the adaptability of cheetahs, together with the habitat heterogeneity found within Phinda, explained their success in this small fenced reserve. The results provide information for the conservation and management of this threatened species, especially with regards to reintroduction efforts in South Africa.	[Rostro-Garcia, Susana; Kamler, Jan F.] Univ Oxford, Recanati Kaplan Ctr, Dept Zool, Wildlife Conservat Res Unit, Abingdon, Oxon, England; [Hunter, Luke T. B.] Panthera, New York, NY 10018 USA	University of Oxford	Hunter, LTB (corresponding author), Panthera, 8 West 40th St,18th Floor, New York, NY 10018 USA.	lhunter@panthera.org	Kamler, Jan F/F-8520-2011; Hunter, Luke T.B./H-3324-2019	Hunter, Luke T.B./0000-0001-9653-6544	IUCN Cat Specialist Group; Pittsburgh Zoo Conservation Fund University of Pretoria; Foundation for Research Development; W.H. Craib Memorial Trust	IUCN Cat Specialist Group; Pittsburgh Zoo Conservation Fund University of Pretoria; Foundation for Research Development; W.H. Craib Memorial Trust	Funding was provided by the IUCN Cat Specialist Group, Pittsburgh Zoo Conservation Fund University of Pretoria, Foundation for Research Development and W.H. Craib Memorial Trust. Conservation Corporation Africa (CCA) provided in-kind support in the form of room, board and fuel for the research vehicle. Funding per se was not received from CCA for the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awaida J, 2013, GRASS GIS MANUAL R C; Balme GA, 2010, ANIM CONSERV, V13, P315, DOI 10.1111/j.1469-1795.2009.00342.x; Balme G, 2007, ANIM BEHAV, V74, P589, DOI 10.1016/j.anbehav.2006.12.014; Barton K, 2020, MUMIN MULTIMODEL INF; Bates DM, 2006, LINEAR MIXED EFFECTS; Berger KM, 2007, J ANIM ECOL, V76, P1075, DOI 10.1111/j.1365-2656.2007.01287.x; Bissett C, 2007, J ZOOL, V271, P310, DOI 10.1111/j.1469-7998.2006.00217.x; Borger L, 2006, J ANIM ECOL, V75, P1393, DOI 10.1111/j.1365-2656.2006.01164.x; Boyce MS, 1999, TRENDS ECOL EVOL, V14, P268, DOI 10.1016/S0169-5347(99)01593-1; Broekhuis F, 2012, THESIS U OXFORD; Broekhuis F, 2013, J ANIM ECOL, V82, P1097, DOI 10.1111/1365-2656.12077; Broomhall LS, 2003, J ZOOL, V261, P119, DOI 10.1017/S0952836903004059; Caro T., 1994, CHEETAHS SERENGETI P; Caro TM, 2003, BIOL CONSERV, V110, P67, DOI 10.1016/S0006-3207(02)00177-5; Ciarniello LM, 2007, ECOL APPL, V17, P1424, DOI 10.1890/06-1100.1; Cozzi G, 2013, J ANIM ECOL, V82, P707, DOI 10.1111/1365-2656.12039; Creel S, 2005, ECOLOGY, V86, P3387, DOI 10.1890/05-0032; Davidson Z, 2012, J MAMMAL, V93, P677, DOI 10.1644/10-MAMM-A-424.1; Di Minin E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071788; Durant S.M., 1998, CAT NEWS, V28, P14; Durant SM, 2000, ANIM BEHAV, V60, P121, DOI 10.1006/anbe.2000.1433; Durant SM, 1998, J ANIM ECOL, V67, P370, DOI 10.1046/j.1365-2656.1998.00202.x; FULLER TK, 1990, AFR J ECOL, V28, P330, DOI 10.1111/j.1365-2028.1990.tb01168.x; Gillies CS, 2006, J ANIM ECOL, V75, P887, DOI 10.1111/j.1365-2656.2006.01106.x; GRASS Development Team, 2012, GEOGRAPHIC RESOURCES; Gros PM, 1999, BIODIVERS CONSERV, V8, P1561, DOI 10.1023/A:1008950114827; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; Hayward MW, 2009, S AFR J WILDL RES, V39, P109, DOI 10.3957/056.039.0207; Hopcraft JGC, 2005, J ANIM ECOL, V74, P559, DOI 10.1111/j.1365-2656.2005.00955.x; Houser AM, 2009, J ZOOL, V278, P108, DOI 10.1111/j.1469-7998.2009.00554.x; Hunter JS, 2007, AFR J ECOL, V45, P275, DOI 10.1111/j.1365-2028.2006.00702.x; Hunter JS, 2007, BEHAV ECOL SOCIOBIOL, V61, P1033, DOI 10.1007/s00265-006-0336-4; Hunter LTB, 2007, ORYX, V41, P196, DOI 10.1017/S003060530700172X; Hunter LTB, 1998, THESIS PRETORIA U PR; JACOBS J, 1974, OECOLOGIA, V14, P413, DOI 10.1007/BF00384581; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Kamler JF, 2013, J MAMMAL, V94, P295, DOI 10.1644/12-MAMM-A-122.1; Klare U, 2010, J WILDLIFE MANAGE, V74, P1030, DOI 10.2193/2009-211; Koper Nicola, 2012, Rangifer, V32, P195; Landguth EL, 2012, ECOGRAPHY, V35, P9, DOI 10.1111/j.1600-0587.2011.07149.x; LAURENSON MK, 1994, J ZOOL, V234, P387, DOI 10.1111/j.1469-7998.1994.tb04855.x; Lindsey P, 2011, ORYX, V45, P587, DOI 10.1017/S003060531000150X; Linnell John D. C., 2000, Diversity and Distributions, V6, P169, DOI 10.1046/j.1472-4642.2000.00069.x; Low A.R., 1996, VEGETATION S AFRICA; Manly B.F.J., 2002, RESOURCE SELECTION A; Marker L, 2002, THESIS U OXFORD; Mills MGL, 2004, WILDLIFE BIOL, V10, P177, DOI 10.2981/wlb.2004.024; Muntifering JR, 2006, ANIM CONSERV, V9, P103, DOI 10.1111/j.1469-1795.2005.00008.x; Oliveira T, 2013, J MAMMAL EVOL; Palomares F, 1999, AM NAT, V153, P492, DOI 10.1086/303189; Palomares F, 2001, WILDLIFE MONOGR, P1; Pettorelli N, 2009, J ZOOL, V277, P141, DOI 10.1111/j.1469-7998.2008.00522.x; Purchase GK, 2000, S AFR J WILDL RES, V30, P139; QGIS Development Team, 2018, QGIS GEOGR INF SYST; R Core Team, 2021, R LANGUAGE ENV STAT; Redfern JV, 2003, ECOLOGY, V84, P2092, DOI 10.1890/01-0625; SCHALLER G B, 1972, P480; Schulze BR., 1965, CLIMATE S AFRICA 8; Switzer TS, 2004, J SEA RES, V51, P229, DOI 10.1016/j.seares.2003.10.001; Thaker M, 2011, ECOLOGY, V92, P398, DOI 10.1890/10-0126.1; Thompson CM, 2002, LANDSCAPE ECOL, V17, P569, DOI 10.1023/A:1021501231182; Valeix M, 2009, ECOLOGY, V90, P23, DOI 10.1890/08-0606.1; van der Meer E, 2013, MAMM BIOL, V78, P336, DOI 10.1016/j.mambio.2013.04.006; van Dyk G, 2003, AFR ZOOL, V38, P79; Vanak AT, 2013, ECOLOGY, V94, P2619, DOI 10.1890/13-0217.1; Wasserman T., 2012, USDA FOREST SERVICE; Whittingham MJ, 2004, IBIS, V146, P210, DOI 10.1111/j.1474-919X.2004.00370.x; Yurewicz KL, 2004, COPEIA, P28, DOI 10.1643/0045-8511(2004)004[0028:RAACOR]2.0.CO;2	68	46	46	1	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117743	10.1371/journal.pone.0117743	http://dx.doi.org/10.1371/journal.pone.0117743			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693067	gold, Green Submitted, Green Published			2022-12-26	WOS:000350061500071
J	Takamiya, M; Weger, BD; Schindler, S; Beil, T; Yang, LX; Armant, O; Ferg, M; Schlunck, G; Reinhard, T; Dickmeis, T; Rastegar, S; Strahle, U				Takamiya, Masanari; Weger, Benjamin D.; Schindler, Simone; Beil, Tanja; Yang, Lixin; Armant, Olivier; Ferg, Marco; Schlunck, Guenther; Reinhard, Thomas; Dickmeis, Thomas; Rastegar, Sepand; Straehle, Uwe			Molecular Description of Eye Defects in the Zebrafish Pax6b Mutant, sunrise, Reveals a Pax6b-Dependent Genetic Network in the Developing Anterior Chamber	PLOS ONE			English	Article							SCALE DEVELOPMENT; PHOTORECEPTOR DEGENERATION; MOUSE MODEL; EXPRESSION; MUTATIONS; CORNEA; LENS; SEGMENT; ONSET; DYSTROPHY	The cornea is a central component of the camera eye of vertebrates and even slight corneal disturbances severely affect vision. The transcription factor PAX6 is required for normal eye development, namely the proper separation of the lens from the developing cornea and the formation of the iris and anterior chamber. Human PAX6 mutations are associated with severe ocular disorders such as aniridia, Peters anomaly and chronic limbal stem cell insufficiency. To develop the zebrafish as a model for corneal disease, we first performed transcriptome and in situ expression analysis to identify marker genes to characterise the cornea in normal and pathological conditions. We show that, at 7 days post fertilisation (dpf), the zebrafish cornea expresses the majority of marker genes (67/84 tested genes) found also expressed in the cornea of juvenile and adult stages. We also characterised homozygous pax6b mutants. Mutant embryos have a thick cornea, iris hypoplasia, a shallow anterior chamber and a small lens. Ultrastructure analysis revealed a disrupted corneal endothelium. pax6b mutants show loss of corneal epithelial gene expression including regulatory genes (sox3, tfap2a, foxc1a and pitx2). In contrast, several genes (pitx2, ctnnb2, dcn and fabp7a) were ectopically expressed in the malformed corneal endothelium. Lack of pax6b function leads to severe disturbance of the corneal gene regulatory programme.	[Takamiya, Masanari; Weger, Benjamin D.; Schindler, Simone; Beil, Tanja; Yang, Lixin; Armant, Olivier; Ferg, Marco; Dickmeis, Thomas; Rastegar, Sepand; Straehle, Uwe] Karlsruhe Inst Technol, Inst Toxicol & Genet, D-76021 Karlsruhe, Germany; [Schlunck, Guenther; Reinhard, Thomas] Univ Freiburg, Med Ctr, Ctr Eye, D-79106 Freiburg, Germany	Helmholtz Association; Karlsruhe Institute of Technology; University of Freiburg	Strahle, U (corresponding author), Karlsruhe Inst Technol, Inst Toxicol & Genet, Postfach 3640, D-76021 Karlsruhe, Germany.	uwe.straehle@kit.edu	Straehle, Uwe/K-7054-2013; yang, lixin/AAW-5386-2021; Rastegar, Sepand/E-2324-2015; yang, lixin/GSO-1670-2022; Weger, Benjamin D/AAG-7551-2019; Dickmeis, Thomas/H-1355-2013	yang, lixin/0000-0003-3377-1998; Rastegar, Sepand/0000-0003-4411-5646; yang, lixin/0000-0003-3377-1998; Weger, Benjamin D/0000-0002-1831-3561; armant, olivier/0000-0001-7101-9209; Takamiya, Masanari/0000-0002-6524-5813; Schindler, Simone/0000-0003-1028-3115	Helmholtz Association; European commission integrating project ZF-MODELS "Zebrafish Models for Human Development and Disease" (6th Framework Programme) [LSHG-CT-2003-503496]; European commission EUTRACC "European Transcriptome Regulome & Cellular Commitment Consortium" [LSHG-CT-2006-037445]; European commission integrating project ZF-HEALTH "Zebrafish Regulomics for Human Health" (7th Framework Programme) [FP7-HEALTH-2009-2-STAGE]	Helmholtz Association(Helmholtz Association); European commission integrating project ZF-MODELS "Zebrafish Models for Human Development and Disease" (6th Framework Programme); European commission EUTRACC "European Transcriptome Regulome & Cellular Commitment Consortium"; European commission integrating project ZF-HEALTH "Zebrafish Regulomics for Human Health" (7th Framework Programme)	US was funded by the Helmholtz Association; the European commission integrating project ZF-MODELS "Zebrafish Models for Human Development and Disease" (6th Framework Programme), LSHG-CT-2003-503496; the European commission EUTRACC "European Transcriptome Regulome & Cellular Commitment Consortium" LSHG-CT-2006-037445; and the European commission integrating project ZF-HEALTH "Zebrafish Regulomics for Human Health" (7th Framework Programme), FP7-HEALTH-2009-2-STAGE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alward WLM, 1998, AM J OPHTHALMOL, V125, P98, DOI 10.1016/S0002-9394(99)80242-6; Armant O, 2013, DEV BIOL, V380, P351, DOI 10.1016/j.ydbio.2013.05.006; Asai-Coakwell M, 2013, HUM MOL GENET, V22, P1432, DOI 10.1093/hmg/dds560; Bischoff AMLC, 2007, AM J OPHTHALMOL, V143, P847, DOI 10.1016/j.ajo.2007.01.037; Bonanno JA, 2012, EXP EYE RES, V95, P2, DOI 10.1016/j.exer.2011.06.004; Bredrup C, 2005, INVEST OPHTH VIS SCI, V46, P420, DOI 10.1167/iovs.04-0804; Chatterjee S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063674; Clark R, 2013, MOL CELL PROTEOMICS, V12, P194, DOI 10.1074/mcp.M112.019745; Conrads TP, 2006, J BIOL CHEM, V281, P37836, DOI 10.1074/jbc.M604581200; Cooke J, 1997, TRENDS GENET, V13, P360, DOI 10.1016/S0168-9525(97)01233-X; Dai CY, 2012, MOL VIS, V18, P2947; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Devoto SH, 2006, EVOL DEV, V8, P101, DOI 10.1111/j.1525-142X.2006.05079.x; Diehn JJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r74; Gibson DJ, 2014, INVEST OPHTH VIS SCI, V55, P2062, DOI 10.1167/iovs.13-12735; Greiling TMS, 2009, DEV DYNAM, V238, P2254, DOI 10.1002/dvdy.21997; Gross JV, 2008, MOL REPROD DEV, V75, P547, DOI 10.1002/mrd.20831; Gu SM, 1997, NAT GENET, V17, P194, DOI 10.1038/ng1097-194; HANSON IM, 1994, NAT GENET, V6, P168, DOI 10.1038/ng0294-168; Heur M, 2013, EXP EYE RES, V106, P1, DOI 10.1016/j.exer.2012.10.009; Hitchcock PF, 2004, ZEBRAFISH, V1, P257, DOI 10.1089/zeb.2004.1.257; HOGAN BLM, 1988, DEVELOPMENT, V103, P115; Jia SJ, 2007, FASEB J, V21, P3318, DOI 10.1096/fj.07-8172com; JOHNS PR, 1977, J COMP NEUROL, V176, P343, DOI 10.1002/cne.901760304; JORDAN T, 1992, NAT GENET, V1, P328, DOI 10.1038/ng0892-328; Jurkunas UV, 2008, INVEST OPHTH VIS SCI, V49, P2946, DOI 10.1167/iovs.07-1405; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095037; Kleinjan DA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040029; Ledee DR, 2004, MOL VIS, V10, P663; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marlhens F, 1997, NAT GENET, V17, P139, DOI 10.1038/ng1097-139; Marlow F, 2002, CURR BIOL, V12, P876, DOI 10.1016/S0960-9822(02)00864-3; McCarthy DJ, 2009, BIOINFORMATICS, V25, P765, DOI 10.1093/bioinformatics/btp053; Nakamura H, 2005, INVEST OPHTH VIS SCI, V46, P4092, DOI 10.1167/iovs.05-0324; NISHIDA K, 1995, AM J OPHTHALMOL, V120, P368, DOI 10.1016/S0002-9394(14)72167-1; Nishimura DY, 1998, NAT GENET, V19, P140, DOI 10.1038/493; Nornes S, 1998, MECH DEVELOP, V77, P185, DOI 10.1016/S0925-4773(98)00156-7; Reneker LW, 2000, DEVELOPMENT, V127, P533; Rezende RA, 2004, CORNEA, V23, P565, DOI 10.1097/01.ico.0000126317.90271.d8; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Silla ZTV, 2014, EXP CELL RES, V322, P381, DOI 10.1016/j.yexcr.2014.01.016; Sire JY, 2004, INT J DEV BIOL, V48, P233, DOI 10.1387/ijdb.15272389; Sire JY, 1997, J ANAT, V190, P545, DOI 10.1046/j.1469-7580.1997.19040545.x; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Song YQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013743; Soules KA, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-12; Stearns G, 2007, J NEUROSCI, V27, P13866, DOI 10.1523/JNEUROSCI.3136-07.2007; Stewart HS, 1999, HUM MUTAT, V14, P126, DOI 10.1002/(SICI)1098-1004(1999)14:2<126::AID-HUMU4>3.0.CO;2-W; STRAHLE U, 1994, TRENDS GENET, V10, P75, DOI 10.1016/0168-9525(94)90221-6; Swamynathan SK, 2007, MOL CELL BIOL, V27, P182, DOI 10.1128/MCB.00846-06; Tang RY, 2007, ACTA BIOCH BIOPH SIN, V39, P384, DOI 10.1111/j.1745-7270.2007.00283.x; Thomas AG, 2014, DEV BIOL, V386, P291, DOI 10.1016/j.ydbio.2013.12.036; TON CCT, 1992, GENOMICS, V13, P251, DOI 10.1016/0888-7543(92)90239-O; Tzoulaki I, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-27; Wasfy MM, 2014, EXP EYE RES, V122, P65, DOI 10.1016/j.exer.2014.03.007; WATERMAN RE, 1970, ANAT REC, V168, P361, DOI 10.1002/ar.1091680304; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Zhai JJ, 2014, EXP THER MED, V7, P791, DOI 10.3892/etm.2014.1530; Zhao XPC, 2006, INVEST OPHTH VIS SCI, V47, P4341, DOI 10.1167/iovs.05-1611	63	22	23	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117645	10.1371/journal.pone.0117645	http://dx.doi.org/10.1371/journal.pone.0117645			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692557	Green Published, gold, Green Submitted			2022-12-26	WOS:000350061500066
J	Xu, KZ; Li, FC; Ma, L; Wang, BB; Zhang, H; Ni, M; Hong, FS; Shen, WD; Li, B				Xu, Kaizun; Li, Fanchi; Ma, Lie; Wang, Binbin; Zhang, Hua; Ni, Min; Hong, Fashui; Shen, Weide; Li, Bing			Mechanism of Enhanced Bombyx mori Nucleopolyhedrovirus-Resistance by Titanium Dioxide Nanoparticles in Silkworm	PLOS ONE			English	Article							NUCLEAR POLYHEDROSIS-VIRUS; NATURAL ORGANIC-MATTER; PROTEIN-KINASE B; MOLECULAR-MECHANISMS; GENE-EXPRESSION; ANATASE TIO2; GLAND DAMAGE; INFECTION; TOXICITY; ACTIVATION	The infection of Bombyx mori nucleopolyhedrovirus (BmNPV) in silkworms is often lethal. It is difficult to prevent, and its lethality is correlated with both viral particle characteristics and silkworm strains. Low doses of titanium dioxide nanoparticles (TiO2 NPs) can promote silkworm growth and improve its resistance to organophosphate pesticides. In this study, TiO2 NPs' effect on BmNPV resistance was investigated by analyzing the characteristics of BmNPV proliferation and transcriptional differences in silkworm midgut and the transcriptional changes of immunity related genes after feeding with TiO2 NPs. We found that low doses of TiO2 NPs improved the resistance of silkworm against BmNPV by 14.88-fold, with the mortalities of the experimental group and control group being 0.56% and 8.33% at 144 h, respectively. The proliferation of BmNPV in the midgut was significantly increased 72 h after infection in both experimental and control groups; the control group reached the peak at 120 h, while the experimental group took 24 more hours to reach the maximal value that was 12.63 times lower than the control, indicating that TiO2 NPs can inhibit BmNPV proliferation in the midgut. Consistently, the expression of the BmNPV-resistant gene Bmlipase-1 had the same increase pattern as the proliferation changes. Immune signaling pathway analysis revealed that TiO2 NPs inhibited the proliferation of silkworm BmNPV to reduce the activation levels of janus kinase/signal transducer and activator of transcription (JAK/STAT) and phosphatidylinositol 3-kinase (PI3K)-Akt signaling pathway, while promoting the expression of Bmakt to improve the immunity. Overall, our results demonstrate that TiO2 NPs increase silkworm resistance against BmNPV by inhibiting virus proliferation and improving immunity in silkworms.	[Xu, Kaizun; Li, Fanchi; Ma, Lie; Wang, Binbin; Zhang, Hua; Ni, Min; Hong, Fashui; Shen, Weide; Li, Bing] Soochow Univ, Sch Basic Med & Biol Sci, Suzhou 215123, Jiangsu, Peoples R China; [Shen, Weide; Li, Bing] Soochow Univ, Natl Engn Lab Modern Silk, Suzhou 215123, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China	Shen, WD (corresponding author), Soochow Univ, Sch Basic Med & Biol Sci, Suzhou 215123, Jiangsu, Peoples R China.	shenwd@suda.edu.cn; lib@suda.edu.cn	li, bing/GWQ-9617-2022		National High Technology Research and Development Program of China (863 Program) [2013AA102507]; State Key Laboratory of Silkworm Genome Biology; transformation project of agriculture scientific and technological achievements [2013GB2C100180]; Doctoral Fund of Ministry of Education of China [20113201110008]; China Agriculture Research System [CARS-22-ZJ0305]; Science & Technology support Program of Suzhou [ZXS2012005, SYN201406]; national cocoons silk development funds; Priority Academic Program Development of Jiangsu Higher Education Institutions	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); State Key Laboratory of Silkworm Genome Biology; transformation project of agriculture scientific and technological achievements; Doctoral Fund of Ministry of Education of China(Ministry of Education, China); China Agriculture Research System; Science & Technology support Program of Suzhou; national cocoons silk development funds; Priority Academic Program Development of Jiangsu Higher Education Institutions	The National High Technology Research and Development Program of China (863 Program) (Grant No. 2013AA102507) and the State Key Laboratory of Silkworm Genome Biology supported the reagents and version cost, the transformation project of agriculture scientific and technological achievements (2013GB2C100180), the projects sponsored by the national cocoons silk development funds in 2014 and the Priority Academic Program Development of Jiangsu Higher Education Institutions supported materials (silkworm and BmNPV), the Doctoral Fund of Ministry of Education of China (20113201110008), the China Agriculture Research System (CARS-22-ZJ0305), and the Science & Technology support Program of Suzhou (ZXS2012005, SYN201406) supported the cost of sequencing and version. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao YY, 2009, GENOMICS, V94, P138, DOI 10.1016/j.ygeno.2009.04.003; Cho M, 2004, WATER RES, V38, P1069, DOI 10.1016/j.watres.2003.10.029; Das S, 2013, APPL MICROBIOL BIOT, V97, P6019, DOI 10.1007/s00253-013-4868-z; Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237; ENGELHARD EK, 1994, P NATL ACAD SCI USA, V91, P3224, DOI 10.1073/pnas.91.8.3224; Esterkin CR, 2005, AICHE J, V51, P2298, DOI 10.1002/aic.10472; Gao FQ, 2006, BIOL TRACE ELEM RES, V111, P239, DOI 10.1385/BTER:111:1:239; Gelis C, 2003, PHOTODERMATOL PHOTO, V19, P242, DOI 10.1034/j.1600-0781.2003.00045.x; Gheshlaghi ZN, 2008, ACTA BIOCH BIOPH SIN, V40, P777, DOI 10.1111/j.1745-7270.2008.00458.x; Gu SH, 2011, INSECT BIOCHEM MOLEC, V41, P197, DOI 10.1016/j.ibmb.2010.12.004; Heinlaan M, 2008, CHEMOSPHERE, V71, P1308, DOI 10.1016/j.chemosphere.2007.11.047; Hu RP, 2011, J HAZARD MATER, V191, P32, DOI 10.1016/j.jhazmat.2011.04.027; HUGHES DS, 1993, VIROLOGY, V194, P608, DOI 10.1006/viro.1993.1300; Jeng HA, 2006, J ENVIRON SCI HEAL A, V41, P2699, DOI 10.1080/10934520600966177; Jiang L, 2014, INSECT BIOCHEM MOLEC, V48, P1, DOI 10.1016/j.ibmb.2014.02.003; Jiang L, 2013, ANTIVIR RES, V98, P171, DOI 10.1016/j.antiviral.2013.02.015; Jiang L, 2012, ARCH VIROL, V157, P1323, DOI 10.1007/s00705-012-1309-8; KEDDIE BA, 1989, SCIENCE, V243, P1728, DOI 10.1126/science.2648574; Leclerc V, 2004, IMMUNOL REV, V198, P59, DOI 10.1111/j.0105-2896.2004.0130.x; Li B, 2014, CHEMOSPHERE, V104, P221, DOI 10.1016/j.chemosphere.2013.11.030; Li B, 2013, J AGR FOOD CHEM, V61, P12238, DOI 10.1021/jf4039259; Li B, 2012, BIOL TRACE ELEM RES, V150, P221, DOI 10.1007/s12011-012-9507-5; Li B, 2012, CHEMOSPHERE, V89, P609, DOI 10.1016/j.chemosphere.2012.05.061; Li B, 2010, AFR J BIOTECHNOL, V9, P1771; Meier R, 1997, J BIOL CHEM, V272, P30491, DOI 10.1074/jbc.272.48.30491; Mikkelsen L, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-32; Nobiron I, 2003, J GEN VIROL, V84, P3029, DOI 10.1099/vir.0.19270-0; Peng GD, 2011, PESTIC BIOCHEM PHYS, V101, P154, DOI 10.1016/j.pestbp.2011.08.010; Ponnuvel KM, 2003, J VIROL, V77, P10725, DOI 10.1128/JVI.77.19.10725-10729.2003; Qin LG, 2012, J PROTEOMICS, V75, P3630, DOI 10.1016/j.jprot.2012.04.015; Rahman MM, 2004, VIRUS RES, V101, P109, DOI 10.1016/j.virusres.2003.12.027; Saeedi R, 2012, ENVIRON ENG SCI, V29, P93, DOI 10.1089/ees.2011.0077; Su JJ, 2014, ENVIRON TOXICOL, V29, P1355, DOI 10.1002/tox.21866; Sun D, 2004, WATER SCI TECHNOL, V49, P103, DOI 10.2166/wst.2004.0030; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Teleman AA, 2010, BIOCHEM J, V425, P13, DOI 10.1042/BJ20091181; Wang JJ, 2007, MUTAT RES-GEN TOX EN, V628, P99, DOI 10.1016/j.mrgentox.2006.12.003; Wang YH, 2013, PESTIC BIOCHEM PHYS, V105, P13, DOI 10.1016/j.pestbp.2012.11.001; Welch H, 1998, J BIOL CHEM, V273, P11248, DOI 10.1074/jbc.273.18.11248; Xiao W, 2009, VIROLOGY, V391, P83, DOI 10.1016/j.virol.2009.06.007; Xu JP, 2005, J APPL ENTOMOL, V129, P425, DOI 10.1111/j.1439-0418.2005.00995.x; Xu JP, 2005, J APPL ENTOMOL, V129, P27, DOI 10.1111/j.1439-0418.2005.00923.x; Yang P, 2002, MATER LETT, V57, P794, DOI 10.1016/S0167-577X(02)00875-3; Yeh MS, 2008, DEV COMP IMMUNOL, V32, P814, DOI 10.1016/j.dci.2007.12.001; Zhang H, 2014, BIOL TRACE ELEM RES, V159, P224, DOI 10.1007/s12011-014-9986-7; Zhang S, 2011, COMP FUNCT GENOM, DOI 10.1155/2011/876064	46	12	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118222	10.1371/journal.pone.0118222	http://dx.doi.org/10.1371/journal.pone.0118222			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692869	gold, Green Submitted, Green Published			2022-12-26	WOS:000350061500109
J	Zhao, ZG; Wang, YK				Zhao, Zhi-Gang; Wang, Yi-Ke			Selection by Pollinators on Floral Traits in Generalized Trollius ranunculoides (Ranunculaceae) along Altitudinal Gradients	PLOS ONE			English	Article							FLOWER SIZE; MEDIATED SELECTION; GEOGRAPHICAL VARIATION; REPRODUCTIVE TRAITS; POLEMONIUM-VISCOSUM; POLLEN LIMITATION; SPATIAL VARIATION; NICOTIANA-GLAUCA; VISITATION RATES; ECOLOGY	Abundance and visitation of pollinator assemblages tend to decrease with altitude, leading to an increase in pollen limitation. Thus increased competition for pollinators may generate stronger selection on attractive traits of flowers at high elevations and cause floral adaptive evolution. Few studies have related geographically variable selection from pollinators and intraspecific floral differentiation. We investigated the variation of Trollius ranunculoides flowers and its pollinators along an altitudinal gradient on the eastern Qinghai-Tibet Plateau, and measured phenotypic selection by pollinators on floral traits across populations. The results showed significant decline of visitation rate of bees along altitudinal gradients, while flies was unchanged. When fitness is estimated by the visitation rate rather than the seed number per plant, phenotypic selection on the sepal length and width shows a significant correlation between the selection strength and the altitude, with stronger selection at higher altitudes. However, significant decreases in the sepal length and width of Trollius ranunculoides along the altitudinal gradient did not correspond to stronger selection of pollinators. In contrast to the pollinator visitation, mean annual precipitation negatively affected the sepal length and width, and contributed more to geographical variation in measured floral traits than the visitation rate of pollinators. Therefore, the sepal size may have been influenced by conflicting selection pressures from biotic and abiotic selective agents. This study supports the hypothesis that lower pollinator availability at high altitude can intensify selection on flower attractive traits, but abiotic selection is preventing a response to selection from pollinators.	[Zhao, Zhi-Gang; Wang, Yi-Ke] Lanzhou Univ, Sch Life Sci, State Key Lab Grassland & Agroecosyst, Lanzhou 730000, Peoples R China	Lanzhou University	Zhao, ZG (corresponding author), Lanzhou Univ, Sch Life Sci, State Key Lab Grassland & Agroecosyst, Lanzhou 730000, Peoples R China.	zhaozhg@lzu.edu.cn	Zhao, Zhigang/ABE-4982-2021	Zhao, Zhigang/0000-0002-5252-4813	National Natural Science Foundation of China [30900162, 31370402]; Fundamental Research Funds for the Central Universities [lzujbky-2013-102]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (30900162 and 31370402 to ZGZ) and the Fundamental Research Funds for the Central Universities (lzujbky-2013-102 to ZGZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner PA, 2005, FUNCT ECOL, V19, P681, DOI 10.1111/j.1365-2435.2005.01009.x; Alexandersson R, 2002, P ROY SOC B-BIOL SCI, V269, P631, DOI 10.1098/rspb.2001.1928; Anderson B, 2008, EVOLUTION, V62, P220, DOI 10.1111/j.1558-5646.2007.00275.x; ARNOLD SJ, 1984, EVOLUTION, V38, P720, DOI 10.1111/j.1558-5646.1984.tb00345.x; ARROYO MTK, 1985, PLANT SYST EVOL, V149, P187, DOI 10.1007/BF00983305; Bingham RA, 1998, NATURE, V391, P238, DOI 10.1038/34564; Blionis GJ, 2001, ECOGRAPHY, V24, P287, DOI 10.1034/j.1600-0587.2001.240306.x; Boyd A, 2002, SYST BOT, V27, P116; Campbell DR, 2004, NEW PHYTOL, V161, P83, DOI 10.1046/j.1469-8137.2003.00919.x; Campbell DR, 1997, AM NAT, V149, P295, DOI 10.1086/285991; Caruso CM, 2000, EVOLUTION, V54, P1546, DOI 10.1111/j.0014-3820.2000.tb00700.x; Chalcoff VR, 2008, ANN BOT-LONDON, V102, P79, DOI 10.1093/aob/mcn057; Cosacov A, 2014, ANN BOT-LONDON, V113, P251, DOI 10.1093/aob/mct239; Dilley JD, 2000, OIKOS, V89, P209, DOI 10.1034/j.1600-0706.2000.890201.x; Fabbro T, 2004, FLORA, V199, P70, DOI 10.1078/0367-2530-00128; FAEGRI K, 1979, P244; Fenster CB, 2004, ANNU REV ECOL EVOL S, V35, P375, DOI 10.1146/annurev.ecolsys.34.011802.132347; Fulkerson JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032790; GALEN C, 1987, EVOLUTION, V41, P599, DOI 10.2307/2409261; Galen C, 1999, BIOSCIENCE, V49, P631, DOI 10.2307/1313439; GALEN C, 1989, EVOLUTION, V43, P882, DOI 10.1111/j.1558-5646.1989.tb05185.x; Galen C, 1999, OECOLOGIA, V118, P461, DOI 10.1007/s004420050749; Galen C, 1996, EVOLUTION, V50, P120, DOI 10.1111/j.1558-5646.1996.tb04478.x; GALEN C, 1985, ECOLOGY, V66, P792, DOI 10.2307/1940540; GRANT V, 1949, EVOLUTION, V3, P82, DOI 10.2307/2405454; Harder LD, 2009, NEW PHYTOL, V183, P530, DOI 10.1111/j.1469-8137.2009.02914.x; Herrera C.M., 2006, ECOLOGY EVOLUTION FL, P278; Herrera J, 2005, ANN BOT-LONDON, V95, P431, DOI 10.1093/aob/mci041; Herrera J, 2009, ANN BOT-LONDON, V103, P1119, DOI 10.1093/aob/mcp046; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Johnson SD, 1997, EVOLUTION, V51, P45, DOI 10.1111/j.1558-5646.1997.tb02387.x; Kay KM, 2009, ANNU REV ECOL EVOL S, V40, P637, DOI 10.1146/annurev.ecolsys.110308.120310; Kimball S, 2008, OIKOS, V117, P1064, DOI 10.1111/j.0030-1299.2008.16573.x; Korner C., 2003, ALPINE PLANT LIFE FU, V2nd ed.; Kudo Gaku, 1999, Plant Species Biology, V14, P181, DOI 10.1046/j.1442-1984.1999.00012.x; LAMBERS H, 1992, ADV ECOL RES, V23, P187, DOI 10.1016/S0065-2504(08)60148-8; Lambrecht SC, 2013, INT J PLANT SCI, V174, P74, DOI 10.1086/668230; Maad J, 2013, NORD J BOT, V31, P361, DOI 10.1111/j.1756-1051.2013.01766.x; Malo JE, 2002, DIVERS DISTRIB, V8, P365, DOI 10.1046/j.1472-4642.2002.00161.x; Medel R, 2007, ECOGRAPHY, V30, P812, DOI 10.1111/j.2007.0906-7590.05175.x; Moeller DA, 2006, ECOLOGY, V87, P1510, DOI 10.1890/0012-9658(2006)87[1510:GSOPCR]2.0.CO;2; Moeller DA, 2005, OECOLOGIA, V142, P28, DOI 10.1007/s00442-004-1693-1; Moeller DA, 2012, ECOLOGY, V93, P1036, DOI 10.1890/11-1462.1; Nattero J, 2011, ACTA OECOL, V37, P503, DOI 10.1016/j.actao.2011.07.001; Nattero J, 2010, OIKOS, V119, P852, DOI 10.1111/j.1600-0706.2009.17766.x; Niklas K.., 1994, PLANT ALLOMETRY; NILSSON LA, 1988, NATURE, V334, P147, DOI 10.1038/334147a0; Perez-Barrales R, 2007, OIKOS, V116, P1904, DOI 10.1111/j.0030-1299.2007.15994.x; Price MV, 2005, ECOLOGY, V86, P2106, DOI 10.1890/04-1274; Rey PJ, 2006, J EVOLUTION BIOL, V19, P21, DOI 10.1111/j.1420-9101.2005.00992.x; ROBERTSON JL, 1990, EVOLUTION, V44, P121, DOI 10.1111/j.1558-5646.1990.tb04283.x; Schlumpberger BO, 2009, ANN BOT-LONDON, V103, P1489, DOI 10.1093/aob/mcp075; Scobell SA, 2002, AM MIDL NAT, V147, P1, DOI 10.1674/0003-0031(2002)147[0001:VAFTOA]2.0.CO;2; Silva-Montellano A, 2003, AM J BOT, V90, P377, DOI 10.3732/ajb.90.3.377; STEBBINS G. L., 1970, Annual review of ecology and systematics., V1, P307, DOI 10.1146/annurev.es.01.110170.001515; Strauss S.Y., 2006, ECOLOGY EVOLUTION FL, P120; Thompson J. N., 2005, INTERSPEC INTERACT; TOTLAND O, 1993, CAN J BOT, V71, P1072, DOI 10.1139/b93-124; Totland O, 2004, OIKOS, V106, P558, DOI 10.1111/j.0030-1299.2004.12991.x; Totland O, 2001, ECOLOGY, V82, P2233, DOI 10.1890/0012-9658(2001)082[2233:EDPLAS]2.0.CO;2; Van der Niet T, 2014, ANN BOT-LONDON, V113, P199, DOI 10.1093/aob/mct290; Ye XQ, 2011, PLANT BIOLOGY, V13, P551, DOI 10.1111/j.1438-8677.2010.00402.x; Zhao ZG, 2013, INT J PLANT SCI, V174, P637, DOI 10.1086/669910; Zhao ZG, 2007, PLANT ECOL, V193, P241, DOI 10.1007/s11258-006-9262-9; Zhao ZG, 2006, AUST J BOT, V54, P691, DOI 10.1071/BT05015	65	50	60	3	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118299	10.1371/journal.pone.0118299	http://dx.doi.org/10.1371/journal.pone.0118299			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692295	Green Published, Green Submitted, gold			2022-12-26	WOS:000350061500114
J	Hong, SW; Lee, SB; Jee, DH; Ahn, MD				Hong, Seung Woo; Lee, Seung Bum; Jee, Dong-hyun; Ahn, Myung Douk			Interocular Retinal Nerve Fiber Layer Thickness Difference in Normal Adults	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; SYMMETRY; GLAUCOMA; AGE	Purpose To determine the interocular retinal nerve fiber layer (RNFL) thickness difference of normal subjects. Methods Both eyes of 230 normal adults received peripapillary RNFL thickness measurements using OCT. The effect of ocular cyclotorsion on the RNFL thickness profile was mathematically corrected. The fractional and absolute interocular RNFL thickness differences at 256 points of peripapillary area were calculated. We divided the subjects into 3 groups according to the locations of superior and inferior peak thickness, respectively, and compared the interocular RNFL thickness differences between the subgroups. Results The fractional interocular RNFL thickness difference exhibited smaller regional variations than the absolute interocular difference. The means of fractional interocular differences were 0.100 +/- 0.077 in the temporal half area and 0.146 +/- 0.105 in the nasal half area, and the tolerance limits for the 95th and 99th distributions were about 0.246 and 0.344 in the temporal half area and 0.293 and 0.408 in the nasal half area, respectively. The fractional interocular differences of subgroups classified by the locations of superior and inferior peak RNFL thickness showed difference at smaller areas than the absolute interocular differences (19 and 8 points versus 49 and 23 points, respectively). Conclusion Glaucoma can be strongly suspected, if interocular fractional RNFL thickness difference is over 25% at 5 consecutive points or over 35% at 3 consecutive points in the temporal half area. The fractional interocular comparison is a better diagnostic approach because the fractional interocular RNFL thickness difference is less influenced by the locations of peak RNFL thickness.	[Hong, Seung Woo; Lee, Seung Bum; Jee, Dong-hyun; Ahn, Myung Douk] Catholic Univ Korea, Coll Med, Dept Ophthalmol & Visual Sci, Seoul, South Korea; [Hong, Seung Woo] Armed Forces Capital Hosp Korea, Dept Ophthalmol, Songnam, Gyeonggi Provin, South Korea	Catholic University of Korea	Ahn, MD (corresponding author), Catholic Univ Korea, Coll Med, Dept Ophthalmol & Visual Sci, Seoul, South Korea.	narusia@catholic.ac.kr		Hong, Seung Woo/0000-0002-4800-636X	Committee of Armed Forces Capital Hospital Ophthalmology Alumni, Seoul [11003]	Committee of Armed Forces Capital Hospital Ophthalmology Alumni, Seoul	This work received financial support from the Committee of Armed Forces Capital Hospital Ophthalmology Alumni, Seoul (Grant No. 11003). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Budenz DL, 2005, OPHTHALMOLOGY, V112, P3, DOI 10.1016/j.ophtha.2004.06.039; Budenz DL, 2007, OPHTHALMOLOGY, V114, P1046, DOI 10.1016/j.ophtha.2006.08.046; Budenz Donald L, 2008, Trans Am Ophthalmol Soc, V106, P252; Chung HJ, 2014, J GLAUCOMA, V23, P471, DOI 10.1097/IJG.0b013e31827b1382; Essock EA, 1999, J GLAUCOMA, V8, P90; Frank M.J., 1979, AEQUATIONES MATH, V19, P194, DOI DOI 10.1007/BF02189866; Hollands H, 2013, JAMA-J AM MED ASSOC, V309, P2034, DOI [10.1001/jama.2013.4982, DOI 10.1001/JAMA.2013.4982]; Hong SW, 2010, INVEST OPHTH VIS SCI, V51, P3515, DOI 10.1167/iovs.09-4888; Hood DC, 2007, BRIT J OPHTHALMOL, V91, P905, DOI 10.1136/bjo.2006.111252; Hougaard JL, 2007, ACTA OPHTHALMOL SCAN, V85, P251, DOI 10.1111/j.1600-0420.2006.00826.x; Huynh SC, 2007, AM J OPHTHALMOL, V143, P518, DOI 10.1016/j.ajo.2006.09.050; Hwang YH, 2012, J GLAUCOMA, V21, P260, DOI 10.1097/IJG.0b013e31820719e1; Hwang YH, 2011, BRIT J OPHTHALMOL, V95, P1547, DOI 10.1136/bjo.2010.194118; Jee D, 2014, J GLAUCOMA, V23, pE125, DOI 10.1097/IJG.0000000000000032; Kanamori A, 2006, GRAEF ARCH CLIN EXP, V244, P58, DOI 10.1007/s00417-005-0029-0; Kurimoto Y, 2000, BRIT J OPHTHALMOL, V84, P469, DOI 10.1136/bjo.84.5.469; Lee Jong Yeon, 2012, Korean J Ophthalmol, V26, P163, DOI 10.3341/kjo.2012.26.3.163; Leung CKS, 2012, OPHTHALMOLOGY, V119, P731, DOI 10.1016/j.ophtha.2011.10.010; Leung CKS, 2009, OPHTHALMOLOGY, V116, P1257, DOI 10.1016/j.ophtha.2009.04.013; Mitchell P, 1999, OPHTHALMOLOGY, V106, P2010, DOI 10.1016/S0161-6420(99)90416-5; Mwanza JC, 2011, AM J OPHTHALMOL, V151, P514, DOI 10.1016/j.ajo.2010.09.015; Sung KR, 2009, OPHTHALMOLOGY, V116, P1119, DOI 10.1016/j.ophtha.2009.01.004; Yamashita T, 2013, INVEST OPHTH VIS SCI, V54, P5481, DOI 10.1167/iovs.12-11008	23	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0116313	10.1371/journal.pone.0116313	http://dx.doi.org/10.1371/journal.pone.0116313			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679786	Green Submitted, Green Published, gold			2022-12-26	WOS:000350682600017
J	Zhang, H; Hu, L; Qiu, W; Deng, T; Zhang, Y; Bergholz, J; Xiao, ZX				Zhang, H.; Hu, L.; Qiu, W.; Deng, T.; Zhang, Y.; Bergholz, J.; Xiao, Z-X			MDMX exerts its oncogenic activity via suppression of retinoblastoma protein	ONCOGENE			English	Article							TUMOR-SUPPRESSOR; MOLECULAR-BASIS; P53 ACTIVITY; DOMAIN; INACTIVATION; CANCER; PHOSPHORYLATION; UBIQUITINATION; MECHANISMS; CELLS	Inactivation of the retinoblastoma protein (RB) has a major role in the development of human malignancies. We have previously shown that MDM2, an ubiquitin E3 ligase and major negative regulator of p53, binds to and promotes proteasome-mediated degradation of RB. MDMX, a homolog of MDM2, also binds to and inhibits p53 transactivation activity, yet it does not possess intrinsic ubiquitin ligase activity. Here, we show that MDMX binds to and promotes RB degradation in an MDM2-dependent manner. Specifically, the MDMX C-terminal ring domain binds to the RB C-pocket and enhances MDM2-RB interaction. Silencing MDMX induces RB accumulation, cell cycle arrest and senescence-like phenotypes, which are reverted by simultaneous RB knockdown. Furthermore, MDMX ablation leads to significant retardation of xenograft tumor growth, concomitant with RB accumulation. These results demonstrate that MDMX exerts oncogenic activity via suppression of RB, and suggest that both MDM2 and MDMX could be chemotherapeutic targets.	[Zhang, H.; Hu, L.; Deng, T.; Zhang, Y.; Bergholz, J.; Xiao, Z-X] Sichuan Univ, Ctr Growth Metab & Aging, Key Lab Bioresource & Ecoenvironm, Minist Educ,Coll Life Sci, Chengdu 610014, Peoples R China; [Zhang, H.; Hu, L.; Deng, T.; Zhang, Y.; Bergholz, J.; Xiao, Z-X] Sichuan Univ, State Key Lab Biotherapy, Chengdu 610014, Peoples R China; [Qiu, W.; Xiao, Z-X] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Sichuan University; Sichuan University; Boston University	Xiao, ZX (corresponding author), Sichuan Univ, Ctr Growth Metab & Aging, Key Lab Bioresource & Ecoenvironm, Minist Educ,Coll Life Sci, Chengdu 610014, Peoples R China.	jimzx@scu.edu.cn	zhang, haibo/K-5146-2019		National Key Basic Research Program (973 Program) of China [2012CB910700]; National Natural Science Foundation of China (NSFC) [81330054, 31171362]; NSFC [31350110216]	National Key Basic Research Program (973 Program) of China(National Basic Research Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NSFC(National Natural Science Foundation of China (NSFC))	We thank Dr Scott Lowe (Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA) for kindly providing short hairpin RNA plasmids against human RB. This work was supported by the National Key Basic Research Program (973 Program) of China (2012CB910700) and National Natural Science Foundation of China (NSFC) grant (81330054 and 31171362) to Z-XX, and NSFC grant (31350110216) to JB.	Avni D, 2003, MOL CELL, V12, P735, DOI 10.1016/S1097-2765(03)00355-1; Bottger V, 1999, ONCOGENE, V18, P189, DOI 10.1038/sj.onc.1202281; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Cicchillitti L, 2003, J BIOL CHEM, V278, P19509, DOI 10.1074/jbc.M300511200; Classon M, 2002, NAT REV CANCER, V2, P910, DOI 10.1038/nrc950; CORDONCARDO C, 1994, CANCER RES, V54, P794; Di Fiore R, 2013, J CELL PHYSIOL, V228, P1676, DOI 10.1002/jcp.24329; Dick FA, 2013, NAT REV MOL CELL BIO, V14, P297, DOI 10.1038/nrm3567; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Gu JJ, 2002, J BIOL CHEM, V277, P19251, DOI 10.1074/jbc.C200150200; Harbour JW, 1999, CELL, V98, P859, DOI 10.1016/S0092-8674(00)81519-6; Henley SA, 2012, CELL DIV, V7, DOI 10.1186/1747-1028-7-10; Honda R, 2000, ONCOGENE, V19, P1473, DOI 10.1038/sj.onc.1203464; Huang L, 2011, P NATL ACAD SCI USA, V108, P12001, DOI 10.1073/pnas.1102309108; Jin Y, 2008, MOL CELL BIOL, V28, P1218, DOI 10.1128/MCB.01198-07; Kato MV, 1996, CANCER LETT, V106, P75, DOI 10.1016/0304-3835(96)04305-4; Kawai H, 2007, CANCER RES, V67, P6026, DOI 10.1158/0008-5472.CAN-07-1313; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Laurie NA, 2006, NATURE, V444, P61, DOI 10.1038/nature05194; Lee C, 2002, GENE DEV, V16, P3199, DOI 10.1101/gad.1046102; Linares LK, 2003, P NATL ACAD SCI USA, V100, P12009, DOI 10.1073/pnas.2030930100; Linke K, 2008, CELL DEATH DIFFER, V15, P841, DOI 10.1038/sj.cdd.4402309; LUDLOW JW, 1993, MOL CELL BIOL, V13, P367, DOI 10.1128/MCB.13.1.367; Marine JC, 2006, CELL DEATH DIFFER, V13, P927, DOI 10.1038/sj.cdd.4401912; Marine JC, 2010, CELL DEATH DIFFER, V17, P93, DOI 10.1038/cdd.2009.68; Okamoto K, 2009, FEBS LETT, V583, P2710, DOI 10.1016/j.febslet.2009.07.021; Pant V, 2011, P NATL ACAD SCI USA, V108, P11995, DOI 10.1073/pnas.1102241108; Reinke V, 1997, RADIAT RES, V148, P115, DOI 10.2307/3579567; Sdek P, 2005, MOL CELL, V20, P699, DOI 10.1016/j.molcel.2005.10.017; Sdek P, 2004, J BIOL CHEM, V279, P53317, DOI 10.1074/jbc.M406062200; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sharp DA, 1999, J BIOL CHEM, V274, P38189, DOI 10.1074/jbc.274.53.38189; Shvarts A, 1996, EMBO J, V15, P5349, DOI 10.1002/j.1460-2075.1996.tb00919.x; Suda T, 2011, ONCOL REP, V26, P49, DOI 10.3892/or.2011.1270; Tanimura S, 1999, FEBS LETT, V447, P5, DOI 10.1016/S0014-5793(99)00254-9; Thomas DM, 2003, CANCER BIOL THER, V2, P124, DOI 10.4161/cbt.2.2.235; Uchida C, 2006, FEBS LETT, V580, P1753, DOI 10.1016/j.febslet.2006.02.029; Wade M, 2013, NAT REV CANCER, V13, P83, DOI 10.1038/nrc3430; Wade M, 2009, MOL CANCER RES, V7, P1, DOI 10.1158/1541-7786.MCR-08-0423; WATANABE T, 1994, BLOOD, V84, P3158; Wu L, 1997, MOL MED, V3, P441, DOI 10.1007/BF03401691; Wunderlich M, 2004, CELL CYCLE, V3, P472; Xiao B, 2003, P NATL ACAD SCI USA, V100, P2363, DOI 10.1073/pnas.0436813100; XIAO ZX, 1995, NATURE, V375, P694, DOI 10.1038/375694a0; Zarkowska T, 1997, J BIOL CHEM, V272, P12738, DOI 10.1074/jbc.272.19.12738	47	16	17	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 29	2015	34	44					5560	5569		10.1038/onc.2015.11	http://dx.doi.org/10.1038/onc.2015.11			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CV9FX	25703327				2022-12-26	WOS:000364594000005
J	Franz, NM; Chen, MM; Yu, SZ; Kianmajd, P; Bowers, S; Ludascher, B				Franz, Nico M.; Chen, Mingmin; Yu, Shizhuo; Kianmajd, Parisa; Bowers, Shawn; Ludaescher, Bertram			Reasoning over Taxonomic Change: Exploring Alignments for the Perelleschus Use Case	PLOS ONE			English	Article							COLEOPTERA; TAXA; ONTOLOGIES; SYSTEM; MODEL; NAMES; REPRESENTATION; CURCULIONIDAE; PHYLOGENY; ORGANISM	Classifications and phylogenetic inferences of organismal groups change in light of new insights. Over time these changes can result in an imperfect tracking of taxonomic perspectives through the re-/use of Code-compliant or informal names. To mitigate these limitations, we introduce a novel approach for aligning taxonomies through the interaction of human experts and logic reasoners. We explore the performance of this approach with the Perelleschus use case of Franz & Cardona-Duque (2013). The use case includes six taxonomies published from 1936 to 2013, 54 taxonomic concepts (i.e., circumscriptions of names individuated according to their respective source publications), and 75 expert-asserted Region Connection Calculus articulations (e. g., congruence, proper inclusion, overlap, or exclusion). An Open Source reasoning toolkit is used to analyze 13 paired Perelleschus taxonomy alignments under heterogeneous constraints and interpretations. The reasoning workflow optimizes the logical consistency and expressiveness of the input and infers the set of maximally informative relations among the entailed taxonomic concepts. The latter are then used to produce merge visualizations that represent all congruent and non-congruent taxonomic elements among the aligned input trees. In this small use case with 653 input concepts per alignment, the information gained through the reasoning process is on average one order of magnitude greater than in the input. The approach offers scalable solutions for tracking provenance among succeeding taxonomic perspectives that may have differential biases in naming conventions, phylogenetic resolution, ingroup and outgroup sampling, or ostensive (member-referencing) versus intensional (property-referencing) concepts and articulations.	[Franz, Nico M.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85281 USA; [Chen, Mingmin; Yu, Shizhuo; Kianmajd, Parisa; Ludaescher, Bertram] Univ Calif Davis, Dept Comp Sci, Davis, CA 95616 USA; [Bowers, Shawn] Gonzaga Univ, Dept Comp Sci, Spokane, WA 99258 USA	Arizona State University; Arizona State University-Tempe; University of California System; University of California Davis; Gonzaga University	Franz, NM (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85281 USA.	nico.franz@asu.edu			National Science Foundation [DEB-1155984, DBI-1342595, IIS-118088, DBI-1147273]; Direct For Biological Sciences [1155984] Funding Source: National Science Foundation; Div Of Biological Infrastructure [1147273] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Support was provided by the National Science Foundation (http://www.nsf.gov/) by grants DEB-1155984 and DBI-1342595 to NMF and IIS-118088 and DBI-1147273 to BL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baral C, 2004, LECT NOTES ARTIF INT, V2923, P21; Baskauf SJ, 2014, SEMANTIC WE IN PRESS; BEACH JH, 1993, ADVANCES IN COMPUTER METHODS FOR SYSTEMATIC BIOLOGY, P241; Berendsohn W.G., 2003, SCHRIFTENREIHE VEGET, V39, P1; Berendsohn WG, 1997, TAXON, V46, P283, DOI 10.2307/1224098; BERENDSOHN WG, 1995, TAXON, V44, P207, DOI 10.2307/1222443; Bizer C, 2009, INT J SEMANT WEB INF, V5, P1, DOI 10.4018/jswis.2009081901; Bouchard P, 2011, ZOOKEYS, P1, DOI 10.3897/zookeys.88.807; Boyle B, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-16; Brewka G, 2011, COMMUN ACM, V54, P92, DOI 10.1145/2043174.2043195; Brigandt I, 2009, ACTA BIOTHEOR, V57, P77, DOI 10.1007/s10441-008-9056-7; Bryant D., 2003, Bioconsensus. DIMACS Working Group Meetings on Bioconsensus, P163; Bryant HN, 2002, BIOL REV, V77, P39, DOI 10.1017/S1464793101005802; Cha SH, 2009, J PATTERN RECOGNIT R, V4, P1, DOI 10.13176/11.44; Chawuthai R, 2013, S4BIODIV 2013 SEMANT, V797, P1; Chen M, 2015, EULER PROJECT SOURCE; Chen M., 2014, ARXIV14021992CSLO; Chen M, 2014, LECT NOTES COMPUT SC, V8620, P127, DOI DOI 10.1007/978-3-319-09870-8_; Chen M, 2014, LECT NOTES IN PRESS; Chen M, 2014, THESIS U CALIFORNIA; Cheney J, 2007, FOUND TRENDS DATABAS, V1, P379, DOI 10.1561/1900000006; Cui H, 2012, J AM SOC INF SCI TEC, V63, P738, DOI 10.1002/asi.22618; Dahdul WM, 2010, SYST BIOL, V59, P369, DOI 10.1093/sysbio/syq013; de Paula R, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S11-S6; Deans AR, 2012, TRENDS ECOL EVOL, V27, P78, DOI 10.1016/j.tree.2011.11.007; DEQUEIROZ K, 1992, ANNU REV ECOL SYST, V23, P449, DOI 10.1146/annurev.ecolsys.23.1.449; Devitt M., 1999, LANGUAGE REALITY INT; Erdem Esra, 2011, Logic Programming, Knowledge Representation, and Nonmonotonic Reasoning. Essays Dedicated to Michael Gelfond on the Occasion of his 65th Birthday, P415, DOI 10.1007/978-3-642-20832-4_26; Euzenat J., 2013, ONTOLOGY MATCHING, V2; FABRICIUS JC, 1792, SECUNDUM CLASSES ORD, V1; Ferreiros J, 2001, B SYMB LOG, V7, P441, DOI 10.2307/2687794; Franz NM, 2009, SYST BIODIVERS, V7, P5, DOI 10.1017/S147720000800282X; Franz N.M., 2009, LETT LINNAEUS, P63; Franz NM, 2008, SYST ASSOC SPEC VOL, V76, P63; Franz NM, 2013, SYST BIODIVERS, V11, P209, DOI 10.1080/14772000.2013.806371; Franz Nico M., 2010, Biodiversity Informatics, V7, P45; Franz NM, 2006, SYST ENTOMOL, V31, P220, DOI 10.1111/j.1365-3113.2005.00308.x; Franz NM, 2005, CLADISTICS, V21, P495, DOI 10.1111/j.1096-0031.2005.00080.x; Franz NM, 2003, INSECT SYST EVOL, V34, P153, DOI 10.1163/187631203788964818; Franz NM, 2001, T AM ENTOMOL SOC, V127, P255; Franz NM, 2015, SEMANTIC WE IN PRESS; Gansner ER, 2000, SOFTWARE PRACT EXPER, V30, P1203, DOI 10.1002/1097-024X(200009)30:11<1203::AID-SPE338>3.0.CO;2-N; Gebser M, 2011, AI COMMUN, V24, P107, DOI 10.3233/AIC-2011-0491; Gelfond M, 2008, FOUND ARTIF INTELL, P285, DOI 10.1016/S1574-6526(07)03007-6; GEOFFROY M., 2003, SCHRIFT VEGETATIONSK, V39, P71; Geoffroy M, 2003, SCHRIFT VEGETATIONSK, V39, P83; Gradstein SR, 2001, TAXON, V50, P1075, DOI 10.2307/1224722; Graham M, 2010, INFORM VISUAL, V9, P235, DOI 10.1057/ivs.2009.29; GUNTHER K, 1936, ENTOMOLOGISCHE RUNDS, V53, P190; Hendler J, 2008, FOUND ARTIF INTELL, P821, DOI 10.1016/S1574-6526(07)03021-0; Howse J, 2002, LECT NOTES ARTIF INT, V2317, P76; ICZN (International Commission on Zoological Nomenclature), 1999, INT CODE ZOOLOGICAL, V4th; Kennedy J, 2006, OMICS, V10, P220, DOI 10.1089/omi.2006.10.220; Kennedy JB, 2005, LECT NOTES COMPUT SC, V3615, P80; KOPERSKI M, 1999, STUTTGARTER BEITR C, V590, P1; KOPERSKI M., 2000, SCHRIFTENREIHE VEGET, V34, P1; Lacordaire T., 1863, HIST NATURELLE INSEC, V6; Lifschitz V, 2008, LECT NOTES COMPUT SC, V5366, P37, DOI 10.1007/978-3-540-89982-2_8; Lukasiewicz T, 2010, IEEE T KNOWL DATA EN, V22, P1577, DOI 10.1109/TKDE.2010.111; Marakeby H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089142; McCarthy J., 1989, PHILOS LOGIC ARTIFIC, P161; McCune W, 2010, PROVER9 AND MACE4; McNEILL J., 2012, INT CODE NOMENCLATUR; Meiri S, 2007, PLOS BIOL, V5, P1385, DOI 10.1371/journal.pbio.0050194; Midford PE, 2013, J BIOMED SEMANT, V4, DOI 10.1186/2041-1480-4-34; Moreau Luc, 2010, Foundations and Trends in Web Science, V2, P99, DOI 10.1561/1800000010; Mungall CJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r2; NIXON KC, 1993, CLADISTICS, V9, P413, DOI 10.1111/j.1096-0031.1993.tb00234.x; Padial JM, 2006, SYST BIOL, V55, P859, DOI 10.1080/1063515060081588; Page R., 2011, DARK TAXA GENBANK PO; Page RDM, 2008, BRIEF BIOINFORM, V9, P345, DOI 10.1093/bib/bbn022; Page Roderic D.M., 2006, Biodiversity Informatics, V3, P1; Page RDM, 2013, PEERJ, V1, DOI 10.7717/peerj.190; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Patterson DJ, 2010, TRENDS ECOL EVOL, V25, P686, DOI 10.1016/j.tree.2010.09.004; Prendini L, 2001, SYST BIOL, V50, P290, DOI 10.1080/10635150118650; Randell D. A., 1992, Principles of Knowledge Representation and Reasoning: Proceedings of the Third International Conference (KR '92), P165; Reimer M., 2010, STANFORD ENCY PHILOS; Sangster G, 2014, BIOL REV, V89, P199, DOI 10.1111/brv.12051; Schuh RT, 2003, BOT REV, V69, P59, DOI 10.1663/0006-8101(2003)069[0059:TLSAIY]2.0.CO;2; SCHUH RT, 2009, BIOL SYSTEMATICS PRI; Schulz S, 2008, BIOINFORMATICS, V24, pI313, DOI 10.1093/bioinformatics/btn158; Smith B, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r46; Smith SA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003223; Thau D, 2008, P 2 INT WORKSH ONT I, P47, DOI DOI 10.1145/1458484.1458492; Thau D, 2008, PH D RSQUO 08, P11; Thau D, 2009, P AAAI SPRING S BENC, P49; Thau D, 2007, ECOL INFORM, V2, P195, DOI 10.1016/j.ecoinf.2007.07.005; Thau D, 2009, LECT NOTES COMPUT SC, V5871, P1103, DOI 10.1007/978-3-642-05151-7_26; Thau D, 2010, I C DATA ENGIN WORKS, P151, DOI 10.1109/ICDEW.2010.5452756; Thau DM, 2010, THESIS U CALIFORNIA; Thomson RC, 2010, SYST BIOL, V59, P42, DOI 10.1093/sysbio/syp075; Tschope O, 2013, TAXON, V62, P1248, DOI 10.12705/626.4; Tuominen J, 2011, LECT NOTES COMPUT SC, V6644, P255, DOI 10.1007/978-3-642-21064-8_18; Vane-Wright R.I., 2003, Systematics and Biodiversity, V1, P3, DOI 10.1017/S1477200003001063; Vines TH, 2014, CURR BIOL, V24, P94, DOI 10.1016/j.cub.2013.11.014; Voss E., 1954, Beitraege zur Fauna-Perus Jena Bd, V4, P193; Weakley A. S., 2012, FLORA SO MIDATLANTIC; Wibmer G. J., 1986, MEM AM ENTOMOL I, V39, P1; Witteveen J, 2014, BIOL PHIL IN PRESS	101	17	18	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0118247	10.1371/journal.pone.0118247	http://dx.doi.org/10.1371/journal.pone.0118247			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25700173	Green Submitted, Green Published, gold			2022-12-26	WOS:000349789800034
J	Klaver, R; Sanchez, V; Damm, OS; Redmann, K; Lahrmann, E; Sandhowe-Klaverkamp, R; Rohde, C; Wistuba, J; Ehmcke, J; Schlatt, S; Gromoll, J				Klaever, Ruth; Sanchez, Victoria; Damm, Oliver S.; Redmann, Klaus; Lahrmann, Elisabeth; Sandhowe-Klaverkamp, Reinhild; Rohde, Christian; Wistuba, Joachim; Ehmcke, Jens; Schlatt, Stefan; Gromoll, Joerg			Direct but No Transgenerational Effects of Decitabine and Vorinostat on Male Fertility	PLOS ONE			English	Article							HISTONE-DEACETYLASE INHIBITOR; DNA METHYLATION; IMPRINTED GENES; MURINE SPERMATOGENESIS; GERM-CELLS; SPERM DNA; MOUSE; 5-AZA-2'-DEOXYCYTIDINE; INHERITANCE; EPIGENETICS	Establishment and maintenance of the correct epigenetic code is essential for a plethora of physiological pathways and disturbed epigenetic patterns can provoke severe consequences, e.g. tumour formation. In recent years, epigenetic drugs altering the epigenome of tumours actively have been developed for anti-cancer therapies. However, such drugs could potentially also affect other physiological pathways and systems in which intact epigenetic patterns are essential. Amongst those, male fertility is one of the most prominent. Consequently, we addressed possible direct effects of two epigenetic drugs, decitabine and vorinostat, on both, the male germ line and fertility. In addition, we checked for putative transgenerational epigenetic effects on the germ line of subsequent generations (F1-F3). Parental adult male C57BI/6 mice were treated with either decitabine or vorinostat and analysed as well as three subsequent untreated generations derived from these males. Treatment directly affected several reproductive parameters as testis (decitabine & vorinostat) and epididymis weight, size of accessory sex glands (vorinostat), the height of the seminiferous epithelium and sperm concentration and morphology (decitabine). Furthermore, after decitabine administration, DNA methylation of a number of loci was altered in sperm. However, when analysing fertility of treated mice (fertilisation, litter size and sex ratio), no major effect of the selected epigenetic drugs on male fertility was detected. In subsequent generations (F1-F3 generations) only subtle changes on reproductive organs, sperm parameters and DNA methylation but no overall effect on fertility was observed. Consequently, in mice, decitabine and vorinostat neither affected male fertility per se nor caused marked transgenerational effects. We therefore suggest that both drugs do not inducemajor adverse effects-in terms of male fertility and transgenerational epigenetic inheritance-when used in anti-cancer-therapies.	[Klaever, Ruth; Sanchez, Victoria; Damm, Oliver S.; Redmann, Klaus; Lahrmann, Elisabeth; Sandhowe-Klaverkamp, Reinhild; Wistuba, Joachim; Ehmcke, Jens; Schlatt, Stefan; Gromoll, Joerg] Univ Munster, Ctr Reprod Med & Androl, Inst Reprod & Regenerat Biol, D-48149 Munster, Germany; [Rohde, Christian] Univ Halle, Dept Hematol & Oncol, Halle, Germany; [Ehmcke, Jens] Univ Munster, Fac Med, Cent Anim Facil, D-48149 Munster, Germany	University of Munster; Martin Luther University Halle Wittenberg; University of Munster	Gromoll, J (corresponding author), Univ Munster, Ctr Reprod Med & Androl, Inst Reprod & Regenerat Biol, D-48149 Munster, Germany.	Joerg.Gromoll@ukmuenster.de	Gromoll, Joerg/AAB-2146-2019	Gromoll, Joerg/0000-0002-7788-8138	Graduate Program Cell Dynamics and Disease (CEDAD); International Max Planck Research School Molecular Biomedicine (IMPRS-MBM); German Research Foundation (Research Unit "Germ cell potential") [FOR 1041]	Graduate Program Cell Dynamics and Disease (CEDAD); International Max Planck Research School Molecular Biomedicine (IMPRS-MBM); German Research Foundation (Research Unit "Germ cell potential")	This study was supported by Graduate Program Cell Dynamics and Disease (CEDAD) and the International Max Planck Research School - Molecular Biomedicine (IMPRS-MBM) and by German Research Foundation (Research Unit "Germ cell potential" (FOR 1041)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankolkar M, 2012, FERTIL STERIL, V98, P1186, DOI 10.1016/j.fertnstert.2012.07.1143; Benchaib M, 2005, HUM REPROD, V20, P768, DOI 10.1093/humrep/deh684; Biermann K, 2007, J ANDROL, V28, P466, DOI 10.2164/jandrol.106.002048; Braunschweig M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030583; Cisneros FJ, 2003, J APPL TOXICOL, V23, P115, DOI 10.1002/jat.898; Cordero MI, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.32; Damm OS, 2010, ASIAN J ANDROL, V12, P578, DOI 10.1038/aja.2010.50; Daxinger L, 2010, GENOME RES, V20, P1623, DOI 10.1101/gr.106138.110; Ehmcke J, 2006, HUM REPROD UPDATE, V12, P275, DOI 10.1093/humupd/dmk001; El Hajj N, 2011, SEX DEV, V5, P60, DOI 10.1159/000323806; Evenson D, 2001, CURR PROTOC CYTOM, DOI DOI 10.1002/0471142956.CY0713S13; Fenic I, 2004, J ANDROL, V25, P811; Franklin TB, 2010, NEUROBIOL DIS, V39, P61, DOI 10.1016/j.nbd.2009.11.012; Gonzalez C, 2012, STEM CELL TRANSL MED, V1, P668, DOI 10.5966/sctm.2012-0076; Guerrero-Bosagna C, 2012, REPROD TOXICOL, V34, P694, DOI 10.1016/j.reprotox.2012.09.005; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hrzenjak A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-49; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kelly TK, 2010, NAT BIOTECHNOL, V28, P1069, DOI 10.1038/nbt.1678; Kelly TLJ, 2003, J ANDROL, V24, P822; Kelly WK, 2005, NAT CLIN PRACT ONCOL, V2, P150, DOI 10.1038/ncponc0106; Klaver R, 2013, ANDROLOGY-US, V1, P731, DOI 10.1111/j.2047-2927.2013.00118.x; Kobayashi H, 2007, HUM MOL GENET, V16, P2542, DOI 10.1093/hmg/ddm187; Kobayashi H, 2009, EUR J HUM GENET, V17, P1582, DOI 10.1038/ejhg.2009.68; Mack GS, 2010, NAT BIOTECHNOL, V28, P1259, DOI 10.1038/nbt.1724; Manikkam M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055387; Manikkam M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046249; Marks PA, 2007, NAT BIOTECHNOL, V25, P84, DOI 10.1038/nbt1272; Marques CJ, 2008, MOL HUM REPROD, V14, P67, DOI 10.1093/molehr/gam093; Mohamed ESA, 2010, HUM REPROD, V25, P2427, DOI 10.1093/humrep/deq205; Oakes CC, 2007, J PHARMACOL EXP THER, V322, P1171, DOI 10.1124/jpet.107.121699; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Plautz SC, 2013, ECOTOXICOLOGY, V22, P854, DOI 10.1007/s10646-013-1056-y; Poplinski A, 2010, INT J ANDROL, V33, P642, DOI 10.1111/j.1365-2605.2009.01000.x; Qiu J, 2006, NATURE, V441, P143, DOI 10.1038/441143a; RAMAN R, 1995, MOL REPROD DEV, V42, P284, DOI 10.1002/mrd.1080420304; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Reuter K, 2014, TISSUE CELL, V46, P86, DOI 10.1016/j.tice.2013.12.001; Richards EJ, 2006, NAT REV GENET, V7, P395, DOI 10.1038/nrg1834; Rotondo JC, 2012, HUM REPROD, V27, P3632, DOI 10.1093/humrep/des319; Santos F, 2004, REPRODUCTION, V127, P643, DOI 10.1530/rep.1.00221; Schoofs T, 2013, BLOOD, V121, P178, DOI 10.1182/blood-2012-08-448860; Smith ZD, 2009, METHODS, V48, P226, DOI 10.1016/j.ymeth.2009.05.003; Stimson L, 2009, ANN ONCOL, V20, P1293, DOI 10.1093/annonc/mdn792; Stouder C, 2010, REPRODUCTION, V139, P373, DOI 10.1530/REP-09-0340; Stresemann C, 2008, INT J CANCER, V123, P8, DOI 10.1002/ijc.23607; Trasler JM, 2009, MOL CELL ENDOCRINOL, V306, P33, DOI 10.1016/j.mce.2008.12.018; Trost LW, 2012, CURR TREAT OPTION ON, V13, P146, DOI 10.1007/s11864-012-0191-7; TURUSOV VS, 1990, CANCER LETT, V55, P227, DOI 10.1016/0304-3835(90)90123-F; Walker AK, 2012, PSYCHONEUROENDOCRINO, V37, P1320, DOI 10.1016/j.psyneuen.2012.01.005; Wise LD, 2008, BIRTH DEFECTS RES B, V83, P19, DOI 10.1002/bdrb.20139; World Health Organization (WHO), 2021, WHO LAB MAN EX PROC, V6th, DOI DOI 10.HTTP://WHQLIBD0C.WH0.INT/PUBLICATI0NS/2010/9789241547789_; Yang XJ, 2010, TRENDS PHARMACOL SCI, V31, P536, DOI 10.1016/j.tips.2010.08.001; Youngson NA, 2008, ANNU REV GENOM HUM G, V9, P233, DOI 10.1146/annurev.genom.9.081307.164445; Zucchi Fabiola C. R., 2012, Frontiers in Genetics, V3, P96, DOI 10.3389/fgene.2012.00096	55	9	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117839	10.1371/journal.pone.0117839	http://dx.doi.org/10.1371/journal.pone.0117839			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692788	Green Submitted, gold, Green Published			2022-12-26	WOS:000350061500078
J	Kryvasheyeu, Y; Chen, HH; Moro, E; Van Hentenryck, P; Cebrian, M				Kryvasheyeu, Yury; Chen, Haohui; Moro, Esteban; Van Hentenryck, Pascal; Cebrian, Manuel			Performance of Social Network Sensors during Hurricane Sandy	PLOS ONE			English	Article							CLIMATE; SENTIMENT; SCIENCE; RISK	Information flow during catastrophic events is a critical aspect of disaster management. Modern communication platforms, in particular online social networks, provide an opportunity to study such flow and derive early-warning sensors, thus improving emergency preparedness and response. Performance of the social networks sensor method, based on topological and behavioral properties derived from the "friendship paradox", is studied here for over 50 million Twitter messages posted before, during, and after Hurricane Sandy. We find that differences in users' network centrality effectively translate into moderate awareness advantage (up to 26 hours); and that geo-location of users within or outside of the hurricane-affected area plays a significant role in determining the scale of such an advantage. Emotional response appears to be universal regardless of the position in the network topology, and displays characteristic, easily detectable patterns, opening a possibility to implement a simple "sentiment sensing" technique that can detect and locate disasters.	[Kryvasheyeu, Yury; Chen, Haohui; Van Hentenryck, Pascal; Cebrian, Manuel] Natl Informat & Commun Technol Australia, Melbourne, Vic, Australia; [Moro, Esteban] Univ Carlos III Madrid, Dept Math, Leganas, Spain; [Moro, Esteban] Univ Carlos III Madrid, GISC, Leganas, Spain; [Moro, Esteban] Univ Autonoma Madrid, Inst Ingn Conocimiento, Madrid, Spain; [Van Hentenryck, Pascal] Australian Natl Univ, Res Sch Comp Sci, Canberra, ACT, Australia; [Cebrian, Manuel] Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA	Universidad Carlos III de Madrid; Universidad Carlos III de Madrid; Autonomous University of Madrid; Australian National University; University of California System; University of California San Diego	Cebrian, M (corresponding author), Natl Informat & Commun Technol Australia, Melbourne, Vic, Australia.	manuel.cebrian@nicta.com.au	Moro, Esteban/AAB-1159-2019; Chen, Haohui/AAE-5619-2022; Chen, Haohui/T-8965-2018	Moro, Esteban/0000-0003-2894-1024; Chen, Haohui/0000-0001-8976-3634; Chen, Haohui/0000-0001-8976-3634	Australian Government; Australian Research Council through the ICT Centre of Excellence program; Spanish Ministry of Science and Technology [FIS2013-47532-C3-3-P]; Army Research Laboratory [W911NF-09-2-0053, W911NF-11-1-0363]; National Science Foundation [0905645]; DARPA/Lockheed Martin Guard Dog Programme [PO 4100149822]	Australian Government(Australian GovernmentCGIAR); Australian Research Council through the ICT Centre of Excellence program(Australian Research Council); Spanish Ministry of Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); National Science Foundation(National Science Foundation (NSF)); DARPA/Lockheed Martin Guard Dog Programme	Yury Kryvasheyeu, Haohui Chen, Pascal Van Hentenryck and Manuel Cebrian acknowledge the support of the Australian Government represented by the Department of Broadband, Communications and Digital Economy; and the Australian Research Council through the ICT Centre of Excellence program. Esteban Moro acknowledges the support of Spanish Ministry of Science and Technology under grant FIS2013-47532-C3-3-P. This research was also supported by the Army Research Laboratory under Cooperative Agreement Numbers W911NF-09-2-0053 and W911NF-11-1-0363, the National Science Foundation under grant 0905645, and DARPA/Lockheed Martin Guard Dog Programme under PO 4100149822. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagrow JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017680; Baker E.J., 1991, INT J MASS EMERGENCI, V9, P287; Blake ES., 2013, NATL HURRICANE CTR, V12, P1; Caragea C., 2011, P 8 INT C INF SYST C; Christakis NA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012948; Cooper S, 2010, NATURE, V466, P756, DOI 10.1038/nature09304; Cutter SL, 2008, P NATL ACAD SCI USA, V105, P2301, DOI 10.1073/pnas.0710375105; Diffenbaugh NS, 2013, SCIENCE, V341, P486, DOI 10.1126/science.1237123; Earle PS, 2011, ANN GEOPHYS-ITALY, V54, P708, DOI 10.4401/ag-5364; Eom Y-H, 2014, ARXIV14011458; FELD SL, 1991, AM J SOCIOL, V96, P1464, DOI 10.1086/229693; Gao L, 2014, SCI REP-UK, V4, DOI 10.1038/srep03997; Garcia-Herranz M., 2014, PLoS ONE, V9, pe92413, DOI 10.1371/journal.pone.0092413; Golder SA, 2011, SCIENCE, V333, P1878, DOI 10.1126/science.1202775; Guikema SD, 2009, SCIENCE, V323, P1302, DOI 10.1126/science.1169057; Guy M, 2010, LECT NOTES COMPUT SC, V6065, P42; Helbing D, 2000, NATURE, V407, P487, DOI 10.1038/35035023; Helbing D, 2013, NATURE, V497, P51, DOI 10.1038/nature12047; Helbing D, 2012, EPJ DATA SCI, V1, DOI 10.1140/epjds7; Hodas NO, 2013, P 7 INT AAAI C WEBL, P225; Hughes AL, 2009, INT J EMERG MANAG, V6, P248, DOI 10.1504/IJEM.2009.031564; Kennedy D, 2002, SCIENCE, V295, P405, DOI 10.1126/science.295.5554.405; Kooti F, 2014, P 8 INT AAAI C WEBL, P266; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Li J, 2010, ELECTR J INF SYS DEV, V42; Mislove A, 2011, P INT AAAI C WEB SOC; National Hurricane Center, 2013, NHC GIS ARCH TROP CY; Nelson Bryn, 2013, Nature, V495, P271; Pennebaker J. W., 2001, LINGUISTIC INQUIRY W; Perry RW, 2003, DISASTERS, V27, P336, DOI 10.1111/j.0361-3666.2003.00237.x; Pickard G, 2011, SCIENCE, V334, P509, DOI 10.1126/science.1205869; Preis T, 2013, SCI REP-UK, V3, DOI 10.1038/srep03141; Press F, 1999, SCIENCE, V284, P1927, DOI 10.1126/science.284.5422.1927; Quarantelli E.L., 1980, EVACUATION BEHAV PRO; Rahwan I, 2013, COMPUTER, V46, P68, DOI 10.1109/MC.2012.295; Riad JK, 1999, J APPL SOC PSYCHOL, V29, P918, DOI 10.1111/j.1559-1816.1999.tb00132.x; Sakaki T., 2010, P 19 INT C WORLD WID, P851, DOI [10.1145/1772690.1772777, DOI 10.1145/1772690.1772777, 10.1145/1772690.1772777.]; Schiermeier Q, 2006, NATURE, V441, P674, DOI 10.1038/441674b; Sun LJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep05099; Taboada M, 2011, COMPUT LINGUIST, V37, P267, DOI 10.1162/COLI_a_00049; Thelwall M, 2010, J AM SOC INF SCI TEC, V61, P2544, DOI 10.1002/asi.21416; Tollefson J, 2012, NATURE NEWS, DOI [10.1111/cob.12003, DOI 10.1111/COB.12003]; van Aalst MK, 2006, DISASTERS, V30, P5, DOI 10.1111/j.1467-9523.2006.00303.x; Vespignani A, 2009, SCIENCE, V325, P425, DOI 10.1126/science.1171990; von Ahn L, 2008, SCIENCE, V321, P1465, DOI 10.1126/science.1160379; Wang D, 2012, SOCIAL NETWORKS EMER; Watts D, 2013, WORKSH CURR KNOWL RE	47	70	72	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117288	10.1371/journal.pone.0117288	http://dx.doi.org/10.1371/journal.pone.0117288			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC0WZ	25692690	Green Published, gold, Green Submitted			2022-12-26	WOS:000350061500047
J	Ouennane, S; Leprohon, P; Moineau, S				Ouennane, Siham; Leprohon, Philippe; Moineau, Sylvain			Diverse Virulent Pneumophages Infect Streptococcus mitis	PLOS ONE			English	Article							FATAL PNEUMOCOCCAL PNEUMONIA; BACTERIOPHAGE LYTIC ENZYME; LACTOCOCCUS-LACTIS; TEMPERATE BACTERIOPHAGE; GENOMIC ANALYSIS; DNA-REPLICATION; ENDOLYSIN CPL-1; RESCUES MICE; PHAGE; EVOLUTION	Streptococcus mitis has emerged as one of the leading causes of bacterial endocarditis and is related to Streptococcus pneumoniae. Antibiotic resistance has also increased among strains of S. mitis and S. pneumoniae. Phages are being reinvestigated as alternatives to antibiotics for managing infections. In this study, the two virulent phages Cp-1 (Podoviridae) and Dp-1 (Siphoviridae), previously isolated from S. pneumoniae, were found to also infect S. mitis. Microbiological assays showed that both pneumophages could not only replicate in S. mitis but also produced more visible plaques on this host. However, the burst size and phage adsorption data were lower in S. mitis as compared to S. pneumoniae. A comparison of the genomes of each phage grown on both hosts produced identical nucleotide sequences, confirming that the same phages infect both bacterial species. We also discovered that the genomic sequence of podophage Cp-1 of the Felix d'Herelle collection is different than the previously reported sequence and thus renamed SOCP.	[Ouennane, Siham; Moineau, Sylvain] Univ Laval, Fac Med Dent, Felix Herelle Reference Ctr Bacterial Viruses, Grp Rech Ecol Buccale,Fac Sci & Genie,Dept Bioch, Quebec City, PQ, Canada; [Leprohon, Philippe] Univ Laval, Fac Med, Dept Microbiol Infectiol & Immunol, Quebec City, PQ G1K 7P4, Canada	Laval University; Laval University	Moineau, S (corresponding author), Univ Laval, Fac Med Dent, Felix Herelle Reference Ctr Bacterial Viruses, Grp Rech Ecol Buccale,Fac Sci & Genie,Dept Bioch, Quebec City, PQ, Canada.	Sylvain.Moineau@bcm.ulaval.ca	Moineau, Sylvain/N-3578-2013; Leprohon, Philippe/U-5474-2019; Moineau, Sylvain/I-7231-2019	Moineau, Sylvain/0000-0002-2832-5101	Canadian Institutes of Health Research (CIHR); Programme Canadien de Bourse de la Francophonie (PCBF); CIHR	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Programme Canadien de Bourse de la Francophonie (PCBF); CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by an Emerging Team Grant from the Canadian Institutes of Health Research (CIHR). S.O. is the recipient of a scholarship from the Programme Canadien de Bourse de la Francophonie (PCBF) and (CIHR). S.M. holds a Tier 1 Canada Research Chair in Bacteriophages. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai J, 2011, J CLIN MICROBIOL, V49, P1646, DOI 10.1128/JCM.01990-10; Arbique JC, 2004, J CLIN MICROBIOL, V42, P4686, DOI 10.1128/JCM.42.10.4686-4696.2004; Benmayor R, 2009, CURR BIOL, V19, P764, DOI 10.1016/j.cub.2009.03.023; CARRASCOSA M, 1994, CLIN INFECT DIS, V19, P781, DOI 10.1093/clinids/19.4.781; Denapaite D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009426; Djurkovic S, 2005, ANTIMICROB AGENTS CH, V49, P1225, DOI 10.1128/AAC.49.3.1225-1228.2005; Doehn JM, 2013, J ANTIMICROB CHEMOTH, V68, P2111, DOI 10.1093/jac/dkt131; Doern CD, 2010, J CLIN MICROBIOL, V48, P3829, DOI 10.1128/JCM.01563-10; Donkor ES, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00007; Duplessis M, 2001, MOL MICROBIOL, V41, P325, DOI 10.1046/j.1365-2958.2001.02521.x; Gindreau E, 2000, J VIROL, V74, P7803, DOI 10.1128/JVI.74.17.7803-7813.2000; Gutierrez A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2607; Hauser R, 2011, J BACTERIOL, V193, P3135, DOI 10.1128/JB.01481-10; Hall JPJ, 2013, CURR OPIN VIROL, V3, P572, DOI 10.1016/j.coviro.2013.07.001; Henderson-Begg SK, 2006, J ANTIMICROB CHEMOTH, V57, P849, DOI 10.1093/jac/dkl064; Ikryannikova LN, 2013, CLIN MICROBIOL INFEC, V19, P1066, DOI 10.1111/1469-0691.12113; Joyce EA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-404; Kilian M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002683; Kotsonis SE, 2008, APPL ENVIRON MICROB, V74, P3453, DOI 10.1128/AEM.02379-07; Kraemer L, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-41; KRAUSE RM, 1957, J EXP MED, V106, P365, DOI 10.1084/jem.106.3.365; Loeffler JM, 2003, ANTIMICROB AGENTS CH, V47, P375, DOI 10.1128/AAC.47.1.375-377.2003; Loeffler JM, 2003, INFECT IMMUN, V71, P6199, DOI 10.1128/IAI.71.11.6199-6204.2003; Longas E, 2008, P NATL ACAD SCI USA, V105, P18290, DOI 10.1073/pnas.0809882105; LOPEZ R, 1982, J BACTERIOL, V151, P1581, DOI 10.1128/JB.151.3.1581-1590.1982; LOPEZ R, 1977, J VIROL, V24, P201, DOI 10.1128/JVI.24.1.201-210.1977; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Madhour A, 2011, IRAN J MICROBIOL, V3, P58; MARK DF, 1976, P NATL ACAD SCI USA, V73, P780, DOI 10.1073/pnas.73.3.780; Martin AC, 1996, J MOL BIOL, V260, P369, DOI 10.1006/jmbi.1996.0407; Martin AC, 1998, J VIROL, V72, P3491; McCullers JA, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030028; MCDONNELL M, 1975, VIROLOGY, V63, P577, DOI 10.1016/0042-6822(75)90329-3; Mitchell J, 2011, MOL ORAL MICROBIOL, V26, P89, DOI 10.1111/j.2041-1014.2010.00601.x; MOINEAU S, 1993, APPL ENVIRON MICROB, V59, P208, DOI 10.1128/AEM.59.1.208-212.1993; Nelson D, 2001, P NATL ACAD SCI USA, V98, P4107, DOI 10.1073/pnas.061038398; Prudhomme M, 2006, SCIENCE, V313, P89, DOI 10.1126/science.1127912; Ramirez M, 1999, J BACTERIOL, V181, P3618, DOI 10.1128/JB.181.12.3618-3625.1999; Raskin DM, 2006, CELL, V124, P703, DOI 10.1016/j.cell.2006.02.002; Rigvava S, 2013, CAN J MICROBIOL, V59, P18, DOI 10.1139/cjm-2012-0385; Romero P, 2009, J BACTERIOL, V191, P4854, DOI 10.1128/JB.01272-08; RONDA C, 1981, J VIROL, V40, P551, DOI 10.1128/JVI.40.2.551-559.1981; RONDA C, 1989, FEMS MICROBIOL LETT, V65, P187, DOI 10.1016/0378-1097(89)90389-3; RONDALAIN C, 1977, J VIROL, V21, P366, DOI 10.1128/JVI.21.1.366-374.1977; Rousseau GM, 2009, APPL ENVIRON MICROB, V75, P5336, DOI 10.1128/AEM.00761-09; Rukke HV, 2012, MOL ORAL MICROBIOL, V27, P95, DOI 10.1111/j.2041-1014.2011.00635.x; Sabri M, 2011, J BACTERIOL, V193, P551, DOI 10.1128/JB.01117-10; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Samson JE, 2010, APPL ENVIRON MICROB, V76, P6843, DOI 10.1128/AEM.00796-10; Serwer P, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-21; Sheppard CL, 2004, J MED MICROBIOL, V53, P189, DOI 10.1099/jmm.0.05460-0; Siboo IR, 2003, J BACTERIOL, V185, P6968, DOI 10.1128/JB.185.23.6968-6975.2003; Staden R, 2000, Methods Mol Biol, V132, P115; Sunderkotter C, 2014, HAUTARZT, V65, P113, DOI 10.1007/s00105-013-2743-6; TIRABY JG, 1975, VIROLOGY, V68, P566, DOI 10.1016/0042-6822(75)90300-1; Witzenrath M, 2009, CRIT CARE MED, V37, P642, DOI 10.1097/CCM.0b013e31819586a6; Zahner D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025124	57	11	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118807	10.1371/journal.pone.0118807	http://dx.doi.org/10.1371/journal.pone.0118807			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692983	Green Submitted, Green Published, gold			2022-12-26	WOS:000350061500130
J	Bergman, ZJ; Mclaurin, JD; Eritano, AS; Johnson, BM; Sims, AQ; Riggs, B				Bergman, Zane J.; Mclaurin, Justin D.; Eritano, Anthony S.; Johnson, Brittany M.; Sims, Amanda Q.; Riggs, Blake			Spatial Reorganization of the Endoplasmic Reticulum during Mitosis Relies on Mitotic Kinase Cyclin A in the Early Drosophila Embryo	PLOS ONE			English	Article							NUCLEAR-ENVELOPE BREAKDOWN; TO-TUBULE TRANSFORMATION; CELL-CYCLE; CHROMOSOME CONDENSATION; MEMBRANE-PROTEINS; MAMMALIAN-CELLS; LAVA LAMP; MICROTUBULES; GOLGI; POLO	Mitotic cyclin-dependent kinase with their cyclin partners (cyclin:Cdks) are the master regulators of cell cycle progression responsible for regulating a host of activities during mitosis. Nuclear mitotic events, including chromosome condensation and segregation have been directly linked to Cdk activity. However, the regulation and timing of cytoplasmic mitotic events by cyclin: Cdks is poorly understood. In order to examine these mitotic cytoplasmic events, we looked at the dramatic changes in the endoplasmic reticulum (ER) during mitosis in the early Drosophila embryo. The dynamic changes of the ER can be arrested in an interphase state by inhibition of either DNA or protein synthesis. Here we show that this block can be alleviated by micro-injection of Cyclin A (CycA) in which defined mitotic ER clusters gathered at the spindle poles. Conversely, micro-injection of Cyclin B (CycB) did not affect spatial reorganization of the ER, suggesting CycA possesses the ability to initiate mitotic ER events in the cytoplasm. Additionally, RNAi-mediated simultaneous inhibition of all 3 mitotic cyclins (A, B and B3) blocked spatial reorganization of the ER. Our results suggest that mitotic ER reorganization events rely on CycA and that control and timing of nuclear and cytoplasmic events during mitosis may be defined by release of CycA from the nucleus as a consequence of breakdown of the nuclear envelope.	[Bergman, Zane J.; Mclaurin, Justin D.; Eritano, Anthony S.; Johnson, Brittany M.; Sims, Amanda Q.; Riggs, Blake] San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA	California State University System; San Francisco State University	Riggs, B (corresponding author), San Francisco State Univ, Dept Biol, 1600 Holloway Ave, San Francisco, CA 94132 USA.	riggs@sfsu.edu	Eritano, Anthony/AAG-6597-2019	Eritano, Anthony/0000-0002-3214-9593	National Institute of Health, Minority Biomedical Research Support (MBRS) [R25-GM059298Z]; Genentech Foundation [3179555]; National Institute of Health, Support of Competitive Research (SCORE) Program [5SC2 GM098229-02]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC2GM098229] Funding Source: NIH RePORTER	National Institute of Health, Minority Biomedical Research Support (MBRS); Genentech Foundation(Roche HoldingGenentech); National Institute of Health, Support of Competitive Research (SCORE) Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding provided by National Institute of Health, Minority Biomedical Research Support (MBRS) R25-GM059298Z, BMJ, ASE, Genentech Foundation MS Dissertation Scholarship, grant #3179555, JDM, National Institute of Health, Support of Competitive Research (SCORE) Program, 5SC2 GM098229-02, BR, ZJB, AQS. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DJ, 2008, J CELL SCI, V121, P137, DOI 10.1242/jcs.005777; Anderson DJ, 2009, J CELL BIOL, V186, P183, DOI 10.1083/jcb.200901106; Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Bobinnec Y, 2003, CELL MOTIL CYTOSKEL, V54, P217, DOI 10.1002/cm.10094; Brust-Mascher Ingrid, 2009, J Vis Exp, DOI 10.3791/1382; Chen SL, 2012, NAT CELL BIOL, V14, P707, DOI 10.1038/ncb2523; Debec A, 1996, J CELL BIOL, V134, P103, DOI 10.1083/jcb.134.1.103; Dreier L, 2000, J CELL BIOL, V148, P883, DOI 10.1083/jcb.148.5.883; Echard A, 2003, CURR BIOL, V13, P373, DOI 10.1016/S0960-9822(03)00127-1; EDGAR BA, 1994, CURR BIOL, V4, P522, DOI 10.1016/S0960-9822(00)00113-5; FOE VE, 1983, J CELL SCI, V61, P31; Foley E, 2004, PLOS BIOL, V2, P1091, DOI 10.1371/journal.pbio.0020203; Frescas D, 2006, J CELL BIOL, V173, P219, DOI 10.1083/jcb.200601156; Gavet O, 2010, J CELL BIOL, V189, P247, DOI 10.1083/jcb.200909144; GLOVER DM, 1991, TRENDS GENET, V7, P125, DOI 10.1016/0168-9525(91)90457-2; Gong DQ, 2007, CURR BIOL, V17, P85, DOI 10.1016/j.cub.2006.11.066; Gong D, 2010, MOL BIOL CELL, V21, P3149, DOI 10.1091/mbc.E10-05-0393; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; HEALD R, 1993, CELL, V74, P463, DOI 10.1016/0092-8674(93)80048-J; Hinchcliffe EH, 1999, J CELL SCI, V112, P1139; Hughes AFW, 1952, MITOTIC CYCLIC CYTOP; Irniger S, 2002, FEBS LETT, V532, P7, DOI 10.1016/S0014-5793(02)03657-8; JACKMAN M, 1995, EMBO J, V14, P1646, DOI 10.1002/j.1460-2075.1995.tb07153.x; Klopfenstein DRC, 1998, EMBO J, V17, P6168, DOI 10.1093/emboj/17.21.6168; Lee CP, 2007, J VIROL, V81, P5166, DOI 10.1128/JVI.00120-07; LEHNER CF, 1990, CELL, V61, P535, DOI 10.1016/0092-8674(90)90535-M; LLAMAZARES S, 1991, GENE DEV, V5, P2153, DOI 10.1101/gad.5.12a.2153; Lowe M, 1998, CELL, V94, P783, DOI 10.1016/S0092-8674(00)81737-7; Lu L, 2011, J CELL BIOL, V194, P425, DOI 10.1083/jcb.201012063; Lu L, 2009, MOL BIOL CELL, V20, P3471, DOI 10.1091/mbc.E09-04-0327; Lumb JH, 2012, BBA-MOL CELL RES, V1823, P192, DOI 10.1016/j.bbamcr.2011.08.010; LUSCHER B, 1991, EMBO J, V10, P865, DOI 10.1002/j.1460-2075.1991.tb08019.x; McCleland ML, 2008, CURR BIOL, V18, P245, DOI 10.1016/j.cub.2008.01.041; McCleland ML, 2009, J CELL BIOL, V184, P639, DOI 10.1083/jcb.200810012; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Nakajima H, 2008, J CELL BIOL, V181, P89, DOI 10.1083/jcb.200708176; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Oliveira RA, 2010, NAT CELL BIOL, V12, P185, DOI 10.1038/ncb2018; Orso G, 2009, NATURE, V460, P978, DOI 10.1038/nature08280; Papoulas O, 2005, NAT CELL BIOL, V7, P612, DOI 10.1038/ncb1264; Parry DH, 2001, CURR BIOL, V11, P671, DOI 10.1016/S0960-9822(01)00204-4; Pines J, 2006, TRENDS CELL BIOL, V16, P55, DOI 10.1016/j.tcb.2005.11.006; Poteryaev D, 2005, MOL BIOL CELL, V16, P2139, DOI 10.1091/mbc.E04-08-0726; Puhka M, 2007, J CELL BIOL, V179, P895, DOI 10.1083/jcb.200705112; Puhka M, 2012, MOL BIOL CELL, V23, P2424, DOI 10.1091/mbc.E10-12-0950; Rape M, 2006, CELL, V124, P89, DOI 10.1016/j.cell.2005.10.032; Roll-Mecak A, 2005, CURR BIOL, V15, P650, DOI 10.1016/j.cub.2005.02.029; Royou A, 2008, J CELL BIOL, V183, P63, DOI 10.1083/jcb.200801153; Sharp DJ, 2000, NAT CELL BIOL, V2, P922, DOI 10.1038/35046574; Shibata Y, 2006, CELL, V126, P435, DOI 10.1016/j.cell.2006.07.019; Sisson JC, 2000, J CELL BIOL, V151, P905, DOI 10.1083/jcb.151.4.905; Stiffler LA, 1999, DEVELOPMENT, V126, P5505; Sullivan M, 2007, NAT REV MOL CELL BIO, V8, P894, DOI 10.1038/nrm2276; SUNKEL CE, 1988, J CELL SCI, V89, P25; Takizawa CG, 2000, CURR OPIN CELL BIOL, V12, P658, DOI 10.1016/S0955-0674(00)00149-6; TERASAKI M, 1986, J CELL BIOL, V103, P1557, DOI 10.1083/jcb.103.4.1557; Tram U, 2001, METHOD CELL BIOL, V67, P113; Tsang WY, 2007, J CELL BIOL, V178, P621, DOI 10.1083/jcb.200701166; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Voeltz GK, 2002, EMBO REP, V3, P944, DOI 10.1093/embo-reports/kvf202; Wang SY, 2013, J CELL BIOL, V203, P801, DOI 10.1083/jcb.201308001; Watanabe N, 2005, P NATL ACAD SCI USA, V102, P11663, DOI 10.1073/pnas.0500410102; Waterman-Storer CM, 1998, CURR BIOL, V8, P798, DOI 10.1016/S0960-9822(98)70321-5; Yang J, 1999, TRENDS CELL BIOL, V9, P207, DOI 10.1016/S0962-8924(99)01577-9; Yu KR, 2000, NAT CELL BIOL, V2, P609, DOI 10.1038/35023555	66	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117859	10.1371/journal.pone.0117859	http://dx.doi.org/10.1371/journal.pone.0117859			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689737	Green Submitted, gold, Green Published			2022-12-26	WOS:000350322700079
J	Hu, L; Xiao, YH; Fang, M; Gao, Y; Huang, L; Jia, AQ; Chen, JH				Hu, Lin; Xiao, Yu-hong; Fang, Ming; Gao, Yu; Huang, Li; Jia, An-qi; Chen, Ji-hua			Effects of Type I Collagen Degradation on the Durability of Three Adhesive Systems in the Early Phase of Dentin Bonding	PLOS ONE			English	Article							ENZYMATIC DEGRADATION; INTERFACES; SEPARATION; FIBRILS; MATRIX; STEP	Objective This study was designed to evaluate the effects of type I collagen degradation on the durability of three adhesive systems in the early phase of dentin bonding. Methods Bonded dentin specimens were prepared using three different types of adhesive systems. Micro-tensile bond strength and degradation of collagen were tested before, and after 1 month or 4 months of aging in artificial saliva. The relationship between micro-tensile bond strength and collagen degradation was analyzed by calculating their Pearson's correlation coefficient. Results Aging induced time-dependent reduction in micro-tensile bond strengths for all the tested adhesive systems, although such reduction for the single-step self-etching adhesive G-Bond (GB) was not statistically significant. The bond strength of the two-step self-etching primer adhesive system Clearfil SE Bond (SEB) was similar to that of the two-step etchand-rinse self-priming adhesive system Single Bond 2 (SB), and they were both significantly reduced after one or four months of aging. A negative correlation was found between the degree of collagen degradation and magnitude of micro-tensile bond strength (r = -0.65, p = 0.003). The Pearson's correlation coefficient was 0.426, indicating that 42.6% of the aging-induced reduction in bond strength can be explained by the degradation of collagen. Conclusions In the early phase of dentin bonding, there was a negative correlation between the degree of collagen degradation and the magnitude of micro-tensile bond strength. The reduction of bond strength was accompanied by the degradation of collagen. These results provide evidence for the causative relationship between the degradation of collagen and the deterioration of dentin-adhesive interface.	[Hu, Lin; Fang, Ming; Gao, Yu; Huang, Li; Chen, Ji-hua] Fourth Mil Med Univ, Sch Stomatol, Dept Prosthodont, State Key Lab Mil Stomatol, Xian 710032, Peoples R China; [Xiao, Yu-hong; Jia, An-qi] Chengdu Mil Command, Dept Stomatol, Kunming Gen Hosp, Kunming 650032, Peoples R China	Air Force Military Medical University; Kunming General Hospital	Chen, JH (corresponding author), Fourth Mil Med Univ, Sch Stomatol, Dept Prosthodont, State Key Lab Mil Stomatol, Xian 710032, Peoples R China.	jhchen@fmmu.edu.cn		Chen, Ji-hua/0000-0002-1151-0693	Natural Science Foundation of China [81130078, 30973356]; Program for Changjiang Scholars and Innovative Research Team in University [IRT13051]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This research work was financially supported by grants from Program No. IRT13051 for Changjiang Scholars and Innovative Research Team in University and the grants from Natural Science Foundation of China (No. 81130078, 30973356). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharjee A, 2005, IUBMB LIFE, V57, P161, DOI 10.1080/15216540500090710; Breschi L, 2002, DENT MATER, V18, P26, DOI 10.1016/S0109-5641(01)00017-3; De Munck J, 2003, J DENT RES, V82, P136, DOI 10.1177/154405910308200212; De Munck J, 2009, J DENT RES, V88, P1101, DOI 10.1177/0022034509346952; De Munck J, 2010, EUR J ORAL SCI, V118, P494, DOI 10.1111/j.1600-0722.2010.00758.x; Hashimoto M, 2010, EUR J ORAL SCI, V118, P404, DOI 10.1111/j.1600-0722.2010.00744.x; Inoue S, 2001, J Adhes Dent, V3, P237; Kinney JH, 1996, J BIOMECH ENG-T ASME, V118, P133, DOI 10.1115/1.2795939; KLONT B, 1990, J DENT RES, V69, P896, DOI 10.1177/00220345900690031301; Marshall GW, 1997, J DENT, V25, P441, DOI 10.1016/S0300-5712(96)00065-6; Pashley DH, 2011, DENT MATER, V27, P1, DOI 10.1016/j.dental.2010.10.016; PASHLEY DH, 1991, J PROSTHET DENT, V66, P777, DOI 10.1016/0022-3913(91)90414-R; Pashley DH, 2004, J DENT RES, V83, P216, DOI 10.1177/154405910408300306; Perdigao J, 2004, DENT MATER, V26, pe24; Poitevin A, 2008, J ADHES DENT, V10, P7; Reis A, 2004, DENT MATER, V20, P669, DOI 10.1016/j.dental.2003.11.006; Scott JE, 1998, J ANAT, V192, P391, DOI 10.1046/j.1469-7580.1998.19230391.x; Shin TP, 2009, DENT MATER, V25, P1050, DOI 10.1016/j.dental.2009.03.006; Shono Y, 1999, J Adhes Dent, V1, P211; Spencer P, 2002, J BIOMED MATER RES, V62, P447, DOI 10.1002/jbm.10364; Spreafico D, 2006, J DENT, V34, P237, DOI 10.1016/j.jdent.2005.06.004; Van Landuyt KL, 2005, J DENT RES, V84, P183, DOI 10.1177/154405910508400214; Van Meerbeek B, 2003, OPER DENT, V28, P215; Van Meerbeek B, 2011, DENT MATER, V27, P17, DOI 10.1016/j.dental.2010.10.023; Yang B, 2005, BIOMATERIALS, V26, P5021, DOI 10.1016/j.biomaterials.2005.01.024; Yoshida Y, 2004, J DENT RES, V83, P454, DOI 10.1177/154405910408300604; Zhang SC, 2009, INT J ORAL SCI, V1, P163, DOI 10.4248/IJOS.09044; Zheng X, 2011, J MICROSC-OXFORD, V241, P162, DOI 10.1111/j.1365-2818.2010.03412.x	28	9	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0116790	10.1371/journal.pone.0116790	http://dx.doi.org/10.1371/journal.pone.0116790			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689141	Green Published, Green Submitted, gold			2022-12-26	WOS:000350322700022
J	Jean, MRN; Gonzalez-Rizzo, S; Gauffre-Autelin, P; Lengger, SK; Schouten, S; Gros, O				Jean, Maitena R. N.; Gonzalez-Rizzo, Silvina; Gauffre-Autelin, Pauline; Lengger, Sabine K.; Schouten, Stefan; Gros, Olivier			Two New Beggiatoa Species Inhabiting Marine Mangrove Sediments in the Caribbean	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; FILAMENTOUS SULFUR BACTERIA; TARGETED OLIGONUCLEOTIDE PROBES; RAMAN MICROSPECTROMETRY; NICHE DIFFERENTIATION; OXIDIZING BACTERIA; NITRATE; MAT; HYPERSALINE; THIOPLOCA	Beggiatoaceae, giant sulphur-oxidizing bacteria, are well known to occur in cold and temperate waters, as well as hydrothermal vents, where they form dense mats on the floor. However, they have never been described in tropical marine mangroves. Here, we describe two new species of benthic Beggiatoaceae colonizing a marine mangrove adjacent to mangrove roots. We combined phylogenetic and lipid analysis with electron microscopy in order to describe these organisms. Furthermore, oxygen and sulphide measurements in and ex situ were performed in a mesocosm to characterize their environment. Based on this, two new species, Candidatus Maribeggiatoa sp. and Candidatus Isobeggiatoa sp. inhabiting tropical marine mangroves in Guadeloupe were identified. The species identified as Candidatus Maribeggiatoa group suggests that this genus could harbour a third cluster with organisms ranging from 60 to 120 mu m in diameter. This is also the first description of an Isobeggiatoa species outside of Arctic and temperate waters. The multiphasic approach also gives information about the environment and indications for the metabolism of these bacteria. Our study shows the widespread occurrence of members of Beggiatoaceae family and provides new insight in their potential role in shallow-water marine sulphide-rich environments such as mangroves.	[Jean, Maitena R. N.; Gonzalez-Rizzo, Silvina; Gauffre-Autelin, Pauline; Gros, Olivier] Univ Antilles Guyane, Equipe Biol Mangrove, UMR Evolut Paris Seine 7138, Inst Biol Paris Seine,UFR Sci Exactes & Nat,Dept, BP 592, Pointe A Pitre 97159, Guadeloupe, France; [Lengger, Sabine K.; Schouten, Stefan] Royal NIOZ Netherlands Inst Sea Res, Dept Marine Organ Biogeochem, NL-1790 AB Den Burg, Texel, Netherlands; [Gros, Olivier] Univ Antilles Guyane, Ctr Commun Caracterisat Mat Antilles Guyane, UFR Sci Exactes & Nat, Pointe A Pitre 97159, Guadeloupe, France	UDICE-French Research Universities; Sorbonne Universite; Universite de Montpellier; Universite des Antilles; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Universite de Montpellier; Universite des Antilles	Gonzalez-Rizzo, S (corresponding author), Univ Antilles Guyane, Equipe Biol Mangrove, UMR Evolut Paris Seine 7138, Inst Biol Paris Seine,UFR Sci Exactes & Nat,Dept, BP 592, Pointe A Pitre 97159, Guadeloupe, France.	sgonzale@univ-ag.fr	Lengger, Sabine/Q-4402-2019; Lengger, Sabine/L-7124-2016	Lengger, Sabine/0000-0003-4047-8773; Lengger, Sabine/0000-0003-4047-8773; GONZALEZ-RIZZO, Silvina/0000-0002-0097-138X	Region Guadeloupe; Region Guadeloupe	Region Guadeloupe; Region Guadeloupe	MRNJ was the recipient of a grant from Region Guadeloupe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 1999, APPL ENVIRON MICROB, V65, P270; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; BauerNebelsick M, 1996, EUR J PROTISTOL, V32, P18, DOI 10.1016/S0932-4739(96)80036-8; Bernard C, 1995, MAR ECOL PROG SER, V128, P171, DOI 10.3354/meps128171; Bernhard JM, 2003, LIMNOL OCEANOGR, V48, P813, DOI 10.4319/lo.2003.48.2.0813; Cohen Y., 1989, MICROBIAL MATPHYSL; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; D'Imperio S, 2008, APPL ENVIRON MICROB, V74, P5802, DOI 10.1128/AEM.00852-08; de Albuquerque JP, 2010, MICRON, V41, P507, DOI 10.1016/j.micron.2010.01.009; Deming JW, 1997, MICROSC RES TECHNIQ, V37, P162, DOI 10.1002/(SICI)1097-0029(19970415)37:2<162::AID-JEMT4>3.0.CO;2-Q; Demopoulos AWJ, 2010, DEEP-SEA RES PT II, V57, P1972, DOI 10.1016/j.dsr2.2010.05.011; Desai MS, 2013, ISME J, V7, P2411, DOI 10.1038/ismej.2013.126; Dillon JG, 2007, APPL ENVIRON MICROB, V73, P5218, DOI 10.1128/AEM.00357-07; Dunker R, 2010, FEMS MICROBIOL ECOL, V73, P234, DOI 10.1111/j.1574-6941.2010.00887.x; Fenchel T, 1995, MAR ECOL PROG SER, V128, P161, DOI 10.3354/meps128161; Frenkiel L, 1996, MAR BIOL, V125, P511; Friedrich CG, 2005, CURR OPIN MICROBIOL, V8, P253, DOI 10.1016/j.mib.2005.04.005; Fuchs BM, 1998, APPL ENVIRON MICROB, V64, P4973; GARCIAPICHEL F, 1994, APPL ENVIRON MICROB, V60, P1500, DOI 10.1128/AEM.60.5.1500-1511.1994; Glauert AM, 1975, PRACTICAL METHODS EL; Grunke S, 2011, GEOBIOLOGY, V9, P330, DOI 10.1111/j.1472-4669.2011.00281.x; Guan HX, 2010, CHINESE SCI BULL, V55, P730, DOI 10.1007/s11434-009-0478-7; Guezennec J, 1998, FEMS MICROBIOL ECOL, V26, P89, DOI 10.1016/S0168-6496(98)00022-1; Himmel D, 2009, BIOL CELL, V101, P43, DOI 10.1042/BC20080051; Hinck S, 2007, APPL ENVIRON MICROB, V73, P7013, DOI 10.1128/AEM.00548-07; Hogslund S, 2009, ISME J, V3, P647, DOI 10.1038/ismej.2009.17; JACQ E, 1989, ARCH MICROBIOL, V152, P64, DOI 10.1007/BF00447013; JORGENSEN BB, 1977, MAR BIOL, V41, P19, DOI 10.1007/BF00390577; Jorgensen BB, 2010, FEMS MICROBIOL ECOL, V73, P500, DOI 10.1111/j.1574-6941.2010.00918.x; Kalanetra KM, 2004, APPL ENVIRON MICROB, V70, P7487, DOI 10.1128/AEM.70.12.7487-7496.2004; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Lane DJ, 1991, NUCL ACID TECHNIQUES, P115; Laurent MCZ, 2009, MAR ENVIRON RES, V67, P83, DOI 10.1016/j.marenvres.2008.11.006; Le Bris N, 2001, DEEP-SEA RES PT I, V48, P1941, DOI 10.1016/S0967-0637(00)00112-6; Lee RY, 2008, BIOGEOCHEMISTRY, V87, P181, DOI 10.1007/s10533-008-9176-9; Lengger SK, 2012, ORG GEOCHEM, V47, P34, DOI 10.1016/j.orggeochem.2012.02.009; Macalady JL, 2008, ISME J, V2, P590, DOI 10.1038/ismej.2008.25; MAIER S, 1984, INT J SYST BACTERIOL, V34, P344, DOI 10.1099/00207713-34-3-344; Maurin LC, 2010, MAR ENVIRON RES, V69, P382, DOI 10.1016/j.marenvres.2010.02.001; MCCAFFREY MA, 1989, ORG GEOCHEM, V14, P61, DOI 10.1016/0146-6380(89)90019-3; McHatton SC, 1996, APPL ENVIRON MICROB, V62, P954, DOI 10.1128/AEM.62.3.954-958.1996; McKay LJ, 2012, DEEP-SEA RES PT I, V67, P21, DOI 10.1016/j.dsr.2012.04.011; MILLERO FJ, 1987, ENVIRON SCI TECHNOL, V21, P439, DOI 10.1021/es00159a003; Muller F, 2010, ENVIRON MICROBIOL, V12, P2371, DOI 10.1111/j.1462-2920.2010.02309.x; Mussmann M, 2003, ENVIRON MICROBIOL, V5, P523, DOI 10.1046/j.1462-2920.2003.00440.x; NELSON DC, 1986, APPL ENVIRON MICROB, V52, P225, DOI 10.1128/AEM.52.2.225-233.1986; Ott JA, 1998, MAR ECOL, V19, P299; Otte S, 1999, APPL ENVIRON MICROB, V65, P3148; Pascal PY, 2014, MAR ECOL PROG SER, V516, P127, DOI 10.3354/meps11035; Preisler A, 2007, ISME J, V1, P341, DOI 10.1038/ismej.2007.50; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Rigonato J, 2013, ENVIRON MICROBIOL, V15, P1103, DOI 10.1111/j.1462-2920.2012.02830.x; Rinke C, 2009, FEMS MICROBIOL ECOL, V67, P229, DOI 10.1111/j.1574-6941.2008.00628.x; Salman V, 2013, ANTON LEEUW INT J G, V104, P169, DOI 10.1007/s10482-013-9952-y; Salman V, 2011, SYST APPL MICROBIOL, V34, P243, DOI 10.1016/j.syapm.2011.02.001; Saravanakumar C, 2012, SYST APPL MICROBIOL, V35, P396, DOI 10.1016/j.syapm.2012.05.006; Sayama M, 2005, APPL ENVIRON MICROB, V71, P7575, DOI 10.1128/AEM.71.11.7575-7577.2005; Schauer R, 2011, ENVIRON MICROBIOL, V13, P2633, DOI 10.1111/j.1462-2920.2011.02530.x; Schulz HN, 2001, ANNU REV MICROBIOL, V55, P105, DOI 10.1146/annurev.micro.55.1.105; Stewart FJ, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00134; STROHL WR, 1981, CURR MICROBIOL, V6, P75, DOI 10.1007/BF01569007; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tindall BJ, 2010, INT J SYST EVOL MICR, V60, P249, DOI 10.1099/ijs.0.016949-0; Tunnicliffe V, 2003, ECOSY WORLD, V28, P81; VARGAS A, 1985, ARCH MICROBIOL, V142, P279, DOI 10.1007/BF00693404; WALLNER G, 1993, CYTOMETRY, V14, P136, DOI 10.1002/cyto.990140205; Yarza P, 2008, SYST APPL MICROBIOL, V31, P241, DOI 10.1016/j.syapm.2008.07.001; Yucel M, 2010, CHEM GEOL, V269, P364, DOI 10.1016/j.chemgeo.2009.10.010; Zhang CL, 2005, APPL ENVIRON MICROB, V71, P2106, DOI 10.1128/AEM.71.4.2106-2112.2005	70	15	16	4	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117832	10.1371/journal.pone.0117832	http://dx.doi.org/10.1371/journal.pone.0117832			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689402	Green Published, gold			2022-12-26	WOS:000350322700076
J	Martin, JA; Ramsay, J; Hughes, C; Peters, DM; Edwards, MG				Martin, Jason A.; Ramsay, Jill; Hughes, Christopher; Peters, Derek M.; Edwards, Martin G.			Age and Grip Strength Predict Hand Dexterity in Adults	PLOS ONE			English	Article							UPPER EXTREMITY PERFORMANCE; MOTOR OUTPUT VARIABILITY; ESSENTIAL TREMOR; OLD ADULTS; NERVE-CONDUCTION; MUSCLE STRENGTH; ELDERLY-PEOPLE; NORMATIVE DATA; FORCE CONTROL; MOVEMENT	In the scientific literature, there is much evidence of a relationship between age and dexterity, where increased age is related to slower, less nimble and less smooth, less coordinated and less controlled performances. While some suggest that the relationship is a direct consequence of reduced muscle strength associated to increased age, there is a lack of research that has systematically investigated the relationships between age, strength and hand dexterity. Therefore, the aim of this study was to examine the associations between age, grip strength and dexterity. 107 adults (range 18-93 years) completed a series of hand dexterity tasks (i.e. steadiness, line tracking, aiming, and tapping) and a test of maximal grip strength. We performed three phases of analyses. Firstly, we evaluated the simple relationships between pairs of variables; replicating the existing literature; and found significant relationships of increased age and reduced strength; increased age and reduced dexterity, and; reduced strength and reduced dexterity. Secondly, we used standard Multiple Regression (MR) models to determine which of the age and strength factors accounted for the greater variance in dexterity. The results showed that both age and strength made significant contributions to the data variance, but that age explained more of the variance in steadiness and line tracking dexterity, whereas strength explained more of the variance in aiming and tapping dexterity. In a third phase of analysis, we used MR analyses to show an interaction between age and strength on steadiness hand dexterity. Simple Slopes post-hoc analyses showed that the interaction was explained by the middle to older aged adults showing a relationship between reduced strength and reduced hand steadiness, whereas younger aged adults showed no relationship between strength and steadiness hand dexterity. The results are discussed in terms of how age and grip strength predict different types of hand dexterity in adults.	[Martin, Jason A.] Univ Hosp Bonn, Dept Radiol, Funct Neuroimaging Grp, D-53127 Bonn, Germany; [Martin, Jason A.] Univ Tubingen, Ctr Integrat Neurosci, Hertie Inst Clin Brain Res, Div Neuropsychol, D-72076 Tubingen, Germany; [Ramsay, Jill] Univ Birmingham, Sch Hlth & Populat Sci, Birmingham, W Midlands, England; [Hughes, Christopher; Peters, Derek M.] Univ Worcester, Inst Sport & Exercise Sci, Worcester, England; [Peters, Derek M.] Univ Agder, Fac Hlth & Sport Sci, Kristiansand, Norway; [Edwards, Martin G.] Catholic Univ Louvain, Psychol Sci Res Inst, Louvain La Neuve, Belgium; [Edwards, Martin G.] Catholic Univ Louvain, Inst Neurosci, Louvain La Neuve, Belgium	University of Bonn; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Birmingham; University of Worcester; University of Agder; Universite Catholique Louvain; Universite Catholique Louvain	Martin, JA (corresponding author), Univ Hosp Bonn, Dept Radiol, Funct Neuroimaging Grp, Sigmund Freud Str 25, D-53127 Bonn, Germany.	Jason.Martin@ukb.uni-bonn.de	Martin, Jason/AAV-1498-2021	Martin, Jason/0000-0001-8194-4297; Edwards, Martin/0000-0003-4532-2436; Peters, Derek/0000-0002-7873-7737	University of Birmingham; University of Worcester	University of Birmingham; University of Worcester	Funding for the individuals involved in the current study was received from the University of Birmingham and the University of Worcester. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken L. S., 1991, MULTIPLE REGRESSION; AMRHEIN PC, 1991, PSYCHOL AGING, V6, P451, DOI 10.1037/0882-7974.6.3.451; ANNETT M, 1976, BRIT J PSYCHOL, V67, P587, DOI 10.1111/j.2044-8295.1976.tb01550.x; BARNSLEY RH, 1970, PERCEPT MOTOR SKILL, V30, P343, DOI 10.2466/pms.1970.30.2.343; Barry BK, 2007, J NEUROPHYSIOL, V97, P3206, DOI 10.1152/jn.01280.2006; BASSEY EJ, 1993, CLIN SCI, V84, P331, DOI 10.1042/cs0840331; BENNETT KMB, 1994, J GERONTOL, V49, pP1, DOI 10.1093/geronj/49.1.P1; Bilodeau M, 2000, MUSCLE NERVE, V23, P771, DOI 10.1002/(SICI)1097-4598(200005)23:5<771::AID-MUS15>3.0.CO;2-9; BOUCHE P, 1993, J NEUROL, V240, P263, DOI 10.1007/BF00838158; Bowden JL, 2013, EXP GERONTOL, V48, P756, DOI 10.1016/j.exger.2013.03.011; BROWN M, 1995, J GERONTOL A-BIOL, V50, P55; Carlton LG, 1993, FORCE VARIABILITY, P128; Carmeli E, 2003, J GERONTOL A-BIOL, V58, P146, DOI 10.1093/gerona/58.2.M146; Carmeli E, 2002, EXP GERONTOL, V37, P477, DOI 10.1016/S0531-5565(01)00220-0; Carnahan H, 1998, EXP AGING RES, V24, P289; CERELLA J, 1985, PSYCHOL BULL, V98, P67, DOI 10.1037/0033-2909.98.1.67; Christou E.A., 2002, PROG MOTOR CONTROL, V2, P195; Christou EA, 2001, J GERONTOL A-BIOL, V56, pB524, DOI 10.1093/gerona/56.12.B524; Christou EA, 2002, J APPL PHYSIOL, V93, P489, DOI 10.1152/japplphysiol.00335.2001; Cohen J., 1983, APPL MULTIPLE REGRES; Cole KJ, 2006, EXP BRAIN RES, V175, P285, DOI 10.1007/s00221-006-0553-0; COLE KJ, 1991, J MOTOR BEHAV, V23, P251, DOI 10.1080/00222895.1991.9942036; CORDO P, 1994, J NEUROPHYSIOL, V71, P1848, DOI 10.1152/jn.1994.71.5.1848; DESROSIERS J, 1994, ARCH PHYS MED REHAB, V75, P751; DESROSIERS J, 1995, ARCH PHYS MED REHAB, V76, P1125, DOI 10.1016/S0003-9993(95)80120-0; Desrosiers J, 1999, EXP GERONTOL, V34, P393, DOI 10.1016/S0531-5565(99)00018-2; Desrosiers J, 1998, J GERONTOL A-BIOL, V53, pB362, DOI 10.1093/gerona/53A.5.B362; DOHERTY TJ, 1993, J APPL PHYSIOL, V74, P868, DOI 10.1152/jappl.1993.74.2.868; Doherty TJ, 1997, J APPL PHYSIOL, V82, P93, DOI 10.1152/jappl.1997.82.1.93; DORFMAN LJ, 1979, NEUROLOGY, V29, P38, DOI 10.1212/WNL.29.1.38; Dutta C, 1997, MUSCLE NERVE, pS5; Elble RJ, 2000, NEUROLOGY, V55, P1547, DOI 10.1212/WNL.55.10.1547; ELBLE RJ, 1995, EXP GERONTOL, V30, P337, DOI 10.1016/0531-5565(94)00055-8; ELBLE RJ, 1994, MOVEMENT DISORD, V9, P589, DOI 10.1002/mds.870090602; Enoka RM, 2003, J ELECTROMYOGR KINES, V13, P1, DOI 10.1016/S1050-6411(02)00084-6; Farber SD, 1991, OCCUPATIONAL THERAPY; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; Fleishman E.A., 1972, PSYCHOMOTOR DOMAIN, P78; FLEISHMAN EA, 1962, J APPL PSYCHOL, V46, P96, DOI 10.1037/h0038499; FLEISHMAN EA, 1953, PSYCHOL BULL, V50, P241, DOI 10.1037/h0059989; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GALGANSKI ME, 1993, J NEUROPHYSIOL, V69, P2108, DOI 10.1152/jn.1993.69.6.2108; Grabiner M D, 1995, Exerc Sport Sci Rev, V23, P65; Graves AE, 2000, J NEUROPHYSIOL, V83, P2030, DOI 10.1152/jn.2000.83.4.2030; Hakkinen K, 1998, J APPL PHYSIOL, V84, P1341, DOI 10.1152/jappl.1998.84.4.1341; Hamilton AFD, 2002, J NEUROPHYSIOL, V87, P2434, DOI 10.1152/jn.00875.2001; Harridge SDR, 1998, PRINCIPLES PRACTICE, VII, P898; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; HINSON M, 1989, OCCUP THER J RES, V9, P53, DOI 10.1177/153944928900900106; Hirsch CH, 1997, J GERONTOL A-BIOL, V52, pM192, DOI 10.1093/gerona/52A.4.M192; Hortobagyi T, 2006, EXERC SPORT SCI REV, V34, P29, DOI 10.1097/00003677-200601000-00007; KALLMAN DA, 1990, J GERONTOL, V45, pM82, DOI 10.1093/geronj/45.3.M82; KAPLAN FS, 1985, ACTA ORTHOP SCAND, V56, P72, DOI 10.3109/17453678508992984; Kauranen K, 1996, PERCEPT MOTOR SKILL, V82, P515, DOI 10.2466/pms.1996.82.2.515; KEEN DA, 1994, J APPL PHYSIOL, V77, P2648, DOI 10.1152/jappl.1994.77.6.2648; Kim SJ, 1999, J MOTOR BEHAV, V31, P341, DOI 10.1080/00222899909600999; Kinoshita H, 1996, EUR J APPL PHYSIOL, V74, P450; Krampe RT, 2002, NEUROSCI BIOBEHAV R, V26, P769, DOI 10.1016/S0149-7634(02)00064-7; Krampe RT, 1996, J EXP PSYCHOL GEN, V125, P331, DOI 10.1037/0096-3445.125.4.331; Kurokawa K, 1999, GERONTOLOGY, V45, P168, DOI 10.1159/000022081; Laidlaw DH, 1999, J APPL PHYSIOL, V87, P1786, DOI 10.1152/jappl.1999.87.5.1786; LARSSON L, 1979, J APPL PHYSIOL, V46, P451, DOI 10.1152/jappl.1979.46.3.451; LEXELL J, 1995, J GERONTOL A-BIOL, V50, P11; Lexell J, 1997, J NUTR, V127, pS1011, DOI 10.1093/jn/127.5.1011S; Macaluso A, 2004, EUR J APPL PHYSIOL, V91, P450, DOI 10.1007/s00421-003-0991-3; Macaluso A, 2002, MUSCLE NERVE, V25, P858, DOI 10.1002/mus.10113; Mackenzie R A, 1981, Clin Exp Neurol, V18, P109; Marmon AR, 2011, MED SCI SPORT EXER, V43, P560, DOI 10.1249/MSS.0b013e3181f3f3ab; MATHIOWETZ V, 1985, ARCH PHYS MED REHAB, V66, P69; MCDONAGH MJN, 1984, GERONTOLOGY, V30, P49, DOI 10.1159/000212606; Metter EJ, 2005, J GERONTOL A-BIOL, V60, P840, DOI 10.1093/gerona/60.7.840; Metter EJ, 1998, AGING-CLIN EXP RES, V10, P471, DOI 10.1007/BF03340161; Michimata A, 2008, TOHOKU J EXP MED, V214, P257, DOI 10.1620/tjem.214.257; Mitrushina M., 2005, HDB NORMATIVE DATA N; Narici MV, 2010, BRIT MED BULL, V95, P139, DOI 10.1093/bmb/ldq008; NORRIS AH, 1953, J APPL PHYSIOL, V5, P589, DOI 10.1152/jappl.1953.5.10.589; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Payne AM, 2004, EXERC SPORT SCI REV, V32, P36, DOI 10.1097/00003677-200401000-00008; PROVINS KA, 1972, NEUROPSYCHOLOGIA, V10, P199, DOI 10.1016/0028-3932(72)90060-7; Raczek J, 1998, THEORETICAL EMPIRICA; Raczek J., 2001, J HUM KINET, V6, P113; Raczek J, 1997, SCHRIFTEN DTSCH VERE, V87, P293; Rantanen T, 1998, J APPL PHYSIOL, V85, P2047, DOI 10.1152/jappl.1998.85.6.2047; RIGAL RA, 1992, PERCEPT MOTOR SKILL, V75, P851, DOI 10.2466/pms.1992.75.3.851; Schaubert KL, 2005, J STRENGTH COND RES, V19, P717, DOI 10.1519/R-15954.1; Schoppe K. P., 1974, DIAGNOSTICA, V20, P43; Smith CD, 1999, NEUROLOGY, V53, P1458, DOI 10.1212/WNL.53.7.1458; Spirduso WW, 1995, PHYS DIMENSIONS AGIN; Tracy BL, 2001, MED SCI SPORT EXER, V33, pS254, DOI 10.1097/00005768-200105001-01429; Trombly C., 1989, OCCUPATIONAL THERAPY; van Galen GP, 2000, BIOL PSYCHOL, V51, P151, DOI 10.1016/S0301-0511(99)00037-X; Vianna LC, 2007, J STRENGTH COND RES, V21, P1310; Voelcker-Rehage C, 2005, EXP BRAIN RES, V166, P61, DOI 10.1007/s00221-005-2342-6; Wishart LR, 2000, J GERONTOL B-PSYCHOL, V55, pP85, DOI 10.1093/geronb/55.2.P85; Zoltan B, 1990, OCCUPATIONAL THERAPY	95	60	63	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117598	10.1371/journal.pone.0117598	http://dx.doi.org/10.1371/journal.pone.0117598			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689161	Green Published, Green Accepted, gold			2022-12-26	WOS:000350322700061
J	Wenz, H; Ehrlich, G; Wenz, R; al Mahdi, MM; Scharf, J; Groden, C; Schmiedek, P; Seiz-Rosenhagen, M				Wenz, Holger; Ehrlich, Gregory; Wenz, Ralf; al Mahdi, Mohamad-Motaz; Scharf, Johann; Groden, Christoph; Schmiedek, Peter; Seiz-Rosenhagen, Marcel			MR Angiography Follow-Up 10 Years after Cryptogenic Nonperimesencephalic Subarachnoid Hemorrhage	PLOS ONE			English	Article							DIGITAL-SUBTRACTION-ANGIOGRAPHY; INTRACRANIAL ANEURYSMS; PERIMESENCEPHALIC HEMORRHAGE; REPEAT ANGIOGRAPHY; DIAGNOSIS; ENLARGEMENT; FREQUENCY; PATTERNS; ETIOLOGY; COILS	Objectives Long-term magnetic resonance angiography (MRA) follow-up studies regarding cryptogenic nonperimesencephalic subarachnoid hemorrhage (nSAH) are scarce. This single-centre study identified all patients with angiographically verified cryptogenic nSAH from 1998 to 2007: The two main objectives were to prospectively assess the incidence of de novo aneurysm with 3.0-MRI years after cryptogenic nSAH in patients without evidence for further hemorrhage, and retrospectively assess patient demographics and outcome. Methods From prospectively maintained report databases all patients with angiographically verified cryptogenic nSAH were identified. 21 of 29 patients received high-resolution 3T-MRI including time-of-flight and contrast-enhanced angiography, 10.2 +/- 2.8 years after cryptogenic nSAH. MRA follow-up imaging was compared with initial digital subtraction angiography (DSA) and CT/MRA. Post-hemorrhage images were related to current MRI with reference to persistent lesions resulting from delayed cerebral ischemia (DCI) and post-hemorrhagic siderosis. Patient-based objectives were retrospectively abstracted from clinical databases. Results 29 patients were identified with cryptogenic nSAH, 17 (59%) were male. Mean age at time of hemorrhage was 52.9 +/- 14.4 years (range 4 - 74 years). 21 persons were available for long-term follow-up. In these, there were 213.5 person years of MRI-follow-up. No de novo aneurysm was detected. Mean modified Rankin Scale (mRS) during discharge was 1.28. Post-hemorrhage radiographic vasospasm was found in three patients (10.3%); DCI-related lesions occurred in one patient (3.4%). Five patients (17.2%) needed temporary external ventricular drainage; long-term CSF shunt dependency was necessary only in one patient 3.4%). Initial DSA retrospectively showed a 2 x 2 mm aneurysm of the right distal ICA in one patient, which remained stable. Post-hemorrhage siderosis was detected 8.1 years after the initial bleeding in one patient (4.8%). Conclusion Patients with cryptogenic nSAH have favourable outcomes and do not exhibit higher risks for de novo aneurysms. Therefore the need for long-term follow up after cryptogenic nSAH is questionable.	[Wenz, Holger; Wenz, Ralf; Scharf, Johann; Groden, Christoph] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Neuroradiol, Mannheim, Germany; [Ehrlich, Gregory; al Mahdi, Mohamad-Motaz; Schmiedek, Peter; Seiz-Rosenhagen, Marcel] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Neurosurg, Mannheim, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Wenz, H (corresponding author), Heidelberg Univ, Univ Med Ctr Mannheim, Dept Neuroradiol, Mannheim, Germany.	Holger-Wenz@gmx.de						Andaluz N, 2008, NEUROSURGERY, V62, P1040, DOI 10.1227/01.neu.0000325865.22011.1f; Bakker NA, 2014, J NEUROSURG, V120, P99, DOI 10.3171/2013.9.JNS131337; Canovas D, 2012, EUR J NEUROL, V19, P457, DOI 10.1111/j.1468-1331.2011.03542.x; Dalyai R, 2013, NEUROSURGERY, V72, P646, DOI 10.1227/NEU.0b013e3182846de8; Ferre JC, 2009, EUR J RADIOL, V72, P365, DOI 10.1016/j.ejrad.2008.08.005; Fontanella M, 2011, NEUROSURG REV, V34, P477, DOI 10.1007/s10143-011-0323-8; Li MH, 2014, RADIOLOGY, V271, P553, DOI 10.1148/radiol.14122770; Lindvall P, 2012, VASC ENDOVASC SURG, V46, P325, DOI 10.1177/1538574412445602; Luo ZR, 2012, EUR J RADIOL, V81, P118, DOI 10.1016/j.ejrad.2011.05.003; Majoie CBLM, 2005, AM J NEURORADIOL, V26, P1349; Molyneux AJ, 2009, LANCET NEUROL, V8, P427, DOI 10.1016/S1474-4422(09)70080-8; Plowman RS, 2011, J NEUROSURG, V114, P863, DOI 10.3171/2010.6.JNS091058; Pyysalo LM, 2011, J NEUROL NEUROSUR PS, V82, P1264, DOI 10.1136/jnnp.2010.239335; RINKEL GJE, 1991, LANCET, V338, P964, DOI 10.1016/0140-6736(91)91836-J; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; Ruigrok YM, 2002, CEREBROVASC DIS, V14, P221, DOI 10.1159/000065668; Schievink WI, 1997, STROKE, V28, P2572; Schwab KE, 2008, NEUROSURGERY, V63, P29, DOI 10.1227/01.NEU.0000335068.53190.46; Schwartz TH, 1996, NEUROSURGERY, V39, P433, DOI 10.1097/00006123-199609000-00001; Sica GT, 2006, RADIOLOGY, V238, P780, DOI 10.1148/radiol.2383041109; So TY, 2010, J CLIN NEUROSCI, V17, P29, DOI 10.1016/j.jocn.2009.04.010; Sprengers ME, 2009, AM J NEURORADIOL, V30, P303, DOI 10.3174/ajnr.A1353; Urbach H, 2008, NEURORADIOLOGY, V50, P383, DOI 10.1007/s00234-007-0355-5; Urbach H, 1998, NEURORADIOLOGY, V40, P6, DOI 10.1007/s002340050528; van der Schaaf IC, 2004, STROKE, V35, P1614, DOI 10.1161/01.STR.0000131657.08655.ce; VANCALENBERGH F, 1993, SURG NEUROL, V39, P320, DOI 10.1016/0090-3019(93)90014-R; VANGIJN J, 1985, NEUROLOGY, V35, P493, DOI 10.1212/WNL.35.4.493; Wenz H, 2014, CLIN NEURORADIOL; Wermer MJH, 2005, BRAIN, V128, P2421, DOI 10.1093/brain/awh587; Yeung R, 2009, CAN J NEUROL SCI, V36, P176, DOI 10.1017/S0317167100006533	30	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117925	10.1371/journal.pone.0117925	http://dx.doi.org/10.1371/journal.pone.0117925			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25688554	Green Submitted, Green Published, gold			2022-12-26	WOS:000350322700083
J	Arriero, E; Muller, I; Juvaste, R; Martinez, FJ; Bertolero, A				Arriero, Elena; Mueller, Inge; Juvaste, Risto; Javier Martinez, Francisco; Bertolero, Albert			Variation in Immune Parameters and Disease Prevalence among Lesser Black-Backed Gulls (Larus fuscus sp.) with Different Migratory Strategies	PLOS ONE			English	Article							INFLUENZA-A VIRUS; HEMAGGLUTININ SUBTYPE; AVIAN MALARIA; LIFE-HISTORY; ANNUAL-CYCLE; WILD; RESISTANCE; ANTIBODIES; INFECTION; PARASITES	The ability to control infections is a key trait for migrants that must be balanced against other costly features of the migratory life. In this study we explored the links between migration and disease ecology by examining natural variation in parasite exposure and immunity in several populations of Lesser Black-backed Gulls (Larus fuscus) with different migratory strategies. We found higher activity of natural antibodies in long distance migrants from the nominate subspecies L.f.fuscus. Circulating levels of IgY showed large variation at the population level, while immune parameters associated with antimicrobial activity showed extensive variation at the individual level irrespective of population or migratory strategy. Pathogen prevalence showed large geographical variation. However, the seroprevalence of one of the gull-specific subtypes of avian influenza (H16) was associated to the migratory strategy, with lower prevalence among the long-distance migrants, suggesting that migration may play a role in disease dynamics of certain pathogens at the population level.				elena.arriero@bio.ucm.es	Martinez, Javier/H-2827-2015; Bertolero, Albert/I-6448-2019; Arriero, Elena/J-8224-2016	Martinez, Javier/0000-0003-2657-1154; Bertolero, Albert/0000-0002-6834-2600; Arriero, Elena/0000-0003-4230-6537; Juvaste, Risto/0000-0001-9740-501X	Max Planck Institute for Ornithology (Wikelski group); EU-funded SYNTHESYS grant; Spanish Ministry of Economy and Competitiveness [BFU2011-25957]; Wissenschaftskolleg zu Berlin	Max Planck Institute for Ornithology (Wikelski group); EU-funded SYNTHESYS grant; Spanish Ministry of Economy and Competitiveness(Spanish Government); Wissenschaftskolleg zu Berlin(Austrian Science Fund (FWF))	This study was supported by the Max Planck Institute for Ornithology (Wikelski group), an EU-funded SYNTHESYS grant to EA, and by the Spanish Ministry of Economy and Competitiveness (project BFU2011-25957 to EA). During writing, EA was supported by the Wissenschaftskolleg zu Berlin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alerstam T, 1993, BIRD MIGRATION; Alexander D.J., 1988, NEWCASTLE DIS; Altizer SM, 2001, EVOL ECOL RES, V3, P611; Altizer S, 2011, SCIENCE, V331, P296, DOI 10.1126/science.1194694; Ardia DR, 2007, ECOGRAPHY, V30, P23, DOI 10.1111/j.2006.0906-7590.04939.x; Arnal A, 2014, CRIT REV MICROBIOL, V7828, P1; Arriero E, 2008, J EVOLUTION BIOL, V21, P1504, DOI 10.1111/j.1420-9101.2008.01613.x; Atkinson Carter T., 2008, P13; Barbosa A, 2007, POLAR BIOL, V30, P219, DOI 10.1007/s00300-006-0175-9; Bonneaud C, 2006, EVOLUTION, V60, P383, DOI 10.1111/j.0014-3820.2006.tb01114.x; Bradley CA, 2005, ECOL LETT, V8, P290, DOI 10.1111/j.1461-0248.2005.00722.x; Brown JD, 2010, J WILDLIFE DIS, V46, P896, DOI 10.7589/0090-3558-46.3.896; Buehler DM, 2010, INTEGR COMP BIOL, V50, P346, DOI 10.1093/icb/icq055; Buehler DM, 2009, J ORNITHOL, V150, P815, DOI 10.1007/s10336-009-0402-6; Buehler DM, 2008, AM NAT, V172, P783, DOI 10.1086/592865; Bustnes JO, 2013, IBIS, V155, P402, DOI 10.1111/ibi.12022; Campbell T, 2007, AVIAN EXOTIC ANIMAL, DOI [10.1093/jxb/erm028, DOI 10.1093/JXB/ERM028]; CEC, 2006, OFF J EUR COMMUNITIE; Cramp S., 1988, HDB BIRDS EUROPE; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; GARLAND T, 1994, ANNU REV PHYSIOL, V56, P579, DOI 10.1146/annurev.ph.56.030194.003051; Grasman KA, 2000, COMP BIOCHEM PHYS C, V125, P365, DOI 10.1016/S0742-8413(99)00118-8; GROSS WB, 1983, AVIAN DIS, V27, P972, DOI 10.2307/1590198; Gylfe A, 2000, NATURE, V403, P724, DOI 10.1038/35001663; HINSHAW VS, 1982, J VIROL, V42, P865, DOI 10.1128/JVI.42.3.865-872.1982; Hubalek Z, 2004, J WILDLIFE DIS, V40, P639, DOI 10.7589/0090-3558-40.4.639; Klaassen M, 2012, PHILOS T R SOC B, V367, P1719, DOI 10.1098/rstb.2012.0008; Klaassen RHG, 2012, BEHAV ECOL, V23, P58, DOI 10.1093/beheco/arr150; Klasing KC, 1998, POULTRY SCI, V77, P1119, DOI 10.1093/ps/77.8.1119; Klein, 2012, ECOIMMUNOLOGY, P497; Krauss S, 2007, PLOS PATHOG, V3, P1684, DOI 10.1371/journal.ppat.0030167; Krauss S, 2010, P ROY SOC B-BIOL SCI, V277, P3373, DOI 10.1098/rspb.2010.1090; Latorre-Margalef N, 2009, P ROY SOC B-BIOL SCI, V276, P1029, DOI 10.1098/rspb.2008.1501; Lee KA, 2006, INTEGR COMP BIOL, V46, P1000, DOI 10.1093/icb/icl049; Lewis NS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058534; Liebers D, 2004, P ROY SOC B-BIOL SCI, V271, P893, DOI 10.1098/rspb.2004.2679; Liebers D, 2002, J EVOLUTION BIOL, V15, P1021, DOI 10.1046/j.1420-9101.2002.00454.x; LOEHLE C, 1995, ECOLOGY, V76, P326, DOI 10.2307/1941192; Malling OK, 2003, GULLS EUROPE ASIA N; Martinez J, 2003, FUNCT ECOL, V17, P700, DOI 10.1046/j.1365-2435.2003.00771.x; Martinez J, 2009, PARASITOLOGY, V136, P713, DOI 10.1017/S0031182009006118; Matson KD, 2005, DEV COMP IMMUNOL, V29, P275, DOI 10.1016/j.dci.2004.07.006; Mayr E., 1963, ANIMAL SPECIES EVOLU, P12; McCurdy DG, 1998, OIKOS, V82, P303, DOI 10.2307/3546970; McFerran J, 1988, NEWCASTLE DIS; McWilliams Scott R., 2005, P67; Mendes L, 2005, OIKOS, V109, P396, DOI 10.1111/j.0030-1299.2005.13509.x; Millet S, 2007, DEV COMP IMMUNOL, V31, P188, DOI 10.1016/j.dci.2006.05.013; Moller AP, 1998, EVOL ECOL, V12, P945, DOI 10.1023/A:1006516222343; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Murphy K, 2008, JANEWAYS IMMUNOBIOLO, DOI [10.1080/13803390802438454, DOI 10.1080/13803390802438454]; O'Neal DM, 2012, ECOIMMUNOLOGY, P7; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Ochsenbein AF, 2000, IMMUNOL TODAY, V21, P624, DOI 10.1016/S0167-5699(00)01754-0; OIE World Organization for Animal Health, 2008, MAN DIAGN TESTS VACC, P576, DOI DOI 10.1111/J.1440-1681.2008.05117.X; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Owen JC, 2008, J ETHOL, V26, P383, DOI 10.1007/s10164-008-0092-1; Owen JC, 2006, CONDOR, V108, P389, DOI 10.1650/0010-5422(2006)108[389:SDIICO]2.0.CO;2; Quaye IK, 2008, T ROY SOC TROP MED H, V102, P735, DOI 10.1016/j.trstmh.2008.04.010; Quillfeldt P, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-26; Ricklefs RE, 2002, P ROY SOC B-BIOL SCI, V269, P885, DOI 10.1098/rspb.2001.1940; Ricklefs Robert E., 2005, P210; Turner AK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002343; Valkiunas G, 2004, AVIAN MALARIA PARASI; van Gils JA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000184; Verhagen JH, 2014, EMERG INFECT DIS, V20, P138, DOI 10.3201/eid2001.130984; Verhagen JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038256; Waldenstrom J, 2002, MOL ECOL, V11, P1545, DOI 10.1046/j.1365-294X.2002.01523.x; Wikelski M, 2003, NATURE, V423, P704, DOI 10.1038/423704a; Wilcove D.S., 2008, NO WAY HOME DECLINE; Wille M, 2011, ARCH VIROL, V156, P107, DOI 10.1007/s00705-010-0839-1; Yohannes E, 2009, J ORNITHOL, V150, P287, DOI 10.1007/s10336-008-0349-z	72	9	9	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0118279	10.1371/journal.pone.0118279	http://dx.doi.org/10.1371/journal.pone.0118279			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679797	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000350682600115
J	Hammer, N; Glatzner, J; Feja, C; Kuhne, C; Meixensberger, J; Planitzer, U; Schleifenbaum, S; Tillmann, BN; Winkler, D				Hammer, Niels; Glaetzner, Juliane; Feja, Christine; Kuehne, Christian; Meixensberger, Juergen; Planitzer, Uwe; Schleifenbaum, Stefan; Tillmann, Bernhard N.; Winkler, Dirk			Human Vagus Nerve Branching in the Cervical Region	PLOS ONE			English	Article							INFERIOR LARYNGEAL NERVE; PRIMARY HEADACHE DISORDERS; SURGICAL ANATOMY; RESISTANT EPILEPSY; STIMULATION; EFFICACY; NEUROSTIMULATION; GLOSSOPHARYNGEAL; FORMALDEHYDE; BRADYCARDIA	Background Vagus nerve stimulation is increasingly applied to treat epilepsy, psychiatric conditions and potentially chronic heart failure. After implanting vagus nerve electrodes to the cervical vagus nerve, side effects such as voice alterations and dyspnea or missing therapeutic effects are observed at different frequencies. Cervical vagus nerve branching might partly be responsible for these effects. However, vagus nerve branching has not yet been described in the context of vagus nerve stimulation. Materials and Methods Branching of the cervical vagus nerve was investigated macroscopically in 35 body donors (66 cervical sides) in the carotid sheath. After X-ray imaging for determining the vertebral levels of cervical vagus nerve branching, samples were removed to confirm histologically the nerve and to calculate cervical vagus nerve diameters and cross-sections. Results Cervical vagus nerve branching was observed in 29% of all cases (26% unilaterally, 3% bilaterally) and proven histologically in all cases. Right-sided branching (22%) was more common than left-sided branching (12%) and occurred on the level of the fourth and fifth vertebra on the left and on the level of the second to fifth vertebra on the right side. Vagus nerves without branching were significantly larger than vagus nerves with branches, concerning their diameters (4.79mm vs. 3.78mm) and cross-sections (7.24 mm(2) vs. 5.28 mm(2)). Discussion Cervical vagus nerve branching is considerably more frequent than described previously. The side-dependent differences of vagus nerve branching may be linked to the asymmetric effects of the vagus nerve. Cervical vagus nerve branching should be taken into account when identifying main trunk of the vagus nerve for implanting electrodes to minimize potential side effects or lacking therapeutic benefits of vagus nerve stimulation.	[Hammer, Niels; Feja, Christine; Planitzer, Uwe] Univ Leipzig, Fac Med, Inst Anat, D-04109 Leipzig, Germany; [Glaetzner, Juliane; Meixensberger, Juergen; Planitzer, Uwe; Winkler, Dirk] Univ Clin Leipzig, Fac Med, Dept Neurosurg, Leipzig, Germany; [Kuehne, Christian] Univ Clin Leipzig, Fac Med, Dept Cardiol, Leipzig, Germany; [Schleifenbaum, Stefan] Univ Clin Leipzig, Dept Orthoped Trauma & Reconstruct Surg, Leipzig, Germany; [Tillmann, Bernhard N.] Univ Kiel, Inst Anat, Kiel, Germany	Leipzig University; Leipzig University; Leipzig University; Leipzig University; University of Kiel	Hammer, N (corresponding author), Univ Leipzig, Fac Med, Inst Anat, D-04109 Leipzig, Germany.	nlshammer@googlemail.com		Hammer, Niels/0000-0001-8230-9383; Schleifenbaum, Stefan/0000-0002-9075-3756				Alexopoulos AV, 2006, SEIZURE-EUR J EPILEP, V15, P491, DOI 10.1016/j.seizure.2006.06.002; Arakawa T, 2008, ANAT SCI INT, V83, P112, DOI 10.1111/j.1447-073X.2007.00183.x; Ardesch JJ, 2007, CLIN NEUROL NEUROSUR, V109, P849, DOI 10.1016/j.clineuro.2007.07.024; Asconape JJ, 1999, EPILEPSIA, V40, P1452, DOI 10.1111/j.1528-1157.1999.tb02019.x; Berthoud HR, 2000, AUTON NEUROSCI-BASIC, V85, P1, DOI 10.1016/S1566-0702(00)00215-0; Bliss RD, 2000, WORLD J SURG, V24, P891, DOI 10.1007/s002680010173; Bonaz B, 2013, NEUROGASTROENT MOTIL, V25, P208, DOI 10.1111/nmo.12076; Bos I, 2008, PATHOLOGE, V29, P280, DOI 10.1007/s00292-007-0921-y; Cernea CR, 2009, ARCH OTOLARYNGOL, V135, P1098, DOI 10.1001/archoto.2009.151; Chae JH, 2003, J PSYCHIATR RES, V37, P443, DOI 10.1016/S0022-3956(03)00074-8; Chambers A, 2013, Ont Health Technol Assess Ser, V13, P1; Coady MA, 2000, J VASC SURG, V32, P192, DOI 10.1067/mva.2000.105680; Crumrine P K, 2000, Semin Pediatr Neurol, V7, P216, DOI 10.1053/spen.2000.9218; DALY MD, 1953, J PHYSIOL-LONDON, V120, P579; Diamond M, 2011, CLIN ANAT, V24, P10, DOI 10.1002/ca.21072; Dionigi G, 2010, LANGENBECK ARCH SURG, V395, P893, DOI 10.1007/s00423-010-0693-3; Elliott RE, 2011, J NEUROSURG-PEDIATR, V7, P491, DOI 10.3171/2011.2.PEDS10505; Englot DJ, 2011, J NEUROSURG, V115, P1248, DOI 10.3171/2011.7.JNS11977; EVANS DHL, 1954, J ANAT, V88, P320; FERNANDO DA, 1994, ANN ANAT, V176, P333, DOI 10.1016/S0940-9602(11)80511-X; Fick W.B., 1925, Z MIKROSK ANAT FORSC, V2, P429; Fornai F, 2011, EUR J NEUROSCI, V33, P2169, DOI 10.1111/j.1460-9568.2011.07707.x; George MS, 2000, BIOL PSYCHIAT, V47, P287, DOI 10.1016/S0006-3223(99)00308-X; Geraci G, 2011, G CHIR, V32, P251; Gerson R, 2011, EPILEPSY BEHAV, V20, P138, DOI 10.1016/j.yebeh.2010.11.005; Hafferl A, 1969, LEHRBUCH TOPOGRAPHIS, VXVI; Hammer N, 2012, J MECH BEHAV BIOMED, V16, P81, DOI 10.1016/j.jmbbm.2012.04.025; Hammer N, 2012, ANAT SCI EDUC, V5, P225, DOI 10.1002/ase.1270; Hammer N, 2011, JNCI-J NATL CANCER I, V103, P610, DOI 10.1093/jnci/djr035; Howland Robert H, 2014, Curr Behav Neurosci Rep, V1, P64; JANES RD, 1986, AM J CARDIOL, V57, P299, DOI 10.1016/0002-9149(86)90908-2; Jenkins B, 2011, HEADACHE, V51, P1408, DOI 10.1111/j.1526-4610.2011.01967.x; Jenkins B, 2011, HEADACHE, V51, P1254, DOI 10.1111/j.1526-4610.2011.01966.x; JO A, 1971, Anatomischer Anzeiger, V129, P180; Kahlow H, 2013, SEIZURE-EUR J EPILEP, V22, P827, DOI 10.1016/j.seizure.2013.06.011; Kim W, 2001, AM J OPHTHALMOL, V131, P383, DOI 10.1016/S0002-9394(00)00782-0; Kobayashi M, 2007, ACTA OTO-LARYNGOL, V127, P332, DOI 10.1080/00016480600801415; Labar Douglas, 2002, Curr Neurol Neurosci Rep, V2, P357, DOI 10.1007/s11910-002-0011-8; LANG J, 1987, ACTA ANAT, V130, P309; Lang J, 1986, Gegenbaurs Morphol Jahrb, V132, P617; Larson TC, 2002, SEMIN ULTRASOUND CT, V23, P238, DOI 10.1016/S0887-2171(02)90049-1; Martelletti P, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-86; MEI N, 1980, CELL TISSUE RES, V209, P423; Milby AH, 2009, NEUROTHERAPEUTICS, V6, P228, DOI 10.1016/j.nurt.2009.01.010; Miner JR, 2012, ACAD EMERG MED, V19, P421, DOI 10.1111/j.1553-2712.2012.01329.x; Miyake N, 2010, ANAT REC, V293, P438, DOI 10.1002/ar.21089; Onkka P, 2013, HEART RHYTHM, V10, P585, DOI 10.1016/j.hrthm.2012.12.015; Qiabi M, 2011, CAN J NEUROL SCI, V38, P902, DOI 10.1017/S0317167100012506; Rauber A, 1987, ANATOMIE MENSCHEN LE, VXII; RUTECKI P, 1990, EPILEPSIA, V31, pS1, DOI 10.1111/j.1528-1157.1990.tb05843.x; Sabbah Hani N, 2011, Cleve Clin J Med, V78 Suppl 1, pS24, DOI 10.3949/ccjm.78.s1.04; Schwartz PJ, 2011, CURR OPIN CARDIOL, V26, P51, DOI 10.1097/HCO.0b013e3283413961; Schweizer V, 1997, CLIN OTOLARYNGOL, V22, P362, DOI 10.1046/j.1365-2273.1997.00028.x; Seki A, 2014, HEART RHYTHM, V11, P1411, DOI 10.1016/j.hrthm.2014.04.032; Shindo ML, 2005, OTOLARYNG HEAD NECK, V133, P514, DOI 10.1016/j.otohns.2005.07.010; Spalteholz W, 1909, EINGEWEIDE GEHIRN NE; Spuck SN, 2007, J NEUROLOGIE NEUROCH, V8, P16, DOI [10.1371/ journal. pone. 0116716, DOI 10.1371/J0URNAL.P0NE.0116716]; STOHR PHILIPP, 1927, ZEITSCHR ZELLFORSCH U MIKROSK ANAT, V5, P117, DOI 10.1007/BF00398904; Tanganelli P, 2002, CLIN NEUROL NEUROSUR, V105, P9, DOI 10.1016/S0303-8467(02)00018-5; Vonck K, 2001, J CLIN NEUROPHYSIOL, V18, P394, DOI 10.1097/00004691-200109000-00002; Wachsmuth W, 1985, UBERGEORDNETE SYSTEM, VXXII; Waldeyer A, 1967, KOPF HALS AUGEN OHR, VXV; Waseem H, 2014, EPILEPSY BEHAV, V31, P110, DOI 10.1016/j.yebeh.2013.12.002; Weiand G, 2004, CHIRURG, V75, P187, DOI 10.1007/s00104-003-0776-6; Yetisir F, 2012, INT J SURG, V10, P506, DOI 10.1016/j.ijsu.2012.07.006; YOSHIDA Y, 1992, FOLIA PHONIATR, V44, P194, DOI 10.1159/000266152; Zenker W, 1985, NERVENSYSTEM HAUT SI, VXVI	67	40	40	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0118006	10.1371/journal.pone.0118006	http://dx.doi.org/10.1371/journal.pone.0118006			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679804	Green Published, gold			2022-12-26	WOS:000350682600101
J	Pannu, J; Belle, JI; Forster, M; Duerr, CU; Shen, SY; Kane, L; Harcourt, K; Fritz, JH; Clare, S; Nijnik, A				Pannu, Jaspreet; Belle, Jad I.; Foerster, Michael; Duerr, Claudia U.; Shen, Shiyang; Kane, Leanne; Harcourt, Katherine; Fritz, Joerg H.; Clare, Simon; Nijnik, Anastasia			Ubiquitin Specific Protease 21 Is Dispensable for Normal Development, Hematopoiesis and Lymphocyte Differentiation	PLOS ONE			English	Article							TRANSCRIPTION FACTOR GATA-3; KAPPA-B ACTIVATION; POLYUBIQUITIN BINDING; GENE-EXPRESSION; GENOME-WIDE; CELL-DEATH; T-CELLS; USP21; DEUBIQUITINASE; RIP1	USP21 is a ubiquitin specific protease that catalyzes protein deubiquitination, however the identification of its physiological substrates remains challenging. USP21 is known to deubiquitinate transcription factor GATA3 and death-domain kinase RIPK1 in vitro, however the in vivo settings where this regulation plays a biologically significant role remain unknown. In order to determine whether USP21 is an essential and non-redundant regulator of GATA3 or RIPK1 activity in vivo, we characterized Usp21-deficient mice, focusing on mouse viability and development, hematopoietic stem cell function, and lymphocyte differentiation. The Usp21-knockout mice were found to be viable and fertile, with no significant dysmorphology, in contrast to the GATA3 and RIPK1 knockout lines that exhibit embryonic or perinatal lethality. Loss of USP21 also had no effect on hematopoietic stem cell function, lymphocyte development, or the responses of antigen presenting cells to TLR and TNFR stimulation. GATA3 levels in hematopoietic stem cells or T lymphocytes remained unchanged. We observed that aged Usp21-knockout mice exhibited spontaneous T cell activation, however this was not linked to altered GATA3 levels in the affected cells. The contrast in the phenotype of the Usp21-knockout line with the previously characterized GATA3 and RIPK1 knockout mice strongly indicates that USP21 is redundant for the regulation of GATA3 and RIPK1 activity during mouse development, in hematopoietic stem cells, and in lymphocyte differentiation. The Usp21-deficient mouse line characterized in this study may serve as a useful tool for the future characterization of USP21 physiological functions.	[Pannu, Jaspreet; Belle, Jad I.; Foerster, Michael; Shen, Shiyang; Nijnik, Anastasia] McGill Univ, Dept Physiol, Montreal, PQ, Canada; [Pannu, Jaspreet] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Belle, Jad I.; Foerster, Michael; Duerr, Claudia U.; Shen, Shiyang; Fritz, Joerg H.; Nijnik, Anastasia] McGill Univ, Complex Traits Grp, Montreal, PQ, Canada; [Duerr, Claudia U.; Fritz, Joerg H.] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada; [Kane, Leanne; Harcourt, Katherine; Clare, Simon] Wellcome Trust Sanger Inst, Hinxton, England	McGill University; McGill University; McGill University; McGill University; Wellcome Trust Sanger Institute	Nijnik, A (corresponding author), McGill Univ, Dept Physiol, Montreal, PQ, Canada.	anastasiya.nyzhnyk@mcgill.ca	Nijnik, Anastasia/W-2697-2019; Pannu, Jaspreet/AAJ-5296-2020	Belle, Jad/0000-0001-8944-9792; Pannu, Jaspreet/0000-0002-1030-8776	McGill University; Canadian Institutes of Health Research (CIHR); Wellcome Trust [098051]; International Postdoctoral Fellowship from the German Research Association [DFG FO 900/1-1]; Canadian Institutes of Health Research; German National Academy of Sciences Leopoldina	McGill University; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); International Postdoctoral Fellowship from the German Research Association; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); German National Academy of Sciences Leopoldina	The work was funded by Startup Funds from McGill University, an Operating Grant from the Canadian Institutes of Health Research (CIHR), and the Wellcome Trust 098051. AN is a Canada Research Chair in Hematopoiesis and Lymphocyte Development, Tier 2. MF is a recipient of International Postdoctoral Fellowship from the German Research Association (grant number DFG FO 900/1-1). CUD was supported by the Canadian Institutes of Health Research and the German National Academy of Sciences Leopoldina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccala R, 2007, NAT MED, V13, P543, DOI 10.1038/nm1590; Bogunovic D, 2012, SCIENCE, V337, P1684, DOI 10.1126/science.1224026; Challen GA, 2009, CYTOM PART A, V75A, P14, DOI 10.1002/cyto.a.20674; Clague MJ, 2013, PHYSIOL REV, V93, P1289, DOI 10.1152/physrev.00002.2013; Cusson N, 2002, J EXP MED, V196, P15, DOI 10.1084/jem.20011470; Cusson-Hermance N, 2005, J BIOL CHEM, V280, P36560, DOI 10.1074/jbc.M506831200; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Fan YH, 2014, J EXP MED, V211, P313, DOI 10.1084/jem.20122844; Festjens N, 2007, CELL DEATH DIFFER, V14, P400, DOI 10.1038/sj.cdd.4402085; Frelin C, 2013, NAT IMMUNOL, V14, P1037, DOI 10.1038/ni.2692; Gong LM, 2000, J BIOL CHEM, V275, P14212, DOI 10.1074/jbc.275.19.14212; Harty RN, 2009, J INNATE IMMUN, V1, P397, DOI 10.1159/000226245; Hosoya T, 2010, IMMUNOL REV, V238, P110, DOI 10.1111/j.1600-065X.2010.00954.x; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Kim KI, 2005, J IMMUNOL, V175, P847, DOI 10.4049/jimmunol.175.2.847; Ku CJ, 2012, BLOOD, V119, P2242, DOI 10.1182/blood-2011-07-366070; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Nakagawa T, 2008, GENE DEV, V22, P37, DOI 10.1101/gad.1609708; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Okuda H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079813; PANDOLFI PP, 1995, NAT GENET, V11, P40, DOI 10.1038/ng0995-40; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Tao LQ, 2014, INT J CLIN EXP PATHO, V7, P4930; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Urbe S, 2012, MOL BIOL CELL, V23, P1095, DOI 10.1091/mbc.E11-08-0668; Wan YY, 2014, TRENDS IMMUNOL, V35, P233, DOI 10.1016/j.it.2014.04.002; Wang YQ, 2011, IMMUNITY, V35, P337, DOI 10.1016/j.immuni.2011.08.012; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; White JK, 2013, CELL, V154, P452, DOI 10.1016/j.cell.2013.06.022; Wohlfert EA, 2011, J CLIN INVEST, V121, P4503, DOI 10.1172/JCI57456; Xu GF, 2010, J BIOL CHEM, V285, P969, DOI 10.1074/jbc.M109.042689; Ye Y, 2011, EMBO REP, V12, P350, DOI 10.1038/embor.2011.17; Zhang HB, 2011, NATURE, V471, P373, DOI 10.1038/nature09878; Zhang J, 2013, J BIOL CHEM, V288, P9373, DOI 10.1074/jbc.M112.374744; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	38	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117304	10.1371/journal.pone.0117304	http://dx.doi.org/10.1371/journal.pone.0117304			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680095	Green Published, gold, Green Submitted			2022-12-26	WOS:000350682600061
J	Yeh, HM; Chang, YC; Lin, C; Yeh, CH; Lee, CN; Shyu, MK; Hung, MH; Hsiao, PN; Wang, YH; Tseng, YH; Tsao, J; Lai, LP; Lin, LY; Lo, MT				Yeh, Huei-Ming; Chang, Yi-Chung; Lin, Chen; Yeh, Chien-Hung; Lee, Chien-Nan; Shyu, Ming-Kwang; Hung, Ming-Hui; Hsiao, Po-Ni; Wang, Yung-Hung; Tseng, Yu-Hsin; Tsao, Jenho; Lai, Ling-Ping; Lin, Lian-Yu; Lo, Men-Tzung			A New Method to Derive Fetal Heart Rate from Maternal Abdominal Electrocardiogram: Monitoring Fetal Heart Rate during Cesarean Section	PLOS ONE			English	Article							RATE-VARIABILITY; ECG EXTRACTION; POINCARE PLOT; HEMODIALYSIS; DYNAMICS	Background Monitoring of fetal heart rate (FHR) is important during labor since it is a sensitive marker to obtain significant information about fetal condition. To take immediate response during cesarean section (CS), we noninvasively derive FHR from maternal abdominal ECG. Methods We recruited 17 pregnant women delivered by elective cesarean section, with abdominal ECG obtained before and during the entire CS. First, a QRS-template is created by averaging all the maternal ECG heart beats. Then, Hilbert transform was applied to QRS-template to generate the other basis which is orthogonal to the QRS-template. Second, maternal QRS, P and T waves were adaptively subtracted from the composited ECG. Third, Gabor transformation was applied to obtain time-frequency spectrogram of FHR. Heart rate variability (HRV) parameters including standard deviation of normal-to-normal intervals (SDNN), 0V, 1V, 2V derived from symbolic dynamics of HRV and SD1, SD2 derived from Poincare plot. Three emphasized stages includes: (1) before anesthesia, (2) 5 minutes after anesthesia and (3) 5 minutes before CS delivery. Results FHRs were successfully derived fromall maternal abdominal ECGs. FHR increased 5 minutes after anesthesia and 5 minutes before delivery. As for HRV parameters, SDNN increased both 5 minutes after anesthesia and 5 minutes before delivery (21.30 +/- 9.05 vs. 13.01 +/- 6.89, P < 0.001 and 22.88 +/- 12.01 vs. 13.01 +/- 6.89, P < 0.05). SD1 did not change during anesthesia, while SD2 increased significantly 5 minutes after anesthesia (27.92 +/- 12.28 vs. 16.18 +/- 10.01, P < 0.001) and both SD2 and 0V percentage increased significantly 5 minutes before delivery (30.54 +/- 15.88 vs. 16.18 +/- 10.01, P < 0.05; 0.39 +/- 0.14 vs. 0.30 +/- 0.13, P < 0.05). Conclusions We developed a novel method to automatically derive FHR from maternal abdominal ECGs and proved that it is feasible during CS.	[Yeh, Huei-Ming; Hung, Ming-Hui; Hsiao, Po-Ni] Natl Taiwan Univ Hosp, Dept Anesthesiol, Taipei, Taiwan; [Chang, Yi-Chung; Tsao, Jenho] Natl Taiwan Univ, Grad Inst Commun Engn, Taipei 10764, Taiwan; [Chang, Yi-Chung; Lin, Chen; Yeh, Chien-Hung; Wang, Yung-Hung; Tseng, Yu-Hsin; Lo, Men-Tzung] Natl Cent Univ, Res Ctr Adapt Data Anal, Taoyuan, Taiwan; [Chang, Yi-Chung; Lin, Chen; Yeh, Chien-Hung; Wang, Yung-Hung; Tseng, Yu-Hsin; Lo, Men-Tzung] Natl Cent Univ, Ctr Dynam Biomarkers & Translat Med, Taoyuan, Taiwan; [Yeh, Chien-Hung] Natl Cent Univ, Dept Elect Engn, Taoyuan, Taiwan; [Lee, Chien-Nan; Shyu, Ming-Kwang] Natl Taiwan Univ Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Tseng, Yu-Hsin; Lai, Ling-Ping; Lin, Lian-Yu] Natl Taiwan Univ Hosp, Cardiovasc Ctr, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Central University; National Central University; National Central University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Lin, LY (corresponding author), Natl Taiwan Univ Hosp, Cardiovasc Ctr, Taipei, Taiwan.	hspenos@gmail.com; mzlo@ncu.edu.tw	Wang, Pa-Chun/AAD-4094-2019; huang, yuting/T-4341-2019; Hung, Ming-Hui/AAS-4520-2020	Hung, Ming-Hui/0000-0002-2575-3004; Yeh, Chien-Hung/0000-0002-6886-2964; LAI, LING-PING/0000-0002-9651-7420; SHYU, MING-KWANG/0000-0001-9057-4101; LIN, LIAN-YU/0000-0001-7505-6429; Lin, Chen/0000-0001-6261-8509; HSIAO, PO-NI/0000-0001-6630-0047; Lee, Chien-Nan/0000-0002-1725-0407	National Science Council [NSC 100-2221-E-008-008-MY2, NSC 101-2911-I-008-001]; CGH [CNJRF-101CGH-NCU-A4, VGHUST102-G1-2-3]; NCU [CNJRF-101CGH-NCU-A4, VGHUST102-G1-2-3]	National Science Council(Ministry of Science and Technology, Taiwan); CGH; NCU	Funding was provided by the National Science Council (NSC 100-2221-E-008-008-MY2, NSC 101-2911-I-008-001), joint foundation of CGH and NCU (CNJRF-101CGH-NCU-A4, VGHUST102-G1-2-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOUD S, 1990, COMPUT BIOL MED, V20, P147, DOI 10.1016/0010-4825(90)90001-6; ABBOUD S, 1992, COMPUT BIOL MED, V22, P325, DOI 10.1016/0010-4825(92)90021-E; Abrao KC, 2009, OBSTET GYNECOL, V113, P41, DOI 10.1097/AOG.0b013e31818f5eb6; Aljadeff G, 1997, SLEEP, V20, P151, DOI 10.1093/sleep/20.2.151; Amer-Wahlin I, 2002, J Matern Fetal Neonatal Med, V12, P260, DOI 10.1080/713605678; BERGVELD P, 1981, IEEE T BIO-MED ENG, V28, P348, DOI 10.1109/TBME.1981.324803; Castells F, 2005, MED BIOL ENG COMPUT, V43, P557, DOI 10.1007/BF02351028; Chang YC, U.S. Patent Application, Patent No. [13/682,757, 13682757]; Cheng F, 1992, IEEE T IMAGE PROCESS, V1, P533, DOI 10.1109/83.199924; Clifford G, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.02.066; DOWNS HS, 1963, CALIF MED, V99, P374; Guzzetti S, 2005, CIRCULATION, V112, P465, DOI 10.1161/CIRCULATIONAHA.104.518449; Hayano J, 1999, NEPHROL DIAL TRANSPL, V14, P1480, DOI 10.1093/ndt/14.6.1480; HUTSON JM, 1982, CLIN PERINATOL, V9, P325, DOI 10.1016/S0095-5108(18)31028-5; Ibrahimy MI, 2003, IEEE T BIO-MED ENG, V50, P258, DOI 10.1109/TBME.2002.807642; Kamen P, 1996, Aust Fam Physician, V25, P1087; Kamen PW, 1996, CLIN SCI, V91, P201, DOI 10.1042/cs0910201; Kanjilal PP, 1997, IEEE T BIO-MED ENG, V44, P51, DOI 10.1109/10.553712; Karmakar CK, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-17; Karmakar CK, 2010, J ELECTROCARDIOL, V43, P719, DOI 10.1016/j.jelectrocard.2010.09.001; Karvounis EC, 2009, IEEE T BIO-MED ENG, V56, P1394, DOI 10.1109/TBME.2009.2014691; Kotas M, 2007, B POL ACAD SCI-TECH, V55, P331; Lerma C, 2003, CLIN PHYSIOL FUNCT I, V23, P72; Muralikrishnan Krishnan, 2013, Indian J Physiol Pharmacol, V57, P31; Selesnick IW, 2001, IEEE SIGNAL PROC LET, V8, P170, DOI 10.1109/97.923042; Stein PK, 2005, J CARDIOVASC ELECTR, V16, P954, DOI 10.1111/j.1540-8167.2005.40788.x; Tulppo MP, 1996, AM J PHYSIOL-HEART C, V271, pH244, DOI 10.1152/ajpheart.1996.271.1.H244; Wu SC, 2013, COMPUT BIOL MED, V43, P1622, DOI 10.1016/j.compbiomed.2013.07.028	28	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117509	10.1371/journal.pone.0117509	http://dx.doi.org/10.1371/journal.pone.0117509			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680192	Green Submitted, Green Published, gold			2022-12-26	WOS:000350682600069
J	Beier, UH; Angelin, A; Akimova, T; Wang, LQ; Liu, YJ; Xiao, HY; Koike, MA; Hancock, SA; Bhatti, TR; Han, RX; Jiao, J; Veasey, SC; Sims, CA; Baur, JA; Wallace, DC; Hancock, WW				Beier, Ulf H.; Angelin, Alessia; Akimova, Tatiana; Wang, Liqing; Liu, Yujie; Xiao, Haiyan; Koike, Maya A.; Hancock, Saege A.; Bhatti, Tricia R.; Han, Rongxiang; Jiao, Jing; Veasey, Sigrid C.; Sims, Carrie A.; Baur, Joseph A.; Wallace, Douglas C.; Hancock, Wayne W.			Essential role of mitochondrial energy metabolism in Foxp3(+) T-regulatory cell function and allograft survival	FASEB JOURNAL			English	Article						histone deacetylase; immunity; immunometabolism; immunoregulation; transplant survival	ENHANCER FACTOR-2 MEF2; MOLECULAR-MECHANISMS; EFFECTOR; IMMUNOMETABOLISM; EXPRESSION; MEMORY; DIFFERENTIATION; INFLAMMATION; INHIBITION; ACTIVATION	Conventional T (Tcon) cells and Foxp3(+) T-regulatory (Treg) cells are thought to have differing metabolic requirements, but little is known of mitochondrial functions within these cell populations in vivo. In murine studies, we found that activation of both Tcon and Treg cells led to myocyte enhancer factor 2 (Mef2)-induced expression of genes important to oxidative phosphorylation (OXPHOS). Inhibition of OXPHOS impaired both Tcon and Treg cell function compared to wild-type cells but disproportionally affected Treg cells. Deletion of Pgc1 alpha or Sirt3, which are key regulators of OXPHOS, abrogated Treg-dependent suppressive function and impaired allograft survival. Mef2 is inhibited by histone/protein deacetylase-9 (Hdac9), and Hdac9 deletion increased Treg suppressive function. Hdac9(-/-) Treg showed increased expression of Pgc1 alpha and Sirt3, and improved mitochondrial respiration, compared to wild-type Treg cells. Our data show that key OXPHOS regulators are required for optimal Treg function and Treg-dependent allograft acceptance. These findings provide a novel approach to increase Treg function and give insights into the fundamental mechanisms by which mitochondrial energy metabolism regulates immune cell functions in vivo.	[Beier, Ulf H.; Xiao, Haiyan; Jiao, Jing] Childrens Hosp Philadelphia, Dept Pediat, Div Nephrol, Philadelphia, PA 19104 USA; [Angelin, Alessia; Koike, Maya A.; Hancock, Saege A.; Wallace, Douglas C.] Childrens Hosp Philadelphia, Ctr Mitochondrial & Epigen Med, Philadelphia, PA 19104 USA; [Akimova, Tatiana; Wang, Liqing; Liu, Yujie; Bhatti, Tricia R.; Han, Rongxiang; Hancock, Wayne W.] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Div Transplant Immunol, Philadelphia, PA 19104 USA; [Akimova, Tatiana; Wang, Liqing; Liu, Yujie; Bhatti, Tricia R.; Han, Rongxiang; Hancock, Wayne W.] Childrens Hosp Philadelphia, Biesecker Ctr Pediat Liver Dis, Philadelphia, PA 19104 USA; [Akimova, Tatiana; Wang, Liqing; Liu, Yujie; Bhatti, Tricia R.; Han, Rongxiang; Hancock, Wayne W.] Univ Penn, Philadelphia, PA 19104 USA; [Veasey, Sigrid C.] Univ Penn, Dept Med, Ctr Sleep & Circadian Neurobiol, Philadelphia, PA 19104 USA; [Sims, Carrie A.; Baur, Joseph A.] Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA; [Sims, Carrie A.; Baur, Joseph A.] Univ Penn, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Sims, Carrie A.] Univ Penn, Hosp Univ Penn, Div Traumatol & Surg Crit Care, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Hancock, WW (corresponding author), 916 B ARC,3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	whancock@mail.med.upenn.edu		Akimova, Tatiana/0000-0003-2767-8762; Beier, Ulf/0000-0002-3672-572X	U.S. National Institutes of Health [K08AI095353, AI073489, AI095276, NS21325, NS070298, AG24373, DIC73691]; Simons Foundation [205844]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079588, R01HL124576, R01HL123331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI095353, P01AI073489, R56AI095276] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K08GM097614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021328, R01NS021325, R01NS070298] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024373, RF1AG054104] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The work was supported by the U.S. National Institutes of Health (Grants K08AI095353, AI073489, AI095276, NS21325, NS070298, AG24373, and DIC73691), as well as Simons Foundation (Grant 205844).	Akimova T, 2012, AM J TRANSPLANT, V12, P3449, DOI 10.1111/j.1600-6143.2012.04269.x; Akimova T, 2010, CLIN IMMUNOL, V136, P348, DOI 10.1016/j.clim.2010.04.018; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Battke F, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-121; Beier UH, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002873; Beier UH, 2011, CURR OPIN IMMUNOL, V23, P670, DOI 10.1016/j.coi.2011.07.002; Beier UH, 2011, MOL CELL BIOL, V31, P1022, DOI 10.1128/MCB.01206-10; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chi H, 2012, NAT REV IMMUNOL, V12, P325, DOI 10.1038/nri3198; Czubryt MP, 2004, RECENT PROG HORM RES, V59, P105, DOI 10.1210/rp.59.1.105; de Zoeten EF, 2010, GASTROENTEROLOGY, V138, P583, DOI 10.1053/j.gastro.2009.10.037; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Feuerer M, 2009, NAT IMMUNOL, V10, P689, DOI 10.1038/ni.1760; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Issa F, 2013, TRENDS IMMUNOL, V34, P107, DOI 10.1016/j.it.2012.11.003; Kim do Y, 2012, PLOS ONE, V7; Kong XX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011707; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Macintyre AN, 2014, CELL METAB, V20, P61, DOI 10.1016/j.cmet.2014.05.004; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Marelli-Berg FM, 2012, IMMUNOLOGY, V136, P363, DOI 10.1111/j.1365-2567.2012.03583.x; Mathis D, 2011, NAT REV IMMUNOL, V11, P81, DOI 10.1038/nri2922; Maus MV, 2014, BLOOD, V123, P2625, DOI 10.1182/blood-2013-11-492231; McDonald L., 1998, KETOGENIC DIET COMPL, V1; Michalek RD, 2011, P NATL ACAD SCI USA, V108, P18348, DOI 10.1073/pnas.1108856108; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Mockler MB, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00107; Mukhopadhyay P, 2007, NAT PROTOC, V2, P2295, DOI 10.1038/nprot.2007.327; Nath N, 2009, J IMMUNOL, V182, P8005, DOI 10.4049/jimmunol.0803563; Nishikawa H, 2010, INT J CANCER, V127, P759, DOI 10.1002/ijc.25429; Ostroukhova M, 2012, AM J PHYSIOL-LUNG C, V302, pL300, DOI 10.1152/ajplung.00221.2011; Pearce EL, 2010, CURR OPIN IMMUNOL, V22, P314, DOI 10.1016/j.coi.2010.01.018; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Pollizzi KN, 2014, NAT REV IMMUNOL, V14, P435, DOI 10.1038/nri3701; Procaccini C, 2010, IMMUNITY, V33, P929, DOI 10.1016/j.immuni.2010.11.024; Rathmell JC, 2012, IMMUNOL REV, V249, P5, DOI 10.1111/j.1600-065X.2012.01158.x; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Swanson BJ, 1998, MOL IMMUNOL, V35, P445, DOI 10.1016/S0161-5890(98)00058-3; Tao R, 2005, J IMMUNOL, V175, P5774, DOI 10.4049/jimmunol.175.9.5774; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; van der Windt GJW, 2012, IMMUNOL REV, V249, P27, DOI 10.1111/j.1600-065X.2012.01150.x; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Viollet B, 2012, CLIN SCI, V122, P253, DOI 10.1042/CS20110386; Wang LQ, 2009, NAT REV DRUG DISCOV, V8, P969, DOI 10.1038/nrd3031; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9	49	152	154	4	27	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2315	2326		10.1096/fj.14-268409	http://dx.doi.org/10.1096/fj.14-268409			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	25681462	Green Published			2022-12-26	WOS:000355209500010
J	He, KM; Xing, R; Yan, XH; Tian, AJ; Zhang, ML; Yuan, JH; Lv, ZZ; Fang, XH; Li, ZJ; Zhang, YY				He, Kangmin; Xing, Rui; Yan, Xiaohua; Tian, Aiju; Zhang, Mingliang; Yuan, Jinghe; Lv, Zhizhen; Fang, Xiaohong; Li, Zijian; Zhang, Youyi			Mammalian actin-binding protein 1/HIP-55 is essential for the scission of clathrin-coated pits by regulating dynamin-actin interaction	FASEB JOURNAL			English	Article						membrane trafficking; adaptor protein; quantitative live-cell imaging	MEDIATED ENDOCYTOSIS; ADAPTER PROTEIN; CYTOSKELETON; ACTIVATION; RECEPTORS; GTPASE	Actin and dynamin work cooperatively to drive the invagination and scission of clathrin-coated pits (CCPs). However, little is known about the mechanism that orchestrates the spatiotemporal recruitment of dynamin and actin. Here, we have identified the mammalian actin-binding protein 1 (mAbp1; also called HIP-55 or SH3P7), which could bind toclathrin, actin, as well as dynamin, as an adaptor that links the dynamic recruitment of dynamin and actin for the scission of CCPs. Live-cell imaging reveals that mAbp1 is specifically recruited at a late stage of the long-lived CCPs. mAbp1 knockdown impaired CCP scission by reducing dynamin recruitment at the plasma membrane. However, actin disruption remarkably eliminates mAbp1 recruitment and thus dynamin recruitment. These data suggest that by binding to both clathrin and F-actin, mAbp1 is specifically recruited at a late stage of CCP formation, which subsequently recruits dynamin to CCPs.	[He, Kangmin; Xing, Rui; Tian, Aiju; Zhang, Mingliang; Lv, Zhizhen; Li, Zijian; Zhang, Youyi] Peking Univ, Hosp 3, Inst Vasc Med, Beijing 100871, Peoples R China; [He, Kangmin; Xing, Rui; Tian, Aiju; Zhang, Mingliang; Lv, Zhizhen; Li, Zijian; Zhang, Youyi] Peking Univ, Acad Adv Interdisciplinary Studies, Key Lab Cardiovascular Mol Biol & Regulatory Pept, Key Lab Mol Cardiovasc Sci,Minist Educ,Minist Hlt, Beijing 100871, Peoples R China; [He, Kangmin; Xing, Rui; Tian, Aiju; Zhang, Mingliang; Lv, Zhizhen; Li, Zijian; Zhang, Youyi] Beijing Key Lab Cardiovasc Receptors Res, Beijing 100871, Peoples R China; [He, Kangmin; Yuan, Jinghe; Fang, Xiaohong] Chinese Acad Sci, Inst Chem, Key Lab Mol Nanostruct & Nanotechnol, Beijing Natl Lab Mol Sci, Beijing 100080, Peoples R China; [Yan, Xiaohua] Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Sch Life Sci, Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China	Peking University; Peking University; Chinese Academy of Sciences; Institute of Chemistry, CAS; Tsinghua University	Li, ZJ (corresponding author), 49 Huayuan North Rd, Beijing 100191, Peoples R China.	lizijian@bjmu.edu.cn; zhangyy@bjmu.edu.cn	Yan, Xiaohua/J-4922-2015	Yan, Xiaohua/0000-0002-7528-5771; Zhang, Mingliang/0000-0003-2285-3592	National Key Basic Research Program of the People's Republic of China [2013CB933701, 2012CB518000, 2011CB503903]; Natural Science Foundation of China [81471893, 81070078, 81270157, 81270159]; Emory Global Health Institute (Atlanta, GA, USA)	National Key Basic Research Program of the People's Republic of China; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Emory Global Health Institute (Atlanta, GA, USA)	The authors sincerely thank Dr. Haian Fu (Emory University, Atlanta, GA, USA) for the HIP-55/mammalian actin-binding protein 1 plasmid, HIP-55/mammalian actin-binding protein 1-knockdown cell line, and valuable discussions. The authors thank Laura Smales for helping with language editing. The authors also thank Drs. Sanford M. Simon, Richard D. Minshall, and Lois E. Greene for their generous gifts of the clathrin-Discosoma sp. red fluorescent protein, enhanced green fluorescent proteina-adaptin, caveolin-1-enhanced green fluorescent protein, and enhanced green fluorescent protein-clathrin. This work was supported by the National Key Basic Research Program of the People's Republic of China (2013CB933701, 2012CB518000, and 2011CB503903) and the Natural Science Foundation of China (81471893, 81070078, 81270157, and 81270159). This work was supported in part by the Emory Global Health Institute (Atlanta, GA, USA).	Aguet F, 2013, DEV CELL, V26, P279, DOI 10.1016/j.devcel.2013.06.019; Boulant S, 2011, NAT CELL BIOL, V13, P1124, DOI 10.1038/ncb2307; Chen C, 2012, BRIT J PHARMACOL, V166, P676, DOI 10.1111/j.1476-5381.2011.01785.x; Collins A, 2011, CURR BIOL, V21, P1167, DOI 10.1016/j.cub.2011.05.048; Connert S, 2006, EMBO J, V25, P1611, DOI 10.1038/sj.emboj.7601053; Cortesio CL, 2010, MOL BIOL CELL, V21, P186, DOI 10.1091/mbc.E09-02-0106; Daumke O, 2014, CELL, V156, P882, DOI 10.1016/j.cell.2014.02.017; Ensenat D, 1999, J BIOL CHEM, V274, P33945, DOI 10.1074/jbc.274.48.33945; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Grassart A, 2014, J CELL BIOL, V205, P721, DOI 10.1083/jcb.201403041; Kessels MM, 2000, MOL BIOL CELL, V11, P393, DOI 10.1091/mbc.11.1.393; Kessels MM, 2001, J CELL BIOL, V153, P351, DOI 10.1083/jcb.153.2.351; Kirchhausen T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016725; Larbolette O, 1999, MOL CELL BIOL, V19, P1539; Li ZJ, 2014, ONCOTARGET, V5, P3197, DOI 10.18632/oncotarget.1900; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Mooren OL, 2012, ANNU REV BIOCHEM, V81, P661, DOI 10.1146/annurev-biochem-060910-094416; Mousavi SA, 2004, BIOCHEM J, V377, P1, DOI 10.1042/BJ20031000; Onabajo OO, 2008, J IMMUNOL, V180, P6685, DOI 10.4049/jimmunol.180.10.6685; Pelkmans L, 2002, TRAFFIC, V3, P311, DOI 10.1034/j.1600-0854.2002.30501.x; Perrais D, 2005, DEV CELL, V9, P581, DOI 10.1016/j.devcel.2005.10.002; Rappoport J, 2004, TRAFFIC, V5, P327, DOI 10.1111/j.1600-0854.2004.00187.x; Rappoport JZ, 2006, AM J PHYSIOL-CELL PH, V291, pC1072, DOI 10.1152/ajpcell.00160.2006; Sverdlov M, 2009, MOL BIOL CELL, V20, P4531, DOI 10.1091/mbc.E08-10-0997; Taylor MJ, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001302; Taylor MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000604; Ungewickell EJ, 2007, CURR OPIN CELL BIOL, V19, P417, DOI 10.1016/j.ceb.2007.05.003; Wu XF, 2001, J CELL BIOL, V155, P291, DOI 10.1083/jcb.200104085	30	7	8	0	28	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2495	2503		10.1096/fj.14-264259	http://dx.doi.org/10.1096/fj.14-264259			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	25690657				2022-12-26	WOS:000355209500026
J	Wilkie-Grantham, RP; Magon, NJ; Harwood, DT; Kettle, AJ; Vissers, MC; Winterbourn, CC; Hampton, MB				Wilkie-Grantham, Rachel P.; Magon, Nicholas J.; Harwood, D. Tim; Kettle, Anthony J.; Vissers, Margreet C.; Winterbourn, Christine C.; Hampton, Mark B.			Myeloperoxidase-dependent Lipid Peroxidation Promotes the Oxidative Modification of Cytosolic Proteins in Phagocytic Neutrophils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADPH OXIDASE ACTIVATION; ARACHIDONIC-ACID; CROSS-LINKING; CALPROTECTIN; BINDING; BACTERIAL; CALCIUM; S100A8; ACTIN; STIMULATION	Phagocytic neutrophils generate reactive oxygen species to kill microbes. Oxidant generation occurs within an intracellular phagosome, but diffusible species can react with the neutrophil and surrounding tissue. To investigate the extent of oxidative modification, we assessed the carbonylation of cytosolic proteins in phagocytic neutrophils. A 4-fold increase in protein carbonylation was measured within 15 min of initiating phagocytosis. Carbonylation was dependent on NADPH oxidase and myeloperoxidase activity and was inhibited by butylated hydroxytoluene and Trolox, indicating a role for myeloperoxidase-dependent lipid peroxidation. Proteomic analysis of target proteins revealed significant carbonylation of the S100A9 subunit of calprotectin, a truncated form of Hsp70, actin, and hemoglobin from contaminating erythrocytes. The addition of the reactive aldehyde 4-hydroxynonenal (HNE) caused carbonylation, and HNE-glutathione adducts were detected in the cytosol of phagocytic neutrophils. The posttranslational modification of neutrophil proteins will influence the functioning and fate of these immune cells in the period following phagocytic activation, and provides a marker of neutrophil activation during infection and inflammation.	[Wilkie-Grantham, Rachel P.; Magon, Nicholas J.; Harwood, D. Tim; Kettle, Anthony J.; Vissers, Margreet C.; Winterbourn, Christine C.; Hampton, Mark B.] Univ Otago, Dept Pathol, Ctr Free Rad Res, Christchurch 8140, New Zealand	University of Otago	Hampton, MB (corresponding author), Univ Otago, Dept Pathol, POB 4345, Christchurch 8140, New Zealand.	mark.hampton@otago.ac.nz	Hampton, Mark B/A-8490-2008; Vissers, Margreet C M/T-4159-2017; Harwood, Tim/H-3636-2012	Hampton, Mark B/0000-0002-7349-3729; Kettle, Tony/0000-0002-8218-7766	Health Research Council of New Zealand; University of Otago	Health Research Council of New Zealand(Health Research Council of New Zealand); University of Otago	This work was supported by the Health Research Council of New Zealand, and Ph.D. scholarships from the University of Otago to R.W. and N.M.	Aldini G, 2005, J MASS SPECTROM, V40, P946, DOI 10.1002/jms.872; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; Baty JW, 2002, PROTEOMICS, V2, P1261, DOI 10.1002/1615-9861(200209)2:9<1261::AID-PROT1261>3.0.CO;2-Q; Bouzidi F, 2004, BIOCHEM BIOPH RES CO, V325, P1060, DOI 10.1016/j.bbrc.2004.10.134; Boyum A, 1968, Scand J Clin Lab Invest Suppl, V97, P7; Buss H, 1997, FREE RADICAL BIO MED, V23, P361, DOI 10.1016/S0891-5849(97)00104-4; CHAI YC, 1994, ARCH BIOCHEM BIOPHYS, V310, P273, DOI 10.1006/abbi.1994.1167; Chapman ALP, 2002, J BIOL CHEM, V277, P9757, DOI 10.1074/jbc.M106134200; Chapman ALP, 2013, J BIOL CHEM, V288, P6465, DOI 10.1074/jbc.M112.418970; Corbin BD, 2008, SCIENCE, V319, P962, DOI 10.1126/science.1152449; Dalle-Donne I, 2007, FREE RADICAL BIO MED, V42, P583, DOI 10.1016/j.freeradbiomed.2006.11.026; Doussiere J, 2002, EUR J BIOCHEM, V269, P3246, DOI 10.1046/j.1432-1033.2002.03002.x; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Guignard F, 1996, EUR J BIOCHEM, V241, P265, DOI 10.1111/j.1432-1033.1996.0265t.x; Hampton MB, 1998, BLOOD, V92, P3007, DOI 10.1182/blood.V92.9.3007.421k47_3007_3017; HAMPTON MB, 1994, J LEUKOCYTE BIOL, V55, P147, DOI 10.1002/jlb.55.2.147; Harrison CA, 1999, J BIOL CHEM, V274, P8561, DOI 10.1074/jbc.274.13.8561; Heinecke JW, 2002, TOXICOLOGY, V177, P11, DOI 10.1016/S0300-483X(02)00192-0; Ilg EC, 1996, BIOCHEM BIOPH RES CO, V225, P146, DOI 10.1006/bbrc.1996.1144; Kerkhoff C, 2005, FASEB J, V19, P467, DOI 10.1096/fj.04-2377fje; Kerkhoff C, 1999, J BIOL CHEM, V274, P32672, DOI 10.1074/jbc.274.46.32672; Klempt M, 1997, FEBS LETT, V408, P81, DOI 10.1016/S0014-5793(97)00394-3; LEMARCHAND P, 1992, J BIOL CHEM, V267, P19379; Lim SY, 2010, J BIOL CHEM, V285, P14377, DOI 10.1074/jbc.M109.075242; Lusitani D, 2003, INFECT IMMUN, V71, P4711, DOI 10.1128/IAI.71.8.4711-4716.2003; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; OLIVER CN, 1987, ARCH BIOCHEM BIOPHYS, V253, P62, DOI 10.1016/0003-9861(87)90637-0; Parker H, 2012, J LEUKOCYTE BIOL, V92, P841, DOI 10.1189/jlb.1211601; Poullis A, 2003, J GASTROEN HEPATOL, V18, P756, DOI 10.1046/j.1440-1746.2003.03014.x; QUINN MT, 1995, J LEUKOCYTE BIOL, V57, P415, DOI 10.1002/jlb.57.3.415; Requena JR, 2001, P NATL ACAD SCI USA, V98, P69, DOI 10.1073/pnas.011526698; Roseth AG, 1999, SCAND J GASTROENTERO, V34, P50; Roulin K, 1999, EXP CELL RES, V247, P410, DOI 10.1006/excr.1998.4382; Sahara S, 2010, BIOCHEM BIOPH RES CO, V393, P806, DOI 10.1016/j.bbrc.2010.02.087; Sohnle PG, 2000, J INFECT DIS, V182, P1272, DOI 10.1086/315810; UCHIDA K, 1993, J BIOL CHEM, V268, P6388; VISSERS MCM, 1991, ARCH BIOCHEM BIOPHYS, V285, P53, DOI 10.1016/0003-9861(91)90327-F; Yousefi R, 2007, ACTA BIOCH BIOPH SIN, V39, P795, DOI 10.1111/j.1745-7270.2007.00343.x; Zhang RL, 2002, J BIOL CHEM, V277, P46116, DOI 10.1074/jbc.M209124200	39	22	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9896	9905		10.1074/jbc.M114.613422	http://dx.doi.org/10.1074/jbc.M114.613422			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25697357	Green Published, hybrid			2022-12-26	WOS:000352729400048
J	Sun, F; Xiao, YD; Qu, ZX				Sun, Fan; Xiao, Yadong; Qu, Zhaoxia			Oncovirus Kaposi Sarcoma Herpesvirus (KSHV) Represses Tumor Suppressor PDLIM2 to Persistently Activate Nuclear Factor kappa B (NF-kappa B) and STAT3 Transcription Factors for Tumorigenesis and Tumor Maintenance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer; NF-kappa B (NF-KB); STAT3; Tumor Suppressor Gene; Tumor Virus; HIV; AIDS-related Malignancies; KSHV; HHV8; PDLIM2	DOMAIN-CONTAINING PROTEIN-2; DNA-SEQUENCES; MOLECULAR-BIOLOGY; VIRUS; HUMAN-HERPESVIRUS-8; EXPRESSION; APOPTOSIS; LYMPHOMA; TAX; DEGRADATION	Background: Kaposi sarcoma herpesvirus (KSHV) causes malignancies in patients with AIDS or immunosuppression. Results: KSHV represses tumor suppressor gene PDLIM2, whose reconstitution suppresses tumorigenesis of KSHV-associated cancer cells. Conclusion: KSHV suppresses PDLIM2 for tumorigenesis. Significance: These studies not only reveal an important mechanism underlying KSHV pathogenesis but also provide immediate therapeutic strategies for KSHV-mediated cancers. Kaposi sarcoma herpesvirus (KSHV) is the most common cause of malignancies among AIDS patients. However, how KSHV induces tumorigenesis remains largely unknown. Here, we demonstrate that one important mechanism underlying the tumorigenesis of KSHV is through transcriptional repression of the tumor suppressor gene PDZ-LIM domain-containing protein 2 (PDLIM2). PDLIM2 expression is repressed in KSHV-transformed human umbilical vascular endothelial cells as well as in KSHV-associated cancer cell lines and primary tumors. Importantly, PDLIM2 repression is essential for KSHV-induced persistent activation of nuclear factor B (NF-B) and signal transducer and activator of transcription 3 (STAT3) and subsequent tumorigenesis and tumor maintenance. Our mechanistic studies indicate that PDLIM2 repression by KSHV involves DNA methylation. Notably, the epigenetic repression of PDLIM2 can be reversed by 5-aza-2-deoxycytidine and vitamin D to suppress KSHV-associated cancer cell growth. These studies not only improve our understanding of KSHV pathogenesis but also provide immediate therapeutic strategies for KSHV-mediated cancers, particularly those associated with AIDS.	[Sun, Fan; Xiao, Yadong; Qu, Zhaoxia] Univ Pittsburgh, Inst Canc, Sch Med, Pittsburgh, PA 15232 USA; [Sun, Fan; Qu, Zhaoxia] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Qu, ZX (corresponding author), Hillman Canc Ctr Res Pavil, 5117 Ctr Ave, Pittsburgh, PA 15213 USA.	quz@upmc.edu	SUN, FAN/K-8683-2017; SUN, FAN/GWA-1524-2022	SUN, FAN/0000-0002-3538-9701	National Institutes of Health through the NCI [P30CA047904-24S]; Competitive Medical Research Fund (CMRF); NATIONAL CANCER INSTITUTE [P30CA047904] Funding Source: NIH RePORTER	National Institutes of Health through the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Competitive Medical Research Fund (CMRF); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant P30CA047904-24S through the NCI (to Z. Q.). This work was also supported by a grant from the Competitive Medical Research Fund (CMRF).	Aoki Y, 2003, BLOOD, V101, P1535, DOI 10.1182/blood-2002-07-2130; Boshoff C, 1998, BLOOD, V91, P1671, DOI 10.1182/blood.V91.5.1671.1671_1671_1679; Bottero V, 2011, J VIROL, V85, P1980, DOI 10.1128/JVI.01911-10; Brinkmann MM, 2003, J VIROL, V77, P9346, DOI 10.1128/JVI.77.17.9346-9358.2003; Brown HJ, 2003, J VIROL, V77, P8532, DOI 10.1128/JVI.77.15.8532-8540.2003; Burger M, 2005, ONCOGENE, V24, P2067, DOI 10.1038/SJ.ONC.1208442; Cai QL, 2010, ADV VIRUS RES, V78, P87, DOI 10.1016/S0065-3527(10)78003-9; Casper C, 2008, REV MED VIROL, V18, P321, DOI 10.1002/rmv.583; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chugh P, 2005, P NATL ACAD SCI USA, V102, P12885, DOI 10.1073/pnas.0408577102; Cousins E, 2013, J VIROL, V87, P10816, DOI 10.1128/JVI.02047-13; Cousins E, 2014, RECENT RESULTS CANC, V193, P227, DOI 10.1007/978-3-642-38965-8_13; de Oliveira DE, 2010, TRENDS MICROBIOL, V18, P248, DOI 10.1016/j.tim.2010.04.001; Fu J, 2010, ONCOGENE, V29, P6499, DOI 10.1038/onc.2010.374; Fu J, 2011, BLOOD, V117, P1652, DOI 10.1182/blood-2010-08-303073; Gwack Y, 2002, J BIOL CHEM, V277, P6438, DOI 10.1074/jbc.M108289200; He ZH, 2014, J VIROL, V88, P444, DOI 10.1128/JVI.01716-13; Keller SA, 2006, BLOOD, V107, P3295, DOI 10.1182/blood-2005-07-2730; Keller SA, 2000, BLOOD, V96, P2537; Konrad A, 2009, J VIROL, V83, P2563, DOI 10.1128/JVI.01512-08; Lei XF, 2010, NAT CELL BIOL, V12, P193, DOI 10.1038/ncb2019; Martin D, 2008, ONCOGENE, V27, P1844, DOI [10.1038/sj.onc.1210817, 10.1038/onc.2009.351]; Matta H, 2007, ONCOGENE, V26, P1656, DOI 10.1038/sj.onc.1209931; Matta H, 2007, J BIOL CHEM, V282, P24858, DOI 10.1074/jbc.M700118200; Molden J, 1997, J BIOL CHEM, V272, P19625, DOI 10.1074/jbc.272.31.19625; Muromoto R, 2006, FEBS LETT, V580, P93, DOI 10.1016/j.febslet.2005.11.057; Pati S, 2001, J VIROL, V75, P8660, DOI 10.1128/JVI.75.18.8660-8673.2001; Punjabi AS, 2007, J VIROL, V81, P2449, DOI 10.1128/JVI.01769-06; Qing GL, 2005, J BIOL CHEM, V280, P18, DOI 10.1074/jbc.M406619200; Qing GL, 2007, P NATL ACAD SCI USA, V104, P5324, DOI 10.1073/pnas.0609914104; Qu ZX, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-23; Qu ZX, 2011, VIRUSES-BASEL, V3, P714, DOI 10.3390/v3060714; Qu ZX, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-18; Qu ZX, 2010, CANCER RES, V70, P1766, DOI 10.1158/0008-5472.CAN-09-3263; Qu ZX, 2010, J BIOL CHEM, V285, P11786, DOI 10.1074/jbc.M109.086561; Qu ZX, 2004, J BIOL CHEM, V279, P44563, DOI 10.1074/jbc.M403689200; Robe PA, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-372; Schwarz M, 2001, J IMMUNOL, V167, P505, DOI 10.4049/jimmunol.167.1.505; SOULIER J, 1995, BLOOD, V86, P1276, DOI 10.1182/blood.V86.4.1276.bloodjournal8641276; Sun QM, 2003, J BIOL CHEM, V278, P52437, DOI 10.1074/jbc.M304199200; Suthaus J, 2012, BLOOD, V119, P5173, DOI 10.1182/blood-2011-09-377705; Tanaka T, 2005, IMMUNITY, V22, P729, DOI 10.1016/j.immuni.2005.04.008; Tanaka T, 2007, NAT IMMUNOL, V8, P584, DOI 10.1038/ni1464; Tanaka T, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001637; Vanoirbeek E, 2014, ONCOGENE, V33, P1904, DOI 10.1038/onc.2013.123; Wen KW, 2010, CANCER LETT, V289, P140, DOI 10.1016/j.canlet.2009.07.004; Xiao GT, 2006, CYTOKINE GROWTH F R, V17, P281, DOI 10.1016/j.cytogfr.2006.04.005; Xiao GT, 2011, AM J CANCER RES, V1, P192; Yan PR, 2009, NEOPLASIA, V11, P1036, DOI 10.1593/neo.09752; Yan PR, 2009, BLOOD, V113, P4370, DOI 10.1182/blood-2008-10-185660; Zhou J, 2015, ONCOGENE, V34, P3804, DOI 10.1038/onc.2014.318	52	37	37	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7362	7368		10.1074/jbc.C115.637918	http://dx.doi.org/10.1074/jbc.C115.637918			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25681443	Green Published, hybrid			2022-12-26	WOS:000351613600006
J	Kopp, TI; Andersen, V; Tjonneland, A; Vogel, U				Kopp, Tine Iskov; Andersen, Vibeke; Tjonneland, Anne; Vogel, Ulla			Polymorphisms in NFKB1 and TLR4 and Interaction with Dietary and Life Style Factors in Relation to Colorectal Cancer in a Danish Prospective Case-Cohort Study	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-4; NF-KAPPA-B; INFLAMMATORY-BOWEL-DISEASE; RESISTANCE 1 MDR1; CROHNS-DISEASE; ULCERATIVE-COLITIS; EPIDEMIOLOGIC EVIDENCE; PROMOTER POLYMORPHISM; BACTERIAL METABOLITES; GENE INTERACTIONS	Maintenance of a balance between commensal bacteria and the mucosal immune system is crucial and intestinal dysbiosis may be a key event in the pathogenesis of colorectal cancer (CRC). The toll-like receptor 4 (TLR4) is an important pattern-recognition receptor that regulates inflammation and barrier function in the gut by a mechanism that involves activation of the nuclear factor-kappa B (NF-kappa B) transcription factor. Dietary and life style factors may impact these functions. We therefore used a Danish prospective case-cohort study of 1010 CRC cases and 1829 randomly selected participants from the Danish Diet, Cancer and Health cohort to investigate three polymorphisms in NFKB1 and TLR4 and their possible interactions with diet and life style factors in relation to risk of CRC. Homozygous carriage of the variant allele of the TLR4/rs5030728 polymorphism was associated with increased risk of CRC (incidence rate ratio (IRR) = 1.30; 95% confidence interval (CI): 1.05-1.60; P = 0.02 (gene-dose model); IRR = 1.24; 95% CI: 1.01-1.51; P = 0.04 (recessive model)). Del-carriers of the NFKB1/rs28362491 polymorphism had a 17% (95% CI: 1.03-1.34; P = 0.02) increased risk of CRC compared to homozygous carriers of the ins-allele. However, none of these risk estimates withstood adjustment for multiple comparisons. We found no strong gene-environment interactions between the examined polymorphism and diet and life style factors in relation to CRC risk.	[Kopp, Tine Iskov] Tech Univ Denmark, Natl Food Inst, DK-2860 Soborg, Denmark; [Andersen, Vibeke] Hosp Southern Jutland, Organ Ctr, DK-6200 Aabenraa, Denmark; [Andersen, Vibeke] Univ Southern Denmark, Inst Reg Hlth Res, DK-5000 Odense, Denmark; [Andersen, Vibeke] Reg Hosp Viborg, Dept Med, DK-8800 Viborg, Denmark; [Tjonneland, Anne] Danish Canc Soc, Res Ctr, DK-2100 Copenhagen, Denmark; [Vogel, Ulla] Natl Res Ctr Working Environm, DK-2100 Copenhagen, Denmark	Technical University of Denmark; University of Southern Denmark; Danish Cancer Society; National Research Centre for the Working Environment	Kopp, TI (corresponding author), Tech Univ Denmark, Natl Food Inst, DK-2860 Soborg, Denmark.	tinis@food.dtu.dk	Vogel, Ulla B/I-5048-2012; Vogel, Ulla/ABC-2212-2020; Andersen, Vibeke/I-7932-2012	Vogel, Ulla B/0000-0001-6807-1524; Vogel, Ulla/0000-0001-6807-1524; Andersen, Vibeke/0000-0002-0127-2863; Tjonneland, Anne/0000-0003-4385-2097; Kopp, Tine/0000-0003-3729-4420	Danish Research Councils in the programme 'An integrated approach to risk-benefit assessment of human health effects of food and food contaminants'; Danish Council for Independent Research [09-06 7572]; Danish Council for Independent Research Medical Sciences [09-073597]	Danish Research Councils in the programme 'An integrated approach to risk-benefit assessment of human health effects of food and food contaminants'; Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Danish Council for Independent Research Medical Sciences(Det Frie Forskningsrad (DFF))	The project was supported by a PhD stipend from the Danish Research Councils in the programme 'An integrated approach to risk-benefit assessment of human health effects of food and food contaminants' (Forskeruddannelse 2009-10), and by a Mobility PhD grant (09-06 7572) from the Danish Council for Independent Research (www.ufm.dk) and as part of the project: "Beef versus pork consumption in the etiology of cancers in the colon and rectum: investigations performed within the Diet, Cancer and Health cohort" also from the Danish Council for Independent Research; Medical Sciences (grant no. 09-073597) (www.ufm.dk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Andersen V, 2013, ALIMENT PHARM THER, V37, P383, DOI 10.1111/apt.12180; Andersen V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078366; Andersen V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072119; Andersen V, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-183; Andersen V, 2012, SCAND J GASTROENTERO, V47, P572, DOI 10.3109/00365521.2012.668933; Andersen V, 2011, WORLD J GASTROENTERO, V17, P197, DOI 10.3748/wjg.v17.i2.197; Andersen V, 2011, EUR J GASTROEN HEPAT, V23, P282, DOI 10.1097/MEG.0b013e3283417f76; Andersen V, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-484; Andersen V, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-407; Andersen V, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-18; Bank S, 2014, PHARMACOGENOMICS J; Bank S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098815; BARLOW WE, 1994, BIOMETRICS, V50, P1064, DOI 10.2307/2533444; Barlow WE, 1999, J CLIN EPIDEMIOL, V52, P1165, DOI 10.1016/S0895-4356(99)00102-X; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BINGHAM SA, 1990, P NUTR SOC, V49, P153, DOI 10.1079/PNS19900021; Bingham SA, 2003, LANCET, V361, P1496, DOI 10.1016/S0140-6736(03)13174-1; Borm MEA, 2005, INT J IMMUNOGENET, V32, P401, DOI 10.1111/j.1744-313X.2005.00546.x; Brand S, 2005, INFLAMM BOWEL DIS, V11, P645, DOI 10.1097/01.MIB.0000168372.94907.d2; Browning BL, 2007, AM J GASTROENTEROL, V102, P2504, DOI 10.1111/j.1572-0241.2007.01463.x; Cao SJ, 2006, J BIOL CHEM, V281, P26041, DOI 10.1074/jbc.M602222200; Cogliano VJ, 2011, JNCI-J NATL CANCER I, V103, P1827, DOI 10.1093/jnci/djr483; Cuda C, 2011, METABOLISM, V60, P1131, DOI 10.1016/j.metabol.2010.12.006; CUMMINGS JH, 1979, AM J CLIN NUTR, V32, P2094, DOI 10.1093/ajcn/32.10.2094; Davoodi H, 2011, IRAN J ALLERGY ASTHM, V10, P91, DOI 010.02/ijaai.9199; De Jager PL, 2007, GENES IMMUN, V8, P387, DOI 10.1038/sj.gene.6364398; De Preter V, 2013, INFLAMM BOWEL DIS, V19, pE43, DOI 10.1002/ibd.22970; Durko L, 2014, CURR COLORECT CANC R, V10, P45, DOI 10.1007/s11888-013-0203-4; Eyking A, 2011, GASTROENTEROLOGY, V141, P2154, DOI 10.1053/j.gastro.2011.08.043; Ferlay J, 2014, IARC CANCERBASE; Franchimont D, 2004, GUT, V53, P987, DOI 10.1136/gut.2003.030205; Friis S, 2009, CANCER CAUSE CONTROL, V20, P731, DOI 10.1007/s10552-008-9286-7; Fukata M, 2007, BIOCHEM SOC T, V35, P1473, DOI 10.1042/BST0351473; Fukata M, 2006, GASTROENTEROLOGY, V131, P862, DOI 10.1053/j.gastro.2006.06.017; Fukata M, 2009, INFLAMM BOWEL DIS, V15, P997, DOI 10.1002/ibd.20880; Garlanda C, 2007, CANCER RES, V67, P6017, DOI 10.1158/0008-5472.CAN-07-0560; Gast A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024370; Geypens B, 1997, GUT, V41, P70, DOI 10.1136/gut.41.1.70; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Hansen RD, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-54; Hansen RD, 2007, MUTAT RES-FUND MOL M, V619, P68, DOI 10.1016/j.mrfmmm.2007.02.002; Hansen RD, 2009, MUTAT RES-FUND MOL M, V664, P13, DOI 10.1016/j.mrfmmm.2009.01.009; Heerdt BG, 1997, CELL GROWTH DIFFER, V8, P523; Hornef MW, 2003, J EXP MED, V198, P1225, DOI 10.1084/jem.20022194; Huxley RR, 2009, INT J CANCER, V125, P171, DOI 10.1002/ijc.24343; Jelavic TB, 2006, CLIN GENET, V70, P156, DOI 10.1111/j.1399-0004.2006.00651.x; Karban AS, 2004, HUM MOL GENET, V13, P35, DOI 10.1093/hmg/ddh008; Kopp TI, 2013, CANCER GENET-NY, V206, P266, DOI 10.1016/j.cancergen.2013.06.001; Kutikhin AG, 2014, TUMOUR BIOL; Landi S, 2006, J NEGAT RESULTS BIOM, V5, DOI 10.1186/1477-5751-5-15; Le Leu RK, 2007, CANCER BIOL THER, V6, P259, DOI 10.4161/cbt.6.2.4078; Le Leu R, 2013, DIGEST DIS SCI, V58, P3475, DOI 10.1007/s10620-013-2844-1; Lewander A, 2007, SCAND J GASTROENTERO, V42, P1332, DOI 10.1080/00365520701396026; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Murphy N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039361; Omrane I, 2014, TUMOR BIOL, V35, P545, DOI 10.1007/s13277-013-1075-6; Pereira SG, 2008, INT J BIOCHEM CELL B, V40, P1425, DOI 10.1016/j.biocel.2007.05.004; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Pimentel-Nunes P, 2013, DIGEST LIVER DIS, V45, P63, DOI 10.1016/j.dld.2012.08.006; Santarelli RL, 2008, NUTR CANCER, V60, P131, DOI 10.1080/01635580701684872; Segain JP, 2000, GUT, V47, P397, DOI 10.1136/gut.47.3.397; Slattery ML, 2012, INT J CANCER, V130, P2974, DOI 10.1002/ijc.26314; Suzairi MSM, 2013, CANCER EPIDEMIOL, V37, P634, DOI 10.1016/j.canep.2013.05.007; TJONNELAND A, 1991, INT J EPIDEMIOL, V20, P906, DOI 10.1093/ije/20.4.906; Tjonneland A, 2007, SCAND J PUBLIC HEALT, V35, P432, DOI 10.1080/14034940601047986; Vogel U, 2007, MUTAT RES-FUND MOL M, V624, P88, DOI 10.1016/j.mrfmmm.2007.04.006; Vogel U, 2011, ATHEROSCLEROSIS, V219, P200, DOI 10.1016/j.atherosclerosis.2011.06.018; WHITEHEAD RH, 1986, GUT, V27, P1457, DOI 10.1136/gut.27.12.1457; Xiao H, 2007, IMMUNITY, V26, P461, DOI 10.1016/j.immuni.2007.02.012; Young GP, 2005, MOL NUTR FOOD RES, V49, P571, DOI 10.1002/mnfr.200500026	73	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0116394	10.1371/journal.pone.0116394	http://dx.doi.org/10.1371/journal.pone.0116394			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25705893	Green Published, gold, Green Submitted			2022-12-26	WOS:000350662100035
J	An, GZ; Xu, H; Zhou, Y; Du, L; Miao, X; Jiang, DP; Li, KC; Guo, GZ; Zhang, C; Ding, GR				An, Guang-Zhou; Xu, Hui; Zhou, Yan; Du, Le; Miao, Xia; Jiang, Da-Peng; Li, Kang-Chu; Guo, Guo-Zhen; Zhang, Chen; Ding, Gui-Rong			Effects of Long-Term 50Hz Power-Line Frequency Electromagnetic Field on Cell Behavior in Balb/c 3T3 Cells	PLOS ONE			English	Article							MAGNETIC-FIELD; LEUKEMIA RISK; EXPOSURE; APOPTOSIS; DIFFERENTIATION; TRANSFORMATION; GROWTH	Power-line frequency electromagnetic field (PF-EMF) was reported as a human carcinogen by some epidemiological research, but the conclusion is lack of robust experiment evidence. To identify the effects of long-term PF-EMF exposure on cell behavior, Balb/c 3T3 cells in exponential growth phase were exposed or sham-exposed to 50 Hertz (Hz) PF-EMF at 2.3 mT for 2 hours (h) one day, 5 days every week. After 11 weeks exposure, cells were collected instantly. Cell morphology was observed under invert microscope and Giemsa staining, cell viability was detected by 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay, cell cycle and apoptosis was examined by flow cytometry, the protein level of Proliferating Cell Nuclear Antigen (PCNA) and CyclinD1 was detected by western blot, cell transformation was examined by soft agar clone assay and plate clone forming test, and cell migration ability was observed by scratch adhesion test. It was found that after PF-EMF exposure, cell morphology, apoptosis, cell migration ability and cell transformation didn't change. However, compared with sham group, cell viability obviously decreased and cell cycle distribution also changed after 11 weeks PF-EMF exposure. Meanwhile, the protein level of PCNA and CyclinD1 significantly decreased after PF-EMF exposure. These data suggested that although long-term 50Hz PF-EMF exposure under this experimental condition had no effects on apoptosis, cell migration ability and cell transformation, it could affect cell proliferation and cell cycle by down-regulation the expression of PCNA and CyclinD1 protein.	[An, Guang-Zhou; Zhou, Yan; Du, Le; Miao, Xia; Jiang, Da-Peng; Li, Kang-Chu; Guo, Guo-Zhen; Ding, Gui-Rong] Fourth Mil Med Univ, Fac Prevent Med, Dept Radiat Med, Xian 710032, Shaanxi Provinc, Peoples R China; [Xu, Hui] Taishan Med Coll, Radiol Coll, Taishan, Shandong, Peoples R China; [Zhang, Chen] China Acad Telecommun Res, Minist Ind & Informat Technol, Beijing, Peoples R China	Air Force Military Medical University; Shandong First Medical University & Shandong Academy of Medical Sciences	Zhang, C (corresponding author), China Acad Telecommun Res, Minist Ind & Informat Technol, Beijing, Peoples R China.	zhangchen@emcite.com; dingzhao@fmmu.edu.cn			National Natural Science Foundation of China [31170798]; National Basic Research Program of China [2011CB503705, 2011CB503704]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China (31170798) and National Basic Research Program of China (2011CB503705, 2011CB503704). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldi I, 2011, INT J CANCER, V129, P1477, DOI 10.1002/ijc.25765; Chen QS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069272; Cho H, 2012, BIOTECHNOL PROGR, V28, P1329, DOI 10.1002/btpr.1607; Cho S, 2014, DRUG CHEM TOXICOL, V37, P440, DOI 10.3109/01480545.2013.879662; Fedrowitz M, 2004, CANCER RES, V1, P234; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Ismael SJ, 1998, BIOELECTROMAGNETICS, V19, P131, DOI 10.1002/(SICI)1521-186X(1998)19:2<131::AID-BEM13>3.0.CO;2-T; Kheifets LI, 1997, AM J EPIDEMIOL, V146, P87, DOI 10.1093/oxfordjournals.aje.a009194; Lim K, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/296019; LONDON SJ, 1994, AM J IND MED, V26, P47, DOI 10.1002/ajim.4700260105; LOSCHER W, 1994, LIFE SCI, V54, P1531, DOI 10.1016/0024-3205(94)90024-8; Morabito C, 2010, CELL PHYSIOL BIOCHEM, V26, P947, DOI 10.1159/000324003; ONO M, 1988, MOL CELL BIOL, V8, P4190, DOI 10.1128/MCB.8.10.4190; RANNUG A, 1993, BIOELECTROMAGNETICS, V14, P17, DOI 10.1002/bem.2250140105; Reid A, 2011, BRIT J CANCER, V105, P1409, DOI 10.1038/bjc.2011.365; Reipert BM, 1997, LIFE SCI, V61, P1571, DOI 10.1016/S0024-3205(97)00736-4; Sermage-Faure C, 2013, BRIT J CANCER, V108, P1899, DOI 10.1038/bjc.2013.128; Simko M, 1998, BIOELECTROMAGNETICS, V19, P85, DOI 10.1002/(SICI)1521-186X(1998)19:2<85::AID-BEM5>3.0.CO;2-#; Sulpizio M, 2011, J CELL BIOCHEM, V112, P3797, DOI 10.1002/jcb.23310; UMEDA M, 1989, CARCINOGENESIS, V10, P1665, DOI 10.1093/carcin/10.9.1665; Vianale G, 2008, BRIT J DERMATOL, V158, P1189, DOI 10.1111/j.1365-2133.2008.08540.x; Wang Xing, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P821; Yan JH, 2010, ELECTROMAGN BIOL MED, V29, P165, DOI 10.3109/01676830.2010.505490; Zhou J, 2014, BIOELECTROMAGNETICS, V35, P30, DOI 10.1002/bem.21794; Zhou J, 2011, BONE, V49, P753, DOI 10.1016/j.bone.2011.06.026	25	11	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0117672	10.1371/journal.pone.0117672	http://dx.doi.org/10.1371/journal.pone.0117672			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695503	gold, Green Published, Green Submitted			2022-12-26	WOS:000350062300027
J	Bubl, E; Dorr, M; Riedel, A; Ebert, D; Philipsen, A; Bach, M; van Elst, LT				Bubl, Emanuel; Doerr, Michael; Riedel, Andreas; Ebert, Dieter; Philipsen, Alexandra; Bach, Michael; van Elst, Ludger Tebartz			Elevated Background Noise in Adult Attention Deficit Hyperactivity Disorder Is Associated with Inattention	PLOS ONE			English	Article							COGNITIVE-BEHAVIORAL THERAPY; MEDICATION-TREATED ADULTS; DEFICIT/HYPERACTIVITY DISORDER; PREFRONTAL CORTEX; METHYLPHENIDATE RITALIN; SUPERIOR COLLICULUS; NUCLEUS-ACCUMBENS; RECEPTOR ACTIONS; WORKING-MEMORY; RATING-SCALE	Background Inattention and distractibility are core symptoms of attention deficit hyperactivity disorder (ADHD). Still the neuronal organization is largely unknown. Previously we studied the electrophysiological activity of a distinct neuronal network-the retina-and found no change in stimulus-driven neural activity in patients with ADHD. However there is growing evidence for an elevated non stimulus-driven neural activity, or neuronal background noise, as underlying pathophysiological correlate. To further examine the biological bases that might underlie ADHD and problems with inattention, we performed a new analysis to test the hypothesis of an elevated background noise as underlying neuronal correlate for ADHD and problems with inattention in humans. A direct measure of background noise in patients with ADHD has not been described yet. Methods The retinal background noise was assessed based on pattern electroretinogram (PERG) data in 20 unmedicated ADHD patients and 20 healthy controls. The PERG is an electrophysiological measure for retinal ganglion cell function. ADHD severity was assessed by interview and questionnaire. Results Noise amplitude was significantly higher (138%) in patients with ADHD compared to the control group (p = 0.0047). Noise amplitude correlated significantly with psychometric measures for ADHD (CAARS) especially inattention (r = 0.44, p = 0.004). Conclusions The data provide evidence that an elevated background noise is associated with symptoms of inattention in ADHD and support the use of therapeutic interventions that reduce noise and distraction in patients with ADHD.	[Bubl, Emanuel; Doerr, Michael; Riedel, Andreas; Ebert, Dieter; Philipsen, Alexandra; van Elst, Ludger Tebartz] Univ Freiburg, Dept Psychiat & Psychotherapy, D-79106 Freiburg, Germany; [Bach, Michael] Univ Freiburg, Univ Eye Hosp, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg	Bubl, E (corresponding author), Univ Freiburg, Dept Psychiat & Psychotherapy, Hauptstr 5, D-79106 Freiburg, Germany.	emanuel.bubl@uniklinik-freiburg.de	Bach, Michael/A-6637-2010; Philipsen, Alexandra/E-4505-2017	Bach, Michael/0000-0003-2028-535X; Philipsen, Alexandra/0000-0001-6876-518X; Bubl, Emanuel/0000-0003-4951-8970				Arnsten AFT, 2012, NEURON, V76, P223, DOI 10.1016/j.neuron.2012.08.038; Arnsten AFT, 2011, BIOL PSYCHIAT, V69, pE89, DOI 10.1016/j.biopsych.2011.01.027; Arnsten AFT, 2009, CNS DRUGS, V23, P33, DOI 10.2165/00023210-200923000-00005; Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; Bach M, 1997, SPATIAL VISION, V10, P403, DOI 10.1163/156856897X00311; Bach M, 1999, DOC OPHTHALMOL, V99, P69, DOI 10.1023/A:1002648202420; Bach M., 2006, PRINCIPLES PRACTICE, P185; Bach M., 2000, FREIBURG EVOKED POTE; Bach M., 2007, PREPARATION MONTAGE; Bach M, 2007, GRAEF ARCH CLIN EXP, V245, P965, DOI 10.1007/s00417-006-0474-4; Bach M, 2013, DOC OPHTHALMOL, V126, P1, DOI 10.1007/s10633-012-9353-y; Biederman J, 2005, LANCET, V366, P237, DOI 10.1016/S0140-6736(05)66915-2; Bodis-Wollner I, 2009, J NEURAL TRANSM, V116, P1493, DOI 10.1007/s00702-009-0292-z; Brennan AR, 2008, ANN NY ACAD SCI, V1129, P236, DOI 10.1196/annals.1417.007; Bubl E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061728; Bubl E, 2012, BRIT J PSYCHIAT, V201, P151, DOI 10.1192/bjp.bp.111.100560; Bubl E, 2010, BIOL PSYCHIAT, V68, P205, DOI 10.1016/j.biopsych.2010.02.009; Bundesarztekammer B, 2007, BUNDESARZTEKAMMER 7; Comoli E, 2003, NAT NEUROSCI, V6, P974, DOI 10.1038/nn1113; Conners C K, 2002, J Atten Disord, V6 Suppl 1, pS17; del Campo N, 2011, BIOL PSYCHIAT, V69, pE145, DOI 10.1016/j.biopsych.2011.02.036; Dommett E, 2005, SCIENCE, V307, P1476, DOI 10.1126/science.1107026; Dommett EJ, 2009, NEUROSCIENCE, V164, P1369, DOI 10.1016/j.neuroscience.2009.09.007; DOWLING JE, 1986, TRENDS NEUROSCI, V9, P236, DOI 10.1016/0166-2236(86)90065-2; First M. B., 1997, STRUCTURED CLIN INTE; Forssberg Hans, 2006, Behav Brain Funct, V2, P40, DOI 10.1186/1744-9081-2-40; GHILARDI MF, 1989, ANN NEUROL, V25, P357, DOI 10.1002/ana.410250407; Goldman-Rakic P S, 1998, Adv Pharmacol, V42, P707; Kim Y, 2009, P NATL ACAD SCI USA, V106, P2915, DOI 10.1073/pnas.0813179106; Kiyatkin EA, 1996, J NEUROPHYSIOL, V75, P142, DOI 10.1152/jn.1996.75.1.142; Kroener S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006507; MAFFEI L, 1981, SCIENCE, V211, P953, DOI 10.1126/science.7466368; Mattay VS, 2003, P NATL ACAD SCI USA, V100, P6186, DOI 10.1073/pnas.0931309100; Mazer JA, 2011, BIOL PSYCHIAT, V69, P1147, DOI 10.1016/j.biopsych.2011.03.014; Meigen T, 1999, DOC OPHTHALMOL, V98, P207, DOI 10.1023/A:1002097208337; National Institute for Health and Care Excellence, CLIN GUID; NORCIA AM, 1989, VISION RES, V29, P627, DOI 10.1016/0042-6989(89)90048-5; Retz W, 2012, WORLD J BIOL PSYCHIA, V13, P48, DOI 10.3109/15622975.2010.540257; Retz-Junginger P, 2002, NERVENARZT, V73, P830, DOI 10.1007/s00115-001-1215-x; ROLLS ET, 1984, NEUROSCIENCE, V12, P1201, DOI 10.1016/0306-4522(84)90014-9; Rosler M, 2004, NERVENARZT, V75, P888, DOI 10.1007/s00115-003-1622-2; Safren SA, 2005, BEHAV RES THER, V43, P831, DOI 10.1016/j.brat.2004.07.001; Safren SA, 2010, JAMA-J AM MED ASSOC, V304, P875, DOI 10.1001/jama.2010.1192; Schulz KP, 2012, ARCH GEN PSYCHIAT, V69, P952, DOI 10.1001/archgenpsychiatry.2011.2053; STRASBURGER H, 1987, CLIN VISION SCI, V1, P245; SWANSON JM, 1995, NEW ENGL J MED, V333, P944, DOI 10.1056/NEJM199510053331419; SYKES DH, 1971, J CHILD PSYCHOL PSYC, V12, P129, DOI 10.1111/j.1469-7610.1971.tb01056.x; SYKES DH, 1972, PSYCHOPHARMACOLOGIA, V25, P262, DOI 10.1007/BF00422506; van Elst LT, 1997, BRAIN, V120, P2219, DOI 10.1093/brain/120.12.2219; Vijayraghavan S, 2007, NAT NEUROSCI, V10, P376, DOI 10.1038/nn1846; Volkow ND, 2011, MOL PSYCHIATR, V16, P1147, DOI 10.1038/mp.2010.97; Volkow N D, 2001, J Neurosci, V21, pRC121; Volkow ND, 2005, BIOL PSYCHIAT, V57, P1410, DOI 10.1016/j.biopsych.2004.11.006; Volkow ND, 2004, AM J PSYCHIAT, V161, P1173, DOI 10.1176/appi.ajp.161.7.1173; Volkow ND, 2007, ARCH GEN PSYCHIAT, V64, P932, DOI 10.1001/archpsyc.64.8.932; Volkow ND, 2012, J NEUROSCI, V32, P841, DOI 10.1523/JNEUROSCI.4461-11.2012; Volkow ND, 2009, JAMA-J AM MED ASSOC, V302, P1084, DOI 10.1001/jama.2009.1308; Volkow ND, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002017; Wang M, 2004, SCIENCE, V303, P853, DOI 10.1126/science.1091162; WARD MF, 1993, AM J PSYCHIAT, V150, P885; Wilmshurst L, 2011, J ATTEN DISORD, V15, P11, DOI 10.1177/1087054709347261; WURTZ RH, 1972, INVEST OPHTH VISUAL, V11, P441	62	15	15	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118271	10.1371/journal.pone.0118271	http://dx.doi.org/10.1371/journal.pone.0118271			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC0WZ	25693192	gold, Green Submitted, Green Published			2022-12-26	WOS:000350061500113
J	Kaur, P; Ghosh, A; Krishnamurthy, RV; Bhattacharjee, DG; Achar, V; Datta, S; Narayanan, S; Anbarasu, A; Ramaiah, S				Kaur, Parvinder; Ghosh, Anirban; Krishnamurthy, Ramya Vadageri; Bhattacharjee, Deepa Gagwani; Achar, Vijayashree; Datta, Santanu; Narayanan, Shridhar; Anbarasu, Anand; Ramaiah, Sudha			A High-Throughput Cidality Screen for Mycobacterium Tuberculosis	PLOS ONE			English	Article							INFECTION; DISCOVERY; ASSAY	Exposure to Mycobacterium tuberculosis (Mtb) aerosols is a major threat to tuberculosis (TB) researchers, even in bio-safety level-3 (BSL-3) facilities. Automation and highthroughput screens (HTS) in BSL3 facilities are essential for minimizing manual aerosolgenerating interventions and facilitating TB research. In the present study, we report the development and validation of a high-throughput, 24-well 'spot-assay' for selecting bactericidal compounds against Mtb. The bactericidal screen concept was first validated in the fastgrowing surrogate Mycobacterium smegmatis (Msm) and subsequently confirmed in Mtb using the following reference anti-tubercular drugs: rifampicin, isoniazid, ofloxacin and ethambutol (RIOE, acting on different targets). The potential use of the spot-assay to select bactericidal compounds from a large library was confirmed by screening on Mtb, with parallel plating by the conventional gold standard method (correlation, r(2) = 0.808). An automated spot-assay further enabled an MBC90 determination on resistant and sensitive Mtb clinical isolates. The implementation of the spot-assay in kinetic screens to enumerate residual Mtb after either genetic silencing (anti-sense RNA, AS-RNA) or chemical inhibition corroborated its ability to detect cidality. This relatively simple, economical and quantitative HTS considerably minimized the bio-hazard risk and enabled the selection of novel vulnerable Mtb targets and mycobactericidal compounds. Thus, spot-assays have great potential to impact the TB drug discovery process.	[Kaur, Parvinder; Bhattacharjee, Deepa Gagwani; Achar, Vijayashree; Narayanan, Shridhar] AstraZeneca India Private Ltd, Bangalore, Karnataka, India; [Ghosh, Anirban] Katholieke Univ Leuven, Dept Microbial & Mol Syst, B-3001 Leuven, Belgium; [Krishnamurthy, Ramya Vadageri] Gangagen Biotech Private Ltd, Bangalore, Karnataka, India; [Datta, Santanu] Cellworks India, Bangalore, Karnataka, India; [Anbarasu, Anand; Ramaiah, Sudha] VIT Univ, Sch Biosci & Technol, Med & Biol Comp Lab, Vellore, Tamil Nadu, India	AstraZeneca; KU Leuven; Vellore Institute of Technology	Kaur, P (corresponding author), AstraZeneca India Private Ltd, Bangalore, Karnataka, India.	parvinder149@gmail.com	Anbarasu, Anand/U-6323-2019; Ramaiah, Sudha/T-3682-2019; Anbarasu, Anand/K-4076-2017	Anbarasu, Anand/0000-0003-2216-7488				Altaf M, 2010, TUBERCULOSIS, V90, P333, DOI 10.1016/j.tube.2010.09.002; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Beydon MH, 2000, J BIOMOL SCREEN, V5, P13, DOI 10.1177/108705710000500105; CLSI-Clinical and Laboratory Standards Institute (CLSI), SUSC TEST MYC NOC OT; Collins LA, 1998, ANTIMICROB AGENTS CH, V42, P344; COOKSEY RC, 1995, ANTIMICROB AGENTS CH, V39, P754, DOI 10.1128/AAC.39.3.754; Davey HM, 2011, APPL ENVIRON MICROB, V77, P5571, DOI 10.1128/AEM.00744-11; GILCHRIS.JE, 1973, APPL MICROBIOL, V25, P244, DOI 10.1108/03068299810193425; Jagannathan V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014336; Jayaram R, 2003, ANTIMICROB AGENTS CH, V47, P2118, DOI 10.1128/AAC.47.7.2118-2124.2003; Kaur P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005923; McNerney R, 2004, J CLIN MICROBIOL, V42, P2115, DOI 10.1128/JCM.42.5.2115-2120.2004; Primm T. D., 2007, CURRENT BIOACTIVE CO, V3, P1; RILEY RL, 1957, AM REV TUBERC PULM, V75, P420; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Wedum AG, 1969, ASSESSMENT RISK HUMA; Wells WF, 1934, AM J HYG, V20, P611, DOI 10.1093/oxfordjournals.aje.a118097; World Health Organization, 2021, 10 THREATS GLOB HLTH; Zhang L, 2011, INT DRUG DISCOV, P60	19	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117577	10.1371/journal.pone.0117577	http://dx.doi.org/10.1371/journal.pone.0117577			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693161	Green Published, Green Submitted, gold			2022-12-26	WOS:000350061500062
J	Knudsen, S; Hother, C; Gronbaek, K; Jensen, T; Hansen, A; Mazin, W; Dahlgaard, J; Moller, MB; Ralfkiaer, E; Brown, PD				Knudsen, Steen; Hother, Christoffer; Gronbaek, Kirsten; Jensen, Thomas; Hansen, Anker; Mazin, Wiktor; Dahlgaard, Jesper; Moller, Michael Boe; Ralfkiaer, Elizabeth; Brown, Peter de Nully			Development and Blind Clinical Validation of a MicroRNA Based Predictor of Response to Treatment with R-CHO(E)P in DLBCL	PLOS ONE			English	Article							CELL; EXPRESSION; CANCER; SURVIVAL; MODEL	MicroRNAs (miRNA) are a group of short noncoding RNAs that regulate gene expression at the posttranscriptional level. It has been shown that microRNAs are independent predictors of outcome in patients with diffuse large B-cell lymphoma (DLBCL) treated with the drug combination R-CHOP. Based on the measured growth inhibition of 60 human cancer cell lines (NCI60) in the presence of doxorubicine, cyclophosphamide, vincristine and etoposide as well as the baseline microRNA expression of the 60 cell lines, a microRNA based response predictor to CHOP was developed. The response predictor consisting of 20 microRNAs was blindly validated in a cohort of 116 de novo DLBCL patients treated with R-CHOP or R-CHOEP as first line treatment. The predicted sensitivity based on diagnostic FFPE samples matched the clinical response, with decreasing sensitivity in poor responders (P = 0.03). When the International Prognostic Index (IPI) was included in the prediction analysis, the separation between responders and non-responders improved (P = 0.001). Thirteen patients developed relapse, and five patients predicted sensitive to their second and third line treatment survived a median 1194 days, while eight patients predicted not sensitive to their second and third line treatment survived a median 187 days (90% CI: 485 days versus 227 days). Among the latter group it was predicted that four would have been sensitive to another second line treatment than the one they received. The predictions were almost the same when diagnostic biopsies were used as when relapse biopsies were used. These preliminary findings warrant testing in a larger cohort of relapse patients to confirm whether the miRNA based predictor can select the optimal second line treatment and increase survival.	[Knudsen, Steen; Jensen, Thomas; Hansen, Anker; Mazin, Wiktor; Dahlgaard, Jesper] Med Prognosis Inst, Horsholm, Denmark; [Hother, Christoffer; Gronbaek, Kirsten; Brown, Peter de Nully] Rigshosp, Dept Hematol, DK-2100 Copenhagen, Denmark; [Ralfkiaer, Elizabeth] Rigshosp, Dept Pathol, DK-2100 Copenhagen, Denmark; [Moller, Michael Boe] Odense Univ Hosp, Dept Pathol, DK-5000 Odense, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Southern Denmark; Odense University Hospital	Knudsen, S (corresponding author), Med Prognosis Inst, Horsholm, Denmark.	steen@medical-prognosis.com	Møller, Michael B/G-8340-2016; Møller, Michael Boe/AAD-2113-2019	Møller, Michael B/0000-0003-2041-3630; Møller, Michael Boe/0000-0003-2041-3630; Dahlgaard, Jesper/0000-0002-1798-6799; Gronbaek, Kirsten/0000-0002-1535-9601	Danish Council for Strategic Research; MPI; Novo Nordisk Fonden [NNF13OC0003435] Funding Source: researchfish	Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); MPI; Novo Nordisk Fonden(Novo Nordisk Foundation)	MPI acknowledges support from the Danish Council for Strategic Research (http://ufm.dk/forskning-og-innovation/rad-og-udvalg/detstrategiske-forskningsrad). ER acknowledges support from MPI. MPI had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Alencar AJ, 2011, CLIN CANCER RES, V17, P4125, DOI 10.1158/1078-0432.CCR-11-0224; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Chen JJ, 2012, MOL CANCER THER, V11, P34, DOI 10.1158/1535-7163.MCT-11-0620; Cheson BD, 1999, J CLIN ONCOL, V17, P1244, DOI 10.1200/JCO.1999.17.4.1244; Glinsmann-Gibson BJ, 2010, BLOOD, V116, P1282; Han S, 2003, BREAST CANCER RES TR, V82, P11, DOI 10.1023/B:BREA.0000003843.53726.63; Ivanovska I, 2008, MOL CELL BIOL, V28, P2167, DOI 10.1128/MCB.01977-07; Knudsen S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087415; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Li C, 2009, BLOOD, V113, P6681, DOI 10.1182/blood-2009-01-202028; Li Y, 2009, CANCER SCI, V100, P1234, DOI 10.1111/j.1349-7006.2009.01164.x; Montes-Moreno S, 2011, BLOOD, V118, P1034, DOI 10.1182/blood-2010-11-321554; Patnaik SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049918; Poliseno L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000594; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; SHIPP MA, 1993, NEW ENGL J MED, V329, P987, DOI 10.1056/nejm199309303291402; Volinia S, 2010, GENOME RES, V20, P589, DOI 10.1101/gr.098046.109; Wang WT, 2013, JNCI-J NATL CANCER I, V105, P1284, DOI 10.1093/jnci/djt202; Wright G, 2003, P NATL ACAD SCI USA, V100, P9991, DOI 10.1073/pnas.1732008100	20	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0115538	10.1371/journal.pone.0115538	http://dx.doi.org/10.1371/journal.pone.0115538			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692889	Green Published, Green Submitted, gold			2022-12-26	WOS:000350061500009
J	Marzinelli, EM; Williams, SB; Babcock, RC; Barrett, NS; Johnson, CR; Jordan, A; Kendrick, GA; Pizarro, OR; Smale, DA; Steinberg, PD				Marzinelli, Ezequiel M.; Williams, Stefan B.; Babcock, Russell C.; Barrett, Neville S.; Johnson, Craig R.; Jordan, Alan; Kendrick, Gary A.; Pizarro, Oscar R.; Smale, Dan A.; Steinberg, Peter D.			Large-Scale Geographic Variation in Distribution and Abundance of Australian Deep-Water Kelp Forests	PLOS ONE			English	Article							NEW-SOUTH-WALES; ECKLONIA-RADIATA; CLIMATE-CHANGE; SUBTIDAL HABITAT; SEA-URCHINS; CORAL-REEFS; BIODIVERSITY; COMMUNITIES; TEMPERATURE; RESILIENCE	Despite the significance of marine habitat-forming organisms, little is known about their largescale distribution and abundance in deeper waters, where they are difficult to access. Such information is necessary to develop sound conservation and management strategies. Kelps are main habitat-formers in temperate reefs worldwide; however, these habitats are highly sensitive to environmental change. The kelp Ecklonia radiate is the major habitat-forming organism on subtidal reefs in temperate Australia. Here, we provide large-scale ecological data encompassing the latitudinal distribution along the continent of these kelp forests, which is a necessary first step towards quantitative inferences about the effects of climatic change and other stressors on these valuable habitats. We used the Autonomous Underwater Vehicle (AUV) facility of Australia's IntegratedMarine Observing System (IMOS) to survey 157,000 m(2) of seabed, of which ca 13,000 m(2) were used to quantify kelp covers at multiple spatial scales (10100 m to 100-1,000 km) and depths (15-60 m) across several regions ca 2-6 degrees latitude apart along the East and West coast of Australia. We investigated the large-scale geographic variation in distribution and abundance of deep-water kelp (>15 m depth) and their relationships with physical variables. Kelp cover generally increased with latitude despite great variability at smaller spatial scales. Maximum depth of kelp occurrence was 40-50 m. Kelp latitudinal distribution along the continent was most strongly related to water temperature and substratum availability. This extensive survey data, coupled with ongoing AUV missions, will allow for the detection of long-term shifts in the distribution and abundance of habitat-forming kelp and the organisms they support on a continental scale, and provide information necessary for successful implementation and management of conservation reserves.	[Marzinelli, Ezequiel M.; Steinberg, Peter D.] Sydney Inst Marine Sci, Mosman, NSW, Australia; [Marzinelli, Ezequiel M.; Steinberg, Peter D.] Univ New S Wales, Ctr Marine Bioinnovat, Sydney, NSW, Australia; [Marzinelli, Ezequiel M.; Steinberg, Peter D.] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Williams, Stefan B.; Pizarro, Oscar R.] Univ Sydney, Australian Ctr Field Robot, Sydney, NSW 2006, Australia; [Babcock, Russell C.] CSIRO Marine & Atmospher Res, Brisbane, Qld, Australia; [Barrett, Neville S.; Johnson, Craig R.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Jordan, Alan] New South Wales Govt, Port Stephens Fisheries Inst, Dept Primary Ind, Nelson Bay, NSW, Australia; [Kendrick, Gary A.; Smale, Dan A.] Univ Western Australia, Oceans Inst, Perth, WA 6009, Australia; [Kendrick, Gary A.; Smale, Dan A.] Univ Western Australia, Sch Plant Biol, Perth, WA 6009, Australia; [Smale, Dan A.] The Lab, Marine Biol Assoc United Kingdom, Plymouth, Devon, England	Sydney Institute of Marine Science; University of New South Wales Sydney; University of New South Wales Sydney; University of Sydney; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Tasmania; NSW Department of Primary Industries; University of Western Australia; University of Western Australia; Marine Biological Association United Kingdom	Marzinelli, EM (corresponding author), Sydney Inst Marine Sci, Mosman, NSW, Australia.	e.marzinelli@unsw.edu.au	Kendrick, Gary Andrew/B-3460-2011; Babcock, Russell C/A-3794-2012; Johnson, Craig R/E-1788-2013; Smale, Daniel/Y-2909-2019; Marzinelli, Ezequiel/AAH-2906-2019; Barrett, Neville S/J-7593-2014; Williams, Stefan/AAE-4376-2020	Kendrick, Gary Andrew/0000-0002-0276-6064; Babcock, Russell C/0000-0002-7756-1290; Johnson, Craig R/0000-0002-9511-905X; Smale, Daniel/0000-0003-4157-541X; Marzinelli, Ezequiel/0000-0002-3762-3389; Barrett, Neville S/0000-0002-6167-1356; Williams, Stefan/0000-0001-9416-5639; Pizarro, Oscar/0000-0001-6612-2738; Steinberg, Peter/0000-0002-1781-0726	IMOS through the Department of Innovation, Industry, Science and Research National Collaborative Research Infrastructure Scheme and Education Investment Fund; Office of Science and Research; University of Western Australia; University of Sydney, Sydney Institute of Marine Science; NSW Office of Environment and Heritage; Institute of Marine and Antarctic Studies; Natural Environment Research Council [NE/K008439/1] Funding Source: researchfish; NERC [NE/K008439/1] Funding Source: UKRI	IMOS through the Department of Innovation, Industry, Science and Research National Collaborative Research Infrastructure Scheme and Education Investment Fund; Office of Science and Research; University of Western Australia; University of Sydney, Sydney Institute of Marine Science; NSW Office of Environment and Heritage; Institute of Marine and Antarctic Studies; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by IMOS through the Department of Innovation, Industry, Science and Research National Collaborative Research Infrastructure Scheme and Education Investment Fund. Additional funding in NSW was provided by the Office of Science and Research. Logistic support was provided by the University of Western Australia, University of Sydney, Sydney Institute of Marine Science, NSW Office of Environment and Heritage, Institute of Marine and Antarctic Studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2007, PLYMOUTH PRIMER E, DOI [10.1093/jxb/erm028, DOI 10.1093/JXB/ERM028]; ANDREW NL, 1993, MAR ECOL PROG SER, V99, P89, DOI 10.3354/meps099089; [Anonymous], 2013, NAT CLIM CHANGE, DOI [10.1038/nclimate1627, DOI 10.1038/NCLIMATE1627]; Bearham D, 2013, MAR ECOL PROG SER, V476, P59, DOI 10.3354/meps10148; Bruno JF, 2001, MARINE COMMUNITY ECOLOGY, P201; Connell SD, 2008, J BIOGEOGR, V35, P1608, DOI 10.1111/j.1365-2699.2008.01903.x; Connell SD, 2008, MAR ECOL PROG SER, V360, P63, DOI 10.3354/meps07526; Connell Sean D., 2007, P378; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; CRESSWELL GR, 1983, AUST J MAR FRESH RES, V34, P105; DAYTON PK, 1985, ANNU REV ECOL SYST, V16, P215, DOI 10.1146/annurev.es.16.110185.001243; DAYTON PK, 1984, ECOL MONOGR, V54, P253, DOI 10.2307/1942498; DAYTON PK, 1985, ECOL MONOGR, V55, P447, DOI 10.2307/2937131; Edgar GJ, 2009, MAR ECOL PROG SER, V388, P51, DOI 10.3354/meps08149; Fairhead VA, 2004, MAR BIOL, V145, P41, DOI 10.1007/s00227-004-1308-8; FLETCHER WJ, 1987, ECOL MONOGR, V57, P89, DOI 10.2307/1942640; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Fowler-Walker MJ, 2002, MAR ECOL PROG SER, V240, P49, DOI 10.3354/meps240049; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Hughes TP, 2002, ECOL LETT, V5, P775, DOI 10.1046/j.1461-0248.2002.00383.x; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Johnson C.R., 2005, 2001044 U TASM SCH Z; Johnson CR, 2011, J EXP MAR BIOL ECOL, V400, P17, DOI 10.1016/j.jembe.2011.02.032; Jordan A, 2010, SEABED HABITAT MAPPI, P207; KIRKMAN H, 1984, J EXP MAR BIOL ECOL, V76, P119, DOI 10.1016/0022-0981(84)90060-1; LARKUM AWD, 1986, J EXP MAR BIOL ECOL, V96, P177, DOI 10.1016/0022-0981(86)90241-8; Ling SD, 2009, P NATL ACAD SCI USA, V106, P22341, DOI 10.1073/pnas.0907529106; Mabin CJT, 2013, MAR ECOL PROG SER, V483, P117, DOI 10.3354/meps10261; Mann KH, 1973, SCIENCE, P182; Menge BA, 2011, J EXP MAR BIOL ECOL, V400, P236, DOI 10.1016/j.jembe.2011.02.003; Nichol S., 2009, SE TASMANIA TEMPERAT; Pan YD, 2013, ANNU REV ECOL EVOL S, V44, P593, DOI 10.1146/annurev-ecolsys-110512-135914; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Parnell PE, 2010, LIMNOL OCEANOGR, V55, P2686, DOI 10.4319/lo.2010.55.6.2686; Poloczanska ES, 2007, OCEANOGR MAR BIOL, V45, P407; Rossi V, 2014, J GEOPHYS RES-OCEANS, V119, P445, DOI 10.1002/2013JC009284; Roughan M., 2004, J GEOPHYS RES-OCEANS, V1978-2012, P109; Russell BD, 2009, GLOBAL CHANGE BIOL, V15, P2153, DOI 10.1111/j.1365-2486.2009.01886.x; Schaeffer A, 2013, J PHYS OCEANOGR, V43, P1042, DOI 10.1175/JPO-D-12-0177.1; Schiel DR, 2006, ANNU REV ECOL EVOL S, V37, P343, DOI 10.1146/annurev.ecolsys.37.091305.110251; SCHIEL DR, 1986, OCEANOGR MAR BIOL, V24, P265; Sherman AD, 2009, DEEP-SEA RES PT II, V56, P1754, DOI 10.1016/j.dsr2.2009.05.020; Siddon CE, 2003, MAR ECOL PROG SER, V261, P99, DOI 10.3354/meps261099; Smale DA, 2013, ECOL EVOL, V3, P4016, DOI 10.1002/ece3.774; Smale DA, 2012, ICES J MAR SCI, V69, P1108, DOI 10.1093/icesjms/fss082; Steneck RS, 2014, MARINE COMMUNITY ECOLOGY AND CONSERVATION, P315; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; Thompson PA, 2011, DEEP-SEA RES PT II, V58, P645, DOI 10.1016/j.dsr2.2010.10.003; Toohey BD, 2007, OIKOS, V116, P1618, DOI 10.1111/j.2007.0030-1299.15689.x; Turner W, 2003, TRENDS ECOL EVOL, V18, P306, DOI 10.1016/S0169-5347(03)00070-3; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; UNDERWOOD AJ, 1991, AUST J ECOL, V16, P231, DOI 10.1111/j.1442-9993.1991.tb01050.x; Underwood AJ, 1993, SPECIES DIVERSITY EC, P38; Vanderklift MA, 2005, MAR ECOL PROG SER, V299, P101, DOI 10.3354/meps299101; Verges A, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0846; Wernberg T, 2003, MAR BIOL, V143, P47, DOI 10.1007/s00227-003-1069-9; Wernberg T, 2012, GLOBAL CHANGE BIOL, V18, P1491, DOI 10.1111/j.1365-2486.2012.02656.x; Wernberg T, 2011, J EXP MAR BIOL ECOL, V400, P7, DOI 10.1016/j.jembe.2011.02.021; Wernberg T, 2010, ECOL LETT, V13, P685, DOI 10.1111/j.1461-0248.2010.01466.x; Williams SB, 2012, IEEE ROBOT AUTOM MAG, V19, P73, DOI 10.1109/MRA.2011.2181772; Winer B.J., 1991, STAT PRINCIPLES EXPT; WITMAN JD, 1988, TRENDS ECOL EVOL, V3, P285, DOI 10.1016/0169-5347(88)90099-7; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	64	56	56	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118390	10.1371/journal.pone.0118390	http://dx.doi.org/10.1371/journal.pone.0118390			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693066	gold, Green Accepted, Green Published			2022-12-26	WOS:000350061500121
J	van Bussel, FCG; van Bussel, BCT; Hoeks, APG; Op't Roodt, J; Henry, RMA; Ferreira, I; Vanmolkot, FHM; Schalkwijk, CG; Stehouwer, CDA; Reesink, KD				van Bussel, Frank C. G.; van Bussel, Bas C. T.; Hoeks, Arnold P. G.; Op't Roodt, Jos; Henry, Ronald M. A.; Ferreira, Isabel; Vanmolkot, Floris H. M.; Schalkwijk, Casper G.; Stehouwer, Coen D. A.; Reesink, Koen D.			A Control Systems Approach to Quantify Wall Shear Stress Normalization by Flow-Mediated Dilation in the Brachial Artery	PLOS ONE			English	Article							ENDOTHELIUM-DEPENDENT VASODILATION; ULTRASOUND ASSESSMENT; HYPERGLYCEMIA; REPRODUCIBILITY; DYSFUNCTION; AGREEMENT; RESPONSES; IMPAIRS; IMPACT; ADULTS	Flow-mediated dilation is aimed at normalization of local wall shear stress under varying blood flow conditions. Blood flow velocity and vessel diameter are continuous and opposing influences that modulate wall shear stress. We derived an index FMDv to quantify wall shear stress normalization performance by flow-mediated dilation in the brachial artery. In 22 fasting presumed healthy men, we first assessed intra-and inter-session reproducibilities of two indices pFMD(v) and mFMD(v), which consider the relative peak and relative mean hyperemic change in flow velocity, respectively. Second, utilizing oral glucose loading, we evaluated the tracking performance of both FMDv indices, in comparison with existing indices [i.e., the relative peak diameter increase (%FMD), the peak to baseline diameter ratio (D-peak/D-base), and the relative peak diameter increase normalized to the full area under the curve of blood flow velocity with hyperemia (FMD/shear(AUC)) or with area integrated to peak hyperemia (FMD/shear(AUC_peak))]. Inter-session and intra-session reproducibilities for pFMD(v), mFMD(v) and %FMD were comparable (intra-class correlation coefficients within 0.521-0.677 range). Both pFMD(v) and mFMD(v) showed more clearly a reduction after glucose loading (reduction of similar to 45%, p <= 0.001) than the other indices (% given are relative reductions): %FMD (similar to 11%, p >= 0.074); D-peak/D-base (similar to 11%, p >= 0.074); FMD/shear(AUC_peak) (similar to 20%, p >= 0.016) and FMD/shear(AUC) (similar to 38%, p <= 0.038). Further analysis indicated that wall shear stress normalization under normal (fasting) conditions is already far from ideal (FMDv << 1), which (therefore) does not materially change with glucose loading. Our approach might be useful in intervention studies to detect intrinsic changes in shear stress normalization performance in conduit arteries.	[van Bussel, Frank C. G.; Hoeks, Arnold P. G.; Reesink, Koen D.] Maastricht Univ, Med Ctr, Dept Biomed Engn, NL-6200 MD Maastricht, Netherlands; [van Bussel, Frank C. G.] Maastricht Univ, Med Ctr, Dept Radiol, NL-6200 MD Maastricht, Netherlands; [van Bussel, Bas C. T.; Op't Roodt, Jos; Henry, Ronald M. A.; Ferreira, Isabel; Vanmolkot, Floris H. M.; Schalkwijk, Casper G.; Stehouwer, Coen D. A.] Maastricht Univ, Med Ctr, Dept Internal Med, NL-6200 MD Maastricht, Netherlands; [Ferreira, Isabel] Maastricht Univ, Med Ctr, Dept Clin Epidemiol & Med Technol Assessment, NL-6200 MD Maastricht, Netherlands; [van Bussel, Bas C. T.; Stehouwer, Coen D. A.] Maastricht Univ, Med Ctr, Sch Nutr Toxicol & Metab NUTRIM, NL-6200 MD Maastricht, Netherlands; [Hoeks, Arnold P. G.; Op't Roodt, Jos; Henry, Ronald M. A.; Ferreira, Isabel; Vanmolkot, Floris H. M.; Schalkwijk, Casper G.; Stehouwer, Coen D. A.; Reesink, Koen D.] Maastricht Univ, Med Ctr, Sch Cardiovasc Dis CARIM, NL-6200 MD Maastricht, Netherlands; [van Bussel, Frank C. G.] Maastricht Univ, Med Ctr, Sch Mental Hlth & Neurosci MHeNS, NL-6200 MD Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University; Maastricht University; Maastricht University; Maastricht University; Maastricht University	Reesink, KD (corresponding author), Maastricht Univ, Med Ctr, Dept Biomed Engn, NL-6200 MD Maastricht, Netherlands.	k.reesink@maastrichtuniversity.nl	Ferreira, Isabel/B-6033-2008; Stehouwer, Coen/AAB-3435-2021	Ferreira, Isabel/0000-0003-1434-0607; Reesink, Koen/0000-0003-2354-883X; Stehouwer, Coen/0000-0001-8752-3223; Schalkwijk, Casper G/0000-0003-0190-2690; op 't Roodt, Jos/0000-0003-3535-6894	Dutch Organization for Scientific Research (NWO) [Veni-STW10261]	Dutch Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This study was supported by grant Veni-STW10261 for Dr Reesink from the Dutch Organization for Scientific Research (NWO; Ministry of Education, Culture, and Science, the Netherlands). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari CM, 1998, J VASC SURG, V28, P687, DOI 10.1016/S0741-5214(98)70095-3; Atkinson G, 2013, J HYPERTENS, V31, P287, DOI 10.1097/HJH.0b013e32835b8164; Black MA, 2008, HYPERTENSION, V51, P203, DOI 10.1161/HYPERTENSIONAHA.107.101014; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bland JM, 2005, DO I ANAL OBSERVER S; Brunner H, 2005, J HYPERTENS, V23, P233, DOI 10.1097/00004872-200502000-00001; CELERMAJER DS, 1992, LANCET, V340, P1111, DOI 10.1016/0140-6736(92)93147-F; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; Davies PF, 2005, ANN BIOMED ENG, V33, P1714, DOI 10.1007/s10439-005-8774-0; de Vet HCW, 2006, J CLIN EPIDEMIOL, V59, P1033, DOI 10.1016/j.jclinepi.2005.10.015; Donald AE, 2008, J AM COLL CARDIOL, V51, P1959, DOI 10.1016/j.jacc.2008.02.044; Ghiadoni L, 2012, J HYPERTENS, V30, P1399, DOI 10.1097/HJH.0b013e328353f222; Green DJ, 2011, HYPERTENSION, V57, P363, DOI 10.1161/HYPERTENSIONAHA.110.167015; Harris RA, 2010, HYPERTENSION, V55, P1075, DOI 10.1161/HYPERTENSIONAHA.110.150821; Henry RMA, 2004, ATHEROSCLEROSIS, V174, P49, DOI 10.1016/j.atherosclerosis.2004.01.002; Hilgers RHP, 2003, ARTERIOSCL THROM VAS, V23, P1826, DOI 10.1161/01.ATV.0000090672.07568.60; Inaba Y, 2010, INT J CARDIOVAS IMAG, V26, P631, DOI 10.1007/s10554-010-9616-1; Kawano H, 1999, J AM COLL CARDIOL, V34, P146, DOI 10.1016/S0735-1097(99)00168-0; Mah E, 2011, J NUTR, V141, P1961, DOI 10.3945/jn.111.144592; Major-Pedersen A, 2008, EXP DIABETES RES, DOI 10.1155/2008/672021; Mitchell GF, 2004, HYPERTENSION, V44, P134, DOI 10.1161/01.HYP.0000137305.77635.68; Nicholls SJ, 2006, J AM COLL CARDIOL, V48, P715, DOI 10.1016/j.jacc.2006.04.080; Nishiyama SK, 2007, J APPL PHYSIOL, V103, P843, DOI 10.1152/japplphysiol.00273.2007; Padilla J, 2008, CARDIOVASC ULTRASOUN, V6, DOI 10.1186/1476-7120-6-44; Parker BA, 2009, J APPL PHYSIOL, V107, P1357, DOI 10.1152/japplphysiol.91302.2009; Pyke KE, 2004, J APPL PHYSIOL, V97, P499, DOI 10.1152/japplphysiol.01245.2003; Pyke KE, 2007, J APPL PHYSIOL, V102, P1510, DOI 10.1152/japplphysiol.01024.2006; Renaudin C, 1998, DIABETOLOGIA, V41, P26, DOI 10.1007/s001250050862; Reneman RS, 2006, J VASC RES, V43, P251, DOI 10.1159/000091648; Siafarikas A, 2004, CLIN SCI, V107, P191, DOI 10.1042/CS20040004; Silber HA, 2001, J AM COLL CARDIOL, V38, P1859, DOI 10.1016/S0735-1097(01)01649-7; SORENSEN KE, 1995, BRIT HEART J, V74, P247; Stoner L, 2012, J ATHEROSCLER THROMB, DOI [10.3390/jpm2020050, DOI 10.3390/JPM2020050]; Thijssen DHJ, 2008, AM J PHYSIOL-HEART C, V295, pH1594, DOI 10.1152/ajpheart.00669.2008; Thijssen DHJ, 2011, AM J PHYSIOL-HEART C, V300, pH2, DOI 10.1152/ajpheart.00471.2010; Title LM, 2000, J AM COLL CARDIOL, V36, P2185, DOI 10.1016/S0735-1097(00)00980-3; Twisk JWR, 2003, APPL LONGITUDINAL DA; Watanabe K, 2011, EUR J CLIN INVEST, V41, P465, DOI 10.1111/j.1365-2362.2010.02424.x; Welsch MA, 2002, MED SCI SPORT EXER, V34, P960, DOI 10.1097/00005768-200206000-00009; Weseler AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028460; Woodman RJ, 2001, J APPL PHYSIOL, V91, P929, DOI 10.1152/jappl.2001.91.2.929; Xiang GD, 2008, CLIN ENDOCRINOL, V68, P716, DOI 10.1111/j.1365-2265.2007.03099.x	42	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0115977	10.1371/journal.pone.0115977	http://dx.doi.org/10.1371/journal.pone.0115977			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693114	Green Submitted, Green Published, gold			2022-12-26	WOS:000350061500011
J	Hiroshima, Y; Zhang, Y; Zhang, N; Maawy, A; Mii, S; Yamamoto, M; Uehara, F; Miwa, S; Yano, S; Murakami, T; Momiyama, M; Chishima, T; Tanaka, K; Ichikawa, Y; Bouvet, M; Murata, T; Endo, I; Hoffman, RM				Hiroshima, Yukihiko; Zhang, Yong; Zhang, Nan; Maawy, Ali; Mii, Sumiyuki; Yamamoto, Mako; Uehara, Fuminari; Miwa, Shinji; Yano, Shuya; Murakami, Takashi; Momiyama, Masashi; Chishima, Takashi; Tanaka, Kuniya; Ichikawa, Yasushi; Bouvet, Michael; Murata, Takuya; Endo, Itaru; Hoffman, Robert M.			Establishment of a Patient-Derived Orthotopic Xenograft (PDOX) Model of HER-2-Positive Cervical Cancer Expressing the Clinical Metastatic Pattern	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; ANTI-CEA ANTIBODY; NUDE-MOUSE MODEL; FLUORESCENCE-GUIDED SURGERY; HUMAN COLON-CANCER; UTERINE CERVIX; IMAGING-SYSTEM; BREAST-CANCER; MICE; SPECIMENS	Squamous cell carcinoma of the cervix, highly prevalent in the developing world, is often metastatic and treatment resistant with no standard treatment protocol. Our laboratory pioneered the patient-derived orthotopic xenograft (PDOX) nude mouse model with the technique of surgical orthotopic implantation (SOI). Unlike subcutaneous transplant patient-derived xenograft (PDX) models, PDOX models metastasize. Most importantly, the metastasis pattern correlates to the patient. In the present report, we describe the development of a PDOX model of HER-2-positive cervical cancer. Metastasis after SOI in nude mice included peritoneal dissemination, liver metastasis, lung metastasis as well as lymph node metastasis reflecting the metastatic pattern in the donor patient. Metastasis was detected in 4 of 6 nude mice with primary tumors. Primary tumors and metastases in the nude mice had histological structures similar to the original tumor and were stained by an anti-HER-2 antibody in the same pattern as the patient's cancer. The metastatic pattern, histology and HER-2 tumor expression of the patient were thus preserved in the PDOX model. In contrast, subcutaneous transplantation of the patient's cervical tumors resulted in primary growth but not metastasis.	[Hiroshima, Yukihiko; Zhang, Yong; Zhang, Nan; Mii, Sumiyuki; Yamamoto, Mako; Uehara, Fuminari; Miwa, Shinji; Yano, Shuya; Murakami, Takashi; Hoffman, Robert M.] AntiCancer Inc, San Diego, CA 92111 USA; [Hiroshima, Yukihiko; Maawy, Ali; Mii, Sumiyuki; Yamamoto, Mako; Uehara, Fuminari; Miwa, Shinji; Yano, Shuya; Murakami, Takashi; Bouvet, Michael; Endo, Itaru] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; [Hiroshima, Yukihiko; Murakami, Takashi; Momiyama, Masashi; Chishima, Takashi; Tanaka, Kuniya; Ichikawa, Yasushi; Endo, Itaru] Yokohama City Univ, Grad Sch Med, Yokohama, Kanagawa 232, Japan; [Murata, Takuya] Kawasaki Univ, Sch Med, Dept Obstet & Gynecol, Kawasaki, Kanagawa, Japan	Anti Cancer Inc; University of California System; University of California San Diego; Yokohama City University	Hoffman, RM (corresponding author), AntiCancer Inc, San Diego, CA 92111 USA.	all@anticancer.com	Yano, Shuya/AAL-8028-2020; Zhang, Nan/GXH-0361-2022; Miwa, Shinji/AAI-9309-2020	Miwa, Shinji/0000-0002-5962-8287; Murakami, Takashi/0000-0002-9429-5705; UEHARA, FUMINARI/0000-0001-6567-2113	National Cancer Institute [CA CA132971, CA142669]; JSPS [26830081, 26462070, 24592009]; NATIONAL CANCER INSTITUTE [R01CA132971, R01CA142669] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by National Cancer Institute grant numbers CA CA132971 and CA142669 and JSPS KAKENHI grant numbers 26830081 to YH, 26462070 to IE and 24592009 to KT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertotti A, 2011, CANCER DISCOV, V1, P508, DOI 10.1158/2159-8290.CD-11-0109; Braud AC, 2002, EUR CYTOKINE NETW, V13, P115; Costa MJ, 1995, AM J CLIN PATHOL, V104, P634; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; Dong X, 2010, CLIN CANCER RES, V16, P1442, DOI 10.1158/1078-0432.CCR-09-2878; Fu X, 1993, ANTICANCER RES, V25, P283; FU XY, 1993, ANTICANCER RES, V13, P901; FU XY, 1992, P NATL ACAD SCI USA, V89, P5645, DOI 10.1073/pnas.89.12.5645; FU XY, 1991, P NATL ACAD SCI USA, V88, P9345, DOI 10.1073/pnas.88.20.9345; Furukawa Kubota, 1993, INT J CANCER, V53, P608; Gamez RG, 2009, DIAGN CYTOPATHOL, V37, P381, DOI 10.1002/dc.21027; Hashimoto K, 2011, EUR J OBSTET GYN R B, V159, P394, DOI 10.1016/j.ejogrb.2011.07.001; Hiroshima Y, 2014, J SURG ONCO IN PRESS, DOI [10.1002/jso.23861, DOI 10.1002/JSO.23861]; Hiroshima Y, 2014, ONCOTARGET IN PRESS; Hiroshima Y, 2014, J CELL BIOCHEM, V115, P1254, DOI 10.1002/jcb.24769; Hiroshima Y, 2014, J LAPAROENDOSC ADV S, V24, P241, DOI 10.1089/lap.2013.0418; Hiroshima Y, 2014, J SURG RES, V187, P510, DOI 10.1016/j.jss.2013.11.1083; Hoffman RM, 1999, INVEST NEW DRUG, V17, P343, DOI 10.1023/A:1006326203858; Kaushal S, 2008, J GASTROINTEST SURG, V12, P1938, DOI 10.1007/s11605-008-0581-0; KIHANA T, 1994, CANCER, V73, P148, DOI 10.1002/1097-0142(19940101)73:1<148::AID-CNCR2820730125>3.0.CO;2-C; Metildi CA, 2014, J SURG ONCOL, V109, P451, DOI 10.1002/jso.23507; Sabatier R, 2012, CASE REP ONCOL, V5, P464, DOI 10.1159/000342255; Suetsugu A, 2012, ANTICANCER RES, V32, P3063; Suetsugu A, 2012, J CELL BIOCHEM, V113, P2290, DOI 10.1002/jcb.24099; Suetsugu A, 2012, ANTICANCER RES, V32, P1175; Tentler JJ, 2012, NAT REV CLIN ONCOL, V9, P338, DOI 10.1038/nrclinonc.2012.61; Urabe A, 2006, HISTOPATHOLOGY, V49, P493, DOI 10.1111/j.1365-2559.2006.02536.x; Wang CW, 2009, AM J CLIN PATHOL, V131, P715, DOI 10.1309/AJCPTPBC6V5KUITM; WANG XO, 1992, INT J CANCER, V51, P992; Yan M, 2014, CANCER TREAT REV, V40, P770, DOI 10.1016/j.ctrv.2014.02.008	30	83	84	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117417	10.1371/journal.pone.0117417	http://dx.doi.org/10.1371/journal.pone.0117417			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689852	gold, Green Submitted, Green Published			2022-12-26	WOS:000350322700042
J	Mo, XQ; Yang, CJ; Wang, XL; Burkhardt, BR; Li, YB; Xia, HP; Cao, XP				Mo, Xiaoqing; Yang, Chijiao; Wang, Xuelan; Burkhardt, Brant R.; Li, Yangbin; Xia, Haipeng; Cao, Xiaopei			F3MB(PANDER) Decreases Mice Hepatic Triglyceride and Is Associated with Decreased DGAT1 Expression	PLOS ONE			English	Article							PANCREATIC-DERIVED FACTOR; SECRETING BETA-CELLS; FACTOR PANDER; CYTOKINE; FAM3B; LIVER; FAT; LIPOGENESIS; METABOLISM; PERILIPIN	Objective Pancreatic-derived factor (PANDER, also named as FAM3B) is secreted by pancreatic a and beta cells. Increasing evidence suggests that it may serve a hormonal function related to glycemic and lipid metabolism. In this study, we investigated the effects of PANDER overexpression on hepatic and adipose triglyceride metabolism in high-fat diet-fed male C57BL/6 mice. Methods PANDER overexpression was achieved by tail-vein injection of recombinant Ad-PANDER and Ad-GFP injected mice served as a control. The TG metabolism in both groups were compared. Results Adenoviral-mediated overexpression of PANDER did not affect body weight, food consumption, or liver enzymes. The triglyceride (TG) content of both liver and adipose tissue was significantly decreased in Ad-PANDER mice (liver: 6.16 +/- 1.89 mg/g vs. control 14.95 +/- 2.27 mg/g, P<0.05; adipose: 39.31 +/- 1.99 mg/100mg vs. 47.22 +/- 2.21 mg/100mg, P<0.05). The free fatty acid (FFA) content of adipose tissue in Ad-PANDER mice was also decreased (1.38 +/- 0.18 mg/g vs. 2.77 +/- 0.31 mg/g, P<0.01). The investigation of key enzymes of triglyceride hydrolysis and FFA oxidation in liver and adipose tissue showed that p-HSL/HSL was significantly increased and that DGAT1 gene and protein expression were significantly reduced in the liver of PANDER-overexpressing mice. PKA phosphorylation was also significantly increased in the livers of Ad-PANDER mice. No differences in ATGL, CPT1, ACOX1, or DGAT2 expression were observed. Conclusion Overexpression of PANDER is associated with observable decreases in TG, increases in PKA phosphorylation, and decreased DGAT1 expression, suggesting a possible interrelationship. The mechanisms by which this occurs remain to be elucidated.	[Mo, Xiaoqing; Yang, Chijiao; Li, Yangbin; Xia, Haipeng; Cao, Xiaopei] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Endocrinol, Guangzhou 510080, Guangdong, Peoples R China; [Wang, Xuelan] Sun Yat Sen Univ, Sch Med, Dept Pharmacol, Guangzhou 510080, Guangdong, Peoples R China; [Burkhardt, Brant R.] Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA	Sun Yat Sen University; Sun Yat Sen University; State University System of Florida; University of South Florida	Cao, XP (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Endocrinol, 58 Zhongshan 2nd Rd, Guangzhou 510080, Guangdong, Peoples R China.	caoxp@mail.sysu.edu.cn			Natural Science Foundation of China [30570887, 81370907]; Science and Technology Foundation of Guangdong Province [2011B0 410 31800358]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Foundation of Guangdong Province	This study was supported by the Natural Science Foundation of China (No. 30570887, and No. 81370907), and the Science and Technology Foundation of Guangdong Province (No. 2011B0 410 31800358). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brasaemle DL, 2009, MOL CELL BIOCHEM, V326, P15, DOI 10.1007/s11010-008-9998-8; Burkhardt BR, 2005, BBA-GENE STRUCT EXPR, V1730, P215, DOI 10.1016/j.bbaexp.2005.07.003; Cao XP, 2003, DIABETES, V52, P2296, DOI 10.2337/diabetes.52.9.2296; Chen Shuo, 2011, Zhonghua Yi Xue Za Zhi, V91, P1413; Ducharme NA, 2008, ENDOCRINOLOGY, V149, P942, DOI 10.1210/en.2007-1713; FAIN JN, 1983, J LIPID RES, V24, P945; Farese RV, 2000, CURR OPIN LIPIDOL, V11, P229, DOI 10.1097/00041433-200006000-00002; FOLCH J, 1957, J BIOL CHEM, V226, P497; GREENBERG AS, 1991, J BIOL CHEM, V266, P11341; Herrmann J, 2004, ARCH VIROL, V149, P1611, DOI 10.1007/s00705-004-0300-4; HONNOR RC, 1985, J BIOL CHEM, V260, P5130; Hutley L, 2005, AM J MED SCI, V330, P280, DOI 10.1097/00000441-200512000-00005; Levine JA, 2011, DIABETES, V60, P2667, DOI 10.2337/db11-1118; Lewis GF, 2002, ENDOCR REV, V23, P201, DOI 10.1210/er.23.2.201; Li J, 2011, HEPATOLOGY, V53, P1906, DOI 10.1002/hep.24295; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ogden CL, 2012, PREVALENCE OBESITY U, V82, P1; Robert-Cooperman CE, 2010, DIABETES, V59, P2209, DOI 10.2337/db09-1552; SCHMITZPEIFFER C, 1992, CELL SIGNAL, V4, P37, DOI 10.1016/0898-6568(92)90006-T; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Wang OM, 2008, ENDOCRINOLOGY, V149, P672, DOI 10.1210/en.2007-0106; Wilson CG, 2010, ENDOCRINOLOGY, V151, P5174, DOI 10.1210/en.2010-0379; Xu WZ, 2005, MOL CELL ENDOCRINOL, V240, P74, DOI 10.1016/j.mce.2005.05.010; Yang JC, 2005, BIOCHEMISTRY-US, V44, P11342, DOI 10.1021/bi0503908; Zhu Y, 2002, GENOMICS, V80, P144, DOI 10.1006/geno.2002.6816	25	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117156	10.1371/journal.pone.0117156	http://dx.doi.org/10.1371/journal.pone.0117156			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679806	Green Submitted, gold, Green Published			2022-12-26	WOS:000350682600052
J	Yang, RT; Zhang, CJ; Gao, R; Zhang, LN				Yang, Runtao; Zhang, Chengjin; Gao, Rui; Zhang, Lina			An Ensemble Method with Hybrid Features to Identify Extracellular Matrix Proteins	PLOS ONE			English	Article							PHYSICOCHEMICAL PROPERTIES; GENERAL-FORM; PREDICTION; ATTRIBUTES; SEQUENCE; DIFFERENTIATION; EXPRESSION; MACHINE; PSEAAC; GRAM	The extracellular matrix (ECM) is a dynamic composite of secreted proteins that play important roles in numerous biological processes such as tissue morphogenesis, differentiation and homeostasis. Furthermore, various diseases are caused by the dysfunction of ECM proteins. Therefore, identifying these important ECM proteins may assist in understanding related biological processes and drug development. In view of the serious imbalance in the training dataset, a Random Forest-based ensemble method with hybrid features is developed in this paper to identify ECM proteins. Hybrid features are employed by incorporating sequence composition, physicochemical properties, evolutionary and structural information. The Information Gain Ratio and Incremental Feature Selection (IGR-IFS) methods are adopted to select the optimal features. Finally, the resulting predictor termed IECMP (Identify ECM Proteins) achieves an balanced accuracy of 86.4% using the 10-fold cross-validation on the training dataset, which is much higher than results obtained by other methods (ECMPRED: 71.0%, ECMPP: 77.8%). Moreover, when tested on a common independent dataset, our method also achieves significantly improved performance over ECMPP and ECMPRED. These results indicate that IECMP is an effective method for ECM protein prediction, which has a more balanced prediction capability for positive and negative samples. It is anticipated that the proposed method will provide significant information to fully decipher the molecular mechanisms of ECM-related biological processes and discover candidate drug targets. For public access, we develop a user-friendly web server for ECM protein identification that is freely accessible at http://iecmp.weka.cc.	[Yang, Runtao; Zhang, Chengjin; Gao, Rui; Zhang, Lina] Shandong Univ, Sch Control Sci & Engn, Jinan 250100, Peoples R China; [Zhang, Chengjin] Shandong Univ, Sch Mech Elect & Informat Engn, Weihai, Peoples R China	Shandong University; Shandong University	Zhang, CJ (corresponding author), Shandong Univ, Sch Control Sci & Engn, Jinan 250100, Peoples R China.	cjzhang@sdu.edu.cn; gaorui@sdu.edu.cn			National Natural Science Foundation of China [61174044, 61473335, 61174218]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Natural Science Foundation of China (http://www.nsfc.gov.cn; No. 61174044, 61473335, and 61174218). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afridi TH, 2012, AMINO ACIDS, V42, P1443, DOI 10.1007/s00726-011-0888-0; Ahmad S, 2003, PROTEINS, V50, P629, DOI 10.1002/prot.10328; Anitha J, 2012, IJCA ADV COMPUTING C, V1, P7; Apweiler R, 2000, BIOINFORMATICS, V16, P1145, DOI 10.1093/bioinformatics/16.12.1145; Asadabadi Ebrahim Barzegari, 2013, Avicenna Journal of Medical Biotechnology, V5, P148; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bakhtiarizadeh MR, 2014, J THEOR BIOL, V356, P213, DOI 10.1016/j.jtbi.2014.04.040; Bi XL, 2008, CARCINOGENESIS, V29, P1435, DOI 10.1093/carcin/bgn141; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Campbell NE, 2010, J ONCOL, V2010, DOI 10.1155/2010/586905; Chagnot C, 2012, CELL MICROBIOL, V14, P1687, DOI 10.1111/cmi.12002; Chou KC, 2004, BIOCHEM BIOPH RES CO, V320, P1236, DOI 10.1016/j.bbrc.2004.06.073; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; Cromar GL, 2012, PROTEINS, V80, P1522, DOI 10.1002/prot.24036; Ding SY, 2014, J THEOR BIOL, V353, P19, DOI 10.1016/j.jtbi.2014.02.034; DUBCHAK I, 1995, P NATL ACAD SCI USA, V92, P8700, DOI 10.1073/pnas.92.19.8700; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Endo Y, 2012, DEV CELL, V23, P305, DOI 10.1016/j.devcel.2012.07.006; Feng YQ, 2003, 2003 INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND CYBERNETICS, VOLS 1-5, PROCEEDINGS, P2085, DOI 10.1109/ICMLC.2003.1259848; Han GS, 2014, J THEOR BIOL, V344, P31, DOI 10.1016/j.jtbi.2013.11.017; Hayat M, 2014, J THEOR BIOL, V346, P8, DOI 10.1016/j.jtbi.2013.12.015; Hayat M, 2013, AMINO ACIDS, V44, P1317, DOI 10.1007/s00726-013-1466-4; Hayat M, 2012, ANAL BIOCHEM, V424, P35, DOI 10.1016/j.ab.2012.02.007; Hoglund A, 2005, ONLINE J BIOINFORM, V6, P51; Hosseinzadeh F, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-238; Hubmacher D, 2013, CURR OPIN RHEUMATOL, V25, P65, DOI 10.1097/BOR.0b013e32835b137b; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Jung J, 2010, J COMPUT BIOL, V17, P97, DOI 10.1089/cmb.2008.0236; Kandaswamy KK, 2013, J THEOR BIOL, V317, P377, DOI 10.1016/j.jtbi.2012.10.015; Kandaswamy KK, 2010, BIOCHEM BIOPH RES CO, V391, P1306, DOI 10.1016/j.bbrc.2009.12.019; Karsdal MA, 2013, ASSAY DRUG DEV TECHN, V11, P70, DOI 10.1089/adt.2012.474; Lampe AK, 2005, J MED GENET, V42, P673, DOI 10.1136/jmg.2002.002311; Landreh M, 2011, FEBS J, V278, P3815, DOI 10.1111/j.1742-4658.2011.08215.x; Li LQ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031057, 10.1371/journal.pone.0045115]; Lin H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075726; Liu B, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S2-S3; Lu XQ, 2004, J CHEM INF COMP SCI, V44, P1228, DOI 10.1021/ci0342977; MALLAT SG, 1989, IEEE T PATTERN ANAL, V11, P674, DOI 10.1109/34.192463; Mathews S, 2012, DIFFERENTIATION, V84, P185, DOI 10.1016/j.diff.2012.05.001; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Mohamed TP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S57; Muiznieks LD, 2013, BBA-MOL BASIS DIS, V1832, P866, DOI 10.1016/j.bbadis.2012.11.022; Myasnikova E, 2001, BIOINFORMATICS, V17, P3, DOI 10.1093/bioinformatics/17.1.3; Parisien M, 2007, PROTEINS, V68, P824, DOI 10.1002/prot.21475; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Pugalenthi G, 2008, BIOCHEM BIOPH RES CO, V367, P630, DOI 10.1016/j.bbrc.2008.01.038; Qu W, 2012, NEURAL COMPUT APPL, V21, P337, DOI 10.1007/s00521-011-0739-7; Robert MG, 2009, ENTROPY INFORM THEOR; Rutnam ZJ, 2013, MATRIX BIOL, V32, P74, DOI 10.1016/j.matbio.2012.11.003; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Shen HB, 2008, ANAL BIOCHEM, V373, P386, DOI 10.1016/j.ab.2007.10.012; Sun XY, 2012, MOL BIOSYST, V8, P3178, DOI 10.1039/c2mb25280e; VANNUCCI M, 2001, SANKHYA B, V63, P218; Weiss G. M., 2004, SIGKDD EXPLORATIONS, V6, P7, DOI DOI 10.1145/1007730.1007734; Witten I.H., 2005, DATA MINING PRACTICA; Yang XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084439; Zhang JH, 2012, CIRC RES, V111, P1125, DOI 10.1161/CIRCRESAHA.112.273144; Zou CX, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-90; Zuo YC, 2014, ANAL BIOCHEM, V458, P14, DOI 10.1016/j.ab.2014.04.032	62	19	20	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0117804	10.1371/journal.pone.0117804	http://dx.doi.org/10.1371/journal.pone.0117804			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680094	Green Published, Green Submitted, gold			2022-12-26	WOS:000350682600089
J	Zhao, D; Besser, AH; Wander, SA; Sun, J; Zhou, W; Wang, B; Ince, T; Durante, MA; Guo, W; Mills, G; Theodorescu, D; Slingerland, J				Zhao, D.; Besser, A. H.; Wander, S. A.; Sun, J.; Zhou, W.; Wang, B.; Ince, T.; Durante, M. A.; Guo, W.; Mills, G.; Theodorescu, D.; Slingerland, J.			Cytoplasmic p27 promotes epithelial-mesenchymal transition and tumor metastasis via STAT3-mediated Twist1 upregulation	ONCOGENE			English	Article							KINASE INHIBITOR P27(KIP1); GROWTH-FACTOR-BETA; CELL-CYCLE; DEPENDENT KINASE; BREAST-CANCER; CDK INHIBITOR; TARGETED THERAPIES; ONCOGENIC FUNCTION; MAMMALIAN-CELLS; MICE LACKING	p27 restrains normal cell growth, but PI3K-dependent C-terminal phosphorylation of p27 at threonine 157 (T157) and T198 promotes cancer cell invasion. Here, we describe an oncogenic feedforward loop in which p27pT157pT198 binds Janus kinase 2 (JAK2) promoting STAT3 (signal transducer and activator of transcription 3) recruitment and activation. STAT3 induces TWIST1 to drive a p27-dependent epithelial-mesenchymal transition (EMT) and further activates AKT contributing to acquisition and maintenance of metastatic potential. p27 knockdown in highly metastatic PI3K-activated cells reduces STAT3 binding to the TWIST1 promoter, TWIST1 promoter activity and TWIST1 expression, reverts EMT and impairs metastasis, whereas activated STAT3 rescues p27 knockdown. Cell cycle-defective phosphomimetic p27T157DT198D (p27CK-DD) activates STAT3 to induce a TWIST1-dependent EMT in human mammary epithelial cells and increases breast and bladder cancer invasion and metastasis. Data support a mechanism in which PI3K-deregulated p27 binds JAK2, to drive STAT3 activation and EMT through STAT3-mediated TWIST1 induction. Furthermore, STAT3, once activated, feeds forward to further activate AKT.	[Zhao, D.; Besser, A. H.; Wander, S. A.; Sun, J.; Zhou, W.; Wang, B.; Ince, T.; Durante, M. A.; Slingerland, J.] Univ Miami, Miller Sch Med, Braman Family Breast Canc Inst, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA; [Zhao, D.; Besser, A. H.; Wander, S. A.; Durante, M. A.] Univ Miami, Miller Sch Med, Sheila & David Fuente Grad Program Canc Biol, Miami, FL 33136 USA; [Zhou, W.; Wang, B.; Slingerland, J.] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA; [Ince, T.] Univ Miami, Miller Sch Med, Stem Cell Res Inst, Dept Pathol, Miami, FL 33136 USA; [Guo, W.; Mills, G.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Guo, W.; Mills, G.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Theodorescu, D.] Univ Colorado, Ctr Canc, Aurora, CO USA; [Slingerland, J.] Univ Miami, Miller Sch Med, Dept Med, Miami, FL 33136 USA	University of Miami; University of Miami; University of Miami; University of Miami; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Miami	Slingerland, J (corresponding author), Univ Miami, Miller Sch Med, Braman Family Breast Canc Inst, Sylvester Comprehens Canc Ctr, 1501 NW 10th Ave,BRB708, Miami, FL 33136 USA.	jslingerland@med.miami.edu	Durante, Michael/ABH-8217-2020; Zhou, Wen/A-5763-2010; Zhao, Dekuang/H-5671-2015	Durante, Michael/0000-0003-3137-6847; Zhou, Wen/0000-0002-5496-5815; Ince, Tan/0000-0003-0315-6425; Zhao, Dekuang/0000-0002-7251-2481	UMSCCC Analytical Imaging Core Facility; Doris Duke Charitable Foundation;  [NCI-2R01CA105118-05A]; NATIONAL CANCER INSTITUTE [R01CA105118, R01CA075115, P50CA083639] Funding Source: NIH RePORTER	UMSCCC Analytical Imaging Core Facility; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We acknowledge the support of lab members, the UMSCCC Analytical Imaging Core Facility and Grant NCI-2R01CA105118-05A. A grant from the Doris Duke Charitable Foundation supported AB, SW and JMS.	Ansieau S, 2010, ONCOGENE, V29, P3173, DOI 10.1038/onc.2010.92; Besson A, 2004, GENE DEV, V18, P862, DOI 10.1101/gad.1185504; Besson A, 2004, NAT REV CANCER, V4, P948, DOI 10.1038/nrc1501; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Besson A, 2007, GENE DEV, V21, P1731, DOI 10.1101/gad.1556607; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Cheng GZ, 2008, J BIOL CHEM, V283, P14665, DOI 10.1074/jbc.M707429200; Chiang AC, 2008, NEW ENGL J MED, V359, P2814, DOI 10.1056/NEJMra0805239; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Denicourt C, 2007, CANCER RES, V67, P9238, DOI 10.1158/0008-5472.CAN-07-1375; Devarajan E, 2009, CURR MOL MED, V9, P626, DOI 10.2174/156652409788488720; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Fero ML, 1998, NATURE, V396, P177, DOI 10.1038/24179; Fujita N, 2002, J BIOL CHEM, V277, P28706, DOI 10.1074/jbc.M203668200; Fujita N, 2003, J BIOL CHEM, V278, P49254, DOI 10.1074/jbc.M306614200; HENGST L, 1994, P NATL ACAD SCI USA, V91, P5291, DOI 10.1073/pnas.91.12.5291; Hennessy Bryan T, 2010, Clin Proteomics, V6, P129, DOI 10.1007/s12014-010-9055-y; Hidaka T, 2009, ANTICANCER RES, V29, P597; Hong F, 2008, MOL CELL, V30, P701, DOI 10.1016/j.molcel.2008.04.027; Ince TA, 2007, CANCER CELL, V12, P160, DOI 10.1016/j.ccr.2007.06.013; Jakel H, 2011, ONCOGENE, V30, P3502, DOI 10.1038/onc.2011.68; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kim MY, 2009, CELL, V139, P1315, DOI 10.1016/j.cell.2009.11.025; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; KOFF A, 1993, SCIENCE, V260, P536, DOI 10.1126/science.8475385; Kossatz U, 2006, EMBO J, V25, P5159, DOI 10.1038/sj.emboj.7601388; Kruck S, 2012, BJU INT, V109, P1565, DOI 10.1111/j.1464-410X.2011.10649.x; Larreaa MD, 2009, P NATL ACAD SCI USA, V106, P9268, DOI 10.1073/pnas.0805057106; Li H, 2012, CELL STEM CELL, V11, P845, DOI 10.1016/j.stem.2012.09.014; Li R, 2006, J UROLOGY, V175, P528, DOI 10.1016/S0022-5347(05)00151-5; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Liang J, 2002, COLD SPRING HARB CEL, V3; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; Lieblein JC, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-302; Lo HW, 2007, CANCER RES, V67, P9066, DOI 10.1158/0008-5472.CAN-07-0575; Marotta LLC, 2011, J CLIN INVEST, V121, P2723, DOI 10.1172/JCI44745; Menchon C, 2011, CELL CYCLE, V10, P1435, DOI 10.4161/cc.10.9.15421; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Motti ML, 2004, CELL CYCLE, V3, P1074; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Nitz MD, 2008, METHOD ENZYMOL, V439, P219, DOI 10.1016/S0076-6879(07)00417-X; Pippa R, 2012, ONCOGENE, V31, P4207, DOI 10.1038/onc.2011.582; Piva R, 1999, J NEUROPATH EXP NEUR, V58, P691, DOI 10.1097/00005072-199907000-00002; POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9; Puisieux A, 2014, NAT CELL BIOL, V16, P488, DOI 10.1038/ncb2976; Serres MP, 2011, ONCOGENE, V30, P2846, DOI 10.1038/onc.2011.9; Sethi N, 2011, NAT REV CANCER, V11, P735, DOI 10.1038/nrc3125; Shin I, 2002, NAT MED, V8, P1145, DOI 10.1038/nm759; Slingerland J, 2000, J CELL PHYSIOL, V183, P10, DOI 10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I; SLINGERLAND JM, 1994, MOL CELL BIOL, V14, P3683, DOI 10.1128/MCB.14.6.3683; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Viglietto G, 2002, NAT MED, V8, P1136, DOI 10.1038/nm762; Vlach J, 1997, EMBO J, V16, P5334, DOI 10.1093/emboj/16.17.5334; Wander SA, 2013, BREAST CANCER RES TR, V138, P369, DOI 10.1007/s10549-012-2389-6; Wander SA, 2011, CLIN CANCER RES, V17, P12, DOI 10.1158/1078-0432.CCR-10-0752; Xiong H, 2012, J BIOL CHEM, V287, P5819, DOI 10.1074/jbc.M111.295964; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006	60	84	89	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2015	34	43					5447	5459		10.1038/onc.2014.473	http://dx.doi.org/10.1038/onc.2014.473			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CU4EM	25684140	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000363479700005
J	Dey, S; Biswas, M; Sen, U; Dasgupta, J				Dey, Sanjay; Biswas, Maitree; Sen, Udayaditya; Dasgupta, Jhimli			Unique ATPase Site Architecture Triggers cis-Mediated Synchronized ATP Binding in Heptameric AAA(+)-ATPase Domain of Flagellar Regulatory Protein FlrC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIBRIO-CHOLERAE MOTILITY; ENHANCER-BINDING; TRANSCRIPTIONAL ACTIVATOR; CONFORMATIONAL-CHANGES; RECEIVER DOMAINS; STRUCTURAL BASIS; AAA+ ATPASE; AAA(+); PHOSPHORYLATION; ORGANIZATION	Bacterial enhancer-binding proteins (bEBPs) oligomerize through AAA(+) domains and use ATP hydrolysis-driven energy to isomerize the RNA polymerase-sigma(54) complex during transcriptional initiation. Here, we describe the first structure of the central AAA(+) domain of the flagellar regulatory protein FlrC (FlrC(C)), a bEBP that controls flagellar synthesis in Vibrio cholerae. Our results showed that FlrC(C) forms heptamer both in nucleotide (Nt)-free and -bound states without ATP-dependent subunit remodeling. Unlike the bEBPs such as NtrC1 or PspF, a novel cis-mediated "all or none" ATP binding occurs in the heptameric FlrC(C), because constriction at the ATPase site, caused by loop L3 and helix alpha 7, restricts the proximity of the trans-protomer required for Nt binding. A unique "closed to open" movement of Walker A, assisted by trans-acting "Glu switch" Glu-286, facilitates ATP binding and hydrolysis. Fluorescence quenching and ATPase assays on FlrC(C) and mutants revealed that although Arg-349 of sensor II, positioned by trans-acting Glu-286 and Tyr-290, acts as a key residue to bind and hydrolyze ATP, Arg-319 of alpha 7 anchors ribose and controls the rate of ATP hydrolysis by retarding the expulsion of ADP. Heptameric state of FlrC(C) is restored in solution even with the transition state mimicking ADP center dot AlF3. Structural results and pull-down assays indicated that L3 renders an in-built geometry to L1 and L2 causing sigma(54)-FlrC(C) interaction independent of Nt binding. Collectively, our results underscore a novel mechanism of ATP binding and sigma(54) interaction that strives to understand the transcriptional mechanism of the bEBPs, which probably interact directly with the RNA polymerase-sigma(54) complex without DNA looping.	[Dey, Sanjay; Biswas, Maitree; Dasgupta, Jhimli] St Xaviers Coll, Dept Biotechnol, Kolkata 700016, India; [Sen, Udayaditya] Saha Inst Nucl Phys, Crystallog & Mol Biol Div, Kolkata 700064, India	St. Xavier's College Kolkata; Saha Institute of Nuclear Physics	Dasgupta, J (corresponding author), St Xaviers Coll, Dept Biotechnol, 30 Pk St, Kolkata 700016, India.	jhimli@sxccal.edu		Sen, Udayaditya/0000-0001-5742-2907; Dasgupta, Jhimli/0000-0002-8030-1262	Department of Biotechnology, Government of India (DBT(IYBA)) [BT/03/IYBA/2010]	Department of Biotechnology, Government of India (DBT(IYBA))	This work was supported by the Department of Biotechnology, Government of India (DBT(IYBA)) Grant BT/03/IYBA/2010.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ades SE, 2006, CURR BIOL, V16, pR46, DOI 10.1016/j.cub.2006.01.005; Batchelor JD, 2009, J MOL BIOL, V393, P634, DOI 10.1016/j.jmb.2009.08.033; Batchelor JD, 2008, J MOL BIOL, V384, P1058, DOI 10.1016/j.jmb.2008.10.024; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; Bochtler M, 2000, NATURE, V403, P800, DOI 10.1038/35001629; Bose D, 2008, MOL CELL, V32, P337, DOI 10.1016/j.molcel.2008.09.015; Bush M, 2012, MICROBIOL MOL BIOL R, V76, P497, DOI 10.1128/MMBR.00006-12; Chen BY, 2010, STRUCTURE, V18, P1420, DOI 10.1016/j.str.2010.08.018; Cho H, 2001, P NATL ACAD SCI USA, V98, P8525, DOI 10.1073/pnas.131213698; Correa NE, 2005, J BACTERIOL, V187, P3158, DOI 10.1128/JB.187.9.3158-3170.2005; Correa NE, 2000, MOL MICROBIOL, V35, P743, DOI 10.1046/j.1365-2958.2000.01745.x; Dasgupta N, 2003, MOL MICROBIOL, V50, P809, DOI 10.1046/j.1365-2958.2003.03740.x; De Carlo S, 2006, GENE DEV, V20, P1485, DOI 10.1101/gad.1418306; Dey S, 2013, ACTA CRYSTALLOGR F, V69, P800, DOI 10.1107/S1744309113015613; Doucleff M, 2005, J MOL BIOL, V353, P242, DOI 10.1016/j.jmb.2005.08.003; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; Hendrixson DR, 2003, MOL MICROBIOL, V50, P687, DOI 10.1046/j.1365-2958.2003.03731.x; Jagannathan A, 2001, J BACTERIOL, V183, P2937, DOI 10.1128/JB.183.9.2937-2942.2001; Joly N, 2012, MOL CELL, V47, P484, DOI 10.1016/j.molcel.2012.06.012; Joly N, 2010, J BIOL CHEM, V285, P15178, DOI 10.1074/jbc.M110.103150; Jyot J, 2002, J BACTERIOL, V184, P5251, DOI 10.1128/JB.184.19.5251-5260.2002; Klose KE, 1998, MOL MICROBIOL, V28, P501, DOI 10.1046/j.1365-2958.1998.00809.x; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LEE JH, 1995, P NATL ACAD SCI USA, V92, P9702, DOI 10.1073/pnas.92.21.9702; Lee JH, 2000, J BACTERIOL, V182, P5188, DOI 10.1128/JB.182.18.5188-5195.2000; Lee SY, 2003, GENE DEV, V17, P2552, DOI 10.1101/gad.1125603; Lenzen CU, 1998, CELL, V94, P525, DOI 10.1016/S0092-8674(00)81593-7; Mani RS, 2003, BIOCHEMISTRY-US, V42, P12077, DOI 10.1021/bi030127b; McCarter LL, 2001, MICROBIOL MOL BIOL R, V65, P445, DOI 10.1128/MMBR.65.3.445-462.2001; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Mir MA, 2001, BIOCHEMISTRY-US, V40, P11578, DOI 10.1021/bi010731r; Neuwald AF, 1999, GENOME RES, V9, P27; Prouty MG, 2001, MOL MICROBIOL, V39, P1595, DOI 10.1046/j.1365-2958.2001.02348.x; Rappas M, 2006, J MOL BIOL, V357, P481, DOI 10.1016/j.jmb.2005.12.052; Rappas M, 2005, SCIENCE, V307, P1972, DOI 10.1126/science.1105932; Schumacher J, 2006, J STRUCT BIOL, V156, P190, DOI 10.1016/j.jsb.2006.01.006; Shi YM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000514; Srivastava D, 2013, MOL MICROBIOL, V90, P1262, DOI 10.1111/mmi.12432; Syed KA, 2009, J BACTERIOL, V191, P6555, DOI 10.1128/JB.00949-09; Sysoeva TA, 2013, GENE DEV, V27, P2500, DOI 10.1101/gad.229385.113; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wang J, 2001, STRUCTURE, V9, P1107, DOI 10.1016/S0969-2126(01)00670-0; Xu H, 2001, CURR OPIN MICROBIOL, V4, P138, DOI 10.1016/S1369-5274(00)00179-X; Zhang N, 2012, NUCLEIC ACIDS RES, V40, P9139, DOI 10.1093/nar/gks661; Zhang XD, 2000, MOL CELL, V6, P1473, DOI 10.1016/S1097-2765(00)00143-X	48	9	9	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					8734	8747		10.1074/jbc.M114.611434	http://dx.doi.org/10.1074/jbc.M114.611434			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25688103	Green Published, hybrid			2022-12-26	WOS:000352207100005
J	Satoh, S; Mori, K; Ueda, Y; Sejima, H; Dansako, H; Ikeda, M; Kato, N				Satoh, Shinya; Mori, Kyoko; Ueda, Youki; Sejima, Hiroe; Dansako, Hiromichi; Ikeda, Masanori; Kato, Nobuyuki			Establishment of Hepatitis C Virus RNA-Replicating Cell Lines Possessing Ribavirin-Resistant Phenotype	PLOS ONE			English	Article							NON-B-HEPATITIS; NON-A; HUMAN HEPATOCYTES; INFECTION; INTERFERON; TELAPREVIR; THERAPY; CULTURE; GENOME; BOCEPREVIR	Background Ribavirin (RBV) is a potential partner of interferon-based therapy and recently approved therapy using direct acting antivirals for patients with chronic hepatitis C. However, the precise mechanisms underlying RBV action against hepatitis C virus (HCV) replication are not yet understood. To clarify this point, we attempted to develop RBV-resistant cells from RBV-sensitive HCV RNA-replicating cells. Methodology/Principal Findings By repetitive RBV (100 mu M) treatment (10 weeks) of 3.5-year-cultured OL8 cells, in which genome-length HCV RNA (O strain of genotype 1b) efficiently replicates, dozens of colonies that survived RBV treatment were obtained. These colonies were mixed together and further treated with high doses of RBV (up to 200 mu M). By such RBV treatment, we successfully established 12 RBV-survived genome-length HCV RNA-replicating cell lines. Among them, three representative cell lines were characterized. HCV RNA replication in these cells resisted RBV significantly more than that in the parental OL8 cells. Genetic analysis of HCV found several common and conserved amino acid substitutions in HCV proteins among the three RBV-resistant cell species. Furthermore, using cDNA microarray and quantitative RT-PCR analyses, we identified 5 host genes whose expression levels were commonly altered by more than four-fold among these RBV-resistant cells compared with the parental cells. Moreover, to determine whether viral or host factor contributes to RBV resistance, we developed newly HCV RNA-replicating cells by introducing total RNAs isolated from RBV-sensitive parental cells or RBV-resistant cells into the HCV RNA-cured-parental or -RBV-resistant cells using an electroporation method, and evaluated the degrees of RBV resistance of these developed cells. Consequently, we found that RBV-resistant phenotype was conferred mainly by host factor and partially by viral factor. Conclusions/Significance These newly established HCV RNA-replicating cell lines should become useful tools for further understanding the anti-HCV mechanisms of RBV.	[Satoh, Shinya; Mori, Kyoko; Ueda, Youki; Sejima, Hiroe; Dansako, Hiromichi; Ikeda, Masanori; Kato, Nobuyuki] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Tumor Virol, Okayama 7008558, Japan	Okayama University	Kato, N (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Tumor Virol, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	nkato@md.okayama-u.ac.jp	Dansako, Hiromichi/M-1421-2019; Dansako, Hiromichi/N-3109-2019; Ueda, Youki/J-3529-2015; DANSAKO, Hiromichi/B-2025-2011	Dansako, Hiromichi/0000-0002-2353-3024; Ueda, Youki/0000-0002-2627-8524; DANSAKO, Hiromichi/0000-0002-2353-3024	Ministry of Health, Labor, and Welfare of Japan; Japan Society for the Promotion of Science (JSPS) [25293110]	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a grant-in-aid for research on hepatitis from the Ministry of Health, Labor, and Welfare of Japan; and by a grant-in-aid for Scientific Research (B) (Grant no. 25293110) from the Japan Society for the Promotion of Science (JSPS). Y.U. was supported by a Research Fellowship for Young Scientists from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amako Y, 2011, J BIOL CHEM, V286, P11265, DOI 10.1074/jbc.M110.182097; Blackham S, 2010, J VIROL, V84, P5404, DOI 10.1128/JVI.02529-09; Chevaliez S, 2007, ADV DRUG DELIVER REV, V59, P1222, DOI 10.1016/j.addr.2007.07.002; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Esteban R, 2012, BEST PRACT RES CL GA, V26, P445, DOI 10.1016/j.bpg.2012.09.001; Feld JJ, 2005, NATURE, V436, P967, DOI 10.1038/nature04082; Fu Y, 2011, EMBO REP, V12, P785, DOI 10.1038/embor.2011.139; Fukuchi Y, 2010, J HEPATOL, V52, P486, DOI 10.1016/j.jhep.2010.01.011; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Hayes CN, 2015, J FORMOS MED ASSOC, V114, P204, DOI 10.1016/j.jfma.2014.09.001; Hezode C, 2009, NEW ENGL J MED, V360, P1839, DOI 10.1056/NEJMoa0807650; Ibarra KD, 2009, J VIROL, V83, P4538, DOI 10.1128/JVI.02280-08; Ikeda M, 2005, BIOCHEM BIOPH RES CO, V329, P1350, DOI 10.1016/j.bbrc.2005.02.138; Jacobson IM, 2013, NEW ENGL J MED, V368, P1867, DOI 10.1056/NEJMoa1214854; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Kato N, 2005, J GEN VIROL, V86, P645, DOI 10.1099/vir.0.80479-0; Kato N, 2003, BIOCHEM BIOPH RES CO, V306, P756, DOI 10.1016/S0006-291X(03)01047-7; Kato N, 2001, ACTA MED OKAYAMA, V55, P133; KATO N, 1990, P NATL ACAD SCI USA, V87, P9524, DOI 10.1073/pnas.87.24.9524; Kato N, 2009, ARCH VIROL, V154, P77, DOI 10.1007/s00705-008-0282-8; Kato N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091156; Kato N, 2009, VIRUS RES, V146, P41, DOI 10.1016/j.virusres.2009.08.006; Koh C, 2014, ANTIVIR RES, V104, P34, DOI 10.1016/j.antiviral.2014.01.005; KUO G, 1989, SCIENCE, V244, P362, DOI 10.1126/science.2496467; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Mori K, 2013, HEPATOLOGY, V58, P1236, DOI 10.1002/hep.26421; Mori K, 2011, VIRUS RES, V157, P61, DOI 10.1016/j.virusres.2011.02.005; Mori K, 2010, HEPATOL RES, V40, P1248, DOI 10.1111/j.1872-034X.2010.00730.x; Paeshuyse J, 2011, CURR OPIN VIROL, V1, P590, DOI 10.1016/j.coviro.2011.10.030; Pietschmann T, 2001, J VIROL, V75, P1252, DOI 10.1128/JVI.75.3.1252-1264.2001; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Sarrazin C, 2012, J HEPATOL, V56, pS88, DOI 10.1016/S0168-8278(12)60010-5; Sejima H, 2012, VIRUS RES, V167, P74, DOI 10.1016/j.virusres.2012.04.008; Thomas DL, 2000, CURR TOP MICROBIOL, V242, P25; Thomas E, 2011, HEPATOLOGY, V53, P32, DOI 10.1002/hep.23985; Zhou SF, 2003, VIROLOGY, V310, P333, DOI 10.1016/S0042-6822(03)00152-1	36	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0118313	10.1371/journal.pone.0118313	http://dx.doi.org/10.1371/journal.pone.0118313			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25699517	Green Published, gold, Green Submitted			2022-12-26	WOS:000349789800036
J	Gulli, M; Salvatori, E; Fusaro, L; Pellacani, C; Manes, F; Marmiroli, N				Gulli, Mariolina; Salvatori, Elisabetta; Fusaro, Lina; Pellacani, Claudia; Manes, Fausto; Marmiroli, Nelson			Comparison of Drought Stress Response and Gene Expression between a GM Maize Variety and a Near-Isogenic Non-GM Variety	PLOS ONE			English	Article							C-4 PHOTOSYNTHESIS; WATER-STRESS; BT; LIMITATIONS; PROTEINS; CORN; CONTAMINATION; VARIABILITY; PROTEOMICS; TOLERANCE	Maize MON810, grown and commercialised worldwide, is the only cultivated GM event in the EU. Maize MON810, variety DKC6575, and the corresponding near-isogenic line Tietar were studied in different growth conditions, to compare their behaviour in response to drought. Main photosynthetic parameters were significantly affected by drought stress in both GM and non-GM varieties to a similar extent. Though DKC6575 (GM) had a greater sensitivity in the early phase of stress response as compared with Tietar (non-GM), after six days of stress they behaved similarly, and both varieties recovered from stress damage. Profiling gene expression in water deficit regimes and in a generalised drought stress condition showed an up-regulation of many stress-responsive genes, but a greater number of differentially expressed genes was observed in Tietar, with genes belonging to transcription factor families and genes encoding heat shock proteins, late embryogenesis abundant proteins and detoxification enzymes. Since induction of these genes have been indicated from the literature as typical of stress responses, their activation in Tietar rather than in DKC6575 may be reminiscent of a more efficient response to drought. DKC6575 was also analysed for the expression of the transgene CryIAb (encoding the delta-endotoxin insecticidal protein) in water deficit conditions. In all the experiments, the CryIAb transcript was not influenced by drought stress, but was expressed at a constant level. This suggests that though possessing a different pattern of sensitivity to stress, the GM variety maintains the same expression level for the transgene.	[Gulli, Mariolina; Pellacani, Claudia; Marmiroli, Nelson] Univ Parma, Dept Life Sci, I-43124 Parma, Italy; [Salvatori, Elisabetta; Fusaro, Lina; Manes, Fausto] Univ Roma La Sapienza, Dept Environm Biol, I-00185 Rome, Italy	University of Parma; Sapienza University Rome	Marmiroli, N (corresponding author), Univ Parma, Dept Life Sci, Parco Area Sci 11a, I-43124 Parma, Italy.	nelson.marmiroli@unipr.it	Fusaro, Lina/Q-4369-2017; Salvatori, Elisabetta/F-8931-2010; Gullì, Mariolina/G-9759-2011	Fusaro, Lina/0000-0003-3316-707X; Gullì, Mariolina/0000-0001-8326-4965; MANES, Fausto/0000-0002-4563-4272; Pellacani, Claudia/0000-0002-2853-3429; SALVATORI, ELISABETTA/0000-0002-5603-5064	Italian Ministery of University and Research; Regione Emilia-Romagna	Italian Ministery of University and Research; Regione Emilia-Romagna(Regione Emilia Romagna)	Funding from Italian Ministery of University and Research, National projects PRIN 2006 (NM, FM) and Regione Emilia-Romagna (IT) to SITEIA. PARMA Technopole (POR FESR 2007-2013) (NM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas HK, 2013, J AGR FOOD CHEM, V61, P11759, DOI 10.1021/jf400754g; Accinelli C, 2014, CROP PROT, V63, P9, DOI 10.1016/j.cropro.2014.04.021; Amara I, 2012, PLANT CELL PHYSIOL, V53, P312, DOI 10.1093/pcp/pcr183; Applied Biosystems, 2008, GUID PERF REL QUANT; Barros E, 2010, PLANT BIOTECHNOL J, V8, P436, DOI 10.1111/j.1467-7652.2009.00487.x; Batista R, 2010, REGUL TOXICOL PHARM, V58, pS8, DOI 10.1016/j.yrtph.2010.08.019; Baudo MM, 2006, PLANT BIOTECHNOL J, V4, P369, DOI 10.1111/j.1467-7652.2006.00193.x; Baudo Maria Marcela, 2009, V478, P247, DOI 10.1007/978-1-59745-379-0_15; Benesova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038017; Brewer MJ, 2014, ENVIRON ENTOMOL, V43, P828, DOI 10.1603/EN13309; Cellini F, 2004, FOOD CHEM TOXICOL, V42, P1089, DOI 10.1016/j.fct.2004.02.003; Cheng KC, 2008, J AGR FOOD CHEM, V56, P3057, DOI 10.1021/jf073505i; Coll A, 2008, PLANT MOL BIOL, V68, P105, DOI 10.1007/s11103-008-9355-z; Coll A, 2010, PLANT MOL BIOL, V73, P349, DOI 10.1007/s11103-010-9624-5; Cornic G, 2002, ANN BOT-LONDON, V89, P887, DOI 10.1093/aob/mcf064; de Sousa-Majer MJ, 2004, J EXP BOT, V55, P497, DOI 10.1093/jxb/erh037; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Edwards GE, 2004, ANNU REV PLANT BIOL, V55, P173, DOI 10.1146/annurev.arplant.55.031903.141725; EFSA (European Food Safety Authority). S, 2009, EFSA J, V1149, P1, DOI DOI 10.2903/J.EFSA.2009.1149; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Escalona JM, 1999, AUST J PLANT PHYSIOL, V26, P421, DOI 10.1071/PP99019; Flexas J, 2006, PHYSIOL PLANTARUM, V127, P343, DOI 10.1111/j.1399-3054.2006.00621.x; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Gomez I, 2014, BIOCHEM J, V459, P383, DOI 10.1042/BJ20131408; Gulli M, 2007, FEBS LETT, V581, P4841, DOI 10.1016/j.febslet.2007.09.010; Guo PG, 2009, J EXP BOT, V60, P3531, DOI 10.1093/jxb/erp194; Hanin M, 2011, PLANT SIGNAL BEHAV, V6, P1503, DOI 10.4161/psb.6.10.17088; Hayano-Kanashiro C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007531; Herman RA, 2013, J AGR FOOD CHEM, V61, P11695, DOI 10.1021/jf400135r; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kaman H, 2011, AGR WATER MANAGE, V98, P801, DOI 10.1016/j.agwat.2010.12.003; Konig A, 2004, FOOD CHEM TOXICOL, V42, P1047, DOI 10.1016/j.fct.2004.02.019; Long SP, 2003, J EXP BOT, V54, P2393, DOI 10.1093/jxb/erg262; Lopes MS, 2011, J EXP BOT, V62, P3135, DOI 10.1093/jxb/err105; La Paz JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100895; Ma BL, 2005, FIELD CROP RES, V93, P199, DOI 10.1016/j.fcr.2004.09.021; Maestri E, 2002, PLANT MOL BIOL, V48, P667, DOI 10.1023/A:1014826730024; Marmiroli N, 2008, ANAL BIOANAL CHEM, V392, P369, DOI 10.1007/s00216-008-2303-6; Martins CM, 2008, ANN APPL BIOL, V152, P255, DOI 10.1111/j.1744-7348.2007.00214.x; Mittler R, 2010, ANNU REV PLANT BIOL, V61, P443, DOI 10.1146/annurev-arplant-042809-112116; Ogbaga CC, 2014, PHYSIOL PLANTARUM, V152, P389, DOI 10.1111/ppl.12196; Rabbani MA, 2003, PLANT PHYSIOL, V133, P1755, DOI 10.1104/pp.103.025742; Ripley BS, 2007, J EXP BOT, V58, P1351, DOI 10.1093/jxb/erl302; Salvatori E, 2013, ENVIRON EXP BOT, V87, P79, DOI 10.1016/j.envexpbot.2012.09.008; Samson MC, 2013, FOOD CONTROL, V30, P518, DOI 10.1016/j.foodcont.2012.08.001; Sharkey TD, 2007, PLANT CELL ENVIRON, V30, P1035, DOI 10.1111/j.1365-3040.2007.01710.x; Shewry PR, 2007, TRENDS FOOD SCI TECH, V18, P201, DOI 10.1016/j.tifs.2006.12.010; Shiferaw B, 2011, FOOD SECUR, V3, P475, DOI 10.1007/s12571-011-0153-0; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Talame V, 2007, J EXP BOT, V58, P229, DOI 10.1093/jxb/erl163; Thornton PK, 2014, GLOBAL CHANGE BIOL, V20, P3313, DOI 10.1111/gcb.12581; Traore SB, 2000, AGRON J, V92, P1027, DOI 10.2134/agronj2000.9251027x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang Fei, 2014, Australian Journal of Crop Science, V8, P18; Zeller SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011405	57	11	11	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117073	10.1371/journal.pone.0117073	http://dx.doi.org/10.1371/journal.pone.0117073			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692547	Green Submitted, Green Published, gold			2022-12-26	WOS:000350061500036
J	Hamada-Tsutsumi, S; Iio, E; Watanabe, T; Murakami, S; Isogawa, M; Iijima, S; Inoue, T; Matsunami, K; Tajiri, K; Ozawa, T; Kishi, H; Muraguchi, A; Joh, T; Tanaka, Y				Hamada-Tsutsumi, Susumu; Iio, Etsuko; Watanabe, Tsunamasa; Murakami, Shuko; Isogawa, Masanori; Iijima, Sayuki; Inoue, Takako; Matsunami, Kayoko; Tajiri, Kazuto; Ozawa, Tatsuhiko; Kishi, Hiroyuki; Muraguchi, Atsushi; Joh, Takashi; Tanaka, Yasuhito			Validation of Cross-Genotype Neutralization by Hepatitis B Virus-Specific Monoclonal Antibodies by In Vitro and In Vivo Infection	PLOS ONE			English	Article							SURFACE-ANTIGEN; CELL-LINE; VACCINE; DNA; DIVERSITY; MUTATION; EPITOPE; BLOOD	Vaccines based on hepatitis B virus (HBV) genotype A have been used worldwide for immunoprophylaxis and are thought to prevent infections by non-A HBV strains effectively, whereas, vaccines generated from genotype C have been used in several Asian countries, including Japan and Korea, where HBV genotype C is prevalent. However, acute hepatitis B caused by HBV genotype A infection has been increasing in Japan and little is known about the efficacy of immunization with genotype C-based vaccines against non-C infection. We have isolated human monoclonal antibodies (mAbs) from individuals who were immunized with the genotype C-based vaccine. In this study, the efficacies of these two mAbs, HB0116 and HB0478, were analyzed using in vivo and in vitro models of HBV infection. Intravenous inoculation of HBV genotype C into chimeric mice with human hepatocytes resulted in the establishment of HBV infection after five weeks, whereas preincubation of the inocula with HB0116 or HB0478 protected chimeric mice from genotype C infection completely. Interestingly, both HB0116 and HB0478 were found to block completely genotype A infection. Moreover, infection by a genotype C strain with an immune escape substitution of amino acid 145 in the hepatitis B surface protein was also completely inhibited by incubation with HB0478. Finally, in vitro analysis of dose dependency revealed that the amounts of HB0478 required for complete protection against genotype C and genotype A infection were 5.5 mIU and 55 mIU, respectively. These results suggested that genotype C-based vaccines have ability to induce cross-genotype immunity against HBV infection.	[Hamada-Tsutsumi, Susumu; Iio, Etsuko; Watanabe, Tsunamasa; Murakami, Shuko; Isogawa, Masanori; Iijima, Sayuki; Inoue, Takako; Matsunami, Kayoko; Tanaka, Yasuhito] Nagoya City Univ, Grad Sch Med Sci, Dept Virol, Nagoya, Aichi, Japan; [Hamada-Tsutsumi, Susumu; Iio, Etsuko; Watanabe, Tsunamasa; Murakami, Shuko; Isogawa, Masanori; Iijima, Sayuki; Inoue, Takako; Matsunami, Kayoko; Tanaka, Yasuhito] Nagoya City Univ, Grad Sch Med Sci, Liver Unit, Nagoya, Aichi, Japan; [Iio, Etsuko; Matsunami, Kayoko; Joh, Takashi] Nagoya City Univ, Grad Sch Med Sci, Dept Gastroenterol & Metab, Nagoya, Aichi, Japan; [Tajiri, Kazuto] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Internal Med 3, Toyama 930, Japan; [Tajiri, Kazuto; Ozawa, Tatsuhiko; Kishi, Hiroyuki; Muraguchi, Atsushi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Immunol, Toyama 930, Japan	Nagoya City University; Nagoya City University; Nagoya City University; University of Toyama; University of Toyama	Tanaka, Y (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Virol, Nagoya, Aichi, Japan.	ytanaka@med.nagoya-cu.ac.jp	Isogawa, Masanori/AAN-8969-2021	Isogawa, Masanori/0000-0001-8730-4303; Tanaka, Yasuhito/0000-0002-2473-6966; Ozawa, Tatsuhiko/0000-0002-3112-452X	Ministry of Health, Labour, and Welfare of Japan [009, 011, 013]; Ministry of Education, Culture, Sports, Science and Technology, Japan [25293176]	Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by grants from the Ministry of Health, Labour, and Welfare of Japan (009, 011, and 013), and a grant-in-aid from the Ministry of Education, Culture, Sports, Science and Technology, Japan (25293176). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe A, 1999, J CLIN MICROBIOL, V37, P2899, DOI 10.1128/JCM.37.9.2899-2903.1999; Allweiss L, 2014, J HEPATOL, V60, P500, DOI 10.1016/j.jhep.2013.10.021; Avazova D, 2008, J MED VIROL, V80, P217, DOI 10.1002/jmv.21035; Cassidy A, 2011, EXPERT REV VACCINES, V10, P1709, DOI [10.1586/ERV.11.151, 10.1586/erv.11.151]; Cerec V, 2007, HEPATOLOGY, V45, P957, DOI 10.1002/hep.21536; Cooreman MP, 2001, J BIOMED SCI, V8, P237, DOI 10.1007/BF02256597; Fujiwara K, 2005, J VIROL, V79, P14404, DOI 10.1128/JVI.79.22.14404-14410.2005; Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699; ITOH Y, 1986, P NATL ACAD SCI USA, V83, P9174, DOI 10.1073/pnas.83.23.9174; IWARSON S, 1985, J MED VIROL, V16, P89, DOI 10.1002/jmv.1890160112; Jin A, 2009, NAT MED, V15, P1088, DOI 10.1038/nm.1966; Kim BK, 2011, ANTIVIR THER, V16, P1169, DOI 10.3851/IMP1982; Komatsu Haruki, 2012, BMC Res Notes, V5, P22, DOI 10.1186/1756-0500-5-22; Kurbanov F, 2010, HEPATOL RES, V40, P14, DOI 10.1111/j.1872-034X.2009.00601.x; Laras A, 2006, HEPATOLOGY, V44, P694, DOI 10.1002/hep.21299; Lee PI, 1997, J INFECT DIS, V176, P427, DOI 10.1086/514060; Matsuura K, 2009, J CLIN MICROBIOL, V47, P1476, DOI 10.1128/JCM.02081-08; Mercer DF, 2001, NAT MED, V7, P927, DOI 10.1038/90968; Miyakawa Y, 2003, INTERVIROLOGY, V46, P329, DOI 10.1159/000074988; Ogata Norio, 2009, Rinsho Byori, V57, P954; Qiu XX, 1996, J IMMUNOL, V156, P3350; Shokrgozar MA, 2002, VACCINE, V20, P2215, DOI 10.1016/S0264-410X(02)00116-0; Stramer SL, 2011, NEW ENGL J MED, V364, P236, DOI 10.1056/NEJMoa1007644; Sugiyama M, 2009, GASTROENTEROLOGY, V136, P652, DOI 10.1053/j.gastro.2008.10.048; Tajiri K, 2007, CYTOM PART A, V71A, P961, DOI 10.1002/cyto.a.20471; Tajiri K, 2010, ANTIVIR RES, V87, P40, DOI 10.1016/j.antiviral.2010.04.006; Tokilmitsu Y, 2007, CYTOM PART A, V71A, P1003, DOI 10.1002/cyto.a.20478; Wu CC, 2012, J VIROL, V86, P4658, DOI 10.1128/JVI.06353-11; Yan H, 2012, ELIFE, V1, DOI 10.7554/eLife.00049; Zanetti AR, 2008, VACCINE, V26, P6266, DOI 10.1016/j.vaccine.2008.09.056	30	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118062	10.1371/journal.pone.0118062	http://dx.doi.org/10.1371/journal.pone.0118062			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693196	Green Published, gold, Green Submitted			2022-12-26	WOS:000350061500093
J	Hayashi, T; Fukuda, N; Uchiyama, S; Inada, N				Hayashi, Teruyuki; Fukuda, Nanaho; Uchiyama, Seiichi; Inada, Noriko			A Cell-Permeable Fluorescent Polymeric Thermometer for Intracellular Temperature Mapping in Mammalian Cell Lines	PLOS ONE			English	Article							DELIVERY; THERMOGENESIS; PROTEINS; HEAT	Changes in intracellular temperatures reflect the activity of the cell. Thus, the tool to measure intracellular temperatures could provide valuable information about cellular status. We previously reported a method to analyze the intracellular temperature distribution using a fluorescent polymeric thermometer (FPT) in combination with fluorescence lifetime imaging microscopy (FLIM). Intracellular delivery of the FPT used in the previous study required microinjection. We now report a novel FPT that is cell permeable and highly photostable, and we describe the application of this FPT to the imaging of intracellular temperature distributions in various types of mammalian cell lines. This cell-permeable FPT displayed a temperature resolution of 0.05 degrees C to 0.54 degrees C within the range from 28 degrees C to 38 degrees C in HeLa cell extracts. Using our optimized protocol, this cell-permeable FPT spontaneously diffused into HeLa cells within 10 min of incubation and exhibited minimal toxicity over several hours of observation. FLIM analysis confirmed a temperature difference between the nucleus and the cytoplasm and heat production near the mitochondria, which were also detected previously using the microinjected FPT. We also showed that this cell-permeable FPT protocol can be applied to other mammalian cell lines, COS7 and NIH/3T3 cells. Thus, this cell-permeable FPT represents a promising tool to study cellular states and functions with respect to temperature.	[Hayashi, Teruyuki; Fukuda, Nanaho; Inada, Noriko] Nara Inst Sci & Technol, Grad Sch Biol Sci, Ikoma, Nara, Japan; [Uchiyama, Seiichi] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo, Japan	Nara Institute of Science & Technology; University of Tokyo	Inada, N (corresponding author), Nara Inst Sci & Technol, Grad Sch Biol Sci, Ikoma, Nara, Japan.	norikoi@bs.naist.jp	UCHIYAMA, SEIICHI/AAV-8284-2021	INADA, NORIKO/0000-0002-9931-4063	Development of Advanced Measurement and Analysis System; NAIST by MEXT; Mitsubishi Foundation [25103]; JST	Development of Advanced Measurement and Analysis System; NAIST by MEXT; Mitsubishi Foundation; JST(Japan Science & Technology Agency (JST))	This work was supported by the Development of Advanced Measurement and Analysis System by JST (http://www.jst.go.jp/sentan/, for SU and NI), Grants-in-Aid for Scientific Research for Plant Graduate Students from NAIST by MEXT, and The Mitsubishi Foundation (http://www.mitsubishi-zaidan.jp/, ID: 25103 for NI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai S, 2014, SCI REP-UK, V4, DOI 10.1038/srep06701; Baffou G, 2014, NAT METHODS, V11, P899, DOI 10.1038/nmeth.3073; Becker W, 2008, BH TCSPC HDB, P167; Berezin MY, 2010, CHEM REV, V110, P2641, DOI 10.1021/cr900343z; BRIGHT GR, 1987, J CELL BIOL, V104, P1019, DOI 10.1083/jcb.104.4.1019; Brites CDS, 2012, NANOSCALE, V4, P4799, DOI 10.1039/c2nr30663h; Donner JS, 2013, ACS NANO, V7, P8666, DOI 10.1021/nn403659n; Donner JS, 2012, NANO LETT, V12, P2107, DOI 10.1021/nl300389y; Gota C, 2009, J AM CHEM SOC, V131, P2766, DOI 10.1021/ja807714j; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Inada N, 2013, IMAGING MED, V5, P303, DOI DOI 10.2217/iim.13.34; Jaque D, 2012, NANOSCALE, V4, P4301, DOI 10.1039/c2nr30764b; Kamkaew A, 2011, ORG BIOMOL CHEM, V9, P6513, DOI 10.1039/c1ob05874f; Kiyonaka S, 2013, NAT METHODS, V10, P1232, DOI [10.1038/NMETH.2690, 10.1038/nmeth.2690]; Kostarelos K, 2007, NAT NANOTECHNOL, V2, P108, DOI 10.1038/nnano.2006.209; KRISHAN A, 1975, J CELL BIOL, V66, P188, DOI 10.1083/jcb.66.1.188; Kucsko G, 2013, NATURE, V500, P54, DOI 10.1038/nature12373; Lodish H, 2007, MOL CELL BIOL, P448; Moreno-Sanchez R, 2007, FEBS J, V274, P1393, DOI 10.1111/j.1742-4658.2007.05686.x; Morris MC, 2001, NAT BIOTECHNOL, V19, P1173, DOI 10.1038/nbt1201-1173; NAKAMURA T, 1978, J BIOCHEM-TOKYO, V84, P39, DOI 10.1093/oxfordjournals.jbchem.a132117; Okabe K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1714; Rodriguez-Enriquez S, 2006, TOXICOL APPL PHARM, V215, P208, DOI 10.1016/j.taap.2006.02.005; Sato MK, 2014, BIOPHYS J, V106, P2458, DOI 10.1016/j.bpj.2014.04.044; Shalek AK, 2010, P NATL ACAD SCI USA, V107, P1870, DOI 10.1073/pnas.0909350107; SOMERO GN, 1995, ANNU REV PHYSIOL, V57, P43, DOI 10.1146/annurev.ph.57.030195.000355; Suzuki M, 2007, BIOPHYS J, V92, pL46, DOI 10.1529/biophysj.106.098673; Takei Y, 2014, ACS NANO, V8, P198, DOI 10.1021/nn405456e; Tsuji T, 2013, ANAL CHEM, V85, P9815, DOI 10.1021/ac402128f; Uchiyama S, 2012, CHEM-EUR J, V18, P9552, DOI 10.1002/chem.201200597; Wang CL, 2011, CELL RES, V21, P1517, DOI 10.1038/cr.2011.117; Wang XD, 2013, CHEM SOC REV, V42, P7834, DOI 10.1039/c3cs60102a; Wang YH, 2006, BIOCHEM BIOPH RES CO, V346, P758, DOI 10.1016/j.bbrc.2006.05.205; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yang JM, 2011, ACS NANO, V5, P5067, DOI 10.1021/nn201142f; Zohar O, 1998, BIOPHYS J, V74, P82, DOI 10.1016/S0006-3495(98)77769-0	36	82	83	2	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117677	10.1371/journal.pone.0117677	http://dx.doi.org/10.1371/journal.pone.0117677			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692871	Green Published, gold, Green Submitted			2022-12-26	WOS:000350061500069
J	Rizzitelli, A; Smoll, NR; Chae, MP; Rozen, WM; Hunter-Smith, DJ				Rizzitelli, Alexandra; Smoll, Nicolas R.; Chae, Michael P.; Rozen, Warren M.; Hunter-Smith, David J.			Incidence and Overall Survival of Malignant Ameloblastoma	PLOS ONE			English	Article							ODONTOGENIC-TUMORS; RELATIVE SURVIVAL; POPULATION; CARCINOMA; AGE	Background Malignant ameloblastoma, comprising metastasizing ameloblastoma and ameloblastic carcinoma, represents 1.6-2.2% of all odontogenic tumors. Due to its rare nature, malignant ameloblastoma has only been reported in the literature in small case series or case reports. Using the Surveillance, Epidemiology and End-Results (SEER) database, we have performed a population-based study to determine the incidence rate and the absolute survival of malignant ameloblastoma. Method Using the International Classification of Diseases for Oncology (ICD-O) codes 9310/3 and 9270/3, data from the SEER database were used to calculate the incidence rate and absolute survival rate of population with malignant ameloblastoma. Results The overall incidence rate of malignant ameloblastoma was 1.79 per 10 million person/year. The incidence rate was higher in males than females and also higher in black versus white population. The median overall survival was 17.6 years from the time of diagnosis and increasing age was associated with a statistically significant poorer survival. Conclusions To our best knowledge, we report the largest population-based series of malignant ameloblastoma. The incidence rate was 1.79 per 10 million person/year and the overall survival was 17.6 years.	[Rizzitelli, Alexandra; Smoll, Nicolas R.; Chae, Michael P.; Rozen, Warren M.; Hunter-Smith, David J.] Peninsula Hlth, Frankston Hosp, Dept Plast & Reconstruct Surg, Frankston, Vic 3199, Australia; [Smoll, Nicolas R.; Chae, Michael P.; Rozen, Warren M.; Hunter-Smith, David J.] Monash Univ, Monash Med Ctr, Dept Surg, Clayton, Vic 3168, Australia; [Chae, Michael P.; Rozen, Warren M.; Hunter-Smith, David J.] Peninsula Hlth, Peninsula Clin Sch, Monash Univ Plast & Reconstruct Surg Unit, Frankston, Vic 3199, Australia; [Rozen, Warren M.] James Cook Univ, Townsville Hosp, Sch Clin, Sch Med & Dent,Dept Surg, Townsville, Qld 4814, Australia	Frankston Hospital; Monash University; James Cook University	Rozen, WM (corresponding author), Peninsula Hlth, Frankston Hosp, Dept Plast & Reconstruct Surg, 2 Hastings Rd, Frankston, Vic 3199, Australia.	warrenrozen@hotmail.com	Hunter-Smith, David James/U-7055-2019; Rozen, Warren Matthew/AAE-6296-2022; Smoll, Nicolas/D-3322-2013	Rozen, Warren Matthew/0000-0002-4092-182X; Hunter-Smith, David James/0000-0001-5660-0572; Smoll, Nicolas/0000-0002-6923-9701; Hunter-Smith, David/0000-0001-8544-1531				ADAMI HO, 1986, NEW ENGL J MED, V315, P559, DOI 10.1056/NEJM198608283150906; ATKINSON CH, 1984, CANCER-AM CANCER SOC, V53, P869, DOI 10.1002/1097-0142(19840215)53:4<869::AID-CNCR2820530409>3.0.CO;2-V; Branch R, 1989, RELATION TUMOR SIZE; Casaroto AR, 2012, ANTICANCER RES, V32, P1515; ELZAY RP, 1982, ORAL SURG ORAL MED O, V54, P299, DOI 10.1016/0030-4220(82)90099-8; GARDNER DG, 1988, INT J ORAL MAX SURG, V17, P201, DOI 10.1016/S0901-5027(88)80033-X; GARDNER DG, 1980, CANCER, V46, P2514, DOI 10.1002/1097-0142(19801201)46:11<2514::AID-CNCR2820461133>3.0.CO;2-9; Group A YAOPR, 2006, RES CARE IMPERATIVES; HOUSTON G, 1993, J ORAL MAXIL SURG, V51, P1152, DOI 10.1016/S0278-2391(10)80458-6; Jing W, 2007, INT J ORAL MAX SURG, V36, P20, DOI 10.1016/j.ijom.2006.10.011; Kar Indu Bhusan, 2014, Ann Maxillofac Surg, V4, P70, DOI 10.4103/2231-0746.133070; Ladeinde AL, 2005, ORAL SURG ORAL MED O, V99, P191, DOI 10.1016/j.tripleo.2004.08.031; Li J, 2014, ONCOL LETT, V8, P914, DOI 10.3892/ol.2014.2230; MOSADOMI A, 1975, ORAL SURG ORAL MED O, V40, P502, DOI 10.1016/0030-4220(75)90248-0; Mosqueda Taylor Adalberto, 2003, Med Oral, V8, P110; Mundry R, 2009, AM NAT, V173, P119, DOI 10.1086/593303; Nattinger AB, 1997, J CLIN EPIDEMIOL, V50, P939, DOI 10.1016/S0895-4356(97)00099-1; REGEZI JA, 1978, J ORAL SURG, V36, P771; Satagopan JM, 2004, BRIT J CANCER, V91, P1229, DOI 10.1038/sj.bjc.6602102; Sciubba JJ, 2005, WHO CLASSIFICATION T, P286; SHEAR M, 1978, COMMUNITY DENT ORAL, V6, P195, DOI 10.1111/j.1600-0528.1978.tb01149.x; SLOOTWEG PJ, 1984, ORAL SURG ORAL MED O, V57, P168, DOI 10.1016/0030-4220(84)90207-X; Smoll NR, 2014, NEURO-ONCOLOGY, V16, P1400, DOI 10.1093/neuonc/nou053; Smoll NR, 2013, CANCER-AM CANCER SOC, V119, P2029, DOI 10.1002/cncr.28032; Smoll NR, 2012, NEUROEPIDEMIOLOGY, V39, P63, DOI 10.1159/000339319; Smoll NR, 2012, CANCER-AM CANCER SOC, V118, P1313, DOI 10.1002/cncr.26387; Verneuil A, 2002, AM J OTOLARYNG, V23, P44, DOI 10.1053/ajot.2002.28769; Yoon HJ, 2011, ORAL SURG ORAL MED O, V112, P767, DOI 10.1016/j.tripleo.2011.06.036; Zhang J, 2010, BRIT J ORAL MAX SURG, V48, P549, DOI 10.1016/j.bjoms.2009.08.020	29	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117789	10.1371/journal.pone.0117789	http://dx.doi.org/10.1371/journal.pone.0117789			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692490	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000350061500075
J	Zhang, L; Li, YY; Gu, ZW; Wang, YY; Shi, M; Ji, Y; Sun, J; Xu, XP; Zhang, LR; Jiang, JT; Shi, WF				Zhang, Li; Li, Yuanyuan; Gu, Zhiwen; Wang, Yuyue; Shi, Mei; Ji, Yun; Sun, Jing; Xu, Xiaopeng; Zhang, Lirong; Jiang, Jingtin; Shi, Weifeng			Resveratrol Inhibits Enterovirus 71 Replication and Pro-Inflammatory Cytokine Secretion in Rhabdosarcoma Cells through Blocking IKKs/NF-kappa B Signaling Pathway	PLOS ONE			English	Article							BURKITTS-LYMPHOMA CELLS; ANTIVIRAL ACTIVITY; VIRUS-REPLICATION; IN-VITRO; ADHESION MOLECULES; OXIDATIVE STRESS; INFECTION; POLYDATIN; RIBAVIRIN; EXPRESSION	Polydatin and resveratrol, as major active components in Polygonum cuspidatum, have anti-inflammatory, antioxidant and antitumor functions. However, the effect and mechanism of polydatin and resveratrol on enterovirus 71 (EV71) have not been reported. In this study, resveratrol revealed strong antiviral activity on EV71, while polydatin had weak effect. Neither polydatin nor resveratrol exhibited influence on viral attachment. Resveratrol could effectively inhibit the synthesis of EV71/VP1 and the phosphorylation of IKK alpha, IKK beta, IKK gamma, IKB alpha, NF-kappa B p50 and NF-kappa B p65, respectively. Meanwhile, the remarkably increased secretion of IL-6 and TNF-alpha in EV71-infected rhabdosarcoma (RD) cells could be blocked by resveratrol. These results demonstrated that resveratrol inhibited EV71 replication and cytokine secretion in EV71-infected RD cells through blocking IKKs/NF-kappa B signaling pathway. Thus, resveratrol may have potent antiviral effect on EV71 infection.	[Zhang, Li; Li, Yuanyuan; Gu, Zhiwen; Wang, Yuyue; Shi, Mei; Ji, Yun; Sun, Jing; Xu, Xiaopeng; Zhang, Lirong; Shi, Weifeng] Soochow Univ, Affiliated Hosp 3, Clin Lab, Changzhou 213003, Jiangsu, Peoples R China; [Jiang, Jingtin] Soochow Univ, Affiliated Hosp 3, Oncol Lab, Changzhou 213003, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China	Shi, WF (corresponding author), Soochow Univ, Affiliated Hosp 3, Clin Lab, Changzhou 213003, Jiangsu, Peoples R China.	shiweifeng67@163.com	Sun, Jing/AAS-1582-2020; SUN, JIN/GPX-9641-2022; Zhang, Li/GWM-7501-2022	Sun, Jing/0000-0002-0097-2438; 				Augustine N, 2014, PHYTOMEDICINE, V21, P286, DOI 10.1016/j.phymed.2013.09.010; Bougie I, 2004, J BIOL CHEM, V279, P22124, DOI 10.1074/jbc.M400908200; Campagna M, 2010, BIOCHEM SOC T, V38, P50, DOI 10.1042/BST0380050; Carrizzo A, 2013, FOOD CHEM TOXICOL, V61, P215, DOI 10.1016/j.fct.2013.07.021; Chen LY, 2013, FOOD CHEM TOXICOL, V52, P28, DOI 10.1016/j.fct.2012.10.037; Chen X, 2013, EVID-BASED COMPL ALT, V2013, DOI DOI 10.1155/2013/504563; Cheng YF, 2006, BRAIN RES, V1110, P193, DOI 10.1016/j.brainres.2006.06.065; Chu X, 2005, J CHROMATOGR A, V1097, P33, DOI 10.1016/j.chroma.2005.08.008; Clouser CL, 2012, BIOORG MED CHEM LETT, V22, P6642, DOI 10.1016/j.bmcl.2012.08.108; Cui S, 2011, J MOL BIOL, V408, P449, DOI 10.1016/j.jmb.2011.03.007; De Leo A, 2012, ANTIVIR RES, V96, P196, DOI 10.1016/j.antiviral.2012.09.003; De Leo A, 2011, MOL CANCER RES, V9, P1346, DOI 10.1158/1541-7786.MCR-11-0145; De Maria S, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-264; Deng YH, 2011, PHYTOTHER RES, V25, P451, DOI 10.1002/ptr.3279; Docherty JJ, 1999, ANTIVIR RES, V43, P145, DOI 10.1016/S0166-3542(99)00042-X; Docherty JJ, 2006, ANTIVIR RES, V72, P171, DOI 10.1016/j.antiviral.2006.07.004; Du QH, 2013, PHARM BIOL, V51, P1347, DOI 10.3109/13880209.2013.792849; Evers DL, 2004, ANTIVIR RES, V63, P85, DOI 10.1016/j.antiviral.2004.03.002; Faith SA, 2006, ANTIVIR RES, V72, P242, DOI 10.1016/j.antiviral.2006.06.011; Ghanim H, 2011, J CLIN ENDOCR METAB, V96, P1409, DOI 10.1210/jc.2010-1812; Guo JP, 2006, WORLD J GASTROENTERO, V12, P4078, DOI 10.3748/wjg.v12.i25.4078; Guo R, 2014, MED SCI MONIT BASIC, V20, P82, DOI 10.12659/MSMBR.890858; Han JF, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-116; Heldt CL, 2006, J VIROL METHODS, V135, P56, DOI 10.1016/j.jviromet.2006.01.022; Heredia A, 2014, AIDS, V28, P317, DOI 10.1097/QAD.0000000000000168; Hsu CH, 2011, J MICROBIOL IMMUNOL, V44, P265, DOI 10.1016/j.jmii.2011.01.029; Irani DN, 2008, NEUROL CLIN, V26, P635, DOI 10.1016/j.ncl.2008.03.003; Ji H, 2012, BRAIN RES BULL, V87, P50, DOI 10.1016/j.brainresbull.2011.09.021; Kaminski BM, 2014, APOPTOSIS; Klebl Bert M., 2005, Antiviral Chemistry & Chemotherapy, V16, P69; Kumar N, 2008, J VIROL, V82, P9880, DOI 10.1128/JVI.00909-08; La Frazia S, 2006, ANTIVIR THER, V11, P995; Lanzilli G, 2012, INFLAMMATION, V35, P240, DOI 10.1007/s10753-011-9310-z; Li X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076007; Li ZH, 2008, J INFECT DIS, V197, P854, DOI 10.1086/527326; Lin HC, 2012, CANCER PREV RES, V5, P952, DOI 10.1158/1940-6207.CAPR-12-0001; Lin TY, 2009, AM J CHINESE MED, V37, P143, DOI 10.1142/S0192415X09006734; Liu H, 2014, J BIOCH MOL TOXICOL; Mankan AK, 2009, J CELL MOL MED, V13, P631, DOI 10.1111/j.1582-4934.2009.00632.x; Palamara AT, 2005, J INFECT DIS, V191, P1719, DOI 10.1086/429694; Ravagnan G, 2013, INFLAMMATION, V36, P26, DOI 10.1007/s10753-012-9516-8; Rawlinson SM, 2006, CURR DRUG TARGETS, V7, P1623, DOI 10.2174/138945006779025383; Rivas-Aravena A, 2011, J VIROL, V85, P8037, DOI 10.1128/JVI.00533-11; Shang LQ, 2013, ANTIVIR RES, V97, P183, DOI 10.1016/j.antiviral.2012.12.005; Tung WH, 2011, J CELL BIOCHEM, V112, P559, DOI 10.1002/jcb.22946; Wu KX, 2010, DRUG DISCOV TODAY, V15, P1041, DOI 10.1016/j.drudis.2010.10.008; Zhang GF, 2012, ARCH VIROL, V157, P669, DOI 10.1007/s00705-011-1222-6; Zhang HS, 2009, LIFE SCI, V85, P484, DOI 10.1016/j.lfs.2009.07.014; Zhang XN, 2013, ANTIVIR RES, V97, P264, DOI 10.1016/j.antiviral.2012.12.029; Zhao Qi, 2013, Infectious Disorders - Drug Targets, V13, P116	50	47	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0116879	10.1371/journal.pone.0116879	http://dx.doi.org/10.1371/journal.pone.0116879			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692777	Green Submitted, Green Published, gold			2022-12-26	WOS:000350061500028
J	Bugrysheva, JV; Pappas, CJ; Terekhova, DA; Iyer, R; Godfrey, HP; Schwartz, I; Cabello, FC				Bugrysheva, Julia V.; Pappas, Christopher J.; Terekhova, Darya A.; Iyer, Radha; Godfrey, Henry P.; Schwartz, Ira; Cabello, Felipe C.			Characterization of the Rel(Bbu) Regulon in Borrelia burgdorferi Reveals Modulation of Glycerol Metabolism by (p)ppGpp	PLOS ONE			English	Article							CARBON STORAGE REGULATOR; AMINO-ACID STARVATION; STRINGENT RESPONSE; GENE-EXPRESSION; ESCHERICHIA-COLI; GUANOSINE TETRAPHOSPHATE; CHITOBIOSE UTILIZATION; RNA-POLYMERASE; LIFE-STYLE; PPGPP	The bacterial stringent response is triggered by deficiencies of available nutrients and other environmental stresses. It is mediated by 5'-triphosphate-guanosine-3'-diphosphate and 5'diphosphate- guanosine-3'-diphosphate (collectively (p) ppGpp) and generates global changes in gene expression and metabolism that enable bacteria to adapt to and survive these challenges. Borrelia burgdorferi encounters multiple stressors in its cycling between ticks and mammals that could trigger the stringent response. We have previously shown that the B. burgdorferi stringent response is mediated by a single enzyme, RelBbu, with both (p) ppGpp synthase and hydrolase activities, and that a B. burgdorferi 297 relBbu null deletion mutant was defective in adapting to stationary phase, incapable of down-regulating synthesis of rRNA and could not infect mice. We have now used this deletion mutant and microarray analysis to identify genes comprising the rel regulon in B. burgdorferi cultured at 34 degrees C, and found that transcription of genes involved in glycerol metabolism is induced by relBbu. Culture of the wild type parental strain, the relBbu deletion mutant and its complemented derivative at 34 degrees C and 25 degrees C in media containing glucose or glycerol as principal carbon sources revealed a growth defect in the mutant, most evident at the lower temperature. Transcriptional analysis of the glp operon for glycerol uptake and metabolism in these three strains confirmed that relBbu was necessary and sufficient to increase transcription of this operon in the presence of glycerol at both temperatures. These results confirm and extend previous findings regarding the stringent response in B. burgdorferi. They also demonstrate that the stringent response regulates glycerol metabolism in this organism and is likely crucial for its optimal growth in ticks.	[Bugrysheva, Julia V.; Pappas, Christopher J.; Terekhova, Darya A.; Iyer, Radha; Schwartz, Ira; Cabello, Felipe C.] New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA; [Godfrey, Henry P.] New York Med Coll, Dept Pathol, Valhalla, NY 10595 USA	New York Medical College; New York Medical College	Cabello, FC (corresponding author), New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA.	cabello@nymc.edu		Godfrey, Henry/0000-0002-7195-6363; PAPPAS, CHRISTOPHER/0000-0001-8606-0749	National Institutes of Health [5R01 AI48856-07, 5R01 AI45801]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048856, R01AI045801] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grant 5R01 AI48856-07 from National Institutes of Health http://www.nih.gov/ to FCC and by grant 5R01 AI45801 from National Institutes of Health to IS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093110; Amato SM, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00070; Atkinson GC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023479; Balsalobre C, 2011, MOL MICROBIOL, V79, P827, DOI 10.1111/j.1365-2958.2010.07521.x; BARBOUR AG, 1984, YALE J BIOL MED, V57, P521; Bernardo LMD, 2009, J BIOL CHEM, V284, P828, DOI 10.1074/jbc.M807707200; Boutte CC, 2013, TRENDS MICROBIOL, V21, P174, DOI 10.1016/j.tim.2013.01.002; Brown L, 2002, J BACTERIOL, V184, P4455, DOI 10.1128/JB.184.16.4455-4465.2002; Bugrysheva J, 2003, J BACTERIOL, V185, P957, DOI 10.1128/JB.185.3.957-965.2003; Bugrysheva J, 2002, INFECT IMMUN, V70, P3061, DOI 10.1128/IAI.70.6.3061-3067.2002; Bugrysheva JV, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-17; Bugrysheva JV, 2005, INFECT IMMUN, V73, P4972, DOI 10.1128/IAI.73.8.4972-4981.2005; Calmano MJ, 2007, MOL MICROBIOL, V65, P1193, DOI 10.1111/j.1365-2958.2007.05860.x; Casjens S, 1997, J BACTERIOL, V179, P217, DOI 10.1128/jb.179.1.217-227.1997; Casjens SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033280; Chandrangsu P, 2011, MOL MICROBIOL, V80, P1337, DOI 10.1111/j.1365-2958.2011.07649.x; Charity JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000641; Concepcion MB, 2003, J BACTERIOL, V185, P444, DOI 10.1128/JB.185.2.444-452.2003; Dalebroux ZD, 2012, NAT REV MICROBIOL, V10, P203, DOI 10.1038/nrmicro2720; Dalebroux ZD, 2010, MICROBIOL MOL BIOL R, V74, P171, DOI 10.1128/MMBR.00046-09; Damman CJ, 2000, J BACTERIOL, V182, P6791, DOI 10.1128/JB.182.23.6791-6797.2000; Dunham-Ems SM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002532; Dunham-Ems SM, 2009, J CLIN INVEST, V119, P3652, DOI 10.1172/JCI39401; Durfee T, 2008, J BACTERIOL, V190, P1084, DOI 10.1128/JB.01092-07; Edwards AN, 2011, MOL MICROBIOL, V80, P1561, DOI 10.1111/j.1365-2958.2011.07663.x; English BP, 2011, P NATL ACAD SCI USA, V108, pE365, DOI 10.1073/pnas.1102255108; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Gaca AO, 2012, MICROBIOL-SGM, V158, P1994, DOI 10.1099/mic.0.060236-0; Geiger T, 2014, J BACTERIOL, V196, P894, DOI 10.1128/JB.01201-13; Geiger T, 2010, INFECT IMMUN, V78, P1873, DOI 10.1128/IAI.01439-09; Godfrey HP, 2002, TRENDS MICROBIOL, V10, P349, DOI 10.1016/S0966-842X(02)02403-4; Gummesson B, 2013, J BIOL CHEM, V288, P21055, DOI 10.1074/jbc.M113.479998; Gupta RS, 2000, FEMS MICROBIOL REV, V24, P367, DOI 10.1111/j.1574-6976.2000.tb00547.x; He M, 2014, INFECT IMMUN, V82, P445, DOI 10.1128/IAI.01238-13; He M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002133; He P, 2013, FEMS MICROBIOL LETT, V348, P133, DOI 10.1111/1574-6968.12279; Helaine S, 2014, SCIENCE, V343, P204, DOI 10.1126/science.1244705; Hoon-Hanks LL, 2012, FEMS IMMUNOL MED MIC, V66, P157, DOI 10.1111/j.1574-695X.2012.00996.x; Iyer R, 2013, J CLIN MICROBIOL, V51, P857, DOI 10.1128/JCM.02785-12; Kanjee U, 2012, MOL MICROBIOL, V85, P1029, DOI 10.1111/j.1365-2958.2012.08177.x; Karna SLR, 2013, INFECT IMMUN, V81, P2972, DOI 10.1128/IAI.00494-13; Karna SLR, 2011, INFECT IMMUN, V79, P732, DOI 10.1128/IAI.00882-10; Kazmierczak KM, 2009, MOL MICROBIOL, V72, P590, DOI 10.1111/j.1365-2958.2009.06669.x; Klinkenberg LG, 2010, J INFECT DIS, V202, P1397, DOI 10.1086/656524; Kolmsee T, 2011, MICROBIOL-SGM, V157, P2871, DOI 10.1099/mic.0.052357-0; Kvint K, 2000, J BIOL CHEM, V275, P14795, DOI 10.1074/jbc.C000128200; Lemke JJ, 2011, P NATL ACAD SCI USA, V108, P5712, DOI 10.1073/pnas.1019383108; Lemke JJ, 2009, MOL MICROBIOL, V74, P1368, DOI 10.1111/j.1365-2958.2009.06939.x; Lennon CW, 2012, GENE DEV, V26, P2634, DOI 10.1101/gad.204693.112; Lin B, 2001, BBA-MOL CELL RES, V1499, P222, DOI 10.1016/S0167-4889(00)00121-X; Liu MZ, 2005, J BIOL CHEM, V280, P15921, DOI 10.1074/jbc.M414050200; Magnusson LU, 2007, J BACTERIOL, V189, P5193, DOI 10.1128/JB.00330-07; Mechold U, 1997, J BACTERIOL, V179, P2658, DOI 10.1128/jb.179.8.2658-2667.1997; Mwangi MM, 2013, MICROB DRUG RESIST, V19, P153, DOI 10.1089/mdr.2013.0053; My L, 2013, J BACTERIOL, V195, P3784, DOI 10.1128/JB.00384-13; Na HS, 2006, VACCINE, V24, P2027, DOI 10.1016/j.vaccine.2005.11.031; Novak EA, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00056; Ouyang ZM, 2014, INFECT IMMUN, V82, P1511, DOI 10.1128/IAI.01555-13; Ouyang ZM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001272; Ouyang ZM, 2009, MOL MICROBIOL, V74, P1331, DOI 10.1111/j.1365-2958.2009.06945.x; Pal RR, 2012, J BACTERIOL, V194, P5638, DOI 10.1128/JB.00518-12; Pappas CJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002102; Park SI, 2010, J MICROBIOL, V48, P674, DOI 10.1007/s12275-010-0179-6; Perederina A, 2004, CELL, V118, P297, DOI 10.1016/j.cell.2004.06.030; Persky NS, 2009, MOL MICROBIOL, V73, P253, DOI 10.1111/j.1365-2958.2009.06767.x; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Potrykus K, 2011, ENVIRON MICROBIOL, V13, P563, DOI 10.1111/j.1462-2920.2010.02357.x; Radolf JD, 2012, NAT REV MICROBIOL, V10, P87, DOI 10.1038/nrmicro2714; Revel AT, 2002, P NATL ACAD SCI USA, V99, P1562, DOI 10.1073/pnas.032667699; Rhodes RG, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-108; Roberts JW, 2009, GENE DEV, V23, P143, DOI 10.1101/gad.1770509; Samuels DS, 2011, ANNU REV MICROBIOL, V65, P479, DOI 10.1146/annurev.micro.112408.134040; Sharma UK, 2010, FEMS MICROBIOL REV, V34, P646, DOI 10.1111/j.1574-6976.2010.00223.x; SKARE JT, 2010, BORRELIA MOL BIOL HO, P67; Sultan SZ, 2013, INFECT IMMUN, V81, P2012, DOI 10.1128/IAI.01228-12; Sun W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006720; Sze CW, 2013, INFECT IMMUN, V81, P1775, DOI 10.1128/IAI.00050-13; Sze CW, 2011, MOL MICROBIOL, V82, P851, DOI 10.1111/j.1365-2958.2011.07853.x; Sze CW, 2011, INFECT IMMUN, V79, P1270, DOI 10.1128/IAI.00871-10; Tilly K, 2004, VECTOR-BORNE ZOONOT, V4, P159, DOI 10.1089/1530366041210738; Tilly K, 2001, J BACTERIOL, V183, P5544, DOI 10.1128/JB.183.19.5544-5553.2001; Traxler MF, 2008, MOL MICROBIOL, V68, P1128, DOI 10.1111/j.1365-2958.2008.06229.x; Traxler MF, 2011, MOL MICROBIOL, V79, P830, DOI 10.1111/j.1365-2958.2010.07498.x; Traxler MF, 2006, P NATL ACAD SCI USA, V103, P2374, DOI 10.1073/pnas.0510995103; Van Laar TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038171; von Lackum K, 2005, FEMS MICROBIOL LETT, V243, P173, DOI 10.1016/j.femsle.2004.12.002; Wang XG, 2004, J BACTERIOL, V186, P51, DOI 10.1128/JB.186.1.51-60.2004; Wexselblatt E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002925	88	29	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0118063	10.1371/journal.pone.0118063	http://dx.doi.org/10.1371/journal.pone.0118063			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25688856	Green Submitted, Green Published, gold			2022-12-26	WOS:000350322700097
J	Gong, YQ; Zhan, QQ; Nguyen, KS; Nguyen, HT; Wang, YH; Gong, X				Gong, Yi-Qing; Zhan, Qing-Qing; Khang Sinh Nguyen; Hiep Tien Nguyen; Wang, Yue-Hua; Gong, Xun			The Historical Demography and Genetic Variation of the Endangered Cycas multipinnata (Cycadaceae) in the Red River Region, Examined by Chloroplast DNA Sequences and Microsatellite Markers	PLOS ONE			English	Article							STATISTICAL TESTS; POPULATION-GROWTH; MITOCHONDRIAL; INFERENCE; SOFTWARE; LOCI; BOTTLENECKS; NEUTRALITY; PHYLOGENY; MUTATIONS	Cycas multipinnata C.J. Chen & S.Y. Yang is a cycad endemic to the Red River drainage region that occurs under evergreen forest on steep limestone slopes in Southwest China and northern Vietnam. It is listed as endangered due to habitat loss and over-collecting for the ornamental plant trade, and only several populations remain. In this study, we assess the genetic variation, population structure, and phylogeography of Cycas multipinnata populations to help develop strategies for the conservation of the species. 60 individuals from six populations were used for chloroplast DNA (cpDNA) sequencing and 100 individuals from five populations were genotyped using 17 nuclear microsatellites. High genetic differentiation among populations was detected, suggesting that pollen or seed dispersal was restricted within populations. Two main genetic clusters were observed in both the cpDNA and microsatellite loci, corresponding to Yunnan China and northern Vietnam. These clusters indicated low levels of gene flow between the regions since their divergence in the late Pleistocene, which was inferred from both Bayesian and coalescent analysis. In addition, the result of a Bayesian skyline plot based on cpDNA portrayed a long history of constant population size followed by a decline in the last 50,000 years of Cycas multipinnata that was perhaps affected by the Quaternary glaciations, a finding that was also supported by the Garza-Williamson index calculated from the microsatellite data. The genetic consequences produced by climatic oscillations and anthropogenic disturbances are considered key pressures on Cycas multipinnata. To establish a conservation management plan, each population of Cycas multipinnata should be recognized as a Management Unit (MU). In situ and ex situ actions, such as controlling overexploitation and creating a germplasm bank with high genetic diversity, should be urgently implemented to preserve this species.	[Gong, Yi-Qing; Wang, Yue-Hua] Yunnan Univ, Inst Plant Sci, Sch Life Sci, Kunming, Yunnan, Peoples R China; [Gong, Yi-Qing; Zhan, Qing-Qing; Gong, Xun] Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Divers & Biogeog East Asia, Kunming, Yunnan, Peoples R China; [Gong, Yi-Qing] Univ Chinese Acad Sci, Beijing, Peoples R China; [Khang Sinh Nguyen] Vietnam Acad Sci & Technol, Inst Ecol & Biol Resources, Hanoi, Vietnam; [Hiep Tien Nguyen] Ctr Plant Conservat, Hanoi, Vietnam	Yunnan University; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Vietnam Academy of Science & Technology (VAST)	Wang, YH (corresponding author), Yunnan Univ, Inst Plant Sci, Sch Life Sci, Kunming, Yunnan, Peoples R China.	wangyh58212@126.com; gongxun@mail.kib.ac.cn		Yiqing, Gong/0000-0002-9990-6536	National Natural Science Foundation of China; Yunnan Natural Science Foundation [U1136602]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Natural Science Foundation(Natural Science Foundation of Yunnan Province)	This work was supported by the National Natural Science Foundation of China and Yunnan Natural Science Foundation (U1136602 to XG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Bader E, 2005, ARCGIS SERVER ADM DE; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Cantrill DJ, 2000, ALCHERINGA, V24, P307, DOI 10.1080/03115510008619534; Chaw SM, 2005, MOL PHYLOGENET EVOL, V37, P214, DOI 10.1016/j.ympev.2005.01.006; Chen J, 1994, ACTA PHYTOTAX SINICA, V32, P239; Chiang YC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-161; Cibrian-Jaramillo A, 2008, CONSERV GENET, V9, P1051, DOI 10.1007/s10592-007-9447-3; Cornuet JM, 1996, GENETICS, V144, P2001; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; DONALDSON JS, 2003, CYCADS STATUS SURVEY; Doyle J. J., 1991, Molecular techniques in taxonomy., P283; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Feng XY, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-187; Frankel OH, 1995, CONSERVATION PLANT B; Frankham R., 2002, INTRO CONSERVATION G, DOI 10.1017/CBO9780511808999; Fu L.K., 1992, CHINA PLANT RED DATA; FU YX, 1993, GENETICS, V133, P693; Fu YX, 1997, GENETICS, V147, P915; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Hall R., 1996, SPECIAL PUBLICATIONS, V106, P153, DOI DOI 10.1144/GSL.SP.1996.106.01.11; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hartl Daniel L., 1997; Hermsen EJ, 2006, AM J BOT, V93, P724, DOI 10.3732/ajb.93.5.724; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hill KD, 2008, TELOPEA, V12, P71; Hill KD, 2004, BOT REV, V70, P134, DOI 10.1663/0006-8101(2004)070[0134:TGCCIV]2.0.CO;2; Jolivet P, 2005, CYCAD NEWSLETTER, V28, P3; Jones D, 2002, CYCADS WORLD ANCIENT, DOI [10.1002/bdrc.21052, DOI 10.1002/BDRC.21052]; Ju LP, 2011, AM J BOT, V98, pE84, DOI 10.3732/ajb.1000504; Kimura M, 1984, NEUTRAL THEORY MOL E; Kovach WL., 1999, MVSP MULTIVARIATE ST, P137; Kuchma O, 2011, MUTAT RES-GEN TOX EN, V725, P29, DOI 10.1016/j.mrgentox.2011.07.003; LEARY RL, 1990, SCIENCE, V249, P1152, DOI 10.1126/science.249.4973.1152; Li L, 2009, CONSERV GENET, V10, P793, DOI 10.1007/s10592-008-9664-4; [李楠 Li Nan], 2005, [古生物学报, Acta Palaeontologica Sinica], V44, P423; LI WH, 1991, FUNDAMENTALS MOL EVO; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; Nagalingum NS, 2011, SCIENCE, V334, P796, DOI 10.1126/science.1209926; O'Connell LM, 2004, J HERED, V95, P172, DOI 10.1093/jhered/esh024; Osborne R., 2012, Proceedings of Cycad 2008. The 8th International Conference on Cycad Biology, Panama City, Panama, 13-15 January 2008, P480; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pons O, 1996, GENETICS, V144, P1237; Pritchard JK, 2000, GENETICS, V155, P945; Rai HS, 2003, MOL PHYLOGENET EVOL, V29, P350, DOI 10.1016/S1055-7903(03)00131-3; Rambaut A., 2009, TRACER MCMC TRACE AN; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; SLATKIN M, 1989, EVOLUTION, V43, P1349, DOI 10.1111/j.1558-5646.1989.tb02587.x; Swofford DL., 2003, PAUP PHYLOGENETIC AN; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang W., 2004, ENCEPHALARTOS, V80:, P23; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tian Bo, 2002, Acta Botanica Yunnanica, V24, P370; Wang X, 2006, PROG NAT SCI-MATER, V16, P213; Wang X, 2009, CHINESE SCI BULL, V54, P3116, DOI 10.1007/s11434-009-0384-z; Wang ZF, 2008, CONSERV GENET, V9, P1079, DOI 10.1007/s10592-007-9461-5; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Williamson-Natesan EG, 2005, CONSERV GENET, V6, P551, DOI 10.1007/s10592-005-9009-5; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Wright S, 1931, GENETICS, V16, P0097; WRIGHT S, 1978, P580; Yang Y, 2008, MOL ECOL RESOUR, V8, P913, DOI 10.1111/j.1755-0998.2008.02114.x; Zgurski JM, 2008, MOL PHYLOGENET EVOL, V47, P1232, DOI 10.1016/j.ympev.2008.03.002; Zhan QQ, 2011, CONSERV GENET, V12, P959, DOI 10.1007/s10592-011-0198-9; Zhang FM, 2010, AM J BOT, V97, pE159, DOI 10.3732/ajb.1000377; Zhang JW, 2010, J SYST EVOL, V48, P286, DOI 10.1111/j.1759-6831.2010.00079.x; Zhang M, 2009, CONSERV GENET, V10, P1175, DOI 10.1007/s10592-008-9737-4; Zhang W, 2012, REV PALAEOBOT PALYNO, V183, P50, DOI 10.1016/j.revpalbo.2012.07.005; ZHIFENG G, 1989, REV PALAEOBOT PALYNO, V60, P205, DOI 10.1016/0034-6667(89)90044-4; Zhong ZR, 2011, MOL GENET GENOMICS, V286, P411, DOI 10.1007/s00438-011-0653-9; Zonneveld BJM, 2012, PLANT BIOLOGY, V14, P253, DOI 10.1111/j.1438-8677.2011.00522.x	81	16	18	4	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117719	10.1371/journal.pone.0117719	http://dx.doi.org/10.1371/journal.pone.0117719			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689828	gold, Green Published, Green Submitted			2022-12-26	WOS:000350322700067
J	Li, L; Hamzeh, N; Gillespie, M; Elliott, J; Wang, JR; Gottschall, EB; Mroz, PM; Maier, LA				Li, Li; Hamzeh, Nabeel; Gillespie, May; Elliott, Jill; Wang, Jieru; Gottschall, Eva Brigitte; Mroz, Peggy M.; Maier, Lisa A.			Beryllium Increases the CD14(dim)CD16+Subset in the Lung of Chronic Beryllium Disease	PLOS ONE			English	Article							PERIPHERAL-BLOOD; IN-VITRO; HYPERSENSITIVITY PNEUMONITIS; PULMONARY SARCOIDOSIS; ALVEOLAR MACROPHAGES; RHEUMATOID-ARTHRITIS; ASTHMATIC SUBJECTS; CD16(+) MONOCYTES; T-CELLS; INFLAMMATION	CD14(dim)CD16+ and CD14(bright)CD16+ cells, which compose a minor population of monocytes in human peripheral blood mononuclear cells (PBMC), have been implicated in several inflammatory diseases. The aim of this study was to investigate whether this phenotype was present as a subset of lung infiltrative alveolar macrophages (AMs) in the granulomatous lung disease, chronic beryllium disease (CBD). The monocytes subsets was determined from PBMC cells and bronchoalveolar lavage (BAL) cells from CBD, beryllium sensitized Non-smoker (BeS-NS) and healthy subjects (HS) using flow cytometry. The impact of smoking on the AMs cell phenotype was determined by using BAL cells from BeS smokers (BeS-S). In comparison with the other monocyte subpopulations, CD14(dim)CD16+ cells were at decreased frequency in PBMCs of both BeS-NS and CBD and showed higher HLA-DR expression, compared to HS. The AMs from CBD and BeS-NS demonstrated a CD14(dim)CD16+phenotype, while CD14(bright)CD16+ cells were found at increased frequency in AMs of BeS, compared to HS. Fresh AMs from BeS-NS and CBD demonstrated significantly greater CD16, CD40, CD86 and HLA-DR than HS and BeS-S. The expression of CD16 on AMs from both CBD and BeS-NS was downregulated significantly after 10 mu M BeSO4 stimulation. The phagocytic activity of AMs decreased after 10 mu M BeSO4 treatment in both BeS-NS and CBD, although was altered or reduced in HS and BeS-S. These results suggest that Be increases the CD14(dim)CD16+ subsets in the lung of CBD subjects. We speculate that Be-stimulates the compartmentalization of a more mature CD16+ macrophage phenotype and that in turn these macrophages are a source of Th1 cytokines and chemokines that perpetuate the Be immune response in CBD. The protective effect of cigarette smoking in BeS-S may be due to the low expression of co-stimulatory markers on AMs from smokers as well as the decreased phagocytic function.	[Li, Li; Hamzeh, Nabeel; Gillespie, May; Elliott, Jill; Gottschall, Eva Brigitte; Mroz, Peggy M.; Maier, Lisa A.] Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA; [Li, Li; Hamzeh, Nabeel; Gottschall, Eva Brigitte; Maier, Lisa A.] Univ Colorado, Sch Med, Dept Med, Div Pulm & Crit Care Sci, Denver, CO USA; [Gottschall, Eva Brigitte; Maier, Lisa A.] Univ Colorado, Colorado Sch Publ Hlth, Environm Occupat Hlth Dept, Denver, CO 80202 USA; [Wang, Jieru] Univ Pittsburgh, Childrens Hosp Pittsburgh, Sch Med, Dept Pediat,Div Pulm Med Allergy & Immunol, Pittsburgh, PA USA	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Colorado School of Public Health; University of Colorado System; University of Colorado Denver; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Li, L (corresponding author), Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA.	lil@njhealth.org	Maier, Lisa/AAA-4378-2020	Hamzeh, Nabeel/0000-0001-7296-8975	NIH from National Institute of Environmental Health Sciences [K12 HL090147-01]; National Institute of Environmental Health Sciences [K01ES020857-01, P01 ES11810-06A1]; National Center for Advancing Translational Sciences [UL1 TR000154]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082, UL1TR000154] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K12HL090147, R01HL113655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI101953] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES011810, K01ES020857] Funding Source: NIH RePORTER	NIH from National Institute of Environmental Health Sciences; National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding provided by NIH K12 HL090147-01 from National Institute of Environmental Health Sciences, http://www.niehs.nih.gov, supplies and first author salary support; K01ES020857-01 from National Institute of Environmental Health Sciences, http://www.niehs.nih.gov, supplies and first author salary support; P01 ES11810-06A1 from National Institute of Environmental Health Sciences, http://www.niehs.nih.gov, personnel support; UL1 TR000154 from National Center for Advancing Translational Sciences, http://www.ncats.nih.gov, patient care, recruitment and supplies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida J, 2001, CLIN IMMUNOL, V100, P325, DOI 10.1006/clim.2001.5072; Ancuta P, 2000, EUR J IMMUNOL; [Anonymous], [No title captured]; Belge KU, 2002, J IMMUNOL, V168, P3536, DOI 10.4049/jimmunol.168.7.3536; Blanchet MR, 2004, AM J RESP CRIT CARE, V169, P903, DOI 10.1164/rccm.200210-1154OC; Burastero SE, 1999, J ALLERGY CLIN IMMUN, V103, P1136, DOI 10.1016/S0091-6749(99)70189-2; Cairns AP, 2002, RHEUMATOL INT, V21, P189, DOI 10.1007/s00296-001-0165-8; Chaudhary A, 2004, TOXICOLOGY, V201, P9, DOI 10.1016/j.tox.2004.03.025; CHELEN CJ, 1995, J CLIN INVEST, V95, P1415, DOI 10.1172/JCI117796; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; DOUGLAS JG, 1986, THORAX, V41, P787, DOI 10.1136/thx.41.10.787; Frankenberger M, 2012, EUR J IMMUNOL, V42, P957, DOI 10.1002/eji.201141907; Frasch SC, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.181800; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gerber JS, 2001, MICROBES INFECT, V3, P131, DOI 10.1016/S1286-4579(00)01360-5; Henneberger PK, 2001, INT ARCH OCC ENV HEA, V74, P167, DOI 10.1007/s004200100237; Kawanaka N, 2002, ARTHRITIS RHEUM, V46, P2578, DOI 10.1002/art.10545; Lensmar C, 1999, CLIN EXP ALLERGY, V29, P1632, DOI 10.1046/j.1365-2222.1999.00757.x; Li L, 2014, HUM IMMUNOL, V75, P1155, DOI 10.1016/j.humimm.2014.10.010; Moniuszko M, 2009, CLIN IMMUNOL, V130, P338, DOI 10.1016/j.clim.2008.09.011; Newman LS, 2001, J OCCUP ENVIRON MED, V43, P231, DOI 10.1097/00043764-200103000-00011; NEWMAN LS, 2003, INTERSTITIAL LUNG DI, P435; NIEWOEHNER DE, 1974, NEW ENGL J MED, V291, P755, DOI 10.1056/NEJM197410102911503; OHTSUKA Y, 1995, INTERNAL MED, V34, P966, DOI 10.2169/internalmedicine.34.966; Okamoto H, 2003, J DERMATOL, V30, P503, DOI 10.1111/j.1346-8138.2003.tb00424.x; Prior C, 1996, EUR RESPIR J, V9, P47, DOI 10.1183/09031936.96.09010047; RIVIER A, 1995, CLIN EXP IMMUNOL, V100, P314; Sawyer RT, 2005, FREE RADICAL BIO MED, V38, P928, DOI 10.1016/j.freeradbiomed.2004.12.014; Sawyer RT, 2004, AM J RESP CELL MOL, V31, P470, DOI 10.1165/rcmb.2004-0090OC; Sawyer RT, 2004, AM J RESP CELL MOL, V31, P122, DOI 10.1165/rcmb.2003-0336OC; Sawyer RT, 1999, TOXICOLOGY, V138, P155, DOI 10.1016/S0300-483X(99)00101-8; Sawyer RT, 2000, TOXICOLOGY, V149, P129, DOI 10.1016/S0300-483X(00)00237-7; Skrzeczynska-Moncznik J, 2008, SCAND J IMMUNOL, V67, P152, DOI 10.1111/j.1365-3083.2007.02051.x; Vanham G, 1996, CLIN EXP IMMUNOL, V103, P30, DOI 10.1046/j.1365-2249.1996.907600.x; Wahlstrom J, 1999, THORAX, V54, P339, DOI 10.1136/thx.54.4.339; Wang JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029879; WARREN CPW, 1977, THORAX, V32, P567, DOI 10.1136/thx.32.5.567; WATTERS LC, 1987, AM REV RESPIR DIS, V135, P696; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; XIA WJ, 1995, J EXP MED, V181, P1275, DOI 10.1084/jem.181.4.1275; Yamasaki H, 1999, J IMMUNOL, V163, P3516; Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510	42	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117276	10.1371/journal.pone.0117276	http://dx.doi.org/10.1371/journal.pone.0117276			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689051	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000350322700034
J	Wang, HX; Ayala, JC; Benitez, JA; Silva, AJ				Wang, Hongxia; Ayala, Julio C.; Benitez, Jorge A.; Silva, Anisia J.			RNA-Seq Analysis Identifies New Genes Regulated by the Histone-Like Nucleoid Structuring Protein (H-NS) Affecting Vibrio cholerae Virulence, Stress Response and Chemotaxis	PLOS ONE			English	Article							ESCHERICHIA-COLI; BINDING-SITES; TOXR REGULON; CURVED DNA; EXPRESSION; MOTILITY; REPRESSION; DOMAIN; RPOS; HEMAGGLUTININ/PROTEASE	The histone-like nucleoid structuring protein (H-NS) functions as a transcriptional silencer by binding to AT-rich sequences at bacterial promoters. However, H-NS repression can be counteracted by other transcription factors in response to environmental changes. The identification of potential toxic factors, the expression of which is prevented by H-NS could facilitate the discovery of new regulatory proteins that may contribute to the emergence of new pathogenic variants by anti-silencing. Vibrio cholerae hns mutants of the El Tor biotype exhibit altered virulence, motility and environmental stress response phenotypes compared to wild type. We used an RNA-seq analysis approach to determine the basis of the above hns phenotypes and identify new targets of H-NS transcriptional silencing. H-NS affected the expression of 18% of all predicted genes in a growth phase-dependent manner. Loss of H-NS resulted in diminished expression of numerous genes encoding methyl-accepting chemotaxis proteins as well as chemotaxis toward the attractants glycine and serine. Deletion of hns also induced an endogenous envelope stress response resulting in elevated expression of rpoE encoding the extracytoplamic sigma factor E (sE). The RNA-seq analysis identified new genes directly repressed by H-NS that can affect virulence and biofilm development in the El Tor biotype cholera bacterium. We show that H-NS and the quorum sensing regulator HapR silence the transcription of the vieSAB three-component regulatory system in El Tor biotype V. cholerae. We also demonstrate that H-NS directly represses the transcription of hlyA (hemolysin), rtxCA (the repeat in toxin or RTX), rtxBDE (RTX transport) and the biosynthesis of indole. Of these genes, H-NS occupancy at the hlyA promoter was diminished by overexpression of the transcription activator HlyU. We discuss the role of H-NS transcriptional silencing in phenotypic differences exhibited by V. cholerae biotypes.				asilva-benitez@msm.edu	Wang, Hongxia/G-6655-2018	Silva, Alcino/0000-0001-5525-0494; AYALA FIGUEREDO, JULIO/0000-0001-9998-3091	National Institutes of Health [AI104993, AI103693]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F31AI106288, SC1AI104993, R21AI103693] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	National Institutes of Health AI104993 AJS, National Institutes of Health AI103693 JAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atlung T, 1997, MOL MICROBIOL, V24, P7, DOI 10.1046/j.1365-2958.1997.3151679.x; Beyhan S, 2006, INFECT IMMUN, V74, P3633, DOI 10.1128/IAI.01750-05; Boardman BK, 2007, J BACTERIOL, V189, P1827, DOI 10.1128/JB.01766-06; Boin MA, 2004, FEMS MICROBIOL LETT, V239, P1, DOI 10.1016/j.femsle.2004.08.039; Butler SM, 2004, P NATL ACAD SCI USA, V101, P5018, DOI 10.1073/pnas.0308052101; Cerdan R, 2003, J MOL BIOL, V334, P179, DOI 10.1016/j.jmb.2003.09.051; Cordero CL, 2006, J BIOL CHEM, V281, P32366, DOI 10.1074/jbc.M605275200; Dame RT, 2001, BIOCHIMIE, V83, P231; DELORENZO V, 1993, GENE, V123, P17, DOI 10.1016/0378-1119(93)90533-9; DONNENBERG MS, 1991, INFECT IMMUN, V59, P4310, DOI 10.1128/IAI.59.12.4310-4317.1991; Dorman CJ, 2013, NAT REV MICROBIOL, V11, P349, DOI 10.1038/nrmicro3007; Dorman CJ, 2009, FEMS MICROBIOL REV, V33, P587, DOI 10.1111/j.1574-6976.2008.00155.x; Dorman CJ, 2004, NAT REV MICROBIOL, V2, P391, DOI 10.1038/nrmicro883; Faruque SM, 2006, P NATL ACAD SCI USA, V103, P6350, DOI 10.1073/pnas.0601277103; Faruque SM, 2005, P NATL ACAD SCI USA, V102, P1702, DOI 10.1073/pnas.0408992102; Faruque SM, 2005, P NATL ACAD SCI USA, V102, P6119, DOI 10.1073/pnas.0502069102; Figueroa-Arredondo P, 2001, INFECT IMMUN, V69, P1613, DOI 10.1128/IAI.69.3.1613-1624.2001; Ghosh A, 2006, INFECT IMMUN, V74, P3060, DOI 10.1128/IAI.74.5.3060-3064.2006; Giannoukos G, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r23; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HERRINGTON DA, 1988, J EXP MED, V168, P1487, DOI 10.1084/jem.168.4.1487; IWANAGA M, 1986, MICROBIOL IMMUNOL, V30, P1075, DOI 10.1111/j.1348-0421.1986.tb03037.x; Jensen MA, 2006, P NATL ACAD SCI USA, V103, P4652, DOI 10.1073/pnas.0600166103; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; Kovacikova G, 2002, INFECT IMMUN, V70, P5355, DOI 10.1128/IAI.70.10.5355-5362.2002; Kovacikova G, 2001, MOL MICROBIOL, V41, P393, DOI 10.1046/j.1365-2958.2001.02518.x; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lang B, 2007, NUCLEIC ACIDS RES, V35, P6330, DOI 10.1093/nar/gkm712; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee SH, 1998, J BACTERIOL, V180, P2298, DOI 10.1128/JB.180.9.2298-2305.1998; Lenz DH, 2007, MOL MICROBIOL, V63, P859, DOI 10.1111/j.1365-2958.2006.05545.x; Liang W, 2007, MICROBIOL-SGM, V153, P2964, DOI 10.1099/mic.0.2007/006668-0; Lin W, 1999, P NATL ACAD SCI USA, V96, P1071, DOI 10.1073/pnas.96.3.1071; Liu MQ, 2012, MICROBIOLOGYOPEN, V1, P502, DOI 10.1002/mbo3.48; Matz C, 2005, P NATL ACAD SCI USA, V102, P16819, DOI 10.1073/pnas.0505350102; Mou XY, 2013, INFECT IMMUN, V81, P3566, DOI 10.1128/IAI.00506-13; Mueller RS, 2009, J BACTERIOL, V191, P3504, DOI 10.1128/JB.01240-08; Munch R, 2005, BIOINFORMATICS, V21, P4187, DOI 10.1093/bioinformatics/bti635; Nishiyama S, 2012, INFECT IMMUN, V80, P3170, DOI 10.1128/IAI.00039-12; Nye MB, 2000, J BACTERIOL, V182, P4295, DOI 10.1128/JB.182.15.4295-4303.2000; Nye MB, 2003, MOL MICROBIOL, V50, P427, DOI 10.1046/j.1365-2958.2003.03701.x; OWENHUGHES TA, 1992, CELL, V71, P255, DOI 10.1016/0092-8674(92)90354-F; Raivio TL, 2005, MOL MICROBIOL, V56, P1119, DOI 10.1111/j.1365-2958.2005.04625.x; Raivio TL, 2001, ANNU REV MICROBIOL, V55, P591, DOI 10.1146/annurev.micro.55.1.591; ROTHMEL RK, 1991, J BACTERIOL, V173, P4717, DOI 10.1128/jb.173.15.4717-4724.1991; Schoolnik G. K., 2000, Genome Biology, V1, P1016, DOI 10.1186/gb-2000-1-3-reviews1016; Shin M, 2005, GENE DEV, V19, P2388, DOI 10.1101/gad.1316305; Sikora AE, 2009, J BACTERIOL, V191, P5398, DOI 10.1128/JB.00092-09; Silva AJ, 2006, INFECT IMMUN, V74, P2072, DOI 10.1128/IAI.74.4.2072-2079.2006; Silva AJ, 2003, MICROBIOL-SGM, V149, P1883, DOI 10.1099/mic.0.26086-0; Silva AJ, 2008, J BACTERIOL, V190, P7335, DOI 10.1128/JB.00360-08; Spurio R, 1997, EMBO J, V16, P1795, DOI 10.1093/emboj/16.7.1795; Srivastava D, 2011, J BACTERIOL, V193, P6331, DOI 10.1128/JB.05167-11; STEWART V, 1986, J BACTERIOL, V167, P383, DOI 10.1128/jb.167.1.383-386.1986; Stonehouse E, 2008, J BACTERIOL, V190, P4736, DOI 10.1128/JB.00089-08; Stonehouse EA, 2011, J BACTERIOL, V193, P979, DOI 10.1128/JB.01343-09; Stroebner JA, 1998, INFECT IMMUN, V56, P2891; Stulke J, 1999, CURR OPIN MICROBIOL, V2, P195, DOI 10.1016/S1369-5274(99)80034-4; Tamayo R, 2010, INFECT IMMUN, V78, P3560, DOI 10.1128/IAI.00048-10; Tending C, 2000, J BACTERIOL, V182, P2006; Tischler AD, 2002, J BACTERIOL, V184, P4104, DOI 10.1128/JB.184.15.4104-4113.2002; Tischler AD, 2005, INFECT IMMUN, V73, P5873, DOI 10.1128/IAI.73.9.5873-5882.2005; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsou AM, 2009, NUCLEIC ACIDS RES, V37, P2747, DOI 10.1093/nar/gkp121; UEGUCHI C, 1993, EMBO J, V12, P1039, DOI 10.1002/j.1460-2075.1993.tb05745.x; Wang HX, 2014, J BACTERIOL, V196, P1020, DOI 10.1128/JB.00993-13; Wang HX, 2013, ANTIMICROB AGENTS CH, V57, P3950, DOI 10.1128/AAC.00473-13; Wang HX, 2012, APPL ENVIRON MICROB, V78, P2482, DOI 10.1128/AEM.07629-11; Wang HX, 2012, J BACTERIOL, V194, P1205, DOI 10.1128/JB.05900-11; WILLIAMS SG, 1991, MOL MICROBIOL, V5, P2031, DOI 10.1111/j.1365-2958.1991.tb00825.x; Yanofsky C, 2007, RNA, V13, P1141, DOI 10.1261/rna.620507; Yu RR, 2002, MOL MICROBIOL, V43, P119, DOI 10.1046/j.1365-2958.2002.02721.x	73	39	39	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0118295	10.1371/journal.pone.0118295	http://dx.doi.org/10.1371/journal.pone.0118295			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679988	Green Published, gold, Green Submitted			2022-12-26	WOS:000350682600116
J	Wei, X; Zhang, Z; Shi, PJ; Wang, P; Chen, Y; Song, X; Tao, FL				Wei, Xing; Zhang, Zhao; Shi, Peijun; Wang, Pin; Chen, Yi; Song, Xiao; Tao, Fulu			Is Yield Increase Sufficient to Achieve Food Security in China?	PLOS ONE			English	Article							AGRICULTURAL SUSTAINABILITY; USE EFFICIENCY; WINTER-WHEAT; SOIL QUALITY; HEAT-STRESS; HYBRID RICE; WATER; CLIMATE; CHALLENGES; RESOURCES	Increasing demand for food, driven by unprecedented population growth and increasing consumption, will keep challenging food security in China. Although cereal yields have substantially improved during the last three decades, whether it will keep thriving to meet the increasing demand is not known yet. Thus, an integrated analysis on the trends of crop yield and cultivated area is essential to better understand current state of food security in China, especially on county scale. So far, yield stagnation has extensively dominated the main cereal- growing areas across China. Rice yield is facing the most severe stagnation that 53.9% counties tracked in the study have stagnated significantly, followed by maize (42.4%) and wheat (41.9%). As another important element for production sustainability, but often neglected is the planted area patterns. It has been further demonstrated that the loss in productive arable land for rice and wheat have dramatically increased the pressure on achieving food security. Not only a great deal of the planted areas have stagnated since 1980, but also collapsed. 48.4% and 54.4% of rice-and wheat-growing counties have lost their cropland areas to varying degrees. Besides, 27.6% and 35.8% of them have retrograded below the level of the 1980s. The combined influence (both loss in yield and area) has determined the crop sustainable production in China to be pessimistic for rice and wheat, and consequently no surprise to find that more than half of counties rank a lower level of production sustainability. Therefore, given the potential yield increase in wheat and maize, as well as substantial area loss of rice and wheat, the possible targeted adaptation measures for both yield and cropping area is required at county scale. Moreover, policies on food trade, alongside advocation of low calorie diets, reducing food loss and waste can help to enhance food security.	[Wei, Xing; Zhang, Zhao; Shi, Peijun; Wang, Pin; Chen, Yi; Song, Xiao] Beijing Normal Univ, MOE Acad Disaster Reduct & Emergency Management, Key Lab Environm Change & Nat Disaster, State Key Lab Earth Surface Processes & Resources, Beijing 100875, Peoples R China; [Tao, Fulu] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing 100101, Peoples R China	Beijing Normal University; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Zhang, Z (corresponding author), Beijing Normal Univ, MOE Acad Disaster Reduct & Emergency Management, Key Lab Environm Change & Nat Disaster, State Key Lab Earth Surface Processes & Resources, Beijing 100875, Peoples R China.	zhangzhao@bnu.edu.cn	张|Zhang, 朝|Zhao/AAF-8815-2019	Shi, Peijun/0000-0002-2968-7331; Tao, F/0000-0001-8574-0080	Creative Research Groups of National Natural Science Foundation of China [41321001]; National Basic Research Program of China [2012CB955404]; Program of Introducing Talents of Discipline to Universities [B08008]; State Key Laboratory of Earth Surface Processes and Resource Ecology, Beijing Normal University [2014-ZY-02]	Creative Research Groups of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Program of Introducing Talents of Discipline to Universities(Ministry of Education, China - 111 Project); State Key Laboratory of Earth Surface Processes and Resource Ecology, Beijing Normal University	This research was supported by the Creative Research Groups of National Natural Science Foundation of China (No. 41321001), National Basic Research Program of China (No. 2012CB955404), The Program of Introducing Talents of Discipline to Universities (B08008), and State Key Laboratory of Earth Surface Processes and Resource Ecology, Beijing Normal University (2014-ZY-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Brown L R, 1998, World Watch, V11, P10; Brown L.R., 1995, WHO WILL FEED CHINA; Bureau CS, 1980, CHIN STAT YB; Cassman KG, 1999, P NATL ACAD SCI USA, V96, P5952, DOI 10.1073/pnas.96.11.5952; Cassman KG, 2003, ANNU REV ENV RESOUR, V28, P315, DOI 10.1146/annurev.energy.28.040202.122858; Dodge Y., 2003, OXFORD DICT STAT TER; Fader M, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/1/014046; Fan XM, 2007, AGRON J, V99, P220, DOI 10.2134/agronj2006.0144; FAOWIFAD, 2012, STAT FOOD INS WORLD, DOI [10.1016/j.asjsur.2012.06.010, DOI 10.1016/J.ASJSUR.2012.06.010]; Fekete A, 2014, INT J DISAST RISK SC, V5, P3, DOI 10.1007/s13753-014-0008-3; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Fu XY, 2013, INT J DISAST RISK SC, V4, P51, DOI 10.1007/s13753-013-0006-x; Glantz MH, 2013, INT J DISAST RISK SC, V4, P1, DOI 10.1007/s13753-013-0002-1; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Gregory PJ, 2005, PHILOS T R SOC B, V360, P2139, DOI 10.1098/rstb.2005.1745; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; Huang M, 2012, SCI AGR, V69, P103, DOI 10.1590/S0103-90162012000200003; Jalava M, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/7/074016; Jiang L, 2013, INT J DISAST RISK SC, V4, P101, DOI 10.1007/s13753-013-0011-0; Jiao J, 2013, CAIJING MAGAZINE, P377; Kang SZ, 2002, AGR WATER MANAGE, V55, P203, DOI 10.1016/S0378-3774(01)00180-9; Karlen DL, 1997, SOIL SCI SOC AM J, V61, P4, DOI 10.2136/sssaj1997.03615995006100010001x; Kijne JW, 2003, WATER PRODUCTIVITY A; Kummu M, 2012, SCI TOTAL ENVIRON, V438, P477, DOI 10.1016/j.scitotenv.2012.08.092; Lai JS, 2010, NAT GENET, V42, P1027, DOI 10.1038/ng.684; Licker R, 2010, GLOBAL ECOL BIOGEOGR, V19, P769, DOI 10.1111/j.1466-8238.2010.00563.x; Liu B, 2014, GLOBAL CHANGE BIOL, V20, P372, DOI 10.1111/gcb.12442; Liu JG, 2013, ENVIRON SCI TECHNOL, V47, P10137, DOI 10.1021/es401426b; Liu JY, 2003, SCI CHINA SER D, V46, P373; Lobell DB, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/1/014002; Lobell DB, 2009, ANNU REV ENV RESOUR, V34, P179, DOI 10.1146/annurev.environ.041008.093740; MENDELSOHN R, 1994, AM ECON REV, V84, P753; Neumann K, 2010, AGR SYST, V103, P316, DOI 10.1016/j.agsy.2010.02.004; Peng SB, 2004, P NATL ACAD SCI USA, V101, P9971, DOI 10.1073/pnas.0403720101; Peng SB, 2009, PLANT PROD SCI, V12, P3, DOI 10.1626/pps.12.3; PIMENTEL D, 1995, SCIENCE, V267, P1117, DOI 10.1126/science.267.5201.1117; Porkka M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082714; Pradhan P, 2014, ENVIRON SCI TECHNOL, V48, P9463, DOI 10.1021/es5005939; Pradhan P, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/4/044044; Pradhan P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062228; Pretty J, 2008, PHILOS T R SOC B, V363, P447, DOI 10.1098/rstb.2007.2163; Ray DK, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2296; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Rozelle S, 1997, FOOD POLICY, V22, P229, DOI 10.1016/S0306-9192(97)00011-0; Scherr S. J, 1999, SOIL DEGRADATION THR; Shi WJ, 2013, FOOD SECUR, V5, P69, DOI 10.1007/s12571-012-0225-9; Shuai JB, 2013, CLIM RES, V58, P133, DOI 10.3354/cr01194; Sun YJ, 2012, FIELD CROP RES, V127, P85, DOI 10.1016/j.fcr.2011.11.015; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Yang H, 2003, AGR WATER MANAGE, V61, P143, DOI 10.1016/S0378-3774(02)00164-6; Yearbook CA, 1980, EDITORIAL BOARD CHIN; You C, 2013, P NATL ACAD SCI USA, V110, P7182, DOI 10.1073/pnas.1302420110; Zhang T, 2013, GLOBAL CHANGE BIOL; Zhang TY, 2013, GLOBAL CHANGE BIOL, V19, P563, DOI 10.1111/gcb.12057; Zhang YHP, 2013, ENERGY SCI ENG, V1, P27, DOI 10.1002/ese3.2; Zhang Z, 2014, EUR J AGRON, V59, P49, DOI 10.1016/j.eja.2014.05.008; Zwart SJ, 2004, AGR WATER MANAGE, V69, P115, DOI 10.1016/j.agwat.2004.04.007	59	37	40	8	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0116430	10.1371/journal.pone.0116430	http://dx.doi.org/10.1371/journal.pone.0116430			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680193	gold, Green Published, Green Submitted			2022-12-26	WOS:000350682600020
J	Jiang, HW; Wang, YQ; Viniegra, A; Sima, C; McCulloch, CA; Glogauer, M				Jiang, Hongwei; Wang, Yongqiang; Viniegra, Ana; Sima, Corneliu; McCulloch, Christopher A.; Glogauer, Michael			Adseverin plays a role in osteoclast differentiation and periodontal disease-mediated bone loss	FASEB JOURNAL			English	Article						osteoclastogenesis; fusion; actin; bone resorption	CELL-CELL FUSION; ACTIN RING; GELSOLIN; PROTEIN; RESORPTION; PODOSOMES; EXOCYTOSIS; EXPRESSION; REGULATORS; MICE	Osteoclast differentiation and function are highly dependent on the assembly and turnover of actin filaments, but little is known about the roles of actin binding proteins in these processes. Adseverin (Ads), a member of the gelsolin superfamily of actin capping and severing proteins, regulates actin filament turnover and can regulate the turnover of cortical actin filaments of chromaffin cells during exocytosis. Using a conditional Ads knockout mouse model, we confirmed our previous finding in cultured cells that Ads plays a role in osteoclastogenesis (OCG) and actin cytoskeletal organization in osteoclasts. Here we show that Ads is required for osteoclast formation and that when alveolar bone resorption is experimentally induced in mice, genetic deletion of Ads prevents osteoclast-mediated bone loss. Further, when Ads-null osteoclasts are cultured, they exhibit defective OCG, disorganized podosome-based actin filament superstructures, and decreased bone resorption. Reintroduction of Ads into Ads-null osteoclast precursor cells restored these osteoclast defects. Collectively, these data demonstrate a unique and osteoclast-specific role for Ads in OCG and osteoclast function.	[Jiang, Hongwei; Wang, Yongqiang; Viniegra, Ana; Sima, Corneliu; McCulloch, Christopher A.; Glogauer, Michael] Univ Toronto, Fac Dent, Matrix Dynam Grp, Toronto, ON M5S 1A1, Canada; [Jiang, Hongwei] Sun Yat Sen Univ, Guanghua Sch Stomatol, Dept Operat Dent & Endodont, Guangzhou 510275, Guangdong, Peoples R China; [Jiang, Hongwei] Guangdong Prov Key Lab Stomatol, Guangzhou, Guangdong, Peoples R China	University of Toronto; Sun Yat Sen University	Glogauer, M (corresponding author), Room 221,Fitzgerald Bldg,150 Coll St, Toronto, ON M5S 3E2, Canada.	michael.glogauer@utoronto.ca	Glogauer, Michael/D-2504-2011	Viniegra, Ana/0000-0002-7100-2252; Sima, Corneliu/0000-0003-3526-4850	National Nature Science Foundation of China [81100742]; Natural Science Foundation of Guangdong Province [S2013010015833]; Canadian Institutes of Health Research Team [TBO-122068]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Canadian Institutes of Health Research Team(Canadian Institutes of Health Research (CIHR))	The authors gratefully acknowledge Siavash Hassanpour for the preparation of the recombinant TAT-Ads protein, and Chunxiang Sun for mice genotyping. This work was supported by National Nature Science Foundation of China Grant 81100742, Natural Science Foundation of Guangdong Province Grant S2013010015833, and Canadian Institutes of Health Research Team Grant TBO-122068 (to C.A.M. and M.G.).	Abmayr SM, 2012, DEVELOPMENT, V139, P641, DOI 10.1242/dev.068353; Blangy A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045909; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Castro CHM, 2004, J CELL SCI, V117, P2853, DOI 10.1242/jcs.01133; Chellaiah M, 2000, J CELL BIOL, V148, P665, DOI 10.1083/jcb.148.4.665; Chiu WSM, 2004, GENESIS, V39, P178, DOI 10.1002/gene.20041; Chumnarnsilpa S, 2009, P NATL ACAD SCI USA, V106, P13719, DOI 10.1073/pnas.0812383106; Destaing O, 2003, MOL BIOL CELL, V14, P407, DOI 10.1091/mbc.E02-07-0389; Di Benedetto G, 2008, CIRC RES, V103, P836, DOI 10.1161/CIRCRESAHA.108.174813; Glogauer M, 2000, J CELL BIOL, V150, P785, DOI 10.1083/jcb.150.4.785; Gotz A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060642; Hartwig JH, 1991, CURR OPIN CELL BIOL, V3, P87, DOI 10.1016/0955-0674(91)90170-4; Hassanpour S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109078; Helming L, 2009, TRENDS CELL BIOL, V19, P514, DOI 10.1016/j.tcb.2009.07.005; Henriksen K, 2007, OSTEOPOROSIS INT, V18, P681, DOI 10.1007/s00198-006-0286-8; JANMEY PA, 1987, NATURE, V325, P362, DOI 10.1038/325362a0; Jurdic P, 2006, EUR J CELL BIOL, V85, P195, DOI 10.1016/j.ejcb.2005.09.008; KANEHISA J, 1990, BONE, V11, P287, DOI 10.1016/8756-3282(90)90082-A; Lee CYS, 2009, IMPLANT DENT, V18, P492, DOI 10.1097/ID.0b013e3181c6837c; Lueck A, 2000, BIOCHEMISTRY-US, V39, P5274, DOI 10.1021/bi992871v; Lueck A, 1998, J CELL SCI, V111, P3633; MAEKAWA S, 1990, J BIOL CHEM, V265, P10940; Nurminsky D, 2007, DEV BIOL, V302, P427, DOI 10.1016/j.ydbio.2006.09.052; Pene TD, 2005, J NEUROCHEM, V92, P780, DOI 10.1111/j.1471-4159.2004.02907.x; RODRIGUEZ DCA, 1990, EMBO J, V9, P43; SAKURAI T, 1991, J BIOL CHEM, V266, P15979; Shilagardi K, 2013, SCIENCE, V340, P359, DOI 10.1126/science.1234781; Silacci P, 2004, CELL MOL LIFE SCI, V61, P2614, DOI 10.1007/s00018-004-4225-6; Sima C, 2014, AM J PATHOL, V184, P472, DOI 10.1016/j.ajpath.2013.10.018; Spinardi L, 2006, EUR J CELL BIOL, V85, P191, DOI 10.1016/j.ejcb.2005.08.005; VITALE ML, 1991, J CELL BIOL, V113, P1057, DOI 10.1083/jcb.113.5.1057; Wang YQ, 2008, J BONE MINER RES, V23, P260, DOI 10.1359/JBMR.071013; Wilson SR, 2009, J BIOL CHEM, V284, P2584, DOI 10.1074/jbc.M805280200; Woo JT, 2000, J BONE MINER RES, V15, P650, DOI 10.1359/jbmr.2000.15.4.650; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Yang GZ, 2008, BIOCHEM BIOPH RES CO, V366, P352, DOI 10.1016/j.bbrc.2007.11.106	36	13	14	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2281	2291		10.1096/fj.14-265744	http://dx.doi.org/10.1096/fj.14-265744			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	25681458				2022-12-26	WOS:000355209500007
J	Nishino, Y; Gilmour, S; Shibuya, K				Nishino, Yoshitaka; Gilmour, Stuart; Shibuya, Kenji			Inequality in Diabetes-Related Hospital Admissions in England by Socioeconomic Deprivation and Ethnicity: Facility-Based Cross-Sectional Analysis	PLOS ONE			English	Article							PRIMARY-CARE; INTERMEDIATE OUTCOMES; SOUTH ASIANS; PREVALENCE; QUALITY; 21ST-CENTURY; PREVENTION; FRAMEWORK; DATABASE; OBESITY	Objective To investigate the effect of social deprivation and ethnicity on inpatient admissions due to diabetes in England. Design Facility-based cross-sectional analysis. Setting National Health Service (NHS) trusts in England reporting inpatient admissions with better than 80% data reporting quality from 2010-2011 (355 facilities). Participants Non-obstetric patients over 16 years old in all NHS facilities in England. The sample size after exclusions was 5,147,859 all-cause admissions. Main Outcome Measures The relative risk of inpatient admissions and readmissions due to diabetes adjusted for confounders. Results There were 445,504 diabetes-related hospital admissions in England in 2010, giving a directly (age-sex) standardized rate of 1049.0 per 100,000 population (95% confidence interval (CI): 1046.0-1052.1). The relative risk of inpatient admission in the most deprived quintile was 2.08 times higher than that of the least deprived quintile (95% CI: 2.02-2.14), and the effect of deprivation varied across ethnicities. About 30.1% of patients admitted due to diabetes were readmitted at least once due to diabetes. South Asians showed 2.62 times (95% CI: 2.51 - 2.74) higher admission risk. Readmission risk increased with IMD among white British but not other ethnicities. South Asians showed slightly lower risk of readmission than white British (0.86, 95% CI: 0.80 - 0.94). Conclusions More deprived areas had higher rates of inpatient admissions and readmissions due to diabetes. South Asian British showed higher admission risk and lower readmission risk than white British. However, there was almost no difference by ethnicity in readmission due to diabetes. Higher rates of admission among deprived people may not necessarily reflect higher prevalence, but higher admission rates in south Asian British may be explained by their higher prevalence because their lower readmission risk suggests no inequality in primary care to prevent readmission. Better interventions in poorer areas, are needed to reduce these inequalities.	[Nishino, Yoshitaka; Gilmour, Stuart; Shibuya, Kenji] Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Nishino, Y (corresponding author), Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	ny28tom@cameo.plala.or.jp		Shibuya, Kenji/0000-0003-2528-7530	Ministry of Health, Labour and Welfare, Japan [H24-25-007]	Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This study was in part supported by a Grant-in-Aid for Scientific Research from the Ministry of Health, Labour and Welfare, Japan (Grant No. H24-25-007) (http://www.mhlw.go.jp/english/policy/other/research-projects/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Agyemang C, 2011, EPIDEMIOLOGY, V22, P563, DOI 10.1097/EDE.0b013e31821d1096; Appleby J, 2011, BMJ, V342; Ashworth M, 2007, BRIT J GEN PRACT, V57, P441; Blackledge HM, 2003, HEART, V89, P615, DOI 10.1136/heart.89.6.615; BRADDON FFM, 1986, BMJ-BRIT MED J, V293, P299, DOI 10.1136/bmj.293.6542.299; Chiu M, 2011, DIABETES CARE, V34, P1741, DOI 10.2337/dc10-2300; Correa-De-Araujo R, 2006, WOMEN HEALTH ISS, V16, P56, DOI 10.1016/j.whi.2005.08.003; Dalton ARH, 2011, DIABETIC MED, V28, P525, DOI 10.1111/j.1464-5491.2011.03251.x; Department for Communities and Local Government, 2011, ENGL IND DEPR 2010 T; Dixon A, 2012, EUR J PUBLIC HEALTH, V22, P9, DOI 10.1093/eurpub/ckq177; Engelgau MM, 2003, J AM SOC NEPHROL, V14, pS88, DOI 10.1097/01.ASN.0000070143.71933.B0; Farmer A, 2012, DIABETIC MED; Fischbacher CM, 2009, J PUBLIC HEALTH-UK, V31, P239, DOI 10.1093/pubmed/fdp003; Forouhi NG, 2006, DIABETIC MED, V23, P189, DOI 10.1111/j.1464-5491.2005.01787.x; Gray A, 2002, BRIT MED J, V325, P860, DOI 10.1136/bmj.325.7369.860; Gulliford MC, 2007, DIABETIC MED, V24, P505, DOI 10.1111/j.1464-5491.2007.02090.x; Guthrie B, 2009, DIABETIC MED, V26, P1269, DOI 10.1111/j.1464-5491.2009.02837.x; Hex N, 2012, DIABETIC MED, V29, P855, DOI 10.1111/j.1464-5491.2012.03698.x; Imkampe AK, 2011, EUR J PUBLIC HEALTH, V21, P484, DOI 10.1093/eurpub/ckq106; James GD, 2012, J ROY SOC MED, V105, P300, DOI 10.1258/jrsm.2012.110289; Majeed A, 2000, BRIT MED J, V321, P1057, DOI 10.1136/bmj.321.7268.1057; MCKEIGUE PM, 1991, LANCET, V337, P382, DOI 10.1016/0140-6736(91)91164-P; Morris S, 2005, SOC SCI MED, V60, P1251, DOI 10.1016/j.socscimed.2004.07.016; National Institute for Health and Care Excellence, 2013, ASS BOD MASS IND WAI; NHS England, 2013, NHS ENGL BOARD AGR I; Office for National Statistics, 2012, 2011 CENS ENGL WAL P; Office for National Statistics Neighbourhood Statistics, LOW SUP OUTP AR POP; Office of National Statistics, 2012, EX SUMM 2010 BAS NPP; Reid FDA, 1999, BRIT MED J, V319, P98, DOI 10.1136/bmj.319.7202.98; Ricci-Cabello I, 2010, HEALTH SOC CARE COMM, V18, P572, DOI 10.1111/j.1365-2524.2010.00960.x; Riste L, 2001, DIABETES CARE, V24, P1377, DOI 10.2337/diacare.24.8.1377; Sheikh A, 2011, BMJ-BRIT MED J, V343, P343, DOI DOI 10.1136/BMJ.D6054; Smith JA, 2012, BMJ, V344; The Health and Social Care Information Centre, 2010, HES DAT DICT; Thompson R, 2012, DIABETIC MED; Waller J, 2009, BRIT J CANCER, V101, pS24, DOI 10.1038/sj.bjc.6605387	36	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0116689	10.1371/journal.pone.0116689	http://dx.doi.org/10.1371/journal.pone.0116689			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9BI	25705895	Green Published, gold, Green Submitted			2022-12-26	WOS:000350662100045
J	Marsili, S; Genini, S; Sudharsan, R; Gingrich, J; Aguirre, GD; Beltran, WA				Marsili, Stefania; Genini, Sem; Sudharsan, Raghavi; Gingrich, Jeremy; Aguirre, Gustavo D.; Beltran, William A.			Exclusion of the Unfolded Protein Response in Light-Induced Retinal Degeneration in the Canine T4R RHO Model of Autosomal Dominant Retinitis Pigmentosa	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; PHOTORECEPTOR DEGENERATION; RHODOPSIN MUTATIONS; MUTANT RHODOPSIN; QUALITY-CONTROL; ER STRESS; IN-VIVO; TRANSGENIC MICE; CELL-DEATH; CROSS-TALK	Purpose To examine the occurrence of endoplasmic reticulum (ER) stress and the unfolded protein response (UPR) following acute light damage in the naturally-occurring canine model of RHO-adRP (T4R RHO dog). Methods The left eyes of T4R RHO dogs were briefly light-exposed and retinas collected 3, 6 and 24 hours later. The contra-lateral eyes were shielded and used as controls. To evaluate the time course of cell death, histology and TUNEL assays were performed. Electron microscopy was used to examine ultrastructural alterations in photoreceptors at 15 min, 1 hour, and 6 hours after light exposure. Gene expression of markers of ER stress and UPR were assessed by RT-PCR, qRT-PCR and western blot at the 6 hour time-point. Calpain and caspase-3 activation were assessed at 1, 3 and 6 hours after exposure. Results A brief exposure to clinically-relevant levels of white light causes within minutes acute disruption of the rod outer segment disc membranes, followed by prominent ultrastructural alterations in the inner segments and the initiation of cell death by 6 hours. Activation of the PERK and IRE1 pathways, and downstream targets (BIP, CHOP) of the UPR was not observed. However increased transcription of caspase-12 and hsp70 occurred, as well as calpain activation, but not that of caspase-3. Conclusion The UPR is not activated in the early phase of light-induced photoreceptor cell death in the T4R RHO model. Instead, disruption in rods of disc and plasma membranes within minutes after light exposure followed by increase in calpain activity and caspase-12 expression suggests a different mechanism of degeneration.	[Marsili, Stefania; Genini, Sem; Sudharsan, Raghavi; Gingrich, Jeremy; Aguirre, Gustavo D.; Beltran, William A.] Univ Penn, Sch Vet Med, Dept Clin Studies, Sect Ophthalmol, Philadelphia, PA 19104 USA	University of Pennsylvania	Beltran, WA (corresponding author), Univ Penn, Sch Vet Med, Dept Clin Studies, Sect Ophthalmol, Philadelphia, PA 19104 USA.	wbeltran@vet.upenn.edu	marsili, stefania/AAY-9743-2020	marsili, stefania/0000-0003-0117-8874; Aguirre, Gustavo/0000-0002-5228-256X	National Institutes of Health (NIH) [R24EY022012, EY-006855, PN2EY018241, P30EY001583]; Foundation Fighting Blindness; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR002512] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [PN2EY018241, U01EY006855, R24EY022012, P30EY001583, R01EY006855] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010939] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness(European Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by: National Institutes of Health (NIH) R24EY022012 (WAB), EY-006855 (GDA), PN2EY018241 (WAB), P30EY001583, and Foundation Fighting Blindness (GDA).	Adekeye A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083871; Arango-Gonzalez B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112142; Beltran WA, 2006, INVEST OPHTH VIS SCI, V47, P1669, DOI 10.1167/iovs.05-0845; Budzynski E, 2010, J BIOL CHEM, V285, P14521, DOI 10.1074/jbc.M110.112409; Chen YY, 2014, J BIOL CHEM, V289, P9288, DOI 10.1074/jbc.M114.551713; Chen YF, 2011, J CELL BIOCHEM, V112, P520, DOI 10.1002/jcb.22942; Cideciyan AV, 1998, P NATL ACAD SCI USA, V95, P7103, DOI 10.1073/pnas.95.12.7103; Cideciyan AV, 2005, P NATL ACAD SCI USA, V102, P5233, DOI 10.1073/pnas.0408892102; Czogalla A, 2005, CELL MOL LIFE SCI, V62, P1913, DOI 10.1007/s00018-005-5097-0; Daiger SP, 2013, CLIN GENET, V84, P132, DOI 10.1111/cge.12203; Frederick JM, 2001, INVEST OPHTH VIS SCI, V42, P826; Gorbatyuk M, 2013, MOL VIS, V19, P1985; Gorbatyuk MS, 2010, P NATL ACAD SCI USA, V107, P5961, DOI 10.1073/pnas.0911991107; Griciuc A, 2011, TRENDS MOL MED, V17, P442, DOI 10.1016/j.molmed.2011.04.002; Gu D, 2007, INVEST OPHTH VIS SCI, V48, P4907, DOI 10.1167/iovs.07-0428; Gu D, 2009, INVEST OPHTH VIS SCI, V50, P3482, DOI 10.1167/iovs.08-3111; Haeri M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030101; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; HECKENLIVELY JR, 1991, ARCH OPHTHALMOL-CHIC, V109, P84, DOI 10.1001/archopht.1991.01080010086038; Heier CR, 2013, EMBO MOL MED, V5, P1569, DOI 10.1002/emmm.201302621; Hiramatsu N, 2007, FEBS LETT, V581, P2055, DOI 10.1016/j.febslet.2007.04.040; Hitomi J, 2004, NEUROSCI LETT, V357, P127, DOI 10.1016/j.neulet.2003.12.080; Iannaccone A, 2006, VISION RES, V46, P4556, DOI 10.1016/j.visres.2006.08.018; INGLEHEARN CF, 1992, HUM MOL GENET, V1, P41, DOI 10.1093/hmg/1.1.41; Kaur J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022181; KAUSHAL S, 1994, BIOCHEMISTRY-US, V33, P6121, DOI 10.1021/bi00186a011; Kijas JW, 2002, P NATL ACAD SCI USA, V99, P6328, DOI 10.1073/pnas.082714499; Kobayashi T, 2002, J BIOL CHEM, V277, P47358, DOI 10.1074/jbc.M207783200; Krebs MP, 2010, J MOL BIOL, V395, P1063, DOI 10.1016/j.jmb.2009.11.015; Krizaj D, 2012, ADV EXP MED BIOL, V740, P873, DOI 10.1007/978-94-007-2888-2_39; Kroeger H, 2012, INVEST OPHTH VIS SCI, V53, P7590, DOI 10.1167/iovs.12-10221; Kunte MM, 2012, INVEST OPHTH VIS SCI, V53, P3792, DOI 10.1167/iovs.11-9235; Li TS, 1998, P NATL ACAD SCI USA, V95, P11933, DOI 10.1073/pnas.95.20.11933; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Liu XR, 1997, J CELL SCI, V110, P2589; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mendes HF, 2005, TRENDS MOL MED, V11, P177, DOI 10.1016/j.molmed.2005.02.007; Mizukoshi S, 2010, EXP EYE RES, V91, P353, DOI 10.1016/j.exer.2010.06.004; Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887; Nakanishi T, 2013, J NEUROCHEM, V125, P111, DOI 10.1111/jnc.12116; Nashine S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063205; Noorwez SM, 2004, J BIOL CHEM, V279, P16278, DOI 10.1074/jbc.M312101200; Noorwez SM, 2003, J BIOL CHEM, V278, P14442, DOI 10.1074/jbc.M300087200; Olivari S, 2007, FEBS LETT, V581, P3658, DOI 10.1016/j.febslet.2007.04.070; Organisciak DT, 2003, INVEST OPHTH VIS SCI, V44, P486, DOI 10.1167/iovs.02-0708; Paquet-Durand F, 2006, J NEUROCHEM, V96, P802, DOI 10.1111/j.1471-4159.2005.03628.x; Parfitt DA, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.214; Paskowitz DM, 2006, BRIT J OPHTHALMOL, V90, P1060, DOI 10.1136/bjo.2006.097436; Sakami S, 2014, HUM MOL GENET, V23, P1723, DOI 10.1093/hmg/ddt561; Sakami S, 2011, J BIOL CHEM, V286, P10551, DOI 10.1074/jbc.M110.209759; Saliba RS, 2002, J CELL SCI, V115, P2907; Sanges D, 2006, P NATL ACAD SCI USA, V103, P17366, DOI 10.1073/pnas.0606276103; Shen Y, 2005, MOL BIOL CELL, V16, P40, DOI 10.1091/mbc.E04-05-0434; Shinde VM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033266; Sohocki MM, 2001, HUM MUTAT, V17, P42, DOI 10.1002/1098-1004(2001)17:1<42::AID-HUMU5>3.0.CO;2-K; Sullivan LS, 2006, INVEST OPHTH VIS SCI, V47, P3052, DOI 10.1167/iovs.05-1443; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P6481, DOI 10.1073/pnas.88.15.6481; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P8840, DOI 10.1073/pnas.88.19.8840; SUNG CH, 1993, J BIOL CHEM, V268, P26645; Tam BM, 2006, INVEST OPHTH VIS SCI, V47, P3234, DOI 10.1167/iovs.06-0213; Tam BM, 2014, J NEUROSCI, V34, P13336, DOI 10.1523/JNEUROSCI.1655-14.2014; Tam BM, 2010, INVEST OPHTH VIS SCI, V51, P1327, DOI 10.1167/iovs.09-4123; Tam BM, 2009, J NEUROSCI, V29, P15145, DOI 10.1523/JNEUROSCI.4259-09.2009; Uemura A, 2009, J CELL SCI, V122, P2877, DOI 10.1242/jcs.040584; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Wang M, 1997, VISUAL NEUROSCI, V14, P55, DOI 10.1017/S0952523800008750; White DA, 2007, INVEST OPHTH VIS SCI, V48, P1942, DOI 10.1167/iovs.06-1131; Yamashita K, 1999, BBA-GEN SUBJECTS, V1473, P147, DOI 10.1016/S0304-4165(99)00175-0; Yang LP, 2008, J NEUROSCI RES, V86, P910, DOI 10.1002/jnr.21535; Yang LP, 2007, INVEST OPHTH VIS SCI, V48, P5191, DOI 10.1167/iovs.07-0512; Yang Y, 2005, MOL CELLS, V20, P173; Yoneda T, 2001, J BIOL CHEM, V276, P13935, DOI 10.1074/jbc.M010677200; Yu M, 2000, J BIOL CHEM, V275, P24984, DOI 10.1074/jbc.M000739200; Zhang SX, 2014, EXP EYE RES, V125, P30, DOI 10.1016/j.exer.2014.04.015; Zhu L, 2004, J BIOL CHEM, V279, P53828, DOI 10.1074/jbc.M408472200	75	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0115723	10.1371/journal.pone.0115723	http://dx.doi.org/10.1371/journal.pone.0115723			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695253	Green Published, Green Submitted, gold			2022-12-26	WOS:000350062300009
J	Chatio, S; Aborigo, R; Adongo, PB; Anyorigiya, T; Akweongo, P; Oduro, A				Chatio, Samuel; Aborigo, Raymond; Adongo, Philip Baba; Anyorigiya, Thomas; Akweongo, Patricia; Oduro, Abraham			Adherence and Uptake of Artemisinin-Based Combination Treatments for Uncomplicated Malaria: A Qualitative Study in Northern Ghana	PLOS ONE			English	Article							DRUG-THERAPY; HEALTH	Background Based on the recommendations of the World Health Organization in 2004, Ghana changed her antimalarial drug policy from mono-therapy to Artemisinin-based Combination Therapy (ACTs). The country is currently using three first line drugs artesunate-amodiaquine, artemether- lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated malaria. Despite this policy, little or no qualitative studies have been conducted to establish the factors influencing adherence to the new treatment for malaria. This study explored factors influencing adherence to the use of ACTs in northern Ghana. Methods This was a qualitative study comprising forty (40) in-depth interviews with patients with malaria who visited selected public and private health facilities and received ACTs. Systematic sampling technique was used to select participants who were given ACTs for the interviews. Nvivo 9 software was used to code the data into themes for further analysis. Results The study revealed very important differences in knowledge about ACTs. As expected, the less or illiterates could not mention the type of ACT they would prefer to use for treating their malaria. The educated ones had a good knowledge on ACTs and preferred artemether-lumefantrinee in treating their malaria. The reason was that the drug was good and it had minimal or no side effects. Individual attitudes toward the use of medications and the side effects associated with the use of these ACTs were found to be the main factors affecting adherence to the use of ACTs. Perceived cure of illness after the initial dose greatly affected adherence. Other factors such as forgetfulness and lack of information also influenced patient adherence to ACTs use. Conclusion Individual knowledge, attitudes and behaviors greatly influence patients' adherence to ACTs use. Since ACTs take a number of days to complete, continuous education by health professionals could improve on adherence to ACTs use by patients with malaria.	[Chatio, Samuel; Aborigo, Raymond; Anyorigiya, Thomas; Oduro, Abraham] Navrongo Hlth Res Ctr, Navrongo, Ghana; [Adongo, Philip Baba; Akweongo, Patricia] Univ Ghana, Sch Publ Hlth, Accra, Ghana	Navrongo Health Research Center; University of Ghana	Chatio, S (corresponding author), Navrongo Hlth Res Ctr, POB 114, Navrongo, Ghana.	schatio@yahoo.co.uk		AKWEONGO, PATRICIA/0000-0001-6728-3365; Adongo, Philip Baba/0000-0002-0614-4756; ODURO, ABRAHAM/0000-0002-4191-7419; Chatio, Samuel Tamti/0000-0001-9998-748X	Bill & Melinda Gates foundation	Bill & Melinda Gates foundation(Bill & Melinda Gates FoundationCGIAR)	The study was part of the INDEPTH Effectiveness and Safety Studies (INESS). The INESS research was supported by the Bill & Melinda Gates foundation and facilitated by the INDEPTH Net-work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amukoye E, 1997, ANTIMICROB AGENTS CH, V41, P2261, DOI 10.1128/AAC.41.10.2261; [Anonymous], GLOBAL HLTH; [Anonymous], 2007, UNICEF GHAN FACT SHE; [Anonymous], 2012, QUAL STUD ID SOL LOC; [Anonymous], ASS MON ANT DRUG EFF; [Anonymous], ANT DRUG POL; [Anonymous], 2011, HEAL SCI J; [Anonymous], 2011, COST EFFECTIVENESS A; Baird JK, 2002, AM J TROP MED HYG, V66, P280, DOI 10.4269/ajtmh.2002.66.280; Baranowski T, 2003, OBES RES, V11, p23S, DOI 10.1038/oby.2003.222; Donovan C, 2012, Ghana Med J, V46, P85; Khantikul N, 2009, J HEALTH POPUL NUTR, V27, P4; Lee GKY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062775; Mace KE, 2011, CLIN INFECT DIS, V53, P772, DOI 10.1093/cid/cir498; Maslove DM, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-26; Nyonator FK, 2005, HEALTH POLICY PLANN, V20, P25, DOI 10.1093/heapol/czi003; Oduro AR, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-96; Oduro AR, 2012, INT J EPIDEMIOL, V41, P968, DOI 10.1093/ije/dys111; Onyango EO, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-143; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Sowunmi A, 2001, ANN TROP MED PARASIT, V95, P549, DOI 10.1080/00034980120092507; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2012, WORLD MALARIA REPORT 2012, P1	23	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0116856	10.1371/journal.pone.0116856	http://dx.doi.org/10.1371/journal.pone.0116856			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692568	Green Submitted, gold, Green Published			2022-12-26	WOS:000350061500026
J	Gholizadeh, A; Boruvka, L; Vasat, R; Saberioon, M; Klement, A; Kratina, J; Tejnecky, V; Drabek, O				Gholizadeh, Asa; Boruvka, Lubos; Vasat, Radim; Saberioon, Mohammadmehdi; Klement, Ales; Kratina, Josef; Tejnecky, Vaclav; Drabek, Ondrej			Estimation of Potentially Toxic Elements Contamination in Anthropogenic Soils on a Brown Coal Mining Dumpsite by Reflectance Spectroscopy: A Case Study	PLOS ONE			English	Article							NEAR-INFRARED-SPECTROSCOPY; PARTIAL LEAST-SQUARES; PRINCIPAL COMPONENT; AGRICULTURAL SOILS; RIVER FLOODPLAINS; ORGANIC-MATTER; EXTRACTION; PREDICTION; REGRESSION; MOISTURE	In order to monitor Potentially Toxic Elements (PTEs) in anthropogenic soils on brown coal mining dumpsites, a large number of samples and cumbersome, time-consuming laboratory measurements are required. Due to its rapidity, convenience and accuracy, reflectance spectroscopy within the Visible-Near Infrared (Vis-NIR) region has been used to predict soil constituents. This study evaluated the suitability of Vis-NIR (350-2500 nm) reflectance spectroscopy for predicting PTEs concentration, using samples collected on large brown coal mining dumpsites in the Czech Republic. Partial Least Square Regression (PLSR) and Support Vector Machine Regression (SVMR) with cross-validation were used to relate PTEs data to the reflectance spectral data by applying different preprocessing strategies. According to the criteria of minimal Root Mean Square Error of Prediction of Cross Validation (RMSEPcv) and maximal coefficient of determination (R-cv(2)) and Residual Prediction Deviation (RPD), the SVMR models with the first derivative pretreatment provided the most accurate prediction for As (R-cv(2)) = 0.89, RMSEPcv = 1.89, RPD = 2.63). Less accurate, but acceptable prediction for screening purposes for Cd and Cu (0.66 < R-cv(2)) < 0.81, RMSEPcv = 0.0.8 and 4.08 respectively, 2.0 < RPD < 2.5) were obtained. The PLSR model for predicting Mn (R-cv(2)) = 0.44, RMSEPcv = 116.43, RPD = 1.45) presented an inadequate model. Overall, SVMR models for the Vis-NIR spectra could be used indirectly for an accurate assessment of PTEs' concentrations.	[Gholizadeh, Asa; Boruvka, Lubos; Vasat, Radim; Klement, Ales; Kratina, Josef; Tejnecky, Vaclav; Drabek, Ondrej] Czech Univ Life Sci, Dept Soil Sci & Soil Protect, Fac Agrobiol Food & Nat Resources, Prague 16521 6, Czech Republic; [Saberioon, Mohammadmehdi] Univ South Bohemia Ceske Budejovice, Fac Fisheries & Protect Waters, Lab Image & Signal Proc, Inst Complex Syst, Nove Hrady 37333, Czech Republic	Czech University of Life Sciences Prague; University of South Bohemia Ceske Budejovice	Gholizadeh, A (corresponding author), Czech Univ Life Sci, Dept Soil Sci & Soil Protect, Fac Agrobiol Food & Nat Resources, Kamycka 129, Prague 16521 6, Czech Republic.	gholizadeh@af.czu.cz	Gholizadeh, Asa/AAX-9152-2021; Drábek, Ondřej/AAU-3496-2021; Boruvka, Lubos/U-8869-2019; Tejnecký, Václav/K-9043-2013; Vašát, Radim/AAU-4914-2021; Saberioon, Mohammadmehdi/F-9258-2015	Boruvka, Lubos/0000-0001-5317-0933; Tejnecký, Václav/0000-0003-0296-4981; Vašát, Radim/0000-0001-5739-5523; Saberioon, Mohammadmehdi/0000-0003-1627-4957; Klement, Ales/0000-0002-5835-8086	EC Operational Program [ESF/MEYS CZ.1.07/2.3.00/30.0040]; Czech University of Life Sciences Prague	EC Operational Program; Czech University of Life Sciences Prague	This research was financially supported by the EC Operational Program (Project No.: ESF/MEYS CZ.1.07/2.3.00/30.0040) and Czech University of Life Sciences Prague. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Dor E, 2002, ADV AGRON, V75, P173, DOI 10.1016/S0065-2113(02)75005-0; BenDor E, 1997, REMOTE SENS ENVIRON, V61, P1, DOI 10.1016/S0034-4257(96)00120-4; Bilgili AV, 2010, J ARID ENVIRON, V74, P229, DOI 10.1016/j.jaridenv.2009.08.011; Bray JGP, 2009, AUST J SOIL RES, V47, P433, DOI 10.1071/SR08068; DALAL RC, 1986, SOIL SCI SOC AM J, V50, P120, DOI 10.2136/sssaj1986.03615995005000010023x; Duckworth J., 2004, NEAR INFRARED SPECTR, V44, P115; Dunn BW, 2002, AUST J EXP AGR, V42, P607, DOI 10.1071/EA01172; Gannouni S., 2012, Journal of Geographic Information System, V4, P242, DOI 10.4236/jgis.2012.43029; Gholizadeh A, 2013, APPL SPECTROSC, V67, P1349, DOI 10.1366/13-07288; Gomez C, 2012, GEODERMA, V189, P176, DOI 10.1016/j.geoderma.2012.05.023; HAALAND DM, 1988, ANAL CHEM, V60, P1193, DOI 10.1021/ac00162a020; Imade Anom SW, 2000, IFAC BIOROBOTICS INF, P307; Janik LJ, 1998, AUST J EXP AGR, V38, P681, DOI 10.1071/EA97144; Kemper T, 2002, ENVIRON SCI TECHNOL, V36, P2742, DOI 10.1021/es015747j; Kooistra L, 2003, ANAL CHIM ACTA, V484, P189, DOI 10.1016/S0003-2670(03)00331-3; Kooistra L, 2001, ANAL CHIM ACTA, V446, P97, DOI 10.1016/S0003-2670(01)01265-X; Kooistra L., 2001, INT J APPL EARTH OBS, V3, P337, DOI [10.1016/s0303-2434(01)85041, DOI 10.1016/S0303-2434(01)85041-8]; Martens H., 1989, MULTIVARIATE CALIBRA, P419; MCGRATH SP, 1985, J SCI FOOD AGR, V36, P794, DOI 10.1002/jsfa.2740360906; Mevik BH, 2007, J STAT SOFTW, V18, P1, DOI 10.18637/jss.v018.i02; Meyer D., 2012, E1071 MISC FUNCTIONS; Salazar DM, 2012, PROCEDIA ENGINEER, V35, P245, DOI 10.1016/j.proeng.2012.04.187; Moros J, 2009, ENVIRON SCI TECHNOL, V43, P9314, DOI 10.1021/es9005898; Mouazen AM, 2007, SOIL TILL RES, V93, P13, DOI 10.1016/j.still.2006.03.009; Mouazen AM, 2010, GEODERMA, V158, P23, DOI 10.1016/j.geoderma.2010.03.001; Mouazen AM, 2005, SOIL TILL RES, V80, P171, DOI 10.1016/j.still.2004.03.022; MURRAY I, 1988, ANAL APPL SPECTROSCO, P9; N'guessan YM, 2009, SCI TOTAL ENVIRON, V407, P2939, DOI 10.1016/j.scitotenv.2008.12.047; Pirie A, 2005, AUST J SOIL RES, V43, P713, DOI 10.1071/SR04182; Rao BV, 2009, INT J MINER PROCESS, V91, P55, DOI 10.1016/j.minpro.2008.12.003; Ren HY, 2009, PEDOSPHERE, V19, P719, DOI 10.1016/S1002-0160(09)60167-3; Rinnan A, 2009, TRAC-TREND ANAL CHEM, V28, P1201, DOI 10.1016/j.trac.2009.07.007; Rossel RAV, 2006, GEODERMA, V137, P70, DOI 10.1016/j.geoderma.2006.07.004; Rossel RAV, 2006, GEODERMA, V131, P59, DOI 10.1016/j.geoderma.2005.03.007; Song YX, 2012, APPL CLAY SCI, V64, P75, DOI 10.1016/j.clay.2011.09.010; Stenberg B, 2010, ADV AGRON, V107, P163, DOI 10.1016/S0065-2113(10)07005-7; Stevens A, 2010, GEODERMA, V158, P32, DOI 10.1016/j.geoderma.2009.11.032; Strudl M., 2006, Soil and Water Research, V1, P99; Vapnik V., 2013, NATURE STAT LAERNING; Vohland M, 2011, GEODERMA, V166, P198, DOI 10.1016/j.geoderma.2011.08.001; Vohland M, 2009, J PLANT NUTR SOIL SC, V172, P201, DOI 10.1002/jpln.200700087; Williams P., 2003, NEAR INFRARED TECHNO; Wu YZ, 2007, SOIL SCI SOC AM J, V71, P918, DOI 10.2136/sssaj2006.0285; Wu YZ, 2005, APPL GEOCHEM, V20, P1051, DOI 10.1016/j.apgeochem.2005.01.009; Xie XL, 2012, PEDOSPHERE, V22, P351, DOI 10.1016/S1002-0160(12)60022-8; Zornoza R, 2008, SOIL BIOL BIOCHEM, V40, P1923, DOI 10.1016/j.soilbio.2008.04.003	47	57	61	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117457	10.1371/journal.pone.0117457	http://dx.doi.org/10.1371/journal.pone.0117457			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692671	gold, Green Published, Green Submitted			2022-12-26	WOS:000350061500057
J	Lucas, T; Benihoud, K; Vigant, F; Schmidt, CQA; Bachem, MG; Simmet, T; Kochanek, S				Lucas, Tanja; Benihoud, Karim; Vigant, Frederic; Schmidt, Christoph Q. Andreas; Bachem, Max G.; Simmet, Thomas; Kochanek, Stefan			Hexon Modification to Improve the Activity of Oncolytic Adenovirus Vectors against Neoplastic and Stromal Cells in Pancreatic Cancer	PLOS ONE			English	Article							RETROVIRAL ENVELOPE PROTEINS; MEDIATED GENE-TRANSFER; FACTOR-BETA RECEPTOR; STELLATE CELLS; IN-VIVO; DESMOPLASTIC REACTION; ENHANCED EXPRESSION; SCAVENGER RECEPTORS; NATURAL ANTIBODIES; COATED ADENOVIRUS	Primary pancreatic carcinoma has an unfavourable prognosis and standard treatment strategies mostly fail in advanced cases. Virotherapy might overcome this resistance to current treatment modalities. However, data from clinical studies with oncolytic viruses, including replicating adenoviral (Ad) vectors, have shown only limited activity against pancreatic cancer and other carcinomas. Since pancreatic carcinomas have a complex tumor architecture and frequently a strong stromal compartment consisting of non-neoplastic cell types (mainly pancreatic stellate cells = hPSCs) and extracellular matrix, it is not surprising that Ad vectors replicating in neoplastic cells will likely fail to eradicate this aggressive tumor type. Because the TGF beta receptor (TGFBR) is expressed on both neoplastic cells and hPSCs we inserted the TGFBR targeting peptide CKS17 into the hypervariable region 5 (HVR5) of the capsid protein hexon with the aim to generate a replicating Ad vector with improved activity in complex tumors. We demonstrated increased transduction of both pancreatic cancer cell lines and of hPSCs and enhanced cytotoxicity in co-cultures of both cell types. Surface plasmon resonance analysis demonstrated decreased binding of coagulation factor X to CKS17-modified Ad particles and in vivo biodistribution studies performed in mice indicated decreased transduction of hepatocytes. Thus, to increase activity of replicating Ad vectors we propose to relax tumor cell selectivity by genetic hexon-mediated targeting to the TGFBR (or other receptors present on both neoplastic and non-neoplastic cells within the tumor) to enable replication also in the stromal cell compartment of tumors, while abolishing hepatocyte transduction, and thereby increasing safety.	[Lucas, Tanja; Kochanek, Stefan] Univ Ulm, Dept Gene Therapy, D-89069 Ulm, Germany; [Benihoud, Karim; Vigant, Frederic] Univ Paris 11, Orsay, France; [Benihoud, Karim; Vigant, Frederic] Inst Gustave Roussy, CNRS, UMR 8203, Villejuif, France; [Schmidt, Christoph Q. Andreas; Simmet, Thomas] Univ Ulm, Inst Pharmacol Nat Prod & Clin Pharmacol, D-89069 Ulm, Germany; [Schmidt, Christoph Q. Andreas] Univ Ulm, Tierforschungszentrum, D-89069 Ulm, Germany; [Bachem, Max G.] Univ Ulm, Dept Clin Chem, D-89069 Ulm, Germany	Ulm University; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Ulm University; Ulm University; Ulm University	Kochanek, S (corresponding author), Univ Ulm, Dept Gene Therapy, D-89069 Ulm, Germany.	stefan.kochanek@uni-ulm.de	, BENIHOUD/O-4334-2019	Syrovets, Tatiana/0000-0002-6751-2233	Deutsche Krebshilfe [109545]	Deutsche Krebshilfe(Deutsche Krebshilfe)	This work is supported by grant 109545 (to SK and AW) from the Deutsche Krebshilfe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba R, 2010, BLOOD, V116, P2656, DOI 10.1182/blood-2009-12-260026; Alba R, 2009, BLOOD, V114, P965, DOI 10.1182/blood-2009-03-208835; Alemany R, 2000, J GEN VIROL, V81, P2605, DOI 10.1099/0022-1317-81-11-2605; Alemany R, 2000, NAT BIOTECHNOL, V18, P723, DOI 10.1038/77283; Alemany R, 2001, GENE THER, V8, P1347, DOI 10.1038/sj.gt.3301515; Apte MV, 2004, PANCREAS, V29, P179, DOI 10.1097/00006676-200410000-00002; Bachem MG, 2005, GASTROENTEROLOGY, V128, P907, DOI 10.1053/j.gastro.2004.12.036; Bachem MG, 1998, GASTROENTEROLOGY, V115, P421, DOI 10.1016/S0016-5085(98)70209-4; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Braet Filip, 2002, Comp Hepatol, V1, P1, DOI 10.1186/1476-5926-1-1; Brock P, 2006, J CELL MOL MED, V10, P884, DOI 10.1111/j.1582-4934.2006.tb00532.x; Buchholz M, 2005, ONCOGENE, V24, P6626, DOI 10.1038/sj.onc.1208804; Campos SK, 2006, VIROLOGY, V349, P453, DOI 10.1016/j.virol.2006.01.032; CIANCIOLO GJ, 1985, SCIENCE, V230, P453, DOI 10.1126/science.2996136; CIANCIOLO GJ, 1984, NATURE, V311, P515, DOI 10.1038/311515a0; FRIESS H, 1993, CANCER RES, V53, P2704; Ganesan LP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002281; Green NK, 2004, GENE THER, V11, P1256, DOI 10.1038/sj.gt.3302295; Haag C, 2011, GUT, V60, P225, DOI 10.1136/gut.2009.202325; He JQ, 2013, J LEUKOCYTE BIOL, V93, P301, DOI 10.1189/jlb.0612311; Hecht JR, 2003, CLIN CANCER RES, V9, P555; Helmy KY, 2006, CELL, V124, P915, DOI 10.1016/j.cell.2005.12.039; Huang SS, 1997, J BIOL CHEM, V272, P27155, DOI 10.1074/jbc.272.43.27155; Huang SS, 1998, J BIOL CHEM, V273, P4815, DOI 10.1074/jbc.273.9.4815; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jonson T, 2001, INT J ONCOL, V19, P71; Jullienne B, 2009, GENE THER, V16, P1405, DOI 10.1038/gt.2009.97; Kalyuzhniy O, 2008, P NATL ACAD SCI USA, V105, P5483, DOI 10.1073/pnas.0711757105; Khare R, 2012, J VIROL, V86, P2293, DOI 10.1128/JVI.05760-11; Khare R, 2011, MOL THER, V19, P1254, DOI 10.1038/mt.2011.71; Kim M, 2002, EUR J CANCER, V38, P1917, DOI 10.1016/S0959-8049(02)00131-4; Kreppel F, 2005, MOL THER, V12, P107, DOI 10.1016/j.ymthe.2005.03.006; Kreppel F, 2002, HUM GENE THER, V13, P1151, DOI 10.1089/104303402320138934; Leopold PL, 1998, HUM GENE THER, V9, P367, DOI 10.1089/hum.1998.9.3-367; Mok H, 2005, MOL THER, V11, P66, DOI 10.1016/j.ymthe.2004.09.015; Mulvihlll S, 2001, GENE THER, V8, P308, DOI 10.1038/sj.gt.3301398; Parker AL, 2006, BLOOD, V108, P2554, DOI 10.1182/blood-2006-04-008532; Pearson AS, 1999, CLIN CANCER RES, V5, P4208; Piccolo P, 2013, MOL THER, V21, P767, DOI 10.1038/mt.2012.287; Prill JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082716; Schiedner G, 2000, HUM GENE THER, V11, P2105, DOI 10.1089/104303400750001417; Shashkova EV, 2009, MOL THER, V17, P2121, DOI 10.1038/mt.2009.217; Shayakhmetov DM, 2005, J VIROL, V79, P7478, DOI 10.1128/JVI.79.12.7478-7491.2005; Short JJ, 2010, MOL CANCER THER, V9, P2536, DOI 10.1158/1535-7163.MCT-10-0332; Simard EP, 2012, CA-CANCER J CLIN, V62, P118, DOI 10.3322/caac.20141; Simeone DM, 2000, ANN SURG, V232, P73, DOI 10.1097/00000658-200007000-00011; Snoeys J, 2007, GENE THER, V14, P604, DOI 10.1038/sj.gt.3302899; SONIGO P, 1986, CELL, V45, P375, DOI 10.1016/0092-8674(86)90323-5; van Oosten M, 1998, INFECT IMMUN, V66, P5107, DOI 10.1128/IAI.66.11.5107-5112.1998; VanRooijen N, 1996, HEPATOLOGY, V23, P1239; Venkatasubbarao K, 2000, ANTICANCER RES, V20, P43; Vigant F, 2008, MOL THER, V16, P1474, DOI 10.1038/mt.2008.132; Vigne E, 1999, J VIROL, V73, P5156, DOI 10.1128/JVI.73.6.5156-5161.1999; Waddington SN, 2008, CELL, V132, P397, DOI 10.1016/j.cell.2008.01.016; Waddington SN, 2007, J VIROL, V81, P9568, DOI 10.1128/JVI.00663-07; Wagner M, 1999, PANCREAS, V19, P370, DOI 10.1097/00006676-199911000-00008; Wesseling JG, 2001, GENE THER, V8, P969, DOI 10.1038/sj.gt.3301473; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E; WISSE E, 1970, J ULTRA MOL STRUCT R, V31, P125, DOI 10.1016/S0022-5320(70)90150-4; Worgall S, 1997, HUM GENE THER, V8, P37, DOI 10.1089/hum.1997.8.1-37; Wortmann A, 2008, MOL THER, V16, P154, DOI 10.1038/sj.mt.6300306; Wu HJ, 2005, J VIROL, V79, P3382, DOI 10.1128/JVI.79.6.3382-3390.2005; Xu ZL, 2013, NAT MED, V19, P452, DOI 10.1038/nm.3107; Xu ZL, 2008, J VIROL, V82, P11705, DOI 10.1128/JVI.01320-08; Yen TNF, 2002, SURGERY, V131, P129, DOI 10.1067/msy.2002.119192; Zhou ZH, 2007, J AUTOIMMUN, V29, P219, DOI 10.1016/j.jaut.2007.07.015	67	13	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117254	10.1371/journal.pone.0117254	http://dx.doi.org/10.1371/journal.pone.0117254			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692292	Green Published, Green Submitted, gold			2022-12-26	WOS:000350061500044
J	White, PA; Belant, JL				White, Paula A.; Belant, Jerrold L.			Provisioning of Game Meat to Rural Communities as a Benefit of Sport Hunting in Zambia	PLOS ONE			English	Article							WILDLIFE CONSERVATION; BUSHMEAT TRADE; LAND; CONFLICTS; DRIVERS; IMPACTS; AFRICA	Sport hunting has reportedly multiple benefits to economies and local communities; however, few of these benefits have been quantified. As part of their lease agreements with the Zambia Wildlife Authority, sport hunting operators in Zambia are required to provide annually to local communities free of charge i.e., provision a percentage of the meat obtained through sport hunting. We characterized provisioning of game meat to rural communities by the sport hunting industry in Zambia for three game management areas (GMAs) during 2004-2011. Rural communities located within GMAs where sport hunting occurred received on average > 6,000 kgs per GMA of fresh game meat annually from hunting operators. To assess hunting industry compliance, we also compared the amount of meat expected as per the lease agreements versus observed amounts of meat provisioned from three GMAs during 2007-2009. In seven of eight annual comparisons of these GMAs, provisioning of meat exceeded what was required in the lease agreements. Provisioning occurred throughout the hunting season and peaked during the end of the dry season (September-October) coincident with when rural Zambians are most likely to encounter food shortages. We extrapolated our results across all GMAs and estimated 129,771 kgs of fresh game meat provisioned annually by the sport hunting industry to rural communities in Zambia at an approximate value for the meat alone of > US$600,000 exclusive of distribution costs. During the hunting moratorium (2013-2014), this supply of meat has halted, likely adversely affecting rural communities previously reliant on this food source. Proposed alternatives to sport hunting should consider protein provisioning in addition to other benefits (e.g., employment, community pledges, anti-poaching funds) that rural Zambian communities receive from the sport hunting industry.	[White, Paula A.] Univ Calif Los Angeles, Ctr Trop Res, Inst Environm & Sustainabil, Los Angeles, CA 90089 USA; [Belant, Jerrold L.] Mississippi State Univ, Forest & Wildlife Res Ctr, Carnivore Ecol Lab, Starkville, MS USA	University of California System; University of California Los Angeles; Mississippi State University	White, PA (corresponding author), Univ Calif Los Angeles, Ctr Trop Res, Inst Environm & Sustainabil, Los Angeles, CA 90089 USA.	paw@carnivoreconservation.com	Belant, Jerrold/HDM-7749-2022					AfricaHunting, 2014, HUNT INF COUNTR; Ahmed AU, 2007, WORLDS MOST DEPRIVED, P107; Ahmed J, 2001, LESSONS LEARNED CASE; Astle WL, 1999, HIST WILDLIFE CONSER; Baldus RD, 2004, TOURIST HUNTING ITS; Baldus RD, 2009, PRACTICAL SUMMARY EX; Barnett R., 1997, FOOD THOUGHT UTILIZA; Barnett R, 2005, SPORT HUNTING SO AFR; Becker M, 2013, BIOL CONSERV, V158, P26, DOI 10.1016/j.biocon.2012.08.017; Bennett EL, 2002, CONSERV BIOL, V16, P590, DOI 10.1046/j.1523-1739.2002.01637.x; Bennett EL, 2007, CONSERV BIOL, V21, P884, DOI 10.1111/j.1523-1739.2006.00595.x; Bond Ivan, 1994, Traffic Bulletin, V14, P117; Booth VR, 2009, COMP PRICES HUNTING; Bothma JP., 2010, GAME RANCH MANAGEMEN; Brashares JS, 2011, P NATL ACAD SCI USA, V108, P13931, DOI 10.1073/pnas.1011526108; Brown T, 2007, CONSERV SCI PRACT, V2, P92; Bulletin and Record, 2013, KILL FIELDS ZAMB, V2; Campbell R, 2013, 200 MILLION QUESTION, DOI [10.1007/s13197-013-0993-z, DOI 10.1007/S13197-013-0993-Z]; CBD, 2011, CBD TECHN SER, V56, DOI [10.1016/j.recot.2011.11.003, DOI 10.1016/J.RECOT.2011.11.003]; Child BA, 2012, PASTORALISM, V2, DOI 10.1186/2041-7136-2-18; Damm G.R, 2008, BEST PRACTICES SUSTA, P5; Davies G, 2007, BUSHMEAT LIVELIHOODS, DOI [10.1093/jxb/erm028, DOI 10.1093/JXB/ERM028]; FAO, 2014, FOOD NUTR NUMB, DOI [10.1016/j.fsigen.2014.12.009, DOI 10.1016/J.FSIGEN.2014.12.009]; FAO, 2010, FOOD BAL SHEETS; FAO, 2014, STAT YB 2014 AFR FOO; FEWS, 2014, FOOD SEC OUTL UPD; FTF, 2011, ZAMB FY 2011 2015 MU; GAFSP, 2013, ANN REPORT; Haller T, 2008, HUM ECOL, V36, P699, DOI 10.1007/s10745-008-9191-4; Harvie B.A, 2013, J ECOLOGY NATURAL EN, V5, P88, DOI [10.5897/jene2013.0364, DOI 10.5897/JENE2013.0364]; Henley EC, 2010, ADV FOOD NUTR RES, V60, P21, DOI 10.1016/S1043-4526(10)60002-2; IRIN, 2014, ZAMB MOSQ NET FISH T; Jackson JJ, 1996, TOURIST HUNTING TANZ, P7; King A, 2011, CITES CBNRM P INT S, P78; Leader-Williams N, 2005, CONSERV BIOL SER, V9, P140; Lewis D, 2005, CONSERV BIOL SER, V9, P239; Lewis D, 2005, Conservation and Development Interventions at the Wildlife/Livestock Interface, P153; Lewis DM, 2007, CONSERV SCI PRACT, V2, P177; Lewis DM, 1997, CONSERV BIOL, V11, P59, DOI 10.1046/j.1523-1739.1997.94389.x; Lindsey PA, 2007, BIOL CONSERV, V134, P455, DOI 10.1016/j.biocon.2006.09.005; Lindsey PA, 2006, ANIM CONSERV, V9, P283, DOI 10.1111/j.1469-1795.2006.00034.x; Lindsey PA, 2011, ORYX, V45, P84, DOI 10.1017/S0030605310001274; Lindsey PA, 2013, BIOL CONSERV, V160, P80, DOI 10.1016/j.biocon.2012.12.020; Loveridge Andrew J., 2006, P222; Marks Stuart A., 2005, LARGE MAMMALS BRAVE; Milner-Gulland EJ, 2003, TRENDS ECOL EVOL, V18, P351, DOI 10.1016/S0169-5347(03)00123-X; NASCO, 2013, NASCO 2012 ANN REP; Nasi R, 2008, CONSERVATION USE WIL; Norton-Griffiths M., 1998, CONSERVATION BIOL RE, P279; Nyirenda VR, 2008, ATLAS NATL PARKS ZAM; Oates J. F., 1999, MYTH REALITY RAIN FO; OECD, 2012, AFR EC OUTL, DOI [10.1016/j.asjsur.2012.06.010, DOI 10.1016/J.ASJSUR.2012.06.010]; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Sanjay Gubbi, 2010, Economic and Political Weekly, V45, P22; Shurter S, 2013, GNUSLETTER, DOI [10.1007/s13197-013-0993-z, DOI 10.1007/S13197-013-0993-Z]; Simasiku P, 2008, IMPACT WILDLIFE MANA; Skinner J. D., 1990, MAMMALS SO AFRICAN S; SLCS, 2013, OCT NOV DEC NEWSL; Stier JC, 1973, SAFARI HUNTING LUANG; Von Braun J., 2009, POOREST HUNGRY ASSES; WB, 1986, POV HUNG ISS OPT FOO; Weaver Chris, 2011, Occasional Papers of the IUCN Species Survival Commission, V46, P59; Weaver LC, 2008, BEST PRACTICES SUSTA, V1, P48; Wikipedia, 2014, AIR TRAV DISR 2010 E; ZCSO, 2014, MONTHL NOV 2014, DOI [10.1016/j.fsigen.2014.12.009, DOI 10.1016/J.FSIGEN.2014.12.009]; ZCSO, 2014, MONTHL FEBR 2014, DOI [10.1016/j.fsigen.2014.12.009, DOI 10.1016/J.FSIGEN.2014.12.009]; ZCSO, 2014, ZAMB FIG 1964 2014 R; ZVAC, 2004, ZAMB LIV MAP REZ BAS	68	7	7	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117237	10.1371/journal.pone.0117237	http://dx.doi.org/10.1371/journal.pone.0117237			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693191	Green Published, Green Submitted, gold			2022-12-26	WOS:000350061500043
J	Aureliano, T; Ghilardi, AM; Guilherme, E; Souza, JP; Cavalcanti, M; Riff, D				Aureliano, Tito; Ghilardi, Aline M.; Guilherme, Edson; Souza-Filho, Jonas P.; Cavalcanti, Mauro; Riff, Douglas			Morphometry, Bite-Force, and Paleobiology of the Late Miocene Caiman Purussaurus brasiliensis	PLOS ONE			English	Article							CROCODILE CROCODYLUS-NILOTICUS; ALLIGATOR-MISSISSIPPIENSIS; NORTHERN AUSTRALIA; URUMACO FORMATION; FEEDING ECOLOGY; BODY-SIZE; PERFORMANCE; VENEZUELA; HABITS; GROWTH	Purussaurus brasiliensis thrived in the northwestern portion of South America during the Late Miocene. Although substantial material has been recovered since its early discovery, this fossil crocodilian can still be considered as very poorly understood. In the present work, we used regression equations based on modern crocodilians to present novel details about the morphometry, bite-force and paleobiology of this species. According to our results, an adult Purussaurus brasiliensis was estimated to reach around 12.5 m in length, weighing around 8.4 metric tons, with a mean daily food intake of 40.6 kg. It was capable of generating sustained bite forces of 69,000 N (around 7 metric tons-force). The extreme size and strength reached by this animal seems to have allowed it to include a wide range of prey in its diet, making it a top predator in its ecosystem. As an adult, it would have preyed upon large to very large vertebrates, and, being unmatched by any other carnivore, it avoided competition. The evolution of a large body size granted P. brasiliensis many advantages, but it may also have led to its vulnerability. The constantly changing environment on a large geological scale may have reduced its long-term survival, favoring smaller species more resilient to ecological shifts.	[Aureliano, Tito] Univ Fed Pernambuco, Dept Geol, BR-50740530 Recife, PE, Brazil; [Ghilardi, Aline M.] Univ Fed Rio de Janeiro, Dept Geol, BR-21949900 Rio De Janeiro, RJ, Brazil; [Guilherme, Edson; Souza-Filho, Jonas P.] Univ Fed Acre, Lab Pesquisas Paleontol, BR-69915900 Rio Branco, Acre, Brazil; [Cavalcanti, Mauro] Ecoinformat Studio, BR-20551970 Rio De Janeiro, RJ, Brazil; [Riff, Douglas] Univ Fed Uberlandia, Inst Biol, BR-38400902 Uberlandia, MG, Brazil	Universidade Federal de Pernambuco; Universidade Federal do Rio de Janeiro; Universidade Federal do Acre (UFAC); Universidade Federal de Uberlandia	Aureliano, T (corresponding author), Univ Fed Pernambuco, Dept Geol, BR-50740530 Recife, PE, Brazil.	aureliano.tito@gmail.com	Guilherme, Edson/AAC-1717-2021; Riff, Douglas/B-5183-2012; Guilherme, Edson/J-2341-2014; Aureliano, Tito/L-3061-2019; Ghilardi, Aline Marcele/AAQ-1393-2020; Cavalcanti, Mauro J/N-9739-2013	Riff, Douglas/0000-0003-0805-2828; Guilherme, Edson/0000-0001-8322-1770; Aureliano, Tito/0000-0002-6918-0519; Ghilardi, Aline Marcele/0000-0001-9136-0236; 	FAPEMIG; Post Graduation Department of UFU	FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Post Graduation Department of UFU	The publication cost was fully funded by FAPEMIG and the Post Graduation Department of UFU. The links are: http://www.fapemig.br/ and http://www.portal.ib.ufu.br/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera OA, 2006, J SYST PALAEONTOL, V4, P221, DOI 10.1017/S147720190600188X; Allsteadt J, 1994, VIDA SILVESTRE NEOTR, V3, P24; [Anonymous], 2014, R LANG ENV STAT COMP; Aureliano T, 2010, RES 7 C LAT PAL, P134, DOI [10.1016/j.watres.2015.01.009, DOI 10.1016/J.WATRES.2015.01.009]; Barbosa-Rodrigues B., 1892, VELLOSIA, V2, P41; Begon M., 2009, ECOLOGY INDIVIDUALS; Bocquentin Jean, 2006, Revista Brasileira de Paleontologia, V9, P187; Bocquentin JV, 1990, B MUSEU PARAENSE EMI, V2, P65; Bocquentin-Villanueva J., 1989, AN 11 C BRAS PAL CUR, P427; Brito Simone P., 2002, Herpetological Natural History, V9, P95; BROCHU CA, 1999, J VERTEBR PALEONTOL, V19, P2, DOI DOI 10.4202/APP.00499.2018; Busbey AB, 1995, FUNCTIONAL MORPHOLOG, P227; Canty A, 2014, BOOT BOOTSTRAP R S P; Canty A.J., 2002, R NEWS, V2, P2, DOI DOI 10.1159/000323281; Chandler CL, 1990, THESIS YALE U; Christiansen P, 2007, ECOLOGY, V88, P347, DOI 10.1890/0012-9658(2007)88[347:BFAEAT]2.0.CO;2; COTT H. B., 1961, TRANS ZOOL SOC LONDON, V29, P211; Davison AC, 1997, BOOTSTRAP METHODS TH; DELANY MF, 1986, J WILDLIFE MANAGE, V50, P348, DOI 10.2307/3801926; DENSMORE LD, 1989, AM ZOOL, V29, P831; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Erickson GM, 2004, J ZOOL, V262, P21, DOI 10.1017/S0952836903004400; Erickson GM, 2003, J ZOOL, V260, P317, DOI 10.1017/S0952836903003819; Erickson GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031781; Farlow JO, 2005, J VERTEBR PALEONTOL, V25, P354, DOI 10.1671/0272-4634(2005)025[0354:FDABSO]2.0.CO;2; Gervais P., 1876, J ZOOLOGIE, V5, P232; Grenard S., 1991, HDB ALLIGATORS CROCO; Hoorn C, 2010, SCIENCE, V330, P927, DOI 10.1126/science.1194585; Hoorn C, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P123; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; HUTTON JM, 1987, J ANIM ECOL, V56, P25, DOI 10.2307/4797; Iordansky N.N., 1973, P201; Langston W., 1965, FOSSIL CROCODILIANS; Langston W. Jr., 1973, P263; Latrubesse EM, 2010, EARTH-SCI REV, V99, P99, DOI 10.1016/j.earscirev.2010.02.005; Lundberg JG, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P281; Makarieva AM, 2005, P ROY SOC B-BIOL SCI, V272, P2325, DOI 10.1098/rspb.2005.3223; Marshall L. G., 1991, REV TECNICA YPFB, V12, P631, DOI DOI 10.1007/S10295-008-0468-9; Massare J.A., 1987, Journal of Vertebrate Paleontology, V7, P121; Milan J., 2010, NEW MEXICO MUSEUM NA, V51, P195; Mook C. C., 1941, Proceedings of the United States National Museum, V91, P55; Mook CC, 1921, B AM MUS NAT HIST, V44, P43; Negri FR, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P245; Njau JK, 2006, J HUM EVOL, V50, P142, DOI 10.1016/j.jhevol.2005.08.008; Owen-Smith, 1992, MEGAHERBIVORES INFLU; Patterson B, 1943, COPEIA, V1943, P123; Peng R.D, 2008, SIMPLEBOOT SIMPLE BO; Pienaar U. de V., 1969, Koedoe, VNo. 12, P108; Platt SG, 2013, J ZOOL, V291, P87, DOI 10.1111/jzo.12052; PLOTNICK RE, 1989, SYST ZOOL, V38, P144, DOI 10.2307/2992383; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Prasad Guntupalli V.R., 2002, Annales de Paleontologie, V88, P19, DOI 10.1016/S0753-3969(02)01036-4; Price L.I., 1967, AT S BIOT AM GEOC, P359; Riff D, 2008, PALAEONTOL Z, V82, P178, DOI 10.1007/BF02988408; Riff D, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P259; Rusconi C., 1933, Revista de la Universidad Nacional de Cordoba, V20, P1; Salas-Gismondi R., 2007, Cuadernos del Museo Geominero, V8, P355; Sanchez-Villagra MR, 2003, SCIENCE, V301, P1708, DOI 10.1126/science.1089332; Scheyer TM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2940; Schwimmer DR., 2002, KING CROCODYLIANS PA; Sereno PC, 2001, SCIENCE, V294, P1516, DOI 10.1126/science.1066521; Sokal RR, 1995, BIOMETRY PRINCIPLES, V3, P1995; TAYLOR JA, 1979, AUST WILDLIFE RES, V6, P347, DOI 10.1071/WR9790347; Tchernov E, 1986, CAHIERS PALEONTOLOGI, V1, P65; THORBJARNARSON JB, 1993, HERPETOLOGICA, V49, P108; Verdade L. M., 2000, Revista Brasileira de Biologia, V60, P469; Wallace KM, 2008, J HERPETOL, V42, P361, DOI 10.1670/07-1071.1; WEBB GJW, 1978, AUST WILDLIFE RES, V5, P385; Wesselingh FP, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P302; Woodward G, 2005, TRENDS ECOL EVOL, V20, P402, DOI 10.1016/j.tree.2005.04.005; Zar JH., 2010, BIOSTAT ANAL, V5th; [No title captured]	72	28	28	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117944	10.1371/journal.pone.0117944	http://dx.doi.org/10.1371/journal.pone.0117944			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689140	Green Published, Green Submitted, gold			2022-12-26	WOS:000350322700087
J	Saxena, S; Khan, N; Dehinwal, R; Kumar, A; Sehgal, D				Saxena, Sneha; Khan, Naeem; Dehinwal, Ruchika; Kumar, Ajay; Sehgal, Devinder			Conserved Surface Accessible Nucleoside ABC Transporter Component SP0845 Is Essential for Pneumococcal Virulence and Confers Protection In Vivo	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; PROTEIN-A; SEROTYPE REPLACEMENT; CONJUGATE VACCINE; DISEASE; LIPOPROTEINS; INFECTION; IMMUNOGENICITY; IDENTIFICATION; ANTIBODIES	Streptococcus pneumoniae is a leading cause of bacterial pneumonia, sepsis and meningitis. Surface accessible proteins of S. pneumoniae are being explored for the development of a protein-based vaccine in order to overcome the limitations of existing polysaccharide-based pneumococcal vaccines. To identify a potential vaccine candidate, we resolved surface-associated proteins of S. pneumoniae TIGR4 strain using two-dimensional gel electrophoresis followed by immunoblotting with antisera generated against whole heat-killed TIGR4. Ten immunoreactive spots were identified by mass spectrometric analysis that included a putative lipoprotein SP0845. Analysis of the inferred amino acid sequence of sp0845 homologues from 36 pneumococcal strains indicated that SP0845 was highly conserved (>98% identity) and showed less than 11% identity with any human protein. Our bio-informatic and functional analyses demonstrated that SP0845 is the substrate-binding protein of an ATP-binding cassette (ABC) transporter that is involved in nucleoside uptake with cytidine, uridine, guanosine and inosine as the preferred substrates. Deletion of the gene encoding SP0845 renders pneumococci avirulent suggesting that it is essential for virulence. Immunoblot analysis suggested that SP0845 is expressed in in vitro grown pneumococci and during mice infection. Immunofluorescence microscopy and flow cytometry data indicated that SP0845 is surface exposed in encapsulated strains and accessible to antibodies. Subcutaneous immunization with recombinant SP0845 induced high titer antibodies in mice. Hyperimmune sera raised against SP0845 promoted killing of encapsulated pneumococcal strains in a blood bactericidal assay. Immunization with SP0845 protected mice from intraperitoneal challenge with heterologous pneumococcal serotypes. Based on its surface accessibility, role in virulence and ability to elicit protective immunity, we propose that SP0845 may be a potential candidate for a protein-based pneumococcal vaccine.	[Saxena, Sneha; Khan, Naeem; Dehinwal, Ruchika; Kumar, Ajay; Sehgal, Devinder] Natl Inst Immunol, Mol Immunol Lab, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Sehgal, D (corresponding author), Natl Inst Immunol, Mol Immunol Lab, Aruna Asaf Ali Marg, New Delhi 110067, India.	devinder@nii.ac.in	Dehinwal, Ruchika/GPS-4661-2022; Khan, Naeem/ABB-4214-2021	Dehinwal, Ruchika/0000-0002-7085-4760; 	Department of Biotechnology, Government of India, India [BT/PR13422/BRB/10/759/2009]	Department of Biotechnology, Government of India, India(Department of Biotechnology (DBT) India)	The work reported in this paper was supported by an extramural research grant (BT/PR13422/BRB/10/759/2009) from the Department of Biotechnology (http://dbtindia.nic.in/index.asp), Government of India, India to DS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, Wkly Epidemiol Rec, V87, P129; [Anonymous], 2007, Wkly Epidemiol Rec, V82, P93; Barocchi MA, 2007, VACCINE, V25, P2963, DOI 10.1016/j.vaccine.2007.01.065; Basavanna S, 2009, INFECT IMMUN, V77, P3412, DOI 10.1128/IAI.01543-08; Bergmann S, 2006, MICROBIOL-SGM, V152, P295, DOI 10.1099/mic.0.28610-0; Berry AM, 1996, INFECT IMMUN, V64, P5255, DOI 10.1128/IAI.64.12.5255-5262.1996; Bologa M, 2012, VACCINE, V30, P7461, DOI 10.1016/j.vaccine.2012.10.076; BRILES DE, 1989, INFECT IMMUN, V57, P1457, DOI 10.1128/IAI.57.5.1457-1464.1989; Briles DE, 2003, J INFECT DIS, V188, P339, DOI 10.1086/376571; Briles DE, 2000, J INFECT DIS, V182, P1694, DOI 10.1086/317602; Bryant KA, 2010, PEDIATRICS, V125, P866, DOI 10.1542/peds.2009-1405; Chaffin DO, 1998, GENE, V219, P91, DOI 10.1016/S0378-1119(98)00396-5; Chimalapati S, 2011, INFECT IMMUN, V79, P4965, DOI 10.1128/IAI.05923-11; Dagan R, 2009, VACCINE, V27, pC22, DOI 10.1016/j.vaccine.2009.06.004; Deka RK, 2006, J BIOL CHEM, V281, P8072, DOI 10.1074/jbc.M511405200; Fu Q, 2013, J MICROBIOL BIOTECHN, V23, P579, DOI 10.4014/jmb.1209.09037; Furuya Y, 2013, INFECT IMMUN, V81, P3434, DOI 10.1128/IAI.00408-13; Giefing C, 2008, J EXP MED, V205, P117, DOI 10.1084/jem.20071168; Gladstone RA, 2012, EXPERT REV VACCINES, V11, P889, DOI [10.1586/erv.12.68, 10.1586/ERV.12.68]; Godfroid F, 2011, INFECT IMMUN, V79, P238, DOI 10.1128/IAI.00378-10; Hovenden M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003306; Johnson HL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000348; Johnston JW, 2004, INFECT IMMUN, V72, P5858, DOI 10.1128/IAI.72.10.5858-5867.2004; Jomaa M, 2005, INFECT IMMUN, V73, P6852, DOI 10.1128/IAI.73.10.6852-6859.2005; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kaushik DK, 2008, SCAND J IMMUNOL, V67, P544, DOI 10.1111/j.1365-3083.2008.02107.x; Kovacs-Simon A, 2011, INFECT IMMUN, V79, P548, DOI 10.1128/IAI.00682-10; Ling E, 2004, CLIN EXP IMMUNOL, V138, P290, DOI 10.1111/j.1365-2249.2004.02628.x; Lynch JP, 2009, SEMIN RESP CRIT CARE, V30, P189, DOI 10.1055/s-0029-1202938; Mandi LK, 2012, J CLIN INVEST, V122, P2208, DOI 10.1172/JCI45850; Marra A, 2002, MICROBIOL-SGM, V148, P1483, DOI 10.1099/00221287-148-5-1483; MCDANIEL LS, 1991, INFECT IMMUN, V59, P222, DOI 10.1128/IAI.59.1.222-228.1991; Mera R, 2008, MICROB DRUG RESIST, V14, P101, DOI 10.1089/mdr.2008.0782; Min X, 2012, VACCINE, V30, P3624, DOI 10.1016/j.vaccine.2012.03.042; Miyaji EN, 2013, CELL MOL LIFE SCI, V70, P3303, DOI 10.1007/s00018-012-1234-8; Moffitt KL, 2011, CURR OPIN IMMUNOL, V23, P407, DOI 10.1016/j.coi.2011.04.002; Moffitt KL, 2011, CELL HOST MICROBE, V9, P158, DOI 10.1016/j.chom.2011.01.007; Morsczeck C, 2008, CLIN MICROBIOL INFEC, V14, P74, DOI 10.1111/j.1469-0691.2007.01878.x; Mortz E, 2001, PROTEOMICS, V1, P1359, DOI 10.1002/1615-9861(200111)1:11<1359::AID-PROT1359>3.0.CO;2-Q; Muchnik L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061128; Munoz-Almagro C, 2008, CLIN INFECT DIS, V46, P174, DOI 10.1086/524660; Nieto C, 1997, J BIOL CHEM, V272, P30860, DOI 10.1074/jbc.272.49.30860; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Ogunniyi AD, 2007, INFECT IMMUN, V75, P350, DOI 10.1128/IAI.01103-06; Olafsdottir TA, 2012, INFECT IMMUN, V80, P461, DOI 10.1128/IAI.05801-11; Overweg K, 2000, INFECT IMMUN, V68, P4180, DOI 10.1128/IAI.68.7.4180-4188.2000; Plumptre CD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078916; Pozzi G, 1996, J BACTERIOL, V178, P6087, DOI 10.1128/jb.178.20.6087-6090.1996; Price GA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057269; Prymula R, 2009, EXPERT REV VACCINES, V8, P1479, DOI 10.1586/ERV.09.113; Reffuveille F, 2011, MICROBIOL-SGM, V157, P3001, DOI 10.1099/mic.0.053314-0; Rohatgi S, 2009, J IMMUNOL, V182, P5570, DOI 10.4049/jimmunol.0803254; Rumyantsev AA, 2013, P NATL ACAD SCI USA, V110, P13103, DOI 10.1073/pnas.1306245110; Ryden P, 2013, MOL IMMUNOL, V54, P58, DOI 10.1016/j.molimm.2012.10.043; Seiberling M, 2012, VACCINE, V30, P7455, DOI 10.1016/j.vaccine.2012.10.080; Shevchuk NA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh014; Sutcliffe IC, 2002, MICROBIOL-SGM, V148, P2065, DOI 10.1099/00221287-148-7-2065; Tai SS, 2006, CRIT REV MICROBIOL, V32, P139, DOI 10.1080/10408410600822942; Webb AJ, 2006, J BACTERIOL, V188, P8005, DOI 10.1128/JB.01101-06; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; Wizemann TM, 2001, INFECT IMMUN, V69, P1593, DOI 10.1128/IAI.69.3.1593-1598.2001; Yang H, 2013, J INFECT DIS, V207, P50, DOI 10.1093/infdis/jis651; Zuckert WR, 2014, BBA-MOL CELL RES, V1843, P1509, DOI 10.1016/j.bbamcr.2014.04.022	63	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0118154	10.1371/journal.pone.0118154	http://dx.doi.org/10.1371/journal.pone.0118154			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689507	Green Published, Green Submitted, gold			2022-12-26	WOS:000350322700103
J	Yang, LQ; Li, XY; Li, X; Su, ZC; Zhang, CG; Zhang, HW				Yang, Liqiang; Li, Xinyu; Li, Xu; Su, Zhencheng; Zhang, Chenggang; Zhang, Huiwen			Microbial Community Dynamics during the Bioremediation Process of Chlorimuron-Ethyl-Contaminated Soil by Hansschlegelia sp Strain CHL1	PLOS ONE			English	Article							PHOSPHOLIPID FATTY-ACID; SULFONYLUREA HERBICIDES; METSULFURON-METHYL; ASPERGILLUS-NIGER; TILLAGE SYSTEMS; SOYBEAN FIELD; DIVERSITY; BIODEGRADATION; BACTERIAL; BIOMASS	Long-term and excessive application of chlorimuron-ethyl has led to a series of environmental problems. Strain Hansschlegelia sp. CHL1, a highly efficient chlorimuron-ethyl degrading bacterium isolated in our previous study, was employed in the current soil bioremediation study. The residues of chlorimuron-ethyl in soils were detected, and the changes of soil microbial communities were investigated by phospholipid fatty acid (PLFA) analysis. The results showed that strain CHL1 exhibited significant chlorimuron-ethyl degradation ability at wide range of concentrations between 10 mu g kg(-1) and 1000 mu g kg(-1). High concentrations of chlorimuron-ethyl significantly decreased the total concentration of PLFAs and the Shan-non- Wiener indices and increased the stress level of microbes in soils. The inoculation with strain CHL1, however, reduced the inhibition on soil microbes caused by chlorimuron-ethyl. The results demonstrated that strain CHL1 is effective in the remediation of chlorimuron-ethyl- contaminated soil, and has the potential to remediate chlorimuron-ethyl contaminated soils in situ.	[Yang, Liqiang; Li, Xinyu; Li, Xu; Su, Zhencheng; Zhang, Chenggang; Zhang, Huiwen] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China; [Yang, Liqiang] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, HW (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China.	hwzhang@iae.ac.cn	li, xin/HHS-9461-2022; Li, Lambert LL/F-7146-2015; zhang, hui/GXH-6098-2022; Zhang, Hui/HHN-8494-2022		National High Technology and Development Program (863 Program) of China [2012AA101403]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB15010101]	National High Technology and Development Program (863 Program) of China(National High Technology Research and Development Program of China); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the National High Technology and Development Program (863 Program) of China (2012AA101403) and the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB15010101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen SM, 2001, CHEMOSPHERE, V45, P775, DOI 10.1016/S0045-6535(01)00132-1; Bardgett RD, 1999, SOIL BIOL BIOCHEM, V31, P1021, DOI 10.1016/S0038-0717(99)00016-4; Bardgett RD, 1999, BIOL FERT SOILS, V29, P282, DOI 10.1007/s003740050554; BLACKLOW WM, 1992, AUST J AGR RES, V43, P1157, DOI 10.1071/AR9921157; BLAIR AM, 1988, PESTIC SCI, V22, P195, DOI 10.1002/ps.2780220303; Boschin G, 2003, J ENVIRON SCI HEAL B, V38, P737, DOI 10.1081/PFC-120025557; Byss M, 2008, CHEMOSPHERE, V73, P1518, DOI 10.1016/j.chemosphere.2008.07.030; Cycon M, 2013, APPL SOIL ECOL, V66, P8, DOI 10.1016/j.apsoil.2013.01.014; DERKSEN DA, 1995, WEED RES, V35, P311, DOI 10.1111/j.1365-3180.1995.tb01794.x; Drigo B, 2010, P NATL ACAD SCI USA, V107, P10938, DOI 10.1073/pnas.0912421107; El Fantroussi S, 1999, APPL ENVIRON MICROB, V65, P982; Ellis DE, 2000, ENVIRON SCI TECHNOL, V34, P2254, DOI 10.1021/es990638e; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Garcia-Orenes F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080522; Girvan MS, 2004, APPL ENVIRON MICROB, V70, P2692, DOI 10.1128/AEM.70.5.2692-2701.2004; GUCKERT JB, 1986, APPL ENVIRON MICROB, V52, P794, DOI 10.1128/AEM.52.4.794-801.1986; Hammesfahr U, 2008, SOIL BIOL BIOCHEM, V40, P1583, DOI 10.1016/j.soilbio.2008.01.010; He YH, 2006, J ENVIRON SCI HEAL B, V41, P269, DOI 10.1080/03601230500357298; HEIPIEPER HJ, 1995, CHEMOSPHERE, V30, P1041, DOI 10.1016/0045-6535(95)00015-Z; Herrmann RF, 1997, MICROB ECOL, V33, P78, DOI 10.1007/s002489900010; Kaur A, 2005, CURR SCI INDIA, V89, P1103; Kim YH, 2003, ARCH BIOCHEM BIOPHYS, V416, P209, DOI 10.1016/S0003-9861(03)00297-2; LAMOUREUX GL, 1991, PESTIC BIOCHEM PHYS, V41, P66, DOI 10.1016/0048-3575(91)90061-P; Ma JP, 2009, FEMS MICROBIOL LETT, V296, P203, DOI 10.1111/j.1574-6968.2009.01638.x; Major DW, 2002, ENVIRON SCI TECHNOL, V36, P5106, DOI 10.1021/es0255711; OLSSON PA, 1995, MYCOL RES, V99, P623, DOI 10.1016/S0953-7562(09)80723-5; PETERSEN SO, 1994, APPL ENVIRON MICROB, V60, P2421, DOI 10.1128/AEM.60.7.2421-2430.1994; REDDY KN, 1995, J ENVIRON QUAL, V24, P760, DOI 10.2134/jeq1995.00472425002400040029x; REDDY KN, 1995, J AGR FOOD CHEM, V43, P2752, DOI 10.1021/jf00058a038; Sarmah AK, 2002, J AGR FOOD CHEM, V50, P6253, DOI 10.1021/jf025575p; Sharma S, 2012, FEMS MICROBIOL LETT, V337, P18, DOI 10.1111/1574-6968.12006; Tan HB, 2013, J HAZARD MATER, V260, P368, DOI 10.1016/j.jhazmat.2013.05.043; VESTAL JR, 1989, BIOSCIENCE, V39, P535, DOI 10.2307/1310976; Wang JJ, 2013, ANN MICROBIOL, V63, P335, DOI 10.1007/s13213-012-0479-7; Wang MC, 2008, SOIL BIOL BIOCHEM, V40, P778, DOI 10.1016/j.soilbio.2007.10.012; Xu J, 2013, J ENVIRON SCI HEAL B, V48, P505, DOI 10.1080/03601234.2013.761915; Yang LQ, 2014, J HAZARD MATER, V274, P314, DOI 10.1016/j.jhazmat.2014.04.011; Yang YH, 2000, MICROBIAL ECOL, V39, P72, DOI 10.1007/s002489900180; Ye GB, 2006, CHINESE J ANAL CHEM, V34, P1207, DOI 10.1016/S1872-2040(07)60001-2; Zawoznik MS, 2005, PEST MANAG SCI, V61, P1003, DOI 10.1002/ps.1077; ZELLES L, 1994, SOIL BIOL BIOCHEM, V26, P439, DOI 10.1016/0038-0717(94)90175-9; Zhang CP, 2010, CHEMOSPHERE, V81, P800, DOI 10.1016/j.chemosphere.2010.06.079; Zhang H, 2010, J ENVIRON SCI HEAL B, V45, P501, DOI 10.1080/03601234.2010.493473; Zhang XL, 2011, ENVIRON SCI POLLUT R, V18, P407, DOI 10.1007/s11356-010-0381-4; Zhang XL, 2009, J ENVIRON SCI, V21, P1253, DOI 10.1016/S1001-0742(08)62412-2	45	6	6	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117943	10.1371/journal.pone.0117943	http://dx.doi.org/10.1371/journal.pone.0117943			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689050	Green Published, Green Submitted, gold			2022-12-26	WOS:000350322700086
J	Diaz-Munoz, MD; Bell, SE; Turner, M				Diaz-Munoz, Manuel D.; Bell, Sarah E.; Turner, Martin			Deletion of AU-Rich Elements within the Bcl2 3 ' UTR Reduces Protein Expression and B Cell Survival In Vivo	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; MESSENGER-RNA; LEUKEMIA-CELLS; REVEALS; HUR; NUCLEOLIN; PHOSPHORYLATION; IDENTIFICATION; MAINTENANCE	Post-transcriptional mRNA regulation by RNA binding proteins (RBPs) associated with AU-rich elements (AREs) present in the 30 untranslated region (3'UTR) of specific mRNAs modulates transcript stability and translation in eukaryotic cells. Here we have functionally characterised the importance of the AREs present within the Bcl2 3'UTR in order to maintain Bcl2 expression. Gene targeting deletion of 300 nucleotides of the Bcl2 3' UTR rich in AREs diminishes Bcl2 mRNA stability and protein levels in primary B cells, decreasing cell life-span. Generation of chimeric mice indicates that Bcl2-ARE(Delta/Delta)B cells have an intrinsic competitive disadvantage compared to wild type cells. Biochemical assays and predictions using a bioinformatics approach show that several RBPs bind to the Bcl2 AREs, including AUF1 and HuR proteins. Altogether, association of RBPs to Bcl2 AREs contributes to Bcl2 protein expression by stabilizing Bcl2 mRNA and promotes B cell maintenance.	[Diaz-Munoz, Manuel D.; Bell, Sarah E.; Turner, Martin] Babraham Inst, Lymphocyte Signalling & Dev, Cambridge, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Turner, M (corresponding author), Babraham Inst, Lymphocyte Signalling & Dev, Cambridge, England.	martin.turner@babraham.ac.uk	Diaz-Munoz, Manuel D/H-2080-2018; Diaz-Munoz, Manuel D./AAB-6518-2020; Turner, Martin/N-9976-2014	Diaz-Munoz, Manuel D/0000-0002-9227-7474; Diaz-Munoz, Manuel D./0000-0002-9227-7474; Turner, Martin/0000-0002-3801-9896	Biotechnology and Biological Sciences Research Council; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0407, BBS/E/B/000C0409, BB/J00152X/1] Funding Source: researchfish; BBSRC [BBS/E/B/000C0407, BBS/E/B/000C0409, BB/J00152X/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini F, 2013, BIOINFORMATICS, V29, P2928, DOI 10.1093/bioinformatics/btt495; Allman D, 1996, BLOOD, V87, P5257, DOI 10.1182/blood.V87.12.5257.bloodjournal87125257; Aukema SM, 2011, BLOOD, V117, P2319, DOI 10.1182/blood-2010-09-297879; Bakheet T, 2001, NUCLEIC ACIDS RES, V29, P246, DOI 10.1093/nar/29.1.246; Bose SK, 2006, BIOCHEM J, V396, P99, DOI 10.1042/BJ20051548; DANI C, 1985, P NATL ACAD SCI USA, V82, P4896, DOI 10.1073/pnas.82.15.4896; Donnini M, 2004, J BIOL CHEM, V279, P20154, DOI 10.1074/jbc.M314071200; Ghisolfi L, 2009, J BIOL CHEM, V284, P20946, DOI 10.1074/jbc.M109.023721; Ghosh M, 2009, J CLIN INVEST, V119, P3530, DOI 10.1172/JCI38263; Houzet L, 2001, BLOOD, V98, P1281, DOI 10.1182/blood.V98.5.1281; Hudson BP, 2004, NAT STRUCT MOL BIOL, V11, P257, DOI 10.1038/nsmb738; Ishimaru D, 2010, J BIOL CHEM, V285, P27182, DOI 10.1074/jbc.M109.098830; Ishimaru D, 2009, MOL CANCER RES, V7, P1354, DOI 10.1158/1541-7786.MCR-08-0476; Kelly PN, 2007, BLOOD, V109, P4907, DOI 10.1182/blood-2006-10-051847; Kim HH, 2008, GENE DEV, V22, P1804, DOI 10.1101/gad.1645808; Konig J, 2010, NAT STRUCT MOL BIOL, V17, P909, DOI 10.1038/nsmb.1838; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; Lapucci A, 2002, J BIOL CHEM, V277, P16139, DOI 10.1074/jbc.M201377200; Lebedeva S, 2011, MOL CELL, V43, P340, DOI 10.1016/j.molcel.2011.06.008; Leppek K, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt956; Leskov I, 2013, ONCOGENE, V32, P1066, DOI 10.1038/onc.2012.117; Letai A, 2004, CANCER CELL, V6, P241, DOI 10.1016/j.ccr.2004.07.011; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; MCDONNELL TJ, 1989, CELL, V57, P79, DOI 10.1016/0092-8674(89)90174-8; Meier ID, 2010, FASEB J, V24, P1714, DOI 10.1096/fj.09-140749; Mukherjee N, 2011, MOL CELL, V43, P327, DOI 10.1016/j.molcel.2011.06.007; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Otake Y, 2007, BLOOD, V109, P3069, DOI 10.1182/blood-2006-08-043257; Pandit S, 2013, MOL CELL, V50, P223, DOI 10.1016/j.molcel.2013.03.001; Sadri N, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-1; Schiavone N, 2000, FASEB J, V14, P174, DOI 10.1096/fasebj.14.1.174; Shah N, 2004, BIOINFORMATICS, V20, P636, DOI 10.1093/bioinformatics/btg459; Soundararajan S, 2008, CANCER RES, V68, P2358, DOI 10.1158/0008-5472.CAN-07-5723; Spasic M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002433; STRASSER A, 1990, CURR TOP MICROBIOL, V166, P175; Tiedje C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002977; TSUJIMOTO Y, 1984, SCIENCE, V226, P1097, DOI 10.1126/science.6093263; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; Wilson GM, 2003, J BIOL CHEM, V278, P33029, DOI 10.1074/jbc.M305772200; Xue YC, 2009, MOL CELL, V36, P996, DOI 10.1016/j.molcel.2009.12.003; Zekavati A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102625	42	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0116899	10.1371/journal.pone.0116899	http://dx.doi.org/10.1371/journal.pone.0116899			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25680182	Green Published, gold, Green Submitted			2022-12-26	WOS:000350682600041
J	Wu, YK; Fujishima, K; Kengaku, M				Wu, You Kure; Fujishima, Kazuto; Kengaku, Mineko			Differentiation of Apical and Basal Dendrites in Pyramidal Cells and Granule Cells in Dissociated Hippocampal Cultures	PLOS ONE			English	Article							DENTATE GYRUS; SEMAPHORIN 3A; PROTEIN; EXPRESSION; NEURONS; NEUROGENESIS; MIGRATION; DYNAMICS; REELIN; BRAIN	Hippocampal pyramidal cells and dentate granule cells develop morphologically distinct dendritic arbors, yet also share some common features. Both cell types form a long apical dendrite which extends from the apex of the cell soma, while short basal dendrites are developed only in pyramidal cells. Using quantitative morphometric analyses of mouse hippocampal cultures, we evaluated the differences in dendritic arborization patterns between pyramidal and granule cells. Furthermore, we observed and described the final apical dendrite determination during dendritic polarization by time-lapse imaging. Pyramidal and granule cells in culture exhibited similar dendritic patterns with a single principal dendrite and several minor dendrites so that the cell types were not readily distinguished by appearance. While basal dendrites in granule cells are normally degraded by adulthood in vivo, cultured granule cells retained their minor dendrites. Asymmetric growth of a single principal dendrite harboring the Golgi was observed in both cell types soon after the onset of dendritic growth. Time-lapse imaging revealed that up until the second week in culture, final principal dendrite designation was not stabilized, but was frequently replaced by other minor dendrites. Before dendritic polarity was stabilized, the Golgi moved dynamically within the soma and was repeatedly repositioned at newly emerging principal dendrites. Our results suggest that polarized growth of the apical dendrite is regulated by cell intrinsic programs, while regression of basal dendrites requires cue(s) from the extracellular environment in the dentate gyrus. The apical dendrite designation is determined from among multiple growing dendrites of young developing neurons.	[Wu, You Kure; Kengaku, Mineko] Kyoto Univ, Grad Sch Biostudies, Kyoto, Japan; [Fujishima, Kazuto; Kengaku, Mineko] Kyoto Univ, Inst Integrated Cell Mat Sci WPI ICeMS, Kyoto, Japan	Kyoto University; Kyoto University	Kengaku, M (corresponding author), Kyoto Univ, Grad Sch Biostudies, Kyoto, Japan.	kengaku@icems.kyoto-u.ac.jp			NEXT program of the Japan Society for the Promotion of Science (JSPS); Ministry of Education, Science, Sports and Culture of Japan	NEXT program of the Japan Society for the Promotion of Science (JSPS); Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the NEXT program of the Japan Society for the Promotion of Science (JSPS) and Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan to MK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN J, 1990, J COMP NEUROL, V301, P343, DOI 10.1002/cne.903010303; ALTMAN J, 1990, J COMP NEUROL, V301, P325, DOI 10.1002/cne.903010302; ANGEVINE JAY B., 1965, EXP NEUROL SUPPL, V2, P1; Arikkath J, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00061; Arnold SJ, 2008, GENE DEV, V22, P2479, DOI 10.1101/gad.475408; Baba A, 2002, J NEUROCYTOL, V31, P41, DOI 10.1023/A:1022519632041; BANKER G, 1998, CULTURING NERVE CELL; Barr FA, 1997, CELL, V91, P253, DOI 10.1016/S0092-8674(00)80407-9; BARTHOLOMA A, 1994, MECH DEVELOP, V48, P217, DOI 10.1016/0925-4773(94)90061-2; BAYER SA, 1980, J COMP NEUROL, V190, P87, DOI 10.1002/cne.901900107; BIGNAMI A, 1972, BRAIN RES, V43, P429, DOI 10.1016/0006-8993(72)90398-8; Brandt MD, 2003, MOL CELL NEUROSCI, V24, P603, DOI 10.1016/S1044-7431(03)00207-0; Das SS, 2006, J NEUROSCI, V26, P8115, DOI 10.1523/JNEUROSCI.1015-06.2006; de Anda FC, 2012, NAT NEUROSCI, V15, P1022, DOI 10.1038/nn.3141; Eiraku M, 2005, NAT NEUROSCI, V8, P873, DOI 10.1038/nn1492; Fenstermaker V, 2004, J NEUROBIOL, V58, P403, DOI 10.1002/neu.10304; Fujishima K, 2012, DEVELOPMENT, V139, P3442, DOI 10.1242/dev.081315; Galceran J, 2000, DEVELOPMENT, V127, P469; Galeeva A, 2007, NEUROSCIENCE, V146, P604, DOI 10.1016/j.neuroscience.2007.02.002; Galichet C, 2008, DEVELOPMENT, V135, P2031, DOI 10.1242/dev.015115; Hatanaka Y, 2002, J COMP NEUROL, V454, P1, DOI 10.1002/cne.10421; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Horton AC, 2005, NEURON, V48, P757, DOI 10.1016/j.neuron.2005.11.005; Horton AC, 2006, BRAIN CELL BIOL, V35, P29, DOI 10.1007/s11068-006-9003-y; Iwano T, 2012, DEVELOPMENT, V139, P3051, DOI 10.1242/dev.080002; Jones SP, 2003, HIPPOCAMPUS, V13, P413, DOI 10.1002/hipo.10121; KAUFMAN DL, 1991, J NEUROCHEM, V56, P720, DOI 10.1111/j.1471-4159.1991.tb08211.x; Kitazawa A, 2014, J NEUROSCI, V34, P1115, DOI 10.1523/JNEUROSCI.2254-13.2014; Kurisu J, 2010, J NEUROCHEM, V113, P1598, DOI 10.1111/j.1471-4159.2010.06714.x; Lavado A, 2007, DEV DYNAM, V236, P518, DOI 10.1002/dvdy.21024; Matsuki T, 2008, J CELL SCI, V121, P1869, DOI 10.1242/jcs.027334; Matsuki T, 2010, CELL, V143, P826, DOI 10.1016/j.cell.2010.10.029; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; Meseke M, 2013, EUR J NEUROSCI, V37, P1404, DOI 10.1111/ejn.12153; Nadarajah B, 2003, CEREB CORTEX, V13, P607, DOI 10.1093/cercor/13.6.607; Nakahara S, 2009, HIPPOCAMPUS, V19, P379, DOI 10.1002/hipo.20529; Nakahira E, 2005, J COMP NEUROL, V483, P329, DOI 10.1002/cne.20441; Nakamura F, 2009, J COMP NEUROL, V516, P360, DOI 10.1002/cne.22125; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Niisato E, 2013, DEV NEUROBIOL, V73, P142, DOI 10.1002/dneu.22048; Patel LS, 2004, J NEUROSCI, V24, P9005, DOI 10.1523/JNEUROSCI.2943-04.2004; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Ribak CE, 2000, J COMP NEUROL, V428, P240, DOI 10.1002/1096-9861(20001211)428:2<240::AID-CNE4>3.0.CO;2-Q; Sampo B, 2003, NEURON, V37, P611, DOI 10.1016/S0896-6273(03)00058-8; Schwab MH, 2000, J NEUROSCI, V20, P3714, DOI 10.1523/JNEUROSCI.20-10-03714.2000; SERESS L, 1987, BRAIN RES, V405, P169, DOI 10.1016/0006-8993(87)91003-1; Shapiro LA, 2005, BRAIN RES REV, V48, P43, DOI 10.1016/j.brainresrev.2004.08.003; Spigelman I, 1998, NEUROSCIENCE, V86, P109, DOI 10.1016/S0306-4522(98)00028-1; Srivastava DP, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001350; STANFIELD BB, 1979, J COMP NEUROL, V185, P423, DOI 10.1002/cne.901850303; Tran TS, 2009, NATURE, V462, P1065, DOI 10.1038/nature08628	51	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118482	10.1371/journal.pone.0118482	http://dx.doi.org/10.1371/journal.pone.0118482			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25705877	Green Submitted, Green Published, gold			2022-12-26	WOS:000350662100185
J	Han, XF; Yang, YX; Yan, HL; Wang, XL; Qu, L; Chen, YL				Han, Xufeng; Yang, Yuxin; Yan, Hailong; Wang, Xiaolong; Qu, Lei; Chen, Yulin			Rumen Bacterial Diversity of 80 to 110-Day-Old Goats Using 16S rRNA Sequencing	PLOS ONE			English	Article							GASTROINTESTINAL-TRACT; OIL SUPPLEMENTATION; MICROBIOME; IMPACT; PREVOTELLA; NUMBER; DIET	The ability of rumen microorganisms to use fibrous plant matter plays an important role in ruminant animals; however, little information about rumen colonization by microbial populations after weaning has been reported. In this study, high-throughput sequencing was used to investigate the establishment of this microbial population in 80 to 110-day-old goats. Illumina sequencing of goat rumen samples yielded 101,356,610 nucleotides that were assembled into 256,868 reads with an average read length of 394 nucleotides. Taxonomic analysis of metagenomic reads indicated that the predominant phyla were distinct at different growth stages. The phyla Firmicutes and Synergistetes were predominant in samples taken from 80 to 100-day-old goats, but Bacteroidetes and Firmicutes became the most abundant phyla in samples from 110-day-old animals. There was a remarkable variation in the microbial populations with age; Firmicutes and Synergistetes decreased after weaning, but Bacteroidetes and Proteobacteria increased from 80 to 110 day of age. These findings suggested that colonization of the rumen by microorganisms is related to their function in the rumen digestive system. These results give a better understanding of the role of rumen microbes and the establishment of the microbial population, which help to maintain the host's health and improve animal performance.	[Han, Xufeng; Yang, Yuxin; Wang, Xiaolong; Chen, Yulin] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China; [Yan, Hailong; Qu, Lei] Yulin Univ, Coll Life Sci, Yulin, Shaanxi, Peoples R China	Northwest A&F University - China; Yulin University	Chen, YL (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China.	chenyulindk@163.com	yang, yx/GZM-0464-2022		National Special Research Fund for Nonprofit Sector (Agriculture) [20130305905]; China Agriculture Research System [CARS-40-13]	National Special Research Fund for Nonprofit Sector (Agriculture); China Agriculture Research System	This research was supported by The National Special Research Fund for Nonprofit Sector (Agriculture) (20130305905) and China Agriculture Research System (CARS-40-13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, FRESHWATER FISHERY; [Anonymous], [No title captured]; Bekele AZ, 2010, FEMS MICROBIOL LETT, V305, P49, DOI 10.1111/j.1574-6968.2010.01911.x; Bhatt VD, 2013, MOL BIOL REP, V40, P3363, DOI 10.1007/s11033-012-2411-4; Brown K R, 1977, Trop Doct, V7, P111; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chakravorty S, 2007, J MICROBIOL METH, V69, P330, DOI 10.1016/j.mimet.2007.02.005; CHAO A, 1984, SCAND J STAT, V11, P265; CHAO A, 1992, J AM STAT ASSOC, V87, P210, DOI 10.2307/2290471; Cho YI, 2010, J VET DIAGN INVEST, V22, P509, DOI 10.1177/104063871002200403; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; de Menezes AB, 2011, FEMS MICROBIOL ECOL, V78, P256, DOI 10.1111/j.1574-6941.2011.01151.x; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Fouts DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048289; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; He Li, 2009, Chinese Journal of Applied and Environmental Biology, V15, P414, DOI 10.3724/SP.J.1145.2009.00414; Hespell Robert B., 1997, P59; Huo WJ, 2014, WORLD J MICROB BIOT, V30, P669, DOI 10.1007/s11274-013-1489-8; Jami E, 2013, ISME J, V7, P1069, DOI 10.1038/ismej.2013.2; Jami E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033306; Kehoe SI, 2007, J DAIRY SCI, V90, P4108, DOI 10.3168/jds.2007-0040; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Kong YH, 2010, FEMS MICROBIOL ECOL, V74, P612, DOI 10.1111/j.1574-6941.2010.00977.x; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Li RW, 2012, ENVIRON MICROBIOL, V14, P129, DOI 10.1111/j.1462-2920.2011.02543.x; Mackie RI, 2002, INTEGR COMP BIOL, V42, P319, DOI 10.1093/icb/42.2.319; MORRILL JL, 1995, J DAIRY SCI, V78, P902, DOI 10.3168/jds.S0022-0302(95)76704-2; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Quast C., 2012, NUCLEIC ACIDS RES, V41, pD590, DOI DOI 10.1093/NAR/GKS1219; Rajendhran J, 2011, MICROBIOL RES, V166, P99, DOI 10.1016/j.micres.2010.02.003; Rawls JF, 2004, P NATL ACAD SCI USA, V101, P4596, DOI 10.1073/pnas.0400706101; Signorini ML, 2012, RES VET SCI, V93, P250, DOI 10.1016/j.rvsc.2011.05.001; Simon C, 2011, APPL ENVIRON MICROB, V77, P1153, DOI 10.1128/AEM.02345-10; Singh KM, 2012, MOL BIOL REP, V39, P4841, DOI 10.1007/s11033-011-1278-0; Stevenson DM, 2007, APPL MICROBIOL BIOT, V75, P165, DOI 10.1007/s00253-006-0802-y; Tomsic B, 2007, CARBOHYD POLYM, V69, P478, DOI 10.1016/j.carbpol.2007.01.003; de Oliveira MNV, 2013, VET MICROBIOL, V164, P307, DOI 10.1016/j.vetmic.2013.02.013; Wang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007401; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; Wu SG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040727, 10.1371/journal.pone.0030440]; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100; Yang SL, 2009, ANIMAL, V3, P1562, DOI 10.1017/S1751731109990462; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zened A, 2013, FEMS MICROBIOL ECOL, V83, P504, DOI 10.1111/1574-6941.12011; Zhao LL, 2013, SCI REP-UK, V3, DOI 10.1038/srep01163	48	65	70	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0117811	10.1371/journal.pone.0117811	http://dx.doi.org/10.1371/journal.pone.0117811			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25700157	gold, Green Submitted, Green Published			2022-12-26	WOS:000349789800028
J	Flores-Trevino, S; Morfin-Otero, R; Rodriguez-Noriega, E; Gonzalez-Diaz, E; Perez-Gomez, HR; Bocanegra-Garcia, V; Vera-Cabrera, L; Garza-Gonzalez, E				Flores-Trevino, Samantha; Morfin-Otero, Rayo; Rodriguez-Noriega, Eduardo; Gonzalez-Diaz, Esteban; Perez-Gomez, Hector R.; Bocanegra-Garcia, Virgilio; Vera-Cabrera, Lucio; Garza-Gonzalez, Elvira			Genetic Diversity of Mycobacterium tuberculosis from Guadalajara, Mexico and Identification of a Rare Multidrug Resistant Beijing Genotype	PLOS ONE			English	Article							LENGTH-POLYMORPHISM PATTERNS; MOLECULAR EPIDEMIOLOGY; STRAINS; STABILITY; DIFFERENTIATION; SPOLIGOTYPES; MONTERREY; COMPLEX; LINEAGE	Determining the genetic diversity of M. tuberculosis strains allows identification of the distinct Mycobacterium tuberculosis genotypes responsible for tuberculosis in different regions. Several studies have reported the genetic diversity of M. tuberculosis strains in Mexico, but little information is available from the state of Jalisco. Therefore, the aim of this study was to determine the genetic diversity of Mycobacterium tuberculosis clinical isolates from Western Mexico. Sixty-eight M. tuberculosis isolates were tested for susceptibility to first-line drugs using manual Mycobacteria Growth Indicator Tube method and genotyped using spoligotyping and IS6110-restriction fragment length polymorphism (RFLP) pattern analyses. Forty-seven (69.1%) isolates were grouped into 10 clusters and 21 isolates displayed single patterns by spoligotyping. Three of the 21 single patterns corresponded to orphan patterns in the SITVITWEB database, and 1 new type that contained 2 isolates was created. The most prevalent lineages were T (38.2%), Haarlem (17.7%), LAM (17.7%), X (7.4%), S (5.9%), EAI (1.5%) and Beijing (1.5%). Six (12.8%) of the clustered isolates were MDR, and type 406 of the Beijing family was among the MDR isolates. Seventeen (26.2%) isolates were grouped into 8 clusters and 48 isolates displayed single patterns by IS6110-RFLP. Combination of IS6110-RFLP and spoligotyping reduced the clustering rate to 20.0%. The results show that T, Haarlem, and LAM are predominant lineages among clinical isolates of M. tuberculosis in Guadalajara, Mexico. Clustering rates indicated low transmission of MDR strains. We detected a rare Beijing genotype, SIT406, which was a highly resistant strain. This is the first report of this Beijing genotype in Latin America.	[Flores-Trevino, Samantha; Garza-Gonzalez, Elvira] Univ Autonoma Nuevo Leon, Hosp Univ Dr Jose Eleuterio Gonzalez, Serv Gastroenterol, Monterrey, Nuevo Leon, Mexico; [Morfin-Otero, Rayo; Rodriguez-Noriega, Eduardo; Gonzalez-Diaz, Esteban; Perez-Gomez, Hector R.] Univ Guadalajara, Hosp Civil Guadalajara, Guadalajara 44430, Jalisco, Mexico; [Morfin-Otero, Rayo; Rodriguez-Noriega, Eduardo; Gonzalez-Diaz, Esteban; Perez-Gomez, Hector R.] Univ Guadalajara, Ctr Univ Ciencias Salud, Inst Patol Infecc & Expt, Guadalajara 44430, Jalisco, Mexico; [Bocanegra-Garcia, Virgilio] Inst Politecn Nacl, Ctr Biotecnolog Genom, Lab Med Conservac, Reynosa, Tamaulipas, Mexico; [Vera-Cabrera, Lucio] Univ Autonoma Nuevo Leon, Hosp Univ Dr Jose Eleuterio Gonzalez, Serv Dermatol, Monterrey, Nuevo Leon, Mexico; [Garza-Gonzalez, Elvira] Univ Autonoma Nuevo Leon, Hosp Univ Dr Jose Eleuterio Gonzalez, Dept Clin Pathol, Monterrey, Nuevo Leon, Mexico	Universidad Autonoma de Nuevo Leon; University Hospital Autonomous University of Nuevo Leon; Universidad de Guadalajara; Universidad de Guadalajara; Instituto Politecnico Nacional - Mexico; Universidad Autonoma de Nuevo Leon; University Hospital Autonomous University of Nuevo Leon; Universidad Autonoma de Nuevo Leon; University Hospital Autonomous University of Nuevo Leon	Garza-Gonzalez, E (corresponding author), Univ Autonoma Nuevo Leon, Hosp Univ Dr Jose Eleuterio Gonzalez, Serv Gastroenterol, Monterrey, Nuevo Leon, Mexico.	elvira_garza_gzz@yahoo.com	Vera-Cabrera, Lucio/AAM-3641-2020; Gonzalez-Diaz, Esteban/GVU-0915-2022; Flores-Treviño, Samantha M/E-8601-2019; Flores-Treviño, Samantha/AAB-4537-2020; Morfín-Otero, Rayo/AAR-8027-2021	Vera-Cabrera, Lucio/0000-0002-0890-9660; Gonzalez-Diaz, Esteban/0000-0002-9743-3739; Flores-Treviño, Samantha M/0000-0003-1259-7425; Flores-Treviño, Samantha/0000-0003-1259-7425; Morfín-Otero, Rayo/0000-0001-9576-1950; Rodriguez-Noriega, Eduardo/0000-0002-1386-4815	Instituto Politecnico Nacional	Instituto Politecnico Nacional	VBG is a COFAA and EDI scholarship recipient of the Instituto Politecnico Nacional. We thank Sergio Lozano-Rodriguez, M.D., from the Hospital Universitario for his review of the manuscript.	Aguilar D, 2010, TUBERCULOSIS, V90, P319, DOI 10.1016/j.tube.2010.08.004; Aleksic E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055423; Barnes PF, 2003, NEW ENGL J MED, V349, P1149, DOI 10.1056/NEJMra021964; Belisle John T., 2008, V465, P1, DOI 10.1007/978-1-59745-207-6_1; Bifani PJ, 2002, TRENDS MICROBIOL, V10, P45, DOI 10.1016/S0966-842X(01)02277-6; Buu TN, 2010, CLIN INFECT DIS, V51, P879, DOI 10.1086/656410; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Fenner L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024737; Flores-Trevino S, 2014, ENFERM INFEC MICR CL, DOI [10.1016/j.eimc.2014.10.020, DOI 10.1016/J.EIMC.2014.10.020]; Flores-Trevino S, 2014, SALUD PUBLICA MEXICO, V56, P63; Hanekom M, 2008, J CLIN MICROBIOL, V46, P3338, DOI 10.1128/JCM.00770-08; Hanekom M, 2011, TUBERCULOSIS, V91, P510, DOI 10.1016/j.tube.2011.07.005; Huard RC, 2003, J CLIN MICROBIOL, V41, P1637, DOI 10.1128/JCM.41.4.1637-1650.2003; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kremer K, 2004, J CLIN MICROBIOL, V42, P4040, DOI 10.1128/JCM.42.9.4040-4049.2004; Lok KH, 2002, EMERG INFECT DIS, V8, P1310, DOI 10.3201/eid0811.020291; Lopez-Alvarez R, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-82; Lopez-Rocha Estela, 2013, BMC Res Notes, V6, P172, DOI 10.1186/1756-0500-6-172; Macias Parra Mercedes, 2011, Tuberc Res Treat, V2011, P239042, DOI 10.1155/2011/239042; Martinez-Gamboa A, 2008, ARCH MED RES, V39, P809, DOI 10.1016/j.arcmed.2008.08.006; Martinez-Guarneros A, 2013, INFECT GENET EVOL, V14, P434, DOI 10.1016/j.meegid.2012.12.024; Molina-Torres CA, 2010, J CLIN MICROBIOL, V48, P448, DOI 10.1128/JCM.01894-09; Murcia MI, 2010, INFECT GENET EVOL, V10, P678, DOI 10.1016/j.meegid.2010.03.010; Nakajima C, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-118; Nava-Aguilera E, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/408375; Niemann S, 2000, J CLIN MICROBIOL, V38, P2563, DOI 10.1128/JCM.38.7.2563-2567.2000; Niemann S, 1999, J CLIN MICROBIOL, V37, P3078, DOI 10.1128/JCM.37.2.409-412.1999; Palomino JC, 1999, INT J TUBERC LUNG D, V3, P344; Parwati I, 2010, LANCET INFECT DIS, V10, P103, DOI 10.1016/S1473-3099(09)70330-5; Petroff SA, 1915, J EXP MED, V21, P38, DOI 10.1084/jem.21.1.38; Quitugua TN, 2002, J CLIN MICROBIOL, V40, P2716, DOI 10.1128/JCM.40.8.2716-2724.2002; Realpe T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093848; Secretaria de Salud (Mexico), 2012, PERF EP TUB MEX SIST; Tsolaki AG, 2005, J CLIN MICROBIOL, V43, P3185, DOI 10.1128/JCM.43.7.3185-3191.2005; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; VANSOOLINGEN D, 1995, J CLIN MICROBIOL, V33, P3234, DOI 10.1128/JCM.33.12.3234-3238.1995; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; World Health Organization, 2012, WHOHTMTB201116; Yang ZH, 2001, INT J TUBERC LUNG D, V5, P313; Zazueta-Beltran J, 2009, J INFECT DEV COUNTR, V3, P162	41	17	20	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0118095	10.1371/journal.pone.0118095	http://dx.doi.org/10.1371/journal.pone.0118095			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695431	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000350062300042
J	Jiang, DD; Dumur, CI; Massey, HD; Ramakrishnan, V; Subler, MA; Windle, JJ				Jiang, Dadi; Dumur, Catherine I.; Massey, H. Davis; Ramakrishnan, Viswanathan; Subler, Mark A.; Windle, Jolene J.			Comparison of Effects of p53 Null and Gainof-Function Mutations on Salivary Tumors in MMTV-Hras Transgenic Mice	PLOS ONE			English	Article							P53-INDEPENDENT APOPTOTIC PATHWAYS; OF-FUNCTION PHENOTYPE; LI-FRAUMENI-SYNDROME; MUTANT P53; IN-VIVO; GENE-EXPRESSION; BREAST-CANCER; MOUSE MODELS; GENOMIC INSTABILITY; FAMILIAL SYNDROME	p53 is an important tumor suppressor gene which is mutated in similar to 50% of all human cancers. Some of these mutants appear to have acquired novel functions beyond merely losing wildtype functions. To investigate these gain-of-function effects in vivo, we generated mice of three different genotypes: MMTV-Hras/p53(+/+), MMTV-Hras/p53(-/-), and MMTV-Hras/ p53(R172H/R172H.) Salivary tumors from these mice were characterized with regard to age of tumor onset, tumor growth rates, cell cycle distribution, apoptotic levels, tumor histopathology, as well as response to doxorubicin treatment. Microarray analysis was also performed to profile gene expression. The MMTV-Hras/p53(-/-) and MMTV-Hras/p53(R172H/R172H) mice displayed similar properties with regard to age of tumor onset, tumor growth rates, tumor histopathology, and response to doxorubicin, while both groups were clearly distinct from the MMTV-Hras/p53(+/+) mice by these measurements. In addition, the gene expression profiles of the MMTV-Hras/p53(-/-) and MMTV-Hras/p53(R172H/R172H) tumors were tightly clustered, and clearly distinct from the profiles of the MMTV-Hras/p53(+/+) tumors. Only a small group of genes showing differential expression between the MMTV-Hras/p53(-/-) and MMTVHras/ p53(R172H/R172H) tumors, that did not appear to be regulated by wild-type p53, were identified. Taken together, these results indicate that in this MMTV-Hras-driven salivary tumor model, the major effect of the p53 R172H mutant is due to the loss of wild-type p53 function, with little or no gain-of-function effect on tumorigenesis, which may be explained by the tissue- and tumor type-specific properties of this gain-of-function mutant of p53.	[Jiang, Dadi; Subler, Mark A.; Windle, Jolene J.] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA 23284 USA; [Dumur, Catherine I.; Massey, H. Davis] Virginia Commonwealth Univ, Dept Pathol, Richmond, VA USA; [Dumur, Catherine I.; Massey, H. Davis; Windle, Jolene J.] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA USA; [Ramakrishnan, Viswanathan] Med Univ S Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Medical University of South Carolina	Windle, JJ (corresponding author), Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA 23284 USA.	jjwindle@vcu.edu	Dumur, Catherine/AAH-9489-2020	Windle, Jolene/0000-0001-6690-385X	Department of Defense Breast Cancer Research Program [BC981128]; VCU Massey Cancer Center Pilot Project Grant; Start-up funds	Department of Defense Breast Cancer Research Program(United States Department of Defense); VCU Massey Cancer Center Pilot Project Grant; Start-up funds	Support was provided by the Department of Defense Breast Cancer Research Program - grant # BC981128 (to JJW) [http://cdmrp.army.mil/funding/bcrp.shtml]; VCU Massey Cancer Center Pilot Project Grant - no # (to JJW and MAS) [https://www.massey. vcu.edu/research/funding/mcc-pilot-project-program/]; and Start-up funds (to JJW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acin S, 2011, J PATHOL, V225, P479, DOI 10.1002/path.2971; Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Attardi LD, 1999, CELL MOL LIFE SCI, V55, P48, DOI 10.1007/s000180050269; Bearss DJ, 2000, ONCOGENE, V19, P1114, DOI 10.1038/sj.onc.1203275; Bertling E, 2004, MOL BIOL CELL, V15, P2324, DOI 10.1091/mbc.E04-01-0048; Bieging KT, 2012, TRENDS CELL BIOL, V22, P97, DOI 10.1016/j.tcb.2011.10.006; Blandino G, 1999, ONCOGENE, V18, P477, DOI 10.1038/sj.onc.1202314; Bossi G, 2006, ONCOGENE, V25, P304, DOI 10.1038/sj.onc.1209026; Bossi G, 2008, CELL CYCLE, V7, P1870, DOI 10.4161/cc.7.12.6161; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Broz DK, 2010, CARCINOGENESIS, V31, P1311, DOI 10.1093/carcin/bgp331; CHEN PL, 1990, SCIENCE, V250, P1576, DOI 10.1126/science.2274789; Chicas A, 2000, BIOCHEM BIOPH RES CO, V279, P383, DOI 10.1006/bbrc.2000.3965; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; Desagher S, 2001, MOL CELL, V8, P601, DOI 10.1016/S1097-2765(01)00335-5; Di Agostino S, 2006, CANCER CELL, V10, P191, DOI 10.1016/j.ccr.2006.08.013; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; El-Hizawi S, 2002, CANCER RES, V62, P3264; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; Freed-Pastor WA, 2012, CELL, V148, P244, DOI 10.1016/j.cell.2011.12.017; Gallagher WM, 1999, ONCOGENE, V18, P3608, DOI 10.1038/sj.onc.1202937; Gohler T, 2005, NUCLEIC ACIDS RES, V33, P1087, DOI 10.1093/nar/gki252; Gualberto A, 1998, P NATL ACAD SCI USA, V95, P5166, DOI 10.1073/pnas.95.9.5166; GUALBERTO A, 1995, J BIOL CHEM, V270, P19680, DOI 10.1074/jbc.270.34.19680; Habelhah H, 1999, ONCOGENE, V18, P1771, DOI 10.1038/sj.onc.1202465; HSIAO M, 1994, AM J PATHOL, V145, P702; Hundley JE, 1997, MOL CELL BIOL, V17, P723, DOI 10.1128/MCB.17.2.723; Iwamoto KS, 1996, CANCER RES, V56, P3862; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jiang JH, 2007, MOL CELL BIOL, V27, P8770, DOI 10.1128/MCB.02302-06; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Lanyi A, 1998, ONCOGENE, V16, P3169, DOI 10.1038/sj.onc.1201857; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li BL, 1998, ONCOGENE, V16, P997, DOI 10.1038/sj.onc.1201621; LI FP, 1969, ANN INTERN MED, V71, P747, DOI 10.7326/0003-4819-71-4-747; LI FP, 1969, J NATL CANCER I, V43, P1365; Li RZ, 1998, ONCOGENE, V16, P3269, DOI 10.1038/sj.onc.1201867; Liu G, 2000, P NATL ACAD SCI USA, V97, P4174, DOI 10.1073/pnas.97.8.4174; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; Matas D, 2001, EMBO J, V20, P4163, DOI 10.1093/emboj/20.15.4163; Muller PAJ, 2014, CANCER CELL, V25, P304, DOI 10.1016/j.ccr.2014.01.021; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Murphy KL, 2000, FASEB J, V14, P2291, DOI 10.1096/fj.00-0128com; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; O'Farrell TJ, 2004, CANCER RES, V64, P8199, DOI 10.1158/0008-5472.CAN-03-3639; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Oren M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001107; Peled A, 1996, CANCER RES, V56, P2148; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Poser I, 2004, ONCOGENE, V23, P6115, DOI 10.1038/sj.onc.1207797; PURDIE CA, 1994, ONCOGENE, V9, P603; Ravi R, 2002, CANCER RES, V62, P4180; Sampath J, 2001, J BIOL CHEM, V276, P39359, DOI 10.1074/jbc.M103429200; Sarig R, 2010, J EXP MED, V207, P2127, DOI 10.1084/jem.20100797; Scian MJ, 2004, CANCER RES, V64, P7447, DOI 10.1158/0008-5472.CAN-04-1568; Scian MJ, 2004, ONCOGENE, V23, P4430, DOI 10.1038/sj.onc.1207553; SHAULSKY G, 1991, CANCER RES, V51, P5232; Sigal A, 2001, ONCOGENE, V20, P4891, DOI 10.1038/sj.onc.1204724; SINN E, 1987, CELL, V49, P465, DOI 10.1016/0092-8674(87)90449-1; Stambolsky P, 2010, CANCER CELL, V17, P273, DOI 10.1016/j.ccr.2009.11.025; Strano S, 2007, ONCOGENE, V26, P2212, DOI 10.1038/sj.onc.1210296; Suh YA, 2011, CANCER RES, V71, P7168, DOI 10.1158/0008-5472.CAN-11-0459; Tepper CG, 2005, PROSTATE, V65, P375, DOI 10.1002/pros.20308; Terzian T, 2008, GENE DEV, V22, P1337, DOI 10.1101/gad.1662908; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang XJ, 1998, ONCOGENE, V17, P35, DOI 10.1038/sj.onc.1201890; Weisz L, 2007, ONCOGENE, V26, P2202, DOI 10.1038/sj.onc.1210294; Weisz L, 2004, CANCER RES, V64, P8318, DOI 10.1158/0008-5472.CAN-04-1145; Wijnhoven SWP, 2005, CANCER RES, V65, P8166, DOI 10.1158/0008-5472.CAN-05-1650; Will K, 1998, P NATL ACAD SCI USA, V95, P13681, DOI 10.1073/pnas.95.23.13681; WOLF D, 1984, CELL, V38, P119, DOI 10.1016/0092-8674(84)90532-4; Yamane K, 2005, CANCER RES, V65, P4362, DOI 10.1158/0008-5472.CAN-04-3941	73	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0118029	10.1371/journal.pone.0118029	http://dx.doi.org/10.1371/journal.pone.0118029			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695772	Green Submitted, gold, Green Published			2022-12-26	WOS:000350062300038
J	Pedisic, Z; Greblo, Z; Phongsavan, P; Milton, K; Bauman, AE				Pedisic, Zeljko; Greblo, Zrinka; Phongsavan, Philayrath; Milton, Karen; Bauman, Adrian E.			Are Total, Intensity- and Domain-Specific Physical Activity Levels Associated with Life Satisfaction among University Students?	PLOS ONE			English	Article							QUALITY-OF-LIFE; 18-TO 64-YEAR-OLD SWEDES; SELF-RATED HEALTH; LEISURE-TIME; SPORT PARTICIPATION; DEPRESSIVE SYMPTOMS; DOSE-RESPONSE; MENTAL-HEALTH; FOLLOW-UP; EXERCISE	Background Thorough information about the relationship between physical activity (PA) and life satisfaction is still lacking. Therefore, this study examined the cross-sectional relationships between life satisfaction and meeting the World Health Organization (WHO) moderate to vigorous-intensity PA recommendations, total volume and duration of PA, intensity-specific PA (walking, moderate- and vigorous-intensity), domain-specific PA (work, transport-related, domestic, and leisure-time), and 11 domain and intensity-specific PA types among university students. Additionally, we examined the associations between life satisfaction and gender, age, disposable income, community size, smoking, alcohol intake, body mass index (BMI), and self-rated health. Methods The study included a random sample of 1750 university students in Zagreb, Croatia (response rate = 71.7%; 62.4% females; mean age 21.5 +/- 1.8 years), using the International Physical Activity Questionnaire-long form and the Satisfaction with Life Scale. Results Higher life satisfaction was associated with female gender (beta = 0.13; p = < 0.001), younger age (beta = -0.07; p = 0.024), higher disposable income (beta = 0.10; p = 0.001), and better self-rated health (beta = 0.30; p = <0.001). No significant association was found between life satisfaction and size of community (p = 0.567), smoking status (p = 0.056), alcohol consumption (p = 0.058), or BMI (p = 0.508). Among all PA variables, only leisure-time vigorous-intensity PA was significantly associated with life satisfaction after adjustments for socio-demographic characteristics, lifestyle and self-rated general health (beta = 0.06; p = 0.045). Conclusions This study indicated a weak positive relationship between leisure-time vigorous-intensity PA and life satisfaction, whilst no such association was found for other PA variables. These findings underscore the importance of analyzing domain and intensity-specific PA levels in future studies among university students, as drawing conclusions about the relationship between PA and life satisfaction based on total PA levels only may be misleading.	[Pedisic, Zeljko] Univ Zagreb, Fac Kinesiol, Zagreb 41000, Croatia; [Pedisic, Zeljko; Phongsavan, Philayrath; Milton, Karen; Bauman, Adrian E.] Univ Sydney, Sydney Sch Publ Hlth, Prevent Res Collaborat, Sydney, NSW 2006, Australia; [Greblo, Zrinka] Univ Zagreb, Ctr Croatian Studies, Dept Psychol, Zagreb 41000, Croatia	University of Zagreb; University of Zagreb, Faculty of Kinesiology; University of Sydney; University of Zagreb	Pedisic, Z (corresponding author), Univ Zagreb, Fac Kinesiol, Zagreb 41000, Croatia.	zeljko.pedisic@kif.hr		Phongsavan, Philayrath/0000-0003-2460-5031; Pedisic, Zeljko/0000-0003-2886-3556; Milton, Karen/0000-0002-0506-2214	Faculty of Kinesiology, University of Zagreb	Faculty of Kinesiology, University of Zagreb	This study was funded by the Faculty of Kinesiology, University of Zagreb. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BAF, 2008, J CARDIOVASC NURS, V23, P90, DOI 10.1097/01.JCN.0000305074.43775.d8; Asztalos M, 2010, PUBLIC HEALTH NUTR, V13, P1207, DOI 10.1017/S1368980009992825; Bento TC, 2014, EUR J SPORT SCI, V14, pS352, DOI 10.1080/17461391.2012.704081; Bjarnason T, 2012, CHILD SOC, V26, P51, DOI 10.1111/j.1099-0860.2010.00324.x; Bohnke P, 2008, SOC INDIC RES, V87, P189, DOI 10.1007/s11205-007-9169-4; Bustamante EE, 2013, MENT HEALTH PHYS ACT, V6, P69, DOI 10.1016/j.mhpa.2013.05.001; Campbell A, 2009, J HEALTH PSYCHOL, V14, P780, DOI 10.1177/1359105309338977; Castillo I, 2009, REV PANAM SALUD PUBL, V26, P334, DOI 10.1590/S1020-49892009001000008; Cerin E., 2009, MENTAL HLTH PHYS ACT, V2, P55, DOI [10.1016/j.mhpa.2009.09.004, DOI 10.1016/J.MHPA.2009.09.004]; Chow HPH, 2005, SOC INDIC RES, V70, P139, DOI 10.1007/s11205-004-7526-0; Clark SD, 1999, J SOC BEHAV PERS, V14, P221; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Collins AL, 2009, PSYCHOL AGING, V24, P696, DOI 10.1037/a0016777; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Cummins RA, 1998, SOC INDIC RES, V43, P307, DOI 10.1023/A:1006831107052; De Vos J, 2013, TRANSPORT REV, V33, P421, DOI 10.1080/01441647.2013.815665; Della Giusta M, 2011, FEM ECON, V17, P1, DOI 10.1080/13545701.2011.582028; Diener E, 1999, PSYCHOL BULL, V125, P276, DOI 10.1037//0033-2909.125.2.276; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Diener E., 2000, J HAPPINESS STUD, V1, P41, DOI [10.1023/A:1010076127199, DOI 10.1023/A:1010076127199]; Driver HS, 2000, SLEEP MED REV, V4, P387, DOI 10.1053/smrv.2000.0110; Eid M, 2004, SOC INDIC RES, V65, P245, DOI 10.1023/B:SOCI.0000003801.89195.bc; Eime R, 2014, J PHYS ACT HEALTH, V11, P330, DOI 10.1123/jpah.2012-0073; Eime RM, 2010, MED SCI SPORT EXER, V42, P1022, DOI 10.1249/MSS.0b013e3181c3adaa; Elavsky S, 2005, ANN BEHAV MED, V30, P138, DOI 10.1207/s15324796abm3002_6; Fugl-Meyer AR, 2002, J REHABIL MED, V34, P239, DOI 10.1080/165019702760279242; GEORGE LK, 1985, RES AGING, V7, P209, DOI 10.1177/0164027585007002004; Gilman R, 2003, SCHOOL PSYCHOL QUART, V18, P192, DOI 10.1521/scpq.18.2.192.21858; Gilman R, 2008, J YOUTH ADOLESCENCE, V37, P142, DOI 10.1007/s10964-007-9172-8; Grant N, 2009, INT J BEHAV MED, V16, P259, DOI 10.1007/s12529-009-9032-x; Greenleaf C, 2009, SEX ROLES, V61, P714, DOI 10.1007/s11199-009-9671-z; Hamer Mark, 2012, Methods Mol Biol, V934, P89, DOI 10.1007/978-1-62703-071-7_5; HAVIGHURST RJ, 1961, GERONTOLOGIST, V1, P8, DOI 10.1093/geront/1.1.8; Hawker CL, 2012, NURS EDUC TODAY, V32, P325, DOI 10.1016/j.nedt.2011.07.013; HOLSTEIN B E, 1990, Ugeskrift for Laeger, V152, P2721; International Physical Activity Questionnaire, 2005, INT PHYS ACT QUEST; Joseph RP, 2014, QUAL LIFE RES, V23, P661, DOI 10.1007/s11136-013-0492-8; Jurakic D, 2010, QUAL LIFE RES, V19, P1303, DOI 10.1007/s11136-010-9705-6; Koivumaa-Honkanen H, 2004, SOC PSYCH PSYCH EPID, V39, P994, DOI 10.1007/s00127-004-0833-6; Koivumaa-Honkanen H, 2001, AM J PSYCHIAT, V158, P433, DOI 10.1176/appi.ajp.158.3.433; Koivumaa-Honkanen H, 2000, AM J EPIDEMIOL, V152, P983, DOI 10.1093/aje/152.10.983; Korkeila M, 1998, INT J OBESITY, V22, P949, DOI 10.1038/sj.ijo.0800694; Ku PW, 2014, SOC INDIC RES, V117, P705, DOI 10.1007/s11205-013-0394-8; Kull M, 2012, HEALTH CARE WOMEN IN, V33, P457, DOI 10.1080/07399332.2011.645968; Laaksonen M, 2006, INT ARCH OCC ENV HEA, V79, P205, DOI 10.1007/s00420-005-0054-7; Lacruz ME, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-579; Linna MS, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-231; LONGINO CF, 1982, J GERONTOL, V37, P713, DOI 10.1093/geronj/37.6.713; Lyubomirsky S, 2005, PSYCHOL BULL, V131, P803, DOI 10.1037/0033-2909.131.6.803; MacDonald JM, 2005, J INTERPERS VIOLENCE, V20, P1495, DOI 10.1177/0886260505278718; Maher JP, 2014, J SPORT EXERCISE PSY, V36, P166, DOI 10.1123/jsep.2013-0185; Maher JP, 2013, HEALTH PSYCHOL, V32, P647, DOI 10.1037/a0030129; Malebo A, 2007, S AFR J PSYCHOL, V37, P188, DOI 10.1177/008124630703700113; Marks GN, 1999, SOC INDIC RES, V46, P301; McAuley E, 2008, ANN BEHAV MED, V36, P13, DOI 10.1007/s12160-008-9036-9; McKercher C, 2012, MENTAL HLTH PHYS ACT, V5, P50, DOI [10.1186/S12888-014-0238-3, DOI 10.1016/J.MHPA.2012.03.004]; Melin R, 2003, J REHABIL MED, V35, P84, DOI 10.1080/16501970306119; Morgan K, 1998, AGE AGEING, V27, P35, DOI 10.1093/ageing/27.suppl_3.35; Murphy JG, 2005, PSYCHOL ADDICT BEHAV, V19, P184, DOI 10.1037/0893-164X.19.2.184; Nakamura PM, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-98; O'Loughlin EK, 2013, MENT HEALTH PHYS ACT, V6, P155, DOI 10.1016/j.mhpa.2013.07.003; PARKERSON GR, 1990, ACAD MED, V65, P586, DOI 10.1097/00001888-199009000-00009; Pavot W., 2008, J POSIT PSYCHOL, V3, P137, DOI [10.1080/17439760701756946, DOI 10.1080/17439760701756946]; Pavot W, 2009, SOC INDIC RES SER, V39, P101, DOI 10.1007/978-90-481-2354-4_5; Pedisic Z, 2015, BRIT J SPORT MED, V49, P219, DOI 10.1136/bjsports-2013-093407; Pedisic Z, 2011, KINESIOLOGY, V43, P185; Peeters G, 2014, BRIT J SPORT MED, V48, P996, DOI 10.1136/bjsports-2012-091103; Peiro-Velert C, 2008, EUR J SPORT SCI, V8, P163, DOI 10.1080/17461390802020868; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Proctor C, 2011, J POSIT PSYCHOL, V6, P377, DOI 10.1080/17439760.2011.594079; Proctor CL, 2009, J HAPPINESS STUD, V10, P583, DOI 10.1007/s10902-008-9110-9; Rangul V, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-144; Rangul V, 2011, J ADOLESCENT HEALTH, V48, P616, DOI 10.1016/j.jadohealth.2010.09.013; Valadares ALR, 2011, REV ASSOC MED BRAS, V57, P450, DOI 10.1590/S0104-42302011000400021; Rodriguez A, 2008, SOC INDIC RES, V86, P163, DOI 10.1007/s11205-007-9101-y; Sabiston CM, 2008, J SPORT EXERCISE PSY, V30, P3, DOI 10.1123/jsep.30.1.3; Samitz G, 2011, INT J EPIDEMIOL, V40, P1382, DOI 10.1093/ije/dyr112; Schnohr P, 2005, SCAND J MED SCI SPOR, V15, P107, DOI 10.1111/j.1600-0838.2004.00394.x; Spence JC, 2005, J SPORT EXERCISE PSY, V27, P311, DOI 10.1123/jsep.27.3.311; Strine TW, 2008, J COMMUN HEALTH, V33, P40, DOI 10.1007/s10900-007-9066-4; Strohle A, 2009, J NEURAL TRANSM, V116, P777, DOI 10.1007/s00702-008-0092-x; Stubbe JH, 2007, PREV MED, V44, P148, DOI 10.1016/j.ypmed.2006.09.002; Thogersen-Ntoumani C, 2005, PSYCHOL SPORT EXERC, V6, P609, DOI 10.1016/j.psychsport.2004.12.004; Thome Jennifer, 2004, Eat Behav, V5, P337, DOI 10.1016/j.eatbeh.2004.04.002; Trost SG, 2002, MED SCI SPORT EXER, V34, P1996, DOI 10.1097/00005768-200212000-00020; UNGER JB, 1995, AM J HEALTH PROMOT, V9, P340, DOI 10.4278/0890-1171-9.5.340; Vaez M, 2003, J AM COLL HEALTH, V51, P156, DOI 10.1080/07448480309596344; Vaez Marjan, 2006, Work, V26, P167; Valois RF, 2004, J SCHOOL HEALTH, V74, P59, DOI 10.1111/j.1746-1561.2004.tb04201.x; van den Berg AE, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-74; Vassar M, 2008, SOC INDIC RES, V86, P47, DOI 10.1007/s11205-007-9113-7; Veenhoven R., 1984, CONDITIONS HAPPINESS; VILHJALMSSON R, 1992, SOCIOL QUART, V33, P637, DOI 10.1111/j.1533-8525.1992.tb00148.x; Waliczek TM, 2005, HORTSCIENCE, V40, P1360, DOI 10.21273/HORTSCI.40.5.1360; Waller K, 2010, MED SCI SPORT EXER, V42, P658, DOI 10.1249/MSS.0b013e3181bdeea3; Wang F, 2012, AM J EPIDEMIOL, V176, P1095, DOI 10.1093/aje/kws199; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Withall J, 2014, INT J ENV RES PUB HE, V11, P643, DOI 10.3390/ijerph110100643; Zhang J, 2014, ASIAN J PSYCHIATR, V10, P17, DOI 10.1016/j.ajp.2013.06.014; Zullig KJ, 2011, APPL RES QUAL LIFE, V6, P277, DOI 10.1007/s11482-010-9129-z; Zullig KJ, 2009, J HAPPINESS STUD, V10, P229, DOI 10.1007/s10902-007-9077-y	101	25	27	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0118137	10.1371/journal.pone.0118137	http://dx.doi.org/10.1371/journal.pone.0118137			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC0XE	25695492	gold, Green Submitted, Green Published			2022-12-26	WOS:000350062300043
J	Yang, XR; Koltes, JE; Park, CA; Chen, DW; Reecy, JM				Yang, Xuerong; Koltes, James E.; Park, Carissa A.; Chen, Daiwen; Reecy, James M.			Gene Co-Expression Network Analysis Provides Novel Insights into Myostatin Regulation at Three Different Mouse Developmental Timepoints	PLOS ONE			English	Article							MUSCLE-FIBER-TYPE; TRANSCRIPTIONAL REGULATION; THYMOSIN BETA-4; SKELETAL; GROWTH; EXPRESSION; MICE; MASS; DATABASE; TARGET	Myostatin (Mstn) knockout mice exhibit large increases in skeletal muscle mass. However, relatively few of the genes that mediate or modify MSTN effects are known. In this study, we performed co-expression network analysis using whole transcriptome microarray data from MSTN-null and wild-type mice to identify genes involved in important biological processes and pathways related to skeletal muscle and adipose development. Genes differentially expressed between wild-type and MSTN-null mice were further analyzed for shared DNA motifs using DREME. Differentially expressed genes were identified at 13.5 d.p.c. during primary myogenesis and at d35 during postnatal muscle development, but not at 17.5 d.p.c. during secondary myogenesis. In total, 283 and 2034 genes were differentially expressed at 13.5 d.p.c. and d35, respectively. Over-represented transcription factor binding sites in differentially expressed genes included SMAD3, SP1, ZFP187, and PLAGL1. The use of regulatory (RIF) and phenotypic (PIF) impact factor and differential hubbing co-expression analyses identified both known and potentially novel regulators of skeletal muscle growth, including Apobec2, Atp2a2, and Mmp13 at d35 and Sox2, Tmsb4x, and Vdac1 at 13.5 d.p.c. Among the genes with the highest PIF scores were many fiber type specifying genes. The use of RIF, PIF, and differential hubbing analyses identified both known and potentially novel regulators of muscle development. These results provide new details of how MSTN may mediate transcriptional regulation as well as insight into novel regulators of MSTN signal transduction that merit further study regarding their physiological roles in muscle and adipose development.	[Yang, Xuerong; Chen, Daiwen] Sichuan Agr Univ, Inst Anim Nutr, Yaan, Sichuan, Peoples R China; [Yang, Xuerong; Koltes, James E.; Park, Carissa A.; Reecy, James M.] Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA	Sichuan Agricultural University; Iowa State University	Reecy, JM (corresponding author), Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA.	jreecy@iastate.edu		Reecy, James/0000-0003-4602-0990	China Scholarship Council	China Scholarship Council(China Scholarship Council)	XRY was supported by a scholarship from the China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander MS, 2010, DEV BIOL, V337, P396, DOI 10.1016/j.ydbio.2009.11.015; Anflous-Pharayra K, 2007, BBA-BIOENERGETICS, V1767, P136, DOI 10.1016/j.bbabio.2006.11.013; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bailey TL, 2011, BIOINFORMATICS, V27, P1653, DOI 10.1093/bioinformatics/btr261; Bjornstad JL, 2012, CARDIOVASC RES, V93, P100, DOI 10.1093/cvr/cvr294; Bogdanovich S, 2002, NATURE, V420, P418, DOI 10.1038/nature01154; Cheng Y, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-103; Chien YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071900; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Cotten SW, 2014, AM J TRANSL RES, V6, P43; Deng X, 2012, J BIOL CHEM, V287, P20132, DOI 10.1074/jbc.M112.347211; Druet T, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-796; DUXSON MJ, 1989, DEVELOPMENT, V107, P743; Feldman BJ, 2006, P NATL ACAD SCI USA, V103, P15675, DOI 10.1073/pnas.0607501103; Gaarenstroom T., 2014, SEMIN CELL DEV BIOL; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Goodman CA, 2013, MOL ENDOCRINOL; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hudson NJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000382; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jay A, 2013, CARDIOLOGY, V124, P248, DOI 10.1159/000347138; Koesterke L., 2013, P C EXTR SCI ENG DIS; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Lei HQ, 2013, AM J PHYSIOL-CELL PH, V305, pC529, DOI 10.1152/ajpcell.00051.2013; Li L, 2010, ANN ANAT, V192, P275, DOI 10.1016/j.aanat.2010.07.010; Lipskaia L, 2004, BIOL CELL, V96, P55, DOI 10.1016/j.biolcel.2003.11.001; Liu Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.31; Matsakas A, 2010, REJUV RES, V13, P717, DOI 10.1089/rej.2010.1065; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; Newburger DE, 2009, NUCLEIC ACIDS RES, V37, pD77, DOI 10.1093/nar/gkn660; Nikitin A, 2003, BIOINFORMATICS, V19, P2155, DOI 10.1093/bioinformatics/btg290; ONTELL M, 1984, AM J ANAT, V171, P149, DOI 10.1002/aja.1001710203; Parakati R, 2002, J BIOL CHEM, V277, P9278, DOI 10.1074/jbc.M108411200; Parakati R, 2013, J BIOL CHEM, V288, P13876, DOI 10.1074/jbc.M113.457648; Peille AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080741; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Reverter A, 2008, BIOINFORMATICS, V24, P2491, DOI 10.1093/bioinformatics/btn482; Reverter A, 2010, BIOINFORMATICS, V26, P896, DOI 10.1093/bioinformatics/btq051; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Sato Y, 2010, J BIOL CHEM, V285, P7111, DOI 10.1074/jbc.M109.052977; Shoshan-Barmatzt V, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00164; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Spurney CF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008976; Steelman CA, 2006, FASEB J, V20, P580, DOI 10.1096/fj.05-5125fje; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sunadome K, 2011, DEV CELL, V20, P192, DOI 10.1016/j.devcel.2010.12.005; Swift F, 2012, P NATL ACAD SCI USA, V109, P3997, DOI 10.1073/pnas.1120172109; Tokura Y, 2011, J BIOCHEM, V149, P43, DOI 10.1093/jb/mvq115; Turbendian HK, 2013, DEVELOPMENT, V140, P1639, DOI 10.1242/dev.093260; Vangheluwe P, 2006, J MOL CELL CARDIOL, V41, P308, DOI 10.1016/j.yjmcc.2006.05.014; Vonica A, 2011, DEV BIOL, V350, P13, DOI 10.1016/j.ydbio.2010.09.016; Whittle AJ, 2012, CELL, V149, P871, DOI 10.1016/j.cell.2012.02.066; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001	55	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0117607	10.1371/journal.pone.0117607	http://dx.doi.org/10.1371/journal.pone.0117607			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695797	Green Published, Green Submitted, gold			2022-12-26	WOS:000350062300024
J	Pan, HS; Liu, B; Lu, YH; Wyckhuys, KAG				Pan, Hongsheng; Liu, Bing; Lu, Yanhui; Wyckhuys, Kris A. G.			Seasonal Alterations in Host Range and Fidelity in the Polyphagous Mirid Bug, Apolygus lucorum (Heteroptera: Miridae)	PLOS ONE			English	Article							TARNISHED PLANT BUG; HEMIPTERA-MIRIDAE; PEST-MANAGEMENT; BT COTTON; OVIPOSITION BEHAVIOR; PHYTOPHAGOUS INSECTS; NORTHERN CHINA; CENTRAL TEXAS; DIET BREADTH; PERFORMANCE	In herbivorous insects, host plant switching is commonly observed and plays an important role in their annual life cycle. However, much remains to be learned about seasonal host switching of various pestiferous arthropods under natural conditions. From 2006 until 2012, we assessed Apolygus lucorum (Meyer-Dr) host plant use in successive spring, summer and winter seasons at one single location (Langfang, China). Data were used to quantify changes in host plant breadth and host fidelity between seasons. Host fidelity of A. lucorum differed between seasons, with 87.9% of spring hosts also used in the summer and 36.1% of summer hosts used in winter. In contrast, as little as 25.6% host plant species were shared between winter and spring. Annual herbaceous plants are most often used for over-wintering, while perennial woody plants are relatively important for initial population build-up in the spring. Our study contributes to an improved understanding of evolutionary interactions between A. lucorum and its host plants and lays the groundwork for the design of population management strategies for this important pest in myriad crops.	[Pan, Hongsheng; Liu, Bing; Lu, Yanhui] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Wyckhuys, Kris A. G.] Int Ctr Trop Agr CIAT Asia, Hanoi, Vietnam	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Lu, YH (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	yhlu@ippcaas.cn	Wyckhuys, Kris/AAJ-4352-2020	Wyckhuys, Kris/0000-0003-0922-488X; Lu, Yanhui/0000-0002-6552-0248	National Basic Research Program of China [2012CB114104]; National Natural Science Funds [31222046, 31321004]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Funds(National Natural Science Foundation of China (NSFC))	This research was supported by the National Basic Research Program of China (No. 2012CB114104) and the National Natural Science Funds (No. 31222046, 31321004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernays E. A., 1994, Host-plant selection by phytophagous insects.; Bernays EA, 2001, ANNU REV ENTOMOL, V46, P703, DOI 10.1146/annurev.ento.46.1.703; Bucheli S, 2002, CLADISTICS, V18, P71, DOI 10.1006/clad.2001.0181; Cane JH, 2006, PLANT-POLLINATOR INTERACTIONS: FROM SPECIALIZATION TO GENERALIZATION, P99; Cao C. Y., 1983, MANAGEMENT COTTON MI; Carriere Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039862; Chen Zhan-Ce, 2010, Acta Entomologica Sinica, V53, P47; CLARIDGE MF, 1978, OECOLOGIA, V37, P247, DOI 10.1007/BF00344995; Cook SM, 2007, ANNU REV ENTOMOL, V52, P375, DOI 10.1146/annurev.ento.52.110405.091407; Craig TP, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P20; Cronin JT, 2001, OIKOS, V93, P312, DOI 10.1034/j.1600-0706.2001.930214.x; Di Giulio M, 2003, ECOL ENTOMOL, V28, P51, DOI 10.1046/j.1365-2311.2002.00488.x; Dong JW, 2013, ARTHROPOD-PLANT INTE, V7, P83, DOI 10.1007/s11829-012-9222-3; Esquivel JF, 2007, ENVIRON ENTOMOL, V36, P725, DOI 10.1603/0046-225X(2007)36[725:HPOTTP]2.0.CO;2; Esquivel JF, 2009, ENVIRON ENTOMOL, V38, P766, DOI 10.1603/022.038.0329; Foster SP, 1997, ANNU REV ENTOMOL, V42, P123, DOI 10.1146/annurev.ento.42.1.123; Franzke A, 2010, ECOL ENTOMOL, V35, P126, DOI 10.1111/j.1365-2311.2009.01168.x; Geng HH, 2012, APPL ENTOMOL ZOOL, V47, P191, DOI 10.1007/s13355-012-0107-9; Gripenberg S, 2007, J ANIM ECOL, V76, P854, DOI 10.1111/j.1365-2656.2007.01261.x; Gripenberg S, 2010, ECOL LETT, V13, P383, DOI 10.1111/j.1461-0248.2009.01433.x; HOLOPAINEN JK, 1991, J APPL ENTOMOL, V111, P484, DOI 10.1111/j.1439-0418.1991.tb00351.x; Hunter MD, 2002, AGR FOREST ENTOMOL, V4, P159, DOI 10.1046/j.1461-9563.2002.00152.x; Kennedy GG, 2000, ANNU REV ENTOMOL, V45, P467, DOI 10.1146/annurev.ento.45.1.467; Kohno K, 2005, ENTOMOL SCI, V8, P313, DOI 10.1111/j.1479-8298.2005.00130.x; Lee KP, 2006, J EXP BIOL, V209, P2076, DOI 10.1242/jeb.02253; Lopez-Vaamonde C, 2003, EVOLUTION, V57, P1804, DOI 10.1111/j.0014-3820.2003.tb00588.x; Lu Y., 2008, BIOL CONTROL COTTON; Lu YH, 2008, CROP PROT, V27, P465, DOI 10.1016/j.cropro.2007.07.017; Lu YH, 2009, CROP PROT, V28, P77, DOI 10.1016/j.cropro.2008.08.018; Lu YH, 2012, J ECON ENTOMOL, V105, P1603, DOI 10.1603/EC12003; Lu YanHui, 2011, Outlooks on Pest Management, V22, P248, DOI 10.1564/22dec02; Lu YH, 2010, CROP PROT, V29, P1026, DOI 10.1016/j.cropro.2010.03.017; Lu YH, 2010, SCIENCE, V328, P1151, DOI 10.1126/science.1187881; Mody K, 2007, ECOLOGY, V88, P1012, DOI 10.1890/06-1338; MORAN NA, 1983, ECOL ENTOMOL, V8, P371, DOI 10.1111/j.1365-2311.1983.tb00517.x; Pan HS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068980; Pan HS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059000; PANIZZI AR, 1993, ENTOMOL EXP APPL, V68, P109, DOI 10.1007/BF02380529; Panizzi AR, 1997, ANNU REV ENTOMOL, V42, P99, DOI 10.1146/annurev.ento.42.1.99; Powell G, 2001, APPL ENTOMOL ZOOL, V36, P259, DOI 10.1303/aez.2001.259; RAUSHER MD, 1987, ECOLOGY, V68, P869, DOI 10.2307/1938358; RENWICK JAA, 1994, ANNU REV ENTOMOL, V39, P377, DOI 10.1146/annurev.en.39.010194.002113; SAS Institute, 2005, SAS STAT US GUID VER; Schoonhoven L. M., 2005, Insect-plant biology; Schwarz J, 2009, J CHEM ECOL, V35, P58, DOI 10.1007/s10886-008-9575-3; Scott D.R., 1977, Bulletin Ent Soc Amer, V23, P19; Scriber JM, 2010, INSECT SCI, V17, P471, DOI 10.1111/j.1744-7917.2010.01357.x; Shelton AM, 2006, ANNU REV ENTOMOL, V51, P285, DOI 10.1146/annurev.ento.51.110104.150959; Simpson S.J., 1990, P111; SINGER MC, 1983, EVOLUTION, V37, P389, DOI 10.1111/j.1558-5646.1983.tb05547.x; Sivakoff FS, 2013, ENTOMOL EXP APPL, V149, P11, DOI 10.1111/eea.12101; SNODGRASS GL, 1984, ENVIRON ENTOMOL, V13, P110, DOI 10.1093/ee/13.1.110; THOMPSON JN, 1991, ANNU REV ENTOMOL, V36, P65, DOI 10.1146/annurev.en.36.010191.000433; Tscharntke T, 2004, ANNU REV ENTOMOL, V49, P405, DOI 10.1146/annurev.ento.49.061802.123339; Unsicker SB, 2008, OECOLOGIA, V156, P313, DOI 10.1007/s00442-008-0973-6; VELASCO LRI, 1993, ENVIRON ENTOMOL, V22, P326, DOI 10.1093/ee/22.2.326; WALDBAUER GP, 1991, ANNU REV ENTOMOL, V36, P43, DOI 10.1146/annurev.en.36.010191.000355; Wang ZR., 1990, FARMLAND WEEDS CHINA; Wheeler Jr A. G., 2001, BIOL PLANT BUGS; WOMACK CL, 1987, ENVIRON ENTOMOL, V16, P1266, DOI 10.1093/ee/16.6.1266; YOUNG OP, 1986, ANN ENTOMOL SOC AM, V79, P747, DOI 10.1093/aesa/79.4.747	61	21	32	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117153	10.1371/journal.pone.0117153	http://dx.doi.org/10.1371/journal.pone.0117153			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692969	Green Published, Green Submitted, gold			2022-12-26	WOS:000350061500040
J	Rewicz, T; Wattier, R; Grabowski, M; Rigaud, T; Bacela-Spychalska, K				Rewicz, Tomasz; Wattier, Remi; Grabowski, Michal; Rigaud, Thierry; Bacela-Spychalska, Karolina			Out of the Black Sea: Phylogeography of the Invasive Killer Shrimp Dikerogammarus villosus across Europe	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; POPULATION-GENETICS; PREDATORY IMPACT; INTRASPECIFIC HYBRIDIZATION; INTERFERENCE COMPETITION; MULTIPLE SOURCES; RANGE EXTENSION; NORTH-AMERICA; F-STATISTICS; ZEBRA MUSSEL	The amphipod Dikerogammarus villosus has colonized most of the European main inland water bodies in less than 20 years, having deteriorating effect on the local benthic communities. Our aim was to reveal the species phylogeography in the native Black Sea area, to define the source populations for the colonization routes in continental Europe and for the newly established UK populations. We tested for the loss of genetic diversity between source and invasive populations as well as along invasion route. We tested also for isolation by distance. Thirty three native and invasive populations were genotyped for mtDNA (COI, 16S) and seven polymorphic nuclear microsatellites to assess cryptic diversity (presence of deeply divergent lineages), historical demography, level of diversity within lineage (e.g., number of alleles), and population structure. A wide range of methods was used, including minimum spanning network, molecular clock, Bayesian clustering and Mantel test. Our results identified that sea level and salinity changes during Pleistocene impacted the species phylogeography in the Black Sea native region with four differentiated populations inhabiting, respectively, the Dnieper, Dniester, Danube deltas and Durungol liman. The invasion of continental Europe is associated with two sources, i.e., the Danube and Dnieper deltas, which gave origin to two independent invasion routes (Western and Eastern) for which no loss of diversity and no isolation by distance were observed. The UK population has originated in the Western Route and, despite very recent colonization, no drastic loss of diversity was observed. The results show that the invasion of the killer shrimp is not associated with the costs of loosing genetic diversity, which may contribute to the success of this invader in the newly colonized areas. Additionally, while it has not yet occurred, it might be expected that future interbreeding between the genetically diversified populations from two independent invasion routes will potentially even enhance this success.	[Rewicz, Tomasz; Grabowski, Michal; Bacela-Spychalska, Karolina] Univ Lodz, Dept Invertebrate Zool & Hydrobiol, Lod, Poland; [Wattier, Remi; Rigaud, Thierry] Univ Bourgogne, Equipe Ecol Evolut, UMR CNRS Biogeosci 6282, Dijon, France	University of Lodz; Universite de Bourgogne	Rewicz, T (corresponding author), Univ Lodz, Dept Invertebrate Zool & Hydrobiol, Lod, Poland.	tomek.rewicz@gmail.com	Wattier, Remi/ABC-3410-2021; Bacela-Spychalska, Karolina/E-4234-2015; Rigaud, Thierry/T-4053-2017; Rewicz, Tomasz/H-5332-2018; Rigaud, Thierry/ABE-2552-2020; Grabowski, Michal/K-1016-2012	Bacela-Spychalska, Karolina/0000-0003-4498-5107; Rigaud, Thierry/0000-0002-0163-6639; Rewicz, Tomasz/0000-0002-2085-4973; Rigaud, Thierry/0000-0002-0163-6639; Grabowski, Michal/0000-0002-4551-3454	Polish Ministry for Science and Higher Education [NN304081535, NN304350139, N N303 579439]; Region Bourgogne [07HCP 59]; French Foreign Office [604506E]	Polish Ministry for Science and Higher Education(Ministry of Science and Higher Education, Poland); Region Bourgogne(Region Bourgogne-Franche-Comte); French Foreign Office	The study was funded within the Polish Ministry for Science and Higher Education grants: sampling (NN304081535, NN304350139, N N303 579439), molecular analysis (NN304350139). Karolina Bacela-Spychalska was funded by a postdoctoral grant from the Region Bourgogne (grant #07HCP 59) and from the French Foreign Office (Programe Egide, grant # 604506E). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency E, 2012, INVASIVE SHRIMP DIKE, V5, P1; Anderson LG, 2014, PLOS ONE, P9, DOI [10.1371/journal.pone.0115916, DOI 10.1371/JOURNAL.PONE.0115916]; Astanei I, 2005, MOL ECOL, V14, P1655, DOI 10.1111/j.1365-294X.2005.02530.x; Audzijonyte A, 2009, DIVERS DISTRIB, V15, P346, DOI 10.1111/j.1472-4642.2008.00541.x; Audzijonyte A, 2008, DIVERS DISTRIB, V14, P179, DOI 10.1111/j.1472-4642.2007.00434.x; Audzijonyte A, 2006, MOL ECOL, V15, P2969, DOI 10.1111/j.1365-294X.2006.03018.x; Ayres D, 2009, BIOL INVASIONS, V11, P1087, DOI 10.1007/s10530-008-9391-2; Bacela Karolina, 2008, Aquatic Invasions, V3, P95, DOI 10.3391/ai.2008.3.1.16; Bacela-Spychalska K, 2013, AQUAT CONSERV, V23, P606, DOI 10.1002/aqc.2329; Badertscher S, 2011, NAT GEOSCI, V4, P236, DOI [10.1038/NGEO1106, 10.1038/ngeo1106]; Badtke M, 2006, KANAL BYDGOSKI; Baele G, 2013, MOL BIOL EVOL, V30, P239, DOI 10.1093/molbev/mss243; Bastrop R, 1998, MOL BIOL EVOL, V15, P97, DOI 10.1093/oxfordjournals.molbev.a025919; Benvenuto C, 2012, EVOL ECOL, V26, P1311, DOI 10.1007/s10682-011-9553-z; bij de Vaate A, 2002, CAN J FISH AQUAT SCI, V59, P1159, DOI 10.1139/F02-098; Boets P, 2013, RIVER RES APPL; Bollache L, 2004, ARCH HYDROBIOL, V160, P57, DOI 10.1127/0003-9136/2004/0160-0057; Bossdorf O, 2005, OECOLOGIA, V144, P1, DOI 10.1007/s00442-005-0070-z; Brooks SJ, 2008, FUND APPL LIMNOL, V172, P183, DOI 10.1127/1863-9135/2008/0172-0183; Brown JE, 2008, MOL ECOL, V17, P2598, DOI 10.1111/j.1365-294X.2008.03777.x; Bruijs MCM, 2001, ARCH HYDROBIOL, V152, P633; Casellato Sandra, 2007, V2, P495; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Costa FO, 2007, CAN J FISH AQUAT SCI, V64, P272, DOI 10.1139/F07-008; Cristescu MEA, 2004, HEREDITY, V92, P197, DOI 10.1038/sj.hdy.6800395; Cristescu MEA, 2003, MOL ECOL, V12, P985, DOI 10.1046/j.1365-294X.2003.01801.x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Devin S, 2004, INT REV HYDROBIOL, V89, P21, DOI 10.1002/iroh.200310667; Dick JTA, 2002, CAN J FISH AQUAT SCI, V59, P1078, DOI 10.1139/F02-074; Diez-del-Molino D, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0082806, DOI 10.1371/JOURNAL.PONE.0082806]; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Dumont HJ, 2000, ADV ECOL RES, V31, P181, DOI 10.1016/S0065-2504(00)31012-1; Dybdahl MF, 2011, BIOL INVASIONS, V13, P1663, DOI 10.1007/s10530-010-9923-4; Estoup A, 2010, MOL ECOL, V19, P4113, DOI 10.1111/j.1365-294X.2010.04773.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Facon B, 2005, J EVOLUTION BIOL, V18, P524, DOI 10.1111/j.1420-9101.2005.00887.x; Fitzpatrick BM, 2012, BIOL INVASIONS, V14, P245, DOI 10.1007/s10530-011-0064-1; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gallardo B, 2013, BIOL CONSERV, V160, P225, DOI 10.1016/j.biocon.2013.02.001; Gallardo B, 2013, J APPL ECOL, V50, P757, DOI 10.1111/1365-2664.12079; Gallardo B, 2013, ECOL APPL, V23, P352, DOI 10.1890/12-1018.1; Gallardo B, 2012, BIOL INVASIONS, V14, P1265, DOI 10.1007/s10530-011-0154-0; Gillis NK, 2009, DIVERS DISTRIB, V15, P784, DOI 10.1111/j.1472-4642.2009.00591.x; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Grabowski Michal, 2007, Aquatic Invasions, V2, P25; Grabowski M, 2007, HYDROBIOLOGIA, V590, P75, DOI 10.1007/s10750-007-0759-6; Grabowski M, 2012, AQUAT INVASIONS, V7, P337, DOI 10.3391/ai.2012.7.3.005; Grabowski M, 2009, BIOL INVASIONS, V11, P2107, DOI 10.1007/s10530-009-9502-8; Hassan M, 2005, J FISH BIOL, V66, P865, DOI 10.1111/j.0022-1112.2005.00643.x; Heled J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-289; Hou ZG, 2007, MOL PHYLOGENET EVOL, V45, P596, DOI 10.1016/j.ympev.2007.06.006; Hou ZG, 2014, ZOOL J LINN SOC-LOND, V170, P591, DOI 10.1111/zoj.12119; Hupalo Kamil, 2014, Lauterbornia, V77, P9; Jazdzewski K., 1980, Crustaceana Supplement (Leiden), P84; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kolbe JJ, 2007, CONSERV BIOL, V21, P1612, DOI 10.1111/j.1523-1739.2007.00826.x; Konikov E, 2007, QUATERN INT, V167, P49, DOI 10.1016/j.quaint.2006.11.012; Lambertini M, 2011, SCIENCE, V333, P404, DOI 10.1126/science.333.6041.404-b; Larson ER, 2012, FRESHWATER BIOL, V57, P1823, DOI 10.1111/j.1365-2427.2012.02841.x; Leberg PL, 2002, MOL ECOL, V11, P2445, DOI 10.1046/j.1365-294X.2002.01612.x; Leuven RSEW, 2009, BIOL INVASIONS, V11, P1989, DOI 10.1007/s10530-009-9491-7; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Luquet E, 2011, BIOL INVASIONS, V13, P1901, DOI 10.1007/s10530-011-0010-2; MacNeil C, 2005, J ZOOL, V267, P31, DOI 10.1017/S0952836905007351; Macneil C, 2013, AQUAT CONSERV, V23, P667, DOI 10.1002/aqc.2337; MacNeil C, 2013, FRESHWATER BIOL, V58, P171, DOI 10.1111/fwb.12048; MacNeil C, 2010, AQUAT INVASIONS, V5, P441, DOI 10.3391/ai.2010.5.4.15; Mamos T, 2014, J ZOOL SYST EVOL RES, V52, P237, DOI 10.1111/jzs.12062; Matsukura K, 2013, BIOL INVASIONS, V15, P2039, DOI 10.1007/s10530-013-0431-1; Meraner A, 2013, MOL ECOL, V22, P5295, DOI 10.1111/mec.12470; Mordukhai-Boltovskoi F.D., 1960, CASPIAN FAUNA AZOV B; Muhlfeld CC, 2009, BIOL LETTERS, V5, P328, DOI 10.1098/rsbl.2009.0033; Muirhead JR, 2008, MOL ECOL, V17, P1020, DOI 10.1111/j.1365-294X.2008.03669.x; Muller JC, 2002, FRESHWATER BIOL, V47, P2039, DOI 10.1046/j.1365-2427.2002.00944.x; Nahavandi N, 2013, MOL PHYLOGENET EVOL, V69, P1063, DOI 10.1016/j.ympev.2013.05.021; Nei M., 2000, MOL EVOLUTION PHYLOG; Neilson ME, 2011, DIVERS DISTRIB, V17, P688, DOI 10.1111/j.1472-4642.2011.00762.x; Ohayon JL, 2007, J FISH BIOL, V71, P360, DOI 10.1111/j.1095-8649.2007.01659.x; Paolucci EM, 2013, DIVERS DISTRIB, V19, P988, DOI 10.1111/ddi.12073; Pilgrim EM, 2013, BIOL INVASIONS, V15, P2415, DOI 10.1007/s10530-013-0462-7; Piscart C, 2011, LIMNOLOGICA, V41, P107, DOI 10.1016/j.limno.2010.09.002; Pockl M, 2007, FRESHWATER BIOL, V52, P50, DOI 10.1111/j.1365-2427.2006.01671.x; Pockl M, 2009, BIOL INVASIONS, V11, P2021, DOI 10.1007/s10530-009-9485-5; Popescu I, 2004, MAR GEOL, V206, P249, DOI 10.1016/j.margeo.2004.03.003; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rewicz T, 2014, MOL BIOL RE IN PRESS; Rewicz T, 2014, AQUAT INVASIONS, V9, P267, DOI 10.3391/ai.2014.9.3.04; Ricciardi A, 2000, TRENDS ECOL EVOL, V15, P62, DOI 10.1016/S0169-5347(99)01745-0; Richardson DM, 2013, DIVERS DISTRIB, V19, P1461, DOI 10.1111/ddi.12150; Rosenthal DM, 2008, MOL ECOL, V17, P4657, DOI 10.1111/j.1365-294X.2008.03844.x; Rousset F, 1997, GENETICS, V145, P1219; Simberloff D, 2013, TRENDS ECOL EVOL, V28, P58, DOI 10.1016/j.tree.2012.07.013; Slothouber Galbreath JGM, 2010, BIOL INVASIONS, V12, P191, DOI 10.1007/s10530-009-9442-3; StatSoft Inc., 2011, STAT DAT AN SOFTW SY; Stepien CA, 2005, RISK ANAL, V25, P1043, DOI 10.1111/j.1539-6924.2005.00655.x; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tompkins DM, 2006, ECOL STU AN, V186, P67; van Riel MC, 2006, HYDROBIOLOGIA, V565, P39, DOI 10.1007/s10750-005-1904-8; van Riel MC, 2009, BIOL INVASIONS, V11, P2119, DOI 10.1007/s10530-009-9486-4; van Riel MC, 2007, ACTA OECOL, V31, P282, DOI 10.1016/j.actao.2006.12.006; Vanderploeg HA, 2002, CAN J FISH AQUAT SCI, V59, P1209, DOI 10.1139/F02-087; Wattier RA, 2006, MOL ECOL NOTES, V6, P487, DOI 10.1111/j.1471-8286.2006.01283.x; Wattier RA, 2007, OIKOS, V116, P1941, DOI [10.1111/j.2007.0030-1299.15921.x, 10.1111/j.0030-1299.2007.15921.x]; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wijnhoven S, 2003, AQUAT ECOL, V37, P151, DOI 10.1023/A:1023982200529; Wysocka A, 2014, J BIOGEOGR, V41, P1758, DOI 10.1111/jbi.12335; Zaiko A, 2009, HELGOLAND MAR RES, V63, P85, DOI 10.1007/s10152-008-0135-6; Zhan AB, 2012, DIVERS DISTRIB, V18, P1042, DOI 10.1111/j.1472-4642.2012.00894.x	111	55	56	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118121	10.1371/journal.pone.0118121	http://dx.doi.org/10.1371/journal.pone.0118121			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692865	Green Published, gold, Green Submitted			2022-12-26	WOS:000350061500099
J	Waghela, BN; Sharma, A; Dhumale, S; Pandey, SM; Pathak, C				Waghela, Bhargav N.; Sharma, Anupama; Dhumale, Suhashini; Pandey, Shashibahl M.; Pathak, Chandramani			Curcumin Conjugated with PLGA Potentiates Sustainability, Anti-Proliferative Activity and Apoptosis in Human Colon Carcinoma Cells	PLOS ONE			English	Article							NF-KAPPA-B; I CLINICAL-TRIAL; COLORECTAL-CANCER; SIGNALING PATHWAY; REACTIVE OXYGEN; INHIBITS GROWTH; GENE-EXPRESSION; BIOAVAILABILITY; PROLIFERATION; SUPPRESSION	Curcumin, an ingredient of turmeric, exhibits a variety of biological activities such as anti-inflammatory, anti-atherosclerotic, anti-proliferative, anti-oxidant, anti-cancer and anti-metastatic. It is a highly pleiotropic molecule that inhibits cell proliferation and induces apoptosis in cancer cells. Despite its imperative biological activities, chemical instability, photo-instability and poor bioavailability limits its utilization as an effective therapeutic agent. Therefore, enhancing the bioavailability of curcumin may improve its therapeutic index for clinical setting. In the present study, we have conjugated curcumin with a biodegradable polymer Poly (D, L-lactic-co-glycolic acid) and evaluated its apoptotic potential in human colon carcinoma cells (HCT 116). The results show that curcumin-PLGA conjugate efficiently inhibits cell proliferation and cell survival in human colon carcinoma cells as compared to native curcumin. Additionally, curcumin conjugated with PLGA shows improved cellular uptake and exhibits controlled release at physiological pH as compared to native curcumin. The curcumin-PLGA conjugate efficiently activates the cascade of caspases and promotes intrinsic apoptotic signaling. Thus, the results suggest that conjugation potentiates the sustainability, anti-proliferative and apoptotic activity of curcumin. This approach could be a promising strategy to improve the therapeutic index of cancer therapy.	[Waghela, Bhargav N.; Sharma, Anupama; Dhumale, Suhashini; Pathak, Chandramani] Indian Inst Adv Res, Dept Cell Biol, Gandhinagar, Gujarat, India; [Pandey, Shashibahl M.] Smt CHM Coll, Dept Zool, Ulhasnagar, Maharashtra, India		Pathak, C (corresponding author), Indian Inst Adv Res, Dept Cell Biol, Gandhinagar, Gujarat, India.	cmpathak@iiar.res.in	Pathak, Chandramani/E-4662-2016	Pathak, Chandramani/0000-0002-9389-8096	Department of Biotechnology, Ministry of Science & Technology, Government of India	Department of Biotechnology, Ministry of Science & Technology, Government of India(Department of Biotechnology (DBT) India)	This study was supported by grants from the Department of Biotechnology, Ministry of Science & Technology, Government of India.	Aggarwal BB, 2007, ADV EXP MED BIOL, V595, P1; Aggarwal BB, 2009, TRENDS PHARMACOL SCI, V30, P85, DOI 10.1016/j.tips.2008.11.002; Anand P, 2008, BIOCHEM PHARMACOL, V76, P1590, DOI 10.1016/j.bcp.2008.08.008; Anto RJ, 2002, CARCINOGENESIS, V23, P143, DOI 10.1093/carcin/23.1.143; Archana S, 2012, NANOSTRUCTURE SCI TE, P9; Carroll RE, 2011, CANCER PREV RES, V4, P354, DOI 10.1158/1940-6207.CAPR-10-0098; Chen A, 2006, ONCOGENE, V25, P278, DOI [10.1038/sj.onc.1209019, 10.1038/sj.onc.1209573]; Chen HW, 2004, MOL PHARMACOL, V65, P99, DOI 10.1124/mol.65.1.99; Chen QY, 2010, ONCOL REP, V23, P397, DOI 10.3892/or_00000648; Cheng AL, 2001, ANTICANCER RES, V21, P2895; Collett GP, 2004, CARCINOGENESIS, V25, P2183, DOI 10.1093/carcin/bgh233; Danhier F, 2012, J CONTROL RELEASE, V161, P505, DOI 10.1016/j.jconrel.2012.01.043; Dhillon N, 2008, CLIN CANCER RES, V14, P4491, DOI 10.1158/1078-0432.CCR-08-0024; Duncan R, 2006, NAT REV CANCER, V6, P688, DOI 10.1038/nrc1958; Edwards BK, 2010, CANCER-AM CANCER SOC, V116, P544, DOI 10.1002/cncr.24760; Garcea G, 2004, BRIT J CANCER, V90, P1011, DOI 10.1038/sj.bjc.6601623; Goel A, 2008, BIOCHEM PHARMACOL, V75, P787, DOI 10.1016/j.bcp.2007.08.016; Gupta SC, 2013, AAPS J, V15, P195, DOI 10.1208/s12248-012-9432-8; Hu M, 2007, MOL PHARMACEUT, V4, P803, DOI 10.1021/mp7001363; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Kopecek J, 2001, J CONTROL RELEASE, V74, P147, DOI 10.1016/S0168-3659(01)00330-3; Kunnumakkara AB, 2008, CANCER LETT, V269, P199, DOI 10.1016/j.canlet.2008.03.009; Lev-Ari S, 2014, J NUTR BIOCHEM, V25, P843, DOI 10.1016/j.jnutbio.2014.03.014; Liang T, 2014, INT J MOL SCI, V15, P15754, DOI 10.3390/ijms150915754; Mackenzie GG, 2008, INT J CANCER, V123, P56, DOI 10.1002/ijc.23477; Manju S, 2011, J COLLOID INTERF SCI, V359, P318, DOI 10.1016/j.jcis.2011.03.071; Minear S, 2011, EUKARYOT CELL, V10, P1574, DOI 10.1128/EC.05163-11; Nair KL, 2012, INT J PHARMACEUT, V425, P44, DOI 10.1016/j.ijpharm.2012.01.003; Park S, 2013, MOL CELL BIOCHEM, V383, P39, DOI 10.1007/s11010-013-1752-1; Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387; Ranjan K, 2014, BIOFACTORS, V40, P157, DOI 10.1002/biof.1098; Shakibaei M, 2007, BIOCHEM PHARMACOL, V73, P1434, DOI 10.1016/j.bcp.2007.01.005; Shankar Sharmila, 2007, J Mol Signal, V2, P10, DOI 10.1186/1750-2187-2-10; Sharma RA, 2001, CLIN CANCER RES, V7, P1894; Sharma RA, 2004, CLIN CANCER RES, V10, P6847, DOI 10.1158/1078-0432.CCR-04-0744; Shehzad A, 2010, DRUG TODAY, V46, P523, DOI 10.1358/dot.2010.46.7.1509560; Shen HM, 2006, FREE RADICAL BIO MED, V40, P928, DOI 10.1016/j.freeradbiomed.2005.10.056; Simon A, 1998, CANCER LETT, V129, P111, DOI 10.1016/S0304-3835(98)00092-5; Strimpakos AS, 2008, ANTIOXID REDOX SIGN, V10, P511, DOI 10.1089/ars.2007.1769; Sung B, 2009, MOL CANCER THER, V8, P959, DOI 10.1158/1535-7163.MCT-08-0905; Tang HD, 2010, BIOMATERIALS, V31, P7139, DOI 10.1016/j.biomaterials.2010.06.007; Watson JL, 2010, CANCER LETT, V297, P1, DOI 10.1016/j.canlet.2010.04.018; Wright JS, 2002, J MOL STRUC-THEOCHEM, V591, P10; Zhang CL, 2010, J INVEST DERMATOL, V130, P2110, DOI 10.1038/jid.2010.86; Zikaki K, 2014, APOPTOSIS, V19, P958, DOI 10.1007/s10495-014-0979-y	45	52	56	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117526	10.1371/journal.pone.0117526	http://dx.doi.org/10.1371/journal.pone.0117526			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692854	Green Submitted, gold, Green Published			2022-12-26	WOS:000350061500059
J	Deuschl, C; Goricke, S; Gramsch, C; Ozkan, N; Lehnerdt, G; Kastrup, O; Ringelstein, A; Wanke, I; Forsting, M; Schlamann, M				Deuschl, Cornelius; Goericke, Sophia; Gramsch, Carolin; Oezkan, Neriman; Lehnerdt, Goetz; Kastrup, Oliver; Ringelstein, Adrian; Wanke, Isabel; Forsting, Michael; Schlamann, Marc			Value of DSA in the Diagnostic Workup of Pulsatile Tinnitus	PLOS ONE			English	Article							DURAL ARTERIOVENOUS-FISTULAS; MR-ANGIOGRAPHY; VENOUS DRAINAGE; CLASSIFICATION; MALFORMATIONS; EXPERIENCE	Objectives Pulsatile tinnitus (PT) is a rare complaint, but can be a symptom of life-threatening disease. It is often caused by vascular pathologies, e.g. dural arteriovenous fistula (dAVF), arteriovenous malformation (AVM) or vascularized tumors. The current diagnostic pathway includes clinical examination, cranial MRI and additional DSA. The aim of this study was to evaluate the diagnostic impact of DSA in the diagnostic workup of patients with PT in comparison to MRI alone. Methods Retrospectively, 54 consecutive patients with pulsatile tinnitus were evaluated. All patients had a diagnostic workup including cranial MRI and DSA. MRI examinations were blinded to the results of DSA and retrospectively analyzed in consensus by two experienced neuroradiologists. The MR-examinations were evaluated for each performed sequence separately: time-of-flight-angiography, ce-MRA, T2, ce-T1-sequence and ce-T1-sequence with fat saturation. Results 37 of the 54 patients revealed a pathology explaining PT on MRI, which was detected by the readers in 100% and proofed by means of DSA. 24 dAVF, four paraganglioma, two AVM and seven more pathologies were described. All patients without pathology on MRI did also not show any pathology in DSA. Conclusions MR imaging is sufficient to exclude pathology in patients with pulsatile tinnitus.	[Deuschl, Cornelius; Goericke, Sophia; Gramsch, Carolin; Ringelstein, Adrian; Wanke, Isabel; Forsting, Michael; Schlamann, Marc] Univ Hosp Essen, Inst Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany; [Oezkan, Neriman] Univ Hosp Essen, Clin Neurosurg, Essen, Germany; [Lehnerdt, Goetz] Univ Hosp Essen, Clin Otolaryngol, Essen, Germany; [Kastrup, Oliver] Univ Hosp Essen, Neurol Clin, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen	Deuschl, C (corresponding author), Univ Hosp Essen, Inst Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany.	Cornelius.Deuschl@uk-essen.de						BORDEN JA, 1995, J NEUROSURG, V82, P166, DOI 10.3171/jns.1995.82.2.0166; COCHRAN JH, 1979, ANN OTO RHINOL LARYN, V88, P297, DOI 10.1177/000348947908800226; COGNARD C, 1995, RADIOLOGY, V194, P671, DOI 10.1148/radiology.194.3.7862961; DIETZ RR, 1994, AM J NEURORADIOL, V15, P879; Farb RI, 2009, AM J NEURORADIOL, V30, P1546, DOI 10.3174/ajnr.A1646; Geibprasert S, 2009, AM J NEURORADIOL, V30, P1459, DOI 10.3174/ajnr.A1500; Hofmann E, 2013, DTSCH ARZTEBL INT, V110, P451, DOI 10.3238/arztebl.2013.0451; JUNGREIS CA, 1991, ANN OTO RHINOL LARYN, V100, P951, DOI 10.1177/000348949110001116; Letourneau-Guillon L, 2012, AM J NEURORADIOL, V33, P301, DOI 10.3174/ajnr.A2777; Madani G, 2009, CLIN RADIOL, V64, P319, DOI 10.1016/j.crad.2008.08.014; Mattox DE, 2008, ACTA OTO-LARYNGOL, V128, P427, DOI 10.1080/00016480701840106; Meckel S, 2007, AM J NEURORADIOL, V28, P877; Noguchi K, 2010, AM J NEURORADIOL, V31, P1903, DOI 10.3174/ajnr.A2231; REMLEY KB, 1990, RADIOLOGY, V174, P383, DOI 10.1148/radiology.174.2.2296650; Saini J, 2009, AJNR Am J Neuroradiol, V30, pE6, DOI 10.3174/ajnr.A1265; Seeger A, 2014, CLIN NEURORADIOL, DOI [10.1007/s00062-014-0358-7, DOI 10.1007/S00062-014-0358-7]; SILA CA, 1987, STROKE, V18, P252, DOI 10.1161/01.STR.18.1.252; SISMANIS A, 1994, LARYNGOSCOPE, V104, P681; Sismanis A, 1998, AM J OTOL, V19, P472; Soderman M, 2008, STROKE, V39, P1735, DOI 10.1161/STROKEAHA.107.506485; Waldvogel D, 1998, J NEUROL, V245, P137, DOI 10.1007/s004150050193; Wu HM, 2014, J MAGN RESON IMAGING, V39, P1320, DOI 10.1002/jmri.24279; YARDLEY MPJ, 1992, BRIT J CLIN PRACT, V46, P71	23	12	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117814	10.1371/journal.pone.0117814	http://dx.doi.org/10.1371/journal.pone.0117814			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689158	Green Submitted, Green Published, gold			2022-12-26	WOS:000350322700074
J	McCann, MR; Patel, P; Frimpong, A; Xiao, YZ; Siqueira, WL; Seguin, CA				McCann, Matthew R.; Patel, Priya; Frimpong, Agya; Xiao, Yizhi; Siqueira, Walter L.; Seguin, Cheryle A.			Proteomic Signature of the Murine Intervertebral Disc	PLOS ONE			English	Article							HUMAN NUCLEUS PULPOSUS; CARTILAGE CELLS; GENE; DEGENERATION; EXPRESSION; MASS; SOX6; IDENTIFICATION; MICROARRAY; PHENOTYPE	Low back pain is the most common musculoskeletal problem and the single most common cause of disability, often attributed to degeneration of the intervertebral disc. Lack of effective treatment is directly related to our limited understanding of the pathways responsible for maintaining disc health. While transcriptional analysis has permitted initial insights into the biology of the intervertebral disc, complete proteomic characterization is required. We therefore employed liquid chromatography electrospray ionization tandem mass spectrometry (LC-ESI-MS/MS) protein/peptide separation and mass spectrometric analyses to characterize the protein content of intervertebral discs from skeletally mature wild-type mice. A total of 1360 proteins were identified and categorized using PANTHER. Identified proteins were primarily intracellular/plasma membrane (35%), organelle (30%), macromolecular complex (10%), extracellular region (9%). Molecular function categorization resulted in three distinct categories: catalytic activity (33%), binding (molecule interactions) (29%), and structural activity (13%). To validate our list, we confirmed the presence of 14 of 20 previously identified IVD-associated markers, including matrix proteins, transcriptional regulators, and secreted proteins. Immunohistochemical analysis confirmed distinct localization patterns of select protein with the intervertebral disc. Characterization of the protein composition of healthy intervertebral disc tissue is an important first step in identifying cellular processes and pathways disrupted during aging or disease progression.	[McCann, Matthew R.; Patel, Priya; Seguin, Cheryle A.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada; [Frimpong, Agya; Xiao, Yizhi; Siqueira, Walter L.] Univ Western Ontario, Schulich Sch Med & Dent, Sch Dent, London, ON N6A 5C1, Canada; [Frimpong, Agya; Xiao, Yizhi; Siqueira, Walter L.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Biochem, London, ON N6A 5C1, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Seguin, CA (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada.	cheryle.seguin@schulich.uwo.ca	Seguin, Cheryle A/G-4511-2013; McCann, Matthew/V-4127-2019; Siqueira, Walter/ABE-8924-2020; Siqueira, Walter/ABE-4069-2021	Siqueira, Walter/0000-0003-1921-3658; McCann, Matthew/0000-0003-2953-6258; Seguin, Cheryle/0000-0001-6503-9107	Natural Sciences and Engineering Research Council of Canada [RGPIN-371813, 371546]; Canada Foundation for Innovation-Leaders Opportunity Fund [25086, 25116]; CIHR Doctoral Research Award; Joint Motion Program - A CIHR Training Program in Musculoskeletal Health Research and Leadership; CIHR New Investigator Award; Arthritis Society/Canadian Arthritis Network	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation-Leaders Opportunity Fund; CIHR Doctoral Research Award(Canadian Institutes of Health Research (CIHR)); Joint Motion Program - A CIHR Training Program in Musculoskeletal Health Research and Leadership(Canadian Institutes of Health Research (CIHR)); CIHR New Investigator Award(Canadian Institutes of Health Research (CIHR)); Arthritis Society/Canadian Arthritis Network	This work was funded by the Natural Sciences and Engineering Research Council of Canada [RGPIN-371813 to C.A.S and 371546 to W.L.S]. Infrastructure was provided by the Canada Foundation for Innovation-Leaders Opportunity Fund [25086 to C.A.S and 25116 to W.L.S.]. M.R.M. is the recipient of a CIHR Doctoral Research Award and is supported by the Joint Motion Program - A CIHR Training Program in Musculoskeletal Health Research and Leadership. W.L.S. is the recipient of a CIHR New Investigator Award; C.A.S. is the recipient of a Scholar Award from The Arthritis Society/Canadian Arthritis Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balague F, 2011, LANCET; Bedore J, 2013, ARTHRITIS RHEUM-US, V65, P2634, DOI 10.1002/art.38075; Choi KS, 2008, DEV DYNAM, V237, P3953, DOI 10.1002/dvdy.21805; Elias JE, 2005, NAT METHODS, V2, P667, DOI 10.1038/NMETH785; Ellis K, 2013, J CELL BIOL, V200, P667, DOI 10.1083/jcb.201212095; Fisher LW, 1995, ACTA ORTHOP SCAND, V66, P61, DOI 10.3109/17453679509157649; Foster BL, 2012, INT J ORAL SCI, V4, P119, DOI 10.1038/ijos.2012.57; Friedman BW, 2012, ANN EMERG MED, V59, P128, DOI 10.1016/j.annemergmed.2011.09.012; GOTZ W, 1995, CELL TISSUE RES, V280, P455; Gruber HE, 2005, J HISTOCHEM CYTOCHEM, V53, P1131, DOI 10.1369/jhc.5A6687.2005; He JN, 2006, BONE, V38, P826, DOI 10.1016/j.bone.2005.11.021; Hoy D, 2012, ARTHRITIS RHEUM-US, V64, P2028, DOI 10.1002/art.34347; Jaubert J, 1999, P NATL ACAD SCI USA, V96, P10278, DOI 10.1073/pnas.96.18.10278; JOHNSTONE B, 1993, BIOCHEM J, V292, P661, DOI 10.1042/bj2920661; Kessels MY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090568; Kislinger T, 2010, J PROTEOMICS, V73, P2205, DOI 10.1016/j.jprot.2010.05.004; Lee CR, 2007, EUR SPINE J, V16, P2174, DOI 10.1007/s00586-007-0475-y; Lefebvre V, 2010, INT J BIOCHEM CELL B, V42, P429, DOI 10.1016/j.biocel.2009.07.016; LYONS G, 1981, BIOCHIM BIOPHYS ACTA, V673, P443, DOI 10.1016/0304-4165(81)90476-1; McCann MR, 2011, J CELL COMMUN SIGNAL, V5, P39, DOI 10.1007/s12079-010-0116-9; MCCANN MR, 2011, DIS MODEL MECH; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Millecamps M, 2012, PAIN, V153, P1167, DOI 10.1016/j.pain.2012.01.027; Minogue BM, 2010, ARTHRITIS RHEUM-US, V62, P3695, DOI 10.1002/art.27710; Minogue BM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2929; Ohrt-Nissen S, 2013, CONNECT TISSUE RES, V54, P197, DOI 10.3109/03008207.2013.781594; Olsen CL, 1997, DEVELOPMENT, V124, P3609; Onnerfjord P, 2012, J BIOL CHEM, V287, P18913, DOI 10.1074/jbc.M111.298968; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Poiraudeau S, 1999, SPINE, V24, P837, DOI 10.1097/00007632-199905010-00002; ROBERTS S, 1989, SPINE, V14, P166, DOI 10.1097/00007632-198902000-00005; Rutges J, 2010, OSTEOARTHR CARTILAGE, V18, P416, DOI 10.1016/j.joca.2009.09.009; Sakai D, 2009, SPINE, V34, P1448, DOI 10.1097/BRS.0b013e3181a55705; Siqueira WL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042204; Smith LJ, 2009, EUR SPINE J, V18, P439, DOI 10.1007/s00586-009-0918-8; Smits P, 2003, DEVELOPMENT, V130, P1135, DOI 10.1242/dev.00331; Smits P, 2001, DEV CELL, V1, P277, DOI 10.1016/S1534-5807(01)00003-X; Sohn P, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-29; Spagnoli A, 2007, J CELL BIOL, V177, P1105, DOI 10.1083/jcb.200611031; Tamplin OJ, 2011, DEV BIOL, V360, P415, DOI 10.1016/j.ydbio.2011.10.002; Urban JPG, 2007, J MAGN RESON IMAGING, V25, P419, DOI 10.1002/jmri.20874; Urban JPG, 2003, ARTHRITIS RES THER, V5, P120, DOI 10.1186/ar629; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Williams F.M., 2012, ANN RHEUM DIS; Xiang R, 2004, J PROTEOME RES, V3, P1278, DOI 10.1021/pr049852e	45	19	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117807	10.1371/journal.pone.0117807	http://dx.doi.org/10.1371/journal.pone.0117807			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689066	Green Published, Green Submitted, gold			2022-12-26	WOS:000350322700073
J	McCrudden, CM; O'Rourke, MG; Cherry, KE; Yuen, HF; O'Rourke, D; Babur, M; Telfer, BA; Thomas, HD; Keane, P; Nambirajan, T; Hagan, C; O'Sullivan, JM; Shaw, C; Williams, KJ; Curtin, NJ; Hirst, DG; Robson, T				McCrudden, Cian M.; O'Rourke, Martin G.; Cherry, Kim E.; Yuen, Hiu-Fung; O'Rourke, Declan; Babur, Muhammad; Telfer, Brian A.; Thomas, Huw D.; Keane, Patrick; Nambirajan, Thiagarajan; Hagan, Chris; O'Sullivan, Joe M.; Shaw, Chris; Williams, Kaye J.; Curtin, Nicola J.; Hirst, David G.; Robson, Tracy			Vasoactivity of Rucaparib, a PARP-1 Inhibitor, is a Complex Process that Involves Myosin Light Chain Kinase, P2 Receptors, and PARP Itself	PLOS ONE			English	Article							POLY(ADP-RIBOSE) POLYMERASE-1 INHIBITORS; DEPENDENT PROTEIN-KINASE; SMOOTH-MUSCLE; DNA-REPAIR; NICOTINAMIDE; RADIOSENSITIZATION; AG014699; EFFICACY; MICE; CHEMOPOTENTIATION	Therapeutic inhibition of poly(ADP-ribose) polymerase (PARP), as monotherapy or to supplement the potencies of other agents, is a promising strategy in cancer treatment. We previously reported that the first PARP inhibitor to enter clinical trial, rucaparib (AG014699), induced vasodilation in vivo in xenografts, potentiating response to temozolomide. We now report that rucaparib inhibits the activity of the muscle contraction mediator myosin light chain kinase (MLCK) 10-fold more potently than its commercially available inhibitor ML-9. Moreover, rucaparib produces additive relaxation above the maximal degree achievable with ML-9, suggesting that MLCK inhibition is not solely responsible for dilation. Inhibition of nitric oxide synthesis using L-NMMA also failed to impact rucaparib's activity. Rucaparib contains the nicotinamide pharmacophore, suggesting it may inhibit other NAD+-dependent processes. NAD+ exerts P2 purinergic receptor-dependent inhibition of smooth muscle contraction. Indiscriminate blockade of the P2 purinergic receptors with suramin abrogated rucaparib-induced vasodilation in rat arterial tissue without affecting ML-9-evoked dilation, although the specific receptor subtypes responsible have not been unequivocally identified. Furthermore, dorsal window chamber and real time tumor vessel perfusion analyses in PARP-1(-/-) mice indicate a potential role for PARP in dilation of tumor-recruited vessels. Finally, rucaparib provoked relaxation in 70% of patient-derived tumor-associated vessels. These data provide tantalising evidence of the complexity of the mechanism underlying rucaparib-mediated vasodilation.	[McCrudden, Cian M.; O'Rourke, Martin G.; Cherry, Kim E.; Hirst, David G.; Robson, Tracy] Queens Univ Belfast, Sch Pharm, Belfast, Antrim, North Ireland; [Yuen, Hiu-Fung; O'Sullivan, Joe M.] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland; [O'Rourke, Declan; Keane, Patrick; Nambirajan, Thiagarajan; Hagan, Chris; O'Sullivan, Joe M.] Belfast Hlth & Social Care Trust, Belfast, Antrim, North Ireland; [Babur, Muhammad; Telfer, Brian A.; Williams, Kaye J.] Univ Manchester, Manchester Pharm Sch, Manchester, Lancs, England; [Thomas, Huw D.; Curtin, Nicola J.] Newcastle Univ, Northern Inst Canc Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Queens University Belfast; Queens University Belfast; University of Manchester; Newcastle University - UK	McCrudden, CM (corresponding author), Queens Univ Belfast, Sch Pharm, Belfast, Antrim, North Ireland.	c.mccrudden@qub.ac.uk		Curtin, Nicola/0000-0003-1369-1843; Robson, Tracy/0000-0003-4262-6872; O'Sullivan, Joe/0000-0001-6999-2739	Cancer Research UK [C1278/A5965]	Cancer Research UK(Cancer Research UK)	This work was funded by one Project Grant (C1278/A5965) awarded by Cancer Research UK to CS, DGH, and TR. (http://www.cancerresearchuk.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alano CC, 2010, J NEUROSCI, V30, P2967, DOI 10.1523/JNEUROSCI.5552-09.2010; Ali M, 2011, MOL CANCER THER, V10, P2320, DOI 10.1158/1535-7163.MCT-11-0356; Ali M, 2009, CLIN CANCER RES, V15, P6106, DOI 10.1158/1078-0432.CCR-09-0398; Calabrese CR, 2004, J NATL CANCER I, V96, P56, DOI 10.1093/jnci/djh005; Calabrese CR, 2003, CLIN CANCER RES, V9, P2711; CLEAVER JE, 1987, EXP CELL RES, V172, P258, DOI 10.1016/0014-4827(87)90385-5; Curtin NJ, 2013, MOL ASPECTS MED, V34, P1217, DOI 10.1016/j.mam.2013.01.006; DALZIEL HH, 1994, PHARMACOL REV, V46, P449; deMurcia JM, 1997, P NATL ACAD SCI USA, V94, P7303, DOI 10.1073/pnas.94.14.7303; Deng MX, 2011, CYTOSKELETON, V68, P139, DOI 10.1002/cm.20471; English FA, 2012, REPROD SCI, V19, P806, DOI 10.1177/1933719111433885; GONG MC, 1992, J BIOL CHEM, V267, P14662; HORSMAN MR, 1989, RADIAT RES, V118, P139, DOI 10.2307/3577429; Kunapuli SP, 1998, BIOCHEM J, V336, P513, DOI 10.1042/bj3360513; Lincoln TM, 2001, J APPL PHYSIOL, V91, P1421, DOI 10.1152/jappl.2001.91.3.1421; Murai J, 2014, MOL CANC THER; Murai J, 2012, CANCER RES, V72, P5588, DOI 10.1158/0008-5472.CAN-12-2753; Murray J, 2014, BRIT J CANCER, V110, P1977, DOI 10.1038/bjc.2014.91; Mutafova-Yambolieva VN, 2007, P NATL ACAD SCI USA, V104, P16359, DOI 10.1073/pnas.0705510104; Pacher P, 2004, J PHARMACOL EXP THER, V311, P485, DOI 10.1124/jpet.104.069658; Pal SK, 2009, MATURITAS, V63, P269, DOI 10.1016/j.maturitas.2009.06.010; Patel AG, 2012, CLIN CANCER RES, V18, P1655, DOI 10.1158/1078-0432.CCR-11-2890; Patel AG, 2012, J BIOL CHEM, V287, P4198, DOI 10.1074/jbc.M111.296475; PLUMMER R, 2006, J CLIN ONCOL, V24, P8013; Plummer R, 2008, CLIN CANCER RES, V14, P7917, DOI 10.1158/1078-0432.CCR-08-1223; Quenet D, 2009, INT J BIOCHEM CELL B, V41, P60, DOI 10.1016/j.biocel.2008.07.023; Ruddock MW, 2004, ONCOL RES, V14, P483, DOI 10.3727/0965040042380478; Ruddock MW, 2000, RADIOTHER ONCOL, V54, P179, DOI 10.1016/S0167-8140(99)00163-2; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Senra JM, 2011, MOL CANCER THER, V10, P1949, DOI 10.1158/1535-7163.MCT-11-0278; Shapiro G, 2013, MOL CANCER THER, V12, DOI 10.1158/1535-7163.TARG-13-A218; Skalitzky DJ, 2003, J MED CHEM, V46, P210, DOI 10.1021/jm0255769; Soriano FG, 2001, CIRC RES, V89, P684, DOI 10.1161/hh2001.097797; Thomas HD, 2007, MOL CANCER THER, V6, P945, DOI 10.1158/1535-7163.MCT-06-0552; Veuger SJ, 2003, CANCER RES, V63, P6008; Wahlberg E, 2012, NAT BIOTECHNOL, V30, P283, DOI 10.1038/nbt.2121; Wallace A, 2006, NEUROPHARMACOLOGY, V50, P191, DOI 10.1016/j.neuropharm.2005.08.019; Williams KJ, 2007, MOL CANCER THER, V6, P599, DOI 10.1158/1535-7163.MCT-06-0508	38	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0118187	10.1371/journal.pone.0118187	http://dx.doi.org/10.1371/journal.pone.0118187			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689628	Green Submitted, Green Published, gold			2022-12-26	WOS:000350322700104
J	Polglase, GR; Dawson, JA; Kluckow, M; Gill, AW; Davis, PG; te Pas, AB; Crossley, KJ; McDougall, A; Wallace, EM; Hooper, SB				Polglase, Graeme R.; Dawson, Jennifer A.; Kluckow, Martin; Gill, Andrew W.; Davis, Peter G.; te Pas, Arjan B.; Crossley, Kelly J.; McDougall, Annie; Wallace, Euan M.; Hooper, Stuart B.			Ventilation Onset Prior to Umbilical Cord Clamping (Physiological-Based Cord Clamping) Improves Systemic and Cerebral Oxygenation in Preterm Lambs	PLOS ONE			English	Article							BLOOD-FLOW; PLACENTAL TRANSFUSION; RESUSCITATION; INFANTS; BIRTH; TRANSITION; LUNG; PRESSURE; DELIVERY; SATURATION	Background As measurement of arterial oxygen saturation (SpO(2)) is common in the delivery room, target SpO(2) ranges allow clinicians to titrate oxygen therapy for preterm infants in order to achieve saturation levels similar to those seen in normal term infants in the first minutes of life. However, the influence of the onset of ventilation and the timing of cord clamping on systemic and cerebral oxygenation is not known. Aim We investigated whether the initiation of ventilation, prior to, or after umbilical cord clamping, altered systemic and cerebral oxygenation in preterm lambs. Methods Systemic and cerebral blood-flows, pressures and peripheral SpO(2) and regional cerebral tissue oxygenation (SctO(2)) were measured continuously in apnoeic preterm lambs (126 +/- 1 day gestation). Positive pressure ventilation was initiated either 1) prior to umbilical cord clamping, or 2) after umbilical cord clamping. Lambs were monitored intensively prior to intervention, and for 10 minutes following umbilical cord clamping. Results Clamping the umbilical cord prior to ventilation resulted in a rapid decrease in SpO(2) and SctO(2), and an increase in arterial pressure, cerebral blood flow and cerebral oxygen extraction. Ventilation restored oxygenation and haemodynamics by 5-6 minutes. No such disturbances in peripheral or cerebral oxygenation and haemodynamics were observed when ventilation was initiated prior to cord clamping. Conclusion The establishment of ventilation prior to umbilical cord clamping facilitated a smooth transition to systemic and cerebral oxygenation following birth. SpO(2) nomograms may need to be re-evaluated to reflect physiological management of preterm infants in the delivery room.	[Polglase, Graeme R.; Crossley, Kelly J.; McDougall, Annie; Wallace, Euan M.; Hooper, Stuart B.] Prince Henrys Inst, Monash Inst Med Res, Ritchie Ctr, Clayton, Vic, Australia; [Polglase, Graeme R.; Crossley, Kelly J.; McDougall, Annie; Wallace, Euan M.; Hooper, Stuart B.] Monash Univ, Dept Obstet & Gynaecol, Clayton, Vic 3168, Australia; [Dawson, Jennifer A.; Davis, Peter G.] Royal Womens Hosp, Newborn Res Ctr, Melbourne, Vic, Australia; [Kluckow, Martin] Royal N Shore Hosp, Dept Neonatol, Sydney, NSW, Australia; [Kluckow, Martin] Univ Sydney, Sydney, NSW 2006, Australia; [Gill, Andrew W.] Univ Western Australia, Ctr Neonatal Res & Educ, Nedlands, WA 6009, Australia; [te Pas, Arjan B.] Leiden Univ, Med Ctr, Dept Pediat, Div Neonatol, Leiden, Netherlands	Monash University; Prince Henry's Institute of Medical Research; Monash University; Royal North Shore Hospital; University of Sydney; University of Sydney; University of Western Australia; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Polglase, GR (corresponding author), Prince Henrys Inst, Monash Inst Med Res, Ritchie Ctr, Clayton, Vic, Australia.	graeme.polglase@monash.edu	pas, arjan te/AAA-9019-2020; Crossley, Kelly J/I-7407-2013; Wallace, Euan M/K-6774-2015	pas, arjan te/0000-0001-7831-8797; Crossley, Kelly J/0000-0002-1580-1156; Wallace, Euan M/0000-0002-4506-5233; Polglase, Graeme/0000-0002-8906-614X; McDougall, Annie/0000-0003-1182-6679; Dawson, Jennifer/0000-0003-2357-6283; Hooper, Stuart/0000-0003-1676-4825; Kluckow, Martin/0000-0003-1875-7530	National Institute of Health [R01HD072848-01A1]; National Health and Medical Research Council (NHMRC) [1067615, 1026890, APP1012686, APP1059111, APP1058537]; Rebecca L. Cooper Medical Research Foundation Fellowship; Financial Markets for Children Research Grant; Victorian Government's Operational Infrastructure Support Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD072848] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Rebecca L. Cooper Medical Research Foundation Fellowship; Financial Markets for Children Research Grant; Victorian Government's Operational Infrastructure Support Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by National Institute of Health R01HD072848-01A1, National Health and Medical Research Council (NHMRC) Project Grant (1067615), NHMRC Research Fellowships (GRP: 1026890, JAD: APP1012686, PGD: APP1059111 and SBH: APP1058537), a Rebecca L. Cooper Medical Research Foundation Fellowship, Financial Markets for Children Research Grant (GRP) and the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, PERINATAL STAT SERIE; Balegar KK, 2014, J PEDIATR-US, V164, P475, DOI 10.1016/j.jpeds.2013.10.041; Barton SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112402; Bhatt S, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00113; Bhatt S, 2013, J PHYSIOL-LONDON, V591, P2113, DOI 10.1113/jphysiol.2012.250084; Dawson JA, 2010, PEDIATRICS, V125, pE1340, DOI 10.1542/peds.2009-1510; DELTORO J, 1991, PEDIATR NEUROL, V7, P3, DOI 10.1016/0887-8994(91)90098-6; Escrig R, 2008, PEDIATRICS, V121, P875, DOI 10.1542/peds.2007-1984; Gandhi B, 2013, J PEDIATR-US, V163, P412, DOI 10.1016/j.jpeds.2013.01.010; Gilmore MM, 2011, J PERINATOL, V31, P722, DOI 10.1038/jp.2011.17; Greisen G, 2005, EARLY HUM DEV, V81, P423, DOI 10.1016/j.earlhumdev.2005.03.005; Hagino K, 2005, J THORAC CARDIOV SUR, V130, P384, DOI 10.1016/j.jtcvs.2005.02.058; Hooper SB, 2005, CURR RESPIR MED REV, V1, P185, DOI 10.2174/1573398054023037; Hooper SB, 2013, SEMIN FETAL NEONAT M, V18, P336, DOI 10.1016/j.siny.2013.08.011; Hooper SB, 2009, CLIN EXP PHARMACOL P, V36, P117, DOI 10.1111/j.1440-1681.2008.05109.x; Hutton EK, 2007, JAMA-J AM MED ASSOC, V297, P1241, DOI 10.1001/jama.297.11.1241; Kamlin COF, 2008, J PEDIATR, V152, P756, DOI 10.1016/j.jpeds.2008.01.002; Khwaja O, 2008, ARCH DIS CHILD-FETAL, V93, pF153, DOI 10.1136/adc.2006.108837; March MI, 2013, J PERINATOL, V33, P763, DOI 10.1038/jp.2013.70; Meyer MP, 2012, ARCH DIS CHILD-FETAL, V97, pF484, DOI 10.1136/adc.2010.199703; MILNER AD, 1978, ARCH DIS CHILD, V53, P545, DOI 10.1136/adc.53.7.545; Niermeyer S, 2013, SEMIN FETAL NEONAT M, V18, P385, DOI 10.1016/j.siny.2013.08.008; NUNN JF, 1987, APPL RESP PHYSL; O'Donnell CPF, 2010, J PEDIATR-US, V156, P846, DOI 10.1016/j.jpeds.2010.01.007; PELTONEN T, 1981, EUR J PEDIATR, V137, P141; Pichler G, 2013, J PEDIATR-US, V163, P1558, DOI 10.1016/j.jpeds.2013.07.007; Polglase GR, 2014, PEDIATR RES, V10, P40; Polglase GR, 2012, REPROD FERT DEVELOP, V24, P510, DOI 10.1071/RD11121; Polglase GR, 2006, CURR PEDIATR REV, V2, P287, DOI 10.2174/157339606778699653; Rabe H, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003248.pub4, 10.1002/14651858.CD003248.pub3]; Rabe H, 2011, OBSTET GYNECOL, V117, P205, DOI 10.1097/AOG.0b013e3181fe46ff; Rook D, 2014, J PEDIATR-US, V164, P1322, DOI 10.1016/j.jpeds.2014.02.019; RUDOLPH AM, 1977, AM REV RESPIR DIS, V115, P11; Schilleman K, 2012, RESUSCITATION, V83, P1135, DOI 10.1016/j.resuscitation.2012.01.036; Smit M, 2014, ARCH DIS CHILD-FETAL, V31, P2013; Sobotka KS, 2011, PEDIATR RES, V70, P56, DOI 10.1203/PDR.0b013e31821d06a1; Sommers R, 2012, PEDIATRICS, V129, pE667, DOI 10.1542/peds.2011-2550; Soul JS, 2007, PEDIATR RES, V61, P467, DOI 10.1203/pdr.0b013e31803237f6; Tiisala R, 1966, Ann Paediatr Fenn, V12, P151; VANBEL F, 1994, PEDIATR RES, V35, P329; Vento M, 2009, PEDIATRICS, V124, pE439, DOI 10.1542/peds.2009-0434; Wang CL, 2008, PEDIATRICS, V121, P1083, DOI 10.1542/peds.2007-1460; Wyllie J, 2010, RESUSCITATION, V81, pE260, DOI 10.1016/j.resuscitation.2010.08.029; YAO AC, 1974, AM J DIS CHILD, V127, P128, DOI 10.1001/archpedi.1974.02110200130021	44	78	79	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2015	10	2							e0117504	10.1371/journal.pone.0117504	http://dx.doi.org/10.1371/journal.pone.0117504			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4KQ	25689406	Green Published, gold			2022-12-26	WOS:000350322700050
J	Schwedt, TJ; Berisha, V; Chong, CD				Schwedt, Todd J.; Berisha, Visar; Chong, Catherine D.			Temporal Lobe Cortical Thickness Correlations Differentiate the Migraine Brain from the Healthy Brain	PLOS ONE			English	Article							STATE FUNCTIONAL CONNECTIVITY; SURFACE-BASED ANALYSIS; HUMAN CEREBRAL-CORTEX; RESTING-STATE; MRI; ABNORMALITIES; SEGMENTATION; RELIABILITY; PAIN; ALLODYNIA	Background Interregional cortical thickness correlations reflect underlying brain structural connectivity and functional connectivity. A few prior studies have shown that migraine is associated with atypical cortical brain structure and atypical functional connectivity amongst cortical regions that participate in sensory processing. However, the specific brain regions that most accurately differentiate the migraine brain from the healthy brain have yet to be determined. The aim of this study was to identify the brain regions that comprised interregional cortical thickness correlations that most differed between migraineurs and healthy controls. Methods This was a cross-sectional brain magnetic resonance imaging (MRI) investigation of 64 adults with migraine and 39 healthy control subjects recruited from tertiary-care medical centers and their surrounding communities. All subjects underwent structural brain MRI imaging on a 3T scanner. Cortical thickness was determined for 70 brain regions that cover the cerebral cortex and cortical thickness correlations amongst these regions were calculated. Cortical thickness correlations that best differentiated groups of six migraineurs from controls and vice versa were identified. Results A model containing 15 interregional cortical thickness correlations differentiated groups of migraineurs from healthy controls with high accuracy. The right temporal pole was involved in 13 of the 15 interregional correlations while the right middle temporal cortex was involved in the other two. Conclusions A model consisting of 15 interregional cortical thickness correlations accurately differentiates the brains of small groups of migraineurs from those of healthy controls. Correlations with the right temporal pole were highly represented in this classifier, suggesting that this region plays an important role in migraine pathophysiology.	[Schwedt, Todd J.; Chong, Catherine D.] Mayo Clin, Dept Neurol, Phoenix, AZ 85054 USA; [Berisha, Visar] Arizona State Univ, Dept Elect Engn, Tempe, AZ 85287 USA; [Berisha, Visar] Arizona State Univ, Dept Speech & Hearing Sci, Tempe, AZ 85287 USA	Mayo Clinic; Mayo Clinic Phoenix; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Schwedt, TJ (corresponding author), Mayo Clin, Dept Neurol, Phoenix, AZ 85054 USA.	Schwedt.todd@mayo.edu		Berisha, Visar/0000-0001-8804-8874	National Institutes of Health [K23NS070891]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS070891] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by National Institutes of Health K23NS070891 to TJS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews TJ, 1997, J NEUROSCI, V17, P2859; Berisha V, 2000, P IEEE ICASSP; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Bigal ME, 2008, NEUROLOGY, V70, P1525, DOI 10.1212/01.wnl.0000310645.31020.b1; Chong CD, 2014, CEPHALALGIA, V34, P1115, DOI 10.1177/0333102414531157; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DaSilva AFM, 2007, NEUROLOGY, V69, P1990, DOI 10.1212/01.wnl.0000291618.32247.2d; Datta R, 2013, CEPHALALGIA, V33, P365, DOI 10.1177/0333102412474503; Demarquay G, 2008, CEPHALALGIA, V28, P1069, DOI 10.1111/j.1468-2982.2008.01672.x; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dickerson BC, 2008, NEUROIMAGE, V39, P10, DOI 10.1016/j.neuroimage.2007.08.042; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Friedman J. H., 2008, TECHNICAL REPORT; Hadjikhani N, 2013, CEPHALALGIA, V33, P1264, DOI 10.1177/0333102413490344; Han X, 2006, NEUROIMAGE, V32, P180, DOI 10.1016/j.neuroimage.2006.02.051; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Henze N, 1999, ANN STAT, V27, P290; Hogstrom LJ, 2013, CEREB CORTEX, V23, P2521, DOI 10.1093/cercor/bhs231; Jovicich J, 2006, NEUROIMAGE, V30, P436, DOI 10.1016/j.neuroimage.2005.09.046; Kelman L, 2004, HEADACHE, V44, P1019, DOI 10.1111/j.1526-4610.2004.04197.x; Lerch JP, 2006, NEUROIMAGE, V31, P993, DOI 10.1016/j.neuroimage.2006.01.042; Liu JX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051250; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Maleki N, 2012, CEPHALALGIA, V32, P607, DOI 10.1177/0333102412445622; Mechelli A, 2004, NATURE, V431, P757, DOI 10.1038/431757a; Mechelli A, 2005, J NEUROSCI, V25, P8303, DOI 10.1523/JNEUROSCI.0357-05.2005; Messina R, 2013, RADIOLOGY, V268, P170, DOI 10.1148/radiol.13122004; Mitelman SA, 2005, NEUROIMAGE, V27, P753, DOI 10.1016/j.neuroimage.2005.05.024; Moulton EA, 2011, CEREB CORTEX, V21, P435, DOI 10.1093/cercor/bhq109; Moulton EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003799; Narr KL, 2005, CEREB CORTEX, V15, P708, DOI 10.1093/cercor/bhh172; Rodriguez-Raecke R, 2009, J NEUROSCI, V29, P13746, DOI 10.1523/JNEUROSCI.3687-09.2009; Russell MB, 1996, CEPHALALGIA, V16, P239, DOI 10.1046/j.1468-2982.1996.1604239.x; Schmidt-Wilcke T, 2008, CEPHALALGIA, V28, P1, DOI 10.1111/j.1468-2982.2007.01428.x; Schmitz N, 2008, HEADACHE, V48, P1044, DOI 10.1111/j.1526-4610.2008.01133.x; Schwedt TJ, 2014, CEPHALALGIA INT J HE; Schwedt TJ, 2014, PAIN MED, V15, P154, DOI 10.1111/pme.12267; Schwedt TJ, 2013, CURR OPIN NEUROL, V26, P248, DOI 10.1097/WCO.0b013e328360edb1; Schwedt TJ, 2013, HEADACHE, V53, P737, DOI 10.1111/head.12081; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Stankewitz A, 2011, NEUROLOGY, V77, P476, DOI 10.1212/WNL.0b013e318227e4a8; STEINMETZ H, 1994, NEW ENGL J MED, V331, P952, DOI 10.1056/NEJM199410063311419; SUDDATH RL, 1990, NEW ENGL J MED, V322, P789, DOI 10.1056/NEJM199003223221201; Thompson PM, 2001, NAT NEUROSCI, V4, P1253, DOI 10.1038/nn758; Wang DF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083767; Wober-Bingol C, 2004, CEPHALALGIA, V24, P12, DOI 10.1111/j.1468-2982.2004.00621.x; Woodruff PWR, 1997, PSYCHOL MED, V27, P1257, DOI 10.1017/S0033291797005229; Wright IC, 1999, CEREB CORTEX, V9, P366, DOI 10.1093/cercor/9.4.366; Xue T, 2013, NMR BIOMED, V26, P1051, DOI 10.1002/nbm.2917; Yao ZJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001006; Zhao L, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-85	61	31	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0116687	10.1371/journal.pone.0116687	http://dx.doi.org/10.1371/journal.pone.0116687			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	25679805	gold, Green Submitted, Green Published			2022-12-26	WOS:000350682600031
